#
#  Prot_reps_drug_resistance.pm
#
package Prot_reps;
use strict;
use gjoseqlib;

our @prot_reps       = gjoseqlib::read_fasta( \*DATA );
our $assignment      = 'Protein matching drug resistance reference sequences';
our $feature_type    = 'protein';
our $max_expect      = 1e-10;
our $max_extrapolate = 10;
our $max_rep_sim     = 0.87;    # identity below which a new rep is needed
our $min_coverage    = 0.70;
our $min_identity    = 0.30;
our $tag             = 'drug_resistance';

1;

__DATA__
>fig|100226.1.peg.751 Ribosome protection-type tetracycline resistance related proteins
MRTLNIGILAHVDAGKTSLTERLLFDHGAVDRLGSVDAGDTRTDDGGIERRRGITIRSAV
AAFTVGDTRVNLIDTPGHSDFVAEVERALEVLDGAVLLLSAVEGVQARTRVLMRALRRLR
LPTIVFVNKIDRAGARTDGLLGDVRRLLTPHVAPLNEVADAGTPRARVTRRPPDGRTAQA
LAEVDTEVLAALVDGPEPTGEDVARALAARTADGSFHPLYHGSALGGQGVAELVEGLLGL
IPAATPGTSGGTEPRGTVFAVRPGPAGERTAYLRLYGGEVHPRRRLTFLRRESDGRTTEV
SGRVTRLDVVGGDATLTAGNIAALTVPGGLRVGDRLGGPTDRAPQFAPPTLQTLVRARHP
EQAAPLRSALLALADQDPLLHARPAASGATALLLYGEVQMEVLAATLAEDFGIEAEFTPG
RVRFLERPAGTGEAAEEMPWLDRTRYFATIGLRVEPGPRGSGGAFGYETELGALPRAFHQ
AVEETVHDTLRTGLTGAAVTDYRVTLIRSGFSSPLSTAADFRGLTPLVLRRALARAGTVL
HEPYQAFEAEVPADTLAAVTALLASLGADFTGTTGGDPAWIVTGELPARRVREAELRLPG
LTRGEAVWSSRPCEDRPLKPGNSGPGTGVGGHSGE
>fig|100226.1.peg.770 Oxetanocin A resistance protein
MREHTADRTRTRARAELRGDCASCFGLCCAALPFARSADFAIDKDAGTPCPNLRTDHRCG
IHATLRERGFTGCTVYDCFGAGQRVSQLTFGGRDWRAGPPEQRRRMFDVFPVVRQLHELL
WYLTEALTLPAARPVHADLRGALADTERLAGGTPEELAGLDVAAHRQRVNVLLLRTSELV
RAGTRGRKKNRRNADLMGARLKGADLAGADLRGAYLIAADLTGADLRGADLIGADLRDAD
LTDADLTGAFFLTQPQVNAARGGPGTGLPDSVTRPVHWTAGR
>fig|100226.1.peg.1326 Permease of the drug/metabolite transporter (DMT) superfamily
MSSVPSPSAPSPARRVLDWRLRFGLLSLVWGFSFLFMKVGTESFAPFQVTLGRLAFGTAV
VAAAMAVKRERLPRGAWTWLHLTVAGFLLNALPFSLFAFSELTIPSSLAGICNATSPLWG
MALSLVALSEDRPTRRRVAGLGIGFLGVLTVLGVWQGFHGLDVTGTALALLASFSYPVGW
IYVRRTLAGSSHSHLSLTGAQLGLATLQLAVVTPLFTSVPTSFPVLPLLAVAALGVLGTG
LAFLIQYDLVAEVGPTTAQMVTYFTPVIATAAGVALLGESLSWSTPVGAAVVLAGAALTQ
SRPRADRAAPAPAPAPAPETPGTTGVRQGSRV
>fig|100226.1.peg.1534 Multidrug resistance efflux pump
MNRTLQPAHPTEAVKRPGRWLALSVLVLAVLLVAVDATVLGLATPYISEDLAPSGTQLLW
IGDVYSFVIAGLLVSMGSLGDRIGRKRILLIGATAFGAISVLNAYAHTPEVMIFARALLG
VAGATLMPATLALIRNLFHDPRERSLAVGIWGAAASAGAAVGPVVGGFLLEHFWWGSVFL
INLPVMVVLVVVGVKMLPESRNPNPGPWDLLSVVLSLVGMVGVVYAVKETAAHGFAWATL
AAGLLGAAALYGFVRRQLTMPVPLLDMRLFRNRGFSGAVLADLLTILGLSGLVFFLSQYL
QLVQGRRPFEAGLAELPAAVGAVVAGLIAGRAARRFSVRAVVAGGLAAVGLALAALTVIG
QHTGYPLLGAALLVVGLGAGFAFTVTADVILSSVPGEQAGAASAVSETAYELGAALGIAV
LGSIVTGVYRDFTGPAGTPDAAHESLGGAVEAAAHLPGPAGEALLDSARQAFVDGLTLAA
GVGAAVLLAAAAASWYLLRGQRLEDGVEHP
>fig|100226.1.peg.1555 Permease of the drug/metabolite transporter (DMT) superfamily
MRAQSSATASPRIAVDATGADAGGASFGTVQAALGVVAFSLTFPATAWGLEGFGPWSLIA
VRSVLAAAVAGSCLVVVGVPPRERSRAWGRVAPPERRHWLGLAVVGAGVVLGFPLLTTLA
LQTSTTAHAAVVVGLLPLTTALLSALRVGTRPSRTFWIAALAGAAAVIAFTVQQSGGALT
SADAYLFAALLVCAAGYTEGGRLARVMPGWQVIGWALVLCLPLTVPMAAIALSLEPVRLT
AHAVTGLLWVAIGSQFLGLVVWYRGMAAIGIPKASQLQLAQPLLTLVWSVLLLGEHLPVA
APLTAAAVLVCIAVTQRARG
>fig|100226.1.peg.1671 Permease of the drug/metabolite transporter (DMT) superfamily
MMTTARTSPPAPWHRRPDLLAAGAATVTVVLWASAFVSIRSAGEAYSPGALALGRLLSGV
LTLGAIWLLRREGLPPRAAWRGIAISGLLWFGFYMVVLNWGEQQVDAGTAALVVNVGPIL
IALLGARLLGDALPPRLLTGMAVSFAGAVTVGLSMSGEGGSSLFGVVLCLLAAVAYAGGV
VAQKPALAHASALQVTTFGCLVGAVLCLPFAGQLVHEAAGAPVSATLNMVYLGVFPTALA
FTTWAYALARTTAGRMGATTYAVPALVVLMSWLALGEVPGLLTLAGGALCLAGVAVSRSR
RRPAAVPDRAAPTAEPRREDAGRA
>fig|100226.1.peg.2258 Permease of the drug/metabolite transporter (DMT) superfamily
MTARGWFLFSLMGVVWGVPYLMIKVAVDEVSPSGVVFARCALGAALLLPFALRKGDLLGT
VRRRWKPMLAFAVIEIIGPWWTLTDAERHLSSSTAGLLIAGVPIVAVLLARFFGAEERVG
ARRITGLGLGLAGVAVLTVPHLTGGDARSLAEVLVTVVGYATAPLIAARHLKDVPTLQLI
TPCLTLAAVVYAPAAFLTRPATLPSGEALAALAGLGLVCTAIAFVAFLELIKEVGPTRAG
VITYVNPAVAVAAGALLLDEELTLGIGVAFTLILAGSVLATAAAGPGREARRVPWSTRQT
SRAGGRVESLTGLPEERPGSTGQGDG
>fig|100226.1.peg.2309 Multidrug resistance protein B
MAGDVREATESEPDPARPAAPGEREQVSSGVLVSIGALLLGMLLAALDQTIVSTALPTIV
SDLGGLEHLSWVVTAYLLAATAATPLWGKLGDQYGRKKLFQLAIGIFLVGSALCGIAQGM
GQLIAFRALQGLGGGGLMVLSMAIVGDLVPPRERGRYQGLFGAVFGATSVLGPLLGGVFT
EHLSWRWVFYINLPIGVVALAVIAAVLHIPRRTTRHVIDYLGTLLIASVATSLVLVASLG
GTTWAWSSPQIIGLAVLAVVLAVLFVAVERRAAEPVLPLKLFRVRTFALSAVISFVIGFA
MFGAMTYLPTFLQVVRGVTPTMSGVYMLPMVFGLLLSSTVSGQIVSRTGRWKVFPVAGTA
VTTLGLLLLHQLDENSATAEMGAYFFVFGLGLGLVMQVLVLIVQNAVAYEDLGVATSGAT
FFRSIGASFGVAIFGTIFASRLGDQLTDAFRGAALPPGVSVDTLKADPRGIGALPPALRP
EAIHAYASSITDVFLYAAPVALLAFLLAWLLKEDRLRGSVTAPDATQTLASNPVERSSHD
EVCRALSVLGTREGRREIYRRITARAGYDLLPASSWMLLRVRKYGRVEPAQLAERSPVPL
ATVMAAARQVEERHLAVREGPDLVLTRQGREVAERLALAREESLAELLGDWWGPDRPTDL
VRLVRELTGELCGSERERPHEGRTPARAG
>fig|100226.1.peg.2611 Permease of the drug/metabolite transporter (DMT) superfamily
MAATRPAVIALTALAPVSWGSTYAVTTEFLPPDRPLFTGLMRALPAGLLLLALARVLPRG
AWWGKAAVLGVLNIGAFFPLLFLAAYRMPGGMAAVVGSVGPLLVVGLSALLLGQRPTTRS
VLTGVAAASGVSLVVLEAAGALDPLGVLAALAATASMSTGTVLAGRWGRPEGVGPLALTG
WQLTAGGLLLAPLALLVEGAPPALDGPAVGGYLYLALANTALAYWLWFRGIGRLSATQVT
FLGPLSPLTAAVIGWAALGEALGPVQLAGTALAFGATLVGQTVPSAPRTPPVAAGAGPFS
SASRNGRKDSMDLTGAALRR
>fig|100226.1.peg.2860 Quaternary ammonium compound-resistance protein SugE
MAWVLLFVAGLLEVGWSIGMKYTDGFTRLWPSVFTGAGIVASMMLLSYAARTLPIGTAYG
VWVGIGAAGAAVLGMVVLGEPATAARIFFICLLLVAVVGLKATSGH
>fig|100226.1.peg.5165 Quaternary ammonium compound-resistance protein SugE
MAWLLVIVAGVLETGFAVCLKLSHGFTRLWPTIAFCAFALGSFGLLTMSLKKLDVGPAYA
VWTGIGAAGTAIYGMIFLGDLVSTLKIVSISFVIIGVIGLQLSGSAH
>fig|100226.1.peg.7457 Chloramphenicol resistance protein
MPLAVYILGLSVFALGTSEFMLSGLLPPIADDMDVSIPRAGLLISAFAIGMVVGAPLLAV
ATLRLPRKTTLVALISVFGVGQVAGALATSYEVLFVSRVVSALACAGFWAVGAAAAIAMV
PVTARARAMAVMIGGLSIANVLGVPAGAFLGEHLGWRSAFWAVGGASAVALVGVVTLIPR
IPLPERRPRLRGELAIYRDRQVWLSIVVTALAAGGVFCAFSYLAPLLTDVAGLADGWVPT
VLALFGVGALIGTTIGGRVADAHLFGVLLSGITASTVLLAALALFASSPAVVIVLSLLLG
VSAFYTAPALNARMFNVAGAAPTLAGATTTAAFNLGNTGGPWLGGTVIDADLGYEATAWA
GGAMTLVAIAFVAVSLRLHTRSRVVTGGGPASETASLERAQRV
>fig|100226.1.peg.7593 Chloramphenicol resistance protein
MPLPLYLLAVAVCAMGTSEFMLAGLVPDIASDLGVTVGTAGTLTSAFATGMIVGAPLVAA
LARTWPRRSSLLGFILAFAAAHAVGAGTTSFPVLVACRVVAALANAGFLAVALTTAAALV
PADKKGRALAVLLSGTTVATVAGVPGGSLLGTWLGWRATFWAVAVCCLPAAFGVLKAIPA
GRATAAATGGPPLRVELAALKTPRLLLAMLLGALVNAATFASFTFLAPVVTDTAGLGDLW
ISVALVLFGAGSFAGVTVAGRLSDRRPAQVLAVAGPLLLVGWPALAMLADRPVALLTLVF
VQGALSFALGSTLITRVLYEAAGAPTMAGSYATAALNVGAAAGPLVAATTLGHTTGNLGP
LWASGLLVAVALLVAFPFRTVITTAAPADATR
>fig|100226.1.peg.8006 Methylenomycin A resistance protein, Mmr
MTTVRTGGAQTAEVPAGGRRDVPSGVKITALATGFVMATLDVTVVNVAGATIQESLDTTL
TQLTWIVDGYVLTFASLLMLAGGLANRIGAKTVYLWGMGVFFLASLACALAPTAETLIAA
RLVQGAGAALFMPSSLSLLVFSFPEKRQRTRMLGLWSAIVATSSGLGPTVGGLMVSAFGW
ESIFLLNLPIGAIGMAMTYRYIAATESRATRLAVPGHLLWIVALAAVSFALIEGPQLGWT
AGPVLTAYAVAVTAAALLALREHRVTNPVMPWQLFRGPGFTGANLVGFLFNFALFGSTFM
LGLYFQHARGATPFQAGLELLPMTIFFPVANIVYARISARFSNGTLLTAFLLLAGAASLS
MVTITASTPYWVVAVAVGVANIGAGIISPGMTAALVDAAGPENANVAGSVLNANRQIGSL
VGIAAMGVVLHSTSDWDHGAAISFLAVGLAYLLGGLSAWRLIARPERRSAVTAAT
>fig|1002809.3.peg.669 Permease of the drug/metabolite transporter (DMT) superfamily
MKFPPQLLLILATLLWGGNFVIGRAVSGDIPPITLAFLRWIVAFLVFFPIAYNRTKKEWP
ALKQHWGAVIILAITGVAAFNTLVYIGLHDTTSINASLMNSSTPIIIYILSFIFLKERLT
KFQMIGTLLSLAGVLFIISGGSLQSLLSFSFNKGDLIVLIAVVCWSFYSLLIKKYAGKLP
GYSTFLVTIAIGAIMLLPFAVYELLTTSQAIVWNASTIGAIFYVGIIASIVAFLSWNNGV
VSLGANKAGIYLNFIPLFATIFAVLFLNEQLLIAQVIGGIAVITGVFISSIK
>fig|1002809.3.peg.790 Drug resistance transporter, EmrB/QacA family
MEAPIFNVKSPKGMAAVLMISTFVGLFGETALNMALTNIMDDFGVSAASAAWLTTGYLLV
LAVLVPLSSYLVRWFTTRQLVVAAVVFAVIGSLLGALAPNFAVLLAGRFVQALATGIILP
LMFSVVMLIFPVQKRGAVMGIVGIILTAGPALGPSIAGLIVSSLSWRYIFWIMVVVYAVV
IVLAFSKVDNVSNVTRPKIDLLSLIASTFGFGGVVFALATLAEQSITKPIVWVPLVVGFV
LLVVFGIRQTKMDEPMIDLSVFKSPMFSLGVALMVATMFMILSVAILVPMFLKTVLGFAA
LTAGLCMLPGNILNIIMSPIVGTNFDKVGAKIFTRIGFTLILVSMIVFLTTISATTATWI
IIVNLCVFFVGVSMTIMPAQTNAMNSLAPHKFADGSAALNTLTQIAGASGTAIAITMFTI
GQQNYIEKFSNALPAEFLAHGVHSAFIVVTVVAVLGLVGSFFVKNSKPVGN
>fig|1002809.3.peg.843 Permease of the drug/metabolite transporter (DMT) superfamily
MFKKSTVALIALILIWGASWPINKLAVPYSPPLLYAGQRALLGGILLTVIIWKTRKAINW
RENWQKYCIGAFFNTILFFGLQTAGLLYLPSGLFSVLVYFQPILLGLFAWLLLGEDLSPV
KILGLFLGFVGVAVVSVDGLMVHISAIGVTLGLLTAVSWAFGVIYVKKISKEVDAYWMVA
LQCIIGGVFLLGTGSVFESWSAIEWNRNYLSGLGFGATIGIPLAYILYYNLVNAGEASKV
GSYTFLIPIVAVLLGVLFLGETVTYSLVIGMLLVAISIYFVNFQYKTKNKSISKD
>fig|1002809.3.peg.961 Multidrug resistance protein
MKAQRAVIIALYVVAMFMVSIDGTIVNVLLPTIAVEFGVTPGATNGINIGYLVSIAVALP
AAGYLSNRYGVKRMYVLSVSLFTLASLLCGWAGSLQALILARVLQGLAGGIITPVSMTLL
FRTFSPPERQNLSRSLVLPIAFAPAIGPLVGGLFSEYLSWNWAFFINIPFGIIIVLIGLF
ALTEFEIFKAPFDTKGYMLIALGLPLLMLTLSLIASDGVSITVVFCAIVGVFLLRRFYVY
ERKIKEPLLDVRLYEQPLFLSSSLVAMCSMGALMGMLYLFPLMYQYAYSASALESSLITF
TEALGLMVASKLLPRTSKRFGMLHTVRLGLIGTVMIFCCIAIIGPSANPWLLRGLMFAVG
ICLGHSVIGSQLSAFHHVAKSQMSKATTLYNMLNRVGAAVGIALVATTLTVSGRYFSEIL
SYQYALVATVVLLLAGLGCSLFAKEQETILKGEKA
>fig|1002809.3.peg.1102 Permease of the drug/metabolite transporter (DMT) superfamily
MEKPPIHPYIPIIIGVISVSLSAIFVKLSSADAGVIAFYRMLFSIMIMLPWFLIKYKNEI
KVLSKRDWIFSSIAGVFLSFHFILWFESLNYTSVASSTVLVTMQPLFAFIGTYLFFKEKI
TLQTFIAGGIAILGSVLISWGDFKISGTALYGDILALIACALITGYLLFGQDVRKRLSLV
TYTMVVYSVSTVTLFFYIIVKGESFGPYPAIDWMWFILLAIIPNLLGHNLFNWVLKWTST
NVISIAILFEPVGAALLAMFIFNEYLTVSQIVGGLVVILGIMLFVIDLKKFFRKKA
>fig|1002809.3.peg.1127 Multidrug resistance protein B
MPKQVWLLIIGTFVNTVGNSFLWPLNSIYIHDHLGKSLTTAGIVLMLNSLAGVFGNLVGG
YLFDKLGGYKAILIGVVFNLLSITLLTIWHDWPQYIIFLTMMGFSGGIVYPAIYAIAGSA
WPEGGRRAFNSIFLANNVGVAIGPALAGIVADIKFDYVFSANLFFYAVFFVLVITTYKRF
DMKGLTTKPFSGNETKRRNRGPIVALSILSISLIVCWLSYSQWSATISSYTQGLGMSLSE
YSLLWTINGFMIVAVQPIIRPLVTRWENKIKHQLVLGLILMSLSYIVVYFAQDFKMFAAA
MVILTFGEVFFTPVIPMIANKLAPHGQEGFYQGLVNSASTIGRMIGPVFGGLMVDLYGMQ
ILMLILSVLIIVAIIPCLVFDRTLGKEQT
>fig|1002809.3.peg.1256 Drug resistance transporter, EmrB/QacA family
MEQTKDVKTFQKPPYLMIAVLFVGAFVAFLNNTLLNVALPSIMTAFDIKDYSTVQWLATG
YMLVSGVLVPTSAYLITKFRTRPLFILSMAIFVIGTALASFAPSFSFLLAGRMIQAAGAA
TMAPILMNVMLISFPVEKRGQAMGMFGLVMVLAPAIGPTLSGWIVEHYDWSVLFKMILPI
AVLSLLLAVWKLEDVLPNRDAKIDILSIVLSTIGFGGLLYGFSTASSAGWSAVEVWGTIT
VGAIGLAWFIIRQFRLEQPLLDLRIYTYPSYALASVVSMVLSVAMFSGMILTPAYVQSVR
GIEPFEAGLMMLPGAIVMGIMSPITGKLFDRFGPRILAVVGLTITTLATIGLGYLEVDST
YLFIISVYTIRMLGISMVMMPIMTNGLNALPNRLNPHGTAMNNTAQQVAGAIGTAVLVTV
FNSHTKTRAAEIAADMQANASSAVQPTAEQIAQAQAQVMQQAMLDGITYSFFVAAAVTVV
ALILALFIKRVDITKREDFTGAVQEKK
>fig|1002809.3.peg.1709 Vancomycin B-type resistance protein VanW
MKTNFIYLVLFGLCLLGCEKASYSGTSETDGVKEHQIEASTSSPLSEREAIVGEYPLIYP
AVITLIDPRTMEIVKSFTPQLLGYGTDRELYEANIKKVARELARGSKERTGYDQTMVLHK
IGENGEIIEGNPGIVLKESELVEKILAASPKGDHIFLPLYILESNLEIDIPSLDDVTVAS
FTTYFNGAESGRSENIELSAKAIHNILVGDGDYFSFNTMVGERTVEKGYQPAPEIINKEL
VMGIGGGICQTSSTLFNAVDQLGIRITERHHHSLNIGYVPTGRDATVSYGSLDFKFQNTS
GAPFLIKTYYSKGSLTIALTTSHQYKDLLKK
>fig|1002809.3.peg.1784 Drug resistance transporter, EmrB/QacA family
MSDIYGRRQILIIGILVILVSEMITPLMVSNIYHLMIFRAIQGLGGALAAVVGLIVISDI
FDLANRAKFLGFYGALNAITAIVAPTLGGIFVQYMSWHWVFYSIAPIGVIGLYLVVKYMP
NIPRTENAKLDYKGISILSAAILVFVAITTFGGSRIPWLSVPMFVLVTVFVLSIFGFITS
QKKVAHPIVPLRLFKYRVFVVCMLSVFAVMFAATGLIFLLPMFLQNLFGFTPTETGLFMT
FRGTTSFIFAAMSGFLVVKLKDFKLVAIIAMVIFASMIFTLTFFTTSASTLALTIICLIW
GTSSGVLISIFHTGIQMNLPDKDISVAMSVIQLAVAVSSLLATSFLGLFLRLPNLSQGLS
YLLFACLGAVVLALGIFVITLQKRNLKIEEEEPAAEQLV
>fig|1002809.3.peg.1926 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
METLQQDLMNKPVKKLFFHFFFPAVFGMLLMSVNLLLDGIFVGHGVGEVGLAGVNLAAPI
FTIILAISLWIGIGGATNFSMAMGEEMADEARSSFTLALAIFTAILGVISIVGYLNLQTV
AGWLGANEETLAPTTDYLGVLFALGWVLGLQQLLSIFIRNDGRPMLGMVSLGLTSVVNIL
LNYVFIFVLDMGVYGAALATILGGVVGVLVFVPHFFNKKVVLNKWRFNWSLPLGRRILAI
GFPSLLAESGAFVLVVGYNLSVVAALGTEGVTAFSVINYLHGFMFLAFFGIETAMQPMVS
YYHGSKKKAQLKETLALAEKTALILGVTLFVIGYLLAPQLVQLFGVDDPAIVQLAVEGIR
LFFIGYLFIGLSFVYMTYFQSVGKVWSATLIIVMRSYIVFLIYLFVLPKVFGVNGIWLTM
PIAEMTMAIVIVMFVRKRVKQTLI
>fig|1002809.3.peg.1980 Permease of the drug/metabolite transporter (DMT) superfamily
MKNKRMIGFLLVVSGSFFWGIGGTMAQQLFSLGIEVSWLVSTRLVIAGILLLIAQAIFKD
QGQIFKIWRERRDAFRLLVFAIVGMLGVQYTYMASIKEGNAAVATLLQYLAPVMIIIWVT
VRGLSKFTKKDAVTIVLALSGSFFLLTNGSLSAFAVPLPAILWGLLSGVTLAFYTLYVIP
LLKRFDSLVVVGWAMLLAGLTISFVQPPWDVDVSVLTGATLVYLVIVIIFGTMLAFWFYI
ESLQTLTAKETSLLGNIEPLTAVLATVLWLKEPFGGFQWLGTSLILVMMIYIALKADRQK
DEDLDKVEDAIVEDN
>fig|1002809.3.peg.2185 Tetracycline resistance protein
MVQKTRVESSEEQTATLKSYILYPEKQKALYKRTLFVVSVSQIFGGAGLAAGVTVGALLA
QQMLGTEAYAGLPSALFTLGSAGAALLVGRLSQASGRRIGLATGFMIGGLGAIGVIIAAI
INSVLLLFLSLLVYGSGTATNLQARYAGTDLANNKQRATAISLTMVFTTFGAVAGPNLVN
VMGDIALSIGVPALAGPFILAAAAYILAGIVLFVMLRPDPLLIARSIEASNNEKHAKTHS
AITEQVENRRGIIVGATIMVLTQIVMVAIMTMTPVHMRHHGHSIGEVGIVIGYHIGAMYL
PSLVTGFLVDKLGRTAMAIASGITLLLAGLTAAFAPGDSMVFLVIALSLLGLGWNFGLIS
GTALIVDSTTTSTRAKTQGTLDVFVALSGAAGGALSGVIMAGSSYLTLSFIGGILSLLLI
PVMLWSRSAKN
>fig|1002809.3.peg.2231 Membrane component of multidrug resistance system
MQNELSEQTRKILLIVMIAGCFFSTLNQTLLNVALSDLMNTFSVSPTTIQWLATGFMLVN
GILVPITAFLIKRFSTRQLFISAMLFLLAGSVVAACAMNFGMLLTGRMIQAVGAGIILPL
MMTVIVYLFPEERRGAIMGKVGFAIIFAPAIAPTLAGFIIDYLSWRWLFISLIPFIVIII
VLAYKYLMNVNEGAKLKIDLISLIYSTFGFGLLLFGFSSAGSRGWDDGVILTTIGAGLII
IFLFCQRQLSSQDPLLNLSVFRYKMYSMTTIINVAITIIMYADLILLPMYLQDGRGFSAL
DAGLLLLPGAIINAFLSPVTGKLFDKYGAKPLFIFGLVLVALSMWLVIDLSSTTSYVYIL
VRTIILRIGLAFITMPLNTAALNAIPRELASHGSAVNNTIRQLAGAIGTAVIVTVYTLQL
TGTSVQVNESYATAASSTYFYMFLLAIVAFIVVLFVPKHKRTMPAQETN
>fig|1002809.3.peg.2236 Permease of the drug/metabolite transporter (DMT) superfamily
MQKYKGELLMLITAVMWGSGFVGMAKGLEHWTVFQLMAGRFLLASIILSFIFYKKLKLIS
KAVIWKGAILGAILFIAFTLQTMGLEYTTPSKNAFLTAINVIIVPIIAYVIYKRRIDRFE
FIAAGVAVVGIGFLSLQDSMTINFGDFLSILCAVGFAFDIFYTNVFVKTEDALALTIVQF
YTATVLSVISVVMLGEVPTTYTSEGLGIIVYLAIFCTAVAYVCQNIGMQYANPTKSAIIL
STESLFGTMFSVLILNEILTGRMLVGCVLIFFAILFAEVKPTFRRKKSYI
>fig|1002809.3.peg.2366 Transporter, drug/metabolite exporter family protein
MERLKGIAMIIVGSIFWGATGPMMEWLLQQTAMTAEFMLAVRLMIAGILILGIAAMQKKS
IFSIWKNRNYSVQLLIFSVIGMVGLQFTFVKSIEVSNAIIATLLQFLAPIFIVIYTSVVG
KVLPPRSQLIGIFGTLVGLFLLLTNGSVSGLLVSNEALVWGLLLGFTYAFYTLYPARLMA
EVGVIIIIGWGMIIGGLMFSVAGQLWKTEQWLLLLDPVNVFLIIATGIFGSFAYILFLTS
LKYISPVETSILSSFEPLTAMVISVVWLGATLYSWQYVGILLMLVFVVYLSIAGSKKATL
RMSK
>fig|1002809.3.peg.2467 Ribosome protection-type tetracycline resistance related proteins, group 2
MHTTIGVVAHVDSGKTTFCEQLLYHTNAIKKRGRVDHQDAFLDNHAIERQRGITIFAEQG
RIDYNGQAYTLIDTPGHIDFAPEMERAIHVMDAAIVIISAVDGIEGHTETVWHLLREHHV
PTFIFINKVDREGADVAAVMSAIKKDLSPNALLFNDGFDTTVKEWLAERDEQLMEKYFAD
NLAENDCLESLKHAINHEQAFVCMSGSALKDEGVLAFFETIAQLMETKFDVNGPFEGKVY
KIRHDHQQRLTFMKALSGVLKVRDEFTFGETTEKVTEIRLYNGNSFTTVPQVQAGDIFAV
KGLAMPLIGDVIGATETNPAQFDMIPTLQAKVIYEGALHIKELHRVFREIEAEEPSLRVV
WNEKFQEISVHVMGTIQLEVLTELVKERFGIEVQFGKPQILYKETIAAPAIGYGHFEPLK
HYAEVHLKMELNNRGAGITFSNRCHADDLSVGHQRLIEKHLFERDHHGLLTGFPVTDIHL
TLLTGRAHNKHTDGGDFREASFRALRQGLEQVKNVLLEPYYRFKMKASSDHIGRMMSDIQ
QASGSFEAPNLTEDTVTLYGRAPVATFMDYSTQFAAYTNGKGALTLQFEGYDVCHNSDEI
IEQIGYNKNADPEYTSSSIFCAKGKGYSVPWNKAKAAMHCEVHEID
>fig|1002809.3.peg.2582 Permease of the drug/metabolite transporter (DMT) superfamily
MEFSMKKGMLLGFIGIVCFSFTLPATSIAVPYFGETIVGLGRTVIAAIIVGTVFIVKKQP
LPSISQFKSLLIVAVGAVLAFPLLTTYAMKSLPVSHGAIELALLPLATAGFAMWRGGERP
SKRYWIASATGAVTVIIYAIYLGLGQLHKGDFALIAAVILLGLSYAEGGKLSKEVGSWQV
IAWAILIGAPFFIIPVGLGLSDRMLDAPIEAWISLFYLGIVSQFLAYVAWYGGMSLGGIA
RVGQIQYLQPFLMIGFSVLFLGESITWITIVLAMIVVLCVIVGKNADDKQSLELK
>fig|1002809.3.peg.2591 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENSTKELSLFKLTWPLFLELFLFMLMGLADTFMLSAVSDDAVAGVGTANQYIQIAILLL
GVIGTGASIVVSQYLGSRLIAEASQIAALSVTLNLLVGLVISGLFILFSDVLMKMMNLQG
AVLEAAQSYLVIVGGFIFVQALITSMSSIIRVQGWTKQTMYVSLAMNIVHVVLNYILIFG
KFGMPELGVEGAAISSVVSRVLASVVFFWLLYQALEVRIEWADYYRLSKNYISKILKIGI
PSALEQVLYQTNQIVLLYYVTFIGAEALSARQYAVNISMFTYLFAMAIGMATAILVGRYV
GAGEKELAYSKVWFGVKSALIFTLSMVAIIILFREPFMRIFTDNEEIIQIGASVLLLSIL
LETGRTINITIINSLRASGDAAYPVRIGFISMIVIGLSLGYLFVFVLDLGLVGVWLAIAC
DEWIRAVLVIFRWRSRKWERYAIVSSDK
>fig|1002809.3.peg.2609 Permease of the drug/metabolite transporter (DMT) superfamily
MNVRSMLKLTISMAIFGSIGFFTTQTGLPAVELVFVRCICATIFLGGLWLITGGHKTEDW
NRSEVMKTIVCGIFLVLNWVFLFKAFEVMSISVAISIYNLAPIFVLILGSVFLAEKMGIR
SICATAICFFGSILIIGIESFTSVSQFMNSGFIWALLSAICYALTMFTSKTIHGMSSYAL
TYIQTITGIILLLPFCDFAAFEGLTNTNWLYILGTGLIHTGFVYYLFFDSVRDLPTVIVS
VLVFVDPVVAILLDALLLSFRPDLLQVLGIVLIFGSILYTVFYPKQTINKVKTSSSQ
>fig|1002809.3.peg.2621 Permease of the drug/metabolite transporter (DMT) superfamily
MSLQGKANILMVIVTMFWGLSYTFMVMGLESLEAFNVVALRCLIAFIIAGLIFLPKMLRV
NIKTILYASIQGFLLFTIFALSLLGLKTTSAGNAGFILSLTVVLVPIMTSFIEKRLPSRA
VSFAVVATMIGITVLTLKESLTFQTGDLLVAIAAVCYSIYLILNSKFTKNVESISYGVYQ
LGIAGLFGAVFTMMFESPMFPSNSSSWIAVLGLGIICTAFCFIAQAVVQQYTSPTHTGLI
FSLEPIFAALFAMIFLGEGLTAQLVIGGSFILIGNTVAQLEQFIAMKKIPAPTHSETTL
>fig|1002809.3.peg.2625 Probable multidrug resistance transporter, MFS superfamily
MELQEQTNKIFTKRFISLFFTNMSIFLVFYGLITTLPLYAIGELGKSDDDSGLLVTVFLI
SAIIVRPFSGKLLDLFGKKRLLILSLVLYFACTVLYLFFKPFLLLLALRFFQGIWFSIAT
TASGSLAADIIPKRRKGAGLGYFAMSTNLAVVFGPFIGLLIIQYLGFDMLFIVLSVLVAI
GGLLALTIQTKDLPKPVVTDRSFKFSFNDLFERSALPLAALASLIAFSYASVLSFLSLYA
EQKDLLSVASYFFAVFAVAMISVRPFTGRIYDTIGAKFVIIPSFFIFALGLIILGNADQE
IPFLLSAIFIGAGYGTLTTSFQSLCIQSTSIQRSGYATATYFTLFDIGIAIGSYLLGMVA
VKLGYEFVYYIAAFIIIVVFALYMLVLNRQKHKIEQ
>fig|1002809.3.peg.3228 Teicoplanin resistance protein vanZ
MIHSFLLSMIAYCTVSFPIYCILRMFYMKNKTSSARRELVMLLFFFYSISIFSQTIIPSF
QISNGQIIFDTSSAYVRSNFTPLQTIMLYYDQLNGPLANIAFYNLAGNIVLFIPFGFFIP
LLWKKFRGWRIMHIVAFAIPLFIESTQYFIGRSIDVDDVLLNAIAIVIGFVLFKIFRRLR
KMSAPK
>fig|1002809.3.peg.3521 Drug/metabolite transporter (DMT) superfamily protein
MKINKGVFFVLLGAGCFGFTPVFAKLGFGHGYSLGQINLVQMVISFLLLWSIAFLKGDGT
KGLTKKNIIPIMITGCFIGLTSIFYYGAMQYLPASLAIILMFQFVWIGILFEWVFNKIKP
APITIFSIVLILVGVFFASNILNGDMQGLPIKGFVMGILSAFTYAAFIFFSGKVAVDVNP
LTRTSLMVTGSTILVFILFMKDIPTVFPLEGSLVTSAAGVSLFGAVLPPLFYAVGAPLIS
GGLANILTSVELPVAILSASIILAETVKAVQWLGIVLILVAIVLNEIGPNIIRMKKRSKR
TILHQHNKN
>fig|1002809.3.peg.3555 Quaternary ammonium compound-resistance protein SugE
MGWIFVILAAILETIGVIGLKKFSTSKKPKDLVTLVAGFGSAFYFLYASFEYLQVSIAYA
VWIGLGTTAAVIINMLFFGESRSIGRMVAVFVIVIGVSGLKYVS
>fig|1002809.3.peg.3556 Broad-specificity multidrug efflux pump YkkC
MKKSWIYVGLTSLCELLWIYGFNVASASWHWAIIIPLITVDFYFLAKACEGLPTGTVYAI
FAAIGTIGTALMDVYLFGESFTTLKIVFISIIVIGVMMLNIADTLSERKVEKGAL
>fig|1002809.3.peg.3635 Permease of the drug/metabolite transporter (DMT) superfamily
MNILPYLFVLMAAMLWGTVGTTQTFLTEGISSFAVACVRSGIGGGVLLLAVLAMRKISFR
NWSWKWTILAAIAIALFQSLFFTSVRFTGVAVGTVVTIGSAPVFAGFIEWIFWKVRPTLV
WAIATVLAIVGCLLLFMNQGETAINPLGIGLALAAGSMFALYTNVSKQLMKREETLPAVA
MTFSICALFLLPLAAKDGFGWLTEGVNIWPILFMALAATSLAYILFLGGLKKISSSAAVT
LSLAEPLTAALLGVFLVGEHLTFVSWIGVSLLLGGIIVLTFGTKKAAS
>fig|1002809.3.peg.3691 Multidrug resistance protein B
MKDYKITLGLLLLNLFIAFLGIGLVIPVLPTLMNELQISGTVVGYLTAAFAIAQLIVSPL
AGKAVDKYGRKIMIVIGLFIFGISEFLFGLGKTIEVLFISRVLGGISAAFIMPAVTAFIA
DITTMETRPKALGYMSAAISTGFIIGPGIGGFLADFGTRVPFYFAGALGTTAAILSIILL
REPERNMVNVENAPVQTSGFKRILEPMYLIAFILIFVASFGLAAFESFFSLFVDHKFSFT
PTDIAIVITGGAIVGAIAQVALFDRLAQKWGEIKLIRYSLILSGVLVFLMTVVSSYFAIL
LVTCIVFVGFDLFRPAVTSYLSKIAGNEQGFVGGMNSMFTSLANIFGPILGGMLFDIDIN
YPYYFATVVIFFGILLTLIWKKPASYM
>fig|1002809.3.peg.3843 Multidrug resistance protein B
MSTTTVKQSNPVYPIMVSIGVCHLINDTMQAVIPAMFPLLERDLGLTFTQLGMISFVLNM
FASLLQPAVGFMTDKKPFPYALPLGMVSSFIGLTMLILAGEYWMILVSVLFLGLGSAIFH
PEGSRVSFMAAGNKRGLAQSIYQVGGNSGQALAPLLSAFIILPFGMYGVSVILIFTSIGI
FLLTKISMWYKRQLEAEKRSKIKKMLVSSLPPLTKKQVGMALLVLLFIIFARSFYVTNIT
SFYVFYLSEQYGMSVERGQLFIFIFMAVGVVGTFFGGPLSDRFGRKNVILLSVIAPIPFC
LALPFVPLPAVLVLLIIIGLLIMVSFTVTVVYAQELVPSKIGTMAGLTVGVAFGMGAIGS
IVIGMLIDKMGIHFTMNAVSVLTLLLLVAFLLPRDRVGD
>fig|1002809.3.peg.3851 Permease of the drug/metabolite transporter (DMT) superfamily
MKQNWIYPLLIVIAASSYGVLSTIVKVAMQHGYTSSEAVTSQYFVGFLLALVLFVVTQRT
LPKLSKKGAITLLLAGTCTAITGIVYGHSLNYLPASLAVVMLFQFTWIGLFMDCFLKRRL
PTRIELISLVFLFVGTILAAGVIDVDLSQIAWQGWALGLLAAFTFAAFMQFNAQPVEGVT
TIGRTFILSVVSLIIVFIFLSPEIVWNGQLTGGLWKFGLALGLFGIILPILLFSIAAPKV
GGALVPILSAMELPVAITVSVIVLNESLTLLQIFGIVFVLFGMVLPSYFASKKVRVIDQK
QQLP
>fig|1005048.3.peg.86 Glyoxalase/bleomycin resistance protein/dioxygenase
MIHIREIDHIVLRVTDLEQMLRFYCDALGCTVDRRLDNIGLVQLRAGSAMLDLVPVDGKL
GSVGGAAPGKEGRNLDHFCFRVEPFDEATIRAHLVAHGVAAGELESRNGAEGEGPSIYVT
DPEGNVVELKGPPYD
>fig|1005048.3.peg.789 Fosmidomycin resistance protein
MGSHDAEKTGFRVLGAISFAHFLNDMIQSLILSIYPLLKGNFNLSFAQIGLITLTYQITA
SILQPLVGLYTDKHPKPYSLALGMGFTLVGLLILSVAPSYGILLFAAALVGTGSSIFHPE
SSRVARMASGGRHGLAQSIFQVGGNAGSSMGPLLAAWIVIPHGQTSIAWFSAAALLAIVV
LWQIGNWYKRKRQEAKSKPAKAKQHHVALPRNKVLFSVGILLMLVFSKYFYMASLSSYFT
FYLIDKFQLSVQSAQLHLFVFLFAVAAGTVLGGPIGDKVGRKVVIWVSILGVAPFTLMLP
YANLFWTGVLTVVIGVILASAFSAILVFAQELVPGKVGTVSGLFFGFAFGMGGIGAAALG
QLADMTSIRFVYQVCSFLPLIGLLAAFLPNLEGHRRKAAG
>fig|1005048.3.peg.1085 Permease of the drug/metabolite transporter (DMT) superfamily
MSGKLQPGSRQIFLGGLAIAVAGAILFSAKAIVAKLIYRYPVDAVLLITFRMLFALPLFA
AVALWKARSEAPLSNQDRMRIVVLGLIGYYLSSFLDFLGLQYISAGLERLILFLTPSFVL
LMSFLFYRRRVTWLEWAALLISYLGTVLVFLHDVRLGGSNVGLGSALVLGAAISYALYLM
LSGELVSRVGAMRLVAYAMCVSCAACIVQFLLLRPWPILLQQPAAVYGLSVINAVFCTVL
PVFLTMVAVARIGPATAAQAGMVGPVSTLFLGALILAEPVTAIQLTGTGLVLAGIYLISK
KKS
>fig|1005048.3.peg.1277 Acriflavin resistance protein
MSISAAFIKRPIGTTLLAIAIFLIGAAVWPLLPVAPLPQVDFPTIQVSANLPGGNPETMA
SSVAQPLERQFSLIAGLSQMTSTSSLGSTQITLQFDLNRSIDAAALDVQAAITAASGQLP
ANLPSPPTFRKVNPADSPILVMSVQSDALPLIQVNDFADNILAQQISQIPGVGLVNIGGV
QKPSVRIQVDPTKLAAIGISLEDIRGVIASLTVNQPKGTVDGAKQSFTVYTNDQLLSAEP
WNDMVLAYKNGAPIRVRDVGVAVDAAENLKVAGWAYAGAAAPAGNTITNGRSIVLAITKQ
PGANVIETVDRIKAALPRLQAAIPPTVHVNTLIDRTQTIRASVSDVEFTLVLTIALVVLV
IFLFLRNVPATLIPSVTVPLALLGTAGIMFLLGFSLDNLSLMALTIAVGFVVDDAIVMLE
NIYRYVEEGMAPIEAAYKGAGEIGFTIISISVSLVAVFIPLLLMGGIVGRLFREFAITVT
LTIAVSVVISLTLTPMLCSRFLKSHTAESHGRMYQMFERGFDAMLNGYKRGLHVVLRHQF
ITLMVFFATMAATVVLFVIIPKGFFPQQDTGFVYGFAESAQDSSFASMNKRMLALADVVR
KDPDVTGFGMSGGGSTFNTGNFFISLKPKDEGRTASADEVIARLRPQLAKVQGVNLFLQA
GQDINVGGRLSRTQYQYTVTDSNLDELNVWAPKLLNRFRQLPQLTDVASDQQNAAAAANL
TIDRARASSFGITPALIDSTIYDAIGQRQVAQYFTQINSYHVILEVTPKLQEDPELFNKL
YLTSPVTGQQVPLSTFVTIDTNKTSYLSISHQGQFPAVTISFNLAPNVALGEAVDAIQKA
QSEMGVPATLTGAFQGTAKAFGDSLSSQPYLIAAALVAVYIVLGLLYESYIHPLTILSTL
PSAGVGALLILMMGGYDLSVIALIGIILLIGIVKKNGIMMIDFALTAERQHGMKPEEAIY
QACLLRFRPIMMTTMCALLSGLPLMLGHGAGSELRRPLGYAMVGGLVLSQALTLFTTPVV
YLYLDRAHYWYMRRKEARQARKAARKAAA
>fig|1005048.3.peg.1496 Permeases of the drug/metabolite transporter (DMT) superfamily
MTAGVIALVLCAALLHASWNAMLKSSGDRLWAITLMTIGSAVASIPIVLWAPLPALASWP
YILMSVVLHAGYNLFLVRAYRAGDFGQSYPIARGSSPLLVSLGAALFAGEQLGILTLAGV
VLISAGIISLAQIKFRRGSSVAGSRQWDAPLSAFTTGVFIAGYTIVDGLGSRLAGSAASY
AGWMFLLDGLPLLMIYLSMHGSLRIALRERATWNALGGGAMSLLAYGIVIWAITLAPMGP
VSALRETSVLFAALIARMFLGEALTLRRLLSCAVIALGAVMLGWSA
>fig|1005048.3.peg.1709 Inner membrane component of tripartite multidrug resistance system
MPSISSELPIKPLAGAQLIGAGLLLAAANFIAVLDTTIANVSVSTISGALGASSSQGTYV
ITSYAVAEAITVPLTGWLANRFGAVRVFITSMVMFGVFSALCGLANSLGLLIAFRIFQGL
AGGPLIPLSQTLLLRVFPKEKAPTAVGLWAMTTLIAPIAGPILGGVLCDQYSWPYIFYIN
VPVALICGYLGWKMFKRYESSLVKVPIDKVGMGLMIVWVAALQLMLDQGKEKDWFASPEI
MALALVATIGFIAFLIWELTERNPVVDLRVFRHRGYSASVITICLAFGAFFGATVLTPLW
LQGYMGYTATHSGQTTALSGILAVMTAPFVAKLSTKVDPRKLVCLGVLWLGSVTLLRSFN
STDMTTFQIGWPLLLQGIGMPLFFVPLTGLALSSVNFSETASAAGLMSFCRTMSGAIATS
LVNTSWENKAIYYHAELSGLVDQAGNASNTLVQSGLSAEQARLSIEQTVQSQSIMLSTNH
IFMMAALSFLLAATAVWFAPKPKRIADTSAAH
>fig|1005048.3.peg.1710 Membrane fusion component of tripartite multidrug resistance system
MSHSDSQAVQELASTEATLKAEQAATTKKRKKLFAILGGVVLLGGLSYATYWHFIGSRYI
STDNAYTAAEISQITPAINGIVADVKVVDTQYVKQGEVLVVIDNSDAKLALLQAEADLDR
SQRRVQAYFANDAGLAAQVLARDAEQSRAAAQVLSAQADLQRAELDLRRREALAKSGSVS
GEELTNARSALLTAQASMKVAEAGAIQAKSNRSAAIGAQQASTVLTANTTVATNPEVELA
RAKRDQAKLDLERTVLRAPVDGVVARRQVQVGQRVQAGTALMTVVPTQSMHVDANFKEGQ
LTQVQLGQPVTMSADIYGGSVEYHGTVVGLSGGTGSAFAMIPAQNATGNWIKVVQRLPVR
ISIDRKELIAKPLSVGLSMEVAIDTRGDKSAPAARM
>fig|1005048.3.peg.1711 Outer membrane component of tripartite multidrug resistance system
MPRPCFPPYAALSLCVLALSISGCAPFSEIGPRAVPKDISSYQAGQLAGNAVSWPDDNWW
TIYRDPQLDRLIAEGLKGAPSLAAAQARLLKAQGVAQQQGAALLPQVSANASADYMKQSY
NNGVPPEFVPPNYNVEGKATLNLSYEIDFWGKNRAALAAATSDLEAARADAAQARIALAT
SIAAAYAEFERLLSQHDTAQEALQVRIQTLDLFEQRRLNGLETLGSVKQVVARKASAEAD
LLSLDESIALQRNKLAALLGAGPDRGLSLQRPVLDLSKPFALPSQLPVNLLGRRPDVVAA
RLRAEAAAKQIKVAKAQFYPNVNLTAYLGFQSLGLGMLTKAGSDIGSIGPAISLPIFEGG
RLRGQYRQASASYDEAVANYDNAVTQALQDVADAAVSEKALSGRLGKVQEAVDAAAAAAQ
IAQNRYAGGLATYLDVLNAQDTLLTNQRDLSTLRSRMFALDVQLVRALGGGYRQAAI
>fig|1005048.3.peg.1912 Methylenomycin A resistance protein
MAPSGLLPLLTLAIGFVMAMLDVTAVNVALSDISLNLSVPLSGLVWVVDGYTLTFAALLL
VGGALADRYGAKTIYLSGLVVFMLGSLLCGAAPDGNTLIAARMLQGVGSALFMPSSLSLL
THAYEDDRVRARMLGTWSAIVAVAAAMGPLVGGVLVHGFGWRSVFLINVPVGLLGLLLAH
TVIPAAPRHWRPLPAASHALGITGLASLCFTLIEGPVYGWTSSPILATAALVVIALMLLV
RRERRGAEPLLPRALFATPRFAAANAIGFLINFGAFGQLFLLSLFLQQARGADALHTGLQ
LLPVMAVFSVGNLLSGRITARWGARLPMLGGLLLAALLAALLTGMRPHTSYLLFAMAAAI
ANWGVGIAVPAMTTTVMQVAGRIHANSAAAALNANRQIGALVGVAIIGSILHAAPDWDLR
IPLAFGAIAIAYGGAALLVWRFIKSPGKD
>fig|1005048.3.peg.1933 Permease of the drug/metabolite transporter (DMT) superfamily
MNIAELFLLAAIWGASFLFMRVGTPEFGPVPLIFLRVGIAALVLLPVLRSAAARSHLRSK
AWPMLVVGVTNSAIPFSLFAYSTLYVNAGFDAVLNATVPLWTGLIAFVWLKAPMSRAQVI
GMLVGMAGVVVLVWDKIGEGQAGVWLATAAVLLATLCYGFAINYSKTRLVGVPPFVVAGG
SQLAATLVLLPLAFWYWPTATVSATAWYAVLALGVVCTGLAYAIFYRLLDRVGSAYAASV
TFLIPIFGVIWGAIFLKEEVTPGMVLGCVIILLGTALATGKLNLSVFLRDKTAK
>fig|1005048.3.peg.2315 Outer membrane component of tripartite multidrug resistance system
MKPIMSYPFRKSLSCLGMAGLLAACAAGPDFQAPPAPVVPQYTAGVQPLATVSSAGAGGG
AQHFDPGMDIPAQWWTLFHSPQLDALVREALANSPSIVQAKAALRQASENLGGQIGATRY
PQVDLQVGGVRQQIDTAALGIPNVPQAGPFTLYNASLDVSYTVDVFGADTRMLEGLQAQV
DNQAAELQAARLTLAGNVVTAAIRHASLHAQIASTGQMLQLQRQQLGIMEQRLAAGGIAE
RDLKNQRTLVAQSEAALPALLQQQAQTSHQLAVYLGKAPAQADMPPLDLDSLTLPDRLPL
SLPSALARQRPDIRAAEATLHQASAQVGVASANLYPQLTLSGSVGTEQGRIADLADSLNV
WNIGLNLMQPLFHGGELRAKKRAAVAAYDAAAASYQQTVLQALQQVADSLRALENDAKVL
QARAQAAENAQGSLAITSRQYQAGGVSHLSLLDAQRQGLQTALDRTVAQAARYADTAALL
QALGGGWWNTVASDQP
>fig|1005048.3.peg.2525 Probable transmembrane drug efflux protein
MSDGKKTGFNLSRWALEHIPLTRYLMVVLVIGGILSYGRLGQDEDPPFTFRAMVVSAQWP
GATALQMADQVTDKLEKKLQETPHIDTIRSYSKPGETLIILTLQESAPPKETADAWYQVR
KKINDIKLTLPQGVVGPFFNDEFGETYGSIFAVSGDGFNYADVKDYADFVRQQLLTLPSV
AKVDLFGVQDEKIFIEFSQKKFSQLGITVRDIVNQLSAQNALQSTGVLATATDNLQIRVS
GALASPKDLENLQLRANNTTFRLGDFAVVKREYQDPPQTKMRFNGKEVIGLGVSMAKGGD
IISLGKDMERMTAQIKAKLPVGIDLERVSNQPKIVAESVNEFLKTLMEAVLIVLAVSFLS
LGFHTKPFRIDVRPGLVVALTIPLVLAVTFLFMSIFSIDLHKISLGALIIALGLLVDDAI
IAVEMMVRKMEEGLSRLEAATFAYTSTAMPMLTGTLITAAGFLPIGLAKSAAGEYTFSMF
SVNALALLISWLVAVLFTPYIGFLLLKVKPAAGADGHHELFNTPFYTRVRRTVNWCVEWR
KTTIALTLMVFALGVFGFKFIEEQFFPDSSRPELMIELWLPEGSSFAATEAEAKKFEAYI
HAAPELESMTTYVGSGSPRFYLPLDQILPQTNVAQLVLLTKDLASRDALRLRITEAFKHG
FPEVRGRVKLLPSGPPVPYAVQFRVSGTDAAKVRTIADQVKSVMNGNPNIIGLNDNWNES
VKVLRIDLDQDKLRTLGIGSQTVMQTVNTMLTGTTIGQYREHDRLIDIVVRQPLDERATI
DALNQANVPTASGKSVPLAQVATVKLVWEPGVVWREWRNWAITVQADVIDGVQGPTVTAQ
IDPQLDKIRAQLPPGYIIDVAGAAHDSGKAQDSIAANVPLVIFIIFTLLMLQLHSFSRSL
LVFLTGPLGVAGAAAALLLLHRPFGFVAQLGVIALFGMIIRNSVILIDQIEHDIANGVAP
WNAIVESAVRRCRPIMLTAAAAVLAMIPLSRSVFWGPMAVAIMGGLIVATGLTLLFLPAL
YAAWFRVKKPQPENAADNHG
>fig|1005048.3.peg.2543 Permease of the drug/metabolite transporter (DMT) superfamily
MNLTTFAFIISGVCLNAVAQLLLKAGTNAVGVISLTPQNWFATGIKLATQLPILGGLTCY
VISLIVWIIGLSRVDVTIAYPMLSLGYVISAVGAWYFLGEAVSAQRLVAIGVIIVGVVLL
TRS
>fig|1005048.3.peg.2545 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MKPELSVVIPVYNEESGLAKLFERLYPALDALGISYEILYVNDGSRDKSAAILAEQFRLR
PDVTRVVLFNGNFGQHMAILAGFEATRGDIVVTLDADLQNPPEEIGNLVAKMREGYDYVG
SIRRKRQDSAWRTVASKAMNLLREKITGIRMTDQGNMLRAYGRNVVDLINQCQEVNTFVP
ALAYTFARKETEIVVEHEERSAGESKYSLYSLIRLNFDLVTGFSIMPLQLFSLIGIVLSF
ASAALFFILVARRFLFGAEVQGVFTLFAFAFFLMGMILFGIGLVGEYVGRIYQQVRARPR
YVVQAMLEQSSAEDKQAS
>fig|1005048.3.peg.2548 Polymyxin resistance protein PmrJ, predicted deacetylase
MPNLVRLLSKYQARATFLFSLGHDHTGWALKQVFRPGFFQKVSRTSVVEHYGLKTLMYGV
LLPAPDIGKTCANYMQAVRDAGFECGVHTWDHRVWQDHVRQRGADWTSQQMQRSFDRFTQ
IFGQAPNTHGAAGWQMNPYAFEQLEKFGIAYASDGRAMLADDGALADQAAGPHRLQVNGK
TLACIQLPTTLPTLDELLGRSFGGVELTPANIAAHILALTATPRDHVFTLHAELEGQKLA
PIFEQLLQAWKAQGYDLVAMEDYYRQVKDQQLPTVPLAWAELPGRSGEMIMQASSS
>fig|1005048.3.peg.2558 Outer membrane component of tripartite multidrug resistance system
MISAAVLLLAACANFSGIHSTASTNNPDDYASASALPGQGGLWPAGSWVSTIGGSQLQQL
VDEALAGNPNLQAAAARIGAARAMVEAAGATSKPQVGASLSATRERFSENSIYPPPFGGM
YVTDYETALNFSYDLDFWGKHSAQLRSAISQSKAAEAEHYAARLALTAGISKAWLQLGRQ
YAQLDLTNQQLVLRDKLDKLTQQRFAAGLDTQSDNQQSRQQVAGLRAEQAQWQEAIALTR
NQIAALMGQGPDRGLKIAPPALPADAAIALPDQLPLGLLGRRPDVVAARWQVEAAQSDIK
VAKTEFYPDINLSAMAGFSSLSFSQFLNHSSKVVGIGPAIHLPIFEGGALRAQLKGRVAA
YDGAVATYNQALNDAFHEVADSVQSLQAAETQGKNQQAAVDAAERGMKLAEQRQQVGTAN
MLQVVSTQISWLAQRKLELDTRARRADLRVNLIKSLGGGFDASAEGLNPAEASTGTASPQ
ANAAN
>fig|1005048.3.peg.2559 Membrane fusion component of tripartite multidrug resistance system
MTTPNQTPENPSPAAAAPAPAAANGNGKRRSLLIGVTIALIIVLIAYGIWWFIYARHYEN
TDDAYVGGNVVQVTPQVGGTVLAINTDDTELVQAGKPLVELDKADAKVALDQAEAQLAQT
VRQVRTLFVNNNALVSNVTARTSELERARADLARRQQLISTGAVSKEELDHAKVAVQGAE
AALQATREQLASNRVLTDHTTVEQHPNVQNAAAQVRNAYINLARTTLLAPTTGYVAKRSV
QVGQRIAAGTPLLSIVPLNALWVDANFKEVQINNMRIGQPVTLKSDLYGSKIEYHGKVVG
LAAGTGSAFALLPAQNASGNWIKIVQRIPVRISLDAKDLETHPLRIGVSMDATVDIAQTE
GTSLTAGTARTTPAYTTDVFDKSGQEADARIASIIAANNNAAAAH
>fig|1005048.3.peg.2560 Inner membrane component of tripartite multidrug resistance system
MSSPKPAMPARPPSQPLPPLTGGKLVMGTVALSLAVFMNVLDSSIANVSIPAISGDLGVS
PQQGTWVITSFAVANAISVPLTGWLTQRFGQVRLFVTSIILFVLSSILCGLAPSMEVLIA
ARVLQGAVAGPMIPLSQSLLLSSYTPAKSGMALAFWGMTTLVAPVMGPLLGGWISDNYTW
PWIFYINIPVGVFAAWATWSIYHKRESAVYKLPIDKIGLALLVIWVGSLQIMLDKGKELD
WFNSSTIVILGAISLIAFIYFVIWELGDDHPVVDLTLFKGRNFSGGVIAISVGYGLMFGG
LVILPLWLQTTLGYTATLAGEVMAPVGIFAIILSPFIGKILPKVDARWVASTAFLIFAVV
FFLRAQFTENVDTFTLMIPTVIQGAAMAMFFIPLTSIILSGQPPEKMPSAAGLSNFVRIM
FGGMGTSITSTFWDRRTSLHHSQLTEFTGPHSPAFTEAVHNLTAQGMSEPAAWATIERLI
TVKAATQGATDIFWISAVLFLMLIALVWLTKPSRSSVPADAGGAH
>fig|1005048.3.peg.2622 Permease of the drug/metabolite transporter (DMT) superfamily
MTDESKGMWLGLVGVAVFSLTLPFTRMAVAELNPVFVALGRAVVAALCSMLLLWKLKAKL
PTAAQWKPLALTALGVVVGFPVFSSVAMRYVPAAHGAIVLGVLPLATALFGALRFGERPS
AGFWIAAVIGSLIVVVFALSQGGGGLQAADLALLAAVLAAAMGYAEGGRLSQTMGGQQVI
AWALLLSLPVLLPVTVWLGWHYGVSASPRAWLGFAYVSVFSMFIGFLFWYKGLALGGIAR
VGQVQLLQPFLTLLGAALLLGETLQAGNMLFALAVLVVVAFGRKMAVRRQAA
>fig|1005048.3.peg.2845 Permease of the drug/metabolite transporter (DMT) superfamily
MQPTHILLALLTVTIWGMNFVVIKIGLAGLPPLLFSALRFVFAALPLVFFIKRPAIPWRY
LAGFGLFQFALQFSLLFSGMQLGIGAGLASLVIQLQAFFTIGLAVLLLGERPLLTQLLGA
LVALAGIVLVATHLEAQATVIGFLLVIGAGLSWASANIVTKKIGKVNPLALMAWGSLMAA
PPLLLASAVLEGPAAWHVAFAHFGWTSAAAVFYQSYPNTIIGYGIWTILMRKYPAATVAP
FSLLVPLVGMLSAAVLLGESLQWWKIVAGVLVLGGLALNLFGGRLMLALKARA
>fig|1005048.3.peg.2931 Permease of the drug/metabolite transporter (DMT) superfamily
MTISSASRSPNSSAKGLWFADLLLLLVAIVWGTSYGVAKDALVFYPVLGFVAIRFCMTFF
LLLPSLRQLARPEGRAALRAGVPLGLILLAIFICETFGVALTQASNAAFLISLCVVFTPF
VEWLVMAQRPPISAFVVAFVSLLGTWLLTIGSNLTFNLGDGLMLAAALLRAFMMVMTKRL
TVDKDMSNLTLTAVQSGVVGFGCLLVASLFMQGGLPPLPSDPSFWVSTIYLVLFCTIFAF
FAQNYGLRRSNPTRVSLLMGSEPVFGALFASFWLGEKLGALSWVGGALIVGATLWATLPR
SMINFGAFFSTRNIKPENAPIIGAGIDSSQ
>fig|1005048.3.peg.2957 Permease of the drug/metabolite transporter (DMT) superfamily
MDKKVSGTVEMTAAMIISGTIGWFVVVSGQPVLDVVFWRCVFGAATLLAVCAAMGLLRGA
ITLRLLALAALGGVAIVINWLLLFISYSHASISISTAVYNTQPFMLVGLGAVFFSERLTL
NKLTWLAIAFGGMLLIVLAQPGAADGGSNYLAGILMALGAAFFYAVAAIIAKKLAGTPPH
LIALVQVCVGMLMLAPFAHLSALPSDIGTWSILVTVGVVHTGLMYILLYGAIQKLPTYLT
GSLSFIYPIVAIAVDFLAFGHRLQLSQLAGAAAILIAAAGMNLGWSLWKPKVQMQ
>fig|1005048.3.peg.2995 Glyoxalase/bleomycin resistance protein/dioxygenase
MISHVFVGVADFQRAFGFYSAIMEVLELQLKFCDADKPWAAWMASGKARPLFIIGAPYSG
AAAAGNGQMIALLAPTRTAVDKAYAAALRNGGSCEGAPGLRLEYHPDYYGAYFRDADGNK
LCVCCHDAVA
>fig|1005048.3.peg.3142 Permeases of the drug/metabolite transporter (DMT) superfamily
MHSASLPAAAPAHRLLAAMPMVFVLLWSTGFVVAKFGLPYAPPLTFLLLRFAGVLLVLLP
LVLLMRAPWPAGQVRHIALAGILLQGGYLAGVWCAIKLGMPAGVSALIVGMQPILTAFAA
PLIGESVRPRQWLGLLLGICGVGLVVAAKVSLIGLSWQSISLCLLALLSITLGTLYQKRN
CPQFDLRTGTIIQFAASIVVLLPFAIFYEHLGPSLDTVQWTPRFIGALLWSILALSIGAI
FLLFALIRKSAATRVTSLLYLTPPTTALMAWLMFGEVFNLLGMAGMAVAILGVVFVMKK
>fig|1005048.3.peg.3316 Quaternary ammonium compound-resistance protein SugE
MAWIILVLAGIAEVIWAVGLKYSEGFTRNLPSLITCVGMAISIWLLAIAMRTLPLGTAYA
VWTGIGAVGSFIAGIVLLGEAVSLARIASVSLIVLGLIGLKLSTAA
>fig|1005048.3.peg.3330 Glyoxalase/bleomycin resistance protein/dioxygenase
MPAIALNHYNLRAPRALLLQLKEFYCEVIGLQAGARPPFDNFGFWLYAGDQAVLHLSEAR
AGDIRHTDTATTFDHVAFSCVDPEQMEACLQAHALPYQVAFVPTMQQKQIFLRDPAGNGV
ELNFAHLS
>fig|1005048.3.peg.3470 Permease of the drug/metabolite transporter (DMT) superfamily
MRHTKSYAYLALAMMLVGANIGFGKAIIAVMPVLVFGLLRFVIAVVVMAPQFFKAAPRLE
RHEWLTLFGQAFFGTFLFTLCMLYGVQHTTATAAGVITSTLPAAVAILSRLILKERLQPR
TLASILLAIAGIAVLNLSKSDSGDGGQTPLIGNLFVMAAVLCEATYVVLSKRLTQTLSPM
RITAYSHLFGLLLMLPFGLTAALSYDFSQVTPGMWLLVFWYALAASVIAFWLWLTGTKHV
QANVAGIFTALMPLAAAFIGVVFLHESLSWAHFVALALVLTGIAVASWPQSMKTVQEV
>fig|1005048.3.peg.3779 Outer membrane component of tripartite multidrug resistance system
MLLLSACADFSGIDKQSRLTDGNSLSGGATLANLSQTAWPTGAWWQNYRDPQLDTLVQQA
VAGSPSLKIAQARIRQASSLAGVARAATLPKVGAEATSTRGLYSSEYIFPPPLGGSWNWD
NEITVKASYDLDLWDKDRSALESALDTVHVSAAEARSAQLNLEVAVVRGYLQLATQYALR
DIAVTTLAQQTLIASFAQRRLAAGLGTRLEVSQAETALPDARANIEKIDENIALLRNQIA
ALSGQGPGSGEAIQRPQLAARLVGADHSAPLAIGLPDNVPAHLVGRRPDVIAQRWRVEAM
DKNIDVAKAAFYPDINISAFVGLQALGFTNFLSASSAVRGAGPAISLPIFEGGRLRANLG
AQTAALDGAIESYNNTLVQALQSVADQIIRLKSQQQQRAQSEQALALSKQSYDLAMRGYQ
AGLTANINVIQTQLVLLQQQIRVAQIRASYLDSWAQLMQALGGGLGDDLPQPADAVAAEK
>fig|1005048.3.peg.3782 Fusaric acid resistance protein fusE
MKSSSIIKTLLQVAITLIVVLIAFLLVRALWDRYMNTPWTRDGRVRADVISVAADVSGIV
VAVPVVDNSYVHKGDLLMKIDPARYALALAQAEATVAERRIGLSTKQRDAARRAKLDGDV
ISNENRENSSADASAAQAQYQAALAARDSARLNLDRTEIRATVDGWITNLNVHAGDFAQA
GTPKLAVIDANSFWVYGYFEENKLPLMKVGDAVDMRLLGSEQLINGHIDSISRGITDRDN
ALGSYGLANVNPSFNWVRLAQRVPVRIHIDKVPDGITLAAGMTCTVIVKPGEPKPQK
>fig|1005048.3.peg.4401 Multidrug resistance transporter, Bcr/CflA family
MTNTPATSASEKLLPGWLLLLGALTAIGSLSIDMYLPSFPTIAQQFGVGSNLVQLTLASF
LVGLAVGQMFYGPLSDRFGRKPPLYVGMTLYLLGSLACMVSQDVVALILFRFLQGLGGCA
GMVIARAVIRDRLGTTGAARAFSLMMLVMGLAPILAPLIGGSVLKFWGWRVIFGGLAAFG
LFCLLAIHYTMQETLDRHKAEPLHLGRTLKQYGRLLLDRQFVAYSLVGGLIQGGMFAYIT
GSSFVLIELHGIKPEHFGFVFGTNAFGLIAASQINARLVGRYSLDTILGRALWLPALLSL
FIALLVACGVNNLPILLVGFFGYLACYGFISPNASAIALSQQGKQAGTASALMGTLQFTL
GITSGVGMSLWHDGTALPLMVVMATCGVGGLLLHRFVARPEHRRQLQTAAHS
>fig|1005048.3.peg.4452 Permease of the drug/metabolite transporter (DMT) superfamily
MAMSLMLILCLCWGLQQVAIKVAAPNISPILQNGLRSAVAAVLVSGLMWWRGSKFSLTDG
SFWPGLATGLLFAGEFLCVSIGLNYTTASHMSVFVYTAPIFTVLGLHWLVPGERFGLTQW
LGVIAAFAGVTVAFAGGFDAGAGFSRTLVGDALGVLAAVFWAATTIMIKRSVLTNTAPSM
TLWYQLAVAAVTLPLLALVTGQAEVVTPLTGIMWTSLVFQSLIVAFGSFLAWFWMLRRYL
ASRLTVFSFLTPLFGVSFGVLLLDDPIGLPFVFGAVLVLSGIVLVNWQRS
>fig|1005058.3.peg.80 Inner membrane component of tripartite multidrug resistance system
MNQTPIKGGALVMMTLGLALATFMQVLDSTIANVAIPTIAGDLGASSTQGTWVITSFGVA
NAIAIPITGWLARRFGEVKLFLVSVLIFVIASWLCGISHSLNMLIACRIIQGLAAGPIVP
LSQSLLLNNYPPQRRAMALAFWSMTVVVAPICGPILGGWLSDDFHWGWIFFINIPVGILV
ILFTQITLGDRETKTYQQPIDSIGLILLILGVGALQLMLDRGREEDWFNSTEIVVLAIVA
AVGLIALIIWELGEKHPIVDIALFQKRNFTVGCLCTSLAFLIYLGSVVLIPLLLQQVYGY
TATWAGLATAPIGLFPLLLSPIIGRFGHKVDMRLLVTVSFFVYALTFHWRAVTFEPEMDF
AAVALPQFIQGIAVACFFMPLTTITLSGLKPEETASASSLFNFLRTLAGSVGTSLTTFMW
YNREALHHGEMVENITPYNPASQQYFHAMAEKGLNETQTAASLANQITHQGLIIGANEIF
YISAIAFMLLFVIIWLAKPPFGARH
>fig|1005058.3.peg.884 Multiple antibiotic resistance protein MarC
MFDSFLVQFVVLWAVIDPIGSVPVYLTKTIGLSATDRKKIARNAVLIATGILFFFLITGQ
FLLEAMQIPLTAFQVAGGLVLLLFALTMVFSEGKAEQEMRLSSNINELAVYPLAVPSIAS
PGAMMAIVLLTDNHRFSFADQIVTAAIMALVLLITYLLLIAANRIQRLIGTTGAAIISRV
MGLILAAIAVNHILSGIKAFFIEVIPTVT
>fig|1005058.3.peg.1088 Permease of the drug/metabolite transporter (DMT) superfamily
MQNRLTLGIFLALSAAALNSTIGIFSKVLIEQGLTIEAISFIKTIIAFVLVSIVLFRQPQ
KEQQQSICPHYSSTVKLWGQIAFCAFLGVFVMFFFETLAYQYGQAANVVVVLMASAAVSA
LIGGWLLLAEPIVFSAIVGTLIAILGIFIISWSGSGTWQAVVNASLAGIGYGLFSVFIKR
FRLNGGLPLIKMLMFFGAIYLLFPFIQHFETINWSWSIALNLLALAVLPTLLGFYCTTKA
LVYLSAAKVQVTELSEPIFSMCLAWLFLSEIPTLYFFIGAVCIVLGIILINQLYKFAR
>fig|1005058.3.peg.1243 Permease of the drug/metabolite transporter (DMT) superfamily
MQKQKLAIPGILIGCVVFGLGSLIVAHVPVGAYAIAFWRLLIAAIIFFILAKLFKQPFPK
SKQTIRYGLLAGVFLAFDLGFWHESVYAVGPGISTLLNSLQIFFLAAIGFFYFKEKQSIV
QLFSLVLAVIGVYLITGSEFQHNDNALWGFVSGVVSSLLLALSMVYIRKTHEAEPCAIFP
LMLLVSVGGILALIIPSLLFNFDNLYPTTALDWFWVFVYGAVMQCFAWGMIAYSVPLLSL
AVTGLLLLSEPIAALVIDYSVLNKPINLIQWCGAAITMFAIYLGSVSSQPKKSKIRSLKG
QNKG
>fig|1005058.3.peg.1310 Modulator of drug activity B
MKFLLLNGGKAFGHSQGKLNTTLHNTAKETLLALGHEVQETIIDAGYDINQEIEKFLWMD
VVIWQMPGWWMGEPWIVKKYIDEVFTFGHGKLYQSDGRHRVNPTEGYGTGGLLQGRKHML
SLTWNAPIEAFEREGDFFEGKGVDGVYLHFRKANEFIGLSPLPTFICNDVIKNPNVEQHI
TEYKAHLNKLFAK
>fig|1005058.3.peg.1935 Tetracycline resistance protein C
MFLRLSRPHHHDTINILTVCYFKSIMENKNHQQENFKSTYQSLVNSARILFVEKGYQAVS
IDEISGKALVTKGAFYHHFKNKKQLLSACYKQQLIMIDAYITTKTDLTNGWSALESIFEH
YLDYIIDNNKNLIPIQEVMPIIGWNELEKISLEYITGKVNAIVSKLIQENQLKAYDDDVL
KNLLNGWFMHIAIHAKNLKELADKKGQFIAIYRGFLLSLKDK
>fig|1005058.3.peg.2037 Glyoxalase/bleomycin resistance protein/dioxygenase
MSPLIGFHHIALIVSNYEVSKHFYINILGAEVIAETYRQARQSYKLDLRFRDGSQIELFS
FPITPPRPTTPEACGLRHLAFKVDDLQQAIEYLNQHNVECEPVRIDELTGKQFTFFKDPD
GLPLELYQWEN
>fig|1006551.4.peg.91 Multidrug resistance protein A (ErmA)
MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIVAVAYGIYWFLVLRHFEETDDAYVAGN
QVQIMAQVSGSVTKVWADNTDYVQKGDPLVTLDQTDAQQAFEKAQTQLAASVRQTRQQMI
NSKQLQASIDVKKTALSQAQTDLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQ
YNANQAIVLGTKLEQQPAVLQAATEVRNAWLALQRTKIVSPISGYVSRRSVQPGAQITTT
TPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAF
SLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRGGEMLASQVR
SSPVYESNAREIGLEPVNKLINDIIQANAG
>fig|1006551.4.peg.382 Permease of the drug/metabolite transporter (DMT) superfamily
MAFVSRNLMVDLFLTALAPAIWGSTYIVTSQFLPPDRPFIAALLRVLPAGIALLIWSRRF
PLRAEWWKLIVTGILNIGAFQALLFIAAYRLPGGLAAVIGAIQPLLVMLLTWCVDRQRSP
WLAVLSALMGIAGMAMLLLSPQTTLEPLGIAAAFLGAMSMALGTWLSRRWAIALPVIALT
GWQLLVGGIVLAPIALLVDPPLHQVTLTQAAGYLWLCVAGAMLAYGLWFRGISRLSPVAV
SAMSLLSPVTAVLLGWVFLGQKIEGLALVGLVIVLFSVLSIQRALSNKSAVAGR
>fig|1006551.4.peg.389 Inner membrane component of tripartite multidrug resistance system
MTSSRSSVIRKKWPLLALVLAAIVALILVIWQLQTSPETNDAYVYADTIDVVPEVSGRIV
EMPIRDNQRVKKGDLLFRIDPRPYQAMLDDAKARLTTLDAQIMLTQRTIKAQEYNAQSVS
AAVERAKALVKQTTSSRIRLEPLVPQGFASQEDLDQARTAEKAARAELEATLLQAKQASA
AVTGVDAMVAQRAGILAQIALAELHLEFTEVRAPFNGVVVALKTTIGQYASALKPVFTLL
DDDHWYVVANFRETDLKNVRPGVPARITVMTNHSRAFEGVVDSVGTGVLPDGGSVIEGLP
VIQKSINWVHVSQRFPVKIAVKDPDPNLFRMGASASAVLQPQ
>fig|1006551.4.peg.390 Membrane fusion component of tripartite multidrug resistance system
MQSLWPFLTRELRDAPGRANYTLRLTLSCAVLIVLFMTLHIPFLAVALIVVFYVSQPNVL
MIKLVSVVFVVTVSVALGGVLLIIKWTYDYPLIRLVASVILFFCAIYLMRVLGKLGLAFF
VVALAVIYAQTFPSMTSQSEILVRLLLWLWVAINTAILVTLLVNACFQQAFPGYQFKARL
VVMLRQTARRLSQPDDGTPPPTVTEIAGQFNQLRSLYQQAARATPEIAASPQAWQSLMAA
ALSCSHLTALLLPGDDHPDARRRIASQLNALADNLPAAAEVQPLIVPRDGANSAILQEIA
EVLARLARGETIPLPQGEVEKAPLLLPDAWSNPAYLHFALKTLLATLLCYVFYTAADWQG
IHTIMLSCVIVAQPGLGATMQKTWLRIGGALLATLIALLLIVFVQPWTDSLSGLLAMTLP
VFALAAWIAAGSERIAYAGIQIGFTFALAFLSWFGPLSNLTELRDRVIGILLGVLVSSIV
HLYLWPDSEAPQLKARLAQLYRQLAQTLAARDDEVQQVPLFAALTESETLINRVAAEPLG
TYAHPWPEAKSWPARATFRQAEEILRLSEGYRLYAAPEDTFLARCARRLEAYASDIDAQQ
NTVERVQAPQPDPANPFGAPLVNALAALPTWPLASSVIPRQATRS
>fig|1006551.4.peg.391 Outer membrane component of tripartite multidrug resistance system
MTKTTPLPRVWRSLALAFALTQLAGCALIQDDPGQVPLVNPQQAELAKVIHLANSGWPTA
RWWESYQDPQLNMLVNRALQNSPTMQAARLRISQSQSTVELAQSAMGIQATAVAAQNRLR
VTNKQFTWPYSFSLPVDKNGPWYTLNTVGVGATLNIDLWGADRARVAAAIGEKNARQAET
AGIELDLASSVAQLYFAMQATFQKIELLNQLEAIARLSVQAHEHRTARGVEDSVDVANAQ
AELLAAQQQVITAQGTLTQYRETLRALIGADAHSMPEIHPVALPTLQETLPDSLSFELLA
RRPDLQALRGYVSASMSQVDAAKAAFYPHFDIKAFWGYNALSVGDLFKSSFQQINILPGL
YLPLFDGGRLNANLKSTRTASNILIKQYNQAVLDAVRDVAISSSQLNDLNQQAALQQQKV
TAAMVTTRSASAHHQRGLVSYYAAQEARRPAIAQQLLLLDIQAQRLSTDITLIKALGGDY
RGPAQSENAPSR
>fig|1006551.4.peg.406 Glyoxalase/bleomycin resistance protein/dioxygenase
MRELVNTIAHIGYQVSDLTRSLAFYEPLGFQRQQRFSKPSPQGAIEVAFLEMAGAVLELY
QLPEGTPFDAPRCGIDHLALEVSDLDAVQQRLAALGYPLDEGPIEEENVRFLLIRGPDGE
RLEFDAFKR
>fig|1006551.4.peg.747 Permease of the drug/metabolite transporter (DMT) superfamily
MKQQAGIGIILALTTAMCWGALPIAMKQVLEVMEPPTVVFYRFLMASFGLGAILAMKRKL
PPLRIFRKPRWLVLLVIATAGLFGNFILFSSSLQYLSPTASQVIGQLSPVGMMVASVFVL
KEKMRGTQVVGALMLVSGLVMFFNTSLIEIFTRLTDYTWGVIFGVGAATVWVCYGVAQKV
LLRRLASQQILFLLYTLCTISLLPLAKPSQVLALSDWQLACLVFCGLNTLVGYGALAEAM
ARWQAAQVSALITLTPLFTLLFSDLLSLAWPDVFARPLLNLMGYLGAFVVVAGAMYSAVG
HRLWGRWRKREAVVPLPRSGE
>fig|1006551.4.peg.806 Fusaric acid resistance protein fusE
MAIFRAWVYYTASPWTRDARFSADIVAIAPDVSGLISQVNIKDNQLVKKDQVLFVIDQPR
YQKALAEAEADVSYYQTLAQEKRVEAGRRNRLGVQAMSREEIDQANNVLQTVEHQLAKAT
ASRDLAKLDLERTVIRAPADGWVTNLNVYRGEFITRGSTAVALVKQNTFYVMAYLEETKL
EGVRPGFRAEITPLGSVHTLRGTVDSIAAGVTNASSSSDSKGLASIDSNLEWVRLAQRVP
VRIRLDQQQGNLWPAGTTATVVITGKEDRDTRQANFFQKLAMRLREFG
>fig|1006551.4.peg.1012 Polymyxin resistance protein PmrM
MGLIWALFSVGLASGAQLLLRSAMVELPPLTEIFTFLNHLLHLRAGTFGLAFGLMGYLLS
MVCWYFALHQLPLAKAYALLSLSYILVWAAAIWLPGWHEPFHWQSLLGVLLIVAGVLTIF
WPVKRLN
>fig|1006551.4.peg.1013 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MSVWICLVFASLLSCAGQLCQKQATRPSKSGRRGYHILGWLGLALLSLGCSMLLWLSVLQ
SIPVSIAYPMLSLNFVWVTLAAWGIWREPVARRHWLGVGLIVVGIVILGSRI
>fig|1006551.4.peg.1015 Polymyxin resistance protein PmrJ, predicted deacetylase
MKQVGLRIDVDTFRGTRDGVPRLLALLSQHGIQASFFFSVGPDNMGRHIWRLIKPKFLWK
MLRSKAASLYGWDILLAGTAWPGRRIGAGNEDVIRAAAQEHEVGLHAWDHYSWQAWSGVW
PQERLTLEVERGLLELERIIGRPVTCSAVAGWRADQRVIKAKEAFDFLYNSDCRGTGPFL
PQLGNGAPGTVQIPVTLPTWDEVVGNAVDSAGFNRYLLDCIHRDAGTPVYTIHAEVEGIA
FAEQFDELLTMAAQEEIRFCPLSQLLPADFSVLPRGKVVRGELAGREGWLGREQLLNSGV
>fig|1006551.4.peg.1017 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MFSYPPVKKVSVVIPVYNEQESLPELIRRTDTACATLGRQYEILLVDDGSSDDSARMLTE
AAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDTFFRKSASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLFG
SVIALLGFAFGLMLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQPETASQEEDRS
>fig|1006551.4.peg.1154 Membrane fusion component of tripartite multidrug resistance system
MDLLIILTYVAIAWSIFKIFKIPVNKWTVPTAALGGVFIVSALILLMNYNHPYTFTAQKA
VISIPITPQVTGVVSSVTDKANQRVKKGEVLFTIDPVRYQARVDRLQADLVTALHSINTL
KAQLSEAQANTTRVSAERDRLYKDYQRYLKGSQARVNPFSESDIDNARQNYLAQDAMVKG
SVAEQAQIQSQLDSMINGEQSQVVSLRAQLAEAKYNLDQTTVRAPSDGYITQVLIRPGTY
AASLPLRPVMVFIPQQKRLIVAQFRQNSLLRLEKGDDAEAVFNALPGQVFRGKLVSILPV
VPGGTYQAQGTLQALTVTPGTDGVLATIELEPDAAVDALPDGIYAQVAVYSDHFTHVSVM
RKVLLRMTSWMHYLYLDH
>fig|1006551.4.peg.1247 Permease of the drug/metabolite transporter (DMT) superfamily
MTRQRQADLLLIAATVIAACGWIFSREAIAGMPVFAFLGLRFLFAALLLLPFCRGLRVER
QQWPRMIISGLWFALNLCLWIYSVSTTPSLGEGAFIMSLSMLFVPLTAWVMMKARPARAY
WECLPIAVVGLGLLSLHMPIAFHPSQGWFLLTALVQSIWFCYTSKSAREVPLIPLTTVQL
GITGIVGLGISAAVESWTQPFTLPTFGWLLASIVIATSLRFGLQMKGQKYAAVASAAIIM
VLEPLLTVIAAALWYGEQLPLQKIIGGLLILVAQLWFRWRMLKPLR
>fig|1006551.4.peg.1291 Multidrug resistance protein D
MKRHKNFNLLLMLVLLVAVGQMAQTIYIPAIADMAISLNVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMLATLVAITTHSLPVLIAASAMQGMGTGVGGVMARTL
PRDLYEGAQLRHANSLLNMGILVSPLLAPLIGGILDTLWNWRACFVFLLVLCAGVTFSMA
RWMPETRPTGAPRTRLITNYKTLFGTGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMSVSILFILPIPAAFFGAWFAGRPNKRFPTLMWQSVICCLLAGVLMWIPGLLGVMTVW
TLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMMPQT
GQGSLGLLMMLMGLLILLCWLPLASRFHQHQQPV
>fig|1006551.4.peg.1974 Fosfomycin resistance protein FosA
MLSGLNHLTLAVSQLAPSVAFYQQLPGMTLRARWDNGAYFSCGDLWLCLSLDPQRRVISP
EESDYTHYAFSIAEADFALFAGRLNAAGVPVWKTNKSEGASHYFLDPDGHKLELHVGNLA
QRLAACRAKPYKGMVFFGEDEQAAGNP
>fig|1006551.4.peg.2389 Permease of the drug/metabolite transporter (DMT) superfamily
MRIADYLRLLLLAAIWGASFLFMRIAVPQFGAINTAFLRVFFGSTGLAVILFIFKSSFDF
KDKFKSSVMLGVINSGLPFLMYCLAAKWLPAGYSAILNATTPLMGAVIGFAFFAEKLTFR
KWAGMLLGIVGIIAIATIGEPLSAEKQIAVVIACLIATSCYATAGFLTRSWISNKGGLDP
KIVAFGSQIGASFFLLPFFIWSTHSGPTVNWLQQEAWISVIAAGAICTAFAYILYFRLIA
DIGPLRSLTVTFLIPPFGVLWGYMVLNETVNNGFVIGAIIIGIAVWMVVSPEKNN
>fig|1006551.4.peg.2576 Multidrug resistance-like ATP-binding protein mdlB
MRSFTELWPTLKRLLAYGSPWRKPLMIAVAIMWVAAVAEVSGPLLISYFIDNMVAKNSLP
LKLVCGLAAAYIGLQLLAAGLHYCQALLFNRAAVGVVQQLRSDVMDAALRQPLSEFDTQP
VGQLISRVTNDTEVIRDLYVTVVATVLRSAALIGAMLVAMFSLDWRMALVAIAIFPAVLI
VMMIYQRYSTPIVRRVRAWLADINDGFNEVINGMGVIQQFRQQARFGERMREASYAHYLA
RMQTLRLDGFLLRPLLSLFSSLILCGLLMLFGFSSSGTIEVGVLYAFISYLGRLNEPLIE
LTTQQSMLQQAVVAGERVFELMDKPRQAWGEDSEPLRSGAMSIDHVSFAYRDDSLVLQDI
NLDIPSRSFVALVGHTGSGKSTLASLMMGYYPLTQGEIRIDGRPLSSLSHSALRQGIAMV
QQDPVVLADTFYANVTLGRDISEEQVWEALEAVQLAALAREMENGIYTLLGEQGNNLSVG
QKQLLALARVLVDTPQVLILDEATANIDSGTEQAIQQALARVREHTTLVVIAHRLSTIVE
ADTILVLHRGQAVERGSHQQLLAARGRYWQMYQLQLAGEELAASAQEESLIA
>fig|1006551.4.peg.3295 Drug resistance transporter EmrB/QacA subfamily
MLWMQAAIITLGAFATMLSSTMLSAALPAMAAGLGVTDTAIQWIATAYLMALAAGVPLSA
WAARRFGATQLWLYGLILFAIFSAVCALSPHFEVLLAARVMQGLAGGLLVPAGQTILGLV
VGRERLGRVIGTIGVAIVIAPLLGTSLGAVLLESCGWRGLFWITVPFCLCACLAGWKLLP
RPTIKTDRPLSLDWLGLALVFCSLPMLMEGMKELSLNSGKYGRNVIMLSVGALFTCLFIY
RSLRIESPLLHLELFKHRGFTLSAVLMAIGGAVNFGGQFLLPLYFRDVCHVTLAEVGLLL
TPQLIGSAIGFPMAGYFSDKLGPRTVLIIGGLLAAFATLPLAMIDEGSRYTLVGGAIAVR
GFGLALATVPAMAAGLAMAGSRHVADAAPVLNILQRVGAMAGAALVTACYVRFAHTRGSL
AAFHHAGWLLTGGAVLLALCALFMVNHSTLTTQEE
>fig|1006551.4.peg.3310 Permease of the drug/metabolite transporter (DMT) superfamily
MPYLLLTLAALFWGGNYVVGHILVQGADPILMTEARWALTALLLVLLYQRQIRDSRPLFR
QNGATLLVLTLCGQVSFPLTLYIGLQSTSALNAAIYMSATPCMVLMINRLIFHDRVSARN
WWGVIFSTAGVLLLLLHGNLSNAEGLKGFSQGDLWAMGSALSWAVYCSLLRNKDRRIPAN
AFVAVSSLLGALILLPVVIFWLWLHPATSFAAYHDIAFLTGLAYLVIFPSWLAYLFWNKG
IAAIGATRGEIYTHIIPLSGGILSIVFLHTQPHLYHLLSSLLILTGIAICSFAKKAAAYS
>fig|1006551.4.peg.3936 Permease of the drug/metabolite transporter (DMT) superfamily
MNALLYGLVVVIWGTTWIAIFLQQGPVAAPVSIFWRFAVASVAMLTILLVTRRLRPLAAR
DHLFCLLQGCCVFCFNFWCFYTAAAYINTGLESVIFSMAVLFNAINSFLFYRQQPPGRFW
LAAALGLAGIVTLFWDDLWASGLNASLLLGIALSALGTFGFSLGNMLSIRHQRRGLETLT
TNSWAMLYGTLVMGAIALVRGDNFAPQWTLSYMGALLYLAVFGSVIAFGAYFTLVGRIGA
GKAAYSTLLFPLVALTISTFYEGYVWHSSAVAGLALILVGNLVMFARPEQWLLRRRLAWV
RSDRC
>fig|1006551.4.peg.4265 Multiple antibiotic resistance protein MarC
MMDLFKAIGLGLVVILPLANPLTTVALFLGLAGNMNNAERNRQSLMASVYVFAILMVAWY
AGQVVMNTFGISIPGLRIAGGLIVAFIGFRMLFPQQKAHDSMEAKLKSEELEDEPTANIA
FVPLAMPSTAGPGTIAMIISSASTVKHGASFPDWVVLVAPPIIFALVGIILWGCLRSSGA
IMRLVGKGGIEAISRLMGFLLVCMGVQFIINGVLEIISTYHA
>fig|1006551.4.peg.4266 Multiple antibiotic resistance protein marR
MVNQKKDRLLNDYLSPMDITSTQFRVLCSIRCEVCITPVELKTVLSVDPGAMTRMLDRLV
CKGWIERLPNPTDKRGVLVQLTPDGAALCEQCHQVVGQKLHQELTKNLSTDEVATLECLL
KKVLS
>fig|1006551.4.peg.4267 Multiple antibiotic resistance protein MarA
MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRS
RKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHQYRITNVPGESRYLL
PLNNCC
>fig|1006551.4.peg.4268 Multiple antibiotic resistance protein MarB
MKLFASAAIVLLALVSSQSYAEQTSTPVRHNNRDAMIIPSEHNDSPFDFNHMASGSDKSD
ELGVPYYNQQSL
>fig|1006551.4.peg.4269 Permease of the drug/metabolite transporter (DMT) superfamily
MIYAADELFGSLILFAKIPITTEAGMTRKDGLLALLVVVVWGLNFVVIKVGLHNMPPLML
AGLRFLLVAFPALLFVARPKIPLSLLLGYGLTISFGQFAFLFCAISLGMPAGLASLVLQA
QAFFTIILGAFIFGERLQGKQLAGIALAIFGVLVLVEASLGGQHVPLVGFMLTLAAALSW
ACGNIFNKKIMSHASRPPIMSLVVWSALIPVLPFMLASWILDGPQVMAESLLHIDLLTIL
SLLYLAFIATIVGYGIWGALLGRYETWRVAPLSLLVPVVGMASAALLLGETLNSLQLLGA
VLIMAGLYINVFGLRIVRPGMARG
>fig|1006551.4.peg.4400 beta-lactam resistance protein
MENVFNRIVELIGWIVLGVSALLLVIAHHIDNYQSPPAVDAVQTKPLSK
>fig|1006551.4.peg.4422 Fusaric acid resistance protein fusE
MKKLKYLSTLLVAALAIIAAWLVWNYYTQSPWTRDGKVRAEQVGVTPQVSGSILQLNVRD
NQLVKAGDVLFRIDDTPYKIALLNARAQLAKAKAEVARAQAEQKKAASDASRRRHLSQNF
ISAEDLENANTALNTATTNLEAAKAVVGVAQATLDHAQWQLTQTEIKAPVDGWVTNLSTR
VGDYAAVGHPVFALVDSRSFYVVGYFEETKLRNIRPGDSAQIILYSSKQKLQGHVSSIGR
AIVDQSVESGGDLVANIKPNIPWVRLAQRVPVRIEFDHLPPDTILVSGTTCTVAIGAQ
>fig|1006551.4.peg.4441 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQKYFIEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSLLVMVVLWNAGYIISSMHNID
PAMAEKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGIGCGVATASVYWVMFFSMLFWVRRARSMRDIHHTERFSKPDFAVIQRLVQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPLSLAAAVTIRVG
FRLGQGSTLEAQTSARTGVGVGVCMAVFTAVFTILMRKQIALLYNDNPEVVTLASQLMLL
AAIYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYLLALTDIVVPRMGPAG
FWCGFIIGLTSAAVMMMLRMRFLQRQPSSVILQRAAR
>fig|1006551.4.peg.4656 Albicidin resistance protein
MLIQVGELAKRAGITVRTLHHYEQTGLLTPSARSAAGYRLYNLAAVQRLHMIKALAQAGL
ELATIKDYLDRDAFSLSDLLVKQIATLDRQLQTLSTLRQRLALLREELDCGDEPDLESWL
QTLELMKMYDRWFSQQELQVLPFAEQDAQRNQIWLELVGEAQQLMGERCPADEPRAIALA
TRWMAQLEQDTAGRPEFLTRLNEMHAAEPQMREQTGVTPEMIDFITRAFAESKLAIWARY
LNAEELAFTRQHYFDRLMEWPALVAELHRACREKREPASAEGQQLAQRWLALFQSYAGKD
PHTQQKFRYAMEREPHLMKGTWMTPEVLGWLQQAIGVMMRQAPGPAAG
>fig|1006551.4.peg.4700 Multidrug resistance protein D
MLGRAALVLVTALLMFPQIAETIYSPALTDISARFSVSAPQAALTLSVYFIGFAVGVLLW
GGFSDRYGRRPALLAGLGVYALGCLMALWATDFSLLLAARIVTAAGAATGSVVTQTVLRD
CYRGRQLAGIFSFIGLALAVSPAVGVYIGGGLTALWGMRGVFSALALLAAALLLGCLALM
PETRPQNLRRGPFLHVLRRMVGDTRVALAAILVAAFNVSLFSYYSLAPFLFARFDLDALT
FGYSGMALAAGSLLGALLNHRLLRRNVSLGRILAIACILHLAGGVAVYVLRESIWFVAPV
ALVTLAWAMAIPLVLGSALSAYGDCRGTAGAFFGLFYYVLIGAGLLAAGWGQSLGASLLA
CAGVSMLAGWRYIIVLNEG
>fig|1006551.4.peg.4856 Permease of the drug/metabolite transporter (DMT) superfamily
MSTRQLLPLIGALFALYIIWGSTYFAIAVGVASWPPLMMAGVRFLSAGAVLTAWLLATGH
KLPARKPLLNAALIGVLLLAVGNGFVTLAEHQHVPSGIAAVMVATVPLFTLCFSRFFGIA
TRKLEWLGIAIGLAGIVLLNSGGNLNGNPWGALLILIGSMSWAFGSVYGSRIELPTGMMA
GAIEMLAAGVVLMIASTLTGEKLTQMPSWSGIFAVAYLAIFGSLIAINAYMYLIRNVTPA
VATSYAYVNPVVAVLLGTGFAGESLSAVEWLALGIIIFAVVLVTLGKYLLPARREITSCR
AEK
>fig|1006551.4.peg.5200 MFS family multidrug transport protein, bicyclomycin resistance protein
MTAKQNSSLGIVFILGLLAMLMPLSIDMYLPALPVIAAQFNVPDGSAQMTLSTYILGFAL
GQLLYGPMADSMGRKPVILGGTLVFAAAAVACALSQTIDMLITMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTVAPLVAPMVGGAVLVWFSWHAIFWILAVAALLASAM
IAFFISETLPPERRQKFHIRTTLGNFATLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
ININHVSPQHFGYYFALNVVFLFVMTMINSRFVRRVGALNMFRAGLWIQFAMAAWMVVCA
LFGVGFWALVFGVAAFIGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSMATFTTAWPMLISIAFCASSSILFYLYASRRRKAAR
>fig|1007096.3.peg.517 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPKSKSYEIDMCNGPVLSKMLLFALPLMCSGILQLLFNAADVIVVGRYAGDNSMAAVGSN
AALINLLTNLFIGLSVGANVLAARYFGAKREVELRATVHTAMLLALCSGVGLILAGMAGA
RQVLIWMQAPPAVLELAALYLRIYFLGMPAMMVYNFGAALLRAKGDTQRPLYFLLLAGVV
NVALNLLLVIVFHLGVAGVAIATVVSQCISAVLVVICLARETGGFRLELKALQIQKEPLK
GILRVGLPAGVQGVIFSLSNVVIQSSINSLGEVVMAGSAAAANIEGFVYAAMNAIYQATL
SFSSQNTGAGQLNRINRILLTGQGLVTVTGAVLSIGVWQAGRLLLGIYTDDPAVVEAGFV
RLGIVCAPYAICGMMDIMVGVLRGIGYSVMPMIVSLMGVCALRLVWIATVFQIPQYHTPE
CVYWSYPVSWVVTLFVHILCYLWAKRRTDLRFAAAMAERKAEKELSLFENTK
>fig|1007096.3.peg.623 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEGRQEEKYIRMTTEPVGRLICELAVPCIISMLVTSIYNMADTYFVGKLDSNSATGAVGV
VFSLMAVIQAIGFFFGHGSGNYISRKLGEQDGAEARRMSSTGFTLALLAGAVLCVLGEIF
LTPLANLLGATPTILPYARDYMRIILIGAPWMTASLVLNNQLRFQGSAAYGMVGISAGAV
LNIALDPVFIFALKMGVAGAALATVLSQFASFCLLLWQCGRGGNLRPHLKDAQIKRFYCQ
EIARGGLPSLARQGLASLATICLNRSARGYGDTVIAAMAVVTRVMMFGGSALIGFGQGFQ
PVCGFNYGAKLYHRVRQGFWFCVKWGTAFLLVVCALGAVFAPELVALFRNDPEVIRVGAL
AMRCQCVGFALSGWVVISNMTLQTIGDTGPATFLAAARQGVFFIPAVLILPRLFNLWGVI
LAQPVSDILAFAVAVPLMLRALGKMRETGKN
>fig|1007096.3.peg.1015 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRELRRGLQAAPLSNCHRAPLQSRRENERKRVFMEERSKKLTENKMGVMPVGKLVFNMSL
PIMISMLVQALYNVVDSIFVSRISENALTAVSLAFPMQALMIAVSTGTAVGINALLSRAL
GARDPKRAQSVALNGIFLAGLSVLAFILIGWLVSPVFFRSQTDVAEIVDGGITYLTICSC
VSFGLFFGITFERILQSTGRTLYTMFTQGLGAIINIILDPILIFGLFGLPRMGVAGAAVA
TVIGQICSMCLSLFFCLKKNPEVPLKFKGFRPNGEIIRDIYLIGVPSIIMQAIGSIMVYG
MNRILIPFTTTAATVFGAYFKLQSFIFMPVFGLNNGVIPIVAYNYGAQKKNRIMRAFKVS
LATAACIMVVGTLIFLLVPGWLLALFDASDEMLAIGAPALQIISLSFPMAAVGIVCSGVF
QALGNSVLSMIVSLARQLILLLPAAWLLSLSGNLDMVWWAFPIAEVVSLILTIVFFRWTY
HKHIVPLAGAQS
>fig|1007096.3.peg.1090 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFSVLRQKPGFYSRLWRLALPIILQNLITTSLGFVDTFMVGLLGNEELSAVTAANTPIFL
VQVIIFGLMSGLTVLVCQYWGKGDAASINRVMGVAMYVGIAISGVAALLLFLFPEGVMAL
VTNNAQLIELGAPYVRIVGVSYVFNAVSSVYVSMQRSTENPGFGMLVFATSMLLNTFLNY
CLIFGNFGAPRLGITGAAAATLASRVVEFIIVLVYAICNKRVPLIPKALFCPGRAMLKSA
AVYAGPVILNETLWGLGTTVMTAIMGHMVISADMLAAYAIMGNIDKFSTVACFGVAGATA
VIVGKRIGERADKEEVYNLSCCLLLVSFLLGAVIALALLIVLPTVFIPYLYPLFSLTEKA
TEVAVTMCVVYIVMMPLKSYDISNITGVLRAGGDARMAAILDLCPLWLVSVPLTALTGLV
LDAPIWLVCFGIYSENTCKMPLGIIRLHSRKWINDVTIHEGE
>fig|1007096.3.peg.1163 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGQSNQKIDIFERMPVKRAVLKQIAPAIAGQMITLIYSLADTYFVGMLNQSAATAAITVA
FPMFLMLTAISNLFGVGGASAIARALGKKDLEKARQIAGISFWSGLVAGILYSCVFLFLG
EPVLRLCGATERTFAIALGYARWVILIGGPFTILNTLLANLVRAEGSAMHASVGVSMGGI
LNTILDPIFVLPQFLGLGAVGAGVATAISNAAAMAYFICYAVKKKNATVVSLSPKNLRYT
GRHIKEILAVGFPSAVQFALTVVSISVQSKFVSRYATEAVAGLGIVKKLDQLPLYFTMGV
SNGLLPLLAYNYSVGNQERRKQAFHFGCTISLGFSVLCLICYEAFAPLLAGIFIEDPATI
QYASGFLRIMVTAMPMMSLCYPIIVQFQAMGKAKPALVCSVIRKGILDIPISFVMDALIP
LYGLMWVQPIVDTISLAVAGILYRKQNRRG
>fig|1007096.3.peg.1196 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEQQGADLRSGKVGKLLFSLALPTVTSQIVNMLYNLVDRIYIGHIPGVGRAALTGVGVCL
PIIMLITAFSSLAGAGGAPRASIEEGKGNPEESERIMGNCLTLLLIASVVLTAFFVLFNR
PILLSFGASADTIDYAVAYMRIYALGTIFVQLTLGMNIFITAQGFSKVSMQTVLIGAGLN
TVLDPIFIFALNLGVQGAALATILSQAVSAVWVLRFLMGRKTKWRLKRQYLRPRAKVVLP
CVALGLSPFIMQATESVLAVCFNTSLLKYGGDIAVGAMTVLTSIMQFAMLPLQGLTQGAQ
PIISYNYGARLPQRVREAFRLLLRVCVIYSASLWALVELFPGIFVRMFNSDPELVAYAVP
ALRVYMAMCCIFGIQIACQQTFIALGNAKSSLFLAVLRKIILLIPLIYILPNFFENQAFA
VFLAEPVADTMAVLTTAIMFAVQFKKSMKRLEAPPWEK
>fig|1007096.3.peg.1378 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTVGSPARHIFLFALPLLLGSFLQQLYNMVDSWVVGNYVGDAALAAVGVGFPVIFMFTSL
FMGIANGGTVVIAQYYGAGKLDRVRDAVDTIYTTFLVSAIPVTILALLLVKPLLFLLRVD
EAAYHEAWVYLMIVCAGLVGTIGYNTNAGILNGIGNSRTTLLFLAVAAGLNIALDLILVL
CAGMGVAGVALGTIISQTFSWLFGLLYINRKYPQIAIHPFCFRFDKTLFRQVLGIGLPAG
FQMSLVSIGVMTVMSKVNTFGTAYTAAYNVGNKLDSMAFLAVQALTNSVTAFVGQNVGAK
KPERVRQGVRMTVTATVVWCLLMTVVLLVWSDRLFHLFSPEAAVAEAGNYYIRAIMPPYA
LFGVMYILNGAMRGAGESVFPMTVTILSMIVLRVPAVYYLANHFGPAYMFYGFGIGWIGG
FVLCVTYYLSGRWKKRGSLADETS
>fig|1007096.3.peg.1426 Vancomycin B-type resistance protein VanW
MNTVEVQEQRKKHSKLPVVLLCVLGALTAGYMGLCAYAANSGAIWRGTEVLGQDLSGLTV
TQAARKLDSTLPKLKIGVYLYDGSLEEAPERADTPDAKIALADLGITADTSALAQSAYQK
NLKGNFLTLGWRYLTNHGVSCSAAGLISLDADKTASAAQAATDSLSYPKEDTSYEVADSA
LMVHMAKDGRSIDSEILAKHLAAGEWDTDLSLDVPYSTETAQTMSAQEIYDQVSGEMKNA
GYDPETRSIIPERTGAEFDVAVAQSTMDSAAPGSTVEISAAIEYPAVTAEELKPVLFRDE
LGSYTTHVGGSAARISNVKLSSAAVNGTVLNSGDIFDYNEVVGQRTSARGYQAAPAYVQG
ETVDEIGGGVCQPSSTLYLATLKSNLEIVERYAHRYVPAYIPKGMDATVSWGGPNYRFRN
NTNYPIKIQAVLSKGYLTMTLYGTKTDDVTVKMTNKVLSTTEYETIYEDDPTLPAGTQTV
KTTPYTGYKVETYRNLYDGNGKLISSSYEAGSDYKVRNKIIVKGPALPSVPTGGTSSEPV
PPETAPGTPPGTTPGTSPETGGVPSTTPVIPEETTTAPSSGETQQPEIDPNAVISPLPAA
>fig|1007096.3.peg.1790 Permease of the drug/metabolite transporter (DMT) superfamily
MQKTSFVRQNILPVLAAFIWGTSFVAQSVGADYVEPFTFNAARSAIAFIFLLALCAVFRF
RRKKDFEAQAKPRPHYRRDLVIGGLCCGAALTLGANLQQKGIETTTSGKAGFITALYIVI
VPILGIFLKKKVGKMVWGSVALAVGGLYCLCIQQGSSIAAGDFYIFLCSLCFSAHILIID
HFTQKVDGMELSCAQFFVAAVLSAVGMLATEQPTWEALRLCVGPLLFVGIFSSGVAYTLQ
ILAQRDSNPTVVSLLLSLESVFATVAGAVVLGDRMSGREYFGCFLMLTAVVLAQIPVKEK
QVAVVEVEEAEEEPLPPET
>fig|1007096.3.peg.2055 Vancomycin B-type resistance protein VanW
MLMQNSERPKKRSAARLRAGKLYYGALRRLLWIKMRNSFASARQEQLLPYTCFAHQTVLL
RKLKDVDMWMQENKIVNLKIAARRVNGILLRPGEIFSYWKLIGRPSRGKGYLPGMILRNG
SFQGGIGGGLCQLSNLIFWMTLHTPLTVLERHRHGYDVFPDSNRTQPFGSGATCFYPYGD
LMIRNDTQDIYQLLIRVGADDLEGEWRISEKPQDRFEIVERNHEFRSEYWGGYTRHNQLY
QQRFNLYGELLDERLAVENSAITMYAPFLSGDVPSTNVKQSNDTEGGYSC
>fig|1007096.3.peg.2064 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKRLFLYPAFCFWEEKKMDLLYGNVKKVYFNYLSAAFGSALISSIYSTVDMAVVGQYQGP
AGTAALAIVSPIWNIVYSLGLLMGIGGSVLLGAAKGRGDEQQKNEWFTSALIGTIVLAVI
SWGVVALFDTQLLQLFGAEETLLPLAKEYLFPIKFIVPLFLFNQLFTAFLRNDNAPALAT
VAVLSGGIFNVFGDFFFVFTLDMGIFGAGLATAIGALISVLVMLTHFFTRKNTLKLVKPH
GIVGQLKRITVTGISTFFIDAAMGILTMLFNRQIVRYLGTDALAVYGIIVMISTVVQCCA
YSVGQAAQPIISINYGAESWTRIKETLKYALYAVCFFSLTWTALICAIPNGFVRVFMTPS
AEILRIAPFILRSYGISFLLLPLNIFSTYYFQALMKPVPSFAVSVARGLLISGSLILTLP
VVAGANALWYAMPITEAVVAVAVVGLMVKYTKQLAN
>fig|1007096.3.peg.2065 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNETIYHKPLNFKNLLVFVIPTMLMTVIQSLYSMIDGVFISNLIGTDALSALTLIAPFFS
ILMAIAAMLASGGSAVVMKKMGEGKEQEAKEDFTMLILVNILIGIVLTLGGTAFVSQLSG
SFGASPVVTAYCQSYLSTYIAFIVPELLFSNVLMYVIAAGGSKLAMASSLFGGVFNIAFD
FIFIKLFGFGMMGAALASGLGMMIPCLIIMAYFFNKKRMLHFVRPKFRGCVLTRTLSNGV
SEFFSNLVSGVVMLLFNRSMLHYAGENGVAASTIIFYVFSFMNAVYMGYMLGTSPMFSYF
YGEQNREKLRKLKALSLKLIGALGIATTILTVLSSRQLIGIFTGPDNPAYAMALHGNRLF
SAALLIAGFNTFSSALFTALGNGLISAVISFSRTFVFLAGCILILPVFLGIDGLWLSVPI
AECMALVLSVCFVKKYETKYGY
>fig|1007096.3.peg.2259 Permease of the drug/metabolite transporter (DMT) superfamily
MNATKQTSLGYFFALFTVVVWGTTFVASKQLLAVYTPARIMLMRFVLAYLALWIIRPRPL
KLPWKTELRFLVLGVSGCSLYFLTENTALLYTTAANVSIIVSAAPIFTAILAHFMIDEKF
HRNTLFGFLVAFAGVVLVVCNGAFVLHLSPMGDLLALLAACCWAVYSVLLRRTAADLDPI
LVTRRTMLWGMITAIPMSIPGGAFTLSPLSSPLLAFDLLFLGLIGSALCYVLWAKAFTLL
GVVPTNNCIYLIPFVTIVAAHFTLKEPISAAAILGAGLITAGVVLAQRRKIDDGAPKAEL
SEET
>fig|1007096.3.peg.2912 Ribosome protection-type tetracycline resistance related proteins, group 2
MKKLAIGILAHVDAGKTTLTEGLLYTGGVLRKLGRVDHRDAFLDTFALERERGITIFSKQ
AVLPLDGLELTLLDTPGHADFSSEAERTLRVLDCAVLVVSGADGVQGHTLTLWRLLARYG
VPTFLFVNKMDQPGTDRSALLAELKSRLDGGCVDFSGPDAERGEEIALCGEAAMEEYLAC
GQLKDETIAALVGERKLFPCLFGAALRLGGVEELLDGLRRFAPSPVYGSAFGAMVYKISR
DPQGARLTHLKVTGGTLRVKDLLCGSRDGEDWQEKADQIRVYSGAKFRAVDAAEAGTVCA
VTGLTRTFCGEGLGEEEASAPPMLEPALTCQVLLPDRCDPHTALMQLRQIEEEDPQLHVS
WQERTGAINLQLMGTIQLEILQRLLKERFDLDVAFGPGAIVYRETIAAPVIGIGHFEPLR
HYAEVHLLLEPLERGAGLRFASACSEDVLALGWQRLVLSQLAGRSHPGVLTGSPVTDMKI
TLIAGRAHEKHTEGGDFRQAAWRALRQGLLSAQSVLLEPWYDFRLTLPTAQTGRAMADLQ
RMGGDFAPPETVGEEALFTGSAPASALRDYAAEVTAYTRGRGRLTCAPGGYRPCRNQEAV
VDAAGYDPERDLENPADSVFCAHGAGYNVKWDQVPAHAHVNSGVHLGARPLDEQSPPAAA
RSASYVGTVEQDKELQAIFERTYGPVKRRAFQKPVPASSARPEPAAAPRPAGPEYLLVDG
YNVIFAWDELKTVAAEHLDAARRELCDLMSNYQAFRRCKVIVVFDAYKVKGGIEKVEKYH
NIHVVYTKEAETADAYIERTTYQIGREHRVRVVSSDGAEQIIILGHGALRVSAAGFHEEM
LQTTGEIKKILEKNNLTGKVRPLREALTKALEKGSE
>fig|1007105.3.peg.140 Multidrug resistance ABC transporter ATP-binding and permease protein
MLRWFESLLNSFPPEEAPLPPRGLLPFLWACTRGSRRYLAALALLSASVSIYEAWLFAFL
GQIVDLLATWQAGAPASAHERRVLWTVGIVLVASIGLVALRTMVQHQALAINLPLRLRWD
FHRLMLRQSLSFFSDEFAGRVTTKVMQTALAVREVLFTFIEIVLGIGVYFVTIVALAGGF
DARLTLPFIGWIILFGLAMAYFVPRLGKVGQEQAHARSSMTGRVTDAYTNITTVKLFSHT
KREAHFARAAMEDFKDTGFRQMRLVSRFEIVNQALVAALIFSVGGYALWLWHSEQVGAGA
VAAVTAMALRVNGMSHWIMWQMASLFESIGTVQDGIATLSRGAKVQDAPGAPALRVMRGE
VEFDHVFFNYNGERQVLDGLSLTVRPGEKIGLVGRSGAGKSTLINLLLRFYDLDSGRIRI
DGQDIAQVTQESLRGAIGMVTQDTSLLHRSIHDNIAYGRPDASDAEIRAAAVHAQADDFI
QQLSDPQGRNGYDTTVGERGVKLSGGQRQRVAIARVMLKNAPILLLDEATSALDSEVEVA
IQESLNAMMEGKTVIAIAHRLSTIAAMDRLVVMDQGRIIEQGTHAELLAQNGTYARLWRH
QSGGFLAEETSELA
>fig|1007105.3.peg.147 Outer membrane component of tripartite multidrug resistance system
MIERLSLRFTSLAMALLLAGCAVGPDYQRPDVDVPNAFKEASLSPEAAKQWKMAQPADAL
ARGRWWAIFNDPILDGLEDQAMSANQDLKVAAARVKQARALRQNAEAGLLPSLDAGFGPT
RQRQSSAAQGLPEDTGSSAQTLWRAQAGISYEADLFGRIASDVDAATADAEQSAALFQSV
RLALQADVAQAYFRIRRLDAEQDLYRRTVDLRGKTLELVQQRYDEGEISELDLARAKSAL
SSASSQALGIKRERAVAEHALATLLGKTPAQFALAPEPLGRVSVDIPAGLPSSLLERRPD
IAAAERAMAAANARVGVAKAAFFPRLTLTGAFGYESSELGNLLEWSSRTFLLGPLVGTML
TLPIFDGGRREAGLERARALYEEDVAAYRQTVLSAFREVEDGLSSLRILKDQTQVQDAAV
QQASRAAELSQIQYREGSVSYLDVIDADRQVLVQQRASLALDGERAQTAVALIRAIGGGW
DIDRQLASR
>fig|1007105.3.peg.452 Permease of the drug/metabolite transporter (DMT) superfamily
MFAGMGACVKVAADYGASLPHVVLFRGIPSVLLLFIWTQLTHRSLVPNSWKLHIWRNLSG
VSSMWLGFFAISHLPLPTAISLNYTAPLFIACWMLGWGGTQRDPVRIVAVALGFLGVLAV
LRPSIAHEHLLAAALGLGAGALSAIAMMQIRSLGRVGEPEWRTVFIFSCFVCFTGSAGLL
VDGWRDISLSAWLALTGVGVFGLVGQLAMTRAFGMGSALLTAALQYTTIIFAALLGIIFW
DDVPDAIAWAGMGLIIASGLLSIWRTYTEDRIMRGQTVVQMQAATVDTAIEETRRV
>fig|1007105.3.peg.519 Outer membrane component of tripartite multidrug resistance system
MKSLLPIVFVAVLSGCAAIKPGEPAVVKTDAVRLGLQDSAIAWPTEQWWQRYGDPQLNQL
LGQALAGSPSLDAAQARLNLANAAVSSARAVRLPQANAGYQLTRERFSENYIYPPPYGGS
MQTDNSLRLDIGFDLDLWGRNRSHYAAAVSRQRAAEADAQMARNTLVSAVVQSYFNLQNA
LAQQQVLGQLVTQLENVLDITRQRVTAGLDTEVETNQADSAVSAARVQLSQAATNADLLR
HQIAALLGAGPQRGQEIQRAKLTQTPRGVPDSIPLSLLGRRPDIVAARLRVKASDSDISA
AKAEFYPNVNLSAFAGFMSLGLSNLLEGGSQTYGVGPAITLPIFHGGALNAQLDARQAER
DLAIADYNQTLLTAVREVADATSAIQALQQQTLDQAASLRAITSAYKIAVNRYKSGLGNF
VQVLQAQNEVQKQAILNTDMQTRAYKLDAQLATALGGGYDSPTATH
>fig|1007105.3.peg.817 Permease of the drug/metabolite transporter (DMT) superfamily
MGDNTGPPLFEFSMSFSSNQLKAYGCLALSMSLVGAYVALTKPLALVLPVFLLGWMRFGI
GAIAMLRWIRKPASEPTLSVQTRWLIFLESFLGNFLFTLCMIVGVSMTSAVSAGVIMSSI
PATVAVLSRVFLKEAISARVWAAIACGVLGIGLLSLTQTPGTGNALDLPGGDSSRQWLGN
LLIFGAVLCEGSYAVIGKKLTAVLGPKRISAVINLWGFVLMTPMGLYTALQFDFTAVDPS
MWLLLLFYGLAASVWTVWLWMVGLKSVPASQAGVFTVMLPISAALVGVLVLGENLGGMQL
LAFAIALAGLLLATLPSRGMKASH
>fig|1007105.3.peg.1609 Multidrug resistance protein
MISTAKPAGLWQQAREILRQAWPVLISSWASIIFGVMDTAMAGHASAADLQVMALAASIY
ITVFVGLMGVVHALIPIIAQHFGGQRYIEVGRTWGQGVWLALGLSLVGAAAMLFPGMWLS
LSGGVEPVVRDGITWYLRALVLALPATLVFRTIYALGTAVSRPKTVMVINLLSVGFKFFF
NWILIFGKFGMPALGAVGAGLSTAIVGWMTLLAGLWAIRHDPYYLRFKPAVGRPHWPSQK
ELLRLGIPMGGSYLIEVCAFTFMALLIAREGMFVTGGHQIMSNLAALSYMMPMAVGIATA
SLTAQAIGAGDLQRARLTGRAGIGIVLLGATVTATVLVVAKQPILRLYTDDMQVAIVAGA
LLQLLPWFHLFDATQCIGSYLLRAYKVAVVPLILQIVALTGLGLIGGWWLGFGPAADTLK
PVVTRIAPGAPMGAASMWLMALAGLALSASLLFAWYGHVVRSHMRAGRV
>fig|1007105.3.peg.1615 Multidrug resistance transporter, Bcr/CflA family
MHQMPPQQNTLTTIPSWLILMGLLTAIGPLAIDMYLPAFPAIAQGLGATHGDVERTLASY
LLGLALAQLFYGPLADRYGRKKPLMLGLAIYTVAAIACGYTNDIEHLGFWRVVQAFGGAA
GIVIPRAVIRDNFDTRDASKALSLLMLVMGVTPILAPILGGQVLVFASWRGIFAIMAACS
ALLLAAVALTMRETLQPEKVIPLGARVIARNYLALLGHKRFMCYTLAGGFGAAGMFSYIA
GSPRIFIDIYQVDPRYFGLLFGLNAAALIIAAQVSARLLSRHTPEKLLRPAQIILAGVTL
VAVALTLANAINLLSLMVCLMIFMASQGFVNPNSAALSLREQGHRLGAASAMMGALQMLC
GAGAGLAVSSWQSPTALPLTAILAFCACLSWFFGRMALRTAAKPLD
>fig|1007105.3.peg.2137 Multidrug resistance protein B
MPAESTVSPASTPLTPKDIRSIIIGLMLAILLGALDSTIISVALPKMAADLQGINLLAWV
MSGYLIAMAVATPIYGKLGDIYGRRSVLSSAIVLFLVASVACAMAPTMPVLVAARILQGL
GGGGLISVAQATIADVVSPRDRGRYQAYISGAFAVASVSGPVLGGVLTAYLSWRWVFWIN
LPLGLIALLISRRALAKLHVPQHKRSVDYLGAALLSLGLTAILLAITRAGQQNVPGLDHN
SLWMIVIAVVSLAAFGWHALRVPEPIVPLGLFRIRTVSICCLILFIAFVELVALTVLVPL
ELQMLTSVGADGAAWRLIPLSLGVPLGAYISGRLMTHWGTYKHIQLTGALLMPIAIFLLA
FADPASTFTMAVLLSLIGFSIGLQLPTSTVAVQNAVPHRHVGVATAASAFCRSLGSAIGI
ALLTAFLLIWLRAGAGAIGNGMNGADIINTLIGHSHTSIQDIDLSGLAPIARLSFQKVYM
LAAAIATVSILLSALLKNESLSEKPAAKSSKE
>fig|1007105.3.peg.2658 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MNALVENWRLDADHDSHVELSVVVPLYNEHEVITMMYQRLTTVLSGLAISYELVLVDDGS
HDGTPNVINLLAKSDPNVTAVFLSRNFGKEAALTAGIEHAAGAAVIIIDADLQDPPELIP
QMLAAWKDGVDVVCMRRRSRAGETWLKRCSAHHFYRLLNAISDVDIPPDAGDFRLLSRKA
VYALQQLNERNRYMKGLFAWIGLPTAIIEYDRMPRAAGATKWDYLGLLNLAFQGITSFST
APLRFAMGSGLLTALFGVLFTLWIVIKALVLGDPVQGYPSLISMITILGGVQLLSIGLLG
EYLGKTYYEAKQRPVYLVRDVMRRGKPVQEMATDKGRSSKVKEAYASFK
>fig|1007105.3.peg.3048 Permease of the drug/metabolite transporter (DMT) superfamily
MTSNAHEAGGDREASLAIRISLLTCLSMLAFAGNSILCRLALMERHIDPLSFTALRLASG
TLVLYALVYLSSHRAAARQTTPVRQSGSWAGAIALVLYAVAFSLAYVNMESGVGALILFG
SVQLSMLLYGMIKGERLGALSMVGLLASIAGLVFLLLPGSSAPPLAAAALMAIAGAAWGW
YSILGKGATNPLASTASNFGRAVPLSLLAALPLLATLHWDARGLSYAILSGTVTSGLGYV
VWYGVMKQLSVLKASTVQLSVPILTAVMGAALLGEALTLQLILSCILVLGGIGLVLVSKG
RSQA
>fig|1007105.3.peg.3142 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTMKLSIVVPVYKSQSILPELVEQIKTSFEEQGLAGQFELILVNDCSPDHSWQVIGQLAK
INPFIRGISLRKNFGQHSATMAGLNHARGEVVIIMDDDLQHPPSEITNLMAAINNGADAC
YTRYIERQHALWKKIGSRFNDWVATVLLDKPQGLYLSSFKALSRELVQEVIKYDGPYAYL
DGLILEVTRSIAVVDIKHQARHDGEGNYNLRRSISLWLRMATSFSVFPLRVATFFGFCLA
AVSLIFVAVVIVQKLLDPSIAMGWTSLMATVLFVGGVQTFCVGLLGEYLGRTYLRINGKP
QFVVRETTWADKS
>fig|1007105.3.peg.3606 Permease of the drug/metabolite transporter (DMT) superfamily
MPTSQGTPLWLAAAPALFLLLWSFGFIFLKLGLAYADPFTFLALRYACVVAILAIPCLWL
RPPLPATPQVWMHLSIVGLLVQAGYFSFAYLSLKQGVSAGALAIITAQQPLLVGLLAPAI
ASERVGAIRWAGLLMGVVGAGIVIFAKSAVEVASTAGLLYGVLALLCMTGGTLWEKRYGT
EVHPISANMIQYTVGLAVAAPLAFLLEPMQVQWTIGLFASLAYLVVGNSIIAISLLLAMV
RRGEASRVSALFCLVPPTTALLAFPILGEAIPVLAWPGMVLAVAGIYLVMRKS
>fig|101510.15.peg.507 Glyoxalase/bleomycin resistance protein/dioxygenase
MEFTMSDLQHTVKGVDHVAYPTFDPAATVTFYRDVLGFPVVHSICAAGWGPEKHPDFIHF
FFDIGNDDRLAFFYYFGLEPFDGGPQGDSYSRFAEDVPIFFIRSRHLAIHVDSEDDLMEY
RRRLDHSAWPVEMQIQHETIESIYTHDPNGYMIEITRALRPVTPQEDLDANLTIDALVDV
VTGPDPSMAALLTRKAELITERAAAWHQEQESKEMVTR
>fig|101510.15.peg.1069 Glyoxalase/bleomycin resistance protein/dioxygenase
MADATIGSILLASTHPDRLRDWYTAAFSPKVERTPGEPGYDVLDFDGFYIMLDRRDDVGD
TNPEPGRILLNVEVTDARAAADRIDELGATWLSPLEDRDGSWFGTAVDPDGNYVQIIQLS
AQARAEMS
>fig|101510.15.peg.1550 Drug resistance transporter, Bcr-CflA family protein
MPSLLCCFMTETEERAAPTADRTTTRPSLRVILVLGAMVALGPFTIDMYLPALPDIGTDL
GASSSAVQLTITGTLLGLALGQLIVGPLADSLGRRRPLIAGIGVHVVASVLAVFAPTVAV
LGVLRVFQGIGAAAAAVVALAVVRDLFSGNTVAVVMSRLMLVLGVAPVLAPSIGGALLIA
VDWRGIFVVLAVIGTLTALIGVWGLTETLPPERRRKSNLRAVLSTYKSLLGDRAFMVLAL
VSSVAMGSLFSYVSGASFVFQDQYGLDEQQFALLFSSGAIALIGASQLNVRALARWSPLQ
ITVSALAFATVAGLALVTTAHFEFGGLVGFVVPLWFLLAGVGFVLPNAPALALGRHGEAA
GTAAALLGALQFGVGALIAPLVGVLGNTGVALAITMTACAGLGLVALAAAAKAEAH
>fig|101510.15.peg.1790 Glyoxalase/bleomycin resistance protein/dioxygenase
MSSFPGLTHVAITVSDLPASTAWYTALFESAPVLDEDEESGTFHHTVFALDGGMLFGLHT
HPDSGAPARFDERQVGLDHIAFQCSPDALPRWVERLDALGIEHGGIKTAHYGSGISFRDP
DNIALEFFAPPVSTS
>fig|101510.15.peg.1969 Multidrug resistance protein B
MTSPTAANAAPDKLDGTVLKIASVVVLGAIMSILDVTVVSVALPTFATEFDTTYATVAWT
MTAYTLALATVIPVTGWAADRFGTKRLYMTALVLFVLGSVLCSFAWDITSLIGFRVLQGL
GGGMLMPLGMTIMTKAAGPDRVGRVMAVLGIPMLLGPIGGPILGGWLIEAASWHWIFLIN
LPIGIIALAAAFIILPSDNASPSESFDFLGMLLLSPGLALFLFGVSSIPEVGTVASARVL
VPGAIGLALIVAFVVHALRKDHPLIDLHLFKNRQLSVAVITTSLFIVAFMGAGLLFPSYF
IQVGGHTTLAAGLLMAPQGIGAMLTMPVAGRLVDKIGPGKIVLTGLPLILIGLGVFTQVA
SDSPTWLLMGALFVMGMGMGCTMMPLMTAAIVTLSNEQVARGSTLMNIVQQTAGSIGTAV
MSVVLTNQLLDRGLDSQTVAMQHVPEVAAQEPPGMVDQVLSQAADAFGNTFLVATVLIAL
TLIPAFLLPRKKSVNPKLEAEGAPTVMMH
>fig|101510.15.peg.2208 Probable ABC multidrug resistance transporter, ATP-binding component
MDNLTFNVKPGMVTGFLGPNGAGKSTTMRMILGLDRPTAGSALIDGKPYSDLVQPLRTVG
ALLDAKWVHPNRSARAHLQWMAASNSLPKSRVDEVLHLVGLTEVAGKKAGGFSLGMSQRL
GLAATLLGDPKVLLFDEPVNGLDPEGIVWIRKFMQRLAAEGRTVLVSSHLLSEMALTAEH
LVVIGRGRLIADTTVSEFVSKSSESTVRVRSPQLDALRSALTSNGLTVREDGSDGQQALV
VVDSSTDVVGGIAGSQGIVLHELASQRGSLEDAFMKLTGDDVQYHAEGVEDVMRGAL
>fig|101510.15.peg.2629 Probable ABC drug resistance transporter, permease component
MISAPAHTLAEPAPADLRFHPLRDSATMLRRNLDHMLRYPSMTVTLVGMPVVFLLLFVYV
FGGTLGAGLGGVSGGRAEYVNYVVPAIILMTVTAAVQGTAISVAMDMTEGIIARFRTMHI
ARVSVLTGHVLGSVIQAMLSVAIVIGVALLVGFRPTAGVGAWLATAGFLVVVTFALVWLS
VALGQVSKTVEAASNVGMPLVLLPFLGSGFVPTDSMPAGLRWFAEYQPFTPIIETLRGLL
MGTPIGNNAWIALGWCAVIALGGYLWSKRLFNREYSR
>fig|101510.15.peg.3920 Glyoxalase/bleomycin resistance protein/dioxygenase
MGTTDEQERSQRFAEQRDRIRAEHLKPVAARPASSARGLHHTALISSDVERTVRFYQDLL
EFPLTELIENRDYAGSSHFFFDIGNGNLLAFFDFPGLDVGPYQEVLGGLHHIAISVEPDR
WEHLRTKLIDASVELVEHSEVSMYFRDPDGARLELIADPLGEMYGSHVL
>fig|101510.15.peg.4177 Glyoxalase/bleomycin resistance protein/dioxygenase
MLRGLITVSLFADDIPAAREWYCALLGITPYFERPDSENPAYIEYRIGDYQHELGIIDRR
YAPHGAADGPSGVVVFWHVDDVTAAVEKLLTMGAKEHEPRTERESGFVTASVVDPFGNIL
GVMYNPHYLDVLGSRGEA
>fig|101510.15.peg.4385 Drug-export protein
MNTAVGQAQSATAGDELGPGTSPALAALLAGTFVGTVSNNIVNVPLNAILTDFDAGLGSG
IFVVVGFLLTFAATMPLAGWIGDRFGRRRVYCAALLGTAVCSLGAALAPSLPVLVIWRSL
GGIAAAAFAPAVMGLIAWLFGPPRRARAVGAWAAVNGIGQAVGPSMGGIVSDWWGWRWAF
VPLVPVALIGFAATLRYIPRYPGKKMRLDVIGASTVTLGAVLLILGLTTVSMEQVPAWVS
IATIGGGVVVTAGFVLHCRRAANPFVPIDLVIESRFLRSALAAFTQMFALGALLLALPLY
LTGSGSSTTQAGLMLFVLPVVMTCVAPVVGRLVDRIGARVVMRTGLAVLISSQVALAITL
SADVRNPVAVGAVLLVAGVGIGMVQTPAAAGSTRSPAGAVGTGLGLFNLIRFGGSAVGAA
WVGVAAHLSADPYGLLFAVAALVVLAGLAGTFAGENPVAG
>fig|101510.15.peg.4565 Glyoxalase/bleomycin resistance protein/dioxygenase
MTGRIVHFEIPFDDGDRARAFYRDAFGWAIAEIPDMDYSMVTTGPVGESGMPDEPGYING
GMMQRGEVTTPVVTVDVESIESALERIESLGGKTVTGRTPVGNMGFAAYFTDSEGNVVGL
WETAR
>fig|101510.15.peg.4781 Quaternary ammonium compound-resistance protein SugE
MLSGILEAVWATALGRSEGFTKLGPSAVFGVALILSMAGLAFAMRSLPIGTSYAVWVGIG
AALTVGFAMVTGAESSSLVKILLILGIVGCVVGLKVLH
>fig|101510.15.peg.4836 ABC-type drug export system, ATP-binding protein
MMFRRAQTAARLRPAGGALELSHVTYSFGDYAAVKDLSLVIEAGECFGLLGPNGAGKTTT
IRLLNTLLPLQGGDVSIFGYDVRTQAMAVRRLLGYVPQQLSIEGALTARENVSWFARLYD
VPRPERRRRVDEVLEMVDLADVADRVASSFSGGMVRRLELAQALVNRPSLLVLDEPTVGL
DPVARDSVWTRVTEMQKQYGMTVLLTTHYMEEAEALCDRVALMHRGELRAVGSPSGLVAE
LGPDSTLDDVFRHFTGDSLTADEKGGLRDVRSARRTARRMG
>fig|101510.15.peg.5248 Vancomycin B-type resistance protein VanW
MNDEDGDKGSKAPERSTPDPSATAESVEPENVADPPAPEPDEVPAPDEAAAPENAPASDE
APAPDAPAEQPNADDAPTTQLNLGDLGERSEEQAPDAPLWVEPPANEDVTQVIPAIPPGP
VPGPTQAYTTPADEPTVVAPAAAAQIPPQPAPEPSAPAEPSAEPTKPARAPWVKIAAVTG
GVIALIGIAYAADLAVSSGKVPRGVTVAGVDVGGSSREEAEAILQAQVGPRADQPLTVTA
GDVSTQLVPSAAGLGVDWEATLDRADSQPLNPFTRLTSFFTTDEIGVVSTRNEAALASAV
DGLRTETDRASREGTVVFEGPTPVPVDPSTGQNLNGEGAEAALTEEWAFGRTVELPVDVV
PVTVTKEGVQRALAEVAVPAASADLVVTGRDGKVATAARQQIGAIVGFEPDGNGGLKPTY
NIEAAIGILAPQLVSTEIAPKDATITLDGGSPTVVPAVVGDLVQWPKTLETLPELLRGNG
SHTTAAVYGPVPPALTTEAAQALGVKEVIGEFTTGGFSAASGTNIRLAASEINGALVKPG
DTFSLNGYTGPRGTAQGYVESGIINNGRPDTAVGGGVSQVATTLYNAAYFAGMEDVAHTE
HSYYISRYPEAREATVFEGAIDLQFRNTGKTGVMIQAIGGASDLTIRFWGTKTVDVESIT
GNRTKPTEPDTVTLPAGDHCIASSGAPGFTASDTRVISDHATGQEISRDTRTVRYDPVPI
VKCEAPAPAPKPDERTPAASPAPSESPKPTTPKPNPNDGE
>fig|101510.15.peg.5259 Glyoxalase/bleomycin resistance protein/dioxygenase
MPDRPSLTGAPCWIDLTSSDPRQVIPFYTGLFGWRSDTNEDPQYGGYSIFSMNGKPIAGL
GPQQQGNPYGNVWTTYIASEDAEATAAKAAEAGGQVMMPAMVVGDQGTMAILGDPAGAVI
GVWQADQHGGFGLVDEPGAPVWHETLSRNYAAALPFYADVFGWTFRTLGDTDEFRYSQAN
LGDRTVAGVMDADSFLPEGVPSFWQFYIGVEDTDAAVAKVTELGGTVRRAPEDTPFGRLA
SVADPLGATFQITTLQS
>fig|101510.15.peg.5300 Probable drug/metabolite transporter, permease component
MTRNSTHVGATMALTSMLCVQSGLAISVGVSERVGAEGAAWLRLAWAGVLLAVIVRPRPK
AFTRSSLGACVLLGVVTAAVTLLFMAAVDRIPLGTASALEFLGPLGVAVLHGRGRLKWPA
LAAVGVLLLTQPWAGGVDPVGILFALGAAACWALYIVLTQRVGDEVAGLNGLAVSMPVAG
LVATAVGGPSMLGKMTPDLLMIGLGLAILLPVVPFTLEMLALRRLNTAAFGTLMSLEPAL
ALIIGLVVLHQIPDHAAVAGICFVVAAGIGAARAGARTTPDQGDVTESAAPLSAPT
>fig|101510.15.peg.5597 Glyoxalase/bleomycin resistance protein/dioxygenase
MSFQGELVSFVASTDLDVSEMFYVETLGLTLVSRDEFALALDCNGSLLRVTLVQAKADTG
YTVLGWKVGDLNKVVETLRSKGIEFTEYPGMDQDEHAAWRAPDGIRVAWFRDPHGNVLSL
FEDPN
>fig|101510.15.peg.5918 Multidrug resistance protein B
MPTVAAALSAGPAAQTWILSSMSVGLAAVLLTAGALADDYGRRRVFHWGAWLLALGAVVG
AVSQEPVLFIVGRLIQGVAGAALIAASLGAVAHAFTTPAARATASGIWGASVGAGIAVGP
VVAGLLDLAGWWRGLYWALAVASLVIGQVATRALAESRSAVPKRIDVPGAVTLCAAMVLV
LVALVEGRQGNIAATVLCGVGAAVFTLVFVAVERRRPFPMLDLTLFRRRDFLAATLAALA
TGAGIIGLMSFACTFLVKTMHVSTLAAAGVIALWSGTSVVASLLARTLPARLAGSPQLVI
GLAGVGLAMLTMTGLTPDSSLLRLVPGLLLAGVASGLLNAGLGRQAVASVPADQGGLGSG
ANNTARYLGSSIGVTVVSIIALDPAGTVDGMMLGWNSAAVTTGLISLVGAGVVGVLVRGT
AVRR
>fig|101510.15.peg.6259 Glyoxalase/bleomycin resistance protein/dioxygenase
MTISFNHTIVAAKNKQESATFFTTLFGLPDAVPAGHFLAVALDNGVSLDFAEPPVEFPPQ
HYAFLVGEDDFDRIYGLIVEWGLDHWADPRQTLPGTINTNDGGRGVYFLDPSGHYLEIIT
RPYGSGG
>fig|101510.15.peg.6691 Drug resistance transporter EmrB/QacA subfamily
MATLDNLVMTSALPVIQRDLGASVGQLQWFMNAYTLAFATLMLTLSALGDRLGRRRVFLW
GIVLFALASIASALSTTSEMLIAARAVQGVGAAAIMPLSLTLLAGAVPLAKRALAIGIWG
GVSGLGVALGPVVGGAVVDGVSWQAVFWINVPVAAVAIPLALYALGESKGKRQPLDPLGV
VLAGAAVFLGVWGIVHGNDDGWTSATVLGALVAAAVLLAAFVVRELRTPFPVMPLRLFRS
RQFSLANVIGLTFTLGMMGAVFLLSQYLQIVMGYSPFEAGLRTLPWTAAPMLVAPIAGLL
APRLGVRTLLVTGLVLQGLSLLWMASLIVPGATYGSMVPAFVMAGAGMGLTFAPNATAVL
ADMPEADHGTASSTNATLREIGVALGIALLTAVFLGAGGSLTPTGYIDALAPALYVGAGF
VAVAVVAAALMPGRSKAVLAST
>fig|101510.15.peg.7091 Daunorubicin resistance ABC transporter ATPase subunit
MNAPTVVVEDLHVAYNKTWALDGVDLEAAAGTTLGVLGHNGAGKTTLIRTLTTLVRPTIG
RVQIEGLDVVVHATEVRRRIGVTGQYAGLDEFLTARENLELIGRLTGLRRTARERADALI
DRLGLQEYASRRVGELSGGSRRRVDLAASLVGSPSVLFLDEPTTGLDPLARAGLWDVVDE
LTDAGTTVVLTTQYLEEADRLADHIVVLRRGRVAARGTPAELKRIVGGKVLSATIPAGQL
AALPFVPDTDPRVDGDRLRVSVTVGDAPAATALVADLHRGGIEVTDLDVTSPSLDDVFTH
LAHTGAHK
>fig|101510.15.peg.7139 Drug resistance transporter EmrB/QacA subfamily
MTEPTGLVNDEARADDRIERRHLQVIGVLLVASFVVILNETVMSIAIPVLQVELGVHPSV
GQWLTTAFMLTMAVIIPLTGYLIQRIPTRTLFVLAMSLFTAGTLIAFAAPGFGVLLFARI
VQASGTALMLPLLMTTIMTLVPPARRGAMMGNISIVIAVAPALGPTLSGFILDHFGWRWI
FGFVAPIALATLVLGARFVVSVSETTKAGIDILSIPLAVLGFGGLVYGLVSIGESAQKSP
TIPVWVPFLIGAAAMSGFLARQFRLQREDRALLDLRVFGYRQFSISVVAMLVGMATMMGT
FIIVPYFAQSVIHLDPFETGLITLPGGLLMGLAGPIVGRVYDRRGPLVLVIPGSILVSIG
VWMLTTLNTSTSLWWLLLSNMALCLGLAATFTPLMTSGLGSVAAHLYAHGSAVVGTFQQV
AGAAGTALFVTVMTVIASRSGHPHDSPDAIAEGVRMVFVVAGILSFVLIAACAFVRKPAD
PVEHAHPASVDAPALGT
>fig|101510.15.peg.7580 Major facilitator superfamily multidrug resistance protein
MSINEAPSEDGCPEGQTDGRIHGVRRQIAIVAVILLLCELNAMAVAMLVPGLRPMAAEFP
VEGLAWTITIVSLVGAMVMPLGGKLVDRFGQRPVVLTACAVFLVGSLISALSSSFALMIV
GRALQGTIAVMPVIAYRVFRDSLPPRVVPIALGALGTGFGVSGLLAPVIGGAFVDGLGYR
SIFWFFFAFTAVLAPLSVIVLPRTPRQRSAEVGRVDILGGLLLALGIGGILLGLGQGDKW
GWLAPLTLLVILGGFIALGMFVLVESRVEEPMIDLRVLRNPAVALTLTVGLVGFMACGMM
AIALPQMLQTPSSTGMMYAFGLSALMVGLAQIPFGITSMVFGPLGGLLTKRFNPRAIMIS
SMASFAIGSTLLALAHHSLVLVLVWLCVMGVGFGLFWAAQPNLMVEAVPRKYTGVSGGIQ
VCSVSISTAIASAIVGAVLSSNVADVGPEGPLYNDAAFTTIFLVGAGSAVIALIISMFMR
HGRQPATGGAATDLELDVEGATFARVGSADGQGLA
>fig|101510.15.peg.7935 Probable glyoxalase/bleomycin resistance protein, dioxygenase superfamily
MSAVTTNQPLGTPTWIDLGIPDLDRAMTFYGSVFGWEFDVGPEEYGRYTMCLLGGNKVAA
LMPNPDENATEFWWNVYLATDDLDATVARSAAAGGTLLMEPKDIADQGRMAMVRDPSGAQ
FGLWQGRAHVGCELVNEPNTLLRNDLVTPNPGPARDFYAAVFDFTLDGNDDLPGVDFTFL
RRPDGHEIGGIVGDPAASASSWGTLFQVVDTDAVVAAARANGGTADDPTDMPYGRTADVA
DPFGATFTVGSPLPGGQG
>fig|101510.15.peg.8990 Multidrug resistance transporter, Bcr/CflA family
MATGVYLPGLPSIASALGTSNIGVQLTLTTFMVGLGLGQLLAGALSDSWGRRRLLLGGSV
AFTVASAVCALAPTIGVLTVARLIAGFSGGIGVVLARAVISDRARGIEAARLFSVMMIIG
GVAPVIAPVLGGMLLGPIGWRGTFWVLTAIGGIMTFGVATAIPETLPPETRHTGGLLVLG
QNFRQVVGDRRFVGYAAAMAIGAGAMFSYIAASPFVVQKIFGFTPTQFSLVFAFNALSLV
TAMTINSRLVSRISVRRLLIFGVGVVWVSGLGLLAVSLFSPTTPWPLLALLLTMMFGMGL
TMGNAVALAQDQVPSVAGTGSAVIGAAQFAVAAIVSPLVGLGGESTSVPMAVSIAVCGTI
ALTALLTLTRDRPETRLPGFRFQKNAL
>fig|1026882.3.peg.117 Acriflavine resistance protein a precursor
MKISPSISRVIALSALLILTACQSDEQQQGAQQQESHVDVVTLAPQKVTLRSSLPARTTA
FRQAEVRPQVNGIIEKRLFEEGAQVKEGQQLYQIDAALYEAEVANAKAQLMRAKAALQTA
KSKEARYKNLLADNAISQQDYDDALATYQQTEADIKVQEATLKTAETNLNYTHVYAPISG
QIGKSNFTEGALVTAQQTAVLTTIYQLDPIYIDVSQPSKQLLDLRKRIIARQINKEKAPK
VTITLEDGTAYSETGTLQFAEANVDPTTGDVVLRAIMPNPDNLLLPGMFVKATIEEGQLD
NVILAPQKGITFDREGNATALVVNKENKVELRQLELDQAVNDNWIVKSGLNAGDQIIVEG
LQKVAPEASVKIDNNTLQTADSGA
>fig|1026882.3.peg.320 Acriflavin resistance protein
MLEAPIRNGKLLTVIVLIIMVLGIAAAKRIPVQMIPDLDVQTISVVTGWPGATPQDIEKE
ILIEQERYLRSVPNLARMESLADTGQATIELEFPFGVDVNETLIEVSNALSQVSNYPENV
DQPRLYSSSFSENAFMYFAVTPLPGNPLSLDMDMVTDFIDDDVRPRMERVPGVSEVQLRG
GAERQIQIHIDPAKLAQRGLSLTDVRDAIRERNRDTSAGDLDDGKRRYFIRTVGRFKDVE
SLRELTLAHRNNTDIKLKDVAEVRLDHYEVRGLSIVNDEAALTMAVKRETGSNVIDIKQA
MLKEIDEIRQDQLHPNGLTISLIGDDVRYVQASVEKVTQNLALGAILATLILYLFLRSGR
ATVIGLLGMPVCTIAAFIGLLAFDRTINVISLAGIAFAIGMTVDNTIVVLESIEQARRRG
LDRIQAAITGVKEVWTAVLASSMTTVLVFAPVLFVDEEAGQLYSDIAIAISTAILASMLF
AVAVVPAACARVGFGDDRDHGDDLKHPGPILKMVSWLNTSPLKRLLSIVIIFTSTMGAGW
YLLPPAEYLPEGEEPKAFSMMIAPPGYNIPEMRLLADDIRQHLSEALHADPQKFDNGEHR
LPALKYYFQRINPGSIWILSEPVRPQDLQAMMDALTSMFKEYPGMRGFSNRGSIISSNQG
GTRAVNLDISGADQESLYSTAEYAMRRAEKLFGNPQIESEPSALSLDQPLVEIRPNWDRL
AEIDMSADDFGYTVAALSDGAYVDEFFMNDDKIDMFIFSTAGQNQTLSSLANVPIMTPQG
TVLPLNALANIVDTVDSDQLRRVNGRRTVTLLIIPPREIALETAVNQVRTQMLPNMQAEG
EVAKGVSISISGAADQLDATRESLSGNLVIALILIYLLLVAIFSHWWYPLLILATVPLGI
AGGIVGLAAVNAAGPLLNLFGLPAIIQPFDMITMLGFVILLGTVVNNPILIVEQARRNLE
DKAVSVRDAVNQAVATRLRPILMSTATTVFGLAPLVFIPGAGTELYRGVGIVVLVGILCS
MIVTLTFLPSLLITVLNWAERFSVKKTEINEATTRM
>fig|1026882.3.peg.1124 Multidrug resistance efflux pump
MVKLKKFLLPVLIFGLTILIVVVLVATKPKATPKDAQQKAWLVNAVAAQMTTVSPQVTVY
GRIETPRDATLKAAVEADVEQVLVLEGETVTQGELLLQLDKTDVELVKQQRQADVDEIIA
SIANENVRYRRDLALLENQKQLVNLADKAVQRAKKLEQNKLTSQAALDESSAAYQQQELA
LKQLQNDIAEHPSRIAQLEASKKRAEALLKQSEVNLERTDIRAPFPSRVAKLNVAVGDRV
RPGDSLINVYDLNNLEVRAQIPGRYSQQIRQMMQRHQLIQATAMIDDERVKLELKRLSGE
VRLDSGGIDGLFRLVNHPNNLPLGTFVELQLQLSEQHNVIELPFSALYGLDRVYLIEDGH
LKAVTIERVGEVVGKDNQHRLLIRSDEIASGDLIVTTQLPNAITGLAVETKL
>fig|1026882.3.peg.1216 Quaternary ammonium compound-resistance protein SugE
MNWLILITAGLLEVGWAIGLKYTDGFTKPAASITTFLLMIVSLYMLSIALRSLPMGTAYA
IWVGVGMVGTVIVGALFFNEAFSLIKLVSLVLIITGIAGLKWSTS
>fig|1026882.3.peg.1502 Glyoxalase/bleomycin resistance protein/dioxygenase
MSENKLVRPGKTGGMRHIALFVDDLAACEFFYTELLGMHVEWRPDEQNVYLSSGNDNLAL
HQAAEPPAPSHQQKLDHIGFIIPSMDEVDAWFDFLSANNVEIRNPPRTHRDGARSFYCYD
PSGTVVQIIYHPPIS
>fig|1026882.3.peg.1791 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKAVLSGPIIPTFLRFAIPSILGLLAITTASIVDGIFVGQFVSAEGLAAINLLIPYLSL
IFGLALMLSIGGAVRAGYYLGQKRFAAASDVFSQCLIAIVVIGLSFMLLSWFFADSILGF
LGTPESLLTLIRPYFYIINAVLVVQISTMVMYYFIRQDNAQTLASSALISGALINIVLDA
LFIIVFDWGLKGAAAATAIAQVIQLIMLSRYFLRAEKTLSFSLTQQHWSEIKPAMFNGGS
EFINEISGGLVILVLNWLLVSRLGVEGIAAFAVINYLIFISLMLYYGISDALHLVVSQNH
GAQNVQRIRQFLLTALSCILLISISLTLCLVFFPEQISRLFLDETAEQTLLLSQQFIALL
WPLFLINGVNVIMSIYLTAIQKPIPSMVIALSRGLFLPVLLLLLFSWLLPEPEFLIALPL
SEWLTFIIAIVLFSWYRPSKQT
>fig|1026882.3.peg.1848 Multidrug resistance transporter, Bcr/CflA family
MNQTTTPTKALILLLAALTALTPLAIDAYLPAIPQMANDLITSIHDTEISLSLYLAGFAL
GQILGGPFSDHFGRRTATGSGLTIFCLGTIGIIFSQDIHSVWGFRVIQAIGGGVAVVNAA
AVIRDLSHGKDSARHLSNMAVIMMLAPLLAPLIGMLILHISGWRLIFVFLLVYGLTIGIA
LFFRLPETRKKTTERTSMLKRYGMVLSHRCALGFIFSQCFALAGMFAFITGSPSVYMGYF
EISETIYPFLFGLNVIGMMLANRLNIRLLHYYKPHFLLSLGQAAQILTSLILLSYVSVIA
QPQLWFVVSLLILFITAMGLIVSNATSGTVEFFPHNSATATALLGSIGFAAGALSGSLVG
LLGDGTPWPMVLIMFICSLLGPILRTLLQYGQQQPQTQP
>fig|1026882.3.peg.1994 Multidrug resistance efflux pump
MSEVSAASLENSPRLGHSLLLLITLFFICAFWWASVTELDEVTRGQGKVIPSSKVQVIQN
LEGGILSEVLVNEGDLVDKGDVLLRIDDTRFSSSFRETQLKYWELLARKARLTAEVEGKP
LELPEEIIKQQPSLAASERSLYQSRQLELQSSINVLEQQVKQREQELLENQAKLNKLSTS
YDLSRQELEMSEPLVSVGVISEVELLRLKRATNDLRGEMETTRLAIPRIRSTLNEAKQKI
KDTTLRFKSDAASQLSEVQSELAITKETTTSQQDRVRRTLVRSPVKGKIKQLKINTVGGV
IQPGMDLVEIVPVEDNLLIEANIRPSDIAFLSPGQQAMVKLTAYDFSIYGGLPATLERIS
ADTIINDEGESFYLIYLRTDKNYIDSSKGPLEIIPGMTVTVDILTGKKTVLDYLFKPILK
AKNEAMRER
>fig|1026882.3.peg.2089 Multiple antibiotic transporter
MLDYTEYTKFLVSLIAIVNPLGIIPIYISLTADYSSAERAKIARTVIIAATTILLVTAFL
GQWILEFFGISINSFRVGGGIMLLLMGIGMLHNTSKGLKQNHELAQQSGESIAVVPLAMP
LLAGPGAISTVIINAYKGHGVAHYSIIALDIILLGLLLWILLLLVPWIARRMSTNGINIA
TRIMGLILAAIAVEFIANGLKGLFPALAG
>fig|1026882.3.peg.2255 Permease of the drug/metabolite transporter (DMT) superfamily
MLMWALCYPLIKLSLPYAPVMITAFLRAVTAGSVLIAIALLINRRFPNTIRIWVYIAIIG
FSGTGLGLWGMFYAGKLLNPGFATVLTNTQPLIAGVLGWYVLNEKLGKIPLTGTVVGFIG
IIIISTNTLFDTGETVLQGILYVFLASTGVAISNVLLKKIAGQVDVFIAMGLQLLFGSIP
LAFLAFNTSHFSLLDWQLNYTLILLSLALVGTALPYVTWFWLMHRTSLYKLNVYNFLTPV
FGLYLGLNFFSETLTELQWLGAGLIIVAILLVTATNGGIKTES
>fig|1026882.3.peg.2493 Multidrug resistance protein A
MKWAKLGLLSICLVGIIVGLGLWWQHQKTYPSTDDAYVEANILTVSSQESGRVTELNATE
NAYVKAGDVLLKIDDSDLQSAVDEATSELEKTIQKHMMAGSDVSEAIANLNAVQATLRDA
ELEFERQQTLYERRIISKSTLDKTQANLDKIKADRDSARAALNTAQTQLGGKTDEDPAVR
AARATLKRAQIALSHAIIYAPADGWIANLTLRPGDVITAGQSLFSLVEKNDWWVTANFKE
TALSRIQPGQPASIEVDMYPDLKLTGKVASLGMGSGAIFSLLPPENATGNWVHVTQRFPV
RIHLDYQPSPDQQQRLRAGASVTATVDTTNLDKAND
>fig|1026882.3.peg.2696 Permeases of the drug/metabolite transporter (DMT) superfamily
MEVLVVLSRLLFSAFSNVFQKQLTHRGFDSLFIVFSAYIVLAVICLPLLFLFDPFSLTAT
FWINIFFAALLDMAGTVYLVISLSKTDLSVFGPLNAYKVVVSMILAMIFIGEIPNLQGFF
GVAVIVAGSYFLFPAKTAQQSRIWTLLKDKGVQYRFLSILLFSIGTLPLKTAVVNGGALA
TTVFWCLLGLPLAAMTQWFFIKGKLQENMTKAQANIQSFIYLGCLIFLMQYMTMLVFSQL
FVAYSLALFQLSMVLQVFLGYRIFNEQYIWRRLSACLVMVAGSLLVLNA
>fig|1026882.3.peg.2780 Acriflavin resistance protein
MTDIKPTLGISGRIAALFQDNALTPLMALLALLLGLFALMVTPREEEPQIDVTMADIFIA
YPGASAKEVESLIATPAEQVVSEISGLKHVYSVSKPELAIITAQFEVGENRTDAIVRLYN
KIYSNLDWLPKNLGVSQPIIKPKGIDDVPILTLTLWRQGQQDSNQLKQLAQSLEVELKRV
DGTRDIYTVGGADTVVNITLDPEAMAAYHIDSHRLSQALSAANQSAEAGTTVQNNQMTSV
QAGQFIVSADTLKSLIVGVFNDQPVYLTDVADIALGPEQPRQYVWFGTGPAASDKQIRAQ
GEYDAVTIAIAKQPGTNAADIADAVLQQVTALKGVMIADDVQVTVTRNYGETADQKADTL
IHKLIFVTVAVVLLVLFALGWREAIIVGVAVVITLLLMLFASWAWGFTLNRVSLFALIFS
IGILVDDAIVVVENIHRHIQQGKLTLKQAIPIAVDEVGQPTILATLAVIAALLPMAFVSG
LMGPYMSPIPINASMGMLLSLMVAYIVTPWMVLKMLSHSRSANHEKVAESQYNAVFQRIL
SPFLLHENAARRRKLLWGGLIMLVVVSVGLAAVKLVILKMLPFDNKSEVQIVIDMPEGSP
LEKTAAVTRALTDYLSTVADVTDYQAYVGTASPINFNGLVRQYYLREAWHQADIQINLRD
KHQRDEHSHALALKLREPLTAIAKKWDARIKVVEVPAGPPVLSPIVAELYGLNEQQRQNQ
ASQLVKVFEQTDGIVDIDSSIEAKADRQIINVDRNKASLFGLSQQQIVEAIQLALTGEDV
GYLHDDNVKYAIPLRLQWSIEDKANLDAVLNMKLINQQGELIRLSDVVNVVDGEHQQTLY
HKDLQAVTYVTADMAGKVDSPLYGMFSVYQQLENMPIQQYLVSVPSLALQDSLKWDGEWQ
ITYETFRDMGLAYAVGIILIYLLIVAQFRSYLLPLIIMVPIPLTVIGVMPGHALLGAPFT
ATSMIGMIAMAGIIVRNSILLVDFIRHAMAEGMTAEKAVIAAAATRAKPIILTALAAMVG
AVFILDDPIFNGLAIALLFGILVSTLLTLLVIPLLYYSYIKTR
>fig|1026882.3.peg.2913 Daunorubicin resistance ABC transporter ATP-binding subunit
MAYKNQYAILTKGLTKQYGQALAVNGLDLSIEPGQFYGLLGPNGAGKSTTIHMLTTMTSA
SSGEAWIAGREVKRYPVQTRALVGLVFQDSALDRMMTVDENLQFAAALYNLNKQQAEQRI
AELLSVFGLEKKRHQKLVALSGGQRRAVDIARGVLHKPQVLFLDEPTIGLDLPNRRSIWR
FIEQLRKDEGMTVFLTTHYLEEAEACDHVDFIQKGQLQKGGAPKKLIKNLAAYMLEIDCA
DTEVVSQQMRPQFGEPLWEDQHLTYRIQDKETDFYQLQKTLGNAVNAMQWRKPNLNDVYL
WTVCPPDYGVVT
>fig|1028307.3.peg.241 Multidrug resistance protein B
MSLVSSCSLDQGFEAPRRYLAAAAILIGVLMAALDSSIVNVALPSIASALRVDSASGIWI
TNGYQVASAATMLICASLGSRIGEKRFYTAGMVLFTLSSLGCSLAPTFGVLVTMRILQGV
SYAVMISVGLGLYRVIFPPCALGTIFGLNALAFAVGTAIGPALGGFIISSLSWPWLFYIN
ILPGGAAIVFSLISLGEDNEKEQGFDWAGAVSSAAALGLMVVAVDQIGRWEGRTLIYCAV
ASVALFAFFFIAQTRAKHPLLPLDIFRSRQYTLAVISSSSLFIAQGMALVGLPFVLQHTY
HYSVLESAFIFTPWPVAVAICAPLAGSLSNRFNPTQISTVGVVIFCLGLGSLALLPGAAT
VNDFLWRTAVCGVGYGLFLPPNNKEMFANVSANRTATASGVLSTARTTGLSIGAALVAMV
IALLNGLTGLAGAQFSVYVFGLACVIAAISSLASTLRLHR
>fig|1028307.3.peg.458 Transcriptional repressor of for multidrug resistance pump (MarR family) protein
MDKTHSSTPPESHESRFHKEEFPFFWVVNVYARYTQLMEIELKKIDIDLSRFRVLMLVHQ
YHRASISRITEYAVSKMPTVTKIVGRLRDDGLLTTHVSVSDGRVTEAELTAAGEAKVAEA
RALAETVFAKAFKGVTPAQEKKMNQVLALILHNLDD
>fig|1028307.3.peg.1880 Permease of the drug/metabolite transporter (DMT) superfamily
MDASFPTPSIFANKKVAYVCATLCCLLWGSSYPAIKNGYELLYIATDDVPSKIVFAGYRF
LFAGLLLLLFALAQRKPIARLNGRQCGQLAMLGLTQTAIQYAFFYVGLAFTTGVKGSIMN
ATGTFFSVLLAHFIYQNDRLSYNKTIGCVLGFIGVMLVNFNTSLGDFNFVWQGDGFVVLA
AFILSAATLYGKRISQTVDPTVMTGWQLAFGGLVLVAGGYLTGGELRMHSVTAAMILGYL
TLLSSVAFALWSVLLKHNRVSMIAPFNFVIPVAGTVLSAIFLGENIFEWKYAIALVLVCV
GIRWVNKNQAR
>fig|1028307.3.peg.2658 Multidrug resistance efflux pump
METLLLLCYAALCIVIFKVFRIPLNKWTVPTAVLGGVILIGMLILGMNYNFPYSEVGKQV
YRTVPIVSQTRGRVTSVPVKPNQMLHEGDILFTIDPTPFQAKVDDLTAQVKAASQDALSL
DAGLTSAQADLSKAVAERDRAQREYARFQAGHDKGAFSDQMVDTRRQNWKASQAAVDAAR
AKVAQARNDLNSVVHGENTKVASLLAQLREAQFKLDNTVVRAPSDGYVSTVGLRPGTMST
ALGLKPVMTFVPTDNANSREYVAAFRQNALQRLQKGEQAELLFPSIPGTVFKAQVAEVLP
AIGESQFQGQGTLLTANDLAARGRALVVLKVTDDRLANYQLPQGADVEAAVYSEHFEHLS
LIRKILIRMKSWESYLYLDH
>fig|1028307.3.peg.3201 Permease of the drug/metabolite transporter (DMT) superfamily
MSSLKLSITPQELILIVITMFWGGTFLAVQYAVNFSGPFFFVGLRFATAALAVALLSLRT
LRGLTWLEVKAGVAIGVAIALGYSLQTWGLQSISSSKSAFITAMYVPLVPLLQWLCLGRM
PGVMSCVGIVLAFIGLILLAGPENNLLALGIGEMITLASAVAIAAEIILISAWARQVDVR
RVTVVQLATASLVAFAAMAPAGESIPPMRPELLAVALGLGIFSAIIQVTMNWAQRSVSPT
RATLIYTGEPVWAGVFGRIAGERLPLLALVGCLFILAGVLVSELKWKKKSRPQIAAEEAP
ELAERREP
>fig|1028307.3.peg.3516 Glyoxalase/bleomycin resistance protein/dioxygenase
MKVAHIALWTRHLEQQARFWVEFFAGEINEKYRSKTNPGFESYFVKIGSDVAIELMTKPG
LHDSTHDNNHTGWVHLAIAVGGTEQVNALAKRAEMAGILVSAPRTTGDGYYEAVIKDPDG
NLVEIVA
>fig|103690.1.peg.3858 Permease of the drug/metabolite transporter (DMT) superfamily
MQLKLSASKFPIAPLLLIAPFFLWGTAMVAMKGVMPHTTPFFLAGVRLLPAGVLILIAAA
LSGRPQPNSWQAWLWISLFGLVDGTLFQGFLAEGLVRTSAGLGSVMIDSQPLAVALLSLW
LFQERIGLWGWLGLGLGVTGISLIGLPDEWIFSLLGTGAEVTIGNWQNLFASGEWLMLLA
ALSMAVGTVLIRFVTRYVDPVTATGWHMIIGGLPLWGISSVVESQQWENLVGSEWLALAY
ATVFGSAIAYGLFFYFASSGSLTSLSSLTFLTPIFALLFGHLLLSEVLSTLQWVGVFLTL
ISIYLINQRDNLAGQNKQSVMEEISAKSQPILAEATAKKLNPLTVKVRESEPETLP
>fig|1045004.4.peg.268 Multidrug resistance ABC transporter ATP-binding and permease protein
MVPLIVQRLIDSYERGIDYRQIIFLAAIFVMQLLFNALGLYLFALIGAIATKNYQQGTFN
QVLQHRVGWFEEQESTNLANKIYNNIDLLRTLFTNSLPEMISGVLTIVGIAVVLLSLNWA
LTIVTLFGVLLMVGVFGLLGAPLANRIADFQDQKSLFATHTSKFFRLVKMIKANAAEKIV
QKDDADDMKVLFESGRRLARINALINPLIGAVMMLIMLGIFGYGGYLLNNGSITNGVLIA
FLLYVIQIMVPLGSFSEFFHGYVGAKTAMNVLMQLRDNSQNERQGGCALPRDSQSDLVFK
DVNFAYDDAKTITLDDINMVFKPNTMTAIVGPSGAGKTTIVSLIEQFYAANSGVILSGTS
DITQFSLFSWRQSIGYISQKADLLGSSLRDYLSFGRKENYSDNQIKDVLGKVGLLEAFNG
HLDDKLLEDGNNISGGQLQRLAIAQAILKEAGIYIFDESTANLDADSEMKVKQIMEELAE
KHIVIAIAHRLSTIKSADNIYFLEDGTITGSGTHSQLLANHKTQLLANHKTYARYVAEQM
L
>fig|1045004.4.peg.636 Multidrug resistance ABC transporter ATP-binding and permease protein
MAKKSKQQKSGLTALFKYAEIKKSLLMTGLIFSVLSAALSLVFPLFIANLIDSFRKHFSL
PLVLAVIVTLLFSTLFSVLNSYTMGKASQTFIASIRKKASARLMNIPIKFFTDKQSGEIS
NHIANDTQSIDLLIRQNISSFISGVILVIGSIVILFLINWSLTLIVLLALIAVFLILSPI
SNIQNKTSASLQNELGHFSSRLNQVASEIRMIKSFNGQESQKEKLNDSVDRLYRFNMKVL
KINSLLDPIEYTILFSSIFFVLIIGGLMVSSSGMTIGALVSFFIYFLQIMTPISIIAQTI
NQFQSANGASKWLVALLQTGEETDNQQLVPAGTFASPLVFDQVSFAYNPKADVLSNLNFK
IPAGSVTAFVGPSGGGKSTIISLIEKFYLPSKGECPWLEKISKISACIIGVIMLPMCPSR
VQCLLGRCVII
>fig|1045004.4.peg.637 Multidrug resistance ABC transporter ATP-binding and permease protein
MLVGTLRDNLTIGLKKEVSDEQINQALKDASAFDFVEKLPKKLDTDLSERGANLSGGQLQ
RIMIARAFLKQADIYIFDEATASLDSQSEFFIQQAIDKIKAKATIIMIAHRLATVKNADQ
ILFLDHGQITGEGTHDELYKTHPLYRKYVQEQLLKQG
>fig|1045004.4.peg.703 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MSKYLKEQWAWTLFCVFLIALMSGSKVAAALINTYLLNSLISFQRNRFLLLVGLAILTWV
IFAFLIYVVYSLRARLVQKMSLSLRHDISQQISGLPYSRFHAKNSDDYSSWLMNDVTMIE
NGGFSVFFDIISVSLDAIFSIIALLSFHWSLVVLTLLLSVVTIFAPQLMQKKLKKASVET
SQANENFAASVNDTLHGFDTLFAYNLTQRIINHVDKSGRLPQTKKVQLGRTQAAATSIGV
LANAGSQLITIAWTGALALARLTPIGSILSTGALASNVFNGLANLGPTLTSVKSLNPLFA
KYHLGVDTSLNTSNQSTKSLADATINLTNLSYRYQDKIALKPVSIKLPLNSKVIITGESG
AGKSTLLNILAGKLLNYSGSVKIAGQELKDLSSEQLRKTITYVDQIPYIFNGTIRDNLTL
GEKFSDDAIFQALKRSDLFDFVMAQKQGLDSSVGEKGQLFSGGQRQRLALARGLLRNPQI
LLVDEGTNSLKSESAIQVEKQFLSLQDMTVIFVTHQLHEEIRPEIDQLITLA
>fig|1045004.4.peg.766 Lincomycin-resistance
MANKQVRRPFVVILGILVVNFLGLFSETSLNIALPVLRETFSVSSAAIQWLVIAYMLMIG
LALPLSTLISHWFKTKDIIIFAIFIFALGSVIAACANSFTVLLIGRTIQGIATGLFIPLM
FTIATIIFPSNKFGSVMGVIGVVMGFAPVIGPTLSGIIIDSLSWRWIFWLFLPFLLLSLL
LTIFTMPNVIEQTHPRVDWLSVILSMLGFGLLVSSVGLISNLGIASPIVIILILLSLLIL
FIYIHRQLRINRPILNFKILTNSRYRNGTLIVIFNFGIVLAAMYLLPQMLQNGLGQKANT
TGWILLPAGVLNAVISVIAGRLSDRFGARYLVLTGTVIFIAGLIMMSIINLKSGIPYIIS
AQSMLLSGSAMLFPPAQSYSLRSLSAAHSSDGSTIMNTCQQIMGALSTSITNSLLVFGGT
LHPLQNTAARFMSASRFAFIFAFVLAVLILIVAFQIKGKDKTSRQTA
>fig|1045004.4.peg.1068 Permease of the drug/metabolite transporter (DMT) superfamily
MLGPFLWGLNGVVTQYLFDQVGMDVNWVLSIRLFFAGLALFIYVLVFDRQNLFNLIKDKS
VRWRLIVFMIFGDFMSQYSYIIAISESNAALATILTSLSLLFVIFFYVIVQHHLPQRIDL
LSLIVALAGTFLLVTHGRIGHLQLSSAGLFWGLFAALVYAFATIYPIKLVSKYGPLPVTA
LSLFVSGILFNCYRPFFEHVPKMSGVNWFLLIFFTIVSTAFGTAMWFLSLHLVGATTMSL
LSAVEPLTAAILSITLLHLAVQGIDVLGSGLILLMMCLQAFKHQRVR
>fig|1045004.4.peg.1647 Multidrug resistance ABC transporter ATP-binding and permease protein
MENKGNPNKNLGLKWVLAQLPVSLLILIIIFAIIASLEGVISGYAIGQITAIATTHVASP
ALFVLRFVLIYFAVYTGLYIFILLQNRAIKYLNVALKQAFMKNAFQTDYVHQDADKLLNQ
VTADAKQIEQRYFSNLVNLLLSVIAIITSSVFVIAINPMLGLIDVILSFSIMIPTLFDNK
KLDQYSSDWSMANQHYLGQVKEIFAGIDIIKNFRAEKTMLAANDAKLNESENRYLALNNR
QFFTQYFSWLMIIISFLGPVLIGLLFRQYQLFGVTISAIVTLALSGGNVATQVRTGIQYY
AGMKTTRALRQSVIPDPTPEENSAANLPDKPLLSVADVSFSYKNHPILKDVSLSLPYGGK
LLLSGDSGSGKSTFLNLLTNKLDVQTGSITLGGQQIHENDFAYITQTNWVFNDTVKENLT
LGQNFSNAALLASLKEVNLANELGDDPLNYQCGEGGKNLSGGQKQRIAIARALLRKRPLL
LLDEVTAALDEKNSEKLRDLIYRLPQTIIEIAHHYDTDQIQANHVQHLQLSAGKISPAN
>fig|1045004.4.peg.1746 Drug resistance transporter, EmrB/QacA family
MSAKSVDIHNKRYSRFMFVLVILFATFAGMLMQTSLGTALPTLMDDFHINLATAQEATTW
FLLANGIMIPVSAYLSTKFPTKKLYIFAFGLLLVGQFISYSAPVTNWTWFLIGRIIQAIS
VGITMPLMQVVLVYIFPAEKRGAAMGLSGLVIGMAPAIGPTLSGWILDSSHSFASFTLSN
SWRSIFLLPMAVIALTFLLSFIFLRDVIPNQPVHLDFRSLVQSTLGFGLFLWGLTNVANA
NYGGWTDMTHVIIPGAVGIFFIIIFLWHQLEMRHPFLDIRVFAVKQFSVTTVLISLSMMA
MIGIEMMLPTYLQQLRGLSPLSSGLTLLPGALLIGIMSPIAGAVYDRSGAKRLARVGFLI
LLIATIPFLFFGLNTPRDFITVFYSLRMFGIAMVMMPLTASAMSALPKEKAADGTASNNT
VRQVLTAMVVSLLSSVTQNIANTNAPVASLKQQNIFEFGQRTLDASLKGFHVSFAISLFF
ALLGLILAGMLHSGKVIEQDPDLLDEKGGN
>fig|1048339.3.peg.42 Vancomycin B-type resistance protein VanW
MTESTPVSSAGGSGGRRTALRVGIVAGGAVAAVGLLYGVAVATTGGNIPRNTEVLGIPIG
GKSVEDARMHLSVALPERLPDAMTVVAGDKRLSRPTGELGLDVDLEATAEKAREGWASPF
RAIKTLFGAGREVDPVPAVNTETLQTAVEEMNDEVSLGFVEGGLDFSTGVAKPIAPVPGR
GLDDEAVAAALTDAFLAGDSEVAAAIVDVQPEIDQAAVDRALAGIGAKAMSGPVTITVAK
NAVELTPAEFGPFLSTEPADGELRLVVDAEGLVDSLEDEVEDLGRPPRDAKFRFDEEEET
VEIIPSRAGIVLDARVLGDKLADVLIGDGPRTVDAGARTQAPEFSTADAEALGISDKLSS
FKTEYPYAAYRVTNIGRAAELINGSIVMPDEIWSLNKTVGERTVKNGFVRGYIIKNGQFI
EDLGGGVSQSATTTYNAAFFAGLKDIEHHPHSLYISRYPAGREATVAWGSKDLRFQNDSG
HPVYIQATHKVGSIEVSMWGTKVWDEIESISSPRRNIVSPKTVESEDPDCEEQSPVDGFD
ITITRVFIKDGEEVKRETYDTHYFPTDKIVCVEPGKGTKSPTPGSSSSPDPSPSRTPKPP
KSTPTPKPEPSPSATPTTTSSAPPLPVGSGDDDSGRD
>fig|1048339.3.peg.58 ABC drug efflux pump, inner membrane subunit, DrrB family
MMNPQITLSTARRVLIQLGRDHRTVAMLLVLPSALLGLMCWVYSDIPGRFDRVGPQLLGI
LPFVVMFVVTSVATLRERRAGTLERLLTTPMNKLDLLLGYGLAFGLVAIVQSGIAALLTM
TLYGVDAETKGGWALFLSAAVVGVFGAAAGLFASAFARTEFQAVQLLPAVVIPQLFLCGL
FVPRSQLDDVLNAVSDVLPLSYAVDAMNQAMQRGGLTGQVGRDLAIVGGSALLALAAGAA
TLRRQSA
>fig|1048339.3.peg.308 Probable antibiotic-resistance protein
MTRPKVIDAWIQPWTKEVVEGLPDRALHVFKQYGQASRLQDGISLEVMMEEMDAAQVDIS
LISGGPMVPMHLVLEAMERWPDRLRAVVWTDPTQTSIVRALADLEALVRNYPVCGFKMEA
FALWRDPTDRVFYPLYAKCAELGIALQTQVGGTGPLYPSRTGQPLLIDEIALDFPELKIV
CGHVGSPWVDEMIHVAWKHPNVFIDTSARLPKYFEPAFTKFLTSFGQDKCIYASDWPVLD
FQRPLGQVDSLGLSPEVREKFLVSNAITAFGLDDLRA
>fig|1048339.3.peg.2767 Probable multidrug resistance transporter, MFS superfamily
MGGDRRGWRRHAIDLSPLEHRDYRRLWAGNAIAFVGFQVTAVAVPVEIYDITGSSFWVGM
MGAVGLVPLIVFGLWGGAVADALDRRRVLLVGSVTMWLTTLGLLAHSLLDGDSVTVLLAL
VALQSAAFAVVGSTRGAIIPRVVPPEQIAAANTLGFTTSNVSMMAGPLLAALIITQVSLS
AAYALDAVLYLAALYAAVRLPSLPPLGEISAPGLRSVIDGLAFIATRPVLLVSFAVDIVA
MVFAMPRALFPARAEELGGDAAVGWLFAALAIGAVVAGATSGWVGRVQRQGVALVVAIVV
WGLAVAGAGLAGNLWLAVFLLAVGGAADLVSAVYRQTMLQTYAPDEMRGRMQGVFIVVVA
GGPRLGDVRAGTTAAAVGVQASWVGGGLLCAAVVLLALAVPVFRRYRAPTATDPRPSDDP
T
>fig|1048339.3.peg.3351 Vancomycin B-type resistance protein VanW
MSRFLARRITIVVVAAAALLGLGLYAAAYAAAGSDIKKGTTVLGIDIGGLSRAEAESKLA
AELPAVISKKVTVRAGEKSFELDTVKSGITVDAAATVAKAGERSLNPGVLFPVLFGAKDR
IDPVLAVDDKALTAAVTGIAKKVNQKVREGRVKFTAGEAVAVQPREGRSLLVPETAEALR
KAYETGAAEVTAALKTTPPVVGQAEVDRVMNSFAGPAMAGPITVKLDGQNVTLSTAKLDD
YLKITPSGPTLNWTVDTDRMVEDLAEENPKLVTPPKDARFTFERNKPKLVPGEDGEKIEA
VSFGEQMRAALVAPVPRTVEAQVVPAEPELTTEEAQNLGITEKISSFRTNYPIAPYRVNN
IGRAAELINESLVLPGEIWSLNKTVGERTEANGFVKGFIIDKGQFKEDLGGGVSQSATTV
FNAVFFAGLKDIEHHTHSLYISRYPAGREATVAWGAKDLRFQNDTPTGILVRATTQPGWI
RVTIWGTKYYDKIESVSSDRYNYKQPKTITSAAADCTPQSPVAGFDIDVTRVFYKDGKVV
KREKFFTRYIPTDRIICTNPRKD
>fig|1049789.4.peg.31 Acriflavine resistance protein
MIEKGQKILESRPVSTGMFLFGLILFGAISYVKNPISLFPNTTYPGLTVSIEYPGADVKD
LEEMITIPIEESISGVGGIEEIYSFTERGKTEINVEFEKESNLEFKSLEVRERIDIVAGN
FPREVHKPFIYSYDPDNRPTMILTLKSETFDFIELRTIADNEVKRYLENIEGISKISVTG
GKVREVLVSCDMQKLRAYGLDLSEIQRSIRENNTTSAVANLKKQGLSSKLLLLGRYKDLN
DLKTLPVFSTKEGRNILLEDLANVSFSYREEESSSRLNGKENVSLYIYKSSLGNTLSISK
EIHRKLDDLKISGVNFKLIYDQSETVKKSYLNLIACGGVGLILFFLLLYYHRNYKQVRIR
TTLLTQTILNFFLFQFVLYIFKLDFDIIIFSAFILGFAIWTLVSFLLLEKTPQDLSNLKQ
VSTLPEFSALISIVLFLSLPLYFLDREIGEASFKLGVFIVLFLVFSYFSFSPIKRFFNQI
RNRYFPSFISEPLQLELKFSLFQGLEPKITRKTILLIYVVVLLASIYRVVKIDKEFYYTI
ENKKILGYVELPSGTGFGFTNSITKRIEEKILALSEIEEVTSKVEGGHSFLIITLKDSAI
AGDTFLEKMKKQVGNTSPAFVYFSRESDASKFKEIVVDVLGEDTEKLDETVKLLAEKARK
IPGVEEVILRYKPPRDELSLVLDKYKTSHSNLSNLEIGTYLKLAIQGAVVSKFIEDSKEI
DIRVRLSEEYRNSEKSLENYFIKNSTGKYAPLTEISSPKESKSPIKIFRKNKKRVLSFAI
RTGKISHSKILSDLKSLGEELPDGYHLELGRSLEKTVETESKIYIVIGFAILFLFGILSS
YFESFILALKALVKLSLPSSISFLFLSYVFGAFTLSMYLGILILLSISSFLIIVSHKMEE
TKSLKSIFYAFLPVVCLFISEVLFASEGGKFLKEIEITILVGFFVFAALLPFINPKPKNN
TTE
>fig|1049789.4.peg.356 Acriflavin resistance protein
MNNTRETPLGFAGKIANLFINSRLTPVISIASILLGILAVTLTPKEEEPQISVPMVDIHI
SSPGFVAKETERKVVEPIERAVWGLEGVEYVYSASADHGAIITVRFKVGEPLEPSLVKIH
HSLMEIKSTLPPNVSEPTVRSYTIDDVPFLALTFSSETRDDYSLRSIVAPLARELSSTPD
VARMELLGGRKEAVRVIAEPEKMQVYGLSISDIANGIRANQGFMPSGKNWGKDFLYDIEI
GTPISNAKQVMLTPLVRRGGNVVRVSDVAEVHDGAEEKVRQSSILDKSLGPDHRNAVTIL
FSKRKGTDISKLSREILERSEFFTKDLPKDIAMTVLRDYGATAGDKSSELIEHLLIATFS
VSVLIAVWMGIRASFVVSISIPVTLSLTLALYYFLGYTLNRVTLFALIFSIGILVDDAIV
VVENIERHLKLKPGQGIVKTTLQAVSEVGNPTILATFTVIAAILPMAFVRGLMGPYMKPI
PVGASLAMILSLLVAFIVTPWASVRFLKLHSKVEKKSVKDSKLNLLYESFTAWLLYSRKN
AILFGLSIIILLLASFSLVALKFVKVKMLPFDDKEEFQVLIDYDPKTPLEKTTKYTRVLA
NSLIENSNIQKIQIFVGDPAPFSFSGMVKHSFLRNKEWQADLHIVLKNKNERNKKSHDII
ESLRPSITDFGKQNNAITKVLEIPPGPPVLATFVAEVYAPTEQEREDVAIEIKKSLSLQQ
GVVDIDSSLRAQRPSIVFPFDYVSAGNLGVQAVTIAQASNYVFQETSLSTLSETSRPEDI
AISLSLKDSIRASKTPFAKLNVTTLESGSIRADQVLDQPTIHENRIRNRKNLRSLEYVTA
EFSGAEESPVYGILNLSDKVTHPTFTSEIPSVLNQAVVKWDGEWFITYEVFRDLGISFAI
VMLIIYVLVLGWFQDYLVPLIIMAPIPISLIGILPGHWLLGAYFTATSMIGFIAGAGIIV
RNSIILVDFINTEISSGAPLRQAVINAGLVRFRPMLLTASAVVVGSSVMLFDPIFQGLAI
SLIFGEVAATLLSRFAIPAIYYWFLMNRGHISKKN
>fig|1049789.4.peg.582 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MNNMEDPKKQTDNSTSPAETTPKAIGIGGIFFFSDNLKETKEWYAKNLGLEINEWGSSSF
ESRNINKPDEINSLQWTPFKKGDEYFSPSKKEFMINYRVQNIEGLVNKLKENGVTVLDSI
ATYDFGKFVHIMDAEGNKIELWESVDNG
>fig|1049789.4.peg.802 Glyoxalase/bleomycin resistance protein/dioxygenase
MKKLLIAICILITGISFWWAITSSQSDYHKIDNIDFSYATLILNSPNPERLSEFYRNALG
AQRSKEEAVWSLDGSIKSVISLRTAGYDEQGPLLTILKSDKSNIESPLPNDLGYAHICFE
SDDIPGLIEQILKNGGKILSSFKDLEKVPAAYATDPDGNVFEIHLPFPAPVTPRTIYRSL
NSLVRISFKLAPAKVDAIRFLHVNINSTDWIKTMNFYTKALGTSATGFERNYRGEFIENL
TGINGAVVRGRHVELPGYSEGGPTFEIFTYNKSSSKKPRTMTEMGFVATGFQVQNLDTAI
KKIISEGGTLVSRRGSQSAILKDIDGNILILAPKNKFLRINR
>fig|1049789.4.peg.1100 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIFFKIIQTLIAKVVWMEAIQKDTQLELERTSIWGELKKALTGTEADYTQISLGKAVFLL
SVPMVLELVMESAFAVVDIYFVGALGPSAVAAVGLTETYLFLLYSLAIGMSTAVTAIIAR
RIGEGDKEQAGIAAVQSVFLSILVSLPFAIFGVWFAKDLLLLMGGDPWVIEHGSRYTQWI
FGGNIVIMLLFGLNAVFRGAGDAAIAMRVLWISNGLNIILDPIFIFGFGPVPALGIEGAA
IATNIGRGVGVVFQVYLLLKGGKHIRVLGSQISVHWKIISDIVRTSLGGIGQTIIGMTSW
IFLVRIISDFGSEAVAGATITLRIMMFTLMPSWGMSNAVATLVGQNLGARRPDRAERSVW
IVGAWNMFFLIGVSICYFIFRESLVSIFTSDAKVISIGSEWLGIVSYSYFVYAWWMVSVQ
AFNGAGDTMTPTIINLVFFWIFQIPFAYVLAKVLSYGYSGVFWASMITETSVGLFTLWLF
RKGGWKTSKV
>fig|1049789.4.peg.1196 Acriflavin resistance protein
MRAIIESFIKNRLFFYLGTSFVFLAGIVSLLGLRRDTFPNVDMKQLVITTKFPGASPADV
ELRVTYPIEEKIKEIDGIDEIRSFSRNSASDIDVRVSLEEKDPEKILDEIRRAVDNAISE
FPPQVTEKPKIIERKSSSYPVLEFSVFGGKDEIELHTTAEFLERELEKISGVARVDVFGK
RDREWQILVNANRLKHYQLDLSDITTAIRNRNVNLPAGSVDSETAFDLRIDGEFRNPSDI
YKIPIRTNDLFSKVELGSLARVEDTFEYPRFLAIANGKQGLILSVVKKERADAIDVADHV
RKRLAELEKTAPPEIKTVMLSDEAKRTSKRLDIVSNNALIGFCIVFGILFLFLDFRTATI
TSLSLPISMLMTFAVLPFFDVSFNMISMMGLIIALGMLVDNSIVISENIYTYLGKNMDSF
TASVKGTLEMLVPIFGSYLTTVAAFLPMLFMSGVMGKFVWQIPLVVIVALTASLIESFLF
LPARITAFAKTPDQLKRTTGFRKTLDAFFHRMEERFSDFVAFTLRHKYSSFITILILILA
SFVALSRMKFILFPKEDIEIFTVKAEFPSSFRIYQTREKMKYMETIIKRIPPDELVSYSI
KIGVQQTDPEDPLSRYGENLGVILVYLTPESERKRKAGEILASLESDFRKTPSLVDVYME
EFGAAPPIGAPITVSILGKDYKDLTKVSAELQTFLKTIPGVHSVRDDYRYGRKQMQVRLD
EGLESFTGVSTFAAANMLRTAYDGERAGTVRKGRTKIYLRVMYDKDFRKNPDEIKHIPLR
NKAGNITHLSKISKMELVDSPELLSHREFERAITVNAEIKVDQITAHEANSKIIEVFKPL
IERQYPGISLAFGGEEKDTQRSMESLGKAGLLALFGIFAILALTMQNFWKPFLILSTIPL
GIMGIVLGFPLSGKSISFLAMIGIIGLAGVLVNASIVLVDCIDSIQKGSTDSMDEILLEA
SRRRFRPILLTTLTTVAGILPTAYGLGGTDPVLVPMTLALGWGLGFGTLGSLLYVPVTLS
VFHRFASKKKKVHH
>fig|1049789.4.peg.1424 Permease of the drug/metabolite transporter (DMT) superfamily
MQITSSVKFYILLVIAMISWGFAWPSAKSIVGLENPNVIIFWRFLATAISILPILLWRKE
SLRLPDIKSFFQVCVGGVLYTAYNQFFLLGLSSGFAGAGGVLVTTMNPIFTYILGHLLQK
QYPGKKDAFGLLLGLSGGLVLLHIWDKPTEGVFQSGNIFFLLCAFSWAILSMNSHSTGQK
ISPLVYSFYVFTIGTIFDFIFALPYGLSNVFSLDWMFWGQIFYLSVISTTFGTTVYFFAS
TKLGSRIASSFIFLVPATAVLGSWIFLGEVPSLTTLFGGSLAVSAVLILNGNRTKKTEIQ
AES
>fig|1049789.4.peg.1659 Tetracycline resistance protein
MRKQSFILVLTVFIDMMGFSLIFPIFPETLNHFLAQAGDPVLDLLAGWTSHLLDNSGGDW
KLFVALFGGIVASLYSVLQFLFAPIWGKLSDRTGRRPVLVFTCTGSFLGYLVWLASGSFS
LFVLSRILTGLMGGNISVATAAMADLTEEKDRAKGMGMIGAGIGLGFIAGPSIGGILAHT
DPSTLLPFFPWSKMTVFPSVALAASAAALVNLLFVLFRFRETLPITLRRKPEGRLHPILG
VLDIGSREVLFLSLLNFLFLFFFSGFEFSLNFYLDQFLNFKPIQIGYTFVYIGLIIVVVQ
GGIIRRISGKIPEKQIGLFACGLLTLGFLLLSFTNSHTQLFLALTLLAMGSAFLNPSISA
MVSLFSPPQDQGKNIGLLRSLGSLGRGISPIAFSLVYSQRGPQISFLVSAVLSAVFLILF
WFLRQPKKHHA
>fig|1049789.4.peg.1965 Acriflavine resistance protein homolog
MKTILEYFLSKSIFVNLLTFLIIMFGGLTAVLMNREAFPNINFDIVSISTLYPGASPQEV
EKLVTNPLEKAIKEVDGIKEYRSTSIEGRSGIVVTLDPDAKDSQKVVDDIKSAIDRVEDT
PEDAEDPIVTEITTARTPVIEVSVTLKNDDGSVESEKKLKAHAKIVEQSLLDISGVAKVV
RRGWRDTEMQVDLNPSGLNSRYLTGQDVINALRNRNVNVPGGNVTGSENEIILRTVGEFD
TPDEISRVHVRGNEIGYAIRVQDVSKVTEGLKEADYLENVNGKKTVALTVLKRQSSDAIK
VVDDVKNTVEKFRQSNKEFEYAFVNDLSKYIRRRLNVLISNAGFGMVLVTASLFFFLGWR
VALMTALGIPVSFGATFILMNYFGLTLNLISMFGLVLVVGILVDDAIIICENVYRYIEEG
LPPYEATLKGTLEVVSPVTATVTTTIAAFAPMLFMSGIFGKFVYSIPLVVIIALCASLSE
AFFILPNHLYDINKRHVKTGEIKGESGWFARFRNTKYIPVLKFSLAHPWAMTFGIVGLLI
VSFIVLANYPRFKLFPGSVDQFYVKITAKTGASLSETYRYLKVIEKEIAKIPPEDLENFA
TRVGIIQANPNDPFTKRGKHFGMTMAYLTAEENRKKCHKTDDIIRRLRKKTLWLLNDESR
KIEEGRIKKESADKKDECDVDEPAVIPEEFASLRGKLVALEYEKLSGGPPVGKPIAIEIR
GDEYDTLSKIAAEYKEVLGKVNGVTDIADDFNEGKDEVRIKVSESLASTAGVSVSRVAQA
INTAFQGTVATKIKRTDEEVEVKVRFPESYRQSVGSLNHVYVSNLQGKMIPVSRLITIQK
NPGFSNINHLDGKRVMTVSANLASGKNTNPSKANSESKKLADARKILEKYPGYTVRFGGE
NKDTDDSFKSLGLAFAAAFLIIYIILASLFGSLLQPLVVVSAIPFSFIGVILAFVSHGEY
FGFLAFLGIVGLSGVVVNDSIVLVDFANSLRKNNPNKDIIEVLLETGNLRLRAVILTTVT
TVLGLLPTAYGIGGFDPFLVPMALAFGWGLAFASLVTLVMVPVFYLHLYRYQTWFSGLSD
RIWSAKPKSITYSFESSPIPQKQKKKK
>fig|1049789.4.peg.1995 ABC-type drug export system, membrane protein
MINFINKTLIISELEIRKIIHDPSEIITRSVQPALWLLIFGQVFAKMPFLANRTDYLSFM
TPGILAQSVLFVSIFSGIAIIWERDLGLIQKMLSTPTPRTAMVLGKAISAGFRTLPIVVI
IYLLALILGVSIHWDIFKILGVLLFVFLGSIFFSTFSLIIACLVKTRERFMGIGQLLTMP
LFFASNAIYPIEIMPDWLKVVSHVNPLTYVIDALRSLMLDFPSNFGVLVDFGVLFIASLL
VVLIGGVLYKRVAV
>fig|1049789.4.peg.1996 ABC-type drug export system, ATP-binding protein
MNILELHDLSKSFGKLTVVSSLNLMVEEGEIFALIGPNGAGKTTTIKMLTTLLPPSSGEA
FIGGFNLKTQTDQIRRIIGYVPQMVSVDGNLTGYENLMLFAKLYDLPRKEQKERVKDALH
FMGLDSFGDVLIQKYSGGMVRRLEIAQATIHRPKLLFLDEPIVGLDPIGRNVVWEHILAL
RKKYATTIVMTTHLMDEAEKICTKIALMSRGKLAAIGSPAQLKESVGGSDKSLEEVFIHY
AREDLNESDGNFHSVNLERKTARRLG
>fig|1049789.4.peg.2121 Daunorubicin resistance ABC transporter, permease protein yadH
MNFREKFNAFSTIVRKETVRILRIWIQTLIPPGITISLYFLIFGKLVGSQIGDVGGHTYI
QFIVPGLVMMSVILNAYNNVVSSFYGAKFGKNIEELLVSPTPAYLIVLGYSIGGVIRGIL
VGIIVTVVSLFFTELRLYSPWIVIVTVALSALMFSMGGFLNALFAKKFDDVTIIPTFILT
PLTYLGGVFYSIQMLPEAWQIVSKFNPILYMVNAFRYGFLGVSDIDPGLAIGLLAVGTIL
LYSLSVFLLSRGIGTRT
>fig|1049789.4.peg.3055 Permease of the drug/metabolite transporter (DMT) superfamily
MDSKQETLLTRLSMGASEETKGFIYALLGTVLFSSKGVLVKLVYNYGVDSVTVLAFRMLF
AIPFFAVVLYRESSRSDAAPIASKDYLNVVALAFIGYYLASFFDFWGLEYLSASMERLVL
FTYPALVLLLSFLFLGKKAHSVELYAVALTYSGILLAFLPDAEANGQKSLVGAALVFLSA
LAYSVYLIGSGQMIPKLGSRRFTALLMLWSGGFVLLHFFLRKEVSSIFLQPLPVYAYGFA
LGFLTTVLPAFLTTAGIQRIGSNKASIAGSAGPIFTLFLSAILLNEKITWENLGGTTLVL
SGVLLLSRKKKIVV
>fig|1049789.4.peg.3666 Acriflavine resistance
MGVDLFPDVNIPIVSVTTIYPGAGPEEIEELISKPLEEELSSISGLKKISSRNQEGVSVV
FGEFTLSTDIKYAEQQFRDKVGLVRPKLPDGIKEPKVVRFDPADQPIVRLAVFADLGQAQ
LYDLAKETVKSKLEQITGVGSVKLVGGTRREIQIELDRNKLISYQMPMVVIAGRLKSAGL
NTPVGKFESGTKETSYRTLGRYESISQIENTIVSFGGDVGNSVLIKELGSVRDGTEDEET
LGYLWASKSDAVEEEDVALFAHPFIWTGQTFRKIKNLFSSKKKEAVEKEIKPALFIDVYK
QSGGNTVAVADEVLKRIDKLNADIKPLAGNPRIRLIRDGSRWIRYNVEDVTEAIVLGVLL
AVITVYFFLGNFRSTVITGLALPNSMLGAFILMWIMGFTINVMTLLALSLAVGLLVDDAI
VVRENIFRKLEEGHNVLEASEKGTMEVALAVVGTSLTVIAVFFPVGFLSGIVGQFFKQFG
LTVVFAMIISLFDGLFVAPMLSAYFAGKLDHSKRNKAVVAFDKFQTWLEKIYGITMKFAL
AHPGKVILLTFLIFVLSLVSCSFVKKTFLPANDQGEFLVTLDLPPGTSLQGTKEVADKVL
LDLQKFPEMDKIAVTIGKPDGGEPNSATLAIALVSSKKRKKTTVAIKDEIRDILKNYAFA
RPAVSDYSAVGGGVQYPFQLVIKGDNLAEMEAYSKKVIDRLKAIPDLADIDTDFRAGKPE
YQIALDNTRMQLVGVLPGVAGAELRYQIAGDTVSKFYDKGIEYDVRMRLHPDQRNLRAAY
GQTKVPNIANKLIPLNAIGSGKETVGPSRINRIDRARTIVINANLAPGGAIQSATEGATK
IMTTELPPPAGVRFNFQGQSEDFKELIVNILVAFGLALVFIYLVLSSLYESFITPVTILF
AIPPAISGAFFALFITGEMLNLFSMIGLILLMGLVAKNSILLVDYAMQAIRDRGITRDEA
IFEAGLVRLRPILMTSLAMIMGTVPIALGLGEAAKSRTAMGIAIIGGLILSTLVTLIVVP
SIFGGIDRFREWIESKFRPDMGATVSHTESTTAGGNNHRETADLSEWAKAVEEPVKKPTS
KKKK
>fig|1049789.4.peg.3964 Quaternary ammonium compound-resistance protein SugE
MNWILLITAGLFEVGFTTCMKLSDGFRDWKYAIGFLIFACLSFFFLNRSTQTISLGTAYA
VWTGIGAAGTVVIGIFFFGESAQAWRIFFLSTLIASVIGLKFVAIE
>fig|1049789.4.peg.4097 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MIIVEGIDYIVIPTGDLDSSVKFYSELFDFETIEERTGEFAIIGLDSVNIKLLHTNGTKG
ALSEAKSPVLSFVLDVDDFTEAIVELESKSVQIVRGPEARDGGEFLHFLDPSGNILEINY
KES
>fig|1049789.4.peg.4197 Multidrug resistance transporter, Bcr/CflA family
MYLPGLQSISRDFDTPISNVQLTLTSFFFGISFGQLVYGPLIDKFGRRTPMMAGLIIYTV
SSIGCSLSVSVWSLVFFRFLQSLGACAGMVVPRAVVRDVFSPHEGAKVFSQIILVMGIAP
IVAPTVGGLLLTYTNWRAIFVVLTLISIIVSIGAWLYLPETGKKDSSVSLKPGGVLKEYY
EVLCVPRFNAYVIASGLSAAVMFAYIAGSPFVFMGIFGLSESEYGWFFGSNAAGLILASQ
LNRLLLRKFEAESIVNAISIFYVPIGILLVLSATYHWGMISMIGLIFLLVSGFGFIVPNA
SALAMAPFTRNAGSASALMGAMQMVSAVVATASVSLLHDGTALPMTLVMSGAGILSLLSL
VILRPKSRLSIEE
>fig|1049789.4.peg.4757 Acriflavin resistance
MMMIGIILLGTIGFSRMGLSQMPDVDFPVVNVTLNLEGANASVMETDVVDPIEEVLLTVQ
GVVEVRSVSTDNSATITVELELKRDVDVAIQEIQTKIAQVQNKLPDALDPPILMKSNPDD
TPIIWISLTAVGRTDQEKMIFVKSHLKDKFQEISGVGEIILGGYVDRTINVFLDPIRLTR
AELTVNDITNTLTEQNIEVPSGRVENKSSEVSLRAVGDVPTVEQFSNIFINSRSGAAMFR
PVRLREVAHIEDGLDEIRRISRFNGISAVGLGIKKLKGANAVQVGDLIKKKIAELKPTLP
KGYDLSIANDNTTFIRDSVKELIFTLVLSALLTGFVCRLFLGSWSSTWNVLLAIPTSVMG
TFLILYFAGFTLNTFTLLGLSLAVGIVVDDAIMVLENISRHREMGKTWFQAALDGASEIR
FAALAATLAIIAIFLPVAFMSGIIGRYFLEFGVTVAVAVALSLFEALSFTPMRASRYREH
KLQEHKKRGGKATIRFPEPVSDPNRFEQTIAKFKAAVAPISFFKKMDPIIERFLQFSERI
YGKALDYVIAFPKIILILSTLLFVLSLGFLLLLKKEFIPPQDMGRFIIRAKMPIGSSIYR
TNEAMKKVEEYLLKKPEISKYMSNIGGMGGTESNGAMFFVSVKDMGQRPKSKKTGREITQ
NEIFGDLRKDLKALVPECKFSVQDLSQRGFSAGRGYPVELVLSGPDWANLAKVADEIRNR
LDQSGVLLDIDTDYVSGQPEVRILPNREAAALRGVSMANIGNTIGPLMGGKKVSRFTENG
RSYDVRVKINKEQGEKADIIPNISVRNTYGEFVRLKDVLVLQATNTLKNITRVNRDRTIK
IFGNPPVAVGQNKATEESIRIAKEVLPEGYSVDVTGSAKTAGESASSLLFALVMGIVMSY
MILASQFNSLKQPLYILLAMPFSFSGALIALYFTKQSFNMYSFIGLIMLLGLVKKNSILL
VEFVNHVRSQGKSIAESIREGCPVRLRPVLMTSFSSIAAAIPPALALGPGSETRVPMAIT
ILGGLVLSTLITFIVVPAAYFLMEKESNDKLSHNR
>fig|1049789.4.peg.4828 Permease of the drug/metabolite transporter (DMT) superfamily
MEQRFAMKQFKNEGALILCTLVWGGTFTATKLSLVSVSPSLFLGIRFAIASAVFLIYALL
QKPTKEFYGESKKPRLWFPILLGFWMFLGFACQTIGLKFTTATKSGFLTGTLVVITPILQ
TIFFRRIPNAGNLLGVIIVMLGLFFLSFDPEVGSGKLSFLFHWGDVITIAGAFFFSLYIL
LMDRVSREVSIQTLLLSQTLTTSILSFLLAFGLDYLGWETLMWHWETGVLPALVYNGLIS
SVGTTFLQTKYQKAVTPTRAGLIFSLEPVFSAVIAYYTLGERMQFVGLLGCGLVMTGVLF
AELFGSSKERVSKTGA
>fig|1051632.5.peg.49 Glyoxalase/bleomycin resistance protein
MSFHFVGIDHVQLAGPPQCEETARRFYGEILGWVELPKPEHLRRRGGLWFQCGAQQVHIG
IQKDFTPATKAHPAFYVRDIQALREHVIKNGLDPIEDEPLPGADRFYLTDPFGNRLEFLE
WL
>fig|1051632.5.peg.212 Multidrug resistance protein homolog
MKHFPSAVWATAFATFVAFMGIGVVDPLLPLIGRAMGATHAEVEWLFTSYIAVMALTMLV
SGVLGTRLGGKRTMLLGLGLVVVFATLSGKSPSIEFLAIVRGGWGLGNAFFTSTALSIIV
GLSTGGMGPAITLYEAALGLGIATGPLLGGFLGSYSWRDPFFGTATLMAIAFLATYFLVK
EPARRETPRTARDIFRALGYRPVLTNALIGLTYSFAFFTILAYSPLTLSHLSPVALGLTY
FAWGILVAFSSVVVVNWLIARWSPMTVLKVNLAVLIGVLVLMGFLPSQDLLGLVVATGFF
CGISNALFTTLAMEVSPFPRSIASGAYNFVRWAGAAIAPALAGWIGQRFGLTWPFFLAAG
VLFFGWVALMPATRLLEGALRQHGDHLAREVKTS
>fig|1051632.5.peg.329 Membrane component of multidrug resistance system
MATNPGQPRVAWGITLFVLIVGAFMSILDTSIVNIAIPKLESVFSVTTDQVQWVVTIYLL
ALGVVVPASSYLGDRFGYHRIYIFSLVLFTIGSALSGLSWNLTALIVFRVIQAIGGGLIM
PVTMAMIYRIVPRDRIGTAMGFWGLALIVAPAIGPTLGGYLVEYVNWRYIFYVNVPIGII
GVLLALRYVPPFPVIHRGDFDLPGFLMVAAGLFGLLLVFSEGQSWGWTSEASILVLMASL
WALVWFVVWELGRAHPLLDLRVFKYDSFTVANLLTVIITIGMYSGIFYVPLFLQTVAGFG
ALKTGLIMMPAALASAFMMPISGRLYDRIGARPLALVGLSLLAITTYLLHNLTINTPIPT
IILWLVLRGFGMGMSMMPITTGGMSAVPGHEVGSASAVNNILQRVGGSFGLAVMTALLTN
RQAVHAQAMAATITPTANGYAVWNQVHALFAQLGFGVVPTTQLTTTELYGLVQEQSFVLA
MGDIFVVAALVTAVGVFVALFLKTYRTHNGERAMSMGD
>fig|1051632.5.peg.447 Drug resistance transporter, EmrB/QacA subfamily
MNPAALRASRGVLLATFLGAMDSTVMGTIGPTVASRFHALVWEPWMITAFMLCTTLATPV
FGRLADTTDNRRLYAVALTVFAAGSAWTALSPSMDFLLIGRIIQGLGAGGLFTMGLILLG
RLFTGPTRATMQARQSAMWGIAAVLGPTLGGVAALGAGWRLLFAINVPLAWMAIRVMRAV
ELPPPDQQAPPLDRAGLALLTIVLVAVLALPTLWATGEPVKWLWAALGTALIGGSLLLAV
ERRIRDPLIPWALWRHPVVRRTTSLAILASALIYSLVTLVPLWTRQLWHADALTTGWVTL
PIPLGWAIGSIMVGRRLKSWGFRRMGLWGTGIFGLGIASLDIAPRFPLPLIIGAGGGLLA
GVGMGSVIMTGLLLVQSTASVDTLGAATGLYNFGRNLGNALGPGVLGGVAVGMATIGHPN
GLRASTAGWLHALNGTWLGIVALTLGVAILLMRFPQHVPNPDPSVDTWNPVSPS
>fig|1051632.5.peg.454 Permease of the drug/metabolite transporter (DMT) superfamily
MTHQLKQPSQRVSRRGVTDALLVLVAIIWGSSYITTKDVVNHVPVLFFLMVRFGIAAIGF
GLVGWQHLSRATATTWLTGISLGLFLTGIFVAETFGVKHTTAIAAGFLISLNVVLVPWVE
KWILHYPIHWALMVSMVIALGGTALVTSSHGGQFVVNLGDGLILLAASLRAIQMTVTKRW
VSEERIDIIALNVIQFMTVWIVCGGLTAITSNSLTIINALKSVSFWLVAGYLGLLGTVAA
FVIQMVSIRHTSAARAALLLGLEPAFSALFGVIGGERLSLSSAIGGGLIVAGTLWGQQAE
YRRRLEIENRT
>fig|1051632.5.peg.503 Drug resistance transporter EmrB/QacA subfamily
MRKWLVLGVVVLGLWMDLMDMTIVNVAIPAIQNDLGTSLQGVQYVVTSYLITIGVFEPIT
AYWADTQGMKRMYLASLAIFTVASALNGLAWSLPSLIAFRILQGIGGGMIMPLALSIVSV
TFAPEERALALGLMGLPLLAAPALGPTIGGWFVQFHTWRDVFWINVPIGIVAFIAALRAL
QEFPTTRKPLDLGGFVLAAIGFASLLVALSNGPTAGWGSLEIVLLLQIAIFSLALFGLWE
ARHPSPLFDLRILRLRWYSSANVVTFFTMMGLFGVLYLLPVFLETVGGLGPMDTGMTLIP
LVLSAAITIPLSGLLLPRLGAVGLTSLGLTVMGLGTAQLMHLGLSWDAGWLRLWVSVIGA
GLGLGIMPAITVAYGSLPPAWMNQGSAMLNLMRQVGSALGVALYTTIIQMREPVYWTQLA
STVTVTNFRAQARLAAWQQQGIAHGLSPAQAHVWALTMMAHQLQQTATLWAFHNAFGAAA
VAAVIGIGPALWLWGSRQVLRPPDARHTALGEPGGVT
>fig|1051632.5.peg.695 Permease of the drug/metabolite transporter (DMT) superfamily
MRRGFLFLISATLLWSGNYVAGRVLARQMDPLELNAIRWTISAVLLWGILRAGGKTLRWR
SHWAVYFLLGLLGMVLFSSLTYLGLARLPAVQAGLISGLNPVMIVLLSLWLLKETPDRST
WAGVLLAVLGVVILVETKRANWSAHLITGDVLLVLAAWAWAFYTVVGKRVAGDPLELTTG
AAVMSVIPNWLLSWVGSSPSGGHLSAVGWGALIYVSTGPSVVAYWLWNLGVRRVGASRSA
PTMNLLPLWTVVLGVGLLHEQLALNQIIGGVIVLAGAWLSGRPRPSAMGLAH
>fig|1051632.5.peg.796 Permease of the drug/metabolite transporter (DMT) superfamily
MKYCQLRIPRRLQGYLMVLLSATFWGVSGTAAQKLFVVGHVHPGWLVSIRMLGSGALLLL
GSVMRQASTSLRLLKRAAWGPLLAFAIVGLLGVQYTYFEAIHTGNAAMATLLQYMGPSFI
AVYGALTTRRWPSPVGFGALLLALGGTLLLVTGGHLAHLAVPATAIVWGLLSALFLAFYT
IYPVPLIRQWGSLPVVGWGMVIGGLVAAGLTRFPDGGPSRWTPSILGLVLFVVLIGTLLA
FFLYLASLTRLSPTEASIAGSAEPISAVLAATLWLHVRFTSMQMVGGMAIVAAVVVVAWL
RPFEQRSSASAGASGRGG
>fig|1051632.5.peg.1017 Vancomycin B-type resistance protein VanW
MRYWIMVVWLLLWPNVPLPTFLAPHGGRQWAQLEYVPSAPVVVVPGESAARAMKLPYLLA
RQTTNYNHASPSQAKNIELVAQRLNGTVVKPGQIFSYYARVGPYTAENGFGWGRMFVGDR
IVPSIGGGVCQGSSTLYAALLRTGLPIIERHHHGLTVPYLPPGEDATVASDYLDFRFKNN
RTTPILITAQAGQRHLTVAIWGATPGPEIVVKHQILAEYPFKILKRVDPKLKPGQEQVLA
PGQKGVSVKTWLEIKTPHGTETRDLGIDRYRPSPRIIAVGPKTPSADSTGP
>fig|1051632.5.peg.1018 Permeases of the drug/metabolite transporter (DMT) superfamily
MLVFWMIARVASLTGERIMFHAIGDGLDPWVTASSTYGGAALLLWLTAWTTGQAVWVPGA
WLPSVVYAGSFWLYIAALSRGPVSQVTPVANASLLVAFFVRPSWGVMSVLALVLFAVGLW
WLVPKTGRLSTAVWWMLLSDGGLVWGRLLDSRLAGGAPALAYAATLYSGVTLVFLAGTLI
RRQGVSLGRVWRQRGASLAGASFFNGFSYLTVVMLLGYLPPSGVEAVSAIAGITGTWMGA
LWFHEEHVGRRVLAAVFMTAGAFLLILHHVQNAPTADLPLDRRAFFR
>fig|1051632.5.peg.1268 Permease of the drug/metabolite transporter (DMT) superfamily
MIDPEIRDRSVSPRSGGPRRTWAGLLALALVTAIWGYSNVLIRQLEHQWDPLLLLWVRYA
LVGLVGIPWLVTQGLSWSSWLWGGLVGAILAVTTLAQAIAMESVSVDQMAFITALYVVLT
PLVMAFFRRRRPPRAVMAFALVSLTGVLLLVGHLTFTVAIGTLWSFAAAGLATLQIISTA
RFSRRLGAFELTFTGALGAAVILGLLLLIPGTHGPFHPVWSWRSLWRLLYLAGPGTLLAF
WLQIWGQSRLTATQAAFLFNVEPVWTAVFAWLVLGQTLSPGQGIGAGLILVSLLALSRDG
>fig|1051632.5.peg.1747 Permease of the drug/metabolite transporter (DMT) superfamily
MKGYDPAGRTGGSIIQRLGGMIALAAAATIWGGMYVVSKELLTAVSPVLLMWLRYGIASV
VMLGGLIARRQLQFDRDTLKWALRVGVMGYVLSIGAQFWGTALSTATLGSVITAATPAFM
VLFARLLYHEGMTAAKITAVGLATLGVLLVVPWQGAARITWGSGILVAAALTWALMSVWV
GYMPPTISTTRVTAYAIGIAWVLITPAAWVSLPTVSAGVWQSQAFWLGVLYVGVLSTALA
FWLWSYGLRQVDPATGGVFFFFQPLSGTILAALFLHEAVDPSLVIGGVLIVAGVIVSQWA
QKTPSPRPVGNRGDGEDSSVNP
>fig|1051632.5.peg.2023 Drug resistance transporter, EmrB/QacA subfamily
MMPRQTLIIVGSAAMCVGLSALDMSITTIAAPRIVASLRGPITQVALIFATYLGAAVLIL
PWSGVLADRWSSPGVLIGGLALFGVGSVGCLIAPNFLVFLLSRTVQGLGGGVLMVLPMTI
IGQRYAPNERPRWQGILAAAYGLATLVGPPLGGWITTVFGWRWIFGLNLPLTAIALVGGS
GIPSHRGSSGESPHWTNLVLFSGIVGFILLLTTRHWSAMEYGVFIVGLLILGVPFVQQVR
NRQSSLWPQELEESLIISRGFLLMFLIAASIEMGAVYSPLLFQRIFLITPQQTGIWLIPM
SLVAILASLWSGKWMTETGLYRRLLIGAQFIMVFGLMLATLSLVTHILGILEISTLLFGL
GLGLQQPILAVVIQAATPDTYIGRMSSLLPLVWNVGALVGILISSFALALFHGLWGWVTL
YLMASAILLLTVGIAIRLPYRSILDVTSHSENASGGYSV
>fig|1051632.5.peg.2526 Drug resistance transporter EmrB/QacA subfamily
MAVLNSTTLLIALPTLTRVLHMSTFLAIWVLLVYMVVQTALVLTVGRLSDVWGRKKLYVA
GFAIFTVAALLAGLAPNGLLLLVIRGIQAIGGAMVMGNSTAIVTDAFPRHELGLALGINS
IVIALGQVLGPILGGLLVTWFSWHWIFWFNVPIGIVGTLWAWKQLQDVVPPAREPALDYR
GNITYIVSLVALLMGVTAGGIMGWTQPLAVGALLMGALGAMLFIRLEKTAAYPLLSLSLF
ENRVFLLSNLANFFIAMVRGAVILLFVFYFQGARGDSPLEAGLLVIPLAAAMGVIGPISG
WLADHIGPRVPASLGALCVAIGFVGFGITLHRSTGYGLIAVWMILVGFGNGLFNSPNTST
IMGAVSPQSRGVAAGIRTMLFNTGGVFAIALVMALIASRLPSSVMMAVLAGETARISTSG
LENLLLALRSIFLILAIIALAAALFSWIPARRQDPTPTVSRLSHTRVS
>fig|1051632.5.peg.2528 Permease of the drug/metabolite transporter (DMT) superfamily
MTAEAIIYTILWASAAIATKFGLMAGPPLMLAGFRFTFAGVILLIIRRITRHPLIPPRRW
WRPLFILGALNTTVYLGASFVALTVMPAGLFNLFVATNPLMVLLVERFVLHRTITRNQWA
GLILATIGLALGAGQSIWQWHTPIWSLALIVLGQTAMAIGSIYFHVRRIDLPNMAVNMWQ
LLIGATLLWPIALGTERTVPIHWNAEWWGALVWLIGGVSIGAMLFWFHLLRHGGARQASF
WLLLTPVIGYILGWLLLHESFTWADLGATLLVIGGLILAQISIPAAPAETPSTNY
>fig|1051632.5.peg.2711 Multidrug resistance protein B
MDRKWVVALAFVAAMFMNIMDTTVVNTALPAIARQFHTTPAGADWVVIGYLLSLAVWILA
SGWLGDHWGTKRVFLAALAIFTGASWLAGLSQTLGQLVLSRLIQGIGGGIMAPVGQAMLY
RAFPPAERARASMILTIPMVMAPATGPVIGGFLVDHWSWHWVFYINLPIGLITWIFSFRW
LPEYRTFTQTRFDGSGFLLSALGLLLFVYSLSEGPLVGWAHPQIWLSGLLGVVLLIALLR
IERQRAHPLVAVAALDNHLFRTSLAIGFFGRAAFLGILYVMPQFLQEARLLSPLQSGLTT
FPEALGVILSTQVVGRLYPRIGPRRLMTAGLFGVALVIAAMTSLNLRSSLWEIRSLMFLL
GVGMAYMIMPLQTAAFAQISHELMGRAAALYNAQLQVSGAMGVALLTTMMTSFGNGSIHQ
VNPYHLAFELGAALALLGSLSALWIHDHDALNTMTIKSQAS
>fig|1051632.5.peg.2945 Drug resistance transporter, EmrB/QacA family
MLAMALAAMDSTIVATAIPTIVRDLGGFSLFPWVFSIYLLTQAAMVPIYGKLADLFGRKP
VLMAGTGIFIAGSVFSGLAWNMLALIVFRGFQGIGAAAIIPITSTIVGDLFTLEERAKMQ
GYLSSVWGLSAVIGPAIGGFFVQYASWRWVFYINLPIGLAALLMLGGYLHESVSRQAHRL
DYEGAFLLMAAIGCLITALLEGGVHWKWTSPASILLLAAGLVGLALFVGQERRAPEPVLP
LWVFRQRAISAANTASLGIGILTIGLSSYLPTFVQGVLERSPLVAGFALGMMSIGWPLAS
SLSGRLYLTVGFRATALIGSAVTILGSLGFVLLSPESSPWQAGLASFVMGCGLGLGSTSL
LVSIQSVVAWNRRGMVTGSNMFMRQLGSAIGVAGYGGLVNARLSAAFHHPPATVASRLPH
NLNAAGLALGRLASMPEAVSRYIRLALAGAIHRVFWGVFLVAAMTFLIEWALPQHLRKKR
VPDPDRLRP
>fig|1051632.5.peg.2963 Drug resistance transporter, EmrB/QacA subfamily
MSEKGVIESRPTVSRPSTALSGRALWLSFAAATTGTFMVNVDASVVNVALPVLQHQFQLP
ISTLQWVITGYLLIITALLPMAGYLADALGRREVFMGGVLVFTLGSLASALAPNFSGLVA
ARVLQGIGGATIMANVMAIIALIFPVHERGRALGLIGSVVAAGTLAGPPLGGLLTAWYGW
RSIFWINLPVGLWGLWGSWRYLPHFPPDPHASLQRFDWAGAGFFMATTSLLQFGLADLHH
WTGLAFLAADGLSLAAFIRIESRNDHPLIPLRLFRVRAFSFNMLAGMAYWVLMMFPAFLM
PFYLHTERHLPISWVGLSLVPQALAMIIVSPWGGRWADRRGIMGPGRTGLALFILADVLL
ASLPLSAPLWTIWLALAIIGVAAGLFSSPQNAAVLNSVTAHDTGLASSLLATQRNLGRAV
GVALGSGILSLVWLLIGAGPNPSHTDPHYIHWLLIGIRGVFWSGIGFALIGLWLLTDPAK
SPGSGGKA
>fig|1051632.5.peg.3316 Drug resistance transporter, EmrB/QacA family
MMTSRAKTWIVVSIMLAMMLTALDMTIVGTAMPSIVSDLHGVSIYSWVFSAYLLTSTTPI
PIYGKLADMLGRKRVFMVGTGLFMIGSALAGVSQSMPELILFRALQGLGAAGVLPVALTI
VGDIFTLEQRGRVQGLFSGVWALSAVIGPLTGAAIVEHVSWRWVFYINVPLGILVMLILW
LAFHEQVESHGHAIDYPGTVILTAGVTLVLLGLLDTGTTREILLGIALVTLVGFVFWEQH
FSEPVLPLSIFRHRMILLGNIMNFFGGIIMFGLISYMPLFVQGVQGQSPTVSGQAITPMM
IGWPLAALSIGSLIKKVGYRVLGILGGTLVMLGTAWLGLVGDRTTLVLVGSMLAIGAGLG
FSLTSLLIGVQNAVPWNLRGVVTGSTQFFRNIGGAIGVAILAAVFNEGLSRAISRAPRLH
GLNTASVTETLLVPRLRDRLAPTLHQLLLSTLNHGLAAVFLTIFGIGVLAFVTMLALPAK
PRAWDQEAETAPTEEVG
>fig|1051632.5.peg.3350 Drug resistance transporter, EmrB/QacA subfamily
MSSEAARAQGLRALWEALPSERFTTRPNYIWYVVGTVCIGAFMAAVDASIVNVAIPDLSR
YFSAPASIVGWVLISYLLTLATLLTLFGRLADMWGRRPLYTFGFLVFIIGSAACGAAPNL
LFLIVARVFQAAGAAMLQANSVAIITATVPANVRGRAIGFQGSAQAIGLSVGPAVGGALI
GLFGWRAIFYVNVPVGIIGTLMAAMILPKDKLTNTGTQFDWWGALLFSPFLVSLMLALTW
GPHLGWTSPTVLGLFLVSVILLVAFILREKGFRAPLVDINLFKLRVFTMGNLTGLMSYMV
MFGVLFLMPFYFEKVSGYVSAVVGLLLTAVPIGMTVVAPQAGGLADRYGSRLLTTAGMGV
TALGTLLLSVMMSLHADLPVLIVGLFLVGAGLGMFTPPNNSSVMGALPPTRLGVGGGILN
MARSLGMAMGTAVSSSLMAIFLGIFGSHLVRGSKLVWIPTMRYALLALAIVAAVAAVLSI
LKTTRENASPQEKIEVPMEF
>fig|1051632.5.peg.3475 Permease of the drug/metabolite transporter (DMT) superfamily
MTKAATQATGTSPGKLESLGVVYGLAGVLVFSLTLPASKAAVGSFGVLIVGPGRALIAAL
FAALTLWTRHERLPQKKYLPGFIIISVGAVFGFPLLTAWAMDRVPASHGAVELALLPLAT
AAVSALRNGERPSWFFWSCSAGGAATVVMYTWFAGLGRIHLADLALIGAVIVVAFAYAEG
GRMASELGGWQVIAWSVVFSVPALVVLLIADFSFVGVPDVWHATWTAWAGLLYLGIGSQF
FGFVAWYTGMGMGGVARVSQIQYLQPFFTIIFSWVWLGEQLTIKTLVAAIVVVLWVAVGK
RATVRRP
>fig|1051632.5.peg.3520 Drug resistance transporter EmrB/QacA subfamily
MQSRHTRKWWILSVVTLVAFVTNLDGTIVVVGLPRMIEGLHVSMTTGLWTLTSYIITSTV
FLLPAGRWSDLIGRKKIFLSGLLIFTGSTFLCGIAPTGSFLLAFRFVQGMGAALALATAT
PIIVSTFPPQQLGRALGINSTSWVMGSIVGPVAGGLLVGTLGWRWVFFVAIPFALIGVVG
SMIVLKDTASTPSVPTDWVGALTFGLGLLSLLLALSFGPKWGWFSTREVGLGLLTTLAFI
AFIEIERRLPHPLFNLGLLAHPHYRSGLLITLSYSIGFFATTFLLTLYVQGALHRSPVEA
GLLLVPLSAPQLVMGPLGGAWADRYGPSRLIALGIIGMAGGTFWLGHLSTAYRVWTIVLP
LLLISASNGLAWPSLTKAVMSAAPRDKSGSASGMFFSFRNVGMALSLTVALVVAAASLPP
ALASQIYVGTGHVLNSRLAASLVHATNTGFQVFVGFYALAFVALLPFFRRRSDAVRPSAP
PLP
>fig|1051632.5.peg.3714 Permease of the drug/metabolite transporter (DMT) superfamily
MSRLGAKIWLLGITLIWGATFTLTKGALTDVGVLPFLGARFGLAALGLAVLAWGRGADWS
WPGLLRGAGLGVLLFGGYLFQTWGLTTIQPAMSGFITGLNVVLVPLVARIWLKTPIRSNA
WGALGLAILGLAVLSGIHWQGWARGDGLTFVAAVFLAWQLVAVERWAASGATLSLAFVEI
AVVAVLSGLGSRLTGQPVWSPDMLKGPVLRALVVNGLLGTALAFWIQTLAQQVLPAFEAA
LIFMLEPVFAALVAAWIGHESFSWRTIVGGAMILAAMMIADPEWRQWWKVRHHLSNTST
>fig|106370.11.peg.719 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MHHRHGPAIGAGTTTSDRQDAGPGRRWAGTTTGSHTDVSVSAIHRPEHPQAGTPVQAASG
DGVAAVGPDAPYVTIVLPCYNEQDHVLLELERITAAMDASGYSYEVLAIDDKSTDNTLAV
LREVAPRFPRMRVMPFRRNGGSGTARRIGTQEARGKIVVWTDADMTYPNERIPEFVRYLD
DNLDVDQVVGARRTEEGTHKWARVPAKWFIRMIAQRLSGMKIPDLNSGLRAFRRDVSLPY
LRLLPPGFSCVTTITMSFLSNQHPVDYIPIDYAKRSGTSKFHPFRDARRYILQVLRMVMY
FDPIKVLMPVALWIMGLGFVKLIVDLIRYDFHVATSTLLAILVGFQIVVLALIGDLVARS
RSDT
>fig|106370.11.peg.1227 Drug resistance transporter EmrB/QacA subfamily
MAAQTQAPAAAGGGMTGGSGDRLDPALIRLAGIVLVGAVVVQLDATITSVAINTLARSFN
VGISTIQWVSTGYLLALAMVIPVTGWSAERFGAKRMWLLSLVLFLVGSALCGAAWSAGSL
IAFRIVQGLGGGLLLPLMQTIIAQAAGPERLGRLMAAVGVPALVTPVLGPVIGGLIVDDL
DWRWIFFINVPVCLIGLVLAWLGMPDVRTPGRHRFDALGFALLSPGLAAIVYGFSVAGRQ
GDFTGVRVIVPLALGAALLVLFTVHALRTAVEPIIDLRLFRSRAFAGSSGMMFLFGISLF
GAMFLLPLYEQQARGRSAAAAGLLLAPQGLGMMIALIVLGRVADRRSPRLFVLVGLLLSA
LGSVAYTQVAADTSEVLLGVSLTVRGIGLAMALIPVMSSAYHGLRREEIPRATSAGRIFQ
QIGGSLGTAILAVVLSHQITGRPAGTGPADPVALAGAFGTAFWWTLGSTVLAAPFAFLLP
GRPAGAEQPAPSGPPVELPRPAGAVPTRRRSGDHGELKSHETSPGRRAAVSGAEGNRHDG
REYRVPAPRGGRGGGQWRG
>fig|106370.11.peg.1834 Tunicamycin resistance
MLVCPCLTILRLVPTLIWINGPNAVGKTQVAHNLHRRLPGSFISDPEHLGFAMRRMLPKP
RRMDFRDVPLWRQAVSEMLHLALQGPEDPVIAPMTILDPGLLGELTASARAAGHRVEHVT
LLADRTTMIRRIHRRGETSRSFSARQLDRALDVLRAPEFARHLPTDTLSISAVADDVASH
TGFTLSPDTSGRLVRQGRQLAVQLRHIRLNA
>fig|106370.11.peg.2262 Drug resistance transporter, EmrB/QacA family
MDPGVRTSASRNTLMSLLAHERARPRAVRDLPGGWWLAVATVCFGAFMGQLDASIVTLAY
GPLCAQFHAPLAAVTWVSLAYLLTLVALLVPVGRLADAHGRKQFYLYGLLVFTATSAACG
LAPSLAALIGSRVAQAVGAAMLQANSVALVATSAPRPRMRAALGVQAAAQALGLALGPTL
GGALVTTLGWRWVFAINVPVGTIALIAGYYLLPRTRQRTDPAPFDWPGLALLATATTTLL
LAISAVSGLNLPSAATAILAILAPLAGYGLVQRERRAPAPLIDLRLLRIPALAGGLVGAL
CGYLVLFGPLVLVPVVLTDRGTSPLHAGLVLTALPGGFALAASGAGAVLPDRWSDRRRYA
LGAVTCTMALAAALAVPLSAPWLIPPMAMLGLGLGVYTPTNNTTIMSAIPAHASGTGGGL
VNMTRGLGTALGVAMVTLAVHLAAGATGPRLAIVGLTAASLLLFTPLLTPSRGMRNIGTE
NSARC
>fig|106370.11.peg.2344 Drug resistance transporter EmrB/QacA subfamily
MIEPGPAAVAGQLGQRQHGHREAQPEQCGKHRQEQHAAADAANSVSPGVELRFLAAEPAL
GLGDLHAFPGPHPQTRGAGGELLLPLGIFRDRNFALSNVAVAAAGAAVPAVLVPLYFYLE
SVRAMSGADAGLVVAPMAILAMVCVPIIGIFGDLIHPRVIPSAGFALFAVTLMIFAMFMT
PDSVIGCS
>fig|106370.11.peg.4107 Multidrug resistance protein B
MTRPEAHSGSADGPNPSNDLEQAGPSLVPLATTLIVGAFAALLDTTVVAVAIDTLGRDLQ
ADITVIQWVTTSYLLAMAAVIPVVGWLVDRFGARAIWSGALGLFLAGSVLSGLAWSAGAL
IAFRVLQGLGGGMILPLTQLVLARAAGPQHFGRVMGVVGLVGQLAPISGPVLGGLLIDTW
GWRWIFFVNVPIVVVSLLMTTRWFPREDPRTERSLDVVGLVLLPTGIVAMIYALSNVESG
STVVSAQVLVAALVGVALLAAFVLRPTTPGRPSLIDLRLFGDRSFRGGSVMLFVFGVTSW
GPMFVLPLYYQQLRGLSALDAGFALAPQSVGLGLAYLATGRYADRLAPRPLVAGGLVVAS
AGTLPFVFATADSNLTLLGISLFVRGIGFGAASLPASAAVYRTLRTADIPGATSASNVIQ
RVGAATGTAVMALILQADGFTPALTWMFVLTSGALAGTVFLPGQKPAPAPRDTVPTTTAT
GAQ
>fig|1069080.3.peg.215 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFLQENQAIKAENHLMEPSDKEHTQLEIPISLINLLRFASPAIIMMLFIASYTIVDGIFV
ANYLGTEALAAVNIVFPFSSIIFSLAIMLSTGGSALVGIKLGSKAELQAKQYFTLLLVSA
AGAGICLSAGALIFREQILSFLGAEGATLAYAQTFFTITASFAPVVILQILFENFFITIG
KARVALGLTIVAGLVNAALDYLFLAVWGWGIEGAALATAAGSFFPVAYALYYFTNQQQLL
AFVKPIWEWAIIKQACFNGSSEMISQLSGGIIALLFNIILLKLFGIAGVAAVSIVLYSEF
LVLAIYSGFSMGIAPLLSYNYGGKERLKIKKLVRLALGIVLLLSSGIYVLLNFFTGNIVA
LFVPINSEVYILAKQGLTIFAVGYILAGVNIFAAAMFTAFGNGRISAILAILRTFVFIVL
GLYVWPKIISGIGVWLAVPCAELLTIIFTIYYLQTNRKRYSY
>fig|1069080.3.peg.352 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKLSFAVASKRILQFMLPILLTMLTVAGMNAIDIIMSGHASTADLAGVSVGNSIWFPIYT
GFNGVIIALTTIIAHLLGQNKPQEVSTALKHGLYLAILTGAAIIFFINLIISNINYFITI
EPYVQEVAVGYIRAISWGVIPLCLCNTLRQFIEALNFARIISLVYLSALPLNALINYGLI
FGNWGLPKLGGIGAGYATSITYTIICLILLIIITQQQPFASYRIFQIIRLDYRIFFEQLR
LGLPIGFSIFLEMSIFSLTALIISKFGTVTIAANQAAFSAVTIIYMFLLSLSIALNIIIS
YELGANNPVTAKQFAHYGLKFSLFLSLAVIVLLFFTRAQVAALYSNDPTVQILIQDFLVY
VLFYQLADAILTPSQGILRAYKDVNMAFYIALISYWLVCFPIGYILDNYYNFGAVAYWNG
FVCGMSVGALISLYRINYLQKTSLPKI
>fig|1069080.3.peg.506 Permease of the drug/metabolite transporter (DMT) superfamily
MKPRDLFMALLIVTIWGANFTVIKLGLADIPPMLLAGLRYVFATLPAIFFIKRPNISWKY
LALYGLTVGIGQFSCLFYALKIGMPAGIASIVLQAQPFFTVIFSAFLFKESLYRLQILGF
AIAFTGLYLIGGDTSGVPLPLAAFLLTILAACFWSISNIVIRYSAIEATQKQEKLDMLAV
VIWSSLLLPVPFFLLALLFNSPQELLSVVTNLKPSSLAAVLYLALGATVFACGMWNILLS
KYSPTKIAPLSLLVPVTGLITANLVLGEQLSFWQTLGGIIIILALLVLNFKSLPWANAFK
AK
>fig|1069080.3.peg.597 Multidrug resistance ABC transporter ATP-binding and permease protein
MQVYGKYIKKYRVPAFGAMLCVTLEAGCDLLGPTLMAKIINEGIIAHSMAEVTKWGGMML
LITICGAFFAITRSILASTVSQRIGADLRYEVFKKILNFSEASADKIATGSLITRMTNDI
NQLTQFINGMMRIFIKAPLVCLGSIILATLLNPQLSIIIYGFVALVATVIAISLKLSYPL
YAKVQQAIDRVNSVVQEYLLGIRLVKALGTYNEETERFEQANKNLEQRSLASQMIFMVSG
PLIMLLFGTATTGVLYWGSSLFAKNLANPGEISAFIIYMTQMLIAIMMITSIFNVFVRTK
TSSERILEVLNSEEDFSNSGIEQKLQGSIEFSRVSFAYPNGSGLLALRDVSFKINAGENL
AIIGPTGSGKSTLAWLLLRFYQANQGKILLDGVELNSLAVHNLRSQIAIVPQKSLLFSGT
IEENLLWGNMQADKIQRQRALELARADFVQEFPAAEQTVLGSRGVNLSGGQRQRLSLARA
LLKQAKILILDDATSALDGVTEAKVLKNLQTVASNHTVIIITQRCSTAMAAGRILVLDEG
EKVGFGTHSELMQQCPTYQEIYKTQIESNKVS
>fig|1069080.3.peg.813 Vancomycin B-type resistance protein VanW
MQCGKRKFYGFVALITLVTIFFVASVSFDIGEQIVENIRIQNVAVGKLTRTQALQELKQQ
IRKPVLKLSYKNKNYYITPEDIAYGYDYQASIEQVYQVGRIPQENIYQRYVDIYYTRQYG
RSYQLVCTYDKELLHTKIQEIIREIQIQPQDAKLIGSTQQNNLQVEQIGVLVEAYGLYYQ
ILEALHKGQDCEIRIETLNFLPGRYAQDLVKFKKMLGRQSFSSDEADLALIDCLDGIVWK
KNTSISWQQQLNRIEKSTNYSIPKGNSQLMLEGFYQLSQQLQLFSERISLDEAGKLIVQK
GNLDLIIRNNSNQDIYISCYKERNKIYLEFWGEN
>fig|1069080.3.peg.1269 Permease of the drug/metabolite transporter (DMT) superfamily
MTHYHPFVCMAYIFIWGTILLLPLMLVFNAFQPLVFNFFQPPNFSLLGILVYLGIFSSVY
SYFIWYKAINTIGAVKTSVFMYLNPLISTITGAFFLSESLAITTMIGGACILCGVYLVNK
NK
>fig|1069080.3.peg.1287 Broad-specificity multidrug efflux pump YkkC
MLILSSFLLLIRAYKLIPVGIAYAVFVGIGTIGTYIVSIYFFNEKLSFVQFIFLFLLLIG
IIGLKITTQEVKK
>fig|1069080.3.peg.1340 Permease of the drug/metabolite transporter (DMT) superfamily
MQENQLAGHLSVFITILIWGTTFISTKVLLVDFTPLEILFFRFSMGLLALMLIYPQRLKV
TDNKQELYFAGAGLCGVTLYFLLENIALTYSMASNVGVISCIAPFFTALFSYCFLGGEKL
RANFLLGFGAALFGISLITFNSSTSFQLNPLGDFLAVLATIVWAAYSIFTKKISAYGYNT
IQMTRRIFAYGLVFMLPALFFLDFRVGLERFANPVNLFNIIFLGLGASAMCFVTWNFSVK
LLGVVKTSIYIYLVPVITVVTSVIVLKEQITLLAIVGSVLTVSGVFISDSQNGLKLLANL
VRKR
>fig|1069080.3.peg.1483 Permease of the drug/metabolite transporter (DMT) superfamily
MKNNISKSLATLLVLTASIAYGTLSTTIKLAYKAGFTVGEMVFGQIFLAFLFMFCFALIK
DYKFLGSIKPKTILILIGAGSISSLTTIFYNLCLQYISASLAIILLFQFTWIGILLDYIF
NKVKPSRLRIIALLIILLGTYFALNISYQALAVNPLGIIFGLASAFSYSFFIYFSGNLAT
NIPIIYKNSIMLSGSLIISLVFFPPIFLFTPSVIPISFYLYSSYLAVLGMVLPFYFFSKG
VPIIGTTSATLIGALELPTVLIGATLILGEKIVLHQIIGICLIILGIFISTRTKIST
>fig|1069080.3.peg.1765 Fosmidomycin resistance protein
MSVKYNLPILLLAIAHLVTDLTQGAVPILLPFLKEKFLLNYSQVGMIVLVQNLTSSVIQP
LFGYYTDKISIFWLLPASVLVATIGIVLTGYATSYSSLLFIVIITGVGVAAFHPQASRSA
MLLSSADSKGKNMGLFSVGGNLGFALGSIIMSVLIVLPGDLYNTVYFLIPGILVFAWLMQ
ARGQLDTYTKVGSKGEKIKPAAKVAQAYYYLLMLISFIFIRSTIQMGITTYLPLYYIENL
AGEPKYAANLISMFLVFGVLGTFLGASLSDKFGRKKIILASMVITLPLLILLPYSSGLST
IVLTAVLGFALVFSFATTVVLAQELLPNNIGMASGLTIGFSIGLGGVGVTALGFLADNFG
LEIVFKLLMFLPLLGLVLVSRLPNDQK
>fig|1069534.5.peg.148 Multidrug resistance protein B
MMNAALIDGSDLSDIDDFAKKYDGKVSAKEKYKYVGRTVKERVKNFKRDNTGFSCSTDYK
KGKLVWFSVPYDKGWDATLDGKKIEIIKSAGMMAVKVPKGEHNLVFKYHTPGFKLGIIVS
IISFIVFGIYTAILVFRKRIN
>fig|1069534.5.peg.616 Multidrug resistance protein B
MTTKKKWHVMPAVVSTTIMSFCGVLIETSMNVTFPTLMKQFGIDAGLIQWVTTANLLTVA
ISIPLSAYLIRNVSEKNLFVSSNLFFLLGVILDSIAGNFELLLAGRILQGIGTGLALPLA
MHIILEHVPLEKRGFMVGVATMTTCFAPAIGPTYGGIILHHFDWNKIFLFLVPILAISFV
VGIMSIPQRKIETKTGFNFGGYFFLALGLALLLVAIERFSLWLLLLSIMALLMFYFSNKK
KRLISLNVFSNHRFVWFMYGALVTQAIALGISFIFPNYLQIGLHQNTVTAGLFMLPGATF
VAFLAPVSGRLMDELGYFKPIVFGMTLASLGLAFLAFVLPNAGVKLLLCGDVATKIGMGL
ATSSLVATSLSQLEREESIDGNSVLNTLQQFSGALSTTVVSVIFGWAQKTMSNGSMVGSR
ISIVLILAITLIALGLVLKLKFEARS
>fig|1069534.5.peg.624 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSILMSIMQLIVIPVNGITQGVQPIISCNYGAEDMLRVKETVVRLVSVCLLGTLILAGVA
IFCPGIYASMFTNDAELVALTCRIMPSFFLGIAIWVIRAACQATFLALGQANVSLFIATL
RKIILLIPLALILPKFSGVKGIYIAEPVSDVISVIVTVITLKRIFIEMEDKS
>fig|1069534.5.peg.639 Ribosome protection-type tetracycline resistance related proteins, group 2
MLNNLLCYNTFRQYERSDGTLFPQTTLKHIVTGIIAPVDSGKTTLTEALLYKAGELKKLG
RVDNGDAFLDFEELERKRGITIFSHQANLTWKNLQLTLLDTPGHVDFVSQTEQVLRVLDC
AIMVVSARNLITSHARTLWSLLDFYHVPTFVFVNKLDLSDLSKADIVQRLKQLDQGIMAF
DGTETEELAELDDALLEKYLENDSIDRTDVLALIKQRKAFPCFFGSALKLEGIDALLQGL
ADFAPELESRNEFSARVFKISHTEKNERLTWLRVFGGSLHPKDMILDDQKANELRVYDAK
RYGAAKEIVAGQICAIPNLNETFVGQGLGFLENDAASCMTPVLSYALNPNGCDLHACLVA
LKELEDEDEHLHVVWSKQLNELRVQLMGPIQLEVLQQILKDRYELDVSFEQGRTLYKETI
TQTIEGVGHFEPLRHYAEAHLIMEPGKPGSGLVFSSDCSLEELDKNWQNQILSCLKSKEH
LGVLIGAPLTDVKITLATGRASIKHTVGGDFRQASGRAVRQGLMMLKERHGLKLLEPWYR
FVLKVPEEKLGRAMNDIQQMSGTFSLDQASGTLSGLAPVSEMQSYAETVRTYTHGKGLLE
LSVDGYRQCHNEQEVVSNSSYDPLSDLENTPQSVFCAHGAGYTVDWSDVPKMAHVPYRSS
>fig|1069534.5.peg.1059 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSDLRTFMNYVIPSVLSFALSGVYAIVDGFFVGNTMGDIGLSAINVAYPITAVILAVGTG
IGMGGAVQYSISSAQNKPKKAMNFVNGTLWLLIVSSIIITLSAGLFPEFFVSLLGAKGTL
LEMGTIYIRVIALGAFLQIGSTGLVPMIRNYGGAFFSMVAMISGFVTNIILDYLLVWVLN
LGMTGAGLATILGEGLTFLLAMIYLLKKSSISLKIPLSIIKKISGPVIRVGIAPFGMSLA
PNISLVIINWFSIKYGGDRAVATYACISYVICVIYLILQGVGDGSQPLMSRYYGAKNLHK
LKITRDMAYVFSLILALLGCFATFYAKGAIGALFGTSASVNAEIEKIIPIFLVSVPFVSI
SRIATASFYATEKTAFSYVLTFIEPVLMLILMLILPPLFGGQIMVWWSSVFARIISAILA
YALKLVVEKSEKTQLS
>fig|1069534.5.peg.1210 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQRTIDTVQSMEKGSLFLASTSHLPQRKMKTLTKGNPIKLILLFAVPLLIGNLFQQLYSL
SDTIIVGQTLGVDALAAVGSTGSIQFLIIGFAQGLTAGLSILTAQYFGAGDYQKVRQSFV
TSIVITVIVTVLLTIFSLTFVGKILELMQTPAEIKNDAQTFISVIFASMVVLMAYNLLSN
IIRALGDSKTPLYFLIFATIVNVILELLFLLVFHWGIAGAGFATVLAQGISVVLCIVYII
RKLPLLQIEWKDFKTITKESLGKHLYVGLPMAFQMSIIAIGAVLLQSALNGLGTTAVAAS
TAGGKIDQLATLPMMSLGVAMSTFTAQNYGAKKCGRILQGVRQTIIVSITVAIIGAVLII
IFGKQLVTLFVGNQAPAVLKLSQTYFNITCTFYWVLGILFVIRYTLQGLGQSIVPTLAGI
AELVMRSSAALFLAKALGYAGACCANPMAWAGSCFVLIPSYVKSYKMLKQREKEQDNKSN
EESGTEF
>fig|1069534.5.peg.1436 Permease of the drug/metabolite transporter (DMT) superfamily
MTDKEQHKEIFKKKNLILLILFAVFGMVPSQLTFFLAIRYGNAATATILQFLGPVFIIVC
LAIQYRKLPRRIDVISLMIAVLGTILIVTNGKIGTLALSAAGIFWGIMAGVSQASYTLIP
RRLLEQFDARLVTGLGMVIGSVLFWPLILTTKIPSITPFTVGSFAYIIIFGTMASYLCYL
QSVKYIPASTTGMLSAFEPLTANVLSVIWFHETLGAFQTAGAVLILSTAFLQAMALKGK
>fig|1069534.5.peg.1438 Permease of the drug/metabolite transporter (DMT) superfamily
MSKRNQGIMLAIIGTMFWGISGPFAQALFAQNVKPLWLVGARLLLAGILLSQVLICV
>fig|1069534.5.peg.1912 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNDNAVMTEGSYKKKIVYFAIPIFFGSLFQQMYSTADSLIVGNFLGSSALAAVSSSGNL
IFLLIGFIQGLTIGCSVVIARFIGARDHKMTSLAVHTTVALGLVSSLVLTLVGIFLAPQI
LRLMSTPEEIMDQSVEFFRMYFLGSAGFVMYNTLVSILQASGDSKHPVYYLIIASIINIL
LDLLFIGVFRFGVGAAGVATSISQTISALLALHQLMTQSGSCRVDLRKIRFQPQILKMII
KFGLPSGLQNSIIGLSNVIIQSYINFYGKNAVAGIGSYCKVEGFAFLPVTCFTMALTTFV
AQNLGAKEYQRIRAGVRFGTICTLVLAEGLGILLFVFSPQLIGAFDSTPAVVSFGVARAH
VCGPFFFLVAFTHVMAAVMRGAGKAMIPMIIMMICWCAVRILTLYVVGMFYQTIQTTYWV
YPLTWMLSSLAFLLCYRRLDFTKL
>fig|1069534.5.peg.2097 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIGIPASLTNLMQSYNMTIINRYLIDYGSKAVAAMGIAIKVNMIIMMIMVGFAFGAQPLI
GYSYGAKDNKRLQKIIRFDLLVEVGFSALAAVFIIIFAPHLIGSFMDDSAVVAYGTGMLR
WFTLTTPFCGIVLVLTTCFIAMGKAVPSFVLSISRQGVIFTVVILITAACFGYDGIICAQ
PVADFLTAVVGIFMYAAARKSDQTLRKED
>fig|1069534.5.peg.2098 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENKQELFEKAPVWKAYFIISLPVVFSMLVTLIYNMVDTFFVSGTQNADLVAGVSQCTPL
FTLMLALGDIFGLGGSSIISRLFGQKDDATAKNVSGFCFYAAVISGLIVTGLMFLFQTPI
LKMLGATDSTVKYASQYYFFIAWGAPLIILSLTPSNIIRTEGLALQSMIASVAGSIVNIA
LDPLFIFTFKMGGLAVQRLQR
>fig|1073972.4.peg.245 Vancomycin B-type resistance protein VanW
MYKILKTYKNLRLEKSISSVIFTILIILSIVFPISFVNYRISSLVNSWEGKVYSGVTINN
VDVSGLSRSALKDFLVEKFSGSITNDIVEFRLNGKGIDIQSNELGITYDYDRAIDEAFSF
SDGLTYTQKVNQILNPQKIKDIKLNEIFDISDYQVESLYNKLSNRFNVDPINAEISIVDG
QPVIVKESYSSIEIDKESLISMISDTDPSSAFQNGMNLSAKSLNSKYTSDILGKINGKLS
SYSTSYKSSSSERATNVELSASFINGTILMPGESFSFNRIVGQRTRERGFKDAAIIVGNV
YESGLGGGICQTSSTLHQAVVRAGIIPTQRRNHSLPTSYMPLGFDAAVAWGSLDYVFKNT
YSFPILIDISTEGRNLTVSIYGDVTAVDKTYSTVAETQESIPYSTKYVNDNTLAKGTQVV
QKNGVNGSKVKVYLVSKDKKTGKVIEKKHVWNDYYAPQDKVVRVGTK
>fig|1073972.4.peg.380 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGTIQLSDKFNYKKLLRFTFPSMIMMVFTSLYMVVDGFFVSNFVGKVPFAAVNFIMPVLI
ILASIGFMFGSGGSDLVSKILGEGDQDKARRLFSLIVYSTIICGIIIFIVSFIFIESIVS
FMGADGEMLENCIIYGKIILVALPFYMIQFEFQSFFITAGKPHMGLITTVVCGVTNMILD
ALFMAVFSWGIVGAAVATTISQILGATISVLYFCRPNAGVLRLTKTKMNAKALLKTCTNG
SSELMSNISLSIVSMLYNFQLMKYAGENGIAVYGVLMYVNMIFLSIFIGYSTGVAPVIGY
HYGAKNYSELKGLLRKSCIIICIFALIMFGLAESLAGTLASIFVGYDMELMGMTERAFKI
YSISFLFSGFAIYGSSFFTALNDGVTSALISFLRSLVFQIVAVIVLPLIFGIDGIWFSVI
AAEIVAVLITVLFIIGKRSKYRYL
>fig|1073972.4.peg.441 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVKIFFKYSISSMIAMLVTSLYTIMDGIFVGRGIGDTGLAAVNMVLPITIMYFGLATMIA
VGGGSLVSKSFGENNEIKAQNIFGQTIRLIVLLSLFLSVIALFGCHKIMYLVGARDEILY
YSSEYLKYYSLFCSFNLIGIVINSFVRNDGNPKLGMIANIFGAITNIVLDYIFIFKFKWG
IQGAALATGIGQIMTIIILMNHFIFKKGALRFKRASFNSDVLKSIVMIGFPSFLAEITFS
MIIFFYNIALIFFVGSKALTAFSVINYINSNIYMVLLGMNFGVQPLISYSFGEKNGKDML
KFYGFSKRFGFSLTFIYVLICLIWGNNLIKIFTSDLEIIRIAYFGLNVSNLAFFILGINL
TTSIYYQAMEIPRYSNVICIFRSFIFLPISLLILSRLFGLTGIWMSLIFSEGLSLLFINF
VVRVKRITEKLIFN
>fig|1073972.4.peg.1181 Multidrug resistance protein B
MNKSNRQFTKIFLLNMIVYISLTMVHPITPKFINENNLPTFYFGLLQGCLNISTFISAPT
FGIICNIYGKKITMLISLIGYTIGQIIFGFFPNNVSVIIARIISGIFIAGYFVSSMAYVS
SITPVKLKLKKISYFNASNSIGVILGSLIGGILGINDYKLTFFTQISISLLSIILITILF
KDNTPKNKDSKFTLKILNFKDLSKIKKSNKFVYLILLIMILTFLAIQGYASTISYYVEDI
LNLPTSINGVILGSSGMFTLITNLIIIPIVGKKFNSKSLYMFSILLSGSSILIAMSVTNQ
YITVIALLIFIITHTLITPTIQTLLLENSTQNQGEILGIQNGFKAIGSFLGSILSGLLFN
VWFKLPFIVIGLSLILSFIILKSFKEKSPHH
>fig|1073972.4.peg.1328 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKRMDLLNDDLKKIFIRYLIPGILSSLAISLYIFVDTMFVGIGVGRDGLTALNVTVPLFT
LFTSINLCIGIGGSNILSLNKASGGKDSNKIFTIAFLFTIMIGIIISVLGVVFTDQIGKV
LGATPDISYLFRDYFRILVGFTWAFLISGVLGCFIRNDGAPKLVMTATVVANITNVVLDY
IFIFEWNLGIKGAVIATVISPIVNILILSTYFFKKNSNIKLCKVRFDFRLLSRILNNGFG
TFLLEMSRGISIFIFNNILVRLGGNIYVASYGIILNVSYVIICIFSGIAQSIQPIVSMNY
GHNSIKRTKTVFRYGFITSIFIGVSSFLIALMFSENISSLFINNDFELLSITIYGMKIYF
IGCIFMAFNIVTIYFFQSINQSQKSILISLCSGILFIILGFLILIPILKINGVWFVYPFS
EFLGCIVCLLIIKRTNIENKKELIL
>fig|1078846.3.peg.1897 Permease of the drug/metabolite transporter (DMT) superfamily
MPSNQSPAEQRNQMTGFALVLLGAFGFSAKAILIKLAYAADVQIDAITLMALRMLFSLPF
FLVVAFWNNAASVAAPMTGRQWLLAIALGLTGYYIASYLDFLGLQTISAGLERVILFLYP
TFVVLLSALFHKRKISLRVGLALVLSYTGMLLVFMEQLSLASANILLGSALVLASAVTFA
IFTMGSGVMTHSIGSTRFTAYTMTVASMATLAHFGLRHGTEIKHLSTGVYVLALVMAVFS
TVLPSFFMNAGIRRIGASSASIISTTGPIATLALAFFILDEAITGTQLAGTFLVLAGVYV
VSKK
>fig|1078846.3.peg.2020 Permease of the drug/metabolite transporter (DMT) superfamily
METTQSICGTCLVLIKRAYFLAFLAMMAIAGNSLLCRLALKHAVMDAASFTTARIMASAL
MLISICLPRLGRYCCLAP
>fig|1078846.3.peg.2397 Acriflavin resistance protein
MHDSLVLLDSIREHEGSDKPITELIIEACTSRFRPILLAFLTNFAGFLPTLLETSPQAQF
LIPMTLSLSAGLLFGMAASLVLTPVCYAMMGEK
>fig|1078846.3.peg.2842 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTIRSKQLVALTLPVALSAMLDNAYRVIDQHAVQWLGVEAQAAIASCTFILIAYYAIYSI
ISAGTLSLVARAVGAGQAAGQKQLMGNALAGSVLLGSMVLALSGLYAPVLTNLLGLSDSV
ADQASMYLRWHAVYCLPQAIMPTLNAILIAFGCTRTVLLLQIIATVLNILLNPVCIYQLG
YGIGGSAMATGLSQAVAAATGLVLLRRTTPFRWSDLGLGRPVLKIAKIGLPMCWGTMMFA
LVYGAMLHWVISPLGAPVNAALGIGFSALEGFTWPVFWGFSMGIASIVGRSLGAGNLNEA
KQAIRLAFKLLTMAGLAVSGIFFFGATLLCGLFTQDALVLGEAVRYAQILAFSQLFVAYE
SLAEGVLGGAGKTHSILYWSAPLNLLRIPFSWLFAVYFGYGAAAVWWVIGASTLLKAMGK
WWSVRSGAWQKV
>fig|1078846.3.peg.3002 Multiple antibiotic resistance protein MarC
MLNWNEYLQLLVGLLSVVNPIGIIPTFISLTTNRPPQERRHTAIVCAFSVAMVLFISLLA
GEPILHFFGIGLPAFRVSGGLLVMMMGISMLSANNDNIRHTPEEKAESYEKDSIAIVPLA
IPLLSGPGAISTTIVYAHGGQSLEHFLLVGSVILSVSVLVLAALLAAPKIADAMGRTGMN
VVTRVMGLFLTSIAVEFIAKGLGELFPVLVKIFP
>fig|1078846.3.peg.3097 Glyoxalase/bleomycin resistance protein/dioxygenase
MDISGINHINIVVTSAQLPDVVAFYEQIIGLRQGLRAVSKRNGAWLYCHDTAIIHLSVVE
QAPYTGKDTLFNHVALSCSGVTGWVSHLNRHAVHFDIDYRPSPEMTQLFLYDPVGIRIEL
NFAGERLEPSA
>fig|1078846.3.peg.3728 Membrane fusion component of tripartite multidrug resistance system
MMDTVKKSRHRFKNIANLLGDKAGGQLRQWRYRRNRRLLSVTLSAVLVGVVYWAYWQRHA
SHFVTTNDAYVIGNLVALKAQTSGTVVDVRVDTTQYAHKGEVLVRLDGLAAKVALEQAEA
NLAETVRQVETLSSTAERLRQKIAAQEAPLGRTRRDLLRYRSVAQEGAVSAQQIENTEFT
VRELEAGIRQTRAELGGAEALIHGVALEHNPKVLQAASALKQAYLDKVRQNIVAPVSGYI
AKRHIQPGEQVHPDTPLLAIVPLDYLWIEANFLEDELTEVQPGQAAEITVDLYGSEIVYH
GEVLGIGAGTGSVFGLLPPDNATGNYIHITERVPVRISLRPEELKAHPLRPGLSAVARID
TRQKGRSVLQPFTATPPESYRTDVYDTQLDGAEALVDKIVKGNRAMARAPV
>fig|1078846.3.peg.3730 Inner membrane component of tripartite multidrug resistance system
MSLDDDNTRAAWAPLTHDSLNAELAGKSSLGASQFVLLNFALLLGNVLVLFNTGAFASIS
LHATGELGVSPSHASWIQTYYFISLAIALPVSAWLAARFGEVRWYLIAMLAMALGSLLCS
LAHDLTWFLLGRALQGFFGGLTIPLSQTLLLREYPESKKAFGISLWSMAALSPFTLGPLL
GGWIADNLGWHWLFYLNVPLPLLSAALVWALLSDRVSVRSLRPFDTMGFVLLAIALACLQ
TALNQGQDEDWYNSAFIVSLAIAGVLALVYFIIWELGERYPLLNLRLFARRNFAIGTIGL
SVSFLLMYGLLSVLLVRLQSVSGYTSFLAGAVLVPLLFFAKPMAGFFHLIVHRYDARLLV
CLNMLSFALFCYMTSTYDFFQRNSWFTHTLWSQVLEGFCLGGLFVPMTTLFLSGLNAKRQ
TQAVELGGILRILGGSVASPLLGVLWERRTAFHQSHIVQTLGTYDALGREALTSLDTAGF
HGQLTIARLAQAANQHAAILGLDDAFRLSAWIFLGLATWVWFAYPVKPITKMGKKERLRE
NALESLVEEP
>fig|1078846.3.peg.3768 Permease of the drug/metabolite transporter (DMT) superfamily
MRAKVWAALLAVYVVWGSTYLMIRFVVETLPPFLSAGLRFLVSGVILLGWRCLAGDAVPT
LRQWRSAAIVGTLLLLGGNGLVCWAEQTVPSGVAALIIGTVPMFLVIADALRPNGTRPSL
RVLAGLVIGFLGIYLLVGPSAISNGMPLNGPGVAALLLASLLWAAGSIYSKNADLPETAL
MTTGAEMLCGGFALMTVSALSEEWGVFSFAQVSASSWLALAYLILFGSMIGFASYAWLLQ
NASIPLVATYAYVNPLVAVFLGNWFAQEPLTPRILSASAIIIGSVIFMNSSYRGKPAATQ
GAGK
>fig|1078846.3.peg.4001 Acriflavin resistance protein
MSIETKKDSLTVAIVRLFTTSHLSLLFLIISLLAGAAALFLTPREEDPQIIVPVMDVFVQ
VPGASAEEVEKQVTTPLETLLRQIQGVEYVYSASRPGESVVTVRYLVGENLENSVIKTRD
KVLANQDIIPPGVTNWLVKPVEIDDVPILMLSLSPQRSDMEATDLRRVADELVERLREVD
NVGKSWVVGSAPRRISIYPDPAKLQAGNITLLDIQQALAKNNVNLPVGTLTEQNKEIILE
AGPHYQTAEQIGGTVVKVVEGRLLTLRDVAQIIDGGADTDTYTRIGFGPAVAHMQTAGEV
AKLPAVGEERPLTTIAIAKRKGSNAVSVAEQVLTVTEQLKGTLIPDDVLITITRNYGETA
DHKVNELVMHLSIAILTIIVLLALSLGFKESLIVSLAVPMTFAVTLLCDYLFGYTINRVT
LFALILSLGLLVDDPIVDVENIHRHYKLRKEPPLQALLSAVDEIRPPTILATFAVIMSFV
PMFFITGMMGPYMAPMAFNVPVAMLMSLVIAFTVTPWASFKLLKGDYGKDHGEAFDLKTT
RGFKIYQAIVAPLLASKAKAWLFLLIVMIAFVASAMMAVTRIVPLKLLPFDNKNELQLIV
DMPKGSSLETTDEVAAALGHYLATVNEVSSYQSYVGLSSPMDFNGMVRHYYLRQGANVGD
IRIVLADKKHRDQPSHNIALRIRPEIERIAKQYGANIKIVEMPPGPPVLSTLVAEIYGPP
EASYADLLHVAKRVRGDIEKTAGVVDVDDFAEAEHGKLHYLVDHDKAALLGISTAQVAQT
LQLAIAGGSVGVLHIPQERQPLTIQLQLPRAARSSEADLLALSVQTSNGQLVRLSEIGSF
KHEQGERAIYHKNLQRVAYVTGEMAGRSPVEAILDLFGTFDEKPLPDGYKAEMAGEGEWK
ITVDVFRDLGLAFGAAMVMIYVLLVGQTGSLGVPLIMMIAIPLTVIGIMPGFWFINLFTE
PVGGYATPIYFTATAMIGMIALAGIVVRNSIILIDFIENIYRNNPLISLADAIVEAGATR
LNPIFLTAASAVLGSMMIVLDPIFSGLAWSFIFGIIASTLFSLVVIPVVYFLIKRNMPKQ
IIQEQ
>fig|1078846.3.peg.4649 Inner membrane component of tripartite multidrug resistance system
MENHQADPHVTSIKRRLLLGRIIGTLIVLGALMTGTLAWRINYQHPRTNDAMIRANIVGI
ASEVGGRIVELHVEDNQYVKKGELLYVIDPRPYLARLAQAKAELLLAEKEVDSRRASSGS
AELAIARLEHQRAAAEAEANRIEAEDEYLHNYLERIEPLAEKQYVTADQLKQARSKYAAS
RAELADARAKALSAQSAIEEAKSESRRAVSLIAQSGNVNARIEAAKAVVTAAELDVEYCS
VRAPFDAYVTNLNTREGEYTKAGAQLFALVDDRHWYAIANFKETYLQSIRPGQEAEVFLV
AYPGKRYRGVVTGIGWANSPDNIKQQGVLPEVQRTLNWVVLASRFPVRIEINERDPEHPL
RMGMTAFVTVLDRLAEIPKPLSAKEDIANTPPIPQ
>fig|1085623.3.peg.424 Acriflavin resistance protein
MSNVQNKSPWYTTFFRSGHLLVLSIIIILVAGLSAVSSLPRLEDPRIDLRNVLILTSYPG
ASPERVEALVSDVLEDELRELYEIKEIKSTSKAGFSSLLVELQDWVDDSSNQQIFSKIRD
SLENASAKLPVGASKPLLEDKRGATAFTMLISIDAANPDTTSLSVSGRLASELVDRVRNV
PGTELVRLYGHPIEEIVVALNPQALAAAGLSIAQVSDRIRSADSKLPAGVLRTDQKNIRV
QVAEPLENLDIVANIPLVAADGSYLRLADVATIEQSWQTPEREFAFVDGQRTIFMAARMQ
TTVRVDQWTEAVKSKIADFNTEFDGTSQANMVFEQNEYTQARLTELTENLLLGSLVVMLV
ILVFMGARASWIVGLALPLCAAFAIFSLSFFDQQIHQMSIFGIIIAIGLLIDNAIVITDE
IRLNLLDQNLTRLQALEKSVKHLFSPLLASTLTTVLGFMPIFLLTGNIGDFIGAIAISVV
MALLGSLAISLTIIAALAARYLPRDGGVGHAWYRRGWQMPAVSHQFSKLLGKLIKRPLLV
LPLISIFCLSGFVLSQQLPSVFFPSADRDQFEIYVWLPNGASIKQTKQVAQSIDVLIREK
QEVQQVTWLVGASTPSIYYNQVMSRDNSPEFANAVVTTNSIAGAAALIPKLQYELQDAYP
NAQIVVRPFGQGPPIPAPIEVDIFGPDINTLNALGEQVRLAMSKVPGITQTIASITTGEP
ELQYDVSENDSYIAQLSLTEIAKQLQLALAGTTGGSVLQGTEELPVRVRINDYQRGSMKE
LDALPLMNRELIQNGASIGVASLGEFTLVPSISGITRLDGERVNKVQAFLLQGVPAIDAS
EQLRELLENGDFVLPQGYRIKMAGDADEQQQALGQLATYAPVLLVLMITALILTFNSVRF
AAVIGMVAVLSVGLGMFSLWVSGLPIGFNPLLGSAGLIGVAINGSIVVIAAINGNAKAKS
GDTKAIVEETMSCSRHILSTTFTTVGGLIPLLLFSQGSFWPPLAVVLAGGVGFSVILSLF
FTPTIVAMMCRIRTSKLQKRAQRTANA
>fig|1085623.3.peg.511 Multiple antibiotic resistance protein MarC
MIEILSAATMLFLIMDPLGNLPIYMSVLKTIDPKRRRVVIIRELVIALVILMVFLHSGQA
LLDFLKIKQETVSIAGGIILFIIAIKMIFPRPGGIMGLPAGEEPFIVPLAVPMIAGPSTM
AALILLANQEPNKMTQWSVALFAAWLISAIILTMSNTFHRVLGEKGLNAIERLMGMILVM
IAIQMLLNGIGRYFQHQLS
>fig|1085623.3.peg.614 Glyoxalase/bleomycin resistance protein/dioxygenase
MPAPFHLAIPVTNLADAEAFYGTLMGCEQGRRSEHWIDWNFFGHQLVTHLVAEMPTAPAP
NQVDSKAVPVPHFGVVLNMEEWTVLAEKLSTAKQSFVIEPYIRFAGKVGEQGTFFLLDPA
GNALEFKGFADESQIFAK
>fig|1085623.3.peg.826 Acriflavin resistance protein
MIAWFAKNDVAANILLFVIMISGLYVATTQIPVDLFPEFEQRNVQVSMVLPGASPQEVEE
GITIKIEEAIQDLEGIRQITSQSREGSASVTVEVEEGYAVRDLLDEMKIRVDAVNNFPVE
AESLLVQVPQWRRDAIGVVLYGDYDSLTLRRFADGIRDELAALSSISQVEVSNVLPYEIS
IEIQEWSLRQYDISLEQVAAVLRQNSTDVSAGNLKTEGGDIFIRSLGQAYKADDFGDIPI
ITTQDGTMIRLRDIANIRDEFEETPLRTRFNGVSAIEVEVFRTGDESIIEVTSAVRDYID
AKQVDMPQGLSLDYWRDRSEPIKARLQTLSTSAWQGLLLVIALLALFLRPSVAFWVCLGI
PMSFMGAFLFMPLFDVTLNLMSLFAFILVLGIVVDDAIVTGENVYSHLQRGEDPLSAAIK
GTQEVAVPVTFGILTTAAAFLPLAFQTGRGSWYAAIPFVIIPVLLFSLIESKFILPAHLK
HVKARNDKNSSKLSMVQQKIANSLEVLIAKVYQPALAQAMRWRYATWMAMFAILIIIIGT
IAAGHTKFVFFPRVQSEVATATLVMPAGTAFESTDRIISSMTQHAKDLQKEYTDADTGES
VIRNIYSISGGRNSTTGRVQIDMIPPELRTVDVTTREVVNQWRERVGQVAGAEQLNYRAE
IGGWGGAPINIELKGRDTESLNELAEKLKQQLGQYAAVSDIEDSLSDGKEELQLALKPEA
RLLGLDLNTVARQVRQAVFGFEVQRVQRGRDEVRVMVRYPLESRQSIETLEQMMIRVGPN
REVPLWQIADVLPGLSPDSILRVDRQRTISVSADFDKQGGDLSLVQSEIREWLQQEVLTY
PSTNFEMGGEARDQEESSQGLLVGGIGLAILIYILLAIPFKSYLQPIIVMSVIPFGLVGA
VIGHWIMGMDLTLLSFMGMLALSGVVVNDSLVLVDYINQKRKEGVALKDAVYNAGGRRFR
PVLLTSLTTFAGLMPLLFEESTQAQFLIPMAISLGFGILFATVITLFIVPLNYLILEDIQ
RYFKRYGADMKGLVSSKAK
>fig|1085623.3.peg.915 Permease of the drug/metabolite transporter (DMT) superfamily
MENYHDNFKGVIAIVIASFLWGTTGTVASYSPDVSSLAIGAFSMGIGGVLLVVTAQKKLF
IDYKLMLEQPRILLFGGASVAIYPLAFYTSMRFSGVAIGTVVSIATAPFFAAILEHLISK
KHISQQWILSFVIGAIGIALLTLGRDQSNNTAYSINQQGLGILLGCIAGLTYAGYSWAAR
RLIESGVHSKASMSGLFGCAALLLLPSLWFTGDNLFSSSTNALVSLYMAIIPMFLGYLLF
GFGLNYIDASKATLITLIEPLVATILAVFIIGEKFKVIGWIGVALVSLCLLMQTIKPQNQ
LRLAFKST
>fig|1085623.3.peg.1029 Glyoxalase/bleomycin resistance protein/dioxygenase precursor
MVLGLLSISLKVADIAISKAFYEKLGFNQMAGHVDQKWVVMKDPNDQVIGLFEGMLEKNM
LTFNPGWDANAKHIDDYIDVRYLQKMLSDKGIDCGQMIGENNKGPANFMLTDPDGNPILI
DQHR
>fig|1085623.3.peg.1297 Acriflavin resistance protein
MTDLNADNDKKVAEEQTGIIAYFANNSVAANLLMGFIIIMGVISYITIPRQMFPTIERNY
INISVQYPGASPQEIEENIVLKIEEQLNDITEIKKSIGRSWRGGGRVTLEINLNEEVNEV
LDKVKARVDSIGTFPAAMEPVTISQQEFRQEVMQLTIVGDLSLDDLKPIAEQIEDEILQL
QNVQLANARSPDDEIAIEIKPEVLRKYNLSIEDVTQAIRRFSANFSAGQIRTESGMIAVR
VENQFYNGEEFRDIPVKIGPSGSKVLLKDVATIKDGFTEGERYFKYNGKNAISLEVSATK
AQSIIPVAESVKSYMEARNQTLPESVEIKVLVDMTYYLNGRLDMMLKNLVQGAILVFLML
ALFLRFKLAFWVMLGLPICFLGAMMLMPIFGMTINILSLFAFIMVLGIVVDDAIVIGESA
YTEVEANGGGVANVVRGAKRVATPATFGVLTTIAVFAPFTMGEGPQSDFFFNIAVVVIFC
LIFSLIESKLILPAHIAHTNFKPLKEDSWRQKFNTAYFGFVNGRYRRFITLCTEWRWPVL
GLFIAMLFISIGLINANYVRVVPNPKVPHDFPSIRIEMAETVSDTITIDALKTIEKVIQD
VDKQIVEEYGSPMVRDILVFNNSRTEGEVMVPLVAEDDRVMDTFELARRWREAVPNIAGM
KSFTVRDDVNGGGDGGEFAYLLFGADIETLNNAGRYLINLLQEEKGLFDVSSTIDPDSKE
VQMTLKAVAYDLGLDLTSIASQVGASFYGGEAQRVLRNGEEVKVMVRYPEFTRERFSELK
YAVIKTPSGQEVLLGDVVELTEKPGISYIRREGGYRSVYVWGSIDEQLVEPNEVTETVKE
KLLPQMKERFPSVKTELGGDIKEQQEQNSEQLMFFAAGLIMVYILLAVPLKSYAQPLIVM
SVIPFSFTGAVWGHYWLGLDMSLFSTFGLIAAAGVVINDSLVMTDFVNQRRKEGYSIREA
VIDAGCARFRAITLTSITTFAGVLPIMFETSLQAAFVIPMAVALGFAVMYATLVTLILVP
CLYIILLDLGRPFVAIKQRFFSSKVVLN
>fig|1085623.3.peg.1841 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNQTITKQAFLTEMKTLLTLAWPLLIAQVTQTLMGVSDTIMAGRYSYTDMAAVAIGFSIT
MPVLMFIQGVTLGLSPIISRLQGSKQTNKVANALHQCIWLSLILSAFALLLIFVVVPLLE
NIEMEAAVRTITVDYIIYILLAAPGFALYQSLRNCCEGLSSTRPTMIIMFAGLLVNIPAN
YILINGLFGLPEMGGAGCGLATLLVIYVMAFVTLLYMMIAKKLKQYDLFTKFHWPKLDLQ
LSQLKIGLPIAFTIVFEVTLFGVVAVLLARFGAEVVASHQIALNFSSLMFMLPMSIGMAV
AIRIGYSVGNEDALNAKISVYCALVCSIVIALFTATMTVILSTEISALYTENQGVIMIAS
SLLFFAALFQFSDGIQVVSANALRGYKDTKAMLILSFVSYWLVGLPVGIILGLTDWFFPV
MAAKGFWIGFISGLSCAAVLMFWRVKVIQKRVAHDVKAYA
>fig|1085623.3.peg.1864 Acriflavin resistance protein
MSKQYEEEHIDTEKGIIAWFARNSVAANLLMFVIILGGIFGIIRVQKQVFPTFEVNVISV
QVPYLGAAPQEVEEGVILKLEEAIKDLEGIKKMTSTAREGVGSISIEVEDGYDVQNLLDE
VKVQVDAIPSFPGNTEKPVVYRIKFPQDVLWVSVYGETTERELKEYAQGIRDDIANLGGI
SDVSVVGSRDYEISVEISERKLQEYNLTFNELVTAIRQSSIDLPGGSIRSENGDILLRAN
GQAYNAWDFAKIVLVSREDGTRLLLGDIATINDGFIEDRQFALFDGKPAVSIRVRAVGDQ
NALQISKSVNSYLDEKRKTMPANLSADTWGDSSFYLADRLSMMLKNMGFGALLVFIVLSL
FLRVKLAFWVIVGLPVCFLGTLMFMPASQIDVSINMLSLFGFILVLGIVVDDAIIMGESA
YSEIDKKGHSTDAIIRGVKRVAMPATFGVLTTIAAFSPMLMVSGTFGVIWKTIGIVVIMC
LIFSLIESKLILPAHLVHMKLKPYDPSKATKFQKFRDIFSIGIKSFIENKYIPFLKKAVQ
YRYTTLASFIGLLIITIGLFASGLVRWQFFPTIPSDFMQASVELEPGSSLGQRDQAINAM
LDAMYKMDDEVADETGTKAVKHVIAFDNGTLGGSVFVELTKGETRELTDVQIQDIWREYL
PEIPGVKNFNIGSPGGPGGGNGLSFEFRSDNISQLENISKELRSYLGSYAGITEVNDSFS
GGSDEIKLALKPEAESLGLSLSQLAQQVRYGFYGAEAQRIQRDDEEIKVMVRYPKDERNS
IGNLETMRVRAPNGDDIPFSEVADIELGQGYANIIRVDGNRSVSVTAKVNADVVDTRDLL
IDVQTKVIPEMLERYPAVDFRLQGNSKDESEAIVSLAQGFLFALVAIYALMAIPLKSYSQ
PIIIMSVIPFGMVGAIVGHLILGQAVSVLSICGIIALAGVVVNDSLIMVDFVNRARAEGR
TLIEAVLKSGSERFRAIILTSLTTFMGLMPIVFERSLQAQVVIPMAISLAFGILFATVIT
LLLIPALYMILDDFKRVFKRKDKTMLTQPLPDNG
>fig|1085623.3.peg.2179 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLNGDIAKTLKSMTIPMIVGMIMLMTFSIVDTFFVSMLGTEQLAAISFTFPVTFTVISLN
IGLGIGTSAIIGKYIGSGDTVHAKTIATGALMLSALLVGILAVVGVFSIEFIFSLMGADE
TLMPFIKAYMVPWYLAGIFLAIPMVGNSVLRAFGDTKTPSIIMAAGGAINAVLDPILIFG
WGPMPALGIQGAAIATAIAWAVCVVWILYLLAVKRQLIESRLLSLQEFIVASKGVLKIGL
PAAGANMLTPIAGGVMTAVVATYGAEAVAAWGVGNRLESMASIIVLALSMSLPPFISQNY
GANKLARIKTAFDMAAKFVMLWQLMVFVILVIFSGYIAQVFAEEASVKRDITLFLCIVPL
GYGLQGIIILVNSSFNAMHKPMSALVLSILRLFVFYVPIASLGSYLYGLIGLFWGCVIAN
VVTSVLAYIWFNRNLKNEMALQTFSPVLGSEK
>fig|1085623.3.peg.2439 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MSSKYISIVVPAKNEAENIDILVDEIITHLDSLYQFEIIYIDDGSSDSTAEKVLGLMRRY
PDQVRLIQHDSSVGQSTAIYTGVKQACGELIVTIDADGQNNPADMINLIKTAEAFPKGVD
FCVAGYRKKRKDTAWKRFQSRVANGVRATLLGDDTPDTGCGLKVIPRKTFLRLPYFNHMH
RYLPSLIKRLGGKIVVVEVGHRDRQHGESNYGMWGRLFAGLVDMLGVMWLQRRNKLPVVR
ELFPDD
>fig|1085623.3.peg.2586 Permease of the drug/metabolite transporter (DMT) superfamily
MSNPLLFLATVMIWGSTWIAINYQINVVDPAVSVAFRFSIAAAILGFWCWFRKLPLRMPL
ETHKKLILVGILFYTLDYSFLYAAQHHIISALLALLSSSVIYINVVLRRVLLGKPMRLEV
VIGATFGLIGIAMIFIPEFEAMSVNEGLTVGLLFAAASFLSAGVGNVVSEKILDVGTPVI
QMNFWAMSYSLIFTFGFAFISGASFTLPTVASYYYALLYLALFGSVLAFGAYMKLLQQIG
SDKAAYVVLVYPIIALAISTLFEGYQWTILSAIGVIVVLFGNAVAMGKIALFMRKNAVLN
T
>fig|1085623.3.peg.2618 Acriflavin resistance protein
MNLSDIGLSYNRLVMTVVLSLMVFGGVSYFSLPAQEDPSIKVREAVITTNFPGMPAEKIE
LLITKTVEEGVRNVDEVEEIRSISMQGTSVVYVDLYDRYFDLDQIWDKVRNELDKVRSEF
PEGTPPHFINDNFGDVAILTVALQADDGIFMGDMFDMAQHARDMIYTVDGTQSVSILGAQ
QENIVIEVSDVKAAQLGVSPSQLLDTLQQQNVIRSGGNVNLNGKSFSIVPSGDFTSIESI
KEVIFTLPNTNNSIRLEDIATVYRSIQTPEFQTAYFNGERAIVLAVAKNDRFSVTEYTPR
LEKMLRALEQQMPAGISLNVITRQADQVNAAVDGVSINVIQTLAIVLAVVILFLGVRIGL
IVGAIVPAVVLIVLAVLNFSGMALERMSLATLIISLGLLVDNGIVVAEDFKKRLENGEKR
REIVSDIGRTLAIPLLTSSVTTMLVFLPLMLAESSSGEYTRSVSIVIIYSLFTSWLLSLM
VTPYLCFLFIKDEAVKKKSGFQAKVANFFDLINPVYKSILRFVLKYRAFTMALTILLFLG
AGFAMSTVPVKFFPDSDRAQVLAYIDLPAGSSMRETEDVLEKVFDVLDDKERYPYVENYA
AYGGFGGPRFVLSLTPITPESSKAFVMLNLVDRQYQNETIKSLREDFANDFPKVNARVTK
MFLGPSDSNKIDVQIIGPDKDYIYNTALEIEEIFRNLEGTVEIKNDWENKITQIDVQIDQ
ARAKRAGVTSADVARSLETFFSGRVVSEFREGDDLIPIIIRGKAEDRYDISRIYGINVYS
ASRNVNVPLEQVADINFSPQYARIARENLFRTVTIEAKNLNMTAEDMVPILQPEFDKIRE
RLPPAHRLEFDGVVKDSKESQASLNANLPLCLAAVMLVLIAQFNSLRRAGIVILTVPLIL
IGAVIGLLSVQANFGFMVILGLYALAGIIVNNAIVLIDRIDIERKETEDQYEAIVEACMR
RLRPIIMSTVTTILGLLPLILSKDALFFGMASALAFGLAIGTLLTLGVVPVLYSLFFNIK
KQTAPE
>fig|1085623.3.peg.2762 Permease of the drug/metabolite transporter (DMT) superfamily
MNFRLIVGTVTAMLAFAGNSVLCRLASEQLTIDPASFTSIRLLSGAIVLTILLLSIPKLM
LAEQPLSADGDANSNDVYVNKCFRLLSLKQSSWLGGFSLFAYAAGFSFAYISLPTGTGAL
ILFAMVQITMLSYALVQGSRFSLAQWFGFAMALVGLVYLFLPGISAPPLLGATLMGIAGI
AWGVYSILGKRVVNPTQSTTENFIRASIITLLLSLIFINDISISSRGALLAIASGALTSG
IGYAIWYAVLPFLKAASSASLQLTVPVIATIGGVVWLGEEVSIRLALASISILGGVAIVV
LLPKRE
>fig|1085623.3.peg.2905 Permeases of the drug/metabolite transporter (DMT) superfamily
MDPVKKSLISLHITVMLLGGTALFSQLIPLGSIDITFARSVFACLLLFAVAKLSGDGLRL
NSNRDYFIAFGLGIIMAVHWVTYFMAMQLSSVSVGIIALFTFPVITVLIEPYFEKNRLLW
QDIASAVVVLAGIALIVPDASLENDVTLGVIVGIFSAFLYAMRNLLHRHYFSHYSGAKAM
AWQTLIVCPTLVFFVSDELVMIDLNTLWLLLALGTFFTAIPHAMIATTLQHLRAKTFSLV
ACMQPFYAILFAMILINEQPTWQTLVGGLLVISAAIYETINTHKENQKAKQCS
>fig|1085623.3.peg.2967 Glyoxalase/Bleomycin resistance /Dioxygenase superfamily protein
MLSYATIGVSDLNKSEAFYNELLAPLGAKTLIKMDRIIFIGKSMAEPMLAICIPYNEEPQ
HCGNGNMLAIAPGSKEKCDELYKKAISLGASCDGEPGQRIPDVFYGAYFRDLDGNKIVFN
HFG
>fig|1085623.3.peg.2985 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTEASEKKEDKNSLVEGPVLPIISRLAMPMIFGIVAVFSISLVDTYFVGKLGTAQLAALS
FTFPVTMAIASLSSGLGAGASSVVSRAIGADNRSHAKRLSTDSLLLASLLVVLISAIGYF
TITPLFKLLGASGDVLKYIIQYMEIWYISMPFLVIPIVANAIIRSVGNALWPSIIMFFAA
AVNIALTPVLIFGFGPIPAMNIEGAAISTMIARIVTFILALYVAIYREEIIQVSKPEYQV
FIDSCKSVLKIALPAGAGSVINPIGIGIVTAIIAGYGDDTVAAFGVATRIESFACIPMLA
LSASIGPIAGQNWGAGNKHRVIQTLKYCYLICVLWSLVIIALFYGFADQFSSLLASSESV
AAKSTDYLYIVAVSLVGYGWIIVSSAAFNSLGKSVTGFNYYAVRTFALYVPLSLAASIWF
DEKWVYIAIAIANLVSGFLVAGYTLLWLKKAKQEDCHPDWTLNLLSS
>fig|1085623.3.peg.3262 Permease of the drug/metabolite transporter (DMT) superfamily
MKTSHLIELLVLGAIWGASFMLMKSTVPAFGVFALVEVRATLAALFLLPVVYFTRQWADL
SGNWAKLLFVGAINTAIPFSLFAYTSVHLDAGLTSILNATAPMFGAVIAYFYLQDRIGVH
GVIGTFLGFLGVVIISQDTQSASPVTLLPVLTALAATCCYGIAACFMKKHLSGVKPFAIA
AGSQVFAALLLFPFALYAWPDVNPDAGTWGAALVLALVCTGVAYIMYFDLIAKVGASQAM
TVGYLVPMFGILWGMVVLGEVLSNYAMIGGSLIIIGVMITTGILKRRRAKINL
>fig|1085623.3.peg.3273 Permease of the drug/metabolite transporter (DMT) superfamily
MHASINTLILVGKTLVLSILKPFYPVLFLLVWSAGYAMGKLALVYTEPLNLLAFRFAGAF
LALTPLVILLRLPIPNFRKSYALMGTGLFLHIGHFGSIYVGMKLGASASIMALFAASQPV
LVIIASALLARKIPAWNVWASLTLGLLGATLIIGVNMQGNEGYLLGAILGFTAVVGLSIG
QVIEKQRKLGVHPIVATWVQYAFASAISIPFAFAFEGLVFENALPFWGAMAFLIFGNSIV
GILLMFTMVRQGSIAKVASIMFMVPAVGALVAWLVADEVPKLIAIPGFILAMLGALWTNK
IANKSLTEPKKPRGQVS
>fig|1085623.3.peg.3354 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily protein 9
MSLALWNKSDTPIQTLRATQRTRQNANSVLKLHHHAFKCKNAEETRVFYEDILKMPLVCA
IVEPSDPITGAETPYAHLYFELADGSWLAFFDFPSKYEELECGFDKTDVWTHHIALEVPD
EATLIAHRKNLDDHGIEYMNIDHEYCNSVYFFDPNGLVVEFTHNVDETERYFHDKARDVK
QDMEHWLKVRAEHYPEKA
>fig|1085623.3.peg.3417 Efflux pump antibiotic resistance protein
MSRFPVTTVALIAVCIGYLIAPMGMAAVNVAIPVLAEDLQASAIKVSWLPTLYILANVAF
MLPFGKLADNYGRKRVYAYGLLLNALSALMCAIGTDIDWILFWRFMQGAAGAMIFSTGVA
IITSVTPSHKRGAALGVLAACVYIGLTLAPAVGGWLTELLGWRAVFYFQIPLVIALLILM
KLKLHGEWKNEHHSRFDWIGSAIFITFACTLVYGLSKLPSLLGFALLLVSLLSLVGFIVH
QSRDRQPLIRVQMFRESRVFSLSLSTSFLMYGSNFAIIFLLSLYLQYIKGFSPAYAGQIL
LMQALCMAIVAPFAGKLADRFQPRIIATIGCSIVAVGFLFLIQISPDTTAFYIGGSLGLV
GLGFGLFSTPNNSAIMGAVKEQEVGVASASMNLSRTIGNLVGMSLVNLMMHYYIGDANFG
PESNPALMSTISLALLMSLSFVIIASVISAVRGKQ
>fig|1088868.3.peg.206 Membrane fusion component of tripartite multidrug resistance system
MADAGEVMDQQSVSANEETGKSKANPLKKFLIIGVCCLLVIGAGIYWWLTRDDIDTDDAF
TAGRIVYIAPHVNGYVTDLLINDNQFVHKGDLLLKIDSRDYEAAKKEAEGNLIRAQGQYI
ASQYMLEVAKKNYPGQLKVAQGQLGIAKAQAFKAKTEYVRQHSIVKAATTQQAIDNATAA
YEQAKAEIIKAEGNLLIAQPVEANIQTSNSQINEQKGALEAAEAKLRQAELNVGWTEVRA
PHDGWISKRNVEQGNYVTTGQSILAIVEPEVWVIANYKETQITNMRPGQKVKIEVDAYPF
LKLKGHIDSLQAGTGAVFSAFPPENATGNYVKIVQRVPVKILIDEGLDPKIPLALGLSVT
PTVYTK
>fig|1088868.3.peg.207 Inner membrane component of tripartite multidrug resistance system
MSEMVVADDGIDRSGWKPKYNPWLIAVVVTLAAFMEILDTTIVNVSLPHIAGSLSTTYDN
ATWALTSYLAANAVVLTISGWLGRVLGRKRYFIICILMFTVSSFLCGMAGSLGELIIFRL
MQGFFGGGLQPNQQSIILDIFPPEKRGAAFGLTAMATVVAPILGPSLGGWITDNYSWRWV
FYLNVPIGIFTVFAVLMLLEDPPWEKKRKERVDVIGLTLITMGLGCLEVMVDRGENADWF
GSFDIRLMGVFAFIGIVGAIFWLLKAKNPVVDLHVFKDRNFAVSSILMAGLGGCLYASAI
IVPQFSQQVVGYTAFLSGLVLTPGGIVIIFLLPIVGRIINVVPMRYVIAFGFFWMGSAMF
FSAHLTPTLDFDHLVLFRVAQTACLAFLFVPLSTIAFMTIPAKYNADAAALFSMVRNVLG
ALCISGATALVTQTRQADQARIVHTMSPLNQPFNEYLAHMKAVAQQAGYAAQDQASVAMR
YLYTDFQKQVAILAYNDVFMIIGFCAFLLVPICFLLDGYTAKKKKEK
>fig|1088868.3.peg.592 Permease of the drug/metabolite transporter (DMT) superfamily
MIYIIIAGIIWGLGGVVGQYVLQYKHLDAAWIISIRLWIPGVILLTLCYRKHKKAIFNPL
KTPRELMILLFFSVVGIMNSQLSYFLAIQYSNAATATILQYLYPVVIAIILAFYLKKRPS
FALIISIILALVGAFCLVTDGSIDKITLPPKAIIFGALCVVGSVAYTLSPIPLLQRYNTT
TIAGWGMLFGGIILNCFHPFWHISGIIDFASVISIIFIVLVTGMIAFLLYLIGVKLLGSS
KGSILATIEPLAAAFFSVVILHVDFNIVDWIGAACIIAMIVILAKNKV
>fig|1088868.3.peg.597 Permease of the drug/metabolite transporter (DMT) superfamily
MDFFILTILYKRVLPRMSTVQQVSNGKSKVLVATASGLLTILLWSSLAVTTTSLPNMPRF
QLLWFGFGEAFIIGSIILTLTGRVREMAQPFAPWFTAFCGIFFFHLFYFVGLDFAPPAKV
TLLSYLWPTMLVVCIALLSKKQFHIAYLLGALMGLIGTIFLMPADQGSVLTSGNLFGYLL
GVLCAIVWTIYSIVNRKYISVPTGMMIGVCGGISLVSMMIHFAFELTVMPNSWQEMLIIL
YVGCGPMGIAFLAWDYATKNANLSLMGSLSYLAPLLSTLWLVIAGRAPATMGLLIAVILI
VGGAVVATYPLKK
>fig|1088868.3.peg.881 Drug resistance transporter, EmrB/QacA family
MNAINQNKQNTLLPIVAAIAFFMASLDTTAVNTIIPYLATVFHSPLATTKNIIIFYMIAN
SLFIPLTGVLCQKYGCRIIFCAALCIFSVGSLLCGISGTLNELLIARVIQGIGGALMLPV
GRLAVIQTFPKDQLIKALSLVTIPGLTGPLIGPIVGGGIASYLDWPVIFFINLPFGIAGI
YFALKYFPTQKDENLRIDTWGYIIFAASIALITYALSLYSETKYYMTPTIIICVGTVFLA
AYWIRSLYHDYPLFAPKLFKIRSFSVGLLGNLVARLGCGAVPFMIPLMLQRLLGLSPVAC
GMAMLPLAISAMMAKPFVSKAIHIAGYRNFLFINTLILSASYMSYCLVNEHSGWVLISTL
MFITGFINSMQFTAMNTVTVLDLSAKRQASGSCLLSTVMQVSMASGVAVSAILLTLDETI
HLHALPATHFHFTWLYLGLITAVSAFIFVLLPNKRI
>fig|1088868.3.peg.1309 Permease of the drug/metabolite transporter (DMT) superfamily
MYIESPMPSQNHQFLGIIAVIIAAILWGTTGVSASFAPQVSPIAIGSMAMGVGGLLQAAI
ATNIIRSYRFNLYRQWPYVLCGALSVAIYPLVFYASMRMAGVTIGTVVSIGSAPLLSAVI
EAIMEKAKFSTKWIIGATLGIIGIALLSLSGQEHHADQTQHPHLILGIGLALLAGLTYAL
YSWIARYLMQQNIPSKAAMGSIFGIGGLLLMPVLFMTGSAFLASWSNAAVGIYMALVPMF
IGYICFGYGLARIAASTAITITLLEPIVAAFLAVIIIKESLSIMGWIGVILVFTCLVCVI
MPSRKK
>fig|1088868.3.peg.1516 Multiple antibiotic resistance (MarC)-related proteins
MHLTETFPLLHAFTSVSGSFLFALSALIPIADPLGSCLIFYQVTEEREDAERKLLARKIA
IYAFVILAFSIFIGEFVLRFFGISINAVRIAGGLVIAVRAWTLLNAPEQNADRKQKEAEQ
GGRTMALPNGLDAAFFPLTMPFTIGPGCIAVAIALSSVRPTGAGNGAAIFSFYNGLILAV
VVVCLTIFITYTFCDKIMKVLGKSRARILSRMAALILLCIGVQIVGTGIQGFLIPIFQQH
>fig|1088868.3.peg.2200 Outer membrane component of tripartite multidrug resistance system
MKYTFSFLSMVIVIPTLVGCAVGPDYHKEDVWTPSKWSKPTQNLQASVNSQVVMDKINPQ
WWDYFHDPVLSDLERRAVTANLDVQMATQRLIASRAQLMIAGSARFPSVNGSAGYQRNQY
SKKGFSRAIDKIRNREPALGNMVNPSDIDVPAFNQWDDALDTSWEVDLWGRVRRQYESAK
ALKQMSEEDRRGILIAQQAEVAQNYMTLRGLQAQLQIVKENEKIAQDILDLANQRFNGGL
VTELDVRSAEAQLEQTRADIPNLEQQIIEYINALGLLLGEPPRALSTELSTPKPIPPVPS
QVPIGFPSELAQRRPDIRQAEAKLHSATAEVGVAEADFYPKVTIDARLGFQSLSLRDLGF
WSSRAWSVGPSLSLPIFEGGKLKGQLTLKKAEQKEAALAYRKTVLQAWQEVDNALNAYQA
EQLRQVRLQDTVKSNQRSVYLAQAQYRQGLQTFINVLNAERRLLSSQQDLVNSNTQISIN
LVQLYKALGGGWESTYPDSSQIASTQPQTEVQTQGQTQTMSKKN
>fig|1112215.3.peg.838 Drug resistance transporter EmrB/QacA subfamily
MTTTNEPPVATTHTSTASDPAAKRSILLLFAGLMVTMLLSALDQTIFSTALPTIVGELDG
VNHMLWVTTAYILAATIMMPVYGKLGDLIGRKGLFVGAISIFMIGSVVGGLAPDMTWLIV
GRAVQGLGGGGLMILSQAIIADVVPARERGRYMGAIGGVFALASVAGPLLGGWFTESIGW
RWAFWMNLPLGALAILAAITLLKLPKHDNTRKPTIDIAGMILLAITSTAIVLVTTWGGTQ
YDWDSLIIIGLIALAVVGGFSFVMVERAAPEPIMPLHMFKERNFVLTTTSGLITGIAMFG
ALAYMPTYLQMVTGVNATQAGLLMIPMMGALLVSSVTAGQLVSRTGRYKWLPLTGSFIVA
IGLALLSTMTPDLPIWVLCSYLAVMGLGLGMSMQILVLIVQNTFPNSQVGTATSSNNYFR
QIGASIGTAVVGSLFVARLTELLGTRLPAAAASATGDTNSLTPAAVRDLPDAIREIIVGA
YNDSLTPVFLYMVPLVLVSAVLLMFIKEVPLATTIDRGDKSETLDGLGVEDGTDTEGATT
AADAESHELITVSDQTGATSIIRSQP
>fig|1112215.3.peg.1446 Permease of the drug/metabolite transporter (DMT) superfamily
MPLRSILAAVLVAVIWGLNFVVIDVGLEGMPPTLFLALRFMVVIVPAIFFVPRPKSRFRD
VVLIGSFMSLGQFGLLYTALAIGMPPGLASLVLQAQVVLTVVFAALALRETPTRSQLVGV
ALGAAGLVVVGSGRGVETPVLAFFVTLAAAASWAIGNVIARRVGRIGSTFSPLAGLSLTV
WSALVVPIPMLGLAFVINGADAVGFALTHLTVPQLLSTLYTAWLASLVGYGIWNTLLARH
AASAVVPFTMLVPPVGMTTAWLALGEVPTTIEIVGGVMLLLGVAITTGVLGRRRRQRHTP
SGEVAASADPVENPL
>fig|1112215.3.peg.1553 Permease of the drug/metabolite transporter (DMT) superfamily
MSAPVADAGRVEKHDSTSNLGTTLRFAAAGLVWGSSFLFIKIALDGVSFGQVAWSRAVLG
AIALVIVFTVSRRKLPRKPIVWAHFTVLAFLFAVFPYLLFAWAEQYVSSGLASIYNATTP
IMTAIFATLVFRVEKLTRSQIAGVTLGIFGVLVIIAPWQAGDISGSLLGQLACLGAALCY
GAAMSYQRKFVAPYKIAGVTSATMNIGIAAVIYILLTPLIAVGPVNLTLPVVASLLALGV
LGTGMAYVWNYRVLAEWGPTRTSTVTYITPVIGVILGFVILKETMSWHEPVGAVLVIIGV
LLAQGRLKWPRGAARTHAALK
>fig|1112215.3.peg.2590 Multidrug resistance transporter, Bcr/CflA family
MTTVVHPGDSLSARQRLVYVLVLGALTALGPFTVDLYLPAFPLIEADLETTAAVVQLTLT
ATTLGFALGQLIVGPLSDRFGRRLPLIVATSVHLIASLGVALAGDIEMLFVFRLVQGMGA
AAGAVVTMAIVRDLFGGLPLVRMLSRLALVQGLAPILAPLIGSQLLLITPWRGMFVFLAI
YGALVLLAAWFFIVETLPPARRRDLGHATARDRYKALFTDRVFVGTAIIAGMTFSGLFAY
LSSSPFLLQNVYGLDPQAFGLVFAANSVGVVVGVQASAFLMRYIGPQWILAGAGVGLLLS
ASTIVFLDVVNGDLFAVLIPLFFFVMFCGFSFPTTQVLALANHGGEAATAASVLGAVNFG
LAGLTSPIVGWFGITNAIPMGIVMACTATVSIIIMWTVVRPRTVPALSR
>fig|1112215.3.peg.2968 Multidrug resistance protein
MTTFLQILVNTAVANITTSYLWFALTFWVYLETRSVLATGIIGGAYMLLVAAFSMVFGTI
VDRHRKHVVMLFAGLVTLVAFGIAGTIYALFPESILLDLGGPMYWIFAGIILFGAVIENM
RNIALSTTVTLLVPQERHANANGLVGTVQGLSFLVTSVFSGLSIGLLGMGWTLVIAIVLS
AAALIHLTVLRIPEQKPEPEEGGRSPLVDLRGSITAVRAATGLFALSSSRHSTTSSAVCT
SH
>fig|1112215.3.peg.2969 Multidrug resistance protein
MDPYGLELFPVEVWGIVLGVSSSGFIIGGLLVAKFGLGRNPIRTMLFLVGLMGVLGAMFT
IRDWWWLYAGGILLYMTLVPAVEAAEQTVIQKIVPYRTQGRVFGFAQAFEAAAAPITAFA
IAPIAQFLIIPYMDSQNGQDAFRWLLGDGAARGIALVFLIAGLLMVVVAIVAFSTKSYRF
LSQQYAGTTASVPAAEPAENS
>fig|1117647.4.peg.21 Permease of the drug/metabolite transporter (DMT) superfamily
MSNRDLLIVVALMALWGLNFSAIQLGVDQINPLLLTAARFFCAVIPAILFVPRPAVAWRY
LVAYGLSFGVGIWGMMTLAMDMGLSPGMAGLLLQLNIVSGLALGWWLFGEVITAQKIAGA
GLALAGLLLTLLLTDGSVSWAGLGLAMIAAQCWSLMGVTVKKANTDKVFAFGVWGMAFAP
LPLVLLAWGWFGAEVFYQLPDRFNGRALFSILFQAWPTTLLGYWLWNRLNRRYPMSLVAP
FTLLVPLFGFLGSVVFYGEQLGPVKIAACVLILTGLAIGQGWVKLPVGRRQPV
>fig|1117647.4.peg.1038 Permease of the drug/metabolite transporter (DMT) superfamily
MLHSTRFALFMLVLVCAIWGVGFVVTEHALGKLSTQSLNALRFALAALSLLPLWYWSGNR
RAFAEHGKMLLGASAGLGFVLFLAFYTQTEGLRHTSVSNAGFITGMLVPLVPLLNWLLFR
QRIGKHVLIAVALSSLGLWLLTGGASALNKGDLLVLAGAVGYATHIVLTGHYARKLPVLA
LAMLQMVAVSVYSLLASAIFDADRSQTVFVLSVEHWANLLTPDIIGAFIWMAVLSTAFGF
WVQTHCQQMLEAHKVALVFALEPIFAHIAGAIWLDERLTLAGWLGAGAIIGAMLLAELGD
RKANAKLHPGDLAVAPDPGD
>fig|1117647.4.peg.1191 Acriflavin resistance protein
MTDNQPELIEQEDPTRRGIIAWFARNTVAANLLMVFILLGGLISAITMKQQMFPEIEIDW
LQVQVYYPGAAPKEVEEGITLKVEEALKSLQGLERVITYSRRGMSQAYIKVAKGFDPQEV
LDEVKGQVDSISSFPAGIERPRIERFKYRQEVMYLSLYGDLSPTQLKDLGRKIHEEIQSL
PSVSVSEYFSGLGYEIGVEVSKDRLREYNLTFQDIAQAIRNYSSNMSAGQIKAADGYISL
RVENQAYRGYQFEQIPLVNLRDGTQVKLGDVATISDGFEDGIQYQKFNGKNSVAFFIGAT
RDQNIMSVAQVVKNYVEKKEAQLPDGVHLETWVDMTYYLQGRLDMMKSNMWMGAALVFFL
LAIFLRVRLAFWVMLGLPISFLGAFMFMPLEWVNISINIASLFGFILVLGVVVDDAIVIG
ESAYNEIEEKGQSVENVIRGAQKVAMPATFGVLTTVAAFFPMLLADGPSKGFSIAIGGVV
ILCLLFSLVESKLILPAHLAHMKQRPHNPKNPFHWLRQHVDGGLRHFVENIYRPKLQSLL
NYRWAVLASFLAVLLISFGFFGSGLIRFIGTPKVPSDFPDINIEMQITASEQATLDAALA
VENMIYEVDKQLEAEFGQKMIRSLNVELRSRTSARIMSMLVDPEVRPVDTFELAARWREA
MPPLPGVKTLTIQDSLFGNDRDDGDISFRLESTNQEELYLAVQDLRDKLSTLKGVGDIND
SRRQQTHEVQFQLKPLAYSMGLTLADVARQVGYGFYGIEAQRILRNGEEIKVMVRYPEHQ
RNGVALVEDTVIRAPNGAEVPLSEVADFTMVMAPAEIRRENSKRSINVWASVDAQQAEPQ
KIAQDIRDNFLPAMLKNYPSVKSSISGRIQEEMDDQAKQMRNFLLSMIVVYALLAIPLRS
YTQPMMIMSVIPFGIIGSMIGHMIMGMDMSAMSVFGLIAVAGVVVNDSLVMVDYVNNARR
EGSPLIQAVVDAGCRRFRAIILTSLTTFIGVVPILLETSMQAKIVIPMAVSLAFGVLFAT
VITLLMIPCLYVAGNDIRGLFRRKQPSQDVAASPQSV
>fig|1117647.4.peg.1678 Acriflavin resistance protein
MNIAERSIKNSTITWVVTGILLVVGMIAFNNLSRLEDPEFTIKEAMIITPYPGASAREVE
IEVSDLVERATQEMGQLFYVESHSYRDKSIVKVRIKDQYDKDGLPQVWDELRRKVNDIQH
QLPPGAGPSLVNDDFGDVFGVYIALTGDGYTQKDLYEFAKFLRRELLLVQDVKKITFYGQ
PKEVIYVEMQRDKMTALGISPQDIYSALGAKNTAEQAGYMTVGNRRLAVSPTGEFHSEQQ
FAGLVINARNLQNQQVVLGDVATITRGLQDPPNNLLRFDGEPAIGLAISTTSGGNVVTMG
EGLYQKVEELKPQIPLGIQLNVVSMQSDSVVEAINNFLISLIEAVVIVVVVLLFFMGLRS
GLIIGTVLAVTITGTFIFMSILGITLERISLGALIIALGMLVDNAIVVTDGMRVRMEQGE
DALSAARKVVSQTAMPLLGATAVAIAAFAAIGTSQDATGEYTRSLFTVILISLTMSWVTA
VTTTPLLCKTFLKSGQLGSQGAPYQGVFYQRYRQFLTLAIQHRWVAIGITVALFAASLIG
FGYVKQSFFPDSTRPQFMVDLWLPEGTHIHETERRLAPFEEKLKGYSNVTKVTTQVGGSS
PRFLLTYQPEQPNSNFARLLVDVDDYRIINQFSQQVQNDLEFIDPDVNVNVRLFVLGPAT
GGKVQLRLSGPDHQELRRLGNEVLNVLRQHPNVKGIRNEWGEQVQVIKPVMSDVLASQLG
IGRPEIAQATAHTVEGVRAGVYRERDELIPIVARAPEHERRNLDNLDQLPIWSPTAQRMI
PLGQVVSHFDVDFENPHIWRQDRVSMLRIHFDQREGLSSELLADLKADVEKAINVDVAGY
LKLAADADIDHQSSTIPIKYRDRLPIAGKPGYYAAWGGENEDSDKGSTAIMGSIPVFFGL
MVFIVICLFNSLRKTAVIWLVVPLAIVGVTAGLLLFNQPFGFMALLGFMSLAGMLIKNAI
VLVDQIGEELSTGKNGVEAVIESGVSRLIPVAMAAATTILGMIPLLGDAFFIAMAVTIMF
GLGFATVLTLVVVPVLYATIFRFR
>fig|1117647.4.peg.1739 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNRSMQPMLTEGPVSGHLREMAMPMVWGLLATMSFNAVDTFFVAMLGHEPLAAMSFTFPV
VMVLTSIAIGLGAGTSSTVARAIGSDNHHLAQRMATDAMSLTTIIALVVCGIGWFTIEPL
FKLLGAEDQLVPLIHDYMWIWYFSAPCLMVPMVGLASLRAMGLARIQGTLMIAAAALNLV
LDPILIFGLFGFPRLELEGAALATLITRALSLVVVLWVLHKRLGMLVNPFARFDEVWASW
RAILHVGVPAMVNNVIIPMASGVVVYLVASYGTVAVAGLGIAMRIEPIALIVFYALSGVV
GPFCGQNLGAQKFARLDETLRVVTRFCLGFGVVLALVLWLAGELLIRLFSDQQEVIDVAR
SYLLIVPFSYGAYGLVMSVNAAFNGIGQPMPGVAISFMRVLGFYLPLALMMQWLWGLTGL
FVATASCNFLVGLVAWLWLRQRFHTTATAATT
>fig|1117647.4.peg.2627 Acriflavin resistance protein
MRLREQKAQPDDAARKGTGEVWGALLASTATTVAIFLPVVFLKDVEGQLFSDLALTITIA
VSISLLVAVTIVPLLASRWLKEEGLTDHNIGLWQRITSLVMRITHTPKQRWSLIAGLITA
PLLATWLLLPELDYLPPVKRDAVDTWFRFPPATNIDTIEREIVDVINQRMAPYMKGEKEP
ALKNYYVLVWPGGGTMGARVQDQSRVDELLKIVREEITVNLPDTMAFSAQGNLFGGFGGD
RAIPVHIQASDARQLADVAEQAVGWVREALPEAQSRVDPGTADAEPELRLLPNDRALQEQ
GWTRRDLGAVVRMLGKGLWVGEHFDSVKRMDVILRAQAWDDPEALINLPLATPTGGMVPL
SQLVTLDRTVGPNQIRRIDRRRTLTLVVVPPETMSLEKALHALQTDVEPKIRAALPSDGN
IQYGGSADNLKQALGTMGENFLIALLILFLLMSVLFRSPKDSALVLLAMPLAMVGGVLAM
QILNLINFQPLDLLTMIGFVIMLGLVVNNAILLVHQTRSAEREGMNRHLAVEQALMLRLR
PIFMSTLTSIFGMLPLLLMPGAGSVIYRGLAAVIVGGMCVSTIFTLVLLPCFLRMGAKSQ
PKLADIPPHSELRRLKSVA
>fig|1117647.4.peg.2628 Acriflavin resistance protein
MNLTAATLRNPPAAIVAIVFAVAFGLFSLNKLPIQLFPDIESPVINISTGWRAASPKEME
SEIVEPIEEVLQGLPGVKEMAAGANAGFAWINLTFGMDTDMQKTLVDVISRMNRLKPLPR
DAMQPVITLGGWDGGTPALTWYFLQVLPENPNKVEDYFTFVEEVISPALESIPGVARAGI
GNGNGPMEELQIRFDPYRAAQLGVQLPMVAGLLGQSNDVSGGFVDIGRRQYTLRMAGRWE
PEQLGQMVIEWRDGKPILLGDIAEVKVSLPDRNNLATQNGNPAIGIRIDRESGANVLATL
NAVKEKIDELRAGPLKERNLTMVQSFDASVFIYRAINLVTSNIFLGVLPGCGNFVVVFAP
RPRHPDCRPHHSHFAVVHVHHAAVHRPHAERDFTRRPRLCRGHGIGCGYCGTGKCGALAR
TKSPTR
>fig|1117647.4.peg.2649 Acriflavin resistance protein
MNSLIKWFSANPIAANLLMILVLIAGAMSLNGTDKEVFPGALVNQIEISMAYPGAGPREV
EEQICIRIEEAVASLDGIKEITSVARQGTGSVVIEVASGYDTQRLLNNVKTKIDAINTFP
VDAERPLVNERLFTSELMSLAMYGDVDERLLKDTSQWVRDEISVLPGVSLVEVDATRTDE
VAVEIRENALRRYGLTFEQVVSAIQKTSVNLPAGVIKSSHGDIQIQARGQAYDGDAFGQT
VVLSRPDGAAVLLRDVATITDGFSETDVIARYNGLPAVFVELYVTENPNVLQTSESVRQY
LTGLPQRLPQGISVDISRDWSEVFSARLKLLSSNAVSGLLLVFVVLMLFLRPALAIWVCA
GITVAFAGAMWLMPALGVSFNMLSLFAFLLILGIVVDDAIIVSESIYTRQQKGATGIASA
QDGALKVAGPVFFAVVSTMIFFVPMLFIPNTLGDIVYPIPVIVISCLLFSLVESMLILPS
HLAHLKPERAPGSKPALWLSLARQRCAEGLQHAASHWYGPFIRRCLHDVRLPIAGFFALF
LVAMSIYGAGWIRQSFMPQVPSDFLHARIQLEEGVPFSRAQALLEKVEQAAAALKTDATL
IAAIDGNPAFIRSVESWASPQNVRVRLALMDAETRAVGSPQVARRWRELIGELPEAKEFD
VGFTINARDKAIRLRVGINENTLERQRQALDAVKAALAAYPGVNEVKDSLQSARDEIELT
LLPNAELLGLGLQDVARQVRQGFYGAEAQRVPRGKEDVRVMVRYPRAERESVDSLYDMRI
RTQSGDEVPFETVAQGEYVAGYTVINRVDRQRANSVTAELDSSDSGQAFAIVNAVLAEHG
DTWRREFPGFRLEVAGDMKAQNEFMQELVRDFFLSLLVIYALMAIAFRSYGQPLLIMSAI
PFGFMGAVFGHLLLGREISMLSMLGFLACAGVVVNDNLVLIDRINQLRARGMAVLEAVAQ
AGRDRFRAIVLTSLTTFIGLVPIMAETSVQARFLIPMVISLAFGVLLASTVTLVLVPCLY
VAGVNLKRRAQALLAR
>fig|1117647.4.peg.2795 Glyoxalase/bleomycin resistance protein/dioxygenase
MDLGAFSVSLAVKDIHASRQFYSALGFNEIAGDIAQNWLIMKNGQHVIGLFQGMFDNNIL
TFNPRWHQDCTENPDAPDIRDIQAALKAAGIALDSEVDPNSQGPASLTLTDPDGNTLLLD
QHC
>fig|1117647.4.peg.3126 Acriflavin resistance protein
MSHWLDRTVGSTLKGGLPLFIFIASLLTGVLALQFTAREEEPQIVVPMVDVLVQAPGLSA
RQTERQVTTPLEKLLAQIPGVEHVYSVSQTGQAAVTLRFYVGQDREEAILNTYNKLYSNQ
DRIPGVVSDWLVRPVEVDDVPIMVLSLWSSDPGRYTDFELRRFAEDISTGLQAIPQTSEV
KVVGGRPRTITLKVKPEALSARKITPAEIVSALGLSNQLQSAGLWTFNNEAIQLESGDFI
RTRAELEQLVVSVIDGVPVYLQDLVTINDGPEEARHYTWIDFAPGHPEFRSANDGYPMVA
ISVAKQRGSNAVTVADAVHQLIATLEQELLPPEIQVEVIRDYGQTANEKVNNLTSSLGFA
IITVVIFIGVFLGWRQALVVGLAVPICYGATLGLDMAFGYTINRVTLFALILSLGLLVDD
PITGVDNISRFLKEGSGSKAERIVGAISELKVPLVMSTLTIVLAFVPLAFITGMMGPYMA
PMAFNVPVSVIASTLVAFLVTPWLASKFLKADDYVAEPSANNESAYARMITPLLDNPRRA
KGVLWIMLALFIGAALLPMFRTVPLKLLPFDNKNEVQIVVDMPESASLEQTAAMARRISA
QVSQVPEVRAVAAFVGTPSPMDFNGMVRRYYQRTGNHMADLRLTLVDKTEREHQSHGVVL
RLRALLAPFNTGDINIKVVEVPPGPPVLSTLVAEIYGEGLTDYATQRDAARVLMDRLARE
AHVTEIDSTVEAHQSRQRFVLDKQKAALSGVATEDVNATLAMANGGYNAGFLQGYLHAER
ESAPLPVQLRLPVDERASLNDFLSLQVKGRPGIAQQSNPQGLETAPQPLVSLGELGGFVA
LDADRAIHHKDLQPVVYVMAELNGRTPAEIIADVNADQGAEPGAAQTEWQSRNFITSFFA
GPGDGWQLPAGTTLKWTGEGEWRITKDVFRDMGLAFAFALAAIFVVLRMQTASTALSLII
MSAIPLTIIGIMPGFWFLNQWGERVIAGSPEPVLFTATAMIGMIALAGIVVRNSLILVEF
ITQARAAGNSIRDALIAAGSVRMRPVLLTAGTTLLGNLVITLDPVFSGLALAIIFGIIAS
TLFTLIVVPVVYLLVFGNSEHAHD
>fig|1117647.4.peg.3637 Glyoxalase/bleomycin resistance protein/dioxygenase
MQFNHFNLEVPADQLDKVKQFYQQVFGWREGDRPAFSRPGYWLYEGDLPILHLVQHRGGQ
TAAGNGALNHLAFRTSQLAAFRNTLDKLNIPYRQVILADAGISQLFFHDPTGLKLEVNGP
AL
>fig|1117647.4.peg.3861 Multiple resistance and pH regulation protein F precursor
MFIAVTLAILVTIGLALARALAGPTTYDRIAAANMFGTKTVLLIAVLAFLSDRADLLDIA
LVYALINFIGVIAALKLVTRGNFHGSSDKDSGII
>fig|1120924.3.peg.1 Permease of the drug/metabolite transporter (DMT) superfamily
MLVQRVMKKSVMPQRHEWPRLMILSAMVCLGFYTTQTFAMQFVDSGLSAVLVFTMPIFIG
VLAHYFLNEYLTRQKIFGLILGTLGLIAILWPQLHHLGLNLSLVGQIMLIGSGLFWAMST
VYIKKYFATYDKIKLTIWQLLLGGVVVFIGALSFEPVDAKVWLNPLNESLLIYIAIIGTG
FAFALWNWIVSQVDTFVASISIMCIPILSLLFGALIWHEALTLNIVIGAAFICMGIVMSA
LTLTHQKTSMQYSRCPK
>fig|1120924.3.peg.34 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MQLTPFLSCVVPAYNEAENLKKFIPALAANLEQQQLSYEIIVVDDGSRDDTLHVLQSMVD
HYPLVVLELSRNFGKEAALSAGLDRVRGDITLLIDADFQHPLDAIPTMVNLWKNGYDMVY
GIRDRSSESWLKRILTNNYYKVLNMSSPIDIPENAGDFRLMDAKVVDAVRRLPEKNRYMK
GLYAWVGFKSIGIHFSEQQRQFGQSSFNGKALFRLAMSGLTGFTDLPLRLSIYLGALLAL
SAMGYGIWVLIETLIEGIRVPGWATLVIGLTLLGGIQLLFLGIVGEYIARIYAEVKNRPK
YIVSSEYSHVKAAHQLQDFDQHVSKP
>fig|1120924.3.peg.322 Multidrug resistance transporter, Bcr/CflA family
MSESRLNRQYSTAWIMLLALLTALGPLSIDMYLPALPQMAEDFGVSTAMVANTLPAYFLG
LAIGQLVYGPISDRIGRKKPLYVGLTLYVIASASCVLADNEWSLIFARIIQALGGCVGVV
IARAAIRDRLDVQGSAQAFSSMMIVMGIAPIAAPALGAFVLEFFHWQAIFWILALIGCIS
LVCIHFFFIETLVPEKRLRLSLNQVFTLYIAIFKDASFRFPMFAGCLTGGVLFSYISSAS
AVLMDQYGLSQQQFAYAFGFNALGIIILSSLNKKLVSRLSTLQRLKIGGFIQLTGALVVL
VSGLLIHAPIVMVMTGLFLAVSGLGMTGPNAMALAMSQQGSRAGTASAIMGSMQFACGLL
AGVLLNFLIWNALFNMGLMMLLFSGVGVIAIFVVARQLKLQTT
>fig|1120924.3.peg.367 Membrane fusion component of tripartite multidrug resistance system
MSDEQAPKVPPQAASNDNTQAQSNAQSTNSSTPTPYKPVQRVGKLIPTKKSTLFIMFFVL
LVGIGLIMWAWRIGPFHTMIEQTDNSYVKGKTTVLSSQINGYIKEVLVKDFDDVKQGQPL
LYIDATTYDQKVTQAESAVAQAQNTLANQTQTIAQREADIIAAQAQVDQAQAEYQLSLDQ
LRRYQQLGDSGAASKSEQDQIAATAKNNLAALKKAKANVKVANEALKTAQVAEVGLNAQV
TSAQAQLDQAKTTKNYSVITAPMDGQLGEVTPRIGQYVAAGSQLLYLIPNQTWVIANFKE
TQIAHMKIGQPATFTVDALDHQKFKGHIEQISPAAGSEFSVLKADNATGNFTKVVQRISV
RIAIDPNQDELKRLRPGMSVITSVDTSSR
>fig|1120924.3.peg.447 Bacteriocin resistance protein, putative
MHRESVLIKPAIEEQFRGIVRQAYDYSCGSAALTTLLNGYVGTKLTEQQTMNGLLRFGEY
QRIIERRSFSLLDMKRFVTALGLESGGYRGEFSDLVNQGQPAIVPISYAGFKHFVVYKGY
KDGRVYVADPALGNISFDEVRFKEIWENNTLFLIQVPEAQRQHMLALQESDMRHVEDTTI
NKYAFIDMQYPSFYMERIADRISTVRRAPDMDKNSYTYGQNIDTFMRLYYKRK
>fig|1120924.3.peg.538 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTPKRSLITQQKLWKTFLIFLLPLIATNILQNLSGTINTVFVGQMMGVDAIAAVAVFFPI
LFCMMAFIIGLSAGSTVLIGQAWGAQNIEKVRCVVGSTLFMTIIGGCIIAALGVFFSREI
LTLLGTDASVMHLSLPYVQWMLAGSPLLFVYIIYTSILRGVGDSITPLIALGMTSLIGLV
ITPVLIAGYFGFPKLGIVAPAIATIIGYLSVLAFLAVYLNKKNHPLKPDLALLRHIRHHS
EISRLILRLGIPTGVQMITTSVAGLVIVGLVNRFGAHATAAYGAVNQVLNYIQFPALSIA
IAASIFGAQAIGMGKSDLLARVTRTALWMNIIITGTLVILAYLFSKYLMALFITDESVVQ
LGQELLFIVLWSILFFGAAAIFASIMRSSGTVTVPMLINIAAILFIEVPCAYWFSTLWGL
KGIWIGYALAFVCLCIMQAAYYQFVWKKKTIKALI
>fig|1120924.3.peg.660 Outer membrane component of tripartite multidrug resistance system
MHQFFSLQIRVKPSKLLSAFSLGVMGVLSGCQIVKPEPSAQLNIQAQFSQPAQYGLDAKK
WETEDWKIAVPSDQLPRGEWWQIFQDTQLNQLVEQLNRENASIAQYEAQYRQATALLNQA
TASTKPTVTGNTNVTRAKSGESATTANYNMGLNASWEPDFWGKVRQNIWVNQDKAQASEA
ELNSIRLSMQAQLTTSYLQWVILGFQLQSQQESLKNLQKFLQLTHNQYQAGIVASTTVDQ
AQSQYQTALANYTEMQLAQIQLQHAIAMLIGQPQDQLQLILPKTLPVLPQIPVNLPSSIL
QRRPDVAAAERTMAAANAQVGVAKLAVFPDFSLGGNLGYKSSKLSNLFSAPNFIWSVGPT
LAATLFDGGLRHAQTEQAKASYDASAAVYKQTVMSAIQNVEDNIAAQYLLSKEVAQEQQS
LAAATRAEQSTTNQYKAGIVGYLNVLTAQNNRLSAQNNVWSLTSKQYQTTVNLISAMGGS
F
>fig|1120924.3.peg.788 Permease of the drug/metabolite transporter (DMT) superfamily
MAISLAAETQPPAFKLYLCIAVTVFCWGYSPIGVHNALHSYTPQHIALLRFLIASFFLLL
LVMKKGIQPLKWKDAPALAVLGFFSVTLHHLLINTGQQYVSAVASSILSQSIPLFTFIIS
ALLFKEKIVFKQWLCILLGLGGAVLVVSGDHGFGVPSPYSLMIVLAAIAWGLYFNLYKKF
ALNYDALSMMCYIIWFGTIPLLFYSAHLPSEILHATWQANMSIVLLGIFPSAMAYVLWGY
VLKNMPLTIASNFLYCSPIVAMSLAVVFLNEKPSMIVLLGGVMIVGSLVWMNWGNRRTIK
>fig|1120924.3.peg.964 Permease of the drug/metabolite transporter (DMT) superfamily
MRFSFSPVQTGSLCAVSAAFLFSTKAIFIKQAYALSPLVDATLLMALRMISALPFFLLLC
WFNRHHNQAISAKDWLVLIFSGLLGYYFASWLDFMGLMLISASLERIILFLYPTLTVLAS
SFLYHQKLNIKTWFAIFLSYGGTVLVMLQEGKNAPSQGGFWLGASLVFASAVAFAVYLLL
TPALIKKFGSWNFTGLASSVACLGTIMHYLIATPAPLTVINELPLAVWGYGISLGFFVTV
IPTILLMQGIQRLGASQSAMIASIGPILTILLAVIFLNEQLNLWQWLGCVLNILGVLLIT
LSKTRLKH
>fig|1120924.3.peg.1482 Acriflavin resistance protein
MNIFALFVHRPVANILLGIAMTLLGILAFFRLPVAALPQVDIPTIVVRANLPGASPESMS
ATVATPLERAMMGVSGIKAINSSSSQNSTQVILHFDLDTDINEAAREVQAAINVAMSQLP
SGMPSPPEYFKVNPSQSPIFYLALSSRYLSAGKLYELASNQLKPNLAQTSGVGEVEIDGA
SMPAVRIILNPNALISQGISLEQVRDAVKKSNVVQSLGVIEHQNNRWQVALSTHIKDAAD
FSNLIVHQTAQGIVRLKDVAEVEDSVENRYVAGFHNGEPAVMIKISRQPNANTIATIEKI
KAKLPELNSMIPADAKLTTVMDGSEVIHTGLQEARETLLFSIFLVVVVVVLMLGRLRSAI
VPSIAMLVTLVGAISLIYLAGFSFNNLSIMAVIVAIGLVVDDAIVVLENIERHIEQGEHP
FSAAIQGVREVGFTLVAMNLALIIIFISVLFMGGVIERLFREFSLTLVFIVVVSVFVSLI
LTPSLSARCLQSINVQNRQPLYDYSQRMMHGLTRHYIHSLQWIIRHTYLVILLWLGAIIG
SVYVYQSLPKRILPEQDTGRIESFIRGDDGFSFQIMQPKIATFSQSLLKDPAIKDVIGTS
GGAGGTTNSFFMVSLKPKAEREGKTTREIAERIRQNAPWIAGAIFSARVQQDLELDDPFS
GNSGQDYLLLLQSDDVALLRKWAPKVAEAIQKLPELEEVETLGDEGAQHVTLDINREAAR
RLGVDVESISSVLNNSFSQRQISTIYDQTNQFHVVMEIDKRFTENPEALADIKVPNQNGE
YVPLTNFATWSYGITNDRVHRRNQYAAMGIGYVLKQGYTAEQAEYAIRSVLPQVMLPNQI
FVATDKDVEAESLQAGLSTPMLLVTVIALIYIVLGITYESMVHPLTILSTIPAIALGGLL
TLWLFNFEFTLIALLGMFLLIGIVVKNAILLIDFTLQQRRLGKTALESVVSAATLRFRPI
LMTNTAALLGAIPLALSTTEGSELRQPLGLVIVGGLALGQLLTLYTTPVMYLVLEKLAQI
FKKFKMSNAIGYRNR
>fig|1120924.3.peg.2380 Permease of the drug/metabolite transporter (DMT) superfamily
MPTKTNIMLTYIVLVFIWASTPLAIVWSVSDLNVLWAMVLRFFIALPLAVIILFVLRVKF
PTDKIAVHSYIAGSFSLIGSQVFTYIATQYLSSGIIALMFGLAPIIAGLIGCFAFGQQLN
RLQWLGMAIAITGLAVICVGGASQHIHPLGIGLMLISVFTYCCSIYWVKKVNADVQPIAQ
ATGSILISTLVSLCLLPFIWAHAPTHIPEIKSLMALLYTTIMASLIAMFCYFKLVKNIQP
TTLSLTNVMTPILALVIGALFNHERISLMVVIGAMIILSGLFLYFYRDIQANRRFSQHMK
QQLRQK
>fig|1120924.3.peg.2470 Permeases of the drug/metabolite transporter (DMT) superfamily
MQAWRNAFQKQLSTSVDIYGTTLARFLFSPIFAFSYLAFLYSQQPVTVHVSFSHKFWLYI
VIAGISQIYATALMVKLFQQKNYAIGVGLAKSEAILAALVGVLFLQEHLTAWGWVGVSIG
AVAVFLLSKGRQHSELSFKTLIIGLGSGLCFAITSLLVREASLELGMLPFLHRAAWVLCS
LISFQCVIMLLYLGLFSRHTLYHMWQRIGLTFKVSVCSFLASLGWFSAMSMQTVAIVKTL
GQVEILFSLLISAFFFKEKLAKTDHLGLWLVIVAAIMVIWA
>fig|1120924.3.peg.2725 Membrane fusion component of tripartite multidrug resistance system
MDELSQTDDRQEPNYTRRKKVAWIVLILLFLGILLGILYYWFVYRFYESTENAYVKSDLT
WIMPKVSGEVIELLAKENQYVEKDQPLVILDNRDLQARADQAKAMLALKQAGLSVQSENE
KSAQSTILEAQSARDAAQADVSRLSSDYRRYQQLLKEGVITRQRFEATQAEYLSAQAQLN
KAQAAIQAAQAQFSGVQAGRAQLYADLDNAKATVKLYDVDLGASEIQAPVAGKIGSLAVR
LGSRVSPQTRLMAIIPKNSLYVEANFKETQIEKMRVGQTVSLVLDAYPSLTYRGKVESFA
PASGATFSMMPPDNATGNFNKVVQRIPVRISILPHPQIDLIKPGMSVEAKVDLRSQSS
>fig|1120924.3.peg.2726 Multidrug resistance protein B
MTMSSASIEWQFSPRVAWLIFIAMIFGNFMAILDIQIVASSLNEIQAGMSASRYEVTWVQ
TVYLIAEIIAIPMSSVLSRILSTRIYYALCATGFTISSLLCALAWNLESLLVFRAFQGFM
GGGMIPTSMTALFLLFPEAKRAVPLVLFGMISTLGPAIGPTVGGWLTTSFSWHWMFLINI
IPGIIISVVIYASQAIDQANYKLLKELDWLSLIGMAMFLGGLEYFLDEGGRYDWFADFGV
RIAFLVSLLGAMIFFYRSYVQPKPLLDLSVFKNKNFTLSCMITFVIGMALYGLGYMIPVF
LGQVREMNSSQIGHIMMVTGIVMFFFAPVLAWLIPNFDARKTVFIGMLMAAFGVWLNAHL
TIQSDYDFMFWPQVYRGIGLMICLIVISHLAMSTLPEHKIADASGIYNLMRNIGGAVGLA
LINSRIDWLTAWHATELNSQLTPANWIFVERLAQLKAQYAELGDLSEQLAMQVIYRQVHY
QALAASFNDLLKLLAIIMLVVAFLTFFMDRGKKVSF
>fig|1120924.3.peg.2771 Permease of the drug/metabolite transporter (DMT) superfamily
MNQTTKVHGWAFLLPVIAVLIWSLNIAVTRYAVDLISPASISFYRWLIAFIVLTPFMLKS
VWRKRHLVRQHMGQLAILSAFGMVLYQGLAYTAAHYTTATNMGIVNAFIPVFTIFVSMLI
LKEIPNLFAILGSAISFFGLLYILSKGDLSQLAQMGGHWGDLLMMVAVFFYAFYGVFLKK
WQLQIPLLISLYVQIGFALIYHIPFLLYFGLDPINAQNAPSLFYAGIFPSLVAPLLWMLA
VQQIGPNRTSIFMNLVPVFTAIIASLWLAEQWTIEHSIGGIMILLGIIMAQKKAARVISQ
QAP
>fig|1120924.3.peg.3200 Permease of the drug/metabolite transporter (DMT) superfamily
MCIWGGFTIFSRLNAQWHISAWDIVAIRFAIAFCILMPILIYKKDLAFLWQREAVILALI
GGIGYCLTVYSAFLYAPAAHAAIFLNGCIPLCTAIAAYILFKQPFDGHTWLSFCIMLGAI
TLMSFLMMQRDHVSFGVGDLLFVMSAICWGVFTVLLKQWKLSAWHSMASVAIWSAVIYLP
VYLLFFPKHFTGVNPIHLMIQGVFHGVFVVIISTLAYIAAIERLGAFKTGSIVTLAPFIA
AVVAVPLLNEPLSASIICGLIGMGIGALQPWRWRLKDTLTIELEKQKQKSD
>fig|1120924.3.peg.3207 Fusaric acid resistance protein fusE
MSQVDLRKIVRPVVTLLMAIVAIAVIIHLWNYYNSAPWTRDGRVRGDVIQVSSDVSGLVT
EVLVQDNQTVKKGQVLFKIDVVRQQLDVEQARSDLAKAKAGLAQSQANLIAAKANLTKSE
ANTALAEKNAARYSSLLDGAISKQEQDQIYATRDQSRAEIAQMKAAIEQAEATIVQQKSL
IEVAQSNLNLALLNMQRSEVVAPADGTLSNFGLQVGNYVKTGDAVAALIDRHQLYVVGYF
EETKLNHIHIGDQATVQLMGDDQKIRGHVQGIASGIEDRERSSSSTLLANVNPTFTWVRL
AQRVPVKIVLDEAPKNSLAFVAGRTATVNIVQSNSQKN
>fig|1120961.3.peg.326 Permease of the drug/metabolite transporter (DMT) superfamily
MDKDSGDTHKNSATIIGFTAVLMWALLALFTDATGNIPPFQLAFMTFFIGTLIGIIWNIG
RKKPTNEEPIPLRVALAGGIALFAYHALYFGAVKNAPAVEASLIAYLWPLLIVVCSALLP
GEKLDWHHVLGAFAGFAGTILIVTGGKGFTIDPAAAFGYGLAFAAAFTWTAYSLVSRKFA
DVPTKSVIAYCAVTTVLALAAHLMFEETTLPSTTLQWLAIIGLGLLPVGAAFYTWDYGMK
RGDVQVIGASSYAAPLLSTIILIAFGRAIFSWSIVFACLLITFGAMLAAKNIIRRRKPDQ
L
>fig|1120961.3.peg.461 Permease of the drug/metabolite transporter (DMT) superfamily
MRRIYANLLLLFVGAVWGMGFVAQSTAMDAIEPIFFTGIRFLAAAIAVLPFAIWEQKRRA
RTMPESEPTLTRKNILNFAILGAILFSSLATQQIGLLTTSVTNSGFLTGIYVVMVPVLGL
LVLRQVPHTIIWPASALTLTGIFLLSGGSLTGLTTGDYWTILCAVLWACHVLFLGRVLTT
QRGGNTPFTLATIQFFTCAILGLVLASFFETVSWAILVAAAPEILFAGVVSGGVAFTLQA
VAQQYTTAPQAAIFMSSEALFAALFGAIILGERIGFSGYIGCLLIFTAMLAVEIIPMLRL
RGRTQIS
>fig|1120961.3.peg.560 Permease of the drug/metabolite transporter (DMT) superfamily
MSYARDIALTALAPAIWGSSYIVATEFLPLIDPLIVSLLRALPAGIILLIIVKELPKGWW
IAKIFLLGALNFSIFWTMLFIAAYRLPGGVAAVVGSLQPFIVIFAARLIIGTPIKLLSIV
AVMAGMLGVALLILTPKASLDLFGIGAALIGSASMALGTVMSKKWQPPVPPLTFTAWQLT
AGGILLLPTLLLVEGQWSDFSLTNFAGIAYLGLIGAAFTYLLWFRGIARLNPSSVAILGI
LSPLVATLLGWFILGESLSALQLFGVGIVLVSVIAGQYALRPNRVVLKPAMSK
>fig|1120961.3.peg.958 Permease of the drug/metabolite transporter (DMT) superfamily
MFIFEAAAMLAALTWAFTSILSADPAKHLGAIAFNRWRMTIVFVALIAWATLFGTWSSIT
GDAFWALFWSGFIGIFLGDTALFLTMNRLGPRRTAILFSMNAPISVLLGYLFLGEALALQ
TFLGVSITIIGVILAIIFGKRKTQLHKWESITGTLWVGILFGTLAALAQAIGALIARPIM
ETGVDPVAASALRVGTAAFGLWALMLLPHKNFKQANPGSVSIWTQVALSGLLGMGLGMTL
LLFALSGGKVGVITTLSATTPALLLPILWWRTKEAPAIGAWIGAILVILGSALIFNA
>fig|1120961.3.peg.1052 Permease of the drug/metabolite transporter (DMT) superfamily
MANGIKLETVAPALFVLLWSTGWIVAKYANDYAGPLTFLTWRFAIAALAFAVIAVIMSAK
WPTTRAGWLHAIISGLFLHAIYLGGVWWAIKQGVPASISGLLAALQPLMTAMIAFWIIKE
RLTMRQRMGIAVGLFGLLIAIGPRLLSLDTDALLTASLPLIINVIAMASVTFGTIYQKRF
LQEGDLIPVATLQYVGAFIFIAPAAMILEPSLVFDLNIHSILAMIWSVFGLSLGAILLLL
YLIRRGQVSRAASLIYLVPPAVGIEAWILFGETPTIPFIIGTLIVVAGVWLVNHKRPVQK
ST
>fig|1120961.3.peg.1173 Permease of the drug/metabolite transporter (DMT) superfamily
MQNNKNAYIFLFLTTLFWGGNAVAGKLAVGHVSPMMLTSIRWGVAVSLLLLIGGKQFWQD
RAIIKPHLPLLFIYGGLGFAVFNVTMYSALNHTSAINVAIEQAAVPAVIFIGNFILFRMR
VSALQIFGFSLSLIGVAVVASHGSLERLAALEINKGDMFMGIGVLAYAAYSVILRYKPDL
HWKSLMTTMAIAAFIVSLPFAYFELKGPNAILPDAQGWAIGFYTAIFPAIIAQVLWIKGI
DLIGANRAGVFINLVPIIGTILAVIILGEVFGLYHGIAMALVVGGIWIAESSGRKAHRNA
PDVPR
>fig|1120961.3.peg.1369 Glyoxalase/bleomycin resistance protein/dioxygenase
MPDKAKMLGTACVLLVRDFKKSVDYWENCLGFTAHIWGEPPNFAIMERDNIRIMLSHAPD
HTNKPNWEVGGGIWNSYFWVDDVQSIYQEFIANGAKIDYTLHEKPYGVLEFGIQDLDGHD
IAFGQDLN
>fig|1120961.3.peg.1700 Permease of the drug/metabolite transporter (DMT) superfamily
MLAVRFNWTIAVLLFLITALVMTAFAANSVLARAALLGPTIDPASFTTVRLISGAAMLAL
LLLTRKQTSIRGLIGGGNWHSAFWLFAYAVTLSFAYIGLDTGVGALILFALVQATMIGWS
VFKGDRPIVPEWAGLIIAFSAFVWLVSPGLEAPDPFSAFLMALSGIAWGAYSLRGRGATD
PLKATAGNFILAVPMAIAVSAICFSQNNASTYGILLGIASGAITSGIGYAIWYRVLPQLS
AMQGSIVQLTVPVIAGLGGLIWSGEPFTLRFVLGSVFILGGVALAIISKTKRV
>fig|1120961.3.peg.1879 Drug resistance transporter, Bcr/CflA subfamily
MTNFERVALYALLISITALSLDMLLPLLPTIAQEFKSSDSNQIYFVISAVIFGMIFGEII
FGPLADAIGRKPALIIGLAVFLFGTIIALTAHNLTWLLIGRAIQGIGVSGPKIATRALIR
DQFQAAQMARMMSMVFFMLIGVTMLAPILGQWLGNALGWRSIFYFYLIITFVAGGWLLLR
HKETLPRNARTPLLLKEMLKNLNLILKNGRVLSYTCIAGLVFGAQLTFLSVAQSIFDKTY
GRADSFVYWVAALSLCIGLSSLLNSYLVMRKPMDYLVGFALSGLGFIGAILFTFSQVSDT
YPPFIVFITATAFAFGCIGTVFGNINAMAMTYLGRVAGLGASVISSVSSLIAFALAAFMS
QIHDGTPFALSICFMIAGLGGLTALIMARQLDEISV
>fig|1120961.3.peg.1882 Permease of the drug/metabolite transporter (DMT) superfamily
MLLKQSESRMSKPTINSSMTTIEWVMLITLSVVFGGSFFFVGVIVQDMPPKTIVFFRVLI
AALALHLFMRVTGRKIPWTGTAWFAFFAMGLLNNVIPFSLIVWGQTQIASGVASILNATT
PLFTVMIAHALTTDEKLTITRVSGIVAGFIGVAIMIGGGAIADGAATALAQIACIGAAIS
YGFASVFGKRFKGMTISPYAVATGQVTASTIMMFPIMMIFDQPWTLSMPSTQSIFALLAL
GLISSAFAYILFFSILDGAGATNLSLVTFLVPVSAIFLGIVFLGEILLPRHLAGLGLIIV
GLILVDGRVLKRRVTA
>fig|1120961.3.peg.2118 Glyoxalase/bleomycin resistance protein/dioxygenase
MHITKLDHVNIRTTQLDVMVKWYCDVLGMKSGPRPDFPFPGAWIYAGDNAVVHLIGVEND
AGAGSETLLKLEHFALSATGLAAFEEKLKSRGEEYRRGELPDFKIVQINVYDPDGNHIHV
DFRTDEEVA
>fig|1120961.3.peg.2378 Glyoxalase/bleomycin resistance protein/dioxygenase
MIDHSGISAADISKAVSFYDQAFAPLSISMLAEVPIEFTDGKRVVGYGTHRPQFWLSEGE
AQKPPVHFAFAAPTRAAVDAFYEAALKAGGSDNGAPGIRAHYHENYYGAFVLDPEGNNIE
AVCHKAKT
>fig|1120961.3.peg.2478 Permeases of the drug/metabolite transporter (DMT) superfamily
MTPYQKGLLITGFGGLVLTIDIPLIRLGGGDAWSAQFTRSGLGLVIALLCWIFIRLRQGK
RVSLLPGRAGMVVAAFYGLSAIAFVAAVFNTTTANLVFILTSTTIFSALLGWVILRERPK
TATLITMAIMVFAVFLIVSESIQSGNYFGDLCAVAASFGLSMAIVFARLSGKDMGFAPMI
GGILPLILATGVLLSKGGVSAFHLDAAWWTIANGAIVIPIAFWCLATGPKYLSGPEVGMF
YLLETVLAPIWVWIIFSEAPTRNTMIGGTILIIALIGHSLWQLRSERKRRSAERNELATN
IG
>fig|1120961.3.peg.2542 Permease of the drug/metabolite transporter (DMT) superfamily
MNPIRKASPADLALLLFVAIIWAMAFIAIKIAVPEVGPLWLAAIRVGIGALVLAPYAIYR
GMALPSSSRMWTLIIAMAILNVVIPFFLISWAELTIDAGVTSLLMGVGPFLALVSGHFFT
NDDKINTRKAIGVLFGFVGVLTVVGADALSHMGDSNILGQLAALGGSLCYVTAGVLIRKI
DMPPTRLAFLALLIGTVILFPVALLFADPISAMPSSNAMMALIFLGVLPTGVAYIIRFYL
INKVGYSTFSMSINLIPVFGIFLGFLILGEPLRPQILIALALVLIGLFIAKSGGPKGEKI
DKEAVS
>fig|1120961.3.peg.2758 Permease of the drug/metabolite transporter (DMT) superfamily
MIAAPAFFSTNLIFGRYVAPETDPFILAFIRWACVAIILLPFAIKSGGAQMVRLIRTEWP
FFLFLSFLGMGISGSGVYLGLQSTTATNATLIYSTAPILIILLERVFAARKSSPGEGLGI
AVAFVGIVIIVAKGSFDTIAQFAFNPGDLLIALAALSWAGYSILYRSERFSGLSSVTLFG
IIAIFGAIINLPVATYAFYTGAQLPHSASAWSAVAGIIFISSLIAFSAYQYGVRALGASI
AGLFMYLMTPYGVLMAVIFLGEELLPFHIIGIICVMVGVTMATFPKSMLDKFKRKAA
>fig|1120961.3.peg.3118 Bicyclomycin resistance protein
MTISADIYQAAKPKIWILVVLAAVGPLAINIFVPSMPSIALDLDAPYATVQLGLSMYLLA
TAAISLFSGPLSDKYGRKPVLVGSLILFLVGSTICLLADNASSFLIGRIIQAASATGMVL
SRAIVRDVYPREKSASMIGYVVMGMAVAPMIGPAIGGYIDSVAGWRWSFGLLTSFGLIAL
LATLILLPETNTNIGQSASNQIQGYISLATMPIFWLFVGSASFTSAVFFSFLGGGPAVSS
LFFGQTPFEYGMYFSLCALGYAFGNGIAGRYSEAVGLEKMMSLGAIFSFIGPVVSLLLFY
LSAEPAAWMLFVPLSLIGLGNGMTLPNVTAATISVRPEAAGAASGLLGSLQIGGGGLASI
IGGIVVGETGSPYGLCALLVGFGLAALIITLMAARMSRRYEAN
>fig|1120961.3.peg.3214 Drug resistance transporter, Bcr/CflA family
MFRFAVILGLLSAVGPLAIDMYLPALPLIEAGLGADVTAVQASLTVYFIAFGVAQLFFGP
YSDQVGRKKPLYIGLAIFAIGSIGCALAPTIGWLLAGRFVQGIGGAVVMVVPRAIIRDQY
TGTQATRLMALIMMVISVSPMLAPLAGSVLMEVASWRGIFWALAVLTLASLALTLFALPE
TLAHDNKVPVNVTSLMRGCGILLRDKKFMGLTFIGGFGMASFFVFLANAAFVYTSEFGLS
PVQFSLAFAVNALGFFSSSQLAANLGEKFGMEKVVATATFGFLVFTGLLLGLVLAGFGTL
PVIVGVLFLANACLGLVVPSTMVMALDDHGDMAGLASSLGGTLQMVAGGLMVVLASPFFD
NTALPMVAAITVCAVVAFVLTRLVLNKSDIAVTPV
>fig|1120961.3.peg.3296 Permease of the drug/metabolite transporter (DMT) superfamily
MKYIIFILFTVATNAAAQLMLKQGMTTLSPSVLAQDNIILKLLMVVFSPWVFFGLATFVI
SMASHMFVLSKVDLSFAYPFLSLAYVLVAVLAWQLFGEELGTYKIAGIVFICIGTVLIAQ
SGSPTQETSISQTTTEEYNS
>fig|1121428.3.peg.571 Permease of the drug/metabolite transporter (DMT) superfamily
MNSMIGGALYLSLAAAIWGGMYVVSKFALATVPPFTLLFLRYLVAALLLVGILWRKQEKL
LPDTARGLILQVGLVGYFFSIAAQFIGTKLSSAHMGAVITTLSPVFLSAFAVVILKERLT
VKQAVAMAVALAGVLVVVGVPGRQGEPSALAGNLFLLGAALCWGYYSVISRKVSTVYSPL
QITTWGILIATLFTFPCLYFEYGQWSPADLLQLPIVLSVLYIGIISTALAFFSWNKGLAL
VPSHQAGLFFFLQPVVGTLLGWFFLDEHLSGSFFIGSLLIMAGVYYNMKQTAGSE
>fig|1121428.3.peg.634 Vancomycin B-type resistance protein VanW
MNKARLTFLVTLALGFQLLVCIGLSSTATVLYYRDTILPGTSVQGVDLGGLKAAAAEQAL
RRALPWPSPDSLLMLVDPEGQSTHIRYSDINYRADYQATVQEALKQSRQAAAWHNIGALF
GAIHQGHNMPLVKTFNQAAFSKILNQLADKYNVPARNAQFAFNGNNVILFAESKGRQLDI
PGTLKQLRELPPDQHRLALQFKTVEPEVVISDYNGINTRLAIFVTQFDSSNKARSHNIEL
ASKLINNLIVPPKQVFSLNKVLGPRSQDRGYLQAPVIINNKLTSDYGGGVCQVATTLYNA
VALAGLQVVERVPHSLPVPYAPPGQDATIAGDAIDFKFLNNTDYPILISSQVQHGKLLVS
IFGHRQGASARLIKIETERSITKPERKYVQEQNLAPGQVVVRRPGRDGYQLKTYEITMEN
DKEVDRRLLSQAIVEPEPEVIAVGPGISTKGQVKK
>fig|1121428.3.peg.727 Efflux pump antibiotic resistance protein
MEKDAALKKYTLLTACGASFLTPFMGSAVNLAIPSIGKEFNSSALLLSWVATSYILASAA
FLVPFGRLADIVGRKKIFMLGVLGFWLSSVLCGFARSVEALIAFRVIQGIGSAMIFGTGM
AILTSVFPPQERGKVLGINVATVYTGLSLGPVLGGVLNHHFGWPSIFYFTSLIALSVFFL
TVTKLSGEWAGAREERYDFLGAALYALGLVALMYGISAVATSPWAKYILLFGFVVLLVFV
RYELRVKHPVLNLSLFKHNTVFAFSNLAAFINYSATFAVGFLLSLYFQVVLGFNSQITGF
ILLSQPVIMALLSPFAGSLSDRKDPRIVSSWGMTLTTVGLFIFCFLDRNTPLWLIIMNLL
LLGTGFALFSSPNTNSVMGSVEKRFYGIASSALGTMRLTGQAVSMAIVTLLLALYVGNVK
LSQAPADLLVKGTKTTFIVFALLCFMGIFASLARGKKPAGLQKAPPYK
>fig|1121428.3.peg.746 Acriflavin resistance protein
MFLTNLSLKRPVFATVTVLALLAVGIISYIGLNINDYPEVEFPYVVVTVVQPGASPEQVE
SKIVSKLEEAIGQISGVKHIYATAREGVATVFAEFSLETSPEVAAQDVRDKIGTIRGELP
QDIEEPIIARFDPSAMPIASLAVTGSLSQRELTTVVEDLIKRRLETVNGVGAIDIYGDVK
REIHLQLDKYKLAAYGLTTAEVINSLRSENMEVPGGKVGNGDREMTLRTVGSINRVEEFA
NLPVARRDGVQLYVKDIATVVDGVEETDSLSRYQGKPAIGIDIIKQSGANTVEVADRIKA
VLAEVKQELPPGVQLEMVRDNSVYIRDAVKDVRNTLIEGSVLAVLTVFIFLRDWRSTLIG
ALAIPTSIIATFFAMKVLGFTLNFMSLMALSLAVGLLIDDAIVVIENIVRHLRLGKSPLE
AARDGTGELGLAVTATTLTVVAVFLPVGMMTGIVGQFFKQFGLTVVFSVLVSLFVAFTLV
PMLASRCLKEEEHLPGGPVGKFLKWFNRGFDKITAFYADFLKVVLRNRKKTLGIALLLFL
GSLMLIPLLGSTFVPSSDIGELYVVADLDAGLGMAAAGQVTAEMEKVLQGFPEVTKLYTT
VTNERANIFVKLVDKHHRDKTIDRLAMDMRHQLNAIPGVKVTVNQQAGMSDGAAIQFRLL
GDDLDQLQVYAEQAQKIMESIPGTVDVSGSYKPGKPEGQVQIKRDVAADLGVSTASVADT
LRTLFNGVVVSQYEEGEERFDVRVRLAEDHRRNLADLSNIYLPGAQGLVPLSQVSETVFA
TSPSQINRFDRTKEIVLSCNTDGSISMGEFNKIFKERVAKEMNLPPGYSFYEGGDAERMG
ETFTAMLLALVTAVLFIFFILAAQFESYIDPFSIMLSLPMAVVGAILALLTVGSDLSIMS
MIGIIMLMGLVTKNAILLIDFTKQERARGVERNEALRKAALTRLRPIVMTSTAMILGMLP
LALALGPGAEGRAPMAHAIIGGLITSTLLTLVVVPVIYTILDDLKAKTTALKHRFMQAGD
GA
>fig|1121428.3.peg.903 Permease of the drug/metabolite transporter (DMT) superfamily
MKPSIKGFFFLVGATFLWGVSGTVAKILFNHQVNPMHLVTIRLTLSFAVLLLYLAVWQPH
LLKVKKSQLPYLAVLGTAGVGLVQFSYLFTISQTNVATAVFLQYLAPALVAVYAFLRQRE
SKSPVKLLALLLTAGGGYLIVSGVPGGGLAVNWPGLASGLVSAASLAFYTLYGKKGLATM
NHWTMLLYCFGFGALVWNIFQPPWVAMVGHSLTEWYFFLYIAVFATVLPFGFYFCGLNCL
TPVITSLTSTMEPVVAAVVAFLALGETLYPLQLVGCSMILIGVIAIQCVPEQEKLPDKQS
VSQEG
>fig|1121428.3.peg.1465 Acriflavin resistance protein
MHITELSVKRPKMMTMVILVFVILGLYTYRQIGVELYPAVNTPFVSISVSYPGAGAEEIE
TQIVKPIEDAVSSLSRLKTVTSTASAGSANINLEFALSADADQAAIDVQKKMDALRRRLP
DGADDPVVIKRDINAAPVMLLALSGDSGRTELYDLANDVIKERLQRLAGVSEVAVFGGLR
REIRIEVDKNKLTGYGLSINQIVNRLKAENINDPSGRLDRPEAEYNVRVLGEFRSVQEIE
EIAIPTASGYAVPLKAVATVTDGYQEVRVHSRVNGQNAIGIQIYKQSDASMVAVGQAVKQ
ELAALQTQLPPGTSLKISRDNSDFVQRSVNGTRSNIIEGIITTGLVLFLFLRQWRASLIV
LLAIPTSLMATVMMMYFCGFTFNMMSLMGLALCIGILVDDSIVILENIHRHLHMGKTPWQ
AAIEGRREIGMAAIAITLSDVVVFAPLAFMNGMIGQFFRQFGLTIVFATLFSLFVSFTLT
PMLASRLYKEGDTAESARPTRKSLFDILWQHTVPLGQQIKSKYTNMLLWSLSNRKKVLVL
SALAFFLSLSLIPLKLIGTEFMPRTDEGGLTVSLEMPVGTPLEKTNEVLRRLEHYIGQIP
DVQYYNTMAGSGGRGGAGGANTGRIEVQLRPKQQRQKSAAQIAEEIRKQGMAVKDAKVFV
AESDSRGGGGGSAVRILVAGHDPEQINLLADQVKEKVAKVQGVTDARTDWSLGQPEIQIK
VDHNRAAHYGLSVQEVAGTARTAVNGQNAGVLRDGEQEVNITVKMANAQLQDIESLQNLL
INSNGIPVALGQVANLEYGSGPKSIRREDKQRVITVSAGIKERPLGDVMADIRKELAGIQ
LPAGCSIKFSGQDQSMRESFSELISALILSVVLVYMVLVMLYESFSTPLIRMLSLPLGIV
GALTALALTKNNINIFTLIGIIMLDGLVAKNGTLLIDYTHTLLERGRTLKDALTEAAVTR
LKPILMTTVTMVAGMLPTALSITEGAENRSGMAWVLIGGLLTSTVFTLFVIPVVYTIFDD
YKTKWRHRRFSSQVSQPAPEITA
>fig|1121428.3.peg.1501 Membrane component of multidrug resistance system
MGLHNQDNSSRRQNQPPPYAAEAKSIPWGALLILVIGAFMAILDSSIVNVALPRFMTLFG
SSADEIQWILTGYMLTSGVVVPITGYLGDRFGNKRMYIWSVAAFTLGSLLCGLAWSTQSL
TVFRVIQAIGGGMIIPVSMAMIYRIIPREKIGLALGIWGIAAIMAPAVGPTLGGYLVDNY
SWHWIFTINIPIGIVAIMLAIAYLEETPVQKNLKPDLVGILLSSAGCFALLLALSEGQDK
GWTSQYIVTLLVFSGFVLCLFALWELQVPNPLIDIRLLKNPVLSASLLATCLTTIGLFSA
VFLIPIYAQNLLGYTPMETGLLMMPMALVTGLMMPISGKLFDKFGAFWLGMIGMSLVVAV
TYYLHTLTLDTSYRHLQVILSLRAVGLGLATMPLTTAGMNTVPRFLVGRASALNNTVRQI
SGSMGIAYLTYVMLQRQAYHTAVLNESVSLTSPVASLAQAQIKGYLVGYGLNGEAARQGS
YSVISGLLARQSFMNAISDTFVVSAVIIALVLPLMFLLSKQRVEQERIKQQNLSQGRLPA
>fig|1121428.3.peg.2139 Permease of the drug/metabolite transporter (DMT) superfamily
MTKMKQLQADLALLAVTVVWGATFVVVQDALSGIGPYFFTGIRFAIAFALLGLIYFRRLA
NLDRATLRAGCLIGVILFAGYAFQTVGLKYTTASNAGFITGLAVVLVPVFTSLITKQLPA
PAVLLGVTGATLGLALLSLGDNLSVNYGDVLTFFCAVSYAGHILLVGRYAPRHDPVLLAI
LQIGTVAVISLLFGLCLETLPAQFSKPVWQGLIITAIPATALAFLIQNSVQRYTSPTHAA
IIFITEPVFAAATAWLVAGEVLTTRQWVGCLLILAGMLVAELKDYLFNVTKIKQARET
>fig|1121428.3.peg.2177 Vancomycin B-type resistance protein VanW
MAEQILKRVVPVVLPLLFLISLAVFLATQMSFAPADRILPGVYMLSINLSLLDYPQAVSA
LKKLEQDMQKPLTVKYQGKSWLLPMDRVGLKLNCQQEARRAINIGRSGPLWQRFCERRQA
YRGIRLEPEIIIDTGLLQQQVSQTAKDIILPPRDAGLIINNDDTVEISPAQSGREIDIQQ
LRQDIRERLLQQDTSPIELKPVEIPPARTTEEVQAMGVDTLLGMFSTQFDPNNVNRAYNI
SVAAAALDGLSIRPQEIVSFNEVVGPRSTEAGYKNAPIIINNELVDGLGGGVCQVSSTLY
NAVLLANLEVTERANHSLPVPYVPIGRDATVVFDAVDLKFKNNTDYWLYLQSFVTGGRLT
VKIFGNHRFKRDVVIRSWVEETYPPRTVVEKDYSLRLGDRVVKQKGAQGYRAASERIVMQ
DGKVIKVEKLPYSVYKARHQIISQGMAPPASLVKNPDPPGEAVEQDRGNPDVLP
>fig|1121428.3.peg.2372 Permease of the drug/metabolite transporter (DMT) superfamily
MVFLSYIKVRFQYFRLHEDDTVSIEFFLWGVFHHRIEIPVLMLRQKMAGFSLISRTELET
GQGDPGEIMSRENQITITGVQQLLDKLRKWLLWLQVVQEDVDFFLRHLVLEKFYWRISFG
TTDAAATGMLAGLAWSFAGLVTALFYHKIAPGRVQPVIKVEPDFKKAGFATSADCIFKIR
IGYIMVTGLKILKKKANKQGVNFLGRTSHRRSHENCHGKY
>fig|1121428.3.peg.2429 Vancomycin B-type resistance protein VanW
MPFLIGLLGLVALVAGVVSGFWIFQLNHAEAQCIPPGIFVEGIDLSNLDRRQAAAKLQQY
EQTLLSKQIQLSYQDQAWHMTLQELGFMAKSDEVLNLALQNNFSLLQQRLQAYFRPVRRD
YHVTIEINKEQMTKALESVVRSIERPARNAELVISDHGRVMIQPDQKGYQVNLEQVYKQL
LNTDIRQASIQVNLAVNELIADKTTADIEKLRINGKIAEFTTKFDANNVNRTVNIRTAAA
RINGVMLAPGQEFSFNKVVGERTGKAGYRPAAVIVANKFEEALGGGICQVSTTLYNAILL
AGLTPVERHNHSLAIGYVPLGRDAAVAWQQLDFKFKNTLPGHLYLRTVVTSDAITVQVFG
DTAAKKDIVVRSWVTETIMPDQVIKEYDPALPPGEEVTVAPAYAGFRAKAERIFKENGTV
VKREALPDSYYQPRPKIVKVGQKTEQTDPNLQAVETEF
>fig|1121428.3.peg.2764 Permease of the drug/metabolite transporter (DMT) superfamily
MISGSNMFSYAVLILATVSWGGAFVAAKMVVGEIPALVAAALRFWLAFLCLLPFMLVQEG
RKAKISSKDWPALVFLGFSGIFLYNILFFNGLRVSAAMDGSLLVACGPVLTALLSAFFLQ
EPLHWRQAAGFLVSLGGVVVIVTKGVPAALLSWDINHGDLMLTCSALTWSFYSVGGKVIM
KRLSPLTCSTYAMGIGAVMLTLAAVTQWQDNPFGRMTIVSVAGLTYLAVIASALSFVLWF
AGINRVGAGKAAIFQNLVPLSGAVFSVLLLGEQWQLFHAVGGGLILGGVYLVTKPAGTVL
PAGKVSRGI
>fig|1121451.3.peg.182 Acriflavin resistance protein
MNLARWCIENNRTAIALFLLVALGGAMTFVSIPKNEDPDFTIRTAVVMTVFPGASPQRVE
ELVTDKLEEKIREIDVIKNVKSQSMTGISIIEVEFLENIKDMDPVWQRLRNKVSDAVPTL
PSEAQAPIVNDEFGDVYGILVALTGDGFTYRELKDVADYTRDELLHVPGVGKVERWGLQD
ERIFIDFSNSRMAAAGISPFLLGQVIDHQNTIRPSGSAKVGPERIYIEPTGEFKSVDDIA
SLSMRVEGMKTSMKLSDVTDVSRGFADPPSVMARYNGKPAIMLAISMAEGNNIMELGEKV
TARLDELSADLYHGMEYNIVVYQPEYVETAVSDFMLNLLESFIFVVIVILAFAGFRTGLV
AGSLVPMAMLGCIGLMPYFDVGLQRISIASLIISLGILVDNGVVVSEAILVRLAAGEERM
NAVSNAVSELWMPLLAASMTTVFAFLPIPLAESTTGEYCFSLFVVVTLTLLCSWILSMSM
VPMLCYYVLKPKVVIQTFSSRMYRAYRAMLLCCLKHRTVFLAVVLAGCVVAFWGFKFVPK
MFFPPNERAQFTIDFWQPFGSDITTTAEEVGRLEQFLLADKDVVSVGTFIGHGGPRWYLP
LNLEQRNDNLSTFVVNTKSIDSVDALMTRTRQELKANFPDADFSLKKLMNGPPVGAPVQI
RISGPDQKTLYRLRDKIVAMLEARAGVSRVWDDWGQWTKKMVVEVDQDKAREAGLSSFDV
AASLQSGMSGYQASIFREGDTNIPIVLRSEDAFRNRLDKLESINIYSYQDGKSVPLNQIA
VSKLVWQPSDIRRRDQTRTMTVKADLFDGYFAMQILNSVRPEIEALTKTSQWPVGYSVAY
GGEFEKSEESQASINANMPLAMGLLVLVLIFQFNSFRRPLIILMTLPPMMCGITPGMILT
NSPFGFMPMLGMISLLGIIVNNAIMLIDRIEIQRKKGINLDDSIVLASLERARPIIMTAT
TTIIGMVPLSLQGGEMWRPMANCIMSGLMFATVLTLILCPVLYSVFFKQSYKGYNWNPAV
IEHGKDG
>fig|1121451.3.peg.751 Multiple antibiotic resistance (MarC)-related proteins
MLAIFFQTYLKLFFILTPFFAISAFLSLTQEMSPAERKRTAVKVTMAVIISSVLLYLYGR
YIFELFGITLDAFRIGAGAVLFLSALNMVGGGTKKFEAGNEDDDISVVPLAIPIIVGPGT
IGALLVMGSTVQGYKDMVLACTALVAAVLTVGVLLFLSSGFKRLLGKRGLNIMSRLTGLI
VASIAAQIFFTGLRNFMLN
>fig|1121451.3.peg.1051 Permease of the drug/metabolite transporter (DMT) superfamily
MTDRSLKADILLLITAIIWGAAFVAQRVGMDYMGPLTFNAVRFALGAVALLPLIYSLDRE
KKKDGTYRKVELGSFLKGSLIAGGALFLGATFQQWGMVYTTAGNAGFITGLYVVFVPVFG
LFFKQKTGLPTWIGALLAVTGMYLLSVNEEFHIEFGDLLVLCSAFFWAGHVIVISLLATR
VDPVKFAGGQFVACSIFSFMGAFIFENVSLAGIIDGAVPILYGGLMSVGVAYTLQVIAQQ
DAKPAHAAIILSLESVFAALAGYVLLGEMLTVQGMAGCALMLCGMIISQVKSS
>fig|1121451.3.peg.1414 Acriflavin resistance protein
MSVPANSENSQGLIASAVRFFLHSKLTIVLVIGALLLGVAAIQLTPREEEPQIVVPMADI
MVQAPGAGVEEVEKLITTPLERILWQIDGVEYVYSVSRRDASLVTVRFFVGEDREESLIK
LHNAIAKNTDIAPRIASGWVIKPVEIDDVPIVALTLFPAAGRNDISDFELRRVAEELSTR
LAEVEDLSRVSLVSGRSREVRVELLPERMAGFNISPVEIAAVLEGADQSAVAGAVLAGNR
EITVSANSFLDSASDVNNLIVGVSESRPVYLRDVAVVKDGPEEPSSYSRIGFSRLYMTLT
GQDVEESSRPAVTIALSKKKGTNAVKVAEAVLARMDRLKETVLPAGIEVEVVRDYGKTAD
SKVSDLLGSLGFAVFTVIILLAFTLGWREASVVALAVPISFSLALFVNYMLGYTINRVTL
FALILSLGLVVDDPITNVDNIQRHILMKKKKAAEATLDAVSEVLPPVIMSTLAIIVSFVP
LFFITGMMGPYMAPMAANVPLTVTFSTFCALTIVPWMAFRLLKNIQPQKVATDTGPGRIE
IFYSAVITPFLDSRFRRWMLVGVIVIGLIVSMALAGFRLVPLKMLPYDNKNEFQIIIDMD
EGTPLEQTDRVVRQFEEILRGVPEVTNFVTYAGEPSPMDFNGLVRHYYWRSGGHMADIRV
NLVDKSLRSEQSHAIVLRLRHELEAVAARNNACIKIVESPPGPPVISTITTEVYGAEDRP
YSALIEGAKQIVSVMKTESGVVDIDDSTAAERIMVDFVLDKEKAALHGVNAREVVATLQM
ALSGMVPATVHAEGERNPLPVKLILPFVRRADVASLSQLRVKTAAGKRVPLAELGELVEI
NQEQPIYHKNLKRVVYVFAEMAGRAPGEAILDMQGKLKKDPLPPFIWTDWAGEGEWQITL
DVFRDLGLAFGAALLGIYILLIVETGSFGMPLLIMSAIPLTLLGIMPGFWLLNLVSAEKV
QGLVGAGFVDPVFFTATGMIGMIALGGIVIRNSLVLIDFIRKSLAEGMELKAAIIKSGAV
RLRPIALTAATTALGAWPITLDPIFSGLAWALIFGLLASTLFTLVVIPVGYYAFEKNG
>fig|1121451.3.peg.1638 Multiple antibiotic resistance (MarC)-related proteins
MEIKSLSAIFEIAFPLFLIMDPLGNLPVCLSMLKEFSPAKQRKILLRELLFALGIIILFM
YLGAGLMKMLNIHQSTLRIAGGVILFIISMKMIFPKPEGSATEAEKDPFIVPIAVPLFAG
PSLLAAVMVYGSRGDADLTVLSGTMLAWGLTFIIMMAGPTLARILGKRGLRACERLMGLV
LILLAVQMLEDGVAFYINNVLGK
>fig|1121451.3.peg.1803 Acriflavin resistance protein
MAGNPVASNLLMFILLVGGLVMAFNIKQEVFPEFTMDTVTVSVVYSGASPEEVEQGIVLA
VEDAVMGLDGVKEVSSSASEGSGSVIVEAEEGYDLQRLSQDIKSEVDRITSFPEEAEDPK
VKIASRKRQVMTLMVHGDEEPLALRKLAEQVREELINTSGVTQVELSEVSGLQVTIEVPQ
DKLRAYGLTLSDVAAKLAQTSVELPGGGIKTEAGEILVRFKERKDYAREFARVPIVTGED
GTQVLLEDIADVKEDFQSDDYISSFNGDPAVRLNVYRVGTQTPISVSDAVHEKLEIINEG
LPDGVSVAVRNDSSDIFKQRMDLLLKNAYMGLGLVFIFLALFLEPRLAFWVAMGIPISFL
GAMLILAPAGASVNMVSMFAFIISLGIVVDDAIVTGENVFTMRQQGMSWYEAACEGAKRI
AMPVTFSVLTNIVAFMPMFFIPGVMGKIFKVIPLVVISVFFISLVESLFVLPAHLGHCRG
RKPGKIMGYILRHQQKISGGLLTFIHKVYRPFLDRAVTWKYLTVAIGFACLIVAFAYIKS
GRMGFTLFPKIESDYAYLTVDLPYGTAKEVTLRVQDKVLDAAEQVAQENGGEELVEGVYS
SIGGVGRRGSSGSHVLKVQVFLTDADSRPITTEEFVNQWRRNLGPIPGSESILFESDRGG
PGAGGSLEIELSHSNIEVLKRASADLAKALATYPKVKDIDSGYSPGKRQLDFELLPTGRS
LGLTSRSVANQIRSSYYGAEVLRQQRGRNEVKVMVRLPESERVSKYNFEEMMIRTPKGTD
VPLREVVKIKDGRAYTTIDRRNGRRVVSVSADVNPRKETSQIMSAVVADVLPQLKADYPG
LGYSLEGKQADLKESTDSLISGLLIAMMVIYALLAIPFKSYFQPIIVMICIPFGIVGAVV
GHILLGYSLSLMSLFGIVALSGVVVNDSLVFIDYVNIQRRKGHCAYDAVLEAGTARFRPI
LLTTLTTFGGLAPMILETSRQARFLIPMAISLGFGILFATAITLLLVPSFYLIFEDIRLG
LRKLFRRSDDDFRDDGITEHYPVKHCKHKSE
>fig|1121451.3.peg.2767 Permease of the drug/metabolite transporter (DMT) superfamily
MQQHDQKKAYIYGLSAVLIWSTVASAFKIALSHMEPLHLLFYAVIFSTLALLIILIIQKK
IGQITLMSKRELLKNALPGLLNPFLYYIILFEAYNLLPAQEAQPLNYTWAITLSLLSIPL
LGQKMTARELLAIFTSYLGVVVISTHGDLLDIKFSNGYGVFLALVSTIVWALYWIYNTKS
TADPLIGLFLNFCLGLPFVTAAMFIFSGPPPVNGPAILSAAYVGLFEMGITFALWLKALK
LTEKTARISNLIFLSPFLSLILIHLILGEEILPSTLVGLIFIVGGNIIQQMGKRTA
>fig|1121451.3.peg.3168 Permease of the drug/metabolite transporter (DMT) superfamily
MSSTTLLYFKLIGSVTFWGGTWIAGRILAEDLTPYSAAFLRFLFATIFMFFLVRRTTGRK
PECQLADILPLAFLGLTGVFLYNILFFTGLQTVTAGRAALIIAGTPTFIALGSALFFKEK
FTPGKIAGFLLAITGVATTIGDGNPISIITQGASYGDLCIVGCVFSWAAYSLAGKPVMKR
INPIESVYWSSLFGTIMLLGPALYHGLLNEILNASMTDYSCILYLALLGTGLGFSWYFEA
IREIGPSKTGIFINLVPVTAIILGAIILGEPVGLPLIIGGMLTISGVYITNRS
>fig|1121451.3.peg.3172 Permease of the drug/metabolite transporter (DMT) superfamily
MMSFFQSKYIAVVALLVAVFLWSSSFIALKVAMAVYDPMVVIFGRMILASLCFLFFIPSF
KKQAIQKGDLKWLAFMAFCEPCMYFIFESHALVYTSASQAGMIVATLPLLMAVSARFILK
EKLSKKTLSGFILAVIGGIWLSLSSSSTEASPAPMLGNFLEFLAMCCAVGYMTVLKKMTA
RYSALYLTAFQAFMGAIFYLPLLALPSTTLPTVFDPVAVWTIVYLGVCITLGAYGLYNFG
MSRLPANQTTAYVNLIPVFTLFMGWAILDETFTSMQFAAAGLVMSGVIMSQDRKMSS
>fig|1121451.3.peg.3285 5-nitroimidazole antibiotic resistance protein
MAGENKARKGQTKDKTIIDQYLSEGEILHLALKDRIGIFSVPVNYGFYGDKLYVHSSKQG
RKIQALREGGVIGFSIVVSHEVVGKDAPCKWGCSFKSIIGTGVPRILDDKEKAAALNLIM
KQYSGKEWEFNPAAIDAVDVVEIMITSVSARSVEKE
>fig|1121862.3.peg.305 Acriflavin resistance protein
MNIAEYSISHRVISWMFVVILLVGGAVSFFGLGQLEFPEFTIKQAMVITHYPGASPEQVE
EEATLPLEEAIQQLEYVKVIDSISSNGRSQIMVELKEQYPSSQLPQIWDELRRKINDAQS
SLPPGVYPSVVVDDFSDVFGMLFNITGDGYTSRDLENYADYLKRELVLVDGVKKVSIAGA
RQEQVVVEMSQAKLANLGIDPAWIFSLIQNQNVVSNAGNMLVDGRSIRIHPTGEFRNVRE
LEQLIISPPGSTQLVRLGDIASVRRSYDETPDTLYTSNSHPALSLGVSFASGVNVVDVGE
RVRNRLSELTSEQPVGIELTTVYDQPATVSESVNGFLINLAEAIVIVIVVLLLAMGVRAG
LLMGAVLLLTISGTFIVMKVLGIDLEMISLGALIIALGMLVDNAIVVTEGIQVGLQRGQT
RLEAAKRVVSQNQWPLLGATVIAIMAFAPIGLSDDATGEFCLSLFQVLLISLMLSWITAI
TLTPFFCNILFKKYEKATENQETFSVDPYQGALFTLYKQLLNFSLKHRPVTLGLTLLALV
LAILSFGFVKNVFFPPSNTPIFFVDFWMPEGSDIRATESELARFEQQVLSMPGVSNVTSV
IGMGAQRFILPYQPEKQYTSYGQLIIEAESLEAINTLIPPLEIVLDEQFSDVEYRIKLMQ
NGPAAPAEIEARFYGEDPEVLRSLAVQAMTVLRNEPTATNIRHGWRNQVSLVRPHLDEAS
ARRSGISKQALDDALLVNFTGRQVGIYREGSQLMPLIVRSPETERLNADSITDLQVWSAD
YNSYVPITQAISSFDTEWENPLIIRRDRKRMLSVMADPDLMSDETTDSVFRKVRTNIEAI
PLPEGYTLEWGGAYELSTDAQNATFASIPMGYLAMFLITVFLFNTIRQPLAIWATVPLAL
IGVVTGLLVLNTPFSFMGLLGLLSLSGMLIKNGIVLVEQIKLELEEGWEEHEAIFHASVS
RLRPVCMAALTTMLGMIPLLFDAFFKSMAVTIIFGLGFATVLTLVVLPVIYSLLYKINFK
GFDYRKIGHH
>fig|1121862.3.peg.417 Acriflavin resistance protein
MNITRATINNNRTALVLVIVLIIAGLQAYKNLPRAYDPGFVIRVAKVITHFPGASPERVE
QLITDKLEKVIQEIPELDFVKSTSRTGISIITVSIQESYTNMRPIWDNLRRKIESAAKDM
PDGVIGPEVNDEFGDVFGIVVTLTGPEFTYAELKDIADQARDEFLRVPEVAKVEIYGAQE
ERIFIEYNNARLSELGLSPTQLMQMLENRNIVVPGGAITLDMERIELEPSGNFESVDDIR
HTIVSIPGSNNVVYLEDIATVKRGYVDPASSKVHSSGQQALGLGLSMREGGNNIRMGEQV
QEVLNYLNQTYPIGIDFNVINFSPKEVEDKVNDFVSNLIQAVLVVAAVMLVALGPRTGLI
VASLIPMSMISAMLVMSFFDIGLDQISLAALIIALGMLVDNGIVMAESIMVQMNNGKKPV
EAAIDSASELRVPLLTSSLTTAAAFLPIYLAESAVGEFTASLFLVVTITLLCSWLLSMTL
IPLLCVQFLKPKKESTDYNRGFYQRYRELLTWVLKHRVISLAATAVLFAVVMSGFKYVPK
IFFPPSDRLYFKTELELPLGTAIERTEAIIKELEAFITEEMKINGARTEGVISWISHIGT
GGPRFVLQHSPEPASPNYAMMVINTTSSDAIGGMIDKLDSYAFDNFPDLQITSRRIESGV
SITNPVEIRLYGKETDQLFSLVEQLKAEMAQINGLKNISDDWGQRIKKLKVVINQSRALR
VGATSQDIAISLQSGLSGLELTQYREGEDAIPVLLRSVEADRQDIDKLETLSVYIQSTGE
SVTLKQVADIEVVWEPAQILRRDGLKTVSVGAQLTPGMTAAEGFAQLQPWLDEHSHRWPA
GYRYELGGEAESSGKANQSIGEKLPMAAFLILILLVAQFNSLRKPAIILATIPLGMIGVI
IGLLTAQSFFGFMTLLGVISLAGIVINNAIVLLERIKYEIDDNGLSAQEAIIVAAQRRLR
PILLTTATTVLGMIPLYLGGGEMWEPMAVAIIAGLLFSTILTLGLVPVLYSLFYRVKY
>fig|1121862.3.peg.768 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQMLSSRFHHFIDESKALLGLSLPIIVTQLATNGMNFVDTSMAGQASARDLAAIAVGTSL
WLPASLLLRGILMMLTPVTAHHRGAGNNPGISKDLGQTLWIALLCSAALISYLNFSEDIL
VYMTVAPEIIPVGVGYLHALAFGLPGIALFYMLNSFLEGMGNTRAPMVISLLGLLVNIPV
NYVLIYGKFGLPELGAVGCGWATSIVYWMMSILIFLYIRTHHRYEHLLDLRATLPDFTRI
RELFRLGLPIGVSICVCGSIFAVIALLIGKLGANNIAAAQIALNFSSMTYMVPMSLSFGI
TIRVGHSLGKGLNDEARIQAICGILTAALIAVLSVLCILIFRQQIISLYTNDPLIVKGAS
VLLVCAAMYQISDAVQASASGALRGYKDTRVPMVLSCGAYWGIALPVGYAFAMTDIFGAP
MGTEGFWVGIISGLTLAAGLLLGRLVRLMKL
>fig|1121862.3.peg.904 Permease of the drug/metabolite transporter (DMT) superfamily
MKYALRNINTSRQGSIAVLLSALMWGTTGAAASFISDVNPMAVGAFSMGIGGILLALTAR
KKLIEECLLLSHSWRIILIGSLSLTVYPQAFYSSMHFAGVAVGNVISIASAPFMTVIIER
LLLNKKQITFRWLFSAVLGASGIVLLTLSDAYSTQAIIEDSSRQIGVLLGLLAALTYAGY
TCAAKKLMEQGAHSTSAMGSIFCCASLILLPTLLFTGEHLFSSIENTVAVWYLALVPMFL
GYLCFGFGLRFIPASKATLLTLFEPVVAVCLAVIIVKEVIALTGWFGMGLIMVCLIIQAS
EKDETRRGLLKEYSKAG
>fig|1121862.3.peg.1802 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSVHTTDDKMTSGSTTVDFFRFVVPSILGLVALSSAGIVDGIFVGNYVGATALAAVNLVV
PLYSVFFGLCVMMLVGGAVVAGKALGAGDTRKASNIFTKSLTVIVIFALIVASLAFLFAG
NIAAFVGAEGEALPLTTEYIRIISPFMFFMGLAYTLSYFSRVDDAPNYALAGLVLTALTN
IALDALFIKVWGWGVSGAAFASGIAYTVGTAFLVIRFFGKQARIRLIKPYGSWFELFRAA
YNGFSEFINEMSGGLVMFVINWILMIEAGTTGVAAFTIVNYILWLSIMVAYGTAEALGPL
VSVNFGARKPERIASFMKLGVGLAIMVGITFATVLLVYPEELASVFIRSDEVATLALTMS
IIAVIWPAFLFNGINITLSGYFTGMHAATQSALIAMSRSLVLPLVLIILFWKTLGLEGAF
LALPVAEILTFALSVTLFYRATPKMMVSKDVAAGNNEIDSLGGVHN
>fig|1121862.3.peg.2003 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MASIDLRSDPIPSSFFYYLLPAVSGMLVKSLYVLVDSIMVGRGVGADALAALSLTVPFFA
LFLALALMIGVGGSALMSTQFGRGNYTEGQNIFFQSVLLTLVISGFLVSVGFIWLDEVVL
MTGASEALFTMTRDYLEIMLMFFMIYAVGWVLSCFVRNDGNPRLAMYSLVVSALTNVVLD
YVFIFVFPWGVKGAALATGLSQLVLFAGVITHFVRSKGVLRLKLPSSNVKWVGKIMSTGL
PTFFIESTIGVSTLIFNWVLIRHGGDLYVTAYSIVINVAVLVLFILMGVGQACQPIISFN
HGAKSVSRVRETLVLGVKTAVGVGIAALMLASLETDWLVGLFVVDYPVLFDLASLAMPLY
FMAFPCMAINLMIASFFQAVEKPMLATALSIVRGFGFVVLGLVVMPWLMPEYGIWLVVPF
AEMITLVFSLVLYHRHHVQSSGSSTVVLSA
>fig|1121862.3.peg.2130 Multidrug resistance protein A
MDNTAPHPVRRWLLTVAVLLLAFIAGYFYFEHQKNYPSTNDAYVHGNIIYIAPQIGGRIS
VVNVDNYEHVHTGEMLLQIDPSSYEAQLNKAKASYQVATEENEAASEGILAASTNISTAA
ANLRKVQLNFRRTMTLVSEGVLPQQEADTARAALATAQDSLTSARAHMAQLIAEQGAEGE
EAPAVQEAAAALMLATLNLSYTNIAAPADGELGKVNVHPGSVVSVGQALMPLVVAESFWI
QANFKEDDLGRIQPGMSARVQLDMYPDSSFSGKVESISPASGSAFSLLPPENATGNWVKI
TQRFPVSVRLADADNQRGKEPLRVGASATVTVDTIAADHEQ
>fig|1121862.3.peg.2131 Multidrug resistance protein B
MSNNISRQAITITIILSSLMVLIDMTVANVALPDMMGTLGATSEQITWVLTSFSMAEAIC
IPLAGFLTLRFGERQLLLYSIAGFIVMSAMCGQADSLMEMIFFRIFQGIFGAAVIPLSQS
VLMQVYPKEEQGRAMALFAIGVMVGPVLGPVIGGILTEHLNWRWVFYINLPVGGVCLLLI
FRNIQISNRGKSSVDWLLIITMALGIGLLQMVLSQGNEKNWFSSDFILLSTIISVLMITA
FIIRSFWTKGEIAPVWLLKDRNLAISCLIVSCFAVGTFGVLQLQPMLLQELLNYPVETSG
FIMAPRGVASAVVLIMAAPLMDKLDSRILIFVGLVFNAVGVWQMSLYSLEIDPFWIVLPS
IIQGAGLGLVFAPLSKIAFSTLDPAFITGGTAMFNLCRTIGSSIGIAVINTYFSYVKQLE
WQSLGGSLSPDNRLLQNYAEVAGQGITNTDFLEQIAALLKQQSSMLAFVYCFTLMVFIYL
FLILLLPIFRKKAPASSS
>fig|1121862.3.peg.2434 Multiple antibiotic resistance protein MarC
MELFFKDFIMLWSTIDPVGTLALFTGLTARLSKSQKRKVALKATTYAFVILLSALVLGQI
ILKAMSIQLISLQLAGGIILFLFGLQMIFSDPEEGTGSREPGHQLAVFPLAVPSIASPGA
IMAVIVLTDNNMKTFTQQAMTAGAMTSVLLITCGLMLIADRIFRVIGHNGSAIIIRVMGM
ILAALSVELVMTALGVQRWMS
>fig|1121862.3.peg.2447 Drug resistance transporter, Bcr/CflA subfamily
MMDSVLNRSRPGIGLLATLLALPQLSETIYTPVLPAIAQGFGVSESMAQLTMSIYFVGFA
LGVLTWGWLADRWGRRRAMLAGLLCYGMGAAGALFSSEFMLLLGARFLLAFGISVGSVVT
QTVIRDCYSGKALGKLFSTVGAVISLSLAIGPVLGSIGAIAGGYQTVFMMLGGTALLMTL
WVGLSLPETHPGHESVKSSKGSLLVRMIRDRKIRVYSIMVAGANLVLFGYFTLGPFLIKQ
IGFSASVFGVTGVLIALGSALGAMFNRQLLTRHSGGQLILRGCWLGVSGALLQLIITLFL
PSVPFVALLLVVAPMVLMVIAFGLIVPNLLSSALSEYKDELGTAGALFGLSYYLLIAAGL
ALISHHYVSFAGYMPAVFLVIFLLMLMIWFCYRQHILRR
>fig|1121862.3.peg.2679 Multidrug resistance protein D
MKQQGFFQVLFVIVVLTACGQLTNTIYVPTMSQMAADFGVVPGTVQAAIALYLIPYGISQ
FLYGPLSDRFGRKPLMLIGLVIFIAGSLIGSFAHSFEMLLLASFVQGMGTGVGGVMARTV
MRDLYSGLHLQRANSYISMALIFTPLMAPMLGGFLGTAFGWQASFWFLTGFGVLVWLLVL
GRFGETHKNVGKRSMGALASYRYVLSNVQFNGFMISLVATFAGIAVFEAAAGVLFGELMG
LDPRVISVLFVIPIPGYLFGSWLAGQMAKKHSLESIIGRGVVMLVIGSGSMLVAGLMGYL
NAWVILVPATLYFLGSGLLFPTATTAALEPFPENAGVAGAVLGGMQNLGGGLVTLVAASI
PMASQVPVAAILCVLTLLVVMTVRILLAPAAGRATV
>fig|1121862.3.peg.2698 Bicyclomycin resistance protein
MFHITSPNKTWNYPLARTLLLMVPFDLLASLGMDIYLPALPGMGEFFSASPFMVQLTLSL
YMLMLGCGQLIFGPLSDRYGRRPVLLFGCLLFVICSIGLTMTGSIELFIFFRLCQAAGGS
AALVATFATVRDVYGHKPESATLYALLGGMLAFVPALGPIVGSLLIGWFGWASVFWGLAV
SGSVAGVHALFSWPETHCSVGGGSIKHAFGRVITSPAFLLYTSGFTVAMGSFFVYFSIAP
GILIGKLGYSSLVFSLLFAMAAVAMIIVSRFAGSIARKFGISGTLKLGMAVILAGALLML
LGSTLQLPEAPVLLLPMMVIAVGISITCSVCATGALAEFKDIAGTGVALYYCLEAVLVCL
LGTAVVMLFPVGSLWPLIAFSGIGSLVVMASAAWINK
>fig|1121862.3.peg.2792 Multidrug resistance ABC transporter ATP-binding and permease protein
MKLLWKLRFILKDYWQQYLLAFICLQIVSALNLLPPWLIGHVVDGIKDKSLTNQELFNYV
AGIVVTGVAVYGFRYVWRAKLYGASIELIRKQRSRLFAHFTQLSPEFYQQHTTGDLMAHA
TNDLNAVEESVGVGIMTLVDSLIAGLTVLFAMVFLVSGKLTLLAMLPFPLLVWVTKRYGV
ALYSRFGRSQAAFSNLNEETRESITGIRAVKAHQLTDRQTQRFEQLSMEAVEANTSVARV
DALFGPSISLFFGLSFVLALVGGAWLISHGQLTVGLLTSFTLYLSQMLGPMLQFGWQFNV
FQRGSASWGRLEKLLSRKPKVSNAPDAQQAPDDTSLSINIQSFSYNAASDEKPVLQGIST
EIAAGAFIGITGRTGSGKSTLLRLILREFDLPEGSFIQMGNIPLQQLTVESLREKLAWVP
QEPMLFSGTIADNIRFSAPDASLEAVEKAAKLAAIDEEIMGFKDGYDTLLGENGINLSGG
QKQRLALARALLADAEILLLDDAFSALDMKTEARILKNLMAMKGKKTIILVTQRLPELIT
ADHILVLDRGRIIEQGNHDRLMASDQPEENTTEHWYAKIFRQQARTLLHPLEVKPDTVIK
RSDVA
>fig|1121862.3.peg.2793 Multidrug resistance ABC transporter ATP-binding and permease protein
MIANDEKKTSGYRGLARLVRYAKPYQWQFLGAFLILLLATSLEMLAPWLMKIILDEHIAP
GVNDTMGLAMMGSALFGTYLGSAILQYIQNVKFQENALKVVHDIRRMLFAHVLRLPMSYF
DSEPTGRLVSRITNDSEVLRQMFVGVIPAILQAFFRVVGIFIAMALLDVRLMFMTAMLIP
VMLLAIHLYQKISHPVIHGVRSQLANINTRVNESLNGMRIIQAMGQEAHLQQQFDKDNEE
WSQLKRKNINIDSLLLMPFTHLLNGIALAVVVGWFGYQSGFSLVEVGTLYAFINYLGRFF
EPFRQITMQMSSLQQSLVASERLFQVLNEETEDTQHGQSKNQTDSPEIHSGKLEFNNVTL
SYDSKNMALDNVSFTVEPGQFVAIVGHSGSGKSSVINLLMRFYQHQEGQILIDNQPLTSL
KEDTLRQGLGLVFQEPYIFSGTMAENISLNHDQITDEHVQAAARKVHADPFIQELDESYE
HKPGPGGKALSTGERQLLSFARTIAQNPKILLLDEATANIDGETEHHIKEALITLRENRT
TIAVAHRLSTIQDADQILVMDKGRIVQSGTHEELLLQEGHYRDLYLAQQTEEQLGTTQQP
GLTMAAANA
>fig|1121862.3.peg.2827 Permease of the drug/metabolite transporter (DMT) superfamily
MNTTIKADLVLLLVTLLAASGWLFSKFAIGGMPPIGYIGVRYIAAALLLLPFAARQLFQL
NKSQLFICVMVGLIQMAAMYLWIQAVDSSDRLGEGAFIMSLSMIMVPFMGRLLYGSRIDR
FTLFALPFAIAGIALLALKGSWEFEPAQGLYLMATLFIALHFVFTNRNAPGIPSMALTFI
LLLVPGVLGMAISVTTESWPEQIATDTWVWVAAAVLVATSLRYFLYTWALKHSEAGHAAL
IMVIEPVWTALMSAIWMGESMTSQKLLGCGLIFMALLVARWRSIFKPAIAESQLVRE
>fig|1121862.3.peg.2883 Acriflavin resistance protein
MSRLSDALINRGPIAWMARNSVTANLLMLFFIVGGLLTSFQIRKEVYPNYQLNSVKITVS
YSGATPDEMEMGIVLPIENAIRGIEGIKQVNSRALGGFANITAELVNNVNVDRVLGEIES
EVNRTNLPAGAEKPRVTRSAIQHESMELILYGDVDPVALRETTSLVRDTLLRSPYLTQVE
MHWASKYEVKVYVDKENLERYGLTLDSLSNSISRYAVTQSGGKLETAGGDILVEVDNRQE
WAKDFSSVPVVSTAQGGHIYLDEIATIEDGFADRKFSFFYNGKPSTSIKIYRVGDQTPIG
ISEAVHDMMPQLQALLPPGILLEIVNDDAILYEQRMALLLKNAFSGLVLVLVVLALFLDL
RLAFWVTMGIPTAFLGSLIFLPAMDVSINMISMFAFIIALGIVVDDAIIAGENVYDHMNQ
GMPFAQAAIIGVKDIAVPLTFSILTNIVAFIPIWFLPGTMGMMFQVIPLVVITVFAISWI
EALFILPAHLVHLKNDNPALIFRFATALQALFNRGLNRLIVHFYKPVMRVLLEFRYLVVA
LGIAMLMTSISYIAGGHMGFTTMPKVEAEFSVGRATLPVGTSLEDATAIRHRLERSAQKV
MDENGGKALVKGISSIQRNLDGEFIIIVRMFLQPSEVRTMSTKEVSRLWRESTGTIPGVE
GIRFSSAGSGPGSDVAGVTIEMRHHDNNMLEEASNELAMMLAGYAGVIDIENTFSSGSSK
LNLKLLPAGQSLGLNEKELAKQVRSAFNGVRSIRQQRGSEEVDIKVMLPDYQRASEFDLE
QLPVRVGNDYVPLGQVASITRDYSASVIQRREGRRRVIVSADITPSSEAMTLSQTLSEET
FPILKQSYPGLDIGFRGDQIEQKESMDSLFVNGIMVMLALYCLLAIPFRSYSQPFIIMAI
IPFGLIGSVLGHVALGYTMSVVSLLGVLALSGVVINDSLILVTEANERREKDMLGVHDAL
LEACHRRFRPIILTTLTTFGGLAPMILETSNQARFMIPMAISLGFGILFATFITLLLLPC
MYSVLEDIKGVFTNTAYEAEVPLKS
>fig|1121862.3.peg.3045 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLFHNHCILREFRALLKLSLPLMGTYLVMSLAGFIDTLMAGQYSSVDLAGVAIAYTAWIP
VNVFLVGLLMGKTAFISQLYGARKLRDIVAMGQQGLLLATGSGIVGLALLSVFSELLIYV
DASNAVREIASGYLTFVALGMPGVALNQALRSYLEGQGYVRSVMVAQVLGLLINIPLNYA
LIYGRFGLPEMGGLGCGIATAVIMWLSPLFMVAYICFNKALKSTSPFCYALDLDLEKLKA
LVAIGLPIAVTLFCQFLVFMVITVLLASHGHVVVGAHQIVFNVSTLLMMVPSAIGGAVTI
RAAYYIGAGHSSMGGFVSLVGLSISFMVMCVLGVGGWWARFSIVRLYTQDLAVIELAASL
MGLVVIYLLLTVIQQLGAAALRAYRDAFSVMWIMLVSLWGIMLPLGYFLANMDFLGAPLG
VKGFWLAMVVAYFLAAIGTCCRCCLVVK
>fig|1121862.3.peg.3434 Permease of the drug/metabolite transporter (DMT) superfamily
MYSVKTKALRADLLLLMVSAIWGFAFVAQIKGMEHLGPFLFNACRFALGFLSLLPVYFLL
EAFSAKKNGKKESGVESVKKYDNHLLLKWGPITGIVLFLASSFQQVGLLYTTAGNSGFIT
GFYIILVPILGICFGHSTRPVTWLGGAIALAGLYFLTVNDGLSLNKGDLLTLGSALMYAI
QILLIGWLSRHVHPLRLSLTQFFMTALCSLLVALYLEPISLDAITQSVGPLLFAGVLSTG
VAFTIQIIAQQDAASSHAAIIMSLEAVFAVFGGWLLLDEQLGSRGVVGCALMMAGMLLSQ
LRRPRGRSTA
>fig|1121862.3.peg.3582 Permease of the drug/metabolite transporter (DMT) superfamily
MDASLISGVQKEDNNTFLYASYVVLLGSCFPIMRYASIHFDTVNNNAIRFLAGGILFLIM
VIAKYRNEVSKLLAEPVMIVKLLLIGVLMTVNMYFFMNGMQLTTALTGSIFSILGMPVAT
IMASIFFADERKKAANPRFIIGCLLSIAGSFLFIFNADTTGHSENFVLGSAFWVLAITIA
AMQNLLVKNLAKDLHPVVISAATATIAGLIYLFIATATGKIQELSTTPDSLIIFLIMAGM
FGMLVGMLMAFYIIRKSGVITFNMLQIMAPLSTAIIAYITLGETISTIQAFGAAIVVVGC
THSLKANRVN
>fig|1121862.3.peg.3870 Acriflavin resistance protein
MDIARYTIAKRTSVWVIIALTLIGGYISYLKLGRFEDPEFVIRQAVINTPYYGATAQEVS
DEVTDLIEGAVQSLQELKEVKSVSKQGMSEVTVEIQLEFAKSSADLQQVWDKLRRKISDV
QRQLPPGAGPSIVNDDFSDVYALFFAVTGEGFTDKQLQDYVDTLRRELVLVPGVAKTATL
AEQQETIFVEISSERMAKFGLSAEQVLQVLQKQNLVTVAGSIETNSMRIPVIPDASVHSF
DDLKNLQVGVGENSTVLRLGDIADLKRGYQEPASMLMRYNGERAIGFGISNVTGGNVVDM
GDAVKARIAELESQRPLGMELHVISMQSDSVRASVANFIDNLIAAVAIVFVVLLLFMGVR
SGVIIGFVLLLTVAGTLCIMLVEDIAMQRISLGALIIALGMLVDNAIVVTDGILVRLQKN
PDEDRAALASEIVKSTQWPLLGGTVVGICAFSAIGLSPSDMGEYAGSLFWVILYSMLLSW
VFAVTVTPMLCHDFLKVKAIAADQKPGRMVTAYKALLMWVLKHRLISSALLMGTLAVAIW
GVQFVPPGFMPDSQRPQFVVDVYLPQGSDITRTEAIIADVEQDVKAKEGITNIASFIGGG
GLRFMLTYSPEARNPSYGQLLIDIDDYTRIAPLIGELQSELASKYPDASIKVWKFMLGRG
GGKKIEAGFKGPDSQVLRQLAEQAKAIMLSDSNLIAVQDDWRQQVPVLRPVYSAEEAQRF
GLTTPEINQAIAQTLTGRNVGVYREGDDLIPIVVRAPEGERNHQRAIENTEVFSPKANTF
IPVSQLVESVDVVYQDAILRRIDRVPTILVQADPAPGVLTADAFNLLRSKIEAIEMPPGY
ELTWYGEFKASKDANEGLVISAPYGFAAMILSVIFMFNALRQPLVIWLTTPLALVGVAAG
LVIFQTPFEFMAILGFLSLIGMMVKNAIVLVDQADVEIRDGKPPYHAIIDAALSRARPVL
LGALTTILGVAPLLIDPFFKSMAVTIMFGLLFATILTLVVIPLFYAVFFRVKIEEA
>fig|1121862.3.peg.3905 Quaternary ammonium compound-resistance protein SugE
MAWVYLLLAGMFEIGWPVGLKMAQSPDTRWLGIFTAIICIGLSGYTMWLAQKEIPMGTVY
AVWTGLGAAGAFFVGIIFYGEAASLMRYMGVLLIIAGVVTLKLAY
>fig|1121862.3.peg.4015 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRTNLSAFARYRAELRELLYLAGPIMGAQLATTGMTFVDTSMAGQYSAMDLAAIALGSSI
WMPVYLLIRGILMAITPTVAHLYGARQTGEIGGQVRQGLWVALLMSLLALVFIYKSDVVL
QWLQVEPEMAAKTLEYLKALAWGIPAICLFQALTCYCEGMGKTKPSMVFSFIALALNIPL
NYVLIYGKFGFPELGGVGCGYATAVCFWVMFLMMAGYTMLGQQHRKIGLFDHWDLPSLSI
ISSQLKLGVPIGLAIFFEASIFSVVALLIGKLGAIVVAGHQIALNFTSLAFMVPMSLAMG
LTIRVGQALGAGKTEQAAYSSYAGIATTLVSATVSASVMMFLPGVVTSIYTQNPEVAILA
AQLLVYAALFQYADGIQIAANGALRGYKDTRVPMAMILFACWGVALPLGYILGLTDWIVE
PMGPHGLWIGLVTALTMGAFLLTLRLRAIIRRNRMLASEIMPMPA
>fig|1121862.3.peg.4237 Acriflavin resistance protein
MKSLLPFFIARPKIVNLLVGCVFLAGFLLLDGLRYEYNPRVDMGTVNITTTRLGSGPEEI
ERSITMPIEEELLKVEGIEKIFSSSMDGMSVITARLDINYHDKTLLLSDIQKAVDRAYTR
LPQDLLDKPLIEEQSTQKTPVIEIHLVGNVSEEILRASARKVAEGLREVEGVSGEHRIGY
RRSEVKVFLSPEKLTQLGISIDEVRKAIVSRNVRDSGGSLSSFNAEKKVISVGQFQQPKD
IESVIIRAYEPGNVVRVSDVASVISGYGDWEVESRTDGRRSIILQVHKKPTSDELHTASN
VRNYIERMRAQMPAGIELIDVNDISRLTIQMLDVLVSNAALGLALVLVILYVTLSPRLAF
WVAMGLPFSIILTFLTIDALGISVNAINLVAIILMLGILVDDAVVVGESVQYQRELGLSG
PEAAIKGTQSVAKPVMFAVLTTILAFVPMLAMGGRDGAFMKDFPIAVLIVLTVSLFESQY
ILPTHLAHKSGSIEQKQSRFLSRWSSIYEKVISTLIRHSRKSTLAFIVVFIGVMAFGAST
INFQLYPAVDIDNVNVKIELPAGSRMTDTREVVSALETRARELIPASDLLNITSQIGHHD
TDFYGATEGRSESWALMIVQLKPLSQRTVKTHEMVELLRTELKKVSPVTHLVVEPQTDIP
VTDKPIQVEFISSEESRFPAAQKLLDYLEQHPAVTESWSSFKPGRDVVDLTFNYELLASR
GLTVREITDAVRVAMDGLIVDELQTLDERIYYRLQYPPSRESQLSTLENLSIINHRGEQI
FLNSLVEFNWRSGEADIKHYQGRRTTTVYAEMDTAVMSLEQLNQDVSDFIATQSWPQTHP
DLRVYQGGALVQQADSLGRMGDAFLICLLAIFIALVLLFNSYSQPALVLLCLPFGVMGVV
LGFGLQGIDMGYVALTGVLGLMGVLVNDSLVLLHTLNNQKTDRASLLSNSEIAAGAAMRF
RPIVITSLTTVAGLIPTAYGIAGTNSYITPMVMAMAWGVGFGMFVTLLLLPCLYTIDRDI
KAYFHRRSEAKKDLSWQNSEQV
>fig|1121862.3.peg.4262 Permease of the drug/metabolite transporter (DMT) superfamily
MQNILLFSLCSFVWGSTWYAITFQLGDVDPLWSISYRFLLAGLILMAVCFLQRAPVQFTV
RQHLRIFLQGICFCGISYWLVYLSELYINSAQSALVCTSMLYLNVIIGRFWLGNPVRLPV
VIGGVLGSLGIVMVFLPELASSLTTDLMKGIVMAFVGCIFFSIGSLICEINKKSGLPLLP
VVMTAMMYSSIFTAVFALSLGKLPSFQWSKPYVFSLLYLALFGSILAMTSYVALIGRIGA
DRTAYVDIIYPIIALFIATMFEGYQWTTLSLLGVLVVLAGNYIALGVNFDKAHIAK
>fig|1121862.3.peg.4881 Bicyclomycin resistance protein
MGAIAIIPMLPITLYIPILPHIASQFGYDTEIFQLTLPLFIISQVVAMPITAMLSDTGYR
LQALYWALMVFIIGTVLCIGWPSLWLFCTGRVLQAFSAATLMTVIPALINECYDTNSVAR
ILSYVTAIGFVIPIVGPELSTLASQHWSWYSVFVFMLAYSMTTFLICRRSIGKATPPANR
LTIEPLKKGLYHWKIMVQDKETQAFLVCHTGIAVVGQIYISNSAFLFLDYYQLTEISYSY
LISVLYVSRTAITLINGLLLKHIPYSKLIDLSLPVLMILALCMLLLDWFYGASLIPSLIL
VVAFFALSGLVVTNALTGVLKNHESWSMQASALLFIVFSGTASMLNIALIALHDGTPRVL
SMVSMLILILTYLLYQRIKSGS
>fig|1121862.3.peg.4984 Permease of the drug/metabolite transporter (DMT) superfamily
MLRNYLFLFGIGVIWGSQFIFQQMAVADISPVWVGAGRSLIGFLTLVIICQVMRIKSNGG
QWFKFSLIGLLEATIPFILVAWGQQYLDTAIAAILMGTIPFFTVILAPLVIKGARITFAG
IGSVLLGFSGLVMLFYPELMSGSSTTNLMAAGAIIVASACFSVALLLLKGVENEHPLIIA
RNVLGSASVQIILFAMLVAPVTEITPTASSLMAVTYLGTLCAGLVYFLYMMLIRDAGPVF
ASLNNYLVPMIGVLLGATINGEALSVHSWAALATIMMAVAFNQIFTGKSSKGSESSEPEE
ASAEGLLPAK
>fig|1121862.3.peg.4993 Glyoxalase/bleomycin resistance protein/dioxygenase
MIAENLFGPVRQWGFLVKDLDHAMSQWHDVMGVGPWWGYRNVPLETEVNGKAYEVRMDVG
LAFQNGVQIELIQQTNNVPSPYSDFFLHSDEKQVFHQIAFFAPDIELALEKARNAGLVEV
GLCKTPLQRFYYLNAPWLGNTVIELMEVNDSFVSGYEFCAREAASWDGSNPYRLISL
>fig|1121876.3.peg.163 Permease of the drug/metabolite transporter (DMT) superfamily
MNYLLLLLIGAIWGAQFVLIDASLIAFSPEQLALFRTFYAVVFLVLFCLILNIRRSNARS
LTDWVKVASIGVLEVVIPFTLVMWAQQFLTGSMASILMGTIPFFTLLLVMLTKVERASVS
KFVAMIVGFIGLLVLLAPDLLSSGLSGSVVPKLAILLGSLSFAGALIVIKSMPKENAFIL
SRDAFAFGTVIMFVINLAQGNLSDLHFPLIPVTTSVVLGVFCSGLVYVLYVYLIKRAGAG
FCSLSNYLVPLFGSVLGVLIMNDHITLRMVVACLLILLSIAVEPFLSYLKYIVKSRQGAK
SA
>fig|1121876.3.peg.368 Permease of the drug/metabolite transporter (DMT) superfamily
MSNGTKALLALMLTIIFWSSAFVGIRFIMENFSSGGLALSRYFVASIAMAIPFVFIRNKK
MPSVKEALQFLIMGCLGFFIYNVLLNEGEITVSAGIANFIVSQLPLFVIIFASIFYRERI
NRYGAFGIIISILGTLLILLSEHQGGSFVGVVFIYVATLSAAIYSTMQKKLLVKFHPIEV
ISYCIWAGTLMLLIFLPVTWKNLSHATSLDYMVIIYMGVFPGAIAYALWAYAFKHIKASI
ASSTLYVMPISSLFLAWLFLGEHAEMLTVMGGIIAVLGAVILSKFGVKK
>fig|1121876.3.peg.502 Multidrug resistance protein D
MEKTKTGESMQSNKSLVFYPMILMIAYWVITKAGLPFVDEMSQFFAVSHQRIQQILSLSL
IISSLSPLLWGPLIDYISLKRFAIIASVLSFVITILMLITTSVTIFTITYIIATSIIFSL
SVCSRSFPFIYFDQLEQKQKAIGITFMGVYFCSFMIPLFSGWIGFYLGWEFGYSLVLLWL
FIVFIAMYRLKSNTEPVAIEKVGFLKNAMMIFMHMRTKGFLRYALFVAILNGLAWTYIIA
LPFWLASIFTIGSKYLALYLFPLALPGLLCPIIVSFLERFMSKEAIMKLSVIIFLIAGVL
AIFLGVKLWDSAVIYIIPGVLLNLASAMAFAIASTKVFTHVKTAFNAASGLFSLIQYFAF
GVIVFVESYISIHHYYLEGVLVCIGGVFLLILQRGRAN
>fig|1121876.3.peg.549 Multidrug resistance transporter, Bcr/CflA family
MSKLTILMVLSVCIITPFANDIFIASFPSMQLAFHSDKITLIMTSFMLGLAISQLFYGPL
LDRFGRKVVLLGGLVIYCIASTFILFSGNILMLLILRFFQGVGVCSTIVSAMAIARDVYK
KEELVKAMATIMAIIGVCPVLAPLFGSFLQSSFGWRASFVLLLVLGIVYFFVVLFLYKES
IKEKNMHALKLSMLYKNYISLLQKKAFTGYILVSACSYGVLFSYAAASSILIIKHLHYSV
MSYGVLFALNASAIVLMSILTPRLSARYGISRMVIIGCIFILLGALFAILMGVLIGENIY
TLMLPMWIATIGIGMIRPSASAGAIALAEHKITGSAAALFNFSSFVGGSIATYLIANFTL
TVVNYGIFAFIIACIAICLSLYVYHAEFVHNFRCDGIKEA
>fig|1121876.3.peg.572 Permease of the drug/metabolite transporter (DMT) superfamily
MTIVIWSLLLFGVFLNACAQLFLKFGVDRIGEFSFTLQNLIPIGWKLATNYFVILGLLCY
VISVVVWLMVLSRIPVGIAYPMVSIGYIITAIAGYFLLGESLTVTRVIGILVIIIGVYLV
ARV
>fig|1121876.3.peg.640 Drug resistance transporter, Bcr/CflA family
MSVNRYFIAFFVNFTIPLGGMSTDIYLPSLPAMAKYFNTSSTEVQLTVTLFALGLAIGQV
LTGPISDALGRKKIYLLGIILQLASVLYILLSTTVLSLIIVRFIQGFGAALMMVPARAML
NDVFEGAALKKQYTYITAAFALGPIIAPFIGGYLQHYFNWHASFIFVLIYLVVLFIICLL
FVPETINSKKNFSLSHLTHSYHTVLTNKKFVTGALLLSFFFGYVATFNVAGPFIIQNLMG
KNAIFYGYIALLMGVAWFAGNMISRLFFRFKLKHKSYALLGLILLMSVIMFVINLSSLSV
PRFITPVFIITMSAGFLFPIYVGECLSLFRQEAASANGLLFAIIWVSFSLFSFIAANLKV
HSLMPLLSCYVIVSLILLLVYIMIVARHHS
>fig|1121876.3.peg.969 Permease of the drug/metabolite transporter (DMT) superfamily
MTQKPKQPKALYAISLLILLGALWGSGYTIARYCMTHGVHPLGYGFWQSLGPMIFLLLVI
IFARIPFSLKPNYIRYYIACGVLGIAIPNTVMYFAAAHIPSGILTVLINTVPILIFPLSI
LFALEHFSLKRFFVVLLGFLGILLTILSNLTLPTLHNIPWSIIALIAPLSFALCAVWIAA
FRPMPSNSLSLSLGMLIISSLCLVPLTLIMGAFHPISFPLQINDWLIILEIILSSLGYIV
LFVLIKLAGPIYYSLVGGMASVFGLLWGKLFYGESLNSSSWLGVFCIIGAIILLTLLLKK
EKEVAEN
>fig|1121876.3.peg.1223 Membrane fusion component of tripartite multidrug resistance system
MTSENETQGEQEVKKSKGWIKYATVLAVVVLCIIGFYIYVKYTEIYPSTEDAYVNANTVY
ISAQVTGKVDKIYVEDNQAVKKGQLLLTIEPQSFEYALQEAKANLALAEQQIQAIEDSIR
LEEAKLKEAEAQEFVARQKQKRISKLVAQNMSSKESGDEALGDYNVAVASVNAAKASISQ
QKRQLVLQASKIEAEKSQVETAKLNLSYTKIYAPTSGYITNFSLRPGSMINQNQSLFVLV
SNTGFWVDANYKETQMERMKAGQSAEVVLDMYPNVTLHGVVESISSGSGSVFSLLPPENA
SGNWVKVTQRFPVKVIIDPKEIKKVPQFRVGASASVTIDTRSK
>fig|1121876.3.peg.1336 Drug resistance transporter, Bcr/CflA family
MLEMQASKSAKAIFVTMILITSMLGIFVSDIYVPSLPSIGDEFGTNASILAFSVTFYFIV
FAFAQLIYGPLSERFGRRKIFLSGLAISIFGTCITLFSINFTMLIIGRTFEAIGMAAPMS
LGRVILRDVIPDKTSYARFMSFMGIGTLLAPVLAPIVGAFLAHVFHWRADFIFILLLSVS
CYVLCYYFLIETLLSPSKRLSAKLSIQTYIWVIKNKVFIKNTTISSCVMASIIAYLSLSA
FLFQQHFGLSEINYAIVFAIGEAFIMIGMFANGMALKYISIENSQRIGVILFLFSSILMI
IQAFIFPDNLVFIMIAVMIFNFSAGVIFPTSSALAIVTFKTRLGAVGSLYGCLSMLVAGL
VGGAAMLVPLSAIHLIAILFLITAIISFVFLFGVKND
>fig|1121876.3.peg.1407 Multidrug resistance protein D
MKTRYLGLIILFIFPIGQMSIDIYAPSLPAISHDFLASSTDVKLTVSLFVVTYAIAQLFY
GPLSDQFGRKKPLITAMLIYIIGTLLATFAAKLYVLYIARFLQGIGVAGIMVIVRAMISE
SFKGNMLKKISSYIALLFSGSAIISPWIGGLLQYISGWRSVFILLLIYGLISFILMLSLP
ETHHKRAQFNLLQFIQNSKEIVTHCTFLSAICFQSVVLSFFFVFALQGTFVIQKGLGMSA
SAFGELALIIGFGVLIGSLINKTYSTRIATLQLIKICFSLMLLTSIIFVIFSCLFPQSLY
LMVIASFIWALIATTAGPSFFSLFLSTFSMNAGLSNALSGFATYTLVGIITFIMSHFQQT
NLLPICIYTLFASIIAWGSYFAIKRPLREFS
>fig|1121876.3.peg.1540 Bcr/CflA family drug resistance transporter
MSNKLKAIATPSLFILVLMISVGPFGDTIYAPSLPSIAKAFNTAYHNVQLTITFYLFGYA
VSQILYGPFSDRYGRKPIMVIGAVAFLLGSIICLISTDITILIAGRFIQGFGACAGAVIS
SAAVRDAFSHKEQGKVFAKMNTAFAIAPGVGAIVGTFITWQMNFSILFALAIILLIAVII
LFPETLKKKNKGATRPRKLISNYFSLFRTQGYFVYLCILGLSIGMVYSCLVEAPALVIDT
LHLSKPWFIVIAAGIVLAFMVGSLICTMLCHRLKQNSILLVGMVISLIGSLLLLIFMSLE
IVNLISLLIPVVIVFTGIAFVIPIATAQALAPFEMTAGSASAMMGFFQMGMASAITAIVT
ALPLRDTMTLPVSFSLLSLVSIIILASYVIKHKRKSPAI
>fig|1121876.3.peg.1885 Multidrug resistance protein B
MSEKHHTISTAAKWLITITVMLSAMIEIIDTTIVNVALKDMAGSLGASTDEISWVVTSYI
VSAAICMPLTGFFVRIFGRKRLLLINIVGFLIFSMLCGLSTSLDQMVFFRIMQGIFGASL
VPLSQYVLRDTFPPKEQVKAMAVWGIGIMAAPVLGPTLGGYITDWMNWRWIFYINIPVCL
LAILMTLLFITETKREKVKIDWIGLALLVITISTLQIFLDRGNTDGWLSSHFILGLLLTW
IIAGIIFIVRGWITPRNILNLHLFQDRNYAASCILLVLYTAGIFGMMTVQPLIMQGYMNY
SASLSGELMAPRGIAAAIAMVFVTPLAKKIDLRLIILLGILITAYGNYLYAGVPLMSDPW
NLTYPGIVQGIGMGFFFVPVSTMALQTLAPAALAEGSGMFSFFRNLGTSVGTSVMVTVLT
QQAQVAWHSMIQKINTMNPDYHMWLQHMSWSAEDPHTLAEVVKLILPQANIIAFDDVSYL
SYLLLLVAIPFIFMLKKPKNTAVSMEH
>fig|1121876.3.peg.2120 Multidrug resistance protein D
MAQFDRNFYRILFLIIILTAAGQMTNTIYVPALSQMAEEFSVNAGRMQAVIACYLFPYGL
FQFAYGPLSDYFGRKPLILIGIALFTLGSLIALFATHFATLLLASFIQGSGIAVAGVMAR
TVMRDLYSGRALHSANSLMAIALILAPLLAPILGGFFTDLYSWRVIFLFLSAYGIALLII
QMLFFQETNLYKGIKGSFLQKYKIVLSNPNFMLNLILLIVANGGIAIFEVSSGAIFTSIL
QLSPATASFLFIIPLPFYMIGSFVAGKLARFYTLDRLLIIGCLVLITSGIFMVGFYYLIG
VELLAIILPGSIYFFGCGIIFPTATTKALEAFPNIAGTAGAVLGGTQNLGAGILTALSAL
IPLHSQLPLAVILSALAISALVAIRMLPANPQDNS
>fig|1121876.3.peg.2177 Membrane fusion component of tripartite multidrug resistance system
MPALWNLIKKSKVVITIIIILIIGYLIYFYVYFAKITDNAYVVANTRSVAAEVPGIIDQV
NVRNGEFVKKGALLFSLRSNLYQYRYEEAQAALNAAKAQLSETKQKIAILINDVNTSEKS
LALAKERYEGDKTLYEQNLSAKLVYHESRNQYYKAQNALDNAKEQLTAANIAKARSEFQL
DEASAAVKVAKHNLHATKVYAASNGVVNNLFLSPGSPVKAYEPLFAFVDTSTWWVQANFK
ETNLSGVHVGQKATIRLRMYLGEKVYHGVVVSTNWAVGRNETNPNNNLQSVPSENQWLLL
PQRFPVLIRINNIDPHYPLHMGASAYVSLD
>fig|1122132.3.peg.255 Permease of the drug/metabolite transporter (DMT) superfamily
MSLLSRAFSWLFNRPYLLLSLTFLFWAINIVLGRYVAGSIPPVALSQIRWLGASLIILPI
AWPHLKRDWPTIRSHLGLMVLLAAAGIGAYNTLAYYGLQYTEALNGLLMQSIAPLVIGVW
SLILFRDRMTSAQITGVGLSLCGVVLIICRGDPTVLLHLTLNVGDIIMLVAISCSGFYSA
LLKKAPRIHYWSMLGFIIPVGALTILPFFALEMASGKIIQATPLTFAVLAYVIVIPSVVA
YLFFNRGVALIGPNRAGPFFHLLPVFGSAIAIVFLGEQPRWYHGAGYALIIGGITIAQLS
LARIRAFGR
>fig|1122132.3.peg.325 Permease of the drug/metabolite transporter (DMT) superfamily
MAMGISPIFVRLTDVGPFASAFWRVGGALPVLLAWALYEARRAGISPGSVFRLDGPILAS
GLLFAGDLIFWHLAILRTSVANATFLATMAPVWVVLGSGFFIGEKVGRDVLAGLALCLIG
ATFLIGMSWQVRPDHLDGDLFGIVTSFFFGGYFLAVRAARRTSSAGKITFLSTLVTSLAL
LLMALATEPRILPASLDSAASLAGLAFISQAGGQGLLAFALGHLPAAFSALVIFLEAIAA
ALAGWLFLGEAVSAGQAIGGALILVGIFIARPQRPR
>fig|1122132.3.peg.435 Permeases of the drug/metabolite transporter (DMT) superfamily
MPTADAEASQRLRGIALYCLAMLCFAVLDASAKFAAQYVPVLSIVWVRFAIHALLAVALF
QPWRHWAVYRTRRPVLQILRALFLTGSTFFNFLAVHQLQLDQTMSIGFSAPFITAALAGP
ILGEWAGPRRWAAIIVGFIGVLIITMPGFGNLNPAIFLSLIAACCNACYILSTRMLTRSD
SSAGMLLYSAVVPLILLTPVAQPLEAMPPTILVALCLFLTGALGFVGHWFLIRAHHHTAV
PVLAPFMYTGLIWMILLGYFVFGDVPEPRTLVGASIIIASGLYLLYRERVRAPGGD
>fig|1122132.3.peg.888 Phosphotransferase (aminonucleoside antibiotic resistance)
MSKPRLVIITGAMAAGKSTVAQAVAEALPKSVHLRGDVFRKMIVGGAAVMGPVLDEEALA
QLKLRHDLACDVARRYHAAGFSVVYQDILIGRYLTDVAARLADLDPQIVVLAPDAATLAR
RDRDRGKTGYSASFPPEILADALVRETPRTGLWIDSSQMSVTDVVARILAG
>fig|1122132.3.peg.1080 Acriflavin resistance protein
MSGINLSAWSLNHRSFVVYWMIAVMVAGIASFIGLGRNEDPPITIKTMIVHAVWPGATIE
DTLNQVTERLERKIQEIPEVDDVRSSTSAGSTTLFVNLRQDVTSAEVPDVWYEVRKGIGD
IRQTLPSGVLGPFFNDSFGDTFGIIYGFTADGFTHRDLRDYVEAARSRLLQVPDVSQIEI
IGAQDERIYVEFSTKQLAGMGIDRTALLNALRAQNVVSPAGVLETGEERISLRVSGAFET
EQDLLDINFVANGQLVRLRDIAQIHRGYASPPQPQFRVDGKPAIGLGIAMRDGGDILALG
ENIRKAMAEITADLPLGIQPTLVADQAVVVDEAIGDFTTSLWQAIAIIAVVSFVSLGIRA
GTVVALAIPISLAMVFAVMNIVGIDLQRISLGALIIALSLLVDDAMTTVDSMTSRLAAGE
SKEDAAANTFKTLALAMLTGTLVTAAGFVPIGFAQSSAGEYTFSIFAVVGIALVVSWLGA
VIFSPLIGAVLLKSPKQKPDPNKVSIVVRVFRAILLTAMRMRWITIALTLAAFVGALLLL
PHVPRQFFPASDRTELMVDLRLPQNASIYQSGDVSARFDAIMRDDPDVERWSTYIGRGAI
RFYLPLNVELPNEFFAQAVVIAKDVDARLRLEKRLETVLAEQFPDSVSRVAPLELGPPVG
WPVQYRVSGPDVDQVRDISLRLAQIVSANPDTKRVNFDWMEPARMVRVKIDQDQARLLGL
SSQALAAALNAVVTGTTVTQVRDDIYLVDVIARATDEQRVSLANLQTLQVPLPNGRTVPL
SQFATFEHGQEYPLIWRRDRVPTLTVQSDVRAGGSPEAVVAELTDEVEALRATLPRGYDI
AVGGVVEESAQSLQSVMAVVPIMLFLMVSFLMAQLQSFGRLFLVLCVVPMGLIGVVGALF
LFNRPLGFVAILGILSLLGLIAKNAVILIEQIEAERKRGLPIWDAVVEATVSRFRPIMLT
AISTVLGMIPIAATIFWGPMAFAIMGGLLVATILTLVFLPTLYVTFYRGREGEAAPAAAT
PAPVASAAT
>fig|1122132.3.peg.1396 Permease of the drug/metabolite transporter (DMT) superfamily
MSRESGSATAIGAAAIGLWACLAALTGASRTVPTFEALAITFAIAAVAALVGFTAMRGWA
GVRHGLTLWPRKAWILTTVAIFAYHALYFAALRLAPPAQASLINYLWPLLIVLFSGLIPG
GTTKLGGPQILGAIMGFAATLLLVGGPGPVEASGTAMAGYLAALVCAFTWSLYSVLNNRI
NAPGSEPMIVVCALVAVLAALCHLAIGETFVMPDFGASLSLLALGIGPIGAAFVAWDHAT
KHGKLALLGAMSYAAPPLSTLILVLSGQAEPSLTLLAATLLVVAGAGLAAFGSRLKRPVV
SPLPEGEVDARSAAGQGLGKPPERS
>fig|1122132.3.peg.1451 Permeases of the drug/metabolite transporter (DMT) superfamily
MVLGIFLYSANDTLGKWLTATYSVGMIMLVRSIAAMCVLTPFIHKQGGLAKLRQAPRPGL
QLLRVFVTVGEIGFFYWSVSLLPLADVMTYYLAGPIYVTALSAVLLKEKVDGPRWLAILA
GFIGVVIVLQPSSESLSWGALIAIGGSLFFAALMIVTRQLRGTPDSTLLTFSTMATLVTG
AVIAPFTWVTPTPIDFGALALIGVVALLAQLCVTRSLRLAPASVVVPYQYTMLIWAVVFG
YFVFGDEPKISMLIGAAIIIAAGFYIFWREQRTGKPKPGDTIAEEVGDNVPG
>fig|1122132.3.peg.1466 Permease of the drug/metabolite transporter (DMT) superfamily
MKPSELFAYLFLAVTWGFSFLILLKVVHAFGWVGAVAFRAFIASGVLLVVAWATGRRLRF
AAGWRPFAVVGATTVAGQLIGLSFATPRIGTAMAAICVASIPLFSMVIGRVWGNERMSGR
SVAGLVLGFAGIVLLVGFPAVPVTPGFVLGCAAALASAFCAAFGSNYANRHLRYTGALEV
TIGSFFAGGLLALPLLPAVPVPGVPGPVDYAYLLLLGGVMSAVTYVTYFWLLGRIGATRT
ISVEFVVTVFAVLIGAGLLGETLTLVQLVGAAVIIAGCALVLGIVPSRPLREKAR
>fig|1122132.3.peg.1678 Multidrug resistance protein B
MAGPQLPPALPEMTPRRTLGFVAMAVGMFMAILDIQIVSSSLTEIQAGLSASAQEISWVQ
TAYLIAEIIMIPLSGFLGRALSTRYLFAIAAGGFTITSIGCATSSSIGEMIVWRAAQGFI
GGGMIPAVFAAAFTIFPPNRRAMVSAIVGLIATLAPTVGPTIGGYLTSIFSWHWLFLINV
IPGVFVTIGVLACVDWDKPNLKLLQHFDYIGLITLALFLGSLEYVLEEGSANDWFQDETI
AALAVVAVVAGILFFWRVLRAHEPIVDVRAFQNRNFATGALFSFMLGVGLYGLVYLYPVY
LARVRGYDSLQIGETMFVTGLFMMITAPIVGRLGQKMDPRYMMAFGLSLFALSCLELVPI
TKDWAFSELFIPQAMRGVALMTSMMPVSMLALGTLPPERMKNASGLFNLTRNLGGAVGLA
VITTVLNNRWDLHITRLHEQVQWGREAATERLDMMTKGFAATLGSDANVAALKTLTLAVK
REALVMAFSDVFLVLAVMFGLIVLLVPLASKPQAAPAGGGGGH
>fig|1122132.3.peg.2579 Multidrug resistance efflux pump
MQIKQIFKSGITLTAFAIGVLGVLMVLYAWQLPPFRSSVETTNNAYVKGQVTLLSPQIPG
YVVAVPVQDYMTVKKGDLLVQIDDRMYQQQLAQAQATLQQQQAELSNFAENRLAKQASLD
LAKAQLQSAEAGQEKAELDDKRTGTLVDRGFSTQSSGDQTRVALLQAKSTVAQAEAAVKI
AEQNLALTDAGKASLEAAVASAEATVKLAEINLGNTRIVAPVDGRLGEVAAHVGQYAAAG
TQLTSITPSTVWVIANFKETQLAHIDVGLPATFTVDGLGDIELSGRVMRIAPAAGSEFSV
LKADNATGNFTKVAQRIPLRIEIDPGQSTIADLRPGMSVVVRIDTADKPLPAVATLQ
>fig|1122132.3.peg.2671 Glyoxalase/bleomycin resistance protein/dioxygenase
MLDLRVHHVSIVVTDLERSVAFYQKAFGLERLARPPFKTDGAWLACHGIQIHLILYPEGT
FRTGPIDNSDYHFSFHTRDFYGILDHLLEQGFREDVGEDDPMRLFVIREGLAGFPQLYLL
DPDRNIVEINGAP
>fig|1122132.3.peg.2858 Methylenomycin A resistance protein
MTFAAPQKSTWIALLVAVAFFMENLDGTVIAASLPQMAASFGVEAVDLNIGMSVYMLTLA
IFIPASGWMADRFGARTVFAWAVFVFTIASVFCALSDSVLTFVLARILQGAGGAMMVPVG
RLVVLRNASKSELMRAIAVLTWPALSAPILGPPLGGFITTYASWHWIFILNVPIGIVTLA
LSFWLIPNERVAERQSFDWLGFILTSIACAGLMYGLDLVGQSHVDWVVGAGILAASALFF
WVALRNSSRHPHPLPDLYGLAIQTFAVTMKGGSLFRTAVSAVPFLLPLMFQLGFGLDPFQ
AGLYVLALFAGNLAMKPFTSLVLRTFGFRTTLIGNGLFFVATLFGCAMLTPATPWPILMI
VLFLSGAARSMQFTAIGTMAFVDVPQDRMSGANTLFSLVQQITFGLGIALGAIALRLADA
WLTPDIEGLTLADFHVAFLIVGVVGLFGLYDSFALPRDAGTAVSRHRLRERAVATPRP
>fig|1122132.3.peg.3099 Multiple resistance and pH regulation protein F precursor
MIAAALFAVLVAMALVVVRALRGPTTFDRLLAANSIGNGAILVLALFGFLTGRPEFLDLG
LTYALLNYVGIFAVLKFFRHGSLGAEAEVER
>fig|1122132.3.peg.3122 Permease of the drug/metabolite transporter (DMT) superfamily
MSRPDWALLLILSTLWGGSFFFIAIAGRELPPLTIVALRVGIAALILLGLVAIGGKSLPK
SWRVWRVLLGMGVINSVLPFSLIAWGQTQVPSGLAAVFNATTPFWTALAVQFLTADEKLS
AGKIAGIVLGVAGVGVLIGPGAFLDFGAHGWGALAILLGALSNGFAGALGRNIARLRVEP
IVAATGQMVMATILMIPLALLVDQPWQLAMPGWQAWASILAIAALSTVLAFLIFYRLLAR
AGATNTSLVTFLVPVSAILLGTLVLGERLELQHIAGMALIAAGLVAIDGRAWRWVRARRA
AEAG
>fig|1122132.3.peg.3206 Glyoxalase/bleomycin resistance protein/dioxygenase
MLAEDVAKLATFYRDALGLRVDVTEQNYVAFGGEGIRLAIFSRIGMSPNTHDHPDYRTPF
TGQAFELNFECASTDDVNERFSHIVANGGRSIAAPTKKHWGHYAGFFADPEGNIHSLFAV
LAE
>fig|1122132.3.peg.3566 Multiple antibiotic resistance protein MarC
MDFAFAIKIFSALFAIMNPIANLPIFLSLTTGMTEGEQRRTAILVTVTVAIGSLISAMAG
TAILGFFGLDVNHFRLAGGLIVLLIALNMLNGESSPSHAGSAEEQKSFKSASNVAFYPMS
IPILLGPGTISALVVYAHEAKAGGDVVAFSAGLIAFLALLGTVLISGPFIGRVVSPTIMT
VTKRLMGMILAAIAMEMLVGSLTALFPGWAS
>fig|1122132.3.peg.4149 Permease of the drug/metabolite transporter (DMT) superfamily
MAEVASRTGRATDVVGLAAIATTIIGWASAFAAIRVGLTALTPVELAAARYLTAAVPAGL
YLAIVRPPLPSRRDFVRLVVIGVLFISAYAVLLNTGEQTIAAGPASFIIQVNPILVALIA
MPMLGERFGLYGWLGTLVSFLGVGLIAYGSGDGLGLNVGALLILGAAFCTSISTILQKPL
LGRMPPLVVTAWVLLLGSLPLTPAIPETIAALRIAPATVLWSIVYLAILPTIIGYLTWAI
ALKRFPASMASNFLYCIAPTATLIGYLWLGEIPALLSLLGGALAIGGVLIVNLTRRR
>fig|1122132.3.peg.4259 Permease of the drug/metabolite transporter (DMT) superfamily
MMAAMTDRTMTTTTLRGSSAGDLVLIALFCLIWSSAFAAAKFALPYCPPLLLLSSRFIVA
GGLLLGLAVTAGRFRRPDGATLAKLILLGGLNSALYLGLSFSGMQTVSSAFTAVLISSNP
LLTALLAAPLLGEKMTPQKLGGLLLGMAGVAIVLRSRLAAGTEDWHGTLLVLAGLLSLVA
GTVLFKKLKPEGDLWTGTAIQSLGAGLMLAPVALATESLGDVSLTPSLVGGWLYLVIPVS
IGAYLLWFRLLQKKTATEATALHFLMPPLGLLFGWLVFREPVSLLDLLGIVPIAIGIAMV
TRG
>fig|1122132.3.peg.4307 Membrane fusion component of tripartite multidrug resistance system
MATPGKLGKALGAVVGLGIVAGAAVLGWTYLRHSELNPMSEDAVIQADLVNISSTVPGRI
IQIAVKDNDRVKRGDLLFAIDPVPYRLAVEQTKADLQIAEAALSTQQRTIRAETSNAAIA
SEQISRARVNLDLATQTLERLTALRPKGYVTAQQVDDAATAKRDATISLNQALAQREAAD
ALVSTLDGAEALVSARRAALALAERNLADTEVRSPHDGLVAGLTVATGQFVITGQSVFTL
IDTENWFVTAAFRETELSQIEVGACATGYVMANRSIPLRGRVTGIGWGVSSEEILMIPRN
LPYVPKTLNWVRIAQRFPVRILLDNPPPDLMRVGASALATIHSAERC
>fig|1122135.3.peg.42 Permease of the drug/metabolite transporter (DMT) superfamily
MPQQTNGSSGLLATLAPGSFVILWSSGFVFAKMALPYAETMTLLATRFLIAVALMLIISL
IWKARWPKSMTQALHIAIAGILLHATYLGGVFAAIERGLEAGVAALIVGIQPLLVAFVAG
LFLKEKVTLKQWAGLVLGVSGVVLVVWSKLEDGLGTELGVAIAVIALIGISIGTVYQKRF
CGEMDLRTGAVIQYTAAAVPTGVLAYFTETMVINWTGEMIFAMAWLVIVLSVGAISLLYL
LIRKGAASKVSSLFFLVPPTASLMAWILYDEVFQSTALIGMVMTVLGVALVNLKPIKRFG
LRSRPG
>fig|1122135.3.peg.181 Multidrug resistance protein B
MSDSSQSAGTNSQAQAEQKMTPQNILHLVIVCCGITLYALNNLITSTLLPSAVSDLQGIN
FINWSALVYSTAAIIFSLTGGSLKTSLGGRKTMIIAGLVFTFGALLVSQSSDMIFFLFAR
AIQGAGGGLILATCYTVIGDLFARHHWPKVFAWESAVWAVASLTGPLAGGFFAQTVGWRL
AFYLIAGSALLFVVAVRLCFPPKARLEQETITTSRKEKLAALPILRLIILVMAISSIAIA
GLEPDWSLPLLGVAFLLLLLLLQRDKLAKSPLLPREGINFTTPAGTGLLVIFLASVSTYS
FVVYGPYLLQTVHGLTPLNAGYLVAWESMSWSIAAMICARISQTVRWRPLLIPIGIGTSA
IGLYGISLFLFSGPLWLLTVAIFFAGAGFGIFWADLSSRIIESGPSEERDRRSGAIPTVL
MCGGAFGPALAGIPAQMAGFSDTATLAVLEATAYWVHIAFVPLVLLSLFLSFRVIRPRAT
SVSEQGSLRGTDSFVAAKPVLPTPPDS
>fig|1122135.3.peg.869 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MKSYSMKILILVLFTLVMSLGQLLFKKASMEINWSGGLLELFNPWLIVAITLYAGATLVW
VWILRTVPLNFAYPFTALAFVIVPVAASYIFKESLGWPNVVGTVLIMAGIAVISLKEI
>fig|1122135.3.peg.1403 Permease of the drug/metabolite transporter (DMT) superfamily
MERTARISSQDRFDPLLEFVLLGLLALLWGGSYLLIQISLETIPPLTLIALRVSIAAVLL
GVVMKGRGEALPKDKTTWGMLFVQALFNSIGAWTVLAWGQQYVESGLASVLNSTSPVFVF
FFMLFFVRGETPPLFKLLGACLGIIGVLLIVGPEVLQGLGRDALAQLAVLLGAVLYAGAA
VYGKRLSHLSPTVAATGTMIWAVFCLVPASLLFEKPWQVEMSERSILAALALAIFSTGLA
LLIYFRLLRTLGSLGVASQSYLRAGVGVALGTFVLGEQFDLFVATGVLIALSGVVLINIK
NKKKVFIK
>fig|1122135.3.peg.1417 Fosfomycin resistance protein FosX
MIEGISHMTFIVQDLDRMEAILCQILGAEKVYDSGDTSFSLSRERFFLVAGQWIAIMEGE
PLPARSYNHIAFKIPETAYDDCLLRIRDLGLELREGRSRVEGEGRSIYFYDHDNHMFELH
TGTLDQRLKRYAQG
>fig|1122135.3.peg.1483 Permease of the drug/metabolite transporter (DMT) superfamily
MNDAKKPLWLVLAPVIFTLLWAGGYGVAKVGLQYAEPMTLLSLRFSTVVILLVPFYLYLR
PALPKRRADWLHLVVVGVLVQAVYFGFCWWAFRTGVSAGVLAIFMSLQPILVAILAPTLA
RENVSWKRWFGLLLGLAGVLIVIIARSDIEPPTVIGVGFSIMGLLGITSGVLYEKRFGGT
AHPIVANIVQYAAGFSVVFPIAFFFETMQVQWNGEFIAALGYLAIGNSILAISLLLAMIR
AGEVSRVSSLMFLVPPLAALFGWLLLGEEMPPVAWIGMAVAAVGVAIAAHKRRKSDHAPM
VKQDRMKEV
>fig|1122135.3.peg.1581 Permease of the drug/metabolite transporter (DMT) superfamily
MTSLLYLGTVLIWGTTWLAIAFQIGDVAVEVSAFYRFTLAALAQIVLMSALGKLTWVPFR
QHRWFILQGLLLFCVNFLFFYNATVYTTSGLIAVVFSMATIFNMINGLLFHRQIPALRSL
IGAALGIAGVCALFWDDLGSGDWTGDNITGDNIKGLLLALCGTYCFSLGNMVSQHQQKQG
RNVLTANSYALVYGSVTLGIWCLLQGYSFELEITARYLGALLYLAVPGTVIGFALYLNLV
GRVGAEKAAYCTVLFPIVALSLSTIYEGYVWTPFALLGVALALVGNVIIFTKRKPVPVLS
ASTS
>fig|1122135.3.peg.1745 Permease of the drug/metabolite transporter (DMT) superfamily
MSPQKPGLRQYLLLLLLGAIWGSSFLFIKISLESITPVTLTAFRLLLAFLVMITFVFALG
KKFPTGFHIWRKYAVVAISGNILPFILISWGELHIESGLAAILMAIIPLSTLVVAHFWTD
DEKLSLPKLAGTSIGFAGVVLLVGPEALRGLGDSVLGQLAVAVASFSYGITSVYARKSGL
TKQDPMVNGASILLLASLMAIPLAFAIETPLQLEPSGRSLLALLALAVLSTAIAYTILYY
LLSTAGATYTALNNYIVPVAGMLWGYLFLSERYDAEAFTALLVIFIGIVVSQFGRRQKKQ
EARPCPEAV
>fig|1122135.3.peg.1819 Permease of the drug/metabolite transporter (DMT) superfamily
MRNPTFKDTFILILLAAIWGSAFLAIKITVHEVPPATIAASRLLIATVIIYGYMRSRGLS
LPRSKKFWIQIFFVSFFTMAAPFTLISWAEQYIESGLTAILMATGPLLALVLSHFFSTDD
RFTLFKLLGVIIGFSGVLLILGFDSFSEFGDDVPAQLATMVAAMCYAGSGLLVKRVREKS
NTITTASILLVATLQILPFSLLLDAPWQSLPASSLSTLAALVYLGAIPTALAFILRFYLI
REVSYTFVSYVGYLVPVFGVIWGTVFLGERLPAETLLALAMILSGIAVSRLSLGWFLALK
NNYKK
>fig|1122135.3.peg.1838 Permease of the drug/metabolite transporter (DMT) superfamily
MDNLTETKIPSGGILSGLLAGISFGLITPISPAVYDAGATPMTVTLFRFILGSLAMLVIL
GLTRGSFLVPAKGRLPLLSMSFFIFCVTIFYLSAVQYISVGLAAIVFYTFPVIVTIIDPL
LQKRTPSLLQLGLSLLAFTGITIALGPSLDSLDWRGLGFLCLTSFSMCGGLICGRKVVPL
VPNLTSLFYVNVIGIALSCLYLPLDNSLHIPDNLTEFSLTGLIAGLYLLAILAQITSVGI
IGPSRTAMFLNSEPVVTIAMAVLVLHEALGISQVIGALFVMLAIAGTCYRPVTRPKQQSA
S
>fig|1122135.3.peg.1864 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MARKPGKSRERDLTQGSLPGHFRALAVPASIGMLFNTLYNVVDTFYAGLLSTEAQAALSV
SFTVFFIPIAFGIGLGQGISALVGTAVGKGDRELARTFAAQGLSFAAAFSLCLAVAGYFS
IPFLLDLLGVPDSFHPLSTAYLQIIMLATPAFLIAFSANGILSSQGDTVSNQRALIGGFL
ANCLLNPLFIFGAFGIKGIGFDGLAVSTLVIEWCVAFFLLYQALGSRVLFGCRSADFLPC
WKTISELSGQGLPATFNFLTITLGVLVIQFFLQPFGATAVAAYGIALRIEQLILLPGLGL
TIALLPIIAQNNGAAAHDRIRKAFWWCLGTGGAMMLAGGVILLLSGNFLLGLFTSDPAVI
TVGFNYLLLAAPMLPAYLMLFAMMSFLQGVKRPIWTVWIGIYRQVIASAGFAALFIHLFG
WGSWGVWAAVFASVWSGLLLSSLIVRYVARKEIGGLGTPFSSAKQSLSGKQKQ
>fig|1122135.3.peg.1867 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSARTSPPENMFLAGSLPRLFLKTAAPIILVMLVSGFFTVVDAYFLGAFVGPEALTAVTM
MFPVFMLIVALSTWVSGGFSSVVARLLGARKHDEANAALVSAILLSAAVCLLLITLFLFA
GTGLISWVTKGSVPLSEMGYSYISLLIFFSPLQFLLTINFDALRCEGKMGFIAFLSLLST
LLNIIFNYILIVKLDQGVAGSAYGTILAQFLSITAVGLYHLKARSAFTFSLAALPNPTRF
WKRFLALGXPASLGYLGVSISSAAILYSLQQWGHEHYAATVAAYGIITRIMTFTFLPLLG
LNIAFQTVAGNNQGAKLWPRVNDSLKLALLSAFLYCGSLQILFNVFAEQIAFVFVEDSMI
AGETQRILPQITLFYFAFGLSMVLSGFFQAIGDAKRSAILGLSRTYLFSLPLIFTLPFFF
GEPGIWFAAPMAEFLMILLSLLVLFLNAGTSGMKMGLFRQTI
>fig|1122135.3.peg.2324 Permease of the drug/metabolite transporter (DMT) superfamily
MTDLNFTRKQAGIKTMQQPQINSGILQMSLAMVLSGFIGLFVFESGQSPFNVVFFRCVFG
ATGLGLYCWYKGYLTKEVWVARNITLALLGGAALVCNWILLFSSFELASISVSTTIYHTQ
PFFLVIFGAIFLGEAFSLNKMIWLIIAFSGLVLIVNPDTESFAGNIEMLKGAGLALGAAV
LYTITTIVTKRLKQMKPHLIAFLQVSLGVVMLAPFVDLSAAPSDVAPWGFLIALGLIHTC
FMYIIMYSAFQKLQTPVIAVLSFIYPVVAIIVDYVFYEQNLSMMQILGIVLILLSAAAVN
LGWKLLPGRNVPAKKTA
>fig|1122135.3.peg.2399 Permease of the drug/metabolite transporter (DMT) superfamily
MLIAAAIWGSTFVVQQLAMETMGPMTFTAARFFLGTLVVLPLAWRELKKRKSVAQDTARY
HLTPFDWAMMVGIGVVLCIGTVVQQIGIIHTTVTNAGFLTALYVPLVPLLGLIFFRKRPH
WVTWFAIACSLTGTFLISGMDSSFSLGYGDALVVSSSVFWGLHVLLVGVLAAKTTMPLTL
AAVQFAVCAFLATLGGMLTETVSIAALLSTFWSIAYAGAVSVGLAFTLQVVGQSYTQPAD
AALILSMETVFAALAGALFLQERIGSTEAIGCALILSAILMVEIIPQLLRRKLRFS
>fig|1122135.3.peg.3345 Acriflavin resistance protein
MHSLTGWFIKNPVAANLMMAFFLFLGWLALTTIRIEGFPRIPPESISITTSYSGASTAQI
DELITRKIEKALEGLEGVRSISSQSNNDISVVTLRRSGGQDLQKLLDKVRLRIDGISDFP
SAAERPVIEDGGFDFPALYLNLHGQTDPVTLQKLSELLREELLSRPELSRMNIWGLYERE
MQIELDPQILQRHDLTVADVVTRIRLNSLNFQSGVLRTRGGTIYLKADNQARFSTEYAAI
PVVERTDGTRILLGEIATVQDNFKEGDYLFRFNGELTSGMEVLIGQKENLLRVSEVVHDV
VETFRTRLPPDIKLTIWGDSADYIAERLGLLKDNGIQGLLLVLLVLSLFLNVRLAFWVAM
GIPVSLMGALAVAGSKWVDYSLNDVTTFGLIIVLGILVDDAVVVGESVFEERQSAQDPFL
ATEKGVKRVAVATVFGVLTTIAAFFPMLLLDNPLGKVLAGFSGIVIFALVFSLIESKFIL
PVHLAHTNLHQQPRFFPGRLWARIQQTTQHLLLEFRDRIYAPLLVSAIRHRYATLVLFIA
AATLGIGLIGLGKIRTVFFPDVPGQVITVNLEMDARAPFGLTRDNLDRIRVIGEELSKSL
QQEKSLEAAPVRSMFLIISDTSTAQLFAELTPVSERPDLGIIEFMEQWRQRTGQIEGATQ
LQFTGSEELAGGFLLRLYAKDTDLLALASKDLREFLAGINGVNNVRDSLTPGQPELDIRV
KPEARHLGFTTETLASQIGNAFGGAEVQKIMRDGTELKVIAQNTDKTRDSIDDLLRSRLR
SNNGNWIPFQSVAEIRGGYVSGTIHRENGKLVNTVAASINRSLVAPEEVAQAVFEQLVPE
LVARYPGLEVKKAGELEEIGEIQGGMKQALLLAAVMIYVLMAVPLKSYWQPFIILAIVPL
GFVSAALGHLIMDLPLSVLSFFGMLALTGVVINDSLVLITSYNQLRERGIAASDALCQAG
LGRFRAIFLTTATTVIGLTPLLSETSEQAQYLIPAAVSLAYGELFSTALMLILVPVLLAI
TEDFRRAFLGVGQNDANDPAPPEPT
>fig|1122135.3.peg.3377 Permease of the drug/metabolite transporter (DMT) superfamily
MMPVSSENSVDGGSYGEGAMKGPRLFGSPVSLLLVTGTLIGFNFPLGKIAGEAGVSPMIW
ALIVSLGASAMLLPVQLLRRRLTLPKGQMLRYVIVSALISFVFPNVLLFSVIPHVGSGYA
GLMFALSPVFTLTLAVLFRLKTPGRLGLAGIGLGLVGAMLVSITRGAAPEAPELIWIIAA
LLVPATLACGNIYRTMDWPDQAQPDGLAFWSHGFALVVYLLLLLVSEGTIPLAQLSLVPW
TAVAQGVVAGLTFPVFFRLQQQGGPVLLSQIGYVAAAVGLLVATALLGEVYSAMTWFGAG
VIALGIAVTVIAQVQERKEMTR
>fig|1122135.3.peg.3617 Multidrug resistance transporter, Bcr/CflA family
MNKIFLKILPESIRVMPSVKETESRLFIALLIFLMALGPISTDLYLPSLPSIAAELKADQ
AEIQLTLSVFLLGFATSQLIYGPLSDRFGRRPVFIGALVLYLLASLTCSFSNTIEELIIL
RFVQALGACAGPVLSRTIVRDVYRRDEAARIMSWMGMAMALAPAVGPVIGGQVEILFGWR
ANFLVLSGFSTLALLWLLLRLPETNRDLNMEAMQLPRLIRNYFGLLRNTRYMGYVLISTG
SFSGIFCFISGSPFVLIDQLGLSPDVFGLYFAVIVVGYMAGTFLSAQFTLRLGLHRMIMI
GSSVSFAGGLIAVGLSLFGELNLLNVVGPFAVFTIGAGLTFPNNMAAALAPFPRIAGSAS
ALMGFIQMIFASGVGVLISSYNDGTALSMTASLAGVTGMAFASYVFLIHPHKLETLDSPT
TPAI
>fig|1122137.3.peg.143 Permease of the drug/metabolite transporter (DMT) superfamily
MTADTPAPVQMGLKEWSMLGFLAVLWGASFFAIEIAVTELPPVTIVNIRVGLAALVLYGY
LRVAGIAPPFKGRSDKALVLLAFVLMAIFNNIIPATLIVWGQTHITSSLASILNATMPLF
TVFMAHFFVSGERLSLNRLAGVLVGFSGVVFIVGPYALEGMLSGVAGQVAILGAAFSYSI
AVVIGRRFVRLGIKPVQMALGQAGTAAIILLPVTLIYDKAYLLPVPSWHVIAALVSLATL
STAFAYLLYFRLIAEAGATNASLVTLLIPVVATSLGVSFLGEVFEPAHGIGLLLIAFGLM
LIDGRLGKRRPRLRAEAVPPEGR
>fig|1122137.3.peg.277 Bicyclomycin resistance protein
MHEQHTNPPATDGSKTAGSQAMIAFFTIVAGTVLGLAGIDLVLPSVPAMPAIFGTDIANA
QLVLATYVAGMSVGLLMFGALAGHFGRRRLFIGSLLAFGVLSLLAVMTDNIHVLNIIRFF
QGAAASGGAVLAPGLIRALFSELGAIRAVSAMGSIESLVPGLAPIAGAWLYAEYGWKASF
EITGTAVLAICALVILIPSLLPHIGQKRSGSSASYWRVMKNKSFIRYGLSHALVLGGLLV
FVFSTPAVVIETMDGTIEDFIRMQFVGVCLFIVSANVNGSLVKRFGNEKVIMAGTIIATL
GSATLFAYALFGPNNPYHLVYMFWILNLGHGIRSGPGFVRALQTTHGEDDKGSALMILAT
MLTGAVGTAIVGPFIQFGLVGPTLALVLIVVPALLLMYIFPPFKEGDQPSERG
>fig|1122137.3.peg.396 Tetracycline resistance protein
MPVIIFAVFIDLLGFGIIIPILPFLTLKYGGDAFIGAALMSIYSLATFAAGPIWGRLSDR
IGRRPALAATFFGSTIAYIMLAMSDSLVMLFVARAMSGMMAGNVGIAMAAMADLTDEKNR
GRAMGLIGASFGLGFAFGPFIGGLLGGVGGEANVFVPGLAAAGFSFCAMVLTARFMPETS
KHRVEDASDGPPEPLPHWTKVIRTHGTLALYVMFFVTAIGQSICFAITPFWANATLGWNQ
TQVGFLLAGVGLCVAAIQSLGVGPLFRIFGEVRSLILGAVTHLVGIIILFAAPAHPVTAI
IAFPMIMSGLTISFPALNSLISQRSDKRIQGTALGLSSGVSALGRVFGPLSGGFFFEGFS
PDTPYLAVALTGSIVFVWAIYEVRRLGAMRV
>fig|1122137.3.peg.493 Permease of the drug/metabolite transporter (DMT) superfamily
MQQDMSTPTPGASLGIACGLGAALIWGAWPVITTMGVKANISPVQVVMLRFLVAGILLAP
FALRGPSTLRDWGKAAVFALFAGTPYALLVTSAFEYAPASHGGVIIPGTVLLVSLMAAHL
WLGDRLTKLRAFGAVLILIGLGGLAGGAAGGLRTMFGDMLLMAGGLSWATYTFLLRRWPM
DGLRVASRVAFLSLILVGGLALAGYGEGLTSLPLETLALQGLWQGILSATVALLLFNKAV
GILGSGRASIINALTPVIAVLLSFLMLDEVPTLIEFAGLITIMAGIAIALGIRIKPIRRK
RDTAHVPEVS
>fig|1122137.3.peg.607 Multidrug resistance transporter, Bcr/CflA family
MHLSKENTAGLALLLGSVVALMPLSIDMYLPAFSDIGAHFGTVQSQVELSLTVYFIGVAL
GQLVYGPLADKYGRRIPLIIGLSIAAVTSLACAVAPSVELFVISRFFQALGMCAGGVISR
AIVRDMFEPIDVAKFFSLLMLVMGVAPILAPIVGAQLAINFGWQSIFYLIAAVCVIDILS
VSFLLPETREPNPGVRLSATFSTYRDIIKDRHFLGYSMAGGAAFSSMFAYITGSAFVLID
YYGVAQEDFGFYFGANAAGFIVMSQLNRWLLKHFSYKVIFHTALKVLLGAGIALAICGVV
GVPLWVFLIPLFIYIASLGVVSPNGMAGALEGEARRAGAASALAGSLQFSLSFVFSGAVG
IIHAADPLPLCLIILSGAVIANLFARMTKGPARKAAA
>fig|1122137.3.peg.996 Glyoxalase/bleomycin resistance protein/dioxygenase
MLEKVAFTVYPVTDVPRARAFYEGLLGLDTHGTEKIGKEMAWIEYDLPGGGCFAIANFTE
NTPHATAGGTIAFEVNDLDALLAHLKSNGVEFMSDMTHSPACRMAVCLDPDGNSILLHQL
KNK
>fig|1122137.3.peg.1690 Multidrug resistance protein B
MSQATRHQTPVQEIAHHRGGLIFCLMLAVSLHTIDATIVNVALPHMQGSLQATFDQISWV
VTSYIMASVVLTPLVGWAAARFGVKRLIMLAMVTFTISSVLCGISLTLEAMLASRVLQGA
AGAPLIPLAIATMNRLSTSPGERARMMALFGLGTMVGPVLGPSLGGYITEVASWRWVFFI
NLPVGIIAVLGIAATMKPGAGLPGHRLNLAGFLSLAIAVGSFQLALDRGETEDWFESAEI
IAYALICVASLWVFALNSRFSNRPFLPGALFRDRNFVVGMVLILITAGNMTASVVLQPPM
MQNLMGYPVLDTGILLMWRGIGMVFGMMLAPRLTQVMNPRWLLVIGGISMAAGLSPFIFL
TTETPAVLLSIPPIFHGFGIGIMFVMASTIAYATIPHELQVEASSVFSLIRGLGQAACIS
IVVALVSRYSQINHAELVERLTPLRPYTPSGTISVLTSTPEQLAQANLLVSQQAAMIAYN
NAYLALLFAAATVIIAAFLIKPRQFDDEHAVEHPVEA
>fig|1122137.3.peg.1691 Multidrug resistance protein A
MKRLILYVSVPALILAAVFYVYLTGGRMVTTDNAYVRAGILTGASRVSGEVVEVLVGRNQ
HVDEGALIARLDDSDARVKLQEAEVGVISSRHIVAALKANYRKSVAALEKERQSLAYETR
ELKRAEALARDKNLSEAALDNQRFEVEDARREIAILEEAVQMALTQLGGDADIPADQHPM
VLKSLAAVEAAKVALEHLEVRARTGGTITHIDLHPGEYISAGYPIYGMTVDGDLRIEANP
KETELTYVRIGQSVDVIVDALPGLHFTGKVTSIDPATGAEFAVLPAQNATGNWVKVTQRV
PVQILLDNGQDLSALRSGLSAEVSIDTGHERKVSDLTSMVGL
>fig|1122137.3.peg.1966 Permease of the drug/metabolite transporter (DMT) superfamily
MGVFLAFFGCVLIWGSTWYAIELQLGVVPKEWSLVYRFGLASLVLFAICFIRKERLRIRL
QNHLWMAITGMTLFSTGYVFTYWGTEYLTSGLVAVTFSMLSFLNIVNARIFLGNPVTPST
IGAALIGIAGLVLIFMPEITVLTLEDDTTLGVALCLAATVMASIGNVSAGAASTRSVPVL
SFNAWSIGYGALTNLVFALASGKPIAFDPHAPYVLSLLYLSIVGTVIAFTMYIWLIGKIG
VGRAAYMAVMVPVVALVISTFMEGFVWTIEAAVGLALVVAGNVLMINRKAKAVTPAAPDC
VEPEKL
>fig|1122137.3.peg.2205 Probable antibiotic-resistance protein
MAAIDVWAQVTTERMAREPWMATLLRWTGREGEVIVPTIADTIAAMDAAGVDIAFLSAWH
GPRGSLISNDEVAAQIAEAPDRFRGLATVDISNPMEAVREIRRVVDGKTFVGVRLVPWLL
DLPPNDRRYYPVYAACVDAGVPFCTQIGHTGPLCRSEPGRLIPYLDDVLLDFPELKVVGG
HVGFPWIDEVVSLALKYPNFYVDTSAYAVHRLPDDLVKFMKGPGGKRVMFGTNWPMLSPA
QCLKALDSLGLTDEGKFNFLEGNARRVFGL
>fig|1122137.3.peg.2531 Acriflavin resistance protein
MSDGDDDQKIEGRGILSLVASFLENPVMTNLLMIFLIVGGLMTAVTMRSEVFPTVDVGTI
TVSVNYPGATPLEVEDSITRRVEEAVLGINGVERVRSYAFENRASVVLELEDFVDAYRIK
DEVQAEIDALIDFPPGNAEEPIVAVTQSLSNVLTLVLVGQAAEEDLRRTAELLERDLLTL
EVVSAVNLRGTRAREISIEVSEDTLRKYGFTFTEIADAVRRSSLELSGGTIKTESGQILL
RTDAKARVGEQFKDITLRATTSGELIRLSDIATVTDGLTDDELVNTYNGAPAIFLDILRN
ESKDILLVKDQVAGYVETVDLPEGQSLVIFRDQTEILADRISLLTSNALMGFALVFLLLV
ITLDFKLAFWVAMGIPISFLGGFLIFGSVGVSLNMVTLFALIVVIGIVVDDAIVVGENIY
AEQQAGFKGPRAAFEGVKNIFAPVLVGVLTTMAAFAPLLFQTGTFAEITRPIPIAVISIL
FVSLIEAMLILPSHLSHEKRWSRGALRSFQVKVSRALDSFAVGPLQRLIIKSSEFRYVTL
AAAVGFIFIAFSLVGAGFVRVVFFPNIEGTEISANLAMPEGAPFDATAAAMEQMETALNK
VAADIKAETGEDVIRAVAITTGAKFSQASGPGAVSSNSLASHLGQFTVELVPTDARSVSS
REISRRWQQEVGSVPGAETLTFAATIGPSSVDVGYELSHADQAELQKAASDLADKLSAID
GVSQIDAGLDLGKRQFEFHMKPAGLAAGLRPQDLARQLRQAYFGEEVQRIQRGRDEIKVF
VRYPRDARRDLSALANLRIRLPNGDGVPLDHVASVTEGRSPTSIERVNGRRILTVTADVD
ESVTTPNVVNDIIQSDILPAVMENHPGLRWQLEGGSREQREDFAALARGFMLALLVIYAL
VATQLKSYLQPVIIIVSIPIGIAGAILGHKVLGYDLSFISMFGIVALSGVVVNASVVLVD
RYNIELKDPDTSPLDAAVRATLRRFRPIALTTLTTALGLLPIISETSPQAQFLIPMAVSL
ATGLLVSSALMLFVLPAIVLIVEDIRKLVGAAPPEAAVETE
>fig|1122137.3.peg.3035 Acriflavin resistance protein
MNDKSELLSQLKIDRSQKEAPRSSSKFAYLLGGGALAALIFGGAYMVIGAGGDEQPTAND
AANTSAQQSAATAQSSNAGTATPSAASTTVAPSDSVLNASGYITARRMATVSAEVIGLIK
DVTVEEGMAVKAGQVLATLDATLPQVDLDLAQAQIKVLEARLASTNANLAEAKRVLARAS
ELKNAEFSSEASVTRAQADVDSLSASAASTRADIEVAKLSVLRQKERLDDYTIRAPFDGI
VTVKAAQPGEIVSPSSAGGGFTRTGICTIVDMTSLEIEVDVNESFIGRVFEGQEVKANLD
AYPNWDIPASVIAIIPTADRAKATVRVRVGINISDPRILPDMGVKVAFLKA
>fig|1122137.3.peg.3121 Acriflavin resistance protein
MNKLIEWWARNGVAANLLMVGIFLAGTMGFFSMEREMDPQVRFPGLEISVSWPGAGPQEV
EEQVVARIEESVRDLDNIEWVRSSSGEGFGEVYILAEQSVDFTQFMNDVKIRVDSISSLP
RDIEPPRVSQWVNRDEFIRVAVHGNLSERELKRLAEKLRREAAQLPSVSIVELFGVRREE
VSIEVSEESLRRYNLSFSDVALAIRANSLNTSGGSVRTEAGEYQITARNMADTEHDFNNI
IVRQTEGGATIRVGDVATVVDGFEDNEILATLNGEPAVLLQVMTTERMDIVKASESINEW
ITKRQDSLPPGAKLTLWTDNNEAFQSRMETIGGSAFQGLVLVVLVLMLTLRPKVAFWVAM
GIATAYAGAFVLLPALGISINMLSTFAFLLVLGIVVDDAIVVGESIHTESQRTGGGITAA
VFGTQLVAKPVIFAVLTTIIAFMPWIFLDGSTSEFTRHITWVVIMALVFSLIESLMILPA
HLAHLKPREKLGRFGRLQKKIADGITNFAQRRYRGIAQWAVRNRYITFSVFVSVLILGFG
LFSTGYVKKSFMPEIESDEITVNVTLPEGASYNRALDILAQLQEGERKLVEEVEARTGGK
LIENWYTRSRRDSVLAIVKLSPPEERDMSAKDASIRLRELIGDIPDAKEVSVRYTTSDND
AGFELSVRHPDLDVLREAVGDLEDKLRTYEALYDVRNNLEGASEEIRITLKPGTEKLGLT
LADVSQQVRQAYYGEEVQRIPREGQDVKVMVRYPRESRRSIESLKDFRVRTADGREVPLM
AVAELEYAPGIKRIQRWNGNRAARVSADMKENIRSQVMEDLNANFFPEWEKKYPGIVRGA
IGQAEGEARFIADVLKLYGMALFVMYMMLAIAFRSYWQPIAIMIAMPYAFVGAIFGHFTV
DMTMAIFSYFGVAAAAGVVVNDNLVLVDYCNKLRERGMAPMEAIVEAGVARFRPILLTSV
TTFVGLMPMMMERSIQAAFLQPIVVALASGVLIAFFVTLLMVPALYSIGDDFNRGFATTK
GRIKGMFGSRSNKAPAQAE
>fig|1122137.3.peg.3667 Acriflavin resistance protein
MDFLTRLGLNRSRFTLLLMIALVLSGLLLYKDFPKREAPEITIRTAIVSALYPGMPPERI
ENLVAERVERKIREIAEVKEIRTILTTGRMRTYVELKDSVNDLEPIWQSLRDKMSDISRE
LPEGAYGPFVNTDFGEVTVASIAMTAEGFTYREMEESAKDMQRRLYTVDGIAKVELFGVQ
EERIWLELDARRFKAVGGQLNTLINDLQNQNVVLPAGEINAEGASILLEATGDFKSVRDI
ENMLTRAVGGDELIRLKDLVKVRRGYVSPPENRVYYNGRPALVLAVQMQPGYDIEDVGER
LTEAMHTFEHTLPIGYELNFATYQPTEVSKTVAGALSNVGQTFIVVLLVVLAFLGVRSGL
VISSIVPFAVMFALLGMNALGIALEQVSIAAVIISLGLLVDNGVVIVEDILTRVDRGSKR
RTAALAAGSQYAVPLAVSSLTTIFAFTPFFLLEGSEGEYAFSLGAVLALTLIGSWITALY
FLPLICARVLRKRTEGEEGIEHKAEAEDLPAFARMYENMLRPSLRAAAFVVIGTYGVVIV
TGQLFTGLPKEMFPVSDRNEVLIYLDMPKSAHFEATERVALDVSNWISDGEVNPEVEDHI
IYVGEGGPRFYLSLNPVDPSPSKAFILVNTKSPEQAAEFGARAKRYFYEQVPDARFTIKR
LAMGASESGQVKIEISGPEHEPLLVAGREVERIFAGVPGIVQNESDWGEKLVKMVIEVDQ
DKARRLNMSSQTLAQNLNAYFDGFEVSNFRDDDSTIPIMLRALERDRDSLEDLLNIILPG
EDSIVPLEQLAVLKPALEYSQTWRKNQQPTITVTAKSSQLPAAELYAQVKDQIDAIPLGE
GYQVVVGGELKDSAEIYGKLGAGLPFALLLMILVVMYQFNSFRRIAIIFMSVPLVLVGVP
FGLMITGQPMSFFAILGLISLSGIIINNAIVLVDQIDIEREEMRLMDAIVSAAGQRLRPI
MLTSITTVIGLLPLYLFGGPLWEPLAVVMMFGLAMASVLTLFFVPATYMLFFRTQS
>fig|1122228.3.peg.1390 Drug/metabolite transporter (DMT) superfamily protein
MSKFSPKVIGSLLVIIASIFWGISGVSGQYLIQRGVEVPALTSLRLLISGVVLVSIVAIR
RPEGITPALKSKDFLIGIALFGIFGIVANQFAYLKAIEYTNAGTATVLQYLTPIIVLLYT
CIRLRIPPALLEIVSIILAIGGTFLLASHGQIGNIQLNPAGLTWGILSSFTYASSILISA
AVVKKWGSLLSIGFAMLFGGVIFSLATRIWTYHFTMDMPMFVAYVGIIGIGTILAYTLFI
KGTTMIGAVQGSLLASIEPVASVILTVAIFQTFFYPADFVGMVLILCSATIISTKDVIAR
FFTRSWHKRIS
>fig|1123236.3.peg.667 Fusaric acid resistance protein fusE
MGTVVRIIVTLIIVALAVLAGRWVWERYLHAPWTRDGRVQAHITTISPDVSGWVTQLAVQ
DNQKVEKGELLFTIDNARYQAAIEEQQAAVKARELAWQLAQHEYQRRTKLARNNTISQEE
LEVTRISAEQARAEYNLAMAKLNTLQLNLQRTRVKAPQAGTIVNLDLREGNYVSQGKPVL
SLVRRGSFYVTGYFEETKLSLIHEGQRATIKLMSSNQPLTGKVVSIGEAIADTNINRNEQ
LLPHVQQTFNWVRLAQRVPVDIELDPVPENVRLVAGTTASIHLNEQ
>fig|1123236.3.peg.1751 Methylenomycin A resistance protein
MPSLSHKTATALLVAAALFMEILDATIITTALPIIASEFGVPAAHLSVGVSAYLVAVTIF
IPVSGWAADRFGAKRVFSLAILIFVGASVLCGLSETLLQFTLARILQGIGGAMMVPVGRL
VVLRNLPKEQIVKAMAILTWPALGAPLIGPVLGGWIAQTWHWSWIFFINIPLGAVALLFT
HWLLSNEKGQWQKFDVVGFTLSGLGFGMLMAGLESFSARPDDMTIPALLVVAGVVILSLA
VRHMLTTSNPLFSLAALRFNTFRATMTGGSIIRIALSSAPFIIPLMLQVGLGYSPVEAGT
LLLWLFAGNLAIKPATTWIMNTFGFKNVLVYNTILVATGFFVLALCSESTAGWELGLILF
LSGMTRSMHLTVLNTLSFADVPQTYIRDANTLSAVLMQMTRGMGITAGALALALATFIID
ESRNTPVTADFQLTMVFMGVIALLSLFNSVRLKPGIGNAVLNERQAS
>fig|1123236.3.peg.3117 Bacteriocin resistance protein, putative
MKYILNKTTTAIALLLSTHLANAGMINIADDYSVRLESMVDKRFDRIYRQQFDFSCGSAT
LASLLSFHYNDTVDELSVFKDMFKHGDKEKIRAQGFSLLDMKRYLTRRGYISNGFRITLQ
QLAQAKRPAITIINTGGYMHFVIIKAQRDNRIVVGDPAVGLKIMTQEEFDAVWENDVFFL
IQNNEDVAAYHYQFDKHQQPYAPANLAMPVDIQRLDILSVVAPGNWDF
>fig|1123236.3.peg.3622 Acriflavin resistance protein
MKIATYSIKNPLTVWLLMVIFFVGGIFAVIEIGKLEDPAFAIKQAIITTDYPGATAEEVE
EEVTEQLESRIQQLSQLGDITSRSLPGQSQITIKLRDDFSGEQLPQAWDELRRKVEAATM
RLPQGARQPVVNDDFGDVYGMYYAVIAEGFSHKQKRELSSRLRREVLTVPGVTRAQLGGV
PEETIYVEVTQEKLASLGISLNQIAGVFQTESAIADTGSVRVEDRRIRLVIPPSDDSADT
IRNLKFGIPGTTEQLHIGDIADVYRAETENPTQLVRHNGEAAFTLAIAGRSDKNIVDIGN
RVTSHLNTLREKLPLGVEILPIYEQHKVVDQAIQDFLVNLAASVTIVVAVLLFVMGWRVG
VVVGGTLLLTVLGTVLFMWIFSIQMERISLGALIIAMGMLVDNAIVIGESMLLNRQKGKN
SVEAAEEAAQQTQFPLLAATVIGILAFAGIGLSQDTTGDFMFSLFAVILISLLLSWVLAV
TVTPLLGHYLFKAQSGDTDEDIYDTRGFRAYKKLLSGALRHRRLTIVFLVMTTAAAVVGF
GWVKQSFFPPSNTPIFYVDYYLPQGSDIRATEDDMKAIEATILQQPGVESVTSLIGMGAS
RFMLTYAPELPNPAYGQFIVRTEQREQIPAIMKALRERINRSHPQAEVYTRRIFFGPAEG
AKIEARFMGSDPEVLRALGQKAQNIMYASDSITDIRQNWRQREVIVRPVIDEQQARIAGL
SRTDIADSLEFATVGKRVGVYREEDRQVPVVIRPPAGERRSMSWLEDRLIYSDAEQTFIP
VRQVVKDFEVHSENGIIHRRNRVRTLTVQAEPVGDLTAATARATVVKQIESMALPPGYAL
EWGGEYESSREAQAGLATKLPISFLSMILITILLFNALRQAALIWIIVPMSVCGVTAGLL
LTGLPFSFTALLGLLSLSGMLIKNAIVLVDEADIRRTTADNLHDAITGASLSRLRPVMLA
VLTTVLGMLPLLWDAFFASMAVTIMAGLTFASLLTLVAVPVLYSLFFSEKDMHP
>fig|1123502.3.peg.165 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MALSERMLELRDAPIRKLLWKYALPAIIGSSVSALYNIITRYFIGNADYLNDDAMSAMGL
ALPIMTIIAAFGMLVGAGAGSRISIYLGNEDYEKAERVVGTSLLLTLVITLTISFIFFFT
LTPLVHFLGADEGSYQHTYDFLKYFLPGAIFSNLCFSFNNMMRASGYPKKAMYTMLLTLV
LNGIFAPIFIYWLKWGMEGAAISIILSMFIGTLFVMQHFVNGHSVLQFKAKYIRFDAQIT
KAVLSIGLSPFLMNIVSSSIIFIIIQQVRVYGGSVAVGAYTIVNVLLMLVVLVLLGLTQG
MQPIVGYSFGAKEIARLREALLQTIKIGVGIGIVAMVIGVFFPEWVIMPFNPSPALSDVA
ISAIRIVTMLFPLVGFQIVVTIFFQSIGKVKHSIFLSLSRQILFLIPGLFILPHYFGIAG
VWYAIVVADLISTCTAALFLWIQIREFNRYLKGNA
>fig|1123502.3.peg.292 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MISHVSIQMVAATAASNQFFETSVAILNFIGVGCSIVVAQYLGAGDRETTRKAIHLSITL
NLMLGFVTFLAIWFFGHDLLSVMNTPENILNMAYDYFHIIGICLIFEAVAIILASCLRVY
GYSKAPMYVSLIMNIVTVVGNIFVLYGVFGFPQLGLSGVAGSTLLGRIVGVALLFYLLFF
GIKVRLEWRMFFQFHKKILQQILKIGLPSAGENLSWTAQMLVMLAFVGKMGEDALAAHNI
YLQLSYMLMLFALAIGIGNEILVGHLVGASNFNAASARTWKSLRTGMLVTFAVVVVFYFA
RYLVVDSFTEDPIIKELLLPLFLLSILLEPGRTQNIVMVNALRATGDARFPFYAALVFMW
GIAIPVGYYFGFVLEMGLIGIWIGFLCDEWIRGLVNAWRWKSRKWETKRLNIEH
>fig|1123502.3.peg.377 Permease of the drug/metabolite transporter (DMT) superfamily
MSTEARGHLLALLTIVLWGTTFVSTKILLQHDLSPLEILGARFLLGACFLMLLYPKRLKG
TTWREELCFALAGLCGTTFYFWFENHALLYTLAANAALISSTSPFFTVLLARFFLKEECI
RPIFYVGMLLSFVGVGLMSFSGLQSFELSLKGDALALGAAFIWSIYAIVSKKMGSFGYNT
IQTTRRTFWYGLLFMLPMISWQSLDFSHDALLNYVHQYASPVVMFNLLFLGLGASALCFV
TWNLAVKILGAIKTSLYINAVPMVTVIFSTLILHEHITLLSALGILLVLMGLGISQYQRK
SSNS
>fig|1123502.3.peg.379 Multidrug resistance protein D
MFPQIVETLYSPILPALSSAFAVSEAAAGQTLSLYFMAFAIGIVLWGYLCDRLGRRITFI
LALSVYTVGAVTALWVTDFSALLICRMLMALGAAIGSIGTQTVMRDAYSGEALRKTFAIV
GILMAISPMLGIFMGTLLEMHLGYRAIFMALVLFALMLLLWTILSLPETRPHNMQRVALL
PIARVMLKDGVLLRHMVMIAGFNLMLFSYYQLAPFWLTDLGYPMTLFSYTGLLLGAGSLL
GALINRRCTQAHVPARTLIRIATMVLLISALMAFSLRHSLWLLLPMGIMTFCYGIAIPNI
LAHVLDDYHNARGTAGALLGLGYYLLLGLGLMLSAISGHLAGTLLVTALFMLCINLSE
>fig|1123502.3.peg.1001 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTQPIKISLVVPVYNEEAALPIFYQAVREAPFLKDYDLEIVFINDGSRDQTEAIINALAI
SDPRVQALSFTRNFGKEPALFAGLEHATGDAVIPIDVDLQDPIEVIPELIEKWQAGFDVV
LAKRIDRSSDSFLKRQSAGLFYKLHNKISTPKIEENVGDFRLMSRNVVENIKKLQERNLF
MKGILSWVGGQTAVVEYVRAERSAGDTKFNAWKLWNLAVEGITSFSTAPLRIWAYLGFVV
ALLSFSYGAYMIFEKIVFGNPVSGYPSILVSILFLGGIQLIGIGVLGEYVGRIYMESKQR
PRYLLKKMGSDKK
>fig|1123502.3.peg.1053 Multidrug resistance transporter, Bcr/CflA family
MGIAHPHKMDCMNTQHTQTRIITASLIMLMALLTALDSMAIDMYLPAMPDIASDFQISSG
KVQQTLAIFLAGLAIGQGLYGPLLDRYGRRLPLLIGIVIFIIGSVLSALVPNVEWMLAAR
FIQAIGASAGLVTPRAIVSDTCDLKDSARVFSLLMNAMMLGPILAPMLGGFVLGFGEWRV
IFYIIAIIGGITLLWAWQQVPETLAIEKRTPLNLKAIAKTYGGQFTNRTFMCYAMASGFA
MSGLFLYVGGSSFIFREHFALSATHFSYLFALNSAGLVIFGAVANRLLVKGLSARGLLMI
GMMMHTGFALLLFILTQSMTLSIVPYALLLAGAISALGFVLGNVTALTMHYGGPQAGAVS
AVMGVLQYLLPALMGYVVSLFAQSISVLPLAIGICGLMGILFIFASQDKTA
>fig|1123502.3.peg.1120 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLISGTYQLIDGFFIGHFIGPEGLAGVNIGWSYITVLLGFGLLVGVGTGSLYSIAKGAED
DETARAIIGQSIPLILIPGLIFGIILYVAAPSLVYMLGDPQYQVSKTFQTAALMAVDFIR
VFAVSSPLVIGSLALPFLVRNMGNPYRATLYMAIGVTINIICSYFMIVVWEWSIFGAALA
SIIGESCAMFLGLYYILYQSGENLQWRHFKPRPKLLKEIIINGASTFFMYIYVGFIMMLH
HMMLVKYGGTIAVSAYTITGYIVTIYYLGMEGIANGVQPIISRLYGRENFLSTRAIIRMM
VIVGMTYGIGLTILLQIFPGFFTRLFTSDQELSKVTIHAINIHLSLLFLEGVFVMVTVFF
QAIGEGSKALVISIGNLLIQVPFLLIVPKYFGLDGVWISMPLSSFLLAIPVVYWAYIRYR
HIV
>fig|1123502.3.peg.1141 Quaternary ammonium compound-resistance protein SugE
MNNKAWFYVGLTSVFELIWLYGFNRADAPWEWALVVLFIFMDLNFLAKACQYLAAGTVYA
VFAAVGTIGTILMDTFLLEQTISTAMMVCMGLILLGVLGLNLSDPSVDEEEENHG
>fig|1123502.3.peg.1142 Quaternary ammonium compound-resistance protein SugE
MANYGTWIGWGLVTLAVAAEMVGIFGLSLYTRKKNLINRLLYFGGLAASFVALYYSFHYL
PVSIAYTVLTGIGTAAAVVINIMFFNESKDIKRIISLAFIIAGVCGLKFLS
>fig|1123502.3.peg.1360 Permeases of the drug/metabolite transporter (DMT) superfamily
MTGLIFVLWIANVAFDTLGQIAFKYAATIETKNDTMASYWQGLLRQKWLWIGVIAYIVEF
FLWLAFLTLVPLSKGVLLAAMNIITIMIAGRLLFNEKLIPLRVIGIAFITAGVAIVGIF
>fig|1123502.3.peg.1401 Permease of the drug/metabolite transporter (DMT) superfamily
MNWAAMLYPLVAVMIWAMNAVVNKLSAGVIEPAAISFYRWVLAFLILTPFCIVGTWRNWQ
QLKPLLWKFAVLGFLGMAVYQCLAYYAAYTISATMIGIFLSLTPLLTIILSLLILRTPLT
VGLLVGSGLSFFGITWLISGGNPAILLDIGIGKGELMMLIAASAYALYGVLTMKWKIQAQ
VSTWQSLYWQVIFGVLILVPLFAMTDNVAITRENVNLILFAGIPASIIAPFLWLQGVARL
GASKTSLFMNLSPLFTAIISILFLHENLEPYHIIGGAICLIGVIIAQRVNKVVSLETLRK
RANKKAFE
>fig|1123502.3.peg.1560 Multidrug resistance protein A
MQKMTRTLLGLGALFIALVVVLYLVAHQQKEFVLQGEVEANRVDISVRVQGRAKEVFYDL
GDNVKEGDTLVILENPAMIAQQITAEAQYNVAKANRDVAYSTRPEQIEIQKALLASAEDG
VTLAKQSFDRVQKAIQKGGVSQQVFDEAKTSYEVALKDKLAAEASLQLAENGASIETKHL
ADAQVAQAKAALNQVNTDVDTLIVKATANGQVTAKVAEVGQLYNPGTPLYSLIDLTDMWV
TFNIREDFLRAAKIGDVFEVEIPALKETVEVKITALNALGQYANWRATKATGEFDLRTFE
VRAKPIKNIEALRPGMSVIAKWNTRKAQ
>fig|1123502.3.peg.1789 Permease of the drug/metabolite transporter (DMT) superfamily
MLFLGLFWIFSGKLRHEKWHLPEVLRILLCSVFLILNWVYFFKAIEVSGVTVAISIYHLA
PVIVMILGAFIYKERLTLIPVLAIVICFVGTLAIAEINRTASVAEFFSPGLIFGLLSALF
YALLTLTGKGFKYASSYAITTIQVAFGALLLVPFVDFSAFNGLTELNWFYIAITGFVHTG
IVFYLFFDAIRHLSTQMIAILVFLDPLVAILMDLFITGFIPSMEQWIGIVLIFGGMALTL
MPKKKAALI
>fig|1131462.4.peg.243 Permease, MDR related, probably tetracycline resistance protein
MNSKKILLILGLAGFVVMADNWVVSPILPSISKDIGVDIASSALIITAYMVPFGLFQLIF
GYLADKFGKRQVISFSMVFFTIATALCALGSGLTDLVIYRALTGIFAASVMPVSMALIGD
IFPINERQSAIGTFLGISFLGQGLSMLLGGSIAYFLNWRGVFAVYALLSVIATVLLLTVG
KKIPSSKSETSQVLTPYINLITNPLSLKIYLLVLFEGFLLMGIFSFLGGFIKTTYDFNNF
MIGLIMTVFGLMAVAGGRISGKIASRVGRKKTILIGLICTLVGNLIFILLGNVLAIFIIG
VGLLGLGLMLAHSTFLTIATGFAERWRGVAMSLVAFCMMGGGGLGTAIGSRIVGNSSYLT
LFSVYGIGLIVLILAVLLVKKSFMLNSVELK
>fig|1131462.4.peg.256 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKSFEFGNKSIGKLLWQFSWPAIVGMLVNALYNIVDRIFVGRGVGTLAIAATTVAFPIM
LLLMALGMLVGIGATALISIRLGEQKKDEAEKIVGNALTLLIMLPLLFMVFYFSFSEQLL
VFFGANQEVLPNALDFTNIIVAGSVFGAIGFGMNNFIRAEGNPRIAMLTQILGAVINGVL
NYIFIFHLGLGIAGSALATVSGQFITSLWVLGYFLLGHSTLKLRLKNLKPDFPIYLAILS
IGFAPFAMQLANSVQNMLLNKSVMLYGGDLALSAIGVIMSISTLFFMPIIGVSQGAQPII
GFNYGAGQFERVKATLKKAIIASTCIAVVGYLVIHFWPEQIIGLFSDNDKALTELATHVI
LIFFTMFPLIGFQIICSSYFQAVGKPLQSSVLSLSRQVLLYIPLLLVLPHFWGIEGVWRA
APIADILSVLITATLITLEMKRLSKNQPAVSVG
>fig|1131462.4.peg.768 Permease of the drug/metabolite transporter (DMT) superfamily
MQKQKFAVFQALLAAALFGISTPLSKLLLSHLSPIMIAALLYLGAGTGMFALRLIIKVNR
PLSKEAGIARKDLPFTIGMVILDISAPILLLVGLSTTAAANVALLSNFEIAATALLALWL
FKETIGQRLWTAIILITASSMLLSLKDIQGLSFSAGSIFVLLACLCWGLENNFTKMLSLK
DPMQIVVIKGLGSGTGSLLIAFVTKQMTADYSYILFTLILGFFAYGLSIFFYVRAQRDLG
AARTSAYYAVAPFIGVGLSFIVAKEPITNNFIIAAILMIFGAYYAAREKHDHQHSHEVLC
HEHRHHHGDGHHTHVHGDFTSGEHSHPHEHETIEHAHHHAPDMHHKH
>fig|1131462.4.peg.1849 Efflux pump antibiotic resistance protein
MNDHHDHTHDDSKTVKRTLLFIATAGSFLTPFMISSINIALPAIQKEFAADAVVLSWIAT
SFLLSSAVFLLPIGKLADILGRTRLYKWGIISFTAFTLITGFVPNIELLIVMRVLQGISA
SMIATAGMALITSAFPPQERGKALGFNVSAIYVGLAVGPFLGGFLTEYWGWRSIFLVLVP
LGVLITVLTITYVKSDWADAKNDKLDIPGSLIFAVTLIALIYGSSILPDILGIILILFSI
VCFVFFVKRQLKIPNPVLEIRLFQNNRVFAFSNVAALINYAGSYSVTFLLSLYLQYVQGM
SSEHAGIILIIQPIIQSLISPMAGRLSDKKEPAKIASLGMAGTAAGLFLLSFIGPHTSLF
LIIAALMVLGLGFALFSSPNTNAVMSSVDNHYYGIASASLSVMRVLGQMLSMATATLLIS
IFVGKNQITPEYYPQFIQSIRLAFLISACLCAVGIFFSFSRGKIHVNNNQA
>fig|1131462.4.peg.2462 Daunorubicin resistance ATP-binding protein
MAMIYVEELVKQYDKAKTPAVKGVSFAVNEGEFFAFLGPNGAGKTTTISILTTTLSKTSG
IVTIAGYDVEKEAKQVREKVGIIFQQPSLDLQLSAEENIRFHACLYGMFSYRPTFRLMPS
AYKDRVMELAEIVGIQDALFKPVKKMSGGMQRKLEIIRSLMHTPSVLFLDEPTQGLDAVS
RRSLWEYINTVRKEHGTTVFLTTHYIDEAENVDKVCIVNQGRVASCCSPEEMKKSLVRQE
LILDADDREGLTGELSELGLFHKKDAHIIVPYQDKTAQEIIARLNTKLTLLKINEPTLED
AYVEYLNRTGGAAA
>fig|1132443.3.peg.3976 Outer membrane component of tripartite multidrug resistance system
MRLFKPVIGCLFLISGCAWIPEGDKPAEFMTAPSMDHALSEFHEKQATASLERWPNERWW
QEFGSSELNSLMANGLKDNPGLKAASDRVREAEALARVEGSRLLPFIDADADVAYERVSA
HGLFAALNRKEAAGAHIVASKINLLNFRYEFDFWGKNRAALEASLGEAAADKAEMADTLL
RLTTAIARSYFRGVALRHQLDLATEMVKLRQDLLDISETRLRLGLDSVDPVKESSINLEQ
ARKREALTRDQLDLQRNLLAKLIGKGPDSTQHLFLDKVNIPRDLALPDKLPLELLRHRPD
LTSALFRAEAAAQRIKEAKARFLPTIDLTAFAGVNALRLTKGASTLANVLFSGSSVAYGV
APGLRLPLFEGGRLRAELSAQRAEYDKSVELYNDTLLHAIQEVADSLSGWKESLSILEAH
GRLMSSQRKNQELAEDRVRAGLDDRRELLDRRHAVLEQEYVLKTLETDHLAARVDLIESL
GGGYSKEIEIIQQLIRHKPEHPEGFDLYKWLIFSQKE
>fig|1132443.3.peg.3977 Membrane fusion component of tripartite multidrug resistance system
MNVSHRTIRARRKRYLQLVLLASLAGGLIYAGFWWLHARHWVVTSNAFVSGNLIPVEADA
TGIVTQVLTEESRYVKKGELLVQLDRHRALTALNQSEGKLGQTTREIGALFATRRQMCQK
LIARSASLSRVRHDVVRLRQAAPNGSVSEQALQNAEDEMAALDAQRLEAEAEFNAVEARV
GGTTPKRHPDVETAKHNFIAAYLEYARQHVYAPASGYVAKRKVQVGNRVQPGDPLMTIIP
LDHLWVEANLRETELMRVRPGQAAEIAVDLYGRHLTFHGTVEGLVPGTGSVFALLPPDNA
TGNFIHIVQRVPVRIALRADEILKNPVRPGLSTVTSIHVEESERPPGDSLVTVSSREYAT
DIFAGELTEAEKRAEKIIEDNLPFSSDFAEYRCHAGER
>fig|1132443.3.peg.4003 Multidrug resistance protein B
MKTLETSSPNLILETPALEKNNGSHLGLPQWIGFIGMVFGIFMAVLDIQIVASSLEQIQA
GLSATREEITWVQTAYLVAEVVIIPLSGWLARALSTRYLFALACGGFTLMSLFCALAWNL
PSMVIFRALQGLFGGAMIPTVFAVIYTLFPPRLQPAMVIVVGLVVTVAPTAGPVLGGYLT
DAVSWKALFLVNLAPGLLVSLSTWLFVRVDEPEWDLLDKIDFRGILYIVLFLGSMQFVLE
EGVKEQWFESREIGFFALIAVVSGTAMLYRELTIEHPIVDLWAFRNRNFAVGCIFSFILG
IGLYTIIYLMPVYLANVKGLSSLQIGQYVMVTGLFQFVSAFVAGPMAKILDSRWMLALGL
LLYGLGTWMNGNLTYEAGYWEFFWPQAVRGFALMFCFLPINSLALGTLPAEEVKNASGLY
NLMRNLGGAIGLAVANTLMIQLNKGNYAVLREKVTGGSAEAQAFLSGMKQHLIASSSPDP
ELAALKQLYGLAMREAEVLTLNTLFHILGLVFFAALLLMPWVRKVSAGEDPGGGH
>fig|1132443.3.peg.4004 Multidrug resistance protein A
MHSPFFKSPFFIIALVLAASAGGLLYWFKTIRPFETTDNAYLKAHISLISPKESGYVREV
LFEDNRKVMPGDLLVVIDDHDYQAKVAQAEAQVMLEKATMATLETDKQAQSAMIRQEQAN
MAASEANVEKSGKDLQRFRNLAAEGAISAQTRDTAESAYKQAKAERDKYLSTTQEAISRL
SSLDARITETQARLKAALAALELARIDLANTRIFAPFEGVIGNRSVQVGQLVQPGTVLAY
LIPSDGIFVEANFKETQIARMQPGQTVEIGVDALPDQQFTGMVDSFAPASGSEFSLLPPE
NATGNFTKIVRRVPVKIRFRAGTSLSRLRPGLSTTVRVKVR
>fig|1132443.3.peg.4743 Permease of the drug/metabolite transporter (DMT) superfamily
MPGFFIEKFFCFRMRVCLAYVIVILLWSTTPLAIKWSGEGPGFLFGATARMVIGAGGILL
ALAGSRKRLPWHKSALMTYLAVALQIYGSMMTVYWGAQFIPSGWISVLFGLTPLMTALLA
VYCLGERNLSLGRFLAYFFGIAGLGVMFGSALQSGRNAVMGITAVIIAALLQSLSAVWIK
YINAGLPALVQVAGGLLFALPAYLLTWAVADGHWPILLPPISVASILYLGIVATTFGFVL
YYYLLTRLEATQVALITLVSPVLALLLGRTVNQEPLTFRVLAGSLLILSALVLHEYFDRV
VGLKRVVSNGKSRH
>fig|1140.3.peg.464 Permease of the drug/metabolite transporter (DMT) superfamily
MGDDQSDRLRCAGLPLKFPVSLQLAIATALWGGTFTAGRIAVQQLSPLAVACGRYLLATT
VLLLILWQREGWPPLNRRQQLLLFGLGVSGIALYNWLFFIGLSLIPASRAALIIALNPTA
IALGAAIWTGDRLRSWQWAGVGLSLIGAILLLGSRQAGALTLPGWGDLALVGCVLCWTVY
SLLARQALRSLSPLTVTTGACCWGSVLLIGLWLGQGAQLPVNVSFSTGSAIAFLGLGGTA
LAFCLYANGIERLGAARAGLFINLVPVFGSAIGALLLQEPLSGLTLLGGLLVLAGVGLGT
LQRLQPVPISTTEPVGGDRSPGPPALGHDR
>fig|1140.3.peg.986 Permeases of the drug/metabolite transporter (DMT) superfamily
MPTEIRLAPWLLLASLTATCEATKDLFAKRSLQQLSATRLAALLSLLTTLLLLPIVLWQG
IPAIGPNFWWSCLLGSSLNLVAFWLYARALQMGELSLVAPIVNLTPLFLLLTSPLIVAEH
LAWQDSAGVILLVIGAYQLNRRDRDSSSRLQPLIDLWQQPAQRIMVVVAFLWSITSNLDK
IGVQSSDPYFWLLCLFGSTGIVLLILGRGLGPVRKYPWRSLSAMAIFNSVGVVAQMVALN
QATVVQIISVKRLSTLIGVVYGAVFFGEKQLRQRFLGAALMMAGAIVLL
>fig|1140.3.peg.1243 Multidrug resistance protein B
MNQIIQKIRDFWSGTQGENHCWWALAAVECGNFVVYMDGFIVTLALPAMARHFDVGLPIL
KWVVVAYLLAVTVTLLPAGRLADIWGRKRIVVIGMSVIFISAWLCMLAPTVKILIACRVI
QGIGGGLVLANVMAEITAVFPKQDQRKAMAVNASVLALSQVTGLVLGGLFIVQFGWRSLF
LIILLVSLLGLILSIGILKLRSRTQGRASLDWIGALLAIGATSAPFIFVEELSKNLLNPS
SLLLLAVGVVALLLFVFVEQRVRQPLLNLSLFRSRAFTCGSASAAFYFVSAVSCYFFLPL
YAQLVLGLSPVMAGVLLIPLSVAITVTSLTIGRLGNRFSARTLSTIGLLCVSVALLGLSS
LGANASSTAIIAPLILQGMGGGLFNPPNNTATLNQVPPENLSVANGFLSTSRNFGQAIGA
AIAATLLAQGLSAAGAGDALAGAAGVRLSGFQLEAFLSAQRSAFQLAATLGLVGAVISVL
RPRRAPTAASLKSSGTAQ
>fig|1140.3.peg.2421 Multidrug-efflux transporter quinolene resistance protein NorA
MARQRLAFFSVALNVFMDALGVTLLLPILPELLRPFGSNAFLLGAFASVYTLAQFISTPV
LGSLSDRFGRRPPLILTLVFTGLAYVLLAVGSLVENLPLLFAARILAGLAGGVFAIAQAY
IADRESDPLKRSTQFGWIGAAFGLGFLFGPALGGLLSGINLRLPIWFAAILAFINAALTV
FTVVESLPPERRRIVPWQDLNPLKQLWAVSRNPKLRRSLASAFIYNFAFAGFTSLFVLFV
QNRFGWTPLQVAGVLIAGGFTSALGQGLIFGRLLPYFQEKGLALIGLGGMAVGYLWLAQV
PTPGSQLYPAQILTALFGGFVIPALSGLFSRRVTAEEQGQVLGSVQGWQSLAQVIGPLIL
GVVYDRGGADPFFWSLAALNAIAVLLLLPRSRQPLE
>fig|1146883.3.peg.216 Vancomycin B-type resistance protein VanW
MIFRRAGAGRVPRGVTATAPRDRGTAPGRGVATSGARRVPRGVTATAPRDRGTAPGRGVA
TSGARRVPRGVTATAPRDRGTAPGRGVATSGARRVPRGVTATAPRDRGTAPGRGVATSGA
RRVPRGVTATAPRDRGTAPGRGVVRRTTV
>fig|1146883.3.peg.2312 Probable antibiotic-resistance protein
MSTLNLDELVAIDVHVHVEQDLHGHKSMDDELLAAASKYFKGDPYHPTVPQIAEDYRAQR
MAAVIFTVDSELATGHPTLSNEEIAEAAAQHADVLIPFGSIDPARGAAGVRAARRLVEEH
GVRGFKFHPTIQAFEPNDRRHYPLWAELESLGVPALFHTGQTGIGSGLPGGRGFKLRYSD
PMLLDDVAADFPGLTVIMAHPSVPWQDAAISVATHKANVYIDLSGWSPKYFPPQLVRAAN
TMLRTKVLFGSDYPLLRPDRWLRDFEQLEIKDEVRPLIMKENAVRALGLRGA
>fig|1146883.3.peg.2356 Permease of the drug/metabolite transporter (DMT) superfamily
MPCHGRRRGDRFGTVRLARVTATTSRVQTLGGPALFVLLWSTGFVGAKYGLPYAPPFTFL
AVRLGLAAVLLALVAAALRSARMPDRAQYGRASVAGLLLHAGYLGGVFYAISLGVPAGVA
AVVVSLQPVLTAVLASHVLGERPTSRQWVGLVLGLTGVALVVGPGVLATGSAEPLPTVGL
IACVVALVSGTLGTVWQKRHGDGIPLVWGTTVQYAASAALLLVVALVTEDPSIRWTGEFV
AAFVWLVLVLSIGAVLLLLLLLRRGTAAGVSSLYYLVPPATAIEAYLLFGETLAGLSLVG
IGVTALGVALVVVPQRKRVDQAGSSPE
>fig|1146883.3.peg.2688 ABC daunorubicin resistance transporter, transmembrane permease component
MSAAPTAATDAADTAAVRRAIASTARPPRPGALSAALTFGWRGMLKVKHVPEQLLDVTVT
PVMFVLMFTYLFGGAIAGSTSAYLDYLLPGILVMSVLFTTVYSGVALNTDVTKGVVDRFR
SLPIWRPAPLLGALLGDSVRYVLAGTVIIVLGVLLGFRPDGGFPGAVSALALVVVFSFGL
SWVFSVLGLLLRTPNAVMNAGFMGIFPLTFLSNVFVPPATLPGPLAAFVEVNPISILATA
SRSLMAGEPDLTAILVSLAVAAALALVFLPLTTRLYRSR
>fig|1146883.3.peg.2716 Glyoxalase/bleomycin resistance protein/dioxygenase
MRMIFVNLPVTDRDRADAFYGALGFRRNDQFSDERCVSYVVEENIHVMLLTRERFADFVT
GAVGDPAQATSVLICLSADSREEVDRLVSTAVTAGGKPWLPPQDHGVMYGASFADPDGNV
WEVMWMDPTVVQG
>fig|1146883.3.peg.3025 Glyoxalase/bleomycin resistance protein/dioxygenase
MPAPSHAVPGRSGAERIHHAGLSVGRMPSFPGIAHVSLTVTDVDTSTRWYTALLGSEPRR
TMTDGPFVRRVFAVPGGQAISIVQHDGAPPADTFDPRRPGLDHLSFEVGAEAQLHAWERR
LAELEVEHSTVQRADYGSVLSFKDPDGNALEFIASS
>fig|1146883.3.peg.3068 Vancomycin B-type resistance protein VanW
MLAAAYGVDLLAASGEIPRNTVVAGVDVGGLAPARAAQLLEEELAPRVVADHTVTAADVT
GTLSPATAGITLDVARTVDAAEDQPLNPWTRLVTVFSDREVEPVITGEETALAAQIEGIA
AQVDRAPQDATIAIEGTTPSVVEPADGRALDRDGAAEAITDALASGGDPSVPIELPVDVT
RVDVDVQEAERVLEETVTPALSAPVRVVSQDGGTSAEVPVEAIAAALTFTPQDDGELAVG
LDAPALQAALGDELGAFGTPAQDARFEVSGGAVTVVPSVDGTGIAPAQLVEQLLPVLDDE
APRSVTAELGPVPAEFTTAEAEALGIREEISSFTTRIGNPASGENIRVVAKEVDGAVIMP
GETFSLNGFTGPRGTAQGYVEAGVINNGEFTTAVGGGISQFATTMFNAVFFAGLEDVFHK
PHSYYISRYPAGREATVYYDSIDLTWRNDGDTGVYVDTAWTPESLTVTFYGTERYEIQSV
SSERYNIRQPVVQDKPDSPTCEPQSGSTGFDITVTRIFRDLTTGAELKRENFVTRYAAEP
IINCVPAEPPAPAPEGTAPSPAPAPGGRRPAHGRAA
>fig|1147128.3.peg.826 Drug resistance transporter, EmrB/QacA family
MVIVFITQLDGGAVPTMLPSITRTFGLTTMGSSWVVGLYTLGLVVGTPITSNLSDAHGAR
KVFLWELAFWFLGCLMTAVSPNYAVMLLGRFIQSLGDSGIMVLSMNVLLQRARRNNQGRK
VSTVGIIAGLSAMVSPVLSGMLLGITHGWRAYYFMMLPFLAILFILAWFMMGDSQTDRAW
KTDYLGLGSFSIALALLMVAITFLQYGTAYLALIIGCLLVTVVAGAVFLVHERGLGDSKE
TMPFLPIRLLKLPSYGLTLLLGTLGGMFFSLFVYIPTYVHSVFGLPVRSAGMVMVGVGLG
SVVGSWLGGLLVDKFGYRTTLVFSSSLIGLMALVITLTLHNLQLFMVLSFLMGVGMGSMM
SSPLQVIAGRLAGPENRMQAIGGLSACKKIGTTIAPLLFASAIELGKVGGQAGLASYRNM
FLVVIVIALVNIGLTYCIPFSQKEVADD
>fig|1148.1.peg.28 Multidrug resistance ABC transporter ATP-binding and permease protein
MLLSPQSNRQVLMAYLSPQWGQVLALAIALGGSIILQVLNPQILRYFIDTAMAGGPQTIL
VWLALGFMAIAVVRQGLEIVATYCSETVAWTATNNLRLNLARHTLNLDLTFHKNHCPGEL
VERIDGDVDALARFFSQFVLQVLGNGLLVVGVLVVLWFEQWQAGLGLTLFALVALGILSR
LQSLAVGPWQVYRGISADFYGFITEYLAGLEDIRGNGAVDYVMNRFYTLIRNWLRAFHQA
RLQSTLLWGSTVGLFTVGNAIALALGAYLWRVQGITIGTVYLLFYYASLLQDPIERIREE
LEQFQQAVASLYRIQDLIRQSPSPRLGRSQALPSGSLSVEGKNVWFSYPTTASLKPGDGN
HELPEHRQGHHHEDADYALQNLTWHLPAGKVLGLLGHTGSGKSTFARLLLNFYAIQQGQI
QLGGINLGEISQRELHQRVGFVTQDVQLFQTSIRNNLTFFNPHIPDRLILQALNDLGLEP
WLATLPQGLDTELGTDGGGLSAGQAQLLAFARVFLKDPGLVILDEASSRLDPLTEQLIER
AINRLLEHRTGIIIAHRLKTVERADQILILDRGKVLEYGDRPALAHNPASRFSQLLRTSS
AIKLT
>fig|1148.1.peg.49 Antibiotic resistance
MSPMELTPETKAAVVTQGLTKRFDRQGAVTNVDLSIAEGAVYGLMGPNGAGKTTLIRMLA
TAEEPTKGEIYLFGDRLVAGADNLRIKQYLGYLPDDYPLYEDLNVWDYLDYFARLYHLKN
PGRRHRIQEVLELVQLTSKRHSRINSLSRGMKQRLSLARTIIHEPILLLLDEPVSGLDPL
ARQQFRDIIRVLQAAGMTILISSHVLSDLAELCTAIGVMELGCLVESTTLADLYNRLGQR
TISIFLLEGVEQLQDCLKNQPGVEDWQINYDQGDQPNSAPGTHCSVIFSGSPEDSANLLR
NLIYAGCRVSQFHCQQEDLESIFLKLGHQQVS
>fig|1148.1.peg.168 Transporter, drug/metabolite exporter family
MRILSNVNLMGLLIVLLAAIFFCFHNVIVRILYSQQNILGIWQVGGFVTPTLSHSFLLLL
LRMLWVVPLMALISQRLYGNTWREINQLKQPVNRPVIWEAMGCGFLMFLYLVLLYISISF
IPTGIAITLFFTYPIFTALLAWRLFNDVPSLLRWLVIGLTLIGTFLTIPYAYGGEQQTLV
LGVSTGIASGIVYAGYTVFAQRSFQRLHPVPFTWISFATTLILSILCLIIWQPHEGNLPW
LAITIGSLLSALFTLAGHVLNNWGIHLIGASRAAIIGATNPALTVVLAGLAIQESLTNIQ
IFGVCLVTFSIALLNYEKVSPSTGKNSLK
>fig|1148.1.peg.687 Multidrug resistance ABC transporter ATP-binding and permease protein
MTKPIAPLLSLLNYSRVHRAKIYWAVTCSLLNKIFDLAPPALIGLAVDVVIKQQDSFLSR
WGIVSVQSQLLVLTVASAVIWALESIFEYAYERLWRNLAQDIQHDLRLDAYAHLQQLDLA
YFEERSTGRLMAILNDDINQLERFLDVGANEILQVLTTVVVIGGAFFVITPDIAWMAVVP
MPFVLLGSIYFQSLLTSRYALVREKVSNLNSRLSNNLSGIMTIKSFATEAEEVERLRQDS
DAYRDSNQRAIALSAAFVPLIRVIIFAGFSTILYFGGLDAVRGNLAVGSYSMLVFLTQRL
LWPLTGLGKTLDLYQRAMASTQRVMQLLATPIQAHPGELSLHPSQVQGELVFQNISFAYP
HRSAVLKNVSLRVPAGQTIGIVGATGSGKSTLVKLLLRLYEWDSGDILLDGVDLKKYFLG
DLRRSVGLVSQDVFLFHGTVRENIAYGSADATLAQIERAANLAEAEEFINQLPQGYDTII
GERGQKLSGGQRQRLAIARAILKNPPILILDEATSAVDNETEAAIVRSLEKITKNRTTIT
IAHRLSTVRYADQIYVLENGMVQEMGSHESLLAHQGLYAKLWRVQTGLRSGVS
>fig|1148.1.peg.861 Multidrug resistance ABC transporter ATP-binding and permease protein
MNRASPMTQAVPGLWAVITTFWPQIRAQWRLLLVAMVTLLADVGLRLLEPWPLKLLIDGV
LIPTQTQPSLSLWGFTNLNAAWLLMLIAVGVIIIAVSRAIATYWNTVSLAIVGSRVMAQV
RDQLYGHLQRLSLRYHYQARSGDLIIRVSSDANRLQEILLTAALPLVVSLLTLGGMVGVM
AWLDLKLTLLSLATFPLFWLAANRLSAKIRHASLTQRHQEGAVASTAAESLSAIKLVQAL
SLEQAFADLFSRQNQRSLQENIETKRLAANLERLVDVLIAFGTALVMGYGGHLVIEDALT
AGTVLVFLTYLRNAYKPVQNFAKYTGRLAKAAASGERILNILAETPDIQDKPGAIPAPFF
QGRIEFKYVSFGYHPDQAILDGLNLTVRPGEKIALVGASGSGKSTLLSLLLRLYDPTAGK
IFIDGHDLRDYQLTSLRNQMAVVLQESLLFAATIRENIAYGIEGATMAEIEAAARLANAH
KFILELPQGYDTVVGERGTTLSGGQRQRLAIARAAMRQTPILILDEPTSGLDKVNEQLVF
EALERLAENRTTFLVTHNLQLAIAADQILYLYQGQIREQGTHAELLARQGVYADLFQRQT
LATVTKSLGR
>fig|1148.1.peg.994 Multidrug resistance ABC transporter ATP-binding and permease protein
MGRMAKYIGAGDVRSILIMAGVAAGIFLVRGMAQYGQDTLMAKAALNMALTLREQTYAHL
QRLSLSYFEEAKTGDLSYRLTEDIDRIGEVVNKLFHDFVPSALQLVVVFGYMFYLNWALT
CAVLVIAPLMAVLIGFFGEQLLKFSRRSQTRISNLSSLLTETLGAIRLVKAFAAEDYQLD
LFREEAQQHRRSQFLAERMKALQFVVVGFLEAMGVVVLFCLAAWQISLGNLTGIEFISYV
TGVAMLIDPISHITSNYNLFKQGEASVDRIFEIFDLQPSVEDSPTAIAIDHLQGAVDYDH
VDFAYLEDKLVLKGINLQAQPGEMIALVGASGAGKSTLVNLLMRLHNVTGGCLRIDGHAI
DSITLKSLREQIAIVPQENILFSGTIAQNIAFGKTDLDLAAIEEAARIANAHQFITELSQ
GYYTYVGERGVTLSGGQRQRIAIARAVLRNPSILILDEATSALDSESEALVQEALERIVQ
ERTVFVIAHRLATVRKATRIVVLERGEIVEMGSHQELMAHQGRYARFHAQQFAS
>fig|1148.1.peg.1257 Quinolone resistance Nora protein
MSSFQTLRQLSPSTQKTFALLFASVLMFWLSLTALLPTLPMYAQDVGATKQQVGWIMGSF
ALGLLGSRIWIGQLVDRRGRKIAIVIGALVVALAPLGYLLTATVGALMAIRAFHGICLAA
YTTGYNSLVVDLSPPQQRGEIIGYMSLAVPIGMGFGPAVGAYISQSIGYEFLFIASSLLG
FISLVLALQVRENRPPDQSSAEDVFGDRPRPRSIGKLLTSRSMAVPTLVLLLIGLLFGNL
ATFLPLFVREIDLATYAGVFYSVAAIASFVPRLFLGSLADTYGRGLFIVGSLICYLLSMV
CLAQADNSWELLTAAALEGAGSGILLPTTIALISDRSSLEERGRVFSVCMSGFDGGIAIA
APIMGVLNEIFGYRHVFWLSGGLALAAIMVFGIFSNPTIGRSLRFCIGRSRDLYATPQ
>fig|1148.1.peg.1985 Acriflavin resistance plasma membrane protein
MSSPNSVFSLSGLAIRRHIATLMLTLAIIVLGVFAVFSLPVDLLPSITYPRIGVRLDAPG
VSPEVAVDEITRPLEAALSATEGVVQVYSQTREGQISLDLFFEPGGNIDQALNDATATFN
RARNQLPDDLETPRLFKFDPSQLPVYEFAVTSPELSGPSLRVFAEEELARELGVVPGVAS
VNVSGAAQEEVRINVDLQRLQRSGVSLTQVLDALQSRNVDISGGRIVGTESEPLTRTVGR
FASAQEIEDLVVGTVSGLEDQSAQKVYLRDVATVIDGTEEERIFVTLNGNPAVKVSVQKQ
PEANTIEVVDGVKKRLEELRTEGIIPQAAELTPTLDDSVFIRNSVNNVVVSGLIGTVLAA
IAVLLFLGSLRQTLIIVLAIPLATMAAIIVMKAFGLSLNVFSLGGLALGVGIVVDNSIVM
LETIAEGAGMTPGKVNPLPLTKGEMRNQAIASSQTVESALVASTSTNLVAVLPFLMIGGF
IALIFNELILTISFAVAASILVAVTLVPMAASRLLAIRRRSGLGNWLFFREFNRRFAGAT
AAYARFLSILIRHRLVAVASIFIVFGGSSLWMIGQIPQEILPRINTGQASMFAQFPPGTP
LEENQRLMAIVDDILINQPETEYAFTTVGGFLFGSNVNANALRSSSTITLKPNTDVEAFT
ERVTAELEALNLVDIRLRMAPGQLRGLILSNSPLRNVDVDVVLQGNDADVLDEAGRAVLA
ELGEKVTLARFRPDADPRQPEVQIRPDWQRATELGLTTQAIGQTVQTALDGAVPTQLQRE
NRLVDVRVKLDNDLLSGPGDLAQIPLFIDGDRPIRLGDVATIDQGRAPGEIQRINQRPVF
LIAGTLVEGASLSEALTEVDQVLSAMEFPPGVSRLPSTAAASNEQLQSSLVILGGLAAFL
VFVVMAVQYNSLLDPLVIMFTLPLALAGGILGLYVTQTAIGATVIVGTVLLVGIVVNNAI
IMVELANQIWAEEGISREAAILRAAPQRLRPILMTTITTVLGMFPLALGIGQGSELLQPL
GIVVFSGLSLATLLTLFLIPCLYVLLHQWEGVDIEKVKTDLESRLTEEDVPTKIQ
>fig|1148.1.peg.2120 Acriflavin resistance plasma membrane protein
MLLSISNVFIKNPVLTTVCTIVIILLGAIALPLLPLAKLPDMAPKQVQVTTNYVGSDAQT
AVDNVTTVLERQINGTEQVIYMNSTTDNTGTSTINVYFPVEMDRNIAQVLVQNNVAIAAS
SLPEVVNRQGVTTQTQSPSVTIAYGVYSENDDQGKPIYDDIFVSNFVDRVLLDEIKRIDG
VGSAILIGASEYAMRFWLDPDALAARDLTAADVTNAIRSQNIQVGVGGVNLPPVTDQQRF
QINARALSRFTTPEEAEQIVVKVGDDGTLIRIKDVGRATIGTQNYIQTALFNNAPAVAFV
IYQLPGTNALDTANMVKEKMAELRPLFPPGLNAEVALDNTLFVTASLEEAALTLIEAILL
VILVIFIFLQNWRTTLIPALAIPVSLIGAMAFALAFGFSLNQLTLFGVILATGLVVDDGI
LVVEAIEVKLDQGMKPFQAALDAMGELTGAVISTSLVLMAVFIPVTFFPGTTGIVYKQFA
VIMASAVAVSTFNAISFSPSMSAILMRPKKEVHGPLAWFFNLFNRTFDWLKERYGNIITA
ILKVRLLAIPIFIGSLILTVIVYNITPTGFIPEEDQGYFFMLGNSPAGVSIEYTKDVISQ
ATEIVSARPEVEHVLGMGGFSFLGNDSSKSLFFVKLKNWDERPGQKGSVFGLLAEINREL
AQKIPDAQVFAVNAPPVDGLSSTGGLDFYIQNRGGMPLENFLDYVQQYMEKLRQEPALNP
RTVFTQFTFNAPLLEIGVDREKANAQNVDISEVFNTIGIYMGSSYINQFVMESRLYQVYA
MADGQFRSNPRDIGRLYVRSRTGALVQLSNLIDVKQTTYPPILTNFNIYPAVDVQASPAA
GYSTGQAMATMERLSKEMFPDSIGYAWYGTGYEELQSAGAAPIIFGLAFIMVFLVLSAQY
ESYVDPAIIMMTVPLAILGAIGAILLRANFMVATNMVWPTVNNNVYAQVALVMLIGLASK
NAILIVEFGNQAMDLGMKIPQAAAFAAKERMRPILMTAISGLVGFWPLVIASGAGAMSRW
SLGTAIFGGYLISTILSLFLVPVLYTLVKEAEARFLKGEKGEGDSNPPPPSGEDNGEPVN
NPS
>fig|1148.1.peg.2160 Daunorubicin resistance transmembrane protein
MSQTLTPPKITSLLAPQAAPANPPSLTVEFFQETIALTKRLFIQLQRRPTTLVAGIIQPF
MWLVLFGALFLNAPQGLFGNDLNYAQFLAPGIIVFTAFSGALNAGLPVMFDREFGFLNRL
LVAPLASRYSIVAASTVYIISLSLIQAAVIVGASALLGAGLPNSFGLGMIALIVFLIVLG
VTALSLGLAFALPGHIELIAVIFVTNLPLLFASTALAPLDFMAHWLQVVASLNPLTYAIE
PIRYIYLNGNWGLDSTVLTAPWFSLNFAQVLGVLVLFDGLVLLLIQPLLKRRFL
>fig|1148.1.peg.2161 Daunorubicin resistance ATP-binding protein drrA
MGKSYLMGVAVQVKQLRKKYGAIPAVKDISFAVPRGEIFGLLGPNGAGKTTTIRCLCTLA
KPDGGELWIDGVNVLSDPRQARRRLGYVAQEVAIDKILTGRELLQLQASLYHLDAISSQK
RIDQLLDILGLTAYADQKTGTYSGGLKKRLDLAAGLLHQPTVLVLDEPSVGLDIESRFIL
WEFLRQLRDAGTTVVITSHYLEEIDALADRLAIIDQGTVIATGTPTELKDRVGGDRVTLR
IKEFTADQEAEKASQILRSLAFVQEVIVNQAQGNSLNLVVTPQSNPLSQIEKALLADGLP
IFSLAQSRPSLDDVYLAATGKTLMDADLAAAAQRDLKAEKKQAMKAS
>fig|1148.1.peg.2631 Quaternary ammonium compound-resistance protein
MAWPCLSVRLVHEGKYGLFTSKRRGSLTLLTGAKRLTLTEWKTIGLLLTMVTTQVLGDIW
LSRGMKVFGAVEDYSLAGLWTLFLYLLTSPWIVVGVITLLFALFLYFTATSRLDLSLVLP
LFSSSYILNALLAWLILGEEVSFYRWLATFMIASGVFIVCWSEHRHRSQLMGEKFSPTPA
PVVPVKSSRRSPLWLFPVGIALSRVWFGILILIFTDSAGDVLIARGMKQIGPVRLQSPLK
MVKLIGRILSHPSVLGGIGCQTISFVTFISLLSWTDISLIRPAGALGYVMSLLGAKFLLK
ETIPLARWLGIGVITAGVALIALDEVNLVDQILLFFL
>fig|1148.1.peg.2643 Multidrug resistance ABC transporter ATP-binding and permease protein
MAAPSVKQLLRYLTPHWRAIGAGTFALFLANALGVYIPILMRDSIDDLMPPFEASDVARI
VVLIVVLASLMWFIRMASRILIFGVGRQVEYELKQKIFDHLLKLEPLYFTENTIGDLINR
ATSDVDNIRRLVGFAVLSLINTVFAYALTIPAMFALHIPLTLLAVSVYPLMLMSVNLFSG
KLRDYQLEVQEELSALSELVQEDMSGISLIKIYSQEDNERQAFQTRNQKLLQANLKLARI
RNFLFPLIEGLAYLSLLILLAFGTGLIQDGSITIGDFIALIILVERLVFPTALLGFTITA
YQRGEVSIQRVEAIFHTTPKILTVPQPLPFSPAQATGKITARGLNYCYPGSDLPALEQVD
FTVYPGEMVAIVGPIGSGKSTLVNVLPRLLDIAPGQVFIDDYDITQIALSDLRSAIAFVP
QESFLFSTTIAENIAYSDPSQTDTAIEQAAHQAHLDQEIANFPQHYQTLVGERGITLSGG
QRQRAALARALILDAPLLVLDDALSSVDNQTATRILHYLARRNNTVLFVSHQLSAAAQAD
RIFVMDHGRIVQTGSHEELLQQSGLYQSLWQQNELEKVLS
>fig|1148.1.peg.2644 Chloramphenicol resistance protein
MSEPKPSQPNFSHLEEADYTGRMRQHDRLFGLLAIAAGLIFLQGYMIAPLIPRLAEIFDV
SAQEIGFIVPAYMLAYALAALFYGILSDRFGRWPVIQISIIVFITCTALTATAQTAAQMT
FWRLLTGLGASGVIPLTFALIGDMFPYNQRGAKLGLVFAAMEGGMAAGSAGGAILEPFLG
WQLLFIGTATAPVIVLWRLRRYGALFDAPKATKIPALATVFAGYWAVLSNFRGMRTYGYV
LCNGIYHSGVYTWLGLYLSQRYEMDTLSIGLNILGYGVPGLIFSPLIGKAVDRWGRRWLI
PPGLAMAAIAGLTMVPFIPPLAVTMAILVMSLGYDLTQPLFVGIVTDLAEEDTLGQTMGL
KVFTLFTGFGIGSWLFGEVLHWGFEVALVAFGVMQLLSAIAAIPLFWNEKPSPINVSA
>fig|1148.1.peg.3100 Acriflavin resistance plasma membrane protein
MRINSSSKNRTQKKLGIPSMQSPRAPRWNLSHWAIDHPRFTIGFWLAIAVAGLLTFSSLK
YALFPEVSFPVVIVQSSGAGLDLAQTEQKLTIPLEEKLVTIADADVQSSTYPGQTVASVI
FLMGQSLEQATTAVEQSLQGVTLPAGSEITVAPYNLNESVAVTYAVASETLSLEEMAAPL
QQELMPQLQNIAGVLRVDLLGDANFRSPGVKALAQQTINPPTLTRHNGQDVLAVQVVKTA
QANTLEVVDRVEQLIVEQAPKFPQLKFIEAETTAGYIREATQATIEALLGAIVLAVLIIY
PFLRSGWATLISAIAIPLSLLGTFIVMAALDFNLETLTLLALALIIGIVVDDAIVDVENI
ARHVEAGEPPKRAAKIGTEEIGLTVSATTFSIVVVFLPIALLGGTLGEFFFPFAVTVSAA
VIVSLLVARTLSPVLTVLWLRTQTPRPQSWFSRGLDALGNGYQRVLAWSLGHRWWIVALA
LVSLMAGLAIIPLIPQGFVPTLDRGEFNVIFQSAPPKIAGALSTPPRGNNNDTSAGGAFG
WIDQLATNPEAVLLRRGRRVAEELEPPILADPAVTETFTVVGIQGNPLQGKIYVKLDSDR
EVTTQTVQTEVREALPEIPRVTTRVENILFVQTGDDTPLKLALLGNDLDLLQTTGKALEE
KVMALPGLTQISLTGAEPDSTGILRLRGQRAVYLSASLLPNYALGDLTQQVTAIAEGLLP
PGVELSVQGESARVGSVFREFALAFLLSLLGMAAIFLGLFRRLLEPMVVLLSLPLSIVGA
MVGLLVTQSEFGMISLIGLIFLLGLLDKNAILLIDYANQLRHRGLSRQEALLQTGHIRLR
PILMTTSSTILGMLPLALGWGAGAELRQPMAIAIIGGLFTSSVLSLVVVPVLYSLLDDVW
GQKPRPEKT
>fig|1156986.4.peg.1163 Permease of the drug/metabolite transporter (DMT) superfamily
MQTQMTSLLKSQYRLPLFYLILGAVAIGFAPIFVRLSEVGPIATGFWRVALAFPLLTLFS
IDQGTTQPDTSQPISWRDYAWILFAGVLFGADLATWHFSIHYTTVANATLLANFSPVILA
LWGWLVLGQRPQAQLVWGLVLAILGVAILVHPNLQLGQSTWRGDALAFFTSFYYTAYLLA
MNRARRIFSAVVSMAIASFSSMLFLALLMWGTGEVWFPVSLTGWFVLLGLAFFSHILIAY
AFPYLPATFAATTLLVQPMIAAMAGWFFFAEKLSLLQITGLLVALGGIFLAKKTI
>fig|1156986.4.peg.1716 Permease of the drug/metabolite transporter (DMT) superfamily
MIGFFNAVAYLSQTIGLQTVSSARAAFITGASVIWVPLLSPLFCLTWPTRLDFICAGLGF
LGLYILTSPGQQSLTSGDLWIILTSLSFALQILFLQRLNQTITHYPLFTFYQILFTLPYV
MLGLQHPTFSAALQPAALTGILFCAIFATSLAYYLQNLCPRAGFCEYIRSCPE
>fig|1156986.4.peg.1913 Permease of the drug/metabolite transporter (DMT) superfamily
MDCSIQKSTYLLFLLLAIFWSGSFVAIKAMVLWIPPLLSAMFRIGIALLFLIGLLIFLRK
PVHAPFSLRWRLWVTGLFSQGIPFSLLFWGEKHIAPGLAGILNGTVPLWAFMLGLFSPKT
RDISPLKCVGLIMGLIGTAVIFGPMLDTQGLQPDVLGLIAILLMAISYAIGSLLAQHLLR
DTTFKLDVYTNIYHQHWASFIFVLLLTLFFESWPSSTIFTQHPIIAISALYLGIFSTALG
WLIYLYLIREWDAVRASAVMYLVPIMALFWDFLFFHRIPQWTEGVRVSSSF
>fig|115711.7.peg.812 Multiple antibiotic resistance protein MarC
MLILLNLSLLFYVLFDSPGSIPVFVALLKNFSRKKQQRVILRECLFALGALILFVTFGRS
FFQFLDISLYAFQIIGGFLLFTVSIKMMLAPMPEKAKDDTSKTEPIFFPLAFPVITGPAV
ITALLSYMEEGIYSREIIFTAMIIAWAFSLFTLLCSSFFDRLSGNFGLLALERLFGIALL
LMSVNLMLKGISIAFNIGFYIG
>fig|1157951.4.peg.1405 Albicidin resistance protein
MLFQVGEIAQKTGLTIRTLHHYEEIGLLVPTARTDAGYRLYNVECLERLTQIQMLRQVGV
KLKDIGKILDGHSGNMAQLLQERISALSEQMKQIAKLRYRLEQLQLQMQAGDILTQADWF
SILEMMSMYDKYFTPKELEKMPLYTANTLKSQEWQQRVETVKNLMQEGVTPDSEQARKVS
AEWMIALERDTGGNPDFFARLNKIHLSDNEFALSSGITEEMIEYVAKGFSEHQLAIFKSY
LTDSQFAFVREHYFESGKVWPELIAGLYRAQQSGVSPESPEVQSLAKTWLNMFNQFTGGD
PELQEKIRQIYRENPVISQGTWMTPEIGQYLFAALTAH
>fig|1157951.4.peg.1990 Multidrug resistance protein A
MTGYISRILVEDYQYVREGDVIAEINNQEELLNQQIAKANYKKAQQQLNNLADEIKEYDL
TIEKLWNRYKAAGIEVSQMQRSPLLRKELIKSGAITSQNYLDANSDLQRLIKLEQAAKAE
WEQAKQSKLLLAQQENIRLAERDIALANYQQANTQISYATITAPFDGQLNKIKLNVGSLV
TPGTEIVTVTPRSQPYVIAHLKETQLKNVQSGQSVAISVDAFPDMTFSGVVRDIGAQSSG
ESALIPADNSSGNFTKVVQRIPVYISLLSEQSAIDKLRPGMSVIVNIDTQSTQSQGD
>fig|1157951.4.peg.1991 Tetracycline resistance regulatory protein TetR
MKTPKITRLQILETALQLLETEGIDGLTMRKLADALNIKAASLYWHFSNKLSLVEGMADH
IVAEVALNECDSDDWKSNLLKITTQLRKALLQHRDGARVFAGTYAISDNVLRINNALIKT
FVQSGMSADKAASCTMTVFYFILGCCIEQQAALFSNGSDLQEKLNEFNKLSNDKYPYTWE
AKATLFSDNYDQRFIDGLNLIIGGLGTSK
>fig|1157951.4.peg.2082 Multidrug resistance protein B
MKLLKNHLIIGFLFGIQIISMGAMEMSGPFWPIHLQNNSSDSLLPFALTMVYVAPMIGIM
LTSTFWGKVGDRMGNKAMIIRALLGLSITQILLSFCNDPWLILLLRFIQGACAGYIAPAQ
AYGVAVTAPRKRTHLFALLQVSTNIGSLLGALAGGLILDYLNFFWINMMAGWLCMLSAVA
VFLFLPSDKHSPLLSPANTAHTTKKNGSPQTIVKQLMLLTGLLLMIRLITLPSFSLYIEK
TYSTDYWVIGLIYGLQAMGVILSAQLWAKWFEHQSIVASLTRLRWIIFGCAAIAISLANA
SIIWFALLYFIWGILLGATTPILTALISSASPAKHQGYVLGLSQSINQFASIGGISLGSI
LIIYPGINMLFYYISVGYLICLSTIILLTKHIINKEQYEKKV
>fig|1157951.4.peg.2457 Membrane fusion component of tripartite multidrug resistance system
MKKRTIALILLMLILIAAAALFHSHNQFLLLQGEVDAPEVMVTSKAKGRVIERHVERGDD
VKKGQLLLTLESPELTAQYAALKAARDQAKAQLAQSLHGTREETIRHLQASLAQANSQYQ
NASREYQRLSNLSAKGYVSANELDNARKAKEVAFQQVQGAKAQLEEAKNGDRIELRQKYE
AALNEAEQKLAELQVQLDDLQVKAPVDGEIGPIPAEVGEIFNAGSPLLTMVRIPQSYFIY
NLREDILVDVKKGDRVQLDVSALGDKKIEAEVRYIAPKGDYATKRATRATGDFDLKTFEV
RLYPVEPVDGLRPGMSVLWRWDK
>fig|1157951.4.peg.3043 Permease of the drug/metabolite transporter (DMT) superfamily
MRQYNYLIYALMCVLIWSFIPIVSRFGQNGLDSFQFLFWSNLISAMSVILVALIAGYKPT
KLFILPRDILLKVFVLGFLDCLFYLLLYYGYAIENGIAVLVIQYSWPLIIILLSVFLLKD
KLAGRQIVGVIIGFIAVIITFTKGHITQLQVEDPVALLFVFSGAFCFALMSVFSRQYSID
PYISTVWLFIFSTLTSLVLLLSFSELQLPSKAAFWPTVINGVLINGVSYILWFKAMNTGH
SAKIASIVFLSPVLSVLWLVVILSDPFEIAYIIGVLLVIVSGVLCVGQKRKQSY
>fig|1157951.4.peg.3161 Multidrug resistance protein D
MKRPLSLWLAVALMMFPQIVETIYSPALTGIAIAFHVNAEQASQTLSLYFFAFAFGVVFW
GRMCDTLGRRPTILAGLLLYGVASIGALFVTHFYLLLLMRMLSAFGAAVGSIGTQTAMRD
CYQGHELSKVFSIMGIALAISPAMGMLAGSLLVSSGGYQAVFIGLAVLAIGLLLWSCYRL
PETRPANVIHSPFLTTLFTMIRDKEIVRNVILIAFFNINLFSYYQLAPFHFEQLGLSQQQ
FGLTGILLALGVGIGSTLNRHLLGKNWSPEKLVKLSSFVSLISGCLVFILMHSVWFIAPV
IGVVIGYGIAIPNILAHALSRYSDNKGTAGAILGLFYYIGLAVGLMVAGWSQHLGGVLVI
GSIILSLSSLRYRTQ
>fig|1157951.4.peg.3896 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MIAQLLLLLLVSVLTCLGQIAQKQAVVCWQGDKHNKTASAIRWLVLALLMLGLGMLFWLK
LLESMPLSIAYPMLSINFVLVTLIGQFVYHEQTGLNHWLGVAAIMFGIFLMSISG
>fig|1157951.4.peg.3897 Polymyxin resistance protein PmrM
MNKGYFWVIGSALLVTIAQLSLKAGVVGLPSFTLGWHWLQSEWLLANLANLSIVFVGLVC
YALSMLCWLFALKSIPLNKAYPLISLSYVFVYLLAVILPWYHEPATWLKAGGVAFIILGV
WLISRPTKGQSQK
>fig|1162668.3.peg.397 Acriflavin resistance protein
MSQSSNQKPAMTLIKKYRGFSLLLTVVLSILGIVKAWNLPMTLYPSIDFPRVSVIVRSPD
IPFAEMESRITRPVGITLRGVQGVRELNSRTMQGSAEFFLRFSWHEQMSLALPRVAQAID
RIRGDLPAGTSIQAIRMYPSDTPVLTVALSSTSDNLPQITRIAKTRLIPYISNLPGVWKT
EIAGGKNPEIHVEVDPYKLSGAHRTFSDVISALSTQNRIGVIGPRTEEHRLKTVQIDNTM
TRTAEINKIFLPSPSGVPLPIDLLATVRRGVRPSDETIRISANGSPAVLLLVYRAHGGNA
LTIQRALLDHMNEFRRLLPKGCTPAIVYDQGALVSDAIRHVIWALAIGLSGAMALVILIL
RRGYPILLMGSLLPAILFISAGILGLLGETLNLMVLGGIAAGVGLVIDDFIVIIEGGRHA
HRMSGLLVPFVLSGLITILALVPLFGMNGLVGAFFAPLAISFVTLLGVSLLVNTFVTPAF
IHQEKETPVPISTGILTGLSPAVILGAGTLAFALLLLPLTHLKTNFMARMDEGSFTLDFH
APVGSSINDMDRAVLRVEDHIRALPGVIDTTRRLGTEMGFYITEPNKGDFVIRLSENHPK
STFELIRELRPWVQKNEPELDTDYSQVMEDSLGDLIGVSAPVVVEVHGQNRKDLLGTARM
IRDRLSGIPGLVDLHLSVRPMGDTLDGHVIAPLASLAGLTPEAIIAQTREDLMGITATTV
LSPGGPLPVRVLYPSEYRNGLIPLSHLPISESDGSLIPLSQVVTFTNTPPATEEEDKNLS
PILRIEGRLDHGNLGGVIKEIKAKVSSLTLPKSSWVTYSGAYKQEQKSFRTLGEALLGSV
LLIVTILYGTFRKWTPPLVLTAGMAFSVLSGIAALTFSGRTLNISSFVGLILVVGLSAEN
GFLVANRFESAEGNASEKLKEALSDRFLPIVMTHLANAAALLPLALGGGAGLDMERPLAV
AVLGGLVGSFFSSVFLIPSALSLFTRTVSPQEGLPDVQI
>fig|1162668.3.peg.496 Acriflavin resistance protein
MTGEKHGPGFAGWLSRTFIDSPLTPILILISLALGGLAVLKTPREEDPQIKVPMMDLFVS
DPGMSATEMSRHIVAPLERHLSRIKGVKAVYSQSESGTAVVTVRFHVGEPMGKSLVKIYS
EVMKSRGYLPRDAGPVLVKPMDINDVPVMAVTLYSKTESDAVLHRLSEEVATSFKRIPGT
GQVTVIGGRRRTVRVVLSPSDLTAHHLTAMDVSAAIWRSNRSIDLGSFDRNNISYQVALS
GTLTRVSQVRNLVVSVQHGKSIRLFQVAKVTDGPGPLESYVWIGHPATSPLSGDETAVTV
AVAKKKGINAVVVANQILQKMKDLSARKIPSDVQWTVTRNYGHTANEKADDLLLHLVVAT
VAVILLVALGLSLRESGVVAVAIPVTLALTLFGSMVIGYTVNRVTLFALIFSIGILVDDA
IVVVENINRHFHFLGGKRDRDTLLERAVVAVGEVGNPTILATFTVIGALFPMAFVSGLMG
PYMRPIPVNASLAMTGSLLVALTVVPFLALRMVPPAGHVNKIMGKVDAGIRHLYRSIMLP
LLNSRLRQNLFFASVLLLTVGVMAFFDTRTLLLKMLPFDNKSELDVVIDMPAGTTLESTA
RTAMALERVILKDPSVRSDQAYVGLAAPFDFNGLVRHYYLRRGKRVAEIHINLLPREKRS
LQSHRIAEEMERKLAPVAHSFGARIKMVEVPPGPPVMAPIVAEVTGPDQKSISDYAKKVR
DVFQHAEGVIDVDSTLPDPQVRYRIRVDQEKAALSGVSTEQIEKALTLGLHGETGELHTT
SGKGYVPIVLDVSRKDRSSIKDLDSIMVRSNNGRLLPLGTLIDVSEEGAPAVLYRKNLRP
VVYVTGNTIGSNRSPVYAAVDLSRKLPPSELSGHPEAVRQYFWGYPSSNDKISVRWGGEW
HVTYVTFRDMGIAFIAAIVVIYLLIVIQFKSYVTPLIIMSPIPLALIGVIPGHVLLGSNF
TATSMIGFIALGGIMVRNSILLVDFLHTKKAEGVELKQAVLEAGAVRTRPILLTALALVA
GSFVILSDPIFRGMAIALLAGSMVSTILTLVLVPLLVARVEGKRWPDGRQMVSGN
>fig|1162668.3.peg.1745 Inner membrane component of tripartite multidrug resistance system
MTETPVATAAHEGDLGYPMRERILVTVCAIGATLIETVDSTVVNVGLPKMMGGLDATVDE
VAWIITAYSIGNILMIPMTRFFADKIGRKVYFTGSVFFFTIFSFFCAQSTSMPELVIFRM
LQGVSGAAFFATSQALLIEAYPSRLVGLANALFAIGISLGPAVGPVIGGYIAYHLSWPWM
FYINVPIGIVLTALSYKVIRNSPFTNHEETADVWGILLLALGIPALQIFLENGQEFAWFD
SPLIRASFWIAVISLPLFIVRQFMAKHPLIDLRVLKNRSLAAGCFGLFFLGIVYFGTLFT
VPLMGQILLGWNPYKMGVVLLPGILSFTFTAMFVGGAMGKAPLLPIMFAGMGILLLSLHG
LSSLSIQIGPDAVFWPLIERGIGLACLFPPIMTLAMSTLSREKVSSGAALVSMMGQIGGT
VGIAFMTTMLERFEQQHRSDLSAHLSNSAPFFEQHSQMLNSLFIAHGVSPQAAGPLSFAL
MNQTLDAQAMMLSFGNLYLLTSISCLLLLFAIFGFERSAISHPQKATVAD
>fig|1162668.3.peg.1746 Membrane fusion component of tripartite multidrug resistance system
MNKHYLKFLAGGTFILALVLMGLWWVRDRERNVSTTDAFMTARPHMVTTRIPGVVTKIYV
HDNQIVHPGDLLLELDPKDVLARLDVERADLVSVTRKIPLDVSQMRIAEQNLLKAQSDRD
RGVVLSRGGYATEEDLEHLDVALRIAHHELSKAKKQISLDRAMVKKMQAALAADLLNKHY
LKIVSDVSGRFTNRTASLGMYVSPGLSLATIIPFHTWVIANMKETRITHMKVGDPVTIHV
DAYPDRVFKGKVESIQQATGAIMALLPPENATGNFTKVVQRVPVRIALLPDSDPDHLLIP
GLSVVPTVHVDPSYHPAFGH
>fig|1162668.3.peg.1773 Drug resistance transporter EmrB/QacA subfamily
MRLSPFFSSREISPWLVLATVILGVGMPLADTTITNVGRVFIVSTLGVTSYEAGWLTASY
SLALAVGVPLSHRLRGFLEEKDLYSGAILTFMLGSLCMAGSVNFTEAMLSRGIEGLSAGI
LLPLAPILIQESFPENLRSLAMSYFALFGAVWVTLGPTIGGFIIDNPGWQWAFAINIPIG
FLAIFFAQAFLSNHPRQDPRRFDGTGFVLMATSLGCLFTGFMRAEWVGWHSSGTGFLLFS
GLLLFFLFWIWSALSRDPILPTEVLRKPLFIGILAIVFMQSTQSFGRLYLLAPFLEKNYH
FMAHDAGALVAVGALTEILLSLSFLFSRFLAGKWAILLTTGCILVSISNIDFLFLPATGF
SLSFIVKSQLIFGAGLALTQISLPPLASKLFPQSKVRAATTYLLFAQFIGGAWGTMLGRH
LVLHVKPVFSQMLPQLSTHRMGHSDIFLADRLAQSYTSNIIFYDLGIIGLIGAFLAFVLI
FFLSEKRVGESDRKEKETLAGLPANGKR
>fig|1162668.3.peg.1774 Multidrug resistance efflux pump
MAEESQNHSPEKRSSLFSFAVVTPLLGFLLTVLWGISHWYGETRYVSSDDAYVQGKITYV
SSRQPGRLIGLAVNEGDPVQFGEILATIDRTGDAYLRPQDTTKNLQAFTRIKRDMAKLRS
LEKREKDERDHYQRAKALLSEGYMSPQKLEDLKTNWQQTHVEIVESRKLISAEQQSLDIS
EVHPRNRIVYAPIEGQVAQRLVNLGESVKADQPIVSIINLKDLNNIWLDAFVRETQVWKI
RAGQKVQIHIDGWPKDTFTGHVLEFIPAASQAFSLLPTQNASGTFVKVVQRVPVRIVFDS
LKNRILLPGMSAEVRIDRTSPLSRSGKDHR
>fig|1162668.3.peg.1832 Acriflavin resistance protein
MFLSTFAIKRPVTTLIIFIALISSGLYSYFSLGRNLFPRVSFPILSVTYLLPGVSSKVLE
KTVVPPVEEALSSLPGLKHLHVVSLSGVVSLTAIFSEHSDPRLIYPRLQEKVESVSPSLP
SGTAPPIISVVNPTSLPLLWVILPIPDSMDSRVITDWAMMNLVTPIRKLSGVADVKPIFP
AREVLHISLHRKELTKYLVPVTSVLESLKKVGLSIPAGTMTSGKEEIMVETLDSESTVAS
LSSLPVPDGKGRTIPLSRIATISIGPVRETEIFRIDGTRAIGLRIFKKKGADGLSLSGKI
RKIILERKAVAAVSGVNGQSIVLDPVIRMDRSEMIRKNNRELLETLLFGGALTVLVIWIF
LGSFKTTMIASISIPSSVIATFLMMKMAHFSLNNMTMLGLSLVVGILVDDAIVVLENIHR
HGQMGKPFDQAVSDGVGEIGMAVMATTFSIISVFAPVAFMHGIIGKFFFEFGLTVSFAVL
VSMLVSLTLIPVMMNFSSGSGMKSVSSRVLDGKMDALISKYRALLIKALDHPGSVAGVGF
LSIALAAGILYLLGADLVPRTDDGAFVVRMTAGEASSIDFSKTIFKDVASKIRQQKGIDS
VFYQIGNSYGGSSNRGYFYVLMKPLSMRKTSEEDAIVHLRKLLLTYPAIDFSIDHLSPLG
GNGTDVPIQIILQGPDRKRLASLVESLRMDLEKTKGFVDITTREGERQKLLAVVPKKNLP
AGSSASELGGTLHLYLAGMDTGWARVDGRTIPVHLSMISKDLSSPSDLESLPMMTSTGKV
ILLGDMARVESAVQFKRRVRDDRMPSVTLESNLSGNIPLKTALDDITQWKKDHLPGNYRL
RFGGSGDVMNNAIGSFMMAIGLAIIAVFMVLASQFESFVQPFIITLSIPVSLSGAALALY
LTGNSLNIMSAMGLIILFGLVAKNAILMVDYTNTLRKRGYSRRDALLAACPVRLRPILMT
TVAMVAGMSPMALGIGSGGPLRAPMALVVMGGLISSMLLTLFIVPVAYDFFARWNVFSQK
NEVKD
>fig|1162668.3.peg.2927 Permeases of the drug/metabolite transporter (DMT) superfamily
MPLPDSTIPPEPIMARRQVRWAIMASFLFALSTPPAKVLSSEQTPFLLCGLFYLGSIFGI
IPSILSTPRENGAGGWRKLLLPEKPKQKEIGIAILSVLIGGGAAPILLIWGLKHYPASLG
SLLMNAEGIVTVLLAWLIFREPLNMRLSIGAILGAAGCAIASDSEGSHGFSGAIPFFLAA
GLWALDSNLLRFLSGWSPVTITLWKGLGSSFLLLPLGLFLPHPPMTISIMGEALLTGGLG
YGLSLILFIRSIRAIGVSATGAWFSISPFLGAFLSILFLKEPVTRTFYEASVILFVAVLF
LNGPMSPKTSSDIPRHTG
>fig|1163389.3.peg.10 Permease of the drug/metabolite transporter (DMT) superfamily
MIIFKPSYASIHSSTFALSSLVYLGIFCAGIVYFLYASLIKVADPVFTSFTNYLVLFLEL
FLVY
>fig|1163389.3.peg.11 Permease of the drug/metabolite transporter (DMT) superfamily
MIAFARSFIGCLILCFVCYFLGLKSKSFKKDFAIYSLIAFLEATMPFMLIPWGQKFTSPS
ITAILTGTVLFFLLFYLDH
>fig|1163389.3.peg.27 Membrane fusion component of tripartite multidrug resistance system
MKISKLMAVVIILFIIIFLICIFLYFDASFERDAYLYANFTRVNSVENGQVQKIYIKKGS
YVNKGDTLFELDCRYITKELNILQSQDKKIALELKDIVIKIKLAEKQRDLARESLIVEKR
NFERYKLLIKDGAVSDQQKDLAEKNLISSESQFVKACQNVDNLKIRQNDLLSDEKITQSK
IGQKEYSLSRCSIKATTDGYISNFILQKGDFINKGEDLFSIVDTHKWYVVANVKESNIRY
LSVGQTISMTTSLTGFKKYTGRIVDIEKGITRPEYNNFSALYHIERNIDWVRLDYRFPVL
IEVLSKDTKEFRLGGDVHVWF
>fig|1163389.3.peg.102 Multidrug resistance transporter, Bcr/CflA family
MIYGPLAKRYGDVNTLRIGLLINIVGIIICLFGGYILSMPILLVGRFITAIGSSAGFYHI
K
>fig|1163389.3.peg.349 Multidrug resistance transporter, Bcr/CflA family
MSNDPFKKISSDKTVILIICLFGLMSQFATDSFTPSLPHIADYFHAAAKDIKLTVGIYFF
GMTCSMLGFGYLSDKYGRKQALLAGYLVFCIASIFCMLAQSEKLLLFFRFLQGIGMGSSF
VSFRAIMKDVFSDNQSLAKASLVITSIVSLTPPLSSSDYWRNYPRDYWLAW
>fig|1163389.3.peg.350 Multidrug resistance transporter, Bcr/CflA family
MFFNIQLLTFVLIRIYTEIGVASAIFGFIQIAITTISSSLVSSISLNNQFLFGLLMMVPP
LLIVILKIIDLKKLL
>fig|1163389.3.peg.572 Outer membrane component of tripartite multidrug resistance system
MQVNQAKLKSLISIVNLYQALGAGYNVDNYIDPHYDNPAFDK
>fig|1163389.3.peg.573 Outer membrane component of tripartite multidrug resistance system
MIKNKIISSVLITTTFLISSCSFFDPKYERPEVKAPALWNSQDKNVEITKNWNLTKIAWW
REFHDPILNNLITTALKDNNKLQVSIGNILQANAEINKANYGWLPTTSVGGGGFVAQAFD
INSNSSIPQLNNVGTQTADGSLVGIIPSYTINIARQFKLGEISRLSKKMQVNLKNTTRLS
IISQVSAAYFSLIAAQEQLKLQTQMVNQLELLFYYAKNQHKLGATSPMLEEVIRQQLEAQ
KGKVDMIKNNIVHFQNTLKILMGRNPGKIVTSRMLNDIDADVKVPVNMPSQVLENRPDVA
IAEYKLQTANANIGLARSQFFPSIDLTGTFGNATLALGELATMNAWAWAAEAVTAVPIFN
LSILADSDKAKAQFYQAYYDYISTLQKAFQDVDDTLSERSANRKKLYETNSFSEINRKTR
KYIL
>fig|1163389.3.peg.574 Membrane fusion component of tripartite multidrug resistance system
MTEEKILDTQIPEKKQEQNVKKESKFSPKKIAIGLGIITLTTLSIYGYYKYNKVFPNTDN
AYVNADVINISPKVGGYIEKVYVQNNQYVHEGDKLVQIDPKDYQLQVANANAKIIQAKGQ
LAVAQEQVSVAKSNLTKAQSSLDTATSMADRYIKLYKEDAGSLQDAQKYINQKIQAEKAK
DEAYSSLKQALVQVEIAKAQVGAAKVGYDNASLNLSYTTLIAPDDGYVSNLKIYKGQLVS
TGQPLFGFIDNKTWWIDANFKETDLDRIKPGQSVKIELDMYSHTYTGTVNSISYATGSVF
SLLPPENASGNWVKVTQRFPVKIVLKNDTKYPLRVGASTIVKVDTL
>fig|1163389.3.peg.575 Inner membrane component of tripartite multidrug resistance system
MQTDNTTKIGFWSQKRTIVALAISLLALAEIVDLTIVVVAIPQIMGAIGANVETIADVTT
VYIVTAAIFILLSGLIIEKYGIKRVALVSSVIFGISSIMCGLSTSLAEMIVFRAFQGMGG
AFLPSIAQTYISTNFRNEEYNKMMTVYSMVIVMGPIIGPVLGGAICENMSWEWIFYVNVP
LCIVAFVIIFFMMDATKIKKIKIDYISFGFMAIGVGCLELFIDNGNTNDWFSSIEMIILL
SISIVSLGFFIWRGLIYSSVVKFRIFKNFNFILACFLCFMFVLLFSAAMAYLPTMLQQVY
GYPVDLAGYITAPRGVAAIFGAVITQNFLVKKLGIRTTISLGMLTFGASCLMQASFSPTA
SEFGIVLTTAIQGPGIMMFFVPFMSVLVVGVADEDMGDMSGSFNFFRNFGSSVGTAFVAT
FISRNQQTTYQELSQNISYMNNSFQAWTNTLPIANNTEAIAIAKQQVLHQSSLLSYVNSF
YVVGILSLLLAIVPFLLKEPPKDAAVQAMH
>fig|1163389.3.peg.799 Multidrug resistance transporter, Bcr/CflA family
MYKGIRPSIFILILMVSLGPFGDTIYAPALPEIKTILGTDYPHVQLTITSYLLGYSVSQL
LYGPFSDRFGRKPVMLVGSGFFIISSIICLLSTNVDTLIYARLLQGFGAAAGGVIATVAV
KDAFKVSEQGAIFAIMNIAFALAPAFGAILGVFLSPNLIFWILLVAATFLFVQVTVFFPE
TVKEKNIDALTLRSFFKNYFALFKDHQFFFATFVLGINISVIYACLVTAPDIFINILKLE
KANFLYLLTIMVTAVVLGSIICSKLSRIIAYKHLVNFGMLCTLISGLLFIYAFHKLTGLT
LSIALTGVLSLTFIGVSFSVPLLTPIALENFTATAGAASSVMGFMQIGIASVTTAVISQI
DFGSEFTLAFAFVLLPLIGLIIFFPYSCYFLKK
>fig|1163389.3.peg.864 Permease of the drug/metabolite transporter (DMT) superfamily
MIPFIGSLFKVDRLTIYGIVASGVSLVEIYALSGASFDNFTIGYLWSVLCALMYAVSVVY
LSYETRKDHRSEAFEDLRLLIILQVAFGIPMPLITDVSSFMYLHFNYILIIAIVFCSIST
ITCYYLQNTYQKHLSMSQVLLSSLLSLFLQQFLGNLSIMKKYIYQLLLEAH
>fig|1163389.3.peg.865 Permease of the drug/metabolite transporter (DMT) superfamily
MSIQRKAVFVLFIVTILWGTTFPLIKISLEYVSPGLFVAFRLGLSCLLFLPLVLRAEFNN
KLYLLKVGAIFGSLEGMSFYF
>fig|1163389.3.peg.996 Zwittermicin A resistance protein ZmaR
MKLLEKFEYIKIYSEFDDFIIYFPIILSVVDNKQEGYVFQEGSTFIIVHKFGFCYILGEY
YDYAKLIDRISEKLKVLVPKLRLYDPNGKLKDSRYLLHDRCTRIKYIHSLNMHNDFESQI
EFFDIQDKDDSVYDFFDLELDSRYWSTCLEFRENSFAIVDEYNIGICYAAAISHGYAETD
VFVNKKVRGKGLATGLVKSFVNKCISNNVIPVWDCYSNNQASINLANKTGFKRVFEYYFY
NINI
>fig|1163389.3.peg.1081 Permease of the drug/metabolite transporter (DMT) superfamily
MFIASLSGSVVLFILAFIFNEQIVPTTSRGIAILLAIALFGYLLGNILYISRIKHISLAM
SSLVLLIGPVFALLYGYVLFRETFSIQQLVGMFIIILSVYLGKRY
>fig|1163389.3.peg.1082 Permease of the drug/metabolite transporter (DMT) superfamily
MYILYSFLAITKDEEKLSKKSLYIAALTGFFLALDLAFYSISLIYTSIAEASLLTNPCPF
ITTFIAIIFLKEKVSLKYYLVLLVAFIDLLLLMSQAGLSSQHLLGNWLAIISAICLCSFY
YLF
>fig|1163389.3.peg.1208 Multidrug resistance transporter, Bcr/CflA family
MYKIRKGSKYLVFFVVIFVALPPFAIDAYIPAFGNILVSLMLM
>fig|1163389.3.peg.1288 Multidrug resistance protein D
MRVISGIKRENLLAYFLTYVGYMTLTISMTLTPSLASNLSLSDYVTQIAMSLSFFYV
>fig|1163389.3.peg.1289 Multidrug resistance protein D
MFSISAILFATLTDVFTEKRVLFFSQSLSIFGLICLGLSDNIYAVYVGFVSLGLGMGCYS
SIARALISRNADNNS
>fig|1163389.3.peg.1290 Multidrug resistance protein D
MKKAYSVLSVMIIVAPIVSTYLALLLIPISWRAAYFCMATIEMVLFIFSIKILTADDQRK
IVISASKILSGFAHALSQPRYLLNVMIVAILFSFYLGVLMSSFKGLLVDELNMSIDVFTI
VFLVTSLLYILGIFSYRF
>fig|1163389.3.peg.1291 Multidrug resistance protein D
MATGAAMSNITKGHGTAAAMITFSVALCMSIWGFLKAHFKYVKLSFYTFGFED
>fig|1163389.3.peg.1375 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MESFLRDLANKLLQITPNYTIIVISDGSSDNSVEIIQSLVGQLNIKFISFSRNFGQGAAI
TVGLEASEDADAAIIMDCDFQHPIEVIDEFYEKWCEGFSNIYGVRNRTDQSATRSFLSEI
FFKVSNELMEVKIPANAGYFRLLDKQCIKAFNSLPENGRFIRGLFAWIGFKGYPVPFDVA
DRQDGTASRWGYRKLFKLAFTGIFSFPSVPLRLISIFGLLVSLVAMSYGLYIFIESLFFG
GNVSGWPTIVVSIMFFSGVQLISLGVLGEYISRIFEEAKKRPRYIIDEDESRNL
>fig|1163389.3.peg.1589 Permease of the drug/metabolite transporter (DMT) superfamily
MGIYLILGVREGNVNTCSLCAIFAGVLNAASQVVLYNASKKEDVFIINLWIYTYIGIFLL
LLLPFNISAISSLNEVSMKPVSIWVSVAIIIFGISSQIFRVKAFKYTKDPSLIAPAMYFS
VIVAALLEVVFYDSSIGYMEMIGILMVCVSSILSLIRK
>fig|1163389.3.peg.1715 Permease of the drug/metabolite transporter (DMT) superfamily
MNSSLLQGYVKIFLALVFWASLYHIAPLPLEYVDIYLVGLIRYAMASLIFLVVHYFFTKT
LFPRLNLRQWLYVIAVGFFGVFLYNIAFLWAEKLISGNIVVIIFSFSPCLITILSSYMFQ
MKVNQQAKIGILVALLGTIGVVMFSSNSFMECSTGINMNLGEILSILAVLCFSAYAIFGK
CCVRAGVNMITINTYGAIVGMIMFAVVSLFKSDFSELAHTDIKFWISMLYIAAFATVLAY
LWYLRALEEIGVYKTAVFQNTMPFLVILIGFVLYGETISILSLLLGGVVFLGVYMTNVAV
SKRA
>fig|1163389.3.peg.1725 Teicoplanin resistance associated membrane protein TcaB
MKNITRDSKLFPIVLALFAALTPLAVNTYAPAIPLIASDFGVSDSTVLTTFATYFIGFSF
GMLFWGAISDKYGRKKVIIIGSVIYIISTVLCSYSYNFKMLEIMRLIQGLSDSVGAVIAF
SIARDCYKGAKLTNLVTSIIIILLIAPIVAPIIGTILTNLTHTWQSTFHFLTIYGVVMLL
CAFLIEETLEHKDRKSSLIKLIPSYFQHLSNSRFMLATIASSTIFAALFIYISSSALIYL
GNYATGSLWYCIYYGLCCIAAIFANYLIKRHSSKVQQLKFLYYSVALITISCIVSIIFNS
LNLDNAFFYTLIMFVLCGNVAFSSTLIYSFAIDQIDHSFGTANSIVNFIKNMIAASGSYF
ISFYHGRDLVIASPIAQFIFTLATVILLFGIYKLNKKVINS
>fig|1163389.3.peg.1902 Permease of the drug/metabolite transporter (DMT) superfamily
MLMVYSNEAYAELSTANFTSIFVVIYIGVFPGALGYLFLGYAFRNIPTTVAISSLYFMPI
ISLFLGWIFLEETEAYISIVGGIISVVGAFIISKYGLNKKTN
>fig|1163389.3.peg.1903 Permease of the drug/metabolite transporter (DMT) superfamily
MLNGFSAGGLSLARYGIASIVMLIIFVRQKNKTKPNLKDLLRFAILGFFGFLHIMYC
>fig|1163389.3.peg.2170 MFS family major facilitator transporter, probable multidrug resistance protein
MWKYSPIKTILILGPMVFAFALAMDVYMPVLPDMREAFNTTQQMVQATLSLFLVVTGVGQ
LILGPLSDQFGRFKIILTSSIIFLIGSVLCAISQDIEFLIFSRVVQAVGCCGLSVCAFAI
IRDAFFGKTSSMIYSFINAIISVSPVVGPLIGVQLAIHFPWYSAFIFLTILAFVSFLIIV
FFVKESLPVERRKKITWSVFARYLHVLKSLQFWAYSLAAVSGVVSFFILFSMTPYIINYL
GYPISEIYIVFGSAGVAFLIGSIFAGVIVNALGVYNTAFLGVVCVFIAGVLSFSIYEVWG
LSLWGFFAPCFLATFGCALTAGTGASGSMEPFYEMAGVAAGLFGTMEFAISGIIGSIAML
FPATSSLPIAITMIIISIIAASLLIIVKITQTKE
>fig|1166018.3.peg.251 Outer membrane component of tripartite multidrug resistance system
MNRLILLFLLTGTAVLAQVSPPGGAVTLQPGAGTVQPSAPATAANVPVGNGASNASAAID
LPTSGVLRFSDPILADLVQLGLTNSPNLRAAVSRIEESRGRIRIAQSFLQPSIRSSALIT
TQSLSEHRPVAIPTATDRLPRFQLNTFQLLPVDASWELDVFRRIRGGVTVAQLQAQSFEA
DLNALRLTLAADIARTYYLIRGNEAEQAVFQRNIAARDSTVRIVRERFRVGLVNQIDVQR
AETDLAQLRVQIAGLQRARVELVNALAQLTAQDPATFNLATGTLPASVPTFPYANIPPDL
LRRRPDLLQAERAIQVADAQLLVQQASTQPRVTLVGSGGVLSGQIASWFVPTSATYLLGV
NASVPLYEGRRNRETVALSKQQTRTSQQVYEQTLQVAQREAETALDNLTYLREQLGLQNQ
TVALARTTEQYNRELYVKGFTTYLEVLDAQRTVLSAEQQAVQLRSQEVQYVVALLRALGG
DF
>fig|1166018.3.peg.2141 Outer membrane component of tripartite multidrug resistance system
MKKYLVGLSLWGLSVGGALAQPAPQVLPLDQAIQLALKNNKGLKLADSRTAAAQARAQEV
KDRNLPQATASLAYSRYSLTGPFAFGEGSDGKPLFGIPAGSFPATIGGVTVSKEVFGGFA
EKSAKLSADLLAQASKLDAQRNREELVYTVTEAYYNIVKLIRSTAVIEQNIRQFDERERE
AKNLQKEGVVTANEVLKIQLQRNNLQLSRQQVEKSRQTALYNFGLLIGQPEDQPISVDTT
LRNPATTLAPMSDFLTKAVQVRPEVQANNLRVQAADAQLRTVKSAMYPHLGVSAGYNYIN
PSARVIPEGNSFISAWNVGAGISYNIGSLYNMKGRLNTAKTAIDQATIAGQQQTDQIRSE
VVTAYNNYQLALEQQTVIRTAVDQAQENYRLAESRFRNGLVGSTDLLEADSFLIQAQLNV
INATVDAQLAYQRLLKASGINLN
>fig|1166018.3.peg.2142 Membrane fusion component of tripartite multidrug resistance system
MNTKLLLRVGGVIILVAALFFGYSEFRYLQRYETTDDAQIDGDVDPVTPKVGGYVKAIRF
KDNQFVHEGDTLFVIDDADYRIRVAQAEAALQSAQAGVGVSRSQVNVAAATIQSSQATVQ
TARNQVATAQANLAAAQARARKASQDFDRYSRLLAEKTVPQQQFDAVQAERDAAQAQVQA
AQAQLQTAQAQVAAAGTQTGVTSSQRRATESQISVVQATIKQRQTELDLANLQLSYTIVR
APASGVISKRSVQVGQLIQAGQALCSVVGNDNLWVTANFKETQVGQMQPGQQVNIEVDAF
DGEKFTGRIGSFAGATGAKFSLLPPDNATGNYVKVVQRIPVRIELDKNSPLFARLRPGMS
ATVAVDIQK
>fig|1166018.3.peg.2143 Inner membrane component of tripartite multidrug resistance system
MKLGFDKWVVVLTVTTAALLQTIDSSIVNVTLNQMMGNLGASLGDISWVVTGYAAASAVM
ITMSGWLSAKLGRRNYFAASIVVFTIASVFCGLSTNVWELVFFRVLQGIGGGGLLTTAQS
ILIQTFPKEDIGIANAIFGMGVIIGPSIGPTLGGYITDNLSWNWVFYINIPFGILATVMT
YAYIKEPAEKVAAGSMDWLALIMLTVGIGGLQIILEKGQENDWFDSRFITLMTTAAVLCI
VGFIWRQLTVDIPILDLRLLRRRRYAVGTLFNFILGFGLFASVFIIPVFCQTILGFTASQ
TGLLLMPGSIATGLMMPVVGGLLRKNFTSPIVYAGIGFLMFFGFCFDLSFISLEAGPDYF
FWPLIVRGIGMGLIFIPLTTVTLADLKPVEIPQGSALSNTIRQLGGTFGTAIMTTYISTR
TVFHSSRLGDNISVYNPLSADRLRQYTQLFLSKGDALVTATSKAYRLLQGSVVKQALVMT
YADAFLIIGGFFLVCVPLLLLFIGKKIEAPAHVEMAME
>fig|1166018.3.peg.2209 Permease of the drug/metabolite transporter (DMT) superfamily
MGHYTLFIVHYSLTPMQTPITASAPPRTRYWVGALCVFLAAFCFALKGVLIKVGYGYGVD
SIDLLTLRMLFSMPFYGGTLLWLSQRLPPLQLPAKQWGIVALLGITGYYLASYTNFLGLL
YIDASLERILLFCYPTFVLLMNATVLKRRVAGLQWLALALTYTGILIAFLPHLTSGENTH
MIWLGAFWVVLSGLIYAIYLVGSDTMIARLGAQRYTCYALLAAVVPTVVHNAIENGLHLA
QFPLRVYGLGLLMALVNTVIPTFLMAEGIKRVGSSNASIIGSIGPIFTIVLATSILGEHI
SGWQFVGTALVLAGVFLIGWKGKK
>fig|1166018.3.peg.2272 Acriflavin resistance protein D
MFAEIFINRPVTAIVASIIIVALGVLALLSLPVGQYPDITPPVVQVTSNYTGADAQTVEQ
TVATPIETQVNGTPGMSYVQTNATNDGRMTMNVTFDVGTDVNIAALDVQNRVGIATPQLP
EEVTRLGVTVRKRNPSLFMLVAIFSPKGTHNVSFLDNYTNVYIRDALLRVKGVGDIFSRA
DDFSMRIWLKPDRLAQLGMTADDVTAALQEQNLQVAGGSVGGPPQPSSQAFEYTVFTNSR
ISKETEFENIVVRSDPARGSLVYLKDVARVQLGKFSYASNSFVDGKRAAYLLVYQLPGSN
ALSTAQGVYAAMDQLKKTFPKDIDYVVPFESVSVIQVSISEVVQTLLEALVLVILVVFLF
LQSWRATLITLLAIPVSIIGTFALFVPLGFTINTLTLFAFVLAIGIVVDDAIVVVEAVQA
NIDEKGLSPRDATREAMREISAPVIAIALILAAVFVPVGFIPGIVGRLYQQFAITIAVSV
LISAFVALSLTPALCTLLLREQHIDENAKGLNKFFYKFNQWFGRVTNSYSNGVQRLIKAT
PLVLVGLAVVYVGTVLMFRAKPTGFIPTEDEGRLIVTYEIPEAASTARSLAVLNRVMDTL
RRQSYVNHFAALGGLNAITFASKSNSGTVFMSLKPWEERKERGLQADSLVVKLQRALSSI
NDARVQVVQPPAIPGLGQSSGFTFEIQQRETNDDVRAFDGVVQNFLAEANKRPEIGRAFT
YFTAKSPAYRVDVDRDKCKKLGLSVSNVYRTIQTYLGSQYINDFIIYGRKFRVVAQADTM
YRSDLKALNQFYVRNSNNQLIPISNVITTSVIENAPLISHFNLFRSVELNGAAKPGFSSS
QANDALREVADKVLPAGYSYDFSGLSREEINAGSSSVYIFLLSVGFVFLFLAALYESWSV
PFSVLLSVPLGALGAIIALLLFPYLSNNVYAQIGLITLIGLAAKNAILIVEFAKERVDKG
EDLLESTIEAVRLRLRPILMTSLAFILGVIPLALATGAGGVARATIGRTVLGGMLAATSL
AIFVVPVLYVGITRLAYGKKGLEALKKNAQKDKPDDASQAPEAGQPQQA
>fig|1166018.3.peg.2326 Permease of the drug/metabolite transporter (DMT) superfamily
MQLEATSRVRLLLAFGAIYFVWGTTYLANLYALQGIPPFIISALRYLLAGLLLGALALGK
GQVMPSGTTIRDLAISGILMLVGGSGLVVVAEQYIASGATAVIVATEPLWFVLLDRPRWR
HYFSNKKIVAGLLIGFAGVLLFAQFGPESQATQQNATYQLIGTAIVLAGALLWVVGTLFA
ARRIQPDSYNLWHTTIQLLAASLFAALIALANGEWSTFSMQSVPLPAWGGLAFLIVFGSL
IAYLAFAWLITVQPPALVSTHTFVNPLVAVLVGWLVAGEGVTAGQGIALAVVLVGVVLAQ
LGKVRSEA
>fig|1166018.3.peg.2618 Tetracycline resistance protein
MFNDRRLLHIYAIIFLDVVVGSIIGPVLPEFVRGHTQPQLWLALGTSLFLGVQLVSAPLL
GKLSDAYGRKPIFRLSALGTFLADCLLLPVRMGTYLANRLSDGLTNGLYATVRSAITDIS
PKEALFRNLGIEGAIISLGFVIGPAIAGLLITTLNLTEPVEQARYVVMMAVGLSGLNVLL
SFLLRETHPNDGAANTRGVLWTDLKVALAQSLNVGSLLARLRQKEREHPGLLNLVLMQVA
LTMAVGYYNYFVAYVSLGTLQMNATDISYFFMYFGGLSVAISYGFYGFIADRINQQRWIF
WLAAVGAPVLASYGLVGTSRVWLYVIVTIDCFTYSLIQGLIEGLMAQKTTDTDRGEIFGL
NQAMQGLASFGTTLVFGALSIIDLRLPFAWFAACLVVVAWLARK
>fig|1166018.3.peg.2733 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQTESPLLRPPSLRTDLIDTLRLSIPIIIAQLSNMLMSVTDNLFIGRLLGPVPLGAAGLS
ASLSLLLSSIGIGALSVVSALVSQAHGRADAADINRQYRAGLRVALLLGIVFGGVVAIAA
LGIEWFGQTTAVNALARPFMLIMSASNLPLFVFIAARQLSDGLSYPRIAMVITVAALVVN
ALFNYLLILGIGPFPTMGVQGSAMATLLSRVFMAVAMLLYIHRSRQFRPYFELAFNQQPI
LASMRQIIRLGLPSGLTFFFKIALFSVAIILVGWLGTNQLAAHQIAINLVSSTYMMSMGI
SSAVAIRVGNAYGRGDRDGIRQAGLAAFILTGLLMGTTALIFMLFNETLVSIYLTDAPDV
TRMAAMLVFMAGFFQLADGFQVVGVGMLRGLSDVNVPTVITLFSYWLVALPTSYVLGFTL
GYDVLGVWVGLLVGLSVAAMLLTSRFFRLAD
>fig|1166018.3.peg.2768 Membrane fusion component of tripartite multidrug resistance system
METESSTLKTYLPRLLGVIVLLAGAYWGFTAYRHGQQYESTDNAQIEGSTAPVLARVAGY
VQDVNVDDYATVKRGQPLLTIDPQEYEVALQQAEADYESTLADIRTAQADIRNAQADLAT
AQANSRNTQQSLRVTQSNAEVQAARRSKAQTDLQRDQNLFNDQSLTRKQLDDSKNNLDVQ
ERTYRASEEQIALARSQQGVAQAGILKAQAGIQRTQANIQKMQAMLKVKAAAVQNAKLRL
GYAKLTAPIDGKIGKKTAVVGQYVQPGQTLMTIVNNSTFWVVANFKETQLENMRVGQDVE
IKLDAYPDLDVKGRVASLSESTGAKTALLPPDNASGNFVKITQRVPVKIEILNPDQLKDK
LRAGLSVDAAVRVAN
>fig|1166018.3.peg.2769 Inner membrane component of tripartite multidrug resistance system
MAETALASPPVEAQPALPTGFKKWIIVITAITAAIVELIDISIVNVGLNDIAGNLGVTIE
DVSWVVTAYAIANVIVIPMTGFLQRYFGRKNYYIGSIVLFALASYGCGLATNLPMLVLFR
FLQGVGGGALLSTSQGLIYDAFPLSQRPTAAAIFGAGIVLGPTLGPTLGGYIIDNYHWSW
MFYINVPIGLLATYLSYTFIDKKADELNIDRGSIRIDTLGIALLAIGVGSLQYVLERGEA
DDWFDSLAIRYLTAATIITVPLFIWWELRGTNEPVVDLRVLKNRNLTLGAILITIVGYGL
FTSVLLFPLFAQRIVGLTATQTGLLLIPGGFVTLPMFAISGRLLAKGVSPRNIAIAGYIA
FGTFCFIMSTYNMDATNSYFIWALIIRGIGLALVNVPLINQSVSTLEPRQLPTGIAIVNM
MRQLGGAFGVAITNTYVTQRSAVHRGDLVSHLQPGDPLLTDRLNAISQGLMSRGINAFEA
MSGAYRNLDLIIQKQALMLSYLDTFRLAGLFFVVSFPLLFLLKSKKMSAEAAKAAADAAH
>fig|1166018.3.peg.2770 Outer membrane component of tripartite multidrug resistance system
MRFPLLSILVLLPGLALAQQSTALPDDLRALVQQASANFPLLKQQEQQIQATALQADLAR
TALRPQIGLNGSYQYIDPVPKATLPVNGRDVTLQFQPNHNVNANVAISQSLYDFGRTNAA
VQRAGDNLRIQQRQQELTRHNLTYQVAAAYYGIGFLQRSIVVQDSVIRTAGDNVNVLSAR
LRNGDALQYDVITQQVRLKTAQNRKIDLQNQLDRQRALLTYLTGNADPAVSAASQQFGEP
IQPFALDGQLQTALASNKDVLAAQDRVKLAETEIRIDELSGRPNLVLQGATGFRNGYVPD
VNTPKFNVAAGVAFSMPIYAGRRYRLQNQVAKLNLNANRYAVENANAQLRQQLTQLNADI
AANQTRLQNLNTQVLQARKALELAQTRLRNGVITTVELESAETGIEEAQLAQLAFQYQLL
LNQLELKRLLGESL
>fig|1166018.3.peg.3528 Permease of the drug/metabolite transporter (DMT) superfamily
MSATTTTHEPVINTEKRPLLAWVLLTAIALIWGSSFILMKKALAVFSAQQIASGRIFFAF
LFFLPLILNQSRRPDVREALRQRWVALLVSGVVGYLLPAFLFAEAGAHIPSALSGTLNSL
SPLFVLLLGTLVFGQTFRANQVWGIMLGFTGSMILVFFGESGSFSINGYALLVMLATVMY
GVNTNLIAKYLAHLPALVAIPWTFAFIGPVAGISLFSTDFLSRAQQANTFIPLGAILFLG
GMASGVSSVLFNRVIQLASGVFAASVTYLIPVVAIVWGLFDGEAVSLQQYVGLTISLLGI
YLVNKRS
>fig|1166018.3.peg.4227 Permease of the drug/metabolite transporter (DMT) superfamily
MSQPSRTAQFIPGFLFAMLWASASVATKFGVQSVAPLVLATVRFLIAGSGMLLFAYGIQR
GNPLPKGIEWRRLTIFSFLNTALYLGLFVLALKQVSAGIGSLSTATNPLFITLLSAIWLR
RPLRWQEGAGLLLGLLGVVVATIPLLEQAYATVDGLLILLGSMISVSAATVYYARYEWAL
PTLVINGWQVLLAGFMLLPITLLTTDLSTSQFDVRFWASVGWLIGPVSVVALQLWFGLVR
VDAVRASLWLFLCPVFGFIYSALFTGEPITLYTLAGTLLVIAGLWMGRK
>fig|1166018.3.peg.5090 Permease of the drug/metabolite transporter (DMT) superfamily
MTIDSPRSDVRQPDRVQLWSALGAVYLLWGSTYLFIHFMTEQMPPLYMASVRYLVSGSLL
YGYARLTGSKRPTRQHWQSTALIGFFLLTIANGALTIAVQYIPTGMAALLGGLLPIFLLI
LNWLWFGRVRPTTLSLLGVGVGVVGIYLLIKPDRLVSTGGVHANLIGTSLVAAGNLSWAV
GTLLTPRLPQPGQTLASGMQMLLGGFFLLIISLLTEPVGVFSILIAPTKALWSVLYLVIF
GSIIGFSSYAWLARNATPSLLSTYAFVNPVVAVLLGVLFAGEVFSGRSLLGAGVALIGVV
LLTLGRK
>fig|1166018.3.peg.5192 Permeases of the drug/metabolite transporter (DMT) superfamily
MLLFVGTITSLALLVRILANPLANVFQKKLTHQSADPLFVTAVTYTGLFIACLFVYRWET
ARHLRLDFWANALLMGVLAVLGNTLLVKALQTGDLSVLGPINAYKAVVSLVVGVVLLGEV
PSVAGLLGVGLIVAGSYVVLQPKRGAGGGGWRLMGQPEIRWRVLALICSAVEAVYIKRAV
LLADATTVFVVWCALGCVLSWGWYGSLHRSTLVGQWQLVAKHRLSYLALIALVGLMQLST
TVVFSGMQVGYALALFQTSAVVSVLFGYQFFGERQLLPKLLGATIMAIGAALIVLVR
>fig|1166018.3.peg.5470 Multiple antibiotic resistance protein MarC
MPLNFKEIISVTLILFSVIDVLGSLPVIIDLRQKVGTIESEKATLASGVLMLTFLFVGER
ILKLFGVDVQSFAVAGAIIIFLIGLEMILGRTIFKSEIEADSAAHIVPIAFPLIAGAGTL
TTLISLRAEYQIGNIVVGVILNLILIYIVLKSAAWLEDRIGPGGLNVLRKVFGIILLAIS
IKLLKSNLLPANF
>fig|1169145.3.peg.480 Permease of the drug/metabolite transporter (DMT) superfamily
MEDNRFAATWRWMLVTAIAPVAWGSTYVVTRAVLPDEALWGAVIRALPAGVILLAISRRR
PHGAWWWRSAVLGVLNTGGFFALVYAVAQRLPSGVASTVMAASPLVMMAAGRVILGQRPR
ALALAGGAAGIVGVALMLFGGADAVDGLGVVLAVTALVGSAIGYALATRWGSTDLVASTA
WQLLAGGLLVLPVAVIVEGAPPALDDAAIAGFAYVTVVATALAFVAWFAGLRHLPAGTVG
LIGLLNPVTGVVLGAVVAGEALSGRQLLGLAIVLSGIALGRLPKAGQLPRDSRKLRVGAK
NVEPVAAVEKSRMRS
>fig|1169145.3.peg.1366 Drug resistance transporter, EmrB/QacA subfamily
MRRTTRDWLALSSLCLGFFMLLLDSTITSVALPALIAGLGTTSTLAIWINSGYLVAYAVP
LLIAGRLGDRFGRRRVYLIGLAAFTIGSVLCAVSQDIGSLIGWRVAQGVGAALMTPQCLT
IIRTLFAPPRLAIALGIWGAVGGAATVAGPILGGLLVGAAGWPSIFAVNLPIGVITAVAV
LLWVPASERLPARIPLWAMAGNALGVAALVMGIQGTDAASSSVANIPRWLLVVMGAALVT
SVVWLQRRSLDRALLPVSLFRSHGFVTASWGAAAAAFCVGSAPIPLMLALQEDRGLDVVT
ASIVLVPMGVVCLLAAPVSARLNNTVGLRVVAVIGGVALVLSIGGTAALVWAEAPIWAIA
GVFALFGIANSFLWSPFSIATVTSVERSSIGAASGAFNSVKQLGAVLGSAATAVVLAWTG
NAVALAVLALVGVLSIVAASLLRVTPTDAGDASDQDRGGILIGTVVGGAGAGLGLGFPTA
NLDLEERAGLPADGVYIGGFRAETWSEPLPALISIGTNDTFPGRAHTIEVHVLDFAGDLY
GRRAEVTTDRLIRTQRAFASPEELVEAMRQDEREARSLLIARQSHERKVS
>fig|1169145.3.peg.1400 Permease of the drug/metabolite transporter (DMT) superfamily
MKANRGVLAGLAVVVLWASAFPAIQVAAPAFGVIGLSFVRLAVAMIALLAFAAVKRVSLP
RPRDFGWIVAAGFFGMTAYQLLLNESELHVPAGTASIIVAAAPLVSVAVAFLLFREPVTR
FTVVGSLIALAGVAVVCLARAGVSLSASVWIVVAAMVVQGIYHPLQRPLLKTYTGLEVAT
YTMVAGTAMTLPLVPFGWGRLVEASPTGWIAAVYLGLLPSALGFVLWGYAVGHLPVAIAT
SLLYLVPPIAVFIAWVWLGEIPLPTELIGGLIVIAGVVVISQGARLVRRAHRRQPATVSI
ER
>fig|1169145.3.peg.1662 ABC-type drug export system, membrane protein
MTTTALPASRPQRRNGPTFLTHTLLLTGRQLRAAWRMPAFLVMNLVQPVIWLLLFGQLFK
SVIDIPGFGVGQSYLEYLTPGVVMMLALFGSAWSGTVYIQDMDRGVMDRFLTSPTNRGAM
IVSTLVYQSLLAVVQSLVVVGIAFWAGARFEGGVVGILLLLLGVVLLTAVFCSLSNAVAL
LAREQTALIGISQLITLPLMFLSSAIMNTKLSPEWVQNVSAYNPFEWAVIVGRQALSAHP
DWATLWAHAGLLAALAVVMAAWATSAFRVYQRSA
>fig|1169145.3.peg.1767 Glyoxalase/bleomycin resistance protein/dioxygenase
MAIESVLLNVTDIPRSVEFYRRHLGAEVIGAGDDSAVLDLVTAQLVLYRIDTPAESTWVG
DDLQRGFRHVGFKVSDLDARVDALHDAGVPFHLEPIHAEGDVRITFFYDPDGTLLELVEG
PLQYHEVYDRSAVERDWGLGDPDRPRFDHVAETVADLEATKEHYGELGYSLMSGIHQPSD
DRGFEINFLRHGDSSLEIFTYDKAEKAERSPQLDAPGFVAVAFEGRTAPGTVVGTTGDRE
VYSGPDGLLYTVANA
>fig|1169145.3.peg.2606 Multidrug resistance protein B
MERQLKPWPALWALVIGFFMILIDTTIVSVANPSIMEGLNLGTDYNAVIWVTSAYLLAYA
VPLLITGRLGDRFGPKNLYLIGLVVFTLASAWCGFAGSIGFLIAARVVQGLGAALMTPQT
MAVITRIFPPERRGAAMGLWGAVAGVATLIGPLLGGVLVDSLGWEWIFFINVPVGIVAFI
LAMRLVPKLPTHSHSFDVLGVILSGVGMFLLVFGIQEGSTYDWGVIWGPISVWGLIIAGI
VVLAAFVVWQAFNKKEPLLPLPLFRDRNFSLSNGAITTVGFAVTCMALPLVFYFQTVRGL
TPTESALMLAPTAIFSGVLAPFVGRLIDKVNPRNIATPALVLFAFALFLYSRMLSPDVNI
FLLLIPSALMGIAMSGVWGPISTTATRNLPMNQAGAGSGVFNTTRQIGAVLGSASIAALI
EGRLAVDLPKIPGGANASEAAAGTELPQALHAGFTQAMSEALLLPAAVAFLGALVVVWWE
RPKPPAWARQAGGAGAGAGAGAAAAGAPAAEGAPVAAGATAESADAATHGAHAAPVPVDA
TPHGAHAAPVPPATDLAPGDEPPHGLHAAPVTD
>fig|1169145.3.peg.2727 Glyoxalase/bleomycin resistance protein/dioxygenase
MISSAVTLSYRDAPAAIAWLEALGFDVLQLQSGQDGSVLHSELRWADTVVMLASNDAAYD
VPPLVGASTGVGLYLVTQDVDGMFARAVDAGATVVFPPEETEWGSRRARVLDPGGREWSF
GSYRPGEQWSASA
>fig|1171373.8.peg.200 Multidrug resistance transporter, MFS superfamily
MTSPQQPQEQPAGAPALSTTLLAALALLSAAGPLGTDMYLPTLVRMAGELGTTSSMTQFT
LSAFMIGMAVGQLLIGPLSDSYGRRRLLIGGSVVFFLTSAAAAFANSIGLVIGLRFLMGA
AGGTGSVLSRAIIPDLAHGRAAARGFSVMMAIQGFAPVLAPILGGLLAEPIGWRGIFAVL
AGFNLLMVAAAVFMVPESLPAARRAPGGLRRLFPSIAMISRRRVFVGHALSMAVMFGVMF
SYISASPFVLQRQLGLRSTMYSLAFAANAVMVTLASILNTRFIKHFSLRGIVRTGLTLGF
VGSVGLVLNGLFGPWLWVTLPLLSVTVFGMGLVMGNATALGAAQVRDAAGAGSAMMGALQ
FLVAGIVSPLVGLGSNPALTMAVVMLVCAVLANAAHYLVARPTSE
>fig|1171373.8.peg.459 Permease of the drug/metabolite transporter (DMT) superfamily
MTPAAAHRLGVILIAVTAVLWGTSGTAATFAPQVGPLAIGAAALGIGGLLQGLISIGAQR
RAAPRLRAHAGVVAIGALTVAIYPLAFYSSMRYAGVAVGTVISLASAPLASGLLDRFIDH
RRLGPWWTAAAGMGVVGSVLLCLSRGGDDAAGPGRAVLGVLLGLVAGATYAAYSWAAHRL
IDAGIDRAASMGSVFGIGGLLLMPMLALTGAPILAGPGNLAVAAYMALVPMFLGYVLFGM
GLVRVPASTATTVTLLEPAVSALLAVTVVGERLGARGWTGMAIIAAVLIVLAAEPGSDKA
GPVPGGAAQEVAVP
>fig|1171373.8.peg.672 Multidrug resistance protein B
MSDSWTSPAPRDPRLASVDPRLNRPWPALWSILVGFFMMMIDASIVTVALPRMQRELHAD
LTLLAWVTSAYLLPYAALMLITGRLGDRLGLKRVYMTGLAVFTLASLLCGLSTTAGMLIA
ARALQGVGAAIVSPQTMSMVTRIFPPDGRGRAMAIWGATGGVANIIGPLLGGVLVDGPGW
QWIFYVNLPVGLLGMVAAARFVPALPGTSGRLDWPGVLLSAAGLGLVVFGVQEGQRYSWG
AIAGLITVPRLIVVGLALLVVFVAWQHHMGHEALVPLRLFADRNFSAAVVGIAAMGAIVF
AQNYPLTMFLQNVRDLSPTEAALATLPSAVMSILLANPVGRWLDGHDPKPLAVTGFGCMA
VGLSWLALAMSPSTPILTVLAAMTVIGVGNAFIWSPLSVTATANLSPKLAGAGAGLYSEM
QQVAAVLGSAGIATLMTWRTQTRPDLARAMGDSMWLSVVLAGAGLVACLCFARPRRAADW
QRG
>fig|1171373.8.peg.1245 Permease of the drug/metabolite transporter (DMT) superfamily
MVGFRSSRLAPAALMVMALLWGSTLVVMKGAYAHLSPTDLLANRFLVGALALGLLVPRAW
RANARTIGKGLLLGLLFGAGQVLQAVGLSSTPASVNGFIGGLYVVVTPLLGAIFFGKRVP
RQIWIAVALATVGLGSLALDPADLGAGIGVGELLTFAASVCFAAQIVALGRFATARNVAS
LALYQTIGAALVCAICAAPGGIRIASSGSEWFAVLYLGVVCSAAIAVLQSWAQARVEATR
ASVIMCTEPLWGAVFAIGLAGDPVTLRIILGGVSILAAMVMVVRPPRRRRGLTQDEAGPR
QIEQAGIGDLVGDSK
>fig|1171373.8.peg.2328 ABC-type drug export system, membrane protein
MSEQVVAPPAVLAEGRNIVVVTASRIGAFCLVELQKLKHDRTELFTRAIQPVLWLTIFGT
TFSRIRAIPTGRISYLAYMAPGVIAQSALFVAIIMRVPMTWNPLRWLAVFGVVMLGSAFF
CCLSLTIAGIVLHRDRLMGIGQAITMPLFFASNALYPTAIMPGWVKVLANVNPLSYEVQM
MRGLLLGEPADYLQDLGVLVLAAIAMIVVASSLLGRLSR
>fig|1171373.8.peg.3007 Permease of the drug/metabolite transporter (DMT) superfamily
MRAGSIVVWKRGLMASTPQAVQSRRATAIGVAAILLWSGIVGLIRVTTQHFGATLGPSLI
YTLAAALLWLTRRPKSLRGFSARYLLLGGGMFVIYEVALAMAVGLSDDAHQTIEVSIVNY
LWPTLTVALAAVVNRRERRPGLLIIPGVLLATVGVVGAVGGEAGLSPTRIAANVMSNPLP
YLLSLMAAAVWAAYSVFSPRLAGGRDGITVFISGVAAALWIVNLVSPAPVGDITASGVAG
LIGAAAVIASGYASWNVGILHGNITLLASASYATPVLSTAVSSLLLGAVLPLTFWGNVLL
VVAGSLAGWWATRRTGRR
>fig|1171377.3.peg.25 Permease of the drug/metabolite transporter (DMT) superfamily
MMQKYRGEWLLLLATLTAAFGWLFSKNAIVELPAVAFIALRFSFATLLFLPFALPQLKSL
NRQQWRYAVFVGLSFCLYLFFWVMGVKYTTELGKGAFLLSLAMLAAPLIAWGLYRQRPIR
RFWFALPSAIIGMYLLANNGTEQSGFQLDTLFFLFTAFWAAVQFVLNSRYAQHLPVLALT
TIQLSMVAISASIYSALFETFPTQISSPTWLWLTLSVLIGTNARFLLQTWGQKLSDLGNG
ALIMILEPVWTLLLSTLFMAENLSTTKIMGSTFVLSALLIYRLNVMRQK
>fig|1171377.3.peg.101 Bicyclomycin resistance protein
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSVLAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTYFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNSDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>fig|1171377.3.peg.126 Bicyclomycin resistance protein
MTKANSKFFLVLLLGVLSAFGPFVVDLYLPALPQLAEFFHTSTSMTQLTLTTAMIGLAVG
QLLLGPISDKFGRKKPLILSLLIYIISTIAIMFSPNIETMIILRVIQGLSSAGSVVISRA
VATDLYRGREMTRFFGLLMTINGLAPIISPILGSLLLEYINWQGIFAFLAFIGVAVTLFS
LRLKESLALENRLQGSVISVFGSFRKIIKNRVFMQFVGIETFLFGAMFAYIAASPFILQS
VYSLSAFAFSLCFGANGTALVLGSNFGSRLANRSALKWGVLGFCFAVVYTAAMLLIQPHW
LLVELGFFFTMLMMGLPLPAISSLAMESEREYAGAASALLGFAPFFLGGIVSPLVGIGDI
FYACAIVMLLCAIIGFRLYWSVKDQIKNET
>fig|1171377.3.peg.403 Permease of the drug/metabolite transporter (DMT) superfamily
MNKYSLALLKVHGTAIFFGLSGVFGVLIESSSEALTLGRAIIAFAFIALYFLFKKRPLTK
LTYQEKLMQFVMGGLLALHWISFYLGVKIGGVAVGTLGFASFPAFTALFEMLFFREKPRV
RDFVLLIAISFGLILITPAFEFGNQVTQGLLWGIFSAFSYGVLAVMNRHSATKLSGVESS
LWQYLAIMLILLPFYSGELFFASLSDWFWIGCIGVFCTTFAYTLYVSSLDTINARTAAMI
ISLEPVYAILVAWLWFDDVPSLKMVLGGALIIGAVAWANLKK
>fig|1171377.3.peg.726 Permeases of the drug/metabolite transporter (DMT) superfamily
MSHDHDTPSKWEISSHAALPVVLMLFIQMLAHYIGSPANSIFLSPYLIAFFVAALLALVV
LWKGQICPGQKGRLAFVLPFLAAFALGNFLYTAFFTPKHILLSLANLAALFIPLLYWRFP
DDEPMQKIFSYLGFALGAIGILAYSICYWVELPSLLNWVRGNYFAQIQLGLLLLGWYMML
AKSRLDGFFKLLVQLSLIVLIFNYIWVIFVLYQELNIMPELATLPYFAFFALQFVVLAML
AWLLIGKQGKNIKNPVAWTAATFLSMLYPLTNIF
>fig|1171377.3.peg.827 Permease of the drug/metabolite transporter (DMT) superfamily
MLSRRYLILINLFYVLGIGLNIVLLRFLSQHIEPLNNNGIRFLAGGIVLSLFAIWQYPTQ
LRLLLTQPKNILMSILVGLMLAANMYFWLKGTQLTNAVTASLFGVLAMPFGVLIAALFYP
DERQKTRYKGFWLGSALTILGALGFIWYGNSLTIGEGFMLGALFLFLSICIRNTQNLIVK
SARSVSMFAFSCFTSLSASFSSLFLSMQNSTLSELHSLPVWLIVLLIAAGIYAVFAAMAL
AFNIIQQQGLITYQVLELLIPITTAIAAYFILGEAIHFIQLVFAIIVIIGASCALGIIKV
SRHKVAASAKSA
>fig|1171377.3.peg.894 Bicyclomycin resistance protein
MNVAKREHLCFVIIMGMLAMLPPLAIDMYLPSFIDIAQDLKVSQESVQATLAVFTIGFAG
GQLFWGPVADSFGRKPIILLGLVGSAIAALFLTHVENIQNFYLWRLIQGLCGAAPAVVLG
ALVRDLFERNRFAQMMSVIMIISMIAPLLAPILGGYLAKWFHWHSIFYALMLMGGLCALL
IGFKIPETLVKEKRQPLNFSNIIKNFVALISHKPTLGYVLVGGLSFAGMFCFLTSGSLVY
IGIYGVSPEHFGYFFIMNIAVMMVMTVINGKLVVKVGSEKMLRVGLVIQFTAGLWLAISA
TFQFGFWSMAFGVPFFVGVLSTIGSNATAAILDRYPQMAGTANAVAGTARFGLGSIIGGL
LSMVTLTSERPMLYAMALCTFSCFAAYYFLCCRNKAQ
>fig|1171377.3.peg.896 Multiple antibiotic transporter
MDILNFAIYLQFFIGLFAIVNPFGTLPIFFSMTAHQYETERNRTNLITSISIAVILLVSL
YFGKIILDAFSISLDSFRVAGGILIVSIAMTMISGKLGEHKQNKEEQKADLTEYENIAVV
PLAMPIMAGPGAIGSTIVWGTLYHNWVDFVGFSVAIVLFALICYVLFRFSAPLVKKLGRT
GSNVVTRIMGLILMSLGIEIIVAGLSNLFPGLTAVS
>fig|1171377.3.peg.1322 Permeases of the drug/metabolite transporter (DMT) superfamily
MLELILAILCSVTVGVLIKVARQKGVAIDQSIAVNYLVAISLTFALLKPDFNGQSIMEIV
QTNPSSYIFFALGFLLPSVFLIQAKALEYAGIIRTDAAQRLSLFLPILAAFTLFGEAVTS
NKLVALVLAFIALGCLLWRSQQGMEKGGMIAVISLALVWVGYGVNDILFKQMAKTGSAFP
LTLVISFIFAACLMFIYLLLKRTQWHIPSVAVGLLLGTLNFGNILFYIKAHQAMKDDPTL
VFTGMNLGVICLGTLIGALIFKEKINKINYTGVVVAIVAIVCLFYWR
>fig|1171377.3.peg.1645 Outer membrane component of tripartite multidrug resistance system
MTSFAIFSVILTACSQMQINTESGISLPERFDQAEAAKGSAQIRQWWRNWHDPQLTTLIE
KGLNENLDIRLARARLSEAQANSDYAEAERGINIGASGSAVGGVSDVNTGVSNPGRSRSG
GAYGGISASWEPDFFGQKRSDADAAQAVALSAQEQVYAAQLLVSSEIADNYFRIHALEQQ
NAVLEKNIKTMRELQRYVQGRFNAGQATAYEVNEIAAQITALQARQATLKAQADVFQRNI
AILTGTVPQGFSIVKSGNPLAKIPAAPSGQLPAAVIERRPDIRANALQIQAAAAKSASAR
ADLYPRFNLNFMGRGGRIELNNDLSHISGLSGLAGLDVQLPLFTNGRIQANIDAADARLK
AALIQYDKTLLTALGEVDSAYQNHRSLTAQTRLLQKSHTQAQKQASDAQLLFKHDDKTLD
VAIRARVTALNYQEQLIQSQLAQAQNLLGLYKALGGGWL
>fig|1171377.3.peg.1869 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNLQWHRYPQNTKNLFKLALPIFISQLASSGMGFADIVMAGMISDNDVSAIAVSNSIYFP
LLLFVIGVLNAITPTVSYLNGSNQRHLISHQVKQGSWIALLFSLPLFTVYLGSDWILQSM
DTPAAFAHKAADYMAMLCIGLLPALMAVNLRCFNDGLSNPRPAMLITFFGLLLNIPLNYI
FMFGKFGLPAMGAVGCGLATSIVNWVMFLLILHYCYRSSSQKDIGLFNRFWEKPNRVTQV
KLLKLGLPIGFALFTEVMLFATSSLILSPLGAQVVASHQVALQTSSLFFMIPLSVSMATT
IMVGQTLGAKDVQGAKYLTFHAIFTCILIAFAMAVVILSLKDWIPHIFTSDPTSITIASS
LLIFSAIYQIPDSVQSVCNGILRGYKYTRPILGVTLICYWLIGMPLGIVLARTDWLVMPM
AASGFWLVFCICLSIAAMFFFYYMRKIQCLSDEDLLARLERIK
>fig|1171377.3.peg.1886 Permeases of the drug/metabolite transporter (DMT) superfamily
MQQKPLRGFLYALLASMTWGTLPIAVQPLLATIDAQTLVWYRFWVAGLGLALFFVLTKRL
PSARAFSPRVFKLIFLGVCGLAANFFLFSEALNYISPTTNQVLWQLAPFTMILCGVVIFK
EKFGQHQKMGLILLLIGLAAFFNERMGEILQFGDYAVGILISASAAIIWVCYGIAQKLLS
ATFSSQQILMIIYLGCGVAISPFVSPSQLFEINGFLIGCFLYCCLNTFIGYGAYAEALNY
WDATKVSVVTILLPIFTMIFSHLGHWLMPDFVPELTMNWLSYLGAFIVVAGTILSAIGHK
IFK
>fig|1171377.3.peg.1887 Vancomycin B-type resistance protein VanW
MIPLFIEDNKAFIYTAVDFSATTNGIMNAETVDVINLNANISGNSFTGSANSASLSGTAK
VEGKFYGENAKELGGMFKAADWVGAFGASK
>fig|1171377.3.peg.2189 Permease, MDR related, probably tetracycline resistance protein
MIFLQAKGLSMYEISILQMALNITMFLFEVPSGILSDKFGRKPPAFLGISFSIIYLIGML
YLNEFFYLVIVFIVYGIGISLLSGVDQSLIYEQLDYYGKQEIYHKTIGFYNAISIAALAV
SALVGGWLAENKYWELIFYFGVLFQLMSLLFLYFIKDFYKLLPHNNKAKKSFFGIGILRV
DGKVLFIICILGIFQGVFSSVVLYYQKVLDYAGVSIFYISILYSLSFVFSSFSSVMSGFV
SEKIGEVKAVLLFSLLLLFSFFYLYL
>fig|1172188.3.peg.65 Glyoxalase/bleomycin resistance protein/dioxygenase
MTEQRTYPEGVTSWVDSEQGDVDAAADFYSGLFGWTFDEATPPGVPFRYLIARLDGQDVG
GLGGPATPAAEGAGGGGGDAARWHTYVAVDDAEAATGRVKAAGGAVVQPPTVAGEGGRSV
IVRDPQGLEVRLWEARGRLGSQVTNVPGAWNFSDLHTDEPAAAQQFYARAFGWEFADVGF
ATMIRVPGYGDHLAATTDPGIHERQSGAKVPPGFADAIGWVVPVAPDAEPGWHVTFTVAE
RDAAADQVVRLGGSVVRTGDSDWTRTAVVRDPQGALFTVSQFLG
>fig|1172188.3.peg.659 Phosphotransferase (aminonucleoside antibiotic resistance)
MTARAPGRSPLDGGAACLLVVGAPGAGKSTVTRLVAGRLSRAALLEGDTVSRLVVSGRVW
ALGEPADEADRQTRLTNDNLVALAASFADAGFTPVIDWVVPDRAQLDLYVAGLGDRGLAL
VVLDPGGDVCRHRNELRDPEEQFDFDGQEALVATMRRGFGEVGWWFDTSALTPEETAEQV
LAHAYALGRRGL
>fig|1172188.3.peg.1479 Glyoxalase/bleomycin resistance protein/dioxygenase
MSSPIQRRVGQVFVPVRDMAAAIRWYAAVLGFEPGAASHEDTIYDVPTDGETRLALDANR
PDFIASGPPRFFLWTDDMAATVEHLRRLEVTITSDVEDIGSVFFVQFEDPDGNALMVCQR
T
>fig|1172188.3.peg.1825 Phosphotransferase (aminonucleoside antibiotic resistance)
MSELDESGPRGRLVLVTAARPQARAALASAVAARLHGAVVVDGAALEAAVTSGAVPGWDE
PPTSEQLRRRLLRWSAALAVAETYQLEGLDAVVAEDALGDRLEDFLDLVEPEPVHVVVVR
DGADPATPHWGLWVDGTDPVGATAADVVSRLADALVATSAT
>fig|1172188.3.peg.2061 Vancomycin B-type resistance protein VanW
MAHDWSDDTRRERRSTVLRLLVATIVLGGGYAGLCVWSSQHVPASVSVGGIRVGGMTPES
ARAAIARGSRSLLDTPIVLSVPGRPAPIEVVPRDAGLTVDADRSLEGLTGFTLDPRVVWD
KLTGSVRTPLLTTADDEALTAYLDRLAPGLAVAPVEGRVSFPDGAVSVDMPAPGSTLDVA
ATKLALRRAFPDSTQATAVVREVPPAVSADVVQQVGSQFGSTAMSRPLTLVSGATRVLLS
PAEYAPMVSVVPDGSGGLTPRFDEPGLARLVAGKVTVPSRTASSARWVFEPNNGKPRLVP
SVDGLTFDEDAVARQVVAAISGTERTVDVRAAVAQPPFTTEDAQKAGVTTLVVDFRSPFP
TNDATRTNNLVVATKRINGTYVPPGGTFSLNGILGERTEDKGYADGTVIIDGRLTRGTGG
GISQVSTVVYNLAYFAGVDFLQFSPHAFFIPRYPEGREATVYWPTIDNKWKNDTPYGMLL
QTWVEGGFVHGRVWSTKTWDITSVKGPRRNVVPPKTIRTDSLKCYPQQPNPGFDVTVTRE
WRRPGSAALVRSEPVSTHYVPEDHIICTNPAATPP
>fig|1172188.3.peg.2492 Permease of the drug/metabolite transporter (DMT) superfamily
MAVTLLLWASAFVAIRHLGRDVPPGALSLGRLLVASVALGVLVFRRPRTWPARRDWPLLL
LCGVGWFGIYNLALNEAERRIDAGTSALIVQIGPIIVALLATVFLGEKMTRWLLIGMAVG
FAGVVVIARGFSSGDSGDMVGVWLAVLAAVTYAVGVLAQKPLLGRLPGPEVTWLACVIGA
VVCLPWSGELVSVVRDRDPSTLWWIAYLGIFPTAIAFSTWAYVLARSDAGTLTLTTFLVP
FIATLIAWALLSEVPPPLTFVGGALCIAGVLLTRRKPRVAATAED
>fig|1172188.3.peg.2634 Permease of the drug/metabolite transporter (DMT) superfamily
MEGNRASWTNVALTALPAAIWGSTYAVTQQWLPPGRPLFAATVRALPVGLLMLLWLRRLP
RGDWWWRSLVLGSLNIGLFYALLFFAAYRLPSGLGATLVATAPMVTMAVSWMLLGQRPAR
VSGAAGLVGLVGVALLVLQNGLDKPLDPVGLGAGLLAVVLSSCGFVLTRKWAPTDDVVTM
TSWQLVAGGLVLLPIGLVVEGAPPALDLPAVGALVYLGLLGSGVAYVLWFRGLAILGPTS
ASIIGLVNPVIGVLLGVALLGERFGPVHLVAMVLVIGSVLAAQEPVRARFSRRAPSTGER
TSTRRHTPALPSGAPAGKAVAWPPTPTTLSTSSSSGSDRAVSTSPGASPSAACACSASTA
DSWAVSAPTGAASRRR
>fig|1172188.3.peg.2684 Glyoxalase/bleomycin resistance protein/dioxygenase
MPVHEESFAPGTPCWADVMVDDLDRARDFYGSLFGWTFEDLPPEAGGYVMARKDGHVVAG
AMAKNPDDPGQVSAWTVYLATDDVDATAERAQAAGGVFFLGPMDVLQVGRLAVGADPAGA
AYGLWQAKEHTGTDLVDEPGSLCWAESMSRSYEASRTFYTDVFGYRLQEIGEGGFQYSVA
TLDGDKPVGGIGAIPAAAPADVPSHWMAYFAVADADAAADRVTALGGTVRQPPFDTPYGR
MALVAGPQGETFSVMQLPEQPAAD
>fig|1172188.3.peg.3025 Glyoxalase, Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily
MPIKLENVGIAVDDLEATIAFFTDLGLTVLGRDTVSGEWTDTAVGLDGNHARIAMLQTPD
GHGRLELFEYIHPSAIETTPTLPNEIGMHRVAFSVDDIDEALAIAARHGCHPLRGVATYE
DVYRLTYLRGPSGIIVMLAQELTGR
>fig|1172188.3.peg.3297 Drug resistance transporter EmrB/QacA subfamily
MAEASTSAGSGRSGRAAAQTAASAGGVLAATCLSTFVVNANTSAVSILLPAISADTGMDV
TTLQWAVTGYSLVGAAVIVTSGSLGDVFGRKRVFQLGLMLFVVSCIFIALSSSGGAVIAG
RVIQGAAGATILACGLSLLSVANDGEAQLRAVSLWGAAAAVGAAAGPLMGGVLVSVMGWQ
GLFWVDAVIAVVCILITYRRVSESRDTTRSRSIDYAGSLLIALTLAPLILALSKGGDWGW
ASVATIACLAIGVAAGFAFVAVERRVAVPMLDLALLRNRVLVGSTVAILIGAGTINALMY
LLSLYFQDPNALGFTTLQAGLATLPATIGLVAIAAAVPKLTARLGGRQVVAVGFLLTAIG
FAVIGFVDADWAYRAFLLPLLAVAVGMGMSNGPASSASTACVPEKQVGSASGVSNMARYV
GAAVATALAATIYGAVIADGTAKGRPPADALASGLATTSWVMAGFSLAGVLMAVLMGRHQ
AATGTIHDSAAAAASTAMTLRTTATGAVATGAAKGA
>fig|1172188.3.peg.4078 Oxytetracycline resistance protein OtrA
MDTPPTPPVRPGRTLGLGILAHVDAGKTSLTERLLLHAGVIAELGSVDDGSTQTDTLALE
RDRGITIKAAVVSFELGRPGDPDPLTVNLVDTPGHSDFIAEVERSLAVLDGAVLVVSAVE
GVQAQTRVLMRALRRLRIPTVLFVNKVDRSGARTEVVLREVVDRLGVTPVPLGRVVDEGT
RAAAVVPDGLADLGLPARGPAEREDAEPEGGDRDAAAARERVVEALSRADDRLLADWLDA
PHRVDASRLRAALGEQTRRGLVCPVLLGSAMTGAGVEDLAQALPDLLPARTPDPDAPLAA
TVFAVQRGASGEKVALVSVTSGSLAVRDRVLVHDGRTEWSPAPDPDPRHTTSASGDDGAR
CREERVTGLSVHARGEVRRVARVPAGRIARVVGLERARIGDLVGDAALARPLVHEFSPPT
LETVVEACDPAERALLHTALTRLAEQDPLIDLRHDEVRGETHVSLYGEVQKEVIGATLEA
EYAVAARFSTTSVICRERVTGSGAAFELIDVAPNPFLATVGLRVDPGPPGSGVRFSLEVE
LGSMPASFFTAVEDTVRATLGQGLHGWPVTDCVVTMTHSGYWPRQSHMHQKFDPSMSSTA
GDFRALTPLVLMEAVRLAGTAVEEPVHRFDLEVPSDVLGAALSMLGHVRASPRETAVLGP
VTRLRGEVPAERLHELQQRVPGLTSGLGDLVTAFDGYRPVVGPAPTRSRTDLDPLHRREY
LLRLAGKLSAQPHSSERPTTLE
>fig|1172188.3.peg.4145 Phosphotransferase (aminonucleoside antibiotic resistance)
MSDRPLHTAVDIPQVIVVTGVMAAGKSTVSQLLAERFTRAVHLRGDEFRRVVVRGRVDMS
PHGDPEAERQLALRHAIAAHSANEYAAAGFTVVVQDLFVGTTLQPFLDRLTARPLSLVML
APDVGTVMQRESERVKVGYGDLWSIRDFDHKVRTETPHIGLWLDSSQQTPDETVEEILAR
LAEARIS
>fig|1172188.3.peg.4451 Permease of the drug/metabolite transporter (DMT) superfamily
MTPAARTRLATLLLVALTAVWGSTFFLIRDLVETVPPVDFLAVRFSLSAVIMLLVFWRPV
RALSRRQVLVGVGLGALYGLAQIFQTQGLATTPASVSGFITGTYVVLTPVFTAVLLRERV
AGSTWAAVGLATVGLALLSLNGFSVGVGEAITLLAAALYALHIVGLGRYSASEIATGLSV
VQMVVIAVLCVVGALPGGVVLPSGPRQWASVLYMVVFASILALWVQTWAQAHMPATRAAI
VMTLEPVFAAFFAVTLGDESATLRMVVGGALVLTAMYAVELLARRRPGELPVEALHHEV
>fig|1173022.3.peg.2517 Permeases of the drug/metabolite transporter (DMT) superfamily
MSSSVEKSSSPNSLLSGQNVVYAGIAWSVLALLFYLLFSISVPGEERPFWYSMGTYFFEE
VPFLAAALLCFRNWRSPQIASGRNVWLGIGLGLLSFFIGNLFFGWWELYWGLDPAVSPGD
LFYVLFYVCLGCGLVLAILPRRLNLEPWQWATVIASAVSAIALAIWLLSSPPANAQEASA
IAQPARSAIASTPITQQRDSNTPSQTLIAQKAPNVKVTPKAPATKAPPVPANTSKNQPPG
WVLSLEKVLEPLAAPLSLFYIAGDVFLLIIAALLLLAFWGGRFAQSWRMIAAAAFSFYIA
DMWFTYATDHITDYQSGFLLEVFWVFSGVLFAIGAALEYDNSIRSRRAGRKRA
>fig|1173022.3.peg.2687 Glyoxalase/bleomycin resistance protein/dioxygenase
MFLNSIFVTLATSQLDILVQFYTNLIGIEPESYIPQIYAEFRLNNLRLGIFQPKEANRQE
FDNSGRNPISLCFEVSVLESAIAHITALGYPPPGKIINASHGREIYAYDPDGNRIIFYQS
NKLD
>fig|1173022.3.peg.4533 Vancomycin B-type resistance protein VanW
MNTNNKEKFLPSIKKIIPGELKRSLKIKSRYIGDILTGNAQSMVNFIPINEINKYQFQPQ
SSISQVIKTTSYSENKKHNLALAINRLENIVIQPGKLFSFWHLVGNPNSKNGYKEGRTII
NNQLQSDIGGGLCQLSGLIYWLILKAGLVPTERHPHTHDIYTESTRFAPLGSDATVVYGY
KDLRFINTLPVPICWQFKLLPAEIIASLCSTQKIHQFEIEFRREESNEQRIVQTVRLAQG
KEEIIDTSYYLVLKN
>fig|1173022.3.peg.4649 Methicillin resistance protein
MQSWAWGDFKELEGYQTFRYGLFADNTLVGGAIFYFYTHASQANLLIAPGAPILTPPYLE
SGMQLLLRKAEELAKKLGAIALRIEPLWTKKPDYLSNFVRAPVDLLPSETLLIDLEVSEA
EMLAAMKQKGRYNLRLSWRYGVETEFTTNPQAIPVFYDIFWETVKRQQFFGEPYCFFINL
CQTLFQANMAEIGLAKWQGEILAAILVVYCGNRATYLYGGRSFEHPQVRATYALHWAAMQ
QAKQRGCTIYDLYGFTREPKHSYAKFSQFKSQFGGIPVTTIGAQDYFFYDQLADTLINLF
KNIGGNET
>fig|1173026.3.peg.24 Permease of the drug/metabolite transporter (DMT) superfamily
MCAKHRIDRETIGLGYGFLGVLGFSLTLPATRVAVVKLDPTIVGLGRAIIAAFLAVIVLW
ANHQRRPARKHWRGLIIVAAGVVLAFPLLSAWAMQQLPAAHGAVVLALMPLATALAGSII
VRERPSRRFWLASITGSITVIVFAIFSGAGQMQWADVVLLGAGMAAAISYAEGGRLARIL
GGWQVICWALVIAAPVLSVPFAKAVLQHGLVASPTAWLGFGYVSIISQLLAFFPWYQGLA
IGGVARVGQMQLLKPFLTILASAILLGEAIAPFTLIAAMIVVTSVAIGRTSAIQRN
>fig|1173026.3.peg.703 Permease of the drug/metabolite transporter (DMT) superfamily
MQIWQAPKPWQVGLVLVIGVFGISTASIFVRLAFAAVPGVSSVGFSLVLSAARLIISAIL
LLPAWRYLRSSPPSRTSVYYASVAGVCLALHFATWITSLAYTSIAAASTLVSSPPIWVAL
LSWLWLREKLSPLTLIGIGVALAGGIIVALRGSGVDSVASRPLLGNFLALFGAWMYSLYL
LLGRKAQQEGLGLGSYIAIAYTTGALILLPLPGIFSVSYTGYPSIVYVYILLIAIFSQMI
GHTSLNWGMRWLSPTLVTLAALFEPVGASLLAYFLLGELPGRLTLLGAAILLVGVACAIV
GARQNKLGQTKLSE
>fig|1173026.3.peg.1148 Permease of the drug/metabolite transporter (DMT) superfamily
MVVYLKLILTAVVWGGTFIAGRVIVQDLDPFSAAFCRFAVSSICLLFLTLKQEGQLPRLH
QKQLIQVILLGMTGVFAYNAFFFLGLQTIAASRAALIVALNPTFIALGSALFFKDKLTAF
KIIGIIVSLLGAALAISRGNVVNILDDNLSIGDLFLFGCVFSWVAYTLIGKLAMQQLSPL
VATTYACLIGTIALFFPALSEGILQHFFQINFVTWLVIWYLGFLSSALGFIWYSEGVRVI
GPAKAAIFINLVPVSAILLAAVLLREEITLSLLAGGILVVMGVFLTNKA
>fig|1173026.3.peg.1345 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MASDRTMEQFKLGSVSNTPQDLISNGFAAIALGMALLGIAFASILTVVAQYEIGPNATTF
NRLGIAAIAFAGWNGFRFVSQIHAHSVSALVYTWRDRSLLAIAGTSFAASLTLWAWSLTQ
TSIANSTLLNNMMPLFTTLGAWLVLGQKFSARFVLGMAIAVCGAIAIGIEDFQGANSNLF
GDSAALGAAMLAAVCLLSLEQLRLKFATPTIMQWTCLIGSLGVFPVILLTQEPLFPTSGV
GWCTVISLAIVCQVVGQGLLTYSLAKFSSGLVAVSMLAIPAIAAVLALIIFAEKLSILNL
CAFAVVLAGVYLAISARSD
>fig|1173026.3.peg.1808 Glyoxalase/bleomycin resistance protein/dioxygenase
MKLGAIHHIALTVSDMERSEAFYNKLLGFMGYEQGEKTEQLILWASSHSAMTISPAKQQF
HQKCDRYSPGLHHLAFSADRREDIDKLYQELLEQQVTILDPPAEYDYLPGYYAVYFLDPD
GIKLELAHTPT
>fig|1173026.3.peg.1811 Permease of the drug/metabolite transporter (DMT) superfamily
MKPIDLARLFLLAALWGSSYLFIRITAPVLGVFFTISLRVIIAACALGLYGVLAQQLSTL
KTRWLSYLLLGLLNNVIPFILIAIAIVNLNASIAAILNATTPLFTAIVAAIWLKEPLNKR
KIVGLLLGIVGVAILVGWSPLLLSLSVILGGLSALIAALFYGIAAVYARRRFRHNRATET
AIGQLVGSSVLLIPVTFTSIPNTVPSTEVILAVITLAIACTAFAYLLYFQLIAKAGATQA
ATVTFLIPVFSLLFGKTLLGEPVNFGLIIGLITILLSIWLVFNTKH
>fig|1173026.3.peg.3594 Permease of the drug/metabolite transporter (DMT) superfamily
MNYNNAPEGANFGLLMIMVSAILWGTVGVFVQTIYTLSESNSFSIGFLRLAISLPVLFLA
CARTLGWQMLQIAKRDLALMLLTGAMTAFYQVCYFTSISYIGVAAATLITLCTAPVWVAL
LASLILHERFTLGILLAGLCALGGTSLLVNIQPEQIAVRSQILGVGLALGSALAYASVTL
CSRLLSRRYHPLQSLTVSFFAGAVFLLPIALITGLVLQYPFVGWIALLYLGIVTTAFAYV
LYFSGIRHTPATVASIATLLEPLTSTILAWWLLGENLGTSGIIGGVLLLIAIGILYWDLR
WNQRHSRRN
>fig|1173026.3.peg.3917 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MSIAATELFTLSFVVQLTLALATYTIGVANWVLALRVVKLSVAYPLSSLNYVGILFGSYY
FFNETITFTRILGVLLIFTGVLFVALSQSGRQLISK
>fig|1173026.3.peg.4327 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTVMQMPKHIHTEVREFLKLAIPLASAQVAQSATGFADTVMMGRMGAEVLAAGGLAALIF
LSIMTTASGVVMGVSPLIAEAFGAGKKTRIEQVARQGLWLALLVALPLMIFTAHLDTWLS
YSGQTAKNVQLVNTYLDIMLWGLFPAVGFAALRATVSALSQARPVMMIVVTGTTFNIIGN
YVLGFGKFGFPRMGLAGLGVASVIALWGMFFALALYVFKNQNLRKYRIFQELHRVRLRIL
WELTWVGVPIGLFSGLEIGFFLVVTFWMGTLGTEVLAAHQVVFQTIVVVFMVPLGISYAT
TVRVGQWLGRRSRIGIQQAAWVSMGMTTVFMVGVSIAFLLFPKQIVGIYLDVQNPENAAI
VAIALPLLIIAAIAQVLDGFQKAVYGSLQGLQDTQIPMLLNVLGYWGIGLSVGYGLGFWF
NLGSIGLWIGQSVAIATVAGLFTWRFHKLIARQTLN
>fig|1173026.3.peg.4463 Permease of the drug/metabolite transporter (DMT) superfamily
MTAKLFAPREWQLALPLAIFLHLFYVAPLAVLLASSFQTAPDVPSFTLAQYWQFFQDAVN
RKVLLDTFWLGVQVTLSCLLFGYPVAYIYANAPAKWKGLLTFLILLPLLTSSVVRTFGWV
VILGRQGLVNSLLQGVGFIEEPIRLLFTHQGVAIAMTQIQLPLMILPIVASLAQIDPRLA
AASASLGGGAWRTFWKIIFPLTLPGIISGCLLVFAITVSSFVTPSIIGGGQIMYMPTLIY
QQGVVLLNRSFAATISAILLVMVLIVVFGLSSLGQKSRDYVR
>fig|1179773.3.peg.563 Probable multidrug resistance transporter, MFS superfamily
MKRLLGKVAIDTRPLRIPAFRRLWLSTLVTAIGSQLTAVAVPKQVYDITGSSGWVGVAAG
VALVPLLVFGLWGGAIADVVDRRKLMVVTNIGIAITSVLLWLQAAFDVQNVWLVIALLGL
QQVFFAANAPARSASIARLVPEDQLPGAVALGSTVMVFGGVFGPMLAGALMPVVGLSTLY
LVDSIALTATIWAVWKLPPMPPLDGVVRRAGLADVIDGFRYLSVQKIVMASFLLDIIAMV
FGMPRALFPEMAEVTFGDPPGGGLALGWLFAAIPLGAMVCGLVSGWTSRVSRHGVGVVVS
IIVWGVAMIGFGLSNALWWAVVFLAVGGAADMISMVFRTSILQTAAPDEMRGRMQGVFVV
VVAGGPRVADLLHGTTGALIGPGAATAWGGVAVVIGTVVAAIAIPAVWRYRVTLGTAGET
SPKP
>fig|1179773.3.peg.804 Daunorubicin resistance ABC transporter ATPase subunit
MADVVKVYEGGRKPAVDGLGFAVRRGEVFSLLGPSGAGKTTTVGVLTTRVRPTSGRALVE
GVDVVADPRKARQVLAVVPQRNTLDRALNVRQNLLFHAAHHGLGRAERTRLADGVLNRMG
CRAGPAVPALHRHRPGGRPAGRPADRRAARRRGGRPGRRQAEPGGRLHRPGTARVPHAGG
RPAVPAGGGGEDGVRGVARAARGGADDPDRVRCARRLVGAVGGPGGAAGDRPARRRARRS
AW
>fig|1179773.3.peg.992 Drug resistance transporter, EmrB/QacA family
MSSRRLAIGAGALAVLLGALDAYVVVGVLVDMVRDLGIPVNHLERATPVVTGYLLGYVAG
MPLLGQLSDRFGRRTVLHLCLAGFAVGSAVTALAGDLPLLVAGRVVQGLAGGALLPVTMA
LVGDLWDERRRAGALGVVGAAQELGSVLGTLYGVGVASLFNAWSVFESLEPQSWRWVFWV
NLPLAAVAMLVVQRTVPGGSGRPVRIDVVGGALLALSLGLLVVGLYNPDPEHAVLPPWGW
PALGGAVAVFGGFVWWEKRSPVRLLDPTGVVMRPFLASLGVSLAAGAALMVTLVDVELFA
QTVLRLDSAAAVALLARFLIALPVGALLGGWLASRVGDRWVAVVGMALAGVAYVLISRWP
ADVPSSTLDRDLVVAGFGLGLVIAPVSAAVLRVVPATQHGVASAAVVVARMTGMLVGVAA
LSAWGLHRFRELTANLNTPLPFGVEPAEFTRQAEQYQRALTEALLTEYHEIFLITAVICA
AGAALALLLPAKTSSPDLTATRPRTG
>fig|1179773.3.peg.1037 Multidrug resistance protein B
MLGNDVRSGPRLPGEVWVLVVASFIIAIGFGIVAPVLPAYAKSFDVGTFAVSAIVSAFAL
VRLLFAPVSGRLVSRFGETRTYVVGILIVALGTAACGFATAYWQLLVFRSFAGVGSTMFT
VAAVGLLIRITPAPMRGRASGLWATGFLLGNIAGPIIGAALAEISIRVPFVTYAAALVLA
AAVVWWFLRRSTLAALDPNVEQTTLSVGQALGSPAYRAALASGFANGWAVFGVRISLVPL
FVVEALNGSPALAGISLSVFALGNAAVLMISGKLSDTIGRKPMAMSGLAVSAVGTIWLGF
TTGVPWFMAASLVAGIGAGLLNPPQNAVVADVIGTKAKGGPVLAAFQMVADCGAIIGPLL
AGVLVDHVSYGAAFTLTGVIMIIALVVWAFAPETLPREPSAHVAEVVANESGRLDEGPEV
PTGERLAGRPRQPDA
>fig|1179773.3.peg.1188 Small multidrug resistance protein
MLKWTLLGLAIVFEVFATLCLKASDGFTRLLPTLGLLVGYAAAFYLESQVIRLGLPVAIT
YAVWAGGGIALVAVAGRVLFADPIGPATLAGMALIAAGVGVVSAAATT
>fig|1179773.3.peg.1469 Permease of the drug/metabolite transporter (DMT) superfamily
MGKFVLLSAIWGSSFALIKVAVDAGVPPVWVAFFRCLFGALALWAVCAVQRQGVPRDRRL
WGHALVVAALLNSVPFTLLAYGETKVSSVLAGVFNATTPLMTLVFVLLIVPQEKISGAKL
TGLVVGFAGVLVVLRAWEGLGDDVLVGSLACLGATFCYGAGFAYTRRFFSGGPQSASALS
AVQITCGTAQLAVAAPLVGGLPSWPGWQAAAALLVLGAAGTGLAYVLNLDVIREAGPTVA
STVTYVTPLWSTALGVLLLSEPAGWNTVVGGVVVVAGVLLARKPTNHPMGQKSTRTVVQV
DKPGPA
>fig|1179773.3.peg.1679 Tetracycline resistance protein
MMIMTAVEVVQRRVLRVLGVTQVLGAAGVTIGLAVSTLIAAVLSGSDAVGGLAQTAAALG
AALFALPAARLAARRGRRPALILGYGAGAIGAVVAACAVVLGSWQVLVAALVLFGAASSA
NLAARYAGTDLAHPQRRARSLAIVVWAATLGAVAGPNLADPAGQFAARLSLPVGAGPYLA
AAVLFGAAALVVLRFLRPDPLTLAQSAAPVTPAHCAGGVGDTRGSAAVWRALPATGKLAL
GGITLCHTAMVGLMSMTPVHMDHAGASLRVVGVVISLHVAAMYAASPLFGWMADRLGRVP
VLAIGSALVVAASGVAGMAPAHDAPQLAAGLTLLGFGWSAGLVAGSALLTESVSPTDRPA
AQGLSDLSMNIGGAVGGVAAGIVVTAWSYAALGLLVGFTALPLLVACLFTSLQRSR
>fig|1179773.3.peg.2719 Multidrug resistance protein B
MANAVGKVAERGREPVEVGRGARNAIVAVIMLGMLLAALDQTIVATALPTIVSDLGGAGH
LSWVVTSYLLAETIMTALIGKFGDLFGRKPAFLVSVALFMVGSFLCGWADSMTWLIVARA
IQGLGAGGLMVTSMAVIADVVPLSERGKYQGLIGALFGVSTVVGPLLGGLFVDHLSWRWA
FYVNLPLGVLVLVVGFLRLPGVRTTAKPRIDYLGILLIALAATGLTLVTSWGGVEYEWAS
PTILWMAAGSLVALALFVRVELRAAEPMLPMRLFRNPVFTVCCVLSFVVGFAMLGGVTFL
PTYLQYVHGASATQSGLEMLPLVVGLLVASIVTGNVISKTGRYRVFPILGSLLMVAGLLL
LSLLDVDTAFWEASAYMLVLGLGVGMCMPVPVVVVQSTSSYEDLGVATSGVSFIRTLGSS
FGVAIFGSIYASNLPEKLAAALPPGVDPRAASNVQALHALPDQLKAPIVAAYAETLQGVF
LWAAPVAAVAFVVALFLREVPLRDTARAAATGNNGVGESFAVPQSTVSSQELEKLVALIV
SKERRDPTPEVLAGSGLPLTHAQAWLLVKVFRQSAHRGAATLDRLAAETKVPPGIFEPVA
RQLMTKGLLTESDDDYRFTPEGSATFARLVSSWRDWLHVKLVDWQCDDPEFTEAVDRVAA
DLVITSQSLTTRHPTPV
>fig|1179773.3.peg.3149 Multidrug resistance transporter, MFS superfamily
MAQVRTGPRRLAVVGLYAGGFLGPFGGAMTSSVLPEIGADFQVSAGAAATTLTGYLLPFA
GFMLFSGTVGERWGARRTVRIAYLVYAVASVLCAVSWSFPVLLGGRALQGVANAFTTPLL
LAAIAAVTPKERLGRALGVFASMQAAGQTSAPLVGGLAAEASWRWAFVGAALVAVLLAAA
GVPADPPRTEQPPRLRTAWRPEVLRLAAAGFVGWGCLGGVSFLVALRLGDDFGLGAGERG
LVLTGFGVVGIVCARLTGWMIDHVGPRRCVLLGTTVGSVLLVLIGVLPSLVAVGVLWAVA
GAFSQAVIVGLSALVLGRGGNRGGAISVLQSFRFLGGSASPMAFVPLYHLSPAASFLAPA
ALVLLIPPALLLWRGRDRS
>fig|1179773.3.peg.3266 Permease of the drug/metabolite transporter (DMT) superfamily
MSSAVVRTRLAQGPLPILAACFLWGTTGTVSSLAPSSAPASAVGAAGLVIGGLLLFLTAR
GTRDVLRTADRRLLLLGAVTVAGYALAFYPAVARTGVAVATTVALATAPIVLGIKTRPLV
TLTAVTGCAVLVLGGGDAHVDLVGVALALVAGLSYAAYSVICAHLIALGHPSRAVVGTVF
GGASVITLPVLLLLGVSWLGTYGGWAVVLHLSVFTTFVAYLLFGHGLRHTTAASATTLTL
AEPAVAAVLGVLVLHERLPLVSWCGMALLGVALLTLARR
>fig|1179773.3.peg.4170 Permease of the drug/metabolite transporter (DMT) superfamily
MLNRSVVRMGLLALLWGSVFLWIELALTGLTPVQITVIRCALGTAVLLVLAGFGRQKLPR
DQATWGHLVVAALFCNALPFVLFGIGQQTVDSGVAGVLNATTPLWSVLIGLALRTEPRLT
PARVGGLVLGFAGVVLIFAPWQRDGLASWGALALLGAAASYAVAFTYMGRTLVGRAGPMA
ISAGQMAAATGLSALGLPLSGPAHPNATALVAVVILGVFGTGFTFVLNYRIIEEEGATSA
ATVGYLLPVVSVGLGALVLGEPLTPRIVAGMAVVLLGVALTRSAAAKPPQEGSAPRPSPV
LPTERDQPGGHSTEPR
>fig|1179773.3.peg.4465 Permease of the drug/metabolite transporter (DMT) superfamily
MLSPSRAGLGWGLVGVAAFSFTVPFTRVVVGGGMSPLFVGSGRAVVAAVLAAGALAATRQ
RLPRGGQWARLAVVAGGVVVGFPLLTSFALTSASAGHSAVVIALLPAVTAVIAVLRGRER
PPRSFWVMAAVGAAAAVVFASLRGDGIGGPHWSDLLLLGAVLAAGIGYAEGGLLARELGA
WQTVSWALVLSAPLMAALAGFAVVRQPPTGTPGEWAAFGYLAVVSMFLGFFAWYRGLAIG
PMAQVSQVQLVQPVMTICWAALLLGEQLTWSTALGGVAVIACAAVAVRARLGATQVGTGQ
GLPVDREG
>fig|1179773.3.peg.7039 Permease of the drug/metabolite transporter (DMT) superfamily
MRWAALGVVYVVWGSTYVGIKFAIETMPPLLSAGTRFLAAGLVLALIVGRRLRMTWPQFR
TAALLGLLLPAWGNGLVVVAEQSVASGLAALLVASVPIYVVLLRRLGGERPPRVTYVGVA
VGLVGLAVLLLHDVGGSSWWGPWAVLLAAFGWALGSYLNGRLPTADPFAMSAVEMIVGGA
LLSLVGVVAGESVTLSEVSTTSWLAWGYLVVFGSLLAFSSYVYVLGQLPVSTVATYAYVN
PVIAVLLGVWLADEQFGPWQLAGGLLVVVAVVLVVRAERKCRTEVGVSEPCRR
>fig|1179773.3.peg.7074 Glyoxalase/bleomycin resistance protein/dioxygenase
MGGATFPDMTLTIGMITIDTADPHKLAEFWTKALDTEVRHDWGEFLIIGPAVEGGLQLGL
QRADDIAPGKNRVHFDAHVPDRAAEVARLVELGATEVAEHTVPGLTWTVLADPDGNQFCV
GQPG
>fig|1179773.3.peg.7126 Permease of the drug/metabolite transporter (DMT) superfamily
MKPGHAALAVLTTTIWGVNFVVIKVGLDEFPPLLFSSLRFLAAAVPALWLVGKPRVAWKW
IAAVAATLGVAKFGLLFLGMSEGMPAGLSSLVLQSQVIFTIAFATVLLKERPRPVQLVGI
AIAATGIVLIALDYGLTSPISALLLVVLGAIAWGLSNVATRYAKPPDALSFIVWVSAFAT
LPLLLLSVIFEGPSAIITALGNASWAGVTSLLFVAWVSTLFGFGVWGFLLREHNASTVVP
FALLVPVAGMFSGWLFLDENLSPVRLGAAALVIAGMAATTIPRPARVLTPVP
>fig|1179773.3.peg.7154 Glyoxalase/bleomycin resistance protein/dioxygenase
MDLQAAIDFYTGLFGWTYADIAGHTVAVVDGLPVAELLPADGGFGWTLYLNTPHARATAE
KAHSIGGHVLREPDEVSTLIADPTGGVIGFRHVPPDWLFGTDGHGAYAWAELNTRDGAAA
DEFFQELCGFEMTQIGDGHAVDYTIWAVQGDTVLGRQRMGSAFTPDTPTHWMVYFTADPE
IGTDSVASRVLELGGRVTVEPYDSPFGRVTVVTDHTGAAFSVIDPSRVVPLSEEDTGAPV
DDPYDD
>fig|1179773.3.peg.7198 Quaternary ammonium compound-resistance protein SugE
MHWLYLAIATVFEVAFALGTNATKGFTRLVPSIVTLVAAAGGIYFLSLALRTLDVGVGYT
IWTGIGSVGTVVLGVLLFKERLTGARVLCFGAIVLGVIGLRVAAGV
>fig|1184607.3.peg.886 Permease of the drug/metabolite transporter (DMT) superfamily
MRLRDVLTTAVAPTAWGSTYFVIRHWLPAGIPLTGAALRALPAGLLLMLLARQLPRGSWW
WRTALISGLTVGGFFALIYVAGQRLPSGVAATLMASSAIVLLVMGQVLLGEKAPLRKYVG
GFGGIIGVGLLVGGASLTLDPIGVAASLLAMTSSSLGFVLTKRWQPPVPPLTFAAWQLTA
GGLMIAPVALMIEGNPPPLEMSAVVAFTYLVIIATALAYAVWFHGLQRLPAGTVGLIGLL
NPLSGTLIGLLAAHEKLSTLQVAGTVIILAGVTAGIDRKPEERGEISMESTGEKPAVPHA
EKTPSDSELLCTKQ
>fig|1184607.3.peg.1886 Multiple antibiotic resistance (MarC)-related proteins
MNVIDGAVFGSVFISLLVILDPPGALPVFISLTKSYTRQERLLVAARAAGVAFGLLLTFA
LIGKEILDYLKISVPALQISGGLLLLIIGLELLMGKEADPTEIGRTHVALVPLAVPLFAG
PGVIVTIMVSMQRATTAGQRGAIILALAAAMAVVYLSMRYAGAIHRVLREGGTILVSRIA
GLLCSAIAVQMMADGVIGFVRLV
>fig|1184607.3.peg.2153 Multidrug resistance efflux pump
MTSSCFFINLPLIPLFFQSFEGAPQILLGPTLAISFALSALLGPFWGRLADQYGYRLMMQ
RASGLLVLTYVVTALVPNAEALFVARVLNGLASGFIPAATAYAIRATGEHKRNRTLTTLS
AARNSGAVFGPALGALFAAWWGFRAAAGRKASKSSGARCPMRADPPPVVGSGGFAEGHSR
KMGGGGYLIE
>fig|1184607.3.peg.2631 Permease of the drug/metabolite transporter (DMT) superfamily
MHLTVLAYVFCLVVWGLNFIAVKIQGTPVALEVSLTYRLAGAAVMFLCLAFVVRPSGRPS
RQDLRGIITFGLCNFALSYLFLYYATIWSSAALVTLLFSLKTVMTPIALRISLGDRLSPR
IMIGGVLGIVGVGILVYPMLAGGAQVASLKGVGFALIGTLLTAVGDASSARNARQGVDPV
YSNSIGFIAASLLLLVVCLVQGQKFDIPMSISYLGALAYLTVAASFLAWFFYLKLVERIG
AAVSSYMVALFPAIGGLASVAIGESEPSFHLLFGCLFSCVGAAVALGLGRVFSAARSRLP
>fig|1185876.3.peg.865 Small multidrug resistance protein
MQAWFFLLIAATFETAWTYSVKYMKFTDLKLLRWHNFYSPQIGLPILAPIVGYVVFGIAN
IYFFSMAIKQIPTPTAFAVWTAMALILIKLVDVFIFHANWSVTELFFLMLIGIGIVGLRL
YAAA
>fig|1185876.3.peg.1011 Glyoxalase/bleomycin resistance protein/dioxygenase
MATQQFYAHQLLLPMVSYTYWSATFRVGWSELVFRQTNKPVKPYHFAFNIPLYSLEQYQN
SFQLPYIDTSPSHCKVAYFPKWKARAAYFFDTNGNLVEFIERQDAGFIEPAEDIFQGISE
IGLVTNDVPATTRQLSRQFGIGQFLKSQPMNDFNAIGDDYGLFILAKTGRNWLFTDVPAA
QQQCKVVFQTDGEQTHSLRI
>fig|1185876.3.peg.1913 Glyoxalase/bleomycin resistance protein/dioxygenase
MDAQLIQTLQATHIAAWNEKDRTKRATLLQSIYADTITMYDKELVLHGIEAVSDFIEKLQ
REDPAFQFSAAKPIESVQNGVRLYGHIDTAQGRLNSMDFFVMDEGKVLHLYAFIDIP
>fig|1185876.3.peg.2141 Multidrug resistance transporter, Bcr/CflA family
MTDVIKVGLTMTRRQQFSIILILGTLSTISPFSIDMYLPGFPAIASDLNTSIAQVQLSLT
AYLVGISVGQLLYGPLLDRFGRKLPLYAGLGVYVLASLGCAVSTSIETLILMRLLQALGG
CVGMVAAQALVRDLFPVDQTAQVFSLLTLVIAVSPMIAPTVGGYATVLFGWHSIFVILAV
ITALILLAIVYVLPNGRQADASISLRPQAVLGNFYTVIRQPQFLTYALVGGIASAAPFAY
ISGSPDVFMNIYKVSEQEYGWIFAVLAIAILAPNQLNHVLLKRYSNQQLVSTTLVYQSVV
GFFLVLGTWAGWYNLYGLLGVLFLFLLGQGLVAPNSAALTLAPFVRHTGSAVALMGSFRM
GVGALVSALVSVLHNNTALPMVGVMAGCIFSGFLILLLGQRAIRYRSQHTDVGESIAEAT
L
>fig|1191523.3.peg.150 Permease of the drug/metabolite transporter (DMT) superfamily
MEKLKVAGGYILICIIWGSTWLAIRLGLDSIDPIISVGIRFLLASGFIYFLMKFNDVELQ
VDKKSVKIYLMLAFFSFIIPFGLVYWAEQFIPSGLASILFAIMPFGVIIFSRLMMPQNRV
GLSQLAGVALGFAGIVIIFSENIHIEITNYLWGMIAVLVSSMMQAFIAVAMKKHGGHLHP
LSMNFLPLLIAGIVLIPIAFIFETPSRWIFDAKSVGSILYLAFFGTVVTFTTYYWLLKRM
NVVILSLSAFITPIIAVVLGWLILDEYFSQRVIMGSSLVLIGILFANFKGLIKYFHMRRS
RVNI
>fig|1191523.3.peg.711 Permease of the drug/metabolite transporter (DMT) superfamily
MKKSGLRYALSAVFLWSTVATAFKLTLEGMNYAQLLFYSSLTSTLIFASLIFIRRKSIGE
TLFSKKYIKNNIALGFLNPFLYYLVLFKAYSLLPAQEAQPLNYTWPIIISIFAVIFLKNK
INFRIILGLIMAFTGVIVIATRGNILSLHFHNLFGVSLALGSSLLWGLFWTFNLLDSRKE
DEKLLGSFFFGTIYTFIYLAAFGSFAISSYKYLLGAVYIGFFEMGITFILWLNALRLSDN
KARTATLAYLSPFISLLFIWLILGEKLLLSSIAGLILIVSGIIIQRLNDSIRS
>fig|1191523.3.peg.1700 Permease of the drug/metabolite transporter (DMT) superfamily
MISDTKTRAYLAWAAICLIWGTTYLAIRIGVEDLPPLLFAGFRWFLAGPILFLFLIKKGC
RLPGWQDIKRSAVVGILLLGFGNGFVVFSEQWIPSGLAALLITTVPFWIVGIESFYVRGS
NLNMKIIIGLLAGMSGVTLIFGSNIISIFDPHYIKGVAGLFVAVTSWSVGTVYSKYNATE
VHPLMSAAVQMTIAGTLMTSVSLIIGEHKNLTFTPESVAAFFYLLIVGSLIGYGSYIYAI
EHLPVSFVSTYAYINPVIAIFLGWLVLDEVINLELFLSSAIILSGVYLVKRGSVEARTKL
SRTDR
>fig|1191523.3.peg.1868 Permease of the drug/metabolite transporter (DMT) superfamily
MKNKFSPAHFIGEGALLLMTIIWGGTFVIVKEALNDITPMLFIAARFSIASLLVFTFLLF
KRYQLNSSALRSGFLLGFFLFLGFAFQTAGLKYTTATKSGFITGSLVVMIPALQLLIEKK
KPTKGALMGTALVFVGIIFLSSGSAAPSSFLAEFGKDFNTGDYLTLICALFFALHVVYMD
ILSPGHDFWLLFFAQLITVAALAWITAIFFHSVSFESLYLNINGNLINGILYTSVLATFV
NFGLQTRFQKEVSPTKAGIIYSFEPIFAALFAYFLLNEKISNFGMIGGVFIFGGLIISEI
YDYYFNGGKKT
>fig|1195246.3.peg.249 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLPFSRFEARTILKLSGPIVLAQLTQTLMYFVDTVMAGRVSATDMAAIAVASGLWLPVVL
TMQGLLLALTPIVAQYYGSKQTKPISHYTLQALYLAFIMAALLFVLMLFADIPLSRLNMD
PLLREKTLDYLFYVSFGLFPAAGYMVMRNLFEGLGNTKASMWIAFVGILVNVPANYIFIY
GKLGMPAMGGAGCGVATSLVFVAMFIAMLVYGYTSRSTRPYRHWPEKLWLSLKDQWQIIR
IGTPIAFSIFFEVTLFACIPLVIVHLGPIAVAGHQVAHNYSAIVFMLPLSLGLATTIRVG
HLVGEQNLMELKKAISTAIVLSVAMSLLTVIFTLLFRKYVAALYSPDPAVIALASSLLIL
AAIYQFSDAVQVVAACALRGMKITTPVFFITLISYWPIGFGLGAVLGLTNWLVEPMGPHG
FWTGIIVGLTCAAIALAMVLRKQINRMEHEFKTGATA
>fig|1195246.3.peg.1888 Permease of the drug/metabolite transporter (DMT) superfamily
MALLAAACWAFGSLLSAQAATHLGAFAFTRYRMLIAMSLLWLLSFATGSWQSLQLPQVLL
LILSGAIGIFIGDTALFAAMNRLGPRRAGVLFATHALFSVLLAYLFLGETLWGMTLVGSG
LLVGGVMIAIAFGKRREEQHQWEASPAAMKSGVALALLSALCQAVSTLMLKPLMSEGLDA
IAGSAVRMSTGFVLHLLVLLLGLKVARSYLPLTWRVFWLVAVNASLSMVLGMTLILQALK
TGDAGLVALFSSVSPVLILPMLWLVYRRRPAWGAWLGALLTVAGTALLL
>fig|1195246.3.peg.1958 Multidrug resistance transporter, Bcr/CflA family
MKFVSPSLWQVMLLAAVIAITPLAIDMYLPALPLMASALATTNALVQQSLSIYLAAYALG
MLLFGPLADMLGRRPLALFGLAGFLVASVALSLVSSIEGFLLWRALQAFCGAAATVVIPG
IVRHLYQQHTAKGMSYVSMIMMLAPLIAPAIGSGVMYVTHWQHIFSLLALYAAIMLLLCW
HFLPEIKQQSGNSARPAFFSGYQQVFANRSAWPFIAISMFASFSFFTFLTAVSFVYISYF
GVSEQLFALLFGLNVSALMLANFTNSRLVTRLGPMRMLSIGLVLALLAATSLTAVNAAGL
GLWFTVLSIAPLMASLGLMATNADALILMQFPQHSGTATAVIGTLRFGSGALAGPLLGLL
YTGTALPFSLLMLAGTLCILGSVIWAKALGH
>fig|1195246.3.peg.2591 Ampicillin resistance protein
MTLISMLLALIIERLAVRSDAWQARPYCQAYLKLTAGSGLTKLAEHQLGRYLWILLPGLL
VALLLHLLDNRLLTLVVNTLVLLVGIGCWHYRQLYKQYLNAQERGDEEAAYLAMQQIRHD
SRSDIDSSNGLTLVWLNFRYYAAVVFWFLVLGAFGVITYALLRHLNEQTQTEGAEPVAAS
SDTFAATDDALAETETGAASTADAVTVDEPVVFAETAADTPDSSAAVAKKDALSCMLHWA
DWFPARLFGLGFALVGHFSRASNALLGYFLDFTASNEQVVKDVARAAEPLPEEALNGIED
TSSMVQLSKRNMLFFLAFTAILTLTGWLG
>fig|1195246.3.peg.2675 Permease of the drug/metabolite transporter (DMT) superfamily
MQNILLYLITVLIWGSTWFAIEFQLGEVAIEVSLLYRFALAAALMWLYCWYRKLDMRFSL
RQHGFILLLASLNFALNFLFIYQAQQYLTSAMTAIAFTTMLLMNIINTRLFFGKPVAKRI
YFGALLGIAGIVVLFWPDLDGIDFTNTSLLGLILILSGALSASFGNMVSVRNSREQMPIM
QVNAWGMLYGTLVLLAAALIKGHSFTFSTEPAYLLSLVYLAVFGSVIAFASYFALLKQIG
PEKASYTIVLFPLVAVVLSTLFEDFHWTSYTFSGFALVLLGNAIVLTPFDRIRALLNREQ
PKLAN
>fig|1195246.3.peg.2732 Multiple antibiotic resistance (MarC)-related proteins
MSVTLLIDYWLIAITALFVVVNPLTTAFIFVSLLPNANAAQRARAAKRSTLVSAGIFLLF
GLLGSFIFKVFGITLEAFRIAGGLILFGIAMSMMQKGLDDGEEATGKEPQTDGKLAKDVS
IIPLAIPFIAGPGAIATVMILTSEAQNVWHFITVFLAIGITTFSCYLAMIYAHVLVRYIG
ETGKEIITRLFGLILSVIAVQFVINGVLDIYRSL
>fig|1199245.3.peg.872 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MIYLLIFVVVLLSCAGQLCQKYAANMMPGAGTLGARLRWIATSFLLLAGAFVAWLWVLQR
APIGIVYPILSINFLLVTLATRLLWLECISLRHGIGLLLMVSGIVIMGASL
>fig|1199245.3.peg.873 Polymyxin resistance protein PmrM
MGYRWAYCSVLLVSVAQLLIKWAMMHLPPICSPLLWVDSGHTTPLRVLAGGIIAYFLSTG
CWFMALRRLPLNLAYPLLSLSYVLVAIFSLMIPAFHETYTLSRLMGVALICSGVWLIYHP
SGRNNK
>fig|1203568.3.peg.324 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSQSQGLLRGTPWKAIVLFSVPLLIGNVVQQLYQFVDAMVVGRHLGVLALASVGASMSLL
FLITGFAWGMTSGFAIPVAQAFGANDIKGLRRSVAAGAILSGATSLLMTLVGTIFIRPLL
QLMKTPPELIDDAATFGFWSFLFMFTLVFFNFLAAIIRAVGDSRTPLVFLAIACLLNVAL
VIVFVAVLDWGIAGAAFATAVSQLTSVLLCVTWVRWRIPVLHMGLDDWKVTMPELREHLN
LGLPLGFQTSVIAIGTIAVQVRLNDLGPNAVAAFTAAGRVDGIAVTFLASLGLATSTFVA
QNYGARQIDRVKHGVRQSLVVSIIVSIAIGLALFLLGAVFVELFIGNEQPVVLNLAHDAL
KIYSVAYWTLGVLFVVRGALQGLGHMKPPFYSGIAELVMRVFTAVVLGALFGFIGVAWGA
PLAWIGSIALLIPSYIVISRKLDERTYRSGPRTEEIEVLSAPLLAEKGVVADPTILQGES
FEDVRTGPIPIVRDRGETGQFPALDETYVLMDDQSTSENPEDEQR
>fig|1203568.3.peg.848 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MPAPNLFLTYVSDVERSTDFYSRLFEIEPTFTSPRYVAFEVAPGVLFAIWTGHDENLASA
TPRTNEIGLMIPGPASAIDDVYEEWVAKGVHVIEEPHDDVFGRTFVIADPDHNLVRVSPV
D
>fig|1203568.3.peg.1216 Glyoxalase/bleomycin resistance protein/dioxygenase
MRDATFAIRQVTFDCDDPSALAEFWSSATGCAIAADYGDFVLLDSTPALGFQRVEDPTPG
KNRVHLDGGGVEREALVERLKKLGATELGSHEAPGLVWTVMEDPEGNEFCVGAPTPG
>fig|1203605.3.peg.375 Nisin-resistance protein
MNPIKKTRKVKIIIASVGIVLLAVILAAVHFIGPLFGFWLIPPSPKAHGKYAISLMDRGL
HANTPQWQTKRAEALDAIGKARSREEVTPIIEDALKVAGGKHSFLTTDEQRKEDETLFEL
PTSQADGGVVTVHLPGYSGTSEQGQQYADTVANALTASGACGAIIDLTMNDGGDMGPMLA
GLSPLLPNGEVVTFNTSLGDMVVTLEGGSVKGGGTPTKTDAGATKLNIPVAIITSADTAS
SGEQALLAFRGLDNVRVFGQPSAGYASVNQGFPLYGGLLMQLTVGETIARTSEHFGEIPI
DPDEVVSLDEAPTTAREWLASKGCN
>fig|1203605.3.peg.901 Probable antibiotic-transport integral membrane leucine and valine rich protein ABC transporter
MMRRLGATVWVDLRRQVTEGFWLVALVVALLLAAVLRAVDVEWAVWWPVVLLADLTITAF
YFAAAHVLMQRVEGTLNAQAVSPLRPHEYLASLVVSLAVLSLVEMSVLVLVGCGRRLNWF
AYLAAAAVAAALYVLYGFIAVSKYPSISRFLLPSGLWTAVFAVPMLPLFGAPSGWWLWLH
PLHPVVVLIQVAFGWLAAWWAVPALIVAVIWVLIGFKVASARFQRFLVGDQV
>fig|1203605.3.peg.1730 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MMQIKISDHFTFAKLLRFTAPTAAMMLFTSIYAIVDGLFVANFVGNTEFAGLNFIYPMLQ
MISSLGMMLGSGGSALVAKTLGEAQPERANQLFSLIIRATIVLGVVASAIGAWLVPDVAR
GLGATGQLLEASTLYGRIFLVGLTTMMLQAVFQSFFTAGGRPHTGLWFVIGTGITNMALD
WLLIVPLDMGLAGAAWATVIASLAGGLLPLIWFLRPNPSMLQLGKAVRDWRALGKACTNG
SSEMMANIAMAVVGMLYNYQLLKYTGADGVAAYGIIMYAGFGFAAILLGFAFGVSPLIAY
NHGARRTDELRSLFTKSVTLVTIFDLVMTITIFLVVRPVAGLFAAGNQNLLDLTVQGGRI
YALAFLLIGFNILGGILFTALNNGLLSAVIAFCRTLVFECLCVLVLPGFFGVPGIWASAV
VAEVLAFLVTLSIVLGARRHYGYL
>fig|1203605.3.peg.2442 Multiple antibiotic resistance protein MarC
MELVISSAVIFTMVMDPLGNVPLFLTALRNTAEDRKKRVLVRELLIALVLMLLFLVGGRG
FMRLFHVEAPSLTVAGGVVLLLIALRMIFPTPERSLRERIDDEPFIVPLAVPYVAGPSLL
AMEVVLVSGNPGAIGQYLIALLLSWAVSAVVLFFSASLHKVIGEKALTAVERLMGLVLVI
ISIQMMLSGVAEYFSLR
>fig|1206109.5.peg.275 Multiple antibiotic resistance protein MarC
MFIEYIHSVLFFFITLLPVANPIASTTLLLTLGKKIKAKERKKQIYFATLYVGIIILVCF
YAGKNILNAFGVSINALRLAGGIILLYFGFDLLFNVTEKKQITEKNHLQQSHLNISFVPL
ALPGTAGPGTIALIISSSSSLPSSCLIHFVIWSVTALFTLMFLICLLSANKIFKRIGPSG
IDAISRIMGFILISMGVQFIITGFQNMLIVLFHL
>fig|1208365.4.peg.242 Permease of the drug/metabolite transporter (DMT) superfamily
MESKDWFLLTLLAAIWGSAFMFIKISAVDFGPILLVTLRLLIAGVVFMPLLLQRKYRLLF
RSHLPGILIIGIFSNALPFTLFAFASLGATSNMLGILNGTTAFLTTVIAYFWLSESISTK
QVIGLCLGFFGVIILVNPANGSATLTASLCALFGSLCYAFNGNYLQKYHANSDKKVLIGW
SMLFGGILMVPIAAFNLPEAMPNLNSIFALLWLAVVSTGIGYLGYIRLIERIGAVKTSTL
TYLLPVFSILWGAIFLQEKITIFIFGGFIFVMMGMYFSNTTTRVKK
>fig|1208365.4.peg.1080 Glyoxalase/bleomycin resistance protein/dioxygenase
MKIQSLSYLLIETTDLQEWADYAKDVVGLMKNDSLSDEQNLFLRMDEKSFRFHIKTGSSK
KYLAAGFSLSDKAAFDNAKSELDKAKVDYEDLGHEIAKLRCVEECIGLHDPAGNRLELSY
GSKDASEPFASTQDIKGFITKGLGFGHVVFAAPNLELAHRFYIDILGFGDSDYMNFPMGP
APDAPEVKLNFMHCDNPRHHTVALYESPIPPSGLIHTMVEVNNIDEVGHGLDRAMQNNVH
ISSSLGRHSNDMMVSFYMQTPSGFDLEFGYDGWQVDWDNFEMQKSKIPSFWGHAFSPPES
>fig|1208365.4.peg.1253 Acriflavin resistance protein
MIKIVDFALSKARTTLALALLVIIAGSIARSSLGVAADPNIQLPLVSVSVFLDGASPEDA
SRLIARPLETRLRSVPGVKELSSSARLSYARIVAEFEVGYSIDTALRDIKQAVEEVKFEL
PREAEDPQIREYSFAMFPVMNLSLVGSASVRQKVFIARELQDRLESISEVLAADLVGVPE
EVLVGIIDKSKMETYGITLNQLYNAISSNNLIIPGGAQDTGSGKFNIEVPGIFETAEDVY
NIPIKVTQDAVVTLSDIGEIKRTFKDYSSFAKVNGEDAITLEIRIRVGANAIDAKNKILQ
TVSNFQDTLPSNLTIVKTNDETVWAEMMISELEGNIITAIFLVMVLVIASMGVRVGMLVG
LSIPFCFLLTFIVLKVIGIEFNFLVMMGLLLGLGMLIDGSIVVTEYADRKISEGLNRLEA
YRLASKRMFYPILSSTATTIAAFIPLIFWPGFTGQFMRFLPVTVFIVLSASLVYAMIVTP
VIGSIFGQRRSTLVSGDNEETGEIVFDKISAFYGKWLRVFVKNPGETLIAVLMLLWFLGY
AMYGTFGKGTIYFAEVDPFAAEINIRARGNFSAVESKEIMERVETRISSVNGIENLYLTT
GSQWFNSGGDTMARGFLEVKDTGDGQFTGNQVIQDVQSAVAAIPGIIVEIKPEEGGPSFS
SPIELGIFGNSEQRVASVTEKIEQYMQEEVVGLKNIRSTLPHPLIEWKVEVDKQKAAQLG
VSMIDIGALVQMLTNGFKVGEYRPDDSKDEIEIRARFDSELRSLSGIKDLKVNSINGLIP
ISTFIELIPSQNRQSVVRRNGKFFHEIGLATESGYLPSDKVKEMGAWLEMQDFGPGINTK
FRGQQEETEEVTAFLSGAALTALALMLILLVTQFNNFYQSILVLSAVFMSVVGVLTGLLI
MGKPFSTTMNGIAIVALSGIVVNNNIVLIDTFNRLTREFPDLIKEDVIMKTCKQRLRPIL
LTTTTTIFGLLPLAVGVSIDVLSREIIIGSRVVEWWTLLASSIVFGLSFSTILTLIFTPA
ALILPSRIKAWLQARYGLFKTST
>fig|1209989.3.peg.264 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLVGNIAQQLYNTVDSIVIGRYVGDNALAAVGSALPIFNFLLVFFVAVSTGAGIMVSQYF
GAKDREKLSRSIGACITLTAIVATIIMIIGPIVVRPMLVLINTPESIIDWCASYLLILLV
GNWGFSYFNILSGILRGLGDSLSALMFLLISTVLNIFLDIWFVAGLNMGVPGVALATVIA
QVISAVLCAMKLKTMDYVFDLNLNMLKPKKEYVVQLLKLGLPSGLTQVIFSLAMITVQSL
TNTFGEMIIACNVIVMRVDGFAMMPNFTFGVAMTTFAGQNVGAKKMDRVEEGTRQGLAIA
VGVSIVITIIILIFGRYLMDIFTDTAELVDLSMKMMRILAVGYVAMAVTQVLSGVMRGAG
DTMTPMWISLITTIFLRVPIAYGIAYLTRSAQYPNGRPESVFVSLLIAWVSGAVITSIFY
KKGNWREKVLLS
>fig|1209989.3.peg.1147 Antibiotic ABC transporter, ATP-binding protein
MDEPTASLDPLIESEVYEDFTRIGKDKTVILISHRLSAAKLCDKIIVLNNGEIIEQGSHA
DLMGTKGKYYEVFTLQKHLYT
>fig|1209989.3.peg.1605 Vancomycin B-type resistance protein VanW
MRIEPIIKYKQDKLAQLFDEINKVIMVKPINAVFKTDNDIVHIITDVKGQILDEDMLKEK
IKEAIWTKNQTLVIPVKVWNAEMTKEDLEKMGIRVKIAEYSTEFDKTLKNRTENIKVASE
MLNGCIISPGETFSFNKVVGERTSDKGYKKAPAFINNEVIYDIGGGICQVSSTLYNLALL
TDLEIVERMNHSLPVGYVPLGRDATVSYGTIDLKFKNNTGGYLLLTSEITNDKLIVKFFG
NKKIDKYVELFSETIKTIPSPIIIKKDFNLEKGEIRIEQGNAGYVVNLWKRYANEKNEHK
VLISSDTYNPTPTLLYVGEKVKEITDDKNINATIIP
>fig|1209989.3.peg.3085 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MYSNGINSKAFAEGKVEKVLLRFAFPAIISLLVSELYGMVDTFYVGRYVGPNAIGALTIA
FPIQRLLSSTGLLIAAGACTKVAKYFGEKDYENLKITITNAIMLTVAVMTLMPLIIYIFM
EPILLRSGASSVTLPMAKTYTAIILIGGIFQGLTFVTCYIINSLGNPKVTLYATSFGAVF
NIIIDAILVINYNMGVKGAAIATVVSQIAACTFAMYNFYKVARSINLKNNFSIDIEILKS
IIAIGFTTFIIEISDAIVAVVLNNVLFAHGGDRAVIVSGTIMKVSMLMYVNIIGIASAMQ
PMVAFNYGAKNFKRLKETIRKTLKVVILTSVFLWAIMMLFAEPIIGSFVKDEALMKECAR
AYRIMISIFPTIGLYYISTYVYQAMGEAKMSFLLSIYRQLVLFIPIVLIFVKHWSVIGAW
LAYPATDIIAAITGFIYIRRVKEDINEYVDRAEAARLIIDS
>fig|1215343.11.peg.599 Modulator of drug activity B
MNKVFILNAHQYYGFSSGKLNAAIIHHIDEHFKRKGFEILHTHVMDKYDVKEELDKHLWA
DVIILQTPVYWMGVPWLAKKYMDEVYTAGVDGILCKHDGRSSKAPKDNYGGGGCAIGKKY
MLSLTFNAPKEAFDDPSQYLFQGKSVDDLFYPYHMNFRFFAMEPLPTFSCYDVVKNPEIE
NDFKRLEEHLNTVFKK
>fig|1218108.3.peg.29 Tetracycline resistance element mobilization regulatory protein rteC
MKYFLQNILLEIHNKENKISAQSKRLIDEAYEMTLYLQDLLFSVKKYIIEEGFKNDAEEI
HFFHTIKPQILGKLIFYNKVYRIETTCPVSNGKMYYSYFSTQFANLKREYIEHICNSDFY
RYYRSGRTDRDDTYFKRGNINYQDGLNSIVFEIDPAFSTFFDYKIARIIANELLYSYLLT
KINPDEGPDMILQKQESSKDIFWTDSKNALIELVYALHASGVISHGKIGIRKISLMFQIL
FHIPLGDLHHSFHRMKTRAGSRTAFLDQLKISLEEYMDKDL
>fig|1218108.3.peg.46 Tetracycline resistance element mobilization regulatory protein rteC
MNDFCKNIIRDLDDEINELSIEFNDSLALCEKAIGLTIDKIAKLKQVVLKRGFKDIEEEI
HFFKHLKPNVLSKLIYYNSIYKIETKKPYGGEKVIETHLNNELFNLKRFFDNNLEFYKYY
RTNSTYLDHKYFVRGKYDIKLSLDTYYFESDHSFSTSHDYKVAKIIANDLIQVYLEDNLS
NNIRYSTLKSAEKIKSTLVWTASKTALIELIYALHTQGVFGNGTIDIKVIATYFEQTFNV
NLGDFYHTFLELRNRKTNRTKFIDTLKEGLLRRMDEQEEK
>fig|1218108.3.peg.434 Membrane fusion component of tripartite multidrug resistance system
MEENNQEKKKINSKFIIVLGTLIILGGGYGIYKYLHGQAHEITDDAQVEAKITPVIPKVS
GYIQKILVEDNQMVHKGDTLVVLDGSEFALKLQQSQDALSQAEGQLGVAHAGVSQAGAAI
GVTEAGAVAANTTIETAQANVNTAQANVEAAKVQVWRTKNDFDRYNKLYQNQSITKQQYE
QALAAKETAEKQLRVVQEQLGVSKAQLASTAKQAQATAKQVNTSKAQADASRAQIKVAEA
TIGQSKTNIENAKLYLSYTYVIAAEDGQVSKINLQPGQLVQAGQSLFNIVTVNNLWIVAN
YKETQLEKIREGQEAIIKVDAYPNHEFKAKVTSLSPATGAKFALLPPDNASGNFVKTVQR
VPIKIEFTDKKDEMLKLIRPGMNVEADILLKSNTSVK
>fig|1218108.3.peg.435 Inner membrane component of tripartite multidrug resistance system
MEENNLIEYGSRRVIITITAIMCALLEIVDTTIVNVAMNDMKGSLGVSLTDIAWVVTAYA
IANVIVVPMTSWLSQQFGRRNYFAVSIIIFTAASFLCGNATTLWEIILFRFIQGLGGGAL
LVTSQTIITESYPPEKRGLAQAIYGMGVIVGPTLGPPLGGYIVDNWSWPYIFYINIPIGI
IAVLLTLSFVKSPKYAEKSKLSQVDFLGIILLAIAVGSLQYVLEHGQQDDWFSNSTIVIL
SISSFFGFILFIWRELVFDHPIVNLRVLKDNNLAVGTILSFVLGFGLYGSTFIIPIYTQS
ILGWTATDAGLLLIPSSLMTAFMMPIIATLLQKGVEPKYLVAGGFFIFFCYSFWSFKILT
PDTGSEHFFWPLIVRGVGLGLLFVPITTLSLSNLKGQQIGEGAAFTGMMRQLGGSFGIAI
ITTFISRWTVGHRTDLVSNLDTSDFDVQKHVQSLQMSFIGKGFAPNEALNKAYNLLDLQV
TKQATVLTYMDVFLYLGVIFLICIPFILFFIKKGAGKVISAGH
>fig|1218108.3.peg.687 MCBG protein-like (microcin resistance protein)
MGTNYHCEEEFLKLNFTETQNLSGDYENCKFINCELNGLDLSDLKFIACEFIECNLSNTI
LNNACFQQVDFKNCKMIGFNLETCNPFGLNVNFVHCVLNDSSFYHLLLKKSRFIECSLQN
VDFSYTDLSNCFFDHCNFSDATFDQTILKQANLKTSYNFRINPNENQLKGAIFSKENLIG
LVQHLGLKIE
>fig|1218108.3.peg.735 Acriflavin resistance protein
MIIVLFTILTLGGLFSYTQMGYELIPKFETNVVTISTVYPGASPNEVENSVTKKIEDAVA
ALENVKKVESKSYESLSVVMVTLNSDANADLALNDAQRKINAIEKDLPDDVDPPSLTKFS
LSDLPIITAGVTSSKLTEKDLYDLLDKKIEPVLSRVTGVAQVNLIGGQEREIQVSLDPVK
LKGYGLSVPQVQQAILTSNLDFPTGSVKTRENSTIIRLSGKYKSVDELNSLVISSMNGIQ
VRLSEVAFVQDSQKEVEKIARVNQSSAIIVQVVKQSDANAVAVSELMKETIQKVEADYKK
EGLKIQIVNDTSDFTLAAADHVIFDLVLAVVLVAIVMLLFLHSIRNAFIVMVSIPASLIA
TFIGMYLMGYTLNLMSLLGLSLVVGILVDDAIVVLENIYRHMEMGKSKIRASYDGAKEIG
FTVTAITLVIVVVFLPIAMSSGLVSNIISQFCVTVVIATLLSLLSSFTIVPWLSSRFGKL
EHITGKNIFEKFILWFEKQLTKFTHFISDMLEWCLKSTSRRIGVFIGVFIVLFGTIGILM
GGKYIGGEFFPKTDKGEFLVQMELPKDATIEESNFVTQKAEKFLRGKKEVVDMITTVGQS
SEGFGAAQATAYKSEIDVILNDKSEREDNSFIYAAKVKRELQEELVGVKVKTVPVGLIGA
EQAPIALVVTGPNLESAMKFAELAKHELEQIKGSSEVKLTTEAGNPEINVQVDRDKMSAL
GLNLQTVGLTMQTAFSGNTDGKFRAGEYEYDINIQYNDFNRSNINDVRSLIFVNDKGQQI
RLDQFATVTQSSGPSFLERRDKTPSVTVEAQSVGRTTGDIVTDFKESLKKIDNKKPTGVS
YVWGGDEENQSEGFGTLGYALLAAVILVYLVMVALYDSFIYPFVVLFSIPLSLIGVFVVL
ALTNNSLNIFTILGMIMLIGLVCKNAILLVDFTNHRKEAGETTHNALVQANHARLRPILM
TTIAMVFGMIPIALAKGAGAEMNNGLAWVIIGGLVSSLFLTLIIVPVVYSLFDSAIRRFS
KGEKVDYEAEMVADYEARQIKEEWEE
>fig|1218108.3.peg.760 Permease of the drug/metabolite transporter (DMT) superfamily
MENKNLLKGVLFVAMGSSFYGMLATFVKVAYDQGYTTAEVTASQFVLGIIILGIINLIMS
KKNKNTPAVKPKDKRRLMLAGTSLGFTSLFYYLAVQYINVSIAIVLLMQTVWLSILVESV
LSKKIPSAKKLVAMLLVLAGTVLATNLINQEIELNPKGLFWGFLAACSFTTTMFTSNRVA
TYLPPYKKSIYMLFGGGIIVALFVFFSQLGPYYFSGLMDLYRNFSDDVTSIHPLNLEIFF
TWGLFLSLFGTVLPPILLNKGFPNTGLGLGSIVSSIELPVSVTMAFIVLQEQVLAIQWTG
IAIIIFAIVISNLNFKKN
>fig|1218108.3.peg.777 Drug resistance transporter, Bcr/CflA family
MNNQNKSFLWLIIFLIGFPQISETIYTPSLADLAKTFHVSGNQIQQTLGIYFIGFAIGVF
CWGIISDFIGRKSSMLCGILLYILGSYLCLISKSLEFLLFSRFIQAFGAAAGSNVSQTIL
RDVCTDKERMVIFSKISAVLAFSPAIGPLLGSVVAEIWNVSMVFKLLLLIGVLAFLWSSI
SLKETLNRDIKITDSYKSIVISICKDRYFWLYGTLIGTINGVIFSYYGEAPFIFIEDYHF
SIIEYGCIGFIVAAACFSGANYCRKKIGLIDAKQILNKGNLFFFTGIAGLFILNFLPLKE
KVNVSFLLAGIFLMMFGLSVILPICLSNALNNHKAYLGIAGALLGLFYYCIVGGLTIIMS
MLHGTSAIAFPLFLFFCFLMNAFVISRLK
>fig|1218108.3.peg.1103 Multidrug resistance protein B
MKKILKIYIDAYSGLSQESWMLAIVMLLNRMGSMVLPFLGIYMISELGFSLESSGIVLSC
FGVGSVIGSWLGGWITDKIGNFKVQAISLFLSAPLFLILPYFKTVESFAVIMLVLSTISE
MFRPANSVAITRYAKKENITRAFSLNRMAVNLGFSIGPSMGGFLSNYSYDLLFYCNAGAA
LIAGVVFYVFFKGRKERNAATETTSEKVIIEKERNAYTDTPFLMFNLFCVLFSVAFFQIL
NTLPLFYKDVVHLTQTEIGLLMGFSGFLIVVFEMLLIHYTEKRFSVTQLLVFGSFITAIS
YFIFTFSHTLGMLYLAIGLMSIGEMLVLPLMSTVTAFRSQKNNRGAYMGLNGMSVAIAFI
ISPFLGTHVATDYGFSTLWIITTIVLIIVAIGYHFFTKPLLPKNI
>fig|1218108.3.peg.1323 Permease of the drug/metabolite transporter (DMT) superfamily
MILGVLALTWGSSFILIKQGLVAYTPYQVGALRLSIAGGILAIWGIPSLFKIPKNKLRYV
ALAGFCGNFIPMFLFPMAQTHVSSSMAGILDSLVPLFILLFGALLFNIKGTKNQVSGAVI
GFLGAVLLIGGDGFSGENSLVHCLLIVLATALYGLNSLILTRYLNDVPSFQLSSALFTIW
LLPSIVILFFSGFFDTFEGTEQQLKSLGFVTILGLMGTALAMILFYRLIQATGSLFASMV
TYLMPIISVFWGFLVGEKITWFHLVGFAMILSGVYLTQKKEKKVEIV
>fig|1218108.3.peg.2106 Permease of the drug/metabolite transporter (DMT) superfamily
MKGNQPSKWLIIAAYFVVYVVWGSTYFFIDKALHGFSPFILGSFRFIAASTILMGYCKLK
GYKLWDKQIVKQCMFTGFMLLFIDMAGIIWSEQFLPSGIVAIMAASAAIWFIVLDKPKWK
QNFSSIPTILGVLLGFIGVLMLFYEQTTTAHADADQQFLNMIGLIVLIFCSIAWTLGSLY
SKYVTEKQKKEVTKPKEELNIMVKTAWQMITAGVLFNTVAMFNGEYANFNLENVATEDWL
AMAYLVTFGSILAFGSYVWLLQHRPAVEVSTYAYINPIVAVALSYFFTDDIVTHLQIYGL
AVILFSVLLMNWNLYKNTKLVQKILHFVSRKHYAH
>fig|1218108.3.peg.2182 Permease of the drug/metabolite transporter (DMT) superfamily
MKFKGYAYGLISSISYGLIPLFILPIKQANFSIDTTLFYRFFFSALIVGVYLFVKKQSFR
VHSKQIPVLIVLGLLYGISADALFLGYDYLSAGIASTLLFVYPLIVAIIMVVFFKERITI
STIAAIAFVLAGIFLLSFKDGQFKLNPIGLGIVFISALGYGLYIITVNKSSAREIKGFTL
SFYSFLFTTIYYAIKMLIQKESFILPSLELTFNFFTFAFVTTVISSIALIFAIKNIGSTA
TSILGASEPVVAVAVSVIIFGENFSMSLALGIFMIIFGVTLNVVGDAYQQKRIKSS
>fig|1218108.3.peg.2434 Bleomycin resistance protein
MFLEIHPKLPMRSKEITFKYYVDHLGFVPFLNDLEDYFMVRKDGIEIHFFKFEELVPEEN
YGQVYIRVADIELLYETFVKNKIQIHPNGKLQVKPWGQIEFSILDPDHNLLTFGQAV
>fig|1218108.3.peg.2748 Permease of the drug/metabolite transporter (DMT) superfamily
MKDIKLLIAISIVAIVWGTTFLGIRVAVETIPGWFVAGIRQFIAGIIMFILLLYKKELKW
IGWKNLSYQLIFSSLMLIAANGLTTVAEENLSSSLAALISATSPILVFLGSIFIGLQKFS
FKGLIGVLMCFCGVLFIFWDGLQELANPEFRTGILLLFCAITGWATGTIFTKKMNIQSKN
ISLNLFYQFIFAGIIQIIFAFIFSDNYNFGNWSTKSISAMLYLAVFGSVITFFSFHYALT
KISPIQVSILSYFNTIIAIVLGWLILDEEISKKFIVATILIICGVFITNYKPEIFKKK
>fig|1218108.3.peg.2967 Membrane fusion component of tripartite multidrug resistance system
MGKQQTKGEKRMNRMLSVVAWIFITIGILAIAWFYFFSRSHVNTNDAQVRQYITPVSSKV
SGFIKKVNFDENQFVHKGDTLIVIDGREFQNQIDMAEANLASTAQSVLTYEKAVETKASD
ISIVTANIEAAKIEVWRTEKDYNRFKNLVEEDAATVQQFEEIEAKYKQAKANLSALEQQR
NAVSVSTSAEQTKVAPVRTQILQRKAQLNNAKLTMSYTYIIAPYDGWVGTRNIQQGQLIK
EGQALVQVVSKEKWIIANFKETQIGEIDMDKPVIIKADAYKNLEFEGKIKSLSPASGSEF
SLIKPDNATGNFVKIEQRFPIKIMLKDSKNNEKLRSGMNVIVSTEKLEN
>fig|1218108.3.peg.3026 Glyoxalase/bleomycin resistance protein/dioxygenase
MKYAYTIVYVKNVTETIAFYTKAFAFETKFITPENDYGELISGETTIAFASVELGNSNLK
KGFTAIEKSAKPFGVELAFTSENIETDFKTAIDAGAIEFEPLTEKPWGQKVGYLLDNNGF
LIEICTPIAH
>fig|1218108.3.peg.3031 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNRQKQIILNDNLPKVMWELSWPAVVAMVLYGLNNFLDGIFVGHLISNTALAAVGVAYPL
AQFAQGFGTLIGTGIGSAISIWIGAKDSSKLEKAFGTVNYLTLLFSVLITIPCYIFADKL
VYMMGGREEILTLGVEYFRVTILGSFFWIHGLALNMIIRAEGRMKTAAWMIAVGLVVDLA
LKPLFIDTFGWGVAGAAWATNISMIIYTLLGIWYYAGGKSSFKTKFWSLKKEKEIMKETL
SLGTPGFIMMIMIVIQNIVVFNALAEYGTAADITFFTAVNRFYILLNTPLWGLMRALQPV
TGMNYGAKKYDRSIKAYRLFSFVGLVILLPFWLFVMLFPSEVLTIMIPDMKFLPGQLMDF
RIYMSVLLALPFVFMAMVWFPAIEEAKPATLISILRQMVFYIPIMLIVPGFYGVSSIYLA
SAVIDWVIFFIVIFTVWKSVKKLQAKSIVTP
>fig|1218108.3.peg.3160 AcrA/AcrE family multidrug resistance protein
MVGALAMALSSCGKKDNAAQQAQGPTPYPVVDVPTKVVTSYDEYPTNIEGIVNNEVRAKI
QGYITEVYVDEGQYVQAGQPLFKLETNVLTQNADALRSGVGAAQASVKAAQANVSAAQAA
VNAAQVEVNKLTPLVQKNIISNVQLETAKANLAQAQAGHNQAVAALAQAKSGVTQAQANY
KGAQANVDYSVVRAPVSGVVGSINSRQGTLVGPTDQTAITVVSNTAKVYAYFSMNEKEYL
NFISKSEGATLKDKLNKIPPVELVLANGDIYPEKGKIQTVTGQINPTTGTIDFRVTFNNA
AKLLANGNSGRIRVPKTYVDALVVPAAATFEQQGMTYVYKVKNDSAIATPITVVDNTGNI
VVVKEGVKKGDKVVAQGVGKLRDKTPIKPTPSNFDQIVESTKPVF
>fig|1218108.3.peg.3265 Modulator of drug activity B
MKIFIINGGQKFAHSGGAFNNMLNNWTTDFLKEKGVEFRVTNINDEFDAFDEVENFKWAD
TIIYHFPVWWFQVPNRLKYYIDEVFTAGHNNGVYKNDGRSHTNPDINYGTGGLMHGKKYM
VNTTWNAPETAFTMEGEFFDQHSVDEGILFGFHKMNQFAALERIDGFHFHDLEKNATHER
IDAYEKIYKAHLERVIG
>fig|1218108.3.peg.3374 Glyoxalase/bleomycin resistance protein/dioxygenase
MKNYKPEQYNSLSPYLIVDNALKLVDLLVAVFDGKILRRFDREDGKIGHIEVKLDDSVIM
ISDSTEEYAANKTMLHLYVPDVFKTFEKAVENGCEPIEKPGDPDTRGAFYDFAGNYWAVS
TQTD
>fig|122587.1.peg.167 Bacteriocin resistance protein, putative
MDFSCGAASIATLLNNFYGRHYSEAEILDKMDKTQMRASFDDMQRIMPELGFEAQGYALP
FEQLVQLKIPVIVYLKYRKNNHFSVLNGINGETVLLADPSLGHVSMSKSQFLSAWKTRDG
EMEGKILAIVPKNTDFVRNQMFFNKNPVRQTRFTVEQIQMRQKR
>fig|122587.1.peg.1425 Multiple antibiotic resistance protein MarC
MRRQFAASDACRTGLKEGEIMGLGMEIGKLIVAFLVLINPFSALSLYLDLTNGHSTKERR
KVARTAAVAVFAVIAVFALIGGTLLKVLGISVGSFQVGGGILVLLIAISMMNGNDNPAKQ
NLGAQPETGQVRPARNAGAIAVVPIAIPITIGPGGISTVIIYASAAKTYGDIALIIAAGL
VVSAICYAILIVAGKVSRLLGATGLTILNRIMGMMLAAVSVEIIVSGLKMIFPQLAG
>fig|122587.1.peg.1887 Permease of the drug/metabolite transporter (DMT) superfamily
MFYQILALIIWSSSFIAAKYVYGGIDPALMVGVRLLIAALPALPACRRHVGKIPREEWKP
LLIVSFVNYVLTLLLQFVGLKYTSAASASVIVGLEPLLMVFVGHFFFNDKARAYHWICGA
AAFAGVALLMAGGAEEGGEVGWFGCLLVLLAGAGFCAAMRPTQRLIARIGAPAFTSVSIA
AASLMCLPFSLALAQSYTVDWSVGMVLSLLYLGVGCSWYAYWLWNKGMSRVPANVSGLLI
SLEPVVGVLLAVLILGEHLSPVSVLGVFVVIAATLVAGRLSHQK
>fig|122587.1.peg.2006 Membrane fusion component of tripartite multidrug resistance system
MKSGNSEPNLMDTHTDETKLQNTQAKRKRRLTALTLLFALAAAAAGSAFFLWWQHEEETE
DAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVR
QNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAA
VKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQ
VGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGF
SAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDTSAAGA
PVSKTPGAALPEMESTDWSEVDRTVDEILGQSAP
>fig|1230341.3.peg.1100 Broad-specificity multidrug efflux pump YkkD
MAWVYLIIAGLGEMFGVLMINKFHSERSVTSILLLAAGFSASFLFLALSMETLPMGLAYA
VWTGIGAAGGALFGMILYGEPKDGKRIFFLSLIIAAVIGLKLVSP
>fig|1230341.3.peg.1283 Permease of the drug/metabolite transporter (DMT) superfamily
MKMRGIVLVVLAAVFWGISGGIGDILMGKGWSPLVISFYRGGVGLILFAGWWLAGKKEKP
VFTPPIILFSVLAGAGVAGNFTFYFFAIEASSIAVAATLMYTAPVFVLLASFLLRIEDST
WFKWGCIIGVLLGIVLLTGAYNTDNLSGGVFGITAGLAAGVSYALFIFGFKKATAIGDPK
TILSVAFLTFCLILLPFNDMTEVTYAVTSGDAGWFILLGLVGAGISFIIYVIGMRGTAPS
TASMVAMAEPVTASLFGVLLLGDTLTIIQLAGMAVILFTITILSVKQSGS
>fig|1230341.3.peg.1507 Permease of the drug/metabolite transporter (DMT) superfamily
MPYFLLIFVVIMFSGNIIIGKAINDLPPYTIAFLRLVVAFIVLLPIGLRSARQYKETFFK
YKKPFLIMTLTGITFFNTFIYASLQFTTSTNVSVLETIIPVVTVILSAYILKEKIYKIQW
LGVFVSLLGAMWVVMDGNIFQLAAIEWNIGDAIMIGAIATWAIYSIFVKQYMPLFPNYGA
LLVMSGLSVLVLLPVVILEWIIHGVPAFDAGNMAGILYLGVFPSFLAISMYNLAVDKVGA
SKSSIFLNLLPVFTMAGAAVWLGEDVTFTQVGGALTVIAGVIVTTQGDRISRRRI
>fig|1230341.3.peg.1857 Multidrug resistance protein (efflux transporter)
MAKIPEKWLVVVSVLFGTFTVILNNSMLNPVLPRFIEIFDTTAVGAGWILTIFMVSMGMT
MPLTGYFGDRFGKKKVYLVGLTLFLVGSTSGFFSSSLGMVIASRAIQGSAGGLMMPIAMA
LIFNSFPRNERGLAVGIYGVAAMVAPAIGPTVGGLLIQVLEWPWLFAVNIPFGLIGLLLS
VKFLEQTESDPEKRFDLIGFLLVTSAIGGILFALGRGRTPEILFEPLNLGIIITGLVLIF
VFVRYEIRQEQPLLNLSVFKVPTYAISILITSSASIGLFSGIFLLPLLIQNVYGLNEVWT
GLLFLPAAAMSGVFMSFGGRLLDKKGPKYVLPPGLAIMGISTVGLGMLETSSPFWWILLL
NAIRGAGMGMSNMPATTTGMNAIPDEYVAQGSAMNNIIRQIASSLGIVFFSIYYEVRRAQ
IAVGTNMQEATLQTLNEAFLVSSAVLFIALPFAFFMKGVQDD
>fig|1230341.3.peg.2100 Bicyclomycin resistance protein
MLHNPTGKERFGLALLLGMLGIMGPLNIDMYLPSFPGIARDLATTASMVQLSLTACLIGL
AIGQIVVGPISDASGRKRPLTVFLFLFAIASLLCALAPNIYILIIARFLQGFTASAGVVL
SRAVVRDVFDGRELTKFFALLMVINATAPMIAPMAGGAILWFPFSSWHTIFYFLSLLGLI
IVFTVTWKLPETLPKERRTPSSVGASVKTIGRLLVDRSFIGYALTIGFVHGGSFAYVSGT
PFVYQGIYGVSPQVFSILFGINGLAIITGSFLIGRLGGIIHERKLLQTAVITAVAATFFL
LIMTITKGPLPTLVISIFIYMTCMGMVLTSTFTLAMEKQGHRAGSASAVLGMLPLLFGAA
ASPLAGLDESTAVPMGLILFSTSSLGLVTFFTLARPYAVKKV
>fig|1230341.3.peg.2515 Permease of the drug/metabolite transporter (DMT) superfamily
MSDRNKGILLLLISALGFSMMGAFVKLSGDLPTVQKAFFRNIVAAAITLGFVLKHKDRIF
GKRENQKLLLSRSSLGSVGIVMNFYAIDNLVLSDAEMLNKLSPFILIIFSGIFLKEHARR
YQIVSIIIAFLGTLFIIQPEFSVQVLPYIIGVLGAVFAAGAYTMLRVLGNKEKHYTVVFY
FSFFTTVLLLPFTIFFYEPMSVQQWIFLLLAGAFATVGQFGVTLAYKFAPASEISIFFYS
TVVYSALLSIVLFGQIPTLWSVIGYVIIFSASFYMFLKNNHIDKKQLARQEEKKAFRSS
>fig|123214.3.peg.958 Glyoxalase/bleomycin resistance protein/dioxygenase
MDKLPEDENSIEKGVIFRPHHVSITVKDPEKSRNFYKLFGFKEVFRWSDSSTTVIHMKLN
DLILEIFSFKETESSSDQRESLEEELKIIGVKHFALRVKDIQKAKKFLSEIGIVPENTRI
NKGRTGILYFFIRDPDGIFVEIVQDDRNI
>fig|123214.3.peg.1176 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKKILHLAIPAALTNLLDTLQLLIDILMVGRISPEAVGAVGLSGQLIILIYSFISIFYI
GTNVLVSRFYGEKKPEEAGKAVSGLLIISVLFSLPFFIYTYEFSGSYFSLMGAERSVINL
GTDYTSILSLSIPFLFIGAVLYSSIVASGDTKTPLIISLFTNLLNTFLNYCLIFGNFGFP
RLEVEGAAIATTISYILEVLIYFFIFLSGKTGIKPELSLSFHYVLKALKVGIPAGIEKFV
SFGSFLIFVKIVTGFGTYVLAGYQIGLRIEGLAFMPGFGFATAAMVLVGQYMGAKEPEKA
EKSVIQTVKLAGLFMGIVGVFFIVFPEFFVSLFTDNIKTIREGSLYLRIVGVSQIPLAVD
FVLNGALKGAGATKVTLIINSLSFWIFRIIPAYISAKIFNDILIVYIVMTIETFIKGFIL
WTVFKSGFWKKIKI
>fig|123214.3.peg.1496 Acriflavin resistance protein
MEDKNRSYGLAGRIARAFIKSPLTPLMVLASLLLGLFAVLTTPRDEEPQIVVPMIDIIVP
FPGSEADEVDKLITKPLEKIMWEIPGVDYVYSYAGDGFGVTTVRFYVGEDPEDALVRLYS
KLMSNYYRMPQGAMEPIVKPKSIDDVPILALTFYSDKYSSYEIRRVVEQVEDELKQLYNI
SETTILGSKPKSIYIYFDPSKLNAYHILLPQVVQALQYANSSLPSGEFDKGNYRFKLRTG
QFLNSVKDVENVVIGVYNNKPIYIKDVAKVEIGEGEVTNIVQFGYGIRGEGDKNKLYNAV
TLAIAKKTGSNAVVVAEKILEKLETLKGKVIPADIHVKVTRNYGETATEKANELIEHLLI
ATFSIVLLIAVTLGWRESLIVAVTIPVTLAIALFLSEMYGYSLNRVTLFALIFSIGILVD
NSIVVLENIHRWFSMRKLPNEKAAIVATDEVGNPTILATFAVIVALLPMAFVSGLMGPYM
RPIPINASVAMFFSMLIAFILTPYLALRWLKHDHEHESPEALEKEDEARAGILAKLFERI
YMPLFLSRIKRYIFLGFMGLLLVGSVWLFVERVVLVKMLPYDNKSELFVVLDMPEGTPLE
KTYKVAKEIAEYAKNVNEVENYVIYAGIPAPFDFNGLVRHYYMREGTHYAMIKINLIGKH
ERKAQSHQIAERIRGDIERIAKKHGAKYVAVVEPPPGPPVLSPIVAEVYGPDYKTQLKIA
DEIKNIFEKAEGVIDVGIYANLPQRQYILKPDREKIKRYGFNEDMIVKTVRIALAGYSVG
FIHSAEDLNPVNIVVRLDEKYRTSINDILSMKIPTPKGAIPLGSLVTVKEGSAKNDIYRK
NLQKVVYVIANVDDTVGSPVYPIVDLSEKIRNIKTPDGKGVEILLTHQPHLEDRYYVKWD
GEWQVTYETFRDMGIAFAVALIVLYILLVGWFGSFKMPMVIMSPIPFTLVGIVPGHFIMG
AFFTATSMIGFIALAGIILRNSILLVEFTQQKLQEGYALEEALLEAGIVRTRPILLTAAA
VVVGAFVIIFDPIFNGLAIALIFGTIASTLITLVVVPVLYYMIVGKTAVKLDMPPAVPVD
EKPEK
>fig|1234409.3.peg.194 Permease of the drug/metabolite transporter (DMT) superfamily
MKEKQKGVLLAIIGALCWGIQGPISQFLFQEITLPTEWLMGVKMTLAGILILLFTAWKEK
KAIFGPFKNKKDTIQLLLYAYVGLALVQYMYFLTIKASDAGTATILQSLGTIMIIIFTIF
VYHKWPNRNEWIAVVVAIIGTYLLVTQHGTLAITKKALIFGLLLAFGGAMQTMLPVQLLK
KYSSFTLLGWGMLFGGLLFSIIHPFWENTPEMNGMTISALIFIVLFGTVLSYICFTTSLK
YISATSAGLLASFEPASATLGAVLFLGTSFTGTQVIGALLVLSTVFILALPIPKKKGEQ
>fig|1234409.3.peg.437 Drug resistance transporter, EmrB/QacA family
MTKQRKLIVTIALFIATFMSAIEGTIVTTAMPTIISSLDGLSVMNWVFSIYLLMSAIMTP
IYGKLADLKGRKIIFIIGILFFIIGSSLCGLSQSMEFLIFSRAIQGIGAGSILPLSLTII
ADLYTAEERANIMGLNNAAWGIASIIAPLLGGMIVQYLNWHWIFLINVPIGIIVIGMVFF
GLKENRNNFNSVGKLDIKGAALLMIFLLLFLYAFQLFGDQGFKAPVFLLLIISVIILLLF
IRIEKVTENPIISPKLFNSKSVLIINCVTLCVSGFLTGIDVYTPMWLQTLNGSSATLSGL
ALAPMSIFWMVGSFLAGKLLSRLEVKKILLIGSSLLFVSTIIYSIYPISTPYFVFCIIGV
LLGIGFGMSITTSAVAIQESVETKLVGSATSLNTLFRTLGQSIMVAIYGTVLNMSMNSEM
TKYPQIHQEDLNRFMNVQEVHNVPTGILQSLRSIMYNGLHHIFITSVVIMLLSLVFLLLW
KAKNTNKNEKNEK
>fig|1234409.3.peg.481 Quaternary ammonium compound-resistance protein SugE
MYLLLLALAGLCETVMVYTMRKSAGFKVKSWSILTILVAICSLTLLSIAMTMTEVGIAYG
IWVALGSVGSLLVGTILFKEHLNLGQWIGIICIIIAVIGLKMTV
>fig|1234679.3.peg.310 Drug resistance transporter, Bcr/CflA family
MKKSIETKVKAPALLLLIVLVGFPQISETIFTPSLPDIALAFQTTMGSVQLTLSIYFFAF
ALGVFFWGLISDYIGRRPAILYGVVLYGVGSCLCLWADSIEFLLFARFVQAFGASTGSVV
TQTILRESTTGNQRHALFAQISAALAFTPAIGPLIGGFVDQYWGFSAVFLVLVVMSIGVF
GYAYFGLAETLDASSRSSVALRPIFKRFLKNKKVLTYGFLIGAINGVLFSYYAEAPFIFM
EYFHLSAAIYGLLGIVIALALIIGSMLSKRWLAIWQPEKIIFKGIQIMLVGAVILLTLSF
FNFIPGVIQFSCYLIGIFITLIGTGTALPNCLSLALVDFQDVIGSAGGIFSLYYYLLVSL
ITLGMSVLHNGTLWAMPLYFIGIGIFMLILTKRFIYLLKE
>fig|1234679.3.peg.479 Multidrug resistance ABC transporter ATP-binding and permease protein
MARNKFDVDEELEQEFNKEHYQRLFQYVKPYKKPMLTTLFVILIANIATMLGPYFTKLVI
DDVIPNKNMTLLGWLAVAFIVSVFVTGWCMRYRIQSITLIGQDMLKDMRSDIFEHLQKLP
FSYFDSRPHGKILIRVVNYINTLSDLLSNGLINLISDVISVVITLIFMFAIDFKLTLYSL
ALLPVLFIFVMIIKNKQRKAYQVLSNKQSNLNAYIHESIAGIKVTQSFSREDENYKIFSE
VSNEYRSSWMHAVKVQFLLWPGVQNIAVITTCLIYFVGIRGLGVEVSTGTLIAFIGYVNN
FWNPVINIGNFYNSLITATAYLERIFETLDVEPDIKDAPDAFELPPIKGDVRFRHVTFRY
EEGKDILKDISFHVLPGESIALVGPTGAGKTTVINLLSRFYDINEGEILIDGVDIRRVTL
HSLRKQMGVMLQDTFIFSGTILDNIRYGKLDATEEEVIAAAKVVRAHDFIVDLKEGYHTA
VKERGSTLSAGQRQLISFARALLADPKILILDEATSSIDTKTETLLQDGLDKLLEGRTSF
IIAHRLSTIKNSSRIFYIDQGTVQEAGSHDELMAEKGYYYQLYQSQFDLLKEI
>fig|1234679.3.peg.567 Quaternary ammonium compound-resistance protein SugE
MGFISLVVAGFCELGFVVLLKKSEGFRLKSYGILSMIVMGMSLYLLSIASKTIPIGTAYA
IWAGIGASASVLWGMIFFGESRSFKKIIFVTLIIIGVVGLKLTSH
>fig|1234679.3.peg.729 Quaternary ammonium compound-resistance protein SugE
MNRSWVYVIIGAILEVAWVTGLAHSTTIWQWIATIISVTISYGLFTLAAKNLPVGTLYAV
YTGLGTVGTILVGIWLFNESIYPLKAFLMMTLLIGIIGLKLVEAKGK
>fig|1234679.3.peg.787 Glycopeptide antibiotics resistance protein
MFFLQNLYEFTESNFGDTINHFPLIKLIFYSVDRTLRYFLVWLLIRGIYLLYKHLKGTKI
RVAREFVVQFFVFYVILLFQLTVFRGEYSITNVYIELRPLSEVNWQPFTETFKLTQGTSL
FDFYYNLYGNIFWFIPLGFCVAYLSQNNHPFLRTFFIGLFCSIAIETMQFLFRTGIADVD
DVMFNTTGALIGFVLYEVYFLLKKLFSKQKRRKEAV
>fig|1234679.3.peg.1013 Multidrug resistance protein B
MQMNKKERLPRDLWIVAIGMVLLYTGLSFIWPFNMLYMTENLGMSDTAAGTALLVNSGIG
IIGSVIGGIIFDRVSGYVSLAIGTGILVLTTGSLFLFHGHPAFIYNIWAVSVAMGMVFAG
LYTAAGLTHPSGGRTGFNTIYVAQNIGVAVGPFLAGFLAKDGLGNVYTGSFAFALIYALF
FFVYFRKIDWHSNKVTSETKHKQKGTVRGKATKIGLISFGLLLLTYLFCQLPHVQWQSNL
STYMTSQKGVTTAQYGNLWSINGTLILIGQVLIIPLVARFKEKLSLQIYIGIGLFFCSFL
FAMQAESYGGFLLGMILLTLGEMFAWPAIPAIAYKLAPVGQAGLYQGLVNGTATAARMIA
PIFGAVVVANLGGITSLFIAIFILLGLAIVSLFLQQKTQKMMDI
>fig|1234679.3.peg.1082 Membrane component of multidrug resistance system
METKYQNSHIVTILGVIIMGTFVTILNQTLLSTALPSIMNDFSITATSGQWLTTSYMLIN
GIMIPITAYLVERFTTRQLYLFAMITFFIGTAIAATADVYWVLIIGRMVQAVGAGVVLPL
QTIVILYMFPIEKRGAAMGLIGLGMNFAPAIGPTFSGWVVQNYHWSMLFYFILPFALIDI
IIAFFVLKNVSEVGKPKLDWLSVIYSTLGFGGLLFGFSNASSHDFLSINVLGAILVGIVS
MILLVLRCNRSEHPLLNFKVFKIRGFRLNMIISFIILAGMYGGIILFPIYFQSIRGWSPM
KSGMILLPGSIVIAVMSPITGRLFDKYGGKKLAITGLFLITIMTFCIGFLDLNSSVTLIV
SIQLIRSLGISLTLMPLQTGAFNAVPLDMAAHASAMFNTQRQLSGSMGTALFVVIMTMVS
NSQSAVALGSPILASLKGFQFVFMVVGLFSLAGFLLTFLIREKRKNIEVDVLRN
>fig|1234679.3.peg.1742 Multidrug resistance ABC transporter ATP-binding and permease protein
MLKRFFSYYRPYRKLFILDFSCAIVAAILELAFPIVVNQVIDKLLPTGNWSLIVTAALSL
LFFTL
>fig|1235755.3.peg.47 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily protein
MIKKLAGVMLYVDNQEEAVKFWRDGLGFTVVSEEELPEGYKAVEVAPDGKSETSITIFEK
AFIRKYSPELGMGTPSLMFETEDAGALYEDMKSKGITVGEMTEMAGSKVFNFKDGEDNYF
AVSESD
>fig|1235755.3.peg.220 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MYHTDSKREMYAILMRILWPILITQILLYSMNMIDTMMSGRASVEDLAGVAIGSSFWAPV
STGINGILLAVTAIVANLMGADEKEKVHNTVTQAMYIAVAIAVIVLLSGLFFLDDLLRMM
DLAADVHDISYHYLIGLSTGIIPLFLFSVLRNFIDAQGLTRVSLYVISMSLPLNVFFNYS
LIFGNFGFPELGGIGAGYATAITYWLIFFIAVFMTFKVEMLAAFKLFRRMAVPSPEVMIH
HLKIGIPIGVLLFVETSIFSLMTLLIGIMFTTDIIAANQIVLNFTTMLFMLPLSISMAMT
IVIGFSAGGGRFHDARRYKMMGLATSLALISASSLLLYIFREQISYFYTDDPAVVAIASP
LFLFAIIYQVSDALQALFHGVLRGYKDVIIPSVIAVVSYWPVGLTAGYLLAAYTALGVYG
FWIGISLGLTCAAAGFFMRLFTIEKRNMFGQGESAQ
>fig|1235755.3.peg.402 Drug resistance transporter, EmrB/QacA family
MDNTTKYEYLSENSNVKTLPIMLSLIIGTFFAILNETLLNIALTTLMHEFDITLPTVQWM
ATGFMLVMGIVIPVSALLLQWFTTRQLFLGTMIIFTVGTAICAMAPTFPVLLSGRLIQAI
GTGMLMPIMFNVFLLLYPPEKRGKIMGLVGLVIMFAPAIGPTLSGVIVEYLGWRFLFITV
IPFSLFSIIFAFIFLVNVSEVTKPKIDIPSIIFSTIGFGGTIYGFSSVGKSDAGFMNPEV
MVAITAGGIGIALFAFRQLRLDEPIMDLRVFKYPMYAHAVILFLIIIMTMFASEIILPIY
MQGPLALSAAAAGILLLPGSLLNGALSPFMGALFDKLGPRPLMIPATLILSGTMFLMSRL
DTDSQPWVILVGFMLLMISVSATMMPAQTNGLNQLPKRLYPHGTAVVSTLQPVAGAIGVS
VFISIMNARQMNFLGNASNPDDPATIDQAMVAGVELVYFIAFTISIVAVIMSLFVYRAKP
TDSMKMQQPDIQP
>fig|1235755.3.peg.466 Antibiotic resistance protein
MSETKQKIWTKDFTLIVIANFFIFAAFQMTLPTLPLFVQEIGASDRWIGIVVGIFTFSAL
LIRPTAGKMLDTKGRAPVFLTGLVIFVISMFSLAASYTIAILLLVRIMQGAGWGLSSTSS
GTIATDLVPKERRGEGLGYYGLSGNIALAFGPALGLFLTDHISFTMLFSICGILGFTALM
LALNIRYKKGEKPEQDPKTKDTYVPHFDIVEKRALPAASLLFFITVTFGGIATFLPVYTF
QKGFDSQYIQFYFVIYAAFLMLSRLFAGRLYDRRGIAVVFVPGSLSIIAAMIMLGFLPNP
AYLFIAAALYGFGFGCVQPALQAWAVNRSENNRRGMANATYFSAFDLGVGFGAMMYGFIA
EAFGYSTIYFTSAFSVTLSLILFIIMMNRLNKEQSNAPGI
>fig|1235755.3.peg.904 Fosfomycin resistance protein FosB
MKVGNINHLLFSVSDLDISIEFYENVFNAKLKVRGRKTAYFDLDGHWLALNEEKGIPRNE
IKYSYTHIAFSIEESEFENMYEKLENLGVNILNGRERHARDGRSIYFTDPDGHKFEFHTG
TMQDRLDYYKEEKDHMSFHD
>fig|1235755.3.peg.1356 Permease of the drug/metabolite transporter (DMT) superfamily
MSNMKKSAVTLLGVAVICIAFAAIFVKLSAASASIISMYRMLFASLLLIPIVYRHRSEFN
RLSAREWLSLIIAGGFLALHFGFWFESLQLTSVASSTVILALQPIVAMIAAYLIYRERVA
RAVAISVFISFSGVLIISWGDFSFSDMSALSGNMLSFLSVVAVVCYFMIGQRSVKNLKHW
VYSFVVFTFAGFFLLAFNLIAREEMMSYPPREWILFLMLAIFPTIAHVIFNSLLDAVSPT
TISMSMLLEPVGASLLAYMLLSETLDVLQLIGGVIILIGVYFFLMAQRKNNYIK
>fig|1235755.3.peg.1755 Chloramphenicol resistance protein
MNKKLLITFTVGVFLLGMMELIISGILELMSDDIGISHAMTGQLITVYAVSFAVFGPLLV
KMTEKFRPKPVIIASLVVFIIGNLIFGISNTFLMLSLGRVVTAVAAAVFIVKIMDMTVLL
SRPEIRGKMIALVYMGFSAANVFGIPIGTLIGQQFGWRIIFWLVIIIALLVGIGILSLVP
DRKGEELGEPVQDKVLDKRNVFLYIGVTMAVLIGNYIVIGYISPLMTSNGFTLESVSVAL
LIAGAGGMTGTYIGGLLVDRIGSKRTIIYMLILFMISMAILPLLYGTPVLFYINLFLWSV
FQWSTSPSVQSGLVENVQGSAAMVFSWNMSGLNLGIGIGAVIGGIYISNFDISFAPWLSV
AIVGLGLLSVSFVREHEEIV
>fig|1235755.3.peg.2123 Membrane component of multidrug resistance system
METNNNHKPDYRLIVILLSGAFVALLSNTFLNVALPSIKNDFDISTSTVQWVSTAYMLVS
GIVIPTTAFLMQRFSARKLFIAAMVLFLTGTLVAGFSPVFPVLLLGRMIQASGSAILMPL
LMNVMITSFPPAQRGTAMGLFSLVMFFAPAIGPTLSGFVVQHYSWHMLFFMMAPILLIVL
SIGWFKLPGTDTHYTTKLDIPSVILSTLGFGGILYGFSAAGNSGWMRADVLIALFTGFVA
TFFYIKKQTRMDKPMLDFKVYKFPMFMLASLLIGTMNMALFSGMILMPIYLQDIQGISPL
ETGILLLPGALIMGFMSPVSGRLFDMFGPKVLAITGLVLTVSTTSFFSQLEVDTSYTFLI
ILYSIRAFGMTLVMTPVMTNGMNQLTPELTPHGSSINSMLNQVSGAIGTALLITVMQNRM
NQKLSSVAPSDTAAVNQAMLDGINFAFLIATLLLAVALILAFFLKRVASDEVIGNDMTKA
RPIESDE
>fig|1235755.3.peg.2448 Multidrug resistance protein, efflux transporter
MAEEKVQSKGVVVVIIAAAFLLTFNQFLLITAFPTIMAEFDINATQVQWLTTAFILTTIV
FIPMSGYLSTTYSSKTLVIIAITCLLAGTIIGAWSPNFGVLILSRVIQAIGAGIILPLIQ
TILLIVFPYDRRGFAMGLLGAVTNVAPASAPSISGIIIDYLDWRSLHWVLLPFILITFIL
AIFFMKNVLEQQRTKLDIRSVMLSAAGFSLFIFGLSNISVYGFLDPMSYVPLTAGILGVL
LFTRRQFNIGTPVLNLTLFRNRTFTLAIILIFINMMLLLSTETILPMFAQSALGTSAFLS
GFLLVPGTVILSIITFISGSLYDCYGGRTIAIIGFLCTTVSLVLLNTVGMGDSPYWIMVH
FCLFMTGFGLTLMPLVTVSMSELDDRDIPHGSAIVNTVRQFAMAFGIIILTSIISITVAV
MDAPQAQSTYTGTSYALAVMAVLAFAGFLMTMLIREDRYG
>fig|1235755.3.peg.2548 Permease of the drug/metabolite transporter (DMT) superfamily
MILSAAVLWGTVGTAKTFAPAGADSISIGAMRLLVGGLVLMAVAILMGKMTLKGWPLKSV
LLAALSMALFQPFFFIAVSLTGVAVGTVTAIGSAPVFSGMIEWMVFKTRPAGVWWLSTFL
AVTGCIILMFNSSAVTVDPLGILSALGAGISFASFTILNSGLVKNHHPIASAAIIFMTSA
IMLSPFILIYDSSWLLETEGFLAAMHIGVLATGLAYYLFAIGLRNVKSSTAVTLSLAEPL
TASLLGVFLVGEILDSWSWTGLLMLLMGIVLLVVRPRRKRAGAEA
>fig|1235794.3.peg.1041 Multidrug resistance protein, efflux transporter
MHLSEKGHTYALFAVVVITCALGSLTQTVMNSMLTEVCADFSIDAAVGQWVTTIYMLVMG
ITVPVVVFLAKRFSLKRLVFMALGFYLAGSAVGFCAPAFGVLLLARVLQAVATGITLPLV
QTVAMTRFPRERTGTAMGIGGIAMGFAPNIGPLIGGALANTTGWRSFYIILVGLLAVLWA
ANALLVKSHGDRESQAVFDGPSFVQSTLGFGGFLLGASNAATMPLASPEVWMPALLGLAC
IVVFVRRQLVIPNPLICLDIFRSRHYRAGFVAQNCLFASFMGITLILPLFIQGPCGMTAL
DAGIAFIPATVVALFVNPLAGVLVDKVGARIVCITSAAFLTVGAASFVFVGADTPLWVLT
LLQGVRAVGVSGLVGPLNSYGLAGLNRGIVMDGSAFFATVRQACASFGTALMMLIISVVG
LVFAATDPADAGVTAAALPYNLAFALSTLFAAVVLVTAVWKIR
>fig|1235794.3.peg.1128 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTEQHTSREPDDARHFSPQGKEGGAAGGSAPRGEKLEARSAADDKVLRMGSASIPKLILE
FAIPSVVGMLINGSYAIIDSVFLGHAVGEIGLSAMTVANPIMVVFMAIAMLVGNGGNALA
ALRLGEGKREEAERVLGNVVSLSLVMAVIVAFLGWFPASTDWLLSLSSATDEVRPHATVF
IQIICTGFILQCIGLGVNNFIRTCGAPNRALGTMVIGLVSSVAFNFLFVIMLGWGVAGSG
LATVLGWGCSCVAVLWYFCGRADVPMRLRLSTMGLRPRMDGTIVAYGFPSFCVQAGMAAV
NFVLNFQLVKYGALSPIGADDALATIGVVQRIAQFSIMPLVGISIALQPLLGFNYGAHKV
DRVRKTLWYGIGAATAISLLMFALVQLFAAPIAHAFGIKHDGLVDFTAFAIHLQFLMLPF
VGFQIVSANYFQATGQPARSIFLTLTRQILFLLPLLYVIPLWLPAVAPQYNGLDALLFAM
PIADFLSIFTTALFIGWEMVRLRRLARKYAR
>fig|1235794.3.peg.1378 Permease of the drug/metabolite transporter (DMT) superfamily
MKAHLLALFTILVWSTTFVATKVLIAAGLTPLWILVIRFTLGFLALCCLRPRRLPLADRC
HERLFAAAGLAGVTCYFLLENIALTFTSATAVGAIAATAPLFCALIMLARGSRPAAPAPF
ALGFALAMAGIVLVGSASGKAILAGSAEANFIGCGLSFAAAVVWAIYSTIVGRIAEAGYE
TLAATKRIFGWGLLFMAPALLVAGPAPLAALAEPVVTGNLLFLGLGASAACFVTWNFAVK
HLGAVVTSTYIYLVPALTGTASVIVLGEPLTAPIVGGLGLTIAGLALSNRSHEKKRVPKD
PPSEQTCITET
>fig|1235794.3.peg.1380 Permease of the drug/metabolite transporter (DMT) superfamily
MSQWKQARWPFVAFVLIEVVIFGSGSAVTKFAYESITPLWCLAVRFGLATAVFALFFGRR
MARRLHGVRVRTWLPQALCMAVSYLCCNVALDLTTATNVGFLVALPVVFAPILSTLAERG
RYPKAIIPFQVGVAAGLYLLCSQGGSLAVGAGELFALASSVALAGALVFGKQALVELDAV
TVAGTQIAVAFALCLGCALLWEPALNVAAVRPVAWGIIAFLALFSTCLAFFLQSLALDRL
SSTTVSLLLTGEPVFTALFAYLFLGEILSPMGLAGAMLIVGTVVAATYVDGRADAPAHEA
APVPTRLPRRVVRPRLFVRRVREDRMAA
>fig|1235794.3.peg.1387 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSVDMSKHFSTSALIKFTLPTIAMMIFTSCYTIVDGFFVSNYAGKTALAAVNLILPPVMM
LASFGMMIGTGGSALVAKTLGEGDNARARRHFSLLIIFAFVLGSVLAVGGWFFMEPTAAV
LGATGQMAKDATLYGRMMMISMPFFILQYAFQSFFVTAGKPKYGFYVIVVAGVTNIVLDF
LFVGLFGWGLVGAALATNIGELIGGGIPLVYFARKRSTPLYFVRPHLRWPVIGKACANGS
SEMVTNIAMSMVGILYNWQLLRFIGEDGVAAYGVIMYTAMVFAAVFMGYSIGSSPLMSFQ
YGAQNHTEMRSLLWKSLGLIAVASVVMFLLGQTLAAPLSAIFVSYDAALLELTAKAYRLY
ALCFLFMGFAIYASAFFTALNNGLVSALISFLRTLVFQVAAVIVLPMLFGIDGIWLSVTI
GDALTCLVAATLMIALSGRYGYRKRGEKPAAA
>fig|1235794.3.peg.1408 Vancomycin B-type resistance protein VanW
MAPRSHVKQPMPDDRMAGARPLPEHPALGRRPRFPAASPYAAPLIAVCAVALSACMAFGN
PVIWESAAQKEPAPVDEPAASNPAPAPEPEKAEEEPAPEQETIGEYQAISQSEDPGRSEN
IRLATEAIDGTVIEPGGTFSFNDVVGNTSAERGYQEAAVIRNGEVAQGDGGGVCQVSTAL
YIAAVKADMEIVERHPHSVPSDYAPIGLDATIVYGSFDLRLKNNTDHAITIHAKAVGQTV
DVSIEGDPLPEGRTVDATSQIVSRYERDDAAGTLRQYYVSEAFRVYYQDGVRTTRDLLSS
DIYQVDENTPVTTSEGSVDPNK
>fig|1235794.3.peg.1783 Permease of the drug/metabolite transporter (DMT) superfamily
MSQNLETARPCYDATAMVSLMRHTNVPPWVYKAALLLSAAIWGMGTVVIKSTVDAFPPSW
LVGVRFLGAGLILGAVTLPRIRQAYARNKRGHLRDGAVLGALLFASYWCNSTGLTDTTAS
NSSFLTTLYVVIIPFLGWIIIAKRPTRFNIAAALLCVAGVACVAYGGDGAFSLRFGDLIT
LASAFFLSLHVLYTAKYAPGRSMTLLTVIQFVTAGILGLIVGAVTEPTPRFAALGADTWI
SLVYITVFASCVALGLQNMAVARVDPAQASLFLATESIFGVTFSILLLGEVLTLSSFAGF
ALIFAGIVISEYLPLRAEKKAAERDEGLTAPASQDYTLQAKAAAEAAALELDEADTALR
>fig|1235794.3.peg.1881 Drug resistance transporter, EmrB/QacA subfamily
MLAVLVFGAFVTVLNQTLVTPALPSIMVEMAVDQSTAQWLTTGFTLVNAIMIPITAFLQD
RFSTRKLFVFSMATFAVGTLMAGVGPNFPVLLGGRLVQAMGAGILMPVTMTVLMLVFPVD
RRGSAMGIFGLVIAFAPAIGPTVAGFVIDQADWHILFYIIFALSLVIIAASLFLVDNKAP
ANKGDSVLDPLSLVLSTLGFGLMLYGFSALGSAGLTLVPVATTAVGIVGVVWFFIRQTRL
PHPMLRVDVLKNRRFLIGTIIGMLVQGALLAAGILMPIYVQSLHGLSATVSGLVLMPGAI
LMGVMNPIAGKWFDRHGPRRMAIVGMSLLTLTTFAFAILNLTSSIIYLTIVYTVRMFSMA
LVNMPITTWGMNALDNKVMNHGTSVNNTLRQVAGSLGTAIIIAVSTQVQNFATPGLGAAQ
GTMLGINAAFLVCTLLCLVGLVMTIMFVKDKPGEEAAVDEGGTRKSLLTSIMKTDVYSLS
QEATVEEAMRLFVEKNISAAPIVDASGEPVGFISDGDILKRLSPRRSSFTDPIVLINRTV
PDEEGYDEKLAKVMQMRASGIGAASPICVSVHANLTDVCRVLAENHLKKVPVLEEGHIVG
IINRSDITQYSMAAYLAGNPDRAVYCGDGPSGQHECVEEKQCDCGCEEGK
>fig|1235794.3.peg.2036 Permease of the drug/metabolite transporter (DMT) superfamily
MDIASRTNGEGNRRALLIGGVGYGIICGLTFPLMISNTFLREMSLSHGAGDSFGALFFLA
YAAAMLALALWHLVGRKPLPRASLVVALGAVLLGNGLMLLRYLSIIEGGWSYAIVTGLSI
GFGLAVAELGWMEKIVTMGKADGTLLPRMVSLAYLVGGTAAAFIFLATGPVELTFALLTV
LISGALLTRTPNVADEPPSHAPSRSDNVNLVKAISYLAVFSFVFGAVSQMVETSSHSITV
IEIQATASIIGAALIFLAASLGRKRIVPISDLYGLLFPVVAGALIALPFITTPWVHGIAS
VLIFAAFYLSGMNVRIIVSQLCRGDRISLWVYLGCALGVGSLLVIAGVAFGAAVLSQGSP
ETALALIALISLFILALNPILAHRIEQRASVGADTGDSATAAVPTTQAAENAVEGFAREH
SLTARESEVLLLLCQGRTRTYIADELGLSPNTVKGYIRNVYQKSGSVDKQDLLDRVELFR
ERR
>fig|1235794.3.peg.2352 Nitroimidazole resistance protein
MFVPMRRSKQQLPADECAAILRGATAGVLGTAGTDGYPYAVPVSFAYVPSSEDDAAPDAV
RGRIFLHCATTGHKLDALDADPHVCFTVIAQSEPVPEKLTDRFCSVIAFGTARRAEGDEK
AEGLWALGTKYAPGLDAVVSDEIATTAHRTEVIAIDLESVTGKEGLELLRERGA
>fig|1238674.3.peg.447 Multidrug resistance transporter, Bcr/CflA family
MARQKLGALQLFLLGILSAFGPLSLDLYLPGLPEMQQNLNTTPTMIQLTITASLIGLAIG
QIIIGPWSDRVGRRRALLVGVGIFTLATVGIILTPNIYGVILFRFIQGLGGSAGIVLSLA
VIADSFEGLQLTRNVALNQMINGVFPIVAPVIGGVIIALSHWQMTFIVLAVLGAVLWVAI
YTSLPETAPEFDNSHAQMTPKQTFKTLWSNKGFMFMAWTQAFMMAGLFAYIAGSTFVLET
IYDLSILQFSIVYAINGLGILIAAHISAKLAAKMGEYHALGVFVIISLMGGSLVWLNVVL
SNHVLLMCLAFFLIVAPVGGVSSLTTSIAMQHVQTGTGAASGILGLMRYAMGGLVSPLVG
LMGADSLIPLAIVIAVVQVLGTMMYLKSRP
>fig|1238674.3.peg.1194 Quinolone resistance protein
MEIKDARLALDELEFGNTYIDCHLTYSNDALRLENITLKHCTFDQSDFSQSEWQDCVISQ
CDFSQADFSSAIIYRTTFDHTKLMGANFTKSRLNNVQIKNCMADYAIFAEGQWQAVTFDD
VRLRDTSFQATKIRQGLIFKGCLLDDADFYETSLKGVDFSQSEFSSLRFSMEQAQGAIMS
AEQAVQIALNHGISVL
>fig|1248916.3.peg.619 Glyoxalase/bleomycin resistance protein/dioxygenase
MKRLHVHVGVTDLAQSIAFYTNLFGTGPTLVKEDYAKWMLDDPRVNFAISHGHAATGIEH
LGIQAETADELAEVTARLNQADAPVLAEGETICCYARSEKSWTTDPQGVVWEAFHTMEQA
RTYGSSPMLDTLAAMAPAPAKGGCC
>fig|1248916.3.peg.872 Permease of the drug/metabolite transporter (DMT) superfamily
MASAAPEPRFTPVAWFAFIACTLIWGGTWFVIRTQLGEVPPSWSVTWRFALGAAVMFALC
LVRRKSLRLSLRQHGFALLVAVTQFVLNFNLVYRSEQYLTSGLVSLTFAFLLVTNAALAA
LFLGQRVTGRFMLGSAIGLAGVALLFAPDIGKPGGEQIGINNTTWGLALAFAGVLSASVA
NVLQATPQGRAMPLEAGLAWAMGWGALIDGAVAWGLSGPPVFSTAPVYLAGLAYLGIVAS
AVAFSLYYILIRAVGAGPAAWSGVVVPVVAMGISTLLEGYEWTATAVAGIVLALIGLGVA
LKAKAQQ
>fig|1248916.3.peg.1295 Candidate antibiotic resistance protein (acetyltransferase)
MSIRPARMEDAPALAAIYAPAVLTGTASYEVEPPSAAEMAQRLMKVKSHGWPWLVHVTMG
TVDGYAYVTQFRDRPAYRFSGETSVYVAPNAQRTGIGQALLMAVSSAARTAGFRQLIAVI
GDSGNNASINLHAACGFERAGLLKQIGEKFGKPLDIVMMQRSLIG
>fig|1248916.3.peg.1365 Outer membrane component of tripartite multidrug resistance system
MHRKTFLLIPALAPILALCACAVPPKLGAAPMVRAPATAASTVTLAAKGAVDWPATDWWQ
AWGDPQLNALVAEALAGNPDMAAAEARVVAADAAARQSRATLLPSLTGNASLGGQQLSRN
LGIPPQFVPPGVLESGLINLQAGWNLDLWGQGRAQLRAARREAEAVAVERTQARLFLAAS
VAAAYADFGAALDRLAVTREALAIRQQTLDLTANRVTAGLDNDGARAQAATRLALAQSDL
AAAASQVTAARRRLALLVGAGPDRGFSITPPKIKPLPPGLPEAVSINLVARRPDIVAARL
RAEAAGAREMAAGRAFLPNLTLNATIGQQSLGFGKLLEGNSLYAQFGPALSLPILDGGRR
AAEARSARAARVAAVAAHDAALLRALNEVADAAGAVTVLGLQREALTQGLAEATRARNVA
ALRYDAGLSNQLLVLTADDAVVTARRTLADVDAFRLAADVALVRALGGGFREQEGQ
>fig|1248916.3.peg.2449 Drug resistance transporter, Bcr/CflA subfamily
MHAPSASRQPSLGEILLLGSLTGFGAVTIDLYLPTLPAIARDYGTSAAAVQLTLSTFFVG
MAIGQLFFGPLSDRIGRRPTVLIGCAVYVVASLFCALAPNIEALVAGRFFQALGCCAAMV
TCRAIVRDRYDHRDSARIFSLLMLVLAIAPLLAPTIGGWIAMAAGWHAVFYAFVAVGVAV
AGAVAWRLEESRSAATAQAARGNDVLSTYARLLGHRRLIGYLLVGAANGATLFSYIAASP
DLVVNVWGFSEGQFGLVFAAIAVGIVGSSQINRALLRHRSPDAILAWATLGAAMAGLALW
LATQADAPLLIFMPILFVALSSNGLIAANASAGALNVDPLRAGAISGLMGGVNFGVGALA
SALAAALHDGTARPLALNVAVALLVAATAFHLLAKPR
>fig|1255043.3.peg.1146 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTDLLGSVPVLHISNAERSCEFYCNKLGFQKNWQHQFEPGFPLFVSISRGSVTFFLTEH
PESSAGAFVYIHAEDVDALAQELQARGVTLGQGPVSQPWGMREIQLEDPDGNRLRFGQDI
EEKIS
>fig|1255043.3.peg.1742 Permease of the drug/metabolite transporter (DMT) superfamily
MSVPAAYLGVILIWATTSLAIQWSGDGPGFLFGVAARAAIGAVLALAIARLSRLRVWRRD
AFGVYMVVALGIYGATLSTYWAAQQIPWGWISVIFGFTPIATSAMAALWLPGQGLTRVRL
AGALLGVGGLAAIFSGGAAAGITTVDRRAGRL
>fig|1255043.3.peg.2529 Bacteriocin resistance protein, putative
MPRSVLNRLLRPPADFRRVQRQSWPESCGAAALATLLAEVHALPVTEADVLERLGTRKVV
GLDQLQQVCAQYGLRAFGYALDWDGLGRAGRPALLHLPGASAVGHFAVLRGIGPARVWLA
DPARGNLRLARSQFLRRWAPRGAEGRALYVAAPEADWLPLGEEALRAPPVADEDWFPARQ
SPQRDGVPDMDD
>fig|1255043.3.peg.2790 Multiple antibiotic resistance (MarC)-related proteins
MIEVAIVAFATFFVTVGPVDVAVVYAALTPHHPESARRTMAIRATLVATGILLAFALVGE
TLLGWLGISLPALRTAGGILLLLIGIDMVFARQSGGVSATPSETREASRRTDISVFPLAT
PLIAGPGAMGAAILLMAGAADWRHQATVLAMLLLVLLLTLVCLLAAVRIQRFLGIIGAQV
LTRILGVLLAALAVQFIFDGIIASGVLS
>fig|1255043.3.peg.2949 Acriflavin resistance protein
MINPARLTVHRPVMTGMATLIVILLGLAALTRLPVDLLPDITYPVLTVTTAYPNAGPEEV
EQLVTRPIEQAAAAITGAREIRSTSSEGSSNVRVQFGWGTDLREAVDDLRDRLARIASQL
PEGADQPLVRQFDTQASPIMQLGVGSALDPIQLRALIDNRIAPRFERLPGVAAVDVRGGL
EREIRIEVHPERLQALGIGLDTVRSALQEASVVSPGGPVVEGRREFRLRTEAQFRDLEEI
ANTVVRRDETGPVRLFQIADIRDTHQRPTRTFRVDGADGMVLAIRKLADANTVDVAAAVR
AEVRRIERDFPQVAIQIPSDGSRFISRSIANLGQAILYGSALAVLVLLAFLRNLRFTLVA
ATAIPISVIATFGLVYFGGLTLNLMTLGGIALGVGLMVDNAIVVIESIARNREENPGLGI
PEAAIKGTGQVSAAIVASTLTTLAIFLPLFFAEELAGQLFKPLAAVVAFALAVSLIASLT
LVPMLMARRMLHSASAATATPHGLERTYLRLLEPALRHPWWVVLASLALLLFALQGYRGV
GTEFLPATDEGDIRINLSMEPGTRLEVLDAVTREVEATVRERVPEAQHMVTSIGASAFGF
GSPSSSNLRLNVGPRDARDRSSEEIAAALRQAIGQPPGVTVRVRASGGIFMRGFGRGDDT
ERLSIEVRGFDRVAMNAVALAFGEAVEDIPGVTDVRVGDDGGQPEFLTRIDRARAADLGV
DVRSIAQAIETAIGGSRAGQLRTGGTETRIWVQVQDAEHRRLDELLNLTVAGAGAGGERI
PLRSLVRFEPVIGPSSIQRREQARIATLFVNVAERPLGDIAADVRAALAQIPLPDEVDYQ
VSGDIEEQEAAFSELFLGTVLAILLVYMVMASLYESLRDPLIVMFSVPLAAIGVVLALRL
TGTTLNVQSLIGVMLLVGIVVNNAILLVDRMARLQRGEGRAVRDAVLLAARQRLRPILMT
TLTTILALVPLSLGLGEGGEAQAPMARVVIGGLISSTLITLFLIPALYLIVHRTATATAA
PVVPPSRETA
>fig|1255043.3.peg.2973 Acriflavin resistance protein
MSEHNTQQAGEGQEPEKDLGLAGRMAQSFIHSPLSPLLLLATLAIGVLGLIITPRQEDPQ
ISVPMVDIFVSYPGVPSEQVASLVARPLERLMSEISGVDNVYSVSHRGQSMVTVQFDVGE
EMESSIVKVHDKLMSNRDLMPPGVSEPMVKPKGVDDVPTVTLTLWSHDLDDALLRQIALD
TLQYLNEVPNTSQSFVVSGREEKVRVEVQPERLAGHNVTMDQIAQALQAANSERTAGSVE
IGATSTPIYTGAFLRDAEDIGRILVTVEEGRPVYVRDVAEVIYGPGEVDRFVRYYTGVAG
HHADEAPEGAAAVTIAIAKKEGSNGVAVANGILERLEMLKGQVIPDNVEVSVTRNYGETA
NAKVNELMFKLFIATAAVTVLVFIFLGLRAALVVLIVIPVVLLFTVFSAWLMGYTIDRVS
LFALIFAIGILVDDAIVVVENIYRRWLMKRGVDTETTVDAVAEVGNPTILATFTVIAALL
PMGFVTGMMGPYMQPIPALGSVAMLFSLVAAFLFTPWLAWRLRPTMDYLQRAEEKEHKQN
EMMGQFFSKAIPGLVHNRVYGWGFLIGIVVVFFLTVMLFFTKDVSVKMLPLDNKPEFNVV
INFPEGTALPQTATLTHELAMVLRDLPEVTAVQAYVGTASPFNFNGLVRHYYLRQEPWQA
DVQVQLVDKGDRKRTSHQIAVEARELLAPMADAAGARIQVVEMPPGPPVLQSVVAEVYGP
EPEIRRRVARDLERMFDNAPHLDDVDSFLQAQYDVWHFIVERDKALRRGVTVDAVNRTLE
SAIGGQIVGDVKARSLVEPHLIQIRLPMAVRSDLQRLLLLPVPTMAGGSVPLSELGEFVR
QPQDEPIFHKNLRPVEYVTAETVGRLAAPIYGMLEVQEQLKEYRLPRGGELDPHWVGPPP
NDGTVGFEWAGEWTVTYETFRDMGIAFAIALVLIYMLVVWEFGNFLLPAIVMAPIPLTLI
GIIPGHWLLGAEFTATSMIGFIALAGIIVRNSILLVDFARHAVAEGQSVMDAMIHACQAR
TRPILITAFALLAGSSVILFDPIFQGMAISLMFGTIVATLLTLLVIPLGCISASRTLEEN
ATGGGSGGGAACAVQPEPGGDPGHEGPRFPSSTKMTDPSGGPVMKFIGLAGLYLRSLAAS
FVEGVVQLMRALARWILRLVGGDDRPPSGGGGPTGPAAPPDGSGGPAGGAPSGVETGQAE
SGERDGSGDRAEAADDRSRTQPGSDRVRSASGGRAGGESAAEKTPSGTAAPGAGEKQQRG
SASAEPKPASARTSKPASAAAKTKADPGEASAPADRGAPPRKAGSATGAPEAESDDDEGA
KAASSGSAASSARRRRGIRLK
>fig|1260251.3.peg.361 Permease of the drug/metabolite transporter (DMT) superfamily
MIARDWLLLIILSTVWGGSFFFFEVALQTLPPFTVVLGRVSMAAAALLVIARIRGEPLPF
SATIARRYLLLGAISNAIPFSLIVWGQTQIPSGLASIINAMTPIWAVLVGLLIRSDERMT
AGKAIGVGLGFLGVAVLMGPDLLRELDPYSLGQLSVLGATISYGFAVHYGRRFGATSALV
NAAYMLTAATVWLLPVAILVDHPWTLSPGLSGWTALLGLSLICTAFAFLLYFRLLASAGA
TNMSLVTFIVPVSAISLGALFLGERLGPTAFAGMGILFVGLAIIDGRAARMLRTGTHALW
SGLLGRRVVSKRPE
>fig|1260251.3.peg.370 Multidrug resistance transporter, Bcr/CflA family
MFNQRYRAHPDGTLMIIMLGVFTAFAPLSIDLYLPGMPAMEADFGVSAGLVQQSLSLFFV
GLAGGQLLYGPLADRFGRRYPLLAGSLIYLAAGLLCALAPSIEWLLAGRLLQGFGAAAGP
VIARAIVRDVYAGRRAAQVMSFVILVMTLAPLIAPVVGGWLTTALGWRANFWALVAFAVI
CLVMLLMALPETHPAERRPRTALRHLFAGYLPILRDRAALAYLGAGGMAFAALFAYVAGS
PFVYTRVFGVAESNFGYFFALNVIGLLIGNLVNSRLVMHFGQQIMLTAGVLVMATASVSM
LVMALAGITEQWLITPALFVALGTVGIIAANTVSGLLDRHPRHAGAASALFGVAQFGLGA
LSAVGVGLVSVGPLLTMTLVMAAAALVATASVIALWWQLRRPALAV
>fig|1278308.3.peg.392 Tetracycline resistance protein
MTTTVGAIEHLQRRTMLVLVVMQVIGMIGVGAAPSVGILLATEVTQNEAIAGLARSSSTL
GAALMGLPLGSLAARRGRRVALTLGWYVAAAGAALLVFAAQFSLVVPLFIGLFAIGAGTA
AGLQSRFAATDLAPVAGRGRALALVVWVGTLGSVLGPNLGVPGEWLHDRIGINVFGGAFG
IAAVCLALAATVVWIWLRPDPLVTLQARAGVSTVPGAQRPRLGQALAEVRRSGPGRLALV
GILVGQSVMVAVMTMTPVHLAHHGDTITVIGLTISLHVAAMYVFAPLVGWCVDRLGHRVT
IAIGVALLAAACLVGAAWQHETAAIVTALGLLGVGWSFTSVASSALFSVAVSDAHRAQAQ
GGADALSNLCAAVAAFASGPLMAASDFSVLSLAALVLLVPLAVLLVPRRATG
>fig|1278308.3.peg.1222 Drug resistance transporter, Bcr-CflA family protein
MPHERRLTPLLLTVLGFIAAVGPFATDMYLASFTEIATALGTGPAPVQLTLTAFLFGMSA
GQLVNGPLSDRLGRRPVLLVGLAVFAASSVAMVFTPNIELFIALRVVQGFAGSASVVIAR
AIATDLSLGNTAVRALSMIAMVTALGPLIAPPIGGALATWFGWRGVLAALAVISVTMLAL
ALTFVAESHPPTARPTGHLLAPFRSFATLLRDPVFGGFALAFGFGFAGMMAYISASPFVG
QHLLGMSQLEYSLSFAAGASALILANLANARIAPRVGAGRMLVVGLALLVAGGVGFAVLA
ATGALSIPTFILCAFATTAGTGFTSANSSALAFTRTGPAARGAGSALLGTGQFALGAVAS
PLVGLWGEGTALPMALCVLVAALVAATCGLAALRRSRR
>fig|1279017.3.peg.786 Acriflavin resistance protein
MNIIEKYSPVIISCGLLLICLGVFYGVKIPNTLLPNIDRPQIALATSWPGKTAMEIEQAL
VAPLEQELSSLGFLEEIQTTISNGFAWTLITFHSNADMEQMYIDVLSRLNQVPNWPSQVS
APRLYNFSNGAGATLASFFLYSTNQATEQELSQAFRDHVQPAFSKIPGVASVTVAGTPIE
QRIDIEFDPRGLTQASLTINEVQSRLSDLVDRSGGNLTIGSREYALHFKGQIPIADIEKL
PIATRGPHIIRLGDVAKVKNRMASDWNYFALEGNRSFYFYLMPTEDINVLNTIDMIKTLI
SDLNEGELGRLGMEVAISRDDSKSIRNSLQLVYSSLILGAFLACIILYWFLRDFRTLVLI
FTSIPACIALVILGLYLGGRSINVISLAGIALSIGLMVDAAIIVIENIQRLRGQGASLLT
SIRQGTKEVTGALTASTISSVIVFLPILAMQSATGQLFTDLAYTISSALIASLLFALLLL
PALARHLLKDSPQVNPKGRTQSLNRILQRWTAISVIPIGRVTFRNCVLVLGLPVALLVTY
LSSPSVDVLPDPKQAMISTFINFEGPMAVEVVEREVGQVIMDRIEQGKGRFEEQIVTYGT
LCYPTMCHLYIYTQGDWDFEAFKKWIDKDIVSGLIGTRIHTQQGGLLRFAMPNSRVSQLD
IKGAELPVLQAAGRDLLEHLRSEFPGAQILEGSALSNRGLRIEFEPNQDQLIRMGMTLPE
FNRHLMALTDGIYIGNFYTGTNTLPFYFKAKEPANLEQLLNTEIMIAGQGLIPLRQLTSA
QITQAPDSILRVGQEVSTSLNLTPPTGVAMKDFTEQVDRSVLAFLNKSQYGDLHTQFRGS
ANELKLFLQEFFQIFCVALLILALLMYFALRSLKLALAVLFAIPLSFAGGMLSLRLLNLF
VMQNLDVITMIGFVILMGLVVNNAILLVNQFQSSINKGMHQFDAIKSAVSLRIRPIMLTT
TTCIFGNLPLVLSPGDSAAIYRGLATVITGGMLFSALFVLGFMSAMLSLKVFAAHRINPT
SVVRELTPEGGI
>fig|1279017.3.peg.875 Permease of the drug/metabolite transporter (DMT) superfamily
MSQAQGLPRAFWLLLIGSGFFQMIYMGGLALAYQRANMGLVYPIARALPVLLVALATVLL
GQTLPWLAWLGMLLVTIGCLLVPLVYFRQWHWRAYWRADCAWALVAALGTVGYSLADKGA
LLHLETALDGAVRPMAMAYSYLGMQFFASGLWLLFGCLGSNGRAQLVRSLGDLKLGLVTG
LMMGATYGLVLLAMAMTENVSYVVALRQLSIPLGVGFGIWLLKEPAYRPQLLGVGLVCAG
LIAVSLR
>fig|1279017.3.peg.1610 Drug resistance transporter, EmrB/QacA subfamily
MKYKHISFVGLCLGFFIVMMDMTTVPLMYTTLMDEFTVSPARVAWINNIYLITYAASLLL
GGRLGDSTDRKIVLIGALLVLGLGAAISGAGQTFVEVIVGRALMGIGAGFLTSQSMAYIS
ILFAKGGRGTALGIWGAVAGIATATGPVITQLLLTTADWRWVMWINIPFVLAALVIALRC
LPGDPGSGIRLSETFASAVYGLCLAGVIIGIHYISVAGILRGVGIALILIGAAVIAILIR
KEVKNKSAYILSPELWFDGTFFRICFISGLLGLGVASFYLPLAFLLDVCMNFGPVAISVL
MMTIALSNALVGPYAGHLSDRIKPEGIVRSGLMLFALANGLLGFIGVLMPGGTVTFIALF
LVMMIGGAGTGLAFAPLANLALSRVSFEALGRAAAFFNSIRQALSAMGAVIVAILFDWIV
RLKLGIDLEITATNLRESPGITGLATLVCFLLIALGLSVAAYLSRSSRQDSVQREVLNT
>fig|1279017.3.peg.1757 Acriflavin resistance protein
MKTLSRWFLDNPVAANLLMAFILVAGLLTFQNLRVESFPQIPPTEVEISVVYPGGTARQV
DESITQRIEEAISGVAGIKRITSQSSKGYASLVVKKNTNVKLDRLIEDIRNQVESIEGFP
ALAERPRIYRSEYTNLAAFVMVYGGDNNDSLQQVSSRVERVLKKHPAISKVTNLGKRKQL
LAIEPDLRKLQRYGLSLENLTERIRQWSVEYRSGELRTANGNIVLQGSSLADNLAELRNI
PIITTSTARVRLSDIATVKRDYEQTDSIVRYQGQPAVALMVSTSQKDNLFHIHEATKSVL
ESLESTLPRNMQLDVMADMSPYISEQLDLLSSNALQGLLIVLLLLVLFLDTRLAFWVALG
IPISLAGAITLMGFPSLDYSINDITLFGMILVLGILVDDAVVVGESIHQARQNTTDTKEA
AWKGVEAVAVPTVFGVLTTIAAFSPMLWIENELAKVLSGFSAVVIFALIFSLIESKFILP
AHLSYPNTHTQTSGAIKRWIEIAREKCNRLLNRFSDKIYIPLLSLSLANRKISISLFATF
LLLAYGAMFKGHIASVFFPEIPGRYATVKVTMQHGAANTLTERNTDQLEQAIKRTANRLQ
QEYGLPESPVSKYIVSKEGTKTIELTAELTHDALARVESNRFLEELRLQTGILEGSYAVK
FSLTEEPAGDTAIAVSASNRDQAKQVAGRLKALLAELPGVNDVYDDSQLAKRQLKITVNE
RGASLGIDQSHLAVLIGGAFGQIEIHRLLDKGEETLVLARFPQTETKTLEQLKATPINLD
NNSYVSLGEIAQLKYEREPEVIYRRNRDEVVSIYWRQNRSVSSPENNWERLKEELVPELE
RLYPGVQIKAVGEFAEIVEVQAGFKKSMLLTLLLIYVLLAIPLKSYWQPLIIMSVIPMGF
AGAIIGHGLLGFPVSLLSLFGMMAMTGVVINDSLVLMSRFNQLYAQGVPVKTALLQAGKS
RVRAIFLTTVTTICGLLPLLAETSEQAQYLKPAAISLVFGELFATPITLILIPLLLSFGQ
YKNTSRSDSASLTEQSLLQEVRQL
>fig|1279017.3.peg.1957 Acriflavin resistance protein
MNELRVEDGDIDTKTGAIAWMARNHVTANLLMLVFLVGGLIFSVIVKKEVFPEFSLDLVS
VSISYPGASPEEVERGVLVAAEQAVQGLVGIKEMRGSAREGSAVLNLELEGDADANLVYQ
NIQQAIDSVTTFPADIERPQVNLAERKRDVLDLVLHGNLDERSLRALAMQVYDKLEAHSG
ITQLEAQGVRDLEVAVEIRRDDLRRYDLTLAQVATIVQNAAVDIPTGSVKTDAGEILVRV
TERRDWAREFGDIVVTQGGGGGAVYLRDIATVSDALEDEARNMVFNGEPAVGIKIYRVGD
QTPLSVSDAAREVIDEVRASLPQGVSLTIRDDDSEIFKERLSLLLKNGFIGLLLVFVVLG
AFLELRLAFWVTLGIPISFLGALLFLPGLDISISMVSMFAFIIALGIVVDDAIIAGENIH
EWRQKGYSNLQAAIAGARQVAVPLTFAILTNIVAFIPLMALPGFMGKIFGVIPFVVGSVF
IISWVEALFILPAHLAHSRRGYKSPRAQRFAARQERLARGLDRFVQERFRPLLEACVRHR
YTTIAIAISTLLVVGGYAASGRMGFTLMPRVERDSGRFAVTFPTGTAQHQLEKARSQIIA
GGNKVLEQYDRDAVFLGNRGLMGDDSVQVDFFFVPSDQREFSTGEFVRAWRKEVGVIAGA
LSATTASDRGGPGAGSSLTVELRHIDTAVLDQAAARLGAELAKFPNVSDIDAGVTLGKTQ
LDLTLTETAKSLGLSAEEIGRQIRAALYGDEALRQQRGRDQVKVMVRLPESERVSMDDVN
NIMIRAGSGLWMPLTDLVVIDKGRAYATINRRAGRRVLTASANVEPSDQAALVINELDRS
VIPQLQAEFPGLTISYEGRQADEREGLASLGLTFLLAMAVLYLLLAIPLKSYMQPLIVMV
AIPFGVIGAILGHLVMGYGMSMVSLLGMVALAGVVINDTLVMIEYSNRLREEGVDVETAI
KRAAARRFRPIVLTTVTTFCGLMPMIFETSVQAKFMIPMAISLGYGILAATAISLLLVPC
LYLMFGKDIPRLFSALKNALESFTGTARAGN
>fig|1279017.3.peg.2431 Permease of the drug/metabolite transporter (DMT) superfamily
MKRKQVQAEVLLLLAALFWGVAFVPQKVAMADIEPLAFNAWRFILGGLILVPIVYWLSSR
RDSQPGEVGGKHVNHRWKACLPGGAVLGFWLFLGAALQQVSLLYTTAGRAGFITGFYLLL
VPVIGLSLGHKTNRWTWVGIALALFGLYWLADFAEESQLIGDLMVFASAFVFAIQVLSAD
HLVKRYDALRLACIQFLVCGFLSALASLFTEEATMQSAVDAAWPIAYMMIFSTALAFTFQ
LLAQRYAAPSHATVIMSLEAVFALAAGWLFLNEVLNARELIGCGLMLAGMLVSHYGNHNG
THH
>fig|1279017.3.peg.2842 Glyoxalase/bleomycin resistance protein/dioxygenase
MLKHPDHVTIVVNELQSSVKFFQLLNFELEVTDLISGEKVSKYLQVENVEADHLTMVLKN
SSPRFEIQLLHYRNPKVKSDPSIFSLARPGYNHLCFAVDDIEKTLKFLNENGIRTRSEIL
EYQKRKLVYIEGPEFITIELAEWL
>fig|1279017.3.peg.2983 Acriflavin resistance protein
MNGIIPWFVRNSKAANLLMIMIIIGGIFGISGIDREVFPAIQPGIVEVNISYPGAGPAEV
EQQVTVRVEEAIAEVKGIKEVNSASRRGHSSVEVQAVDGYDELRLLNDIKVQVDSINTFP
EGIERPIIRLQEWDTQLMMIAIGGPVSERQLKETALDLRDKLTLIPGVRSVDIWGERPDE
LSIEVSELDLRRYNLSFNDVADAVRRSSLDLPAGMVRSDRGDIQVQTRGQAYSAEDFERI
PVVSRADGSVLLLRDVATVRDGFEEYNNVILFNGNPAMNLRVVQGEPLDVVGTAERIKTF
MAEARTQLPPGMEFDIWFDFSKAFEGRMNLLTTNALSGFVLVFVMLMLFLRPALAIWVTV
GIMVAFLGALWLLPITGVSLNMLSLFAFLLILGIVVDDAIIVGEAVHAAHDRGVTGLAAA
EEGVKQVSAPVIFAVTSTMVFFIPMLFLPGYTAQMMLALPVVVLLCLAFSLVESLLILPA
HLVGMKPEQPAKTRVGIKLQKLRGHFAGAMKTAGDKYYLPLLKKSLGNSRSTVMIFISAL
GLSISVFMSGYVGSSFSPQVPSDLLELRASMASGEPFHEAERVMNQVLAAADKLAADEEM
LKQNNGEPFVQNSMVFNWRGNIFVILQLTDGELRDVTSKTLALRWRQLIGEMPASVEDLN
IDATINDGGNGMSLNLSTASGDMDELRAAADAVKEKLNTYAGVYDVRDNLTSARRDIEIQ
LKPYATTMGINLADVARQVRQGFYGEEVQRIPRGREDVRVMVRYPQEERASEEQMDRVRI
RTAEGEVPFSAVADAVYVPGYTTIRRNNRERTVRVFAEITPNTSSAQEILKDMRETLAPE
LKRQFPGFSLRTAGEMQEEEEFNGAILAFFVLSLFAIYALLAIAFRSYSQPLLILTAVPF
GFFGAVVGHLLMGHNISIMSMLGFLAAAGVVVNDNLVLMDRINQLRAQGWAVMDAVVQSG
RDRFRPIILTSITTFIGLVPIMFERSIQAQFLIPMVISLAFGVLFATAVTLILVPNLYKV
IEVIRPKSKRLGEGEAPVSLETV
>fig|1279017.3.peg.3396 Multidrug resistance protein A
MTDKLNLNLDRTTQRKLGLILVLVLAALAVGWSLFGSGDIVETENAYVKAEKVSLAPEVS
GVVTKVLVSANQVVSKGQLLIQIDRTAFELAVTEAEARLSQVRNDLLARRAEYAEADAAL
QQARKDADFYRRQLERNEKLGKVAFSEAELDSARQQLERARAQITINAEKLSSLRAELGG
DPGSALEDQADLKVAQAQLDKANYQLSRTRIIAPVDGTIANTVPQVGEMATAGLNLLNMI
GSSGLWVEANLKETELAKVRTGQQAEVTLDAYPDFEWQAQVDSMSPASGSEFALTPPQNA
SGNWKKVVQRVPVRLRLYPLKDAPQLRAGMSAKVRIDTSEDAKVVSARASTDESGRVVL
>fig|1279017.3.peg.3628 MFS permease (drug)
MSGATVAPSLPALENYFSQHPDSALLSRLVLSLPALMIAIFAPLAGIISDRYGRRRLLLL
AVGLYGFAGTSALLQNSLEGILASRILLGVAVAGTMTSVTALVGDYFTPRERQVYMGQQG
AFISLGGVVCLLAGGLLADLHWRGPFAIYGVALLLIPAVLIYLPEPKRSYTLKKSKSIAE
KKIYWLGFSALLGAAMLNSLAFFLIPTQLPFLLQEIGASSPSQAGVAIAAGNLMGALASL
TLFPRAHKIFGKFGIFAFSFTVMATGMGLISIAESFSGIIIAMAIYGSGMGTLIPHIFST
GLESATENMRGRISGALTASVFIGQFLSPFLSQPWVNHFGLASAFSTVALGLLLLAVIAL
ITHWLKTKTSTEIKLR
>fig|1279017.3.peg.4159 Acriflavin resistance protein
MYQDKKTREEVLEAESEHRFNTARFFVDNPSISWALLVGVMLWGVFAYFFMPKSKDPDIP
VRIAMATTTWPGQSAVKVEELVTKQIEDAIAQSEYLYQPDARSFGVKSLTLNGISMVQAQ
LAPHTDVTKAFNDLNLKLIDAQNTLPAGVESTQLNTEFGDTAAVLLAVASPPAGADEIAL
RAKTIREALSKIRAKNASNNREKEKQKVGQRVSMVVALPLSVAGINAEAALQVFSNWMEL
EGYGADFKILHGPGFVGVDFFSDKSDKQLAEARKLFLTQRLSAQTFFPDAWQPIIVRDLA
STRARLSMVAGAKYSYRQLDDFSELVAANIRTLPQVKRVLRSGVLHQQVNLIYSQERLAS
YDLRPDMIAPILNARNNIIPGGTLTVENMDIPIFPSGDFNNYKEIGDVPVALSEDGTPVY
LRGILDVTLGYESPPTLLNYYIYKNKQGNWHRHRSINLSVQMLDGEQIGELGKALDKVLA
RVKVDLPPDLIIERVSDQPRQVKESVGLFIEALIEAIILVVIVAFIGFSDWRSAVLLMIS
IPITLAMTFGFIQFMGVDIQQVSIAALIIALGLLVDDPVVAGDAIKRQMAAGKPSFLAAW
LGPTLLAKAIFFATLTNVVAYLPFLLLTGNQGDFLHSLPVVMACALIASRIVSMTFLPFI
ANIILRPPKVKELSLDLKRKQGLTGHYYRLAGWAIDHRKLVLLTTTVILVCGFALKSQLK
NAFFPDDVQYLSYVDIWLQNDASIDATDSVANKAEQIIRETIAQYQKEIGRDDSILEALS
TTVGGGAPRFWYTINPQQQQPNYGQIIIRLSNKDLTPVLAPKIQQALTENIPGAYLDVRQ
LQTTPVTYPFAIRVSGRVTTGSVQEEQDILLLRQTAEKVKEIVQQSPYARTVRQDWSGES
LTLLLNVMEDRAAMSGVTNADIALASSTGINGTEVATLRQGDKEIPIVARLRLDQRGQLE
DINNLYVFSADSDVRVPLEQVAQTSIRFRTERIHRLEKFRTITVFAFPYAGFISSDIMAD
VKDELDELENTLPSGYQLQVSGDAANAKHGFLQLLMILCVSSSAIFLALVFQFSNLLKPL
VVFATVPLGMVGALLALYVTGQPFGFMAFLGIVSLVGVIVSHIIVLFDFIEIRHAVGDPF
REALLDAGIMRLRPILITISATTFALVPLAVHGGPLWQPLCFAQIGGLILATCGTLLLVP
VLYTIMVVDLKWIRWEERGVKEGDGDIPVTA
>fig|1279017.3.peg.4226 Fusaric acid resistance protein fusE
MKKHRKYILTGGMVFLALFSLVLQFWKYLNNPWTRDGKVQADIIQVTPRVSGQVVELPIR
DNQFVNAGELLFQIDPRIYEAALAEARAQYEEAIDTYNAQRENILAYEARLRESSAAIDL
AQSNINALDAEIMKSRAEFERQQELLPQRATSVRSLQAAQADYESSVEYRAGAEASLAES
LAVLEQSQADLARVRAQLGALGADNPGVRAALAMVRQAELNLEYTTVTAPVSGYVTNLDF
RYGDQAVANQPALSIVDVSTYRIEGYFRETFIRRISPGDKAIVTLMAYPHRPLKGYVESI
GWGIAQDDGTAGNDLLPRVNPTFEWIRLAQRIPVRVHLTERPESVDLRVGFTSSVLILSD
TASAEQDEAAHSP
>fig|1279038.3.peg.162 Drug resistance transporter, Bcr/CflA subfamily
MSSVTAPSLPPTTPQPGLGFLAPLVLFTTVGPVAMQMFLPALPAIQQDFGVTAAEAQMTI
SLALLSFGLSMLVYGPVSDRFGRRRPLQIGMFLYCAGCLLCTIASSLDMLIAGRVLAAIG
GAGGMTLTRAMVRDTYPPSQVAPALSQLMIGQIVPPMLAPVLGGLIAVSFGWRAIFITQT
AVACLALLLVLRLPETLRERHIGASPLTLLTNYGALLRHPRFNAFTLFNAVGIGGYFLCL
AGAPLVLINALHLSPADYGLIFILVPASFMLGNILTSRLARRFAPRVMIPLGAVFSLAGP
VVGLVLVMFLPLTPWSVMIPAGIMTFGHGLSMSSAQAASMAVRPALAGAAAGLGGFLQMA
VGALVTQGFGLIHDGTATPLLAGMAISSLSAVAVYGGCLMLDRRRSPGRAD
>fig|1279038.3.peg.356 Permease of the drug/metabolite transporter (DMT) superfamily
MPALARPSSFLWLALPFCVLWTSAFPAAKLALPDCPPLLLLTMRFLLAGALLMGWAALRG
ERLPGSRRVWGQLAVFALINPTLYLGLSWIGMVKASSALSTILISLNPVVVTLLAALFLR
EQLTGRKMLGLLLGLGGVVLVVQARLSGSGAEDPFSVLLIGLALIALAASTLLWKLWPLT
TPRLMGTALQLLLAGVFFLPVALLTESPAGIHWTPRFLWAMAWIIGPVSIGAYLLWFRML
DTVSASEASAWHFLNPPLGLAMGVVALGETLQTGDLIGIVPIAAGIALVTRSTAAAPAPA
SAR
>fig|1279038.3.peg.372 Permease of the drug/metabolite transporter (DMT) superfamily
MPKPALLSSPPVLLLITGSILGTLAPLSRVAAGAGIPSAVFVFWTCLTAGLLLGAIALLR
GQPLQRQHLRYSLIAGLISLGLPNLLIMVVVVPLGAGMTALTYTLPPLFTLGLAALIGYE
RLTRWRSLGILFGLAGAVTLVFSRFSLNGDSAQMLWMGLALLIPVCLAIGNVYRSRSWPA
GAAPLTLAAGMLLSAALWVLPLGLYQGLLTGLPHWSVIAQGLASTLMYVAFFALQRAAGP
VYLSQIGYVGATMGVLAGVVAFGERPGLPVACGVALIVCGMLCTNRRPAHP
>fig|1279038.3.peg.537 Permease of the drug/metabolite transporter (DMT) superfamily
MRPTQLDTFAMTTMVLLCATWGLTQPTVKMAAAEIGPVLQGGLRCLIAAVLVLLWCRLRG
IRLFDHDGSLKGGLLVGALFAAEFAALFKGLEYTQAARAVLFLYCAPFVVALGGHFKLGE
KLAPVQWLGLTCAFIGLLVGMGDSLSLPGGQELIGDLLALIAGLLWAATTLAIRMTRAGA
VTPAKTLLYQLGTSVVVMIPLGLMMGETWPHFGTLSETAWGVLLFQGIIITFASYLMWFS
LVSRYPVGLLSAFSFLTPLFGMAFGALLLGERLTLPFLSAAVLVGLGIWLVNRRRVKIAG
>fig|1279038.3.peg.673 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MARLARFAEPADLADPRLKRLILTLALPSVAGLLINALYHVVNAAFVGGLGTPAVAAISL
TLPVFSLVAALGEGIGVGVAANVGRLLGEGRSGQAGAIASTGLILATVIGLLVTGALLLA
QGPVITLLGGGGETEPLARIYISILAFTCVLTLIQIVCDFIAIAEGNSRFSMYTLLGSFA
VNIALDPLLIYTLEMGIAGAAWATILAKGVALGAYAVYFARRWGVVQVHTRLIRWRRRVT
GPILAIGMPTTAASILTAVSFAILYHMAGRYGGESAVAAIGIAARVVLLGYFPIIGFCLG
AQAVISYSHGAGDYRRLRDGVRFMLLVTTAFAAVFSAVMLLWPQAVVSLFSDDAGVQAQG
ASALVAFHLFFLLAGLECVLLVLLQSLGKGRLSAVVALAQRGYLLLPLLLALPLVWGMQG
VIAGPAVAAGLAGLIVVPMFLWQMRTLKAQG
>fig|1279038.3.peg.887 Permease of the drug/metabolite transporter (DMT) superfamily
MSRLQAHALLLIAAMIWGSTFVVQKLAVAPDTSGGESIGALAFTGVRFLMGALVVLPLAL
REARAASQSLTRADWLGFLGCGVSLFAGAWLQQVGLGMTTVTNAGFITGLYVPMVPVIAL
LLFRRTPHWAVWPGAAGCAAGIFLLGGGHIDAFNTGDAWVLAGAVFWAIQVTFVGIFASR
SGRPLALAVSQFVIAGVLGSIAAGLLETPRLELFEKAAFELAWAGFLSVGVAFTLQVIGQ
RYTHPATAAILLSSEMAFAALAGAVALGETMGLIQAVGGALILGSIILVEVMPTLQRRPL
KAAE
>fig|1279038.3.peg.899 Permease of the drug/metabolite transporter (DMT) superfamily
MSQVSSPASSSAPTASVSDSRNLGLYAGVVAIWGTSWIALKLQVGSGVEVLPSVAYRFGL
AAAVLFGWCLLRGLPLRFSRAQHLRMAAQGALMFTFNYIFFYYAALYLTSGLLAVASSTV
ILLNLILGLLFLGQRLEPRLVLGICLGLIGVGAVFWPEISHFSLSDAGTRGLLLSLGGTV
CVALSMTLSARNQKAGLPVLQTNAFAMTYGAILTVALAIISGTPFSFAPTVAYVGGLLYL
ALVASILAFGAYLTLAGRIGPTRASYASVLYPIIALALSTVFEGYHWAPSAILGLGLVLI
GNILVLYRKTPAR
>fig|1279038.3.peg.1025 Permease of the drug/metabolite transporter (DMT) superfamily
MPLPHIALAVLVTALWGINFVVIKIGLHDFPPLMLCALRFLFAALPAVFFLRRPDVPWKW
IVALGATLGVVKFGLLFVSMKVGVSAGLASLVLQTQAFFTILLAVLLLGERLTLMRVLAA
AIAFSGIGVLVSGADTAELPLTGLALAICAAVAWGFANLIQKRCAGSKPLNLMVWASLIP
PVPLMLLSFGLEAGPAQAWQTVQAASLAGWGAVVFLAAIATLLGFAIWGWLMGHHPAAQV
APFTLMVPVWGMGSAALLLGESLTPAKLLAAALILSGLILNTFGDRLLQRLRPQTP
>fig|1279038.3.peg.2077 Membrane fusion component of tripartite multidrug resistance system
MAKRVLRVLVLTGVLTGLVGGAAWFWKSRQGHEHTDNAYVHGDLTVISPKISGHVVDLAV
EDNQPVRAGQVLLRIDARDFQVKVDEAAAALQGAEAAILGIDRRIDAQKTVIEEAEAGIR
TWQAELDLAQRELGRTASLVKEEAASRQRLDSNQAALSKARAGLDQARAKVESSRAQSAV
LEADRVRQQAAVAEARAKLDAATINLANTEVTSPVDGVVGNRAVQLGQFITAGSHLLSVV
PLDTVWIEANFKETQIGAMRPGQPVTVTVDAYPDLRLTGAVASFSPASGAQFSLLPPENA
TGNFTKVVQRIPVRISLSADNPLRGQLRPGLSVVVDVQTGAGGTGSANAAER
>fig|1279038.3.peg.2527 Acriflavin resistance protein
MNVSELCIRRPVMTLLLSIAVVVLGLFAYKKLPVAALPSVDFPVINVSASLPGASPETMA
ASVATVLEREFSTIAGVESITSSSNLGSTSISIQFVLDRNIDSAAADVQAAINRTLRRLP
SEMTTPPSYRKVNPADAAIVLLALSSPTMPLSQLNDFAETVVQPRIATLSGVAQVLVYGS
QKYAVRVQVEPNALALRGIGLDDVQKALASANSNTPVGSLSGARQQMILTSNPQLPDADA
FRNLIIAWRGNAPVRLGDVATVLDSVENARTASWYNGTRAIVLAVQRQPEANTVEVVDLV
RQQLPAFRAQLPPSVSIDLMNDRSTSIREAVEDVEFTLILTIVLVVMVIFLFLRRAAATL
IPTLAVPISLVATAGAMYLLGFSVDNISLLALTLSVGLVVDDAIVMLENIVRYIEEGLKP
FDAAIKGAREIGFTILSITLSLVAVFIPILLMGGVVGKVFHEFAVVVTIAIMVSAVVSLT
LTPMLCSRFLTREKHGEEEGPVGRALEAGFDALLRGYKRGLLWSLDHMAVMGLLMIATVI
GTVVLFREVPKGFFPTEDIGQLSVSVEAAPDISFDAMVEKQKLVAATVQAHPAVAGATSA
IGGGASSVISSGRMFVTLKPRSERPGIEKVIQDLRKEVGKIPGIAVYLNPVQNLRIGARS
SKNTYQYTLQGLDLHDLYDWSDKLQDAMRRIPQLQDVASDLERNNPQVYIDINREKAASL
GVNVDQVRSTLYSAFGQREAATIYTPSNDYAVLIELDPRYQQDESALSLVYVRSSTGSLV
SLDSFAAVRRTVGPLSVNHQGQMPAVTLSFNLAPGVSLGDAVDLIHEAERALAMPVTITT
SFAGTAQVFQQTLSNQGVLLAAAVLVIYVVLGILYESFIHPITILSGLPSASLGALATLI
LFKEDLSVIAIIGLLMLIGIVKKNAIMMIDFAVAARREQNLSPREAIEQACLLRFRPIMM
TTMTALMGTLPIAIAFGAAAELRRPLGLAVVGGLVVSQTLTLFITPVLYLYFERLSQWLQ
GLGRRPDSSDAPQAAE
>fig|1279038.3.peg.2889 Permease of the drug/metabolite transporter (DMT) superfamily
MRDAFYYAFCVLAWGSTYFAVTFLKGPVPPSLSVIYRLVIVAVVFALLHPLLRRRLTGLS
ARTHLWLVLFGLGNFGLSYAMMYAAVTMIPSAHAITLFAIKVVMTPVLLGLFLRERIPRA
IWVGGVIGIAGVVLMFWPQLAGGDLRGDAWMGFLLTLGGAAITSFGDVASTRLIRAGGDP
MTLTFWGTTYGVLFLIVVALVQGQALVWDPSLHFALAMGWLVVACSIVAWLMYMHLVKTI
GPARCSNMVTLFPVVGVALSLAFEGVAPTVNVLGGAALVTAGAFLANRGKLAA
>fig|1279038.3.peg.2916 Multidrug resistance protein A
MTDSSAAAAVLPARSGGVDRLRLALFAALPVALAAGAYAYASGGAVMSTDNAYVQADMVA
VSTDVSGLVKSVDVQENQPVTAGQVLFRLDDLPFRLTLQRAETKVQTVRNDLLADQAGYR
DLQAQIQRAQADIAYYANELERKRQLVNSNTTPRSAFDDARHDAQTAQLKLASLTQQAAA
MAARLDGRPADDVETYPAYRDAVAARDEAQRQLDHTVVRAPMDGVVTRVPSLQAGQALPA
ATPAFSLVATDHVWIDAQPKETELTWVHAGQPVTVTVDTYPGAVWHGTVDSISPASGASL
SLLPAQNSSGNWVKVVQRIPVRVRIDTPEGLPPLRVGMSATVDVQTGHVRGLPLVGDHG
>fig|1279038.3.peg.2917 Multidrug resistance protein B
MADGPVPAAGFQPVPHRGMITACVTLAVIMQALDTTIANVALPYIQGAVAASADQINWVL
TSYIVAAAIMTPPSAFLARRFGRKRVLMGSVSGFIIASVLCGIAQSLPEIVGFRLLQGLC
GAALVPLSQSILLDLYSAEERGKAMALFGVSVMVGPVLGPVIGGWLTENTSWRWVFYINV
PIGVLAVLGLSAFVKETARDTAARLDWVGFGLLSLTIGALQMFLDRGQQLDWFSSVEIQA
EALLAAVAAYLFIVHTATARRSFVDPSLFRDRNFVVGLIFIFTIGITYLASLALMTPYLE
SLMGYPVVTAGLVMGPRGLGTMVFMFLVGRLIGRVDTRLLLATGMAMTAWAMYDMSGWTP
DVAASTIVWVGFVQGAGLGFLFVPMSAVTFATLPLQKRAEGTGLYNLSRNIGSAVGISVM
AALLTGNTQINHAEIAAHLTPFNRILEQPVFAHVYNPATAAGQAALDGLVTHQAVIIAYA
DDFLLLMVLSLITIPLVLLLRSPKQAAGTKPEPVVAD
>fig|1279038.3.peg.2963 Permease of the drug/metabolite transporter (DMT) superfamily
MPETAAMPALPLTSSPLRTGLLLGTLGVILFSLTLPVTRLSILLSGLSPLAVTLIRLDVA
SVLAALFLLLARARLPARALLPDLMAVAGGAVIGFPLFMAYAVTLIPPEQSPASHAIVVN
GLLPFATAVAATLLCGDRPSPGFWLVALAGSGCVVGYALTLGGGAFSVGDVAMAAAVLSA
ATGYACGSRLSRHLPSWQVICWAVLLCAPLALPLTIALPWIDGPIPAAAWSLPSLASLLY
LGAISQLIGFFAWYRGLSLGGTARVSQVQLLQPFLSLLGAAVLLNEVLTPLTLIMTVVVA
TLVMIGKRMPVKVG
>fig|1279038.3.peg.3172 Quaternary ammonium compound-resistance protein SugE
MSIHWIILLIAVFTEIAWALSLKAAQTNPGVLTIGASIALTATNMLLLSFAMRGIPVGTA
YAVWTGLGAVGVVAAGIILHADPLTLKRVAFMAVIIFGVIGLKLVGDEG
>fig|1279038.3.peg.3443 Permease of the drug/metabolite transporter (DMT) superfamily
MSVRDTLLALFVMILWGANYVAVKLGVSEFPPLLLITLRFALVAVLLVPFYRITRRQVPG
VLLLSFSFGSAHFALLFVALQMTEAGTSALLLQLGVPFSTLLGVVFLGDRLGIWRISGLL
VAFSGAAVLAWGPHVPAFAPAALLIVSAFFWAVSNLLVKKVTDVSPIALTGWMSLFAVPQ
CLLWTLLFEHGQIEAIQQASLVGWGAMVYTAVGSSIIAYGLWYWLLGRYTVSQVVPISLL
NPVFGVIVGAWVLGEAVGPEKIAGGLLTLGGVGIILWRQAKRGGA
>fig|1279038.3.peg.3556 Permease of the drug/metabolite transporter (DMT) superfamily
MSGGAATPPGRSLTKYLMLLAISLFWGLNWPAVKTILSQVPPLTLRAVGFSLGAVIILSL
TRLTGRSLSIPRRDWPSLAAAGVCNVLVFNLCTAFAQLGMATSRAAVIAFTMPVWATLLA
IPVLKEWPRRQQIAGLVCGMAGLAVLLGPNGLQQGFGPGLMLIAAVSWAIGTIVMKRHVW
GGAVMAVTGWQYVISAVPMVILAALLETPPDPSGFPPQVWLAISWHLLLSLCAAQVLWFV
VVSRVSVGQAAVSTLLIPVVGVTGSVVLLGDTLTPALVIALGLILTGVACVLLPAKKR
>fig|1279038.3.peg.3702 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MAIALDGAVTVASESSGQGPFLSVVVPVYNEGEALHALHSRLTAVLRQMPVSRWEIVLVD
DGSRDTSFEVIRDLAAADPAVRGLRFARNFGKEAGMAAGLRAAAGDVVVLMDGDLQHPPE
LLPEMLQRWTDGAQMVTAVRRSRQTDPTTRRLASRMFYWLFHYVSEVEIPEGAGDFRLFD
RAVVDAINSLPERNRFMKGITSWVGFRQVLIDFEPAERVGGQSAWPFLRLFRYALDGISA
FSMVPLRVWSIAGVTIALLSVIYGGWLVVRTLIWGIDVPGYASLMVAGLFTSGIQLISLG
ALGEYIGRIFNEVKGRPLYIVADRVGQDPRSDAKTETRS
>fig|1279038.3.peg.3744 Permeases of the drug/metabolite transporter (DMT) superfamily
MSAAQTPPSSQAAGLLTSPWVMMVIPPLLWAGNAVVGRLAMAQMSPYALSFWRWSFALLL
LLPFTLRSTLAHWGVIRANALHLISLGVLSVGAYNTLLYMALQTSTAVNVTLVGAVMPLV
ILLLSRILLGEALTVWRVAGLAASFFGVAVVLARGDLSRLTALDLHRGDGLMLLAVLAWS
VFSVRMKARPLGLPPMVFLTVQMLTGLWVAVGAYLWDLGTGGGQVPMTLEALSMIAYTAI
FASLVAFLAWNRGIVRLGANLSGFYVNLIPVFTAVLAVPVLGEPLQAYHFIGMGLIFAGI
GLAAVRGKQQKAEGR
>fig|1298593.3.peg.419 Acriflavin resistance protein
MNLFGYIHRYKRLILALTAMFMLLGIASWLTMARQEDPSFPYRTGTIRVVFPGVSAEQIE
KLITEPLDEQLAEVEELRRVKSTSRDNVAIFVVELLDRIYDTDAAWDRVRRAMEKAEQDF
PKGVVEYVLEDRRMDIPAAVISIVGTADILELAHQAEILKRQLLAVNGVSRIEIEGDPEK
ELRIDLDSAILSQLSINRDQVVAAIQVHNQIIPGGVVRIGDHALRVDTGSDLQQKSDVES
IPIRLATGQYIPLSAIAHIAFVAREPSAAQTYHNGMRSVSLGIYAKRGQVDAIVFGEQIR
QRIDAVRADYQPLDIVETFFQPDYVADRLEGLQFNLLGSILIIAITVIAALGWRNGLLVA
GVLPVVAIIVLALYNLGGGVLHQIAVIGIVISLGILVDNAIVVVESIVQELQAGRSRLEA
VESAFEQMAFPLFTSTGTTVAAFIPLLLSKGGTGDFTRGIPVMIILSLLVSYVISVLVLP
LVAERLVGIPKHDNQRWIKKISDKLIYISRYKAKLALLLVVGVMALTIMAFPLLKLQFFP
QADRNQVVIDMTLPGDSSLERMAEVSADVEQKLLARDDVVGVMRSVGMSGFRFYYNLLAT
IDSTNSARLMVNTRDMAANQAVIDWITHDIQTALPEATIIAKRLGQGPPTPAPVELRLQS
DDPSSLYQAADQVLAILNALPETTMIRSDKDSGLAELSVNIDKTIAQELGVRRDQVAASL
FGQTRGLDAGEFLYSDDPITMRVRSAAGDLTTTAELSGQYIYNAAGQSVPLDAVATLKSQ
WTSAVIRHYKGIPTVTIHSELMPGAAYNTVLKKVFAALDENPLPGAVTLQLGGDAEGSAD
ANRAILKSVPIGVMLLLLFMLVQFNSFRRLTIILATIPLAAVGIIPGLVLSDQPFGFQSL
LGVIALIGIVVNNAIVLLDVVDARLREGADIDSAVAQSIDARTAPILLTTATTVLGLLPL
AFSASTLWPPMAWAIISGLLMSTLLTLIVIPVLCRMMLKTNPVAM
>fig|1298593.3.peg.796 Drug resistance transporter Bcr/CflA subfamily
MYLPAMAQMAGSLDSDIHHVELSVSTFLLGFAIGQITGGPLSDRYGRKPIIIAGLTIFAI
ASLTLSMTTSLSGLLILRAIEAIGGGLATVNSTAIVRDRFEGKDIAKVLSMVAMIMMTAP
LVAPMLGSLIVSFSNWRSIFMLLSVYSAFVMILLVWLLPESHPPHRRSRAKPWVGYGVVL
RHKVARRFILTLACAYSGMFIFITASPYLYLDYFEQSAAQFPWLFGANVVVIMMVNRINM
LLLNRFKPIDLITTGISIQVVMGCILLTLSRYFPDAFTLWTVLPLMMAYVGALGLISANS
MATVLQYFRDVAGSATALIGVVQFCGGAAFGLLWGQLHDNTPVPMMAMMFLSAFCAFVAL
MAARYSREIYEAPAT
>fig|1298593.3.peg.993 Acriflavine resistance protein A (AcrA)
MSGIILKRFFEEGASVNAGEKLYQIEPTLYEAELASAEAQLAVAEANAYSAHLRAERYKK
LSKNSAVSEQELDDSEATAKQTEAQVKAAQAAVRSARINLSYTEITAPISGVIGRSTITE
GALVSAQQSTALTIIRQLSPIYVDIQRPASSVLLMRNPALPREVTLSLEDGTSVEKTGEL
QFSDANVDPGTGTVNVRALFENADHLLLPGMFVRANVPSSLIENALLVPQQAVMRQAGGA
TTTYVVNSDNVVEVRGVEVTRAIGDKWLVKSGLKTDDRVVISGLQKIKPGVTVTPEETK
>fig|1298593.3.peg.1495 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTFKAQEVKAIIRLTLPILATQLAQIGMGTIDTIMSGYVSTRDLAGVAIGTAIWMPIWML
LAGILVALSPMTAQMNAARQRDAMPRLLAAAIYLGLVAGALAGIVVAAIAYSLPSIIEDT
ATAIIARDYLYFIALGMPPSGIYLAYRFYAEAVNHAVFPMRIMLVALLMNIPLNYIFVYG
ALGMPEMGGPGCGVGSLLVILFLMVANAWDTRQRRITKEFPLWEHVRHPNMEYVKDLFRI
GMPIGIAIFFEVSLFTVIALLITDLGPTVVAGHQVALNISSLTFMIPLSAGMALTVRVGH
HLGSKDIIAARTTAWLGVKLNFGLALFNATIIVLGASYIAGLYSPDPLVVAVASSLMIYA
AIFQISDAAQIAAAGALRGYRDTVAVMIITFVAYWLIGLTSGYWLAYGESTQLGAKGFWM
GLVIGLSCAAIALCWRLYLISQRPEVISTEEKALNN
>fig|1298593.3.peg.2274 Permease of the drug/metabolite transporter (DMT) superfamily
MLNIAIFTSLLFIAIGRLPGGIAATLVATLPLQVIMIRAIFGIRPEMHHVFAAIGGVVGV
ACLVWQSTESLDSWGVVAALSASFIMACGILLTARWIKDIPPLQFTSAQLFISGVVLLLY
VILSGREVPDITPSGMLALAWLGPIGMGMGYWLWFRAMKAIPIQRLSFLGLVNPVVAVLV
GVFFMSEEISTGQLFGMCLVLLCVVVGQRK
>fig|1298593.3.peg.2315 Permease of the drug/metabolite transporter (DMT) superfamily
MFSKEALAEFPPLLFIGTRFLLAGLLLTIPGFKPLTRLTKKQWKASAGVGVLFGAAMSFW
IIGLFSAKHLGEGSFITSLSVVLVPLVSWLLFRDSISRSNWIALPLAFTGLGLLSLQHGF
QPEPSQLFFFISALLLSLTFILNGRAASHVPALALSAIQLSIVGIVALSLSAATETWPDH
WTGNMWWWLGLSITVGTAARFFIQTYAQGMSSPSHAAVIMIIEPVWTSLFAAAWFGERME
PSQLFGCSLIFTALVVNRWNAVRKWLKRS
>fig|1298593.3.peg.3261 Acriflavin resistance protein
MKSSISWFANNPVAANLCMICILVLGFLSIPETRKELLPNVSLERISIQSKLPGASVETV
ESSICRPIENRIYDIQGTIDLTSYAYEGICSITLDVDEGFVTKEIVDEVKSRLEAKDLLP
KEATTPDVVELTVRNRVAKLILSGPVSYSVLTASARQLRTDLLEFSAVSIVELEDMKKSE
IRISIPAFNLQKYQISFDEISAMIQKQSGFLPGGMLQTSEGDVLITSDAYRDSSESYANI
VIAADPDGGEVRLGDIADIIDNRFSNQPQASFDRQPAVSIDVFRVGNQNITDISDVIHNH
LADSNLPQNVKVYVWQDESKNFQSRVDLLVSNAFSGLVLLFIVLLLFLSARLSFWVSLGI
PIAFLGTIFILPVFDVSINIVSLFAFILVLGIVVDDAVVVGESIHLQNQKGLYGTEGALQ
GVFEVYKPIFFAVATTVVAFLPLVSLPGPEGKLMRAIPIVVIGTLIFSLIESLYILPAHL
SGTHKNEKPGNKVLTAIQNVFSVFLDTLIKWVYTPVLTVCLRNKGLVVLTFTVVFALFMV
LLSQGWIKTALFAAIEGDVVVANVAFPEGSPREKTEKALRHLIAAADQVQAEYEAKDASA
IEHIYSVVAPKNTFTSYSVDKSMDHKGQVIIELPSSETRTYSGQDVLARWRELAGDIQDT
TSLQYSASLNPTNPDIQIEFSGYDIDDLMSAANQLAEKLREYDGTFDIHTSQEEEKQEAE
IKLKDNAVALGLTLESVIRQINRAFQGNVVQRIQTQDDEVEVWVGLPKNERSSPWYLENM
HIEYAPGQYVSLSTIAAIEYRPSKTHIKRYDRKRVISVSAFVNPAQNSVKNIQTDLATNY
LDGLVKNMPGIKWDVGGYQRAVTLFLDILMKYYLFAILAMYLMMAVLFSSYSQPLLVLYA
IPFGLLGSVTGHILLDLDLTLWSFVGMVAVSGVVVNDNLVLIDYINTQRAKGENVFVSVC
EAGRVRFRPIMLTSLTTFVGLAPLISETSVQAQFLIPMAVSLAFGVVFATLISLLLVPAT
YLMMVEWQTTLLRLFKQTPKGSSEDPVEAAYQRGFEQGTRNARKAVCPYKDDVLSSSWEA
GLNDARNL
>fig|1298593.3.peg.3287 Permease of the drug/metabolite transporter (DMT) superfamily
MFDRPRSSVQYMLLSALGFALMAACVKGAANSGIPVLEIVAARAIVSILLSYLDIKRKRL
SVWGNNKPLLVARGSIGALALICVFYAVSTLPLAQATVLQYTYPAFTALIALWFLRESVQ
FSTMICIGMSIAGVIVMMQPNFHEGVLASTSMLSITAALVGALGSAVAYVMVRHLSQTED
SSVIIFYFPLVAFPIASAALLSADIFVSPNIEQLGLLLLVGIFTQVGQIGLTKAMAMAKA
GKVAAYAYVQVIFSVILGWLFFTEIPSFWAAVGGLIIMSGALINTFYKR
>fig|13035.3.peg.1380 Acriflavin resistance protein
MVSSSTPEQDRPLNIVGRITAYFVNSQVTLLIIVALVIFGLAAALFTPKEENPQITVPGA
DIYFHYPGAPAEVVEETVTVPIEAKIRELPGIDDIYSTSQTGQARITAQFFVGEDWENSL
FRLQNHLFNSQDELPQGVNYQVNPLIVDDVPIVTLTITGENYSDNQLRRVGERLLRELRQ
IPDTGNLTISGGQPRVMRVDLNPEQLAAFQLSPAAIAQQIQAANIQVQAGDVSVGNRRIF
IEGGNLLETADELKAVVVGQGENGSPIYLEDVATVSDGYDDRVTYSRLLNRKDWDVTAPY
PDPSLQPEEDFEERPAITIGIAKKKGTNAVVVAQQIFDRVDELRDEIPNDITIAVSRNAG
RTAARAVGDLYSSLFQAIAIVVILLIAFLGWRDALIVALAIPLTLAGTLLVGWIAGQTIN
RITLFALILSLGILVDDAIAVTENIHRRFEEMPDQSFSQKVRTATLAVAELGVPILLSTI
TVILAFIPMAFVTGMMGPYMGPIPFNVPVAMIISTSLAVIVTPYLAVRVIKVKGRSTDNN
ESNDGQASEEVPNRIYTFYRRIMEPLLDSATRRRFLIFFVVGLLLASFALPLTQAVKFRM
LPKADEERFLVQVDAPLGTELVETDRIVREMETVLKEDSEVIQFESYVGTAAPIDFNGLL
RGNTHRSGEHLADIRVHLTNDDARSVSSEDIVFRLRPQLTEIAQENNAIVKLIEDPPGPP
VRSTMLAEIYGPDYERQRELSKQVADVFRNTAEVVDVDDSVKNQIPQMKLEVDRAKANQA
GLSTQEIAETINMAIRGVDASTLQVPGELTPVQIQVRFAEANRQSIDDLRRIQMPTPEGN
LVPLTELVTFTSTTVDQPIFHRNQVPVTYVFGEMNARSSVYAVMEQMIHFFRNPLPEGYS
IKWEGEWQLTLEVFRDLGLAMLVAVILIYIILVGQFRSFKIPLIMLGAIPLALIGILVGF
SLNGVYFSATGMIGVIALAGIVVRNAIVLLEFVGDRRKEGIELKEAVIEAGAVRFRPILL
TSVTTMLGTLTILSDPVWSGLAWTLLTGMLTSSALTLFIIPLMYYGDQRSSRKQEQTPVN
EKQLVADN
>fig|13035.3.peg.3896 Permease of the drug/metabolite transporter (DMT) superfamily
MQNLIYSNFSLAALFVLLWNSGFIGAEYGLPYTGTFTLLFWRYGALTLVLFAYLLLTKQL
ARQPLKTILHTSLVGVLAHGVWLSCALLALEQNVPAGIVALVVALQPLATGAFSGLVVGE
QASRWQWLGLITGFLGVAIAVGTRIQVNDEASFFGYFIPFGSVIAITIASLLQRRRETSS
QNYPRLSVAETLFYQSFATVLILTLPAVSIEKLEIQWNLALIATLSWLILGVSLASYGLM
WKLLSRLDATRVASLFYLGPPVTMAMAWVAFGDTPQLADIIGLLVVTAGVMFVQFPQLRP
R
>fig|1303518.3.peg.248 Permease of the drug/metabolite transporter (DMT) superfamily
MAFGPFTLTFVRFAPAGLILLLLARLRRRLPPIAREDLWLFLALGGIGIAATYGIFYFGL
QRTTATDASLLFACEPILIALFGYLFLKERLSWLQWTGFLVGITGIWLIAGRALGDWLAL
AGLACECCVSVPAKRLAMRYPGLLVVAYEMLIGAALMLPLALWEWHHHPHEVSLRPLAAL
AFLSLVCSVFCYGIWYRLLSRHAISQMGVFILLQPLLGPLYGHFLRGETLRTNTLIGALL
VFCGIALTIYRKRSSTDSLRG
>fig|1303518.3.peg.320 Membrane fusion component of tripartite multidrug resistance system
MSDENRDSRVLLEPEQKVETPSTVSDGLGAEEGEAPKRKATIKVVGLVLLFFALIIGGIV
GYSYWRYASTHVSTDDAYLTTDVVQITPQVSGSVAKVYVTDNQHVQAGQLLVMLDDSTYR
AAVEQAKANLKAAIAAAQGASTGVGLTQQTTLAQITQAEAGVTQAQTGVETASADVSRAE
AAYAAAQTGVQTALQTAKTAQAGVVAAEAAYRKALQGVQAAKQRLADAEATLQSAKANVV
AAQAKAKQAATDAKRYDQLYQEDAVSAQTRDAADTAAIAAQAALESAQQAVSQAQALVGE
QQAALNSAQQEVTTAQANLQQARAQYAAALYGIKVAKDSAKQAQAQYLAAQKGVNAARAR
VQQAEAQLQQAETAPAQVAVQKSNAHTAAARIAQAAAALHEAEIHLQDTRIYAPVTGRVN
AKTVEIGEQVAPGQALMAVVPDDDIWVVANFKETQITNMRPGQPAEIHVDAFPGITYHGH
VDSLASGTGAVFTLLPPDNATGNFTKVVQRVPVKIVFDPKQPGLDKLRAGLSVEVSVKVK
>fig|1303518.3.peg.331 Inner membrane component of tripartite multidrug resistance system
MTASNLAAKNGRRVVLTDTGEELSPYRWIILVGLITTAILEVLDTTIVNVSLPQMAGNVG
ATTEEISWVATGYILSNVIVLPLTAWLASRFGRKRYLVSSIILFISASFMCGTSRTLGEI
VLWRIVQGAGGAAFISTVQATIREIFPREQQGTVQAIYVMGVIIAPTLGPTIGGWITDNY
TWPWIFFVNVPIGIVAALIIGLFLTEAKHKMQIEKVDWLGISLLAVGLGSLQYVLEEGNR
NNWFDDPVITRLTILSAIALIAMVIWELSPRNTSPVVNFRVTRNRDLSAALILFLILGFG
LYGGVFLYPLFAQNVLGFTATLTGLVLMPGGIATGIAAMFCGRMLNGKVMRADPRIFIWT
GLTLFIYSMWSLAHLTPQSGEPAVRLALIIRGLGLGLLFTPINLVAFNSLKGVEIAQGAS
LLNLCRQLGGSFGIAILSTYLDNMERFHATMLSTHLYPENPYFQSRLTMLQHYLMTRGHD
AVQAHKMALALISYTVQSQAATMAFNNAFLLIGISTLCVSPLVLIMRVRRKPSTNAAAEA
MH
>fig|1303518.3.peg.776 Vancomycin B-type resistance protein VanW
MSRSDRHLLQRISAWRQEKGLLRLFVLLPLPLLAIGSSLLLLYSHHLHSEDVIASGVHLF
TLDLSGKTPEAARGEILQWAQDRAATLLTLHAQGIANHSSVSIRARTLGLGIDVDSTLQT
AEDAGRTGWLSKIVSLIRSSKPDYPIAPTVTVDQKQLHEALTHVAHLTQVPPINARIVLL
PKGGFGLKHEVSGRAIDVDAAASIVTRAWQQFNTPPAPSTDTTDRDGAATTGNLEDRLEL
NLPTQVIQPRITYNILHTIDSKLSSYSTWYAEGKRGHNIEVATEKIDGTLLLPGQIFSFN
NTVGPRVLASGFEVAPVIIHGQLQPGVGGGICQVSGTLYNAALKAGLKTVLRNHHSFPVS
DGGIPTGRDATVAYGELDMRFQNSLPYPVYIVGRAHGGLLTFDIFGHADPDRTVQLVRGR
LHEGDVPVEIIHDPNLPPGRRVVEQKGRPDVRTVWYQIVRVNGKVVSRDVIPSHYEGQPE
IVRIGVKASPAARQPKAHPPTVQPAQPPAPG
>fig|1303518.3.peg.1132 Permeases of the drug/metabolite transporter (DMT) superfamily
MSPLKWKAAFITFIAVFAISFGEAMLSRGMKQIGDGTLWHQVGAVLHNHWVIIGTTFMAA
YFFLYMWALKIAPFSFVLPITALSYPLGGLLATTFLKEHVGPLKWLGYVAIVIGVILVGL
GEASGK
>fig|1303518.3.peg.2341 Vancomycin B-type resistance protein VanW
MRWTEALGLGLFALASGYGFLQIAATSPPREVRIAGYVSSLRGRSPSQRRNARLAAWAVN
GAVVPPGGLFSFDKRVGSWSADHGYVQAPVSYDGELVNAVGGGVCQTSSTLYNAALLAGM
QIVERHPHHFCPEYVPPGRDAAVAQTIIDLRFKNPYPWPVRIECRATQDTLEASFWAPKQ
PTLQAHVETQILSTTQPQRKTMILSNNSRGHGLHARLLSIGVPGYRVITYRTFTRPDGTI
VRRERISDSTYAAADRIIGIYQTSLR
>fig|1316932.3.peg.466 Permease of the drug/metabolite transporter (DMT) superfamily
MFKKYFGEIILFLVTFIAAAGWFFSKHALVGLPPIGFMGGRFILASLILLPFSYRELYRL
DKVQVKYSVITGLTYGIYTIFWVLGLAFSTVFGEGAFLVSLAMLIAPLLSWLIFKHTPPK
IFWLALPIALSGLYFLSAEKGIFHFSLGSTIFLVSSVFGALYFVLNNQYAKQVSLFPLIT
IQLAIVGAVCSLYSYFMESWHFPILTEVWLWFAASVLIATNLRFLMQTLGQKYCHIGTSA
LIMLLEPVWTLLLSVMLLGEQLSATKWLGCSLILIALIIYRLPILRLKK
>fig|1316932.3.peg.670 Permease of the drug/metabolite transporter (DMT) superfamily
MLYLLIATLIWASSFIVGKVAISAFDPVQIMQIRLTLAAFIALPFFIPAYKKIQKNQHIK
VWLISFLTFPLYVILQFSGLKLTSAASAVALLGLNPLLTVLVGYFCFKKQATRLDFILSL
FACLGILIMASGSDDSGSINVLGLLLVTLGSLSFIVGMYLSKEILQSVKVIDLTKIMLVQ
GAITALPITLLFAENWQLPTSLSAWASVAYLGIICTSLAILLWNKGISQSSPILAGILLA
LEPVFGLLMALVFLSEQLSLVTWVGIIIVICTALLSVLLPMMKRYKRLI
>fig|1316932.3.peg.2559 Permease of the drug/metabolite transporter (DMT) superfamily
MISSSLKLGYFSLIVATLFWGGNFVLGKVLSGAVQPITLTYLRWLPAFLILVLLFFRPTW
RVMHLLKPRLGVMWVLGLLGVILFPATLYEGLKTTTALNASLYLAISPVLVLFLNRLVFK
EKISPIILSGAIISLLGVLWLLMQGKLTRLFSLAINQGDLWAIASTISWAVYCCVIRLRP
QGISNTVFLTVLVGLAVLTLTPFFIYEYVAESAKNLANLTALQWSGIGYLVIGPSILSYA
FWNFGIAIVGSAKGAVMTNFTPLFAAMFSIILLNESVHTYHIISAILITAGILICSYKKH
>fig|134676.3.peg.429 Multiple antibiotic resistance protein marR
MTERVMTTERTAASLAKTLREAIIRFSRRVRQARPVGDLTFSQLSALTSLQLHGALTPRE
LADVERVQPPTMTKIVGKLEDRGLVARTPHPTDGRQVILAATDEGRAVYTQNEDIRNEWL
AGQLDRLTPEERDTLARAAEIMLRVARG
>fig|134676.3.peg.479 Multidrug resistance protein mdtL
MTTATARQPAPTVVPARLSRPAAFTAIAAILVTFAAASAVPSPLYVVYQHLWGFSPAMLT
VVFAVYVVALIATLLTLGALSDYIGRRPVLAGAILLEAVALTLFLTAGDVGTLLAARVVQ
GVATGAALSTLGATLIDLNPAHAPGRAGLISGIAPVAGLGIGAFGCGVLVKFAPFPTHLV
YALLLAGMVVAALAVAWMPETSGRRPGAAASLIPRLGVPARLRGDLFALIPIIVASWALG
GLYLSLGPSVASDSFGIHDHLAGGLVVALVCGTGAVTSFLLRQVATPRVLTIAGSGLLLG
GALGFAGLETGSLPLAVIGSIISGAGFGAAALASFSTLARIAEPHERGELLAVALTISYA
ALSIPAVIAGQTATHIGLHITALWYAAIVAALALLALVAQRLRSRSRA
>fig|134676.3.peg.506 Antibiotic transport system permease protein
MTGLGGLLRLILRRDRVILPLWVLLLGLLPRVYLTGFEKLFATDADRLNYAHLSAANAGF
VALYGPLSGDSMGELVVWRAGFLPVMIGLAALLTVIRHTRAEEEAGRSELIRATVVGRWA
PFAAALLVTLTGCLIVGVLVTVTMIGGGLPVAGSAAFGAVFTLSGWLFAGVAAIAAQLTS
GARGARTIAVLALGVSYVLRLGGDISAQGDGRLGRLSWLSPIGWVQRIFPYGADDPWPGL
LALLGTGATVAVGARLLARRDLGSGLIADRLGPAHADRALGSPFGLAWRLHRGRCSAGPP
ASARSGWSSAGWAPAWCSCPGRAAGSATCSAGSAAAGRSPTRTSPPPPGSAGWSSRCTRC
RPPCGCATRSRPATRS
>fig|134676.3.peg.507 Antibiotic transport system permease protein
MRDEEQTGHAELILGTRASRVGWAAGHLLFVLLGPVVALAVEGLLAGLAFGEPGRVPAAS
LAQAPAVWVLGAIAVLLVGALPRHSAAAWGSVAICLLVLLVGGLLGMPQWVLDISPFTHV
PQLPAAGFTVVPEIVLILIAALLSGAGLTALRRRDIPA
>fig|134676.3.peg.1586 EmrB/QacA subfamily drug resistance transporter
MVLSLAQLMVVLDATIVNIALPTAQASLHFSNADRQWVVTGYALAFGSLLLLGGRLSDFF
GRKRMFLIGLIGFASASALGGAANGLEMLIVARALQGAFGAALAPAALSLLSTTFTEPAE
RGKAFGIFGAISGAGGGIGLLLGGVLTEYVSWRWCLYVNLVIAALAVAGAMLKLKDEPSG
AHGRIDVPGTIAAVVGLVGLVYGLGKAETDGWTARGTLGPIIVGVVALILFVLIERRVEH
PLLPLRVVLDRNRGGSYASIAIAGAGMFGIFLFLTYYLAVVLHFTPVKTGLAFLPMLGSV
MLTATTAGSILAPKVGPRPLVPLGALVAAGGLLLLTRLDLDSTYASGVLPGLIVIGLGLG
LVFAPTQNAATSGVEHRDAGVASAMINTVQQIGGSIGTALLSSFAATAATDYAKGKQPSQ
LLQLQAQIESYHTVFWWSAGFFVLAAVVALVLFRTGPLDVDPDAPPAMAH
>fig|134676.3.peg.1690 Glyoxalase/bleomycin resistance protein/dioxygenase
MPIRTITVPVKDLDAARALYTRLLGVEPYADAPYYVGFRPDGGPELGLDPHGDVAAGPIV
YWHVDDINAELTALIAGGGTEERPVHDVGGGTLIATFRDADGNLFGLHQGAAS
>fig|134676.3.peg.1962 Multiple antibiotic resistance protein marR
MRLPRLIFLLFNADRAVRRWIDARSADTGIGASGAGVLFYLAGHENALIGDVTAALGASP
SGMSGLVNRLERSGCVSRSPDPADARAVRLTLTPRGRESVTRARDLVDDLNQQLTAGFDE
AEVAVIERWLEHVSRRDFR
>fig|134676.3.peg.2114 Multidrug resistance transporter, Bcr/CflA family
MSITQAPPTARHRARLALILGALSAFGALTIDMYLPAMPGMADELDAGATLVQLTLTVFV
VGLAVGQVIVGPLSDAWGRRRPLLAGMALYVTGSLWCALSPTAGYLIGGRVLQSLGAAAG
TVLARAIVRDLYQGTAMTRFFATLMVVNGVAPIVAPVIGGQLLTFTTWRAVFLVLAAVGA
ILLVTVALALPESLPRERRAPAHPRATLRAFRTLGTDRHYLRYVVAAALMFAAVFAYISG
SSFVLQDAYGLSAQQFSLVFGLNGLGIVVFGQIGGMLVGRVTGEHTLLRVSLSIAVLGSA
GVLVCAVAGLPLPLLLAFLFLPVAMLGIVLANATSLALAGHGSAAGAASSLQGLLQFLVG
SLAASAMTLAGPATAITMGATMVICSIAALATLR
>fig|134676.3.peg.2243 Multidrug resistance protein mdtA
MAGIVGGALLAVVHSHQQGGATSTIVAVRVGKGDVTLDVATSGTVRPATTRELSFAVNGT
VASIAVRAGSKVKAGQTLAAVDATAATAAVTDARNTLTDAKSRLTDARDQAARVTAAATA
CATAASDRGLLATAASDRGFLATAASDRGFLAGADVSPTATVAVNSCTTRGYPDTGNDPV
LTAQQAVNRAGEAVTRAEAALAGAVITAPIAGTVVSVAGSVGDTVSSGKTFVTLADTYTM
QVEAAFPEADAGSLAVGQSATITLADHDDALTGTVVQVDPVGTSDGTLVRYGAVLSFSAP
PSDLLVGQSAQVAVRVGETRNVLRVPSTAVHDISGGSGTVLLRVGGRSSERTVTVGLRGD
QYTQVTDGLTADDQVVRSW
>fig|134676.3.peg.2517 Permease of the drug/metabolite transporter (DMT) superfamily
MGDLLLLAVAVVWGSSYLTAKTLVAAGGVLVLLALRFLISAVALLPALAVRRSRGRFDRR
ELLVGVGLGVTQTSVLILETFGLSMTSATNAGVLISLTILMTPILEGFTRRRWLPPAFFG
GAAAATLGVVFLVAGPGLRTPSAGDALMLAAAVVRAAHVTLSAHLTRGRSHDTATLAALQ
TLTGAVVCSTVAARALPAAVAAYGPAQWAAVTYLALGCSVFAFVVQLWAIRRTSASRASL
LLGTEPVWAVLFGVALAGDRLTPAALLGIALVLAGTYYGQRLEGRSRAERSPTYARGNDI
VRRTPRPRVGARSVRRSRGI
>fig|134676.3.peg.2884 Small multidrug resistance protein
MRYVLLAVAIGSELFATSMMKATDGFSRLWPTLVVLAGYGVSFVALSQAIKGGIQVGIAY
AIWSAVGTAAIVVIGALFLDEPVTLAKVGGITLIIAGVVMLNLTGAEAH
>fig|134676.3.peg.3133 Antibiotic transport system permease protein
MRAYRALARATARSALAYKNNLFLGLGAVFVQFIAMLAVWRVVLADGSAVQGFGWPQMRA
YLLVAFAAGTLVSVFGDFRTAARIQSGLVALDIIKPVDFQRARLAETLGGTWLEALVVVV
VGGVTLALTGGVPTPPGAALALFAASMLMLVPLKFLIVYVSTLACFWTQNFIGVQWARIA
LVNLLSGALIPLAFLPGWLAAVAQWSPFAGLVSTPALIFVGQVGVGRGLALVAAQLGWVV
ALWFGARLIWRAALRQLTVHGG
>fig|134676.3.peg.3316 Glyoxalase/bleomycin resistance protein/dioxygenase
MLGSAAPIAFLPSTDLERSRRFFADTLGLVVAEVTPFACVVRVGTTMLRVTKTDQLQPQP
FTVFGWEVADIDAVVAGLSGAGITFVRYDGLEQDGAGVWTTPGGDRIAWFRDPDGNTLSL
TQFLPH
>fig|134676.3.peg.3483 Lysostaphin resistance protein A
MATVFFAVATVAAGVFGAVQPFTGIPEEVIQLTQFGPAVAVAVLAGVWPARTRALLHGAG
SGEARTGPVLLSTAVLIVAGAVGAHGVITGGVGFTRPEHPFLLIAVAQLIGACGEEIGWR
CLLQPLLRTRFGPLTASVLVGLLWGLWHVPVFAEGPWYGGLFLLATIALSVVMGLALERA
RSYRLLLAAGFHTLINLGMLLFMNEESGAVLPIALFGASAAVAALVGTASRR
>fig|134676.3.peg.3573 Multiple antibiotic resistance protein marR
MQALMLASRAFVGITVRALAAVPGEVTLPQFRTLVVLAARGPQRSIDIAEELGVNPSTGT
RMLDRLIGKGLVRRTRSATDRRVVRLRLTPDGQRLVEQILDRRRRELERLVDGNPGLWSP
PVIEALTAFATAAGEQAAATERSAAGKPPAVGAQAAGPSGPDWWLGWTPGDAVGENIA
>fig|134676.3.peg.4430 Multiple antibiotic resistance protein marR
MGMTSGEGRGAQLLPVLGQLVRFLRQLEGPDNPSSIALAVLRRLADHGPGRVTDLARLTR
ASQPGMTQLIGRMEKAGQVRRVPDPHDGRGVLVEVTDAGRELLSRTYAYYATTLDRLFEQ
LTPEESDTVVAALPALERLARAGERESAGTR
>fig|134676.3.peg.4494 Glyoxalase/bleomycin resistance protein/dioxygenase
MTSRIGDIIVDCRDPELLAGFWCGVLGYRIFARDATGVAIRGATSSPDILFLHVGDRKAT
KNRLHFDVCPTDRGQDEELTRLLALGARRSSIIGSGSWVVLEDPEGNEFCLMAKRIAAEP
APFHDA
>fig|134676.3.peg.5630 Multidrug resistance protein mdtH
MTVLLLATLVNAIGNGAYVTISVLYLTTVAGLSPAMIAIGLSAGAAAGVLAMTPLGYLAD
RHGPKRLSILALIVLAGAYTALLAVRSPLAFGLLSCVIAVATALVKGANGALAAGSVAAS
GRLRMRARMRTMTNAGIGLGTLGGSIPLLLQTDRAYVVILLVNAATFVVAAALLTRAPAV
PPQVTPPGGPRLVALRDRPFLVFAAVDGLLSAVYNDLLGIGLPLWLAAGAHAPLWLISVT
LVINTAGCVLLQVRTARDVHDLPGARRAAVRGCLILALSCAVLAATAGHPPWLAGTLITL
AAIIHVVGELWLSTGSWGIVFAITPPWAQGQYQGTYFAGRGVGDMLAPPLVTACVLGLHS
AGWLVLAALFAAGGAIYPPVTRWAAARITSIERTPAPA
>fig|134676.3.peg.6051 Multidrug resistance protein B
MRMAQLEPKRGGALAAVALAQFMVTLDMTIVNVALPSLGGDLGFEPTQLPWVVNVYALLF
GGLLMLGGRAADLFGQRRILLSGTALFALASLAGGLAQAPWQLIAARAVQGMGAALMAPA
ALALLTLTQREGRERTRALGVYAAVSAVGGAAGVLSGGLLTQFAGWRWVMLVNVPMAACV
VVLALIGVPGGQLSSGPRRTLDVPGAVLVTGGVGALVLGLLRTDHYGWASATTLVTLGIA
VLLIVLFLLWEARGIKSDPLIRLGLLAKRNVAGANLFILLLCAGQFAAFYFISLYLQDVL
HLDAARAGAAFLPLTLTVVVAINISTRLVPRLGPKPLLVTGGLLAAAGFAWFGALDADGG
FLTDLLGPSLLTGLGMGLSFVPLTGAAVGGLPRHEAGMASAVLNSSRQIGGALGLAALVT
AQASRTDARLAAGDPPLEALTSGFGIGLSLSGALLLAAALVALIVLPGKRAAGVPAGEPA
AQRGASSSSPWPTNAPAGSPPLDAASSVTEPR
>fig|134676.3.peg.6396 Aminoglycoside/hydroxyurea antibiotic resistance kinase
MVEIALPDSFTRRVAQCWGAPGTRWLADLPEIATRVLHDWDLHLDRPCPLSLNWVTRVRR
ADGSAAVLKMGIPGADHLSDEAAALEFFAGRGAVSMLAHDAARGAILLEEVRPGRPARSL
VPDRDEDATAALIGVIRGLHRPAPPGIALPELAARRATFDEHLRRFPDDGPLPRHLVERA
GRLLTELCETAIERVVLHGDLHHDNVLAAGREPWLVIDPHGLTGDPGYEIGAMLYNPYPM
DDDTVLRLVPGRIEQLADGLDIPIERVVAWGFVQAVLSEVWNATGDGIATGRPLRLASLL
LPRLP
>fig|134676.3.peg.6578 Multiple antibiotic resistance protein marR
MRRDLLDLPVLLLGAATTLVDSINEGVRARGFTDLRPAHGFAFVRLAPDGATVIELAEHL
GVTKQAASQMADELVRKGYVERHPHPRDARARLLTLTPRGWACTRAADEAATEALQPWAD
TLGPAHLATVRSALAQLTTPGRIRPTW
>fig|134676.3.peg.6774 Pleiotropic drug resistance protein 3
MSSMSLGRGHVEVLQFLRDRTAVVFTFLFPAMLLLLFGTIFGNDYDRAGASAAQVYTASM
LAYGVLTTGFVTMGSGLALDREDGTLKRLRGTPLPVTSYLMGKLILVLTLSVAEAALILL
VGVVVFDMPLPPASHWVTFAWLMILSVTCCSLLGVAVSAVVRHARSAGAILNVPVVALQF
ISGVFINPITQLPSWLITVASFFPIKWMAQGFRYVFLPDSMKSLEAAGAWELGRVAVVLG
VWCVIGLALCLVTFRWSDKDR
>fig|134676.3.peg.6971 Lincosamide resistance protein
MAGRHVSTAADVVALFDALDVHRVQACLGGGWAVDALLGEQTREHSDIDLWLPATHLEWA
FRAFAALGVDRLFPTPGDRPWNFVLHDGDRRKIDLHLYETRPDGRLHYGSALTGEPFPAA
ALSGRGEIIGRPVRCEAPVWAVTWHTGYPPRAADRHDVPLLCARFGIPLPETFA
>fig|134676.3.peg.7298 EmrB/QacA subfamily drug resistance transporter
MSATGGAPPLSHRQILQVLSGLMLGMFLAALDQTIVASAIRTIGDDLHGLSLQAWVTTAY
LITATISTPLYGKLSDIYGRKRFFVTAITIFVVGSAACSFATSMYQLAVFRAVQGLGAGG
LFSLALAIIGDLVPPRERARYQGYFLAVFGASSVLGPVIGGFFAGADEILGLSGWRWVFL
VNVPIGAVALVVVAKVLHLRHTRRDHRIDWWGAVALCVCLVPLLTAAEQGRTWGWTGSRT
VLCYAVGAAGLVAFLVAEARMGAEALIPLRFFRNRTFALTSFAGFVTGMGMFGGLALLPL
YLQIVHGASPTRSGLQLLPLTAGIMAGSLISGRAISATGRYRVWPMLGAPLMIGGMGLMH
SLAVDTPYWRTGVFMGLFGLGLGFVLQPVTLAVQNAMPPQDMGVATASATFFRQMGATAG
TAVFLSLLFSRVGDRIRDALRVAGADPAFQKLMADPANRRVLGGSLDDTSFLRHVDPVLA
RPFESGFAATIADICLVAGGVLTVALILFAFLPQVPLRGSAPAGPAELSPSSGSATDLSP
SPGSATASPASSRSPHSPSPPARSVDALSLSGVVTGLDQRPLTGARLTLADLAGGQAARA
VTGPDGRYLLTPEVAGAYLLICAADRHQPAAIRLTVTGADARDVRLAAGGRIEGDVVDQH
DRPVAAATVTLTDAAGAVVASAITGPDGGYVLAGLYPAEYTLTGIAPGARPAARTVVLDT
GGVSRADLLLAGNGTLTGQVRAAASGHPVPEASVMAVDEAGAVVATTWTDADGRYAFADL
VPGAYTVTASGYPPVADRVELIGELTAHDIMLGGPREGSRLISP
>fig|134676.3.peg.7397 Glyoxalase/bleomycin resistance protein/dioxygenase
MLDHVGFQCADLAASAAFYDAVLAPLGASRQMDFQVAIGYGNGHPDFWISTLTEGDGFRE
SHIAFGAADRAAVDAFFAAAVASGAEVLHEPRLHPEYHEHYYGAFVRDPDGNNVEAVCHR
PE
>fig|134676.3.peg.7933 Multiple antibiotic resistance protein marR
MPTEPNLADIAEQLRQSIGRLVRTTRAHADSLPRTHAETMGYLSREGPHTIGELAARRRV
THQSMSRTVAELDRLGYVSRAPNPADARGFVITLTETGAAVLDTDRAARRDWVAAAIASR
LTPEEQRLLARIPALLDRLADGAGT
>fig|137722.3.peg.381 Permease of the drug/metabolite transporter (DMT) superfamily
MPADRSVPAKGLRLADQAWLLMMMPPLFWAGNAVMGRAVAGAVPPVGLAFWRWFLGMLIV
LPFAWRHLRHDLTPMLARWKSVLLLATLGIGVFNTLQYIALNSTTALNCVMLQSSMPVMI
VLMSVVLFRDRVGAMQGLGIVVSLAGATTLISHGDPATLLGLELNSGDLWMLAAVVIYAA
YTTLLRRRPAVHGLSFVVVTFAIGALELLPFYIWESLGGHPMRVSGITLLAVGYTVLFPS
IAAYLCFNRAVELLGPNTAGLAIHLVPVFGSLLAILFLGEQLHPYHGIGIALIAAGILLA
TRRRA
>fig|137722.3.peg.662 Permeases of the drug/metabolite transporter (DMT) superfamily
MSDASSFSVDHAQRTQRLALIALLLGALGIAFAPIFVRLSDVGPAAIGFWRTALATPLLA
LWMASESRSGSGRASRRPSGLADYGRLSLAGLFFAGDLAIWHTSIRYTSVANSTLLANFA
PLFVAPAAWFLFKERITGRFVLGMLLALAGAVVLMGQSLRLSADHLFGDALGLLTAIFYA
GYILSVGHLRGEFSTATIMTWSGAITAAVLLPLSLHDGEAMLPAGPSGWAALVGLALFSH
AGGQSLIAYALAHLPASFSSVSLLMQPAAAAILAWILLNEPLGRWQAVGAAVILGGILIA
RRASR
>fig|137722.3.peg.1529 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSSATLPTPEPLRARLAAHIGELLRLAAPVIVSRAGLMVMMAVDTAIVGRFSAQELAYYG
LAHLPGNIMVGTGVGLLMGTVMITAHAFGAGTDAECGRAWRRSIPYALLLGVLFALVSLL
GDPLFQAGGQTPEMAAGGAHVLAVLGLGAPGMMLYITTGFFLEGIKRPLPGMVAMVIGNL
VNAALAWTLVWGHAGLEPLGAVGSAWATTIVRWGMGLGLVAYVWWMRDHDRWQLRRPVAD
WWSGAARQRHLGYAAGLSIGVESGAFGGLGLFAGMISPLALGAYTVGLNLTALPFMAAVG
LASATAVRVGVAYGRGDRSDMALAGWTGLGVTSAILAGVGILYRSVPEALGAIYTGDPEL
LEAVVPLIAFAAWILIADGGQTVMANALRGRHDAWVPTALHFFSYAVVMIPVSAFLVFGL
GHGAHGLFEGILIASLVSVTILSLRFAALSRR
>fig|137722.3.peg.2265 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MSVAHTLQALVVMALWGLNFVVAKWALAEFPPLFVMFLRFALVAVLIIPFFRVPRDKLWK
IALLSVTLGSIHFPIMFTGLKGIDAATASLAAQAQVPFSSLLAAVVFKDKLGWRRAVGMA
AAFAGVAVIAGEPRLGDQMASLLMILGASLAFAVASVQMKLLGSVNGFAVNGWMALFAMP
QLLGLSLLLEHGQMEALANSSWVGWASILYMAVGVTIVAYGLWYPLIGRYDVNQTMPYLL
TVPVFGVASGALLMGDPLTINLAVGGLLTIGGVAVIVKRRPRTVSETVTNPT
>fig|137722.3.peg.2368 Permease of the drug/metabolite transporter (DMT) superfamily
MEAGTAVILNVTTPIFAFLITLLLTRHEELTVGKAVGVGAVDEIGRDLPAQGAIILATVC
YAGAAIYGRAFKGLDPIMPAAGSLLCGAALLLPISVVVDRPWTLAPSGPSLLALAGLSVF
STALAFVLYFRLVDSL
>fig|137722.3.peg.2956 Permeases of the drug/metabolite transporter (DMT) superfamily
MAILAAVLFGVSTPLAKLLVHDLSPWMLAGLLYLGSGIGLGLVRLARGLSASPERNERSI
HGIEWFWLLAAVFAGGVAGPVLLMFGLTATPSSTASLLLNLEGVLTALLAWFVFQEGFDR
RLVAGMAAIVVGAVVLSWGGAVDIAAGWGPAAVAAACLMWAVDNNLTRKVSLADPVDIAT
IKGLVAGSVNVGIASVLGDGLPAVPTAAAAMLVGLLGYGVSLVLFVIALRHIGTARTGAY
FSTAPFVGGIVSLVIFGEPLTAGLVTAAVLMGIGVWLHLTEDHDHEHDHNEIEHDHPHVH
DEHHQHGHDGPVTEPHTHRHRHGRLRHRHAHFPDAHHVHPH
>fig|137722.3.peg.3607 Permeases of the drug/metabolite transporter (DMT) superfamily
MTANAETADLLPAKADSVPYAVGCFLVAIVLFAAMDTLIKVLTAGYPVPQLMFVRSLVAF
LLVGGYTLAWGGGFAAMRTRRPLGHVWRAFAGLISMGCFFYAFRELPLADVYVLSFAGPL
FITALSAPLLGEPVGWRRWAAVVVGFGGVVVMAQPSAGAPLVPVLVGLTAALFYALAALA
VRGLSRTETSASIVLYLLLTTTVVSGALAVPVWTTPTAAGLGLMALVGALGALAQVLLTQ
AFRRAPPAVVAPFEYTGMVWASLFGWMVFGDLPTAPVLAGAMVIIGSGLYILHRETMVAR
RRLGS
>fig|137722.3.peg.4606 Multidrug resistance protein A
MTGMRAFRWVIGGAAIAALGTTLWFATRLPPLTVQGEVSADRVDISPRVAGRVARLGADT
GDRVARGTVLVELESPQLVAALSAAQAALGVARADLDRVNSTRAETITARRADLASANAD
VTLYQDNYGRQAQLIRSGNTPQARLDEAARNLEAAVRKRESAEAALHLAVTGASPEERAL
AAAQVKQAEAALRQRSVDVEELVVRAPMDGQITTKVSELGENFSAGAPLFSMVDIAHPWF
TFNLREDLLSGLAVGDGFRITVPALGSKEIPVRVTMINVQGQYATWRATRATGDFDLRTF
EVRAVPAEPVEGLRPGMSAIWVRQGR
>fig|137722.3.peg.5609 Multidrug resistance protein A
MTTVTDRDTETTPAAPQPVAKPVRRSRWRRWLLMAALPLAVAVGGGYEYVVGGRYVSTDN
AYVQQDKVTISPDVSGRIVEVAVRENQAVHRGDLLFRIDDEPYRLALRQADAALASARLK
VEQLRADLGEALAKQAAAEEKVSFQQREFQRQQDLLKTGVAARATYDSVRHDLMAAQQDL
NTEKQSVVSARAALGGDPDIPTDRHPTVLEALAKKASAQRDLDHTVVAAPADGVVSQTGR
LLVGQYAATGLSMVSLVMSGSSWVEANFKETDLTHMAVGQTATVVLDAYSGRTLTARVES
IGAGTGSEFSVLPAQNATGNWVKVVQRVPVRLRIEAADGNAVPLRTGLSADVEVDTGYSR
PLPGVIGDAVAAIR
>fig|137722.3.peg.5778 Permease of the drug/metabolite transporter (DMT) superfamily
MRASHILLAVAVAAVWGLNFVAIKVGLRDFPPLLFSCLRFALAALPLALLGWGKGPPVPW
RYVIGIGVTLGVVKFPLLFLGMDAGMPAGLASLVLQAQAFFTAIFAAFALGDRPGPRQLG
GMAVAFAGVGLIALEMPAGDSLLGLGLTMAAAAAWGVSNIVMKQARAPDLFSLMVWVSLI
PPLPLLAMSLALEGPERIVHAVTTLTAVGVGSLLYIAVAATLFGFGAWGFLMRHYPASLV
APFSLLVPIFGMSSSALLLGETFTTAKLAGGLLVFAGLALSVLRLPAPRRAGA
>fig|137722.3.peg.6410 Bicyclomycin resistance protein
MLARLAAVRSRSPAESPFFIAALGVLMSFGPMGTDMYLPGMPAIGRDLHAAQDQVQWTLS
AFFLGFGVGQLLWGALSDRFGRRIPVATGILLYAVGCVGCSLTVDVGHLAAWRFIQAVGA
CAGPVLVRAMIRDVFERDRAASVLSMMMLVMGAAPIIAPLIGGQILIWANWRWIFGAQAA
FGAIAMLALATLPETHPPSRRTSLRPMGLFQSYRSLLTNRRYLGYAVGSSFIYAGMFAFI
SGSPFVYIELFGVRPENYGFLFGINIVGMMIVSTINSRAVMRFGSDRMLRIGGWLSAASG
ILLVACVLGGWGGLWGLVGCLFLFMSLTGFCFANSMAGALQSFPQMAGSASALAGMLQFS
SGAVSGWAVGLMADDTALPMAAVIGGAALVSLALNLWLVRPIRRRLPAA
>fig|138119.3.peg.89 Drug resistance transporter, EmrB/QacA family
MNIRKTPLILSLMLAMFLAAVEGTIVTMATPTIARDLQGFEFISLVFSVYLLTSALSTPA
YGKLADLYGRKNILSIGIIIFLAGSFLCGLAQSMVMLIVFRAIQGLGAGAIFTVSFTIIG
DVFSLAERAKIQGALSTVWGIASLVGPFFGGFLIDVLSWHWIFFINIPFGLLSVILLQSS
LKETFAKKKPSIDYAGTLTLSLAIVVFLSIFLFDRSTSPYPSLWVAGLLLLTFFLLYAFY
KIEKKAAEPIIPFAIFTRTTILVNLISFLIYAVLMGVNVYLPIYLQNILGYRPTAAGLAM
LPMSVSWLIVSFILGRLLVRYGGKNVILASNAVLLLSTLLLFTLGIDTPLPIILVYGFIM
GIGFGGASAALTIIVQDSAEYSQRGAAVGTNSLLRTLGQTIGISVFGTIFNLYITKYFTR
QGIEGINPGNLYQPDLSHTALAAEQITLSLNSSMHVLFTAFIIITLLSMILAMTMPGMKK
EKQA
>fig|138119.3.peg.357 Transcriptional activator BmrR for multidrug resistance transporter
MKEQYYSIGQVAKLSNISIPTLRYYDQIDLYKPAHVDTLTSYRYYKESQLYILDMIKSLK
YIGTPLTDIKTVLNYTPAELFCFLEHQEDVIEGKIQGLQEIHKNLQQTKKQLQQQMKTAL
ATDVFEKTEDLQIFTLPVENYAPQSIPNDCYGELIKLVEAEGSRISSHYGCIYPLLDYNS
MDEVRCTHIFTPLMTDRLNSHPAYRRNIRLISESRFIGIAFQYHPDRYIEHYQRLYHYIR
SKELPVADHVYDLFTPTRYSQHKEEEFMVELKVQLL
>fig|138119.3.peg.494 Probable antibiotic-resistance protein
MNIIDFRFRPNTEAILKGISSNPAFKGMCQSIDFNKMLPQTLEEVVEELDRHHVVKAVIS
GRDCETTYGAQSNNPSVIEFCHKFPDKFIGFAGLDPHKGMAALAEITHAVHEEGIKGAAI
DPYLARIYVNDAKYYPIYAKCCELGIPLIIATGPGTLVPNAVIDHVAPRYIDFVARDFPE
LKIIASHGGYPWVNEMITVAQRNANVYLELSEYEFFPQSSAYIEAANSILSDKIMYASAH
PFVDFKLALKNYEQLPLKPEVREKVMYKNAAKVLGLSDGTFSASKAMDAQEVQMIIENVI
AQLSQRGLLADR
>fig|138119.3.peg.510 Multidrug resistance protein B
MNTQYLNKFNIPRPILVLIIGGFIHSVGSSFMWPLNSIFMHNILGRSLTEAGALISLQAL
ATLVGQFISGVLADRFGSRRVMIYGLIGTILPLILISCFPVWEVYAPGLLFYGFAIAFIF
VPINALVFTLWPEGGRRGFNLLYVFNNAGVAVGTALGGFIAALSFKLVFLLNGLFFFIYL
LMVLIFLSAKDIQSKPLSKSRVKVPIFKDRGFPVLIALCAAIFLMWGAYIQINTVLPVTM
TNLGYSLPQYSILWTLNGVIIVAFQPVIHWIIRHWAPTLSRQFYVSCLFYAIGFLILLGN
FPYPSYFIMMIIITLGEMLVLPGVPAAAALIAPEGKTATYQGVVGGAASGGRALGPILGG
LAFDHYGGNMAWALALVFVSIALLPFYLYQRRERTFTQGTGAKEQAI
>fig|138119.3.peg.777 Drug/metabolite transporter (DMT) superfamily protein
MNELIVVKGEEKAQNIRTKAVRGTILTLIGGISWGFSGACGQYLFSVKGIDPHWVTVVRM
LTAGLLLFCLVLFKYREQMVGLLSNKRDRRTLIVFSIFGLIACQYTYLLAISHSNAGTAT
VLQYLGPLLIMIFVCGMDRRLPTKTEGVAIALAVTGTFLLATHGNVSNLVISAQGLFWGL
MAALGLMLYTIIPGKIINKWGSIVVTGCGMLMGGSILLVVIRPWQIPVSLDWQVFWGMLA
IIVIGTVVSFTLYLQGVSDIGPVKASMIASVEPVSAALFSAFWLNTAFVWIDMVGFALII
TTVILLTRQGSSRD
>fig|138119.3.peg.911 Drug/metabolite transporter (DMT) superfamily protein
MSDRNQGYLLIILSAVFYSTLGILGKYIYNTGIEMSLVIVLRLFATVILLGLFLLITRKE
PLLTFSRVVLFQGIFFIATAITFFLAVKYLSAGLATVILFAHPALVAVLAVIFYHEEIGA
AQIVGLILALLGLFFISGLYIESSTALSPLGLILSVLSAVAYGIYALLGQRVVKTDGIWT
ITFTISLMGLVISALIFPHNLPALLSITPYQLFLGFAMAFLGTILPVVLFLKGVQKIGSS
VGTLISIIEIPFALILAYLLLGEVLTPMQVVGTLLILIATTMAVAVKNQKENNERN
>fig|138119.3.peg.1108 Probable antibiotic-transport ATP-binding protein ABC transporter
MMIKVEGAFYRYPGAPRDVIQDISFTVRKGEIFGFLGPSGAGKSTLQKILTGVLRDYQGW
VQVLGTEMKHRKSSFYERIGVDFEFPNFYGKFTALENLQYFASLYHQKTLDPLTLLEQVG
LQHDAHKRVASYSKGMKMRLGFVRCLLHNPQLLFLDEPTSGLDPANARILKDMMLEQKAG
GKTIILTTHNMHDAGELCDRVAFIVDGKIRALNTPQAFQVERSGSAEVNYSYRRDGRTVD
RRSTLTQLGQDDEFVKALQNGSLLRIHSKERTLEEVFIALTGRQLQ
>fig|138119.3.peg.1170 Permease of the drug/metabolite transporter (DMT) superfamily
MKYKPELGILFVTILWGASFAVSKLIMADITPNYYTFLRFAGAFLVLAICFHKRLRHIPK
QTLQAGVLIGLAIACGYVLQTMGLNYTTASKAGFLAGLYVVLVPVMESFLCKCLPRYNMI
LGVCLATAGLALLSLERDFTIGFGDLLVFVGAVFFAVSMVLISRFASKHDPMVLAIIQIG
VTALFSLVLAVFTEPGLSAVQFTPVLLGLVLFAILFGTAVNTAVQNWAQGYLTATTAALI
FVLEPVFGGVFGWLLVGDVIGMKQISGSALIISGMLVTLLLKPGQRAQSKADQGVQLSGR
S
>fig|138119.3.peg.1437 Permease of the drug/metabolite transporter (DMT) superfamily
MAQGCRTAQWKGRVITMAEKRMAYLAAIVYAFIIGLSFMFVKLTLTVATPLDTLAHRFTV
AFLAATLFILFTKHKVNIGWHDVAQIAPLATLYPILFFGFQIFGLARTTSSEAGIIQSTV
PIFTLLLAVFILKEKAGRGQLISVFLSVFGVIYLLAMSGAESQTANIVGSVLIILSAFTN
ALYNVLARRLTQRYSLLTLTYIMTLFGFIAFNSLAIGSRMLAGTVGEFFQPLLHWQFVVA
VLYLGILSSLVTSFLANFVLSKIEAAKMSVFSNVATLITILAGILFLQEAFHFYHVIGGM
MIITGVVGTNLLGARSKAKEKAKDVEE
>fig|138119.3.peg.1443 Multidrug resistance ABC transporter ATP-binding and permease protein
MAGGFRTQQPKAPALVNRPGAGNRFVPAAKPKNTKGTLGRIVKIYLRWAKSIFAVILLTA
ASSLVAVAIPYYVGQAFNTFHIADRSVDTARLVSLLLIILSLYLGNLLLNLLNGTMMLRL
SQKLVYTLRQEFFAKMQRLPLGFYDTRSHGDTMSRITNDMDNISSTIAQTTTQLIASILT
LAGSLAVMLSLNVPLTLVVLLCVPLVFVLTKTIATRSRAYFLAQQRSLGALNGVIEENIL
GLKMVKAFNRQEEVLRKFQEINQGLRASSYKAQVWSGCMMPLMNVINNLVFAAVAICGGI
LTLSQGLAVGTVVSFLTYSKQFAHPLNSVAGMFNTIQSALAGAERVFEILDYEEERADEE
NALEMEHPAGAVAFDEVSFSYDKTQPILKEVSFQVNPGEVVALVGETGAGKTTIVNLLTR
FYDADSGEIRIDGVPVTRIKRASLRRCFSVVLQDTSLFSGTLMDNIRYGREDATEEEVIR
AAQIAHAHGFIAKLPQGYGTRVSAANDTLSQGQKQLISIARALLCDSPILILDEATSSVD
TKTEKDIQKALVSLMQNRTSFLIAHRLSTIRDADRIMVIGEGQILESGNHQSLMTKQGRY
YEMVMSQLGSQMAKSFSLKA
>fig|138119.3.peg.1472 Drug resistance transporter, EmrB/QacA subfamily
MGKSGKAPELEPIPKNIMNIAWILVLGAIMPLLDSTMVNIAINHLSHDFSIGLDLIQWVI
TGYVLAMAISVPLAGWMVQRFNGKWLMIGANILFLAASIASGFSWSIHSLIIFRVVQGFS
AGFIMTLVTTLCVETAGRERMGRLMSTIGIPTVLGPILGPVIGAVIVQFLSWRYIFFVNI
PLGILAITLMIWKLPDFTPANIKAKFDFIGIILLGTASAALIYGITKAAKSATFNNSTTI
AYGVAGIAILAIYMIYAALKKDQAILPLHLFRLKNFSAVMVGLFLAGIATNGPMLLLPLF
FQNIKGFSVLNTGLILIPQGIGMLIARPLIGKLTDKWGARNVVLVSLALTIVGTIPFIFI
NEASSLFVVSLVLFVRGVGIGGVTIPMMTDAYTGMVKQEIAQASVGTRLMQNIGGAFGSA
VMATAVSLSIQGKTPTIPLMTTAYHDGFMLALVLSLVLVIPSLFLTNKTAKQ
>fig|138119.3.peg.1558 Tetracycline resistance protein
MFKNGSDHEQNTEQTIDKKALLFGLMSVFLCGIGFSIITPVVPFLVQPYISNPEEQAIAV
TLLTSVYAACVFLAAPVLGALSDRYGRRPLLLICLLGSAIGYLVFGIGGALWVLFAGRII
EGITGGSIGTIFAYFADIIPPQQRTKYFGWVSAVVGVGTVIGPTLGGLLAKFGYSVPMYF
GTVITLLNVVYGLFYMPESLDKNKRLQEISLIRLNPFIQLANILSMKSLTRLLVSAFLLW
LPNGSLQAVFSQFTLDTFHWQPALIGLMFSIMGLQDIIAQGFIMPKLLLKFSDQQIAMLG
MAAEIIGYSFIAASALFVFYPLLIAGMFIFGFGDSIFGPSFNGMLSKSVPSGEQGRIQGG
SQSIQSLARMMGPLIGGQIYVSLGHAAPAFMGMLLIAAAIPVLHKRPQANM
>fig|138119.3.peg.1757 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEQITTIKLKVHQFIHILLPILISQVALFSMSFFDTAMSGQASSVDLAGVAIGASLWAPA
STGLGGILIAITPIVGHLLGAKRRNEVPYNVLQGIYLALAIAFLLIVAGAMSLDGLLSLM
NLEPQVRFIARGYLLAIAFGIPPYFVHQVLRSFIDALGYTRITMLITLLSLPINICLNYI
FIFGKFGLPAFGGIGAGIATSMTYYCLMLIALFIIHRHPYFKEFALFKRLPPLSWKTWLK
QLKIGIPIGFSIFFETGMFCAVTLLMSRFNTVTIAAHQGAMNFASMIYMIPLSFSMALTI
LVGFEVGARRYHDARQYSLIGLAFSFSIALLTALLLFLFKEQVAWLYSKEWDVILLAKQF
LIYAIFFQFSDALATPIQGILRGYKDVNLPFITSLISYWFIALPIGYFLAAYTSFGAFGF
WIGLISGITTNACCLLLRLRYILRRQVAV
>fig|138119.3.peg.1921 Vancomycin B-type resistance protein VanW
MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVL
AEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPE
LLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGM
ETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGG
EFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSH
SLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDE
PDGYPVKPREWSK
>fig|138119.3.peg.2130 Daunorubicin resistance ATP-binding protein drrA
MRKVFVTKEKKGPWRSRKKEVVAVNTLDLAIRPGEIVGLLGINGAGKTTTIKMLSTLLVP
TAGSIMVDGTDAVKEPMKVKKRINMIAGGERMLYWRLTARENLAYFGSLYGLSGKALTER
IHRLLQAVELEAAADTPVEQYSKGMKQRLQIARGLINNPSYLFLDEPTLGLDAPIAKHLR
EHIRNLAVKEGKGILLTSHYLTEVEALCERVYIIDQGELVLHDTPKRVIQKVAAGEILSL
WVSGLLPATHEHLRQMLVPLEASLTILEQSDGVELRIQSKGEITAQVLKFLFEHGVIPHR
LEVEKPKLEDAILKLAGREEKGREKA
>fig|138119.3.peg.2416 Vancomycin B-type resistance protein VanW
MNLTPEAVSSDPDQLPPGTFLDDLALGGMMQEEAKEKIRSWSKDKLEENLFLVYNETEIQ
LTPEELGITLDFERTWQNLSENTGQESPSVLAIDYVMANQVLHEKLAEFNRSAVDASFKI
ENDQFKITPAISGEAVNVDAFFDEIKEVSLGDLPKRISLTGVEIPAAVTTESLEALAFDG
VIGEYTTKYNAGDKNRTANLITAAKKMDKAVLKPGETFSFNGTIGPRTAETGFKDAYIVI
NNEYVKGIGGGICQVSSTLYNAALLANLSIVERHPHAVVVAYIPLGQDATINYPNLDLKL
RNDSSSYLYFRTKVEAGNLTIKIYGKKTGVKVRFEKEIEKELNYHTVRKIDPDLLPGAVI
QQQSGSKGYIVKTWKIVTDAQGKETKQLLSRDSYAPTNRILKIGAD
>fig|138119.3.peg.2666 Drug resistance transporter, EmrB/QacA family protein
MLILGFIGLLFGMFSIGVMQLILATAMPFIVEEIGGGALYDWVFSSYMLASIATIPLFAK
FADIYGKRKFFILGMCFFALGSLCGGFAATMPYFIGARVIQGVGAGIISPVAMAMVSDMF
PAEQRGKMIGLFGLVQLLSNLLSPPLGSFITKELGWSWIFFLNLGMIAFSMLLVLLGKTV
QESKSDMKLKEIDILGGLLFGGFCLLAVTLANALSHQGRFGVLGAALLPALIFTGTMLVL
NERKQKNPIIKMEFLKTQIIRRSLISAVLSGAIMYGLAALLPLCGVMLSRQGFPLDESKT
LLFFMVSLTSGLLGGSRLNKLQLGQVPRYLWLILSVSSVFLLYSLYTVKIVPFCLFLILM
GLSAGGIMATFLINSQNAVESEDRTVLSGLVQLGRYFGASIGVTLLIGMLPEVSLISGVG
EFIGAFGLLVLLCLAGVLNEIL
>fig|138119.3.peg.2841 Permease of the drug/metabolite transporter (DMT) superfamily
MRWGNKMLGQIIISVILGAFGQILVKIGAKNLELDFAPENLLRSLGAIMQNFPVMSGLFL
YGVSFILWIKVLTKTELSYAYPFVSLGYIFIMAFSVMVFKENISFYRVLGTVLVIVGVIF
ISRS
>fig|138119.3.peg.3113 Glycopeptide antibiotics resistance protein
MLWSKNYKHISIIRELLVMAFVIYCLAVIRVTIFSLHPSAGFGQSGTPSVNIIPFAEMFR
GFHPNHFSLGYMIRHLESNLIGNILLLLPLGFFLPMLWSKFRSFKRTVVIGILSSLSIET
VQYILAYLGLSSGRASDIDDVILNSIGVIIGYMVFQAISCGIKCFRKYSTFTKVD
>fig|138119.3.peg.3180 Vancomycin B-type resistance protein VanW
MKRKRLTQLFPFLLPVRRTQRKLFFYTEMYFDRNHYAKAKAPEFLPFCVYETKSKLLNEN
TGMDMRYQENKVFNLRLAAETVNGLLIRPGETFSFWQRVRYAEKNERYKDGLCVVNDELI
TVPGGGLCHLSNLLFWLFLHMPLTIVERHAHEIKDFPSPDEDEPDGVDATIHEGWLDLKV
KNNTNLTFQIEIAIDEPYIYGRIFMDQAKRYSYEVVNRDKSFFKKEGKTFERVSVCRQVI
DNESKQVVSEKLLYTDVFEIGYVLPEGTAIADEKA
>fig|138119.3.peg.3184 Permease of the drug/metabolite transporter (DMT) superfamily
MFMPRGTPFPRGIFVLSDQRFLFSTHSLLGDLSMQQSKQASNRSIWLIALGAAMWGLDGV
FIVSLLQHVSSSQIVWLEHLLLFLFAAPVLIWKRQELKQLNGGDWLAVLFIGWGGSALAS
ILFTAGFTYGNPNVVLLLQKVQPIFVILLASWMLKERMRKDFYALFVVALIGAYLLTIGL
HLPTSEVSLAQLLGSLCAIGAAALWGGSTVMGKRLIGKLSFTTLTALRFAVALPLLTVIV
LVQQPNWADLGQSLHLAPVWANLLYQTLVPSLLSLLLYYRGLNGVRASHATIAELAFPAT
GLLVNWLILHQTIDLGQWLGFAIVWLVVLQLSRMPNAPKSAVKTSETANLAGL
>fig|138119.3.peg.3464 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPSVKMNQGNNVLGTQPIPGMIWKFAIPAIISAMTNQVYNLIAQVYIGWSVGDLGIAATN
VAFPLAILITALSALFGMGGAAKFGLYMGQGKPEEASQTIGNALVLMVVSGLAVSIAATV
FLRPLLYAFGATEAIMTYAIPYTLITNIGIPFGILAVGASYLIRADGSPSFSMLVVLSGV
IFNLIAAPVFLFGLEMGIGGVALATTLGQMLSSAVAIYYLRVKFKSVSLKREGFQLRGAV
IKGVCALGSAAFFTHLAAAAVQIVQSNALRYYGAQSIYGSEATLAAAGAVIKVMAFLMSV
VIGISLGCQPIFSYNYGSKRYDRVKEAYKLAVSYATMVSVIAFLCIQIFPRPILSIFGSG
NPLFYDFAVQYMHIYLFMTFANGIQPVTSTFFSSIGKARMGFWMSLVRQVILLMPLLLIL
PIFWGINGVLWAGPLADGIAVVLVILFAAREMRIMTGLQLKQVPDAGIARNS
>fig|138119.3.peg.3466 Daunorubicin resistance ATP-binding protein drrA
MSNAIEITDLRKSFSVKAKGRIIKVEAVRGVTLAVKRGEIFGFLGPNGAGKTTTLRMLTT
LLPIDEGKGTICGYDLVGQPQEVRRHIGYVSQLGGADWEATGRENLILAGQLYGMKRHDA
EQRTGELLAVFELAELADRVVRTYSGGQRRRLEIALGMINRPEVLFLDEPTTGLDPQNRA
NLWEQIRKLKEGGTTIFLTTHYLDEADALSDRLAIMDCGIIVAEGTPQELKEQISGDVIQ
IRLADDRTQQAKRLFDKVSFINEIRLEGEDIYLYAKNGAQVLPRIFEMLEAEGVQTQSVS
IATPSLDDVFLKQTGRLLRDGKEDIA
>fig|138119.3.peg.3492 Permease of the drug/metabolite transporter (DMT) superfamily
MSASRFTLLIVVTTFLMGSSFAVVKIGLIYSSPLLLAALRFILAGGIMGIIVGVLKRTHP
TTKGQWVKLLIIGAFQTAGVMGCIFLSLRTITASESAILTFTNPLLVVLFSTVFLKMRYR
LYQWIGVILGLVGVSITMGAQIEFRIGVFFGILSAVFWAIATLLTKRWGGLTDIWVLSAY
QMLFGGLILWVGSFILETPFFIVNGTALLILLWLSLISSIVQFALWYYLLQKGEPGKTSA
FLFLAPFFGVLTGWLLLGDPLYPSLLAGGLLIIIGIFLVNKDFNRKRVSAN
>fig|138119.3.peg.3793 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MATTLVEEKEKQKHFILSGNLWKVMADLSWPAIVAMVLYGMNSVMDAFFVGRYVGEAALA
GVSVAYPLSQISVAFGSLIGVGAGSVLSIALGAKDRKTQEHLLGNVNLLSLIVTAVYMLL
GLAFSTQLIAMMGGRGEALILGDQYFRITIYGAFFWVYGLAGNMIIRAEGKMKTAAVMMG
FGLAVDVIFKYLFIVVFQWGVEGAAWATNIGMLVYTLVSWLYFSKGWATFHSKLASLRWD
QKIGTSVLRLGASSLIMSVMSLVQAIFVFNALSKYGTTWDVAFYGVVYRIFTFLLTPIFG
LMRALQPVIGINYGARQYDRVISSYKIFAVTALVLTLPFWLLSIAIPGPILGLMMKDAAF
SGADLLYFRVYMAILPVLSFIFMAMTLFPSVDKGKPAAMIGIARQLVFYVPVMIFLPKAI
GVAGVYYGSLAIDAVIILWTLFMVRKEFSQLRQKARSDKPESIAYSL
>fig|138119.3.peg.3803 Permeases of the drug/metabolite transporter (DMT) superfamily
MMGSNLAGAQTWQIVAVYAAYAFLVLGAVCLVFMLAAVFRQGDERRNYILTKACTHTFLI
YTGIVFVMGMYALFFQKHHNFSMESTPVASLGLIAILFTGSLFLNKRKYGN
>fig|138119.3.peg.3840 Drug resistance transporter, EmrB/QacA family protein
MLGGSNMTNEQLSRKSPWFSYLGLLLGTFTMIEAMAFQIPALPVLTKEFGVPVATAALIS
LCYYLTATVCGPVFGNIADQIGRKRIAMIGMIIFAISEFMAAFATNYPFFLLARLCQGIG
VAAVLPAGLSYASYLFPPNKRGIAVGVYTAVGTFASAMGGFLGGILIAKFGWQSLYIISG
VLAVLGIALVQITVPETPTAERKPFDYIGSILLLLTIGTWLSLSVLVANFGWVSPYTLGM
LGLALVFAISFWNVEKRTSHPFMDLSIFKNRYFAVPILLYFFIALCSQGSVFTNSYFVTA
KPGLGTAYVGIMTGVIYLAGAVTSLLSGKLIDSFKIKTVLLIGMGTFIVGTLLYSQYTVD
TPFWYIVLTLVFMSGSLLFMAPACMKMSMSAVPPEKLGSGSGTYIMIRDLGSPSGQTTML
AAFGAISASSLAAEITAEAQNSGVSQDMIPAVVEAGKTAGKVIDPALTDHLAKIGVSFQD
LYAKANFDGMVIAINQMSTIIIAIAVAAFIAAVFVLPNTNGGPGGLDPKNK
>fig|138119.3.peg.3928 Vancomycin B-type resistance protein VanW
MKTKKYVGLALLFISLTLAITLGINFMLYAKDDHLFSEGITISGIDVGSLTKEQAQEKIN
QTLENWLAQPLEFQAGGEVITLPLAALNPQVDLETPLNEAYKIGRKASLFARTQKATTAQ
DARFELGLTWDEQRLAETLAESLGLLNKEPVDATFKIGANNLMEIQPEQPGQAVQADALV
NQIKELEPFQDPAPLKVELQEVAPALRAADLEAKKIDGLIASHTTWFDAANLERTANVRL
AAEALDGTLIEPGEIISFNGIVGERTGDKGYQDALIVVNGEFVPGLGGGICQVSSTLYNT
GLLANLKIEERTNHGLAVAYVPLGQDATVVYGAIDLKMRNTTGGYLLLRSKISNGSVTIE
FYGKKTSGQEIVITNQVEKVIPFETEIIHDPTLAPGTQIVKQNGQNGYIATATRTIKVNG
QVVETQSLGRSSYIPSNKIIVKGPEPPAKPKPDPKPEQPAPETPQEPETPAEPDPTEPES
TNSGAGASETEGEPGTEAPGDEG
>fig|1538.8.peg.371 Permease of the drug/metabolite transporter (DMT) superfamily
MGYVFIILAAVIFSTMEIVGKLAVGLNPLQLNFLRFLIGGLILFPPTIKAMRNKKMKFKK
DDLYYFLGTGFLCVVLSMSLFQLAITFTKASTVAIIFSTNPVFTVMFAYLFLKEDLNRGT
IISIILSLVGIVCILNPFGTVSDVKGIVLSILAAVTFSLYSVVGKLRSEKYGSITLNCVS
FLVGDIIMLVIILLSNLPVVSSIINPKGGLSFMSHIPIIYGISAANIIPVIFLGIVVTGL
GYMFYFMAMDETSATTASIVFFIKPALAPIFALIALSEKIPMNTVIGICFILIGSYFSFT
AKGGTRVEEVES
>fig|1538.8.peg.414 Membrane component of multidrug resistance system
MEENNNESIYSWLALIVVVIGTFMSILDSSIVNIAIPKMMAVFGVSMDDSKWILTSYTLA
LGAIIPLTGYLQEVFGSKKIYMFALAMFTLGSMLCGFAWNNTSMIVFRIIQALGGGMIMP
VGMSIIYEIFPRDKIGLALGIWGIASMAAPSIGPTLGGYIIQNMNWRLIFNINVPIGILG
VILAGILLKDSQKITFKSFDVIGFLSSTIGVVSILYVLGEWTSIDWSKVQYPLLLTLGCL
SLILFVVNELTHPQPLLDLTVFKLFDFSVCQIIICVLTMALMGGVYVLPLFLQNIRGYTA
METGLIMLPAALVVGILMPVSGNLFDKIGAKPLVIPGLIILALSSYHLSVLINMNSSREM
ITLILCIRSIGLGFTMMPINTAGMNVVPQNLIGKASALSSTIRQIASSLSVTIMSAIIQS
KTNYNYLKLSEQINVYNKPANDTINILTKSYMQEGLPQGTAKASALSTLSKLFQGQATID
AMAYAVAITSVIVIVTIVLTLMMKSKKTVKGDDHNTNTKELAATK
>fig|1538.8.peg.446 Drug resistance transporter, EmrB/QacA family
MEERLEESNYQQRNYNVVPITIALIMAGFLCMLNETLLNMALKNLMVQFSISANTVQWLS
TGYMLIMGIAIPVSALLIQSFTTRQLFLTSVTIFLVGTVISGFSTAFSILLVGRLIQAIG
TGILIPNIVNTLLIINPIEKRGKALGIFNLVMFCAPAIGPTLSGLIIQSLNWRWLFFIIL
PFSVISLALGYKFIENVTELTKPPIDFLSIVLSTIGFGGFIYGVSNIGSSYTYLIAAPII
ISCIALAIFVLRQLHMSQPMLDMHPFKESMFSLGCILMIIMHMINFATMLILPMFLEGAL
GLSAFTAGLLMLPGGFINGIISPISGHLYDKFGPKALIIPGYAISTITFFLLSRFVSMSI
TIPVIIVLHCLSLVAVGLINTPVQTNSLNQLSPKYYPHGTAIMNTLQQIAGAFGTSLFVA
IMSASQKKYLFAAGNPSNAKSQALSLVFGVKHAFTIETFVLVIALILSLFIANNAINKKS
KSIKA
>fig|1538.8.peg.812 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MERSVKLRDEKVGKLLLEFSIPAIIGMLVNSLYIVIDRIFIGRVVGAMAISGVSLTFPIS
ILIMAFGMLVGIGAAARISIRLGENNKDEAEHILGNAFVLLIIVSIVITILGLIFVDPML
RGFGASDNTIGYARQFITILISVSTFQTVGFGLNNVIRSEGDPKTAMNTMLIGGICNIIL
DFLFIYILHFGIKGAAIATSISQGINMIWVLYYFLKGNSMLRIKKKYLRLNKDIVASIFS
IGMSPFAMQVAASLVNVILNKSLAIYGGDLAIGAMGIINGISTMILMPIFGINQGSQPVI
GFNYGAKLHRRVKKALLLAIAAATFISAAGGIAVQVFPTVLVNMFNKSDMNLTNITVNGI
KIFMIMFPIIGFQIVSSNFFQAIGKAKISMFLALLRQVIVLIPMLLILPRIFKLNGVWMA
APVSDAVASILTALFLYFEIKKLNSNEKENLSSPEISAELTK
>fig|1538.8.peg.1398 Antibiotic resistance protein
MGEGIGYLGISQIIATAFGPEIGIEASNRFGMSKTFIVSAVLIIIAAVCMNFLPNKNQIS
IKNTVDKKHAIHLKDIIAFKILPLSLIGGLFFMGNGLATSFLVLLGEERKINGIGMYFTV
NALFLIFTRPMSGKLYDKKGLSTVMYPALLFSITEALLIAHASALWMILLAAIFKAFGQG
TAQPALQAECFHKLGSQKKGLASSTFFIGANLGQGLGPLLGGTIASSLGYVWLFNFSALA
LLCGIFAYAIYNKKTCSSYF
>fig|1538.8.peg.1442 Vancomycin B-type resistance protein VanW
MIQPIDRNQIIPKKRKLKRKLKINKKKMTRSLIILSILTYIIHSLWIHFLVTRYDNLIYP
GVKVEGINLGGKTKDEAIDTLKRKYVNQIFKKNIIIKVQDKVYTINYSKLNIKYNLDDVV
QDAFKYGKCGNTHNKYKNIKSKNGKQFNLKYSYNKKEINNTISKIENELNRAPVNASITK
DEDDKFKIDLEKDGQEVDRDKLFNDIDKKINNKNMNDVYISGTIRKVAPKIKKSSLVNIN
TKISSFSTNFSSSDDNRSNNIEVAAKTLNGTTIMPGEIFSFNKIVGKRTKENGYKSSKII
VGNKLQPGLGGGVCQVSTTLHNAVVRCGIVPTEREHHNIPVTYVGLGMDATVDYGHIDYK
FKNTLDFPIYIECLTKNKNLVINIYSNSKLNNKIYNLINKVDKASNGKATIAKVYLVTYE
DGKETSTKWINTDNYIK
>fig|1538.8.peg.1498 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEIENNTLKQGKIRKLLLKFAIPSVFALLVSELYNIVDTVYVGHYIGVTTLAAITIAFPI
QKLLVALGLLIAVGASTYAARSLGEKNYSEFKKIVFTSFSLVLISLTIVSLIIFIFRRPI
FYVLGADNLTYPLVNKYVSILLLGGIFQSLSVVACYIMISLKKTKALLYTNLIGVTLNIL
INYILIVKLHFKIEGAAIATVLSQITAFTFAFYKFKNIIREFHMEFSMHSIHNSVTKEII
WGIITVGFSTFIIEIEDALVTVVLNNLLYTEGGESAIVMVGVITKISMFLFVTIIGISSA
MQPIVAYNFGAENYDKVKKVLNTSIKVVLITSFALWSIFMLFPNYIIGFFLNDTTLLNKT
VKAFRLCICLIPLTGIYYVVINYYQAIGEAKKSFLLSIYREIIVFIPLAILLVQLFGIKG
AWAAYPITDASAVLTSFYFLNKALKEDFNQVGVSEKF
>fig|1538.8.peg.1538 Quinolone resistance protein
MVQNSNVTKVLKPKIKDNLPEVDLLQEGISDYDSISSVLVNECLVENFKARRVSFNEVIF
RNVKFINISFEQVEFLDVRFENCDLSNVNLSEASIHRVEFINCKLTGSNFTEAVFRNVMF
DQCSGQYTCFRFTDFKQAIFSNCQLPYVDFYESKFSKLELKDTDITQGQFCNTKLKGMDF
TSCRIDGIAAGVEDIRGAIISYTQAVSLISILGVVLKE
>fig|1538.8.peg.2731 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKQKLSNEYYLENAPITKAIAHLSIPMMIGMSVGTIYNVINAFFIGLLNNTDMLTAVTLG
LPIFTILMAFGNMLGAGGGTFITRLVAKQNIEKAKKIAGYTFYSSIIIGILLGIILTIAL
TPIVKIMGADTSAIINYTKSYSLTMFIGGFAIVMNFALEQVVRAEGASKESMLGMVVSTI
FSLIFDPLFILLFKFNVVGVALSMILANIASSIYYVYYLETKSENLKGFIKNFNISLKDK
IEIYKIGVSELLLAGFLIITTLLLNNYSIRYGESVVASFGIALRIVQVPEFIAMGLALGI
IPLIAYNFSNENFKRLKDSIKQSALWILGLSGGVVTLVYIFRNVIIHLFSNDAAVLSVGV
YIMAAMLISAFFNGFTTLFIGIFQASGQGTPSTIMSITQGILFIPVIIVLNNFFGLHGVI
WSMTITEIITFLTGVILYIIFNNKLKKNQVVAN
>fig|1538.8.peg.2979 Drug resistance transporter EmrB/QacA subfamily
MNSVKSKTGVSTVIIIMLGTFISSFDINVVNTALPIMQSYFHAGMSSIEWIIVGYLMVLG
ATQLTFGRLSDMFGHKKIYVAGLMLFTISSLFCALSTSIVMLIIFRITQATGASMISSSG
SPIIIDAVEPKNRGKSLGMIAISVAVAVCTGPALGGLLASRAGWSSIFFINVPIGIVVSI
LAIKVIKKDDKRRNEVQFDFAGSTLIIAAIFLILLPLNLLSKSYFNIGSIVSFLGGIFVL
LLFIAFEKKSKHPILNMELFKNRVFTGSTFAAMFFYMGEFILVFLAPYYLQKMRMLTPFM
SGVMMLPMSIAMIIAAPLSGTISDNFDSRYIGCIGLAVMALATLFVGGFNASTPIWMLAV
VFFIYGLGGGFFQTPNTSAVMGSVTADRRGVASAALGTMRTFGMMSGEAISAALIAFSMN
KSAAAFISKGLKSTLLWQAEFRFSTKVTCIVAAICVISAIVLSFMRGKSAAPCGNAVVKT
N
>fig|1538.8.peg.3124 Drug resistance transporter EmrB/QacA subfamily
MNEIDEGKYKKWMIFAVTSMANLVVSFSINSLNLALPTLTKEFDVSQNSISWLALVYSLI
PCCTLLIFGRTAELYGYKRQFKIGFLFFGAVCISAPLLSVNLEVLIFFRCLQGIGYSIMI
SITQAIVSRTFDSKERGKALGINSVFISIGMAAGPTIGGFLLTHSSWHAIFYFNVPFCIL
GFVATCLVMPDDRTEVSECKSMDWLGAILFSMSIGAFSVGLNFSIKWGWKSVSFLGCMLF
SVLALYIFIMREKHTESPLMSLHLFKSRTFCMANVVCMLSYLVQQLITYLVPFYLVDILL
LSSDQSGLIMLASPIMMMVMSPVGGSMSDKHGTRLPSGIGLIFICVSCLFMSLLKKSSNY
TVVIFTLIAMGIGNGLSVSSINAAILNSVPRKHAGVASGMLATMRNLGQTLGVASSSVIL
TSRQIVYNKNTNLSVKDIYLFAQRDTYYFGILILIVALVFVFLLPRSITDKSDMV
>fig|1538.8.peg.3353 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNLNNEKLKMMRDEKISKVLLKMGIPTMIGMMVSALYNVVDAYFVGGLGTSQMGAVSITF
PIAQVIVGLGMTFGNGAASYISRLLGEENEIKANETASTALVSSLIVGIISIAVSLCFLD
NILIGLGATKTILPYAREFAVIYITGSILNIFSVTMNNIVTSEGMAKLTMTSMLLSGIFN
IILNPILIYSLGFGIKGSAISTVISQALASILYIWYMLNKKGSLRFSIYNFRFDSTIFIQ
IFKVGIPILVYQLLSSASMGLSNTAARSYGDSAVAAIGVVTRIMALGSYVVFGFMKGYQP
VAGYNYGAKNYDRLNEATKVSLKWATIFCTVIALILIMVPDQIVSLFSKNDAVLINIGGR
ALRANGIIFILFGFEQVYMCLFLALGMGKEGGILSISRQGMFFIPAILVMPQFLGIEGVI
WAQPAADLLTVILTALFMLGVNKKLNNFMNQKEYLN
>fig|1538.8.peg.3975 Permease of the drug/metabolite transporter (DMT) superfamily
MKKRLIGSMCLFLAACIWGGMYVVSKYILEFISPITLVWIRYAIAFVVLFLILMFFNYKK
GRKVVIKKKDWLLIAWIGFIGYFISICLQFMGTKLSDAHMGSLITASTPVFVIIFARFIL
KELFTKKKMISLILATFGVIIVIGLDSMFMKHLLGNIILVGAAVTWALASVYLKIVSKRF
NSLIITTYAMLFALIFTTPLMLTQHNNFTLILNNRNLILGIIYLGVVSTAGAFFLWNKGI
GLMDVGIGSLFLFFQPVTGSIFGWLYLHEQLTFGFFIGGTLIVIAVIIAITKEDN
>fig|1538.8.peg.3977 Vancomycin B-type resistance protein VanW
MMSGKRKTRKSKRKSGGTLKILGLAALTIFLSISCGFIVYHYNDVKYWDNLIYPRVSINN
TDLSEKTKDQAKSIMSSEYLNKFQQKQITITAGNKSYELPYSSLSFTYNLDDTIKLAYSY
GKSSNIFKKYELLKNPKNVNYNLKFSYNTKVIDNMVDKIASEVDTEPVNASLEMGGVKFS
VIPQKDGIKVDKEALKKDIESKIDNNSDQDLTVKAVLKTTKAKIKEDDLKPVDTLISSFS
TAYGGISSGERANNISLATSSINGHVVMPGDTFSFNDVVGQRTAAKGYEAAPVIIGDKVE
SGLGGGICQVSTTLYNAVAKAGLTSTERTHHTMPVHYVPEGMDATVDYGNIDYKFRNDFK
YPIYIQGYTSGGNIVFNLYSNSSVSK
>fig|1538.8.peg.4067 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKFERGVCKLSEKSTKINESYIENEKLGKLIMKFSIPCVLAMVVNALYSIVDQIFIGQGV
GYIGNAATNITFPLVVLALGFSLLLGDGAAAFYSIKLGEKNKEEGAKAIGNAIVLMVILG
LIFLAVGYIFMKKLLWSFGATSTNISVALDYMRIILIGLPFMILAAGLNSIIRADGSPEY
SMLAMIVGAVINIVLNPILIFHFSMGVKGSAIATIIGQILSCTISLSYLKKFKNIKFKRE
YLKLDVKVSKTVMLLGISSLITQAAVTIIIIVSNNMLKIYGAQSIYGSDIPISAIGIVMK
VNDLLLGVVIGIAIGGQPILGYNYGAKNFKRVKDTYFMLIKIATVVSIIGFIIFQFFTQS
IVNLFGQNSALYNEFALKSFKIFLMLCMFIGFELTSCIFFQAVGKPGKAMLLTLCKQTFF
IVPLMIILPKFLGVLGVLYAGPCAEILSVIVTIILITSELKKYSKLTVS
>fig|155920.1.peg.160 Permeases of the drug/metabolite transporter (DMT) superfamily
MLISSKVRTAQLQIHVCVLLWGFTAIFGRLITLEALPLVWWRMTMVVFSLVLLPRVWRGL
RALHPRVMLAYAGIGALVALHWLAFYSAVKLANASVAATCIALAPVFTAVVEPCVVGRPF
RARELLLGLMVLPGVALVVGGVPDGMRIGIFIGVVSALLAALFGSLNKRMVVHADPLTVT
ALELGSGILTLTGLMLLLSLVFPTLHEMPWQIPSAHDIFLLLILSFACTLLPFALSLVAL
RYLSAYSLQLVTNLEPVYSIALAIVLLGEQRELTGLFYLGVAVVLGVVLLHPMLERRGRA
SSPQ
>fig|155920.1.peg.1197 Permeases of the drug/metabolite transporter (DMT) superfamily
MVTQGQLPLRAAMLMLFSTLSFGMMAITIRYASTQIPTTEIAFFRNAFGLLVLLPLILGP
GKPLPRTQHGPRYIARSMLGLISMLCNFWAISHLPLTQAITLSYSTPLFATILASLWLHE
VVRLRRLLAILAGFAGILVLLQPWSGTFSPALLVALAAALLNAVITIQMKQLSHLDPPDT
VVFYTYAFWVPLSLLLALWQWHWPEGVEWVWLIATGIFGTIGQLLWIRALRLGEVSTLQP
IGFMQLPLVTLLGWWLFGEHLDRYTALGASIIIGANVYITHREAVLARRTAAETIQKGVQ
SNGINRAQGPS
>fig|155920.1.peg.1713 Drug:proton antiporter
MSTSPASSATLRTLLCHPGFTAVLAYRIAATLSYQIVSVTIGWHIYEITRNPLLLGLVAL
AEILPFFCIAPFAGYLVDHLPRRRLGMFASLGLAMTPTILLIAAFNTAPVQTTWPIYVAA
SLSGMVRSFIVPVYNALFARVLPREDYARGAGLGTVAFQASLVLSPMLGGILIALGGKEL
AYAAGVVAAIIALLALALLRVEEPAVDKPRAPVLGSIAEGLRFVFSNQIMLGAMALDMFS
VLLGGAVSMLPAFIQDIFHYGPEGLGILRGTPALGSVLAGLWLARYPLQRHAGRTLLLAV
AGFGICTIAFGLSQHFWVSAGILLVYGACDGISVVLRASILQLVTPDEMRGRVSSINSIF
IGSSNELGAFYDGVMARFIGLVHAVVLGGFMTLVVVGITALKAPRLRRLDLRDL
>fig|156586.3.peg.266 Permease of the drug/metabolite transporter (DMT) superfamily
MEKKPVLIILSFFAVYVFWGSTYLWNKMAVTELPPFMLASIRFTTASAIIFVIAVLSGKK
LTITKKQLLNTVLAGFLFLAYGNGVFVWALKYVDSGFASLLASLQPLVLLLMMRFVQRKS
LKIKSIIGVFLGLLGMYLLVSQKGLQMQEDSWIGIIMIMSCIISWSAGSLFVAKADTPSN
FFITTGYQMLSAGVILAIGSWAFDESWSEPLSWQLNTQIAIICLILFGSIAAFTAFNYLL
KVVSTEKVATSSYVNPIIALLLGWYFLNESITMQSMIAAAIMLTGVYFINSRKVR
>fig|156586.3.peg.714 Multiple antibiotic resistance (MarC)-related protein
MDDLLTFAFTVFTGFFAIMNPISNMPIFLTITEGADKETKQRINLKAIIVAFIIVSTFVL
LGNYIFELFGITIPAFKITGGILIFFVGFEMLQSKKSNIKRLKTVNYDENIAISPLAIPI
LAGPGTIVTATNFVANTSSYADIAVVLLVFALMCLLNYIAFSLSDVIAKKIGDNVISVIG
KLMGLIIAIIGTSMIISGLKLSFDVLN
>fig|156586.3.peg.1454 Multidrug resistance protein, AcrB/AcrD family
MLKTFIERPVLSTVISIIIVMLGVISITTLPIEEYPDIAPPTIKVTANYTGANAETVLES
VIVPIEEQINGVEGMTYITSTASNTGTAEITVYFDQETDADIAAVNVQNRVARATPLLPS
EVTQTGVVTQKQETSALMFISMYSESENYDATFIQNYLKINVIPAMQRISGVGDVSVFSQ
QDYAMRIWLNPEKLASYNLIPSDITAALAEQNLEAAAGSLGENNGESFSYALTYSGRFKD
EAQYSDIVIKALGNGEFLRLKDVATIELDAQSYASNAMSMGNPAVFMGIFQTKGSNAQEI
IENIKSTLEDVKADLPEGLDIFVPYDTSLFLNASIDKVITTLLEAFLLVFLVVFIFLQDF
RSTLIPAIAVPVSIIGTFFFLNVFGYSINLLTLFALVLAIGIVVDDAIVVVEAVHAKMDE
GEHNPKKATITAMNEISGAIISITLVMAAVFIPVTFVTGPTGVFYEQFGVTLIIAILISA
VNALTLSPALCALLLKEHKDDEELKGKGPLKRFYTLFNRGFNATIEKYGKSLQFLYKRKF
VSVLLLIIAVVGIYWASTTTPTGFVPNEDRGIVFANIELPPGASLDRTDAVSRKLYAQIE
NIEGIEAVNFIKGRSLISGAGSNYSFGIIKLKNWDEREEASLSAEAITGKLFGVAAGIPD
ANIIFFSPPSIRGFGNSAGFEINLLDKFGGEFTDLDQANKDFSMALMSHPEIKYATSSFS
TSYPQYEMEVNVPLAKEKGVSVSSIFSTLQGYIGGIYASDFSRFGKQFRVYIQALPEDRA
DENALNSMYVRTDSGEMTPITQFVTLERVYGPQSVTRFNLFNSTMISGATNEGFSTGDAI
RVIEEEVAKLPSNYTVAYSGLTREEVNAGNQTTFIFILSILFVYFLLSAQYESYLLPFAV
IFSLPFGVFGAYISTKFLGLENNIYFQIALIMLIGLLAKNAILIVEFALARRKNGESIVD
AAIHGAKSRLRPILMTSFAFILGLMPLALAKGVGSEGNNSIGSGAAGGMLIGTILGVFVI
PILFILFQWLQEKVSGKPAVQTIED
>fig|156586.3.peg.1455 AcrA/AcrE family multidrug resistance protein
MMKRIRNTVIILSISIGVLSCGDKAQPKTLSEAAPSPYPVVQLQSKTVTGFTEYPTTIEG
KVNSDVRAKTSGYVEKVYVDEGQKVRKGQTLFKLETQSLSQDAGAAKAQVNVAQVEVDKL
IPLVEKNIISPVQLETAKANLAQAKANYSGVTANIGYATIKSPIDGFVGAINFREGALIS
PSDATPLTTVSQIDEVYAFFSFNEAQYIDHLQRSKGQNKAERIKNSPDLTLVLANGKEYS
EKGRIQTSTGQINQSTGTIQIRAAFDNPNEILTNGNSGKIKFPIEYKDAIVVPQTATFEQ
QGNIMIFKLGADNKVETSILKVQGTVDNLYVVESGLEPSDKIVISGIGKLKNGMAIAPQD
TSFEEAIKPVATLFRN
>fig|156586.3.peg.1462 Permease of the drug/metabolite transporter (DMT) superfamily
MKADLKKAIIFMLLSTLAFAVMNGVVKYLDGFSAYVKVFFRSLGTLIFTMPYLIFKKIPL
LGNKRTLLIARGVIGAVSLILFFMSLKYLPVGTAVTLRYMSPVFAAIFAVIWLKETIKPW
QWMFFLMALAGVFVLQGFDGTSSVIGLLLVLTSALCMGLVFVVISKIGKQDHPMVIINYF
MIIGTILGGILALNDWKTPVGNEWLLLLGLGVVGFIGQLFMTKSFQIASTNQVAPLKYLE
VIFTVIIGVLWFLEVYTLWSVLGIALVITGLVLNILYKSKQSS
>fig|156586.3.peg.1772 Acriflavin resistance protein
MKEGLAGKVAKVFMNSKLTVLLMIVFMVVGVYSSFLIPREEEPQIDVPMADIFVGYPGAS
PTEVESRVIKPLEQLISNIKGVEYVYSTSMKEQGMVIVQFYVGEDIERSFVKLYNEINKH
MDQMPEGVTMPLVKTRAIDDVPMLGLTLWSENYSDYQLGQMAHELEAEIKKINDVAITHK
IGGRERQLRVVLDKDKLASSGLDFMQVSKMIKANNAQLNAGKFDKNDTEFIVNTGDFLAS
TTDVENLVVGVQQNQPIYLKQVAQIIDGPEVPQSYVSLGFGQGSDKKTDFLSEYPAVTIS
VAKRKGADAMKIADVIIAKVEHLRKTLIPDDVQVEITRNYGETASHKVSELLLHLIGSII
AVTFVVMLAMGWRGGLVVFLSVPITFALTLLSYYMLDYTLNRITLFALVFVTGIVVDDSI
IIAENMHRHFKMKRLPFKDAALYAINEVGNPTILATFTVIASVLPMAFVSGLMGPYMAPM
PIGASIAMILSLFVALTITPYLGYIFLREKDKKGAVEKIEKPLEETLIYRLYNKFERPLM
ENRYKRWLFLIGTFVVLLGTMGLFITNSVAVKMLPFDNKNEFQVVIDMPEGTTLERTGAV
AQEISQYLSTRPEVVNYQNYIGTSAPITFNGLVRHYDLRGGSNMADIQVNLIDKEKRSAQ
SHDIASLLRPDIQEIAAKYNANVKLVEVPPGPPVLSTIVAEIYGPDYEQQIIVANEVQNI
LKNTDDVVDIDRMVENDQTEYQFTINKEKAMLYGVAPQQIAYTMHLALSDRPVTNLYDED
AVQQIGIVLALDEKEKSTIQDISQFKVVSNQGTMVPIADLVEISESISAKSIYRKNQKRV
VYVMADMAGELESPAYAILGMEEKLKSIPMPAGYSISEMYLGQPDFEDDYTVKWDGEWQI
TLEVFRDLGIAFLGAIILIYILIVGWFQNFKAPIVMMVAIPLSLIGIILGHWIMGAFFTA
TSFIGMIALAGIMVRNSVLLIDFINLRTAEGVPLKQAAIEAGAVRTTPILLTAGTVVIGA
FVILFDPIFQGLAISLMGGTIVSTVLTLLVVPLVYYMIEKKNYK
>fig|156586.3.peg.1832 Acriflavin resistance protein
MRKVIAYFIKHSVAVNVVVVGFVIFGIFGMLSLKSSFFPLTDSKIINITATYPGASPQEI
EEGVVLKIEDNLKGIEGIDRVTSASKENAGSITVEILKGYNIDFMLLEVKNAVDRVSSFP
VGMEPLVVSKQEQSRPTISFALSGDNVPLITLKQLARDIENDLRGIDGISQIAISGYPDE
EIEIAVNENTLLGYDISFEEISNAVASSNILTTGGNIKTDREEYLIRANSRSYYGNELSY
IPVKTLADGTSVLLKDVAVIRDRFSETPNATYYDNKLAVNITVTSTNSEDLIDAADKVKL
YIEDYNQRFTNVQLDIVRDLSVTLNQRTALLTENAIVGMLLVLIFLSVFLNTRLAFWVAF
GLPIAFLGMFIFAGQFDVTINVLSLFGMIIVIGILVDDGIVIAENIYQHYEDGKSPVQAA
IDGTMEVIPPILSAIITTLLAFSTFLFLEGRIGDIFGEVSVIVILTLLVSLVEALIILPA
HLAHSKALQPRNDQPKKGLARVFQKMRVVNDYGDKAMNWMRDKLYAPVLRFSLANKFFTF
ALFIAALVLTFGSMNGGIIKTAFFPRISSDQVSINLSMPNGTSEFITDSIINSIEKKALI
VNEQLTEEYLKGDEYGDSIMLFENIIKSQTSSSAASLSINLLPGESRPETVNSEIVSNRL
RELVGEIPGAETLTFGSGGNFGGSPVAVSLLSNDINELKAATAEFKEILSNNPLLKDIED
NDPAGIKEINLELKETAYSLGLTTRTVMAQVRSAFFGTEAQRFQRGQDEIRVWVRYDRDN
RNSIKDLDEFRVLTPSGDRVPLRDIASYTIERGDVVINHLEGRREVLISADLKDPSGSAT
DILANIKSEIIPDLQKKYPTISPNYLSGQAREADKFSQSAAVAGPIILLLIYFVIAFTFR
SWLQPIMLILLIPFSFVAVGWGHWIHGFPVNILSLLGIIALIGIMVNDGLVLIGKFNSLL
KEGLGFDEALFEAGKSRFRAIFLTSITTIAGLAPLLLEKSRQAQFLKPMAISISYGIGMA
TVLTLLMLPLFLSFGNNGKAAIYWLRTGKKATKRDLTSVAKELEEQKHNDEA
>fig|156586.3.peg.1877 Multidrug resistance transporter, Bcr/CflA family
MKVKQVDKENVSKGRKTSVILVLGTLIAIGPFSIDAYLPAFKQIAGDFKVETSAIGFTLT
TYFIGIGLGQLAYGPLMDRYGRRRPLIAGLILYITTSVLSAYAWDVSSLATLRFFTALGA
CAGMVASKAIVRDLFDDDKVAEVLSTLMLIMGIAPIIAPTIGGFIIEHYHWDMIFYGLAG
FAALMLFNVIFILPESSKPNPATSLHPVPVLKEYWTIYKDKAFFLFSTARGFVIGALLGY
VAAAPFIFLDFFNMAQSDFAIIFGSNAAGLIAGSQINRFLLRRFTTFQITYTISILLVVT
TLLLVGHISFFEPEFWVVYPLLFLMMTFIGFQNPNVTALALQPFTVRAGSASAFVGAVSM
IFGSFASWYVSRYVTVSVLPLALMLAGCALLGYAAIETFRIKYARGYAFAKAYLKHPYVS
LKRENAS
>fig|156586.3.peg.2072 Drug:proton antiporter
MTKNDPYAALRFQEFNIFLLMRFLLVFGWSMQFIVIEWQVYSLTKDPWSLALIGLMEFVP
AFSMALFAGHIVDQSEKRNLLAICIGAFSLISLGLFLLTWPEVVGEWSTDSILYCIYGLV
FFGGFLRSFFGPILFSLIALLVPKNAYPNAATWSSSAWQIASVVGLAFSGFSISWYGVHW
SLGIVFTLVFLAFITVFLISKKPILNTKINEPIMQSLKEGLSFVLKTKAILGALTLDMIS
VLFGGAVILLPVFAQDILTVGSEGFGILRAAPSIGAILTMIATAYIPISKNAGMKLLLAI
FGFGISIIIFGLSTSFWISVVALFFSGVTDGVSMVIRQTILQLKTPDHMRGRVASVNSMF
VGSSNELGAFESGVTAKLMGTVTAVVFGGSMTLITVITTAIISPTFRKLDLREDFKSK
>fig|156586.3.peg.2208 Permease of the drug/metabolite transporter (DMT) superfamily
MDNSKLKYIYLIILSLIWGTSFILIKKALGDDGSGHLVLQPLQLGAGRTIISGCILIAIG
WKSFAATDRKDWKWLFVSGLLGTFFPAFLFAYAQTEIDSAISAILNSTVPLITLIMGAVI
FGIAFSRTQLLGVIIGLAGAIALVFSGMKNNPEQNYLFAGLVFIACLCYASNVNIIKRYL
QNIKPLAIATGNFIFILPLAIIVFFGADGASIEFTSEPVLKSLGYIIVLCVFGTVAAKIM
FNKLVQITSPVFASSVTYLMPVVGLTWGMLDGEIFSIWQVLATMVIIFAVVLVTRNKKTS
N
>fig|156586.3.peg.2592 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSTKPSSKSQILGTDSIPALLIRQALPASIGILVMSLNILIDSIFVGNWIGSIAIAAINV
VLPVSFFIAALGMAIGIGGSSIISRALGANNYEKARKVFGNQISITLLITIPCVVFGLWF
MDSLVFSFGGKGAIFEPAKIYYRIVLYGVPILALCMMGNNVIRAEGAPAHAMIAMLIPSV
GNLLLDFILINQFNLGMAGAAWATTVSYILCFAYIAWFFISGKSELIGNIKDLIPEFNIL
KEIGGLGFVTLSRQAMSSVLYLILNNVLFELGGEESVSVFGIVGRMMMFALFPVMGITQG
FLPIAGYNYGALKWSRVREVIFTSIKYACIMGIFIFMGLFFFTREIAGVFTKNETVIEQA
SFALKLVFIAVPIISIQLIGAAYYQAIGKVIPALLLTLLRMGFILIPLVLILPQIYGELG
VWISFPIADILSTIITAWYLWIAMKKLHRS
>fig|156586.3.peg.2596 Permease of the drug/metabolite transporter (DMT) superfamily
MSKRAVAIICGFLVALFYAYNFTAAKEVTPEFVGPYGLTWYRVVITCVIFWVIATIVGPK
EKVPLKELPLLALAAFCGVGFNMVTFMKGLSLTAPISASVLMVTTPIIVLLLSAIFLKER
LYASRILGILIGFSGAALLIFLSNSGSNENATNPALGNFLVFINAVSYSFYIILAKKLTT
RYHVFTLMKWLYLFGVIFITPFGITEGLSFDFSTANTDTLWYIGYVVLFATFGTYMLNII
AIRTLKPSVVAVFVYLQPLLATLIAVGLNKDEITLYKLIAGGLIFTGVFITSIPKKAG
>fig|156586.3.peg.2654 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MKAKVTGIGGVFFKCADVAATKAWYHKHLGLPVDDYGCTFWTGPTTDKASQQWSPFKEDT
TYFNPGDQEFMINYRVDDLVKLIEQLKSAGVQIAGEIEEFDYGKFGWIIDIDGRKIELWE
PANEELFEK
>fig|156889.7.peg.1535 Multidrug resistance ABC transporter ATP-binding and permease protein
MNLILTPIGRFLHRIRHLLPHYQRYRRAFVWGFLLLIATNASAALIPYLMKLAIDTLQRG
EGMTDVKTYALLLALLAVLTALLRIRARTHVFRIGREVERDMRNLYHAQLQDLEAPLFDH
ARTGDLVSRGIGDITALRMFMGPGFLQLTNASLVYILVLPAMLWLNPWLTLMALLPLPFV
VIAARQLTKRLYRYSRMVADRFGGLTAFVQESVAGMGVIRTYAREDAWNQRFYEETDKLY
ATQQDHARLQGMFQPLMLFSGGLGAWIILAVGGPGVVQGNLTVGDFVAFTGYLTLMIQPT
VALGWILTVMQRGLAAIDRLSEVLDITPSNADHPQQALHPEPTTPYAIEIRHLNFFYQQD
RRIAPRSKEAAPSHAVTTAAGDGTEPAAVQTLHDITLTVPHGHFVGLAGRIGSGKSTLLR
CLSRTYPIPQGSLFLDGVDLAHVPEAQLRQHLTMTPQESLLFSRPLLENLLYGQPDEDEA
CAWEAARNAAFDEEVEGMPQGMETLIGERGITLSGGQRQRAALARALVVNPRILLLDDIF
SSVDARTEAHILNALLDRPDRPTMVMVCQRVAALHRADTIYLMDQGRICETGNHQSLMQS
SSLYQALHTEMQRKEQLEEMEQPEVQP
>fig|156889.7.peg.2474 Permeases of the drug/metabolite transporter (DMT) superfamily
MVATIDLFRVTTMFPSTALQAYLARTLSPNVRGALWLLQAGLFFSTVGALVKWIGSDLDA
MQIVFLRCLFGMLLLLPLLLRKGGAILRTQRPRIHAVRAVVGILAMLTTFYAYANLPLAD
VTALSFTNPLFMIPLAVLFLGESIHWRRWSATLVGFAGVVVMLRPGDAPFTLALWAAILS
PLLIAMVQVLFKRMSSTESTLTIIGRYAVASTLLSLPLALGVWRWPTLEALLLIALASAF
GNLASAMLVWAYKVGEATAIAPFDYTRLFFATGFGIWIFDETTSLHTWLGAAIILAATLY
IVHRDRLDRLPKAIAVE
>fig|156889.7.peg.2629 Acriflavin resistance protein
MNLARISVARPVFTSMVTLMVVILGLVSLSRLQIDLLPSIELPTLSVRTQYEGASPEVME
RLVTQIVEEIVATVPGVVEMTSQSSEGNSTVKVSFAWGTDIDTAALDVLATLEDEINELP
EDITRPRVSKFDVDSFPVVILGISSDLDPVPFTQLIEEQIRYRFARIAGVAQVDVWGGYN
RQVRIELDPDRLNALGIPLADVLTAVRNANLDRPAGTLEEGQFEITLRAPAEFVDLDEIR
QTVVVLRDGVPVTLGQLAAVHDRYEKLTRMVRVDDRPGIRVAIRKQAEANTVEVAKRVLA
EIEAVNQAYPRIHVVPVINQGNFIERSIANVARSVLYGGGLAVLVLLFFLGSVRSTVVIS
LAIPISIIATFMLLYFGGFTLNLMTLGGLALGVGMMVDSSVVVLENIVRRRHEARESLHT
ASLMGAQEVTSAIIASTITTLVIFLPLVFVRGVSGILFQELAYVIIFSLICSLLVSLSLV
PMLISKLGRGGEGSVDLPRWADRWQSAMQQSYANLLQRVLEHRWKTVLAAVTLLAGSMLL
LPYIGTEYLPPSDEGEVRITGEMAVGTRLELLDQQAQRMEAIVRQAVPEIQSSVVNVGRW
RGKTNAEIRLALAPVAERSRSNVEIAADLRRRLAGQIPGMKVRTRAPQGQFLLERLLAAE
EGITIEVRGYDLQVLDGLAQAAMAAIADLPGVTDSEASKIAGVPQRGIHIDRAKIADLGL
SVQDVTSAIETAVAGSKAGEFRAAGNAYPILVQLADAEKRGLDEILDLTLRTPAGELVAI
RNLVSTVAGQGPLVIDRKDQQRLVTVSANVAGRDLGSVAAEVQERLMLIPRPAGYDLLLS
GHYEEQGKAFRELIISMLLALVLVYMVLASQYESLRDPIIVMLSVPMAAVGVLLMMFLTH
TTFNLQTFIGCIMLVGIVVNNAILLVDQAGRLRQAGMSGKQAVTEAGRRRLRPILMTTLT
TVLALLPLALGIGEGADMQAPLARAVISGLAGSMLITLVIIPVVYTLFHPDPAPGSTQPA
VEASVP
>fig|156889.7.peg.2791 Permease of the drug/metabolite transporter (DMT) superfamily
MLQNNSYQRGVVLMLLSAVILSSMGLLVRGMTQAQDWQVVLWRGIWATTGMGLVLLVQNR
GGSWQRIREAGWLALLGGVFQGGGSIGFILSMLHTTVANAMFTMSSMPLFTALLAWLVLR
EPLHKITLLAIAVAMAGVGLMVWDGMSYGGALGNLLALGAALCAACLVVVLRYGRGRNML
PTLIFGALISVMVGGVMVPGSWMIPWRDWLLCLLLGGGVTVAGHLLFLLASRDLSGAQLT
LVGLVEFALGPLWVWWFMGEEPSGWSLLGGAVVSLAVVWHTVWGAAWVKPLPGPA
>fig|156889.7.peg.3354 Permeases of the drug/metabolite transporter (DMT) superfamily
MEMIGWLPLALAVALFTALKDLLNKRSVAQLNPWTVARMQHLAAFVVLLPLLPFISVPEI
GPNFWWALLGSGTINVVALLLYVQALHHSDLSLTTPMLTTTPVFLLITSPIIVGEFPSLT
GVMGIVFIVLGAWLLNVQQRHIGFWAPFKALYRERGPRLMLIIAFVWSVSSNLDKVGIQN
SSPLVWLLSLFAFIALGTTLAAHHFGPRESGADWRPHTATLWIQGGLFSAAALCQFLALE
LTMVPYVIAVKRTSALMAVVLGVWLLKEQGGRERMLGAAVMFAGFLLITLAQA
>fig|156889.7.peg.3490 Tetracycline resistance protein
MKRKSTISIIFFTVFLDLLGFGLVLPLLPNYASDPMFHASTMEIGVLMGIYSLMQFLFAP
LWGRLSDHIGRRPVLIIGLFGSALSYLIYGLAESLMVLILSRALAGFMGANIAAAQAAMA
DLTPPEKRAQAMGIIGAAFSLGFVLGPAMGGYLASTYGISAAPLAAALITGLNAVAALFL
LSETRDLSTEQQQPLSKRAHPLSLHPWKQARNYPGALMVCLFMGLFITLFAAFEMALPLW
TQIIMGWDSGSQTMAENGHLFAFVGVVMAIVQGGIVRRLVPKIGEVRTAYSGLICIALGL
MLLGQASNYTTLLIALGLAATGAGLVHPAFSSLVSLNTDKDKQGLMMGLFQSMGALGRVL
GPLWAGIAFVSLKGNLFFVSAMGMTVLLGALIPLSRDRIKDARQIAAQDAKS
>fig|158878.1.peg.34 Bleomycin resistance protein
MRMLQSIPALPVGDIKKSIGFYCDKLGFTLVHHEDGFAVLMCNEVRIHLWEASDEGWRSR
SNDSPVCTGAESFIAGTASCRIEVEGIDELYQHIKPLGILHPNTSLKDQWWDERDFAVID
PDNNLISFFQQIKS
>fig|158878.1.peg.41 Penicillin-binding protein PBP2a, methicillin resistance determinant MecA, transpeptidase
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEV
EMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKED
GMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSK
KDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETES
RNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFE
KGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENG
NKKYDIDE
>fig|158878.1.peg.42 Methicillin resistance regulatory sensor-transducer MecR1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>fig|158878.1.peg.43 Methicillin resistance repressor MecI
MDNKTYEISSAEWEFMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>fig|158878.1.peg.103 Probable antibiotic resistance-related transmembrane efflux protein
MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGM
FVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRVIQGVSAACIMPSTL
AIMKTYYQGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLL
IKGTPETKSEITNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAF
FIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQA
GYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVVIGIALISLVFLPGIFYVISCV
VGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYVGAV
AATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK
>fig|158878.1.peg.107 Permease of the drug/metabolite transporter (DMT) superfamily
MNKLRDTTFLSYLFTIILWGSAFPMIKIALNDFSAESLSAFRLILATIILLPFVIIKKLP
TPELRDIPVIFILGFCGFVIYHTALNFGETLISAGISGILVSTTPIFSSALAYIFLKEHF
SKWNWLSSLVAFIGISIISISKDDYTTINVLGVFIILLASFSESLYFTFQKKYIEKYGFI
AFTLYTIMASSPFMLIFIPEIINDIHGATFTSIVSVLYLAIFPTIIPYVLLAYIVKSVGV
SDATMSLYLTPIVSLLLSYLLLDELPTTLAIIGGIITLLGVSLSNFFQNT
>fig|158878.1.peg.334 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLP
VFAILMGLGNLFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVTLPFSDQ
IAAILGARGETLALTSNYLKVMFLSAPFVILFFILEQFARAIGAPMISMIGMLASVGLNI
ILDPILIFGFDLNVVGAALGTAISNVAAALFFIIYFMKNSDVVSVNIKLAKPNKEMLSEI
FKIGIPAFLMSILMGFTGLVLNLFLAHYGNFAIASYGISFRLVQFPELIIMGLCEGVVPL
IAYNFMANKGRMKDVIKAVIMSIGVIFVVCMIAVFTIGHHMVGLFTTDQAIVEMATFILK
VTMASLLLNGIGFLFTGMLQATGQGRGATIMAILQGAIIIPVLFIMNALFGLTGVIWSLL
IAESLCALAAMLIVYLLRDRLTVDTSELIEG
>fig|158878.1.peg.338 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MNIVGHHHISMYTKDAKRNKDFYTNVLGLRLVEKSVNQDNPSMYHLFYGDEVGTAGTILS
FFEIPHAGHKQPGTETIYRFSLLVPNQAALHYFEKRLDNNGITSERLYYLGQEGVVFKDE
DDLEIILLVNDSFEVPHQWQHNAYSEIPQVYQILGIGPVELRVRNAARTVEFLENVLGYR
KRDNKSFDVLTLAPQGLYSDFVVIEQQGQRERPGRGYIHHIAINTPQMSDLDAIYKKLQQ
QTQSNSGIIDRYFFKSLYYRHNSIMYEFATEAPGFTIDTPLEQLGSQLNLPDFLEAEREQ
IESKLHEI
>fig|158878.1.peg.398 Tetracycline resistance protein TetM
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLTPIVLEQAFRKAGTELLEPYL
SFKVYAPQEYLSRAYNDAPKYCANIVNTQLKNNEVIIIGEIPARCIQDYRNDLTFFTNGL
SVCLAELKGYQVTTGEPVCQTRRLNSRIDKVRYMFNKIT
>fig|158878.1.peg.695 Quinolone resistance protein NorA
MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGT
LADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADIS
PSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDP
KKSTTSGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDI
SIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANGYWSIMLISF
VVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIY
MAIGVSLAGVVIVLIEKQHRAKLKEQNM
>fig|158878.1.peg.1057 FmtA protein involved in methicillin resistance
MKFNKVKLVIHACVLLFIIISIALIFHRLQTKTHSIDPIHKETKLSDNEKYLVDRNKEKV
APSKLKEVYNSKDPKYKKIDKYLQSSLFNGSVAIYENGKLKMSKGYGYQDFEKGIKNTPN
TMFLIGSAQKFSTGLLLKQLEEEHKININDPVSKYLPWFKTSKPIPLKDLMLHQSGLYKY
KSSKDYKNLDQAVKAIQKRGIDPKKYKKHMYNDGNYLVLAKVIEEVTGKSYAENYYTKIG
DPLKLQHTAFYDEQPFKKYLAKGYAYNSTGLSFLRPNILDQYYGAGNLYMTPTDMGKLIT
QIQQYKLFSPKITNPLLHEFGTKQYPDEYRYGFYAKPTLNRLNGGFFGQVFTVYYNDKYV
VVLALNVKGNNEVRIKHIYNDILKQNKPYNTKGVIVQ
>fig|158878.1.peg.1761 Multidrug resistance protein B
MNIPKSVWWLVIGMALNITGSSFLWPLNTIYMKQELGKSLTVAGLVLMINSFGMVIGNLL
GGSLFDKLGGYKTILIGTFTCLCSTTLLNFFHGWPWYAVWLVMLGFGGGMIIPAIYAMAG
AVWPNGGRQTFNAIYLAQNIGVAVGAAMGGFVAEFSFNYIFLANLIMYVVFALVAVTQFN
IEINAKVKYPTHLDITGKKNKARFISLVLICAMFAICWVAYIQWESTIASFTQSINISMA
QYSVLWTINGIMILVAQPLIKPVLYLLKGNLKKQMFVGIIIFMLSFFVTSFAENFTIFVV
GMIILTFGEMFVWPAVPTIANQLAPDGKQGQYQGFVNSAATVGKAFGPFLGGVLVDAFNM
RMMFIGMMLLLVFALILLMVFKENNTQPKKIDA
>fig|158878.1.peg.2166 Drug resistance transporter, EmrB/QacA subfamily
MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLV
NGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMP
LMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIALVA
FVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALIISMV
IIYLFIRRQFNITNVLLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSA
LLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYL
IVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFG
AKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF
>fig|158878.1.peg.2169 Multidrug resistance protein B
MYRRRYFMRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIA
LVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMS
LSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIA
IILVIWTFHFPEEETVAKSKFDTKGLTLFYIFQSTFKNN
>fig|158878.1.peg.2352 Membrane component of multidrug resistance system
MTTTFIISYIILALIIVGVINLFLIRSRKKGKRQQKEQQFTTRQSNQSKFKASDLDKTTD
QSTQRMTHEELRVDNQDDHSQVSLNGYTKGSEKDQEAFTNNNGEEAVAAKNPESEEYKVN
EKIKKEHKNFIFGEGVSRGKILAALLFGMFIAILNQTLLNVALPKINTEFNISASTGQWL
MTGFMLVNGILIPITAYLFNKYSYRKLFLVALVLFTIGSLICAISMNFPIMMVGRVLQAI
GAGVLMPLGSIVIITIYPPEKRGAAMGTMGIAMILAPAIGPTLSGYIVQNYHWNVMFYGM
FIIGIIAILVGFVWFKLYQYTTNPKADIPGIIFSTIGFGALLYGFSEAGNKGWGSVEIET
MFAIGIIFIILFVIRELRMKSPMLNLEVLKFPTFTLTTIINMVVMLSLYGGMILLPIYLQ
NLRGFSALDSGLLLLPGSLIMGLLGPFAGKLLDTIGLKPLAIFGIAVMTYATWELTKLNM
DTPYMTIMGIYVLRSFGMAFIMMPMVTAAINALPGRLASHGNAFLNTMRQLAGSIGTAIL
VTVMTTQTTQHLSAFGEELDKTNPVVQDHMRELASQYGGQEGAMKVLLQFVNKLATVEGI
NDAFIVATIFSIIALILCLFLQSNKKAKATAQKLEASSNNNHE
>fig|158878.1.peg.2355 Teicoplanin resistance associated membrane protein TcaB
MNDLTHFNKRSPIFIIILGSLTAIGALSIDMFLPGLPDIRHDFQTTTSNAQLTLSMFMIG
LAFGNLFAGPISDSTGRRKPLIIAMIIFTLASLGIVFVHNIWLMVALRFLQGVTGGAAAV
ISRAIASDMYSGNELTKFMALLMLVNGIAPVVAPTIGGIILNYSVWRMVFVILTIFGFVM
VIGSLLKVPESLTVTNRESSSGLKTMFKNFKILLKTPRFVLPMLIQGMTFVILFTYISAS
PFIIQKIYGMTAIQFSWMFAGIGITLIISSQLTGYLVDFIDSQKLMRGMTMIQIIGVILV
TIVLLNHWNFWILAIGFIILIAPVTGVATLGFTIAMDESSSGRGSSSSLLGLVQFLFGGV
ASPLVGVKGEDNPIPYIIIIIATAVILIILQIYNMKVFKTNR
>fig|158878.1.peg.2356 Teicoplanin resistance associated membrane protein TcaA
MKSCPKCGQQAQDDVQICTQCGHKFDSRQALYRKSTDEDIQTNNIKMRKMVPWAIGFFIL
ILIIILFFLLRNFNSPEAQTKILVNAIENNDKQKVATLLSTKDNKVDSEEAKVYINYIKD
EVGLKQFVSDLKNTVHKLNKSKTSVASYIQTRSGQNILRVSKNGTRYIFFDNMSFTAPTK
QPIVKPKEKTKYEFKSGGKKKMVIAEANKVTPIGNFILGTYRIPAMKSTENGDFAGYLKF
DFRQSNSETVDVTEDFEEANITVTLKGDTKLNDSSKKVTINDREMAFSSSKTYGPYPQNK
DITISASGKAKGKTFTTQTKTIKASDLKYNTEITLNFDSEDIEDYVEKKEKEENSLKNKL
IEFFAGYSLANNAAFNQSDFDFVSSYIKKGSSFYDDVKKRVSKGSLMMISSPQIIDAEKH
GDKITATVRLINENGKQVDKEYELEQGSQDRLQLIKTSEK
>fig|158878.1.peg.2357 Teicoplanin-resistance associated HTH-type transcriptional regulator TcaR
MVKHLQDHIQFLEQFINNVNALTAKMLKDLQNEYEISLEQSNVLGMLNKEPLTISEITQR
QGVNKAAVSRRIKKLIDAKLVKLDKPNLNIDQRLKFITLTDKGRAYLKERNAIMTDIAQD
ITNDLNSEDIENVRQVLEVINHRIKTYSNHK
>fig|158878.1.peg.2434 Bicyclomycin resistance protein TcaB
MQSTKTKTKHFSFLLLITLGVMTAFGPLTIDMYVPSLPKVQGDFGSTTSEIQLTLSFTMI
GLALGQFIFGPLSDAFGRKRIAVSILIIFILVSGLSMFVDQLPLFLTLRFIQGLTGGGVI
VIAKASAGDKFSGNALAKFLASLMVVNGIITILAPLAGGLALSVATWRSIFTILTIVALI
ILIGVASQLPKTSKDELKQVNFSSVIKDFGSLLKKPAFIIPMLLQGLTYVMLFSYSSASP
FITQKLYNMTPQQFSIMFAVNGVGLIIVSQVVALLVEKLHRHILLIILTIIQVVGVALII
LTLTFHLPLWVLLIAFFLNVCPVTSIGPLGFTMAMEERTGGSGNASSLLGLFQFILGGAV
APLVGLKGEFNTSPYMIIIFITAILLVSLQIIYFKMIKKQHVA
>fig|158878.1.peg.2452 Chloramphenicol resistance protein
MSIMRLFTFILSIFIVGMVEMMVAGIMNLMSQDLHVSEAVVGQLVTMYALTFAICGPILV
KLTNRFSSRPVLLWTLLIFIIGNGIIAVAPNFSILVVGRIISSAAAALIIVKVLAITAML
SAPKNRGKMIGLVYTGFSGANVFGVPIGTVIGDLVGWRYTFLFLIIVSIIVGFLMMIYLP
KDQEIQRGPVNHEAPSHENHVTSKILRPAEVAKYLIITFLVLIANSVTFVFINPLILSNG
HDMSFVSLALLVNGIAGVIGTSLGGIFSDKITSKRWLMISVSIFIVMMLLMNLILPGSGL
LLAGLFIWNIMQWSTNPAVQSGVIQHVEGDTSQVMSWNMSSLNAGIGVGGIIGGLVMTHV
SVQAITYTSAIIGALGLIVVFTLKNNHYAKTFKSS
>fig|158878.1.peg.2462 Antibiotic resistance protein
MKGAMAWPFLRLYILTLMFFSANAILNVFIPLRGHDLGATNTVIGIVMGAYMLTAMVFRP
WAGQIIARVGPIKVLRIILIINAIALIIYGFTGLEGYFVARVMQGVCTAFFSMSLQLGII
DALPEEHRSEGVSLYSLFSTIPNLIGPLVAVGIWNANNISLFAIVIIFIALTTTFFGYRV
TFAEQEPDTSDKIEKMPFNAVTVFAQFFKNKELLNSGIIMIVASIVFGAVSTFVPLYTVS
LGFANAGIFLTIQAIAVVAARFYLRKYIPSDGMWHPKYMVSVLSLLVIASFVVAFGPQVG
AIIFYGSAILIGMTQAMVYPTLTSYLSFVLPKVGRNMLLGLFIACADLGISLGGALMGPI
SDLVGFKWMYLICGMLVIVIMIMSFLKKPTPRPASSL
>fig|158878.1.peg.2746 Antiseptic resistance protein QacA
MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIV
DIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIA
GALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLIN
VPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIP
WVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQW
LQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFF
GHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAV
LGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFND
AFVATALVGGIIMIIISIVVYLLIPKSLDITKQK
>fig|159087.4.peg.201 Permease of the drug/metabolite transporter (DMT) superfamily
MPQKALSLTYAKLVAAMFMWGGTWIAGRIIAQELSAPLAVASIRFVVTALALAGFALLTG
KGAPAPKTTREWGVVSGLGFFGIFLYGLCFFFGLQHITAGRGALVVALNPVVIVLAAWLF
GHERMNRRKALGSAIALAGCLTVIGNGNPLALVEGTVGIGEWLIVGCVMSWTAYTFIGRM
ATRTLSPLATTLYASLIGALLLGLAALVQGDIAPASWSWRVWTGLFFLAIFGTAIAYTWF
TEAVHTLGAGHASVFINLVPVFAVLQAALLLDERLGLPVLFGGLLVIAGVWLTTKQKISL
EISK
>fig|159087.4.peg.1483 Multidrug resistance protein B
MKAIISGKDEAASSLRWRLASLSLPVLLASLGTSIANVALPNLAEAFNATFQEAQWIVLA
YLLAITTLIVSVGRLGDITGRRRLLLAGIFLFTLASGLCGIAPTLWLLIVARALQGLGAA
VMMALTMAFVGETVPKAKTGSAIGLLGTMSAIGTALGPSLGGVLIAGLGWRAIFFVNVPL
GILALLLVWRYLPGDRKGPNVDRVGFDAIGTLLLALTLAAYALAMTLGRGRFGQLNMSLL
MLAAAGIGSFVFAEARVNSPLLRLAMFRNLDLSASLVMSLLVSTVMMATLVVGPFYLARG
LGLDAALVGFVMSVGPLVAALTAVPAGRLADRFGAQRITRIGLLGMAAGAGTLSLLPTMV
GIPGYLAPLVILTSSYALFQTANNTTVMSDVSPEQRGTISGMLNLSRNLGLITGASLMGA
VFSIASAATDITTAPPEAVATGMRITFAVAAALVIVALAISAGACRWTLRKRELAA
>fig|159087.4.peg.1503 Multidrug resistance protein B
MAHLQGRFSRHRSLMPQRSGKITKKALASSEAPYTFLPANEQPTIPMRRLRPATSFDTLS
QRYGERYKWMVLFILALGTVAGVLCTSSFNVAVPALSRHFRLGQDQVQWAMTGFLAAMTV
GMLPTSWLLDRLGFRIIFLLSLAVLTLASVGGYFAPSFTLVVAARILQGLAAGVLQPMGA
LALMRLFPPEIQGRASGILIFSIALTPAIAPSLGGALLDRFGWESIFLLGTPFAVIAALC
AIYLLPAPREIKRKPFDWLGLGWLTLGAIALIESVSSLQHSGLASPWTMGQFALAFVASA
LYYRHARLRSDPLINLDLFRQRTFAMGTLVSFAYGFGLYASTYLIPVFLQNALSFKAGAA
GMALLPSGIALVVMLPLAGRMADHYSPKWITLIGLVAFGASFLIFSIRGGAIQYAEIIAA
TIIGRIGLGMILPALNLATLRHMEPHQLGQSSVVTSYARQLGGVMGVAVLAVFVEWRETV
YGTVPPGIYSAYSQGFLLLTAVFSLAVLAACFMRTEGSRPSPK
>fig|159087.4.peg.1896 Fosmidomycin resistance protein
MTTATLPAPQRSDIEVISVIGFVHGVSHFFHLLLPPLFPWLMAEFGLSFTAIGTTMTVFF
IVSGIGQASAGFLVDRFGAARVLGAGISCFALAGVLLYFATGYPMLIAVAALAGLGNCVF
HPADFTVLNRHVSQQRLGHAFSAHGLSGNLGWAAAPVYITGLATAYGWRTAALGASAVAI
AALALLFWRREALTDPVEHHTEKASEPAGTTFAFLSSRAVWLCFLFFLLITAAFGTIQNF
ASPILQALYGLSITTAALALSTYLVGGAAGIVLGGFLAQKGEHDHLIAGALGVAALLAIL
LAAGIMPAWSILPLMAGIGFCTGTAGPSRDLLVRRAATARFGKAAYGRVYGFVYSGLDLG
LAMAPVIFGGLMDARHFSEVLVGIAILQFLAIFSALRVGKAV
>fig|159087.4.peg.2791 Melittin resistance protein PqaB
MQARPILRSIERFLLSPFSLVLAIVIAFVLNAYSLPLTDVDEGAFSEATREMMARGNLIS
PTLNDAPRHDKPILIYWAQAVSVSVLGVSEIGFRLPSIIASILWLLFLYRFCLHHADRRT
AQVAALVMALSLAVGFIAKAAISDALLNLFIALSMFGIYDFFCSSRDGKSPQQIRRLLFF
VYAMLGLGFLTKGPVAVMFPLLISGIFFVSAGAWRDWLKAAFFWPGWLLFLAIVVPWHVL
VYLDQGDAFFRGFYLKHNLNRYSNTFEGHGGKWYYYLVVLPFVLMPFTGWLLAIVGQLLR
KLCSVPLGLAYGEGLFERYLILWFVVVFGFFSFSGTQLPHYLLYGCTPLFILLARYRPEF
ERRWLAYLPLIAFTLLLAALPEILVFAAAKAGKPFEKTLLDGLVAAFSDEARWLLPLLAV
AVIALTLWRNLPVWQGLIIAGLLQALVVGAVIAPRVIGVTQGPIREAAMVAKQSGGTVVA
WRIIMPSFSVYRQSATPTRVPVEGELVITRTDRRHEVQALLASGLTMRDIYVKSFVTLAR
VEREAAR
>fig|159087.4.peg.3510 Probable multidrug resistance protein norM
MRQSRPMFATAVRGLIAHAFPILIAQLSSIGMMVVDTAVLGHVSSLDLAAVAIGGGIHVS
VVFALVGILQAVAPVVAHLHGAKRDDEVAGILQQGFWLALLLSVPGILFLTHPGVALGMA
DMDAAVEAKVRQYLGLLAWSLPASLCYRTFWAFCNALGKPRVLMGIGFFSLCLHAVLAWG
LALQGWLGEPLGVVGCALSNVLIGWLACLSGGAYLAFGPLGKRYQPFADWQSPRWPIWRE
LLRIGVPMGLSNLVEITSFTLIALFVASLGAPVVAGHRIVANISALIYMLPLSLAIATMA
ALGQAVGARDPLRARATIRAGLVLAACSSSMLGLLLWLGAQPLINAYTDDPAVRSVALGL
VAYIAIYQFFDALQTIAGHCLRAYRVTFFPMLVQTFCFWGIGLLGGAWLCYRWQPPLGVA
GFWLASVISLVFAAVMLLPLLGKAIQAAESTP
>fig|159087.4.peg.3683 Permease of the drug/metabolite transporter (DMT) superfamily
MLAALGFSLKAIFVKLAYPYGVDAITLLALRMGFALPVFLWVGLAGQKAGASLSRRDWGQ
LVLLGCLGYYGASILDFWGLEYISAGLERLILFTYPTLTILIGVLFQGKPFTRREGIAVA
LCYTGIGFAFIHDLGLGEPRNVLIGGALVFGSSISYALYLSGSAPMIARLGAMRFSALAM
LVSSAVTLLHFMATQPFSAFIQPMPVYGWGLAMAIFATIVPVFAQSAAIRRIGAGRASLF
GMVGPMLTIGFGRWLLGEHISPEQTIGATFVVIGILIVSRR
>fig|159087.4.peg.3898 Permease of the drug/metabolite transporter (DMT) superfamily
MKNLFANPYLLLTLTVLSWSGNMVIGRGVRGDIPPLTFAFWRWVIAFALILPLALPHLKT
QWPLLKKGWKPLLVLGLLGVGGYNTFAYLALQDTTATNAALLNSFIPIATIAISWAFLGK
HLRRIEGIGVVVSLCGAMTIISRGDIAVLAHLNLNVGDVWMLVAVLDWAIYTVALAWRPA
GVHPMLMLGATTIIGLSALAPAYAWEMAQGRVMNIHFGSLSALAYVGIFPSFLGYIFYNK
GVAEVGPNKASLFIHLMPVFGTLLSFLFLGEIPFWYHYLGIGLIFTGIWLTTKR
>fig|160488.1.peg.34 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MQTLHRFPERPDPLLTIVVPCFQEEETIPEFHQRITRVVKRLPVSCEILYVDDGSNDRTA
DILRHYQDGSSVRCLSLSRNFGKEAALSAGIDHARGSALIFIDVDLQDPPELIAAMVDYW
QRGYDVVNMQRNLRIGDSWFKRMSARAYYWVMQRLVEKVDMPADVSDFRLIGPAPLAALR
ALDERSRILKGMIGWVGFRTIELPYNRTVRHAGSTKWNAAGLFNLAIESIVSFSRKPLRI
FSLISFGLFVSSICYMLASLVAGSFDIHHLIVGMASFMCVGVAMVGEYLGVTLAEVKRRP
LYFLKHSNKADPVSLHPSMASIEGKKC
>fig|160488.1.peg.175 Inner membrane component of tripartite multidrug resistance system
MNGFFSSVPPARDWFYGVRTFGASMIALYIALLMQLPRPYWAMATVYIVSSPFVGPTSSK
ALYRAVGTLLGAGGAIFLVPPLVQSPLLLSIAVALWTGTLLFLSLNLRTANNYVLMLAGY
TLPMIALAVVDNPLAVFDVASSRAQEICLGIVCAAVVGAIFWPRRLAPVVVGATGNWFNE
AIRYSDTYLARDASADKVGGMRGAMVTTFNSLELMIGQLAHEGAGPHTLKNARELRGRMI
HLLPVIDALDDALVALEGRAPAQFAQLQPVLEAAREWLKGTADSASVAHWATLHEQIGRL
QPATAALDQRAELLLSNALYRLTEWADLWQDCCTLQHALRTDDAKPWRAVYRHWRLGRLT
AFFDRGLMLYSVASTVLAIVVACGLWIGLGWNDGASAVILAAVACSFFAAMDDPAPQIYR
FFFWTLMSVIFSSLYLFLVLPNLHDFPMLVLAFAVPFICIGTLTVQPRFYLGTLLTIVNT
STFISIQGAYDADFFTFLNSNLAGPAGLLFAFIWTLVMRPFGVELAAKRMTRFAWRDIVE
MTEPATLAEHRQVGVQMLDRLMQHLPRLSQTGQDSGVALRDLRVGLNLLDLLAYMPRAGQ
QARERLNTVVEEVGAHYAACLRAGERLHAPAALLRNMERARLALNLDELYERGDARTHLL
HALSGLRLALLPGVEVMLEPAEQPQLPPGLDGAPL
>fig|160488.1.peg.177 Membrane fusion component of tripartite multidrug resistance system
MKKPLLTLGRVVLTLLVVTFAAVLVWQMVVYYMFAPWTRDGHIRADVIQIAPDVSGLIQK
VEVRDNQTVKRGDVLFTIDQDRFTLALRQAKATLGERQETLAQASREAQRNRKLGNLVAA
EQLEESQSREARARSAVSEAQVAVDTAQLNLDRSVVRSPVDGYLNDRAPRNHEFVTAGRP
VLSVVDSASYHVDGYFEETKLGGIHIGDAVDIRVMGDNTRLRGHVQSFAAGIEDRDRSSG
ANLLPNVNPAFSWVRLAQRIPVRIAFDEVPQDFRMIAGRTATVSIIEGQRP
>fig|160488.1.peg.178 Outer membrane component of tripartite multidrug resistance system
MKQLILAGLCLSLGACMMVGPDYEVPGDAAVQRNDLNGPLRQDADSVVSAPVPEDWWQLY
QDQRLNELVRQALSANTELRVAAANIAKARAQVEVAESQGGFNGGVKLGAQRLQESGEAF
LQPEKVPVANIGEAIISASYQFDLWGTFKRGTEAAKANADAVQAAADTARITLVADVVKA
YTQVCSANEEYHIARESLDLQEQSVKLNQRLRDAGRGDETQVTRSQTQFKSLRAELPRFK
AERETGMYTLAALLAKPVDQLPAGTADCAELPHLNQLVPVGDGAALLKRRPDVRQAERQL
AAATAYIGVATGALYPDISIGAQVGTIGILENLGEPSTNRWGFGPQISWSIPTNGTRARI
RMAEASTQAALAHFDGVVLNAIRETQTRLAQYSALLDRRDALAEAEKSAKEAADQTHRYY
QAGRESFLADLQATRTYTDMRAQLAAANSQVAQGQIAVFLALGGGWKGTAKP
>fig|160488.1.peg.582 Multidrug resistance transporter, Bcr/CflA family
MNLRMVLILGALSAFGPLAIDFYLPAFPAMAQAFATDEKHVQATLAAYFLGLSIGQLAYG
PVADRFGRRKPLMFGVTLFTLASLACAYAPNLDTLVVARFIQALGGCAGMVLSRAIVSDK
CDPVASAKVFSQLMLVMGLAPILAPMLGGVLVNLAGWQSIFLALSLFSAGCLLAVSLGLP
ESLPEHIPRQPLSGALRQYLRLLADRVFLGHALTGGIAIAGMFAYIAGSPFVFIKLYGVP
AEHYGWLFGTNAAGFILVAQVNARLLAKRGPAFLLGRAVWLYLVAGLVLLGVAALRPAQL
WPLLVPLFICIASLGCIIPNASACAMSGQGARAGSASALMGCVQFSVAAGAAALVGLLHD
GSAVPMAIVISLCGALVVSVALLTRRLQAKAPA
>fig|160488.1.peg.1261 Inner membrane component of tripartite multidrug resistance system
MTSLTAPSAALAAAPAPAAPAQTAFGLQVVVGLFGVLLAVLCAGLNESVTKISLADIRGA
MGIGADEGAWLLAVYSAASVSAMAFAPWLATTFSLRRFTMSAVGLFAVLGLLQPFAPNLH
SLMLLRVLQGFAAGALPPMLMSVALRFLPPGIKVYGLACYALTATFGPNLGTPLAGLWTE
YVGWQWAFWQIILPSLLAMVCVGWGLPQDPLRLERFKQFDWRGVLLGLPAISCTVLGLSL
GDRWGWFDSPLICWLLGGGLLLLVLFMYNEWSEPLPFFQLRLLQRRNLSFALVTLAGVLV
VLSGVGSIPSAYLAQIQGYRPAQTSPLMMLVAMPQLIALPLTAALCNIRAVDCRWVLGIG
LAMLAVSCVGSSLLTSEWIRGDFYPFYLLQVFGQPMAVLPLLMLSTNGMTPQEGPFASSW
FNTVKGLAAVIAGGLLDVLGTLRRHFHSNHLVDSLGNAPLVDGNAAGLAKRIHDQAQVLT
SADLYLVLACIAVALICLIPFVPTRVYPPRAVA
>fig|160488.1.peg.1262 Membrane fusion component of tripartite multidrug resistance system
MRWLEPWMISRTIEMTNNRKTLFIGSVLAVAVLAGIVGPWMFGSDHRQSTNDAYVTADYT
VVAPKVAGFIKQVLVEDNQQVTAGQLLATIDARDYQAALDAAQAQLLVAQAQSADARATL
ERQDALIAQAEAAVKAAQAEVAFADHEVNRYSRLAEQGAGTVQNAQQARSAVDQARARLA
NAQAARVAARKQVDILTAQVASADGQLKRAEAGLEKAQLDLSYTRITAPVDGMVGERALR
VGAYVNPGARLLSVVPLQQAYVVGNFQETQLTHVQPGQPVRISVDTFSGETLQGHVQSIA
PATGVTFAAVKPDNATGNFTKVVQRIPVKIVLDDGQPLLTRLRVGMSVEATIDTRGDKLD
GKEVSAR
>fig|160488.1.peg.1263 Outer membrane component of tripartite multidrug resistance system
MKPGLRLSPLLLAVLLTGCTLGPDFQRPDSQAPQQWAPLQGEAAASQPQAEPLELRWWET
FHDARLSALIQRVAERNLDLQMASARLLQSRALRSTLAADEVPSVDVNAGYSRARNSADG
LSDPSGKAGKEAFNLWQGDLVAGWELDLWGRVRRQVEAADATVEVAENDRRGVLLALLSE
TAGNYIQLRAVQHTLDVTQDNLRVARHSLKLSQDRQAEGVATRLDVAQASAQVASIESRL
PSLEAQRDDLINALSLLAAEPPRSLQAELLQGGELPAPQQKFAIGLPSELAERRPDIRQA
EARLHAATASIGVAKADFYPSIRLSGSVGFQALQLSDFGGWDSRRFAFGPQMSLPIFEGG
RLKGTLELREAQQQEAALNYRKVVLGAWHEIDDVLRLYNASQLRRDHLAEAVRQNRIALE
TAQRQYVEGAVDFLNVLTVQGALLASEEQWIDSSAAVSQALVGLYKALGGGWQAFDEPPP
NAHG
>fig|160488.1.peg.1265 Permeases of the drug/metabolite transporter (DMT) superfamily
MLIGALLILTWLVLLLRYPAKALPISLAAVCGLGLVALFVVWQDSRESSRLARLDLRLTY
APEHCPADRALQVRMKNGNDVPLTELRWRVAAYAPGDTVNLAENTYNAPRYRGPGELQPG
AEWQDCLPLPPLRSGYRPQTLEFRAEHLQGTFAN
>fig|160488.1.peg.1377 Drug resistance transporter, EmrB/QacA family
MTAALPPTALRNVLTALMLAIFLGALDQTIVAVSLPAISAQFSDVGLLAWVISGYMVAMT
VAVPIYGKLGDLYGRRRMILTGISLFTLASIACAMAQDMPQLVLARVLQGIGAGGMVSVS
QAIIGDFVPPRERGRYQGYFSSMYAAASVAGPVLGGWLTEYLSWRWVFWINLPLGLVALW
AIRRALADMPVQRREAQVDYLGAMLLILGLGSLLLGITLVGQGHAWADPAVLALFGCALL
GLALFIAHERRCPEPLLPLSLFGNRVAVLCWAVIFFASFQSISLTMLMPLRYQGITGAGA
DSAALHLLPLAMGLPMGAFTGGRMTSRTGRYKPQILAGALLMPVAIFAMALTPPQSALLS
ALFMLLTGIACGLQFPTSLVGTQSAVASKDIGVATSTTNLFRSLGGAMGVACMSSLLLAL
LHQGGFELSGNPLLGSLKAAEVDPGTQGRLLETFRQLLMGSAVVAVLGLLAALALPDRQL
RGR
>fig|160488.1.peg.1957 Multidrug resistance protein A
MLAGGGHRAPAMARTSLVDGPCAAVKFVYISGTIVPMPAQLKRRLTLFFALVAIIALAFL
GHWYFKGRFYESTDNAYVQGEITRISSQLGARIETVPVEDNQHVSKGDLLVRLEAADFEL
AVERARAALATREAEYAQAQSRLTQQGSLIAAGQAQLAATQATFDRSRLDLSRAEKLRKP
GFVSEERVTTLSADSHVAGSQVDKARADLQSQRQQVTALNAELKRLDAQIANARTDLAQA
ELNLTRCEIHAPISGTIGQRNARNGQVVQAGAYLLSIVPDEDIWVQANFKETQIGRMHPG
QRAELLFDSYPDTPIEGRVDSLFAASGAQFSLLPPDNATGNFTKVVQRIPIKLTFHADNP
LHGRIRPGMSVTATVDLRSEDEGHNGR
>fig|160488.1.peg.2014 Fosmidomycin resistance protein
MPCARGARCSTGIDMPHAGPKLLTQIAAVHFVSHVHIMLIPALLPVLPGLLGVGFVELGV
ALAVFNIVSALVQAPLGYAVDHYGARKVLKAGLLLGSLSFVLLAASPGYAVLLVAMAMAG
LANGVYHPADYALLANGIEPARLGRSFSIHTFAGFLGSAVTPAVFLGIAAALGTRAALAA
GAVFGVAALLLISIPGSGVYRVARPANKQDTGPTAATGRVRLFTPMIGVLTVLFILLNLS
TSAIEKFSVAALVQGQGLTLAWANAALTAFLLSSAAGVLCGGALADRTRRHGLVAALAFA
LAAALTALVALGLLQGWALVVVLGAIGLLTGVIAPSRDMLVKAAAPPGAEGKTFGLVSTG
FNVGGAIGPVAFGWMLDQRLPNGIFVASVVFMLLTVLLTLAQEMYSARRRATEQLARAL
>fig|160488.1.peg.2048 Membrane fusion component of tripartite multidrug resistance system
MDGTGFARVRGQARSHTRQLLEIEQDSGSHNRQPAGPIRDWKPTMNVAVDKPSPAETEQR
PSAKTRRRLAVIASGSLAAITLLAFTSYWFSTGRYLETTDDAYVRADWVALSPRVAGYVA
KVEVADDQPVKAGDVLVRLQNRDYRARLDQARAGVTEAQAALAAAQASQQVATERIDQQQ
QAILQAEAVVRSATAEQRRSELDVQRYRGLVRDDAATVQRLETASAHASQAQAALQGAQA
ALRQQRSQLAMAKARAAQAEAELQQRAAALARAQAHQQLAEQDEQDTVIRAPITGVVGQR
RVRTGQYVVPGQPLLAVVPLQQAYVVANYKETQLARMRPGQPVEIRVDSFASQPLHGHVA
SFSPASGNVFALLPSDNATGNFTKIVQRFPVRILLDKPLDGPQVLPGMSVVSTVDTRPAE
VADAH
>fig|160488.1.peg.2049 Outer membrane component of tripartite multidrug resistance system
MMPLLHSFPGPARLATALGMLAALAACGHQPTPAEPAVALQADPLANMPAGVSKQPLPER
WWALYQDPQLNRWVQQALAHNQGLAQAEANVQAMLAGIGEFDARRWPSTDMGVAATYGRS
ADDQTLAEATDSNAPSQWQFNPGLELAYQVDIWGQVRAAIQRARVQAEASAAALDLVRLQ
VVAQTTRAYIDQCTYAARLEAAKQALQTLDQSVQLSQRQRQAGVATALDSERLLGLREQV
RAQLPMLSARRQMALYELSMLSGQASVAEATTCVAIPTLSVPLPAGDGWHLLERRPDVRQ
AERELQAATLETDIVRADLYPKVSFGASLTSSDHHLANLGDSRAVMFGIGPLIRWEFPNL
KANRARVSKAEALQRAQVARYRGVALSALKDVRQALARYDGERQRLQALDAALAHSQHSF
ALAQGNYRAGTVDGLALLDSEREMISLRANHTEARGRLAQAQVNLFRALGGRW
>fig|160488.1.peg.3277 Bicyclomycin resistance protein
MNSRLETHANEAEGDAQRANVLTAKVILLLAALAAISNLSTNIILPAFPEMARQLNVSSQ
ELGLTLSSFFITFAFAQLLVGPLADRYGRKRLVVGGLMIFVVGTFWAANAATLDMLILGR
VIQAIGVCAAAVLARAIARDLYEGENLARALSLTMIAAATAPGFSPLIGSMLNTTLGWRA
LFIAVGMSAILIALFYLRGIGETLPAHRRVTQSVPAILIAYGKLASNRLFILPALATSLL
MSGLFASFAAAPSILMEGMGLSSLQVGLYFAATVFVVFAAGLAAPRLAHRWGSRAITLSG
LATACTAGALLLVGPSNPSLGWYSLSMVLFLWGMGIANPLGTALTMTPFGKEAGLASALL
GFLTMAIGAVSTWMVSTPKFPTIAVLGATQTSVCFLAMVLFAWYVKRKAIVR
>fig|160488.1.peg.3515 Inner membrane component of tripartite multidrug resistance system
MSNNAAAQFTPPSLLLTTIGLSLATFMQVLDTTIANVALPTISGNLGVSYEQGTWVITSF
AVSNAIALPLTGWLSRRFGEVKLFIWATLLFVLASFLCGIAQSMPELVGFRVLQGVVAGP
LYPMTQTLLIAVYPPAKRGMALALLAMVTVVAPIAGPILGGWITDSYSWPWIFFINVPIG
LFAAAVVRQQMRTRPVVTSRQPMDYIGLLTLIIGVGALQVVLDKGNDLDWFESSFIIVGS
LISVVFLAVFVIWELTDRHPVVNLRLFVHRNFRIGTIVLVGGYAGFFGINLILPQWLQTQ
MGYTATWAGLAVAPIGLLPVIMSPFVGKYAHRFDLRVLAGLAFLAIGTSCYMRAGFTSEV
DFQHVALVQLFMGIGVALFFMPTLSILLSDLPPHQIADGSGLATFLRTLGGSFAASLTTW
IWIRRADQHHAYLSEHISQFDPTTRHTLEQLGGASPQSYAQLEQILNGQAYMMSTVDYFT
LMSWVFAGLILLVWFAKPPFTAKAGPASAGH
>fig|160488.1.peg.3516 Membrane fusion component of tripartite multidrug resistance system
MATPTDTPTPSVAPEPSRKRKAWLLGLLLLLILAGVGTWAWYSIVGRWHESTDDAYVNGN
VVEITPLVAGTVTSIGADDGDLVHAGQVLLQFDPADSEVALQSAEAKLARSVRQVRGLYS
NVDSLKAQLETRQAELRKAQQDFNRRKVLADSGAIAAEELSHARDDLSVAQAAVNSARQQ
LSTSSALVDDTVVSSHPDVMAAAADLRQAYLDHARTTLVAPVTGYVAKRTVQLGQRLQPG
TATMAVIPLDQVWIDANFKETQLREMRIGQPVEITADVYGSEVKYSGTVDSLGAGTGSAF
ALLPAQNATGNWIKIVQRVPVRIHLSPDQLKDHPLRIGLSTVVEVDLHDQSGPTLAQQPP
QKASYTTQVYDHQLMEADNLIARLIHENSATGKTAQR
>fig|160488.1.peg.3554 Bicyclomycin resistance protein
MNRPAGSLRRHLCSTLLILLCLLGVFPLDVILPSFPALSDEFRVDTKQIAYSVSFFAVGV
AMAQIVIGPLSDGIGRKRLLLAGLSVSIVGALGCVFSTHYETFMAFRLVQALGCGSLVLG
QALVQDLYSGTQRNAMRILLTSASGLFISLSPLAGAFLQQSFGWEASFTVFVIIAAIVSL
LSCVLLHDTPASHDRAPSMSSYRVMLRDTDYLAHSMLSSLAFACHFSFIVIAPLLLMGRL
ELTAYQFSLVFIGYGLAYIVGGMAAAYLNSRVSPQTQIKAGLLLISTAGITLLMWEWVAG
LSVLGALLPMIVCTTGTTLVRPAATTQALARYPRQAGAAASLNTTLLFAGAGLTSSVVAG
LESELPAGLGVLFMVASLCGGWLLACTKDDGMQRC
>fig|160488.1.peg.4505 Permease of the drug/metabolite transporter (DMT) superfamily
MSPIALARLLTLAAVWGASFLFMRIIAPELGTVPTAFFRVSIACLGLIVILAAARVRWNF
QGKLGACLVLGMINSGIPATFYSVAAQVLPAGYSAIFNATTPLMGVLVGVLFFREPMTLA
KLCGIFLGLFGVGILSGAGPVALDMALLQGALACLAATTCYGFAGFLARRWISGLDSRLS
ALGSMLGATLMLTPLFGWSALTQPPASWGGWEVWLSLLGLGLLCTAFAYILYFRLLEEIG
PVKASTVTFLIPVFGVLWGAWLLNEPLSMAHLYGGLLIGLALWLVLRPARS
>fig|160488.1.peg.4543 Permease of the drug/metabolite transporter (DMT) superfamily
MNLSLYLLTVLIWGTTWIALKLQLGVVAIPVSIVYRFALAGLILFAFLLITRRLQPMNRR
GHQICLAQGLCLFCVNFICFLSASQWIASGLIAVVFSTATLWNALNARIFFGQRIAGNVL
GGGALGLLGLGLLFWPELSHHAASRETLYGLGLALLGTLCFSAGNMLSSMQQKAGLKPMT
TNAWGMVYGAVMLAVFCVVSGVPFSMEWNARYIGSLLYLVVPGSVIAFTAYLTLVGRMGP
ERAAYCTVLFPLVALNVSAVAEGYQWTAPALLGLVAVMAGNVLVFRKPRARVAEGVVVAK
>fig|160488.1.peg.4884 Drug resistance transporter EmrB/QacA subfamily
MPERTPLDPVTARWIPWVVAIAFFMQSLDGTILNTALPAMARSLAEDPLRMQGVIIAYML
TVALLIPASGWIADRFGTKRIFFSAILLFSFGSLLCAAANSLGFLIFARVVQGLGGALML
PVGRLVVLRAYPRSELVRIMSFITIPGLLGPLLGPTVGGWLVEILSWHWIFLLNLPVGLL
GCIAVWKFIPDLRGAERTTFDGPGFLLFGAAMVLITIAMEGLGELHLPHLRVMLLLFAGM
ACLAAYWLRAGRDPEPLFSPSLFRVRTFAIGILGNLFARLGSGALPFLVPLLLQVALGYS
PAQAGMSMIPLAAAAMLAKSIARPLIERFGYRIILTGNTLLLGILLASLGLVDEQTPYWL
LLVQLGLLGAVNSMQFTAMNTVTLIDLDDASASSGNSLLSVVAQLSLSLGVACAGALLGG
FTAAGSAEGVETTLGAFQLTFVTIGVMAMLAAAIFLQLAPTDGRRARRPEQHMES
>fig|160490.1.peg.168 Multidrug resistance ABC transporter ATP-binding and permease protein
MLKDAILRYKWYALGSFFMVIGVVASSLLQPHYLKSVLSAVIQNNQEKIYEVGKPLLIIA
LLGLMSGAINTVLAAKIAQGVSADMREKTFRKIQDFSYANIEAFNAGNLVVRLTNDINQI
QSLVMMMFQILFRLPILFIGAFIMAVQTFPQLWWVIVVMVILIALIMGLVMRQMGPRFGK
FQRLMDKINRIAKENLRGVRVVKSFVQEQQQYTKFKETSNDLLALNLSIGYGFSLMQPAL
MLVSYLAVYVSINVVSTMVETDPTVIGNIASFMTYMMQIMFSIIVVGSMGMQVSRAFVSM
ARIRQILSTEPAMTFENEKEETISGSIVFDDVSFTYPNDDEPTLKHISFAIEPGQMVGIV
GATGSGKSTLAQLIPRLFDPQDGQILLGGKPIKTLSQTTLRQSVSIVLQKAILFSGTIAD
NLRQGSAKADIDAMQKAAQIAQAKEFIDRMDSRYESQVEERGSNLSGGQKQRLSIARGVI
NHPKILILDDSTSALDAKSEKRVQEALSHKLEGTTTVIVAQKISSVVKADKILVLDQGQL
IGEGTHAELVANNAIYREIYETQKGREE
>fig|160490.1.peg.169 Multidrug resistance ABC transporter ATP-binding and permease protein
MKTARFFWFYFKRYRFSFTVIAVAVILATYLQVKAPVFLGESLTELGKIGQAYYVAKMSG
QTHFSPDLSAFNAVMFKLLMTYFFTVLANLIYSFLLTRVVSHSTNRMRKGLFGKLERLTV
AFFDRHKDGEILSRFTSDLDNIQNSLNQSLIQVVTNIALYIGLVWMMFRQDSRLALLTIA
STPVALIFLVINIRLARKYTNIQQQEVSALNAFMDETISGQKAIIVQGVQEDTMTAFLKH
NERVRQATFKRRLFSGQLFPVMNGMSLINTAIVIFVGSTIVLSDKSMPAAAALGLVVTFV
QYSQQYYQPMMQIASSWGELQLAFTGAHRIQEMFDETEEVRPQNAPAFTSLKEAVAINHV
DFGYLPGQKVLSDVSIVAPKGKMIAVVGPTGSGKTTIMNLINRFYDVDAGSITFDGRDIR
DYDLDSLRQKVGIVLQESVLFSGTITDNIRFGDQTISQDMVETAARATHIHDFIMSLPKG
YNTYVSDDDNVFSTGQKQLISIARTLLTDPEVLILDEATSNVDTVTESKIQRAMEAIVAG
RTSFVIAHRLKTILNADHIIVLKDGKVIEQGNHHELLHQKGFYAELYHNQFVFE
>fig|160490.1.peg.357 Multidrug resistance efflux pump PmrA
MNWRQNLKVAWLGNFFTGASFSLVMPFMALYVENLGTPTELVEYYAGLAVAVTALASALF
APVWGKLADRYGRKPMMLRASFVMTFTMGGLAIIPNVFWLLILRLLTGVSAGYVPNATAL
IASQAPKEESGYALGTLATGVTAGALIGPLLGGILAELLGIRQVFLLVGVILFLCSLMTA
VYVKEEFKPVRRFEMIPTKVILKQVKSPQIMLGLFVTSMIIQISAQSVAPILSLYIRHLG
QTHNLMFTSGLVVSAMGFSSLFSSSYLGKLGDRFGNHRLLLAALCYSFIMYFSSALAQTS
FQLGVLRFAYGFGVGALMPSINSLLTKLTPKEGISRVFAYNQMFSNLGQVIGPFIGSNVA
VVLGYRSVFYVTSLIVFVNLIWSLIIFRKYIKVKDIV
>fig|160490.1.peg.373 Daunorubicin resistance ATP-binding protein drrA
MVMIEVSHLQKNFSKTIKEPGLKGALKSFVHPPREIFEAVKDLSFEVPKGQILGFIGANG
AGKSTTIKMLTGILKPTSGYCRINGKIPQDNRQYYVRDIGAVFGQRTQLWWDLALQETYV
VLKEIYDVPEKAFRKRMDFLNEVLDLNEFIKDPVRTLSLGQRMRADIAASLLHNPKVLFL
DEPTIGLDVSVKDNIRRAITQINQEEETTILLTTHDLSDIEQLCDRIIMIDKGQEIFDGT
VTQLKQSFGKMKSLSFELKPGQEQVVSQFMGLPDITVERHELSLDIQYDSSRYQTADIIQ
KTMADFAVRDVKMTDVDIEDIVRRFYRKEL
>fig|160490.1.peg.374 Daunorubicin resistance transmembrane protein
MWSFWKRYRPFLSAGIQELITYRVNFFLYRIGDVMGAFVAYYLWKAVFDSSKQSLINGFT
LSDMTFYIIMSFVTTLLTKSDSSFMIGEEVKDGSIIMRLLRPVHFAASYLFMEIGFRWIV
LMSVGFPFLMVLSGIKVMAGLSILQVLASSCLYLVSLLLAFLINFYFNICFGSSAFVFKN
LWGSNLLKNALVAFMSGSLIPLAFFPKMVSIVLSFLPFSSLVYTPVMIVIGKYSLSQIMV
ALSLQIFWLLVMVVLSQVIWKKVQYHLTIQGG
>fig|160490.1.peg.411 Multidrug resistance protein B
MSHHQQTVSKQTIMAIIAIALIGFSGILSETSMNVTFPTLMSVYQLPLNSLQWMTTIYLL
AVAIMMTTSATLKKNVRERPLFFMATGLFTFGTILAVLTQSFAIMLLARIFQGIGTGLVM
PQMFNIILERVPMHKVGLFMGFAGLIISLAPAFGPTYGGFMISHFSWQWIFICILPVPLI
AGILAYYYLEDSPVSEKVPFDWLAFIALSISLTSALLAITSLENGSVNLYYLGLFILSFI
LFLYKNLTAKQPFLDIRILKIPSLTFGLIPFFVFQLINLGINFLTPNFIVMEKIANSSQA
GMVLLPGTLLGALLAPAFGKLYDQKGARLSLYLGNALFSLSLIIMTLQTRHFMLLPFTLL
YILFTFGRNMGFNNSLATAIRELPAEKNADATAIFQMMQQFAGALGTAMASLIANSQAEF
TSGVQSVYLLFTIFALLDFIFFFAMFYHLGKKGLA
>fig|160490.1.peg.1428 Quinolone resistance protein NorA
MPFDSNTYIIPLKYIIFCFFCKMFMKIERSSFSMEEKLFNKHFVAITVINFIVYMVYYLF
TVIIAFVATRELGAQTSQAGLATGIYILGTLLARLIFGKQLEVFGRRLVLRGGAIFYLLT
TLAYFYMPTISMMYLVRFLNGFGYGVVSTATNTIVTAYIPARKRGEGINFYGLSTSLAAA
IGPFVGTFMLDNLHIDFRMIIVLCSVLIGCVVVGAFAFPVKNMSLNAEQLAKTKSWTVDS
FIEKKALFITAIAFLMGIAYASVLGFQKLYTSEIHLTTVGAYFFVVYALIITITRPAMGR
LMDAKGDKWVLYPSYLFLAMGLFLLGSVSSGGSYLLSGALIGFGYGTFMSCGQAASIQGV
DEHRFNTAMSTYMIGLDLGLGAGPYLLGLIKDLALGSGVASFRHLFWLAAVIPLICTLLY
LLKTKTRQVVS
>fig|160492.1.peg.243 Acriflavin resistance protein
MKITHVAMSANRLTLFTAVLLLIAGIATFLNFPSQEEPSVTVRDTLISVAYPGMPSEQVE
TLLAKPIEERLREIVGIKKIVSTVRPGSVLIQLTAYDNVKNLETLWLRVRAKVAEAGTGL
PTGTLGPFLNDDFGRVAVASIAITAPGFSMSEMREPLRRMREQLYTVPGVERITLHGLQE
DQVYVAFDRAKLVEAGLTPGAVIQQLQAQNVVTPGGLVSASGMALTVATSGEVGSVDELR
RFLVSVPGSASAREVPLSQIAQVQVMPADPPQTATVYQGQPAVVLAVSMTSGRNISEFGN
TLRAALEETSQLLPVGFQQHVVTFQADVVNREMSKMHHVMGETVLIVMAVVMLFLGWRTG
LIVGTIVPLTVLSALIIMRAINIELHTVSIVAIIMALGLLVDNAIVIAEDIERRLAIGEN
RRHACIEAGRTLSIPLLTSSLVIVLAFSPFFFGETATNEYLRPLVIVLAVTLLSSWLLSI
TIIPLLCLYFAKAHRAPTEDQGHNLYDSAFYRSYRAIISRVLEHKVLFIGSMLALLAVAV
IVITLIPYSFLPKSDRLQFQMSITLQPGSDSRQTLDTVQQISHWFADKQINPEVVDSIGY
VADGGPRIVLGLNPPLPAPNVAYFTISVHPGTDIDAVIARTRQHMHNAFPYVHAEPKRFS
LGANDAGVVIYRIVGPDEAVLRQSAKQISEALSALPGTYDIYNDWQARIPRYIVHVDQLK
ARRAGISSEEIAQALQMRYSGVNASLIRDDGVAAPIVLRGNATERATQGNPGDTLVYSQA
GGTPLPLSAIAKIENDTEPSTLMRRNLNRTITIIGHNAGMTTGEIVQALAPKVASLKLPP
GYRIELGGEIEDAAQANQALLQFMPHALVAILLLFIMQFNSFRKLFIVVASIPFVLIGAA
TALLITAHPFGFIATFGLLALAGIIVNNAVLLLERIEVELADGLPRREAVVSAAVKRLRP
IVMTKLTCIVGLVPLMLFGGPLWTGMAITMIGGLALGTLVTLGLIPSLYDMLFGLRFGKR
NVVETAG
>fig|160492.1.peg.1761 Drug:proton antiporter
MKPSEPDAASARAPDAPTPAAQRRAQATLIAVLLGFFVITLDAVVVNVALPTLAHDLGAS
VDGLQWVVDGYTLMFGALLLSAGALVDRIGARRAFGLGLVVFILASMACGGAPTLATLVV
ARLVQGAGAAVMMPASMSLIRQAYPDPVRRGHAVALWAMGGSVASTSGPVIGGWLVSLDW
RWIFFVNLPVGLLTLAFLARTPASPRRASPFDAVGQVTAILAMGALIYGAIEAGAQGLGA
TPVLAAFVLALAALAAFVWSQRCGAHPMVPPGLLAPRNARISMAVGFTFMVGYFGLPFVM
SLYLQQHRGLSAPATGIAFLPMMLIGLVLTPFSARLAHRFGARTMIVSGLLSMAVGLAAV
ASLPASAPVGWIAALMVLVGLSGPFVAPPVAAVLLSSVPGALAGTASGVFNTSRQVGGAL
AVAVFGALLVQAPSFMTGLRASLWLAAAIALVTAAMALRLQSTAAPEPSSTG
>fig|160492.1.peg.2371 Acriflavin resistance protein
MSRTHHVGFSTIFIRRPIATSLLMFGVLLLGILGYKKLPMSALPEVDAPSLVVTTQYPGA
NAKTMAALVTTPLEHQLGQISGLDIMSSDSSAGLSTITLQFSTHKNLDIAAQDVQAAIHQ
AILPSALPHQPIYNRVNPADAAIITLKLTSDTLPLRELNTYADAILAQRLSQISGVGLVS
IAGNVRPAVRIQVNPAQLSNMGLTMESLRNTLTQANVNAPKGSLNGKSQSYSIGTNDQLK
DASQYRDTIIHYQNGHPVRLSEVADVVDGVENDQISAWANAKPAVLLEIRRQPGANIIQT
VEQIRAILPQLRAVLPTDVHLDVFSDRTETIRASVHEVKFTLLLTIGLVVAVIFVFLRRL
WATLIPSVAVPLSLAGTFSVMAFNGMSLDNLSLMALVVATGFVVDDAIVMIENIVRYIEQ
GKSGREAAEIGARQIGFTILSLTISLVAVFLPLLLMPGVTGRLFHEFAWVLSTAVVISML
VSLTLTPMMCAYLLKPDTLPESDSPTPSTKITLWTRTVALYERTLDWVLMHQQLTLVVAL
VTVALTIVLYVTIPKGLLPEQDTGLIIGVVQADQDIAFSQMEQRTRAVADALRKDPAVTG
VSAFIGAGTINPTLNHGQLSIVLKPRNQREGLNTIRPRLQRAAAGIPGIVLYLKPVQDVT
LDTHVAATEYQYSLSNVDATELATWATRMTEAMRQIPALTDVDNNLADQGRALQITVDRD
KASLLGVPMQTINDTLYDAFGQRQISTIFTELNQYRVVLEVAPHFRTSTALTQQLGVASN
GSGALTGSNATSFGQAVSSNSSTATGIGNRNTGMTVGTGRIIPLSALADAKVTNAPRVIS
HQQQLPAVTISFNLAQGYSLSHAVKAIEQARTQLQIPPQVRVQFIGKAVEFTSSQSDIVW
LLLASIVVIYIVLGVLYESYIHPLTIISTLPSAGVGALLALMLCGLSLSVDSIVGIVLLI
GIVKKNAIMMIDFAIEARSTGSSAHDAIRRACLLRFRPIIMTTAAALLGALPLALGDGIG
AELRRPLGITIVGGLLLSQLITLYTTPVIYLFFERLSERLRLWRAHRTSVQATPQRV
>fig|160492.1.peg.2372 Acriflavin resistance protein
MNLSAGFIKRPIGTSLLAIGVFVLGLICYLQLSVAPLPKFQIPVIAVKANQPGANASTMA
TTVTAPLERYLGQIPGIKGMRSSSSENNSNIFLLFQSNRNIDSAAQDVQAAINAAQADLP
SGLLTPSYEKANPNDDPVIALALTSDTQSMDALYNVADSLLAQYLRQIQGISSVDIVGAS
TPAIRVDVDMQALNALGLTMDQLQNAVRAANVTSPTGFLSNDTRTTEILLNSTISKAADF
AHLVIATQPNGRIVRLSDIAQVYDGQQDAYQAAWFNHKRAVVMYVFLRTGANVVETVDRV
KAELPALRTYLPSGTVITPYFDHTPTIRASLYEIQTTLLISLAMVMLTMALFLRRLAPTV
IAAATVPLSLAGGAIVMYALDFTLNNVTLLALVIAIGFVVDDAIVMIENISRHLNTGMSP
LEAALTGAREIGSTIVSITVSLVVVFAPFLFDHGMIGTLFREFGITLVAAIIISMLVSLT
LTPALCSCFLSAHVVPEKSNGIGAWLERMYLRILRLYTVALDFSLRHALLLALTPLLLIV
STVMLAGTIKKGTFPIQDTGLIQGRADSSTTVAFQDMINRQHRITEMLLSDPAVKSVAVR
LGSGRKGSRTSFNIELKTRAEGRRESTDTVMIRLSTKAAHYPDLALRLRAVQDLPSNSGD
GANQGAQYRISLQGNDLKQLEGWLPKLQEALSKNPKLRDIGSDMDTAELYQNIVIDRGKA
AQMGVSIGAIDGALYGAFGQRQISTIYSDTNQYTVVINALASQSATPAALDQIHVPNRSG
KMVPITAIAHQVPALNPPQIKHDNQYTTMDLSYNLSPGVSSGEAEAIIEAVIKGLRMPGD
IHIAEDNSFKQDLNPNSMKILLIATLLAVYIVLGMLYENLIHPITILSTLPAAGMGALLA
LYVSDTELSAISMIALVLLIGIVKKNAIMMIDFALVAQRERGLEPHAAVREASIVRFRPI
MMTSMVAILAAMPLAIGVGEGAELRRPLGIAMIGGLLISQSLTLLSTPALYVIFSCLSQR
WHAWRGKYMAARSH
>fig|163164.1.peg.87 Multidrug resistance protein
MCWLYLLLSSILEILWAVTLKFSNSFTKVVPSIATLVIMIISIYFLSLAACFLPIRLCYA
VSSGICTIGITIIGATTFTENINLSQVLCIVLIVIGSIGLKLSI
>fig|163164.1.peg.88 Quaternary ammonium compound-resistance protein SugE
MNWIYLLLSSLIEVFWVITLKHSYGFTHLVPSIISILSMALSTYLLSLATRSIPIGVCYA
IWTGVGAIGASILGVYLFDEPVNLFEVICFILVTFGIIGLKLFDTAKQTVDKME
>fig|163164.1.peg.222 Bicyclomycin resistance protein
MLLPFLLILSLIAKFIEIDISVPSFPDMVHYFNVPEGIIQLTIAYNFLGFCIGGLFFGPL
SECYGRRRIMIIGNTLLLIGAVGCVFAPSIFWLLISRFVQGIGVSTSVVVFAIVADSYKG
DEAVKFIGIMNSVLTVVMAIAPVLGSFINEIVGWRGNYATVAILCLISWVLLLLALPETK
KNRDIFSLKKTMKDYRKLLSNPRFVTLSLMSSLFSAAYMSFITCGPFLYMKTFGLSSTIY
ALHQGAIVGCFSLISLFAGKILQKLGAIKCVISGTSVGAIGSLLLVIFSIIVPHSFYLVT
LSMIIFSIGCAIFQPVIFNASINVFPEIKGTASSAVSFIRAFIMAIFIGLTSYIYNGQTI
SVAVLVLSAIVLELVFTVYLLRLKDPM
>fig|163164.1.peg.341 Bicyclomycin resistance protein
MKTALSQNIISLIMILSVAIVDMATDLYSVALPSIANYFKVEGSVVQLTISLNLVGFAVS
GLIYGPLSDHYGRRPMMLIGMTIFTLASVMCYIADSIMLLILIRFIQGAGAGVAGVVGYA
AIRDMYSGSEYSRVISKLNMVVALSPGIAPVVGSYIISHGYHWKFLFFIMSLAAIAILIF
IYFKLQETLTVNKNETSITNITTNIFKQYISIFRNYRFLGFSAIHGLTFMWLWAYIANYP
FIFESMGIEVQYFGYLISIIVIFYIIGTLINRRYVPKVGVSKMLIIGLVLPIISNSLLVY
FYFADKLNIFILQTAWIPANIGLALIISNNVTSALETIKGIGLGSAVLSFCNMMFGAIGI
YIVGKFFRYGILPNLLLTIACSTIAILMYSQLKCTEKHRE
>fig|163164.1.peg.1193 Multidrug resistance protein D
MQSLLIERNRAVVLLLIVIFIFGSYVYVKMPRESNPGIQIPIISVFVGLPGISAQDSEKL
LVLPIENELRSIEGVRELRAFATNDGAHMILEFGTEYDNKEVLDNVRSKLSNIKSKLPVE
AESPIINEINLSLFPILNVGLIGNLPERALTEIARKLKKEIESLPNVLKVEVAGMRKETV
EVIVEPTVLTKYNIQSNEIFQAISSNNRLVGAGSLENDTGKYSIKISGLLKDIEDIMNIP
IRSQGDAVLRIKDIAKVYPRFEDHQGFARINGLPSVVLGISKRNGKNIIDTVNQVKYLMD
KAKDQLPENLKVVYLNDQSKNVLDVLDDLENGIIFAVLLILIIMMLSMGTRIAILVALSI
PGSFLIGIIALYFMGITLNIVVLFSLIMAVGMLVDDAIVISEYADRKMICGMDKVEAFYT
SVRDMFYPVLSSTLTKLAVFFPLLFWPDTVGKFMQYIPITIILTLTGSLIMALVFIPTLG
AIFGKPSITSKKEIKKMSAIESGEIKNAGPIIRAYIRMLEKVLDHPKKFVCATVFVLFSF
SVLYFTFGPGVKFFPKVDSDNILISVKAKESLSAKERDLILKEVEERILSIEKEIHVSYA
RSGAFSDNVIARIQLELMDWRFRRKAKHILNDIRSSVQDMKGIIINVQEEKPGPSADKPI
QINLSGSVSSLNLAAEKILEIMNQPSSGFINIQDSRSAPEIEWNMSVDKSKATSSEVSVA
TIGDFIKMVTNGVLIGKYRPNNTDEEIDIVLRFPRKDRNMKTIDNLFINTVNGPYPMSNI
VKYAPEKKVNKLNRIDGLRTVTISADVDTGYLVDERVKFIQNSIAQDWDKGVKIDFKGDK
EDQQKSGAFLLKAFILAITLMILVLVTQFNNVYHTFIVMTAVFLSTTCVFFVFFLIQQVF
VVVMCGVGIIALAGIIVNNNILLLDAFHHQIKVHKNDIKRCVINAAISRVRPILLTVATT
VLGLIPMITRLNINFFTLQITYDAPSSQWWVDISTTIASGILAATVLTLFFTPALLVIQK
HEKT
>fig|164546.7.peg.26 Multidrug resistance protein B
MMRVIGGIVLCILLAALDQTVVIPAVPAIANDLNGFGHLSWIVTAYLIVSTVTTPLYGKL
SDSFGRRRLLMVAITLFIGASVACALAQTLGQLILFRALQGVGGGGLMSLAQAAIADVVA
PRQRGRYQGYLATVWAVASIAGPLVGGWVSDHMSWRWLFWVNVPLGLLAMFMCYRGLAML
PARGGRARVDWLGALLLAVAIVAFLLAMSWGGDVYDWLSPELGALLLAAVAAVLLLTWQE
RRAADPMLPPRLFANRAYVLGVAASALAALDIFLCIFALPLHFQLVRGADASTSGLLVMP
FLLATVAGNFIVAWLAPRVGRLRGILTAGYIAGALGLIVLALVTPAVPLAVVLAAMTLAG
VGLGITMVATLMSVQNALERRDTGAGTGALLVLRSLGSALGGAVAGTLLTLEFRHALAAS
GVTQALDLGALRHGSEAFAQLSPSVRAVLAGGVESGFHLIFAVGAAAAVLALLIVRRMPD
VELRSSVTEHAATLAMD
>fig|164546.7.peg.160 Permease of the drug/metabolite transporter (DMT) superfamily
MPSQQPQRGGAWRMVAAMVLSGTIGWFVVTSGQPPLDVVFFRCLFGGAALLGVLTLQRGW
VRMTRAQAGWLVLGGVTLVLNWLALFSAYAYSGIAIATVVYHTQPFFLLMLTSVLQREPF
PFARLPWLVLAFAGVMLITGLEHGAGGASMLAGIGLGLLAALLYAVTTLATRRLQAIPPG
QIAGLQMVLGVLMLAPLAHPAAGSYGGGTWGALLALGLVHTGVMYTLLYGAFQRLSVVSI
ATLSFIYPLVAIVIDVMVFGVVLGPLQVAGMALVLLGVVANQLGWALPLRRRARG
>fig|164546.7.peg.1091 Permease of the drug/metabolite transporter (DMT) superfamily
MRDRRLPAACPMTASAPTAPTDARDKLAGVLLIAVSASAFGAMAIFARFAYAAGADVYGL
LLVRFLLAAAALAWVMRTRGIALPPWRRVLALAAMGGIGYVGQSFCFFSALNHAQASLVA
LLLYLYPLFVTILAAVFLKERLTTAAVVALVLCSVGAGLTVGGGAGSPLGIALGLAAAVI
YSVYIIVGARLTAGVNPIATTTVICTAAALVYGAVGLLRAGAGTPPQFPADAGGWLALAG
IALLSTVLAILTFFAGLQRLGAAQASMLSTLEPVVTVALAALLLGEQIGPAQAVGGGLIL
AGVLWLTRRGSAPAPARADMQGN
>fig|164546.7.peg.1706 Multidrug resistance protein B
MSEGPATPEGSGQRTGLPTRQALRARYGERLRWLVLATLMLGTISSIVSSTIVNVAIPDL
SRHFVLGQERAQWVAASFMIAMTLSMLLTPWLLNRYGLRRTFLGASLLLGAGGLLGGFSP
TYGVMIAMRVAEGIAAGIMQPLPNILILRVFEEREQGKAISMFGFGVVLAPALGPSLGGF
LVEAFGWRSIFFVVVPLTLLAVLMARRFMAVDSIMMGERQPLDWRGLGLAGIATVSLLNG
VVEMRESVPAGLALSGFGVLMLAAFVMWQLRAAYPLMNMRLYSYRQFAAGAVVAFIYGAG
LFGSTYLLPVYMQMALEYTPSRAGLVLFPAGVVLALTIAVAGRFTHRIPPHVQVSFGLAL
LSLSFLLMALGSRATPYLVLVGLAVLGRIGLGCILPSLTLGAMRGVDFTLIAQGSSCINF
LRQLGGAIGVSLAGVGLQWRLAGHGALLGQAGDTAVQAARIRAFDETFLAVGVVIASAML
AAWRIRPRPVPAA
>fig|164546.7.peg.1798 Outer membrane component of tripartite multidrug resistance system
MKPVLSFRFTQPASSRKLARRAGTLALTAIAAAALAGCAALGDSHSTQTMADPAAMATSQ
TLPGEHGQWPSQDWVDQFKDPQLSALVDEAVKDNPSLQAAFARVEASRAMAEATRSALYP
HVEFEGSLIRQRLSETDLFEGTPLAGSWQNQSRLQVGLSYDFDFWGKNRDALEAALSDDR
AAEAESQASRLILATSIARNYARLAALYAQRDVAERAIAQRRDLTELSRQRLAAGLDTQV
ETTQARGTVAASQTDLQRVDEEIALARNQLAALLGKGPDRGLQIERPVLLAQATPTLPDN
LTIGLLGRRPDLVAARWRVEAASKDINVARKEFLPDVSLSAFAGLAALDPSRLLMGISRT
FGIGPTLRLPIFEGGRLRANLKGKYAGYDIAVANYNQALVDALRETADTMTSIRSVDKQI
QTQREALDLAEHAYALATTRYKAGLGTQLTVLNAESNVLQQRRLATDLQARRLDLQMGLM
KALGGGYQEPAEGHESVAHGQAQQPDNTKAGARG
>fig|164546.7.peg.1919 Multidrug resistance efflux pump
MNDTPQPSAAPTVTPPPAPPPPTADTSKKGVRWVLLLIVVSLAWYLLADRLTPYTQQARI
QAFVVPVAAEVSGRVIKVHVRNNQDVAAGTVLFEVDPQQYRIAVDRARAELESTRRQIGA
STAGIESAQASLRAARANEVKARQDSERLERLYSEDPGTISLRRLEVARASLEQAVSQVA
AARAEVQRAREQEGGSDEDNAKLRSAASALEKAELDLANTQVRARAAGLVTDLRTDVGQF
AAAGNPVMTLIPIHDVWINAEMTENNLGRVEPGTPVAIVLDALPGRVFEGRVRSVGYGVN
VGPGTPPGSLPTVQNSRDWLRPAQRFPVIVEFDRGELAPLRGIRVGGQAEVMAFPTEGNP
LNPLGRLFLYLMSWLSYVY
>fig|164546.7.peg.2319 Acriflavin resistance protein
MWFTRLSIRNPVLATMMMMAFIVVGLFSYQRLPVDQFPDITFPVVVVQTEYPGAAPESVE
SDVTRKVEEIVNTISGIDEIFSHSYQGTSVVVIKFDLSVDVGQAAQDVRDKIALIRPQFR
DEVKDPRVLRYDPSDAPIFYLSVSNAPGASRSQRELTTIADQIVRKRLETVRGVGAINLV
GGTRREVEIRIRPAQLEALGIGVDQVMNAIRNENQELPAGELRSSAAETVVQIKGRVPTP
DAFRQIIVARRAGQPVTLGEIADVRDGQEEQESLALLDGKRALFLSVVKAQGQNTVDTVD
GLVRMTDEVRKLVPAGVQLNVVNDTARGIRSSVKEVRSTLLEGAFLTVAIVFLFLGSWRS
TVITGLTLPIALIGTFGVMYLCGFTLNVITLMALSLCVGLLIDDAIVVRENIVRHNLMGK
DHRTAALDGTNEIGLAVLATTFSIVAVFLPVGFMGGIIGRFFHQFGITVVAAVLISMFVS
FTLDPMLSSVWHDPDLHGTGNKRSWYGRTVGRLLDWFSASMDRLGDGYAGMLGWALKHRL
ATAIIAAATFFGSFALVPLIGTEFVPNADLGETQVGFTTPVGTSIEVTEAKVRQVEAALK
SFPEVAYTYATINSGNASGRNNALVSVRLTERRARSLTTAQLNPLIRERLASIAGITLTM
VGMPDGAGGQKAIQVSIQGDDLDELRRLSREAGARMAAIPGLTDLDSSMKDDRPTIEVRI
RRELASDLGVGVAQIGNALRPLLAGDAISSWRAPDDENYDVRVRLPKDARTGMADLSALM
IASSHANADGSPKMVPLRQIAELVPTTGANQISRRDLNREVELTANVAGRSAGEVARDIK
AALDGVNWPAGYKYRFGGSTKSMNESFGYAVSALALAVIFIYMILASQFASFFQPIAIMT
SLPLTLAGVFAALLLFGSTLNMFSIIGFIMLMGLVTKNAILLVDFANQARQGGVDSAYGR
EPLSREAALVEAARVRLRPILMTTLAMIFGMVPLAFSLGEGAEQRAPMGQTVIGGIITSS
VLTLVVVPVIYTYLDDFGAWLRRLWQGEPRATAAAPAQAGSGQPAAGGRPAPAEASAE
>fig|164546.7.peg.2600 Permease of the drug/metabolite transporter (DMT) superfamily
MAHFPALGFRLLCMAGGLVALGVALRLRGDSLAVPRREWGTVVRLALPNMVVWHLFAICA
VKLLSSGRAAILGYTMPIWAVVWGLVFFRERIGAWAWLGIGCALAGTVLLLSGEFAALTG
SPAGTLLMLLAAAGWGFGTQLMKRTQTDVPIGAMTFWMLAVTLPFLALGTLLLEDGWRMP
TAIEWAAIAYNAVVVFAFCHLVWFGLARSLPPVVSSLSIMFIPVVGVFSGMWLLGEQPHW
QDYAAIVLMFLALSSVMLAPLLWRRLRGVPG
>fig|164546.7.peg.3574 Bacteriocin resistance protein, putative
MMKPLGILLACVPWLLATAHVPQAQAADVALYGPVGEPYSVRVTSIREARFKSTIRQQYD
FSCGSAAVATLLTYQYGHPINEATVFQNMYLNGDQQKIRAEGFSLLDMKRFLAALGYEAD
GFELPLSKLEETQVPAIVLIVENGYHHFVVVKGVKGNRVLVGDPARGTRAMSREQFERIW
DSQLLFVIHNRTERARFNVAADWRVAPSGPYWMGVNRDNLFFTVMPRHGAGDF
>fig|164546.7.peg.3690 Multidrug resistance protein B
MFGLTLGLVTGIDFSSTLMMGVASQHIQGGVGAAPEDYLYAISAYAATAVLMNMVLDQLA
RRITYKRFTMASLLVFIAGSLICAEFASPAGLITGKAVQGLGAGGLFAASRILVQLVSTP
AERGPLMLRFGGGAFSMLAITPWLTSIFLDDIGWRAVFLFQAGIALPVLLSVALTYPAPA
PRDSHPPVSTLDWPAAIAAALGALVFLHTLQEMRYTRFFSSLEMPLAALCGVALFAFSGW
RLYRHPDPWIDFSRLAGRQYLYGLGFYTLYYLLSSAWSFLLPTLTQTGLGLTFRTTCMLL
STSGTVSAIGAIVITLGMALVFRKRRVIAIGFIVYACAALLLSTQLMPGAPDYALVPVVL
LEGLTPVLLMVQVASMTYLDVPVEDFSHAYQFKNVCKQIASAMGTGLASVFMQDGLAQHR
THLVEHITRFNPVLQMPDALSAAGLAKLSQEVDRQATLLAGMDLLHGFAALCVAGAVFVL
VQRSFR
>fig|164546.7.peg.4367 Permeases of the drug/metabolite transporter (DMT) superfamily
MPASNPSTRRIDWTTLFLLTFPPLSWAGNAIVGRLAAGTVPPVALNWARWVLAGMLLAPF
AWRGVVEHRAVLRRHAGVITAMGILSIASYNALQYLALTSSTPINVTLIGASTPLFLIVI
GALCFGERVRPWHVAGALLCMVGVTFVLVRGELARLAQLDLVPGDLYMLAATIAWSAYTW
LLRKQRPALPLPVLLFAQIVTGVLASAPVTAWELLTLDQPLQWNGKVAGILLYVATIPSL
LAYFAWDRAIARAGAQLPVFFITLTPVFAALLSTVLLGDWPRWYHGVGLAAIAAGIWLAQ
RR
>fig|164546.7.peg.4630 Outer membrane component of tripartite multidrug resistance system
MGPDYRVPDRAAVRDAVANGPLQGAQAPHVAIAPVPDDWWRLYDDERLDRLITKALAANT
DIRAASANLRRALALLHEVESENLPQGSAGASVARAQLSGESFLQQAQPPVFNLGDLGLG
ASYLIDFFGKLARADEAALAGAQASEATLDMVRVAVAAQTVRAYVQGCAATHALHAAGQQ
LAVQQRTLDATRRLLAAGRAEPAEVARERARTEALRATLPPLQAARSAARYRLALLLGQA
PATLPDADVACDAEPALRAPLPVGDGAALLRRRPDVRQAERELAAATARIGVATADLYPS
IRIGASAGLTGVLSHLGSGPTARWSLGPLVSWSWPTNGVRHRIHGLEAAADAALARFDGV
VLRALQETETALSAYSRERERHAALHAASEHATQVAQQQRRLWQAGRVPWLAHLDAERDL
AAAQAALAASAGEVAGRQVDVFLALGGGWQTARRLAVVPGTMDEKND
>fig|164546.7.peg.4633 Inner membrane component of tripartite multidrug resistance system
MLALYLALALGLARPYWAMATVYFVSHPLTGATRSKAAYRVAGTVLGATAAVATVPQLVN
MPLVLMGAIALWISVLVYLSLLQRTPRSYVCLLAAYTLPIVALPAVSQPAQIFDIAVARI
EEIVIGIVCAGLVGSVVFPARVAPALRARAATWLADAAAWAADILGGSPRADHSRHRLAA
DILQLDQLISQLAYDTEGSYTLRHARALRRRMTMLMPLLSSLESVLQALRGHADGIPPEL
REALAATAAWLGSDAATAPPAALEGCGVPSRPGARGWHDGLAATAADQLQRLCALYAECR
ALQQGIGDRSAGTPPALGESGPEAAGHHHDHGMLLFGAVSSGLAVFCAGLLWIFSGWEDG
AGAVVVASIACCFFAAVDEPRRMAGAFARWSAVCLAISSGYLFLVVPHAHTFEALAAMLA
LPYLGIGLLVARPGFQLIAMLLSVNTAAFANVQAVFDADFLAIFNTCLASAAAMLFAPLW
SVATRPFGARAAARRLVRASWRDLAQAATLRAADGDARLGARMLDRLGQLVPRLGAAGDA
LSADGFHALQVGYCALALRRALPDLPQPARKPVRRVLAALARHFRAQLRAGHRVPVSARL
AAAVDDAMASMAASGPTGQRGTLGALVVLRVTLLPALAMTPSR
>fig|164546.7.peg.4971 Permease of the drug/metabolite transporter (DMT) superfamily
MLLCLLITYVVWGTTYLAIRFTLESFPPLFMMGTRFLCAGLLLGAWLAWRGTPMPSARQL
RHCAVPALFLLVGGMGLTAIAEQTISSGATTVMIGSMPIFALIWGACFGNRPKWFEYVAI
AIGSAGILVLTAGEEFQVSAGGVVALLLAVASWSFGSQLARRLDLPPGAAAFAAEMVIGG
AVLMALSLLRQEPWPSAVSAQAGWAWVYLVVAGSLVAFSAYMYLVSTVSQTLAASYVYVN
PPVALAMGAWLGGEQIAPQTLGAVVLILAALTVLSLGTLRAARAQAA
>fig|164546.7.peg.5085 Bacteriocin resistance protein, putative
MRDEGVVRQQYDYSCGAAALATLLRHYYGEAVSETDVLKQIAAKGPATLSTLSAAATHFG
YEARGYALSLEALRQINVPAIVFLHVGNDNHFSVLRSIDAHSVELADPSLGNRIYSTTDF
LRLWTTRLNRNYPGRALIVMPRDARRAANPAFMRPIPARFAGLTLRPFRP
>fig|164546.7.peg.5170 Inner membrane component of tripartite multidrug resistance system
MAGALGAAWAGAPDLAPWLHSLKVFGAAMLALGTALALGLPRPYWAMATVYLVSSPLAGA
THAKGAYRVIGTLLGAIGAVALVPWLVDQPMLLMAAIACWTGTLLYLSLLEPAPRNYICL
LAAYTLPIVALPTVTHPGTVFDIALTRIEEIVIGIVCASVVSAVVFPSRTAPALAARAAA
WMDHASRWTTDMLAGGASAGQRHDSFSTLAADILALETQMAQLAYESGNAHTLRRARALH
QRMTALLPLVLALADTADALRRHRAGMPEHVAQRLRATLAWIAGAAGSSRPPPSWYPAGR
APAAPADWHARLVAAACVYLDELGDLWQDCRLLQASLRQGGSDPAALRYRVEPAGQARHH
DHAQLLFRAATAGSATLVAGLLWMASGWVDGAVPVGLAALASCFIACTPEPRLVAGRVIA
WSVACALLSWYYQFVVLQLAHDFGSLAALLFGPYLVIGAMTTQPRFALFGVLLAVTAASF
PGPQNLGTASFAGIFNGSLASLAALVFAALWAVLMQPFGQQLVAYRLARANWNEIALAAH
PRAPVNSARLRGRLLDRLLRQWPPLTRRNHASHEQAANALADFLVEVAVLALRRATDRAV
ARVLAGVARHYRRCARAGHAIPPAPALAAQIDAAFAALATPAHGSPRAALAALATLRLAL
YPHDQDGRHARH
>fig|164546.7.peg.5282 Acriflavin resistance protein
MADHDLSRLKIDRQAAAAGVRLRPRRRWLRYAAIAVVLLALAGIAIRLASPRPVQTATVT
SAFPTQNFTLLNATGYVVPQRKAAVASKAQGRLEWLGVLEGSRVKKDEVIARLESKDVAA
SFAQAQAQVQVAQANLALQQAELKDAEVNLRRSRILIVPNAISRTQYDADVARFDKARAS
VNSSRASVVSAQANARAAEVAVEQTVVRAPFDGVVLVKHANVGDNITPFSAAADTKGAIV
TIADMETLEVEADVAESNIARIRVDQPCELLLDALPGLRLAGQVSRIVPTVDRSKATVLV
KVRFVDRDARVLPDMSAKIAFLSRAATAQDRQPVVAVQPAAIATRDGRQVVYVVRDGKAH
EMTVKTGNKLGELVAVQGVKPGDVVVLSPGDQIGDGSRVATSKP
>fig|164546.7.peg.5296 Permeases of the drug/metabolite transporter (DMT) superfamily
MPRPLSTAAWLPAAAFVLIWSTGFIVGKAIVPLADTSLFLLGRFAVAGLMFVGWSLAARA
AWPPLREAPRHLLAGALMQGLYLCAGYGAIAQGLPPAIMALLGALQPLLTALLAIPLLKE
LPSRRTWQGLALGALGVALVVAPAMQAGLDGAARPLSPWIVLLGVLAIVSITMGTLLQKT
AIATCDLRASSAWQSLGALLVAAAMVAVQAAGAPLHWHGAPALWAGLAWAAVGLSGAGTW
LLVSLVRRGQAANAAALMFLAPPLAALQAWLLFGERLSGVQALGMAVAGAGVWLCQTRGR
MRHAEAR
>fig|164546.7.peg.5710 Permease of the drug/metabolite transporter (DMT) superfamily
MTNNEDCAARFDAPRNTLATRTTSTALWATPLFVLLWSSGAIAARLALDHATPFALLTLR
FALVCAVLGALGLARKRLLPPRGERLHTACAGLLLIGGYAVFYFLALDHGMTPGVLATVL
GAQPMLTLLLTERRASAARLGGLALAFAGLAMVVADSLLLARLSPAGVLCALASLASMTL
GAILQKRSTRAPAEVLPLQYGASLAACLLCLPFQPFAFEASLAFAAPLLWLALGISIGAT
LLFYRLIHAGNLVNVTSLFYLVPAGTAALDYLLLGNRMTALALAGMGAVLGGLGLVFRGG
RNPMPG
>fig|167555.5.peg.1690 Permease of the drug/metabolite transporter (DMT) superfamily
MILPFALWGTSMAAMAPLVNAAGPEIVASLRLLPAGLVVLASVPFLKRSWNISKDDLVWF
LVFTLIDATLFQVFLAKGLMETGAGLGSVLIDSQPLMVALLARILFGDAINPIGWIGLVL
GLVGIICLGVPTELLENWFLLGNFESGSNFLSHGEVWMICAATSMALGTVLIRFACRNSD
PVAVTGWHMVLGSVPLIVWHVFDKNWPLFPDWSAFEWTLMSYSSLFGSALAYGLFFWFAS
RKELTSFSTLAFLTPVFALITGGIWLGERLFLLQWIGVVLVLISVLFVSQRRRFWGNKSD
NELIKEA
>fig|167879.3.peg.97 Permease of the drug/metabolite transporter (DMT) superfamily
MTVTSPRIATILLLIVCFIWGVEFVPIDLAIEVMPTNTFNAIRFAVATLSMLPLLWFVQK
KNKGNSKPIDYVLLIRSGMLLGFFLFIGFYTQTEGMRFTTVTNAGFITGLCVPLVPVLGF
LIFRNVVPKSVWIGVVTATAGLYMLTIGDKLVFNKGDILVLICAFGFAGHIIMTDRFVDN
LPIIPLSIVQIFAVSIYSTIAIFIGPDPVFYYQDAEPVSWYQQLFTPLMIFAILVSGILG
TAYAFWAQSVSQTLLKPHKVALIFAAEPVFACIAAWVFLDEVLGEKGMIGAGLILAGMLV
SELGDRKKQPELRALDQTAALK
>fig|167879.3.peg.540 Acriflavin resistance protein
MNITQVAFTYRKSVFLIIAVLLINGLFAYFTLPAQEDPTITIREAIVSTSFPGMAPDRIE
QLITKKLEEEIRKIPQVKEIKSSSATGISIIHVKIYDRYFNLDDIWQNLRNKVTAAHNKM
PSGTHTPFVNDEFGDVSVVTLALTADGFDLGEMYDIAQHIRDTLYGVEGTKKIEILGRQE
ERIFLEASNAKLAQLGISPQSLINELQKQNIVRSGGEVNTGAISFIVEPSGNFNSLVEIG
DTYISIPNTEDFIALKDVVTLRRDFIDPPDKTAYLNGQSAIFFAISMLPENNLLEYAPRV
LNKINEIESSLPIGYNLEIATYQADQVAKTINGVSVNVLQTLAIVLVVVILFLGLRTGLI
VGAIVPFVMLTTLSIMQFSDMKLERMSLATLIISLGLLVDNGIVIAEDFKRRLEDGVDRY
NAMLQGSKELAIPLLSSSVTTVLFFLPLMLAEHVAGEYTRSISLVILITLLTSWILALCV
TPLLCYFFITLPENKKAKVENNESTREEPGKFYRYYETFLHWLLKHKALFMTAMLALFIG
SILSMKYVAKQFFPDSDRTQILVNIDLPNGTSSTETNRQMKDIFTWLEDETRFDFIESYS
AYVGFSGPRFVMSLNPEDPAQNKGFMVLNVKDETDISATVLSLDEQIEHDFPNVSARVKK
MFLGPSDSSTIKIQVKGPDKEVIYKKAQQIMAVLHDVPNTIDIRTDWENLITKIDVQIDQ
HRAKRSGLTSEEIAQALDAYFSGSKITEFREGDNIIPVVLRAEQAERQSLDRLRTLNIYS
NKTGKTVPLFQVANLAPYNQFSIIHHEDLFRTISIQARNTDVAAEDLKLIIDAKIQALAA
DLPINHNIEYDGVIKESRAAQKALGASMPIVLGLILILLVAQFNSFRQAAVITLTIPLSF
IGAVLGLFLMQAPFGFMVTLGLYSLAGIIINNAIVLIDRIKIETASGKSDYQAVVDACLT
RLRPIAMTTITTVMGLLPLIIGKDPLFYGMANVIAFGLGIGTILTLAVVPALYCGFYKIT
DVQVEPV
>fig|167879.3.peg.1801 Multiple antibiotic resistance protein MarC
MNLLMEHALTVFMAFFAIMNPIANTAVFAGLTGDKNKLEQRKIAAKALIITFIVIASFAI
LGKSIFHLFGITLPALRITGGILVFIVGYHMLQGSGSKLHHTQGDDSSDSDVAVSPLAVP
LLAGPGTIATAMNYSSSNGWMEIIITLSVFAALCLITFICFIFSSRILAAIGKSGLSIVT
RLMGLILAVIGVQMLLVGIKAVISTLG
>fig|167879.3.peg.1823 Acriflavin resistance plasma membrane protein
MTAKSLMKSKSITSNKSILSAPSLWMIDNPIASSLLTFSIIILGLLSFNSINQESSPSFQ
INEILIETSYPGATPKDIEQGIILSIEHQLRDNPNIDRISANAYEGSAEIIVELIEGVNP
DTILSQVKNSIEGINSFPVEMENPTITFVEELDSIVEIGLHGNVSELLLYREASQLKQAM
LDALDLAKIDIQGARSPEIVIELNQVKLRQYQLTLAQVLSKVKTSVTDVPAGSINTQGGE
ILIRTLGRKELSEQFSDITIITDDSGNSVTLADIATISDSFQGQIRPFKVNSDAGLELKV
YQNKNSKPIEISKEINAFITDYQSEIPAGLTLTILQDQSDPFSQRINLLISNGLIGMLLV
ILVLSIFLDLRLAFWVSMGIPISIIGTLGLMPLLDIPINMITLFAFIITLGILVDDAVIV
AENIYLKIQQGITMNIALKDGVKEMTLPVVFSVTTNIIAFIPLLYVPGELGVMYKPMTLL
IFAIFTVSLIEALLILPLHLRHIDKPMRFRVISNVQAHCFKRFDHLKTAIYAKWLRTSCN
NPVTIIIIFLSLATLVFSWVYSGRVDSSFVPKIESTRIDAEVEFPTGAPLKNKIDIINYI
EAAGIKAIESLNGQDDYKFRMQDIGSSSGSSTFMIVTDDQRNFTAKEFVDAWRINIGEVP
GVKSIFFDYQVGPGGGKELVIELGHKDADILTLAAKELMNGLNRISGVTDIDSALMDGKL
QYNLTPTPLGKSLGFNSDNLGELIRLRFFGGEAIRQIVAGDEVKVRVMMQRSQQYYANQL
NRLIITAPNGDSVELSQVASITTTKAATSINRVDGIQLVEVTASILRQVASASLILKTIE
EDLLSNLSAKYPELEVELGGEARIESKVNAEIIKGIGLAFALIFAMLAIIFRSYLDAILV
LLIIPFCLAAAMLGHIVMGYSFSVMSLFGMIALSGLVINGSFVMLLKVKALRKEGMGHKE
AVIEAALNRFRPVVLTAVTTAAGLFPMLFETSTQALYLVPMVISLSFGSVFSIATILLLS
PAMFTLSEQFKVNNEKTESLTKSTINTSKVRAFG
>fig|167879.3.peg.2319 Acriflavin resistance plasma membrane protein
MFKSITKESATDKKAAQKYNSIAWMINHGIAPNLLMLLLIVGGLVMSFIIRKEYMPDVTL
DRVGIVINYPGASPDEIESAIALPIEAIITPLEGIKEVKTIIRTGRLFIRAELEGSDNAQ
KIFQDVQQAITRINTFPTEMDKPRIFLASKVRDVMEIVVHGDLDAIGIKRLSEEIRDRIL
QSVDISKVTLHGTAKEEIHIDISQHMLNSLQTDLSTIAKKISLLTKEQSTGTIKSNSGNI
LVKVDERLLWADEFAQLSIMPDKNGGALQLKDVAKITEGFADSKSMITFDGQLAASLRIY
RVGEQSPDKIGKAIEAMWPELEALLPPTAGLTIIDDDAKNYQKRLSLLLKNAFFGLLLVL
FFMSLFLDFRLAFWVVAGIPSAFLGAILFLPSFGISINMVSMFGFIIALGIVVDDAIIAG
ENIYTHMQEGMPFSSAAQLGAQEVAKPLTFAILTNIIAFIPLLFLPGFMKLMFGAIPVVV
ILCFVISWLEALFILPAHLARINQKTTKTPGNNILSKSAYYFSFAMQKAQQNFDKALESF
IQHPYLSVLKKCLSWPALTLSIASLILLWVLGYAFSGKMGFSLMPKMEGRWVKASIVLPE
DFTLMQMNKVKDKLESNAKEMLSKNEIEQAVISIRSEIFENTLEVGLLLVDSEEREISSV
DIKSLWREQSKLLGKQSLNNLGKLRFGSARKNSNSQIEASITLELRHNDTNVLSNAAIAA
QNYLQSDQQSGQYITSITNSMEQGNPQWSLTLNENGQSLGFNGSDVAKQLRSSLYGARVT
RQHRGQNEVTVLVRLPLRERQSSGDIENLLISTGDGGFVPLNEIANISKTYSPATIKRYK
NQRIEQLYIEVEDETKTPQVNDFIHQQLTLRLTRQFAGLKVSMSGDQKEIAQSVSKLELG
TLFALTGIYILLAIAFKSYLQPLLIMAIIPFGAVGAILGHLLLGFGLSIVSLMGMLALAG
VVINDSLIMVEYANKQVTQGHKPKQAIINAGMRRFRPILLTTLTTFGGLAPMVFETSRQA
QFIVPMAVSLGFGILFTTFICLLVLPCLYLITSEYNDIKA
>fig|167879.3.peg.2693 Permeases of the drug/metabolite transporter (DMT) superfamily
MEIWIYFTLLAATMQAVRTAGQKQLSGKLNSMATTGVRYVFALPFAWAYLWWMLDFRQVA
VPALNNDFLQYALIACVMQIVGTVCLVAAFRYRNFAVATSLAKTEAIQVAIVGALVFGAT
LSGLGWFSVIVGVVGVFLVSKVRFNLRDILADSQGLIGMGYGLAAGLGLAITTLLIRESS
LALNTDLMVSAAVTLVFMITVQSVISLIYVYIQDKSQLPLMMKHWRLCLFVGVTSVLGSI
GWFTGASYQNAAYVKALGQVEFFITLALTYRVFKETVTLKEYLGMFLIVLSVVILLLWS
>fig|167879.3.peg.2798 Permease of the drug/metabolite transporter (DMT) superfamily
MSVSIAYLAVLLIWSTTPLGIVWSSESINPSLAVLLRMLIALVLGALVIKIRNIHIPWHK
QAVKLYSFSALGIFGGMLCSYLSAAYLSSGIISLVFGLSPVISALLAKKILSEPNISGMR
KFSMAISLIGLAVVCSDNFTLADDGIYGIIFILMAVFFFSLSGVLVKSVSLAIHPLATTV
GALSVATPLFLVSWLLLDGTLPIETWQAKSLWATLYLGVFGSLIGFYAYFTVLQKLSASN
VTLITLITPVIALTLGAVLNGEVINDKLILGAFMVLLGLSIYHFGHLLPRLKKKRARS
>fig|167879.3.peg.3142 Permeases of the drug/metabolite transporter (DMT) superfamily
MTKSTPHPSSIIKAEQQSLLYLHIAVFLFGGTALFSKLIGLPALDITVYRTGIAALALFI
LLTLQKKQISLSSMKDYGIAILLGCVVGLHWVTYFTGMQMAGVTVGMIAFFTYPVITVFI
EPFFNRTVPKMKDMITAFVVIIGIVLLIPEISFGNQITLGIVTGIISAVFFALRNILHKN
YFSHYSGPHTMLYQTLVACLMLCLFVEVPPMQVTESDWLLLLLVGVVFTATPHALFASSL
RSLSATTAGLISCLQPLYGSILAIILLHERPDILTIIGGLLVVSAAIFETWSVSRGRR
>fig|167879.3.peg.3176 Acriflavin resistance protein
MNYTRAALKNPAAIIVIVVLVMVFGLLSVAKLPIQLTPDIEQPQITIFTGWRSAAPSELE
SVIIEPIENVVKNTQGVIRVDTSINQGFGRINLTFDVGADMQKAMLDVINNLNQVPPLPI
DAIEPIVSANGGGNTATMMIKTLPDNPVEDFGQYQKLIEDVVEPRFARIPGIGEVNLASH
RQREIRVTFDPVKTASLGLSIAEISSVITNSNDTSAGTVNVGRRQYVVRFSGQYSLDNLT
QMIIGYSDERPIYLQDIATVDNTLADRQGFNLRNGQPSYYLTLRRQNGENIVALLDKINI
AIKELNEGPLKAEGLTVDLSFDSSVHIRNALSLVQNNLGLGVLLSLVILWLFLRGMRNIL
IIAITIPVSLLVAFVALSLFDRTLNVISLAGLAFSVGLVLDAAIIVQENIVRLKSKGMDN
HKAVLKGTTEVTGALFASTATSVAIFLPILFMKGIEGQLFSDLALTLSIAVIASLLSAIT
VLPIASKYLLKDVSDIDPFAHYWERLTVLVMKLTNSKFKRVTWISLLLAGSLIISFTLLP
KTDFMPRAPTDGFFFSLDMPPGGNVDFIEHEMASLVKKRLAPYLTGEKSPKIKSYNFYSF
GSNATGGFIYSDDPSRVEELMKVVKADVFSGLPDTEVFMFRGSMINISGNGNGRTIDIDI
HGTDIEGLMEVAKTGIAAINENMPDTTAFPIPSLNLAEPELNLLPNDQRITQAGLNRSDV
ARAISAYTSGLFIGEYFDGNHRSNIILRGEQWETPDELAMMPMHTPLAGIQTLGELTHIT
RSAGPTELKRINGKRTVSIQVSPPATMSLEEATALINEKVIPKMQLDLPENSAISLSGNA
NQMASAISDMISNFILALLILFLLMTALFKSAKDSLMVLLVMPLATAGGVIGLSILNIFT
YQSLDLLTMIGFIILLGLVVNNAILLVDQTNQGGLEGLSRCDAVAQAIRIRARPVYMSTL
TSLFGMLPLMLMPGVGSEIYRGLAAVIVGGMTVSAIFTLVLFPSLLRMTQGKHASPTTNI
VSISATEQELRISNR
>fig|167879.3.peg.3260 Glyoxalase/bleomycin resistance protein/dioxygenase precursor
MKLGAFSVSLAVSNIEASKVFYQKVGFEVIGGDQTQHWLILKNGEHTIGLFQGMFEGNIM
TFNPGWDKDGKTLESFTDIRELLKEFEAQDVEIIQQSISGESGPSSFSIKDPDGNAILID
QHV
>fig|167879.3.peg.3458 Multidrug resistance efflux pump
MDMLIILTYTALCVAIFKTFKIPLNKWSVPTAVLGGVVLLSSIMIIMNYLHPYAKYGKEV
FATIPITPLVAGNIKSVDVIPNIEVKKGDVLFTLYNEEQTIALEKADAAVEQAKNQVLQN
DQALLAATGQVAKADANKDRTKASYYRYMEGHLKGGESSPFTQQELDNRREFYEAALASL
DSAQATERKVRLLTESNILGENTQVAQLKAARNRAQLDLERTFVRAPVDGMPTQVALRPG
MRAGILALRPVMSFIPTEKRRFAARIWQNSLLRLEKGLDAEVILDAVPGHVFKGKVVEIL
PAMAEGEYQGNGVLRGAGSLATHGFTIAIIELEENLDDYNLPRGVQGQAVAFNPKGDFLH
TSMVRKILFRMMSWIKYVYPIK
>fig|167879.3.peg.4022 Permease of the drug/metabolite transporter (DMT) superfamily
MSKSLGFKVSVSFVNIFALPFFFVLLYGSGFVGAKLGLPHSTPLSFLSLRFMAAGLILLI
IAKLIGNQLPNWREAIHISVAGSLTVCLFSVGVFVSIDMGLSPAVSALIVALQPILVALF
ARKLVNEQLNLAQWFGLLFGFLGVIVVVIDSIETTSFSWVAIAMSVLALFGVTFGSLYQK
RYCADMEIFYGGAIQSLVSGLICLALLPFFESFKVVWTGEFIISLVYMVVGVSLGALSLL
YIMIQRGEVSRVASVFYLVPVSAAVSAYLLFGETIESTTLFGASIIALGIFLTNRKSQNN
MVVSMNK
>fig|167879.3.peg.4315 Multidrug resistance efflux pump
MSEQEQQKDATVQEAKTVIETQDPVRKITKYVLIITALIFVWYIIADRHAPWSDQARVQT
YVIPIVPQVSGRVIEVLVKQDQIVAPGDILFKIDPSDYELAVENAEASLEMAGQEIGAGM
ASVVTAQAQLVVAETNVEHVNAQSSRVFEMEDKNVLSHSEGDKARAAIKASKAQVVSAEA
NLDKAKQSLGKEGNANPRIRAAMAQLKKTQLDLSRTVVLAPSYGGITNLQIDTGFYAKAG
AASMTFIEGNNAWVQVNLRENNLANLAIGNSVEIALDVNPGTIYQGKISSIGFAVDTSST
SAVGGLATVESKTGWLRDAQRFPVMITFDDDSTKGKRRLGGQADVQIYTGDNWFVNSLGW
LWIRVLSILSYVY
>fig|167879.3.peg.4769 Permease of the drug/metabolite transporter (DMT) superfamily
MKSKQNQSKQMTGMLYSLLGVLLLTPDALILRWVTIEHSEVLLWRGIFFSLGFSFIVLVR
HRSNAVRALINAGWPGIITGFFFAMNTYCYTQALQQTGAATAMMIISTAPVFAALIAWLW
LGERISLPVGLTITMTLLGMAIIVSDGDDGNSLFGNMMAMGCAIFMAINFNWARRYASLD
ITPGLIFGGLFIIALGWFNTSVVAARPDEIGAMFLSAAIAMPIGFVLLQIAPRYISATEV
SLFLLLESIIAPIWVWLGLGETPSNITLLGSVIVLVALLLYCYVVRLKAQTILTTKEA
>fig|169963.1.peg.108 Multidrug resistance ABC transporter ATP-binding and permease protein
MESMKWIWQYVRKYRLLMIGVFILIFIASGISIIYPLLGGKVIDDVVYQNKTNLLIPLLL
IMIISTIIRTICRYTYQIMCERIGQNSLFRIREDLYKKLQSLDFDFFNNTRVGDIMARMT
GDTDAIRHFVSWVSYNILENVFLFSFAIIIMATIDWKLTLALVIVTPLIAVLTMKMSSKA
QPVFYEIRESFSRLNSMVEENISGNRVVKAFAREDFEMKKFHEHNEDFKKRNLDSADVSR
TYLPVLDSLAGMLVVITLIFGGYLVIKGQMTLGDLVAFNGFLWMLNGPMRMSGWLINDVQ
RFIASSFKIQDMMVTDAKIPIHAEKPAPSLQGHVEFKNVSFHFEDDPNTDVLKNISLKAS
PGQTIAILGETGAGKSTLVNLICRFYDPTSGEILIDGVDARKWHVRELRNHIATVMQDIF
LFSDTIEGNIAFGAPDATMEDVRRMARIADADHFIETMPESYDTIVGERGVGLSGGQKQR
ISLARALLKNPSILILDDTTSAVDMETEVKIQGELKKITENTTTFIIAHRISSVKEADEI
LILNHGEIIERGTHTSLLAEKGYYFDIYNKQLGTEANVNG
>fig|169963.1.peg.490 Permease of the drug/metabolite transporter (DMT) superfamily
MQKEKAPIGLYFLLIAVMASWGFNVTMTKVLVSYFPTVTMTSFRIFTAAITVIIILFITK
KLRLPTKQEFGLILLASIFNIVIHHFFLSNGLKLTTGTNAGLILGSAPIVVAIFSVIFLR
ERIGAWRALGFLAGIFGVSLVVLSNGTGISGISLGDIDIFIAMASQAFSFIIIKKLAGSM
DTGLMTGYMLFLGSVMLFGLSRFMEPDGMSELVTVHSWKLWLLFVVSAVVATAFGNFVYN
YAVGKIGPSRSAIFMNFNPLFSLIGALLFLGEAIKIPQLVGFGFIIIGVLLGSGALMDLI
YERKKTKVRDPEKLLEKEV
>fig|169963.1.peg.514 Drug resistance transporter, EmrB/QacA family
MQQEATGGQKIRPIPIIASFLMAGFIGLFSETALNMALSDLIQVFDISSATVQWLTTGYL
LTLGILVPISGLLLQWFTTRGLFFTAVSFSIAGTLIAALSPTFAMLMIGRVVQAVGTALL
LPLMFNTILLIFPEHKRGSAMGMIGLVIMFAPAVGPTISGLILENLTWNWIFWISLPFLI
IALLFGMKFMQNVSVVTKPKIDILSIILSTLGFGGVVFAFSSAGESGWGSATVLVSIIVG
GIALGLFVWRQLTMEKPLMDLKVFKYPMFTLGLILVFISFMMILSTMILLPLYLQNSLAL
AAFSAGLVLLPGGVLNGLMSPFTGRLFDAYGPRALVIPGFIVAVVALFFLTRIEVGTSAL
TIIVLHSVLMIGISMVMMPAQTNGLNQLPPKLYPDGTAIMNTLQQVSGAIGTAVAITIMS
AGQKAYMETAQGVGPEQMVASLTAGIQNAFVFGLIMACIGLLCSLFIRKAK
>fig|169963.1.peg.738 Multidrug resistance ABC transporter ATP-binding and permease protein
MLEVKHLKKSYKLGKKNETPVLKDINVTIQDGEFAAIIGKSGSGKSTLLNIISGLDTDYE
GKVLYNGEDLQDIDLDAYHFNHIGFIFQSFHLVNHMSVVENVKVPLYLNPELSESDRNAR
ALDLLKQVGLEDFASKKPTQLSGGQKQRVAIARSLANNPDMIIADEPTGALDSVTSDEII
KLLKALAAKGTTVIVVTHDLNIADQTDAVLRLADGEVISFERKKEVVQKVTHKNEKKLRL
NWWATAKISFKSFFNRKFRNLLVALGTSIGIIAILLAFGLGNGVNQSLSKIFGTTFSPNQ
ITTYYKEDGGSKSPEPTTPLTSSEIKKIKQLYEDENITEIYERTTVQGIKFEYDGEYLKG
ISGEMQEANFKPSRYEDLTVKDEYLLSGKMVTSDETGAVIPSSVAKAILGKKDSDELTKS
DGDKLIGKKITLVYAGRNSDTKNTVKTETTISGITNPSKEGFARGFDVSTKTMNDFIKTT
GIEKPILSVDAFTKTTAEAEEIVEKYEDNKDWANYSITNANAFVDTFSQFTDIIVYLIAF
IAGLSLAVAGVMIAIVLYIGVVERTREIGVFRAIGYRKRHIRGLFMMEASYIIILANVLS
SLVAVTIAKIASPILETKIGFEDMIHISFWNFLVTLAITITIGFIFSIYPSNKAAKLDAA
EALRSE
>fig|169963.1.peg.973 Drug resistance transporter, EmrB/QacA family
MEQTKVKAVTIAVFVATFMAAIEGTIVSTAMPTIVSQLDGIELMNWIFSVYLLTSAVTVP
IYGKLSDLYGRKNIFVIATIIFIIGSSLCGFAQNMEQLIIFRAIQGIGAGGILPSTMTII
ADVYPFEKRAKVLGFMGSAWGIAGVFGPLVGGFLVDQLSWHWIFFINVPIGILTILLILL
YLREKVEHVKLPIDYLGASLFTVALLGLLFALQRAGESLNWTEPLVVILFAVSIVLFIAF
YFVEKRAKDPIMPFVLFKNPVVLIGNLIGFLISAFLIGINVYIPMWAQGMLGHGATIAGF
MLAPLSVTWIIGSFIGGKLLMTLGNRHTVGIGVLITAASGLILALFPASTNDIFFYLNSA
FMGFGFGIIFTTTTVTVQDAVPRFQTGIATASNTLFRTVGQTIGVAVFGTIFNSVLTSEF
RAAAGSEVNRSNLNQLISPQTSGNVSTDLVDPLRDILYSGLHTVFWVMFACCIVSYFIHF
ILPKKHISGEK
>fig|169963.1.peg.1838 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQQTVTYGAKWKQFLTIFTPIVITQLTLFSMTFFDTTMSGNYSNQALAGVAIGSSFWAPV
NAAFSGLLMAITPIIAQLIGAKKEKQVKNTVHNGLYIALFLAFILILINFLVVPMILTHM
PVTAEVADIARHFLNGICIGIPAFFISAILRSFIDSLGLTRVTMLITLCTVPFNIFLNYC
FIFGNFGFPEMGGAGSGYATGITYWLVVLVSVILIQTQTRLRKFGVFKGLTALRFSKIKE
IIGIGVPNGLTILFETSIFSAVTILMGAFGTETIAAHQSANSVCTLLYAFPLSVASTLTI
LGGYETGAKRLKDAKQYRHIGMAAAILIGCVNGAILFFFRDIIAGFYTNDPALSNLIMHF
LVYAILFQFADAVLSPVLGALRGYKDVTVTSIVAFISYWLIGLPVGYGLSFTNLGPFGYW
IGLSTGLFVAAFILSIRVRKTEQKLSFNTKDAEISN
>fig|169963.1.peg.2078 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAKNMEILETDSVKKIYFRYLIPSLVGMLLMSLNIVIDGIFVGHKLGGVALAGINIAVPV
FTIFTAISIWIGIGAATQFSFAIGEKNVAKAQTIFTNAILAVVSITVIIGIIAFIFKVPL
AYFLGANDDTIGYVLEYMNILLVFGFALTLENILSIFVRNDGDPNLSMIALIVTAISNVI
LNYLFLFVFEWGVTGSALATMIAIIIGVLILTTHFFKKSSRLKFVKVDWNKAFFKKTLAI
GLPSFLAEVGVSVFTLGYNISIAAIAGTAGVAAFSVLNYTHSVILMLFLGMGSAIQPLIS
YYRGAKARQKELETLKIAIVVAFSTGVGFLLVGFFGSNLLVSMFGNFSVEIRELASNGIK
LFYTAYLFMGFNFVMMTYFQTSDKVKMATWITISREIIFMVIFLLVLPPIIGIPGVWLAI
PISEMIVAASIVFYMKKKHILFK
>fig|169963.1.peg.2578 Multidrug resistance protein
MNSTAVERPVDVNGKSYSRSLLVVTMIIGAFVAILNQTLLATALPMIMDDLHITAATGQW
LTTAFLLTNGIMIPITALLIEKISSKTLFITAMTVFTIGTIIASVAGSFPILLTGRIVQA
AGAGIMMPLLQTIFLLIFPREKRGAAMGLMGLVIAFAPAIGPTLSGWIVDSYDWRVLFLI
LIPIAVIDIILAFFGMKKVVKLTDTKIDFLSIVMSSIGFGALLYGFSSAGNDGWGDTTVI
TMLIVGVVVIALFVWRQLVIDNPMLELHVFKYPVFSLSVILGSIVTMAMIGAEIVLPLYI
QTIRGESALQSGLLLLPGAIIMGIMSPITGIIFDKIGAKWLTITGVTILTIGTIPFMFLT
MDTPLWYIVVFYAVRFFGISMAMMPVSTAGMNALPNHLINHGSAVNNTIRQIAGSIGTAV
LITVLTNVTKDNMPGKALMATDPASFAQKAQDASLDGMRAAFMVAAIFAAIGMILSLFLK
TKKQEPIVKEYTK
>fig|169963.1.peg.2714 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKEQSKRLGEDSIPSLMARLSIPAFIGMFVMGMYNIVDTIFVSYGVGPSGVAALSIAFPV
QMILMAMAAMFGIGGASIISRSLGAGEQKHADKVFHQVIWLVLISSIFIAIVTFIFLDPL
ITLFGAPADIHDIASDFLSLILLGAVFQTFAMAMNNIVRSEGNAKTAMLTMIISAILNMI
LNPIFIMGFGMGVRGSALATVIAQAVGAIWLLIYFLSGKSTLSLKGFSFRMDFPLIRRIM
AIGFPSFIMMSAGSIVTVAVNWMLNIYGGTMAIAVYGIANRIASFVIMPINGVTQGMQPI
VGFNYGSRQFERVMKAVKVSMIAATVMSLIAWGLVEIFPGLLVRIFSNDPELIAQGTTAV
RFMLLAAPTIGFQIVCGGLYQALGRARISFIISLMRQIICLVPLLLILPHFFGLDGIWYA
FPLADLGAFAVCLVIMSKTWRRIFKNPEIV
>fig|169963.1.peg.2902 Multidrug resistance transporter
MNTGKWITAAASLLAFMGIGVVDPLLPSIAESIGASHSQVEMLFTAYIFTMAIMMIPIGI
VAGKMGDKKLIVIGLFIVTIFALLCGLSDTIGALSIFRAGWGFGNSMFMATAMTMLIALS
ETPGHAIGIYEASMGLGMAFGPLLGGILGNISWRYPFFATACLIFIAFLLILFKVKEPKK
VAPAPTEKNEVAIKQMLHLFKYRPFLQIAFSGMFYYYCFFTILAYSPLVLGLSAIQIGFV
FFAWGLCLALGSAKVSHALEIRFNSKQILKGSLLACAVILALLGFIDNTAVDIGLIVISG
LILGINNALFTTTVMEHSPYARSVTSGAYNFVRWLGAAFAPLCSGLLSEALGMKMPFIVA
SIICLAGMGLLFIKLKPAHFTLQQSTSIKSE
>fig|171101.1.peg.50 Teicoplanin resistance protein
MLESKKTTRYVFYVYLMLLTWGILFKFETNPEFIAFFLAPRYINWIPFSEPLIVDGKIVF
AEMLFNLISFIPLGVCFPLIKTNLSSLRIVGTGFLISLLFECLQYILAIGITDITDLTLN
TLGVCVGLLIYQIFIRVFKSQTRKWINILGMLSLGFAYLVLLLLHLIGV
>fig|171101.1.peg.137 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MYTIIKSNIKKFSLLTIFIVAGQLLLIYAATINALVLNELIAMNLERFLKLSIYQMIVWC
GIIFLDWVVKNYQVEVIQEFNLEIRNRVATDISNSTYQEFHSKSSGTYLSWLNNDVQTLN
DQAFKQLFLVIKGISGTIFAVVTLNHYHWSLTVATLFSLMIMLLVPKIFASKMREVSLNL
TNQNEAFLKSSETILNGFDVLASLNLLYVLPKKIKEAGILLKMVIQRKTTVETLAGAISF
FLNIFFQISLVFLTGYLAIKGIVKIGTIEAIGALTGVIFTALGELGGQLSSIIGTKPIFL
KLYSINPIESNKMNDIEPKEVNRDFPLYEAKNICYKYGDKEILKNLNFCFQRNEKYLILG
ESGSGKSTLLKLLNGFLRDYSGELRFCGDDIKKTSYLNMVSNVLYVDQKAYLFEGTIRDN
ILLEENYTDEEILQSLEQVGLSVKDFPNNILDYYVGDDGRLLSGGQKQKITLARGLIRNK
KIVLIDEGTSAIDRRTSLAIERKILDREDLTVIIVTHAPHPELKQYFTKIYQFPKDFI
>fig|171101.1.peg.1734 Multidrug resistance ABC transporter ATP-binding and permease protein
MILLAILFTCFSVYLELEVPTYISKITDLLGSQGTNLDELWQPASMMMGMPFLAFLSVVA
VGFFASRVAASYTSRLRSDIFNRVLDYSQTEIKKFSIPSLLMRTTNDITQVQMLITMDLQ
VVTCGPIMAIWAIGKILGHSEYWLWAVLVAVIVNVLMTTVLMTLAFPKQSLIQGLTDKLN
SITRESLTGIRVVRAYNAEDYQNEKFAAVNDELTR
>fig|171101.1.peg.2134 Drug/metabolite transporter (DMT) superfamily protein
MSNSLKGTLLTVVAGIAWGLSGTSGQYLMAHGISALVLTNLRLLIAGGILMLLAYATAKD
KILVFLKDRKSLLSLLIFALIGLFLNQFAYLSAIQETNAGTATVLQYVCPVGILIYSCIK
DRVAPTLGEIVSIIFAIGGTFLIATHGQLDQLSMTPAGLFWGLFSALTYALYIILPIALI
KKWGSSLVIGVGMVIAGLVALPFTGVLQADIPTSLDFLLAFAGIILIGTVFAYTAFLKGA
SLIGPVKSSLLASIEPISAIFFAFLIMNEQFYPIDFLGMAMILFAVTLISLKDLFLEK
>fig|176279.3.peg.1878 Chloramphenicol resistance protein
MKDNKMLFIIFMIGTFTVGMAEYVVTGLLTQIADDMKVSISSAGLLISVYAISVALIGPL
MRIITLKVHAHRLLPILVAIFIISNLVGMLAPNFNVLLLSRLMSAAMHAPFFGVCMSVAA
TVAPPAKKTQAIALVQAGLTIAVMLGVPFGSFLGGFANWRVVFGFMIVLAIITMLGMIKF
VPNVSLSAEANISKELTVFKNPHILIVIAIIVFGYSGVFTTYTFMEPMIRDFSPFKIVGL
TVCLFMFGLGGVIGNLITGNVPEDKLTKNLYLTFLLLFVTIILFVTVIQNSILALIICFL
FGFGTFGTTPLLNSKIILSGKEAPLLASTLAASIFNVANFLGAIIGSILLSIGLPYIQIT
LISGGIIVLGMLLNLVNQLYEKKHITFNEYS
>fig|176279.3.peg.1946 Multidrug resistance protein
MLEITVLVFITIFGVGSQFFSNLAYSLNQGILQTSFGIGSQYLIIPSVLANFTFALGIPL
GHTLTHKYGFKRNYLCFVFIFLIGSILGLLSFNLIILSIAKMIQSFSSGVLFFTLLPKLF
LNFPKQYRNVFLLMVIVGLFGSNALGGLSGSLSLELDRWHWIFVVNIISAILCLILGNVI
LRKNEYHQTSDIHISRSMMITLVLSTISLMIPMSLLTQKGYHSLWVWPILLIAIFFIVNF
IITNRQATHPIVHFHTLFSKKPFVGATMAISSHLTLLTGIAGINVYIVRILKLPFDISLH
FYFFFFVGVIITGILKMFFYSSVGAGFLGTLGSSALLYVSIHWIILGNTINIPLLYIQGL
LLGFGASMTLVSGSMATLLDGDLKEAAQRSQTMHTIRNFSAAMLIPIIAYTIKNHIQKGT
QSIYAENITDKMIYLKKLQDVAIDADHQIFLLMIIFNMVMFVSSIIQMILGKGRRITPPR
ES
>fig|176299.3.peg.55 Permease of the drug/metabolite transporter (DMT) superfamily
MTRVQANMLLLLAAAIWGGGFVAQSSAMSSIGPFWFVGLRFAIAAIAVLPFALMETRSLK
SPPRRREIGSFILVGLALFGGATTQQVGLLTTTVTNSSFLTGLYVIFVPVIAVVLYRRHP
HWVVWPCALMMLGGIFLLSGGAFETLTTGDILSIICAFFWAIQITLAGRFVSESGRPLAL
SFTQFAVCSLLSCMIGVVFEPISMAAIEASMMEILYVGLVSSGLAFVLQVIGQRYTTAPQ
AAIFLSSEALFGALMASIFLKETISSAGYVGCLIIFVAILIVELVPELTRKRQKTVAEAS
>fig|176299.3.peg.222 Permease of the drug/metabolite transporter (DMT) superfamily
MALPHIFLALITVFLWGFNFVAIKVGVADMPPLFLTGVRYLFAAVPLVFFLPKPNVPWRH
MIVYGMAMGFFQFGLLYPAIKLGLPAGLASLVMQSQAFFTLALAVVFLGERPLPSQIAGA
IVAFGGLAVIGMERMTAAALIPLLMGVGSAIAWACGNIVNRRIGQVNVVSFIAWTSLVPV
LPLVLLSLVVEGPDAIVEGLQNATPTMALVVIYMAYGATIVGAGIWSYLLLRYPAGTVAP
FSLLVPIVGFISAYLAFAEHITIFEIIGAALVILGLALNVFGRRIGVSRFWVRSPQG
>fig|176299.3.peg.1128 Glyoxalase/bleomycin resistance protein/dioxygenase
MAAMMRFPLVCRPEDDKIIVYGRPSSHRPACATKETLTIIRNALVPELAVSDWQKSRAFY
CDLIGFHVVYERPEEGFAYLALGDAQLMIDQIGATRTFVSGNASLEPPFGRGMNLQLAVP
SLQPILFRLERALIGLVLEPEEKWYRRGTVEVGNRQFIVADPDGYLIRPFESLGERAFRF
G
>fig|176299.3.peg.1364 Multidrug resistance protein B
MTSMALEVLVCPPCRKNGKDTALSSMEMVEKNGWGELLSGANLSLLTVISSGIGLHAFNQ
FAVVTALPVAVNDIGGAGFYSWAYSLYFVGSVAGGVTAVLFRERFGARAILLLCCLIFSF
GSVLSAIAGDFLWVVVGRALQGVADGLIVAVCYSLIPAGFRSGLLPKVFAIEAAIWAVAS
FIGPLTGGFATQHISWRATFLLSAPLIIVLVVYTVVAVSAERPVVATRRPLVPLLLCLVG
ALAFSAPSAFEDASLRAISLLAGAALLWASLRAGIQPSSGLFPRDSFRLKTVLGSGFWVL
FLMSYAHALGSVYLAYVAINLWQHEPTFAGFIVVTMPLAWSFVAMLIGSLRSNRLREICL
HYGPYQMVPGCVLLGLGLATGNWGEMLLGQTLIGSAFGMSWAGISQAAMEAAPEEERKMT
GALLPTVATLGSAAGAGASGTVAAATDLVVQIDRADVTTPMLYLYGLGVVVSLLAIMTAR
GLRGERR
>fig|176299.3.peg.1688 Ribosome protection-type tetracycline resistance related proteins
MRTLNLGILAHVDAGKTSLTERLLFDVGVIDKLGSVDTGNTQTDSLELERQRGITIRAAV
VSFTIGDTVVNLIDTPGHPDFIAEVERVLGLLDAAVVVVSAVEGVQAQTRVLVRALQRLA
VPFLFFINKVDRVGARYDEVVRDLADQLRVRPVVMSKITGAGSKHVQVAATDTECEPLFT
ILCETLAENDDELLRDYLLTPDRVDAGRLSLLLGQQTACGVVHPAFAGVAMTGAGLPALI
AAITEMLPARDPDPEGEISGKIFKIERGWGGEKLSYLHLASGTVRLRHILPLPQGPARLT
GIQLFKDGRVQNANSLGAGQIARVTGLAGARVGDSVGVDAVADGAFHFAPPTLETRVVSR
RPSEHAALWLALNQMVEQDPLIGLRRNDETNEVFVSLYGEVQKQIIQSELSTGFGIEAEF
EDSTVICVERLSGSGQGLQTIFREPNPFFATIGLRVEPRPDGAGNSFALEVEFGQMPASF
YRAVEETVFDTLKQGVFGWQVQDCHVAMTAARHTSPSSTAADFRKLTPWVLGTALKQAQP
FVCEPFDHFHIEAPAAAITRLISLLAKAGAATKNSVISGGVATLEGTIASAAVQGVQQQV
PGLTSGLGGMETSFSHYAQAESPPSPRRRSGPDPFNECDYLLRMRRNAE
>fig|176299.3.peg.1896 Drug resistance transporter, Bcr/CflA family
MPPEPIMSTKRTAILGALLTALAPISMAIYTPAMPELTRVFATNESAIKLSLSLYFAGFA
LAQLLAGPASDAFGRRRASLVFLSVFLGGGLLAIFAPTIEVLLLARLIQGIGASVGMTVA
RAIVRDQFTGAEASSIMNLIGIMLAVGPALGPTIGGLSLAAFGWKSVFFLMAGLGAAAIF
SVVIFLRETTVPDKSLIRPRRLLSAYGNLLTEPRFLLAALVLGGSIGALYAQATMLTFIL
INTVGMTPTAFGIGMLMQTGAYFFGSIALRYIAPRLGDRRSVMLGLCFSGTGGLLILLSV
FLIPPSFFSIMGPVAVATVGIALLTPSMVTAALAPFPHIAGSASAMMGFIQMGSGFAGGT
AASLIGSPLTGFGIVIPVMEFTAVASYIGFRIVSRSKT
>fig|176299.3.peg.2585 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTPPFSLVGIDHVVFIVDDMTRALDFYRNVLGCTDGYSYPALGMEQVWCGNALIVLWDV
THPGGTKAAPPVAGGRNVDHICIATGPLNHDALRAHLAKFNVTIEQEAFHGGARGMGYSF
YFRDPFGNKIELKGPAEYPDGRAENA
>fig|176299.3.peg.3739 Tetracycline resistance repressor
MAIGRDRIVDEALRLLNEVGIDKLSTRKLAERLGVQQPALYWHFRNKAELLDAINSEMLL
RYHCDRLPKPGQDWITFTLANARSIRKTLLTVRDGARLTAGTRPSVAEFADVESVLQLYV
ETGFSAEEAFGIAICITRYVVGYVLEEQGERERDRMDQHSPNTDIMAELAQFPLLAKALE
SFPTVGTVNTEAVFESGLSYLLAGMKEKLREKQSR
>fig|176299.3.peg.4861 Permease of the drug/metabolite transporter (DMT) superfamily
MPVKYLLFSLLAVLIWVGNTIVSKLAAGAIAPGTIAFERWFIAFVILTPLVYRDAWRHRR
TIAAHLPKLILLGLLGMAACQGLGYYAAGLTTATNMAIMLSLVPLLTLILSAVFLAERPS
SLAVIGGIISLSGIFIVLGQGDPSRLLSQGVGRGDAMMLAAVLAYAGYGILLRRWAIPLA
TWTSIYVQIGAAVVLLVPSYLLSAPSALTLPNTAMVLYAAIPGSILAPFVWMTAVKHLGA
ARTAIFMNLIPIFTAIVAAIFLGEALYIYHLLGGGMTVAGIILVQRKPFREKSGQKAVVA
RAQ
>fig|177437.4.peg.225 Glyoxalase/bleomycin resistance protein/dioxygenase
MSIKSVNTILYCTRWAETVEFYDKSLNFQRLTTREWFVEFFLTESARLSIADESRCSIKG
ARGMGITISLAVDNLGAAHRKFQIKKLSPTPIKDLWGARVFYLYDPEGNRIEFWE
>fig|177437.4.peg.547 Permease of the drug/metabolite transporter (DMT) superfamily
MTYLKLLLTAIFWGGTFIAGKFLAGDVNPLDAAFVRFAIASIFLLVITRKLEGRLPRIQA
KLILPLILLGATGVFAYNILFFSAFHHINAGKAALIIATNPILISLLSALLFKERLDLIK
GAGIIMSVTGAMVVISNGHLTDLVSYEIGRGELLIYGCVASWVAYSLIGKSVMGSLSPLA
SVCYSSVIGTVFLGIVSIFKGDLTTMGAWSIIDWFSLFYLGFFGTVLGFLWYYEGIREIG
PMKASVFINFVPISAILFAWLILGEPVTASLLVGAALVVSGVYSTNASGIIKRYLTAKG
>fig|177437.4.peg.1027 Permeases of the drug/metabolite transporter (DMT) superfamily
MVSALLFGGATPAGKALLGGVEPQALAGLLYLGAALGVLPVVMGERAFQWPWHAGRNTFL
LLAGAILLGGILGPFLLLLGLKIASSGSVSLWLNLELVATVLLGHFVFQENLSRRAWVAA
GGTLIAAMLLAGNDAGGFFPGLLVFLGCICWGFDNHFTALIDGISPAQTTLWKGSVAGVF
NLVLGGAVAGGIGSPGVVIMALLVGVVSYGCSITLYVMAAQGLGAVRSQMVFSVAPFFGL
LLSVTVLGETFTHVQAVAALLIVVSLFVLFSEQHVHNHRHIAMSHQHSHSHDGLHHNHGH
EGFDPKESHVHWHDHAPEEHTHKHWPDLHHRHDHKKEP
>fig|177437.4.peg.1294 Permease of the drug/metabolite transporter (DMT) superfamily
MPLFAILRCFIKRLKGKFLKNWKPYLAGVLVVLIWSGWITISRYGVHTRLTPADITLLRY
CTAFSVVLPFAVRYPWRKFTLYQYLVVGLGVGFPYTMVSFYGLIEIRAAHAGVLVNGMLP
VFGAIAALLYFKQRVSAVCYGAIALIFAANIVMIGGNFFSSEHLLGIVLLLCAAVIYTFH
MVGVRLWGFTWKDVFVVVPVVNVALFLPLWFFFPSTGFKVPVPEMVLQATYQGLVVNIVA
LSCVAYAIRHLGTITVSLFMSFVPVITAIFAWLLLGENLTGQEITGIVGCTGGLLIYSRG
>fig|177437.4.peg.1736 Multidrug resistance ABC transporter ATP-binding and permease protein
MHGHRNNIFSVQVGEGVARDLREALFVKIQSFSLGNLDNLKTGELMVRLSSDTSAVQRLV
LISLRIGTRAPLIMVGSLILMVNTSLGLALTMVPLLMMSRLSNVWANGMASSKWIYGLIS
TWFPGFTRSTTAGSPLTKQIS
>fig|177437.4.peg.1739 Outer membrane component of tripartite multidrug resistance system
MALSGGCVPVGPDYVAPGFNRMPGRWTPEMTGGMSAVPLDSKALASWWIVLDDPVLTGLI
TRAIDVNLDLRKTRAVLREARARLLISGTDAFPTIKTDASAVRRYQDDESGSSYNAGFDA
FWEMDVFGRVQRAREAATADLEADQESMGDVRVSLVAEVALNYIGVRSFQARLAIAQKSL
AVQEETLQLTQWQRQAGLTSQLDVEQARSSLEETRASVPDLQTGLGQVMNQLALLLGQYP
GTLYKALSVPAPVPVAPMEIAVGVPAEVLRRIPTVRQAERQLAAQTARVGVATAEQYPQF
TLNGSIGFDALSIHDLLFESASRIFSIGPAFSWTLFDAGRLRQNIEVQNALTQQAAIEYE
KAVLTALKDVEDALVAYGGEQVRRQSLLGASTAQQDALDLARDQYASGMVNFQVVLDAQR
SLLSLQNQLAVSNGAVTSDLIRLYKALGGGWTPLSASGATKAH
>fig|177437.4.peg.2213 Fusaric acid resistance protein
MRRQNKGNGGLYAVWFIILVATVAITRFYGLESSNFYGIAETREIVVNFEGAVEIKKINV
TEGQSVEQGMLLVELSSPDLMLKINQISHQLDQLKAQKGVDKSEIQSRLRQLKAEKAAKE
SELRNQIAQLENQYKINKSLLSGLKSISGNGGYGNAEGSSPMELKIKSLKEELSLCVNPL
AIQIELFEKILANSKNPVKIQVERLEQELTLLANENNKLNIYAQISGIIGSVNFKPGAKV
SPFAPILTLHTRTPSFIKGYIYENAYADIAMDEHVNVASLAIADRNITGVVIGIGARIVA
YPERLRKHPDLQMWGREVVIQIPENNHFILGEKVLITSSVKKPGGVEQLKRLFTPSESVA
DVLLACKNFLFEEDILPIIPLETQGIEASALLYLKDIDRYMVLSDDTPGNAPLVMLMDSH
GRITRETAIAGLEKIDDMESVAEADQGILYISSSLSTAKNGKVKETRKNLVSVQRQGNHF
TLVKTIDLYSQLMTHAQREAGQPWADFILGAISKKNLDMEGMMYREGSLFLGFKAPLMNK
ESVILKIDEIDCAMETQTFKPHQISIWRSFSLIPGKGQLQEGISDLLYFKGILYLTGTPL
MKDKGSRSGTLWKLDEATGTPVCLAHFNDLQPEGVASGKEKNSLIICFDQGHKTKSKTCK
IKVN
>fig|177437.4.peg.2275 Fosmidomycin resistance protein
MTENTKLNVKVVAALTLVHFTGDFYSSFTSPLLPVYVDKLALSMAQVGLLTGMIRLLAFV
VQPCVGYLADRYQTRAFILWGVFLTVTCIPFSGIAPNFYVLMAVLAAGSAGSSMFHPSVT
GMLPLYSGPRRGLCMSIFNTGGTLSFAIGPVFISWYVGRFSLEAMPWTMVLGLMSILFCL
RAIPMPVSEGMQNSGFWGSLNESLGHVWKPISLIWIVMVLRAVAGQSFITFMPIFLVQKG
YDLISVGFIVSLFILAGTVSGLLSGSLSDSMGFKRIFFVTHLLMTPALLAYLFMPGAFVY
AGAFIGGFFALATMPLGVLMAQRLAPKGRSMVSSLMMGLAYGLGGLFSPLVGKLADIYSI
ETVLFWTAFVPLITLIPIVKFPQLEKEA
>fig|177437.4.peg.2458 Permease of the drug/metabolite transporter (DMT) superfamily
MKIKNRLENSQILTGYLFAIAATAIWSGNFIVARGLNETIPPITLAFCRWLVAVIVFLPF
ALKPLIAQWGILKKNMGYLSVTSLLGITIFNTLIYFAGHTTTAVNLSLISITFPIFIVIF
SRIFFRERLTLNKGIGIVLVVTGVVLLITRGALSSLLNISFAIGDLWMLLAAIIFAVYSL
LLRSKPQQLSIWAFQAATFILGLIFLFPFFVWEYTITPSIPFDTKAVVSILYVGIFASFF
AFVLWNKAVVAVGPSKAGMVYYTLPLFSGFLAHFFLKENVTIIHFYSVLLIASGIFTANY
EFKGLKRISTAQARP
>fig|177437.4.peg.3442 Multidrug resistance ABC transporter ATP-binding and permease protein
MGPFELIRPYFIERRAYLAAGLFSLLVVDLLQLFIPRIVKRAIDGIASSSLDAGALLRYG
GYILLAAIFIGVFRFSWRYCIMGTARRVEEGIRERLFNHVITMPAPFFDRVSAGDIMAHA
TNDITNIRMALGMGLVGMTDTVVLGLTAVVFMGYINLELTVLALFPMPFIAIFTKILSKR
LFLAYMAVQESFSRLMEASRERFAGIRVIKAFNREDAETLSLTQESQAHVDANMHLVRLR
GLIFPMVTLLTSISLAVVVGLGGRKVIQGTISPGDFVAFIAYLGLLTWPVMALGWVTNMI
QRGKVSIDRINTILNTSVAMGNMDNALTPQKITGNIQIQNLVFHHGSGKDRTRILDNVSV
TAGPGGILGIAGPPGAGKTTLVGLIPRIYDPDSGRILIDGMDVRNIDIHCLRRFISFMPQ
EPFLFSGTILENLKLADALAGQDQINGVIEMAGLTKTIESFPKGINTMIGEKGVMLSGGQ
KQRIALARALLKRAPILILDDPVSQVDIRTAAGIIDTIEALSTSITVIIVSHRFQAFRRA
DNIIVLDKGRIVESGNHEQLVAQGGYYARAQVMQSGGES
>fig|177437.4.peg.3509 Acriflavin resistance protein
MNPARFALNRRTFLAILTLLLIGGGLLAFEHLGRLEDPTFTIKTALVITPYPGATPLEVE
EEITEKVEEAIKSMGQVKEIYSTSQEGISFVYVEMKDAFNKRELPQIWDELRRKVADIQA
TLPPGAGPSQVNDDFGDVYGVFFALTGDNYTLAQLKDQAEYLKKELLLCKDVAKIDFWGI
QQQVLYIEFEPSKLAGLGISPDLIYQTLHLQNVVESSGKVDVNTEYMRISPTGEFKSETM
IADLLIGGAGSMVRLGDIATITRGYWEPPRNMMRYNGRPCIGIGVSTVDGGNVITMGDSV
REKLHELEARQPPGMALNTIYYQSRVVTESVNAFLINLAEAVVIVVVLLMIFMGWQSGML
IGIILLLTILGTFMGMLLMGIDLQKISLGALILALGMLVDNAIVVTDGILVRVTRGESRE
SAAVQVVRENQWPLLGATFVAILAFAAIGYAPGNVGEFCRSLFQVMALSLLLSWLFAVTI
TPLFCVWFLKTPESQAMKDPYGSRIFRIYRRMLHLALRWRYLTLVVVSLLMLLSIIGFGS
IPSAFFPDSTQRYFYVNFWKSQGTHINHTADDLAKIEQFVRQMDGVKNITTFAGEGALRF
LLSYDYQIPNPSYGQLLVEVDDYLQINGLVKQVNAYLAANFPDAEPYARKIVSGPPVTFQ
VEARFRGPDIKVLQDLADQAGKIMEQTPNTRDVRTDWRQQVRVIRPEFSQSQARRSGVTR
SEFSSALKWQFTGVVAGLYREGDELIPIITRPPEKQRNSVGDLDNVQIYSHANRLFIPIN
QVITGVKTVWEWPLIGHRDQQRAVTVQCNPARGLAAPLRLAMAQKIEALDLPPGYSLEWA
GEFEASNDAREPLGKIFPLCVLGMFVIVVGLFNSVRTPLVIFLTVPLSIMGIAAGLLIMD
LPFGFMAILGFLGLSGMLIKNAIVLIEQVEIFLKEDYPPYKAILDSSVSRMRPVIMASGT
TILGMLPLVFDPMFATMAVTIMGGLFVATFLTLIVVPLLYCLFYRIKSEKRYL
>fig|177437.4.peg.3643 Multiple resistance and ph regulation protein f
MDTYILYSAIVLSVFMAIPLYRSVVGPTVQDRIMGVSAIGSKTTVLLIMIGFIFERVDMF
IDIALAYALLNFIAVLAASRYFHKRKGLYQEMDR
>fig|177437.4.peg.3651 Permeases of the drug/metabolite transporter (DMT) superfamily
MGSLTAIHLAVVLFGFAGLFGKFLTCTPLVIVFGRTAFAALALLPLVLASKANPLGEKTP
RLKVYILQGVLLAVHWCTFFLSIQISTVALGLLTFSTFPLFTTLLEPFFFKQQIKQKDLV
MALIVFAGLILVLPSFDFSQKPAQGAVWGTVSGFTFALLAIFNKKNLTFEPPVRLAFFQN
LFAAATILPIFIFVPQTVPAPGEIILIATLGIVFTALAHTLFISSLEGLRATTVSIITCL
EPLYGIILAALLLHEIPGLRMVAGGTIIVLSTLFASLNRKHSQ
>fig|177437.4.peg.3972 Ribosome protection-type tetracycline resistance related proteins, group 2
MTITPSGVIYRETVIKNAQATVRYTMPKPCWAVMTFNVEPGALNSGDFLLATPMGIMAAL
KNAGTRLLEPFYALDIKAPQKLLGTITNDLNNMRADLGIPRFEGNLFALGGTVAVAPAMD
YSIRFNACCSGKVRLKLTLGGYQFSTSSQWTLENLTFSGLEGHGGVTIGWGSDNLIRRAD
FPARITEIQKIHGHPPVQ
>fig|177439.1.peg.119 Permease of the drug/metabolite transporter (DMT) superfamily
MPEKTARPLLIYLYLTLTMFFWAGTFVAGRILGQNLPPSVAGFLRFFVASSSLFLVLRIK
FGAIPRPEKEQLLPLLLLGFTGIFAYNIFFFKGLQHIEAGRAALFIAATPLMITITATLF
LKERLSLKGFLGVLLSFTGAVIVISNGHPEKVLQGGFGIGEQSLLGCAASWAAYTLASRK
VLISMSPLSAVCFSCMLGTAMLFPFAIGDGLFTLMPQITDLGWICVLYMGVGGTALGFCW
YYKALKAIGTTKTSIFLNLVPIFTLILGHFILGEYVNISVLAGGLLVLTGVTITNFQKDN
>fig|177439.1.peg.153 Outer membrane component of tripartite multidrug resistance system
MFASQLRRSLLLLLTPLLLLSCSMIPPKEAHHQQLLTPEEIGIRAEMQIRTCRWWEDFRD
PQLNTLIEMGLRQNLNLQQVSYRLSLAKQQVLLNQAGQKVQANLKLNGGGLAAKGDFPSQ
NSAFALALPMVGYNLDFWGKIENRVLAASNREKAAQVNVTQARLALAVSIAQSYLNLQNN
RQQKQVLHRMITNQKAAEEIIVGSVKRGFLPYEELLQSQSYSHLLRAELTGAKAQEILAK
NQIALYLARTTEQLAPLVDGKLTLIAPLQEVLSIPMNLLARRPDIQGKKWIVQAYAAEIK
VARTAFYPDFNLMLGGAFLAMTNIHPDKLSLLSGSIATSLPLYDGGLRDAGLSIANIMYD
RAVLDYNQSLLGAVREASDAIILLKTSQEQEMLTGISTEKQRQAYDIARKKYQRGISPYL
LMNQAESRWQQTFLNLIKTETATLQSQLRLIMALGGGYSPKAATEK
>fig|177439.1.peg.154 Membrane fusion component of tripartite multidrug resistance system
MPTTSQENKPKRNLLIAIFLIAIAIGIVIWIFLSQRQQESTDDAYVIGNTIIISSKIAGT
VQKISVSNTEFVDQQQILIELEQNDLLIQEKIAEANLTRIVRTVKSQYLTTGQLKDNIRA
TDFKIAELEADLARRAGGDLDGTVTLENLQHMGQAIKIARAQRDSARQGLEAKQTIFPGE
ELQNNPEIKLATAHLQEIYLARINSTIIAPMHGLIANRSIQAGERISPGQPLMAVIPLDN
VWVVANFKETQLGDIRIGQAVELISDIYGKKLPFEGIIAGIGAGTGSAFSAIPAENATGN
WIKIVQRVPVKIFISPDQIKKHPLRIGMSMTVRVDTKDQEEKSFQHIQQHDDISAIYQSH
RQLAEQQARDFLNTLLIHNNK
>fig|177439.1.peg.155 Inner membrane component of tripartite multidrug resistance system
MANSPQSTQWLQGIKLTAATFSLAMAAFMMVLDTTIANVAVPTIAGNVGVSVDQGTWVIT
AFGAANAISMPLTGFLSHRFGEVRLFLFAVIGFTLTSFLCGTATSMESLVIYRILQGAVS
GSIAPLSQSLLLRCYSKEKRGTALALWTLTIIVAPIVGPILGGYLTDNYHWSWIFFINVP
IGIFVLISCSMLLKGKETTRSRPSIDYIGIGLLVFAAGSLQMLLDLGKQHDWFQSTFIIG
LGLVALVSWGVMIIWEYYHDNPVVNVRLFKNRNFSLAVLIMGLGYGIYFGSSVLLPLWLQ
GVMGYTATWAGLATSPSGILAVVSAPMMAYLTRKVDLRLILTYAFVNFAIVGFWRANFSL
DNSFFIIFLPQLVVGAATMPFLVPLQRMIIDGLPSSQIATAVALSSFFRTLSGSFSSSVV
TTAWDDRMTFHYARIAENFTVYNQYSMGYLRDVHGNISLMSKIIMRQAYMLSTVDLFWAT
GVICLCLVPIIWLTKPINIEIE
>fig|177439.1.peg.196 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNSFFSRPWSKFDFIKFVTPSILSLVSISLYMAVDAIFISRFIGTLAMAAVNIIMPLFSI
SIGIGVMVATGASATIGIELGQGKRDRANAHFSFVFCFLFLVFIGLIISQWAIGPERLAL
WLGASKLLLPYCVQYLNIFLFGISALVLQMFFEFFMRLDGKPSWALYSSLLGGATNILLD
YILIVRYGMGVDGAAIASCAGIFISCLNGAIYFLFKAKTLRFIRPLIDWPFLFRSMFNGF
SEMVTEIAAAVQTLVFNYLMLGYAGEAGVAAMSILMHLYFLMSSLYIGLGMGVSPLISFN
YGCRNPGKISELLTRAIQLTLFFALFSFAMAFCFGDNLIQIFAKGQVSVVHIAEGGIKII
AFSFLLNGMNILASAFFTSVNNGKISTLISSLRTFVFILGFALLLPPLIGVTGIWLSLPM
AELSTLLISLFFMKKYRQHYLLPATTGEVKEKNSMQLIKKKEKEEA
>fig|177439.1.peg.290 Permease of the drug/metabolite transporter (DMT) superfamily
MKLIFNSKYTPVIAIFVAMIIWASSFIALKIAFRSYHPMVVIFGRMLIATLCFMVFYKYV
FKGFKYHKGDYKPLLFMAFCEPCLYFIFEAIALKNTSASQAGVITATAPIFILAAASLFL
KEKYNLQSWLGALAALAGVCWITLASATSESAPNPIFGNFCEVLAMACATGYTVCLKSLT
KRYSPLFLTSTQALMGTFFYLPMLFLPFVEMPTEYVALPSFAIIYLGAVVSLIAYGLYNY
ALAHMPAAQGASYINLIPIFSVAMAWLFLGETLNLSQGFAAALIIASVWVSQKGMAKAHD
EKHSLKNK
>fig|177439.1.peg.671 Permease of the drug/metabolite transporter (DMT) superfamily
MSRLQANLLLSLAALIWGSSFVVQQIGTGNLDAASFTGARFLLGSLVVLPFALRQFLHVQ
REVRAFTLRDGLGIALTGSVLCVAAALQQYGILRTTVTNSGFLTALYVPMVPILALLVFR
KKPHWSAWPASICCFVGTYIMSGAQNVVLASGDLWVISSTIFWASHVLLIGIMVQKTEAP
LVVACGQFFICGILGLFLGQYLESPDLNVFAGALTGILCMGFFSVALAFTFQVIGQRYTP
APDAAIILSSETVFAALCGAIFLGERVSDFQLAGGLLIFGGIIAVEILPMLKTARILS
>fig|178306.1.peg.1656 Drug resistance protein, conjectural
MESTSLGTSTSRADLRAYAIFSAPYSLVVFLLPFYIFKLGGGGVEVGFAFSIYATAVVAV
RPVAGYLTDRLGRRSANLLGGLILASAMILLGASYGVFHIYISLFLAGAASSLINVATVA
YITDVGGLENPALYSKMRIAAAIGAVGGGAFIPIAYFLDKLWGYEVAFRASALALAFITL
TALPLLPHETMQLAARYKQGNLGLATCVTILAFLLGLASGLYGPQVLPYIYTKYNLSPFS
AVLAYLPAVFSWLYGPRLARPAPTRVILGVIAMATGLLAMYNAPNPLLFSMSWVLESLGY
AIVSTSLDQSLSRYVSGAYWGRGYGVYQAVNNLGYAIGAAFSGYVPNPFYNAIAPLIFML
PLAVICVKSRRISPRVSTSPLPS
>fig|178306.1.peg.1786 Tetracycline resistance protein
MRPIFTLLGVVAIHMLGFGIVIPVMPYVVKELGGGSEAYGVLVSIFSAVQMVSAPLWGAL
SDRIGRGPVITLGLALAAIGSAMAYGARSLAELALARAVSGMGGGTLGAVQALIADLSPP
ERRASNMALFGVAFGIGFILGPVVGGLLSVWGVRTPFIAAVIFSAAAAALSTSLPRVRGR
VGFSISLQFGAVAGLVLALNLAFSMFESMLVYYAADVFKMAPSDLGVLMLIIGLAVASAQ
PAVRRLEGRVAYTTSALAGFVATGAGIGVLPALGELGLYLGSAVAAVGQMVASSSLFALF
SQGERGRGIGFGALQSTASLGRIIGPSLAGWIYLKLGPSYVFYAAALLLLAASPAFWFWR
R
>fig|178306.1.peg.2372 Multidrug resistance transporter related protein
MDSYDIKYAWRATPLLGSVALLVMYTEAMLMPSLPKIQAEFNVTPADASWILTIYLISGT
ISAAIFGNLGDIYGKKRVLSLVMLAYAIAVTLTGYAPNFETLLLSRAIQGLGMAMFPLAF
SLIREEFPPHMVPTAQGVVSAMFGVGIIIALPVGAYIAQNYGWRATYHTATPIAVLLTFL
IMIYIRESRYRTPRSIDFVGIGLFATMAASFLLAISKGPDWGWLSPRITSLLALSAVSAA
VFLIHELTTDNPFIPRDIFNRNVIAATIAILIVAYAFQMNSQNLSYLFQMPPPYGYGLTV
LQTGLYMLPPAVVQIIVAPISGRLMWRLGAKKIATIGVVFAVIGYQLAAAHLYSGVWTLI
SYVTLGFIGLTLLNVSLINLLTFSVPRQRLGAATGLNTVFRNFGSAIAPTVAGTVLTNFN
TYVYYNTPAGPIYFSVPAKEAYVINIDIATSMFIITLLPILFSKEVLGGNATPK
>fig|180281.4.peg.359 Multiple antibiotic resistance (MarC)-related proteins
MEDLNRSVITLLALINPVICAVMLLERTPGVPHRRRLLLIGNVVLRTGLILLVSAAIGPQ
LLKRLGISLDVFQIVGGVVITSIGYGMFAPSPAPAAATGQESGSPENASLDPIVLFAASP
GTISTVLALSVMHGPDQGLLPTSLAVLIALAITAVVMAVMVLRPGASTRSNSSLVSRFLG
LILIAMGLQFVLTNLRTFFQAAG
>fig|180281.4.peg.814 Glyoxalase/bleomycin resistance protein/dioxygenase
MVSHFDHVTVVVQDVEAARRFFALLGFEEDKALVISGPTFSSYMGVDGIEAEHVTLVLPH
ATPRLEVQLLKYHHPQVHPDPEIANLCRLGFNHICFAVDDLEAEVARLTAKGVQLRNQMM
TFNTRKLVFLSGPEGITVELAEWR
>fig|180281.4.peg.2227 Mitomycin resistance protein
MGPAIAKALLSLGYRVPADLNGADPLDLYNRLGDLRGCRQDPCVLDVFIAITRFLNGEPA
RPWWAYSEDRRRRHPDL
>fig|182217.3.peg.677 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MGNTEVRPGAMTYVIFLLGILFLSFTAPWQKMSNFDPATGAFLRCLGGALCLVPFAFIEA
KKKGWLNKKGIWLSILAGLVLGIDFTAWNYSIFFVGSGIASILLNIQVIILPALALMIDK
EKIPLSYYILAPIMLTGVILAGGALEHGIVDPNGPQEVFGMSIMAVGTICGLTSGCCYGV
YLFASRRAGRINQGQIVQPIMIASFAQLVAPLIWAYVITGNGFDMATGVMVETAQSLDIG
EMIRGLREMHLPKDEIEQLTSVAHAVTAGDPINGVSWFWMFIECVLGQACAWTFAQYGSV
KLNPTLGAGLLILSPVATVAIIAPFLFGETLSTLQIVGVVVALLAVAYQNGLLKAIFTKK
IS
>fig|182217.3.peg.1605 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKVFKRIGAYSMLKAKIDLHKDSIRKLFFYYFIPLAFSMISLSTYSMIDGMFVGKKLGK
EAIAAVNIAWPIFPSLVAYELLFGFGAASIVGYFLGRGKTHRAKLVFSSVFYFVALSTFI
LSMALLPFSETIARLFGSNDALLAMSSRYIEIILMGAVFMVLHPLADVFVVNDKRPILAM
VAMLIGSLTNVFFNYLFIFVLEVGVQGSAYATIIGHGVGFLVLMQHFLFKKGQLSFIKRF
SFPAVISSAKSGVPQSTAELSFALMILIFNATIMHTAGERFLSMYGIIMYNAIIFWTTLF
SISQGIQPIASFSYGARNLERVKGVFLFGLKVAFLVGVVLYGIYYFLDEFLIKMYLQANE
QDLDFIQETKQAMNVYYLGYIFLGMSILCAVFFQSIQCTRSSFIITLSHTLIFIVVLLPL
MSHFYGIKGIWATYPIAQFLAFLSAMGVTYYEIKKGVFTTYREQSLINGAKK
>fig|182217.3.peg.1697 Tetracycline resistance protein tetA(P), putative
MKTLRKNILAYYGANFLLTLAQSLPHAILTPLLLSKGLSLSEILLMQSFFSFCVLVAEYP
SGVLADLMSKKFLFLFSNLFLIASFCCVLFFDSFMLMLLAWGFYGIANACNSGTIEATLI
TDIKENKQDLSKFLARNNQITYLSMIIGSSFGSFLYSKMHASMYMVAILLVLLCMLVVIF
YFKENKVTPKNQKSLSLLKEQVKSSLKELRDNPKLKILLVGHLIVPLFFMSHFQMWQAYF
LAQGIKEQHLFIFYIAFQVISILVHFLKASSYSQKITLSFLVVLLSVSPLLLTNMPYLFI
GVYALMVAFFTYMSYCLGYQFSSFVSKNNISSLSSLMSSCVRVVSVLVLSLSSLELHYFS
PLSIITTHFAITLLILFFFLYKAKVFSV
>fig|186497.1.peg.35 Daunorubicin resistance ATP-binding protein
MTMVDVISVTKTFSTPKGKVVAVDNLSFKVKRGQVFGILGPNGAGKTTTLRMMATIYRPD
SGRILIDGIDVVENPNEARKRMAYMTQEPDLSPTLSVRDYITYYFRFRGLSKREARERCS
YALKTFNLEEHANKKPFQLSTGLKRRVQLACVLSSDAPLVFLDEPTAGVDPKSKRDAWEL
IGEMVREKDMTIILSSHDLYEVEYLADEVLIINYGKAVAQGRPSELKRRFGKTLRIVTKN
PILDFEKLRDTLTSIEMVENVRAITKNSFEVKLNSLDAPINDVLQATMSLGLEIVDAFTA
TLTFEDVYLSIVDVGGEINGKR
>fig|186497.1.peg.36 Daunorubicin resistance membrane protein
MGRGKEFLSSFYVAMSRETKVGIDLEFWLGTMFEPLIYVLLFGPLMEKLVGGVNVGGEEI
SYLAFMFPGVLTLVGINQGFRGATTFIRDRFYGGLETLFTLPVSRSVLFMAKILGACIRA
FVAMATLSVLVIIVEDVSLTPLSFIQSFLVNSTLVVMLSSLMIWLLSKGENPNLPVAISG
IIMLPMMFLSTIFYPKEVFEGSRVMSLVVSLNPMTHASTLTRSFLYGISLPLSEVGISLA
YLAALRFLGFVLGLRGFTRALER
>fig|186497.1.peg.146 Quinolone resistance protein NorA - like protein
MLKSLWYLNFSTLFFFLGVSILNPLVSPYAITLGATPVIVGIVAGTVSIVSLSSKPLGGY
LGDRGFKFHAMFIGNIIGIIAVLLYVLSNILGNIWVFALGRAVHGFAMGIFFPSSLALAV
DLAPKGRVGESLGWRGMMFSLGNIVGPGIGGFISDNFGFVSAFIFSGIFSFIGSLFVLIV
WREIGSVKSEKASERGNYRELLRRSFVSASVSLFLISMAYSGVVTYLPALYKVSGFGQSV
FGMYMMFVGIASFIMRVFGGKIADIKGPIPVARVGILILGSSYLALAFNQYPPFSFIVGV
VSGLGFGLLIPALQYMALANLPGNIRTMGSSIYTMFFDLGMLSGQLAFGVVAEVRGYEGI
FPFIALLPFVSLITVHFPLLRREGNEG
>fig|186497.1.peg.316 Daunorubicin resistance ATP-binding protein drrA
MQGERVDFSCGWIRNRVHWRILKDFRSSTFWSYARNSWCHGGEKMKAIVVEDLEKDYGKV
KALKGISFEVKEGEIFGLIGPNGAGKSTTLKILATLLVPTGGRAEIFGYDVVEEAEEVRK
LISYLPEEAGAYKNLTGYEYLEFMAKLYAKTGKDYKKMLETGVELSGLGERLKDRISTYS
KGMTRKLLLARALMVEPKLAILDEPASGLDIINAYSIRQTIKQFAREKGITFLLSSHNML
EVEFLCDRVALINKGRIVEIGTPKELKEKYNAENLEEVFMSIVGGKKVE
>fig|186497.1.peg.323 Permease of the drug/metabolite transporter (DMT) superfamily
MNERRKAELVLLGATFIWGSTFPVMKIGVEDFPPITFIALRFGIASFVLFLALRKHIRKD
ALFPGLILGFTLFLGHGFQIVGLKYTTPSNSAFITSLYVVFTPFIAFLFFRKGLKMFDAF
SLSLAVIGLYLISNAELRLNYGDALTVVAALSFAFQIVLVEYFGNLGVGLAFWQIFWNFI
LSTVYAGIFEGISLPSDPKVLGGIIYTGIFATALSFTLQVKYQPKVESYKAAIIYSSEPI
FAHLLALAFLNDRLPPKGYLGAFLILLAVWLELYQERKNY
>fig|186497.1.peg.595 Daunorubicin resistance membrane protein
MNVFSTMIYRELKRFVRSPSRIMGSILNPLIWLIFFGKGWSGVFNFPMATRIFGGVDYMT
YLVPGVVVMTVFNMSFMQGLTIIWDKQFGFMKEILVAPASRVESILGRITGGAIVAMIQG
FIMVALSFTIADLKVSGIIPALVLAFFVGIAIAGLGVALALRMSSMEGFQVIVMMLMLPM
MFLSGAFYPVKTMPNWMQWLAKINPLTYAVDGVRYYLAGVTPTFGIINDWIVLIILALAF
AGIAGLEFRKAYLS
>fig|186497.1.peg.716 Drug resistance protein
MMPIIALYAISLGASLPQAGIIAALYSIAAIPASIIAGLLVDRIGRKRMLTLGLMWDAFV
VFLYGYVSSYHQLAILRVLHAFGGSLVFPALFTMARESDCEGKTIS
>fig|186497.1.peg.728 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSEKTTKGVQLLRGDPKKAIVRLSIPMMIGMSVQTLYNLADGIWVSGLGPESLAAVGLFF
PVFMGIIALAAGLGVGTSSAIARRIGARDKEGADNVAVHSLILSLILGVTITITMLPAID
SLFRSMGAKGEAVELAIEYARVLLAGAFIIVFNNVGNGILRGEGDANRAMLAMVLGSGLN
IVLDPIFIYTLGFGVVGAAYATLLSMVVTSLFIAYWLFVKRDTYVDITLRDFSPSREILK
DILRVGLPSSLSQLSMSIAMFFLNSVAITAGGENGVAVFTSAWRITMLGIVPILGMAAAT
TSVTGAAYGERNVEKLETAYLYAIKIAFMIELAVVAFIMLFAPQVAYLFTYSESAQVIKG
DLISALRTLPVFLVLTPFGMMTSAMFQGIGEGEKSLILTIFRTLVMQVGFAYIFVHYTTL
GLRGVWIGIVIGNMVAAIVGFLWGRMRISALKKTSATGGKR
>fig|186497.1.peg.753 Daunorubicin resistance ATP-binding protein
MVELENVRKSINRKEVLRGISLTVKPGEVHAYLGHNGAGKTTAFRPILGLRYLPEYDLLY
PSLSVWDNLKRYASLKGVYDEKELRELLEFFELLECARKKVSALSSGTQRRVAMARAFLG
SPEVLILDEPTRELDPEWRLKFKRFLERYVKERNTAVLFSTHILSDVDELCEKITVIKEG
RVLFSGSLKEFKRGFPTGASISLKVENIKMVAEVLEDNGYYPNHERVHPAGKCRAVGNQH
APREREYNR
>fig|186497.1.peg.850 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSREKIEANREKILNGPIVPTLLVLAYPIIINQLVHVLYNLTDTFWLGKLGRIELSAPGT
AWPLVWFLMSIGSGFVVAGFAFVSQYIGAGDYEKANRYAGALYSLLLIFATGMSIFGIVL
APYFLRFMKVSETIFPYALTYTRIIFAGIPFSFTLFAFNFLLRAIGDTKTPVKINIGTII
LNIILDPFFIFGWGPFPRLGVAGAAIATMLSNSVGSLIGGYLLFTGKVGIHLTLENLKPD
LKFYSRIFRVGLPSSIGDSTSALGFVVLTRVIFTVGRIYGEAHGIKGYEDVAFPTYSITN
RLTNFMFAFSDGISMAMGTMVGQNIGARKYERAKEIAEKAMLINFTILSIGTLLFAIFRV
PIFKFFVNDPMVIAESKKVVMYFSASLPFFGIFSAVNQVFNSAGHTKKSMVLGIIRLWIL
RIPLSYWLGVAMKDTAGMWLGMGLSNVIGALIGLAWFLKGSWLRGVIEEHH
>fig|186497.1.peg.862 Daunorubicin resistance ATP-binding protein drrA
MEAIAVEDLTKSYGEIKALDSLTFSVQEGNILGIIGPNGAGKTTLIRILSLLLKPDKGRI
LLYGHEVNSRKSEIKNFFALLPQEAKAHFYTLTPFEYIYHYLRMRGFSRKDAKIRAGKAV
EEFGIDYADKIMSTLSGGMVRKTLLAMILSADAKIYYLDEPTVGLDVENRLKLWEILREK
SKNSTVVITSHYLNEISSVCDNVLLLKKGRVVAFGKPEKIARQYLSQFHSKIVVFGEFTK
EDYTTRRAGKNTFVYAKSKSEEREVIEELKDTGIPFKREELTIEDIFLVGNLR
>fig|186497.1.peg.1047 Daunorubicin resistance ATP-binding protein drrA
MIIALEIKGLKKRYGNVEALKGITLEVYEGEIFALLGPNGAGKTTLIRILAEGLKYDEGE
IKVFGRTLSRETRRLIGYVPQESIAYDLLTVKENLEFYADIYNAPRERIKELIELFSLPE
KKKAKELSGGFKRRLNLAIALLYDPKILILDEPTTGLDVPSRRDFWEIIRGFKKDGKTVL
LATHYMEEAEELADRVAIMNEGKVISIGTPEELKRLIGEESIITIKGLLKGLEEISYPFI
EKDNEIRVRVRNPREALPKIVENLIKAGSIIKEIRVEEPTLEDVFIKLTGRRLE
>fig|186497.1.peg.1938 Daunorubicin resistance ATP-binding protein drrA
MKVVEVKDLRKLYPKKIPLPFRKVEYFEALKGITFSVKKGELFGLLGPNGAGKTTTIKIL
TTLLEPTSGVAKVLGYDVVKEPREIRRRINLVAEGERTLYWRLSGYENLRYFASIYYVPR
REAEKRIKELLEMVGLWERRNDLVMNYSRGMKQRLAIAKALINDPEVLFLDEPTLGLDVQ
SAVFVRELVRKLVDEEGKTVLLTTHYMQEAEELCDRIAIIDHGRIIALDTPEGLKKMVRD
NTIVEVKVRNYPGSNPFGLAKVEEQEGVAILRGSIDEEEIPRLVEFLVKNNAKVLSVEVE
EPTLEDVFIKLTGRGLRD
>fig|187272.6.peg.686 Permease of the drug/metabolite transporter (DMT) superfamily
MPVSLSLRNPVVLAVLGLVATTLFWGGNAVVARATSEWFPPFTLSFLRWVLALLIILPFA
WGQIRAYRETIRRHWRILWVLAALSVGLFNTLLYLAAQFTTATNITLVNSTMPVVIGLMA
LLFFGQRPRSHELLGIVLAFLGVLAIVSQGDREVLLNLELNPGDLVMLLAVCCWGLYSLL
LKRYGPDIPAVPMLAVMVAMGIPVIVPFLVWELIMVGPVQGTVMEMLPPLIYVGIFPSLL
AYLFWNNGVHVLGPARTALFIYLVPVFGSALAILFLGERLEPYHGVGAAAILAGLYVATR
GLPGRRPVEEEHP
>fig|187272.6.peg.1018 Acriflavin resistance plasma membrane protein
MIRWFAAHPTAANLVLVILVAVGLFAAPTLQRETFPDYRPGEVSIEVAYRGASAADVEDN
ICRRLHDAVKGVEHLDEFVCTAQDNRASATASMAPRGTMARFLGDIDTEVKAITDFPERA
DPAVVRELHRTDLVAAVAITGDLSLVDHEAYAQRLEDRLIALPGVADVITHGLSQRQWQV
EVGHDALAQHGLSAIELAARVAAQNIDSPLGTLETPDREILLRFTDERHDLVGLGELVVL
SDEGGGELRLSEIARLSEHREHTEEKVLMNGRRAVLLEVHKATHADALDVMEAMQGLLET
ERARWGEALTLTVTQDATSIVRDRLQMLVSNGLLGLILVLLVLSLFFRPRLALWAGIGLP
VGFLGAFTVMALTGLSLNMITLVALLMAIGLVMDHAIVITDNISARARAGSRALEAVVEG
ARQVLPGVISSFLTTVVVFTPLSFLAGELGAVLQVLPVVLIAALTASLIEAFLVLPHHLR
GGLDRIQSKGNSRLRQGFDRAFDRFREGVGSLADRAIRFRHGVLAGTLVILLASAGYLVG
GHLGTEAMPDIDGDVLEARILMPQGTPLSRTEAVAKQVSEAMAELNERLTPEQPDGASLV
RNLQVRFNHNPSAGEPGPHVATLSVDLLTAERRTVDLETLTAAWREAIGPIAGVHSLVIQ
EPGFGPAGTPIEVRLSGDDLDELQQASEHLKETLGTYQGVYNVLHDLRPGKPQYQFRMAE
GAHGLGLTAEATARQLRAAILGELGGTLRIGAHDVEILVRHTERDRNRLDALEELTVLGP
DGQRIPLAVATERKAAREWARITRVDGQRTVTVEANVNPRVANAQAIVNDLQNHWLPDFK
AAHPTLAVGFEGQVARSAETGGSVRRALLIGLIGIYVILSFQFRSYVEPLLVMVAIPLAF
MGALWGHVLMGYYLSMPSLVGAASLAGIVVNNAILLILFIKAHRDAGLSAVRAAGQASRD
RLRAILISSGTTTAGVLPLLAESSTQADAIKPLVISVVFGLATSTVLVLFVIPALYVIFD
EHRARRLRSSAEEHP
>fig|187272.6.peg.1119 Permeases of the drug/metabolite transporter (DMT) superfamily
MSDAVRRGATLIIIAELLLATMAATIKAASAELPSEMLVFFRNLFGLLLLLPLLVRGGRR
GLATRVPHLHLLRGLAGVGAMYCFFWTIAHMPLAEALLVKLSAPFFLPLIAWLWLRETLS
GRTVLAIAVGFLGVYFILQPNGAMQGAALQVGAVGLAGAALAALAKVTIRRMGPEESSRR
VVFWFGVTATTVSALPLPWVWQTPTGQTLVLLVVLGACATSAQLLLTRAFAIAPSGRLGP
FTYISVVFGSLYGWWIWGELLGPMTLLGMALVIGAGLLNLTLRRPAAPPARRPAEEHP
>fig|187272.6.peg.1125 Multidrug resistance transporter, Bcr/CflA family
MPHYQLAILLGMTVALGPLALDAYLPAFPAIAGDLGVSKADVGLTLSAYVFALGLAQLIG
GPLSDRYGRQRVLLLGLAVFAAAAFMVAQADSLNEMLAWRVVQGVGGAFCAVSVPAIVRD
QCRGNEAARLFGLIGLVMFIAPASAPALGSALLAVSNWPAIYYALGGYALLLGVLLHYRL
FRRIPVRVPARTPVQSLVTNYLLVLRHRVAMRFIALQTLAFSAMLVFITHASFIYQGWFG
FSSSAFAALFAANVAAMAVLNLVNRRLLLRFPSVHILRTAVATQHLAIALLILLVLLDAP
SWAVVACLMAVTGCMGAIVPNSLAGALDYFPNLGGTAAALLGATQFTVAGAVSALSTRLA
GEALLPIVLIMAVCSLGAVLLANGAPRAVQRQAAMQATPQGLDAPTPPSTPR
>fig|187272.6.peg.1158 Acriflavin resistance protein
MIRGDRAGGLAWFSRHPVAANLVLILMVVGGLYSVTQLNTQFFPNFELDIVNVEVEWQGA
TAEDVADGITRPLEDELRDLDGLREMVSTSAEGIAVITLEFAEGTDMAQAVEDAKERVGR
VRNLPPDSETPTINRITRYDPIARVLLTGEVQPDELRGLARSLEESLLQSGVARVQVTGL
PAEEIRITTRNERLLDLGLSFDRFAGLIASQSRDLPAGEVGEADVARQLRSLEQRRSVAE
FENLQLAIDGRNILLGDIARVERLPRDREVEVYFQGRPAVELLLERAEQEDALDSARILE
EWVAETRPTLPPGVELQVFDESWELISERIGLLVKNGLGGLILVVGILFIFLSGRVAFWV
TVGIPASFLAALTVLWLVGGSINMISLFALIMTLGIIVDDAIVVGEDGLSHYQRGESPFQ
ASEGGARRMFPPVIASSLTTVAAFLPLMAVGGVIGNILFDIPLVVVCVILASLVEAFLVL
PGHLRRSFEAMQRADGGWSGRIWRLLRRQRRQPAAEAGGRTGPPGPGPVRRRIDGAFDTF
RDRYFIPAVRRAIAFRWTTIAVGIALLIGSVGLVAGGRIAFTFFPTVEGTILYGNVSFVA
GTPRERTEAYLGELEQALLGAEEALGGDLLRGHLVYVGKKQSDGAGTQDRGDHYGAIMAE
LVSPDARTVSNREFMAAWRERVPEAAGLERLVVQERMAGPPGDDLDIRLIGPDVQRLKAA
SEALQDALASYTGVSAISDDLPWGQEQWVYSLTDEGRALGLDVAEIGSQLRATYLGELVQ
IFHERRDEVEVRVRLDEEERRGLAALSDFRVQLPEGGAVPLDSVAVLDSRRGFEALRHVD
ARQAVTVTADVDASVANANRILADLEARVLPELAARHGLEYRFGGRAQDQEETLADMRAG
LVLALTLIYIILAWIFGSYGWPLVVMAVIPFSLVGAFLGHWLMGLDLTILSLFGLFGLTG
IVVNNSIILVVFYRQLREQARMAADEALLEASRQRLRPVLLTSLTTIGGLVPLLFETSVQ
AQFLIPMAVSIAGGLAGATLLVLFLVPAMLSVYERAAERLQGDANRFREATDHG
>fig|187272.6.peg.2048 Bacteriocin resistance protein, putative
MPKGFCKGGDIVTLLKHRSFNRAQAGRDFSRVIPQSRPDSCGLAALATLMNEVLHLPTSE
AALQARLKHRRPASLTDLSKLSRQAGLKAHAYAVDLDLLLRVQRPAILHMGASRRIGHYV
VVRGVADDKAWLADPMRGNVHLDLTALKKHWYVPRKPFGHVLYVAGADEEWLPLNEEHLP
GSPPETVSDWFPPPAGR
>fig|187303.17.peg.49 Glyoxalase/bleomycin resistance
MKQPRPRVAPYLTVSPAAAAIAFYTGAFGAQQRALMPSVDGLRIAHCELLINGGSVMLAD
IFPEFGQTRVPMPGEHVTVSISLEYDKAQDVDDVCARAAKLGGKVETAPTNSFWGTRYAS
LRDPFGHRWILNAPLET
>fig|187303.17.peg.1071 Membrane fusion component of tripartite multidrug resistance system
MAPLERGRAESDGPPSSAARRVGFVRRHPALILLGALALIMLGVGGFIYWDYASHFETTD
DAFVDARQYSISPKVSGYLTAVEVTDNQHVSPGDVIARIDQRDYRIALADAEAQLAAAQA
SAKNLDAQIAAQRAQIGASEAQVEQSQAALRFAQQEATRSRTLVQRGTGTVQRQQQTSSQ
LGQEQARRERAGDTLQAARAQVQSLEAQRATAEARIGQASAQVDKARLDLSYTTVKAAES
GRVVRLTAAVGQLVQAGTSLAMFVPDNIWVTANFKETQLDDMRPGQPVQMRIDAYPEREF
RGRVVSVQPGSGTAFSLLPAENATGNYVKIVQRVPVKISFSDLPSDVVLGPGMSVVPSIR
VRPQLSIYERLRTRL
>fig|187303.17.peg.1072 Inner membrane component of tripartite multidrug resistance system
MSVADDVGAAGEASDSPNPWLIAMVVSVATFMEVLDTTIANVALPYIAGGMGVSPDEATW
VVTTYLVSNAVILTASSHLAKALGRKPFFLVCLALFTASSILCGFAWDIRSLLFFRVLQG
LGGGGMVPVSQSILADAFPPEKRGQGFALFGIAVVVAPVIGPTLGGWLSDNYSWHWCFLI
NGPIGLLSIAMVAVVLREPEDRPSAAPFDLVGFLLVSTFLGSLEVVLDRGQREDWFGSNF
IVGFAILSAAAFAFMIPWEATRENPVVDIRMIATRQFGACFAVMMALGAVLIATTQILPQ
LLQLSFGYTATLAGLVLSPGGVVTMAMMIVVGRLSSLVQPKYLIMAGAAIVALSIYNLTS
FYGDVDFWYFARTRIYIGIGLPLIFIPITTASYQGLPPEKTDQASALINVARNVGGSIGV
SLAQNVLAHREQFHLNRLAENTIPSNIQFQETLRRATEHFLALGGTASEARRQAVIWIGR
QMQTQASHLAYIDVFYALTLVAATIIPFALCLRRVRLGASNSAPAH
>fig|187303.17.peg.1838 Acriflavin resistance protein
MAGVNLSRWAVQRPTLMLFLMIAISLTGVYSYMRLGRAEDPSFTIKVAVVTASWPGATAT
EIRDQVADLMEKKLQELPFLDKIDSYTKPGFLAMQVTFKDTTPPKDVPQLFYQLRKKLDD
IAPTLPAGVRGPQVNDEYGDVDTVMYAVTGDGADYDVLDKVVQTLRQRLLAVQDVIKVDV
YGDQGRRIFVEFSEAKLASLAIQPQAVFDSLAKQNAINDAGVFETSSNRVRVQVTSDLKG
ADAIAAIPIEANGKVVRLGDIANVYAGFEDPPSFLARFKGRPAIVVGVVMGKGANVLRFG
ENVGAAVEEIRGKTPVGVDIDQIADQPKVVDEAIGEFTRSFLEALVIVLGVSFVSLGFRT
GIVVALSVPLVLAIVFIFMGPLGIDLQRISLGALIIALGLLVDDAIIAVEMMMVKMEQGF
NRIKAATFAWDSTAFPMLTGTLVTAAGFLPVGFANSAVGEYTGSMFWVLLVALIASWFVA
VMFTPYLGVKLLPDFAKLHPHHDPDEIYRTPFYRWLRAVVTWAVDYRGVVIAGVIGVFAL
AVFGFFVVPKQFFPYAERMELFLQLRLPEGSSIGASLEAAKQAEALLKDDPDAALYTSYV
GQGPPRFWLGLNPQLPNEAYSEIVIVAKDIAARERLKKKLETAIANGALPQARARVDRFY
YGPPVGFPVQFRVVGSDPATVRAIAYQVRDVMRGDEGVDDPHLNWNEQTPRVRLVIDQDR
ARLLGLTPQDVSNRLRLAISGVTIATLRDGIDQVEVVARAIPQERGDLSRIGDMVIYARD
GKAVTVSQVAKIVYDHEEPIFWRRNRDMSITVRSGVKDGVQAPDATMRIWPQLAQIRERL
PPGYRIEMGGAIEESKKGNASIFAVFPLVGLVMLTIVMFQLQNFTRVALVMMSAPLGVIG
ASLALNVAHAPFGFVALLGLIALSGMDMRNSIILVDQVRQDLERGEKYREAIIGATIRRV
RPVALTALAAILAMIPLSGSAFWGPMALTIMGGLFVATFLTVLFLPALYATWFRRHLGEG
LAEAKGARARTLADGLARGAAE
>fig|187303.17.peg.3387 Permeases of the drug/metabolite transporter (DMT) superfamily
MSRIRADLLLVLAAFIWGTAFIAQKNAGELMGPITFVGVRFLLSCVALAPLALYEGRHSE
AALKKGDLPLAGLIGFCVFAAAALQQVGLATTTATNGGFLTALYVVLVPAFVFAQTGVRP
RQVVLVAGLASILGAWLLTDSGRLQSWTSGDALVLIADIAWAAGISLVPTFLARTDRPYF
LAFAQFGVIGVLGAVVGLAGEPFSLDGLIAALPSILYAGLCSGGIAFTIQIVALKYTPAA
EAALIMSLESVFAAVSGAILLSERLTGPAMLGGALILLSAVLVEAGPAAQTIWLTQYWTW
LAQVWSRAR
>fig|187420.1.peg.193 Efflux pump antibiotic resistance protein
MNEYNDRSLRLYVLIAATLSSFLTPFMGSSINVALPVIALQFKIDAILQTWIPTAFLLAA
AIFAVPFGRLSEIYGMKRVFVYGNIIFTVSAILSAFSPSAMALIVFRAIQGVGSAMIFVT
GLAILTRVFPPYERGKAIGINTAAVYIGLSMGPVLGGFLTRFLGWQSIFLSTVPLTVIVL
AVSLLRIDGEWADAAGETFDIPGSISYCIFLFLLMYGFSALPDTMGALMILLSIGAFAVF
LRMELSSTSPVFNVRLFRNLTFSFSSLAALINYSATFAVSLLLSYHLQYIKGLDPGSSGL
ILVTQPIVMALVAPVAGRASDRFNPQTLAGIGMAVTSLALLSLSILDRTTPVPMIIVSLF
VLGLGFGFFSSPNTNAIMGSVERKDYGIASATVSSMRLIGQAFSIGIVTLIFAFLIGRVP
ISPANYDLLIESTRICFLIFGVLCFVGVFAATARRNDG
>fig|188937.1.peg.168 Class H tetracycline resistance efflux protein
MNMETDPESVRQENRPDPSARERISLLPLLTVNFIGTLGFSIVLPFLVFLVNRLGGNAFI
YGLASSMYPAFQLIGAPILGRWSDIYGRKKILLFSQVGTLLSWIIFLGALFLPVVTLFQV
DSEVLGTFAFTLPLAALFFARAFDGLTGGNVSVANAYLADITEEKDRNRNFGKMSISSNL
GFIVGPALAGLLSITAYGEAAPVIGAVVISLIGTLLIIFYIPENKECSLEGPVEAKNIRK
VFGYEIKECRTVRETGKPSFREVFKLPNIPYMLGLYFLIFLGFNIFYTAFPLHAIAALDW
GIAEMGVYFTILSGLLIIVQGSILPRLSKRYSDASLIIFGSLMLGTNFLLLIPGNLFLTY
LATGFFAMGDGLMWPSFLSLLSKIAGKNYQGTVQGFAGSFGGLASITGLILGGLLYELLA
GRAFLLAGMIIYVVFLLNFRLRRFEKELKY
>fig|188937.1.peg.333 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDERSQMLANEKISKLLLKLSVPAMVGMLVQAFYNLVDTIFVGHAYGADSIQAIGGIAVA
FPIQMVGMAVSLAIGIGGSSIISRRMGEREMKKANKTFSNLIFLSILSSLLITGAGISFI
VPLLKLFGATETILPYSLEYLEVILYGTVLFSLAMVTNSIARSEGNAKVAMNSMMMAGGL
NIILDPIFIFGFGMGIRGAAIATVLAQGIGVLYIARYFLSGKSTLRFHPADLKPDSKIIK
EVLAIGASPFARNVSSSFMIIILNNLLAFYGGDIAIAIFGIISKLLMFTLMPMFGIIQGL
QPIVGFNYGAKNFGRVRESVKLAIIITTGMSIAGFLVLYLFPEQLFGIFSGDHQLIVEGK
NAVRIVVLATPLIGFQVVGGALYQALGKARPSLFLSMCRQVLFLIPLVLILPKYLELFGV
WAAFPLADTLAFAVTLIMVIREFKVLAEEGENMRNDPMRNDPLAGN
>fig|188937.1.peg.497 Antibiotic resistance protein McbG
MEYQNEEFEAETFKDTDLTDVSFKDSRFIDCDFENCNLSNVDLDNTKFQNIRFKSCKILG
LDFSKCNDFILAFGFEDSFLSLSVFSNMNLENTDFTNCQIYDCDFVNTNLTNANFENSDL
KNSLFKKSNLSFTSFKNAKNYDINPNENFLKKTVFSIPEVISLLDIYDIVLG
>fig|188937.1.peg.2619 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVSDEELRSGNIFNLFWKFTFPAVVGVIIVGIQEIIDGFFIGNAVGNQGLAGITLAYPPY
LIIIGAGIIIGIGSSSLTALKLGKGNKKEAFEIVHNAFPLSLLTGAIFTVGGLIFCETSL
GLLGTDGPALFFAREYLRIIFAGSVFMVLAISLDPLVRNDGKPRLCMHIMAAGVVINIVL
DYFFVMRMGMGMPGAAAATILSFVLPAVLLMRYLFGSEAKLKLRLRSMSFKPVTVLQIFK
AGTPSFAMQISFALLLFAHNYMLLRYGSELAVSAYGIIGYVFSIFYMLFEGIALGVQPIM
GFNYGAGSYERVSKTLKLTMLSCILVGVFGFMLICLFPETLVQLFSQNDPELLEITLRGM
NIGMFSLLVEGIVLLTSIYYQSINRVRAALFINLGKIFIFLFPLLFILPLFFGLDGVWSA
SPVAEYFMVILVMVMLSKEFRFLRESAKAVTGKPADLKTNAKANIRASTKAEAKYAPSVS
RSSVKAGSKESTGFVAFKHAENAESS
>fig|188937.1.peg.3100 MATE family drug/sodium antiporter
MNKKHASPKTAGKMSMETAEEKGNTEEKKAKKEKLEESRDGKEKTGSIPSQKVTEGVDVL
LGDPKKAVVKLSIPIIVAMSVQTIYSLTDTFWVAGLGADALAAIGFSFPFFVIQMALTSG
LGVGGGAAISRRIGARDKAGVDNVAVHTFVLMVILTVALTIFGLAFVRDLFMYSGAGGTT
DLGVAYARVIFAGSFVFFFANVSNSILRSEGDAKRAMQSMILGSVLNIGLDPIFIYVLGL
GVAGAALATVVSFACSGLLMFYWFFVKKDTYVSFDFHSFKFNLAIANDIFRVGIPSSVEQ
VALAMTALLMNLIIVNVSNTDGVAVYATGWRVASIAVAPLIGVSISVVSISGAAFGEKNF
KKARHALIYATEIGFLAEALIGIAVYVFAPQISAVFTQAETAARIAPELTRLLKIMTVFY
PAVTFGMLSASLFQGAGKGTSALIATLLRSLVLTPLFAVLFAYELGWGLLGVWWGLVAGT
VIGSLITFAWAQVYLGCMIKEEGIGEKC
>fig|188937.1.peg.3324 Multiple antibiotic resistance protein
MVSENLGFFIYVFSSIFVVVSPVGGVVTFISLTSKMTRKEKNEIAKKAVILACSIALFFA
ITGSMILNLFSISVDSLRVAGGILLFTIAFDMMQAKVSRESITEEEITQSQEREDIWVFP
IGLPLLTGPGTISTVIVLMGMADGVQQKGVVLVSIIATFLICLIVFHFSRRLHKFIGYNG
MLVFTRLMGLLLAALAVDLTSTGIINIFGLGT
>fig|188937.1.peg.3492 Multidrug resistance efflux pump
MNTCNLQKNVFPEFFGNINHELYVLSFSRFCEDLGSGMLVALIPLYISDLGASFFSGLPL
VTRAGLVITVFGLFSALTQPLMGRLSDRLDRRRPFILFGLIGYTFFSFLYSQVTSYEQLL
FIRLLQGITVGATIPAVIAMVTHISTSETRGKAVGVYTTIRGVGFGLGPVVGGAIARYWG
FDAGFYFCALLGVVSLGLVTFFVKETRGSPEPVSRKISGKKSYASVYSLAGAMLMMMVGI
MMVVALLPEYEVRLEASELSLGVAVSAYIFARLLFQAPLGSLSDRIGRKKLIVGGLFLSA
PLVVGMGYIASVGQLIIFRAFQGLLVAAIDTPAMALAADLSDGSSLSSRLSIITTAQAAG
MAFGPIFGGFLAGYMTFVTPFYACALLMLLAGFVVIKKVEEPEKVI
>fig|188937.1.peg.4097 Antibiotic resistance ABC transporter permease protein
MSFQFRAIYWRDMLKFFRFKSMLISSLVQPVMWLAFFGLAMSESFDQLTSLVPPMEGVQN
VDYLTFMGAGIIAMDVLFSSLFGGTSLMFDKKFSLLRETLASPVPRFHIILGVGLSGVTK
AFIQTSMIIGFGKLIGMDFFKGYTLTETLISIIGIFLLVGIFTLGFLFLSGSIAITIENP
EGMQSILTLLSMPLFFVSNALYPIESFPAILKFLSMFNPLTLLADGIRYFALGDNFTVIG
IHYVYTLFDISMSFLGLMIFALAMLATSLWRFNKVDV
>fig|188937.1.peg.4098 Antibiotic resistance ABC transporter ATP-binding protein
MTANVIEVNGLEHSYGSVKAVDNISFAVKEGEIFSFLGPNGAGKSTVINILTTLRKIQKG
EAKVNGYDVERESKHVRQSIGIVFQMLCIDHEMTVCENLEYHGKIYSMSKKERKERIDEL
LKLIELEHKRDTLVKDLSGGMKRRLELARGLMTKPAVLFLDEPTIGFDIQTRMRMWEYLR
EIKREGTTIFLTTHYMEEADQLSDRISIIDHGKIIVTGTSEELKNKLGKDLIYLETDDNN
TVAEILRTIGSVKTVTEDTKSLRVMIGEDVTHVLPQIIDKIRKAGIDITTINIKKPSMDD
VFVHYTGHGLREGEPQEKVEGLEPMGEPMGVSA
>fig|188937.1.peg.4503 Multidrug resistance protein
MKTDGIASDSNILNGKEYLVAVGVVLLGLFMSVMDTVIVNIALPSITAYFGNTISESQWV
VTAYLITITAFMIVFGKLSTYTGLKKMFLGGIALFTVSSLGCGMASSLLMLITFRITQAI
GGAMASSISMALIYRISPPDKQGKAIGIMGATVAIASLAGPGIGGILIEMFDWRAIFHIN
IPIGIIGLFIGIPYLKVTDTKKKGENIDWIGAVSFAVGITSLMVLFNAITTKGLYSMEVL
VTFTVMFFAFMLLGWNERRQIDPMLDTGVFREPMFFLPLLSTILFFAAVFMLNITMPFYL
EEVLEFTPLHVGMLMMAIPVVLIVGSPIVGWLYDHYLWQHFSTMGLLVAFSALLICAWAI
LDERLGIILFSMGLFAAGYSLFQSPNNIEIMRGLHKDRAAIASSIANTGRYFGMAIGASF
ASVILSIQFLSTELTKALPEIDINSLTLSSGVTLAIAALLCIIAAWPSYIRNRNN
>fig|190304.1.peg.3 Multidrug resistance protein 2
MAILYDSVITAFLLQLGLKNTQIGLLWSVVLLTQMLFDYPTGSFADRYGRLKIFTIGMVL
TGSAIVMIAYSVSISMLYISAILMGIGESQISGTLFPWFVNSLDKVDNLQEKEEYILKSN
GQVQYSTNIIGILTGFVISFLNLDYKFILILAGTFQAINGIFIYFSFQDNKSTETNLIKI
GKKSFQIFLKDYKLWIYTLTMTIHYSFYSVHLFIWQPRANLLGVIGSKLTGINSVYLSCL
VISGLIIKYKKEIKNYLYVLYVILIPISLIIIYQSQNLILYILGTILLGISNGMVAPQIM
STVHYFIPDEVRSSVISLLSSLSSIFLIFLQVIIGKILDIKGNYYLEILCVLFGIIYIVC
IILILKWLKENRNR
>fig|190304.1.peg.221 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENKHNFMETESITKLLIKFSIPAIVGMFVNALYNVVDRIYIGNIKDIGHLGITGIGVVF
PVVILIFAFSLLIGIGSAAAVSLKLGMKDREEAERFLGVAVFLSFIVSVVLMIIIYFNMD
KIIYFIGGSNETFIYAKDYLFYINLGVPAAILGLVLNSVIRSDGSPKIAMGTLLVGAITN
IVLDPIFIFGFGMGVKGAAIATIISQYVSMLWTIYYFTSNKSKIKLVKKDIKFNFYKAKE
ICLLGSSAFAIQLGFSLVTYILNTVLKKYGGDTSIGAMAIVQSFMTFMAMPIFGINQGIQ
PILGYNYGAEKYKRVKEALYKGIFAATIICIIGYTSVRLFSDTLIKIFTTKPELQEITKY
GLKAYTMVFPIVGFQIVSSIYFQAVGKPRMSFFISLSRQIIVMIPCLIILPIFFGLNGIW
YAAPTADSIATLITYILVRKEIKKLDKLEEMLELRNI
>fig|190304.1.peg.937 Permease of the drug/metabolite transporter (DMT) superfamily
MKNIPAFIFAGFSGYAGYIALFNIATLFSSPSTLSVINALAPAITAIVAYFIFNERIKLI
GCLSMGISFCGILILTLWDGVLTVNKGILYMLAGCLLLSLYNISQRYLTKKYSSFDVSMY
SMLIGGILLVIYSPSSITNMFSISFTSLILIIYMSIFPSIISYFFWTKAFELAKHTTEVT
SFMFVTPVLATLMGIIILGDIPKLSTLIGGVVIILGMILFNKTK
>fig|190304.1.peg.1050 Acriflavin resistance protein B
MLIERGNKMKLIKIAIKRTIVTTMISISLLILGIFAMKSMRTELLPDIEYPVVKIITHWS
GASAEDVEKQITNKIERILPNVEGIENISSESSYENSSISVEFNYGVNIQDKVTEIQREV
FQIKNDLPNSAKNPIIKKTEVGAGAITLFLTFVSPDKKALFSYLENYVKPNLETISGVAE
VSILGGTKKQLQIQIEPAKLASYNLTPMDIYQLIRKSSMVIPLGSLMNGREEYVIQALGE
LESVEEYENILLHSNGDTLRLKDIANVVLTEEDPLNLGFNRGKPATTIAISKSSDGSTIE
INEKIMKAIKNMEETMPSNITYFKIFDSSESIKKSINTVGKSALQGLILASLFLWIFFKN
KKMTLIVSFAFPLAISTTFILMKGIHSTFNLISLMGLAIGVGMLTDNSVVVIDNIYNHIQ
EEKNSIEAAFIGTNQVFSSVLASTLTSIIVFLPIIFTKGIFKEMFQDMVWAIIFSNVAAL
LVSVTFIPMLASKFMKKNIIQTEGKYFSKIQRKYQKFLSISLKHKKKTVLISLLFAFLIF
GIGGKFVKFGFLTKQDYGYYSVIAEFQNGSDFEKIQELRNEIETIIKKESHTKSYFSIIQ
KRNGTISVNVDVGFKEKRKESIFEIVKKVRKEVEKIPDIRTTFFYEYAKGKPKKDIEFQI
VGTDLETIQILARQIYKDVLKIKGVTDVSSTLDSGGKKLEIIFKRDKIQSLNISIKQIEE
TISYYLLGGDRANTITIKSGNEEIEVLVRLSKDNRKSIKQLENLKIKVTDNSFINLSEIA
DIRKVENQLSIDKINRFYSVSIYVNDGGIGTQKIQEELVKIFSEKNKDSSIQYRWGGDAE
KMQRAMKELMLTFLIAIFLIYALLASQFESFLFPFLVMGSIPFSLVGVIIGFLITQHTLD
AVAMVGIILLIGIVVNNAIVLLDFIQQEEKESKNKKEAIEKACNLRLRPILLTSLTTIVG
MIPLSLGIGDGSEVYQGLGISIIFGMSFSTLLTLIFVPTTYYMLTSIFSKKL
>fig|190304.1.peg.1092 Acriflavin resistance protein E
MKIKYILLFLIIFIFTACKKDAEEEIIRPVKIQEINSIQDENFNIDFPAQISPTQKTVLA
FKYAGKIKSINFESGDFVKKGQVIATMDNKDYMVNLEAFSKKYEAAKAVAQNAEVQFSRA
EKLYKGGALAKKDYDNALMQKNVAISTFKEASAGLENARNTLNDTKIIAPYDGYIDKKIV
EVGTVVPEGGPVISFISNEITDISINASLKDVENIRNAKNIVFKDNSSEKVYPLEIKNIA
QNPDSINLTYPVIFTFSNLGKDEKFLSGQTGTVTISVKNNGNQEILIPLDALFEDNGSNV
YLFKNGVAVKTAVEIGELRETDKISIIKGLKSGDKVIVAGVHKLVDGEKVKLLGGTK
>fig|190304.1.peg.1250 Permease of the drug/metabolite transporter (DMT) superfamily
MQENHKYNIYMFIATIFFGMTYVLTKICLKYSTEFHIISFRFLIAFVVSLIFLQKKIFPV
KRTEFLYSLLLGALLFLVFIAMTIGVKYTTATNASFLISLSVIFIPFFSWFFNKEKPKKR
IFVVLIIALIGIILLTLDKNLEFHIGDILCLICATLFTFYVIMTEKIVKNNNPTALGVLQ
FGWVFLFSFLVQYPIESFVIPKNKFFWLSMVLLGIFCTAFGYIAQTIAQKNLSSTVVGFI
LSLEPVFSGIFGYFFLNEYLSFQQYIGAFLLLISVIYVSVKN
>fig|190304.1.peg.1520 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGEERKELNPLGYKLIGKLLKSLAIPAIIANLVNALYNVVDQIFIGQRIGYLGNAATNIA
FPITTMCLAIGLTLGIGGASNFSLELGKGYPEKSKHTAGTAASTLIIIGIILCIVVRIFL
EPLMLDFGATDKILEYSMEYTGITSFGIPFLLFSIGVNPLVRADGNAKYSMIAIVTGAIL
NTILDPLFMFVYNWGIAGAAWATVISQIVSALLLLIYFPRFKSVKFSLNDFIPQLHYLKR
IISLGFASFIYQFSNMIVLVTTNNLLKIYGKNSIYGSDIPIAVFGIVMKINVIFIAIVLG
LVQGAQPIFGFNYGAKSYHRVRETMRLLLKVTFSIATILFIIFQVFPKQIISLFGEGDKL
YFEFATKYMRIFLAFISLNSIQISIATFFPSIGKAIKGAIVSLTKQLIVLFPLLLTLPIF
FGVEGVIYATPLTDLIAFTVAIIFLTNELKHMPKK
>fig|190304.1.peg.1614 Permease of the drug/metabolite transporter (DMT) superfamily
MMNKKRYFGDLMLFLAAFIWGTAFVAQVTGMDRIGPFTFNMARSIIAIICLGAYLIITKS
KLPKDIGVLLQGGLVCGFFIFMGTSLQQIGLQYTTAGKTGFITSFYILIIPFLTMIFLKH
KIDLLTWISIIIGFIGLYLLAIPNLSDFTINRGDFIVFLGSFCWGGHILIIDYYSKKVSP
VQLSFLQFVMLTILSGICALLFENETATMNNIFLSWKSIAYAGFLSSGIAYTLQMVGQKY
TNPIIASLILSLEAVFAALAGYIMLDEVMTSREFLGCSIVFLAIIFSQIPKDIFKKKYVS
LKK
>fig|190304.1.peg.1851 Acriflavin resistance protein B
MSLAGISIRRPVATTMVMVSFIFIGLLAMFSMKKELIPNIKIPVVTITTTWTGAVSENVE
TQVTKKIKDSLSNVDAIDKIQTVSAYGVSNVVVNFDYGVDTDEKVTQIQREVSKIANNLP
NDANTPLVRKIEAAGGNMTAIIAFNADSKTALTTFIKEQLKPRLESLPGIGQVDIFGNPD
KQLQIQVDSDKLASYNLSPMELYNIVRTSVATYPIGKLSTGNKDMIIRFMGELDYIDQYK
NILISSDGNTLRLKDVADIVLTTEDADNVGYLNGKESVVVLLQKSSDGDTITLNNAAFKV
IEEMKPYMPAGTEYSIEMDASENINSSISNVSSSAIQGLVLATIILFIFLKSFRTTILIS
LALPVAIIFTFAFLSMRGTTLNLISLMGLSIGVGMLTDNSVVVVDNIYRHITELNSPVME
ASENATEEVTFSVIASALTTIVVFLPILFIPGLAREFFRDMSYAIIFSNLAAIIVAITMI
PMLASRFLDRKSMKSEDGRLFKKIKAFYLKVINKAISHKGLTVLIMVVLFFFSIFVGPKL
LKFEFMPKQDEGKYSLTAELQNGTDLNKAERIAKELEEIIKSDPHTQSYLMLVSTSSISV
NANVGKKNTRDDSVFTIMNDIRNKTSKVLDARVSMTNQFSGGQTNKDVQFLLQGSNQNEI
KQLGKQLLEKLQSYNGMVDISSTLDPGIIELRVNIDRDKIASYGISPTVVAQTISYYMLG
GDKANTATLKTDTEEIDVLVRLPKDKRNDINTLASLNIKVGDNKFVKLSDVATLQYAEGT
SEIRKKNGIYTVTISGNDGGVGLGAIQSKIIEEFNNLNPPSTVSYSWGGQTENMQKTMSQ
LSFALSISIFLIYALLASQFESFIMPIIIIGSIPLALIGVIWGLVILRQPIDIMVMIGVI
LLAGVVVNNAIVLIDFIKTMRTRGYDKDYSIIYSCETRLRPILMTTMTTVFGMIPMALGL
GEGSEFYRGMAITVIFGLSFSTILTLVLIPILYSIVDSFTSKLMTRIKVISRKSKKKEAK
>fig|190304.1.peg.2038 Permease of the drug/metabolite transporter (DMT) superfamily
MLRKERIFLFLVLLLAIIRGSSYIFIKNIIDNQSPFEIIFFRFFLTEIILLIFYIKEFKT
LNHYDLIFGLLAGIFLFSAFAFQTYGLKYTTVSKQSFLTSLYIVIIPLLDFIFFKNKIKK
NVIALFFLILVGLLFISFKDFKNFEFYLNFGDILTILCALGFALNILLFSKIKKFNINVI
NITIIQMLTIGILAFIFQIIFEKKVINFSMNFSLIYLILICTMLNFTIQNISQKYVPAHI
IGLILSLEAIFGTVFAIIFLNETISQNFIIGTFLIAIAVILIQYFENKRGD
>fig|190304.1.peg.2042 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFKKKIFKTIFKYAIPNVISMWIFTLYTMIDGVFISRFVGSTALAGVNLVLPLINFIFSI
SIMIGVGSSTLMAIKFGENKYDEGNKIFTLSTFLNLFLGIFISAIILLNIDRVINILGAN
KSQEVYRYVKEYLTIIVFFSVFYMSGYAFEIYIKIDGKPSYPAICVLVGGLTNLVLDYVF
VVIFHYGVTGAAIATGISQVASCTMLLLYITLNAKYVKFIKLNKINFEKISKIFRTGFSE
FLTEISSGVLILIYNLVILRKIGVLGVSIFGTVSYITSFITMTMIGFSQGIQPVISYYLG
KKNYKNLKEILKISIIFLGVLGIFCFMFVSLFSEYIGKIFFREQDMILYVKRVLRIYSLS
YLIIGINIFVSAYFTAIKKVIYSALITFPRGILFNSILLLILPNIFGNKVIWIVSFLSEV
LTIFICIYLLKKIKRKGILN
>fig|190304.1.peg.2050 Permease of the drug/metabolite transporter (DMT) superfamily
MRKDYFTRFFYIILMGFGFPIMRFMSIHFETVNNNAVRFLSGGFLFILICIFKFREELKK
ILLESKIILKLLLLGIFMSGNMYFFINGNKVGESLNFLKGTLFLGTAIFIQSIQNLLVKN
VAKKLHTIVISASTATLSGIIYLILSIHTGKIIQLKEVGEGMLIGLSLAGIYGMLTGMLM
AFYIVQKQGVVIFNIIQLLIPVSTAIVGYFTLGETINFYQGIGAIIAIFGCIIALKI
>fig|190485.1.peg.1377 Outer membrane component of tripartite multidrug resistance system
MNAASSFLQRRHPRAVRRLRPILVTTLALALAACASSRGLAPQGTVLEPGAVHAERTFGQ
AQLSPAAWPASDWWRALGDPQLDALIAEGLQHSPSLAAADARLRQAQARTGTAQADRGPS
LSVSGGYAGWQLPESMVGEERGGSYAGSAQVVLDFRYGVDLWGGKRAAWEAAVDQAHAAE
VDAQAARLNLSAAIAEGYAQLAYAWDLQDVANDELARAQKTLELTQRRRGAGIDSELQVR
QAQARVPAAQQQVQSAQQQIDEARNALAALVGQGPDRGLDIARPVLSQSLPPQLPSALPA
DLLGRRPDVVAARWRVEAADKDIAVAKARFYPSLNLTALGGVINSDVGKLLESGSVLGVV
APALSLPIFDGGRLKAGLAGSDAQYDLAVADYNQKVLDALREVADQVNAVRSLEQRARAQ
NDAVQTASAAFGLAQQRYRAGIGSYLEVLSVQEQLLTARQRMAGLHSQQLMASVKLRRAL
GGGFTPEPARDTAHTATSSAQPHS
>fig|190485.1.peg.2300 Outer membrane component of tripartite multidrug resistance system
MQCTDSLRLARMPLAAALASLLLGGCMLGPNYTKPPAVAETAVQAPTLHRASAADVVAAA
PLNHWWEDLRDAQLTQLVTQALADSPNLRAAQARLRANRALANQRRAERLPKLNASALYA
YAEPPQTIVDTLGGLQNGQQGQPPAQGSQALNLEKTELYTAGFDASWELDLFGRRRRAAE
GALAQAQASEAELADAQVQLAAEVGQVYLNYRGLQARLAIADSNLDKIRQSLALVQQRRG
QGAASDLQVEQIATQVQQQQAQRLPLQMQQQEALDQLALMVGREPGALDAQLAAPQPLPM
LPTQVRVDDAGALIRRRPDVRKAERELAASSAQIGEALNGYFPQVSLLGGLSWVAGSPSD
FNSDALTKLAVPMLRWSIFDFGRTRAQVEQARAGNAGREAAYEGAVLAALQDANTALSRF
GSARQQLVVARQAEASATRSAGLMQQRRDAGATSSIDLLDVQRQQLSAQDAAAQAQVQLL
VYYVALQKSLGLGWSEPPQAAAR
>fig|190485.1.peg.2301 Inner membrane component of tripartite multidrug resistance system
MNAAAATGERAGGSAGREKAEPGAWLAVLAGTIGSFMATLDISIVNAALPTIQGEVGASG
TEGTWISTAYLVAEIIMIPLTGWFVRTLGLRNFLLICAVMFTAFSVVCGLSTSLTMMIIG
RVGQGLAGGALIPTALTIVATRLPPSQQTMGTALFGMTVIMGPVIGPLLGGWLTENVSWH
YAFFINVPICVGLVALLLLGLKHEKGNWAGLLDADWLGIYGLTAGLGGLTVVLEEGQRER
WFESSEINTLSVFALSGFLALVISQFGQRAPVIRLSLLLHRSFGAVFIMIMAVGMILFGV
MYMIPQFLSVISGYNTEQAGYVLLLSGLPTVLLMPMMPKLLEVVDVRILVIAGLLCFAAA
CFVNLSLTADTVGMHFVAGQLLQGCGLALAMMSLNQAAISSVPPELAGDASGLFNAGRNL
GGSVGLALISTFQERRMTFHTETIGSAVTANASRAQDFLAGLNAQMQGSAGGEAAIRAVA
QLARLVQQQALVMTYSDLFWIFGVIVVCTIPLAFLLKPLPKGTHLAMH
>fig|190485.1.peg.2302 Membrane fusion component of tripartite multidrug resistance system
MSNHDQQSTDGQSTAADGQGNASRDDDAKKPSPLKNPKVKWTLIIVGVLVVVLLVIWLAY
YLIKGRYMQDTNNAYLQADSVAVAPRVSGYVTQVMVGDNQIVDAGQPLLQIDDRTYQATL
QQAEAAIAAREADIAAATANVAAQESSLVQARTQVASAAASLRFAQAEVKRFAPLAASGA
DTHEHQESLQHDLERARAQYEAAQAQAKGAQSQIQASSAQLEQAKAGVKQATADADQARV
AVEDTRLTSRIHGRVGDKTVQVGQFLAAGTRTMTIVPQQSLYLVANFKETQVGLMRPGQP
AEIEVDALSGVKLHGKVESLSPGTGSQFALLPPENATGNFTKVVQRVPVRIRVLAGEEAR
KVLVPGMSVEVTVDTRSAKDAKQRAEEESDRVQAQERAR
>fig|190485.1.peg.2321 Drug resistance translocase
MSSSVSEAGAAPAPRYPDYRIISLILACAIFMEQMDATVLATALPTLARDFGVAAPAMSI
AMTSYLLALAVLIPASGAIADRFGLRRVFSASIWVFIGGSILCSLADSLPTMVAARVLQG
AGGAMMAPLGRLILLRTVERRHLVSAMAWTLVPAFIGPMLGPPLGGFFVSYLDWRWIFYI
NVPIGITGFLLVRRFIPDIPSESAPARFDLRGFVLCGTALGCLLFGLEMVSQEDGIPRAS
WLLAIGGATALGYLWHARQHPAPLLDLSLLRIDSFRLSVIGGALMRITQGAHPFLLPLLF
QISFGFSAARSGRLILATALGALLMRSITPQLLRRFGYRNSLIGNGVLASLGYMVCALFR
PDWPPALMFGLLLCCGAFMSFQFAAYNTIAYENVPAARMGRASSLYTTLQQLMLSVGVCA
GAMILKLAMLAGDHPQPQQRDFSLAFCVVSLISLSATWWHVRFDKHAGQEMSGHRA
>fig|190485.1.peg.2579 Permease of the drug/metabolite transporter (DMT) superfamily
MSAQPSLQPALGVRDWRTPLELVFLGIVWGCSFLFMRVAAPHFGAAALVEIRLALGATVL
LPFLWVARSRFPLHRWPMLAAIGVLNSALPFLLFAWGAQHAPAAVGAICNAMTVLFTALI
AFVFFGERIGTRRAVALLIGFIGVLVLATGKSAGLSVGPAALAGATASLLYGIGYNLVKR
HMGDLPPAASAASTLGCSALLLAPVAWWQWPSAPVPASAWACAGALGVVCTGLAFLMYYR
LIQRIGPARASTVTYLVPVFGALLAWALLGEALTWTMLLAAVLILGSVAFSQRAR
>fig|190485.1.peg.3335 Permeases of the drug/metabolite transporter (DMT) superfamily
MSVAAAPPEAASRRAIWQLLLAEVLIGSVGVFVHESGQDPVTAVFYRCLFGALFLTVCGV
LGGHLRGLWRERRLLRDAAISGVLLVLNWVALFAGMARSSIGVATMVYHVFPFVMLILAA
VVQGERTRRADLGWTLLAFIGVACSADPLRLWQSADRSYLLGIGLTLLAALLCGASLLMS
RRIGRERPLAVVTVQCWVGTLLLMGFSSSAALHPGLHWAWLVGLGVIHSGIVYVLFYSSY
RHLHVATIAVLAFVYPLVTLLLDYLLYGHALAPVQWLGLGLIVCGTLAVNLKWRWPRWAT
GKAVLQR
>fig|190485.1.peg.3360 Nisin-resistance protein
MQIPEQANRLAIGVVLAGDGAVEVTALRLMAQPVVDAASAAAILDVAIPAIREHALQRSR
IDWATREPQLRAQAASMRKADAYAAIEALIAELDDGHSALLRPSTLRDVEAHATHATVQA
RLLQPDVGYVAVPGLMTSSSDVRGDYQRALSAALDGMASQARCGWIIDLRQNSGGTMWPM
VNGLQPLLGDHVLGYFLNADGEQTPWRARAVPPMSGVRVAQTDRPVAVLIGPNTASAGEM
VAIAFRGRPATRSFGQPSAGQTTSNRTVDLPGGGVLAVASSAMQDRNAQRLDGALQPDMA
LDPQADAIDAAAQWLRMQRCAPAQ
>fig|190485.1.peg.3610 Daunorubicin resistance ABC transporter, permease protein yadH
MNLHAIGAIYRFEMARAFRTLTQSIASPVLSTSLYFVVFGAAIGSRMGAIDGISYGAFII
PGLVMLSLLNESISNASFGIYMPRWAGTIYEVLSAPVAWWEIVIGYVGAAATKSVMLGLL
ILLTARLFVPYEIAHPVWMLGFLVLTALTFSLFGFIIGIWADGFEKLQVIPLMVVTPLTF
LGGSFYSINMLPPIWQKVTLFNPVVYLISGFRWSFYGKADVHIAVSTGMTFLFLLVCLGV
VAAIFRSGYRLKA
>fig|190485.1.peg.3796 Mitomycin resistance protein
MHPAKVDRAHLLRLTDLPNVGPACEKDLQQIGCRMPAQLHGRDAYDMYAQLCLRTGVTHD
PCVIDVFLSLVRFMQGEPARNWWDFSAERKATLAAERTGTRATAPPPGRRVANTSTSTGA
SSDGKHRP
>fig|190485.1.peg.3862 Permease of the drug/metabolite transporter (DMT) superfamily
MSSSHNAAAPAPARNGLVVLALLLVYVVWGSTYLVIRFALAGGAQPLTMVSGARFIVAGT
LLYAVLRWRGVAAPTPAQWKNVAFMGAALLLLGNGMVVLAERSVSSGLAATAVASVPLWM
ALFGALRGQHASRGEWLGIVIGFLGVVWLNAGSSLTATPGGLVLLLIAPIGWAFGSVWSR
GRDLPTPFMTAAGQMLCGGVLLVSTGLLLGERPHAWPTTQGLLAVAYLCVFGSIVAFTAY
VWLLHHVRPALAGSYAYVNPVIAVSLGAWLGHERFSAHDIGAMAVILCGVLVVTLAKARR
>fig|190485.1.peg.4053 Bleomycin resistance protein
MHTAWAVTPPMIAVMCSALIPSTEETRMNASANVGDQTIPILPRRSIAQTLTFYRALGFA
GDAHPHDAGYAILQRGDVELHFFAHPDLDPAACYAGCYLRVTDVDGVYAAMRAAALPAQG
IPRIDPVGDKPWGMREFAIVDESGNLLRIGQQLEP
>fig|190650.1.peg.105 Multiple antibiotic resistance (MarC)-related proteins
MTEANLAVNFFVALFALIDPIGNVPLFAAATLGAAAAGRRMVAVYIGLFMAAFLIFFYFT
GVGLLEFFGISMPAFRIAGGIILFILGLDMVRDDFTTMFADAAEGIEDQSPRAYAKQRFE
RLIVPFAMPLLIGPGSISTVIIYAAEAKDFGAAGMGIGVAVIAAVSLVTVLTFWASPLVS
KVLGRIGMSIVVRVLGLILCALAVQFVLVGVADATRGLIKNDAKAPYAESHK
>fig|190650.1.peg.380 Multidrug resistance protein
METRFVTPFHHLLVNNLVANITNFTIWFALTFYVYLETKSVFATGMIAGVYLVLTAACGI
WFGSLVDHHRKKLAMAGSSLASLLLYALALAVLLLAPKGAIADVGRPWLWALIGLSMLGV
IAGNIRTIALPTLVTLLIPEDRRDKANGLVGMVSGVGFLTTSVISGFLVAWGGMLAALTF
ALGFTVAALVHLLTVPVDEPRVEAEHGAPVAPRRIDLAGTIKVVAAVPGLFALILFATFN
NFLGGIFMALLDAYGLSMVSVQAWGLLFGFLSVAFIISGLAISKTGLGKNPLRTLLLVNL
ISWAVCCVFPLKSSIVMLAMGCFVWMLLGPYAEAAEQTTLQKVVPFERQGRVFGFAQSVE
QAASPLTAFLIGPLTQFIVIPFMTHGAGAAAIGDWFGRGPDRGMALVFTLAGVVGLIVTL
LAFGSKAYRQLSAAYAQGEPAPAA
>fig|190650.1.peg.1274 Tetracycline resistance protein
MWRARRGELSNCCVSSHRRLARGRVRRLRRRHRRLVAAQWAVRLHAALAGRDGLRGWPAG
GAFAQWQGVRGRRRQRLGARRATGVRLASGRLHPGHEHRGRGPFRSGGRGDPRHGRASRL
GQRACAARGASWLSQCGFPGPTWGMVAQPSGRACGAGQQRPPRGGRRGAVMNTTITGGRR
QAALGFIFVTAILDVLSLGVMIPVLPNLVKAFGGGDTAAAADWNVLFATTWGVMQFICSP
ILGLLSDRFGRRPVILTSIFGLGIDFLFMAFAPNLWWLFIGRIFNGMTAASFSTASAYVA
DVTTPENRAKGFGLMGAAFGIGFTFGPALGGWLWEFDHRAPFLVCAALALTNWLYGFFVL
PESLPPERRQPRFDWKKANPIGSLQLLRHHPGLMGLAGVGFLFQLAHNVLPSVFVLYMGF
RYGWSPQTIGLTLMASGIASILIQAFVVGPAVKRLGERGVLLIGLFAGFLGFSIYALAPT
SLLYLAGLPIFAFSGLIQPGLQGLMTRRVGPNEQGQLQGANAAMMGIASIIGPPLFLIPF
AFAVRHDATLHLPGLPILIAAVLMLAATLLAYAKAKPAPAPEPQPA
>fig|190650.1.peg.1512 Antibiotic acyltransferase
MFNAGTGFAQASATPVLSRDGPLDALRFLAALFIVLYHVAERAPVSLFSLSPAFGRGYLA
TDFFLMLSGYVLARTYGARVANSEVDTWTFLKRRVQRIWPPHLVMLALFVAFFLATTAVG
LAPQNPQWFQWDPLLPQIFLVQAWFVPGTSGWNMPTWTLSALIVAYALFPMVWRKVAASS
RPLRLLAMGVCAWVIIDQAALMAFGVHGYQLPLRFGLIRGVPLFLIGVLVARLPVTRLAE
QQALPLAVTSLAIVIGVQALGNFDYFSLALLAFLIYAAGASKPRAWRWAGAAGRLSFPLF
LTNTLTAVVWFGLVRMLDAKLGLPIAAQWTLWALAIPATIIAAWLFERLVDAPLQTWIKS
RSRSGGALAVGKMREASA
>fig|190650.1.peg.1613 Antibiotic hydrolase
MHVTRDVMVTMRDGVRLAIDIYRPAIAGEPTHAPLPVLLERTPYDKRGTNHGDRTRDDPI
PKSKPDLAVQFVRGGYVVAIQDCRGRYASEGVFEKYLGEGADGYDTIAWLAAQPWCDGRV
ATYGLSYGAHVQSAAACLAPPALAAMFLDSGGFSSAYHSGIRQGGAFELKQATWAYKHAL
LSPETQRDPARLAALEAQDLKAWFTRMPWMEGHSPLSAAPEYEKYLLDQWRTGLFGPYWT
QTGVYARGAYDTYADVPMVHMSSWYDPYAVTATENFLGLSGRKRSPVKLILGPWTHGQRS
VTHAGDVDFGPEATLDGALAKDYVALRLAWFDAWLKPDQHAKDPLPPVKLFVMGGGSGRK
TPEGRLDHGGHWRDETAWPPQGARVTDFFLSATGGLSTAREVVDEAFLEYVHDPLNPVPT
IGGAIASGAPVMEPGAFDQREGPHIFGCLPPYRALRDREDVLAFETPPLETDLEVIGPIR
ARLFVSSDGVDTDFTVKLIDVHPPSEDYPDGFAMNLTHGILRARYRERFDWETWMTPGEV
CFIEIEAFPTANRFLKGHRIRLDISSSNFPHFDVNPNTDEPEGYGFTPRRAKNRVYMDAQ
RPSRLLLPIVTR
>fig|190650.1.peg.1652 Multiple antibiotic resistance protein MarC
MDFSPLPTSSLIGAFLLAFPALFSIVNPVGAALIFDQAMGGRSRPERLKLARAIGFYAFL
VLLGSLLLGGYILNFFGVSIGALRVAGGLVVAIRAWGLLMDPEQNEDRKVNQTESAQSHH
DVAFFPLTMPFTTGPGSISVAIALSSQRPTEGDAVAPFFIGASLAAALVAVLVWLCYSAS
GQVMRLLGPSGARVLSRLVAFLLLCIGVQIIASGVENLVAKFLLAHPG
>fig|190650.1.peg.2761 Bleomycin resistance protein
MTDHATPNLPSRDFETTARFYAALGFEQGWRDDGWMILERGSLTLEFFPYPDLDPASSAF
SCCLRLDDLDGFYAVCKATGLPETTLGWPRLHPPRDLGPIIMAALIDPDGTLLRLIGNDA
>fig|190650.1.peg.2870 Bleomycin resistance family protein
MTNFIQVTPFLHVPDLEAALVFFVDLLGFEVPYRQPGYAYVHRETVGFRLLQADEATVTP
RGAGGFAYYIDVRDVDAVVAELTPRLAALPPEDVHGPVDQSYGQREFMIRAPDGGLLVFG
QAIDD
>fig|190650.1.peg.3644 Permease of the drug/metabolite transporter (DMT) superfamily
MRSRGEPLPAGGRMKTLAFVALALAGISWGLGFPTGKLILRETDAAHMVLLRFLVAAVAA
APFALRRPEVRALFRSPIVLLAGALYGVAFLVQFEGLAHVSVTVAALLVGAMPALIAVSA
RVLGEKVSRLSWAGVAAATLGAALIAGKPDGASSPLGVALSIAALFLFLTWLLVLRRAPP
APNPMAIPAVSIIVAALVVLPIALIMHGPPKLALSAPAWTAIVAQGVLATLLATAAWQYG
AAQVGAASAGVFINIEPLMGAACGVLLFGDHLTAALFAGGLLIIGGSFAVVMGERQAKPG
EIQATVAPTP
>fig|190650.1.peg.3688 Membrane fusion component of tripartite multidrug resistance system
MDDCVHLSLVCCAGPDYPARLLSFDKGLAMAASEKKKLVPLIVGGVAIAAVLVGGTLWFL
DKQHFESTDNAFVQADTVQVSPQVSGYVAEVLVADNQRVEPGQVLAKIDPSTFQARVDQA
IANAAAADAAVRAIDDKNSLEQAVIAQRAAGVTSAQADASRAKADLDRYNALADQGWVSQ
QKVQTTRAAATQSAAGVASAQAALEAEKRAAQSLGSAKAQAIAQAAAAHAAVEQAKLDLE
RTVIRAPVSGVVGARAVRPGQLVQPGVALMSVVPLGQAYVVANFKETQVARLRIGQPVEI
KADAFGKEKIVGKVDSFAPATGQEFALIPIENAVGNFTKITQRLPVKIAVDRSQLGAALR
PGLSVEIKVDVRDRSGPSFAEAAQVTPQVARQGAAR
>fig|190650.1.peg.3689 Multidrug resistance protein B
MADAALPADSPSAPATPGATAPVDWTKLFLGFGAMVIGQFMAILDIQIVAASLPQIQAGV
GASTDQVSWIQTAYLIPEVVMIPLSGYLSRLWGTQKLYLASCAGFIVMSILTGLSTSIDM
MIITRALQGFIGGAMIPTVFAVAFTAFPPERRVTASVIMGLIVTLAPTVGPTLGGHLTEW
LSWRWLFFINVPTGLIVLFGVARWGDFDKGDPSLAKGFDWFGLAVMAVFLMSMQYVLEEG
AKEDWLSDSLILWLTVVAVFGGVVFVWRQLTYRNPIVELRAFANRNFTVGVLMTAVSGAS
LFGGTFLLPQFLGRVRHYSASEVGTTMVISGLSMFLTGPIAGRLVRKTDPRLPMCVGFLL
AGFGMYMAHGVTKDWGFWEFAGVQACRGVGVMIAMIATQQITMSTLPPHMVKNASGLVNL
SRNTGGAIGLALLATSITQQTALYYDDLTSKVTQGSAAAGMIAGLTERMMQLGVADPAGA
ARKAVGGMMQQQATVMAFGDSFTLLAIGCFIAAAVSLLAAPVKNAPPPPSDAH
>fig|192952.1.peg.702 Multidrug resistance protein B
MHPDRRLIYVAVFAIMGLSNAVIPILPELAARYHSMYGEFASSLLFSGYFLGALATMLPF
GILSDRFGNLKFIGLGIALTVVSGVFIFLSENLWILIFSRFVEGAACGAFFPAAFSSLSK
CKDPGRCMGEFTFLFNAGLAAGALFSGLLADIFLKSAVLIFTLFALLSGIPLLYRLEELF
NPKKTGTNPKSLSGQDSLKSHFKHSFIKITGLISRRNSGIWLGSFLLNGAVGVLIAYYPD
YSLEILSKARLGGAIASLYICAMVTSLLAGRFKVKEKTIIRIGLAFSALGAFFAIKYPFF
GFSSLGGGSGVAMVGFALAVARMNADRGLAMGLFNTTIYAGLSLLPIVAGFLTETLSLKE
LFLVNGCILTVALLLKN
>fig|192952.1.peg.2552 Quinolone resistance protein
MKTSIPGDGSMLESRIIAAQSDDSYIERMRFEGDILSDVDIARIEFESVQFIQCQFSKCD
FSKASFYNSVFDNCNFANCIFMESYWKGSRILTCKGDGSNFSKSHMKETFLADGSFRYAD
FSSSLMENCSIRDCNFTEAFLSEIRLKKPTLKAVNFAGADFFKTLLKGIDLSDCIIDGIT
VSDTRNELRGAIVNAGQAIELAARVLGIKIV
>fig|194439.1.peg.104 Inner membrane component of tripartite multidrug resistance system
MSSTATTIPGAQALEHHYETGARKWIITATVIIAAMLELIDTTIVNVALNHISGNLGASI
EDVSYVVTSYAIANVIVIPLSGFLGNLFGRRNYFVASIVLFTGASFLCGISTNIWMLVFF
RFIQGIGGGGLLPTSQAILYETFRPEERGAATGIFSMGLVLGPTIGPLLGGYLVDYFAWE
WCFFVNIPIGIAAAWASLTFVKEPKVKPVVEKIDWAGIGLLSVGIGSLQFVLERGEQKDW
FETDYIVWFTIIAVVSLIAFVWLELHTDHPAVDLSVLARSKNLAIGAVLTFIVGFGLYGS
LFIFPVFVQRLLGFTALLTGLVLFPSAMLTGIISMPLGIALQKGASPKLLMTVGMVAFFW
FCWELGNQTLMSGAENFFLVLLIRGFALGFIFIPVTLLAVTGLHGKDIGQATGLNNMVRQ
LGGSFGIAITNTYVTQRVAAHRIDILSHLSPYDPAAVQRLQDMKQALGQYMSSPVEAGQA
AMAALEGIVVRQSYHLAYMDAFKMIAILFAVCLPLLLFIRVDKKETVDMSSVH
>fig|194439.1.peg.105 Membrane fusion component of tripartite multidrug resistance system
MAETQQSNIEAPDNEKGKPKPERSMGRLVIFGILLAIGLVWGGMKLIRSLSYEETDDAQI
AGNIYPVIPRVPGKVVEVLANDNQMVKKGDVLIRLDPSDYQIKRDMAEAQLLKARAAVSG
AKADIIAAAAAQIKLAADLRRSQNLQKQDVISRAELDAATAGATAASAQHAAAGDNYKAA
LAQAKLAEAELKNAELQLSWTTITAPADGKVSKKNVQPGQYVTPGQQLIAIVGSGDLWVV
ANFKETQLEHMRPGQKVIIKVDAFPGKELKGHIDSISAGTGAEFALLPPDNASGNFVKVT
QRVPVKIVFDEKTDLPLAAGMNVIAEVKVK
>fig|194439.1.peg.107 Outer membrane component of tripartite multidrug resistance system
MIAVSFSAGEPLLAAETSGAPLTLDEALRMTREHNPKARQALEELNAADAKVTESRSAWF
PQISGKAGYTYLDPVSEMTFGGLAMKFMPNNNYNARFTAEMMLYDFGRTASTVDLAKAAR
NSARLRQDMTLRDLSLATVQAFYSVLFLQEAVRVQQKEVAALQTNLDHMQKRYDQGAATR
FDLLTTQVRLAGAANREIDYQNQLRNQEITLRRLCGLDEKAPLSLKGSFDITAADMDADK
LAASALDHRPEVMLARENFKAASYKKNLATREFLPKIVGSASWGSTNGYVPDLDKMRTNV
AVGVELQVPIFDGFRKSAALREATAMKRSAEQQQLDAEQVSQAEVRQSVNDLKSSAEKIQ
TTRLQVSQADLAAKHARIRYDNGLATTLDLLDAEAALAEAELANLQARYEYVMNAYSVRR
AAGDLIER
>fig|194439.1.peg.360 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MKLSVVIPLMNEAESIGPLFDALASALQGIDHEIILVDDGSTDSTVAEIKRLAPANARLV
VLNKNYGQTAAMSAGIDEAQGELIATMDGDLQNDPADIPMMIAHLESKGLDVVAGRRAGR
KDGMVLRKIPSKIANAMIRNLTNVHIRDYGCTLKVFKRDVAKNLGLYGELHRFIPVLVQL
YGARMEEVDVRHHARKYGKSKYGIGRTLRVLSDLFFMVFYQKYAHRPMHLFGSLGFVTLF
LGLGINLYLLVLKILGNDIGGRPLLSLGVIMTFIGIQLITTGFIAEFIMRTYYESQNKKP
YIIREIIDKSK
>fig|194439.1.peg.1268 Multidrug resistance protein, FusA/NodT family
MKKRNQVMKRAVPLLLMTLLATIGLTACSPVGEYRRPEVRLPESYPGQTAAGKEMAAVPY
RKFFADPDLLELIDSAVENNHDLLIAMKNIDYAGKTLDVAKLWFLPEVDLSATYDYSRGS
RNSASALKGQARTSRNYTAQLNVSWEADIWAKLRNAKKAAVAEYLRSADVARAVRTTLVS
NVAQGYWNLKMLDEQIDITKRNIALADTTLTMMRLQFDAGNVTSLAVDQQESQLLSAKAT
LPKLEASRTAQENALSILAGRMPGTPIRRSTGYAPFVMPDSLGAGVPLALLSNRPDVRAA
EESLMEAHALTGVNKAMMYPSITITAQGGLNAIESSKWFSTPGSLFNALQGSLLQPIFQH
GQLKAQYEQSKIKRDQAELTFRKTLLVAVGEVSNALAQVEKTGEQETFAKARVAALRKAA
GNSRLLFNSGMATYLEVIAAESSLLQSELELADVQRSRLSAIADLYRAVGGGWRE
>fig|195099.3.peg.345 Multiple antibiotic resistance protein MarC
MGSELYLMFFAAITLLAILNPFGNLTQFLAMSDGLPLMLRKKLFRTILYTAFTIVLVFLL
SGPLFMNYIFRVSLDDLRVSGGLVLIIMAIKNLLFSTKIATKDFSSYQDMDDKEILRQSL
IPMAFPMLVGPGTLASVIVIAEDGGLDVALGGVMIAFIFMFILFHFAATIEKIVGKLILH
VFSRIAQVFIVAMGFKMIIVGLKDIFNL
>fig|195099.3.peg.699 Broad-specificity multidrug efflux pump YkkD
MEWFYLFLATACEIFGVVIMKELVNTKNKLYFLALIVCFGFSFTFLSLSMQNIAMSVAYA
IWTGAGTAGGVMIGVLFYKESKSFLKLFLITVIIACTVGLKFLS
>fig|195099.3.peg.700 Quaternary ammonium compound-resistance protein SugE
MNEKFNINIAWFLIILGGIIECFWVSGLKYSTEIWHYILTAIGVCISFTCFLKACERLEV
SITYSVFVGIGTIGVVLNEMFIFNEAVSIIKLVLIAILLLSIIALKWVSKEA
>fig|195103.9.peg.85 Drug resistance transporter, EmrB/QacA family
MEHVIKKGENAQEVKYNKWAILFCVVTMTFMSCIDGSIVNVALPKISYDLNKPILDTQWI
VTTYLMVISALVLLCGRIGDIKGKCKVFKVGVLIFTIGSFFSGLSKTLPLLIVSRAIQGV
GGSCAMATGMGIITAFFNEKERGKAMGLSASAVAMGVMVGPALGGILVSIRWDLIFWINV
PIGIIAFLLSMVYLPKMETNSKEKIDIRGTIVFAIFIVSSMLSITKGEVLGYTDKYIMLG
FIVSIVSFTVFIYLQKTVESPVLDLNLFKTKLFSLSIVCSALSFLAISSMNIIIPLYLEQ
ALQMSSLHAGLFLMIYPLCLSIVAPLSSSLSDRFNGRLISLIGISLLTVALFFMGRININ
STLIYLGTCCAIMGVGNGIFKSTNNALVMEKVPKHRLGIAGSVNSLVSNLAMAYGFTFAT
TILYGRMSYRLGYKVTNYIPGHEEAFLYGLDCVFFSATIMCLIASVVAFIRYRRKDI
>fig|195103.9.peg.161 Daunorubicin resistance transmembrane protein
MDFFKTIRVYSSFAKGTFKALSSYKANLLMGLIGQLIMISVTYFLWIAIYSSSQEGIMNG
FTLKEMLTYVMITLLIGIVTSNDISQEISFEVRDGSISTNLIKPINYRLRIIFIGIGNFI
FFFLTLFLPGAILISTYAILNGININLASILIFSISIILGCLINIYYSYIFGLLSFKFYN
IWGISQIARAIIMLVSGAMIPLTFFPEIVQKLFNFLPFSSIIYTPAMIYLNKLSYAQIAK
SLGLQLIWVVILMVLSKIMWNKVIDKLTIQGG
>fig|195103.9.peg.723 Permease of the drug/metabolite transporter (DMT) superfamily
MKLKGIILTMLSSITFGFAFTLGPMTYGLEGSNPVTLTFLRNFLSLPFLLVIILLLKIDL
RVTKKQLRDLIILGFVGNAITTLMLNMAFACIDVGIVTPIHFTYPIFVTLGCVIFFHEKL
SKQKVFALIIAMSGIGCFFITALNSASFGKSTLLGLILAVASGMFYAFYIIFMDKSGLKS
EPPFKITFYVAIASTVGMFIYGMLTKELVLSSLTHKAWGLSAIFAFLCTVVALSLLQVGI
KYIGASEAAVISTFEPITSVIFGAILLGEEITLMKIIACSLIFAGVLILSFAKEKSKSNI
KIKESVTN
>fig|195103.9.peg.1399 Drug resistance transporter, EmrB/QacA subfamily
MNNANENSKNTEDLVYKNRWFILAVLVMQPFMACLDSSIVNVALPILQKELGATMAGTEW
IVSSYLIIISASILIFGRLGDMHSKSSVFIKGILIFVLGSFLCGISPSLPILVLSRVVQA
IGAAMLMSTNQGIITDVFPPKERGKALGISGSFVALGSILGPALGGFIVTYFTWHYIFLI
NVPIGIICYIFAKKYLPIRIPKESESMDKPGATMFFIATILIFTSILISQHLGFTSIYVI
LGLIIGLIILALFLIYENKIKNPMLHLSLFKKPIFSVSLICAFISFTAINTINVIQPFYL
NDILGYSPGKISVIMTAYPIVLFVIAPLSGTLSDKIGSKILTLIGLFLTGVSMILLSSLN
SNSSETSIFLMLSLLGFSNGLFQSPNTNLIMSSVPKDKLGIAGGTNALIRNLGLAFGVSA
STSILYAKMSKLAGFRVLGSVPNRPDIFISGMRFVYILVAISCFICLIISIAEYIQSKKN
NK
>fig|195103.9.peg.1433 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNQYELKNEKIGRLLLKYSLPAILSMMVTSLYNTVDRAFIGSIKDIGAFAISGLGVTMP
LFTILGAFCVAISVGGSTNISIKLGEEKKEEAERILGNTFILSIVVALIIMIFGFSFLEK
ILYFFGASKETIIYAKDYMRVILIGAWFNFPGFALNNAIRAEGNPKLAGKIMIISCVLNI
ILDPIFIFLFHMGIKGAALGTIICQFIVFLWTMYYFTLGKSNLKLRIKGKILNKNILRAI
ILIALTPFFMELAAGFIHLITNRVLKDYGGDLAIGAMTSITSIYLLFLMPVFGLSQGMQT
IVAYNYGAKEYKRAKKTLLMTIIIATLILTLGLVLIRIYPREFINIFTKDKELINIALNG
LKIYTLALPTLGVSILGAVYFQSIGNVKKSIFLSLLRQVILFIPIIFIIPRVYGLNGVWI
SQPLADILATVLILIFLIKEFYIRDTHDLICRAERT
>fig|195103.9.peg.1469 Vancomycin B-type resistance protein VanW
MKEEKKKSSTGLLKSKKKIIISIVIVLAIIIGSIVAYIVSIQKKVEEWNDKIYPNVYVEN
VNLSGMTKEKAIEVLEKDVKEPVEHKTIKVQAADKSIEIKYSDLSPEYNIDETVNEAMNY
GKDLNLFEKNNLINGKDKKELNLDFKYDESKLTDYEKKLTEMVNQNAKNATISINGSNIS
VIEGEDGRAIEEDKMVSLVKEAINANPEDNSVVEVPVEVTKPKITKEMLSKIDGVIGSFT
TSYTSSDANRSANVEIAAKTVNGTILMPGDTFSYNNTLGERTTAKGYRDGAAYVGNKVVM
VTGGGICQVSTTLYRAVLRAGIMPTERHNHSMTTTYSGPSEDATVSWGSLDYQFKNPYDF
PIYIQGYTSNKHVTFNIYGNVQGMDGKTYELQTVVNETLKPSVKTVDDPNLPEGQKVVEQ
RPVTGYKSSGYLVTYQNGKEIDKKLIGHDVYKQKDEIIKVGTKKAEQPKQEAPKQEQPAT
AKPEEPKQEATQPSTSQPATNQAPDATPQTPNAGQTPPAQ
>fig|195103.9.peg.1678 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKKLDLLQDKESTLLRKYMIPSVAGMLGLSVCILFDTMFIGHKIGELGLAALNIALPIY
NLYSAIGLTIGVGGATALSVAMGQKKFHRVNRIFTSAVFATIIFCIIISLLEVFFLDKIV
YMLGASEATFPLAKEYLKIILAFNPAFIFASAFIVFVRNDREPKLAMYAVIGSNTTNIVL
DYVFIYIFNLGMFGAALATSIGQLVALGVLSIHFIKKNNTMHIELGGINLDNIGKVLKNG
VPSFLNEISAGFVIFIFNIVIYKFEGDLGVSAYGIITNIVLIFMAVFNGVSQGVQPLISV
NFGAKKEERVKEFLRLTRIIVLILGVGFLGMGLLLPNQMIGLFTSDRGRLLSITRQGIYL
YFIAFLFNGSNILNIAYLQAVEKSKESSLLSTLRGLVFVIIFIIVLPRIIGVYGVWLTIP
ITELSTLLLFLIFEIKSKRKNI
>fig|196162.6.peg.203 Drug exporter-1 ABC transporter (DrugE1) family, ATP-binding protein
MMEPTTTSHEASGSAIELTGLAKTYGRGATARPAVRPTSLSLPWGQVLGLLGPNGAGKTT
LIKMICGLVTPTAGTVRVGGWDLAADRSRAVLQIGAVLEGSRNVYWPLSAWENLLYFGRL
KGLRVAEVRPRAERLLRDLDLWERRQEQVGSYSRGMQQKVAVAAALITDPPILLLDEPTL
GLDVESARIFKDWIAHLARDDNKTILLTTHQLHVAQELAGRSAVIRTGEIIADLPTGELL
SRHAENRWEIRLAGSIDRIADALPGGAVTSTEHDQTRVLLPDDTTTLYAALDRLRAADAR
LVSVQKAQPTLEEVFLRVLRDDAAPSRIAEEVASS
>fig|196162.6.peg.390 Glyoxalase/bleomycin resistance protein/dioxygenase
MDLVQIAQRADDLERATAFYTLLLGSPPVATYEPPGLVFFDLGGVRLLIEHGAPSATVYL
RVEDIDAAVAQAREAGTEVASEPHVIFAHADDTLGPRGTDEWQAFIRDSEGNLVGLVEHR
PR
>fig|196162.6.peg.1052 Glyoxalase/bleomycin resistance protein/dioxygenase
MLNRLFHIAINSTDLDRSVAFYQRLGFQALQDRSVRNDMVKEAFAVPSGDLRFVHLRLGE
DDNATILDIVQWFHPDTEDTGTEPVAQHQRGLTRFSVLTDDTQAVYDELAAEGVEFITKP
TVVMTPEGGWKVALVKDPDGVVVQVTELLAAPAAG
>fig|196162.6.peg.1088 Tetracycline-resistance determinant tetV
MGPRSLLGGEKGLWAGSGVGRVRVRVQLESDGLGVAAVLVGDGDLVAGPVGPDGGDQGVG
AADQLVVDLGDDVALRQAGVVRGRAGVDVLDLGALGHLGSGPARDVGDGDAEAGVGRGLA
VDHLVDDRHHLVHRDGEAEPDRAGLPLHGAGGADRGVDADDVAVEVDERAAAVARVDRSV
GLDRGVRRAVALAVGADVHRPVQRTHDAAGHRRVEPERGPDRHDALADLEVARLPDRRGR
QPGDVLGLDHRGVRQGVGAEDLGLRGGAVVEGDPDRPVVAGELHHVVVGEDLAVGAEDDP
RARTGALGAGHVDLDHRRQHLGSDLLDGAGRCLGVGGVDDLRRRAAAGAARARRASIVER
APGGGAADPCRAAGHQRGRDDRGGEAGPARTTLPRLRVRRHPGRRALGRRTQRRRGGEVR
VRRSRRRTGGLVVHVSTMGGQPVTFLRPFWGGTKNSTPVRREFRATAGGGTGLNAPVTSL
DSLGTREDRLGPLRFRNFRLLVTGSATSSLGNAIAPVALAFAVLDLGGSATDLGLVVAAY
ALAEVATVLFGGVLGDRVARQLMMEGSNAACALSQATVAVLVVGGWATMPVLAGFGVVNG
CLGALSGPSSSAMTRMTVPAERLASAVALRGLLQTSAAVVGFAVGGVLVAAVGPGWAIGV
DAVTFAVAALCFGRLDVPHTRPEGARPSFVSDLGEGLREVLRHTWLWLLIGQALLYHLFY
GGAQSVVGPIVMEDGFGRSSWGLALGTLMAGFVVGGLVCLRWRPRRLLHVGTALLSLTAA
FPLAMALSDRLGPILVGAFVHGVGLQVFDVFWQLAIQENIAEDKLARVYSFDLVGSFIAR
PVGLVLTGPVAQAVGFHRWLVVVGCVMGGSALLSLLSPDVRRLERRS
>fig|196162.6.peg.1169 Glyoxalase/bleomycin resistance protein/dioxygenase
MALTESAVAVMLPTKDAARAQEFYEDRLGLPFAGSNETTGETTFRLSGGSQLVLRLLPDA
APSPNTAMSFEVDDIGAEIATLEGRGVAFEDYDLPGFATVDHILDQHGMKAAWFLDPDGN
VLCLHQPG
>fig|196162.6.peg.1358 Vancomycin B-type resistance protein VanW
MARVNQQPTVPAREKEGGKVVLLMLAGLVLLAGAAYGALYLAAGDKVPRGTTVAGVDIGG
RTPADAEEVLRTGLADRVDRPITVAAEGARSTLDPGEAGLTVDYAASVAEAGGGRSWSPG
RLWDYWTGGDDLDPVLDVDDAAFDAALDKLGEDLGTPPVEGDVKFRDGKVVVTDPATGEE
IHPEAARLAITTAYIAEDATDVELELRPADPEVDAADLQEALEAFANPAMSGPVTLVFGD
SPVRLDPADFGKVLGMGAEDGELVPDLREKKLVKLVDRGISQDGAPVDATVALVDGKPKV
IPAKPGVTYKPSDVSDAFLELVAREGDREMKVPSTVAEPDFTTKDARALKIREQVSTFTT
YYPYAEYRNINIGRAAELIDGTVLKPGDEFSLNGIVGERTRENGFTEGFIISDGIFKEDL
GGGVSQMATTTFNAMFFAGLKDIEHKPHSFYIDRYPVGREATVAWGAVDLRFENDTPYGV
LVHAHVTPATSSSQGVVTVSMYSTKYWDISTTTSDRYNYRQPATRTLTTPDCYPNTGYAG
FDVDVTRTFRRHGEDAVDHTEKFHTAYTPSDTVICKKPKQRGD
>fig|196162.6.peg.1427 Glyoxalase/bleomycin resistance protein/dioxygenase
MSNVPGAPTWIELFAADTDTARTFYGELFGWTVQGSGPEYGGYAQFLRDGAPVAGLMRNE
VGLPDTWSVYLRSTDVAATVASARQHGGQVVVEPMQVGDLGHMAVVADPSGAAVGVWQPL
AFEGTAVRAEVGAPSWFELHTTDYPAAVAFYRDVFGWSTHQMSDTPEFRYTTLGRDDDAL
AGIMDATGHFDGAPSTWVFYVQVADADATVARAVELGGSLLPDSGPHDTPYGRLAVLADP
AGVQLSVVGPNRG
>fig|196162.6.peg.2031 Permease of the drug/metabolite transporter (DMT) superfamily
MSKRTSRWALAAFAVVGFIWGSNFLFMKWAAEEISPRQIALLRVAFGLLPVLALGLARRE
FRRWHLRHTVHFAVMGVLATSLYYVLYAAGTERLPSGLAGALSGAIPLFAFMVGAVALPT
EPMTPRRVLGAFLGLAGVVMMARPWNVHGSVDPVGVLLMVTGSACVGASFVYTRRFITGL
DIPPTALTTYQMALGLVALLPLTDLHGIGAIRGDHRALVGLVLGLGLVGTGLSYVIFYYL
IAELGAATASAASYLPPVVALAIGWIGLGEPLRHADLAAVALILLGVAIIRAGARTYRAE
RGTQ
>fig|196162.6.peg.2738 Permease of the drug/metabolite transporter (DMT) superfamily
MTATLRRELPSVRIGLLQVFAAGVLWGTGGLVVTVLHERDGLGAMTVSAWRMALAAAALI
AFSALTGRWARTRAALRAHPVLAVLVGGGTAAYQGLYFLSVLMVGVSVATVVSLGLAPVL
AAGWEHLVERSTPSAREVLVLAAALGGLLLISGTAGDRADAPGDDPTLGLLLAVLAGVTY
AATTVLGHTLAKRVDPVALTTCATGAGAILLLPFFAVAAARGEPVLSSDPVSTTLLIYLG
VATMALSYGLLYAGLRTTSGSAATIATLVEPLSAALLAAVLLGERLPWPALAGGVLILAA
VVALRPTEDLSPVGAP
>fig|196162.6.peg.2940 Glyoxalase/bleomycin resistance protein/dioxygenase
MEVGPMSDEGSYGSVRYVVRDVQAAVDFYTTHLGFTVRSHPAPPFADITRGALRVLLSGP
ASSGARATPADVDGPGRNRIHLLVDDLAAEVERLSAAGVPLLTDVVSGPGGQQVLLADPA
GNLVELFEPAVAPARIGP
>fig|196162.6.peg.3399 Antibiotic efflux protein
MTSLAEIVAPRRLGTGFRWLLASSWVSNLGDGLALAAGPLLVASQTHDPFLVALAALLQW
LPPLLFGLYAGALADRLDRRLIVVTVDLLRAVVLVLLTLAIATDLVTITLVLVTMFLLGT
AEVFADNTASTLLPMLVHRDDLGVANARLTTGFITVNQLAGPPIGAALFAAGHAVPFVAQ
AVVVALGALLAAQIALPPHGRSRDERPQLRQDVVEAFRWVLHNAAVRTLVLTIFVFNITF
GAAWSILVLYATQRLGMGEVGFGLLTTVSAIGGLIGTLAYGWITRRVSLANIMRAGLVFE
TFTHLALALTTRPAVAMAIFFVFGAHAFIWGTTSTTVRQRAVPGELQGRVGSVNLVGVFG
GLVIGSGIGGGLAQHWGVTAPFWFAFAGSAVFVVLIWGQLVHIAHADEQGQPAGA
>fig|196162.6.peg.3936 Acriflavin resistance protein
MRNAAGPARPARPHHRHGALQDLPVRRLRRPSHTPLGAQPDAADHRPRPRRAHHRRRDHD
ARGVRPEPDVRQPRRHRPVRARRPHRHHAARRPPARTGRHRPAGPAVPRRAEGPGALGPV
DRDRAGGPLDGLVDPGPVDRPDRAAHRRPAARRAGPDRRQRRRRPPVLDRPRYPARRGDR
TDADHRAGPGGGARGVRTHRPLAAPGTGGR
>fig|196164.1.peg.2608 Multidrug resistance protein
MQHFHKVLVNTLIFNVVTGFLAYSLLFWVYLETRNVALAGILNAGYMGALAVTSIFFGSI
VDHNRKKTVMMASSCMTLVLFALAGVVWVLWMDSATISLDSPALWVFSILILIGSIVEHL
RNIALSTVVTLLVPEDRRDKANGLVGVVHGMSFLVTSMMAGMAIGFFGMETTLWVCLVLT
LLAVLHLITVEIPEPEIVTQHADATVPIAPAPSADGEVFTPNPVPSDLHTVSRGLDIRGS
LAIIRGVPGLLALILFTCFNNLVGGVYTALMDPYGLELFSPQVWGVMLGLTGLGFIVGGM
IIARVGLGSNPVRTLLLVNVGIAIIGIVFTIREWGWLFVAGIFVFMLITPAAEATEQTIL
QRVVPFRQQGRVFGLAMAVEMGANPLSAVIVAVVAQAYLIPWMDGPGADTALGVLLGDGT
ARGMALMFMLSGVITLIVVLLAFASRPYRQLSRYYASSSQDIAGQTAQ
>fig|196627.4.peg.1955 Permease of the drug/metabolite transporter (DMT) superfamily
MNDAGLKTRNPVLAPILMVVNGVSLYAGAALAVGLFESFPPALVAWMRVAAAAVILLVLY
RPAVRNFIGQTGFYAAVYGVSTLAMNITFYEAIARIPMGTAVAIEFLGPIAVAALGSKTL
RDWAALVLAGIGVIIISGAQWSANSVGVMFALAAALLWAAYIIAGNRIAGDASSSRTGMA
VGFTWASVLSLPLAIWWWPGLGATELTLIEVIGLALGLGVLSAVIPYGLDQIVLRMAGRS
YFALLLAILPISAALMGALALGQMLSVAELVGIVLVVIAVALRRPS
>fig|196627.4.peg.1956 Albicidin resistance protein
MLIGEVSKLSGVSARMLRHYEKLGLVEPKQSTAGYREYSEGDVRRIFHIEGLRSLGLSLK
QVGDALEDPDFDPQAVISEMIAETSARISMERELLARLKAVRHAQASDWESALDAVQILR
RLRSGDPAQRQAVAYDSVSGKEAVALETLVESALGESHLNAEGALSWAVVQRGEEAVALA
ARGLRSRDAAVRLRAVRIVASAPSAVADRVEWLRPMIRDPDALVRAETALALGKSGDESA
VEQLVSMVLTGLRDVEAAELLAGFGEPVQLDVFKKFARTLDDEETMSPTRGRIAQALAEF
NLAPVAFLVEQLVDDDNPTVAFTAAAIIKAKGLK
>fig|196627.4.peg.2691 Drug resistance transporter, EmrB/QacA family
MTSETLQAQAPTKTQRWAFLAVISGGLFLIGVDNSILYTALPLLREQLAATETQALWIIN
AYPLLMAGLLLGTGTLGDKIGHRRMFLMGLSIFGIASLGAAFAPTAWALVAARAFLGIGA
ATMMPATLALIRITFEDERERNTAIGIWGSVAILGAAAGPIIGGALLEFFWWGSVFLINV
PVAVIALIATLFVAPANIANPSKHWDFLSSFYALLTLAGLIITIKESVNTARHMPLLLGA
VIMLIIGAVLFSSRQKKIEEPLLDLSLFRNRLFLGGVVAAGMAMFTVSGLEMTTSQRFQL
SVGFTPLEAGLLMIPAALGSFPMSIIGGANLHRWGFKPLISGGFAATAVGIALCIWGATH
TDGLPFFIAGLFFMGAGAGSVMSVSSTAIIGSAPVRKAGMASSIEEVSYEFGTLLSVAIL
GSLFPFFYSLHAPAEVADNFSAGVHHAIDGDAARASLDTAYINVLIIALVCAVAAALISS
YLFRGNPKGANNAH
>fig|196627.4.peg.2753 Vancomycin B-type resistance protein VanW
MKNSGKNSAKNRTKGILIGVLVGLIAIFAGIYAVDVFLNKDNIPRGTTVGGVSISNLSAQ
EARTKLETELANDVVQPVTVTAGEQSTTFDPVASGVGIDWDATIEGTGEQSWNPITRFVA
LFKESESPIVSTVDPAAFGPTLDRMVGELYRDPISGNLHIDAGTLVVNDTIDGQAVDRTI
LEQAVTENWLNPEGVKAEPYVVPAAISQDTIDKLAEGAGAKAVSSPFVVRGDDGIEGTIP
VERMGEVVSFPEENGTIRVDINAEAATAMLAEGLKETEIEPTNAQISFSSGSRVVTPEVT
GHGINWEETLADLPNNLTGDGPRTIDAIYEDTPATFTATDAQNATFNEVMGEFTTGGFSA
ASGTNIRLTAQMVDGAVVSPGDTFSLNNYTGPRGAAQGFVDSGIILNGRSDTAVGGGISQ
FATTLYNAYYFAGLEDITHTPHSYYISRYPAGREATIFDGAIDLQFRNNSPYPVMISTSA
DASNVTVRIMGVDTTSVESINNGRWSTTQPNTVRVSGSDCVPSTGAPGFTTSDTRIISDL
SGNEITRETVTTVYDPSPNVVCS
>fig|198094.1.peg.173 Multidrug resistance transporter, Bcr/CflA family
MNEVNQEIYKPVKTNRLWMILVLGTLTAIGPLSIDMYLPSLPKLTDDLQTGASLAQLTLT
ACLLGLSVGQLFVGSISDIYGRRKPLIIALIIYVASSLLCAVAPSIWTLVLLRFLQGASG
SAGIVISRAMVRDMYSGSEMTKFFSLLMLVNGAAPILAPIIGGQLLQFTTWRGVFIVLGA
ISVFMLISATFVLRETLPPEERETGGLSGTLATYGKLLKDRLFMGYALSQGLVTAAMFAY
ISGSPFVLQNIYGASPQQFSLFFAINGIGIIIASQVTGRLAGKVNEKTLFVSGIVIAAVG
GLSLLLTILLGIGLIGVLCSLFLVVSSVGVVSTTGFSLAMRNQKQAAGTASALLGLLQFI
SGALVAPLVGIGGSNTALPMGIVIALCEIGAVLCYLFMARRSEKQFELQARQNLEV
>fig|198094.1.peg.564 Vancomycin B-type resistance protein VanW
MKLSKILIGSAIAGGILLCVGGVSGYQYVSKLNNQLDTTALPNTTFEGISLDGKNKKDIQ
AIINQKITELDQKSLTYIFQNDKQTYTWKDLGINYKEKDIIDKIFKEQEGNAINRYKMRK
QAENGELKRDYKLTPQLNTTAYESFMKDKYNKTLKNPVNAELSIEGTTVNISQSQNGEKI
DKGKLTDLTKQAITSGTSDITLPVTLLKPERSTEDIQKMGIKEVIAEYSTPMAGRNGNQS
FNVNKSANTLSGVIVAPDETFSFNGRVGVTDAAHGYKSAAVYSQGKVIQSAGGGVCQVSS
TLYSAALRADLGIVSRSNHSMPVNYLPLGQDAAVADYGPDLKFKNNTGNHIYIQAFSNGG
SITTRIFGTNTGKNVEVSSQVISRTNDKITAVTYKKVTQNGEVISNGQISKSVYKSAPKQ
>fig|198094.1.peg.696 Drug resistance transporter, Bcr/CflA family
MKKSKLTFILYVVCMSALLGSFAQNIYTPILPMIQNSFHTSLYLVNVTVSLFTFVLAIMQ
LIYGPLIDTKGRKSVLIPSLIISTIGSIGCAFSANIYLFLFFRAVQAIGIAAIPVVAATI
IGDLFEGKERGEAMSLYQMLLALAPAIGPLIGGYLGSINGHVSVFLFLSILGILLLTINI
SLLPETKPTVSQQPQSKKNHWFILKNKTGFSITLIGFIQFCIYFCFLVFLPSISTNLFHL
TASEIGLMFVPMSLSIMLGSYCFKLLQKRFTTKQALFITSFFNIICVTLFSFTYSINIPF
IIIVTSLYGFSMGLSMPTHTTLLTEEFVQERATAIGMYNFIRYLGMGTVPLVGGFLVFNQ
NYFWIFFLGAIMFLLIILYAMKMLRFPTTQKVK
>fig|198094.1.peg.774 Permease of the drug/metabolite transporter (DMT) superfamily
MPYFYVFLLLLTSLLWGGNFVVGKSLVDHASPMTLTSLRWIIAIVCLLPMVWFKEKKIIP
PRAAILPLILMGISGVALFNIFQFLALEKTSATNVGLISTLNAISIALFSVLFLKEKVNT
LQILSMILSFFGVILVLLKGNFALLFSLHFNSGDLWMIAAVCIWGIYSVCSKWATKTTTP
LMATLYSGIFGVILLLPFNIGSFTVTNINTSFITSLLYTGLISTVLCMVFWNIGVQKLGA
TTSGIFLNFNPIFTAILAFLFLGEELTWIQIVGTMIVMTGCYLFSHFKTVTVQPTGTLLR
KHS
>fig|198094.1.peg.877 Drug resistance transporter, EmrB/QacA family
MNMTTKSPASGKVDTSNMKHTPILIALLLGTMVALLNETLLGNALTVLMKEFDVTASTIQ
WLSTAYMLVVGVLVPITALLQQWLTTRQMFLIAMVTFLVGTLIAGFAPTFSVLLVGRIVQ
AVATGLISPLLMNTILIICPPEKRGATMGLIALVMMSAPAIGPTLSGVIVDSLNWRWLFY
IVIPIVIISIMIGMKYIQNVSEITRPKVDYPSILLSTLGFGGLVYSFSASGDLGWSDTKV
YGALIVGLISLCIFIVRQLKIDNPILELRAFKVPMFTLSVGLIVIVMMSLFSTMTLLPMF
LQTVLLVTAFKSGIIMLPGSVISAIMGPIAGKLFDKFSPKVIIVPGIVLVGIAMFLFKGI
TPDTSIVQIIVMHSVLMVGLMFVMTAQTYGLNQLTPDLYPHGTALFNTLQQVAGAIGTAI
FISKMSSGTTSYMESSANPMDPVEKLNGLTSGFQGAFALGLVFIVVAFIVSLFLKEEKKG
VLQNEN
>fig|198094.1.peg.1030 Glyoxalase, Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily
MFQKLECVSIHTKDIEKSVSFYKEMGMEQNWVIERELEEGAIWTLIGLKFPDEKSSELVI
SNHPDINCIEVEVLVEDVQQTYESLKDNKDVKWIREPFPTESGHVAVMEAPDENVFVLVG
K
>fig|198094.1.peg.1497 Permease of the drug/metabolite transporter (DMT) superfamily
MSVKKDWIAPLALLFVSFIWGATFVVVQNAMSFVGPFTFNGIRFLFAGIILLFVQILFSK
KASKQHIKQSSLAGLIVGFFLCIGYVLQTFGLLYTTSSKAGFLTGLSIVMVPILSFIFLK
QKATIFIVIGIAVATAGLYLLTAGDSFQLNIGDILVLGCAVAFAAHILVNGFFSKKISPL
LLSTSQVLAVGLFSSICAFLFEDWEKLFSVALWTNSSFLFALFLTSLFATSIAFFIQTSA
QKHTSPTRVAIIFAMEPVFAALTGVLVANEQLSISAIIGCLCIFLGMVFVELPSKTKKEA
QAA
>fig|198094.1.peg.1517 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEVTEKLREKPIKSLFITYLIPAVLGMVLMSVNIVIDAVMISRGVGANGLAGVNVAIPAF
SIFFSISLWIGMGGATLYSIALGENKIERARSIFTQSMTVAVIIVGILAAICLWRIEDLA
YLFGANEVILPYALDYLHVLLTFGMIYVLENILSTFIRNDGNPNLAMAGLVVTAILNIVF
DYIFIFIFGWGVTGAASATILSAAIGFLVLLTHFFRKSSILKWTKFHFEWDTIKQIMIIG
FPSFITESTVAIVTIGFNIAFVQYAGEVGVASYAMVNSIHAMTLLLFFGVGAALQPIASF
HYGANLSERLREGLQFAVKIAVILGGVAIIVGLFFGKYIIGLFDVQSPQLLELTLTGISL
FFIQYVFLGYNIVYGEYFQSVRQTKKSILIIMSRGLLFIIPLLWIMPKLFGINGIWLVMP
VAEVITAIILFTMNRMKHPVPLNMAGEKEVI
>fig|198094.1.peg.1677 Fosmidomycin resistance protein
MQAVSQKNTVETPTIYRILFAISFGHFLNDSMQAVVPALFPILEKTMNLSYMQVGWIAFA
LNMTSSIMQPVFGMYSDKKPSPFLLPLGMFSSMLGMIGLAFAPNFIIVIISVLFIGLGSA
VFHPEGARVAYMAAGTKRGLAQAIYQVGGNTGNSLAPIFTALIFVPLGQIGSLGFTAFAA
VGIVLLIFVSNWYRNELATGAVRRKKRAALEAENAIVSTHIKFVIVLLVFLTFVRSWYGA
GIGNFYQFYLIEHYGLSIKNAQYFVFAFMIAGVLGTFFGGPLADRFGKKTIIVFSMLGSA
PLALLLPHVSLVWVVPLFLCIGFISSSSFSVIVVYAQELVPGKVGMVSGLIVGLAFGLGA
LGSVVLGKLADIYSLQFIMLLCSCLPLIGLTSWLLPSDKKTIE
>fig|198094.1.peg.1752 Permease of the drug/metabolite transporter (DMT) superfamily
MTQLSRTKTAIILTFLVFMWGINWPLSKFALHYTPPVLFAGVRTLIGGFILLLFALPKYK
ELHLKETWHLYVISSLLNIIIFYGLQTVGLQYMPAGLFSAIVFLQPVLLGIFSWIWLEES
MYGLKIFGLILGFIGVGVISSSSLTGHISIIGILLAIGCAIGWALGTVFIKKTGHRVNSI
WMVTLQLIIGGLCLIGFGSEFESWSSIAWSMPFVSVLLFISFFVIAMGWLAYFTLVGAGE
ASKVGAYTFLIPLIAIIVSSIFLHEAITISLFIGLLFIVVSICFVNIKPKTLAVGQRVEV
K
>fig|198094.1.peg.2247 Multidrug resistance ABC transporter ATP-binding and permease protein
MKSFRKLLQYLKPYMFFAIIGPLFMVLEVAMDLIQPTIMQHIIDVGIANRDLNYVIKMGL
LMIGAAALGLVGGLGCMMYSTKAAVNFATDIRKDVFAKIETFSSENRDSFGTGKLLTIVT
NDITSIQSAMTMTLRVLVRGPLLFIGSIIIVFVTARELFPILLVVVPILLLAIIYIASRA
SGTFKKVQEALDKVNTKLQENLSGVRVIKAYVRQKYEINQFGKVNTNLTKINIRAVQLIS
LMMPIIMLVVNGGIVATLWVGGEKVFNGTLQVGAILAFINYLNIILMSLMSISMVFMQIA
RAFPSADRVQQVLNTDVDITTPKNALAPKRIEGQIDFKNVSYSYTKNNEYVLKDISFRIG
KGEKVGVIGSTGSGKSTLAKLLPRLYDVDQGEICIDGINVKAYDLQKLRGSIGFVPQKAL
LFSGSIEENLRYGKEDATKEELEVAASSACATEFINKLEDSYQYHLTQGATNLSGGQKQR
VSIARALVRKPSILVLDDSTSAVDAKSESNIQSALRREYKGTTTLLIASKISSIIDADKI
LVLDNGELVGDGTHEELLEQCEVYQEIYLSQGGNLHKEGGKEHA
>fig|198094.1.peg.2248 Multidrug resistance ABC transporter ATP-binding and permease protein
MRNFQGQFANKGGRNAPKIDKAKNTKGTVMRVWNYMGYQKAALTFVIFLVLVTTLLGLLG
PYLMGVIIDQYIVPKDVSGTARMCLLLIAIYGVTVLLTWLQTFVMVNVALKTIQKIRQDI
FKKIQTLSLRFFDVRSQGDLMSRVTNDIDNLNQALTQSVVQIISSALTFIGVTIAMFALD
WILAIVTLITVPIMFFVTKKLVAYSGKNFAKRQKDLGELNGFIEEAITGADVTTLYGKEK
ETVQKFNKINEQLRVSATKADTFSAFIFPSMNFINNLGMGLVIGTGSVMVLNGMTTVGVI
AAFINYSRQFSRPLSQFATLMNTIQAAVAGGERVFEIMDEVPEIKNKKDAFVIQNLHGHV
ALENVSFGYEENKTILKEVSLKARPGETIALVGPTGSGKTTIINLLTRFYDVQQGQIYID
EKNIKEYDLNSLRSKIGVVLQDTYLFAGSIMDNIRYGRLDASDEEVINAAKAASAHSFIK
HLPNQYETKIATEGSNLSQGQKQLLAIARAILADTDILILDEATSNIDTRTELQIQEGLN
NLMRGRTSFVIAHRLKTIEKADQILVIKDGSILEKGNHESLMEDRGFYFDLYTSQFKI
>fig|198094.1.peg.2459 Permease of the drug/metabolite transporter (DMT) superfamily
MNYKKWDLRIICAHAFTILIWGSAFPAIRMGLESYTPEHLTLLRLLIASVILLLFSFIYK
LRLPDLKDIPAIFIFGALGFTFYHIALNYGEKTVNAGSASLIVSVTPIVTAIFASVFMNE
KMKLNGWIGGVISFIGIAFISFSQGDAIQLNSGALFILLAAISESLFFVFQSSYLKKYGF
LPFTIYTILSSTVCMLIFLPGMYQEILAAPLEVNLSVIYLGVFPTVLPYIALAYIISRAG
ASEATSSLYLTPITACFVAWIWLGEVPTLVSIIGGGITILGIVIVHIPVLRKEKHSNLAN
NQSV
>fig|198094.1.peg.2514 Permease of the drug/metabolite transporter (DMT) superfamily
MVIFNYILVCIIFGTTFLTIKIGIEAGAPPLFSAGIRFFLAGVILMIIFKLKRKEIMPHI
FSRRIIYAGFCLTFMTFATLYWAEQYISSGLAAVLSATGPMMILLLQTKRNKTKLKKEQL
LALIIALIGVVFVSLPGMHQEISFIWSIACFVLIIGELFYGIGSIRSKEILSDLQSVSLF
LINGIQMFYGGVLLLIVSFIVEQPNVTVLASWSVQWPILYLIFIGSIGGHGLYYWLLSKT
NPVFPSTWLYVSPLIAIIVGYIILGEPLNPIMGIGACFILVGVFLANRSTLRTYFKQGRL
FEKEM
>fig|198094.1.peg.2646 Drug resistance transporter, EmrB/QacA family
MVEKNNKLGFVVAGLLLGILMASMDNTIVVTAMGTIVGDLGGLENFVWVVSAYMVAEMAG
MPIFGKLSDMYGRKRFFIFGLIVFMVGSALCGTAENITQLGIYRAIQGIGGGALVPIAFT
IVFDIFPPEKRGKMGGLFGAVFGLSSIFGPLLGAYITDYISWHWVFYINLPLGVLALIFI
TFFYKESRVHRKQKIDWSGAITLVGAVICLMFALELGGQKYDWDSTFILSLFVGFAILII
SFIFIERKVEEPIISFEMFKQRLFGMSTIIALCYGAAFMSATVYIPLFIQGVYGGSATNS
GLLLLPMMLGSVVTAQLGGFLTTKLSYRNIMIISAVIMLIGLFLLSALTPETSRALLTVY
MIIIGFGVGFSFSVLSMAAIHNFGMEQRGSATSTSNFIRSLGMTLGITIFGMIQRTGFQD
QLEEVFKGMSGGMNTNALGDSRAILSESARSQIPPQILDKIIDALSSSIVQTFMWALVPA
GLAFIFIFFMGNERMVMKKQQKNKKGEISKV
>fig|198094.1.peg.2801 Ribosome protection-type tetracycline resistance related proteins
MTTINIEIVAHVDAGKTSLTERILYETNVIKEVGRVDSGSTQTDSMELERQRGITIKASV
VSFFIDDIKVNVIDTPGHADFIAEVERSFRVLDGAILVISAVEGVQAQTKILMQTLQKLN
IPTILFVNKIDRTGANTEKVVKQIKTILSNETFPFYSVQNEGTKEARIIEYKSYDDCIER
LAPYNESLLESFVNNEIVTDTLLREELEKQIQQANLYPIFFGSALTGIGVTELLEDIPAL
LPANNPSQDEELSGIVFKIEREPSGEKIAYVRVFSGTLHVRKYVHIQRDGSLPHKEKIKK
MCIFHNGNAVQTSTVPSGDFCKVWGLNNIKIGDIIGERTDYIKDIHFAEPQMEAAINAVP
KERIHDLYAALMELCEADPLIKVWKDDIHNELYIRLFGEVQKEVIETTLYEKYNLQVTFS
STRVVCMEKPIGIGNSVEVMGEKANPFYATIGFKVERGELNSGITYKLGVELGSLPLAFH
KASEDTVFQTLKQGLYGWEVTDISVTLTHTGYASPVTTASDFRNLTPLVLMDALKQAETY
VYEPVNEFELTVPEHAISTAMYKLAAILATFAEPIFNNDSYQLTGSLPVAKTESFKRMLH
SFTEGEGVFTTKPAGFTKLMAPLPTRKRVDYNPLNRKDYLLHVLKAY
>fig|198094.1.peg.2819 Permease of the drug/metabolite transporter (DMT) superfamily
MKRWQMEWLLVSVALVWGANYTIGKYGVAYMSSIQFNSLRFLVASPVLLLITFLMERSLR
IERKDWLRLVAVGIVGTTMYQTMFMLSVKYTSATNASLLIAMSPIFTGILAVLHKQERFS
MKVQIGSIVAFIGAAFVLLTGHTGGATYEYAWLGNIIGLVAAIAWGWYPILAQPLITKYS
AMRVTSWSTLIGIVPLVIYCLFNVNSLTWPVDTLSWGSLAYSIIFATIFGLAMWYVGISQ
IGSTKVMVYMYLVPLFAVIFAAVTIGEQINMMQLVGGLIIFVGLYVVKKGGIKKPALNLK
KVS
>fig|198094.1.peg.3217 Glyoxalase, Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily
MITPIFRIFDIEKAKLFYVGFLGFKLDWEHRYEEHMPLYMQISLHDAVMHLSEHHGDASP
GGAIRIKIDDVKDYHSVLLSKEYAYSKPNIEKTPWGTIELTVIDPFSNRIIFYEERV
>fig|198094.1.peg.3344 Glyoxalase, Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily
MSENHNFYDRKEMKGNGFELIIVVDRIEDVYERCKEKRCTIQEEIQTYPWEMRGFKVVDP
DGYFLRITSK
>fig|198094.1.peg.3367 Multidrug resistance ABC transporter ATP-binding and permease protein
MKEYKRILLPLQKEKILVIAAVCSGIFAAILNLSRPLFMGLIVDNLIQRELKEAYFYITL
FTVTRLLMWVNNLSFDYVSSKASQRILREKRIDVLRHFFLLPFEESEKIKQGELETLVVS
DIPNWVRLYDSILIEYIHAIAQFIGAIIALQHIDIQFILWVTPFLFLSAMVPMLLGKKVR
NIASIAQKNQSTVVEMMSQFVKGAQDLRSLQKEKWAIRLFKGVTAQSYKSEVKKTMMQHC
IGVVGTVIETGAYIVVLIIGAQKIMQGEMEVGSLVAVLATIEMLFFPVRYVGDLLMMSQV
AVASASRVFSFLDKRVANSNVERAMGMTITNVSFQENDEEKCRIYNIDLQIQPGELIIIV
GESGVGKTTLLKLMTGLYKPSNGSITYYGNEAQLTTVWQEPRFFRVTVKENMYFGEERLE
NELEKNAELVNVTPIIRGLPEGLQTVLHKSGEEFSGGERKRLALLRAIVSNPHLIILDEP
TAGLDPNNQEFVWNMIEELGSEVTRIVATHDVEKVILADRVVIMKEGSIVACGSPEKLIN
SHSFFKRCE
>fig|198094.1.peg.4082 Permeases of the drug/metabolite transporter (DMT) superfamily
MNGRSFTFAIFVLIIGLAIFGLVSSVITNPMGVLRNIGIMLAVVGIFYLLYKMFTNSSGS
ANSQSSYKRAAKQSSRKHGKQNVAPLSNSFFKSNTSNDKGKKGNPSSLKRKRKQSHLTVI
EGKKNKKKDRASF
>fig|198094.1.peg.4497 Zwittermicin A resistance protein ZmaR
MKKLSVAEYRKILPILESHTKTTTFAYAVCDQVIDGEVFVNEKLTAGLIRTANGIYYVFG
HTDDQNYNEDLFLFIKKAIEKTEKRFTLFTSSEEWEMMIEERFSNVLRNIPRMKFQSATF
EERKRDCNKNTYEVKRIDRRDIERSSEFTEEYYKEYWGSKETFLNGGFGFCIEQGGMIVA
ECVSIFSGNGFAEIDIVTHKAYQGKGLAQAVAARFIEHCIQNDIIPCWDCYVDNIPSQKL
ANKLSFHNPIEYSLFVRKKTGE
>fig|198094.1.peg.4584 Drug resistance transporter, EmrB/QacA family
MRKKVMMSLMLMTFLSAVEGTIVSTAIPRITSDLSGVELVSWVYAIYMLATAVSTPIYGK
LADLFGRKKVLLIGATIFLVGSALCGVVTSMEQLIFFRALQGIGAGAVMPITMTIIGDLY
SEAKDRAKAQGWMSAVWGVSGVIGPLVGGFLVDSLSWRYIFFLNVPFGIIACLMIAIYYK
ESIKPAKHHIDYLGATVFSLSMIALLYALLTGSSKQNWGDVTIIGLLIFAVVSFIIFLFI
EKKSPEPLIPLALFSNRTLSTINILTLIAGAMIISITMYLPIWSQGVLGKNATEAGLILM
PIPVMWTFGAIFSGNLVGKLKTKQIILLGASILSVATFLLFTLSTNSPSFLIYVAVGLFG
LGMGLVTPIYMVTIQAAVPAHTRGTAVGLNTFINTFSQTLGAAVFGTIFNTMIHARGIKN
LDLVSGGHGGATANVVTESQSALASSVHVIYMSTFVLAVCTLIIAWLLLKPATQTSEQ
>fig|198094.1.peg.4822 Teicoplanin resistance protein vanZ
MQSSTQKYVEWIGWGLFLPYSFVLLFKLLLGRSAFYFGNLTYFFETGDWHSIHGGLINLV
PLKSTINYLSGFDTTHLLDPYNIDIVLMNTLGNVIIFIPFGFLLPLLFKQINNVKMASKI
FIKFILLIESLQLLTFTGVFDIDDIMLNMLGALIGYGSFVGIKYILERVRSVDKVDTI
>fig|198215.1.peg.392 Acriflavine resistance protein E (AcrE)
MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRT
SAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAQLTVNRYQKLLGTQYISKQGYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPI
SGRIGKSNVTEGALVQNGQATVLATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENG
KAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
LNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVV
ISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>fig|198215.1.peg.3097 Outer membrane component of tripartite multidrug resistance system
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETA
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDAIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAEHVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
AAPVVEKK
>fig|198215.1.peg.3098 Membrane fusion component of tripartite multidrug resistance system
MTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLI
IAGPILMGCMFLMRTHRLGLVFFAVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLM
TLIGVLWFPNRAITQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLAD
DANWRTQSAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEG
QCWQSDWRLSESEAVAARECNLENICQTLLQLGQMNPNTPPTPAAKPPSMVADAFTNPDY
IRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAI
LALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVF
GPVYDLVEIRDRALGIIIGTVVSAMIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQ
EVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDILHA
WDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPTSQAILPTLL
KQEQHVCQLFARLPDWTAPALTPATEQAQGATQ
>fig|198215.1.peg.4255 Polymyxin resistance protein PmrD
MQWNGWHKKSCCNKQDNRHVLMLCDAGGAIKMIAEVKSDFAVKVGDLLSPLQNALYCINR
EKLHTVKVLSASSYSPDEWERQCTAAGKTQ
>fig|203119.11.peg.316 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQKETASIKKMSVFALTWPIFIETLLRTMLGNVDTFMLSTYSDDAVGAVGVVSQISYILI
MLYNVVSSGTLVLISQYLGAKKKKEASVVAVTSIAGSLIFGLFVGLAVFLFRSQILTFLN
LPPELMGYAMTFLGIVGGFSFTQALIATLSAIIRSYGNTRITMYISVGMNILNIIGNSIF
LYGLLGAPKMGVTGVAIATVISQAVGVVAMLIVMLTGLNQKFSFRDLVPLPWEILRDILK
IGLPSAGEGIAYEASQLTITRIITVLGKVALTTRVYTLNIMYFVMVFSVAVGQGTQIVVG
HLVGAGDNEKAYKTCIKSLRYAVVVAIILAGIVSFFSEQLLGIFTDDRAIIEMGSKLLLI
AVILEPGRVFNIVIINSLRAAGDARFPVIMGIISMWGIGVLLSYFLGVACGLGLIGVWIA
FASDEWFRGIAMLLRWRSRVWYKMALVKNQNIEMPA
>fig|203119.11.peg.927 Permease of the drug/metabolite transporter (DMT) superfamily
MRKFNFGYLFILVTVVFFSTYEVVSKTIIGKVDPFQINFLRFFIGGSLLFLFLLIKRDVK
IDRKSLMIVSAAGILNVVFSMNLLQLSLNVAYAKAAVVAVIFSSNPIFVSIFAAVMDKEK
ITLFKAAGMFLGMLGIAVISINGQAFRDINILSPLLALMSAGLYGLYTVVGRRASSKIGS
IKMNAYSFLIGSLILLSVLLIKGLPAFKFDCSAWPQVVYLSVFVTGIAYLIYFMGLVRTG
AGSGSVVFFLKPVLASVFAIVFLGEKITLNLIFGTFLILLGMAVMFYWEKIRQRFV
>fig|203119.11.peg.1119 Vancomycin B-type resistance protein VanW
MLLDFFSKNKTKILIFAASLLLLVIASVSTYVVVVLNRKTFYDGIAVEGIDVSGLTVDEA
REKVEKKLDRIVYENSLLLNYEGMTWRIGLSDISYDFLVDDAIKRAYSIGREGSVLKRLK
TIRNLKSDKKNVLAKVVFSRPLLEEYITSIKKQVDENPKDATVTYQNGNIMFEKEIIGRF
VDVDKNLGLLENKLIKRDFSPFELEVTNVYPKIMYKDISHIEEVISSFSTVFNSANVNRS
HNIKLACERINNTVLLPGETFSMDASLGSRTKENGYKDAPVIVKGRLIEGVGGGVCQVTS
TLYVAVLKAKLEVVERVKHSMPLGYVEPGQDATISEGYIDFKFRNNTDRACLISASVVGN
RIDIKLLGAKRNSNYDVRLKSVVVERISPPEDEIIVDKSLPKGAVKIEREPVQGLKVIVY
RETYENNRLIEREKISEDIYKPVQGLKRVGPYDSNDTEGGEETVKEEAMEEQTI
>fig|203119.11.peg.1534 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKDISANTSSSGNPLGYAPVLGLIGKFAIPSIISMLVAAAYNITDQIFIGRLVGMLGNGA
TSVAFPVVTFTTAFAQLIGVGTAANFNINMGAKREKEAKHFVGTGITLMPTVGLLIFCIV
FVLKKQILLLCGATENVLPLAMTYLGITAIGLPFQLFTTASSSLIRADGSPTYSMICNVT
GAILNVFLDWLFMFVFGWGIQGAATATVIGQIVSFLLCAIYYFKFRTFQITRRMLGIKWY
YAKRIAKLGTSNFINHTIMMLVNIVLNNSLKIYGAMSIYGSDIPLAVSGIIAKLNSVLSA
FSIGLAQGCQPILGFNMGAKNYSRVKETYKKAVSIAIGISVLAFILFQCFPRQITGIFGS
GDELYGDELYFEFAEKYLKIYMFMVCVFGIQPVTINYFTGTGNVRQGIILSLSRQGFFLI
PLLLILPQFLGLTGVLYAGPIADFMACLLSLTMITLNFKKLDSGREVADK
>fig|203119.11.peg.2540 Vancomycin B-type resistance protein VanW
MTFDDVCNLLKSKYSEKAKDLKVVLNHEGMAAEVDLSEIDLEYKIEEAAQKAFDVGRKGN
IFERLSEIFNTSREGVRLSLEYSYNLGKVNEIIDDFYSKTLISVKEANLSIQDNKVTLTT
GHPGKSIDKEKALEIIDNSIKTCEGGTFDVPVITTMPKAIGVDDIYNQIVVQPVDAKAVV
ENNKVRVVPHELGREISKSELADIIKENENTTDKEILLPVKFIQPKVTTDEVNAKLFRDV
LASSSTSFSTSGQNNYNRGINIGVAASKINGKILAPGEVFSFNDVVGPRTVANGFKIAKE
YVNGKIVDGVGGGVCQVSSTLYSAVLFADLETVERQNHMFTVSYIPLGRDAAVAYNELDF
KFKNNTNWPIKIVSSVKNNTVSFTIYGTKEEPGKTVELKHVQVSSQPSPVKYIDDPNLEE
GKTVVVQSGYTGYTIDTYKIVKINGNVVSNNKIHRSIYRPYETIIKRGTKKVEKVVQTNS
PAPETVLSPTSDPTPDPAASNEVVDETLVE
>fig|203119.11.peg.2908 Vancomycin B-type resistance protein VanW
MGQKNGLKEIFAVATTIFIAVLSVSCSFGERKVENNVYIKDINVGGKSKAEVEEIIKKMS
DSIDVEPKDAILNEDTLEIAPEEPGRKLNVESTLKAVLNAKEGDRIEPVVEEVLPKITRE
DVEKRIVEIGSYSTPLLDESENRVDNIDTASDYLNNEKVLPGEEFSFNETLGKRTAEKGY
KKAPIIKRTESGSIKGYGIGGGICQLSTTLYNAAEKAGLEITERHSHSKKVPYVPQGKDA
MVSYGSSDLKFRNNRQNPIVIKSEISDGKVTVRLYEIRK
>fig|203120.4.peg.537 Permease of the drug/metabolite transporter (DMT) superfamily
MKKQGIICGVLSATLFGISGILASILFRNQNINPEWLVGVRMSLSGIILLIVLFCFSGRR
VFEIWLNKRDVVLIILYGIVGVLLAQSSFFLSVYFGDAATATILQSLGPTIIVILLSLAT
RTLPSRLDIWSILIALTGVFLLITNGNINQLVVNSKALFWGILSAFGLAAYTLIPKPLLE
KQSPLVVVAWGLLVGGTAENFFHPIWYIPSQVSTKDWIIMVFIIIAGTLLPYALYVMSLS
QLKPTTASLLSTIEPMVATLLSVTLLHVHLRMFQVLGILFIISTIFLISLPLERIFKKRL
SDPKIN
>fig|203120.4.peg.947 Multidrug resistance protein B
MENKVSTKNAMAIIAVALVSFSGIMAETAMNVTFPVLTRYFSTSLNSIQWVTTAYLLSVT
IMITTSAYLNKRYNTRYLWLASLIFFATGTLVGGLASNLPVLLIGRVLEGLAAGISMPLM
FNLIVQLVPRSKIGVWMGIGSMVVSLAPSFGPTYGGALIDTLGWRSIFFILLIVPIISLL
LGWRTIDNSKETQANVSFDVLAFGLLSVSLITALILINQLENGTVNILLLGVTIVSLTGF
VIRSLTSKQTFLNIRLLSNSKFLFLLIPVVLYMFANLGINLLLPNYSQKILNTSSFWAGF
SLLPGTLLGGILNPYFGHLYDKHGDKTPLLVGNTIFGISLLVMAYFTKNLGIIAFIIMYM
IFTFGRNMAFSIGMTASIDELSRDKKTDATAILQSAQMFMGALGTTVAALYGAQKSGLAV
GFQHFLWLLFFISLVIFIMFFARQKTGNK
>fig|203122.12.peg.726 Permease of the drug/metabolite transporter (DMT) superfamily
MRVALAYACVVLIWATTPLGINWSNSTLSFAAAVALRMCLALAICWLALVVMRERLVQQR
SDWKAFFAGAIGLYPNMLLVYWSAQFIPSGLMAVILGLYPFTAGLFTYFILKEWVFTPPR
IVALALAVTGLGVIHYEHLALGSDAIYGIMGMLGSTFLFGLSSVWLKASGAAVEPLRQST
GTLLLSTPFFILSWVVTGVNIPAAIDVKSIVGVSYLAVAGSAIGGTLFFYVLKKCSMSSV
SLITLMTPMMALTIGMLFNNETVTQLEFIGCIIILFSLAIYQGALRVVVKQINRLLAVGK
QPVQLP
>fig|203122.12.peg.1022 Permease of the drug/metabolite transporter (DMT) superfamily
MNPQKTGLLSLYFGIFLMSLTGLFAKSIPLDATSITQLRSTVAIVALFIYCMLRGSSLRL
KSFKEAAGIYGLGIFMAIHWVTYFHAMQVSTVAIGMLSLFSYPVITVLLEPLFQKKLPAR
ADLIAGALSFTGVVILTMDDSTGLGGAALTGAAWGIFSALIFSVRNILQKYTYPDVPSGT
LMFHQVVATAVILIPFVDFGSVASLELDKWALIVALGVLCSSMAHTLLALSLKRLPAKSV
AQISCLQPVLGALLAWFVLKETIAPQVLGGGALILAVAAWESYKQSYRPRAVS
>fig|203122.12.peg.1544 Permeases of the drug/metabolite transporter (DMT) superfamily
MTLWIAFTLMAVVMQAVRTAAQKDLSRALSPMATTLTRYLYGIPFVALYLVVLLQTNTEW
ANSFNYAQLNNARFLVFATVAAIVQIIATAFMVKMFTLKNFAIATSFAKTEAIQVALFAS
VFFQDHLNVYGWVSVFIGVVGVLFVSGLKIGKPQSISSATIFYGTLSGALFAWTSLSLRE
ASLSLDLPLVYSAALTLMYMVIIQTAICAIYITFKERKQWQKLMALQKRGLFVGATSALG
SVGWFTAMSLQNPALVKTLGQVEFFITLGITHFYFKERIKWQEMVGIMCIFASILLILYV
>fig|203122.12.peg.2443 Acriflavin resistance protein
MENKQYQQGDSSGGLSGWFVMHPNAAKILLMVIMLAGFVGVNSLPQEVFPPFAPSRVDID
IPVRGGTASDVEELVVKKVEESLEGLAGIERIVANSTDNGARISVELVNGADQQSLLSLI
KSRVDGISGLPISSEPPVFSLPEPVGPVQFINITGDVPLPALLGQAVKFKSELSRLEGIS
YAVIENEPELPLYIDINPDKLQQYQLSLTDVADTVARYSVNVAGGTIQTLGNRYQLRANT
LGNMASDFIDIPIVSAASGVVVRLGDIAEIQLAPHDDYVAGKFNGKPSLMLSVYRDPKVP
FSTASESINALLDAKRAALSPAIELIAWQDESREFTTRISLLVKNGVGGFIIICLLMGIF
VNPQIAIWTAIGIPISILGAMGLMHFAGLDLSLNAVTLLGFIIALGMIVDDALVIGESIQ
YETAQNGHSMHSVVTGVNRVAIPATFGVLTTIAAFFPLTLTEGDMGSKLGGVGMVVICCL
IVSLVESKFVLPSHLRKPSKILQKPAFNKLNALSTGATKKMDGFVERYYKPALDWVVVRP
VRTISAVVGVLVISLAMIPLGLLKMAIIPNIADFALQASFQFHPSVAPSIRETIGDKATE
QLRAVSEEVKQKYNLDYQPVKHISQHYSGSELVVDVELEEAFNAPYDAYDIQQMWRDSLP
YTPGISSLSIDAGSGSSEKIAIELSGENIESLRALSKELREHLASQDDVVDIRDSELANM
IEYRFKPTDLAKSLNISDAEIITQVRAAFYGQEAQRITVGEREARVMVRLEDEYRHSLTG
LNAMLLPIQSADGSKQYIPLSQLVEIEQNVVPSEIRRINKQRTITVYANTKMNTRSPEDV
AEEMGESVLPEMVKAYPGVGFSIEGEAKEANKSLSSILSSAGLAGFILFALMALPLGSFR
YPALILCLIPFGMIGAVWGHIAYGLTFSLMSIFGVIALAGVLINNGLLLVDQYRENIRLG
QDITEAIKQACVRRFRPIVLTSITTLAGLMPLMWEGDPEALWLVPIAISLGVGLLVATAI
TLIIFPAMLLLLDRNKVHEQQEEFTSGIQPKEV
>fig|203122.12.peg.3480 Drug resistance transporter, EmrB/QacA subfamily
MSQANLGCIQVESTHNKWAVALSVSMGGVMSSLDTFILYVATPNLRGVFSATVAEVSWVS
TSYAIASMMCMFLSGWFVDRLGSKRVYQAGLVLFVIGSALCAMATSLEQLILYRVIQGLG
AGILLPVEGVILRRTFPPVQHGLVMGLYGTSIMCGPAFGPMLGGILIDQFSWHFIFIVNI
PIGIISFVMVRHYLIDDPIGADTPKRTFDAPGILWLLFGVVGTVWLLERGDRTYWFEDTQ
NVVLLVVALASWAMLCAHSLTIKQPLLDLKVLKHKTFTAANSLNFLAAFMITGTLFVLPI
YMQELLGFSPTQAGTTMAPRALVMMLAFPLVGWLFNRVPMRLLITTGLVLGIGSGVMMAG
FTFETGWHDMILPQIIQGLGAAFILGPVTTAALISIPKATMPAAAALESTTRLLGSTLGI
AVFASLITHYELRTWELLRHNVTLSSTVLYKRFGGVVEFYYSETSSQLHALEKAYRALNG
RVTEQVLSITYMNLFQLITVGFIAMLIISAFISLKKQQQVA
>fig|203122.12.peg.3486 Permease of the drug/metabolite transporter (DMT) superfamily
MKALTVLPSDKQRLLGIAAACAVVAIWSGWIVSSRWGLNSNIAAIDLTWLRFTTAALVTL
PLAIKYNWRHLPLGKALVVAFGCGFPYVLFAYLGLQFTPSANASVLINGLLPVVTSLLGY
FFLSGKMTKPLLALVAIACISNIIIASSGAQFSVKYLTGIGFLLSATLVLATYMVAVKAW
NISMHEIMVWVPIINALCVTPFWFVFSDGLSALHTIPTTDLLFHIVYQGVIVSVAALFLF
SYAIKCIGALSASLFMAFVPTTTALLAFISINEQPTSGQWIAITLCTLGLVGYNFYSRKE
EKSTSK
>fig|203122.12.peg.3493 Permease of the drug/metabolite transporter (DMT) superfamily
MRQALLRLSVNHTKLLGVLAAFTMMLIWSGWIVSSRQGLTTTLSPLDITWMRFVVASLVT
LPIALSYHWRTFPVRKACFIALSYGAPYAWPAYLGLIITPSANASVIINGGLPVATSLIA
VFFFGARVTKGVILLIGFIFLANILTFMDAELFNRRYFIGVSLLAVATVSLAIYMAAVKA
WEVSVKDIMVWVPLINTAVMTPIWLVFSDGLTSFTSLPVNELLFHVIYQGVIVSVVALFL
FSFAIRAIGAVASSVLMAFVPSVTAVLALLFNNEVPNSLQWLGIACCSIGLIIYSSWDVF
RKKLRAP
>fig|203123.5.peg.94 Drug resistance transporter, EmrB/QacA subfamily
MNQKEGIIDKTTMTTAWVLVFGALAPLLDSTMINIAVHSLVRNLHSSVSTIQWAVTGYVL
ATAIAVTFSSWLLNQFDGKKVFLAGEIIFAFGSVLSALAINAQFLIGARLIQGFAGGIIM
PLLTTLLVQTAGQKVMGQMMATVGLPIIIGPLVGPIIGGIIIKYLSWQWIFWVNVPVAVI
SILLILWKMPSYPAQNKSAKMDFVGIVFLAGATTSMIYGIVKAARKASFANKDTLLFIGL
GLALALLYVFWAMRIKDKAVLPLNLFKYRSFNGSVLGLLIAGTVLNGAMLALPLFFQEVR
GMSVMMAGLALIPQGAGMLVSRTLTGKLTDKFGAKYVVLTSLIITFIGTIPFYWFNHETS
YWIIALVLFVRGIGAGGILMPLMADSYTGMQGALIPAASIGSRTIQNIGSAFGTAIITTL
ITAYSNAKIKGFKQNISSANYHVKAANMSQFVARHLDLIQIHAFQYGFFCISIAALLIAL
PTFLLTNKIEKNQ
>fig|203123.5.peg.97 Drug transport protein
MKNKLFIATLISYLGIYITMPVLSAISTKAHMLPGQIGVMISLGAIAMLVFAPVWGKLSD
KLGRKTVIVAGLMGMGVMFILYTALFRLSISQSKTITILVILLMAVRFLLGIFMTTAPTA
ANAYMADISYPENRAKDMSSLGLATGLAMVLGPIIGGILSSIGTLYLPFYISIIMLILFG
FIFITILPKKDQEKTIPKKLIISKQLLKIRKVFLLSNYLGG
>fig|203123.5.peg.1051 Multidrug resistance ABC transporter ATP-binding and permease protein
MLKRLLIQTHRLNNLLLASIFCGAISTLLQIFIIAAAFYLIIQHQFSWTYALILLFVALA
LGFSRFGEQYLGHFIAFHLLADLRTQLYDHLLSLAPAKLDDKESGKILKLLVKDIEQIEV
FYAHTIAPVVIAVLLSFLQSFLIFLFSPLMGTLALLSYFWIGFVLPLFRKKKIENTSSSL
SKYETENDQLLSETVNGKSLLQQFQKIEQRISLLDKQRDLIGNTIKKGTFSDSAAATATQ
LSLLFFSIAMGYLAFNFSVGNTLCWVIAFTFPFSFGRVLALANLPSSLGNALLSAKNIFK
ILDEKAVSNLSENQEISLIKQSRFVDVNFSYPLRPNKTVLKDASLIGKKSEVIGIIGESG
ERKSALMKLLMKWYQPKKGLIEVYNHDLRKIKKSGLRKQINYVAQNPLILSGTIRENITL
KNNSFSDSKIWESLKKVELDKTVKKMPKELDTKISRLEQRFFFRRIAKTGNCQSIAVPEF
NIDFRRTDKQLGHP
>fig|203123.5.peg.1354 Multidrug resistance ABC transporter ATP-binding and permease protein
MRNPAARMSGNGNGPRPMARVAEHPHNFWGTTVRLFKYLGRNRIGVVFSVLLAIGSVLLS
VSAPKILGRATTIIYKGVVAGLKSEKYQISYQPIIKILIEVSIIYVLSALMSFLQQVIMT
RISQKTIFRLRSEFKAKMARLPIKYYDQHQNGDIMSRVVNDMDNISGTLQQALIQIVTSA
LTFLGVVFFMLTISWSLSFIAFITVPISIFVVRFIAPHAQKLFARQQAVLGIMNGQVEET
FSGHEVIKTFDREIPVIDRFEKQSQKYYQAAWKAQFISVLIFPAMQFLNNLDYLLIAVFG
SIQVANGQLPLGDIQAFLQYTNQFSQPITQIANLSNTIQSTIASAERIFEILDAKEMTND
FKNLPKNIKNPKSLLSFDHVKFGYSDNLLIKDYSLKVDKGQMIAIVGPTGAGKTTIINLL
ERFYDVKDGSIRYKGFDTRTLTRPEARSHFAMVLQETWLFTGTVFDNIKYGNEQATEEQV
VSAAKEAYADGFIRQLSKGYQTILNESASNISQGQRQLLTIARAFLADPEILILDEATSS
VDTRTEILIQRAMEKLQSSRTSFVVAHRLSTIQNADNIVVMNHGSIVETGTHEELLDANG
FYADLYNSQFSNGAI
>fig|203123.5.peg.1355 Multidrug resistance ABC transporter ATP-binding and permease protein
MFFQVAADLILPSITANIVNIGVVKHDISYIWKTGLVMLIVSFFGIVGAICNQLLAATSS
QKLGVKLRSFMFRKVTKMADGDFEKLGQASLITRTTNDVVQMQNATYSMLRMMIRSPMML
IGASVMAYFKSPRLMLVFAAAMPVLALVVILVMTKSVPLFKKIQALTDQINLVFREGLTG
VRVIRAFNQDEFEQNRFKKANINLTQNAINAYVITSLMSPAMTFIISASNIAIVWFGAHL
IAGSLMPVGNLLSFITYATQMLFSFMQLSMIFVVVPRAQASAQRIQQVLDIKDTINDPIK
PKKLDPIDDLKFSHVDFTFSGSSKKVLDDINFEIHKGQTLAIIGGTGSGKSSLINFVPRL
FDVSGGKVLINGDDVRDFSQSDLHKHISFTSQKSFLFEGTVRGNLKYGNSQASEQDMNRA
LEIAQANSFIQEQGGLDAPVEQGGNNFSGGQIQRLSIARAVIKRADIYIFDDTFSALDFK
TDANLRQALSEDKKIKNAIKIIVAQRVSTVADADQILVLEDGKISGLGTHQELLKNNSIY
KEIVDSQLHKNDILAKSGGKIYA
>fig|203124.6.peg.354 Multidrug resistance protein
MSKKTVSQNIKNSIKIYQDSNFQIIIGIISMAILGGPGISPLLPSIAKNWNISPEHIGWV
ISAFFIPITIGTPISGILADRYGRKQILIPALILFAISGTLCSLAPNFQTLIGLRFVQGI
GAAPLESLTLTLISDFYSGKLLTTAMAFKTMSVGLSLVIYPLISSGLTTWGWRYPFLLYL
IAIPLSIWILFSLKNPAIPKQKSFNLKKYLRNIWQSFNNYQVRSLLIVIIVNFIFSLGPC
LTYIPLFADRQLGASYIVIGIILASRGIFLAFASSQLGIFAKYLSELTLIKISFIIYCIA
FIMIPTINNIWLLFIPGILLGLAHGMLVPSTQSLLGQLSPENYRAGFMAVTSSALSFGRT
LGPILAGSMFYIGGMAGVFYSSSIVSLVIFVFISYLVINTQSIKS
>fig|203124.6.peg.3596 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKQKLTEGKISTLLLKLTLPTVWGILALLGFSIIDTYFVAQLGTKELAAISFTFPVITFL
NSVSIGLGIGVSSCISRAIGKRVQTPVLDRDDYKVKRLTTDSLILSLLVGAILVILGLAT
IEPLFTALGAKAETLPLIRQYMKTSYLGGIFAVVPIVGNSIIRATGNTFVPSVVMTVAGI
VNLVLDPILIFGVGPISGMGLQGAALATVISMVATLAASLFFLHYHQQMICWKLPSFKLL
LRNWQNILSIAIPNIGQNIIIPISVSFITSLIATYGTAAVAAFGIASKIEVFCFIVFLAL
SSSFIPFVGQNWGAKQYNRVYLGGNLGFKFSLFWGAIIAIALAIGGSWLVSIFDSDPEVI
EVATKYLLIMPISYGTLGITLISSATFNALGKPLPSVMMSLIRVLFLYVPLTYLGSWLLG
INGIFYGTCFANLVVGIGAYFYFNKTFKFNN
>fig|203124.6.peg.4212 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MEITWKDSDWAYLKAGDDGLALLSPTYEQAGPHFGFVFSDRSEMEMAYKQLQAKEVEVSP
IHEHRDGTASFYGRDLDGNWFEYLYEPVN
>fig|203124.6.peg.4627 Permeases of the drug/metabolite transporter (DMT) superfamily
MSSTSKKLSTLTKSLFSAQIIVMTGLIWGVLALLFFLLFSVPLPGEELPSWYSVGTYIFE
LGAYLIATIISFRNWQSPQMVSGRNVWIGISLGLLFYFIGGLVFGCWELIWELDPDVSLA
DIFYVFSYIFLAWGMTLAITAKKLNLEFWQWVVLALVAAGGVLLAIFVADPSFFGLLSTP
DTTVLEELDTIKIESAQLAPSWVLALDNKLEPFSFWLNLFYIIADVFLLIIATALLLAFW
GGRFSQSWRMIAGATFSLYIADMYFKWADSQTTGEYESGGLLEVFFVFTAILFAIGAVLE
YDISTRSRQSRRSRRSSSS
>fig|203275.8.peg.258 Tetracycline resistance element mobilization regulatory protein rteC
MNMKRRKDDSRTYFLDELREELNRRMKESDLKGGKFKKR
>fig|203275.8.peg.345 Acriflavin resistance protein
MDNPMSAKKSISAFTVIVAFLSVALMGLALVPLLPVKLAPSHTLPGLTVYFSMPNNSARV
IEMTATSKLEAMLARIKGVKNIYSTSGNGWGSVTLELDKHTPIDAARFEASTIVRQTWHD
LPREVSYPYISVRRPDENAARPFMTFTVNSAAVPVVIQQYAENNIKPRLNDIAGLYKIEV
HGATPMEWQLMYDNDRLQALGVTVNDIREAVSQHYTTDFLGMAETRSADGTAAWMRIMLM
SGSRNDAFDATAITVKNCDGALIRLDQLVEVVHTEQEPQSYYRINGLNSIYISLTAEESA
NQLRLSERVQETMDEIRRLLPPGYEIHSSYDATEYIHAELNKIYLRSGLTVLILLLFVLL
ITRNVRYLFLITVSLTINLAIAVIFYYLLGLEIQLYSLAGITISLSLIIDNTIIMTDHLM
HHGNRNVFMPVLAATMTTVGALSIIFFLDEKIRLNLQDFAAVVMVNLCVSLAVALFFVPA
MAEKIRLKKRISRTRILRWFPLRPKRLIVWFNRFYGAMIRLLSRRKWIPFTAIVLTFGLP
VFLIPDKIEKETKFAEQYNRIFDNATYKEKVKPIVNKVLGGTLRLFVDKVYQGSYFTRNE
ELILTITASMPNGTTLAQMNALVEKMEHYLSSFSEIRQFQTHIPNPRRASIRVFFTKAAE
RGGFPYLLKSNVITKALELGGGSWSVYGLQDQGFDNSVREFAGNYGVKFYGYNYDELGAW
ADTLKNTLLLNRRIKEVTINSDFSWYKDDYREFSFDLKKERLAADGFLPGDLFASLQPIF
ARDMWAGSLIIEGEREDIKLASHQGKHYDIWALRHVAHRMGGRMYKLDELADISQGQAPQ
EVAKENQQYRLTLQYDYIGSGTQGRKMLEREVKALSERLPMGYTVEQRDTQWGWGHKDKK
QYGLLGLLIIIIFFTSSVLFNSIRQPLAVIFVIPVSFIGVFLTFYWFRLNFDQGGFASFI
LLSGITVNASIYILNEYNRVRRLRPRLAPIHAYLKAWNAKIIPIFLTVVSTMLGFVPFMA
GTEKEAFWFPLAAGTIGGLAMSILGLWIFLPLMTIRGKKAIK
>fig|203275.8.peg.1110 Tetracycline resistance protein TetQ
MNIINLGILAHIDAGKTSVTENLLFACGATEKRGSVDKGDTITDSMDIEKRRGITIRAST
TSIVWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFKTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLFMQTVVDGVVYPICTSTDIRAEHKEFV
CNHDDDILELYLADKEILPADYWNAIIALVAKAKAYPVLHGSAMCNIGINELLDAIISFI
FPPASVPNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRTVIKVNDSEKFIKIKNLKTIY
QGKEINVDEVVANDIAIIEDIEELRIGDYLGVKPCLIQGLSHQHPALKSSVRPDKPEERS
KLISALNVLFIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKTHFDEIKTI
YKERPKKKVNKIIHIEVPPNPYWASIGLTLEPLPIGSGVQIESEISFGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTYALYYSPISTPADFRQLSPYVFRLALQQSGVDILEPM
LYFELQIPQVASSKAITDLQKMMSEIKGISCNKEWCLIEGKVPLNTSKDYASEVSSYTKG
LGTFMVKPCGYQITKGGYSDNTRMEEKDKLLFMFEKSVSSK
>fig|203275.8.peg.2442 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSVQKPLSALETEPVGSLLTKYALPAIIAMTAVSLYNMVDSIFIGRGVGAMAISGLAITF
PFMNIAAAFGALVGVGASTIVSVRLGQKNYGAAQQVLGNVVCMNIVIGGVFTLVSLIFID
PILYFFGAGEQTIGYARDYIVIILSGNIITHLYLGLNSVLRSSGHPIQAMMMTVTTVVLN
TALDPLFIFVFGWGIQGAAIATVLSQCVTLMWLLFLFSDKKRLLHFRKDMLKPRIGIVKD
ILAIGMAPFLMHLASCMIVILINNGLKRYGGDLAIGAYGIVNRFAFMFLMIVMGLNQGMQ
PIVGYNYGACRINRVQKAFRLTVFFATLVTTFAFLLAQLKPEWIVRVFTTDEELIRLSVY
GMRISVMVFPLIGAQMVITNFFQSIGMAKKSVFLSLTRQVIVLIPCLLIMPKLFGIAGIW
MSMPVSDTVSALVSIAMIYVQLGKFNAKQ
>fig|203275.8.peg.2815 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNAVNILQEGSMMKALTKLGIPIVIAMLIMAIYNVVDTFWVARLGTLPVAAVSVVFPLS
LLFLGIGLMFGVGGGVYISRLLGAKQIVKAGQVASVSVITSVILAALIALVCNAFLPDIL
LFMGANTGMMHLAEAYGRLFVISCVIGALNVSMSNIIVSQGASKTSASAMIIGSVVNVTL
DPLFIYTFGWGVEGAAWATILSRIITTAIYIRFLTKAEVKVSFALFVPTIRMYAGIIKIG
ISMLFLQSLQTLSISLLQRAAVKYGAEAVAAVGIVLKIVTLGTNVVFGFVKGLQPMAGYN
YGAGNFQRLKEAVHCSLILTTSFCVLWSILIMAFTSPVISCFGKDETMQEIVRIALRANT
IMFFTFGFQFVYSTLYMAIGRARQSLLLNIGRQGLFFIPTILLLPSYWGLNGVLYAQPVA
DVFATLMTLLFAVRIHREIGHQSHLTTENL
>fig|204536.4.peg.1198 Acriflavine resistance protein E
MNKKVITAISVVVIIAVAFFILKSIEKKSKSQTDQRPQKPAPAVKVIIPEKQEVPIYYTA
NAVLQAKTSAKLKPQVSGRVEKIFAEEGSFVKAGQPLAVIQPEKEEYQIESQLAVINQLE
ANYLNKKSIYERRKQLYEKELIAKEELDNAKTDMEVALNQLNSAKATLKEYKRQKNETVI
RAPFDGYLDKRYVSIGDYVDSQKDMFYILKLNPIWAVFELPQQYVKNLSLGKEVEIDVDG
IGAVKGKIDYISSSLNENNLIVVKVLLDNKDGLLRENMYGKAKILVDKVEGYKLPEDAVQ
LAGNDNFVYKVVDSKAEKVLVNVLKQEYGYVYVSGDLKQDDKVIVSNLMNVKHGMPVKVI
QQPEVAK
>fig|204536.4.peg.1203 Membrane fusion component of tripartite multidrug resistance system
MNGKGKKVGLIITVLLIVVFLIYAVKWINHRMKYAISDAVFVESDYLSNIGFNRVSGRVV
QLYKKESDEVKAGEVIAKIDDTDYKLQIEALEKEIEALTYQKKQLESQLQRVARETDINE
SISALTVEEISKKLESLKAQKDQIESQIKLAKKDEERYRNLLEKGLVAKRKYEEVHTNLE
VLEKQKLAIEKNISELKVSMEKSKKSVEYAKTQKSITEELQNQINAISSQIESLLKKKQD
LENQLQYTELKAPFNGVVAKKFVSIGDVVKAGQPVYAILKSDSFYVKVLLEETKLEGVKV
GNKAYIKLDAYPDKTFEGVVESIDVASAAKFALVPRDISAGEFTKLAQRIPVKIRITKGD
ISLLRVGLGGEVEIEKSR
>fig|204669.6.peg.497 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MEYVSYSIVIPAYNESDRIQESLTKIVAFLAEQSWTAEVLVVNDGSRDNTAEVVKRFAAQ
HRFIRLIENPGNRGKGYSVRNGMLQAVGDVVLFTDADLSAPITEAPKLFSEIQKGVDVAF
GSRWLVAKMQTERQSIMRQIAGRMYNVIMRIVLGLNFKDTQCGFKAFNRKALETIFTRQH
VERWGFDVELLFLARKFKLKIEEVPVEWAHDDRSKINPLVDGIKMFGEMLSIRWNSIVGR
YTNPHLPKPVVTDATPVVKIAK
>fig|204669.6.peg.594 Multiple antibiotic resistance MarC-related protein
MAADAGVADFDVFDALAPFNSHFLPFGLAVLTRGRFLCEDRSVGTIVFQVGHIMRGAFEA
HIVQFTLVALSSVFFLVDPFAIIPTFLVMTARHDPITRRRMAARACWTAFIVLTAFAFAG
TAIFKIFGITLPAFEIAGGLILLLIGLDMMQAERPTQEGSPETAEGSVKDDVSITPLGIP
MLAGPGAISTVMVLNGTARDWSTTIPVFAAIALTCFASYWILRGAERVSQKMGQTGIRVL
MRIMGLLLMAIAIQFMINGLTNLGVIHAD
>fig|204669.6.peg.1047 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MRVTGFGGLFFKSPDPEKLYQWYETHLGIKRSEWGVSFKWADDPHAADGQTAWSIFKSDT
KYFNPSQASFMMNFRVEGLKDMLAKMRSEGAQVDEKYEETEYGNFGWVMDPDGNRVELWE
PKD
>fig|204669.6.peg.1425 Permease of the drug/metabolite transporter (DMT) superfamily
MSRSLKAHILLIAVTFVWGSTFVLIKAALADVTPLLFNAVRMTLAGLALGLVYWKALRKM
NRAEFIDGMLVALMMYFGYEFQTSGLKLTTPSKSALLTGMSVVLVPLILHFGWRKHVSKW
TIFGVLIACVGLFLLTVPAGTSRGFSLTEMNLGDLLSMGCAVCFAFQIILVGRASERHGF
EPIAFLQVAGAAVLMFATVPIAEHAHVTWSSTVIWAILVTGLLGTAAAFTVQAWAQQFMP
ATNTALIFLLEPVFAWATSFVILHERLNSRSSLGAVLILVGVVLSELLGSQDHPSEEIRV
S
>fig|204669.6.peg.1465 Multidrug resistance protein B
MSSAAVQQQEASATSPWLIAIAVMLATFMEVLDTSIASVALPHIAGSLSATNDEATWVLT
SYLVANAIILPASTWFALRFGRKRFLIICIAIFTVSSFACGAATSLWMILAARAIQGAGG
GALQPLSQAILLESFPPQKRGLAMAVFALGVVVAPVLGPTFGGWLTDTYSWRWAFYINIP
IGILAVFMILRYVVDPPYIKNAKPGRIDAIGLGLLAVWLGALQIILDKGQEVDWWSATWL
RWATLVLLVTFIAFLWWQFTAEKPLVNLRVFTHRNFTLGCIMIGLFGAVIYGMVTLLPLF
YQELMGYTALNAGIAVSPRGVGAIVAMPIIGILTSRIDNRWLIAFGFALFGICSIWFGEV
YLGIGPWTFIWAIILSGFASGCVFVPLSTTTMAGLRNEEIGNASGLYNLLRNIGGSIGIS
IVNMIVARHSQTHRNDLVHNISAQNPNFHNQFGAIANGLKDAGSGGNGAPLWDSTTRAWG
VVNGMVERQARLWSYVDDFRYLALVCFACVPLVFMLKKAVAKKGAVGAAH
>fig|204669.6.peg.2304 Permeases of the drug/metabolite transporter (DMT) superfamily
MSFKRYLILLGVIVFGALGDCFLSRGMKELGSISLGNWHMAFQIFGNPWVVSGVICLLCY
FASYLTSLSWADLTYVLPASAVGYILIALIAKFFLHEQVSFVRWLGILLIVAGVCFVASG
SHVTPRESETPAEAVEVRG
>fig|204669.6.peg.2305 Permeases of the drug/metabolite transporter (DMT) superfamily
MKNVYTWSFIFAVVFASTAGDILQSHAMKKIGDVGKLRRERGIPYVILRVVTSPSFMLGL
MFMAIAFYSLVIALSWGDVSLVVPASASMTFITNAFAAKVFLKEDVDKKRLVAAVLVAAG
VALLAY
>fig|204669.6.peg.2625 Permease of the drug/metabolite transporter (DMT) superfamily
MTSEHSSHPLRGYLYVAAATLCWGISASLGRAAFTGKLLGGLRPIDPLILAQARTTIAFF
LVTPILWTLRGRSSTKLPRREMLQAFLLGVFGLAFSNYAYYLAIQKTTVATAIILQYVAP
VWVLLYMVFTRQQRATASRVWGVVLAVLGCVFAIGVFAGVGHFPFLAIAAGRIKLNTVGV
LAAQVAAVSFAFYSIYGRHLLQVYDRWAVLTNSLLGAALFWIIVNPPWKIIAAHYAPKQY
AFMVLFSITSAAVPFSLYFAGLHHLDATRVIVTAALEPVFSVVIAAIFLGETVTLVQMAG
MAVVLSAISFVQRSDGTAPAIVVDPIE
>fig|204669.6.peg.3097 Multidrug resistance protein B
MEVWVSATTAPPGVLATEAGGVREINPWWVTAAVMMAVFMEVLDTTIVNVSLPHIAGNLS
ASVDESTWVLTSYLVANAIILPMTGWLANHFGRKRILMSSIIGFTLASVACGMAPNLSSL
IFFRVVQGATGGGLQPLSQAIMLEAFPGKKRGKAMAIWALGIVVAPMLGPMLGGWITDSY
SWRWIFYINLPVGLLATMMSQWFIFDPPYIKRSSDVVDYWGIGFLIVGIGSLQVMLDKGQ
EDDWFGSHFITTLAVLTVVGLILFIMRELMAEHPIVDLRVFRVRTYATGVFLMTILGFVL
YGSTVLIPIWLQTLMGYSSLEAGFAVLPRGLGSFLFMPLVGVLMGFVEPRKLLATGLITA
GGSLYFLSLLNTQAGYWDFFWPQLIQGAAMGLLFVPLTTITNDPIAPENMGNATSIFNLM
RNIGGSIGIAMTTTIVARSQQLHYNNLVHNMSSYNPKVQQMMAGARGMFMSKGMDAHSAG
LQAYHSLWGMVMQQAMMLSFIRAFQILSGLFFICLPLILLMRKPKHNEKGGGGMAH
>fig|204669.6.peg.3099 Outer membrane component of tripartite multidrug resistance system
MSFSVNPKSCFWKLTKRLNLALIAFICLGIAVSANSQAPGGGLTASPAESPAAQSPSQSL
SGSPLSGSVVVLKPTGDVLNLSIKDAIQMGLKYNLGVLLSTEGNEAARGAKIRALAELLP
NLSARVGGAVQQVSLAQFGFPATLTGGKLVIGPFAYFDARTYLTQSVFNYTALQNNHAAD
ENLKAANLDYRNTRDLVVLVSGASYLQAVAATSRVDAAQAEFTTAKATYDRAVNLHTAGV
IPAIDVLRAQVQMQSQQQRLLAAKNDFERSKLSLARVIGLPTAQQFALSDKIPYAPLPPV
SFDDELKRAYDNRSDYKAAQARVKAAEDQRKAAVGERIPTVAINGDYGVIGPHFTQANGT
FTAAGGINIPIFQGGRARGDITQADALLKQRNSELENLRGQIEYDLRTAFLDVQTAAEQI
DVAGSTVKLAHDQLEQSQDRFSAGVADNLEVIQAQQAVAVANENYISSLYAHNFAKLSLV
RAVGVAETAVMNFLGGK
>fig|204669.6.peg.3678 Permease of the drug/metabolite transporter (DMT) superfamily
MSSSAETAVTTSVSTGKPQRAALAFSFLSTWIIWGSTYLAIRYAVETIPPLVTAGVRHFT
AGSVLFAYCYFRGFRPTAKHWKGAFLIGAFYFLGGHGTLHWAEQRVSSGLAAVLIATEPL
FIAAIMIFTGKERFSYWTLLGMLCGISGVAYLMGGEALHAPGQMVGILAVLAGSLSWGIG
VCISPNAGLPEDPVASAGMTMFCGSLLLLTTAGVTGEIAAFHPHQVAMRSVLGLLFLIVF
GSIVAFSAYVWLLGQVSPTMVSTHTFVNPAVAVLLGWAMAGEALTARLLVATLAILGSIA
FIRRGTRAAAH
>fig|204669.6.peg.3977 Permease of the drug/metabolite transporter (DMT) superfamily
MTEVQSRHRLQVILAFGLVYVFWGSTYLAIGIADDEKIPAAAICAMRFLIAGTLMLGACA
LMRKKIRVSWEEFGRLAMVGFLLLVCGNTGLTWAEKYVATGFASLIVAITPIWIFCLESF
VYKGDKTSGRGIIGLALGVVGTGVLFWPKLMNPEIRGGMQLLGAVSLLGSSFCWANGTVL
SRRWKSKFTVDPITATAYEMIVAGTVNLCISLALRQHNIRWTHRGVGAILYLVVFGSWVG
FTAYIWLLKHVPTPKVATYAYVNPIVAVFLGWAVLHETIDRYIVAGSVVIVAAVAMVTIA
KVKSAPAVQMVEVETTGD
>fig|204669.6.peg.4464 Permease of the drug/metabolite transporter (DMT) superfamily
MNLSTQTSVNTAPTRGSAGALAITALVLSGCCWGTGFLFGKIALEQMSVTENVAWRFIFG
SLGLLPIIFLRWQPYTRRDWVSLLIASFVGVPIQFLIQFKGLQLTTVSHASLMIGTLPIM
LAMSSVIFLGERLHWQEWFSLAIATFGAVLIALSHGNGVGSPQASVVGDVLVVLSLLAAV
VMVMITKKLIGRHDSLHVTSMMIVLGTLMLIPWAVLTHPMRFDFSTSTWIGVAAQGFIAT
SGAYLLWNWGLAKVPASRAGVFLNMEPLVGALLGVTVLHEHLGWPALLGGAMVVGAAIHF
SKTS
>fig|204773.3.peg.212 Multidrug resistance ABC transporter ATP-binding and permease protein
MLTATIPRQKHKPFENFSPMRRSSASSEPAPLSSGNRNDWATLKTLIPYLWTYKWRVALA
LLFLIAAKFANVGVPLVLKRLIDGLTIDPASPHALLVLPVGILFAYGALRLSTTLFTELR
EYTFAKVTQRAVRTIALQVFRHLHALSLRFHLNRQTGGMTRDIERGTRGISSLVSYTLFS
ILPTLVEITLVLGYLVLHYDIWFSIITAVALVSYIAFTVVVTEWRTHFRRTMNDLDSKAN
TKAIDSLINYETVKYFGNEDYEAKRYDEGLKRYETAAVKSQTSLSVLNTGQSSIIAVAVT
LILWRATQGVISGTMTLGDLVLVNAFMIQLYIPLNFLGVIYREIKQSLADMERLFSLLDQ
HREIADKPNTQALVVQGAEVKFSHVGFSYEAKRQILFDVDFTIAAGTTTAVVGHSGSGKS
TLSRLLFRFYDVNEGAILIDGQDVRDVTQASLRNAIGIVPQDTVLFNDTIEYNIAYGKPG
ASKDDIVAAAKSAYIHDFIESLPDGYATMVGERGLKLSGGEKQRVAIARTLLKHPAILIF
DEATSALDSKAEQAIQAQLKEIAKDRTTMVIAHRLSTIVDAAQILVLDHGRIVERGTHAQ
LLAADGAYAQMWARQQARQDESPASPTDDDAVAESLLHELHTDMLPDA
>fig|204773.3.peg.368 Probable drug resistance transport protein
MSLALENVNVILAGNPVLRDISMHIEPGELVCLVGRNGAGKSTTFRSIMGFQPLKSGAIK
WKRSAINGMQTHKIVELGLGYTPEGSDVFGDLTVEDNIALPTWTRKSGRSAQERIDEAYA
VFPKLKQYLHRGGQQLSGGERKMVSIARALALDPELLLLDEAFEGLSPAIIPTISEGLQS
ILKQGRGVLLAESNFYHLPPFADRLYVIERGEIVFEGTLAQAEADAATMKIIKGA
>fig|204773.3.peg.369 Probable drug resistance transport protein
MSTNDVLLQAQQISRHYGDFIALHNVDLSVSRGEFVSVVGPNGAGKTTLVNVLTGLHQPT
TGNVHFNGSNIAGVGAVDLATRGLARAFQLTSIFPELTVRETIAVSACSYLNMRWNGFGS
LFGSRKVNDIVVRTADAFGLAPWLDTKGSSLPHGRRKLLDVASAFALHPKVMLLDEPTAG
VSTADKHGVMETLLRAAKHMGIEAIMLVEHDMDLVSRYSTRIIAMQAGKKIADLPRDEFF
ANEEIISIVVGKGAH
>fig|204773.3.peg.990 Glyoxalase/bleomycin resistance protein/dioxygenase
MQPRISVITLGVDDLEKSLQFYRDGLGLQTQGIIGKEFEYGAVVFFDLQAGLKLALWPRK
SMTHDSGIAVAPVSATEFTIGHNVSSKDEVDAVMLQAQDAGAIIVKQAQTTFWGGYAGYF
QDPDRHLWEVVWNPAWAAPD
>fig|204773.3.peg.1367 Permeases of the drug/metabolite transporter (DMT) superfamily
MTQKITPSTALLLTIAPLMWAGNAIVGRSINALVPPLTLNFFRWSIAAIILLPFASWIFR
RNSALWTHWRRFALLGLLGVGLYNSLQYLALKTSSPINVTLVAASMPVWMLMIGSMFFGV
RVSAKQALGAVMSIAGVLLVLSRGELQQLLALRLVPGDILMILAAIIWSFYSWLLTLPKD
PAQIRANWIAFLLAQVAFGAVWSGAFSAAEWTFADPHIVWGWSLIAALIFVAIGPAIIAL
RCWGLGVQRVGPTVAGFFSNLTPLFAALMSAAFLGETPHLYHGLAFLLIVGGIVVSSRH
>fig|204773.3.peg.1378 Multiple antibiotic resistance (MarC)-related protein
MLILFFKAAILIPITLVPILNPFGNAAIFASLAGDIDRDAEKRLARQVAINCFVMLLGTM
FIGSHVLMFFGISLPIVRIGGGILVAATGWRLLNDKGQDDIRTQVASKPREVWSEDDFKV
RSFYPISFPLTVGPGTIAASITLGASAPSRLSNLFVSIGSAALGAAMTALVIFLCYRYAN
KMVRLLGRLGTMVVLRLSAFILLCIGIEIFWQGMLGLLAEAGITLH
>fig|204773.3.peg.2545 Multidrug resistance transporter, Bcr/CflA family
MPDTPKPSIRPAATVAIASSALAIMLAALSMLGPFSIDTYLPAFPNIQTSLGASALEVQQ
TLTAYLFSFAVMILWHGALSDAFGRRNIILVSLAVFAVATLGCAAAHSIEYLWAFRMLQG
ISAGAGVVIGRAIIRDLYAGAEAEKLLSLVTMIFSIAPAIAPMLGGWIVKRMDWRAIFLA
LFAYAVLLLLYCYKRLPESLPPEKRHPFNPQFLYQSYKRVFRSPLFHLKAGAVAFNFAGM
FLYVAAAPVFLVEHLGLGPDQFGWQFVPTVAGIFCGALSANRLAGNIPLDRQVLIGFALL
VGASVFNVVYHALYPPMLPWSVAPLFFYTFGMSMVAPGVTLMVLDLFPHIRGIVASCQSF
VLMLLGALVAGIIAPVLSHSPVSLAAGQLLCAAIALSLWLGGRSYRRALDMRKKANAWET
VE
>fig|204773.3.peg.2962 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MLKMGMSAPAIQQAMSNGMRSVYWLALTSPLIWGGMVCFGASAGLWLLVLGKLEVSMAYP
LISLGVVLTTLAGIFILGESVSIYKVLGVSLVIAGVLVLSVKS
>fig|205914.5.peg.27 Tetracycline resistance protein tetA(P), putative
MRHYEKIITSCVSTSATRMLIGAVSTIYMLVSGINLYEVGLIKSTQAILIFVLGFAVGIL
SDRIERKWLHITALIFSTFWLYFFYLAGLYKSFNLFLLAEILNAISLCVYQNNTNAYLVD
QFYHEQPKGELSLALGKLGKWEFSLMAFSALLGGVLYSTLSENLFLLTTIIMSTVTVASF
ILLPKVSRRATHKTLPFIQKQDFLILIRKFSRYKQAIFLFVVLSLYFQIIIQYWQAVVYA
INKSEQNGLILGGMLFSMFMVQSWAGKAIEVKYPFSRLTLALSFLSSMVLSFFAERWQSV
FFYTIAICLALFVVRYTVIQTDTELHRHLLSRFRAKYDMLLNSLVRILTAVVLLIIGYIS
NLYGIQAIQIIGLIIAIIFTLFALITSQNVK
>fig|205914.5.peg.1331 Permeases of the drug/metabolite transporter (DMT) superfamily
MEHSMLTEQSKKHTALLSFLPVLLLIAIDFFTMSLQAQAKAISHLSLAVLVTQLLCILVF
AKGEICNGQRFRLVKVNLYFLIYWGVWLFISLFSNYHYVLTDIVCLCGIALTLAIWQQPQ
DLQMRKSLLVLGTLVGVLGIVTYCLMFIDLPLLYFSQYNPVAQALLGIILANLLLVIAKN
RLQGFIILLPFLMLITLLLNAIIVLGILFFAISQQVVFSNEFSWGLYFILHLVITCIIAI
HLFYKWKFEYYVLLIMSFIVMSFPLWVSFAYVF
>fig|205921.3.peg.1069 Multidrug resistance protein B
MTKKGWRIMPAIITTAILGFSGILIETSMNVTFPLLMKEFGVNPAVIQWVTTGNLLAVAV
TVPLSAFMIKNLSERQIFTLANVLFLSGVLIDSFAPNLPILLVGRVLQGVGTGLALPLLF
HIILTQIPMERRGLMMGVAAMVTLLAPAVGPTYGGVISGMLGWKMIFMLLAPILIISTFI
GLASIPKRQVRINDKLNFPAFVSLGIGLATLLLAIEKMSIFYLLVAIVSFVIFYYLNKQL
EFLNLNVFKDKDFSILLYGVLAFQMIPLALSFLLPNLLQLVLHQTSTKAGLFMFPGAIAV
VFLSPFAGYLLDKIGAFKPIMIGISLSLIGLIGTAIFIPAKSVVVLLAFDILTKIGMGIG
ASNMVTTALTKLKPAQSADGNSILNTLQQFAGAFATAVASQIFTIGQVAIPKNGAIIGSQ
FAVLFVIVVVILAIVGLTYLRKRKAI
>fig|205921.3.peg.1249 Multiple antibiotic resistance protein MarC
MISKFILAFMAFFAIMNPISNLPAFMALVADDDQKISRRIAAKGVLLAFVIIVIFVLSGH
LLFNLFGITLAALKISGGILVGIIGYKMINGIHSPTNKNLEEHKDDPMNVAVSPLAMPLL
AGPGTIATAMGLSSGGLSGKLITILAFAILCVIMYVILISANEITKFLGKNAMTIITKMM
GLILMTIGIEMLITGIKIGFHLT
>fig|205922.3.peg.264 Tabtoxin resistance protein
MNPAQLRRVNAESFAHYRQGLIELLLDAVGYGASVGFMADLDATQARAYFDEVQDNLNKG
NVLLWVVVKDEQVQASVQLGLCQKANGLNRAEVQKLLVREHARRRGLGQQLMQALEQTAR
QYKRGMLYLDTEAGSPAEDFYKALGYTRAGEIPDYACDPNGTYRPTALYYKVLQGAN
>fig|205922.3.peg.643 Bicyclomycin resistance protein
MNPSLILLITCSTVFLAQLGMSIYLPALPQIAKHLQVDATQVAWGLSLYLIGMALPMLLW
GSLAQRIGRKPVLLAALGIYGLANLALPLGATLESFLLLRLLQGIGASGISVMARVLIRD
SFRGDLLAKALSWISISFVVALGIGQYAGSLIQVTLGWQAIFYLLGAVSLLMAAIVSRLS
FPKLVEAPTTASPWEVYRTILIHRAFLLPALAGGLGYGVIIAFNSAAPLILQGPFNWSAT
AYGLLGWPISAAYFLGALAVNRFVLRTGQHRLMTLGVSLVMAGTGVMLAGSLLASSMAWL
LWLPYCVAVFGQSLNYPISLSRANDGAPIAGAYAMALSGFIHQLMAALIGAVASLLASPQ
AWPLSMLCCVLAFGAVLCTRLTPDHQPA
>fig|205922.3.peg.789 Melittin resistance protein PqaB
MSRAASSLLLLAALLFFFALGSHQLQGSTEARVAGIAMEMHLDNDWVTPRLFGEPFLEKP
PLSLWLDAGALRVFGVSPWAVRLASAVAGLLSVMLLYAMLRRFERPKAIAWTAGILLATM
ASYWSNVRGVGEDALLALGVTTALLAFFQAQRASNPGNSLLFVVGIAIATLSKGVLGLAM
PGVVIFAFLLADNLMDKRFKLTDWLRPGLLTLVGLIPLMIWLAVLYQRGGVQAVSEVLLT
NSVGRFSGSFVEAGHYEPFYYYLAKLPQAFLPWNILVYLGLWHFRKELKANRYLLFFSLW
IIAQFILLTLASSKRTVYLMSMTPAAAVIAAEYAGVLFDRLKDHRNGFVGRIARHRQTVA
AGILAVVIASYLGAAQWALPNADKHLSFLPLTEHIQALQASGNQVALFQANERVGGASVF
YTQSVLKGLDTDAQLREFLSASPSNIAVISGDSEPAAPLKVHKTMMVGRQAYYFVGY
>fig|205922.3.peg.1000 Inner membrane component of tripartite multidrug resistance system
MAYRSKVALVYLLGFALDLLNMFAASIAYPDIAAQLRASVTQLAWITNAYMLGLTLIIPM
SVWLAAKVGERRLILGSLLVFGIASGLIAQASSIESLIGWRLLQGLGGGLLLPVGQALAY
REFPATQRAHFTGVVLLVALMVPALSPAAGGLIVEALSWRWIFLLNMPVALFAFGLGLRW
LKADQAASERPKLDARGLLLAVAALSLLLMAVSLASAPATRHLAGGVLLLSVITLWIYLR
DGWNKPGAVLDLQLIKNPSLRLAMLIYLFVPGIFTGTNMIAVLYLHDLGFGAAQTGALML
AWAAASGVAIMLGKRSFNRIGPKPLLIAGMLLQCLGIVVLMQIDQPASGPLILAYALMGL
GGSLCSVTAQTLAFVGITPEKMGHSSALWNINRQLGFCLGAALLSSLLDALGANGFKYCF
LAAALLTLLPMAAVLRFDSTKVLALLRSTHLQEKST
>fig|205922.3.peg.2452 Vancomycin B-type resistance protein VanW
MRRPFKFKEDNGPRRSPRMKPLSLYHPTLYWLRVWQKRLFRHIAWHCSSKRYARPATTSE
RLPYRYLKHTSKLIRKLGESDLALQHNKVINLKLAVAAIDGVTIAPGEYFSFCRLVGRPT
RERGYVEGMELSFGEARTGIGGGICQLSNLIHWMAIHSPLVVIERANHSFDPFPDDGRVL
PFGSGAAIFYNYIDLVLHNPTDRSFQLKLKVGETQLEGELLCDRERAYRYHVFEVGHRFV
REGERVYRENEIWREVREKGQVGALVERERLYGNRVVVKYEVLEGMIEGG
>fig|205922.3.peg.2749 Permease of the drug/metabolite transporter (DMT) superfamily
MSCHEPVRPAASDMPVYLNLALVTMIWGGTWVAGRFLAGSLSPVFAASLRFLLASVALLG
FLRLARIALARPTPRQWLQLALLGFFGIFFYNLCFFYGLRYINASRASLIVALNPAVIGL
ASWLLFKERLSRLKVIGIVICIGGAGVVIVSRHPQLLSETPDAWIGDLLILGCVLSWGVY
SLFSRSLNQSIGPVQTVTFSILLGTLMLWALALSRGEVDVAALAALGSRQWLSLAYLGVL
GSALAYIGYYDGIRKIGATRSGVFIALNPLTAVLAGAILLGEQLTLAMCLGGALILTGIW
LCNKPLAPAGKKRIL
>fig|205922.3.peg.2816 Acriflavin resistance plasma membrane protein
MNLSGPFIKRPVATMLLSLAIMLLGGVSFGLLPVSPLPQMDFPVIVVQASLPGASPEVMA
STVATPLERSFGAIAGVNTMSSRSSQGSTRVILQFDLDRDINGAAREVQAAINASRNLLP
SGMRSMPTYKKVNPSQAPIMVLSLTSDVLEKGQLYDLASTILSQSLSQVQGVGEVQIGGS
SLPAVRIELEPQALNQYGVALDDVRKTIAEANVRRPKGSVEDDQRLWQIQANDQLEKAKD
YESLIIHYNGGAALRLKDVAKVSDGVEDRYNSGFFNDDAAVLLVINRQAGANIIETVNEI
KAQLPALQAVLPASVKLNLAMDRSPVIKATLHEAEMTLLIAVALVILVVFLFLGNFRASL
IPTLAVPVSLVGTFAVMYLYGFSLNNLSLMALILATGLVVDDAIVVLENISRHIDEGVKP
MKAAYLGAKEVGFTLLSMNVSLVAVFLSILFMGGIIESLFREFSITLAAAIVVSLLVSLT
LTPMLCARWLKPHKPGEENRLQRWSRRTNDWMVGKYATSLDWVLRHRRLTLLSLIITVGV
NVALYVVVPKTFMPQQDTGQLIGFVRGDDGLSFSVMQPKMETFRRAVLKDAAVESVAGFI
GGTNGTNNAFMLVRLKPIKERNISAQKVIERLRKEMPKVAGAQLMLMADQDLQFGGGREQ
TTSQYSYILQSGDLGELREWYPKVVTALRALPELTAIDAREGAGAQQVTLIVDRDQAKRL
GVDMEMVTAVLNNAYSQRQISTIYDSLNQYQVVMEVNPKYAQDPVTLKQVQVITADGARI
PLSTFAHYENSLEDDRVSHEGQFASESISFDMAEGVTVEQGSAAIERAIARLGLPEDVIV
KMAGTADAFAATQKSQPFMILGALLAVYLVLGVLYESYIHPLTILSTLPSAGVGALLSIY
VLGGEFSLISLLGLFLLIGVVKKNAILMIDLALQLERHQGMAPLESIRSACLQRLRPILM
TTLAAILGALPLLLGRAEGAEMRQPLGLTIIGGLIFSQVLTLYTTPVVYLYLDKLRHRFN
KWRGVRTDAALETPL
>fig|205922.3.peg.3184 Multidrug resistance efflux pump
MKTLLTRLTTLAVVLLAIVLGWFAWEHYTRAPWTRDARVRADVVTLSADVSGRIVTLAVQ
DNQHVDKGQLLLEIDPARYSLAVEHAKRSVEVSKATLGQSQAAIVASEALLKQRQSEERR
RRTLKQGFAISGEEWEKSSTDVAVAQADLLRNQANLGLAEANVQLAIAALTQAELDLQRT
RVEAPVSGYVTNLLTRQGDYAVAGSALLALVDSSSFYVSGYFEETKLPRIEEGDRVRIEL
MSGEKFGGTVQSIAFAIADRENAPGSRLLANINPSYTWVKLAQRVPVRIGIDPDYSGKDR
LRAGTTATVTVLENPERQAQKSPATE
>fig|205922.3.peg.3467 Membrane fusion component of tripartite multidrug resistance system
MTSMPTVEPDLAVPVSAPKPPLLKRLLLPTAGLAALVLAGLYAVHWWGTGRFLEETDDAY
IGGDVTVIGPKVAGYIEEVLVSDNQKVKAGDVLIRLDARDYRANLAKAEGAVAAEEALLA
NLDATEQLQQAVIGQARAGIDAASAETARSRDDNARYKRLVTTNAVSVESAQRADATFKT
AQALSAKAQAELLAAQRQLTVIETQKQQARAALQQARAERDLAQLNLGYTELRAPVDGVI
GNRRARVGAYAQAGSQQLSVVPASGLWVDANFKEDQLARMKPGQRVSIRADVLSGQEFHG
RLDSLAPASGSQFSVLPPENATGNFTKIVQRVPVRILLDPADGVLGHLRPGLSVTAEVDT
RAQPETTAVASAP
>fig|205922.3.peg.3468 Multidrug resistance protein B
MSTALTAAAQPFNAAEMATATKVFAFATMCIGMFIALLDIQIVSASLRDIGGGLSAGTDE
TAWVQTSYLIAEIIVIPLSGWLSRVFSTRWLFCASAVGFTLASLLCGIAWNIQSMIAFRA
LQGFLGGSMIPLVFTTAFFFFTGKQRVIAAATIGAVASLAPTLGPVIGGWITDISSWHWL
FYINLVPGIFVAVAVPMLVKIDQPELSLLKGADYLSMVFLALFLGCLEYTLEEGPRWNWF
SDQTILTTAWISGLAGLAFVGRTLHVANPIVDLRALKDRNFALGCFFSFVTGIGLFATIY
LTPLFLGRVRGYGALDIGLAVFSTGVFQIMAIPLYAFLANRIDLRWIMMAGLALFALSMW
EFSPINHDWGAGELLLPQALRGIAQQLAVPPAVTLTLGGLAPARLRHASGLFNLMRNLGG
AIGIAACATILNDRTNLHFTRLAEHLNSSNEAVNQWLAQVGGNFAALGQSGDVGLTASLR
QLWLLTYREAQTQTYGDTFLMIMVCFGIATAMVPLMRKVQPPAAPSADAH
>fig|205922.3.peg.3993 Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase (EC 2.4.2.43) @ Melittin resistance protein PqaB @ Polymyxin resistance protein PmrK
MTSENNPLRHTALFPSTTAVERWAIPGLILAFVMFYLLPLMSHGLWIPDETRYGQISQEM
LLSGNWVAPHFMGIRYFEKPIAGYWMIAIGQAIFGDNLFGVRIASALSTGVSVWLTYLLA
RRLWNNPRINAASALLYMSFGLIAGQAGYANLDPQFTLWVNLSMVAVWFAIDNRTPRARL
GGWALLGVACGMGLMTKGFLALLLPVLIALPYMLWQRRFGELVRYGLVAVVVCALVSLPW
VLAVHYREPDFWRFFFWHEHIRRFAAGDDAQHARPWWFYLPLLFASTLPWALLLPSTLLR
MWREKREAKMAYLALWFLLPLAFFSLSSGKLPTYIMPCLLPVALLMGQTVVKWLDQRSGR
FLRLNGVFNTVLASVALVALLYLQATKEIYENTEMFSLSLAYIVVVGWIIANALQVLRPL
TLWAMPALGIGLLVALLPAAMPAQIVNSKMPDQFIAEHQRELSETASLLSNDLGAASALA
WRLKRPQVDLFNTIGELKYGLEDPAMEARKVTMDGVGQWMTEARKKGAVGVVLRVNSTQE
EQEVELLPVDGKHYRRGNLHIFIFAQKQP
>fig|205922.3.peg.4073 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MSLWLLLLACLLTCLGQVAQKCAVENWRGADLSWSRKWRSPWLWLALFALGSGLLVWLLV
LQRLPVSVAYPMLSLNFVIITLIARFVFKEPVDVQHWFGVLLVIGGVALLGQQS
>fig|205922.3.peg.4074 Polymyxin resistance protein PmrM
MNRRRGILFALASVLLVSVAQLSMRWSMTRLPRPDQWLSVPSVDSVALAVVLAAIFAYAL
SMLCWLAALRDLPLGRAYSLLSISYALVYLLAASLPLFNESFSFSKSLGVALVMLGVITI
NTRPARAPELRSSP
>fig|205922.3.peg.4076 Melittin resistance protein PqaB
MIKLSCTIRRQSLIAGLLAFVLFIAGVYGQAPIGFDSRFVLFAQEMLRHGPSVFPTTYGE
PYADYSALSTLFIWLLSLPFGTVNSLTAWLPSAVAGAVIVTLMYRLLAPSSVRWAIVSIA
LLMLTSTFITETRAVSQDLMLAAVAFSVFYLGYAHDHFAAGRRWPLVFILLLLGFGIRGP
IGLVVPTGMLCSYYLLDRQWSRLLLFGVLASLLLAACVGLLLWLAEVSGGPAFRQDVIRM
QFMGRMDGSEGVSGSLYYFTSSLGNYALAYPLALLALAAAWLSKPSQRGPALRLVQYCAA
AGLIVMLGLSIPQAKKARYLLPMLPMAAIIAAYPFQVLHGRVFAWLRVGMQGLWLLIPAL
LIVLLWVAQRRFPESLTDLTPVMIVLGLLQLAASSRLWLPRWRTEVLAFSAVLAVWSAYA
LVFEPVERQLYDTRSFSQAAMVRIHEQPAPLVLHGMGKDAKAIKFMVNVEQDLQPLFTET
TQALEALKAPAWLMMDRSDFQALQGTPLGALQPTLSGPFDKNDYVLLWLTP
>fig|205922.3.peg.4086 Multidrug resistance protein B
MIVSLTIVVSRAITSPLLTLFLSKKLGLNQQDVGLLLGIAVFIATLLALYGGYIIDRLEK
RRLLILAMLSSAIGFVLLTFAKDLYLTTATLVITETASALFLIGSKAILSENLPMGQRAK
AFSLRYTLTNIGYATGPMLGVVIAGVYPIAPFLIAAGIAFGSIFLMIGIPKDASPIAAIG
QPQSFLKTLITLKNDRTLIMFTCGCLLSTVVHGRFTLYLSQYLLVVEDSQRALQTMAALL
ACNAIAVILLQYQIGRFLNREKLRYWIAAGTSLFILGLIGFSLADSLVSWCIAMFIFTLG
EMIIYPSEFLFVDTLAPEELRGSYYGAQNLAALGGALSPVICGFLLMHTPAPTMFYALSA
LTAMGGFLCFMSGRRVALLHK
>fig|207559.3.peg.118 Permeases of the drug/metabolite transporter (DMT) superfamily
MSTQSPENRHGSASGTERGKTADTGGCAPALRGSAAQAAGETAHQLDMKALLRVMAGAVM
ISFSAVFVNVLETSPSASAFYRVLFGGMALLAVALWRRERLSTSPLVLATIAGAGVFFML
DLECWHRSILYIGPGLATILGNFQVFFMAFAGAVFFREALSLRLVVALPLAVCGLWLLVG
VDVDNLPEGTVMGVIMGLLTAVWYTGYILLLRRSQRMACRMPVMMNMALVSLCTAAACGV
STLLQGASFAIPDTVNGMYLLGYGVLCQGVGWLLLSSGLPGLPAAVAGLVMLTQPTLSFV
WDVLLFDRPTGPLGVAGAVMAIVAIWMGLSGQNAAQRRRALKLAGRVSTAPEK
>fig|207559.3.peg.341 Permeases of the drug/metabolite transporter (DMT) superfamily
MQNTMSFSLRSPLNGLRFSGASAGYLSALVAAVVMSLTGIIIKHISDEYALPPAQLAFWR
NALVFLTLLPVLTLLRVPVRVHGKADNRLLVAYGFMLASMNLDWTIAVIETGASVATVLS
YCSAAYSGILGWLLLGERMSRSLALAVVICLSGCALVCGVLTPEVWSGMSTLGLVTGFAS
GLLYAGYGMMGRLAACRGEVPYR
>fig|207559.3.peg.446 Acriflavin resistance protein
MKLPEISVRRPVTTVMVFAAITLLGCVAFFRLNLDLLPDIEPPAVSVITPYPGASATDVE
SEVTKYLEDQLSTTPNLDRLESKSKDNIAIVNCIFNWGTDLDVAVNDIREKIDLAKPDLA
DGAEDPFIFKFSSSMVPVLIMTVTAEESSPDLYRIVDKQIADPLKRVPGVGAVVYIGGQE
RQINVHFDREAIDAYHISVQQIRNVLAAENLNLPVGTVKIGRNELQIRVAGRYRDAAEIA
NTVIGSNGDALVRLRDVATVTDAFEEPQEWARSGKLPAIALIIQKQSGTNTVNVIEAIKD
RLKTLKTEVPADIEIHGILDNSDHIYAMINSLTEAAVVGGLLVIVVCFLFLRRFRTSLVV
SMAIPFSIIVAFIGLFVMDYTINVISMMSLAIAVGMVVDDAIVVLENIVRHVDDGKPPQL
AAVEGTSEVGMAVAASTLTIVAVFAPLLLVKGIAGIIFGQLAFMILITILASLFISLTLT
PMAASRLLRSRDQRKLNPVFVWSERLLNGIEAGYSHVLGWGLRHRNILLSLIVIVFIGSL
ALIPLVGTEFFPEVDSGEVEVVLEMAQGTRVEVTAGTTEEMLNAVNAIPEMEASYALAGQ
TKKGFLTALGFEEGTGIGRIGGRLIDKKERSRHAKEVASELREQVIKLPGVENFSASAVS
VIQKAFLGGGRPISIDILGHDIETTDKAAAKIQRIVETTPGAVDVSVSRKRPRPEVRICL
DRDKAASLGLNVALVADALRTNYYGFDDTKFREAGDDFDIELRLKKDQRETIREIGETPI
TTLTGQTIKLRNVASVRETFGPVEIDRKNRTRVTKVQAGVQGRVLGDVVRDVREKMASLD
LPPGVSIEWGGEVEEQRKAFRDLTLLLILGIVLVYMVMAGEFEDFVDPFIIMFSVPFAFA
GVIWAFVATATPLNLMSFIGVIMLMGIVVKNAIVLVDYTKQLRAGGMTLNEAVVTGGKTR
LRPVLMTSLTTIFGMVPLALSRGEGSEIWNALGITVIGGLSVSGLVTLILVPLMYSLVHR
GKAK
>fig|207559.3.peg.967 Acriflavin resistance plasma membrane protein
MKSVVRFTLRQTVLLNLLFVLLMVVGVFATFSLPVERYPNVDMGKVVVVGFLPGASPQEV
EALVTTKIEDALDGLENVEFVRATSYRQRSDVIVKFLDDTDYDAQYDELRFRVLSVQNDL
PDAMDPPQFIKIDMDTWMPVMSVNLVGDRSNRALTLMAEELKIYLERLPGVKEVTIEGEY
TREYHVELDPHRMSRYGVTFDEVAAALAAGNVSVPAGDFSSHGKEYALLVDERFRSRDDI
AGTIIRRDGDGSFVRVGDVMSGAFVSYREPEVIASVNGRDSVAVNVIKLDNGNALDIGKA
VEAVLAEYAPVLEREGVEAVITRDQRSHIDQAMSTLGSNLLLGIVLVCAVIWLFMGFRNA
MVTSVGIPFAFLVTMVLMKLTGNSLNEITLFSFVLVAGIIVDDAVVVVENIYRHVQAGSP
LREAVVNGTAEVALPIVSATATTVAAFLPMLIMTGSTGQFFALIPKAISFALVASLVECL
FILPLHFLDWPGRSRLASGDADHTREKPFMIALRNLAERLLRFSMRFRWLTLGAVLAAFS
VAVFIFGVSMSGVMPLMRIKFFPDNYTTFYISVEAPEATPISETSRVIRGFAQFMDSLGA
GMTRSASGVAGYYLDDDYQTVHGSNLGMVTVELPVTGQQHFADYPRNDPQAHLDDVRSRI
AQHTPAGWRVRVRAEKDGPPVGKDVNVRVLGSDPASVSGLAAAMQTFLEQRADIAPHLMD
LGDDTGQPSYVFRFRPREERTAEYGLDTRTVAGLAGSVLDGRFVGEFRLADEDVDLRLKI
DNVFLERPEDALDVPVLEHSSGPVRLGDLCTVSSYREVGQLNRYQRQRAVTLTANIRPDA
AISPQFVIHAVQEHYRKIENDFPGATLDFSGEFASTQRSFQSLMMAFVLAVLIIYVILAT
QFQSYVQPLIILSAVVFALTGVVFGTFFTRTLFTVNSFVATVGVTGVVVNDSLVLVDFMN
KLYRDGLDRTAAAIEGMRIRLRPILLTTLTTMLGLLPMAVGIPSYSLVWGSMASTFVTGL
CTATFLTLFVVPVQWHLLMGYQEWRSRRFGRAMHE
>fig|207559.3.peg.1510 Permeases of the drug/metabolite transporter (DMT) superfamily
MSYRMILAALAVVHIVWGGGFIVLKVVQEHLALEHILLGRVILASLLYLLLWKRIPSPCY
RKGDWKVLLLLALCEPFLLFTFETLGLRYTSASQGGMIVACVPLTVALGAFAVYREKIGR
RCLAGIVCAVCGVVVVSALATAGDQAPAPLLGNFFIFCAVLASTCYALSVKHLCARYHYM
YLAGVQVFGATVLFVPGALMQPLPPAHVLFSPQVAGSLLYLGLGITFLVYFVINYALTRI
KAAVVIQFANLIPVSTLVFAYIFLGERLSPTQYAGVGLVLAGVLLAGASGSGELNTGKTQ
GEAHAQKACAAEGAAGD
>fig|207559.3.peg.2778 Melittin resistance protein PqaB
MTQTENTPDAGQHDLHSQTVTPDASTEAAPAAPQRTVCERILDILAFQPLIPLTILLALQ
TVFMLDARALWYSDEVRYANVFEHVVNAGKWIVLHLNGVPYPDKPPVYFWLLEGIRQGMQ
AAGIAGDAPQGIGPRLFFSGAAVSALFYIWATYALARRVAAADKRTALGAGLVLLSVFYF
IGVSHYSRMDLLFAALITLSHICLFTGWKKEKSTFWIVCGFAFAALATLTKGPLGLAFPL
VTSVLFLLWRGKPRRLAGADVAAGAGVMLFILLAWVMGAYLTEQPDFLYNIFHDQIYRRA
THTWHHSQPWWHYMATLPAAWMPWTLLLPVLPFGFLLSKKGARAVAASRTPEKEGMAYLW
IAFLNGFAILSAVSIKIIIYLLPLFAPLAVLTAGGILSLSRARAKWLMRLMALLLLALAA
ALVTLQLGQMFGWEWLTKAVRWPLALEGLWILAAVSAAGAAIMWVAAPAAGGAGALLLAV
LFTTVWIQPLGLITAPSMDNVMSPRMQGELIGSYIEKGYTPVTYKVYSGTYTFYAGADLL
ELDEWADVDAAVSAHRKTVVAMRTKHWDTWENKPADMREVSRQWIVDQEYVVAVRETSSP
DQTEVSAGTEVSAQTEVPAESGQTGEHADLPADSATAPVQLPAANATDSTATQQSAITPS
ADMPADDASQADTAAEEGHETSPADAPAQGNATTI
>fig|207559.3.peg.2782 Permeases of the drug/metabolite transporter (DMT) superfamily
MLWFVLALATAFFSAGEAVLFKRFFGDRPPYEMIVWPMAWSLPLFAGYLLLSDAPEVQQG
FWSVMAVMLPLNMAAFLIQTWAIRLSPISLTVPFLSFTPAFMLGTGYVILGEAIPAQGVA
GIACIVAGSWLLNRAPAASGRTCGAGAALLEPFRAVYREKGSMLMLLAAFIWSLTAVLSK
KLALLGTPMYTAAMFFAIHNTLMLLLIFGFTRVSPRCLRERPLAGAALGVCMFGQIVFHY
LAITLVAAAYMIAVKRLNGIISVVFGRLVFGERVTLWRTAGACVMGAGAAMIALAG
>fig|207559.3.peg.3218 Permease of the drug/metabolite transporter (DMT) superfamily
MPQSRSAAAAPFALFIAVTLWGSSFVATKIGLRQLEPLSIVWLRQLVATLAILPFWLPAW
LRHRHAATVRRSDTGLLLLLAFFQPCLYFVCESYALQLTTASQAGVVSAMMPLMVAVVAG
AMLGEQVTRRMWGGFALSVTGVVWLTLASAPEESAPSPMLGNMLELAAMACGVGYTIACR
KLGSTFSPVIITGVQILAGFLFFLPGAFMLPAGFTSMAAQALTTPGSDAAISLFAVGYLG
LFVTLGAFALYNFGVSALSASKASAWINLVPVVSIVLGHLVLGETFSPYQAGGALLVLGG
LYLCQRTPAPPRHGIMQVQKPQRAGALEKE
>fig|207559.3.peg.3718 Permeases of the drug/metabolite transporter (DMT) superfamily
MQSALGYVYVALAALMWAFIGPLAQICFNEGTTPMEVAFWRCLTGALFFMAHAAVTGRWR
AGLRDAPVFTAFGLVGIALFFGSYQISVREGGAALASIMLYTAPAWVALLARICFAEALT
PHRLAALALAMSGTMLVSLSGGAGSGSVTAGVLWGLVAGFSYSLHYVFGKNYLHRYSSVT
LYSYCLPAGALALLPWVTFSQHSALGWFALIMEGFLCTWLAYLAYCAGLKRLAASRAAIV
ANLEPVAAAVLAYWWWNEILPPVGLAGSALVLSGVFVVVREKNTAATA
>fig|207949.3.peg.631 Permease of the drug/metabolite transporter (DMT) superfamily
MSIDSKAKGYVFGLTAVLIWSGFVLASRQGGLSELNHFDVIALRYGTCALLLLPLWWFKY
RFNVFQTKYIAIALVGGLAYALCTFQGFQLAPASHGALLLPGTMPLFIFILAVIVGQIRV
EAIKLFGIVLISSGVALLFTQQLMMDGDNNSVLKGDVLFLLGALCWGVFSILIKHWNIPP
WHAVISLALLTCLVYLPWYVMFSPKNIDVAGANSILLQMFYQGFLATIVQLYFYGRAVAV
LGASGMGSLMALVPVIAGVSAIFVFDEPVTLYLIVGLCVVTIGAWLTQLEKIQWKRKFAS
>fig|207949.3.peg.1214 Permease of the drug/metabolite transporter (DMT) superfamily
MSSVQGVPVKYQLMLIFAMAVWGSTFVAMKLVVTGMPAMVAVFIRMCLAVAAFAVLIKYV
RKGVVYRKGDWRYLVLMALFEPCLYFLFESQALQYTSAGQAGMITSLFPILIAVSAFFAF
GERLYRRQWLGLFIAVVGVIWMTLAGEESDQAPNPLLGNLLELAAMGAAVGYTLLVKHLT
SRYPALFLTAMQACVGVVFFLPFALDSQWPDSIGVDMWLLLIYLGVGATLGAYGLFNYAL
THVDATVAAGYVNLIPAFAVLFSVVFLGDEINLWQWLAIALVFVGVYLSRDSKVDAQAKD
NIPAA
>fig|207949.3.peg.1511 Permease of the drug/metabolite transporter (DMT) superfamily
MNKTAHFWGWVLLFVCFVWGVEFSLVHMSLDSMGAHTFNGIRFLIAFITLAAWFIYSKHG
FWRRLDKWLVIHGVVLGFLLFTGFATQTIGLQYTTASNAGFITGLNVVMVPIIAWLWLRQ
TQHWYVWLGVALATIGTLLLTGGLSGFGEGELWVLICALGFATHIVYISRFAQTIDALSL
TQVQMITVTVLSFLSAFWWEAESLAGVTQVLLSEGSFVPWVALILGGTLGTAFAYLAQTL
GQQSLEAWRVALIYSTEPLFAALGGFVLLDERLAMLAWIGALFIIAGMLIAELVDDDVVE
ELLDEPNADVK
>fig|207949.3.peg.1629 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MARDLTQGSIGRWLYRLTAPMVVGILSIFLFNLVDTYFISLLGTQPLAAVSFTFPINMLV
MNVAIGLSIATGAVVARALGQKNHLQAQSWVTSSLYLTICIGIGIAILGILFHPFIFKLM
GATDELIPIISEYMVWWFSGSTLLMVMIVVNASIRASGNTKLPSLAMMASAGINVILDPI
LIFGLGPIPALGVQGAAIASVLSWLAAFVFMFRYLQQNRLVEYRLPEGLMRLWQKLFTLA
VPAAITNMLGPIANSVLIAWVAGFGTAAVAAFGVGMRIEPLAMIVVMAFTSSLPPFVGQN
HGAGEVDRIGLALRKSLTFILFWQTAVYLLLILLAEPLSRQFSEEKAVQEIIQTFLFIVP
LSYIGVGFTLLTTATINALHKPKISMKIHILRLFVFYLPFAWVGQAFYGLEGLFIGCALG
NVAIGISVLVMIRHVKKSDQWQQRLLTIQS
>fig|207949.3.peg.1671 Permease of the drug/metabolite transporter (DMT) superfamily
MLPVIAVYAAVVLIWSTTPLAIRLSVDSVDFVQGSALRMWISLALCLLLLPLFRLKLSFN
KLAMQRYMASALGICFAMLCVYWSAQTLPSGLIAVLWGLTPILVSLQSRCLIAGTRLDGL
RLLSMAIAVLGLYVIFAQQIALSPTMAVALAVLLLAVNFHSLSAVLLQKLQLKQQSSEDE
RMHPLVQTTGGLLVSAPIYAIVWLLMSGPLPEVMSWTSIGAIAYLSIIGSAVGFIGYFYL
LTKMSAADASLITLMTPVIALFLGTSIANETLSDRTLMGAGIILFALFIYHLKNIRLVLV
RLAQKD
>fig|208964.1.peg.240 Permeases of the drug/metabolite transporter (DMT) superfamily
MNASTSPLPASDQTLRGILLICAAVFLFASHDGLSKFLSGFYPIVMVVWARYLVHTLLMV
AVFVPRNGLAVIRSRRPLMQLARALCLIGTSLFFTTGLRYLPLAEATAVNFLAPLLVTAL
SVPLLKEKVSLGQWLAVLTGFIGVLFIVRPGGALFTPAALFPLGSALCFGLYQLLTRMLA
NSDSPTTSNFLAGIFNTLIMSLLVPFFWQTPSLLHGLMMIALGGCGMGGHLLLTQAFRHA
PPATLAPFSYGQIIFAGLLGLLVFGHVPDAWALLGILVICASGLVVAWRRGR
>fig|208964.1.peg.1239 Outer membrane component of tripartite multidrug resistance system
MPLASHLRCVALALGISTALGCANRNQPAPRAESLDPGLSRVAGTRGDALPAQWWTLYQD
PGLNHLVAAALRHNRDLAAADAHARALLGHLRGAQGERWPRTEVGYGYQYGRDGDDQTLA
EATDEDLHSQWKHTVRLDLSYQLDLWGEVRARIAAAKADAEAAQAARDLLRVSVASQTTL
AYVRACALARRAEVQRRSVGLLDASLALSERQLAAGLSSELQRRRLLALRERTRAALPML
EARRRAALYELALLSGRSPRQLDAPAATCAGIPQLRRALPTGDGWSLLARRPDVRAAERR
LAAADARRALAEAELYPRISFAVGAETSAATLAGLGGSGALAYAAGPLLSWRFPNRESAR
GRLDSAAAERDAALARFDGAVLGALREVERALALYAGERQRRADLQRALDEQRHAYRLAR
SNYRAGALDALELLDSQRSLVADRARLVDAEMRVAERQVELFRALGGGWQAASSPSHQEN
GQ
>fig|208964.1.peg.1266 Permeases of the drug/metabolite transporter (DMT) superfamily
MRATTCTPRAMPGATRLLAVQLGMVLAWSSGFVGYRYAMEQAPVFLTSFWRFAVCLALLL
PFAWAGLRRLSARQWRRQALIGALAYAGYIAPIAKAIELGVSPGVAALMADLLPLLVALL
ALVLPGQRTRPGQWPGIALGVAGVLWAGHAALALGRAPGWAYGLPLLGMLALALATLLQK
RWDDAPGSLAVVLFVQIGAALPAFAGLALAEGSLRPPLSGGFLFGLAWLVLLPTFGGYGL
YWLGLRHLSAQGGSAALYLSPALTLLWAHWMFAEPLTPMLLGGLLLSLAGLGWLYRAERR
>fig|208964.1.peg.2101 Permease of the drug/metabolite transporter (DMT) superfamily
MASLVTAVLFLVVCISWGTTWLGIKIAVESVPPLTAAGLRFLIAFPLFLLFARLRHETIF
FPRRLLAFFVFVTLGYFSVPYYLLNYGEQYVASGLTALLFSSMPVFILIFSAIFLRERIY
LSQILGIAIGFGSLFMIIRSQGLHLDYTELLGVLAILLAAIMHALSYVITKRQGADIGVI
TFNTLPIGIAGLGLFMAGLVMEHPNLSAVTSRSWAALIYLGLVASVGGFIVYFFLLKRLS
PVVLSFVFIIFPVFAVIIGAWYEGVAISRELIGFTVLLLAGFAITKLPIEKLLGRR
>fig|208964.1.peg.2628 Permeases of the drug/metabolite transporter (DMT) superfamily
MAMAGSQPQRRNSPTQGAAMLALSALFFALMGGLIREASSTVNNETVVFFRNLVGVLFFL
PLALTRGIGPLRTRRPLSHLLRTTYGLGGMYCYFYALAHLPLTDAMLFSYAAPVFTPLIA
HLWIKEPLTRRMMVATLVGFLGVLLVARPSGAVVAPIALVGIASSLMAACAFVSIREMSD
SEPAYRIVFYFALFGTLFSAVPLAWAWQPLNGQELLLLLGAGLFASLGQLTMSQAYALAS
PGVIGPIAYMAIVFAGVIAWLRWDELPSHTSLLGAALIFAASLIPLLGNRPAERPR
>fig|208964.1.peg.3222 Permeases of the drug/metabolite transporter (DMT) superfamily
MNRRSALAALHGGALLFGLTGVFGKLASASPGVIVFGRALFAVLALGLFARLAGQAWRAL
GPAQWLRLALCGLLLAGHWVSFFIAVKTAGVAIATLGFASFPAFTVILEGLLFRERIHLA
EGLLVVLVSLGLVLVTPNFDLASGATLGLLWAILSGLLFALLSLANRSNSGQVGPVQAAL
WQNLVVALCLLPFAVSELPALPALDWLWLALLGVFCTGLAHSLFVASLAVVKARTAALVF
ALEPVYGIAFAWLLFHETPGPRMFLGGALIILAIVLSARLGARGRKTAVGDERGDPERA
>fig|208964.1.peg.3304 Fusaric acid resistance protein fusE
MRASLRVVVTLLVVAAAVLAGIWLWRYYMLSPWTRDARVRADVVVVAPDVSGWVTDLEVK
DNQVVKVGDVLMRIDQERYQANLEQARAVAETRHQQYLLRQNEAARRSRLGIGAISAEDK
ENAQINAAIARSEYQEALAQVKIAELNLKRSELRAARNGQVTNLRLAQGNYATAGQAVMA
LVDQQSFYVVAYFEETKLPGIRVGMRAQVRLMSGDQPIDGTVESISSGITDRNSTPDGQL
LANVEPTFNWVRLAQRIPVRIRLDQVPADVHLSAGMTASVTVQGD
>fig|208964.1.peg.3605 Permease of the drug/metabolite transporter (DMT) superfamily
MADPPRPVERAMRSQALRADVLMLITAMIWGVSFVAQRLGMDAIGPFLYTGLRFVLGALV
LVPLLMLRSRRDGAQPFNRGQLLAGVILGVALTTGINLQQVGLLFTSVTNSGFITGLYVI
VVPLLGLLFGQRTGAGTWLGASLAVLGMALLSIGPGFQVASGDWLQLAGAVVWGAHVLLV
GLFASRYDPIRLAFLQFATCAAVSLLLALVFEEIHWDAIVQAGPALLYGGLLGVGTGFTL
QVVAQKHAIASHAAIILSLEAVFAAIAGALFLAETLHLRGYFGCALMLAGMLVAQLWPRK
LAAEARPA
>fig|208964.1.peg.3893 Outer membrane component of tripartite multidrug resistance system
MVGSFVGFLVVFSAISGCVSTGDIAPEAATLDANALATDHAIQAAAREAGWPQAQWWKVY
ADPQLDAWIEKALDGNPGLAVAHARVRQAKSMAGLVESIESPQIEGKGSLVRHRWPDDYF
YGPGDLARTTSWNNSTEIGLNYKLDLWGRDRSDSERAVDLAHMAAAEARQAQLELEGNIV
RAYVQLSLQYAEMDIAKAMLQQQRDILALAQRRLRGGIGTHFEVSQAEVPLPETERRIEV
IDEEIQLTRNLLAALAGKGPGEGRTIRRPSLNLAAQPSLPSALPAELLGRRPDVVARRWQ
VAALAKGVDVARADFYPNVDLMASVGFSAVGGGMLEFFRSAKYTYSAGPAVTLPIFDGGR
LRSQLGEAAAGYDAAVEQYNQTLVDALKNISDQLIRLHSVDIQKDFAAQSVASAQKTYDI
ATLAYQRGLTDYLNVLNAQTRLFQQQLVQEQVQAARLAAHASLLTALGGGVGAGADTPAQ
RKLAPENVPVRAVSSR
>fig|208964.1.peg.4831 Permeases of the drug/metabolite transporter (DMT) superfamily
MVLDLLKSGVLLAVLASFTFSVMNALVKEASATLPAAEIVFFRSAIGTLLIYLLMRQAGV
ALSRQGVPMLLVRGVMGALYLVCYFYAIAHIPLADASILAHMSPFFVILFSALFLGERIP
RAVYWLLLVVVLGALMIVKPFSYSSYSVYAVVGLLSAVFAAGASVAIRQLSARHHTYEIV
FYFLAVATLVAIPLMWNDFVVPATLREWGLLLAIGVVSLLGQVFLTRAFSHESATIVAVT
RYIGIVFNAGWGWLFWSEVPDALTIAGGVLIVVACIALSRTKKG
>fig|208964.1.peg.5155 Outer membrane component of tripartite multidrug resistance system
MPFPLLHPWPQRLALASAILLAAGCVTSEGLEPNARLQPAGALQAGRSLDGVALSPAAWP
RQDWWTGLGDRQLDQLIGEALQGTPDLQIAEARARQAAATAQAQDAARQPTLDAKASYSG
IRAPTSVAPAPLGGRYSAIKYLSLGFNYDFDLWGGERAAWEAALGQANAARIDSQAARIG
LSASIARAYSDLAHAFTVRDLAEEELKRSQRMTELSQKRMSAGLDSKVQLQQTQTQLATA
RQQLSAAEQDIASARIALAVLLGKGPDRGLELQRPQPLNPASLSLPSVLPAELLGRRADI
VAARWRVEAARRNIDSAKTEFYPNLNLGAMAGLAALHTSDVLQAPSRFFQVAPAISLPIF
DGGRRRANLAERDADYDLAVGQYNKTLVQALGEVSDDLGKLRSLEQQVIDQRQARDIARS
NFDLAMRRYGEGVGSYLDALSVQQQLLVAERQLASLESQQIDLSVQLVQALGGGFQPDSR
SAALATAKAPAE
>fig|208964.1.peg.5483 Multiple antibiotic resistance protein MarC
MDMFGVAVLIFLVTDPFGNIAVFLAALKGVAPGRRLRVAFRELAFALGLLLLFLTLGEHI
LSGLGLSREATGIAGGIILFVIAMRLIFPSPQGLLGEVPDGEPLLVPLATPAVAGPSALA
MLITLRTTFDGPLWELYLAVVLAWAATALILLQAAFLQRFLGPRGLTAIERLAGMLLIML
SVDMLLDNLRSVLHIAA
>fig|209261.1.peg.951 Permease of the drug/metabolite transporter (DMT) superfamily
MRKVSISILFMLVSLTWGTTWLAMRIAVETIPPVFATGMRFMFAAPFLIIIAWLRKKNLL
FPPGQRLFQFVICIFYFSIPFSLMIYGETYVNSGLAAIIFANMPVAVLIASVLFLNEKAK
LMQIAGLTIAITALTGILLEETNTSTESHWQGITALISAVLIHAIIYTQCKKRSCTVSVI
TFNALPCLLAGLILSATGWFFERPQVSTFSVHSILATLYLGAFAGVFGILCYFALQQKAN
AFQASLVFLIFPLIAVSLEDYIYGYAISTHSMLLIIPLAIGIFLTLVARNIPVTSRCRDN
SSQK
>fig|209261.1.peg.1347 Multiple antibiotic resistance protein MarB
MKMLFPALPGLLLIASGYGIAEQTLLPVAQNSRDVMLLPCVGDPPNDLHPVSVNSDKSDE
LGVPYYNDQHL
>fig|211586.9.peg.640 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKDRHGLLSAPIGRVLLNMSLPNLIGIMTILGFSLADTFFISQLGTEALAAISFTFPVTL
IISSIAIGVGAGVSTNLGRLIGSGNAPQAKVFLHDALLLTFILIASLSALGSIFIEPLFS
LLGANETSLPLIHDYMMYWYVGAPLLVLLMVGNQGLRSTGDTRSPAMIMTLAAIINLILD
PLLIFGIGPFPRLEIQGAAIATLFSWLVALSLSGYLLIIKHRMLERAAFDIDRMRANWSK
LAHIAQPAALMNLINPLANAVIMAMLAHIDHSAVAAFGAGTRLESVLLIVVMALSSSLMP
FIAQNLGAGQPQRAKQALLLSLKFILVFQTLLYIPLAFFAQPLASLFSTDPQVLEWLSFY
ILVLPCAYGPLGIVIIFATALNAYHRPMSSLVINLCRLVLLMLPLAALGSYIDGVKGLLL
ALPITNLLMGIACYYLAQRICEPVKATTADTL
>fig|211586.9.peg.1360 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTAISHSATDQRLLQEPIAKLFWRYTIPTIASMLVTGVYVTIDGIFVGHYLGETGLAGMM
LAYPVGAILYAIGAMIGMGSAALVSINLGQGNVAKARKLLGNAFSLCLLAGAFFALVGGV
FSRDILIALGAEGEILENANEYLFWYFALCHFPIISMAFTTLLRNDGRPSMVTFVLILGG
VLNTFLDWLFIVVFPFGLAGAAIATMLSQAVTGLLCLQHFFGARTQLKINLEQMKLKLDN
CINIARVGLPSFLMNLYLSIVLTLHNTAFLWVGGPLHVAAYGVVSYTEAFFYLIFEGIAL
GTQPIYSFNAGAGRFDRVKQARNIAFSMTLLTAALGLVLIYSRPEWLVYLFAGDNPSLTP
VAIEGMRWYFWGLPMEGLILVGASFFQAINCSKQASILTGAKLILIAAIIYCFAWAFGVI
GVWVSLATCSTMLVIWMFIAMQRLKVNA
>fig|211586.9.peg.1724 Acriflavin resistance protein
MNLTRLAIKLPVTTSMFFFAILLFGLASSRLLPLEMFPGIDIPQIVVQVPYKGSTPAEVE
RDITKVLEESLATMGGIDELESESSQEGAEIEINMKWGENVATKSLEAREKIDAVRHLLP
RDVERVFIRQFSTADMPVLTIRISSDRELSGAFDLLDKQLKRPLERVEGVSKVSLYGVEQ
KQIEVRINANRLAASGFSATELQARLARENFVLSAGTLRESNLVYQVSPKGEFRNLEDIK
ALVLVPGLTLGDVADVQFSLPERSEGRHLDQHYAVGLDVFKESGANLVEVSDRVLKVIEQ
AKQDQQFQGIRLFIMEDQASGVKSSLTDLLLSGLVGALLSFIILYLFLRNFKMTMIVVSS
VPISIGMTLAAMYLLGYSLNILSMMGLLLAVGMLIDNAVVVTESVLQEKQGNSVNSNPQD
NENAVMTGVDKVSLAVLAGTLTTAIVFLPNIFGVKVQLTIFLEHVAIAICISLAASLLVA
KTLIPLMLTKFHFDIEPDNTTGKLQNFYNRSLNWVLIRPWRSGLISIAILASTALPISMV
KQDQEDSQSKERIYINYQVEGRHNLNVTEAMVNQMEDYLYKNKEQFHIDTVYSYYAPDDA
SSVILLKKDLPMPLDELKQKIRSGFPKYSIAKPQFGWGDDNSGVRVTLTGRSTSELIHLS
EQVLPLLKNIKGLVDVRSEVNGAQQEVVIRINRQMAARLDLKLNEVASSISMALRGTPLR
SFRHDPSGELRIEMAYEKEWQKSLDKLKQLPVVRIDQRLYTLDNLASIEIQPRFDTIKHY
NRQTSLSIGANLDNLTTEEAQTKIKQVMENVSFPDGYNYSLRGGFERQEEDQSIMVINML
LAIAMIYIVMAALFESLLLPTAIITSILFSITGVFWALLLTGTPMSVMAMIGILILMGVV
VNNGIVLVDQINQMTPELDKLSDTIREVCITRLRPVLMTVGTTVLGLVPLAMDDTQIGGG
GPPYYPMAIAIIGGLSFSTLTSLYLVPLCYQLLYRMRYRAVLQLGESHRFAQKLLPWTAR
>fig|211586.9.peg.1725 Acriflavin resistance protein
MSIISTSVKRPVTVWMFMLAIMLFGMVGFSRLAVKLLPDLSYPTLTIRTMYDGAAPVEVE
QLVSKPIEEAVGVVKGLRKISSISRSGMSDVVLEFEWGTTMDMASLDVREKLDTIALPLD
VKKPLLLRFNPNLDPIMRLALSVPNASEAELKQMRTYAEEELKRRLEALSGVAAVRLSGG
LEQEVHIQLNQEKLSQLNLNADDIKRRINEENINLSAGKVIQGDREYLVRTLNQFNSLDE
LGQVIVYRDAQTLVRLFEVATITDAYKERSDITRIGSQESIELAIYKEGDANTVAVAKKL
RDELVKINKDPQQNKLEVIYDQSEFIESAVSEVTSSALMGSVLAMLVIYLFLRNIIPTLI
ISISIPFSVIATFNMMYFADISLNIMSLGGIALAIGLLVDNAIVVLENIDRCRSEGMSKL
DAAVTGTKEVAGAIFASTMTTLAVFVPLVFVDGIAGALFSDQALTVTFALLASLLVALTS
IPMLASREGFKILPELMKKTPKEKPTTKLGKLKHYSATVFSFPIVLLFNYLPSALLTFVL
IIGRFFSWLLGLIMRPLSSGFNFVYHSTESIYHKLLAIALRKQLATLLLTTGITGACISL
LPRLGMELIPPMNQGEFYVEILLPPGTAVGETDRILQQLALSIKDRPEVKHAYSQAGSGG
LMTSDTARGGENWGRLQVELVDHSAYHQVTQVLRDTARRIPALEAKIEQPELFSFKTPLE
IELTGYDLALLKRSADSLVNALSASDRFADINTSLRDGQPELSIRFDHARLAALGMDAPT
VANRIAQRVGGTVASQYTVRDRKIDILVRSQLDERDQISDIDTLIINPDSSQPIALSAVA
EVSLQLGPSAINRISQQRVALVSANLAYGDLSDAVADAQQILAAQVLPTSVQARFGGQNE
EMEHSFQSLKIALILAVFLVYLVMASQFESLLHPLLILVAVPMALAGSVLGLYITQTHLS
VVVFIGLIMLAGIVVNNAIVLVDRINQLRSEGVEKLEAIRVAAKSRLRPIMMTTLTTVLG
LLPMALGLGDGAEVRAPMAITVIFGLSLSTLLTLIVIPVLYAMFDRKKFDHTNIVSTAEQ
DATTLTVETRP
>fig|211586.9.peg.2114 Multidrug resistance transporter, Bcr/CflA family
MKTSSNIFVNMKFFIFLLYLALLSMLGFIATDMYLPAFKAIESSLNSSPSQVAMSLTCFL
AGLALGQLIYGPLVSKLGKRYALLIGLAVFALSSVAIANSDSVMMLNIARFFQAIGACSA
GVIWQAIVVEQYDAEKAQGIFSNIMPLVALSPALAPILGAYILNEFGWRAIFISLCVIAF
LLVLMTLYFVPGKSKHQDIKPSAVSYGQILKNTRYLGNVVIFGACSGAFFAYLTVWPIVM
EQHGYQATEIGLSFIPQTIMFIVGGYASKLLIKRIGADKTLNVLLSIFGICVVSIVLFTL
LFKTITIFPLLISFSILAAANGAIYPIVVNSALQQFTQHASKAAGLQNFLQITIAFGASS
LVAMWANFGEVAIGWGILCCSLLVILGYVLKTEQTWGDFAHHFTAPDPARVGIVANAKQN
QAD
>fig|211586.9.peg.2128 Multidrug resistance protein D
MMSGEKPSLISAKASTPSAGSATRLLFMLVFMVACGQMAQTIFVPALPLIAQGLAVDASK
LQAVMACYLLAYGLFQFIYGPLSDRYGRKLPLLIGIGIFIIGALLATQATSFNQLICASL
LQGLGTASAGALCRSIPRDHYFGDNLLKFNSYVSMAVVFLPLVAPFLGSLASAYFGWQAV
YWVLFGFGVFVWLLLCFGFKESLPKDKREQQPVLASYRHVLRHRSFRAYLFSLIATFAGI
AAFEAIAGVLYGQYLQLTPFMVSCYFVAPIPGYLLGALIAGRQKQAQRSVFQGVALLGAG
ALFMLIPGLFQLVVGWSLLVGSILFFSGAGMLFPTLTSAALEPFPRQAGIAGALLGGLQN
FGAGLAALTMSLVPMGGQLSIGLLSAVMVLLVIVALHYARDQNDTHQTLLPQKT
>fig|211586.9.peg.3151 Acriflavin resistance protein
MLSQFFIKRPIFAAVLSLLFFITGAIAVWQLPITEYPEVVPPTVVVTANYPGANPKVIAE
TVASPLEQEINGVEDMLYMSSQATSDGRMTLTITFAIGTDVDRAQTQVQSRVDRAMPRLP
QEVQRLGIVTEKSSPDLTMVVHLLSPDNRYDMLYLSNYAALNVKDELARIKGVGAVRLFG
AGEYSLRIWLDPNKVSALGMSPSDIIAAVREQNQQAAAGSLGAQPSGNADFQLLINVKGR
LTELSEFEDIIIKVGQNGEVIRLKDVARVELGAISYALRSLLDNKDAVAIPVFQASGSNA
IQISDDVRAEMARLAKSFPEGLQYEIVYDPTVFVRGSIEAVVKTLLEAVLLVVLVVVLFL
QTWRASIIPLVAVPVSLVGTFAFMHLMGFSLNALSLFGLVLAIGIVVDDAIVVVENVERN
IASGLSPIAATQKAMKEVTGPIVATTLVLAAVFIPTAFMSGLTGQFYKQFALTITISTFI
SAINSLTLSPALSALLLKGHDAPKDALTRLMDKLFGGWLFTPFNRLFNRASEGYGYLVRK
VIRFGGIIGLVYLGMVALTGVQFVNTPTGYVPGQDKQYLVAFAQLPDAASLERTDVVIKK
MSDIALNHPGVAHSIAFPGLSINGFTNSPNSGVVFVALDDFELRKSPELSANAIAGQLNQ
QFAGIQDAFIAIFPPPPVQGLGTIGGFRLQIQDRANLGYEALYQVTQQVMYKAWADPQLA
GIFSSYQVNVPQLELDIDRTKAKQQAVSLDQIFQTLQTYMGSTYVNDFNRFGRTYQVNMQ
ADEAFRQSPQQISQLKVPNVNGDMIPLGSFINVSQSAGPDRVMHYNGFTTAEINGGPAPG
VSSGQAQAAIEKILAETLPIGMTYEWTELTYQQILAGNTGLLVFPLVIVLVFMVLAAQYE
SLSLPLAIILIIPMTLLSALSGVLLYGGDNNIFTQIGLIVLVGLATKNAILIVEFAKEKQ
DHGMEVMESILEAARLRLRPILMTSIAFIMGVVPMVFSTGAGAEMRQAMGVAVFAGMIGV
TIFGLILTPLFYYSLVKRGRRKRTLEV
>fig|211586.9.peg.3603 Acriflavin resistance protein
MRLPEVCIRHPIFASVLSIMAVLLGLIAFQKLDIQYFPEHTTHSASVNASIAGASADFMS
SNVADKLIAAASGIDKVDTMSTDCSEGRCSLTIKFNDDTSDIEYTNLMNKLRSSIEGIND
FPQSMIDKPTVTDDTSATDSASNIITFVNSGGMEKQAMYDYISQQLVPQLKQVQGVGAVW
GPYGGSQKAVRVWLNPEQMKALNIKAADVVGTLGSYNASFTSGAIKGKSRDFSINPLNQV
ETLEDVKDLVIKVSEGKIIRIADVAQVVMGEESLSPSMLSISRHSAMSLQILPLSNANPV
KVASNIKAEIARMQKHLPQGLEMHLAYNQADFIEAAIHEGFAALIEAVILVSLIVVLFLG
SLRAASIPIITIPVCVVGVFAVMSALGFSINVLTILAIILAIGLVVDDAIVVVENCYRHI
ENGETPFNAAIKGCQEIIFPIIAMTLTLAAVYLPIGLMSGLTADLFRQFSFTLAAAVMIS
GVVALTLSPMMSAYLINTTEQHPRWFSRVEVQLQQLNHLYINELNKWFVRKRLMFGVAVV
LVGLAGIAYWQLPKILLPAEDSGFIDVTANGPTGVGRQYHLDHNRELNSVIDGHPAVGAN
LSYIEGEPINHVLLKPWGERSEGIDEVIEDLIAKSKQSVSAYNMSFSIRSADNLNIANNL
RLELTTLDRNKDELSQTAAKVQKLLEDYPGLTNVGNSVLRDQLRYDLSIDRNAIILSGVS
YGDVTNALSTFLGSVKAADLHATDGFTYPIQVQVNLDKLSDFKVLNKLYVTSESGQALPL
SQFVSIKQTTAESNIKTFMGLDSAELTADLMPGYSTDEIKAYLDEQLPSLLNDAQGFKYN
GVVKELMDSQAGTQSLFLLALVFIYLILAAQFESFVDPLIILLTVPLCIVGALLTLAVFG
QSINIYSQIGLLTLVGLVTKHGILLVEFANKQQAQGMSAIEAALSSAKWRLRPILMTSLT
MILSAIPLALATGPGSLGLANIGLVLVGGLLAGTFFSLFVVPVAYVAMSELKARDVVAHL
RSA
>fig|211586.9.peg.4056 Permease of the drug/metabolite transporter (DMT) superfamily
MPFVIALLAPVFWGTTYALVSLYLQDMSPYWVAVWRALPAGVLLLMLRPRLPTLAWSKLS
LLAFCNIGAFFTLLFIGAYRLPGAVAGTLGATLPLIFLILAWLIDKKRPGMKWLLLGLMG
LGGVILLLNPSADLDPIGVLCMLSATTLIAFSSRWMQRWDVGDFLVLTAWQLLLGGLMLI
PLAWLMAGPPQIPSMDVVPSLIWLATANTAVAYWAWLWSMRNLGPEIMGMVALVNPVVAV
SLGVLIVGETLDMRQWAGILVILLSLLLMKLPQKLRWNPLKARG
>fig|211586.9.peg.4078 Drug resistance transporter Bcr/CflA subfamily precursor
MRRNLLPILMSLVLLSPLAIDIYLPSMPTMAAEFAVSASEVQSTLVLFLFAMGVGQILIG
PLADRYGRRPVALFGVLLYGASSLLAAAAIEFHWLQIARVLQGLAACSTSIVVFSAVRDC
YSPKEGAKIYSYLNGAICVIPALAPTLGGLLAMQFGWRSTFVFMTLYAILMMLLVGYRLP
ETRPANTVSTGPLYRWSRYKPVLSNTHFLFYAFACMSAMAAILSYVSYSPVWLIGHLGVS
ELAFSGLFGLNALVNIVACFAAPVVIRKLGNRPTAILALALLVLSAVFIIAAQAFGPSAG
MAAAFAFMLPMMLLCIGFAFLLGPATSMALSAFGERAGTATAMLGFIQMSGASVIAGLVQ
QTNLTAPYAVALVMGFFSIGLLSMMAISRFDHWHQEQLAAEH
>fig|212042.5.peg.158 Bicyclomycin resistance protein
MVMLVLRETVVLFLVIMSITICDISYDMYAPGLPQIGAFFGVAQTIVQLTVSMNLLGGAL
SGLIYGPLSDHYGRRSVMLWGIAIFVIASIGCCFAWSIGVLIVLRFLQGLGAGVAGVVGF
AIVNDIYVGEAAAKNLSIVNMVVSLSPAVGPIMGSYIVSLGYGWRLLFVLVSMISVLLLL
ALIFGLTETIQNRREKLSLSSILAEYGALFRNYRFLCFALVQSLTIMWVWASMANLPFVF
IEGMHLPVEYYGYLVAMSVVSYIAGTIVNRRLIGKLGMMRMIVLGLLSVMIPDVIVIICH
YAFPAFLTPLFIEMIWLPSSFGIAFITSNSVAIAFGEVRDKGAASAFISFGQTIFGACGI
YIVGKFYNGTIVPVSVLPIVCCLLGMTIIWLLTKREGMFPREKTV
>fig|212042.5.peg.434 Multidrug resistance protein D
MVDSACRFCLLDHKRLYNINNMNVIADYFLKNNRFTLFLLLFIAILGVHSYWMLPQERTP
TIKIPVISVRAVVNGISAERAEKLLAIPMEKELRAVSGIKKVLSEVRDGHVSVALKFNHD
ANMRIAMEDVRNQLDVIRPKLPRQLTSLTVQEMDLGSMPILHLAIVGDIEAVVLSKVARE
LKSKIEPLRDVLSVETEGLHEYVLELNFSPELVNYHGIQIQDIQRALSSSYAFVEYGMLE
SDVGSHKVKLEGELDSYKKIMDLVLKAGEDQFVTVRDVATVRFARKDNHELVRVNGKPAV
VLKVAKREGSNITEVVKRVEHICDSAARFLPKDVSLLFLQDQSEEVKSALRELENTLVFS
VILVSVVMMIFMGIRTAILIAVAIPVSVLFSITVVYLMGYTINIVILFTLIMVIGMLVDD
AIVVSEYADRKMAHGFSRLEAYRLAATAMFWPVATSTMIRLSVFIPLLFWPGFTGEFMKY
IPVVSISALVGSWITALIFTPVLGAMFGRGSATSPGELARVNAIEDIDIENLGKGARFYT
KVLGVVLDHPIKFVSIVSGVLIFSTVAYFTLGPGGEFFPDIEPDQATITVKSDSNLSLKE
KDFLMKEVEGRISEVAGIKYLYTRLSDSKASTSSEVLGVIHVEFVNWYLRAKSSKVLRNI
ETLLKDMKGVFFDIAQYSMKPSVGKQLEISLRADDPALVQKAARVLQKEMSASQGFRGVS
SDNPVSGMEWVMMVDRKKADVAAVSVSMIGQYIKMLTDGLLVGTYYPKDSTDGVDIIARF
QEKHRSLKYLDNFLINTMYGPRPVSSFISRKARSSTGTINRIDGLRAITISSDIAPGYSI
ADRVRYIKEVLDREPRVEVAFLGDMEDQAESKTFLIKSFFLILLMIALVLIAEFNSWYYV
MVVMTAVFLSTTCVFLGFLLTSKVFGIVMGGVGIIVLAGVVVNNNILLIDAFCANIKSGL
SYRDAIIKSALSRFRPIFLTVITGVLGLMPMVLRLSVDFIGRNILYDSPTSQLWFELSTT
TSMGLLFATAVTLLFTPAVLMCGGRQKSSHKVL
>fig|212717.8.peg.101 Permease of the drug/metabolite transporter (DMT) superfamily
MKKQNLWADISLLIVAIIWGSGFVATKNALDSISPFFITTLRFSISTLAIGIIFFKRIKN
IDISHLKAGFIIGFFLFSAFSTQTIGLLYTTASKQAFLTGTNVVMVPFFYWFISKEKPNL
YNITATFLCLIGISLLTLDGSMHINKGDLLTLICAIFFACHVVATGYFTKKYDPIILTFT
QFFVTTILSFLSMIILEGVPSAIPKEGIFPVFYLGIFSTFIAFLIQTIAQRYTSPSHTAI
VLCLESVFGTILSCILLGDKFTYKIFIGCVLIFLAIITAETKWEFLRDINKNVQAQEE
>fig|212717.8.peg.327 Vancomycin B-type resistance protein VanW
MAKRKKRKKNSSKKITICLIIAAVLIGLTSVKAGYSYNNIKHYENLFYPGITVGNEDISG
KTLEEGRKIIKEKYANKLLNKKITVKIPEGEYSITFDKIEGKYDIDNSLKKAYDYGKDSN
AFSKYRIIKKAEKKPFELMFSYNEKKVIDFINDVEKKVNKDATNAKLIKKGENFNIIPES
VGKKLNKEKLQKDILTNINGDISKDLVVNGEVKNVQAKVTSDKLTSVNSLIASFGTNYAN
ISSQQRANNIRLSTESINGTVLMPGEVFSFNGAVGERTADRGYQAASVIIGNQVEDGLGG
GICQTSSTLYNAALKANLKSVERAHHTLPSSYVPLGRDATVDWENIDYKFRNDYSFPIYI
EGLTQNGEVRFNIYSHSSVKNRRYEITTDVYENLPTDTKTIQDANLSKGTTEVVQKPYQG
FKVKVYRNIYENEKFINKELISNDFYRPIQGIIKVGTKK
>fig|212717.8.peg.388 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNTISTAEMMEKESISKVLLKLSVPAIIAMLINAIYNIVDTMFVGMLDNTSAIAAVSIV
YPLFMFIGAIGVMFGAGGASYLSRLLGEKKKEEADKTLTSTIIMGCIFSLIFTVIATVFL
DEFLLMYGATETIMPYAKEYGYVIVLGSIFTIGTAIMSNTIRAEGNSRYSMIATCVGAVV
NIILDPILMFNFNMGIKGAAIATVIAQLTSFIFLLRYYYSNRNYINFKINLFKPTFNMFF
EILKIGIPIFVTQVLASFALGFMNLGAKPYGDAAVAAMGIVFRVMSIGFYIVFGIGQGFQ
PVAGYNYGAKNFTRLEESIKISIRWSTIAAIITSLLFIIFAKECMLIFTRDREVIDIGIK
AFRAASLLFPLFGYVNTYAVLFQALGKAVGAFILSISRQGIFYIPLMYVLPKFMGLNGVM
FCQTAADGLAFLETIIMAIWLKKQFKKEVSQESTLGDVKEIS
>fig|212717.8.peg.961 Permease of the drug/metabolite transporter (DMT) superfamily
MKDVKKAHFLAIILMILWGMSYLSIKVVVHEIHPVLSAFYRFLIAAIILFIYLKVRYPEE
KVLKEDKIKMALGGFFGVAMYFLFENYAVYFTTASNVAIIISSIPIFTLISQRIIFKEKI
NVVKAIGASLSIIGIGIILLSKGKVSLFSKGTIGDLMGIGAALCWVAYTVVISKLKGNYR
SIVITTYQTIWGCIFLSPSIFIFQHSIMPSTKAIANLLYLSFFCTCIGYAIYIYCQNKLG
ATVITTYINLQPIVSIISAKILLNENINSKQILGSAIIIIGLFLASKSEKINKQIIEALK
G
>fig|212717.8.peg.1846 Vancomycin B-type resistance protein VanW
MKKLSIWHILIFILIFFSLGFYIFLLYTVKNLNDKIYPGVSVNNIDLSGKTKKEAASIIE
KSLTNNIKGAFKLKSSNKTYVVSFEDLNLKHDLNSTVEEAFSYGKNFSSFKKFSLLMNSK
PVNISSKVLYNKNKLQNSIFSIEKEINKNAIDAKINGITSGVLSFTPGVEGHRLNKEDLL
EEINGNLSTLQNPNSIVEIKLKVDTYPPKINDKNLRKINSLVSSFSTTYENSSKERKNNI
KLATNSIDGTLLLPGDVFSFNEVVGNPTTEKGYKESNIIVNNKLEKGVGGGLCQVSTTLY
NSIIRSNIKSLERKNHSIIPSYVEPGLDSTVSYGNIDYKFKNTLTYPIYIEGIANNEKVT
FNIYSNSSLNKIKYDLISEVHDKIPFKTVYEKDDNLPLNSEKISQNGSFGCRVNVFLVAY
ENGKEISKELIYKDIYNPGNKIVKRKKL
>fig|212717.8.peg.1869 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKKAIKEVLSIALPAVGEMFLYVMIWFFDTAMVGKYGGQVAVSTVGLCSEMMAGIINIF
IILGICVGSISLISRSLGGNNFDLAEEYTSISFFIGIMLSFLISTMAYTFAPKLLHFAGA
KDQVLSLGIVYLRITSIGLFFNMLMNVLNSVLRGTKNTKTPLFASAIVNVVNIFLDWAMI
FGKAGFPELGVKGAAIATSIAHFTGFLFIVIYTFKYSPLKPRLIHIKNMSLPKLKNLIKL
SIPSSLQEAAYSIARIWGIFVMMGLGEASFAANQIATTVESISYMPGTGFGVACTALVGH
KIGEGKFKEANEYAKTCAFLSLIFMSLCSATFLIFPKFIVSLFINKNEVEVIKLGMLCIM
VAAAEQPFMALYLVFGGALKGAGDTKTPFYISLIAAWAIRVPFMLYFIGHLKVSVHYNWW
ITAGQWAFQGIAIYLVFKKRFSHPKKLQDNYLVNG
>fig|212717.8.peg.2518 Permease of the drug/metabolite transporter (DMT) superfamily
MINTKVLATITAISYSVIFGLSFLFTKKALIFATPFQLIAFRFLLAFIFMSILIFSKILK
INYENKDIKGLFFLVLMQPIGYFIFETYGLKLSTSSQAGILTALIPIISSIVAVYILKEI
PSKKQWFFIILSVIGVIFIVIMDKNSDSGNSLLGTFLLLGAIICGSFYHVLSRKVSSTFT
PIETTYFMMGVGAVTFNFISIITHIKDNDFSNYFHLLYNKDFLIPLLFLGILSSVIAFLF
VNFSLCYLEASKCAVFSNLSTVISILAGVLFLDEKIYWYHIIGSITILIGVYFTNYLNSN
NKNTSSEKDVDLDESNKERAISK
>fig|216432.7.peg.504 Permease of the drug/metabolite transporter (DMT) superfamily
MNNRILALLAAFAASAIYGANHTIAKDLMPTVIQPFGFILLRVSGAALLFWVASLFLPRE
KIDRKDWLRFVACALFGMAINMLSFFKGLSLSTPINSSVVITLSPVLLLVLSAIFLKERV
TLLKSIGIGLGLAGALLLILFGMKEQPNAPNIPLGNLLFVLNASSYSVYLILVKPIANKY
RPVTLMKWFFLFAVIINLPIGLSEFTQVEWTALSLGSIWRMLFVIIGTTFLTYLFNIYAL
KILSPSTIGAFMYLQPLLATLIAVLVGSDILTTLRIFAAALIFTGVYISSRKPKKRLQSN
NIQH
>fig|216432.7.peg.1384 Probable multidrug resistance protein
MKFFKFYADSFKGLSREMWYLSIIMFINRAGAMVIPFLSLYLTKSEGYSLPQVGWIMSAF
GIGSVIGAWVGGQLTDTIGHYKTMVLSLILGGLGFIGLQYLHTFWTLVIGVGVVMIFVDS
FRPAAFTAINAYSKPENKTRSVTLLRLAINLGFSMGPALGGLIITSLSYSGLFWVDGVTC
VIAGFLLIKLLDPKTAREEHQEVVQHPLSPYKDFTYLWFILAIILFSLAFVQYFSVMPLF
YTNIYALSEDEIGLLLALNGLVIFLLEMPLIKYLETKAVSVLTYIIWGTILTAFSFLILN
VFSWIGVLIIGMLLMTVGEMIAFPFTNKFALDRAKGGKMGAYMALYSISFSISHIFGHNT
GMNLVSNFGYTATWFTMAALLGIAVLIFLSIKLKQR
>fig|216432.7.peg.2319 Tetracycline resistance element mobilization regulatory protein rteC
MEAALNKLLNQFINIIEEHYSINQINLPIISIAIDCCEKHIIDIRKVFGTYNFDSTNAEV
KFFKYQKPVIYGHLKYYLHIQSYLIYKGSGSITQQRQLVDNNIKKLKKGLKPFAEFVTYC
KQGRSELDEYYYLRKNKSLWPITYRSACIYDPDFSTSHDELRAEIVAYDLIMKFYEKELE
TLRIKELNAYVVDSSNENKFNLEWTSNKIDLVELIYALQTSRAIQNGKISITTLANVFGT
VFNTDLSNIHRTYVELKSRKKDRCKFMKYLMVALENRVITEES
>fig|216596.11.peg.323 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNDMSDTSGSFRKRQRLAPEDLASPELLRLLLRLGLPAMFGLSINAAHHTINMIFVGMIG
DDQIAAIMIVLPVLMLVAAFGEGIGVGVATEVGRTLGAGNRSRAGAIASISLAAGVVFGA
ASAIAILAFPDLLLFGATPALQPLAQHYLMIIAVSVPLTMAQIILDFLAIAEGNARFSMW
TLVACFALNMILDPIMIFGFGLGLQGVAIATILSQLVALCIYAAYHARRLGTVRLTFGWR
WRDIGYLRPVLAVGAPTTLTSLATAGAIAAVVSLAGTYHGEAGIAGVGIALRLLAVGTLP
VIGISLGAQSILSFAWGRGDTTRMLSAARILTVVTSAVSGAYGLGALVFSEELASFFTDD
ATVIGIAGQAIIATHLPLLLFGLRQTVLILFQAQGRPKAAVAIGLAQNGYLLFPLLALLP
PFFGFSGLLAAMFLASALTGLLSAGCLARTLSALRQRAADHLTSIRPYPNFCP
>fig|216596.11.peg.747 Permeases of the drug/metabolite transporter (DMT) superfamily
MTTKTGVANAGNLIMTGVVLMLLGDLLFALNDAMGKWLVASFAVGQVLVIRSVGAFIVLG
PMILRQGPMALFRVEQKGLQFIRVLMATCDVALFYAAVAYLPLADVMTFYMAGPIYIAAL
SHFFLGEKIGWRRWLAVLIGFAGVVIALRPSTAMLSLPSLFGLAGSLAFALSLVMSRYLR
STSDTTLVTWQTIAALVTGIVLSIGHWQPATLIDWSGMLLLGIVATCAHLLITRSLKLAP
ASLLAPLQYTLLLWAIVLGYLFFNDIPDTQIIVGAAIIVVAGLFIFHRKNLKETVPVEAV
PPDGH
>fig|216596.11.peg.1683 Drug resistance transporter, EmrB/QacA family
MSNAAQRSNRVLIVATIMLATFMVAIEATIVATAMPRIVGELGGFSYYSWVFSAFLLAQS
TTTVIYGKLSDIFGRKPVLIGGILIFLVGSLLCGLAWSMMSLVLFRLLQGLGAGAIQPVT
MTIIGDLFKLEERGRVQGAMATVWATSAVVGPLAGGIIVDNISWAWIFWINLPIGVISII
AFMVFLKEDVAHKQAKIDYLGSVLFSISIVALLVMLTETDASAWILLSLFAVFVVTGLLF
LAQEKRAPEPIISIPLWSRRLIATSNTATLLAGMALIGLSTILPLYVQGVLGRSPLVAGF
TLTMLVVGWPLAVMLSSRFYKAFGIRRTLRVGSLMFPFGACFLLFLTPDSSPVVAGAGSF
FMGFGMGLISLTSIVLVQDSVEWSMRGSATASIIFSRSLGNTLGATVLGAILNAGINHYA
SGDAAAGLHEALNQPTGLSALAADPAIRSVFNAALHWSFWGVVVVAVLTFFTTWLIPVGH
GQKGEGAAVPSEAASH
>fig|216596.11.peg.1833 Permease of the drug/metabolite transporter (DMT) superfamily
MSQAAPTLSEASPSNRFALAALLLGGAAIGGSPIFVRLSEVGPMATAFWRVALALIPIVI
VSLMKKERGPKPQSLSDYAMLVLPGVMLALDLAAWHLSLTMTSVANATLLANLAPVFVTL
IAFVFFSARISRVFVIGLAVALSGVVILKGGPAAIGNGDLRGDGIAMIAAFFYACYILAI
GRLRSRFDTIRIMLWSTACAAVCIFPIGLIYEGHMLPATVYGWSIVFGLAFISHAGGQVA
ITYALAYLPPAFSSLTLLLQPVVAAILAWALLNEAIGTMQALGGAVVLAGIMIARTSRVQ
V
>fig|216596.11.peg.2655 Permease of the drug/metabolite transporter (DMT) superfamily
MTTIAFTNDKSPSQVLGYAGGTITVLIWATWFLVTRHSAATPLGSIDIGLIRFGIPALVL
SPVWLKTGLLPKGLPLHLLAIMVSGSGAVFFLLTTLAIHSTPAASSGILLGGSMPLAAAL
IGIALFRERPDGTRIAGLIAIVAGVLILLTRSLADASLPWTSFVLLPAGAVLWASYTHAF
RRSGLTAVQASALIAVWSFLIMGTLALVFGVSLPQATLPEIGLQVLSQGVLSGLVAMVAY
GTAVRTLGGTQAAAFTALTPVLATLGGGLLLGEAIGMTEISAAVITGIGVALSTGIATPR
R
>fig|216596.11.peg.2689 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTDLSEGNAFLTGWLPGVFIKTAAPIVAITTVSGLFTVVDAYFLGAYVGPDALSAVSLIF
PGLMLLVALQSLVSNGMASILARRLGAGDRQGARRVFASAHALAFAVTLILNLVYWTLGR
QIIDAGAAGNAAVADGARLFMGAMTACAPVGFFLSLHLDGLRCEGKIGFMTLVTLSASLL
NILANWLFMAVMHWGVLGSAAGSIASQFVCLAAVLAYRWRRPAILRPSRGLALAEWRGIV
AFGAPMSLGFIGISLASAAILLNVSLWSTHDYVATVAAYGIITRIMTFTYLPLLGLSIAL
QTIVGNNHGAGLGLRVGRSLQIAMLAALVYCTLVEITVELLAGRLGAVFVADPAIIAEVR
RILPWTIGAYFLFGQMLILSSYFQSIGDAPRAAIFGLSRPYLLTLPLTFLLPFVFGEQGI
WMVPVFAEAGMFILAFLVLSQNAKRRGWRYGLLPA
>fig|216596.11.peg.2823 Permeases of the drug/metabolite transporter (DMT) superfamily
MFPTALSDHRKGLLLTAIGGLALSVDIPLMRLADGELWSILAARSIATLGVTLLVATALR
IAKGRWPVLVPGWPGLVTGLLYGLTTVVFLLAVFNTSTANVVFIVAFNPMFAALLSWIFL
KERPAPATLIAMAAMIFGVGLIVRDGLSGGHLFGDTMALLTAFIIAAAITISRASRREMG
FVSLLSTVLPAAIGLISVMPAGGFSIEHPAWILFNGAVMMPLAFWCLATGPRYLSAPEVG
MFYLLETVLAPIWVWLIFAETPAPMTLVGGGILVAAIAAHSVWIVRRKSIAQMAG
>fig|216596.11.peg.4136 Multidrug resistance efflux pump
MALALFVFSIFMERRTPSTSQAQVQAYIVGIAPEVTGRVVEVGVTDNSRVEADQLLFRID
PERYELAVSEAEASLASVGQSMGASTAAVDAAQAKLVTAQVDRDNLREQAARAAELEKRG
VYSKARADSTRSAFGQSEAAVIGAEAELAKAKEQLGPSGNDNPQLRAALAALEKARLDLV
RTTVQAPSAGVVTNLQLTIGKVVSAGQSAMTFIDVGTIWITAAFKENSLEKVAVGNRAEV
LFDALPGRLFPAQVESVGFGVSQGSTDPNTGLPTIRSDSGWVQEPQRFPVRLIIEEAQRP
KGGVRYGSQATVVIYTGDNPVTNAWGSLWIRIMSVLTYVR
>fig|216596.11.peg.4294 Permease of the drug/metabolite transporter (DMT) superfamily
MAMNVLAVHRDTVGTEQAAGNSLAAAYSVGVLCWLLSAGVYIAAKWVSSEMPPWALCFWR
VLIAFAILMPIVRRHFGDMVALVRARALELLAIGGVGLAICQGMIFVGLEHADATTAGII
IALIPIITMILARLMLAEPMGRWQVIGSILAFLGIVVIIIKGSPAALMRLDFNPGELWIV
AGAFCFSLYTVLLRRAKFDLNRLALLVLLLGAAVLTALPFYLSELFSDERSTLNGNGLIA
LAYVAIPGGAVMYYLFNRSIEALGAARAGVLLYIQTIFIAVLAYLILGEQLQRYHLEGAA
LIIAGLLLIILLKPKIKAEAATA
>fig|216596.11.peg.4298 Acriflavin resistance protein
MNTTSEHDRDLAAKLRSLSIEPAAFKTEPPEPRVRRRVIPGAMLALAATASLAVVLLYRP
DTLARIETVLAGLIGKDEAAISVDGTDVPAAGPIRALPSNNPADRALPSREVTGSGYVVA
PDIATIFSKYEGRIAAVEVEAGDRVVSGQVLVRLDDAGARFALQGAEITRQSAELALTAK
TIELAQARSSLTRTERLAGRDAMSAQTLEEARTAFDTAENAAQQARQDVAKADLDIDRAR
EQVEALTVRAPISGTVTRLTAHVGDTVLSREDSVRENESLLAIADMTTMVIDADVAEANI
ALMRPGLRGESVLDGFPDRPFAVEVSKIAPMISREKGTVTLRLSLSSPPSDMRPAMAARI
RLLVGEAGDSTDHQQGAER
>fig|216596.11.peg.4681 Permease of the drug/metabolite transporter (DMT) superfamily
MSRQVQGYVYLALAMLTVGSTVVASKLIASGLPPFGATALRFAIAFPVLLLLMWATGARL
PRFSRHDRLILVIQAGAGSVGYTTLLISGLSLTSAADAGVIIGTLPVVSAAISILLLRER
PQRALLLAVALATSGVLSIAFTPDAAGGSLTGNALIFLAVVCEGLFILLNKRLKTEIAPL
ALSTLMAGIGFIVAAIPAIFEAPFADGISASAVAAVVYYALVPTVGGFLLWYAGAERVSG
TEAALFTALAPVSAVMLAFIILGEPVGLSQIAGIGCVLAAVLGLAFAGSRTVKLAGGR
>fig|216596.11.peg.5082 Permeases of the drug/metabolite transporter (DMT) superfamily
MQATAYICLVIATLCWGGNSVAGKLALGHISPMMLTFLRWFLAVAMIAVISVPQLRKDWP
VVRKNLPLLLFYGVIGYTLFNAMLYSAVQYTTAINVAIEQAGIPMLIFLLNFMFFRTGIS
LAQCLGFGMTLIGVALTAAHGDLATLLQLSLNRGDGLMLIAIAAYSVYTIFLRWKPPLDW
RTLMAVPALGAMLTSLPLLLWEAGRGAARWPDQAGWVITLYTAIFPSLVAQILYIKGVVA
IGANRAGLFINLVPVFGTLLSVALIGERLQSFHVIALVLTLGGIAIAEKGRPKASSPTVT
ASPVD
>fig|216596.11.peg.5507 Membrane fusion component of tripartite multidrug resistance system
MAMSSNQKSNVARIVSENAGTEEVKAEVAGVEAPTAEAREVPSAPAQSAPASVAAPAAPK
KRRSPVLPIVVLALLAGGGWYGYEWWTNGRFMVSTDDAYIEGDIATISPKVTGYVAKVNV
VANQEVKAGDVLATLDNGDYQNALDLAQAQIVTEQLSLQRIDAQIEGANASLVQAQAQKV
ALEAAVRGAEITQKRQSDLQAKSVGTAADLDNANIALDQAKANLAGGDANITAAQANITI
LQAQRKEAEGSVRSLEISRDKAVRDLSFTVLKAPYDGIVGNRSVQEGDLVSPGQRLMALV
PVRQLYIDANFKETQIQHLVPGSKVNVQVDAYSDHPIVGTVESISPASGSVFSLLPPENA
TGNFTKVIQRVPVRIALPQDALDSGRLRAGLSVVVDVDTRTAPSK
>fig|216596.11.peg.7355 Permease of the drug/metabolite transporter (DMT) superfamily
MQVGPVPVLVSVFYRFAVAAVILAAILAVMRQLKLPALRDQPFILAQALCLFSLNFICFY
NAAASIPSGLISVIFSLATIYNAVNARLFFGDRITGRTLLAAALGATGLLLLFGQDVVVD
FDMGTLKGIGLAALGTLFFSLGNMASRRNSAVGISPLTANAWGMTYGAIVLLFLIAVTQT
PIVAPPDITYLAAMLYLAAIGSVIGFTTYLMLVSRIGSSRAAYATVLFPIVALSLSTVFE
GYHWSGLGLIGLALTLLGNVVIFARPLARRPPRSDARLPAEVR
>fig|216596.11.peg.7368 Inner membrane component of tripartite multidrug resistance system
MSERLESARPDETPAIVWLGFMAMCVGMFMAILDVQVVATSLPTIQSALDIDPDQMSWIQ
TAYLIAEVVAIPLTGFLTRLLTMRWLFVTAISLFVAASAGCAMSGSFGELVAWRVLQGFS
GGTLIPSVFSAVFILFRNERQALATTIAGVLAVLAPTVGPIVGGWLTETYSWHWLFLINI
LPGIASAILAARSLPRQATDPSELRHLDGLSLLLMATALTSLELSLKEAPTSGWISAYVL
SLLAVCLASGGVFIWRTLRRNRPIVDLGNFGDRNFLVGSVLSFVLGIGLFGSVYLMPVFL
AFIRGHDALQIGMTMLVTGVAQLITAPIAVALEKRMDARLLSAAGFALFAIGVGMSAFQD
PRSDYDAMFWPQVVRGVAIMFCLLPPTRLALGTLPPDRIPDASGLFNLMRNLGGAIGIAL
IDTIIYTRSEPLGQGLWTRLQAGDVEAATFVGAPLQTISGHSGSFDADTTALLDPLIQTA
ASVQAINEAWMVIAVLTGCALLSVPFARRPKST
>fig|217.1.peg.130 Bacteriocin resistance protein, putative
MKSLFFFLQFISLSFAHTFFDNNFFFFEKPLQSWVEIKSKNLIKQQYDYSCGAASLATLF
TYYLNTKVDENDVLDYIFEKKNLEKKKQQKIEISFLDLANFSESKGFKALALGLDFDTLL
QIKIPVILYLMTRKSPHFSVFIGTDKKFIYLADPSLGNIKIRIQKFKEMFAQRDTKKHSG
SILAILPKDEGSKTRLKEPPKNHEEIFQEAIKNQIIHPF
>fig|217.1.peg.195 Tetracycline resistance protein tetA(P), putative
MQIALIANMPLKRNILVYYASILTAISAQALPHAILTPLLLAKGLSLAEIMWVQATYSMA
MLLAEYPSGVLADLMARKRLFLLSKLVLMCSFSIIWLCEGLTWMLLAWALYGLASALDSG
TIDASLINAIKEQKANLSRFFAIDKQLRFAGMILGSVLGSFLYVRYGASVYIMGLLLLAL
CMIIVFLGFKEGEVLVHSKSLELLKRHIKEGFLELGQKPHLKKLMICSLVLQVFFQTHFQ
LWQAYFLAKDIATSHLFYFYVGFQILGVLIHFIPATSAVSKKSWILLAGLPLILGLLSSV
PIVFIALYALVVAIFSWIAYCVDYHFSLCVSKQKISSLISLKSSISRLASVAILILSSAE
LAFVSVGYVVVWHFLLALVAVAFLLKWTNLQSIGNKPS
>fig|217.1.peg.507 Permease of the drug/metabolite transporter (DMT) superfamily
MLLNRIQRIQTLQKPHHPRNLTNRNFLHFTPPVFLKNHPTSIPTPHQKMHPKNPSLMPNP
RPLKPQTSPKVKNSKAQKHHLKRNINITQKSRFMPFPLLFFLALLAEAFIVYASVLVKIV
DLPPILLGFYRVFLAIPIFFLFALRKGNLSKIPIKDIALMLLAGVFFGLDLVFFNTALHH
TSVTNVNLICSLVVFVLAPIGVFFFKEHLHKSFLLGAGVAVIGIFVLIKGKSDTSIATPY
GDFLALLSNVSYSIFLALIYGLRKKYTAMALMVYVCIGSSLLLGIIAEIKEGFMLPNSAN
AWIYVGLIVLFGQILGQGFFGYIMGKINTQVSSLIMLFSPITAAILGFLILKESIGIFEI
LGMFIILFGVYIAKR
>fig|217.1.peg.977 Acriflavin resistance plasma membrane protein
MNSWIKFCLKNPVGVFVCAIFLLLFGYIALSKIPYQLLPQVTHPVVSVYTIWKGATPYEI
EKEITQRQEKTLKNTPNLLAMTSTSKEGMAIINLEFAISTDMKTALLNISSRLDEVRGYP
ADVEKPIIKPTGENIPISVYLFAKSINPHLDINTAKNFINDEILKYYERIEGVGEVYVSG
GRKKQIFITLDTQKLAFFHITMDEVIASIKKQNVNISAGSMDFFQRSYRISTNGEYTSLD
AIRNTVVKTIDHKNILLRDLASVSEGYEKLTSYNVHNGSNVISLQIRPTASANILDLTNR
VEKLTHRLNEDFLKKRGIVMEWGRDQRQYIKSSISLMRENIFVGILLAIGVLFLFLRNLM
SLVVISLVIPLSIMGSLIFLQAWGRTFNVISLAGISFAVSMIIDSAIVVLENILRQAKIQ
KNFFLACVVGTREVGGALFASSVTTIAIFVPIIFVKDDAGRLFVDIALASSSIILLSLLV
CFFMIPTFLYVLLKRSDFGRKKGKVDAFLVHLGRVLSFWIMQSVRFCVRNKKRQIITVVG
FVGICGIFSYAAFPKTDYLPRGNQNFIFANLSIPPGLSLKEKKRILDALQADFYPFLLEN
HNSHAKIPAIKDFFISTGERVSFYLVSADKKKIPELMDYAQEKIDSIPNVRGSILQQEIF
SGASSSSIDINITGGNLDSISKTAGKLIASIKKNLPKVSISVVPARESNNQEINLYPDKS
ALALNGLNVESFGIMVGVILNGKKVGEYRKDEGILDMILDSKKSLKNDGKTSPEDIFYSQ
IYTPNGGVLPLNTLATIKHEYGVSRIRHFEQQRNILLILNIRDNTPVETLAQILQEKVIA
PIAAESENDITLSGSAGKLQKLKTELLHGFLLAIVITYLILCALYGNFLYPFIIILTVPL
ATTGGLIGLYLVNHFIAKQNLDVLTMLGFIILVGSVVNNAILIVYQTLNNLKKMQPRRAV
FLATKTRLAPIYMSMLTSVLALFPLVIFAGDGSEIYRGLGAILIGGMIFSTFITVLIIPA
LLLLCIKAKQKA
>fig|217.1.peg.1456 Multidrug resistance protein
MSIETKRTYHELLLFFTESKLFKAALFSISATTVLGATIIAPSLPALEKHFSDIGPSAEI
LSKLILTIPSLLMVFFSPIAGFLFERFRRLNIIFFALMIWSLAGISGFFLNNIYLVLTSR
AILGIAASFLMTGIGVLLADYYSGARREKALMLQNFFMAFGAGIFLTLGGFLASMSWRYP
FLVYSLGFVILIFGIFELFEPIKFHHKTHANPTKFTFSKFIPMYLLGMFIMICFYIAPTQ
MPFFMTDYLHIDQTRVGVSLAVVSVAMAIGSLFYMQLRKLFSLYEIFFLALSFFALGFAC
ISLVHNYLSVLIGFCFLGASLGISLINTNAWLFHIAEEGERSRAYGFLASSVFLGQATSP
LITQTFVSHLGIVKMIAIFTLMLFSVSFLFLFMSWRSQDRKF
>fig|218491.3.peg.1636 Polymyxin resistance protein PmrM
MTNKGYFWVVASLVLASAAQVLMKSGMLALPSISMTHWPSLSTLMAGWPVVAVLVGIICY
GLSMVCWFMVLRYLPLSRAYPLISLSYAVVYLAAVFLPWLNEPMSLRKNLGVLIILLGVW
LVSRDAQATK
>fig|218491.3.peg.1771 Multidrug resistance protein B
MKTENNQKQTPVPHRHWILIACMLAMFTAAIEVTIVATALPTIIADLGGFSLLGWVFAGY
LLTQSISIPIYGRLADLYGRKKIFFFGMIVFLLGSILCGFSTQMGWLIVFRTLQGLGAGA
ITPIAFTIVADVYSSTERPKIQGYLSSVWGFSAIIGPLLGAFIVQHFNWALVFWVNVPIG
LFSIFLLARYLPTINVVRQHQLDWTGAFYLVVSVASLLMALLQAEVFGYWVIPLLALSVV
GGILLVRQEKRTQEPLFPLALWRNRVIIAGNLGGLVVGAAMMGVSAFLPTFIQGVMGKTP
LEAGSILAMMSIGWPLASTLSGRLMLWTSYRFTAMCGGIVLIIGSLTLLTVQPDSNLMWA
RLAAFLIGSGMGLSSTTFLVSIQNSVDYSIRGIATASAMFTRMLGSALGTAILGATLNIN
LHWRLPEVSDPLQTLMDPAKRILLSVNQLDTLASQVASSIHGVFIVSALIAAITLLSARM
IPASQRPGQT
>fig|218491.3.peg.2237 Chloramphenicol resistance protein
MLAMPLVTQTFNHKALMRIAIVMAFIQFTNALEYMALTPVFTFMADEFSVPVSFSGYVSG
MYTLGAVLSGIIAFYWIDLFNKKQFLIKNMVLLGALTFLSTLTTHFGTLLVLRFCAGLVG
GTTMGVGTSILINCAPANLRGKILATVITSFSMVSIVGMPAILFLCTHYGWHTALWLISS
LCLLSLPLIVFIIPKDTVQSGVKAKLSIDAQTLLFASCSALVQFSPMLIIPILTPLMLQY
MGAQQTLLPLLFLSGGIAGYLSTKITGVLTSHLSALMLATISTLFFVASLLIPAMGYHNA
VLFITLFLGASYSRLVSASSVAVQYPENEQRASFSSLQTAMMFLITTLAFFLSSLLLPDQ
GITTQNLNRLLVVSALAASGFPVMVIILQKKLAKRTLQPDRPIID
>fig|218491.3.peg.2564 Daunorubicin resistance ATP-binding protein drrA
MTYALELAQLTKTYAGGVKALRGIDLNVEAGDFYALLGPNGAGKSTTIGIISSLVNKTAG
KVRVFGYDLELDKVNAKRQLGLVPQEFNFNPFETVLQIVVNQAGYYGVKRQDALPRAEKY
LKQLDLWGKRDEKAMMLSGGMKRRLMIARALMHEPKLLILDEPTAGVDIELRRSMWGFLK
ELNAQGTTIILTTHYLEEAEMLCRNIGIIQRGELVENTSMKQLLAQLKSETFIFDLAAKS
PLPQIEGYAFRLTDTSTLEVDVMREQGLNALFSQLSAQGITILSMRNKANRLEELFVSLV
NGDGVNGKGEKA
>fig|218491.3.peg.3000 Multidrug resistance-like ATP-binding protein Mdl
MRLFAQLSWYFRREWRRYLGAVALLIAIAILQLLPPKLVGVIVDGVTQHGMSMAEMMQWI
GVMLLTAVMVYLLRYVWRVFLFGASYQLAVELRADFYRQLSRQHPAFYQRHRTGDLMARA
TNDVDRVVFAAGEGVLTLVDSMVMGCAVLIVMCTQISWELTLLALLPMPVMAIFIKRYGT
QLHNRFKFAQAAFSSLNDQAQESLTSIRMIKAFGLENYQSARFAQVAADAGAKNMHVARV
DARFDPTIYIAVGLSNLLAIGGGSWMVINGSITLGLLTSFVMYLGLMIWPMLALAWMFNI
VERGSAAYGRIRQLLAEELVVKDGEESLPAKRGILEVNISAFRYPDNTRDALQHVQFTLA
PGNMLGLCGPTGSGKSTLLALILRHFDSQSGEIRYHDRPLDAIRLDELRNRFAVVGQMPF
LFSDTVAQNIALGRPDATQQEIEQAARLASVHDDILRLPKGYQTEVGERGVMLSGGQKQR
IAIARALLLDAEILVLDDALSAVDGRTEHQILQNLKTWGEKRTLIISAHRLSALTEANEI
VVLQQGQTAQRGTHRALAAEPGWYRDMYRYQQLEAALDDVPQLEGTKNE
>fig|218491.3.peg.3511 Acriflavin resistance periplasmic protein
MAVGMMRPLLLMSALSLPLWGQAATTGDIRVQLSAQRYTVLSSEIAGKVTDIAVKEGEHF
KQGDTLVTFDCTVLREKLNYSNAAENAARKKLAIADRLDKLNSISLSDVDQARSSVSMAQ
AESGVNRAMLQRCVIKAPFSGRVTETKVKRWESVAEGKELLAIYDDSAFELEMIVPSRWL
VWLKQGSAFQVTLDETGLSYPAEISRLSSAIDPVSQSVKAFGRITQSTAGLLPGMSGVAQ
IASPDAAGSVSP
>fig|218491.3.peg.4068 Membrane fusion component of tripartite multidrug resistance system
MTQSPSSSRSTRKWILQAILVIVVVWIAYRFWLAYQPEPIRLQGQIEAQQYSVSSKVPGR
IADVRIEKGQQLDVGDLVFTLLTPELDAKLEQAKAGEAAAGAVALEAKTGAREQQIAAAK
DQWQKAKAGSELSNKTYLRVQNLYQEGVLPLQKRDEAKASWDAARYTEGMAWQEYQMALE
GTRKETLVAAEEKARMAAGSVAEVEAYLAEARVVSPHSGEVSNVLLRNGEIAPQGFPVVT
LLDMSDIWIQLAVREDLLERFAMGTEFEARIPALNNQTFRFKVSYVSVMGDFATWRATDT
RQGFDMRTFEVEARPVQPISGLRVGMSALVEM
>fig|218491.3.peg.4155 Multidrug resistance transporter, Bcr/CflA family
MTHVQTRSEKTSGLLFIAILSALMAFTSLSTDIYLPAMPIMAKDLQGDAELTITGFLMGF
CIAQLVWGPLSDHLGRRTPLFIGMVLFIIGSVGCALSTDISQMVFWRVFQALGACTGPML
ARAMIRDLFSRTRAAQMLSTLIIVMAIAPIAGPLLGGQLIKVTSWHAIFWLLAIIGIMML
ISLRWLPETLPEDRRVKASLPSAFRNYYALLTNANFMRFTLCLTFYYVSAYAFITGSAFV
YITYFGVEPQHYGCLFALNIVGVMGMSMVNRRLVQRYPLETLLKFAVLIATVASFILAIG
AKLNIGGMPLIVISVFVFFSMNGIIAATSTAAALDAVPNIAGSASALIGALQYGSGIISS
LLLALLSDGTPWTMAWIIALFTTASAITALTTRVTKSSS
>fig|218491.3.peg.4156 Multidrug resistance protein B
MAINSLGEPEKNKPGITITLALSILSASLGTSIANIALPTLTAVFSAPFAQVQAVVIAYL
AAMALSVVIAGRLGDRYGLKPVFIAGLVLFAVASLLCALAPHLWQLIGARTLQGIGAAFL
MTLGMALLRQTAGEKHVGRAMGVLGTVSALGTALGPSVGGFILTTAGWRSLFWVQIPLVA
IVLFLAFTLLPTASVKEKVLAQRVSPIRNPTLLSNLTINAAVTSVMMTTLIVGPYYLGPG
LGLKETLVGIVMAIGPATAIFCGIPSGRLVDTWGFGRALTAGLSLVVTGTLMLAILPPLL
GVTGYILSVIVLTPGYQLFQAANNTATLADVPGNQRGTVSGLLNLSRNIGLIAGASVMGQ
AFALGVGTEDFTHATPASLANGMQLTFFLSGGMILAVLAFTHLPRWKRVTR
>fig|218491.3.peg.4458 Bicyclomycin resistance protein
MNDNKMTSGELRATWGLGAVFSLRMLGMFMVLPVLTTYGMALQGASEALIGIAIGIYGLM
QAIFQIPFGLVSDRIGRKPLIVGGLLIFAFGSAIAALSDSIWGIILGRALQGAGAISAAV
MALLSDLTREQNRTKAMAFIGVSFGVTFAIAMVVGPIVTHAFGLQALFWGIAVLSLAGIA
ITLTLIPSAPEHVLNRESAMVRGSFRKVLGNSRLLKLNIGIMCLHILLMSSFVALPRAME
SAGLAPQEHWKVYLVTMLVSFAGVVPFIIYAEVKRRMKQVFIGCIVVLIAGEIVLWASDN
HLWQIIIGVQLFFLAFNVMEALLPSLISKESPAGYKGTAMGVYSTTQFIGVAIGGSLGGG
LFELYGASTVFMAGAAIAAIWLFVSFTMQEPPYLSSLRIALSDLALQDSELEQKIRTQPG
VAEVVIVPDEFSVYVKIDNKKTNRQQLEQVVGQA
>fig|218491.5.peg.2966 Outer membrane component of tripartite multidrug resistance system
MTQARAGLGAATAALLPSGNVSGQATRAYQSVETAQGRLLNSVPGYNRYGNAYETDLNAS
WEIDVFGGLRRDRQAALADYQASEAGVTATRLAVAAQTADIYIALRGLQTRLKIANRQVN
TQQELLEKVQLLHSKGLAAEYQVRQTEGSLSQVQATVPVLQTGIDAAMNALDVMLGTPPG
TYRNQLASSGPIPQPPQLISTGTPADLLRRRPDIIVAERHLAASNARIGVAISEYYPKFS
LNALLGSATSVSSGNLFSNGASQSAGVLGLRWRLFDFGRINAQIDQAKGQEAEALAAYRL
SVLSATEDVENALSALLNRETQTTTLTAGETALASARQSSFIAYQKGTASLIDVLHNDET
LLQTSDARAQAQTESARAAVATFRALGGGWQPPETAAKML
>fig|218491.5.peg.4545 Antiseptic resistance protein QacA
MQSPKKWLILAIVSSALFLIVIDMTVLYTALPTLTHDLHASASEKLWIVNIYALVASGLL
LGMGTLGDKLGHKPLFISGLVVFGAASLFAAYSPTPSMLIAARALLAVGAAMMMPATLSI
IRLTFTDEQERALAIGIWAAVASGGAAFGPVMGGILLEYFWWGSVFLINVPVVLLALIMG
ITMIPHRPGNASHRWDFIGSLLIMVGLIGITYAIKELGKRAPSYEDALIALLIGVTFITL
FVQRQRNSKHPLVDFSLFRLRPFSAAVAAAIVAAAALIGMELAFTQRLQLVVGLSPLQAG
LFILPLSLASFISGPLTGKILPHVNSGTMLAAGLLISGLGMGSYLLLHNASIIIQVISLT
VIGAGVGSTMTAASSTIMQVAPAEKAGMAASIEEVSYELGGATGVTLMGSLLSFAYSATF
MLPAGFSAPDTAYDSLDEALIFAESLPENMQRILTAQAHSAFDSGFSAVLATATLILLLT
SAFVWTTRNNKQQRNQAADA
>fig|219305.4.peg.1697 Permease of the drug/metabolite transporter (DMT) superfamily
MPQVVGEFDMAPVVVDTVPGNRATSSYPCGRVSGVKPDTTPDRAALRSWLPGFLALAAIW
GSSFLFIKVGVRELHPVHLTLYRVAAGALTLLVALPLLRDRLPREPRTWAHQFVVAALGV
AVPFTLFGYGEQRIESMLAGIWNATTPLIVLPMAVLVFRTERLTTRKAVGLGLGFAGVLV
VLGVWAGVGGAHFAGQLMCFGAAACYGFAIPYQKRFVAGSAHSGLSLSAAQLVLATAQLA
VVGPLVAGAPPVPTDLSGGALASVLALGALGTGLAFVINLRNIRVAGASTASTVTYLIPI
FAVLLGALALGERLTWHQPVGALIVLAGVAVTQGLLGRRRRPGAVGVAPPAPPAAPVGTR
>fig|219305.4.peg.1701 Vancomycin B-type resistance protein VanW
MTLYGETRPPADDRPTIKVTAVSWPGDEPDPAAAAAPGPPDTAPARRHRRLRVLLAAGIS
TAVLGAAGGVGAYAYAGDVPRGTTVLGTELGGRSRTDAIRALRAELERAGTPSTPLRVTV
GEKSLEFEPADVGLAVNVEATVDAAAKAQAHPVSRLVGSRAVAPVVTVDAARLDAALRKA
AGDQTREWTVPAIIFTGTTPKAVRPRSGLALDPQRSAQAVRDGWLSGQPVTVPLVENTPA
TSAEEVDRLLDELAHPAVAAPVTLSTDKGSVTIPPAAIARSLRFTADDAGKLTPRVDVKR
LRAALGDKLDTIEVAPRDARMTVTGGKPKPVNGRPGQQLDTEALSRDLLAVLPRADDRKV
TGRLKETQPKLTAEKLAGLGISERVSRFTTHFTGGLSSPRSQNIVQIAKEVDGTVVLPGE
TFSLNGHTGERGYAQGYRDAPVILDGKLVPGVGGGTSQFTTTLFNATYYAGLEDVEHKPH
SYWFSRYPPVIESTIFWPNLDFKFRNNTKYGVLIDTSTTASSVTVSIWSTKIYDSVKTEY
GPRRDVTKPKTVRLKPGPSCIPSNGIDGFTQDAFRVIKKDGKVVKREKFTWRYLAEPRFV
CGGSAD
>fig|219305.4.peg.2002 Permease of the drug/metabolite transporter (DMT) superfamily
MAIVYVLWGSTYLGIRVAVESLPALASAGLRFGAAAVVLALVLRVRRGAGALRVDRRQLG
SAALVGVLLLAGGNGLVVLAESGPPGTAVPSGIAALLVATVPLLVVLLRTVSGDRPRLWT
FAGVTLGFLGLILLVLPTGGSGAVPLAGALTVVAGATCWSAGSFLAGRLRMPTDPFVATV
YEMVAGAVALAVLAAARGELRDFDPGQVTGRSWLALAYLMVAGSLVAFTAYVWLLHHAPI
SLVSTYAYVNPVVAVALGALLAAEPITAQVLIGGAVIIAGVALVVSTERLGRPTGAAARP
ARR
>fig|219305.4.peg.3607 Glyoxalase/bleomycin resistance protein/dioxygenase
MMPELAGVQHVALTVTDAARSADWYAEVLGLRIVVRFEEGGGERYKIILADRAARILVGV
VEHRGAPPERFDERRPGLDHLAFAVDGRAELDAWAAHLDALGVPYSPVAPATLDPRNSVL
VFRDPDHIQLEFFAVPAEN
>fig|219305.4.peg.3718 Multiple resistance and ph regulation protein f
MTVALATVLTVLLSVTALLALARMYRGPSLLDRVIASDVLLNTMVGAVGTEAAINRHATT
LPVLVVLSLLGFVGAVALVRFAVGEES
>fig|219305.4.peg.3729 Tetracycline resistance protein
MATDLTAPAPSRADVAPIQRRTLRLLFVTQIIGGVGVTIGISVGALLAARVAGTAVAGLA
QSAGVVGAALLAVPVTRIMTGYGRRPGLVTAYLVGAVGGVLVVLAAATRQVPLLFLGMLL
FGGGSAASLQARYTAVDLAEPARRGRQLSLVVWATTVGAVAAPNFAALADRTTRGWGLPS
LAGPFAFSAVAFTLTAAVLLVLLRPDPLLTARRLTAAEAPAAADVVPDAAGPTVTGRRGA
GMRATWRVVRERPAARLGIAAVAVGHLVMVAVMSMTPVRLGEYHDDSVVLGVVGVVLSLH
IAGMYALSPVVGWLTDRLGRRQVIIGGLAVLLAACAVAGSAGHHTPGLSVGLVLLGLGWS
GTMVAGSTLLSESVPAAVRPSVQGLSDLTMGLAGAAAGALSGFVMQVAGYPTLALLAAIA
TVPLLALALRVVPTRVPDEED
>fig|219305.4.peg.5363 Glyoxalase/bleomycin resistance protein/dioxygenase
MHDPLGGSFRVSAGTDVVVPGPGRPSWYEYMTTAPADADRFHADALGLRASAPPDAGDDS
YALLLAAGRPVAGRLALPPPLAALLPTGWMVYFAVADPDAVAGRASGLGGRLLVPPRDVA
TGRVAALADPAGAVFTVIRPAPAPE
>fig|219305.4.peg.5800 Glyoxalase/bleomycin resistance protein/dioxygenase
MSTVRVRELDHLVLNVEDVERSLAFYCGVLGLGPVRVDEWRAGRIRFPSVRVSPDTIIDL
VQRHRGESNVDHICLVVDPLDWHDVIASGVFTVLEGPVSRSGARGQAVSLYVQDPDRNTV
ELRWYPADAEPTTPPTP
>fig|221109.1.peg.72 Membrane component of multidrug resistance system
MKDRSTYLDATNLPKVPIIFVMVMGSFIAILNQTLLNVALPVMIVDMNMSANQAQSLTTI
FMLVNGILIPITAFLMEKFTTRQLFLTAMSLFALGTLVCGLAFGYPSLLVGRVIQAAGAG
IMMPLLMNVILSLFPINKRGSAMGYIGLAMMFAPAIGPTLSGLVVQNYSWRVLFFIVLPI
AIIDIILAFFFLRNVTKQSNPKVNYISILMSTVAFGGLLLGFSLAGEMGWKHVEVIAPLM
IGAIVMVFFIRMQLKLKNPILEFRVFKFSMFSLTTVISVVITMSMFAAMILVPIYLQNLR
GFSPLASGLMLLPGALISAFMSPITGKLFDRIGARPLAITGLGITAITTFLFSDLSNETG
YYYLMFVYSLRMVGISMIMMPIMTAGLNQLPQRLYSHGTAMANTLRQMSGAIGTAFLVTV
MSSQTVKHMDEMTQTVVSEEQLKVIENLATIEGINDSFMIATLFAIFGFILSFFIKRRYP
PEESVETVSKEQKRKQPFRNVASGTNQLR
>fig|221109.1.peg.492 Multidrug resistance protein
MNQIHRPTVVALLLAGSFIAILNQTLMITAIPPIIIEMGITANSAQWLTTVFMLVNGIMI
PVSAFLIERFTTRQLFMSSMGIFAIGTLVAGVAPVFEMLLVGRVIQSIGAGVMLPLMTTV
FLLIFPINRRGSVMGLIGLVISFAPAIGPALSGWVTGHFSWRYLFFIIFPIAVIDMIIAY
FALKNVTEVKKTKLDIPSVILSSFGFGGILYGVTNAGNYGWGASITLITLAIGVISLTLF
ILRQLKLTHPMLEFRVFKYAIFPFSVFIGSITFMGLIGTETLIPLFMQNMREFSAFQAGM
AMLPGALVTGFLAPIIGRMFDRYGGKWIVLPGVVIITLATVPFIFIDTETTFAFITTLYA
VRMLGLALIMMPIQTAALNQLPNNLIPHGAAMDGTMRMTAASVGTAVLVTVMTSVESMAE
NQVARPDILGVNVSFSVIAVLGLCTIIAYFFIKFDPSPAKIAKMEEDKSN
>fig|221109.1.peg.983 Tunicamycin resistance
MIIWINGTFGVGKTETAKILHKRIPNSYLYDPEEVGFLIRKQLPVELCEEDFQDHEEWRM
WNYHLLKKITTETEKIVIVPMTLTNEQYYQEIIGRLKKEGIQLHHFTLVAEPQTIIDRLK
KRGDEDNKFIVNRIEKM
>fig|221109.1.peg.1041 Multidrug resistance protein
MSESHVGGSTEKMSRVPILVVLLSGAFVAILNQTLLGTALPHIMSDLELEANTAQWLQSA
FMLVNGIMIPITAFLIGTFTTRSLFLAAMSSFAIGTLICGIAPNFELLLTGRILQAAGAG
IIMPLMQTIMMLIYPREQRGSAMGMFGLIISFAPAIGPSLSGYIVEHSPWRTLFFMVLPI
AIINIGIAYFLLKNVTKRTFPQLDKLSIILSTLGFGGLLYGFSIAGSAGWLSNQVIISMI
VGIIALAWFILRQLNLKTPILEFRVFQYKIFTITTILGMVTFMTMIGAAVILPLYMQDML
GFSAFESGLALLAGAVLQGIMNPVTGRLFDRYGSRYLAIIGLGLIVVTTFMFGMLTAETS
FTYIATIHAIRMLGVAMAMMPVTTAGLNSLPDEFIAHGTAVNNTLRQVSGAIGTALPITI
MSTAAIPSEGLQGLIHGVNVSFIVTAIISIVGLILAFFIHDEKKKRISSR
>fig|221109.1.peg.1196 Antibiotic resistance protein
MNLEKIWTKSFISISLVQLLIFLSFYALLTTLPIYVMDQLGGNEAEGGLVVTVMLLAAII
IRFFSAKLLDKIGKKRGLIISVALFMITSFLYLLVETYTSLLALRFLHGFSFGIITTATG
AIAADIIPASRKGAGLGYFAMAMNVAVVLGPFIGLTLIQYVSFHTLFFILGVLMIVALIN
SMMVQVEEQIVEVNDNRQRLSIHDFIETRALPIAIIASLVSLSYASVMSFISVYASSIGL
ASTASFFFLVFAAVMLITRPSIGRSFDLKGPRFVLLPCLMIFSVGLIALSITNSSWMLLL
AAGLIGLGYGSILPGFQTIAIQLSPDSRSSHATSTFFILYDLGIAIGSFVWGLIVSEIGF
SNLYLVAAAIVVIALFLFEFYYRRPSKKEVNIADVQ
>fig|221109.1.peg.1411 Multidrug resistance ABC transporter ATP-binding and permease protein
METFKKLKRFYWPYKKYFIWSILFMLVVTSITVVYPIMLQITIDDVVVQSRYELIPWICG
LFLGLMVIKGFSTFSFQYLGDLFGMTSVYKLRESLYDKLQTLAFKYYDNAKTGDIMSRLT
ADVEGFRFFLSVGFAELLRIISLILISLSIMFYYSVPLALVTMAAMPFLAIVVFQFDKRV
HPAFRNVRKSFGQLNTRVQENISGMNTVKSLSREDFEIGRFSNSNDNYRQKYLFTSKLWA
RFFPMMEFIGNVSAVVLLAYGGYLVINETMNPGELVAFFSLVWYIMGPLMNLGFIINQFS
QAKASGERLLEILEAKEDIVEKESAIETTIKGHVEFNDVTLTYIKDDDEALKNISFDAPP
GKTIGLIGATGSGKTSITQLITRFYEPEQGEVLLDGRPVSDYKLKTLRSQIGFVLQEPFL
FSTTIRENISYGNPEVTEDQIVQAAKMAQAHDFIMELPNGYDTLLGERGMGLSGGQKQRI
AIARAICIDPSILILDDATSAVDMQTEFKIQKALREVMKNRTSFIIAHRISSLKHADEIL
VLEDGEIVERGTHDDLVNNNGPYERIFNIQYQDREEILSAVK
>fig|221109.1.peg.1412 Multidrug resistance ABC transporter ATP-binding and permease protein
MAKNKDNLKSESKHLQRFHYTIDQAIEKPFNWQQMWRLLQFLKPYSKTYLPGAVLAMMVS
TAIRLAIPILIGKVAFDVAIANKDTTLLTYLVIGIAVLYSISFVANTFRIKWVNILGQNV
IYDLRQKLFSHVQRLSHRFFDSRSAGSILVRILNDINSLQELFTNGIINLLMDLLMLSGI
LVILFVLSPPLALAVIIIIPLMFLISTTLRRKIRRSWQVVRLHQSRMNSHLNEGIQGMRI
TQSFSQEKENAEFFDGVNSGFFQSFRDAAKKSAMFRPLVDICDAAGTIILISYGAYLILN
GTITVGTFVSFAFFLGMFWEPISRLGQMYNQLLMAMASSERIFEFLDERPNVAEKNNALQ
MEEMRGEIEFDKVEFSYNKDRIALKKLSIHIHAGETIALVGHTGSGKSTIANLISRFYDP
TSGAVKIDGSDLRDVTIDSLRQKISVVLQDTFIFSGTIMENIRFGRPNATDEEVIDAAKV
VGADDFIQRLADGYQTEVEERGNILSAGERQLLSFARALLANPSIIILDEATASIDTESE
VKIQQALKRLLKGRTSIIIAHRLSTIREADNIFVLEQGEVLEQGNHQSLIQQKGKYYELV
KSQFTMLDAM
>fig|221109.1.peg.1709 Multidrug resistance protein
MGKNHTSTAILSLGSIPFITTLGNSTLIPILPEMKEALGISNIQVSLTITLFSIAAAICI
PVAGYLSDRFSRKAIIVPSLVIFGAGGLLAGIGAAFFSSAFIWLLIGRIIQGIGAAGTFP
IAMALIGDLFKGSEQSKMLGIYEASNELGKVLSPIIGAAFALITWYFVFFTFPVISFLCA
ILVFFFIKERRNRQTPPPFYQYVKGLFLVFKQEGRWLFTVYLAGGTCLLTIFGILFYLSD
KLETENHIIGVWKGLILAIPLLILVATSYRTGSRIGKNFVKMKRLAVFGFLLMTLSYLSL
IWIEPLVWFIFALCFSSIGAGLVLPCVNTMIAGAVGKEKRGFITSLYGSVRYIGVALGPL
LFGWLMDWSRTGLFLSVACFTFFVALLVLFLLHVNGMDGRDKRTKITYNYY
>fig|221109.1.peg.2135 Daunorubicin resistance
MISVQNLRKSYKKNVVIDQLSVDINSGDIVGLVGENGAGKSSFLRILATLSKADKGTITW
NDVSYEKETKKLRRDIGFVPQEISIWEDFTVEENMKFFEKLSWVNRSESELKQLCLDMKL
SKWKEPVHTLSGGMKRKLNMAISFIHDPKLLLLDEPTVGIDLKSKKEIGEYLYKQSKEHH
KTIIYTSHDMDEIISLCDWVICIGKDSFYENLLKSRGKEIFTI
>fig|221109.1.peg.3060 Multidrug resistance protein
MWLANFFISGSMTMVVPFISLYIESMGDFSEGYVQTWSGLTFAVTFITAFIFSPIWGRIG
DRYGRKKIMIASAFGIGFSVFLMGFADTVWQLFLLRLFMGIVTGFIPMSQAFIATQTPKE
VAGKVLGTLQTGTITGSLMGPLLGGALADAFGYTSTFKWVAITIFISGLLVLFGVKELKM
KFSNNENDTKKYSRKEVLQHILQKPVLFVVMLLSALVQIAHFSIQPILSLFVAEIHGPVN
LAFFAGIAFSAAGLGNLLMARRWGIIGDNHGYVKILIILLFAAGFVYLPGIFVTNIWQLV
ILRFLLGLSIGGIVPLRIAYIRQEAPLSMQGEVLGYNTSLRFLGNIIGPALGGTIAASFG
FSAVFIITSMLLILSGMIMLYVWYRHEYESTSSHSYSSK
>fig|221109.1.peg.3265 Broad-specificity multidrug efflux pump YkkD
MNWIILILAGLSEVVGVNGIQKVSAGKKKSGFAFLIIGFAVSLTLLSIAMSTIPLGVAYA
VWTGMGTVGSVVIGMIFYNDSADRKRIFFLSLIVVAVIGLRIVSN
>fig|221988.1.peg.741 Fosmidomycin resistance protein
MQNKFAVYLAAIGHLVTDMAQGALPALLPLFIKNYGLTYQEAGGLIFANTVLASIAQPFF
GYLADKRSMPWLIPLGMMLSGCCIAAMGFVHSYPGLFFFAMIAGIGSALFHPEGARLVNR
MSGGEKGKAMGIFAVGGNAGFAIGPMFAGLAYLFGAQTLSIFALINTIIALIIFLQLPKL
TVENVVNKAKNTASTTLQNDWRSFAKLSVIIFVRATNFTVLNAFIPIYWIHILHQQETDA
NFALTIFLSMGVAITFIGGLLSDRLGYVRIIRYAYLIFLPTILIFTQSENLWLSFILLIP
LGLGVFTQYSPIVVLGQTYLAKSVGFAAGITLGLGITMGGIFSPIVGWIADHYGLQIALQ
TLSVLSLLGLIFSYRLKITDTEKPEKK
>fig|221988.1.peg.1644 Permease of the drug/metabolite transporter (DMT) superfamily
MLFQIIATLIWASAFIAAKYTYEMMDPVLMVQCRFFIASIIMLPGFFAAYKRVPKERLKI
MWLLALINFPLMFLLQFIGLYFTSAASAVTMLGMIPLLTVLIGFLFFKRRINKIDLLLSL
VALAGIILTVVGGGEDNLINPWGCLLVLGSAVSFCFCLYLSKDVMQEMAPKDYTNVLVIL
GSILCLPFTCVLVRDWSIVPSVKGMISLFYLGIGCTWLAVVLWFKGVQKTPTYISSILTT
LEPIFGVILAILILDERLSTVSAMGILLTLGAAAVSVLIPVLMKKSP
>fig|221988.1.peg.1645 Permease of the drug/metabolite transporter (DMT) superfamily
MFYLIAAVLIWASAFIAAKFSYTMFDPALTVMLRLILSALLVLPTFFRSYRKIPKQYRLQ
LWGLGLLNFPVVLLLQFTGVHYTSVASAVTMLGTEPLVVTLLGHIFFHKPARLLDWLLGI
VALTGIVFVVYGSESGGEVTLLGCTLVLLGSIAFSFSIHLAQSVMKAVEAKAYTDVIIMT
GAISCVPFSLLLVQDWQIHLNIEGISAILYLSVGCTWLAYRLWSKGLRVSSANTASILTT
LEPVFGVLLAILLLGEHLTLTTLFGICLVISAAGISVLSSMLINYIKNKVTIL
>fig|222891.5.peg.51 Bicyclomycin resistance protein
MNRFLHVVLITFVVFVADVAVEIYVPALPSIGVFFSATAMAVKASISSNILGLALSSLFW
GTVSDLWGRKLALLLGSLVFVVSSVLCIFSASIDALVFFRFLQGIGQGVAVVVGFASVKD
FYSGEKCAQVISKLSSVVAVSPTFAPILGTVILFYFSWHYIFLFLASLGLVCLLLLVFFF
QDTLKERNPASLRGLLNSYIRIATNKSYVLYSAITVITFMWLWNVISSAPFLLLEDMGVT
IQEYGYLVAINVMGFLLGTILNSKYIPKVGLKKLVAFGLALPLLSEVLLILLHYTTGFSP
LILECIWFFSAMGLAFVIGNSTTLALDQVGESNNGKATALLVCSEMALGSLSVYLNAPFY
DGTIVPLSLFTIVSVLASMIVFYYAVRNPGNTVKPAR
>fig|222891.5.peg.146 Multidrug resistance protein D
MDLQMLDFLLERNKAVLVLWFILIAAGLYSCFVISKEQTPNMEIPYILVNAVLTGVSAED
STRFLSKELEDSLRSIEHLKSITSQSVENASSILMEFEVGFDSAKALASIRDKLDQVVSK
LPKDTLRPTVEQVSTALIPAVVVTVSSNLGVEATQMVATKLRDRLNTLANVLSTKIIGKR
KKIVEIMIDPKTFSRYNIGLHNIVNTLHQNNTLILSGSFPSNEYLVSTNGLVTHLNKLKE
LPISLNNGNILTLKDIADVNGVFEREKALSRIGGMDTVVIEVSKAGGKNLLETVKQVQEE
VSKMQATLPEGFSLSTEFDTSTEVKEVLTDLKNSIALTVVMVVAIMVVYIGWKMALMTAF
TVPGSIFIAILLLYVGGFTMNIVVLFSLIMSVGMIVDAAIIVNEYADRKMLMGSSAREAY
TLSARKMFWPVLSSTATTLIVLVPLLFWPGLAGEFMKFLPITLIFTLSASVLMSVVFTPV
IGSMIGTPSTSDPVEISKIFAIDQADPSAMGKISGKYCRLLEKLLDHPKAVVAGISVFLV
LSIGGYYIFGKGLQFLPNVEPKSSTILIKAVENLTLAQKRTIVETAEKTICETPEIKTCY
TKIGTLGNDVIGSVQVEFAHWKKRRKIAAINDDIERRMQSIKGIQFELFTQKDGPIQEKP
IKIVISGTSYGEVAQAAASIEEMLSKINGTKSISDDTSVQKLAWEAVIDRNKAARYGVDV
ATVGQYIALATSGITVGEYRGNDHEEKLDIVLTLPEEGKSVSSILGMMIPSQKGMIQLSS
LMKVKPIAKTTTVKRFNSEPTIHVYSDVQPGFLSHNIVKSLRKEIEKHKELSQLKISFKG
EQQDQSETTRFLVVAFLVSTLCMVLILLLQFNSFCQVLIILTAVALSTGGVTFGLLITHQ
PFIVVMSGIGIISLAGIVVNNNILLIDAYNDYMSESTDKKRSIIRAAISRFRPILLTSGT
TVLGLLPMVFCITINLVDFTISYGAPATQWWQSLATTVAGGLSFTTLLTLILTPALLMLS
PTPKLNTRT
>fig|223926.6.peg.1156 MFS family multidrug transport protein, bicyclomycin resistance protein
MTEKAQSAPQSQISFLLFLVLGAIGALTPLAIDMYLPAMPTIAKDLGVAPGAVQITLTAY
TAGFAIGQLIHGPLADSFGRRPVLILGVLFFGLAAVVSATTNGIDALTYVRTAQGFAGAA
AAVIIQAVVRDMFDREDFARAMSFVTLVITIAPLVAPMIGGHLAIWFGWRSIFWVLAIFA
VVVILLVFWKIPETLKPENRQPLRFRTTLKNYARLCSSSEALGLMLSGAFSFSGMFAFLT
AGSFVYIDLYGVRPDQFGYLFGLNIVAMIIMTSINGRLVKKVGSHAMLRFGLFVQLLAGI
GLFVSWLMDFGLWGIVPFVVLFIGTLSTIGSNAMALLLSGYPSMAGTASSLAGTLRFGIG
SLVGALVASLPGNVAWPMIIVMFACSVLSALFYWTLGRKA
>fig|223926.6.peg.1682 Permease of the drug/metabolite transporter (DMT) superfamily
MNILLAMIPAFFWGTTYAVTQFTLPDWPPVLLGALRALPAGLLLLAIKPSLPKKHEWKVL
LVLGTINIAFFFGLIFVMALTLPSAISGVGMISVPVFAMLFGWAVYKRQPSAIQGISGAV
LIALAWFLFDPSSISLNPIGLGAMLAAIMCIVIGSSVTKSLGTKMHWWTVLTWQLILGGV
LLSIAAAVLATINPQPYVHAVQNIDMTNTLGLLWVIVLNTALGYGMYVWLLQRMSVVDFT
FGGIANPIAGIVSGLLLLGENFTPLQYSLMVGMIVMSLLPQILTSLRARKEAITV
>fig|223926.6.peg.1901 Multidrug resistance efflux pump
MTADQKFKHWMRTLIVLFIVLFLYIIIADRHAPLTTEGRVQGYVVQVAPEVSGKVTDVLI
ENNQSVQKGDVLFTIDDRKYKIALEQAELSLQSAYEKEATLYSQREAALANIARAQATFD
NAHREYTRLLTLSKQKVISQSTLDNAFAQNQVSRAALKAERQNLKVIEAQLGDQKGQSTA
VRIAKNGIEKAQLDLANTAVLAPSDGVVTNLQLEVGTMANTNMPLLTFVPTGSLWVAADF
REKSVANVDKTFHALVTFDANPGSVYDFDLASRDYGVAAAQQTPNGALTKVEVNNRWVRD
AQRTRVNLTSSEELPPALFVGSRATIVLYPDNSIFWQLMAQAQIHLASWFHFIY
>fig|223926.6.peg.2350 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQNSIYKQFWKYTIPTVAAMLVNGLYQVVDGIFIGRYVGADGLAGINVAWPVIGSILGIG
MMVGVGTGALTSIKQGEQDQQGAKRVLTTGLLFLLALMPIVATILFFFADDFIRWQGAQE
RVYELGLQYLQILIVACIFSLGSIAVPFLLRNDNSPNLATILMVIGAIINIVLDYVFIAW
MNWELTGAAIATALAQMVVTVLGVGYFFSSKAKLRLTFRELKVQLDAIPKIVLIGTSSFF
MYAYGSTMVALHNALFAQYGSPLLIGAYAILGYIVTVYYLVAEGIANGMQPLVSYNHGAR
NQDNIRKLLQIAMGTSVLGGVVFVVLMNLFPYQLVSVFNDADQQLIESAVMGIRLHMFAL
FMDGFLVVAGAYYQSVNKGSKAMFVTVGNMLIQLPFLFIMPKLLGVTGIWIAFPLSNIAL
SLVVMSMLWRDIKKLMVDSPVEPSIQAS
>fig|223926.6.peg.2719 Permease of the drug/metabolite transporter (DMT) superfamily
MGYEWLALCAAFLWAVSSLISVIPAQHLGAFSYSRWRMGCTAVILSTMAWITGGWLSVSW
EHITPMMASGLIGIFIGDTALFACLNRMGPRQAGLLFSCHAVFSTILGYFLFSESMTAIE
LLGSALVFSGVVMAIFFGRRGQTNNVLEEIKGNIWVGVSLGLTAAICQALGGIIAKPVMQ
TSVDPIAASAIRMISAFVAHCLLLIVGVKVARSTQRITWRVFGITALNGFLAMAVGMTLI
LYALREGNVGMVALLSSTTPIMLLPLLWVYTKRRPNRFAWLGAALAVIGAGILVQ
>fig|223926.6.peg.2746 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFNMLEKNKPENHATDKHGLLSAPIPETLRKMTVPMTMGMIAILMFNLVDTFFISLLGTH
ALAAISYTFPVTFAVNCITMGIGMGLSTNIGRLLGQGHAPQAARFTTHGLLLAVLLVAIA
SSIGFATIAPLFRFLGATDDLIPLIEQYMQVWYLTIPLLVIPMAGNSAIRATGDTKTPAK
IMMLAGLINGMLDPLLIFGYGPFPELGIQGAAIASAFSWLGALCGSFYVLVKREKLLAQP
QWASLKQDWQQTLKIGTPAALSNAMNPLSGAILMMLLSSHGTAAVAAYGAAQRIESILIL
VLMSLTSALTPFMAQNLGAKNPQRAFSGLFLSMRFAVVFQGFIFLMMVPLSIPLAALFSQ
EETVKNLLWHYLLVVPFSYGFQGIVMMLVSGLNAMHKPLRAFQWSFMRLFVFTLPAAWVG
SQVYSIEGLFIGIALGNTLGGLLGYMFALRERKLTLIEQNSAS
>fig|223926.6.peg.2902 Multidrug resistance transporter, Bcr/CflA family
MSSHISNSKKQMALLTLLVLFSPLAIDIYLPALPLIASTFQVDNALAQDTITWFLFAMGV
GQLFAGPLADKLGRRTVALGGITIYAMSALLAWSAQNIEWMLMSRLLQGLGACATSVAAF
ATVRDIFGPEKSGKMISYLNGAICFIPALAPILGSWLTQQFDWRANFSFMAGFAVVSGTL
MFLMMKETNPATEKQAVFKVSRYWSVLSTPSFIFHASLCLMAMAVILAYVTSAPSVLMTG
MGLSMNEFTFWFGINAVINIAGCMLAPKFMERFGTHNTLVVGISTLALAGVVMLVMNGQN
TALSFMLPIFMSSVGFALILGGAAGKALEPFGDKAGTAAALLGLFQMSGSGLLVGTLQRL
PFDPQTLIAIHMWVLLPALVILFSKAGKSWHARFANA
>fig|223926.6.peg.2950 Multidrug resistance protein
MLGFVATDMYLPAFKAMEIDFATGPEQIALSLTVFLVGMAFGQLMWGLASDKFGHRNTLA
AGLVLFTIASFGLAFCDEVWQLLTLRFVQAIGVCAPAVIWQAMVIKRYSSSSQQIFATIM
PLVALSPALAPQLGVVLADSFGWHSIFIALTLVGVVLVAATMAQKNEQAEIKQTSMSADI
KALLGSKTYLGNVFMFATASAAFFAYLTGMPEIMAQLGYEAKDIGLSFIPQTIAFMAGGY
LGKVGVRKFGDEKVLRQLIGLFSVAALLIFVASQWELTSIWPILAPFCLIAVANGALYPI
VVNRALASAHQSPATAAGLQNSLQITVSSLSSALVAAMASQAQMVTGVAIVICMGGLWMG
YILSNRELSKHFTTPDNARVVSEDEL
>fig|223926.6.peg.3057 Multidrug resistance protein A
MYWSWQYSDSHPSTEDAYVRAKILSVAPQVKGQVVSVDVKDFQSVNKGDLLLKIDSRPYL
LAVKQAKAAYQLAVQQHDVADKQVTEAVAGLDAARSNLTEAQVEYKRTDSLVKRKLASDQ
DLDTAKNKLANAQASLEQARATVEKAIANRGEEGAEAAVVQQAAAQLAQAELNLSYTDIT
SPVDGIAGEINTHVGSVVSVGQTLFPVILKDSYWVRANFKETDLTHIKPGMHADVVIDMY
PDVVWKATVEQLSPASGTSFSLMPPENATGNWVKIKQRFPVRLALEVPADAPQLRVGASS
EVTIDLQSSVQ
>fig|223926.6.peg.3079 Permease of the drug/metabolite transporter (DMT) superfamily
MLIRAIPFVFVILWASGFVGARFGLQYAEPATLLSIRMAFNVLLFLVLVAVLRRRLPTGT
DFWHSCVVGALIHGFYLGGTYFAIALGMPAGLSSLLVGIQPILTAALLVAFVREEFKPSQ
WLGLALGFVGIAMVLMGKMEWQSEQHKVLAIGLCLLALVGITLGTLYQKKHCQQVDMVGG
ATVQYLAALIMFLPVAMQFETMQVQWELEFILTVLWLVVVLSCVAILLLLYMVRNGASSS
VASVFYLVPPTTAIQAWLAFGESFDWMGISGFVLAATAVYLVVKKPDLTIKKAIKTEYT
>fig|223926.6.peg.3126 Multidrug resistance protein D
MYVPSIGHMAGEFLVSASSLQAVMACYLIPYGLSQFAYGTLSDRLGRKPIIIVGLLIYIL
GTLVALFAHQFEWFLAGSFIQGLGIGCGGAMSRTLTRDCFEGAELHRANSLISMCVIFSP
LMAPVLGGYLTEAFGWRSSYLFLALFGIAVVITMMTSMMETLPKEKRKFEPVAKSYKHVL
SDRRFQGFLICLVATFAGVGVFEAAAGVLLGGVLALPATTVSLLFILPIPGYLVGAGLSS
YIAQRRSERRALNVGLVSIFIGSAVVLIPGLFGVTTALTLIGGATIYFLGAGILFPAATT
GAIAPFPYHAGTAGATLGGMQNLGAGIATLLASLFPAHNQMPLGVLMMAMSIVAMLGLLW
VHRAHDHSNEMPQVI
>fig|223926.6.peg.3196 Permease of the drug/metabolite transporter (DMT) superfamily
MDFLAIALVVFSAVLHAGWNILGKSHSGSGVAFTMAASLSACGVLTPYLIWYLTTLGWTS
LPVEFWGMLAFSGIAQIVYLVGLIMAYKHADVGVIYPIARALPVMMVGGFSVALGHALSS
QQWLGFVLITFGCILVPLTHVRQVSLVAYLNVGVFWALIAAIGTTGYSVVDKEALTLLTQ
QASTIFNDQYSAIFYLGAQFWAMGLPVLLWCLITRNDQELQAAWRIRKSASMAGIMMAST
YGLVLFAMTMTDNVSLVVALRQISIVFGLLMGIWLLAEKWYLTRGIGVAFILAGIVLSLE
GA
>fig|223926.6.peg.3265 Permease of the drug/metabolite transporter (DMT) superfamily
MKVTSVGAAMLLLIVGNLIAVLSDSLIKSVANEVPMFQFVFFRQISAVMFLLPVCLLAKQ
TNFMEGFKWHAVRAHVWLLGAVFMVMAISSLPLATANAIFYAAPLIMLPLAAIFFGEQLS
KQSVAAAVMGFAGVLVIIRPDQIDWAAISAFVVALTLAINNLLIRKLPKNQSVMQTLLMT
NLAGIPVALLLVLIEDQPWQWGAFPVAAGSSLFIMIYAATCVLAYRSIDSNKIASAEYSG
LIGAVVVGFIWFGEIPDIFMAIGTVMIVVPLIWLSKRERRKQKEHAQLQAQKEHEQQQAH
VA
>fig|223926.6.peg.3308 Acriflavin resistance protein
MINLAEFAIRQRKFVLFFIVLSVIAGIYSYFDLGKLEDPSFTVKTAVVVTLYPGASAEEV
EHQVTDTVETKLQEMAELDRLRSLSRPGLSMVFVDLKESLNSKALPQEWDLLRRKVDDVK
LQLPSSAQISVVQDEFSEVYGMLFSIHSTDAAPEELRRYAEELQRQIKAVDGIKKIELHG
VQPRVVHIDMPDERLAQYGLSIAQVWNQLSTQNSTFEAGKFDAGTERIRIAQTSEFQSLE
DIRNLIINGGTGEFGSGLIRLGDIADITMGYQTPALAENRYNGEPAVTLAVSPVQGINVV
SLGDTIQDIIANYQASLPLGVDISTVAYQPEEVQKSIDDFVGNLLESVAIVFVVLLVFMG
FKSATIVGASLLLTILLTLVYMNIASIDLHRVSLGTFILALGMLVDNAIVITDMMIAKLN
KGIERTRAAIDSVKETAVPLLGATVIAIMGASPVLFSKTDSAEFASSVFYIVASSLLLSW
IVAMTFTVLMAWMFIKPKANNEETKPSRYKQLVFWTVDNPRKALAALVPLILVTAVAIPY
VAVNFIPQSDRSIVFLDYWLPNGAKIEQTSADMRKVEEWLVAQPEVESISSYVGTSAPRF
SVTVEPEPLDPAYGQILINTKDYESISHLVTRGDDWLKEAFPDAEPRFRALKLATKDKFA
VEVRFSGPDETVLHQLAAEAKTIFASNPDAKYIRDDWRQESKVLKPILNQDKMRQAGINR
ADVAFALKRASDGMPLGQMNLNDELIPIQLRGTSQNMASLETLPVRSLLGFNSVPLGQVV
DGFELVTEESMIWRRDRVKTITVQAGVSRDSTPANVRNAIKDQVEAIQLPAGYSMEWGGE
YYDEDKAVTDIMKQQPKAMLIMVIILVAMFNGFKQPIIILATLPLAASGAVFALLGFDKP
FGFMALIGAITLTGMIIKNGIVLMDQIELERTNGKSLSDAIKEATVNRTMAISMGALTTA
LGMIPLLSDLLFDQMAATIIGGLAAATILSLFVMPALYRLVYKEKAPSTQTNAELEEASS
>fig|223926.6.peg.3346 Permease of the drug/metabolite transporter (DMT) superfamily
MVYLLPFFTVMIWGGNSIVNKMAASTIEPSAMSFYRWFVAMVLLTPFCLPAVIKQRHVIR
PYLTKLAFLALLGMVLNQSLGYYAGLTTTASNMALITSLVPLISVFLSVPLLGKSVSMLS
IVGGVISLGGLAFMLGHGDVTYFLHQDMTQGDSLMLLAALVYAAYCVLLKRWKMPFNSLT
LVYMQGFFSVIMLTPLWLSSEQLLPSQEALPLIAYAGIAASIFAPLMWVKAIDLIGADSS
AMFMNLMPVVSVALASTLLGEEIHVYHIIGGLMVISGVILSQIKVRKKQDLVVSESLTTT
TR
>fig|223926.6.peg.3463 Multidrug resistance protein D
MRKTPLLLAMMIIATGQVGVSIYLPSLPLIGHDLNLPQPSIQSLVTLFLVGFGVSQLFYG
PLSDAIGRRPVFILGQSICLIGTVICIVFGDNISALEAGRLLQGLGAGSASVLGRSVLRD
SYDGMQLTKALSYISVTASVMPIVAPLFGGWIAYHFSWQAVFVFVLLYLLAIFILGYLVL
PETLPYPKRKFEVRQVMVNYFYLLTNKQVIGSASYNWLSYLSGLVTLSLYPFLMQQELGL
TAADYGSLMIIPSAGLLMGSLVLNLINNRYKAQQILLMSFAIVALSGCLLLVTPFTVASL
LVAFTCLSFAQGMSFPVSISLLLSPHKQQAGAVSALSGSIQMCLAGLFGGYLVEKWVTDQ
HQLGIFYLFIALISCIVLVVSQYRRAPRQTAQPEASS
>fig|223926.6.peg.3509 Permease of the drug/metabolite transporter (DMT) superfamily
MLYSLSSIFLLIVVGIPKLSYFSPKYLIVGGAMFVCYEIFLALALGYSNSRAQAIEVSIV
NYLWPALTVLFAVLGSNKKPNWLLYPAVTLAFIGVAWTVSGDNGLSPTQIISNVSSNPLV
YFMAFTGAVIWAVYCNLTQRQQSKHNAITLFFIATAVSLWVKYAFADEPTMTFSWSALGY
LFASAALMAGGYGLWNIAIVGGNMVFLATLSYFTPIFSALFSSLILGVTLSNSFWQGVVM
VTVGSLLCWLVTKEKREAAG
>fig|223926.6.peg.3552 Permease of the drug/metabolite transporter (DMT) superfamily
MFNSERKATVILVATTMIAALGWIFSKETIQGLPPFGFIGLRFTIASLCLLPLCFRPLKA
ARLKDVLAASGVGLLLGGAVMTWIYAISISDTLGEGAFIMSLSMLFVPIVAWVMFQQRPQ
RIFWISLPIAVIGLACLSLAGGWKQSASQLWFLGAALILALHFNVNSKYSQKLPVLLLTC
VQLFSAGCLGLLVSFLMESRPEQVDSSIWWWFALSTLLATSLRYVMQTMGQKFVQAGNAA
LIMILEPVWTVVLSILWYGEVLTANKLVGCLLILFSLVIYRTGGRFRFPKRA
>fig|223926.6.peg.4143 Permease of the drug/metabolite transporter (DMT) superfamily
MILGYAAILVTVLLWSGFFISLKGGAISALQPADIALVRFLVPSLILLPFVMKHKAALKV
VPNKYLTGIVLGSGLPYLLVAGTAMHFAPVAHGSALIPGTLPLFVSAIAVLFYQQSLSHH
RIIGLSTVLLGIFVFLLSNIGEEYNWSQLQGHAMFLVGSLMWAVFTISARVANLNAYVCA
GFVAIVSLLMLIIAVGFGWIDSYLAVTPISSWPWEELFSHAMLQGVGAGLIASFTFIYAI
KIIGAEASAAFGSLTPVVATLLAVPIFGEQPDSLTWIALILVTCGSVVASQIFMKHELTQ
TYRPPLHR
>fig|223926.6.peg.4155 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPSTSTNAQPTLAKQLFTMTWPMLFGVLSLMSFQLVDSAFIGQLGVLPLAAQGFTLPLQM
VIIGIQVGLGIATTAVISKALGANDARYAKQLGGLVLMIGSIGVAVFGLLIWLLRYPILS
LLSAPETVMPIIDSYWPWWLLSSWAGAVLYFYYSICRANGNTMLPGTMMMVTSGVNLVLD
PLFIFTLDLGINGAALATLVAFGFGILVVAPRVKRNHWATTQWQDLNVMKSVTSIGNIMG
PAMVSQLLPPLSSMLATKLLASFGTAAVAAWALGSRYEFFAIVSVLALTMSMPPMVGRLL
GAKNYRDIQSLVGIAVKFILGFQLLIAAITFLLANPLALLMTSDTQVEQVLHMHLMIVPI
SLGSLGVCMLMVSICNALGKSYTALTISALRLFVFFLPCLWLGAQLDGIRGLLFGACVGN
IMAGISAYLTYRKTIHKLAIKQATA
>fig|223926.6.peg.4452 Permease of the drug/metabolite transporter (DMT) superfamily
MNHVHKPIVFMLMSTLSLSVTGLLAKQLSEALSVTMFSFLRFFLPAVILLLVLIPKGIKL
PKSTELKPTLLRALCIGLSQLCFIASLQTLTLVESVVLFATGPLFMPVIEKLVWHGKIRA
SIVFGIVMAFSGVVLLAGTEGEFTLRYDLLLGLAGGLFNSGSQLTLYKVSKSNMSPLEIN
FWAFSFAALFILPLALINDGSGLLGAHSFSLSVEPSVLWLLVMSMLIINTQVFRAKAYQL
ASSGSQLAPLIFTNLLFTAVWQSLFFADVMSRTQIAGMGLIVLATVLNGCWDVLVKHHQS
KALQTRTS
>fig|223926.6.peg.4497 Permease of the drug/metabolite transporter (DMT) superfamily
MSTFLLTAITMLAFAANSLLCRLALAEGLIDAGSFTLVRLISGAITLIALLVVRGQWKTD
RPTSRFRFFAGVALFGYAALFSFAYLQLATGTGALLLFGAVQLTLLVIYWWQGERFQFLE
IIGIGLSIVGFVWLMLPSTTRPDISSALLMLISGVCWAAFTALGKQAPSPSSGITWGFIA
ASMIGILLSPLMLSSIHLSLSGILLAITSGAIASGLGYTLWYQVMRKLSLLQAAVSQLSV
PAIALLLGTVVLHESLSLHTLLTSGIILGGIALVFLSRSKKTSKQLASR
>fig|223926.6.peg.4499 Outer membrane component of tripartite multidrug resistance system
MMLPKLTKPSLAILSLLGLSACTTVGPDYVHPPQTPLPSDWSVQKAAKDTQQSEQQLQQW
WQQFNDPTLNRLVELANEQNLDIEAAGLRIVQARSLLGISTGLQYPQVQTVSGNLARAYV
NDQGVNNAALSFDAAWEMDIWGKYARGIESAEAGYYASIASYHDIMVTITAEVARNYINY
RTFQERILLSRRNIEIQERVVHITQVQFDSGNVTELDVQQAKNQLYTTKAAQPSLEVAMK
QSRTALALLLGVLPEEVEKLLQSDGLTQQIADYEAQFKSTGRKSALSGTDEHSIVPRPPL
LDTQVDANLVMRRPDLQVSEMQARAQSAQIGVAETALYPSFSLFGSIGIDSTVPDGSSFS
FSDSLTMVVGPTFSWNIFQYGRVKNNIRFEDARFQETLTNYNKKVLQAVNEVTNAIEAYD
LYLQQKDLRLQSVNSSIRAFNISMTQYENGQISFERLLNSVEKMTRAEDSYAQIKGNVAN
QVIALYKALGGGWQAQTGKPFLEESIAKQMQDRTDWDGYLDEENRTLPPLPIETPTENGD
KNKTEDL
>fig|223926.6.peg.4501 Fusaric acid resistance protein fusE
MKKLFVIALNLVILGGAAWLGYQKFEEYFNNPWTRDGQVRANVIKVAPRVSGPIVNVSVQ
DNQEVKTGDLLFEIDPTTYEVALSQAEVALEKSIVSSRGKKIEYDRLKDIRAKDRGAVSH
KDLIRREIAYEESLLQIKSAEEQLKSARLNLSFTKVYATVDGFVSNLDIRNGTQAVANQP
LLALIDKNSFWVFGFFRENQLAQIEPGSRARVTLMSHPDTPIDATVDSIGWGIAPKDGTV
GYNLLPNVNPVFQWIRLAQRIPVRISIQELPEDVDLRFGLSASIMVMKDSSAENEQ
>fig|223926.6.peg.4566 Multidrug resistance protein D
MNRPINFRTILLACLIISVGQLSMGLVMPSLPWIAKDFSVSLDQAQLLVSIYLLGFGPSQ
FIYGPMSDALGRKKVLLAGLLIAMSGLLMIIFWSHTFTGMVLGRFLQGLGTGCCAVLARA
STRDQFSGNELPVAMSYIAMAASITPLIAPVIGGFINFHFGWSMVFISLLGYVSLAWIII
AFRFKETITRRSAIPSPAKMLVQYRDLLSSRYFMSFASISWLNFSLMITTVSVMPFIMQD
QIGMTSDEYAMWALIPALGMLGGTTICNRIRPVIGNKKMLLCTPVLHISAALWLFFCPVE
PLYLMIGQLLMILGNGIALPCAQALVMQPYKEQAGAAAAMSGGGQMVVSSLVSMTLVQLG
LSEAWHLSLVVVLFTAITLTNILRGFNTEEAQQHREVAEKAS
>fig|224308.1.peg.189 Chloramphenicol resistance protein
MSNTWKIYILAIVSFLVGTSEYIISGILDQIAHTLGITLAAAGQLITIFSLVYALSTPVL
MALTASMDRRKLMMYALGLFVFGNVLAFVLPGYGWFIAARIIMAMGAGVVVVTALTIAAK
IASEGKQGSAIATVVMGFTASLIIGVPLGRMIAVALGWKSVFGAIALLGLIAMVVIFFTL
PYTEGDKPVPLLQQLALFKKRKVAMGLSITFFWLGGYSVAYTYLSPYLLNISGINGKLLS
GVLLIFGIASLVGSKFGGYSTDKWGVPFTLVGGMTLHIVTLILLSLVTHSYIGVLVILIL
WSFAAWSTGPTQQFHLATIEPEMSGVLLSMNQSMMQFAMAVGAGIGGVFVENVSLASITW
VGALGVMIAIIASLLIFNSQPKQALKDINQ
>fig|224308.1.peg.255 Permeases of the drug/metabolite transporter (DMT) superfamily
MRAEEQSKIREAAAGTIFLLIGTVCFASKSIWIKWAYQMGAEPDAVLLYRQLLAVPLFWL
IFLIYRPPMPDGKKKGDLWKACGAGVFCFFLSPLLDFIGLNHVSAMVERILLMSYPLFVF
GFTACRDRKMSSIQDLFAVLAVMFGLFLALGGWNAELFQANMIGAVFILLSSAVYAGYLV
LSGHLVHQIGGIRLNAYGMTAAGAAMMLYTGIKSAAGMNTPMAAYPLSMYGLFAVIAVVT
TVIPFVLMLEGIKRIGAQRAAAISMAGPILTIFYGALFLGERLGLIQVIGCGGVFFVITG
MEYRKLKTGKKE
>fig|224308.1.peg.315 TmrB protein, responsible for tunicamycin resistance
MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPQKMGFALRSMVPQEIAKDDFQSYPLWRA
FNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLR
TRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSL
RRFADRLMVKLNHIRIK
>fig|224308.1.peg.721 Permeases of the drug/metabolite transporter (DMT) superfamily
MKKRLSLDRRFLPYIKKAGGVLVKKQMGAYVSLAAAMAIVGSSVVVGKLMVERIPVFLSS
GLRFLIASVVLLMLLFCIEKGFPALTKKDVFVLLVQSFTGVFLFSICLLYGVQYTTGTES
GILTSTTPMLIGILSFFLLREKIEKKTLIGILLAVCGVMAINLFGAGSQDGTPHALFGNM
LIIAAVIGEALFTLMAKLLSPHISALAISTFVSLFGFLFFLPFALFEASSFDYSVPTVLD
WSYVLYYALFVTVLAFYLWYSGVTKVPAGVSGIFTSVLPVSAVILSGVILKEPFEFVHFI
GIACVIGGIFVTVIKKKQPDAYPAAEEKTL
>fig|224308.1.peg.821 Multidrug resistance ABC transporter ATP-binding and permease protein
MQKALSFLKPYSLLAGIALILMLTELAVELMQPLLIAKIIDDGILKQDLRHVWIWGTVMI
GLTVLSFAAGMLNSFYAAHVSQSFSYDTRKGLFQKIQSFSYSTFGQFSSSSYITRLTNDV
TQVQNMIFMSLRFMLRAPLMIAGGIVLSLAVNVKLGFFLLVTIPILILFLLWVLRKGGAL
FRSVQKRLDQVNTIMQENLIAIKLIKALLRGSHEVKRFIKANTRLMEKTVSAFQLVEFTM
PVLMLLMNLCILLILWAGSYSITSGSTQVGDVVAIINYATRITGALSMFPFLIMIFTRAK
ASGDRIGEVLETEGDEREEGTISDRLSGRIEFQHVSFRYPEMDREALRNVSFSAKPRETI
AILGATGSGKSTLFQLIPRLYQPDSGRIYIDEKPVQDIPAEGLRRQIGYVPQEVLLFSGT
IKENIAWGKENASLDEIMDAAKLAQIHETILKLPNGYDTVLGQRGVNLSGGQKQRISIAR
ALIRKPAILLLDDSTSALDLQTEAKLLEAISTYHCTTLIITQKITTAMKADQILLLEDGE
LIEKGTHSELLSESQLYKRIYESQFGREGSESC
>fig|224308.1.peg.822 Multidrug resistance ABC transporter ATP-binding and permease protein
MLKDIRKPFQYPKLPIDKKEGAKKRAKAKDTKGTLRRIWSYLAERKGLLILVMLMVVISA
IFGLLGPFVIGKAIDHFIVGKTVSGLIPVLLLLLAIYIIQSLSLWFQNYWMITISQGTVF
RMRSELFTHLHELPIPFFDKQRHGELMSRVTNDIENVSSTLNTSVIQILSSVITFVGTIA
VMLYMSPLLTLITLTIIPVMAASLKWITNRTGKLFKEQQKNLGDLNGYIEESVSGAKVIK
AYSREKQITAEFLEKNAALKTSGFWAQTISGFIPKVMNSLNNLSFTMIAAIGGLFALKGW
ISIGSIVVFAEYSRQFTRPLNDLANQFNTMLSAIAGAERVFDVLDEKEEREDEKNAVHQP
IQTGSIEFRDVSFGYDKGQQTLKHLQFTVPAGQSIAFVGPTGAGKTTVTNLLARFYEPND
GKILIDGTDIKTLTRASLRKNMGFVLQDSFLFQGTIRENIRYGRLDASDQEVEAAAKTAN
AHSFIERLPKGYDTVLTQNGSGISQGQKQLISIARAVLADPVLLILDEATSNIDTVTEVN
IQEALARLMEGRTSVIIAHRLNTIQRADQIVVLKNGEMIEKGSHDELIRQKGFYSDLYES
QFEK
>fig|224308.1.peg.840 Drug resistance transporter, EmrB/QacA family
MSEALTEQKSQKWAISLFTIGVFMAALDNGIISAALTTINESFSVSPSWGSWGITLYTLG
LSVSVPIVGKLSDRYGRKKLFLIEVCLFGLGSLLVALSQSFPLFLISRLIQALGGGGIFI
IGSSHILATLPKEKQGKALGLLGAMNGMAAVLGPNIGSFLLDWTGSWHWLFLINLPIAVL
LVVFGACFIAETKAPEAKRLDAAGIFLLSLSILAVMYGMTNLDGANLLHSLGNPEVYGCI
IFGILCFAALISYEKRVEMRGGDPILAYSLLRNHMFQRTLIIGLLSGGLLAAVIFIPSYV
EQYLGVPAAKAGYWMTPLALASGIGAWLGGALTDKKGPVKTVILSGIISCAGFALFPLWV
TEKWEFVIASVAAGIGFGFLLGAPLNVLVSEAAKTNKGTALGTLSLVRQIGLTLAPTLYA
GFITAGFDQIGDEINSRLSDSGYSEKAMQMIPEIDSSEVSSLQEQIERIPVPEVKTAISD
AIHASVASGYDHLYAAAAVVSLLVIAAISIPAFRRQKR
>fig|224308.1.peg.901 Membrane component of multidrug resistance system
MATGKEKNAKNPMSLLIVLMAGLFLAILNQTLLNVAMPHLMTEFGVSATTIQWLTTGYML
VNGVLIPLSAFLITRFGQRSLFLVAMFCFTLGTLVCGIAPNFSTMLIGRLIQAVGGGILQ
PLVMTTILLIFPPESRGKGMGIFGLAMMFAPAVGPTLSGWIIEHYTWRIMFYGLVPIGAI
VIIVAFFIFKNMVEPQKIKLDTLGAILSIVGFASLLYGVSEAGSDGWTDPIVLSTVIIGA
IAIVAFVVQQLRHDDPMLDFRVFKYDIFSLSSVINIIITVALYTGMFLLPIYLQNLVGFT
ALQSGLLLLPGAIVMLIMSPISGILFDKFGPRPLAIIGLLVTVVTTYQYTQLTIDTPYTH
IMLIYSIRAFGMSLLMMPVMTAGMNQLPARLNSHGTAMSNTLRQISGSIGTSLITTIYTN
RTTFHYSQIADKTSTADPNFLHAFQNAVSNLMVNMNVSYDTAKTYVYSHIYKHASLDSNV
MGINDAFMWATLFCVAGLILSIFLRDVRKDKLRKKKKEELSLLPAPKEAKES
>fig|224308.1.peg.1119 Multidrug resistance protein B
MFFASSLIFPFYILFVKNIGSSYTQFGFSYGLFGLSGALIYPLLGRLSERFDSRYFLLLN
SWGMAVLLLYVPHIGSVVQVYIVQVLLGLFGAMQKHGEKVLIANFTDSGERGKKIGNYHF
WTAVFSAAAIMLGGFLADFFTVQMIFYASSILYFLSGLMMMKTG
>fig|224308.1.peg.1686 Multidrug resistance protein
MVAGFIRSSLSGVSLCFWLFGVLFYLSDTLENKYAIDGVAKGGLLAIPLLFLSTSSFIAG
KKIGKDKGRMKFCVVTGMILLTLSFIALWWNHSFYFLFVFLSFGGIGIGMALPALDALIT
EGIESEQCGTISSFYNSMRFIGVALGPPVFAALMSNANWIIFILSAFCSIVSLFLVLFTV
DAKKSEEEKNLGTV
>fig|224308.1.peg.1733 Multidrug resistance protein EbrB
MRGLLYLALAIVSEVFGSTMLKLSEGFTQAWPIAGVIVGFLSAFTFLSFSLKTIDLSSAY
ATWSGVGTALTAIVGFLLFGETISLKGVFGLTLVIAGVVVLNQSKAHAEDKKQTACE
>fig|224308.1.peg.1734 Small multidrug resistance protein
MLIGYIFLTIAICSESIGAAMLKVSDGFKKWKPSALVVIGYSLAFYMLSLTLNHIPLSLS
YATWSGAGTVLTTVIGVKWFKEDLNAKGLIGILLLLSGVVLLNWP
>fig|224308.1.peg.1880 Permease of the drug/metabolite transporter (DMT) superfamily
MVKVMLGIISVTLIWGYTWVAMKVGIHDIPPLLFSGLRLFIGAVPLFLILFIQRKKLSIQ
KEHLKSYIIMSLLMGLGYMGILTYGMQFVDSGKTSVLVYTMPIFVTVISHFSLNEKMNVY
KTMGLVCGLFGLLFIFGKEMLNIDQSALFGELCVLVAALSWGIANVFSKLQFKHIDIIHM
NAWHLMMGAVMLLVFSFIFEAVPSAEWTYQAVWSLLFNGLLSTGFTFVVWFWVLNQIQAS
KASMALMFVPVLALFFGWLQLHEQITINIILGALLICCGIFMNTFTFSRRKV
>fig|224308.1.peg.2378 Multidrug resistance protein B
MKKWKDIHPISWTIIIGTIFGRMATSMSIPFLAIYLTAVQGASASYAGLVIAASSSVGIL
ASFYGGYISDKFGRKNMMLVSIFGWMLVFAGFAAASNLWVFFVVNALNGLCKSLFEPASK
ALLSDMTEEKTRLLVFNLRYAAINIGVVFGPVLGLYFGSSQSTTPFLVPAVIYGLYGIVL
ALQFKKHPSLSAPAQSRNMSVREAFMVTQKDYLFTIALVGITLCTFGYSQFSSTFPQYMA
QNPLIGNGTKLYGLMLTLNAIVVLATQFPIVHFAKRFSPLCSLMLGNVMVSISMAIFTVS
HGVPSIVMIVITFTIGEVLLFSMMDLYVDQIAKPGLKGTYFGAIGFPQLGNVIGPWVGGI
CIDLFGAGRPIYIFSVLSGITLLGLPFLAFAYRQMKMETTKHRSRLEKPL
>fig|224308.1.peg.2406 Transcriptional activator BmrR for multidrug resistance transporter
MKESYYSIGEVSKLANVSIKALRYYDKIDLFKPAYVDPDTSYRYYTDSQLIHLDLIKSLK
YIGTPLEEMKKAQGLRDGRTVCFLYRAGEANQGEIRLFISPGANHFIGEKADETADGISR
RLGEVFVLDEEEIRIIQTEAEGIGPENVLNASYSKLKKFIESADGFTNNSYGATFSFQPY
TSIDEMTYRHIFTPVLTNKQISSITPDMEITTIPKGRYACIAYNFSPEHYFLNLQKLIKY
IADRQLTVVSDVYELIIPIHYSPKKQEEYRVEMKIRIAE
>fig|224308.1.peg.3116 Multidrug resistance protein
MKTKHYWVISLLAVLAVGPGLMSNTALSSVQGLVQKTVGTSVFTSVNPILIGNMAFALLV
PAGPLLRKKFGARPVYLASLPVFILGSLLIACSGDIALMAAGRFLQGAATGVMLMIMIPM
LVLSFPIERRNYALLVLIGGFYGSVIIGTILGTIATSCGHWRWLFFIFGTLSLIGVAVSY
FFLHDEHHGAADQEQPLDRAGILLSVFLAAASAVSFIFLQKWGLSSGYVWIGFGVTLCLL
IGLLIVEYKVKNPFISIKLMLLPKPVLGLLIIAAGTITVAVSLSAFQGLLRQMYDISQEH
LILLSLTLLIGVAIAAILSALLYDKVGPGMLGIIGGLILVFVNFQWLHIQDRSSLYMFAA
LFIMLAAGTGLTVAAGLMGAAMGGPLPDLVKRMTAVQFLRLFVYMGVPILIGFFTKKDAA
RQSGSVQDSMMTAYHDLFFISFILSVLLVCLSFCMNATGMGHKLAHKPHDKAKTAPEKPA
VSAQGLSKATVKSYKVINDTEYRNALRNLQK
>fig|224308.1.peg.3391 Multiple antibiotic resistance protein MarC
MMFSFIVHVFISLFAVSNPIGNVPIFLTLTEGYTAAERKAIARKAAILSFFILAAFLVFG
HLIFKLFDINIHALRVAGGIFIFGIAYNLLNAKESHVQSLHHDEHKESKEKADISVTPLS
IPIIAGPGTIATVMSLSAGHSGIGHYAAVMIGIAAVIALTFLFFHYSAFISSKLGKTEMN
VITRLMGLILAVVAVGMIGAGLKGMFPVLTS
>fig|224308.1.peg.3527 Drug resistance transporter, EmrB/QacA family
MSSRKEWALIVSLLLGAILVPINSTMIAVALSSISHTYNESIASITWVVTVYLIVMAVTQ
PIAGKLGDMYGNKTMYLWGVGLFLIASLGCALSPSLLLLIVFRALQAVGGALLTPNSIAI
IRHVVSEKRLPKVFGFFGLGAGLGAALGPFIGSILIDSFSWHSIFWVNIPFLAIALFTAL
TMFPQYKENKSDAPLDIIGSLLLAGSIVSIILLTKNEAPWGYTVYSVLILLFVPLFFRRE
KRTQHPIIDFALFKSSTFTNANLSVLLSNLMMYAVLLIMPLFMTNQFGLNTSNSGMALSV
FSIFMSASNWVGAQLHHKWGAKKIIFLSFAMMAGANLLFLLLSSSHSVLFLMLSLILGGL
ASGVGLTSMQVSSLATVDPGMSGVASGIFSTFRYFGSIISSALIGLISGYHTLFMILFAV
SIIGVFVSLGIKSDETARIEKNSA
>fig|224308.1.peg.3763 Methylenomycin A resistance protein
MKNSGSIQESTSSTGISVLIVLALGFLMATLDVTVVNVAMADMKNTLSMSLSGVTWVVDG
YILTFASLLLAGGALADRFGSKTIYILGLAVFVMASCLCAASINGQMLIAGRLIQGIGAA
LFMPSSLSLLAASYLDERARARMFGLWAALVSAASALGPFIGGVLVQLAGWQSIFLINVP
IGAAALISAYRILSRVPGKSSRVNIIGHLLGMMALGFLSYALIQGPSAGWRSPVILVAFT
AAVLAFVLFLLREISAKTPILPASLYKNGRFSAAQFIGFLLNFALFGGMFMLSLFLQEAG
GASSFMAGVELLPMMAVFVIGNLLFARLANRFEAGQLMFVSMAVSCIIALLLFVLISPDF
PYWQLAVLMSVMNLCTGITVPAMTTVIMQAAGQRHTNIAGAALNANRQIGALVGVAITGV
IIHLSATWYAGAGFAFLMMGAAYSLAALLVWLFLAAHNGTAASEKM
>fig|224308.1.peg.3998 Tetracycline resistance protein
MSIFYSFSALRGLAMGIFSPIWILYLISKDYDFLQIGLMGAVLEIAKLIFEVPSGVFADR
YGIKISIASSFFFSILTWAFFPFIDSAAICILAMIIWALSDSLISGSFETWMSRVAGEDR
FGKEMMKNTQLLITFLIIGSIASGYLYSLNIYFPFLLVMVIYLLLFIWMSVFIKVPSVSE
TNHGDQNQHDSIKIIKESLKIIFNKKRVLLIVIAGFFTATAYDTISRYWQPFLSDLGFSE
KSLGYIFPLGGFTALVLLTLTIRFEKKIEKNPYLALTSLDSMGMVMTFLLSRAFRPLGIP
CTAFLLAIEDIHHPIVTSYLNKFFPDSYKNTLFSLNSGVGAIGEILSGVIFGIISAAFGL
SAMFVVVAVFLLIPIILYTIVPKIKDNDMKVQIEKSQQV
>fig|224308.1.peg.4084 Tetracycline resistance leader peptide
MKCNKMNRVQLKEGSVSMTL
>fig|224308.1.peg.4087 Permease of the drug/metabolite transporter (DMT) superfamily
MKHLNIYIMLLGFSIFTGATFNLAKYTVGYFSPSSSAAWRFGLAAAVMLIILIFTEGIKK
SQLRKNAVSYIVLGIIGIFGFNALFFVGLKYTSPVNGALIMGLNPLLTAILARIILKDNM
TKKQVLGIFFAFIGVLLVITQGSIETIKTLSISGGDLIIFTGNVCWALYGVLGRRFVKDG
TPLSTTTYTMVIGAVSLIVVSLFTSKPVSLSNIPIGVWGAIAFMAFFTSVLGYLWWNQGI
KEIGASKTSLFFNLVPVVTMIISFAVGTPIKVFQVIGAVLVILGVLTASGVIRIPKYNTK
EQSAI
>fig|224324.1.peg.394 Multiple antibiotic resistance protein MarC
MIITWMEEFGVLFVKAFLSLLAIMNPFSSVPVVISLMNEYSKEEIRVIALKASVYAFFIL
TFFLISGDLLFRFMGITLPAFKVGGGILLFLIALNLVQGEVTKEKGKAHEIEAALRRDNI
ALIPLAMPLLAGPGSITTVLVLRGYLNTLEGKVALFCAIFLSSFTAFVVYSLSTFFYRVL
GRTGINLITRISGILLLAISVQFVVDGLKNLLKH
>fig|224324.1.peg.860 Melittin resistance protein PqaB
MFYILIILLATFSMIPNINEFAFRFEETTRAVVAFEMYHSGNYFQPTILGDPYYNKPPLF
NWFIIISSKFFGWDIVTARAVSVFFTLANAFLIYFFSSKVLKNKEKALLSSVFFITFADV
LFWYGWLAEIDVTLSFFVTLLFIQIYKLWEEGKPIYYYTSALLTGLIFMIKGFPAFAFYG
LSLISLSIFKRDFKVLLNFHAFASYFLALIASFWWLPFSENPEFYFRRLWEESFSRVESS
KDLEKFLIHLITYPLLNVKQLLPASLFVIPLIFTKRISLPRELKFLLFLVIFNYIPYIIS
ATSRGRYVLPLFPILAVIFAHLIHEYLSKNWKKVLLFSLIFVIILRFIYGIFFLPYVNHR
KGEPKLQAKVAYELTKTGKVACDCPKIKDFCLYIGFLRGEPLLRPKYTKAWDYLVDCKER
KDLSLIKKFYVNKKEVYLYGRFASGFAINTFNRSRGSKVFEGMSGARR
>fig|224325.1.peg.263 Permease of the drug/metabolite transporter (DMT) superfamily
MKKWIVLALTVTFWGLAFTAIKYSVRFLSPIAIASLRFAIANTLFAVIIILGKRIKWKDL
PKVFALGIFGVSVYHVFLNLGEVYISSGVASVVISLAPIFVLILSAIFLRERITYSKVVG
IIIAFLGVVVISEPSYANIYGIALVMVSTVAAAIYTTFGKSLLSKYNPITLTSNAMVLGS
IPLYPFLPDSIRSLGGDLNLIGSIVFLGIFSTFFGYLGWYYFLEKEEASRASVFLLAIPV
VSLLAGNILLAEPLTLRTVAGSGLVLLGIYIVVRKR
>fig|224325.1.peg.505 Permease of the drug/metabolite transporter (DMT) superfamily
MNSKTHLLLALTMLIWAGSFIFIKIGLKELDPFNLAFYRFLLASPLLMAWVFWKRGLAKP
SGSEWLHLSVLALSGVTLLYAFQFLALKYTTATNASILINTSAVFVALWGLVKGEANPRK
LAGVFLSFAGVVLIVSKGTLEFFSSKTIFGDVLMIVDGFLWAVYTVLGSKMLLKYDHETL
TAYAFALGTIFLIPFALMSGFANPVTFNPETVAALLYLSILCSVFAYVVWYYALTNADST
SVAVYVYLVPLFTAIFAFYALNEKPDFFTAIGGIITIAGVYLTTAKQHQ
>fig|224325.1.peg.781 Permease of the drug/metabolite transporter (DMT) superfamily
MGEDRRSLRVDYDDNFLRNNICSLKVSFIKQQGGAEGVKRLYADLGLALVALIWGSTFPV
VKIALDSMSPFAFNTVRFFIACLFFLPFLKGWDFKDGFKIGIASFLGYTFQTVGLDYTTA
TNAGFITSTYVVLAPIISWLVYKDVFDKRDVSGVLLAFVGFYFLSGYSGFNIGDILMLFC
ALFFGAEIAMISHYSRLSNPTMLAFWQSFAIFILSAPFAVFTTTKFEINTTVILCLLITA
FFATFVAKMLQNWLQSYTKSSDAAVILSLEGVFAHLFSVAVLAEILTPVQYFGAFLILLA
VIIVSLRV
>fig|224325.1.peg.1315 Multidrug resistance protein
MLRLILSGFFAYASLSCVIPIIPSYASSLGASVFLSAFAAGVFALFPAIAMTPFGMLSEV
YGRRRFLVAGAVTSLLASLLYLQSSTAELLVFSRTLHGLGSALYIPSINALVADISEESR
RGEAMGKLQTALMLGFFAGPLAGGFVSDFFGVKAVFLLALVFSAAALVPVVGVRERSKGG
EIGKQFIFPRKLAPLFAVMFVGMATGSSLALFAIPFYAPELNISQQQAGLLVAVLFLFSA
IIRVPAGILADRAGRNVTALLGMVVTGLGLFSAFKPDFPFLFLASLLCGAGNGIVNTAVF
AAASDYENRGYAMGVANTVLNAGIFAGTTLAGFMAGFLSFQSMMLILAAATLLFSPISLS
KGFGSISEVER
>fig|224325.1.peg.2244 Multidrug resistance protein
MSDDDQSVLKAWIAFLPVSAGLFMVLLDVSVLNVALPRIAEDFGAKMSDLQWIMNAYTLT
MVVLLVLAGRIGDMVRRDRFFILGMVIFVLGSFLCAQSWNTQSMIAFRTLQAIGGTILSG
NVLAIAAELFPPGRRGEVMGLNAILTASSFTLGPIIGGWLTTHLSWHWVFYINIPIGIVA
IAAAWFTLPPLGGREKVPIDWVGAVLLSIGLGALTLGIIEGQNWGWWDEKTLSCFIIALP
YLLAFSLWELRTPYPMLDLSLFKIRNFSVGVVATAILFFGVSASLFVFPYFLQGLKFLSA
EEAGYWLVAIPIMNTFVAPVAGRLSDRMNPKYLMSLGPLFFAIGLINITSIDVDIKYWDF
FAKIAPMGIGMGMLMSPSFNVILSSVPLEKVGMANGTVRSVNTLGQAMGIAVGGVLLTTR
MSDWIPGYANQIPDPGTMKILIEYAKYNPAPLVEMVEGFVDSMHFVFSTMIVFPILTSLI
IALFLHGDEHVRRARAARKGVVA
>fig|224326.1.peg.524 Acriflavine resistance protein
MLVKRIVGKPITMLILFSLLLMISLYTFSRLKVDLLPGIDIPQISIHTVYPGASPREVEE
SVSRVLESGLSSVKNLKNIYSVSSKESSTVSLEFYHGTDLDLVLNEIRDALELVKSSLPS
KSQTPRIFRYNLKNIPVMEIVINSVRPVSELKRYADEIIKPGLERLDGVAIVTVNGGSKK
RVLIEVSQNRLESYGLSLSRISSIIASQNLELSAGNILENNLEYLVEVSGKFKSIEEIGN
VVIAYKIPDISSGINLSPIEIKLKDIANIKTDFEDLSEYVEYNGLPSISLSVQKRSDSNS
IAVSNVVMNEIEKLKLSMPKDMKLEIASDSTDFIKASISTVVNSAYFGAMLAIFVIFFFL
RSFRATIIIGISIPIAIVLTFCLMYFVNISLNIMSLAGLALGIGMVVDCSIVVIDNIYKY
RQKGAKLISSSILGAQEMMLPITSSTFTSICVFGPFLIFKSELGVYGDFFKDFTFTIVIS
LGVSLLVAIFLVPVLSSHYVGLYTSFQKNIKNAFIRKIDAFFASIYYFLEFLYINLLNIV
LNHKLIFGLIVFFSFIGSLLLGLLLDVTTFTRGKENSITINLNFPHKTNLEYAKFYSNRF
LEIVKSEAKGYKSIIATLRADRITFNVLFPLKEESRDNLTQSVDYDSIKYKIMNRIGNLY
PEFNIEPSISGNALGGGDSIKIKISANDFEYIKDYGKILVSMLKKEIPELVNPRLSISDF
QLQIGVEIDRALVYNYGIDMNTILNELKANINGVVAGQYVEKGLNYDIVLKLDRMDVKNL
KDLEKIFITNSSGVKIPFSSIATFEKTNKAESIYRENQALTIYLNAGISPDDNLTQVTAK
VVDFINNKVPHKEGITLKVEGEYNEFSNIMNQFKIIIMMAIIVVFGIMASQFESFLKPFI
IIFTIPLTAIGVVLIHFLAGEKLSIFAAIGMLMLVGVVVNTGIVLVDYTGLLIKRGFGLR
EAIIESCRSRLRPILMSSLTSIIGLIPMAFSSGSGNELLKPIAFTFIGGMTASTFLTLFF
IPMLFEIFPTCFKFQI
>fig|224326.1.peg.857 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSTDKSKTRELILNGNLYKVLFLISFPIVITNIIQAFYDLTDMFYVGKLGAMPLSALSLA
GPVNFFIIAIAMGMATGSISLMSKCIGEGNFSRFSRYAGQLIVLNFVLSLFVTICAFFFI
DHLLDLLGVKGELKELSRVYFYVTIFAIPIMFLSISITYILNAQGETILSMTIVLFANIV
NFILDPILIFSFNMGITGAAWATLFSKLLTVVFYLFLTYRLNYGLKIHLKDLVIDIRSIK
EIVNLGLPSTFGQIMVSLSFFIFNYIVIEISPKFLAAYGLTNTIISFLFLPAMGIGTGII
SIVGQNLGAKKVNRVEEVLKKGFFISLAILLIINSIVIFNKQFILRLFTNDLEVLNYANN
YLLLTTIGTFGYGLQQVFFGGLIGSGRTKIAMIVIFIRLWLIRLPVVFIFQYFGIMENSL
GYAFIISNYLAIIILIAFTCTRYWVKPILIKKYK
>fig|224911.1.peg.932 Multidrug resistance protein A
MADQVIKFQPEQKIDSGKPTKKAGTDPRRRIIAGLRRYRRFLLMVVLPIVAAIGGLTLYL
NGGRYVGTDDAYVGAQKVLVTPDISGKIEKVVVREGQLVKQGDELFEIDPVPFRLAVDEA
RAQLAQAQSTYDNLRANIKIYGDMLSLAQQGVDLKQRDVERKQALVKNSYGSQLDLDNAA
NALVTSGSIAQYVKQQISAAKTQLLGDTDLPLEKFPPYAQAKSKLDNAERNLDHAVVRAP
MGGVATQVEQIQLGRYVTAGTPVFSIIDVAHPWVDANPKESDLTYVTEGQPVTLEVDAFP
NHVFKGKIGSLSPGTGAQFAILPPQNATGNFVKVVQRVPIRIYFDETDKYVRKLKAGMSV
YATIDTGHRRSLAGLFGLSATAGQDKD
>fig|224911.1.peg.935 Permease of the drug/metabolite transporter (DMT) superfamily
MSSPQAIPSAGRPLSAGAIALMLMLCLTWGFNQIAVKLVLPDIPPMLQAMIRSMGALPVL
FIIGTLRGVKFFEKDGTWKPGLIAGLMFGIEFVLIFQGLRLTPASRAVVFLYTAPFFVAL
GSYQVLGERLGGTQWLGLAVSFAGVALAIGVPQPDVDAKVLLGDLMIVGGAALWAATTLV
AKGTRLRFAAPEKALGYQVATSIPILGLAAWLFGESITHTPAPLSLALMAFQAIWVVGTT
FTLWFALVKAYSASKLSAFTFITPLFGVVGSYFIMHDTLSLTFGAAAVLVIAGLFLVNRP
SQTAAAPRDALLNVTKT
>fig|224911.1.peg.3407 Permease of the drug/metabolite transporter (DMT) superfamily
MTKAKTRLAYMGAGVAVVIWGATPAATAIVARELSPGLIGLARLLLSATILIPIAVSLKP
ELPSDRGGWIALLISALVGFAGSFVLQGVGIARTSTSHAALVLALAPIFTATVHFLLSRC
WPRPLWWLGSAIALMGVAILIPGRNPAGSVAAPTLFGDLLVLAGTVTVSVGYVAGARLSA
RIGLFAATCWSLLLAGLITLPAFPALASALGQLSFAVWGALGFLAVFCTLIGFAVWFWAL
EHGGVTSIAPLQFGQPLVSLVIAVAFLSEDIFPATLLALSLVILGVHLSRRAA
>fig|224911.1.peg.4275 Permease of the drug/metabolite transporter (DMT) superfamily
MLDSTRPVLRPRIAPAGLMFLAITSIGWGFNWPVTKFLLAELPPLTLRGVTGVLGAGLLA
ALALVRGDSLKVAREIWPRLLTAAVLNVTGWMVLMGLALLWLPASEAALIAYTMPVWASI
IAWPVLGERPTVLRTLGLVMAFVGLASIMGGNGIAASTEKLPGIIMALFGALGFALGTVF
SKKYPIRLPPITAAAWQIGIGCLPISIVGLLIETSHLELVTPVGWWLLVYSTVVQFCIAY
VSWFAALARLPASVAAIGTMAVPVIGVVASAIALHEPLGPGQIAALVFTLGAVVLATR
>fig|224911.1.peg.4311 Permease of the drug/metabolite transporter (DMT) superfamily
MPPNDNRIDARDWSLLAVLSILWGGSFFFNSAGLRELPPLTLVFLRVALGAAVLLPLLHV
QGISFPKGTLGWKPFFVIGLLNNVIPFSLIVIGQTIIPSGLASILNATTPLFTVTVMAMA
GEEALQMRRVAGVVLGVVGVVILRGWGIETRPGQGFGILLCLGGACSYGFAALAARRLLK
DSAPLGTATFQLMASTVMMAVVAAVMEQPWHLPAPGLTTWLAVLGLAGLSTALAYIVFFQ
ILRRSGATNVMLVTLLIPVTAILLGWLVLGEPISMREIAGAIVIGSALLVIDGRALRMLQ
RVA
>fig|224911.1.peg.6257 Multidrug resistance protein B
MSTTVPSTGAAGDHRAISAAALIAIYMQAVNISIPNAALPHIQATLSMANDEVGWVFSSY
IAASAVTMSITQWLAGRYGRKAVYQAALAIFTFGLVLDTLATTSIQFVLARILQGAASGP
LAPLSLAILLEVTPARHARMSLASTVCSLLGISTGPAIGGWLSEYYGWASIFYVSLPMTA
FIFMTMASLLSEKRAERSQPFDFFGLTTFSVGMIGLQMLLDRGERLEWFASTEIWAEAVA
SVLGFYLFSVHVLTTREHFLRTALFRDRNLVLSTVISFALGFVLLPTLALTSPMLEELLN
YPVDTTGYMTIPRGVALVGALVLTSLVPGQVDYRPFLMGGMALVVYANWLMLGYSPAMDW
RPVVEAGMLQGAGLGMLLPALARAAFGTLDPKLRPEGGALINLSRLYGSTIGIAVVQLFF
YANTQAVHVALAKHLTPFRVAAHGAGPIGKPSLAALNGMVTHQAATVAVIDQFEILMFAM
LVVIPLVFFLRKPRPAG
>fig|224911.1.peg.6258 Multidrug resistance protein A
MRLNFAPIAGWLGDRSFRGSEGAVPLFGADLGRRLRRPLMLALPTVVAVFGAFMYLAQEQ
YVSTDDAFVRAAKVTINARVSGQAVEIAVRDNERVRRGQVLFRIDPEPYQIAVDQAEARL
GSARLQIDSLKATHRQQQAELQSARESASFDEREFDRKKMLVASDFTPRAVYERAETDLK
VARHRMASIEQQIANTVVALNGDPDIDADRHPTVRAARAQLDRARLDLSYATVIAPDDGI
VTKVDDLQIGGFVNAGAPTFSLMSSRDIWIEANFRETGLTHMRPGQEATIDVDAYPDRKF
RAHIVSMSPGTGSDFSVLPPENATGNWVKVVQRLPVRLELDDLDPTRPLFSGISVTARVD
TGHRRSWPHLLQGALATEVK
>fig|224911.1.peg.6622 Multidrug resistance protein A
MAVSRDQAARVLRQDTVETNSANGEPVTETSAVLAEQLRSHVAEEAKRRSDAPGKPVTDK
PATPGSDAPAASGTPKSGKRKFVLVGVGLVLALAAAGYAGYYTLVGRFYIATDDAYVRAN
NTMLGARVAGHISSILAGDNTTVRAGDVIFRIDDGDYKIAVDAAATRIATQQATIDRIGR
QIAALESQVAQAKAQLVSAEAGLKRADLDYERQQALSSKGFASRATFESSEAGRDQGAAA
VKAAQAAYDVAVSNVDVTKAQQAEAQAQLAELKTSLAKAERDLAFTAVRAPVNGTFSNRL
VSAGDFVAVGQRLGNVVPLDDVYIDANFKETQLKRIRPGQPVTIKVDAYGMRKFSGVVDS
IAAGAGSVFTLLPPDNATGNFTKIVQRVPVRIRVPKSVAKQNLLRAGMSVYATVDTNKGA
ADADSEVDLDDPTMIHPQ
>fig|224911.1.peg.8172 Permease of the drug/metabolite transporter (DMT) superfamily
MSTQAQQTTSGQTTLAFEIGLLLLLALIWGSSFTLIKVAIPSIPPFTMVAARVTIAAILL
LLIARAQGHALPRRGSVWAAFLVQGLLQSALPFTLISWGETHIASGLAGVLNATPPMFVL
AIALTTGRGRQTVSGRKIIGVALGLAGVAVTMGADALSGIGTTAPLAQAAVLCASLCYAV
APIWGQRFSGLPAIVTAAGAMSCAAVLMLPAAAVLERPWTLAPPPAQAIAAVIALAVICT
AFAMVIYFRLIHTLGPLGTTSGSYLRAGFAVALGTAWLGERFSWSSLAGMALILAGVVAV
TVPAPARTGKTATGAPSRN
>fig|224914.1.peg.187 Permease of the drug/metabolite transporter (DMT) superfamily
MKRRMKLMESAPFLLIATGTLLGLILPLGKIAAQAGIPPEMWTFLFSASAGVILFAVLCL
RKKRLGFSGGRLRYYICTALISYALPNFLILSAIPHLGAGFTGIMYTLSPVITLLLSMGF
GLRRPNALGIGGIAIGFVGAAMVAMTRGEVGKPTDLLWIAAALLIPVLLAIGNIYRTLDW
PKNSEPTELAAGSHLASAFILFICITLFTGRFPLESFALAPFAALAQSLAAAGMFALFFR
LQAVGGPVYLSQIGYVAAALGLVSGTLFLGEHYPPLTWIGAAVIAAGVAMTTRAQKG
>fig|224914.1.peg.402 Multiple antibiotic resistance protein MarC
METGMIVGKLLPLLFNMMGPIGLMPIFAAMTVQMDKPTRNSVAARAAIFAALGILIAIFI
GDPILQSWGISKPALILAAGVILTLSSIRAVLMPPAAPSQPAAAGDPKALAIRPLAFPTI
VSPQGVGVLIIFVAFLSSLSSTITILTVAGVIVLLDYGAMRIAHWFMATVGMVPLLVLGA
VFGVLQVALGIEMMLSGLLLVLNS
>fig|224914.1.peg.925 Multidrug resistance protein A
MFRFPAGQTEPPNEIVVHAEIVHRRPKIFRCTAPEDTVAETNTSPSPAQDQSPKHPMLRR
ILLIVGPVVAIAIGLWIYFSGGQYVSEDDSYVGAAAVAITPQVSGQVIRVAVGPNQPVKE
GDLLFEIDPQPFQIELDQAKANLAQASEKLAGLVLTYKQQLASVAQAKDDVTFAQEQSPT
SRCPICREALRRQAARSIGC
>fig|224914.1.peg.2340 Multidrug resistance protein
MADGMKHKTAIQQGVSLAPDGLPRPRIYWAWATLMVGLTLAVIDGTIANVALPTIAADFS
AGPAASIWIVNGYQLAIVITMLPLAALGEIYGYRRVYVAGVALFTIASIGCVFSRSLEAL
TLARIIQGLGAAGLMSVNTALLRYTVPQAKFGTAIGLNALFVAVSSTIGPSLAGVMLSSL
SWPWLFVINIPLGIAAVLMGLRSLPDNDRSARKFDVVSAILCAVTFGLLITTIDSAGNKI
GSLAVMLQALCCLLAGIWLTRRSFHMSDPLLPLDLLRIPVFTLSICTSIMSFLAQMMAFI
SLPFLFQTVFGFRPIEVGFLMMPWPIALALVAPLSGKLSDKYSPAILGLLGLITFSVGLA
LVGLLPGHPTIPDICWRMAICGIGFGLFQAPNNRMMITSTPRARSGAASGMLGTARLLGQ
SVGAALVAFLLSQWGVEGTPYILFLASGFALFASVISISRLRH
>fig|224914.1.peg.2575 Multidrug resistance protein 1
MNHRHDMSTTQAAAGDASQMETPHPNGSFTQSNADENHEQYWKQNLVICLLGSFTTLIAM
SLLLPFLPLYVEQLGVISHAAIVQWSGIAYGATFLAAAFVAPLWGRLGDRYGRKLMLIRA
SLGMVTCVWQLVALRLFVGIAGGYSSGSMILVATQTPKDKTGWALGALSAGIMAGIMAGN
LAGPLLGGALPPLIGIRATFWLAGGVIFLTFLATTFLIREERKPPKPTREEKTQSIWAAI
PDKGPVVAMLVTGILLLFANMSIEPILTIYVMQLMDDQTKVTLVSGVVMAAAALGSILSS
SRLGQLADRIGHTRVIIGALAVSALLLVPQAFVTDAWQLIGLRFLMGLALGGLLPCITSV
IRHNVPDRVAGGILGYSVSAQYVGQVAGPVAGGFVGGHFGMRAVFLGTCLMMAAGAIYNW
AVLRNSKTR
>fig|224914.1.peg.2656 Drug resistance transporter, Bcr/CflA family
MNRIIPLVLAIALFMEQMDSNVISTSLPAIAADIGTSPIALKLALTAYLVALAVFIPVSG
WMADRFGAKNVFRAAIAVFVVGSIACAASNSLPAFVIARFLQGMGGAMMTPVGRLVLIRS
TPRNELVSAMAWLTIPAMVGPLVGPPVGGFITTFLTWHWIFLINVPIGMIGIWFATHFLP
DNEERIIKRLDWPGFFLSGFAMSGVVFGLSVVSLPALPPVIGFATLAVGMLCTVLYVLHA
RRTPDPLLNLRLFDNQVFRSAVFGGSIFRFGIGAIPFLLPLMFQLGFGLTPFQSGMMTFV
SAIGAISMKFGAKRIFTRISFRRALMGGSLISAAFIAVNGTFTPATPYWIIIGFLLVGGF
ARSLFFTGVNALAFAEIPNEKTSQATPLTAVAQQVSIAIGVALAGGILEISTMLRGAPLA
LVDFHIGFFVVACVSVLAFFWFARLAPDAGKELATPSVIRHHGKPVTTA
>fig|224914.1.peg.2854 Multidrug resistance protein B
MPRCCIGSISWYTFIAIGFGALVVVLVQGKNYWWFEAPWIGVCLAISILSLAIAAAIELN
RDQPLMNLHWLASPEILRFTLILLVFRMVLAEQTSGALGLFQVFGLQDAQSKGLYTLILL
ASFAGGITCGALLKVERVPVIFGFALLCIAVGAFLDSHATNLTRPHNVYVSQGLIAFGGA
LFLPPAMLAGITKAMKQGPAYMTSFIVVFLFTQNIGGLIGSALFSTFISIREKYHSAHLV
EQLVMSDPLVAQRVQALSGTYAKVLADQGLTKAEGPVLLGQQVTKEATILSYNDAFLAIS
VIAAIALCCQVTYRVYEAFRARRSALAVMS
>fig|224914.1.peg.2855 Multidrug resistance protein B
MSIIYIAASMLLWSTRGLSMYFISANTQQIQGSLGASLTETTWLVAAYMAPFASLTILLL
KIRTQFGLRRFAEVAIAVFLVASLLHLLVYDVWSAIPVRFIAGAAAVPISSVGFLYMLEA
FPPDKKRTWGLSLALTCSGAAGPFARIISPMLFDIGQWQQLYMLEIGLALACFAVVYVLP
LTQIPRAKVLHWLDFVVYIYRNRLRRPCCGACPGQELLVVRGALDRCLSGDINPVACHRC
GHRA
>fig|224914.1.peg.3161 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MNAKTLCIIVPVYNEAEGLSDLLDRLHSAADNIASQFTLNIEFIFIDDGSSDGSFALLKA
HDFGSRPVRLLRFSRNFGKEAALSAGIDAAEGADAAILMDADLQHPPEMIADFVRIWQEE
DADSVYAYKASRLASEGPVKAALSRAFFWVINRDQRYKIPPGAGGFRLVNRRFMAALRSL
PESDRFMKGLYGWVGFNQVGLPLQPPPRMRGTSYYNPLQLLLMSLGAMTSFSTTPLRLMA
LAGIVVAGLSAAYGLYVLSEYFFFPGVPVGLTSILALTAFFGGIQLMFLGLLGEYIGKSV
LEAKKRPIYILAEDIRRKESDDADRG
>fig|226185.1.peg.598 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEQTQQNHFTALFYKNVLLGILSMAAQSIFILADTFFIANGIGTEALAGLNIVLPLVNII
NGLGWMFGVGGATLFSTTVAQKEIKKANQYFSLTIGLVFVIGRLFTLVSLIFSDQIIRGL
QGTGVLFGLAKEYYMIYLSCSLLFILNNCLITFLRNDHNPRLATIAFVSGGIVNIILDYV
FIYQFGWGMAGAAIATVMSPLTSLILITLHKWSPQRVLRFEKFKVKFQDVREIMSIGFSS
FLNEFSSAFVMFLFNIVLLNLVGHVAISAYAIVANLNIIVIAIFTGIGQGAQPLLSRYYG
LGETKVLRKFVKLSFITYLVAGFLFFLISQVFTGQIIEVFNSEGNDQLAQIARTAIRLYA
ISFLFTGLNFMGIYYFSAVRKPKMALMISSLRGFFLIVPVLFILVKLLGLTGVWLAMPVV
EFVTFGLMLVGYLAYRNYLKKREAVT
>fig|226185.1.peg.715 Drug resistance transporter, EmrB/QacA family
MAKETNVKLVTVSVFVATFMTAIEGTIVSTAMPTIVGSLHGMEIMNWVFSIYLLTNAMLT
PIYGKLADKIGRKPVFMIGIIIFILGSSLCGFAQDMLTLIIARAIQGVGAGAILPVALTI
IADMYTLDKRAKILGLNSAAWGIASIFGPLAGGFIVDTVGWHWIFFINVPIGLVLLGLIS
IFLVEPKRERTKMPMDILGSVTLMVVLLTLLLGFQMISDNGFTLVTFGCLSLSVLFFVAF
VMIEKRAQDPVIDLHLFNQPTFVLVNLIAALISGFLMGIDVYIPMWMQGVLGKSAGIGGL
VLAPMSLLWMAGSFIASSFMEKYAMKKVLTIGLSILLVGAIFLVVMPMAVPFWLFFVVSS
VLGVGFGITITTTTVTAQSTVEPEKMGVATSFNTLVRTIGQTVMVSIFGVILNAGMFAKL
EASALNVDADVMNQLVNPHTANLIPAALLKPLRGILYAGLHNVYLVGAGLVVVALLLNIF
AKAQRAKV
>fig|226185.1.peg.1276 Drug resistance transporter, EmrB/QacA family protein
MEKIKSYQEDSEVQKNRWWILVSVAMFTFMSTLDSSIVNIALPTISKEMSVPMNQAEWVV
SIYLMVVCACLLLFGKIGDSFGKIKVYRIGTVIFTIGSLLCGFNQSLSFLLFARVVQSIG
ASMTMATNSGIITEVFPLNERGRALGAVGAFVSLGAIAGPGIGGLILSNFSWSYIFWINV
PVGLVTILIGEKFLPKDITKTKEKIDFSGFACIAIAIMTFFGGIFLGQESGFGSLQSYLL
FIIAVIALGLFIMVERKRKSPLIKFAIFKNKIFTLSLLSAVLIFASNFFVNVVIPFYLQD
ARKLSASYAGLLMMVFPLLMVVGAPLSGYLTDKIGPGILTFGGLLLLCCTSLMYMFLDMN
SPIWYYVIATAIMGLGNALFQSPNNTMVMSSVEKQDLGVAGSMNSFARNLGMVIGIALST
TILYRGMSEAYGERVTTYLANRPDIFIVGMRETFFVAFLLCVAAFILTILRFRKTTK
>fig|226185.1.peg.1697 Drug resistance transporter, EmrB/QacA family protein
MLERTVFMIDRKKVILYTCCMSLFVVTMDVTVVNVALPSIQSDFHTNLSTLQWVTDGYTL
MVASLLLLSGSTADRIGRKRVLQLGLACFGLASFLCGISQTPGQLIAFRMLQGIGGSMLN
PVAMSIITQVFTEKLERAKAIGLWGSVTGISLGMGPIIGGLIVSYFSWRYVFFVNVPIIA
AAIILTQKFVPESKVEKTVKNDFVGQALMILFLFSSIYSIIGLPRKGLFAPDILSTGIIG
CLAIVIFFIYEYNIDNPLINPRFFLSIPFTSASFLAIFGFIIYNGYLFLNTLYLQEMRGF
SPLEAGLSTIPLAFVSFLVAPRAGEMVGRIGTKRPIMLCGISMLAVSFLQLFVTKTTPMI
ILFIIYIFLGIGFGMLNSPITITAIEGMPLSQSGTAAAIAVTCKQIGNSLGVALPSLLIT
KPITSSLTRTPFTNVWLLFGCCAIAIIFLSYLSNSPLAKKSLRRVRFYF
>fig|226185.1.peg.1807 Drug resistance transporter, Bcr/CflA family protein
MKNTRNTVPSLLIIILLVGFPQISESIFTPILPALSSAFNIHDSVAQLTMSIYFVAFAVG
VLFWGILSDTIGRRPAMLLGILCYLIGNIGLFLSPTFPWLLFFRLIQAFGASVGSVITQS
MMRESFNDLQRGKIFAQTSAALSLSPAIGPLVGGLVQTYFGYQHVFSTLIVMAVLLLFYS
FYRLPETFHLGNTLTKAPFWSVAKRLSFDSKVWCYGLLIGGINGLLFSYYAEAPFIFINH
FGFSSVQYGFLGLVLAVSSILAAVLINWLLGYWSAEKIAFAGLLLSIFAACCLLIMTQFE
TIIGLILFIFLFFLGINITLPNALSMALKGYESVIGTASGIFSFVYYLFVSFFTYLISYF
HNGTIWVLPLYFLSFACLLAFSYYVIVYRKTLK
>fig|226185.1.peg.2722 Multidrug resistance ABC transporter ATP-binding and permease protein
MKHAFSSMKRIGRYIKPYRVTFYLVILFTILTVAFNAALPYLTGLPTTEISRNIAAGESI
NFDYVIQCLIWILVVGTGYCVAQFLSGFLMTNVVQQSMRDLRRDIEEKINRLPVSYFDKN
QQGNILSRVTNDVDAVSNAMQQSFINIVSAVLGIVMAVVMMFLINPLMAIFSVIMIPLSL
IISRTIVKISQKYFQGMQNSLGDLNGYVQENMTGFSVLKLYGREKETLEGFKQVNHRLNG
FGFKASFISGLMLPLVQMTAYGTYIGVAVLGSYYVVAGVIVVGQLQAFIQYIWQISQPMG
NITQLSAALQSASASTMRIFEILDEPEEELNEQDVPLPEPILGSVEFENVSFSYDPEKPL
IRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDVRSV
FGMVLQDAWLYKGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINSEGD
NVSLGQKQLLTIARAVISDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIAHRL
STIREADLILVMKQGEIIEKGTHHELLEQGGFYEKLYNSQFAEEGDYEE
>fig|226186.1.peg.110 Tetracycline resistance element mobilization regulatory protein rteC
MNSEIEYENFIKNIDLVIYDKIDIDNWNISIDLIFEVVEFLQKSLEELRTIIIEHPFESK
EEEIYFFKYIKPEVLGRLLYFTDVYNAEMRKPNGSIEVVKKHYNDRLDELTSYFESNLDF
YQYYRSKATHLDNHYFVRGHIDFKLCPNCTPYDRDPEFSTCYDHKAAQILANDMLSIYLN
KRLHYVDKQIIIEESRAFLSEHPFRWTAPKIALVELGYSIYAACVLNNGKADIKEIMTYL
EASFKVDLGDYYRTYITIKDRKKDRTSFLSNLIKCLLKKMDEDDNL
>fig|226186.1.peg.696 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKNDPHILGKESIGKLLLQYSIPAIIGMTITSIYNIIDSIFIGHGVGAMAIAGLAVSFP
LMNLVVAFCTLVSAGGSTIASIRLGQKDMKGATEILSHTLMLCITNSFFFGILSFIFLDD
ILTFFGASPDTLPYARSFMQVILLGTPITYTMIGLNNVMRATGYPKKAMLTSMVTVVANI
ILAPIFIFHFEWGMRGAATATVISQLIGMVWVVSHFCKKDSTVHFEGKVWKMKGRIVESI
FAIGMSPFLMNVCACAIVIVINNSLQEHGGDMAIGAYGIINRLLTLYVMIVLGLTMGMQP
IVGYNFGAQKIDRVKQTLKLGIISGVVITSSGFLICEFFPHAVSAVFTDSDELIGLAVDG
LRLTVLMFPFVGAQIVIGNFFQSIGKVKISIFLSLTRQLLYLLPCLLLFPHWWGLKGIWI
SLPVSDSLAFITAVISLMIYIKKVSKEHPIADKVAE
>fig|226186.1.peg.1108 Multiple antibiotic resistance protein MarC
MQNLILQNAIWYVFCDIIIDNKLYVIMDIFVYLTLCFTSLFTLMDPLGVMPVFLQMTDGM
DTKERRYIALKACTIAFIILVLFTLSGRFLFHFFGISTNGFRIVGGIIIFKIGYDMLQAH
FTHVKLNETERKEYSKDITITPLAIPMLCGPGAISSGITLMEDASEYTFKIVLLGVIALV
CILSFFILCASTQLLKILGETGNNVMMRLMGLILMVIAVECFISGIRPVLIEILKQAHAC
S
>fig|226186.1.peg.1248 Inner membrane component of tripartite multidrug resistance system
MKELGVPVRSWVPDWLGFCCIFIVILPVTMLNGSYTGSMLEVSNTLGTNSEDITMGYYAA
SAGMAIAYPIIPKVLAAVSVKFLLLIDLLLQFFLSWICARSQNADILIACSFAIGFLKGF
LMLWFIRYAQKIFSAKNIRSEFYSYFYPLVYGGGQASMLVTAQLAYHYNWKYMYYFMMLL
ILVSVLFVIICFRHNRPIKSVPLSDLHIREMFIISVGLLMLIYVINYGKVLDWMASAKLC
AYIVISPILIALFIWIQHHSKNPYVSLAPLFQPKAIIGYFYMMLVMFFSTSTTLLTNYLS
IILKVDSTHTYSLYIFLLPGYVIGAFICFWWFRWQRWRFRFLIAGGMSCFVIFFGVLYFG
IAPNSTYEMLYLPIFFRGLGMLTLIIAFALFAVEDLNPKFLLSNAFFLIIFRSVLAPIMA
TSFYSNMLYRLQQKYIYSLSETITTADPLAASRYTQSLNNALAQGHRYDEAVQIATHSLY
GTLQEQSLLLALKEILGYLLVISVIIAVISRFIPFHKTIRVTFAKTGDDMV
>fig|226186.1.peg.1249 Membrane fusion component of tripartite multidrug resistance system
MRARNIILNMVCVCLAVSGLWWTITYFWRYINYEVTNDAFVDQYVAPLNIRASGYIKDIR
FKEHQYVRQGDTLLVLDNREYQIKVKEAEAALLDAHGLQDVLHSGIETSHTNIAVQDANI
AEAKAKLWQLEQDYHRFERLLKEESVPEQQYEQTKAAYEAAEARYQALVAQKQAALSQYA
ETSKKTTGVQAGILRKEADLDLAKLNLSYTVLTAPYDGYMGRRTLEPGQYVQTGQTISYL
VRNKDKWITANYKETQIANIYIGQQVRVKVDALPGKIFNGEVTAISEATGSKYSLVPTDN
SAGNFVKVQQRIPVRIELENISSEEMAQLRAGMMVETEALRK
>fig|226186.1.peg.1250 Outer membrane component of tripartite multidrug resistance system
MFLKTYRVYLMGPLCLMFAGQPAKAQTDSLFLSVDQLFERGVQHSLQLQADALKEAMAQE
RTRTARTSSLPDLQVGLKGGFVGQPVVWERGLSGPTYPDIPDWSQNYAIDFSQPLYQGGK
IRRTIHKAEMEKQVAELQTLTDQAEIKLGLLNQYMNLFSLFKQHEILMRNIEESELRLRD
IRRMKKEGVITNNDVLRSEMQLTNDRLSLQETENSIVLVSQQLDILLGQDENLLLKPDTT
LLHQAVALEAYDDYITLAYTNDPAMKLLRKQTELARNEIRLAQSLSLPSISLYASNTLAR
PVSRTLTDMYNNNWNVGLSVSYPLSSIYKNSHKIKESKLMVSLRKNDEEQKMQRIRMDVR
TAFLRHQEALQRVEALQLSVRQAQENYRIMQNRYLNQLAILTDLLDANSVRLNVELQLVT
ARTRVIYTYYQLQKACGRL
>fig|226186.1.peg.1427 Tetracycline resistance element mobilization regulatory protein rteC
MENFVRNSKLNIEKEIKRIEQQPIALLERIKQIIDVIQTSLTLLKRAVAEYQFQNPEEEI
QFFKVWKPQISGLLMFYIRLYQIEKNRVGKSLSAQCKYLKMELENIQKSFLNNSFYDYYR
AGQTELDNQYFIRENYDILSDVHCHLLDRDSSFTTLHDSSVAMILANSHLIEYVSDEIDS
LSDKLHLKFTSIVDSKLLQWTDSKVALVEFIYAIYAGKCFNNGNTSLKDIAFCCEILFNI
EIGDFYRIFLEIRNRKKSRTQFLDKLKDKIQKMMEELDR
>fig|226186.1.peg.1966 AcrB/AcrD family multidrug resistance protein
MNLRTFIERPVLSAVISITIVVVGIIGLFSLPVEQYPDIAPPTIMVSTTYYGASAETLQK
SVIAPLEEAINGVEDMTYMTSTATNAGTVSITVYFKQGTDPDMAAVNVQNRVSRATGQLP
AEVTQVGVTTSKRQTSILQMFSLSSPDDSYDENFLSNYISINIKPQILRISGVGDLMIMG
GEYSMRVWMKPDVMAQYKLIPSDITGVLAEQNIESATGSFGENSNETYQYTMKYKGRLIT
PEEFGDIVIRSTDNGEVLKLKDIAEVQLGQDSYAYHGGMDGHPGVSCMVFQTAGSNATEV
NQNIDELLEEVRKDLPKGVELTQIMSSNDFLFASIHEVVKTLIEAIILVILVVYVFLQDF
RSTLIPLVGVIVSLIGTFAFMALAGFSINLLTLFALVLVIGTVVDDAIIVVEAVQARFDV
GYRSSYMASIDAMKGISNAVITSSLVFMAVFIPVSFMGGTSGTFYTQFGLTMAVAVGISA
INALTLSPALCALLLKPYINEDGTQKNNFAASFRKAFNSAFDILIEKYKNVVLIFIKRRW
LAWSLLVCSVVLLVFLMNTTKTSLVPDEDQGVVFVNVSTAAGSSLTTTDEVMERIEKRLM
DIPQIKHVQKVAGYGLLAGQGSSFGMLILKLKPWDERPNDEDNVQAVIGQVYGRTADIKD
ASVFAISPGMIPGYGMGNALELHMQDKMGGDINEFFTTTQQYLGVLNQRPEIAMAYSTFD
VRYPQWTVEVDAAKCKRAGITPDAVLSTLSGYYGGQYVSNFNRFSKVYRVMIQADPQFRL
DETSLDNAFVRMSNGEMAPLSQFVTLTRSYGAESLSRFNMYNSIAVNAMPADGYSTGDAI
KAVQETAVQSLPKGYGYDYGGITREENQQSGTTMIIFGICFLMIYLILSALYESFIIPFA
VLLSVPCGLMGSFLFAWMFGLENNIYLQTGLIMLIGLLAKTAILLTEYAAERRKAGMGLI
ASAVSAAKARLRPILMTALTMIFGLFPLMLSSGVGANGNRSLGTGVVGGMTIGTLALLFI
VPTLFIAFQWLQERLRPVQSRPTEDWQIEEEIKVSEEEKSKAGKK
>fig|226186.1.peg.2101 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKDSIDFGSMDISTLFRKLLVPTVLGMVFSAIFVITDGIFVGKGIGSDALAAVNITAPLF
MIATGIGLMFGVGGSVVASIYLSQGKRKAANINITQALVFSTFIVLVMSALCFCFVGPLG
CLLGSSDRLLPLVIEYMIWYLPFLVFYELLSTGMFFIRLDGSPNYAMMCNAIAAIFNIIF
DYIFIFEFGWGMMGAAFATSLGTVVGGLMTVIYLTRFSRNIHLHRIKLSLKSLMLTLRNG
GYMIKLGTSAFISEASIACMMFLGNYVFIHHLGEDGVAAFSIACYFFPIIFMVYNAIAQS
AQPIISYNFGAGQPDRVRKALHLAIRTALICGISFFIITFLCRQNIVSLFIDRSCPAFDI
AVNGIPYFGVGFIFFAANMIGIGYYQSIRRGQRATIITLLRGVVFMLIGFFVLPLVLGVP
GIWLAVSLAELLTTLYIIGIYFKDRFMVHRL
>fig|226186.1.peg.2377 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNKYEERLGTERMLPLVFKMALPAVAAQFVNLLYSIVDRIYIGHIPGIGTDALAGVGVT
TSLIILISSFSAIVGGGGAPLAAIALGQGDRVRAGKILGNGFVLLILFTLLTSVIAYTFM
EPILLFTGASENTLEYAVDYLSIYLLGTIFVEISTGLNSFINAQGRPAIAMFSVLIGALL
NIILDPIFIFWFDMGVKGAALATVLSQACSAVWVVSFLFSRRASLPLEKRYMGLDRKIIL
SILALGVSPFIMASTESLVGFVLNSSLKEFGDIYISALTILQSSMQFASVPLTGFAQGFV
PIISYNFGHGDKQRVKDCFRIVLVTMFSFNLILMLFMILFPSTVASAFTSDERLIETVRW
TMPVFLGGMTIFGLQRACQNMFVALGQARISIFIALLRKAILLIPLALILPNFMGVTGVY
AAEAISDATAAICCTLLFFGQFPKILGRIKGNTLRVE
>fig|226186.1.peg.2792 Inner membrane component of tripartite multidrug resistance system
MPSCPRNYPFYNWVPKPIGIIILLFFFLPILSVGGVYSVNSTEMMSGLGIISEHIQFANF
VTSIGMAAFAPFLYELVCIRREKLMCIAGFALMYVFSYVCAKTDSIFLLALCSLLTGFLR
MVLMMVNLFTLIKYAFGMEATRNITPGMEPKDATGWNKLDIEKCISQPVVYLFFMILGQM
GTALTAWLAFEYEWKYVYYFMMGILLLSILILFITMPNHGFAGRFPINFRKFGNVTAFCI
SLTCITYVLVYGKVLDWYDDPSICWATAISILFAGIFLYMDVTRRSSYFILGALRLRTIR
MGALLYLLLMIINSSAMFVNVYAGVGMHLDNLQNASLANWCMVGYFIGALISIVLGSKGV
HLKYLFALGFFFLALSAGFMYFEVQTAGLYERMKYPVIIRTIGMMILYALTAAYANQRMP
FKYLSTWICIMLTVRMVLGPGIGGAIYSNVLQERQQHYITRYAQNVDLVNPEASASYTNT
VQGMQYQGKSETEAHNMAAMSVKGRIQVQATLSAVKEMAGWTIYAGVICMIFVLVVPYPK
RKLLT
>fig|226186.1.peg.2794 Outer membrane component of tripartite multidrug resistance system
MDSPILSQPIKFVPEYRAIIMKRLLFIFTFFCLLAIHGGAQNILTLENCLRIGIENNLSL
QGKRKAMQKSKYGISENRVKLLPQINGFANFNDNIDPPVSVTDGSSYGVPYNITRTLQYS
ANAGIELQMPLYNQTLYTSISIAEIVDEMSRLSYEKAREDLILQISKMYYLGQVTAEQIA
LIKANITRLEELRDITQAFFDNGMAMEVDLKRVNINLENLKVQYDNAQAMMTQQLNMLKY
IMDYPAEKEIGLLPVNTDSIATVALTGLSENLYELQLLQSQVQLAERQKRLISNGYIPSL
NLTGNWRFAAYTDEAYHWFHSGPSNHWFRSYGVGLTLRIPIFDGLDKKYKIRKAMIDIET
MKLSRLDTRKNLQTQYLNAVNDLMNNQRNFKKQKDNYLLAEEVYTVTTDRYREGITSMTE
VLQDEMRMSEAQNNYISAHYNYRVTNLMLLKLTGQISSLFK
>fig|226186.1.peg.2939 Multidrug resistance protein
MITVNKKWIRLIGIVGCTVWMASCKQAPDAGVKSSYAVMQIEPTDKELSSSYSATIRGRQ
DIDIYPQVSGTIEKLCVTEGQKVRRGQLLFIIDQVPYRAALKTATANVEAARAATSTAEL
TYKSNKELYAQKVVSEFSLKTAENSYLTAKAQLAQAEAQEISARNNLSYTEVKSPSDGVV
GALPYRAGALVSANIPYPLTTVSDNSDMYVYFSMTENQLLALTRQYGDMDEALKNMPEVE
LILNDNSVYQKKGTIESISGVIDRQTGTVVARVVFPNESRLLHSGASGTVVVPSIYKNCI
AIPQTATVRMQDKTIVYKVVDGKAVSTLITVAGINDGREYVVLDGLKAGDEIVSEGAGLV
REGTQVK
>fig|226186.1.peg.3289 Permease of the drug/metabolite transporter (DMT) superfamily
MNKVNGFLYGLLSSASFGLIPLFTIPAMQAGMQFESILFYRFLFACMALGGILLINGQSF
RISRRDIPSLLLLAILYLMSAVFLFWGYKFMASGVATTIHFMYPVLTTLVMMLFFKEKKS
GWRIAAIASAVIGVYFLSGGNTETGSFSFFGLFIVLLSALGYALYLVTMSQLKIGRMKGL
LLTFYVFLFGGIFLLIGTSSISHLQPIREWHTAGNLILLALIPTVVSNLALVRAVKSIGS
TLTSVLGAMEPVTAVCVGIFLFGEAFTTSIGVGIALIIVAVMVIILKR
>fig|226186.1.peg.3336 Outer membrane protein oprM, multidrug resistance protein
MKKQILYMLCATALLSSCHIYKSYDRPEDITASGLYRDPAADNDTLASDTTNFGNLPWRE
VFTDPQLQSLIEQGLKQNTDLLSAALNVKAAEASLMSARLAYAPSIGLSPQGTISSFDKN
AATKTYSLPVTASWQVDLFGQLLNSKRNAQVTLKQTKAYRQAVQTQVIANIANMYYTLLM
LDRQLEITQATAEVLKRNAETVQALSERSTYTSAALAQSKAAYAQVVASIPDIEQSIRET
ENALSTFLGEAPHAIKRGVLEAQALPEELSAGIPLQLLSNRPDVKAAEMSLASCYYNTNS
ARAAFYPQITLSGSAGWTNSAGSAIINPGKLLASAIGSLTQPLFYRGTNIARLKAAKAQE
EQAKLSFQQTLYNAGSEVSNALSLYQNTSKKAESRQMQVESAKKASEDTKELFNLGTSTY
LEVLSAQQSYLSAQISQVSDCFDKMQAVVSLYQALGGGRED
>fig|226186.1.peg.3902 Membrane fusion component of tripartite multidrug resistance system
MAPIKSQNSNMLLAFLTLLGVIAIVAVVGFFMLRKGPEIIQGQAEVTEYRVSSKVPGRIL
EFRVKEGQSVNAGDTLAILEAPDVVAKMEQARAAEAAAQAQNEKAIKGAREEQIQAAYEM
WQKAQAGVTIAEKSYKRVKNLYEQGVMPAQKLDEVTAQRDAAIATEKAAKAQYTMAKNGA
EREDKMAAEALVNRAKGAVAEVESYIKETYLIAPAAGEVSEIFPKVGELVGTGAPIMNIA
ELNDMWVTFNVREDLLKNLTMGAEFEAVVPALDNKTVKLKVYYLKDLGTYAAWKATKTTG
QFDLKTFEVKASPMEKVENLRPGMSVIINK
>fig|226186.1.peg.4049 Permease of the drug/metabolite transporter (DMT) superfamily
MGNNKNLHGHLFALTANVMWGLMSPIGKSALQEFSAISVTTFRMVGAAAAFWILSIFCKQ
EHVDHRDMLKIFFASLFALVFNQGIFIFGLSMTSPIDASIVTTTLPIVTMIVAAIYLKEP
ITNKKVLGIFVGAMGALILIMSSQAASSGNGSLIGDLLCLVAQISFSIYLTVFKGLSQRY
SAVTINKWMFIYASMCYIPFSYQDISVIQWTSIPMVAILQVLYVVLGGSFLAYLCIMTAQ
KLLRPTVVSMYNYMQPIVATIAAILMGIGSFGWEKGIAITLVFLGVYIVTQSKSKADFEK
AGKEL
>fig|226186.1.peg.4502 Probable multiple antibiotic resistance protein marC
MSLSSLLIIFSSSFMALFPVINPLGNGFVVNGFFADLDPSQRKTAIQKLTINFIMIGVGT
LLIGHLFLLIFGLAIPVIQLGGGILICKTAIELLGDSNSSDKEGTSQNVDSFKWKSIEQK
IFYPITFPISIGPGSISVIFTLMASASVKGKLLHTGINYLVIALVIICMAGILYVFLSQG
QRIIQKLGPVGNQIINKLVAFFTFCIGIQISVTGISQIFHLNIL
>fig|226186.1.peg.4571 Quinolone resistance protein
MIKRNAAKPVRVAPPMMEEQEVSTSTLQELLEKEETVSNLIFSKGREEGISKSYKSFKNC
TFRNQTFSECKFRSSQLADIRFENCDLSNISFAESSLYRVEFIACKLLGTNLSETTMNHV
LLHDCNASYINLAMSKMNQVRFSHCHFRNGSFNDCRFSSVAFDSCDLVEADFSHAPLRGI
DLRTSRIGGITLNISDLKGAVITSLQAMDLLPLLGVIIED
>fig|226186.1.peg.4740 Tetracycline resistance element regulator RteB - Bacteroides thetaiotaomicron
MTRATSSVSFALRNDAENKERIFRTLKQANRK
>fig|226900.1.peg.182 Multidrug resistance protein B
MMAGSMVFPFYILLLRNVGNSFSQFGWAYGLFALTSALVYPLVGKISDQVGDKKLLIIYA
WSMAILMLCFPIATEVWHVYILQIVMGILGAVQRNTEKTSLARKVAQEKAGYEIGKYHVW
TSIGGAVAVIATGYLVDFFTIGTIFYIASILYVVSGIVLSSKKI
>fig|226900.1.peg.205 Permease of the drug/metabolite transporter (DMT) superfamily
MRRGQMIIGALACLIASMSWGAMFPVADHALEYIDPFYFSLIRYGAVAIMLIVLLLVKEG
KQAFCLEGRGKLLVFFGTMAFTVYNVLIFLGQMLMGKSGVMVASIMEALMPMISICILWG
YKHIKPKKYMITSMVIAFVGAVFVITKGDMSFFVTLKDNMFPLAFIFIGVVGWVIYTMGG
QTCSDWSTLRYSTLTCVFGTTVTGIITVIITSLGYISVPSMGTISIVKYDLLFMMTLPGI
VALLAWNYGVKILSSINGILFINFVPITTLAIMMMQGYQITMFDIIGTVLVIAALIRNNV
CQRKEENINKRVLQEEQLRQAV
>fig|226900.1.peg.236 Multidrug resistance protein B
MDRNVWIRFIGETLNGIAMMMLMPFFALYLKDKVDSLLEVGVIMALSPIAASFGSLIGGR
IADIYGRKPIMIFSMASNALLMLGFLFIEGFIPYAILSIFLGLSNSLFHPAASAMVADVT
APEKRTEAYGLLRMGHNIGAAIGPIMGASVVVLSKNLVFIIASSTMLFYALLVLLLIQET
MPKRTDKEEHKEKEAGTVWKIVMRDKVLMIYLLAGIIISMGFSQTEGMLPLHFDNEMKHI
FGTNNPYPYLMALNGLLVVLFQFQISKWATDKPVGKTMLYGACLFGIGLFFIGWLPKWFG
EFNTNATIILITLLFVYALYTLGEMIMSPVQMTFVANLAPEHLRGTYMGAASLQWITGSA
FGPLLGGFLLDRLLGHFLFTILAVGCVVAGIVYVSLDRLVEQRQKDTLTKQSS
>fig|226900.1.peg.272 Permease of the drug/metabolite transporter (DMT) superfamily
MKEICMLLVAVILWGTAIAPTKWALESIQPFTLLFIRLFFAGGICMIFSFKELQKSVVHK
KVPWKRMSLLAFTGVAGYFMFTSYGISLTSGLHVSIIDAALPLVTILFSALFLKEEIRLN
YWIGIILGAIGVLFITIPSKSANQEVSLIGDILILLSTFLFAFYTVLLKRPKQEQYLSNE
VFTTLTLIIGAVILLPFALVEIFYYGLPKVETWKTVLSVIYLVIGATILAYWFWNKALER
VSASVSGLYLNALPLISIITSIILLNESLTWRVIMGASLVLIGVGWADKQKLCNLLKGNK
VENRDC
>fig|226900.1.peg.405 Permease of the drug/metabolite transporter (DMT) superfamily
MKTEKFFTHPIGVFIAAIVATFLWGSAFPFIKLSYVELGIQPQEVGEQILFAGYRFFLSG
FMLLLFFKVLGKDMSFKKGTGKQLIQIGLFQTFLQYICFYIGMSYSSGIEGAIISGTSSF
FQILLAHFLYKDDALNMRKIIGVSIGFCGVVLVNMPSDGSLSFHFGIGSLLLLSAAMLYS
YGNILAKEGSKTLDVGYMTAYQMMFGSIGLLCIGALQVGVMPFTFSLHALLMLIYLSFLS
AAGFCIWNTIMKYNKVGKVSMYMFFIPVFGVLLSSMILGEAIHSFVLLGLACVAAGIIVV
NRTPAKQKIEKEKQVA
>fig|226900.1.peg.462 Daunorubicin resistance ATP-binding protein drrA
MKSVIEVQGLRKEFTAYSSRPGLKGAFRDLLNRNYKIVPAVNDVSFTVKQGEMVGYIGEN
GAGKSTTIKMLTGILTPTSGQITVNGMNPHNQREEFVRTIGVVFGQRSQLWWDIAVQESF
RLLKKVYGVSDAQYKEHMEHVIETLDIGPLLDKPVRKLSLGQRMRCELAAALIHNPPLLF
LDEPTIGLDVLVKLKIREFLKEMNERYKTTILLTTHDITDIEALCERVIMLDEGNIMYDG
SLNNLRTQWGAEKEIHFQFVAPVSYQALSMVMPDNHVVWSKAKEENAWVAKIPNEEVIIS
MLISKVVQAFQIKDLKINEVSTEEIIRNIYEEGITHG
>fig|226900.1.peg.463 Daunorubicin resistance transmembrane protein
MGKYIEMIRIRFLMMLAYRTNYYSGILIYTINIGAYYFLWQAIYSGKENIESLSISQMTT
YIAIAWMARAFYFNNIDREIAMEIQEGRVAVELIRPYNYLGMKVMQGLGEGIFRFAFFSI
PGMVIVTLLFSLQITTNFQTWLYFFLSLIFSFIINTQINLMTGMLTFFLFNNSGIMYAKR
VVIDLFSGLLLPISFYPLWAQKAMMFLPFQAISYIPSMIFSEGIQGSKLYEALVFQVIWA
IVLIIPIVLMWRTARKRLIVQGG
>fig|226900.1.peg.511 Permease of the drug/metabolite transporter (DMT) superfamily
MNNGRRIGLIMIITGATLWGLSGPMIQWLFQHTNVSSIDFLTIRLLLAGIFILSFLLIKK
QNIFQIWKHPRYSIQLIIFSILGMLGAQYAFIETVHISNAVTATLFQFLGPVLITMYVAF
EQRKFPASMQLFAIIAALIGTYFIITNGSIENIVLSKEAIIFGLLTAIGFAFYTLHPASL
IKECGTTVVIGWGMLIGGIALLIYNRSFGWNQFSQTLTLKTFSMLILIIISGTLSFLLYI
GSLKYLAATETSILSSIEPLVAAIVSITWLNESFGTYQLLGGVCIVLSVIFLTMPQKETE
PTYTTEQI
>fig|226900.1.peg.592 Bicyclomycin resistance protein
MKYFIYFIVIVAFLDTFSQLPIMSTFAQSLGGTPLIIGLVVGMYSFANMIGNIIAGAAVD
KFGAKKILYISMGITSFIVLLYTVVQSGEQLLVVRFMHGFSDGFLIPAAFTFLSKQTNAK
RQGKAMALSGAAVGTAAIVGPAFSGIMKATAGVEWVFITISILMALGTIVSLFFLPNNVS
RKDTSRTQMMNKEDMVELLKSEPLLQAYIGAFTLMFSQGIVTYMLPVKVEALALKASTTG
MMLSVFGITAILFFLLPTNRIYDRFNRSKLMLIGIAVMAFALSLLGLFATKGMLFIVMMI
YGIGFAILFPSINALLVENTTDDNRGKAFGLFYAFFSLGVVAGSFTVGAIGASPSVSFII
GTAFLLTFAGMIYVRSKVKKTMMG
>fig|226900.1.peg.638 Acriflavin resistance plasma membrane protein
MDRLTKFSLKNRAAIIIMIFLISILGVYSGSKLPMEFLPSIDNPAITVTTLSQGLDAETM
TKDVTDPLEKQFRNLEHVDTITSSTYEGLSRIDIAYTSKANMKDAAREVEKAVNTIKLPK
DVTKPVVSQLNTSMIPLAQITIQKQNGFSKADEKQIEKEIVPQLENIDGVANVMFFGKST
SELSIVLDPNQLKNKNVTSQQVLTVLQGKETSTPAGAITVNQEEYNLRVIGDIKNVNDIK
NITVAPQVKLQDIAQIEIKQHYDTISHINGEEGTGLIIMKEPSKNAVAIGKEIDKKVKEI
DKEYKDQFSIKLLASTHEQVENAVTSMGKEVILGAIAATLIILIFLRNFRTTLIAVVSIP
LSILLTLFLLHQSNITLNILTLGGLAVAVGRLVDDSIVVIENIFRRLQKDSFSKDIILDA
TKEVAVAITSSTLTTVAVFLPIGLVSGAIGKLMLPMVLAVVYSILSSLIVALTVVPLMAF
LLLKKTKHRKPSSSSRYVATLKWALSHKFIILLTAFLLFVGSIAAYILLPKANIKSEDDT
MLSINMTFPAHYNAESQKQKAFDFEKKLLSNSDITDVILRMGSSAEDAQWGQTTKNNLAS
IFVVFKKGSDIDQYIKELKKENKTFEPAELDYIKTSYSSSGGGNNLQFNVTATNEADLKE
AATIVETKLKSMDDLSKVKTNLEDSKKEWQIHIDQTKAEQLGLTPEIAAQQVAFLMKKSP
IGEITINNEKATIMIEHKKENINKQEDILNTNILSPINGPIPLKDIATISEKQTQTEIFH
KDGKETIQITAEASNEDLSKVNTAVNKAMTDLDLPGGAKVNIAGATESMQENFTDLFKIM
GIAIGIVYLIMVITFGQARAPFAILFSLPLAAFGGILGLIISRTPVDVNSLIGALMLIGM
VVTNAIVLIERVQQNREHGMETREALLEAGSTRLRPIIMTAITTIVAMLPLLFGQSQAGS
MVSKSLAVVVIGGLAVSTALTLVVVPVMYELLDKIGRKRRSRRKISTSTETLDI
>fig|226900.1.peg.756 Modulator of drug activity B
MKNIFIINGHEKYGTKEGRLNRTLVDYMVTVLGENHHVKTTTIQDGYNIKEEQDKFLWAD
VVIYQTPIYWFSVPGLFKTYMDEVYEYGLFFKGADEYGTGGLLKKKEYMFSTTWNAPEKA
FGDKTKFFEGESLESALSHLHRVQKFLGMSPLKSFACYDVVKNPDIEKFLVNLKDHLDGV
IK
>fig|226900.1.peg.758 Multidrug resistance protein B
MGFWSMHRNIKIRIITSFLTRTVSTMIFPFMAIYFSIKLGSAVAGALLLINVIVSLVIGL
YGGYVGDLLGRKKVMIIGQSIQVISIACMGVANSDYVDSPWLTFIFMLVNSLGSGLMNPA
TEAMLIDVSTPENRKVMYSINYWAINLSIAIGAIFGGLLFENYRLQLFIVLTLVAIITLY
VMAVYMEEVYVARKTVEKKNVLKGMADSYKVVMKDKAFLIFCAASICTLSLEFQINNYLG
VRLQKEFETVHFFFGNGVTFDLTGIRMLSWISAENTILVVLCSALLIKMLKSFNDLKILY
VGLFIYTIGFTILGTSNSLWILLIAGLFQTVGEMMYVPVRQSIMADMVPNEARGSYMAIN
GMVFQVAKMNGALDVMLGSFIASWGMSALYFIVGMSSILLFMKAIGKEKYEDERNVSQIG
>fig|226900.1.peg.768 Multidrug resistance ABC transporter ATP-binding and permease protein
MLSVLLKLKWFFREHWKRYSIAIGALLIVNIVEVIPPKVLGVTIDNIKTGTLSNEAIIQS
ILILIGVTIVGYGLTFVWQHQLFGGAFVLEKTMRSKFMGHLLKMTPTFYQKNRTGDLMAR
ATNDLKAIAMTAGFGILTLVDSSLYMLTIVFMMGFTISWELTFAALIPLPIMAYAMNIYG
KKLHERFTVAQDAFGDMNDKVLESIAGVRVIRAYVQENADEERFHHLGDDVYEKNMKVAK
IDALFQPTVKMLVGLSYLIGLVYGAYLVFQSKVTLGELVSFNVYLGMMIWPMFAIGELIN
VMQRGNASLDRVNETLAYEPDVKNPKHPKLVQEPDYIQFDDVSFSYPSSTEENLKKVSFT
LKQGETLGVVGKTGSGKTTLVRQLLRQYPLGDGDIAVSDVTLDKMTNENVLGWIGYVPQE
HILFSKTARENILFGNREATEEELEKAIEIAAFKKDLEFLPEGLETLVGEKGVSLSGGQK
QRISIARAVIQNPEILILDDSLSAVDARTEAAIIENIRTERSGKTTIITTHRLSAVQHAD
WILVMDEGAVIEEGTHDQLIQKGGWYAEQFERQQGESESADSGVKI
>fig|226900.1.peg.769 Multidrug resistance ABC transporter ATP-binding and permease protein
MYKAKALTKEEVFAFYKPEINRLLLLGGGYFALLVVVSLFAYGKQFFLQKAANKIIQIMR
EDVFSHIQTLPIRYFDHLPAGKIVSRVTNDTEAIRDLYVTVLATFVSSIIYIIGIFAALF
LLDVKLASLCLLIIPILIVWAILYRKYASVYNHKMRSRLSDINGTVNESIQGMPIIQAFR
QERETKKEFEELNGDYFKYQNKILNLNAATSHNLVAVLRNIAFTGVIWYFGGASLSATGI
ISLGVLYAFVDYLTRLFSPITNMVNQLANLEQARVASERVFELLEEKGEPVEEERMPRLK
GNVKFDNVSFSYNGKDEVLKNISFEAKQGETVALVGHTGSGKSSIMNVLFQFYEFEKGKL
TIDGHDVKEMPKQATREHMGIVLQDPFLFSGTVASNVSLENEKISKERIIKALHDVGAER
FANNINEEITEKGSTLSTGERQLISFARALAFDPAILILDEATSSIDTETEAMIQQALEV
VKKGRTTFIIAHRLSTIKSADQIIVLDRGTILEKGSHDELMKKRGRYYDMYKTQMEGNQS
A
>fig|226900.1.peg.876 Teicoplanin resistance protein vanZ
MHTEVLMSYLYTYFFTIMFCILFQIGFYFKAKRNISIRHFLWVYVFLFYLSLVYKVTQIA
TVWDISRYETWIRVSQINLTLFDTAGSTTYLLNIVLFMPFGFLLPMIWPYFRKIKNTVCA
GFFFSLAIELNQLLNNRITDIDDLFTNTLGAIIGYLLYRALKMIFKREGEKLDTSSSLVI
KYEAIFCLVCSFVGAMLIYHPALFGRPVIIQ
>fig|226900.1.peg.936 Teicoplanin resistance protein vanZ
MSEFDEYIKSILAYSELSDIEQDELFLEMYDHLNSLKEEYMEQGMNEKEAIYKAIQSFGE
SKVIGVEINKSVYEVPRPLKVLSKILCIPYIIICFIVFLGTFISTSTFDSVRSLTGGGTV
YHPIEFWQQFLHISDLETLLQLFGITLWQVKDFIAHPGPWGNSTYWLSVLQHIILVVPFG
FFVPVLINKVTNYKKARKWYVMTFLVWEILHLLTLSDVFDVWQIAINMLGASVGYLLFIS
IMQLDNKFRVMRKKIFEN
>fig|226900.1.peg.1123 Permease of the drug/metabolite transporter (DMT) superfamily
MKQEKSIALPLAISIIAISFAAVFVKMSSAPSSILSMYRLWIIVLIMLPIVWKKREEFNR
IQMKDWGFLIGSGFFLALHFLLWFESLKHTTVASSTIILALQPIVSLVGGFFLFKERTTY
SAIATMGIAILGVMCIGWGDLGLSKQAIYGDILSFLSVIAVVGYLFIGQTTVKKVSHWIY
SFTVFAFAGLFMGIYNVILQVPFTGYTRWDWTVFLLLAIVPTVSHVINTWLLNYVNATPI
SMSILGEPVGASILAFCLLGEKLNAMQIIGSMLVLFGVSVFLLQQQKRTAKNVVNEPVYT
QEL
>fig|226900.1.peg.1272 Gentamicin resistance protein
MDSYKHYIKEALPNLSIHSYKQNEEGWDNVAVIVNDELLFRFPRKQEYAMRIPLEKELCA
ILTQSLQEIEVPQYHLIYKNESDEVPLCSYYTLIHGEPLKTETVATLEDPKLKAIITQLA
TFLAVLHSIPLHQVTTLCFPIEKTCTYWKELQTKLNQYLTTSLTSLQKLALNRLFENFFA
CLATSTFQNTIIHADFTHHHILFNKHNKSISGVIDFGDAQIGDPAFDFAGLYYDFGHEFT
TSVYEQYSTLISHHDPLLIHRITTFYQYSPLLHNIIYNFESENELEFITGTEQLKTILQG
>fig|226900.1.peg.1568 Tetracycline resistance determinant tetV
MKIATRNIILMMIGKMTSLLGAGIYTFAMGLYVLKTTGSGMGFAITLVCGSLPRMICGPI
AGAVADRVNRKWLVIGTDLLSSLTMLSMFILATIFGPSLLFIYISAALLSICASFYSVAL
TSSIPSLVDEGRIQKASALNQTAASLSNILGPIIGGVVYGFFSIKSFFLLNSITFFLAVI
LQLFIVFDLYKKEVAESTEHFLTSIKEGFLYVKRQREIYGLMKIALWVNFFACGLTVALP
YIIVHTLHLSSKQLGTVEGMLAVGMLMGAIALSVRKEVNNPFRSIYTGLFLFAGLSLCTA
FPLLVIIPKVASFIYYIAFMMLTGIAIMIVNIPMQVHMQKTTDPSYLGRVFGLLETIATA
IAPLGMIVYGLLLDMLPTSIVMMTIGGGLLLVVLVGVKQHMAKKQVDVSA
>fig|226900.1.peg.1621 ABC-type multidrug transport system (daunorubicin resistance), ATPase component
MMNTLEIKNLTKKFGNFIAVDNMSLSIKEGEIFGFLGSNGAGKSTTINMIAGLLRSNEGE
ISILGKNIKKHNRFAKMNIGIVPQDIAIYEELTAYENVKFFAGLYGLRGAELKARVEEAL
KFVGLSDKQKSYPKNFSGGMKRRLNIACAIAHRPKLIIMDEPTVGIDPQSRNYILQSVRK
LNEMGSTIIYTSHYMEEVEEICTKIAIVDHGKVIAEGTKEQLKAIITDTKDIWIEVKSVE
NLDVEKLKEINGVKAVQIEENVIKVNSDAGLNNLNKIIQHCINHDIEIRSLEEQAPNLET
VFLTLTGRNLRDK
>fig|226900.1.peg.1644 Drug resistance transporter, EmrB/QacA family
MEQSKGIKIVFLMCLGIFLCMIDTTIMNIALPAIQSSVNTSLEKMSWVLNVYTMTIAVLA
IPLGRIADIFGKAKMYILGLVIFGGGSVLCAFANTGDFLIFSRFIQSIGAAILFPTSMVI
GVSAMPLAKRHVALAILGVTQGLSAAMGPVIGGIITQHLGWRWVFFVNVPVCIIGIVLCC
IMLQIKNEERIISKIDWIGLLLSSTAIFSFTLILVKGNTWGWQSNIALSCYAISTISLIL
FVLVERKIHNPMVNLKLFQDRMFVGASIVVILSNLFLIGVTVLLPTFLTKLQGRTEIEAA
FLVTPISAMIFFVSPVAATLIKKLGKVTIILSGFLIMGLSYYWLQMIDVHSTNIEIIIPC
MILGVGYGLVVGPITVLSASSFEGELLTASQSVVSMLRQVGIVLAVAIFVSNLTHNLTVN
KEKVYRYAEEKVRTIHVNSTEQTEILQMTKEKIENQSLESNINKKQNAMTMGLSKEKKEE
LIRDKTDEILRKVPVEYRDVKREEVMRQVTKEVEKQEESIKKEVLTFSNDVNHYAKNQMA
MSFTDLYKASVPIILICAFVSLLFWEGKALSKKRKGRIVEEA
>fig|226900.1.peg.1714 Quinolone resistance protein
MKIDRPKISPELSSKNFQDIFYEEDPTLEVCEIIDSTFENESVDRVRLYDAVIKNCKFTN
TDFSNIDITDVCLENCDLSNVNLSNSSVHRVEFKNSKLIGVNFTESSLGNVKFENSILNL
AAFGNSKLEKIIFNETSLNNADFFDCKLKKVEFQLCSLDEANFDQTSLKGIDISSSTFDT
LTVSVNDLRGCKVSTYQAVQFATLLGLIIKD
>fig|226900.1.peg.1941 Multidrug resistance protein B
MAFVNMYTVLGNYLSSPTYNLTAEQILYFRLAGLFGMLLSPLAGRLTKRFEVRKVLQGGL
LIAIFSLSSIGFVSYLSLLVMMSVCFVIGIAISVPSLVSLVGQLGGEIRNDTFYWFCSFS
IYN
>fig|226900.1.peg.2224 Permease of the drug/metabolite transporter (DMT) superfamily
MKSPILSYFILFFGVFALSTSAIFVKLADAPATIIAFYRLFFATLILLPLLLFNKNSRNE
LKTLTKKQWTFGFISGLFLAAHYVLWFESLQYTSVASSTVIVTLQPLFSMIGGYFLFKER
FTKGAVIGCLIAISGSIIIGWQDFQISGEALYGDILAFIAAGIITAYFFISQHVRKDLSL
IPYSVISYGSSAGFLGIFAFTQQESFIHYFTQTWLCFIGLAFIATILGQTIFNWLLKWMS
ATVISMSILGETIGTCILAYFILHETISLQQGLGITVIFIGLVLFLLQPSSNKKA
>fig|226900.1.peg.2391 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MITHISDIKLQTVSIEGVKQVYKDILSFPIKKETASFIQFEVTPYTTISFQEVYEPIAPA
HFAFEIPYSKFHETAKWLKDSGLLIVKWQNGNVIGEENGLFNLYFKDGDGNLLEIIAHSY
VKEDVLVPHSPLNILYVREIGLPVKSVPVFTEWLKSNLNMKTMEDGDIFNFVIGGTAYIV
ATWWQRPWIPIAMKALSPKVYVSFGTPDVAFLQRIQNNFKKNSVSFECKRNEVSFIEQGY
TFSIVHTSEFHSDIPKQLNLPLSI
>fig|226900.1.peg.2532 Teicoplanin resistance protein vanZ
MINGSLFIILGVICYLIVRGILIGTKNKKHVIWWKEIVSFLFVVYICMVVAVTLFPLPIG
FPSNVENLNRSVNIIPFASIIKDINQIGSAYDGDALFMIGLIVRNVGGNILLLMPLGFLA
PILWDKYKKFKNTILLGFSISASIELLQLIESLFSGVGRITDIDDVICNVLGSIFGYCIY
NIFLKAINKFNIRVLGKTNSKGVELVDK
>fig|226900.1.peg.2557 Quaternary ammonium compound-resistance protein, C-terminal
MITTIISSVVAFATTNIDDIFILLVLFSQVRTEVIRKEGRAVREKATRKKLYIVIGQYLG
FSMIIFLSIIGSLSSFFIPVSWIGLLGFVPIYMGVKGLLSLRSYKSNEVIDNVTVSLFKV
ASITLANGADNISIYIPMFASQTLETNIVTLVIFFSMIAIWCFISYKLIKAPILAKVLEE
NCHIIVPIVLIGLGMFILFRSGTIGLFS
>fig|226900.1.peg.2737 Zwittermicin A resistance protein ZmaR
MIYEANIHTRKKLVSMFEDFNNVVLLSYLQGHMGTAWVNDLENPKVAQVTVGIFTFYAGD
PNTKETEELLRNIPERILVIVNSEEWKQRLETFHERKIDKFLRYKFKRNPEVFNRSKLKS
FISALPKEYELRRIDEHIANSPTLHKISEDFTSQFHSVEDYINRGIGYSILYNGEVVCGA
SSYSIYNDGIEIEVATDHNHRREGLATVVSAALILDCLENGKYPNWDAANTTSAKLAEKL
GYEFDKAYDTYFVDNR
>fig|226900.1.peg.3004 Zwittermicin A resistance protein ZmaR
MICELSKDDFYRCNRLVNEQGQLEVRAVIAGVNPGRIFVDNVTSPNSGLIWLGNNDGFFF
IGDAENEEFNKEVNRFINHVIVPEARKVGLDCFEGIGNHSKWNKTIERIFQHRKLKSWNQ
RVYMLGKEDYENHHEPKFEQRYTVLKMSKALYENNNNTFKNIDFLQSKILEFWSSPDSFF
NEGIGYCIVYDDLIVSVCFSGFVFENIHCIDIETIEGHQGRKLAQKIAHSFVKDCLENDI
IPYWDCMELNKPSVAVVENVGFTNVFNYVGYYFLFE
>fig|226900.1.peg.3015 Bicyclomycin resistance protein
MSNFKNKAIDKDISSGLIILLATACGIIVANLYYAQPLIGLISNEIGLSNSSAGLIVTLT
QIGYVVGLLFLVPLGDIVENKKLILILLFLSAFALISMVFVKSATLLLIASFFIGLGSVA
AQVLVPLVSYLSSENARGRVVGNVMSGLLLGIMLARPISSLVADMWGWNAIFALSATVII
VLAFVLSKVLPTRKPKAKTNYIALLNSMWQLLRTTPILRRRAIYHACVFGAFSLFWTTVP
LLLFSPAFHFSQTAIALYALVGITGAIAAPIGGRLADLGWTRPATGIALTVVIISLILPL
FIQSSSSFGIAVLVIAAILLDMGVSANLVLSQRLIFSLSPEIRSRLNGLFMAIFFLGGAV
GSFIGGWAYALGGWNLTLWIGIAFPTIALLYFAREE
>fig|226900.1.peg.3044 Permease of the drug/metabolite transporter (DMT) superfamily
MKPIKANLMILLVTMTWGTSYLFMKIGLETVPSFSLVALRFGIAFFVCAAVFFKQFRSIH
FVTLKYGFILGFLLFVVSASVILGLKTTSASNAGFLASLTVIFIPLLSIVLFKDRLSYRL
IISSLVAMTGIGLLTLNNQLTLNSGDLLCILAALFYAFHIIVTGRAAKVANTLQLGILQL
GFAGGFGVLSALIFEEPQLPSTKESWIAVLVLSIFCSAFAYIIQAMAQKYTTPTHTGLIF
SLEPVFSALFAYLFMNEVLSLKGYIGALLILSGVILAEIKVKRKSTLLL
>fig|226900.1.peg.3240 Chloramphenicol resistance protein
MNSYTASSSEVQTNRRSIFALLALAISAFGIGTTEFVSVGLLPSISEDLHVSVTTAGLTV
SLYALGVAFGAPVLTSLTANMSRKTLLMWIMIIFIIGNGIAAVATSFTVLLIARIISALS
HGVFMSIGSTIAAALVPENKRASAIAIMFTGVTVATITGAPIGTFIGQQFGWRTSFLAIV
VIGIIALIANSILIPSNMKKGASVSFRDQFKLITNGRLLLVFIITALGYGGTFVTFTYLS
PLLQEVTGFKANTVTIILLVYGIAIAIGNVIGGKLSNHNPIRALFYMFFIQAIILFVLTF
TAPFKVAGLITIILMGLFAFMNVPGLQVYVVMLAERFVPSAVDVASAINIAAFNAGIALG
AYLGGIVTNSLGLIHTAWVGGIMVVGAVILTAWSMTLEKRDQVK
>fig|226900.1.peg.3281 Daunorubicin resistance transmembrane protein
MKSKTGVLLGRLMRNIMRSPDTIITVAITPIMMMLLFVYVFGGAIKTGTENYVNYLLPGI
LLMAIASGVAYTSVRLFTDVKSGLMARFITMPIKRSSILWAHVLTSLVANVLTIVVVILV
ALLMGFRSSANILDWLAVAGILGMFTLALTWLAIIPGLKARSMEGATAYSYPLVFLPFIS
SAFVPTETMPKIVRAFAENQPVTSIVNAIRALLYKGTVGNDIWIALAWCVGIMIISYFFA
SKAFKRQLG
>fig|226900.1.peg.3282 Daunorubicin resistance ABC transporter ATPase subunit
MSHAAISVKGLKKSFKDKEVLKGVDFEVQRGEIFALLGSNGAGKTTTVNILSTLMKQDSG
EVSICGFDVQSQSDHVRQSISLTGQFAALDGMLTGRENLIMIAKLRGVSNPAQVADNLLA
RFSLTDAANQRADQYSGGMKRRLDIAMSLIGAPAVIFLDEPTTGLDPEARIEVWDTVKEL
AGSGTTILLTTQYLEEAEQLADRIAILHGGKIITTGTLAELKEMFPPAKVEYIEKQPTLE
EIFLSIIGKKEEM
>fig|226900.1.peg.3378 Vancomycin B-type resistance protein VanW
MVGVLCVAIMSGCGAKVSDVALVSDIGGHTVEAKAEVQDTISLVDGRTGTEVKKLDLSSL
GYFEDEAKFKKSVTKVVGEVGKSVDKKMVPSRIAPDGSWQEGKPSYELMEKELVDKLLNV
GMWDATYQLPIVEKKPVATLSDAQGNGTVIGRYETNLGGSTGGRIENIRLSAASINGVVL
AKGDRFSFNSLIGDTTPDKGYQLGKEIVDGKLVDGYGGGVCQTSSTLYNAADQAGLKMVE
RTTHSKTVGYVPQGRDATIAYPYLDLVFENTNDAPVKLYMGIQGGKLVAEVHKMR
>fig|226900.1.peg.3503 Permease of the drug/metabolite transporter (DMT) superfamily
MLRYSLLVLLGACSYGILAIFVKLAYAEGFSLGEVIGSQYLFGWIILLAITLLFSRHRVP
LKQALLLFVAGTSASFTGIFYYASLKTVPASIAIILLFQFVWVGIIIEAVATKTLPSREK
VISVIFLLVGTFLSSGLLEQSAGAFDTTGIILGLLSAVTFATYIFVSGKVAVEVPSLPRG
VLLMTGALTLVMIVFPPTFIFNGAISQGLWKYGLGLGTFSIVIPSIAFTIGIPKIGSGLA
TILGAAELPVTTIMSVFVLKEAVLSSQWFGVSLILIGIAIPQIAYAMRGRYRKHHTHKKV
AA
>fig|226900.1.peg.3518 Multidrug resistance ABC transporter ATP-binding and permease protein
MKPYKGLLSLAFIFLVGATVTEMMGPFLIKQFLDEHLVPRDFERSALVTLFVIYIVAHLL
KVLFTYLNLLYFQNIAFKIVQDMRVEVYEHVQKLSLSFFDRTPIGTLVSRITNDTEAIKD
FYVSVLSTFVKNVVFLVGILVAMFLLDVKLALFSLVLIPIMFAIMVLYRRKSAAFYLEVR
NQLSVLNAKLNESIQGMNIVQVFRQEKRMRKEFEEVNNKHYSAGRRTLKLDALLLRPATD
LVHIVAIALVLGLFGIDALKSPVEVGVLYAFVNYIHRFFQPVNEMMMKLSFFQQALVSSS
RVFHLMDEKDLAPVQKGNENPQIVDGDIEFKNVTFSYDGKRDVLKNVSFHVKQGQTVAFV
GHTGSGKSTIMNLLMRFYNIKSGNIVIDGVDLEKFEEREIRKKIGLVLQDAFLFAGNVKQ
NIRMYNEEITDEEVKEAARFVQANTFIEKLPKQYETEVVERGAAFSSGQRQLIAFARTIA
TNPKVLVLDEATANIDTETEEAIQTALQQMRKGRTTIAIAHRLSTIQDADQIFVMHDGEI
VERGTHQELLSEQGLYYNMYLLQNKVSLQKAL
>fig|226900.1.peg.3519 Multidrug resistance ABC transporter ATP-binding and permease protein
MFMNLAWFFKQEKRAYITGIILLFGVALLELVAPKVIGIVVDEINDGTLTTDKLLKWVVL
LVIVGITMYILRYIWRIMIFGSSLKLARQLRKNLYEHFTKMSPSFYQSNRTGDLMAHATN
DIQAIQQTAGAGVLTLVDSLAVGGCVLVAMGFTISWKLTLLSLIPMPIVAISTNYYGTLL
HKRFHKAQQSFSEINDKVQESMSGMKVIRSLGQEKEDLQAFRRKSEDVVHKNVLVARIDS
LFDPTISLIVGFSFLIAVCYGSVLVVRGELTVGDLVTFTTYLGTLVWPMLAFGWLFNIME
RGRASYDRVEKILSQKSDVVNSENAVHTIASGNVSFAVDSFSYKKNELLHLNDIHFDLKK
GETLGVVGRTGAGKTTLLKCLIREYDHFNGELKIGERDIRDITLHGVRSAISYVPQDHFL
FSASIGENIAFGKADATYNEITQAAEIACIHNDILQFSEGYETVVGERGVSLSGGQKQRI
SIARALLTNAEILILDDCLSAVDAKTEETILSALKRERAGKTTIITAHRLSAIQHANLIL
VVDEGRIVQRGTHEELMKEKGWYKEMYESQQLEALVEKGGV
>fig|226900.1.peg.4469 Permease of the drug/metabolite transporter (DMT) superfamily
MNKNQMLLGSFLCLLAVTAWGFMFPVMARALQFIDPFFFTTLRYGSAAIIFLILLLITEG
KTSLRLEKRTLSLFFYGTVGFAGYGFLVFYGQQLAGPSGAIHAAMIQSLMPLIALSLQWI
TQNRRPQNYTFLCMFVALLGVMLVISKGNIELLFGAASHLSTNILMLCGVTCWVIYTNGA
ARFQSWSPLRYTTLTCLFGSISLIVIVTFLTYTNIVTMPSLRTVVSVRFELFYMSIIAGV
IAVFCWNMGNRYISSINGILFMNLVPILALIGSIFRGYTVDKIEIAGAALTIIALLCNNL
WQRKVNIKIPTSVR
>fig|226900.1.peg.4581 Permease of the drug/metabolite transporter (DMT) superfamily
MRRWGIELLILSVVIIWGINYTIAKYGLLEFTAIEFTALRMMAAAPLLLLLTFCIEKSVY
MERTDIPRLIIVSVVGIVLYQTLFMETVKYTSATNASLLISISPIFTTAFAIFLKQEKFS
SRKLIGSMTAFVGAALVLVAGHSLTSSFYGNGIGLITSICWGLYPVLAGPLIKKYSALRV
TAWSALVGAIPLLLLSGPHVFVMPFHITHGMTLFALLYSIFFVTVFGLVMWYVGVQKIGA
SHTMVYMYITPLVAVLFAAVWANEYVSFQQIIGGIIIFVGLWFVKSEKVKVHSIAGEPIS
K
>fig|226900.1.peg.4872 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MIKELDHVMIKVQNLEESITFYSEQLRLQIIWEYDNYVGFHNGIVIHDSKNSENLTSFFK
VDSVEETVKILKESNVKIILEPTPIPTGYTAAFQDISNNIIHIVDNINLS
>fig|226900.1.peg.4954 Pristinamycin resistance protein VgaB
MTILFARNIEKSFGDRTLFTLPSLEIQAQDRIGIVGVNGAGKSTLLQILSKEIEADRGIV
THHSSIAIILQLSEELPETASSLAKGKWSISNVTDAMSGGERMRLKIAHALEQNAGILFA
DEPTSHLDMVGTEQLEKALSSYKGALVLISHDREFLDNICTKIIEIEDGIIQEYKGNYSN
YRKQKERERIQKQAEYEQYIQEKNRLEQSILQRKQRASNMEKIPTRFSSSESRLYRLSGA
HGQEQVSKAAKALETRLEKLEKKEKPKDLSQAQFDVQYHTPIHSKVAVQFNKATKKIGDR
ILFKNMNGTIAPGAKLAVLGANGSGKTTLFNMLLTNERGMQLSKSCKIGYFEQTLSILKT
DKTILENVLEETNYTEAFVRTILARLLFRREDVHKPVHVLSGGERMKVALAKVFLGNYNM
LLLDEPTNYLDLATQEELETMLQEYPGTILFISHDRAFIRSVADHILQVDESEPRVFHGN
YEQYTKRTTGDSVNVTEQELLRLQTKLTEVIGRNSIPNHHNDISSLEQEYETLLVKIRKC
KEAL
>fig|226900.1.peg.5204 Multidrug resistance protein B
MTSEVNKRTFFTKSTLIIIPLLIICAFAFHYFFLKSDNVFSSTGDALSQFSFFTFLLQHA
FKDGNLFWSWDYGLGGDLFGEFSYYYSTAPFFWLTLLLPKLNFDQIFEMKLYMSILKSTL
AMLFMYGSLRYHNKTIFSSFISAIIYGGCVTFIRHSLLWDFMADAIVFLPLVIWGLDKYI
LERKKGLFLFATALMLASNFYFAFITSIFIYIYAFFQYFATQQNKTIKTFIIYYIRIAFL
YALSLGLSAVCFIPSVNGVFSSDRLATKFTIPLFFEGTFYKNLMESIFFINNTEDYQLAF
PVFILFLITSALLIRNKLVTNKLTFTGFMLVLYMLPYTYSVFNGFSAMQYRWFYLFAFVV
AQTVAYILDWMLLNKQKVNSLIGPLLATTLFIYAFYRKVNINAQPLQTIDKILICTTVLS
IITILLWRYLSKVALQCFIVLNVLVNVIFINYFYSDFALSKHFNQAGVTKESLHGPGLDN
KDEIDAIRYIQNQDKDFYRIINPNNNYKNTPMLQGYHGTSTYQSLVNYHVHDFMKNKYNV
FQGYDSPSMFFQLDKRLFLENMLGVKYYVLSEGANKTEIPYGYKHLQQVGPYNIYKNEFA
LPLGYVYEAGISDEEFSKLNFAEKDQLLLDAVVVNDVGSLPLKQFNTKQLDSKQIKINPN
KMKWENIEKEKDILTVHENGRIIVPIDNNDMLGDLLVEIKIRNINKVSFGVTVNNKSMIK
GNEDGAYAYPLERFVYNLGKDAKPTELIISIPTPGQYELKDLQINSTNYQTVPKKVNTLK
ENSLQNIYYEGNSLKGDINSTKDGLLYLSVPYSKGWSIKVDGKETEFTKANSAFIGVPIS
KGQHVVEMKYVTPYFKMGLVISIISFIICISLLVLGDTKRYSKLKSRFKKRY
>fig|227882.1.peg.1994 Permease of the drug/metabolite transporter (DMT) superfamily
MSSIAVPGALAPRRAWLTDLPVLLVAVVWGASYLAAKDITTARTVIAVLVLRFGVVLPVL
VIAGRRSLRALSAAQWRGAALLGLILSGIFLLETYGVVHTSATNAGLIISLTMIFTPLAE
AAVTRARPPRAFLAAAGVSVLGVVLLTQGGGFTRPSLGDLLMLLAALARTVHVLAMSRVK
SVQGADALPLTTVQLGAAVAVFAVLSTGTDATVWGTAAGFGAREWGGLLFLAAFCTLFAF
CVQMWAVRRTSPSRVSLLLGTEPLWAAAAGITLGGERLGALGLMGGVLVLAGTAWGRRAA
G
>fig|227882.1.peg.5649 Drug resistance transporter EmrB/QacA subfamily precursor
MTETLTSPTTRSPVAPPVLGGLGLFTVLLGAALPLIDFFIVNVALPTIGRDLHASETVLE
LVVAGYGVSYAVLLVLGGRLGDLFGRREFFLGGMAAFGLTSLACGLAPSAWTLVAARVAQ
GAAAAAMLPQVLATIQSATEGPRRAKAMGLYGATAGLSMVAGQILGGVLVAADIAGTGWR
SVFLVNVPVVVVGLFLAARAVPETRSQRPEPVDGPGTVLLAVSLLTLLVPLTEGRAAGWP
LWTWPALAAFPFAAWAFYAVERRADRQGRTPLVPPSLFALTSLRRGLVMIVPFSIGFSGF
MFVIAVALQRGAGLGPVPAGLALAPMAVVFFAVSLCGPRLVARYGTRVVTAGGLIQAVGV
TLIVLAALRSWPDLGVLELLPGAAVAGAGQALQLPVLFRIILSEVPPTRAGVGGGVMITT
QQSGLALGVATLGSLFLALVPGWGMRDALVTTLLVQLAGVALTTALSLRLPRSIS
>fig|227882.1.peg.5651 Drug resistance transporter EmrB/QacA subfamily precursor
MPELSPRRRLLVLAICCLSLLIVSLDNTVLNVALPSMQKELHASVAGLQWTIDAYTLVLA
SLLMLAGSTADRIGRRRVFRTGLVLFTIGSVLCSLAPNLESLVAFRMVQAVGGSMLNPVA
MSIITNTFTEPRERARAIGVWGGVVGISMAAGPIVGGLLVDSVGWRSIFWINLPVGLVAL
LLTWRYVPESRAPKARRPDPVGQLLVIALLGSLTYAIIEAPSSGAAEILAFGGTALAALI
ALLWYEPRRAEPLIDLRFFRSVPFSGATVVAISAFAALSGFLFLSTLYLQNVRGLSALHA
GLWMLPMAVMCFVCAPLSGRLVGSRGPRFSLLTAGIAMTASGVLFAAFEAETSDVTLVIG
YVLFGVGFGFVNAPITNTAVSGMPRAQAGVAAAIASTSRQIGGTLGVAVVGAVLASGVRT
GPYRQVFESAARPGWWIIAGCGLSVLVLGALSSGAWARATARRTAQRLESTEVRDEAGVN
A
>fig|228405.5.peg.473 Permease of the drug/metabolite transporter (DMT) superfamily
MLPMSPVAQLRRMRLYPPLQSGGGGRRRSRLTEGGSQAVPPPHSSPAALTRRAPCPLSQN
PDRPEPIMAIRDFILLCAVCLVWGLNLVVTRWAVADMAIPPIFFAALRFLGVAVCLVPFL
FPRPPNLRTLFFVSIMIGSVHFSLLFIGLQHADASAAAVTGQLGVPFSTLMSMLFLGEVI
RWRRAIGITLAFLGVIIIALDPANFSVSFGLLYIIASAFIGSAGGIVMKRMPQISGLRMQ
AWVGLFSFAPLFALSFAIEENQLATYIDGGWMVWAASAFAILGVSVFGHSAFYTLLKKYD
VSLLSPLTLMTPIWGVIFGIALLNEPLTPRLILGAIVSLSGVLVIALRPNEKMPEAALGK
KAGAGDS
>fig|228405.5.peg.696 Probable multidrug resistance protein norM
MLPSRIARKIIIGISCPPFAFEASRPAAQKSGTDLEKTKGRAVMTATSRLPAWARPKDIA
DLIRLSVPIAVSRMAMMLMGLTDAIVLGQYAPGELAYVLSAWLPISISLGFGVGILLGIQ
VLTSELLGTGREAGSGRVFRRGLWWAVVMGAVLTAVLLPISDPFFHWVFVTIAPASDAPS
AVTPEIVASSTASVTRILALGLAGHMISQACSYYLEALRRPLLVTVVMYVGVVINLFANL
ALVAGWWGFPQMGAEGVAWATTGTRWLITIVLLIFVATLTPAFRRSPPAEKGESRRQLAV
GVGTAISNIAEYGGFNITFIIATWVSIAANAVYGYSVQVIGVCFMFYLGIATATSVRVAE
AIGRGSQEEVRNAGRLGVAATFVMGIILGVLLVLLSGPISRLLVREDAVIGGIAIAPAIA
ALLWLAAAVTVFDGLQATASFALRAQGMVWLPSAIHISSFFLVMIPVCYWLAITLGRGAA
GVLEGAFIAVFVAGMAQFILLEWKAARPDVERAA
>fig|228405.5.peg.2319 Multidrug resistance protein B
MTVAPGIPSQSGPGTARKPLPDDIPAMAGPSVRAQFERFGGIYRWILLFTMLTGSMATML
AATTINVALPAIIGAFGLGQDQAQWMSTAFLASSTIAMLANAWAMTTFGPRATYTFGMVV
FVFGSLLGAVSNTLELLIVSRGLQGISAGLLQPMSMFLIFQTFPDSRRGTAMGVFSIGVV
LAPAFGPALGGIAVDLASWRLVFVATLPLALVALGIAPFLMPKGDRNRSTPRPPLDWVGL
SLLAVAVIGLLAAFAGGNRDGWDSDQTYLRFAIAILAAIAFFFWELRHPFPALNPKVFTY
RQFWSAGLIISATGIAIYASTYLIPLFVQLVQGYSPTAAGVMMIPAGIAMMIGFPIAGRL
TDRVDPRWLLGFGITTFAASAWLLSHVSAMTPYWVLVGWILLSRIGISFCMPPSNTTAVR
AVPPHLLASATGGVSFLMQVGGAFGVNILAIILQRRTIFHGEHLSTAMNETNAEMMYQHA
LQAQTLEMTGMTQVQAFQSAFGLLNQKVAMEASVYAFRDCFFIIFVWFVIVLGALALMPK
PKMIQPAR
>fig|228405.5.peg.2958 Permeases of the drug/metabolite transporter (DMT) superfamily
MQVMSSGLDCTLAPDMRAPHPILLVCFGVVFGCGIDALMKSVMQGSTSVLTATTWRYVLG
SVIMIALSLQARRSMPTLPAIRFHALRSLAQVISAFCFFYSLTQIALAEAVVMGFTAALM
IAPIARVILGEKMSPVTIGASLIGFCGAALAATAESSGAPVEGNRLYGTVAVLASAVLYA
LNIVLLRLRTREEDSLTLVTFMNIFPALFLLPFMLVFTDPMPAEGAWSMLIGAAVFGIGI
WWLMTMAYGRAKAQTLAPFEYTGLIWSALLGYFFFQEIPGWRVWAGAGIIIAACLVVAFE
THFIARREAKMPASDILT
>fig|228405.5.peg.3043 Permease of the drug/metabolite transporter (DMT) superfamily
MALDAAGRTTMTEASLPGAKIARPAIVWILFATLTTLWAGAYGLTRVAVGKGTLEGLPPE
WVLPGRLTGGAIVLLTLMLVMGKRLPPFSDLRRWGVIGAMGVVGSLVPFFLITVAQQTVD
SSLAALYTAAAPVFVVLGATLFFADERMTRNTGLGVLLGFAGVLALFGPDAVRHFGSASV
TAQLLLLLATLSFSASTLIARAAPKMDAIPLAAGFVTVSAVVSWPLALTVHPSEVEADWH
HWAAVAGLGLGPSGIAQALYMALVARAGATFQSLTGYSVPVVGAAFGWLFFRETQSWNAA
LAFALILGGVWLARQGGRGRVG
>fig|228405.5.peg.3118 Multidrug resistance protein 2
MSLLGRRGPHQMDDTETPLHPLSPFQRGMLMLATIAMGAGMSINFVVVAPLTRKAGLGEV
EVAAILTLSTLLYAVMIPRWGRIADRVGRKRVMVFSLIAMGVTNMAFLFALEAGLAGVIT
GTSLMLTLIFVRLWFGLLTPGLQPASMAAMTDATTIRDRAAGLGMLGAGMSIGSILGPAG
AAALAPFGALAPLWGTIVFCILIGILLGFSLPRTVKRPRNAARPKPLSMFDARVRPHLLF
LLSYFIGVGMVQQTLGWFIEDRYALAGDDPAAVGQTAVLYTGIVFSCMAVSTIAVQFGYI
SRLKPDPRKILWVGLALVAVGYTAADVFHAFPVLCAAFLLIGAGSALAIPSANALGSLSV
SREEQGAAAALMSAAPPAGFIFGPLMGAGLYQVNHALPLIASAVLVGSLAVYAMLVTARR
PLAEG
>fig|228405.5.peg.3334 Permease of the drug/metabolite transporter (DMT) superfamily
MTQTPPATAPLPVSLPPARSWIGPLMVLGGGVAIGFAPIGLRIGLQEYGGELGPQAIAMW
RYIFATPILFGLVLLIHRRLPRPPNRFIILAGTFFAIDIALWHWALTMTSVSNATFIVNL
GNVGVGIVAWLFLKERPGMHWFVAASLAICGAAALSLGGAALHTGGLKGDLFALAAAGFV
AGYMMFSKLGRRNLSGIEAIFWLSVVESLVAFLIVLLAGERVLPMTANGFIVPVFLAIVA
HVMGQGLIVSGLGWTNTAVAGILVLAQPVVAAAIAWKLFEEPLTALQAAGAATILVAVWL
AQRQTVPPAG
>fig|228410.1.peg.2100 Permease of the drug/metabolite transporter (DMT) superfamily
MTNTRNENLGYVYGLIAVTAFALTLPAMRAALSALDPVFVALGRGAGAAVLAAVFLWFTR
QRLPTREEAKGLIIVAAGAVIGFPLLAAWAMLYVDASHGGVVLGILPLATAVAAALFSNE
RPSMKFWLFALIGAGLVVGYSLSRAGGTLHPADLALFGSIVCAGVSYAEGARLSKSLGGP
QVISWALVFSFPILIIPAIHYAPVSLNLPLESWLGFIYLTVISQYLGFFPWYHGLALGGI
AKVGQTQLLQPFLTIIASVLLLGEHADLMTWLVATLVVAVVAVGKHAQVKHNDPESATIA
DTSPHS
>fig|229193.1.peg.267 Permease of the drug/metabolite transporter (DMT) superfamily
MNRLPTLYGIIAILLWSMSVALTRGLAEALGPFGAGSAIYSVSGILVWLVAGKPRVRGQH
PAYLYGCGLLFVVYMVAFALAIGMANDRQQTLEIGLINYLWPSLTLLLAVPLLKLRARWW
LWPGAALALFGVIWVVSGGEGLDVKTLAVNISSNPLAYSLALIAAFTWAGYSNLVRLYSQ
GPGALPLFLIACALCLWLMFFMWTPGKLHFTPRAIFELLLMGANTALAYQCWDRAYQCWD
SAMKKGNATLVAALSYFTPLLSILIASVWLNTLPSAAFWPGVAMVVAGSLLCWSASRNPL
RT
>fig|232721.5.peg.348 Permease of the drug/metabolite transporter (DMT) superfamily
MNTASIRSIAMVLLAAMLWGTTGTAQSLAPAGLSPYWVGALRLVIASAFFALLAWPAWRA
RRGGGLRWGPVLLAGACVATYNLSFFAGVKSAGVALGTALAIGSGPIWAGLLQTVAQRRL
PAPVWWLGTLLGVAGGAAMALDGGSTVRAPWTGIALCLLAGLAYAMYALTNKRLVAQAGA
AVVNLAVFGMAGLLSLPVALLLGGAPTVAPGALGIVLYLGLVATGVAYLLFSTALRHISG
ATGVTLALAEPVTAFALAVAVVGESPSAMAYGGLAAVLAGLLLVIWAELRTTRPAVGAAA
A
>fig|232721.5.peg.389 Permease of the drug/metabolite transporter (DMT) superfamily
MRSERQGLLALLLVVAVWGTTFPAMKMMSAHLDALQIIWARFAIALLVLAPLWRGLRRTE
LRWGLLLGALLFLAFWLQIEGLARTSSNRNAFVTGLNVLVVPLLAMAVLGRRYGAALWAA
CAMALAGMVLMFHENEPWNLGDTLTLASTLFYAIYILTLEECARRTAAQPLRATRMAAVQ
ALVMFAAASVLLLARHGEVATTLQALADLPAHALTALAYLGVVASVLVVTLQAWGQQRVD
AMRSAIVFGLEPVFAAATAWVLIGERLGAAGLAGAALIVAALVVSQLPPPRALARPSTP
>fig|232721.5.peg.404 Multiple antibiotic resistance protein MarC
MDLKPLITLLAIVNPLAIVPFFIHYTSGFNAAQRRRTVQVAAFSAFCVIAACALVGLQIL
DFFNISLQSFQVGGGMLLLISAMNMLNAQPAEAKPHTHELEQGAEKAAAGSSIAVVPLTI
PLLTGPAAMSTVVIYADRAQSIWQHLALVGYGVVVGAATALCFALAEPIERVLGKTGINV
MTRLMGLILAALAVEVMADGLSKLFPVLAARS
>fig|232721.5.peg.409 Outer membrane component of tripartite multidrug resistance system
MKNHLSPSSAPALTPPTAPRGSALLYGATLAVALLALPLLSGCADMAGIDSHARMRDPVS
LGLAAAPSSGADAAVQPQTAVSADWWRSFGDAQLDALITQALQGNPGLQQAAARIARAEA
FADTARAAQSPQVNGSLDATRQRYSANGPYPPGQAGAIRSVETARLSGSWELDFFGKHRA
ALAAALGEAQAARADAEAARLLLASRVAQGYFQLARLQAQRAVAERTLQQRTEMLQLVQR
RVQAGLDTQLELRQSEGTLPEARQQIEALREQEALARNALGALIADPQTAQTLTPQALAA
IHFSETPAAVPADLLGRRPDVAAARWRVEAATQDMGVARAQFYPNVSLTAFVGLASVGLD
RFIEAGSREWGVGPALRLPIFDAGRLRANLRGKAADRDAAVESYNAALLEAVRDAADQLA
SSSSIARQITEQRQAGESAQAAYGIARRRYEAGLGTYLQVLTAESQVLAQRRLAVDLAAR
RLDNQVGVMRALGGGYAATPPPMAQAPQAAPTVAAAR
>fig|232721.5.peg.1181 Permease of the drug/metabolite transporter (DMT) superfamily
MSTSLSRADWAKALVVVVVWGLNFVVMKWGLATLSPLVLCALRFLAASLPFLLFVRPPRH
LSWGVMAAYGLVQGVGQFGLLFTGMQLGMPAGMSSVVLQTQAFITMLMAAALLGETPHRW
QWLGLCIAIGGLVFIGAAHGDGASGMTLAGFLLTVGAAAMWAGSNLLTRVAARQGPYEPV
SFIVWSSVFPIVPLLLLACVVDGTEAVVQQLRGLGGRELGVVAYLALLSTLLGYGLWTRL
LQRYAASTVAPLSLLVPVVGLLSAMLLLGERPTAWQWMGTLGVLAGMVINQFGGLWAKRR
RGVASI
>fig|232721.5.peg.2086 Permease of the drug/metabolite transporter (DMT) superfamily
MTAPHTSAEALSPHAPAWVGEFVLLSSLWGASFLFMRLGAAEFGPLPMAGLRVLMAALFL
WPFLLHRGEWPALRRHWRPVLFAGLINSAIPFALFAWAVMHIATGLTSILNATVPLFGAL
VAWLWLGDRISRLRWAGLALGFVGVALLAWRAPAGVGASGSQAGWAIAACLLASTCYAVA
ASYARRYLVGIPPLATATGSQVGAALGLALPMWWAWPAQTPSLRAWAAIAAIAVLCTGIA
YILYFRLIANAGPSRALAVTFLAPVFAVFYGAVFLGEAVTPWMLGCGVIIACGTALSTGL
VGGAVRPGTKTP
>fig|232721.5.peg.2952 Membrane fusion component of tripartite multidrug resistance system
MAMPKKAKITSAVLLLAVAAGCVIYLNRPESSASTQSTDDAYVQADFTLVAPQVSGVIGK
VLVEENQPVKAGDLLAAIDDRDFIVAVDAAKAQVAAAEASVAGLAARVAQQETAIRQAQA
AVAVDDAELKLAEANQKRYRNLAADGSGSIQAQQQAEAQLAIRLASRDKNRAGLQAARQQ
TDILKADLEKAKAALSQAQAAQAAAELKLSYTQITAPINGMIGQKSVRVGAFVNAGKPLL
AVIPLDALYITANFRETQLARVRAGQSVDIKVDALPGAVLKGTVESLGPASGVSYSAVAP
HNATGNFTKIVQRLPVRIRIDPDQLDAANLRVGMSVTPKIRIGE
>fig|232721.5.peg.2954 Outer membrane component of tripartite multidrug resistance system
MTSQPLLTQLLRQAGTALCTISLVGCAVGPDFVKPDDRLATVQLSPRADYAQPNETSAAN
FPSSWWTLFNDPVLAGLQSRAQAGNLNLQIASERIEQSRAQLGIASSLLLPSVGVSAGYS
REAISEHGKFAALGAPTSASDFWQLGFEASWELDLWGRARRSREGAAAAFEATVYEREAA
RVALSAEVARAYLQLRGAQAQLDITRQNLEVADRTLRLAESRERNGVATRFETSSARAQL
ATVEALVPELVQRRNTLMNALALLLGEEPRALDAQLLEAMPLPSLPSNVPVGLPSELAHR
RPDIQRAEAQLHAATAAIGVAKADFYPRIGLRGRVGVEAFEFNDLDSWDSRFFSVGPTVY
LPIFQGGRLKQRVALNEARQRTAAIAYRQTVLQAWHEVDNALDAWAAQQNRHAELRVSYE
QNKQALHAAERGYQEGAADYLNVLAAQRGVLASQTSLNASATNAALTLVNLYKSLGGGWD
PDALTSGRQAGGDAPLTTTTSPASLQSKVDQ
>fig|232721.5.peg.3126 Multidrug resistance transporter, Bcr/CflA family
MSVPSAAIGPQQAPAVPVPVPPGLAILVLALLLSIQPVTTDLYLPALPALTRSLNAPVAA
GQLTLSALLLAFGCSQLAWGPLSDRFGRRPVLLTGLALYTLAAVGAALAPSMAVLIAWRT
AQGVAMGAVVMCARAIVRDLYTPLAGARAMSKALTGLGLVACLCAPLGGLLTEWFNWRAA
LLALTGYAMGTLALVALRMPETLHQRNPHALRPAMLAGTAAQVLRTPAFWAFSLLTTASY
GGLFTFLAASSFVYLDVLGISRTQYGLALLSTAVAYLLGTLLCRRLLARQGLKRTVAIAG
ALSASGGLLMLLAAALGWHSVAALLPPFYLYMVGHGIHQPCGQSGAVGPFPQAAGMASAL
NGFMMMLAGFAIGQWLGGALDGSVWPLVQGVALWSLLLAAIAWTLVQRHAPQEVTHAR
>fig|232721.5.peg.3151 Multidrug resistance transporter, Bcr/CflA family
MRASPSPSAGAPPLWLLVLITLSGTLAMHMFVPALPDAARALGVGPAAVQATISIYIVGL
ALGQLVYGPLSDALGRRPLLLGGLALYAAGSIAAMLAPTAPALIAAWFIQALGGCAGLAL
GRAMVRDTNGPVEAVRALALLNLMMMVGPGMAPLAGSGLVALGGWRAVFVALALAGVATL
LLSWRKVPETGTPTGRVSPGRLARAYAALLRSPTFLAYAVGGGCATTAVYAFIAAAPFII
TEQLGHPLRDVGIALGVVMVGMAIGNALTRRLALSMRLGRLLVWGNAVSVACALVFLALE
LLGYLTLEATVGLMLLFVLGAGMASPAALSKVLTVDARHVGAAAGLYGFAQMALGALFTL
LVGWGSNPALASSCVLLGAALVGQGCLQFALRREKRARGERVRGERARGERARGE
>fig|232721.5.peg.4052 Permease of the drug/metabolite transporter (DMT) superfamily
MPALSRRQLVVLALLTLVWGLNWPVMKMGVAHFPPLTFRMASLWLGLPILAAVIGVRKLP
FTIARTHWGRVALLALTNMVLWHVLMILAIPQLSSGRAAILGYTMPIFSAVLGALVFGDR
LAGRAWMGVGAALVGVVLLLWHEVGALGGRPLGVTLMLVSAASWAMGTQLLRRLTVPVPL
LTLSFWMVAITCVVLTVLAVAFERERWVAPDAQAWAAILYNGLLALGFAQTAWFFLVRTL
PPVASTLSVMMIPVLGVFSGALWLGEVLHWQDWTAVGLMAVAIGTVLWPARAVQAQEFK
>fig|234267.9.peg.427 Multidrug resistance ABC transporter ATP-binding and permease protein
MHRSHTKGYGYHTSARRRHPVYRHRSRLEEVEEEVLGKAYDGRLMRRLLGYMRPYRLLVA
LSLVFLLLQSALQVLGPLLTKTAVDRYIAPTGGQIPEFLARFLPADAWDGLTRIGLVYLT
VLAANFVCEFIQMYVMQYTGQLAMFDLRRELMEHLQGLDLAFYDRNPVGRLVTRVTTDVD
VLNELFASGLVTILGDILVLVFILAIMFSFSPTLTAIMLTAMPFVILTTVIFRRSVSQSY
RRIRVAIAKINSFLQEHITGIAVLQLFNREERSCKEFEQVNREHMEAFKDAITAYGWFYP
VVEFLSMMALAGILTYGGFRVQAGRLSLGVVAAFLQYGLRFFRPIQDLSEKYNILQSAMA
SSERVFKLLDTEAAVLPPESAQPAPAGIAPIEFDHVWFAYKDEDWVLRDVSFTIAPGETI
AVVGHTGAGKTTLISLLLRFYDVQRGSIKVGGVDVRLYGPLDLRRMFGVVLQDPYLFTGT
LEENIRLGTENIRAEEVEAAAEQVNLMDFIRTLPEGFGHTIRERGSGLSTGQKQLISFAR
ALAHNPRYLILDEATSSVDTETEFRVREALNRMVAGRTSIVIAHRLSTIQRADRILVMHK
GHLRESGTHQELLAQRGIYWKLYQLQYKDQERVAAD
>fig|234267.9.peg.623 Drug resistance transporter EmrB/QacA subfamily
MIIDNRYHVNCGLQNAFDRYIIGNQSSAASCPYQNRTGPPGHSPPDPYRDVASGRAAAGR
QTIQGTGRFPGDRQCRLAGPSQSGPGQQAPEPLHQRQPLHVGGYRETLCGPRPAGAGRRC
RALRHLVRRSAGFPAGTGEPDAPRGAHQRPLEVGHRRLHLSPGNLQTQRQSLSDAGRPGD
CCRAVRLYPLRSPGGAPHRLPRHGGRPPGGAHGDRRRPGGRGARDPAFLGGVAQPLAARP
ARSFCERQPRGSAANRSTQGPGVTASVGEWSMGSIARPPCDEAAIRAGACEPQATVNGSW
ILAATILGSSMAFIDGTVVNVALPALQSALRATLADVQWVVESYALFLAALLLTGGSLGD
RYGRRKIFVIGVVLFSIASAWCGMAPNIRQLVLARAVQGIGGALLVPGSLALISANFYQA
ERGRAIGTWSGFTSITAAIGPVLGGWLTEHGSWRWVFFINLPLGIAVVALSLTKVPESRS
GTESRRFDWQGGLLAALGLGGIVFGLIESAPLACVAGAIALIVLLYWEGRAPSPMIPLRL
FGSRDFSGANLLTLFLYAALSGVLFFFPLNLIQVQGYTPTQAGAALLPFILLMFLLSRWS
GGLLDRYGAKLPLVVGPIIAATGFALFARPGIGGSYWTTFFPAVLTLGFGMAVSVAPLTT
TVMNAVDESYAGAASGINNSVSRVAGLLAVAVFGALLSGVFQNTLERRLDAGTVPPPVRA
ELEAQRSKLAAAVTADPRGRRAVQEAFVEGYRVVLWVAAGLALASSLSAAVMIKASGSAS
PRRS
>fig|234267.9.peg.736 Permease of the drug/metabolite transporter (DMT) superfamily
MISWCMAPTPSPSIRRRPDIVPLLLAFAAIYFVWGSTFLAIRFAVETLPPLITMGTRHLM
AGGLLFLWLRFRGEPLPEPRLWRPALFSGAFCFLGCHGLLAWAEKTVPSGLAALLSATLP
VWMILLARMLGQGSELTLKVMGGITLGFLGVAVLVPFHSGARDGIPWTSLAIIVCEIFWA
IGAIFSRGVKGTVPPATFAAMQMLCGGVLLWTLGLILGEGSQLHPESFTTRSVVSLAYLI
VFGSLITFTAYVWLLQVCSPALVSTHSYINPVVAIFCGWALGGEPLTARTLAGTAIILAS
VALVSVRKS
>fig|234267.9.peg.765 Permease of the drug/metabolite transporter (DMT) superfamily
MSRHPLFKAYIALVAVCFFWGTTYLGIRMALESFPPMVLVCVRYMISGSLMLLFARVRGL
YLPKGKELAWACFSGLLTLGIGNGALVYSETMVPSGIAGLIVTISPFWMVGAEALLPGGA
RLHAPTIGGMAIGLAGAAMLFTPDPGTHGVDHKLVIGFLVLTFGMAGWSFGSIIQRRKTG
KAHPVVAGGVQQLAAGLAMIPITLASGDLTIHWKTRGVTAILYLVTFGSLVGYSAYVYAM
DRLPVAIVSIYPYVNAVVAVALGWLFYREPFGIRETLSMIVIFAGVAVVKRYSQKPPEKV
LSAARR
>fig|234267.9.peg.1715 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MNGRFPSLSVFFPAYNDAPSLPGLLAKTFHALEEHVADYEVIVVNDGSYDDTGKVLEELR
QKYHPYLRVVTHEQNRGYGGALRTGFESATREFVFYTDGDGQYDAGELPKLLELMTPDTG
LVNGYKLERHDPAHRIWIGSTYNFCARLLFGIRIRDIDCDFRLIRKSRLQEIRLTSTSGT
ICVELVRKLELTGCGVVETGVRHYPRLHGKSQFFRLKSLATTLGELIRLWVRVVLLRGKK
Y
>fig|234267.9.peg.1768 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MLRARREFVALPHGRGSLACNISYTDVRRWEECLLVRLNAAAAFLRIETLYNPPMHRIPW
STIGLGSLLLISVCSKGGQEVQSQQPENAKPPVKTEQRGRILGIGGVFFKSANRDQMREW
YSKHLGLTDKGGGAMLPWREHDDPKKEHVTVWSIFPASSNYFDPGHAQFMVNYIVDDLDA
LLDRLKKEGVKIDDKRMDESYGRFAWIYDADGNKIELWQPIAKP
>fig|234267.9.peg.1800 Multidrug resistance ABC transporter ATP-binding and permease protein
MLTKCWLLGFSGEGLPRMTNIAEDRAGDESEKSPFDRRVFRALFDIAKQYKRQFIVVSLF
SFLYTGLDLLQPLVYRRAINAVAGMFVNQVPAAAPGLGNLAAQTPEQTLHTLLVSVVLLF
FIAVISYYFYQRASYYGARVASYMESKLIVQTFGHVLRLPLSFFNHQASAGLARRIDQCD
QVAPVVHAVSQQIAPEAVRLVAICAIMLTQNWEMSLMAVCLLPPYVWLARRAALRLQSNL
DPYYQMWEDISAHIADAIGAVKTVKLSGAEAREQDKLREKSIAAYDVYLRRIRTSQKYYL
SQVALSNLSKSLLLGYGGWLVLRHMLTPGDVVMFAAYLDRLYSPIDSLNGLAVSLQENLT
SLRRAVDLRDSGRPEPGGAALPEGQGHVEFRNVHFGYTPEREVLHGINLTLQPGKITALA
GPSGAGKTTTADLLLKLFEPSSGEIFLDGQPLSTAGCASIRAAIGVVASDGTVFRGTLAD
NIRYKRPEASLEETHRVALAAGLGRALERLPEGLNTQVGERGVGLSLGERQRLQIARMLI
DRPRLLVLDEATANLDYATELDVRSALEQMSPKPTMLVIAHRYTMMKNADYVYVLKEGEV
VEEGPPAALLKGQGWFADLARESGEVPSFV
>fig|234267.9.peg.2272 Nisin-resistance protein
MFKARLYSIGTLIVSCAACAAQSTVADATRSDPIEYLHRALDEMHARSLRRDRIDWPLLR
KETLARAAGAEITVDTYDAIRFALASLEDHHSSFHPTPALEDLEKKRKATRRPAPAPIPQ
SPPSSPFTGRYEPEGRLVTSGGKTFAFVVVTKCFPETDGQFIAYETKLQRILADLDKSHP
TGWIVDLRGNVGGNMWPMLAGIGPLLGEGDHLGEFFTLDSHSTWKYRDGVAAEIENGKEQ
RYPAVAGVPYKLAGTPKVAVLIDRRTGSSGEAIAIAFRGRPQTRFFGEHTEGVSTANDVV
KLSDGASMWLTIGVDADRTGKQYMEGFDPDEVVGAGDKILSDGQDPVLQAALRWLSRS
>fig|234267.9.peg.2369 Permease of the drug/metabolite transporter (DMT) superfamily
MPRRRPVRRDAPGFGPEIVDQCRSHRRRHRRQRDCSNGALQGGYPLRKQRAHGPTGGRAG
ERRGPRTRLGKPARQRRTGRGQNQGDRLAAGRDAARTGAHPAICARGGFAPRYSVAPGLF
FHRCQHPARHGHPRARHGRRRTRRRRPYPAGMVQPRWTRSWPQTHPAHSPAPDPRPRGQR
EVNRRKADLALLFNAFIWGSTFILVKSSLSYISPLLFLAIRFSLATAALGLLFRGTWKWR
RRATPAMIGAGCLAGVFLFAGYALQTIGLRLTTAPKSAFLTGLATVMVPLLGALVYRIRP
QLSEVFGVLIATFGMALMTIEGPIDSIGRGDLLTLGGAIAFAAHIVTLGHYSEKIGYELL
SITQVGAAAVSSLTMFWWAETPRFHWNPVVLWAILITGLFCTALAFTIQAWAQRYTTATR
TALIYALEPVVAWTTSFLVVGEGLSGRAAAGAGLILGGVLLVEMKPLKPREHQSR
>fig|234267.9.peg.2504 Inner membrane component of tripartite multidrug resistance system
MPIDESQGWHPGHSPWTVALTVTIATFMEVMDTSIANVSLPHIAGGLSAGVDESTWILTS
YLVSNAIVLPISAWLSNRFGRKRFYMTSVAIFTVSSLLCGLAPSLSLLIFFRILQGVGGG
GLGPSEQAILTDTFPAAKRGMAFAVYGMAVVLAPAIGPTLGGWITDQYSWRWIFFINVPF
GILSLFLTNHMVQDPPDMERAKQDAKKAPVDFLGLVLIATGLGAFQIMLDKGQRDDWFAS
PFITACVIVTVGALGAFVIWEWNHRHPIVELGLLKNRSFAVACMLMLVTFAVMLGSTLLI
PQFAQLELGYTARQAGELLSPGGFTILILMPMIGYLVSRVDARYLIGIGYLIFAASLFHM
TNLYLGVDFRTAVMWRVYQAAGMAFLFVPTNTIAYTDMTPGASNQVSALTNLMRNMGGSV
GISAVTTLLARRQQTHQVFLVRNVTSADPHLKQMLTQFANRFSLRTDSHHAMQQAYGAIY
RQVQSQAAVLAYIDVITIMGALCLAAILLLFFAKKSKPGQAAVAH
>fig|234267.9.peg.2505 Membrane fusion component of tripartite multidrug resistance system
MVDDRTPYASHQEIEQLRDELRRLKEEQEKQKNGRHEDGQPKDEKKEESGEENEKPEEPK
KPHPVRKFILIALVLVLAIGGLLWWLHARNFESTDDAIVDGHTSGLAARVAGTVIAVYVE
ENQFVKAGQVVVDLDPRDYEAAVASARGQLQQAQAQQQAELPSVPVTRVTSQTNIANAGS
SIASAEAGVAAAQRNYEAALDRVREAQATAAKAQSDVDRYRPLAEKDEVPREQFDQVVAT
ATSSAAAVAANQAGAQAALKQVDQARAQLAQARQTAGEVANNAPRQIAIQQANVRSRAGS
AQMSRAQLEQALLNLSYCKIQTPVSGIVARRVAEIGQHVAPGQEVLLVTRLDDLWVTANF
RETQIRRMVAGQSARIHVDALAQDFDGYVESMPAASGSITSLLPPENATGNFIKVVQRLP
VRIRFKQGQNGLDRLRPGMSVEPKVRVR
>fig|234267.9.peg.2506 Outer membrane component of tripartite multidrug resistance system
MRWHTLFFLIILSTPSAGQIGAPQSPGQLPRAQPVPLSGKPQIGSVVPQQTPTPGATNSV
NTINPSVQVQGAYQGSVPAGTSTSTPLALSLEDAVKRGIQYNLGSVTASDATRQARALRL
AALAELLPDLTGNVRETVQQIDLAITGLRLNLPLPGFRFPAIVGPFNYFDTRANFTESLS
VTGVRNWQASRENLSSSEFNIQDSRDLVAFAVAGTYLQILASAARILTANAQIETSRAVY
TQAVDRNRSGLIAHIDVSRSLVELQTQQQRLTSLTNDFEKQKLTLARLIGLPMAQPFTLS
DAIPYREMPPVDIAALIHTAISARHDVQAAAAQVKAAELSRKAAVAEHLPFLDVAADYGI
TGINPSQSHGTFAVTGSVRFPIYRSGRIRADIEQADAALSQRRAEYEDTKARAEQDVRNA
VLDLNAASQQVRVAESNRGLAAETLQQSRDRFRAGVTDTVELVQAQESVATAEQDFISAL
FAFNLARVALARATAQTEQGVTRLLRER
>fig|234267.9.peg.3505 Permease of the drug/metabolite transporter (DMT) superfamily
MGGEKKQAPPRVVYGWLALLLMLWSSNFIFARFALRELPLGVVLGFRYVFSAALMLPVIA
LGGGQSRVKHPWNWHDLPGLLTIGLLGLVGNQALFVVGISMTSVAHAGVITALSPVLVLL
GSAALGHERISGARIVGLLTAACGVVVLQFSRGAAGAATLKGDAVMLASVVVFAGFNLAA
KPYAERAGTVRVNAIAYFAAGLLALPLALWSLSRGAHGSLLAWCGVAYMAAGSSVAGYLI
YAYALRHLAASRVSVVVYLQPIVVTLLAIVALGERPGAGFLPAVGLVLAGVWVVERRG
>fig|234267.9.peg.3637 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MQSSYSGKSKMAAAPHTGEAGRIIAAPTGPLIVAAANAGDDAPELSVVVPTLNESENIVD
FLAAVRRTLDASLPGRYEVIVVDDDSADGTGTIAASLMCGFPELRVVRRQNEGGLAVAVI
RGWQVARGKMLGTINADFQHPPDVLGRLLEREAGADLLVATRHSDGGGLGDWGLTRRITS
WGAAQIGKWLLPEVYARVSDPLSGCYLVRRSAIAGAVLRPLGYKSLMEILVRGNVREIHE
CGYEMRKRERGQSKVHVLHPLQYLRHVMRLRAAARERGR
>fig|234267.9.peg.3861 Multiple antibiotic resistance protein MarC
MIAEEAFGELTKTTLLIVGALFPIVNPIGNTPIFLSLTHGLSSQGRTVLARMIAINGLIL
ILASIFIGTHILAFFGISLPVVQVGGGMVVIATGWTLLRQPNDDGSGDSGARDECHEADY
KRQAFYPLTLPLTVGPGSISVAITVGANRPEGAEWRWPLIGGMLLGSALIAVSIYLSYRF
AERLAQTLGDSAMNVMIRLSSFILLCIGVQILWNGLSALLRTVVH
>fig|234267.9.peg.5700 Daunorubicin resistance ATP-binding protein drrA
MQPHEPIIETRDLTRRFGQLTAVDHLNLSVARGEIFGLVGPDGAGKTTTLRMLCGLMEPS
EGSARVAGHDASRESQAVKDQIGYMAQRFGLYQDLTVEENMVFYADLFDITGPRRDELTA
QLLRMTRMEPFRARQAGRLSGGMKQKLALMCTLLHRPQVLFLDEPTNGVDPVSRRDFWTI
LYQLLKDGITIFMTTAYLDEAERCNRIGLMNKGRLIRCSTPEVMKAETGSATLEGAFIKT
IHEVEGVARS
>fig|234267.9.peg.5701 Daunorubicin resistance ATP-binding protein drrA
MNSVEIHDLVKTFGSFVAVDHVSMEVEKGEIFGFLGPNGAGKSTTIRMLCGLLTPTSGRA
LVNGFDVASQPEEIRRTIGYMSQKFSLYDDLTVEENIDFFTGIYGVPQARRTERKDYVLE
MANLTDRRAAMTRTLSGGWKQRLALGCAILHEPAVLFLDEPTSGVDPLARGAFWHLIHDL
SEAGHTVFVSTHYMDEAEYCHRLALMYRGKVIALGTPAELKSGLKDQSLLNLESSDPLAT
MRALEGVAGVHDVAVFGGGLHITVDNAETGAARIRERLAASGIEVRKLEPIQPSMEDVFV
AMIEAEERKAA
>fig|234267.9.peg.6014 Membrane fusion component of tripartite multidrug resistance system
MADTLVETPKTETPPPRIVRKPKRHRGALIAMLVLLPLLVGGYFLWKYLGTYESTDDAQI
DGHIHAISARISGHISQVLVEDQQIVKAGDVLVVIDPRDYDVAVAKAEADVADARAALTG
SQTEIPITSTNTASTLQTAQSTLADSRAGLLSAQRQLSAAESRLAAAEAQVTEAQANYKK
AADDERRYKQLVDKEEISQQLYEQAAQAAAAAKATVDTRIASVNEARHNVAVAEAAIQQA
QAKVPQAEASIQSALTAPQQVAISRSKAKSSEAKLAQQAALLAQARLNQSYTTIVAPAAG
IIGKKTVEVGQNVSPGQQLMAIVQLDDVWVIANFKETQLRRMQPGQRVRFSVDAYSREYQ
GRITGIGGASGSRFSLLPPENATGNYVKVVQRIPVRIDLDPGQNADHHLRPGMSVDPKVF
LR
>fig|234267.9.peg.6015 Outer membrane component of tripartite multidrug resistance system
MPRTSLPRAKKLLKMDDSQPGDRRALPHFEIGMGPARIGCHVQCTHRRAVSSTPLFVCLA
LLFSSVLAAQENSPFQGSVPTGNATTTPLGLKLDDAIQRGLRANLGLLERGTASQAARAE
RIRALSALYPQVTGSVGETVQQLNLKTLGFGTLGIPGLSGLPSIAGPFSYSTAQANVSAT
VFDWSKRKNLSSARDTEEASKLSIQDARDLVVQAVAYAYLQIIADNSRVESIQAQVTTAE
AIYNRAVDQKKAGVAPAIDVLRAQVEFKTQQQRLLVEQNQFAKDKLTLGRVIGLPPGQPF
YIADATPFTPFSGLTLDQALRTAVAQRADYQSARKLFLAADDALKAARAEWYPTVDLNGY
YGVTGPTPGNSHGVFLVTGALNFNIFNGGRIHGDIEQARAAKQQRADELADLGGQIEVQV
RTAFLDIQSAADQVAVAQSNVELAAQTLQQARDRFASGVADTIEVVQAQESVATASDNLI
SASYAHNLAKASLARALGLAEQGIKKLIEVK
>fig|234267.9.peg.6125 Permeases of the drug/metabolite transporter (DMT) superfamily
MILLDLSSHSGTEATRLRWKTWICVVVVVFSNAFGDFFMKRGLPESARLATPLDYIATLF
QPWVALGVGLLILWQLSRMALLSWADLSYVLPVTSVGYVVVALIGKLLLSEAITPRRWAG
IVLIMAGVALVSIGSPSTVEAAVDADRVVGK
>fig|234267.9.peg.6126 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MKWLLVAMMVGATTAGEVLQAAGMRRHGEIRDFRPGALGRAAAMLARNRFVIGSAVCMAI
SFFAFMKLLSVTELSFAVPVSAVSYVMETVLAKYVLKEQVSRRRWAGALLVIGGVVLVST
>fig|234267.9.peg.6633 Chloramphenicol resistance protein
MSLTRDGRLLFCTRFLRLFSYGALSVVLVFYLTGLGLSQQQTGLLFTLTLLGDTAISLAL
TTQADRIGRRKMLIAGAALMAGAGLAFALTRNPLLLVIAGTIGVISPSGNEVGPFLPIEQ
AALSQVIPSRDRTSVFAWYALTGAVATAAGSLFAGFFTQSLQSARMTPIASQRAILYLYA
AMGLLLGILFTRLSATSEIARDPDRPAIATLLGIGASRPVVLRLSALFALDAFGGGFVVQ
SFAAWWFYLRFGVQPATLGGIFFGANLFAGISALLASRIAARIGLVRTMVFTHLPSNILL
ILVPLMPTLPLAILVLLLRFSISQMDVPTRQSYTMAVVAPEERSAAAGITGVARTTGAAF
APLFAGLLFAHPATISVPFFLAGTLKILYDILLYRAFVNLPPMDGLR
>fig|234267.9.peg.7509 Membrane fusion component of tripartite multidrug resistance system
MANVVDDLPKAESRKVEAAPTVAAPRKSPVKYIVLGMVAIGAAVGAWAWFHFRDQVSSDD
AQVDAHIVAIAPKISGNVTEVLVRDNQQVKAGEVLVRIDPRDYQARVNAARAALLQAESQ
VVTSRTMVPMTNESTQSGVSGAAAQVSDAMAELDRARLNYEQAASSDIAEAEAKVRSKQA
SNDRAQADLARMKPLLDKAEISRLQYDAYQAQARVAESELNAAQEQLKSAQNNANMRKAA
VAAAQSRVNMAQSQVQASMANRKQVDVRRAETGTASAGVEAARANLAAAELMLSYTTIVA
PSDGVVTRKSVEPGQIVQPGQSLMTLIQLQDVWVTANFKETQLAQVRAGQKAEIHVDMYG
KSVAGHVDSIAGATGSRLSLLPAENATGNFVKVVQRIPVKILVDNTNGLVLRPGMNVDAT
IFVN
>fig|234267.9.peg.7511 Outer membrane component of tripartite multidrug resistance system
MKLRIAIAVALAGSAFGQQPAPLKLTLHDAVQLALKQNPQVILANLDVQQSQEDRNLARS
ALLPQVHGAASETVSRVNLEAAIGFRFPGFSQHVGPYRYEQAGVNLQAPVFDLTLWRRYR
ASVVGIETSRIQELGVREESVLLVVSQYLGSQRAAADVQAAQSRVDLAQALYDQAADLQK
NGVGTGIDTLRANVQLQNEKQRQIVARTQLETSLFGLARLLNIDPRTRVELADQVSFFDT
PTIDVNQTLEQAWQVRPELRQVLSQEQRAELDLQGATDARLPRVAVNGFWSQQGLNSSTA
IPVYTYQATVEVPIFTGGRIQADRAKAEITIRQLKQQEQEVRNRIALEVKNAIAQLASAR
NEVDVANLGIQLARQEVDQSRDRFQAGVTNNVEVIQAQDSFARASDNQIAALYRYNQSRA
DLAHSIGQMEALYAR
>fig|234826.3.peg.243 Bicyclomycin resistance protein
MLLSSLAFILAVLSVVLVDITNAMYANYLTQVGAFFGAEQTVTQFTVSCEMLGYSTSGLI
YGPMSDRHGRRPVMLFGMAVFLITGLWCYFANSITVLIIARFFHGVGAGVSAVVGYAIIC
DTYSSEECSKRISLMYMCAVTGSAFIAPGMSSYMIEHGYGWRTVFVVSIVLSAALLSWLV
CKLPETISERRAGCNPITIVSGYVALLRNRRFLAYCFIKVLTMTYTLASVGTLPFVFIEG
MGLQAKYYGYVAAIGGVSFIAGTMANVKLVGRFGMRRMIAVGLVLTVASDVAAIMADYYF
ALTPVLVEAIWIPSSFCISLIASNGAVLAFREVSNKGAASAFIIFCQTVFGVVGMYVVGK
FYNGTIVPICLLTFTCCGISSVILCVCTPRSEA
>fig|235279.1.peg.167 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSAVSVNDKVDMRKDSIYKLFFYFFIPNLCAMLALSTYSTIDGIFVGKKLGENALAAIGL
CWPIFPALIAFELLFGLGAASIASYFLGKGQDNRARLMFSSVFYFATLSSVIIGVILFFC
VEKVALALGANELVLPYVVEYLQVIFLSAVIMVLHPLLDIFVINDKRPILAMMAMIIGSA
SNIVLNYIFLFVLELGMFGSALATAMGHGLGMMILLSHFVRKRGRIYFVWRFSLNAVFAS
AKNGVPQSISELSVAFVMIMFNHTLKALAESEEMKVSYLAIYSIVMYVGVVCFTILLSCA
QGVQPVASYNYGAGEMKRVRGIYAFGVGFATALGILVYAVFMSIDSMLVKLFLKSGQEMI
LEPTLEAMKVYFIGYIFLGFNIVSAIFFQSIQRPKSSFLITLSYNLIFVSILLFVLSYYY
GVFGVWLSYPLSLVCSSIVVIGVIFYESRYGVLGKKVS
>fig|235279.1.peg.684 Multidrug resistance protein (msbA)
MRTILEFFKKFFPYIKGHKLSFAIAIIASLVVGLCTAGTAYLIDPLLDTLSGKVPRANPF
FSFDELAQNNTLTFAMMFMIIGTYLGKSLGTYVQAYFMNFIGQDIVRQVRDRMLRHMLSL
EMVFFNKMRNGELMARITNDIGIIRSAVSNYITEFIRESITIIGLVAIVIYQSPKYALIG
LVIVPLALIPINLIIKKLKKYSRNIMEKNADITAKLHEIFNNIEVIKASNGERLELKKFK
LQNLTFLKISMKAVRVGELITPLMELLGAIMLALVVYMAIIDISKGELSVAQFSSFAGAL
LFIYTPLKRLVNLYGQMQSAIVASDRIFEILNQTQQIRDGGIQLQAPINEIIFKDVHFRY
NEETHALKGISMCFAKNKITALVGKSGSGKSSIINLLLRLYEADSGEVLINSQNIKNYTQ
KSVRNNMAVVTQRIFIFNDSILHNVAYGSKIDEKKVIEALKFAHAWDFVQEMPQGIHTIL
DEFGSNLSGGQRQRIAIARAIYKNPEVLILDEATSALDSQTEEAIKESIEHLRHNKIIII
VAHRPSTIELADEVLHLQLGQIIKQETRSKK
>fig|235279.1.peg.1464 Drug resistance transporter, EmrB/QacA subfamily
MNLILFTILLAVFVVPSSISGTAIALPYIAEDIGSDTTLLQWVVNSFNLFFACFTLIWGA
ISDRLGAKTCLIAGVATYLLGSILSFLAPSLLWLDVGRALAGIGGASVFACGSAILIRTF
EDKERVKAFAFFGTTAGLGITLGPTLSGFLIDLFAWRAIFVFHFLTLGVVLLLSPMLPKD
PQKQQKAFKFDKMGALLFIAFMSSFMLFITKIHAFKEPQTLGILAFCLIVGIVFGVHQRS
LHYKNITPNPTLHIPQPLLDFEVLKNASFFGFSLVAVIAGFSFVVLLTYFPTFLSINFGF
SASFSGLFMLSLTTPMLFCPILAGKMLNKGVDSKALALAMSLMMSLGIFALLIILHTLSG
VTLQLMTLLVLFVIGCGMGLHAGAIDGLALGSVESAKSGLGAGVLNSLRLGSEAVGVSLY
GALMVVFITANLSYLLDSEDSVYPIVESIASGNLSAVENPLISANAPSIYLQSFSYTLGI
LGLISLALSLGVWRLLGRVK
>fig|235909.3.peg.1858 Multidrug resistance protein B
MNWKRSVRVLWLCNFMVSAGMTMVIPFLSLFLWQMGVTEHHALSIWTGLVFSVTFLSAAV
MAPIWGVFADKYGQRANLIRAGIGMGLITGCMAFAASPMTLLALRFLVGFFSGFITVSFS
YLARVVPRDHSGEALGTLQTGSIAGNIIGPLIGGALSDLFGFRPVFLVTGLCILLTLLPV
IFWLEKDPVVPQTKENKASFKEVFRHRPLIVLFIATFLVQIAVLGVNSMMTIFVQSLIGH
SSNLAFLSGLASSITGIATIIGAPYLGKLGDRIGQEKTLPILLVLSGLFALPQVWTDNIY
ELYVWRFLQGLVVGGVWPSIQALINAQSPRRIQGRVFGVTASSRFLGNLTGPTAAGAIAG
FFSISSIFVLSGLLLIATGALVGYATHDRAWREEMKEKIAAWTHRLHSRY
>fig|235909.3.peg.3243 Drug resistance transporter, EmrB/QacA family
MEKALTVPASTIRHRPLLITGLIIAMLFAALDGTIVGTAMPRIVGELHGLGIMTWLTTAY
MLTSTTVVPIAGKLADLLGRRIVYVSGLVIFMAGSALCGMANDMTELIIYRGIQGLGGGI
MMPMAMIVIGDVFTGKERAKWQGVFGGLYGLASVLGPQIGGFIVDHLNWRWVFYINLPVG
ILATVLIAMGLSKYKAEGPVKFDIAGMATLTAGVVSLLLGLTFGGDRYPWGSWQIVSLFA
AAVVFFALFVWAEKRAEEPIIPLRLFRNRTFTLLNGIGFFMSVGMFGAIMFVPFFMQGIV
GVSATQSGTIMTPMMITMIIGSVLGGRLVYRIGVKPQLIIGMAVMASAFGLLGTMDVETS
KWTATMYMIILGLGTGLVMPILTLALQESFPKSELGVVTSSSQFFRSIGGTFGMTVLGAI
MNHRSSALLDERLMPKLEALPAQAKGLVDRFAGMIHDDPQGLYSVLLSPEAMAKIPALLR
DMFVPVLKQSLVDSLQSVFLFGLVFIAVGLLLVFGLKRITLSDRTEAMKQLKQAEEKA
>fig|235909.3.peg.3319 Permeases of the drug/metabolite transporter (DMT) superfamily
MRKSFIYALLVAIMVAWGLNVTALKILVEHFSPVALTALRILTAGLVVLLFLWGIGKLQK
VSWNEAKQIGLAALFSVVAHHFFLALGLARTTAVNAGLVLGMVPLVTALLAIVFLGQRPT
LFRLLGIALGFFGVVFVVANGDGGLGHLSIGDVYIFLAVLAQGISFIMIKKATVEARVMT
GWMLVFGSLWLFVLSLVLEPSGLSSLKEGTLPLWLIFLASAVVATALGHMFYNQAVQHLG
PAESAVFINLNPLFSLLGAHWLLGEPISWMQLAGFLFIVAGVMFGSGGMDDVIARFRRAK
AVEGGRKAGM
>fig|237727.3.peg.984 Tetracycline resistance protein, class A
MSEHAAQPHANTTTLFFVALIVFIDMVGIGLIVPVLPGLLEEVTGETLDQTAQIGGWLLF
AYAVMQFTFAPIIGGLSDRFGRRPVLLFTLFMLGVDYAIMAWAPTLFWLFVGRILSGIMG
ASWAAANSAIADVAEPEERGKFFGIMGAAGAAGFVIGPGIGGLLGSIDVRLPFIAASLLA
IGGAIAGYWLLKETLPSGRRRGFSITRANPLGTLIQMARHPVVFGFLTVIFFMQMAAQSH
QSVWAYHTELVFGWSTLQIGLSVALYGVMVAVTQGGLTGMIIARIGAARTVLIGFIISLP
ANLMFAFAPAGYFMIIGIVIGSLGAMAFPAIQQMMSERIADDAQGELQGAVASTMSITSI
IGPLIMTRAFGTFADSEGLYFPGAPYLLAALFGATALGIAAWNISRIKAAPDPAET
>fig|237727.3.peg.1712 Glyoxalase/bleomycin resistance protein/dioxygenase
MSNANGPRVTGLGGVFYVAADPEATRAWYREKLGVDGEYGPQFAWADEPKTNPYSLISNF
KDDEYIKPGKGGFMINLRVHDLDGFVEGLKAKDVHVLDTADEGYGKFAWILDPNGVKIEL
WEQVAEELP
>fig|237727.3.peg.2091 Drug resistance transporter, Bcr/CflA family
MRKEQWSSGEPQGKGAAMATAAPISAPTKRLGETEMIWMMALLMALQAFGIDAILPALDE
LAVSLSVQGNDRQFVVGVYLLTAGIGALIPGALADRFGRRPILLGSIAVYIVLSIASALV
TTYEALIAVRAAQGFFGAGIVALPPAIIRDRVGGDKMARMMSLIFVIFLMVPAIAPSIGE
VILLIGDWRMIFGAMALQGLIIGAWVYFRLPESLTEENRQEIRPRVIGGNMLRAVSMPSI
IGYVIGSSLVFGALFGFINSSQQLISESFGAPDLFPIIFGICAGSMAFASWSNSRIVERF
GARRVSHTALLTFIFVASLQVYFAFQPNETLWQFVPLMAINMMLLGFIGSNFGSIAMNPF
FDIAGAASSVHGFIRLTVAALLGAAVGYAYDGTPQPLALSLLAAGLACLALVLFSEKGKL
FGPPEPEMGLGAKEA
>fig|237727.3.peg.2536 Permease of the drug/metabolite transporter (DMT) superfamily
MGHPRGSRGRAGQGHRQLVSAATPQVLNWRVIVPFVLTGTIWGSTWLVITGQIDGVPAAW
SVFYRFLLATPALFLVAFFMKRRLKLTGPEHRLALLVGIFQFSGNFLFVYHAELYVTSGI
VALMFGLMMVPNALLARAFLGEKVQGGFMLGSAIAIVGVSFLLIHEWTSNPNAGVIGGNV
GLGIILALLGILAASVANVIQANPTGRAVPMVSLLAWAMLYGTIFDLGFALLTAGPPPLP
TNPNYWAGIVYLALIGSVITFPLHYNLVREIGAGRTAYNAILTISVAMLLSTVFEDYRWT
SLTITGMGLAVIGMVLALRSKQRR
>fig|237727.3.peg.3231 Multidrug resistance protein
MADADPSRDSIPRTENASASGAISNGRMALLFTVMLVTAAGNTAMQSVMPSIGTALEVSD
VWISLAFSWSALLWVVCAPIWARRSDRRGRKAMMSLGLVGFVASMVICGMVLWAGLAGWL
GAFATLILFAAARSLYGGFGSAAPPAVQAYVASRTPRAERTNALSLIASSFGLGTVIGPA
LAPLMVLPFMGLGLTGPFIGFALLGIVVLVLLHLQLPNDQPQFAARGMATSYSGPSETLS
EEELEDEAETGGVTGEMVGEPPRLKWTDPRIRAWIIAQLLGGHAQAMVLGITGFLVLDRL
ALRDTPAEGAGPVGLVLMAGAIASLLAQWGIIPRFNLGPRAATLAGVLTAALGTALLAAG
TQLHVIALGYAIASLGFGLFRPGTTAGTSLAVTRAEQGQASGVVASLAGFSYIYAPALGV
WLYGYSDWGAFGLIIALCLAVAVHGWRGLQADEDLTTERR
>fig|240015.3.peg.272 Permease of the drug/metabolite transporter (DMT) superfamily
MIKSALADISPLLFNLIRMTIASACLLAIYGRRLRRLRWATLGAGALTGLCLAAGYQFQT
AGLRLTTPSKSAFLTGLVVVLVPLLAGIPGLRPPGASLPKWNAWLGVVAAFVGIVLLTAP
QGSGWSILMLREINPGDLLTLACALGFSLHVIALAHFSPRFDFEQLAILQIVFCTLAMGV
TTPLLEKCWVHWTPRVVIALVVAAVLATAAAFTVQAWAQQILPATHTALILALEPVFAWV
TAFLVLRTGLHGREIVGALLILAGIGVTELMPSRMQPTMPEMPSI
>fig|240015.3.peg.566 Glyoxalase/bleomycin resistance protein/dioxygenase
MLSSSRLTAFLTVPDAALARNFYRDTLGLTLTHEDRFALAFDANGTPLRVAIFPDFKPQP
FTVLGWQVPDAVVMSRQMQSAGIAFERFDGLAQDEHGLWNAPGGSRVGWFRDPFGNLLSI
HDAAAAMAI
>fig|240015.3.peg.1259 Multidrug resistance protein B
MPAKQIRPVLGIFAVLLGASLATFFGRLLSVGTADLRGPLGLSADASSWLGTAYNMGMMF
IGPFSVYLGGVLGPRRVLLWCACIFTLATFFMPFAGHLSWLITLLAIAGLTAGSFYPLTL
SFILRNLPQKYMLYGIAAYAIDIVVTTHVADSYEAWVMRDLSWCWLFWSITAATPFMVWL
VQSGIPTQPIPRSAPRQPRISWRGFLYASLGAALVFGALDQGQRLDWWHSGTFAAMALSG
SFLILAAVVRHFCQPHPLVNFPFLRRRNTLLLGLTVMVFRFVLLASVVLVPGYLSAIKGY
RPDQVGPVLLWLAIPQFLAGIFAVYLLGKVDTRLVLAAGFSLIALGSLMDSHLTTAWAGN
TFTVSQLVLAMGEGLAFNSMVGAIILDILNSGSLNKPADVLTFAGFFQTIRLFGGEVGAT
FIRHFLHVREVFHYNLLASGVQGGSAPLLARERALLPVMQSRALTQNALAGRSVELLVVS
VRQQAFTLSLADSFTLIATVAAGCLLIAASLRALKLGFPQIIATPGAGKSTT
>fig|240015.3.peg.1260 Acriflavine resistance protein a precursor
MKKWSFVIPVAVLATAAFLILAIRGHWTSWQSDAVVQKTDDAYVTANQIPLSTRISGTVK
AVDVHDYQGVRAGEPLIVLDDADYQAVVSEAQAAIAAAQAELAANQAAKHAADAQVQSAA
SGIAQAQAAARAAQDAIAAAQAQADDAASEYRRVHALYANQAATQEQYDHALAARESTQA
ALQAKQAQAAQAQAAIASGETARAAALEQRAGLNAKDRALEAQIAAKKAQLIVAQVNLSY
ATISAPASGRIGKLQVHPGQLIGAGVEVVDFVPHDPWVEANYQETQLRRIRVSDRADVHI
DAFPGRTFHGHVQEIAPASGAATALLPPDNATGNFTKVVQRIPVKIVLDDLPPGDLLRPG
LSAEVAIHTNDVQRAAQTAATSN
>fig|240015.3.peg.1290 Acriflavin resistance periplasmic protein
MSGSLHFNNFINCKQEAFIVMTERNRRSMSRISSALLTPIVGAALLPLLVAGCSGKKQAA
ANPHAMGPFPVTVMAVQQKNVPIYGDWIGNLAGYVTANIQPQVSGYLIRQDYKEGSPVHK
GQVLFQIDPRPFQATLDQAKGQLAQVQAQLQLANINVNRDSPLAKAHAIAQSTLDNDLQQ
QAAEKAALESAKASVETAQINLGFTKVRSLIDGIAGLAATQVGALVSPTTTLTTVSQVNP
IKVYFSISEQEYLALSTSVRAMGKADLLDSGNAVPLQLTLANGQVYPHEGRIIFVDRAVN
PQTGTILIAGSFANPRGLLRPGQFGHIKAETHIAENALLIPQQALNQLQGNYVVAVVGSD
HKIHMTPVQLGPEVGNMQVINKGLQPGDLVVIQGIEKLRDGMPVVPHQVSAPAPDTDGAQ
STEGN
>fig|240015.3.peg.1350 Multidrug resistance protein B
MLAQMDATVVNVSLSQLAADLHASLQWIQWVTSGYLLALALTLPLNGWLVERLGAKRVYL
LCFTGFTLSSALCAMSWSANSLIGFRILQGMSGGLMAPMAQLMIAKAAGKQMARVAGYAI
VPVLLGPVAGPVLAGTVLQYATWHWLFLINVPIGVLGIVLAILFLPRDGHEERSSRKLDI
GGLLLLSPALVLLLYGMEHLNEHAGLAAFGLSLALLAGFFYKARRDGERALLDLKLFRRR
VFATAAITQFTGNGLLFAVQMLVPVYLMRGAGESPSMTGWLMAPMGMGMMITSPLVGRLT
QRYGIRGTSSRGAMLALVSTLMLIYLSIERLNPWLVGMVLFLRGMGTSAVGIPSMSAAYA
SVPRAELPMATTSMNIVQRLGGPTLTTLCAGFLGWRLGGAQIGAGRPGAFPESFALLCGL
QLLLWLATLRLPRDMEEAEESKKTAAAA
>fig|240015.3.peg.1899 Inner membrane component of tripartite multidrug resistance system
MSQSSVAPRPAAAASDQDFHYEHWTPRFNPWVITFTVTLATFMEALDSSIANVALPHIAG
SLGASQDEATWVLTSYLVSNAIVLPISGWISNRIGRKRFYMACVAAFTLFSFFCGLAPTL
TWLVIFRVIQGAAGGGLQPSERAILADTFAPEKRSLAFSLYGMAVVLAPAIGPTIGGWIT
DNYTWRWIFFLNIPVGILSLLLTSRIVEDPPYLKRQLARLKESVDGIGLGLLALCIGAAQ
IVFDKGQQDDWFGSHFIVGCTIVAVVCLVLFLYRESTVEHPIVDLKLYRTRNFAMTQIVM
LLIGAALYSTTVMIPQFLQVLMGYTATQAGLALSIGGVVLMILFPIMGFLGQKMDPRLMI
TLGFAVLTFGIWRISDLNLNISFGTALSWRAVMVLGMPMLFVPISVMSYVGIPQEKNNEV
SGLTALARNIGGSVGISFVTTLITRRTQVHENYLAAQVNPSSAQYQSLAQGMQGFLAQAG
AGTGNAAHAAAAQIYNIMKQQAAALAYVDTVHVLVLLTACLIPIGYLMKKPRYRKRS
>fig|240015.3.peg.1922 Permease of the drug/metabolite transporter (DMT) superfamily
MTRVLGYGACALAGCLWGTGFYFGKIALTELPVGHMVLYRFLFACVGLLPVVRWPRFTRR
AWAWLLTASFVGIPVQFLVQFYGLSMTTVSHASLMVGTMPVILAVGAWLFAGEKLDWKGW
LALAGSTTGVALIVLGGRHGAAGGKGPSLAGDLLVVLAMVFALGWILVNQKLMREGHSPL
SVTVWGLLTGTAMLAVWVVWRQGMPPVHGLSGQVWFALAASGLACTAATTLLWNWGMHRV
PASRAGVFLNIEPALGSILGVELLGDRLGPGAWLGGALIITAAVVLTMTGHVEPDSVLE
>fig|240015.3.peg.2125 Permease of the drug/metabolite transporter (DMT) superfamily
MPSSSSHAGPARLAVLLAFGSVYFFWGATYTAMSIGVHLLPAPILAGTRMLIGAALMLLF
CKLRGKKIFYSRGVMARLGLLGVMLLFMGNVGLVWSEKYLASGLAALIVAIVPLYVAVIE
AVTGGEQLRRRGLFGLFLGFLALIALLWPSFHEALLPRHGSSMQIIAAIIVLLGALSFAS
GSVLSRHMQLPVPPLVAAGWEMGAAGLANVVLATATWQWPHATWNWHSLAAIGYLILFGS
LLGFSCYIWLIHHVPVAKVATYAYVNPVVAVILGVLVLHEHMQPTEYFGMVAVIASVALV
TSSQMKSGKPAAAPAPVENEA
>fig|240015.3.peg.2816 Inner membrane component of tripartite multidrug resistance system
MAATATLLPETLAPKKLAARAAINPWVIALTVTLATFMELLDTSIANVSLPYIAGGLGRS
YDEVTWILTTYLVANAVVLPMSAWLSRVFGRKTYYMACVALFTVTSFFCGIAPSLNVILI
ARILQGIGGGGLAPVEQAILVDTFPANKRASAFALYTVAIVTAPAIGPVLGGWITDNFSW
RWVFFINIPIGLLSLFLTNRFVHDPPQFQEERRSARIAGKLRIDGVGIALIGIGSAALEV
TLDRGQIDDWFGSTFICWALSIAITCLVAAIVWELRQKDPIIDLHLLRSRNFAIASFLYF
LFGFGLFGSTTMIPQLLQSLYGYRATDAGLVLGPGAFVITMLAPVGAQLVQRGIVAARTL
LFFALITVGLSFLYYSHFNLATDYDHYAWARALQGLGYAFFFVPLSVITYSQLRPDQNNR
ASSITNFFRNWGGSFGVAFITTMTERRQNFHQAVLGASLTGPSLWLQQAVHRMAGYLAAR
GLSPGDALHYANAIYYQRLEDQARLLAFMDCFHVMGILTLIAAPLVLLTRSFRAGGKAPE
GH
>fig|240015.3.peg.3307 Membrane fusion component of tripartite multidrug resistance system
MADQNPEQKNTPADEQQLDKPENLRPKSRKRFILFGVIAIVLIGGGLYWWHSTFYENTDD
AQIDGNIIQISSRISGHVLNVEVQQNQSVKKGEILVELDPTDYETAVKQDEADLASAEAN
YEAATVNVPITHVSTSSTLSSADATVLSARDSVAQAERQLQAARAQVLSAQANYTKAKLD
LKRYTSLVQKDVISRQQYDAAVATATADQAAVQQAEADVQAYQAAVSVAHAKVAQAQASY
RNAQTGPRQVAIQKAKADQAAAQVKLAEAKLQQAKLNLSYCIIRAPESGIVTTKSVEVGQ
NVSIGQNMATLVSLDNVWVTANFKETQLDNMKVGQPVTISVDAYGGKQFDGKVTEIGGAT
GSMLSLFPPENATGNYVKVVQRIPVRIDFTNPSQDKDHMLRPGMSVEPKVRIK
>fig|240016.6.peg.509 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTPEKNPALNGAVLPTFFYYAVPSMVGLIALTTTSLVDGIFVGNYVGADALAAVTLLVPL
LTVLYALALMFAIGGSVGAGTHMGAKDPGTASSVFSQTLIATVATTTLFTLASIVFEPWL
FRLLNIPTELVPMVGEYFGILRWTLIIQLTTMVLYYFVRADGHPILATISLLVGSLGNIG
LDVFFVCQWGWGLAGAAWSTAIAQVAQAAVLCIYFFSRRRTLHFIWRQTRWSHLFKACYN
GVSEFINEISAGIIIWLLNFLLIGRLGVDGVAAFSVVSYYIYLSLMLTYGVADALHLLVS
QNFGAGNHQRIRQFLSTALIGSSGIGLSLAVSLLLFGDQLTGWFLSGEDAAIVEEASRLA
FAIWPLFLVNGVNVILSCYLTAIHRPTPSAIVAILRGLILPACFLLGLAHLFDQAALRDS
SSQWSFLWALPLAEWITFAVAIAFCYRHRPDRFEPAFPIQPVED
>fig|240016.6.peg.637 Permease of the drug/metabolite transporter (DMT) superfamily
MAPSSSSAGTASSPTLSASPSLTEAAARPPLLLILLAFAAVYLIWGSTYLGIRLATDTMP
PFLMAGSRFVLAGAFLYGVLRWRGEAKPPTVAWKDAAIIGGLLLLGGNGGVSWAQQYVPT
GVSALIVASVPLWIVVTDWLRPGGTRPRATVMIGLALGFFGVVLMVLGKDSKGHPVVIPL
GAAVLVLSTITWALGSIYSRHAKLPGSALMGISMQMMAGGGLQLLVGTLLGELPRLRFDL
ISATSAWAFVYLTLIGSLVGFTAYVWLMRTCSPALVSTYAYVNPLVAVALGSLVLKEPVP
HAMATAGGLILAAVVLITLTSKRRAKGGDATQAGGDSLRSSG
>fig|240016.6.peg.2365 Permease of the drug/metabolite transporter (DMT) superfamily
MSRSFKSSLVTFLIVAGSSLFFCSKAVFVKLAYRYGLDAVTTLALRMAMAFPFFLIGGIW
ASSGKQVHPLTSRDWARLALLGFCGWYFSSVINFMGLEHVSVGLERMILYTYPSIVLLGS
VIVLRKPLRWGVAGAMLLSYLGILIGYYGEASAKTGGETWLGALLVFGSAISYAIFVLMS
GEMIARIGPIRFTSCVVGFSCLYVLIHFVLTHPPGAILKLPPGAYGCGVALAIAGTVIPS
YLFGIGLKRAGAQAFAVIGMIGPLGTVGLAWMLLGEAINPVQVLGLALTLAGGAMVAVRK
>fig|240016.6.peg.2401 Outer membrane component of tripartite multidrug resistance system
MNCLPPQAVAPLLLLAFAGGLVGCVGSNPDRAQSELKVPGKWKGAARSGFPQRPLNTAAL
PKWWERFHDPVLNQLVSTALQNSTDIRTAVSKVRESRARRGVQAAGLFPTVDAGFSARGE
RTDNRNTGVSSSENYGASIDMTWEVDLFGKQRQNIKAATEDLREAGENLYAAQVSLAAEV
ADTYVSLRQAEAQLAVVERTLASRTETTQIARWKEEAKITGSVDTQQAISTLEQARAQVP
SLKQTISQTQNQLSLLASLPPGALDKLLARSDKMPSPPARIAIGIPADTLRQRPDIRAAE
RRVDAAVARTKSAVAERYPDLSLSGSIGVDALKAGRIFSPENVAASIAGSLAAPIFDAGR
IRQDINIQSELESQALIGWEATVLTSLSEVENALIGIQRTAERLVILEQALKAARQAEEL
STQQYEAGLVDLLVVLEAQRTLLSLEDQEVTTRANQASAHIQLYKALGGGWSS
>fig|240016.6.peg.3293 Glyoxalase/bleomycin resistance protein/dioxygenase
MSTPYRPEGFSAITPYLIAPDAARLIQFLVEAFDAKEKILVHDDAGKVRHAGFQIGDSHI
ELADGNPQWKPMAAGLHLYVQDTDAAYLKAIAAGGTSLYEPTDMHYGERSGGVMDPAGNH
WYIATLLPS
>fig|240016.6.peg.3327 Acriflavin resistance protein
MQWLAAISVKRPVFATVLVLVFVVVGALGYTRLPVDRFPKVDFPTVSVVTRLDGATPKEI
ETEITDKIEEAVNTVSGIDELRSVSTEGISQVLVAFNLDKKVDVAAQEVRDRVNRILPNL
PEDVDTPIVEKLDPDAEPIMSISLVAEKPVREISELADKVVRRQLESVAGVGQVTLLGAR
KRQINIWMDPVRLKAFDLAAVDVERALRQQNVQIPSGNVKGNGVEAGLRVLGKAQSVDDI
GRIVVREKDGGLVRLADVARVEDGAEDLQTVARRNGQPTVTLSIRKQSGENTIAVVDAVK
ERLEEIRPTLPEGYKIEIVRDNSLIIRTSTHAVKEHLVLGSIFAALIVLFFLGNGRATLI
SALAIPTSIIASFGVMWVGNVTLNSISLVALALAVGIVIDDAIIVVENIFRHLHEKNESP
HDAAINGTKEIGLAVMATTLSLLAVFIPVAFLSGIVGKFLSSFGLTMAFAIAVSLLVSFT
LAPSMSARMLKITKPNWIERGMTYLVNIFYTPLEGLYMWMLRLSMRHRWIVVLACVGALY
SVGPMMGKVQKALLPPAEEAEFLVNLRTAEGTTLEATDLVAERVARDIRTIPGVEYTLLT
IGDNDQRTPNKAGIYVRLIDPAKRNDSQEQIMDRVRQQIVPKYPKELRMTVLQVPPFSTG
QSSATVQFIIAGSDLDRINQAAENALKEIPNIPGIRDVDSTLVSGKPEIVASVDRAKAGQ
LGVNIADLSSTLRLLVGGADVSTYNEGGEQYDIHLRSEAPYRNSQEALSLLSVPSGRGGT
VSLSNVVKLERREGPAEINRADRRRQVTIMANPAPGVGESQIADAIETIVKKQNLPPDYE
VGPTGRSKELKKAGLAFVTAFGMAFIFMYLILAAQFESWLHPFTILLALPLTLPFAILSL
LLFNQSLNIFSVLGILVLFGMVKKNGILQIDHTNQLRERGMNRLEAILQANKDRLRPILM
TTLAFVAGMVPLMFSKGVGAAFNNATAGVIIGGQMMSLLLTLLATPVFYSLFDDVIGWRK
RRADRREAKRAAREAAAHPAPQPAH
>fig|240016.6.peg.3750 Multiple antibiotic resistance (MarC)-related proteins
MRPTDWISALVLLLIVLDPLGNVPVFSSLLRQVEPARRKRVILRECGIALVVLFLFLAFG
GGFLKLVGLSQSSLGIAGSIILFMIALRMVFESTEKVFGGLPQGEPFIVPMAIPMLAGPS
ALATVILFTTREGISTLGAVGAISIAMGVTCIVLLLGERIIRLVGERGLAAMERLMGLLL
TAIAVEMFLRGVKEFMK
>fig|240016.6.peg.4282 Glyoxalase/bleomycin resistance protein/dioxygenase
MLPSAILETALSVADLNLSREFYARLFGHPILASDERLCAFDVQGRQVLLLFPKDSDPEG
TTMPFGGHIPAHGSHGRSHVGFAIPAESLDEWRQHLHHLSITVESEFTWPRGGRSLYFRD
PDGHLLELLTPGVWPTY
>fig|240016.6.peg.4587 Acriflavin resistance protein
MISWFARNHVAANLLMLAVVAAGAWTLFSGKIPLEVFPDVPSRMLSVSVPYPGSTPEEVE
EMIVLKIEEAIQQVQGIKHINSTASSSGANISIEVEEGSDPRQVLEDVKIRVDAVPQFPE
EAEKPVVQLDDWFMSVITVVISAEMADRDLRRLGEQVRDEVGALPGISHVSLGGIRPLEI
SMEIPEATLRKYGLTLESISRAIQSAAIDLPAGVVQTESGDVAIRTRGRAYSGDDYAKVV
VLTREDGTKLTLGDIAMIEDGFNENPLIARLNGKKCVVVNVMREGSQNAIKIADDVKGYI
EAARSKLPDGVTIEYWNDRSKIVKGRIDLLLGNAQSSLILVFLCIGLFLRLDSVIWVALG
LPVAFLGAFALMPWLGITINTATLFGFILVLGIVVDDAIVISEHVDKLQRQGLPPLQAAI
EGTRRMAVPITFGVLTTVMAFLPMVFEKGDWARMFQPIALVFVTVMLIALVETKIILPAH
LAHPFMEPVMKHLAPFYNFTDGCLQWVITRLYRPSIRWSLDHRYTVLAIFFGGLLLLCGF
FFGGRILFVKFPRIDSERIEARLTMLDGTPFEVTDRHIARIYEIGEQLRREYVGPDGRPV
IRHILATTGTTRLTGSTGGSGGVSHLGEVNMECYGPEERSLKIRTPDIANEWRRRIGQIV
GAEELNFRAEILRSGDPIDVQLSGTNPQELLALSSQIKDKLGQYRGVFDIADSLDSGRNE
IQLRLKPEARQFGVTVNDLARQVRQAFYGFEVQRIQRGRNEVKVMVRSPRNERRNLATLD
TMRVRLADGLELPFSSVAEIKVDKSFTSIRRVDRRRALNVTADVDKSSTDVAVVRAGLSE
YLNELMAAHPHVHWSFEGEARSERESASAGWMALITVGLGLYAMMAIPFKSYTQPLIVLL
VIPFGVVGAVLGHLFHGMPVSMMSLFGMLAVSGVIVNDTLVLVDEINSQRDETGDLEMAA
REGGAARFRAILLTQITTFFGLVPLIFDNSPQSTHNQFLLPVSVAMGYGSLFATVITLYL
VPLSYLAVDDLLGLFRKQPRKAATIASPDDNGAVVRA
>fig|240016.6.peg.4818 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MPDIQPQISVVVPLYNEEENVAELQRQLSQALAGHSYELVFVDDGSTDATSAHVQKSDQV
RLICFRKNSGQSAAMYAGIMAARGEVIVLIDGDLQNDPADIPALVGKLQEGSYDLVCGYR
AKRKDTAFKRLQSRIANAVRSRFIGDGVRDTGCSLKAMRRECRRALLPFNGMHRFIPALI
RHSGYKITEVPVNHRPRIHGVSKYTFANRAWRATKDMVGVSWLLSRMVKIDAEER
>fig|240016.6.peg.5115 Inner membrane component of tripartite multidrug resistance system
MGGGVLLANAQSVIFESFPPERRSLAQAVFGLGVITGPAIGPILGGYLTDTLGWRWIFFI
NLPVGIVSVILAITFLPQDDASQKKTGESVDWLGIVLLTIGLGSLQTLLEEGQQDDWFAS
RFITGLAVTSAVAATLFVWRQLTVSHPVVDLRVLRHRSVAAGSLYSVVLGAGLYGVIFAV
PVFAQNYLHFNAMQTGNLLGPGAITSAVVMIMLARVTKFVDPRILVAMGGLLTALVAFQL
SHITTQSGANELFWPLVMRVGSSVLMFLPLALLPPDNASGNFTKVVQRVPVKITFDPTTL
SGIRQQVRPGLSAIVSIAVK
>fig|240016.6.peg.6450 Membrane fusion component of tripartite multidrug resistance system
MSSRVISLNELPKRGFSPAPNVEHNGAAAPQTTTPAESEPRPPQSTGHRSRKPLLIGLPI
LLVVATTVGFWLHYAAQFVETDNAFIEADVHPVSSRVAGNIQSVLVEDNQKVEAGQPLAQ
LDPRDYEMKLQSARTALEQAAAQVPQAEAALAQAQAISAQTEAQVNASAAQLEKYRLDFD
RAQKLRNLTGKAISDQDFDATKAAYVAAQASHASTQAARQAGEAGVKTAEANLAVARAGQ
HHAQAAVSDAELQLSYTTVRAPAAGTVGKRTLQVGQQIQPGQALLAVVSPDHWLVANFKE
NQLATMKAGQPVEIKIDAIKGQRFEGRVESFAPGTGAKFSLLPPDNATGNFTKIVQRVPV
KITFDHNANTEANHDRITPGLSAIATVKVK
>fig|240016.6.peg.6451 Inner membrane component of tripartite multidrug resistance system
MNATATLPQTGARDSTNPGTSLRNWIAVLGALLGAFMAVLDIQISNSSLQNITGGIGATL
EEGSWISIAYLVPEIIVIPLCGWLAQVFGLRRYLMWNSVLFLVFSMCCGFAWNLESMIAF
RAFQGFTGGALIPMASTMVMIMLPAEKQPVGFALFGLSAMFAPAIGPSIGGWITENYSWP
WIFYLNLVPGIILISAIGYGLNSTPAKLDLLKKGDWWGIAFMAVGLGSLTVFLEEGTRKD
WFGSEFITTLAIIAAITLPVFVILSLIKRKRTPAVNLRLFSRRNFLLGCIVNLVVGLCLY
GMMYLLPLYLAQIQGYNALEIGRTLMWVGLPQLVVMPFIPKIMQWVDKRVVVAFGLGMFG
LSALLMSSMSADTGHDQLIMPQIIRAIGLTCTIVPLSLITTGGIESEQAASASGLFNMLR
NLGGSIGIALLSALLTNREHFHSHHLGEAISTYNPLTNERLTAMAQNFMNQGLDAVTAQS
RALGLLDLGVRKQAYIMAYNDSFHIASLLLFAMIPLIFLTRKATGPAPAGAH
>fig|240292.3.peg.727 Multidrug resistance protein
MPQKSAALRFVILLGFVSLCADATYEGARSITGAYLQVLGASGTVVGLVAGFGELIGYGL
RLVIGYLSDQSRKYWGITTLGYILNTAVVPLLALTGRWEAAAGLMMAERTGKAVRTPPRD
ALLSHGASQIGRGFGFGLHEAMDQTGAVMGPLAVAAMVYFQGEYRHAFTILIVPAVLGLV
VLLVLQFLYPNPSDFEEETEEQKQQEGLPRIFWIYLGAVAVIAAGYADFPLIAFHFQKSG
IATGETIPLFYALAMGVDAIAALIFGYVFDRLGISILIIAAFISCLFAPLVFLGDTNLAL
LGIAFWGIGMGAQESILKAAIAGMVPKHKRATAYGIFSTGYGLSWFLGSALMGILYDHSI
TTLIVFSSATQLLAIPFFTWVKLKADDSPKTITNQAS
>fig|240292.3.peg.824 Permease of the drug/metabolite transporter (DMT) superfamily
MIKFRGRSRLIHRVSGQVYLWLAIFIFGASSAVTRKLTEIGARHFIDGRNPISLCNVLFV
GNLCALMVMLLIYNRQWNKATLAQLSKKDWLGLTAVAILSGALAPGLIFQALSLTGVNNV
ILVGRLEPTLALALSVWLLKERIGFGEFIGAIAAFTGVILTIILQPPGSDMMNMGGWQLG
LGELLVALGSITLAISTIIGKKYLTHIPLGIYSIFRTALGTVIFFFIALLLYGRDHFADV
FSPFLWQWMFLYGGVIVVVGQSFWIIGLKSSTVSTASLVASFTPIAGIMAAYFILGEVPT
MAQYLGGSLIMLGIFLSQVSKSRQTSHKSPIASTPTEQKVEMDIGFKGI
>fig|240292.3.peg.2142 Melittin resistance protein PqaB
MRPITQKKLLLVLLVAALALWLTFLGNLPLRDWDEGTIAQVARDIWQAPVGSMRWLYPTL
AGEAYHNKPPLMHLLIAWAYSIGGINEWTTRFPGAFITALGVPLLYLLGRSLFNRSLPAL
FAALVYLTMLPVVRHGRLAMLDGTLITFFLFVLFCLLKARQNQKYALGVGIGLGLIALTK
GMMVLLLGGIAGLFLLADRQLTLLTSPYLWTGLFLGSAPAIAWYLAQWQHYGGSFLQINL
QSQTFNRVFQPVEGHSGPPWYYVLEILKYGFPWLLFLPGGLYLAAKKRDTSWGCLILVGT
IVYLASISVMRTKLPWYVMPIYPFLALAIGAKLADVWQYHHVKSTTLVVFFVILAIAGLG
GCVYFATTETQPVLIAMSLVLAVSMATVAWLVNQGDRNFIPVLFTGMYLVLIMFVSSQSW
IWELNEAFPVKPVAALIRQHVLPGTKIYTSFAYNRPSLDFYCDCQVLTEPSISQQMAKRN
DYLLLDNTTLEKINLSGNEILGTVENFTLIAPSKN
>fig|240292.3.peg.2550 Melittin resistance protein PqaB
MQEGSFIWGHLERQHRAVDKWIDRLWLVVLLIAALLLFSVNLGGLPLQDWDEGTIAQIAR
EITQESANSIRWLYPTLRGQPYHDTPPLMHIVIAGAYHLGGVNEWTTRLPGAILTALSVP
LLYCLGREIFRQRWAAIYSALIYLTMLPVVRYGRLAMLEGAVVSFLLVMMLCVLRSRRDL
RYCLGIGLSLGLICLTQGLSGFLLGAVVLVFLFWDTPRLLTSYYLWIAIAIGILPVAGWY
SAQLLHYGNDFVQNGLLLQSLQQAGIVNHKNAQPSWFYIVELLKWTWPWLIFLPQTTKLL
WENRNLSWARLILVWSIVYLLLISLMSVKLAWYIFPIYPSLALAFGAQLAEIENLPLLSS
YPRAWVAGLSILAVVASAASIHFSWGIAAKTDLQLIFAAVALTMIMGAILAERGDGQFLK
ILFWGSYISLLLLMKSNYWVWELWQAYPVKPVAAMIEKVNPAAKKIYTSFPYHRPSLDFY
SDRHIIPASAEELKHHWHYDRQPYLLISSSDFQRLQLDSVQILDKTEGWQLITKETNRL
>fig|240292.3.peg.5031 Multiple antibiotic resistance protein MarC
MDTSILIQTFIAVFVLADAIGNIPIVLALTKGMEPEDRNRVIDKASIVAIAVLLLFAFGG
QYILTYLEISMASLRVAGGLLLLLIALQMLRGELETPTIEEGRDVAITPLALPLLAGPGT
LTTVMLFMSKSQSPHLAVVLGILAAMFVTWLILRLANPIEKRIGLEGGVIVTQLLGFLLA
ALAVEIGSTGIRELFLQ
>fig|243090.1.peg.181 Drug transporters
MLASGTELKIANLFSRRSDAFSIRRMPANQALAAAAFVTMTFGGASMLLADDAKSKPIVI
EGAQTTLVTDLTLAAPIAGRVMSVTATEGQQVSKSDVLVQLDDRRAKAELAAAESAAKAA
ELRSTSDVDQRYAERTREVRMRELEQSIDANKRYQNSVTATEIDRLQLVIDQAGLSIEQA
RKELEVAEAQADEKLSLVEMAKLRLSEHRVDSPVVGNVAETMVSVGEWVEAGAPLLRVVS
LDPIRVSGFVDGRVHGGELKGRPVEFEWTQSIGGEDQSIVLSGEVTFVSLEVHPVNSQVR
MWATLRNPDQLARPGVRGTMRILPAVGEAKTPAE
>fig|243090.1.peg.2374 Drug transporters
MRFRRLRLKQRPCQRSWGVAQRRRVATTDTRSAIGLMTPASVSFRSDWLIKATNALNVRV
SSPLPGRVRNWAAGACPWPWSFRCEKLVEDIVFSCLRCHVGRREAVARVSLAKSRIGCVL
ALHFLSQRVIAFRSTTSRRDPRTFHLFYFAGPGGWPLSSLSQESMTESPRRIERDAYGYR
AMVAVAIPLAATVGCFSITLFTDRTLLMWYGPTSSAASMAAGNLYWAIACIPVTAMGFIT
PLAAMAMGRKRGRGAVALRVWSLLWQCLWFTLACVPAFALIGWMSPNLFEAFGHDVELAK
QEARYFQTLLLVAPASMLEAGLTAFFVGRRVTRPILQTNIASSVLNVGLDYWFIFGGLGL
PAMGVFGAALATTIAMWFKVAVFAVMLMRLNSFGRHFRAAWRPSRHVMTEIIVPGSAIGL
QQLIRSGLFSFVLLVIGAASVTGLAATSAALTMYQLLSIPAIGLGTAVTVVTGQALAAKG
IGLASDTIRRGMGLGVVVALTLAIALAAFPETLLQIPLGGISDEERAEIQPLAIRLMWFA
AIYALVDVASLLLAASAKGIGKSFVILVATAVPGVLVVAGGWLLAPDGWLRAGSLVRENQ
IVIHWWSALVLWSTAQAFVLAGSLFWSTNALLPVRVGQAPPSQPDA
>fig|243090.1.peg.3638 Drug transporters
MAEPTKHSHSGELKIGLVCALLAHTMWGLFPIYWRQIGNADSTELVCHRIVWSFVTLGLV
LPVMLWRGRWGGFRVVYQQLRSRKVWAVYSIAAVMIAINWLAFIWAVNNNRVLEASLGYY
INPLLNVVLGVVVLGERLRWPQWMAVGFAAVGVSVMAIGNGGLPWVSMAMATSFAIYGLV
KKKASLPVLLGLMLEVTLLVVPAAIYLGMRLADGVSTMQTGTTIEFGMLLGAGLITIAPL
AFFAAAVQRVDLSLMGILQYIGPTLQFLVGYVLFGETLDLPRKIGFVFVWTGLLIFLLAS
QFKRRRPTLVAEAS
>fig|243090.15.peg.998 Permease of the drug/metabolite transporter (DMT) superfamily
MVTIFDDTFGGEPLIGIVFAMLVVLSIPIGILLTTFSFAKDHKREHWPIAAVSSALLVMI
GLASYNGAWPLAKLLTADFVRGTAFTNNPRFWWMMAREVRDAGFYLLCIAAIVAFGNLLI
YAVHRFCGNIPRPSDSTQS
>fig|243090.15.peg.1089 AcrA/AcrE family multidrug resistance protein
MHNQFLEMISIIRSMLNRSIPILIFVVIPCAFLGCDTMSGSRPAQIISGSHPSSHSKQHT
TTGQANSHHNESHHGSSEPEVTNAHHATGEHHAQHKIVVTSPVARDVTLTRQYVCQIHSR
RHIEVCALEGGYLKDIHVNEGQAVTKGQTMFHILPTIYEAKLDADMAEAQLAQVEFDNTK
SLVQQNIVSTQELKLAEAKLAKAVANVKLAQAEMNFANIKAPFDGIVDRLQEQEGSLVEE
GAMLTTMSDNSVMWVYFNVPESRYLEYQEAMNAGQNQDALDVQLRLANHKIFDQPGKIGA
IEADFDSETGNIAFRADFPNPNGLLRHGQTGTVLINQVAKNAVVIPQRATFEILAKKYAF
VIDVDDIVHQREIVIQNEKDDIFLISEGLQPGEKIVLEGILQVRDGEKVEYEYRDPDTVL
GNLKYHAE
>fig|243090.15.peg.2640 Probable multidrug resistance efflux pump
MGAAIYGYTFLGERQRPQRSKPAKSPVTIVATDDIRFHSGPVVIDVNGVVVPLRELRLAS
EVAGRVVELSENVRAGRKVKQGEVLIRLDATEYELEVKRLQALAQQEAAEENSVQVGIEN
TLQLQSLAQKQLEIARQERERINALVAQRAASASEVDTARRAELAADASLVELENRRREL
TAQLQLVTEKRSLTEVLLERARLDLSRCEIKSPIDGRVVSSEVEEQSFLPTGTTFITIED
TSAVEVRASLTADQMFWIWNSRSVLSTLAASDPAQAEKAVTDADRFNSAVSATISSVIGS
ESHQWSAVFERLDGVGIDLNTRTYPCLFRVESPESSLEGSASRQLTRGMFVDVSIETQPN
QVLVRVAESAVRPGNRLWLNVDGKLRIVPVTIVSRTGDDVVVQIQPELDHLCTLASTRII
VSPISDPVEGMPVGGQPPSPSGEGAGPGKTGQSDSPPIGDTTSNPIQANSSLRVDG
>fig|243090.15.peg.4571 Multidrug resistance efflux pump
MSWILGGVYCGIIWLVFAKLKLMRLSLPLAIILASVGPGLIVVLLFCAQYFHPYTKQAIV
IAQIDPITAQLSTNGRVKEVFVSPNVPIQAGDVLFTVDPIPYENAVEVAKAGLEQAKQNV
QLSESTVELSRATLVRAKADLTYATNDRDRYQKLRESGGASQDELERAVTLFQQSDAALT
QAEQSLKQAGISVGVAKAKQTQAETTLANAEYDLQQTTVKAPADGYVTNLQVHPGMLLGP
ATGPVMSFIRDTDERQKGVVVAVFVEKNFLRIRTDQYAELAMDAYPGEILTGRVLNSINV
SGKGQLVAGGMVPTDLADGKPTQFAVRIQLDDVDSYPLPGGAQGQAAVYTGDVQIAGIPI
MFLIRANSWMNYLF
>fig|243090.15.peg.5396 Acriflavin resistance protein
MTSLSKMVPEGGPIAWMARNSIAANLLMLLLLGGGIWSAFAIQKEVFPQFQLDIVEVAVG
YPGAAPEEVEQGILRPIEEAVRGVEGIREVTSEAREGRGELLIELVGGEDRMKVLQDVDQ
AVSRIRTFPDQIEQPEVRLQSRQQEVMQVAIYGPIDVWALRKLAEQLRDQLQSKEQITQV
ELRRVPAYVTHVEIPRQRLREYGLTLPDVAEIIRTSSQDVAAGSVQTTAGEILLRVKARK
QWAEEFAGIEIVAGRDGPMVTLGDIATIRDGFEEVGFHSQFSQTPSVELDIYRVGSQSPM
DVAEAVQETMEEFETALPPGVKWRIDSNNAEEFRRRLMLVAENAAMAVVIVLVILSLFLE
FRLAFWVMMGMAVSFIGGVLLLPAAGVSINMISLFGFLVVLGIVVDDAVVVGENVYEKRQ
TLKDHEAAAVEGTKEVSGPVTFSILTNIVAFVPLLFIPGETGKFWGPLPVVVIIVLALSL
VESLFILPAHLAHARDAGRDPNSIGARLHHLQQRFSQGFNRLVEFFYRPVLILSLRHRYV
TASLALALFVVIGGYATSAHMGLILMPEVSADEIEAGVRMPVGTTQAQAAKIADTVTKAS
IKMFEEHNLYEVAEGIKTNVRGQSFIDVEIVMKPPDQRDMTANEVIDLWREHIGDLPGVN
QVTFEAERGPGGHRRDISIDLSHSDIDVLEQAATAFVDRVKLYSNARDVNDNYNKGKTQY
DFRLRPEGRSLGLTDEELGEQLRGAFFGSLALRLIRGTNETEVRVKLPEEQREDIHSLED
LIIRTPSGAEVPLLDVAEVEETLAFRSINRRDGRRTISVSMDVEPKRAATQVIEALQNSE
LPKLREDFPGITWSFEGSDAEMRQATASLWGSFGLALAVIYSLLAIAFKGYVQPLIVLVA
IPFGVVGAIIGHIMLGYDLSLVSLMGVIALSGVVINDSLIMIDYANRHRKNQSAFDAISQ
AGLRRFRPILLTTLTTFGGLMPLIFEDSLQAQYIIPMAISLGFGILFATAIILVLVPCLY
LILEDIQKTFTPDTE
>fig|243160.4.peg.22 Outer membrane component of tripartite multidrug resistance system
MKTFPLSACRTAVAVAVAALALAGCANYFGLKNDKAIAPAAQFESARSLPAQGGQWPSLD
WANQFGDPQLPKLIDEALEGNPTIAQAQARIAKASSYIESSRSTLLPKADAKYSWTRELY
SGNALFPPPYGGQWYSENNALASASWELDLWGKNRARLNAAVSQEKAAEADLQQARVTLA
TSVARTYNQLAQLYALRDIAGREISNRQTVDKITDGRVGAGLDTNVERQTARGNIATSQS
TLSDLDGQITNVRYQLAALLGKGPDRGLQIAAPVLSAGGAVALPENLPADLVSRRPDLVA
ARWQVEAAMHDVKEAKAEFFPDINLAAGFGFDAFGWGRFLNFASRQAQFGPAIHLPIFDG
GALRAQLKGRYADFDLSVANYNQTLINALNDVATQVASIRSVDTQMGDAQRALDASTRAY
ELAVIRYKAGLSPQLQVLNADSNRLAAEQTVTNLKMRRRDLQIGLVKALGGGFDAAGTRL
AAPAPASAPAAPAQHASN
>fig|243160.4.peg.601 Permeases of the drug/metabolite transporter (DMT) superfamily
MAILMGLLSALCWGSTDFLAGHAARRVGVTKSLFYSQSFGFLILTASLALHPSSLRITAI
DMGFAVGILAAVCNLIAMAALLRALAIGKASVVAPIVSLYGAVTTILSLATGQSITRLAI
AGLVLCIVGASLASISKAADGKTESPASIGFALLSAAMFGLGFWLQGAFAVKSLGVVSAL
WIYYLTAVVILFATLARARNLSAPPGSIVLLILSISVFSLVGFFSLAYGSTTGHVAIVTV
LSSLASGVTALLGFFVRGERPSALQWAGIATIIVGVVMLKITPQALAA
>fig|243160.4.peg.793 Permeases of the drug/metabolite transporter (DMT) superfamily
MQENERRSAGWPTLAILVGASVWGLIWYPLRLLAALGVTGTVASAATSIVACAFVLIVRR
KSIATVRRHWLLPALGVAAGVTNLGFVWGTIHGEVLRVMLLFYLTPAWTAICAHFILRER
LTAAGAALAALSLGGAVLMLWSPRLGVPLPSNPAEWAGLAAGMSFAMSNVLVVKASRELP
RMKPEMRTATLFAGAAAMGVAAAFVEGLPPLPAGGELGRAALLVVGIGVTVAANNMLVQH
GLARVQANRASIIMLFEIVVTALTAWLFANEVPSAREWAGGLCIVVVTLLSSRVHRARPA
EDEPLEPRDGARAMV
>fig|243160.4.peg.1258 Albicidin resistance protein
MRLKIGELAKKVGLSVRALHHYDAIGLLSPSQRTDGGARLYGRDDLIRLHRIEALKRFGY
SLPAIQASLDGPPAGAPLQILRRQIAALDAQAARAQRLSRHLQHLVAMVAAGGETAAIDW
LNVLELMNMYQKHLDDNELDTLLASGPDTVAPMDPSWVGLVDEVRDAMRRALPADSDAAQ
ALAWRWSRLMNRMTRNDPALAGKLMGIQLGEPRAQHIVGITPAMLTWIGEACAHARCTLF
AKYLNPAQIAEVRRRQLADTHMHAWLALVAELRAHMEAGVDAGAAPVQAIVARWQQLFRD
SFCGEEEGLEAKVRDALMREPDLQLGGGFDEALLVYLNKAHIAGRDIASGDDGPKPSALM
VAKQRAAHQLLDRPLVLDDPIALSILGAAEEQALRADLDRFRYPASLGMRSSVVVRSRLA
DDMRAEAIGRGVRQYVVLGAGLDTSAYRHPEAPGRLFEVDLPATQRWKQARLREAGIALP
RSLRFVPVDFEHVSLADGLARAGFDPGAPALFSWLGVTMYLDEAAVVETLRFIAGCAKGS
AVLFEYVTPLSGLPPMMRIAMEQLTAQLAARGEPWKCFFEPAALAEMLIGLGFGSIGAWS
PDELNRRYLADRADGLHIGATPARLILATV
>fig|243160.4.peg.1676 Bicyclomycin resistance protein
MPHVARRRPDGRLILLLGALAACGPIATDMYLPSLPAIAGGFGVTAAAAQRTLTSFMAGF
SIGMLLYGPLSDTYGRRPVLLGGIALFTLASVGCFVAGSIDMLIAVRFLQAFGAGAASVL
ARAIARDAHEPADAAKVLSMVAIVTAIGPLLAPLIGGQVLRFSGWRGVFVVLALFGAVCA
TAAYLRVPETWPREKRASSAVLNSFAAYGRILVDPVAWGHMLCGGMAFASMFAYITATPF
VYIDYFHVSPQHYGLLFGLNVIGIMLGNFLNARLVGRVGSLKIIAGASLLSGAASFAVAF
FALTGLGGLWSIVASLFFVVGILSANCTTDLMLRYPHNAGAAAAVFGAMQLALGALANGA
PFAMGVTIGATGLLCLGGRMLVLRWHGRPVKGALGRVDAA
>fig|243160.4.peg.2029 Multiple antibiotic resistance (MarC) -related proteins
MESNFLSATVLLILITDPLGNIPLVIAALRDVPRERRVKVILREVAIAFVILLFFMVVGD
RFLRMMSLTDLSLRIGGGIVLFLIALRMIFPHPDGALGSDPRAGGEPFIVPLAIPALAGP
SALATVMLLTSQAPGKTLEWAGALTVTMLVCAVTLVLAERIQQWLGERTVIAFERLMGLV
LVAISVEMMMAGIRAFVHQL
>fig|243160.4.peg.2712 Permease of the drug/metabolite transporter (DMT) superfamily
MTPFDRFLAFVARHPPRLPQSRSGRVALALVFIYFAWGSTYLALHVALESFPPLLLSGLR
NLLAGVGLFVFAMRRRPVRPTLVEIRNAALVGTMLVTMSSGLIALGMRTVSSGSAAVMVA
TVPLFATVIASVAGRRVTGGEWGAVALGMVGIVVLNSGGPSSPGSTLGSITVLAGALFWA
GGAHLAARLALPHDLFLSTALQIGLGGAASTCIAWVLGERIGHVAWVPGAAFVYLMLAGT
MAAYVAYGYLIRHTSPIIASSCMYVNPVVAVALGALLLGEPVTAATVIATIAILGSVGLS
FVFDPARRRAQ
>fig|243160.4.peg.3389 Outer membrane component of tripartite multidrug resistance system
MTQTATHAATRTTTLPVRRPARRLAALALAWALAGCVPSGLKPTLAPRTPGDDALAHTTG
GATHGAWPSPDWVRQLGDPQLDALVDEALRQNPTLQAAQARIGVAQSQLQQFESLTGLTA
TAGASLSKAHVPRSGGTLNTTLNGLPVSVPLVGESVVSSSSLFVGLNYQLDLWGKNAAAT
RGLLSMRDAARVEAEQARLTLSVAIVTLYGELDRAYALRELLQQKRRASEQVEAVLRERA
ARGIDNGYDADDAALKRGKLLEQIALTDEQIQLQRLQLGVLSGRGPERGLSLARPKLAPL
ADAPLPARLPARLPAGLLGRRPDIVAARLRVEAAYAAIDGTRASFYPDVNLAALGGLFAL
TPASLFRHDALGGSIGPALSLPIFDRSRLKAKLGGDVANADMALALYNQTVDAALGEVAR
QLTSLATLDTLLKAQQQALRAAQRMVALAQDRHRRGMGMRKDIDVAQLTLLDERAHVVEL
QARRRTLRVGLIGALGGGFDARPASGAPPAQAGQPFAAASRPVAAHDAQPD
>fig|243160.4.peg.3427 Permease of the drug/metabolite transporter (DMT) superfamily
MTQRLLAAAWRRPVWLLWVPPAFWAGNVVLGRAFSTSFPPVSLAVGRWLVALVALAPFVW
RDVLRERRLLLRHWKLIWACGALGIAGYNALAYVALRTVPAASVAFLNSTLPLMVPLAAA
MLGVERITSRAIVGIVVSFGGVAWIVARGHWEDLVALRFDHGELIVILATANYAIYSVLL
RRKPAAIGPLAFLAATMAAGLAVLAPFWALELAGGARIPFDPKAIGAVLYIGVFASLIAF
ILWGHCVQVLGATVTGVSFHLVALFTAVLAALTLGEPVRSYHLVGIALILFGFFVATRAA
PGVRSAPNARSL
>fig|243160.4.peg.3582 Tetracycline resistance protein
MDLHERTLDAPGAPAAAAHGAGSRLSREVWIILLTLAVDAVGLGVATPVLPDLLRAVGER
PAHVPVMLGSLITCFYFMQFVFGPIVGALSDAWGRRPILLIALGGGALSYAIGATARSYG
GLLAAHMLAGIAASSAAVATAYLADVTPPALRARRFALASSVLGLGLIAGPAFGGVLGAL
GPRVPFVAAGAIAALNFVSAACFLRESLPARRRVPVSWARANLFGSLRLVREDRVFRDLL
AAVCLGMLAYGIYLSCFVLANAARLGWGPRENGLALAGLGLGITLTQTLLLPRLVARLGE
HRTALVGFGAFVLAYGLYSRADSVALVAAALAVHALSLISDPSVRSLISVHAGPQRQGEY
QGALVCLTGLASSIAPLVGGNLFAFFTRAGASTYFPGAPFLAAAVLYALAMLAVWRAMAG
AARRRSASH
>fig|243160.4.peg.3703 Multiple antibiotic resistance protein MarC
MARPRERPPITLVRPSRFPMIVDRLISEILFGFTGLMGIINPFGIAFLFLERTESLTEAQ
RAALARKVAINAFIVLLAAFFVGISLEALRIGGGLAVAVAGWQMLNEPDVPTGGDTAAQP
VEPRNAMARAFFPLTIPLTTGPGSIATAIALNANRTHKLSEFVLSSIVSVAVSALAALVI
WQTYSRAAFLARYLGTEGTKVAMRVSAFLLLCVGVQIMLTGFSEFLRPIADQVK
>fig|243160.4.peg.3704 Multiple antibiotic resistance protein MarC
MDARKRAAARPSRPRRWSRKRSRFFAGGAGAFLYHTDWSVCGPRLDRARRHRAIGGAPPM
TRPSCPAGALEAVETASRDERRVLQRARLKGALRRASDHVAHYQPLLRCGGRASGDVLKT
LADRARVRAVTRVGIGRAVARRESCAAGCQMPDAGCKARAERHEAQRAGPHARSLRSDRL
AGAGAPRSARRRVGCAASAKRPPASGG
>fig|243160.4.peg.4101 Bicyclomycin resistance protein
MHPLRSILPLALFTAVGLLATDLYLPAVPSLPQQLGGSIESAQATLAAFSAALAVSQLVW
GAAADRFGHRRTLAFAVLLQLVAGAACALAPSMGALIGARLAQGFGVGAAMVIVPALVRQ
SFGDGGAVRALAWLGIVESAVPGLAPLVGAALLVVADWRTSFWIIVALSAIAAPLVFRVI
PTARAMRACAPANVGAHAGGYRRLLRSPVYLGYALGHALCFAALLAFVASAPQVVEIWLG
AGPSTFSLMQACGVAAFMLSAARSGKWSDALGLDRIIALGALLQFAASAAFLLLAYADWR
STPLVVASWMLFCGSLGLRGPASMARALAAEPAVAGRAAGLLMFFGLGGAALATQAVAPF
LRLGLAPVAWMCAGFTLASGAVVLWGIAIRGRHRAAATEIA
>fig|243160.4.peg.4140 Methylenomycin A resistance protein
MDTHLPHPALSRAALVRIVSTVSAGFVITQLDVTIVNVALARIGIDLHTSVAGLQWIVDA
YTLALAGLMLSAGALGDRFGARRPFAAGLALFAVASFVCGIAANAATLIAARALQGLAAA
AMLPNSLALLNHACAHDPRLRARAVGWWTASGAISIAAGPVIGGVLIAQFGWRSIFFVNL
PLCAAGLAATRLWIDSDDTRAAAASSASSASSASSAADGAHHSHPAADRRASGPNACAPA
PKRAAGAGTRGLDLPGQCLAVVALTLFTGAVIDWHPALVAIALAAGAAFVFVESRSAHPM
MPLALFRRRTFSVAVLFGVCMNLSYYGIIFVLSLYLQRVRHNTPLEAGLAFLPLTGGFLL
SNVASGWATAHYGPRRPMIAGALIGATGFALLSAVRADTPIAMLVVPFLLIPGGMGLAVP
AMTTTVLASVERARAATASAVLNTARQAGGAIGVAAFGALASGARPPDIVSGLHASAYVS
AALFVFASAMAAFVHGAPQPAAGKPANANAR
>fig|243160.4.peg.4597 Antibiotic transport protein
MLTSVAPPSATSEAVSHRNTAVLVVFTALTNLADGVTKVALPLMATALTHSPARISGVSL
TLTLPWLLVALHVGVLVDRFDRRTLLWLANAARMAAMALLIALLPSGRVTLPVLYASGLT
LGLAEVVALTSAAALIPDAVAPSSRERANAWIAGAETVCNEFCGPLTGGMLVAAGTAIAL
GAVAVGYFGGGVALFFLIGRFRVAHAPHGRPPPVRLQIAEGLGCLWHQPLLRLMAVALTV
LCMCWGAWLALMPLFATTVLGLDSRGYGVTVSALGVGGFVGALSVTLLNRRFGRRTVMLT
DLLGTFAMMAVPVLSTNLWAVAASAFAGGLGGTLWTVNARTISQHLVPGPLLGRYNAAAR
LFSWGAMPIGAGFAGAIAELLGMRAAFAALAVAALLLIVPFLRVASAQALRIGPERRH
>fig|243160.4.peg.4696 Bicyclomycin resistance protein
MSDRGWLSLLMLVVCLPRMTIDAYLPSLPAMADALHGTDAQMQLTLTMYMAGYALSMLLS
GPLSDRYGRRPVLLAGMLVYLGASVACATATSVQGIVVARIGQALGGCCGTVIGRVIVRE
RFGTAMQAAMLSRISAGMALSPVVAPLAGHVVAQWLGWRGVFALLAFGGGAAALMVHRFL
PETRVRAAASERGAGLAKTYLSLLRDRRFVRYSLAIGFVYCTYFPFIAESSALFQRTLRA
SGAVYAAIFGITVLGYLIGSSVFRRASGRFGIDAIIASAAFVNLVGAAALWIGTSVAPPS
VWSIALPMFVVMVSVGVSIPACQFAVLQPFAKLAGTASGLFFFIQMAMTAGCGGMLSRLS
DGSARPMAVVTAASSAAFMAVVMLVRTRGVNGRRG
>fig|243160.4.peg.5238 Outer membrane component of tripartite multidrug resistance system
MSLPIFEGGALVANLRLSQAQQAQAALGYRRAVLLALRDVDNALAAYRTDQTRRDALRDA
AAAERTTFELARDSYRHGLVSFIDVLDAERELSQARQQYVQGSLQLTTDLVSLYKALGGG
WQPVPAAQTPAPAALDAPTQDTPLGATAPARR
>fig|243164.3.peg.772 Permease of the drug/metabolite transporter (DMT) superfamily
MPRHILIALIFTILFWSSAFAAIRVSLADYSPSHLALLRFLVASLALVIYALITRMRLPD
KRDLPAIFLLGLIGISLYHFALNYGEKTVTAGAASLIIASAPIFSVLLARFFYKDKLTPA
GWLGILLSFGGIAVITLGEGQTLSFEPHAFWVLLAALFTSIYIVFQRPLLKKYSGFEFST
YAIWAGTLLLMVGAPGLLKEISEAPASSTLAVVYLGIFPTAISYLLYSYALSKARISQVI
SFLYLNPVFAIGIAFLWLGEIPAPISLLGGLLALAGVILVNRYGHYR
>fig|243230.1.peg.194 Vancomycin B-type resistance protein VanW
MTKFVSAPLICGLALLGALSAAHAQTGIPALPPIAQPLPVPAPAPVTPPAPTVPVPQEPA
PVPQPPMPQPSVPQTPAPQKPVTPRPAPAPSRAPLLIQARANVPALVAGKKTTVPVLKTL
TIPAERAAQLRQRGEVSASLQADLDTFLKSLAAPRDARFEQQDDGQWAVVQPNGLKVDAQ
ATRAAVAKVLRDPRGVSANVVVTGQVAPQRTLDFFASRGITTFLATGFTSYYGSSPERVK
NIHVGAQNFKDRLFEGDVFSFNKFIGPVSERNGYVPGLVIAGDQTASGVGGGICQVSTTV
FRTLYGAGLGIVQRQNHSYQVFYYDPQGLDATIYQPQLDLKFANTTGGPIWFQTEWDDQE
ATLTITAFGQARDYQVQVDAPKTLKTVAPPKDRLIPDASLPAGQRKQVDWAAPGATIEVT
RRFTRGGKTFKQDTLRSVYRPWPNIFRVGTKK
>fig|243230.1.peg.210 Vancomycin B-type resistance protein VanW
MKRFLLPLLLTWPGAALAAQPAPQLALAQDLQLTFKGELKKIDDGQLVTAPVTKSWTLPA
KWVARSREYNKLSSYLTPYLDRVEKETFVRGRPAKFEQVGNKWVATDQPEWKLDRPATEA
KLLEAIRTGATTLPVVFSEKVPQRSVALLAERGVMRNLASARSSFTGSPDFRVKNIVVGS
SKLDYQWVAPGEDFDFNKSMGDINAANGFVPGYIISGGTLALEDGGGICQVSTTIFRALW
EAGLPIVERNQHSYRVHYYDPVGYEATVYAPSKNLRMKNDTDAYIFIQASWNTATQKLRF
DVFGPDTGRKTQISAPVVTDVKPAASPTFTPDKRVVLGQQRLLDQPMEGMTSVITRTVTF
RDGTSQQDSIKSVYKPWGAVYGVHPSDPRLKQTEAQAKK
>fig|243230.1.peg.294 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MPLLNGLDHVQLEAPAGCEVAAREFFAGVLGLPELQKPEALRKNGGCWFGLPDGRQVHVG
VVADYVPRRKGHFALRCDDVGAVARHLAAHGVACTPDKEAGVPRLFLQDPWGGRLEIVQG
AHPSRPLS
>fig|243230.1.peg.694 Permease of the drug/metabolite transporter (DMT) superfamily
MLTPMTSAAPVQGRLDPLSLGAIVVTLVFWASAFTGIRIGLEHFSPGHLALYRFLVASVT
LLLVMAVTRLPVPAPRDLWQIGVLSVAGISLYHVLLNMGERSVPAGTASLIIAAGPVITA
LLAARFLGESLNPLGWLGTAVSLGGVALIVLGQGQGLGFSAGALLVLGAAFFTSLYFVFQ
KGVLARVGSLRFTVWSLILGTVPLLVFLPGFGTELRAAPLPAHLAVLYLGVFPSALAYLT
WTFAISRVGAGVTSSFLYVSPVFALLMAWALLGEVPGAVTLLGGVIALAGVLLVNTRGRP
Q
>fig|243230.1.peg.1406 Multidrug resistance protein-related protein
MTGAAGLRARVPLRPGTLRRVLAGVLLLSCAEFVRSGLYAGYLPQAASKLLGLPKADAVV
FGASAFTAHFIADTAMRGPAGAALLRFGLRPVVLAGAALSLLALVLMSVTHTGWVLLLAA
ALHGIGFSPLWPAVMSLTTDSAQPTHQGRVLTAVSMSVMPFVGLSVLTLGALADAPRSAV
FGLCLGLLTASLLLSLLLPQRLRTAPAPTQNPAAPTDRRQGVKVAAQALAPLIPAAFLQT
LTMTLLGPLMFTLYKELGLTYWGLVALLGLGGAVAFGSMPLTGKLADQGRARLTVTLGFA
SLALALGGIALRPAVWALYPLAMLAGLGYAFIAPGWAALVAQRLPEAQRPAAWGTLMTVE
NLGTSLGPLLGGFAYRTLGVPGPFIAGSGLALLATLGYVLFRRAFDTPAGGPLDPEVASA
PPSETPQL
>fig|243230.1.peg.1601 Antibiotic resistance protein
MTPMRSPIIWINGPFGVGKTHTAHTLHERLPGSFVFEPEEMGQALRKLTPGFSGDPQEHP
MWIPLMLDALQYASREAAGPLIVPVSISDTARHRRLMSGLKDRGLSVHHFTLIAPLNVVL
ERLRRDGQPQVNVGTVEDRLNELRGEQFQTHIDTAGLGTQQVAEQIAAQVGLTLAPPPQG
ALHWLRGALGRRREN
>fig|243230.1.peg.1801 Vancomycin B-type resistance protein VanW
MSAQADKLAPGLRVGGVDVGGMTPDAALIAVREQTQAKEPKIEVQATGTGKSWTLSAGKL
GYQVDPQASLAAARKLSDARPWTERALGVLGQMNLTQPKAQDVPLVTKVDPAVAQATIGK
LTADLATQPVNATVGFDPKTRRYAVLTPDTPGRKANAEAAAKAFAADPSQRVLKVPLTEW
PAQYTAAELSKHAELGNKLMRGVTVKLDGSDRAGSLGPLQVANLYWVKPEGIVLDDKTLK
GAFESLSYQLDQPAQNARYAWRDGVWGKVGEKPGRVTDPQKGLEAFRKGLLDPTKTTITF
PSVQQQPAIKLADLPSPAKLQLIASGSSTYYGSSAERRTNVANAAAKIDGTVVAPGENFS
FLQSLGGISPENGFVGGLIISGGRTVDGLGGGVCQVSTTAFRALYQAGLPVVERNQHSYR
VKYYEPEVGFEAAVYDPGVDLKMKNDTGAPILIRTVNNNNASRLEIQVWGTKPQRTVSVS
PAVILSRSPHPAPQYVFNPNLPAGASKQVDWAQDGYNLYQWFVQF
>fig|243230.1.peg.1884 Kanamycin resistance protein-related protein
MLSPTPPMTPDVSLKPVLDFTPAEWRTLYSFFRDRELAAWNDAKPIRMPEWLFRRVMQEE
EKTGERAGFGVMDAAGRLIGNAELYDFRPSPPLTATTATLGIMIGFPALWGQGYGRAGVR
ALLHWAFAVHNPALQRVRLTTFGHNRRAQRAFAACGFREVGRRTYPERVDVHMEITREEW
QSGAGADA
>fig|243230.1.peg.2351 Drug transport protein
MVGPSLLMKTSNLPSGKLEVYTFGMTATSPAPEPDASTKGRTKIILFLTIFIAMLGLSVL
FPIIGPLGRQLGLTPAQIGWFSTSYSLMQFIFSPIWGNRSEHHGRRPTLLMGLVGFSVSF
GLFGLFAQLGMNGGLALGTLFALLVGTRIIGGIFSSATLPTAQAMMADISSEDDRAASMG
LIGAAFGLGVVFGPAIGGLLSGISLVAPVYFSAGLGLFTAALAYFMVPETRHPGQTRTAT
VDRRSLLSRGGIPLFLAASALTTLASVGMEQTISFYVQDVMKLDPGETAKTVGKMLAIFG
ILAALVQGGAIRPLSKKLPPTPLILVGLVIMAAGMFLLPQMATYWPITAALALIGVGSAI
LSPTLSAALSLSVGKDGQGAVAGLNSSALALGRMVGPLLGTNLYQHVGHGAPYIASGSIL
AVLFVVMLIARPQVQPQTPAA
>fig|243230.1.peg.2523 Multiple antibiotic resistance (MarC)-related proteins
MDWSEVITLSYRTFLTMLVIMDPVGLAPMFIALARDRPAFEKKRLALKATLVAGGIIFVF
GLFGRALLEHLGISLSAFRIAGGILLFMVALDMVSARQSATRETPEEEREAQEREDISVF
PLAIPLIAGPGTLASIMIQTNAAHGNPILMFAVFLVTGIVLALCYLALRLSNQIAKALGL
TGVNVVTRVLGVLLGALAVQYIADGTLELMRGGLPLN
>fig|243230.1.peg.2573 Permease of the drug/metabolite transporter (DMT) superfamily
MTSHLRGILLLLLVTAIWGSTFAVVKELGALLAPPVLLAWRFSIGALVLLPLAALRRTPA
PTVTVTQADGTSLWSDGMVLGLWLIAGYGTQTIALQTTTANRAAFFTALSVVLVPVWLTL
VQRRRMPAVLWAALPLAVAGLALLSWEGGAWVSGDAWALACAVTYAGFILALEKLASRHA
ALPFTLAQVLSVALVAWGWALLSGAPLWPPQAAWAPLFYLGVVATAGTTLLQTLGQRHVS
AAEASLIYALEPVSAALFSFALIGERVGARGALGGALVVLATVLSSRAGETEPVARVLDS
SQDD
>fig|243230.1.peg.2616 Permeases of the drug/metabolite transporter (DMT) superfamily
MWAMNPVFSGLFSALTYGVSDFLAGLASRHDSPLRVVALSHTLSAVALVLLAVGLGQPMP
GQTALLWGAGAGLLGMGAVVAFYRALALGPMGAVSVGAGALSAVVPVGAGLLAGESLGRL
GSLGALGVLLGTALLSFRPGGAGKEGNSGVGLGLLAGLGFGMFFLLLGQAQSPGVLWVLA
AARATSALLSLMIAASTVGLRPRAPALILAAFPGDMLGSLFYLIAVQGGGLALGALFSSL
YPAFTTLMAVAVLRERLRAAQWVGVGFALVGAVLLSQR
>fig|243231.1.peg.263 Multidrug resistance transporter, Bcr/CflA family
MEITSTAPAFQPADMTRRELARLVLILGALTAFSSMSIDMYLPAFPQIARDLGVPLGTVQ
LSISAFLFGSAAGQLVYGPLADRWGRRTPLLGGLALYVAAAFGCAAVHTGEGLLFWRVVM
ALGGGAGMVISRAVVRDLYDTAEAARMFSLLMLVMGAAPILAPIAGGQLLLITGWRGIFG
FLGIFGILSLAAAAACLPESLPPERRSTRGVAEMAAIYGHLLRNRRYLRYAIALGCVAGV
NFSYISGSPFVFIELNGVSPQQFGLFFGANAFGLIGASQVNRRLLRRFSAQRILNVAFTV
NAAAALLLTVAGFTGVGGFPAQVVLLFVCLCMTGFLYPNVTALAMAPFDKAAGSASALLG
TIQYTLGASAGALVGMLHNGTAVPMTAAMAACGLLGWCAAVAGIPRAQVDH
>fig|243231.1.peg.541 Permease of the drug/metabolite transporter (DMT) superfamily
MIQAQTAAPPHAKVTAILLFTTLMWGGSFLFNKIGMREVPPVHFFFFRFALAALLMGGVC
LPRLARLNRHIAVRGAVVGLALAAVNLTFVLGVSGTTISRAGYLNNLFVLFIPLLTFALW
RERVDRVTFGGIALAVVGLWALASGGAEGFNQGDLLSTVCALFIAIHIIAVSRVLRDEDV
YLVTFVQFVTVAAVGLVLCLVLPWPEFTIGRAGAWSLAYCALFPTVICFTLQNAYQRFTT
PTRAGLIYTLDPVWSMLFGVFILGERLTPRELAGCVLILMAVAGPLLARLYLEQRHRRLY
RLDGAEGT
>fig|243231.1.peg.1143 Permeases of the drug/metabolite transporter (DMT) superfamily
MFKTVIIMLMAVSAGTIGDILLAKGMKELGDLSAMNLRGILNVAGQALTSPKLIFGTAML
AIFFFLWLAVLSWEDLSVALPMQALNYVLVAFLSQWFLGETVSPLRWTGTIMVCVGVMLI
TKSGTP
>fig|243231.1.peg.1470 Membrane fusion component of tripartite multidrug resistance system
MTTEQELPDRGENREAPSAQTAPQGKGSGGKRRRAGIFLLILFVVGAVIGLRWLVHGITY
ISTDNAFVESHIHAVSSRVPGTVAAVYVTDNQAVKKGDLLAELDPSDYRTRVSEATAALA
MARNETSGDYAQVEAARAAVDHARARLAQADLDLTRGTALLAKEVIPREQFDRLETAKRV
AVAQVREAEEQMRKAQAEIGLSGSGSREARVALRDAQLATASLNLSYTKILAPADGYVTR
KSVEPGNTVQAGQPLMAVVDLDDVWITANYKESQLTHMKPGQKVTFTVDAYPGRTFSGRI
DSIMAGTGAAFSLLPPENATGNYVKVVQRVPVKIAVDRASDPGHLLRVGMSVVPSVDVER
SLGDILHGLWPF
>fig|243231.1.peg.1471 Outer membrane component of tripartite multidrug resistance system
MKPLPIRSIPFLILALCAATPAMASALSLKECLSLAAAGNYSLAVTASDRLIAQEAITQA
RSGFLPRVDFQGGYTLQAKPQAVNFGERGSIETQDGTYGFFNLSVTQTIYDFGRTSSRRQ
RASLLHEATAQQYAAAEKDVFLQVVEAYFGILEARRLLGTAEEEVAQRTDHLRIATNLFE
QGVVTRNDLLQAQVRLAESSQKRLVAANRLENRWMYLNHLTGRPLDQRDELEEGTESAMP
DTAGAEERAFANRPELTALARSADAADAEVSEARSGYYPELYAKAGVDYVENSKVREQAI
YAATVGLKINLFEGFATESRHRQSVERLTRSRDALRLAREQVRLELATALNDARVAEQRI
KSVETAIRQGEENLRINRDRYQAQVGTATDVLDAQTLLTQIKTDYHRAVFDFQVAKARVS
KAMGEL
>fig|243231.1.peg.2537 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MKISFVIPVHNEQDNLLPLFDEITRMADAERYEYEIIFVDDGSRDNSLQVLKSLARGCPA
VRYLSLAANRGQSAALGVGFAHAAGDVIITMDADGQNDPADVPAMMARYGEGCDMVTGWR
RNRRDTLSKRVGSRIGNGIRNRLTGESIHDTGCSLKVMRADMVKRIKMFKGMHRFLPTLM
RMEGARVVEMEVNHRPRRHGTSNYTNWRRAREGFFDLLAVRWMQRRYQPATIGEKHV
>fig|243231.1.peg.2541 Polymyxin resistance protein PmrJ, predicted deacetylase
MERPTIAIKVDADTFVGTRDGIPRILDILGRFGVKATFYFSLGPDNTGKAVRRIITRRGF
LRTSLRLNAPALLGPRTLLSGLLIPPPIIGNRLADTIRLTARLGHEVGIHGWDHVKWHDL
LPWIPKKMIALELGRACALFEEVMGRRARTAAAPGWTVSADSLEIQDSMLLSFCSDCRGR
TPFYPVVDGRRFGTLQVPTTLPTLDELLGGGIATEREAVDRLMGLVGPGLNVHTVQAEIE
GKRYAPHLASLLDRLTGTGARFVTLGEAADEAKRATVPVCRLTMEEIPGRPGRVAVQGEE
WSEPGPAAGEP
>fig|243231.1.peg.2647 Acriflavin resistance protein
MILSDLSIKRPIFATVMMLVLVTLGAFSYRLLSVEMYPNVEMPVISIVTKYPGASPETVE
REVSKRIEEAVNQIAGVKHVVSTSRESVSTVVVEFRLEERTNEVAQEARAKVNSVRGQLP
AGIEDPIIQKLDFNALPVAALAIQSKTLSQRELTTLVDKRVRKRFESVAGVGKVEMVGGA
KREVNVQVDPVRLESLGLGANDVVRGLQNENVNTPLGRITREGAEYPLRIDGKPDLVGGY
RSMVVAQKGGRPITLGEVAAISDGVEERRTLALVNGVPAIGIDIYKQSGANQVQVVDNVR
KVMEKIRKELPPEVSLTLVRDSSIMTRQSLADVEETLIIGGILTVIIVFLFINSWRSTVI
TGVTLPISVISSFIIMNAMGMTLNVMTLMALSLSIGLLIDDAIVVRENIVRHLEMGKDHM
EASRFGTSEIGLAVFATTLSILAVFVPVAFMRGIVGRFFFPFGITVSFAVLVSLFVSFTL
DPMLSSRWHDPAVHAHGKRRGLARWLESFNDWFDRAADRYRLAIAWALDHRRTVIATAAL
TFFLGIAVMGTLESSFMSEEDTSEFQVSFKAAPNASITESEGRLKAMLAAIGDIPEISHT
YSTIGAGDGGTVRDGLLYVKLREKKERERGQFEIERVVRQRLQQIAGITFSIEKVGNVGG
AAKPLNVNLKGDDIGLLKSYAAQLKEKMYAIPGIVDVSATLEHDTPEYRLRVDREKALSA
GVTSNDVVTALSRLVGGEAVTTYEDEDGDAVDVRVRLPEVLRQNPAQVRDLKISVPDSDG
GTKLIPLASVSTESVAATPSEVNRRDLSRLVTVSANLDGLPIGTAVKKVEEVSKTIAMAP
GYSIGFSGEAEDMAESFGYMGESLLLAVVFVFLILAAQFESFFEPLAIMLSLPLSIVGMA
GMLKLTGDTINIMALIGLIMLMGLVTKNAILLVDYAKVLRRRDGLPRREAVIEAGRTRLR
PIVMTTLAMIFGMLPLFLGIGAGGEGRAPMARAVVGGLITSSLLTLIVVPVMYTYMDDLA
VRLRRWWLGNAEGALAVGPASDGLVASILKKARGISLKKFFGVFACLITLGTGAFSAEAA
DIRVLTLDQALAMADERNRDIAKAREFFRQVEGRYVEERSAALPQFTITGSASWLDDRSQ
KALAGGFIPTRQDVRAAGVELSQALYTWGKVSAAIRAADLGFRTADEQLRTARQDARRDV
AVAFYDILLAREQLAISRQNLEQKERHLDEAQRKYAAGVATDYDVLAAGVSVENARPEVI
RAENLTRLATDRLRYFLALDQEIEVEGALSFEPATVPSHAEALAVARRQRPELEELRRRI
DMAGELVAVADAEDKPRLDLKAGYGWRQLETGDGRGDGAAWNVGLYLSFPVFDGLKARGK
VAQAESERRSLRIEEAKLMDSVSLEIRDAVNNVREAREIVSALEGTVAQAERLLTMAEQG
FELGVKIRLEVDDAELNLRQARGNLAKARRDYLVARVNLERVMGVLGEEGADQNKM
>fig|243231.1.peg.2660 Permease of the drug/metabolite transporter (DMT) superfamily
MALESLHTTRQDRVSHSLVGPRLAGAAFVAASAVGFGALGIFGKVAFASGASTAVVLFLR
FLVAGVLMAALMPVLRLSWPRGRDLWILVGMGAIGYVGQAFCYFTSLRYASAGLTALLLY
LYPALVTLASAALGRQRLTPLKVAAVAASLIGILLTVADGLTGSLSGIAFGAGAAVIYTG
YILVGEQVSRRTGAIPAATVIMLAAATVYGCAVIWQGPHWPTGLAGWGAVVGIALFSTVV
AMVGFFAGMQRLGAADAATLSTLEPVVTLVLAALILGESLGGVQLAGAALVLGAVVALAR
AK
>fig|243231.1.peg.3385 Permease of the drug/metabolite transporter (DMT) superfamily
MNKAKAIVALLLTTFFWGITFTIVKDAVAQVDVFVFLAQRFLMAVVLLVPFCACRRVPLT
MQTVRHGLFLGLFLFGSYAFQTMALRFTTASNTGFLTGLSVVLVPMLGALLFRQAVSQGI
KWGVALAVPGLFLLCTNGAFVLNIGDMLAAICAVCVSLHLILTGKFARDNDVWWLTAMQL
STVALLSFLVAEVGGHRTMAWHPEILWALLICAVFATVFAFLVQTSMQRFLSPAHTALIF
CLEPVFAALYAFWAADERLGTLGYLGALLILAGMVISELAPSGESPEASTAT
>fig|243232.1.peg.731 MATE family drug/sodium antiporter
MKNVEILLDDPKKAVIEVSKPIIVATFIESIYSLVDSIWVSGLGADALAAVGASFPILIS
IYAVSWGLSIGISSGIARRVGAKNKEEADKVANHAIILALIAGILYIIAVYPNLDTLFSL
MGTYGDCKSLAIKYSSILVLGTVIFTICDALYGIFRGEGNTKIVMIASVIGTLTNIILDP
IFIYMLNLGISGASYATLIAIIISLLILAYELFIKKSCYVTVKLSKFKPDLKIIADLIRV
GIPSALIEITVAVSFFIMTSIIMMVGDSRGLAVYTGALRITEFGFIPMLGLASGATSVIG
ATYGARSFEKLKTAYFYTIKIGVLMEIIIVALIMLLSPILAYLFTYTKTSMGIHEELVKA
LRIVPLYLLFTPFILTTSAMFQGIGKGEKSLIISIFRSLICHISYAYLFAVILGLGMFGI
YSGLVVGEFTAGIFAFLFGVLAIKALIKSK
>fig|243232.1.peg.1004 Multiple antibiotic resistance protein MarC
MVGYSGEHFIFNVVKYMDILNFYIYGFVSLFITIDPIGLIPIVHSLTYPYPKEQRIRIIK
KAIISSTVVLLLFALFGNYIFGYFGITIDAFRVAGGILLFKIAWDMLHAEIPKTKHKPDE
RLDLEDIDSIVYVPLAIPLISGPGAITTTMILISKTQSILEKGVVVLSILSAMLVSGIIL
SLTDFIIRRVNIYGINAFVRIMGLLLVAISVQIIFTGIVGLYNSISVQ
>fig|243232.1.peg.1354 Multidrug resistance protein
MVRKVAEQNLQKNNENDRELSKNVYLLGFTSFLNDMSSEMIMPILPMLITSVGGGSLSIG
LVGGLREFISNILMVLIGYCSDKVRKRKIFVVLGYLTSSMFKLLLGLSKSWLGAVIFSSL
ERMGKGIRTAPRDAIISESMPKTLGKGFGIQRAFDTAGAILGSTLSLLFILYLQYSFNQI
ILIAAVIGFLTLIPLYFVKEKPSPSNNKITFRVGIKNLPKELKLFILISAIFTLSNFSYM
FYILRAQEFLMIVDEKMAIIIPIALYILYNIFYATFSIPFGILSDKIGRKSVLTIGYIVY
GIVSLGFAYFISQKSLILLFALYGIAYALFAGNQKAYVSDLSSEDIRATALGLFYTVVGL
TSLPASLIAGYLWKISPEMTFLYGSVLAIISGLLLLFI
>fig|243232.1.peg.1724 Multiple antibiotic resistance protein MarC
MDLQYFILAFSSIFSILNPFGAVPVFITLTESYPKKERDLVAKKTVIYALAILLAFALFG
EWILKFFGISLDAFKIAGGILLLLISLDMVRGQQEAKIHRKEIEAAYEIDEIALMPLATP
LLAGPGSITACMVAMAEASDIGDKFLVILAILLSLGITYLTLLSAESVLDRIGRLGIRIL
TRMMGLILTAIAVQMIVNGIRGALL
>fig|243265.1.peg.177 CpmF protein involved in carbapenem resistance
MKYIYLFLSIIMSSKAYSFDNMKLSFVEGGDFYVGSVFGAQNYESHSNVTLNSFYIMKNE
VTYSEYKEVYEWAILNGYDFDDGCNGSHYEDCLPPEQDEGRHPVTSIKWLDTILFSNALS
EKLKLTPVYFQKGNKIIRKKDKNLEIFINTNANGYRLPTLNEWHVAARGGEPALRLGRYG
YYHSGSNDSKKVAWYPEFNTSNFGTQVVGKLSPNDLDLYDMSGNVSEWVYDSYELGTVKL
YYFCGGSYLSHANSLSSCDNHSSGYIMPDVGFRLVRSYLNEK
>fig|243265.1.peg.178 CpmG protein involved in carbapenem resistance
MKNKFYLIFILLFSFEAFSHCGNKVNLKDGINLIDLNGDGKKDVIFYAKFENNTSHPSNT
LTVFIKNKNGKFNIVPLPNDTGFTWFDFKLSASEIKIQDYELGVKNGVYYIIFFRKKNND
DDIFGEYPVEFIKYDIKYNNEVPGISNYYWDYTKSYLTKKKYKNVSDAMTEYNMECSL
>fig|243265.1.peg.1331 Multidrug resistance protein B
MKNFSLSNYTSIPACIWGLFLGTFVTRSTSMMVWPFISIILYTKFHFTASMIGLVLSLSI
AISSILSFYAGYFSDKVGRAKIIIIGCLISSLAYLILWLSEHQSGFIIGTLLANISWALV
NNPIKAVIGDIIEEKQVRENAMYLRYLFLNAGAVVGPYLGVKLSLDINSISFLIVSLSYV
IFMIPVYLFGKKIKIKLTNNDDFKGTMKVLLNDRVFLMLVINNILMMFIFGHFDSTLPQL
ITSLGFNGYAEFIASLIMLHAVTIVVMQLPFSILTQKMALETKINVGSVLLILSEFMFFI
SFKYYDVYLLWYVAAFIMSISQTILFPCVNVFIDRLAPNDLRGAYFGAASLYSIGFSISP
LVGGTVIQLFNGGVLFQLLAILSVLMLVIFCRMFKLRDKHEINIRRSLKS
>fig|243265.1.peg.1433 Multidrug resistance protein 2
MRMLVGATSTIFILNHGLTLVDIGLMKTIQSFIYFLFDIPSSYLADKFGRKFAIILSTTF
GGVWLIITGIADSKYLFYIAEIFNSISLTILGGVFYSYLIDNSLNDNDTHKILGESNKLQ
FLFMAIFSIIGSLITDFDDRLVWLIAGSGCIILSVSLSWFLPKSITKNRQPNLSFLKEIK
TSIAMLKDNKNYLFITSISLSSSLLYFQIILQYWQPLINYIIEELGVSIFFGIVFSAILL
SQSISGWIISKNEDNNKNHLYSIVILLVCSLTCIYGVYEKNHITTISTIIMFGANQVMTT
SLRSNYHQIIPSELRSTFDSFISTITRLIAVIVIPLIALITENFGWIYFPILISLIISIN
ILCYFFIKKHHKRKPTWNPKS
>fig|243265.1.peg.3357 Probable multidrug resistance protein norM
MAKFSNWRELKQLLFFSFPIIVSQIARTAMSFVDIVMSGHYATADLAAVTLGSSIWFPIF
VLGYGTIIMLAADVAKQKAQHDDEGIKDSLKNYLFLAVILSIPIIILLMLVSWLLSFIGI
DEHILEITQGYVIALACGVPSVMIFNVFRSFLQGLEDTKIAMYLSAGALLLNIPLNYILI
YGKLGLPEMGGIGAGITTAIINNLIAVCLIIYFLLKKEYRRYRPDFSLPKYNSLIRTFYI
GMPSGLALFVEMVFLDVIAITAAPLGAQVIAAHNIMLNITSIIYTITGGIAAAVTVRVGS
YIGKRDKISLTGTIKISIALILSISAVIGVLIYYFAGSFISLYTNDNGVIIIALNIIFLL
CLFQFFDSCQAALSGILRGFHDTRSVFYAPLFGYWLVGLPLGFILALTDWVTERMGIIGF
WYGLVLGLFVNAILLFIILKVRQRGMISRLISY
>fig|243265.1.peg.3899 Bicyclomycin resistance protein
MKNKSLLFIVLMAFLSMGGLVSSDIFLPALSKMGNYYHVSESSIQSTITIFLFGIAFSQL
IYGPLSDCLGRKTVLISGMIIWLISTIGIFYSTHISELLLLRLFQGIGACAGITLSRAII
SDLMEKEEAANLYLIIFPFVGMSPAIAPMIGGMLSEYYGWRSCFLFLTLFITVTLILCLL
VLKESLPINKRQKLSIKNVLVSTYQVIINKEFLYYAAIPCFAYTAYFSYLIESPFILTAM
GLPEKYVGYTYIMLSLSYVLGNLIAKKLSRRQGVRKTISHGYLIFVVGGIAFTIQMFFSS
YPLITSVLTISVLTFGNGFLLPLGTASAIATHSQAAGTASGVMGTLQLGSAGLASLFIGY
ISHHEPIKVASIITVVSLVGSIIYITGNRGGKENK
>fig|243265.1.peg.4055 Bicyclomycin resistance protein
MPPLILRLLPIILIIGMVPSFIEVDITLPAFPQMLNFFSAAESAVQFTLIVNFLGLCIFT
PIFGPLSESYGRRKIILIGATLFFIGSIGCSTVVDLNQLYLFRFIQGAGCSAIWIVGFII
CSDIYKDEESVQVFGILNAAISMALIIAPIAGSLIVAHYNWRFTYHLVALLSFLSLMAVF
IVPETNRNTVKLSVNKVIKNYCQLIFNTRFLIYSFTPGLLVSACIAYVSVVPFLYIDKMG
MSYYIFAVHQAILGICLSVAGFYSGALNRKIGSANCIYLSIIICLIGCGSLMIFSHIYPE
SAILFTLSMAVICIGSAFQYSMVFSRSLALHPELVGSASSLLTFFRLIFFSFSVLISGWA
FTGKLFNSAIVVSSIIAMGLLFSLFVLIDLRNNVVNRRINDESHVS
>fig|243274.1.peg.283 Multidrug resistance ABC transporter ATP-binding and permease protein
MKTLARYLKPYWIFAVLAPLFMVVEVICDLSQPTLLARIVDEGIARGDFSLVLKTGILML
IVALIGAVGGIGCTVFASYASQNFGADLRRDLFRKVLSFSISNVNRFHTSSLITRLTNDV
TQLQNLVMMLLRIVVRAPLLFVGGIVMAVSINVKLSSVLIFLIPPIVLLFVWLTKKGNPL
FRKIQESTDEVNRVVRENLLGVRVVRAFRREEYENENFRKANESLRRSIISAFSLIVFAL
PLFIFIVNMGMIAVLWFGGVLVRNNQMEIGSIMAYTNYLMQIMFSLMMIGNILNFIVRAS
ASAKRVLEVLNEKPAIEEADNALALPNVEGSVSFENVEFRYFENTDPVLSGVNFSVKPGS
LVAVLGETGSGKSTLMNLIPRLIDPERGRVEVDELDVRTVKLKDLRGHISAVPQETVLFS
GTIKENLKWGREDATDDEIVEAAKIAQIHDFIISLPEGYDSRVERGGRNFSGGQKQRLSI
ARALVKKPKVLILDDCTSSVDPITEKRILDGLKRYTKGCTTFIITQKIPTALLADKILVL
HEGKVAGFGTHKELLEHCKPYREIYESQFGNGVMNDA
>fig|243274.1.peg.284 Multidrug resistance ABC transporter ATP-binding and permease protein
MPEIRRRPHGPILEKPALKNPTATLRRLLGYLRPHTFTLIMVFVFVTVSSILGVLSPYLI
GKTIDVVFVPRRFDLLPRYMLILGTIYALTSLLFWLQGKIMLTLSQDVVFRLRKELFEKL
QRVPVGFFDRTPHGDIISRVINDVDNINNVLGNSIIQFFSGIVTLAGAVIMMFRVNVILS
LVTLSIVPLTVLITQIVSSQTRKYFYENQRVLGQLNGIIEEDISGLTVIKLFTREEKEME
KFDRVNESLRKVGTKAQIFSGVLPPLMNMVNNLGFALISGFGGWLALKDIITVGTIATFI
GYSRQFTRPLNELSNQFNMIQMALASAERIFEILDLEEEKDDPDAVELREVRGEIEFKNV
WFSYDKKKPVLKDITFHIKPGQKVALVGPTGSGKTTIVNLLMRFYDVDRGQILVDGIDIR
KIKRSSLRSSIGIVLQDTILFSTTVKENLKYGNPGATDEEIKEAAKLTHSDHFIKHLPEG
YETVLTDNGEDLSQGQRQLLAITRAFLANPKILILDEATSNVDTKTEKSIQAAMWKLMEG
KTSIIIAHRLNTIKNADLIIVLRDGEIVEMGKHDELIQKRGFYYELFTSQYGLVVEKE
>fig|243274.1.peg.580 Permease of the drug/metabolite transporter (DMT) superfamily
MILERFFAWLVVVFWGISFLATKVVVQVLDPFFAGFLRFIFAFFFLFLISGGRPKLFNKN
IVMAGFWGVFSYFAFENSALMFTEPTNAAIIVSSAPVFFLLFSHLVQKKKTTSKMYLGVI
LSFLGVALVVLNGRFVLKLNPLGDLLAFGAALSWVFYTHHIESLGSLSFRENAGIMFWGV
VFFLPFSAGKFQQIREMNSIVVISLLYLGLVCSGLAYFLWNKAIERLGSRTTTNMIYYIP
VVTAVAEHLLKLKLPSALLVGGVVLVVIGLLIFEREVHYETEDSTRGMRKDRTEETRPSA
D
>fig|243274.1.peg.721 Permease of the drug/metabolite transporter (DMT) superfamily
MWRENKALAFLVLTAVLQGSTFPLQKLVLGGVSPFVYNTVRFGSAALLSLFVFGPGRFVK
GFLLGLVLCGAYIFQLWGLKFTSAVKSGFIVSSFVFLVPLFAFLLEREKLRKIHFISFTS
GFLGLYLLTGGVSQITLGNLFQFFCAVLFALHVVLITRFSRSEEEKNMLFWQFVTVGAVN
FLFGLGERWHLNLEAISVGIYSGVFATTLGILWQMRYQKEVGNNTTALVYMTQPFVSLVL
SFLLLGERMSFLQLLGGILVLVALFTGTTLRPRESN
>fig|243274.1.peg.1007 Permease of the drug/metabolite transporter (DMT) superfamily
MDLRVLLSGLAYSTIFGLSFLFTKNALDYVTPLTFLSFRFIVAFLSYLLLLITGAVKLGK
KPYWKLWKLVLFQPVLYFLFETYGLQRVNSSEAGMIIALIPIVVNLLAPFILKEKGDLLH
YLLVGMGFLGVSLIVGFNITPGNIVGKVFMLLAVLSGAMYSVFSRKFSKEFTPTEITFFM
MMTGAVFFTLLSLSTGDFRPVFNVDVVIGALYLGVLSSTVAFFLLNYAIRKLSPIFTTLF
SNFTTVVSVIAGVVFRNETVGIQQIAGMGLIISSLIIMSLRRSYKRLSRAQKL
>fig|243274.1.peg.1705 Permease of the drug/metabolite transporter (DMT) superfamily
MVKALFSLLFVAFIWGSTFPIQKIVLVGVSPTFYIAVRFFIAALVSYFLFGKGNVKYGSI
LGTLLGIAYTTQTWGLTITTSTKSGFITSMYIVFVPVFAYLLEREIPTIFQIVSFFAASL
GLYMISGGIKDFNFGDFLTLICAVSFALHVVLITMFSKRVKEVDLLFPQFLVVGILNLIL
NFFWKNWNFTLPALGSAVFTALAATILAIYLQAKYQKALGNNVSAIVFLGEPVFAAVVSY
FMLGETMAGKQLLGAALLLISMLFSSLERVKIVRDANQKGRDECEDSL
>fig|243275.1.peg.330 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTDKREHLISGNMFKLMLELSIPGIIGMFVISLYSFVDAIFVGRYVSSVALGAVSLAYTF
TLINNGIAVLVGIGSASVLSRAVGRSDQETVDSIMGNVLLLTLLFSLGTMTIGLIFAPQL
LILIGAEGEMLRLGVSYLRIVYIGSVFVNFGQAANMVMRGEGRMGLAMLLMGISAVLNII
LDAVFVIVLKKGLEGTAIATVISQVVLAICNFCYFAFFSKNVKFKHFKLQKSIVKETLSI
GFSAMLMQVFALLQQAVMYSTLKRYGGEDQVILMGAFFRYMMLSFIPLWGISQGYQPFAG
TNFGAQKFERVKKGTFLFYGFGLFLSLIFWLVFLIIPEQVLGLFLKNKELISLGRTNAML
AMSLFPLSAIMIINLTLFQALGKAKYAGILVIARQFLLYIPAVLILPVFFGTRGVWISTP
IIDTLVTVLSAFIVIKLFKKDLSPKDKPLSA
>fig|243275.1.peg.347 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDSKELRRFNILTKPIFPLLVKTSIPTIIGMLISVIYNLTDTFFVGRLNNRAMIAAIGIV
FSFVSIIQAIGFWFGYGSGNAMSKKIGEQDYAEAETISSVGIVFAIIIGILIAIGASIFI
LPLSKFIGGSASQDVLTFTVQYLRIIIISIPFSLYALTVYNQLRLCGNVRDGMVGLLSGM
LSNMVLDPVLMFIFKQGFIGAGYATLIGQIIGCIVLTLLAKRHESISFNLKKVQYSKERM
YHILAGGMPNFSRQAITSAALVLLNVKAAQYGESMIAALTVSSRVAALAYMIMIGWGQGF
QPICAMNYGAKQYSRVKKAFITTVLIGTIFLTAASIILFLFAEQCIGVMSKDDEVIFAGI
KILRMQCFSLPLLSFFAVSSMFMQNIGHYFSSLLISISRQGFFYLPLLYILPALYGKTGI
YLLQPFSDVLSFLFAVAVVYRWYSSGAFSSALNAG
>fig|243275.1.peg.669 Permease of the drug/metabolite transporter (DMT) superfamily
MNKNIIAIIYAVAAAAFYALNVPCSKILLQNISPVFMAGLLYIGAGLGVGILYLFNFKKE
QKSERLDKNYLPYTIGMIFLDIVAPILLMLGVKYGTSSNASLLGNFEIVATALIALIIFK
EKVTWRLWIAIFFITASSIILSFENIEGLNFSIGSLFVLGATICWGLENNCTRRMSDKST
YQIVTIKGLCSGFGSIIVAFVSGETDFTLKYIPFALLLGFVSYGLSIFTYIRAQKYLGAA
KTSAYYSIAPFIGTFLAFVLLKEKISTKYISALFVMIIGTAFAVYDTLIRKHLHGHRHTF
THTHNGITHTHTISHSHLHNHFISDSKHGHHHSIEELENELKNEIGK
>fig|243275.1.peg.804 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENEKQKEFILNGNLWKVIFDLSWPAVIAMILLGANNVLDGIFVGHFAEEGAFAGISVAL
PPIITIIGLGILIGSGAGTLLSIAIGAEDKNIQKKILGNVNFLTLIISVIVMTLGFLFSE
QTLFLMGGRGNALIHGSKYYRTILWGTPIWIYAIALNNLIRSEGKMKTAAAIMGISLIVN
GCANYTLMVIFNFGIKGAAIGTNIGMAVQAIISTLYFAKKNPDSPVSVFTIRIDGEIISK
IISMGLASFIMQFMGTIQMLLVLNVLNHYGSQDDIAFYGIITRIFSFILQTIGGFMIALS
PIIGINFGADKTERLISAFKRFVFAALILIAPLWILILIFPQTSVSLMMKNPHLSIHNIS
YFRIYMALLPVMPLVFFALAFFPAVNKGKISSILGILQQIVFYIPIMLILPIFIGIAGIY
YGTFLIEILSAIPISILIIREFRLLRSGITKWQKN
>fig|243275.1.peg.1869 Permease of the drug/metabolite transporter (DMT) superfamily
MSFKLKSGSRIRILSRLALLSATLLWGSTFVAVSSTNDFFKPNFLLACRFLPACLILCAV
FFKRLKQLDKRYVKAGMILGLIMFAGYSLQAIAITTAGGLPGRSSFLVATYCVLVPFVNA
VVLKKRPDKFNLFAAFLCFAGILAISMPDLISESQKGINWGDVLSLISSFIFAVYIVLLP
KFMEELDVPLITLTQFAFAGTYALIFSLLFEDNSNTVWNYQSVFTLVYLTVLCTALCVLL
QAVGQKNTPPTTAALIFSLESVFSIFLSIMLTDEKFTPALALGCSFIFIAIIISETKLSF
LKKKSVEVNC
>fig|243275.1.peg.2452 Permease of the drug/metabolite transporter (DMT) superfamily
MFQHRTIFCLYKFRLVFFFVFLYNADLSYNTPFQKGKLVPGLFEAFCICRFTDDAKEFIL
TNTKINVLSRLALLIVAIVWGSSLVVVSETTDFFKPNFLLGLRFSIACFLLCLVFYKKLK
LIDKDYLINGGIVGFFLFIAYSSQTFGVTTAGGLPGRSAFLSASYCVIVPFLGWLVNRIR
PDRYNASAAVLCILGIGLVSFKDLVLSSSVGITLGDFYALLSGLLFASHIVSITRLSKRK
DPILMTIIQFGAAAILSWLVTLIFEDNSAIVWSYSSVGSVLYLAAICTGLALLLQNIGQK
HTDASSAAIILGLESIFGIIFSVIFKGESLDVYSVFGFILIFIAIIISETKLSFLKKEKA
>fig|243276.1.peg.983 Multiple antibiotic resistance protein MarC
MLCMLEMDSARQRFVRDVEHIRHEDMHEMGICARRGFTCSDTHPHRKRHSQKKCCTRAVP
TQGNGDCRTRGSSRILTPRMSTWTHIWSTAFTLLFIIDPIGNIPVVLSVLRTVPAERHTR
IIFRELLLGLVLMLSFLFCGKVFLSLFQLETGVMKMAGSVILFLVGIKMVFPDQHALPST
TEEEPFIVPIATPMIAGPSAFTTLVIMGETKGTSRLATCAALLVAWTLACLIMISAPCLY
RLLKEKGITALERITGILLLILSIQMCVEGARGIIATS
>fig|243277.1.peg.1393 Outer membrane component of tripartite multidrug resistance system
MKNSVQTVGLLHKAAPYFTASLLSAFVLTGCSVPDHYPDLATMWEANELSSTNTFSHQAE
MDWPSANWWQRYQDAQLNHLIEEALQHSPSLEMAMARLKGAQGFARQAGAIRSFDLGLAA
SATESKVSERYQSATPPDGWNDYGTLTLNFQYDFDFWGKNRAAVVAATSELAAAEAESVA
ARLMISTSIANAYAELARLYANQETVHAALQVRNKTVELLEKRYANGLETLGSVSQAKAV
AASVEAELLGIQESIQLQKNALAALVGQGPDRAASIEEPHITLTSRYGLPSEAGVGLLGH
RADITAARWRAEAAAQQVGIAQAQFYPDVTLSAFIGYQAFGLDHLFDSGNDAGAIGPAIY
LPLFTGGRLEGQLTSAEARYQEAVAQYNGTLVQALYEVADVVTSSQALQARINKTEQAVQ
QAEQALHIATNRYQGGLATYLDVLVAEESLLNNQRALVNLQSRAFSLDLALIHALGGGFE
TTES
>fig|243277.1.peg.2832 Permease of the drug/metabolite transporter (DMT) superfamily
MSLVNLLQLLCLAAIWGGSFLFMRIAAHSFGPAYLIEARVGFAALSLFLVAQLLRRSLPI
RQHWPHFLILGLINTAVPFLLFAYAALTLNVSTLSILNSTAPIWGAVIGFLWHGTPLSRK
AVAGLLLGVSGVAVIVGWDMVAIGHHAALPMVCAALAAASYGLATNYTKQAPQLSAFENA
HGSMWAACLWVAPLMWFVPLRETPSSLEWGAVILLGVICTGLAYLIYFRLVKAIGAASTL
SVTFLIPVFGILWGYWILDEPIGLNTLFGTLLVLAGTMLVTGFSLRNARLSRQPQPH
>fig|243277.1.peg.3688 Permease of the drug/metabolite transporter (DMT) superfamily
MPNHVLPVLFMLLSTFSLSLTGLLTQYLSHIIPITLLGFLRFIIPALFLLVAMKLTHFRW
PQRNMWFSLLIRAVCIAGSQLCFIYALQSLSLVESVVLFSTGPLFIPLLEKWLWGGQLAW
RTVLSVCIIFVGVVMLAGNTGSIEWRPELLAGLSAGLFNAGSQLSLYRAAQSDMRSIEIH
GWTFLVAALLLSPLLLLVPWSSDVGASLGMSWDISGAVTFAALLLSAILVVNTQVFRAKA
YRLAKSGSQLAPLIFTNLLFSALWQVLFFDVDYTLAQQVGLAVIIVTTVINGILPRLTER
KTRLKSA
>fig|243365.1.peg.122 Probable multidrug resistance protein
MSHSSLAVRQSNPATAAAILLILFNPLGVDLYLSALPALQRHFQADVSASISVFVFCLGL
GQLLFGPLADRAGRRPVALGGLLAYALGSALASLSDSMGSFMLARMLQGLGASASSVCAF
TIIRDCFSGNAASQRYSLLNGALNIVPALAPALGGVLTELYGWQSCFLFLAVSALAALAL
LSRLMPETRPERLEDAAGPGFLQVLRHPALLRNGACSSTALGLIVSYVTLAPTVLIERGG
LSAATFGLLFGANALLIMAASFVGLGLIGRLGPRRVLKTGLAIMLAAGALLPALAHQAGA
WHYMLPVAVLSVGFAFTLGPAAGLAMAPFAESAGRAAALLGCAQMLFASALSALLAALPV
AGELALGGAVIALSLLCLALQWRAPARG
>fig|243365.1.peg.219 Permease of the drug/metabolite transporter (DMT) superfamily
MRVAAPAFGPLPLIALRVGLAACLLLPLLLWRGLWPLWRDNWLPVAAVGVFFTAFPFSLI
AWAQLSLPAGMASVLNATTPLMTALWAWPLAGERLSPRRMAGLGLGLAGVLALLAGHGAR
FEVRSLAPVLAMLGATASYGWAGHMARRWLPGMPPLVTACGGLASGALLMLPLAWLSWPA
LPPPPQAWTALLLLAAFCTALAYLIFYRLINRLGATRASGVTYLVPVFGVLWGALFLGEA
IGAGMVLGAALILAGVLALNARR
>fig|243365.1.peg.719 Methylenomycin A resistance protein
MPHAQSVRTGLPTLLALSAGMFMAVLDTNIVNLALPALLRSLDASLSQLTWIVDAYALGF
AGLMLSAGWLADRFGPRRMLAWGLALFVLASLLCGLAPGARTLILFRLLQGMAAALFIPS
SLGLLRHAFPHPAERARAVGLYGGLSASAAAAGPVLGGLLLAPLGWRGAFLINVPIGLAA
LLAIPFVVPHRQAMPTRGADLPGQAAGMLTLLLASYALIEGPRLGAPVLFALLLAVAGCG
RLFWQLENANPQAMVPPELFRNPVFAAANWVGFAIGVAYFGTLLLLSLYLQQGLGLDALH
AGLAMLPLAGCLIIGNVAAGRLLPRLGARRQIRGGLLLSAAGYLLLALADGHALAWSLLA
MLPLALGTALAIAPMTATVLESAPPHLSGTASAVLNAVRQTGALVGAAGAALAVGYGADL
RHALAIGLSVAALASLSGALIAGWIPRAGQQAAPEPAPAAR
>fig|243365.1.peg.768 Outer membrane component of tripartite multidrug resistance system
METDKVNKKSWPQTAGVLLISAVLSGCASFGPDAAPDQMVGADQLKLAVAGQQNVRADWW
RQLNDPELDRLVEATLKDAPSLKLAAARLRQARAAVGIVESKDGPQLDAMANAVQIHADP
LKALPHNDKDYINAYTAALVGSWEFDFWGKNHAAVSAALGQQQAVAYEGQQTRLLLTQAV
VAQYTQLQRSLAQSRLLSQRLAIAQSRQKLTQARVNAGLLPGDNQRGNEVSIERLQQQQS
ALDNDIARSRHALAALTGQGPQQQDSLNPGKLDAAPQPALDKLDANLLGRRPDIAAQRAR
VESMTASVKEARAEFYPNVKLTVFAGQSSLKMDQLWKSESSLWGFMPAISLPIFHSGQLQ
SNLSKQQAGYDMAVQQYNQTVLDALRDAADAVSGWQNSQRQLQQSERALQSSRKANDSMA
ARLRAGLVNKLSLLDSQDALLSQQSANIDAQAANRLAWASLNTALGGGFDNQAASR
>fig|243365.1.peg.771 Multidrug resistance transporter, Bcr/CflA family
MSRTSRNHFGLAALLAALSTLGPFSIDTFLPAMRAIGDTLSASPLEMQQALTVYLFCYAL
MMLWHGSISDAVGRRPVVLATTLLFGLASVGCALSNTLGQLLLFRALQGLCGGAGLVVGR
AIIRDRLEGAAAQRLMSQVTMLFSLSPAVAPVVGGWLFGAFGWHSIFAFMALIGFALFAL
CWFGLPETHPKAARQPLHPRPLLASYWRVGRTVNFQLLTAAVSFNFAGFFLYVPSAPVFL
MQHLRLGPTEFLWLFGPAVSGIMFGAYLSGRMAGHFSSREVVSRAYWLMFAAALANLVYN
LLAPEQALPWAVLPLALYTTGMSLAAPSITLNLMDQFPELRGTASSLQGFCQTMVSSLVA
GVIAPLAWASPLRLALVMNLLLLLGFICRMGYRFRQLGKDENKPAV
>fig|243365.1.peg.1135 Permease of the drug/metabolite transporter (DMT) superfamily
MPYLALTLAMFLWSSAFIVLKYVFQFYHPLAVLFARMAIATLCLLPLAMGGRIRWRYRQG
DWPWLLAMGLCEPCLYFLFEANALMHTSASQAGVITATLPMMMAAGAAAFLHERQPRQVW
LGIALSFAGVIWLSMDSQAGPGAPNPLLGNALEFCAMVCASGYVLIAKRLSARYSPLALT
GVQTLAGCAWFGLAMLTPWGAWPDALLLVPSLWVLYLGAAITLGAYGLYTWAVSRIPVAR
AGAFNNLIPVFTVAMAWLLLGETPQPWQGAAGALVFAGVWLSQRRPT
>fig|243365.1.peg.1160 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTDARNFVPPYLLELHAAERPADPLVSCLIPAYNESENIVPMLETLHRLLSAHGYRHELV
VVDDGSRDDTVPKALEAAKRLPVTLIQLSRNFGKEIALTAGIDNIGGDVAVLIDGDFQHP
PEMVPVFLAKWREGYDMVYSVRANRDGETLAKRAFTRVFYALLNSGAPLKIPENTQDFRV
LDKSILEALRRMPERNRFMKGLYNWVGFTQLAMETQTRERRAGKSSFNFRSLFNLGLTGL
TAFSNMPLRIWTLVGCVISLLSIGYAIWELVHTLLFGNPVSGWPTLAVAVTFLGGVQLLS
IGILGEYVGRIFNEVKGRPTYLISRIAKPRDERDE
>fig|243365.1.peg.1179 Probable multidrug resistance protein
MDLRSPVVRRVLLSSFLLSLSRAVISPLLVLALGKQLQLSVQATGTLLALVLLGSALFGL
YGGYWLDRLPRGPALRGAALLMAAGSVLLPYGHGYATVVTALAAGELAMVVYSIAVKAIL
SDVVAERWRSKAFSMRYTLANVAWALGPMLCAGMLFWHETAPYWLGGLLALAGLAAQPRL
PQRRHDPAALPDGFAATLRTLAGDRVLVWFTVSSLLAYVVYGRFSGYLPLFLLTRMDEAE
AMRWMSALISCNAVVVVLLQYPLGRLLKPNRLMRAIVGGFLLIGAGMLWLGNVDSLPLMC
AAIALFTLGEIVLVPAEYLYIDAIAPDALKGSYYGAQNLASLGGALGPAMVGALLSRGPS
WVVFAALALLCVAGAGLALYSERLRLRGLRLANRIDASALPGSLS
>fig|243365.1.peg.1361 Permease of the drug/metabolite transporter (DMT) superfamily
MLNNPMPLALGAILLWASLATLGALTRTLPPFFVVGVSLCVGSLLSAHRIRDWKVPPLTL
LTGIYGLFGYHFLLFFAFRQAPALEANLLNYLWPLLIVMLSPLLRPGTRLTRRHIIGGVM
GFIGAGLIVTGGKLALSQQYLTGYLLAISAAMVWSTFSLLLGRLPAFSGSAMGGFCLASG
LLSLLCHALFESPAHPSASQWATLALLGLGPMGGAFFLWERALRLGDPRQIGSLSYSTPL
LSTLLLSASGQGQLNSLAAVAILLILGGALLGTLPGRRHAQTQAT
>fig|243365.1.peg.2455 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDLLPVSTLFWRYAIPSIAGMLVTGLYAVIDGVFVGHYVGSHGLAAINLAYPLVMLQVGL
GAMISMGAATRIAIQQGAGDMRAARGTLLTALALLLLLSALIPALGLPNIDLLLAWLKAD
VQPQVAEQARDYLLLMLAGAGLTMGPMLLTYLVRNDGRPKLSTALMTLGALLNIGLDYLF
VGVMGKGLAGAAIGTLLAEAVVLILALAYFLSPRASLRIRADRLRPDWRGLWPILALGAP
SLLMELNLALLLYAHNHQLLVWGNDLSVAAYAVAGYSESLFTLVIHGLAVGMQPLLGHAI
GAGQAERARDALRHGVKVGLIIGVAAWAAVQLFPAWIAGWYSDGSAALVEEGSRALRLHL
LAMPLDGLVIVGTTALQAMALTRLALGVTVGKTALLLPALGLLPLAMGLDGVWLAMPLVN
LLLGTAVALLLWRQFGQLRGRSLAAQA
>fig|243365.1.peg.2550 Probable mitomycin resistance protein
MHPSRCPPPDAATDLLQLPNVGPRAAADLRLLGFNHPADLRGRDPHQLYLRLCDATGERH
DPCVLDVLMSVCHYMDTGEARAWPSFTAERKRRWTV
>fig|243365.1.peg.2729 Probable multiple antibiotic resistance protein marC
MQLLSTFITKFLFVMAALLPIMNPPGLVPIFISMTARNTPQQRRYLARRIAIYCALLLVG
SMFVGGYVLSFFGVSLPVVQMSGGLLITFAAWRMLNDTPAESSQPSAEQARVDSQAELKQ
RAFYPLTFPLTVGPGSVSVAITIGATLTGSGKGLVRFVISPIAGLSAVLVGSTLVYLCYA
NADKLLRYLGQTGSVVFLRLSAFILLCLGVQIMWDGFGELASQWLRDNAGLLH
>fig|243365.1.peg.3243 Transmembrane multidrug resistance efflux protein
MQPSVNNESLFSQGRTAACIGGIALISLLAFESIAVAAAMPAVAAALGGLDFYAIAFGGT
LATSVAGMTLGGEICDRYGAARSAWLGLAAFIAGLLAAGAASDMYTLVLGRLMQGLGSGL
LGVAIYVGMSRAVPPALHPKLFAMFAGAWVVPALIGPGIAAGLVHIFGWRAVFLAVAALA
PVAGALLLPALSRQEAPAGAAKPMRWRRLGWSLLAASGALALHGGSHLPQTQYILPMLAA
GFALAFFAARRLLPAGSLRAAEGLPSVVAMRGLIAAAFFASEAFVPLILTTRYHWSLGSA
GLALTASAVMWSLGSATQTRLRGDAARRRGLTLGFAAMGAGLCFALGAASLSLHAGWVVA
GWAVTGLGIGLSFPMLSVLTMKLSRPDEQGSNASALQLSDALSSSIALALAGLLIHALSR
PSAPPDALPILAMSALLALIGAWVSPRAFASAAPARAEAGAGQLS
>fig|243365.1.peg.3479 Permease of the drug/metabolite transporter (DMT) superfamily
MAMLFPLLAVLIWAANTIVSKAAAQVLDPAAISIYRWLLAALVLTPFCLPVLRRRMGELK
PWLGKLLVLAMLGMVMFQCLAYYAAHSTSATNMGVITALVPLLGLLLNAAVFRQKVAALA
WLGVAVSLSGVVYLLGKGDPASLLANGVNTGDALILAGAASYALYGILLRRWAPPFGAWL
NLYLQASLAVLLLLPLTLTAQSMAIPAKGIGLVLFAGIGSSLVAAYFWMRGIQKLGSERT
AIFMNLLPLFTALLASALLGETIHHYHWLGGGLILLGVALGQGLLRLGGAKRPAFVNK
>fig|243365.1.peg.3736 Probable multidrug resistance protein
MPQAALLRRLSRPYRGLPPSVYIQVVCSFINNVGGISKLFLPLYLRESYQLPYNQIGMLM
AFYGAGMLAGSLKGGSLTDRFDSRALGVLALAVSGLCMVLLALRIPVWLFMPVLVLSGMA
DGGFRPINQRLALEPCAPQQRPVAQGMMRVAFNLGVAIAGVSSGFLAAYGYQWVYAANAA
GTLLGACWMACSYARRVESTRPQRRRADDEDALAGPWRDASFLRSILALVLITLAFDQMY
VTLALFLREHYQLGPQWVGYLFTLNGLMVVALQIPISRRILRWGLARSTQLGVLLTGCSF
LWLNAGHGVPWAVLMMMTLTFGELLLSPSYAHLVMHRSEGRLRGSYLGLYNAAWNGRTLV
APALGTALYGQFGGQMLWWLCALAACLGVAIQHGALKAMLAPAAERG
>fig|243365.1.peg.4365 Probable multiple antibiotic resistance protein marC
MFKTLSLQFLFGGLLSLITITNPLSKIPLFITLTREMSDSHRDSQARRACVFAAAIMAVS
LLAGNLIMAAFGISYGALRIAGGFVVAVLGYRMLFLSQDPGQAPRQSGEREDYAFFPLAM
PGISGPGTIAVVIGISTEIAELSTLPAKALAFAMTFAAIGLTCVGMWLTLKSSLLISERL
GRGGREVMTRLMGFLLICIGVQFVGSGIRTFMAGS
>fig|244592.3.peg.585 Multidrug resistance efflux pump
MFEKKFLVVFVAVLFLILIGNEISRHFFAYTSDAYITSDYASMSPAVAGTLAELHVTNDT
EVRKGDPLFTLDQTPYKLAAESAAANVAVSEQALQVAKDGVEEAKTNVTATKAILDDAEA
TQRRLSTLQESGVVTEQRLDDATRDLAEAQANYERALAARTGAQDQLKQKAAELRQATAE
KAVADYNLEQTVVRAPFDGQVVPFNTKTGQYLDAGDVVLILVSRTGYRIVANVHEQHVQF
IKPGQPVYYMVSTAPWVFFEGSVRGISKGIARSTLETQALPYVDPETDWIRLSQRFPVEI
NLSVHPDDRQAFMGADARVLILNTDPPPPTGSSHGSGQ
>fig|244592.3.peg.1525 Permease of the drug/metabolite transporter (DMT) superfamily
MVGRASLPGHLIEELRKLPIKLSSIPVLVHFIAAQDKPAHPTFARFSGVGNRKHMVPGRH
SPGWSSLMKLQHWILLICLGAIWGGSFIFAKVAVAEIPALTLVFFRVASACLALWLVLWA
QGTLEQFPLKMAASFLAMGLLNNVIPFSLLFAGQTVIGAGLASILNATTPVFTVLVAGVL
FRQETLGIHKIAGIALGIAGVATMLSGSLSGIVSDPLWAQAACLGAALSYAFAATFAKRF
KGLPPLISATGQLSGSTLIMAPIALFASRSWSVADPSVIAWLNVLALGIFATALAYLMYF
RLLAEAGATNASLVTLLVPASALFFGWLLLGEELSAIQLAGFALLLSGLVVLDGRLFARF
KPVSTSAK
>fig|244592.3.peg.1799 Outer membrane component of tripartite multidrug resistance system
MVGPDFERPEAPVLDSWGKGANLSVDHRTGFTTRSAASVPWWHVFKDEALNGLIAEAYRQ
NVELQAAGVRVYQARAQLGIARGELFPQVQQLKGNSENIRFSTQDPIIRDLERAGLVDSH
ISRVSAGFDAAWEIDIWGKIRRDVQSAKANLNANLASYDDALVTLTGDIAATYVTIRELQ
QLAASSRKNAALQKKSLNLTQLRLENGVASQLDVHEATVLYNNTLAAIPGYEAELAQAYN
AMSVLLSEPPGKMKARFSGRSGFPRVPAEVAIGVPADMLRRRPDIRQAEYIAGAQSAQIG
VAKADLFPAFTISGAIGVRADDFSNLFTGGATTALFNPGFSWNFLNYGRIRNNVRVQDAK
FQEALLTYENTVLSAYAEVENALTGFLRSKQQALYLRRSLRAARSSVGEVEAQYEDGTAS
YNRVVDAQKSLLVAEERLIAAEANVLTNLVAVYKGLGGGWAPENVRGLISDETRAQMADR
TRWGQLLDNPVGPSGKS
>fig|244592.3.peg.1807 Multidrug resistance transporter, Bcr/CflA family
MTAAPATLMSARRTALLGAGLVAVGPISMALYTPAMPALVEFFGTTDGAVKLTLTSYFAG
FAATQLVCGPLTDAFGRKPVTILFLGIYLISSVLATFSPTVEFMVAARALQGVGAAIGIS
VSRAIVRDQFTGQASARIMNTIAMMLALGPAISPTIGGFVLELFGWREVFWCMVIYGVAL
MVAVTVFQVETNPSPGKHHLNPRQLAINYTTLLKDPRFLAPAILIGCGLGNIYALATVLP
FVLIYEVGLSPSVFGLTMILQSGSFILGTVITGQLLKVTDAHKLVPFGLAMLVVASVLMC
AMTLTQEPSVASVMAPVGLFVFALAFVLPASFTDSMAPFPHIAGAASSMLGFLQFGGGVA
ASLIVAMVGDPVLGLAFVLPAMPVAGVVCYLLLRGQDTQHAAAE
>fig|244592.3.peg.2796 Probable phosphinothricin acetyltransferase (antibiotic resistance) protein
MPLRDAEPGDIPAILALYNQAVRETTAAWTSQEETLDERITWFETRQNAGWPVIVATSPE
DKLIGFASYGAFRPREGYRKTLEHTVYVDPDFQGQGIGAKLLQQLIDKAQAQEVHVLVGV
VDGDNTASIALHKKLGFEIAGRLPEAGTKFGRWLDLVFLTKIVTPGLDSPDV
>fig|244592.3.peg.3619 Permease of the drug/metabolite transporter (DMT) superfamily
MQARDFLLWSLLAALWGSSFLAIGVAVKDINPATLVFARMAIAAPVLGCVLLLRGGGFNL
GVRGWIIAAIVGLSGNVLPFLLISYAEQEVNTGLAALIMGIAPIITLVAAPLVHFEDSLT
RLKVFGALAGFAGVAVLAAPDLSEGRIGSLLPELCLVVAACCYAFTALFSRRFPYPEPLK
MAAASVFVGLLALGGYMALFASEPGLPAAPVPALAAVLYLGLGPTALAALIYFYLIPRIG
AARLQQVNYAVPVIGTLLGIAVLGEQPGWTAWPALGLIVFGVYLVTRPDKTEPAPARPMG
EPAE
>fig|244592.3.peg.4855 Bicyclomycin resistance protein
MASDLTAHTTREPKRIAFVVMLMGISTLSPFAMNIYLPSVDGMMSAFSATAAEIQLTLAF
YFIAIAVAQIFLGPISDQFGRRPVIVAGMVLFVIGSVLCLMAPTVEALIAARIVQAIGGG
AGLVLARAIVRDVYGRDKAASMIGYVAMGMAVAPTIGPAIGGFLDAHYGWRGGFVLMLIF
GIGVTICAWLFLPETNQHKKAVSLKQIGQGYADLFKEKMFWVFCGASTFMAWLYFAYLGG
APFVAAGVFNMAPAEIGLYLMVVSIGYIIGNFITGRIAARAGIARMIALGVITGVFGVSL
LVVGTLTDSLTGPLFFMPMFFIGLGNGLGIPSAISGAVSIRPDLAGTASGMLSFLQVGAG
ALVSSAVAYMFSADIAGGGEMPMILVMVVGGVFGLACVLAVFLGERQDTQYEDR
>fig|244592.3.peg.5109 Drug resistance transporter, Bcr/CflA subfamily
MNLTVLSPAGSPPRQISLILLSAISIVSLNMHIPSLTAMSADFGVSYADISLSISLYMVL
TACLQIVAGPLSDRYGRRPVLLAAVTIFLAASAGCALAEDFWVFMVFRLVQGAIATAAVI
SRAIVRDSAAPQNAAVRLGEIGMAMALAPMLAPMLGGLLESGFGWRSTFWAFALAAAALW
LLSWKDVGETNASRHSSFGDQLKGYPALAADPAFWSYTLCMAFSVGVFFVYITGIPLVAT
GYFGMSPVGTGVVMGLPPVGFMLGNWIVIRLGQKVPLSLLMMTGRLVTLVALLIAALLLS
LGRADALSFFPWMIAIGIGNGLTMPSANAGVMSVNPKLAGTASGLSGAITILMGAGAAAA
TGVALDAIPGPATLLSILIGFSGVALVLAHAARGAEQRVSNAI
>fig|244592.3.peg.5277 Permease of the drug/metabolite transporter (DMT) superfamily
MSERTTGILEMTFAMTLIGTLGIFVVFSGESPVTVAFWRCLFGAIGLALICSLKGAFAFK
ISPKQFLLAVLGGIALTTNWVMLFYAIGHASISLTTAIYNTQPFMLVCFGVLFFGEHLTL
RKLCWLGLAFCGVVVIAQSKPELAYANGNFAVGVALSIGAAFLWAVAVVVTKKLSGIPSH
LIALIQVSAGAILLAPFASVSDLPSQSTAWASLLTLGFVHTAMMYTILYSAVQKLPTDLQ
GALTFLYPSVAYVTDYLVLGQKLGTVQILGVAVIMLAAAGMTLGWRLPFFRKEKSYHQA
>fig|245012.3.peg.208 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKTMRETLTAGRSIDLTSGPVARSMWLFALPLMTGNLLQQFYNVADTLIVGRFLGAGAL
AAVGSSYTVMTFLTSVILGLCMGSGVLFSMLCGAGETERMKNSFVQSFFFIALVTGLVEG
LALLLIDPMLAVFQIPADILKDTKAYLQIIFIGLVFTFVYNYFAALLRALGNSLVPLMFL
AVSALGNIVLDLVLILEFHMGTAGAAWATITAQFLSALGIGIYVWVKMPHLLPGRRHFYR
DSEILKKITRYSLLTCVQQSVMNFGILMVQGLINSYGVTVMAAFAAAVKIDSFAYMPVQD
FGNAFSTFIAQNHGAGRKERIRLGLRAAVLSSGAFCLVISFVVVAFGGRLMTIFISPEET
QIIRIGAQYLHVEGACYVGIGCLFLLYGLYRGLGHAGVSVILTVISLGTRVALAYLLSPI
PSVGLLGIWWAVPIGWFLADIAGFAYFWKLDRKEKREAIS
>fig|245012.3.peg.223 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTYLYNMTAGIIRSLGDSRTPVYFLLLSSVINIVLDLFTIIVLKMGPAGAAWATVISQGV
SGVLCLLYMKKHFEILRLQKDERKIDGQIMKILCKMGIPMGLQYSITAIGSVILQASVNT
LGSMAVAAVAAGSKVSLFFCCPFDALGGTMATYAGQNVGAKKLERIRQGVKSASVIGCIY
SAAAFLVLLLFSGKIALLFMDAGETETISRVSLFLTANSAFYIPLVFVNVVRFAIQGMGY
STFAILAGVFEMAARGLVGLFLVPVFGYIAACFGSPLAWVFADIFLIPAFSHCLRRMKKN
FEENEEKYTAGQLSK
>fig|245012.3.peg.486 Multidrug resistance protein
MGSSVLMPLYVQSVMGYSAVISGLVTLPGSLATTLVSPFAGRIYDKMGIKRLFVIGSAIM
LFSNIGMYFLTMSTPLWTAAVLNVIRNVSIGSLMMPLLTWGTSSIQIKKVADASSLLTSF
RTIAGSIGSAVFVGIMTAVSEGSAAAYGEGALMHGMNIAFLCMAAGSVILLLISVFGVRK
ENICNREGTETNG
>fig|245012.3.peg.508 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSQAVKAKKKTCSMLTDHPGKALLLFAFPMILGNLFQQFYNIMDSVVVGQFVSENALASV
GASYAITNVFIAVAIGGGTGSSVIISQFLGAGQITKMKTAVSTTLLNFLVISVFLGVFGL
AYSDRILALMNVPGNIFEDAALYLSIYFLGLPFLFMYNVQASVFNSLGDSRTPLWLLIFS
SLLNIVLDLLFVIQFGMAVRGVAVATLIAQGLSAVLSFCLLMRKLRGYEHRREEFRFYDR
GMMLSMVKVAIPSILQQSIVQMGILLVQSVVNTFGSSAIAGYSAGTRIESISIVPMLAIG
NAMSTFTAQNIGAGNEKRVREGYRTCYFALAAFAAALCVLTQSFGSLFISAFLDAEVSEE
AFSVAMSYADFISFFYILIGLKATTDGLLRGAGDVTVFTVSNLANLTIRVFVASFFAPRY
GLEFVWYAVPLGWATNYAISFGWYLTGHWKRIRLIEGGEKRPYRA
>fig|245012.3.peg.533 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MWGICGYFSISSSQQAVRESGLQYTHIVFLFSFGLFAEANATKLLQAKGNTVLPMLAQIA
GAVLNILLDPILIYGLFGLPAMGIRGAAVATVLGQWLAMFIVILPVFRRFPVFSGRVLPA
DCIRIYRAGLPAIAMQSLNTLYIVGLNLVLKQFSESAVLVLGIYYKLQTFFFIPLMGLQQ
VILPLISFYHGAEQPQRERQVLGCSIKLSLAVMLTALGAFMIRPRRPSFHLHSRTGCPLH
RLHRASDHLPQFPVRRPGNDVYRIFSERRARENQPAGDCASPGRSPGPPGLAVPL
>fig|245012.3.peg.543 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKHETKALQSGNPLEYKPIPQLLLAFSVPAIISCLINSIYNIVDQIFIGQGVGYLGNAAT
TIAFPVMTIILAFGTLIGAGSSANAAISLGERRNRRAEIILNNAFALALVSGIILMAVGL
LFLRPILSLFGATEASMPYAVDYTSIILLGTPFNLIGIVLSNLARTDGHPRLSMYGMMIG
AGLNTILDPIYIFIFHWGVKGAAIATITSQIISAIILTAYFLRANKNPQHMRLRLRSMRF
AGPIVSRSLTLGVSSGITQSVACIMQVVLNNSLVHYGNLEAAGGGDIALSAMGIVSKISM
ILASLAIGFGIGAQPILGFNRGAGKYDRIKTTYKICSIMASVCLITGWVLCQLFPEQIIS
LFGHESAAFTDFAVKCMRIYLFGIFCAGFQIVSTNYFQATGQPLKAAILSSLRQLVLLIP
LILILPLFWGLDGILFAGPVADISSTIIVSLFVIPEMKKLNQKISEMRTAAQ
>fig|245012.3.peg.664 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGVRGAALATIISQFFSAVWIVRFLTGKRTILRLRLSCLRPQWKRIRAIVGLGMSGFTMA
ITNCTVQIVCNATLQTFGGDLYVGVMTVINSLREVASMPVQGVTNSAQPVMGFNYGAKEY
GRVKKAIVFTSLFSIAYTTLAWAFLHGFPEFFIRIFNQDQALIEAGVPALRLYFFGFFMM
SLQFAGQAVFVALGMSRQAIFFSIFRKVVIVVPLTLLLPSVFGMGTNGVFLAEPISNFIG
GAACFGTMLLLVWTELTRRERAKTV
>fig|245012.3.peg.825 Acriflavin resistance protein
MPAQVAQSVYLMISGSEATTLDQDGEEISVNVEYPDGWYETVDQVKGIVVSGAAGNSVAL
ADIADIYFKDSPQSITRKDKEYQVTISGDFVNGTQEEQMDAIETQIYDEEVAPRLTENVT
RAQNAMDESMAEEFASLGGAIAMAIFLVFVVMAAQFESPKFSLMVMTTIPFSLIGAFGLL
FLADASISMASLLGFLMLFGTVVNSGILYVDTADQYRAEMDRDTALVEAGATRLRPILMT
TLTTVVSMIPMAMAYGDSGETMQGLALVNVGGLVASTVLSLLMLPIYYTLMNRKPKYDEL
DVD
>fig|245012.3.peg.1500 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQKGEQKMKIENDLGRDDVRLLVMRIAIPSMLAQFVSVLYSVVDRMYIGNIPEIGETALA
GVGVCGPIVTLITAFGSLVGVGGAPLMSIRLGEKDEKGASQILANCFLLLSAISLIIMAA
ALLLKNRLLVWFGASEAIFPYANDYITIYLLGTIFALLSIGMNQFIICQGFAKVAMKSVM
LGAVVNIVLDPVFIFGFDMGVKGGALATVISQMASAAFVLAFLFGKRVPIRITFGNYQWR
IMRKVIFLGLSPFLIVAFDNVLVIAMNASLQHYGGPEGDMLLTCNTIVQSFMLMVTMPLG
GITGGTQSILGYNFGARRSDRVLAAQQWIVTLALIFTAVMFIIAQAVPQYFVRIFTREPE
YVELTVWAIRVFTLGIIPLSIQYGIVDGYTGMGIAPIAISLSAFRKTLYLLGVFLIPMIF
GVRAVFYTEPFSDFLGTAVSIAVYLLTMKKILRRRENGAL
>fig|245012.3.peg.1525 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAVPALKLFSSAYLIRWFSFATQSYMSAVEKPVPAMIISVCTAVVFPLLIIAVLWPMGLN
GLWLNVPATSLLAAILAFFILNRFERKEMREAAR
>fig|245012.3.peg.1528 Acriflavin resistance protein
MEDLKNVPITTSSGEIIMLQDVANITEAKEEQGGISRYDGQETISISITKNQSNTAMEVS
NAVKETIETLTADDSDLTIEIVNDSADTILDSLKDVAVTMILAVVISMIIIFLFFGDVKA
SLIVGSSIPTSILLSLIAITSAGFSLNVITMSALTLGVGMMVDNSIVVLESCFRVTKENW
DKGIVGYAKSALQGTNVVFASIIGGTATTCVVFIPLASLQGMSGQMFGPLGFTVVFCMIA
SLLSAVTVVPLCYVVYKPREKEGAVLSRPVERLQDLYRRIMKRLLRHKAMVMSVSVAMLV
ATVYLASGMETELITADDTAQISIDIEARPGILDEKADTALEEIEQIVSS
>fig|245012.3.peg.1529 Acriflavin resistance protein
MGITKFVLKRPVTIVMALLCLLVFGISSVFNATLEQMPEMETPMLIISTRYDGAGPEDIC
ELVTEPIEDEVSTLEGVKSVSSTSSDGSSMVMLEYDYGTDMDEAYSDLTKKMNSIERQLP
DDAEEPTVMEMSMDASTTMMLSISHRTQSNLYDYVDQKIVPELEKITSVASVEATGGSSE
YIKVELISEKMAQYKVTMSQITSAIEAANLSSPSGDTVVGNLELSVTT
>fig|245012.3.peg.1554 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNYKELFSKTPPTKLFFTAAIPGSIGMLASALYQTIDGVLVGRILSGNAFAALNLAMPLV
IINFSLADLIGVGSAVPISVRLGEKKEAEANNIFTSACLMIVITGLILGLAIFLAAPALI
GLMGAEGELAKLAVQYLRVYCLCSPVTTIVFAMDNYLKICGRVRSSMALNIVISVLSAVL
EFIFLFVFRFGIWAAALATCTSMFLCALAALYPFFSRKMQLRFVRPRLNRTMIKTIVTCG
SPNFLNNVAGRITSIIMNMILLRVGGATAVSVYGILMFADGFVQPLLYGMCDSLQPAVGY
NWGAGALKRVKDIEKRCFTAG
>fig|245012.3.peg.1559 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLAISCCILADTFFVSQRLGTDGLAALNLAIPIYDVIHGTGLMLGMGGATRFSICKSRGE
DREANLMFTNTLFLAGACSVFFVLSGLLFSERLAVLLGADEAVLEMNKYVNLKVLMLFSP
AFLMNDIFLCFVRNDKNPGMSMAATIGGSFSNIILDYVFMFPLGMGIFGAALATGLAPVI
GIAIMSPHWLKRSKGFHAVKTGLLPNR
>fig|245012.3.peg.1560 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNASLGFPSLLAQLSSGVVMIVFNKIILELEGNTGVAAYGVIANIALVVVAVYSGVGQGI
QPLVSREYGYGRKEREVQLLRWAAAVVLALSVLIYGGLFGLAEPIVGIFNSENSVRMGQI
AVIGLKLYFISVPFVGLNIVLTTYFSAVEQAVPAQVISLLRGLVLLIPMAFFMAEAGGLT
GVWLAVPVTEFLSVVLGGWLYFRMEKGGAKRAKNRLPEDI
>fig|245012.3.peg.1774 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENFNGIAGIGIGIGMMTVVGQCLGAGRPDEARYYIKKLSYAAEAAVFVSCILIFLLSGP
ITRLAGLEAESASLCLFMVGWITVVKPLVWTAAFIPGYGLRAAGDVKFSMLLSCLSMWTC
RVTLCIFLIRVCGFGPMAVWIGMFTDWAVRGFFFVRRFRSGKWLEHEVAD
>fig|245012.3.peg.1775 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNQKESAPSGAGHLYSNRQLFALMVPLICEQLFTSFMGTVDSMMVSNVSEAAISAVSLVD
SINILVIQAFYALAAGGAIICANYMGQKREEQAKRCADQLLFIVLAISLAVLAVCQLFRG
PILGLIFGSVEKEVMDSAMVYFFYTSLSFPFIALFDSGSAIFRAQNNSRLPMAVTVATNL
LNIFGNAVLIWGAGLGVAGAAISTLVSRIIAAVCVLLFLRRKSGQIIIGNFIFLRPDGRL
IKNILRIGIPSGVENGMFQFGKLAIQSTVPLWEQRPLPPRP
>fig|245012.3.peg.1875 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKENTSGSRSLNNGLNNNSDNRSHNNTLLTERLPRLFLLFVLPAVISMVISGTQSMIDGI
FLGRFAGVNAMASVNIAGPYMQIITGCTMVICIGTFSYLGRTLGENTNPQKAKDIFRTAV
VSLAACALILMAAGLFLSRPLALLLGANEVLLDETALYIRTVAVFIPAICFMMHFGFTAR
LLEKPHLYLIATLCCVSCNVIMDYLAVK
>fig|245012.3.peg.2179 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTEMKKQVDLLNGKIISALTELAIPIMGTAAVQMAYNLTDMAWIGRVGATAVASVGAAGM
YTWLS
>fig|245012.3.peg.2284 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEERENTMGSRPVFPLLMSMSVPPMISMLIQSLYNIVDSIFVARISDKALTAVSLAYPLQ
NLIIAVAVGYGVGINACIARSLGAKRQEETNQTAAHGALGTALHCILFILVGVFLTEPFL
RLFTDDPEIFSMGCSYTYIVVCFSFGSLFHIYIEKMFQATGNMVMPMILQGVGALINIIL
DPIMIFGLFGFPAMGVTGAAAATVAGQILACILAVTLFNLKEKNIRVSFRAFHFDRRIFF
RIYSIGIPSCIMLSLPSLLVGILNSLLVGLSSVAVAVFGLYFKLQSFVYMPENGIIQGMR
PIISYNYGAGHLDRMRETVRCSMISCGAILAAGTLLFLAVPDYIMMMFGAEGEMMEMGMS
CLRIISLGFIFSAAGTVFSGCFEAIGRGLHSLAVSLVRQLVVIPPLAFLLAETMGVTGVW
IAFPAAEILAALLGLVLYRGQMRKVKLELLGSLKKEERR
>fig|245012.3.peg.2560 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MERDLTKGNIVFTLAGFSLPLILSGVLQQLYNWADAFIVGNIEGELALAAVGATGTITNL
FVMVITGLTLGLSILAAQKYGRGERESLRRILSTFSIVLGVLFLLTAAAGLWLSDGILRL
LHTPEDIFDISEGYLRIILTGIPFSTIYNVYSAVLRGLGDSRAPFLSVLVSAAANVILDL
AFVGGLRMGAPGAAAATVISQALMTVFIVCYAGRKYEILRFSREEKLVDKKILVQGFQLG
LPPAIQSSVNSCGNLLLQNFMNSFGTQTVAAITTAYRVDSILLLPIINLGSGISTVTAQN
MGAGNRARAKKVLFAGSVMMLCVSICLTFLILSAGGPLIALFGVTEESTAIGASFFRSIA
GFYTVYGFAMAFRGFLEGCGDVLYSSIAGIAALASRILISYLCVSVWGNMVIAYAEGISW
ILLLALYLVRFLWKQRKPCGRREETER
>fig|245012.3.peg.2713 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQTPNLYFRIYFLGATFNLVYNMGAGILRAVGDSMRPLYYLCVSSVVNIVLDLLFVSQLH
MGVDGVAWATIISQLISAILTVRALMTSDDIYRLELKKLKIDFRMMKRILNMGIPSGIQQ
SIISLSNVIVQANVNVYGAMAMAGFGAYNKVDGFVVLPMQSFCMAATTFTGQNIGARRMD
RVKKGLFQGMVICSIYTVGVSVLLFFKAHSILEIFSSDPGVISYGLKTMIVMVPFYLLLS
AHQILMGTMRGAGKSMQTMLISVGNMCVLRVIYINLFVPLFPSFDAVMWCYPITWATTVL
MDLAYMKWGRWLGQAGDRKKKRH
>fig|245012.3.peg.2714 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKKQKKNSVLMTEGVIWKQLIAFSIPLLIGNLFQQLYNTVDSVVVGQFIGSEALAAVGSS
NSLINLIIGMFMGISVGAGVIISQYYGAKSAEKMSWAVHTSMALSLVGGVVLTVVGEAFS
PVILRWMKTPEEVLANSQSVFQDLFSGGHLQSGLQYGSGNSEGGGRFYETSLLPVRVIGS
KHCPGSSLCEPASHGSGRRGMGYDYLPAYLSHTDGAGADDLRRYLPSGA
>fig|245012.3.peg.2761 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAYPLTTICLSIALLIGIGSASRFSLELGAGRKESAAQAVGTAVCMMVLFGVIYVVLIEL
FLHPLLTVFGATKDVMPYAESYTRITAVGMPLLILTNGISNLARADGSPKYSMTCMLVGA
VINTILDPIFIFVLHQGVAGAALATVIGQVFSCLMALNYLRRFSHVELRRSHFRLRLPVC
LKIASLGMSNSLNQLAITFVQIVLNNSLTYYGAHSVYGSEIPLASCGIVMKTNAILLAVI
IGISQGSQPIIGFNYGARQYERVRGIYRLAITCNLIISGIGFLLFQLFPRQIIALFGTGD
ALYFEFAIKFLRIFLFMVIINGVQLISANFFAAIGKPVKGVVLSLTRQVFFLVPLILILP
LVWGIEGIMFAGPIADFAAFITTMILIRREMGHIRAAQAELEAA
>fig|246194.3.peg.77 Vancomycin B-type resistance protein VanW
MKKSYIILTVLIALVIMFLAGIVGFSYYTYIKPYQGKIAYGVTVEGEPVGGMTFKEFKRY
LEGLNNELQNQPVVLTLGNKTWTYKKGDLGISLNTAEMYRKAYELGRKGSLLKQIMERRQ
LNKAAVDIKYLVRLEERKLLAKLDQINKEIYVEPKNAEFRLLPNETFAIIPHKTGIALDS
EQAVKDVRANLLENPLKVSFKLKEVLPDKTTEDIKKMRLTGLLASFTTSFDVRKVNRSYN
IGVAAGKLNGILIAPGEVFSFNKTVGPRSAKEGYKNAPVILRDQLVEALGGGVCQVSTTL
YNAVLLANLPIVERHNHSLPVAYVPPGRDATVTDGGKDFKFKNNLPCYLYIKSYVNGNRI
TFKIFGDASLKKHVVIKSWVTKTIPYKTIIIKDSSLPEGKKVVKQEGALGKYAKAQRIVY
QNGRVVKVENLRDSYYKPMNEIILVGTKKVPNSSAKESSVTENVY
>fig|246194.3.peg.256 Drug resistance transporter, EmrB/QacA family protein
MEYRWRVMWVVALGTFMAPLDASVVNIALLSIIKDFKASLATGEWVILIYLLFISTLLLT
YGRLGDLYGKKLVYVTGFVVFTVGSLLCGLSPTLGFLIGARVIQSLGAGMMMAMAPAIVT
EVFPSQERGKALGINGMMVAAALAFGPSAGGFLTHFFGWRSVFFINLPIGLIGSILAFKI
IKNDFTREKHSFDFLGAFLSFLGLGSLLILLTFFEKYGFTHPLMIGALVISILAFLLFLY
TEKKVSEPMVDLGLFKNRDFSFSNLSAFLSYVALYQVVFLMPIYLQQLRHFTPEKAGMVM
SVHPLLTMIVAPLSGSLSDKIGSKVLAPLGMTVMALGLFALSRLNSETTVGIIILSLMLI
GLGSAIFQSPNNSTIMGSVPKNRLGTASGFLATMRNVGMVMGVAVAGAVFTGRRTYYLTY
YLQNHYTKELATVKAFVLAFREAFLVGAFIALLSAAASLVRSRGRKEKLLQK
>fig|246194.3.peg.914 Permease of the drug/metabolite transporter (DMT) superfamily
MGDNERIKGLVLAILATSLWGINGTVTRYLLINNLDPVVLVQIRLTVSALLLFILLFILK
INVKISRDDIISLLILGIFGLSLVQMTYFYTISLTNVATAVFLQYLSPVFVALYGVFFKA
EEITGSKLTAIGMSLLGSFLIVTQNGEIQLPFMGLLSGLLSALSQSFYIIYGKKVLNRFS
PITVLAYGWLFGAVFWWLLIPPNKALMHQVFTLRDVFGISYVIIFATVIPFLLYFESLKY
LNSTTMSVVSLVEPVVAVIVAYLVLGEKLTPLSTLGAVLILFAIYKITRS
>fig|246194.3.peg.1031 Permease of the drug/metabolite transporter (DMT) superfamily
MELKTKQLLADISLIVVTAFWGTTFVIIKNILANIEPFSFLSFRFLLSTFFLLPLLLQKE
GFSPKGVFFGSIAGFFLWLGYILQTIGLKYTSAANSGFITGLAVVMVPVLSSILNKKPVT
PGVIFGTGLSFLGLFIMSFDFKAGFNTGDLLTLAGALFFSMQIVSVERFSPNFSATSLTL
GQIATVGVLSLPAALWLEEPFKPYPNEVFYAIVFTAIFATVLAFLVQSKAQQFTSASHVA
LIFTLEPVFALLFAVLFGGESLVAKQGIGAFFILAGMLTAEFLDQYWPKAKDEKKANL
>fig|246194.3.peg.1047 Fosmidomycin resistance protein
MGEVILLEKAVKSAKPNLGVLLLLSMGHLVTDMAQGALPALLPILKQAFALNYAKTSLLV
LMSNIASSVIQPFFGYIADRRPARWLLPLGCLLAGVGVAVTGRMPWFSLLLIVVTIASVG
VAAYHPEGSRVANLASGVRKGRGMAVFSVGGNLGFGLGSIYMAWLLSKGGLKATVFFLLP
SLLIAVLFLFSWPRLTSLRDEVVEKKAKGNGQGSGQEIKAESKKRTIAAFFLLLLYIVFR
TWMHAGLYTYVPLYYTDYLKGDPHLAGYIVSVFLLAGAVGTLLGGPLTDILGAPKVMAGS
MALLIPLIFFFSRTNNGFVYFVLLALVGATLISTFSTTVVLGQQLIPHRKGLASGFTMGF
GVGMGGVGVTLLGVLADHLGVPAVFHVLNILAVGGFVLALILIRYFPWSSKTME
>fig|246194.3.peg.1488 Fosmidomycin resistance protein
MNYNYNKIRYAIAFGHFWIDFYANVLASTMYLLARDLHLSLTRQGILVAVVSFAGSVMQP
YLGYLVDKKGKSTHLLFSLLLMGLLTTATGLFQNFYPVLILFTLGALGSALYHPLGSVLT
TSISEKKNTAVSFYVTWGNIGYSIAPVILVPVVEALGRKGLLLFSLPMFLALIFLYLSKS
HQLPLPHEERKETLPSFRATIKSAFTGLLLLNLIVWGRAWIQVALGNYSIQYFLHQGLSA
NQSSILLSAYLLAGTAGVVAGGFVSEKHGERFTLLATFLLSGATLIMMFFTPPPFSYLGM
LITGFLLNMSFPATIVMGQNLIPENAGMVSGMMMGLAFGLGGMGAMLTGTVADYTSLAFS
LKLLVVIPFIISALTLVYFQKISLPKPKIK
>fig|246194.3.peg.2430 Inner membrane component of tripartite multidrug resistance system
MEHQRHNFGENKWLTMFVVVIGTFMAILDTSIVNIAIPKMMQVFAVGTEEIQWVLTGYML
VMGVVIPVTGYLGDTYGYKRLYIAALFFFTLGSALCGFAWSNNSMIAARVVQAIGGGMMM
PASMTIIFNTFPKEERGMALGIWGISVMVAPAIGPTLSGYLVEYFNWRLIFTINIPIGLF
GMVMALLFLKESVRRPHATFDLPGFITSSVGFFALLLALSKGTDWGWSSAKILFLFWLSA
LSLTLFTYFELKSPEPLLDLSVLKNPTFAMSLVITMINTMGLFGGLFLFPIFFENLRGYP
PMDTGLIMLPAALASGLVMPIAGRLFDRFGAKPVVLFGLTLAIISSYGLSLTHINTELWW
LQTLLIIRAMGIGFSMMPVNTAGMNALPNYQVGRASAINNTLRQVSSSLGVAIITTITQQ
RVAFHTARMVEGLNQASPVFQNTVNFLKSGLSFMGVSPLVSVKGAMGVIAMRLYQVAYAK
AITDAILVTAFIMVFGVILTFFLKEERKNQEEKEKLPVAEF
>fig|246194.3.peg.2433 Permease of the drug/metabolite transporter (DMT) superfamily
MNKSYLYLGITVVLFSTYEVVGRALAGLVNPFQLNFLRFFFGGFVLLPVALSNIKRKNVK
LTGSDFLFAFLIGLLNVVLSMSFLQIGINMTKASLAAAIFSSNPLFVVLFAYLILDEKLN
FQKILGLFIGIVGVVIVFYKDLELGISHVYGILMLILAAVTYGLYTVLGKRFSQKTDSVI
MNSFSFILGSVFLLPIILLKHYPLFSLQPKAILPMAYLTFFVTGLAYYTYFLGLTNISAG
NGSMVFFIKPVLASFFAWAILGEKITFEFIAGTMVILLGIYIVQWAGQVNDGATCEKLRT
LEK
>fig|246195.3.peg.500 Drug resistance transporter
MMTEPATQQPSRYLPCLLTLAIFMQMLDTTILNTALPSIARSLHESPLSMQSAIVAYALT
VALLMPLSGYLCDRYGTRKVFANAMLLFVVGSVLCAAAPSLTFLVLGRMIQGMGGAMLSP
VPRVVVMRAYPRNQIVSMLNLIVMPALIGPIIGPLLGGYLVEYAHWSWIFLINLPIGILA
ILATHRVMPDFTGAANPRLDIVGFLLFAGGALGISLAMETVLHPAGKLFSSLTALLGIVS
FYGYWHYARGNPDALYAANLFKVRTYRVGLSGNLVSRLGMSSVPFLLPLLLQVVFGYSAS
AAGWMLMPIAFAAMFGKMVTLPLISYFGYRRLLIINTRLIGILIMSLALPQPHTSPWLLM
PLLAGIGLSNSVQFTSMNTISLADLRIYQTGSGNSLLAVDQQLSISMGITLGAAVLTGFR
SSQWIGDDLHLAFRLTFIVIGCITFTSSWVFARLHPYDGQNLLPSEKD
>fig|246195.3.peg.851 Multiple antibiotic resistance (MarC)-related protein
MSLTAAILTLFLIINPLGNVPVFLSILKNLSPKRQRIVLLRELCIAYAIMVVFLFGGSSI
LHGLNISREAVSISGAIVLFIIALRMIFPLRSGSVMGADDTEGEEEPLIVPIAIPFVAGP
SLLATLIMMVESDPSLTTRWFFAMTISWFISLLIFLCAPFFFKILRKRGLKAVERLMGMI
LISISVQMMLNVYMALQATGA
>fig|246197.19.peg.93 Drug resistance transporter EmrB/QacA subfamily
MLARCGASPGARPLAAPERAQSCRRTETAGAAKGLCRWPSGRNVPTFPLAPLTREPPRHM
APSAAPATANAPPAFPAFTRSQKVFTLLGAVLGLLLAALDQTIVATAGPAIQADLRIPAS
LYPWLTTSYFVASTTMVPVWGKLSDLLGRRAVLAAGILIFLAGSFLCGVARSTVALILFR
AVQGLGSAALFTAALAVVADLFEPRERGKYQGLFGAMFGLSSVVGPLAGGFITDHLGWHW
VFFINLPVGAVALALVLSRMPRLKPQRVSRGGLDLVGAFTLAVALVPLLLALSLGQTDGG
DWAWTSWRILGLFALSAVGLVAFLWAERRAPEPLLDLTLFRLRAFSAGNAAVFIVGGAFL
SGIVFLPLFMVNVVGLSATRSGLTVMPLTLGVVAGNVLSGQLVSRVGRYKALLLGSLVLL
MAGFAVMAFTLTPDSTQAEVTAKMVLVGLGLGPSIPLYTMAIQNAVPPDQIGVGTAAATF
FRQLGMTLGVALLGTVFASTLSSELEARMAQATSALPDSVKAEVTRAAPGVSGEGGPTGQ
VFRADEVKARVRAEFDAERRRAETTAAPEARAKVDADERQALAAVDAADRALKMAFTRGV
SAVYHVALFIAGAALLVTLFLPEQHLRRKRRRIESRASAPEQ
>fig|246197.19.peg.179 Permease of the drug/metabolite transporter (DMT) superfamily
MTRAPGWSRVRPPAMSRTAGFLIVALSGVCFGALGLFGRLAYAAGTDVATLLFLRFSIAG
AVLASVMVLRRQRWPRGGVLVVLMLLGAAGYFSQSGVYFFALQHAPAGLVALLLYSFPAL
VALVQRVVFKEHLGRVKWLAVVLSVGGTVLTADLSQGGATLPGVLLGLLSALFYTVYVVA
SGRVSGRAGPLASSTVILCSAGFSFGVAMLVRGPAFPGSVTGWAAVVGLALVATVAAVLL
FFVGIQRIGPVNTSLVSNLEPLTAVVLGALFLDERLTPRQVLGGVLILGAAVMLARADVP
RASPEPPAGGGAPGAVPG
>fig|246197.19.peg.1413 Drug resistance transporter, EmrB/QacA family
MARRPARATSRKARSCSEVMRIPQKAYAEDAVSAWGPGAYREVMDGSGVTAEPMVSARPG
VARRTATGAVLLALVVSAFEGTVVTSAMPTITRELGGQHLYSWVFSAFLFASTVGVLVSG
KLADRLGRKPVFFSGMGLFLVGSALCGLADSVPGLIAFRVIQGLGAGALQPTTLTISADL
YTLRERVAVQGLFTGAWGAGNVVGPLIGGWLVMHASWRWVFLVNVPVGLFAAALLYLSYR
DPPRRPEVRMDRWGPVLAGSSAALLLFSLEPGAASLRWACALAAVGAGWLLVWQQRTTVS
PLLPAELLRDRAVLSGIVGGIAGGSLLYSMAAWVPLWMTEQGGHTPLAAGLALLPMLLGW
SVGSTFGVKLLVRGGMRLSAGVGFAVAALGAGWLSLAAARGWGVPAALMGLAVLGLGLGP
AASTSLIGPQSRAPWHHRGIVTSALYATRLLGGSLAVALLALASGHFALQFGIAAGLTAV
AALGLALLAPGRTEPAASGA
>fig|246197.19.peg.1493 Membrane component of multidrug resistance system
MSGFGLALQRLPPPMHSAAEPTVPRFWPFMFTLFVGSFMSVLSSSTITIAIPELQRHFGA
ELSSVQWTLTGFMLAMGTSAPLTGYLGGRFSFKWVYVASLVAFLVASVLCGVAWDTRSLV
AFRFVQGAFCGAIMPVTMTLIYQLLPRERQALAASLWTLSSMLAPAFGPTLAGWLMTLGN
WRWLFFMNVPLGLAAVAMAVRAVPYYRLEVPKAFDFPGLLTVITGTLALLIALSQGRAWG
WTDSKTVSLAVLGTVSLVYFVVRQLRTHAPLLDLRVLANGRYVVTLLISSIITISLYSGA
FLIPLFLQEIQGVTPLKTGLILLPASLSMALLMPLVGRMYGKLGPSTLMTAGVLLIAGGT
YALSRLTPDVSHTYVLMWMLVRNVGISLSIMPASNAGMEQLSRELSGHASSISNWLRNVF
GAFSIAIFTSLLSSFAAREAQVLAREGMTERRDIELLSFVTGINQVYLVATVIALVAVPL
SLMVRKYVSGLEASRGAR
>fig|246197.19.peg.1938 Multidrug resistance protein D
MSPRPPFLLAILLLSFPQIVETIYSPALPLIATAYRVTPAETGQTLSLWFAAFAFGVVAW
GRLSDLWGRRPALLAGLALYAAGAAWAMVASDFSHLLAARLISAFGAAVGSIVTQTALRD
SHAGPELGRVFAVLGLALAISPAVGLFAGQLLAAKAGHSGVFAALGLLAAFMLGLSLWRW
PETRPATLSVAPFWPTFRVMLRDPGIWRCTLLIAAFNAAIFAWYQLGPFLFAGLENPWLS
FGQSGFLLAAGALAGALMNRALLRRGWTAEALIALGVLLLGAGTALVILLTALLPQSLAF
LSGVTLISSAYAVAIPNVLGIALRAYADRFGTAGAVLSLFYYNLLGAGLVIAGYGQRLDF
ALAVCALLAAIVSVRPMRCRGALSEESPPGGKSRIPCSSSGGGRS
>fig|246197.19.peg.2958 Permease of the drug/metabolite transporter (DMT) superfamily
MPGSKRRLARATPRAYSPAAVSTPTTAVVPAPSRGISASDLAIVGVVIAWGTNYTVVKEA
METLPPLAFMSLRFTIAALAMGALLLGVEGWKPLPRPVFLKLLGLGLVGNTVYQVCFIVG
LANTSVANSGMLTAVTPVLVATLGAVFGVDRLTRPLIAALALGVVGMLLVLGGRGASEHG
ASLIGDGLIVGASLCWAIYTVGIRTVGPEVSALRITAISMLTGAPGVVLVGVPELLRLET
ENIRAGAWAGVVYSALVPLVLAYFTWGRTVQKVGSSRAGLYNTGIPVVAALTAWAVRGEQ
PTWMQVLGAGLVLSGVLLSRRKS
>fig|246197.19.peg.4119 Drug resistance transporter, EmrB/QacA family
MPGHPASSSAEAGGDAPRGSRLASIAVASALFMEFVDSTALSTALPRLSLAFGTDPIHLK
LALTSYILALAVLAPASGWVADRFGPRRVFMLAMSVFLLGSVLCGFSQSLTQLVIFRTLQ
GLGGALMTPVGRIIVVSSAPRERLVAALSWFTMPALVGPLVGPPLAGLILGVADWPWIFF
INVPVGILGMLAVARFVPPLHQPDPGPFDTRGFVLVAVAITTLIGAAETVGIGLMPLSLQ
LGLAAVAFLSLGAYVWHALRVERPVLNLRLLRIDTFRASMIGGTLTRMGLGASPFLLPLL
FQVGLGWTPVEAGLVTIGGGVGALACKSVAPYIIRRFGFRQTLIFANLTSAVLTAMPAFF
RNSTPIPLIVGVLMVSGFMRSMQFTAINTVAYADIPPDTVSNASTLSVVTMQMALGLGIS
FGGLMLHLARGAGEAPLTPDRFVLPFIAVGIMSSLAGPLYRRLSPNAGAHIGGRRVG
>fig|246197.19.peg.4331 Drug resistance transporter, EmrB/QacA family
MKPPGPAPTHVGVGPSFVSESVCARTLSDHPGREAACCWRPPPAAVKEGLSRVGVFMRTT
HRPLTTLALALSLFMAALEATVVSTAMPTVVGELGGIQHYAWVFTAYMLSSTITVPIYGK
LADLYGRKPVLVFGIVLFLVGSIASGLSTSMAMLIGFRTLQGLGAGAMQPVALTVIGDIY
TLEERAKVQGAFSAVWGIAGLIGPITGGFLVKYLTWHWVFFINVPVGVGCLVLLLSYFHE
RVERKPQKLDYAGAALLTGWVVALLVGVQGVGVNLWGLPVAAVLLAAFVAVERKVAEPII
PMSIFKVPAIVISSIAGALFSAAMFGATTYVPLFVQGVLGGTPTEAGGMITPMIVGWPLA
ALVAGKLLLKTGFRPLIVGGLGLTVVGTSLMALLLGPQAPRLLPEVAMGLFGIGMGFAST
ALLIAVQTSVGWELRGVATASNMFFRTIGGAIGVGLMGGVMVSQLLKDPTVPISAANALM
SPDHGQDLPADLLATLSGALGTGLSINFWLICAFTVAAFAAGLFFPKVSRTTTVSSTEVV
APH
>fig|246197.19.peg.4462 Permease of the drug/metabolite transporter (DMT) superfamily
MPSARTVREPQAEVGCAPAGAGVRAGVTRSHTVRYFAMVAAGATLWGCWALFFRPAGLAG
PQNAFLVLLAMSLPAPFLFRRDALRDRRATLAMLVVALADAANTALFFAAMERGPVSIAV
LTHYLAPLLLALLAPWVLGEERSTRALIGGPVTLVGLALLIGRPDGDFSGLTALLGAGSA
CFYAIIVLAAKQAARAYSPMAVTSLHAPISAGVLLLCFGDRVLPPTVDGGTLLVLVGGIV
CGLIGNILFHTGLRHVPTAATAALTYLEPLTASLVGWAFFSETLTPVALGGGLLVLVAGA
WVAAERRATLQAVPLRAAAR
>fig|246197.19.peg.4466 Vancomycin B-type resistance protein VanW
MVSDPGVSFPGAALAECSDMPSPPIAPRLLELSAHALLWRRSKQWMLQANRLVRWSATPE
RWPRPLLAPTHEKGVLLGSHTVNLERSDSDADPVLEAGKQHNVRLAAPAFDGLLLAPDRP
LSFWRTLGRLTERKGYRHGLALSGGCLTPSIGGGICLLANALFEFGARQGWHILERWGHT
MEAVPPPPGALWGMDATVAWPYVDLVMAPREGAVRLGARVSDGKLRLSIHGAEAPRTRSR
LWSEDESLLELAEGTLRINRVVRRVEDTSSGAVLEERTIAENRRRLLNPEARKRTCLTCG
ETACHARVEVPRSEVRAP
>fig|246197.19.peg.4793 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MVISRYHRHATICDPCNWIKTGFSASEPPTSQVRPPRSLVAQYPSISLFFPAWNEEDYVE
RAVSRALEVLPALTDDFEIIVVNDASTDRTREVCEALAQKVPQLRVIHHPVNLKLGGAMR
TGLAASTKDIVVYSDVDLPWDMRELERALHLMSYLEADMICAFRFDRTSEGAKRIIYSFV
YNMLIRSLFDIQIKDVNFSFKVMHRRVLEAMELHSQGSFIDAELVVKAIRQGFRVFQMGV
DYFPRTRGVSTLASPSVITKMVRELVKLYPKMRAPQPPVHPVRLPPSVQQLHAVPPGRTA
RG
>fig|246197.19.peg.5288 Permease of the drug/metabolite transporter (DMT) superfamily
MRRRRLRGRPGCVKKPAAVAAVTSPGEPGVILSGGPRDMSTSTSDMLGGGTEPSSRSQRL
RADGALALITSFWGITFVVVKDALGHGDPFSFLTLRFIVGAVVLSVLAGRQVLIARNLRI
GSMLGTFLFLGFSLQTVGLTTTTPSRSAFITGLCVLLVPLLSMVLYRKAPKFTSLLGVGV
AAVGLYFFTQPDGGLGSGGLSSGDVLSLGGAVAYACHILMTERHAPKQGVMGLVAVQLWT
VALLSALCLPFVERRVAWHPSFVGAVLVCGVFASAVAISLQTWGQARTTAVRAALIYSLE
SVFAALYSVLLGYETLGPREWLGGALILSGVLMSEVGAAAWVWWRARAPAR
>fig|246197.19.peg.5308 Permease of the drug/metabolite transporter (DMT) superfamily
MGAPSARPLTSTSPQSLGPVYAGLMLQVLISAGTYLAGKRAMSELAPLTVVLWRFVLSGS
VFMLLLCFLPGPRLPPRNEWGRVLMLGLLAGPVNQVFFFYGLSQSTAAHAALLYALTPLG
VYLLSLGRGHERASFRAMGGIVTAFAGVVVLLLGRGLADASGSLMGDLLILGAVMSWVVY
TTEGKPFVAIHGPIRATSWSMVASTLMMMLMAPFFAKPEAVLAASSAARYSIVYLGLLTS
VVAYLLWYFALSRVPASKVAVFSNLQPAATALAAWVILDEALHWEIAVGGVLVLLGVRLT
QAAHVRPPAVAPAAPERPPVSSSVG
>fig|246197.19.peg.5977 Glyoxalase/bleomycin resistance protein/dioxygenase
MKKPAVGSVGWMDLTVKDAVAVRDFYKDVAGWSATGLDMGGYEDFVMMPPGGGETPAGGI
CHARGKNADIPSGWMMYITVADLEQSLERVTAMGGRVLGTIRGSAKTGRFCFIEDPSGTA
CALYQSGSD
>fig|246197.19.peg.6668 Multidrug resistance transporter, Bcr/CflA family
MYSHGVPFQQPCFWVRGTFTVRRPEAGYSPGLGPRPRESMTTPSTQSIEKGTLGLELLLG
TLTAFAPLSIDMYLPALPRIAEDLQSTAPAIQLTLASCFAGLALGQLFTGPLIDRFGRTR
PLYAGLALYVLGSLGCALAPSASMLVAMRFVQALGGSVALVVPRAVVRDLWSGANAARTM
SRLMLVMGVAPILAPLLGGMVLQYSGWRAIFVVLAAVGAVALAFVLKSLPETAPPHVGAQ
SMRSRMGALMKDPDFVGPALAGGFAQAGMFAYIAGSPFVFISLYGIPEEHFGWFFGVNAM
GLIAVAQLNRKLVTHLPLHRLLRLALSLCVVAAVAVLAVAWTGFMGLWGIAVTLFFFVSA
MGLVGPNAAAIALERHATRAGMASAALGALQFTAAAGASWAVSTFNNGTAMPMAGVMTAM
ALLAWLAAFFGLRARTRQQEAGEGAQAHGPRIVSSSSAP
>fig|246200.3.peg.1512 Bicyclomycin resistance protein
MQSPPAPSHRSPPALATLILLSGLSALGMNIFLPSLPNMTEYFQTDYRLMQLSVALYLAV
NAAMQVVIGPLADKAGRRPVILWGLVLFLFVTLGCIYAPTVEVFLFFRMCQAVIAVAIVL
SRAAVRDMYQQDEAASMLGWVTMGMAVVPMIGPALGGVLDQYFGWQANFWILFVLGVAAL
ILTYVDFGETALKSGKTLIQQFREYPALLTSPRFWGYSLASGLSSGAFFAYLGGAPFVST
EVFGMEPARMGLFFGAPALGYFAGNFVSGAFSVRVGVDRMVLWGCLMNALGVTLSLVTLL
AGFGSEYSFFGFMTLVGLGNGMAIPNATAGALSVRPHLAGSASGLNGAIMLGGGAALSAW
AGALLSPETGAMPLLLLMLATALLGVVAIFSVIWRARRLGL
>fig|246200.3.peg.1776 Permease of the drug/metabolite transporter (DMT) superfamily
MTQSPDITAKSWAMVATLGFVWGGTFLINELALEGITPFWLAAGRVCFGALLSTLVWRAM
GGRLFSAPLSGSERLSLVIIALLSSAVPFSLIAWGQQYVTAGFTGVSMASIALMVLPLAH
FFVPGERMTWRRALGFAIGFAGVALLMGAQAFESSGAALELPGRLACLAATACYAVASIL
MRRLPAVDPMGLSTVLLLIGVVAVLPMAWIAEGPPPSTDLRTLGLIVFLGMVPTAAANLL
RVTLIRSAGPVFMSLTNYQVPIWSVLLGAALLGEPLPPVLLWSLLLILGGVGLSQYGALR
RLFTRQ
>fig|246200.3.peg.1840 Antibiotic efflux protein
MAAPLVIRNRNFRLLFTAGALTNLGDGVLVLAVPWLAALMTRDAVAIAAVAAAARLPWLL
FALPAGVIIDRSDRRKLIARADLMRAGIVLAILLLALGDPAPGAIWALAGLAFLLGSAEV
LRDNAAQTILPALVDPDDLEAANGQLWSTEQLTGQFIGPPLAGVLISAGIAVPFGLDVAV
LVLAAGLVWLISLPPQVPSRARFAQALAEGIAFMRGDALLLRLAVVLGLANFIAMATITV
QVLFAQEVLGLGAAHYGMVLSAGAVGAICGSLLAPRAMRLIGTQACLFLSIAVWGAGYAS
IGLSNSGWVMGLALTAIMAAAMLWNVITVSWRQRRIPPAMLGRVNSIYRFFGWGSMPLGA
LAGGALVVLAEQQMSREMALRAPFLLAGLCCLALLIYALARLRLE
>fig|246200.3.peg.2378 Permease of the drug/metabolite transporter (DMT) superfamily
MSDQKTLSPRAWAELLLLGLIWGASFLAIRVALDEVPVVTAVLHRTFWAALLLWLVVWAS
RIALPRDPRVWGAFLVMGLLNNVIPFGLMAWGQLYIETGLTSILNASTAIFGVLVAAAVF
ADERLTPRRLLGVSIGFAGVVITIGFEHLTRFDPRSTAQLAVLAGTLSYAFAGAWARARL
GGLAPQLAAAGMLTGSSLILLPAALLIDGPVTLSLQPVTWAAIGYYALVATAGAYLLYYR
VLAMAGAGNLMLVTLVIPPVAIGLGAWIRDEALPANAFGGLALLALGLMLLNRRPRRRD
>fig|246200.3.peg.2834 Bicyclomycin resistance protein
MGWSGARDRDSADLPSKPPDPLMRHASNPPHLITLVLLTALSVLTLNMFLPSLAHMGQDF
EVDYGLINLAIAGYLGVSAILQLIIGPLSDRFGRRPVLLIAMAIFLVASIGCVLAGSIWV
FLGFRLLQAAVVAGPISSSASIRDQYPPNEAASKLGYVAMAMALAPMLGPMLGGALDMLF
GWRAGFVLYSILGAVMLALLWVDFGETNTERSVTFKAQWQQYPHLFRSRRFWGYALCASF
SIGGFYAFITGAPLVAAAWFDLSPALLGLGIGIITGGFMVGNFVTGRIAARTRLTTMILL
GRIIASTGPAIGLILFLTGAGSVWVFFGSAVLVGFGNGLTNANAVAGLMSVRPRLAASAA
GLSGALTVALGAVLTTVTGIVVSAENAPFAVLGLMSGSSFLGLLAVLYVRWVDLREPLPD
T
>fig|246200.3.peg.2871 Drug/metabolite exporter family protein
MCRTRPSCGRMEEKRPVDAAGAVALIGIAALLAFNQVVIKVTGGGFGPLFQAGLRSALGL
VFVLIWMRLLRKPIVFPRAALMGALITGLLFTVEFMALFAALDLTSVSRVSILFYSMPVW
LALGGHFLLPGERLSGMRVLGLMLAMGGVVLALLERDAAHVSLLGDALAVFAAMCWAAIA
LGVRLTPLGRVPAEMQLMSQLVISAPLLLVLAPLTGETLRTPGLLHWAGLLFQAVGVVGL
GFLIWFRLLAVYRANGVASFSFLSPVLAVILGWLLLGEQVGPLVWLALGLVAAGIVLINR
R
>fig|246200.3.peg.4191 Permease of the drug/metabolite transporter (DMT) superfamily
MDLRAIAMGLAFAFMWSSAFSSARIIVADASPLFSLACRFLISGLLGVIIARAMGQTWRL
TRNQWKATIVFGICQNALYLGLNFYAMQTVEASVAAIIASTMPLLVALASWGLFGERLPA
LGIAGLLAGFLGVALIMGARIGAGVDLFGVLLCGLGALALAAATLALRGATSGGNFMMVV
GLQMLVGSAVLFLATPIFETVHVTPTLPLALAFAYTTLVPGLTATFVWVLLLNRIGAIRA
ATFHFLNPVFGVAIAAALLGERLGALDAIGVAITTAGILAVQLSRQASARKP
>fig|246200.7.peg.100 Permease of the drug/metabolite transporter (DMT) superfamily
MVLAILLSLLALVLFDMMGLIIKYLSPRYGAAELSAYRNFFGVFPSVIALWSSPGWHRAG
RPWRIRQWRLGLMRGVYVTFAQFLFYYSLGKLAFATASTITYANAVFMTALAVPLLGERV
GLMRWAAVLLGFAGVLLVMKPGSDSFTPDALAPLGAAFLYALTGVSARQMDSAVPSALIN
LYSVVAALVGALALALLSGGFTPLAQWSDLGWIAAMGGFGGTAVLCLVASYRMTEQSNLA
PFSYFGIPIAFVAGWLVFDETPWADLFPGAFFIAGGGLMIVWRERIRSRAGRRISN
>fig|246200.7.peg.1464 Permeases of the drug/metabolite transporter (DMT) superfamily
MSLWIPVTLAAALFQTVRFMLQKSLATVKLSASGATFARFLYSAPLALAGLLIATTAGGY
DLPALGARFWIFVAIGGTAQILATICVVALFKQRNFAVGITFKKTEVIQTAIVGFVILGE
GVSFGALGAILLGLVAVLLLSKTPGGSGAWWRHLTNRASQLGLGSGVLFAFSAVSYRAAS
LELGDLTPWFRALVTLAAVVSFQLVSMALWLWWRDRAQLAAVWATRNTGAFVGLTSLGGS
FCWFLAFTLQNAAYVKALGQVELIFSLMASTLFFREKITTREIAGIGLLGLSILALVLAI
>fig|246200.7.peg.1547 Acriflavin resistance protein
MSEGSQNTPLGIAGGLTRGFIGSALTPLMILAALAMGLVALISLPREEEPQISVPLVDIH
IQAPGLKAEDAVKLVTEPMETIVKAIGDVDHVYSQTGDDYAMVTARFLVGTPADTAILRV
HDKVRANMDRIPVGIGEPLIVGRGIDDVAIVSLTLSPRDGAGDVSANDLTRIARELQVQL
AKIGDVGLTYLVGEAPEAIRIAPDPERLALYGVTLQQLAAKVEGANRALATGLVRDGGEQ
IALVAGETLHAPAEIANLLLTTRDNRPVYVRDVADVRFVPDTSERIVANVTRDDSGGFRR
SPAVTLALAKRAGANAVVVAEEILHRVHLLEHDLIPDSVEVTVTRDYGETANEKANELLF
HLGLATVSIVVLVLFSIGWRESIVVAVVIPVTILLTLFAAWVMGYTLNRVSLFALIFSIG
ILVDDAIVVIENIARHWAMPDSASRTQKAIRAVAEVGNPTIVATLTVVAALLPMLFVSGL
MGPYMSPIPANASAAMIFSFFVAVIITPWLMVKIAGRAPAHAHDAAAQHGGALGRLYRAV
ARPLLRTKSGSGLFLLVAAVLSFGSLGALYTRDVTVKLLPFDNKSELSVVIDLPEGASVE
DTDAVAQQVARRVLELPEVISAQTHAGDAAPFNFNGLVRHYYLRARPELGDVQINLLPKD
ARTRTSHDIALDIRERLSTLDLPEGTVLKTVEPPPGPPVIATLLAEVYGPDADSRRAAAT
RIREAFESVPFVVDVDDSFGTQARRLRATVSTDQLEFFGVQERDVFSTLAILNAGQTVGY
SHRGEGRRPIPIEVARDSADRVVDERFLSTPVPANVLPGARGVVELGDVVELREERASYP
VFRHNGRAAEMVMAELAGDFEAPLYGMLAVAEALDAMDWPEGGKPQIRLNGQPEDESVIT
LLWDGEWEVTWITFRDMGAAFGVALLGIYILVVAQFGSFRLPLVVLTPVPLTFLGIIIGH
WLFNAPFSAPSMIGFIALAGIIVRNSILLVDFIRHANPERDKIETLIEAGAIRFKPILLT
AVAAMIGAAVILTDPIFQGLALSLLFGLLSSTLLTVLVIPAIYRVFKT
>fig|246201.1.peg.1787 Permease of the drug/metabolite transporter (DMT) superfamily
MSSGWITSMRLTLAGSLVLIWSAVQLKSQVLDIWRDKKNYLPFLAYAILGIFSVQYFFYL
CVEYSNAATATILQFISPVFILFYNRLVYQKRASKSAILYVLVAMLGVCLMATKGDLSQL
SMTPLALVTGLLSAMGVMFNVILPQPFAKRYGFVPTVGWGMILAGLFSNVLSPVYQLSFT
PDIWSILICLIIAFFGTAFAFFISMKAVSLVSPLVVSVISASEPLSSALLSVLFLGLVVD
WSLLLAMALIILPMIFLSIEEAKESK
>fig|247156.1.peg.887 Permease of the drug/metabolite transporter (DMT) superfamily
MASGLAFASSGPLAKSVLAAGWSPGAVLAVRLTGAAAVMLVAAALADPRGLARSPRHLRT
IGGFGVVAVAGVQATFFLSLQHLQVGVALMIQFLAPVVVIAWDWVVRGRRPTPLTLLGAA
VALGGAALVIDVFHTEGLRPVGLAWAALSMLCNAAFFLLSARTSDSLAPVTLLGAGLGVA
AVTSWALGLSSVLPLHFGTGTAVLAARELPVWAALALLITISTVVAYACGVAGAARIGST
LMSLVLLSEVLFAVALSRILLGEAIAPIQMVGALLVVGGIALARSGGQRRPAASEVPAPG
PQAT
>fig|247156.1.peg.1442 Drug transporter
MTTVSQRTQRPPNLARRTLLIACGATFIALLDLSVVNIAFPSLARDYPDTPVTTLTWVVS
GYGVAFAALLTPAGRFADALGRRRLFLIALAAFALTSLLCGLAPDAATLIAGRVAQGAAA
ALMMPAALGLILAVTPRERIGAAIGAWSAAGSFAAVVGPPLGGALVEAFGWRAVFVVNVP
IALALMLPARGLPETGLRPPGSGLPDPVGTIAVALGLGGLVVGVTEGQRWGWTAPTTLLA
LGVGAALVAVAIARSARLTVTGRAAGAALAVGLWRSRPYALANAASFVFAGAMYSWLMAG
PLFLDAVWGYSVLGSAGAMTAGALTSMITATAAGRITAPAVRRWAGVLGALLFAAAALWM
SSDSFGPDPALWTAWIPAGVLGGGGIGLVLTALGTAAAAALPPEQFAAGIGMNLTARQVG
GALGVAVMAAVLAAHPGDALTGLHTHFAVCAAIAALTAVLTALPSRQEQP
>fig|247156.1.peg.2923 Multidrug resistance protein B
MSSSVETGTRPDPDAMTHREVLEAMTGLLAALFTALLSTTIVATALPTIIGDLQGSQTAY
AWVITTALLANAASTPIWGKLADLFNKKLLVQLSIVIFVAGSILAGVAHSVDVLLAARVV
QGIGMGGLTALVVAIIGSIVAPRERGRYSGLMGAVMAVSMSGGPILGGVIVDSPLGWRWC
FFVCVPLAVIALFLLQRTLRLPTERKDDVSIDWLGAVLLTAGVSVLLIWVSFAGKAGYYD
WVSRESVLYVGGGVLLLAATVWVEARAKAPIIPLKIVTERTTGLAIIASIAVGVGMFGAT
TFLGQYFQTSRAYSPTIAGVLTIPMVAGMLVASVVSGQMITRFGKWKSFVVSGAALMVVG
FSLLATIDHATNLWLVGIYITVIGLGMGMMMQNLVLAVQNTVSVQNIGAASSSVAFFRTF
GGAIGVSVLGSVLATRVSELSAEGFARLGIRPSGEGGSNLDLSGLPAPVLDVIRASYGDA
TGRIFLIAAVATFVALLAAAVLPNRPLRRTIDIDPAQDPMRTGVPAAPEERDGVELEKAR
TS
>fig|247156.1.peg.3258 Multidrug resistance protein B
MTSSTPKPSPETTASVAEMPVSEQDSGWRGLFSRPHRTAVIVMAGGVGLYAMNLYFTAAL
MPTVVGELGGQQYYAWAATAYLITAVTATMIVSRMLAVRGSGGSYVVAYLLFAGGTVVGA
GSPTMEFFVAGRAIQGLGAGLLTGLGYATIRRVLPPQLWTRATGLVSAMFGVGTLLGPAL
GGVFAEGGAWRAAFATLTGIAILLLLVTVRALPTRRPEEATRTPVPVASILALALTAALL
SLRSALSGVWVPVTVAAGLLLLIAFFVIDSRDPDGVLPRLAYTPGNPLKWVYVTVAALCA
GVMVENFIPLFAQQLADATPIVAGLLGAVLSLGWTLAQLFSVAAAERTARILVRTGPVLL
TAGLAAYGLLQADGAGWLHLTVWAVLLFVAGAGIGLAFPHLSVAAMRAGKDEAEGAKAAA
AVSTTQLIAFTLTSALAGNLLALGGDSPLASARWLILGIAVLTAIGVATALVATRTATTR
SRLHQW
>fig|247156.1.peg.4681 Probable multidrug resistance protein norM
MTPFGPDTRRLAALATPIALTQLAQIAVSTTNIALMGTLGVGAVAAGGLALVLFNQIRTM
CVGLVTGTGNQVAAAVSAADKRGDSPAGEVREIVRASFLVATLAGLLGGAVLIGLGWSLQ
WLGQDASVLAEARPLLVALAPGLLPCLWFQVLRQYTVGMQRPQALLLVTLASIALNLVLA
LAFIHGWAGVPALGLTGVGVATSLVFLITFGVFWAMVRHDERLGAMLSVRPWPVRGRTVL
AELRLGTPIALTYGSEAGMFSVLALVMGSLGPAALAAHNVVYQIIYIVFQVAIGLSHGAS
ILVSHAVARDEHAHARHVAWLALRYAGVVAAVTGALYVLAPQLVLRPFLDPADTATLDIA
RALLLIGIVLQFFDAAQNIGTGLLRGLKETGAGFRLSLIGYWLVGLPTALVLALPVGLGA
PGVWWGLTAGLAATAILMVRRYFVLLDGLALPRPRPLPQAVGTA
>fig|247639.3.peg.1038 Permease of the drug/metabolite transporter (DMT) superfamily
MTGPRYMLLSAFAFALMGAMVKIASAEGLPLLQIIFVRAIISVLLCLIAIRRSGSNPLGR
QRGLLLARGVVGFMALTGVFYAFINLPYAQATVLQYLHPVFTAGLAFWFLSERPTPATLI
CIALSLLGLGCVVYPYLQSTNTSVMPIAAVLAGLGGALGSGIAYTLVRKLATTEHPSVIV
LYFPMVCVPATLLLGAGDFIWPSQIGWLTLLGVGCFTQLGQISLTKAMQTDSASRATSLS
YLQIVFAASLGWLLFKEVPATATVIGAAFILFGALISAALQPNPDKKRGAGNA
>fig|247639.3.peg.1525 Acriflavin resistance protein
MKGLISWFVRNPIAANLLMFSLVVGGLLGLIEVRKEEFPNIDVPTITVSVPYLGAAPSEV
ETGVCIRIEEAVQGIEGIEKIKTQAAENRCVVALELTNASYQDRALDDVKAQVNAISTFP
ANTERPVVALVSLRSVVMYIAVSGETDERSLKNLTESLREEILEIPSVSLVDTMYVRPDE
ISVEIPEFTLRRHSLTLGQVAEAIRQSSIDIPGGSIKTESGEIRLRGTAQRYSGRELEDI
PIITNADGTRVLLRDIAVIRDGFEQQDLSAMLDGRPTQLLKVWRLGKDNTLAMARDLSEF
LEVKQRSLPSGLELRIWSNEADELVSRLSTLINNATGGLLLVILTLALFLRLRLALWVTA
GIPVSILGAIAFFPSADLGISTLSLMGFLLSLGILVDDAIVVGERIHTHEGFTPDSREAA
INGTTEVAIPVFFGVLTTMAAFIPIVTVDSMLGSFFGAIGWTVLLCLVFSLIESQLVLPA
HLAHRNRERGKSAIGARWENFQENVSGGLERFAQQRYQPALRLVLKYRYVTLGAAVAALI
IIVGLLASGRIVFQFFPTVSGNEIYASVELPEGYPVERTATALEVIQASADQLIVELNEG
LPEGATAVVNQFKTIGLPISKSTISGSEESGSHIAEMSITLYPHDERGGMTPKQAAKRWR
ELTPDIPDVIEKSFTASAVSLGEDINIQIRGKDLEVMSAAASALTKILSSFDAIYDISDS
YRAGKQELVLRVRPEAESLGLTQADLGSQVRHAFYGAEAQRVQRGRDDMRIMVRYPEADR
RSLDDYNQLYIRLPNGAEVPIESVASTQLSTGNATIRRVDGQRTINVTAYADRTRIAPET
VLRLVEDQHIPRLEAEFPGTTFSLAGEAEERASALTGLARTSLLALIIIYTLLAVPLKSY
LQPLVVMASIPFGLIGAILGHFILGYDLVFFSILGIVALSGVVINASLVLVDFINKRRLN
LEITVAEAVTRAGVARFRPIFLTSVTTFVGLAPLMLNADLATAPFVPLAVSLGFGVIFAT
AVTLLLVPALYLILDDFSGPPDNETNTDHGSKQGEA
>fig|247639.3.peg.1607 Acriflavin resistance protein
MQGPLSWMIKNPIAANLLMLLLIVGGVLTTPSLDKQFFPTAQINQVSVTMPFPGAGPAEV
EEQISVRIEEAIHDLNGIKEIRSTAVQGLGTVMVEATQNYPMQRLTSDIKTRVDAINSFP
ADAERPIVTEITYRHLMTVVQLSGDLDEYELKELGEALRDDLARQPWVSMVDLITARPYE
VSINISETMLRRYGLTFDQVVAAIQGTSLNLPAGAIKTQEGDVRVQTRGQAYGRADFERI
TLLTQTDGTELLLGDVAIIEDGFVDLDLNVTFDENPALGLRVYVTSNPDVLKTNQVVKDW
VAEQQLSLPPGVSLTIWRDISKSFRGRVTTLLENGIGGLLLVAAVLVLFLRPKLAFWVGS
GIAVAFLGTLFMLQFTGISLNMISLFAFLLVLGIVVDDAIIVGESIHTHQARGERGHVGA
LLGVRGVFKPVMFAVISTMIFFVPMLLLPGDWSTAARSIPVVVLLALAFSLVECLLILPA
HLAHLGPEKEPKTRVMQRLAGWRQACASGMVWFARYRYRPFLRWALSHHYAAAGVFLVAF
SMSIALYGGGWVRSAFFPKVNSDYVVASVEMPEGGPYSDTVALRDRMVAAAQVLKADWNA
RPEFFVTPAISHVSATTNDNKINIEIGTVSEGVDTEQIALDFRDLVGPVPQAKEIRMDFT
IQDPGKQIKLLFASRNTEDLEGLAPRVRAALLAYPGVFDVSDSFDSPRDEVVLDLKPAAE
ALGVTLASVAKQVRQAFYGAEAQRIPRGREDVKVMVRYPESERRSLANLDEMYIRTPTGK
EVPFGTVATYRIEPGYQKLERLNRMRTLEIGADVRADGASPRAVVDGIVVNKLPLWQQEY
PGLELNLDGELQEEAEFKSSMLMFMGLAMLVIFGLMAIAFKSYWQPFLVLTAIPFGIMGA
IFGHALLDWEVSIFSMMGVIACAGVVVNDNLVLIDRINHLREQGYELWDALLQGAEDRFR
PIILTSLTTFVGLLPIMSETSVQAQFLIPMVTSLAFGVLFATGVTLVLVPALYLVGDDVT
GFLQRLLGGDKVSAATDSSVVTTAH
>fig|247639.3.peg.1700 Permease of the drug/metabolite transporter (DMT) superfamily
MILRSYYWLLLASTLLMASAFVVSKLFIVDGIHPLVLVASRFTLAGALAIIWLSLRRQLE
TPKTLSDVGGVFLVGTLQTAVLFGTGFIAMEHLSAATISLLTLTMPIWVTGMLALMNRKF
PPLLQLIALGVGMAGVALIIGSGVSEAGMGELQWFALALVGAACWASATVFTKTSGLSIT
GWSLNAWQMLVGGGEVLILALAMDLPGIKLVLVSDILLFIWLVVPASILSFGFWFSALKL
GGAAVTSGYLFLIPLFTALISVPVLNASFAPMQLLGGVAVAAAVWLMSRSST
>fig|247639.3.peg.2328 Glyoxalase/bleomycin resistance protein/dioxygenase
MSVEVIASEKAEAADSLWGLALKTADIDATHQRLNEAGVEVSEVRDGRKKDTRVCTVKSH
ALNVPTLLIEHPVK
>fig|247639.3.peg.3295 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAAAKLMTVTLFRREMRQLLRFAFPLFIAQSAQMGTGVVDTIMAARYGEQDLAAISIGIN
IWLPVYLLILGTVFATATIVAQDFGGGRIEKIRQQLPQSLWVAVFLGLTLSPAIWYAGPI
LDLLGLNPTTRQLALDYAQMVALGMPATAIFQALRYHTQGLGITQPFAFAAVAGFLINVP
LNYAFIFGEWGAPELGAKGCGIATAISMWLSVFLIGAYVLRSKKIRLYLPEWKPVAPDWA
KIREILSVGAPIGLTFFLEMGVFSVIALLVASLGDTAISAHQIAFNVWDLYYIPMLAIGT
AMSTRIGHAIGAGWREGIYRAMIVGGAISAVVAIGTMLILLSFPGAIIGIYTDAPDIQLL
ATRLLTLSAFFILIDGAQIVGSFILRAYKETQFPFIMMVVSYWLVALPLGWWLGIEVPDN
PNDGAAGFWYATITGISVCTVLIGARIWVILRRELPSTAAE
>fig|251221.1.peg.268 Drug resistance transporter, EmrB/QacA family
MKTRRPSFGRYHRKCALVTGDSVVQYQRPIDYTTALDERTKRLVMGAVLIALFLTSLDQT
VVVAALPKIVADLGDLDLLAWTSASYLLVSTTSLPILGKLSDLYGRKNILLIGIAIFLLG
SFLCGLAPSMLMLVVFRGIQGLGAGAITSVALTIPADLYVPAERAQLQGIIAAVFALSSI
VGPLLGGVLTDTLGWHWIFFINLPFGLLALAFIVAFMPRLNSGLTRSIDYWGAVLLMLTV
VPLLVALSLEKEKYAWDSPLVLGLLAAAAVSFGLFVFAELRAKEPILPLSLFRIPIFSLI
CAMSVMVGATFIVAILFLPVFLVNVMGASATEAGVALIPETLGLLVSSFISGLVVQRTGR
YKAAMLVGLVLMSIGIFLLTQLSLTTTIAQVWFSIAIFGLGAGATFPQANLALQNAVPFE
YVGVATAGRLFFAQLGQTVSAALYGALLVAYLNTALVDSLQPVAARLPASLATHLDPGRL
RNGGEQAAAELAALGTEMAPRFTPEVRRRTEAQVRTAVRRSFAEAVARVYQASLPLPLIA
LLLGLLVPELPLKRSNSPDTPPAAVHE
>fig|251221.1.peg.2822 Drug resistance transporter EmrB/QacA subfamily precursor
MTKQVARNTTRDLGAQPDNKWAILLAVSIGTFLVPLDITVVALALPDIESSLRTSFADLQ
WIINGYNLSFTAFLLAAGTLADRFGRRRLFLVGLALFTLTSLTCGLATTPLTLTLARSIQ
GLGGALLLISSLAILSQTFREGPERANAFGVWGLVMGVGASLGPMIGGLLVDLLSWRWIF
LLNVPIGVGLVAFTLSKVDESRDPGAARVDWLGLTTFTSALFSLCFALIQGNELGWTSAA
ILGLLAAAAVLLFAFALIERRQSQPMFDLSLLGNPAFVGTSLLAASNGASFWAMIVYLPL
FFQNVLGYSPLQAGLMLLPLTVPLLVCPPLGGRLAQVLPARLLLSGGMLMVGLGFVWMYG
VNAGSPWTAFLPGFLLAGIGAGLINAEIANVAIAVLPPQRSGMGSGITSTFRHGAHALGI
ALLGSLLTQRVATSLEQSTLPGLVTERSTQLASQIAAGDLIGVVRTLPPELQNAFAAAAQ
NSFIDGFNLIVLLAAATALLGALATFVLVKDQRSQSQLQRQERPSASKS
>fig|252305.5.peg.1593 Multidrug resistance protein B
MPSKTEHPVTPPPDLPGPDAATLRVLLITVATTLFLASTGNTIVTTALPRIVSDLGGLAY
ISWVVTAFLLASTVGAPIAGKLGDMYGRKIVLQVAIGVFLLGGLICGVARSMEVLIAGRF
VQGLGGGALIVVSMAVVADVLPPRERGRVQGALSSVFGFSTVVGPLIGGFLVQTVGWHWI
FFVNFPIGVVAFVILTRTLKSSTEKVPHKMDFVGSALLLILLSSVVLIANLAGSVYAWTS
LTVLFLLALAPMALVGFVSAERRAAEPVMPLDLFRIRNFQAANSVNFLVGMAMFGTIAFI
PMFLQVVKHVGPVSSGLYLVAMMGGLIGTSFAAGRVISSTGRYKVMPTVSTAVLAGAMLL
LTTINPETPLAVITLYLFLVGAGIGPTMSVGIVSIQSAVPREHLGVGTASANMFRLIGGA
IGTSVFGALFTLGLGRHVQPLMPQVQEVRELTSAMVDRLEPAAQAAVLQGFSDALMPVYF
VGAAVAAIACLASTRLVELPLGPVPRDRRGTPAE
>fig|252305.5.peg.2558 Drug/metabolite exporter family protein
MRAMRKDHLDPAGFAALVLFTTVLAGNQIVMKLTNAGLSPIFQAGLRSLLACLVVLAWVR
VRGLGLGPFRRNFWPGLALGLFFSIEFAALYTALDMTSVSRASIIFYTMPMHLSLAAHFL
IPGERLTPQKVAGLVCAFAGVVIVLADRSGGEASLLGDVLALVGALGWAAIALTVRITRI
SEAPPEAQQIWQLSVSAVVFLAIAPLFGPVLRDPGPEHIWLMAYQVLLVASLGFLAWFYL
LKRYPAATVASFSFLTPVLAVFMGWALLDETLRWSVLLSLTLVSVGIVLINRKPRARGNG
RARAAATPPT
>fig|257309.1.peg.1871 Sulfonamide resistance protein
MLRSRVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPV
SPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIA
EADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGM
GFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELH
AIGNGADYVRTHAPGDLRSAITFSETLAKFRSRNARDRGLDHA
>fig|257310.1.peg.62 Permease of the drug/metabolite transporter (DMT) superfamily
MGERLVRCCPYQPRRRDPVASHPSSHYVSTAIASPANVGRVYLQLLLVMAAWGVNLVAVK
YLTFHMDVQVVAAVRIVVAFVAVSAILLWRLHGVPRLSLRQFGWLACAGLLVVYAHQILL
VNALRLTPAANATLIMATSPLFSVVLAAFFYRERLTASRIGGAALGLGGVALVVAGGDGV
LASVGRGDVLALCAVIVFVIGGLIIQRVSRALDPLTILWYMYLVGAVTLSAHAAFSPATY
LASSWTLEPWPWLVVLFSSVIASGVSNLLWNAGIARLGMSRAAMFVNWLPIFGLLAAAVF
LGERITALHFAGLACVLSGTWLGLRTAPAPAAGQADARPARARRA
>fig|257310.1.peg.118 Multidrug resistance protein B
MSAPPTQDPEITTTTQESPHSRRDLLRAMAGVSATVVLVAFDSTIVTTTLPRVAAALNGM
ALYAWVGTAYLLATAASILIFGRLGDMYGRKPLMLVSVSLVALGSIACGLAQSMPQLIAF
RTLQGIGGGMMIATAFAAPADLFPDAGQRVRWMALVSATFAMASGIGPVLGGAATQALGW
RAAFFISPLAAVAALFLLARYFPRIRPAQTASRRIDWVGGLLLIVVVGAPLAAIELAFAP
GDGAHPRVALALAVAGIAAVALLVPIERRVRSPIFPLRVLAGLEPRLLNLAAVAVGATMF
ILIFYSPLLLQHELDYSPSEAGLLLTPLVAAISFGSIINGRLFPRQTEPQRLMVFGSCLL
AAGSAMMLAVSAGTSAWWIVAAFFVNGTALGFLLPNLTLFMQMLSERRDVGVASALVQTT
RAMGSAAGTALVGIAISHSSVLDGVRAGLILCVLLSLFSAVVAHRVKMKNVAATPAA
>fig|257310.1.peg.3048 Probable antibiotic-resistance protein
MIVDMRLRPPIPGFARSTLYQAGPKTSHPDFPVEPSVGQCSLPLLISEMDAAGVAVGVVP
GRYSMEPFGIVSNDELATLFADHPGRFVGFMGLDLGWPMQRMLDEIDARVGTPGFRGVAL
EPTISADASFCGMNDKRLYPIYEACVKHGVPVSVTLSAVLQAFTKRPYEHSNPVQAYQVA
IDFPSLDIVIAHAAYPWVMEMIGVCLTCPNVWLSPDLYLTNVFPGAQEYAKAAATYLPRR
TLFGTGYPAKPFKPMIDAYAAWGWPQDVVAAILGGNAARLLRLADQ
>fig|257310.1.peg.3064 Inner membrane component of tripartite multidrug resistance system
MKLPTADEAVFSIKCYLGAMLALYLAYSIGLPRPFWAMTTAYVVAQPWSGAVRSKAVYRL
GGTFFGSAMTIYTVPRLANYPVLMTLAMVLWVGLCLYIAVLDRTPRSYLFMLAGYTAAMI
GFPSVTDPALVFDTALARVEEISLGIICATLVHSVVLPRGIGRAMMGRLDATVRDARSWI
QDVLNQRGAAQHARDRRALANDITQLRLLSTHVPFDTGNIRWTANALRAMQEHITALTPA
VSAVEDRLQALQAQGRALPPPAARVLADISAWMDDSAHATREQAVQLRAALTRLAPAIDR
QSGWHDALLASLVARLRELVDSYDACLVLRQDIHAGLGGAPTGRTRRLTRGAALHRDHGL
ALLSALAAALAISVCCLFWIGTAWTNGATAAMMAAIFSCFFAAQDNPVPGIMQFLTYTIY
SIPLSALYLLGIMPALHSFEMLALAIFPVAFVTGVYIARPTTTGKAMAVFFGLSGTLALQ
DTHAADLVSFVDTIVAQIIGVAVAAIIAAVFRTVSAEWSARRIQAANWKELAALAGAGRA
PARLDFTARMLDRIGLLQPRLALSKRRDDQLADDALQDLRVGKDIAELQRARRHLPMADP
AIQPVLRTLAGLFRKRPGRLGGERPAELLQTIDRALYSVSNTPVAHAARERAVVALVGLR
RAFFPEAAAYRPGRDVESPAS
>fig|257310.1.peg.3067 Outer membrane component of tripartite multidrug resistance system
MSIRSLLPLIPALALAGCAAVGPDYRLPEQAAAKRPAAAAPFVQAREQAVYRQDELPPHW
WRLYQDRQLDSLVEQALAANADLRVAAANLERAQAVTRQAQARQQPTVDVSAAPAFGHAS
GVQELQPGLRPQDSWSYSGGLGVSYQLDLFGQIRRAIEAAQDDAQAAQAAYDAARVTVAA
ETARAYADLCAAGMQLDSARHSVQVQQQSVDAVQRLLAAGRGTTLDVARARSQLEQLQAE
LPPFQAGQRTALYRLAALTGHAPAELPQSLLACVRPPRLAQAIPVGDGAALLRRRPDIRQ
AERSLAAATARIGVATADLYPKISLGLSGASAGPAALFGEPGTFSWSVGPLISWTLPDTG
AAQARIAQAEASTKGALARFDATVLNALRETESALVTYARQLDRDAALRAAREQGAQAAA
QARQLFRLGKTDYLTVLDAERTLAGNESALAASQAQLAGDQIAVFLALGGGWE
>fig|257310.1.peg.3565 Multidrug resistance ABC transporter ATP-binding and permease protein
MKKPQNLAGAGRREVPAEWRDAIHSHLDAGETVLAWLETDLDARLRFETGMVLATDRRIL
ACAPGRREWSSWPYSPDLRLALHDHAGAASLELDAGARRLASWRFTLGRNPAAQRLLEQF
ESLQALRLAGAAPTAGESPRPCPTCQAPIPADREDCPECSQEPAAPPATWALLRLWRFAR
PYRGALLAGFLLTLLGTAATLVPPYLTMPLMDDVLIPFQNGAPIDYAKVRLYLAGLLASA
VLAWGLGWARTYILAWVSERIGADLRTTTYEHLQQLSLEYFGGKRTGDLMARIGSETDRI
CVFLSLHLLDFATDVLMIAMTAAILVSINPWLALATLVPLPFIMWMIHVVRDRLRHGFEK
VDRIWSEITNVLADTIPGIRVVKAFAQERREVQRFREANNRNLEVNDRVNTVWSLFSPTV
TLLTEIGLLIVWIFGIWQVSQKHITVGVLAAFLAYIGRFYTRLDSMSRIVSVTQKAAAGA
KRIFDILDHVSSVPEPHKPVHLPRVNGHIELRDVGFRYGNRSVIRGLDLSIAPGEMIGLV
GHSGSGKSTLINLICRFYDVSEGAVLVDGVDIRSLRIADYRRNIGLVLQEPFLFFGTIAD
NISYGKPDATRAEIIAAARAAHAHEFILRLPHGYDSLVGERGQALSGGERQRISIARALL
IDPRILIMDEATSSVDTTTEKEIQKALDNLVRGRTTIAIAHRLSTLRRADRLVVLDRGQI
VEEGAHEALMAREGAYYRLYQAQQTRQAEGGDDGSDAIAAIA
>fig|257310.1.peg.3706 Permease of the drug/metabolite transporter (DMT) superfamily
MNRAAFDRVGLGLMLLTIFVWAGSWIAMKLVVPYIGPFDFIAVRYLSGAVVLFSILVATG
RPLGMPPWKLTLLAAATQITGFQGFVQTALISGGVGKVSLMAYTMPFWVVLFAWALQGER
PTARHWGGIALAAVGLVCFLDPWAGLGDLAPVALGLCSGLCWGLGTVLSKRMFERHAPDI
MTFTAWQMLLGGVVILPFAWLVPQIPAQWGGWRLWLGMSYIVLVATALGWILWLLVVRRV
PASIAGLSSLGVPVVAVLLAWAILGERPTLTEMAGMALILFGLWVVSRAARPAPRAVS
>fig|257310.1.peg.4251 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MFMYTEFRSQLLAGAGTSAAGQSARMAVLAGDGATGVQVSCVVPGLNEAANLRVLVPALR
ACLEQWCASWEIIVVDDGSTDDTAELMAQWSAVEGIRYVQLSRNFGKEAALTAGLEAADG
DAVICLDADMQHPPELIGDMLAAWRNGAEMVYAVRRQRDDEPWFKRVGARAFYRLLSTAR
GVEVPPHAGDFRLMDRRVVEALVALPERTRFMKGLYAWVGFKSQAVPYTPQARRHGASHF
SAWKLFRLACDGLTAFTTWPLRLVSLIGVLFALLSLSYGGYLVADYLISGNAVSGWTTIV
TALLFFAGINLISLGVVGEYVARIFDEVKGRPLFIARQRRGRAKRAAKARSQ
>fig|257310.1.peg.4422 Multidrug resistance protein B
MSADPATAAAPPPLANPDAARAARMIPFIVGCALFMQMLDSTVVATALPAMAAALGSTPV
RLNVAITSYLLAVAVFVPISGWAADRFGARRVLIAAIALFTLSSVGCALSQNLGQLVVAR
IVQGMAGAMMVPVGRIILLRTVPKQDLLKAMSFLSIPALLGPVIGPPVGGFMVTYMSWHW
IFLINIPIGILGIALVLRFVSEIREENAPRLDLPGFLLSGICLAALVSAFEALGHGLLPP
LELGALIAAGLLCGVLYVWHSRRVEHPILDLSLLRTPTFAISVLGGNLCRFAVGAVPFLL
AMLLQVGFGLSPFAAGMITFASAAGALLMKFVATPIVTRYGFRRVLTINAILTGLFIVAC
AAFTPVTPAWAMIAVLLAGGFFRSLQFTAVNTLTYADIGPERMSRASSFAAMAQQLGISL
GVGVAAVTLNVSMAARGAASLAIGDVVVGFMVVGALCMLSVLSFRRLAPSAGAQLQNVKV
PRDGK
>fig|257310.1.peg.4672 Probable antibiotic-resistance protein
MKIIDFRLRPPAMGFLNARIYTRPDIRNRFTRQLGFEPAPSAEEKSLELMFEEMAAAGIE
QGVCVGRNSSVLGSVSNADVAAVAKAYPDKFHPVGSIEAATRKEAMAQMQEILDLGIRIV
NLEPGVWATPMHVDDRRLYPLYAFCEDNGIPVIMMTGGNAGPDITYTNPEHIDRVLGDFP
DLTVVSSHGNWPWVQEIIHVAFRRPNLYLSPDMYLYNLPGHADFIQAANSFLADRMLFGT
AYPMCPLKEYTEWFLTLPIKPDAMEKILHGNAERLLAQAGR
>fig|257311.1.peg.4335 Inner membrane component of tripartite multidrug resistance system
MSHQQALTVINGMIDTQAYTLSALDVFYASAAIFLLLTGLVWLARPKSAKSAGGGAAEAA
AGAH
>fig|257311.1.peg.4414 Acriflavin resistance protein
MTLTLAAVYAPIGLMGGLTGSLFKEFAFTLAAAVGVSGVIALTLSPVMSSFLLNSRVSEG
WMARKAEHFFQRLGDAYGRVLDVSLRHRWVTGLIAAVVLASLPVLYGSAQRELAPVEDQA
MILTAVKSPQHANIDYVEKFGQKWDAVMQEIPEQNGRWLINGSDGVANSIGGVNLVTWQA
RKRSADEIQGDLQNRVNAIEGSNTFAFQLPSLPGSTGGLPVQMVLMSAADYRVVYDAMET
LKQAARASGLFMVVDSDLDYNNPVVRVDIDRAKANSLGVTMKAIGDTLAVLVGENYVNRF
GMDGRSYDVIPQSPRGMRLTPQSLGQFYVKSASGAQVPLATLVKISMGVEPNRLTQFDQL
NSATFQAIPMPGVTMGDAVQFLTEQARLLLPGSSHDWQSDARQYSQEGSALVVTFLFAII
VIYLVLAAQYESLRDPLIILISVPMSICGALIPLALGMATINIYTQIGLVTLIGLISKHG
ILMVEFANEMQAHAGLDRRAAMERAARIRLRPILMTTAAMVVGLVPLLFASGAGAHSRFS
LGLVIVVGMLVGTLFTLFVLPTMYTLLARDHRAAGQSARARELARLDAQAGAASPAHETA
S
>fig|257363.1.peg.141 Multidrug resistance protein B
MPNNDLKKLPLSKKQLLAFFGMIVGMFMSVLDIQIVASSLSVIASGLAASSNELSWIQTS
YLIAEVIIIPITGFLARLLSTRICYFIASLGFTMMSVLCSLANNIESMIIFRALQGFCGG
AMIPLVFSTVFIIFPASQRPTVTILIGLIVTVAPTLGPTLGGYITEILSWHFMFLLNVIP
GIFVCTVVFLYVDFDKPNYQLLKNFDFLGILLMSLTLGLLQYVLEEGNKAGWLDNKLILF
LSITVALGFILLIIRELTFINPILDLNTFLYKDFTFGCIYSFILGIGLYGTVYILPLFLF
TIAKYDTLQIGATMMVTGVAQFLSAPLAGRMLGLGIDSRLMLTIGLGGFALGCHLNSFLT
TDSKFAAFVLPQFIRGFSLMFCFIPINNIALCNMPKEKIANASGLYNLTRNLGGAVGLAI
ISTILSNDTKIFMQYLSENISYTSIMALTKLDYYTELLSWKVLNPEQGAYLLLADKLNND
AFVIAINNIFNMIGLLFIFIMLLIPFTSNIELTGNVNVH
>fig|257363.1.peg.226 Multidrug resistance protein A
MFSVLQQVIYKYKYHSFIKYVIIIVLIVFTYFGYRIYVWANTQSTDNAYIDADISNVSTE
VSGVLTKLFVTNNTRVNKGDLIGEIDDRDYKARLAALDASIQACIKNIEIIEKKISIGQM
RLEQVTEKLKLTKISFDIISIDLTRVQALSNAKFVSSKTLDDSKNGYQKVKTEYKQAQLD
LDISKHNLQLLELEKAAAQEKLKELIENKKVTLRSLQNTKIIAMVPGIFSNSNLAIGNYI
VKGKVLFSIVQDNTMYIKANFKETQIKNFKSGMKVKIVFDALPAKVIYGKIRNIAPATGA
KFSLIPPDNATGNFTKIVQRVPVLIDFAPTNDTLVPGMSARVSIRTDQST
>fig|257363.1.peg.566 MFS-type bicyclomycin resistance protein
MKIIVKIPVWMLLSLFILSPTTETIYTSGLPSLTKYFSIDGCITQITSTLYFLGFAVGIL
SLGRLSDIYGRRPIVLLGLFIYIVSSIISIFSVNIEMLMIARFIQAFGVSVGSVIGQSMA
RDSYQGAELSYVYAILSPWLLFIPSLGSYIGGYIIEYSSWHYVFVFFSLIGTILLALYYK
ILPETNYYIDFSQSSKYFEVFNIIIKDKILWLYAFIIGAFNGIYYGFFIEAPFILIDKMK
VLPSFYGKLAFLLSFSAIFGGFLGGYLIKKRQVHDKKVMSIGFIFSLCGCILFVVNAFIL
EFILVSNGLAISMIFVPMMIHIIGHSLLIPITLRYALEDYAKVTGTAGSIFGAIYYIVIA
AVTYCVSKIHGETISNFSLLCLVSSISSVISFYYICILYKKKSIVANEK
>fig|257363.1.peg.662 Bicyclomycin resistance protein
MKLLITVIIMEILAGSEIDLFIPSFPEIQDTFNLSTFMTELLLGVNLIAYCITSLIVGNL
GDKYGRRPIIILGLLIFNLGSLFCVFANNYETILFGRFFQGCGIASVAVLVYVVLADIYS
IQEQQKLMGVLNGTIALSMAVAPVIGSYVNLFWGWHANFILLLSVGLISLILGIFFIPKG
QVNKKTRISLKEYIPIFKSPKAIYYILTMIFLAQGYWIFIGIAPILYMQDLGVTLEYFGL
YQGAMAALFSIMSFSSGYCFKKFGIKNCFYFGVIFIILFLLGNSILIVYNINNPLTITIV
TLLLSLGVIYPINILWPLLLEAVADGKARMTAIFTAARLILTAFGLQLVGFLYNGTFTPI
GITISIVTLFGLVTLNQLFKYDKIFEIYEIV
>fig|258594.1.peg.1913 Drug resistance transporter, EmrB/QacA family
MTVDHPPATSHVPQTAAKTRPSALALTILLLGGFITVFDLFVVNIAIPSMQADLGVSFAE
IGFVIAGYELAFGVLLIAGGRLGDRHGRRRLFALGMAGFAITSFLCGIAPDATSLIVARL
LQGATGAILFPQVYALLRVMYDDAGRRRAFGLLGMTLGLAAIVGQVFGGLIVESDLFGLG
WRIIFLINLPIGIIALLSARIIPESRSSDAMGVDWPGIGLATAGLLLLLLPLLEGPNLDW
PLWTWASMAVSVVLLTAFLVWEHLVARRGGDPAIDLTLFRNTGFSVGSVVVLLIYSTATS
LFLCFALLVQSGLGLTPFAAGTLFAPASVGFVVASLVAPKLVARFGNIAIAGGTLVYAAG
IGWLIVTAAGLGDGAGIFALLPPLVLFGFGQGLSMTPLLNLVIGYVEESHAGMAAGFIST
MQQVGGAFGVSVVGIFFVGILGKDAGEGVSQAGRYADAFSGAMIYNLAAVIVAAALIALI
VRKSPARQ
>fig|258594.1.peg.3679 Multidrug resistance protein B
MTASQAKQPITPLVGVPRSLAAVTFGLASFMAVVDITVANVSVPTISGNLGVSPEEGEWT
ITFFAISNAICIPLTGWLGRRFGQARLFAGSVAAFTLASILCGLAPTFETLLIARVLQGA
VAGPIVPLSQALLVAVFPPEKRTFAVAMWAMTNMAGPVAGPMLGGWITDQFSWPWIFLIN
APVGAFVVVSAGVLLRGKDTPTVRLPVDVVGLALLAIAVGCLQVTFDRGRTLGWFASPLI
CATATISVVGLVLLVVWELGEAHPIVDLRLFEFRNFAIGTLSVAVGFGLYFAALVLVPLW
LQTDLGYSSTWAGVATAPMGVFGIVLAPFLGRWVATHGPRLYASIAFAAWALVALWRSTM
TTGVTIADVALIHLAQGIGIAFFLTPVVSLSLAGLPPDKLASASGLQTAIRMMAGSLCAS
IAQTFWDERARFHRNHLVDAVTELSGRAATALNQLRSAGLTEQQSWTVINQQIDVQARML
SLNDFFYVSAFAFAAALGIIWLARGPKQST
>fig|258594.1.peg.4084 Membrane fusion component of tripartite multidrug resistance system
MASEPADGNKRSRESGSHDQEQAPPPTDHDDTQGKLAPSMLSNPWLRWGLITAAILLLLG
GTGYGWYWWTTGSYFQSTNDAYLKADQVSIAPNVSGYLVGVPVVQNQTIAAGDQLAKIDD
RSYRVRVEQAKAQLDQARAGKARAEAELNRQYAQIEQANAQLGQSEVSLAFAENQVARYR
PLAASGAEATERYDQIRNQRDQARAQVALNNAQVESARRMVPSIEAQIAEAQAAIEQAEA
QLHQAQIDLDNTVVVSPIAGRVGDLTARVGQFVQPGMRMMTVVPLHDLYLEANYKETQIG
LMRVGQPATIEVDALPNEKLHGEVLSFSPGTGSEFSLLPPQNATGNFTKVVQRVPVRIRI
DAGPEARKVLVPGLSIVVDVDTRNAKADIDRQRGELQDSRKAAQ
>fig|258594.1.peg.4086 Outer membrane component of tripartite multidrug resistance system
MAGDPRSHATELIERALADSPSIQIVEARVRQARASAREQYANLLPSGSVAGAYLHNRIP
LGDARRGLENVAGGQAIAGQIPDGTNLDLYDANFDASWEIDIFGGRQRAAEQAVAQADAA
VARFADAHVQLAAQVAQSYVGLRDAQHRLDLTLQSVKLQQEAIDLTAQRLGGGTTSDLDL
ERLRTQLASTEAMADPLRATIDQNRGQLAVLVGLEPGTLDSQLRRPRPVPVPPRPLRIGD
PAGMLRRRPDIREAERNLAATNAQIGQAVAGYFPRVTLLGNVGSLSTSTAVFGTAGSLIG
NVGPTLQWNVLDFGRTLARIRQAEAGSDAAIAQYQNTVLTALQDAESSLSRFGHQRNQVT
KLARASASADKAAELMRQRNRAGTVSVIDLLDVERQRLQTVQSLAQAQAQLMNDYIALQK
SLGLGWSDDPVFEVASSKAPDQ
>fig|259536.4.peg.422 Multidrug resistance transporter, Bcr/CflA family
MSAPKFPLPNKPVAADRVRSADLPVAWIMMLGLIVAVGPLSIDMYLPALPSMADDFGVST
AFMANSVPAYFVGLVFGQLFYGPFSDRVGRVKPLYIGMVLYVIASIICATTNNEYVLFTG
RTLQALGACVGAVVTRAAIRDRLTAKQTAKAFSIMILVMGLAPILAPSLGAVFLQFFSWH
SIFWFLAAFGTLNLLLTKFFFFETLSEENRNVRPAKEILSQYWELLKDPTFNYPAIGGGL
LMGAMFVYISSASELIMDTYGLSATHFGWLFGMNAAGFVALTQLNQWLTNRFRILSILRF
GAMMQVISAGALFTLGIVFGTDAWLPLVLACIFFCIAGLGLTQPNSSAIALAFQQRRAGM
ASALQGSLMFSVGIFGGLLLNLFPVNPVLKIGIAMFSLMSLGCYLIWQIDRNLNLDNAD
>fig|259536.4.peg.689 Permease of the drug/metabolite transporter (DMT) superfamily
MTPIHIALAVLVTFIWGVNFTFIAWALESFPPLMLTALRFFFTAVPLVLFLKPPKFNRTL
FIYAIGTFVMQYAFVFTAMHLGASAGLTALLLQVQIFITVLLAYVILGEAVSRMQIIGML
VGVLGLGVIALNLGGDMPLVGFICILIAAIGWSFGNIASKQASTQQSTSNISTASPVDSN
NRTSALSALSLVVWGGLIACVILTLSSLLFETEAWHLTTFTHASFKSWLSLGFIVYVSTL
IGFGLWAHLLSQNIASKVVPFALLVPVFGMATSVLLIGEVVTWWKVLAMVLILSGLILAN
VKIGLGRRSAHA
>fig|259564.8.peg.598 Permease of the drug/metabolite transporter (DMT) superfamily
MFGSVFSWVFYTTIIDKFRSKDMVILSRDITMFGTIFLFPFALLEARDMRVDIVSQSDLV
VAIVILMYLAILGSALGFLLWNKAIDLAGSSTTTNGLYFVPPIAIFGDSIILGNLPNLYV
LVSAVLVFVGVYLSEKA
>fig|259564.8.peg.2212 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSEDELAVESIGKLFRKFALPAVVGFIIGGVQITIDGYFIGNGVGTLGLASVTLVYPLLI
GMIATAMLIGTGGASLVAIELGKGNRKRAHRIASDMLPLMFVLGTFFAILGLFFTEPLLR
MVGATGTVFVMANDYLRIMFIGSICLIAGIGLDPLVRNDGRPNFAMKMMVVGAMTNVVLD
YLFVMCWGMGMQGAAIATIIAFAVSMIAFVSYFFSRYAQLRLYLSDISPDIKIIAGILKT
GFPAFVMQASLGVLVLSYNYMLLRYGSEIAVSSYGVIEYSFAIFFMIFEGISAGVQPIIG
FNHGAKLYDRVYVATKMAILSCFLVGLSGFILLYTFPETIIQLFNRNDPELLATAVEGMR
IFIFGIIVEGVIISVAVYYQSVNKIKPSLFIHFGKIFIFILPLLFILPRYYGLTGVWMAA
PVGIYLMLIVVGVMFLKEIKILKHPPTEVNE
>fig|261594.1.peg.2143 Multidrug resistance protein
MKRVLAVFFTIMFMIGTDTFLISPLLPTLQQVYHISTELSGWMVSSYALGYAAFALIAGP
ISDSINRKKVMVIGMSFFALSTFLCGIAPSFLWMLIFRFLAGVSAAFVSPQVWASIPLLI
EKEQIVKAIGIATAGLSLSQILGLPVGSYLAMIHYTTPFFIIGILSALLVILIYGVLPEI
QPVHIRENKTNILKRYKQLLSDSKVSLSYFAYFVFQTGNFAAFSFFGVWLSIQFGLQIHE
IGTAMLVLGLGNLTGNIFGHRIVNKIGYNLSFYGGIIFIAVLYALLPHVNNIIIVELLFF
VLFFVTGILFVLMMRHLQNISIVARGTGAALANASMYIGQMIGAAIAGMLFAASHNFIFV
GSFTALLYILALFLFRKSEKLTENRETGIAS
>fig|262543.4.peg.428 Quinolone resistance protein
MKKQIIQLPELPQQLTSETFADVEIDDPYLYQTLYEKETLPVELTERLDVNQVCFRNVSF
AGLVFERASFENVRFEQCDLTGCQFQDSRFHRVVFEDCRLTGIHFESNTIDHVTIKDCQA
NYAQVIRTALRHVTLEQTSMRESHFFEMKPIDFRLHEVDLSESQWVETALKGLDLRQADL
SGITIDPRFLPGAIVTESQAITFARLLGLVIPSHG
>fig|262543.4.peg.511 Permease of the drug/metabolite transporter (DMT) superfamily
MNRSKATLFVLIGAISYGVLSTIVKLAYGAGFDSAAVSGSQFFFGWLMIFVLALLSKNLR
LHPKTALTLMAIGISSGTTGYLYYQSLQTVSASVAIILLFQFTWIGVVIDSILAKRLPSR
SHFLSAVLLIGGAVLASAAYTSALDVRGTLFGLGAAVSFSIFLLASGRVANHVPVIKKSF
YMMTGGLLFVMIMYPPTTFLTATNFEQGLIWYALPLGLFALILPPLLFAAGAPHLSPASV
SLLGAAELPTAVICSVLILGEHLSGSQWIGIIIILIGIFYPIYVSSLKQSTTSVPRQNDL
S
>fig|262543.4.peg.900 Permeases of the drug/metabolite transporter (DMT) superfamily
MIRQRIGSTFALVVLLFAFVGFGYKLANDPGSLFSQLLFFAITAGIIFLLFKFLTRNSVN
SSTNSQYRKSVAQSKKMYAKNNPSPRRTDFKKKPVKTTKTAASSKVRPLRDRSKAPHLTV
IEGKKGKKKKRAF
>fig|262543.4.peg.963 Drug resistance transporter, EmrB/QacA family
MRKNVTIALLLATFLAAIEGTIVATATPVMASELNGAKLVSWIFAGFLLFMAVSTPIYGK
MADLYGRKRVLLFGIGVFTVASLACGLAQSMEMLILFRAAQGIGAGAVLPIAMTIIGDLY
TYEERGKIQGVLSAVWGISGVAGPLVGGFLVETLSWRYIFLLNVPFALISFIMIVLFYKE
NVTETSRKIDYRGAILFATGMSALLYGLLSGSESESFAETLILISFAVSVILLFWFYRVE
KKASDPLLPPAVIRHPVILVINLAVFFSAWVLVSMSAYIPIFAQGVLGKSPTEAGFMLMP
LSLFWTLTAIVGGRTIGIASPRYRTMTGMGLLVIGMAILIGIGRESSDVFIYLAVSLIGI
GFGLAQPVFMVVLQTSVDWSLRGSATAVNSFLSTTGQTLGVAIFGTLFNVSIIQAFSDSK
LLSGYSIDPFFQSGTASRYGADVQSAAEQALANGLHLVFIGGLVCAILAFFMTFRLPKVR
PEDPTN
>fig|262543.4.peg.1119 Multidrug resistance protein B
MFTALKQLDRNIWIRFVGETITGVMMFMIAPFLVLYYSEQLDSYFLVGLIMATGPITSLF
GSFLGGYLADLYGRKPLMVISIVGDVIALIGFSFADSFWPLLLMNALLGLTNSLFHPAAS
AMVADVTPPERLNESFGLLRMGHNVGAAFGPLIGSAVLFIDRSLIFYAAAAVFFLYALVL
LVFIQETKPEQIEHTHDEPKLSAFTVLRKDHVFVIFIAAGVFISMGFALVESMLPVFLKE
ALPGLPNDKNPFPYLMGLNGIMVVLFQFPVAARLSGKAFGKVMLLGASIFGLGMILLAFI
PSYLFSLGTGYIVLVTILLVIYALYTLGEMIMSPVQMTFIALIAPEHLRGTYNGAASIQW
LIGGVTAPLLGSLFLDSGNGQYALAGVGVACCLSGLVYLALDRSIQRAKRLSQSA
>fig|262543.4.peg.2345 Multidrug resistance protein B
MQRLKQLHPLTVGVLLGTFFARLGTFITMPFFAIYLSVVLKFSPVDVGWILSISAIASLV
MSFVGGTLSDRYGRRTMMLSGTFGFVLVFIGLAQVETFWAFFILSALNGIFRSIFEPSAR
ALISDTTEEENRLFVFNIRYTCINIAAAIGPGIALLLSAGNTSITFYITAFVYFGYGVAI
FILFRRHPITESHGGKKVSFGATVRLLKTDVAFTFALAGIIFGVFGYSQFNSTLPQFLTT
TTLLSGGTSLFALLITINAITVLVVQYPIMKFGVKTSPLVSITVGIATVAVGLFVMGTAG
TVWLMIGAMFIFTCGEVMMFTMTDILTDSFATPELRGSYFGAMGLTSIGQSVGPVIGGQL
LLYFGPERPLPIFGILALLTVLGIPLLLLSQRVHRQTKPEEEKEVVSL
>fig|262543.4.peg.2850 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MHPSGEATNLNENLCPCFEKKEALLMMNKNTARLGEAPINKLLIGLSLPAMIGMLVTALY
NIVDTIFVAQGIGTVAVAAVGIAFPVQLVLMAISNSVGIGGAAIASQRLGQKNLAGASRA
YANVLMTVFVVSMLAIITAFIFVEPLLRVFGATPEITPYSIDFLRVLLLGSPFFMLTMAS
SAMLRAEGRASYQMRVMLTTVAINIVLTPLFIFGLDWGIQGAALGTVVAQIVGSVLIFRF
FFTKSKKTSLVLDREAFRFDPKLVGRIGQIGSSSFIMQVSQSILFITVNHMLVRYGGTTE
LATFAVINKFMALVGMPIMGIVQGMQPIVGYNFGSKQFDRMSQAIKLAIRYGLTLSITLW
LLIQLFPRFWVGMFTEDATLLNEGSTAMRILFAISFVYGIQMIVNGMYQSLAKARIALFL
SLSRQTLYTIPLVLILPMFFGVQGVWFAFPIADLMAVLTAVVFAYRDRIMLFKPDEYAAP
EEQEKAAQAK
>fig|262724.1.peg.163 Permeases of the drug/metabolite transporter (DMT) superfamily
MDASLLLPLGFGLLSALTWGAGDFGGGMASRRAHAQAVVLWASGIGLLLFLLLAQVFGEA
PQGRDLPYALLGGASGALGLLAFYRALAQGEMGLAAPVAGVVGAALPVALGALLEGWPGL
FPALGMGLGLLAVWLVSRPEGRARPGNLGLALLAGLGFGGFYAFMDRVEGLFYPAAWAKL
TAFLLVLPAALRARPWPGGREAPWVLLAGLGDAGGNLFFLLAAQAGRLDVAAVLSSFYPV
FTVLLAWLVLKERLSRRRLTGVGLSLLAMALIALG
>fig|262724.1.peg.377 Acriflavin resistance protein B
MRENPLVAFFVERFVFATSIFVGMVLVGLLLGLGLGVELLPRFSVPVIAISTSYPGAGPE
EVAEQVSKPLEDALSTLTGVDVIGSSSTEGFSLVFVQFKQGVDVDQGAVEASQKVAAIRS
TLPKDASAPVVQKFDPSASPILYLALEAPGEDLAEVLRYAERTLKPRLQLVSGVADIRLT
GAPKTAIKVYLDPDRLQALGIPPLQVVQALSASALNLPLGALTEEERRLVYTLRATPRTA
SEVAEVLVDPGRGIRVRDVARVEEAREAPTTLNRVNGRPAVVLAVVKTPDANAVAVAQGV
RRALEETSLPPGYRAEVALDTTRFIQAAVEDTVREAFLAALAVSLVVLVFLGKLNSVFSV
ILAIPITLSGAILLFGVLGFTYNLISLLALTVAVGIVVDDSIVVAENIDRYRRMGLGLKE
AVLKGASEVSAAVAAATLSLLAVFLPISFLPGLIGQIFQQFGLGMAAAIGVSWLEALLFL
TVRLAYFPDPDPPTLKEALRAALLLPKDLAWAYRRGFRTALGLLLGLGAAFLLYRQGPLH
LLLLVLYPALLGLGRYLGRLLLDLAGALARLLHEATEGGVRRLTEGYARALEAALARPYL
VLGLAGLAFLSVFPILPRIPFNFTPRADTGVLTATLLLPKDTPLSVSDRAARALEAYFLA
HPAVERVVTTVGASATGGAQVGDPSRVQLQIVLKPKGERPDIFTLTEVFNREGKEALKDF
PGADLRVLAQTGPEAGDADLQFFVTGPDREALEARVQAIVDRIAEKPYVLNVKSTLEATQ
RERVFVPDPARLSGTGLTPQDVAQTLRLYLSGTQAATARRSGEEYPVVVQADPLRYSGEG
GLLSLPVYAPALQAFLPLGSLGRFEERPSPTLISRRNQAYAAGININLKPEAPGALQVQA
ELEQDLRAAGLLGDGVELVASGLGSFTEELASLAPLAFGLALVLNYLVIASQFNAWRYPL
YLLLPVPLALVGAFWLTYFLGTGLDVISVLGVVMLIGLVTKNAILLLDFASRRMREKPLK
EALVEAARLRLRPILMTTLTVLIISLPLLLGAGEGSEYRRPLGVVILGGMLSSTLLTLFV
VPAAFFAVEGRLARKGGKG
>fig|262724.1.peg.525 Multidrug resistance protein-related protein
MFRFLPWRREGLSALLRLILVVGLLEGVRSGYFAGLLPFYAPEHLGLGPAAFTLAFTLHQ
LAENLSKAAGGLLAERLGYGLTVTLAAATGLLALLLTPRADSAWILWTLGALWGLTFSSL
YPGLMTLASRIARPGMDARALAFTLSLVMPWVGLGLVGVGQVAQRHPLQALHLLLAAQGL
ALLVALSLVRFRIPVPPPSRERYPLYRLLLFVPAAFGQTFAPGLVSLFLLRFAKEELGLE
PLALGGLLVLGGGAAFLLLPFTGRLVDRRGYQAALVLGLFLLALVMARLGTGPHPYELPA
AALLGGLGFSLFLPGWNGLLAKNLPQENRAAIWGSLMTVEGLGLALGPVAGGLLWEAFGL
PAPFLAGSGIFLALSLFYLLLFRVRKLWRR
>fig|262724.1.peg.625 Multidrug resistance protein B
MNFTPDAKEVRYTMVGILLGLFLAALDQTIVSTAMPRIVGELKGAEYYAWVTTSYLLAST
VSAPVFGRLTELFSRKAVLVAAVLLFLLGSALSGLSQNMVELVLFRGVQGLGGGALFALA
LTTLAALFPPRERGRLAGVFGAMFGLSSAVGPWLGGLLTDHFSWRWVFYVNMPVGAVALW
FILRHMPRLSPGKREPFDFLGAFLLAAWAVPLMLAFSWGGSTYPWDSPRILGLFALAAAA
FGLWVLVELRVPHPLFDLAVFRIPTFTYAALASFFYGPAFLGAVAFLPLYLQVVKGVSAS
QSGVTVLPLTFGVILGSVGGGQLAARHGRYKGLVLGSALFLLGIFLLFHFLLRVDTPLWL
AVFLFFLAGLGLGPAQSLLNIAAQNDVPMNRIGSATSAVQFMRQIGATMGVAFLGTVLAS
ALSDHLKAAFPQGAAGAPVLAQGGEGMALDLDREFARLEDLLARALRGDEAAYRALLQDP
MVPKAYLQGLSPGGLPARFAALKEEVRAALAGDEAARRALLQDPALPEDLKAFLRAPRGA
LGPEAVEAALAQAEARALEEATRQAVAGLEAAKARLKEALSFGITEALRRIFLYSALFTL
GALVFVLLLPDRELKGRPAPVE
>fig|262724.1.peg.970 Multidrug resistance ABC transporter ATP-binding and permease protein
MTEDTYSKAFDRALFARILRYVWPYRLQVVLALLFLLVVTLAAAATPLFFKWAIDLALVP
TEPRPLAERFHLLLWISLGFLAVRAVHFAATYGETYLIQWVGQRVLFDLRSDLFAKLMRL
HPGFYDRNPVGRLMTRVTSDVDAINQFITGGLVGVIADLFTLVGLLGFMLFLSPKLTLVV
LLVAPVLLAVTTWVRLGMRSAYREMRLRLARVNAALQENLSGVETIQLFVKEREREEKFD
RLNRDLFRAWVEIIRWFALFFPVVGFLGDFAVASLVYYGGGEVVRGAVSLGLLVAFVDYT
RQLFQPLQDLSDKFNLFQGAMASAERIFGVLDTEEELKDPEDPTPIRGFRGEVEFRDVWL
AYTPKGVEPTEKDWVLKGVSFRVRPGEKVALVGATGAGKTSVVSLIARFYDPQRGCVFLD
GVDVRRYRQEELRRHVGIVLQEPFLFSGTVLDNLRLFDPSVPPERVEEVARFLGAHEFIL
RLPKGYQTVLGERGAGLSTGEKQLLALVRALLASPDILLILDEATASVDSETEKRLQEAL
YKAMEGRTSLIIAHRLSTIRHVDRILVFRKGRLVEEGSHEELLAKGGYYAALYRLQFQEA
>fig|262724.1.peg.971 Multidrug resistance ABC transporter ATP-binding and permease protein
MTGRSAAPLLRRLWPYVGRYRWRYLWAVLAGLVSIFFFVLTPYFLRLAVDAVQAGRGFGV
YALAIVASAALSGLLSYAMRRLAVVASRQVEYDLRRDLLHHLLTLDRDFYHKHRVGDLMN
RLNTDLSAVREMVGPGILMGSRLSFLVLLAFLSMYAVNARLAFYLTLILPGIFLAMRFLL
RLIDRRYREAQEVFDRISTLAQEAFSGIRVVKGYALERRMVAWFQDLNRLYVEKSLALAR
VEGPLHALLGFLMGFAFLTVLWAGGAMVVRGELSVGELVQFNAYLAQLTWPILGLGWVMA
LYQRGLTSLRRLFELLDEKPAIRDEDPLPLALEDLSGEVRFEGVGLKRDGRWLLRGLTLT
IPEGMTLGITGRTGSGKSLLAALVPRLLDPSEGRVYVGGHEARRIPLAVLRKAVGVAPQE
PFLFSETILENIAFGLDEVDRERVEWAARLAGIHEEILAFPKGYETVLGERGITLSGGQR
QRVALARALAKRPKILILDDALSAVDAETEARILQGLKTVLGKQTTLLISHRTAALRHAD
WIIVLDGGRIVEEGTHESLLQAGGLYAEMDRLQKEVEA
>fig|262724.1.peg.1626 Fosmidomycin resistance protein
MLPLLLAWLHTTNDLFSNFLTPLLPKLMDRFGVGLGTAGLLVSAYSLTGSLLQPFAGLVA
DRVDRRLLAALGPVLVALGMGSMGLWPRFEALLFVLALAGVGSALFHASGASLVGEYAPK
ERRGFWLSFFGSAGNLGLSLGPIVALYVAGRWGLEALFWLTPLVLLPALVLLRLPPVRRA
GRPAGFRDFLRVFRGDVARLWGMATLRSLVFLSFSTTLPYWYATKGLPDGYTALSLSIYS
LSATLGILVGGTLSDRLGRKAVLVGTLTLGLPLYLGLLFFPAENPLYLLLLAATGALMNA
GIPVAVALAQELEPGQTATVSGLLMGFTWGFAGLFYAPIGRLIEAFGVLPVLLGLGVLLL
PAWALARGVREPARTMGV
>fig|262724.1.peg.1716 Multidrug resistance protein 2
MSPLALLFLTLFNSVLGLSILFPILGPLGRALGLTEVQVGLFSTGYALMQFLLSPYWGRR
SERGRKPVLLVGILGFAASFLLFGVFALLGERGLVPPGLLFFLLLLARLLGGAFSSATLP
TAQAYVADVTGRENRTAGMALLGAAFGLAVILGPALGAGLAALFGLLAPVFFSAGIALLN
ALFVYLVLPESRPRGQEAGARLSPFDPRVFPLLLLGLALNLSSVALEQTIAFYFQDRLLL
GGVETAQKVGLALVLYGVVAVFVQGVLVRKTGWPPRVLLSLGLPLGILGFVLLVYAKTFW
ALALGLALQGAGQGLALPGVTAALSLAVGEGEQGLVAGLNSSAQALGRMLGPIVGTGLYR
LAPEGPYVLGASLLLLALLFLPALFRRARL
>fig|262724.1.peg.1927 Vancomycin B-type resistance protein VanW
MRPFVLLILLGLALGQSAPLEAVLVLREDVLEEGRLVAYTGTQRYPVASEAELLRLLDRL
ARPPRPPRFIYQDGRWRGVEKKGLAFDREEALKAFREARAQGKKRFLLPVRYTPPSPSLK
DLYALGVREHLATAETGFWGSSPERVHNIRLAASRLDGLLVPPGPFSFNRALGPIALETG
FKEAYVIVGDRTETGVGGGVCQVSTTLFRAFFFAGLPILERHAHSYQVAYYKPPGLDAAV
IQPYKDLKVLNDTPGALWIQASVQEGRLRFHLFGTKDREVAWEGPFITDRKPPLPPREIP
DPTLPPGARKQVDFAAEGAKVVVRRRVRYGDGRVREDQVVSVYRPWGAVYLVGPSPAPEA
PPAPPEEAGAAP
>fig|262724.1.peg.1981 Permease of the drug/metabolite transporter (DMT) superfamily
MRGYVLGLLALNLLTLIWGTTFVVVKGAVEGMAPSLLILLRFGVAALFFLPWLFRLPVGV
FGPGMELAFWLFVGYASQTLGLAHTSASRSAFITALSVVLVPLLLRLAGREVGPAFLAAF
LALAGVGLLSYDPYQPPFNVGDLWTFLTALAYALYIVRLEVHARAFPSLPLTAVQVLGTA
LFALPWVLAEGGAWGPVAWGAVLYLGVVATALTTWLQTWGQRHVPAPQAAILYTLEPVWA
AFFAYLALGERLSPSGLLGALLVLLATLLAIRRSPA
>fig|263358.5.peg.348 Glyoxalase/bleomycin resistance protein/dioxygenase
MLRRCHDAGEGGRAAATAGSRGVAVASVPSGTPCWADLATPGLDRARRFYPELFGWTGRV
DPEPEAGGYTTFQLDGRAVAGVGPPAVPDQVPIWSTYVATDDADLVTGRVERAGGQVVVP
PFEVFDRGRMAVFSDPAGAAFSVWQPMAFSGAEVFDVPGAMCWTELVTPDTDGARIFYEL
VFGWQPEEEPMGQTSYTGWRLGDRMVAGMMPPREEAFAADSPAYWTLYFSVADADATAAR
AAELGGTILVPPRDIPAGRVTALRDPDGALFSLIALTP
>fig|263358.5.peg.535 EmrB/QacA family drug resistance transporter
MTPSRTRPSPSPAETPADPPAQPAPIAGRARTIALVAVLVGLLLDLLDIVIVNVALPTIQ
EEIGASSSDMQWMVGGYTLAFATMLVTGGRLGDIYGRKKIFIIGMVGFAAASLVAGIAAN
PEQLIVARFVQGGMGALMVPQVLSILQVMYPPQERGRAFSALSVVFAVGTVAGPIVGALL
TAVDIAGLTWRTIFLVNLPIAAVCLFITVKLVPESKGESAQRLDVKGAILVGLGMLLLVF
PLIQGPEQGWPAWTLISLVASLLAFAALVAVQRRQTESPLIPISLFSHRSFRGGLAVSLL
FMSGVMPFFLVNTLYLQFGQGFSVIKAGLIGVLWGFAVPLFTAISARHITPKLGRLGLQL
GLVMLIAAMVILITVIHQFDTITPWALAPGLILGGAGMGMTFAPLLTYTLNDVPLHSAGA
ASGVFNTVQQMGAAIGIALSSMVFFIALAVQSPAVGDDLRNTVKEELSARGVPVAAVDAA
ADSARACFDERIKAANPEADVAACRAVASQSGADVADRHDELQFIANRTAYQQTTVRALV
YQIVVFTLAIAASFLLPRRVEHQG
>fig|263358.5.peg.547 Glyoxalase/bleomycin resistance protein/dioxygenase
MSERSFSPVIPFLRYQDPTAAVDWLVNTFGLERFDVTEVDGKVVHAELSWGNSTIQLGGG
GPHDTLGMVSPRELPATSGGIYICVGDAADVDKHYERTVQAGAKLVYELHDTSYGSRDYG
AYDLEGHVWSFGSYLPREASA
>fig|263358.5.peg.561 Glyoxalase/bleomycin resistance protein/dioxygenase
MAGEPSFIEFAVPVPERTRDFYEALFGWKFTMLTHGSYIEMPGAPAGLEAGSHPDTDPPH
IIVYFAVDDLAAAVERVKELGGEVGPLRPPSPDYGAFAECRDNQGVAFGLRELPKAS
>fig|263358.5.peg.569 Glyoxalase/bleomycin resistance protein/dioxygenase
MANDSVPPLNGGTHINLTVRDLDRSTDWYCRALGFTVVRDARPVESGFTFRTLLHSRALT
SIVLGQADRPVEEPFDEHRVGLHHLAFHVPERDDLHTWVAHLDAVGVEHGGVQELFLEAG
HGVWLRDPDNIWLELYWLNADYFMQRMREHHRARRAERVGGQQ
>fig|263358.5.peg.1140 Bicyclomycin resistance protein
MPQTATPSTAPDRVAVPTGRAAIGLLVLLGSLTAIGPLSLDTYLPALPDMTRDLSASQAR
IQLSLTTCLIGVAVGQLVTGPLSDRWGRRRPVIVGLAAYTLLSLLCTLAPSAETFAAARF
FQGFAGGMGTVVARAIVRDLYAGRAAAKYFSRLTLIFGLAPMIAPAFGSLLLNFGDWRVI
FVALTVIGALLATVVAWRLPETLPVARRNTGGLLSIARIARVLITDRIYLGYTLTQGLAF
AGLLGYLSGSSFVLQDVFGLSVGMYSLIFGVNSLAFVAVGQLNARLLDRHGPRQLLITAL
GLGLLAALGLIAGALLQALPLVIVAMLVFLGSLGMVMPNGTALALDRHGAHAGTAAALLG
GIQAVVAAGAAPLVGIGGEGSALPMALVIAGAAAGSLLVVLTLARRR
>fig|263358.5.peg.1357 Glyoxalase/bleomycin resistance protein/dioxygenase
MIGRLRSTVIDCPDPRALAGFYAELLGLPLMEEDSEGNGWVVLGGPPGHQPRLAFQRAPD
LRPPDWPDPERPQQLHLDVTVDDVEAAERAVLALGARRLPGEGDGFRVYADPVGHPFCLC
WD
>fig|263358.5.peg.1520 Glyoxalase/bleomycin resistance protein/dioxygenase
MGMSQPTTHRHHCIDYIEFTVTDLAEAKRFYAEAFGWQFTDYGTAYAGIRGGSGAEVGGL
RQEQQARTGGGPLVLLYSADLEQSVEAVEKAGGTVVAGPYEFPGGRRFHFTDPSGNELGV
WAEA
>fig|263358.5.peg.1642 Glyoxalase/bleomycin resistance protein/dioxygenase
MNWTLEVVVVPVSDLDRAKAFYAERLGFTVDHDTVVNDDIRLVQLTPPGSGCSIVIGKGA
VPQMPPGSLKGLQLVVPDLHKARTQLLERGVEVSEIQVMGENPRPVPDPLDNVGFIHFAD
PDGNAWAVQQISSRA
>fig|263358.5.peg.2119 Tetracycline resistance protein
MNPLSVRQVRRRYLVLHGLRWLPVGLLIPVTILLMQERGLTLTQIGLAIAAQGVVVLALE
LPTGGFADALGRKPVLVVASLVGLVSTGLLVVADSFALLVAVWALQGVFRALDSGPLESW
YVDTTLAADPDARYENGLGQGGTVLGLAMAAGALLSGALVALGPIGPLSALTGPVIAAVG
LQVVYLVALLALLTERRAVTGPAALRASVREAPRMVGEAFGLLRRSRVLLALVAVELFWG
FGMATFEGLLPIRLAEVVADADRAATLLGPASTAAWLASAGGAALTPLLIRRLGAAPGAA
LLRILQGITVVGMALFAGPTGVLIAFVACYAVHGASNPLHMGLLHRQVAGPYRTSLISLN
SMVAMPAGALGGVVLGYIGDRAGVSTAMLVGAVVLAVAAPLYLPAWRAGRQSADDGRDAG
VPDTGPSPGDGESAARPSGDSVPAAGPPGVPVARLAGDGEPAAGQAQRTEVSGKAAV
>fig|263358.5.peg.2422 Multidrug resistance protein B
MTQSPSDRIDGPLLRLLGVMVLGGVMSYFDATIINVSVETLTAHFDATLGTISWVATGYL
LAVAVAIPLAGWAVARFGARRVWLAALTLFLVASALCALAWDVGSLIAFRVFQGFAGGLL
EPIMLTVVATAAGPSRMGRAMGLISIPITLGPVLGPIIGGLILQNLTWQWIFLVNVPIAL
LAIALALLIMRDDRPEPGAAPPLDLIGVALLSPGFAALIYALSQAGTAGFGATRVIVGLA
VGVVLVAAYVAHALRSAQPLIDLRLFRSSGFTSSVLTMFLLGGMLFSLLFLLPLFYQQVR
GQGVLAAGLLLVPLGLGTMVGMPVAGKLADTFGPRRLVPTGALLIALSALVYTQAGPDTS
QVLLTAAQLVTGFGLGLVGAPTMGSVYRTVAPEAVGGATGTLFILNQIGASLGVAVVALI
VQSGLTDGRTPADSFDQAFWWTVAGGVIVALASRFLPGRPQPVTPTPADAETAAA
>fig|263358.5.peg.2763 EmrB/QacA subfamily drug resistance transporter protein
MADRRIMVPLSGVVLAQLLAMVDLNLTAAALPVIAADLGGTDRFAWVVTAAVLASTVTTP
LYGKLSDVYGRRALLVAALAVLTLGSLLCGLAQSMNQLIAARAVQGAGAGGLMISAYAVY
AELLDPRRLVRYQIVTATLVNIGTAFGPLAGGVLTDSFGWRWVFLATVPPSVLALLLVAT
LRLPPVAAGGRVDYAGMLWLGAALTTLVLLAGVAGTQWAFASPGVIALVVAAAVLLALWW
RSAHRAADPVLPPALLRDRVVRSVAVQGWNTGAGMLVVVTFLPIVFVSLGASAADAGMYL
LTLTFGTLVVSLAGTPLLARAARTQWFGVTGTVLLAAGTAWLAFTHPDLGPGGWAGWALA
TMAIGVGIGLGFQVYTLTLLRHAPRVHLGAALAMQSLSRQVGGSLVLAVLSAVFHSRLAA
GGSTSTLDAAQTVFGLTALLLVVGVVAAVRLPVPSLTVAERSPVTTVETG
>fig|263358.5.peg.2817 EmrB/QacA subfamily drug resistance transporter protein
MVENFSGASTARLGARQWLAIGALGASFLVVAADSTIVYAAIPSIQRALDLSTATVQWLM
SAFLISFGGVLLLSSRLAELFGRRRLFTIGLALMTAASMLSAVAWAGEVLIGARVLQGIG
AALIATTALPLLAIALGPGPARVRALGLWTLIGAFGGTTGLLLGGLLTDTVGWRWVFLVN
VPVGIVAALLAPILPADRCGGSGHPLEVAGGVSLVGALTLIGWTVVAAFAPGSSTGPALL
RLAAAAVLLLLFLVIEARTGRRLVRPGLLRSRTRLGGLVVLFAAGTLIDAVLLLVTLYGQ
GALGLSATRFGALMVALTLSSVVGSYVGQVVVVRHGLRLVALTGMSVAGAGLLALAMVNG
PLDTVDFLSVLPVVGVGAGAAFVAAQIAVTLGASDADSAAASGLSDASFSLGGALGLAAV
SAVLVANQTELPVPMGAALPMAFTVTAGLAAIGLVAALLLMGQQRTPVPSQGT
>fig|263358.5.peg.3073 Antibiotic efflux protein
MIAVLHGRFPAGRPPCTGGVEQGREVCDDLPVTGVDEPVATARPAGSEQTGTGSGGLGGR
YWRLWSASAVSNLADGIVKIALPLTAVGYTTSPVLVAGVAAAFSLPWLLFALPAGALVDR
LDRRQVMLAANSLRAALLGTLALAVALDAGSIWLLYLVAFGAGTAETLYDTSAQSILPQL
VPRAALPRANGRLYAVELAANQFVGPPLAGFLVAGGVAYAMLGPAGLWAAAVVALLLVGG
RFRVARQGTSTLRADIAEGVRFLWRHRLLRTLALMVGVSNLTTTATFAVLVLYAVGPNSA
IGLSEPGYGLLLTTLAAGIVLGSLVAARIERLLGRARALGVAMVAIAVVVGVPAVSTNPF
VLGGVFFVGGILLTSWSVITVSLRQQITPDRLLGRVNSGYRLLAWGSMPLGALVGGGLAE
VFGLQAVFVIMGVLALILLVGMFWVTDAAIEAAERAAA
>fig|263358.5.peg.3098 Glyoxalase/bleomycin resistance protein/dioxygenase
MLKCREPEVLARFWCEVLDFVVLDREGEGCIEIGPREGFGGPQPTIFLIRTDEPTIGHAR
LHIDVNATDRDQDAELERLLGLGAELVDIGQPVEASWHVLADPEGNEFCLLKRRLDPV
>fig|263358.5.peg.3608 Glyoxalase/bleomycin resistance protein/dioxygenase
MITNVSLTSVFVKDIDAAKAFYIDVLGFVERTDITIGDGSYRWCTVGHPGQPELEVHLQL
PGPPLSPEVAELFARARDEGSLFALGLAVDDCRKTYDDLRAKGVEFLQEPADRPYGVEAV
ARDNSGNWLVLVEHKEFSPADFD
>fig|263358.5.peg.3820 Glyoxalase/bleomycin resistance protein/dioxygenase
MTPELDLIGMVSTDLARTVAFYRRLGIDIPADAEREPHVEVRLPNGLRLAWDDVATIRSF
DPDWTPPVGGARTALAFRCADPAEVDRWYAELTAAGGHGHRPPWDAVWGQRYAVVHDPDG
NAIDLFAPLPPAES
>fig|263358.5.peg.4308 Glyoxalase/bleomycin resistance protein/dioxygenase
MIHHVQLACPRDSEDRSRAFYVDLLGLTELTKPPTLAARGGCWFSGYGAELHLGVEDDFR
PARKAHPALLRPDLDALATRLTAAGCPVTWSDDLPGLRRFHTTDPHGNRLEFLTPTHPTP
SPR
>fig|263820.1.peg.449 Multidrug resistance protein
MRRIALFVIVLGLMMTGVDTTAVILALPDITTDLHSSLSTTIWVIIMYLLVIAVMTTQLG
RIGDSLGRGKMYNSGFIIFTLGSALAGTSIFADELIFFRAVQAFGGALMQANSGAIVADI
FPVNERGRAYGYTSIGWTTGATLGILVGGLITTYIGWQYIFYINVPIGIMAAVLGIMNIK
DDKRQESHSDIPGFLSLLASLVLIAYGASNITGYGVDKFNILLIITGIAILIFFIFIERR
AEYPIINMKIFKNHIFSFSILASFFQSMGYLSVVFIVIMYLQGIRGLSPLNASLLLVPGY
VLGSVIAPFAGRLSDRIGSRIPATLGLSMMMAGVLIYMSFSVTTPLYFVIIASLVGGLGT
SLFYPANNSAVMANAPRGFYGVSSGILRTFANIGTLISYVLAITIASITVPRYVAFEVFL
GLHNIVGTIAGKFMTGIRSALIMSFIILVIAVILSISRGRENRAEKAVKLKT
>fig|263820.1.peg.597 Multiple antibiotic resistance protein MarC
MNYAYLFISSLVTLFAIMNPIGAVPILIALTDGYTKDERNNVILKSVFTAAGMMLGFMLI
GVYIFQVLRISIYDFEIAGGMLLFKVAFDMLQGRTSPTKITSTEKEESVEREAIGVAPLG
TPLLAGPGTITTAIIFFNGNGNAIMTRFVVIMSVIILIILTYIILKFSIPIFARLGKTGS
IVITRIMGLLLASIGVQLVASGIINVFHI
>fig|263820.1.peg.630 Permease of the drug/metabolite transporter (DMT) superfamily
MDRRIFYLLLLIFVVFIWGLTFPFMKITLYYISPVVLLAFRFIISSILLIPLIKKRNFLL
EKKHLKYGLSAGFMLFLAYYFQTVGLKYTTPSQSGLITGLYVVMLPLISYFYLHIKANRG
DLIAVMLGTAGLIIMSKIDFSGSYLFGDVLTLICAFFYAMQTAYVFKYSRDLDSGVFTFY
QLIVVGVLSAILISYNPDISGLVVPIVIFTLIFTAALAGTFAIYINTRALMYVEPTAAGI
IYVGEPMFAVLSSIIILGEIPNIYTIIGGIIIISGMLVESIDKYLAAKTTF
>fig|263820.1.peg.729 Daunorubicin resistance ATP-binding protein drrA
MIELINLSKTYPDGKVAVDHLNYKIDSGIVSIIGRNGAGKTTLLRMLSTQLRPSSGDALI
DGISIVREPEKVRKKIVSIPQEASPIGILTAYEQVNMFLAARGFSFHEAKNAAIKALKDV
GLDAMHKPTDTLSGGMKRKMFVAIALAANADTVFLDEPTTGLDPLSRFEVWSAIKKLNGN
VILTTHYMEEAEELSKKIYMMESGKIIKSGSVDELISNMRNLVRIESYKPMENSYTIGSL
YIKYVDKSEVYRYIKMDYNVKPVSIEDLFIMRGVTLES
>fig|263820.1.peg.730 Daunorubicin resistance ATP-binding protein DrrB
MNLRFILLMAWYYGIKAIKRGPSYLIASLATPLTLLFLVFVLSHGTLVKYAIVGGLIAFV
GSVGLSSAGDAAFMRLQLRVQDMYVASNIKPFDYMMAFTLSYLVFSVPGIILYIALGMHY
HLFNLYNSIYMLLIMISLILTTTSISFIIAGSINHLRNIWGITGILSILTSILPPTFYPY
YYVPRPFLYLLSLSPTTPAAVLVQGVFHLAPLFKNMIYIIIIETVFYTVLGRFAIRWREN
>fig|263820.1.peg.914 Involved in antibiotic resistance
MINLENKRIDEFNNQKRDLVNDFVDLISSRTFKSTLRIAIIVLLGINGPLTFTDLQRSLR
IGKGSLKNHLDVLETEDFIKGRNVITLNGPRLVYQITDKGREFYNKYIDLFDRFKLL
>fig|263820.1.peg.976 Multidrug resistance ABC transporter ATP-binding and permease protein
MNNYSIRRVLRDLMIYKKRLYLVSMAIIGSSIVAMIGPYIIGLAVDAITHRDLSLILDFG
IIYIIIYIINYAFERLRTYNMTYISQGFIMNLRNREFERLQYVPLGYYTYRKAGEIISRI
TNDGEAMSDFLTFQMPQVLAGVIGIIFSMAIMLYLDWNLALYSFIVIPLLLITVFSISGK
IRNYYNETRIKIARLTGFASESINGISSIKEFGSEQRFIDEFSVKNYENYLANIRANRLG
SIFSSLVDIIQALGIIIVIGVGATQVINHAIQIGLLVSFIVYVQSFFNPLAQLSQFYNSY
QSSKVAIKRIYSIIDEEQDDNKYKYKIEDFGSEIKFENVSFSYGSKPALKNINFSLKRGE
KLAIIGKTGAGKSTLINLLLRFYRPESGEIKIDNININDVDIYSYRSLFGVILQEPLLFN
GSIMDNIKFNGNYTDDDVINLIKRFNLEGIFSEKDLYENVGENGHGLSQGQRQAVSILRA
MIRNPEIVIMDEATSQLDPETEEIIQNAIRSVNKTFIVIAHHLSTILDSDQAILLENGEI
KSTGTPEHVLKINGLLD
>fig|263820.1.peg.977 Multidrug resistance ABC transporter ATP-binding and permease protein
MVLISGILSSYLTILVPVFIGDAIDSVPRYYKIFDYIILILIVSSLSSLFGFILEYYSSK
TGNIFARRIRDMSFKRVLSNSYDKLENQDSGDLLSRITMDVDASRRFVTISISNLFSTTA
LLFIALYELTRIYYLFSIIFLIVMVPTIYLTFKMQRMQRGYWRSLRKKYGNMNSKIGENI
SGMRVVRSFNAEDFEIKSFKDKTQDYFSDYVGIAAVRSFYTPLLAAIISISIGFIIITSG
ISSAAGIPIGSIVAAINIFTLVLRPVRFYGRYISFYENGMASLERLSEIDYSNENYSKKE
PTGYDIIIENLSFFRNNKKIINNISLNIHENEHIALTGGTASGKTTFLNLISGLYKNYDG
SIRLGGIEIRDISPGLLRRIIGIIPQNPFIFSGSIFYNIDFGRGYSLSQVINAARLAKID
DFIETLPDKYNTVIGEHGINLSGGQRQRIALARALIGDPKILVMDDFTSSLDIVTEEELI
NDIRPLLDGKTVVISGYKKKTLELADDVYYMSNGALLPVESGVNE
>fig|263820.1.peg.1080 Multiple antibiotic resistance protein MarC
MPLLVVIDPFGSLAIFVSMTASYNKDTKLSISRDAVLYGGMILIIFAALGEIIIQFFGIS
IEALEIAGGIILLLMGIEMVREGAKPESSSGSKNLGIVPFATPLLAGPGAISLVIILMKG
SLTTKIFTIVSILIVLALVYIFFIFSSKILEILGEKIMTAITRIFGLLLAGFAIQYFLDA
LISLGLIK
>fig|263820.1.peg.1096 Daunorubicin resistance ATP-binding protein drrA
MENIIETKNLTKIYKNLRAVDNLNMTVRSGEIFGLLGQNGAGKTTTIKMLTTIIKPTSGT
AIVDGHDIVKESMKVRDSIGIVPQELTTDEDLSGYENLMLIADFYNIKKSDARAKALELL
KMVDLEDAARRPVSTYSGGMRKRIELIAGLVHSPKVLFLDEPTLGLDVQTRTNLWSYIKA
IKENLGITIILTSHYLEEVDALADHIAIIDHGRLLKVGTSEELKEGLGGDIISMELNSES
EVNLLKDFPAKETSINGSSIRFKVENSDAILPELMDILYRNHIWPRKMTVEKPSLDEAFL
EYTGRKINDETPMDYGKTMNYMRRISR
>fig|263820.1.peg.1097 Daunorubicin resistance ATP-binding protein DrrB
MSGLLPLTGRELKKWYRNPTYLIVSVIQPIFWILLFGSAIDIAKFAFPGAPVSSFFNGAP
DYITFLLGGILTVLSLFTAMFSGINIIWDRRLGVLTRFLASPIHRSSIVFSRMLASVVKI
AVQAAILIGIAAVIPDGLKFPHGFTVFDALILFTAMLLISVIFGSIFSVIAIKMTQVNTI
MGIVNLVNLPLMFASTALFPGAIMQPWLHHVAMYNPISWSADTIRTVIINGDLNAAQMHS
VGLDLLYLFIFAVVMILITYFASEKGIQN
>fig|263820.1.peg.1498 Multi drug ABC transporter permease protein
MGNLYNVYMQYVKNYYRSKSFYLMLTLILVISILMTYFSLKYVNDLPAFLGRNVSFHLKK
ILFYFIWSFVLINIPVFSSVFFGSPAISSEIENKTAYYIFPLPINRYKLYIGKYLSAFTV
TFIIVLIYSSFEVIILHYLFGSIPLSFYYSIGLLAIFIFTILSITFMISSIFNKNTYAYI
TVFIIYYIVFEAGSLIINLLYKITPIYLLNEAADIVEKVYLNINTSSFVTSPSLAPATNT
EIYTSVLIMIIYMIISFVAGIIIFERKEVS
>fig|263820.1.peg.1499 Multi drug ABC transporter ATP binding protein
MEISIRNLTKRYGRILALNKINMHASGPGCIAILGPNGAGKTTMLKLISNIIKPTDGSVL
INNINVSDYPERALKYLGALIEQPEFYYYLNGYEILKFAAKVKGLKNNIDDEIKRLADLT
DMNDYLYRKTGTYSRGMKQRLALAVAMIGDPEIIILDEPTFGLDPKGMAYIRDLIKNLSR
EKLVILSTHLIYEAKEVSNRTLIIDHGEIKYDSINSDNKRKILVTFDGSISNIKSDFIRD
FVIDKNRIIITPREDADNYNIIYDLIKNGVKVNSAQDYDDLEETYISITS
>fig|263820.1.peg.1530 Tetracycline resistance protein
MDKGILPLFVTAMIDFIGFGIIIPIAPFYTRDLGATPFEFSILLVVYSLAQFIASPYLGR
LSDRIGRKNVLVLGLSGEIAGYLIFGLSPVLSLLYIGRAITGATSGNLPVIYSFVSDKTS
SDNRTRAIGMIGAAIGIGFVIGPFIGGSLSIFGYRVPILFAAVLSFINMVLVLRIKEERK
KTNYKKGSILKAFEIAPYIFISITFIALGFVMLQTTLAYYGQALYSWGSLAVGIILGIVG
MEQALFQLLLVFRLTRRIGSIRTVMLGIISFTMAFLILSFRVNEYIAIFSLTLFSLGYSL
FQTPVISIISDIAPVEIRGSTLGITQSAQSLSNIIGPLIAGYTFEFISIYSPYMLAAAFG
ILSLLFISIFIIKSGSALKDIGYT
>fig|264198.3.peg.748 Outer membrane component of tripartite multidrug resistance system
MTQGQPFPPARRFGRSLAVLAATAMAASLAACAFGPDYHAPAPDLPAAYAHAAALQAQEA
APAAPALDSWWKGFDDPALTRIIERALAQNLDLAASVARVDQARAAADYAGAALLPEGSL
SGSVARQRQSLESPLGKIASKSPGFERNNTLYNAGAGASWEIDIAGGLRRGAEAADAEAQ
AAEAEHLGVRVLVAAEAADAYFRVRGAQQRITIAQQQVQTNARLLDLVKLRLADGIGAER
ERAQAEARLAQTRVTIPPLQIELDTQLNRLDVLMGAAPGTYAAELATPGARTGVPQIPLA
QGPAALLERRPDVIAAERRLAASSARIGVATAEYYPKLSLAALLGFESLSASKMFTAATF
QPAAMAGLRWRLFDFGRVDAEVAQARGANAEALATYRKSMLRATEDVENAIVTLTQLQLQ
SQDLTVEVDAQARSRGAAEEAYKGGAVSLFEVLEEDRQLLAARDQQARAGTDNARAAVAA
FRALGGGW
>fig|264198.3.peg.4312 Drug resistance transporter, EmrB/QacA family
MTSTAQSGHGSGQVLPFRESLLAMLGVAFVSMLVALDQTVVGTALPTVVAELQGFEYYAW
VATSYLLLSVITVPIFGRLGDYYGRKPFVLASIVVFSVASALCGMATSMPFLVAARGLQG
IGGGMLVGTAFACIPDLFPDSHVRLRWQVLMSAAFGVANAIGPSLGGILTEWYGWRAVFY
VNLPVGVLSLWFVWRYLPHLRQQSHSGPIRVDWLGALLIGVGLGCMQMSVELLPQRGVDW
LTAGLLAVAVAALVGLWQWERRCANPILPLDMFRNPGVAPLLQLAVLVGFTMFAVLIYAP
LLLQGGFGYSPRDAGLLVTPLVVCITVGSIVNGRIITRIRRPNAMLFAGFGMLAAGCLAL
SQATRGMPHSLLLAIMLVAGFGLGFIMPNLTVFAQQTVGREHLGIATAMLQSLRMVGGMI
GTAMVGTMVSRSYTAGVEQSLAAVNAQGWLTRMADPQVLIDKAAQAGLLTELQQAGHNGA
LLLEQARVSLVTAIHFGLVIAAAAALIGLWRARRVPPVRLVRAGQQPAMAAD
>fig|264198.3.peg.4993 Multidrug resistance protein B
MSVGSRWQSLWQLRLSVRWLRWLSHRQRQTLLMMLLALATGVEFLENIMFVFASSHIMGG
LDADPRSFALAQAAYAVGSMLMILKQQWLSRRFGYRYYLTGALLIFMAGTLGAATSHSLA
QLVGARFVQGFGGGALFTSCRILVAVLFGPADRPRASRIFMTGIFVASALGPAFAAELVD
HGVWQDVFYGALPFAALAALGAWVLLPDAEPRRPAPSPGLGPLLLFGAAVVTLQAALTEA
RFDIFSHPLRLALIAAAGLGLLAVFLWHQWHHETPVLHLRALRNPIYLAGIGMYFVYYMI
NNLSAYVFPIYAEQALRIPLATTGWLNTFAAIVSLVGVIIYLRYGSRLTRKKPLMVTGLM
MMAATAWWFSRMPPDAGPPALAWGLVGKGLFGVMVIIPIAGLTFRSLSGEEFAHGYRSKN
LMRQIASSFASAIGAVLLQNRQFAVHDSLVHALGQRVAETQLWMQSVQAALAARGFDEAQ
ARHGAMAQLAGLVEQQARLIACEDIYRLIAVLALTAAVYMLLQRRLD
>fig|264198.3.peg.5092 Multidrug resistance protein B
MPNPIITISARESHSGANYADRNASYWKRNLAVATFGSFTTLVSLSMLLPFLPLYVEQLG
ITAQNEIVQWSGVAFGVTFLATAVTAPLWGRLADRFGRKPMLVRAAVGMAIVMSMIGLAH
NIYELVALRFAAGLIGGYASAATVMIGTQAPAERAGWALGVLSSGALVGNLVGPLVGGLL
PNLIGIRGTFFAGGAMISVAALLTIFLVREDFRRPAKRTLSHEAIADRHERSSRVPLVAL
LVTATMVLFSNMSIEPIITVYIGQLGVPRAQLSTIAGIVMASSALGSVLTASRLGALADR
LGAWRVIIGCLVATAVVMIPQAFVTNWWTLAILRGLMGMTVAGLLPAIGKLVRQATKEHQ
SGKMLGYLQSAQFAGQVTGPLIGGQIGVHVGMRAVFFVTSAVLLGCAAFDRWAKTR
>fig|264198.3.peg.5258 Outer membrane component of tripartite multidrug resistance system
MNAADFSMRASILAILACLALAGCAVGPDFERPTPSAPDVFHRIQSAQASSKAVDAEFNV
EWWTLLNDPLLNNLESRLVDANLDVAAASARLRQSRSTQQVVGAAQLPRLDGAASYYRER
GSPNGIVSLLGVSPTGSPPQPASGSSPLGVAPVPGSSGSPPFDLYQFGFDASWEIDIWGR
VRRSVEAAGALTEASFEDRNAILLSARAELARDYVELRDLQSLLEITKQNLEIARDTARL
TQVRAREGVTTDLDVANAAAQVASIESLMPTLEARLEAAINAIGLLLAEEPGALRQELAE
RREVPELPERVPVGFPSEIVQRRPDIRRAEAQLHAATASIGMAKADFYPRISLNGSAGFQ
SLQLSSLADWASRQFVVGPSITFPIFEGGRLKGTLHLREAQQQEAAIAYKRTVLDAWREV
DDALVAYDAEQRRRDRLVTVVSENQRALAIAQRRYKAGAVDYLDVLNVQRQLLRSQSNLE
QSRATAATNLITLCKVLGGGWESAYARTPTAN
>fig|264198.3.peg.5816 Bicyclomycin resistance protein
MEMKGSRADERAAPGVLTAQSDPQPKALPGIAAMAAIAAGLSMLGQFAIATYLPAFAIMS
DALHATNAQVQQSLTAYLLPFALMLPWHGAISDAVGRRRMVLLGCALFTIGSLVCAGATG
IDMLHAGRVLQGISAGIGVIVGRAMVRDVFDGMQAQQVMALVAMIFALAPAIAPVCGGWL
LLWTGWRSIFVFLALVSASLLVACWRWVPETLPPARRHPLHPALLARGYGSMLTHWRFVA
LTLANAGVNVGIYVYIFAAPTFVTRHLGLGAQSFGWLFIPIVAGIMLGSLVSHRMAGRIS
PVRSVLLGHAVMLFAGILNIVLTALHAPAMPWALIALPVYGAGMTITQPSLQLLALDCFP
ERRGLASSGYVTVQQLGNFLMSALLVPLLLDSTVKLAVCMAALQLFGLAMFMGGQRDRAV
VVSS
>fig|264198.3.peg.6318 Permease of the drug/metabolite transporter (DMT) superfamily
MPMAICALLIWSTLAVSVVSLSEMSLLLTTGIGLAGGGLIGLPWVPWRSLRPRAVAVGAL
AMFGYHALYFVSLRTADPVAANLLHYLWPLLIILFSPIMLKGVRMEVRHIVAGVLGFAAA
CVCLAPAVSIQGSQIGGLSVALMSAAIWAYYSVWSGRFPEIPTAAVSLYCLLAGIGSLVA
YLALGALPDLDAWQLGGRFGAPTPGQWLMLGYLAIGPLGGAFYLWDHAMKKGNPHQIALI
AYAVPIASTTFVSLFLGRGLEIATALGAALVTLAVAVGGRPSRAKPPYTAETGIQDG
>fig|264201.1.peg.127 Multidrug resistance protein B
MPVKTLSPAALIILTLALGLGTFIQVLDSSIANVSISHIAGDLAVSPNQGTWVITSFAIS
NGIVLAITGWLAARFGRVRLFIWSTSLFSITSWLCGLAWDLNVLILFRTLQGASAGALIP
LSQALLLTNYPEEKKGVALGFWSMIVIVAPILGPIVGGYITDNYGWPWIFYINIPIGFLS
AWMTGLLIQDPPHEGKSKVPLDLTGLLLLTIGISSLQVFLDKGQELDWLNSLTIRVLIVT
CVIAFTIFIPWNYYAKHPVMNFSYFRHRNFTIGTILGAIGFLMFFGSAVLLPLWLETEMG
YTAFWAGFAVMPIGIIPLFLSSTIGKSVSRFDPRIMTTFSFISFGLTFFWFSELTPSVSL
FKLMLPRFFQGIGLSFFFIPLVTISLSPIPNHELAGASGIFNFIRLIAGGGFGTALYVTL
WDRREIFHHSRLTEATTIYDPLTWEFYENLKQSLSLSQPESNLILEDLLSAQSYLLAVND
VFWLTGWVFLACIPLIWLCKKNTTNKTQQVAMD
>fig|264201.15.peg.1902 Permease of the drug/metabolite transporter (DMT) superfamily
MFYVILLYALFASVFTIAKTGLEYSQPFFLVGTRMLLAGCLLLGYQKIVNKEHFSFDKQT
WWRIVQLAAFNIYLTNVFEFWGLKYLTSFKTCFIYSLSPFLSALFCYTLFSEKLTTKKWM
GLLIGFMGFLPILMNQTSSEEATGHLLFFSWAELSVMMAAICSVYGWIVLMQLVKENNLS
PITANGTSMFIGGAFALCHSLLVENWSPIPVTNIPIYLECTFLLILISNLICYNLYGTLL
KKYSATFISFAGFTTPLFTALFGWVFLGEVVTWPFYISFGIVFLGLVLFDKEELQQSYRG
KLLSQPQLSE
>fig|264203.3.peg.208 Permease of the drug/metabolite transporter (DMT) superfamily
MNEAERESQPESKLTSPKVFLPFLLVILIWSTTWIVIRDQLHSVPANWSICYRFFVAGLL
MMLFCRIKGYKLALDRGNQFFCITVGLLLISVDYGFLYAAEKHITSGLVAVVFALIIIPN
SFFARVFLGKKSSPYFILGAVLAGIGLGLLFRSQLAYLPDRTEMKLGLGMSLLAVLATSL
GEILLSTPRGKSQPMPVFLAWSMLWGSLGIGSAAFFLDGAPVIGGIAYLGGLLYLTLFAS
VLAFVLYFYVLHIIGPDMAAYAHVLSPVLAMVISTLYENYIWSSSAIAGSIMVLAGLLLA
MKSQKKSIRSVMVKARID
>fig|264203.3.peg.1774 Permeases of the drug/metabolite transporter (DMT) superfamily
MNRLWNNAWITLSLAAFMWASNFVIGRIIPPSMPPVSLSFWRWTLAACILLPFVWSSLKK
EWRVVLRHWPIILLLGTTGQAGSNTLAYYGLHSTGATVALLIQSATPVVILLFAFFLYGE
KPSPKRIVAMLFAFGGILFVIAAKGNGGAASTIGGTLLLTATMLCQALYATILRHKPPTT
PLVLLFSCFVAASLVLLPFQIPYGVGLPFHDSHSLSAIIYLAIGPSIFAFLFFNRGVHII
GASRASIFLYLMPVFGSLIAVPFLGERLGWMHLTGFLLVGVGFVLSREKVKSILSR
>fig|264203.3.peg.1802 Outer membrane component of tripartite multidrug resistance system
MHLKRPLITSISVAALLLTGCASIPKLGKAPKVKDVHDYATAQSLAGNGSAWPGEGWWKS
YGDPQLDQLMTEALAKAPDMAIAKARILSAAGSKQRAGAGLLPSVNGFVGTGAGHLMRDQ
EIRQVTGRNDEFKDWGDGGSSFLTIRYNIDIWGGYRAKLAAATSEAKAAIVDSHEAALTL
TTSIAAAYANLSRLFEERQVLNRTLAVRSHVLELTQQRLGHGLDNDSTMQDASARLANAQ
ADLTANQESIDLVRHQIAALMGAGPDRGMAITRPQSVKLRAVGLPDNAALDLLGRRPDIV
AARLTAEAAGYRVKVAKTQFYPNVSLNGIVGYQTRALEHMATHGLALGAASAALNLPIFR
GGSLSGQYREAWATYQEAVASYDKTLSQALQQVADAATSQKQLNLQLDQTVQALNHAELS
YNVLANRYKSGLVTYIEVLQGEENVLTLRKAVADLRARAFQLDVSLIQALGGGFTAA
>fig|264462.1.peg.238 Permease of the drug/metabolite transporter (DMT) superfamily
MPARFENLILYAICTLIWGSTWLVITFQIDAASPVTSVFWRFLLSTAILLLFCFWKKQNL
KYSRQDHLLFAGQGVLMFSINYMLTYVAETMVSSGMVALSFTLLVYYNMFGMRLFFKKPI
TQNVIWGSLLGGVGIVFIFLNEILNFDPSSRTIWGLLVGFLATLSASLGNMVAQKSYQKR
IPVVVTNTWGMLYGSLFTLIVALVLQHDLSIPLNARFLGALFYLALFGSVIAFGAYLSLA
GRIGAEKAAYTSVLSPVIALTLSSFFENFHWTPYIILGVVLCLLGNVLTLTKRAG
>fig|264462.1.peg.359 Drug resistance transporter, Bcr/CflA family
MQSSAKPNTPFALLILLLASLTAFGPLSIDMYLPAFPAIAENLNVPLSSVQMSLASFFIG
LATGQIFYGPITDRFGRKKPLYVGLGIYALASLVCAFTKNVEMLILFRFLQALGSCAGVV
ISRAIVRDLFTHQETARVFSLLMLVMGVAPILAPFFGGYISEFFGWRAIFALMVIISTSC
IVMLAIFLPETHQPDQRVHIKDSLKNYVQIIKDRHFMGYALAGGAAQAGLFAYITGSSFV
FINLFEIPAKSFGWVFGSNAIGLIACSQINARLLKRLSYDVILEKIFVVLGVLGVILAMA
GIFNWGFWGLAIPLFLFIAALGMTFPNATAGAMATQRKAAGSASALLGTLQYGIAALSSA
AVSRLHDGTTLPMCAMIGFCGVLALALHRLLVKKAA
>fig|264462.1.peg.419 Multidrug resistance protein
MTATSNKSQLAIIFFTVFLYLVGFGVVIPILPILSRNFGATALETGLLLSVYSLMQFLFA
PFWGRLSDRMGRRPILLFCLVGETLSYIMFAWARSLEWLFVARILAGFFGASLSTASAYI
SDITPKHERSKGMALIGAAFGLGFVVGPALGGGLAVWGQHINPAPHFDTSFASYWVAALC
FANFLFGVKFLKESLSEKSESAAKRKRFSIMWQYLNKKTVGPLMTVFLLSSLAMSSMEAT
LILFMGEKYQWDVKQVSFGFAYIGVIIIFTQGFLVRRLLPKWGERKVLRLGVLLLALGLT
GIAIADSITGMAITMTLLSLGNGLANPSTLGSISLLSDANEQGAAMGVTQSMASLGRILG
PALGGALYGTVAITAPFWASGLMAFLGLAIVIIIYKFIPEHGRVG
>fig|264462.1.peg.1432 Multidrug resistance protein
MKKLSALGHLNTTTFSAIQMMTFTLIPFIAEKATLSLSSVVLSFSVGSFLFLWSSPFWAS
RSDSWGRMKVLSVGMLGLFLSTGILTAVLMAPGTYWMNELAVWGSRLLYGLTAAAIVPVS
QALQIDQHPEQTPLKSMLSNSMSLNVGRALGPLYLLLGGGSNMLLILQSTVVWALVVLGL
NLFGITQSEAPKATQTERISILEWKSALRHISDIFSLAILFTSFVGILNFSLASILKKSF
DLTSVDSSVLMAKLLLVSAILAVLTQALGKVLFKNPWQGAMIVGVATLLGASLILGDLGG
WAQLWLAIVLLSVGLSLIPPCYMALMATRGPELQFGRRAGLAAAANTLGYTFGGGLAALT
FKLDLFGIESVMTALVVVMALNIALLYRRREAVYA
>fig|264462.1.peg.1946 Daunorubicin resistance ABC transporter, permease protein yadH
MTGFVTIFQREIARFLKVLVQTVITPFISSFLYLLIFGVSLGQQMASHQGVSYLSFLIPG
LMMMGLINNAFQNSSSSIVSSKFSGDLEDLRVAPITDQEIIWAMSLGALVRGSIVAVITY
GVGSLFMYYQQGEWLLVAHPLAALFFVVLAGLIFGMIGISIAFWANTFDQLSAFSAFILL
PLTYLGGVFLSIEHLHPFWQTVSKANPLLYLINGLRYGILGVSDVNVWTAAVISLIGFGV
FYAVALVSLRKGSFQRW
>fig|264462.1.peg.2047 Permeases of the drug/metabolite transporter (DMT) superfamily
MGFDTIKRHGAAVFCGPALWKGFKTTTMTLGPLLLLLSALLHAAWNGLAKASKDKESFLF
LTILLSGLLTAASLPISGTGFIFPDNRAFAIAVLSGVFEGFYFLTLSKALRASSLGKSYA
IMRGGAMVLVWMYSTVLLGERAHGLQFLGAVFVLLGILAMNFQDLLKGKRQNLKNDIWAY
ISAIFIAGYHLAYHEALTENTDPKPLFLVAMIVSLPFLLYGIRSAPWQRLKATMTSHPAR
VLLCGSFATASFLIFLYGLKVSAPGFAISLRNSSIFFAVLFSVFLKESLTRTQILGATTI
GLGALLLSL
>fig|264462.1.peg.2230 Permease of the drug/metabolite transporter (DMT) superfamily
MVLTKQESGPRRLTKNRAAVELIFAGVLWGFGFVATVWALEAFSPVETLFFRFVIASVVG
EILYLILKGPNFTSLREEIFRALPAGLLLGGMLLLQTIGLKYTTATKSGFLTSLYVILVP
LFNAWLFKSPSSWKNYALTALALAGTFVLVNANLSGINTGDLWTLGCSVFAAFHIIYIGK
ISNKVGNAFRFNNFQSAWCLLALTPLLLTQERSDWNLLSYKPLLGILCLGLGSSIIAFYL
QIRTQKVLSDSTASMLFLLESPFAALFGFLILSERLSWFQASGAVIIMIASVLQIAVDPG
QKPQETTSPRV
>fig|264462.1.peg.2992 Permeases of the drug/metabolite transporter (DMT) superfamily
MKNMNPRLRGSLEISVASVGFGFLGIFGKWAFQSGLSVGELLSYRFALAAVLLWIFLLLF
RPSWVRLSVRQIVIAALLGIFGYAFFSTLYFTAVDGLSITLAALLLYTYPFWVNVFSHFF
TQDKISGKEALCLVAASSGLVMLLWGHIEVKNIWAVAAGLGAAISYAIYVLLSGRLQKNV
RPITSALYVITFGALALSLFHHPHYSAISNLSDIQATSILGLAFVCTIIPLTLELAALQK
LKSTEVALLMMIEPITAALMGALIFHERLTPVQLLGALVIGAALVTNTLYSRPTPSAD
>fig|264730.3.peg.1729 Glyoxalase/bleomycin resistance protein/dioxygenase
MIDHLDHLVLTTADVDACKDFYVRVMGMAPERFRQGRLAFRFGNQKINVHERGKEFEPKA
HLPVPGALDLCFIASIPLAQVIAHLQEQDWPIVEGPVERTGATGPIRSVYVRDPDLNLIE
ISELA
>fig|264730.3.peg.1864 Permease of the drug/metabolite transporter (DMT) superfamily
MSMNQHLSISPSVTRPAWHQAIPLILLEAALVLTWSSGFIGARFSLDYAPPLLVVFWRCV
VVTLILMPFVTRQLRSIPLATLLKNAGIGLLAMAGYVAGVTQGIALGVPAGLAALFADLL
PMGMALLAAAVLGQRLVWQIWAGLVVGLVGVVLVTYSTLAVGDAPLWAYGLPLLGMLSLA
IATLWQKHSTHMQPMDLLPNLWLQCFISSFAFAIIQGTQGSLAPIPSTGFALSVIWTVGL
ATLGGYGLYWVCLRRASATRVASVLYLSPPVTMLWAWVMFNEPLSWQMASGMAVSGVGVW
MVVRAEARQVAS
>fig|264730.3.peg.4236 Permease of the drug/metabolite transporter (DMT) superfamily
MQYAFPLITVLIWAINTAVTKASAGVIFPAEIGFYRWALAGLLFTPFMLRPVWANRAAIK
PVLGKIFILAVLGTAMYQSLAYFAASLTTATNMGIIQSLVPMMAQGLSIACLGNRLTRGA
LLGAVLSFVGVVVVVSAGNPAGLIDHGVNRGDAMVLVATASYAVYSTLLKKWQLCLPPLQ
LLYVQILLALIVLLPPFILSAKTGLNASNIPMVLYAAIPTSMLAPWLWMTSIMRLGPSRT
TLFFNLMPIATALIAAATLGEQLALYHLFGGALTLCGVILAERWTTPLRSKTS
>fig|264730.3.peg.4286 Permease of the drug/metabolite transporter (DMT) superfamily
MEDKNQSQGVIQLSLAMLISGTIGLFVVESGQSAINAVFFRCLIGGGVLLAYIFYKKMLK
ASYFSKKNVVCLLVIGCSIVINWVTLFNSYTHISIGLATTIYHVQPFLVFFGGALFLRES
LSKHRLVYVCIAFAGVLLIVNPGGESQDSNYLVGCGLALFAAFFYAVATIATKKMDKIPP
HIVALSQMAIGVVVLLPLANFDKLPSTAVQWSLVLTLGVVHSAIMYIMIYSAYQKLPTSK
IAVLGYVYPLMAVAVDYLYFGRALNSLQVLGGVMIIFSGLMGTLNANPFVRKTKAVNI
>fig|264731.4.peg.254 Acriflavin resistance protein
MEHYSITLLIIGILFVMGIYGMYIMPKDEFPHATIRQGVVVAVYPGATSEEVEQQVARPL
ERYLFTYGEVNRVKTTTQSQNGMCIVMVKLNDDVNNKDEVWSKIKHGLNGFKAQLPSGVL
AIVVNDDFGNTSALLIAIESDQRSYRELKQYSDDLSDRLRRIPSVANVKLFGEQKEQISL
YIDRQRMQAYGIGQQMLFSRLQAQGITTMSGAISDDDQQIPIHVEAQENSEEEIANQIIF
SDPVTGKVARVRDVARVVREYEPNASRIEQDGHPCVLLSMEMTPGNNVVQYGEQVDKVLK
EFSLNELPEDVKVTRIADKPKVVAMSVSDFLRDLLISMAIIILVMMVLFPLRSAIVSAIT
IPLSTFVSVAIMYIMGIELNIVTLAALIVVLGMIVDNSIVVIDGYLEYLGKGFKPFDAAI
ESARQYFMPMLLATICICAIFYPFLITMKGMFHDCLEDFPVTITINLMVSLVLAVTVIPF
LETRIIKPGKVSTDGNAITKWVQKTYNKVLDFTFAHPWLTIGGGIGVILLSTLIAPTLKI
RLFPYADRDQFAVEIFLPEGKGMAETEVIADSVQHVLAKDERITGITGFIGCSSPRFMDA
YAPQMAGNNYAQFIVNTKSNKATLDLLAQYQPQLSEAFPNAYVKFKRLDYLEVSELEYRF
YGDNLDSLHVVVERLMERMRKMPELEWVHTDYLQPYPIINVELDPVTSAQLGITRTTAQL
ALSATSSDLRVGQIWEKDYELPIVVKDDADMTFSDIANLGIASPASMVSGGLRSTNSTVP
LRQIAKVQPKWSESRIMHRGGERCITVTAQFAQGVYTAPVEKEIARMMNEEIKLPQGVRA
EVGGEIEYGDEAMPQIIGGITIALIIVYFFLLFNFKKYGVTTVCMAALGLMIPGALIGLG
LMNRALGLTSIFGLITLMGMIMRNEILIFEHAIDLIKKHVAEHGDWKTDRQAYNAAVRQA
AYDAGKRRMVPIFLTTATTAVGVVPMIIAQSSFWMPVGVTIFAGGIGSLIMVVTMLPVIY
WKVSTK
>fig|264731.4.peg.310 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTDQRLGTEPIRRLFVSMTVPVVLQQLLMLLNNVVDRIWIAHIPDVGQLAFTASGVCVPI
VYMIIALAELTGTGISSRVGLILGQGHHHQAERTLGSMMAFSILLAILTLLLVEVFCPEL
IRIFGGSPQTAAMAECYLRISTPGNAACIISSMLAPFLLVQGYSNEALFVIGSGIVINMI
LDPIFIFLFGWGIAGAAWATTVAEVTSAVVAIVMLARVGNLRIRMKLLSLDWRHIVPCLA
LGTAPMAMMLAETAQMGVYNQTLYHLAGDWGVGTMALVIMLHDFLFFPVRGMAYGSQPIT
SYNLGAGKWQRVWDNVKLLLAFTLVWSMMVCLLMMILTEPVVRLVVGDGPMVDYAVPMVR
LSFVVFFVATVQFASQCTLQAMNRPVLTFWIGISRTLLLLVPFVWLLPRLLTDHADMGVF
LAQPATDVVVGTVTVIILFKLLQNYKNIQNNKV
>fig|264731.4.peg.395 Permease of the drug/metabolite transporter (DMT) superfamily
MTQQSIFQRPVWAALMAFTAAFLWGWAYPFIKLGFAEFEITADMTGSKMLFAGIRFCISG
LIILSIARFTHRSFQFNEAAKPNLIGSALFLLGFTLLNTTLHYAAFYIGLSHSQGSRAAI
LNSLSVFTLVLLACMFFKSDKLTTRKILGCTIGFGGILSLNLGGEGSGQFTLLGDGMIIL
NALCGAFAGLMTRGVNKRVDVFVGTGYSLGIGGALLIIPGLLLGGTLPHVTLLGLFYLLM
LIGISTIGFALYNKLLTCNPVGKIAIWNSLIPVVGAVTSCLCLGEPFLPKYILAATLTTA
GIYIINKGKV
>fig|264731.4.peg.483 Membrane fusion component of tripartite multidrug resistance system
MEKNKITTYIYNAIVILCIVGGAVYAASQFMHFGGGEVTDNARVCQNIVPQNCRVQGFIR
EVRFNEFQEVKKGDTLVVIEDAEFRLRLAQAEADLTRAERGSQGTASSIHTTKTSIGVTE
AGIEAARVQMENAKREDARFQKLLEQDAVTQQQYDNVHTGYLSAKAGYEQALRSRNTQTA
VVAEQGHHLSASEAAIELARAQVEIARLNLSYCYIIATCDGVVGSKDIHVGQLVNPGQTM
VSIVDKHEKWVEANYQESQMPNIKVGDKVRFTADAVPDVEYTGVVERISDATGSAFSLVP
IDNATGNFVKVEQRVTVRVKIDVNDELQKLHGGYNVVCKVEE
>fig|264731.4.peg.484 Drug resistance transporter, EmrB/QacA family protein
MGKLTEFLMKAPPPPAGMGFAMPMMKGWVPRKLQPWIYVLTALCFQFSGGIYLGALDEIR
GTTNFMIEDVMFLLYATLAGMAVWFPMLFRMKFRFTNQQLLCTSAIVMGICNVITMHSQS
MPVLMLACFIAGIAKIQGTFECMSNIQLWITPKRDFAVFFPVLHIILLTAIEGGGWLAAW
MGHHFTWQMMHTFTVGTMSFVLLSQIVLCRPFCPMPNRFSLKGTDWQGALLICVTMLLFS
YIFVYGDHYRWFANRHIRMVGAFALIFAGLTLYRLIHNRYPYVELRLLKCRNVVPILIVT
ILAELAFGAEHTLEEILYTEVVGLEELTKESQYMWALPGMFLGIAFDLYWLKVQKWKVWK
LIGIAFLSISAYALLMYSTLGMAVNIEQYQLSIMLRGFGYGVLAPTLMWALDESVPSLEM
FFMGLFVFNIPHMYLGGAMGYGFYTTIFSHFLNEDMMNYGRQLTLTNLDLSQFDFGAFMG
NSYLHSMMLVAIKQVYGYVIWFALLLASVFLLCDIPAVRTNIRKVPLWPVLAIEYLARKH
KNA
>fig|264731.4.peg.543 Permease of the drug/metabolite transporter (DMT) superfamily
MFKVQNSKLQAHSAIFLANTIFGLGVPVTKLLLDEWVTPMGYMASRSLGACIVFWAIAAF
LPKEKVERKDLITILLGGLLGFVVSQTLTAWSLDYTSPVYFSLIATLTPVAVMLCAALTI
GEKITPMKSIGVLLGIAGAVLMVLMSQSMGSGKNDLIGIVLAILSVLTWAIYLIITRNVA
SKYSPVTQLKYVFLISAIVTVPIAWPELSANALYTPEWGWDGVAEMAFIVIGATALGFFL
IPFAMKYLQATTVSIYTNLQPVIASFVAILLGQDVITWDKPVAGALVLISAYIVTVVTEK
KNS
>fig|264731.4.peg.2063 Multidrug resistance ABC transporter ATP-binding and permease protein
MNYIAWLWHHSRGIRFNTVVRIVTGIGQVALGLLMVWLSRKFIDETIRTGTADDVLRMVL
LLVLTVLGGVALRQVGYWLTTTAGVHQSNALRLRIFSSLFRRQLYTEQELHSGDVTSRLV
KDIETISSVCTDTIPQIAITFIQLCGAFLLMRWFDARLAWALLLLTPMAIVFGKLISRRL
RKMTLDIREDESRIQMQVQESMEHNAVLRSLGSEQWVTDRLESMQQRLKGNVMRRMRFTV
AMRIVMGCVFGLGYLLAFVWGGISLRNGTITFGVMTSFLQLVGMIQHPILQLLNMVPTVI
HCTASIDRLEELSVQDKKEIRDNPCNSVPNKMVRLDDVSFRYANGDSEILQHFTHQFAPG
TKTAIMGQTGIGKTTLFRLILGFIQPTSGRVEVGGNICYVPQGNTLMSGTIRYNLQLAKP
TATDDELRQVLHTACADFVFDLEDGLDTELGERGCGLSEGQAQRIAIARGLLHDGDILLL
DEISSSLDESTEKDLYHRIFTALPQKTMIFITHRSTVCELCDDIVLIENEKKQFASHS
>fig|264731.4.peg.2335 Permease of the drug/metabolite transporter (DMT) superfamily
MKRFLPHLIAFIVVAIWGVTFVCTKLLLLGGLTAAQIFILRFIIAYLLLLGYSLSKGIHW
LSNSWRDELNMMALGVFGGSLYFLTENSAMNYTTTTNTSIIVSLCPLFASAIIGAFYKTE
RLNRWQTAGTVMASLGVIMVVMNGHFVLHLSPLGDALAFGACMCWAFYSLLIIPVSKRYP
TVFITRKVFFYGLLSMIPYIILHPDLNIQLVINKPTLLANLLFLGCVASMLCYVAWNWVL
KRLGAVVATNYVYLNPVTTIVFAWMVLNEQITVWFIIGTVLILYGMYLVNTKRPKLSA
>fig|264732.9.peg.664 Vancomycin B-type resistance protein VanW
METALIRLPDDGQREMENLLRSFYWLVVLVAFFFAWPVLEPALAADPVVAYEDPDTQRAM
IAVRDFSTVLGGEVDWEAATSTVSIRVYGRPALYLDVKAGTLAGVPLQPRPQIKDGVTYA
PLRQVAEALGARVDWREDGIHVYTPAGEQVSIKYIHLLGRYTITFPEKEAGSPSLHNARL
AGQYLNGLVVPPGGVVSFNNVVGPRTGARGFVPGIIFMGDQKVPEIGGGICRTATLLHNA
VLSAGLEVVERHRHGLPVTYVPPGYDATVYYGVLDYRFRNNRPVPIKLEFTSQGSSITMA
IWELG
>fig|264732.9.peg.979 Multidrug resistance protein related protein
MLAKTKENYKWYALSCTTLGALLSVLNSNTLLIALPVIARALHASLETIIWTLMIYMLAV
TVMVPAIGRVADIIGRKKLYVSGFALFTVASLLCGLVQSGGQLVAARFIQSVGGSLMLAN
STAIVTDAFPKGQLGRALGINSMVIGAGAVIGPILGGLLTSWHWRWIFFFNVPLGIIGTL
WAAIQLREIIELPEGQRFDWLGTSLFTIGFTFILLALTFGDMVGWHTPWIVASLVGGSLL
MLLFIYIENHVDQPMLDLSLFRQRLLAAAYASNLLNGIARGAVTFLLIFFFQGIWGIDPL
WAGILLTPFALAMMFVAPVSGILSDRYGSRELSSLGLAVSAIGLYGLTRLQINTPMTVVI
LWMVIMGLGSGFFFSPNTNAIMGAVAAERRGIAAGTRTMMNNAGMVISIALGLAMTASSM
TPEAMQGLFAGTQVGSQGIAVQEFMNGLHRAFWLSFIISIVAAVVALMRGPHEVYYQETG
SGSNKA
>fig|264732.9.peg.1090 Permease of the drug/metabolite transporter (DMT) superfamily
MGINREGYMKKAKDSSGEGRGLFLAVLAAAALGLEGISAKLAYAGGANILSILAIRFLAA
GILFWGSLIVFPLDWKLNLGTMVRLTVLALGGQATTILLLFYAFERIPATVAMLFFYLYP
VIVSLLATVFLKETLTRAKIGALVLAFTGLAIILGVPTGNLEIWGIVTALLAACTNGIYM
VGQTGLLKTIEPRVFNAYATLTIGVAYFILAIVTGTFSLAFNSQAILAIATLSLICTLLA
YTAVAWSLKYIGASRAAIISTLEPVVTAVLGFLILGERLHPIQLLGGALILAGVTVQQVL
TSKDSGEGHGYGIIKQ
>fig|264732.9.peg.1200 Probable multidrug resistance protein
MLQNDAYPAPNPRRWLILFAVMAAGIMGPIDGSVVNVALPTIGRVFNVDLNTVGWVSMAY
LLVLGSLILTYGRLGDMYGFRRVLLTGIVIFTIASGICALAPNIWVLIVFRAVQAIGAGM
FMAMGPAIITSVFPPYERGRALGTNGMIIAVGLALGPTLGGFLVTVAGWEAIFTINIPIG
IISYIMCRQVVPESRDLKPQQFDLIGAAMGFISLSAFLLAGSYGEEWGWTSPATLVLSVV
FLVGGWLFLRWEKRVQEPMLDLTLFHNKVFSAANFAALMNFMSQYALIFLLPFYLQQILN
YTAGHTGLILTASPLVVLMLAPVSGALSDRLGTRWLAFTGQAIVSLALFLMVGLKVTSRA
FDIIWRLCLFGLGTGIFQSPNNSAVMGSVPRHRLGIGSGVLATVRNVGMVLGIAVSSGVF
TWQRSAKLVAWGPGSATAAFMAGMKSAFLVGAILAAAGAIASLVRSDNFPPGEH
>fig|264732.9.peg.1204 Permease of the drug/metabolite transporter (DMT) superfamily
MSLPLPAPKTSTSIKDHLSLLLTVTIWASTFINIKIVLLQVPPNTLAFLRFLVASIVLGL
HLIWRRQPFVKRQDWPLAGLTGLTGITLYNFLQNQGLKYAGATDAAILAAMAPVFIALLA
WLLLRERISRRQVAGIIMAFSGSVLVATNGSPEGLVLNPARLYGDLLVLLTGLSWAVYSI
SLKRLLNRYTPVTVLTCSTIAGTIFLFPLALLESPINWAAVDISCWLNVLYLGLLASALA
YLIWNTVLTRVPAVTAGVYLYLLPVITAIIAALFLREIPGTFTITGGIIVLLGTYLAGK
>fig|264732.9.peg.1524 Fosmidomycin resistance protein
MRKRILYLLSLGHMVTDINQGLLPIFLSVYKDQYGLSYAAAGLVVFLSNISSSVIQPLFG
YWSDRHQLRWLLPAGCLVAGLGMVAAGYAANYYLLVAAVFISGLGVAAYHPEASKSAHYI
SGPMQASSMSIFSVGGNVGFGLGPLIATFILSHGGLRASWIILIPTSVTVALLSHTLPAL
GRAMAGGHQAAPAGNPRAKTSQAPLVAITLLVLVVIMRSWLQSGLTYYIPFYYLNFLHGN
EHFASSMLSIFLIAGAVGTLVGGRLADYWGAKRMIIGSMLVLIPMVVTFPYVQGAWVAIL
LALSGFALVSTFAPAIVLAQNILPEHVGMASGLMMGFAIGTGGLGTFLLGGIADAHGVPF
TIQIMAVIPAIGAALAFFIPDLRQQPSARQVRVEPVPEEKNSRA
>fig|264732.9.peg.1638 Vancomycin B-type resistance protein VanW
MARWKLGVLLFFLLGLALLALARFYFSGRILPGVAVAGRPVGGMDLERARKVITELAAEV
ENRQVSLRLGEQVLASTPGALGLEVDVEATLARAYALGRQGPLVKRLVLLSARKRRVEPV
THLDQQRLQAGLERLGGAWRREPADARIEIVAGGQPRLVPAVTGWQVDAAILKSRLEEAT
TGQTIDIPLNRLEPRLTTAELAARRITRQVASFTTLFDPAEADRTHNIRLAAGTLDGLWL
PPGGEFSFNRTVGPRTPDRGYRDALVVEEGNFVPGTGGGVCQVSSTLYNVALLAGLTITE
RQPHGLPITYVPPGRDATVAYGLIDLKFRNDTPYWYLLKTGVEAGKLTMAFYAADEAPRA
EVTSQVLETIPPLEEIEWEPDWPPGRVELKREGKPGFRTQVIRIIYQDDKKGQPEVVSRD
LYPPQPRIIRKGGQGG
>fig|264732.9.peg.1854 Permease of the drug/metabolite transporter (DMT) superfamily
MAIKEAAIRPITSGCAAGADRRLGYIAIILASLLYGGNVIAGRVIAPLVPPLALAAARGL
LGLPVLLLFALKAGGKPRLADLPYMALMGFLGISIAYGTFSWSMQNSPAVNAAIIFATFP
AVTLVLLAIGWHVKPSRYQVAGIIMAFIGLALVSTRGSLAQLLAMRFQPVDLVLLANVTA
ASLYNILGQRMVERYSPIVTSTYSLFFGTLFLLPAGFWEVSRQGWYLPPSGWLLLIYMGC
IIAGLAVLLTFEAVERIGCGPVAMFNNLNPLFAIALAALFLGEKLSWYHWAGIILVLGGV
CISLRQQPGRQQGQKQGQQ
>fig|264732.9.peg.1943 Multiple antibiotic resistance protein MarC
MSVFFLHAVVSILAILNPIGNLPIFLSLVEGEATADQIATARRATLAAFGFLTLFVLLGN
NILLFFGITLAAFRVAGSIILFSIGYKILQGRNIHSRSLAPDIHEDIMARDDVAITPLAT
PILAGPGSITTVMLLVGSEWRLRTILLTVAAIAVVTLGTYLIFRYATLITRHLGPMEMNI
ISRVMGLLLAVIAVQMGASGLLELFPGLGR
>fig|264732.9.peg.2253 Probable multidrug resistance protein
MYSPTVLIPFFYQKVLGFTPQKAGFLMMAFLAAMAITASFSGWLSDKIGYVLLTTSGLVL
NGLALVALANINLQTPLTLIIIYIAVMGTSLGMFQSPNNSCVTGSVPKNKLGAATGISQL
IKNLGMVIGITFSVAIFSSRMAGMPVEYNQAFVKSMGFVYYLAAVLSFAGAVISSRRSK
>fig|264732.9.peg.2259 Permease of the drug/metabolite transporter (DMT) superfamily
MVYLLVGLNILLLVSGQILWKLGVARDAGFKAVLASFFSPLVLAGLALYVLATVIWLYVL
AREQFSLLYPLQSLAYALGVVVAWLVFKEAVPLTRWIGVLVIMAGVALVAMK
>fig|264732.9.peg.2348 Permease of the drug/metabolite transporter (DMT) superfamily
MQPKHIYALILVALIWGLTFPAMKIGSFYLPPLSFAAWRFFLGALCLLPLAGRRQGKLWH
AGRDFWPLFLLGLLQTAIMGGALHLGISMVKSGITSVVLYSYPFFFTFLAFLLLREPLTG
KQMAGLIIGFAGLILVVDPWKMHPTHAEFIGILVLLGGSIGWGLASVYLKAAFKTRDKLE
VTTYQMFYGSLVLMLVAAFADHGLRFSWTAPGLGIMLYTALLTSALGFVILLTIQARYPA
SQTSVYLFLVPVFGVLFSSLLLGEKLTLNLLLGLALVAAGIITVNLGAPVQAREKTDCVA
SGK
>fig|265072.7.peg.175 Outer membrane component of tripartite multidrug resistance system
MKTPPPLPFPRSRHQHWQIAIAALCLALAGCQSMAPDYERPAAPVAEHFPQAGTGTADAP
SLAWQDYFADTTLQDLIQEALANNRDLRSAIQRVEGARALYGVQRADLFPGLNAQGSFGR
SRTPEDMSLIGRPMVLSEYRVGFGITNWELDFWGRIRSLRDAALETFLAAESAQRASAIS
LVAQVANSYLNLRELDQRILIAEKTIESRQESVRIFQRRFDVGSTSKLDLKQVQALLAQA
QTLRYQLQQSRAIELNALTLLVGKPVDLPPASHAFSETKMLHQLKPGLPSDVLTQRPDII
AAEHILKSANANIGAARAAFFPRVTLTTSLGTASRELDGLFDTGSHAWSFAPSISLPIFD
GWRNRSNLELANVRRDLAVTSYEQTIQTAFREVADALAAQHSIRQQLVSQQEMLDAQAER
ARLAKLRYDHGATSYFEVLDAERSLLEVEQQLVQMQRALFSSQVSLYAALGGGSHSITVP
PPSTTPAARQPSN
>fig|265072.7.peg.374 Multidrug resistance protein, AcrB/AcrD family
MVYAIIQTPPGSTLEVTNKIARQLQGIASKVEGVQSVSSLAGYEVLTEGRGSNAGTCIIN
LKDWSERKQSVHQIIEELEEKTKDFGAVIEFFEPPAVPGYGAASGLALRLLDKTDNTDYH
EFDKINQDFMKALAKRKELTGLFTFYAANYPQYEIQIDNKLAMQKKVSIAKAMDNLDILI
GSTYEQGFIRFNNFFKVYTQAGPEFRRYPTDILNYYVKNEEGEMVPYSAFMKLKKMQGPN
EITRYNLYNSATIRAMPADGYTTDDAIKAVEQVAKATLPHGYDIGWEGLSFDEANRGNEA
IIIFGVVLVFVYMVLAAQYESFILPLVVVLSLPAGVFGSFFMLKALGLANDIYAQVGLVM
LVGLLGKNAVLIVEYAVQKHAQGLSIKDAAIESARVRFRPILMTSFAFIAGLIPLVVATG
AGAVGNRTIGSSALGGMLFGTIFGVILIPGLYYIFAKLSDGKSMIRNEEFEPLTETYHYS
KSDDDQE
>fig|265072.7.peg.449 Multiple antibiotic resistance protein MarC
MTGQPGTARVRHDGQHVAAYRLVDAAPARHRHTVLECILTVIFNNKKRTGTMSILEALKY
ISIVVIGLLPIMNPLTTIPLYMALTQRMTPETRKLQARKACIYAFFILTTFLLLGNGIIA
LFGISMAGIRVAGGLIILILALRMIFSGLDSSSSVDSEPEEIKSANLDYSFSPLAMPSLA
GPGSIAVVMSFGSQIPEGSHLIGDPIVIAGIAITIGIAYLALSSATHIEKMLGEHGMQAV
TKIMGFLLTCVAVQFLASGIRDFYIEFSTI
>fig|265072.7.peg.1404 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTTDRSQSNPHISVIVPAFNESSAITSTVENIANQLATLSPHWDIVVIDDGSRDKTADIV
RGLPAYLRTTLVRFSRNFGKEYAITAGLEYASGDIVICMDADGQHSPALISEMLEKWRAG
YDMVYAVRQNRHIESGFKRWGSKLFYEIMTLGERITIPRDAGDFRLMNRNVVNALRKLPE
RNRFMKGMYAWVGYKSIGIPYTPLPRSHGVSTFSRLKLIQLAWTGITSFSVIPLRLASAV
GGLLALLAFIYGIWVILEKMFFHESIPGWPTVVASLMFFSGVQLLFIGILGEYIARIYDE
VKGRPPYIVAEVSASYQGKESQL
>fig|265072.7.peg.2382 Permease of the drug/metabolite transporter (DMT) superfamily
MKAGTSTTLRAFAALLLLAVLWGYNWVVMKHALDYAGAFQFGAMRTFYGAVCLMALLVLM
RKPLKPREVPTLIWLGVLQTCGFTGLIIWALVEGGAGKTAVLTYTMPFWVMVLAWPLLGE
KIRGIQWLAVLFSVMGLLFILDPLHLGSDLFSMSLAILGGVFWAISVIVAKKLHQRVPDL
DLMSLTAWQMLFGSLPLVAVAFIVPAPPIDWSINFIGAVLYNAVLCNALAWLLWLYALQH
LPAGIASMTSLLAPVIGVLAAWWQLGEEPERGEVIGMILIGVALLIISLHSMKRREVVNP
AMGQD
>fig|265072.7.peg.2506 Permease of the drug/metabolite transporter (DMT) superfamily
MPPFLAKFFSSRQQALGVLFALVSAIGFSAKAIFVKLAYVEPVDAVTLLALRMAFSVPFF
IVAMFYGQEKAVAMQRRDWLAVLVLGFIGYYLASFLDFLGLQYISAGLERLILFLYPTMV
VLISALLFRERIGRTVMVALLLSYAGIVLVFVHDFSMSGDGLFLGGGLVFASAFAYAVYL
VGAGHTIARIGAMRFTAYAMTVACLACIAQFLLTHPLDALRQSGRVYVLTANMALFSTVL
PAFALAAAMKRIGSMQTSMIGALGPVATIYLAYVFLGEQLSLIQFLGSVLVLVGVMMISL
RKKK
>fig|265072.7.peg.2607 Permease of the drug/metabolite transporter (DMT) superfamily
MSASSRDADAWGGMVSDDQPMTRLLGKSCSIVHHKLAYTMRLMQKPAVSPFTLYLILILP
PLFWAGNFVVGRAVHTDIPPFTLSLGRWVIALLCILPFAWPTMRRDLPLYWQYRWRLLAV
SVVGVAAFNTLVYSGLHHTTATNGILLNSCIPILILLFGAMFYRLRLHSLQLLGLALSFF
GVLTIILHGEWERLLSLAFSSGDLVIFTAMICWALYTLWLRDLPASIHRLGLMGAQIMVA
VIVLLPLFIWEQAHGQHARWGQETWLALAYVGIFPSVIAYTLYTIGVEKAGAARAGLFIH
LMPVFGSLLSVIFLGEHLHLFHAIGIAAILGGLALSNRHQHP
>fig|265072.7.peg.2613 Outer membrane component of tripartite multidrug resistance system
MHRNILKAFSTAVIAVLPGCMSMSGISTTAQPKDTAQLEAGHDISEARHDLPWPGEAWWQ
VFQDPQLDALVNHSLQQHPDIRAARSRTAIAEAQAQAAGALLAPQASANGTLVRERFTSL
QFIPPPWAGHTEWNNKATLNLGYDLDLWGQRAQQWQSALDRTQATAAEAQQVKLSLTTAL
VMQYIALSRAHALHDITHHRLDIAHQQLDIRKRALAAGLGTEIEVTEAESLIPALRAQLE
AGDERITLLRQQLAALAGEGPGYAERLHPPKLSLDADIGLPDALPANLVGRRPDIVAAKW
RIEAARHNIASAKAAFYPNINLLGFVGLQAMGFGKILTESGMVAGVGPALSLPLFDGGLR
RGNLAATTADYDLAVEQYNSILLQSLQEISAQLVTLRSNAIQHAELLDALRLAQRSRKLA
LTHHQAGLANYLQVLEAEHHVLTQHAALVDLEASRLSAYADLMKALGGGAGQPQ
>fig|266117.6.peg.200 Permease of the drug/metabolite transporter (DMT) superfamily
MAWRKGGFFGVLLVALGASLWGTDGVLRVPLLEDMSPLSIVFAEHLFLAAYSVPAVVIGR
RAFRGFGLPQWGALLVIGWGGSALATLLFTAAFAVGNPTVVILLQKTQPLFAIALSALLL
REPLGWRYWPGFAVAMVGAYLVSFADLSPFRQLPGAEALTAALALGAALLWGSSTVLGRL
VLREVPFHTLTGARLLLALPLLAGIVLAQGTLGQAAQGLAGHPGRLALLALLPGLLALLL
YYRGLSSTRASYATLAELTFPATAVVLNWAVLGVGIGASQLAGFLLLWGAVLYLSHLNAR
SPSPEGPALEPGRG
>fig|266117.6.peg.377 Daunorubicin resistance ATP-binding protein drrA
MVEALRMRGVRKRFRRRRGEVVCALEDVSLEIRRGEVVGILGPNGSGKSTLVRVISTLVL
PDSGSVEVFGVDALRHPKRVQRSMNRVSVEASFFKKLSAMENLLYGAKLYGVSDREARPR
IEEIMGHIGFDYKRAAEPMEHLSRGMQQKVALARALLTSPMLMLLDEPTTGLDPRSRRDV
QAFIRRIREAHDSSILLCTHDMGEAEELCDRVGIMVGGRIIALDEPRRLKERYASGGRLP
DLEEVFMAATGYTVEEASAEEGER
>fig|266117.6.peg.551 Multidrug resistance protein B
MSAAGHKNIIFIGVALGMLSAAAAQTIVSPAMPRIVAELGGMNHYSWVATAALLASAVTV
PVVGKLSDMYGRRGFFIWGLVVFMAGSALSGAAQGFWWLVAARAVQGLGMGTIMPLAQTI
IGDIISPRERGRYVGYLGAVFGVASITGPLVGGWITDNFSWRWLFYVNLPLGVAALAFVV
AYLHLPHTPRRHAVDYAGFATLAVGLSAVLLATSWGGTEYPWGSWQIVGLYGLGAAVLAV
FLVNEHRAEEPVLPLRLWKSGVFTFSNIANLAISMGMFGAIYYIPVFAQGVLGVSVTNSG
AITLPLMLAALPVSVLVGRMITRTGRYKLFLLAGVAVMWLGYLILSNLDYGSTQAELTLA
MVVVGLGLGAVMQTFTLVVQNAVTREDLGVATAATQFTRSTGATVGIAVFGTIMTNRMQT
EIPAHLPPAARRHSAALFGDSGGGVGAVLDPSSLSHLPAPVVEGIQQGLAAAMHPVFVAG
LPVLAVAFLATLLVKELPLRTVAFADMDRAVPGGRDDEARRLLLSGVALDWAARRIESAN
GDAPHLLRAAASLVGPDGGRSERERALRASREVIRPAARLLLAGYLLRRRPASGAAAGEN
GREEVVR
>fig|266117.6.peg.670 Permease of the drug/metabolite transporter (DMT) superfamily
MDSAGRRGSAWAELSLLLTAFFFGTNFVAVKHVVEEVPPVLFAAARFTAAGLLLWAVLRL
FEPASRLKRADLPPVAGLGLLGITATQTVFTIGVHHTTAANTAVIYSTAPVWGMLLGFAL
GLERPRLSGVAGVAMCLAGVAAIEGGGLRLAGTSLLGDALILLAAVFWGSYTVLSLPLLR
RYTPLAVAAYPMLLGGLAAFPLAALDLRVEPSALGGSVWFAALYSTLFSSAFGFVGWQKG
VARVGANRVLVYQYLVALSGVAAGMVVLGEGFGPLQALGAAVVLVGVYLARRRA
>fig|266117.6.peg.928 Permeases of the drug/metabolite transporter (DMT) superfamily
MKGSGRPGALLLLFALLVLFWGTAFAAIKIGVSYCPPLLFAGLRALLGGAVMVPLALARD
GVPDLRRGWRAFALLSLLNVVLFFGLQTYAVLLLPSGSAALLVYLQPILVGLLAWPLLGE
RLSAGGVAGLLLGFAGIAVVGAGSLSGGLEALSPAGVALGAASALAWAAGTVCFKMVQDG
VSTLWSVAVQFVAGGGVLTAAGALVEGWGRVAWGAGAFWASLLYASLVGVSLAWIIWFSL
VRAGEASRVSAYIFAVPLTAVAVGVIFLDEPFGPALLLGAALVVAGIYLVNRSGRVAP
>fig|266117.6.peg.1124 Fosmidomycin resistance protein
MDRRAMAALSAGHLFTDVNQGAVAAIIPFLVSQRGISLAAAGALVLASTVSSSVVQPLFG
VLSDRRPLPALMPLGVLVAGLGMALVGVAPGYAAVFACTVLSGVGVAAFHPESARFANYV
SGSRRARGMSLFSVGGNVGFALGPVLTTPLVLLFGLPGTLFLALPAAAMAAILIYELPRL
NAFRPGRGIEAGGGGEAAAEDRWGPFALMAGVVVLRSLIYFGLVAFVASYYVRVLGTSEA
WGNTALAVLTGAGAAGTLALGPLADRFGRRTVIVCSMLVLAPVLFAFAHAGPVSGMVLLA
LAGGAIVGTFGVTVVMGQEYLPRSIGLAAGVTMGLSIGLGGAGAPVLGYFADHYGLHATM
LLISGLPLPALLLALALPGGGRV
>fig|266117.6.peg.1146 Vancomycin B-type resistance protein VanW
MSLKRVAGRDAPRRGGRDDAPWERGSSGRAGTGGARRFVGPFIIALAAVAVLVALDYWMN
AGRIYRGVEVGDVALGGKTPEEAREIVLRRAEGALERVELRGGPEGEISFDARRMGIDYK
VRETVQAAYAVGREGNLLERLGERLRAAYGTVQIEPRVDYRPSVARQRIEEVASRLDRPP
RQAEVNVYGSEVDVVGSREGYRVDVEATMRSVGEAVEDMSGEARLVGRVLEPEYTTAEAE
RAAERARRALDGELVLTYEGRRWTVSPAAIGDSLDITARDGEFRVGVDRDRLRENLSGVY
AAINQEPVEAGYEISGEQITVTPSRTGRAIQDEKLLGAIEEGIFEGRREYRIPVAVDRPE
LTTAEAERLKPTDLLATYQTNYLTYDDSPGRVENLEIASEAVDGTLLAPGEVFSFNELAA
PLDYHDTKVIINGRVDTAEGGGLCQVSSTLYMAANLAGLDVIERHPHYAELPYIRPGFDA
TVWFGALDMKFKNTSPGYILIREWVDRSTGTVNAAIYGRPSGIEVDMRSEKVSETVDEEG
NPVTTWITYQTVRKNGEVVFDGVLHKDVYKYLKPAAPDAPYDERPVN
>fig|266117.6.peg.1151 Permeases of the drug/metabolite transporter (DMT) superfamily
MVAVGSAAVLIRLAEAPALAVAFWRCALGAALLLPFALARRERFPRGRELRVGVASGVAL
GAHFGLWISSLDYTSVAASVVLVSTQPVFVAVLAYLLFGERTSALSLAGILLAIAGTVLI
AADRSAGQAAPLGNALALAGALAVAFYVLIGRSSRTGGLGVLPYSVVVYSSAALVLLAAG
LAWGVRMWGFPPETWLWLWAITLGPQLMGHTVFNWALRYVEASVVSGSILAEPVIAALLA
WAVLAERPGWPTLAGGAVVLLGLALLLRGHRRGAAGP
>fig|266117.6.peg.1956 Drug resistance transporter, EmrB/QacA family
MGLSRRRKILVTLATLIGTFLAALDSTVVGTAMPTVIGDLGGLGLYPWVFASYLLAATVT
GPLFGRLSDAYGRKPVYLAGVSLFLLGSVLCGTAGSMGALIVYRTIQGLGAGAVQPVAVT
IVGDIFELETRARIQGLFGAVWGVSAVVGPAAGGLITDYLSWRWVFYVNVPFGLAAGALL
ALALRESFERRPGRADYPGVFLLTGGLLAVLLAVLGAGSLLADLALLAGGASALALFVLA
EARAPDPIVPLELFRERLFAVASAGNAALGGVLLGVSVYVPLYVQGALGGTALTAGTVVA
PLSIGWPVGSFVGGRMLLRAGYRTTLLVGSAFVVAGSAMCLALDAATPLAYVILSVFVIG
LGMGFSSTSYLVSVQNAVPWHRRGIATSSVVFFRTIGGSLGVAVMGALLDLSLGERYRAA
VERAAGENGALARLLSDPNALLQPALRAKIPEGAYGELASALASALSPAFWAVAVMAVAA
LAVSALFPAGRAEDFVKREPRP
>fig|266117.6.peg.2302 Kanamycin resistance protein-related protein
MAGREKEGADIHAEELDTLRGGEVSLRPPREEDVETVYEWDRDPELAAWNGRAPVSVSLE
AARRDYLLRWEDPGVKTFIIEAEGRPVGLATLYDFRGGGCELGIKIGPEELRGRGYATEA
VRLLVDYAFQRLGLRVVRGSTLAHNRRMRRVFEKCGFERVGEGSILSRYDNRRYAEVFYE
RRRH
>fig|266264.4.peg.4109 Glyoxalase/bleomycin resistance protein/dioxygenase
MEPAHPASPRDAWQFDHLNVSIGADHALRALFEGVMDMHPGYRPPFPFPGLWLYEGDQAM
VHAVDDDSLSASSGEVRMGHIAFRSQARATDVIARLQAAGLRFRVAHVPADGTIQIFVPL
PGGLVVELDVPGDPDIATSHQYSAERRAPDASDI
>fig|266264.4.peg.4941 Permease of the drug/metabolite transporter (DMT) superfamily
MSATVPSTASSRAPATTGFRSFLPLIGAVVIWGGNWPVMKMGLAHISPLWFAACRFGSAA
LISFLVLGALRRLRLPSRQEWPLVIGVGLLQMGAFTALALWALQYVPPGRASVIAYATAI
WVIPLSSLVLGERPSRLQWLATAFSYAGIAVIVAPALGGWELHTVMGLTMLLGASLAWSV
SIIQLRANRAIRLGADMIPWECAVATVPLIALAWLRDGAPDLGAMVDIWPVIAYTGPLAT
ALTFIVVLNVTQSLPPAATSIAMLGVPVIGLVLSTVAWHEQISLDLSIGLALIGMGVVTT
ALAPRLGRLAAR
>fig|266264.4.peg.5001 Multidrug resistance efflux pump
MDALILGVYALAVWLVFFKFKWLPWNTPTMVIVVTIPVVAMTVLVLTLNVVAPSSHDVRV
VGKVLQVVPQVRGRIVELPAEGNRSYKKGDVLLRIDPTPYQASVRQLEGRLMADDAALAE
AEAAARQLSESVRGAAGRVSAVQARLSLARRRVSEHDALLSAGAGSKFDREEASAREHEL
EGDLLSAQAAEEEARQKLSAKSQGEFVAIATARAKRAETEVMLENARWELEQTVYRAPSD
GRVVNLQVRVGTMLVPFPFSPAFSFVEDQQEVLAFYHQNELYNVKTGDLAEIYLPTAPGE
IIKARVDSIVWAQSQGQFAQGGMIPNTGATDVVPNRFAVKLALRDESSGLTLPVGAVGAG
AIYTERMEMFHIIRMVFLRVSSKLNYLVFKLH
>fig|266264.4.peg.5174 Inner membrane component of tripartite multidrug resistance system
MGSWPSARDWVFSIKAFVAAMLALWIAMYLGLPRPYWAMGSVYIVAHPLTGATRSKALYR
VLGTLLGAAAGILMVPPLVNAPPLLMGAVAIWTACLLYVALLHRTPRSYVFMLAAYTLPL
VALPSVDNPAGIFDLAVARSEEICLGILCASVVGAVVFPASVANVLRDKSRQWMADATLW
ASDMLSASPGKQVSRHHSRHRLAADILALDQLISQLSYDAESAQRVRAARELRGRMTMLL
PVMSSLATVVESMQSAGGVPEPLAAQMRAVKAWIQAGAAEGERPELTSTPVQAGWDAALV
AAAEDRLQQMAALWHDCVSLCRRLGEKHIEGEWLPEFLRWDVGRARHYDHGMLLFSTVTV
ALAIFAMGMIWIHTGWADGAGAVALGAISCCFFAALDEPAPMIQSFFNWNVVCLLISMVM
LFAVLPIAHDFEMLVLMFAVPYLIIGLLVAQPRLAMIGMPLAVVTANDIGISGAYSANFQ
SFFNSNLAGIAGIAFALVWTLAVRPFGTRAATRRLVRSGWSDIAENAVSTRPESHSTLRA
RMLDRLAQLVPRLAASESEVSADGFSEVRVELCTLALQREMAELEADEQHAVNRVLRSVS
GYYQSRLKGAIDAPPPALLTRLGKAQQKVRSRIALAALVDLQVALFPPVVVPATVSGKA
>fig|266264.4.peg.5622 Drug resistance transporter, EmrB/QacA family
MSAPQAPSAPHSPPDVPVMQVIFGLMLAIMLGALEQSIVAVVLPEIALQLNGFEDMAWVI
SAYLVASTVVTPIYGKLSDVLGRRSVLTFSIVLFVLASIACAMATTMPMLIVARILQGLG
GGGLISVSQATIADVVPLRERGKYQGYVSGVWAVASMAGPVIGGYLAHFLSWRWIFWINI
PLGLIALIVVRRALRHLPVSGRKHRIDYLGALLFGGGLSGVLVFLTRMGQGHSPLEPQTI
GLLAAGLIGLVLFIWQERRAVDPVIPLKMLAVPTVAICCLTLFLCFFQLIAMSVLLPLRF
QVVGGAGADTAALRLVPLTLAIPFGAYASGRLMSWSGRYKPLQLAGCLVAPIAIVGLAFV
PPQAVVPAALVMIVLGLSIGLQLPSGLVATQNSVPPQQVGIATALTAFSRLLGGAVGVAV
LTTVLIALLRHSGMAVSDLHGGEDVLMSMFRRAMDAGDQGDAAAVREAAEHAFRLLFLMS
AGVSLIAPFFVMRLKEKTLRGSPAGAAASAAAE
>fig|266264.4.peg.5968 Outer membrane component of tripartite multidrug resistance system
MSVSFRATLLTLAAAMFAAGCTVGPDYRGAPQVAGNAIDTGKFPRAGEGTDSQTPRVADW
WHALGDTQLDGLIESALKQSPDIRVARARVRQARAGLAGNKANLFPTVAVDAATLRTRSP
NLSALSGQGSSNAGRGPLSLYIAAFDASWEIDLFGGTRRSIEAASAEADAADAQLADAHV
QLAAEVAQAYITLREQQESLAHLTSSEQLEAEMFELTQQRRARGVASQLEVERLMTQLDN
TRAQMSPVQASIAESLDQLAMLTGRSPGTLDAELSAPKPLPGVPETVAVGDPGALLKSRP
DIRAAERRLASSTAQIGVRKADWFPKLSLLGSLGFAATDPSHLARKENGTWMTLPRLQWN
ILDFGRVAAGVEGAEGGRDEAEASYESVVLKALRDADVALSRYGHQREHVVVLRRVEASA
ERASTLQQQRYRAGTASMLEWLDVERTRVVAQQSRISGDADLLKDFVSLQKSLGLGWQSS
AAPAS
>fig|266779.9.peg.1518 Permeases of the drug/metabolite transporter (DMT) superfamily
MSALIKAAGNVPAGQIVFFRSFFAIFPIVVMLAWQRELGTAFHTKHPMGHVLRAIVGVAS
MGFGFFGLTRLPLPEAVTLSYAQPLLVVVFSAIFLHETVRIYRWSAVLIGFVGVVIIAWP
NLTLFAGDGPGMETEQAIGVIATLVGAAFSAVAMLLVRRLVHTEKTSTIVMWFSVTATVI
SLGTIPFGWVWLSFWQFLFLAGAGICGGIAQIFMTQCYRHAELSTIAPFEYTSMVLAIVV
GYFAFSDIPTIYTLVGGLIVVVAGLLIIWRERRLGLKRVAARRFVPPSP
>fig|266779.9.peg.2208 Permeases of the drug/metabolite transporter (DMT) superfamily
MLQALPLAVTMGAAMVLAEPVGWRRWSAISVGFVGVMIIVRPGLGDFSAWSLLALLTVGF
CAVRDLSTRLIPQDIPSVGVSVATSAGVTLSGAALLPFTGGWQPVEVPSALSIFLAGILV
VVGYQFVIKAMRQGDISFMAPFRYTSLLWAILLGFLVFGDVPDALMLFGSALVVGSGLYA
LYRERIVGHDLPITESTAPAITTSGLDTKPVHDRRI
>fig|266779.9.peg.2500 Probable antibiotic-resistance protein
MRIFDCRLRPPFGEFLTTSYFTDVPRITRMAAEMGLEAPASLAETSMELLFTEMDAAGVG
VGLAAGRISPGLGNVSNASVRELCRLWPDRFVGLAVVDPGKAAEASAEIDRAMRDGFKGA
LIEPGLLGNALAIDDRRIYPFYSHCEDAGIPLFIMAGGNAGPDLSFTNPEHLDRVAADFP
RLKLVSLHGSWPWVLQILHVCLRRQNVYLCPDMYLAGRMPGFEEYVRAANGFLSDRLLFG
SSYPVLALDRAVKSVQQIGFRPEVLERIFFRNAAALLGL
>fig|266779.9.peg.3340 Acriflavin resistance protein
MNVSALFIRRPVLSTVLALLILLLGIQGLFNLSVREYPEVEETVITVTTTYPGASPDLIQ
GFITSPIAAAVSTTENIDYVSSQSRPSTSVVTVQMQLGSDSDAALTEVMSKVQQVRGQLP
SDADDPTIVKGTGMQFAIMYIALQNPNMTPEQLTEYIERVIRPRVSTIQGVAEVQIIGAQ
NYAMRIWIDPIRLAARGVTAGEVVSAVNASNFLSAPGKTKNEYVAYPITTETTLQTPDAF
AALPLKSEGDEVVRLRDVADVELAAESTETIVNFNGRPGTFIGIFPTPSANPLDTADAVI
AEMPAIQATLPEGMNMEVVYDATESISASIEEVFKTIGEAVAIVVIVILLFLGSFRSVLM
PIVTIPLSLIGVCFLLFLAGFSINLLSLLAMVLAIGLVVDDAIVVVENIHRHMEEGMSPF
QAAFTGMKEISSAVVAMTITLAAVFAPLAFTGGLTGSLFREFAFTLAGAVVISGIVALTI
TPMMSARILKSGSHSRFQSFVDRTFTRLENRYERLVSGSLKYRPVTLMIVIALVSLTGFL
FFKTSSELAPEEDVGALFSIVNAPRYATSEYTNLYTTQMRDLTEDLPELRVDFSIVGFGG
STNSAIALWAFKDWADRNRSQKEIQQDIQQRISKVAGVEAFVFAPPTLPGTGGGLPISVV
IQTTGDPSQVYEIAEEIKNKAQQSGRFIVVQNSMAFDAPQVTVSVDRERAAALNIPASEI
GRTLGALVGGGSMAQFDRDSNSYDIITQVPEAYRSNPESLGGYFVRSATGGMVPLSAVVS
IKTNASPAAIEQFNQLNSATISALPRPDVTTGTGLQTIEEVARTTLPEGFFLDYSGQSRL
EKEQGNTILVAFILAVVVIYLVLAAQFESFRDPLIIMMSVPLSIFGAIVPLNLGLGTLNI
YTQVGLITLIGLITKHGILLVEFANQQREVHGLSRREAIVASARVRLRPILMTTAAMALG
VVPLILAQGAGAAARYSMGLVIFSGILIGTMFTLFVVPMFYTFISSRDIHVRGQVPEDAA
PAHA
>fig|266779.9.peg.4090 Acriflavin resistance protein
MDIVRLAIRNARLTLSILLFFIVAGSLAYINIPKEAEPDVPIPIIYVSLAYQGISPEDSE
RLLLRPIETALKSLEGVKEMRSAAYQGGGFVLVEFQAGYDFSNAIEDVRAKVSDAKGELP
EDAEEPTVNEVNVSEFPILVVTLSGNLPERQLTIAAKELRDRIEEVPGVLEGALQGSRDE
LLEVIIDPVKLSSYNIQLDQLISGINASNSLVAAGALQGQEGRYAVKVPALIENSEDIAN
LPIVATRDAVVRARDLASVRSTFTDAETITRLNGHSAIAIEVKKRVGANLVETVDAVKKI
SEEFVTAMPEGVSVTFSQDKSTMIRDMLDELQNHVVIAIILVFIVVLYTLSGRASFLIGL
AVPASFLMGIFALSMLGYTVNMVVLFSLILAVGMLVDDAIIVTEFAERRMNEGMPRAEAF
ELAAKRMAGPVIAATMTRIAAFSPLLFWPGIVGEFMKYLPITLIVTLAASMAYALIFAPT
LGAMFAKAHVEEERKRDGWYIRLVKQAVRFPKTVLLLTIALLVGVQWSYSKWGAGVEFFP
SVEPEYGLMYVHARGNMSLDEMDRLVRPAEEKLLNWPGIESVYTRVGQTRGGGQDIDEDV
IGIIQYEFVDWRERKPASEILNDLRAEMAGMPGAEIEVRVPDAGPPTGQPIQIQLSAADP
QYLNDQAAMVAERIGQIDGVIDISDGLPPPGVDWALEVDRAKAAQFGVSPVAVGTVVQLV
TNGLKLSDYRPAGADDAVDIRLRLPEDRRTLSMLDQLRVETPEGPVPISNFVTRQPERST
GILNRIDAQRTITVTANVASGYQVAEVQAQVTAALQDMNLGATRWKLAGSSEESDAAASF
LTNAFGAAIFLIFVVLLAQFNRFTSVFLVLMTVVMATIGVFLGLLITGQPFGIVMSGIGV
IALAGVVVNNNIVLIDTYDRLRDEGMSKYDAIIETCRERARPVLLTAFSAVLGVLPIAFG
LGLELFHHEVTIGAPSTQWWISLSSAIVYGLTFATVLTLIVTPSALMVFTREKRPAGQKR
GGLISRLFRRRKGEKAADEEKPDADHGGFTAFPKAAE
>fig|266779.9.peg.4652 Permease of the drug/metabolite transporter (DMT) superfamily
MITRFTPILVLVAFLNALCFPLITVGLEHAPHMTFAALRAIVAGMSLALVAALLRRPIPM
DLRMWMALGAMGMGATGFAYFGMFHAAEFVSPGLATILTNTQPLIAAVLAFAFLSERLRP
SQYIGLGIGFLGIVTVAMPRLGIGNGPGELFALSYLILAASGLAVSNVLMKTVRSRIDPL
VAMAAQLLLGAVPLAILALLTEQPSDIHLSADFVIALTLLALPGTALSYWLWFWVLDRIS
LSHANAFTFLTPVLALLLGVTMFDEQIGPPLILGLLLTGIGVVIVERNSRSRIAPTT
>fig|266834.1.peg.595 Multiple antibiotic resistance protein MarC
MLTIKSLAIAGLLGRTMLENFEISLPVLAMTGGIILFLVALRTVLHQSSSLPDQTTEPGQ
PSDLRLALTPLAFPTILAVIVFATLAGGRQAEGRTVAAIVLLILAMDWAAMIFAESILRW
IGTSLQVLAVVLGVTQAALGLQIILHSLSTVSW
>fig|266834.1.peg.1065 Permease of the drug/metabolite transporter (DMT) superfamily
MSARILCQQMFVWHTARMNKNAADIPMTPFLPALAIAGTVITWSFSFAAIGYALREVEPL
PLAAIRFALAAVFAIAWIAWRRPRWFLPRDFVVLAISGLLGIAAYNVLLNLGQAAVSAGA
AGFIVNTQPLFMVLLAVLFLKERFGRWNWVGTIVGFSGVALIASGQPGGLSFGTGSTLIV
LAAACAAAYSILQRPLFARAEPLDVTGARHRCRRSRPHALATGRRLPIDARASGHLADDH
VPGRRSGHYRSKLLDLRTQEFRCRAGRSISLFGSTVLCWTGVAPAR
>fig|266834.1.peg.1221 Glyoxalase/bleomycin resistance protein/dioxygenase
MRKTPIKCQTTPGCPVSGHLKRPLLDQTIPCRLERHPGDWNVALKRMDNVGIVVEDLEGT
IEFFRELGLELEGKATIGGEWAGRVTGLGDQHVEIAMMRTPDGHSRLELSRFLTPPIVAD
HRNAPVNSLGYLRVMFTVDDISETLERLRTRGAQLVGEVVDYEDVYRLCYIRGPGGLLIG
LAQELG
>fig|266834.1.peg.1474 Permeases of the drug/metabolite transporter (DMT) superfamily
MAAAAKRVYHHPMRSKTNGYVFALLAIVIFSIQDGISKHLGAIYPPVFVAMIRYWAFAGF
AAAIAARAPGGFAATAVTRKPLIQLLRGVLLPVQIVVVITSFTIVGLAHSQAILAATPLF
VALLSMPLLGERVGWRRWSAIAVGLLGVLLILRPEDGSFDLNFLLPLAAAVMFAFYVITT
RLASREDSAMTSFFYTGIVGAFAISLVGPFFWATLSGADWVWMVLLCITGTSSHYFLIRA
YDMLDAAAVQPLTYLQLVFASIMGVTIFGETLTTGMIIGSVLVVAAGIFTLWREHVVGRQ
KSRLPPR
>fig|266834.1.peg.3498 Permeases of the drug/metabolite transporter (DMT) superfamily
MSELSLSKAAIDHNRISYGLTLMVLSVLLSPLIDIFSKLAIATVPSAEITAARFLLQIVF
ILPIVLVRGTLFDLTWRKSALHALRGGLLVVTMLSFITTLKVMEVADAIAIFFVEPIILT
ILGSIFLKETIGWRRYTACAVGFLGSLLVIQPSMQEVGLVALLPIVAAFGLAVFLLVTRM
VAQNEDPWSMQFHAGIWGGLFCLALLWFGEGSGSSVFDPVWPDGRAWYYLLGVGVTATIS
GVLGVYAYRAAPASVLAPLQYLEIVSATIFGWLVFGDLPDALKWLGIAIIIGSGLYIIWR
ERQVQKTAGIAPVSPAI
>fig|266834.1.peg.4253 Permeases of the drug/metabolite transporter (DMT) superfamily
MSVDATVAPAAGGLPRNLRAAALGFLAFAVFSGTDVLVKLLAERFEVPQVTFMVTLAALA
MLAVYAGVTGTTASLRPRHPGLALLRAFLLAVDTLLIHYAFSVLPLSEAYLLAFLTPVLV
AVLAFALLAERLSMLAWCGVVVGFLGVAVALRPGIAPLNLGHAAAAGSALVFALSLVLLR
RAKATESDLALVSTLLVVLAAVALAVASIGGGLAPVGPGDLLIAFFAGLFMLGGHLLLVR
AFRMGDASVVAPFQYSQIVWGCLYGALFFAAPIELHTVAGALVIVLSGWLVLK
>fig|266834.1.peg.6040 Multidrug resistance protein B
MTIATATPSRDISMAGGLLVAGIVLATLTEAIASTVLSLGRGDIIGDTYATPDEFAWLDV
GYTTFKLIGFMAASWLMSRFDPRNLVVGSTLAMGMACGIAAMTARLDLLVALRMIQGFSG
GTLLVGGQAIIFLTFPHSRQPLLQAFFAMGSVVAPATIAPALQGLLLDSQSWTWIFFSII
PLALAAAGLLLLADGPVATRAQRRPFDWIGFSLISAALFCFTYVFSQGSRWDWFEEPRIL
WLAVIGTATLLAFLGQQVLAKGQGLFDFTLFETEDFCFAFIVSFVAGAALFGSAFLIPSF
AVSVLAFTPTDAGQLLLPSGALFIGALLIAAFLMQLRRVPPVATVPFGILMIMAAMWMLS
GSTSESGAGDMMAAILLRGAGLGFLFLSITLIAFSNLNSRNLASGIGLFNTGRQLGGLIG
VSALQTLIEHNVSHNLAVLGANVTAGAPAVADRLTTTAALLTAKGMDAAAASRGAASLLG
RAVAGQSTVIAFDTAFNAIGLLFVIAAPVLVGIKIGLARYAKARAEKGRAGVAAKPSGHH
TLPIKRVPAS
>fig|266834.1.peg.6041 Membrane fusion component of tripartite multidrug resistance system
MESLEEKVAIITGARSGNGVAVARPNRKKMIGLALCLGAVVVVVAGWTWARESGAASTDN
AYVRGDVTSLAPKVAGYVTAVEVEDNQAVRAGDVLFRIDDRDYRAKLAQAVANVEAAEAR
LTNVDAEMALQHALIRQAEAQRRSVVAELNLAAKAYDRRRELIRSETISQAHVDESDAAK
SRAEANVLAASATVEAQQQRIAVLAAQREAAVAAVAQAEAARDLAGIDLESTVVRAPVGG
VIGNRQVRVGRLVAPGASLLDIVPLDNVWIVANFKETQLEHIRPGQRASITIDGYKSGAL
EGVVDSFAPGSGSAFSLLPADNATGNFVRVVQRVPVKIRFAGNPLSGRLLPGLSARVEID
LEGGS
>fig|266834.1.peg.6058 Permeases of the drug/metabolite transporter (DMT) superfamily
MTHQPISLSAPRHHRLLWPMMATLLVVGWSSGFVGIRYASEEAGVMLVLFWRTLLSGVIL
LPFALTIGPLLRMRGIAEQMLFGVMSVFLYLGGFALAIEQRVPTGLVALISDLLPLAIAA
LSQPVLGERLSARQWFGTAIAVFGVLIVSFDSLSFGAAPLWAYGLTVGSMLVFALASVLH
KRRRTQHMPVHQSLCIHTLTGSVLFGLCAMMQGDLAPPLTRAFAVGMVWLVLIATFAAYS
IYYTSLRLFPVAQVSAAIYLSPPVTMLWAWALFSEPLTAATFIGLTATLVGVWMTSRS
>fig|266835.1.peg.204 Permeases of the drug/metabolite transporter (DMT) superfamily
MHFIPASIRGPLFMIVSTGSYLVNDTMMKLATAGLPSYEVLFLRGVAAALWGFPLLFLLG
YGKQIPLIFDGHVLRRNLLELAAILCYVVALANMQIADSTALGQITPLLMLVGSSILFGE
RIGGQRMALIGLGFIGALMVAQPTMQGISVYALLALGNAALSAARDLAGRRVSAEVPGMI
VAISAVVVVLIGAGAAHLVSERWVMPEARHLLLMAGAGFFLIFGHFFIFMAYRVGPTSAV
APFYYCFTVWAVISGLLVFGQFPNALAVCGILLVVASGLTIVSLDQRKRRLTVVA
>fig|266835.1.peg.1997 Permeases of the drug/metabolite transporter (DMT) superfamily
MKSSSLAGAVSPMIPVLVCAFGIFLLSGMDAAMKVLVIAVGVYNTVLWRSMLATLIAGAG
WLAGPRSLPTAAVLRLHALRAVVVGIVLMSFFWGLARLPLAEAVGLSFVAPLFALLLAAL
LLGERIQRKAIWASLAGIAGVAIIVAGQFGQKTYAGDALLGTAAVLVSTVFYAYNLILAR
RQAMLAKPIEIMLFQNLCVAVMLGLAAPWLAISLPSNLWLPLAGVTALSLAGQFLMSWAY
ARAEAQYLIPTEYSAFIWAIALGWFFFDEAVTWTTLAGAGLIVASCLIAARSNPRLAEPI
EVAV
>fig|266835.1.peg.2001 Multidrug resistance protein A
MNKVLSAAELQPAQPSAVQIPAPAKSRRKPIVMLGAAIAIGVAGWYGFQWWQAGRFVMST
DDAYVGGNVTPLAPRVAGHIDQILVEDNQHVDAGQLIIRIDDRPFKAAVERARASVQQQQ
SALDNLRAQVSLQNSLIEQAEADLEAKSAAATFTTQDAKRYEVLASTRAGSQQDAQRSLA
ADGQAKASVSASRAGLAAARQQLDVLNTQISEATAAVLAAKADLDTAELDLGFTQIRAPI
DGLVGNRLAQVGTYVSPGSYLLTIVPQSGLWVDANFKEDQLRRMADGQAATVYTDIAPDQ
PLKGHVSSLGPATGAIFSVIPAQNATGNFTKIVQRVPVRITIDPDQARKVALRPGLSTVV
TVDTGAH
>fig|266835.1.peg.2080 Kanamycin resistance protein
MSSRPAETGLPNGLRQLVSGYRWHRQTIGQSQAGVFRLAADGRPALFLKCERSGPFAELA
DEAARLRWLTGQGVACPDVIALESHAGYDWLLMSAVAGEDLASAAIDQADVIGIMASALR
DLHAIDIRSCPFDHRLIRRIAAARARMEGGQVDESDFDEERQGRTDAEVFAELEALRPAT
EDLVVTHGDACLPNVMTAGGGFSGFIDCGRLGVADRHQDLALACWSIRYNLGQVWIEPFL
KRYEPPETEPAKLSWYRLLDEFF
>fig|266835.1.peg.2121 Permeases of the drug/metabolite transporter (DMT) superfamily
MKDLPTSRFPAASLALAMMIAGTVGAFVTEAGLHPVTIVFWRCVFGAMFLGAWCLLRGYL
PDRTLSPSRLALAALAGACMVLSWTAFFAGFAMTSIATTTIVYHVQPFFVVIIGVVFLKE
RISLDQMLWMLGAFLGVVLASGLVVSHAQASAAWALGIALTLVAALLYAVATILAKGLGQ
QRAEVTVLCQTIIGIVMLAPFAGIGQHVPAHSWGWLVSIGVLHTGIAYVLMNSAFPRLTT
PVIGIITFIYPVVAIIIDWAVYGHPLGPAQAAGMALIALATLGVRLGWRFPLRRVSAA
>fig|266835.1.peg.2706 Permeases of the drug/metabolite transporter (DMT) superfamily
MKNRMVRGILSLCLGVLVFSLQDPLVKAVSSGYPVTEVMAIRSIVALPILIILVHADVGL
RAILSKRFGLLTIRAFIQFTSYTVYYLAIAALPLADAVALYFMAPLFIMALAGPYLGERV
SWRTLATVLIGLFGVIVMVRPGAGLFDWAALLSLGSAALYGFSQLMARKIGDTESSTVMA
FYQNGAYLVGAAVVAGTFHLAGINHAVHPSIEFLVRPWIWPTLPDFLKMAACGFVASAGM
ILLSQGYRLAPANRVATFEYTGILWSPLWGFLFFAEVPRSTTVIGAALIIGAGLLALNTA
RRRSAAPVLAAADPV
>fig|266835.1.peg.4097 Permeases of the drug/metabolite transporter (DMT) superfamily
MSSGCAPSASIFKLLSPRKWKNVPNGILLALLAYASYSGSDAVIKSLGGQFTVFEIGFFV
TLFAGFFLFFARPAGERWRDFWRMKRPWAVQARAWAGIASGVLSVYAFTHIPLAEVYALI
FLAPLLVTILSTVILKEKVGPWRWLAVVAGFAGVMLVVRPGFRELNLGHLAAFVNAFLAA
TSVILLRSLAQQEKRTSMLGVLVGYGLLFNGAGAAATSFTLPNAVQLVWLAMAGAFTAGG
QFMQLLAAKYAPANRIAPTHYSQIVWAVILGALFFQEYPDWLTLVGLAIVGGSGLLTMVR
EEVRLGTVRWNPFARTRL
>fig|266835.1.peg.5120 Permeases of the drug/metabolite transporter (DMT) superfamily
MTDAASSPGLVASTFSPREERVGMLLVFLSALMWSFGGTIARFITVGDSWTIIFWRSVWA
AAFLVLFMTWRDGWRGMLRSFRDMGLPGLGVGFCFAIASTAFVVALAYTTVANILLMQAG
VPLLAALLAWALFRERVGVVTWVAIAAVIAGVAIMVSESLDGAVSPIGDGLALLIAFMFS
IATVITRRFASVRMTPATCLGTLLAAGFAASQAAAFTVSAADMGFLFAFGVVNLGIGLAF
FATGARLIPAAIAALLGTFEPILGPIWVWLIHSEVPSGRTIVGGAVVVTALLVHIGFEFK
RQARPRRAGITGVPSPN
>fig|266835.1.peg.6162 Permeases of the drug/metabolite transporter (DMT) superfamily
MTDAAAAKPEATERTLGIILVSSSAAVFGLTGVLTKSIHADPLTITCWRGFVGSILISLY
VLWRHHRSGNRGTLRLGWRGWLLAVEGALASIAFISAFKFTYVANVAVIYATSPFIAALL
AWVLVREPFRLQTMLAAAVSMCGVGIMVWSGFGTGHLFGDGLALLMTAGSALYMIMVRAF
RDTPVVWAGAVSAFLLFILGWFITDPLAVSARDAVLLVTFGASFALSSILWTEGARLIPA
PESGLLGSAEVPFAILFAFLFLAEIPPVASMVGGAIVLCAVFVHAGRDWLAARSHQAASN
IS
>fig|266835.1.peg.6234 Permease of the drug/metabolite transporter (DMT) superfamily
MVQHRDRAPGRLFRHGSSSISALVFAAGAVALWSTNALVGKSLLATHPVSQVQFLQFAGA
ALVFALIRFMSREAAPSVAPRAAVAALAVGIIGLVGTMVLQYIAFASMPVIEANLVAYTW
PLMVAAAVIAFDNPRRPALLGLAAVLGFVGVALVISGGRENNWFQGDLVGYFAAFGSALC
MAFYSVMVGRLATSPDRLLLPSSLVGVALALLWSAGEGVAWPAGMDLALGLYLGAGPMGL
GYYFWSRALKLEGSGKVAVVAYLTPIASTLLLTLSGEQLTTTAIAGAVLVIGSCIAVGLE
RSEAQDYV
>fig|266835.1.peg.6505 Permeases of the drug/metabolite transporter (DMT) superfamily
MSAMTGTLNQTQRMDTTAAIAVALTVVGWASAFPAIRAGLAAFGPLELGALRFAIAAVPA
AIFLAVKRPALPRLDEVWRLVFGGAIFVALYTAMLNFGELTVSAGAAGFIINVSPIFTAI
MAMALLGERFSRWAWAGTAISFAGIGVIAMADGQGLHFNAGALLVLGSALCSAVNTIVQK
PLFARHHPLTISASNMVLGALCLSPFLPSGFAQAAVANTAGLGAVIFLGIVPSLIAYAAW
ATALSRLPAARASNFLYLVSPMSALIGFFWLGEVPTLLGILGGALALGGVIVVNLKR
>fig|266835.1.peg.6645 Streptomycin phosphotransferase, streptomycin-resistance
MDAPALPARWKVSAPELIAETFSSRIWKVVRDDGSPAVVKALKPFDDVADELRGEHFLAW
RRGEGAVRLLGRDGHSMLLEYAGETLLTQVLDEQGDNAATAIAAELMTKLFSPSQHPYPP
ELQPLTERYTSLFRKAATDRGAGHASIYVEAAAIAERLLDNPHDIRPLHGDLHHDNILHG
PRGWLVIDPKGVLGNPGFDAANMFYNPLDRDDLCLDPERIAHMAEVFAKTLGESPAAILD
HAIAYGCLSAAWHHEDDNAVEENRELSIAKAIRAMRANF
>fig|266835.1.peg.7242 Permease of the drug/metabolite transporter (DMT) superfamily
MVISPMTGSSREKLAIVCGFAAIYLIWGSTYLALAVAVQTIPPFALMGTRSIVGGVILLA
YSKAKADDGGSIRSWIRASLCGVLFFVGCHGVLAYAEQRMPSGLAALLLATIPFWIIVGR
SILGRSDKPLVRTILLLLPGLLGVVLVAWRSVAGPAALHLSDILLLLMASASWALGTLIA
EGHNNKGSSVALAGRELITGGAALMFLSLARGEPIGAVEQISLSSFLGWSYLTLAGTVVA
FGSYIWLLKKISPALVATYTFVNPVIAMFLGWAFLGEEVSVTTVIGGFLVVASVACLLVA
NRNSTHKEAASWSTPPKTAAAIAKG
>fig|266940.5.peg.2801 Drug:proton antiporter
MMLPASMALVREAFPDAARRARALGVWAVGGAVSALVGQPLGGLATSIDWRWVFSINVPV
GAAMLLALLAVAPSPTRPARFDAAGQVLSVLGLSALVYGLIEGGHAGFGAGPVVAALAVA
AAALAAFVAVQARGRHPMMPLNLFHARGFRLALPVGFAFMVANYGHVFLVSLFLQQQLDL
SPTHAGLVFIPAALFAIAGNLTSGPVTNRFGARVPVVLGQSCMVVGLLALIPATAQRSPW
LVALCLIPIGVGGSLAMPSVTSVVLEGVPSERAGTASAVFNTFRQVGGAVAIAVFGALIA
DPDTFTGGLRTSLLVAATLLTVTAVLSTRIQPRAHVG
>fig|266940.5.peg.2859 Nisin-resistance protein
MPSAARLCTRRSSRRLSGSELSPGRDAPPAAEARPSSRSSSSGPARTPGSRAEGRHERDR
DVRHGPHDDDRERQSRLRPPRGTGWSNSDPTPRAPTAARGSPGPTPAPAPRWVPQRFGHH
RGRRAPLHRGLPRRPRPRDRLPGPSAAAVRRLRHRWGQPQPRTARGQQYPVPPGGCRPRR
PADGFRTSAAPRRHRRPAHRPRAHRRCVGGLDGFPRPPACSTVLVMPTTDVETYARRALR
AIETRALHLDRANWPEHRAEVLGAARTATHPAQLHPLLRQAVRHAGGAHSGLIEPGRRSL
FDAQDHPLPTARLIGTTAVLSLPACPAGARGADAYVRAAAAALHHVGERAGAAGARGWVV
DLRGNLGGSMWPMLAAVAPLLGGEGRIGAFVDRDGHRTPWRLSRGCVGTARWALRRRALA
RCSDPRPLPGPVLVLTDERTASSGEAVVVAFRGAPGVRSCGRATHGSSTANDVVVLPDGA
TLLITCAALADRTGTVHTGRLHPDHPLQGTARTSGPAPGAASGGADAAGPAPDETLLRAL
ELLP
>fig|266940.5.peg.3527 Bicyclomycin resistance protein
MPTPLAVPTGRPRLGVLPGFLAALSPLSQLGFTPVAVVLGDRLGLSVGQVGLTVGIYAAA
AAVATLVLGPLFDLVSPRRVLPVAVAANVVLSASLLLEPGFAGILVSRVLSGLTNSALML
CASVVVADANRGDGTARERGFSRLQTFTSLGAVAGLGVGATAAGLGAPQVWSWTVVGYGL
VVLALTPAISRRLPAALPGVAGAGPGARVSAVLREVGAALRVPRTALLLVAAAGVGWAIQ
AAHYAVSLLSEQLHPPLWQRVLLAVMIPAGVFLGSSANQVLLGRRSAARVFSRAYPALPV
SCAVLALVVGAGGGWGVVALLTTLVVLGAVLGTLMPLSPAVLVGWHPGLRGSVTAADSVA
KGLGSTVSPVVLGAVAAATSLGAGFLVLAAVAALAAVCARAATPGPPQRG
>fig|266940.5.peg.3627 Drug resistance transporter, EmrB/QacA subfamily
MRPHRTSGDVAGHHDPHPGEAVAGQRMSTTTPTTSTQPAPGVAPKMSHKEILEALSGLLL
GMFVAILSSTVVSNALPRIVNDLHGTESGYTWVVTAALLATTISTPIWGKLADLFSKKLL
VQIALVIFVVASAIAGLSTSMGMLITLRVFQGLGGGGLLALAQVILASMVSPRERGRYSG
YLGATFALATVGGPLIGGVLTEHLSWHWCFYVGVPFAVIAFFVLQFKLKLPEQPRREVSI
DYLGAILLALGISALLIWVSLAGTEFDWASWWTVALVAAGVVFLALAVLAEHRAKEPIVP
LKFFRNPTIALSAAASLFVGVAMFGATIFLSQYFQLARHESPTMAGVMTIPMIAGLFLAS
TVAGQAITRTGKWKAWLVVGGVLLTAGLALMGTIEYDTNYWVVAPYMALIGLGVGMMMQN
LVLAVQNVADARDMGSASSFVAFARSLGGAIGVSALGAVLGHRVTSHLETGLSTAGIDPA
AATSALGSSTGVPDLDAIPAPLRAVVQAAYGSSIADVFLLAAPFALIAFVITLFFKERAL
RSDDGTGQDVAEATTSSPDRVAATTTGTPGAHGAARPDREETTSVPAQPTRTDTGLSLSG
AVRHHDQRPLAGAVVTLADQSGQQVSRTSTGADGSYRLALPTGGTYLLIVAAAHVAPSAT
LVGVGDTSITRDVTLSGRSAITGRVLAHEVTGDVDAGDHHGVRGALVTLTDVTGEVVGST
RTDGGGSYAFDQLMGGSYVLTAQSESHRPLARGVEVPDSGALACDLVLTGGGRLTGTVVA
ASDGRVLKEAAVTLVDSSGEVVGSVLTGADGSYSFEDLAGGHYTLTAAGFAPVATSVDIE
EDTVSAAQITLGSGDAPSTLDLTRFEDTSRVGEDRR
>fig|266940.5.peg.3990 Permease of the drug/metabolite transporter (DMT) superfamily
MTRRAALMFAALGFAWGIPYLLIKVVGEELPPSTLVLARTALAALVLAPIALSRKDVRAG
LPDLLRRWPALAAYTGFEIVGPWLFLARAEQDLPSSTTAVVISAVPVVGVLVAFAGGRAE
RLGRTGWTGLALGTLGVATLVGFDLVPGQFGAVAELAVVVVGYAVGPAVLSRHLGDLPGT
TVVLASLVLAALVYVPVVLLGPGLPAALPSGQVVASLVVLAVVCTAGAFLLLFALIGEMG
PVRATAIVYVNPVVAVLAGAVVLGERITATTLAGFALVLAGSFLATRKPANRPEQPAAPL
TVEV
>fig|266940.5.peg.4605 Drug resistance transporter, Bcr-CflA family protein
MRCTLDEAPEDTLRMTAPPTEPSTQPTQRTRRTAAARPAPRTPSTAGLVVLLGAMAALGA
VTIDLYLPSLPEVAVDLGTTEARTQLTITGVLVGAGLGQLVVGPLSDAYGRRRPAAVGFV
VYVVATLLCAVAPNLPALVAFRVLSGVGASAGAVIGMAVIRDLFVGPAAARLQSRLVLVI
GVAPLFAPTVGGAIAAHTGWRPVLALLAVAGLGVLIAVWRRLPETRPELTDTPAQARAEE
ERAPVTPPRGARVLRTFTGYGALLRDRRFLALAAMPGLALATIMAYVSTSVFVLQDGFGL
SGTGFAVYFAVNGTALVGGSQLNAALVGRFGSARLLRVGVAAAFVFGLALAGVLMARTDE
LLLFAVPLYLLLLVLGLIMPNAVTLALEPYGDSAGAAAALVTALQSGIGGLVGVLVGVLG
GDEHATGLVIGAAVVLNVVLLLSVSRSIRPSVRT
>fig|267377.1.peg.166 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKTTKGVQNLLGDPKKAIVKISLPMVIAMSFQSLYNVIDAIWVAGLGSDALAAIGLFFPF
MFAIMAISNGVGIGGSSAISRRIGQNNKDAADNIAVHSIVLGIIIGILLIGVIPFLGAIF
SLIGASGITVTMAVEYSTILFGGAVVLLFTNIANAILRGEGDTKRAMYAIILGSVLNIVL
DPIFIYVLNMGVAGAAWATLLSLVITGILFVYWLFIKKDTFLKISFEKFKLDINIIKEIF
SIGLPASISHLTMAFSMFLLTAIVAKAGGNDGIAVFSTGWRIVSMGTIPLVGLATGVTVV
TGAAYGSANPEKLEISYKYALKMGILVETIIAALILIFENQITYLFTYSENSVHILEGLL
VFLKYMFLFYPTLPLGMLTAAMFQGVSKGNNSLFISLLRTIILQIPMAYTFGIIFNQGLT
GVWFGMILGHVIAVSIAYLLGIYTIRQFKTTLTPETVKFK
>fig|267377.1.peg.266 Multiple antibiotic resistance protein MarC
MDVQFIILAFTSLFSILNPFGVIPTYLVLTSQYSKVEKIKIIRKSMLAAFALLMMFALLG
NQIIGFFGISIPAIKITGGVLLFLIALDMIQGNTSKVEKSPKLESHLKSHSEEIEDMDEI
AIVPLTVPLLTGPGSISAVIAMMAQTSDFDGKLSVIIAISLCIIISYFVLKFSKDLEKML
GKIGFKVLTKMMGLVLTAISIQMALDGILMVFG
>fig|267377.1.peg.552 Transporter, drug/metabolite exporter family
MNKVKGTAYTIYSSVAFGIMPFLTKFAYDGGANAVTTLMFRFLIAGLILYVFLKFKKISL
KISRHNFVEILFYGAFLYALNTVFLYEAYNYIPTGIATTLHFIYPVTVTLLMISIFKENL
GINKVLALIFSFLGMYCLLGGNCAGFDIYGVLLAAGSGLVYAGYIVSAGKCKYSKIDSYV
TIFYLSILSSVLLFIYGLFTNTLTLNMAFSSYASIGLISIFCTVLALIAFLEGIKLIGPS
NTAILSTLEPIVSIILGILLLNEVLSFKIGLGSVLVLISVIIVTIEKSKVSDTVKN
>fig|267377.1.peg.670 Permease of the drug/metabolite transporter (DMT) superfamily
MNDRSLGILLMFLTVIFWGISFVSTKIILEFIPPITIGFIRVVIAAVILIFFIRNFTKYS
KEDFVYIVLAGFLGITSYYLFENVALKYTTATNASLIAATVPIFYLIVSDIVEKKIPSKI
KYFGSLIGLFGVFILILNGKFVLELNPLGDILMFGAVCTWVLYTFVIQKLQKHDDLKVTR
DITLIGAVFFIPFTIMELGYNGMFEFTILLNPYIAFSLLYLAIFCSAIAYLFWNMAIRLA
GASTTTNGVYIIPIVAMITDAIILKNIPNIYAIIGAVLVLFGVYISENGGKLKINL
>fig|267377.1.peg.699 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAYKSEFLGTEDVKKLLVKLSVPAIIGMLIMALYNIVDGFFIGRWVGTAAFTGIALIFPF
QMMIMAFGVTFGIGGSSLLSRKLGEGNLDFARKAGGNAISSVLILSVLITIVGVVFMVPI
LNLLGTSADIFPYAKDYYEIILYGTIFNSYLVAANNLVRAEGMAKVAMFAMVVPAIINII
LDPILIIVFNMGIKGAAIATVLSQIIGVIYILKHQFGKNTSIKYAMNDFLINLKILKETV
FIGASEFAKLIISSILLILGNNLLGIYGGDIAIAIYGVIMRIAMLLLMPVLGIVQGFQPI
VGYNYGKGQLNRVSESIKLALVGTSGLCLLGFILVMIFPEKFIQIFITDPEVISQGVFAT
RIFFMFSFLIGAQMTIGGLYQSLGKAKPAFIISCARQTLFLMPALIILPLFFGLNGIWFS
FPIGDLLGFTLASGIIFKDRKSLNLSS
>fig|267377.1.peg.733 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKQVKKLENEKINNLMIRYVIPSIAGTVIIGIYGIIDGIFIGRTIGAEGLAGVTFSFPVL
IAISSIGVMIGAGSSAIISISLGKKDYKKASCILKTALTYIILISLIITCFGYLLIDPVI
SFMNLSKNLESYVVGYSKIIILGAIAQIFAISLDPILRNDGFPKKSMIILALMSVFNIIL
DYMLIVVFNFGVMGAAAATVLAQGLGSILYLKHFLSGKSNVKIGKNSPFLEFSLIKRIAK
TGFSPFIMELAFGILMIVHNIQFMRYGSSLDVSAYGIVIYITSFLYMVYLGISEGVQPLI
SYNHGAKKFNRVFEILKKAVFVNAILGICSFLTILKFPNLLIKIFNPHDTNLIATTTIGL
EIHNFAILIMGVSMVLMMYFLATEQPKIAGFLSLGRTLIFILPAIILLPIYLGIKGIWWA
TVFSEYLSFIITIYFITKEFKKIKYEKIRG
>fig|267608.1.peg.614 Permeases of the drug/metabolite transporter (DMT) superfamily
MLLGTIGVFVHQANAGPLTATWFRCAFGLLGLTLWVLLRRQTGFLRLTRATGPWILSAGV
LMVLGWGLFFTAIERTSAGVAIVLFHIQPLWVLVLGAWWLKEPISRRRIGSVCAAMLGLV
LATGIPEHTALFGASEMLRPGDWLGVASCLIGAFCTACVTLIAKRLRDLPAGILAWWQCA
VGTLVLWVWPMEHGWPAWGMAWMWLAGLGLIHTGLAYTLIYVGMARLNTGRIAIFQFAYP
AVAIVIDWLFFDQRLDGAQLFGIALMSVAIRFAERAPKAGVPRGMTGPHSASR
>fig|267608.1.peg.3573 Permeases of the drug/metabolite transporter (DMT) superfamily
MRSRMPLANRASRTFEPTILTRSQHPLQGIAFLIAAVAFFAVFDTLTKYISITVPVVMAL
WFRYLFQMVATGATLLPSRGRSLLRTRRPWLQVVRGLLLLLVSLFSFLSLRRMPVGDVTA
IVMLTPLVVTFVAAVSLGEQVSATRWIFMAGGFFGALMVIRPGGAAFDWGMLLPLGMVVA
NAAFQVVTSRLANVDEAGTTQFYTGAVGALLLTCMLPFGWQALGGKWWWLLILIGIVSSS
GHALLIMAYTRAPVAMLTPYLYMQIGFAMIGGWLVFSHVPDGWSVAGIAIIAMCGAAGTW
VAARERRMAMLVAVDV
>fig|267608.1.peg.3881 Inner membrane component of tripartite multidrug resistance system
MLLAAILSGLNNRVPGLALADVQGALGFAQDDASWLNTAYAAGELAAMPFATWFAVTFSM
RRFHLAMLAGALVLSAILPFVQSLSLLLALRALQGLLSGALIPMLMMSALRFLPPPIRLH
GLALYAMTATFAPNVALWLAALCVDRLEDWRWVYWQAIPLGLVAMGLVAWGVPKMPPALS
RLKQGNWLGMALGVPGLALVVAGLDQGVRLDWFHSPLIVAALGVGIVLTALFLASEWRHP
APFMQLQMLGRRNLGVGFSVFVCLLMTMATAVTLPASLLGRLQGFRMEQMASIGLIVGLP
QLVLGPAVALLLYQRWVDARHVFAAGLACIAAACWLGAGITSEWMVPQFMWAEILQAIGQ
PMAVIALLFLATSVVQPMEGPSVAGIVNTFRAFSSVLGGALIGQLTTVRSHFHADMLLDH
AGHLLPRLPPSDPGALTLAAMVAQQAGVLAAADVYRVFGWLALLLIPIVLKLQYIPAPAQ
TRTPQATPPAGTQTGTAH
>fig|267671.1.peg.58 Drug:Na+ antiporter of the multi antimicrobial extrusion family
MSRKELNTLLPKDLSISIETRHKFYKLTFYNILANITVPLTGIVDTSILGNLNTYVFMAG
AALSGILFDFMFWMFGFLRMGTTGLTAQAVGEKNEKESIFILVRSISLACFFGAMILIFS
PWIREIGFQILEGSSEVKMAGISYFDARIPGSIAVLCNYVFTGWFLGRGKSSVVLIATVV
GNGINVILDVWFIFKLGWEAYGAGLATSISQFGMLLIFIFLFFIELKIQNISKFLFLNNK
NLFSVQGFSSLLHLNKDIFLRTFFLIITFSIFRNFSSEAGTEILATNSILLQLILVSAYL
VDGAAFATESLAGNIYGKKNWKLLKELLYLAFYNSIFFTSIFLGSVFLFPNFIFGMITKS
DKVLSLLIDYRFWLFPVLEVGAIAFILDGFFIGLTKGKILRNSMLISTAFFFFPIVYLGK
IQKDNHLLWLSLVLFMVGRALTLSFQAKKIFENSKLQNVN
>fig|267671.1.peg.474 Acriflavine resistance
MNENRLPSKITTQMIIGAVLLFGVISAFMLNYSLFPVVKNPALSIVVDYPGTDAETVENT
ITIPLENQVSTIGGISEIRSTSEKGKSLIRLDFENDTNIDVKTLEIKERIETIINTFPKE
VRKPRVLNFDPNEMPIAVISLNATDSRSLGELRAFADSIVKKDIEGINGVSKVTVSGGKI
KEILISFDIRKLNSYNIRLADINEAIYFNNRTSTIASVEEKGGLYQVRLKGKFSKLDDLV
DLPISSPDIGKSITLGNVANIQNSYRDEDSTYRVNGNQNIGIYVYKKYDANILSISSEIK
KTVSHLSQDGTKFDLLYNQADNIRNTYFNLICIIAVTIAILFFAAKKKGNIDIPKFIGTI
LSQLILSFLLISFIHFILKKDFDLLCVLSIYLSFAIWIVFYFNFIQNHTIDSIGEKKLLL
FITPSIPILFFPGILLNNTVAVNLIRMAIMTSIGVLNNYIVYKYFYQNLSTNKLDKFPTI
ITIPEKSKTQSVLYEPQKNKRDLILNFLLIIVPIVMIFALIQSSKEVYFNVEDDRIYGYV
ELPADSNFEYTDEIVQKIESKLVANPNVKDVISQVEPSHAFLIINYHKSFFSSDSIIPSL
NQSVGRQNPAFCYFTKESDLGRMKEVSLDIVGQSHSDLNKSVPKIANLITNLPGIHEVIL
NFKQPRNELQLDLNNRDPLLQNSEIGSFLRTVVQGSVISKYNENNNELDIRVRASKEFRD
SEKQLNKFLIKNNSGEFSSIGSSFTQRETLSPIKFFRKNKRPNLSISVRTDSYNPNTLLK
LVQNSSQTLLNNNERIELNHRIEKLSKSNTNFTVYIILILLTCFFFFIIYTESLKTSFIY
FCSLLFFYCIFASIYLIIFKTYDIGFHIGSVIVLISLLLHILSNFPEIKRQNTIPINWDF
YLVAIALFLPLLILSTPELNVFKKVFGLFMISLILSRFLLIHFNFRFANVFEKVLSTNNI
SKISGGKNVRR
>fig|267671.1.peg.475 Acriflavin resistance
MKSVVRFCVSKPITVLMAWFAIIIFGIIGLKNAKITLLPEIVFPKISVITGYPNASPEEI
ENLITKPLTDSIGTVGGIEKVTSESLEGISIITVQFSFHKSVDFAMIELREKIDLIRDQL
PQDASKPIATRFDPAQSAFQEIIIFPKNESDSKSLKSFIEENVKVFLERIEGMAYVQISG
GFEKEVRVEIDPERMTTYGVSIPEIQKSIVSANINVPAGSLPVGNKDLLLRTVGEYKSLE
DIKETIIATNNTGIPIPIGSVASVYRSYRERTGLARYNGKDCIVLYLYKESGRNSVELAD
KVTKELESINTTFADKLSAQLVYDESVFIRDSVWGLVWSLILGAFLAFLILMLLIQSFRA
PLILLIIIPASLLATFLLFYIFHISLNMMSLGGLALGIGMLFDTSNVVFSSIERNLTKRK
SILESSIEGTSEVAGSILSATLTTIIVFLPIIFIKSFIGILFSEMAIAIILSISISLFAS
VTIIPTLYVLFENTNFDSKLIDHPIFAKSADLYQTALITYEKKLIEYLERPKKLFSILLT
GIFFSSIFLFILPREFMPTVDNGEFTINIENVPNSTLNSTTGIAEVIEKILLSNKDIKSV
ISKIGSDNDDFIAKVNGNSGTNIAKIRVILVSNPKHTTTEIIEEVRRRISFTEDIRINFD
ANGDIIGKILDPNGSRLNLEIHGEDLKTLSTIGKNLIDKLKKEQVATDLRNSLETKKNEY
VIEFDPIKASSLKLTNDYISQYVKVASYGSNISKIKYQEDDLNIRLLIKKDSIDNLNKLQ
NLNIKTPTGEFIKLSQLANIQENTSSSSIKRSGNSRINVVQGNLNSNKSIDSIIQNMKLP
LGYRIKIGGESENMEKSFKELLFAFALASILIYMLLSSQFQSLKLSAIMICTIPLMFIGI
FPALFLFGKSFNISAFLGLVLLLGVVVDNASLYYEYLIISLNESKELSKAIIESGKIVFR
PILMNNLTTILGLIPVAFEFQKGAEFQSPMAIVVIIGLLSSFAFSLFLLPILFFYILQKQ
KFKTIK
>fig|267671.1.peg.956 Permease of the drug/metabolite transporter (DMT) superfamily
MFHIRHEIYLILCTLIWGGTFTMTIFGLRDTSPSIFLGLRFGIASMIFLPFAWKEFRKGK
IWYPGAFLLGMFLYLGFACETIGLKTTTATKSSFLIGTLVVITPIFEAILKKRMPGKGNL
LGASVVFTGICLIFAGEIGMEGTLTITNGDWITLGGAIFFSLYIIQMDRVSIQIPIRISV
FYQSFVAGFFALISVIILHFVGIEKIRLNPSARLIPGVLYNALLASVLTTFLQTKFQRYV
SPTRVGIIFSLEPVFSSIIAFLLLGEKSGPVRIVGCTIVFLGLILAESIGKDQNLSMENT
N
>fig|267671.1.peg.2318 Drug/metabolite exporter
MDFMEVSESKWKPFLGTCIVLIGAIFFSAKAIFVKLVYRYDIDSITALTLRMLFAIPFFA
WIAFRSKNTKTSVNLTKKDWGLIFILGFLGFYLASLFDFIGLEYISAGLERLTLFVYPTI
VLIIGSFLFKRKIKKAEVFAIFLTYSGILVAFIGDIQTEGPNATKGVLFVLASAISYSLY
LVGSESLIPKLGSVRFTSYLMLISGLIVVIHFFIVRNPKNLIQPPNVYLYGLALGILTTV
IPAYLTTEGIRMIGSGRAAIIGSTGPISTILLAWIFLEEPITSSGIAGTILVLTGVLWIG
RKKTDLKND
>fig|267671.1.peg.2514 Drug proton antiporter
MTQTQIKHDPFQALRISDFRSFLFGKFTVTLSISIQTTVVGWQMYHLTGSNLHVGFIGLA
EAIPSISMALFSGLVIDSFPRKKIVVSALCLLSICSLLLLTLVIPNINWILRDFGVYPIY
AVIFLSGIARGFLNPATAAFQTQLVDKETFPNAATWSGIAWQTSLVLGPLAGGVLIVLGL
YFAYSVDLILMSLGLIMVLFVKGKPVPSKPESSESIWESLSGGWKFVSTHQIILGAISLD
LFAVLFGGAVALLPSFTEKILGQSPEIFGILRSAQGVGAVLCAFFIAAKPPKKHSGWILL
SCVFGFGICIILFGFSEDYRISFLCLAAAGAFDMVSVVIRHTIVQMHTPDHMRGRVSAVN
HIFIGSSNEIGEFESGVTAEWLGIRRSIVAGGILTLLTVGLVGAITPRLRKMQLKDIL
>fig|267747.1.peg.170 Multidrug resistance ABC transporter ATP-binding and permease protein
MTGKDAQQAPTRNEQAEIARASSQQGHRGSQVTEKPISFGPSLKRLLGQLKPHRITLTIV
VIMATISVAFNVIGPKILGRATDVIFGGIVGKQIGKHIPAARGMTAETFINTLGQASHGG
DRGKIITLLQQYPHVVIGSGIDFHRLGVIIGWALGLYACAALLMFLQGFLLNTAIQRSMY
DLRRQVSAKLDKLPLSYFDGQPHGELMSRMTNDIDNVSQTLLQTLQQLLNALLTIIGALI
MMFWISPLLAVISLVVIPIAGVIAGLIGKRAQGQFAQMWKATGELNSRVEEAYSGHALVK
TFGRSRAVAQEFHERNEELRQATAKAQFVSGLIQPVMFLLGNANYAIIVLIGCLRVAKGQ
MPLGNVQAFIQYSRMFTQPITQIASMANLLQSGVASAERVFQVLDADELSTDAHGSLPAT
KGRVVFDHVRFSYNPDKPLITDLSLVAEPGQTIAVVGPTGAGKTTLVNLLMRFYEIDDGT
ITLDGVDISAVPRAELRSRLGMVLQDTWLFSGTIHDNIAYGCPEASEEDILNAARAAHVD
HFVHTLPDGYDTIIDDDGSNVSVGQKQLITIARAFLAAPDLLILDEATSSVDTRTEMLVQ
EAMANLRKERTSFVIAHRLSTIRDADLILVMEHGDIVEQGGHSELLEHQGHYYELYQAQF
AAASHE
>fig|267748.1.peg.350 Unspecified toxin/drug ABC transporter ATP-binding and permease protein
MLFKYMKIKVQNDLKECGLVVIQSFYKYYFKTWLDINFLKAISKFNQKGLSIYDLNLLAK
QINLKTTSYEIKYSDFQNLKITKPIIVLLKENNYIHFVIVEKKSNHNYLILDPIEGKYFL
DEKSFEKMYLNIVIEVEKLKDLVIVEKVKSNFKLEIKNFYTSWNILLSIFMLIFSFCFTF
LLKIIFEEIFPSKDENLLWQIIILFFWISFLNIVLNLIKKLIISKTINKLSKLNLGIYFQ
KYNTLNLNYSNKITNIDHLKRIEILDSYINFKTNLNYFLIVEFINLIASSIFLIYINWEI
FIISFCVGFLILNTNFLFNKILKNNYVKIQKSNINFSTSIIDKIYSKQELKNSTQNQFLD
NKINEFKIELVKSNFKFLLKSNFKEFLLKTISSLSSILIIYLMSLRVINNSISLGELLLF
LSVFNFFLNPFYSFSDLISEIPLQKENKKILDFILNGQFEKNYSQKPIEKINSISLKNFS
FSYTSEQEIFKNINFYFEKNLQLKGPNGSGKSTLMKIIALSNLEDFSKILVNDLSVDNYD
IDSVRTNILYLYNDFYFFKSTLIDFVTLKNLDYLNTFNSNIIQFNLMEFLDRLNLNLNTP
IESNGINLSSGQKQLILLLRLFVKKFDVILLDEVFENLQSSIFYEISKIIKDYQNQAIFL
EISHNENFLYKGNELYI
>fig|269483.3.peg.31 Permeases of the drug/metabolite transporter (DMT) superfamily
MNGNERFAGIGYGLLAALIWGGFPVVTRLGVTHSALDAYDIAFIRFVVSGTLLLPVLLRS
GLGTLRPASIALMVIGAGAPYILTVAAALGHAPVGYFALTPGSMIALTAILGRQVAHERL
SAAQVAGIVTILAGIALAASDALRGAIGLPALVLFMLGGLLWAVYNVTTKRAGAGALHAT
AVVSVGSAVLYCPLYLAARGGAVLHAPVAAIATQAIYQGVLMSVLALYCFSQAVVALGPA
IGATFAALMPLLATLEAMLLLDERPHAPALAGIAIVTAGMAVSLASRWRTGHAPAIRRLN
SAAHG
>fig|269483.3.peg.193 Permeases of the drug/metabolite transporter (DMT) superfamily
MQLFLLQLVFVLSWSSGFIGAKLGAETAGAFNLLFWRFLLVTLCLAIVLNRQLGRLTWEK
LRYHAVIGFLSQFLYLTCVYIAIQHGLPPGIAAIVAALQPLITAAMTSLEGSERSGARQW
AGLVVGFVGVGIVIGGQYALPAGSVGLVMYLLPLVSALGLSIATIYQRRRALTAARSNED
GLFLPLFVQGCVSLVLFAACGIGTGNLHVPTQPNVWISVVWLTVFSTFVAYLSLWALLKR
MPATRVATLVYLEPPVTLMWAAWMFGDRIEVTTYLGIVVVAVGVWLAGKHVERPARARRA
NMEAAGR
>fig|269483.3.peg.553 Bicyclomycin resistance protein
MSHFSLILVVSLLSAFGLIASDVYLPAMPSMAHAFSIGAWQMPQTVSAYLIALACAQLFY
GPLSDRWGRKPVLTVGILVYILGSIGCASASGFASFLGWRVLEALGAASGLVIGRAIIAD
TCDKHASAKVYSIVYPLVSLSPAIAPAIGGYLAAWFGWRSDFIFVAAFGGVALVLVQLLL
KETRPPVTPGQQRAVPLAGFADVLGDRAFIRYTLVVCAIYCAWFVYLTQSPFIFSGLGLS
EQQSGWLYLPLTAGIISANLLSRRMLDRMSYDAIVAAGVGCFVAGGIAFALCESSQVKGI
IAIVMPMFLVSLSNGSSLSLAVSGAIASEHGRAATASGLVGFFQIGSASLAATVSSSLLG
TGSHVLATAMPFFAIVAAVAIVPRWYAARRTLSMRKAQPR
>fig|269483.3.peg.934 Drug transporter
MPRYRRAALVLAACLGTFLATLDISIVNVALPTLQTALDTDIGGLQWVVNAYALALSAFM
LSAGPLGDRYGHKRVWLASVILFTAGSVVCACAGSIEPLLIGRAIQGLAGALLIPGAMPI
LTHAFPDARERARAIGGWSAFSALALILGPLVGGLLVEHGGWQNIFLVNVPIGIVTVLLG
AWGIPERRHPQHAAFDPLGQVLSVIWLGLLTYGLIGIGEAGAWHVKVLVPLAGAAVAFVA
FVQVETRVERPLLPVWLFRDRRLVRANLASFVLGFSGYSSLFFLSLFLQQAQGRTPAEAG
WQLMPQFVMTAITSMLFGRIAARIPLHALMVAGYGLIGAMLAVMAGFGAGTPYLPVGIVL
AVLGVGMGLAVPATGMTVMELAPAERAGMASATMNALRQTGMSMGIAVLGSMMSVGALHR
MTGAMQAAGSAHADTLARQAVMEHVFAAGRPALLGAYRDAMAYGFSIAVLCSGILSILIA
AMLMMRRETKQQSGRAAACVTSSQPE
>fig|269483.3.peg.1004 Permeases of the drug/metabolite transporter (DMT) superfamily
MNNATLAMPGANAYGKGVAACVAATILMGVMFPVMTDALRTIDPFTFTSLRYLIAGAGFI
ALLRIVEGPGAFSSAGEPVALAWLLGSIGFCGFGSFVFLGQQLAGDEGALTASIMMATQP
MMGLLLNALVRRVAPAPVSVLFVVLSFTGVALVITRGDLIGALHEPQHYAANALIIVGAL
CWVVYTFGAARFTRWSALKYTTFTTWLGLTTIVAVNLVLIVTHRIAAPSLAAVHAVLPHL
VYMGPVAGFGAILLWMTGNRMLGPMNGTLFMDIVPITAFIVSAFTGLVPNHAQIAGAALT
GTALILNNLYLRRRARRIDTAPARVPSASA
>fig|269483.3.peg.1691 Permease of the drug/metabolite transporter (DMT) superfamily
MNAPAPPAALVATRPHAAIYVKLTLVALFWGGTFIAGRILAASMPATTAATGRFAIAALL
LVVLTWKIEGGLPKLSSRQVVTTFGLGATGIFLYNVCFFAALARMPAGRTALFVALNPVA
TAVLLSIVVRGERLSLSRWAGIAVALFGALVVISRGELLRVLTDLGNTFGAGERYMLCAV
LSWAAYTVIGRRALDGLSPLAATTYAALWGLALLIVAHLVGSPAGSTTPLTWQAIASMLY
LGAVGTVVAFVWYSQGIRELGPARAAVFTNLVPVFGVLLSVALLGEPLSPSMLAGGALVI
AGVALTNRARR
>fig|269483.3.peg.2411 Outer membrane component of tripartite multidrug resistance system
MKKLLVALAVSALAAGCAVQPAQHPALQDSVRTLAPDGWDTDVPRADIDAAAWWAQFRDP
VLDRLIATVLNDNLDLQAAAERVKQAQALTVQKRAVLLPELDATAHAADARQNTPPPLGY
VRQAGAGLALSWSPDVFGGERLDLLAAQAELVGQKHAEDAMRLALAADAASAYVDLRWAQ
QELKILQDNAKIRQHALELTRKRQAFGLSTELDVTRAQNQLDALEARIPPTQAQVSHQLN
LIAVYSGRTPESVDRLVLAQAGEIPAPPVGSPGTLPSQALLRRPDVLTAYAQVERRAAQV
GVAKAERYPKFSLNLTDGILAASYLGLPTLTDNLFSAALSATSPIFNAGRITADITQSES
RMRESELGLRQTMLQALREVEDARANLVSSDEASRRLGSALAASDKALGLANQLYKGGAT
DFLDVLSAQEVYLRDSDSLNQVKREHALAAVALYRSLGGGWSRNEAAGGPEVEAVAKN
>fig|269483.3.peg.3014 Outer membrane component of tripartite multidrug resistance system
MHASSFPPVSFRSSVAAALLSAAMLAACSVGDPYRPPVADAARAAPFDAAADAPVASGGT
LPDRWWQLFDDPVLDALVREALAQNRDLAVAAARVARARAVLDEAGAARLPDTTAGFGVD
YGKHAPDQIVASAKGTDARTRWGFAPSFAVSWEVDLWGRVGHLVDAARADSEAVQAASDA
MRVAVAAETTAAYAQACAYGERIDVAERSVAIADRLAALTARQRAHGLVSDLEVARSRAF
ADDTRAELPALAGARRAALVELAVLTGHAPGAIPDAAARCHATPALARPFPVGDGAALLR
RRPDLRESERRLAASNARIGVATAELYPSIVLGGSVNWLSTTGDPSSLGDKYAIAWGVGP
LITWRFPNLAASRAQLAQARADDAAARASFDAQVLRALKETEQALARYGAEWRHKAALDT
ARAEHARAYRLAELNYDAGALDFLGVLDAQRSLVAVDAALAASTQQVALDQVAVFKALGG
GWQR
>fig|269483.3.peg.3193 Permease of the drug/metabolite transporter (DMT) superfamily
MAFPTTPDPCQDINPSNAMNKSPFLFPFCAIALWAGNVVVSKLSASTIDPSAITFYRLLL
AVALMSVFTLRPAWRNRAALVAHLPKLAVLGFLAMALFQSLSYEAAKTTSATNMAIITAL
VPLMTMALSSLLLGDPPSVGMIGGGVLSLAGVVYLIAEGHPTTIAARGVHTGDLLMLAAS
AAYALYGVLLKRWRIGALPAWQSTYVQALAALVFMVPMLLRLPAQAAWPTRASVPLILYA
GVLASVVLPYLWMQGVRLLGPSRCAMFMNLLPVMTAGGAIVLLGESLKLYHLIGGGVALV
GVAIAQRFPFQASASQGVRQ
>fig|269483.3.peg.3764 Membrane fusion component of tripartite multidrug resistance system
MPPPAARLSEHRMSTEQFASSNLQRLAGFIGGEVRPYPGRMNVMLRCLLTSALVIVTSMA
LQVPLLPVSLIVVFFVTQSNVVVTRLTGVLFVVGSTIAVGSTILVLKFTYDYPLLRILLA
GTLVFLSVYMMRVAKIGVVFFIVGLTVIYGQTFVDSTDQAELLVRAELWAWVAVTYAIAL
TLLINTLFLPVEPMRQLCSAMGGQLKAIDTSLAGLEHWALVASAPGAYEIQVGALTLKKL
LRFATMRDAAYRANQALHLARVATVSRLYAATGHLPASSAGLTVDAIPVLRDAIQRLADA
VEADGQFVAPGALIDLGGDGLPGALAEMRDALLEFSGRSAAPQGVQSPAEKERLLVPDAV
TNPVYAQFALKTLMAAMISYLFYIATDWQGIHTMMLTCLIVAQPSLGSSVQRAVLRIGGA
AVGSVLALAMVVWVMPHLDGVVGLLMMVLPVIALAAWVSAGSEHISYAGTQIMFTFSLAV
LEQFGPAINLTEIRDRMIGILFGVAVSAVVHACLWPEAEGEALRQRAAKLLRRIGAQLRS
DGTGPIPVTLWAELSDSEAMSARVALEPGWQMADGEQESLTLRMQTLLARVREILLATDA
FGAERNAQKLPGGIATATTAFQAELAGLLDGYASALAERPLTINAPPCASLAALSDCCAA
ELSTLPTDALRAAYDRLLTRASNLAVQVAGLPAWAPGSVGTVLTSRAS
>fig|269483.3.peg.6041 Outer membrane component of tripartite multidrug resistance system
MKRASALIAAYALASCTIVPRPLVPVPVGHDTFRHAGTPLAHEAALTDWPALFGDPQLSA
LVDAALTHNNDIRAASARIDQAQALLGMHEASLLPSVTVDPSFSRARVSGTVDNALPKRM
MHNWSAPVTASYEIDLWGRVRGDVDIERENVLQAIADRDAVRLRVATDVASDYLTLHYVE
QDLNALTRVIDLRYTALDVISARVRAGAASDLDSLRAAADLDTARADLADSQRTRENLID
ALAILTGVSPTAIAIDPTAVNLRVPDVPSGLPSALLGHRPDVFAAERRVDAASLELGIAR
KAWLPTLSLTAQGGFASRDLRTFLDRNSSLWSFGLSMAETIFDGGKRDAAVAAAQAGVTV
ADANYRSIAIGALREVQDALNNIASEKERIARLDSAARTTEAAARLSVSRYEHGYVSYLE
VIDADRDALNAQRQWIHSRQAYSVATVSLVRALGGGWIPPVPADAR
>fig|269483.3.peg.6042 Membrane fusion component of tripartite multidrug resistance system
MVTQTPQDTPSEPPERGRRLPIVLIAMFAILLVTVLIYEFEVRDLSTDDAYVTGHLHVIS
PRVSGTVERVLVNDNQFVHAGDPLTLLDPRDFDVRVALQRSRVAQAQSDAARARALVEQA
VATRISAQADADKAELDYARANELTRETPRGLSKQEYDAADAARKSARARIVAADAQLRS
TRAAAQAADAVSGQNDAELRDALLQREYTTVIAPSDGYVGKKTVETGEHVAPGQALLTIV
EPHPWVVANFRETQLRHVRVGEPVRLHFDALPDVEFVGHIDSQSPATGSQFSLLPPDNAT
GNFTKVTQRVPVKILLDGRAAIEPRIHPGLSVVVTLQRGRHSP
>fig|269483.3.peg.6043 Inner membrane component of tripartite multidrug resistance system
MSTMLVAGGGTPEASPVPGATVPPFRSIAAIAAVLFGAVISTLTSRITSLGLADLRGALG
IGFDEGAWINTAFIASQMFIGPLAIAAAFLLGTRRVLLAGAVVFLVAESVLPLCPGFGSL
IICQSVAGLASGVFVPLTVGFIVRTLPSRFIPFGIAAYAMNLEMSLNLSATLEGWYSEHL
NWRWLFWQNALMTIPFIVCLLLSLSNEPIKRFASGADYRGMLLGASGFTCLCIALDQGER
LFWLESPLIVTLLCISIVTISTFLVHELVSKQAGLNLGYLVRPNVLLLMLLVGLVRFTVL
NTSFIPSLFLASTYGLRPLQIGDTLRWIAMPQFLFAPCVALLLQRFDSRRLIVIGFVMVA
IAFALGSRLTSVWAEPDFIPSQLLQALGQTMALTSVIFFFGKHVTAEHALTFGAVVQTTR
LLGGQLGTTSIAVVQRIMEATHSNRVGLHVALSDPVTLERLRVGAASLVTHGATFATGDS
GTYVLLDRAVRVQATTLALADNFRVAMTCAMVGALIGMMLRPVRAPRSS
>fig|269483.3.peg.6523 Permeases of the drug/metabolite transporter (DMT) superfamily
MNDNARKTGYLIMATLCWGIAIPFSKMVLPALSPAWLIVLQIAASVAVLACLAAVQRVSL
QGIAPAQIAVVALIGMLEPRGAYYLGFVGMQSTSALHTAVIFALEPLGILAFNIVLFRFR
VDGRLLVAGVVALMGVVVITLGDASADGHASLRGDAFVFAGVMVAALYVSLSTQAVTLPS
ATAMLLIQQAGSLLLALVLLGIDAGGSGPHRLPAWPAVWPALAIGVLQFTLAFLFYFRGA
RDNASYWSVVVLNLIPVVGIAASILILGESASPIYFVGGAITIGAALYTHLRERRSEPGP
ARA
>fig|269796.9.peg.245 Probable multidrug resistance protein norM
MAGNLDVLTLGTVATGAALWVPMMIFLLGLLYGVTPTIGKMLGENASEAVSGVAARGLLV
GLLGGALLGALLFWMSTPLFRLFGVAPELIPEASAYLNWMALAMPGMGLFLAFRFVIEAH
HVGWIVTVVAVLGVAAKIWLNDALVHGHAGLPALGTGGFGAASVALYWGMAVMLAGATFL
HGAVKPLWTHRLSGADLSLAAIGRFLRFGLPIALNFLSDYLIMAVVAVFIATLGAVAIGA
HQITFNILMVLLMMPTGLSMAATILISRSPGGGHTATLGPVMSWTLGIGVAFSIVLAVLL
AAFDAPVIRLYTDDAEVIALALDLLGVVVFILTIDVVAIALGFFLRGLGDPGSPFLILLA
AHWLISLPVGYVLCFTDWVVAPQGPLGWWYGLSTGLLVACCLLGLRLRQRLSRAAQPVCS
PAEATVAGVAE
>fig|269796.9.peg.267 Permease of the drug/metabolite transporter (DMT) superfamily
MSQPSALPAADSLAALHPGFKSSALVWLGVMVALWGFSWPVMKICVGLAPPLWLAAIRFT
SSGLCLFAFLACRGELRLPPRADWPIVASVGGLQMMAFTGLGLVAMQYTDAGRAALLAYT
TPLWAVVTAWIAFGQRPTAAQGVALCVGLSGVAVICSPADMDWGDSTVLLGNALLLLSAM
CWSFVILHVRRHRFTARPIDLAPWQMLLAALPLIVIAASVDGSPLTIAWTPELIGFLIYF
GPIATSACFVISSEYGRRVSAFAMSNITLGVPVIGMLSSIFLLGERVTVPLIIGLTLIVS
GVALAALAVNRKAAAGRADTALRSQAGKANWPTA
>fig|269796.9.peg.387 Permease of the drug/metabolite transporter (DMT) superfamily
MSAPASGFSAPRSPKAPVDWAPWMVLISTIALSFKGISAKYAYDAGMGVGMVLILRFVLA
APFFWVGERLLGAGRPRLPLGWAEIRPCILAGVLFSVATYSDFSSVQLIGAGLSRVILFT
YPAVILIIGAFSRRTWPARRQMLAFAITYLGLLIIIVPSVGLVAVDVMLEGVAMSLLSSV
TYGSFLVYSQSLTGRLGSARFTAISNTVTMLMIVPFALAMGGDLTIPNTTALIWAVVIAT
VCTVLPFFLLFEGIRRWGAEKTGLMTLSGPALTIAMAWVLLDETLTPLQLIGFAVVMAGV
GALQGVDRPLLRLLRRGRRAEA
>fig|269796.9.peg.590 Permease of the drug/metabolite transporter (DMT) superfamily
MSVILFCVVVLCWGFTWFGIHLQLGTIAPEVSILWRFLLAAIVLAFGLAASGRFKPAPLA
HHPWFALLGLCLFSTNFVLMYSATQYIASGIVSVVFCMATVFNAANQWLFLKRVPAVRTV
GGALIGIAGIALLFGESFLHVEASADTALGVALALGGTYVFSLGNLVSLRATASGTDLPN
AVVRAMAWGSVFLALFVLARGVPFAMDWSARYVGSLLYLAIPGSVIGFTAYLSLVSRIGP
DRAAYSAVLFPVVALTVSTLFEGYQWSAWAMAGLPLILIGNLVIFARLPARWRRAAA
>fig|269796.9.peg.731 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSARHAAQQVNPFLTVPIGRLFVSNALPMAVVMSMGGVLNVVDGIFVGHFIGSDALAAVS
LAFPVAMVLSALTTLTGGGMSSLMARYLGAGDRGAAGRIFAETHGLVLAISVGLVVLWAV
VGAALVDSMAAGNPKVAGLAQDYLQIMILGAPAQLMLGVHADALRNEGRAGLIAALSVLV
NLFNIGANGLGIVVLGLGISGSALGTVAAQALGLALVIGVRGHSKGLLPLSVLRARNWLG
AWSQIIRLGLPLCLSFIGIAMVASVVIVSLRLSAGTDYNALVAAYGVVTRLLGFAFLPQM
AIALATQSITGNNAGAGRTDRARAALRLALGAAFLWCLPVVLAGVFAGTTLGSWFSDDPA
VIDAVAEILRPMMLFYAASGPVLVLALYVHALGQPGRTAALTLVKPWLLTPLLILALSIG
FGVSEMWLAFPMADAIILMLAVMIGRNVLHTAGTRAAHAEEGA
>fig|269796.9.peg.915 Outer membrane component of tripartite multidrug resistance system
MNMAFLVAPSLIALILGGCAPWDGIDRQSAMTDAKTLALSAPSDPIPEVAPWPEGEWWRG
YHDAQLNQLIGEALAGNPSLKVAQARLRRAGALAGLAEAALSPHLDGGASIIDQRFNEGG
LYPDSLAGKVKTENKIALEGAYTLDLWGGREAEYRSALGELRASEIDAQAARLDLAAAIA
QSYARLAAAFDQRDISHEVLRQKQEIQALTARQVRSGLVTEVETRQADAAIAAARADIAG
DEERISLLRRDLAVLTGAGPDRGAAITRPGLSMRAGVGLPSTLPADLIGRRPDIVAHRWR
IEAATRSIDAAKARFYPNVDLTAFLGFKSIGLANFMTAGSFMAGAGPAITLPIFDAGRLR
SQLAEANATLDITVELYNGAVLEALRDIVGSLTSWRANQARLAEKSLAVASLEEAYRLAL
LRYREGLANYLTVLSAETALIAERRQEAEFRNRQYGLSIALAHALGGGFAPQGPPPSRAA
SGDPAPRAPL
>fig|269796.9.peg.1952 Permeases of the drug/metabolite transporter (DMT) superfamily
MLMVCGAFLLVGSSVVASKVVTAAFPPFTATAVRFAIAVGLLIPWMVLSQGWPAWPGRRA
VLALGLQALTGCVLFSVLLLEGLRRSGGVEAGLTLGTLPAVVALLAVPLLGERLDRRIGV
AVLLAAGAGALLHGGKGAGGSGWLGPVLLFGAVVCEALFTLLGKRAVVHLSPVVTATAVS
FASLALSLGPALTEQPLAALSSAPAAAWLGALWLGAPVTVGGFVLFHAGVAGTSGGAAGV
ASALVPLSAAGLSALLLGEALLPTDLMAGALVLGAILLLALPTGKAG
>fig|269796.9.peg.3389 Permease of the drug/metabolite transporter (DMT) superfamily
MDLGYLKSKESGFIAGMILCTAFMGSSFPSGKYLISEEAMPAFYAGGWRFLLAGGLILAF
CAAKDGLGAILPASGGSVIKGALFVLVVGCLQTAGTMGFLNLALTTLSASMASLLLFTNP
LWVAILAHFALGETLSWHKVVALVCGILGVSLCLGGGADHGLGGIVIALAGSLCWALCTL
ISKKHKFDKSVFVFTGWQLTLGALVMLAISKLSGEAYDIDRITGWGIACFIWLVGPASIG
SFGLWFTALSRRGATVTSSYLFLVPLFSAVFSMMVLGEAVSPHSLIGGAIIIVALWLINL
PQTVSAVWRERLGL
>fig|269796.9.peg.3484 Permease of the drug/metabolite transporter (DMT) superfamily
MVDPAVSLVWRFGLASLIMVAWALARGQSLRFSLRDHAWLALQGISLFCANYLLIYTATG
LLRSGLVAVACSTIVAMNIVLGAAFFGQPIRPRVAAGAGLGLVGITLVFSPEFSHLSLGD
EALRGFVFCLIGTAFASLGNLLAGRNQRTGIGVLAGSGLGMGYGALAMALFAALSGKAFL
IDLSLPYLGSLLYLAVFGSVIAFGCYLTLLGRIGADRASYCAVVYPVVALGLSTAFEGYR
WSAAGAAGLALVLAGNLLILRRPGAAAPGAGSLTTSLSPRGGGR
>fig|269797.3.peg.1328 Permeases of the drug/metabolite transporter (DMT) superfamily
MENMMLWLAFAILTAFSESIKDVLNKRLLTQVNEYLLAWSLVLFALPWLVLSLFFTGIPP
LKTEFWSYLIIDSILNIVANLLYIRAIKHGDLSSTVPIINFTPLFLIVTSPLILGERLNI
FGCIGVLLVLTGSYFINFQVRDKGYLYPFHMLLKEKGPRTMLCVALIWSITSTMDKIGVI
NSSSFFWAISLNICIFALMSLFLLHNSKVDSKKINHNLKDFVFLGFFYALGWLAQMTAIS
LISVAYVISIKRSSTLISVILGYLLFKESNIKWRLPGATIMFVGFLVLALS
>fig|269798.12.peg.1245 Drug/metabolite exporter
MTAIPNSIQKQYLGVFLGVCSAACFSTKAIMVKIAYMYGADTVFILFLRLFFSLPLYIIL
AVIYSKNADMKITRIQWIWIVLLGFIGYYISSLFDFMGLSYISASLERLILFIYPTLIVV
LNTLLFGSKLQRKDYLALVLTYIGIFFIYLGNTESTTENLIKGSILVFACALTYAFYIVG
SGRLIPVIGAQRYTAYAMLVSTLSVMIHQGLVNGIPDLTHTSSEILWVGFAMAIIATVIP
SLTLAQSIKLIGTEKSSIIATLGPVFTIALANIILKEPFTLRQGIGTAFIITGVWIVGKK
DS
>fig|269798.12.peg.1339 Multiple antibiotic resistance protein MarC
MSIDWSFALVVFTGLFAIINPIGNAPIFISFVDHLDKHQQKAIALKSVTVGFIILAIFVV
FGYALFNVFNISIQAFRITGGLLVLKVGFDMINSKPKDAATLVKNSEATDTGFAISPLAT
PILVGPGTLSTAVSFVGVGNKIENSIIIICSSAIILTITYFVFISSTTLIAKIGKEALNV
VTKIMGLLIASIGIQMIITSIEELIHNYKL
>fig|269798.12.peg.1787 Multiple antibiotic resistance protein MarC
MDLIFATVAALLPIINPFSTAPMFLSLTQGDTKSYRNAQATQGVIYMLAILLVSLVGGSF
IMNFFGLSMPGMRIAGGILVAGVGMKMLKPNDEIETTEAETKEAENKKDISFTPLAMPSL
SGPGSISVVIGMSSLAKNISDYCYIALGIIFVACVVLLVLRSSVGLVKVLGVNGLHAMTK
IMGFLILCVGIQFIIHGTMDILTGNEMLEFLKKVHQNV
>fig|269798.12.peg.2075 Multidrug resistance transporter, Bcr/CflA family
MRHTQNRHLITLILGMLATVSPFAIDFYLPAFSQIANELGTTTARISLSVSSYFIGMALG
QLLYGPLLDRFGRKPPLYAGLIIFIIASIGCCFSTGVEMLITLRFIQALGGSVAGVAAMA
MVKDFFPPEQNHRIFAMLILTIGLSPLLAPSIGGFVATAFNWKFVFVLLALIALFAITIV
FLFLPEGQEPDKTVTLQLKPMAKTYLSILSDTQFFTYTISGAFAFASLFIYVAGSPIVFI
DLFHVSKQMYGAIFAFLSIGFIGASQLNILLVQKFSSASIFRFAMRLQVAAGMVFSIVAW
NGWMDLYTTILMLFVFLSCVGLINPNASALALAPFTKNIGSAAAMMGCSQIGIAAVASIA
VGMFDAASVLPMVLSMSATACIALALLMWGEKKMAGKIVAADASKGVVVH
>fig|269798.12.peg.2312 Permease of the drug/metabolite transporter (DMT) superfamily
MNRIARAHIFLSILTIISGFNYTIAKIAMPVPIQPSSIIWIRMCCTTIFFFFFILLAKRS
FFIAAEDRLRLFLCAIFGITINQIFFFEGLSRTMPINTSLIMAGIPITVFILSAIFLKEK
MNWMNTLGLTLSAAGAALLLLDSKGKLNGLFIGDLFILINAISYGIFLILARQLMQKYDS
VTVIFWIFLIGACLTFPYSYANYTHTDWAHLPVLVWLAVGFIVVFATIVNYYIGVDVLKD
VSPAVSSMYVYIQPIFTTAIAMYFGSDKMDAQKLFYALAILLGVYLVSKSTGKKTLVDDK
KGPA
>fig|269798.12.peg.3318 Permease of the drug/metabolite transporter (DMT) superfamily
MLLSIVSFSLMHLCVKAIPDIPVVQTIFLRSVFSIVFCCIAIKQAKVSVWGNNKTFLVLR
GLVGMLSLICFFYSIQMLPLGTAVTIGNLVPFFTLFLAFVFLKEKIPHIKWLFFAVSFVG
VLLMKGLDDELPALGIILGLCAAFFTATAHFVVRKLRDTDDTSVIMFYFPFITIPFMLPF
AILQWETPDAREWLFLVLIGITTHVGQLFLTKAYKHEEVKNISYVYYLGIILSFVYGVSF
FGEFISVKSSVGVGLVILGMVLNMLG
>fig|269798.12.peg.3630 Permease of the drug/metabolite transporter (DMT) superfamily
MFFWGLSWPSGKVAASYGSPVTIVLIRYIVVFAGFLPVFFFMKAPLTIHRKGIPSLLAAG
LLLSAYTYLFFYGLKNGLAGAGGVLVTTMNPIMAYSIGLVLNRKKPSRNETIGLVLGLVA
GATLLKIWGSLDELFASGNIYFLLAAFVWAVMSRITSKASTYGSSMSFSLWMYLATVLIM
IPFVNLTDLNNILHNADQYFWWNILFSGIFATSLATSYYFYATTTLGPEKASSFIFLVPV
SAAVSSWVFLNETLLLHTIIGGVLGIAAVYMINRKKEIM
>fig|269799.3.peg.3236 Permeases of the drug/metabolite transporter (DMT) superfamily
MSTLAFTLIVISAVMHALWNLLVKRSRHKTVFIWWMFVASSSLFTLTIPFLPERFRWPDP
ATLLLVTAGAVCFVLYHLLNGRAYRGGDLSVVYPLSQTSMVYVPIWGMSILGERLTMPGI
AGILLVILGAFSVQMERLSLAEFLRPFRNLGSPTVRNALAAGFIYSLGSIAEKVGVRDYT
PLYFTYFLVLIMLGLMSVNLLRPCYRPLIVAEFREHWPLILVSGPVMMASFLTFRYGLNL
SPMSYAVPVRQVSILMGVLIGILFLGESCGRIRLGAALVILAGAIMIRLG
>fig|269799.3.peg.3428 Permeases of the drug/metabolite transporter (DMT) superfamily
MYSGQFLAVISAALFGISPVLCKLVIGEMSPALLAGLLYLGSGIGLHILLLFQGKKSIEE
VKRLSPKKRLALLGSILSGGVVAPLFLAYGIKFGTASEVSLLLNIETVATTLIAWFVFRE
HVGLGVWGGKALILLGSVFVILKNDGSLAFSFAGLLVLLACAFWGIDNNLTRDIEELPAT
VLASIKGFGAGAFNTLLALALSTGTATVPQVAGSLLIGAMSYGMSLVLFVEALRRIGSAR
TSTLFAIGPFVGTFLSVLILGERPPATYWVAASLMLAGIALLQREMHGHPHTHEELSHSH
KHLHDEHHQHEHAEGEGTEPHDHPHLHEPLTHSHVHWPDIHHRHSH
>fig|269800.4.peg.243 Permease of the drug/metabolite transporter (DMT) superfamily
MSLPRSSPPSALPRWRGPLLLALAGVLWGTGGFAGAFLQQLTGIHPIATACYRLLAGGVL
AIVALGVSGQLRGLPRSPAVLRRVAAAGVLLAAFQACYFAAIAVSSVSLATLIAIGSVPV
FVTCAAAVLERRLPRPTLLAAVCCGVLGLVLLSGDPGGDVPPGRVALGVGCALGAGAAFA
ALTLVNRRPVPGLDPLRVTALGCLLGGTLLVPLAAATGMTFTPTLPAVGVLLYLGLAPTA
LAYLAYFGGMRTTPAPVAALAVILEPLTATVLSLLLLGEVLTPTGTVGAVLLFGAILLEY
VRPPRR
>fig|269800.4.peg.2011 Bicyclomycin resistance protein
MSLTALRSRTPVISAVLRAPAPRRPTSAPRPQQRPQRSAALLVFVLSLLTATSALATDLY
LPAFPEIAADLGATESQVQLTLTAIMVGLAVGQLVLGPLSDRWGRRLPLLIGAAVFTLSS
LASAVAPSTEVLSALRLLQGFSAAAGAVISRAVVRDIFHGEDSARFFSRLSLLTGVAPMV
APMLGGQLLLAGSWRLLFVVLALIGVANLVLVYVALPETLPRTPAAGRGTQRGSVLGALL
RLQLDPRFMGPTLVMSLSFAMTFTYISAFSFVSESEFGTTPQQFSLIFGVNSLGMVLGNQ
VNTMLINRMDGPRRLLAGLLGALASVAVLVGLAISEQANVVVVTAALFTMMFFTGLISPN
ATTLAIASQPSSVAGTGSALLGALQFAIGGGLAATTGMGEGGEASLLSMSVVMLVTAAAA
GAVFAGWAFLARRVPAPRTA
>fig|271065.3.peg.1585 Acriflavin resistance protein
MDQVKLDGLFAWFADNPVAANLLMLVILAGGAFGMIDVDKEVFPRFSPHQIEVTAIFPGA
GPAEVEQSVCIPIEEAVHDLSGIKHLHGEIRGDTCTIGVEILPNRDREQMMALLRSRIQS
IRRLPKQLENIDVLPSDRKDDDGVIWVALHGETDAFSLQRFGDRIQQQLATIPGVSRVRN
YGEIGYEISVEVAPEQLRKYRLTLDDVAGAIRQASVELPGGLVKNPDGELLLRVDSRAKD
ADAVGSLIIKTLPDGNRLRLDQIATIKDGLEERLYTWRHNGQTAQGWEIHTEQDSVAVAR
QVKSTIEAMRANLPEGLRLITWWDDSQAYDERIGALLENGLIGFLLVCSVLTLFLRLRVA
LWAGAGIFTSILGAFWLMPMLDISLNMLSLFGFLLAMGVLVDDAIIIGESVHSRQMEGRE
TPLQAAVNGVKAVALPVTLSVLIVLAAFLPGLYLPGWAGQMMRPICLIMILTLVFSLIEA
LLILPSHLVAAVESNANPTRLQKLRTKLNQGMDRFVDRVYRPLLKIALSWRYLTVALFAA
LLILCSGLVASDRVRQSINPDVTKDSFWVSIQLPQSAPYSEAQALATRVENALFALRDEL
DGVAEAGRDANNRDNVTQMYERSVIVGIETIIWEHGAGIWLELSSEGRQRIKVENFIRDW
RQRIGDIGRGKVDFIFKEGDEPYDIELMLGSDQPNILAPAVEQLKQQIKAFPGVYDVIDS
AEPGKPEIHLTLKPDAERLGLSLEQLAEQVRQGYYGAEVYRFMRGRKEVKVMVRYPLHER
RSLDQLKAQPIRLPNETSAPLTNLAEVDLIQGYSRIHREDRQRVLKVQARVDPTLTDANE
LYVLLEKDVFQTLENQFPGLNIQTGQQRQEQKALLAAFSKNTLIALLVIYALIAVPFRSY
SKPIIFLLAAPVAWCGAVLAHWAVGLPLSMESLVGMIAASGIVINDSLVLLYCIRQSGDD
RDPPVEALIIEACASRFRPILLAFLTTFAGFLPTLLETSAQAQFLIPMTLSLSAGLLVGM
LASLILTPVCYTILDRRRSPVVPDAHATLSFD
>fig|271065.3.peg.3148 Outer membrane component of tripartite multidrug resistance system
MTDNLAKQHTVSACLLGGTLLIAGCAWFPESTQRAVMNALPEIGQTISEAQQRLPATDRW
PDPAWWDIFNNPQLQTLIEASLESNPDLKATAARLSQAQSMVDAQAAELYPTVHANITFN
AQRFSANSVQVKFAGENFRHMLINPLILRYHLDFWGRDKAALQAAVGRAVAVENELADAK
LLLSATVAQGYFDLSESAEKLKLIQQIVRHKEALLKLEQTRLELGLVERSAPLTTGIELN
AAREIEAAFRAKVDLQRHLLAALAGRGPDWGQSIAADPSLFPKRLNLPADLPLSLLAHRP
DIAAARLHAEAAAEEIKVAETAFYPDVNLIAFTGLHSVSMTDVMLQGASLAYAVGPSIEF
PIFEGGRLRANLTYQEATYDAAVERYNASLLHAVQEVADALTRWQEIEDRLAKHQHSLEA
AQSNESLAQTLNRAGLNNRSDLLEARIQVLDQRYHLATLENERFKTAVQLFKALGGGYTE
NDKL
>fig|271065.3.peg.3149 Membrane fusion component of tripartite multidrug resistance system
MTTAVPQKIRPREILRKRNRRLKGVTLAILLAGLSYFAYWWYMNRDWVATDDAFVAGHLI
TIKALTEGIVVEVAAENTQAVQAGDLLVRLDGNHAEVALQQAKAELAETVRNIVTLKAQI
DTLNHRVIARQASLATVRHDLKRYESALFEGAVSEQQVQNARDRLRELEAAISEAEAEKS
GIQAQLLETDIDHHPSVEKAKSRVKKAYLDYRRSNIFAPVSGYVSNRRAHVGDHIKSGMP
LMAIVPLDEVWIEANFLETQIASIRPGQSAEIKIDAYGGERLYHGTVQGLNPGTGSVFAV
LPTNNATGNFIHIAERVPVRIGLDPKEIQEHPLQPGLSTLTRINISETGEPLLTSSVSIR
SEFYRTTIFDNELEEAERLIREIIYKNQPNNNRLNE
>fig|272557.1.peg.19 Antibiotic resistance protein
MPSLSPGEESRIHLTTKALSLALTAFLVMYVEAVLYTSVPAIQAELGISPVEASWIFTSY
LVTGSVLIPLMGRLGDAVGRRRTLILILIIFGISLLLGGSVNSFRLLLGLRAAQGVGMTA
LPLIYAIVREEFPPNRAPVIQGILAAMNGIGLLIALPAGGWVTENLDWRLNFVLISPLAL
LSILLNIALLKDTRDLSLDKSLSGMRVSVASVLSFAALVTSLLILITIHTTGESGEYAQG
LLLAIFIVSLLAFRWSERRSSAPLLPISTFNRSVRLGVFCASIIAVTFQLVLFVLPYLLQ
TPHPNGFGLTPTESGVYMMLLIVSYAISSPLAGYLVVRVGMKRIAYAGSLLSAAAYLAVA
VKPLQSPLLEVTLVSLGFVGMAFINNSLINIVVYSADKSYLSTTTSLYTLLRTLGSALGP
LIGGLIFSMCSYSEIKTTQITSFSIDPLSYSLAFAAASSLFLIVLAMVLQIDEPSLLKDL
SPSRVLT
>fig|272557.1.peg.51 Permeases of the drug/metabolite transporter (DMT) superfamily
MSVGVWLYGCGCGMDRRSSELLGVAAALTAALLWSTIGVVQRLAEARGADTETLIVGRTL
GGSLLALALLAIYRAVPTRRSFAVAVLGLAPLYYTYMMSVSIVGAAVASLLLYTAPAWVA
LLGTVFLGETPSVRDVVTIILGLAGAALVSLGGEGKAGELRLLGIVLGVASGFFYALYIV
MARFFQSRGAGVMEVSLAPIALTGPLLGVALKPSLPPNSVEVAASIYFAVFTMVTPYLLN
VYALRRIEAHRVSVMSLIEPLSAVLLAVLLLGEDLTALQALGGVLILAAALGASFK
>fig|272557.1.peg.1758 Multiple antibiotic resistance protein MarC
MADLYTVVSSIILLFIVLDPVGVSPYVASIVARRPEGERERIVRTALASAGAILVAFTLI
GVAVLDILGVSMDEFKVAAGLLLLIYATADLFEIKIGYSEPSGDEVAIFPLATPLLAGPG
SIATVMYIMGSSGIAVALIAILVNLVLAYPILHASLKLVRLLGRHGSLLVAKFTAFLMVG
FAVSIIFDGLRGIVPGVFS
>fig|272557.1.peg.1760 Antibiotic transport-associated protein
MARYHILIFIAWFIVTALLLPYALALDEVLVTETESFLPETAESRMAEEKVKEILAAEGY
GGADSLLGLLGSANALIMVTGLREPLDPSSYQLLKEQGYDELRAEYNLFSWIDIVDKAME
NLEPALEEAVRGGVQAFEGGYSIWNSYLEVSQRLSNLSQSVDGLSLLLTESDKAYSTLAS
SWGELAALRGVLESASTPLIDVCTAIAPVYSTVYLDVVRTEGALEFYTNAYATGLQDVDI
TVVTLLTYVPEAGLEPVDRGFVVYVYTETLSLGGPGAFNNAAAAEITYTIVQARIGDSSL
LQAYHQAWLHAVSETPELKLFMAEDAKVGQIRLKAAVEDIADQVTEATVMALAEEASSIM
PDDIKPIYTIYVESLIEEGCTEEAKERALQTAITQLLKSRGLPEEHASTLASAFARGDYN
SYLQTAALASATLALAEANMTELQPEDLASVLVAFDPEASGAIASGETLEDALSVLLSRI
AGLTPDTARLIIEERIEEAAAEIVLSNTPPQAADLAQALLAPAPPATEEEALQRIRSYLE
QQLASQGMPEDLAVKAAEAAEEAWREGIVDAVIQRLVGEVAHDAAKGVLDELRGVLVEDD
MGGFLIAYLGGGGYEGAKAAAEDVRRLVNEALDGDARVMLAGEEALRKELQEAVVEDLRR
SDAASSIIVVAILAAVIGTILGVIIPFIGIGAGLTAALAILYFLASNDLVDVTSQSRAIV
FTTGLGLGIDYSAYVTKKFRDNIRGSRGAWEAAGKAASNSVRPVLAGAFAAAAGFSSLML
AFEFPFVKSIGATVPIAILSVAVASLTLTPAILALVGWAGILWFPTCPYKAYQPGSRVFK
SLVSAAGKAAPVLLPLLVVAGLAGVYYAATSFEGSFDILISIPRETGVYESMQHLVSEYD
ASRLFPQYIVASSSTLAPDVADAADDLECVREAETDGRLIYVVLDTNPLNTEAVKCVEEL
RGKVREVDPGSLVGGTAAVNLDLRDYLYRAFYNRVIPAAAVLVAAIIAVFYGSIPAALAG
VASILFAAAWSLSIVSILSGWTGIEAPWFAPVLLAAALLGVGMDYISFYVNHAREAYLRG
EHSRYYVEAASTGTGLVIGLAMIMGGAYAGLTLSRVEALQAIGVSLSLGVILAGLLASLL
LIPPVMALLKARFWWPLARGRKSGGAGKVERG
>fig|272557.1.peg.1785 Permease of the drug/metabolite transporter (DMT) superfamily
MSGWEYLVLALAVANVSTASILVRLAGVHGFAAATWRLVLSTILTAAILVAAYAVKKHRK
PVLPGGVDLLLVAASGVALALHFDLWMASLFHMSVAMSVTVVDSYPAVLAIVGFRLFKEK
YTPLQLLGAVIAMVGVAGIAFYSSRGASAPPGGDPIKGFLLAFAGMLAVAAYFSIGKGLR
SKYSTLEYTLPVYGFAAIVSLLLTTLVVRAPLTGYTAETYLYLILLALLPMLGGHTLINL
LLRRLSLLAATVPILGEPVGAAALAWILLGEKVSTLEALLMVVVLAGIGLVLYEENRVKK
EIKQGLASEGP
>fig|272558.1.peg.290 Multidrug resistance ABC transporter ATP-binding and permease protein
MKLEIKSVTKKYKEKTAVHDFSMDLLSGECVGLIGPNGAGKTTLIKMITNILDPTRGDIL
LNGKRISEMKREIGYLPQYPDFYQWMTASETLLFMGQLSGISKKKLTKSIPEILSKVGLR
GEENSKVSTFSGGMKQRLGIAQALLHKPSFIVMDEPVSALDPIGRREVLNIIEEIKKDST
ILLSTHILADAEEICERLVMIKNGEKIEDTTMMELLNRNSKNKIRVEITDESKDWIEVVK
KLNYVQDVEVTGNKVNVEVKNIELHKNMLLANALKHDVNIVKFELDHDTLEELFLKLVVG
E
>fig|272558.1.peg.390 Permease of the drug/metabolite transporter (DMT) superfamily
MNQTISAQLKIMFAMVIVGSSVVAGKMLVESFPVFLASELRFLIAALILVPMLLKKEGIP
TFSKKEVGILFLQALSGVFLFSIFMLYGLMYTTAMEGGIIMSTLPAVVALMAFITLKEKL
TRLTIIGILLAVGGTLAINTSGTLSDVERGVAPLLGNLLIIGAVISEALFIIFGKSISQR
VSPLAISTMVSVFGVVLFLPFAIYEATRFPLTDVSLNDWLIIFYFGVVVTVIAFVLMYQG
IEKVPASTVGVLTGVLPISAVLLSALILKESFSTFHVAGMGLVLAAILLISIDSNVEKKE
VASLKKKKGIS
>fig|272558.1.peg.396 Permease of the drug/metabolite transporter (DMT) superfamily
MRLYVMLLSLSLIWGFSFVFIEHLLGIVGVWGTVVVRCFAGAIILLPILLMRRKLFYRPA
PWKALMIVGIFNAGLPWGLIALSQTEIYSSTAAVLNALTPLFTGLIGFLLYSNALSRQQW
GGIVLGFSGVVVLTGFQLQLLAPEHFVGVGTMILATICYGFASQYVKRHLHDTDVVLITT
FSLLFGGLVGLIGMWITDSLHVVRVPLTIDWLSLISIIGLGCLGSGMAHLLYYDLMKKGG
PEFATTVTYLIPMTAIIWGKLFLDELITKNIVIGMLMILMGVYFTSRKRNVCSKANEDSN
KGELA
>fig|272558.1.peg.1403 Multidrug resistance protein
MTRVTDTLLYVVLGMAPLLMVLGNSMFIPMLPTIQAEWGLSVVQGGWLLTSFTVPAALLI
PISGILSERYGQKRIGLASLVILGTGCVLSSIAVVIETRPFWLLLTGRIIQGLGTGGLTP
ISLMVASELFSGKKRNEALGFLEVSNGIGKIISPIIGGLILLASWYYSFVVLFALALLAF
VGFYTLVNEPKKHETTLSARAYTKKLSQSLQENWKMFVPIFIIGSLGMLILFGYLFAVSN
MIGEVSPFWKGVILAVPFLLFAVASFWTSRWLTPEFASFQKAMMVGTTLMTGAMFLMLWQ
HDRTILFMLVSLFSLGLGMFFPPASAAVAALTNNVSRSVIMPLYSMARFLGVAVGPVIFG
FWLERNISIHTMSFFIISLSFFIMCVLWYSGFLRKTNLSHESS
>fig|272558.1.peg.1741 Permease of the drug/metabolite transporter (DMT) superfamily
MNRWLTYFLVFFVMVLWGLNVVMLKLLVTSFPPVTMTALRIFVAGFVVLLVLLLLKTFRQ
LTATEWKYVILAAIFGVLGHHFFLSIGLTMTSASNAVLILALLPLTTSLLAILLLGDMLT
RWRGFGIFLGLIGVCTIVLFGEGGLAGIRTGDGVIFLAMMIQALSFVYIKKATDTLDAKQ
VTGMMLLIGSLLLFVTSFIIEPNGLASMGDKALWIWWVFVISAVFATGLGHIIYNQAIHQ
LGTGETAIFNNLVPFFGLLFSALFLGEAIALAQIAGLLFIVAGVILGTGHVDAWMQKRKR
RFDQVG
>fig|272558.1.peg.1937 Permease of the drug/metabolite transporter (DMT) superfamily
MRIKFITAVFLGACSYGVLSTLVKLAYENGVPTAVVTSSQFLIGWFLLATLLAFTQKKRR
LTMKEKIQLMLAGIPTGLVGIFYYLSLVTIEASVAIILLFQFVWIGVVLESLINRQFPTK
KTVGSLIILLIGTVLASGSPWFNQGTVHWLGVLFGLLAAVSFALFILANAKVLPQLPTVQ
RSYYMVSGSLMAVLFIFGPQLFYQPLTTYGQLGWYGVLLGFFGVCIPPLLFAYGMPQIGS
GLGSILSSIELPVAVLLSVIVLKETVILSQWIGVFFIFLAIILPNIEWKKEQLAKNPL
>fig|272558.1.peg.2098 ABC transporter (ATP-binding protein) (daunorubicin resistance)
MLETINLCKTFKGQPAVQEVNMYLNSGESVGLLGPNGAGKSTTISMISTLIKPTSGEIKL
NGINIISHPGDIRKILGVVPQELALYQELSAYENLKFFGSTYKMKGKHLENRIQHALEIV
GLKDRQKDLVKTFSGGMKRRINIAAALLHEPKILILDEPTVGIDPQSRNHILETVRTLNE
NEGTTVLYTSHYMEEVEQLCDRLYIMDHGEIIAAGTKEELLSILSTEDTIKVELSKIDET
FVQNVKMIEGVRKVEASHSQLKMIAKKGSHLIRELVHLTDQHQIQMIHFHTETPSLEDVF
LHLTGRTLRD
>fig|272558.1.peg.2116 Chloramphenicol resistance protein
MSNKKTALTIFLLSLGAFVTGTAEFVFSGILEIISLDLGVSIAAAGQLLTMYSLSYAAGA
LILVLLTAKYNRKKVLMYAIFTFLIGNLIAFVSYSYSLLMFSRVVMAMSGGLYIVVATNY
AAQIVSPEKRGSAIAKIITGFTVSLVLGVPIGTFFSAYVDWRYIFLIIALISLFLIISLY
KLLPEIQANKPLPFTTQLQIMKDRRLMTGLGTTIFWILGYTMVFAYISPLLSREAEMPLE
MISVALFVLGTSAFIGSRFGGFAVDKWGPARTISISLIILQHSFRS
>fig|272558.1.peg.2163 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEQKQQSERLGTEAIPKLLRSLSIPAMIGMFVMALYNVVDTIFISYAVGIEGVAGVTIAF
PIMMIMMSMAGALGIGGASVISRRLGERRGEEANQVFGNILTVILVLSVIGFISAFTLLG
PALQLFGATSVTQGYATDYLFPILLGSIFFFFAFAANNIIRSEGNATFAMVTMIVPAVLN
ILLDVLFIFGLNMGVLGASIATVIAQASVTGLVLRYFLTGKSTLSLHWSDLRMKGSVIKE
VCLVGLPAFVQQSSASLMMIAINSMLLRFGSDFYVGVFGLVQRIMMFVMMPMMGIMQAMQ
PIVGYNYGAKQYSRLRETVMLGFKVATIFSIGIFALLMLFPEALLRVFTADREVIQAGVS
AMHILFCVTFLIGAQIVAGGLYQSLGKPKQALILSLSRQIIFLIPLVLILPHIFGLSGVW
WAFPIADVLSFILTVVLLYRDRNVFFLKTKEERELDLVKTASST
>fig|272558.1.peg.2592 Multidrug resistance protein B
MKGWKRNLYILVVCQFLVVSAMTMIIPFLPLYLQELGVTDPSEVSLWAGIIFAANFLTAF
LFSPLWSRLADRYGRKMMILRSGFGMALIIGLTGFAQGPLSLLCLRLLNGVISGFIPASI
GLVATNTPKEKAGYALGFLQAGAVSGGICGPLIGGIMAQAFGYRMIFFLTGLCIFIAALV
VLLFVNEQFTPNPKEEKTNTWGEFKKITAIRPIFSLYVVVFLIQFAVMGVNPLISLFVEE
LVSGVNVALFAGLAISATGFANMLSSMQLGKLSDKAGAHHVLFFCLLGTVIFMIPQAFVQ
QLWQLIVLRFFVGLSLGGLLPAANALVRMHAPKGMESRTYGFSTSALYLGNMVGPTVGGA
VVATVGIRGLFLISAFTLLLTVWIVKGKVMPASDKQFRYEQNERKIASS
>fig|272558.1.peg.3211 Multidrug resistance protein
MNIGFGMVVPYFAIYLGTYTGLDPVSIGLIVGTTSIGSLVGGFLGGTLSDQFGRKKIMLV
SLVVASAIYAGFMLQDYALLLVCLTLVMGFCTSFFEPCAKALMADFTESKKRMKAFSLRY
IGANIGFAIGPLIGIVAGVTASSRLPFIVVSTILLAYALFLQWLFRAFGVQEISIGEKEH
VNLTGAFKAIQSDRVLLLFLFGGLLATVVHGQFSVILSQYFELEFQSGLAYLMLLWSVHS
GVIVICGIPLVKVMERLSPLRAIVIGSLFFAVGVIGFAFSFNFMTFCLAMIVFTIGEMFL
IPAEYSIVDEITPNHMRGTYYGSLNFTSLGSFIGPWLSGILLVHFGGKFMFIGLALICAL
SLFFFIAGHLKRRAYTVGEAVREAERGL
>fig|272558.1.peg.3496 Transcriptional activator BmrR for multidrug resistance transporter
MKNQFPIGEMAKLHNTSIKTLRYYDEIGLLKPDYIDPNNGYRYYSTEQFEHLNTIHYLKE
LGFSLKEIKKHLEDRDIDGFLTLLEKQKELTEAKIKELERINRRFENRIHDIKWARHIEE
LGIVTIKDMEKRKIVRLKETIRSEPELEITLRQLENKSKMTSSIFIGGVGLTVSMRNIKS
NKFNEYNSIFILIEDDIQNPLVATLQEGKYACIYFRGNHHDSPKYYKALLNYIQTNNLHM
IGDAIERTIIDHYISESKDDYLTEIQIPIKY
>fig|272558.1.peg.3856 Quinolone resistance protein
MKQKIKAPQLPSSLTSATILQLEEGDDQIGSIQLIGDETNGLICPDHLEIRQSSFKQVTL
LNSSFSRSDLSDVVFEKCDLSNVQFQDAIIHKAEFRRCRMTGFNGSGASFRHVRFIDCLL
DYSAFGFSNMKNVAFSHCSLQEADFYQSVLKHTEIQDCQMHGANFAQTDLSDMDLRTCSF
QQLTVSFDKLQGCTVTSEQAIGFAKILGLNIEDH
>fig|272558.1.peg.3880 Multidrug resistance protein
MKTTKKRETLWQQPGYKKLFTSYSISMVGQWFDLVALLVLFGYVWNADPLLLAFIPIAFA
LPQMLFGQFAGVFVKKYHKVKVMAVADGVTSLLTISLLFTGHPLVVLGIISLRATVNVVH
YPAQQSLLRQLIRDDLRLQAITWNGAVSQAAKIIGPMGGGALLTAFSPHTLILLNGIAFL
LSALLLTTLFRNVKVVEKDTSLENQSSFWASWKAGWQVVFKRKVIYFSFAIALLGMSVIQ
MVDIQFPVLFRQIAAAQPQMVAWIMAAIGTGAIAMMAFLGRMKQLRNVGMWLAGAMICIG
IAFLGIGMLQEGFLMMIPIGLGLIAGLGTGTSMVVSNYIIQTEPREQEVSQVAGIYQSLI
SMAILLPPLLGAWLIHLIGVILLFQIVGAVLLIIGGIALCFHPILFTTKQGTKEAGTKLL
IVKE
>fig|272558.1.peg.4045 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEMSKQLGKKFNLLTLLAYAAPTMALMLFMSIYTMVDGMFIARYVGATALSAVNIFFPIY
GLIIAIALMLGTGANAIIAKKIGENNEEEAKENFTFIVICGAVLGLVITVFGLLLMEPIL
LMLGAGATEELFDFTYTYAKIILCTSPFMILQMLFQNFFVTAGKPNLGLTITVVGGVANI
VLDYVFIVLLQMGIAGAGIATAIGIFIPAAYGFVYFIYNKESGLHFVKPKVDGKVLLNSC
INGSSEMVSNLASSIVTFAFNLLMIKHLGVDGVAAITIMLYVMFILSSISMGYSAGVAPI
ISYNYGSKNSSQLKRVFNYSLLIIVIGSVTMYGVSMMFGAYFIQFMAPEGSAVYHIAIEG
LNIFSISFLFMGFNIFSSMVFTAFSNGKISAAISFLRTLVFVLASLWILPAILGVTGIWL
AIPLAEILSVIVCIFFLTHYRNDYHYA
>fig|272559.3.peg.71 Permease of the drug/metabolite transporter (DMT) superfamily
MMKNKKVEANLSMVVSKTFSGLNMNALKYLLPVWVSPLSGVTLRCVFAAIAFWIIGMFVK
PEISTRKEKIFLFLLGALGIYGFMFLYLMGLSKTTPVSSSIFTSLQPIWVFVIAVVFFKE
KISAMKIAGISLGLGGAILCILAQKSDDLASDALTGNMLCLLSSIAYAVYLVASNRILKS
VGMFTVLKYTFAGAAFSSIVVSAVTGFHAPVFSGPLHWFPLSVLLFVLIFPTVVSYLLVP
IGLKYLKTTVVAIYGYLILIVATIVSLLVGQDRFSWSQTIAIGMICVSVYLVEVAETKEK
PVSNSDKPSSLPPHGS
>fig|272559.3.peg.782 Bicyclomycin resistance protein
MTDRQNSRRFLLLFLGVLSAFGPFIMDMYLPTLPAMADFFHTSSSMVQLGLTTSMIGLAA
GQLIFGPLSDKYGRRPPLLLAMILFLLATVGCIFSHTISQFVTSRFLQGIAGAGGVVISR
SIATDEYSGQQLAGMLAVIGGINGIATVIAPIGGGILAQITSWQGIFICLFFMGVVLLSG
SLHLNESLPAKHRQTVSWQDLYHSFGEVLHNRRYVGYVLQYGFTMGILFVNISSAPFIMQ
QHYGLSPLSFSLCFGINAIAMVISSAISIKLPTMERALYIGSRGMLSVSALLMVFLSLRC
DFWIYELLIFALLSMIGMTFTASNTLAMECERRNAGIASALLGATGFAFGGIVSPLVSLG
DMMTSTGILFLAGSACAYACTRYVLSQSVQPSGVLYH
>fig|272559.3.peg.1185 Tetracycline resistance element mobilization regulatory protein rteC
MKEVVDRILEQVEADISEIDLYGYNIIETSLSMVHRLQTVLNDLRTKIQTYVFLTKEDEI
LFFKTQKPEILGRLLFFYKIYKIETQCPNGSDEAIRNYINRELDNLTYFFNRNLDFYQYY
RSHSTVYDEYYFVRGKADLRLCTDSAQFDKDPNFSTGYDYKVAKIIANEMLRIYLNKRLV
KLGTNNQIEDNLQKCFKYPFRFTGKKAYLIELGYSLVSSGDINNGNVEIKEMMNFLSTIF
HIDLGDYYASYIAMKERKDRTAYLHHLIDSLIKRMNEDDMKC
>fig|272559.3.peg.1195 Permease of the drug/metabolite transporter (DMT) superfamily
MKSLKGIIYAMISSGTFGLIPLFTIPLMGNMEMNESNILFYRFLFSTLMMGAVCLLHKST
LKINMKHLISIIGLGALYALTALFLIYSYHYITSGVATTIHFLYPICVSFLMVVFFKEQK
SKSLFLAASLSLIGVALMCWSGGGSIRLMGIGLAALTILTYGIYIVALNQLDIGKLPAEV
LTFYVLLGGCVIFFIYSLFTAGISSIPSTKAGFYILALAFLSTVISDLTLILAVKYAGST
TTAILGSMEPLVAVVVGVLVFSEHFTLQSLIGLLLILMSVIIVILADQQKKSKRITEQKI
IKPH
>fig|272559.3.peg.1654 Tetracycline resistance element mobilization regulatory protein rteC
MEEYFNGLLKEVDQRMATTAPGMDGKEVIGVCREMVSYLKGKNRELKEYALAHPFAGDAK
EILYFKYYKPALTGRLLYYYRVYQIESGCPACLRVAEPYYRKAMERAERMMERYLPFYQY
YHSGATYRDSYYFLRAKGELSPESGSFVLDEEAEFSTGYDILAARLISVEMLLVHLSRRM
ERAAQGTETEAVPEKEHRWTNTKVAAILLVYGIHVTGSVDEGNAEIGELAALFEKHFHVD
LGNVYHAFGRLRGQQNPTAFLDEMKERLLKKMRDMDSR
>fig|272559.3.peg.1875 Permease of the drug/metabolite transporter (DMT) superfamily
MKTTQRTAGWYHVMAAVTVMIWGTTFVATKVLIKYGLSPVDILFYRFLLAYICIWFFSPR
VLLAKSWQDELRFVGLGLCGGSLYFVAENTALGMTLASNVSLIICTTPILTALLAPFFYK
GDKLKARLIGGSLMALIGVGLVVFNGSFILQLSPAGDILTLIAALMWAFYCLLLRRMNTH
YPTLFITRKVFFYGLVTLLPLFLVYPLQTDIHILFRPVVALNLLFLGVIASMLCYIMWNT
AVKQLGVVCATSYIYVVPLITLLTSAIVIDETITIVALLGSALILSGVYIAERGVNLKK
>fig|272559.3.peg.2680 Multidrug resistance protein B
MGNIMIGTFMAVLDSTVVNTGLPVIMGTLGADINVAEWVLTGYMLSMASILPAAGWLSER
FGYKKIYFLSLLVFTAGSFMCGSSSTIEELIFWRVIEGFGCGMLLPVGMAIVSDVFPPEQ
RGTALGFWSIASAASVSFGPAIGGYLVDYMDWNYIFYVNIPIGILALIVTAIVQKEHVKG
TGVPFDIPGFITSAIFLPVFMYGLSEVNSSTNSMGWSSPVVLGAMWIAVVTFILFLYFEF
TVKTPLINLRLFVDRDFALSNLILFVFGIGMFGSTFLIPLYLQDNLGYSALQAGMFFMPV
GIIQGVASPLSGKLMQRINPKVFIVSGILLMALSFYMNYYLSFLTEKWYIILSLYLRGLG
MGLLFTPLLTLSLVNIRNSDMAQASSITNIVRQMGGSFGVAIFSHLLTQRTAFHTQRYGE
ALNYTGDVYRQTLHSLSRFIEHTGGRTPDTAKEVAEMLILKRIDLEGYISAINDDFFIAF
IVTLLCVVPVLFLRTKKG
>fig|272559.3.peg.2985 Permease of the drug/metabolite transporter (DMT) superfamily
MNIIMNINSKAKGFVCGAVAAATYGMNPLFTLPLYKEGMSVDSVLFYRYGFAVLILGILM
KVQGQSFALKKNEVLPLIVGGLLFSASSLLLFLSYKHMDAGIASTILFVYPVMVALIMFL
FFHEKVSLLTVFCILLALSGIGLLYKGEGGETLSLVGMLLVILSSLSYAVYIVGVNHSTL
KLMSTAKLTFYALLFGLSIYIVRLNFCSDLQAVPSLPAWGNILAMAFLPTVISLVCTAVS
IHTIGSTSTAILGALEPVTALFFGVMIFGERLTPRLMLGILMILVAVTFIVVGKPLMTFL
KEEVAGGMKRKLTR
>fig|272559.3.peg.3009 Bicyclomycin resistance protein
MTKRIGNSRLYILIFIGIVSAFGPFVTDFYLPALPVLSEYFDTTASLVQLSLTFSMVGLA
VGQLIIGPLSDKYGRKLPLMVSLVIFCISTVGCLYSPEIHGFIFARLLQGLSGAGGVVIS
KSIAIDLYQGKELTRFFAMLSSVQGLAPVCAPVLGGILLGAMDWKGIFWILLAIGILLIV
ALSAFKESLEIKKRQKGNVFSTFKYYLPVLRNRQFMRYVLIQAFAMGVMFTYIAASPFIF
QNHFGTSPFAYSLCFGVNALGIMLGSLAVSRFKDATAALRFGVAGFTTMSLPVAAALIFS
PSVWIVEGTLFFLLAFLGLILPGSTTLALDMERKNSGNASALLGFLMFVFGGLLSPLTGI
GNMLYSTGIIIVACCVGTWFFTYKATSSAR
>fig|272562.1.peg.85 Permease, MDR related, probably tetracycline resistance protein
MKSSKLSIIKYYLYTFGVQMRLTRIVNILYLVQCVHISIVQFTLLQSIFSITQFVMEVPS
GMLGDFFKKKNITTYGLILSATAQLLICSRLVVNAENPFVILAFAFAIEGIGRALISGAD
DALFYENIRADGYAAEYDKIRGRYQLISSISVGIVTSLGTILYTINNSIPYIGQCIMTII
SIGSIMTVKEHNVKKTLRKNENGKNSIKVFLTSILQVRNSPHIVFMMCLVCLTFGVINTV
FGIMPDYISEIGFSNTQTGTVFMLLSFIGGIVATQAYRISNKRYGQLVLVTVLCMSSGVS
LVGLRGNKEMIFIGLALLYVIIDVLDPIAMKSFNAYVDDSIRSTFLSMVSFMVSTSTMIL
YPIAGIIVEAFGMLTLLIAISAVVIPLLGVSCIIYKKYSVN
>fig|272562.1.peg.122 Permease, MDR related, probably tetracycline resistance protein
MNTTINNSNLKYNNLILILGLAGFVSAADNWFVSPALQPIASELSISVSTAGIILTSYMI
PYGVMQPVYGFFSDRWSKASVLKIIVGGLAIGTAGSAFVRALPLLCLFRIITGFFAAGII
AVSLGLIGDTIPKLERQIYVGRFMGIVFLGQGLSAGLGGLITKYISWRGAFVFFAVVAAI
SDIILIKGLSSDSKKISFNCKQNNFFLQTKIAICTPAGRKIFPLALISGFLLLGLYSYLG
SFLHDVMHLDYLECGVLIMFYGFACLIGGTKVGKLSKRYGKKNIILLGEGFALITALSLY
FFHYWEIALVATVFLGFGYICIQSTLATLAFDVNPENTGLPSGLIGLGLFGGGGLGSLFS
GWLLSIDGYEAIWIVFASFIVVISLITLKIKLN
>fig|272562.1.peg.818 Teicoplanin resistance protein vanZ
MSITIKFILSVILIKLFNDIVNKKSKQEKNEVPLKYYIMKCVFILYLIVVLDVVGFPSLW
EWKMMMSLSQPIFNPHINLIPFKEMGIEDALNIVLFMPFGFFLPTLWKRYHKFWMTASFG
LAFSLTIELSQLFSRSRVTDIDDLIMNGLGTVLGFMIFYIIRKKNYHTDEKEENNLFVKV
EPFVCIIIVIICNFLF
>fig|272562.1.peg.827 ABC transporter ATP-binding protein (multidrug resistance protein)
MKYSNINKKLGSFLSSSKNIIKTVKLLWKSSSLSFIATLIITVLNGIIVPINMVISKYLI
DSVVNALKNKSPIDSLNKVLFWLVVEFGVIAFSYVIGRVNTYFSTIQSKCLNNSISELLI
KKANELDLSYFENDEFYNKIEKANSQAVGTTIQIVNGLTQIVKNFTTLVGAIVIVFQLSP
IILLLCIMTSIPMFIINIKIYKQKYNIYSKRIEKTRLAHYLQMVMMDYIPVKEIKLNRIG
DWLEKIILSIYKDNLNQDKKIEKKQLLIMSIVDIFNTIISYGYKIYVIFITLTQRLSIGS
MNMYISALTNLEDSVKNTLDNFALLYSNNLYIENLFYVLDLKPLILNNNSGKKEFINEIR
DSIEFRNVSFKYPNSKKYALKNVSFKIEANQNCAIVGLNGCGKTTLIKLLTRLYDPTEGE
IYIDNINIKEFNIESLYKGIGIVFQDFMKYPFDVKKNIGFGNIDNLDNFELIKTAAKKAN
AYTFIQGLSNKFDTKLQKMWSNGVDLSLGQWQKLAISRAFMSNACLLILDEPTASIDAKS
EYELFKDFKELMGEGTSILISHRFSTVKMADKIIVLKDGEIVEQGNHDSLIKSDGLYAEL
YNMQADAYLVNEDKNIDVSKDKLKDIV
>fig|272562.1.peg.857 Vancomycin B-type resistance protein VanW
MKKVVIGAFSSAIIIILIVLSSIYIKVKKWDGLVYRGVTIDRVDVSSKTKKEVQDIVKKK
FDKIVQNRTINMVTDDNKTIPLKYSDINVKYDIDKAVSGAFDYGKSLSIYDRYKLLHNPK
KLEISVGMTYDKNALENSIKNLSNTLNKKAKDATIVKTASGFQITPEADGKKVNEDKLKA
DIEGKITDNNITDYNVKINMDAVKANATQDKLKGINTLISSFNTEYASLSSPQRANNITL
ATKAINGIVLMPGDSFSFNGVVGERTAAKGYQSAPVLIGNKSDMGLGGGICQVSTTLYNT
VLTSGIKATERHHHTLPSHYVPVGYDATVDYGTLDYKFKNTLSFPIYIEGNTDNGHVTFN
IYSDASLLSKTYKVSSENISDSVPKAKVYLETYENGTLISKDMIANDAYSK
>fig|272562.1.peg.994 Teicoplanin resistance protein vanZ
MKKIKNKKKIFKVILFGLFIIYIIALFKIILFKSISFLQIFKGYNKSRSINLIPFKSIIQ
FIDTYKEMGSFRAFANLAGNLIVFMPFGYLVPTLNKRFSRIRSTVIASFGLSLFFEVTQY
VLEIGSSDIDDIILNTLGAVAGYSVLTCLRKISSKVVIQNFCIMCITVIFLITGSIVAFR
EYGVMLNLTKLKEVINGGRDIPKISADAVGHTVQIKENDIKLEKVSIYNKNKGGKSHDKG
ERNIDIVFNKSTKVYFERDDYKDNTMTITNIKVNEKKLYTLKKNSMISVWGNNREGKLFA
NFIIVYLK
>fig|272562.1.peg.1012 Probable cation efflux pump (multidrug resistance protein)
MKLLQLFNDKKFFKAAFGLAIPIIIQNFILSSLNLVDNIIIGGLGETAIAGVGLANQYFF
LLDLALFGTASGASIFTAQYWGKRDTKNIKRVLGICLITTIILSGIFTIGALAFPNIIIG
FFSQDKNVISLGANYLRIICFSYIVTGISFAYSIILRTVGQVKIPMIVSGTALAINTFLN
FSLVYGIGSFHGIGVYGSAIATLIARFIEFFLMLLAIYKLKLPIAAKLHELLDLSTTFVK
RFFKVAVPVMLNESMWGLGVTAYAAVYAHMGTAVIAATNITSTIDRLSMVVFFGFGNAAA
IMIGNRIGQKDEKTAFLYAKRFIILSPFIGIFMGIILYTSSPAILYAYNINSQVHMYSKE
ILHIIGMFLWIKIFNYTNVVGILRSGGDTKFCLMLDMGGMWLVGVPFVALTGIYFKLPIG
IVYYFVFMEEFVKLLVGLPRLLSKKWINNLVSKPSEVSI
>fig|272562.1.peg.1210 Permease of the drug/metabolite transporter (DMT) superfamily
MKKGYMYIALTTIIFSTMEIALKLVSKSFNPIQLNFTRFFIGGLFLVPFALNTLHKRHLS
ISTKDLRFFALLGLLGTVISMSLYQLAVQNTKASVVAVLFSCNPVFVTILAFFLLREAIH
KNNIAALILEVIGTIVIIDPLNTKLSILGLALTIASTLIFAAYGVFGKKKCAKYGGIVVT
CFGFLFGSIEMLVLIGITHITPIANLFSSNGIAIFSNIPLFTGYSLKNLPLMCFICLINT
GAGFACYFKAMEETSAQTTSLVFFFKPILAPILALILLHEIIPVNMIIGILFILAGSISS
ILPELLAQRQTKLEKTA
>fig|272562.1.peg.1237 Permease of the drug/metabolite transporter (DMT) superfamily
MSKSTKVDLVFLFFTAIWGLSFPLTKNVLGYTSIFAFLSLRFTSAAVILIIIFWKKLKLI
NTKIILYGSLIGLMFFGSLAFQVASLRFTTSSNSSFISALSVVIVPLVSAGYYKKKIDFS
CVLGVLFAVVGLFFISGGVNFKLNIGDLFSFLCAICITFQIIFIDIFCSKCDSALLSLIQ
VVFCAIFYNIVLFIIGTKPIVFNTQLTVSIFITGILGTAVAYTGIVFLEKFTSPTHTALI
FCAEPVFATIFAMFIPNNNGSCESITINTFIGCGVILLSMVISELKIGNNIPQKIIKL
>fig|272562.1.peg.1605 Tetracycline resistance protein TetP
MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGSVDSGNTQTDSMELERKRGITIKSS
TISFNWNDVKINIIDTPGHVDFISEVERSLSVLDGAIIVISGVEGIQSQTRILFNTLKEL
NIPTIIFVNKLDRIGADFNKVFEEIKKNISNRVVRLQEAYDMGSKDVYIRNLSDICPINN
DAVDVISDLDEVFLERYISGVEPNKEEVQEKLSLYAREGSLYPVFCGAAAIGLGIGDLLD
GICSYLPFAGDECEGNLSGVVFKIERTSTNEKKVYVRLFGGRVSVRDRIQVPSKEIVEKV
KKINSLENGRIIETQSIEAGDIGILYGLTDFQVGDVIGVSNNKIKNISIAKPTLKTTISA
IDKEENQELFKALTLLAEEDPLLELEMNDIDEEIYVNLFGEVQMEILSSILDGLYGIKVE
FSNIQTIYKEKPKGVGMSIMRMQEDLNPFWATVALKIEPKGRGEGLRYISNVSVGSLPKS
FQNAIEEAVVKTSKQGLFGWEVTDAKVTLTCGEFFSPASTPSDFRNVTPMVFMEALYRAQ
TVLLEPLYEFELRIPQDVLSKAIWDLETMRAIFDSPIVIGDEFSIRGLIPVENSKEYKMK
IASYTKGKGMFTTKFYGYKEVSAKFAKARPKTTYDPLNKKEYLLYKLNAIRD
>fig|272562.1.peg.1694 Permease of the drug/metabolite transporter (DMT) superfamily
MNGKQKILPYIAATVSSTIFGLSFLFSKMALKVAGPLSLVALRFLLAFIIMTILVLFRVI
KVDYRNKPIGQLVLLGLAEPVIYFIFETYGVKNISSSMAGLMLALIPIVVTIMGSYFLKE
VPSLKRTSFIVLSVSGVALIGVMGSSGGSGNSPIGILFLLGAVTCAGAYSIISRKTSVHF
KPVEITYFMMFFAAFCFNIMAAIQLLAEGKINEYFSPLKSSTFVISILYLGILSSIVAYF
LTNFTLSKIQASRSSVFSNLSTIVSIIAGVIILKESFHLYHLVGSVLILTGVWGTNKFK
>fig|272562.1.peg.1767 Probable cation efflux pump, multidrug resistance protein (FS)
MALVRKDVVKLAAPIFVEQLFVTLMGMINTMMAGHIGKEAVSAIGMIDSINNIFIAFFSA
LAVGGTVVVAQYIGQNNIKKANESTKQALYSTIIIAFVITIIMAILKGPLLGFLFGSAEK
EVILDANSYFGITLLTYPLITIDLVSNGILRGAGDTKTPMKISILMNVLNVAFTALFIWG
IKINGTVVVKSLGITGAALGIATARTIGGIIILIVMVRGSRIVQLKKLTEFKFDMTLLKP
IFGIGVPASVESLLFNGGKLIMQIFIVGMGTVAMASNTIVNSISNFLNIPGNSLVIAATA
LVGQHMGRDDDKGAEKCLSYITKLSTVLLAIVGILSILFSRHLPSPVYWK
>fig|272562.1.peg.1768 Probable cation efflux pump, multidrug resistance protein (FS)
MVSYLFFFQDIYLPLYTGNNDIIKLSSKVLIANAFAMIIWSSAFTLPAGLKGAGDAKYTM
VTSIIGMWLFRIVLGNFLGNTMKFGLLGIFLGMYTDWLVRGILYIIRFRSGKWKNHVVVK
RVKTSVKA
>fig|272562.1.peg.1812 Quinolone resistance protein
MQRKKKLKIVNPDIYEELEEVLEGEIIVEDDSYIELKSFENVSLENKQAKKVSISQSIFK
NVSFNNTSFKGIDLTDVIFEKCDLSNADFTESVIYRTQFKNCKLMGINLSEGTLNNVTFD
NCMARYSICTLLRCKNVLFKECTFTSTDFYKSQFTNVEFLNSELIEAQMHETSLKGIDLT
SCSIDGIGLNIEDLKGCIVGPEQLMCFANLLGVILK
>fig|272562.1.peg.2536 Multidrug resistance ABC transporter ATP-binding and permease protein
MKKGTLFRLASYVGKYKMYMFISLIFALISNVLIAFMPLIVGKGIDNIKSQGKVDFNNLL
KIIIVLAAVYLISSIFTWLFTAVANILAYNTVRDLRNEALSKISTLPLKYFDVNPHGDIM
SRLTNDMDAISDGLFQGITQFFPAIVTIISSILLMLSLSIKLTGIIILMTPLCFFIASFI
TKRSNKMFKQQQNTVGELNGYIEEIIGNEKIVKLFGYEKRAEKKFSEINSRLYNCGQLAQ
FYSSLTNPSTRFVNNITYVLVGAVGGLLAVLSGLSIGTISSFLTYSTQFSQPINNVTGVA
TQLQAAFASAERVFSILDEIPEKKDNEGAKKFEHCEGNISFNNVSFSYNKKQPLIENFSV
DIKKGSTIAIVGPTGAGKTTMVNLLMRFYDIDGGKITIDGKDINKMKRNDVRGQFGMVLQ
DTWLFEGTIKENIAYGKPDASMEEIESAAKKAYIHNFIKRLSDGYDTRITESGGNLSEGQ
KQLLTIARVMLINPPMLILDEATSSVDTRTEIKIQNAFLKMMEGRTSFVIAHRLSTIKDA
DLILVMKNGHIVERGKHEELVNSEGLYREIYESQFKNAV
>fig|272562.1.peg.3475 Probable cation efflux pump (multidrug resistance protein)
MKSLATDMTEGNVSKHLIKFAIPLILGNLFQLTYNASDSIIVGRFVGKNALAAVGIANPI
MNIVMFFIVGICLGASVLMSEYYGAGNVKKLRREISTTVIAGFIFTVLIIIICVIFTEPI
LGLVKTPKEIIPEAAIYLRIIFISLIFTFFYNIYAAALRSIGDSKNPLLFLMISAVLNVV
MDIVFVVWLKMGVAGSAIATSVAEMMSCVFCIVYVHFKIPILKFSFKDMVIDKGLLRSTV
NYSWATAMQQTCLYVGKFMVQGAVNPLGVNSIAAFNAVNRVDDFAFAPEQSISNAMTTFL
AQNRGANKYKRIKKGFLTGMKLETLYWCILVGIVYLGSTAIMKLFVSGSEVKVISIGSYY
LKLMAFFYLLPSWTNGVQGYFRGMGDMKITLRSTFSQIVGRVAFSYILAPRIGMVGIAFS
CLGGWIVMLAYEVPCLIKYRRNFNNKLSESSI
>fig|272562.1.peg.3489 Multidrug resistance protein B
MSKDKKRIIALAIFLLGIFMGAIDSGIVSPARDVIRSSFGIGESLSVWMVTIYTLAYAVS
MPIVSKLSDRYGRKKVYVISIATFALGSFLCGVSNFYGNYTFFLVARVIQAIGGGGIMPI
ANAFIGVSFPPEKRGTALGFVGGIYGIATILGPTMGSSVLNLAGNNHWGWIFFINLPISL
IILALSVNLKENLGEAKKKMDLKGSIVLSAMILSLMYALTNLNFSDIVKSLRSSVVYPFL
IVFFITLPIFIVIEKKAEDPILNLRYFKEKQILLTLILGFITGVGLMAVIFIPQFAENIL
KLKTGNGGYLVTFMSVFAGVSAPLGGKFIDKYSAKLVTALGMICTVFGTFFLAFYTTSNP
NFISIMIGLVFVGFGMGFTMGTPLNYLMLSFVDEKESASALSTLSLIRSIGVAVSPNIMI
NFISEAGKRVQGNIMSVMPQISVPVFLQGKSAVRTIDISKLSGSGKISNAAISKFQSADV
TNIVKVLKEFAASIIDKMLPGIKAQILRQMGPTSKMAPHIDLNKVFSSWKADYLNKIDQK
RAVIESTFQSTISSGYKNMFIAAGIIALVGFIAALMLENKKMRVKNNI
>fig|272562.1.peg.3563 Probable cation efflux pump (multidrug resistance protein)
MLNVIKNINQRKDMVISIFALSWPSILEQLLETAVQYVSSAMVGQLGAEASAAVGLTTTA
TWLINSPSFAMGIGVLSYISLSIGAKKFRRAKIAAVQSIIITLILGIFMGIGTLAISPFL
PKWLGAAPEIQRNASLYFGIICIPMIFRVAIIVFGAVIRSTGDMKTPMKVNLIMNLINIV
LNFILIYGKQTISIGSFKITTYGGNLGVVGSAIAAATAYTVSGILMFLALYKNKIVSPKG
EKLKLNIPIMRRCVNVGFPVTIERVATSLGQVVFSSLVTRLGTLAFAAHSIAITAEQAFY
IPGYGMEATASTLAGNALGEKNEKKLNQISVTIIGMAITIMTVTGTILFLFPDFMMSLFI
KDPVVIKSGSSVLRLVAISEPVFGALIILEGIFNGVGETKTPVLVSILSMWGVRILSTSI
CIYVFHLGLKSVWICMIADNVFRFTILFIRFLNGAWKKKLNL
>fig|272562.1.peg.3590 Multidrug resistance protein B
MKTKNYFDLKKVLPAVLTIAVGMLLVMMDTTIMNVALPHIQSTFNTNLATSQWAITAYTL
AMAAVIPYSGWLADRFSAKKIFGIAILFFTIASLLVSISTNIEQVIFYRILQGLSGGIVG
PIGIAISFKIIPIEKRGSMMGLLGLPMLLAPTIGPALSGFLIKYYNWHTIFLINIPIGLL
SLILVFLFLPNFKSKHNTKIDLRGAFLSPLAFPLLIYGVHVGSDKGWQSPISIISIALGF
LMLLTFIFLETKTQTPLLEVKVFKISEFRKGIILMWLNQIAVFGSMLLIPLYLQNIRNYS
SLEAGLMMVPQAIASFIGMTVGGRLFDKYGTKSAAIPGFLLTGFSLILLAQITNTTALAY
LIICIILLGLGQGLVNMQVNNHALQSVPLNLINRVTPMTNELLQVINSLSIAFITAFLSN
QIKTAFRKHSLAVSGNIAFHNTFILLTIFIAIGLGLTFFLKNKKSKEAS
>fig|272564.4.peg.581 Acriflavin resistance protein
MNNKKGLLYHIISNWRFTIFFTILTMALGIYSYYIVPKQESPDISAPFAVITTIYPGAAP
EDVEKLVTRVIEDEIREVPGYKTSQSITKNSLSVVVLELHNDVDVKEAWNELGQILDGAQ
GKIPAECFDIEADTKLSETAGMIISLSGAGYTYEQLADYAEQFKSRLAKIDGISRFTVTG
VQNKAARIEVKIAELNKYNISLDELVSLIQAQNLQIPSGSLSDQRVKVNVSSPGLFTSLS
DLENMIIDVSAETGAPIRLQDLADIRWDIEDADYQLKHNGQNAIMLSGFFKENRNILLVG
EDVRAELDRLKAELPPELIVDEVVYQPTDVDKSVAEFFKNLLEGMALVLIVVFLGMGFKN
ALVASTAVPLSIVITFIAMHLLGIQLQEISIAGLILALGILVDDAIVIIDAIQVHIDQGL
EKMEACIRGMKQAMIPVFSATLTIAAAFSPMLFVPGPAGEFLRSLPQTVIIAVSASFLVA
ITVTPVLAYLFFDKLKKEDDKRTPLRRVYGYALQIGMQYKKSTVCAAILLIAIAGYGALQ
LQIEFFPKADKNVFYINLYSENASDISATARLAEQVEGILQENEEIVSYSTALGGGLPKF
YITLPKATPAKDFGQIMVKVDLDKGEFANNEDLALHLQEQLDQHLIGGSANVLLLEKAMP
GDPLEVRVSGADPLQVRDGVALIRRELEGVPGTMKVADDYVAGEYEFVVDVDTERATTMG
ITNYDIQRQINIALSGAEASLFRIAGNEYPILVQSDVKSKEDLENLAIKSSLTGHKILLK
QLGNIHLQATVPTINKYDGVQAVTISGKVQPGFSAVTIENTLKQRLTQSGFDFSGLTVSY
EGEAKDIKDNFGSLGTTAIFALFLIYVILMIQFRSFLQPAIIFITIPLSVIGVVAGLMLF
AQPLSFTALVGVVSLMGLVIRNAILLIEFINLAREEGMSIDEACHFAVNRRYRPIILAAV
TTVIGLVPLAFSGSDLFTPMSVALMSGLLISTLFTLVVVPVLYSLLVREGKGTAPGASAA
GKREMGQSV
>fig|272564.4.peg.2257 Multidrug resistance ABC transporter ATP-binding and permease protein
MSAAEKQTGFGPGRQGPGGGRGFFGGPPGGPGGPGGGEKARDFNKTLRTLTGYLTPHKTT
ISIVVFFALFSTVFTIVGPKLLGKVTTKLAEGLFAWYNQTGLLTDFNYIGKIIGALVVLY
VISSICSYVQGYLMSGVAMDVTYRLRKEIAEKMSRVPLNYYDTRSHGEVLSRITNDVDLI
NQTLNQSLNQIITSAASIVGILIMMLSISWMMTVAALLVIPLSLGIVGVVIKRSQRFFRE
QQHSLGELNGHIEEMYGGHTIVQAFNGEAESVAFFERVNDQLYHSAWKSQFVTSIMMPVM
SFVGNLGYVVVSILGGYLAVKRVVDIGDIQAFIQYMRSFTQPIAQLSSISNTLQSTAAAA
ERVFEFLAEGEETPETAHPVTLDQFSGHVRFEHVSFGYSKDKQIIHDFSADIKAGQRVAI
VGPTGAGKTTIMKLLMRFYEIDSGRILISDHDIYDFSRHDLRSLFGMVLQDTWLYNASIK
ENIRYGTFAATDEEVMEAAKAAHCDEFIRALPGGYDMVLNEESSNISQGQKQLFTIARAI
LADPKILILDEATSSVDTRTEILIQKAMENLMRNRTSFVIAHRLSTIRDADMILVLKDGD
IVEQGNHEELLAQNGFYADLYQSQFEEAEAV
>fig|272564.4.peg.2540 Daunorubicin resistance ABC transporter, permease protein
MSGQVLTRKKSRIYREASTVLAIFAREVTVALKSPGTLIMSLAMPMIMMGMIGGNLMQNM
AGGLGFQFGTFMLVGMLVNMLFMTTTMGVASLVDDHDSNFSEEMLIAPVSRYGIVIGKIF
GSMFGAVLSMVGTLIVGLVMGITLPFTQLLLILALSPLICLSAGALAMILIGLIQNRKTA
NLAVMLITMPQMFLSGAIIPINHSSGVLLVLSRMMPMTYCLDLVRAVVYRGTPEYSSVVM
FNPVVNFAAIVGLTVLCLIIGTFFFARSEKNR
>fig|272564.4.peg.2599 Drug resistance transporter, EmrB/QacA subfamily
MPTIMEELHIEATTAQWLVSGFTLVNAIVIAISAFLMDRFRTKQLFLSIFVLFLAGSLLA
SWGVNFTVLLIGRLLQAICAGIMMPLSMTIILLLFPHEKRGSAMGMYSLVIMVAPAIGPV
LAGVLTDKVGWRIMFLVMAVLAGAIILLASLIMKNYGDVKQTTLDKPSFTMASLGLLALL
YGFSLLGNISMILTASALVLAGVVILFLFVRRQLSLTQPFLQIKVLGNAQYRNGTIILML
IQASLAAATITLPIYIQTVRGMSATVSGMVMMPGAILGAVFGYFAGKLYDAFGARYVGLF
GGFLLLLGSLGMALFDFDTTIGFMTAAYTLRSVGLMLANTPINMWSIKKLPDEILHHGNA
VGITLRQVATTLCTAVMVSVMSFASSVYAAKGEIQSQMYGISMTYWLSVVIGLVALILVA
VKVKNRKKTVAAVTEAVYELDIAMRADPYTVSCDDNLKQVVEKFIGYKTSGLPIIDAQKH
LIGFVSDGDVMRYFTKQDLRFVAEFYSAVIPDTDTLNSKARKLLSMNVMEIASPNAIAVS
HDTPLLEVCEIFSRRKINKLPVTQNDILIGTISRGDIMRALMTRLPLGGED
>fig|272564.4.peg.4245 Permeases of the drug/metabolite transporter (DMT) superfamily
MDMRQTEHELEHKISAYIDALFAGVGASQQLFDLKEEITTNLNEKTLDYKNRGISEDQAF
KEAIVSLGDLSGLVAEMRQIGQDKAKQAVYSTMTARISLAGTIAGSLIILFGFFNVAMLY
FMKLDAVSISGSGIFIVAGGALLTYSLLTRETRQKYAMNKIRAGLYALSVGLLLFGMFSA
AVAGFATGEVFIAIASLMMFFLVGFGVFLFLILTGPDRRKR
>fig|272568.11.peg.1436 Outer membrane component of tripartite multidrug resistance system
MLLAAMVPAACDLAPRYAPPVAPVPASFKERDGWALAVPGDDVPKGPWWRIFHDPVLDAL
EDRVTIANQDLRVAVAQYDEARADARTAQAGYYPTLDFTGSASRSGLSRETANVFNKSTF
NSYSLGLDLQYEVDVWGRVRNTAKAGRARAQASAGDLATVDLSLHAELATDYFTLRGYDA
MQAVLDQTVGNYRHALALTQAQFDVGYAAQPDVSAATAQLDGLLTQAADNRLRRAMLEHA
IAILTGQPPATFAVAARSLDSAPPPIAPGLPVALLQRRPDIAAAERRVAAANADIGVARA
AYFPAFNINAMMGVQAAMPNHLLVAPAQAWSFGPEALLNVFDGGRRAALNAHARAVYDEE
VARYRQTVLDACRDVEDSLVSLRRLAEESATQQQAVIAAQDATHRAGELNTGGLASYYNV
ILARNIELSDRLSEVDIRVRRMTASVALIKALGGGWGG
>fig|272568.11.peg.1696 Outer membrane component of tripartite multidrug resistance system
MPHWHRGLPDAESHPEESPADPQWWTIYRDPVLTALEQQVASANLDLRASAYRLAESLAE
RRIASAAQFPHVEGNASYARERASTNGILGLLGTLERAGAGDVASGAQGFGPVAVPGTVG
NPSFNLPQYGMSASWEVDLWGHVRRQVEAANAAVKATQDMQRDVLVSLMAETAQDYLDLR
GVQAQIAIVGRNIDTARHSVVLTGLRFAQGASTQLDVADSRGQLSEFQSRLPILQSQEVH
LINALSFLVAREPGALRAQLATPAPIPPVPDAVPVGLPSELAERRPDIRMAEEQLHVATA
SIGVAVADFFPRVTLSGSLDVQALQFSGLGSWASRQYGFGPTMTLPLFEGGRLTGQLRLR
RAQQKEAAITLQRTILKAWQEIDDAMADFSAAQQQRDRLKETVAQNETAVRLAQQQYVQG
ASDFLNVLTLQNALLASQNQLVRSTTAVSVSVARLYRALGGGWEARYPVATAQRAAIRQE
GQGGRQG
>fig|272568.11.peg.1799 Outer membrane component of tripartite multidrug resistance system
MLLAATMLAGCTVGPRYQPDRMKLPPGFAEDEHAATPAEIARTNAELKDWWHRFGDAELD
RLVDRAIAGNYDLQIAGQRILAERALRDVQASAWYPQVDANTTDGDSRYSINVDNWPLRP
GDPANRPGASYLSYGVSASWQIDVFGRIRRAVEASEHAVEENVEERRAVLMTMLSSLVSD
YMVLRDTQLRLEISNRNIGVAQEAYDLTRRLYLEGVGNTLQIAQAKAELDAQQAAREPLR
THIAQITHAIDVLMGQVPGTTEAELKVARPLPQVPEFPATVPSIVLGNRPDIRRAERAYA
EATARIGVAVAQMYPNFAIPLNFNPNASAMYQVFEAGALSWQFFMLASLPLMHGGKLTGQ
IRTAQAAAEASRLTYRQTVLGAFREVEDAMAAWHDDVEHTELLHRAAEDSRLASDRARKL
YAAGLVGFLEVLTTERTALAAENAEAVARLERLQDAIDLYTAMGAGWQGVGVTASALPVS
LEKQNVLARAFQD
>fig|272568.11.peg.1809 Membrane fusion component of tripartite multidrug resistance system
MADEDRNGNRGHTDSKQKHGSPVMRGLFIGGGAVVVVFIAVVLAIIFVPTRRVWTDDAYV
TAHYTVVAPRVSGQVVAVNVTDNQSVKAGQVLVELDPRDYRTALDQARATLERDRSLVQD
AASAVTRQPSIIDESVGAAARVRAQLIFARQNAQRYANLAKTGAGSTQENQQSTATLRDM
EANLQSLEARVAAARAQLPILQARHKAAQATVDLDNARVRQAELNLSYTRIRALEDGMIG
ERSVQTGNYVSPGAALMALVPLDQIWIRANYRELALRHMRPGQPVRIHVDAYDVTLNGIV
DSIPPASGAVFAPIAPENATGNFTKIVQRLPVKIILAPNQPLAKLLRLGFSVETTVDTGF
ADVVGAQGHDAAATVTGREGAGP
>fig|272568.11.peg.1810 Inner membrane component of tripartite multidrug resistance system
MSVSPWLAVTLTLRRFSLAVPWLAVLSSSLIPLTGNLTLLYILRIFQGLSGGFTVPLLMT
TALRVLPPPIRLYGLAAYALTATFFPSLSTAFAGLWTDLVDWRFVFWQSIPLCTIAFVLL
WYGMPVEQPRHERFWRFDWQGFLLVLIGMGAFSTMLQMGDWMDWFNSPAICVMALLSGVC
IPLFVLNEWFHPLPLFKFQLLERRNFAYGASTLLTFMIISLSSSALPADFLREAAGYRPE
QTYPITLEIAAIQIVMLPLMAVLLNRKGVDSRIVSLIGMACILTACIGDFFVTSNWNRDQ
FYLWQAFQGVGNAMIVMPLLMMSTNALVPEEGPFASAMVNTPRAVAEAVGIWLIQLVHRE
RGALHSDRITDRLGQDRFQLVQGMNPVLQRPAALTPDGLPAFPGSMTALHAQVTRQTATL
TYSDDWLIIAGIVVCLMVWVCVLPVRTYPPRIVFQSK
>fig|272568.11.peg.2700 Outer membrane component of tripartite multidrug resistance system
MPPACRNWGPRRAIRASGWARRDCSRCWGGAGSGTGQPAFLVGIGGLTQGTDLYQVGFDA
SWELDLFGRVRRSVEQAHAQVAAQVARQGDARLTLQGDVVRAYLQWRAAQALLDLAGEVA
AARARAVVLRAFQRRLGLADGTDVDLARAALVRAQGQAAGFQRQAGQALNRLAILTGQPP
GALDGPLVAVRPLPDPPPRVPVVLPAALARLRPDIRAAEADLHAATAGIGAAVAQLYPDI
TLSGQVGQRTLTLGSLADWGNTFYQFGPAISLPLFQGGRLRAAIRLARARQQEAALAYRQ
RVLDALGEVEDALVALRTDGAARESDRAAMASVTDRLALARTRYRDGTGDALAVLDARAE
LGGAGQDDIQARLAVLLDVVALCKATGGGWPEAGD
>fig|272568.11.peg.2710 Outer membrane component of tripartite multidrug resistance system
MIVRSLRRTVMSGGAMLSLAALSACDLAPTYHPPTYVVPASWHGQAPFATATPADTQLPS
NWWTMLHDPQLDALEDKATAANADLQAAAERFVQARAMVMQARADLLPHFGLAFGASDNK
QSADRLFRYKGATTATDEFYGGLASWEPDFWSEIRNQVRMAKYSAQEKAADFAAARLSLQ
AELANDYVALRGYDAQDAIYRKSIAYYERAVSVTQTQLANQAAPKLDLARAQNRLYVTQA
AEMDILAEREVTEHAIAVLTNSAPSSFHIAPVDTLTFTRAAIPVGVPSDLLQRRPDIAAA
ERQMAQANRSIGVSRAAFYPHISLNANGGFDANGFDLANLANSMWSYGASASMPIFEGGL
RRAALQASWSTYRETRDHYRSSVLSAFREVEDGLSRTDRLWAENDRLKAAVSAALDMQNM
TMTLYKGGLSAYLDAIIAQEAALDAQISQVQVETRYVQAEVGLIRALGGGWNDRLLPTPD
QTMTFSILQYDGLHHPTPAGGIDTPGDTDTRYDDLTGATTLRTGTVPVSGR
>fig|272620.3.peg.1873 Glyoxalase/bleomycin resistance protein/dioxygenase
MGELSMQSVDVGFTHVAFTVRCLASSIDFYTRYTAMTIIHQREPDLPSARKVAWLSDRTR
PFALVLVQSDDPADTPLGPFGHLGVACATQAEIDEKVALARREGVLRREPEQLGDPVGYF
AFFADPDGNTLELSWGQRVGLEVILAGKPGE
>fig|272620.3.peg.2453 polymyxin resistance protein B
MEWWVKKVQDNASASLCRVVLQSGALEMIAEIEACRLRLREGDKLTPLADARYCLNNNPT
QTLKIRNATHYSSERWTNAGK
>fig|272620.3.peg.3717 Acriflavine resistance protein F (AcrF)
MSKFFIHRPVFAWVLAIIMMIAGGLAILQLPIAQYPTIAPPAVAISATYPGADAQTVQDT
VTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFKSGTDPDIAQVQVQNKLQLATPLLPQ
EVQQQGISVEKSSSSFLLVAGFISDNPTTTQDDISDYVASNVKDPISRLNGVGDVQLFGA
QYAMRVWLDGNLLNKYNLTPVDVINALQVQNDQIAAGQLGGTPALKGQQLNASIIAQTRL
KDPQEFGKVTLRVNADGSVVHLKDVARIELGGENYNVVARINGKPASGLGIKLATGANAL
DTATAIKAKLAELQPYFPQGMKVVYPYDTTPFVKISIHEVVKTLFEAIILVFLVMYLFLQ
NMRATLIPTIAVPVVLLGTFAVLSMFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
VEEKLSPKEATEKSMSQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALVLTPALCATLLKPASAEHHEKKGFFGWFNARFDRSVNHYTNSVSGILRGTGRYL
VIYLLIVVGMAVLFMRLPTSFLPDEDQGVFLTMIQLPSGATQERTQKVLDTVTDYYLHNE
KANVESVFTVNGFSFSGQGQNSGMAFVSLKPWEARSGDKNSVESIIKRATVAFSQIKDAM
VFPFNMPAIIELGTATGFDFELIDQGGLGHTALTQARNQLLGMVKQHPDQLVRVRPNGLE
DTPQFKLDVDQEKAQALGVSLSDINETISAALGGYYVNDFIDRGRVKKVYVQADAHFRML
PSDINNMYVRSANGEMVPFSAFVTSRWIYGSPRLERYNGLPSMEILGEASPGKSTGEAMA
LMETLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVM
LVVPLGVIGALLAATLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGIIE
ATLEASRMRLRPILMTSLAFILGVMPLVISHGAGSGAQNAVGTGVMGGMLTATLLAIFFV
PVFFVVVRRRFTRHAE
>fig|272620.3.peg.4282 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MGYAMARKSDPLAFGGLALLTLIWSFSWIAMKQVTSYIGAFDFTALRCIFGAVVQWIVML
IRGKALKPTPFGYTLAIALLQTCGMVGLAQWALMSGGAGKVAILSYTMPFWVVVMAALFL
GERMRRWQYIAIGVACVGLILVLQPWQLDFTSLKSALLAILSGVSWGAGAIVAKRMYTRY
PQVDLLALTTWQMLYAAVVMSVVAWLVPQQAVDWQPDVFWALAYSAILATALAWSLWLFV
LRNLPASIAGLSTLAVPVCGVLFSWWLLHENPGKVEGCGIALIVLALAMISIKRRGA
>fig|272621.3.peg.291 Multidrug resistance protein
MGVKMAEKRNKKIILMMATLLLGSFITTLAETLMNNGLPMIMEETHISQMNAQWLNTGYM
LVAGMVMPLATFFMHRFPLRHLFTATMSIFLLGSLVATFAPNFLFLLIGRLVQAMVVGIN
MPLVTNVLTIIIPAKNRGLAIGIAGIIINLGPAIGPTLSGVILEFYSWRMLFIILLPFTV
LTLICT
>fig|272621.3.peg.726 Glycopeptide antibiotics resistance protein
MLFFGPLYSFLAKQYATNINHFALVKLTLLALDKTVFYFLIFAVIRLIWLLFVRRRRSIK
SEAGVWIFAFYLILILMLTTFRDTYFPWQPNLNFSRPLSDVNLIFMKETWKMIYAPSRLD
FFYNSFGNVLCFVPFGILFPIVFSKKESFLKTTISGMFLSIGIETLQFLLMTGVSDIDDV
FFNTCGAILGYLIYILFKKR
>fig|272621.3.peg.1405 Lincomycin-resistance
MENTQMGMKARIDVKHPWLAILPLMIGSFVGMFSETSLNIALPQLMKALQVGQSSIQWLV
TGYMLVIGIILPLSSLFTKWFTTKKLVLFGLAAFIIGSLISGFGINFSMVLMGRMIQGIG
TGIILPLMFTIAMLIFPPNKLGTVNGVLALVIMFAPAIGPTLTGLILAVGSWRDIFFTFV
VFLVIAFVIGLFTLQNVSQITKPKVDFISIILSIIAFSGLIAGASFASELGWLSIQVLAC
LIGGIIALIFYVKRQLKLTVPVLNMRVFEHRNFTLGAVLVMIDFGIILSAMYLLPQYLQN
GLLVAVALTGIIMLPGGIINALVSALAGRMYDNSGAKWPTRIGFTIALIGAIMLSLVTTH
SASWYVILAHVVLMIGAPLAMSPSQTSALNSLKGLESADGSAILNTMQQIVGALATALAT
SFLTLGRNAVNGSAAFKFTNGVHYGMYFTCALAIIGMIISLFVTDDGKE
>fig|272621.3.peg.1778 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MNINFKWIIKNLPFWLLILIVITLIAGGFEGVINGIILGQFPNLVGKSGTDLILFLIRST
IIFVATYTAIVLQNIFLNMARKRLRVKLKKTMLINSFALKEDAASGLNHISNDATKIDDQ
YFAVIAGILSTGTAAVISTIYVLQVNLLMGIIFVAFSCLSLIPMLFGKNELGKLGEQWSN
ENSQMMRSASDWFKGLRDILQYQAQKPFFKRVSQDVETSENTLLKQENLQWWIQYANLLF
TVLAIIAPWAIGFYFITTHQFGVTISALLSLTLSANSVVQNFRGLMQYWAQVASTTEIRK
IKVAKYDIFKDIKTENEKPDIKFDNVSLTYKDHPIYQNLNFDLAYGKKVLLQGPSGSGKS
TLLNMVSGLLKPTRGTIKIGGEDPNPAQSVYIAQTPWLFQGTIKDNLCLGESFTDQQLLK
VLNEVGLADELGKDPLNRVIHPEQEDLSGGQKQRLVIARALLRDRPIILLDEITAALDEK
NSDDIREILYNTPKTIIESAHHINFDLIKKYGFESWKISDHQVAKS
>fig|272623.1.peg.133 Multidrug resistance efflux pump
MKESWQRNLIVLWFGTFMTGIGSSLIAPFISLYISTLGHYSKTELNIWSGLVFSSTFIVL
AIVSPLWGRLADQKGRKLMLLRASLGMAISISLMAFVTAAWQLLILRMLLGAFSGFVSNS
MALMASSAPKEKSGAVLSLLTTGSVAGTLIGPIIGGILVNITGYRRVFSVTGIIMFLVFF
LALFFVKEIFKPVEKKNMLSYKQVWEVVTHPAIIWGMFFATLITQMTNQSINPVLSLYVQ
ELMHGQGNITFMAGIVAAAPGIVTLVAAPFLGRLGDKVGQRKILGFGLFFSLIVFSITAM
TTNVWFLIVMRLLVGVSDAAILPSVQAILAKESPQAITGRIFSYNQSAQSIGAFAGPLLG
SAIAGFIDYRYVFVGSAILVVFNLINYFTHTKSLAVKN
>fig|272623.1.peg.246 Drug resistance transporter, EmrB/QacA family
MNKIQEKRSIRAFMLSNVMAGLEGSIVATALPAMMAELHGIKLMSWVVTIYMLLMAVSSP
IWTKLAERFEYKQMFVLGTLLFTIGSLGEGLAINMLMVIVARALMGLGAGVMIQLPFVIY
GMMYQADERRRVIGNTVAAYSFSTIAGPIVGGLIVTLLDWRWVFFINIPIGIYMAFIVWK
NFDLKTDHTKKSIDFAGSASLSIAVIAIMLHFQMMGNAVINLPLLLILLVVSFLFFIGFY
FAEKRAVDPIVPLELFKNPSFIAKNIMFFMQYGFFGFYTNYLPTWGQGVMGATALVGGMV
LIPSAIMLVIGTRNVNHLIQKVGEKKTIYIGFSIMVLGAIFLFSLPEHASIMMLFVATAI
LGTAFGIVNITLQVAVQESVAKHLIGAATAVNALLRTMGTTLVLSGLSIALNRTFTEATA
HNPKLTTTLLNQISDAKALKNIPVNLIAPLRHTLFNGMHLLALISGLLLFIALFVNWLDP
WKKGLE
>fig|272623.1.peg.388 Efflux pump antibiotic resistance protein
MSDRIKALIALGIFTFMSTLDGSIVNIALPTMSKELHVSTSQITWVVTIYLIVISAIVLI
FGRLGDLIGKSRIARIGWGIFILGSALAGLNFGWGLGFLLFARVIQAIGASMFMATGFGI
ISEIFPPESRARALSISAMFVSVGSIAGPALGGLILQVASWNYIFWINVPIGILAWIFGN
HALPKEKTSGKWSDIDFKGGTLMTSVIVLLFLALNFGQALGWTNPLIIIGALLGFILFGI
FILTEKKVAQPLLDLGIFKSKLFSMSIIMALFNFTVAMFSSILLPFYLQDFRNYGPGLAG
MIMMAYPVAMLIASPLAGSAADKMDKEIVTFVGISGIVLSQLGYLLINPHSAPWLVVVIL
LIQGMSMGIFQSPNNALIMETVDRKYLGIAGSVNSLARNMAFVLGTSLATLILFTAMSNQ
LGYKVTTYLHNQPDVFLHGFHVAFYFSTFLVLVTWVLGLFRLLGRKK
>fig|272623.1.peg.599 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily protein
MAFNICVNLYVKEVEKEVDFFRSIGFLEIERHKMENSDSVVISPLSDGNAFLQIWDIEFI
KKVSPEVANDKPSLLFTVYNIEEMNEKLKKITPTTSDLMDANGKKAFNFQSPSGNYYAFM
EI
>fig|272623.1.peg.624 Drug resistance transporter, EmrB/QacA subfamily
MAKSKKNEKEKLPKELTRNAWILVVGAIAPMLDSTMVNIAINKLQSDLHTSLDMIQWAIT
GYVLALAVAVPVCGYVVNHIDGKKVMQWSLLSFGLFSFLSGIAWNIDSFIIFRAVQGFSA
GFITLLMTTLLMQITPPDKLGQLMAVVSTPIILGPIIGPVLGGAIVSGANWHWIFYINIP
VVIIAVLLNHFYLSSFKPFNPKAKLDWFGTLLLAGGSVGLIYGMMKGSTNAKNFFNSQMI
TFVIIGLALFVIYGIYNRIRKNNTVLPLRFFKSKNFTAANIGIFLAGIASNGPMLLLPLF
FQNTKGFTAVEAGLMLIPQGLGMMVTRPLIGKMIDRMGARPVVLVSLAISLLGTLPFIFV
HENTNLIWLGLVLFVRGMGIGGLQMPMMTDIFIGLDKQDIPGASVGQRIIQNVGSSFGSA
VISAVVTAVVTSEIAGQMTTKLHQLAAMHTNLTPTVIAKAKTSVEKAVTLNGYQLGFLVS
SIVLIVIAIPAMFLSQKKVNK
>fig|272623.1.peg.774 Quinolone resistance protein
MTINQRTIFSGCSFKNTTFEFTDNTISEFTDCLFEKCDFSNLNFNKIGIYRSIFKSCKLL
GTDFTESHLQDLQFTENLMTYANFSGSTLKSVRFLENEAKETFFTACNFKNVELLKNQLE
AANFWETALAGIDFSTNQFERMEVTPQLAKNMKISLSQAPFFTSLFGIEII
>fig|272623.1.peg.924 Permease of the drug/metabolite transporter (DMT) superfamily
MNPLDVWYNIKMNVKKQIFKGTLYAVVAGCMWGISGIFGQLFFRDYHGSPLWITSTRLTI
AGIILLAMSFSRDHKRFFDVWKSKKNMPTLFLYVFGGVFSVQYFYYVAIQLSNSATATIL
QYTAPVFIMLYLLIFQRQVPKPKSVLFVILAMIGVFLLITDGNIKHLSISPLALVTGLLA
GVAVVIYSIIPRPLLDKYGALNMTGWGMMLAGIACNIFYPVWRIDFRIEPLSIFYVLTIS
IVGTALAFLLLLRAFQLISPLVVSVATATEPLTSVFLSIPLFGLKLTPLELLGIVMVIVS
VILLSKSEQA
>fig|272623.1.peg.1383 Drug-export protein
MNKNNHFHLLGAVIATGILSFSGVLIETAMNVTFPTLINEFGLSTSKIQWVTTIYLLVIA
ITIPLSSYFNERFSARKLFLVANLIFLVGVLTNCFSPNFAMLLFGRLLQGVGTGIGLPLM
FHLILTKAPLHKRGMMMGIGTLTTSIAPAIGPTYGGIISNSLDWRYIYIFLLPLVVISLV
LGLACLPREGEKTPKKLALRPVIALSIMFFAFISALSAEHLMTFALLFIVGLVGAFLFVQ
FNRKESLIDLGILKNHRFVALIFSLLVYQALLLGLSFVLPSFIQVSAGFSSSVAGLFMFS
GALIGAVLAPISGKVLDQIGARKPITTGLILAALGLALIFVFLPTKSLALLLGAHIVLML
GLGISYSNLMTCSLSTLATDQLSDGNALVNTLQQFIGAVATAVVATTLSIFQGLNGFKVG
TSHGTSIILALFFILIIVSLIVSFPNLKKIRANH
>fig|272623.1.peg.1519 Permease of the drug/metabolite transporter (DMT) superfamily
MTKFKGIIYASLGAAFFGISSIIAGLLFNRCSIEPGWLVTTRMLFSGLLLLAWLAITKHN
IFSVWSSVKSSLRIVAFGIFGVLFAQSSFLLSVYYGNAAIATILQSLGPSIIIIILAIKS
KAIPRRLDIIAIFLSLIGVFLLVTNGNIGELSFSASALVWGLLSALGVCAYTLIPCPLIK
EHPPLSLVAWALLIGGVISNFLHPVTNLPKNFDQTDLLLVSLIVVVGTLLAYSLYINSLK
YTEPHIVGMLGMLEPVTAILISTLFLGVSFLGFQQLGIFVVFLSLFLINFPAKKK
>fig|272623.1.peg.1580 Drug resistance transporter, EmrB/QacA family
MNTELETNTANHKISAKTRFSIVAVALVAFMGILAETSLNVTFPTLEKTFGLPLSTVQWV
TTAYLLVVAIVMPTSSYISQRFQNRTLFFSGLIFFTLGDLLSLISPNFTILMAGRLIQGI
GTGIAIPLMFNLVLTKIPRERVGLWMGFAGMILSIAPALGPTYGGLLTGTLGWRMIFAII
LIIPICLFPLGAWAIEKSEKKRPGKFDFIAFIFLSLAMTSALLALDSLSSAHFSWIWLVV
FILGLIAFIWRSKTSTLNFIDINVFKSPTFTLSVLVYCILQFVNLGINFIIPNFLQVSLG
TTSTLAGFALLPGSLIGSAAQGPIGALYDRKGAKGILYSGNTVFFIALVLLTIFTKNLTL
LGVMGLYVVFTIGRSSSFATTMTNSLAQLPHDKAASGNAWFTTTSQFAASAGTATASLIA
TKSSNLTTGTQHVFMFFLCLALLNFVFYTLILNKKIK
>fig|272623.1.peg.1822 Drug and analog sensitivity
MEFRLAKKSDAKRLLEIYKPYVEKTAITFEYEVPTIAEFEKRIEKIGSRYPYIVAIENDK
IIGYAYAGAYRERAAYDWVVELSIYLDENERQHGAGSALYQKLLTALSVLNYQRAYACIT
YPNPASVAFHKKFGFEQIGLFPKAGYKFEQWYGIVWLERSLQTTDKVTAIKLLTDLSENE
LEKILAN
>fig|272624.3.peg.3 Multidrug resistance efflux pump PmrA
MKEKFATWYKIVTKHIRFFFSYSIPMFFKKAKNYINLPIIVVGLALIIGLFHLFSYLIPF
TDNAFVVTNVTPVAADVSGFITEIYVKNGQKVKKNDPIFSVYRVPYELAYQQAMADYKEG
LKKIDVFQKQIERTVALIKATDAELEKAQFALGLKKNKNVAEAVSVLELKNLGYDVSTLS
NKRNALQQEVAVLQAKIEQQRHTVASLKAKMDNAKVNLDLTIVRAPGDGVIDNMYVSPNT
PIEIHKPVFSFIDTANYYIQANFNETDLRNVRQGDKAYIILRMYYFDKIFHGVVVNSLWA
AERQSTAPKSQIQVVTNQNEWLLLPQRFPLQIKILDPDPDYPLNPGASAYVYISTKR
>fig|272624.3.peg.105 Drug resistance transporter, Bcr/CflA
MKKNALLIVLLTWFLGNMDIHFLTPALPSLVDYFSVTPNTVQLTISLFLLGKALSMILWG
LLSERYGRKPIFIGGLLLFILSNFLIALNHSILPFLVCRFLQGISVGATLLMGRAMINDT
HNEQNATKYFAWLFTLAGLFICFLPFFGGLINSYWNWQIASLIIAAYGLLLLPLCRGLKE
TKPHYVKFPRLGHSIMVVFNHPLFVSYLLISALMMAGESAFNTSASFILIKGENFTSAQY
GTIKTTMAIMHLLGTACCGLIAKYYHSIQLTKLGVRFFIFAAFLMWLFVFSAENIYLTFI
VPMVIYYFGTGFIVASATASAVRPFPQQMALALAITLFCQFNCSAFFSFITSMIGIQQVE
TFMFLLSLVSILSFLALLKLQRMEPC
>fig|272624.3.peg.106 Multidrug resistance protein B
MNKLVQKMMLSGQFLMILALEMTNPFLPLLIAHQSNTPVPSVVIYNTLSLVLPMLANILL
TPIWGLAADRYGYKPMLMRASWALVLTQASMIFVNSVFWILIIRLLQGAFAGFLVAMQTY
ALSITEWQSKSTQLSRLQSSKAIATSTAGFLGGLALSFTNYQGLFGLATLICLGTTVVMH
YKLPSPPKQQIKKRSQTLNHSYTSKSVFFFLCVLIMLTQIAKFLPDPGFTLYLNKYCSNN
LVLIGFLYSLPAMGMLCSSVWCGKQFDYCRSQPSLVNQYLIRYSVFGAILMIIQANVDNF
YLFALIRILWGIVLAALLPALFALCSDRNLLPGYALGLANSFAKLGNLIGLLLGGLFAFY
LPYPAIFMIIAGIYSLFAIFVYGYDRLNVRQMTDFSNSYFNVKS
>fig|272624.3.peg.435 ABC transporter ATP-binding protein Uup, erythromycin resistance
MNHKPIQFKDLSLIYPHKTCFQDFSGEIHFADRIALIGRNGSGKSTLLKMLCGLFLAPAG
EIKIPHDVRFGHLPQVLENCPDLSGGQRLNRVLSKILSYEPNVLLLDEPTNHLDRRNRCS
LMRMLEHYPGTLIIASHDIELINTVTDTLWHIDLGQVTVFRGTYFDYQQILEDKKASIEQ
ELSRIVRQKKESHLALMKEQERNKRARVQGEKKITQRKWPTIRSHTKLGSAITTGNKRLS
HINYKKQQLLEELSSLNYPEVIKPKFRLKGLGHHKPLIRIQDASVAYEAVVILENIHFHL
SGCERAALYGKNASGKSTFVKAILGESQIKRTGEWAVPDCNTIGYIDQHYQHLNFNETVL
DLMRSSMPHAFHTEIRAHLNDFLFRKNEEVEIKVKNLSGGEKARLSMALIAANPPKLLIL
DEITNNVDLETRTHIIQVLREFQGAMLVISHDYDFLESIHIETRYQIHQGKIHHFNEKQL
EVVHHD
>fig|272624.3.peg.733 Permease of the drug/metabolite transporter (DMT) superfamily
MNSQEQRGSFYAILSGFLYGFIGYFGISAIHGDLSASNMLFWRFLISSIFILIVLIPQLK
NINDTYKSMFTAFLSGVLYYGLSTLLYFYASLYIGSGLSMVIFFTYPVIIMVFNYFFYSQ
TIPKIYYLAISVILIGMALLIDVNEIAFDLWGIFLGLASAFFYACYIVSSKNNEISPNVS
TLMVCLGCMTTSLIVACLDHTFKVPTSFPVWLNLFGIGLVATVIPILLMLHSLKYISSEK
ASILSVLEPVFVVIFGVVLLGEELKPWHALGIVLVLAGALITLFSHRINLNQWLGAIYKS
>fig|272624.3.peg.1081 Drug resistance transporter, Bcr/CflA family
MNSDRRFAIGIFYFADVEANALFSNTFVLLVNNDIVISLVRNHSKGYLMHQEHPGQTDTP
KIDPWLIFVILMLMALMQTTTDQYIPSLPAITTALNSTEASIQLTISMFMLGLSLSHIFY
GPLSDKIGRKPPLMFGVGLSILGSLVCFVAPNVSVLILGRFLQGFGIGCCNSVGRSLVRD
LFTDRLLAKIGSYVGVVSIFIMAASPTLGGFIQEMAGWKANFMFLFVFGILVWLLAFCIL
PETNKHLNPEATKIKVMAKNYFTLLRSKIFVGYTMCACFAFAGMVSYLTIAPFLFQNTMG
LSPLEFGRLTFFIAGAICFSGIVNSQLVMRKGISFMVCTGVLFMIVGGLSLLLITILGWS
QIYFIMISMTLFSAGAGFTFINAFAGAFHPFPQMAGTVGALYASMQDLSAALTSGFIAGI
KGYGQYSLAIILLILGLSSLVAWYYLGLQDDAISN
>fig|272624.3.peg.1220 Multidrug resistance protein
MLSVLSYRLSLLPKLSKTCYLLLLFSFLECVAGGIAYYLSLYLGTSTPLTKLQIGQVGSI
VGFGALAGALCSTYITDKLNNKNIIIASFLFLGLGFFCLPQSMSFLLISGCVFIIGFATS
IFLTTNNTLLLQNAPQDQNSLRFIQSMKIVSENLGNSFSILLIMFFAAQYYGQIFEVIGL
FFFLFALNTMKYLNVKQNSLEDSSYEEKETNQQGNNKRLYVTISAVFIVGIIYAQQRIAY
PLFLHEAFSSFTITAILFWLDPIIVSLFQVKITKIVSPLKISHQLAIGGLLLGTGLFALL
IVDSIGGAIMACLTFILGEMLFMPTSFVRCYESAGNKRKGMVAGAWRSAYSSGLIVGPVL
SGFLMEYYSYNACWILAGILGFFLFILFSVKK
>fig|272624.3.peg.1227 Permease of the drug/metabolite transporter (DMT) superfamily
MANLFSFLFLGTLGWGMSLYLMKILLVSLTPTEIVLYRMAIGAASLFILAKLFKLKTDNI
RGLILDGIIVGTFNMTLPFYLTTYAVKTVSSSLASVINGLTPLCTLILGMVFFSSKQKLG
VLNLLSIVLGFIGIIIINSDVSIYQGSAVEFIALLATTISYGVTANYFKYHARTKEPILV
SAVSAFVSAITMLIFKCATESSINSWGIPQGMNQIIALLWLGIIGSGFCLYLYCSLIQNA
GAVFASMITYLMTITGVIMGMIFLHETISHQVMIGCIFIFFSLILVNHAPLLEKILVSIS
RQISLKSARRYELNQ
>fig|272624.3.peg.1303 RND efflux membrane fusion protein, acriflavin resistance protein E
MNKRLTIMGIILLVVFGGIIAFNLIKAYMIKQFFASYAPPAVTVSSAVAQAVDWKPTIDA
VGNFVAINGVDVNSEASGNVVQIHFESGQYVEKDEPLITIDDSIDQALLKFNQSELTLKE
LSYKRQTDLFKRGATPSSSVDEAKANLQQAQAKVEQIQAQIKQKHIGAPFSGRLGIRQVN
LGQYVTPGQTSIVSLQSLDPLYLEFYLPEQYYKRIHLNQPVTFRVEEFPNILFEGVIHAV
NSKVDLTTHNVQVQALLPNCPADAIQDPTKSPLIKARKQVRGDKLIVACSTELNKQNKIR
NFVFIPGMFASIEVDQPAEPNTIIVPSTAISYSLYGNAVYIIEKSKEGKKNKDGTDQLVV
NRVFVTTGEQQGNYTVIKKGIKAGQLVVSTGDLKLQNGTPVVINNSVKLDTDSDPNQLGQ
>fig|272624.3.peg.2285 Glyoxalase/bleomycin resistance protein/dioxygenase
MTQAAFGEFCWNELATSDVKKAKDFYGKVFGWQFREIESKEMTYTLIQCNDKEMAGIWQI
PKDQQSHIPPHWMAYIYVQDVSEALKKAKQHGAQEVKGITQAGEMGRFAIIVDPTGAHVA
LWESFE
>fig|272624.3.peg.2500 Permease of the drug/metabolite transporter (DMT) superfamily
MVIDVKKSNTYFIQGMLFLIFAQIMVGINIVFSKYVLSSIPVLYILALRFTLAAVILLLL
HWLTPAKKLPMYSYFLQLKRRDWFFIFAQALSAGVLFNFLILWGLQYTDANVAGIITSAL
PAIIAIMSWLILGEKISGKKAICVGFATLGLVVIACDKLGDINVSHSFLGDALVLTSLLP
EAMYYILSKMHVNSLPVFLISSLLNGINAILLLFCLSFSTWDSFTIHTLDWLILIILGLS
SGLFYVFWYFGCQTVDGVMASLSTAIMPLATVTIAWIFLGEQLTIGQIIGMGMVILSITV
YAKR
>fig|272624.3.peg.2781 Bicyclomycin resistance protein
MFIRNLQLFIVVASCILVLIGTDILLPSLPNIAHALSVSSNEAKMLISIFMIGQFSTVLI
WGVIADRLGRRKTLFLGMLIFFIGSIFSLKADSIQLLLACRFLQGTGAVVVPVAGWALVQ
DLFPKDEGARIMTWIGTLTAVIPLFAPALGGQLDVLYGWRSNLYCIAFYSFILCVIMLFL
PRTIPVQKTTTADLKETLSIYIRIIKNKTFISYIALFGLLNCGEWCFLTVAPFYYSHAHI
AADTMGILLMITSMGFVCGSLLASRLFNRLGIDKIIALGIQLAVMSSLMLLIGEYFHWSK
YQLYNAITIGVYILSSALLWGATTSRALQCFDDCRGSASAIRSLILLCFAAFGTYSGRLV
NHNSLFPVGLFLLFMAFIAFIVFNNKELKTERHMEGIPI
>fig|272631.1.peg.1262 Probable multidrug resistance pump
MELRPFYPSVNWGYALPDSLWWIAKAWAISAACVVVLVMLSFITRWGRQYWRITRGYFIG
PQSVGVWLMLAVLLFSVVISVRLNVLFSYQSKDLYNALQAAFEGAGAQNDLVKQSGMHGF
WMSLGIFSILAVIFIARVMADIYLTQRFIIAWRMWLTNHLTTDWLDQRAYYREQFIDNTI
DNPDQRIQQDIDIFTAGAGGTPNGPSNGTGSTLLFGAVESVISVISFTAILWNLSGRLAV
FEFEIPRAMFWIVIVYVLLATIITFWIGRPLIGLNFANEKLNAAFRYALVRLRDAAEAVA
FYRGEEAERKQLEQRFTPIIDNYRRYVSRTIRFLGWNASVSQTIVPLPWILQAPRLFAGK
INLGDVGQTATAFGNIHDSLSFFRNNYAAFAAFRAAIIRLHGLVVANARSRELPHVTAKS
TNDGTVHVVAVEVRTSAGEQLIDPLDLQLNCGSSLVITGRSGVGKTTMLRSLAELWPYAS
GTLSRPDGKNETMFLSQLPYVPLGNLRGVVCYPNAPADIPEDTVRDTLTKVALNPLCDRL
DEERDWAKILSPGEQQRIAFARILLTKPKAIFLDESTSALDEGLEFALYQMLRSELPDCI
IVSVSHRRAVELLHAQQLELLGGGQWRLGPVEKEPLHV
>fig|272631.1.peg.1655 Multidrug resistance protein B
MCAAATIGAASLLGLLAGRRAGLAVDFFINVRRYLSARPWRFGLGLVLSTQGHRFDLISV
GLSESGTFLIVFRL
>fig|272843.1.peg.1049 Permease of the drug/metabolite transporter (DMT) superfamily
MTKLSIQRDNLICLSYVALMGFGFPIMRYMSIHFDTLNNNAVRFLSGGSVFILACFFYYR
AELTRVFHQPKLLLSFLLLACFMTANMYFFINGMKYTSALSGSIFGVLAMPLSIFMAAII
YQDERKKVMQIPFAVGSSILILGSLLFVLYGQHSASDSDFLLGSLFLTLAIFIQSIQNLV
VKQVARGTNVVVLSAFTAFLSGMIYLVWALKSEIIFRLAEVSIGALVELSLAGVYGMMTG
MLLAFFIVKTQGIVRFNVIQLLVPISTALVGYVTLGEVMNVYQGIGALCVLLGCILCLRI
RT
>fig|272844.1.peg.223 Multidrug resistance protein
MERDAKVLVIANAVGQLFLQFSWFVMPFYLKVLGYGMDKMGVLFSVQTFIGGLSFLLAGQ
ISLRIGYKRTLILAALLGLLGRILQVIGYNFYILILGFFLVGINMGLRDPNYSALLSEKV
KSEEERHRIFSYSFGLGTLMNAIGVLVAGYAPGYLISLGYRKEIAYRLVIALALLQFLVV
IPALMLVKDVPVKESRIKWRKDLIVRILKFSLPSAIIGLGAGITIPYMSIYFNLRFGRDI
KEISWVFFGQQLVMGLGSFILPELVRKIGAVKVITYFQWSAALLFLIFPSIPTFILASIV
YVIRSILMNIVWPVNDSFMMGFFSTEEKATAAGIRRAFSTFMRGAGNYIGGLLFAVSLSY
PFYATAILYIFATAMFYAFFIKHN
>fig|272844.1.peg.1139 Multidrug resistance protein (multidrug-ef flux transporter)
MNRNFWLFVAGRFISQLGWAIQEVALPLYVLDVTHSAKIMTLFVLADLIPSIITTPIAGV
FGDRYDRKKIMVGFDLIRGVLLFLVIAFNFLTIRCLLVVQVIMAIMNAFFSAGTGAMYPD
LVKPEELERANSIVMSASIISRLVGPAIGGFVYGFGGIKLAILMNAISFFGSGLFEIFIK
YEWKTRNIEGFSDFVRDIKEGLKFIMSNSFISTLIGLVILLNALGAPFASIIYPYAMREI
LKFSSQQFGLVESAFMLGALIGNLIVGAFLGAKAGRYIFRLFLVNGAVELIFILIISPFL
ALPRNSAFMLLLVLGATMGMAGAMINVPLASKLQRAVPSEIRGRVFSTMEMLARIANPLS
LVVVGPLVDTIGAWKTASFLWLGSGVVILYYWIFKGKELTSEEESKLVENFPGVPPED
>fig|272844.1.peg.1385 Multiple antibiotic resistance protein related
MLEVLKTFAVLYVGLFAITNPVGAVPIFMGVVSHLAPDKRHEVAEKVSITVLVTLLTFAL
VGKWIFKFFGSSVDAFAIAGGILLFRMGMEMLSGKLSSVKIDEEDVTLEEVAVIPLAIPL
ISGPGAITTVMLYMTRESPPIVIATIIAIGISVYIILASGNKIIEKLGRVGIKVTTRMMG
LILTSMAIQMIINGIKGAFGI
>fig|272844.1.peg.1459 Multidrug resistance protein
MRPRELAILQGLQEKSGKIRKITMRKNILMFAIGMFFADFAWGLGFPYLGVYMKLIGGTM
FLVGLLSVVYNLTSTIFQYPFGYLSDKTGKRKPFIILGILASGTTYGLVALITSPILLLG
LRAFQGALGASLAPAHSALISELSPRIGSMFGFFGFVENLGFMAGNFAGGYIVKTLGMKM
MFIITSLVSLIGILFLLKIKERGRAKAGGDRLIIVKEGRESDRVELKEIAFKKLMKGRLG
IFYVAVLLAMIASGAVYATVSVYFEEKFGEEFVGYLFGIDSLSAALSALIIGRLIDKYGE
KLFFRLSLVGYIITFMGYALANSVIIMALISILSGLKWTMLTNSSSTYVARRVPTSERGQ
GMGLLNTMMTLGWVIGPLIGGILADNFGFAVMLYSTVPILFLGFLLSFRI
>fig|272942.6.peg.926 Bicyclomycin resistance protein
MAFLNRKTPPHIVTLVLATGVAALSLNIFLPSLPGMARHFGVDYGLMQLAVSAYLAASAV
AQFVIGPISDRYGRRPVLLWVVAIFTLASVVALFAPNAHAFLAARFVQAVVATAFVLARA
AVRDMVPGPGAASMIGYVTMGMSLVPMIGPAVGGLLDGLFGWQANLAVLALSGALLFALV
WADMGETVSGGGLGFGAQMRAYPILLRSPRFWGYALSAAASAGLFYAYLGGAALVGEQAF
GLSPVEVGYFFALPSLGYLIGNWISGRFSLHLGMDRMVLSGTVLATAAIAVALIAKAAGV
LGPITFFTAVGVTGIGNGLSLPSANAGLMSVRADLAGTASGLGATMTIGTGAVLASLTAT
FLGAEVEVARLLWVMFGSSALSVAAILWVMRRPQ
>fig|272942.6.peg.1353 Permease of the drug/metabolite transporter (DMT) superfamily
MSDVFSAPRPRAETAAFALSALAAVFWGSNFEATRVVLQEMPPWTAAAGRFLIAALAILG
WLWLAEGSGLPALRRNWKVFLGLGVVGVAGFNAALFLGMRSSSPVTAALIMGTSPLTTTL
IEAALTRRWPKAGTLAGMAISLVGVALTVGAFSGARLAPGDGLILLGSLAWALYTVGCRR
WVVAASPLETSVWTMLAGALALLGAAFALETPVASVLAASPAAWGATLWMALAGSVLAYL
FWQVGIQIRGPGATSVLFNLVPVSALAIAALFGRTPELSQLAGVALAILGVLLASGRLTV
PRR
>fig|272943.3.peg.158 Permeases of the drug/metabolite transporter (DMT) superfamily
MENLRGIVMMVVSMAGFAMEDMFVKLAAANMPTGQILMLLGLFAAPLFWALARREGKAVL
SREALAGPILWRNGGEMVGTAGFVTALTLGQLSSVSAILQAAPLVVTFGAALFLGERVGW
RRWSAIAVGFVGVIVVIRPGLDGFDTASLWAVLGVAGLAIRDLATRRVAPSTSTMQVGAW
AFLTVAVLGAMMLAVGGGATWPTPGQAALLLGAVSFSFVGYWTLILATRVGDVSAIVPFR
YSRLVFAMLIGFLVFHERPDGWMLAGAALIIGSGLYSFMREQRLRRLSMRAAAE
>fig|272943.3.peg.289 Glyoxalase/bleomycin resistance protein/dioxygenase
MIDQCSLHVTDLERSRCFYDAALGRLGIPTGRAARSGVHWVGDGVEAFSINEIRSGRNAR
QVREAHLAFVARSRPAVDAFHAAALRAGGRNDREPGLRPEYHPNYYAALVLDPDGHRIEA
VCHTPD
>fig|272943.3.peg.399 Permeases of the drug/metabolite transporter (DMT) superfamily
MISQDRTRAAAGFILLYAVVIGFTDNYVRVIADEAGLWQFHLTRSVMALAILAAVAPALG
LRLRPVDWRAVAARSAIHGTAMLIYFGALAFLPVAQVAAGLFTAPIFVLVISRFVYGERI
GPVRVLAVLTGFAGVLLVLGPEAMAGASFAAGLPVLAGLLYGMGNIATRAWCPQESAGTL
LGGFFVALGVLGAAGLAVLALVSLPVPEGPDGFVMRGFVVPSQDFWFWTFVQAAGSLFAV
GMMIRAYQAATASRVSVFEYVILPASAIWGWLLWDERLSPVAAAGMALIALAGIAIAVGS
RPPAATATPA
>fig|272943.3.peg.447 Permeases of the drug/metabolite transporter (DMT) superfamily
MTLASLLLVVLASFIHASWNLLAKTAASVGPVFVFAYNLIACVAYAPWVLYLLIHDGIIW
TWTGIGFVLLSGLIHLAYSLCLQRGYQVADLSVVYPVARGTGPMLSTLGAFLILGETPSG
TGLIGLALVVAGILLIATRGSLAAFTRPGGQAGVRWGTATGGLIASYTVVDAFAVTALGI
APVVLDWFSNLLRFFLLLPLVIADPRRALSAMRGHWGAAIGVGLLSPLSYILVLAALTGG
APLSLVAPMREMSMMVGALLGMLILREAVGRWRLVGCAVLIAGVILLSAG
>fig|272943.3.peg.590 Multidrug resistance efflux pump
MLELLLTSFPAIFRYYQLKRRAEAMTVWNMRTAVFAWAVMAMGLFLVIFYFHPKSYSGLL
PFRTISVVAQTSGPVTEIHVENGQRVAAGDLLFKIEDSSQKARLNQAEAEFDKIAAAEIK
AQDTLRVALASVAAATSTLEKLSVDRDNARQLLTRNVGTQDTLRQTEASVAAADAEREAA
QAQADLARAELSQAIPAQHKAAEAALQVARADLAKTEVRSFSDGLVTQLALSVGSPAATL
ILSPAMLIIPDRPEDLPLRFTAGFNQVARSTLYVGMPAEIACNTNINLSFRDTVLPARIQ
AIQPAIASGQVVPGGRLLEAESGMQRGSLLVYLELIHPEQESITIDGSGCVVQTYTDNLD
GIFGHVIAATGVIKAAGLRLKVWGAMVAGVGLGGGH
>fig|272943.3.peg.631 Permeases of the drug/metabolite transporter (DMT) superfamily
MTAWILSLEGTPEGARIALLLALTSAFAHACFGALQKGRHDPWLSRGAIDSFMLLLSAPV
AVFLVPWPRGVEWLVMAGVMAIHLAYKIAMARAYSRAAYTVVYPVVRGVGPLATLAFAAL
FLGEHYVAIQWLGVAILSAAILALARLNFTASPQIGRMDLKAGLVWAFAGGLMVAIYTTF
DAWAIRLMPDPFTFLAWFFLMTSLDFPLLLGYRLLKARQMPEAAAALALRGFVGALVAFV
SFGGVMLGTRLGKVAEVSSLRETSTLFAAAIGWLLLGERSGPAKILLMGLIALGAILVQL
A
>fig|272943.3.peg.871 Permeases of the drug/metabolite transporter (DMT) superfamily
MSASARSSSEDRIPLAVTSIILTVLALSLGDALVKMTSGSFVIWQIFVVRSLILLPILMG
VALSLGCLRVPQAGIWIAVRSLMLIAMWICYYLALPNLSLSAAAAAYYTLPIFITLFSAV
FVGDSITAKGWAAVVLGFVGVLFILRPSAGDFNLYALLPLLAAMLYAGAMILTRTRCQSE
HPVILSLALNLGFIIAGGIAACLIWQLPADMRQGFLLSEWTAMGWSEWVSMGLLAASILI
GSIGAAIAYQNGPPAMIGAFDFAYVGFAVLWGIVFFNETPDLIASIGMIMIVGGGILSLR
Q
>fig|272943.3.peg.1937 Permeases of the drug/metabolite transporter (DMT) superfamily
MPAQQSLLSATFWMAGAIASFSAMAVSGRMVSGIHDTFEIMAWRSLVGLAVVLLWATLSG
RLGEIRTRHFGGHLVRNLSHFTGQNLWFWALGLIPLAQVIALEFTSPLWVILLSPFLLGE
RITSLRALSTVVGFAGILIVARPDFAALDVGVLAAAGSAVFFAGSIILTKRLTRHDSIVT
IMFWLTLIQAVLGLLCTFADGETTWPTTVSGFWLVMIGLSGLAAHLCLTQALARASAGFV
VTVDFLRLPVFAILGMILFSEPLDAMVILGGGIILAANWISIRAAGRASRPQDAR
>fig|272943.3.peg.2113 Permeases of the drug/metabolite transporter (DMT) superfamily
MTASSDRILPGVALMIAFCVLAPLLDVCAKLASATIPVGQITGARFLVQAALMLPVVALM
GTGWRMSRRMAGLVALRAIFLILSTYSFVAAVTVMPIADALAIAFVEPFILLILGRILFG
DEVGPRRIAASIVGFGGALLVIQPSLVAFGLVALWPLGTAVFFAFYMLVTRQMSRGMHPV
SMQFHTALAGVLLLVPVMAWGHAAGVPSLTLVRPDGMGWALLFGVGFWAAASHMCMTYAL
KFAPSATLAPLHYCEIVAAVGLGYLVFGDFPNLLTWAGIGTIAASGLYIIHRERLSARVL
PTPAPAP
>fig|272943.3.peg.2577 Permeases of the drug/metabolite transporter (DMT) superfamily
MAKSNTRGALLALLAFAIYATHDVVVKVLGRDYTAVQILFFATLLGFPLASMMLMRDRAD
GNLRPRHPWWVLLRTCCIVTTGLCAFYAFSVLPLAQTYAILFTMPLLVTLLAIPLLGETI
GLHRGAAIATGLLGVLIVLRPGAEPLSLGHAAALLAAVTSSLGSVIVRKIGQDERSVVLL
LYPMVANFFVLGAALPFVYRPMPVEHLGMMGIIAAFSFVAMLLTITAYRMAEAVIVAPMQ
YSQMVWAAIFGWLIFGERSDVWTWVGAGVIIASGLYIVGRESRRNVSENRPASQTRLRPE
VGLMPRLLRRRETRDTP
>fig|272943.3.peg.2642 Permeases of the drug/metabolite transporter (DMT) superfamily
MTEQNTRLGIGLMVLTTCIFALQDGISRHLAEHYSVLMVVMIRYWFFAAFVIAVAARQAG
GLAPAIRSRFPVLQVLRGLLLAAEVCVMVVGFVKLGLVASHAVFICYPLLVAALSGPVLG
ETVGWRRWLAIGAGFVGILIILQPGLAVFSPWALVPLAAATLFATYALLTRYVARGDSAA
VSFFWTGTVGAVAMTAVGLWHWEPMAPGDWFWMAALCCTAALGHWCLIRAYEVAEASAVQ
PFAYLQLPFAAMLGFFVFDERPGWNVVLGACVVVSAGLFTLWREQVRARARAGR
>fig|272943.3.peg.2680 Permeases of the drug/metabolite transporter (DMT) superfamily
MSLFVLLAVLGAAFLHASWNAIIKVGTSKVAAMVILSVAEVPIGLAIALTRPWPAAEVWP
WVLAAGCCHFAYKSFLTFAYEHGDLSRVYPIARGAAPMAVALVGAFALSDAVTAGQYAGI
AVLGAGILLMARGVFTSGEERRLLPFALGSAAATACYTMIDGLGARVSGDAVAYVAWVFV
ADGLIFGTGMVAWKGTALLRADARAWASGTAACAASYGAYAISIWAMTVAPIAVVAALRE
TSILFAVLIGWLVFGERMTRDKAMASALIVAGVMLTRL
>fig|272943.3.peg.2904 Permeases of the drug/metabolite transporter (DMT) superfamily
MAQARRLVRPLDAAGLAIMLGLCLVWGFQQVAMKAMAGAADPLLQVAVRSSGSAVLVWAY
SRFWRRDRWLAGLTWREGLLVGALFGVEYLFVGIGLRHVGSGLMSILLYTAPLFVAVSLH
LTLREERLTGRQWIGCLLSFAGVVVIFLRPGEALRGEEGAALLLAGSLCALLAGFCWGMT
TVAVRLTRLSGAPFAQTLFYQLLGGALCAWPVVLAEGRTGWAGGLDLWLLTFYQTVIVCF
ASYLVWFWLLQRYLASRLGAMSLLSPVFAAALGAALLREPLTPGFLLATALIVAGLVTVM
LHDRRERPRLLPPR
>fig|272943.3.peg.2916 Permeases of the drug/metabolite transporter (DMT) superfamily
MSARPAVPSRTRTLEGVLWMLASGVSFVGVTGIVRYLGTDIPAAQGAFLRFAFGALFLLP
TLVPVLRQGVPMSTLKLYGLRGAFHTAAVICWFYAMARIPVAEVTAIGYLNPVLVTVGAA
LFFSERLALRRILAVAVALVGALIVLRPGLRELSAGHLSQLCAATLFAGSYLLARRLSDV
AGAGAIVAMMSATVTLGLLPFALLVWVPVGVDQLLWLALVAVFATAGHYCMTRAFGAAPL
TVTQPVTFLQLLWATLLGALAFGERVDPFVLLGGGIIISAISYITWRESVLKRRASAVAL
ENT
>fig|272943.3.peg.3276 Probable antibiotic-resistance protein
MLIDFSSRPPHPDFSPPAPHLQNYRRVYQASERRSAASDAAQGLDSWLETYERLGARHVV
LKARDLTTTFGFRISNEAVAEFIRAHGPRYVGFAGVDPWQEDAVDHFDHAIRHLGLRGLN
LQCFELKMRPDDERLFPLYEKAIELDVPVNIHCGINFSTHTPMALGRPEYLDNVMVRYPE
LRAVASPPGWPWVQELIGVAWRHPNLSIGLLAVRPKLLAKAHSGYEPLLQYGRTLLKEKI
IFGSAFPMMPVETALAELDALGLDADTRRLWLHDNAARLLGLDTAAT
>fig|272943.3.peg.3688 Permeases of the drug/metabolite transporter (DMT) superfamily
MPSRSLSLLCVILAAVLWGTTGTVQSLLPPEREPLIVAAIRLAVGATLLTLMALRLPESR
RAFRRLPWRPVLVAGLAIGLYNLLFFVAVTQAGVGVGTAIAIGSAPVWVTLYEAAVLRRL
PTGVRAAGQVLSVLGAALLVAGAGAGSASLTGAALAAAAGAAYATYSVATSRVGAQVPSD
TLAAATFGVAMLLAAPALFLLPVSWVADLRAWPALLFLGAVTTGVAYALFTRGLAGLATS
TAVTLSLVEPLTAWILAIVVLGEAVTAQRLLGAALLFAGLAIVTLAPARPAVRATRGENQ
RAGTSRG
>fig|273057.1.peg.498 Multidrug resistance related protein
MGLKQTLKEIYYIVADKRLLYFSLSLGISTFAYSLLTYYFPIIMTNLDITTFTIGIIYSI
ISFLYVVFNIPLGAIVDKIGSKNAVTLSALMAVPLFLLMGTLNPLLFIISLVIFESVIRI
VNSLGAHRFMLNYTNAGKAFGVFSLITSILAAIGIMLGGYLLQHSVSTLLFTIIAVLFGI
SGIIRFLELPKDENKVEVKRSLRLGFKYLKEDKKLLLYLLVSILSSGLSLETYYVTIYFV
KDLLLPLTFVGVLYSSYALIMAFLPLLFSVILSKRSNFKNLSILIFSNSVIFFLVPLFTN
VYILFLLFYAWTVIVAMESIVDYNVAQSVTKPEIRGTQVALISTFVRIFSVFYNAIVGLL
FQITPLYSFYFTGFLGILAIFTIKFAEFIGVLK
>fig|273057.1.peg.551 Multiple antibiotic resistance protein MarC
MSELVSIPEIAFKLYAIMDPLSILPYLIALYEEFNRNSQNKISWRFLVNKLSIAVTVLLL
FFSILGGPLLAFLGISVSALEIGGGIILVYLGVDTLGGFQQLKFLSSRIEEAIITPIATP
LIVGPGTMTGLITLSVSNNLIILILGSLLAALLVYLSLLLGPIIIRILGNTGTVAVGRFM
AIIIAAFGVQLIIDGISQIKLI
>fig|273057.1.peg.897 Fosmidomycin resistance protein
MKIRILTLTSLSHFINDGNSWVLPVTFIFLITYLGISKFLIGILSGAFFFGISALASPLV
SKIADKFTNYSSIMGIGILLWGIGLISFGYSIQLHFLPLVFISVAIAGFASAFYHPIGAA
VLSITYKGNAGIALGINGSMGSLGRAIYPTLTLSLFAILNKDMTLDMLIIGIISIIAALP
SIFLKISITKEEDHKTPSSSNTTSTRGTLFVVILLTIIALLRSIFGQGISQFLPTLLVEN
YGYSYNVNLGEAITIALAAAIVGQPILGFLSDRVGRRLIYAISTFGAALTLLLFLKIPNI
ALLSLFGFFNFSAFPLMLSIVGDFVPRNSASFANSLVWGLGVTGGGVIGPIVVGAVSQVS
NLVFASEIVTIMAFVAGALTALIPKPPKRTKVPLFG
>fig|273057.1.peg.1024 Multidrug resistance protein
MLKNRNEVLKISFSAFFADLGYQAVVASFPIIFVLIFKAPIPLYGFAEALNYGIGTVMAY
AGGLAGDRFGRKRIAILGNVLILFTSLIGLSRDYIQALIFFMIGWWFRNFRSPPRRAMMA
EVTSPEERSEAFGILHSLDIAGALIAIIYLTVLLYLRVSIFFVLLFTSIPLLMSTIVLTM
VNAGKKSEKAKRKEAESKITQKRVFWTLILSTMFFGFSQYSFGFPILTTTEITGKEYLGV
LSYGIFLGASSLFGYLFGRIRMKEFESLAFLGYLIGALGSLGFAYLSSFGVFSLYPLSFL
MGTSVASTETFEPTIISKITKEEAFSTSMGYLSAGRSIGIFLGNVIMGFLYQISYTYAYL
FAAITSLISFALILNLIMRPNAS
>fig|273057.1.peg.1190 Antibiotic ABC transporter ATP binding protein
MIVVSNIVKKYGNKIALDNVSLEVKKREFVSLIGPNGAGKTTLIRILLTLMKPDRGEVQI
LGENPFKSKRIFKEVGYVQEIPNYPPFLTGKQVLELSAKIRGVDKSEVNRVLEFVEMENY
ANNPIVKYSKGMVQRIAIAEALLGNPSILIMDEPNMGIDPIFSLKTRELLNKLKRKDNVS
ILMTSHELEDVKKLSDRIFMIYKGKIVFSGTVEDMVKEFLGIQVVVETDEIEKAEGVLKG
IEYVKGIFNDGNRLIAKLNEDRREELLKDLVTSGVKVKGFYIDLNLEEAYMRALGNV
>fig|273057.1.peg.1389 Multidrug resistance transporter related protein
MERAFLRYVPILAFITIMTMYVEMVILPSLPEIENQFSITSSEASWVLSSETLAGMTLAP
FLGKLADSYGRKKVLISILVVYILSVFLTAISPNYSILLISRSIQGIGLSINPIAYTILR
ERIPDRELPIAQGIIASTFAIGAAVALPIGSYISQYFSWEFAYETAIPLLILSTIIIYVI
LPSSESKGSDRKIDDVGVILLSLSFLILGIGLTEAPTWGWTSLQFFTSLLLSILLFYLFA
LHISKSRNPIIDPYDFKNPNVAVPLISSFITGFGLFLTFQSLVFIFELPSPIGYGMTILQ
TGETMAPIALIILIAGPFFGRLVTKIGYMKVILTSSSVSSFLLLFLAYIISLRISVLELM
GFLSLILFFISGMNVTRVTLLIASSKRERMSTLTGTNTSMRLMGNTLGPIVVGSLEDTFK
TPIFEGYLNNIPIFAFVPSRLAFEYAFLISMATTVLVTILATRIRERPSTTTYA
>fig|273057.1.peg.1734 Multidrug resistance protein
MDPKGTMRTLITLTLMLTLVNYVETMVIPALPKIEDQFSTTATTVAWVTSAYLIVGAIAS
PLFGKLGDRYGKKKVYLLSIGFYSLAVLLAGFSTNIYFLIFARAIQGLGYATFPLAIAII
TDLFPKERVAWAQGILSATLAAGPALGLLVGSYIVQDLGWPYAFHTAFILSIILVIVSAK
YIVEIPQKTKEKIDYLGATFLMLTVVPLLVYLSNGPNVGWTSTSQFLLIVISIIAFPIFL
WVEGRTNEPLMRLDLFRIRNIMVANIAGLISGAGMFLMFTGLVYYLQLPKPYGLGLSIIE
SGLLMAPVALVMMIVGPIVGRLINNIGPKPLLMIGSIISIVGYLLLDTFRYSIYEVVVDV
MITAVGLVNIMIPLVNMVAVSLPEEQRGIGIGMNTLIRTIGSSIGPVISTVFMDTYTTWI
IYDFNNQIVPVAQVPSYSAFHYMYTAAVGIMFLNLIVALFTRNYVIKAGQHA
>fig|273057.1.peg.2022 Multidrug resistance protein
MKGIKIIVARVIYAIHWFYLAPLIPFLAGKLNLSLQIVGLIPLSFFLGSGIMQIPSAFLS
TRIGLRNTLLLGLFIMSISPLLIPLSSNFIELLIFYLMDGVGASMFFSTGGGILASLNRD
SPSLALGLYNASFAVGGLIGLNWYIVFGNYLSFYILSILTFLSLIINVNNSNLKPCWRII
RDNRIVILGISIAGIWGVYYVIGELYPTFAYYYLHLNLIDSSLFTSLLLVSSVIGGSLTF
LADRKIKKFNLLIISSLLGSVPSLLLYTKVYLLGIVITGIFNELAISVLYSIIASLQRDA
NATMGLALVNSLNILIGMNFELLASYSGYYMWIAVNIIGLLLFSLIVLVRQNISI
>fig|273057.1.peg.2459 Permease, multidrug resistance protein
MNTNSILIVLTLGSLMAAVDTTIVLLALPTITSSLHTDLLSSIWVLLAYMIVISVLSTQA
GRIGDLFGKGKIYNLGFVIFTAASALCGISSNIDMLIVFRIIQAIGGSMLVANSSSIVAD
VFPPNRRGKAYGITSLGWNIGALVGIVLGGVLTTFFGWQYIFYINVPIGIVAVLLGVMNI
KDINKVNTKLDMLGAILLGISLALISLSLMFIAASGISTDNIIELALGVALIPFFLLNET
RSKYPILNLKIFKIRLLTYSILANFLQGIGGLSLSFLLIMYLQGVRGLSPLDSSLLLTPG
YVIASILAPFMGRVADRGKPGIVAGIGLMFIFITMILYFFLLTPTTDYYLIVGISAITGI
GSAMFWPSNSTAIMFHAPKEYYGSVSGLSRTLGNIGTILSYVLSIVVATLSIPRSVAFEI
FIGTTTLNGDVSVTFVNGLHFAFLISSIIIVVAMIFSFMSGKTQESAIK
>fig|273057.1.peg.2489 Multidrug resistance protein
MWLKQVMIKYKDTRWMYLIIPYNASTGPLSTLVTLQILSLGGNAINVAYAISLSNAVLIP
ASILWGFMADRMDRKKQILLSLAGVSIPLVFMPFMNSISLVTLNYALITFMSTASATPFN
LLIMESVEKKHWGSLFSRFSLFSSIGVLLGLVISTFLVILLRIDQIEEILGFSVLATLIA
SIKILPKPIITFERTAIIHHKESFLTRMRHLPMMFLHLPNIHHFKMFSMTRLFRKPINYV
PLLYLGIVLFYISSGIFNTVYPAGLYVKGLNKSEVLAVISVGMVFQILGFRISSMLLESK
DEKGLAHISLILRGVSYVVLGIFAQLFLGIPIFISGLIFYPLAAGIAYAIFYSSSTTLIF
KIVGERRQGTGLGVYSTVVGISLFLGSLLSGYITHYISYGIDFITAGIILLFASWIFRYL
EEG
>fig|273057.1.peg.2608 Permease of the drug/metabolite transporter (DMT) superfamily
MKILKYLLPYVTITSFNYYFAKDAITFSSPIFFNLIRYVISSIIFLSISRGKILFNRDVI
QLAVYTTVSSLLWAYGLLYVSPAESAVLSYTMPLFSIPISFIILLERPAVLEIVGVVIGF
SGVILYGLPLVHGLTLFGSIITIVNALFWGLFTVFYRKLKGYDPITVNASQFSIGSIILA
LLLPIHHNIDPNPEFYIGIAYTSTLGGAISFFLWNMMVKAEKIPKVTVLSFSVPILTTLV
EFLLYHVLPFPIQLFGIFLMFLGILISRSRTLLS
>fig|273063.1.peg.2348 Permease of the drug/metabolite transporter (DMT) superfamily
MLVWSSAYPLIKIALQYMSPIILAIIRLLVGGLILLIYGKGIIYGLKEFIGSLLNVAIFM
ILLNLGVLLSPNPALSATLIYTQPVFVAIFSYFIFKEKIGILKIFGIIIAISGAIIASGN
LEVNIGALISLLGGITWAVGTIYYRKYLINEDVIRLNSFFALSSVPVLVPLIPFQFYFKV
SLEGIVVAIIIGITAQALGFIFWFSSVKNLGAFKASSISLLVPALSYFFSYIILGDMPTL
IEMIGSFLVLFGVLLTNLKISNFSSRF
>fig|273068.3.peg.314 Permease of the drug/metabolite transporter (DMT) superfamily
MSKQLQSDIVLTLVTMIWGSTFIIVKNAIQSLPVYNFLFIRFLLAFLLLAAIFYKKLKKI
DKSTLMAASLIGTMLFLGYAFQTMGLLYTTASKSGFITGFSVVLVPILEAILLKRKPTKA
ATVGVVLAFIGLILLTTNIDLSINIGDFLTLLCAFAFAMHIVLISKYASKMDTYLLATVQ
IGMVALLSGIVSLIFEKPFIPTSLDVWGAIIITGVFATAFAFVAQNTMQAYTTATHTALI
FSLEPVFAALAAYLIAGETMSIRAIIGGAFMLAGIILSELPEKEPEKR
>fig|273068.3.peg.1085 Multidrug resistance ABC transporter ATP-binding and permease protein
MEYQQEEIMAKPFDWKIMKRLLTYAKPYWFYILIGVIAILLVTVSNLLRPYLVQQAIDNY
INNPHISKEQAIQGVIRIGSLYIVIITVAFLINYGQVYLIQYTGQKIIFNLRQQIFEHLQ
KLSLSFFDRNPVGRLVTRVTNDTDTLNEMYTSVITNLFNDVFIIAGIVIAMVSYNLKLAF
IALSTTPLILTGMYIYRKLASQAYRLVRVRLARINAFLSEHISGMKIVQLFVTENKKMEE
FKKINKEYYDANMRQLTIFAIFRPSMDVIYSLTLALLIWYGGRDIIAGKIEFGVLYAFVN
YLQQLFQPIFDISEKYDILQSAMASAERIFILLDTKEEVKDPEDPIPLEEVKGKIEFKNV
WFSYNGKEWVLKDVSFEVNPGETVAFVGATGAGKTSIINLLCRFYDIQKGEILIDGIDIR
KVRQQDLRKHIGIVLQDVFLFTGDIKSNIRLNNKNITDNDIYRVAKYVNAHQFIKKLPEG
YNSKVTERGSTLSAGQRQLLAFARALAFNPKILVLDEATANIDTETERLIQDALEKLTKG
RTTLVIAHRLSTIQHADKIIVLHKGRIREIGTHQELLQKKGLYYNLYMLQYKDQLSESKI
S
>fig|273068.3.peg.1086 Multidrug resistance ABC transporter ATP-binding and permease protein
MKSFTTVIPFIKRHKWDYIIGIIFLLGVDLLQMIIPHLLGSVTDLFKSKDLTPKILLNYS
LWIIGISLLVFAFRFIWRIKIMGMSRLLEKDLREDLFSKLLTLSPQYYHEHKTGDLMAHA
TNDINAIRMAAGPGIIMSIDASFLSITIILIMIFTINFKLTLFALLPLPVLALVVNRFGK
IIHARFTKVQEAFASLTDKVQESISGIRVIKAFVQEKEEIENFRQENFRNFLANMNMIKI
WGLFDPAVQFLAALSFTIALLYGGTQVIRGVISLGEFVAFTAYLGMLIWPMMAFGWVINI
FQRGAASMERINVILNEVPEITDKFADPNITTIKGDIEIKNLTFSYKKDLPPVLKNINLK
IPRGKTLAIIGKTGSGKSTLVNLIARLYTVPCDKIFIDGHDINEIPLKVLRENIGFVPQD
NFIFSDTIANNIAFTKEEPLEKIQKFAEMADVHKDIVEFPQQYDTVVGERGVTLSGGQKQ
RIAIARALIKDPKILILDDSLSAVDTNTEERILNNLKEFMKDRTTIIVSHRISTIKNADE
IIVLDEGEIVERGTHEELLNLKGLYYSIYEKQQLEEAIQKEG
>fig|273068.3.peg.1300 Vancomycin B-type resistance protein VanW
MQAKGGSNKNKKRNYFYLVTVLALAVFLSFAFAYFYVLLTSSYIAKGVFIEGINVGGMER
EEALSIIKEKFKVPKFSIVAFYEGQSFEITTEDIGLQYNYEEVVNKAYEVGRNGNVLDRI
REIYTVGREGRNYNLSLSYDEKPLKEFIDRIAEKIDKKPENASIRIVRGVKSITPEKLGF
KVDKEKTLSNIVDELSKAIENKLFGRVEVEVSVKKVLPQVTKSMLDSINGRISTFSTVFN
AEDVNRSDNLVVASRAINGTLLLPGEVFSLNKALGPRVIERGYKEAPVIIDNKLVPALGG
GICQVATTLYNAVLRADITVVERYHHSFPVAYVPPGQDATISGDVLDLKFKNSTQYPIYI
ESYIEGNRLIINLYGHVENPSRWVDIQSEIVEKYEPSVKYIEDPNLHEGEVIEEVKPQTG
YKVNVYRLTYENGKLVKKEFLYRDLYKPVDGVIKKGTKKVPKENNPLKATSPVVPPTDTS
PPPDTSTEESPAN
>fig|273068.3.peg.2136 Permeases of the drug/metabolite transporter (DMT) superfamily
MRRGEVLALSAGALWGTTGLFVRMIVKLGFTTADVAFLRMFFGALLAFSIIAVLRQSFSL
PLWSWKYLLGTGILSLTLFNWSYFQAIKLTTLPIAVALLYTAPAFVVVLARIFYGERITL
RKSIALILTLTGVLLVSGALRSFITGEEISWLGVLYGLLSAVGYGLYTIFAKPLSGHIPP
ERIAAFTFLIATIALVPISSVLAKPSIFFNTHVILLGFLFGAFSTALPYFLYTRALTFME
AGRAAIFTTMEPVVATLIGVFVLKEPFNLFEFLGITCIISAVILLSLSDKVSTPNIDN
>fig|273075.1.peg.149 Multidrug resistance protein B
MPEPAFTYRSILLRKQIQAVSGAQFIRVLARSQIWIFIPVYLTKVRDLPVYFSGILFLLT
AMIALPISVYGGNLVDTIGRRKVSLAVPVLLFALMIITALSILYRSSIVFIVIEFLSIEP
ISVIQWIADNAIVSDVTGIGERTGSFGILRIAGNLGFSADPAIGGFLAGYSYAYIFLFGA
AGAVIELLLYYHLVNETGKLRTGSGKFSMPLSDRYFVVVAIMIGVTYFVSGQWGTTLTLF
LSVIYGISNNMIGILYSINGITVILLQMPIIRMIERINGFWQLALGTIVYGFGFFVLALT
HSFLLLGLDIVFITIGENILAPVTNSIISKIAPEDRRGEYFGSAQLISGFISPLAPVMGT
LLIYRNANDPLMVWSPVLGIAILASISIIIAGNRLMKSIQAHV
>fig|273075.1.peg.156 Multidrug resistance protein
MPDNRWFASYLMSSMASGITNPMIPLFVVVYLHSNVFFVGLASAVSSAASVPALILWGDL
SDAVSKRKIFVLIGFFGAFVSFLPIVFVHSIYQYLAILITFQVLAMASVPVSTIMLLEQN
DRSVWPQIISKFSMVSGIGSVLGLGLGTALITFYYSPSDLPYVYIVSSAVYLIAGIMALR
FIHEPRRILNRNAIQANTFRIIERPRYFPVAVIHYLRLNGKNNGHRLDRNLVLFIAMTAF
LMFGFQIFFVPYPVMVIDFGANNTLIFLMYMFNSAFSTVSFIFSGRIVNRIGGKTSLFLA
VTTRIMVFGLSSLIPNISSRDLAIISAVSIYSFLGGIWSIISVSQTNYVSKNATQQTRGK
AIGLYNSLLGVGQIFGGLVSGEVTTLFGYSIDYIMAAAVITIGMVIILRIYRGERLFLTG
MRPMAKA
>fig|273075.1.peg.221 Permease of the drug/metabolite transporter (DMT) superfamily
MQKNGEPVLFFFMAFFWGLNYIMVKYAYVYDVSSSILLMRVLYALVFSAIIFVRQIRFPR
TPMEHLKVFVLSNLNITAFFALWFFGETGVSASLTSIVIYSYPIMSLVASYALLNDRFGR
GKAMGIALGFAGLIIIFFRSINVSNYIDLIMLILAALSWAMGTVFYRKFLTGYDSAGLNT
LQLLYAMPAVILIAFMTGGINRNLMIPQFNLIMLYMGSLGTAVAYFIFLTLYRRYRVSDI
SAFFFIVPAISVILSVILLHEAVSRIMLIGFAVMSVGIYLSGRLR
>fig|273075.1.peg.410 Multidrug resistance protein B
MVQYKWVALSNTTIGVLMASINGTIMMISLPAIFRGINLNPFLPSSFQYLLWILMGYMVV
TAVLLVTVGRLSDMYGRVRLFNLGFAIFTAGSILLFLTPGHGTSAAMYMIMFRMVQAVGA
SFLFANSAAIITDAFPSNERGKAMGINQIAGLAGSLIGLILGGILATINWRYVFLVSVPV
GALGTIWSYLKLKDQSVRRKDEKIDLPGNVTFAAGLTLILIGITYGLMPYGSSSMGWSSP
WVISAMASGAAMLVAFPFIELHVDQPMFNMHLFKYRGFTFGNFAGFFQSMGMGGVMFMVI
ILLQGIWLPLHGYSYSSVPFWAGIYTIPMMAGFVLFGPIAGALSDRIGARLLTTLGMSVS
AVAFILLTLFPYNFSYPPFAATLFMMGSGMGLFGAPNITAVMNSLPPHYRGTGSGMRATL
QNTGQTASMGIFFSIVLITLTAYLSSSFNTALAAAGASVLIPVFDKIPATSALFSAFLGY
NPMQTILGLLPASFASLISPSSLAILEGTHWFPLALAPAFMKALHASFYAGAGILVVAAL
LSAFRGKRFVYGEETELKEKMQQTTEAKLSSQLEVMRDGKK
>fig|273075.1.peg.509 Multidrug resistance protein related protein
MLLRLVLSIIVNNERFSSLIGDRNVSLIGIIEGIRTFAAFLPIPVFSIYALRFTSSGLLA
GLAMGVYGIAMIFSQIMMGSLSDIIGRKRVSMVSSVLFSLGNLISWHPFSIQILVFSRLL
AGLGAISSPLMALLNERSDMDERTSRMAFVGTLSGLGIVIGVIAGPEISTYIGIDTIFLF
SAILGFISLLPILMLAEDRVTVRRRLKIKWDPSFTFSSFVSSFILFAIFFFLPIYWMSRS
QILPYGSFIAISLVAAGSIGILISIKFGMLSRITAITLTLFAVSSLAMFYFSEYPYAVMS
GFFIFAIGYTIFEISFIPLLIKEHGGDYGSLIGFFNGGRYAGEFAGSLTMGALIKNPIDL
HGLHLLFLAIVFMITLSILLLKIRFSKYGNVFNIHN
>fig|273075.1.peg.605 Multidrug resistance protein related protein
MDSYKIIAITVTSIGSLLAVINSTSLLISLPTIMISLHTTFFFVIWILVIYPLVMTIGAP
LFGRYSDFVGRNRLYALGYLFFISGSIIASLSPDVMILLVARLLQGVGGALLFSNSLAII
ADAFRQDELKWAIGTNSLVIGIATAIGPLVGGILTAINWRYVFAFNVPFGIAGYVMALKL
REIEKRKVKINWKPAIFFSTFIVFIVIYLTFSPPNLWLNPVEVIYLLISVVSFVLFIFLS
RGGDDSLIDISLFRIRSFATQSVATFLNSITRYSALLIAIIMLQGPLGISPLESSIMVIP
YAVSLSLSSYLVGNINTKRFEGHLIYAGLFLSFFGSVVLSLVRNVNVPFYLGLVMVGFGI
GLFYTPSNAILMSTAPPDRRGSAAGIRTVILNLGSVIGMSMVFTIVALYVPETALSSAFL
GIKIPGFEAVKLSFLKGISITFLVSGMASLLAFLAVLGEKLAETNKK
>fig|273075.1.peg.720 ATP-binding protein related resistance protein
MENGNLLEVRNLSKIYPGGSGVRNASIKIRYGSIHALLGNNGAGKSTTMKCITGLLEPDS
IEISFRGTTYPWNSKDLKKHIGYVPELPAFPKVFTVHDCIVSYGRMMGLGKAEAVGRAMP
IVSILGLEEHMKKRVSSLSRGMLQKLDIVIALLSDPDVIIMDEPTAGLDVSAVEELFGII
RSLRDRGKSILISSHQLRDIETISDSVTVMDSGHVIFDGSIKDLYASAGSVEVVAEFSRI
DGKLMETIKRMQGVMDVRMEDVPNRISIAFSGSTDPCGYLRDLAFRDGVSLISCSRSQSD
LRTAFIRMVEYVRGQRKDQ
>fig|273075.1.peg.777 Multidrug resistance protein related protein
MPSGYRHGYQDRKELLAICMDVTSGVAKLHGTPSIRGRGPILLTTSIGSFLTPFLSSAAA
FAVPSIGRYFHLSFIQAAIIPMVLLIPLASMMIFLGKFADAVGRVLIFRMGFMVFMAFSL
VAAFSRSYTMLLASLFMVGFGSAALSTNGTAIVSYIFSRGGRGFALGINAMAVYLGLTFA
PFLGGTLIEAYDWQSVFYFSAGMAVVGYAVSMFSLRSIDMRGRRSREIPQAGLFMASLLS
ITSFAALGYFFGYLRLIYLIVIGLILLGIFVYREIRSDVQVIPRQMVSGNRTFVASNITA
LLNYLSTFSIVFVFSIYLQAILRITPFISGLIILPEPVMMVLLSPVAGRLSDRYGSRVIA
SLGMIIIGASFIYLFVYAGRDIRVIMASLAVIGVGFGLFSAPNTNSVMSSIDPMFSGIGS
GFLGTMRFLGQLFSIIMASSILSSYIPRELVSGIFSGAVVSIDPAYAADFVHGFRIVMIV
SGILSLAGAYTSLLKNRGR
>fig|273075.1.peg.913 Multidrug resistance protein NorA related protein
MDYKPKAYSIIFARSLYALNWFDIAPALKYISIDLNINVIKIGLVTTSFYIGLALFQLVG
GSLAHRIGNLVVSVTGLTILGLAGIFSGLSGNFIELSVSRFMAGAGSALFFSPALGIISD
IVPVDRYGSYVSVYNGAFSFGAGTGIFAFGYLDTVSGWRISLVIGGALLLIADLAMFLMI
RGGNTKVRRPMKELITAVKKPEIWILPVVTVGSAISETIMGQLFVYYLEEYRHFPAITAS
AAGSFFLFVGLPGGFISAYIIRRYSKKIQVASLLAVMGLIFFLVPFEVNIIEILTTLFAF
SVLSIYGFSYLYMEASMINKSAVSFSLSIVNFVQMMISSAIPYLYTYAIYSISIMLAGIC
WA
>fig|273075.1.peg.990 Permease of the drug/metabolite transporter (DMT) superfamily
MKEIKYLIPYVLISSFSYYFAKNGVDQVSPAIFMSMRYFIAGLTLLPFAKHLKFSWSILI
LSIMTSTSTALWAYGLIYVSPAESAILSYSMPVFSLPIAFLMVKEKPSAIEIAGISIGFA
GVILYGMPLMHGFTLFGAILTIANAVFWALFTVYYRKLKEEDPVSINTMQFFIGGAILLA
YIPFDTRFDPGLSFVADVLWMALLGGSVQFILWNVMIKMSSVNKITVLAFSVPIFTMILS
IFIDHEIPNIMEIAGVIVMFTGIFLSRLKGGISVVKETST
>fig|273075.1.peg.1016 Fosmidomycin resistance protein
MDTNIAFSGEAKIRSLVYTSLGHFTNDFNILLFSVLITYYHSDFGISLALLGAVAIIYSI
ISGLLSTPVGRYADKTRRYRFLMMVGFIILGVSIYLFALSFVSARIALPVMIVASILFGF
GQAFYHPLGSSILNLTYGNGSASALGINGAFGSIGRSALPVILVPLIILVGEKYALVILG
TYMILAGIIIYAGLGFIREHEIPEKSRSASSSKNRDMLSRYSGVLAIIVAMVFIRAMFLT
GTTTYISQFVLDRVKSETIMSIVLTVSFLTAVGGQPYFGRLTQRHGGKVTIGLTTGLSTL
FFIFFMLAGTNPIINTVTYALYVFTAFSGFPVLMGYVNQIVPRDISTTAGGMVWGLGNTV
GGGIGIAVISVLLYFHITLAETMWIMTIFGAVSLVLFPFIPSKDAAARLKASST
>fig|273075.1.peg.1044 Multidrug resistance protein B
MRSMMSNHSARTIAISAFAGLLVTYVETMITPALPILVSFFDTNYDHLSWIITAYIISGT
VSSAIFGRLADMYGKKNIFVILAVFYTIAVSFGGFARTLEELIIIRTVQGIGMGMFPVSF
ALINDQVPKHRLALAQGIVSSTFSGGAAIGLVAGAWITQNYGWQWSYHSSIPVAVLLVIV
ASIYLHDESERKPAKIDFIGVGSLGLAIVSFILAISEGEYWGWASPSIIGLFLFSAAMFA
AFVLYERNTPEPFIRMDLLRIRNVLLANMTGLFAMSGMFFLFYTVPALLQDPEPTGFGIS
IVESGLILLPAAVLNMALAPLAAKITTSRGPKTAIIIGLFILLFSYLGLYYNRSSIIAIL
EDSAVMGMGISFIFVGIINILLISVPRDRSGESTGMNVVFRNIGTSLAPAIGGVMETMFV
TYVIVGAIPVKFHGLPITPIMENFPSSEAYDAIYVIGMAFVVIAMILSMFMKNVIVGGEK
R
>fig|273075.1.peg.1051 Multidrug resistance protein related protein
MILASRAFRSAGLIFMALSLPLYLLLNRISIVNVGIIYVGTALANVSVTIAIGMLGDRIG
YKYSLVFGEIPALLASGILAFTRSVPLIVIATVISGSAGAPGGMRGSFSVGITPYLARIW
QEPSIRIERMAQITFVASIASIGGSLLLYLHGFITRIYGDLGAFEILYHVAFILILLSFV
SLTMIRRDRRQKKTTKFLRKETMKFSARVIITNVINGSAIGFSMALISAWFEIRYGVSAS
KIGLVFTISYITTAIGSLLASRIHISRERAVYFGSLTRILQGILLIAMAASPIFIMGSTI
YIVRTVVAGFGTPIRNVVNIQGIKDEDLGTASSIQGAPSRIMQSTSGIAGYLMDYYPPLP
VEIGGLIQIVGGFVYFKLLRRY
>fig|273075.1.peg.1166 Multidrug resistance protein NorA related protein
MSLYLHHIGYSLFTVGVILGSAIVISSILTFFMAMLADHYGRKSLLIVLYLIFAVSAFGF
LVSKEMFILILLSGLGSFTGSGGGPIGSGGAFGAVQTALITEFTEKNRFSRVLSTASAVG
LLASSAGSFLIDVVERIGGDVYRLFYLAGIMGIVGMLITVFLNDNGIRSRKLLPSISWKK
MIRLSIPTIPNGIGAGFVSPIFSLWFHLRFGISSGEIGVIFGISNIFVLIFMIVIPRIIR
SESELNAIVWTRAASSMLLVALAFIPFLQIAALVYILRQGLQMGAVPVRQSFSMGIVDST
ERATASGVTSMTRTGFSAVSPPLAGDLLSISSIYPPLIGGIITAADPLLYYMLFRDSFRR
KS
>fig|273075.1.peg.1380 Multidrug resistance (emrA) protein related
MTIDYSRKYFVLSITTLGSLMAAIDSTIVFLALPAMGHYFSSSVSYLTWIVVAYIISATI
FMIPSADIMRKIGKKQLYLIGFVIFALSSLVIALSSNVIMAIIFRFIEGIGAGFLSAVGI
PILLDAFPPQERGRAVGINSISWAIGTLVGPVLGGYLVLYDWRYVFLINVPIGIIAAILG
LARIPHYPKENAQKYDPIPLIGLIAFLLPLTVGISFINVYFLVASAIIFPFFIMAQRRNP
IIPSVLLKNRNYVRVSISSTLQALSFFGVLYALSLYLQISRGMSSLSASLYLFTYPLASM
IANPVSGFLFDRTGKGAHLLVIGLVMQAFGIFMVAYTMTLIPIYLFIAGFGGSLFWAPST
TMVVDAAGPKFRGIANSSLFTLRNMSLILGISVFPIFVSAFSHVKSSSIIITAFGANLSA
STSYYLITVSLLSVLAIIPIVGFLRSKRESIESKAEIPG
>fig|273075.1.peg.1443 Permease of the drug/metabolite transporter (DMT) superfamily
MFRSKRYQMVAYAITGSALWGLSGTVSSILFSRYGMPFSTLVTIRMVFSGLILLAAGRGF
VGKKDLPMFLVFAIPGLFGVQILYLATISFSNAPVATLLQFLFFPMVAVYDYITIRSLTV
SSLILALIFSVAGIYELTTGFPLGGTALRISLTALILGLATAATAALYTVTSARIVKEYG
GLRTVASGMMVGGLVSLPLGSFSGVPYFHGLGQADVIPVLALTIFVIVFGTSMAFYLYIN
SMRYISPVEAAVSGTFEPVAAAMSSYLLLGIKLSAMQYLGGALIVISILVIVISKNRRG
>fig|273075.1.peg.1467 Permease of the drug/metabolite transporter (DMT) superfamily
MDRKDAIYLALLIFVTFIWGVTFPMIKDVFAYLSPVSFLAVRFAVASLIFLPFVYRKLIQ
TNRNTIKYGVVAGIFLFIAYYLQTVGLKYTEPALSGTITGIYVVFVPIISYLYLKRRVMR
IEVYSSVFAFLGLVLMSYSGLHNLAIESGDILTFIAAIFYAMQLVYISKYASNVDPLVFS
FLQIVVVGVLSLAFMPTDMYPIVFSYYALFVIVFTAIFATFLATYVYVSALSRMNVTKVG
VILIGEPIFADITSIFLFNEPVGPIEILGICIMIVSIGVISYFSD
>fig|273116.1.peg.394 Multidrug resistance protein
MVFGIVEALGYGIGSDFSYIGGRLWDSHSPKKLTILGNSLIPLMSLIGLAGTYIGASALY
IGGWWSRNFRNPPPRVMIIQSSKEEDISRAICLLHGLDITGGTIAGILPLSFTALGLPLS
RVFLFSIAPLVVSNLLVASTRSVHXVKQEEVKIKNVDSAKAEKNVVYGVFLATLSFGFSY
HSIGFPILTAAQSADSTISGLVLFPVFMASSSVGGFLYSRLRISKEVRLLGYLGYTLTGV
GTLLISLVYLYRAPELYYYLSAVVIGLGTSGVETFEPTIISKIIKGSRTGSGVGYLTSFI
SIGLFTSNILMGLLYYEISPLSAYLYAGLAAILGGLIILFAGRKFKYY
>fig|273121.1.peg.255 Permease of the drug/metabolite transporter (DMT) superfamily
MSLKSRELLADVSLLGISVIWGVTFLMVQDAIKEVPVFAFLFWRFLLATVLFFLIGIALK
PSFDLPSIRAGAILGVMFCLAFSLQTFGLEHSLSSVVGFITGLNVVFVPLFLWMLFSQKQ
TPFALLGIALAVVGLWMVSTNGGGIGLGKGELLTLGCAALFALHIVYTGIFSKRHRLFPL
ILAQFSTATLLCLLFSLLFDPFTIPSTLSYPFLKALFITALFATVLAFLVQTYMQRFTTP
AKTAVIFTMEPVSAGIFGYFYAGEPLGSIQILGAGIIVLAMLSVELGSLLYRRKKRLN
>fig|273121.1.peg.383 Acriflavin resistance protein D
MIKYVIAKPVVVIVGIILVALFGVLSLSQMPYQLTPSVTRPIITINTLWTGATPYEMERE
IIERQEKVLKGIDNLISMESRSRNGRADITLEFKIGTSLTEAMLKVSNKLDEVKKYPDGI
DKPIITATGESTSPVVWMVLKTQKENPRHINEYRTFFNESVIQYFERIDGVAEVFFPSGT
DREMHVVIDHNKLASYQLTLQDLISVLDLENANVSAGTMDYGRRSYRVRSVAEYKSPEQI
EQTVVWSDGQRRVRIADLGYVKEGYARPTAYVEHNFESGAVVGIKPTPGTNILELSDEVE
RVFFRLNEGVLAKEGLYLDWMYDQRSYINGAISLVRQNILIGAFLAVVVLWLFLRSFTST
VVIALSMPISILGTFIVMNALGRTLNVVSMAGISFAVGMLVDSAIVVLENIDRHKRLGKG
IFAASYEGTKEVVGALVASVLTTVAIFIPIINMEEEAGQLFRDIALTASSAVLFSMVVSI
LIIPMFSYQLLKLFGVEKPHPKSTLEGVGARIIDTVVAWVKGCTASVGSRLATIFFFTFL
SLAISYALFPKMEYLPEGNQNFVTTVLNPPPGLSYEERQNIGKEVFRLNESYFVQKGYEK
NEKGEMPPIRHMFFLGSENFMYFGTRGAIEDRAGEMIPQFLKTIESLPGMTGVSMQPGIF
ERGMGKGRTIDVDISGVEIESLIQTASAMQRLIKQRLPQGTQVRPLPSLELIYPEINLYP
DSDKLKAAGLNPSTFGVALDVLMDGRAIAEYKEEGREKIDLVLKANKGELKTPEEIYNAL
IYTPSAGILPLSSLSEIKREYGITEIRHFERKRTVTLQVTPPKNMPLEEAMEKIQGEFVE
ELQKQGLIGSNELRLSGTADKLTQTRLALQGGFVLAVVIIYLLMAALYENFIYPLIIIFT
VPLAVAGGVIGLKLVNLFLANQPLDILTMLGFIILVGTVVNNAILIVYQAINNIREEGME
AYEAVILSVRTRLRPIYMSTLTSLFGMLPLVLAPGPGSEVYRGLGAVILGGLTFSTLITV
FVIPSLLLFVIQKERLKIDIEKAEKAGGIA
>fig|273121.1.peg.796 Permease of the drug/metabolite transporter (DMT) superfamily
MSNSSKGALYVALCITLWSLIPIFAKLGQSNLDHHQYLFFSSLLSFLALLGVGYYRRELG
NFWRYSLQTLLFLAFLGFLDFFYYWLLYFGYKEAQGLEVLVFQYSWPIFIVILSPWFLGE
KLSMKHALSLLFGFLGVAVVLSQGKMSEIEFSNFKALFLVLLGAFSFALFSVLSKRVSAK
ALHAVTLYFLSATLYSSLALSLFSSWEMPSWGDWPFILVNGIFLNGISYLFWVEALRLGD
ASKVAPFLFFIPPLSAFWLILFLDEPWVWAYGVGLMLVILSGIINARRKR
>fig|273121.1.peg.861 Permease of the drug/metabolite transporter (DMT) superfamily
MSNRSTLLPYGALILAMFIWGSSFIALKYAFISYDSSWVIFWRLLFATLFLLLFIPKMSL
RSFRPQDLPALLLMALLEPCLYFVFESKAIENTTASQAGMISSMLPVLVALLAAWLLGER
LKSRMMIGFLVAILGALWLSLSSSLSDYAPNPLLGNFLEFLAMLCAAFFTISVKRLSQRY
NAFFLTGFQSLMGALFFGVLTFASPLSEPMGRDELHFGAIGAIVYLGVVVSFGGYGLYNY
ALSKVEASQAAGFTNLIPLFSLILGYLLLGETLNSSQLFGCGLIFLGVVGAFYRQKSRG
>fig|273121.1.peg.1958 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGLAAVNLCVPLFYLFMSLEVLFGFGGSALASMALGRGDDEEAREIFSSVALFMLFLSSL
LALGLFAYRDSLALWLGAGEKLLPYVKEYLGVIVLAAPIMMVQPLLEAFVRNDRAPYLAM
SSMVVGSLSNIVLNYLFIFIFSWGLFGAALATVLGHLIGLLILGGHFYLKRGNIYFSSLR
LRFSYVFRAFANGVAPALSEAAAGIVVVLFNLKLMEISKEEGVAIFGAVSYIGVMAVTAL
VAASQGLQPIASFNHGAGFYDRVRAVFRFSFGITLVLGFVLYALSWSFAPFLAELFFPLD
APLAKESAEAMRIYYAGYLFLGLNILSAVFFQSIGRSLVSFVISLSYNFVFILFWLELLP
RFFGLQGIWLSYPLAMISGFLLVLWVIARERKIQTKEPLCKTPL
>fig|279010.5.peg.841 Vancomycin B-type resistance protein VanW
MLKIWMTGLLLLAQPAGHSDSLTITQQGKKVAVVNREDFTMPLPGTPMIDDKKYNEFVDR
LERKVHKDPVNAVINDQGRIVPGKVGYSLSRKGFKEQFYAYFYGDGPSTIEVPELNVYPK
VDSELLSHIRTQRIGQYVTYFNSGNKSRTHNISLAAKAIDNHVVFPNETFSFNKVVGMRT
PDKGYMKAPVIVRGELSEGVGGGICQVSSTLFNAVDRAGLEIVQRYSHSRRVPYVPPGRD
ATVSWGGPDLRFQNKYNQPVLIRAKRHGGTMVVTLYSSDVVNHQLRKVPKAPAQIPKEEH
QSGDH
>fig|279010.5.peg.1804 Multidrug resistance protein B
MFAQFKAFSRLHPLIRFLLIGTLVTKAAKSMTTPFLALYLHMKTGADFGTIGLVIGLGYF
SSTVGGVVGGALSDKIGRKKVMLSSIFIWSFVFILFGLVHDFMWFLLLNILSWLCHSCFE
PVSKALMAELSEREMRFRIFSLRYLAINVGAAVGPLLGAYFGLAKTGTPFIITGLVYFGY
AILLSLMMIRLTTVKETKIAPEKVQAGSVLKTLKQDKALRLYIAGGILFLFSYSQMESTL
LQYLNNDFANGVKIFSTLITLNAVTVILLQVPLTRLFERYKSLTTISIGTVFCILGNIGF
SIANGWIVFMLSMFVLTIGEILCFPSMNVLLDELAPDHMKGAYYGMQNLYNIGEFLGPWL
GGMMLALYGGKAVFLIAACSVFLALGAYHVGRRKFLSAQHYGVSPFSY
>fig|279010.5.peg.2644 Tetracycline resistance protein
MKNSKIQTFKHQKKAFWWLSFVAFFSVMNETVFNVALPDIKNQFGVSPAAANWVNTSFII
SFAAGSVVYSRLSDMYGVRKLFVAGLLIYGGGSFMGLLAQAYFPAVIFARFVQGSGASAV
PALILVIITRYVRPEGRGKAFGIVGSLVAMGEGIGPAIGGMIDCTLYSLVVSVYSADGSA
DGDSFLL
>fig|279010.5.peg.2645 Tetracycline resistance protein
MIVHYIHWSFLFILPMAVLMAIPFFFRNMPDEAAAKANLDIIGIGLLTISIVMFAVYISL
YHVFYLLAGIFCLIGAAVHTRHAEHPFIDRSLIKNRRYIGVVLAGCTVLGSVAGGALTDR
FGSRFVFTLGWLLILSTMAAASQVGDRTPWLMTIMLVFIFGGLSFVKTAISNSTAESLEE
KAAGAGMGMLNFACFLSEGIGVALAGGLMAVHGFGYSALPAMNDAWSAVFSRSFAIFTVF
VLAGGLLYLLTCKRKKS
>fig|279010.5.peg.2723 Glyoxalase/bleomycin resistance protein (EC 4.4.1.5)
MKKKTSGIHHITAIVGHPQENVDFYAGVLGLRLVKKTVNFDDPGTYHLYFGNEGGKPGTI
ITFFPWVGARRGVIGDGQVGVTSYVVPKGAMAFWENRLAKFNLPYTKMNRFGEEYLEFDD
PHGLHLEIVEREEGEKNSWKIGEITPDKAIKGFGGATLLSKQPEKTAELLEKVMGLEKVG
EEGDFVRFRSSGDIGNIIDLKLTTIGSGQMGIGTVHHIAWRAIDDNDQLEWQKYVAENGY
RVTPVQDRNYFNAIYFREHGEILFEIATDPPGFAHDESHQTMGEQLMLPAQYEHYREQLE
RRLIPITVKALD
>fig|279010.5.peg.3076 Transcriptional activator BmrR for multidrug resistance transporter
MKEYFSIGETARLNNISIQTLRYYDKIGIFKPQCTDRDNGYRYYHVKQFFYLDIIKYLKS
IKTPLEEIKRIISHTSAPELMQTFLEEQENVIEREMEKLERARQLLQRRKDQLHEQLEIR
AKKEEGLVYVRHIEGQTILKAATPQVNPHDQSDLYYRKLAEVLEERGDMVDNYYGLIYDL
KPYKNSGDIYCNSVYTTIYDGAKIDTEEQNIGMDTIPSGEYVCISFDCSSTNYFSYYQKL
YHFIETHGIQTDGKVYQVSFPNSYNSLKEEDFLTEFRVLKK
>fig|279010.5.peg.3290 Drug resistance transporter, EmrB/QacA family
MAGLKKKRALFLTAVASGTMLNPLNSSMISLALHSIQHEFHLSFATVSWLISSFYLASAV
AQPVTGKIGDLIGRKKMFLSGLVLVAVSAIGAPLAPAFSVLLIMRLFQSIGSGAIYPSGV
GLIRSHIHEKQASALSVLSIFSSAMTAFGPTVGGFLIVLGGWPAIFLVNFPFILFSFLLG
MYMFPKDEKKAGLNVRAVIKRLDLTGILLFAGGIVLLLAFLLSLSTGEPRFAEGMFGLVL
LLMFVWWELRVNSPFIDIRLLIARRTLTSVYAQFIMLNIFNYCLFFGLPSYFQDEMHLSV
QTSGLLMLFMSGTSVLISPFVGKWIDRSGETQPVLIGSCLMAAGAILLTLFFVDAPMLWK
GIILSLLGVSYGLGNVALQAAMFTASPPDIVGTTSGLFQTCRYLGSIFSSVILGLLFGEE
ITAGHFQDLGMVMIAVAIGSILMSFRFIKLMKD
>fig|279010.5.peg.3456 Lincomycin resistance protein lmrB
MSQSDVAIPSSKKIGIPKYLIISVLTILAIGPQYFLNLSYTLSQVVIQNGLHLSPDDMRI
PSILTNLAFALGVPLGRIFSRRFGIRNSYLTLITLFLCGSLIDAFSAGLFSLLIGRVIQG
LCSGMLFLTILPVKLISFPNKVRNLFLFFVISGLFGASAIGAVFGSLSLSADAWRWVFIL
NICSPVLCLVIGFFSLPKQAADEREHHSIDKTGVFMLSLLMVVLTVPLINLQKTGVHSFY
VWPFFLAGFIILALFVITDLRAREPLVPFRSLWSAKAVSGTVMAVASHIAIIVSLAGING
FLENIAEASFESMTRFYLCFFAGILATAVLSTLLYDHFGAGLLGCIGALEMIIVGMEWRS
VQPGVSMESLYLHAVLLGSGVSMVLVSGALGTALAGDIHQASKRSVSLHFIRNFAGAWAA
PVIGWFASMKNAVHYEMIRGHISEADPEIQLELSKMIRDFVSSGLSVGDAKNMAAYTIVA
NARKASALGAYHDLFTILLWLSIIMLAASIGKAATGKGRSLVQKRLRLPDPSASQQKEIG
>fig|279010.5.peg.3509 Multidrug resistance ABC transporter ATP-binding and permease protein
MRSFLGCSNLSVRFYHRPETVLDRVSLSIEQGEKVLILGPSGSGKSTLLSVLSGIIPEHI
EAEVTGEVNRRKSAGVMFQDPDSQFCMLHVDEEIAFSLENRSVPPKDMDRIISELMELVG
LKIDKKTPIETLSGGMKQRLALACLLALEPEVLFFDEPTAQLDPASRQDIFALLRDVSRK
SGQTMVFVEHVLDGCIEWMDRVILFNEKGQIIADGKPEEIVKHFQPEMKAAGIWQPKLYP
AVWEDVTTQDDHPLAVKLSSTLKMKEEEAKNRPSADRDILIRTEDAAIGYRKKIVADGIN
LEIPRGEWISVIGGNGSGKSTFLKSLIRLEAVKKGRIYLEGRELKKWSDRTLYEKAGFVF
QNPELQFIRDTVFDEIAFGARQRSWPEEQVERKTAELLQEFGLDGHQKAHPFTLSLGQKR
RLSVATMLLFDQDLLLLDEPTFGQDEKTAKELIKRLKERQERGTTIVMVTHDMDIVDEHS
DRVIVFHQGKAAYQGTPYQLFSDQDLVRRFSLIPPLHYRFMHERKERVPV
>fig|279010.5.peg.3683 Multidrug resistance protein B
MKKMARLYMLMLNVFIVMLGIGLIIPLMPTFIEEFGASGSTLGLLIAASGITQLLFSPVA
GEMTDKYGRRKMIILGIGAFAVSQLLFALASQMWLLFVSRLLGGAGAAFLVPAMFAYIAD
ITSEKDRSKGMGLISAAMSLGFVIGPGAGGYLAAFGLTFPFYVSAGLAGLATVLSLLVLP
ETLSQEKMLEKRRSVQKREPLAKQMARALRSPYAFLFILVFILNFGIMNFEAVFSLYVDH
KHGFTPGDIAFVITAASLIGVFVQAVALGMLTNRFGEKKLMNMTLIGSAGALAVCSIAGS
YWLVFGATIVFFMLTSILRPAINTLISKMAGDEQGFAAGMNNAFMSLANIVGPTVAGLLF
DVNVEIPYIFGVVVLVLSFLAAVSWGRKQQARTIPEKV
>fig|279010.5.peg.3949 Permease of the drug/metabolite transporter (DMT) superfamily
MLTNVLKYRVHILFIVLCLIGGTTWAFQKAGLSDSLPFWSAGMRFMIASILIAAFLLARR
QFVLSKELLVLSFLNGIMYFSVPFGSVYWASLYLPSGLVSILAASISVFALMINRLVKGT
PATKLQKWGICLALLGITIVFGNQLLIKVDVIEIVAMIVILCAMFGSAFIQIKVQQRIRS
LPILSFNSLSMLSGGAVLLISSLIFESGTRTFSGVSLYALLYLAVVGSILGFWINIYLLK
KWHISKATSHLFISPVIALYIGFLFLDEKLNANIYLGTLFVIFGVMFINLKKEERIAKID
ETKQKLGHHLSK
>fig|279238.18.peg.94 Permeases of the drug/metabolite transporter (DMT) superfamily
MHFLALLTGNVALALGPWFVRLADSGPVSAGLWRLALALPLLAIFALRGREPMWGYQRKD
WAIIVGAGVVFALDLASWHVGIERTRLGNATLFGNSGSVILMVWGLIAMHRRPHLREFAA
VALALGGAGLLLGRSMEIDTRTLAGDLFCILAGLFYVVYILLVQHVRGRFGSWSLLFWSS
LAGCPVLLVTALALGEPVLPGTWWPLVGLMLASQIVGQGLLVYSLRHFPPLVIGLVLLTQ
PAVSVVVGWLSFGEVLALPDAIGMALVGAALVLARLGEGKSA
>fig|279238.18.peg.1750 Outer membrane component of tripartite multidrug resistance system
MAGALVVAALLAGCTTVGPNYAGAPDAAPQAVSRGTFARAGADALAAAPAARWWESLGDP
VLNQLVEQALADAPGIAAANARVAQSRAALAANRTAVLPQLNTSFAAPYINVPGGLLSPN
GESGGRDEINAYNLGFDAAWEIDLFGGTRRKIEAASARAEAAEASAADARVTLSAEIARA
YVGLRARQAMVGLQERQVEIDRELASLARQRFEAGRIPQQPVNGAEAQAFSSEADLAKSR
AEIAVLMDQIAVLTGKEPGTLDALLVAPAPVPLPPAQVAVGDPALLLRSRPDIRAAERQL
AAANADVGSRIADKFPKISFLGLLGLGGQDFGDVFDPGNIVGIALPQIKWSLFDGGRAER
QVEAARGAFAEAEANYRRTVLSALQDAEGSLARFGAQRVAFGKALDAETRARRNVELQQQ
RLAAGTIGKPDRLDAERQALQLAMAATSARAELTTGFVAVEKALGLGWTAPEPAK
>fig|279238.18.peg.1900 Permeases of the drug/metabolite transporter (DMT) superfamily
MQDSHRSALIFALLGFALLSVGDAVVKSMAGMWPGTAIGALRYVFGAVGLGIVLLLREGP
SGFAFPKPRWQVLRGFCVAMSAMSFFSAVHLMPIGEATAISFTSPMITALLAAVLLKEPL
RRETWIASIVAFGGVLLILRPNFGLLGLAALLPMVSATGMALLIIANRKVAGMGSALSMQ
FNVALIGSLFLCIATLSGHFSGVAFFAVQVPAMSVIAKCALIAVSASTAHALIYMATTRA
GAATIAPMTYVQLLMAGVLGWGLFGERPDGVAAAGAVIIVGAGLYLWRAGRAPEEPTMTD
>fig|279238.18.peg.3505 Outer membrane component of tripartite multidrug resistance system
METADTIEAAQTLAARGNTTWPPDQWWRLAGDPQLTALIEEGLSNAPQVAVAVARVRRAE
AEAQRVGAARLPTIGAEAEGGLRRQSGNNGIPAQFLPDGWQDYGQTSLSFGFDLDLWGRN
RAAYAAATSEARAAMVDAAQARLVLSVAITAAYAELGRHYRERDNAAATLANRRLMRDLV
AQRQRNGLDNLASLRRADAEVALAEQDLAAVDENIGIRRNQLAALLGAGPDRGTSITRLP
LAPSTPGGVPAGVTTDLLGRRPDIVAARERVEAAASRVKVARAGFFPSINLRALIGLQAL
GLGNLVASGSLFGSVGPAISLPIFQGGALKAQYGSAEAAYDEAVANYNQTVVTAYQQAAD
AVTQRDAADKRLGATRTALAASEEALGLVRTRYEAGLASYLDVLASERGVQDLRVAVIGL
ETYERGATLAMIRALGGGFDAGTTQPSGQTEQ
>fig|279238.18.peg.4013 Inner membrane component of tripartite multidrug resistance system
MLIGTMAAMIMYTLDTTIANVALPHMTASLGATQDTITWVLTSYVLASAVALPLAGWLVD
RVGIRNMMLASVLLFTAASMLCGAAQSLEQMVLFRVLQGLGGAFLSPLAQTVTLDSSTAA
ERPRMMGIYTQGVMLGPITGPIIGGFLTDNYNWRWVFYVNVPVGVLCFLLLLLYLPKTPT
RERKVDLTGWLLVALTVSSIQLILDRGLTLDWFASAEIVTYAVVAGACAWLGLFHLSGSR
NPLFPTALFHDRNFTVGLAFMFLIGLVMMSVMALLPGLLQQIYGYTPLQSGMLLAPRGVG
MLASITLFGRFMAKVDARILLAFGLSLMGASMWMMTGWSTEMPRTPIIMAGLLQGLGLSF
TFMPMNLISFATLPPQYRTDASSLGNLMRNLGSSIGIAAASVELARNIQVNHAELGAHVT
RSLVPFNLDRITAYGGTAETALRVMDGLVNQQAAMIAYINDFYAMAMACFVAIPLLLLVR
TGAKKG
>fig|279238.18.peg.4014 Membrane fusion component of tripartite multidrug resistance system
MAEADPFPIQESSAARAVGEHERRTRSKRLRTVLMALGPILAIGGGLWYWFGRPGVVETD
NAYIKQDIVSVAGEVTGLVTSVKVKENQHVKAGDVLFTIDPSSFTVATRQADAQIASAQA
RVIALNADVTAKAADLAGARDDLALAQANYAREKALMDRGFNTRARMDAAEHAVATARDR
IVSIQAEVEQARAELAQGSQVPGVNPEIAAAQANRAKAALDVERTVVRAPADGIVTQVTR
LQIGQMVFPGVPMLSIVRDGGARIEANFKETDLNHMRPGQRADIEIDAYPGLKLKGRVES
IGAGTGSEFSVLPAQNATGNWVKVIQRVPVRIAIEDKSPRPLIAGLSSDVTVHVGK
>fig|279714.3.peg.585 Inner membrane component of tripartite multidrug resistance system
MMTLPSWRDWLFSAKTFLAAILALYIGMALGLPRPYWAMSTVYIVSHPLIGATRSKGLYR
VIGTLIGGAAAILFVPRFVNEPIMLSLVISLWTGTLLCLSLRDRTPRNYLFMLSAYTLPM
IALPAVSQPEAVFDIALARSEEIVLGIVCASVVASIVFPSKVAPVLEARIGAWFKDAGAW
AAEALSPAFASSHPATRHRLAADILSLDQYITHLAYDAANADMVHTTRELQSRMSMLLPI
LSSLTATLDAARKLEQGVPAPLTGLMKAIARWILSSPGARGRDEAARFQRQLADARRSGP
DAEWNDLLIAHAVTRLQSLIRLWQDCLDLRDMIARGEADTAWKPAYRRWELGGKARHYDH
GMILFAAASASLAIFLSCLLWIGMGWNDGASAVILGAVSSCFFAAQDEPAPLIRTFFTWA
AVSIPLTAVLLFLIIPAAHEFETLALMLAIPFLAIGTLASHPRFTMAAMLLTVNTASFLG
LQGAYDADFTAFFNSSVAGVCGVLFALCWTLLTRPFGAELAMRRLLRASWKDLAETAAGS
HRGDYANLTSHMLDRLGLLVPRLAASDDDHGDAGFGELRVGFSTLDLQRDEHRLPETAHV
AIDRVLQSVAGHYRECVGHHGQRQPPASLREEIDRALSLTKAELGRAAREAQNALVELRI
TLFPDAARFVALTGVPATGPSAGETP
>fig|279714.3.peg.614 Transcription repressor of tripartite multidrug resistance system
MSDSFKPYESAITAIASQIPGAPLREAILTRLFLHVSGELSDFFDARLKEYGLNYTTWTS
LVVLYSSPQHRLLPSELSVFINTSRTHCTRIADELVDKGWVERVASEADRRQTYLQLTAA
GVAFVEQLQPQRREQYRQLWSSFSPEEQNQLDALLRKMLVLLKS
>fig|279714.3.peg.647 Permease of the drug/metabolite transporter (DMT) superfamily
MDGIESLARLEWRHAYAKNKGMILAALAAIGFSAKAIFVKMGYRYGASAEALLVLRMAFA
LPFFLLLALQSTQADVDQLTWRDWRQLVVLGLLGYYLSSWLDFVGLRFVSAALERLTLYL
YPTLVLFISVLWLGKRYPAKVWWGVVLAYLGVVLAFVQDLRDAELIHQALFGLSWVLASA
VSFALYLVGSGEAIARFGATRFTALATLVACIAVFIHFAVTMPLAALQLPAPVYLIGLAM
GVFSTALPLLCMNMAIRQLGAGKAASVGTLGPVLTMALGWLVLGENLSVLQIVGAGLVIS
GVGLVSSSK
>fig|279714.3.peg.1497 Membrane fusion component of tripartite multidrug resistance system
MTNKTELSPGSPLPTGQAPSHPAASGRGARKGRLILALILLATAAVAGRMWWRSHYFEET
DNAYLAGHVSTISPRIAGVVHQVLVSDNQLVRAGDPLLELDAADQEVKIAQIKAQIAQTD
EQVRQIAEQLEQARAEAQAAQALVARAAAQFQRNDAEAKRVSALHDVQLKSVSKSELEGA
IAARDSAAAEAQAQQFQAKAASAKSGSVAAARAAALAQKKVLAAQLRDAELQLKYTRIVA
PVDGRIGKKSVEVGTRVQAGQQLLAIVQDGVWVNANFKETQLHDLYPGQQATVRIDAFPG
RTFSGKVDSFAPASGAQFALLPPDNATGNFTKIVQRIPVKVLLDPNDVKAMGGRLAPGMS
AFVEVDLRQGAPAGTVR
>fig|279714.3.peg.1498 Inner membrane component of tripartite multidrug resistance system
MAAMAEKTAVAARPMPPPAAVLPLPEPAVDARTWIAIFAAILGVFMAILDIQVTNASLRE
IRGALSATVEEGSWMTTSYLAAEVVVIPLTAFFVRVFGARAYMLGNVVLFLVFSTLCGYA
WNLPSMIVFRALQGFTGGALIPTAMTLILTRLPPSKRTIGLAWLMLSSTMAPAFGPTLGG
VLTNFYGWPSIFFINWAPGVLMLAGLAYGLKREPLQLKLLREADWLAITAMTVGLGSLIV
FLEEGNSKDWFASDLIRACALAALLGIVAWVAILQSRGKPFVNLALFARRTFGVSSLVGA
AAGMGLYGSTFVLPLFLSEIAGYNSLQIGEVIMWMGLPQIVMMPLAAAFAKRFDNRVICS
LGLLLFASSCFMNATMDATTGYDQLVFSQVLRALGQPLIVLTLSNFAIHRIEAANLSSAS
GLYNMSRILGGAVGTAVLATTITWREHFHSARIGESVSLFSDAVQERLGQLGSQFLAGSG
DPVAAQQQALAALDHLVRREAYVLAYTDSFFILGCVLLASIAVMWLADRVVAGGK
>fig|279714.3.peg.1499 Outer membrane component of tripartite multidrug resistance system
MLKKTMICTVLASLLAGCATPALQPPAPTELVPASYQHAGAPAAHDLPRQWWRLYHDATL
NQLVETTLRDNPYTQVAHLRQIAAEAQTRLANADRLPQLNAGVGFSNSRTSTNTALGQIL
GHQTISGDKITAGFDAAWQIDVWNRVGYAVAAAKAGVEAEQAFARMVEQTLSWEVATTYW
QYRLAESDLTLLTDIRQQRAEAESVQAGRFDAGLSSELDLARARLELKNADVEIEDARKR
LSLAEHELATLTVKPVAEFSVPRDAAYRLPDVPAISPGLPASILRQRPDLAQSAQNIRAL
LAQKEIADTAFYPSISLTGNFGFASMELRNLTNSDSRQFTLGPLAISLPILDGGRIRANQ
KIADARYQEALNVHKVQLLIALREVDDALTEVESCRTQAGLLDAALESARRVSLLAKARY
DKGAVNYLEVTQAERDLSTAELKFRRNQLKGLLASTQLVYVLGGGWKDEAAPTR
>fig|279714.3.peg.2091 Multidrug resistance transporter, Bcr/CflA family
MPIVAAGLHPTRLIVLLSALVAFGPLSIDMYLPSLPAIARDLAAPVGLVQFTIGGFLTGF
CLGMLLYGPLSDRFGRRPVLLAGIALYLVASLACAFASSAEQLIALRVLQAVGGGAGSVM
GRTVVRDVFPLDRAAQVLSLMHLVTMIAPLVAPVLGGWLLLAAGWRSLFLALALFGAVCL
ALVALRLPETHPAERRGEVSLASAFSAYGHLLTDTPTLGYMLALGLTFGAMFAYITGSPF
VYIDYFGVAPQHYGWLFGLNIASVIVLTTLNKWLVKRVALDTLLQAQTAVIAAAGLALWL
AGAHSLLAVVLPLLVSVGLTGSIGPNTMARLLQRHSERAGAAMALAVSGQFGLGMLASAL
VAALHDGTPRAMCQVVALFGVAACLGLQLIRLPAATARPQSSTL
>fig|279714.3.peg.2249 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVAQIAHVAMGFVDTVMSGRVSTNDLAAVSLGSSVFITVYVTLVGIATALNPLIAHQFGA
GEREPIGETVRQGMWFCLFLGLIGSALMIFGQPWLRDSLTLSNDVEDKVMLFLDGVALGL
PAALMQRALHAFASGLSRPKPIMLVGVVALLLNIPLNYALIHGLYGLPAMGGAGCGWATA
AALWFNFLALLGYVALHRHFRPYAFTRRWSWPDWARYRAMLKLGLPIGLSFFFEVSLFSF
IAFLVAKLGTTVVASHQAVLSVSSIIYMMPQSISTAMSVRVGQAVGAGDYRQARFTAGTG
LLTGLVLAGLTMLLMLTLREDIIRLYTTDPEVIRIGAGLLVFAAVFQLTDATQCISSGAL
RGYKITTAPMIIHVVSFWGLGLSLGMVLGLTDWPLPFLTLPMGIEGFWAALVFSLSVAAF
LLVGYLSRESRRRLVRQHTES
>fig|279714.3.peg.2704 Permease of the drug/metabolite transporter (DMT) superfamily
MPPSLIGLIQVLLSAVAFGTMAILARFAYADGTSTTTLLLLRFVIAGLVLLPWVALQRLP
WPTGRPLLALIVMGAVGYAGMSACYFNALNHASAGTVALLLYLYPVLVLLLSMLLGERLT
TLRLIALLLALSGLAVTIGLEFSARPLGLVLGVGAALIYSCYILIGSRFTAGTHPLAATC
VVILSAAASYALQSTWQGWGPPHSARGWLAIGMMALICTVAAVALFLNGLEKIGATRASL
VSTVEPVVTLLLAWGLLGEPIGLSQALGGLLILGAVLLVSREADPKRTELTELHD
>fig|279808.3.peg.645 Glyoxalase/bleomycin resistance protein (EC 4.4.1.5)
MEPITHIHHISAIVGDAQETYDFYTNVLNLSLIKQTVNYDDTKTYHLYFSNDRAQHDMVL
TFFNWPNQYRGRIGSGQVGHLAFRIPKDSMSHWEMKLNANGIQTRQTDSFNQTTLEFEDI
HGLTLAMVESDEERVNNDIIGFHGVTMLSGNPQATEALLQNDLGLEYIQETDDNVHYQTS
GSVHHQIIGKKFVNPQPVRWGGGIFHHIAWSVPNDEVHVQWRDYLHNKGLHVTDVKERFY
FHAVYMKEPGNLIFEFATAGPGFTIDESVDDLGRQLQLPPFYEERRYEIEGHLMPIKLNE
Y
>fig|279808.3.peg.1736 Erythromycin resistance ATP-binding protein msrA
MEQYTIKFNQINHKLTDLRSLNIGHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESG
TVETVGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNY
SPILLLDEPTNHLDKIGKDYLKNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRV
FKGNYTQYQNQYEQEQLEQQRQYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIA
PDRLSASKQKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPII
AQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMA
YYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALDRSCNVLSGGERTKLSL
AVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELT
GQSIHDIT
>fig|279808.3.peg.2434 Drug resistance transporter, EmrB/QacA subfamily
MLDLTMINIAIKQLNNTFNTTIEITQWGITGYVLALALVIPIAGWLVNQFNGKYVFIGAS
ILFGITSVLAGISWNAESFIVFRIIQGMSAGIITTLMFTLLIKTTGQDNIGKVMAVVSTP
MIFGPILGPVIGGFIIHIVSWRWMFFINVLVVIIAILLQIKYLPNFVPFNKSKSIDILGM
ILLGLISISTIYGLTKASDYHSFYNRTTILLLIIGCIMILIYYIHNKVKHDNTILPLSLF
CKGNYTASFIGLFLSNIGIMGPMVIIPLYFQTFKHYTPIEAALALIPQGIGMLITRPYLG
KLIDQYGAKWVVLISVIISMFGSIPLLFITDHTSIIALSIILFLRGCSIGGINLGLTTDT
YMGIKESVLAEAGVGINMIENIGSSFGTAFIATIIRVVINQLGKSLMHNIIAYHARFLVS
VITLFLIIVPGLFLTQKSKATI
>fig|281309.3.peg.752 Glyoxalase, Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily
MNVEQCIVLEVKNLKETLYFYEGILGIKPSLERPQLDVTGVWYDSDSKRISFVMNRMLGG
REKGVTDSCEVLTFTISNIEKLKKKLAFYEILYTENECAKSIVVQDPDGYKLQVVEKDE
>fig|281689.4.peg.151 Efflux pump antibiotic resistance protein
MAEKNLRFATLSVVCVAHFLMPFMMSAVGVALPVIGREFHASAVQLGLIETSYVASASIF
LLAMGRLGDIVGRRKIFQIGLGLFTLAGGLISQAWAVDVVIGLRFFQGMGGAMVMATTMA
IVVAVFPEKDRGKALGIAVASVYAGISCGPFIGGTLVSILGWRSIFYLCIPLGLTALLTT
TLLLRDEWVGAAGEPFDWQGWLIYAVSIASLVVGATHLAEGVLFRVLLAGGVCGVVLFLW
FETKRRFPLLNMDLLLHNRVFALSNLAAMFNYAGTFSMTFFLSLFLQVVLGFAPHEAGGV
LIIQPLVQTLFSPVCGRLSDRYPADWVATAGMALCALGIGMAATLTAVSPLSFIVVILVV
LGLGFALFSSPNTRVIMTSVAERDLGVASGFSASMRTLGMMGSMTIVTVIFSWQMAGQPI
TPQTQDLFIQSMHIALQIFSGLCAIAVFSSFGRHQSPSKQSGVLNDE
>fig|281689.4.peg.675 Acriflavin resistance plasma membrane protein
MKNFVTLNLKQKVFINVVFVILMVSGVYSLFNTPVENLPPVAIGKVVITTIHYGASARDV
EQLVTREIEEAIDGLENVEYVQSTSMRNVSSILIKFIDDTDYRHLYDELRLRVLNVREQL
PDAVDDPIFTYLDSQDWKPVIIANLIGDLSNTSLTLLAEELKSDLRKLDGVQEVALEGDY
HQEFQVHIDPQRLRDTGISFAEVAKAIADANVKIPSGRYRQQGHNTLLDTGQVFDRQQQV
LDVAVRRDGDGNFIRVRDLATLASLSHREPDLISTVNGQSTVKLKVKKQDAANAITIAER
VKQEVERFNQLHQRDGVTTVLTNDSTIEIDDSIRTLGGNMVLGMILVTLVLWITLGFRNA
MLTAIGIPFSFLVTIIIVKLTGESINTISLFSFVLVSGIIVDDAVIIIENVYRHLYMGKT
RRTAIVDGVSEVFLPVISSAMTTICAFAPMLIMTGSTGDFFSVIPKAVSFALFASLVESL
FILPVHILDYGPRQMSANLHPEGDYHHLQEGPFAPLWKIYRGLLNTLLNHKWLTMAGITT
AFMVTMVMMIVSVTGIMPLIKVKFYQDSYLRYHVTVDMPTGTSVEGTDAVIRDLSRYLVS
LGPGQTLSTSGSAGLKEDQDYQIHRAQHYGQVVVELPPQSEMDLPTGNDQISTYIDQMYD
QVEAYVDQHADQWPGRPTIQVFGESTGPPSGKAVNIRLSAMDIDQARAASDDVLAYLHND
PAFADLINLEDNRASIQSVLNFEVRRDRALEYGLSSSDATRLIAGSLNGMQAGNYRTTRE
EIDLMVKLARQEDSGRGLLNPEQVATIPIVEHSEQPILIGDLANLDYRQEPDARTRYNGK
PTLTITADIRTGSQLSASRVQVLAQRYFDSINDRYPGVSIAFGGEFESTARAYTSLAAAF
VIAVLAIYLILASQFNDYIQPIIILSAIAFAFIGVVLGMFFTRSVFTIGSFMAVIGLAGV
AVNDSLILIDFMNKERERGLGLREAVINGCSARMRPVLITTLTTMLGMLPMAIGIPHKSI
TWAPMATAFATGLASATTLALLLIPVEYELTENAKERVRNFMRRRQRQNLKQQREKNK
>fig|281689.4.peg.726 Permease of the drug/metabolite transporter (DMT) superfamily
MAVISAFGFSFKAILIKLAYALPQQVPVDAVTLLILRMLFALPFFLLLLRSSGHQGRNLN
RKDLAVVIILGAVGYYGASLFDFLGLKYVSAGLERVVLFSFPLLTLFFDAIFSGRKIRSY
EWLAVVICYCGIGLAFVHDMDVSGVQEEVWVGGGLVFLSALCYAFYLSGGRHLIARYGSS
RFACLALVVSTAATLLHFAVSHPLSDLVQPWQIYLLAFIMGTFSTVMPVLTLAAAVRRIG
SSPAALISSLGPVLTIFFSWLILDEAVSLLQMGGTLLVIGGIWLVGKKGRQAAD
>fig|281689.4.peg.842 Permease of the drug/metabolite transporter (DMT) superfamily
MNDLLKSHLMVLLATFFIAGSFLASARLAGVINPFSLTLMRFVASFVLLLPLVLSRRDWR
RKIVTVLPRATVISFFYAMFFACLFEALKTTTSLNTGTLYTLVPFMTALLCLVFLRQPIG
GQTFLIYILGAASACWVIFEGQLDRLLAFSLNQGDWLFLGGSLLICGYSLSMKLLYRRSD
PMPVLVFCILFTGALWMGTALLVLGYPLDWHNIHGEHLAAMSYLVVASTLMTVYLYQRST
VVLGPRRVMAYIYLNPAAIAVLLWWFEGVKIPTIVLPGIVACSLATVLLQREPRS
>fig|281689.4.peg.1584 Permease, MDR related, probably tetracycline resistance protein
MARIEHNILKIYLIKTARWLMLTTPFLPLFMAENGIDKSGYGLLASIQALSIVFFEVPSG
YLADAIGRKKTLVLGSILGALGYVIYSVSFSFSGFLVAMVVLGIGQSLISGSDSAMLYET
LVDMNRTGEYSRYEGRVIALGSLMETIGAPLGGLLAVASLRYPFVAQSVVALIALPAALT
LVVPEQEARIRGTSINLLPALKRSLLLDRTLLLLVIYAALVGGGTYTMAKAIPYWFNDSF
ASSAMQLGIFWSVLNLSAAFFSHHAYKIEQRLNPPLFMTIIGSVVSASFIALGVLPAYPA
MAVLVLFYCTRGLATPILKNYINEQTDSQVRATVLSVRMFLVYVLFAALFPVMGWVGDAS
GWSTALVLAGICFAVIYGSALFAFTVTKKSA
>fig|281689.4.peg.2534 Permease of the drug/metabolite transporter (DMT) superfamily
MMKRSLIVVFQKPIVRLFIGTICISLAPIFIKASNMPPDSSAFYRMLFAGLSIGFLLSLG
RENIICSKKQILFLAGGGFFLALDFMCWHRSIHLIGPGVATLLTNLQVFFTAAFSFLLFR
QRVTRLFIFSVPVAFCGLYLITGADFGALAGYQALGITLGLLSALFYSGYILFLHRTMKS
SVLGAKPSMFVVSLSSTALLALTAPINGASFVIPDLATLGTLLGVGILSTTLGWTLISSS
MRAVPVTTAGLVLLLQPTLAFIWEVLLFDKPVVLLETVGVLLILAAIYCGSYSKPTPAPL
KSTKQSNRPIKRG
>fig|281689.4.peg.2726 Multidrug resistance protein B
MIFQGDTMDKAHRWLFKGVFFINFAVTLGLGVSDAFFSVFAQSLGARGAILGAAIGFYAA
SKIVFSPFMGKLSDRFGRKRLIVISLMVFLLVSLLCLSITRVQTLIILRLMQGLGCAMFR
PVVLSLVGETTLPHSRGKMVATFDMSFYGALSLGPLIGGIIMDQWGFDGIFVLLAGLCLA
ALLVAVLLIPTDDNTARTTTMPVSANRQARSRRSLQHSALPGLLVFIFGRACGIVIFVSF
MPILLMSKLGLTGVEVGMVMASTSVVMTLCLRPMGKLTDRCSRSVLVMVGGTVVSLLYVL
IPLATTFHQVLVLGMAIGLFSGLSQPASTALLVEEGQRFGTGFAVGMFNASLNLGFVVGP
VLGALLLSSEGLSSVFYVAGLCGGLAVVLFSITTRATASYGQAWHVRS
>fig|281689.4.peg.3210 Bicyclomycin resistance protein
MKPSIEQHKALYITYLALLAATPPLSTDMYLAALPEIASSWGVGKDLINLTLVLWFASFS
VSILISGSLSDKYGRKPLLLWGLSLFVVTSFLCAGAGSAQMLILFRIFQGLGAGAPAAIV
LAIIRDRFTGKERHQAIAYVMTIVAVAPMVAPIIGAMLLEFFNWRFIFVMQGVMVSITLL
VTFAFKESLADPLNISLKRLMTRYTVHFRNKEFMFASISMGILVLPFYGFIAFSPIYYIT
IHGLSEKMFSLLFGLNALSSMCGAFSSSFIVKWVSDKTVITVSIYGCVIAGIGLMVLGSQ
HFLYFFVFMAFFSFCTGISRPISGNMILGLVKTDVGSASSFLVFYQFISGALCMAFVTLQ
WSYPVLVYGSLTTIVSILVLILWARIAPHLNPIH
>fig|281689.4.peg.3321 Acriflavin resistance protein D
MSVLHYSIKKPVSVAVFVIMILMFGIIGLNKLPVQLTPDVELPEITVTTTWPGATPYDIE
QEIIEDQEDALKGLQNLISLESSSYNNYGTISLVFKVGVDIDNALLRVANKLDEVGDYPE
NVDKPIIEAAGANSSPVIWLLLKTKQGNETPIDQYRTFYDNEVEQHLERIDGVGSLFVGG
GTEKELQVVVDREKMARHNITISQVTHSLQQANENTSAGNLSIGKKDYRIRTVSRFQNET
DPLDVVLVDDGIKRVYLRDVATTQEGFEKRTFAVQNNGKPCIVVGIRKEKGANVIDLVQR
AHETIDELNAGLLADNGLTFDWVYDQTPYINTAISIVKQNALIGGLLAIVVLLVFLRSVS
GTAITAIAIPVSVIGTFISLWVFHRNLNVVSLAGISFAIGMLVDSAIVVLENIDRHRQMG
KKAFDAALDGASEVFGAVLASTATTVAVFLPVIFIEQEAGQLFRDIAIAITFAILLSMIV
SLVVIPCLANLVYGRRPVIKQKTDRIGRFGQRFVDGIMRFSDLSLKSVATRIMTVTLLTL
TAALLVWILLPKSEYLPQGNRNLIMNILIPPPGLSVEKRESIGQYVYKQVEPYVKEDWKD
GIPQIKTTFFVATPDLNIMGSLSTHETEARGMMPLMTRVMNSIPDMIGVSLQAGIFESNI
GEGRAVEVNITGTELPTLVNAGRTLYGAISQAIPQSQIRPVPSLEISYPEVSIVPDKKKL
VANGLTETELGEYVDVLMDGRQIGDYMPDGTRKVDLVVKASDAEVRSPEDILNSTIVNRY
GELIRVGDIARAEYEQGMTQIDHYERRRNITLQVTPSADIPLQQATETIEGLVAQLRKGG
KLDGTQIFIGGNADKLVETREALQWNLLLALVITYLLMAVLFENFFYPLIIMFSVPLAAA
GGFIGLKAVNLFVAPQGFDILTMLGFIILIGTVVNNAILIVHQSLNNVRFEGMKGIDAIR
ESVRTRIRPIFMSTTTSLFGLLPLVLSTGAGSELYRGIGSVLLGGLLVSTVFTLFVIPAL
LAFFIHRERAENAE
>fig|283942.3.peg.76 Permease of the drug/metabolite transporter (DMT) superfamily
MLIKKGLLAFGPMEVGALRISSAGLVLAPFIARRLNKITRKHWLKLASVGLVGSLIPAFM
FAIAQTQLASGVTGVLNALTPIATLVIGALFFHQKARLAQVIGVAIGLFGTLLLVTASAN
GSWDFNLYALLVLAATVCYGLNLNLIKHKISDLSPLTITGISLLMAAVPATIYLFAGTEF
ITQVQQPGAMLSLFSVLALGIAGTAGALVIFNHVVQLTNTVFTSSVTYLIPIVALILGIL
DGEDFWLQQGVGMLAILVGVWFANRRGRSGMAGIPQK
>fig|287752.3.peg.3051 Drug resistance transporter, Bcr/CflA family protein
MLVTLMIASALSPLAINIFIPSMASIAADLSADGATVGLGLSLYLVATALIQLVAGPLSD
RYGRRPIILGGMVLFLVGTLLCLMADDVALFLVGRVVQAASATGIALSRAIVRDVYSRER
AAAMIGYVTMGLAVAPMIGPLIGGVLDTAFGWRSVFWLLTGIGIVTIVLLAFDLSETNSE
TGRPILPQLRAYGELAGSSAFWIYVGTSSLTSAVFFGFLGGAPFIAMTVLGMTPAGYSVW
FALCAIGYMLGNFATARLSERFRIKTMMVTGAAISLAATSLSLALIAGGLLSPLTLFAPM
LFVGFGNGLVLPTATAGGVSVMPQAAGAAAGMLGACQIGVGALSSILAALLATGSGGAVG
LLLLMTGIAIAGLGVALSARRVNAAG
>fig|288000.5.peg.1811 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MLGTDVSDLTTTAADAASQGLSIVIPVYNEGAGLTALHERLNNLARTLRQRFGLACELVY
VDDGSRDNTLAIARTLQADALDVQVVSLSRNFGKEAALMAGLDHARRGAVLFMDGDGQHP
PALVEQLVTHWIKDGYDVVYTAKAHRDNEPFLRRVAVHGFYALINWGARQKIPEDAGDFR
LLSPRAVAALRQLPERNRFFKGLASWIGFRQIRVDYEPAARAHGVTRFNVTSLLGLSIEG
LTSFSVAPLRFASLLGILLASAAFLFGLSILWETLTTGKSVPGYPSLMVGLMTIGGVQLI
MIGIMGEYIGKILSELKARPIYFVAEHSEKRAALDSRSDGAERTAAE
>fig|288000.5.peg.2589 Permease of the drug/metabolite transporter (DMT) superfamily
MPDQGSHSRSDPGLPQLAATSRGQVSGAVTAPPLEGAGNDRAGALIVAISAVAFSTAGLF
TRLVEADVWTMLFWRGLFGGIMIGAYVIWTERTAHRKAFTAIGWAGVLTATCSTAGTICF
VAALRMTTVADVTIVYATAPFIAAGIAWVWPRERPRCVTLVASGLALLGVVILSAAALPA
ARMLGNLLALTMTILLALMMVINRRFRHVSMVPAACLSAFACAVLVAPLADPMSVTGADL
VLLMLFGTTQFGMGLLLLTIGSRRIPAARASLLGNLELPLAPLWIWIAFGELPSRSTLVG
GAVVCAALLLDLAADQAPGRWLGRPPLHQKAPDMGRG
>fig|288000.5.peg.3480 Glyoxalase/bleomycin resistance protein/dioxygenase
MGVSVGVLDHFNIRTRNLAETVRFYEDVLGLENGARPNFAFPGAWMYSEGRAVVHLVDIS
PTSEAQKPDSGVVHHVAFVSRGFAAMKARLAAKGMPFEARQVPGGELWQIFVRDPNGVMI
ELNYEAAKEQAGDAPVETASDIGTMVAF
>fig|288000.5.peg.4654 Bicyclomycin resistance protein
MTQSVPFSVAVALGLITLLAPVSVDMYLPSLPVMAEEMNTTYPAMQLTLMVFLLAMGAGQ
IVFGPVIDAYGRRRPLLVALAIFVVASLCAAVAHSVEALLLARLLQGLAASLAIVTAMST
VRDIASGVAAVQIFALLMTIQGLGPVMAPVLGGMIGAGLGWRAVFYFLAALGAIVLANTF
TRLPESLPPNKRSSLHPVQVWRTYVSIVMDRRFLVPGLALSGVFFILFGYIGGASYVYQS
FYGLPSREFGFIFGATGIAVLIGAIICARLVKTFDVERLALAGVLAMLGGALIGWVSVLV
GIGLPGIVAGMILTLAGLGTAEATLTSIALASRASALGASTALLGAVPLVLGAAATPLAA
LLAEIGPAWWLAFLALAGVVTAGLTLASLRMVAGQGVRVVQH
>fig|288000.5.peg.5468 Multidrug resistance protein B
MTTSTEARSGLMGGRAIAVLIMLFLFQTLNFFDKLVFGLSAVPMMKELGLSPKEFGLIGS
SFFLLFSLSGMAVGMFVVGRFPVKWLLLIMAGVWSATQLPIFFSSSIAVLVLCRIILGAG
EGPGLPTALHACYNWFPADRRSVPSAVVLQGISVGLLAGGPILTYVIVNYGWRTGFLFCG
LLGLVWMAGWFFIGGEGPYSAAHGPEATAAKDKALPVRVLWGDATVIGVIIMSTASYWIV
GMSATWLPPFLQLGLGYKQVDVGWVISGIYLFQSPLLLGGSWLTQYLQRKGFSLRACLGH
ASGLALLAAGCALLLSIVTTGPLQLACVAIAFAAPSLTTIFGPVALGAIAPAVQRGRLIV
VIYSGNAASALVSNALTGWIVGEAGSNVPLGYAHAMTFTASVLITGAISAFALIFPERTI
ARFARTTQDPSSSSAVAAAST
>fig|288000.5.peg.6008 Multidrug resistance transporter, Bcr/CflA family
MISRPPRTATIQAAPSRTVLILLVVMTGLAPISLYLLVPALPLLATTFGRDASVVQMTVS
FYMIGIAISQLLLGPLSDRFGRRPVMLAGLALSIVASFGCIFAATLPQLIAARFFQALGG
ASGMVISRAIIRDLYPRERIGAMISLVVAVMMIAQMLSPLTGGLIEIAFGWHAIFYVVAA
VSVAVAIAVTMALPETRPTRVEGASFRRDVTALVKSRAFLGYMLCQVLASQIIFAFAGGG
PYIVEVQMGRSSAEYGAWFATTGFAYFVGNLFCVRYAPRHSLDRLIWFGLGLQLTGAALN
FTWSLFGFNQVPSVLFGTQMLLMFANAAVMANSAAGAISVRPGAAGTASGAMGFLQMGVG
ALTSQLGAYLGGHYATTLPLTSAILALSLACACSMIFLVPRTAVTVTKELIERAEEDEAG
VM
>fig|288705.3.peg.43 Permease of the drug/metabolite transporter (DMT) superfamily
MKPKHALLAVLVTLIWGTNFLAINATLQSIPPMLSVALRFVLAIFPWIFFIKPPKIGWKV
IVTLGLAVNAGQFGLMYLAMHMGLPTGLAPLVLQAQVLLTVLIAMFFVKEKPNLGQSIGI
GLGIVGLIVVGVGRAQVAPILPFILGLGAALSWSIGNVVSRQVQKNASTATSGLSLVIWS
AAVVPVPMFALSFLLEGPEQIGFALSHLQLPAIIGALFTAYISTIVGYGIWNYLLGKYSS
AVVGPFTLLIPVIGIASAWLVLQEAPSIPELVGGGLLLAGVATAVIRFGRKPRPVPEVLS
EQIQAEGVLR
>fig|288705.3.peg.766 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MVNTVKFAQIAPVFPVVDLERSISHYEALGFEVAKYDGDEDYAYAKLGAVRIHLWQAPGI
DPETNFSAAFIEVDDADARALQWKAVSDNAEIRCPTGMPVDTEYGLREGAHVDPDGNLMR
FAHKLT
>fig|288705.3.peg.1949 Ribosome protection-type tetracycline resistance related proteins
MALEVELGALPLSFHVALAEAVRDCLSQGLAGWQVTDCLVTITHTAYDSVMSAAGDFRRL
LPLVLMRALARAGTEVCEPLSEISLEIPLSAFSAVIGMLGRAGAKTTSTEIAAERCQITA
VLPAASAICVTQGLADLTAGDGTSTSHPAGYRPVVKVPPPDLGPTVIR
>fig|288705.3.peg.2509 Vancomycin B-type resistance protein VanW
MILHSPLEIVEYHHHSAYDLFPDFNRQIPYGTGTSIVYNYLDYRFRNNLDQSFQIIVYLT
EEHLRGELRAEQPLPLKYHVHEEDAYFYQAGEQIFRHNRIIRTVTDKRTGNQVLHEELLE
NNGLVCYDRDLIKSAILSQKPSESVANSVS
>fig|288705.3.peg.2979 Multidrug resistance protein B
MFWLASIAALAAITVDVFIPTAKEIATATGAIRIVTNAQKSDPAASASIAPARLAADNEM
VVRGVVVGPAGKPVRNAVVTALDLDGEPADWSRADNEGRYALALPGEGRYLVVSSAEGWA
PTSEVAEFVAGEQGRVITLSVRFGLSGTVRSGGRRVEEALVTLTKPTGEFFGSARTDVAG
NYELPLPQTGRYIVTVLATGATRAVARQVVLTGQSLVVDFEDLPLAELVTS
>fig|288705.3.peg.3501 Transporter, drug/metabolite exporter family
MRKVNLLALGLVLAAAVARAVWNLAAKKAGTGGVPFLWLASLCSAVILAPLGIWGILAFS
GQ
>fig|288705.3.peg.3606 Glyoxalase/bleomycin resistance protein/dioxygenase
MIDFAKTFSGFSVNDIAVAQSFYTEKLGLEVLENNGMLNLYFGGHRHLIYPKSDHEPASY
TVLNFPTNEIEATIDQLVGRGVQFEKYPGVDERGINRRGGPLIAWFKDPAGNVLSVIESR
VTEPQLAELQTAASRQKFPLI
>fig|289376.4.peg.116 Membrane fusion component of tripartite multidrug resistance system
MSLKSIGERFKNSKKIKIAILIVVAVGALIFMSKEIYYYIVYERTDDAYIEGTIVPISPQ
VSGKVSKVYVDYNQRVKKGEPLVEIETDDYLADVKAKRENVNTLYNQLQEISSSLNEAMA
KLKTAEANLQAAHAQRVLAEKEYQRIKGLYEEDLVSKSRFDSAEASLKVAIAQERAAESQ
IKEVKSTINTFTVKLKTQQHLIGKAQEELKISEINLKRTLIFSPRDGRIAKKSVEVGQYV
RPGQLIMAVVDEQDIWVGANFKETQIEKMRVGQPVRIKVDAYPGKIFKGHVASFQPGTGA
VFSLFPPENATGNFVKVVQRIPVRIIVDSPFEPDYPLWPGMSVIPYVDVTVNTGAKLKDV
IGKQ
>fig|289376.4.peg.1225 Multidrug resistance protein B
MKRFWIVLTVMLPTFIEILDTTINNVALRHIQGSLSAGVDESTWIITSYLVSNAIVIPMA
GWLSKIFGRKNYLIFSITVFTISSFLCGMAWSLTSLIFFRVLQGIGGGGLQPLSQSILLE
TFPKEKYGTAMAIYGMGIIMAPILGPIVGGWIADNFSWRWIYYINIPVGIISILMTYLII
EDPHYLKREKLRIDYPGIIFLALGIGCLQIMLDKGEREDWFESKFIITLFVISILSLATL
LWWELKRAEHPIVNFRLFKDRNFFFGNLVMFFTFVNLFGSIILLPIYVQNLMGYTAFLAG
LVLGPAGIVQFIAFPISGKIVDRINPKIPLAFGIIMCAYSTHLMSLFNLQAGFWDFVYPR
AVLALGMAFVITPLAAMTVAYIPKEKMQDATPLNGVIRNIGGSVGTAIVTTIVSQRTQFH
QARLVENLTPYDIPYQIIIEKLNEYLSIRTFLPPENPIYRELIRQAQTIAFNEAFWILSI
AMISMIVTIMFFRKPIYKKKGGNAGAVH
>fig|289376.4.peg.1367 Outer membrane component of tripartite multidrug resistance system
MIDMQINNDTENLAKWWESFNDKTLSQLIEIAIKNNLDLKQAQARIKEAKARREVAGAKL
FPSIDAKSSASYSKTRGTKIEDNTVEHLYSAGIDASWEADIFGGKRKSLEAYQAEFEASQ
WDFKATIVSLISEVALNYIELKTYQNRIEIAEKNLNSQTETYNLTKWKYMAGLNDAIDVT
QAEYSMENTRAQLPSLRTAIEEKINTIAVLLGKQPQQISEELKKSHTKPLISEKISLRIP
ADVLKMRPDIRKAERQLAAQSARVDEAIAGFYPKFTLSGSFGIEALSLNSLVKAATKIIT
GDFLISLPIFHADEIRQNVEIQTALQEQALLNYEATVLNAIKEVENALVAYAEEQKRKQA
LEKAVEASQLSFALALQKYEVGLTDFSTVLETQRSLLNLQDQLEQSKGNIFIYLIKLYKA
FGGGWESFANEEEN
>fig|290315.4.peg.81 Outer membrane component of tripartite multidrug resistance system
MKKTLKRHAGIAAAALMLTFPPRLEAVAEPASARLTLEETIRLVRENNPALKAASEEVNA
ADARIRQQKSAYYPQITASAGYTWIDPVSEMGFGGSEPIQFMPNDNYEAKVTARATLLDF
GKRGIEVDMARTGKNAAGHTFEIIRRDLSYRTVELFYGILFLRESIRVEEKEIAALQKAF
DYTTKRYQAGTATKFDVLSTDVRIQAARSKKLGLEHQLRRHELTLHRLTGLAANTPLDLK
GSFSVHPENPDETTLVAAAVRQRPEVLLAGENEQSARLRRSRSMKEGLPVVRASASWGVS
NGYQPDIDEIRENVAAGIHMELPLFTGFRTSAERQEAAALLRAAAQRRLDTEEQIATEVA
ETLHALDTAREKILTTESQVRQAKLAAEHARARYENGIATTLDLLDTEAALAQAELARLQ
AAYDYVLNNYTLKRATGEIFW
>fig|290315.4.peg.110 Glyoxalase/bleomycin resistance protein/dioxygenase
MNSNALSACFCTSGVDACREFYQRHFAAEVIFDCGWYVNLRFGKDGPTLQFMQPRQGMVA
FCGKGVVLNWSVDDVDAEHERLIRYGLDVIMPLEDHPWGDRGFSVADPVGNTLYIYSDRE
PSEEFRQYYKNCEAGPPDYA
>fig|290315.4.peg.1721 Acriflavin resistance protein
MTLTELSIKRPSLVVVLFSVLGILGFFSYLQLQYELLPKMTPPVVSIAVQYPGGAPDEVE
TSLTKPLEEAVSALEKIETISSISSEGLSVVTVEFSNDADIDLALQDAQRKINEIRDRLP
DDAKDPVISKFALDEVPVLRIGAISSLSDTDFYQLLKDNIKPQLSSIDGVGQVYLTGGRE
REIRVNLDLDRLQAYGFTVTDVLGTINRANLDFPTGKIDAADRQFVVRLAGKFIGLDELK
NLVLRSSAQGSRVHLKDVAEVRDGFRDITTLTRLNGKNAVGLMIMKQSDANTVDVSRLVR
QELKRLETLYGRDGVRFDIAQDASTFTIEAVTAVQHDLIIAILLVALVMLLFLHSLRNSL
IVMVSIPTSLVTTFIGMYVFDFSLNLMTLLALSLVVGILVDDSIVVLENIYRHIENGEEP
REAALSGRNEIGFTALSITLVDVVVFLPLSLVTGIVGNILREFSIVMVLSTMVSLFVSFT
VTPLLASRFSRAERLEPDNALSCFAIGFEQNFKRLTEWYVTGLRWSLKNGWKVIAGSTLL
LLFSFSLLGFGFIGGEFIEVSDRGEFSVIMEFEPGTNLDETNRQTRQIERRISSMPEVDN
VLVSVGSSSEGFFNQSADNISELNVRLIPKEARAVSTDDLMKEIRRSLQDIPGLKASINP
IGIFGTANETPVIVIFSGPFRSEVSRTAESFRDSLKAISGTADVKLTSTVGNPELRARID
REKMASFGLSIADVGAALRTAYAGDEAGKYREGGNEYDIRVMLDEYFRKDTRAIEQLTFR
TQNGEQVRLGQFVTFGVERGYTKLQRKDRNNAVWVKAQVVDRPVGSIGQDIEQVIGNMKA
DGTMPQTVSYAYESDLKRQGESFSTLLVAFLVAIVFVYLIMVALYDSYVWPMVVIFSIPL
AVIGALFALASFGKSLSIFTILGMIMLVGLVGKNAILLVDFITKFRQEGMALHEAIIEAG
RERLRPILMTTFTLVFGLLPIALSGSSGSEWKSGLAVALIGGLSSSMFLTLLVIPVVYAG
FDKLRERIETIRKKRFPKVDA
>fig|290318.4.peg.789 Tetracycline resistance protein
MKKSPLFILLLTVMLDLIGFGIVLPLLPTYAKDLGASPFMIGLIAAIFSIMQFIFSPLWG
KLSDRIGRRPVMLFSIFITAVSYLVFSQTTTIALLIFSRGLSGIGSANIAAAQAYITDVT
DSKSRSGAMGMIGAAFGIGFIIGPLIGGLLKHNYGIPMVGYVSAGLIFVDFILAVFFLPE
SNKNAKKLSFRRSGTEHSADRPPTSAVLAQKINEYAAGVKLAFSSRPLAMLMIANYLFTF
AIVNMQVASILLWKEYFLASDQQIGYIFAFVGLFSVIVQGGMIRNLVKKFGEHKLFLWGH
LFTFIGVFFVPFAPKESLFTIGLTILFFFAVGTSLVAPINLSLISLYSYKQQQGEILGIS
QSVNSFARIMGPFSGSILYGMNFHAPYIVAGVLTIIGFIIALDLFKYKIDALDPGRDTVA
ETIGS
>fig|290318.4.peg.1102 Acriflavin resistance protein
MKSIIRHFVRYPVLGNVLFLAVILFGLVAFTQIRTTFFPDIPPNFIYVSALYPGASPEEI
EEAVTLKIEDRLKGVGGIDRVTSVSTENSMTVTVELKKGFDPDDLLQEVTNSVNQISTFP
AELEQLRIYKQERMDFVIAYSMYGDVDLNTLKGYARSLERELRNSGSATRITISGFPLEE
IEVGLRENDMRAYGITFSEVAAAVGRANIKITGGTIRGSSEELLIRADSKGYYADDLRNL
VVRSGGNGAVVRLGELADVRDRWSDDPDRSWFNGKPAVIVDIERSADEDMFDIVGKVETV
VEAFDRRHEDISIDVLRNGSAIVKERAQILSSNGFFGMVLVVLFLAFSLNPRLALWVAAG
IPFSFAGMFMLGAVYGLSINVVSLLAMILVVGIIVDDGIVIAESIYQRFEKGEKPLEAAL
NGTMAVIPSVTAAVLTSVVLFFLFLFLDGDLGQRVKDIAFVASTTLLVSLLEGIFILPAH
IAHSKALHGRPEGKGWVLRKSEEFLHFQRDVLYAPVLRFSIANPLITAVVPVALLVITFG
AMRGGLIKATFFPVIERDNVQITLEMPAGTPGVVTAEVLAVMEQKIRSVDEDYRRSAGGG
KGLVSAIARDIGPQAHEGGLRVTLVESRLRSIGSLEAGNRFRDAIGRVPGANKLLVGGGS
LWGMPVSIALKSDNLAQLDGARRMLESELKGMEQLKDVADNDPPGLEEVNVRLKEKAYGL
GLTTGEVMSRVRSAFFGSEAQSLVRGIDEVKVWVRYSRAERSSIGALESMFIRLDDGRTI
PLREIADLSVSRGISSIKHIDAQRVVKIEADIADPKTSVPQLLDVITGRIMPPVLAAYPD
VSFNFEGQSRESGKTTGSMRIAFPVLLFIMYLIIVVTFRSFSQAFLVMLLLPFTLVGVAW
GHFIQGYILSILSLFGVIALIGIVVNDSLVFISTLNSRIKEGEPFGNALYEVGLSRFRPI
ILTTITTIAGLGPLIFEQSRQAQFLSPMAISVAYGLLFGTTLTLIIIPALLVLHNAARRR
LFSFIARRPITPEEAEPAWREEAFSREQ
>fig|290339.8.peg.2243 Membrane fusion component of tripartite multidrug resistance system
MAENHNNNADEEKRQDQQDDNSKTEDGGKDKGKGDGENRKRPGKKPLIILGIVVVIMVIG
AIIWWFMTRNLETTDDAFIEGDAVTVAPKVAGYVTELRVKDNQRVKKGDLLVVIDPRDAT
AQRDQAQAQLSLAESQLHQAQAQLALAKVQYPAQRDQAKAQVLRAQAELANARAEYQRQR
GVDPRATSKQNIDAANAQLRSAEAGLANAQAQLEVAEQVQLQIRQQETNVEARQSQVEQA
RAQLKTAELNLSYTEVRAPFDGYVTKRNVQNGTLVQAGSALFSIVSPDIWVVANFKESQL
ERMRPGNKVEISVDAFPDLELEGHVESIQQGSGSRFSAFPAENATGNFVKIVQRVPVKIV
IDKGLENWNQPLPLGLSVEPEVTVE
>fig|290397.13.peg.52 Permease of the drug/metabolite transporter (DMT) superfamily
MADLALLVLTLLWGTTFALVKEALEIASPGVFLTARFGLAAVALLAAWALRPRAPLGDGF
WRHGILLGLTMLVGFVLQTVALRHTTPARSGFITGLNVLVVPVVARWFLGRRVRPAFWVG
VAFALAGLVMLTRPFTPGAVTEEVRFGDLLTLFCAVAYGLQVTFTSEWAPRHPLAPFVAV
QVLVTLAGALVLAPLEGPRFDPAGAGHFALVVAFTGLVMTALAFFVMNWGQRHTTAVRAA
LIFSLEPAAAAVFSWLYYGEPLGPLDWAGGALMVLGVVAGEVGGVLEARAPRRARGERAS
TGPG
>fig|290397.13.peg.215 Permease of the drug/metabolite transporter (DMT) superfamily
MRAAVRTRIVATYLAVAALWGSTWMAIRIGLEDLPPLRFAGVRMAIAALVLAPFALRGGA
WREVVGPARAQLALVAVLQIALPYGLMFVAQQWVPSGLAAVLFASFPVWIALLARALVPG
ETLTPARVASALLGIAGVAVLQLPHLGDLEGSGRLLLGGALVVLSSMIVALANVLVRRHL
AAVSPLAMTAGQTAVGAVLLLAAAALLEQGRPAAFTASAVAALAWLAVFGTALTYVGLYW
LVPRVPMAAIGALPLLDTSVAVTLGALVLHEPVGWNLALGGGMVLAAAALTIPRRR
>fig|290397.13.peg.945 Probable multidrug resistance protein norM (Multidrug-efflux transporter)
MSPAAPPLRAELRALLRLALPLSLAHGGQALMGVVDAAIVGRAGAVPLAGTGLGASLFFA
VAVLGMGIMHGLDPLISQAIGAGDERRARHLLWQAAWLAALLAAAFTLPIALIPAALVPL
GISADVAAQAGPYIWWRLPGLFFFLYYFGARAYLQAHGRGRPMVVATVGANLLNVPADLL
LVFGGASLPAWTGPLRLVPALGAAGAAIATSLCIALQAFVLVRATRAVSLGGPRPGGLAR
PDRAALATAVRVGGPVGLHMFAEVGFFSLVSFLAGRLGAEALGAHQIALAVASLTFTMAV
GLGDAGSVRVGLAVGAHDRAGARRAGLCAFAGGASIMLVPALAFTFAPGVIGRIMTDDPG
VLALAVPLLRVAAIFQLSDGLQAVGAGVLRGAGETRFTFLANLAGHWLIGLPATLLLGFT
MGHGVVGLWGGFCFGLTAVAVALLGRFLRVSSRGIVPLAERAAA
>fig|290397.13.peg.1179 Acriflavin resistance protein
MTLSDVAIRRPVFTAMMSVTLVVLGLLGLRRLGTDLYPDVSMPFVTVTTTYPGASPGDVE
ENVTRPIEDAVSSIAGIDKVFSSSREDVSLVFIEFELSVPLGEAVQNVRDKVGIAQGELP
LGARAPVIAQYDVAAQPVLVFSAASGQDPVALREKLDDQVRPRLEQLEGVAAVRIVGGAE
PEVSVDLFRDRLRAVGLDPDAVFRRIQGEHLDLPGGKFPAGDGEVGIRVRGEFRDVDALR
RMPVTAAQDGSLVRLAEVALVRKGAKEPKTLVRTDGVDAVAVEVVKQAGANSAAVANEVK
RLLPELQAELGFRAQVLVDQSVIIEANAHEVWVAIFFGGAMAVLIILLFLLDVRGTVISA
LALPTSVVGTLFVMYWMGFSLNQLTLLGLSLAIGLLIDDAVVVRESITRRLEAGEPPPVA
ASRGTQEIALAVMATTFTLVAVFVPVAFMQGITGQFFRQFGLTITVAVLISLFVAFTLDP
MLSARFVRAHVPGQERREHPVARRIRAAFDANDRVYARTLDWVLRHRALTFAAAALLFLA
SLVVAPLLGSEFAPKEDRNQLIVNLEYPPGTSLATASRRSATLEERVRALPGVTAVYATI
GYQEDPRQVRWRVNLVDKNARPDGVETYKAWIRGVLAADERLATRAVSDPPMLEGIGDFP
PVLMHVTGRDFARLREEAERLVAAMREIPALTDIQLKDSPGKPELQVEVDREEAARLGVP
AGAVALQVRLATQGEVAGKLREGRRESEIRVRLAGDDRESRGALDGMWISTPRGPVALAQ
LARLERSTSPAVIEHQRRERSISVWAQIAPGYDLGGAVQALRAKVGARPLPAGYAYIWDG
MQKEQAESQANMGMALLIAVVFIFIVLASQFESFVHPFTIMLSLPLAIVGAVLGLGIAGQ
TVNLGSLIGIILLMGLVTKNAILLVDGALQHLREGDDPETAVRRSGPRRLRPILMTSGAM
ILGMLPTALGKGMGSEFRAPMAIAVIGGVITSTMLTLWVVPVVFVWVEKLRRRGRRGPRA
VADAPEPPAARDRAAGGA
>fig|290397.13.peg.1469 Regulator of antibiotic transport complexes
MNDVLDATLDLLARVGYARLTFDAVAERAGVSKTTVYRRWPSKPDLVRPALLRLVDVFPK
ARDTGTLRGDLVELARVRLLDDTRQRARAIALMRANVGVLDDAELQALGRLVTERANQPI
VAAVERGIARGELPPGTDPALVIEPIYATLQFHVFLRSEEPSLAYVEQLVDLVLAGARAG
AAVRRTGA
>fig|290397.13.peg.1471 Acriflavin resistance protein
MDVIKTFITRPVFTAMLVLAVVVFGLNAYPKIGVDQLPDVDVPVVTVTTVLPGADPESIE
RDVSDPLEEALNGLAGLESMRSVNVESVSQVVLQFSLETAVDVAAQDVRDRVQATLSKLP
GDAEQPIVEKLDVGAAPILTLALSGPVPPEELTRLAEDVLKPALQRQGGVGSVEVVGGRE
REIRIVVDPARLRTFGVAASEVAQAVRGGSVDVPAGRAEDPRAEVVVKVSGEARTVDELR
DVVVATPGGAPVRLRDVADVVDGPAEARSSAADDGRPAVALVVKKQSGANTVEVAERVTS
SLSGLEKLLPGGAQLRVVRDNAKFIRSSIDGVKEDLVLGGLLAVAIVLVFLRTWRTTVVA
AMALPTSVIGTFAAMHVLGYTFNVITMLALTLSIGLLIDDAIVVIENVSRHAEEGAPPAK
AAHAGTKEIALAVLAVTLAILAVFVPVAFMEGIVGRFFSAFGMTVAVAVAISYLVSMTLT
PMASAYVLRAHGEPGPVSRAIERALSAVERFYRRVLVWALDHVAATLAIAVALLLATVGL
GRFLQFTFIPAQDMSEVKVTLELPAGTPLERTARELEALRTQLAAVPGVTHVFATAGGGV
QEEVHKGELIVTVVPLGERAYSQEDLKGWLRGGLRRPADAQVAVQDVAMMAGGGSRPQPV
QLNVRGQDWAEVVAAAEKVRAHMAASPLFSDVDSTYRPGKPQVTVRIDRDRAAALGIPAA
TLGSSVRAYLGGDDFAQFRQGTDSYDIRLKLPPDARGADRLGELTVRSAAGQLVELRNVA
DLIEEPTLSQIDRQEQLRQITLLADLPRGVSLGAAMQDLSAFAAKELPPAIITDFEGQGK
ELGKTAGAFVQALLLGIVLVYMILAAQFGSLLDPFTIMLSLPFAVIGALGALLATGQFMS
IFALIGMIMLMGLVTKNGILLVEFANQLRARGRSARDALLEAGPIRLRPILMTTVAMIAG
MVPVALARGDGAEMRVPMAIAIIGGLVTSTVLTLVVVPVFYRLLDRLKRPRRVELLESPP
EVERPTGT
>fig|290397.13.peg.1568 Multidrug resistance protein B
MSAARPPTNKWLVTVSVTFGTLMGAIDASIVNVALPQIRGAVGATVQEITWITTGFAIAT
VIVMPLTAFLGRLFGQKRVYMACLLVFVAGSALCGMASNLGQVVAFRAIQGLGAGALQPT
EQAILRQTFPPKEQGMAMALFAMAVMVGPAIGPTLGGYIVDDFHWSWIFFINLPVGALGL
FMVWRFVHEPEDIRAANAAAAAEQRRNMDWLGIALLAVGLATLQYFLEEGQRDDWFESRT
ITAVAAVAALALALFVWRELVAKVPAVNLRLFRDTVFTSGTVIGAVMFAILMASMFLLPL
FMQELLGFTAMQSGLALMPRVLVMMLVTPVVGRLYSRVSPRLLVAIGVVLVSLGSFDVSR
ITLESTSSGIVHAILIQGVGFSFLFVPLTTAALSNVPRARLADATGLNSLLRQVGASMGL
AVFATLLERSGVHARAAVASHLTPDRPEVQERLAQLGAFFAQRGFDPVSAREAALRALDG
VVRKQSMVIAFEQVLFVTGLLFLCVLPLLYFLKVNRHGPNEKVHVEMEP
>fig|290397.13.peg.1569 Multidrug resistance protein A
MTPPADPKLHEVRAPPAPAEAAARPGGRRRVVVGAGLVAVVIALALGAHALLTRGEESTD
DAQVEADVVAIAPRVAGPVAEVLVADNAQVRQGQPLVRIDPADYQVRVRQAEAELATAQA
QAAAAEAQVSVARAGVTRAEAEAEKAALDLRRAEELKAGDAIAAERYDATRIAGATARAG
AGANRAQYAAALASGELARARVKAAQAAVDLARLQLSYTEVRAPASGRVSRLAARVGQIV
QPAQSLGQLVPDRTYVVANFKETQTGDIRPGQPVDVEIDAYGGRTLHGKVESISGGTGAR
FALLPPDNASGNFVKVVERVPVRIAWDAVPADLPLRAGLSAFVTVHTR
>fig|290397.13.peg.2615 Multiple antibiotic resistance (MarC) -related proteins
MALQLATLCFVSFSALFFVVDPFSAVPFFLALTRNDDPRRRREIALRASVTAFAVLAAFA
LTGEWIFRLLGIGLPAFKVAGGVVLLLLALDMVRTQPSRTRITQGEVDASADKEDVAIVP
LAMPLLAGPGSIATAIVLMVRARGEDWWHPLPVLLAIALTCLASYLILAGAARTEKVLGR
TGLAILERVAGLLLVAIAVQFMMDGLAEGLPRAFPLR
>fig|290397.13.peg.2841 Permease of the drug/metabolite transporter (DMT) superfamily
MVHLVMFLHSAISAGTYLAAKRALGELSPFEVALVRFGLSSLAFGLLLWRRPVRVARRDL
LALAGLGIVAIPVNQGFFLAGMAWTTPGHAALLYALTPVFVFLFARVRLGERAGPAKVAG
IALAFAGVVVVLLGRGAVGLHGSSRQLAGDLLILLAVVAWSVFAVAGKPYAQRYGAVGST
GVALVLGTLAYLPVGLVATDWSRLAALSPTGWAALGYLVLLTSVVAYILYYWALSRAEAS
RVAIWSNLQPVLTALLAWAIAGERLTAPFVAGGAMVIAGVILTERG
>fig|290397.13.peg.4095 Quaternary ammonium compound-resistance protein SugE
MTTTNETNGGNGRAWFMLLLAGAFEIGYALSVAGSRAFTVPGWSISAGVFFLLTLYALSV
ALRTIDVGIGYAVWAGIGSVGAAILGGVLLDQPLTPVQAFWLAVIIAGVVWLKLADRARA
DGPGARA
>fig|290397.13.peg.4096 Quaternary ammonium compound-resistance protein SugE
MSWIHLGVAVIFEIAVAISAGNARGFTRPWWTTATLVSGAIGTFFLSLALLTFDVGVGYA
IWTSVAGVGVVVLGAMFLGQRLGWQKLLGILLVIGGVVGLRLSGAA
>fig|290398.4.peg.28 Fusaric acid resistance protein conserved region
MLRISTDHWLLALRTVLAVWLALFLALRLDLYQPAWAILAVMIVTLQPVMFTGGTPPIGI
IIGRGVARFFGTLFGAVAGLVLIAFFGQQPMLYLLFSGAWLAFCMYWVMLEQDEYLGYVM
MLSGYTATLVSLTALGTGVEDIWTIALGRFTETALGIGCGVLMHLLIAPRFGSRALPEAL
SGFLKNAAEETLAALDSPRPRATQDARLKALLGDYQQFEKLRGLTHLETRRLSRFIPALD
RFASDSLALITAIRELETALDYLRACEDGEHWLAQLNAHAAPLLATIAEQPAGEPLEKLT
LPDFAWDPERVSPRSRVRAELARQRLGEVLGLLQHGRRLRHALNAPASARVHALPREKRT
RTTHNEHFVARYNALRVFVAFELLGLFWIHSGWHSGYLAMMLLGVFTMLFAKAPNPAAVV
YQFLWGTLAAVTLGAVLLFLVLPVINGFPLLAIAIGIPVMVGTLLTPRPRWAAMGLSGAI
TLMTLLNLHSTYTFSPTTYINGGLASLIGTTTAMFTYALMRQRSPAERIRTLLGAYWRGV
ARLMCEPALPNRARLESRLYDRLGRLVALGGTDDTLREALDLHALALCVWRIRRLREELA
PHRRELEAWLDDIGQRLVARRHHSPEVWHELSNQARQWVDRFYHEPRLSVATAGEIAMLG
HLMREAPGVTLEAQADDDAPTAPHDRRTTPPRQETPHVR
>fig|290398.4.peg.220 Multidrug resistance protein A
MKIKKRLYTALALVVLVVLALVWGVHWWQTGRFFEETDNAYVHADSVAVRAEVTGRVAEV
AVADNQRVAAGDILVKLDPSDAKSQLAQAQASLAVAQANAVSAARQVEQQQAAIEEAQAR
VTSAQADVEQARLHLERSQRLAEKNYASQQEYQDDQAALQVAEATLAARRATLASSRKQL
DVLNAERDSAEANIEAARADLDNARHQLDKTRLRAPVAGVIGNKTVEVGTLAQPSLTLMH
LVPIRSAYVVANYKETQTARMRSGQPVSLHVDAYPDIAFEGVVDSLAPATGSRFSLLPND
NATGNFNKIVQRVPVRIRVTGPEEALGRLRDGLSVVPTVDTRDLDPEDDA
>fig|290398.4.peg.438 Broad-specificity multidrug efflux pump YkkC
MTMRWLILPLAALAEVGWATGLKLASSPLEWLATVIVAAMSLLLAVRAVRFLPASTVYTV
FVGLGAAGTVVADAWLFGTRFSWPSLACIGLILVGVIGLHQFSGKPAAPASVSRTDASRE
GVSS
>fig|290398.4.peg.496 Glyoxalase/bleomycin resistance protein/dioxygenase
MSIVGIEELEFGVEDTEKGKRFAADFGLRPRQQDGDQAVSDTFEALNGARLRVRAVDDVD
LPEAFESGSTLRRMTWGAASSEALQTLRERLADQPGFVDHGDALECRDPNGLTVRIRVST
LRDVELEVPAINQWGDIRRVDQPSPVYEAAHPVGIGHAVFFVDDLTATEHFYRECLGFHV
SDRYIDRAVFLRMQARGGHHNLFLLKVPHRGRGLNHVAFTVRDIHEVIGGGLAMTRQAWT
TFIGPGRHPISSAYFWYVNSPLGGAFEYYTNEDFLTEAWSPRELEHSLASFTEWAVEGGI
DIETRRQKAPHERA
>fig|290398.4.peg.956 Glyoxalase/bleomycin resistance protein/dioxygenase
MISLPSRQDRHFPCTSCYGHFAMLNAIDHVVVTVTDLELSIDFYTRVLGLDAHYHDATRT
DLCLDGFALRLHGPEASAARPAESPVPGSQTLGFRSSLPLAEVKAHLEALAIPMELAPGA
TPDDIETWSSLYVRDPDGNLIEISRPRRR
>fig|290398.4.peg.1018 Drug resistance transporter EmrB/QacA subfamily
MTQVDRLFERYGPRYRLWVTLTVMLGLVALGMSITIVNVAVPYIKGAFGMSDSQVQWLST
GFLASTTVSLLVAPWLVSAVGQRATFIGLLVVFIAASFLGGLGQGMGMLVAARVIQGGMT
GLIRPVAMQALFAAYPPEGRGMATAMYGMCLGLPLTLATVIGGWLVEHFTWRYVFFVTLP
ICVAAAAMGYFFLPSREQKGPRPPFDWAGVVLLFVSVFSLLAAFSNGQRWGWYDPRVPGL
LLVALVCGAAFVVWQNRTAHPLIDLAIFRNRVFVAGTLAMFLFGGTFYGIMYLLPQFVQS
VLHYSPITAGQIFLPSTVVLGVLVPLVGWLSDRHPPHRLTVPGLGCTMYAVWLMAQMDWN
TSFTYLATAMGILSIGMAAFPPPTLSNAIAGLPRHLTGHGSGAINFALQLGGALGTAALV
ILLDRRTAQHGQELNAGVNADNALANLQLDKLAELAGHLGSSATQQGAMGGYLMERIETI
WASILAYQDGFWVLTGSLFIVAIPSLLLSRWRATTPR
>fig|290398.4.peg.1537 Tetracycline resistance protein, class A (TetA(A))
MSSARLLPLLVGCVMLSPLAIDIYLPSLTVMAETFDAPFSRLQFTVTLLLLSVGLGQILV
GPLTDRFGRRPVLLCGVVVYMLGALVGMTATSLGPLYVSRVLQGLGACATMTVAFAAVRD
CFTAAQGAKLYSYLNGALCIIPALAPVVGGSLAVTFGWRSNFAFMFAFAAILGIGAVWRF
AETRPSNTVVERRLYHWARYRPVLASARFVYFAGLAGVIMSAILVYVSSAPVVLVDRLGL
SELAFSGWFGANALVNIVAFFFAPRIIHRLGRVGTVRLGLCLIIASGILQALSVMYLPLT
ALGFMVPVGVLSVGFSLALGAASSLALEPFRERAGTAAALLGALQLGGGALLATCLLATA
LPPQWALALIAVLIVSPLLWLSYRVAPEA
>fig|290398.4.peg.1854 Drug resistance transporter Bcr/CflA subfamily
MTRLNARRLALLVAANTALAPFAIDAYLPAMPTLAEAVNASVHHTELSLSVFLFGFAIGQ
LLCGPLSDRFGRRPVLLTGLVVFLVASLGIMQVSSLETLWGLRFVQALGGGACVVNSAAI
VRDCFSGREAAKVMSTMAMILMLAPLVAPTVGSVLLGFFNWQSIFLFLALYAAFLLFFLG
TRLPETHGRDPDAPSMRQVLRNYASVIRHREAMGYICAVSMSFAGMFAFITGSPYLYMEH
YGISAAVYPFVFGANILVMASSNRLNIYLLKRRTPQQNLVVGLGIQLCAGVALVALILSG
MDSIYSVAPLMVVFVGMQGLIAPNAMSSMLDHFPNMSATATALQGCLQFSSGAFAGMLVG
AFEIASAWPTVLTMLGASLLGNIGVRVLAGRALGAQEEEGAVTER
>fig|290398.4.peg.1937 Glyoxalase/bleomycin resistance protein/dioxygenase
MPRLRGVLETALYVTDMARARAFFEDVMTLTPFTADHRFTAYAAGPGSVLLLFQQGSTQE
TVTLPQGMGTIPPHDGAGRVHLALAIDRDELEEWETQLAAHDIPIEGRTHWPKGGESLYF
RDPDEHLLELATPGVWPNY
>fig|290398.4.peg.2393 Permease of the drug/metabolite transporter (DMT) superfamily
MMNHDKLLGNSISRLTGRGTGFIFAGVIIGGGLSWPLMKMTLGNMSPQVFLIWRLVFATI
SAFVLVKMTRQFRIPGREVWFPIISVACLQMGAFLWLITVGVTMVPAGRAALLAYTSPIW
MIPLAVLWLDEKLDRSVIASLVFGLAGLAFLFLPSNHVLSNAQALVGNGLLLLAAVVWAF
QIALLRRYPSRWSTLQLLPWQLLAATLGLSSLTIAFSDVSLFQGLDIRSLLVTTYVGIVS
TTFVFWGMLHIARTMPAISSTISFLGIPVVGLLSSVLLLSERLDVGLVVGFVLIAVAVFI
QSKSSRL
>fig|290398.4.peg.2404 Glyoxalase/bleomycin resistance protein/dioxygenase
MTESTAVTRLLPNICTDKMEETRDFYKELLGFVVGFEHQGWYIQMASPDKPELQIGIMRL
DHEFTPRPFQYPAQGVIISVQVEDVEETYAAVKARGFELAHDLCDEEFGMRRFMVADPNG
LLVNMFSFP
>fig|290398.4.peg.2891 Fusaric acid resistance protein conserved region
MSSTTRTQTEPPMSPWIETYLTPSKTSLQFAAKTTLAMLLALYIALWCDLDRPYWALISA
AFLQIRPMSGMVVEKGICQIGGTLIGALAGIVIMAFFAQARVPALIALTLWIMLCAYGSS
LLRNNFSYGCIMGAVTAMLIVVISANQPPSGIFDIAVARLSELGLGALCATLVSALLWPT
HVKEHLAGQADEVINQAFTHAGQRLDASDDAAAMQQSLTASLEPLTMLETDSQAARYEGP
DGNGRIRATHVLTRRTLRFFATLGALHQLLHDHRDRINAPLQQLATEIAEGFRGAEHVKG
VPAARRELQALRKRAHGYSDTQLDPLQRRVILALREVLGHAMIMLDAREAIAHPGRKQLR
AGSLSWHRDHLVALLNAGRAGLVFSCLAVFWLQTHWSNGQVAMLLGTLFSAFFATRDNPV
TICMMFFKGMLAALPSAFLFGHVLLSQANGFPMLAMLFVTPLFLGLLGASNPRLMGYCLA
FTIFNILLTMPGNGMDFSFDSFANRAIAVIVGLSAVVMGFRLIPGLGAPIRRRRLIGAIS
HDLRHIGDLPLHEEESRFSGRMADRLLQLARHDDMLPEDHRHLFMIGLNGLDLGRSCLRL
RHRLDDAAPPVRDAMRHLLTTLAAAFEDSAHGRAPQGIQAAGRALDDALVRHGDIEEDWR
WLLAGLVERLELTLARQANVMAERLTPAPAA
>fig|290402.34.peg.259 Probable multidrug resistance protein
MSKIESNKMAFTLLALAIGTFMSALDSSVVSIVIPVIQKYFNVNIAFVEWVITAYLLVVS
SVLLTFGKLSDLYGHKKIYLMGFTAFTLGSFLCGISLNIQMLIVFRIFQALGAGMMFSTS
SAIITASVPSNKRGKSFGIIAIAISAACCAGPVIGGILASMMGWQSIFYINIPIGILGIY
LSYRYIPEDKKKISVPFDLGGAVLIFITLFLILLPLDLSGSESISTTMFIILIVLGIALG
VLFIVYEGKTNYPLLNLNLFKNKTFSAGLIATTFNYMAQFIMAFLVPLYFQNTLQLSPMM
TGVLFLPMPVSSILIAPISGSFSDKHDSRIMSSTGMGILAIALFMLSFLNMGTSSWYIVI
AMILSGVGSGLFQSPNNSAVMGSVPAQHRGVASGTLSTMRNLGMVMGVAVSGALFSYSTN
YANSIYSTQGLNGVNLSQAVSTYGLRITFTAAAIIALAAMVASLIKGKTTTVAEAKSNIP
SNN
>fig|290402.34.peg.534 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENTENIDEKSLYYLEKAPVTKAIIHMATPMILSSIASVVYNIIDAFFVGKLNNTAMMAA
VILALPFSLVLMAIGQMFGVGSGTYISRLLGEGNTDNTRKVSSINFWSSMLMGIILMMIC
LPFLSSILPLLGASGETLQYTRNFIMVLVIGAPIIIVNMALDASVRAEGASTISMTGTIA
GIIINIILNPFFIFVLNMNVMGSALASVCGNIVSVLYFIYYLQKKSTVQSLSIKDFKPSK
EIYGEIFKVGVSALLMSGFFVIISLLFNNYSMIYGDSVVAGFGIAQRVVQIVDCIGMGFA
MGVVPLIAFAYSANNQKRLMEIVKKTILYMLGLTLTLGAVLFALRLQIIGIFSIDPNVIA
IGQITLIAQLSSTVFAALCEFFTGIFQAQGDGVKSNIMAAVRGVLFVPILIVGNLLFTVN
GVIWAMTATEGLSCLIGIALWLGIRRKSLLEISMNKQIS
>fig|290402.34.peg.589 Vancomycin B-type resistance protein VanW
MEKRTGKRANASKNNYNKKKKIMLAIFTLIIVGAAALIAYSIAIKGIVKEWDDKIYPGVT
VQEVNIGGMTKEEAKNKLTQTFVTSIENKKLSIKIEDKQYELIYSDINPKYDIDATVEEA
YKLGKKDGVLSRYISIKSNNSKSKEVPIKFSYNEEKLKEYEEKLQIAVNQPAKDAAVSIQ
KNNIVIKPETEGKTVNLDTLDQKLKENINGDINSDNSVSIDLEVTKPKITQEDLSKIKGV
MGTFSSNYSTSPEGRCNNIEIATSAINGTIVMPGEIFSFNDVVGPRTAERGYKEAGTYVG
NKIEPGIGGGICQVSTTIYRAAMKANLRSIERTNHSMAVGYAQPGLDATVSYGYLDYKFK
NTYDFPIYIQGNTSGKVVTYSIYGDPSALNGRTYDMASEILETIPPETKVVDDSSLPVGQ
EVTEGAGMTGYRARAYQITYENGSEVNREVVSTDTYASVGIVVKKGTQPVDATQQPETTA
EPPAAQPTGEPPVAQPTQ
>fig|290402.34.peg.1035 Multidrug resistance ABC transporter ATP-binding and permease protein
MIKKFISFYKPYKLLFILDLVVALIASLCDLVYPVMTRDLVNESIPNKDLRTIIVFAIAL
LIIFGIKAACGYFMQYWGHVVGVRMQGDMRRHIFKHLQKLPNSFFDNNKTGDIMSRIIND
LMDISELAHHGPEDLFISIVMLIGSFIILCTINIPLTVLIFAFIPFIVWFTLYERKKMNK
AFLETKVETGAVNANLENSISGIKISKAFVSHEAEEEKFEKGNKRFINARERAYKVMAEY
SSGAGFGMDVLSYVGLIGGGIFTLIGLINIGDFMAYMLFIKIFMTPIKKLIDFMEQFQNG
ITGFQRYIEIMSQDKEKDKANATELENVQGEIEFKDVNFSYEGKEVLKNISIKINKGKML
ALVGASGGGKTTFCNLIPRFYEVDSGDILIDNKSIYDVKLDSLRENIGIVQQEVFLFTGT
IRDNILFGKTDATEEELLRAAKMANIHEFINTLPEGYDTYIGERGVKLSGGQKQRISIAR
VFLKNPPILILDEATSALDNATERIIQESLEKLCAGRTTIVVAHRLSTIKNADEIIVLGK
TGIIEAGTHEELMEKQGEYSNLHRLAAV
>fig|290402.34.peg.2197 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKIQELEQKPIGKLLIQYSVPTVLSLLINSLYIVIDRMFIGNISEVGTLALTGIGLTMP
ITTIVVALSALISMGASSNISIKLGEGNKEEAENFAGNALSLSIVLGLLVTSLYMIFQNS
ILGWLGINGEVLSYTKDFITIIMAGTVFNMLGFCLPFIVRSDGNPIFSAAITITGCILNI
LLDALFIYVFHMGIKGAAIATVIAQFTTVILGLYYFMKLKNTLILKKINFKLHISIVKAI
FLIGLVPFSNQLSVSVAQIVSNYSLNLYGGELAIGAMTVLNSITILFLMPVYGIAQGFQP
IIGYNYAKKNYGRTLKTLALAVLFSTGFLAVSAIIMQLFPKFAVSLFTQNPELVNISING
LKKYTVLIFLISIPTFGSGFMMLTGKPKTAVLLSISRQSVILALTIFFLPKVIGQDGLWF
AQPITDLLSSIITIILFIKGYSDILYKKNINKGIRKTISRIL
>fig|290402.34.peg.2201 Permease of the drug/metabolite transporter (DMT) superfamily
MRKITSNNEQIQKEDRMRIALSGFLGITLYFAIENIGVSMTSSSNSALIVASFPAVTTLL
EFFIYHSKPNVKKILGIILAIIGVAVLTQINVDGNSKSMLGNIILIGAGVVWAFYNFITR
DLTNKYSAMTLTYYQMLAGFIFFLPFVIIEGKTWRMPTMTSASALIYLSVGCSIVAFLLY
NLGLRKLSASISVSLMNLVPVLGLIFSILILHESVSTVQILGGIIVIIGVILSSIQKG
>fig|290402.34.peg.2213 Lincomycin resistance protein lmrB
MNKKYKLESNQGINFISIIAILVASAFVATFNETILNVALSAIMKDMNVSAGTVQWLVTA
YMTVAAVMVPVTAFLIQSFKTRKLFLSAMGLLLIGTICAAFSNSFAMLLISRMIQSSGTG
MIIPIMMNTILLVAPKEKLGISMAICVPAILLGPAFGPTVSGIVLQYFSWHALFIMLIPI
VSIIMILGSLFVVNVGELTKPKMDYLSIILSTIGVGTIIYAISSISEGNIKITLISFIIG
IICLILFIKRQNALKEPMLNLSPFKYPKFVIGTILVMIAMMVTFTMSIMLPMYMEGALGK
TSSVAGLALLPAVICAGLAAPVGGKIYDKFGVKFLIPLGTGIVTVFVFLISLSKSDTSLV
HLVIIYICMNIGVGIFMSPSQTHGLNQLPKEYYPHGVAIVNTLQQVSAAMGSSLFIGIMS
AAQINALEVHHATNEVAIATGFSTAAFVVCGFAFVGLILSFFFGRNISQVKDKEQVGCTT
R
>fig|290402.34.peg.2619 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSVKYVHDMTEGNEVSHIIKFTWPMLIGNVFQQFYNLIDSIVVGKFVGANALAAVGACGS
LSFLFFSVCLGLSVGIGIIISQYFGAKKEEQVKRAIANSTYVIGASGVVMSILGVVFARQ
VLQLLNTPPEILNDSVAFLRIASGGMIAVAAYNAIAAILRALGDSSTPLVFLIISCAINV
LLDLIFVLKFGLGVSGTAYATVISQACAAIGCLVFALIKNPYFKLKKEHWKISESIITKC
IRIGVPVAAQNSLIAVSLVALQSVVNGFGETAVAAFTATSRVEQLIQQPFNSLGAAMSTF
AGQNMGANKLDRVKKGYHKSILIVAGFSLLAFLAAQFGGQAIMEVFVKDESVINLGDKAI
KITSCAYFPLGMIYVTRGVLNGTGDAFYAMVNGFVEVAGRVGFSSGLAMIPFLGVWSVWV
TSGLTWTITAIASVIRYRQGKWQDKSIVKPVEKTIEYKKCAEGK
>fig|290402.34.peg.2665 Acriflavin resistance protein
MSITEISVKRPAAMWMAVILFIGLGIMGYKSMGADLMPSMNIPVISVMTTYNGASAEDIK
KDIVKPIEDAVSGISGVDVLNSTSGEGYGTVTITFKMSANINTAYLDVQKAVELTSAKLP
KAADKPILYKMDMSSIPMMIVSINGDASYEELYNQSDILKQRLEKVPGVGNISLLGADKK
QLMIKIDKATMEYYGVNIDTLMGTLQASNVNVPAGEIKQEGLDQSVRIIGQFSSVDAVRN
LLIPAGNGVTIRLGDIAKIDLEVPDANVLTRFGGNKTIAMMLGKQSDSNVVEVADSVKKE
LEDVKKTLPKGTEVNILMDTTTFINSSLTQIKHNLAEGIITTAFVLYLFFRSFRSSLVVL
IAIPTSLVATFFMMYQMHFTLNMLSLMGLSLVVGTLVDDSIVVIENIQRHMDMGKNPIAA
AIEGRKEVGMAAIAITLCDVVVFAPVSLVSGLVGQMFREFGLTIVAATMFSLIVSFTITP
MLSSRLLKNENLKGVLVKKEKSKFLSKINFKFIKIISSKFNKINAKTEGSFDKLVETYKK
ALIWSLDNRKKVLAIVVAGVVLSIMLIPMGAIKSEFIPMADQSSLQISMKLAPGSTLKQT
DEKVSEVEKYLQDTKEVKNYFSLIGHDGEATADKSIAQIFINLVPKGERKKSQSELASEI
RRFGKNMSGVDLNVAESSSSGGSSKPVSIKIKGNDTDTIRDLSNEVEKLLSAVPGITDIS
NSTSSRSSELRVNIDSLAATQYNISTTNIGSVVRMALAGTNVGVYRSKNEENDITLKFEN
GQIKSAEDLKSLKITNSSGQQIPLSQVASIQKIDSAPTISREDKQDMATVEANLQGRVLG
EVTDDINAKLKALSVPDGYSISFGGNQKQMAESFSSLGLALCASLALVYMILVVLYESFL
TPFIRMMALPCAIIGAFGLLALTGQTLNLMSIIGLIMLEGLASKNGTLLIDYTNTLMKRG
MNLRDALIESGATRLRPIIMTSATMIVSMLPVALSMGEGTEMKKSMAIVIIGGMVASTIL
SPIVLPIIYTLMDDLKKVVSFKKKKIHTIEGGSTYEV
>fig|290402.34.peg.2820 Acriflavin resistance protein
MGLIKAAIRNKKIVLFLVTIAILSGCYCYYIVPKQEMPDVSSPAAMITTVYPGGSPSDIE
SLVSKKVEEKVEEIDGYDYCESYSVNNASIVVVFLTNDCDKEKAWRDMRDKIKDLKSDLP
DGCQDSDINTNLTETAGMILSISGDNYTYEQLGNYADDIKKQLSNVSGISRFDIKGKQDN
QVKVEVDLNKINKYPISFEDICGALKAQNVDIPSGNLDLKTGKMKVETPGSFTSLKEIED
TVVNVSTDTGQTIRLKDIAKVYMGYDDDSSLKFTSNGENAVLLTGYFQDNKNIVLIGKDV
TKKLDEIKKQLPPDLKIDQVTFQPKAVDESVSFFMENLRDGVILVVITVLIGMGFRNAMV
VSAVIPISISMSFVAMNALGIKVQEMSTTALIIALGILVDDAIVIGDVVQVGIDEGMSGD
EAAFHGIKKLFVPVFTSTLIIIGAFAPLLNIPGGAGEFLRTLPQVVMICIACSYLSALFV
TPAMASIFFRKSKKVEKESIIKRFFHKLLNYGLKNKIKIIIICLCLFAVSIGLLNSIGTK
FFPYADKDILYIDVANEKVDNIDSTSDLVKQVEDIVKSDEDVTSYTSAIGGAVPKFYITI
PPLAPAKDKAQIMMNIDLNKTKKFSTRQELAEYLQSQIDSKISGGIATVKLLEQAMPTGA
PIRIRLTGDDLEKLYSASDQIQEKLNGIPGTTNVRDDAAKKTYQYEVDIDSAKAVQHGLL
KSDIEKQISIAIRGYAASVYRKNGSDYDILVKSNATSVEDLKNLQVKSSLAKNKVLLSEV
ATIKLDSQIDQIKHYKKDKTVTVYSDIKTGYNAVTVENALSPEINKMDIDGVNAIYDGEK
HQIDLNFTSLGIAAAMCILIIYVILFVQFKSFVQPLIIMCALPLSLIGVTAGLLTFKMQL
SLTAVMGIISLIGVVIRNGILLVEYIIEGRKEGLSIDEACLNAVSQRFRPIILSSVATIT
GLIPLAFSKSALFGPMSVTIIFGLASATFLTFVVVPVVYSLVNTRLEERPIKTDKLNIKL
LKFWKKQG
>fig|290402.34.peg.2874 Membrane component of multidrug resistance system
MENKKESSSKWLIMSVVIMAIFMVNLDTSIINISITKMMQTFNASIDQIQWVVSSYTLTL
GVVIPSTSYFGDKFGTKSVFVMALILFTLGSLLCGISWNENIMIIARVIQGIGGACIISL
GMTILMTTFDKSEIGMAIGLMGMCVMAAPALGPSLGGYIIQNFNWRFLFFINLPVGIVAI
IMAILIFKKSEHTSSKKFDIIGFLTSSIGMSCVLYVLGKSDLDWNDIKNIVLMIVGGYSL
IIFVVNELLIEEPMLDLKLLKNYTFCMSNIIMNIAMLALYGGVFLMPIFLQQIRGLDSMS
TGLILFPEAIATAISMILYGKIGNKFDVRLFAVFALVLIGINSYSMSKITLDTPNIDITI
LLMIRGFGVGFLMAPVQTVGFSGLPKAAMSNASALTNTVKQVGTSIGVTIITSIMQHRNV
VDYSNLASQVTSFNKNSMKLFEMLQGALIKGGISGSDAKGIALSKIFGEVASQAQLQALN
ETMFIISIITAIVIIPTLLLKQGKQEETDAAVVE
>fig|290402.34.peg.2977 Methylenomycin A resistance protein
MTKEIKVALLMAASLFMEILDGTIVTTALPKMAQYFHTGSSTIALLVSVYLITVAIFIPL
SGWMANQFGKKKIWIIAVILFTISSLSSALAPNFSFLLIMRIIQGISGALMTPTARLIVL
EKTPASQLLKMISYLIWPALIAPAIAPLVGGFIVTYWNWQWIFLINVPIGLITALIGAKL
IDTDKVKNKTSFDLIGFIEIALSSGIILVGTEIATHGKDYWLSALGLVILGIILGFIVFR
HLKKSDDPLFSLDSLKITSFRIFQTSGSVLWLCVGALPYILTIFLQTVFQWSAVKAGSYV
LFIFVGNIGIKPFTNIIIRKLGYRGALLSSFGMVFITSIALAFIQINTFPAWIMFLALVS
GVGRSLALTAYNGLSFSEIAPQDRNSANTLNAVVSTLAQGMGISIITVVVNLLQIFFSIT
ISYKLSFVFLGLLMLYPVIEVIFLPKNIGHATIS
>fig|290402.34.peg.3039 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNMREELLTKEPVALMIKLCVPAVLGMLVIGLYSFVDAIYAGQMIGTNAMGAVSVAYPF
ALINSGISTLIGMGSASVLSRAIGKKDSDIINKIMGNLLVLILILSAIVTVIGVVFAREV
LLISGASGEILDLAVRYMQIVFIGSFFINFAQSANMIMRAEGRMKKAMIFMAIGAITNII
LAPIMIILFNHQVEGAAVATLVSQIIQAVITMVYFIKESENVRFHGFKIEFDLLPEIFSI
GFSAMLMQIMMFIQQVVIYKMASTYGGDSEIILIGAALRVLAFSFIPLWGMGQGLQPVVG
TNYGAKQYDRVKKSINVFVAGATVLALCFWIPIQLFPKEILSLFIKDGSIVYEGINNFRL
MYIIFPVLGFWIMSVTAFQSIGKGKNASVLVISRQIALIVPLIIILPMLMGIEGVWAAVP
ITDGIVFIVTAIMMINEYKGIGKAHQSKVEVEGKGSKKLLG
>fig|290402.34.peg.3106 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTELENFILEGSIKKLLFKFSIPAISVFLANVLYNIIDAIFIGNQPNGSLGIAALTIVFP
IQQIILALSQMIGVGIASITSRSLGAGDKLRAEKAVGTALTSSVLLGILIMVIGLVFIRP
MLYIFGSLENILPYAVTFFRITLYCSVFFVFSIVANSIIQSEGHANIAMISMIIGPVINI
PLDYILVTRLQYGIKGAAIATDISQIICFIFLLVYMCFNSKILGVKVKNLTINIKLLKEA
ISLGLSTFMTQLAYGILAIVLNNSLKVYGGSDLYVSAIGIYNRVFGFITITMYGIRQALQ
PIIGFNYGAKKFDRVKQSLKLAILASVVISLVFLVIIISFTNKIAGAFTSDNGLIALTVP
ILRVMIFMSPLVGVQVIASSFFQYIGKPKPALFLSIMKPFIFLIPLMLIIPIFLKVTGIF
VSVPLADFLAAMISLIFIYREIKKMNKLNLI
>fig|290402.34.peg.3704 Permease of the drug/metabolite transporter (DMT) superfamily
MIYLLLFINIIMLASGQVLWKIGVGKSSFNLSIQGIIDMFFNPYILVGGIIYVFATVIWI
YILSKEELSRIYPLQSLCYIGGILAGVLIFKECFTLNKGLGAIFIIIGTFIIAR
>fig|290402.34.peg.3834 Teicoplanin resistance protein
MENKKTKQEALTIRLLLVYLVVLTWIILFKMQFSLKELGYFRSINIIPFHESVIVNGRIE
FSEIYDNILIFVPFGIYIDMIKRKWYFVKKAALIAGVSLIYEVLQFTFAIGASDITDIIG
NTFGGIVGITIYGVFLKLLKTEFKANKIINIIALIGTILAILLLAFLVLVNN
>fig|290512.6.peg.237 Permease of the drug/metabolite transporter (DMT) superfamily
MRTMSVLLMIIASACFATMAALIKALGPSLPIPEIIFFRSIIPLPFFLAVLLIKKQRIFV
VAWKTLILRSLFGFLAMSGFYFALIHLPLAESVFLGRTQPLILALLAPWVVNEKPTGAVW
IAIGTGLLGVICIIQPSFGWMPAAWASIGAASASAMAHLLVRRLNRTDAPVTIVTNFFLV
SAILSGVWTAAVFTPPVASQWALLIGIALFSTFGQFLMTIAYRKDHAPVVAAASYASIIF
SIFYGYAFWHELPPASAGIGGTLIITGSCILIRSRI
>fig|290512.6.peg.826 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDMIKGNITLVFFYHAIPNVLGMLALSSSGIIDGIFVGNIVGDYALASINIIMPLFSFLI
GVGIMFSVGGMVRCGKYIGEGNHQAANEVFSKTLITVGVSTLILSAAGLMFIDQVIMLLG
ANDVLAPLVREYLIIMLLFMFFLPVSLCLAFFVRVDGQPVFAAVAIISAAVINVLLDWQL
VGVWKMGLQGAALATGAAHITSFSVLLLHFITKKSVLRFFWPRHAWGEMLHAAYNGMSEF
TNQLSAAIVILVFNWVMIRRFGVEGVAAFTIMHYIFFAEQIIVYGFSDALQPIISTNFGA
RRPDRISGFLVLGISCAVTVGVVLVVLLLAIPEKLASLFLDNGTDATYRLTLAFISFSWP
AFLWNGSNVVFSSYFTAIHKPLPSAVIALSRTLFFPLIFITVLPIFFGDAGIFVSFSIAE
FLTFLIVLLFFSVMRPQKVIQPASA
>fig|290512.6.peg.1489 Acriflavin resistance protein
MKALFRYFAERHLLAYILTILVFLFGAATLWQINRAQYPKVDLGQMVVTTQYPGASPEDV
EQNVTNKIEDELKSVTDIRRVFSMSMENVSIVIVDIEPDASDPRGVKREIREAVFRITDF
PAEVTESSLITDIKSSIFPILEVGLTGDMPYPELREFARRFEKKLKDIPGVASVQRYGYR
DREIQVELFPDKIRELQIPMQGVVDAIQQRNIRATGGSLESFTSEKNVVTLAQFRNPEEV
GEVVVRSSFDGPIIRVSDIAEVTDGFEEERVLSRINGHPAISFLINKSESADIIRTVQSI
RKLVDEEGQQLPEGIRFIYGLDFSQYVENQLSIVVTNGAIGLVLVLIALTFFLNLRTAFW
VALGIPFTLLGGISLLPLFDVELDSVTLTSLIIVIGIVVDDAIIISENIFQRREQGDSPV
DAVVNGVFKVYKPVLTTVVTTFLAFAPMFFMPGILGKFVFVIPLTISLALFVSIFEAFLI
LPAHILPGLYTRDSGNQKTTMRNWFVPLRNGFEKLLLFLLRLRYLLIFLGFLSLGGALYY
GLNYMSYILFPTKGADAFNIWVELPVGSSLNATSAKAAEFEKLLEVLPEEEVSAYLTRIG
TQADIVPMEKENFVELSVKLTPYGTRDRSADEIVADIRQKAMEIDGVQKTTFFVESGGPP
VGKPVTIRVVGSDDELRTGLGDAVFSYLSGIEGVTDPDRDDKEGKEQIEITIRHDRLSRL
GLSVSDIARTVRTAYDGQVVTSVRYGEEEVDFRVMLQKYTRRNIEYLEELSIPNRTGRLI
PLKEVAGFEQGAGPSIFYHYDGERSITLSADVAQEKITPIEVMQQVERQFAVNRDFPGIK
LVFGGEAQESQESLKGLFVAFGIAAVGIYFLLVLLFNSLTQPLLVMMSIPFAIIGVVIAF
ALHGEVFSFLGLLGVVGMAGVVVNDSLVLVNYLNELYQSGKSTDIPQLVAKGTADRLRAI
LLTTITTAAGLLPLAYGIGGTDASMMPMALALGWGLLLATPLTLVLIPCLYMIGFDIRSL
WKNIRKPQAS
>fig|292415.3.peg.1242 Permeases of the drug/metabolite transporter (DMT) superfamily
MCRGFSAGLYTCGRLPEPSFFKPDIIRPMPALTSQRALPVASLVYAAALWGVIWYPYRLL
DEAGVGGVASGVFSYALPLVLMGWLHLRDLRKARGHWLWLSALGLAAGWTNLAYVLGVLE
GEVVRVLLLFYLSPLWTVLFARFLLHERLNRAGWAVMALAAGGALTMLWRPGEWPLPANR
AEWLGLSAGVMFALSNVIARHLDGVTEGAKAVAVWGGVVVLGVVGLALRPADLDFASTAP
VEVWALLLAVGVLIGSMTYAVQYGLARVPANQAIVVFLFELVVAAIAAYFLSEERMGLQE
WLGAAMIITASLFSGHMEDAQAQETRHG
>fig|292459.1.peg.32 Multidrug resistance protein B
MDSQVSTAASRSGSGWKVLTAVVFGVFMVILDSTVVNVAFKTLQEEYAANLNLTQWVLSV
YTMALGIATPLSGFLGDRFGEKRVFIASIFLFGLSSLLCGLAPSLGLLILFRALQGAAGG
VATPLGTSLLYKAFPPEDRGAAMGVFGIALVAAPALGPILGGWLVDLGHWRWIFYINVPI
ALVGTLLGSLLLPSSTGSRTARFDPLGLLFSSAGLGSLLYAASQASDLGWTAPEVVRFFL
IGAVALLIFALVELFVAREPLLDLRLFGNRAFLVAILTGWVSVLALCGAEFLMPLYLQVL
RGRTALEAGVLLLPAGERVHVHLLRLAGGTGPGCHAARMAGPDPAAEQGYSRGRCPFLGA
QPPSFRHIANFEGPAAGVSAAGPPFLPRRAGGTVFAIVAERGVMQR
>fig|292459.1.peg.343 Permease of the drug/metabolite transporter (DMT) superfamily
MQIRTWQADLVLLGITAIWGATFPMVKNATSLEAGGVPTYWFLAVRFLMAALLLAAVFHR
RLRRLPAATWRAGVLLGIFLFAGYAFQTFGLAYTTSAKAAFITGLSVVIVPVLSLVWLRT
APSPAAWLGVLTALAGLAMLSLDGSLAPSRGDLLVLMGAFGFGLHVAGVSRFGAAHDRYA
LAVIQLGTAGVLSALLHLADRGTVLPGVAGVLWWGGPAHVGTAVIVCGLLATAAAYLLQN
LLQPYTTATHTALIFAAEPVWGAVFAYLLAGEVLTPRGYAGAALIIAGMLMAELPAGRDR
RAAAS
>fig|292459.1.peg.1020 Bicyclomycin resistance protein
MQQGLLAPQKRLGTAGLIALITVLNMTAPLSTDMYLPSFPTMMDEFGVTAGVLNLTLVGF
FFFFAVGMLVFGPFSDRYGRKPVLVAGLGLYLAASLACAGAGSIWQLILFRVLQALGAGC
MVSVSTALVKDCFDGRMRGTILATIQSMSVVAPMLAPIIGAFIVQYATWRTTFLMLAGIS
LCSLTAALLLQEPLPPGARLRGPILGSLGRLFVVARNPSFTSLLLVVALIPAGFMAYISV
SSYIYQDFFGLSETAYSLFFATNAGVSVLGPLTYIAINRKVPPRLIITGALGLALCGGLA
VLLLGRTAPLAFLLSFIPYSFGSSLIRPVSTNTLLSQQDSDTGSASALINFGNTAMGSLG
MVLAALPWPDFVTGLGTIAAGCALLALLGWAVLLLSSIPLRGIKEGLSSGD
>fig|292459.1.peg.1662 Tetracycline resistance protein
MLAFGFATVFTLLPVYYINEAELTPFQLVLVGTVLESTVFIFEVPTGVVADVYSRRLSVI
IGTLLLGIGLAIEGAIPAVVAIFIGEVIRGIGHTFTSGAMEAWLASEIGAETVGNVYLRG
NQVEQGASLLGIATSVALARWGLHAPILAGALIILAAGIFLILAMRETSFVPAARMERGS
WKATLDTAREGIRTIRRSPLLVTFVLIALFVGMSGEGYDRLWEAHLLENIPFPSLFDLRA
TTWFGIIAGLSSVLSIVVTETVHRRLDQSHERSVALFLVLCTAAQAAAVLGFAWSGQFFL
AVACHLVASLCKGIAAPLRNSWLVRSVDPQVRATVISTVGQADAIGQTAFGPVIGWIGSV
RGLRIALSVAGIALSPLVPLFIRAARVARHKPATAAFE
>fig|292459.1.peg.1688 Permeases of the drug/metabolite transporter (DMT) superfamily
MERTRGRQTLGYMMVFGAASLWGTLGVVSRNLYVGGLSAQAVVTLRASMAAALLLAALTV
LRPATLRVRLRDIPLFAAYGLVSVAAFYLLYFLTIQHLSVAAAAVLMYTAPAFVAVAAAL
TLGEPLTQGKLLALTLTMAGCALVARAYEPSVFRGQLIGVLTGLGSGFTYGMYSIFGKHA
LKRYNPWTVQAYSLLFGAAPLVLFFGREAVRSLARSPEALPWLAYLALVTTLGAYGLYLS
GLQVVEASHAALLSTVEPVVAALLGFWILEESLRLPQVIGILLVLGSAVILNAQRGEPAG
AASRQAGVPPAGVGTECARRTPGGAP
>fig|292459.1.peg.1995 Drug resistance transporter, EmrB/QacA family
MRDRRMLTVFALMLASFLTAVDVTIVDTAMPRIVGSLGGFSMLTWLVSAYMLTSTATMPV
YGKLADIIGRKRTFTIGAVIFVIGSALCGAAPSMEALILFRALQGLGAGAMQPTVQTILG
DIFTPAERAKVQGWFSAVWGFSALAGPLVGGLMVDYLSWRYLFYINLPLGALALYMVWRH
FDERVQRRKARVDYLGAVTLTGGMTLLLLVLLTGGSQLPWGSPQILGMAGGAAVLLLLFL
WTQGRALDPILPLRLFRIPVIGWGNLSSLMVGGVMYGTSVYLPIWAQGVQGYSATRSGAS
LLWLSIGWPLAAVLGSRLIVRMGVRPSALLGLGLNVAGSAALVALARTMAEIPEVLLALV
TFVIGAGMGFSTLAFILGIQSSVDWAQRGVATASFQFIRTLGGMIWVSAMGGVMNLDLLG
RLQRIPGVAARTAAEAGQWANRLLDPAQRAALGPELQAAMQEALADALRNVHLVMLLAAV
LSLAAALLLPNLRFAPEKAPQASTAD
>fig|292459.1.peg.2037 Permease of the drug/metabolite transporter (DMT) superfamily
MHGAGLADSSDECALRVVSGPSPSGPAALGAEGCRSHCVPPAGLPAQGCPSTAAGVARFQ
VKVPREQTAPPGPVIFRSVGPFRCSRAPGDGRGPPNGGIVPLPLITLLGLLVAVLAVGCS
AILIRLSDAPALVLSFYRLAISVALLAVPALARERETLRRLTGRDWLLLAGSAVCLALHF
YVWIESLNFTTVASSTVLVTSSPFIVLALGWRLLGERTNRIGLAAVAIGVAGGVIVGWGD
FRVSGSALYGDLLAFLGAVTVSGYTIAGRIARQKMSTTLYTTAVYALAAALLWLMMLPRG
IPLAPYPPREWALFAALAVIPTILGHNLFNWALRWVSAATVSMCTLGEPVIASALAWILF
REAPGWATVVGGILLMAGIALFVRYGAQPD
>fig|292459.1.peg.2485 Fosmidomycin resistance protein
MNSTVSAGRPVLALLLVLSLTHAVIDLTSGAIVALLPAMREAYSLSYAMVGLIPLFANLT
STFTQPVFGIISDRSEMRWLLPLSVALGGLGLAAVGYVSNYWLVLAAVVISALGSAAFHP
EGAHAAHNLAGERRALAMAIYSVGGNLGYALGPGFAAALIAAFGLRGTGLAALLPLALAA
FLIWLLPRWRAHEQEAAARKREQAEPGETNWRGTVLITLVVILRSIIHLGMTTYVPFFWI
DVLGNAPATAGLVQTTYLLAGVLGTLLGAPLADRFGTKPVLIASFALLLPVQAVLASLRG
WPLLIGLFAAGFLVVSTFTTTLVMTQEYMPRSLGLASGLNLGLAFGMGGVGTSVLGIVAD
HFGVLVVMRCIASLVLPALLLTLALPPVRLNRA
>fig|292459.1.peg.2601 Multidrug resistance ABC transporter ATP-binding and permease protein
MRGGPGAFRLDDYDVKLSQVDPRIYRLLGTLIRPYVPKLAAGVLLMVATALTGLVGPYLT
QVAIDRFVAERDPAGLDLVALAFLATALLNWWSSYGQTYIVSYVGQSIIYDLRDRMFRHL
QRLSFRFFDSMATGRIMSRLMSDVDAINQLVSSGLVSLFADSMVLVTIMGTMLWMNWRLA
LVSFITIPTLLLVLRLFRGWMRDAFMAQRRRAADMNAHLAEAIAGIRVTQAYVREARNQA
QFDGINERLRQANLGAVRVWATMMPSIEVVSAFGVTLVLWYGGILLRGGTADVTVGQVAA
FILYLNRFFQPIRDLSQVFNVFQAAVVSAERVAELLDQQPEIVDRPGARDLPRVAGRVEF
RDVVFGYEPGQVVLKGINLRAEPGETIALVGPTGAGKSSVINLLARFYEPQEGQVLVDGV
DLSTVTQRSWRSQLGIVLQDTFLFSGTIRDNIRYGRPDATDEEVEAAARAVGAHDFIVRL
EKGYDTEVHERGAKLSVGQRQLIAFARALCADPAVLILDEATSNIDTHTEAVIQEALQTL
LRGRTAFVIAHRLSTIRSADRIYYIEDGQVVEQGRHAELLALGGRYARMYRGQWEGE
>fig|293826.4.peg.272 Acriflavin resistance protein
MTKWCLEHRSIVAVLSIFIFLSGIFVYTTMERQENPDVVAPGATVKTIYPGATPEDIEKF
IVKPLESKIGEIPDVKMMLSYSLDNVGVIIIRLEDLSDEDINETWNLLRQKVDEAELPEQ
AWDPEIDTDLIDTYGMLFTISGDRFEYKELKSIADELQEELEKMDGIAQVDINGYIDEEI
HINLDLLRMKHFNIPVETIGMALKATNINIPGGSLKLRGTNVPISTTGEYKNIHDIENTI
VGMSEAGNVIYLKDVADIEQVEGDRDVFVGSNGEKALLMNLKYSDGENIVNIGEEVMTFL
EEYKNTIAEDMNITVITDQAEYVEDAINLFEKNLLSAISLVVVVVLISMGYRSALVVSSA
IPITVMATFAFMRFTGIVLHQVSISSLIVCLGLLVANAIVANDSMDLYLSKGMSRKEAIV
YGINEVKIPILTSTLTTVASFLPLLLMEGVAGKFVKSLPIMVTVALFSSFILSLTVVPAM
GYTFLKGSQGEKKKSLFSDVSDFFLKQYKFILKATLKMPIITILVAMGLLVFSTTMISSL
GLQLFPFVERDQYVIDVTLIEGTSAEKTKEVITEIEEMLKEDPSVDSFLSKVGDGIPKFY
PSFVPNQIASNQAQFVVNGKVSEMVALQDRIDQTVVGARVEVKQLENAVPVGLPIQVRVS
GNDIDTLIRTSNEIKEILYTVEEGQHVQDDYGHEVLKMVIDVNQDKASMVGITNYDIAST
VRMAINGHEVIKMRPDDTDDDIPVVLRIPTDEKNTVQVLDNIFVTSQFTGRNVPIQQIAD
IHSEFSLSRILRRDRDRTITVGLYPKPGYSAAEVLNVVEERMEGFEVPQGYMMEFGGESE
DRTEAFESLIGPFFLAAMLIYVILMFQFMDLRQPLIIMGTIPLSFIGVIWGLKITGYPLG
FMALMGTVSLMGIVVNNGIVLLDYINILAKSGIEAKEAVIEACATRLRPIMIGMITTVIG
LVPMALIGGSLWAPLAYAIIFGLMVSSILTMLVIPSAFMLFRRRDKKGNGIIDEALTDKE
IKETVS
>fig|293826.4.peg.528 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSIQLNKKDSKRRKFILEGDLWQVVLSISMPLAIYNGFNHLFSFLDTMMAAHIGSEVVSA
ISYLVQIKTMIMAIGAGLAIGGGIIIARYYGADDIRNAKKCANTLVFLTIGISLILLAVL
LPFTKQILRLANTPEELIAVGSGYFTVEIIMIISIFINNVYIAIEKAKGNTKSILHLNLM
VLAVKLALTALFVYVLNYGITMMAMATLIAHLMLTVFAMTHMLRPDNVFRISFKDVDLSL
KFIWPILVLALPIFFERFTFSFGKVIVNSMSAFYGSMVVGALGVSNNIGGVIISIGNGFQ
EGEASIISQNLGNENFERAVNVFKKTLIVSLVLGGMGLLLTTVFMDQIIRVFARGDLAFA
EEITNVFKYERWAVVTMTVSSAVMGLLYGFGYTKLSLVINFMRLFALRIPTLYLFQTFTN
LGSESVGIAMLVSNGLIGVTSVIIGFVIIEKMKKEGRYHKIVTTH
>fig|293826.4.peg.867 Permease of the drug/metabolite transporter (DMT) superfamily
MEQSKMRAQVFVLMAAILWGTTGSAQAFAPQNATPIVIGALRMAIGGTFLLLVARVRGGF
KTKIKVDKKLLVIASICMAFYQPLFFSGVFKTGIALGTVLALGSAPVFSGIIEYFIGEKL
SKRWLIGTILSIIGCTLLFGGQDSMNVDVLGSSLSLGAGLSYAIYVKVSKKLFENSRRDE
VNGLVFFISAIILSPILLMNDLSWVMSTRGIMTTLHLGIVTAALAYTLFAYGLVNTSTPK
AVALTLAEPLTAAMLGVFMFNEIFTSVSMIGGLLLFCGLIINSYPEKENVNVKDKMKALQ
I
>fig|293826.4.peg.1058 Multidrug resistance protein
MYGIPHLKFKKDIWFLLASILIIHIAAYIIVPIFPILLRGQKGLNPTQIGLVIGAGSLFI
QLGSIVAGFISSRLGNKLAMVIGNACQAIALFGLGSVHTLYPLILFSSLNGIGTGIYVPT
VKSAISYIASEENRTTAFSMRGVAAHAGTSVAGIFVLLSAVNRNFYIASGIYIVLMIISW
IYLPTNCGEEPCPPLPFNRYIEIFKNRTFMNFTFVSIFLWALHTQLNFLLPLRGEAILDN
TNIIGTIWTITSVTVILIQPFISQMFLNKISPKLSICIGSILVGSGVTLIGWANSFYFLV
LCAIIFILGEMFMMPTLDSVTSLIADPKMIGAYFGVANLASGIGAAFGTFASGRLIDLYG
ITESVLPWVMYGIATVVISGLIFLPAIKTLDQNNEGAK
>fig|293826.4.peg.1297 Acriflavin resistance protein
MFKNMIKLSIKNKTVTIFSMIMITLFGLYSYFTIPKQEYPETPAPAAMITVIYPGASAEE
VEALVTEKLEEKLTELRNYDYTDSTSLNSAAAILLILDMDISEAELDQTWNELYRMMEDV
KNHLPAGVADININTNLIETSGILIGLSSDNYSYEQLVTYGERLKNNLIGLGGINRFEII
GEQEKELKVEVDLQKLDLYNLSISQITNILAAQNIQLPSGSIQNDRMKFYVNQEGLFKSL
EEIENTILHIREDNIIVRLKDIAQVYMGLKDSNYKIRNNGENGILLVGYFKGDVNVVTAG
KEVRTVLEDFKKQLPEDISVDEIVYQPEEVEKSVNDFVKNLIGGIFIVILVVMLGMGIRN
ATTVSFAIPLSMFITFITMGLLGIKIHMITITGLIMALGMLVDNAIVVSDSIQNKIDEDI
DQLTACVEGTKEVAIPVLSSTLTTIAAFSPLLFLPVATGAFLGGIPQMIIISLIASYGIA
IFITPLMAYLFFRKSKSNRKKDGKIKGIFEGLLVLGMKYKVRTLLASFIILVLSLTLVST
LPQELFPKSDKDMIYIDIQTEYLSNLDKTDDLVKEIEAVLREQPEIISYTSSIGGGIPRF
DISIMPQANAPNSAQIVMRVNLLNGETFKTNEELVRHLQEIYDERIVGADVIVKELEVEG
GLGAPIQIRVKGNEMEDIIEAKEKIKEALINIEGSTNVRDDLPLLDYQFSMTIDGNRALS
YGLTKQEIQNEVNMALMGRKTSVFREEGKEFDILVKGNISRLEEFENLKIKSTATGLQVL
LKDVANINFEPVIGQINRYQGERAIAVQGNVAEGYNAIEVQTVLEEKIKDIDFPNVTVVP
EGEKADMEGDLGNMGISAIFALFLLFIILMIQFNSVIQPGIILASIPLSLIGSMVALVVL
RQPLSLFSILGIVSLMGVVINNAIILIDYINTQRKTGMPIEEACSKAVSARFRPVILSTT
TTVFGLFPLAFFGNDLFRPMAVAFMGGLMVATLLTLVIIPVLYSLIEGKIEAFKRRRDKK
KLI
>fig|293826.4.peg.1432 Probable antibiotic-transport ATP-binding protein ABC transporter
MIKVSDLGFAYQKSRAKAIKGIDFHIKKGEIFGFLGPSGAGKTTTQRIIIGLLQGYSGSV
EVMGKERREWGQEFFERIGVAFDFPNLYLKLTAAENLQLVAAYYQNKPRNIEVLLDRVGL
LPDRDKKVEAFSKGMKMRLNFIRAILHDPELLFFDEPTSGLDPLNAKIIKDIILELKAQG
RTIFLTTHNMTVAEQLCDRVAFIVEGEIPVIDSPKELMVQHGAHTVKIEYHKGNTTKAET
FPMEGLKENQQVFDILKRRDIKTIHSQEATLEDIFIKLTGRKLI
>fig|293826.4.peg.1433 Probable antibiotic-transport integral membrane leucine and valine rich protein ABC transporter
MRILNALKADMRFQFKQGFYFVYVILTLMYMILISQFPHGFTSYAVPIVIFTDPSFIGFF
FIGGIVMLEKVQGILQYLVVTPLRPREYLISKVISLTLLAEVAGFAIAYVTYKAPFNWIL
LFIGIFLTAAFFTLYGFVVAASCNTINEYFIKMIPYMLGLMIPTLYYFTYPNVWILRLLP
SVAGFNLVNGAFNGIRFLEMAAYIGYLVLINIVTLIRVEKYFIKKVLRGE
>fig|293826.4.peg.2032 Fosfomycin resistance protein FosA
MMINGINHITFAVSDLEKSVEFYVDLLELRLVGKWDKGAYLLAGNQWVALNVDDAVTLET
KSDYTHISFNVLSTDFKKMKDKLESAGVKSFKENSSEGDSFYFLDPDGHKLELHYNNLED
RLKWVRENGWLTFELY
>fig|293826.4.peg.3501 Vancomycin B-type resistance protein VanW
MKTNFEGIDKRKAFLWGAGLILIVIVIGLIAMLALSFNSGKIHPHIYIEEVDVGGLSKEE
ALAKIQKIYDKGVSENQLQLHFESQEWKRSYQELGYTYLYEEAVAEAYGVGRSGSIIEQL
KQIMRTRKTAPVIRLRGKHQGEKVAILIGEIRSEVDKEPINAKIKREEGTFVITEEEVGV
QVDQVLLRTRIREALASSYSGILPVPVKHVLASVTREDLKVIEVTIGEFATNFNAQQEGR
TKNIEIGSSSIDGTLIMPGEIFSFNEKTGPRSVEEGYQEAPVILAGRLVPGVGGGICQVS
TTLYNAVIRGDLEIVNRQNHSLPVSYVPLGHDATVAYGYLDFEFKNSTEHPIYIESTVLG
NRLEVRIFGKNVPPYQVRLASEIVERISPTREVKQDPNLLVGERKVQQEGKQGYRVKTDK
VYYEGNQEIRREQISTDYYPPVKTIIAEGTKPRPQRSEANQEDIEESRELKEAEEIPEDS
EVSEE
>fig|293826.4.peg.3612 Permease of the drug/metabolite transporter (DMT) superfamily
MNHKKYYGLMTFGTILWAGAFIAGKLGVEKLSPLLLTYFRMLFATIIIFPILIFKDKNWK
IEKKLIKYVLLTGLVGMIGYHLLFFTALRYTTASNASIINATNPILTSIFAYVILKDHLS
PRRIFFILTAFIGVLTTIIDWDFINLIHFSFNKGDLIMILGTTCWALYSIIVKQVMHHFT
PFKLTAYTFLASVVLLTPFALYEMMYTDFSSIGIMPFYAVFYMAIFPTVMGYTIQQVVIK
ELGPSTTSLFINLVPIFSVLFATVFLKESFNYLNLISGGLIIYSVFSFSKKPKVDNIIMQ
QQFPTV
>fig|293826.4.peg.3779 Daunorubicin resistance ATP-binding protein drrA
MSFKYDNKYAIEVNNLVKTYKDSIRALDGLSFSIKPGIIYGLLGPNGAGKSTTVKILTTL
SRPNSGEAKVLGIDVISEPGKVRSVIGCVSQKSGICFESTGRENLILQGQLQGMGGKQLN
DRVDELINIFKLNEAANRSTMTYSGGMLRKLDIAMGIIHNPQMLFLDEPTTGLDPEARGA
LWDIITDLSKMEKVTILLTSHYLDEIDRLADCLAIIDEGKVVVEGSPKQLKEELEGDIIK
VELQKDYFSKKSQMINILQEQQGVKKVEVKGRKVQLQVGNGSTILPNILQLIQSLSVEVL
SVEVIPPSLDVVYFKYTGKNIEN
>fig|293826.4.peg.4085 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENNVDLTKDNVTKLFLKYLIPSIASTLVLSLCILFDTIFIARGVGSEGLAALNIAIPLF
SILIGTGLLFGIGGAAAFSISMGQKRQEQAKVFFTHSVIMACVVGLLFSIIGLLFSERIS
YLLGATSENIGLVNGYVGILLPFGFFFLVNQTVAVFVRNDQAPKLAMWSMIIGNVINIVL
DALFIFHFQWGMKGAAIATGIANAVSLLILCIHFFSKENRLVFIRVMPHYKTVRRIIGNG
FSSFILELSFGIVIFAFNTVLLSIKGTLAVSAYSIIANVSIIFIAIFIGVSQAMQPIVSV
NYGARKKERVQEVLRFAIYISLGLSLFFFGVGMLFPHWIVSLFTPDSQELIDITVQGIYI
YFTGFLFTGINIIMAAYFQAIEYRMYATILTMSRGVIFILLGLIIFPNLFGILGVWMTGP
LAELLTFGCMLFLAVRVKQQVKKRSIE
>fig|293826.4.peg.4471 Probable multidrug resistance protein norM (Multidrug-efflux transporter)
MATSLQIPSKIEVRRKILSMILPITMENVLQMSAGFVTMAMIGRISAVAVAAVGISMRIT
QIIWALFRGVTTGATVFVAQSYGSGNLIKLKKVIQQTLLSSIILVLILQQLLFWFAPQIL
NFFKGDPTLIESGIMYLRTLSWGLPFVAVIQVVAGVLQGMGNAKTPMKIALIMNVINMIL
SYTFIFGPLGLPAMGLRGAAVALVVAQSVAALLGIYVLFNRHGILGTVFNRSFFKLDMKQ
VIQVYRVGSPTAVESIFWQVSSIALTMIILDFGEVSLAAYQLGLQAESISYMPAMGFSVA
STAFIGQALGAKDPQLGKRYLKEIVTGSFLITIFSASVLIFFPAFIMRLLTDQQEIIDVG
IKYLFFMGLVQIPQNMAGVLNGALRGAGFTRVPMIVAGTGLWLIRIPFSYILVQFFDVGI
TAIWIVMCFDLVFRFILSFTLYKRKNIYEQEPVIEKMTVKSEG
>fig|293826.4.peg.4490 Probable antibiotic-transport ATP-binding protein ABC transporter
MITVKNLYHSYTKDEHYAVKDVSFEVNQGEIFGFLGPSGAGKSTTQNILIGLLSLQRGTV
LIDGQNIGNKSKTLFNHIGVSFERPNIYKKLSGVENLQFHSEMYDVPTEDPMGLLKRVGL
EDAAHQKAGGYSKGMLQRLVFARSMINQPKIWFLDEPTSGLDPNTASTIKGIIKEKKEQG
TTIFLTTHNMHIAEEICDRVAFITNGEISAIDSPRNLKLIYGERFVKVEYLKEEILKKRS
YSLTDEKERQQLKEIIASQHIETMHTQEATLEEIFIKITGKELK
>fig|293826.4.peg.4532 Permease of the drug/metabolite transporter (DMT) superfamily
MNKRDIGIGLIVATLWGLNFIAIKLGLADMPPLLLATIRFMVVCIPAIFFLPKPPVDWRW
LIALGLTLNVGQFAFLFMGVKLGMPAGLSSLVHQSQVFFTLVIATLFLGEQWKWNHVVGL
IIATGGMVVVGSQQGGSMTAVGFWLTLIAAASWGIGNVIMRRTTKDAPPFSMLSLVVWAG
GIAILPLGLFSLYFEGATAWKLAWDSLNWITIVSIIYLAYFASLGGYGLWGRLLSCYPAA
VVSPFSLLVPVIGMSSAALFLNETFSLWQIIGALLVMLGLAVNVFGGRLNKNANKKRMLV
EKIKLLN
>fig|293826.4.peg.4546 Permease of the drug/metabolite transporter (DMT) superfamily
MKQSYRAYVEMTLGMFISGSAVVVGKIVVIDMPIFLFQIYSLAIALIFSGMILLCRKEGS
SVVQLSKKNLVVLFFQALMGTFLYRVFLLYGLRFTSARESGAILSTIPAVIALLSWIFLK
EKIRSNTIWGIFFSILGIIVFNFTTSSTDIALSYRLFGNLLVFFAVLGESLFTFLRKKLS
PVPSPLVSTFMVSFYGFMLALPLALYEQYHFNLSSLTYKHYFAILYYGAFVTVLSFSLWF
AGISKVSGSTAGAYYGIFPISVFLLSYFILGEPIYLKHIVGLLFIVSSIILLSKQSTVKD
IQIASHPETHKDK
>fig|296591.12.peg.417 Multiple antibiotic resistance (MarC)-related proteins
MVAGDRLLHAMRLTDASFEIAGGVILFLMAMGMAFPGMGVSLADSGHGGEPMLVPPAIPV
ITGPSALATVLLLAARQPDRGWTWAAAIGLLLSAMAVDKLISGLRRAFPGVTG
>fig|296591.12.peg.429 Permease of the drug/metabolite transporter (DMT) superfamily
MTTATAILRPPGSKGAGVAFFFCALVAFASYDAFCKQMLQYYPAPFINLMRYLSVICIAF
AMLLHHGDLRIWRAPQKKLLVLRGVMLGTVATCFMTALIWMPLAEATAIYFTAPLLMVAL
SPWLVGEQVRRSRWVAVTVGFGGMLLIVRPGGDLPWLGTVLMAVSAVCYAIFQLLTRRLA
GLVPSPVQYGYTALVCLAVTALPAPFFLPVHRPAPGEVLLLLAGGACSGAAQWLLLAAFE
RVEASTLAPLNYFQLLLAVAFSTFWFRKPPDGLAMSGIALIVAAGIYLARSRPAGPAVLA
AARAGG
>fig|296591.12.peg.1867 Permease of the drug/metabolite transporter (DMT) superfamily
MQTRHFIQLIALSAFWGASFPLLRIASPALGPWVVASLRCTLAAMVLAVLMHTLRDRWPP
RAAWPRLALLSLLTVVIPFVLFNWAALVIPAGYSAVLNATAPLFGVLGAAAASEERLTSR
RLLGCAVGFAGVALLVQLGPVAVTPQVVLAALACTAAAASYGVGTVLMKRATMAYAPLPA
SAAVFVAATLILLLPAGMAAPSAHPTPGALLAVAMLGIVTSGFLYWISMRLMREISASAA
TSAAFMIPLFGVTWGALFLGEAVTASMLPGCVLVLAATALITGFNPFRSSSSEP
>fig|296591.12.peg.2192 Mitomycin resistance protein
MPKAETAALAKVLTDIPNIGASIAQDLHSVGINTPADVAHMDPLAVFEALRTPMGHRHDL
CVLDTFMAAKKFMNGGPRQPWWDFTAERKALLAKHDRR
>fig|296591.12.peg.2848 Permease of the drug/metabolite transporter (DMT) superfamily
MVWGSTYLAIRFALVSFPPFFQMGTRFLVAGMLVMAWVIIRKQQLPTLREWRNALVIGTL
MLGGGMGLTASAEVHIGSGLIATFIAVVPLMVCAWGLLLGQRPSRLELAGMAVGLAGVLL
LVRGASFSAAPVGLACIAGATLLWSLGSVLSTERLPLASGPAGFASEMLCGGAVLMAISL
ALGEQHEVASNWPFQPAALVAWLYLVVFGSLIAFSAYMYLLANSSPAVATSYAFVNPLIA
IFLGAFFAGEHVTRGEWIACGVILTGVFLIFRGKSATGGRK
>fig|296591.12.peg.3123 Permeases of the drug/metabolite transporter (DMT) superfamily
MPAVFVLIWSTGFIVAKYGLPYAPPLTFLAIRYFLSIACFLIWIALARASWPREGRQWLH
LAVTGVLMQAGYLGGVWVAVKAGMGSGLTALIVGLQPVLTALWVSWMASGDTRQQGSTVT
SRQWMGLALGLGGLLLVVSHKLGGGHEVTALTLTATLFALFSITVGTLYQKRFVKPADVR
CAGAVQMGAALLVTLPLVFFETGAIVWNHQFVGAMAWSVLVLTLGGSSLLYLLIQRGAAT
SVTSLLYLVPPTTALMAWLLFDEAITMTTVVGTALTALGVSFVVRSAKPPAAA
>fig|296591.12.peg.3397 Probable drug resistance transport protein
MSKLSVKNLTTGFDKVNVLHDVSIEVEPGKITCILGSNGAGKSTLIRSILGLTPPRQGEI
WWDGRNLAGEKTHKIIASGIACIPEGRKVFPRMTVGENLALGAFLESSPTRIGERLARVY
EIFPRLKERSAQLAGTMSGGEQAMVSIGRGLMAEPKLLLIDEPSLGLSPLYVKENFKVIK
QINDLGVTVLLVEQNARQTLAIAHYGYVLSQGKVVASGSAQALSENDEVRSAYFG
>fig|296591.12.peg.3398 Probable drug resistance transport protein
MMAGQSLISVDRLTMRFGGLTALDELSMTVHEGEILGLLGPNGSGKTTFFNVLTGLYKAS
SGSISLGGENILGKTPQQIYRSGVARTFQRSRLSLSLTVFDNIVIGDYQHMQHGLIFNLL
RRKAFRAEYEAYVEKVKSLLEIFSPPLVGRLFEPVESFTMIDRRRIEVCRALLSRPRLLL
LDEPSAGMTHDETDELMQDILQVRGKLDKLSVVLIEHEMNVIERITDRCVVLNYGKKIAE
GSYVEITADPHVQTAYLGEAA
>fig|296591.12.peg.3496 Outer membrane component of tripartite multidrug resistance system
MNRIHSTLRMSLAPLVAALVLAGCATSASIDASSLPKAPQAFKENASQVASATATSAQVQ
SQGTWWKVFADPVLDQLVEQAGRNNNSVQVAAGRLAQARAIARNTDADRLPQVGLGAGAT
RQSNATTGNVPQTVVSANANFSYEVDLFGKLSLNSDAASLDAQSREALLRSTKLLVQADV
AQTYLNLRALDTERSLVRDTLQAYRNTLRLTEVRFKEGDVAELDVARVRAEVASTESEAL
ALDRRRAELEHALAVLVGEVASSFQVAPAEWTTALPVIPAGVPSTVLVRRPDVSAAQSTM
QAAQARAGVAKAAWFPTFSLTATGGYAAPEISDLFKLSTRAWGVGALLSLPIFDGGRREA
GVQNANAELDIALANYREQILVAFKDVEDQLAALRLLADQSEAQSRSVASATRATVLSDS
RYRNGFVSQLELLDAQRSELRNRRQALQVKASQYLATVGLIRALGGGWST
>fig|296591.12.peg.4201 Glyoxalase/bleomycin resistance protein/dioxygenase
MSARDLLPQPALRGVDHTARPTWKLRETIEFYRDKLGLPLVHVISARGWGPATHPDFLHF
FFDSGNGSTIAFFYYLGSDQPATMEDRASKPPLPDDHVFDATHTAWIVESAEELQAWKQR
LEAQGLNVSVETAHEVIESIYVRDPNGYFVEFTRKLRPLDRLDADDGALTLQAALEAEDA
AVRRGSHLARIDDIWSAKARLLDERGGAGDRVGSAVAIYVPRLAEFSALVHDAAARPECR
VTAVGDYDLIEAGQAMEFRRKALGLKPAVWYGLFTGGVRGHIEVFERDRVVIAPARP
>fig|296591.12.peg.5584 Acriflavin resistance protein
MSQHKLNSAGRLANLFVTSKLTILFMLACILLGLLAVTLTPREENPQIVVPGAQVWVTLP
GASAEEVEELVIRPLEGIVKQIAGVDHTYATAVNSMGVLMVQFKVGEDKEKSLVKLYDRV
LGQRERLPAGAGEPLIRSVDVDDVPIVTVTLASEIYDDYALKRLADRLMEGLRSLDKVSA
ISVKGGRDRELRIELDPQRLQAFGVTLDQVHATLRASNVAAPLGTVVQQGQNRQVFLDGF
LSSAQDLKRLIVGSHAGRPIYLGDVAQVIDGPPQERTHLSRLAFGPADGRFGKTQQAEMP
AVTLAVAKKAGSNAVFVANDVLERIERMKAQFVPTGVELVVTRNDGQKADAAVSGLIEHL
GIAVLAVFLVTAAFLGLKEALIVGVTVPLILALTLGAAYLFGLSINRVSLFALILSLGLL
VDGAIVVIENIHRNYSRLGKQDKRLVTVQATNEIGNPTNLATLAVMLVFGSLLVVSGMPG
QYFYPVAFNVPVAMAASLLVAYAVVPWAANRWLKLGEGHDLEDHDTKDRLHRFYRHLMSP
LVDRSRSRWLAFLLAGLAIAVSLLQPAWQFVRPAGLGGPQSWFGVELAMMPKDDKNTFNI
TLDMPATAPVEATDRFAREVGALLRENAYVRNYQSWIGEAGVIDFNGLLRGSGNKQGPHV
AEIRVNLLNKADRSKTSIAIVRELRPTLQAMAARYPGSTVQLVEDPPGPPVRATVLAEIY
GKDLQQLRTLSAQVKAAFQQTRDMVEVTDSEAQDVYQYRLTVDREKAALSGLSVAEVAVA
LRRLIDGEEMGRARIAGEKNPVPIRLQIPRRHQIDPALLARVSVTNRQGQRVPLSEVVQV
VPGAVDRTISHKDGERVTYVGGELESTAPVYAVLDLDRRLDGLLLADGSRLTTGNLRLNP
VAPDTLEGPRLLWDGELRMTLDTYRDMLGALGLALTFIFLVLVAYYQSFSLPLVAMAAIP
LGLAGIFPGHWLMGQPFTATSMIGIIALAGVVVRNSLLIIDFVLDYRRQGMDLREAILEA
GAVRLRPILLTALAIMLGSAVMLSDPVFGGLAISLIFGTLASTALTLVVVPLLLYLLLRY
KDRKEAIMEKGTL
>fig|297245.3.peg.2836 Mitomycin resistance protein
MNVGEATYKDLQLLGINSIHQLANASADQLYARLQQITGQLHDPCVWDVFAAAINEARTG
EKQPWWQWTKIRKKRQLEGTFCI
>fig|297246.3.peg.75 Acriflavin resistance protein
MWIVRIALARPYTFIVLALLLLIIGPLSILRTPTDIFPDINIPVISVIWSYSELPPDDMG
NRITSVFERVLPTTVNDIEHIESESLIGVSVVKLFFQPGVNIELALSQVTSIAQTILRSL
PEGTLPPLILNYKASTVPILQLVLSSDTIPEQELNDLGNNFIRPQLAPVAGASLPYPYGG
KVRQVQVDLDLQAMQTYGVSPLEINTAISAQNLIIPAGTQKIGDYEYIVKLNSSPLKVND
LNDMPVKTTPGRVLYIRDVAHVRDGFTPQTNIVRVDGKRAVMMSVQKTGGASTLGIIKQI
KALLPKIKEIMPAGLNLGQFADQSIFVTAAIQGVITEGIIAASLTALMILIFLGSVRSTL
IISISIPLSIIGSLTILSALGETINIMTLGGLALAVGILVDDATVAIENINWNLEQGKEV
EEAILDGAHQIAIPALVSTLCITIVFVPMFYLGGVAQYLFVPLAEAVIFAMLISYLLSRT
LIPTLAKYLLHKHDPEIKEQSQNFFVRLHHQFEKKFEIFRERYSNLLNKALHNATYFVGI
FLVFVISSVVLLWPWLGSNFFPNVDAGQIKLHIRAPTGTRVEVTARYVDTIDKLIRTIIP
PQELDTIVDNIGLPVSGINLSYSNSAPVGPEDADILISLKEKHHSVFDYQRELRTVLNQK
FPDISFAFLPADIVNQTINFGLPSPIDIQIIGLKQDENRVYAKKLMQRLKKVPGLVDIRE
HQAMNYPELFVDIDRSKAKELGITQRNIAMSLFIALSGSFQTSPTFWLSPENNVSYPLVV
QAPQYVMNSLQALRNIMIDGISPNIQSPAQHQILGALGTITRKWTSVVESHYNVMPVIDI
FAATQDRDLGSITHDINQIIAEMNSEVPLGSTIAIRGQIDTQHQAFQGLYWGIVFSVLLI
YLLIVINFQSWVDPFIIITALPAAIAGIAWFLFITCTTLSVPALTGAIMCMGVATSNSIL
IISFARQHLLETNNPLLAAMEAGRTRIRPVLMTASAMIIGMMPMALGLGDGGEQNAPLGR
AVIGGLSFATIATLFFVPTVFYIIHNHQLKVKQRNNHA
>fig|298386.1.peg.178 Permease of the drug/metabolite transporter (DMT) superfamily
MNKKHLPLLLFCSVCFIWGTTWLAMEVAVDTIPPIFATGLRFLIASPILVLLSKIFNQPL
LFPKGKNKWIAIVAVFYFAIPFTLMIAGEMYISSGLASIIFANMPIAVMITSTLFLGLRL
AIHQFIGLFIAVISLFIILSNELGIGGDNLLIGSGALGLAVAIHAVMYVMVQKHCKDIQV
ITYNALPSFVAAILLFITSLAFENINVQAFSSSSLMAVGYLGTFASVGGIVAYFKLGQIS
TPFTASICFLIFPLVALALSAATSGAAISEQSILMLLPLLSGILLTKVPLSKFKAARKLV
TSSQ
>fig|298386.1.peg.467 Bacteriocin resistance protein, putative
MFMKTSLLIIAGFFLSSSVFALDYFPSRGAYNVKVKSYQEKVFGDVQRQQYDFSCGSAAV
ASLLTYHYGLETSENSVFEYMFKYGDKEKIEQQGFSMLDMKKYLEAQGLTANGYKLPLMK
LKKLGVPGITIVNFDGYMHFVVIKGMNSSQVILGDPSRGTLTMDIDDFEAGYKGLVLLVK
NNVKVGKESFIKQENYSIYTPSPVSEAVIRESLATFSITLPGANDY
>fig|298386.1.peg.526 Multidrug resistance protein B
MMKIQPFAILALALLALFPQGITAEIYTTGAAEMAGTLGLSADEASWFKTLNMFGQLMAF
PLAAWLSYRIGYRALFRLGAGIGLICALISSLWMSSAPQMIAWFGHGVSASFLLLFAHAI
VLRNLGYRAIAFVEGVMLLSVVLIPLSIYPYFLSHLAENNLWHWSFAVQVIPFIGMLYWA
RFGHWPCPDERQKIRFNFLQAVLLSGFICGVTYLLLRGERFNWFRDPEIIELTLLTLVIG
AAAIIAMRRRWGKGEYLRFKALASPHGKVGMLDAAVAGFVIMGTTILVSTYVTQVMHYSH
EHLGELEMIGFAGMIGGLIIALIATCNPKRNPENVIPAGVSIMLLACALLAGSNAHSGVS
DLWPALLLKGLAVGILNITLTVHILRSFPKHQVAEGITWFYLFRNFGSLLAITEFSRLMY
IETVGSVSKLAENYNASSETFVLHQQMTADLLQQGMINPSSEQIALLLSEQLKTQAMSVA
GVNNFQWIIFSIILLVPIMVIAMKWANNQPHHQDNESEVH
>fig|298386.1.peg.527 Multidrug resistance efflux pump
MNMNMKTMIKKSVVASLLACAVAGFYYYLAPAPGMVATDNAYVHGEISQISAEVAGVVTK
VYVTDNQYVQAGELLAEVDKRDYIALRDQAKSAFAMAEATVDNVNERIKLQMININEAAT
RITSAKSDADFQHKEWQRFSDLLRKKLISKSSYDGQKTQMQQSSADLDATKLQLAAAKQQ
LTTLKTERARMIAQRDQTDAALDLAKLNLEDTELRAPISGIVGNRVVRAGRYVNKGNPLL
AIVPIDDIWIEANYKENQITNIYPGQEVHINLDSFPNYQLKGYVISASPATGAQFSLLPP
DNATGNFVKIVQRVPVKISIQLPDELRGRIVPGLSAEVEVDTNDKA
>fig|298386.1.peg.824 Drug resistance transporter, EmrB/QacA family
MSPKTIFTSVALVIALGSLEKSIVTTPLPIIGAELNAGQALTWVITAYLLAATAVLPVYG
KLSDIFGRVKMLNISILLFILGSVACALSQDLTQLIASRVLQGIGGGGLIALAFTVIADS
IPAREVGKYQGYISIVYAVSSIAGPLLGGYFSEQLSWRWIFWINIPLGALAVWMINKNLR
HLSVKRASKFDWKGAGLLMTATTLLLLLISPEASLDATIASITLFTVMLLLVWVERKAVD
PILPVRLVSLPGYVISVLLILCSQLLMFAVLVYLPLQMQWQKGMTASGSGLLMMIFMFSI
TTGAYFGGKQIARKGYYKRFVVVGFLLSAIALWLLHFDLYLSAALAAAGLGLGLTLPALS
VVVQNVLPAEDRGIGMSLFGFGRELGGAIGVAICATIFHSQVPVVVAEGSENTLAHFDPE
ALAQGFSMTYAGMAVVAVIAFLLAVFAMKGQALSSDLKPHAVKDK
>fig|298386.1.peg.1345 Bicyclomycin resistance protein
MLFFLVIISAFPPLTIDLYLPALPQMVNVFNTDQAMVNLTLSSYFVTYAVGLLFWGPLSE
KFGRKPILLAGIGGYMLASIFCALAGNIEQLIGARILQAFAGSAITVVATAIVKDLYDGR
ERQKIMATIMSLVIIAPMVAPVLGAFLLQIASWRMMFVTLAIFGAFASVLAFCYEETLET
KYDGSILRSWGRLGVVLKNPRFVALLMIFSITPMALMAFLAAGSYIYINGFGLTEQQFSY
AFAFNALCASFGPTIYMKLSRYIPVQKIITLCFLLLAIAGLLTITIGHMSPWVFACIAAP
ATLMVITMRVPGTNLMLDQQDNDTGSAVALIQFCSMICGSLGMVLVSVRPESLIENLGAI
QLFVGITGGFLWLLAKNRSFVTEKLVN
>fig|298386.1.peg.1534 Multidrug resistance efflux pump
MQKTVANIAPEVTGVVTKVNVENGESVKAGDVLFSIDSRSYELAVRQSQAELHQVQESNS
AKWQELQAANQTLAQRKIEWQNAKTKLTRYQSLLSKGLITQQEFDDVQMNDSVAERVVQS
AHADSLRIQAELATEDNNAAVELAKAKLEQAELDLSHAVVVAKIDGTVSNLQLQAGTYMN
KGTVAMFLVNEANSWLKADFNEKGISHLMVGTSVLIAFDAMPGQLFEGQVINRDSAIYDA
SSQNSMLSDVTNDSRWIREQQKIRTRIQVDGVDSALISGSKASVIVKNGNGLIDAIGYSW
IQLVAYFRYIY
>fig|298386.1.peg.1799 Multidrug resistance efflux pump
MLEGLAVWALFIYLLRLVGMPWNKYSKSFSYLGGTGWLMFVWVGLITFAPMDLSGGSLVQ
SPHIQLRPGSTKIKGHVKAIYVSPNEKVKEGQLIYEIDDEPYVIAKNKAESLLNSAEVSL
SISKEDARISESSYQASLKDIEISKNEISAAEEDLRWKQTTYNRYIEQNKVVNHTITESM
LDEQSTAVEVAKAKKITLVSQLDKSILSASKAKLDFEKSQLNVNSHEVDVVTEQENVAQA
QWNLDNTKVHAPADGYLTNFIMREGQYVGVMPRIQMYTEEKYVLMRVNHQAIRNVKSGQM
AEFTSAVYPGKVFNAEVEGIIEATGESQGSLLARDDNVRQVTGANVANKYHFVRLKLYET
GGYDIPVGSVGLAWISTEKPIGFLGFLDVVRGIIIRMKSQIFYIWSM
>fig|298386.1.peg.1913 Multidrug resistance efflux pump
MSDENMPKVQVEPRERIASKSGKPKRVKKVRVKKEKSPPNKVKRLTTFVLALCLGLFVFY
IAADRIIPSTDMARVRGFVIPITPLVSGRLAEVTVEPNEIVNPGDILVKIDSADYELAIQ
EAEQGLVNAGKSVGVQTASIASAQAKLTDALANQAHLRAQATRILTMEKKGIVSKSDADK
TRASLASAKAQVEAAQAGIEQAKKQLGSTGNENSEVKSALLKLQKAQLDLDRTVIRAPAI
GGVTNFRLDEGFYAQAGQPLFTFVSGEDVWIDAYFRENSIGNMKVGDSVDIVLDYAPGRV
FAGKIAGIDWGISWGENEQAGKLAAVTSQTGWLRQTQRFPVTIRFDDETARGFRRVGGQA
DIIVYTEQSSIMNTFGRVWIRIMSWLSYVR
>fig|298386.1.peg.1981 Outer membrane component of tripartite multidrug resistance system
MNRFHKNASIPILLSLSVLSGCSMTPPEEPQHQSMLTNEQIQLKSHDIQAIHRQWWNQFG
DQQLTQLIQLGLTNNLTLQQAKQRIALATQQVALAESGDKPKLNLNVSGGGIGANTQSFN
MSNADYSAIGMLLPSFSYQFDFWGKNEATITAASDQKLSLQAQEAQARLVISASIASSYF
ALQNNYRLEQNLTTLLDEINHQNKVITAQVKRGLASEAESFQNQGDIDTLSAQLSDAKTQ
QQLAKNQLALYLAKTPDQLGQLTLPNAQAINQLAAVDTIPMNLLGRRPDIIASKWMVEAN
EQGIKQAKASYYPDVNLMVMGVFQKLSNMNPANLFLGGATVAASLPLYDGGVRDANYASA
NIQFDQAVTNYNQTVLNAVKQTSDAIVSLQEAQKQQVLAQSSVTHYQQAYDILNNRYERG
LSSFADMNSARMQWHQQVVKVTNTESAILQNQLQLIVALGGDYQQEQSVLASTPSNNE
>fig|298386.1.peg.2024 Permease of the drug/metabolite transporter (DMT) superfamily
MTTDLRPVIFMLISTFSLSLNSLLAKFLSDSLSIEMLSFLRFLFPAVLLLWLMALTKWAV
PDRKMWQALGLRAFCIAASQLCFLFAINRLSLVETVVLFSTGPLFIPLLEKLLFKTQIQS
ATLINLAITFTGVLLMADNTSGVVLKPELLVGLGAGIFNAGSQISLYRVSKGALSPIALN
AWGFLLAAVITLPLVLFQTDKSTLQQTASDMADIQTLLLPMLILLAVCIVNTQVFRVKAY
QLANSSSQLAPLIFTNLIFSSVWQVMFFNQPLEWNKVTGISLIVISTLFNTFLPLIVRKI
RVRLIEN
>fig|298386.1.peg.2034 Permease of the drug/metabolite transporter (DMT) superfamily
MEIQNRKEFSFGLMAMGVTLLIWASFFISLRASSQSALTIGDIALLRFLPAALVFGWLAL
PKAKKIKQTPKRYLLAIALGAGLPFLLLAANGLRLAPVADGASLIPGILPLFVTSIAAIC
YRERISSMRKAGIMLIFFGICLFLATSLLSGSSQIATGHALLLMASFSWAWFTIAMRVSG
LTPIEGGAVLSLSACTCLPVLYLLGLVDFNLLNAPSSEIAFHFIIQGIAAGLIANFTFGY
AISRLGAEMSAALGSFTPVLAALIAVPMFAESLNMNTVLAMMLIVLGAISASEIITTKKV
AIKVG
>fig|298386.1.peg.2064 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQDNTIAIDSNESITRTFWRYAIPSIAAMVVNGLYQVIDGIFVGHYVGYEGLAGINIAWP
IIGIIAGLGIMIGMGAGSLLSIYRGEGNNAKAQQTLSSSLWLIALFGALTMLFIHYFGPA
LLTAQGAIGNTLNFSLDYINVFTWGAGFTIAAGALPMLIRNDDSPNFATGLMILGAVMNI
ILDYLFIGLFYLGLKGAAIATVISQLTVLIIGVGYFFSARSQIKINKLTFNFAIASKAVT
LGASSLCMFLYFSFIVALHNKLFMVYGTSVHVGAFAIIGYLGTMYYLIAEGIASGMQPPV
SYYFGSKQIDKIKATVVLALKIILISGVVSVVLLNMYPETVISLFSKNDPLLLAETQNGL
RLHLFALYLDGFIFLASVYFMAVNQGGKALTISIGNMLIQLPFLYFLPQWLGVDGIWLSV
PISNIVLTLIVAPLLWRDIQRSSQKHSELITNMAS
>fig|298386.1.peg.2648 Acriflavin resistance plasma membrane protein
MIRYFSRHPTAANLLMLALLLLGLVALPQIKRETFPEFSPAYIIASVIYPGASPQEVEES
ICMRMEDAVDGLSNIVETRCEAVEGSASLVLKLTNSDVVSRMLVDVQTQINGINDFPNEI
ESPIVRELDWNEPVVDVAISADTSWPQLKAYAEDLKRKLKLDYGVSLVAVGGFSDHQIRI
ELKEAAIRQLGLSVGDIADRLARQNIKLPSGNIELGDKNLLIRFDEQKITPTALANTVIG
ADSEGGVLRLGDIATLTDRFELDEQKILFDGKPSAILKISKNKADDALRIKDRVQQFVED
ERKIAPTGVTLSMTNDLSSVLWDRLTMMVRNGWQGVVLVFATMWLFFTFRYSFWVAAGLP
VAFFGSLFLMVGLGLSINIMSLVALLMAIGIMMDDAIVIAESIAAHLERGQSITNAVTNG
VKKVFPGVLSSYLTTVCIFGSLLFLEGEMGAVLKVVPQVLILVLTLSLVEAFLILPHHLS
YSLQKQKEHEKPDIAFKVWFLNKFDSFRNNQLVSAVEAVVRWRYLFLGSVIAMLFISLSL
LAGGALKFVGFPELDGDIAEARVILPPGSSLAQTEKVVQTIVTAAEKLNVEWSDKQEGGN
TLVEHITEQYNFNPDADESGPHVATVRLDLRGAESRNTVIDEFVAAWRDEIGTIADPVSL
VFKQPVMGPGGRAVEIQMQNDDLTELKAASIEIQQYLSQFDGVFGILDDMRMGKQEVLVK
LRPGAESFGVDGQMIASQLRAAYFGQTADEIQIGPENIEVEVRFDKQEAANLQTLASFPI
ILSDGSQIPLASISTLEYQRNYVRIQRVNGLRTLSVFADLESSKVSSTEILKVFRNDLMP
QLKLKYPNLRFNFEGEAKDTAETGQSMGVGFAMGIFGVFVILSFQFRSYLEPFIVLLAIP
LALIGVLWGHWLLGHALSMPSIMGFVSLAGVVVNDSILLVQYIRHHVYDGDSVHDAVVKA
SRERFRAVFLTSLTTAAGLLPLLLETSLQAQVIQPLVISIVFGIFTSTLLVLFMIPAAYA
ILADFGLVKKHQALAA
>fig|298386.1.peg.4390 Bicyclomycin resistance protein
MKNQPSKITLAWFACLSMLGFLATDMYLPAFATIQEEFGTTQSLIGISLSIFLLGMALGQ
LIYGPLSDRIGRIKVLIAGMTLFSVASVLCAFAPNVEMFLVARFAQALGACSATVIWQAV
VVDRYEGKVSERVFATIMPLVALSPALAPLAGAMLEGQFGWRSIFVSLVGFGAVLAIMSL
KETESAPTAKNHEKVFVQLKKDYKQILSSKKFIGNMLIFAACSAAFFAYLTGSPFIMGAM
GYSGADIGLSYAPQTVGFIIGGYGCRTLLAKYESKKILPWLLTLFVTTVVMMFFISLSTS
PTSIWPILLPFCFLAVANGAIYPIVVSQALSEFRNCSATAAGLLNFMQTMVCVAASALVS
AFTANGLITVTTAMFVTGFIALIGFSLVVQARREIPQDAQTA
>fig|298653.4.peg.371 Regulatory protein, MerR:Albicidin resistance
MLTISQLASYAGVTVRAVRHYHAKGLLPEPERDHSGYRRYDAHAVVELIRIRTLADAGVP
LARVRELLAAGEEEFNTAVADIDQRLRAEIRERQRHRERIAQLAAGDSLALPPEAVAYLD
RMRELGLPDLMIGGERDSWILVAAQLPEHMPLYMKVKQQQLDDPATVELYRDLAAMIGWE
ADDPRVAAVGDRLVALIEADAEGWENHDEVMPDELAQLLDSVFLDSVPIARRLLERLEER
GWRGWTKFERIQPK
>fig|298653.4.peg.433 Bicyclomycin resistance protein
MNSARRTLLVLGFLVALGPFTVDFYIPAFPLVQADFGTSAAAVQLTLTATTIGFALGQLA
IGPWSDSIGRRRPLLVATALHVAGSLGVAAAPTVEVMLVFRLLQGAGAAGSGVVALAMVR
DLFDGALFVRMAARLAVVTGLAPVVAPFAGSLMLSHMSWRGLFVCIALYGLAVLAVAAFL
VRETAPLVRRAGAPLGRYRVLVTDRGFVGAALAGGLLVSSVFTYMSSSSFLFQETYGLSA
QRYSLVFAANAVGFVIGAQTSARLVTRIGPRRLLRYVLPSLGFLGFTLLLAAFAGENVVV
VTFVTALYFLLAGAVGPCLQVIGMAPHGERAGTAAALMGAANFGLAGATAPVAGLLGVGS
IGPIGLVMGLTMTVAVVVFRVLARDRREARAGAPSPVP
>fig|298653.4.peg.660 Drug resistance transporter, EmrB/QacA family
MEIASRAGRMSGAAGALLREPARPARIRESPLATVLAVGTVCIGSFLGQLDASIVTIALA
DLRADFGMSLGLATWVSLSYLVTLVATIAALGRLADMYGRKLLTLYGFALFTVASVGAAL
APGIGVLIVCRVAQALGAAMLQANSVALIATTVEPRRLTAALGAQGAAQAFGLSLGPLAG
GLLLELGGWRWVFWAHIPAGVIGFVLGVLLLPRTRAHAPRTPFDWRGLALLVPTVSAVLL
ALSVGESARSVGPLAAVGGLVLVAALGGVLFVRRESSAASPMVDLPLVLHRAVGPRLAAG
TFSFLVLFGLLLTIPQNSDDGAVAVGLLLATLPIAIGVAAPVAGTLVTRLGVRAVTSGAM
VCVAGGLGLLAAGGSGPAVGVPSLALIGCGLGLFTPSNNGAVMAAVPAQQSGMASGVVNM
TRGLGTALGVSVSALAYAAGGFVATMLLLAAIALGGALLAATAAAPTVPGSALPRQREND
RAAP
>fig|298653.4.peg.896 Outer membrane component of tripartite multidrug resistance system
MTRLPVRIEDHLDRRTWTVEPGLCQLTVWRRHSEFRVCPPPGAPAPDPARPGAAGAGPHS
GPDGSPPGPAVSLGPAFSSGSAFLSGPAFLSGSAFSSGPAASLGSAVMPGTAIALDPAIL
SDPAFPLGAAFFPAAAAAAAGRGVGTRATSLVSPSVPPPVGQASWPAQAAAASALRGVAE
GAAR
>fig|298653.4.peg.2301 Fosmidomycin resistance protein
MPASVPYFVLERNYGYLAASGLTLAAALGSALPQPVIGLLVDRRRVGPLAAVGVILAGLG
VGLAGLVPGYALTWSLVLLSGIGVAMFHPAAGRAARIDAGDSTAAMSIFAAGGSVGFFLA
PVLATPALATLGLAATALFILPAVLVGFVLLRAHQRQAAAAKVAAVTTAGGKDLWSPFLL
LTTVEIARSVLFFGVNTFIELYWLRHLHAGHTAAGAALACFLAGGVAGTLAGGRVADRAG
AVRTVQAGTALAIPTLVALRAAPGPGTALLAAMTAGVAINIPFSVLVKLGQDYLPTRPGT
AAGVTLGLAVSIGGLGAPGLGAIADAWGIAAVFSVLCLVPVPGLLLATFLPEIRPAPPQD
AQERRRPA
>fig|298653.4.peg.3275 Multidrug resistance protein B
MSAEARDADRLDPPLRRLIAVVLLGGIMGILDGSVVAVGVDTLAARFHASLSTIGWVSTG
YLLALTIAIPITTWAVDRFGARRLWLTALVVFLSASLASGLAWNITSLIVFRVIQGLAAG
VLDPLVLTLLARAAGPRRAGRVMGLMGMVLSAGPVLGLIVGGIVLESASWRWMFLINLPV
GVVALLGAARAVPADPPRQTPTSRLDVLGVALIGPGFAAVVLALTQAADRTAVVAWQVLV
PLVAAVTLLAGYAVHALRGRPHRSTPPLIDLRLFASPGFAASVAVMTLVGLTMFANLFVL
PLYYQQQHGRGALGAGLLVAPFAVAAVICMPLSGRLSDRLGPRALVRGGAVVAVLGQLAF
TGIGAHTNEVWPALAAFVVGAGLSFVGAPTMGSLYRTLPPESVSQGSSVLYILNQLGAAI
GIAVVTLILATVGPENTRGMAGFHGVHWFALAAVAVILAMSAFLPRRDATTEAAVPAAGA
ATATATATATTSTSTSTSTSGTVPPALSAATAQEGTR
>fig|298653.4.peg.5172 Multidrug resistance protein B
MPGGPRGQGGPRGSAGTSAGTGPGGPQTASLTHGAVGRLVVALGTATLLQWLGAFAIAPI
LPLYLEERDVSAGGVGMVMAAFFLGALLSQYPAGLATTTRGHRPVLVAGLVAYAVGCAGL
IVSPGIMCDTAMRVLQGAGAGAFEVAVLTAIAATVPPDLTGRAVSAVYTGQIAGTAIGPL
LGGLAGEQRMDLLFLGAGVAAAVASVPVLVLLRPDGPGHAPALSVASTGSDASAVGPTAG
GGAGVPGGRAGGAEAVAAVAAVAVHRDGSPGHAGRRAPAWASRRRTWSPLAAVGPGVEGL
LLVAAVNGLAVGTYETCWSLLLTDRGISTELVGLSFTLFSLPYIVCAMPAGWLADHNDRR
WLVVAATATTGVTVATYSFIGSFWLIVLVSCAEAIALAVSFPSAQSLLAQESGPGGAGRA
QGLFTTTQTAATAGAALTSGALYAANAHLPFVLTAVAALAVAGSLPRLWRRVRGTVVPAA
VPSGAVPSGAVPAGAVPAASTGPAGGAFASHLITR
>fig|298653.4.peg.6277 Multidrug resistance protein B
MSSDLGSLAGPEEAGEPQEAGELRAEGEREGIRGEPGGRSVPSGSAGPPHTGLVFTVLVL
GGLLVVLDITIINVAIRTLAADLDASLPVIQWVSTGYTLALAVTVPTTAWLVARFGSGRV
YMVALSLFVLGSVLCGLAWNIDALIAFRVVQGIGGGLVNPVAMTIVLRATPPERRGRAMG
LLGLPVLVGPVIGPTLGGWLVDISWRWIFLVNLPLGLAALLLASRVLRPVTAAAGAVQRG
GTLESADGRLDVPGLALVAPGLALFVYGLAESGRRGTVTSAGVLVPALAGLALAVVFVVR
AARMRAPLVQVALLRLRAVASGTATLALFAAAYFGSMFVLPLYWQLVRGLSPAETGMLAI
PQALATGASLQVASRMVDRVPPARVVGFGIVTASCGLITATLLLGVDTPYWQMVVAMSVM
GVGAGSTIMPTITTALRHLSDRDAPSGSTLLTITNQVSVSIGTALTSVVLAAGLTTQGVA
GAAGGGGEGVLPTVVDGPAAARLAEACQDTLFVSAALLVAALVVALTAIPGGPFSASRRR
RVQPRIRAPRRRRVRPRGEAQDQSPVRAARTGDLTPPR
>fig|298653.4.peg.6688 Drug resistance transporter, EmrB/QacA family
MDVPLNRRPSQRAVVATLFVATMFITIMDTTIVNVALPSIAADLGVSSGSIDEVVIAYLV
SLAVSIPASGWLADRFGSRPVFLAALGVFTAASALCGLAGSLTALVVFRVLQGVGGGLLT
PVGMAMLYRVYPPAERARAARILIVPTVVAPAVGPILGGVLTDQASWHWVFLVNVPIGIA
AFGFGLAFLAGSRVPGAGRFDALGFVLSASGFALVLYALSVGPNHGWLSAGTLTAAGVGL
LATGATVWWELRRTQPLLALRLLGNDLFRTVSLTLSIAFMAFMGVLFLVPLFMQTVRGVS
ATTSGLVVFPEALGVLTATQIAGRLYPRIGPRRLMAGGLVFAAASMLALGFLDSAGSLWP
LRALLFGVGFGIGFVMMPAQTAAFATISTQQTAQASALFNAQRQLASAIGVALVSTALSL
ARPAATGPAATGPGGGSVVGDTGSFRWAFAVAAALAALGLLAALRVRDADAAPTMRPPAA
VPATAAETVLLGHGRDDQGGGSRAGADGHVDRARVGSEDVGGAAGDPDTDAVAGGEAVVD
RPDADLEGGGLPGGHRRR
>fig|298653.4.peg.6691 Probable multidrug resistance transporter, MFS superfamily
MDASEVSNGASPDSGPGSGAGTDAPSRASAIVAVLAAVGVLVSLMQTLMVPLIPVLPKLL
HSNASDASWAITATLLTGAVANPVFGRLGDLFGKRRMLLLSGYILVAGSLVCALTDSLVP
IVAGRALQGLGLAIIPLGISIMRDLLPPKRLIPAMALMSSSLGIGGALGLPIAAIVAQNL
DWHVLFWGSAIATLILVALVTVVVPESPVRGSGSFDLPGAVALSAGLVALLLAVSKGSTW
GWSSATTLGLFGAAVAVLLAWGRWETRAKAPLVDLRTSTRRPVLLTNLSSTVLGFAMYAM
SLICPQIMQLPRATGHGLGQSLLATGLWMAPAGLMMMVVSPFAGRLITARGPKVALLSGT
AVMTVGYVAALGLMGSPVGVLVIACSISGGVGLAYAAMPTLIMASVPASEGAAANGLNTL
MRSIGTSTASAVIGVVLANMTISFGTTQVPSLTGLRVGFLIGAGAALVAFLVALAIPARK
SAAPASVVPDQRSPHDRSTGAAGAAAGSVAEGAAATDAVEARA
>fig|299768.3.peg.1028 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKIIVKIISKWKLLGFIIFALLYSCQGLLISLIIQMAGSVDIENRGMIVIFGLLSLTFFI
FIYICMYFNNILLRSIIKDINLFISKKALRLFAEKRLEYSASEFNSFLTQDIPMFWKEYL
SPLFLYPIFGTSILVSVMYLVSQDVVVGLLFTIGGFLMIIPQFVFHKLLKRRGEKLSKVR
EISLANITDFSAGIDTIVSNRVEQEYCQHVYDTIDKMESGQYRYYTSHNLVMFWTGPLKG
LGLVGPFVIGMVMMSTTHLSLTVLIAMMTASMNLISPLQQLLEATSTLQSATVVKEKVLN
ILLKEDIKREEVSKTFPTTLGISIKNVSKKYADKIIFDDISVSVEAGNRVLLTGASGSGK
STLFHILTGDDRDYDGEICFLDGHGKKYAPSHDLVSVIHQKPYIFKGTLRANVSLYQNYN
DNDIRKVLQRVQLWDELGQDFDYYLDGNNLSGGQMMKIEIARALLRPRPILLADEITAAL
DKQNADEIHKLLFSQPFTILEIAHKFHQDEYEKVYTLNNGKVL
>fig|299768.3.peg.1821 Tetracycline resistance protein tetA(P), putative
MIKKQIFHYLFATFLVTVAYTLPHSILTVLLLEKGLSISQILIIQSAYSLAIILFEFPSG
MLSDNWSRKYLYLSSRVLLIIMFLIVLISSNFYFLYLAWFIYGIAAAFESGTLDSYLINK
LKRSSNDKLIESFISKDNKIQFASMIIGSGIGGILYFMIGIKIYIIAIILVCLSIFDIGF
FFQEDRDYYKEKINIDTFKKQISISFKELKENSILRVIIVFDLLTQLFFQAHFQLWQSFL
LEKGIDKRYFTAFYFLFQIISILSYSIHTDKLQKLVNYRLFLLLVIALPLFFLSNLPVVY
LIAYILYVFIFYIIQFVLNIYFNKQVSTKTISSLISLKSTISRISGLLILYALSFLLNYM
SVSLVISLAFILSLLSILLLLNYFIKNYI
>fig|299768.3.peg.1827 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MSILNNDIKIIEESGFESFYSLVSTVFTTFFSIIALFSYDYRIVLLSILLTLILTYLPRS
FAHKMEKAMKRFSIGNETFISSLTDQLLGYDTLYYSNKKEMLSIKCGEVIKKFIFEKIVF
IKTSSLIEIIMSLFSIISQMLVLLLTGYLIILKQVSIGSISSVGQISGNIFNSLTTFNQL
QVSISSVNIIFEKFGAFEKSSHYRYIDKDIEEIKLTNVGYSFKDKEIFKNINCSFEKGKN
YAIVGESGSGKSTLINIILGNNKQYSGSVKYNDVEISDIEESQLFKSVSYIGNITHIYHD
SLRNNLTLWDNKINESEIINILKQVNLIDLIPRLDDEVSMSFLSEGQKQRLGIARAYLTK
TNVIIMDESMANLDRDNAFLIENQLLNDPTRMYITVSHHLQEKLLDRFHSIITL
>fig|299768.3.peg.1830 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MLRSYVTKKHLTFYFLAIVITWLEAIITPALIQYIVASFTNRQLHLLWQILLWGIGGNLV
LVLGLAGKRYYYARLMTDFKVGIKRAIFRTFLYSRQIPDEEVLSDLENDVQQLENSYIEP
TVIIVSSLGFTVVSIAYALWTNFYLGLLFIIFYSVPVLCSGLGSKRLDRIAEQKSLANQN
YIARVNNMIAGVAPIRHYQGQNLFFKRFSKDLEQALQEEVSYEKQRSLNSLFINSIDAFC
SVAPIVIGGFMTYQNYLSAASFVGIYLVSHNIGYQFQELSYFINTRKSAKSLCDKYQDLF
GNKLATDSIFDQSVFPIQLEQVSVEKDGETILAPCDLTIHAGEKIAIIGESGAGKTTLLN
ILYGEIHPSQGQIRYQGRELTSCQLYQAGAYILQSSHVFDDLSVEENIALGQEIDQQRMD
NILQETGLLSLKGKVPSNQTLSGGEKQRLEIARALYHKRQFILADEVKANLDAKNQEKIN
QLLFSLPQAVVEVIHHYTKEDLKRYDKVIHLKK
>fig|300267.13.peg.3461 Transcription repressor of tripartite multidrug resistance system
MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMA
LITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEK
GHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQAGVVLEAMS
>fig|300852.3.peg.1887 Kanamycin resistance protein-related protein
MEWPRFGRVVLKPFSAGLSEAEWKGLYETFRDPEVAEWNGSSPLRSPFWLFKRFVLAEAR
RKDRVAFVILDEKGEYLGTLELYDLTPEEATLGILIGRKDRWGQGYGTEAVRAALDYAFR
VLGLRRVKLRTFAHNLRARRAFQKAGFREVGVVPGPRGREDVHMEVRREDLGPEA
>fig|300852.3.peg.1973 Permease of the drug/metabolite transporter (DMT) superfamily
MGYLYVLLAAFLWGLIGPLSRMAFQEGLTPLTVAFYRALLSWIFFLAHAARTGGLRVAPR
DLPVFPLFGLLGVALFYGAYQLAVLYGGAALASVLLYTAPAWVALLSWAFLREPPTARSW
GAVALTLLGVGLLGLGGGSEVRFGVRAFLFGLASGFFYALHYLLGKLYLGRYATPTFFAY
ALPVAALALAPWAEFGPLTPRALGALLALSLFSTYGAYLAFYAGLRRLPATVASVVATLE
PVVAVVLAYLLFGEVLSPLGYFGALLVILAVLLAVRR
>fig|300852.3.peg.2126 Bicyclomycin resistance protein
MGPLEELLFLGTLMALGAFSIDVMLPALEATAHRYGTSPTAAQLVVGLYFLGFALGQLLW
GPLMDALGRRKVLRGALFGFSLAALATVAAPGFSLLLAARFVQGFFAASFRIGVTASIRD
RYRGEAMARRLSYALLVLMVAPVLAPALGVALLALGPWAPYALPAFLGLLALLWSGRFRE
TLPEEARRPLRLASLGEGALLVLRDRRAGLYALALGGVFGILYAYLAASAELYKAHLGLS
NPAFALAFGATGLVLAGANLLGPQVVARLGLGKALRRAVAGLLALLLFLPLHALAPRPFP
FWLHLTLVLLLVVFTFPNAQARALEGLGKVAGLAASFTGFLSTLLAALLGTLVGQASGGA
PLPFSLGLLGLGVLAFAAVFLAEASPLCGSPPPGGPGGSPPGSAPPGGGGGPGG
>fig|302409.3.peg.653 Bicyclomycin resistance protein
MKVFKRNILILIITVIVMTEMSSDIYLPSLPKISDFFHVDYSIAQLTISLNLAGISISGL
LYGPLSDYYGRRPVMLLGIVIFTIASVACYFANNVMMLIIMRFIQGFGTGVAGVVGYAII
KDMYSGDECAKNISIVNIAVAFSPVLGPILGSTVISYEYNWNVLFMIISVISVIVLICLF
SFLRETLVIDRSKNNISFRSVMYKYKELICNYRFFGFALIHSLTIMWIWSCITNLPFVFV
NDMGVPVAYYGYFVAINVAAYIIGAIINQKFVEKFGMSNMLILGLILTTLSDASVFILYQ
VIEITPLLAEIMWIPSGMGIAFILGNNMTCAFSEIKETGIGSAFILFLQTIFGAIGIYIL
SCFYDGTLIPVIIFPVVCSILCIIIYFVLKVTEKKPNM
>fig|302409.3.peg.837 Multidrug resistance protein D
MRKISEIFLERNRVSIFLLIVILIFGSYSYFDIAKEKNPEIKKPVLSIHTVLQGMSSEDI
EKLVIYPIEQEVMSIKGVTKVTSLAKNGYANVILEFSAGFDDKEALDNVRSKVDIIRAKL
PQEATFPVVNQENLGLLPVLNIALTGDLPDRALFKIARNLQAKLEGLSNVQNVKIIGNRK
DVLEINVSPNAINMYNLQVHEVINSILNNNQFINIGNLDVTSSKYALHVSGLLKNVQDIV
NIPIKTDGYSIVTVGDVATVKLIYQNDTEIIRVNGQPSLVLEISKQPGKNILDTIFQIKD
MIHNTKDVLPHNLSIIYLQDQSEEISDVLNELQNSILVSVLLVVVIMMIFMGTKTALLVA
ISIPGSFLLGIIVMYLLGYTLNIVILFSLIMAIGMLVDDAIVVTEYADRKMINGLGRKEA
FKQAAYDMFWPVASATLTKLVVYIPLLLWPGTTGEFMKYIPIALITTLSASWIMALIFIP
VLGSMIGKPSVTDKQSIAKIMAIETGKFTNLGRFSKSYVNILKSVLNHPKKFICAVIAVL
VLSTFGYFTIGPGIEFFPNIEPERILITIKSNSNLSIAERDNILNKIEERIFNVKGIKFL
YVKVGLFEYLLDSNNVIGKIQLELKNWFLRRKSEEILNEVMEKLQDIRGVIIEVLEERVK
PVTGKPIRIDISSYNVDKIHNVADKIIYVMKNSLGFENITDNRSSSELEWKIDIDKNKAA
KFGVDVSMISQFIKMIANGIMLNKYHPDNVNDEVDIFLRFSKEYRNLNTIDNLFVNTIHG
YTAVSDFVTHKAQHKDSIISRINGKRTISIVADLANGYLLDDMVSLLNKELKKNMDPEVL
VELKGEIQDQEESLKFLVKAFLIIIVLIMLILLTEFNSFYDTFIIMTAIFLSTNCVFLGL
FVTNHVFSVVMSGVGIIVLAGVIVNNNILLIDAFYANISNTNDKKDAIIKASISRLRPIL
LTVITGIVGLLPMVFRISFDFVNQRVIYNSPSSQLWCELSYTISIGLLLATVITLFFTPA
LLVLGKCNRINKSDRMVCY
>fig|309798.3.peg.181 Permease of the drug/metabolite transporter (DMT) superfamily
MSRKSQDTLGYIYLIATTFFWGTTFVFSKEVLNYLDPFSYLFWRYVIAFIPLIPFIRIRK
KDMLDGFWLSITNAIALITQFVALTTINASTAAFIVSLSIPLTPLLEMLWLKKRQSSTVT
LGQIVSVVGFLALSYVPGEKFSVSIGAFLMLISALAYTVQFVLIPTLHIENQLNTSAYMI
GFTALWSLPFTRSFSIPRGVLSPLLYLALVATTLTIWLQLQGQKNVSATTAAYIFAFEPI
FAYLFAHFTVGENLTTFGNIGALLIFLSALLVQYGEYRTSKANGS
>fig|309798.3.peg.446 5-nitroimidazole antibiotic resistance protein
MRRSDREVKDSARIDEIIRMCDCCRLGLVDGDGVYIVPLNFGFKSENGRRTLYFHGAKEG
KKIEVIKAHPFVGFELDTNHAVTAGEKACDYSFLYSSVIGKGVGAVVEDIEEKRAALQLI
MEHYSGKGNWSLPDEAVEGVAVIRLEVVELSCKEHA
>fig|309798.3.peg.1088 Drug:proton antiporter
MSRELKALGMGYLLWGFSIGLYTTQWPVFLLYKLGDPGQVGLANGLISATAVLSYFIGAW
MGNHFPKKPLFMLSWGGSAIAPLLWAFGSSDWTIYLGCALFGFISSYSSPLINSYFLDEL
GDEFMKGSMYTSSTYSIGMMVGPFVGGVLKDIGGYELLMIVTAISFVFSAVPLAFLKKDE
PKKKSLMLPKDRSYYQALLWAAVMSFAMMITVPYAPLYAKERFALSGTMLGLLGSISAIG
AVLLAYLAVRVSHRSIILRISVWCGILGTMLLISNRWFLWVAFFFRGAFMNTYSLITSGV
SHRVPKDYSYIGFALLTATIAAFNSLASAVGGYIYNTGPIVLFLLSSVLMWFSLHLYRLL
AESRQ
>fig|309799.3.peg.141 Permease of the drug/metabolite transporter (DMT) superfamily
MHNLSFSYISSYISLILATTIWGFGFVAVKESVTHITPIQVLFIRFFSSAFFLIIIYYNS
IRSSRLQTIKRGFILGFFLFLAFWTQTIGIFYTTPGKNAFLTSTNVVIVPFLYWLIRGKK
PKFFHIVSALLCVLGVFLLSYSGDAFYLNKGDFFSLLCALFFGFHIVFTDIFIKNDDLIN
LSFWQFLTVSLISLLLILIKYNFVWFKNLVFIIIGEKNKRLLFSLVYICLFSTLLAYILQ
TYSQKFIKPYITSIILSTEAIWGYLASYLLYKEDINLPTILGCGLILSSAIIVSLIDLKT
N
>fig|309799.3.peg.213 Daunorubicin resistance transmembrane protein
MKKYIYIAKGFLLERMVYRFSLFFNALEKYIYILLIFFLWKAIYKSLGQENLSMNFESTF
TYLSLATAIFGLFQTWVDWDISQLMISGNLSIILTKPLDFQIYMFFKRITWVILNLLTIT
LPVLVLLKFILRMPINMGINFLFFVISVIISYLIYFNIDFIVGVTAFFTESIWGLSVTKD
SIILFLSGGIIPIPLFPENLRKILEILPFKTIYHMPIEILINKSLTIFDYLNSLAIQIFW
LFVFLTLSRIYYKLTERFIKINGG
>fig|309799.3.peg.488 Permease of the drug/metabolite transporter (DMT) superfamily
MKRIIGLILVIIACLFWSISFSVSKILLKTLSPFELAFIRFFLASIFSLIVFLPKIKKAS
FNRKYQKPLFIAGLFGVTLYFIFENTGLKFTDASEGALIVGSFPALGLLTEYILHKEKLP
LNRILGVLLSISGVFLIMSDSGLNLKFNNLFGDFLILLSGVSWVIYNWEIKKVNQKYPYE
ILTTFQMIWGSILFLPFLMFTGLKIPKTLDALIGIFFLSFFCSGLGYLFYNYGLKTLSVS
QVMNILNLIPLFGAIWGVIYLKETLTLIKIVGGILIILGVSLSSSK
>fig|309799.3.peg.691 Permease of the drug/metabolite transporter (DMT) superfamily
MRYDELKGLLILTLITFVWGSTFSFTKIALEVFTPFFLLFLRFLLGAFALFLFLILKRQR
ISINFSGVILGIINFSAIAFQTFGLRYTTATKTAFITGLSVLLVPFFEKLVFKNKIYWNL
WLAVFTGFIGLIFLTTDFSSISTINWGDFLVLVCAVLYAIQIVYISYVVERREIFDLAFS
EILFTAIFSFLFFLIFEPRNLPLNFILKNSLSVIYLGIGATAFTLTLQLVGQKYVSPTKS
ALIYNLEPVFATLFAFLLLSEKLNFQQIIGASLILISLFISIPSSFQNKS
>fig|309799.3.peg.1489 Multidrug resistance ABC transporter
MNNNRLIRLFSFMWKDGGSIFLGIMYLVSLLFLSSQVFLLNYFAAISLKLISDGMIEKST
NKLAEGVWYLLTRFGLFLLIIPIFAYLYQYAVRKTTIIIRRRLFEHIIDLPMYEFEKNHT
GDFLSRINFDVNTAEGVYSWQLMVLLMSIVSAIGCSVAIFLINKIIFFYVVLVTSVNILV
NAIFMKRLREISNKIQEAFSKVTQKLSDIVGGAYIIRAFDIADMIFKKYVEINSLLYRLA
LRRVNYSSILASFNYTVGYFIFFGMLALGGYLMIRDKITFGNMVAAVQLMGPVVYFFGSL
GNFLTNLQISLAGAERIFEILDKSKEENERKKYEKNIHIINKNNWVIRFENVSFSYDSTQ
EVLKGISFEVKEGEKIAIVGPSGGGKSTIFKLLLGFYPHYDGNIYVLGKEIRSYTLEELR
NLISYMPQDVYLFNTSVYENIRYGNLRAKDGEITEALKRSNSYDFVIKLPDGLSTKVGER
GVFLSGGQRQRLSIARAILKNSPILLLDEATSSLDSESENLVIQALNNLIKDKTALIIAH
RLSTVKDVDRIIVIDGGKIVEEGNHSELLEKGGKYKELWDKGFQVNGREGRE
>fig|309799.3.peg.1877 Efflux pump antibiotic resistance protein
MGGVLTQYVGWKGIFIFTFILSFLSIILGISYRLDEVRNEEKLDLLGGFLFSLFVFLILF
GTSQILKFTGIVSVGIGLVTLLGFYFVERRVSNPILDMNLLMNNKTFTFANATALINYAS
TFGVSFLLSLYLQNIKGVSPRDAGLFLVFQPLTQAFFSAWAGRLSDRRRPEILASIGMFI
ISSSLFLLSRIDTESSIFLIPLYGIFLGFGFALFSAPNTNIIMSSIDKRYYGFASSFLAT
MRIMGQSLSMVMIGIVFSLESSFMNSYRILMLTYGILCILGVFLSIKRHEVHKLS
>fig|309799.3.peg.1911 Multidrug resistance ABC transporter ATP-binding and permease protein
MRYLLKLIKIAKPYWGYLIISAISLLILTGLNLIGPWLIRSLIGIITNISQYPNARVDII
RISLILVLSYILGIIFQFLRNYFSHYAAWHLVADVRMMVYDKLQNLSYRYFVDKQTGQLM
SRVVNDTANLEMLIAHAVPDLISNLLILIGIAVILFIINPILAALSLIPIPFLLLSSTVF
AKKIMPIFRKAQKALADLNADLQDNLSGIREIQLFNKQEKEYKKIKEKVYNQIHALLSAL
KLSAIFHPTVGFLSSLGNLIVVSVGGIMALSGKIQVQDIVGFLLYLGMFYQPINALAQIL
ENVQQALAGAERVFEVLETEPEIKEKENATELKNVKGKITFENVTFSYNPGVPVLKNISF
EINPGEMVAFVGPTGVGKTTIMYLINRFFDPDSGRIKIDDIDIRDVTLKSLHENISMVLQ
DVFLFNGTIFENIAYGKENATLEEVIEAAKIAHAHEFIERLPKGYFTEIGERGIKLSGGQ
KQRLAIARAVLKNAPILILDEATSSVDTETESEIQKAINNLAGTRTILIIAHRLSTVKRA
DKIIVLKDGEIVEIGTHEELMKRKGLYYKLCSVQFAEDKMAEIVRS
>fig|309801.4.peg.481 Drug resistance transporter, EmrB/QacA subfamily
MIIVDATIVNVAIPSIIEDLGLQLTDAEWVNTVYSLVFAALLVTVGRLGDLYGRKRIYLG
GLALFVGASLLCASAPSGTLLIAARALQGIGAACILPSTLSSVNAMFRGRERALAFGIWG
SVIGGMAALGPLVGGWLTTDFSWRWAFYINLPIGLVAGTIALLTVPETRDPSAAPGIDLI
GIVTSAIGFAALVFGLIEGERYGWWRPTDTFRIGSWEWPFATLSPVPVALALAALFLPTF
ALYELRRVRANRPVLLDLRLFRYRTFRWGNLAALIVSLGEFGIVFVLPLYLQAVLGYTAF
QTGLVLLATAIGAFLGGPAAANLAQRFGARQVIRAGMLFEAVGLLLIVPFLAPDTTGWRL
APALFLYGLGVGLATAQLTSVILAEVPTAQSGQASGTQSTTRQVGAALGIALLGTILAAG
LGSGTKSRLIDQLGIPPQQAAALARAAKQSAGQILVQLQTQPGTQPIVQAIEAAFTDAAR
RTALVAAAFILVGFIASWLIPDIRPERGPTAVSEPATAESRPTG
>fig|309801.4.peg.536 Daunorubicin resistance ABC transporter membrane protein
MASIELTEPVRPPSPLLRASIGVLTLWQRDLLRFWRDRTRIAGGLAQPLLFLAIFGAGLS
PWMGNLGGTMFGPDYLQFLYPGIIGMSVLFSSIFSAVSVVWDREFGFLKELLVAPIPRWS
IVIGKALGGSSTAMFQGLLLLILAPVIGVRLSLSTILLLIPLLFLLAFSLSSIGLVIAAR
MRSTEGFGLIMNFLVTPLLFLSGALYPLNNLPTWLLILTRLDPVTYGIDAIRRVVLSSSG
VPQPVIDQLGVTLFGHPLDPLTDAAVVLGLGLVLITVAARQFARPD
>fig|309801.4.peg.825 Vancomycin B-type resistance protein VanW
MSIAEVVREVVTTRMPGQWLRRVVTGASVIVAGAVLVSVAAIFAYGWLQGDRIYPGVRVA
GVDVGGLTVDEAAQRVTNALAALTNQEIVLTFQGAELALPVRELEPEWNAQVAVNQAHRV
GRSGNLWRDSASWLAARLGLEVIPVPVTYRADRLEAAVRTLAERAARPPQDAFFTVDEDG
SLYVAPAREGVGIDLGIARQSVEGALASGRVGRVELAPVTLPPTYTESDLEPLKPRVQAL
VGSPIVLTLDGESRWMISPPDLARLLTLTSHEGALRASFDRGKLEEYLSRIAGVVVAPAQ
DAHVRWNGSAFEVVPARPGAVLDVVATVNEFLVRVERGERTIPVQARPASPLVTEAMADE
ARARAQALVDRGLTVRWPNGTRTLRGGELAALLTFEQRRQGENVVGLDVSIDRSTVRSLL
EAIAPQIQRDARDAVLRYRDGKVIVVTPEQTGQRLDIEGSLIAFERAVRSGRSAVDLVVA
NVEPRVTSAMASQIRIRERISAGATYYGDSAPNRRHNVELAVQRVNGALVPPGEVFSFTG
TVGAINLENGYKVGYGIVATNGRVQTVPSVGGGVCQVSTTVFHAAFWGGFPIVERNWHLY
WIPLYGQPPSGLIGLDATVDTDYGLDFKFRNTTSDWIAVVAWADGSWVHVEIWGTKPNWR
VVVDDPVVTNVVKADPTPVIREDSSLAPGEQVVVERARDGFSVAIRRRVYEGDRLIDDVT
LRSTYQPSQNVTLVGPQPSPTPTETPEEGTPQPTEATTPVPEATPTPVP
>fig|309801.4.peg.873 Permease of the drug/metabolite transporter (DMT) superfamily
MIGLGFAVAGVLAVSTSAVLIRLAGSVSAFEIAFWRLLVATLALVPVALATRTLGAVRSL
GWPRLAIYGATLAVHFVAYNAALQFAPVAHVLPLLYTSTIMLAILSAFLLKESLRPRQIA
GIVIVLSGVVVLTGFEPRFGLRIAIGDGLALLSAAAYAAYSLVGRRERARIPLLAYAIAV
YGSAAVWVFPFALLAALSAGASVARYDWQVVAALLGLGLIPNTLGHTLYNASVRRLNAAI
ANVIYTQEMTGAILLAWLILGEVPGVNAVVGAIIMLVGILFVLLP
>fig|309801.4.peg.1106 Drug resistance transporter EmrB/QacA subfamily
MERAQTERSRLALILPGLLLGMLLAALDQTIVGTAMPRVIAELQGLEHYAWVFTAYMLTS
TVTVPLYGKLSDLYGRRTFFLFGMIVFLIGSALSGMAQSMTQLIFFRALQGIGGGALFPI
AIAIVGDLFPPAERGKWQGLFAAVFGFSAIIGPSLGGWITDNWGWRWVFYVNMPVGALAL
LTTGLTMPKLASGRQHRIDYLGAALLVSGVTPLLLAFSWAGTEYPWSSPPIIGLFGASAL
FLVLFVAAELRAPEPILDLRLFGNRIFTPTLLAAFLIAIGMFGTILYLPLFVQAVLGRTA
TNSGAVLTPMMLGFVFSSIVGGQILSRTGRYKILAIGTVAVAVIGMFLLSRMDVTTTSTT
VVRNMIILGLGIGTTMSLFTIIVQNAFPAQRLGEVTSALTFFRSIGGTVGAAILGTVMTN
RFQHELTTRIPDTIRASIPAQQLDAIKNPQVFMSPEAMQQMQQQAAAFGPRGQEMLQLLL
TAVRQSLASAIDTVFFVGMLILIGAFLLTFFIPEIPLRRRSPGGAPLAH
>fig|309801.4.peg.1984 Glyoxalase/bleomycin resistance protein/dioxygenase
MVALRRIQHVSITAPLDGAERARAFYNGVLGLREKPVPETLAGLNILLWFDVGPSELHIV
AEDDETRGRSRRHVCFEVDDLAAVRARLSEAGYQPYDAAPIPGRPRFFCRDPFGNLLEFM
VFAEEGSER
>fig|309801.4.peg.2310 Permease of the drug/metabolite transporter (DMT) superfamily
MTRGQLVQLVLLGTIWGSSYLFIKLAVAGIPPLALVEGRLLLGALVLLAVRWVTRQPWPS
RAVWLHLALMAVIGNVVPFLLIAWSEQHIDSGLASVLNATTPFFTVLFAVLIFRAERLTQ
AKAIGLTLGFLGVAVLSGADLAAVGAASTQGQLAVLASSACYGLGFAYARRFLRGAPLAL
AAGQIALAALILLPPALATEDLAALRPGPVEILSLLALGVASSGLAYVLYYRLIAAAGAV
IASLATYLMPPVGVTLGWLVLGEPVGWRLLVGIILILLGMAVVQGRAGWSAWRGRTARAS
TLLADD
>fig|309801.4.peg.2521 Permease of the drug/metabolite transporter (DMT) superfamily
MRVATWRRWVDGEAFLAVLIWGASFPIVKHGVDSFGPLGFAVVRLIVAIACLLLWLRWRG
EALRIERADWPRLAVAGFGAMGLFQILFLVGMHHTTATHSALFLNTSPLWALPISWLVER
QRPRLGAIIGAVLGFAGVVAMIGRPEGEARSTLWGDLLTLGAALCWVGVTLIPRPLVRRY
GAVPITTWMLIASLVVVSLVGFPETMQSLHEVPGWGAWGALLYTGILAMVGANVFWQRAV
QRLGAATTLVYYYLQPGIALVLGAMFVGERIRVTQVIGIMAVFVGVLLAQRAGLQENVPR
IAAPVTRRSP
>fig|309801.4.peg.2765 Permease of the drug/metabolite transporter (DMT) superfamily
MREQAIADRRAARQHTIGGHLLLATTAVLWGSSYIGTRAIVGDVPPLLLGFLRALSATVV
LGVLAKLAGESLRARSSAWIPLAGLGVLGVAYFYIGLNLALQWTTATAASFLSLPYPALT
AVGGWLFLRERLGARQIAGIGLAALGATWLTVASAQDNVGGAWIGNLLALSITVAWTAYT
LLGRRLLLKWTPLAATFHMMAAGTLVLALAAGLEYFGGGRPRWTVESTLITLYLGVVCTG
LGYAFWNAGLRRVRAATASVYLYLQPVTVVVLGIALLGEQPSLVTLVAGALVIAGTALTA
GGERAR
>fig|309807.19.peg.1222 Acriflavin resistance protein
MSFLVVIVVGAVSFYYLPVDLLPEIEYPQVSVTTSYPNVGPEEMEQIITDPVANAVSSVS
NVERITSQSSEGSSRVNMEFGQGTDLNAAANDVRAALDRIRDDLPVEAEPPSIRKFDPNS
QEIVSISVESRRDLPSLTRLMERNLSKQFEQIPGVGTINVQGGIYRQVQVNLNRERLMSY
DLSAAQVQQSISSSNVALPGGNVKEGLKDLYVRTQGEYESLDEIRNTVVTTANGTPVRVQ
DVAEVIDGYEDLGRIAELNGIPVLRLDIQKRSGANTVSVANRVREEVKRVNQTRSDLNLT
VVSDQSDFIRKSINNVQSSAIWGSLLAILVLYLFLRNGSTTFIIALSIPISIIATFALLF
FNDLTLNQMTFGGLALGVGLIVDNAIVVLENIIRQREENGRSLREAASMGTREVAGAILA
STITTSVIFLPLVFARTTTASLFQSLALVVVFALACSLLVALTLVPMMASRFLTVDAGEG
DAAEDTSKSWFQRAFASLENQYSDAIRAALQRRWLVFGATGALLVGALLLWPYVSVELAP
QTDANQIDVDMQMAQGTNIAVVMKYLEELEQRVQPMLPQDEVENFAKQVQPWGAEVEVQL
KSAEERSINTFALADSIRSEVVGKVPGADLRVSAQSGLWILRRVFSVGGGNEALRVQLRG
YDLEQAQKLAQRVKQELETVEGVAGARSGRREGQPEQNIRFLRDKISSLGLTTQEVARAV
QTNLGGSRAASYRTGGEQFPITVRLRPEDRLSVQDLDNVSIQTPDGNSVPLSTLVTTQRG
RGPTEIQRINGQRVTYISANLTSDAVLGEVVNRARQKVSTLSLPEGFSVTFGGQYREQQK
AQTDFLIAIFMALVLIYMVMAGQFERFLDPLIVMFSVPLVLVGVLPTLVFTGTTVNIQSV
MGFVMLIGIVVNNAIVLVDYINLMRRDRDLPLTEAVAEAGRLRLRPILMTTLTTVLGLVP
LALGIGAGAEIQAALARVVIGGLTASTLITLLLIPVAYVSLELTARTVRSKLPDWSWLPD
STVQPRRA
>fig|309807.19.peg.2462 Daunorubicin resistance ABC transporter ATPase subunit
MPAPAVDIQKVHHSYGAHPALRDVTLQVDPGALYGLLGPNGSGKTTLFRILSTLMPPSEG
RAHVFGLDTARESGAVRQRIGTVFQEAALDEALTVRENLRFQGALYGLHGAERRERTEDL
LRRLDVADRAADPVADLSGGLRRRVDLARGLLHRPDLLLLDEPTSGLDPAARRTFWAAVQ
QLRADEGTTLLLATHLMDEAERCDRVGILSDGALVADGRPNTLKADLGDETIWLEADAPT
ALRDRIEAQFGVPTRIVGATVQVAPPDPPAFLSSLYEALSDHIRSATIRTPTLEDVFMVH
AGVSPTESRERVLARGDDSND
>fig|311403.8.peg.173 Glyoxalase/bleomycin resistance protein/dioxygenase
MIKVNRIVYAAFETPDLDGQVDHYTKTMGLTLMDRDSSAAYLSSSGDRHTVVLRKGAEAR
CDALGFQLPQGTDLGEYAKQIAGHGIQAQRQSDCQPGIKDSLVFVDSKGTKVETFVEAPI
AGIGFQPSGISPNKLGHVAFNAVDVQAAVKFYCEVLGFKVSDWMGDFFAFLRCGPDHHTI
NLVSGAKNKMHHIAFELRDWTHIRDACDWLATDRIPVIWGPVRHGIGHNISTYHRNADGQ
IIELFCELDRVNESLEVYEPRRVHQEFPQKGKVWTDKPMAANMWGSMPPEGFLD
>fig|311403.8.peg.203 Membrane fusion component of tripartite multidrug resistance system
MIVVVGTLVAVATENWDRWTAQASVQSTDNAYIRAELTRLSARVSGNLKSAPVQDFEHVK
AGQLLMEIDPSDYEVKVAQAKASLDSAVAQLQNLANQERLQHAAIDQANAQFQAASVTAE
LARQEAVRQTALLQSGSGTKQKQEQADAEKQQTAAAAQASQASVVSARAQLDVVSGQRAQ
LQASVDAAKSNLDAAQLNLSYTKVVAPFDGIVSERQVHVGDYISVASNLLTVVPLPNVYV
TANFKETQLARMSVGQRVIIKVDTFPGQVFRGHVESLSPASGSQFALLPADNATGNFTKV
TQRIPVRIAFDEDASVLEKLRPGMSSVVAVQVDNVTGG
>fig|311403.8.peg.243 Permease of the drug/metabolite transporter (DMT) superfamily
MAGILLIGLSFFSGNLPSKIRIRDLPTCCVTGALMWVSGNGLATLASRHATSGFIVMAMG
MIPVWTTLITSIMNRALPSRTMILGLFTGMIGLSFVIVPPALSSEVSSVAQGYAVSTALI
LCAAGLTWSLGSVLQQPLIGRLAPTTAAGIQMLSAALILTTIGKLQAAPLLPQFGLATNQ
IAAFLFLVVFGSAICLVSYIKVIKSFNPTIASTFAYVNPLVGVALGWALLGELPETAASL
GMALILFGVFLVVARPSKRSAAYEGQSKLSRFSEENGK
>fig|311403.8.peg.353 Multidrug resistance transporter, Bcr/CflA family
MGFASISTDLYLPAMPAMGRDLGADTGAIELTISGFLIGFSLGQLLWGPVGDRYGRRLPV
AIGLVLFVIGSAGCAMAGSASTMIGWRIVQAVGACAGVVLSRAMVRDLYEGSRAAQMMST
LMTVMAIAPLLGPVVGGQILAFAGWRAIFWTLVGVGLLTLAALFTLPETLPAERRNLQPL
GRAIIGYGTLLRHRRLLGYAGTGGFLYGGIYAYIAGTPFAYITYHHVPAGLYGLLFAIGI
VGIMIANIANSRLVSRFGGDRLLLHGSAAAALSGVVLAMAAWTDWGGLWGLVVPLFLFIS
ATGFIVANSIAGALTDFPERAGTVSALVGALHYGSGIFGSALVGTFADGTPWPMGWVIAL
AGIGSFVCARSLASSRKI
>fig|311403.8.peg.1000 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKAVADMNDPRVMRLVLTIALPAVAGLAASAGHHAINAIFLGALGPEVLAGISLVMPLFL
LVAATGQGLGIGLATLLARHLGEGDVPAASSVAVTALAATIPIGIVLSVLIYLGLPSFVG
ALGASNELLAPGLNYGRLLAFGVTLGLLQAVCDFIAIAEGNSRFSMIVLIASFALNAILD
PVFIFLLQFRETGAAFATILSSVAALLCYVVYFQRRWGKVRVTMRLVHWQLLRPIARIGI
PAAATSVVTGVGFLVLLREAAVHGGDAGVAATAIAIRLMTLGQLPVFGFCLGAQSVVSHA
VGAGDPLRVRAIIRVMLMVTIPVASLYSALLFLGAEPIVRLFTDSPEVAAEAASYLRALF
PVFPLAAFQSVLLVMLQSRGRAGLSAVVGLAPQGYLLIPLLLLLPLWIGFAGVALAPAGA
AILAAILGLVIARREWLALLPTSPGQLIGQSTLHP
>fig|311403.8.peg.1764 Acriflavin resistance protein
MIGSGYVVAEKMITLRPEISGKVAELPLDIGDHFAAGQIIVRLDTTTDEIELRIARSQAA
SADAAVHRVEVSLAQARRTLERTKLLVERGVKALSSLDEDSLSVVQLTSDLDVARQAAET
ARLQVEKQDRNLVLHRIVAPFDGVIVTRLAGLGDIVASGTDGGGPRDGIAILLDPNSLTI
DVDIAQSNAARIEPGQTAVAVLDAFPDRTFKMRVRTIVPAASLQKGTVTARLEFLTPPAR
VLPNMAAKVTLDAPELQANTNERGF
>fig|311403.8.peg.3028 Drug resistance transporter, EmrB/QacA family
MTARNQQAAPQPTLSESGPPDRREIRAVILGLMIVLGLAAIDQSIVATALPRIVSDLGGV
THLSWVVSAYVLASTSTMPLYGKLSDQYGRKPMIYAAILIFLLGSILSGMAQTLLQLIIF
RAIQGIGAGGLMPLAQIIIGDLVPPARRGRSQGSIAAVFAVCSVIGPVVGGVITDLLSWH
WIFYVNLPIGAVALVMIGRAMKRPHQARSRRIDYLGAALLTACTTGLLLVLALGGNEWPW
NSPEIIGLSAASLILTVLFVFHVRRESEPVLPPDLFRNRLFVIACLVLALTFMGMLGASL
FFPLFFQMVMGVSPSQSGLLTGPLMVGFVISSMFNGRVLLQRSGRYKPAQLFGLGLATTA
FAVLTWAAAESLGFAVIEPSIFALGLGLGLVMPTMTIAVQNALPLAHRGVGTATLAFFRS
LGGLIGVTGSGAILAYRVQQATGASGSLDMSSLTESGLKQLATASPEAHAAAIALYRHAI
AMTFATGTVIVALALIALLFLPELPLRADHGEGARPQR
>fig|311403.8.peg.4036 Inner membrane component of tripartite multidrug resistance system
MSLPSWRDWLFSGKAFVAAMLALFIALSLDLPRPYWAMAAVYVVANPLAGATSSKALFRA
LGTLLGASAAVFFVPIFVNAPMLLSIVIALWTGTLLFISMLDRTSRSYVFMLAGYTLPMI
ALPTVGAPETVFDVALARSEEILIGIACASVVSAVFFPTSVRSVLGQRITTWLDDAGSWA
DEILRGEGASPATPLKRQKLASDVTGLDLIISQLGYDAGSRDIVRHSRELRSRLLMLLPL
FSSLADRLHALKAREKALPPELLAVMNEVADWLSQGGKGETDKTAILLSGKIEALQNADP
DLNWDDLVLSSALARLKEIVDLWQDCLTLRNEIVAGKRAGSWRPAFRHRDVVGRSRHYDY
ALLAFSAGSVVVGIFMACFLWIVTGWEDGAGFVTMAAVACSFFAALDRPAPFITSMFVWT
AFSLVIAFIYLFGILPGINSYELLVLAFAPPFLVIGLLIPRPQSNMLAMLLTVNGATFIA
LQDHYTADFSTFINGAIAALAGVGFALVWTQLTRPFGSELAASRLVRAGWSDLAETAAGA
RRGDHTRLSGRILDRLGQLVPRLAAVEDRELKKVDGYADVRLGFNVLMLQKERPQLSTAG
ASSVGTVLSGVADFYRSRVKAGQAIDPSDGLRQSIDNSLEAIALRDGSAGRPSLDALVGL
RRALFPHAEPPQSWQPPMSDTSSPLSIAAE
>fig|311403.8.peg.5285 Permease of the drug/metabolite transporter (DMT) superfamily
MSSNPTSSTNDTAAIMTSAALAPLLTVLIWSGNTVVTKAAAGVISPGSISFYRWLLAFLI
LLPFVGPAAWRNRALLNQYWLKIATLGALGMVIYQSLAYEAAKTTSAVNMGVIVALMPLL
STLLAGVLAGERLTATTLAGGVISLIGLIYLTSHGDPATLLSGGFHIGDGLMIVAVLSNS
LYGVMLKRWAMPLPMWQQLFWQIGFSTILLIPVFLMGDISPITSANLPLILYAAIPTSLV
APLCWMIGIQKLGAARTSLLINLLPIVVAALAWAVLGEQLHAYHAIGGALALIGVGIGLR
QTKVAKGEEEPGADQAAWETEEV
>fig|311403.8.peg.5734 Permeases of the drug/metabolite transporter (DMT) superfamily
MSAAVIGLALSAAILHATWNAFLRSGGDRLWTVTVMSFASTIVALPFVLIYPLPASGAWL
YIVLSAALQVGYSIFLVAAYRYGELGQVYPIVRGTIPLLVTVGGFIITGDEINSYQIAGV
VLVALGIMSLALGKGRASTSSILFALVTGAIIAAYATVDSIGVRQTGQSGAYTAWVLVLY
GTFLLVAFVVLRRRLVVDFRAPDTWKALGGGLVAMVAYGVIVAAFALGPAGPITALRETS
VVFAVLIGWLFLGEALAVRRIIACVIVASGAILLGH
>fig|311403.8.peg.6567 Glyoxalase/bleomycin resistance protein/dioxygenase
MGAGLFPDLKPHHVGISVCNLDEAIAFWSEIFGFELDFTAELKPIRTTIAFLKRDGFRIE
LFEKYGASAVPEERLKPNTDLLVQGTKHIAFSVENVQDAAEKLHARGVRIVGIMRGHGTP
MQHEDAPHLDGTKQPAMALFFLDDSNVLVEIIRRSDFAD
>fig|311403.8.peg.6676 Permease of the drug/metabolite transporter (DMT) superfamily
MEKATAARFFGQAAIWGASFTFIKFALQDFSPNQLVLFRLILGAVTLAAIILFTGRSFKL
SGTAWFHVAVSSIFANVVPYLLLSFGEQHTSAGLAGVLIGGTPLVTLFISTLALRAEPAT
PRKVTGFFLGFLGVALVVSPWKVEGSSLLGALACFGAAASYAVGYAYVSRFLSPLKLDPI
TLGANQLISAAVLLGLALPFFAWPAIETVSVIPLLSLLYLGVLASGFANILYFRLIQDVG
AATASAVDYVVPVFAVLFGAVLLLEPLSWNVILGGAVILIGMAIAEGRIGSSSLSPASSG
KANKS
>fig|312153.3.peg.593 Multiple antibiotic resistance protein MarC
MLLFAGNDLSVVIHTQFQRIYMLSIALASFVTVFAALFPVINPLGDGPIFLNMVQGCSEG
VRNKLARSVSVNCFFMLLASMLIGPQLLLFFGISLPALKLAGGAVVIAMGWNLLNQKSAS
DKGANESTGITDETSDGSAFFPLTMPLTVGPGSIATAIALVAAYQESSSFSIANELPAVI
GTVAALFALSLTIYFIYRESSGIQRIFGVNGTNVLMRLFAFILLAIGVQIFLGGINGYLE
LIKLLPVH
>fig|312153.3.peg.1396 Permeases of the drug/metabolite transporter (DMT) superfamily
MQSASAAHHHRRYLYGILMAGVGSMLFSGKAILVKLAFGYGANAETLIALRMLMALPLFW
SIYWWESRRKQMSPLTWLDRGKLFFLGFLGYFLSSYVDFLGLQYISVGLERIVLYLTPTI
VLVISYFVLQKPITRMQWYALVVGYLGVTVVFIQDASSTGIHAWLGMLLVFTSACSYAMY
MIGSGEMVRRIGSVRLVVYASSASAVLSIAQSTIYDPSAIFNQVAPIYWLSLLNASLCTV
IPMLLIMIAINRIGSPLVAQAGILGPVSTIFMGYLILSEPVTWMQIGGMTLVIAAMWLLV
RSDPPKKKSPDSNESSDVDDAKILN
>fig|312153.3.peg.1548 Fosmidomycin resistance protein
MTVAQIRRASDVRVIGLISLAHGSSHFFHLVLPPMFPWLKNEFALSYAELGLLMSIFFVV
SCIVQAASGFLVDRIGARPVLFAGVALLSLAGLTYSQSTGYSMLILGAVIAGLGNGVFHP
VDYTLINHKISPPNLPYAYSMHGVTGYLGWAAAPAFMVGIAQLSDWRMAFLSAAALEALI
LLILWLNKSQLIDDVKERHAQSHADEQAINPGGAPASAFAFLKLPAVWLCWIFFFFSMAS
TSSLQSFAPSGLFKVYQIPIDVGSYFITLLALGSAGGVLFGGYLAAKLKAPERIVSSCLS
VTVVMCLLLATGMVSAEIIPFIFFALGFGYGVVAPSRDLLVKLATPKGVSGRVYGIVYSG
IDLGAAVGPFIFGFFMDAGLPKALFIGIAIFQIMIIPTVFKVSSNTVSKAV
>fig|312153.3.peg.1681 Permease of the drug/metabolite transporter (DMT) superfamily
MNKETKGIWLGLVGVVIFSMTLPATKIAVPDFSAIPLSFYRAAIAGVAALIYIAAKKIAL
PQKSDLPTLGIISILISFVFPISIAIAMQDLPSSHGGIVLGISPLLTALFATLRFGERPS
RGFWITAILGSALVLAFSIKESGGALQLSDLALLLAAVSASYGYAEAGNLSQKMGGIAVI
SWVAIISLIPSLPIAIYYAMHSSVTAIPIMNASLPAWLALLFVSIFSAYIGNIFWYTGLS
MGGISHVGQVQLLQPFCTLALSSVLVFEPLTISNIFFASAVLVVVAIGKRMPVAKVKT
>fig|312284.4.peg.15 Permease of the drug/metabolite transporter (DMT) superfamily
MQALRPESFGTVAIVSAAMLWGTTGTAASFFPGAVSPIAVGAVTMVGGGLLLFLVSFRGA
IAAFHDVSSRRWLLLGAVGVFVYPLAFYSSMNLAGVAVGNVVSLGTGPVFAAVLERVIER
ESLSTLWKVTTPIALLGVVLLSLGGHALNQGDQGSATFGIVLGLLAGLSYALYTYCSTRV
IRAGHSSGATMGAVFGAGAIGLLPVLMIFGAPLLHSVPSLAIASYLIVGPMFVAYLLFGV
GLRTTRSSTATTITLLEPVVATLLAVVVVGELLTPTAWGGLGLIFVAVTVLSTARHPRKT
LVSP
>fig|312284.4.peg.976 Tetracycline resistance protein
MRQTVAMDIDRAVQSRIVRTLVAGQVLAGLGLGATVAVGAILAADLGGETLSGAAATSST
LGAALVSIPLARLAQRWGRRPALALGAGVAAGGSLITVVAIGVAFFPLLILGFAMLGVGT
AVGLQARFAATDVAAPEHRGRDLSLVVWSTTIGAVAGPNLIGPGEAVAQWLSLPTNTGSF
VFAIAAQVAAMVLYLVMLRPDPLTLAGSRPVEPATTADAGIVRGRGPLVFAVAAIAISHA
VMVSIMAMTPVHLSNHGASLTIIGFTISLHIAGMYSLSPVFGWTSDRFGRIPTILIGQAF
FAAAVLVVALGQLSNAAVTVGLVLLGLGWSASTVAGSALVADLSTGATRLRIQGRSDTIM
SLAGAVGGGFAGPILAIVGYAGLAWGAGVLVLIVTAAALVVWRSKPLSTADSLPVPNVRS
ESK
>fig|312309.3.peg.727 Multidrug resistance protein A
MTELKKKKNKAPLIATVIFILCGALGAGYWYGYGQYFQSTDNAYLQGDITTISSKVGGYI
QQTLVEDNQKVKAGDLLATIDDRDFLAEQEKAEANVAVNAAAITNLNAELKLQDIRIRQS
ASQIESAQADLERAQQQVKRTKALIKKNYSSQDELDNNVSHLKVAIANLDAAKANYQASK
EQINVIESQIGQANAMLNQAKTALDQANLNLSYTKIYAPIDGIVGKRSLREGLLVQAGMP
LLSLVPTKEVWIEANFKETQLEKIHHGQKVFVDLDAYPDLHLKGIVESFSPATGAKFALL
PPENATGNFTKIVQRVPVKISILNTDLLDGKLIPGLSVVATVDTRG
>fig|312309.3.peg.1332 Probable multidrug resistance protein norM
MKKILTLAFPLIVSQLISMALVLTDVWMMSRLSVSALAGGGLGASVYFFIFIVASSTVGC
VANLIAIAYGQRLARPEFGNQQIRLAIKGAVLLSVILSVILLFAFSYAPNVLRLAGQPEE
MISLAMEYVDALKWAMFPSLILLVLRGLTSALGNVRSIMVMSVITVVLNVPISYVLTFQL
GMGLYGLGLGTAVAALMVMLGYGLWVFKQQEYKPFAPWLNLEEYSIKLITPLLVMGLPIA
VAALLEHGLIYGGTLMAGTISIASLALHQILLQCLSFTWNFNFGFSQAAAILVGRDFGAN
NVDGIKKTSQHSFVLVTVMSVFIAAVFIIWPESIADLFQLDNGENNMSALLTSVIWVVAL
CFVVDAWQLLAINLLRGMKIVSLPTVMTAIGYWVCGLPAAWYLMPIFGLSGIWAGIGIGL
GVTGILLLVQLLISIARVKTHYQEIEN
>fig|312309.3.peg.2691 Permease of the drug/metabolite transporter (DMT) superfamily
MMITLVLSSFLSRDNIMRGMIYLIIATILAAIGWGASKMVVMTIPGDIFIGTRFLLASFV
LAPFCFKQFRTLTGKQILALSGVGLVLSFALQVWVYAVSITTSLAEGAFIMSLAMIIAPI
ISWILFRNKPNKAFWIALPISILGMILLTLGNGWKLEASQLGFMLSALLLSMHFVLNKRI
IGAITPLLSICVQLFVVGLSGCLYASLNSHPSFEITQHAVFWFLISTIVATAIRYLAQTL
GQFSVNIETASLIMILEPVWTLVLSISVLHEVVAPQKLIGGAVIFLSLFVYIKLSRRLK
>fig|313589.5.peg.1134 Multidrug resistance efflux protein
MSAPNSTTSPTRGGVFGPEYAALTLALLSLISVIAFEGMAVSTAMPEVALELDAVRSYGL
AFSVMLTTQLLGIVLAGVWCDRSGSLPSLLTGQGLFAVGCAICGASTDFAPFLVGRAVAG
LGAGLTFVAAFVLIGRTYPEALRPKVFSVISAAWVLPSLIGPVIAGWVTSTWSWRWVFWM
VIAPVAVALVVLLIRRSQIRAADSTVDASSRDHGTHVRAAWLGLGIAVSAGVMQWGTHEL
ELTWSAQTVAALVGLVGVFLCAPRLLPPGTFTMRRGLSSVMISRFFLPCAFFGTITYIPL
MLTGERGLSLAQAGSVLAIGSIGWSLGSWIQGRDRFSGVRDRLVSLGGGALAVGLAGVVL
VTWAGWWPWFIAAPLAVAGMGMGMGTASLSVLALSLTAPSDHGSASSNLQLSDVLGSVIG
IAATGAVFAALHTRAGEDVPAFVAMWLGTSVVATLVIVAGRRIRT
>fig|313589.5.peg.1488 Vancomycin B-type resistance protein VanW
MTDAFDQQPGQPRRRRGAIAVLVGAFVLLVAGYVGVAAYASGRTPADTKVGGVQVGGLDP
AAARKVLETAVAQRGSAPVALTAGGKSATIAPAEAGLAIDLDASVEDLTGFSLNPVKLVS
HLTGGATRSLETEVDDSKLKAAVTKAAQALAVAPKEGSISVAGGKVAVVAPVKGQAVEVD
KTADLIADSWPRTAPIVAPVTASTPAVSAEELQRVKTEFADKAVSGPIAVKAGDKTFEIS
AASLAAGITFPADADGKITPKFDDKIIIAAVTAAADKADATAKATDATVSYASGQPAVVP
SKTGVALDPTKIVAPVTAALTSPERAAIIPVTVSQPKFTTEQAKATLPKGMISTFTTHFP
ANGGGRVSNIRLAARTLNNTYVAPGATFSLNGVLGKRTPEKGYVKGGVISEGRLSENYGG
GISQVSTTLFNAAFFAGVKFEQYQAHGFYISRYPEGREATISFPYPDNRWTNTTDGGIVI
RSSSSGGQITVSFYGTKKWDIVATKSPRRNVVTPKKITDPSPKCITQNPTPGFDVTVTRI
FKQGGATLRTEAFNTHYNPEDDVTCTHPDAK
>fig|313589.5.peg.2253 Permease of the drug/metabolite transporter (DMT) superfamily
MYAGHAGPVPTRHRLLAMLVAVLWGVNFIAIHATLVQFPPFFAVALRWAPLAIAAVLFVP
KPDVAWRWILLYGLGFGILQFTFLYWGMATGMPAGLASLVLQSSAPFTVVLGALLGEHLS
PRRGLGVLIAVGGLAVVGSQRGDVSAVWPFVLTVLGGLGWAVGNLAVRRARATQPVRLTM
WMSVVPPIPMFLLSLVVEGPTRIADSLTTLGTQVGLAAVLGLIYTSLIATVIGTGIWSWL
MARHPAGTVAPFSMLVPVTGLTSAWLLLGERPSLVEWLGCAIVVVGVLLTAGGRHTPRPS
PAASAPTVENATIRADASGQSRGKAAVTSSSRSLASRSAIVARTPSVP
>fig|313589.5.peg.2914 Tetracycline-resistance determinant tetV
MARPDSDTTSNTSPPASAEPTERKLPRALTPFRGAAYRRLAVALVFSTFATGVWAIAQVW
EVVRIGGGASQLSVVATAAALGVIIPALLAGVVADRVPQKRILLVVAGVELLCMALVATL
SLLDITQLWMLATVAFVNGMAMAFYYPAYTAWLPALVEPQDLMAVNGFEGMVRPTIGQAI
GPAVAGAAIAAANPGTAIVIAACSVLLGLLALMSVPETPLRRQLDEGHAQHPIASAYSDM
REGFSYMVRTPWLLATLLFASLMILVMMGPFEVLVPFLIKDRLGGGPREHAWVLAAFGVG
GAIGSLAMASLRMPRRYLTWMNLLWGVGSLPLAVIGYAGHIWIVIAAAFVLGMTFSAPMV
IWGTLLQRRVPPHLMGRVSSLDFFVSISLMPVSMALAGPVSHAIGIRPTFLIAGIVPGII
AVIAILCARLPADEIANPLRD
>fig|313589.5.peg.3713 Permease of the drug/metabolite transporter (DMT) superfamily
MSPAPRVPWQAKFMALVFIWGSSFLLMKVGLESLSAVQIAALRLVTGAATILVLLWIRGG
SLPQERWVWKHLIVTGLLLGTLPFTLFALSETRVSSALAGIGNATTPIATVLATMAFLPG
ARATRPKVIAVVIGFIGVVTIMQPWASGRPDLVGFGMALAGGVCYGIGWTYNRRFLAGAD
LGGLSQPAATLLMGCVLMVPVILVWGALQPGGIGAIWAYDRARLGTSQIEAGSAGGGWIW
LPLLCILALGIVGTGAAYILQFDVVRGAGPVIGSTITYLIPIVSVLLGVLVLGESLGLFE
VIGFVIVLAAAAVINAPARRPRPRLRAPLGRSSVVAPDPETVPMGHEVEGVSQPRVP
>fig|313590.6.peg.744 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MEYRLTIVVPVYNEEDNLLRVESEFNAYFKTAKAKSKVLFVNDGSKDTSLDIIKDICTRS
TDFEYIAFTENCGLSAAIKAGFDHADTELVGYIDSDLQTAPDDFNILIEEIGPYDLVTGV
RADRQDSFVKNMSSKIANGIRRSFTHDGMDDTGCPLKIIKTNYAQRIPMFKGLHRFLPAM
ILLQEGKVKQVPVRHFPRVAGEAKFGVWNRLLGPLMDCFAYLWMKKKYINYKVGNSSRG
>fig|313590.6.peg.887 Permeases of the drug/metabolite transporter (DMT) superfamily
MSNNTTRHILEINLAMLFVSTSGVLGRYIDLPPAVTIGIRSFLAMLLLGLFVKWKGFSFT
LARKDILAIALSGVFMGLHWITYFYSLQLSNVAIGMLSLFTYPVMTSLLEPVFLKTQFSK
MHLLLGVLVLIGIYFLAPSFDTENDYFLAILIGLLSALCFAIRNLLVKTKIGSYNGSVVM
WYQTLVIAIMLIPAYFIFDAEGFVKELPYIGMLALITTALGHTMFLFSIKRFSVTAASLM
GSVQPIYGIILGIIFLNEIPGWRTVLGGSLILFSVVVESLRASRNK
>fig|313594.4.peg.960 Permease of the drug/metabolite transporter (DMT) superfamily
MNKRILALIAVSIATLIYGITFTVAKEVMPLYIKPYAFILLRVSGGTLVFWTLGLFLKQQ
KIEKSDYQKIGVASFFGIALNMLTFFKGLSITTPISAAVMMVMAPIMVLLFSSILIKKAI
GKQRIVGVFVGLIGALLLITFGSASEQSSTNNNWGNFLVFVNAASYGLYLVLAKQLLVKY
HPVVFVKWLYLFGLLFVIPFGYAEFIEIAWSGIPKNSYWNIAFIVLLTSCVTYLFNLYGL
SKLKPTTVGVFIYLQPVIAAIYALIVGSDSLNLVKISATLLIFLGVYLVTKQVEK
>fig|313595.4.peg.580 Ribosome protection-type tetracycline resistance related proteins, group 2
MKKPTINIGILAHVDAGKTTLTEQFLYNSGAIKILGSVDKGSTRTDSLDIEKERGISIKA
ATTSFEWKGVKINLIDTPGHVDFSSEVERVLCIVDTAVLVVSAVEGVQAHTLNIWDSLKE
LQIPTLIFINKIDRQGADAETTIAQLEHDLKAKPVVLFSSENEGLTNAAITSVFNTSTHT
EIKEKTIEHLLECEEHLLERFLNSESITDDDYLQRIRRLTIDNMITPVYTGIAKKNIGVT
ELMDGIIDYCPTSKTTTTKELSAFVFKLEHHKIYGTMAHVKVFSGELSSKSTIYNHTQQL
ESKINQTKQLHHTKYTDNVILTAGNIGVITGVLGTKSGDVIGNPEGIPKLPQLHIPVLTV
QVIPDNNTDYNALAEALQQLDREDPSLSFKWFKAEKELQLLLMGQMQIEILEYVLNTRFS
IKASFTDPEVVYKETISSKAEGYIRYWMPKPCWAIMTFLIEPAPLNSGVRYRSIVSQNDV
HIKYQNEIERSIPKALVQGILGWEVTDVKITLIKGEDHNVHSRPGDFNLATPMGIMQGLK
IGGTHLLEPILSFEIKANEALLGKIVSELSTRRANFETPQFVDDTFRLRGTIPVATSLDF
SIKLNAITSGKLRLKLQFYGYDTCPKGEGAIREYKGVNPLDEAQWILHRRGAYKADERII
>fig|313595.4.peg.858 Permease of the drug/metabolite transporter (DMT) superfamily
MNSILKGGLLVALGASCYGLLTTFVKLAYEEHYTPYEVTFAQLLIGFIALVILNLFLKKS
EPPIKDSKLRRKTILYLILSGTSLGFTSIFYYLAIQYITVSVGIVLLMQSVWIGVVLDGI
INKIKPTKRKIFSVILILIGTVLAADLLIEKQEIDFAGIGYGILAALSYTVTIMTSNSVG
LQYHPITRSKWMMLGGLLVVSVITLPELINYMDFGIFIVWGPILALFGTILPPLFFTAGM
PKINVGLGAIISSIELPVAVLMGYFVLQEEQNLYKWIGIALILSSIVLMNLRKVKKNPV
>fig|313595.4.peg.974 Nisin-resistance protein
MKNLKPLLIIVLFLFISCSSDDDSPETNIRVTNFINEVVDIMEVNSINRNTISWDDFRTR
VLTRAQNVTGTDNPLRLALQLLEDNHSFIRKTNGTFISGSSIFCPPSDLSPVPTPDNVGY
IKINSFSGNDQSESLAFAENIQNEIRVQDSENISGWIVDLRNNPGGNMWPMLAGVGPVLG
EGIAGYFIGPDNESTPWSYANGAAILGQNTIANVTSAYTLLHSDSKVAVLLNRAVISSGE
AIAISFIGRSNTETFGEATCGLSTANAGFSLSDGSTLFLTTAFMADRNQNVYGESILPDN
VVSDGELIQAAIDYINN
>fig|313595.4.peg.3085 Acriflavin resistance protein
MNIAKFSIKKSRITLMALGTIILFGISIYSSLSRDSMPPYTVRVANIITEFPGASPERLE
LLVTDKVEKISQELPELKDVKSTSRTGLSVVTVTLKEEVSPEELQTVWNSLRRKLDGMEG
LPNNVAPFLDDDGIGDVYGIVVGLVSDGFSYAKMKPYVDAIKNDFIRLPDAAKVVLGGVQ
EERVFIEFDNTRLKSYGLSTIKLQQIVQNTNILSSGGEVNLGNERIILEPTGNFETISDI
KNMLVPINDKGSLVKLGDITTISKGYIDPSEQRVRINGNDAISLHINLKENSNIIELGNE
VNSIIQKWQDKLPVGLEIQRVSSLDTYIDDKVSGFVINLLQSIGIVLLVMLVFLGFRTGL
IIASLIPIVTIMTLLIMGLMNIGLNQVTLAALIMALGMLVDNAIVVAETVIVKMEEGLSA
KKAAIDACSELFTPLLISTLTTSIAFLAFYLSPTNMGDIVGPIFIIVSIALLSSWVVALS
VITTFCYLFLKVIPKKERKQSSIDKVINNLKKQYKNIIIKSLHHKWKVVSVIGIAFILSL
VGFTQIPFLFFPDSDRNMITVDVNLPEGTKIEATTAVVKELEQYMKDSLQVNNKRSNGIL
DWSSYIGQGPESYDLGYAQDEANSNYAHIMVNTSSFEFNKKMIAKLDAFGYDNFANADIR
VKALAAGGGTVPIEIKLIGENSDELAKIAAAVKTRLSKISGTKNVKDNWGPKTKKFIVQI
DQNRALKAGVNNQDIAISLQTNLDGFQTGEYREDDKSIPILMRNEVNKKQTLTSLKTLNI
YSQTTGKSVPLLQVAAILPQWQYASIRRYNLDKSISITSELREGGNAATITTEIASWLAS
QKENWPTDYTYEFGGDEKETNENMGSVISYLPLSGFIIVLLLIIQFNSFRKMTMVVSTIP
LALIGVVIGLLIFREPFGFMPFLGTISLAGIVINNAIVLIDRMEIEQKNLNRRVEDAIIT
ACLQRFRPILLATFTTVLGLIPLYLSGGELWEGMAISIMIGLLFGTVITLVFIPTLYSIL
FKVNYKDYTFDDRLLDD
>fig|313596.4.peg.915 Permease of the drug/metabolite transporter (DMT) superfamily
MYLMILAVIWGSSYILIKKALAGFSPLQLGSVRIAMAGGMLLLIGRRSLRTIGRHQWKWV
ALSGVVGSLVPMYLFAFAETEISSSVAAVLNSLVPLFTLFVGYFAFGIGFSRNQLLGVLV
GFAGALLLIGIGSLAHPGRNYWYAGLVVLASLGYACNANIIKSKLSGISPMGIAVGNFVC
ILPVALVLTGLSGALSEPVRASAEFWPSVGYLFLLCAFGTCIAKVLFNHLIHISTPVFSV
SVTYLIPVVGILWGLADGEAFGLKQVGAAGLILLGVYLVNKKKRLQVQAHKNRSGS
>fig|313596.4.peg.1376 MFS permease (drug)
MYENRWEVKLSLLLVSSLTIASMITISASLPDMSRDFSGYPNGQALVKLSLSLPALFIAL
TSLLAGGYIDRKGRKPLLGVALVAYALAGSSGYWLEDLYAILAGRALLGVCVGITMTIVT
TLIADYYQGAARQRFAGTQIALMSLAGILFISLGGFLADIRWDVPFLLYLFSLLILPIAL
RFIREPEMLAEIIQKTPGGRAPREIWLVFGTVMLMWILFFIVPVQIPFYLKSLGVEQNAL
IGLAIASSTLFSAVASFFYARIKGRLSFARIFFAGFGLMAVAFLVVAFSGTYALVVVGML
LAGLGMGLLIPNANILVMQLAPPAVRGKQIGRLTTFWFLGQFISPLVLLPFIGLYSLETV
FLGIGILTAALALLFLMSSPLWKKAG
>fig|313598.3.peg.2127 Permeases of the drug/metabolite transporter (DMT) superfamily
MDKSYIKQLSGLLLASFFISTSGVLGKHIAMPSEVIIWFRSILAMVFLFVFCRYKQINLT
IKSTKDYKTFIIGGVLMAAHWVTYFYALKLSNVAIGILTLYTFPIIIALLEPLFFKIKFN
PIYILLGFMVLLGLFILTPEFDLESSQLKGVLFGVFSAFCYAIRILIMKKHVANYNGTML
MFYQTVIITILLFPVLFFMDLSGLESQLPYILLLALITTAIGHSLMLHSLKFFSAATASI
ISSLQPIFGIGLAYLFLEEIPTVHTFWGGSLILATVIIESLRSKK
>fig|313603.4.peg.48 Glyoxalase/bleomycin resistance protein/dioxygenase
MIGNKIKGLGEIILRVNDMELMRKFYIETIGLELIHESQCYTFFKVADGYAGHHQTIAIF
AKNNRTAFDEILSTIDVKKSTLHHFALEIDKVDYDNILTFCNRQKIEHVTEVFEWVKWKS
IFIKDPESNIIEFVCYDDNI
>fig|313603.4.peg.879 MCBG protein-like (microcin resistance protein)
MNKPFIADQTFKGQDFTKDRLQKGEYENCIFEGCDFSNGFLDNQNFIECDFVDCNLSNTN
TAHSIFNEVTFSHCKIMGLKFEECNDFLMAFSFIDCVLNFSSFYQLKLKGIRFSDCKLIE
VDFTESDLTDAVFDSCDLGKAIFNLSILEKTDFETSYNFQIDPEQNRLKKAKFSKDNILG
LLGKYDLNISN
>fig|313603.4.peg.1509 Permease of the drug/metabolite transporter (DMT) superfamily
MGFSALQLGSLRIVFASTLLLIIGYRSLKSISIRDWKWILMAGLLSSFFPPFLFALAQTQ
LDSGVTSIFNSAVPLFTTIVGIILFGAIITKRQIAGVLIGLFGTLSLILAGMEFNPDKNY
WYSIFILLSALGYALNINIIKKHLGHLSPLAVTTGSFAVAFIPAIVIVVYSGVFSQIGED
LQMQNSLWYLLALAFLGTAVANIYFNKLIHLSSPVFAASVTYTIPIVAVLWGVWDGETIN
LYQLIGGGIILFGVYLVNRKKRPSV
>fig|313603.4.peg.1889 Permease of the drug/metabolite transporter (DMT) superfamily
MTKKVSVTGGGVLFAIVGVVLFSAKAVMVKMAYEYNIDHLSLLLFRMIFAFPFYLVIAFW
KRPLHPKEIGKRDYLWVVFFGFIGYYLASLFDFMGLQYLKAGLERIILFIYPTIVVLLSW
IIFKNRITRLQALAIAVTYIGVLITFWNEVGISGDSIVFGAFLIFLSAFTYASYLVGSGW
LIPKFGAVQFTAYAMIVSTICVVLHYVFVNGFYLANYPNEVYLLGFMMAIFSTLIPSFLV
SAAINRLGASTFSIFGSLGPVSTIVLAFFFLGEQISQLQFFGMLVVICGVILVSRKKA
>fig|313603.4.peg.2587 Glyoxalase/bleomycin resistance protein/dioxygenase
MKGFLHQIHPVLPVKDVVEALDFYVNRLGFKIAFADDSKKPTYAGIIRDGIEIHLQWHDS
SEWDKKVDRPMLRIVTQNIESLYNEYAKKDVFHAHTLLRETAWGTREFAFFDPFKNGLTF
YRDI
>fig|314225.8.peg.75 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSENAKLTRGSIPGHLVSQTLPMIIGVAAIMSIGLVDAYFIGQLGSEQLAAISFIFPITV
AITSLGVGIMVGINSVVARALGEGDDDMAARRANFGIVFAIGCGLVFAISLFVLLDPLFR
LMNAEDALLPFIQTYMRPYLMGFPLLLAIMGFNGVLRGQGEARKTSYVSLTYAAANWVLD
PLLITGAFGFEGFGIAGAAYATVIGWLLGVGMAWWLMRGTPLPVDFGLLRRCSLTEPMKA
ITRVAGPAAFSNAINPIGLSVLTALVAVEGQAAVAGFGAAGRLQSFAVVPLLGLSGSIGA
IVGQNWGAHQRDRAKQATLYAGGFCIVWGLSIAVALFAAGEWFAGFFTDDPAVVDEFARY
LTIAAWGYAGYGLLIVGNGILNAVDRAGWALAQSCFRVFAVMVPFAWLLRGSWGSDAIYG
AELAANLVGGAVAMALVWWILNRKPAGQTA
>fig|314225.8.peg.1667 Permease of the drug/metabolite transporter (DMT) superfamily
MNAKSLAIMLFCNCAWAFNTIVSKWAVDDLAVPPLFYTVLRSLLVAVVLIPFLRRIPPDP
VRVLLVGLSISGGSFALLYIGLQTASPSAAGIVSLAGAPLTVIFAMFILGEKVRWRRGIG
IALAFAGVAIAIGSPSGSESGIGLLFIILSVLVGAVGSVFFKKITIGSVEMQAWAAVISI
VVVAPLSFGSETGQVAAVRAEPLLVGLCVLFAGLVVSVVAHSAYFKLLQEHDANLLVPLT
LINPLLTIALGAWLTGDPIGWPLLIGAAIAMAGVAIILVRPSGTIFKPLLVRPRL
>fig|314225.8.peg.2884 Probable multidrug resistance protein norM
MYAIGVARQSQSVHNIGVRTGLICHMARLISIRAGCMHEMAPEVDTADSWRAEIAATFRL
AWPLALANLLQMLIWAIDVFFVARLGEFELAASSLAVSLFSILGWATITLVSMVSALIAA
ELGRSRYAIAEVRRSVRMGVWLCVICGVLVMLILSQAEAILLASGQRAELAARAYDYMGI
VLWAMIPLLVASVLRSFVSALGRPIFATAITALAIGVNALGNYALVFGNLGAPALGLEGS
AIATVVTSIFIVLAYVVAIQQDRRLRRYAIWGRFWRPEWDRLRDLVVLGTPVFFTTIAEA
GLFGGAALLMGLIGESELAGHTIALQIAAFAFQVPFGVSQAATIRVGYFYGARDHEAIKR
AGAVALLIAVAFMAFTASVMLLMPEAILGLYIDTSKSVNAAMMAFALQYIVIAALFQLVD
GLQVVAAGALRGLQDTRVPMVMAIFSYWVPGFGTSYYLGFYTPLKGTGVWIGFAVGLTFA
TVLLTGRWLMRERLGLAHRPARKPGAKPPAA
>fig|314225.8.peg.3004 Outer membrane component of tripartite multidrug resistance system
MRKTLTLLAPMALLAGCMSGPDYAGPPQLATAAGNAFVRAGPEIDPLAPIAGDWWTLLGD
PVLNELEARAQVGNPGVAAARARIEQARASVRQERANRLPAVAAQATAVQANIPGLDIGS
GPPPGSPGAPADTEEQDSLSVYNVGLNANWEIDFAGGQARRVEAINAQAAASVANAEDAK
VQLAAEVARAYVSLREAQGRLELVQRERDLQQQILELTYQRYTQGALALFPVGDANAELE
LLKSQIAEAQADIDVFKDTLAVLTGEAPGALDGLLAAQAEIPLPPERVAVGDPAALIARR
PDVRAAERMLAAANARIGVAEAARFPKISFMGILGLGGSEPDDILDPGNLSAIALPRLQW
NLLDFGRTAASIDQAESARDEAEARYLEVVLGALRDAEQSLARFGQQRANVAALAQISRQ
ADTAAELNEQRRAAGVISQGELNTSIRKREQARANLDRAIAAMTNGWIAIQKSLGLGWVE
LSRDNRTSVEPAPVDRKSVMKPEQS
>fig|314230.4.peg.298 Tetracycline resistance protein
MSSAPADKIETTSRGSLAVVFLTVFIDLLGFGIVLPLLPIYAAQFGVDEHGIELGLLMAS
FSAMQFLFAPLWGLLSDRIGRRPVIMIGLSGSVIFYAIFGIATEWQCIWLLFVARIGAGI
AGATISTAQAYIADTTSLENRSKGMALIGMAFGLGFTFGPLLGFLAAPSGEGDPGPWPGY
VAAILSAGALILAWFKLPESMPRDSAVRSSNTHRGLSLGSLRTALGTKSIRGLLIAFFVC
VFSFANFETTLGMMIHGSRLPGSPFHFSFRAVCLTFAFIGATLAIVQGGIVRRLAGRVSE
GTLAATGGIAQIIGFLLIAAAVNTGSTGVLFLALAIIVGGFAFVTPSLNSLLSRRSDPEK
QGEILGLAQSVNSMARIVGSGLGIPLLMISMTLPAYVAAGLMAVGVVLVIAAARGGSDFE
TETPSEAAETETI
>fig|314230.4.peg.842 Daunorubicin resistance ABC transporter ATPase subunit
MAAISIENVSYSYGARRALNDLSLQIEAGEIFVFLGPNGGGKTTLFRLLSTLAPLQAGKI
DLLGFDLASQRDQVRRRIGVVFQSPSLDKKLTVAENMRQQSALYGLSGAAAREAEDRMMR
RLGVIDRAGDLAEQLSGGLRRRVELAKGMIHRPQLLLLDEPSTGLDPGARSSLWEYLQRI
RTEQGVTIVLTTHLLEEAEKADRIAILDEGTLVALDRPAALKASVGGDSVTITTRGDVEA
LAGQLRQIVTEEVRVMESAVRFESADASQLAPRIMQSLGDQIESITFGKPTLEDVFIDKT
GRQYWREEASDGK
>fig|314230.4.peg.1943 Permease of the drug/metabolite transporter (DMT) superfamily
MRPTDYAKLTVLAAIWGGSFLLMRIMAPALGPFGLASSRLLIAGIVLVTFFTARGLEIEW
RRNWRQYTVIALLNAAIPFTMFGFAALYIPAGYSAVINATTPIFGVAWSALVFGERPTWM
MVVGAILGLLGVGVIAGLGPVAPSWELLAGSGACLTAAVCYSAAGVYIKTHTGRLKPMAV
ASAAQLIAGTLLIPGMAFYHPTPALITPLVIACTITLALLCSAVGFVLYYQLLADCGPTK
ALSVTYVVPVFGVLWGALFLGETITPLMIGGMALVIGGTFLLVRRH
>fig|314230.4.peg.2485 Inner membrane component of tripartite multidrug resistance system
MIGALRFFLLGAKTDVPRAAASATMFRSVNPWVIAAIVVIPTFMEVLDTTIANVALRYIA
GGLSAAVIDSEWVITSYLAANATILPISGWLSSRLGRRNYFIGSIVVFTFASALCGFATS
LEQLICFRILQGLAGGGLQPSSQGVLLDAFPQEKQGSAMTVFGVAALIAPVIGPTLGGYL
TVNFDWRWIFYINIPIGAFAALAAWTVLEDPPYLKLETAEHRKAGWRLDGIGLGVLAITV
SAWEVLMSKGQEWDWFGDPFWRVQTLAIAFAVGLAFLFWYEMRIADPVVNFRPLAERNFL
ISTLVIFSSFGVLYAASTTLPNLLQTLFGYDAFASGLVLSPSGIFAVATILIVGPLITRG
WDARIFVACGLVLIALGCYWMSLMTLAIGPWQAVWPRVVMIIGLSMIFAPLNVAAFLYIP
RNLRGAAVGLFALLRNEGGSVGTSVAQTIEVRREQFHTSRIGEFLDPLNPAVNQYLNDAH
AYFYRLCGDSALADKMALQTLSNERARQAASLAYFDDFFIFAVVALLLIGLVLLMKRSVA
AKSHLPGAE
>fig|314230.4.peg.2486 Membrane fusion component of tripartite multidrug resistance system
MRSVAIATALIVCAWLGGPWILRSLKTVSTDDAYVDGHVTFVAPRVSGQVLNVLVDDNVR
VQKGDLLLQIDPEPYETDVALKEAQVRVAEANLSTAEAQVEGIVAQTRSNRFALEHAMES
VRNQIAVLRSNVAQAKVEEASLVLAQRNFDRNRKLATDNVIAQSEFDVYTAQLAEAESRV
DSAKEVVQQTRSALGLPINEANPLDMPADLDQNFSVVRETLANLMQSIAEIGYRPKSWDL
TPNQAIDDFFHLNVSGDLDTIYKQLIADAPAIKQAAAALLQAQRQLDLAKLNLRYCNIVS
DIDGVVTRRNVNPGNFVQSGESVLAVRSLTEIWVNANFKETQLNNLRIGQRVDLHVDMYG
RERQFHGRISGFTMGTGQTLELLPPQNATGNFVKIVQRLPVRIDLLEYDPDEAPLFAGLS
VTPYVFYQEPASGPNAGKLLQTPAELPVRKRESPHAETRTALCTGEVQ
>fig|314230.4.peg.2833 Permease, MDR related, probably tetracycline resistance protein
MLAGADKRDLNSHNHSQFETPTGLTPIIARFYLYSIFKNLRFSDPFLILYFLDLRLSYTE
IGLLMGFQHLITVLLEFPSGILADSWGRRRATALCFVFYTLSFIGLGATDLRGVIPLFAW
LSGCLTFFGLGEAMRTGSHKAIMLDYLDSTSQAELATQLIGRTRAASKYSSGAAAICGGI
LLTATRDYSWLFYLSAAAAICGFFLMLTYPRELEGDAFRARQSQADKGEPKVEGFRSMWR
QSGFLAILVQSILFESQTKIALKYFTQPFLKVGLQLFGVAIVAPLGVSGIAASGALWVGL
SEFVRDGLGGFGARLSATYEQWAGNRFFALNQIFTCGFVAVTCLAFCNWNLQWGLFPGLL
LLFGLTILQNMRRPIFVSTLNTKMPKTRRASVLSLESFIRAVTVAALLPVIGIAADAFGL
VAVWAICAVILSFGFIFRLDANSLATPTDEPHA
>fig|314230.4.peg.4237 Probable multidrug resistance protein
MRDLVRWAIRNTPAMNTIMISVIGVGVLSFFMLRRETFPEFELEIVLVTVPYPGASPEEV
ESGICEKIEEAVKDTVGIKKMTSVANNDYGAVILELNADVDAQRVLNEVRGDVERIPSFP
LLAEDPEVQQITLRESAITVGVLAPDVEHPSAEMEWRLRDLAEEIRVELLALPNVSQAEV
SGAKDYQIDIEIEEDTLRRFGLTLKQVSEIVRDENLEMPGGLIRTASQEVLVRGNNKRDI
GREIAKLPLIKTQDGVVLTVGDLAVVRDDFDDVTSFQRVDGRPAIAISVNRTSKEDLIVI
TDEVKNFVKEHGDLIPEGYSMVTWGDQSEEVRDRLNTLTTNGWQGLVLVLIILALFMNTR
LAFWVSMGIPISMLGACAILLYCGQTLNMLTMFSFLMALGIVVDDAIVIGENIYAHREMG
KSFHRAAVDGTAEVLPSVVMSIATTILAFVPMFFVAGVMGKFMAVMPLAMIAILVISLLE
AAFILPCHLAHGDDSDDLINNAIDFFAYPFRPIGAAFNRVGDWTSARLDWVIENAYQPGL
KYSLGNPFTIFTLAVCIMAISIAVVWAGFVPLNLFPSMDSKTIVANVGFPDGTPAVLADE
ATQKIEAAIRAVNAKHEENGETVVELIRRNVGFAQMRQGPGQTSDQFGSHLGAVVVRLTS
PGLRTVSSSQLIEEWRDATGPIVGSDVLVFDSQDIGPGGKQIEFKLLTNPKNMARLEAAV
EDAKDELAKSAGVYDIEDDSSPGKMELRLRLKENAQAMNVTERDLAETIRATYYGDEVMR
LQRGRHEVKLMVRYPREDRRSLAEFDQIRVRTGDGSERPITELAHVEIVRPLSEINRLDQ
KRSITVSANVNQRVANSNAIIENLKTEYVPKMMEKFPGVTIRWEGQKEQQSESLGSLFIG
TGVALAAMFVLLTIEFNSYFQPLIVMIAIPFGLIGAVVGHLLLGLELTLFSFFGLVALCG
VVVNDSIVLVDFINHRLKDGLPIYEALLDTGRRRFRPVLLTSITTIAGLTPLLFETSLQA
QVLIPMAVSLCFGLMASTFLVLYLVPVLYLIYAILGGQVSKHDEIETTEERREIEKQELV
TSEVS
>fig|314232.4.peg.914 Probable multidrug resistance protein norM
MATTPIIATARTEVAPLLHLALPIVAGLAASTLIGVVDTIMIAPLGTLPLAAASLTTAAM
IIFYSAIYGFVSAVGIEAAHRHGGAQADAVAAALRAGLGLAPLAGLVASLLMVLILLILP
LIGQPPEVLAIITPYWLAMAAVLVPVALLMVIAQVLNAMDRPWTAAGFAFLAVILNIPLN
YGLIWGIGNWPGLGLVGAGLASLIAETLALLIAITWLARHRLLRAQPDAALRKRLAWGGL
PLAIGYTGEGAAFAVVGLMLGIFGATALAANQIVQAVGGVLYMLPLGMAAAVAIRIGQAS
GSGDPARLRPIAVAAIGVVTVWMVAVTIMLILLGGRIAAALSDDSGVVALATAMFVIVAL
IQVADGVQSTALGALRGIMDFVWPTRLTLLSYWLFALPLAAALGFWAGFGPLGVWAGYGV
GIALVAIILPARFWWLTAAANR
>fig|314232.4.peg.2637 Permease of the drug/metabolite transporter (DMT) superfamily
MPQQPTPLNWISIALLGLIWGATFMVVATALEGYGPLTVACARTTLGAGAMLALMVVLRR
PLPDFTPQMRAYLLAIGIFNTAVPFALLSWGQQYVPSAFAGISMAALPLFVLPLAHLFSD
EKLRLRSALGVVIGFCGAVVLIGPGVLRIGTGWEPLGQLACLAAAMSYAVSSVMTRRCPP
IDPITMTALLLSVGAAALIPAMLIVEGIPGAAAPRPMLAIVFLGVIPTALAAVLRVATIR
SAGAVFMTLVNYQVPVWSMLFGVLVLNEVLPLRFFAALALILLGLAISQWAGLKRLFAAA
RASGGDT
>fig|314254.5.peg.779 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSTDHPHAAFLTGGLPSLYVKTALPIIILMVMSGLLNVTDAWFLGVFSGEQALAAVTVSF
PIFMLLSALGMLVASGMSSLLARALGQGDRSGAESVFASAHALSLAISLVLVLLYVLLGG
PVLTRLSLGDEALAAEAARYIGVLIWGAPIALILSVQADGLRNEGQAGFMALAGLGVTLA
NIAFNAVLIIALQMGAAGAAIGTVLAQGVSVVIILAWRVRHPLLMSASFSGWFRTRKGWA
HILALGAPPALGLFGVALGSLTVLSVLQLSKAEDYQGIVAAYGVATRVMTFAILPVIGLS
QALQTVTGINHGAGLTGRVRDSLRFALLTALCYGVVVEGSVLLFAPQIGGFFVSGEALAP
QIAFILRRLMALFALGAPLFLLGLYFQAQGDAVRAAILGLAKPYLLFIPLVIGLGLGLGS
DAIWWASPLADIGVLALAIIVFASRRAVPARG
>fig|314254.5.peg.2276 Permease of the drug/metabolite transporter (DMT) superfamily
MTPDSPGPKGWGALGLLALVWGSAFAFIAVAVDTLPPSIIVLGRLSLAAVILTGWAFYRR
RRFPPLKDVRWLWFLALGFLGNALPFTLIAIGQKTVPSGIAGILMGMMPLTVIAAAHFIL
PNERLSLRKASGFLIGFSGIVILMGPAALKGMLEADFLAQLLIFIATLSYAANAVTYQAS
PETPPSVIAAGSMICAALLSLPVALYDIVAGPAITPSLPSIMAVLALGLLPTALATIVYM
GVARKVGASFIALINYMVPVVATVIGLARGEPMTLTTMIALGVILLGVYVARRKPRVAP
>fig|314254.5.peg.2383 Multidrug resistance protein 2
MRRRAFRLLFLCLIATSIGNSMLFAILPPLARELQVDEIFVGAIYTLSALLFLIMSPVWG
ALSDRYGRRPLIVFGLSAFAGSCLVFAAGAWAGQVGLLPPMAAIIAMALARSIFGGLGSA
TNPSAQAYVADRTEPSQRTRALSSLTAAFGLGTVIGPALAGFFSHRIGISTFMVLVAIMV
GIAAVCVRLFLPEQTPPQKKGRPINPLVQFRFAGDPRLTAFMIYGCAMWMAQAASLQSLS
FYIMDRLGMDAAGGLQLGSIALTMGAAGLIFAQLVVIPVLNTSPRVLMIIGAVMVVLGNA
TMIFAPNYVVIVIGYMFNSFGFGLARSGFTAGASLAVEPEEQGRAAGLTTATAGVGFMIA
PITGLWLYQSVAPAAPFELNASLAVIGCALALLHPRVRETTAALVPNVEDTPPA
>fig|314260.5.peg.230 Acriflavin resistance protein
MNGFVAWWARNSVAANLLMVLILVAGMATFLFQIEREVFPTASLDQVNVSVSWPGASPRD
VEEQIVLRIEEAVSGLDNVKEISAQAREGSAQVTVEMEDGADYDSFLNLVKARVDGVSNL
PPSSFPPVVSRPTADTPITFVSVTGDPAQISEVELNRLARRYRDELAQIPFSSPLIEVQG
YQEEEVAVEITESALRRYGLTFDEVAAAIGSTSVNRSMGEIRTTTGNIPIATRQLADTAD
EFEALVIRRNQDGSVVRVGDVATVTDGFAERNSIFRIDGKPARLIEVLQPETVNIVNTSR
AISDWIDEKQSSLPPGVELKEQYTLAELYFGRMKLVSENAVAGLILVLIILFLFLRPTVA
IWVSAGIGISFIGTFIFLPMVDVSLNMLSLFAMLLVIGIVVDDALVVGESIHRQTEIGKQ
GLDAAVLGTQIVLKPVVFAVLTTMIAFSPFLLIGGVWGDFTKHIAWTIILALTFSLIESF
LILPAHLAHLSKPKSGGLLSFQGKIADALVTFGDMIYRPVLQLALASRYVTVAIFLGLFA
VSVALLQLGYVKFQFQPDVEQRLIMLTVDMQSATPMSRTEQVLEQVETAIEQLDQELLDR
NGQDTVLSATVAAWPGWINVTLIMSPSDARDQTLGTISERLRTLIGPVPDSEDISLSTNF
ANDGGDRFIVGLQSADIDELSAAVTEVKAFIGQFGELYDVGDSLQSAQDELVFELKPGAE
RFGLSIGEVSRQVRQAFYGEEAQRLPRNGQDVRVMVRYPLETRENFESLSSMRIRLADGR
EIPLSAVADYRYGPAVRRIDRVDRERSVRVWSRVREGADAGPIRADFYSTFVPQLLAKYP
SVEIKRRGNDEEQREFQQNVTVLYGLALFCMYMLLAIAFSSYFQPLMIMSAIPFGFMGAL
FGHLLLGENFAMFSIFGICAAGGVVVNDNLVLVDYVNRLRREGVGAAAALVEAGVVRFRP
ILLTSVTTFVGLVPILLEDSYDAKFLRPMVIALAFGVLFALFVTLIFVPALYAVGVDIAR
FYRGLWTGEDQPRLGHEGGLSGPTPHHPEIDDDRLHPAE
>fig|314260.5.peg.285 Permease of the drug/metabolite transporter (DMT) superfamily
MRIEHPAAGLWPSLALASVAALWGATFLLTQMGMDGAGPFSIVALRFGAAALILAALRPQ
QIRRITFYELKAGILLAAVALVGYGAQAVALQTAPSARVAFLAALYVPIVPVIGLVVWRR
PVAAPVFIGALLALGGIVAMSHGGAHLGLSATDGLAALSAVSIAAEVFLLGLVMRRADPL
RVSFVLVLAIALMAGGVASLSGEAAPRWDGSLLTVVAIFGIGTAYSQTIMGWGQARISPE
RASLLYATEPLWAGALGLAVGEALGTGDIVGGALIVMAVGISAMRRLPALPLPLRRSLRA
NRQSLLETGNGAR
>fig|314260.5.peg.770 Glyoxalase/bleomycin resistance protein/dioxygenase
MLFTHAIVGSSDLDRSKTFYDAALGALGLDPVLAGDRVVYVRDNVAFGFGPPRNGEAPNP
GNGLTISFAAPSKEAVDAFHEAGQSAGGTDEGAPGLRPNAPGRAYGAYLRDPDGNKICAF
AQLGDDEEG
>fig|314260.5.peg.2415 Permease of the drug/metabolite transporter (DMT) superfamily
MILGGSAFSGIRAALLSAAPLTVAAGRLWVAAFAMAIIMRVAGERWPALIDQGRLNPLWG
SAIAIGLIGYSMPMTMFPLAQLTVPSLLAGIYMAFMPIATVILAAAYADEPLTRGKMIGT
ALGFAGALTLIGPAAFRNILAADVVAQLMLLAATLGYAIAAVLLRRAAPLAALSFTSMML
IAGALGASLPAILIERGDGLPTLQGAAAIVYLGLFPTALNGLIITLMVRSAGAGFLGLAN
YFTPFAAIGFGLVLFNEALLANHLAGLFLALAGVFVAQPRPLLTLFKWLQDRRGV
>fig|314260.5.peg.2651 Permease of the drug/metabolite transporter (DMT) superfamily
MTPFRGAVLLMVCTLWGLHIVVVRATVDDVPALLYVALRMSLVAVLLIPFLRWHKGRMRP
ILVAGLCFGGFNYAFLFNGLRFVPAGVGALLVELYVPIAMGLSILLLGERVGWRRGTGAA
LAVLGAVIIVTGEGEAMSGATNLPLGAVLLIAGAFCEALGAILIKRVHGVSALQLLAWFG
VVGGVVSWGLTIVLIGDQVPDAIPNLATGGFVSALIYSAIGASIMGHASYYWLLQRVDVT
VLAPSGVLTTVIAVTAGTLFLDEPLTARLIVGGALTLLGVGIIAIRSAKKATTEASLPVG
GPEGVRIQEPSHVRSD
>fig|314262.3.peg.2472 Permease of the drug/metabolite transporter (DMT) superfamily
MSITSLNTFSGLAWAVVAITVWSGSLVMLRLGVTTSLNAYDLTMLRFGVAALILAPVALR
RGTGTDRLGLIGLVAMVVMFGAPYVLLISLAMKTAPAAAAGALNPGVMAIVSVLLGRAIF
GDRIGAARFTGLLVTATGIVLFTRSGGAITTGHLILIGTGTMWASYTLIVRCAAVPALNA
TAIVAVGSAVFYLPVYLAALPKQILAAPIADVLMQAGFQGVLVSVVAIYAFNRSAELLGP
VAGATLPALIPVVTLGLGILVLGETTGSGEIVSAILVTLGLALILVGRPAMRWFSNHILR
GLKSRGHSLGQ
>fig|314262.3.peg.4268 Permease of the drug/metabolite transporter (DMT) superfamily
MTTAPGASNWIKLIILGLIWGSSFMAVTIALNGLGPVSIAAARITLGAVSLLIMISLMGI
RLPSLQNRIGRQVWLCALGMGFFTNALPFSLLSWGQTYVASGFAGVCMAVVPLFVLPLAH
FMVPGERMTLHRTLGFTIGFGGVLTLIGLKAFASAGSDFESLARLACLAAALCYAIGSII
TRLCPSVNMLSLSAAALSCGAVMIIPTALWQEGLPSLPEGRSLLAVLYLGLVPTALAQVM
LVQVARSAGPSFLSTVNYQVPVWSVFFGALLLDETLPPQLFAALVLILGGLLLSRAPAHR
QRP
>fig|314264.3.peg.68 Permease of the drug/metabolite transporter
MILRRPFPRGWRTWLTLGIVGIGATSLGFLGMFHAAEFVSPGLATVIANAQPLLATILGV
AWLGERLPKVGRVGLSIGFMGILVIALPHLLDGGQEGSAIGFAYIVLAAVGVTISNVAIK
SVAGKVDGLFAMGLQLLIGSVPLGLAALAVEDQNAIQWNAVFTASLLGLALFGSALVYWL
WFSVLEAVELNRAIVFSFLVPIFGLSIGALFFGERLSGIQFSGIALVILGIVFVNFKGAR
RSQGR
>fig|314264.3.peg.2748 Permeases of the drug/metabolite transporter (DMT) superfamily precursor
MATLSAHPTPAPSRALQGILCVEIAMLLFVGQDAMMKTLLTLYPVWLLIFVRSIVTLLVM
TPLILILGAPHRLLTPLWPLHLLRAFLFATGFSMFYAAFPFMGLAEVSTIFFSAPLITAL
FASVFLRETIGPHRCAALVVGFIGVLIAMNPAGENFSWVAILPLLCAVTYAISQIIARQI
GDRESTLTVGLYTLTFAGLLILPMGWLVNQVIEITPATHHLRWELPPEAFGDLPRLALLG
VIGMAAYSLVSRAYQIANASLVAPFDYTYLPFAAILAYVLWDEVPALNVLAGMTLIIASG
LYLGWRELRAARHSDEVPVTAEAIFAPGSPLPPQIPEEESAK
>fig|314264.3.peg.3052 Multidrug resistance protein B
MSQIDRYFERYGPAYKWLATGSIMVATISVVLSTTIVNVAIPAVMGAFGISAVQAQWIST
GFLAAMTATMLLADWANRAFGMRLTMITAMGVFLAGSVLGGLAPNETVLTLARVVQGAAA
GIVQPLAMIMLFKVFPPDKRGAAMGIYGVGVVLAPALGPWIGGVLMDAFDWRFVFYLGLP
FAGLAILLANLFLPTREESGPIPAFDFVGVAILSIFLAVLLSTLSNAQRLGWDTNIILSG
FTISGASAIAFITWEMHTDRPMLDMRLFANFAFSSASVVAFIMGAGLFGSTYLLPVFVQQ
IQGMTPTQAGLLLMPSGFAMLVVFPIAGRLSDKVPPPVLIGSGMLVFAWSSWLMAEANVH
TAFWALAWWTVLSRVGLGLVFPAISSGALKVLPPHLIGQGSGASNFIRQLGGAFGVNLLT
VFIERRTIMHADAFAATQTSDNAATMEFLREVAGLMHSSGLPDTQIMPAAASFLGQVVVI
QSSNAAFHDSFLVVCGIFLLALVPTWFMWHAPSPAA
>fig|314264.3.peg.3118 Multidrug resistance ABC transporter ATP-binding and permease protein
MTKAPVALSITTGACGAEAKGPPPPRFGERAVARAKLGVAYGALLGVEAVERDILEAMIA
SKAGGGPADQPQPRALADGLEAAGLMARVEPVAHPHPDHWPALAQMTSGQFVLVLSQAGS
VLTIHDTTCADQRAEVPLAEFEPFFTGLVVRAEAPVQSLSRAHDAPEAAPHWFWGQFGGF
RRHIAEVALGSFVANILAVAVALFALQVYDRVIPHQSEATLWVLAAGAGLALVMEAALKI
ARAQLMDGAGRQIELNVQRLLMDRILGMRSEIAGKGPSQIFSAMREFGSVREFFTASTIG
TLTDLPFIVVFLALVASIAGNVVWVLILGGVIMVIPGFLLQRRMMRLTQEMQGAGARGAR
LLHEAIFELDTLKTQRAEDRFRRIWGELTALQAIKSSEQRRLGSVLTFWAQAVQQATYIA
AVILGSYLVFAGEFTVGSIIAVGILTSRTLGPLTQLSGTLARWGNVKSALAGLDAIALAG
QDAAEGRSYLRRTSLSGAYELREVQFAYDAGGAPVLDIPGLIIQPGQVVAVLGTNGSGKS
TFLKLLSGLYAPSRGRLMLDGTDMGQIAPRDLRRMIGYLGQDVRLFTGSLRENLNLTLLE
RDDARLMQALEFAGLGPFVRGHPKGLDLEILDGGQGLSQGQRQSIGWARLWLQDPAVCLL
DEPTAALDQTLERTLVSRLDIWLKGRTAVIATHRMPILSLTSRTLILQAGRMAVDGPRDQ
VLAHLAQAAGTGPGGA
>fig|314266.4.peg.22 Drug resistance transporter, Bcr/CflA subfamily
MAMNALSIDPMLPALPAIGRDLAIPQPNDRQLIISVYFMGLGIGSLLFGVLSDRFGRKMV
LGSAMAMFIASSVLCASAQSFVMMLAGRGFAGFFAGASRVITVSIIRDRFRGDAMARVMS
LIFAVFMLIPVIAPSFGQAILWVAPWRWIFWVLVILASLILVWMLARMPETLAMENRTRI
TVGGLMATIGVVLRTRSSIGYMLASGVVMGGLIGFILSVQQIFFDVFDAATIFPIGFATI
AGCMGVGSLINSRLVQRFGARRMSQTALIAFCLIAAIHLAVILKGWETLATFVALQSLTM
LTVAFTAANFSAISMEPFHKGAGVASSFQAFLTTAVSAALGSLVGRAFDGTTLPFTLGLL
VFGVLSFLIVVWAERGKLFTRPNLAALRDPVESVGR
>fig|314266.4.peg.1561 Permease of the drug/metabolite transporter (DMT) superfamily
MEDFNAFVDGLSGAVFFKLPLLGTQIELIVLYLALPMLFFTLWLGFPNVTQVGRAIHILR
TQPHEGEAKGDVSQWGALSTALSGTIGLGNIAGVAVALTMGGPGAILWMFIIGWFAMTVK
MAEVTLGLKYRVFDDRGHVHGGPMYVLKAVGAARGWPRLGLALGGAYAFFALFGAIPMVQ
VNQSFAQVQVVTGMTNGWAYGVFIAGAVALVTLGGAAWLGEVSKRLTPLKVAVYLGGVFA
ILILHVADIPAALALIWNGAWSGDAATGGAVGAFVAGMRRAVFASEAGVGSAVMAHSLAR
TQHPVSEGLVALLEPLLGTMIVCALGGLALVVAGTWNGGLEGIAITSAAFAQVSPWFPWL
LAVVVFLFAYSTLVAWGFYGLQAWGYLFGNGPRAQWTYKILYIVALPPAAAIDLGRVVGI
VDSSFFLMAIPNVIALYLCAGELRRDVKDYLVKSKS
>fig|314266.4.peg.2035 Glyoxalase/bleomycin resistance protein/dioxygenase
MPGSPVIPCLRYADAPAAIAFLCDAFGFERHVIYADDLDNSIIHHAQLTLGEGMLMLGSV
RDGESESLYTWSTVRDLGGTTACVYMVVEDVDAHCLHARNEGAVVVDEPHDNPGYPGRGY
TALDPEGNVWSFGSFDPWAPLQGGGD
>fig|314266.4.peg.2208 Permease of the drug/metabolite transporter (DMT) superfamily
MMFAGLLGTAQFMLNFNFVYRAEQHLTSGVVAVIYAMLLIPNSLLAYVTFRQPVTRGFVL
GSAIAMTGIVMMLVHEYRAADVAPDTVLLGAAFSILGLLSASVANVMQGTDIARRLPMMA
VLAWAMLIGAVVDAGFAWATAGPPVIELRLGYLAGIAYLGIAGSVVTFPLYFRLIQTIGA
GRAAYTAVLIPVIAMLISTLLEGYRWTGFAAPGAVLAVAGMVVAMRSKNP
>fig|314266.4.peg.2506 Permease of the drug/metabolite transporter (DMT) superfamily
MIGLVASLLFVLIWSTGFIVARAVVPHGAPELVLAIRLGATTCLLTGAAAFAGQSWPRGR
RLGLHLTAGAMLHGLYLTVSWWSVSRGMPAGIMSLLGATQPLMVAVASVALLGDRLPGRS
WLGLFIAITGVVCVLMPAIESSGTTAVPVIPVLAGIFAIIAMTGGTLIQRGQIASDPILM
SGAAQNLGGTIVAVSATLIVGEWRWDNDPILWIGLGWSVLGLSAGGLSLLVWLVRHQGPT
AMSMLLLLVPPLAAIEAWALFGEQLGPVQLIGFALALGGVLLGRSQGRAKGRDAAAELVE
PA
>fig|314267.3.peg.345 Drug resistance transporter, Bcr/CflA family protein
MSQISLSSSRAFAVTATLGLLSLFPPLATDMYLAALGDLATSMDATHTAAELSLSLFFLG
LCFGQIMIGPLTDTYGRKGPLLIGTVLFTVTSVVLPLLSDIAWFNALRFIQAIGASAGMV
VGRAMVKDLYEGRKAAKVMTVLVMLLTLGPIASPTLGSLLLEAFGWRSIFATMALISLVA
LLLSVITLPETLPAEGRQPHPFRTGAKTAKRLLSERGFLIMALVAGLIQSGMFAFITGSS
GVFQGIYGLSSIGFGMMFAAIATALIIFGRINGMLLNRYSPEQILTAVLPLFFAATLVLT
LLSQTSSLLVFAIPLWISIGCVGLLSANAMSIAMSLTEKAAGMGSALLGAIQFALAFAVS
TSVAIGGAGTALPMSLGLVVPAGLATVLFFAAGRFTVPSSSRLTS
>fig|314267.3.peg.3161 Permease of the drug/metabolite transporter (DMT) superfamily
MLSSPSLPAAHGLGPRQIPLRPLVGYLAIAVTVLVWAGFALSTRAASGAQLTFGDVALIR
SGIPALFFLPFLPKRIAVLRQLPAHRWLMIAAGAGLPFFWLAAMGGAQTSATHVGALIAG
TTPVSVAVLTWVIYRQRPAVLLPLGIILVGVAALIGASGNLAAGSLTGVALLLSASLLWG
CYTLGLRGSGLDPIGCALVLALPSTLVLLPLLATGVLPSNLTQVRLAEAMPFILAQGVGV
GLVSSLTYAIAIARLGVAKCAAIGSLAPAIAAVLAVPLLHEALTLGTILAVLIICAGVML
ANRPKE
>fig|314275.6.peg.382 Lipid A phosphoethanolamine transferase, associated with polymyxin resistance
MNGYGETARADKFSSNSYSRRTSPNIQNAGAISFSKVTSCGTATAVSVPCMFSRLSRENY
DSRIADSQDNVLDIIHRAGVDVTWIDNNSSCKGVCKRVKTLDFDPSRDPKFCDGDYCYDE
VLVDLLRETLSRPSKEHRVIVLHMIGSHGPTYYRRYPEKFAKFVPDCPRSDIQNCEEAEL
TNTYDNTIAYTDYVLGQIIEQLSTIPNSSMLYLSDHGESLGEKGLYLHGFPYNLAPVEQT
HVPMVYWASKFSQPEYSDCVKSLSSHPYSHDNLFDTLLGLTNVQSSTYQPTQDILRKCES
>fig|314275.6.peg.2568 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDASWCDITTENADELVSFYEAVMGWKKEAIDMGGYSDFVMMKSDGTPVGGICHKRGVN
ENYPSGWINYFTVESLDNALRAVVDKGGKQVGEVRHHGNDSFCVIIDPSGAACALYEKGQ
G
>fig|314275.6.peg.2828 Permease of the drug/metabolite transporter (DMT) superfamily
MSSLSVTEKAQSKGIKMLLVAVLCLGLNWPGMKLGLEIVGPVWMVCLRFLLSLPVLALFV
LITKKRLPVLNRKDRSVVFVVAFFQFILSMGLITVSLQYIPAGTASILIYTTPLWMLLID
TLWYRQRPPSKRLILTGISTIGCAMILFASGQPGAWLPLFGMLLASALWAVAIRRVSFHK
WKGSVIEAVFWQFTIAGFAMLAIALMVEPTPNFGAYDISDWLLLAYIGPVATGLGFGLMV
AAGPKLPPDKIVLISTLTPIVGYVSSVLLLKETLLPMVVAGAILMIAALIVNGLPQSTLK
KMLGKGQAK
>fig|314275.6.peg.3153 Drug resistance transporter, Bcr/CflA family
MTGTFTILSILGQVSTSIYSPFFYDLAIMYSSHVRVIEKSVAIFLIAFSISQLLSGFICD
YVNKQSFLLYGLLVFMAGTAMVTLADKESTFLIGRIIQGLGGGVGVSVSRGLSRQLFNEK
QLNISLSITNIAFAIAPAIAPLVGTLIGGCFGVSAIFYFVLMMGLMALLLLFSVGSTINQ
YTSPNSANVLSDTLALIKNSIVNIVSVGVASGLLYGVVFCFITIAPSMVMQQFELSKTMF
SIYSLFATLCFVVGSLTNIRLAAIATITKFKLSSIFILGLSLLFCLVTIGTGDAELVAIL
IYCYIAFFFIGIAMPCSVTMILGFSKTSAGFLAALTGFFHLTGAAAGAYFVTLFTAGPTL
SFSVTTMALSMGSVVICVFIRK
>fig|314283.5.peg.60 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTQQTERLGTAPVGKLFVSMSLPMIFAMLVNGLYNIVDAIFVTRGVGPLAIGGVSIVFPV
QMIVFAFAAVLGSGAASIVSRRLGAKDHEAARHAAQTTLTFSILFSFVICALVLLAMKPI
LSLLGVTEALMPYSVDYLLPILLGSPIAIMGAVFGDLLRAEGKMQYMMMLMLTGSVLNMI
LDPIFIFVLDMGVQGAAIATVIAQTAGLCLAVSFYLRGKTAIHLTAREWRIDWRALWPVV
ALGLPFFISHAGASFMIATTNNALSQVGGNAADIYISAYGLVGRVLMFVILPLIGMMIAF
QTITGYNYGAGELSRVRTMVRLGLTSSLILCGSVSAIMLTVPQVFLGIFTSDPELLQRAM
QISRTVFLCFTLVGSTFIITGYFQATGHARMALIASSARVYLFLIPAMLTLPRLIGIDGA
WMAFPLADVSSAILAVLLFVPFYKALRSQPTPVA
>fig|314283.5.peg.268 Probable multidrug resistance protein
MIKMNRTLSVLMFATFTNYIGFVVPMFLSLFLHEEGHSLGVIGYILTAYGFGGFIGGYLG
GYLSDKTSPFQVIIVSLTISISALVGIFFSESLYLLSFLLLTFGFSDHAFRPAFTMLLVN
NTSEEKRTYVFGIRNAVMNISIGISAAAGAAVFDLNVKYIFLFDAFLNVITLILLLSFSP
KLVTTTRQILSSEIESSIGWKNLNSTFIFLSLVMVLNVIVFSQFKTTFAIYLKEVFNFSS
KDISFIFLLNTLLVIFIEVPLIAFTARFNQVRLMLLGSCALCFGFAAISLSSNYTFPFLS
VIVWTVGEMLFFPIILNEFVKASTNHRGKVVGWHQTLFATGNFLGAPIGFYFYQYLDGDA
VWLLCAAIGFVSLFALPILSFQKSRQEAVNAT
>fig|314283.5.peg.346 Permease of the drug/metabolite transporter (DMT) superfamily
MTNATPSSYALLFFQGAIWGSSFQAIKFALEGFGPMTVAAGRIGLAAVMMLLYARARGHR
LPRNGRVLGMLAIVGLFNCAIPFFLIPWGEQSLDSGRTAIFMATGPLIALAIAHFTTTDE
RLNRFKLLGFVMGFVGVLLVIGLDSFSAGAAEWLPQLAIIGAATSYAISGAIAKRVLNVS
SSVFTACVLSSAALMTLPASLILETPVTDLAATGLSRPLLALIYLGLIPTGLAFLIRFHL
IKTVGYTFVSQVGYLVPVFGVLFGALIFQEAITANIVTGLCLILTGIFVSRLSARHREPL
>fig|314283.5.peg.524 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQNELLSQPIPNLVVRKSIPMVFGVLAILLFTLVDTWFISLLGTEPLAAMSFSFPVTFIV
SSMAMGMGIGLSAVVGRLLGGGDHEQAKRFTTDSLILSTILVLVLGVVGLLLMDPLFRLL
GAPDSVLVHIRAYMGVWFLVIPLLVIPMVGNSAIRASGDVKTPSVVMLISGLVNGVLDPI
FIFVLDMGVRGAALATGVSWLITFVVAFHVLKNRLNLLTLEKPEKSLLFIHWRQLMSIGM
PAALAQMLNPMANAIQVAILAGFGVAGVAAFGASSRIEAIFLVFIMALGSVMPTVLGQNL
GAGQKQRSARTISFTIHLVIGLYLAMYALIFLLAPYLAGLFTDETQVAELATLYLRIMPL
SYAWLGVGIVASQILNVLHRPMASLWMNVLRLFGFLIPFAWLGGQLFGTLGVFSGVALAH
TVSGLLIYVYILKIARGIDEPSVNDPGATSGGLS
>fig|314283.5.peg.872 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAEIQIDETHQPTALKNASLRERVQQEWRTLLALGSPILIGQLAQMANGVIDTVMAGRAS
AEDLTGVAIGNSLWVPLFLFMMGLLNATQPLISGHRGGQRDDQVMPVTWNALYIALAAAA
LAIMLLINVDPVLNLVGMDDTSAAIADGYLEAFVWGLPAILILVTLRGLTDGLGHTRIFM
VFSILTALFNAPLNYVLIFGKFGLPELGGIGCGYATAISQWLTLFCLLVYFNVSRSFRHL
HLWAHRQWPQWVRVKEILLLGIPIGFTIFVESVMFAVVALLLASFGADVIAGHQIALNVV
SVLFMVPLSLGLALTIRISFLIGANNPATARLASRSSLILTLLIAVVYALLLVFFAEPIA
GLYSREPAVIEVAVELLWYGALFQLADVLQVVAISALRGYKDTRIPMFIMVASFWVVGIP
LGFILAHTDWIVQPMGAPGFWIGLIAGLTHAAAWLIPRLFWYSDQAVQR
>fig|314283.5.peg.1297 Multidrug resistance protein B
MSGELTLNGLSTRQGPAYKWFVTLTVVLGTISTVLTATIVNVALPDIMQALQMTPDRVQL
LSTGFLAAMTGSMLLTAWFVDSYGQRLTYVLVISVFVIASIVGGFAPNSTVLILARIGQG
IAAGLMQPLSMLVIFKVFPVEKRGSAMGIYGVGIVLAPALGPTLGGFLVDLFSWRYVFFV
SIPFSLTGLLMAFRFLPNQTENKERLAFDWLGLFAIAAFLVTLLSAFTLGSAHGWISVTV
ISCAVAAVMSLLFFIWWENKCSAPLFNLSVFANVTFSNAALVGFMLGAGMYGSTFLIPLY
VQSVLSYSATSAGLLLMPSGLIMGIIFPIAGRLADRSPAVITISLGLLAFALSSFLMTKA
ELDTSFWALAFWIVLGRIGLALVTPSLNVGSMRVLPPALLSQGSGAINFVRQLGGAFGVN
LIAVYLHIRMLVHAGKMDEEFNPQLVQIPKNHSELLAYHDAFSVMAIVFALALIPAIWMH
WSSRRTSRS
>fig|314283.5.peg.2039 Permeases of the drug/metabolite transporter (DMT) superfamily
MQKHLFIAVLLAATANFFWAANAIVGKVVVAELPAFTLSQFRWIGAFLILAPFGLYRIRR
QWDWYRQRLPQLVGLSILSVTLYNTLQYWALEHTEPVKVGAMLALMPLAIAIVSSFFGSR
RLSLPEWATASIAVIGAVTVISDGQWQNLLGGSGFSAGEVLMLVAITSWAFYSVFLKNTA
SAQIDVIGLLTFFVGSGTVMILPFWVYDMLTETVFLPSGGQWGAVAFVALFPSVVSLLCW
NMAVRLSDANIAGLMVTTAPLFNALLTIVFLEHAVSSAQWVGIALVMTGVASTLLIARRN
LSATAS
>fig|314283.5.peg.2262 Permease of the drug/metabolite transporter (DMT) superfamily
MQRLDAILLLLLSAIWGASFLFMRIASPEFGPIALILVRMGVAFLTLTPFLLNRAFRQKI
ISHAGPLAILGILNQVIPFTLLSFATLRLEAGFTSLINATTPIFTAIVAVLFFASPINRQ
QLLGLIVAFAGMFVLSADKLNFHTGGTGWAILAGLGATFCYGLAVNYSHRTMSGLNAREI
AVGSMFFSSLVLLVPGLWFWPEQNPGLSAWISALLLATFCTSLAFLLFYRVLRSAGAVAS
STVTFMVPVFAVGWGVMLLGEAITPRLILGMLITLAGTALTVQIVRIQRLQPKPLDS
>fig|314283.5.peg.2791 Permease of the drug/metabolite transporter (DMT) superfamily
MHPERKALFFALAAVLLWSTVATAFKLALQYNSVPALLFGASLTSLLALAATLYRQGRLK
TAVFQLRHNLKTTTLLGAINPVIYYLVLFEAYRRLPAQVAQPVNYTWAITLALLSVPILK
HRLTRFDLAGLLLGYSGVVVISIAGKNITGSLDGIGLTLALISTLLWAAFWLLNTRSAVE
PLVQLFHNFLLATPFLALLLIITGQSLSLTVPSLLSLVYVGLFEMGITFMLWQQALSLTQ
RAAQIGTLIFLSPLISLFLISWILKEPLQWQTFAGLGLIIGGVWLSKRKA
>fig|314283.5.peg.3419 Multidrug resistance transporter, Bcr/CflA family
MQGFMHSKSATFYITLILTISLSVIAIDSIIPAIPSMTLAFQTDPGLSQLTIGLYLAGYA
LGQIPMGLLSDRFGRRPVFLIGMTGFTLLSVATVFADTISQLLVIRFVQGVAGTVGPVVA
RAVARDTHHGKDLDKLMAILVTSLAAGAMIAPILGTLIVSLFGWKAPLILNAVIGGLCLI
LLLTSLPESHRPNRDLHPWVQTKQSALAFFTNRQALVASFVVSFTFFAYFSIATGLGSIL
VDYYHYPAHVVGWGFALAVTFYMVSAQVCRFRIHRQSAEKLMHQGSLFYLLAVVVAALLI
VTLLLGAQLSVVALYGLLLLFLVGMGHVFAPASAVTMQPLGHIAGFAASMLGTLQMGLGT
LGASLTAVFYDQTPISLIGVLMLGALFSAILIRTHYRS
>fig|314283.5.peg.3922 Permease of the drug/metabolite transporter (DMT) superfamily
MTQSTLLSVSPISVSSGQRTLGMICALMTVMVWSGYFLSLRAGALSPLGTLELSLIRFSL
PALLLSPLFFRSIQAYRQVHPLYLAGIVLGSGWGFFYLSLMAMKASSVLVGSTLIPGAAP
AFVTLVAVAVFRQPLPMTRHLGLLLILLGVVGFIGSAIWPFQARQLTGIGLLLCAAFIWA
LFTLSVRQSELAPLQVAALVVVPNGVAVAGWALFRLSEIDFTGVSLTMIGTQVIVQGILV
GIFSGLFYSTAIRRLGAEPTSAIGSATPVVASVLAWLLLGEGVSWVPALALICTATGVLV
ASRAK
>fig|314283.5.peg.4010 Permease of the drug/metabolite transporter (DMT) superfamily
MEYLGYLAALGAAASWACAGLLSVGPVRQLGPIPFNALRMLMVASLLTLWLTFTDHWSWP
SRDSFGILMLSGFVGIFLGDTLLFTAVKILGPRMAGLLFATNAPLTFIIGILIFKETYTL
LNLLGVLGVIGGVFIAISSRANAGKHHWEQSVGHVGLGLLAGFGAATCQSLGVVLIANLL
TDGQDPVFATMLRVWVAVICLFLTLLLFPRFTGGFRPYRSLTPRLTGRLFLSGFMGMALG
MSLYLTSVSLAPMGIVTILSATTPVILLPIAWLITAERPHNRSLYAAILVVMGAALIFTN
GG
>fig|314283.5.peg.4143 Multiple antibiotic resistance (MarC)-related proteins
MIDLYISITIKFVFLFAPFFVVSMFLALTRGEPVEVKRAVIARAILASGVIAITLFFAGP
FIFQAIGITLDSFRIGAGSLLFLTAVSLVNSGTRTHAKGLPEEDRDDIAVVPLAIPVIVG
PATIGTILVLGAELPTFRETFVGMLGMLSGLGLLTGLLLLSGLLERVLGKTGLNILSKIS
GLILAAMAAEIVFTGVQGFLS
>fig|314285.4.peg.309 Acriflavin resistance protein
MDTTAYSAPDPALTGPIAWMARNPVAANLLLVIVVIAGLFAISTLDKEVFPTFPTETFTV
TVPYPGSSPEEVERGIVLRVEEAIRDIVGIKEIRSEAREGVGIVTVVMEAGSDMSKAVGL
AKVRVDGIASFPGDSEKPIVEEIESSSRAIRLSLFGDIEPRKFKELSEQIREDILDLGGI
SELTIEGERDYEISIELSDEKLRRYGLTFDMVVAAVQAGSQDLPGGLLRTDSGAITLRSS
SQAYRGRDFEELSLISRADGTRIRVGDVATVRDGFAEQPVLSLVDGKPALTFTIDRVGDQ
NVLGITESIRDYVERKQAELPEGVRLQAWGDASRILSGRIDLMLRNAAQGGILVVIALAL
FLDLSLAFWVVLGLPFAVLGCLAALEIFGLPVSINVLSVFGFILVLGLLVDDAIVTAESA
YARLERDGEGLKSVVGGVHRVATATIFGALTTAVAFGPSLFLTEGFARIMSHIGWVVILC
VIFSLIETKLVLPAHLRHIRVPQPGDEMGFFRGVQQRVAQSLMNFARGPYRRALGLAVSY
RYTTLAIFFAGLIVCLALVPSGILRVTFFPSVPSDNIGVTLDMPQGTPWQKTHEYARRIE
SAAQAMNERFKAQDAQGRDVIRTLLVLSESDTQARVIVDLIVSEERDIDSVVLGKWLREE
LGPLPGVRSFRIDAAAGPGGSPIDIQLEGDDLEQLRQAASELKLSLARVDGVRDIRDSFN
AGGRELDISVTPEGEALGLGDVDLARQIRQAFFGAEVQRVQRGRDEVRVYVRLPQRDRTQ
LDSLQSLWISLPNGGRAPFSVVGRVREQTSLSVINRIDLSRVVNVRADVDKAQTSSSDVM
ALAESSMLPEILARHPLVRYSVAGEVDEQRKTSDGLLYGGILVMLLIYAALAIPLKSYLE
PLLIMSIIPFGVTGALLGHLILGMDVSILSAIGIIGLIGVVVNDSLVMVDFINHYIEEGY
DWKSAVLEAGPTRFRAVILTSLTTFIGLLPIQLETSIQAQFVKPMATSVAFGIFFSTAVT
LFLIPTLYYVGQDIRRAFGGKEALPAEA
>fig|314285.4.peg.317 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTAAHDRDRIDPRYDPVTGSVVATFFRYAVPSVLGMLAVTSAGIIDGIFIGNFVGAKALA
AVNLAQPTWAAFTAIVFTLAVGGSVICGRFLGQQDILAASSIFTRTLLASVGAGIITAGA
DLLFLEDLVRLLGATPEVQPLVTAYMRVVLIFAPVFVAGLTMDYFVRVNGRPVLAASGLV
AFAATNIALNTLFIVYLDWGIVGAAWASALAEFAFFFILLSHWFHPRCSLRLTLVRGQWG
DLWSAVWNGFSEFINELSVGLVVLFFNWVMISRQGVEGVAAYTIVTYLMMIGLEVSYGIS
ESLQPMISRNLGAGNPRRIRQFMLTAVAAAFSVGLLVSVLLLALPESMISLFLGPQEQAT
AVIALVFIGYFWPTFLLNGTNITLASYFTALHRPLPSAVIALSRSLVLPCIGLLLLPRFW
GDAGVYLAIPLAELFTFILAIVLVLRLKSTPEGSRDTNTDTKL
>fig|314285.4.peg.1689 Multidrug resistance transporter, Bcr/CflA family
MAREHNALVYHCAPMAYTPENSRLDPGSKATLMFLAALVALGPLSVDMYLPAMPAMQQAF
NTDIVHMHFTLSAYLWGFAVFHLACGPLADRFGRKPVLLGGTGLFVLASAGCALANSVEE
LTTYRFMQGVGACVGPTLARTITRDIFGPKGAARALSLIAMLMALAPAVAPGLGGLMLRY
VEWPAVFVFLSVYGSIVMVIIGFRIPETLAEPQSLRPGNIAANYLVLLRDPVFLPIAAAS
ALVYAGLMAYLACSGFVFIDMLGVPVEYFGFIFLSSVFGYMGGSAVSARLAVRYATSELL
LLGGVIATVAVLSMLPLHLLAPTSILALILPMSFYSAALGLVLPQAMAMAMEHFPRIAAT
NSSLFGFLQMGLSAVITVAVGSVLVSSPLPMIITMAVTQVLALLLMVYGRAQSKKHYPIH
PLSTEPDSP
>fig|314285.4.peg.1899 Multidrug resistance protein
MIPILPFLSPRLGASDFDIAMIIASYAVCAGVAGPWWGKLSDHIGRKPVLMICTTGAALA
YVLLASAQSLTMIFVARAFAGLMAGNFGVASAMMADITPPADRARGMGMIGASFGLGLVL
GPVLGGLLSGPEGSFVVPCLTAAVMSVLAVIAAWFFLPESHHRDKSQPQTQERKLSLWTV
LRKTQSRLLMLQYIWHTASVSAATYLFPLWVYALLNWSAREVGIVFGVQGALMALTQGLL
MGPLVKLLGELRLLRVCVSGFFVGLLFAVFAQGAVSMVGSVLVALTGATLCMPVLNSFAS
QRAVPELRGRMMGATSAAAAWGRVLGPLLAGALLTVGGFRLAWSLPLGMVAMYWLWAFSR
WPKRPVPIFDPNTQG
>fig|314285.4.peg.2004 Tetracycline resistance protein
MAFSSLPGVVWLYTLIQSLAVSVGSMMVIVGGVLGATLAPEPSYATLPVAVMISGTAVSV
LPITRLMRRFGRRPIFLAVTIVAVLASLLAAQAASDGSFLLFCSAALGFGCALAGIQQLR
FAAMEAVATHLVPKAASTVLLGGLAAAIIGPQLATSGRDLVGAEFVGTFLLMAGISGVCT
LLFLFTPSSRAQATEVSGDIRSLREMLSNPTLIMAIVAAVGGYGLMSFIMTATPVHMHVY
EGHGLDQTKLVIQSHILAMFLPSFFSGWLISRWGTARVIVLGLLAYVLTVLLALAGSAIL
NYWTALVLLGVGWNFLFLAGTTLLPMTYAPAERFKVQGLNEMLVFGFQAIAALSAGAVLH
WLGWQNLLLACIPLILLLLLTLLWWQKSQNAADLGVEAKTGL
>fig|314285.4.peg.2221 Permease of the drug/metabolite transporter (DMT) superfamily
MRRNYLSLYPIPVMQTVLLYAVTVLIWGTSWFAIKYQLGTVDPLVSIAHRMALAAVFCAV
LTQLTQGFVRLSLQNHLRIFFQGLCLFSCNYLFIYAATADLSSGLIAVIFSTMVALNALG
GALFLNMPLRAPVVVGGLLGLLGMAALFYPELETLGCSDPRLQALLLCFLGTLCASAGNL
VAAGSLRRGLPVLTCNTWGMFYGGCTLYLAALLLDIPIVVDLSRDYLSSLAYLAFFATVL
AFWAYVSLIGRIGPDRAAYTTLLFPIVALLVSSVLEGYAWTLWSAAGLSLVLLGNWLAMR
GVRS
>fig|314285.4.peg.2582 Bacteriocin resistance protein, putative
MLQLVTPAQAFDNWLSLRDAGVVRQERDFSCGAAALATVLTHYYGEPVSEAALLEQLLRE
RVNTGDTKVQQQALSFADLAMLAGSRHYPSMGLAVAFEDLKKLKLPVIVALVIEGRGHFS
VLRRVDSDDRVFLADPSWGNRQLGKQAFLRSFSTPGTSAQGRILIIGSKRDSKNGSKSGS
GGDERFRHRTPRRALMAPGV
>fig|314285.4.peg.2642 Acriflavin resistance protein
MSIGAYSVRTPVISWLVIVIMVAGGIFGFQKMGKLEDPAFTIKMAKIITQYPGASAQEVY
DEVTYHLEDAIQKLPQLKRLKMSVSRPGLSDITIEFKDEYGADELPNVFDELRRKISDVT
RQLPPGALAPVVIDDFGDVYGVYLMITGEGYSWRDLYDVADDIKRQLVLVEGVRKVSIDG
EQQEVVYLDMSRVRLAELGIDPATIAGVLGSQNSVVDAGNVRVGDDYLRIKPTGEFDSVQ
EIGNVLISSRNRDLVALKDIATITRAYQEVPVKLYYHNGLPALSVGISMAKGQNVVEAGK
RLQARIDDLQTLIPVGMSLEAVYDQPAEVEESVSGFVMSVAQAVIIVIAVLLLFMGLRSG
LIIGSVLLITVSGTLLLMYLFGIELQRISLGALVIALGMLVDNAIVVAEGMQVRMQSGMK
AIEAATEAVGKTIWALLGGTAIGILAFSAIGLSPDNTGEFAGSLFYVILISLSLSWITAV
STTPLLCSLLLKPGGPDQVQNPYGGKLFLAYRSLVAFAVNHRWFTVALVGGLFALGVVGF
GQVKSGFFPASSTPLFFVDIYEPEGTDIRKTRDDTLEVSDFLRQQPGVLQTTAVIGGAHQ
RFTLVYDAREPTPVYSQIIVRTETPEQVEALQERVAEKLRRETPWIDPIVKSLRIGPGRD
AKIEARFSGPDATVLRQLSEQAEAIMRNDAEAVDIRNDWRSPVKLVTPVFNEQVGRQLGI
SREALGDAMKSAFDGLPAGSYRDRNRVLPLRMRATENERNDVNSVRDVQIWSAVLGQTVP
ATAVISGYRTDYENAVLRSRNRIATIIASCNPRGELATPLFERIRPQIEAIELPPGYELS
WGGEYEDNANAQEGLGRSLPVGILLMILTSIVLFGKLRQPLIIWLTVPLAIVGISAGLLA
TNGAFDFMSLLGALSLIGLLIKNAIVLIEEIDQQIAEGNDPYEAVLDSAVSRARPVVLAS
GTTILGLIPLLSDVFFVNMSVTIMAGLGFASILTLTVVPTLYATFFNIRKDDGEGAPESD
APSVESSASA
>fig|314292.23.peg.919 Multidrug resistance transporter, Bcr/CflA family
MFPISHEGKWFRFLMVFIFLGAAMETDIYLPTFPDILNDFNTNAVMVQRILSYNFIGICL
GSLMYGPLSDHFGRRKILMFGFSVFLASSVGCIFAKTIEELLAFRLLQGFGSSACVIVGT
AMIFDLFDEEQAAKLIADLNTLVVSLMALAPLIGGWISLNMGYKANFMFIAILVLISAIK
CFLFLPESLNIHKRKKIHPKRVATDYKTVLASSVFWYNTLITSLILAAYMIYVSNMSLLY
VEQLNVSPDVFPLYQMATLGIFVIVSLNNGRLIDKYGIEKLKTIGLGLIFLTTLILFFAS
DGMMNSPQFLTGTMCLFSAGAGLSIGIFFAKSMQVFPELTGIAASLVTAIRLFIVSAAID
LGSNVYNGTTQSVIHVMTGVVVVLAVLSLLNLNRQA
>fig|314292.23.peg.1119 Acriflavin resistance protein
MKAKGLIAWFTHNHVAANLLMLLVILGGLFSISLINKEIFPAFAMNRIMITASYPGASPE
DIEQSINIKIEQSLDNVKNIKRIESVASQGLASLTLELETGADLEKVLDDVKQQIDAITT
FPVNMETPLIKRAEFTSNVMFISLYGNLNERQLKEYAKQVRDDILLETSASDVVVSGVKD
YEIAIDVSENALRKYGLTFEQVANAVQQRSIDLPGGIIKAKDGDLLVRTNGQLYSGDAFS
SIVLRTRSDGSRLLLSDVATVSDGFVENRVLNRFNRQRAAVIQVRNLTDEDATKISHQVS
EYIAKKQAQLPSGVYLDTWGDMSHYLEGRLNMMLSNMLYGGVLVFVILALFLDIRVAFWV
ILGIPFCFLGTLLFMPTPFIAVSINLISLFGFILVLGIVVDDAIVVGESVYTEVKDKGQR
IENVIKGVQNVAIPATFGVLTTMAAFIPMLISDAPRTEFFKAIAWIVLLCLSFSLIESKL
ILPAHLARMRLTQPSKKPHLFSRLKLRFNSTVDRFINHNYRRFITVCTRHRYSVLATFSG
ILMLAIALVVSGQLRWVFFPNLPSDYIQVNVDMDVSSSDENNARVAAQIEDALYQADAKI
YQELGVNVVKHTFMNMANRQDLFILAELHKTETLPISSFEILKQWKAQMPPLVGVKNITY
DASIDRKQSDLQFSLKGENLTELAAASKAMQQLLSEYDGTLNIKDDLSSPIPEVKLKLTA
AGEALGLSLSALANQVRHAFFGYEAQRVLRNNEEVKVMVRYPQQERSTIGYLENMKVRLP
NGKFVPFTEVATANIESSYTNINRVDRKRSVIVSANVDKAQTAPSDIYNDILTNKLDKLQ
QQYPDIKIALDGRAKDEKNTKGSLIRDSLLALLTIFALMAIPLRSYSQPLIIMSVIPFGI
IGAIAGHYLAGLTLNLLSVFGILALAGVVVNDSLVLVTFINRALKQGVDLQQAVIDAGCA
RFRAIVLTSLTTFFGLAPILLEDSLQAQIVIPMATSLAFGILFATVVTLLLVPSLYLILQ
DVQSVIRRFYHWWWQPRTSE
>fig|314292.23.peg.1179 Permease of the drug/metabolite transporter (DMT) superfamily
MNKYQTLMNVALTALAPIIWGSTYIVTTELLPADLPLLASVIRALGAGLVLLLFCKIRPS
GIWWGKIAVLGLLNIGLFFYCLFAAAYYLPGGLAALVMSIQPLIVMGLGAIFFKNKLSAT
HVASAMVGVAGISLLVLNSAVELNWRGVLIGLIGTCSMALGILLTKHWGRPKDMSLLGFT
GWQLTLGGLMLLPIAIWYEDFPRAMTALNITGYAYLSLIGGVFGYFVWFRGIEKLNPVIT
SFLGFFSSVSACLLGYIFLGQSFTQLQIFGSVAIIISVYMARPKSEKQPNELTQEPVESV
QR
>fig|314292.23.peg.1401 Multidrug resistance protein B
MSYRYKIASVFLIGFFLDCINIFMSAIALPSIATTFNTGTANVAWVANSYILGMTLVIPM
STWLASRYSSRNVLSFSMVLFGCSVFFCGLSTSLYELIGWRFIQGIGAGLMIPIGQSLTF
SLFQQKQRAKVSTFIMMVALIAPAISPTIGGLIVEHLSWHWVFFSSAPLSIIVSILAWYW
VDNYNKADSERPDIKGLFLVSTALIALLVGMSIYSNSQYGIKAELIGTFAIVAALILVVI
YIEHDKNHHDPIINLSLFKNNKLTLSIIIYYAIPGVFTGINLLNIFFLQDVLHFSADKTG
MFMILYGIGAFIAIVACGKTYNHIGPKKLFVISLLIHSAGVASLLWVHLGSPIYVIILAY
ILMGLGGGLGANCAQTTALMDFDEHQMLKGSVIWNINRQISFCVGAAFFTMLFNLFCMNA
HFQNADAYHLTYLIAVLIGIFTLIFIVKRQKVTL
>fig|314292.23.peg.1594 Permease of the drug/metabolite transporter (DMT) superfamily
MTSPNSNNNPINENVSSPHAELNKGIVYALIGTALFSIKPVFIKLAYQYGGDAVSIMSLR
AISSVPIYIIMMLWLLRKTEHRDNLKQYGLAASAIGVLGYYVASYLDIAAMAHISAQLER
LLIFLFPSFVVLISWTVLKQKPAQGTFKAIALGYTGVAFIVFHDLGSMGNNVLLGSGLAI
ASAFVFACYLIMSKKLITQMGSQLFTCIGMGSAGIIILIQSQWQGVNVIDLDPMLILLGI
ALGIFCTVLPSFFVAAAMQKLNPSQLSLTSNVGPAITAVFAITLLNEPFTFYHAIGMLFV
VYSVISMKKRGQ
>fig|314292.23.peg.1596 Permease of the drug/metabolite transporter (DMT) superfamily
MEQVEQNKSVFINTSLIATIGVLAAAVFWGTSFGVAKESMLYTGVLMFLVIRFCCTLLVI
FPLVSKKLNKQIWLQLAPTGGILSIIYLAETYGLKHTTASNAAFLISLFIIFTPAVDALF
NRHKLAVTDLFAGCIAIAGVWLLVGDSLNTVTFNIGNILILIAAMGRAAFVVTTKKKMNQ
QHCDPMVATFIQLSVVTVVCISLLVFTVPVEQFIIPSAPEFWLYIGYLVIFCTLFAFYFQ
NYGVKHTSPTQVSFLLGLEPVFGGLFAHWWLGERFEQLQWVGAGLIVLAAMFISVKPKFF
SRTKKPI
>fig|314292.23.peg.2079 Multidrug resistance transporter, Bcr/CflA family
MSLLRLLSISLLMACSYFFASDMYAPSLPVMSEALNVSSTAVQQTVSAFFIALGLSQLVC
GAVAERFGRRPIAILGAVIFIIGSALCLYADQLSGLIIGRAVQGIGVGALFLLCRTIMQD
SLTKEQLVDVMSWFSILFMCLPATTPAIGGYLESHFGWHSSFWFMLGLAVLLFVVIALGL
KETHLEKNIHATKPSVVARDYSMIATNSQFLRYLIMMVMANSGALVFYLMGAFIAKEQYH
LPVQYFGMSSLLLIGCSLCARIVYIRFLKYTATEGRIIKVASCIMLLGALTILSNVVFHS
MAMIIIGMGIYCFGAGLTTSVVAVSALYLFPKHKGQTGALFGSLQMVGIFTLTFIVSHLA
SVEWMMACVLITMALLNISVQRWWNDNSVVLAKA
>fig|314292.23.peg.2085 Multidrug resistance protein D
MNKKTISTLLAVSLLMFPQLIETMYSPALTSIKNHFSVTTSEAAQALSLFFMVFAVGVVF
WGTMCDVIGRRLSTLLGIAICIASATFCYYSPTFQGLLYGFGACAFGAAVGSVCTQTILR
DSFEGASLTRIFSIASTSIGLSPVIGMLLGSWLTAHGGYTWVFAAMVIMLSLLLLWGGFA
LPETKPNHIKRDSLFLVANKMIRDGHIWYIALMVGLANIALFSYYSIAPFMFEHLGASVK
FFGNTSFVLAAGSILGSLLNIRLIRKHIRGDIIVMLSTLMMLAAGLGVYLLQETVWFFIP
MALVSLSFGLALPNLFSTALINYRNHLGTAGALLGLFYYLIIGFGLDHAAHVGNLAMTLL
VCGGCSFVLVLLKLFTAKTSKQTSENATTS
>fig|314292.23.peg.2103 Permease of the drug/metabolite transporter (DMT) superfamily
MSSLAIQTTSQYKFGVLAILLASLLWGTTGTAASFADQLSPLAIGAFATGASGVIQAALS
WRSIMHHFKQIMALKLLLAVSCLALSVYPLAFYTSMKLSGVTVGTVISIASAPFFTVFLE
CLFSKV
>fig|314292.23.peg.2785 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTYNKVTQGPIISTFFLFAFPALIALLAITTASLVDGIFVGKYLGPQALAAINILIPYIT
FMFALGLMVAIGGTVTAGKFIGEGNYKEANGIFTLSLISIFLFATLVAIISLFFNESLFL
FLGVDEQLAPLTQAYFQVISVVLIIQLTTMVLYYFVRADGFPTLATTALVLGSVVNIMLD
VLFLGYFQWGIQSAAWATGIAQIIQLLVLCTFFTKKQRLIKFQLCYSSVKPYFKGLLNGI
SEYINEISVGIVIFTIHWLLMKEQGNTAISGFAVANYMLFISMMLFYGIIDALHILVSQN
YGAKNFTRINQFMLLATVTVISISALLIVSALSVSDLITKLFIENTESDAYQLALSYIGV
IWPCFIFSGINVLLSCYFTAMHCPLQSSIIALSRGLVLPVSLLLLFTNFIPSIPFLFALP
IAELSTFIIALTLYLRFQHSIKHKSKLVTI
>fig|314292.23.peg.3753 Multidrug resistance protein D
MNDSTEISLSDQVKGVVKENWNVLFLAILIVSIGQLSLGLVFPLLPWIHLDFNINQRLAE
GLIVSYLMGYGPSQLLYGPLSYVYGRRHVLLIGLFISILGLGIILTFHYYFYILIIGRFI
QGIGGGCESVIARSMLHDSYKNKFFLSAMTGLSIISAFTPIFSPIMGGLVNHHFGWFAVF
ICLFIYTVLGFLILFFYLPETLTTPRVSISFIAIFQYYGTLLKDRYFLSYAMIGWVNWAL
VIFSGSLAPFILESQLHISSANYAYWSIIPAVAFLFASTLCFILRKSYGTHHIVFIAPVI
QLSVVMIFLSQPMSLLTLTIGFIGVAIAQALIYPCSQSLLLVPYSNQLGTVSALSGGGQM
LFSAIFIFIAWQFNLDNFYSLTAIIFITSVIGLLFALLGKRCTASASLENELFK
>fig|314292.23.peg.4230 Permease of the drug/metabolite transporter (DMT) superfamily
MKQTAVSLGILLLIFGNLSASLSDVAVKLLNGEVHPLQYMFLRQVISLIIILPFWLSQPK
PQREVGSWKINTIRAYLVLAGSSMLLVALTYLPLATANALFYAAPLLMIPLSIVLLGEYP
TKGKVIATAIGFIGILIVLRPTQFHWAAIAALGTATTLALYNVLVRKLPQSQTVSSTLFW
TSVLSLPVATPLAWYFWQPISLENLGLIAASALFTLGYQGCVVLAYRQSETHKIGLAEYS
GLIFVALFGWIWFNESLDTLTLIGILLIVLPMMPRPKRKKFTTQIDIQ
>fig|314345.3.peg.1250 Outer membrane component of tripartite multidrug resistance system
MMGMQQKPLLMAGICLLFAGCTVGPDFRRPDAPAVSGYTREKLAEHTAAADVAGGQAQSF
LSGADIPSQWWTLFHSQQLNQMVEDALNNNPDLAAAKAALVQAQENTYAAQGVYYPSLDA
NASASRKKTTGSQYGNPGGRGTQFNLFNASVDVAYVFDLFGGERRNVEALAAVAESEGYQ
LEAARLTLTSNVVTAAIEEASLRGQIAATEEIIESEQQQLEMLQKQFELGGISKSDVLAG
KTRLAQTRATLPALHKKLALIRNQLTALAGRFPEQESGSAFTLSALQLPQQLPLSLPSEL
VRQRPDIRAAEAQLHTASAQVGVATAKFFPQISISGSFGSVATTTANLFSPGTGVWSIGT
NLLQPILHGGSSIHNRRAAVAAYNKAAAQYQSTVLAAFQNVADVLRSLQSDAEGLQAQTH
AVQAASEQLDMARAQFSAGAINNLLLLDAQRSYEQARISLVQAQASRYADTAALFQALGG
GWWHHADTTAMTSAAQTDVKP
>fig|314345.3.peg.1648 Multidrug resistance protein A
MIVIPCIAAIVVGIVYLKGGRYIETDNAYVKAEKVAVSPQVSGQITDLLVHENQPVKAGQ
LLFRIDPAPFQVALDKAEAKLAQVRTDLAVLKASYSEKEAEIALARTNLVFARHDQRRKS
TLAANKFISASTLDNAQQSTDTAEQRISVLEKSLARIAATLGGSIDVPIEDHPDYRIAMA
EVDQARLMLARTEIRAAQPGIVSKLPKIGQYVSAGSAALMLVVSNNFWVEANFTEKDLTY
VHPGQPVTIHIDTYPDTAWTGVVKSLSPATGAEFSVIPAQNATGNWIKIAQRLPVRISIK
TTAGKPQLLAGLSTTVEIDTSHHRHILGLSL
>fig|314345.3.peg.1948 Acriflavin resistance protein
MDRKDLNIAGRLGAAAMGTSMTPIISILIFLIGLVALVLTPREENPVIDVPAANVIVRMQ
GASPEEVQNLIVRPLEMVLGEMTGVDHTYGTAMDSMGVVTVMFKVGEDKEASLVKLYDRM
MHNLDRIPPGASQPLIKPLDVDDVPVSVITLSTPAMDGLALKRLAERVREQLIPLKGVSV
ADIVGGRDREVRIDLDPARMTAYGITLDQLHQVLAAANSGGPVGDLVGENHVTKVWLDGY
LKSAQDVGRLIVGEADGKAVYLRDIASVVDGPAEVEQYHRIGFGAADKKGFGEEERPAVS
IALAKKRGTNAVFVTERINKKLESLKGDLIPDNVQVTITRDSGNLANAAVNMLIEHLGIA
IVSVIIIMLLFLGWREAAIVTMNIPLILFIVLAIGLLADQTINRITLFALILSLGLLVDD
AIVVIENIHRHLHHGAKSLQDKAELIIRATNETGKPTIIATIAVILAFIPMAFVTGMMGP
YMAPIPFNAPIAMAASLVIAYMFTPWIAQRWLPCRMVEPTMEEEDEKTTDWVHRTYMKLA
TPLIEKRGIRSLFWLIVLLLFAFSMWEPAWQFVRPAGINGPLTAGTVELKMLPKGNKNTF
NITIDMPEGTTLEETDGVTRQIADIVRVNPMVTDYEAYVGQAGPIDFNGMLRGALFRNSP
YQAELRVNLVDKQERSIHSDQIVLQLRKALAPIIAAHPRASIKLVEDPPGPPVRATLLGE
IYGPDYATQRAIAAQVKKRFAATYDVTDIDDSVGEAQTQLTIVVDKEKASRLGVATRQVE
LALKDFLGGYNAGAIHVDASRHPVMLHVQLPKKLRATSDDLSRIYVSGKSGPVQLSSIAT
VRKTTARLPIFSKDSHPVVYVTAEPKIGSQVYPLLDMDSHIDGSQIAPGERLKTGGMHFT
DAVPDDTFGYQMLWDGEMRLTLDVFRDLGAAFIVGLILIYLLMVAYYGEFILPMLVMAPT
ALTLIGIFPGHWITGQPFTATSMIGMIALAGIVVRNSLLLIDFILDYRRQGYDVKTAVLE
AGAVRARPILLTALAVIAGTSIMISDPVFGGLGVSMAFGTLAATVLTLFIIPLIYYLWQR
NTPWPSDDGAQCNTI
>fig|314607.3.peg.100 Glyoxalase/bleomycin resistance protein/dioxygenase
MIEGINHYNLRADEETIEVLKDFYIEIVGLNLGHRPPFKNGGYWLYANQKDVLHLSFSKN
DIVNELNVNSTFDHMAFTCQDEDMYIDLLTKKNIKFSIREIPEIGTRQIFFKDPAGNGIE
LIFPYN
>fig|314607.3.peg.104 Permease of the drug/metabolite transporter (DMT) superfamily
MQNSFKLKLLPILSVVLMTFFWGYNWVVMKQAVQLVGPWEFAFIRNFFGALILLVLLVLM
QKSLKIINFKFVFLIGMFQMIGFTVLVLVALVNGGTAKTSVLTFTMPIWANLLALYFLKE
KMTNKQILAIAVSLIGLILIFDPVHKNADFNSMLIAISAGFFWGCGVISVKKYNKKYPQV
DLLNLTAWQMLLGSLPILIVILAKGIEIYEINPYFWKASLFNIIFCNALAWLLWNYGVKH
LKTGEVSTISLLAPVIGSLAAFLELHEALKINEGIGLIMIFSGVLFMILLASREGSK
>fig|316056.14.peg.3157 Permeases of the drug/metabolite transporter (DMT) superfamily
MISPRDVARKLTRRHDERPFRGIVLIIAATVFLACSDALGKYLTLTLPSIEVAWLRFLVF
VLIMVPVAMASGSSPLKSVRPGLQVLRGLALVFSSVIFISSLRYQPIAQASATSFVAPLF
VTALSVVVLGETVGPRRWIATLVGLVGVLIVVQPGTAAFNPAALLTLASALLWAATLVMT
RMISGADRVVTTMAFAAIVGFAVLSVLVPFVWVTPSLSDLGLGLGVGIASTAGQWIVVLA
FRHAAASMLAPFSYIQLVWVTIIGVVVFGELPGLWTFVGAAIIIGSGIYTAHRERLRHLR
QVAAEPYPSA
>fig|316056.14.peg.3212 Permease of the drug/metabolite transporter (DMT) superfamily
MKLTDIALALTIALIWGLGFVFTRLGVAEMSPTVLTLVRFAVAALPCILLPRPKLAWPIW
IGISLLLVWQYLTQTYGMAQGVPAGLTAVIVQSQALFTIGFAALLLREFPTRGQLAGIVV
ASCGLLLICFTVGYDFSVLAFAVTMTAPLAFALSNLLLRQAREVPMLDLFAWVSLASLPP
LGAAALVADGPAAIWQQVSHLSPGGIGCVLALSLGSTTLGYWIWGRLLHAYTAAQVVPFA
LLVPFIGAGASALVFGEQFGTLRLAGMIIVVGGIAIMLFAGRSKALPEVA
>fig|316056.14.peg.4356 Permease of the drug/metabolite transporter (DMT) superfamily
MTGSPWLGLSLLLAVSLLWGTSFVLIEIAAQDYGALSIALSRAAVAAVVLGGVAVLSVRR
LRIAARIWPRIVLLSVVGQVVPFFLLGLSGRLTSSSSSAVMMGAAPIATIVVAGLMLQER
WSAGRWLGVVVAGAGVVIAFGWNGIFPSPAPAGFGSDDALGKLCALGAALGYAFGAIIFR
SIPPQIPPMVVAALSLSCSSLLLAAGAVLQGDALIAFGRAGAASSTAMVALGVLNTGCAY
AIYYKLISISGAGFASLNNYLVPIIGATAGAVLLGEAISWNLALGLLMIVCGILLSALLQ
N
>fig|316056.14.peg.4561 Permease of the drug/metabolite transporter (DMT) superfamily
MTKLIVQDMSPVWSTALRCGIAAATLGPLLWAQGNFIIPKRGDVPVVFCTALLHMVAFSA
LVAAGLQFVPAGRAIVLGYTTPIWVAVGARIFLSEAITTRRAIGIAIGLAGLAVIFDSRA
LDWGDRKSLLGSSLILTAAFCWAANIVYVRAHKWISTPFQLVFWQVLIAAIVLSILAMST
EGVPHIEWSQRLVGLLLYSGVICTALAHWAMSMVNRSLPAVTTSLGLLATPVLGIVSAAI
VLNETLEPSLFIAMALIIGGIALGTVSGGKSTQMQPRASREGLSDR
>fig|316067.3.peg.442 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTRLSVVIPVYNAEKTIESLCNTLFDLYRNSFELEVVLVNDNSRDSTHIICQRLHEANPE
TVTYIRLARNFGEHSAVMAGLNNATGDYAVIMDDDFQNPPEEISRMVAEIEKGYDVVYTH
YPVKRDSIFRNLGSAFNDKMANVILQKPADLYLSSFKIMNRFLINEVIIYTGPDPYIDAI
IFRSTSNIGRVEVRHDKRRHGRSNYTIGKLISLWGNMVVSYSLIPLRILGLAGFIMTLIG
VYVGGTSLLDAILPYRQDPTEYETLIALTTFFRGFQLLAVSVVGEYVGRIYLALNCDPQF
VIREKFSAQKKLQFAAVHTGLNHGYNKKTGN
>fig|316067.3.peg.959 Glyoxalase/bleomycin resistance protein/dioxygenase
MPIKMKNVVVFVLDLEKAKQFYKDQLKLPLVQESPTMMEFFPGGGPTLGVALAMHDAAKP
LAGRHTGITLIVSDIEELCKELAAAGVKFAEPLERTPWGKMAVVLDPDGNQFALVEG
>fig|316067.3.peg.1183 Glyoxalase/bleomycin resistance protein/dioxygenase
MGNPFVHVELTTTDLARAKAFYTALFDWQLEDIPGMDYTLIKVGDGTGGGMMQTPGPGVS
SSWLAYVLVDNVQAATAKAMTLGATICKEVTEIPGIGWFSVITDPTGATLALWQTNPVGC
GSPE
>fig|316067.3.peg.2431 Acriflavin resistance protein
MADNDLNRLKIDKTVVAAGRPRHKRPLVWIIGVVAVILAILAAKGVLAPRVEVEVATVSQ
IYPSQAFTLLNASGYVVAQRKAAVASKTTAQLEWLGVEEGSRVQQGQIIARLENKDATAV
RGQAAANLNNARAVLEQAKAELHDASLSFNRQKELVTHGVVARADFDAAEARFKRAKAGV
AAAEANIAALSSALRGAEAQLDYTLIRAPFNAVVLTKDADVGDIVTPLGAAANAKAAVVT
IADMDSLQVEADVSESNLGKIKVGQPCEITLDALPDVRFRGITHTIVPTADRSKATVMVK
VKFVDQDRRILPEMSAKVAFLERPVKAEEQRPVTAVNPQAVLDREGAKSVFLVKDDKAIK
TAVTTGPRVGDMLQVTSGVKAGDKIVLRPLDKLRDGSGIKTAEKQ
>fig|316274.3.peg.325 Tetracycline resistance protein
MHVQPQARFSYLVLSFGTRLLLSCIFTASMLYRIQVLQLDPLQLVLVGTMLEAAAFALEI
PTGVVADVYSRRLSVVLGVAFLGLGALSEVWLGSFVGSLLAQVVWALGYTLMSGATEAWI
TDELGVEVVEALFLKAAQLNSIASLLGIGLGVALATIGLVWPIVGGGLALVGLAISIRWF
MPETQFSPAPAAERQSWGRFGATLGHGWQAVRGQPVLLSIMVMSAIAGAASEGYDRLWEA
HLLNNIGLPTWLDLQPVSWFGAIAALGTLASLVAVIVIKRLASNTTERSIWLLRWQYGLL
AAGLLGLALTQQFAIALFWIMLIRMLRQSIQPLYSAWLNRLIESRSRATIISINSQADAF
GQILGGPIIGLIASRMGLPAAFVAASCCLWPMLVLLRQRQLNRQ
>fig|316274.3.peg.445 Daunorubicin resistance ATP-binding protein drrA
MSVIDVRNLGKTYRTIEKEGGVKGAIKALFRPQYREKVAVHDLNFQIDAGEIVGYIGVNG
AGKSTTIKMLTGILYPTTGAVTVLGHDPQRERVANARNIGVVFGQRSQLWWDLALIESLN
LVANIYEVEPSRYKQLLSHFSEVLELDEILKTPIRSMSLGQKMRAELAAAFIHEPKIVYL
DEPTIGLDVMVKQRIREFIKDYNQTHNTTVMLTTHDLGDIEQLCSRVIIIDAGSKVYDGP
LHAIKQQFGKYRTITFETNQPITNVQLPPACEQLSLSEYSLELKFDRSQLSASQVATALM
QQIDVADFTLNEPDLESIIKHLYQNPTAYNEVAVNE
>fig|316274.3.peg.446 Daunorubicin resistance transmembrane protein
MNKLAYRLRIYRSVVGMNIKEMLAYNLWFWSQLGAHLFLTIVYVSFWKALYSERETIAGL
TMQQTLTYIILARMIAPLVQWGYTQEFGYWIREGTISSELLRPVDFQERIFIGHLTRTFV
ALAQQLLVTGSFAVLVFDIRLPTDPLIWLSFLISLLLGCSILFCFDWIFGCVAFYSTEVW
GLQVVRGSILMLFSGVLLPLTMLPSGLQTLAQWMPFAQSVSIPVSLLSGITPLDQLGSIW
LQQLAWLAVMLMLSRLMFNFSVRKITVQGG
>fig|316274.3.peg.471 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MATASIEKLGTAPIGKLLLAMSSQTTISLLVYTIYSITNTYVLSIGINGLAAAGAAIIAP
VLLALGAVSTTVGAGGASVVSRALGAHQPDRAARVVANTFIIFWAAALIISVIGTLAIEP
IVYLLGATESIAPYAIDYGRIIFLGAITSTGYSAIIRADGNTGFSTAIWIIPVSLTIGFW
WLLVIVFPLGMTGAAIATVLGQAASAGMSIYFFFFRKQRSYNIRLSYFKPDWAIMREILL
IGSPSLIKNLSASIMAIVTNNLLRTLGGTSALSVFAIVGSLYSGLMTPQTGIIQGMQPIV
GYNLGQRNLQRVWQTIKLSLRAAVGYGLLISSICLIIPSGLISLLSHDQALIAEGQTALR
LLALAYPLTGISLVSAAALQAAGWAKQALLLLVGSIIGIKLPILLLGSQLFGLNGIWAAE
AISELLLCGAAFWLLNKLRQQTYQPLGPEGN
>fig|316274.3.peg.1029 Drug resistance transporter, EmrB/QacA family
METAIKQAASAAVEFEQPRYTKRETLLTMLSVLLVMLLASLDQTIVGTAMPKVITDLHGF
DRYTWVTTAYLLASTVMVPIYGKLSDMFGRKPLFIFGLIVFLIGSGLCGAAQSMNQLIIF
RGLQGLGAAALMPIALAIVGDLFTPRERARWQGITGGVFGISAILGPTAGGWLTEHVSWR
WIFYVNLPLGIIALLTLVFLMPTLGRKAQRVKIDYIGSILLVAGTVPLLLGFTWAGSQYA
WLSAQVLSMFGLSIVFLGAFIAFEAWLERNNGQPIIEPSLFKNSIFRISVLITIISNMAL
FGNIFFLPLFVQGVIGTSITNSGLIMTPLMLTAIICSVVAGQIVAATGKYKIIAIVGMAI
SVLGGFLLLQLDINSTNTNVAIDMVVLGLGMGAGMSLYTLITQNALPNKIGQATSALTFF
RSIGSTIALAAMGSVMNSAYLPAFKAAIPAEVAQNVPAESLAAFNNPQILLSPETQSLIQ
AQFAQGGQQGEALYNTLLGAVKYGLVDGIHHVFIFSFGITLLGFVVVFFLKEIELRGGRK
KAEAQIEQTGEAGAAGMAAFH
>fig|316274.3.peg.1421 Drug resistance transporter EmrB/QacA subfamily
MKRIVIDQKIAVCVVFVAALFMSIMDGTIINVALATIQQDFGASSSAINAIVVIYLICIA
VVIPASGWLGDRWNTKWVFLTSLGLFTLASLACGLAQNIEQLMLTRAAQGIAAGALMPVG
TTMLFRTFPPHQRIQVSRVLIIPTVIAPAVGPVLGGFLVDHLSWHWVFFVNGPIGLAALI
FGVIWLQAPAQEEVGAFDWLGFILAGAGFAALLYTLTEGASKGWGSPIILVSAAIGVGAL
AALVVVELAKAKPMLDLRLFSIRLFRVSNLVAIFGSAAFTGILFLMPQFLQNVVGASALE
SGLTTSPEAIGVVLSSQIVARLYPKVGPRRLTFGGVLGVAVMMGLMSTIDAETNLWLVRA
LMFGTGVGMAYLFLPIEAAVFAQIPHASTGQASAIFSMQQQLGSALGVAILGSVLALNHS
GTTVNQNAQSYQYAFLAAAILAFVSACVALFIRDRDAAATMAQHGEHSELSHSIA
>fig|316274.3.peg.1467 Drug resistance transporter, EmrB/QacA family
MRVETTHASAVATSTREKGIILTLLIATFVVILNETIMGVALPRLKDEFQVEASTVQWLT
TAYLLVMAVLIPTTGFLIQRFSTRTLFLTAMGLFTFGTVAAAAAPGFEVLLVGRVFQAAG
TALMLPLLMTVILVLVPMERRGAMMSTASMVISVAPAIGPALSGLIIQALSWRFMFIFVI
PIALAVLAYGYLRLVNVGKLQAASLDRTSILLAAIGFGGLVYGFSRAGEPGSSLTEPIVL
AAIGMGLVGIALFAWRQTRLSSPLLDLRVFRFPMFTLSVVLMMVVMVTLFASAILLPFYF
QQIRQFNTLQTGLFLLPGGALMGFSGLFVGRIFDRSGPRMLVIGGMVLVVLALWQWTFLN
ATTSVIWLLSLHVIFSLGLACLFTPILTTGLNQLPQTLHSHGTAISNTLQQVAGAIGTAL
LITIMSAGQAQPGQTIAPNPLADLTIGIQNAFVVAAGIAVVGLVLALFLRRTGEPSGEPT
FIH
>fig|316274.3.peg.2359 Quinolone resistance protein
MNFMVRPRRKRYQGITPPQHCPPAELKTVSELSLSDNSNYAQLIIQQLNFNQQRAKDIFM
EQSLVRQCQFNQVVLQQSQLVDSSFEQCDLSHANWEKSHLERLEWRNSRLGGMKFVEAQA
EHLVFSTCQLDYSVWWSARLEHVRFEDCRMLEISFEAAKLSDICFRNCDLSRANFRQATL
SNVDIRGSQIGGMQIEPKQLQGLIIEPRQALEIAQSLGLTIRELETEDQA
>fig|316274.3.peg.2624 Fosmidomycin resistance protein
MATRTSGQAVALTGLSVMVMMTFSHAMNDMWTSLLAPLLPSIRDTYQVSIGQTGILVAIL
SFAGSMLQPLLGAVGDYIDRRWLAAFGPVLTAIGLTLIGYVPNFFMLGALIMLGGLGSAI
FHPAGAAYIAMGANPQQRGLFVSIFSAGGTVGMAFGPLIAAQFDLVSLPYLLPVGIAVGV
LTFLMIPSAKQNRSQPKTLRDYISVFQGPLRWLWFMSVLRSLSSVSYSSLLGFMLRDRFD
QAMADAHVGPTLAVFNIASAVGGIIGGRISDRIGRTVVLRSSILSTIPLFIGLVLSSPLN
WWYYPLTALVGAMVMANIPVSIVTAQEYAPQHIATASAMMMGFAWGTSGVLYPIIGSLAD
WTSPTWAMIAAIGLLLPAFFITVRLPEPERTTTIG
>fig|316274.3.peg.2693 Vancomycin B-type resistance protein VanW
MADEFYQKYGPIERRRQNGDVQQFDATAPLADDLPVRSAAPPKRKRSRLRTFMWGAGITL
GLVGLLFGIGLWYLNRTFEGRIYPNVAIQGIDMSQKTPEEAKALLAEQYADLLKRPVGLS
FNGQTWEPTADQAGISLSIEQSVDEAYSLGRGGNIINTLQAVSGIWQNGYDIPLAVTVDQ
AQLSEYLTTATNDLITAPVNANLIVAGNTATMTPAREGRLILIDETAQDILTQLQTLSPA
QVVLRTEMVMPTVLDDGVFEAKQTIDAVLQSPLTLIAGDLQWELSTDDLRALIRLDTHTD
ANGKTKMVASLNDQMIRQRVATFADEIGRGSVNPRVAWDGGALTIVREGRTGLRLDEEAS
ARRIIEQATIGETRTIELVIREVQPDVTAENIHSLGIVEAVGVGKSSYKGSASYRVTNIK
AGSRLLDGILIKPGEEFSFNNAVGSIDEANGFVKGYAIVGNRTQEEWGGGICQDSTTLFR
AAFHAGLPITERHTHSFRISWYEVYEPYGMDAAIFTGALDFRFVNDTGKWLLLNTYVDDS
TATVTYALYGTAPQREVILDGPYVTKEYPKPTEPTYIADPKEPVGVFHQTDTARDGMDII
VYRIIRQDGQVILREPFNTHFKPWPDIYVHNPATPLPPKGCKPTDPCANPATPTPEPQPP
QQPEPTPEPQPEPTPGGEIVVPTPNP
>fig|316274.3.peg.2766 Vancomycin B-type resistance protein VanW
MPGQRWRLLPSLVLGLALLGLAPSVPTASVSAAVQAQQTTAWEPYRYFAATGHNISFDVK
RFYERQGDLEVFGLPLTEVIWENGFQVQYFERARLEIHPENKGTDFYILATRLGAVAAEG
RQNEDPFVWRTGPSYEGATFYPESGHSLGNGFRDYWTKYGGLYTFGYPISEEFSEVNAED
GQTYTVQYFERARMEWHPEHAGTKWEIQLGLLGKQYINRMGIDQNLLKPALEVQKLGSAT
TYYRGSNAERINNIKRAADRFKGVTVKAGQVYSFNQNVGDVSEEAGFTDGYAIVDGKLEK
VVGGGLCQVSTTMYRAVFNSGMPIIERYGHSYIVYYYENILGFDATVFVPDVDFRWKNDL
GTDIFMWTDTDTSAGRVTFSLWGYGDGRRATMEGPTYSNEQKPGKPVWQYDKTMRRGAVE
QLVHGRAGMDVTMYRVINKANGTSNRERFFTRYYPWEDFYLYGPGVKPPAGVTIAPPRYP
>fig|316274.3.peg.2913 Daunorubicin resistance ATP-binding protein drrA
MLIANTNYTAARRCLLSVRGTMQPEYAIRTVNLQRTYKTKERILKALDGVDLAVRPGELF
GFLGPNGAGKTTTIKILTTLLLPTGGTAEVWGFDVLHEADAVRRHINMVSGGESSGYGLL
TVRENLWMFTQFHGMDSKLANKRIDELLEVMGLADRAKTRVSFLSTGLRQKMNYIRGLLT
DPDVLFLDEPTLGLDVEAARTLRTYTRHWLDTNPGKTVVLTTHYMQEADELCDRVAIISG
GTILACDTPTSLKHSLQEDVVFRLFTTPVNPAFLQAVEQIAGVQSISQRSGDQRDELSLI
LRDDAILPHVLSQLAAHNAGLLSLEKRQPTLEDVFVNLVGHSLSESEASA
>fig|316274.3.peg.3161 Daunorubicin resistance ATP-binding protein
MDRSSAMIIAEELRKQFGDFHAVKGVSLEVKPGEVLALLGPNGAGKTTSIRMLAAILKPT
SGRAVVGGFNVETHAREVRHAVGLLTEFPGLYHRMKSLDYLLFFGRLQGMNDRDCGNRAV
QLLQQFGLWEAREKRIDGYSKGMKQKLALIRAMIHDPNILYLDEPTTAMDPHSARTVRDA
IAGLRSAQRSIILCTHNLNEAEELADRIAVVHDGGIAVQGTIAELSQQLMGDPIWELRLA
QPQPELAQRLADLLTIEEVGDSWLRYRTTEPQTLNPVLIQRISGWGWPLLAINEVQRSLE
DVYLTIVGQTHRERMSSPLEQPNAAAVAEVAL
>fig|316274.3.peg.3417 Permease of the drug/metabolite transporter (DMT) superfamily
MPKQGRNSATQPRLIDRLLAFKEGNLGMTLRQTGVLLILALVWGASFLFIRLGVETIPPI
TFVFLRLAIAAVLIYAVLRWQKVQLPRERKLWYSLGFVGFVNAALPYCLFAWGEHKMGTN
ASGLASIYNATTPLWTVILAFAFVRSERLTGVRTFGIVLGFAGVVYLFSRSIGNINSLDT
WGQIACIIASSMYGIGTLYVRRNFGSLPALIPAFGQMASGAIMLLPVALVVDHNSWQMPS
LVSLGSLFGLAILGTGIAQILYFWLVKQVGAARTAQVTYILPIFAIFWGWLFLNEAIRSD
MLIGLCLILLGVIIVNGKWPFRRQTVAAPSN
>fig|316274.3.peg.3887 Permeases of the drug/metabolite transporter (DMT) superfamily
MNSMQAVQISTNQNRVEIPWRAYVALAIGIVCIALSAIWVKWAAVPGPVSAFYRMLIPAA
ILLPWWFAKRPKHLPKQATRLSLLGGVFFAFDLALWNSAILLTSAANSTLFANNAPLWVG
LGAWLIFRERLPQRFWWGMAIALIGVVVIMGENLQQLTMSQGDLLAISAGGFYAAYLLTT
QRARAELDTLTFMTLGIVVSVVILGLMCLIGGYSIIGFSPQTWWSLMGLGLVSHLGGWLA
INYALGHIKAATASVSLLGQPVLTALISIPLLNESLNIFQIIGGSLVIGGIWLVNTQKA
>fig|316274.3.peg.3890 Permeases of the drug/metabolite transporter (DMT) superfamily
MIMQFTVLAASIKRGLGEHGTAIRLFGSALGLLIAGQLCYRKALLGATQHNLESLWQVSQ
SFWGMLGIGLILLSLFPWLALLARRQLSFFYPLWSIATIVLVVINWWWFGGGMSWQTLAG
IGLVLLGVSLLFRGGHSI
>fig|316274.3.peg.4051 Daunorubicin resistance ATP-binding protein drrA
MTISISVKDLRKSYGKDSAVLKGLSLDLYQDEILALLGPNGSGKTTLIKILATLLTKDSG
KVHILGQDLDDDENEIRHLFGYVGQDTERSAYSRLTVVENLQFFGALRGLDKRQVNAQIE
KLVEYFDFKSNLKKYFGYLSGGQKQTVVIMRALLHDPAVIYLDEPTKGLDPLIAKNIRSF
LKKYVKEEHKTLLLTSHILSEVDELSSRVALIHDGVIASVGTAQELKQGVGVDGFIELQK
HSIPLGVVDKILRLPPVLNSDDQDSEWVSFGINNMVDAMEGIIHILREEQIQSQFRYRNV
SLEDAFVYRMGLLSDGFEA
>fig|316274.3.peg.4146 Vancomycin B-type resistance protein VanW
MGAVMMSSMAAVAPNPQALAWARAGLLAIKYGRYRDSAALLTRAVKLDPMLGEAWRWLGA
LHSGQRQAYCLRWAQRSLPSATIPRLPSVVAAPIAPVRSKAKPQRRGNWRKVARWSSAAA
LAALLGFGGFQAAYANRVYPGIQAFGQSLSGLTSNEAAQAILPTLQAWNNHHFKVQLGDQ
TAIVPFNALTSFDPQVIAERALQIGREDSWSQRLSNQSLGIVGTIKADGLLLNQASLDQA
IQTLAEASDRSAVDAQFQHNANGAWAVSNDVIGLKLDRDQTKAAFQAAWDSIDWAAAPHD
YEVVVVQQALQPQQKATELNALLPTLNQQTAAPLIITIKGNEHQFDRTSLLDLHRLPQAG
QRFGNNDAAIKAIVQELAQNYDQPAQASRLVRNGNRAIEWQFGQIGYTLDQAQLQTQIGQ
ALNTANNAALDFSLHETVPPAGELEALGIYQVIGVGASDFSSYPDYNRDRNVDVGGKEFD
GLLIAPGEVVSFGGTVGDISLEKGYQIGEMIENGVAVPSIGGGICQVSTTLFRAVFWAGL
PIEERHNHSWRLAWYEVDAPAGMDATIALGGPDLKFRNDTNGYILIDVETDLVKKNQTFT
LYGSDTGRTVTMEATGNGWNFFQIFRTITERDGISRSDRWDSYYTQ
>fig|316274.3.peg.4240 Permease of the drug/metabolite transporter (DMT) superfamily
MKRWQSDGVLLLIVMLWGSTFFVVRDATDHWPPLAFVALRFGLATLALLPWAIKSFGQWT
RTDWQAGLITGGLLCVGYITQTIGISMTTASRAGFVTGLNVIFVPLMGAVLWRTKVSAKV
WAGVVLAVAGLYVLSIDPAAQAGTEPVSLWGDFLVFICAVTFAGHILAIGHWTKQASPIA
MNLIQVAVVAVVAGIGSLLFETVPALPADVFWAGAYLGIICTAVLLAIQIIVQRYASPTR
TALIFVLEPVFAALFASTFGNETISSTFVWGGLLMMIGIVIAELPPLAIFNKQEPNETV
>fig|316275.9.peg.4351 Multidrug resistance protein D
MLCGLLTYGVGCLLAIMATDFDMVLIARVISAFGAAVGSVIGQTILRDSYEGKELGKVFS
LAIVAVSISPVVGLLLGGFLSEYFGHLVVFSLLLFMAFILLTVSAFSLPETKPAHIQTVS
FMSVFKAMLKDGDIWKSAILVACFNVMMFSYYSLAPFMFSQFGLSSIEFGYSGVILASAS
VIGSSMNKHLLAKEWGSQRLIQIAVLLSFMGAVQVYLYQDSLWFLVGMAMVVVGFGMASP
NIFSTALVNYKHQVGTAGAVLGLLYYSLIGGGLGLAGVIGNLGLVLIAMSLLAGTMLLSR
E
>fig|316279.3.peg.1084 Drug resistance transporter, EmrB/QacA family
MTNINKWWLLVLVALPTLSTCLSTNVVMSALVSIGQTFPDVAGIGEWTLLIYSMTAASLS
ILAGVLGDRYGLRKMYTIGLIIFLLGALGASFATTGESLLVFRSLSGIGSAILAPVALAF
LNRIFSGVEKPIAFGYWAATITIGNVIGPFLGGLIQSISSWRLTFPIAALPALIALAFAG
ILPAYKPGNTRKNIDIKGIAYLSALPAVILFTLAMAGRLNPSSIIIFLSLIGIGFFTFWK
HLNKTENPVIDLQILENYKWWRPSIIQLIIRCLFMAMLILLTGYFHSIQGLSELNSSSAL
FPFLISVGVMAFTSGYICKSIGIRKLMTTMFSLGLAGAVILLSVQPDGFRLIDWIAICFI
GLLAGSTSQLSRLSMANFGVNDSMKGASINTLIINVGISIGAAYPTLIRSIVSKQAHLSN
IISKENLLHIMHEEVMVLILLFCIGIWQAGKLQDLTEPKTLST
>fig|317025.3.peg.15 Acriflavin resistance protein
MSSTGEKQTSDLNIAGKLAKAFIHSKITMMIMVAVTLAGALAYMVTPREYNPQIVVPAAN
IIVPKGGATPSEVQNMVVKPLETIMGALPGVKHTFGYASNDFGVVTVQFDVGENQVDSLV
KLYNQLMQNMDKMPPDTQQPLIKPINVDDVPILTLAVTSDELSGYDLRDISLKLVENLRN
TPGVSFTDVVGGKKRAVNVWLDAQKIALTGMSLEQISKMLKGSNVSLPVGSLVSNNESHP
IRVNGFLGNAEEVGEIIIGMEKGRPIYLKDIARIEDGPKETDTDTRIGYGVASEQSARGE
RPAVTISVAKKPGTNAVTVADAVLDKLHELKKSTLPANVEVFVTRNDGEKANAAVNLLME
HLAIAVASVIVVMVLFLGWREAGIVTLTVPLILFVVLFVGYVSGQTINRITLFALILSLG
LLVDAAIVVIENIHRHIHDGFDPEKFDEVLIRATNEIGNPTNVATFAVILAFIPMMFVTG
MMGPFMAPIPFNVPVAMIASLLIAYILVPYASYRFLGKKALKEMKERESLASHHVTKPDW
MQSLYEKSIVPMLESRTKRNVFLSVVLISLFAAMVQPALQFLRGDGMNNPLHSAGVEVKM
LPYDNTSTFLVQVDMPEGTALEATDIVVRRVNDVIANTPFVTDYSVYLGDHAPIDFAALV
RGDLIKEGSNFAQIRVNLVNKHDRDLTSHEIVQLLDKRLASLKKVFPNANIKLYETPPGP
PVTTQVMAELYGPDYDKLRTAAKEINAKMYDIYGLSNIDDSVTATTSSYQINIDRTQANL
LGIVPAEVAKMLRDYINGFELGYMHLDNVREPVNIIVRLPRSERTVPEQLLSLNVQSRAG
DSVPISAFAKIKEVPQAKPIIGRDQHQMVMVGGELLRSSPVYAVLSLDGMLDGVKLPESN
VTFHTANLGFVEAQPEDVMGYTLLWGGEMRLTLDVFRDMGSAFIVALVFIYLILVGYYRS
FMMPVIVMGAIPLTMIGVFPGHWLTGQAFTATSMIGVIALAGIVVRNSLLLIDFILEYRQ
EGKTLKDSVIEAGKVRFRPILLTALAIMFGSMIMITDPVFGGLAVSLIFGTLSSTVLTLL
VIPLLYFIWQWHSGVKYTEGNQIKP
>fig|317025.3.peg.210 Acriflavin resistance protein
MNIAEYAIKKRTVTLILTLFVIIGGLFSYENMGRLEDPEFTIKEAVIITYYPGASAEQVA
EEVSDKLETKIQELGEVKKIRSLNKRGSSVITVEMKNKYGKNDLPLIWQKLRSKVNDITP
SLPPGASKPIVKDDFGDVYGILFAITGDGFSYAEIKEYAKFLRKELLLVPDVAKVDMTGV
QNETIYIELNRNQIVSLGIGIDEIVDTLNNKNTILPAGSVKVGPEYIAINPTGKVDAIED
IQNLIIQSKNGYTNQKSNLIYLKDIANIYRGYKEPPNSMIRFNGFPAIALGVSTVEGGNV
VKMGNAIKARLNELQTQIPIGIELNPISLQSERVTQSINAFIINLIEAVLIVVAVLVIFM
GFRSALIIGVALFITVMATFILMKTQGILLERISLGALIIALGMLVDNAIVVIDGMLIRI
QKGMDRIKAASEVVKQSLWPLLGATSVAILAFGAIGLSQDSTGEYTRSLFYVILYSLLLS
WLVAITVVPLLGVMFIKVSTNQSDPFATRFYQGLKKTLIVLLNHRWLTVLVMLGLLYSSF
LAFAQLKDSFFPSSTRDQFMFHMYFPEGTDIREVSEVSHEFEQIVLKDEKVKNISTFVGS
GAPRFLLTYSPEKDPSSYVYMVVTVDNYQDIPDLMKKYHDYVLVHYPSVLPRPEAFALGP
TKPAVEAVIYGEDADTLRDIGSQIEAIMRDQGATAIRSEWRERVKEVVPVFDEVRAREIG
VTREDFNRSLDVNFTGIRVGYYREKDEMIPMVTRNAEKDRFDVDQINNIQVWSSGARKYV
PINQVVKEIKVDFVDAASHRKNRNRVYKVMCDPAIGALKSSIFAKVRAPIEALTLPEGYR
LEWEGEFEASNDAQAGLMASIPTFLILMILIVIALFNSIKEPLIIWLTVPLALVGVGFGL
FVTNQPFDFMALLGFLSLTGMLIKNSIVLIDEINLELSGGQERFDAIIHSVLSRTRPVSM
GALTTVLGMIPLLSDAFFVAMAVTIMAGLAFATILTLLFVPVLYAIFHNVKVPRAVKVS
>fig|317655.9.peg.282 Probable antibiotic-resistance protein
MAAARGCGRGTPSITRGDMMRALLLSLALLAPFASAIANDDVIDTHVHLWNGEASLAEYR
AKLKAAGLSVERFGAMWFGGPNQARAGNPADISARNDALIALGKKHPDMIPIATVHPYDG
DAALAEVTRVASRGVKLLKIHPHTQGFDAADPRVLTLVKHAGASGLVVLLDNASIVPADN
EKLFNLALAAPKTKFIFAHMGGMGFRFWNILALARTAEGLFAENIFFDISGVTLFADSPV
KDEYVWTIRNVGVDQVLIASDYPQMSLAKTLEAFDKLDLTEEERAKIRSGNAKRLLGL
>fig|317655.9.peg.2011 Membrane fusion component of tripartite multidrug resistance system
MAAHHLSETPRGHKAGSARRIDRGRTDHPVAHDRPAGRGRAARTPRRPGRPPRVAALPDR
ARRRTARRHPPRGRGAERGGARRTERRRTRPARRSGRAGARQPVAPRLPERSGARLMDQL
APSRPEAEAAAPPPAAPRADPLPSPAADTAARPGWRTRLIMFGLPLALVAGGAGWWLLSG
GSVSTDNAYVQMDKVSVAAEVGGRITEVAVRDGEQVAKGQLLFRIDSEPYALNVAQATAA
IDAARVEVGNLAAGANTSAVEIAAAREEVRFAQVNFERQAALMEKGFTTRAAYDASRHAL
AQARERVRQAEAAAVEARTRLAAGPASGINPQVEAARVQRAQAEVNLARTSVRAPSAGRV
AQADRLQVGQAMVAGLPALTLVDTAHPWVEANFKETDLADMRVGQRAEIRFDAYPGLKVR
GHVLMIGAGTGSEFSVLPAQNATGNWVKVTQRVPVRIAFDEKPARDMIAGLSAEVTVFTG
GGTVAGK
>fig|317655.9.peg.2640 Tetracycline resistance protein, class A
MTATRTIPFIVVTIFIDAVGFGIIMPVLPQLVMEVGQIDLPHAIEVGAWIGLVMAVATFL
ASPVLGNLSDRFGRRRILLLALGGLAVDYALLTVVETLPWLFVARALSGIFGGSYAAAQA
AIADITPPEERARNFGFVGAAFGVGFVAGPAIGGFLGEMSPRAPFVAAAILATANMLYGY
FIFPETLPKERRRAFDWRRANPLGAWKMMRALPGMDGVAGVLVLWQIASLVYPMTWSFYC
IAQLGWSPGMIGASLAAVGVMIALGQMFVVGPAVARFGERDAATFGLLVAVAVYIGYAFT
TSTLGAFLLLIPIALQAPVQPSLMAMMSRRATADTQGEVQGVSAMAMGLGQLAAPMLLTG
TMAYFTADAAPVHFPGAAFLVAAIFGLLAIAMLRRLPRATQTADQMPPSVTA
>fig|318161.14.peg.299 Permease of the drug/metabolite transporter (DMT) superfamily
MNIKDYALCIFIMAIWGINFSMVKLGLNGIDPMLLTGLRFTLAVIPAIFFVKKPDVHLFY
LIGYGLTFGVGVWGLSTWSISSGLSPGMAALLLQTNVIFGLCLGWFLLKESVTPSRLIGS
LISLSGLAVGLMVTDGSVNVQGVVLILVAAFAWSISGILIKKSNTKNAFAFTLWSMLFAP
IPLFLISYFQIGASAFTTLLDNLTGMAVFSILYQAYATTLFGYWIWNRMIVLYPLSQVAP
FTLLVPIFAILGSNILFQEAISLQKVLGCSLITFGLLIGSFSLKRVRSLVQLIM
>fig|318161.14.peg.1136 Acriflavin resistance protein
MVVILCVLTVFLGVLCAYNNKIQLLPNVEPPKISFFVIWPGASENFLITDVVQPYEEAIL
GRLERLESLKVTTRPERASFEVTFSFGTNLEEAESKLAALLSRARTLPLNVKPLTFHHGG
TNVSNRVVGSYFITSESSEFSPKQLSVISNLAKQKFKLLPGVESVELNPALESQLQIRLD
MNKLYQLNLSFDAIRQIVGGLLTQPVIQLYENERVITAKFKPTTLLEDIRQIPIAHVDGV
SILLQDVAQVEVGPITQTAVSRFNGQEAIAMRILRYADANLIEVQKKVDEVLAQEAVTLD
SAGLIYNLSFDTSIFIERAIFWIIGSLATGFILTTFVSYCFFRRFKPTILATLVILLSTC
GVLIVLYLTKTSINVISLAGITFATGMFVDGVLIIVEYLDRLKPDKRSSLERTRSSLNKL
VPALLVSTITTVIVFIPIIFSQGAESQLFKGLSLVIASGLLFALFFTVLLVPFFAEYFGQ
PEPRSEIAFPFVTNAVRSLIKSKRSSVFFVIFLVGGSLLSLSIFIPSLSYLPSVKRDTVD
VYIPLSGDLRIETVQHNIVGPINDILQAVPSEIIVKNNYVIAWPHFATAAVRLNDSKQIP
ALIPYLQQSLKEHLPSNRVLVLQGELLGGLESANDIEINLYVSDQQWLAENISIVRNIIE
SALPDISIRVIPDVERFVKEYEFSPNLLSLRDSGITNDELTNLFRTIGKSDFIGKWKSDD
EVVNAYITIEDNYQDVANIPYVSRNGVRTYMGSLTNIKTSDVLPSLNRLNGSAALTISLR
PTSNERTVSSVLAVLEQDVAPAIRQLMGDKGYIGIEGSASSLSKTKWFLALLLFFIVLSF
IVILAFLFRSIKLSMYVLLSLIPALAGGILAYNFLSFVTMSDFNVLTMLGFAIMLGIVAN
NSILLVDAANNVSAHCSDCDAILFAVNERVRAIVISSLTTVLGILPLLLFPSEASQLYQG
IAAIIVGGIVVNLLTVLFLTAATIRIFGLERPTLGFPQNLEVEIVNKGL
>fig|318161.14.peg.1545 Permease of the drug/metabolite transporter (DMT) superfamily
MLSFFLETNAPLETVLSTSVQTWGVLAFVGYISTLIAFAIWGKLLKSYSAAVVTPFALLI
PVVGLVTSSLMLNESLTRDEILGAVLILLGLVFCVAGKKSFILIAKYRGAK
>fig|318161.14.peg.2719 Multidrug resistance protein D
MYLFLAILLLSCAQFGSQILMPALPGVAASFGLEDSIAQQVIMVYFIGFGLSQLIYGPWS
DSAGRRKVFLVGQGLYVLGTLLCVLAPSEWYLALGRFIQGIGAGAPLIVSRTLLSDHFTG
ELRKKAMASLAIAASFISVLAPVLGGTLTSAVGWQSLFALLGLYLLLSGLIGWYLLPRQV
QHRRSQHGQIQDSQIKQTKATPVKGIVGQYRLLLLDRRFLMPALFKWLPSLLYLTSATLL
PFILQHKLDLSAQQYGMAMMLPATGLILGTCLAKLLHAQLSYPSQLLLFLPLLFLAGAGF
ILLPFTLTNCLLSYSLFMVCGGAFYTISLHLLIEPFEQQTGIVNALCGAIDMLVFSVFAM
LVNHYWVDTIAKLGWLYLVVSSALLLVGLALKSKSGSEPAFDVKSMT
>fig|318161.14.peg.3622 Acriflavin resistance protein
MVMDFCLKYRRTILALCALLVALGIAQGLRMPVQLLPTIERTEIQISGRWQQNAPEDVEV
QMAVQLENALASLPGLKLMESQVSTGSVTTRLLFEDGADPVASLIATSAKLNQVQSWPQS
ADEPQITQDGISESETVATLMLYPRAGVDADFALLDEAVRHQVIPALLRIPGVSRVDNSF
SHRDKVIWVNFDPAKMSRFGISVAQLQQKIAQLQDQSGGSMDLGKDSVALRFKGQPSRSA
LSQHIIHWQEGRPVYLGDVAEFVDGFAPGRNITFKSGREAYYLSLNRSRGHNSFDIVQGI
KQRIEELNAVELQPLGLELGMSLDTSENIERAIAIVGSNMLIGIALVYLVLFFFIRRHSA
ALVVITTVPLSICLTLLLLSATGASLNVISLAGLAFSVGLIIDAAVVVQEAIEARCASMQ
NTAQAIKEAVSKVAKALFASTLTTLLIFVPIAGFAGDVGQLLADLALTMALAITVSLLVA
LVVVPLLVFVSRRADGKDYHSDYWVKMADVVLSSSNTRAKQTLLLLMLIVFPVVAIPLLL
PPKDLLPNAGDTLLRASIQLPQGRNIETLRRDVAEVLIARLRPYMLEDAAIPVRSYNLVV
ASNFAFLVAYPKNPEQLDMLIAEFNQKIFADLPEVSVYVEQEPMIYFRSSASKQIHLNVH
GDDLSKMLVVAEDLKKEIIEQGIAQGVQITPAADDDAQRLLVYPNSWADHDFGLSQQQLA
DIVSAYSGGLYAGEFIDGLETYDFYLKGPKWYNPQQLRQLQVQTPNGDTVDLGTLAGVQQ
QRGPSRLLRFDGRRTVRLIITPPAGSSLGGLTDSLRRLLAQDYAAQLTAQQMHVSFKGSA
DEFEQAMNNIMWVVVVALGGLALVLMLILGSAQAAGHILLTLPIALFGGAFALWFINLIT
PVSMDILTMMGFIISAGLVLNNAILIVAEQRDGIVQGLNSNQALHQAVLRRSRAIYISGL
TSVFGMLPLMLSPGIGAQMYRGMATVLVGSMSFSLVFCVFVVAALSYRGNMPVGRG
>fig|318586.4.peg.169 Glyoxalase/bleomycin resistance protein/dioxygenase
MKLELHHINVCTKDVPHLNEFYRKILNLGGVDDDEHVQDTTKGYYSGVEFVTDGKIEFHL
ATTDLGVSYRTNQPVNPLERGHIAFRTDDIEAFKKHLTDNGVPFADYGVWAMAGWYQIFF
QDPEGTIIEVHQINYGK
>fig|318586.4.peg.2489 Probable efflux transporter protein, acriflavin resistance protein family
MTNRGFNLSDWALHHRSLVWFLLIISMVAGTLSYLRLGREEDPNFTIKIMVISASLPGAT
IEDTLNQVTTRIETKLEELDELKFTRSVTMPGQSVVYLELDPTIRGPQVPEVWKRVRNMM
SDIRPEFPQEFQGFQFNDDFGDVFGNIYAFTSDGFTQRELRDRVEDIRKQVQALPMAGKT
QLLGVRKEQIYLEFSSARLAALGLNHNQVVQTLALQNAISPSGIVQAGPEQVLVRVGGQF
DDAQSIAAVNLRVGDRFFNIGDVATVTRGYEDPPSALFRYNGKEAVGLQIGMREGGNILE
FGQHVDALMAEVARGLPIGIEMAKFADQPHVVDEAVGHFVQALAEAVAIVLLVSFVSLGL
RAGFVVTLTIPLVLAITFVILDIYGITLQRISLGALIIALGLLVDDAMIAIETMISRLEV
GDSLERAASHAWSSIAFPMLTGTLVTVAGFIPIGLNSSAAGEFTFSLFVVIAVSLIVSWI
VAVLFAPLLGVTMLPATMVHKSERPSWLRRRFHGLLLWGMHHKWLTIAVTLAVFAISVVG
MRFVEQQFFPTSDRTEIIVDVTERANASIAKTDADMARIEAMLAEERDALFWTTYVGRGA
PRFVLSMDVPTPGPYMGQIVIQTPDLAARDRLKARLIEFAGRELIGTDIYVKNLEIGPPV
GKPVQYRVSSPDLDQARDAARELAAVLATEPRLRDIALDWNEPARVVRLQVNQDQARRLG
LTNEDISGALSGTFSGRTITQLRDGIFLINVTARGSQEDRESLASIQNLQLATPTGTPIP
LASLAKLEYDTEQPLIMQRDGLPTVTVKADIASKDQPATLVEALADKVARFQAGLPPGVK
VVVGGTVETSAESQEPIAAVVPIMLLIMASLVMVQMQGFRLSFIVFAAAPLGLIGVVAAL
LPFGVPMGFVAILGILALIGILIRNSVILVHEIQELIAKGHAKWDAVFEASDSRARPILL
TAAAASLALIPISRQVFWGPMAFAMMGGIIAGTLVTLIFVPALYCAVFGVRPPKGDPMPS
AEDRARAAAQE
>fig|319225.3.peg.940 Multidrug resistance protein, AcrA/AcrE family
MNNTMRFFPGRSVAPALLGFVLLFSGCGQKGGGPGIAELPVLTLKPSDARVESAYPAVLE
GRVNVEIRPRIDGTLEKIHVGEGSFVKAGQPLFTIDDRSYRQAYMAAAAARDAAKIDVDR
LLPLVEHKVVSGVQLDAARAKFRAADAAREAARIDLGYSVLRSPVSGYVGMIPFRIGSLV
SRNQTERLTIISDNSRVHAYFSMSESDFLRFRNAYPGHTIREKLRAVPEVQLQLSDGSGF
AEKGRLETLSGLFDAETGSIRLMASFPNPDGLLRSGNTGRVVVPSIYHDVILVPVAATVE
LQDKILVALLDKEGKLKRRPIKVEALSGSDYVVSSGVRAGDRIVTAGYERLPDGTPVKPA
APAPAVSKEKP
>fig|319795.16.peg.821 Permease of the drug/metabolite transporter (DMT) superfamily
MYAKVGPEGATLERVTVTPAPAAPPTTVRAGLGLALVAALGFSTLGIWGKLAGRVGLDSF
SVLAWRFGLVALALLPLAGRELTWRQRRPLLGVGLLYALATTCYFGALSRITAGATGLLL
YLAPAFVILFAWLLGRRPDAAKLGAVALAALGLGLVVGIPGAGDRDPLGLGLGAGAGALY
AAYLLASERWLSGVPPLASTGHMALVAGLYFAALAAGTGTLHVPTTAAQWGVIVGMAALA
TLVAVPALYGAVERLGAARASLIGTLEPLFTVLLTFLILAEPLRPAVLLGGALILAGAVL
AQRGNRSAP
>fig|319795.16.peg.1247 Tetracycline resistance protein, class A
MPAMQAHFAGLANADVLVRLTVTVVGLAIAVSAPVSGYLTDRIGRRPVLVGAMLLYALAG
SSGLYAPTLGTLLLGRVLLGLAVGATMTAGSALVADLFAGQERARFLGLQSAFTSLGGVI
FLPLGGLLAGIGWRLPFAVYLAALLLVPLALRLPRGETAGERRAEVAAERIPWRPVALAY
GVALSYMLVYYLMPTQIPYRLEGLGVAPALVGFVMGVSTLSGALAALWFSRRGGTRTPIR
MAGLSLLALAVGWTVVSLAPGAGWVVPGLIIGGAGAGLVTPNLNTFLAALAPAHARGRVM
SGLSVSIFLGQFLSPLLARPFVHGTDVSRTFAAAATFAVLVGTALLLLGRRRAALAG
>fig|319795.16.peg.1727 Drug resistance transporter, EmrB/QacA family
MTVPHPPGAPPQRINYAQTLSLATKREILFGVLLGLFLSALDQTIVATAMPRIAADLNGL
NLYAWVTTAYLLTNTALVPIYGKLSDLYGRKPVLMVGILIFLLGSALCGLSGEAFLGNLF
GGGMMQLVVFRGLQGIGAAALGSVAFAIVADLFEPAERPRYQGLFGAVFGLSSVIGPLLG
GFLTDQISWRWVFYVNLPLGLIALSFIASKMPRLASGLQAKVDWLGAFLIILFAVPLLLA
LTWGADNTYAWTSATILGLFGLSAAALVAFLFVESRHPSPILPLTLFRNPTFGWGAVARF
LIGAGFLGAVLFLSLYLVQVKGVSATRAGTATIPLTVGLIIGSVGSGQIASRIGRYKPLI
LIGLVVAALGFFSLSTLTADTPYSGVILRMVLLGLGLGPALPLYTTALQLAVKPWEIGVA
TSAGQFFQQMGSTIGTAIFGAMLTAGLTTNLATQFAAQAAAQQGTVATTLKTISERIRSG
AAGGSQDRNAAPQSPEQIRATFATLRQNVTRAIERGDPAAIAAIQKDPTLPAEAKQRLAT
VPAGGVAAGVTAGFNQVYAAIAGAVNSGNPAQVAAVAANPQLPAPLRQRLAQLPPQALQN
PQARTQILAGIKQGLDAAAAAAAQQAQQQALTAALQGVNDGEQIALASARATKVAFAETI
ASIYRSSILVALLAFLATLLMPNLRMPTRQQGERLAPVHVEA
>fig|319795.16.peg.2524 Multidrug resistance protein B
MTAAPSSAGLAPRDKILAFVGILTVLFLSSLNMTVVGSAMPRVISDLGGFHLYAWAFTAY
SLATTITVPIVGTVSDRYGRRPLILLGIVVFTLGSVLLGFVQNMNQLIVLRALQGVGGGM
LMAMSFTAIADLFTPIERGRYQGYTGAVWGISSVVGPLVGGFLTDHLGWRSVFFVNVPFA
LLALYFVGRFFRMPAPSASRMQRPFDALGALLLAGAVVTLTLALSWGGGTYAWDSPRILG
LLAATLVLGGGYVWHSRQQAQPILNLRLLRDPAISLASLAGFLTSAGMYAAILYLPLYMQ
GVRGSSASGSGLALTPLMFGLIVTSTLSGQIVSRTGRYKGLIMGGALVATAALLLSTTLS
TTTPLWIAVGLMVLLGLGLGPVNSQLTLAVQNAAPREQLGSATSGNQFFRQIGGTLAVSL
FGALVNAQLAQNLAAKLPPAAAQLPAPMQDAIANPNVLSSPQATGQLEAALARLGHADLI
MPILTALRGVMAGAIDHVFLIAGVLVGVAFLVTALMPERPLAGRRAGARVEGRQAAATD
>fig|319795.16.peg.2554 Small multidrug resistance protein
MRAWIALFSAIACEVTGTLALKLLGLHTPWLALAVTGSLIVLSYLLLSLVFRRIPVAVAF
AVWEAVGLAAVTLLSVWLLGDHLTQLQLLALGGLLLGARLLHGGTRARGEA
>fig|321955.3.peg.455 Antibiotic efflux protein
MVGVESDPARLMDMAIGRGFNALWSTSALSNLADGLAFVSMPLLAASMTDDPRLVAGLAT
LYAVIRLVAALPIGVWVDRFDRRTLIVAANILRGGALAGFALTIQFGVSSLIVLYSAMAV
VAALESVADSAAIAILPSLVGTQRLESANGRIAATQLIADEFAGPPLGGFLFALAASVPA
FAMGGLWALAGVIALALPTRSPSTLSADAHSSRRSVFAEAVDGIAWLRRHHVVGGLAVIG
ALASIGYMLPFSILVLFARERLGLNGTGYGLLLAFSALGGLLGSMLASRLRARLGSRWTI
VASLILGAVALGGLALTQNPIVAGLLLALYILHAVVWNICSLSLRQRLVPDDLLGRVGGA
TRVLGLSGLAVGSALGGILADFDLRIPIAAGGVLFLACCFVAVIMLRGELDLGIRPTSAP
RESGD
>fig|321955.3.peg.1791 Lincomycin-resistance
MIAVAAAAAFLATFNETFLNVAFTPIMSDFGINVSSVQWLTTGYLLVAAVFVPVANVLYH
RFPTRTLFISVVAIMVIGSVIGALAPTFSVLLIGRLLQAIGTGLLTPIGMNITLAVSPRE
KLGMNMGIMAAMTTLGPSLAIVLSGALLTIAPWTTLMWVFGGLCVAVLIAGAIFLRTVAE
LGRPVLDIPSFLLVALALVGILYGVTAAFGGSALIAGGAFVVGLIALWLFIVRQRRIEHP
LLDLRPFSSKPFVLGVIMTMLGLLFVFAMNVVIPLFLQGARGMEPMGASITLAPGILLTV
ILGPVAGRLFDRHGGKWSIPLGFLVMAVFVTLVGVAASGTSILLFGILYIPAVLATAFVI
GPAQTFALSHLDRETSPHGVTVVSTSFQIAGCVGTSLAAGLYGALSGARIDAGADDLDAL
LTGFHGSVGLVVLTSAIGIVLAIVAYRSVRGGGSGVPAAGAATQQEELPAVQ
>fig|321955.3.peg.2525 Tetracycline resistance protein
MEPAARAAATMTAHEDVEAGMPAQSHSVFRRNQWALSLAQLFSGIGIATGFAVGGILAER
LTGRTELAGFAQTASILGAGLLAVPLAKLAERRSRRLALASAYAIALCGAILIVSAILLG
IDIAFFIGMGCFGAATAAGLQGRYAATDAAPDHLKGSAMSVVIWATTIGSVIGPNLSGPG
AGIGRALGLDPLAGPFVIAIAGFGLALLSVLFLRRLTPATRDSSSTSPRRGGTWQAIRRS
PSALMGLLSVVTGHMIMVATMVMTPLHMDHHGLGLELIGITIGGHILGMYGLSPVFGYLT
DKYSAGRVILGGHALFALSLVLGLIDALGESSFLRLSVALFVLGLGWSACLIAGSTLLTK
EIDPTHRMSVQGLSDAGMNFGAAALAALSGPLLAIGGFAAITLMGFVVLAVAVIASIRAG
YGTAHTT
>fig|321955.3.peg.2869 Vancomycin B-type resistance protein VanW
MPTQTLSHPSPNPGGRPQGTAETPKRRPWLIAGFIVLVLAVLYLVIGFLTGRVLSPGTTV
AGVDIGGKSTTSAESTLREELGETAGEKIELKAGKPTAALDPEKAGVGFDISETISRATG
FTLNPVIIWDRLFGDDEIEPVISIDDEKFEDATGKVTESLKFEPVDAEVSYVKAKPEVKD
GTDGQSVDAEQVRTAIEDSWLRTEGPLPVTAADVEPDITTAEAKDVADGFAKDAVSGDLT
VRAEPAKDASSDVDAGDMTISPATIAKTLTFEPKDSKLTPVFDEEDLQKRVLAANKDVGK
PAKDASFTIKDGKPQVVKSETGIGIKKDELTTAVTDAISGKTDKPTVTLASVEPDFTTKD
AEKADVSDVMSEYSTGYSSEPNRDTNLKVAAKKVSGTVVQPGEQFSLNEAIGQRTAANGY
KAAGVISDGQMKEDFGGGVSQVSTTLFNAAFFAGFELDEHQAHSRYISRYPEGREATLDW
STIDMKFTNTSKQPVVLDMYLSDGEVHAKVFGDKKLKVKSDSSDRYNYSSPGSVTESGPE
CTPQTPKQGWSIKITRTMEDIASGKTTRDSFVTVYRPVNKVECKD
>fig|321967.8.peg.77 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKALLLWSAINLSVWGTFLISNYFQAVFQEKLTQRIMIDVRDTISRKIVGSSYAQYHKQT
TGEYLSEYVNDVGNIESNAIKNLFSLLSDGTTVVFATIALAAYHLLFIPMILFLSILMLK
IPSRLGKPMTVATTEMSNGNAAFSNQVTNVLNGFDVLLNANKLSKLQELVKTAAKRYAEV
KVSYTKTNARISNSIAALSIFCQVMVDIMTSILAILGAIPLGAISSTGSIAASIFNSLSS
LSNDAVQIKATHPLFDKVIQGSSKSAMAHESTQEPAFQHALKVVDLSYSINGNKILDHLN
LTFERGGKYAIVGRSGVGKSTLLKILDGQITDYTGHVYIDDQDLRTMTMTALTKISQYVD
QNVYLFNDSVANNTSLWANKQKSGNSLQQALLKAKVDFVKSPDQMIEENGQNLSGGQKQR
LALARFFYSPKPIAFVDEGTSALDAETARQVTKQFLNDPDMTLIEVSHHLDAQLKGAYDQ
VINLGA
>fig|321967.8.peg.115 Permease of the drug/metabolite transporter (DMT) superfamily
MSRRQYGFLLNILSVAVMAVTPVMNKFSMITLSPLAASFYNALVSLILTLVTIAFTKTKL
VWIKQPIIWALGLTNCLGIFLQYMSLFFLDPVSVGLVGRFYIVFAILLSVLLLRERFDRK
EIVPIVLCMIGTALVSDFSGDVNNILGLACALGYTFSFALTNTLAKKALINIDEKILLLY
NQGTAVVILGGFLLGSGQLSLAPNLGMGAVAISAFCSGFLGLLLFYRGLKLISFRDANLI
RALNPIFVLVYSLPFFTIQMTPAFLLGGFCIILSIVWMSLPMKKVGVD
>fig|321967.8.peg.184 Lincomycin resistance protein lmrB
MAAVFIATFMTSVEVTIVTTALPAIISDLHGLAYQSWIMSAYLLTTAITTPIYGKLADTI
GRRGIFQWGVVLFTLGTLLSGLAPHIFLLILARALQGIGAGAVMPLTFTIIADYYDFAHR
ANVLALNNTAWRLSALVGPLIGGFLVDQLSWHWVFFVNVPLGILVFLLIQIGYREPSREH
GVLTIDWLGILWLAVTLIALLLGIQALDRQPVLAGVLLALALVAGLLLYHQEQKAPDPLI
APKMFHNFTFTVQILTALLLSGVLIGYQVYFPIWLQSLYHLGATTAGLVVTSSSVLWLAS
SFLVGPLIKRFVPRTMTLWLVAILTLAYLLLTIASPHFPVWAFYVIAMINGTVMGIVISM
NTVLSQHLVGKEYVGSATSILTLGRSLGQTVMTGIYGATLTLVIRANLHGNTFKAVNAAI
SANAAAKSHDPQVAATILTGLHGVFVMVVIVMVLVFILNLRDPNRHVIQ
>fig|321967.8.peg.194 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKSTSKLLTNQKTLTILMIFLTVIESLGRVASSLTLAPLTDQLISKNLHGVVFWLLSTIG
IWGVTLTVNYGNSLLKAQIIRKVTNQLRVDIANGLNTVPISEYKKVNHNEYVSWLTNDVN
MIDQNGLEAFFSLLSSATTLLFAITSLAFYHYSLALAAIILGLLTMTIPQFFSKVMTHET
NRLATANSSFLGKADDIIGGFSVFFSHNLGNTLTNKLATASDHQGKEKLLYAKNVGLVNL
LISGVNVGAQMLVMTLTCLLVIGGYFSVGVISASGSLAGTVFNNLAGMIQSIFQMKSVAV
LLDKDIQATKIKTVSEDDSFNHALTVDHLSFGYEGKPVIKDISYNFEKGGKYAVVGKSGA
GKSTLINLISGRLRDYAGTIQVDGDELKSMPATLLNAKIELVDQKAYIFNESIEENITLG
HAKSQALLSNVVSFLGIDKFTNLATKIHEHGSNLSGGQRQKLALARALAFHKPILIVDEV
TAGIDSENAQEIEDALLAEKDLTVIMITHNLTEKTRAQLTDTLELA
>fig|321967.8.peg.417 Multidrug resistance ABC transporter
MINLNGRRGPRNLHPEKVTLVDWKQTVRRIWGYLDTDRRKLLIVFGLTLFTTLATIVGNR
VNGIVVDQFITKGRLRELFIVSGLLAGMYFLSSIFTYFQTSITTKVAQRTSAAIRHDLFA
KMQRLPMRYFDTHDNGDIMSRLTNDVDNINTALMQTFVQLYTGIISVVGMGIAMLLLSPL
LTGIVVLASVATFFYSRTAARITQKAFTIQQQELGSLNTQIEENVSGKQLVQLFDHQQDT
IDRFNETNARYTAAAYRAQLFSGVIGPFNNMTNNFAYLLITFAGAVAILRGGTSITVGVI
FTFLIYLRNFTGPINNILNLINTLQLSLASAERVFQVVDAEPEKDAPNAVELDHTAGNVK
FDHVSFAYDGKTEVLHDISFTAHQGEVVAIVGPTGAGKTTIMNLLTDLYPLTSGSITLDD
HDVTQITFASLRRLVTVVQQESFLFTATIRENIRMGRPDATDAEVETAAKAANADGFINQ
LPDGYDTMLSENASRLSQGQRQLLSIARAFAAQAPVLVLDEATASIDSNTETDVQHAMNR
LMQQRTSFVIAHRLSTIRNASKILVIDQGKLIESGTHEQLLAAGGFYAKLYNSPLADMDK
MKR
>fig|321967.8.peg.2139 Multidrug resistance ABC transporter ATP-binding and permease protein
MIRSLLRYTHHLTGAIIISFLIGLVAELTKVVVLVLAAMMLFDPQNASHLLIPGIIAAVI
VGLGSFGEQYAGHFVAFHVLAELRGAVYRKLVQLAPAKLDSQGSGKLLKLIGSDIEAMEI
FYAHTIVPVAIGLIYGVLMVAVYSSLNGPAAAVVLVSYAAVGLLIPYYRHEQMTAKAQAA
DRQKAVNQQYLLESVRGMAVLRQLEVADARMKTGNEGFDHEATAFQQSQFGQLLKNMSAT
LVMLVAWLFIVWLNGWTQPQPLQQALLAVFPLTFGPLLALTNLPASLLNGFAAARNLLNL
LQEAPATSAAIDATQTLNQIAIIQVDHVTFKYPSRDETVLRQVSLSLHAGEIVGFVGASG
SGKSTLAKLIMGWYPLTQGRILIDGIDLTKIDPASLRAQVNYLPQTPVFFSESVRDNLTL
HDATITDAQIWTVLDQVKLTSRLRQAEKGLDENVVSGQLQFSSGEQQRLELARALLHPSS
VLVLDEPTSNLDTENERLILDTIKAYYHGIVIMISHRAESAAYADRLYRFADHRVSAAST
EPKQQA
>fig|321967.8.peg.2140 Multidrug resistance ABC transporter ATP-binding and permease protein
MLGLLKYGRDQRWAGVIETVFDWLPTLLPIMIALNFAAKRPGNALVITVILVLIWLGYVI
GYERHHRHAWAMSAKRELRDHYFEALYQRNNAGDATAADNAVIQRDLGGLNNLDMFYSTL
FPTLIQAGLTFLLLIGLSVWYGSWLAFLPLACVFLIGFAMMFLGKKMSAQNKAHLAGFLR
MGGRFMNDLSGMNTLVMYNAADRYAKKFADDSEYFRQATMNLLRTQLQVLFVINGFVYLT
VFAGGFVTALQLAAGQLPAAGAFATWFALAMMMVNARQLGYFFHVVKSNGPALAGILATI
AKSKTTPATVKITDNRPLKQLVLQDVAIGYEADAPLVSDINATLVPGKLYGLAGENGTGK
STLTQALLGQLTPLSGTIMADNTPVTALSNAQRAAVFGYVAANDYIFSGTIKENLLLGNQ
FGDQWQQHLDELGLMHFVTDLQDGYATEVGEGGRLLSPGQRQQLAFARMLLADKTVYLLD
EMTSSIDAANAAIILAAIKRLSRQKIVLFISHDLSAMAEADVVWFIHDHQLISADHAQLY
RDQPAYRHLVDNPEAMLKEGQPS
>fig|321967.8.peg.2156 Permease of the drug/metabolite transporter (DMT) superfamily
MIIAGIVLMLVAFWKERKAILAPWRNTRDALQLILFILFGMIGMQYIYFKAVAVANAATA
TILQYLSPVVVLIFLALRLREKPRRIDIVTICFAMMGTALVVTKGHFTHLAISPNAFFWG
IMAALAAAAYTLLPAGLLHRHSPIVVTAWAQLIGGLLIDVFDPFWKEIPHLDHAGWAGYW
FIVIFGTIIAYSVYLASLQFISPTAATLLDAFEPLGATVVSVVFLHMHMGFAEILGGVII
ILTVAMMAMATPHGPKLEDRSSD
>fig|321967.8.peg.2392 Daunorubicin resistance transmembrane protein
MTLRLMMIRIGLKRSVANRYAFGFYLFGNLISIAVMFFLWQSVLRHRPSAVFAETITYLI
FMQLLTAVFPKTSFAIHDDIRTGNIARLLLRPVPLLTHYFWESVGYSFGKLIFIGIPDVI
LLVAVRQSALAWQTLPLLVMAVMLGYVLYFELEAIIGLFSFYTYSIWGINTFKAAVLLAV
SGNVFPVNFYPAAVKTIAQFLPFQYAFGAIDELLSQQQAADFWPTLFMQSLYIATLFGVY
HLQLKIAIQRVVIQGG
>fig|321967.8.peg.2681 Drug resistance transporter EmrB/QacA subfamily precursor
MPNATMITTPKRHQWLALTAMSMGVFMGLLDVTVVNVALPTMVNDFNTNFTNLQWVLNAY
TLVYAVSLLIMSKLGDMYGRKKVFLGSLILFVLASTVNGMASSLIVLDIGRGIQAIGGAG
MNSLSMALVASNFSGNKRGVALGILGSVIGMSTASGPLIGGFLVENFGWPSIFYVNVPVG
IVAVIMTLTFVNETPSYGQHERIDFAGMLFSGLGLFSLIYGLIIKEGHPHWSWMDIRIGG
WIIAGFILIALFIWTESRVQQPMMSLNFFKQCHFVGTIFVAFALGASLYSFNTFLTALMQ
NYIGYSALQTGVRQLTISGWSLVLGPISGYLGTRFSKKRMISASLLVGACGFLVMLNAMG
PRVGFMDLMPGMLMIGFTNGIVSPLINTVGMEGVAPQQMGMASGLLNIFRQLGIVIGVVG
FGLMQAIQYENYLNTHIHTVGMPSQMTTGIHAALIKAGPFSGHTIAWSKRLTETPFAQKL
QSVVVHAYDNGMAAVLIAALVVILIGSLAAAVLMRKESHADVHA
>fig|323097.3.peg.889 Glyoxalase/bleomycin resistance protein/dioxygenase
MANNSRPNLVGINHVALEVGNVEEALSFYGAIFDFELRGSHLDEAGRTTMAFIDMGDQFL
ALSEGRKQGPDDARHFGLVVDDRSKVRELAELAGARMVEGSFNFFDPWGNRVEVVEYRDV
QFAKTDAVLNAMQISPDKSERARAELREKGIGVAPT
>fig|323097.3.peg.1687 Acriflavin resistance protein
MALNVSAWSIRHPLPSVLFSIILLTLGWVSFTKLAITRLPNADIPVISVAVSQFGAAPAE
LEAQVTKTIEDGVSGVEGVRHISSSITDGLSLTTIQFALETNTDRALNDVKDAVTRVRAN
LPQNVNEPLIQRVDVIGLPIVTYAAISPGKTPEQLSYFVDDVVKRALQGVRGVAQVERIG
GVEREILVSLDPDRLRAAGLTAVDVSQRLRGINVDVAGGRAEIGRNDQAIRTLAGAKTIN
ELAGTMISLPAGGELRLDDLGTVTDTIADRRTFARFNGEPVVALGIKRSKGASDVVVAKA
VQERIDALKEQYPEVDLKLIDTSVEFTKGNYEAAISTLFEGATLAVIIVFLFLRDIRATV
IAAISLPLSIFPAFWAMDLLGFSLNLVSFLAITLSTGILVDDAIVEIENIVRHMRMGKSA
YRAALEAADEIGLAVIAISLTIIAIFAPASFMSGIAGQFFKQFGITVSVQVFFSLLAARF
VTPVLAAYFMKDHPHEAPPPGPVLRAYASLVTWSVRHYFVTVLIGFAVFAASIWSIKLLP
QGFLPAQDTARSLLAMELPPGSQLAYTEKVTENIAARLRKRPEVTSVFVDGGRVPPGLQE
VRRASLIINYTPKQDRGITQRELELSIGQELESVPDIRYWFLDENGLRAVSLVVTGPDIG
IVSNVANELATQMKRIPLLANVTPETSLDRPELRIQPRADLAARLGVSTEQLSQTIRVAT
IGDVGPALAKFDAGDRQVPIHVQLEDSARADLKMLEQMRVPIGGGRGHVPLSVVADIRLD
QGPTSINRYDRQRQATIAADLVGTAALGDATRRINELPVMKTLPKGVTVNPSGDAESLNE
LSEGFATAITAGLMMVYAVLVLLFGTFLQPITILFSLPLSIGGAIMALLLTGKQLTTPVW
IGILMLMGIVTKNAIMLVEFAVESIRQGRAREEAIIDAGMKRARPIVMTTVAMVAGMMPS
ALAFGAGGEFRSPMALAVIGGLIFSTILSLVFVPAMFLVMDDVGAFIWRYGKRLLTSGTE
VAEPAAAEREPPNGRLPGAE
>fig|323097.3.peg.1825 Glyoxalase/bleomycin resistance protein/dioxygenase
MPDASIPVAAGTRIGHVHLKVADLERALGFYCGVLGFELTQRYGDQAAFISAGGYHHHIG
LNTWESKGGSPPAPGTTGLFHTAILYPTRAALADALHRVREAGIALDGASDHGVSEALYL
RDPDQNGVELYWDRPQQEWPRDTDGGLAMFTRRLDLDDLMRQREA
>fig|323097.3.peg.2454 Glyoxalase/bleomycin resistance protein/dioxygenase
MPEKAKPVPDGFHTVTPYLVVDDAKAVITFMQQAFQAEFVHRPTRRPDGKLMHATLRIGD
ARVMIGNASERAKAMPAMLYVYVPNVDEVYAAAIKAGGTEIMAPSDMFYGDRSGGVTDPG
GNQWYIGTHIEDVSDAELQKRANEMFAKG
>fig|323097.3.peg.3634 Glyoxalase/bleomycin resistance protein/dioxygenase
MLGRLNHVAIAVRDAEKAAKIYGAAFGADISAAVPLPEHGVITVFAALPNTKIEFIQPLG
EASPIAKFIERNADGGIHHICYEVPDIVATRDILIAEGARVLGDGEPKIGAHGKPVLFFH
PKDFSGALVEIEQS
>fig|323259.5.peg.193 Multidrug resistance efflux pump
MVTESKKKIYSSIGGHFLVDLYSPFLPIILPVLITNMNLSFFLAGFMVTAYNVTSSLVQP
VAGLFSDRTGKKVPIWICVLLSSAGISLAVLTNNYLLMLALVSGAALGNALFHPAAMESV
YRLSPIEKRGIFNSIFTTSGSISYSIGPLIAGVMITFFGLSSIAWLVIPGILGAVWIYSV
DKKFNTLVSAHYERKKPVSKQKKERYWWVPAGLVVFLCSLRAWTYVGIITYLPALLMLGQ
HGMDTITTSLIVTIMLFIGVAGQIAGGYLSDRYGRKNMLVFGFAAAVPFFCLIFLSQGWL
MYSGIFMYSFFACFCYVTSVTMMQELLPESVGFASGLTLGLCVGVGGIGAAIIGWAADNM
GSLPDAMFLMIIPTALSPILALFIRYPDQRRIRGRDADLPE
>fig|323259.5.peg.353 Permease of the drug/metabolite transporter (DMT) superfamily
MNILRNPGPVYGQLLVVIGAVLISLSPVFVVLSGVSASASAFYRMALSLPPLLLLLVFIR
GKIWLGPRQLGIALLASIFYTLDLICWHQSILLIGPGLATILGNFQVFVLAAFSVLVLHT
RVTPRLILAIPVSIIGLYLICGVQWSTASDGFQMGVLLALTTAFWYGGYVLFLRLLQTSF
DLEGKIANLCMISILTTIITGLVVIGSGDSFDVPSVDSWLYLAAYAIICQVIAWLLISAG
LPFTVPIKVGLILLLQPAGAFIWDILIFRLPFTCVTVLGVVLTLGAIYLGSTSTSPGEKS
ES
>fig|323259.5.peg.488 Efflux pump antibiotic resistance protein
MLTAALPEIEHEFSVPGIYESWILPIVLLVGAAASPFVGTAGDRFGHKRLLIICLVIYSV
GLISGLVAPDIWVLLFGRAMQGAGIAAFPLGYAIIRQRLCETGADTGIGIISAMYGAGTF
IGVITGSFITGLFSWRVTYMVLIPATCILLLCIWKYIGDDEPVNGHGSLDFAGFFSLLLF
LLLSLVFFSLPTEDQIGFFGLLLLVSAVLVFGLFIRIERRASHPLADIQLMKRRPVAVFM
VIGFLTVFTFFVLLQMMPYIIRLPTGLALSAEMVGLILIPGTLCDMAAGPLTGRMIPVIG
CRLPCITGSLLLLSAGCLLFLFPVTLPVLVIAWMVFSFGMSMLATADLIGVLEFIGEERT
AEATGIIQSMQTLGGMIGPIVTGIILATSQVSTMYLGEIWEIPKTGTYYQVFLVVIIISS
LLLVISWIYVKDRRKERNEHTHPSV
>fig|323259.5.peg.634 Drug resistance transporter, EmrB/QacA family protein
MAFLFVNVQKGYIPLIIAISLATFMASLDGTIVNIALPTISESFSLSSSAVSWVATIYLL
VMAGCVLIFGKISDLIGFKRIFLTGFIIFTIGSFLCGFLPDLTGSFLTLIGSRAFQGVGG
AMITAIAPAMVTAFIPMNMKGKAMGIIMTMAGLATAIGPTVGGFLTQYLSWHWIFFINVP
VGIIALLLGLRVIPGQPSHQTLEVFDRIGAGLIFVGLAFLLYGFSEGTNLGWTSPVIIGS
LGLAVVLLGLFVWKELHIQNPILEIRLFHDKNFLLINLVIFLVFFSFSGVNYLLPFYLEY
VGGYSTSEAGLILTALSVAMMVAGIIAGVLYNHLGGRILSIIAAVVLLIGYFLITHLRIY
TPTIFVTVCLLCIGFGLGLIITPISNMIMTSASKKYQGMVSSLTSLERFAPMTIGIAIYN
VIFIQGMTTIAAHYDITKNAPVEIQMKVLTAGFDLAFLLSFILGIVILVLTVMARYTMHP
DYQGEDIDKMAAGLV
>fig|323259.5.peg.684 Multidrug resistance efflux pump
MSAFRRIGELTIAHLINDIYAPILMALQPVLITMYGYGYFEAALLPVVHSLTSSLLQPLF
GYLADNKGIKVSIGISILLSGIGVSVLGLIPNQYYIMLLCVALSGVGHASFHPGALCQVS
ILATGSSRGKLTSLFVVGGNMGMALGPIIAGIILTTGGVPQVIWLIVPAIATALFLHVNP
ITDCCNIKQEKTSEGKENWRPVMLLFTGATLRSWVTFGAMTFLPTYLVLEGYSLLEATTL
VSIMMIAGVAGQLSGGALSDRIGRKKVIVFTTLASIPAFIAILLTHGLFLILSMMIFGFL
LWSSFSVTIALSHEMIPSKIGLISGLFLGIAMGAGAIGVSISGAVADMAGLYTCLETFPV
ILMVSVIIFMMVKSSSPHPNQD
>fig|323259.5.peg.1586 Multiple antibiotic resistance protein MarC
MAPDLISFSLFALSSILIVVNPLGALLVYNSITEFMDSKDKRKVAAYGCRIAGAVLIFFT
LFGSSLLSLFGITISAFTVAGGVLLFGIGMEMVYARTSRAKVTATEKYESIDAEDISSMP
LAFPMISGPGTITTVIVLSQDTPIFSEPVELGIILGSVIVTILITYIVLISSEQITKRIG
QREYRVVNRLMGIMLMAIAVQFIINGISQAFPMLTGSAT
>fig|323259.5.peg.1650 Multiple antibiotic resistance protein MarC
MVSDVGYLVGAIGTFFAILDPFGNLPFFIAYTNTLSAPVRRKTALVLSAFIFVAMAVFLF
SGQMVLSFFHISLPAFQIAGGIILFGVALSMMSGTHTITMNRVISDTGKEMLLEKNESIL
PTIIVPLGIPLYVGPGSIAAAILFGSNAPTETAFLGGLLVILLIVIFITILNLSSDYIGK
VLGNQGIEILVRLMGLVLAAIAVQLTLDGITGAITTMILPSLSG
>fig|323259.5.peg.2150 Efflux pump antibiotic resistance protein
MSQIISNQLHQRLLLTAAAVGMFLDGLDGSIVTIILPQISESFNTDTGTASWVIITYLLM
MAGLILIIGKIAERGHIRKIFLLGLCVFTAGSAACGIAPDLEILLAARILQGIGAAMLAA
TASLLCVTYLPKDMYGMAFGAISMSVSVGVATGPAIGGFIAQYFSWHWAFLMNVPVGILI
LAFGMYIIPPDIPREIQPFDLYGSILLFGLMVSCVYCLERISHLGISDLQILLSGSISIA
CLIAFYIRERMCHILLIHIRVFSVMNFTATLLAFLIYGCVSMGIFYLLPFFLQAGMAYDP
AMAGLFLLIPPLITAIIGIPMGRWSDLIGRRPFAIAAAVLSIAASGIFMIIIPETGFIPL
IFGLLIMGLFMGCFGGPVASRVVENAPPGEEGTGTSLMVTAVYLGSVLGTALFATFFTLG
SAETGISAFSDLDPEKFLHGFHLSMTAGFILSVLALILSVIVREKKTRENSVRI
>fig|323259.5.peg.3329 5-nitroimidazole antibiotic resistance protein
MRRKDKELTDTERIEEILTGALFCHVALCDHDRPYCVPMCLAYHDGKILLHSADAGRKID
ILHTNPHVCIIVETGIQ
>fig|323848.3.peg.738 Multidrug resistance protein MexB
MSSRFFIDRPIFASVLSIIIVVVGLVALRNLPIAQFPEITPPMVQIDADYPGASAEVVAE
SVARPIEVQLPGIDNLLYYESTSSNDGHMTMKLTFEIGTDVDIAQVQTQNRQRLAEPQLP
DEVVRQGITVKKTSPDLLAVIALSSSDPRHDTIYLSNYALLRVLDNVKRLPGVGDAIIFG
SQNYSMRLILDPVRMAQLDLTPTDIAAVVREQNRDFPAGRIGREPSPKGTELTIPVITQG
RMSEVKEFEDMIVRAYPDGSMVRLRDVARVELGAQSYDLEGRWNGKPNTFLLTFLAPGAN
ALDTVHRVRQEMDKLARSFPAGVSYDIPYDTTIFIEVSIKEVLKTLVEATLLVILVVFVF
LQSWRATIIPAVAVPISLIGTLAGMAALGFSINTLTLFGMVLAIGIVVDDAIVVVENVER
HMREGLPPREAARVAMDEVAGPVIAIVLVLGAVFVPVAFLGGITGELYKQFAITIALSVA
ISGFVALTLSPALCALILKPGHGEPAKYWKLFNRSFDWMQTRYTNGVGMVLKRSMIALCI
FAVMIFVLLGLFRTIPGSFLPEEDQGYFITVVQLPDGASKERTIDVLSKVEQYFLSIPAV
HSTDALAGQNFVFGTRGANQATMFVPLQSWDTRKSAGEHVTGLIASAFQEFAKIPEALIL
AFNAPSIRGLGSTGGFSLQVQDPSGGDFKEFAEITQKFVAKAVEHPAIAAASTNFRVSAP
RLYARVDRERAKALGVPISEVFDSMQAYFGNLYINDFVKYGRIYRVQTEAQPQYRSRPED
IEKIYVRARNDKGHVMIPLNSVITTEFTSGPDPVTHFNGFNSALVLGGAASGYSSGQALD
ALEQIADEILAPKGYTIDWSGISFQERQAGGKSVLVFAFALLMVFLVLAALYESWSVPLA
VILAIPFGILGALLAIWVRELTNDIYFQIGLVTLIGLSAKNAILIVEFANQRYANGEPLL
DAAMEAARLRFRPIIMTSMAFILGVFPLVIASGAGAASRNSIGTGVFGGMLAATFLAIFF
VPLFFVVIRKMTHRRGQPEVRASHAAPDNSPSTVEDE
>fig|323848.3.peg.779 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MKHSEPRISVVIPAFRSERTLPELCIRLGKVLPSVCPEYEIIIVEDGGGGQTWEIIQALA
AADARIRGMLHSRNYGQHNAILSGIRAARFEIIITMDDDLQNPPEEIPALLTKLAEGYDV
VYGTPCQEKHGVLRDIASLITKRMLEHAMGGDVSRHISAYRVFKTHLRDAFKDYRNPFVS
IDVLLTWATTHFAAIPVRHDSRTVGASGYTLARLVRHTLNMVTGYSVFPLQLASWTGFLF
TLLGMCLLMYVLGRYLLYGSGMAGFPFLASIIAIFAGAQMFALGIIGEYLSRMHVNSMGR
PLAVIKEATFPVNSTSNKEGSRSG
>fig|323848.3.peg.2020 Permeases of the drug/metabolite transporter (DMT) superfamily
MLTKQNKQYTRGGHGAFPIAALLVGATIWGLLWYPYRLLEQAGVSGAAATVITYLVALLL
GLAVFRHELRTIRILDMETWLLVGIGLSAGWANLAYVLGVLHGEIMRVMLLFYLSPLWTI
VFARFLLGEMLSMHGYLVIVFSLGGAIIMLWQPEGSLLPSSYADWMGISAGFMFALANVL
SRKDQYHDVQLKSVAVWLGVALVALGYSLFLAGLPASVDVSTYTFLLLLLVGLTVFALSL
VVQYGLTHTPANQAIVIMLFELVVAAVAAYFLTDEAMTLREWAGGAMIVSASLFSARMNR
E
>fig|323848.3.peg.2453 Permease of the drug/metabolite transporter (DMT) superfamily
MSEALKSWSGWIAVFFSICIWTGFILVSRYGGMGTLTSWDIALLRFGVGASIAVFFLPRI
LLPPLKVIALFSLFGGIGYAAVVYAAFRWAPAAHASVLLPGTLPFLTAIIAWLWFGEKFT
GARRLALLIVFAGILLTAADSLSLGTHISPTQILGDVLFLCGSSLWAIFTLLLARYPMPP
LAATVTTTLGSAAVYLPVWLLFLPSNLALAPLREIILQAAYQGVLVVFIAMLLYTFAVRR
LGSQTVALLMAFVPVISALAAVPVLGEPLPLLTLAGLGAVTVGAVLGARRR
>fig|324057.4.peg.427 Permease of the drug/metabolite transporter (DMT) superfamily
MWNMVWILVSVIMGAAGQVLLKFGAMHPNESMSGPLRMLNLYNAGGIFLYGASALIWMFV
LRKVELSYAYPFVSLAYIIVLVASYYFFGESINTYKIAGLVLIVGGIAFISRA
>fig|324057.4.peg.542 Permease of the drug/metabolite transporter (DMT) superfamily
MGHKEMRLPYFLAVLNAVIIGLSFLFAKTALDYASPLDTLAFRFTSSFLVMSIPVLFGWI
KLSYRGKPLRKVLLLASMYPLGFFTLQGYGLQHANSAEGGILYAFTPVVTMIIASMFLKE
TTTVLQKLSIFLSVFGVVFIFVMKGSSIDLSNLLGISLLLLTCFAFAGYTVLARSLSRQF
SPAEITYLMMGIGFVFFTVTSLTSHASAGTLSHIFAPLASGTFIASLIFLGIVSSLLTAL
TSNYILSKMEASKMSVFANLSTIVSMTAGAVFLGEEITIYHLIGSVLIIAGVIGTNRLGR
KKTAGHENSQKLNAVNHSRS
>fig|324057.4.peg.629 Daunorubicin resistance transmembrane protein
MLQAYWYITKMKLLINLTYRFEVFTSVATNLILMLASVFLWQTAYKGGSGTVESLSLQDI
TTYTILSIIISTIFVCDVQNTIYYKIREGQIVTDFYRPIPLFACYLAEDIGEMLSSLLNR
ALPLVVFASVFFGIPRPASFRSFLLFLPSCLLSYAILWLLSALIGLIAFWVMELGNMGNV
KDAIVRVLSGSIVPLWFFPESVQTVSKFLPFQYTYQTPLGIYIGNTSTSEAFTSMAVQAV
WIAVLYLILAAGWARTKKKTLIQGG
>fig|324057.4.peg.750 Permease of the drug/metabolite transporter (DMT) superfamily
MNRASKSFSAYELLYVVGIIAISFSSIFIKWSSAEPSVIGMYRLYLTVLIMLPLAWKYKQ
ELLYHTARQLLLLLASGVMLALHFLFWMSSLKHTTVASSTIFLALEPVLVMLGSYLIFKT
KANKMMLLGMGIAMIGTVIIGSSDLALSKEALYGDVLSILGTIAVALHMLIGKQLRSNTS
AFAYNFLVFTIAATTLAVYNLIQGYRFTGYSSHEWGIFLLLAIVPTLFGHYLFNWLLKYM
NATAVSMSVLGEPVIASLLAWALLKEALTGWQLGAGVVILFGVWLFMRHGKE
>fig|324057.4.peg.912 Fosmidomycin resistance protein
MTTTAALQAQRNPAIWMLFGVSFAHLLNDAMQTAVPSSFPLFQSEMHLSFTKIGWVAFML
NITASLLQPFIGYVSDRRPMPFLLPLGMLFSLAGVVGFAYADSFWMLLVSSALIGVGSSV
LHPESSRVARMAASGGKGMAQSVFQVGGNTGQALAPLLVAFLLMPHGQRGFLWFTIFAVA
GIVIQQIISRWYAGQLAAAALIKKAANRVLDQQSPHSTMFVAGTMALLIILLFSKFVYIA
GMTGYYSFYFIDHYGLSFSRAQICLFALQFAGMVGTLLGGPLADKFGRKTMIWISIAGTA
PFSLLLPYASPAVALVLCCAIGLILMSGFSVIIVYAQELMPRHIGTVSGLFFGLAFGMGG
LGSVLLGWLTDVKDVAFTIELCSFLPLLGLCAFLLPKDSKLMGKV
>fig|324057.4.peg.1142 Permease of the drug/metabolite transporter (DMT) superfamily
MLKLKKASLPSHPFVLLFISILSVSVSSILIKFSDTPTSVAGMYRLFITVIIMLPFVPWR
QLRSLKLNMKDWSIVVLAGILLGLHFLFWMESLVHTSVASSMVILALQPLFVMIGSYLLF
KEQANVLTIACLVAALFGSILIAWGDIGVSREALIGDGLSLIGTLAVSGYLLAGQKVSSK
IDANVYSIIVFFIGGVVLLINNLLNGYSFTDYNSSDWIYFLLLSIIPTIFGQFLFNVLLK
SIGATTVSVGIIGEPVLAIILAYLLLGENISLFQLAGGMITLFGMGMYFWAKSFIGGRKV
GNHG
>fig|324057.4.peg.1995 Permease of the drug/metabolite transporter (DMT) superfamily
MDPVFRIILLKTLTSTQIVLLEHIILFIAAAPVLWKFRADLRDVRLRQLGALLFVSWGGS
ALATILFTQGLVHGNPNAVLLLQKLQPLFAIVMARMLLKELLPKKIGPLLVLAIVGTYLL
TFGFTLPFGHVNEFVQVGSLLSLGAAALWGGSTVMGRYLLGSMKYETVTSLRFMMALPLL
LVITWSEGAAWKLAEGTDPVAVIVNLLLQALLPGLVSLLVYYKGLSKIKASYATIAELSF
PMVGVLLNWTVFGQVITSAQIAGFVFIWFTLFFISRQQN
>fig|324057.4.peg.2767 Teicoplanin resistance protein vanZ
MIKLLFIRDSSYRWSVYNYNIVPFHTIKSLIYHRHAYNTDTWVKNLFGNIVLFIPLGVCF
PLLSRRLFQAARSLAAIIILLFLVESIQLVTKVGSFDVDDIILNTLGACIGLVFIKLFAS
RLRS
>fig|324057.4.peg.2908 Multidrug resistance protein
MKSLSQYPKEIKVFLIASLINAIGSALMWPLVTMFVFDQLGRTMSDAGLVILVQSIGGIA
GQLLGGALYHRVGVKKLIIGALALNAAGLLFLPALSHAWTVFIVMMGLIGLFNALSMPAI
QAFIGFRFAERRGELFNIVYIANNIGVAVGTALSGFLADVSYSLSFVLNGVTSGVFALFF
LFYLQRVGTGSGDHSAELMRKKQAAGGASLWLLVTDVRLYLFMALGGMLINLGNSIWNTG
VSPFIIEHGMSKQMFGYLWTLNGILIFVAQPVTNLIKRLAASSIKAQLTASAVLYMSGYV
VILIMHSFPGMVLGMILTTLGEMLIAPAIPAFLSENSGKNAPFYLGLTGGIGSAGRVIGP
YMMSGLYDGGGLTPVAWLAVITAAVSVGSFVIHSWVNKENRAPATNSSNVRTSQA
>fig|324057.4.peg.3950 Daunorubicin resistance transmembrane protein
MISLSKPAKYVFIGKITLRSQLAYVVDFLIRSVFLLLILYIFMQLWQTTFAGEGTATING
YTFKQMMWYLVFTESMVLATPSLSTRIEEEVKSGDVAFKLIRPVSFIAFHYAEYMSEVAI
RYVINLILGSAIGLLLVGPLPVGIGLAWLPIMALGGFTVNFMLGMLVALSAFWVEETRGL
EFVYNKILFTIGGMLMPLELFPESLQRIGHWLPFQTVVYFPARTAVGMHLGEISRALAIQ
WLWVVIIGVMVWLLYRKGVRKLNVNGG
>fig|324057.4.peg.3956 Permease of the drug/metabolite transporter (DMT) superfamily
MKTKAWLFLVLANLFWAGNLIFGKSVTAEFPPIWVAFLRWAIAAMALIPMAQLIEKPNWR
KVWKANWGILLFLSLVGVVFYTLLTYTALQHTSSTNGSLINSLTPAVMIVLSLLFLKEKM
TVWQGAGLVLSFLGVLTVLTKGHLLGVFRTPYNEGDGILLIAVFLWAIYSIISKRAQHLP
PITFVAFTAVIGVVFMVPLLFIQPLQTEHTTALGVTGVIYLGLFPSIGSFLFWNQGVKQL
GPGKASITMNLMPIFTAILSVLTGQQLLASQIVGGVIVIAGMLLSANLIKRSDRNGTKRM
TKHRTGVI
>fig|324057.4.peg.5084 Permease of the drug/metabolite transporter (DMT) superfamily
MKLWHYALIVCLGGCCYGVLSTFVKLAYAAGFSVSAVTGGQYLFGAVLSWLIVLLVNRKA
PTRKQTVKLMLSGIPFGLTGIFYYQALQTLNASLAIVILFQFVWIGTLLEWLLLKKKPTR
NKLMSITLTLIGSVLAANILFQGNMSLSWTGCVWGLLAALTFSTFVFLSSTVERSTPPLL
KSALLSTGGLITIFIVFPPTFLLDWHVVTGLLPYGLALGVFGVVLPPLLFSIGMPHVGSG
LGTILTASELPIVVILSSFVLAEPISAPQWIGVVIILSGIVSSNLRLRKSDQPSLAA
>fig|324057.4.peg.5418 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDAQNLHYFEKAPVAKAVAHFAVPMMLGTSMSVIYSILNAYFLGTLNNTAMLTALALTLP
LFAVIMALGNLIGMGSGTFISRLLGERKYDDVKHVSSFAFYSSLVLGLIVIAVGLPLIDP
IVHGLGATPESFGFTKDYVTIMLIGSPIVVLFFTLENIVRSEGAAITSMTGMILSVVVNI
ILDALVVYVFHWDVIGVASATVVSNLVACVFFAFHMGKKSQFLTISMKWFKATKEIMSNV
FKIGVPVFIMSIFLGAMSLIFNHYLVEYGDQSVAAYGISSRLLQFPEFILMGLCEGVVPL
IAFTFTANKSRMKETIGFTIKMIVSLAVVFGIIVYLISDHLIGLFTNDPQLIEMGSYILH
VTFLSLFITGMTTLFTGIFQATAQGTAAFIMSIIQGVTLIPVLYIANQMNGFHGVVWSLV
IADTVAFLVGAVMLYILRNKLQPDLESLAQ
>fig|324057.4.peg.5684 Vancomycin B-type resistance protein VanW
MWKKLHLWVIIVFALLLVASVGYGALSYYSGQDTVPEKVTAGGVDIGGLSIDDALKKLDQ
YEQMLESRTVTVEGNAEAKAEGSQTWKAAEIGYNAEFVGVKEELKKLRTGNVWTRSKFRY
HFTTSFELKQSYDPAVFDKLVLAEFDWIDSNKPVNATRKITDNDEVVYTSHTDAYRIDVA
PLEEKVASWITVPDSQLGGQPEQVLTVQLGVKTVHPEITLEKLKDEGIDRKIMEFTTNFA
TSAEGRAFNVTSTAKALNDWVLEPGEVFSYGDVVAKTEKEYGYKEAPVISNGKLVPGIGG
GICQVSSTLYNAIIRTAGIDIVERRNHSLPVAYLPKGQDATFASGSIDFRFRNSTGKQLI
IRTVVENRKLTVKLFGTMPENIRYDIESSIVKTVQPAVQKVTDKSLGAGQSVTVQNGSIG
YVVDTYRTMYKDGKQVSREKISHDTYRAQPIVVHVAAGAGGSSGSQSSGGAVEDGI
>fig|324057.4.peg.5828 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAVSAATLTGGTLNAVLGTTITAGTVAVSGATITAGTLDALLGATITAGTLTAVLGTTIT
AGTVAVSAATITGGTLNAVLGTTITAGTLTALLGATITAGTLSSVTSISQKSFQEVANLN
NLTADAYTAVPAITTSVFGTYSYFVYNKGPGTNAATARVEISANGTNWYTDVESVTGIAV
GSVDVLVPQRFLKYTRLAYRSTTTGSATTVDVYFNGQGT
>fig|324057.4.peg.6000 Drug resistance transporter EmrB/QacA subfamily
MNAKQDDNRFWFVILAIFFGNFSSILNSGTVTVALPFMMKDLHSDLNDTQWVTTGFMLAM
GSIAPIVGYLGDKISYKRLYMFSLVGFLICSVLCGCSWNIGSLVLFRILQGLFCGAILPA
TLTIVYQAVPAEKQALGVSLWSVASMFAPAIGPTLGGLLTEYYGWKAIFFMNIPLALLAI
VLASRYLPMQQVNKGSSLDLAGLLTAVTGSTSLMMYFTQGNKIGWFSGWGILWITLGVVS
IALFIRRELTAKAPLLNLRVFRHTTFTFGIVVNCILTIGLYAGAFLLPIYMENALGSSSL
TVGLMMLPGALLMIGASLLSGRLHGKIRPEYPLLGGAFLLIIATWAFSRLSLTTSYAFII
GWMICRYVGLGFSSPNIMTLSMSAIPKESTGHASAITNWLRQVIASFAIGIFSSVYSVRT
QTHFTELSSSGGVKTSLQETASVLAMNDTFIVACVVTVVAIPFILVLSSRSRISGEKAAS
TVSK
>fig|324057.4.peg.6191 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLLGTVDVFMLSRISDKATGAVGLANEIIYFCIMMFGFVGIGTSVAVSQYIGARRAKEAS
RISAMAISMNLIFGILVSIVIVSFGESLLRLLNLNPEQIGIANHYLKIIGGFIWIEALSY
AVSSVIRSTGNTKSVMFVTLGVNLLHMGGNYLLIFGNLGFPEWGVTGAAISTVVSRLLGI
VVLFILLYRRIAVPIQRKDYVRWKGSYAKQILSIGLPAAGEHLSYQSQYLMIIGFVNMIG
ITALNTHVYVMNVSNYFMALALAIGMGTEIIVGQMVGAGEMKEAYRRLMKSVKISFLLTI
AVVGVAAIFRHELIGLFTKDPEIIAAGASIFLLSIILEPGRTFNMVIINSLRAAGDARFP
VLAGVISMWGVSVPLAYLLGVHFGIGLLGIWIAFTVDEWLRGVMMLLRWRSRVWEKKALV
KPASVVSDQGVEAPI
>fig|324602.4.peg.100 Drug resistance transporter, EmrB/QacA family
MAVPETDTRRAIMTVLFVGVFMSALDSAIIGPIVPALRAAFAIDNTQVVLVTIIFTLCSL
SSTTLMASLSDRYGRRNVYLLNVFGFALGSLIIALSHDLTMVLIGRALQGVCAGGITPTA
SAVIGDVLPSAERAKALGLIGATSGMAFLVGPVLASLILAVAAWQWIFLLNLPVAAAVIF
LGWRALPRATAVHRATAATAFDWPGLTLLVLILVSITLGINQLLDRLLGLTLWPWLFLLV
ALLTPLLAWREVRAPVPLLPPRLFTNRQLQIVYLLAAGSGIAMGSIIFITSVAVNFGVPI
SQAGFFLLPLVFLASVTSIIAGRILPRIGGRMAMLIGYGQLMIGTGLLGLPAAPFWLFIL
ATLIMGSGLGIVVGGTLRALVLEEVAAGDRGVAQSVINIAISIGTLIAVALMASIADAFD
LSTAYLACTGAMALMTAISLALRRQFSPPSTANAS
>fig|324602.4.peg.455 Vancomycin B-type resistance protein VanW
MSVQHSQPFNPTHERTDGEVFSPSLPGAVDWPDQVVHPPAVQRGTGRRTRRKVSRGWWWL
LLVVLSGLAIVGTGMVFLDRSYAGRILPNVTVRGVAVGNMTREEARAAIEASFAPFLAQP
VVLTYSGRSWTPTLAELGVALEIDEALDAALAVGRSANLFTDLQQMSAVWQYGIDIPLRL
SIDQDAMQRYLLARVAEVEQPARDAHLMLHGTTVEVAPSAVGRQVLVAETLQEILSAIQD
LNPDTVALRTRALEPSLRDDAAFLAQDQIAALLAGPVTLLVDNRPFVWSLDELARMIRVE
RISDPMGDRLEVSVDHDMVMEKLIALGDSTEVKGTYPRLNWNEGKLEIFQPGKPGKRIDE
AQALNAVLEALNKPADQRTVTVNFREIPPPVTADNLDQLGITTLLGVGRSDFTGSAPYRV
TNIQAGMRLLHGILIPPGEEFSFNQTIGRIDSSNGFVEGYAIIQNRTQLEWGGGICQDST
TVFRAAFWAGLPITERWGHSFYISWYDRYGFGPYGDGPGMDATIFTGGPDLKFLNDTGGW
ILMQTMVDTRRNLAEVRLYGPETGRKVLLEGPVITNRTPPPTEPVYVAVPERPVGQPRQS
DKARGGMDILFTRIVLGPDGKEIERREFVTRFKPWPDIFEYNPADLGPDGKPLPTPTPPP
AEPIPVEQPPVEPPTDATG
>fig|324602.4.peg.1029 Vancomycin B-type resistance protein VanW
MERSLPAGIPHRHRSRFWRIIEWLLVIAVLIILAILLGYGAIILSDRLLAERIYPNISVR
GLPIGGMTRAEARAALHRRYAEFLATPVTLHFNDQVWRPAAEDLGLHLAIEEALDAAFAI
GHQSEWEVNAQIAAATWQYGIDLPLHLTFDQRVAQATLQMIATEIDRAPIDASVDLRGST
VVVGREAWGRQTLIDETLADIAAAVQSLQPQEIAIRTRILEPQVRDSDLAPTVSELRLLL
SGPIQLEGQGGQCRAGCRWEWSLDQIASWIRLRSLTAVDGRPAMAVMIDQAAIRAALTPI
AAALREEGGLPRVDWNDGNLRIRTPGTPGRGLAVEEAMARINAVLYSSERTVTLPLRELP
PPVTADNLAALGISAPVGVGVSSFRNSAPYRITNIQAGTRQMDGVLIPPGATFSFNTTLG
PVTAERGFVEGYAIIDNRTQKEWGGGLCQVSTTVFRAAFFAGLPITERHAHSFRIGWYEE
LGEPPGLDAAIFTGVHDLRFVNDTGGWLLLTGTVDTRRQQLTITLYGSPTNRRVEYSYRI
LERMPAPTRPVYIDDPTLPSGVVRQTDTARDGLRVEIYRTVYADGAVHLRDTIPTTFQPW
PDIFVRGVGR
>fig|324602.4.peg.1271 Vancomycin B-type resistance protein VanW
MPNNRYYQEYGPIYRRRAGQRPPLADDELPPDEPRRPRVRRPVRHRRRVPVWLWLVVGLV
LLVAIPTGALYAVDIVYPETILPGVSLNGESIGGYTRTDLIIELRRRYRSFEQQPVTLTF
RDQQWQPTLAELGVAFDVERLVNSAFALGRSGDPLTRAYELWLLWQEGIDITPRLTVDLA
QTQRYLLGLAPQIERLPADAVLSLADARVVGQPSQPGTQLLVDATANDVLLAIRALQPQT
VPIRTRQIVPQIDDTDLVVAQQIADQLLRSALELKVEDQTIVWTPERLAELLRVTPVDGR
LTIEVDPDRLARAVEGLAQMIDTGTAEPRLRFSDGRVRIVAEGQPGRRLRQADAVTAIAD
VLMQPSPVTRTLTLPVERVEPQITAATLDNLGIVELVAEGRSSFAGSAPYRITNIRAGAA
RMNGVLIAPGEEFSFNRQLGEVNAENGFVEGYAIIGNRTQLEWGGGVCQVSTTVFRAAFW
AGLPITERHAHSFYISWYDRFGLGPNGDGQGLDAAIFTGVQDLKFINDTGRWLLMQTSID
EQAQVLVVQLYGTRPEREVRIEGPIIANEVRAPTEPVYIDDPSLPRGTIRQTDVARSGRD
ISIYRIVTEADGEVRRELFFTRFRPWPNIFVRGSG
>fig|324602.4.peg.1543 Multidrug-efflux transporter quinolene resistance protein NorA
MKSRSPLVFIFLTIFIDLLGIGIVLPLLPEYVKIVEQSTWPWLAENRAFIVGALTASYAL
MQFLFAPVLGALGDRFGRRPVLLLSLVGAGVSYLVFALAEQLTFLGVETVIGLLFLARIA
AGITGASISTAQAYIADVTPPNERARGLGMIGAAFGLGFMLGPALGGLLANVSLHAPALF
AAALSFANATFGFFRLPESLPPEKRVQSHVRDLNPIKRLLAVAGDQRVQPFILGSVLFNL
AFAGLQSNFPVYSDERFGFSPQQNAFVFAFIGLIAVVVQGFLIRKLVARFGEARLTIAGL
ILMAIGFAATGLASAGWMLFPAIGLVALGGGMVTPSLTSLVSQSVSAQEQGATLGGVQSY
NSLMMVAGPLLAGMLFDLVGQTAPYLIGAGLLAASLVVLYGTLRERFTGTPQPTTTTVST
ETMVQVE
>fig|324602.4.peg.1552 Tetracycline resistance protein
MEQTILDHAVVTRRIIGALFVTQSLASAAFIANIAVNAIVGAQLSGNDALAGLPATLMLA
GAALSAYPAGRAMQRFGRRPGLTVGMLLGLAGMLIDGVAVISHSFWLFLVGLFLVGMARG
ITDQSRYAAADAVPPARRAGAISTVVFAGTIGAVGGPLLVGPLGRIAAAGGLPDLTGPMF
GGALLFALAALILFAFLRPDPRVLAIQQANQPVTTTMTPLTATRSLPTILRVPLVRAGLI
SMVLGQVVMVLVMSVTSLHMSHHHHGLDSISLVIGAHTFGMFGLSMITGRIADRLGRPLT
IIAGAFLLIAGALIAPASLLTPWLALGLFLVGLGWNFCYIAGSSLLADAITPGERGAVQG
ASDLLVNLGSALGSLSSGFILAGFGYLVLCIIGAVLSLAPLSAALWWGQSSRQVVTGAD
>fig|324602.4.peg.1861 Probable multidrug resistance protein norM (Multidrug-efflux transporter)
MQPEMLSIENEEITTHPAPSHAQLEKRVLRLAWPVIGENLLQTMLGVVDTILVASLGAVA
LAGVGAALQVIYVTTGALSALSVGVAVLVAQAYGGGRLKEASFLARQGLLWSILIGLPVT
AIGLPLTPTLIGLFGLAPDVSQVGIDYLAVTMSTITTLTMMFLIGGVLRGVGDTRTPMII
TAFANVINVIASAALIFGWLGLPVLGAVGSAWGSVIARFAGAILLVGVLWRGRNGVRAGG
RGGWWPRMRVLRNILRIGMPAALEEVLIIGAIATLTPVVATLGTVPLAAHRVAINVLSLS
FLPGIGFGLAATALVGQAIGAQRPAEARRIATIAMRWALIWMGGLGVLFMIFAEGLVRLF
NSDPQLVAEGAAAVRVVALTQPAWAITFALGGALRGLGDTLSPLVISGSAIWICVGLALV
IVLWWLPALWGIWLAFLIVGPFEALVFWRKWQQRITSWRPGSA
>fig|324602.4.peg.2549 Fosmidomycin resistance protein
MLRNRVFTAVVGGHFMVDLLNSLGAVLLAVLAVPLGLSNQQIGLALTIYTLLGALSQPLF
GWIADRLPGRTLQLAAIGVIWMATCYTGVALAPNWTILLPCFLLAALGSGLFHPIGTASA
AAAVPDKPASATSIFFFGGQIGLATGPILAGIVLTMAGTPGIVPIALAAAIPAGVLLLAQ
QTARSRRLNRAAPTPNTHPWTKLAVVLLIAFIVLVVVRSSIQTVYQSFLPKLFSDRGWEP
AIYGALAGTFMASGAIGNVINGWMADRFGMRAATVWPLILSVPAGLACFIATPLWAIFIG
CGLAGMLVGGQHSILVLHAQRILPVRQGLASGLILGFTFASGAIGTWFSGIIADVIGLET
VMIGVTLLGLPAAALALTLPGRPKATVTRDIPAGMQAEVRGS
>fig|324602.4.peg.2659 Probable antibiotic-transport integral membrane leucine and valine rich protein ABC transporter
MNRLLHTTYWDIVRQYRNGFYFVTVLIVALLVVLLRQLDGVDWQLWWPAILLETLVVNSF
FFMAGLVLLEKGEGVLEAQVVTPLRDWEYLLAKIISLFVLSASESLALILLVSGPAFNWL
WMLIGIGCFVAMYTLYGFFVVARYDSISEFILPSALWTMGFSIPLLPYFDLWQHWLIYLH
PLQAPLILVEAAYKPLPAWQLWYGILYSLVWISIGWVVGRHTFYRFVVTKEGSRRRSVSL
ARSL
>fig|324602.4.peg.3036 Permease of the drug/metabolite transporter (DMT) superfamily
MTTTTTRVEQPVLFAGLTPTDLTMLLVVLIWGANFSIVKAALTEIPPLVFATLRFTSASV
LLVGFMFWREGKRALPDRRTFWKLTWIGVVGNTIYQALFTYSLTMTTAANGSLIIATTPA
LVALAAALLGIERIRRVMAVGIALAISGVALVVAERGLSLGGQGLLGDLLMLGAAFCWMM
YTLGVRTLGQGLSPLAITTWTMVTGVPGMILISLPDWSTVVWDQVSLQAWLALAYSTLLA
LVLAYVLWNNSVRVAGSARTAIYGCAIPLVATLIAWPLIGEQPTWVQGIGGLLIVSGVLL
TRRP
>fig|324602.4.peg.3075 Drug resistance transporter, EmrB/QacA family
MSRQHTILITMGVMMSLFMASMESTVIATAMPGIVRDLGDIESFSWVFAIYMLTSTTAGP
IFGRLSDLFGRRPVYMVAIAIFSLGSLLCGLATTMPMLIAARALQGLGAGGLLPLAFIIV
GDIFTLDQRAKVQGLFSGVWGISSVIGPLIGGFLVDQISWHWVFWINLPPAAIAAALVWI
AWRDPVRANAKRPPIDIAGALLLSVGIILLLLGLDQPTTPSGILMLSAAVATLALLVMVE
LRAPAPILPFHLLRDRTFAIACLHGILAGGVLFGSMNYVPLFAQGVLGTSATEAGTTLTP
LMLGWVFTSIIGGRLLLRMSYRTLTIGGMVMFVAGAILMARLRPDMSRLELAIALGLMGI
GMGASIPSFLIAVQSTVARNVLGAATASLQFSRTIGGTIGVAVLGTLLTNRLSAELAARG
LQADAVPVEALIGEGATAMTLAGEPRLALAAALTAVFAAPLVFALLALAVTFLAPSHSPD
DLRRKREQREEVTTAKEVAPQQAG
>fig|324602.4.peg.3329 Membrane fusion component of tripartite multidrug resistance system
MRRIIIGTLLGGLFTILTACAAPAPAATPVPTAAPAAQPTAVPQPTTAPLTIELPNQPTI
SLGVTASGEVVARSSAELSFRIPGVVAEVFVNEGDTVQAGDPLVALDARELELQVAQAEA
SLAQARANYERLLEGATPEEIAAVRAQVAQAQAALRQARGSVTEADIAAAEAALAQAIAR
RNDLLDGPNNAELTAARAAVEQAEANLNIQRTNLSAAKSNAELQMLQAANALRDAQQAYS
DLYWENREREQQLAKFGLELPKEAKDAEEQLLRAVESAEARYKQTQLAYEQARQNEIDGI
AAAEAQLRSAQSNLQRLLDGPTADLIAAADAAVAQAQATLERLRGDQRAGALAAAQAGVA
AAQANLERITAPPTAQNLAAAEAAVKIAEAALAAAKLNLEKAVLRAPFAGVVAQVNVDPG
DLAGTGALPVVQIVDASELYVEAAISDTDIARVREGQKVEVRLDALPGTVFTGTLDFVAP
VANAVGNVRTFTVRVKLDRQEELRAGMSVRITILTDN
>fig|324602.4.peg.3438 Drug resistance transporter, EmrB/QacA family
MSDERRRNQILGLLFVGVLMAALDIAIVGPALPAIQRVFGVDERALSWVFSIYVLGNLVG
TPTIAALSDRFGRRALYVVSLSGFALGSLLVAIAPSFPMLLLGRLVQGVSAGGVIPVASA
VIGDTFPPERRGSALGLIGAVFGIAFLIGPIIGGLLLLIGWQWLFLINLPLAAVLIIFSL
RLLPGRTRQSAATFDLAGLIVLGLMLTGLAYGLTELDPARLSNGSLPLPAIGALIVAFAL
APIFIAIEQRAGEPILQPAIFRSRQIWITAVLAIGAGIAESAVVFVPALLTAAYGVSSST
ASFMLLPVVLAMAIGSPVSGRLLDRFGSRIVVSIGVALSGIGMLILSTWPTSLVAFYLAA
VVSGLGLAILLGAALRYILLNEVSANERAAAQGLLTVTMGSGQLLGAVLVGVLAATGGGA
VAGYALAFFVIGIVMLLLTPFALALKSRSAERATAMAHAH
>fig|324602.4.peg.3707 Permease of the drug/metabolite transporter (DMT) superfamily
MQQIDEQVIRQTPPAVSTEIEQPTPRKGSLAMSTIMLILIATTLGVIGQMMLKQGMGAMG
PLALTLETAPGIVWRIVTSPMVIGGLLVYGIGTFFWLVTLSRIDLSVAYPFVSLNHIIIF
LLAWLVLHEQVNPLRAAGVIVICAGMLMVARS
>fig|324602.4.peg.3748 Tetracycline resistance protein
MNPAYRTHLILSFLIDGAHVLIWTGFTIYQLTVVNMSPLQLVLVGSVLEITILLCEVPTG
VIADLISRRLSIMLGFTLTGGAYLLQALVPTFPIAVLGAVIWGVGITCVSGAYDAWLADE
LGQEHLGSALLRGEQVARVAALCGLAGSAILGSIALGLPVLVGGCLFIIGAAYCLIAMPE
THFRRAVDDERTTWHRMATTLRDGVRLVRRRPYLLRLLAVLFFFGLFSEAWDRLWQSHLV
LTFDLAALTPIAPIVLLAALIGIEMLLSIAAAEVLRRRLRSDDQRQTQRLVFGFTAVMVA
GLLIYGLAPHIGIAVIAFLGFSVARGLIGPLLSTWQNAQIDDSRVRATVLSLGGQSDALG
QLAGGLPLGAIGNRSLRAAFVTSAILLVPNLWLLRGRPTLAAVPVLEAAELVDGSTTN
>fig|324602.4.peg.3820 Chloramphenicol resistance protein
MITGTTTNLQTLSWFHVAMLVWMRWLISLVFRLVYPLLTFLAASFAVDLSTASLLITVQV
AASLLSPLGGVLSDRFGDRIVILWGGIIFVLGVAVCGVSSSFGLFLSGYALVGLAVAIAM
PALQSYVSARSHYSQRARLLGVLELSWALSALLGIPLVTWVAEQFGLAMVFAGLTVVGIA
TVALMTMLPNDERIHYTQFGGDTSAGVNPIQIVLKPVILAALSFIFVQMAAVELIFVSYA
GWLEYTFGATTTELGLVFGLLGVVELIGSLAATLFTDRIGKRRAVLGGFALVGVWLLLLP
QSTSWLTFLILLLAFDLCFEFAIVSTFPLISGLSAQGRGTVLAAMTASIGGGRILGSLVA
PWLSVTAGYAVNSTLAGILVLCGVGFGIIAMREGRA
>fig|325240.9.peg.688 Multidrug resistance protein A
MSKSKLIIAVPLLLAAVAGGGYYWWTQVRFIETTDNAYVEADISHISVKVPGYVVLSDVT
DNQHVQKGELLAQLEDNQFSAKVSQAEASLASSKADLQTLAAKVELQRALITQASAGVVA
AESDKIRAQQQLSRSKKLKVSNYSSQDDVDQLQAGFDSAAARLDEAKAVLVAKQRELAVF
NAQLDQAGSVVEQADATLELAKIQLNDTRVTAPFSGVIGKRGAMVGQYVQPGQALYSLVP
DGAVWITANFKETQIQHMQPGQSVLVSLDAFPDKTFIGVIDSLSPASGAKFSLLPAENAT
GNFTKIVQRIPVRIRLDLSEEEAHMLPGLSAVVKVDTASGTAISAIAANTGR
>fig|325240.9.peg.1170 Permease of the drug/metabolite transporter (DMT) superfamily
MKSHTPYMTFVCLLICVFSWGSVFPIAKRVLEEMSGESLVFWRFTIAAVTLALYIVFTRQ
AWPKLSLAQYIVIALVGVIGVGGLNLALFNGLQHTSAANGALIMALSPLVTSIVNALLQR
EWLSRQQVFSLVGGLAGVLLVITNGSVQQLLNFSFNQGDVMIAAGMLAWSGYTICSQRVG
HWLPVLPFTLLSMIAASVSMSVVGLGRGEFHPWQELMGLSTTAFSSVLYIGLFATVLGYL
FWINGVKALGPAKASVFFNLVPVFAALTALAMGQAVTEIQLVGMLIVILALMLPMLVNLR
ATRGLVVKRC
>fig|325240.9.peg.1643 Permease of the drug/metabolite transporter (DMT) superfamily
MQPLLMILAAQLLIASGNLLVKLLENDAPVFQLVLYRQLFATLLVLPFVWRLQGNLKLSP
YYKVHLARALLIGLGNAIFMLAILHLPLATVTAVIYTSPLLLLVLSALFLHERIGYRRSV
AGIIGFTGILLISQPTEFNLYIGLAFFGAMTSALNSLILKAYSTHEHPFSMLFWSNAFAM
IFLIPATLYEGADFSLPVAQVGLTLGLFYIGMTYLIIHAYRRADASQMAPVEYTGLIFAA
LFGWWILDEELSLVMLIGIGLVIFSSILPSYSELKAKWKSRRS
>fig|325240.9.peg.2223 Permeases of the drug/metabolite transporter (DMT) superfamily
MSHLTITKDKLMICLFFIIPPLLWSSNFIVGRAIRNDLSPVMITFSRWLIALMVILPFAH
KYLKRDFHQYLQYPIRVIATAVTGVLSFSILVYSGLHHTSSTNALLLNSCVPVFILLFSA
VVYKQPLNARQFFGLCLSFIGVLSIIFKGDLKGLLSLQLSQGDLLLLMAMISFAFYTLWL
KRIPYTVNRLGLLSIQIVITLLGTLPFVLWESYSGGSQQHWSNDIYLAVLFLGIGPSFIS
YLLFSRCVEAIGAERAGFSIHLIPIFGVILSLLFLVESIHWFHMVGSATILFGVGLSSMQ
SERNSRSCQ
>fig|325240.9.peg.2468 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPINLGELFVKHATANTFKPASINVEPSDIVPLAATETPSHGKYHSGSQSTESLGTLAIP
TLYLRFALPMAFAMMLSGSYNLVDSYFILKYIGADALAGVTIAFPLQMMIFALACMIGNG
TATLVSRFLGANEFDKASQIANTGFALALACGVIVTVVSLAQLDNLLAFIGVSSTLALAA
TEYLQPILCFSLFTFLLSLSGDLLRAQGKVVVMLLVILLSAVMNILFDTLFIAVLEMGVS
GAAWATVAGQCVSLFIAVVYFVPNNRFANKQALHRQAAQPICFRIEQIKLNLTEIKAILG
LGSPILLSYLGIACVISLVNHILVSHLANVVPNTPAANEVAYMISAYGLIGRFNIFIALP
LMALTSAAQTISAYNYGAMASSRVLACAKWGIVLTCCYLSVVTIIFMGFPTSVFGVFTDD
LALIAACVKISSVTFIALPLAGITGIAIAVYQGTNRPKLALLLSGIKIYGLLLPLLVLLP
QLSFADISFITGALNINIMRNALIELWMAFPIADILACLLSLLIISIWPFIHVPRANRVS
HGGNAK
>fig|325240.9.peg.3105 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MRLFCILSIYCLKLIHTPVNAATAMAKVIGLGGIFFKSADPVTLATWYKTHLQVPIENWG
GAAFYHTDKATLGYHVWTPFAHSTDYFAPSDKSFMFNFIVDDLAQALTQVEQGGGQLVGG
IEDSEFGRFGWFIDPDGNKVELWQPSVIPPEK
>fig|325240.9.peg.3533 Permease of the drug/metabolite transporter (DMT) superfamily
MAAVMYLLMIFVWGFSWIAIKWQHGEVATEVSIFYRFAIASLLMFAIGFAFNKLQAVKLR
QHPWFALQGVCLFCLNFIAFYTATHYIASGLTAVIMATAPIFNAIHGRIFYGTPTTRNFW
LGVSVGLGGIILLFGADLLATQWSQTLVWGLLFSLLGTWFFSIGNMISIRNSRDNVSPFT
STAYAMCYGSAALLLIIWFKGLSFSLPLTTSYLGSLFYLAVVASVIGFTAYLILVERIGA
NAAAYLLVITPVVALSVSSVFEDYHWTWYSSVGLLLVALGNMLTRRQRPLAWFKSSTTPA
LKA
>fig|326297.7.peg.940 Multidrug resistance efflux pump
MPQSANTSKKISTYLFVTVLGIWLYSLWADRVTPMTTQAFVHAYLVRITPEVAGNIVQVN
VDNDKRVEAGELLFEIDATQYQIAREKAQADLERVGQSLGASTAAVQVAQAKVGDARAAL
DNAKAQATRVETLAERGVLSQAELDNAREAAQRAQASLEAAQASLLQAKQNLGPVGENNP
ELKAAMAALAKAELDLKRTRVVAPSRGVVTNVQLSPGQYMAPGQPALTFIDPREVWISAM
MRENSLEHIREGGKVGLVFDALPGRVFEGVVDSIGWGSGGANNIDQTTGFETAQTGKQQA
KRFPVHIRFDTAPMANELRFGSQVTVAFYTGESSVGETLAQLWLWCWSKLTYVS
>fig|326297.7.peg.941 Permease of the drug/metabolite transporter (DMT) superfamily
MSPERTEGLRLWYFKGFSSRANPILRIAVAALVPLFVLHYLENPLPMLVSVFAVIMLTLM
PGRPSLQVLSKLSMVVVAAAMVQHAAGILLSGTGTGSWMFLFAVLFYSLSRIHLNPKDIV
GTMMMILGIMVTILHWQFATTVSDLPLVLAANFVGAIVMVYLVFWLFPGEELGAEADTAW
EVTPSHWLKIVVKSLFLLLVIFLLIDSDNSQSLLIAITLANLIKDPNPMAGTHNGRQRLW
TTAVGVLLTLPLLLAFWLDMHWWLLMLFAIALALWGSATALEHRVSMAEYQLLMSSFVML
VYQVISHDGTSSLTSSLTRFGAVVLAVLLGVMMLGMLSELGVTRTGSRVAKPSNVGQD
>fig|326297.7.peg.1034 Permease of the drug/metabolite transporter (DMT) superfamily
MALGAWLKLLLLSAIWGASFLFIRIGVTELGPAWLMFLRVTFAALFLLGGAIYLKKALIG
SAPLKHFIILGGINTALPFLLYGFAATELAASLMSVLNATAPLWSTLLLAIWQRSMPRGA
ALGGLITGFCGVVLLAGVESLSLSEEGLWALAAGLGAAICYAFASIYTKASNHGNAYSNA
HGCMWAASAWLLPTLLFAAPPEAMPSSGTLAAVVTLGVLCSGVAYLLYFRLIDEVGATSA
LTVTFLIPVFGILWGALFLGEHIGWHTLVGTAIILLGTAISTGSIPRLRRLAGERI
>fig|326297.7.peg.1682 Multidrug resistance transporter, Bcr/CflA family
MISNSLTKRRSLVFFPYLALLSMLGFLATDMYLPAFNQIESSLNTSASLVAMTLTCFLGG
LAIGQLAYGSLCDKFGKRNTLMAGLGVFAVSSILLGFTENISVFFVLRVIQAFGACSAAV
IWQALVMEKFDEGEARKVFSSIMPLVALSPALAPLMGAWVSEQFGWRAIFIILAIVGLLL
AAMTPALAKESRTRSQSEPILVKNILKNRAFQNNVAIFGACSAAFFCYLTLWPAVMQHHG
YAAAEIGLSFIPQTLAFMLGGFACKKALHSHSPEAIKNMLITGFVVLSLVLFLLTQLGAG
ILAVLWVFAALAAINGAVYPLLVTDALAPFSNNATKAAGWQNFLQLGMAFIASAAVALIA
HWFEKAIGTGILVCAAIVLVAWWRMNWSTWRGSWCFPDPARMGVLRTEKREHSDNDTKTH
GVCNVSSQQKDTD
>fig|326297.7.peg.1902 Gentamicin resistance protein
MSLPVNRYCVNNHKGPELYQLSDTLTDWIVETIGEPVLTVELNNQGWSNLVLEINGRWIV
RLPKRLTDSEGNSLTNRYLMEKQLLETLSLAIDKDTSSHLSAAILPNVHLAPRHVADCML
YRKLQGSPLDWQSEQLSTLNNHMCTSLAASIGALLAKLHATELAHPQLVAFPYGDEDFVG
SVLPALRPLVDADSYKNAQTYFITMLETVATQAEFSSRLCHGDFGPANILLGRDYQLTGV
LDFSDVCLGDPAMDFAPLWRRSPSEFMHDLFSAYRHTSGEDHWQSLQPQTLNHRIQFHAL
RKAAFVVWYGTRYGFEDGITGSLVFLEEYFKSP
>fig|326298.3.peg.200 Acriflavin resistance protein
MFERVLKFFIENYKINYTLFFLLFAAGIYAYSQIPKEISPSIEPNSVTIHGSYAGASVDI
LNKMAVQEIEDEVKNIVGVDSVTSVVSPGRFTIVLEFDKRVDKATIIRDAEDAIALIKPN
LPSDMDDPVIRGVAHSRSIMHVSIISSKISRDKLKLLSKKLKSNLLSVKDISDVTIFGDS
DLFYEVLIDEKKVNAYNLSLDEILRVFSELSYIFPLGKIDNVKEQYYISTQNDKKLSCEL
ENTIININDQQIVLKDIAKIEKKYEDSSTLASMNGEDSITLAISQNPKGDAIRIADDVKK
LISEMSVDDVDFNIRMDNSIVIRDRLNIVISNILFGLILITLLTAVLINIRIALIIALGI
PTSFVMGAIYFYFTAYSINVNSLIGVLIAIGILVDDAIVVSENIQQYIEKGYSAKEAALL
GTQEVAKAVTIASLTTLFSFIPLLMLSGKLGEIIQLIPIAFSALVIASLIESFIFLPIHA
AHTLSSNSKTMSWEKINLLYLRALKKLVGYQKSFLLIFLIIVPALIYYGVKHSKFQMFQP
FDTSSINITFKAKPTTTLEQSLEIVQTLEKNILKEKDRFFVKHVSSTAGYRRSATGTTEI
YPYVGYISIELHNMKPENFVDKYITPYLSFYYDSKDRIRDKSSQDISKDIREWLKEQDYQ
ERFNLNNLMVVENSMGQTKADIRIGVISDDYKKALSAIREIEDGFSKIDGIKYFGDDVKV
GTQEIKLKLNSYAEELGITEKYLGTYISGLFLSRKVGTIFDGKELLDIKVKSFYIKDDLE
SFAELEIPIKNRGHVKLKDICEFEKVESLENLVKDDGETNFYVFANVDPSIITATEVLQM
MNPLIDKLKNTQDIRLKFKGEKEQKETMQTEMILASILAIILIFISILYLFNSLRETLIV
MSVIPFSILGVYIGHFIMGLNISLPSLIGALGLAGVIVNDGILMMATIKRAKTKEEIFIL
APKRFRPIILTSVTTIVGLCSLIFFATAEAVTFQPLAVAMGFGLLWGTILNLFYLPVTYN
FLHGYKNYNKRSKIFKTFE
>fig|326298.3.peg.1218 Acriflavin resistance protein
MFKKFQDTVFEGIQNPKKRNFILIATFIAFVLSVLMIAPSKMVLAKMLPGKNNDTFTIYA
TLSEGSSIEQTSRVSECVAKYLKNEKEITDFEIFLGMGAPLDFAGLIKGSHFKNSENVSE
IVVNLTKKHHRDEPSYFMVQRIRPEIQNNCTKLYEKTTITFVEPPAGPPVLAAIVAEVYG
QDSDGVRLLSNRVKEVFEKTSGLVDIEVMQDEIYDTFEVEVDSTKVSLSGVNIKQLNDVL
YLAFEGMQIAVKNSSTINDQIPIYLSLSKESKKFSSKDINDIKAKLSSLKLMNQMGMMTP
LTELVTIVPKKSNPMIMSKNLHKMTNVMAETDMVSQVYPLMEARNTILDTFNDKYEIEKI
GLFNLRLVDKASKDVYELIWDGEMEVTLDTFVELGAAFIAALVLIFLLMVIYYKSYALSG
IILLGSFLSIIGVIVGHYIMDIFTADTFFLTATSLIGFIALIGISSRNSLLLIDFTASLM
RDSKMKKAEAIAYATATRAKPIFLTAAAIILASTLLAGDAVFGGLGVALIFGTIAAVIAS
LIIVPILLYKSDLNRHFNLDEI
>fig|326424.13.peg.817 Glyoxalase/bleomycin resistance protein/dioxygenase
MDPPPAGAPFTGLGAVEAALAGLTFHHFAIVVTDLELARELYTVSLGIDSWHTRALSGPA
VYRGRPVALDGARVAIGRLGAGLVELIAPGCQPSAARETLDRRGEGLFAIGYLVDDVAAQ
LRVPVSAGARIEQVRPDARHPVEACLDAGSGLLVDLVQSGSSWPV
>fig|326424.13.peg.1124 Glyoxalase/bleomycin resistance protein/dioxygenase
MAVLRIVADLPSRSLPAARRFYAAVLGLEPIMDHGWVVTLSDPDRPGPQLTLLTHDLTAP
AVPAVSVEVDDVDAAHAAALAAGAGIVHPLTDEPWGVRRFFVRDPDGNVVNVLGHARA
>fig|326424.13.peg.1243 Glyoxalase/bleomycin resistance protein/dioxygenase
MEIKELGHLVLYVRNIERSVAFYRDVLGWRQVFPDPAASADGPLRVPAAGFSAGRTHHEL
LLIEVGEDAAAVPAGRRIGLYHFGLKVGDTDDELREVLARIREAGVDIVGASDHTITHSL
YILDPDGNEIELYIDVAGVDWQSQPHLIAAPIRPLRL
>fig|326424.13.peg.1439 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDISPIPDDYPRLCPYLCVDGAAAAIEFYASVLGATERMRLAGPGGTVAHAELALGDSV
LMLSDEFPEMGAVSPASVGGSPVTISLYVEDVDATYDRALAAGATAVRPVADQFYGDRSG
QFTDPFGHRWSIASRVEQVPPQEMAARMSAMGGD
>fig|326424.13.peg.2156 Tetracenomycin C resistance and export protein
MIMVGLDGTVVSIANPRIAEDLHASLSDLQWVTNAYLLALAVLLIPAGKLGDRFGRRLIF
LIGVVGFALTSLAVGLVGSIEGVIIFRTLQGVAGALLMPNTLAILRSAFPPEKLNSAIGI
WGGASAISIAGGPIIGGLLVEHVSWESVFYINVPVGAIALIVGLFVLAESRDESGSQRFD
APGLLTLGGGLFALVFGMIKAQGWGWGSGRTIGFLVAAVVLLVLFVVIETRVRAPLLPMR
LFRNRSLSLSTLIVTLTFFAMFGVLFFLTLYLQNVHGYSAVQAGVRTLPLSAVFMVSSPL
GAALNGRFGPRVPITIGMALMLASFVVLTQLEPDSSFNLLWPPFVAVGVGVGLIITAASD
AIIGNAPIEDSGVAGGLQSTATQLGGVLGTAVLGSVLASRVGSVLVDRLVGAGVPAEQAG
RLAQAKELVGQGLVPPATGSSASVQGAIEAGSHAAFMSGLHVAMVIGAVLSGVAMVLALF
IRPGQNAGNAVAHV
>fig|326424.13.peg.3510 Drug resistance transporter EmrB/QacA subfamily
MRTGPALVALAGAALLAVLDGTVVAVALDPLAHAFSAPLTTVVWVTIAYLLAAATALPLL
GWASARFGGRTVFLTGLGLFLLGSLLCTAARSPGMLIGFRALQGFGGGLLEPSAMTLSAA
LATRESMGRVLGVMSTVVNVAPAAGPILGGLLLETGHWQWLFGVNIPLGLLVGAATLAYV
PAGRPDPAAARPGADLRGLALLTAGYLGVLFAVNRAGEQSGDWPVPAAAAGGIVLLVAYV
RHAVTTTAVPALDLRLLRRPGFAASVAVMGLVGLIMYGQTTALPVVGLDQHGLHGFDQGL
LVCALGLGLLVSMTTGGRLSDRLGARSLVRSGAVASAVLLATFAASAEHLPLAAACALFV
AVGLSFGLTASPTVASLYRTLPPAEQPQGTTSIFMAVQFAASLGVALLSLLQARAGADWV
TALFALFAGAAAGIGLLAARLPGRPG
>fig|326424.13.peg.3766 Drug resistance transporter, EmrB/QacA subfamily
MTTATSPQGAATAAPPGGSGLALTAIVGAEFMLQVDGMIVNVALPDTQSDLGLSTTSASW
VLNGFFLAFGGLLLLSGRLGDVFGHRRLFLLGIGLVAGASLLAGLAPNFGVLLTGRVLQG
AGAALAGPTGLALLSMVFQGERQQRAFGLYSTITGLGAATGLILGGILTGGLGSWRWCLL
VNVPFGLIILVIALRSLGTAADGARSRSLSLPSAALVTAGLTALVYGLVQAADRGWGDLW
TVVPLAITVVVAAALLVVDRRAPEPLLPGRIFTNRTRVGGFINLLLLSSVLGGFVFYLSQ
YLQTTLDYGALRTGLAILPFGLALLVTTQLLTKWLSGLGLTTRGTIGLALLALGVAWFIR
LDADSAYAEGVLPGLVVMGLGVGLAIIPLNMIILSTSRPEDVGITAGILQAALTVGGSIG
LAVLLIPFNAGGRPVAENISTVFTWATVDCVAGFVVAVLFWFGPGLRPSATRTSSPEATA
PEPPAPREPAAVESRS
>fig|326424.13.peg.4835 Glyoxalase/bleomycin resistance protein/dioxygenase
MTRDAAATTDFYSTVMRMELVAAVMHERVPSTGDTMPYLHIFFRMQDGSTVAFFEVPDLP
AAAAPSHPAHDVFRHIALEVPTTDMVDEWREWVRGHGVDVLGPVDHTIIYSIYFHDPDGN
RLEITTPLVADWNDRPIQARRALEAWTATKERARRDGTEVSAALHELVVTSEPTTFD
>fig|326424.13.peg.5651 Drug resistance transporter, Bcr/CflA family
MTQTVPVTSAGIVDQSEVDQSEVDQSEVDQPDAGQSDADRGRITITTMVLLGAMTGLGPF
SMSVHLPGLPRMADDLATSQSSVQLTMTACVVGIAVGQVVAGPLSDAYGRRRPLLVAMAL
YCATSAVCAAAWTVPMLAGLRFAQGMFAAFGMTIARAVIRDVADGQRLVRLFARMALVSG
LTPIIAPNLGSALLVVTDWRGIFVVLAALGALFAALSVGSLRETLPPARRTRLRPASTAR
TYAALATDGAFLAPSLVVGLAYGAMFSYVSSSSFVLSDAYGVSQTVFGVLFAANAVGFMA
GGQLGAALAGRRGTIRALRITLPAAATAAAGITLAALAGSGPAVVGTLFLTVASIGACMP
IASAEAMRTRPDSSGTASGLLGLTQFALGGLIGPIVGAFGSTSALPLGIGMCLCLLAAFA
LCLRPAAPRPTPSPAA
>fig|326424.13.peg.5769 Drug resistance transporter EmrB/QacA subfamily
MSGGTVSVEASVEGGRGAVGTAPSAPRAKWAVLAVCCLAQFMVVLDISIVNVALPAMQTD
LGMSASGLQWVVNAYTLAFAGLLLFGGRAADLFGRRRVFVFGLVLFTLASLAGGLAQSET
QLIIARAVQGLGGAVLAPATLSLLMTSFAEGRERTRALGAWGATAASGGAFGTVVGGILT
DVADWRWVLFVNVPIGVALVVAARVVLVESRGQVSRVRDLDLPGTLTVTGGLVLLVYAIV
RTETSSWSSPLTIGLLAAAVVLLGAFVAIEATTANPLVPLNIFRYPGIAVANVVAALLGA
AMFAVFFFLTLFLQRVENYSPLRAGLSMLPMPLMIIVASQLVTRTIGRLGARPIVMFGAA
VGSSGLLWLSAITPGGSYWTHVFGPLAVMGFGMGTTMVSMVSAATAGVPIRLAGLASGLI
NTGRQIGAAVGLAAVTTIATHHTEGRLRHGIGQPEALTSGYALGLFIGGCVFAVGVPVAF
LLPRLRRPEPAAAGSSPSAQLTAESATATADTVTADTVTADSDDEQAVARTAEV
>fig|326424.13.peg.6109 Permease of the drug/metabolite transporter (DMT) superfamily
MRQNHVYLVDTYHFVVETEVRWDMPSSTPDSASRRRTAVRSLAADVGGLAASRPAPTGRA
PTAPAPPVAAEHGRTAWLADLGVLGVAVVWGSTYVAMQWSGRFISVPAFLFLRFAMGAST
IVVLAPRAWRGLTRQEMSIGALFGCLLFGILYLETLGVRHTLASNAGFLISLSVILVPLI
ERTFLRARIARVTYPLTLVSLAGCALLTLDRGFTVRGGDLIILGAALIRAVQIVLFSSQS
KGRDISLLRVTGVELWVVACGGLLVSLFRPGRSVHEATHLPGEAWLVIAYLGVAGTAFAF
LTQLYAARASSPTRVGLMMSTEPFFAAVFAVVLLSENLGPTQLTGGGLVLLSAYLGRWAD
ARRLASRPESPAAAPVPPEGATRRGPLRRSYGTDPRT
>fig|326426.4.peg.87 Permease of the drug/metabolite transporter (DMT) superfamily
MHMADDARNASGTPAPTASHAGHSGGHVVSSRATAVGLMAIVLWSFMTGTVRIVAESFGA
TLGSALIYTVGGVLLLVFRRPAPIREFPKKYLIIGGLLFVFYESSISLSLGLASTAASSV
EVSLVNYLWPTMMVLLAAGVSRRRHAVWKVLPGAIVATVGVALAVGGNSGLDWQAAAGHI
ADNPLPYVLAFAGALAWSVYAVFTPAWSHGVDGTSVFFPCVAVALWIIHFASGQGWPAEP
PSLVAWLFVFIAAAAIGGGYACWGYGILHGSMERLAIASYATPVLSTGASAVLLGLALSL
PFWCGALLVAAGSVLNYLVSARRSDPTT
>fig|326426.4.peg.92 5-nitroimidazole antibiotic resistance protein
MSMENIAGARKPAKREDERTVAGEHRMMRRADREVTDPEQIAAIIAACDIVEVAYADAEG
LAIVPLNFGFDYEYDEADGVAATALVNGAETVGSTGVVAADEVGCPGKLTLWFHSAPHGR
KLDAIRAAAGGRLPVAFTMQADCEVVAGRATCNWGEAFKSIVGNGEASLVKDLGECRHGL
QALMAQQAHMPHVEFTDAQVRSVTVWKIEVDYFTTKVRAKPAPAHIHQRPAVPRAGVIGA
R
>fig|326426.4.peg.672 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVQVHGMRRASADAKYQQMTGQPVKPLILKLCLPAVISNLVTTAYNLTDTFFIGQLGTAQ
SGAIGIAFSIMTVMQALGFFFGNGAGNSMSRELGKQNNERASRLLAVGFAGAVISGLVIA
AIGLLILRPLVVMLGSTSTIAPYAVQYLTPLLVAAPCVCGSFALNGLLRYQGQSAFGMIG
LVSGALLNFLLAPLFIFVAGLGIFGAGLATAICQTVSFAILTTMSRKFGVMKLSLRNCKP
DVLLMREVAGGGLPSLIRQGAGSISVTCVNIAANPFGDAAIAGMAIVMRIMLGANSVIVG
LGQGFQPVCGYNYGAGLFARVKEGYWFCVRLATCVLVALAVLLWVFAPQLVEIFRSDPAV
VAVGVAALHIQCCTVILNGFNMMGNMMTQTMGRTGIASFLALCRQGLFLAPIVLILPMTF
GVLGVEMAQSVSDVLTFLVTIPFMRRILHELR
>fig|326426.4.peg.887 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKTIKTVRGNPLAAEPLGRLLIKFAIPSVLSMLVDALYNIVDQIFIGRGVGYLGIAAAT
VTFPFVTILLSIATLLGIGGSVYTSMNLGAGKEAEAEKTLGTVFTLSVAIGILFTVICLT
FLKPLALAFGATKGAQGSLSYVLDYVPIILLGAPFSMAAIALSSMARACGSPILAMGCFL
VGAVINLVLDPIYIFVFNWGVKGAAIATVTSQIMSAVILLVYFLKKGHIRLRRKNICPTL
PICGQIFAFGLPSCMIQVAVTILQIELNKAVVSCEMAGVGSEAALSSLGIVLRISSVVVA
ICVGIALGMQPIIGFNKGAGFEHRVKETYKKAVGAATVVSVIGWLICELFPAEILQIFGM
NEPASMAFGIKCMRISLFGLAFTGFQVVSAQYYLAAGQAVKAMLLSILRPLLLMVPLIHI
FSGIWGMDGILYAGPTADILTALIAAGLVGYDSRKKRKGV
>fig|326426.4.peg.905 Multidrug resistance protein B, MFS member, bile efflux, induced upon bile salt exposure
MTSQKNAEFGSAASSVKPIDPHTRFIVVGVIVVGSFIALLNQTVMSPALPALMRDFNIAT
GTVQWVTSVYMLVSGIMVPISGYLIDKFSTRKLFAGALATFMVGTLLCAVAPNFMLLLVG
RILQSAGSGVLLPLVAVVPMLVYPPDKRGTAMGMAGIVMAAGPAIGPVVGGLVIDSFGWR
PMFIGIAVVALVILVGGTMMLKNVGELKNPKLNILSVILSTIAFGGLLYGFSSASTMGWA
SPVVITSIVVGLVAFVAFVYKQVKLDEPLLRVDTLATRNFRNSAILVTLINAAVAATNVT
LPIFIQNVLGQSATVTGMVMLPAAAVGIIMSPVAGAAFDKFGPRGVGIGGLALMTISLGL
LGTINTRTSVLFVAVFCALQASGQAIANMPINTWGVNALPNDMIAHGNAIANTGRQIAAA
IATSLLVTAETSVTASHMSQGVKSATARGIAFSYLLCAAISLIALIICIFTVTSRAKEKA
ARNAKAYEAQASAEVAAETTEGQPAEHHYAGAYVAPAASLFKQAQEQSIGGIMDDQPYSC
LDSDDITHVVREFIRLNVSSLPVVNGDGRLVGFVSDGDVLKSIATYESRTVSTGTGSTMV
VFDDETVASKVQALSGKKVMDIATRKVVTATPDQHVGEVARILAKKQFKKLPVVNGDGRL
VGVIRRKSVMEHAFDALFPKDDR
>fig|326426.4.peg.1154 Transporter, drug/metabolite exporter family
MGNLRAPRSARGRVMAAAGMVMVGSLGIQTSSSLSASLFGALGPIPVGSMRMLVAAIVIL
ALTRPKLAGRSKGEWLGIVVYGLAMAAMNVCLYSAIDRIPMGVAVTLEFLGPCVVALAGS
HHWREGLCAVVALVGVGLISFTPGGYFNPAGYLFALGSAVCFGLYTLFADRVGKAGTGLD
GLALSVTVAALATSPVSITRAPHVSAAQWGVIAASAVLGVAIPYTMDTLSGRITSARVVG
TLFSIDPAMSVIIAALILRQTITAVAVIGVIVVSLVGALLVWSSGGDAVNG
>fig|326426.4.peg.1223 Permease of the drug/metabolite transporter (DMT) superfamily
MGLVERCNRLRSRWSRTFPPNLARLMLLACAALWGGSYLLAKFAMTAIPAQWLMALRMFG
ACMCMLALFHKHIVPHLTPKIIVPALVVGLTYWGTMITQTIGLQTIEPGRSAFLTAAYCV
ITPFATWIISKTKPRAINLVAGVICLTGVGFVSLKPGGSLSLSSGDWLTIATAVIFSFNL
TCLGVYTKRFDPIAVTFVQFSVAGILFFIGALATEPAPDAGWLAPPVVASVLYLFLGATM
SAQIMQNIGLAHVPASQASIIMCTESLFAVSFSALFWGERILWSSLVGFALIFAAVLMSV
IKPTKYSLHRN
>fig|326426.4.peg.1282 Permease of the drug/metabolite transporter (DMT) superfamily
MKRQELVGMLCLLLTALIWGFAFVAQVQGMDSMSPMFFNATRFTLGALSLVPILLWQRGR
GSSSTSEAADTAAVGAGDQLVQTSSPAIRLLANPIIISVICGIVLFTASTLQQYGILYGK
SAGRAGFLTAMYIVMVPLLAFVFLRRRIGVLVFAAVALSIAGFYSLCITDGFGSIGLADI
LLVFTAVLFAVHILVIDTLGAKVDAIKLSFGQFCTTAVLSWTGSLIEGSVDWAGAAHSWI
PILYAGFGSVGIAYTLQVVGQQWVPPTRASLLMSLESFFSAVGGALLLGEVMTPRGYLGC
ALIFIGTLLAQAPAKLPKFLRKD
>fig|326426.4.peg.1815 Permease of the drug/metabolite transporter (DMT) superfamily
MKRGMAIAGLIVVTAIWGGGFVASDIALNSLTPMQIMAIRFLLGAVLMSLISVREFRNIN
IKEIGAGVLMGIALFAAFALQIIGLQYTTPSKNAFLTALNVVMVPFIAFLVLRKRIGWRG
VLGACLSVVGVAVLSLNGNMTLGLGDALSLLCAVGFAFQIFFTGLFVQRYRATILNCVQM
VTAFVLSVVVMVAMGQVHLTPTTDGWWSVLYLGAVSTTICYLLQTACQQYVDETKAAIIL
SMESVFGTLFSILLLGEVVTPRMIVGCAIILVAVVISNLAASSEDEQPADTPVPEPSGEV
SG
>fig|326426.4.peg.1821 Multiple antibiotic transport protein marC
MASFATLTADLSKKELRCQARYTSLYVFAILAAFTILGSFILDMFRLELPAIQIAGGFVV
AHSGYRMLVPTSDHGDPEAHQDNDIAFTPMALPLIAGPGAIGEVIGLSARYTEPRERLAI
LIAVLVISIVIMALLRWCTPLVHKLGPDGILGLTRIMGFIILCIGVELMIHGVSTLAIGL
>fig|326442.4.peg.603 Permease of the drug/metabolite transporter (DMT) superfamily
MLGSDFIQLCKLPAMPASLCLIIATFLWGSSFIALKYAIAIYDPALVIFLRMLTTLFLSL
CLWRYVIRFEYRVGDWKYLIAMSLAEPCLYFLFEGHAMEYTSASQAGVIVSCLPIIIAVL
AFFMLKEYISKSIIIGFTFCIGGSILLTVLSPNSDQAPNPLLGNFLELMAMVCAAFYTVC
IKHLASRYSPLTLIALQGISGSLFFAPFLLFIDLPSENQHNITALLSILYLGSFVTLGGY
GMYNYAISKVSVLTAAAYSNLIPIFTLILSAIILNEVLNLWQWLSIFVVFVGVMISQRHQ
ELVVDIPSAESGEDISTDLTTSDIISAETNSLNSVPDANASKG
>fig|326442.4.peg.1424 Drug resistance transporter Bcr/CflA subfamily
MQTQPAKPNLTLLLILALLVIFCPMAIDIYLPAFPTIAEQFAVSEQQVQQSVAIFMLTVG
LGQLIAGPLADKFGRKPVAVIGISLYAGSALLAYYAPSFNILLLARALQGLGACATFVVA
FAIVRDKYGAQRSGQMITYLNGIICFIPALAPILGAWLTVQFGWRMNFLFLTFFAIFGLV
ITLLFFKETRPADSYYQGHILDLRRFMPIISTPIFLFNSLLCMVAMSAILVYVTLAPGWL
ITHLGGTVADFTFWFTLNAVCSIVASFIAPMYIKNNSQRALRLGVGLLIFSGLLMLALST
IQTALALMLPMLIAALGFALSLGSAAGMALSRFAKQAGTASALLGAMQMSGASILVFATQ
FLGLTTPWLIAFHLLLLLPLWLILISKKGHALHPTQG
>fig|326442.4.peg.3412 Acriflavin resistance protein
MDLAKWTINNKLISTIIIILTLGFGFSSYKNMARFEDPEFIIRTAQVFVPYSGASPLEVA
REVTEPLERAIQELQEIDTISSTSSSGMSEIKVEIKSEFSPTKSELQIIWTKLRNKINDA
RPSLPPGTGTPQIFDDFGDVYGLSYLITAEGYSPDELHAYAKNLQSDILQVKGVAKVAMT
GVQQEGIFVEIAREDLATLGSSISNIYSILDKQNTVISAGNTQIGDQRIFIDPTGSINSI
ETIQNLLVSATNDGKAIYLKDIANVYRGFQSPATKLVRYNGQPAISLGVASVLGTNVVKV
FERVDERVKQAENVRPIGITVHEYYHQGKVVQASVDNFVVNVIVALIIVVVTLLVFMGLR
SGLVIGAVLLLTIFATLATMDFSGIPMHRISLGALIIALGMMVDNAIVVTEGILVGTKQG
RKKLEIASEVVKQTRWPLLGGTLVGIVAFAPIGLAPGDTAEFTGHLFWVILISLLYSWLF
AITLTPLFCFCLFKEQDKDTSTTAKPNMIMAAYQSIVVSSLNHRWLTVAVVIFTFSASMW
GFQFVKSGFFPASTTPQMVVDFWLPQGTDIEKTKKDMIKLESFIQQQESIEGVQTLIGGG
GLRFMLIYGAESPNSSYGQILAKVDDYKVLDTMIPKVQAYIDDTFPEAQGKVWRFVMGPG
GGSKIEATFKGPEPAVIRELADKAKAIMIDDGGALSIKDTWRQQVRVIEPQYSPINAQRA
GVTRKAIAEALQQNFSGKTVGQYREGEELIPIIVRAPLKERSNVNDIGNIQIPSQITGKT
IPLEQVTNGFKTVWRDGILKREDRMWTIKAQADPLPGQLASELFNRVRPQIEAIDLPAGY
TLEWDGEYGQSKESNEMLASTLPLGLLAMVLIVVVLFNALKQPIIIWLVVPLALIGVVFG
LVTTQTPLEFMGILGLLSLSGLLIKNAIVLVDQMDMEIKQGKPRYDAIVDSANSRVRPVM
MGTLTTVLGVIPLYFDAFFQSMAVVLVFGLLFATLLTLIVIPVLYAIFMGVKKDERTPVN
A
>fig|329726.14.peg.566 Permease of the drug/metabolite transporter (DMT) superfamily
MSVHNFLKLLLLAAIWGSSFLFTRIAAPEWGPIWLIELRVLIASLTLLPLVFKLDLWPQI
QRQWRPLLLLGILNSALPFSLLAYASLSLSSGFTAILNATTPLFGLWIVVLWLQEKLSVP
RLVGFAVGFLGVVFLVGWQDIPLTFNQGIAIAAGLLAALLYAIAAPYIQQQFAGVPALAV
TTGSQLSAAVSLVPLLPFSIPSQIPSSKAILSVLALGILSSVLAQMLYFHLIKVMGPSKT
LTVAYLIPLFAMLWGALALGEIVTTSMGVGCGLVLLGTAIANDLFTPTKNS
>fig|329726.14.peg.1093 Glyoxalase/bleomycin resistance protein/dioxygenase
MTNSAATQGAHHIGLTVPDLQQTRTFFVDTLGFKQVGEKPDYPAVFVSDGTIMITLWQAV
NPEQATPFDRKNVIGLHHFALKMESLTVLNELHQTLTQTPDVEIEFAPESLGGSPMHHMM
CYIPGGIRMEFIAAG
>fig|329726.14.peg.1590 Permease of the drug/metabolite transporter (DMT) superfamily
MVPVFGVVPALWTLSRRDSDRKQREVSRVATLIGLAWLIGTLLLTSGVAVTSGENAQSMG
ISQLLFNSLFTSSYFLSNLWLMVRVWRRQSLDLPGLKRITKYLP
>fig|329726.14.peg.2378 Vancomycin B-type resistance protein VanW
MTASSWRTPLRLLKCRLRQSLKEMRRGYGPQYAQQQAPINSSRFNHLWSQCQTPIKQRSS
ANNLHQNRLINMSLAAQFVDGLILQPQQIFGFWRRIPQPTIQNGFRAGPMLIRGQLTTDA
GGGLCQISTTLFGAFLAGNLEILERSNHSVDTYGDDRFFTLGQDAAVVYGYKDLVVRNLH
PVPLQLRLQIDQAQLTATASLWGPTPISDTISLNSEVIQSLPAPPDGIPGWRVRTQRWVQ
PPESPKILTYQTEDTYHPYPL
>fig|329726.14.peg.2733 Glyoxalase/bleomycin resistance protein/dioxygenase
MDYKPAGFHTMTSNATYRDTKAAIELYEQAFGLAVDTLLETPDGTVMHVSATIGDSHLFM
SDEFEGSPRQAPGPKSPVAFYLYLPDVDASYQKAIDAGLTSVSEPEDMFWGDRTATVADP
FGYAWTLATQVKEVLPQDAIAIFNQMMAKAS
>fig|329726.14.peg.2955 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MLAAIVALSLAAIFIKLSERELGPFATIFNRFWVAYIVLWVWHEWESLRGSKEAVKEIEY
TQRDQGLLVAAALMFWGCIALWAWSLTRTEVANSTLLHNLTPLFTTLGGWLLLQQRFDRR
FVVGLVVAIIGAVALSVGDFQVSTSHLTGDLASLLSAVFSAANLMIIERLRAKFSVNTIL
QWCCFWGAIWTLPVVLLTEDRLFPVSASGWLSVICLAIVCQVLGQGLQAFSLKRLSSGLV
GILLLLDPVLAALTAWVLFAESLTLLKWTAFFVVLLGVYLAKSSDAATHPVEEGA
>fig|329726.14.peg.3842 Permease of the drug/metabolite transporter (DMT) superfamily
MPSLSFSAINPKLALVISRALAALRPSLIAFLVANAMLLSGGTQTPISFCNVLFVGNLCA
ALAVGTWFGWRSLIQDWRSLDRRIQVGLFLNGGLAALLSSLIFVGLAYTSVTNAVLLGRL
GPVIYALVGTLILGRKIKRFEWIGFSLIIAGVLAIVLKTSNFEINQGDLFILLSALVYAA
SSTLGKLMLSQQTNLRIVVFSRNLISAIIFFVIANLVFGPEHFMDVLAGQLWIVMVVYAL
IIIVLAQFLWYSALEQLNSQTVGKWTALSPVFGVTYAFVLNGERPSLAQVLAFLVIMAGI
CITSFNRQSSRPMETNEMADGAESCMSTS
>fig|329726.14.peg.3938 Vancomycin B-type resistance protein VanW
MPVNYLQQPQPQQRTRLRLLLGRQYYIQKRKWEWQFSGTKFAVPKGANRLPITVFSHQSF
LLRQLKDVDMWLQHNKVTNLQLAINCINPVIIYPGEVFSFWYLVGNPTKRRGFKLGMTLN
NGQVKSGYGGGLCQLANLIYWMALHSPLTIKERWRHSYDVFPDLNRSLPFGSGATVAYNY
IDLQLENNTHQPFQLCLWLTDTDLCGELRSDTKCPYHYDVLERNHQITGPVAGRYMRHNQ
IFRKKRHVLTDEVFPDEFITENHALMMYSPLLSSGDEEASSSKSSAHS
>fig|329726.14.peg.4888 Permeases of the drug/metabolite transporter (DMT) superfamily
MITKDLERPQQTLETLERPADPQVLEALYEQPASQTASILPFAALLAAVCILSCSAIFTR
LSEEELTASATIFNRFWIASLALGMWSGFQQFRQPPAETDQTSQSIQIRDLLWFGCLGIL
IYGRAGSWAWSLTQTSVANSNLLHNMTPLFATLGGWLFLGHRFNRQFLMGMSLAITGVLI
IGVGDFQVGTSGLVGDGAALLSAVFYAANFLVIEKLRTRFTTTTIMLSSCVVTGLLTIPV
VLVGGNQLFPTSTTVWLAVIALGVISQGLGQGLLAYCLKQFTSGFVSVFMLMEPLITALL
AWKVFGEQLNVLNWVAFFIILTGLYLATISKGAAKSRPIH
>fig|329726.14.peg.5381 Quaternary ammonium compound-resistance protein
MKVFGEITSFHPDALGQLVGYLFTSPWIGLGVVTLTISMLIYLVSLTRLDMSFVLPMHAF
SYVLNALMAWLILKEPVSLARWLAAIFISLGVFIVGWSKRIDDRKAQLQQDADPNIKSSW
MLLLPLSFYLPKMWLGVLVLVLADCTADILVARGVKKIGKFSARSLTSILQWLKSVFVNP
GVLIGVASYTVSFLMFISLLSWADISLVRPATGLGYIINLCGAHFILKEHISSGRLAGII
VIGWGVGIISLTG
>fig|329726.14.peg.6029 Acriflavin resistance protein
MWTHFYRNTRLLILTICIILVWGLSSFHVLPRMEDPAISQWTGKITTRFPSASATRVDSL
VTEKLEQKLQEVEEIKFIESTSQLGTSLIFIVLKDTVKNHDEVWSSIRDRIADITPQLPS
GVLAPKYEDMNDGRGYTLIVALTWELDTPPNYAILNRLSENLKQQLRGIGGIEEIEFWGA
PSEEILVEINPVVLGKLGITPQQLAQQIRLSDAKVSSGRLLSPNNDLLLEVNSEIDSLER
IRQIPIRTDKNSEQLIPLGDIALVKKSRRDPPSELAIINGKPGITLAVLVEPNRRVDQWM
EEANQTLEAFRGTISSDIGLDIILNQNRYVETRLNSLFMNLMIGVVFVVASTTLLMGGKS
ALVLGLSLPLSILMVFGGMRLLEIPLHQMSLTGLVIALGMLIDNAIVVVDEIKHLFEEGL
NPQKAIARAVSYLAIPLLASTLTTVLTFFPIAILRGHIGEYVRTISISVIVAISSSLLFS
LTIIPAIMSRMYQKGEIHQRNMAWWRTGFSNPQITKVYRRILGSILTTPLLGVGLAIILP
IIGFMAVGHIPEQFFPPAERNQFQIKLELPLSTSMEQTKSIVEKASNLIAQHSEVTDLHW
FIGTYAPTFYYTVARHGIKGEVPHYATAMVQTNTGRSIPKLIHNLQRELDQGFPSARILV
EQLKQALPIPPIELRVYGPDLDILEELGNQVRSELVQVPQVIHTRTSLGEFLPKLTLSLD
EEQAQLTGLDNTQIAQQLNTNLEGTVGGSILEDTVELPLRVRLSSDNRANLDQITTIGLV
PKPPLSPEKSTSIPLSALGQIDLIPETAIITRRNGQRVNTVQGFITAGVLPSTVLADFQQ
RLNNSNFQLPPGYSMEWGGEAAERNEAVGNLLSTAGIFIVLMVSVLVLSFNSFRSAGIIL
LVAVGSVGLALASLWLFGYPLGFMAILGTVGLVGVAINDSIVVLAAIRTNPRARKGFRPA
MVDVIVRSTRHVLTTTITTVSGFIPLLLDGGELWPPLAICIAGGVGGATFLALFFVPCAY
LIVFGQTYPKSFKLSGNPTS
>fig|329726.14.peg.7138 Glyoxalase/bleomycin resistance protein/dioxygenase
MNTQGKKLYPFVPSGPNFQESLKFFVELGFEKLWENENDGLAALRFGEAQFLLSNIDIQE
WQSNQIIVYEVDDLEAYYLELQAKDIPTKFPGRKIGPPTDYPWGREVQFIDPGGVCWHVR
QYEGN
>fig|329726.14.peg.7720 Glyoxalase/bleomycin resistance protein/dioxygenase
MVAIMNNKFLNGFFRCSLIVAGISVCQWFNPVNRQPSKDASVKHRTPALSERDEIGRLKR
AININGKDKLGDQFIGASRVKDRIEIWKQTDLIRSGNPKSLNALAKSDCDKALRIFGIGP
VNMFSFDPIDIEYFDEQAPDAKRFRCDQMAALERESYIRPKE
>fig|330214.5.peg.12 Glyoxalase/bleomycin resistance protein/dioxygenase
MAVHVYGCNHIVIEVTDAKKAVKFYADVFGLKMLQGGEGAAWCKLGEHQFLAIFEVERLQ
PDRVKHFGLMVRDAEQIKEVRRKLTRKYKLKMEPHFRCDFRDPWGNRIQVGDLSDESLVW
LLPYQEVQKAGITFSKPSRARQGKERQDA
>fig|330214.5.peg.687 Acriflavin resistance protein
MWLTLLALRNRIGILMLSLAMVILGATSLERLPVDLFPNIQVPVAFVGVIYKGAPPLDIE
QSVVYPIEKAVSSASNVEHVESFAKQGIGAVQVWFNWGADINVGQMEVMQRITQILNSLP
PGILQPFIVKFDVSNIPVAFVTASGGDLDERALYDLAYNTIAPQIEQISNVAAATVEGGK
IRQININLDPALLQARGLSILDVVKAVKASNLILPSGDIKAGNLDYNVFTNTQFKTVEPI
NDVVVKIDQRGNPVRVRDVGVLSDSSDIQTNVVRTDGKRSVYLRVNKQPIANTVEVVDAL
RKAIPKMIGIPPGVQLGISFDQSIYIRQSIKNLIEQALHGSLLAAAVILLFLRNLTSTLI
ISVAIPLSILVTFIVLYFSNQTLNVFTMGGLALGIGRLVDDSIVELENIQRHLNIDRNRW
DAIVNAAREVAMPIFASTVTTVVVFLPMFFIVGIARLLLIPLTLTIAIALFTSFFVSRTV
TPALCYRFLKPEEEAHRSLPSWFVNIMQWSQRRYDALDEGYERSLRWVLAHRRTLLVSVI
TIFVGSLLLLPLIGTEFLPVSDESQFRIVLRGPVGQRVEKTVDQVAEVERVLREKIPPDE
LEAIASSTGVLAQGRSSLFNPNTGPHTSVISVYLVSPDKRRRNQVEIMNAVRPAIIKLFP
GVAMFFDPGGLVKRVTSFGSQKSIDVEIYGYDFEKARTVIHQVQDTMHKIPGMADIEVSR
EENYPEVNVVVDREKAALLGISETDVANAVLFSLNGNGQTDPIIFTDPQNGNEYYISAWL
ADEHRKDLSAIENVLLTTKNGEPVLLKNLATLKLNAGPVKIERKYFQRVVHITANPVGRD
LGSIAQDLESAFAQMQLPPGFSIRLAGQIQQQRETFEGLTYASALALILVYMVMAAQFKS
LIDPFIIMFSVPMGIPGVIVILYLTNTTISTSSLMGLIMMLGIVVSNGVLLVDYTNVLRR
RGLDLAAAVVTASRTRLRPILMTSLATVVGLMPMALGLGTGSETNAPLARAVVGGLTVST
ILTLFLVPTVYTMLEERFPRRADQLAAADSETPATQPA
>fig|330214.5.peg.994 Permease of the drug/metabolite transporter (DMT) superfamily
MQKPSVFAAYAALTTSALVWGGSIVGQKLALGVFSAVETSLLRGFGALVILIPLWWWREG
GRTTWTARDLKLLSLLGLGVLGNHLLTLFGLRYIGAATAGVIIGASPAITALLSSLLVRD
IPFKTVAAGCAVSFAGVALVSGVGGGAPSGDSPWLGGTLVLLGLVSWALYSIGGRQVMER
LSPLTVNWTTLLLSLLLQIPLLWTDQKLLLTGATAVPISGWVALVYLIVFATALGQQAWL
YGVQGVGPSRAGVFVNLIPVSALLLSALVLGEAIGIREIVGIALILAGVWLVGWQSARLT
RAG
>fig|330214.5.peg.1156 Permease of the drug/metabolite transporter (DMT) superfamily
MPQFALLLTTFVWGATFPATKAALEQISPLSFLFLRFLLGMIVVFAVLLFLRRPLIRDAY
MMRASLIATAWLFIGYVLQTVGLRFTTASNSAFITVLYVVFVPLYLFRLGLHTWVSNGIA
LAGLWLLVKPTASANLGDLLTLGSAAAFAAHMVCLERYTRAADPVSLFAWQLLLMTAAMS
GAMWWEQPTPAMFEPSRVLAIGLVVTGILATGAFAVQMWAQRLLPAQQVALLFAVEPAVA
AWLAWYFLGEQLDAQGWFGSGMILGGVLLGSWVTGESSPSQPDSMAARSEGG
>fig|330214.5.peg.3243 Multiple antibiotic resistance MarC-related protein
MTIAEYALLAFSSLFVIVDPIAVVPAFLAMTPRDSVAQRLRTARVACLVSVALLTGFALF
GQTVLKLLGITLPAVQIAGGLILLLVALDMLRAQRSTVQETAAETAAGTNKDDIAVTPLA
IPMLAGPAAISTVILLETQATTWMLQAVLLGCLVLIGLASYSILAIGARSAKWLNPIAEK
IISRLMGLLLAALAVQFMVNALTGDQGLLRGLTGH
>fig|330214.5.peg.3975 Glyoxalase/bleomycin resistance protein/dioxygenase
MPTHRGLRHLALRVTDLARSRSFYERFLGMKVVWEPDPDNVYFSSGSDNLALHQIAPAEL
AQYQPLGGQLLDHVGVILESPAHVDEMFRDVQQDAAQYGATIAKPPKQHRDGSYSFYFTD
PDGNVIQALYEPTISRMEFLPPA
>fig|330779.3.peg.1569 Permease of the drug/metabolite transporter (DMT) superfamily
MYSKDFTGSVMQRDTITFFKWIIPLSLAWGIAYPLTKVVTFSVSPILVSVARVIVGTLFF
YFLGRGFSIGIKQFVNALFNVIILLALVNVGIYLSPSPGLVATMIYTQPIFVLVIELILG
SKISLRGMSGVVIGVLGVLISATLSFNIGLLFGIMGSLSWAIGTVYYYRNLSKDNVIKLN
AFMSLISIPFLSSLTPLDYYFDFNVTSVVLLIILALIAQVAGFYFWFNAVRDLGSVSAST
GSLLVPVIAYLTSILILKVVPNVPEIIGLILILVGVYLSLNSRKGK
>fig|331104.5.peg.491 Multiple antibiotic resistance protein MarC
MEWINSLISCFMILFSIIDILGNAPIIMGFKSKGNIIETKKVIVTSLVIFLSFLFLGQPM
LKIIGVDVHSFSVAGSIVLFLIGLEMILGVDLHKVTENAQTSIVPIAFPLIAGPGSLTTL
ISLRTTYDVNIILLSLILNMIVVYFVIDRCDFIAEKIGNNGLDILKKIFGIVLLAFAVKI
FGANAGQLFQP
>fig|334380.3.peg.511 Drug resistance transporter, Bcr/CflA family protein
MINNHWKYNLTIITLLIFITELATDIYVPSLPRIASAFNTSEYKVMLTVSINLIGLSLSG
LLYGPLSDAIGRKKVLLLGITIFCFSSLFCIYVSTIELIVFWRLLQGIGGGASVTVGLAT
ISDIYKGNERAKMMSRLNMVVAFSPALGPIIGSQIAAYDNRWYLPLAIIPSLAFPVLLLL
ITLFKETLTQTNIGINFNNIKASFKEVLSNKNFICYLLIQSLTFGWLWADIVNLPFIFIK
DMNVPTEHYGYYIIANVTVYIIGIVANQKLVQFKGPEKMILYGIVLILFSGISLTFGTIY
FTLTAYIVLLLKLPAAIGVGFTLGNASALSLMQITNYGTASAIIGSTEMLLGSLGIKIIS
YLYNGTILPLSILVVVFSLISLLIFQKIKSPTV
>fig|334380.3.peg.1998 Permeases of the drug/metabolite transporter (DMT) superfamily
MNSDLNNYLKGILWFFLALLCSVLNDIISKKIGLSLSAAQISFLRSFGSTLALIPFILFT
GIKTLKSKTLKIHFLRGILLFCSLSTWVYGLTITSVASVTIISFSIPLITLILANLVLNE
DVKWYRWVATILGFIGVIIAIPTTKTIFDIRILVLFLSAFIFAILDIINKKFVNSESMLS
MLFYSAFFTTIVALPFAYYSWKPLNYTYWPLIFILGCSANLILYFLLKAFSLVDSSAVAP
YRYIELILSAIAGFLYFNEAVSYYIWFGGAILIFSTTFIFYTEKANINKH
>fig|334390.3.peg.799 Membrane component of multidrug resistance system
MVFGTFFGLLCSTLMNTGLPQLMRVFSVSEGTVQWIINAYMLTNAMMIPLSAYLIRRWSF
RTLFIIATAVFLVGTVGGAVAPTFWTVVIARVVQAAGAGIMMPLVNVLAIRYAEPKKKGT
IMGIIGLAFNFSPIIGPTVSGLILDDLSWRWLFLVIVPFSVLTLVAAVIQLPRIPHNENP
HFDTRGMAIVSIGLWALLMGLSNVSTSPFWTWQVLGLLVVGAVALVIFYFSQRGVKAPLI
NFSVMAYDQFVVATLINMLIVATMFGNTILLPLLVQNVQQKSALVSGLVILPGALVTGFL
SRLSGRLYDRLSVRRLVLFGLVVDGAGTLFQATIGAASGPVVLALFQAVRQLGLVSILIP
LQTHALGILPFDLVPDGVATFNTIRQVAASLGTAVLVSVVGLMGQWGHRGTLFGIQAGFA
TCFIFLVAAMMIAGRLKNQFKLGRPTVSAG
>fig|334390.3.peg.1421 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTNTPNIIKESNHYITRNIAASLGLSIYVIIDTLFISIAAGPLGLTVLNLALPLFSAFNA
TGLLLGVGGAAYYSLNKLTHPERVEHLFSQLIIFVAGLGILVTILINLFATPLLHLLGAN
AATLPMGLTYVRIISLAAPFYMANYIVVNFVRNDGNPNLTMIATLTETTGVILVDWLFIF
GLGLHMEGAALAVLFSPVCSLTVLSFHRRFKGRQLHWYWTWPRLKSVATAARLGVAAASN
ELANGVSIYVFNLVLLHLAGNYAVAAYGVISNIAIVTIAIANGVALGAQPLISREVGDHR
FTAGKQILNHAFKITISLALLLTLILVLFKGPIIGIFNAEHQAQLVKYATVGLPIYFTSA
VFTAINLMAIIFLTAIGSSRFAFVLSFLRGYLILIPMIIGLGALLGITGVWAAVPITEFL
VTMLALLLIRARLKEWGH
>fig|334390.3.peg.1523 Permease of the drug/metabolite transporter (DMT) superfamily
MSIKHPRLVGNTILWVVAAIWGSSYVLMKMVTNAQMPAGMINGWRGLIAASFVGLIFFKK
LRHMSAHDVHVGIVAGIINYIAFQCGTIGLFYTTPANNAFLTATYVAMVPFLAWLGHQRP
RRQDFWAVGVAIIGMVILTRLVQTGFALHFGDLIVLVAAFFYAIQILYYGGAATKVSPWV
MVFWVSLLQGIGGMSYSVLFERSQWPGIEWGRALPPLLTVALLVTLMTQLLQIYAQRLTS
ATTAGMIMMTESLFSSLFSVLLGFDRLTWSLLIGGGLLVVANLISQINFSRFSH
>fig|334390.3.peg.1823 Permease of the drug/metabolite transporter (DMT) superfamily
MQISQSRANLMLVLVAILWGSSYVFAKQVVDAGMQSGLINGCRGTFCVAAGYLLFHAKIN
QMSRRDLKIGLTAGLINFSGYYLQTAALRYTTPAKNAFLTTMYVVIAPFILWLFWHQAPR
RKDYFAIILAVIGMALLSGISPANFTLQLGDLLTLISAIFWALQLIYFAKFASTVSSPWI
VIFLIGLVQGSLGWVCALLFERPSFAHVHWLQALVPLAILAIVVTFLAQGMQITAQHFTT
PTAAGIILMLESLFASLMSVALGFDRLTPQLVIGGVILILANLLMQLDLAKMPFVKRISS
N
>fig|334413.6.peg.401 Multidrug resistance ABC transporter, ATP-binding protein and permease
MVFTVLMTIFEIIGPIILAYIINNLLTGEKLVYNIRKLALVLCLYAAVFFVDSLWKYNST
VYLEKTANKIARRMQMDVYDHIQKMPISFYDNLPAGKVVSRITNDTKTVKSFYQMVLAQL
MVSIMVSIFMIAMVLITDTKIGIIVCLFFPIMFYIFRKFLQKSRFAFTNMRKYISEENAK
INETIGNIEIIKAFNLEDDFSKDYETSAKNVYDYGYMVTKAYGTMSYNVSELLRNFANIT
ILGLYAYNVLTGNTDVKLGSMYLTMEYTTRTFSYISNCVQRMGSLEQSFSAAEHVFELLD
TEVEEFPEREIGDIKGDVKFENVDFSYIENEPVLKDLSLDIKSGESVAFVGFTGSGKTTI
INLLLGFYKPQKGTITIDGKNFNDYSVDSIRENISLVPQDPVLFMGDVKSNIRLDKDFTD
EEVEKALRDIGADRLIDFRNGLDEEVKDNGESFSAGEKQLIAFARSYITNPKILILDEAT
ANIDTQTEAVIQYAIDKLKQNRTTFIIAHRLSTIKNVDCIYVLDKGVVVEKGTHEELLAN
GKIYTRMYREQNKKG
>fig|334413.6.peg.623 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGNKKSNIEFITNGNITDVIFKLSIPLMISNLIKTLYGITDGIYVARISSEDYAATSFTW
PVLYLFIAVGLGVSVAATSLMSQRLGARKLKDCSIYAVHTLILTTVLGVIFSILGLITAP
FIVRWMGAKGSFEYKSYIFLAINSLGLLFDMIFFGYQSILNSQGRTKSMTIISTISSVTN
VVIDPFFIFDNVLGIPGLNMGLAGAAWATVLSKVLLVVFAVRVVKKESEIEVNFKNFKLD
MGIIKHIFSIAIPASLGSSGEAIGFTVLNGFIQSYGTTTLAAFSMGNRLSDIFNQGAIGI
GMALTSITGQNIGAGKKERSKSIFKRANIIITFFSLASAIIILLFKDQLLSVFIKDRSDI
ELWRQASEYMYFSAIITFFMGYFSAINGFFQGVGKTKLTMYLSLARLWALRLPLIMILKS
LTNLGSTGIWISMLVSNGLTVLIGFIIYKQGQWER
>fig|334413.6.peg.1007 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKTRNLTEGNIYKELISLALPIMATSFIQMSYNLMDLFWLGRLSIESVAAAGTVGFFGWL
SYAICMMLSVGVQISVADCIGKKDMESVQKYISNAIKFALIVGIIFISLMILFKVQIIHF
FNLDESVTKLAFEYYGFFVASIFFNFVNPVLTGILNGQGESKIPFIINTIALGINIVLDP
ILIFGFGFVKPMGIKGAALATFIAQMSACIMFMIARFEYFKYLKEKMHLNYVKRLFDLGF
PIALQECLFATFSIIMAAIIAHWGKEAIAAQKIGNQIESITWLTVGGFSVALSTFIAQNN
GAKKYSRVMDGYKKGMKICIGIGICTTIILFTFAPQLFKLFIPDDPNTLNIGVVYLRILS
ISEILMCVEIATTGFLNGISLTKYPSINGIVFNFIRIPLSLLVMYSNLRIEWIWVIISSL
VICKGISLFIIFYTRVYKNKLKYLLD
>fig|334413.6.peg.1138 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGKQDMKTQLLTKSPKDLLFQLAIPGIIGMIVIGLYPFMDGIFAGWIIGDYAMSAISISM
SLTIINGGVSALIGVGSASILSRAIGKGDKETTDKIFGNFCYWVILFSIVITILGLIFAP
NFLDLVGAKGNIKELGVRYLRVVFFGSIFVNFAQAGNMTMRGEGALKQSMIIMGVGAILN
IILDPIFMKLMGEYAIEGAAIATVISQIVQAILTFRYFSKKSAFVGIHKIQKSKDISSEM
FSIGSSAMMMQILFAVQQTFLFKQAFAYGGDNWGILMAATMRLYMFSFIPLWGMSQGLQP
VIGANFGAKQYKRVKDTMKVFMYGATILAALSWIPSMFYSEKLLSLFSVRSEIIEAGVMN
FKMFYSTFILYGIMIMTLTFFQSIGDGKKASMIVMLRQLILFIPAILLLPKFFGASAVWW
AEPIVDFSMIMLGLFLMLNGLRKMGKDKA
>fig|334413.6.peg.1473 Permease of the drug/metabolite transporter (DMT) superfamily
MNNRTKGIIAILLSAFGFALMNLFIPLAGDLPTIQKSFFRNLIAFLVAFALLLKSNKKEE
VKELHDVKSIPWKTLILRASLGTAGIFCNYYALDHLFISDASVLNKLAPFATLILSWVFL
KEDLRKEHIISILIAFVGVLFVVKPTLQIQEILPYLIGILGGVCAGGAYTCVRKLNTLGV
NSSFIVAFFSGFSCIVCIPFMIFNFVPMGTSSILALIGVGLAALIGQFGITLAYKFAPAS
EISVFDYSTIIFTGLFGFLFLHQSPDYLSIIGYVLIFSGALINFMNNRRKQRMLINEKSA
RV
>fig|334413.6.peg.1476 Daunorubicin resistance transmembrane protein
MKKYLASMKIEYLNSKEYFISFVSSIFYIPITIIVYYFLWKFIMKGQADIAGMNFDDVIA
YFMTILVVKNSISNTMAETYYIFQDINSGNIDTLITKPIYYPLTRFCISIGRVVISMPLG
IAFWIAVQLYFNKFSFASLGYFIISLFLGFCLMFQVLCILGLLTFWLKSVLSLRDIFWYI
LAIFSGEVVPLAFFSGKFEIIQHNPLAGIYYIPANIINSNNMSLLLLEQIVYMAIFSVII
YFMWKRGIKHYESQGG
>fig|334413.6.peg.1560 5-nitroimidazole antibiotic resistance protein
MRRKDREITSFEEQLKIIDACDVCRLGLVDDEGYPYILPLNFGYEVIENELVLYFHGALE
GYKYELIDKNNKASFEMDCNHDLYSNREIGYCTMNYSSIMGKGIVEYVTDSQEKFNALTV
MTDKYHMDHFEFNPKAIPRTRVFKLKVTSMTAKHKEMKK
>fig|334413.6.peg.1675 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLVQALYNVVDRIFLGAGVNQMSIGGVYLIFPIFLFLMAFGMLIGVGGNSLSSIKFGEGK
KTESEIILGTSMVLSIIFGVLISGIFLLNLKWFLKIFGASDTLMPYAYDYGKIILYGAPF
QMVGFAMNNFIRGEGNPRAAMVTMFIGAISNIILDYIFIFPMQMGVKGAAWATIIGQVLS
SIWVVRYFLSDRALLRLTKETFRLDFHFCKQIFALGVSPFAMQLVASGINIIFNNSLKIY
GGDLATSSMSVIYSVSQIAFMPIFGINQGIQPILGFNFGAHKYRRVQHTLRIAVVAGTVY
MVLNWAFTMIRPDLLVKIFISRPEDYAVIKDIAIPGLRIYNSMIFMLGYSIIGSSLFQAI
GKPKIGFILTMTRQLIYLLPLMLIFPKLFGLTGVWSAMPVSDVLSTLTTTYFLVKSGFLV
KTIHNDDEFVLGI
>fig|335283.5.peg.2039 Outer membrane component of tripartite multidrug resistance system
MLPVLPPQLPAGLPSELLTPRPDLLASFARLRATDACLDSALPPIMFTAAGGTRDQALTN
LIDPNSLVWNLFAGAFQPLFTGGHVRGGIALAQARATETLHRYKETVLNAFVKLNRRWQQ
KNDCVRRKPNCAPLCSRRKL
>fig|335283.5.peg.2582 Multiple antibiotic resistance (MarC) -related proteins
MINPMDQYIQAIVALLAIANPLSAVPVFLQAVDGLDRTQRRKSALLAAISVFTILFVAAV
AGNWMLDIFGISISAFRCGGGLVILLMGLTMLQGRTSSVQQESLTHNERRSKIFVPIAMP
LVAGPGAITTVITIALAEPYWKNLSVALTAIVVLTMVLWVVLLLSQGVQGLLSPLGQKIL
LRFFGLILVAIGVQFILAGAYEFFTDAIAQQALR
>fig|335284.3.peg.808 Permease of the drug/metabolite transporter (DMT) superfamily
MSNRDLIIFITLSFMWSLSFIFYRIGVPEFGSLAFASLRVVLAGLTMLVFVILKKKNRVG
IRENWKVLTLVGLFSAAVPFILFAFSARSVNAGVLAVLNASVPMISGFIASVFFKDRLSK
KQILGLVIGVIGVMILMSENLFGGQGAGSGSGLLPMGYALLACVGYALGANITRNYLENV
SPVAITAGSLIIASVIMLPVAVYEFPYGKSISLTAWISVICIGVFSTAIALIFMNQLIKS
IGPVRATSITLVIPIFAIILGYLLLGEALDTPAIIGSIVILFGTYLSLNLSFKKMLKS
>fig|335284.3.peg.887 Multidrug resistance ABC transporter ATP-binding and permease protein
MPTSPQPRRVQLDKKPPVEKKERRALLWDILKKLAVFAKPYRLLIIATLILTVLGSFTAQ
VNAFVLRYAVDTLTEIATLADPWEAGVRMLTIISAVLLTKEILSIFISFGQRFFGEKIRI
NLSRDLSQKIIDRILTYRMAFYTSSENDSGKLQTRIDYGVSSLTSLVQNFFIDMLPLFAS
AIVSLIIMFSTNFWIGLVGLIIIPIYFFISQRQARRLQGFRRQMRGFREAKSGMVISLIN
SISVVKSFVRESIEAEKHLQIQKEMTDNQLRIRSIGFIYDAVKTFIEQIGVVVIILLTAY
FVLKGQMTIGMILFHVMLFQNVAAPIRQLHRIYDQINNALTYAEGFFEILEDESQVENIT
GRSSKDLKGLIELKNVYFTYPNGTQALKDVSFTIKPNRITALVGLSGAGKSTIISLLVKF
YAPDAGSICLDGYDLADCDTHELRQNIGLVLQSNHIFSGTIGDNIRYGDMNASDDDIVIA
AKKASIHEQIMSLSKGYESTAKSLSGGQQQRIALARMFLKDPPIVFLDEPTASLDAIASQ
QVKKSLDLIKKDRTVIMVSHNIAQIIDADDLVVIEDGRVVETGTHEELYHKGGKYFEIFS
AMSDSLNLDKISQTLNS
>fig|335284.3.peg.2405 Permease, drug/metabolite transporter (DMT) superfamily
MAHTDSATSARQSWIGTIQIITAAVCWGTLGIFSTYLNQNGFSGWQTTILRIVTAALIIL
VMLPKLWPQLIKLRPKQWLGLALQSLIGVLGMSVCYFFAVIYVGAGPAVALLYTAPVFSL
LFSAFLLNESITRQSALLALMAVFGVGLTMLGEQAQVNWGIALGLLSGICYSLYGVLGKR
AMHDAHPAPLVFFTSIIISAGILLLLPETYKTYGQLLTLPLSTWGYALGLSLIGTVVPFA
LYMKALEKLPATRASVFTIFEPLTAIALATLLLHQSLSWIQYVGVILILLAALFNAVLNG
TTTRVPRWLKRRQRI
>fig|335541.4.peg.436 Vancomycin B-type resistance protein VanW
MTDAGKLWLKVISMAVIAISASLLIVSFALAARDQDYYPSNLWLGGISLADMSKEEAYAL
LQSELASNLGDKLSLVVGKQEISLPMEEIGISYDVAASLDKIEEELFPGQGVATLVKHSV
ARGQRQEIKPALSWSKKAILEKILQIKRDYDQPAIDARIVYNHDFLEYRAHQNGYSINVN
ASMNHISDALGKGILGPIEIIATEVHPRVKIEDIETVKDVIAVSARRIDHVSQETSALLE
KLNGLIIMHGEKLDLPTIMDSGREAAMDVGSETKAQIKGAIVQACLQAGMQEKDKQSVME
NKLQYPLLLTTSMSEHTLLVKIYGCQTELGKEITLLSEREDVYPEVQIKLNHRLSPQQRI
IQQEGKKGFILRNYRVVTSGGKVVEKSLLSEELTPASDTIIVVGPGNTRK
>fig|335541.4.peg.448 Vancomycin B-type resistance protein VanW
MGGRILASERVKTSIFFSLILLLGIASAGAMYFFQVFYKSPYFMPGVKIASTTVGGYTNK
QAASRLERDLEDCKKTPVIFYYQGYSFASKLEELSYPINYEEAVNKVWQQEQERDWPSKL
TNLDGSREIFYPLKLEYKPEIKAQMIDEWNKVLGVAAEDARLEIDKQKGLVLIPARKGLK
VDPEQTFANLPQEWGAMKEIKIPITMQEEWPQVKDEDLSNMGELSSFSTWFNVNEINRSH
NLYLASSAINTSMLPPGEIFSFNRRVGERVIETGYRDAMVIVNGKFEPGLGGGVCQVSST
LYNTVLLAGLEIVERHNHALAVAYVPVGRDATVVYGLQDFRFKNNSPYPLYIRAWAQAGK
LTMTIYGNLTEKRNINLSTIVDRVIPFKEIRENDPSLNPGQEKIDHAGIQGYVVRSFRNY
MDDEGRLLKSEQLASDYYKPLDKLIYVGPGIKVESPPENVDNPENPPNEVEPDPLGDSTG
EAAPLVEPGPPETPSPQPENGDEGTPPITI
>fig|335541.4.peg.864 Vancomycin B-type resistance protein VanW
MENMALKEQKLPLEPALDKETGEVIPEQEGCIVDIEGSVSKALQAEEGDKLELLMRAIPS
RYSSRDLQKITLSRGYYETWFTGTYQRYTNVSLACSSVNNSLLWPGQEFSFNETVGPRTP
ERGYMPAPVFLMGASELDYGGGVCQVATTVFNAAGKAGLKIIERHLHSRRVHYVAEGKDA
TVSYGDLDLKFSNNTGSPLIIKAGINRGKVWVNILGEED
>fig|335541.4.peg.916 Permease of the drug/metabolite transporter (DMT) superfamily
MSAAKKRMQAEVSMLLVAAIWGSTFVVVKNALQEIGPFLFLGLRFLLAFLILLILSFPCI
KKTNRHTLLAGGLLGLFLFIGYVFQTIGLKYTTSTNAGFITGISVVLVPIIFSLLYRQRP
TVSTTITVILAATGLFFLSFPRNSFSLAYGDFLVLICAFGFAFHIIFVDRYSHQHNAIAI
TAVQILFVGILSLLIGLINEPWPEHFSANLLTALFITAVFATSLAFLLQNALQKYSTPTR
IAIVLTTEPIFAALAGYLWAEEILSHRAMFGAGLILVSMLISILTRKSKNLIEANA
>fig|335541.4.peg.1069 Acriflavin resistance protein
MIRGILSKIIASSRFITIFIILSLVLGLYSYYLLPKQESPEVSAPVAMISNIYPGASPQE
VERMVTRVIESNIRKLPGYDFSESYSRNSISVVLLQLQNDAPVEESWNELRRILSDTQRE
LPPECLPIQLNTDLAETAGIIVSLSGQHYNPEELAVVAEKFKKRLEQVEGIARFEIFGEE
KKRIEVEIDHTRLAASGLSLEEIFNILQAQNVVIPPGAIVEEGIKTNVRIPGWYNSLDDI
ENTIIGVSPDGISQRLKDIANIRWELEPDRPLARYNGQSALLLTGYFEAEENILLVGKKL
RDELDKLKSEAPHDLLVDQVLFQPDEVNKNLYRFLRNLLEGIILVIIVVLLGMGWKNALV
ASTAIPLSIMLSFMAMYLLGIKVQEISIAALIIVLGILVDDAIVMVDAIQVGLDKGLKRM
EACLQGLKQAAIPILTATLVIIIAFSPIFVLPGAPGEFLQSLPQIVLISLLASYVVAMFI
TPAMAYRFFTPSQHRKDDWLRRFFAYLLHESMARKRTAIISSLLIFSLAVYALTFMGLQF
FPSADKDLLYIDINAPAGSTRVRTEELLLQVEDILSREGEVLAYTSSVGSAVPKFYITLP
VSPQAPDFAQVMLRIRPQQGDRFQNNEEMASYLQEKLDSRISAGNIKVKLLEKAFPVAPV
QLRISGEQRENLRQAAELIKSKLKQIPGSRNVEDNGEKEIQQLLVEADAEKASRLGISNY
DIQRQTSLALEGGRASVLRQEGEQYSILLRSDINSRQQLENLSIKSAYSKRSVPLKEIVG
IEVKPQLSSINKYDGQNSIKVRSDIRPGYSAVEIEKELKDKLSSVELPGVSLLYDGEYKQ
IKDNFGILTRAALLALFLIYFILVLQFHSFIQPLVIFLTIPLALIGSILGLLLFRQPLSF
MAFIGMVSLTGLVIRNAILLIAFINDARERGLAVEKACEDAVERRFRPIILSAVTATIGL
VPLALSGSSLFVPLAIAIIFGLLVATLLTMVIIPVVYSLLLPERTEVKA
>fig|335541.4.peg.1076 Probable multidrug resistance protein
MKLEEKWRVLIIICIGIFMSTVDGSILNIANPTIARELSVSMREIQWVVTAYMLVITTSL
LFFGKLGDMLGSSKIYSYGFLIFTIGSLLCSLSPSLAYLVAARVIQAIGASMMMATGIGI
VSNTFPPGERGKALGITGSIVGVGNMTGPSLGGILIGNFSWPVIFLINVPIGILAFYLGM
RYLPQQAKSLAQKKHDLGGLLLFALSTILLLLSFSGSHGIEWKLFSLGLLIMLLFYLFEK
RISEAVLDLELFKIKNFTHGNLMAFAAYSAQTSVFFLMPFFLENLLHYPPAFSGLIMTIP
PVTMAITAPLAGALSDRIGNRRITPLSFLFMTSAYLLLSTLEQESGLLKIAGSLLLMGVG
MGSFGSPNSSSILGSIPREKAGYAGGFMATVRNFSFSLGVAASVSTFAYFLSLYQQKNSY
IAAYAGAAHAVYRIAAIISILAFLLSLLEREPARSTESESLN
>fig|335541.4.peg.1307 Vancomycin B-type resistance protein VanW
MRIRYIRIGLISLLILLLGTINHAIYTDNLSDRPGKNLDFLPYATSKDRIIYSTPSASSS
VTLLPWENDPDFQAAMAENKAKIQLANYCTVLQNPLPGEETNVYIAACLLQGTVVKSGQI
FSQNEKIGPYSQDKGFQPGPVYIGHQLKTTVGGGVCKIASTLYNVTILSNLPVIERYAHS
MPVPYVPLGQDATVCYGVKDFKFLNNSPYPILIWAESIGNRLYIAFYGQTTPPKVKWHHE
IVKEIKTYNIYRKNYALEAGKEKVILQGMDGAVVRSWLTIEDPQQGRITTKKLGKDYYNP
MPSIVEKGMKKATSTIPPH
>fig|335541.4.peg.1759 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNEPSRQLDMGSDPVFRVLLTLAIPAMISMFFQNLYEFVDTMFIAWLGSAPLAAQSLSM
PLFYLVLSLGKGAQIGATTLMSQARGQDKPEETAKLSESALPLLLLSILPLFLLLIPELC
AGFYHFLGARGPVLTEAYPYTFWLVLSFPIMAYVMIGEAISMSHGNTLMPMKAMLIGNAI
NLTLDPILMFYLGWGIAGASIATLIGQLLSAVYIYRQLKQAKLPVPVLYLRKDMPLYWKK
ISHLGIFVTISQLVSPLGLSLVNVVLASFGPAAIGAWNIMARLEMMGLLPLYGMAGALIP
YVAFNYGQENWERIRSGVRIFLLGTGVIILPIMAVLILGAPWLVLPFRSDAQVTELAMHA
IRIAALAHIFAPLELALFGTAQGLKRPWYSLLTSVARLLVFRYPLAVFFASFWGVNGVYW
SQPLAVALSGILSGILLWRLLTGEVFQAKLPRGEEMNYSEV
>fig|335541.4.peg.1996 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVDHIIAGQVLGSDALAAMSLVNPLFFLLTTLGTLVCVGSSTLASVSMGSEDRSTANKLF
TLTMLLILLLGTVFSIVGFIFIEPLVKLLSNDPELYDLVYAYCRGLIPGAICIMAVYLPL
NYFRIEGRAFLGMIMFLIMAALDIILDLWFTVVMGMGMLGLALATVISALLAVAIMSPFL
FIKGGGYRFAPIGQSLRLVYAIAITGSPPALNNLYTVVRTFVLNMLILAVGGPIAVASFA
FVNSVNTLAQAIISGISQTVSPLVGVFYGERDVLSIKKVVFLAFRYGIITMAIFSISISL
LAKPICLAFNLSSPEQLHIAVPALIISSISLLGAVVNNIFVYYYMTIGRTSIANRITLFR
GFLFIIPAAGAMAQAMGILGIWAAFSISELLTLLMTILTIRKTLLKEQDLRGLLLLNYRD
VAEGRFIAFSVDSNNESVLESSDKISEFCTSCKLNSKQSMVISLAIEEILLLMVQHIFAG
NKNKSIDVRIFVRDDVTTMRFRCAGRKFNPLDYYQQAMENADTSEALALGESMGLQMITK
MTKQVDYTTSLGLNNIIIRI
>fig|335543.6.peg.98 Multidrug resistance protein B
MDVEPATESKTMNPFSQLFGLCAVGFFARLSYALARSPVLPLFALYLGAAPEIIGWVVGI
STVTGIFFKLPSGALSDVIGRRKTMLVGLVVFALTPFAYFWVKDAALLLIVRFVHGFATA
VYGPVAMAVVADVAGCRKGEMLSWFSSVTIAGSLLGAPLGGFLLFTLARSGSPSLEHFHW
VYLASGAFGCVALILGGKLLAGGDETVTQVGLKASLAQFGAGIREVVSDRRVVLTSSMEG
LQNMTMGALEAFLPIYAVKVAGLNEFQAGLLWGAQVLVTIVSKPLMGRLSDRYGRKPAIV
IGMLACAVAFAAIPLLTRFELLILASLLFGLGEAFVTSSSAALVADLCQERHFGTAMGTF
GTIFDVGHASGPILAGVLIASWGYLPAFSIMSAALVVALPVFILGVKVESRTSMVTSRVW
RRRHRKGLP
>fig|335543.6.peg.2458 Multidrug resistance protein B
MRRGSLLRGERRSAEESLVELPVADRSAARESGREGRTTKAFVIAAALLALFLGALDALI
MSAAMPTIVADLGGLPLYGWVFSSYLLTRAISLPIFGKLSDLFDRRRLYLIAIAIFLASS
MLGGAAQSMLQLIICRAIQGVGAGGTFALAYIVVADLSPVEKRAKWMGFISFVWGIASIL
GPALGGFIVACMSWRWIFFLNVPIGAVALLGIFLFMRDAREARTQADIDYAGAMTLVLSV
LALLLAFMLGGRTYSWLSVEILALLAVAVGGAIGFCIAEKAASDPILRLSFFGNSGFSMA
NASAFFSSFAIFSLSSYSPLFIQGGMGKSPAQLGLAMVPLSLAWSLGAIVCGQLVGPKTE
KPFALAGSFFLVAGSLLTLSFSPSTSLAFCSFTLALAGFGMGIVSVSTLLIVQNSLGASN
LGVSTSSQQFARTLGGTIGVGLSGSLVAAQLGKALDPLIHSAPGDGLPVSVFKHLSANIE
SLLQPEIQAALSPHLQKTLQAAVASGVEVVFWAVLITAVISLVFCCLLPAPGK
>fig|335543.6.peg.3224 Permeases of the drug/metabolite transporter (DMT) superfamily
MITALLVLIIVVSNAAGDVLITRGMKQIGEVASISPRELLSVAGRVFTNLSFLSGVASLA
VSFFAFLAVLSWADLSFVVPATSLVYVVTIIGARFVLKEEVNGLRWAGTLLVCMGVALVC
VP
>fig|335543.6.peg.3225 Permeases of the drug/metabolite transporter (DMT) superfamily
MLMKTAVVLTIAVFAQAIGNACLSKGMKGIALDQFDGSFSAMLLLDAMREPLIWLGTLLL
ILFLVMFSATLTWADLSLVLPATAFGYILNVFFGYHFLNETVSNARWAGTVLIFVGVVLV
AGSGRKSKRRLDGDA
>fig|335543.6.peg.3636 Fosmidomycin resistance protein
MPGTARRTLQRLLSNAFWRCSLPGLIDDSESLLKKTRQIAAPRDGLRCETGRRKARQAAF
GGTCPKSGAPATGRRPKTIGMEVMSQFNLKILLLLSCGHMVVDIYQGALPAILPFLKDRL
DLSYTVAGTILIASNLTSSVIQPLFGFLSDKKEKAYLLPLGTFAAGAGFSLLAGAGHYLL
ILLLVAISGFGIAAYHPEGFKTARFFTGQKMATGMSVFAVGGNFGNALGPIIALSIINYF
GFSSLPWMFLPAAAFTIGIIALRKSVAIPAKDRPAVAENTPPIPRRAHRAMIVIICVIIM
RTWTQIGLMTYIPFYYIDVLKQDPVFAGKLVSMLLLGGAFGTLAGSPLADRWGHRLWLRF
SMLGSFFLFPLIFHLQGFLLSVAVTLFGAVLISTFSVTVVMGQNLLPRNLGVASGLIVGF
AIGAGGIGVTLLGILADHFGVPFAFKCIGFLPLAGFLMSLLLEYPLKKTA
>fig|335992.3.peg.115 Multiple antibiotic transporter
MLEIFIQTFFLYFIVIDPLGNTPLFLAVTQNMSSQQRVKTALSATIIASIILLFFAFLGS
TLLNYLNISFPAFTIGGGIILLIISMEMLFDKRQQRKEDDIDFNSENVSVFPLATPIIAG
PAAITSVIVSVSDMGSNFTNQSVGMIALASVLLLTFIFFFTASKFSQIINKKVISVISRV
IAIILVGLSVQYILDGIKTFLA
>fig|335992.3.peg.151 Permease of the drug/metabolite transporter (DMT) superfamily
MNVINKIPGPILVFMGACCLSFGGLIVKSFEGSTLWQILFWRSLFFSLTVLLFLIITYKK
KLFKAFYDSGLPGLIGGVILSFGFCGYVFAMYNTTVANTNFIISTQILFLAIFGYLFLKE
TISSITLASIILAITGVLLMVGNSLSPGEMSGNLAAFSMPITFAVLIIIVRKFPTVDMVP
AQFIAGVSSCFIGFLLSEKLMISSHDIFLGFTAGFFQVGFGFIFITMGARSTPSAMVGII
MLSESVLGPMWAFLFAAERPSLFTLIGGGVILFAVLLQFYSLLFSNKKEKIIN
>fig|335992.3.peg.184 Permease of the drug/metabolite transporter (DMT) superfamily
MNNFFLFIVTLFCWSPTWYVIKFQLGYVDPLVSVFYRFLIAAIVIFVYLIYKKKNLKFSL
NQHLWFLLFGVCLYSLNYVFFYLSNTYLISAFPAVVFSTVVIMNILGEGFYFKKKPSLKT
LLGATIGMIGIIIIFNDEIFNFSFANGTHVGLFLALLGTFSASTGNMVHQRNLNNNFSLI
PTLAYSMLYGSLVTLLITQIKGTELLFEYSFSYIASLAYLSIIGSIFAFIFYLRLLEKVG
AGRAGYVGVVMPVLALLISTIFENLEWQQDLIIGLPILIIGAVLVINQKIKPIK
>fig|335992.3.peg.273 Permeases of the drug/metabolite transporter (DMT) superfamily
MFAKVKINNELLGILYMLLCQFSFATNDAFVKNIYQHYNEIFVLNQIIFIRGIFTLLFIL
LFLYIKKQLNFKLIFSSTELKIRGFLESLAALFFFIGIALLPFAKVYILLSMAPIILTAF
GAIFMNEKVRWRRWSAVILGFIGVVVVVNPGKLEFGYYFIFPILAAIMLSIRDMYTKNFK
KDYHSLQTAFMTCFVVTIFFGILSIYKFYDFTLKDIFILFISAFFLAMGYIFSIATIKIA
LVSVTSTFRYSVILWGIIYGYFLFDEVPSTNSYIGALIIIISGLIIISRQKQIGVIK
>fig|335992.3.peg.340 Permease of the drug/metabolite transporter (DMT) superfamily
MVKIFPFIFIVLWSSAFVTTKPIIDNSDPFAALAFRFFVVAFGFYIYSIYIKQKILTNSR
NLLQSLFSGVLFHGVYLGGVFYSVSIGMPTGIAALIVTLQPILTNALAGKFLGEKVTFKQ
WIGVILGFIGAALVLGFDIGSSLPIFGVIASFVALLAITTSTLWQKKISNNLPLSVSNMY
QAIGGCSFHIIIILIFSEPYINFTSTFLIAMSHQIFLVSFGAFTILMFLIKNNSASKTVS
IFFLIPPTTAIMAWIFLNEKLNNLDLVGFAVATFGVYIATRKQ
>fig|335992.3.peg.567 Permease, drug/metabolite exporter family
MTVRHYFLVLFIMFLFGSSYPINKLALNTSLTPVLAASLRMFILFVCLVPFCKFKIPNKK
YYLPLAGFSFSMGFGVFIFLNLSLQKATMVAPIIIGAQLAIPFAILASSLFLGEKVTPKM
WVLIFISFFGIFLIGYDPNLKSEIFAIFLCAISAFFYGVANVFSRYIKDIDVKLTNTVMG
FTGFILLFLFSIFFEGNTVYQLLNIDFYTWLLLLHNGVMVSVIAHTSLFYLYKFYSVNKI
MPFYSLFPVFGLILTFFIFGEIPTLLSAIGGLIIIFSVYRLQKIR
>fig|335992.3.peg.643 Permease of the drug/metabolite transporter (DMT) superfamily
MRQPRLIDYTLLVVLALIWASAFFNIKIATESFGPITIAFLRVFFGSIPVLLLCFYKKIK
IEAFSKDWYWFAIIGFVNLVLPFFLIAYGVKSVQSNLAAILMSTTPLSSTILGHFYTKNE
KFNLVKTFGILIGFSGIIYLFSDNLLINDSNFISALLILLGSTCYVIGGVLTLKISKKKN
ENVTGSILIWAILILIPFVYFIEKPWNSIPSIESTISVVYLGMVSTGVAWLLRFKILKDN
GLIFQSQVSYLIPIFGTILSYIFLKEIITPKILLSLLAVVVGIYFVKKADQKKTT
>fig|335992.3.peg.737 Quaternary ammonium compound-resistance protein qacH
MNMTTSYLFLALAVVLGVASNSFAKSAEGFTLLVPSIITAITIVLCMYALSMVMKNIPMG
ITYASFAGLAIISTVGVGIIKYNQVPNLYSIVGLCFIIVGVLMVNLLGNN
>fig|335992.3.peg.738 Quaternary ammonium compound-resistance protein qacH
MNLTGGYIFLVLAIILGISSNGFLKATDGFTNIYPTIFCIITIVACIFCLSKAMTIIPVG
FTYATYGGLTITAVTIFGVVKYNQTPNLYAVLGISLIIIGVILLNTMGKTN
>fig|335992.3.peg.969 Transporter, drug/metabolite exporter, EamA family
MFLAVIGFGSGPPFVKLALEEFQIVDLLAVRFAIAFLLMLTFALIMRVDLSIKKIGLAPF
LMGLLNPFLVTLAFHVGLMLTSPINGVAIISTMPIMQPFVAKIFLNEKIEIKVLIGAFIT
IIGTYILLSSQTIIGQGNYIGDFIIFAGMTLASINEVIGRKKMQTNVNQLGVNTYQYFTG
FILSFLILFIIWPNSTFGYSFHLEFTPSVIAAITLSFITFGSYLFYNYALRRVPIGRISL
MYPLTGPIGALSAWVVIDAEITLKIFISLGIILVGTVIPYINKK
>fig|335992.3.peg.1025 Drug/metabolite transporter
MLTKNQLGFLYMFLSVCTFSVMDLLVKWSSDYPTGEVLFFRGFFGLLPTYFLIPKGKLKT
FYTTERSKEHLFRCLMGLMALIAIVVALRELPLAVVVSLSYAAPLFITVLSIFLLSEKVG
IFRWLAVLIGFIGVIIIAEPGFKGMNYLYFLPLIFCIGMAFVTITIRKLSTTEPIWLISI
FFTITISIAGLATIPMGWKMPNFQDFILLALIGVTGGSANLFLTQSYKLSEVSLVAPLKY
LALVFAIFFGYFIWNEIPTIKTLIGASLVVLASLIIFRREIYHKQKIPSTTRHE
>fig|335992.3.peg.1234 Permeases of the drug/metabolite transporter (DMT) superfamily
MLPIMDGFAKYLSADMPVLQITWARYFFTVAFTLPIMFLFYNKQLVWTDKPKLQIIRGLI
LLSANICFFYAISVISLAKALTLAFVAPLIVTAFSPIFLGEKVGIRRWTAVIIGFIGSLV
VIRPGFVEINLASLAALGTGVMYGFYLIITRKLSTSDNPLLTLLLTGLVGLIAVSGLMPF
VWVNPTPSQWSMMASIGVFACIGHLFLILSLKYADASKLAPFSYFEIITNIIIGYYFFSD
FPDNWTFLGLSIIIMSGVYISRRESYIKSY
>fig|336407.4.peg.21 Multidrug resistance protein
MNTKLLYRLARNLRFYKKDLIIVIISLLSVSLALLLIGNVFRNLVDQGLVLDRTAAVDKS
ILYICLLIIILSIASFFRSYFINNVAEKVSSQIRKEAYSNLINYEITEFEELKIGDIISR
LTSDIDQISKLIVNFLSFFIRNSVMLVGSIILMFFESFKLASIVIITIPLLLIPIIKFGK
HVKALSKKTLESQSLLASDINESFSNIKTIHAFGGQAAKITEFNNLLQDYLTYSAARLKI
RALFFAFSMAFIFLGVTLVIWIGALDIVKGNLSSGQIISFIYYAIIAGFSSGGIFELLSE
MHLPLAALERIVTIIDKSPIVHNNYSDLKPVNSISLEFKNVNFSYPSRPNLKILNNISFK
IDSTQFIGIVGRSGSGKSTLMQLLLRFYVQESGIILVNNQDIALLNPNEIRKLIAYVPQE
ASIFSGTIKSNIMFGNDSSEEEITEIIKITGIADFTDKIPDGINAKIGEKGVRLSGGQKQ
RIALARALLRKPQILLLDEAMNALDSQSEQKLLSSIRDIMKGKIVISIAHRISSIESADN
ILIIDKGAVEAEGTHAHLLKTSDLYRTIYKEVDLL
>fig|336407.4.peg.57 Multidrug resistance protein
MNNNLDNDYQAFYIIKRLIKNHIKPYATKIYVAIFCMAVAAICTAIIVHAVRPIIDKIFL
THDRRMLVIMPIVLIVTFFVKGISEYYQNYLIKFVGQRVLNDLQIKMYEHLLFADISFIQ
KQSSGRLISRFTNDISLMRGAVSNLLVGCAKHFLTVVCLIITMFNLEPLLSCVVFLVFPL
AVYPVQKMGRRIRRIFARSQEELGHYTSKLDEAFQSIKIIKSFVGEKIESKRAVLIINNI
LEYYKKTSKLDALVSPIMEGLSGIAVGGMVWYGGTLVLDGKTTPGALFAFLASFAAAYRP
FKSLVSLNINLQEGIAAAKRVFSILDTEPLIKDHSNSKEIDLSDAQITFEKLALSFESKL
AIKHIDLKLKPNKMIAFVGRSGSGKTSLSNLLARFYDPTEGRILINTYDIKDIKLTSLRS
QIALVTQDTHLFDTSVAENIAYSQPNATQEEIIKAAQYADAHEFIMQLPNGYDTQIGVQG
TTLSGGQRQRLSIARAFLKDAPILIWDEATSSLDQSSEQKILESLKKLRKGKTTLIITHR
LSSITDLDNIIVMKNGAVCEQGNHKQLLDNKGEYYALYNKELRETLD
>fig|338187.4.peg.1949 Multidrug resistance transporter, Bcr/CflA family
MSKLQIIFISLIMASSYFFASSMYVPSLPEIQNALHTSEALVQQSLSVFFIALACSQLLA
GPFSERYGRKPVALLSAVIFVAGSVLCALSQNIESLLIGRVVQGFGVGGLYLLCRTILQD
AFEKSELMGILAWYGIIFMSLPGLTPILGGYLTTHFSWEANFIFLLGLAVVTLLVIAVIK
RETISQHNPDAIKPKQMLKDYAFITSNLTFLCYLAMMISGTSCLLLFQVMGSFVAQNQFD
ISVADFGLGAMTLMISSVVSRLFWNQFLKHRLSENLTLFFGCVIQVSGCALTTFSLMVKS
YSFMLLGFCVMSFGVAFLLAIAGVSALYMFPKHKGQVGAIYGALQMIGAFGFTYGLSMLP
ATQSMMVLTSWMLAMTSAIAFFIIFIEQRRAVGQACTFSEN
>fig|338963.3.peg.594 Multidrug resistance protein norM
MNIFPVAKSRLCGMKIESFALMKLTGPILTAHLAQQALAFTDTVMAGRVGATDLAGVAVG
ASLWIPVSLFIYGVLLAVTPMVAQMHGAGRTTETGPLVRRGLWVALPMVVMAMLMLRHAG
GVFVLMEVIPQVASIASNYLKAIAWGLPAAAVFFLLRNLSEGMGLARPSMLIGLASLPIN
VAANFVFIYGKLGFPALGGVGCGWASTLTLWFMCGCMCATILWGRGYAVTHCFDFRRSCG
EEGAMHILRLGFPIGCSLLVESSVFALIALFLAPLGASVVASHQITLNYSATVFMIPLSV
SSAITIRVGHAVGSRARDLARLTTRTGLLMNTVIAIMTAAFTVFFAEQIACLYTFDRQVI
GMVVGLLYLNALYQVSDAFQVGAIAALRGYKDTRVPLLLILVAFWGIAMPLGYSLSLTSF
WGAPMGAKGFWISLVVGLSISAVLLGGRLCRLQRGMARMENGGE
>fig|338963.3.peg.1692 Outer membrane component of tripartite multidrug resistance system
MRSFWGIAFLLVLVGCSVHRPVPVELPVPVPDRYLESTAAPGEPVAQPWWHIFEDPALDR
LMLQAFGANLELDQVLARWQQAEAAVRSVESARRPSLGLDGQAGRQRQMTFLGPVTADHY
SLSVVAGFELDVWRKLASRSEAARREQAAAAADVEAICLSLSARLADLYYTAVEQRAQHA
LLENTIVSYLDILERVERRYRAGIAPALEVYQARQNLAAARARLPQVEARLAAAEHGLAV
LLGRYPQGGLAGQLAVLPAPAKNYPLGVPSQLLNRRPDVKAALLRVKSADNRVAEAIAER
FPAFNLAGGYGGGADTPRQVFASPNIFWNLLVNLTQPILDGGRRRAEVDRRQALFKELLA
SYQTRVLEAFREVEDALAAERASREQVAQLQARRASTSAALRLATDRYTLGVSEYLQVLT
AQVLHLETESGLLSARRQQVADRISLARALGGHWMLQQCRQSRNDSVIFPTEDSDHDK
>fig|338963.3.peg.2601 Multidrug resistance transporter, Bcr/CflA family
MSAHTEIRTNMRLVVILLGVLTAIGPLTIDTYLPAFTAIAADLHTDVATVSLSMSSYFIG
IAVGQLIYGPLLDVFGRKGPLVYGLVLYILASLGCALSYNVEWLIGLRLVLALGGCAGMV
AARAVVRDLFPLHETARVFSSLMLVMGLAPIVAPTLGGLIVASLGWRYIFFLMGGSAVVM
LAGVWWILPAIPGHGRREALHPRSALRDYLAVLAVPGFTLRMVTGSFYIAGLFIYLTASP
LIFMDMFGMSGPHYGWTMGGNALALVIGSQVNARLLKRFSLGGVLWRSNLLLLAVSALFV
LGAILVPVPLWMVLVFAALYLFCLGFLLPDVTALIMEPFGREQAGSASALLGAVQMMAGA
LAAALVSWGYDGTVAVMAIGMPVCALGSVGLLWRERYPVRVQD
>fig|338963.3.peg.2883 Fusaric acid resistance protein conserved region
MKSTIRRPRRFDLLAAVKGVAAQTGKEAAIWLFALKQTLAVLLAMWVSLRFELGQPSTAM
VTVYVLMHPQSGMVLTKSAYRILGTLFGAAACLVLFALFPQQRVLFLLGLSLWVGFCTAG
AALNRNFRCYGFTLAGYTAAMVGLSLVNHPMSFFAYASNRISEVAVGILCAGLVGDLIFP
QHLGSTIVRSVQSRYTEFCGFVQALFTGKMSPRDVEGTHLRFIHSVLTLESLRGASLLET
TQTPRGDARLRRMNRDFMAASTTLHSIDQLMKRLQKAESPAAPGLVLLAESLAEALLNDG
EPARTEAEAHRSSRRIAAYNATLDERVAALHHDLGTPPDSPTTLDFVTGVELIRRLAQEI
QDYTGAYAAGPEEHSPLGSEDLHFASRTDPAVAILNGIRAMLTLFLISMFWIGTSWQYGN
VAVMSVAIGCSLFAPAPDPTKALTGGLIGHALGFPAAFICKFLILPHLSGFGMLCAVLVP
FLLVGSWLAMSPKTANYSLAYSVMVCFMIAPSNSMQYDPMYMLNFGNALMLGLAAAAVMF
AIFIPPTGSWFKHRIPKMLRRQVLKVCSAPLSGLEHRFESGTRDLLQKIAAGQSAQNSPD
QNALDWMFLALETGRAVIHLRQAAQNMSQQLRLKEVDESIALIQQLFRRPTGGNHAAAIT
GVENAIDAIRSQQNRETAGHLLDGDLHQMTTSLHFIRIALLDDETALAASTNGPAPRHRG
EISYAA
>fig|338963.3.peg.3000 Multiple antibiotic resistance protein MarC
MPNLGFFTLLLHDALLLLAVINPLGNIPVYRDLTSGMDFSKRRAMIQLGVGTAAAMIIGF
ALLGDWSLKNLFEVTLDEFRIAGGILLFIVAVRGVMTGSLSYNLLSDDFRTRAIFPLAFP
IIVGPGTLAVTIILAQNRPPLHMLAVSSVSCIIVYLIASSAHSLMRVIGGYAAMIIPRLL
YIFLAAKAVALIMHGLTGYVQGLLKGVA
>fig|338966.5.peg.1379 Vancomycin B-type resistance protein VanW
MGPHRHGIFLLLVCLIFASTAWGEPPFGQLWSGFSTSLSNRSPEQRKNAAIAGQALDGAI
IPPGGTFSFNQRVGAREREKGFLPAPYLTSNGTLDDTPGGGICQLASTLYNAGLLAGLEV
VERHPHSRAVAHVPPGRDATISSWRKDLRLRNPFPHPLKLRIDSGNDRLTVSFRSPVARL
FQVEIQSSQISQEPETVAISAGKSGQPGSHGFSTRTWRITHTNGIDKRELISEDNYPAPS
RVIAGGGN
>fig|338966.5.peg.1408 Permeases of the drug/metabolite transporter (DMT) superfamily
MVRRNNNPASYQTMHERAPFSGLDEARRSDTTSAAPHRQETAMISPWIPLSLLCAFSLAT
SDALAKRALTHHNEHLILWLRLLLASPFLLAMLPFIPIPTLAPGFYRATLVSLPLEALAS
VLYIRALKLSPLSLTLPLLALTPLFLLAVPSLLLGERISRAGTAGVLLIVTGTYCLNLGR
ARREFLEPLRATMRDRGARCMLGVALIYSVTSTLGKQAVAASSPLFFAAIYIPLLTLLLT
PLALRNMKGGVRGVFASGAVKEAILPALFYALMVLTHMSAIAMTRVAYMISLKRLSLLMG
VIYGHVLFHEQGIAGRLAGTLLMLCGVALITLYP
>fig|338966.5.peg.2598 Outer membrane component of tripartite multidrug resistance system
MKFQPVSLALVILLILASHARGAALSLSDCLEKAEKHNPELRTLAWEPIMAEQNVAQAVS
ARYPRLDGRVGYTMQKDPQAAIIMGRVAELQDSDYAHGGLEALYTIYDFGKREARISQAR
ATADAIRSRYDARRTDVSLQVIEVYFGILEGMQLVEAARDEITQVEQHRRMAQALFDEGV
VTRNDILQADVRLASARQTLLSRNNSLDNTWLRLNYLTGSAPSFRGELSSEAGIGDRTDA
PTGDSAALTKRPEILALRKGVDASQAELKESRSAYLPELYTRLALEYVDNSKYREQTIMS
AGVGLKVNLFDGFATTAARDRAARNLSRSQDLLRQGETQVQLEISTARNDLRVAGERITV
TETAIRQSQENLRINHERYKERVGTATEVLDAQTLLTQTRTDYFRALFDRQVAAARLRRA
LGEL
>fig|338969.3.peg.466 Permease of the drug/metabolite transporter (DMT) superfamily
MVTVLVWTSFILIARASSDPARGGTLTPFDLAFCRIVGASLVLLPWGALLVYRDRDRGIH
QSSLLGVSPLSWRVTATVGLFGGLLYALLAYNGFVFAPAAHASVLMPGSLPLWTALLAAL
ILHDHITPVRALGLGLIVLGDLLVGGRSLIGAFDGGEVWKGDLLFMLAALTWACYSVLAR
RHHLNAVRATIAITAFAFVTYVPVYTVLLLGGWVHGQVFSAPLREVLFQAVFQGWGSVVV
SGITFTKMIQHFGPVRSTMITALVPGLSALGAVLLLGEPLYWNLAAGLVLVTLGILFGIR
VALPVATKTIAAQAGSTVARG
>fig|338969.3.peg.573 Permease of the drug/metabolite transporter (DMT) superfamily
MLAWLAYLTASVVWGSTFLAIAFAIETFTPFGLSAVRFIPAGILALLIGQIRKERFPSWR
EIPHIALVGITLLGVCMGLIGWAEGRVSSGVTAALGATVPLFLALMDPRGLDPKAWCGLG
MGFLGVLVLLWPSGQGPALSGAAALVLSASLWAYGTLYGKRHADESGHFSQIGVEMLVAG
VLSLLAASLTGGISHGTWNPRSLLAVGYLITFGSILAYSAYIYLSKVWPCAKAGTYAYWN
PIVGVLLGCWFRGETFHARMLPGLACILLGVALVQIPWPKALRFGSANQGAKQISR
>fig|338969.3.peg.1770 Probable multidrug resistance protein norM
MPSISSLRRLSAPAPRARIGREARALWQLAWPILIGQLANVGMSVVEVAMAGHASANDLA
GVALGVSIWNMVIITLMGVMMAVSPVVAHLVGAREFSQVPHVVRQALWQALGVGLIAVLL
ANLAGSVFDHLALQAQVRDLAKDFVVITSLALPAFAAYRVLYGYSISLNQTKPVMVIALG
ALLLNVVVNWLLVFGKLGLPRLGGLGCAWSTLVCVWFNLLALLWWMRRASAYRSTWPFAC
FEWPHWPQVRSLLHLGLPIGITYFAETSAFSLIALLIAKFGSTEMAAHQIALNFSSLVFM
LPLSLGLALLTRVGQALGAGEAHAARFRAWVGVAMALAFAVLSATGMALFNGQIAAAYTS
DEAVAGTAAQLLILAAFFQLSDATQVATSCAIRGYKVTRAPMLIQLTAFWVFSLPLGYAL
GLAPKWLPWAPAQPMAARGFWIALVVGLTVAALGLSALLRFVARQHLPADQHTAISKPT
>fig|338969.3.peg.3587 Fosmidomycin resistance protein
MRSARLKRFTYHRSMTSTSLHLPLAVPLKQDATIIGLVGLAHASSHFAHLLLAPLFPVFM
TEFGLSYAELGLLMTTFFVVSGLGQASAGFAVDRLGARPLLFVALGIFVLACGAASLVTG
YAGLVGVAALAGLGNAIFHPVDFTILNQRVSAPRLGHAFSAHGLTGYLGWAAAPVFLVTL
SSLYNWRTAYLAAAVMYVGILVWLILQRDKLSTQVAVQHADVGAEHSMAFMKLPVVWWCF
AFFLFSTMTLAVVQSFSVSILKAMHGVSFEAATLTLTAYMLCGAVGIFVGGFVAARTGHS
DRVVAMSMAVAAVLLALCGTGLLGATGTMVVLAGTGFAVGIGGPSRDMMIKNATPQGATG
RVYGLVYSGLDTGFALSPFVFGVFMDRGWYGATLFGAAAVLLLSVVAALGVGQRTARSRR
>fig|339671.5.peg.1055 Permeases of the drug/metabolite transporter (DMT) superfamily
MSEEKTSPFLTALWSAFPVILFFLLDYYGFMVSKQIYAVSQFGSGIFVAEILALIVFIKG
QICNGQRSRLIRANQYLGAFWLVWLALSCWMLPGENLLPVGIAALGFMVSLIIQFRQFLI
IGIWVSGLGIISYIGYLLALDSPDWLRYNPVTQALVGVILVNILLVVSSNRLQGFISLLP
FIMAILLALNVIFTLTILDYASNVYPVLFYFLLHLVMMGIIALHVLRKIQFGYNALMILL
FIAASLPIWTIFFAL
>fig|339671.5.peg.1291 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQNPLDLKPTSTFIIRLRYKQSFFREFCKNPPKNDRAFHNERMVMQQTEIKGMDKPIPAL
LLKFTLPSIVTMLFFGVQNLIDALVIGNVLGATALGGVNIILPLFSVEFVVALIVGVGIQ
TLVSQGLGNKNAEQVQNAVKTGFIGLAVVSLIASSLLWIFREPLVRAMGADDVLMPHALA
YFSGLVPFMLPMTLAFYLDLLIKAFGKPLLSTLIMSSAVVLNIVLSLTFVLWLDWGVFGA
SFATSIAFSLAFAVALFYLPKPYSLFKGNFSRRLLFKACYNGLSEGVSELSSAIAVLIIN
RTVMAMLGADGVSAYSAISYIQFIGVLVFLGISDGLIPVMAYHFGAGKTERLQRIFLFTA
KVNATLGVLIFTALQLWGSYFVSLFFQSGDQKVIQLATNSLKIFSWVFLAEGITLLIISY
FTALGNAFGSMIIAALRGVIFIAVGMAILPPLLGTDGIWFTLIGSELLGLLAAVWLVRCY
QSAPATSSTQHSW
>fig|339671.5.peg.1604 Quaternary ammonium compound-resistance protein SugE
MNSKGLTYIIIGASLECAWAYGLKHAADGLEWAVTIFCIVASFWVFTKAFKYMGASIAYV
LYTGLGTLFVVLLDMVTTVQAGGAIDFVKLFFVVTLMSGVIVIKSAK
>fig|339671.5.peg.1605 Quaternary ammonium compound-resistance protein SugE
MSFITLIIAGLFEVAGVSTLNVFSTARTTQRKTAFLLATIVLFAASLSSLSLAMQDILLS
IAYAVWTGIGAAGAVAVGVWISKDKITLQKAAGLVLTITSAIALKVM
>fig|339860.6.peg.495 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNTNKNMKNNNEKNDKVDLIRGDPKIAIKAIAWPMIITLVLNMVYNMVDRVWVAGLGSDP
LAAIGFVTPLFIIIGGIANGFGAGANSLISRYIGANKKDSADNSALHGVIIGLILSILIP
LILLPCLENLLIVMGASSVITYAKPYAAIIILGSFTLIFNGILSSELRAEGDVKRATIAL
IFTGVLNMIIDPIFIYTLNLGVEGAALATILSATVATCLMLYWMFIKKDTYLSFKIKEFH
YNAKITKELIAVALPASVEQLIISVLTIIGNLILSIVATTTIIAGYTAAWSVIQVGMMTS
VGIGTAAITVGGVAYGARDYEKLKTTCYYSIKLSMIIAIAIVILIEIFAPQIALLFSYST
SSAHLGVIITETLRILALFLLGIPLGLCSACVFQGMGKGTISLILTVIRELILVLLLTLI
FTFVFGLAQYGLYYGLVLGVAIGSIIGFIVFKYYLKRLIKYKE
>fig|339860.6.peg.890 Efflux pump antibiotic resistance protein
MNILLIIKKYNIMVNEKIMNKYVILIAMLASFGVAFTSNAVSVALPTIAVDFNITNIMQN
WLVNIYLLVIAAASVPFGKICGKYGLNKTMGIGLIGYVVGSILSGIAFNIEFMLVARIIQ
GIASAVLFVNSMAIITEQVPPQKRGQAIGITVTGVYLGLTLAPTVSGFLVEYVGWRSIFY
ITVPLILISYYLLTRIDKEWIIGGGDPIDVKGSLLYVVGILILMYGFTILHDVIGIITVV
IGLVILAIFAKYELKEQYPIYDMHLFRNVKYTSSNIASLISYFATFVVTYILNYHLQYLN
GFSPETTGLILIVTPLIMAIGAPIAGRLSDKINPQILAAIGMIIVSIALVILCFLDETTP
LYMIFISMILQGVGFSLFSTPNNNVILGSVDKKDIATASASLSTVRTIGQSFSLGLLTLV
FAYIMGNVPIIPQHYPQLILSSQVTMILSTILCIIAILLSLMGIKSGNKN
>fig|339860.6.peg.1355 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVEESENTIGVNILDGDAKVAVRKLSFPLMVSLVIGSLYYIVDAMWISGLGVDALTAIGF
IIPLQFIILGIGAGLGSGITAVISKYIGMKNHKLANNASFHSLLLIIIFSVIITLLLLVF
MEPLYILIGASGMNLQLALEFSRVFFVGSILLIFPQAMYGILRAEGDVKRTMYAMFLSTI
INIILDPIFIYQLNMGIAGAAYATLISLLIVCLVIIYWIYIKKDTYLKPYRTYFKYDAGI
IRDILKIGIPASIEFFVLSFVGIIMNLLLLMVSNSDYVAVYETGWRLISFAFEPLIGIGS
ALVSIVGFNYGAKRFNRINEAYNYAMFLGTIIGIISAVILYVFANQIAYLFAYSSTSSML
HEPFVVFLKYFSITFLTFPIGVVSTYLFQGFGKANVSLLLTFTREAVCAIIFSYLFAVVF
NMGLNGVWLGNVVGYTIGAFIAFIIGKIYVSRLLKNN
>fig|340099.4.peg.409 Daunorubicin resistance transmembrane protein
MKTLYTFMGYFEYSIKKLLMYRIYIIGELLSSLIVPVIISFFLWRALIETNPINYSLKEM
MIYIIISNIILLFTQIHAEHDIERDIKTYRLGQKLLLPIDYLTSISYSYLTSSLAKFTIV
YLPIIVIISIWAKIEIPANRLLYLPITLTFGFLLNALFSFIIGLLSFWLTEIWGIAAVRN
LLTGLFSGAIFPLDLLPKKVESFMLLTPFPYMTFIPAKLISDDSFDIKIVNKGLFISLIW
VLILGLIVFLLVKNGLKKYTSHGA
>fig|340099.4.peg.929 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKAFLLKYKKEFVIVVFFAILAALMNVFVAFILKMFFDVATIGRLENFYTAVEIALVFVI
FNSLVLWLAQISKFDYIKKSLIHLKNVLFEKIIGKDLNQFDEVNTGKYISIVSNDINMIE
ENYFNNFFELVSSGVGFLAALIVLFILSYKITFIIIGLTVLSMLIPRVLDRKISDLR
>fig|340099.4.peg.1518 Probable multidrug resistance protein
MSQKQYNKWLILSAVVIGSIMGPIDGSIVNIAMPEFTKIFHTNITTVSWVSMTYLLVLSS
LMMTFGRLGDMLGYKKLYQYGLLTFSISSAILSLSVNIYMLIIMRAFQAIGAGMLMSMTS
AIITSVFPPNERGKALGINAMSISIGLAIGPTLGGFLLSNLGWQSIFYINVPIGIIGYIW
AHIVVPDNKGVPEKFDIYGSISFFGFLASLLLFISEGGTWGWTSLPSIISLLTSVTFLTI
FVIIENKVDFPMFDFSLLKIRSFTFGNISTLLNFMSQNTMTFLTPFLLQHLGFTTEKAGI
VMTSFPLVMFVVAPLSGILADRYGAQILSTIGALISATALFLMVTLTEKSTMFSIMTHLA
LFGVGNAIFQTPNNSAVMGSAPKNRLGVASAFLATMRNVGMVMGIAVGSAIFTNRLKVYQ
ALKFSSNTTFMMAIKEAYIAAGIFSLICAFTSLVRNDVKLIKGKD
>fig|340102.3.peg.138 Multiple antibiotic resistance protein MarC
MTPIEFIGLVGQVYAIMNPIGKLAIVGPLAVERPAHIRKIMAVTIFTVFVLSSIFAVSGG
FILNIFGVSIDSFRIAGGIVLMAISIMTLVSGSYVGVVEITEEQAVVPLATPLIVGPGTI
TALIVISSLYGPFVALGVALTASTLVAITLIIGIRVVKYVGATPLRLLGRFMSLVIASVA
TEMIITGIRNHITKWFS
>fig|340102.3.peg.962 Efflux pump antibiotic resistance protein
MRRALFAVFLSSFITPFMTSGLSVALPIIASDFSVGSAEAMAIFVLLNLAVAMWVLPFGR
LADMWGPHVVFRAGLGVAGVGFLLAALSPTIGFFYASLLVAGVGLAAVFGSNNALIFRLV
PPEKRAEAVGLNSMSVYVGLVVGPVLGGAVAQLSWRLILAIGAALTAVPYVMVRKSPRPA
GGGRFDVLGSALLATSTALVVIGVYAGSPSLAVPGLLLLAAAIFVEWRSPSPVLDVRLFR
NYVFTASLAAALLNYLATSALQPSLSLLFQKAFAMPPHYAGLLLSTQAAAMALFSPIAGR
AGNRLPLAALAAAGSAILAVTLFAYSAAPSPATAPLALSLIGVGFALFIVPNTTIILSAA
PPERRGTASALIAEARVVGMALSNAAAGQIMKNVPNITAGVSSVLAFLAYVSLATLALSL
VRAGGRPRKR
>fig|340177.8.peg.1222 AcrA/AcrE family multidrug resistance protein
MNNIVKPVLFIALCSSLTLSGCGDKPEMGRDGAKNQEQPALVVQQLQPSDAVVVSRYPAL
LEGKVTVEIRPQVDGVLRSILIDEGAFVKAGQPLFAIDDAVYRAQYQGALASQHAAEARV
VAAKLEVERLQPLVQNQVIAEVQLETARANYKAAQAAFDVAVAATRSAKVNLDYTVIKAP
INGFVGKITLRQGSLVTKNQAAWLTMLSDVSEVYASFSISENELLRFRQQYGQSDGRLGS
GSNNVPATLVLADGTRYPQQGRLATLSGQFDALTGAMRVRAIFANPQALLRSGGTGSVEL
SSSYNNVILVPQSATVEMQDKVFVMRLMQGNKVQKQAITIAAKSGNNYVVTGGIQAGDTI
VLVGADRLQDGMVITPRYETSPAQSATINSAVKRP
>fig|340177.8.peg.1319 Quinolone resistance protein
MLMFNHFIAMECYQQTFEKKDFYENPLTMGTYEECHFHGCTFINVDLSHYIFINCTFDGC
DLSMVKLNNTSLQEVLFCNCKLLGVPFSDCRQLLLSFRLERCMARLALFCRLKLKGSLWS
ECMLQEADFSEADLSNALFERCEFPQATFFHTNLEGADFRTSWHYSINPATNRVRKARFS
LAGIAGLLESFDVVIE
>fig|342108.5.peg.776 Permease of the drug/metabolite transporter (DMT) superfamily
MISLSQWRSIMGPIAIYALAALSALFWAANFNLAGPILADMAPLAAASGRFVLAAVIMVV
LVAGRGELGALLAAARKSGGRLALLGVVGIAGFNLLFFDAMRTTSAVNGALIMATNPLLT
AVLAALFLGEQLPGRQIAALPVALAGVSMVILGGARGEVVFGLGDVEMMGANLAWAVYNV
LARRLMPAGSPLVNAAIPMAAGALVLTAAAGLSGAEFTLPGPKAAAALAAMTVFGSVLAY
LFWNAAIARMGAGRTALFLNLVPVFAASIATLTGTPPNPAQLAGGAVVVAAVIFSMLPRR
PQPCLA
>fig|342108.5.peg.1824 Glyoxalase, Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily
MALLGHDHVNVVVTDMERSIRFYSALFGLGIVMDRPLSGEWFEQVTGLENARARCVILAA
PDGTCRIELLQFKTRQPAEAPLPSTPGLRHLALRVDDLGTCLETLHRQFGQTVTATQVPD
HIIRGGKGMCYIRDPDGAIIELCQYGLEQPEFR
>fig|342610.6.peg.1553 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MQRVTGIGGVFFKAKDAPTLRAWYKRHLGIDVQDWGGSSFSWCDANGQAAKGSTVWCISS
ATEGVFAPSNAPFMINYRVEALHDLVKVLKAEGCEVLDNIEESEYGIFAWVIDPEGNKVE
LWQPPNGH
>fig|342610.6.peg.3826 Acriflavin resistance protein
MSQHQLPSSSGNNNPLHGIIAWFANNSVAANLLLVSVIVMGVMSLSTLRKEAFPSLEPDK
ISVSVKYDSGDALQAEEGIALKIEEALETVPGIKRITSTSDATGSHVSIEKKTDYSLDEL
LTDVKNQVDAINNFPADAEQPVIDKSRRQDHALTIQLYGDTDRHTLQTLGELLKADLLAQ
SGISDVEQKGVLDPMMSVEIDEGKLQAYGLTISDISDVINQESSSPLSTSLRDSSKIIRL
KAANQAYWQSDFANIVLLTTPSGAQIKMGDVAKVTDTFAEDANSLGRYNQQNAVAIEILM
DDNSDITAIVEQAHSVIDNWQERGLLPQNVELTSWYDKSTMITERLSLLTKNAVTGIMMV
FVILAIFLNVRVALWVAGGLPFVFFGTLYFMTDTYAGLTINEMTTFGFIMALGIVVDDAV
VVGESVYSTRRQHGDSLNNTILGTMKVAVPTIFGVLTTVAAFMTLSNVSGPLGQIYAQFA
TVVTICLLLSVVESKLILPSHLAHIDTQRQVKAGLSGLWSKVQHGADYGLNWFSDNIYRK
VIEYSLRFRYAVVAGFMAFLILVIGMPMTGAVKVGFFPSIPGDTVSADLVMQNDAAFGQT
NTSLFMLEQTALQAEKNLMAKLDSQESEITSLQVVSSGDTSGSVTVELISGGAFSASEFA
KEWQRLSGTPEGSKKLQILATRKMVDNFKVELKAWDDETVMAAGALFKERLENTPGVNGI
DDNFNPGQPQLKFTLNAQGRALGMDTASLSQQVLQAFGGAIVQRYQRDKDEVKVRVRYPE
NARQTPADIMQSRIRLPDGTVVPLVNVATISSEYQQDEITRIDGLRAIYLSAQVDKNVIA
SNVLVDNLRRDLVPELTAQFPNLNVYFAGEAEQQSETTSSMSTMFIAALLVIYVLLAIPL
KSYIQPLLIMVAIPFGIVGAILGHWWNDLTISILSLNGILALSGVVVNDSLLLVSRFNEL
VKEEGLSVHDAIVASCTSRLRAVLLTSVTTYAGLVPLLGETSMQAQFLIPAAASLGYGIL
FATVITLILIPGLLMIQIDAKRGIINLLTLLGLRAKPDTESASTPAHS
>fig|342610.6.peg.4121 Permease of the drug/metabolite transporter (DMT) superfamily
MQLRDFIELVLLASIWGAAFIFTRTATPEFGPISLITMRASIASLILLPFVCNRVAIRQI
TEHWRGILIVGLTNTAIPFCLFSYSLLHIGAGYASVMNATAPMFGAMIGWLWLKQRIPSV
AVLGLLIGFLGVAVLSAAQAAAFDGISILPTLATLVATALYGYAGCFTKQHLSAVGPMAL
AAGSLFAATLCLLPLNIWFMPSTLPSPSSWVDAIALGALCTALAYLMYFRLIAKVGPSNA
LTVAYLIPAFGILWGIVLLNETLTPSMWVGVILVICGVLLVTGVASRVIAKRRLKAKPAV
>fig|343509.6.peg.367 Bicyclomycin resistance protein
MGAVTIMFTTWRAVFAIMLGYALLTMATLWLMTHETLNRRAPLRLLTTFDHYYRLLMQRH
FVLPALSIGSGVGGIYTLSIALPFVLIYRLRLSTFSFGLVMMFQTGSYITGSLLANRLLR
LHSLTSIIRLGVSVIALGGILFLLLPHLCVPAVWVWISPAAIWVFGNALVAPGLTSFAME
RQAEKAGSASALLGFIQIGIGFLDNTLLGSFYTDVAQGTAWLVPMSAFIAVSCGLASKRA
>fig|343509.6.peg.2371 Permease of the drug/metabolite transporter (DMT) superfamily
MAVFNLMLAILMNGQRGGPAVYAGLLLSLFGIGWLMCADGTWTPLRIMLHNIRQNPLSYT
LAFCGAIIWALYCNVTRKYAGAIMGTSYAAWNISIIQGNMTLLATASYFTLVFSEEFASL
WLVSI
>fig|343509.6.peg.3022 Multidrug resistance protein B
MLGATLNINLQRRLPGIDDPVQHLIGQDGQGLAHMVQQVAVSMHGVYWVSMLISLCALVA
AGLLPHGLRPRQED
>fig|343509.6.peg.3925 Multidrug resistance protein B
MLAGIGGVVAEPRNLVSFSVLFGMSQNIGGLLGTFQVLREKFHSSQLTERLTLANPLVAE
RVNSYTAAYGGVLNDSYLQGVQGLSQLQSIASREANTLAYNDVYLLTTAIALVTLVWILW
RLLRLRIQARRAQGHDDKTSGNGGGAGKRKKQ
>fig|343509.6.peg.4088 Permease of the drug/metabolite transporter (DMT) superfamily
MAIISAGNAAFLISMFVIFTPLVEWLVCRGRLDRRLLLSALLSLLGVYWLCGGRALHLGR
GDGLVTAVALLRACLVCYTRRLTAHRPVPALALNAVQTGMVAVGGWLLLLVTFRSPPPLP
ASWSFWGITLYLALFATLFAFFAQNYAAGRTSPSRLSLLLGTEPFFGSLLAALLLNEHLT
TSGWIGGGCIFSSLLMVLTRRRAMLSLAG
>fig|347257.4.peg.635 Multidrug resistance ABC transporter ATP-binding and permease protein
MLKMVKILPSKIKWVFIIGSFLTLIYALLNVMLPLLIKKYIDLILTEDRQAPYRMDFLNG
RIDFGFVSYNEAFKWLTIVVLLQTILTASLAFLSTLVIVLAAERSSYFYRNTLYKKIQSY
SLKNIADLKAESIITRISNDIAIFWEFLVNGTSVMIKGIFLIIGGLTVASLVDWKMSLSI
IAIIPIVIVMGTIISLKTGPLLKQTQKAVDAVTKVVDENISGIRVIKTFNLETKRLDLLK
DINNAWYDSQYKSAMIFSTAYPVFQMLINWLMIGIYSVAGYYATISQINKDILTNIHLFI
DLLWQVAVGILLMLLFLSSLFRARVAATRIIEAYDYETDNLRVEKGEIIDEYDVEIKNLS
FKYYDASPNFAIANVDISLPYRKSLGIIGPMGSGKSTIVNLLVNNYKYKEGSIKIGNKEV
SLVNSKNLHETVGIVHQEALLYTGTIRSNMLWAKDDASDEEIMQALKDACADDFVSKFED
GLDHPVYQGGKNLSGGQKQRLSIARALLRKPKILILDDSTSALDNITASKVIDNIKEKYE
CSTIIISQKISNIKNADEIIVMSTNGFIISRGTHNHLAHSCEFYKQIYETQLEQ
>fig|348780.3.peg.237 Multidrug resistance protein homolog
MFGTDRRVVVLALARMADAVANSFLIIVLPLYIASGELALPAFEGASVLGIPLTVELLIG
VALSLFGFVNSFAQPFTGRLSDRTARRKIYILFGLVVLAVTSVAYALVESYEALLVVRAL
QGLGGAFVIPTTIALVNDLARSDAERGGNFGVFNTFRLIGFGFGPIVAGVVVQAGPYALP
LGTELSGFNAAFGVAVLGALVSFTLVTVLIEEPPMAAADATDDLSIAVFGDSRLLDPVFV
LGVATFFMAVSIALFATLQEPINDRLSQGPLWFGIQFAAVVVANVILQMPIGRAADRIGR
RPFLVWGLVLLVPAVLAQGLVTSSWTMLVVRLLHGVSVAMVFAPALAVAGDLAEEGESGT
TLSVLTMAFGLGTAVGPLSSGVLFGYAFVVPFAAGAVLAFLALVLVATQVEETLETATGG
PILGGR
>fig|348780.3.peg.1522 Permease of the drug/metabolite transporter (DMT) superfamily
MRPLRNLGLFFLLAALWGFSFPAISAGLEALPPLLFAALRYDVGGVVLLAFLAARGADWR
PRTGEDALAILIAGAFLIAGNSLLFVGQQTVPSGVAAIIYALIPVLTTALAAVLLPAEPL
SARRIVGVALGLVGVAVIARPDPEGLLSAQLVGVAFVVAAALSVALGSVLLRRRTPTVGV
APMTAWAMVVGGLLLHAGSFVAGERLAHATPSAVAVVSVVYLAVFASAVGYVVYFTLLER
FGPLEINLVSYVVPVVATLGGIALLGETLTAGMVAGFVLIASGFVVIKARTIADELGR
>fig|348780.3.peg.2004 Fosfomycin resistance protein FofB
MLGDCRWLTLEVTSLDSVAPFYRERLSLPLIEATDRQYRFDAGGSSELRLRRPTAVPRGG
LHTHYAFSCPADAYDAWWDRLDADFDLQEVDFGSMRSLYLYDPAGNCVEIAGADEPSGTA
GRTLSGIFEVVFEVADLPASEQFYTALGFEVVDRGENRTRTRLTNGPLDIELWEPQLGLA
DARGGVHVDVGINAESPAAVADNVAERVTKREQLDDGAVRIRDPDGHYLTFVRSER
>fig|348780.3.peg.2392 Permease of the drug/metabolite transporter (DMT) superfamily
MSLRRAIGLFAVASLAFGGTFVAARAGQVYIPPLLFVAIRFDLAAILLLGYAAYATEGSI
RPRTRGDIGGVLAAGVLTIGLANGLLFVGQGYVTSAVGAILFSLVPIIAPLFAALLLSDE
RVSALGAVGMGVAAIGVGMVVGVSPSNLLAESGVGAALVLGGAASAALGTVLTRRCEATI
SSTAQVAWGLPISAVLLHGMSLAVGESAAAIEWTLTAIVSLAYVTVVAGAVGYIAYFALI
EEVGALRSSLIFYASPLVAALGGWWFLGEAITTTTVAGFVTVVAGFLVIGHEQFRAAFRR
LADGRGQATGGYEPSD
>fig|349124.5.peg.724 Bacteriocin resistance protein, putative
MNRHATPLATLGALACLALATPAPAQAAGLPIPHLGGGHHVVVESLQSVRFRGVERQALD
YSCGSAAVATLLSYHYDHSVGEPEVFAGMFAAADQQRVRTDGFSMLDMQRYLAELGYRAD
GFNLTLEQVAALRIPSIVLIDTGGYLHFVVIKGIRDGQVLVGDPAMGLRAYNAETFKQLR
RGPLLVIRDRHDLAQLTFNPDRAWAVQTRPPFEHAREHQGLSDFTRNLRRPGDW
>fig|349124.5.peg.1615 Permease of the drug/metabolite transporter (DMT) superfamily
MLNRALLSGLVAGIFSVSLWGSLPLLRQLTELPAMMTTVVALAAAAAVAWCSAIFVREPH
SRMPDPDLSYWLGGVLSLVAALYLYFAALAWGEPARVTLVTYLWPVVFVLVANWLAGCGV
QLRVLLGMGVAFIGVAPLILGDAPAGAETPLVAYVFGVISGCAWAAFSVYLTQAGTIPFR
GYARMFAQAAVIAVVLAVLFGESVGTPQSTDWLAAALIGVGPYGIAFMTWGFALRKGPTG
LLGVLTYMVPVISAVVLVLTGFTEPELALLVAGLAVVGGALLAQSAEAQSESGAAERDPD
AVEDASARRAMDRASPENIRE
>fig|349161.4.peg.324 Permease of the drug/metabolite transporter (DMT) superfamily
MSAKRVYILMVLAALFWSGAFITGKLAVREFPPFALTFFRFSFALPFVLWEKPLTYLPNA
TTEGWLAILYMAVFASVLGYLFQLIAIQNIGAPKAAIFINLVPVFTIMQSLLFLGEPFSW
FKMLSACIIVTGVYLTTRPESGVKEAAGIKA
>fig|349161.4.peg.569 Permease of the drug/metabolite transporter (DMT) superfamily
MHKHRGIIFLIAAITFFSMMPIWVKLAYTTGLSAFDVTFLRSGMAAAMLGIFILYRKINF
HVERQQLGPLLLSSTLGYTATMISLYLSYKYVSAGVATSLHYLFPVLVMLLEYFIYHEKL
QFYKWMALLTSLAGIYLIAEPGGSSFSLRGVGLAISSAVFFTFYVLSINHPQLKKMDSLV
LAFYDCLIASITSLVLLVAQGNWPLTLTLKGLYYTGLVSFFCTALALIFFIKGVQSIGSA
NASILSTLEPVLSLVAGIIILHEPLTWYTSLGCILIIVAVILIGYSDLSEDSPA
>fig|349161.4.peg.818 Vancomycin B-type resistance protein VanW
MTHSFCQVCLIMLLAEFLATALYYWGKLHINQYTWVSVPSIATLVMAILLFALNPIVLAK
EKTPTVAAAPKKENSIKQMETIPMPKQDERMVEQGGRKPVVKGIGPKLNVYTPQGSETEL
DLSEKPALLFAWWCPHCDYVLQEIAQYSLSDRPYLVVTNLKGDDLKAIDEKLKANGLAGV
PYFLYYEQPPVESVPASIWWSEGKLNTSPGYSIKPDSKKLLSKARIPITKDNGGKNAILA
GKAIDGAVIPPGGIFSFNQIVGERSPERGYRVSGVIESDGNGGYKYSQGTGGGVCRTSTV
VHWAAKKASLEVAEYHKHSLPVAYGKVDEDAAVAWPYADYKFRNNTGDKLSVKVQHTDSW
LEVEIWKG
>fig|349161.4.peg.947 Vancomycin B-type resistance protein VanW
MAVGFFARPWILWGAFYYATAGILTLTFRKNFSVAAFLSTGTIFHMTLTYYVYQAEKSIC
PSCLLFLIAGLILTLMYVFKDFSRWDPKFLPGAGLGLLIVSVILLTLGYNNTGAQSQPAF
AETKKTQPEETITITVNKPSSETSKKQETIPGEPEPLSFGSQVEVKTKHGEALKIDLNKK
TALLVAWWCPHCDYALKNISKYYSNDRPYIVFCYNDGDQRDFIEKKLKSANLTDAEYYIL
EGDPPVDGVPTMVWWEKGKLKQGRAFEVSSSVQKLIGRAEIRIGKGNGAINAALSGEAIN
GKEIPPGGVFSFNETVGERTVERGYVAARQIISTPEGYDYADGIGGGICRTSTVLHKAVM
AAGLLEVEHHSHSLPVDYEEDTAVAWGGWDYKFRNILSVPVTIKCQKINENLVVELWQN
>fig|349161.4.peg.1502 Permease of the drug/metabolite transporter (DMT) superfamily
MGRYIHLLLLTVSFFWGTSFAAAKIGLQELHPLNLVILRFTIASVIFYVLLQIRKERAIE
VKDIPTFIILGFMGITSYFYIQFTGLQYTNTIHSALIIATSPIMVAIIGAALKIEKISRA
MSCGIALSFIGVSLVISEGNWAGIFQSTTIKGDLMLLSNAIVWAGFTLYGKKILLKYSPF
VAMAYIHIFGTLLLLPLLAVPDLLGTHSLMKQLAELSWPTVSAALYLALFCSVYAYFVWY
AGVEKIGAIRTSVFAYFNPLFATLTGVLLLNEKISFITIFGGCMVMAGVYITNEFKPKTA
ARDNKKGLNISD
>fig|349161.4.peg.2622 Permease of the drug/metabolite transporter (DMT) superfamily
MIYMLMVFLAGCSFGLVSTVVKLAYGSGLQPDAVIFAQFFLGWAILVALSLFVPRHKIDL
KTGLKLIMVGITNSLAGILFFLSLKTLPASIAIVIMFQFTWIGVIIEAIADRKWPGKEKI
ISLPFLIMGILLAGGVFGSEIKLDIMGVIYACLTALTFAFFIFFSGCVAPNHPPINRSVW
IISGALLFTFVLYPPKFLITGGIEGGLLGYGLVLGLLGPVIPTLFLAKGVPQIGPGMATI
LASSELPVAVIASSIMLGEYVSPLQWCGVLLILLGICLPQLSQLKNQTGKTT
>fig|349163.4.peg.640 Permease of the drug/metabolite transporter (DMT) superfamily
MEAMSDIARPSSPVSGFLSRPNAPVLVLLSVTVIWGWTFLLTRLSLLFIGPYAFVGWRFG
VAALAVVLVTRPHPASFNRMEITGGITIGLVLFLGYGLQADGLRTVASGESAFLTALYVP
MVPLLEFLIFRRRPGLFATAGLVLAFVGLVLVSGMTGLSLAFDRGQWLTLGGALGAALEI
VLIGHSALAADPRRIAIVQLATVSVISFAVEAVRGGIMITTRAFPFAAMTGMGLATAFVL
VAQNWAQRSIPANRATLIYTLEPVWAGLVGAAFGEIFAPAQVLGGVLIIASVVLSQWKS
>fig|349163.4.peg.1052 Membrane fusion component of tripartite multidrug resistance system
MNELKERSENRPAVSRATPVDGSRRSRRPFIILVLVLLGLAGASLVYWWRTRDFASTTDA
EIDGSIHQIAPRISGQVVAVLVKDNQHVVRGQLLVRLDDGTQKVALDRAEAERAQAQAQL
GAREADLAEARANVEVADATLFRAKRDEARYAKVDPRAVTPTTRDAIAADLRAAVARTDA
ARQQVKAAQAAVAAADAAVKAAGVAVENARLELGYTEIRAPVSGWVAKKTVRTGNVVGAG
TAMMAVVGDHVWVTANYKETELGAIRPGQSVNVYVDAVPGVAFHARVASIQHGTGSIFSL
LPAENATGNYVKVVQRVPVRIEFDDSRISRYLLAPGMSVEPYIRIRGK
>fig|349163.4.peg.1053 Inner membrane component of tripartite multidrug resistance system
MSLLYASRPNTPRSAAGLYNPWLIVAMVALAPFMEVLDTTIANVALTHIAGSLAVSPDES
TWVLTSYLVSNSIILPITGWLQDVVGRKRLFLICVALFTASSVFCAVSTSLTMLIVARVL
QGLGGGGLQPITQSMYADSFPAEKRAQVFAVFGLVIIVAPATGPILGGWLTDHLSWHWVF
LINLPIGLIAFTLIAIFVDEPELLVRERAARLAGGLRFDWLGLLLVAVGFGALQIFLDKF
SIDDGFGSFFIRSLFAVWAVSLSTLVVWEWGHPEPVVNVRLFAHRNFAISCLVMFVIGFI
LLSTTQLLPQLTQTLMGYSSETAGFALALGGLATIGLMPLAGVVTGRIIPARVLLVGGLV
ETGIALIFQSHLAPNASFYTISIDRVLQVIALPFLFIPISALSYVGLPPARNGDASAIIN
QVRNIGGSIGISFVTTLLAWRTQFHHARLAESVTPYASLHGQTLSQIGAAVQHQAAFMSY
LDLFHILGLMALLVWPVVLLLSTPSSPAAEGVVYEI
>fig|349163.4.peg.1054 Outer membrane component of tripartite multidrug resistance system
MRSEVFAPRLRRRALMGTAMLAAMALGGCELGPNFHAPRTRTAASFLANRPALTSPDTVS
QGKVDLAWWQSFDDPALTTLEHEAIARNLDVKAATERLAEAEAQAQIEGAALYPNLNFSG
SYTREKPSNKGVFTALSGGGSTSTSTNAGSTASGSSTSIGGGGLPGSELQPFNLFQYGFS
SVFDFDLWGKNRRAVEASLAAVQASRDARRAVLLNTEAEVAHDYINLRAQQAVLAITRRN
LASAEHIANLTRQREQAGLANALDVADAQAQAESVRAQIPTLRTAIAADINQLSLLLGEG
PEALRAQLVTAKPIPPVPPVVPIGLPSQLLQRRPDIREATARLHQATAEIGVATASFFPD
ISLAGSVSLQALQFSNLNQLSAVTYAIGPQITMPLFEGGRLRGELHLRKAQQREAAVNYA
KTVLTAFHQVDNALTAYDEEQKTQAALQADVTQTRRALSLAQERYREGLIDYLQVLTAQQ
SELAAEQAQAQSQAKISTDLVSLYQALGGGWEQNEPAAG
>fig|349163.4.peg.1334 Multidrug resistance transporter, Bcr/CflA family
MSSAQSAVAADAPDLATSRRLPLLLGFLIAIGPVSVDMYLPAFPTIARQFHDPAGPGLTL
AAYFAGLAAGQMTQGPFSDRAGRRLPILLGLALYTLASIGCALAWNTASLSAFRLVAAFG
GSAAVVVPRAMVRDIADGPAAALLFSRLMLVMGVAPIIAPILGSAVIAFGSWRWIFALAT
LYGIVAIGLVWFRLPDTLPLARRSTVGFRTIIIRYGQISAERGFLTHALTGTFAIGALFA
YLAGTPAVFIGEFHWDPISYALLFGLNAAIYIGFNQWNPHLVARAGLRPVISAAVAALVC
GTIVLVAAALRGGGPLPIIAGLFICQASYGLSLPSSLVAALSRHQAHAGSASALLGTWQY
LGGAITGALVGAFADGTARPMAFAMFACAVLAALAAAFRPQRLT
>fig|349163.4.peg.2358 Multidrug resistance protein A
MSQTSTATGPVAREAEMRQEATRGRSRSGRMLRPLLMIGGVLVILGAILVYWLLSGGTVN
VTDTYVRAARVALSTDVSGLVETVDVHDNQQVKKGQVLFTLDPSRFRVAIAQAKANLAEV
GQEIEATRAGYRAEIAKIRTQQSVVDNDRLNFARYAALVHTGGVTRTAYDDAKYKLQGDE
ATLASMTAQAGVDLAKLSGNPKIKIGDTPQYKAAKAALATAELNYRHSIVRAPFAGVVTE
TDKLEPGMFLPAGTSAFALVSTSDVWIRSQPKETSLTWVKPGDKVKVHVDAYPGQTWQGV
VASISPASGSSFSILPAENSSGNWVKVVQRIPLRVNITGGPKDLVLRNGMTAEITITTGH
QNRLSDLF
>fig|349163.4.peg.2359 Multidrug resistance protein B
MAGPASHEEEMQLSGLPRAIVTVGCMIGTLMQALDATIANVSLPYMQGSLSASYDEITWV
LTSYVIAAAIMTAPVGWLAAQYGRKNIFLISLVGFTVSSMMCGVATSLGEMVMDRLLQGV
FGAALVPLSQSTMLDIYPVEKRGSAMAIWGVGVMIGPILGPTLGGYLTYFYNWRYVFFVN
VPFGIAAVLALGAFMPKRARRPASGQFDWIGFAVLSLFLGSLQIMLDRGQEKDWFGSPEI
VTFAVLAVIGLYLFIVHMMTAKNPFIPRGVFADRNLNAGLITMFAVGSVLLSSATLMPPF
LEKLGNYPVETAGLVMAPRGIGTMGAMMLAGRLSNRIDPRALMAAGFALLVVSFWMMMQW
LPSSPQSYMIETLIVQGMGLGFVFTPLQVVAFYTLPQALRTQGTSLLSLMRNIGMAVGIS
VTEAVQVQMAQVNHATLADHVTPFSRNLQVGGAVSRLLDPMTHAGAALLNATLDQQAQII
SFIDAFKFMMVISIPTMLCLLLMRRPPQAAMAAKAEKPEMAVME
>fig|349163.4.peg.2497 Multidrug resistance protein B
MSVSSSTRELDARSRAGRKNEVALVPMTIGACLGLAAGSFCGGSLQSIYPYVAGRLATSS
DHALWTLTYFLIHWALGIALMPWFARKLGFKRLFLASMIMLAIGAGMGILSHSLMTMLVA
RGVQGISSGLLVPLVQTLLLRHFPKRHHTLATALWSNSMLVPFFFGPAFGGWLAVNYDWI
DLFWLVIPFALLAFVLIRVSLPEDRPTAPPPPFDLVGLALLWLGLIALQIVLNQGEQFGW
FGSPFIQRYTVAAILLLGCFIIWELTSEAPLLELRFVTNRNFGFGLLLLCLGWSIFVGWS
SILPLWTEVDLGYNGWWGGVLLIPLALTAIPVASAMGRIARHVSLRMLAALCFLLFAIAF
AMAVYNPEIGLAATVPSELLQGIAVGMLFVPLTMIILSEIPADDLAAASTTSNFIRLASD
IVGVTMLQTLWQRHTESVAALTRSAMSESLVRQALAHARQDGMSHAQTMAMIAGRLQLDA
STWSLDDALRLSAWICLGAAAVSLVVLKKPRPQGG
>fig|349163.4.peg.2572 Permease of the drug/metabolite transporter (DMT) superfamily
MIAAYAALAASMVIVGGNVVLLKLLAAHLPTFPLLFMRTSFATLCLAPLVAPRLPAPRTL
AILFMQAACGTLLYNGMMVAGLKLTGAVQAGLVLASLPAVIALGAALFLREHLRPLQWAA
VVLAGVGIAALARGGGGFSLVGDALIFGAVCGEAGYALFARRAAGLLPVMQATFWMQACG
AAMTAPLAIASFGQVHFTWLIAGLLLVNSLTSSVLAVILWYHGMRRVQAGIAGTFTALLP
ATATLMGVLVLAEPFTRGDAMGFAALFVSMVLILRPQRRPPWKRKASA
>fig|349163.4.peg.2823 Fosmidomycin resistance protein
MAVVMDQGLRTVGGTVRYGRLAALSWLHFLNDGSANYLPGVLPAVLLAMGEPVSLAGTVM
AALLIGQALQVGTGLLADRFGGRGFIAAGVLGTALAAALIGRSGSLALLLPALVLIGISN
AMFHPQALAGARQLSGPRVGLGMSLFLVGGEVGRGLWPLIASFVVVTWGLKALSLLAIPA
VASILLLWAVLPVQPPRHVAAQPIAWRRHLGPMSALVAFQSLRALAIFGTTTFLPVLWHL
RGHSLTAGAALITVMLVVGIIGNVGGGHLADRIGRRPILAGSSLAGAALLAAFLLTSGAA
QWIALGLLGIALFATLPVGILVGQDIFPENRSLGSGIALGLSNGLAAVGLMGLGLISSAV
PPLHILWLLVAILLAAALLALRLGPRTHPKRT
>fig|349163.4.peg.2877 Polymyxin resistance protein PmrL, sucrose-6 phosphate hydrolase
MIDNLILLLFTLLMASGQLLFRKVGLDLRGHSLASGVPVLLRAPALYAALALYGIATLIW
IWILSRVPLSRAYPYVALGVVLVPLASRAVYGDAIRPIFWLGALLIVAGILVTQLGSSG
>fig|349163.4.peg.3042 Bacteriocin resistance protein, putative
MTQTPQPRDRTRLSGTHAPGCRAILAALCLACGIAGPAAAGNFPINGLSLGAGSVNMPIQ
SFESMRFSQTIHQAYDFSCGSAALATLLTYAYHRPVTEKKVFLSMFRNGNREAIERYGFS
LLDMKTYLAREGIPSGGFDAPLSKLAGLHVPAIVLINDHGYHHFVVVRSIAEGRVLLSDP
AVGLRSESVARFRKQWSGIFFLILSQAEIAQKNYNDPSLWQGSPPAPTEIARYALSLARL
QEVTIPIANRF
>fig|349163.4.peg.3129 Multiple antibiotic resistance protein MarC
MDLAFAARFLGAFFAIMNPFVTLPIFLSMTADRTVAEQRSIALQIGTYSTVMCLVIAVAG
NAIIGFFGISIDAFRVAGGLVLLGIAFSMLNGHPITAHERGDHEKSADSAADAADDAEGG
IAFYPLTFPLVVGPGTIATLIIYAGQARGVPEYVAFGLITALLLAVLIVVLYFAASIGRL
LSARMRVVMTRLMGMILAAIAVGMVTAGLKILLPGLT
>fig|349163.4.peg.3367 Tetracycline resistance protein
MGFIFAVLVIDSIGFGLIAPILPDLVEKLSATPASHAALWVGVLSMTFAATQFFAAPVLG
QLSDRFGRRRLILVSLAGSAANYLLLAFAPNLLWLFVGRLIAGATAGNVSAASAYIADIT
PPERRAQRFGLIGAAFGLGFTTGPVIGGFLGAIDLRLPFLVSAGLVAVNVVYGIFVLPES
LPPERRRPFRLREATPLGAMRLLTTVPRLWRLAAAWSVRWFGLGAIQAVFVLYASLRFGW
GPRENGIFFACTGIASTLVQFGLVRRAVTLLGERGAAFVGFACNAAAYMIFGVAPTASWL
FAGVGLMALGSIANPAIRSMLSRAAPADQQGRMNGALSSIEGLTAIVAPLTGAVVFEAFS
GVLPWRFPGAPFVMVAVMLAGAAMLVWSVKPVQAAPEIAPSPARN
>fig|349307.9.peg.367 Daunorubicin resistance ATP-binding protein drrA
MKDAVCASGICKGFNTIFRGKKEVLKDINLLIDGEEIFGILGPNGSGKTTLLSIFSTLIY
PDSGELTILGIDARRNTHEVRKLINISTGKPNFPWSLTVKENLRHSGMLYGLHGRELDRA
VDWSMESFELYQYQDTRFENLSTGVKQRLSLAKAMLNGPKLLFLDEPTTGLDPQMAQRTR
ALVKRIHRDMGVSVVMTTHYMPEAEELCGMIAFLKEGRIIAQDTPARLKRNLKIGERMRI
RYSGNIDCDALRSIPGLISAEISKGRADLVVDKNEATFSRVMRTFQSAEILELELEEPDL
EDVFIELAG
>fig|349307.9.peg.1382 Multiple antibiotic resistance protein
MSCTHNLEARYIGGSYLDLAIYLQYFVYVFTSLFIIVSPIEATMVFVSLTQDASPAERDR
ICVRTTLVAFSIAMVFALAGDMILRFFGITVDSLRVAGGILLFLVAIDMLRAKPHKKVTQ
AEIEDATTREDISIFPLAIPLLTGPGTITTVIVHMGASNTLPEKMIVLLAICLTFGATYA
ILKSAEHIHDILGVTGIMVFTRILGLILGAIAVDFVSVGAWNIYISMASGA
>fig|349521.5.peg.451 Permease of the drug/metabolite transporter (DMT) superfamily
MAVVIFAYAMVILVWATTPLGVVWSSQSFHPTVAVGLRMTIAAVVTGVIIRLYRIPLHWD
RDSLYSYLCGTMGVFGAMMLTYFASKTVPSGLISVMYGLSPIMSGLLGVYLLDGARFQKS
QWLALALAISGLATVFGKDLHATGSIVFGLMLVLGAVMLFSLSGVLLKKQKATPHPLALT
FGSILLALPGYFILWALMDGATPRIELHDRGLWAVVYLALIGSVLGFFSYYYVLQKLQPS
TVAMATLVTPVLALMLGVTLNDETIHPTVLLGGCLILVGLALYFDLPRKALRWLRPISEP
ALVLPLSNEENKCTDQQRAGEIEIKAHSNHGSLRN
>fig|349521.5.peg.1028 Drug resistance transporter, EmrB/QacA family
MANSVEPLSEYHGALAALLLSTFLTSLAISSVNILLPALVSSLDANYAQVQWVVLAYMIA
LSSFLVIAGGLGDTYGRRPLFIAGLGIFMVGSALCGMTENIGMLSAYRGVQGIGAAIVVS
LNLALVRDVAPTGHTGRVMGWVGGMSAVGTAAGPVLGGLITGFADWRWVFWLNLPLGALT
LLLAVRYLPRASQGAGKGSKPFDLMGAALLAMIVLIYSFGIKLKLEGALLRFFMAGLALV
LLVAFVLVERAKPSPLLHLSLLHDYRYGLSYLIQFIVASAVMTALVIGPFYLISLGLNLS
MTGLVMGCSPVCVMITSSLIGRRVKQETCSNMASIGVLFLFFGSLGLAHLSAATGVIGYI
ACLMVTAIGYAIFTVANNTQLMARAAPEQRGQISGLLNLSRNLGMLTGAALMSALFDSVT
NASALSALTLQLAETGLHRVYVCVSVVLCFGLVVRGYWHFREYREKDGIRTLT
>fig|349521.5.peg.1511 Permease of the drug/metabolite transporter (DMT) superfamily
MTAFLYIACILLWGTSWIAIHMQLGEVPILTSIFYRFAIAALLLLPTLFLLKKIQKTQPV
DHLWFAGQGLCFFSLNFLCFYHATQYIPSGIVAIIFSTVLLFNSINRWLFLRQSTSQSEF
IGIAFGIVGIVLLFWRELTQQNFGADFFTGMLFALLGTLIFSLGNMVSVRNGAKGITPLT
GNGYSMAYGAMVLLIAVFATDTPLRFSFTSQYIFSLLYLAIFASVLGFTIYLTLVNKIGI
NKAAYCMVAFPVVAILISTLFEDYRWDATTFSGVGVIIFGNFLMVSKLWWRPASLARQQS
>fig|349521.5.peg.1635 Permease of the drug/metabolite transporter (DMT) superfamily
MSLLDLLLGLLANLAWGFNFIAGKEGAQHFQPLLFTALRFAILLALTAPWLKPAKGYMKP
LLSVAFVLGVLHFSMMFLGLNAGGNIASVAIATQLYVPFSAILAAAILKESIGWIKGGAI
VLALAGVFIIGFDPVVFNHLDALAWVVGAAASMAVATILMKQCPTLGVMRLQAWIALVAT
PSLLALSYIFEDGQWSLLVQSEWSDYWAPLYSAVAASIIGHGIVYRLLGRYSVSLVTPMM
LLAPIFAMVFGVVWFGDVLTWKLSLGGALTLLGVVIINIPREQLRRVMHLLAGKRGASV
>fig|349521.5.peg.2050 Permeases of the drug/metabolite transporter (DMT) superfamily
MPQDRFLRGVAFIILGECFFVLTGMVVKHISVEAHVWQMVFFRNLFGLAFLTPLLLRSGR
SAFKTQRLPLHFLRAALGVAAFSCLIYTFASIRLAESTMLKLMLPLFIPVIAWAWLRERP
TPILAFSLGLGFLGVIIILQPDSLAAAARLAILAGLWGALFAAGAKVVIGRLGATEPSVR
IVFYFNLFSTILSCIPMLWYWRALEPITLVWLLLFAILATIGQLSTTHAYTLASPGKIGL
YSYASLPIAGLLGWLIWSEELYLELWIGSGLIVLAGALTFFYSRPRKPEIATAQD
>fig|349521.5.peg.2220 Permease of the drug/metabolite transporter (DMT) superfamily
MTVERARIGQGIAMGVLAALIWGIWPVISRLGVQQTLTAYDVAAIRFIVAGVIFLPWVIK
SGLGGLTWRQALILTTGAGAPYVLISVGGLTLAPASHGGVIISGCSFLFATLGSVLLLGD
RPTSQRWIGFVLIALGILSIGYRSITSSSAALADAWIGDLIFVLSGFLWASYTLNSKRYN
VPPVMGAAVVSVLSMLLYVPAWLAFGEPHIFQASAQELIVQGVFQGVLAAAIALVCYTKS
ISILGAAQAAVFTSLAPGLAVLFGDLILGETPSSAEYIGVSLVILGLLTSLGLFNWRRAS
GAVATDS
>fig|349521.5.peg.2492 Permease of the drug/metabolite transporter (DMT) superfamily
MSASASINAHSEASLTRVTPILSDSKQKLLGYGAACLTVLIWSSYFLSLKFGALSPLGIF
DLALFRFCIPGLILTPLLIKRRHRILAAPKLYLLGVMLGAGLPFFLLSAAAMGWAPVADG
STLIPGAAPLFVTGMAVLIFKEPLSVWRRYGLLAVAVGASCFLYSSLSNPSGDLWRGHVL
FLFCSAMWAVFTISVRQSGLKPLEAAAVVTTPNAALLLIWALWSQPELAWSSLPVMELTA
QMLVQGIGVGLGAGFLYSFAISRLGAEITSAIGSMTPVCATLLAAVLLQESVEFASLLGL
GLVTSGVICASGLLNREKA
>fig|349521.5.peg.2844 Multidrug resistance protein A
MTPDQKFAQWIKYSCIVFVLVFAYFLIADIAMPLTPQAMATRIVTKVSPRISGPITAVHV
ENNQPVHKGDILFDIDPEPFKIALEQAQLNLERVKQNNTQLDASIAAARADVDAAAATLS
QKNREALRLKTLFQRNVVSQQQLDTAESNATTAQAKLASMKAHLKELEVSRGELSDANLT
IRTAETQLKQAQLNLSYTRIKAEEDGVITNLQLEAGAYAVAGSPLVALVSDNLDVIADFR
EKSLRNFDLNNEALVAFDGKPGQVFQAHLTSLDAGVSAGQFDADGRLATPTQSNRWVRDA
QRMRLHLQLDADAQHLPSGARATVQLLPDGAIFSTFAKAQIRFLSLLHYIY
>fig|349521.5.peg.3186 Permease of the drug/metabolite transporter (DMT) superfamily
MQRKELDMWRNHPFAFGIIAITVAAILFGVAGALAKVLFHADISPLDLTAVRSIVACAVF
SLAMLLTQPGVFRIKKSALPLLIATGLAFTAVNITFYYAISMISVAAAITLEYTAPFFVL
LISVVSASRRVDARDVGIVALSVAGCFLLTGGEAELFSLNAGVLVGLACGLAFAVFNMLG
NACKRRGVGATTVTLYAFLISSALWLAALPTLTVHEIDYSGDVILYIAFIAIIATIIPYW
LLMYGLRHVDALPATIIGMFDPLVAGLVAYALVGERLTVVNMVGIGVIIVAVCLITIKEK
NAPSSSQKNNAKKAPDESSGTLQEPTQNAY
>fig|349521.5.peg.3248 Permeases of the drug/metabolite transporter (DMT) superfamily
MENTHNSKAMTFVFIAVVAGTGMDAFVKQVGEDVDTWQLLFLRWCFAALLLIPMAVKEGA
GIFVWKSPKAHLMRGVLNCVASFLLFYSLANLPLAVVVTIFFAEPLFIVPISALWLREKV
APGHWLATLVGFIGVLLIARPSGDFAPLEIIYPLAGALGFALLHIGTKKYGSQESPISLM
FWLAILTILMSGPMAVAEWSPVSVKDFSFIGLIAVLGSVYSYFWIVGLRIGSAAIAAHIS
YLALPLAYLIGWAFFDETPDFYTLLGSGVIFLSVLMVSVKNGMKLPLPRALRRDKTYDAK
AS
>fig|349521.5.peg.3592 Permeases of the drug/metabolite transporter (DMT) superfamily
MKQIQQSPDNAAPFLAMAALSAVFMGTIGVIAKYAQLSAETVTFYRLFFGAAMMLGYLLV
IRKASLLWCWPSWRVLINGGFLAGFIVFYIQAMEHTSMANAIMTIYLAPVVASVFAHLFL
SEKLSASAMGLILTALFGFAMMMEFRLEFGGSQDALGMTYAGLAMLCYAGFIIINRATPA
HVHVYARSWYQMLIGALCMAPLMLQQQQVIAPAQWGWLLAAGLIPGFLAILFAVIALREL
PSATFGTLAYLEPIAVVTFGWALFDQALSPLQIAGCGLIMCSGIAQAVLTQRRNAAISGQ
VCSVAQG
>fig|349521.5.peg.3692 Multidrug resistance transporter, Bcr/CflA family
MSGRSGLGILAPFLRYNQALLLFRTKLQRSRLMTSSTTHSRLAFILAMAVALGPFAIDTY
LPAFPDIAKAIGADIHDVSLSISVYILGLAIGQLIGGPLSDRLGRSRIMLIGLGVFLFSC
LMLSQSESLASLLVWRFTQAFGGGWCAVSVPAIIRDRTEGQETAKLFSLIGLIMIAAPAI
APTLGSAILAFADWRWIFLFLALYTGVVIVTLWFSLFADAPPHTPPPKRNVLADYLEILK
NTAALRFIFIQSLGFSVMLTFLTHASFIYQEWFGLSEFAFSLLFAGNIAVMALMSMANRA
LLTWVESAQLLRLAVWLQTCGVIALVSITILHPSLYLFAPALMLSVGSLGAAMPNGSACF
IQFFKSNSGTASALMGALQFTISGAISALSSALSDGTLIPIVAVMLLCALLNAAFAWGAP
SAAQKAPAGV
>fig|349521.5.peg.3780 Probable multidrug resistance protein norM
MAKARRETLPKSEQGTMSRLREVLKLSLPLSAAQVAQSAMIFCDSIMFGILGVEELAGAG
LGSAIFNFILVVISGLLAAVANEVAFHTGRGAQKDIIRIVKAGLILVVIVAAMVALAMKV
TPALLLGMGQEPQAVAYASQYLGQAAWISLPAFAFMVLRGLAAGMSRTTSIMRISFAAVA
LNVPLSYALMTGWRFFPELGIAGVAIGTALVSVFMCVMLVLDLNRYAEVREVLSGLTKIR
SRLVDFKPFYSLGLPIMLAWTMEAGLFTAATLLAGAMGAVALAAHQIALQAASMSFNIYI
GFAQGASIRVGQCYGEGRMGELKSYAWTGLSLGGLFCLVSALVFLLLPEQIVGLFTLGGE
GALDQDVLTLGVSLLAVAAIFQVVDGAQVIMMTALRALRMGATPTLITVVGYWLVGFPVA
WLLKGQWGIVGVWMGLGVGLGFTAICLTTLFNWRVNRALKGELQKENSTFVTAPTESQLT
HN
>fig|349521.5.peg.3930 Drug resistance transporter, EmrB/QacA family
MSHKKTLLSVSLLIFLGALEKTIVTTPLPVIGTELNAMNDIAWVVTAYLLTATSVIPICG
KLSDLFGRLKVIIVSLGIFCIGSLLCALATDMQSLILSRALQGVGGGALISLAFVVISDV
IPAREIGRYQGYISAIYVVSNIAGPVFGSLLTEHLSWRWIFAINIPLTLLAAFIAIRSIK
DKVVKREDRFNWGGSLLLVSSTTLLILLLSEDLSLPHAFSLVGALFIAGAWTYLLTDKKR
SVVPRHLFKLPNYAACILTMGVCQILMTAALIYFPLQMQVQNGVSLTLSGYSMLLFTLGV
CVSAYFSGKHIAATGAYKTHILVGFILIAVAFFLMLMKVAFVPLFPVIGLGIGFTLPGVT
CAVQNVLPAADRGVGISFFGYVRELSGAAGVVVCSSLYRGGGSLQAAYSAFGVIYLAMCL
FASLAFIIVAGFITEKELMTQVAE
>fig|349521.5.peg.4067 Permease of the drug/metabolite transporter (DMT) superfamily
MEKKDLINLLALAGLWGASFLFMRIAAPEFGPVAMVQLRITIAALCLTPIMLIKYRRQLR
WAHVPHYIFLGVSNSALPFVLLGFATLHVSAGFTSILNAAVPLWSAIIAALWLGDWLNRW
QTVGLLIGFFGVSILIVSKGEFSLTGPTLAIMAALTATLSYGVSANYTKRFMTGVQPMVL
AAASQIAAALALAPFTWSSMPQGDISTAAWTSVIVMGVFSTALAYIIFYGLLSRIGPTKT
VTVTYLIPVFAMFWGYVVLDEPVTIYMLSGCLVVFAGTALTNSLIKPKLAAAQ
>fig|349521.5.peg.4516 Drug resistance transporter, EmrB/QacA family
MSDTLLQALFDRHGPAYRWLAMLTVMMGTVSAVLTSTIVNVALPDIMSHFSIGQGVAHWL
STGFLAAMTTTMLTTAWLTQRFGLRHALGFAMLLFAGASVLGGLGPNAESVILARVLQGA
AAGMLQPIAMHVLFRVFPRNERGRAIGIYGMGVILAPALGPVLGGVIVDQLDWRYIFFAP
LPITMAGFLMALRYMPHREAAGEQHGFDWTSFFYLCLFIGCALDGLTRLQHGLVQPVWQT
VGALLAVFSLILFVRRQRYSRSPLLELALLRVPSFRSAFLVALGLGMALFGSTYIIPLFV
QTALNYSATEAGMMMAPAGVALGILFPFSGRAADKGAPHRLVIAGLALFAGASLLWVFIG
LEPSFFYLAVLVLVGRVGLALMMPALSTGGLVEVSDAQLGQASGMINFARQFGGAMGINI
LAVMLEWGSSAGDGRHVASMLSYTEAFVLLGVIAIIALWPAARIGKTDASVQTAPESA
>fig|349521.5.peg.4777 Drug resistance transporter, EmrB/QacA family
MAGHVGHSHCLCQRLLMSANAGRKAVNPWLIAPLVALAAFMEVLDISIANVSLQHIAGSL
GAGPEETTWILTSYLVTNAIALPIAGWLSDYFGRTRFFIGSIIGFTLASLACGMAPGLEM
LIIFRAVQGLAGGALQPVSQAILADSFPLEKRGMAFAMYGIAVVAAPAIGPTLGGWITDE
FSWRWIFLINVPVGIVLIMLVKRYLPDEPANHDGSKVDYFGFALIAIGLGCLQWMLDTGQ
REDWFESPQIVALAVIVVVALLTYIVRSFDQKNPIVDLTLYRYPNFAMANVIMFMMGFVL
FGSTALLPLLMQTLMGYSAFDAGLVLSPGGFAIMFMMPIVGRLVGAVDSRILLTLGLGVS
SLALWNLGELTLAVDRDQLAMARVWQTLGLAFLFIPTTSSAYVGLPTSANNQAAAMLSFM
RNLGGGVGIALLMTFLDRVATVNRGHLVANTSPVSEVWSHHYMQLQQISGDATRALMMAN
QQVAEQARFIAFMDSFKLLAVMFALLIPLVWKLKPLPRSGVGAPQGAH
>fig|349521.5.peg.4778 Multidrug resistance efflux pump
MSKKMIRLMLFFSLAGVAGCGYYLWHAGKVSTDDAFVERDVIYLTPRVSGVLVEVLVSDN
QKVATGDLLARIDPKPYEAELQSASARVAMQQAAMVKAQADLEAFVARLEARKQDALAQV
NVAKAEKQHHESNLARLDAQIAQARRDVDRYERLAGRKQVSEQALEDAKTNLATLSAERE
TVKASIDVAASKVAAAHSQQKTVASDERNIAVLRAAIGQSEAALKQAQADEARASLALQW
TEIRATSNGWISRVEKHPGSFVSPQTNFAIEVTGAAWVKANFKETQIGDVRVGDKVSVEV
DAYPGVTFSAKVESFQPGTGSRFSLLPPENASGNYVKVVQRVPVKIIFDEVPDGVQLWPG
MSVIPTVYVSGS
>fig|349521.5.peg.4816 Permease of the drug/metabolite transporter (DMT) superfamily
MLCAIFLRQNVQWSTWGWMLMAFVGVFLAAEVSFSGASFEALQGMGLALGAAFFYALATI
FTRQAPGVSPAAMAAAQLGFCLPLLGAWLLWNGADWSQVDWKYVGLLGGLNSIAQYVLLY
FAISHLTLERLSILSFLYPITTLLVDMLFYDMELSAAQTVGIALILLANTAILRRKPQPD
KGARAGSPTGRQAIAE
>fig|349521.5.peg.5274 Permeases of the drug/metabolite transporter (DMT) superfamily
MQATYIPYLFVLLWATGFVSAKWGLPYAEPFTFLSLRMLLVVPLFAFLAIAMKRPRLNAV
QRRQQMITGVGTHGLYLGGVFYAIAAGMPAGIVALIVGVQPLLTALVSWPLGIGSPLRPL
QWIGVLLGLAGLGVVVLQGGKLSGHITGEGLSASIIALLGISGSTLWQSVKGGKTDLIAG
GLWQYIAALIMFLIAAFALETREVQWNPNFIGAWMWSVFVLSLAAVLLWLYMLKIGEATK
VTQYLYLTPPTTAVMAYLLFDEPLTLQTGLGVALVVAGLYLARRGAMAGKPALSKA
>fig|349521.5.peg.5405 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MEADIILRKVDKAPTEDAQTEASASAQNKKLSSVSVVFPAYNEETNIEMTVLKAIGAFKK
HFETVEIIVVNDGSSDGTRDILERLRQEHEEVRPIHHVQNKGYGGAVRTGLKSGRGDFIF
FSDSDGQFDLEEVDLLLRHINDYDIVVGYRAQRADPWHRKLNAYCWGVLVRYLFGIRVRD
IDCAFKIFRRDFIQSIRIEAEGAMINTEILAQAGMMHCTIKQVPVSHYPRLSGAATGANP
LVIFKAFVELFNLYGKLKATGYKELQTKA
>fig|349521.5.peg.5844 Permease of the drug/metabolite transporter (DMT) superfamily
MYWLLGVLAPAVWGTTYVVTQAWLQDLGPLWVSVLRALPAGLLLMCLDLKSLRHMDMRRS
VILGALNISVFFFFLFTAALRLPSGVAGTLMALTPLTTLLFLWWWQRQAPNPIQLLCAFG
GLIGVGVVIFQPSSQIDPVGVAASFGAVVSLTVGTFLAKKWSPPKGILAFTGLQLFLGGM
LLLPLAFLLEGPMPALNREAMLGLLWVDLVNTALGYLAWFIAMRRLPVSALSFLALLSPV
SAVISGRLVLEEWFTPAQYAGIAMVLLSVTLAQFARAKTQPKMAQQAS
>fig|349741.3.peg.531 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTDPQVQLSIVATVYCTGGYLAEFCSRSFAAALEAGYDPSCTEVVLVNDGCPRDGLEQAL
KEREKDGRVRVVDLSRNFGHHLAMYVACEEARGERVFLIDSDLEESPEWLVNFSREMDST
GADVVYGVQEKRKGGLFEAVSGELFYTLFNLLSDQQITRNMVTARLMSARFLREMLKFQD
REPFFFGLCVSAGFRQVPCRVKKASSSPTTYTFRKKMALAVNSVVSYSARPLVYISYFGL
AVTLVAMLYVAWVVVRQLLYNVAPPGWASSVASIWLVGGLILMSLGVIGIYISKIYKETK
HRPAVVVARRYE
>fig|349741.3.peg.873 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKRNAIDLGTLDVCTLFRKYFIPTLFGMLSISAVTAVDGILVGHGIGSDGIAAINICIPL
LMLFTGIGLMAGVGSSVVASIQLSKGKLEAARLNVTQALLFVTIAAIVPSALMMAYPSAT
ARFLGASEHLTPMVREYLLWFIPSLIFQMWCSVCLFMIRLDGAPKLAMMCNIIAAIITVI
LGWLFIFPLGWGLTGAAFAATIALFASGATGLIYLWIFAHKLRLYPIKWSIRSFRFSLLN
IVCQCRIGSSALLTEATLATLMFVGNHTLMKYLGDNGVGAFGIACYYLPFVFMVGNAIAQ
SAQPIISYNFGLGEKKRVADTKRIALFTSVVCGIVTTAAFILFPHILVGLFVNPDSTAAL
IAIEGFPYFSLAFVFFIINLMLIGYYQSVENVKLANLFALLRGFVFLIPCFILLPEAMGT
NGAWLALCLSEMLTILTVAVLFILRKKKTLLHQTGEECS
>fig|349741.3.peg.1088 Multiple antibiotic resistance protein MarC
MQDFLSTVILLFIVIDPVGLAPMIQGMLKKYSPAQQKAILTRELVFALSLLLLFFFSGKF
LLNLLGLEPSTLSISGGILLFLVALGMVFPAKDMLSSSGRADGKDEPFIVPIAMPLMAGP
SSLSIIMLHASQTPDSISQMTYAGAIVTAWFLSGMVLFIAQKFLRLLGEKGTIALERMMG
MVLIMISVQMFMNGLAGYGVK
>fig|349741.3.peg.1660 Permease of the drug/metabolite transporter (DMT) superfamily
MQSACGSGECATRRAAGRTMPSEALKGHIAMGAAAVIWGLMSPVSKLVMQQGEVSSASLA
TFRLLGAALLFWLASAFVPREPIKRKHRLPLFYASLFGIIFNQMAFTVGVGFTSPADAAI
ITTITPVLTMILAAFVLREMVTGKKIIGVCASAIGAMLLVSGSGAHAAALPGDNNLLGDI
LCLASQCSVAVYFVFFKNLIGRYSPVTLLKWMFTYAAAACLPFTFREVGSIHYSALPVQT
WLGIAYVVALATFVSYICLSFAQQRLKPTAVSMYNYCQPVIASSVAVMWGMDHFGWMKVL
SVLLVFTGVLLVTGTRGKRAVQEQ
>fig|349741.3.peg.2162 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEGNKKMNKTWNLKEMKKLIPLALPVLVVNLSIVGMGAVDAIVAGRAGVTDMAAVALGSS
VYLPVALFACGVLMIIGPVIANMRGKSHESRVGYMTNHGLWLAFMLSLVSMPVIYVLRNV
FGWISDDAAMCQMASAYMFAIMWGLPANLGFVALKSLNEGSNMTRPAMYVGLCGLLLNIP
LNYMFVFGMYGFPRMGGAGCGAATAVIFYIEFLLMFLLVYFNPKHRPYRRHIISWRRPTP
SVITHLVRLGVPIGVSQLCEVMLFCAAALVLAPLGETQVASHQIAGNVGGLVFMLPLSVG
LAASIRVAYHHGRNDLAGTRSAILSSYVLVLTICLCTFGGITLFREQIVHLYNDSELIVS
TASVLLVLAAAYQLPDCLQVLSVGVLRGFRDTASITFITFFSYWMVGFPACYILARTDWI
VPAMGARGIWTGFIIGLAVAAVLLLWRVRRTTRREFSLMRQAGE
>fig|349741.3.peg.2169 Acriflavin resistance periplasmic protein
MYNKPLTFAATTLLLCSPVMILTSCEGEKDSAAQAPALVPEVQVTKLVTKDVPIRQEWVG
TLRGTEDAEIRSQVTGYLLSKDYRDGAYVKKGQVLFQIDPRPFQATLDQAQGRLEQYEAT
LKKYKLDVERYTPLVKTGSVSRKQLDDALQQVQETEAAIATAKAQVDEAKINLKFTTITA
PISGLAGLATPSIGNLLTPSSPTPLTTISSIDPIRVDFSVSERDFLNSMDNNLTRQKHLK
FDVILANGTEYPMQGEPVAIDRNVDAQTGTINIVGHIPNPNLTLRPGMFVRVRATVKTLE
NAALVPPRAILSAQSAKFIIYLDDKNIPHMQVVNLGPVVDGMQVINIIPMPHSTFTKDSP
IVVEGIMQAAKVQGQAPVKPLPYKPVVSQPVMPSIGAQSFEKARTPEGMKDGEAQPSAK
>fig|349968.3.peg.581 Fusaric acid resistance protein fusE
MVSSDSLLFVIDPQPYQLALDNTQAAVVRAQSELAKANHEAERRRYLPKNIISGADLEIA
NLTADSMKAAYQGAVANLEQAKWNLSKTRIYAPANGYITNLQTRVGNYATTGTPLVALID
TDSFYVMGYFEETKLRHIREGNEAKIVLYNGNIPLRGVVESIGRARSSKCASLKLTGA
>fig|349968.3.peg.1912 Multidrug resistance protein B
MPYLSAVCMSKKWMIFYVIILMYLPVSIDATVLHVAAPRLGIALSATGSELLWIIDIYSL
VMACLLLPMGALGDRIGFKRLALMGSVLFGLASLAAALAPSVAALIVARAFLAIGAAMIL
PATLSAVRHIFTDERERALALGVWVAIGTMGAAMGPLVGGILLEHFYWGSVFLINIPIII
AVVIATLVVIPSQPMRTEQTWKLAPALVLITAILMLVYAAKTGLRGGGDMVVTSLTALFG
GVMLFAFVRHQLSTSAPMIDFRLISQRVIAVGMVMAMTAMITLVGFELLLTQELQFVLGK
SPLDAGIFLLPLMIASGVSGPLSGWLVARLGLRTVASAGIALSSLSFLGLAWTDFATQTY
LAWGWMILLGFSIEASLLASTAAIMSAAPPEKAGAAGAVEGMAYELGAGLGVAIFGLMLS
RAYSASIVLPADLPTDLVAQATASISETIQVVNSLGGNEPLLASAKLAFSASHSLVLGTA
SGLLMLLALAVGFTMPGKRVLQLAH
>fig|350058.5.peg.761 Probable antibiotic-transport integral membrane leucine and alanine and valine rich protein ABC transporter
MSVSMTPRLRAWAAFGRNDLRGTYRDPLLVMLVLAPAIWTIGTAVVVPRLSVALAQRYDF
DLVPYYPLVVTGLLLLTSIIIVGGLAAFLVLDEIDAGTLTALRVTPVTLASFFGYRAATV
VAVTTAYVAVTIPLTGLLPSSVVWPLIPIGMVAGLSSVVTMLLIVAVASNKVQGIAMLRL
LGLLIAGIPCLPWFVDSAWNLAFGVLPPYWAAKAFWVACANGTWWPYLIGGVVFNAAAGW
PLLRRFVAKNT
>fig|350058.5.peg.762 Probable antibiotic-transport integral membrane leucine and valine rich protein ABC transporter
MKRWVSALRLEATLQVRQRFVHAAVISGMLWLVVLLPMPQHLRSIVEPYVLIGDITIVGF
FFIGGAVFFEKQERTLGAVICSPLRFIEYLSVKILVLTGVSLFIAVVVTLATHGTDFRPG
FLVAGVVLGTLVMLLVGFISALPFDSVSDWFLSTVVPLLILSLPVMYMLGVWTNPAFYLV
PTQGPLLMFLAVFDQVSLAPWQVGYAVLYPLICAAGLYRLARVMFGRYVVERSGVA
>fig|350058.5.peg.1109 Vancomycin B-type resistance protein VanW
MPLEGRPAGTPGGTVHPQVIPGAKPAKPRSFRRLWLLLTAPFAVLAGLYLGDLILSSDRV
PRGVTAAGVPIGGLTLTDAEEQLRAEVTPRTTGPIPVTAGPERSEIDPTSAGLSVDWRAT
VEQAGAQPLNPITRLSSLFTTREIGVVSTADDAALAAALEQLGTRVAQDPVEGTVRFAGR
EPVGVNPQAGRRLDVDAATELLKRDWATGSTVDLPMIELEPRTTASDVEAAVADIAVPAV
SGPLVITGEDDARAVISETVIATALTFDVDDREIVATVDQNAIADAARPQLADSEIPRRD
ATIDFTTSPPAKVPSQDGRRIDYDDTLADLMDVLTDTTDREVAAVYVDEPATFTTADIDA
LGPVQVIGEFQTSGFSGDSGVNIKRAAGAIDGIVVAPGETFSLNGATNPRNAANGYVEAG
IILNGKPDSGIGGGVSQVATTLFNAAYFAGMELVEHQEHSYYISRYPAGREATVFGDAID
VKFRNDGPTPVQIQTTWTSSAITVQLVGIKRYEVTSAQSPRSAPTSPRTITIPAGESCSA
SSGAPGFTITDTRTLRDIVTGDTRTESHTVSYDPIPKVVCGG
>fig|350058.5.peg.2269 EmrB/QacA family drug resistance transporter
MTALNDAERAAIQRDAEGSGKRGSGRASDRALPARIPGLGETAGGRGGDGARAGRTPAWV
PSRRFFAAVIAIGGMQLLATMDSTIAIVALPKIQDELNLSDAGRSWVITAYVLTFGGLML
LGGRLGDTIGRKRTFIVGVTLFTIASVLCGIAWDEATLVIARLLQGVGAAIASPTALALI
ATTFPKGPARNAATAVFAAMTGVGSVMGLVVGGALTEVSWRLAFLVNVPIGLIMIYLARK
TLRETNKERLKLDAAGALLATMGCTAAVFAFSMGPESGWASPVTVASAVAAVGCLLAFLW
VERTAENPVVPFALFHDRNRVATFAAVFLAGGVMFTLTVTIGLYVQDIMGYSALRAGIGF
IPFVIALGIGLGLSSALVSKFPPRVLVIGGGVLVLAAMIYGSTLDAGIPYFPNLVLPITI
GGFGIGMIVVPLMISAIAGVGFDQIGPVSAIALMLQNLGGPVVLAVIQAVITSRTLYLGG
TTGPVKDMNAAQLHALDQGYSYGLLWVAAVAVIVGGAALFIGYTAEQVAHAQEVKDAIDA
GEL
>fig|350058.5.peg.2685 Probable unidentified antibiotic-transport integral membrane ABC transporter
MTTENRFTPGTFTPDPRPAPVPRMLAAQFRLELRLLLRNGEQLLLTMFIPITLLVGLTLL
PLGSFGDNRAATFVPAIMALAVISTAFTGQAIAVAFDRRYGALKRLGATALPVWGIIAGK
SLAVGAVVILQSILFGAIGFALGWRPPLAGLALGAVIIALGTAVFAALGLLLGGTLRAEI
VLALANLLWFVFAGLGALTLEAGVVPSTVQWVARLTPSGALTEALTQAMTSSMDWFGLAV
LAVWGAVAGLCALRWFRFT
>fig|350058.5.peg.3295 Multidrug resistance protein B
MTHTEAGSAAVATGSWRELLGPKYLGASTVLAGGVALYATNEFLTISLMPSAVADIGGHR
FYAWVTTVYLVGSVMAATTVHSVLTRLGPRWAYLLGLTVFGLGSLVCAVAPSMEILLAGR
TVQGAAGGLLAGLGYAVINTVLPSVLWKKASALVSAMWGVGTLVGPAAGGLFAQYSSWRW
AFGILVVMTTAMSALVPMALPARARAAHLGSGAPPGRIPFWSLLLLGAAALLVSVAGIPH
DVRATAGLVVAGFVLVAVFVVVDRRVAASVLPPSAFGRGPLKWIYLTLGGLMAATMVDMY
VPLFGQRLAHLTPVAAGFLGAGLAIGWTVGEIGSASLTRHRVVVRTVAVAPAVMATGLTI
GALTQHRDAGPMLVALWAVGLIITGAGVGIAWPHLSAWAMSKVDDPAEGPAAAAAINTVQ
VISAAFGAALAGVIVNLSHTGDVAAARWLFASFAVLAVLATVASTRSGRLRSR
>fig|350058.5.peg.3940 Multidrug resistance protein B
MSQHRPHDAIAAEPTDDHPFRALWVMMVGFFLIVVDSTVIAVANPVLKNDFDVEYHSVIW
VTSGYLLAFAAFLLIGGRLGDRFGSKPVYLVGLTLFAAASVWCGLSTSVGMLIAARVAQG
VGAALLTPQIMSTITRTFPPQRHGMAMSVWGATAGVGMLAGPLIGGVLLAGLGWQWIFFV
NAPIGAIGIALAVRLVPNLPGRPVRIDVVGALLSGAGICLIVLGLQEGQHERWSWWIWVA
IAGGLVSITAFLRWQTVHADEPLIPMSLMSHRNFVLSTAGIALVSFVFVSFGVPLMIYLQ
EVCGLSPVHAALLTAPMAVATAVLAPVVGRIVDRAHPRPVVGFGFGLLTAGLIWLAVEMT
PDTPAWRLALPLTMVGAAGAFTWEPLSAIATRGLTSELAGAGSAVCNTARHVGAALSSAG
IAALMAVLLGDEHAEEAGARHETLAPLVDSLKDPFAGAMAQSMLLPAAAAAMGVLTALFL
VGGDATARAAPLSLRPWGDASVSS
>fig|350058.5.peg.4504 Tetracycline-resistance determinant tetV
MVGNHRSVSTQYETGRSSARSDSEQPVAPAGWRVLAPFRYREYRLLIAAVSLSIFAEGMW
AVVMALQVIELSNDPAALSLVATCLGAGLVGFVLVGGLAADRLSQRGIIIVVEAVNTVAV
TAVAVLGFVDALRIWHMAVAAAALGIAAAFFFPAYSAILPRILPPEQLLAANGIEGVVRP
VFQRAVGPAIAGLVVGALFPSAGALVVAVLFATGLALLVATRPPKAKDTGAQHEPRPHLL
RDLRDGWVFMLRTPWLLWTLLFASLFVLVVLGPIEVLLPFVVAERFTHGAQTYGFILAFF
GLGSALGALGVSSRRLPRRYLTVMMAMWSVGSVPLVIVGVTSSFPLMALATFVIGVTDGT
AMVIWGTLLQRRVPPELLGRVSSLDFFVSLAFMPVSFAIVGPLSKIVSMEAIFLAAGLLP
VLLAAVAVWAAKMHRDEVAHPLR
>fig|350688.3.peg.237 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFNNLIQTLYNLADTFWVSKLGTMPMAAMTLVSPVIFLTLSIGTGINVAGTALISQYIGS
NDEEKSIKVSTQMFTFSVILSIILGIIGYLLTPFIVTFMGGQDEIFTYSSQYLTIMFWEI
PGMFLFLVYTAIKQSQGDTFTPMVLNVLGVILNILLDPIFIFTFNMGIKGAAIATVLSRM
IFALYAIYTLFAHKDGIYLDRNNLKMEKDILKEIIAIGLPSTLGQSAASFGFVILNSFVI
SYGANTLAAFGIGNRINSLVLMPVMGIGSALATIVGQNLGADKKDRAKLAVQTALKLSTI
LMVIGGVIMVIVSSSIVSIFVKDDPDVLQQGTEYLRLVSISLPLMGFFQVFVGTFQGSGH
TIYAMMMDMGRLWGLRIPMIILFKNFTQWGPNGVWYAMLLSNAITCVFGFIIFLSGKWQK
QVIHKKKALA
>fig|350688.3.peg.801 Multidrug resistance ABC transporter ATP-binding and permease protein
MKFILKYLKRYPKLIIFNILGIFSFVAVQLGIPTIMASMIDKGIGNSDIAYIKRMGILML
LLSIAGGAGTILITYASSRISTYMIRDIRNDVFAQSQKFAHTEYTKFGVSSMITRTTSDA
FQLMIFANLLFRTALLAPIMIFISIFMTIKTSLSLSLIIGASFPFIILGVIIVAKVTGPI
SDAQQKGLDRLNKISRENLLGIRVIRAFRKSGYEAERFAGINEVYASNSKKLFKIISFAQ
PAFFFLLHLSMLAVFWVSTIMIGKGTLQVGQLVAFLDYQFHALFSVMLFSMVFVMYPRAR
VSANRIQELLDQEPSITNPTAGIKETKGKAKVEFHHVTFQYPDGELPVLKDVSFTAQQGE
TIAFIGSTGSGKSTLINLIPRFYDVTKGAIKINDVDIRDYDMDVLRRKIGFIPQKAFLFY
GTIEENLKFGNPDATSEDMNHAIEIAQAKEFIENKPDKLQELISEGAKNFSGGQKQRISI
ARALIRKPEIYIFDDSFSALDYKTDATLRQALRHETKESIVFIVAQRISTIMDADKIIVL
NEGEVVGIGTHKELLKTCSIYYEIADSQLRKEELEQ
>fig|350688.3.peg.834 Permease of the drug/metabolite transporter (DMT) superfamily
MNNKIIRGEILLIITAIIWGTSFVAQRVGMELIGPFTFTATRFLVGTLSLIPIILITDKV
NKKEEENKTENKTEAETGIRKELLIGGIACGLALFSGISFQQAGLQYTTAGKAGFITALY
IVLVPLLGLFLKKKVDKNVWIGLILAVMALYLLCFTEDFSISKGDLIVLCGTVFWAIHIL
VIDHFAPKVNGLKMSCIQFFTAGILSLIIAFFTETIEMSAILNSAGPILYTGIVVVGVAY
TFQIIGQRGTNPTVAAIILSMESVFAVVSGMVLLGESMSLKEILGCILMLAAVLITQIQP
TKSNVEIEEKA
>fig|350688.3.peg.2312 Teicoplanin resistance protein vanZ
MESIIRYVLNMVPYMIAMLPILIAVRISIKLPIIKEGKKLNIVHEIGVIIFILYLVGLAS
QTIIPKFELGRNSIEIVGRIGFDYNRINTIPFNKIKEVLSLVRLGNFNYLWIEVLGNIGV
FSVIGFMLPLLWTKLENIKTVLLCFSISVCIETVQLILPRATDVDDLIMNTLGGLIGYIG
YMIFKRLFPKSTSKFKGESEL
>fig|350688.3.peg.2820 Vancomycin B-type resistance protein VanW
MRTKRLTERFPYLLPIRKLQRKVFFYIGMKLDANQYATKKAHNILEHQVFTTKSKMVNTE
SGYDIQYQLNKVDNLKLVAKTIHKVIIEPNETFSFWMLAKNAEKYGKYKKGLAMVNNEIT
SVEGGGLCQISNLLFWVFLHTPLTVVERNPHSAETIPQPKGDIPVGVDATIAEGWLDLKV
KNETEETFQVLVEFDEDFIHGTIVSNKPQDVLYTVESENLRYARENGKIYRYNEIYKVGY
GQFNGEIVSKELVLNNKYEIRYDIESEIGPI
>fig|351160.3.peg.73 Drug resistance transporter, Bcr/CflA subfamily
MLLALISAFVPLSMDMYLPALPGMATVFDVPVSLVNLTLILFFVFFAAGILIWGPLSDKY
GRKPILLTGLAIYLTASILCALSTDIYQLIVFRTLQAIGGSAASAVATAIVKDVYHSRDR
ERILAIVQSMVMIAPAVAPVIGAFILSFISWRGVFWTLAIIGFIAFAGSVAYTETIPRRN
DVSIPGSLGRLWVVLKNPGFTSLLALFSMTSISMMAFVASSSYVYQVEFGTTEQVYSYYF
ALNGIGLILGPMIYVRLSARFDRNSIVKACFALIAISGVLVFFLGSLSPIIFALCILPAT
VASVCSRPPGTSMMLEQQTGDTGSASSLMGCAQTVMGTTGMLLISFDWGTGIIPTVGAII
AMIGVITSAGWLYLSGKPFIKKSDGDAR
>fig|351160.3.peg.166 Permease of the drug/metabolite transporter (DMT) superfamily
MAFSDDRMAGENPQQNHALILIGLFIINVFWGGSFIANAIALKSMGPIEIAALRFFIAAP
LLVIVTLAWKGWSIFRIDLKDLGVLIIMALTGVTLQYVIQVTAQNYTTAINASLLINTSV
FFIMFLSAMFLAEKLSVHKVLGAVIGFGGVALLVSGGNLSLDVGLHVIGDAMILFCALLW
SVYSIYGKKIAAKYDPLTVLNYLFILGTIGIIPFYLLTPHQNPASLPLDALGAIVFLSIF
CSIIAYLIYNVALEKMDASRVALFIYVVPLSTIILAWLILGESMTLLSIIGGIAVCAGMY
IAERK
>fig|351160.3.peg.167 Permease of the drug/metabolite transporter (DMT) superfamily
MLVMIVWGGSFIASKVGLDGMYPIELATLRFAIATPVLLAFTLLFYGWRSLIIEKKDLWV
LVGMAMTGITLQYITQLIAMTYTTVTNTALLINMGTFFVVIPSIIFLKEKFNVDNLLGIV
IAFAGLALVVTNGKIEFSPQLIGDGIILISAALWAVYILIGNKLAGKYSVLTQLNYIFVI
GFIGLLPFYFLTPHHDLSQLSTVSWASLLYLAIFCSIIAYFFFNDAIIKIGPSKSAIYQY
LEPVFAVIFAILLLNEPLTGFILVGGIMTVLGIGMADNNIRIFTRRRKKPVEVPAEPPDA
GHH
>fig|351160.3.peg.1680 Multiple antibiotic resistance (MarC)-related protein
MNFELFVSAAISIFVMSDPFGNIPIFLSLTGGMNRPQRRRVITKASIAATVIIFIFAVVG
QPAMNLLGISLNALSIAGGMLLLLIALDMLMSTGLHAKRTESTENTTHEDEEADSIAITP
MATPLIVGPGVMAATVVFMNRAAGLMDQALVLSAVLIAMLGSWIVMVNSDLLYAILHRDG
TRVLTKVMGIILAAIATEMMISGLLNAFPALAG
>fig|351160.3.peg.1734 Permease of the drug/metabolite transporter (DMT) superfamily
MIGLVLVNVFWGASSIAAKEALIQLTPVEIVTVRFAVAFIAVLALALLFNRDALNVRPAD
LPVLIFMSVAGVSLQFVLQVMALVYTTVTNFSLLFNLSAIFIMIFGVLLLKERPSGKQAL
GALIGFGGVFLIVTGGSGGLSLAHLSGDLLGLASAALFGLYAIASKTVADRYGPLTILIY
TFLFGILGLLPVYYFATPMTPLAALTPLSWASIGFLAVCCSVIAFLIFNHGLSRLPSADV
GITIYVSPLAGVALAVLLLGETLTTFTIAGAALVMAGLYVTQAREGGHSGEEEAKEKADR
PATADG
>fig|351160.3.peg.1808 Probable antibiotic-transport integral membrane leucine and valine rich protein ABC transporter
MINRLVPTLLVDFRQQVRYGFIVASLFTMIVFIAMLSQFSQYGSPVFVPLFVFGNLMIGT
FFFIGGMVLFEKGEGVLQALIVSPLRVEEYLGSKVLTLTALAFIENMAIVLAIFGTGYNV
LLLAAGTILAAVIYVLLGFVMVSRFKSISEYLMPAAFVIVALMLPLVDYLQIFETPLVYL
HPMQAPLLVMKAAFVPVESWQLAYGVLYSLIVIAVAFVLSKRAFDRHIINRKGGN
>fig|351160.3.peg.2378 Permeases of the drug/metabolite transporter (DMT) superfamily
MMDRQQIYPVFLAVGGAALFGASAPLAKALLGSVDPIVLAALLYLGCGAGLLLAKITTRL
RTVKREAGLAKTDLPWLAASAISGGVIAPILLMLGLQATPAATASLLLNFECVATTSIAV
LAFREAVGRRVWVAIGLITVAAAVLTLDLSGAFGISAGALAVVGACIFWGIDNNVTCRIS
AKDPVTIGLIKGLAAGTFSLILAAALSRQMPAGITPVVIVLIVGALCYGLSIVMFIRATR
GMGAARTSAWFGIAPFAGTALSLVLFTDAPGLQLLLSLPLMIAGAALLFGEHHDHVHVHT
AVYHEHYYEPDTHHPFKTPGSGMHHHEEVRHTHAHRPDIHHRHEHEEEKKE
>fig|351160.3.peg.2893 Daunorubicin resistance ABC transporter ATPase subunit
MTGNNAIEVKGLTKKFGDFTAVDNISFNVNEREIFGFLGPNGAGKSTTIRMLCTLARPTS
GDALVNGYDLVKEAVKVRESIGLVSEKMIMYEQLTAAENLRFFGNLYAMPKQKIEARIDE
LLKLVNMTEWKNTQIKKYSTGMRQRINVVRALLTEPKIIFMDEPTLGLDPQTTLSIRELI
RDINRNGTTVILTTHAMVEAEALSNRIAIIDHGKIIALDTPHELKKLVKGNDLTMFNARI
SNLTPVMIEKIKALDCVAAIAQPDAYDLKISARGSDGLDRIIDTIRANGGNIAAFNTTEP
TLEDVFLSVTGKEMRDQANEKATARHRHGPRAPKARVR
>fig|351160.3.peg.2908 Drug resistance transporter, EmrB/QacA family
MLAIGVFIAQLDATIFVPALNTVVSEFNTSYEWVVWSVTIYMLAFTVTMPLAGKIADLYG
RKRLYILGVALFCIGSLACGLAWDIPSLLVFRVIQAIGGGMILPAALSEIGAVVPEKSRG
MAMGIMMAINAVAAIIGPNLGGFLVEHFGWRYVFYINPPIGILAILLALRFTETYGHEKH
SIDFPGAAMLGGFLLTLMLGVIRLSSLPLSDITVFPLFVIAAILLISLVLFERKAKEPIL
SIPLLARPEVLAVNFAALAFGFCFFSIVLYVPSYSQMVLGLGIQDSGSILTPLTVSVLVM
AILGGRLADKIGIRFVLLAGAIVTCGALFAMAYALSGTLVLAIILLIMGIGVGFSMGSFQ
SLTLALVPPNMKGSASGIVNTFMNMGGIIGPTIGSYYISGGTKKLEALMASMSTHAGSGM
SSGMPAGGTGSPDMESMMAQALQDIMGPAFQDIFVLSAIVSVGVVILIGYVVVRGYFSAR
TEMQETETA
>fig|351348.5.peg.298 Permease of the drug/metabolite transporter (DMT) superfamily
MLRHHNQPFPGMISATAALAASVLMHVLWNLIARHQPGAAWPLWWALLAHLVMLAPWGFY
ALWQADAWSPEFLGLMAISASANALYFFGLWKSYKHAPVAMVYPLVRSSPVLIALWWLIL
TGDSPSLTGWLGILVSVAGLMILAGSQPGQGERAAIPWALLAMLCTSVYSISDKLATGQL
PGFAAIIGFVSVGYSAAFLVLTLALRRQTGRWTPPQRLPIPIIVIGGLCVGLAYALVIHA
MRFLPSAEVVAYSNTGIVLATLASIYWFGEKSNTGRRLIGSAVICTGLLLLAL
>fig|351348.5.peg.465 Multidrug resistance protein B
MADQSVEGLRARYGDRWRWLAVLTVVLGTMATVLSATVVNVALHDIMVEFGIRQGQVHWL
ATGFIAAMTTTMLASAWLLDRFGVRKTLSTAMAMFTLISLAGGLAPTPELLIAARIGQGA
MAGLMQPMGMYLVFRIFPADQRGRAMGIYGMGVILAPALGPVLGGFLVDQFHWRWVMFAP
APVTLLGVWMALRFLPSPRSRPAPYMFDLSGMVLLGAAVAVTLETLNRLQDWPGDSVRIA
WQGALAAILIIGFIVRERRAAHPLVRLALLREPVFLYATLGAMALGLALFGSTYLIPLFV
QTSLGFSATEAGLLMLPAGVVLGMVFPVAGRLADKRSARGLVLFGIAMFACSAVLFAATG
ALVGFVWLALWAVVGRIGIGFMLPALSTGALNPLAPEQLGAGSSTINFARQLGGALGVNI
VALTIEFGEHEGGLPTVSAFASAWWLVAVCVALAAVPIWKMRA
>fig|351348.5.peg.1986 Permease of the drug/metabolite transporter (DMT) superfamily
MSPLISIDAGSIMSDAHKSDLYLVLVTLLAAIGWMLSKEAVLMMPPLMFMAARFLIAGAF
LALLALPSLLRLSRDQILRSLGVGFVFGIAMTCWIMGLYHTDSMGEGAFLTSLGVVIVPI
IARTVFGEQQPLSTWLAIPIAVAGLALLSLENGFRPDPGQLYFVLAATIFALYFTLNTRA
ANQRIVVDKQGKTVEKKKVPALPLTAIALLTVGTVTLAESAISERWTHILTNPEPMLYVW
VLASALIATAARFLLQTYAQSLSVNSHGVVILVLEPVWVAVFAVAWFGETMTLLQIAGCA
LIFAALLVNRWNALSRAIKALMKAKNPRQRG
>fig|351348.5.peg.3221 Permease of the drug/metabolite transporter (DMT) superfamily
MRSIRIMPISAHYGLTVLIWGLTWTAIRLQVESASVDLAVFYRFVMASVVALAVLAVTRR
LSRLTLGQHGWLFLQGLTLYSVNFLLIYRAAESMTSGLLAVVFSLAALFNAFNGWLWLRT
RPTARLYPAVALGVTGVALLFWHDLQLGNATGASILFAVAGTFWFSMGNLVSVKVKAAGV
PLFTANAWAMVYGALILGLWCLIQGVEWMLPATSVFWGATVFLAVPGSIVAFYCYITVIQ
VLGADKAGYAAVLFPVVALSVSTWLEGFEWTTPAMLGALLAILGNYVLFRPGKRQSVSAT
SVPEQRT
>fig|351348.5.peg.3291 Permease of the drug/metabolite transporter (DMT) superfamily
MPVCFSNRQFVMIHGALLIALASLLWATTGIVAKFLFNGTELEAITLGFLRLVVALPFFW
LLMRREQRQLVARNPGQTVPGSSLRSLSGKAMLTLTALGLFQAFYQGSYLLAVDLTGAGI
ATLISLCLPPVLVAILAAPLLGEKPGLLTILAAIAAILGTGMLVVSDMDTAGTLRLAGIL
MALLAAAVYTGFTLTSRYNSTGTPVFTTAFICFGTAALLLLPVVALSGGFAGLETMGLKH
WLMVLYIGVVPTCIGYLLFFTGMKTTPATVSSIVVVLEPLFIALLAWLILGEELGQIGVA
GAFILTVAVIVASRYGKAPGASQES
>fig|351348.5.peg.3593 Acriflavin resistance protein
MTRRLLNYQRLLGMVVTMLCLLGIAAYSTMPRQEDPSFPYRAGMITVSYPGASAEAVERL
VLQPLTDELRQVEELDWSQGTARTGVALARLKLRDRIYDTDSAWDRVRQAMERARQDFPD
DVGLMELDDRLIDIPAVVLAVGGSPSVTELSEVAERLKQNLLDIPGISRIELEGDADEQI
TLALDDAALYRLGVPPKRILDTLARRNQTIPGGFVVVEGKRLSVLPNTEFTDIDAIRATP
IELPDGSQVPLAAAAEVWRGPAEPRQPETWFDGERVVLLSIIMEEGSTDAIRFGERIRER
LDQVRSDFEPYQIREMFFQPDKVSDRLDDLAWSLVLSVLIIVAVVFTGMGIRMGLLVASI
LPMVALISVGLYDLGGGVLHQIAVIGMVISLGILIDNAIVIVENIQGHLDEGMRRLDALR
KAVGELAGPLGASTGTTLAAFAPLLMAKGGAADFTRGVPVMIMLTLSVSYLLAISAVPLL
AARFLRPRKNIHKDRLMGLARSLGGLVYRYPGRLIVAGTLLVAISVGMTPFMAQQFFPNA
DRPRVIVEVYLPEGTDQAQTSEAAAELERAIRARPETLEVHRFVGFTGPAFYYNLQRAPQ
APNRARLVVRTPALEDTTDLVDWIRHELAPTVPELDISAGILGQGPPRTAPVEVRIYHPD
DATRARATEQVFSVLRGVTGTVDVRHDLDIGVPSIAINVDDATAARYGLTRADVAQSLYG
QSYGVVAERYRQEDDPIPIILRSREGTALSLSRLLSVNTYNDQGDAIPLSAVATVETTWE
PAARYLRNGVRVNAVTANLEEGYSFSQALDGLFAALDEQPLPAGTRVELGGDAEGSNDAN
SALLTAAPIGILLLLFFLLLQFNSFRRVGIILLTVPLATVGIFPGLVLSSSPFGFQSLLG
VIALVGIVVNNAIVLLDVMDRELEKGRAIADAVRTAVEQRTRPILLTTATTVAGLLPLAF
SSSTLWPPMAWAIISGLLASTVLTLLVIPSVCTKVIKLPVAEPENAPA
>fig|351348.5.peg.3746 Bacteriocin resistance protein, putative
MATNRIGNRQGRSRQALSATPVAPRCGGLSHWPLFRCCLTGVLAGMLSTAGHAGTVLVPG
PAGDVPVSVTSFQNQRFSAVFQQEYDFSCGSAALASLLSFHYGDEVSEQEVFEGMWTLAD
QDKVRQQGFSMLDMKRYLESEGYLADGFRMPLAGLRDQVRVPVIALVTLGGYRHFVVIKG
ISDQEVLVGDPARGLKAYSWAEFQEHWDGSAFVIRSHLDMGRASFLDRDDWPGLARAPLF
KGLGSPALGHTLPYWPSTQEW
>fig|351348.5.peg.4085 Multidrug resistance transporter, Bcr/CflA family
MLALTSIWTTILLAAAVALGPLAVDMYLPALPQIGADFHAGTDQVQLTLSVYLAGFAIAQ
LICGPLADRFGRKPIMIGGFLLFTVASIGCAMANNIETLQLFRFLQALGGSAGPVLGRAI
IRDIYTPREAAKILALLASIMALAPAVAPTLGGLMVGGLSWHWIFIAMGGYALVMAAVTA
FGIPEPLKPEYRQPLRLCHLFANYRRISTDASFIGYTLTNAAIYGGLFAFLSGASFVLID
VLGVQPEHFGFYFAAIVVGYIAGNLGSIRLARYLGPDQILFYGLITALAGGAIMALLAYQ
QVYSPWAVMIPQAIFMAGTGLVLPQCMAGALANFPTMAGSASALFGFTQMTAAAIAGAIV
GALHNGTPMVMATVIAACAGLAMIGYLLLVQRHPAKAFETGKASA
>fig|351348.5.peg.4092 Permease of the drug/metabolite transporter (DMT) superfamily
MGTEPAGDGVSDLNATTQNSGQTLAYIGLVLTPLFWAGNAVVARGTVEHIPPLSMSLWRW
VLALAIILPFGLPGIWRHRQVIRQRLGSMIALATFSVAAFNSLLYVAAMTTTATNIALIN
ATIPIFVALLAWLLLGDRTRPIQILGIAMALAGILCVIARGDVSVLTGLQAQPGDLVMVA
AVFSWGLFSVLLRRQAVPLPALTFLTTQILLGTLILAPVYLVDFLFFSGGFALSQSTALP
LIYFAIFPGILAYAFWNHGVHSIGPARAAIFMYLTPVYASVLAVVFLGENLSLFHLVGGL
LILGGLILATRTGRRLSRPPVTRLDKGEPND
>fig|351605.4.peg.1168 Multidrug resistance protein B
MAENSRKFRTWIGFLAMSGGTFMAVLDTQIVAGSLPEIGASLGATVKEASWIQTAYMIAE
VIMIPLAGWLSRSMSLRYLYSLACALFTLASLLCAFAWSIESIIVIRVLQGLCSGIIAPL
LYQAIYLMFPRERQAGVTLYVVMIISLAPIIGPTLGGWITQTLSWRWLFLINLLPGVLVT
ASVFGLVRDAGPKWDLLKQFDLPGIVLAALFLGCLEYVLGEGRDNEWFDSHLIVFLAVVA
AISALLLVWRELACRHPVINLRTFCDRNFATGCLLNFIMGVGLFGSGYLMTLFLSTVKGY
NSQQIGQVMMVPGITMLLTLPLVRIVRQYLESRTCLAIGLAMFGFALWTNGSLTAEIGFE
HLFLPQVLRGLAIILCLSPITELALGRLSIEAVPNASGLYSLMRSLGGGIGIAVINILAE
QRMALHHQRLAEALNPSRFPVGELLDQLEVPFAGSMVDLEQARQGGVKLLAMLVRRESLV
MAYNDMWLLVAALFGMMLLLIPVVQKVERRS
>fig|351605.4.peg.1169 Multidrug resistance protein A
MRKFLPLVIALSLLAGGCGFGWYWLSTGRFMEKTDNAYIRSEITQVSSKVSGYVKDVPAE
DNTLVAAGDPLVRIEDLEFGVRLELGRKKLEERKAAQLVAYNRSRLQDSRIDACTAQLAA
ARAEQLKKTGDLRRFGSLFPDGIVSELDYDAVVTAEKKARAETGSAVANLKMAESELAAL
LAEERRLEAELHQQEEELKLLAKELADTVVRSPITGEVGNRRVRAGQYVKPGTVLLTVIP
RNVLWVEANFKEVQLSRMHEGQPVSIEVDAFPGRPLTGRVESLSPASGAEYSVLPPENAT
GNFTKIVQRVPVKIRFQPGQPLLRELRAGMSVVVSLDTRPGSGSGPAVSRLNRR
>fig|351605.4.peg.3034 Multidrug resistance protein A
MAEEQNGNSRKKKKAFAIVSVIVVICLIATYFYSSYRKTHISTDDAFIDGNIHTIAAKIN
GTVKSVNVTDNQPVKKGSLLIELDPVDYSVRLQEAASAVGAERAKFSEADTRISAAKATL
DLQRANFKFAEIEKNRAENLYQKEVYSRVQYERAMTAYEVTAAQVKGAEEQLRNTESQKL
TQSFTIDEKKATAAMAALNYNYTKIYAPVDGYVTKKSVQLGNQIQAGQPLMAMVGSNEIW
LTANFKETQIEYIRPGQTVEFSVDSYPGRKFKGKVDSIMPGTGVTFSAFPAENATGNYVK
VVQRIPVKIVVTEGMDKKHVLRIGMSAEPTVLAK
>fig|351607.5.peg.1019 Permease of the drug/metabolite transporter (DMT) superfamily
MTQRITGVVLAFVTAVISGVAVYLNSDAVKHFHDQTVYTTAKNGVAGVLLIGIWAAAGWR
TGRASPRTGGVGQSHPVGPRRILAFLALAIVGGSVPFALFFQGLAAAQATQAAFLHKTLI
VWVALLAVPLLRERVGWPHLVAILLLLVGQALLAGRAGTVAFGRGEAMILAATLLWSVEV
VYVKRLLRRFSSHLLAVVRMAGGTALLVAWLALTGKFHQLIALDAAQWQWVIVTGVLLTG
YVATWYAALARAQAVDVTAVLVFGAVITALLSAMFGSGSLKVPALVAITVGCGLIAWAAL
RYSPNARKPVVTASPSR
>fig|351607.5.peg.1669 Drug transporter
MRIRQLLPSTLAGRDAVHRRGLGLAAVCTLLFLTFLDNTIVSVALGDIQQRLSAGVQSLQ
WVVNAYALTFASAMLLAGALGDRVGERKVMFSGAAVFCIGSVICAVAPDTSVLIAGRGVM
GIGAAASEPGTLAMIRYLFPGRRERARATGVWAGVSGLALALGPVIGGIIVGLSSWRWIF
WFNLAFGVAALAIAAIVVPETPRVPSRRIDLVGGLLGAGSLALLVFGVLRGELDGFGAAH
VISLLVASVVVGLVFLWWQFHASEPLIPPQFLRMPAFVVPNIVAFATYFGTFAVFFFAAL
YLNIVVGFSGLRIALQFIPMMVIMIAASVLTGRWIGRTGARRPVVLGCGVFTLGLLLTDG
ALTRHPHYLPLAASLALAGLGIGITVVPTAFAAMSAVPVDRAGVASSAVNTSREIGAVVG
TAVLGAIVNSALISHATSTLNALGWSKLKGFVTSAILNGGASLGGPLGQASPEIQKLVNA
LYDAFAEGLHIALVLSACLVLAAGVLAASVRGPRLAESEETALGHVHLPS
>fig|351627.4.peg.465 Efflux pump antibiotic resistance protein
MERTDEQKINKNILIATTTSSFLVPFMSSAINIAAPDIAKKFNLVAENLNLVITIFLLFS
AAFILPMGKLSDTFDRTKIFITGLISFTISTLMCAIAPNITVLFIFRALQGFFSAFVFVT
SIAILIENHSPKIRGRLLGINTATVYLGTSIGPFLGGILVRLFGFRSIFLFAFLVGFVAS
FISLFLLKKEIKVQQHTSLAESLKNLDKIGTIFSIVGLFLLIYGASTFELGKTPKMLFFL
GGVLLILFVGFELATQNPLLDVKLFVKIPQFGFSNLAALINYSCTFSASYLLSLYLQIVK
ALPAQVVGSILILQPISQVITSLISGRASEKIEPRKLATAGMVLTTAGLFIFSLFSSKTN
IVLVIVNLIIMGIGFGLFSSPNTNVVMSSVPQSLYGAASSTISVMRVMGQAFSMAIVSFI
FSLYLKGAKLSHENYLMILKSMKISFFVFSVLSIVGIVASIKRGNIYNQENSN
>fig|351627.4.peg.962 Permease of the drug/metabolite transporter (DMT) superfamily
MKGRSIKLSTRKRILADGILLFVTMVWGSSFVLMKNTISQLHPLTFLAIRFLLAWLVVTA
IFWRNLKKLKPKEIVYGSIIGFFLFLGMALQVVGLKYTYASKSAFITGLTVVLVPIFAGI
IERKIPRVNVIVGVIFAFVGLFLLNGAKISHFNFGDFLTLLADFGFVFQIIFIDIFTSKE
DVSTINIAIFQLMSAAVLYIIFSLFFGVNPFSIKLTLNSILTILITGILGTALAFTAQVF
VQKYTTPTHTALIFSAEPVFGAIFSAIIPSVVTHTTEILPLISYIGCGLILIGMVIAEIS
FNKNLDMELS
>fig|351627.4.peg.1074 Daunorubicin resistance transmembrane protein
MNLKYKFEKCFYISYYAFKQSSTYWMNNFLSMLSSIIFIAIVYYIWTAVYSSTNNFNFIA
LNKTITYVCVITIINQIISRNTEMEIGAKVINGNISIDLIRPINFFGYLFFNRVGVVFFN
FVFSIIPLIFTAKVIFKIDIVKDISTLVITITSVLLSFILVYMFEFLVGLVSFWTTQVFG
VSLLKSSLINLLAGLTVPLTFYPESIQKILINLPFQAMYNIPASIYSGLTYRVNIIQHFL
IVLGINSVVKYLLEQIIWIFIFSLITFLCWRIVSKKIVVQGG
>fig|351627.4.peg.1414 Tetracycline resistance protein
MLAYFITVLIKGTAKGLFFPIWILHMSNLKVSLFAIGILGSVLETIRFVTEIPFGAFADR
YGRKVSLFLSALLNFIAFFLFSLGNTFCMFLFSVLIMGLADSFESGALEAWLADYLILKG
KSDKFEIEIRKMYIVFITGSIIGAVFITFMYKINAILPFIVSAILYIIAALITYFFVPES
LQESYNSNSNESMINKIKLSICYIISTKSLFLLSLAVFLFAIGLDGIERFYQTFLKFKKF
NIFLISNIYIISAIFSLMFMLLQNKLDSPKKNELLIIGCLKISMFMIVTIAVFVKLNIIS
YLCLILFFILEVLLRPYLQSYLNRYINSEIRATALSFFQFAEASGEILAGIGIGYFIKVL
GISYGLFVSAAFILISGLAVFVLLFFERIYRNVD
>fig|351627.4.peg.1480 Vancomycin B-type resistance protein VanW
MRRYVLIGIVVALLVLAGILGYTLYSNVKQVLNTDRIYKGIYIENTPVGGLTRAEAYELL
ENTYLEPLRSKKIEVEVDGNEYKLDYASLDIKINIGEAIEQAYSIGRKGNISRRFREIRR
VYDHPVVIRLKFEYNEGKLKEFVDELFEKYYESPVNASIRKVGNQFVITPEKLGRKLDYN
DLINKLKDMIKNKKEGKVRARFVQIVPRITKNELSKIKEVIGSFTTKFDASNRARSENIR
IAARKINGSLIMPGEVFSLSKVIGPVTVENGFKIAKVIVNNEFVDGVGGGLCQIATTMYN
AVLMAQLKVVERVPHSALISYVPPGRDATIASGSIDFKFKNTTNAPIYLESYTSQNTVTI
NFYGKNTHKGEVVKFESEVLEKVPYKKVYKNDPMLPKGVQKLSNKPQNGLKVKTYMLIYE
NGKLKEKKLLSIDYYKPVNAIILVGTKENTTVNSSVYN
>fig|354242.8.peg.589 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSSIFSTLSPFRLFVKCAVPNVISMAFISFYYIVDGIFVGKYLGSDALAALALIIPFIMM
SFALADMIAIGSAVQISMHLGLGKKNLTRKIFSSSMLIIFIISCFIGILEYFLGPVLIDC
LNVSDEIKTMTKECMFVFALFAPFTMLSFALDNYLRICGKTAYSMVMNVIIALSNIVLDY
IFIVELGWGLFSAALATCLGLVLGGIFGIFPFLFQNLELKISSLYMNLKIFKNILYNGSS
EFFGNISGSLYSIFANFVLLKISDTQAVAAFSIVLYIDSFIIMLIIAIGDAMQPALSYNY
AKKDFSRIKAIIKVVFFAGGFLSLFSIVLILIFGENLITLFTKENNQEFKTFAYTALMLF
AFNYFFAWFNVLSGSFLTAFNKASFSLVLSLAQNLFIPLFFLLFLSCFMGLNGVWLSPFF
AEFCVLILAWIFLKRIFKDLSL
>fig|355278.4.peg.837 Permease of the drug/metabolite transporter (DMT) superfamily
MSRIFTPELFLVIAAILWGGTFVVIKLALDSVPPFLFLAVRFSLAGFITILLYRKTLFSK
ANRRWDYIVPAFFVACSALLGYAFQTIGLVYTSATQSGFMTGAYVIFVPLLEIAIERKLP
SLRTWIAVVIVVIGLFCISQNGKTYDEFVNEFGFSYGDGLTLIGAFFFAVYIILIDIYSK
KIPTQILVSFEILLIAIVSSFLFPVESIFSKQSISIQFDLKFWIGIIYTSVFATIFTTQI
QTRYQKAVSPARAGLLYSLEPVFSFFLAYLVLGERLGTVGAIGSLLTLFGILYSEMGKWN
KREE
>fig|355278.4.peg.2656 Glyoxalase/bleomycin resistance protein/dioxygenase
MAFQQIQTGIITEKLKETKEFYQTWLGLEIKFETEWFILLCLPNQPEIELAIMAPNQVQV
RKPYFQKPYQNAGVWLIFETKEIEQEYQKMKEKKAPIDLTLTEEEWGDVHFTLVDPNGIG
IDIVQERNMNS
>fig|357544.13.peg.603 Multidrug resistance protein (spaB)
MDTIKNIPLRTFVLLYKSSPKRVVLASITVLFIGIIPSINILVMIKLIDIVVNLLQNHMH
FEYSLLLPTLLLWGALLFLTHVFLGILSSLQTIIAEQFSINIITQLANKLTKVKNLNFFE
NKDHTIKLNAIHNGLYIRPLNYVSNLFFNLQRIIGLVSLFGILFSISIYLPFIMIFATVP
CILISNHIAKKHSASIDELQDQKESMQNYLYSGLDNQKNKDNLLFNFMLNFHHKFIETKE
LYLNNFVKIAQKNLMLTIYADILITTLSIALFFLMVFIILSKSCGGNCWIYPSV
>fig|357804.5.peg.432 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MKSEIFVSVVLIVKNQTDKLINYLDKLSPYLNEQYNDYEVVIIDEKSTDDIEHKLRKSLE
THQSIRHIRLSQEVSTDVALAAGIENAIGDFVVNLNILTDHPELVNALLESGLAGNDVVV
GVSQKINSFIYRHLRKLSTWLLKSIGYSLPSNSTGTFCFSRRAVNAITESGRFYCKLHLK
IANTGYTLSPFLCDDFISNTHKKSLTHGIKETLHHMVFNSTKPLRWMSALGIFGSLMAML
FSFYSLIVHFINDQVAPGWTTTILFMSFLFAMMFTMLSFFGEYLARLLNDRSEHKEYNIV
YERNSSVMLDEDRSNVLFTSLGESVNNSQTGRNR
>fig|357804.5.peg.434 Permeases of the drug/metabolite transporter (DMT) superfamily
MKWLILILGILSNASASVLIKVAMSSKEAPIQLSNPLSIIGNLPLVSGIALYGMAFILYA
LALTYLPLNIAHPILTSGSIALVSSASVLLFGENLSIINVAGIFFIIIGVWALTVN
>fig|357804.5.peg.3489 Permease of the drug/metabolite transporter (DMT) superfamily
MLASFSTFEQAWLFIILSVLMHVSWNLMARQVNPKADFLWWGLLGHLLLLGGYGLYHLVQ
IEWSWTLTGLIAITAFANSLYFLSLREAYALAPVAFVYPIARSSPILVAIWALWIFDETL
SNLACLGILVSIIGLWILGNTVKHKHNPKVLLWTLSAAFFTSIYSLSDKAISQQIDSFSA
LLGVVTLGYLSAWITLCLYRKKHCETIIPAVCPHLGVWLAGSLFIGTAYALVILAMQTLP
TAYVLSMTNIGILLAVVLSILFFKDRVHLKQKIVATLFITSGLLILGIFG
>fig|357808.3.peg.1083 Permease of the drug/metabolite transporter (DMT) superfamily
MQATKVQAHRREQSASKGSSMTPMMLTLILILIPTVTGVAGQLLLKVGMSQLGALEISVA
AIPSLIMRIILSPYIIVGLAIYFGGVFFWLLALNRADLSYVYPFASLSYVLITLASWLLL
HEAVPPLRWIGLVVICIGVMLVARS
>fig|357808.3.peg.2624 Multidrug resistance ABC transporter ATP-binding and permease protein
MSPLRRSLTFLKPYLWLAFGAFVSLVLAAGANLVTPQALRLLIDQGIAGRNPGALAWLSV
ALVGIAIIRGVFSFTSGFWSEKASQAVAYDLRNALFAKIQGLSFSYHDRAQTGQLMTRIT
SDVEQVRTFIGMGLLQLLNAAALIIGCITAMLLMNWQLALLVLLTVPLMAGVIGFFMNVV
RPLFDQIQQRLGALNTALQENLAGVRVVQAFAREPYEWQRYGRLNQRLLDANLQSIRAMS
LAFPLIFFIGNLGTLAVIWFGGYQVIGGALTIGELVAFNTYLALLIMPLMMLGMIMAQLA
RAAVSAERIFEVLDVESEVHDRPGARPLPPVKGRVVFDHVWFGYGVRANDHPASDARRPI
REEKYILKDVSFVAEPGQTVAILGKTGAGKSTIINLIPRFYDVTHGRVTIDGIDVRDVTL
ESLRAQIGIVLQDTTLFSGSVRDNIAYGRPDATDAEVEAAARAAQAHEFITALPNGYNTI
IGERGVGLSGGQKQRIAIARALLRDPRILILDDSTSSVDAETEYQIQLALERLMEGRTSF
VIAQRISTVRRADLILVLDNGRIVAQGAHEELLATSALYGEIIDSQFGGVREEVETVEEE
MLNVER
>fig|357808.3.peg.2659 Vancomycin B-type resistance protein VanW
MSAEQVHFSSVADAAEREGFPVTARTRVRPPRRRGDGWLWFALAVITLVALGVAGGITSF
YRSYEGRIYPNVSIQGIAVGEMTPEQAESALRSRYAAFLRQPVVITYGDRQWTPTLDELG
MTFDFRGAVDAAYNAGRGRGVVDDVRELAAIWQHGLDVPLHVSYDETRAQAYLTQLAREI
ERAPADAQVRLDGAQIAIVGAVIGRQVLVDATLAHVSQQLQAFVPATIPLQTREIPPRLD
DATVAAARAQIETILQGPLTLRVGKNEYEWTVADLADMIIINRVPSAEGDRIAVTLDQDM
IARRIRQIADETEKPGTRPRVAWNNGDLKIIKPGKPGLRLDEVRARDMVIAAVMGRDRTL
ELPMVPTDPPVTEANLHQLGIRELVSIGKSDFTGSAAYRIHNIGVGMQLLNGLLIAPGEE
FSFNKNIGQINAANGFVEGAAIIQNRTQQEFGGGICQDSTTLFRAAFWAGLPITERWGHS
FYISWYDKYALGPRGNGPGLDATIFTGGPDLKFINDTGAWLLIQAWSNPKTGVAQIELYG
TKPNRTVDLTHKVYDHTPAPSEPVFVADPKVPRGTIKHTDKARGGMTIDVYRLVVENGAP
RPPELFRTRFRPWPNIYTLNPADIGPDGKPLIPFPQGDQPAPTPAPPPEQPTEPPPPPGV
EPATGNQINP
>fig|357808.3.peg.3391 Permeases of the drug/metabolite transporter (DMT) superfamily
MQASSTSSSPERRPAPSWSGIGIALLAHTGWGAYPVLARYLQTVSDLPGMALLGLGNLIA
LLVYLPFIWRRIDGRILRSALIWGFALVVVLRSITNLLAARFTLAIYIQTITLMTPLFVA
LLSAGLFREPLPPGTWTAIGLSLVGALLMMSGEIGASGVSLALTASDWIGIALAAASALC
LAIYMILVPRTVRHAVPGEAVLLMQLTTLTVTSTGISLLVGDEWERFTTLTSGDWAAFAA
FVFGVLLGANLGQIVSLRQLGAPLVSSVMAWRLIATLALAAILLGERLDSWWQALGAVMV
MITITGYLWRQARPFVGRLRTENQELRTENREPGTRNQELRTEN
>fig|357808.3.peg.3518 Membrane fusion component of tripartite multidrug resistance system
MSLPILRVAIGMLAVVLLIGAVLMASGRTGVLPATQSAPDSAPPPPVVAPGTQPIVANGI
VAPATHVDLRFETGGIVRDVLVREGDVVQAGDPILRLDTSDLELRCAQVRAQLSAAQAQY
ELLAGPVAPADIQRAQAVLARARAHLREVSGAVTPTARRAAQARLEAARVALARLEEGPN
PADVRALRAELRQAEAELRATHDRLSLEKTTLRLQMEQAANVLRDRQTEYARIRDENQAR
TEPLTADQRVREASARLAMENAEKALEQARVAYEAALQAERTGIAAAEARVEAVKARLDR
ILAGADADQIAAARAAVAQAEDDLARLQDERRAALVEIARMEVAIAEAELERLLAGARPA
EAAIARARVEEARAALQQAELALERATLRAPITGVVAALNIRPGEVADPHLVAARLADVR
GWRIETTNLSELNVTRLREGDPAIIRLNAIPDLEIPGRVTSIKPLGAGQEGDVTLYTVII
TPDRLDERLRWNMTAMVQITPGR
>fig|357808.3.peg.4219 Bleomycin resistance protein
MQQIAHKMMFRYAIPKFPASDIQASLEFYKNKMGFTEVFDYGDYAAIKRDAVEIHLWECQ
DKNIAENTACRVAVSDIESLYAEYKQTGVIHPHGTLEEKPWGGKEFVALGIDGNGLFFFE
YKGN
>fig|357808.3.peg.4251 Permease of the drug/metabolite transporter (DMT) superfamily
MQPQPHTGYTLSALAAVVWASTAPGLAYLMTQYATPGLTLALWRDLLIALVCGGGLLAFR
PSLLHIGRRAVGHLALTGMVSIGIYHALWLWSVTLNGAAIAVVLIYTYPAFVTLGAWALF
REPIKKVHLAALALALAGCALVVRAYDPAILRISWLGAMVGLLTALTHTVYVLVGQRNAP
SISPWATLAYTMTFGSLTLLALALAADQLAPMTRSYIWAIETPAAWAILAIIAIGPTLGG
YALFTLSLRHIPGKVAGLISVIEAPVATLIAVTLLGERLEALQIAGMGMILVAVVLPRLV
AQIEGAPQ
>fig|357808.3.peg.4467 Daunorubicin resistance ATP-binding protein drrA
MHAIETWDLTRAFGDRVAVERLTFTAPRGAVFGFLGPNGAGKTTTVRMLAALIAPTSGSA
VVAGYRLGEEDQDIRRNVGLLTESPGLYERLSARQNLIFFARLYDLDAARAEAQTERYLR
MLGLWDRRDDPVGSFSKGMRQKLAIARALLHEPAIIFLDEPTAGLDPEAARTVREFIKEL
RAEGRTIFLTTHNLPEADELCDTIAVFRTRLLRIGAPDTLRAELFGSSTRIRVAGDATMF
LDVVRALPFVRAAAASGDALTLSLDNPDEQNPILVQALIKAGAAIRYVEPREHSLEDVYL
HLVREAEPIGQSHA
>fig|357809.4.peg.145 Vancomycin B-type resistance protein VanW
MKMKQNVLMTVLLCLMVIICVGCNNEAPPKEQDHSLDGALLDVTPSISPESVTATPNADF
ISEEGKETITENTTPLKPGNVEIDANAILGQFTTHFYNSSKARKNNIVNAAKKIHLKVVN
PGEVFSTVGAISPITKDNGYDDAGTYQDGRVVNAIGGGVCQVSTTLYNAVLGAELKVTER
HPHSMTVSYVELGRDAAIAGDYMDFCFQNTLETPIVIEAIADPAGSITVRIRGVETRDKS
KRKVSYESVILETIEPGPAVITYDKNQPKNYLKVTQSAHSGYKVELYRLIYYQGELIDRI
LLNTSTYEAAPQYLTIGIK
>fig|357809.4.peg.160 Antirepressor regulating drug resistance, predicted signal transduction N-terminal membrane component
MEGNFKGRKKNALNLKTPSAWIIVAATVFVLIFSIVFATNRANEGIGDHDFYNFNVNGFT
LGADIDKMDTSALTPTEPLNINNGYDYNFEEVRYSADENTGRLKKMFVNVYDGAYIPVVT
IHTGEAASYIPNNLTTIEQITTIFGQGKKGWQDREQGLRYMEYRQKEGRLSATE
>fig|357809.4.peg.377 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRMKENKDYLLKGTLWKAILMLAIPIAVNNFIQTMYNLTDSYWLGKIGTDPQSAITVVTP
IQSIIVNFGTGITVAGAILISQYLGAKDEKNAKSMVGQLFASCMIFSVVCAAICFLLTPA
LVGWLAGGESFSSMAVTYLRIVILDMPFLFTINIFTAVNQSQGDTVRPMFLNLLGIVLNM
ILDPLFMLGFGWGVAGAALATLLAKVPCAIIALYSLCNNKKSLYITKESLKIQKDKLKSI
AKIGLPTAIGGSTMQLGFLLMTSSVIKYGSTAVSAYGIGNRVNGLVTMPANAMGSAVATI
VGQCIGARDQVRAQKAYLMARRIAVIFLFIGGLILSRNTVSEPIVRIFSNDPDVIRLGTQ
FLQLMAFWCFTNGIYTTTNGLHQGSGHTMINMTIDATRLWVFRLATLFICERLLHMGVQS
IWYAVVVSNGISAVILWIIYKMGVWKKQVIS
>fig|357809.4.peg.716 5-nitroimidazole antibiotic resistance protein
MEVFMVNQEYCELTNKEIQSILKHTKWCHLGISDCDQPYIVPMYFSFEPKGNNICFTLLS
LRNGQKMRYMEHNQKVCLEFDLQRENYFFSIIVNGTVTICPPIYKNSLLEVVSNQISGRC
YMLY
>fig|357809.4.peg.1058 Permease of the drug/metabolite transporter (DMT) superfamily
MPRKTLGHVFALFTILIWGATFIASKMLLTEFTPFQIMLMRFIIAYVVLLIMNHKLHKII
WKDEIMFCLLAIFGSTLYFICENIALTYTLASNVGIIIALAPILTALLAHFTTHDERLHK
GIFLGFFVAFIGVVLVVFNGTVLLKLNPMGDILSLLAAVMWAVYSTLLKRCVHKYDGIYL
TRRVVFYAILTTLPLVIKENKYFPLETLKEPKLFLSLMLLGILGSGICYVTWNYASKWLG
IVVTNNYIYLNPFVTMVAAGVLLGEPITIMGLLGSALIIGGIIISDRIKSNKNIENKNYE
IGKEL
>fig|357809.4.peg.2201 Permease of the drug/metabolite transporter (DMT) superfamily
MRNSTKAYLAITLQSLIIGFSFSVVKVALNSTDTIGLLAHRFTVTAISVLLYKFFKPNSI
SVSLSDWKKVAPFGLAYPVVFFLFQTLGLTIITSSEAGIVYAISPILTFIVARIVLKERA
NRPQTVFMILSVLGVIFINTMKGFNIGNYSYLGFLFILMSVASFSIYNVFIKKLSKGYSA
MTIVYVVSICGCVIFNLVSVIQHLVVGNLGAYFKPFTNLSFVLSILYLGVIASFISSILS
TYALGKLEATTVSLFNNVATVVSILVGIVFLHEQLNYYHYIGIIAILVGTIGFNLLKSPQ
KDINK
>fig|357809.4.peg.2374 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKQLDLKKDSTRKLFFRYLLPSISATLVTSIYILADSIMIGKGVGPEGIAALNIVLPLFT
LFFGTGLLFGVGGSVLMSIANGSNDSLLGKQYFTTSVLSVTFISIFLLIIMQLGFKPILY
FLGATDVTFTLASEYGRTLVAGAPVFMFSALLQAFIRNDKDPNLSMIGVITGGVTNIILD
YIFIYIFHWGMFGGAIATVIGSSITCLILIVHFFKKTNQLKLVKNGFSMKRFSKVVTSGL
ASFLIEISNGIVTFLFNIQLVKYIGDIGITVYSIIANSSFIVMSLANGVAQASQPILAIN
FGAGERKRVDEVKHLGFITTTIIGSIIVALGALFPGVITGLFVHATDEILSLAIPAIRMY
ILAFLFMNLNIFISGYFQAVMKPQYAMGVNLLRGLILGSAFVLILPLFIGANGIWISMPI
VETISFAVALALNYKMKKVI
>fig|357809.4.peg.2400 Multidrug resistance ABC transporter ATP-binding and permease protein
MKRLYIYLRDYKKECVLAPLFKMLEASFELIVPLVMAAIIDTGIEHGDKSYIVNMCLILV
GLGIIGLVCSVIAQFYSAKAAVGFATKLRHALFAHLMNLSFNEIDTLGTSTMITRMTSDV
NQTQTGVNMVLRLFLRSPFVVFGAMIMAFTIDTKSAWIFLIAIILLSIVVFGIMAISIPM
LKRVQKNLDSVLQITRENLLGTRVIRAFRREEKERREFYQRNGELTRKQKRAGFLSALMN
PVTYVIINIATAYLIWVGAVQVDYGALTRGQVIALYSYMSQILIELIKLANLIITVNKSV
ACANRVADVFDITNSMENVNNGILNLEKEGSIEFRNVSLEYQGAGEESLSDIDFTVKKGQ
TIGIIGGTGSGKSSLVNLLPRFYDVTKGEVLLGGKNIKDYPIKELRDNIGIVMQKAVMFQ
GTIESNLYFGKNEAGIEEMEEAIEIAQATDVVNAKGGLEASIEQGGRNLSGGQKQRLSIA
RALVKKPEILILDDSASALDYATDARLRSAIKSLSYQPTVFIVSQRASSILYADLILVLE
DGRLVGKGTHSELIDNCEVYQEIYYSQFPKEVKAL
>fig|357809.4.peg.3254 Teicoplanin resistance protein vanZ
MTGTNFIPFHTMMSYLKNSDNLNSSIIYTNIFGNLAAFAPMGFFLPLLFQKLRKFLPFAC
VMFLTIAVIELAQFITNLGVMDIDDLILNLSGASIAFFLCKLPFLMKIFQRFHWIS
>fig|357809.4.peg.3821 Daunorubicin resistance transmembrane protein
MKYIRHQFEVMKAVALVTYKEWSAYRTHSMVSIFVGPVYFIVQYFIWTSAYGGKAEINGM
QLSQIITYFGASTLIGYLTMDFADWNLQMLIQTGKFLTFSLRPIHHRFFAFSQKVGHRFL
GLLFEFIPCYLIFSLLFGVEMIPKRIGWTLLSVAFAFLMNFYVHYILGMTAFWFIQSSGI
RRVFDLLSGVFSGAFIPLVFFPEAVQRVLFFLPFPYMSYVPAMVFTGEFHLAGINMPIPT
IVGLQGIAVGVVIILSELIYKASMHHFNGVGV
>fig|358681.3.peg.65 Permease of the drug/metabolite transporter (DMT) superfamily
MRYILLVFLGACSYGILSTIVKLAYKQGYSPAEVIGGQMFLGFVLTWIPALFFLRTKPPL
RQLLLLVAVGLTVGSTGMMYYNALQYIPASIAIVLLFQFTWMGVLIEAVMTRKMPGKETI
FSLLLLLTGTLFAGGIFESGGLAQFHILGVIFGLLSAVSFTLFILFSGKTAISVNPWLRS
SSMATGSFLLASLIYPPAFLFNGALLDGLFPYVFLLAFFGILIPTVFFNYGMPHIGPGMG
AILGAAELPMAVLSSYVILNESVSILQVSGVLIILLGIILPEWLRQRNIRRNKVTS
>fig|358681.3.peg.221 Permease of the drug/metabolite transporter (DMT) superfamily
MKNNERLLFLMLAGVVTLWGLNVVMVKYLTTFPPLYVAAIRMTVGGICLSPLIFLYRKSL
RFSKTDWFLLAGVGASSIALHQITLAAGVQYTTAGNASLILGLNPLATALLAMLFLGEGM
SLKKGLGIGMGFAGVLIVVISQHGGLHMNGWGDAIMFFSMLMYVTGGLLIRKLVVRGVPV
LLITALSQTFGVIFLWGVALTVQPASYYFSLDVSSFQWLVIFASGALSTALGSVGWNYGI
RQLGASRTAVFLNGMPMASLVFAAIFLGESLQLVHLLALCMIVGGVYLGSRSLVRPKATC
AAAPSDITTKA
>fig|358681.3.peg.452 Multidrug resistance protein B
MWPLTTLYVHTILQRSMTEAGFVLMIQSLAGIFGQFIGGSLFHRLGAKRLIVGALIFQGL
IQFSIPFVQSWPAYLILMMGLGFTFNLSFPAIQAFIGFRWKEQRRELFNIVYVGNNLGMA
IGTALAGVIATLSFQLTFWFNSTSTLLFALFFFLFMKNISHQELVGENLEEQQKHHVKNS
FTLLFRYQLYLFMALGAALIFFSNTVWNTGVAPYITEQGMPLSSYSWLWTINGIIIFAGQ
PITSWIKRLLNQSLSAQLVVSAIAYAVGFGCMLVYHGSYYAFVVGMVITTFGEMLISPTI
PTFISEKTGENAPFYLGVVGAITTGGRLLGPLAMGFMYDHGGIHPTLFLATLVSAGSVLL
CLLHAYFHRENRAEVAKY
>fig|358681.3.peg.696 Permease of the drug/metabolite transporter (DMT) superfamily
MKSKVLSALFCLAALWGASFLFIRIASPVLGPFLTIQGRVTIAAIALLIYTACIGRSADF
QSRWKQYLILGALNAAIPFMLIATAAIHLNASMSAILNSLTPVFSALVAWGWIKETLTLG
KWVGIIVGIIGVAILVGWSSIPLTFEVIVAVGLSILSTVSYGFGGVYAKKALAGVPPLSV
AVGQQIGASILLIPFTLFNLPTSMDSLTPAAIFSVVGVAIFCTAIAYPLFFYLISNAGPT
KTQSVTLLIPLFGMIWGVVFLDETITAGMITGLIVILGSIFLIYDIRPQPAKNKPSQKAG
>fig|358681.3.peg.702 Permease of the drug/metabolite transporter (DMT) superfamily
MNPLYVGVLYIFGSAAGFGVMSIFAVYAYEAGVSVSTLLFLRFLLATALFFGLLLWRKES
LRLDKRQVLAMFCLGGILYTLQSLSFFSAVQYIPTSMAALLLYTFPVFVAILSYFVEKER
LTKKTVIAMLITLVGLGLVLGLSFGGIQPVGVLLALAAALFYSVYIVVGNRVVKGVSSYV
TSAYIALFATISTFFIALKDGGVDLSFAVQGWWAILGIVVFSTVVAISFFFRGLQLIGST
KASVLSTLEPVVTFGFSALLFGEAFSLLQLLGGCAVLVGAALIVSGKGGEPELAPKQASS
>fig|358681.3.peg.760 Drug resistance transporter EmrB/QacA subfamily
MQQLTEKKKVTIMIAIITAMFFAAINQTIIGVAMPRIISKLGGMDYYSWAITIYLLTSTV
ASVLVGKLSDIYGRKPFILTGIALFSIGALLSGFSTDIFQLITYRGIQGAGAGIIMSTAF
TAMGDLYEPRERAKWGGIMSAVFGVSSVLGPLMGGYIVDHLDWHWVFWIFLPIGVIAFLL
IMIHFPKVPKQEGESVDYFGSLFLTLTIVPMLLAFSWAGNGPGKHAWGSWQIIGLFASTI
IALIVFIMIERKVKTPVLPLGLFKNSIFTVSNLVGFFLNAGMMGAIIYVPFFVQGVKGIS
PTMAGYVAMPMSIAMLGTSAIAGQIMTKTGKYKKMALGGLLVMTFGMVLMYFMSPTTPIY
LLVIYMIILGLGIGIAMPVFSLTVQNAVAPQQLGVATATSQLFRNLGGTIGIAVMGTVMS
ASMTAKMTQLSGAMGQVNNPAAADPALAEKLSLFTNPQNLLDQPKIEAALASLPPDLQPL
FTHMLDMIREAMSYGITTTFLTGAIVAGMAVIIALFLKEIPLRSGKMGQKPEGEAGKA
>fig|358681.3.peg.842 Permease of the drug/metabolite transporter (DMT) superfamily
MLLVLSLFTEQVHMESMLTANAILSLLYLVFVGSMMGHSIFYWLVAKTNPVFPSTWLYIS
PLIALSLGVILYNEPLYLLSLAGGITIIVGIILINMDGLKQLMGKKANKLRDVSN
>fig|358681.3.peg.897 Probable phosphinothricin acetyltransferase (antibiotic resistance) protein
MLQIRDAVLSDLPAMLAIYNYAVENLVATFDLEPQTLAQREVWFHKHGGRHPIIVAEYEG
NVIGYCSLSVFREKPAYQKSTELSIYIAPDQSGKGVGTTLMSAILERARQLEYHTIVSGI
VGGNDASVKLHEKFGFTLAGRFQEVGFKFGEWHDVHFYQWMVK
>fig|358681.3.peg.1136 Antibiotic resistance protein
MDGVRYKMREVLDKSKIETFLQQARIGHLGMVDGHLPYVVPLNFVWTNGKLYFHGATGGR
RNQVVDANPEVCFTVCEEYGTITDPVPAKTDTAYMSVMIFGKAEPIVDLDEATHMLQEMM
NKYVPGYYNRPLPKQHVEKYRSAVFGGPVQVYRIDPQHITAKENPIEEEKMFNPGKTV
>fig|358681.3.peg.1144 Multidrug resistance protein
MSKMRQVLEAYHPIVHLLMAGTVFVQLTQSMSIPFLAIYLGETTKLSHAYIGLIIGAGPL
AGTVGGFVGGILSDLFGRQKLMFFSLLAMACSMIGFITLAHPIGLLVISMVMGLAASIFA
TVSKALMGDLTPEQKRFRVFSNRYLASNLGFAIGPMLGAFWGISGSNLAFVLTGVSLVSF
AVILVVACRRCGVTDNSGENGEVERASLGEIWQVLRRDVVLLTFVTGGILLVTVYGQMSV
TLSQYLRENFSEGVALFGTLMSVNGFTVLLLQIPVTRLVERYSLFARIAGGAVLMAIGEV
GFAFSSNWVWFITAMIVFTLGEILIIPAEYAQIDEISPANMRGTYYGAQSATMLGSFLGP
WAGGMVLTAYGGPVMFGVMGVLALVSLIFYWLGRRMHEQRKQPRNAIVETAM
>fig|358681.3.peg.1181 Permease of the drug/metabolite transporter (DMT) superfamily
MTGKKDSKLFGVTIALLAVYLFWGGTYLGMKIAIESMPPFIMAGARFFLAGSILFLIGRW
KGAELPSAAEWRGAGIVGALLLLGGNGVVAWAQLKVPSAIASLLIATVPLWILVFNWVGG
SKKKPTVGVMGGILFGLAGIAVLVVHPESSGNQGIDTVGIFALLFASISWAVGSLYSRNA
KLPASPVMATALQMIIGGSLLGITSLFLDDWTKLHLSEITLRSWIAFGYLVGFGSIVAYT
AYIWLLKNAEPSLVSTYAYVNPIVAVFLGWLIADEQLTSQTLIAAVMIIAAVAIITMFRE
KKSPGATQTIARKEKGKLQVHK
>fig|358681.3.peg.1196 Methicillin resistance regulatory protein MecI
MSTSMPSISEAEWRVMNVLWEKSPLTANEIISSLQGQTDWNPKTVRTLLNRLVQKNAVGV
NQNQRVYTFYPLYSQNECQHAEAQSFLQRIYSGALKSMLVQFIQKESLSDEEIQELRSIL
DAKQSSTDPHQK
>fig|358681.3.peg.1392 Membrane component of multidrug resistance system
MAEAVAHREEKSGNGGMWLSLVAILSGTFVAILNNSLINVALPAMVNIFGSSTETMQWVL
TGYMLANAVMIPMSGSLSAKFGAKKIFVLSLSAFTCSSILCALAWSDSSLIAFRVVQGVS
GGMIMPIGMSMIYMIVPREKIGMALGIFGIASMTAPALGPTLGGYLIEFLSWQFLFLVGV
PFGIFAVIMSIVLLKETPKKPELKFDFLGAFLAIVGFGTLLLALSKGQAEGWTSFFIVSL
FFIAVMSLILFVWVELGKESPLLDLRLLKIPTFTISILTSGFVMMGMMGGIFLMPIFLQN
IQGLTAMESGILLMPQSIAMAIMMPISGKLMDKYGVGPIGLVGLTIMSITTYELHNLSAD
SMHSWIDMILTIRGIGIGLCMMTLSTVGMNAVPRTSVGDASPLSNVLRQVMSSFAIAILT
VIMQARQNFHMASISDNLNTDMATQFISGISGMYAQVGVDAASATGGASAILYGMMAKES
LVQGIGDTFLVSVIPIVLSIPLLYFLHKKPKKTQQQVPATEKATA
>fig|358681.3.peg.1559 Drug resistance transporter, EmrB/QacA family
MGAHNRWLMIAVGLGIMLNPLNSSMISVAIARLQNVYRLDFTVVSWIIFSFYIASAIAQP
VMGKASDLFGRKKIFLIGLVVSFVASLLAPLSPNFGWLIVFRIVQSIGTSMMVAVGMALV
RIHITEKQATALSVLSIFLSGAAAIGPFIGGVLLHYWDWSAIFLINIPFVVASLLLAWRM
IPNDESAASVTQNMSFRKWLELIDATGIVLFAVGLVALLVGLLSAKSSGHVSWWHIMVGG
IGFVTLGAFVRHELKTTSPFIPLRTFAKYPAMTWVNIEFMLVNVLFYSLFFGLPSYLQMV
RHVSEFHTGMLMLSLGLCSLIVSPLAGRWIDHSGPRPALLASAILMTFGSLWLVMFNQDS
QVVSVCVALAAFGISNGLNNVGMQAALFKSSPKEIIGVASGLFNTSRYLGTILSSLLISI
VMGDTFSTEGLQVLGMILTTISLSLVLMSWRRESRQAGES
>fig|358681.3.peg.1788 Permease of the drug/metabolite transporter (DMT) superfamily
MADITLLLVAVIWGTTFLIVQQAIASLPPNTFNGVRFTIAALFLLIIYFIRNRHRGQTSE
WRGPLLRAGVILGFWLCLGYALQTVGLLYTSPSKAGFITGLAVVLVPLFSFLLLRERVKP
FAIFGVILAAFGLYLLTQNQSFSFNLGDALIFVAAICFAMQIVFTGKYAPRFAALPLAIT
QLGTVAVMSWLYAFFFEDWSRAFDPAILFIPEVAFGLIVTSIFATALAFLAQTALQKQTS
STRVALIFALEPVFAAVTSYVFIHEILSGRQLTGCLLIFTGMILAELPIQEWVRNFRQRK
PNDGRESA
>fig|358681.3.peg.1971 Multidrug resistance protein
MSIFTQMTKQQRIGLLFVILILFIDMLLYSLLIPIVPYFTEKLQPSSTMMGVLFSSYAIA
MLIATPIFGPISDRMGRRTMLLIGLLGLAASTLLFAFSETMGLLITARFVQGIAAAATWP
TALALLADLFPSKMRGTVMGIALTAISTGTLLGAPIGGWLFEISDHRMPFLAAAAFTVIN
IVLVYLFLKEDATKTVSEKLHVGGFIRNPQVIFIAGIVLLAEISLCLLEPTLPVFFTEKL
SMTPTTIGLLFGVMTLAYGMIAPVAGSLSGRMNPYKLMFGGIMTLAVFLPFLAWADSLWQ
AMLAMALIGASIGFTLSPTLGTLGAIIDQGGSGAYGTAYSLFNMFHGIGMVAGPLAGGIL
TDLLPVSSALLIVAASILGFGILLFVQLKASKSTSLSIKESEMKF
>fig|358681.3.peg.2615 Multidrug resistance efflux pump PmrA
MLIRSGFSLGLLYFLTYLITDPYLFLVLRIFQGLLAGYVPAAIALVATNTPEKSVGYALG
IMATSGATGGIIGPLVGGVVSHVWGNAEAFIFSGFVVLVAALIATFFVKETNLNRSGSRS
SVREDLRAAMANRPLMSILGMSLMVTISVMLLEPLLTVYVMQLGASQQDASLSSGIIFAA
VGIATVIAAPQWGKLGSNIGYSKILFIGLMGGAVGNLLQFFFTNLYGFGILRFAYGLFFA
AVYPSINAMIVKVTEPEFRGRAFSLNQSSTQLATMMGPIIGGFLGGLIPIRYVFIINGIA
LLITAIVIRSKRSQLIGQPLKQQTTEHQLATK
>fig|358681.3.peg.2655 Transporter, drug/metabolite exporter, EamA family
MHRVKEGTIMIRSYLLLLFCVTLWGSNFVFGSMLVKEFPPLFLADVRLLFTSMFLIIYAW
LAKKFVKITARELGLLVLLGLIGTLANQTAYFNGLLTTDATTASLILSLSPIVTAVLASL
FLKEQFTLRMKIGSGLALMGTFFVVGIGAGLSITKGVLLIVIAMVAFSSSMIIIRKLTQT
IQPFIATVYSTTVGTLFLTPAAMLTIEPGAQISHEVWAWAMLILTAILMQGICGIVWNQQ
LKVVGTGKAAIFLNLQPFVAMLVGFLLLGSQVTSIQVGGSLLIVVGVIVASVQKKQAVQP
SKSV
>fig|358681.3.peg.3102 Drug resistance transporter, EmrB/QacA family
MSRSEKRNRFIIFAMALGLLMSSLDNTITSAAISHIIKDIGGFESMSWVFTSYVLAATST
MLIFGKMSDLFGRKLFYLLGITIFLIGSALCGVAQSIEQLIAFRALQGIGSGALFPITFT
ILFTLSSDPKYTARISGVFAGIFGLSSIAGPQVGTLLSDYLGWRWCFYVNVPIGLLSLLT
LLFSLKESRSQSKPKIDYLGTVTLIVSCIAVMLALEWGGKAYEWSSWQIISLFALAIIVG
IAFILVERHAQEPILPLQIFKNRMVVATCIACLSQGAIMFAAITYLPIFAVAVLGYPNSN
SVLTPLMLSLTGGAVVFGMLQTKFSFRSLMAFSMLASVVSSILLMYVSTGISFFFLTLLM
ILFGFAAIGPLMSVAQNAIVHSVDKPYIGISSSIVGFCRNMGGVLGASITAAVVNQNYAS
IVSTGASLHGISLEKVADLLNPEVLMREPLKIEPSIHSFLSDSLGTAINHGYIVGLIFAV
IGFFSVLYAGPGKLERHQKSVES
>fig|358681.3.peg.3673 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTTSPLLPQIGAIFVAVSDIERARDWYCRLLGIPADGEIMFGHIYCIPLQSGLTLVLDS
KNFPNRITDDTLLFHFNTQDIEASYSFLKESEVEVVTPIQHGHWFNFRDPDGNLIMVSQC
>fig|358681.3.peg.3895 Permease of the drug/metabolite transporter (DMT) superfamily
MKHAFQLGFTPFEMSGSQLIFGGLIMTVMAIFFSKQRFSFKYLLLLAPASLMMASTSLFY
HQAVSRVSASLAIVLLFQFTWIGVLLEAIVDRKWPTAEKWVSLAMLGAGTVLASGLSESG
IQSVDMVGLIFGLMSGATFALVIFFSGRILPGMDPYLRSAISISMAALMLSIVYPPTFLV
NGQLLQGLLPLGLLVAIFGSVIPIFCLAVGVPRIGNGLATILSAVELPTVVLLSSFVLQE
TVSLPQWGGVFMILAAICVPQVKWRKLFSPSHDLEQERM
>fig|358681.3.peg.4089 Antibiotic efflux protein
MKELWQQRSFRWYWLGMFLSSLGDQFGWMGLTWFVMKKTGSPAAMGGVVLAYMLPAVFAG
LVAGVLLDRFDRRKLIMMDNIARGLIFIALVALLQVDQVPLFVIYVLIVIAGILSPLSTA
GAQTLLPRIVSDKNQLVKANGVMETQWQIVYMFGPALAGVLIGLIGEAYVLLIDAASFFV
CAFCFSRLPRELTKSANPTTIVKGQMGVFFRSLWSDMRTGYRYLFGRKQLIILVFFTFLF
NMSYGPIEIALPLYANQDLAGGSVALGMLWSALAIGALLGSLFFSTVTWKLPLGSTLAGI
IVAWGLTTLPIALFSRLEIAMASMVVAGFCFAPYNIMYRSYLQKQVPDALLGRVLTSVRT
ITGTGMPAGAAVSGVLIPFLGVQGIIGAGAAVCIIFGLLAFGALKNLEDSSSLPIEER
>fig|358681.3.peg.4151 Multidrug resistance protein B
MRQKWESYPSSIRLLAIAAVIFSTGMACIWPLVTIYIHNHLGKPLTVAGFLLLLNQGAFL
IGSIVGGMLFDRWGKMRTIIVGSIGVILISLGLGVTEDFTIYVVLLLLNGLFYGLLSPVM
NALAVVLWPDGGRKGINLIYVTLNVGVAAGSALGGFLASVSFAWTFFGNAISQVIVLAMF
MLILPRQLKMVEQQRQNSTTGQSMPEQATDDVLRQPQQEPKVVWGALLLLCGGLLISWIV
YVQWTTVLSTYMQSLGISLRQYSLLWTLNGGLILFGQPLIAWVIRRFARTLKAQMLLGAY
IFALSMLILSQSTAYAGFVAGMFIMTLGEMLVWPAVPAVAAQFTPEGREGFIQGLIAGTG
SAGRMLGPLLGAFIFQSIHAQGLLFVMASLCLLSVAFFAFHTSFHKRRHHVPVQNQAS
>fig|358681.3.peg.4787 Permease of the drug/metabolite transporter (DMT) superfamily
MSTQLPIEKQVLPKEQPITSDQLHTEKMGLLYGFIGVLSFSLTLPVTKMVVTVLSPLSAG
LGRALVAAVLAALVLLLKRVPFPTWQETKKLFLVSAGVVAGFPFFSSWAMERVPATHGAV
IIALLPLATAGAAIFFSGERPTRKYWISSVIACVTILAYAISSGFGALQWADLALLGAVI
SAAIGYAVGGELSKTMGGWQVISWSLIFAFPFLVVPLTGPLLTDLKQATWPVWLGFGYIS
VISMFLGFFAWYHGLAIGGVSKVSQIQYLQPFLSIIAAWLLLSEPLTLGAVLSAVIVVLA
VAKGRKASVQQKA
>fig|358681.3.peg.5675 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MKMGASSLTSNNDMLLLKFLHYFTNLPIMVGLALYGLSAFIWIAALEKVQLSYAYPMAAL
GYVLVAVLSFLIFNEPLSLTRIAGLAIIVVGVVVISQS
>fig|358681.3.peg.5702 Probable multidrug resistance efflux protein
MSTEGIWSTHYRALTIGIILVVTATAFEGLAVTTIAPGLSRELQGEDLYGWVFSAYLLAQ
LIGTVVTGQFVDRKGPAQPFIVTIVLFALGIVVAAIAPDMLTLLLGRVMQGFGAGALVNC
VYTMITLRYPDSLRPQILAVFSSAYILPGLFGPYVAGIIAEQLSWRYVFWLILPFIFLSA
LLTTPSFRGLQPPKASAANNLSLLLPFFLAIGTGALLFGLGKIPSIYGFLLSIAGLLALS
VPLYKLMPKGTLVARPGLPAVMASRGLFVAAYYGTQTYLVLGLTSILGLTADKAGLAVAS
AAISWSVAANVQAKLDKKDQGAGRKKRMIIGLVIMLIGVACTVPLTLIQQDLFGIVVAIF
SQIIMGFGIGLAHPTSGAIAFSLAKSGEEGKVSAELSIADTFTPAIVIGMGGAIVSVMTA
FAFSLSVGITVSLLLQTFIVILGLASATRLATGSVPVQEKGDTLG
>fig|360106.5.peg.1274 Broad-specificity multidrug efflux pump YkkD
MHLLALLLAGGCEVLGIVFLNKFSHSNGIRKIVNFMFIVATFGFSLSLLRYAMQVLPMSV
SYAIWTGIGAIGAVFVGVVFNHEKLGIKKYVYLFLIVFSVIMLKLI
>fig|360106.5.peg.1275 Quaternary ammonium compound-resistance protein SugE
MSNKGLFFVIFGAIVEGGWAYGLKYADSNLEYLITIILICCSFFSFMAAFKYLPASVAYT
LFIGFGTLFIVGTEIISDYFRGSSIDFLRIVFIFTLIIGVLGLKRSES
>fig|360106.5.peg.1647 Permease of the drug/metabolite transporter (DMT) superfamily
MKKSVIAEILLIFVAISWGMTFVPVAEAIKSVNVFSFLFWRFLIATIFMFVFCIKICKFD
KKSIYYGLFLGFWLFCGFAFQTYALKYSYSSTVAFITGLSVVLVPFLMLVFFKQSVNKFA
FGGALIAFIGLYFLSGTGEFGLGKGEILSIICAVCYALHISFTGVLVSKCNIYAMVICEF
FAVTILSFFGAILFESGDTNSLFQGLQISFETEFLMALIVCALFATVFAFFVQSYAQIYT
TATKTALIFTLEPVSAGLAGYYIANEILSVTQVLGATAILFGVLFSEIGSNLIKQATLKF
EN
>fig|360107.5.peg.800 Nitroimidazole resistance protein NimB
MRVKMRRQDRNLTDIEAFEIIDKSQFAVLSCFDFRNEPEIFTIPILIVRRGKSIFVHGAK
LGSKAEIFKDNTPVSFVCVSYAHVPEHDISYLQDIKKDYKRLAGEVFTTEYKSVVAKTKV
YKIKNENKKIEILKLLCEKYTPKYMDFFATAAIPALSKINIYEFKIYELSAKAKIL
>fig|362242.7.peg.2004 ABC drug efflux pump, inner membrane subunit, DrrB family
MILLVPVLVITLMYFMFENAPHRPGTQTPFNNACLILLGLFPLVVIFIITSFTMQRERAS
GTSERVLTTPLRRLDMLAGYGTAFSLAAAAQATVACIVSFWLLGFDTAGSPVWVFVIAVV
NAILGVGLGLLFSAFARTEFQAVQFIPLVMVPQLLLAGIIVPRAVMPTWLEWVSNAMPAS
YALEALQQVGAHPELTYIALRDIVVVVVFAVASLCLAAATLRRRTP
>fig|362242.7.peg.2271 Membrane protein, MMPL family, RND superfamily drug exporter
MNKSTLAGTALAVTAAAGSGSIASPPRTSDWYARLRKPSYQPPSVAFPMVWTTLYSDIAA
SSAVAIDRLNATGQRDKARRYIGALSINLVLNAGWSWLFFRFHRLGASALGAAVLATSSA
DLVRRTADADRRAGLAMLPYAVWCAFATVLATHVWRLNR
>fig|362242.7.peg.2628 Multidrug resistance protein B
MILTSQLNNGENASGASKAEILREHRPGVPLDQPVLHELSRAYSVVFVVAVVLAVLAFIP
LAFLPKWSALTALSQTSSLERTPEPDAAPHGRQSPPEDTRPGAGRNSSSNDLTPSGPDG
>fig|362242.7.peg.3019 Drug transporter
MCTLATSDGPLIAVSLASGEVPGALLQPDGPPRVPGIGDTLIRTMTIGSQRGADVALGLA
QVVIRPDTSAVGLLEFHQIDAAREAGRAAARESMPQIMALLNQRR
>fig|362242.7.peg.3020 EmrB/QacA family drug resistance transporter
MSGVSISSFEKVTSRHSKRPGATPARTHLAGHARKGFANLTHRRQPSSAAVLLVAAFGAF
LAFLDSTIVNIAFPDIQKSFPSYDLGSLSWILNAYNIVFAAFLVAAGRMADLLGRRRTFT
FGVVIFTIASGLCAVAGSGEWLVAFRVLQGIGAAVLVPASLALVVEGFEPARRAHAVGLW
GAAAAIASGLGPPIGGMLVDWASWRWVFLVNIPLGVVAVLATSRALVESRAAGRRRKPDL
RGATLLAGALGLLTLALVKGPDWGWVSVPTLAVFAASAITLVGFVLSSMAAPVPLVEPAY
LRSRPFVVGNVLTLVAAAGFYCYVLTHVLYLNYVWGYSLLKAGFAIAPAALVAAVVAALL
GRVADRHGHRLIVTLGALVWAGSLFWYLQRVGTEPDFLRRWLPGQLLQGIGVGATLPVLS
SAALTGVAKGGSYATTSAVVSTTRQLGAVIGVAALVILIGKPEHGAAADALRRGWAMAAI
CFVVVAIAAVLLGRTNSKPGQELEPEPAAAARAAPTTTEPAAALIANRATDEADLLGNLP
LFAGLDAAALAELADRVEEVELQAGSYLFLAGDASDSLYVIRRGRVQVLHGDIVIKELGR
GEVLGELGLLIDAPRSASVRALRDSRLVRLTKAQFDQIANRGVLAALVRVLATRLREAPP
PAVHTTSPGVVVSLVGVGADAPVQSVAAGLLTALSEQLRVVDPGRVDIDGLDRAERGADK
VLLHAGAQDTDWRDFCLRVADRIVLVTGDPDPGAAALPARAQGADLVLAGPTASREQRRS
WEELITPRSVHAVHYRRVVQDLRPLAARLAGRSIGLVLGGGGARGFAHLGILEELEQAGV
AIDRFAGTSMGAVIASLGASGLDAATADAYAYEYFIRNNPLRDYAVPIKGLVRGRRTLTL
LEAAFGDRLVEELPKEFRCVSVDLIAGNPSCTAGAGSLMWLDVRYGCLESIRRRSTRVGC
MGMVACWTTCPCAPWQRRTAR
>fig|362242.7.peg.3206 Multidrug resistance transporter, MFS superfamily
MLLCVVPLNQIPMDAYTPALPQMETSIGTTATALQSTVTVFMIGMALSYLAVGIMSDSWG
RKPVLMGCAAALTVTSLACAAANNVAMLLVLRFLQGGACSAFIVIAIAIAADCFEGARLR
SVNVLLGADWSAAPILAPAVGGFIVEYASWR
>fig|362242.7.peg.4643 Glyoxalase/bleomycin resistance protein/dioxygenase
MGRIGVSSTSIGHVRLTVTDIERSRRFYESVFEWPVLIELPANADEATRRQLAFLYGGVI
YDLGGALLGLRPVANDSFNENRVGLDHIAFRVGSIDELNSAAAHLDDLGIAHEPVKDIGP
SYILEFRDPDNIALELTAPK
>fig|362242.7.peg.4736 Probable antibiotic-resistance protein
MTIDAWMQHPTQRFLRSDMLASLRRWTDSSIPEAQIPIEATIASMDAADVEFGLLSAWRG
PNGQDLVSND
>fig|362242.7.peg.4845 Drug resistance transporter, EmrB/QacA subfamily
MSGIRVSMNRGNVRPKLVLGVIVLGSFIASIDLTIVNVALPTLSRALQASNAELQWIVDS
YAIAAAGLLLAAGNLGDRYGRRGWLTIGLVIVGASSAVAASAGSAQAVIGARAVMGVGAA
IIFPTSLALVTNVFVDSTHRARAIGVWSAVTGIAVVIGPILGGWLIEHFSVGSVFWVNVP
IAVVAIVSVNMFVPTSRNPDRPPLDLPGLLVSTVGVTVLTYTLIETPNIGWASARTAAGF
ALAVVLLAVFLWLERRTWHPILDLSIFANRRFSGGTAAVTTAYLVMCGFIFVATQYLQFV
AAYRAFDTGVRLVPLAFSYAGLSVIAPRIVERVGTTAVVTSGLVMVAVSVACAGGFDAGT
PYWLIAAVMAALGSGLGLTMAPASEAIMGSLSPTAAGVGSAVTGVARQLGACLGVAIVGS
VFASVYLRSMSSNAALHGLDPAARAAMRQSMAAAKQVLDQLPVGEAPAIRHAVESAFLES
FGVGCLACAVFAAVGAVVVAFLLPARGEVRDDVAVSVAASAIGPAEGGK
>fig|362242.7.peg.5531 Drug transporter
MLAAPDGALITCEGDHGDTYYVILEGAAQVLDDDTAVHHLGPGEGFGEQAILRDVPRTAT
VRAVGDTTLVAVDREAFQRARR
>fig|362242.7.peg.5719 Multidrug resistance protein
MTSGSAPQWLTRNLRVLSLVSLLQDAASELLYPLLPIYLATVLGAPPSVVGAVEGAAEGA
ASLTKIVSGPLGDRFARRPLIASGYGMAALGKLIVAAAGAWPGVLAGRVVDRLGKGLRGA
PRDALLVDGVDPAQRGRAFGFHRTMDTLGAVIGPLLGLAGYELFDHQIGPVLYLAVIPAM
LSVLLIAWVREPPRNLAKAKPASILDGTRRLPRRYWAVVSFLVLFSIANFPDALLLLRLK
QIGFSVVGVIMAYVGYNAVYALASFPVGALADRLGRPVVYAFGLVLFAVGYLGLGITTDT
ATAWALIAAYGLFTACYDGVGKAWISAIVSAELQSSAQGVFQGLSGFAVLAAGLWAGFLW
GVDGRLPLLISGGAGAVFALALLAAAAGTRRRAR
>fig|365046.3.peg.105 Permease of the drug/metabolite transporter (DMT) superfamily
MPHQRKQHLDTLAITLLIACCLFWGFQQILIKATVAEVPPLWQAALRFAGATALLGLWCV
VRGVPLFARDGTLRAGLLAGALFTGEFACIYLGLRDTTASRLTVFLYTSPFVVALLLPRF
VPVEKLRGAQWVGLLIAFGAVALAFAEGFAGHMVTPRQLRGDALALAAGTLWGLTTLVIR
SSAMATASAEKTLFYQVAVTAAVAPLLSLALGETWSLGYSARAWGSLALQTVVGAFASYL
AWMWLLRHYPATRMSSFTFLTPVFALVFGVALLDEPLTAQLVLALAGVAVGIVLVNRKPA
G
>fig|365046.3.peg.2660 Phosphinothricin N-acetyltransferase (Phosphinothricin-resistance protein)-like protein
MQPIACTEERHAGAMLDIFNDAILNSTALYDYRPRPPQSMAAWFATKRQNGFPVLGLEDA
QGTLLGFASYGTFRAWPAYKYTVEHSIYLHRDHRGRGLGRLLLQALVEAAREREVHVLVG
AIDAANAASIALHEKLGFSHAGTVRQAAFKFGRWLDLALYQRILETPREPRDG
>fig|367737.4.peg.802 Acriflavin resistance A precursor
MIKKSLVAISFLFLGFNSLIADEAKAPNEAPGLPVQTFTITKQNNTTNKTYPTILKAYEQ
VDVIARVSGILKEKHFKEGDFVKKGTLLYKIEPDTYLANLNMKKAEYTKAKKDYERAKSL
IATKSISPQSFDDYTYQYESSKAALDEAQINLNYTTVTAPIDGIVGIKQHDIGDLVGSSS
NNSLLVTITNTNPIHAEFSLPKDDMNKYLSQIKDKSAKIKLITDGKTYENGEIDYIAPVI
DTNTDTLLLRAKFENANNELIVGNFTKIEISNLSLGDVFVVPENAVLKTVQATIVFVVDE
NNIAKPRPVVTGDLVKEGMVIKSGLKPNEQIVTSNFAKLRPDTKVQIVNKEK
>fig|367737.4.peg.978 Acriflavin resistance protein, AcrA/AcrE family
MKKLLLIQLLFINLFATTLELDGMVESENEKVISSKMMGYITKINVNEGDKVKKGDILYE
IDASNISYNADILKNQVKNLELNLKRYKNLLDQDLVSKYDYEQLELNLISAKAKLSELNA
QYDYLKIKATNNGLIVKKSIKEGEMAMPGMPHMILTDLDSLIIKTNIAESMLKDIKLNQE
VKITIPSQNYESIGKIVAIFPNIISNTHSFTLKISFDKKNFNIYPNMYAKIFMQIGSNDE
Q
>fig|367737.4.peg.1528 Permease of the drug/metabolite transporter (DMT) superfamily
MNEKLKGILFGIISAICYGTNPLGALFLYEEGLNTNSIIFYRFFLASILLGLLMVFQKKS
FYVTKREIFILAILGVLFGISALALYSSFLYMDAGIACTILFVFPVFVAIILAIFFKERI
SLMTAISIFLALVGIALLYKGGDIKLNFIGVMIVLFSALFYAIYIVVSNKSSIFMSSIKL
TFYVSIFCTLTIFIYSLFDSSKSIELLTTTNMWLYALMLAIVPTILSLIFLAKAIQIIGS
TPTAIVGAFEPLTAVLIGVTIFDEKFTLQISIGISLILISVILIIIGKSMSLEKIFTTIH
KVKYTFLRYWRWK
>fig|367737.4.peg.1829 Acriflavin resistance protein
MYKLIDYFYKNSQLNHTILVFFLILGIFSYINIPKEVFPTTQLEKLDIEGSYSGASAESL
NNFAVSEIENQLNSISGLGKITSYIYSGFFSINIELQDGVDKTIKLNEVKDAVSLAKRYF
PSDMEEPNVRIMDEEWSLLSIALSSSKYNQRELLKIADNLKNSLMQIKNINKVRNFGDAD
LQIELALDNKKINMYGLNSSSVIDAISQLSYIYPVGNIEQVGDHVYLSAANNKFDSKFWE
NSILKIDGKKIYLNDIANITIGYPKKETISRLNGENTLTLRVYKNKNGDSIKLTKEIKEL
LKSTEASYEDITLVVSRDNSKLINERLNTILANITLGLILVGFAMYILISPRLSFVIILG
IPFSFIIGLLFLEMMGYSLNMVSMMAMLIALGIVVDDAIIVSENIQRHIDEGYELDKAIL
KGTKQMIGPVIIAGITTVFAFISMLFVSGEMGLFIKLIPIVITCLIVSSIIESFLFLPLH
AKHILKVNEKQLDWTKVYNFYENILHKVIEHKRSFLVIFFITIPIISIILIKTSRFQLFP
DIDSSNIEIAVKLENSIPIEITDNIAKKYEKALLDNAKELYIKNITTTIGLYVDIADNEE
EIENAFILSVELEEFREENFVENYINPILNFSFDFERSDKVRLISSNDAMNMIRDLINPL
LKEDNAVDYNIISQKMGIDSTDIEILLNSYDTSLLVQNIEKLKEKLKNINGVKDISDNTI
LGQSEYKYIVNAYGRQLGLTDSDIAKAISSFFLEREQANTFNEDGIIKIITKSINKDSIK
ELKNFYIPLENNQFVQLKEVVDFKIERNFNEMQKINGQIYKKVMANVQNDIVNATEVLEK
LEGTIEDIKKSGIQINFGGEKEKSDKLALDIIKAFLVSIFLIFITLLIIFPSFKSTFVIL
SVIPFTILGPIIGHFIMGINLNSQSMIGMLGLAGVVINDGIIMLNFLHHTRTKKEFFENA
KLRVRPILITSITTMLGLFTLIFFPTGESIMLQPIAVSLGFGILWGTVLNLVYVPALFAT
LYKIKD
>fig|367737.4.peg.2167 Drug resistance transporter, Bcr/CflA subfamily
MKKRLINFKFILTIALIEVLCYMAVDMYLASMPNIASYFGTSYSKVQLTLTFYLFSMGIG
QLFFGPIIDYFGRKIPLILGVLLYSLCSILITLSTNIELFLLFRIIQGLSVALIYVCIIS
MVRDVSKGRVAANIFAILITIGAITPILAPTFGGYIEQEFGWKTVFYTLFSLAILLSIMS
FFTLQETLKEEKKVKINFKNIFIIYFKIIKDRKFLTPAITACLMYMFVFAYIAGASFAYQ
EIYKLDSKTFGLIFGLTGSALLFGALLSTKLLKVFNMKQLSISGAFILVIGSIISFFSAN
ITFIGFDGIVAGFFISFFGLGLCEASLFSMAMSSQEKSVGATAALLGSLQLLLPASATLV
AGYLVEISIIYWLGIILFLGILSFLFTYIVFNNKKL
>fig|367928.5.peg.650 Permease of the drug/metabolite transporter (DMT) superfamily
MADAGQESSEGISVSKPVARVMMLVNAAVWGSGYTMLKHVQENMPTQWMMFFRMASAVLL
MAIVFFPRLRRIRLRRYIVPGLILALTYWLGFIFQLKGLETTSPGRNSFFTDTYCVMVPF
VVWAFTRKRPSWQHLVAAFVCAFGIGLVSLSGGGGAELMHMSFGDAMTIIGAFFFALNLV
LVGFIGKDFDAIALMLAEFVWCALLFGAGAVLTEGGPSMAWARWDIVLCIAYLVVGSTVI
AQVFQTIAIQNLPTSEASVILSTECIFAMLVSVIFTGETLTVPSLCGFALIFGAILLSEI
QLPSAKRQRGTTEGD
>fig|368407.6.peg.250 Efflux pump antibiotic resistance protein
MEQEESKSYSRRFILILVTVATFLNPFTGSAINLALPAIGGEFSADAATLAWVTSAYLLA
SVIFLLPAGRLGDSRGKVTVFLAGIVVYTAGSLLTILTPTMDLLLVCRFIQGMGGAMIYA
NSVALITHLYPPGERGYAIGLNTTAVYAGLSLGPFLGGALTQFLGWRSIFIVTALLAVPV
LFYAGKFPAFLNERQREHFDVAGLILSSALILCLFLGLAWVTTPTGATLLAAALVLGAVF
FRVERGRQNPLLPVTLLEKNRVFAASNAAALINYSATFAVGFLLSLYLQYIRGYEPVAAG
TLLLLQPIVQVFVAPVAGRLADRMQPGLVASVGMGITAVGLFGFSLLGETTPIAAILALL
VLLGVGLGIFSSPNTTAIMGCVEKRYYGSASAMVAMMRSLGMMLSMGAVLVVFAVIMGST
TVTPAIFPEFLASLRLIFLAFAVLSAFGVLLSLRRNKC
>fig|368407.6.peg.496 Multiple antibiotic resistance protein MarC
MDLITEIAGFVGLTLVAVASITAVMNPASTTAVFTALTEGMTPDERRQVILTTVRISFIV
LAFFALTGQLVFSIFNITVPAFQIAGGILLVTVATGMLGSRGESYQAGDLENIAIVPLAF
PLSCGPGTITAVILLTSAGASSLIAVFLGIAVALVISYVGMLYGPRIFAFIGEGGLRVVP
KLMAVIVLAIAIQFIISGIAEAMPQLLSNVDFGGDAGTE
>fig|368407.6.peg.533 Tetracycline resistance protein
MTTEKPHRLRTLRNRIAASPDAILVLVVLVIFMDMMIYGLLIPVFPQYAPRLGVGESVIG
IIFGIYAGMLLLFSIPMGLLSDRVGRRPLIVAGMLLLALATALFGFSTTITHLVAARTVQ
GVSAAATWSAGLALLADTCDPARLGEKMGVALSAVGVGTILGPVAGGLLFEYAGYTATFL
IPAALAASVGLAVLAVPVRTCRRESGPHRSPMLPRGSLLSLAACAVVIVAVSGTYGVFDP
YLPVYLHAVFSASPATIGVVFAVLAVAAILAQPAAGRIFDRYGGSRYLIGGGLLLAGGAT
VAAMQAGSLPLTAAAVFVLGVALSCALVPTMPLLADIYRDHGSQGAAYGMYNTFFAIGLS
AGPFAGAVLAGRWPLPAIFLGLAAFLGVTGILSGLAFGRLTQR
>fig|368407.6.peg.1356 Permeases of the drug/metabolite transporter (DMT) superfamily
MTLFGGLLAPVTLVYSLPGTPAATAALLLNFEAVATTLIAATIFREWVSRRVWVALGCIT
ASCLLLTWNPAAGLGLSLPALGILLTCLFWAVDNNLGQRLSAKDPLLVISVKGIGAGTVT
LLVALTAGEHLPATATAAAAMAVGFLCYGGLTSILFLLALRGIGAARAGSLLAVSPFFGV
LFSLLLFAELPAGAFYVALPVMAIGAWLMISEEHSHPHRHPGVVHEHRHRHDDQHHDHDH
EAGDPPLSAAGEHSHVHAHAELAHEHPHQPDIHHRHLHRR
>fig|368407.6.peg.1700 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPTSDSEDDTPASSNQTEGTKILLADPKTAILRLSLPMMIAMTLMTLYNVVDAFWVAGLG
ADALAAVGFAFPLFIITIGLASGLGTGGEAALARTIGARDRAGASSVAMHTLLLMTVLAV
AVTIPLYLFAHDIFVLMGAGDAVGLATEYARILFMGTFALLFGEVAYALMHGEGDAKRTM
YAMAAGAVANIALDPILIYGLDMGIGGAAWATILAEVIAAVPMVYWLFVKRDTYISLRFR
EFSPDAAVARNVLGVGLPAAAEQLALALMALILNGVIVLIASTDGVAVYSVGWRVVSIGL
TPILAISSAVVAVTGATYGARAYARMETALRFAARLGLGIGLGLAVATFAFAPRIAALFT
AGDTAGIAPELTTYLQVMSLVYPMVGFGLFSASFFQGTGLGARSLTITVLQNVVLSILFA
WIFAAGLGLGLSGIWWGVAAGNAIGAALGYAWARRYSAGLQIRQAGATAA
>fig|368407.6.peg.1835 Fosmidomycin resistance protein
MTVDTKPVWGLSAAHLVTDLYSPVLPAILPLLIAEQGYSFFLAGLIVTVYNLTSSFVQPL
VGWVFDTRGFAVHVGTSVAISAIFISIVGLLDNYFLVLASVAVAALGHAFFHPSALGTVS
RLASDSIRGRITSYFVIGGNLGYAIGPICAGVAVGLMGLPGLVVLAVPGLVMAVVLRRIL
PAPDRAAVPKMPAPAAKPSYRAIVLLIAASGLRAWAIFGSVAFLPTILTMRGIDLVTANI
LVSGMLIAGVVGQVVGGVLSDRYGRKEFTIIGLVTAIPPFVIFLTTGGILSLAALMVFGF
ILWSTFAVTVAMAHEIAPGNVGLVSGLMLGLAVGVGGMGVSVTGWIADMTTLTLGLATIP
LAIVLAVPLFLLVPYPWKSLVRGRLPSRG
>fig|368408.5.peg.1210 Daunorubicin resistance ATP-binding protein drrA
MYVVEARDLRKTYVSRKRRGLFRVEETRVEALKGVSLTAVKGEVLGILGPNGAGKSTLVK
ILATLLLPDSGYARIMGFDVVSERDEVRKLIGVSLSVEKGFFYKLTGRENLKYFGMLYGL
DGKALEERVNEVLRDVGLQPYADKLYEEMSLGMKARLSIARALLTDPPVLILDEPTLGLD
PVSARRIRSLLTSLAHSKGKTVLVTTHNMFEAEIICDRVAIISEGRILAVDSVDSLKKRV
ADSVFLEIRIAGLAGLQVQNVLRNVPGVEVRTAHRKGLGDKVVVSVPVAHAEEAFERVLH
ELRSAGLKVRSISIVEPSLEDVFIKLAGHRVSSP
>fig|368408.5.peg.1496 Daunorubicin resistance ATP-binding protein drrA
MRVAMSGGAVVAKNLVKVFRTREGGALFRGKRREVVALQGVSFEIRPGEIFGLLGPNGAG
KTTTIKILSTLLLPDSGEAWVNGYSVLEEPRKVRESIGVSLYSDRGFYWKLTGRENLEYF
ARLYHLERGYARRRIEELLKLLDLEKDADRLVEEYSTGMKSKLNIARALLHDPPVLFLDE
PTIGLDPNSARKVREVVLELKKSGKTILLTTHNMFEADMLADRVAIINKGRIIAVGSPRE
LKSRISGKQVVEVEVAGRPEEVREKVKSVQGVLATSLSAGSGNPYAGTLRVVYEGDGVLR
EVLSAVLDSGAKLLSVRTVEPTLEDVFAFYTGGGLEEN
>fig|368408.5.peg.1544 Daunorubicin resistance ATP-binding protein drrA
MLALVAEDLWKVYGSGERRVEALRGISIEVREGEVVALLGPNGSGKSTFMGIAAGVVRPT
RGRLLVYGGEPYSDAGVRGRISYMPQDYGLYAELTGIENYEFYAALMEVDAKEAKRRLEE
LSGLLGLGEWFYKRRVSTYSGGMKRKASLALALASNPDLLLLDEPTSGLDPNARREVWGV
VDGMRRSGKTVVLATHLFEDAERLADRVVVMRGGEVVAAGSQEDLKRKVGYKYAVDLELR
EEPGAELLERVRMLGYEAIPAGGSRVTVLGNSPNLLDEVEAIGGAGVVSASMRRVSLGDV
YFLLTGVRLE
>fig|368408.5.peg.1629 Multidrug resistance protein
MFGVVCVSRKAETQSGERAEPRASTGGGRAEKVLVAYGLASSFAGNLVSPFMALYLYGLA
GGRFFQAGIASQAPVAVSVIMGLFWARLSDTNGSRKKFVQLSLATGSLASLALSFASSIN
DAILVQILGAFTGSAGGAAFSALMAEVFKDKRGSRLGVYNASTVIGGFAGSMLSGFLYNW
IGFRWMLRLNALLGVLPLVLISMIPEEGNRNPVSSRKLVSIPKIPRRFWKLYLARLVLSL
PGALSGGVFSVYFVKYLNGPPEAWSTLVAVTTLFGLASIPYGRLADRLSTREMFVLAGLG
WTALYLGYFLSPNYLVFSLFFVIPVWPAFWLAYSKALMDLSDESERATFYAFEGTLSALF
GSAVGVAAGLVADLYSPRTLFLLSSASALLGAAVAGVLLR
>fig|368408.5.peg.1743 Multiple antibiotic resistance protein MarC
MVPLSVALADTLFKSLFVAVQLYAVLNPVSVIPTFVNLTEGLDSREKVHAVRKASMIVFS
LMVVFSLIGDPLLRLLNVSIASLRLGGGVLLMVIAVDMLSGMSRTKGLESGDEALVVPIA
TPLLVGPGTITTLIVLSASEGLPVTLLGALLATLLVYATLAFGESLLELLGRNFVRSLGR
FMAIIIAGISAEMIHRALLEWGIATR
>fig|368408.5.peg.1937 Permease of the drug/metabolite transporter (DMT) superfamily
MHAKKGFYLDNNYRSSVLGEVFALVAALSFSGAAIFYRAGVRGSQVNPIVLSGLRGMFAL
ALLLVVGFFYRVDFSKPPVFYLAVFLSMLGSFILGDSSFLYGLQRAPLGVVYPVAYTFSV
FTALFSHFILGEELTLRDAVSSLLIVLGVALVYSENFSLGKQALVGALAGLSASVSWGAG
ATLMGLALRWGNAVEVNISRLSMLVIATLPLILKNSSEVFRQVRVHLLALGGILGIGVGP
LLFMNSISFIGASRSSIFISSTPVLTVLLSRIFLGEKTGGKLLLGTLAVSAGLALQSL
>fig|36870.1.peg.157 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MLNFKKLSIIIPVYNEQDSLIELIKRTVNTCSKLKIKYEIIIIDDGSNDKSINILEKEAL
KQNSKIVAIFLKKNYGQHSAIMAGFKHSSGDLVITMDADLQNPPEEIPKLILNAEKGYDV
IGTFRQNRKDNWFRKISSRLINIIIQIVIGKSMKDYGCMLRAYNRNIINSILEYNKKNIF
IPILANTLSKNIIEIPVLHYEREFGCSKYNLIKLIKLIYDLFFCISFNLIKKNKMFNIFI
ILIFLAVLMSIVFFFIFFLKIKLNIFYKILFIPIIITLFLIKSFIIIILKILIDIFFVKA
KKNSIYYINKIIKNNFSKKKDVT
>fig|36870.1.peg.440 Multiple antibiotic resistance protein MarC
MDKYLSNIILLFFIIDPLGNLPVILSMLSSFEAKKKRLIILREMLIALILMIIFLFYGEK
VLFIFNIKMEIISISGGIILFLMSIKMIFKENENNVIKKEKKAPFIVPIAIPLLAGPGVF
STLIFLSDKNVNKSYEILLSLIIAWTFSLIIFLFSTIISNFFNEKRSNEIERLMGLILIM
ISVQMIFEGVKNYFLIN
>fig|369723.3.peg.208 Antibiotic efflux protein
MPFMVTSSVPLGRPFWTFWSAATLANVGDGIRLAAFPLLAASLTANPVGVAAVTAAQALP
WLVTGLLAGSLADRRGARTLLAQADLARVVVLGVLVVAVATGWASLPLVLLASFLLGIGE
TVRDTAAQTALPGLVPERLLERANGKLVAGEIVGNEFVGPPVGAALFVAGAALPFAANGA
SLALAVMLLLTLPISVAARPPQGTPKQASPGVVAGLRWLARHRVLRTLALVTAAVAAADS
AWFAILVLYAESRLSVGATGFGILLAAGALGGLLGSSVVDRLVAGTGTA
>fig|369723.3.peg.663 Antibiotic transport protein
MATAQPKLQADPHGARRNEWILVVFTGTTNIADAVARIALPLLAAQISRSPIVVTAVAAI
MSLPWLVAALHIGVLVDRMDRRALLMAAEIARMLSVGALLVAVLTATPTLLLIYIAALVI
GLADVVAGISGVSIVPSAVPKHRWETANARITALEYLFNGFAGQPIGGFLVAIGFGLALS
VTGFAYVVGAILLLLLVGNFKVAAPPTTHKRSVNKDIREGLRFLWQHRLLRTMALLIAIM
AGCWAAWLALIPVYAVGGPLGLDERQYGFLLTCLGAGGVIGTVIVGPVNRWIGRRWSMFT
DIIGAFGLVAAPALLPAAPSSAWIVGAAAFVAGAGGTMWTVNSRFITQSLVPADMLGRFS
AASRLVAWGMTPVAAILAGILAQIFSYRVAFGFFAVLCVLLIYPFFKVVTRERIAEVDGP
TGAPATPAPRGEQDGNTGTTDDGEDLPETATTGGSR
>fig|369723.3.peg.1666 Regulator of antibiotic transport complexes
MAWGTSSPWRCAARASDSVAGTEGSRKRVGTQPYRRCGTLSHVTTEKRRAPAGAAVLRGE
ITTAIRRAVLQELAAVGYGRLSIEAIARRAGVGKTAIYRRWSSKVDLVLEVVVAAVGKRF
PLPDTGGLRGDLELVFLIMTRALGHPLAAQIIPDLLAEAARNEQIAQTLQRVLRDNQRDI
GGQVVGRAVSRGELPPDIDLDIAVDLIVGPLYWRLAVSRTPLAVEELPGLAAAVAAALGV
ASQPAVPSELGVPLPGTVTRTDTGQS
>fig|369723.3.peg.2254 Tetracycline-resistance determinant tetV
MAEATAVTATARRFRPQFSFAPLRTRGYRLLFAAELVSVFGDAFHAVALPFLVYQFGGGA
RDLGLLVAGYGLCRLVTTPLGGVFSDRIGPWRVMLISDLIRILFTAGIVVVAVTGAGGMF
GVAVLVAGTGLGAGMFQPAAYAITPRLLPAEQLQAGNGLHSTATFAAGMIGPGVAGLVVI
ALSPAVAFGVDAVTFAVSAACLAMIGGMGRAAAMPLAAPTGGGGSPQHESGDGTPPSDPT
IGFWRLLRESALLRTVLLVTGAANLTVGGMVRVGLPSLNNDDFAAGAGGLGGLLAAFTAG
SLVGGLCSAGLAGLPRRGATAMVSGLVLGGAVALVPFAGYLGAVVALSVAGLASTVTNVL
VITIVQQNTAPHLLGRVMSAIVFAALSLFPFSTIAAGLVIDAYGSTAIFLGTAAALLAAF
GYGFTRRELRQR
>fig|369723.3.peg.2371 Antibiotic efflux protein
MRALVSARLGADFTKLWTASAVSNVGDGVTMAAGPLLIASITTNPALIGGAVFVQQLPWL
LFALISGAYVDRLDRRKLVVAVNTLRAAALTALTLAVATDTTTVALVYAVFFLLGTGETL
ADTAAGAFLPAIVASDRLATANARLMATFTIANQFVAKPLGAWLFVIAAAVPFGVNALTF
AVAAALVATIRPIPALPPVAPRRSLRMEITDGVRWLFGHRLLRTLAVSMGLANLAFCAAF
ATLVLYARQRLGLSDIGYGFLLTTFAVGGLIGTVLAPRLQRIVGTGTLLRAGLVVELVTH
ATLAITTTPLVAAAILIAFGIHTMVWGVVVVTLRQRVVPTQLLGRVGSVYSLLDLGGAAL
GSLLGGLLAGAWGLTTPFWVAAAVMALIAAATWRPLRTASAT
>fig|369723.3.peg.4109 Antibiotic efflux protein
MTLGRNFAKLWWSQGLSNLGDGLVLAAVPLLAVTMTRDPLLVAGMTVAQFLPWLLFTLPA
GALADRIDRRLIMVAGNLVRAVGFGLLVLTLVADVRSIAVLYIAVFLAGTAETLVDNAAL
TVPPRLVQRSDLERANGWLFATQSAINNFVGPTAGAALFAMSAVMVFSSTAGFFALAALA
AIMLPRMMPTASDSSGDKHTPGEVVRSIREGWSYFWNHRLMRRVAFISGSINLFSSATGG
LLVLLATGPLGVPASWYGLFIAVPAVGAVLGSLIAARVVPAIGGGPVTWLAALVPAASYV
VLGLSGSIVLSEVAMFLAAVATALNQIVVSTLRQAAVPDGVLGRVTAGYRLIVLGAVPVG
ALLGGGLGRWLGPETTFVVCGVGLTVAAIVFASRVTTRALREAEEVARTAAREPAA
>fig|369723.3.peg.4319 Quinolone resistance protein
MPVRSSGPRRATDPRKRREPRSPVPPTEVDLWEATVLESESTLTCQALYSARLTGQDASS
VTFRQCRFRGADLAECRLDQVVLSDCLVTDSSWANLRADGGEMARVRLAQCRMTGVTWAD
GVLRDVTVTGCRVDLSAWRMTTFDAVRFEDCNLQGADFTNADLRGATFRGCDLTGAVFHH
ASMEGTRFRGCTLAGVGDFSSWRGAVVDHEDLISLSYGLAQAAGIQVEN
>fig|369723.3.peg.4349 Drug resistance transporter
MVQHTITPPSSPSSHRRRLPYRYWVAIVYVLGLFVEIMDTSIVNVAVPALAAEFETTPNH
TYWAVLGYLLSLALFIPASGWIGDRFGSKRVFLVALALFTVASALCGLAQTLDQLIAFRI
LQGVGAGMLTPVGGAMLYRAFPQSQRAKAATAVFGVAVLAPAMGPVLGGLLVDTASWRWI
FYINIPLGILTMALAATVLVEHREPHAHRFDIAGFVLGGAALTTTLYGLSLGPTLGWTSP
TIVAALICAPLLAVAFVMVERTRSEPLVQVALFKDPMFRIGNIAGSFLSGGYLGLIFLLP
LFLQGPQGQSALHSGLILLPQSVGALVSSQIAGRWWYRHYGPRPLMLYGALLAAASGVAF
LAVGADTDPLVTAALLGLRGLAIGPVFIALQTATYATISPAATGQAVAIYNTQRQVSAAV
GIALGAAWLTARTPNSAEAVDTVSAFHESFVLVSILLLVGALISARIKNADARATMDPPP
EPPTHTAGEESDRTAQLSVHAADGAGAHPPRSST
>fig|370438.3.peg.866 Vancomycin B-type resistance protein VanW
MPPSKKVLILLLFLVLQSGAGIIGAAVALDSKYTDVIQQGVTVKGIQLGGLSRAEALLKL
QNALPPLPDQNLTISNEERISFINLHELDGSYDYLSSVNEALSYGKTGGALNRLISVLRL
KAAPVDLKVSINFSEGKLSEKIKSIQTEWDTPPGDAEIKLVNGSAAIIPEKKGYRLDFEK
TLERARQALARGDLAIAAAGQVLEPAVTAADLEEIRILLSEYVTFYDPGDQNRAHNIAVA
SAAINATLLKPGEIFSLNQKLGPRLAETGYLKAPVYIGGRLAQDIGGGVCQVATTLYNAV
LLADLAVVERHPHPKPVAYVPIGLDATIAGDYYDLKFMNNLSSPVYLSSTAEGGKLTVRI
FGAVKKEGCSVRITSESTAIDPDIVTYHDDTLPEGETRIKHLGKAGYKAWVYRELIVDNQ
VVSKTLISSDYYESEDRVIVTGKKAKENPPGDEDK
>fig|370438.3.peg.1057 Acriflavin resistance protein
MRVTELAIKRPAAMTMVIMFFIVLGLVGYSRLSSDLFPKTNIPFVTIVTTYPGAGAREVE
SQVVDPIEEAVSSIPGLKRTTTTASEGMAITILEFTMSTDSDIAAIDAQKAIDSVLYRLP
KDADKPIVQKYNMNAQPIMTIVLSGNRPLPSIYSAAKDIVKQQLETTPGVGKVTLVGGQE
REIQVLVNRAKMEGYGLSINQVVNRLSLENINMPAGELKQPSTDFTVRLLGEYRSLSELE
EIRIPFPGGSVALKEIATVKDGLAEATQYARLNGRQAIAVIIQKQNDASIVDTSEAVLRQ
LEQIKKQLPKDMELVVTQNNADFIKGALDDTKRSLLEGVLMTGVVLMFFLREWRSVFTVM
LAIPTSIISTFLMMYFAGFSFNLLSLMGLTLCVGILVDDSIVVLENIHRHRTMGKEPERA
AIDGRLEIGMAAVAITMQDVVVFMPIAFMSGLVGQFFRQFGLTVVFATLFSLFVSFTLTP
MLSARLGGNGGRAGLPDSIPRLSNFAGRFSAFGRRSVAAYRRLLLWSLGHRRAVAAAVAG
ALVVSLGLIFTGAIGSEFMANPDQSKFTINLELPAGTPLNKTDEVVRRFEERLKNMPEVK
YYLSMPGKSSDLFARGTNNAQIEVTLHPKNMRSRTVWQVADEVRGWKHDFPGLKLTVFEA
VMVGTDQLGSPIQLEVVGPDEEKLAALAAKVQEIVEKTPGAVDVRSSWKATGQPEVQVTV
DRLRAASYGLSAAEIARAMRASVDGDIAARYREEGKEYDIRVRLDRVNLTSMADVGEIKI
GNAAGRLVPLNQVAKIELGSGPTTISHLNRQRLIVISANTKDRPLGDIAGDINAALAGLK
IPEGYRVQFYGTQKDMEETFSDLIKALILAVTLVYMILVILYESFLTPLVRMLSLPCGAI
GALWALFITGNTFNMMSLIGLVMLDGLAAKSGTLLIDYTNTLMKRGLTLREALLEAGTTR
LRPIVMTAATMVGGMLPTALALAEGSEYRKSMAIVIIGGLVTTTLLTPVLIPVAYTLLED
FKGWLGRKWHLKKERFLQKKVRKPDRDTGTGA
>fig|370438.3.peg.1202 Vancomycin B-type resistance protein VanW
MLPVKITRIIYGLLIAAAVVIPLVLFSSGFFAAVSKRVLPGIEVMGISLEGLNKAEGLAR
LAELEKELRATRVLLRYQEDSWPLLLNEVGFNLNEEEIMEAALSAGRSGPLLQRWQERKR
FKKTGLSLKPVIEFDREKLAGRVNELAAKIIVKPRDASFQINSDDTVTIIPGSNGIGVDL
GKLEEDIINVLSEGKKREVNLSLTTVPPARSTELLESMGVKGLLASYTTSFDPSKTSRTY
NISVAAKAFDELLIRPGHEVSFNKVVGPRSSEAGYKTAPIIVNNEFVDGLGGGVCQVSTT
LYNCVLLANLDIIERSNHSIPVSYVPIGRDATVVYDAIDFKFRNNTGDYLYVKSYVSNGH
ITFKMYGNTAYKRDVSVNTWIVKEIEPKTVYETDPNLPKGEQVVKQEGSKGFIVAAERVV
RKNGVVEKREMLPSSDYSPVNKIIAVGVMERAVPQIAPSTPAPSPVRLNEQVSGSQGNAA
VTGPAGPGGSDGDQAPASGSGSPAVMVIPGSKPPAGGGDAGGSRAPGGWSAPPERNGASP
>fig|370438.3.peg.2912 Fosmidomycin resistance protein
MTALSGHGFRQIRGTKMNKKTLTILGVGHAVTDISQSAVPMMLTFLQPVLALSHLQVGVV
VLALNLFSSVIQPAFGLFSDRRRMAWLIPAGCLLAGLGMALVGFSPGYIFLLAAVMVCGL
GVAAYHPEGSKFARLASGSRRASGMAMYTVGGNIGFALGPGLATFFYEAAGLRGTAGFLA
LNGLMAALLWIYLSEIAPAVPKNSPAGPVNPARGKAGDAAGMSGVALVFPVVLLILVIVM
RTWVHFGIVTFLPQYFVNYLHHSNAYAASVVTLFLLCGALGSTVGGPAADRWGLKNIMIV
STSLVIPLLYLFPHVSGIWTLIVVALTGFVLISTFAVTVVFGQELLPNNIGLISGLTLGF
AIGMGGVGTTFLGWLADRWGLPVVFKVMVLFPVLGLLLIAFLPGTGALARRKRALSGGE
>fig|372461.16.peg.282 Multidrug resistance-like ATP-binding protein Mdl
MEIFKKLKWYFFQEWKKYIGTIVILICITLLQLLPSKIIGITIDLILNNKISTYNVFLKL
LKIIFISIIIYILRYFWKILLFSTSYNLTSELRKKFCKSLLKKDFYFFSKYKNGDLITRI
TNDIDRVVFSTGEGILTIIDSIIVGFSIFFMMCIQTNWKLTVFSLIPMPIMAYVIKGYGI
QLYKNFQKSQKYFSLLNNQAQDSLNNIKMIRNFGLEKSEIKKFSLINNLVKKKDFQVSKI
DSKIEPIIHNSIALSNLFAILGGSYLISKKQITFGQLTSFILYLGSMIWPILAFAWMFNI
LSRGKVSLKRIYEIIEMKKKKNKKKEYNINYNKNNLKIKIKKFYYPNRNKNSLKNIKIKI
PNKTTLGICGPTGSTLFDIQRYFEIPNGYINYNKQNIKNIPIKKWRNIISIVNQQPFLFS
DNILNNISFGNSKATFKEIKYAAKLACIHSEIKKLPKGYQTNIGEKGIKLSGGQKQRITI
ARAFLFPCKIFILDDPLSSVDHNTERKIIKNIYKHTKKYQLTTIVITHRLSILKKFKKII
VLKNGKILQKGSHNKLLSENNWYRNMYNYQKYKI
>fig|372461.16.peg.283 Multidrug resistance-like ATP-binding protein mdlB
MFIALKQPMEIFDQKPISSIVTKITNDTESVKEFYETILSSFLKSIILFSMILISMFILD
WKMALISSIIAPSIILIMIIHQYLSKPIIKKTKLLISKFNNTINEIINGISVIQQFNQEK
KFIKKINNINNNYYIYKIKTLKIDGLLLRPLLNIISSIILSSIIFITKAFPNKILEMSIL
HTFINYLRYLNEPLVTIINQQSLLQQALVSFERIFKFIDSPIKIYGNNYSMFKTGKINFK
NVYFNYPNTKRKILKNITLKIQDKSYIALVGKTGSGKTTLSNLILGHYPIQKGELLLDNK
KINTISNCTLRKNVSFVQQEPTILHDSLIKNVSLNRKIKKKKIIKALYKSQLKELIENLP
KGYKTILEKNGNSLSQGQKQLIGIARILISNPKILIFDEATASIDSESEQKIQKILADIR
KKSTVIIIAHRLSTIVDADLIIVLDKGKIIEMGNHKKLLKKKKIYYNMYIHQNNNKKKK
>fig|373903.4.peg.641 Permease of the drug/metabolite transporter (DMT) superfamily
MLQKAKTKTRVIKADLLLLLVVTVWGTTFPVMKMILVDTDPFYFIALRFMVAFLALYLVF
HKKVTRDDFSGETVRKGVILGLCLLAGYAFQIVGLQYTTASRSAFITGLSVVMVPLLSIM
IIKQIPGPYTWTGVALATIGLYLLTGAGKIAVNLGDYLTFFCAVSFALQIVLLSKYLPGN
KPVVLTLIQMAVVGGGSFLVSLFSNGITGVTGPALGVIIYTGLLATAMAYLIQSYAQQFT
PPTHTGVIFTLEPVFGALFSYLILGEVMGFTGLFGGLLIVTGMLITEVKAEGV
>fig|373903.4.peg.1105 Permease of the drug/metabolite transporter (DMT) superfamily
MKKNLEYFYVLFLIPFLWGSTFLFTKVCLRFFPPVFLGGLRYLTGGLIFAIILILKYGYS
HTITTIKRNFAGIVLVGFTGVTIAVLFQNLGLMYTTASSAALLNSFEPVMVFFLSILILK
EKATLNKILGLIIGFLGVIIIISNGNLSSLFSLNTNLLGNLLMLVSLLGYSFYTIIGKIV
LNDTPPLIVVGVSTLFGGITLLIPSFFLEQIPDLTLTPPEVWFSFIYMATLPTCLAYYLY
FKLLQNINASKTVGIILMIPLYGSGLGILILKEPVNPWFVLGSILVLTGAWLTESGKKIL
NYVRNIRKYFEPAQVE
>fig|373903.4.peg.1375 Permease of the drug/metabolite transporter (DMT) superfamily
MREENIFTGKYSVPFLATLACILWGTAFPFLKISYQELGIGKNDYLLKILFASYRFLMAA
VILLIWRVIKTRKSISHDITTLGKKSIIKLLLLGFIQTTLQYFFFYNGLANTTGVKASIL
NTLGIFLTVVLSHFIFYYDKLNLQKSLGLVLGFSGVVLVNLSRGEFSFSFNFLGEGFIIM
AAITSALSNLLVKKISLKIEPTIITAYQMLMGALILFLIAVTGVSPLSLNMSLKALLILI
YLSFVSAAGFGLWYSLIKYNKLGYISIYRFVIPVSGVFFSTLLLNEGITGYIFTALVFVS
TGIVLINYKRT
>fig|373994.3.peg.3433 Multiple antibiotic resistance MarC-related protein
MMNQSIFVGFLSTFLPMFAIANPIGAVPVFLSLLKSPEKPTEPPEPRRMPDESEEHYQLK
RSELKAYEIKYQQYLEECKKYKQHSREQAKQTAIFVFIVLAVFLFGGKAILEHFDISLGV
LRIAGGIIVAKIGWTLAVANTTLTKEEKEAAQAKDNISFTPMAIPMISGPGAISLVISLT
EEVNEWTAYLSSFMAIAFLSLLVWLCLRSSEYLNQVIGDDGMGALKRVFGFFVLAIAVQL
IVNGILGVLEAYQQVLFAVAN
>fig|373994.3.peg.4775 Acriflavin resistance protein D
MSLIKTAVRWRHGTFVLFCILALFGVLSLLSLPLELRPGGDRPEITISTSYSGASPREVE
ELITRPIEERLEEVQGIQEVTSSSASGISTINLEFNWDSDIDRRLVDVLNKLQQVEALPP
EAGESDVEIVSGSSSPMMWTILVAKEGFTPNDEHYRDLVDDVIVPRFRQVQGVGQFLVSG
GREREVEVVVDPKALADRNLTIGDVVNALRSNNRDIRGGPLVLGRREYRVRTVSRSTDVK
QLEDFVLRRDESGTVYLRDVAKAQMGRKIQDRALIRDNKPAVAVGIVRQPNANVPEISQG
IRQALVDLEKRFDREGEGITFDIPYDENDYINQSISFVQGNLMMGAVLAALILLLFLGSL
RTVAVIAITIPTTLITVFIVFAALGRSLNVISLASLAFAVGMVVDNAIVVLENVFTHMQM
GKSPVKAAIEGTEEVGGAMLASTLTTIAVFAPIVLVQGEAGQLFFDIGIGLSASVLFSLF
AALTLVPMLSGLFLNQAEAQRILQGMGNNGAGSREQGTGGERRNNQQIDSLLIASDQIIP
NPTNTSPRSKGHPSPYQGEGKGVRFFRNGFLAIQNLITKVSQIFLFFQRRFENFLLATVS
WSIGVGRKGRRLIVLAIPVTLLFISFQLLPPADYLPEGNRNLILWLAQPFPGTSIPEAIK
LSQGPRDFVSEQPEIMRSLYVHRNGLRAIAAFVEPEQATGNKLDEIVDRFRKQGGNFPGY
RFLVPRRVSIFRDPGKEFEVNIVGQDLEQLNQLQQQVMQQLRGLEGVQNARSNFVTGAPE
LQVIPNRVRLAEVGLSEAELGAVVEAALGGLRASEFTDGKRELDVTVELQNTSVETPEQL
RQLPLNIGNGRQVQLSDVAQVVEATGPDAINHVDLERSITLTVNVSREAPLGELIEQTEQ
QILEPLRETLPTGFRAELAGSADVLSETLMQLGSTFVLSLLITYLLLVALYRSFSFPVLI
MATVPMGISGALLSLILANTIPGVVVPLDMITGLGFVILTGVVVNNAILLVDRSLQLQQE
GKSYNDSLYLAVKDRLRPIFMSAGTSVLGMLPLAVIPGKGAELYQGLGIVLTGGLAFSTI
LTPTVVPALMGLLRDFSGNKEIGTKQLQGVDEVEVTNV
>fig|374847.3.peg.481 Permease of the drug/metabolite transporter (DMT) superfamily
MNRMGAGEWGLLIILSVLWGASFLFMGILVKELPPLTISASRLTIASLLIGILASRRPKN
LPWRELLILGVLNNTIPYALILWGQRYVSSSVASIINSTSPFFTSIFAHFLTDDEKINKF
SMMGISLGFSGVLAMAWDSAQGSLIGELAIITAVICYSYATVYGRRFYSMGLSPLDIAFG
QLSTAAATSIPLAILERPWLAMPSQRAWVSIIGISVFSTALAYLIFFRILERAGATNANL
VTLLIPVTATLLCTAFLGERLELRHIVGMCLIMTGLLIMNLRGEL
>fig|374847.3.peg.508 Multidrug resistance protein
MGNALSKISMIAEAFFAGFYVSITRGLFIPMLAYSGYPVRDISLVLVPTAVGGILVSSIV
YRDPRLFESRFKRVIISSHVLERLMWFSLPFLLLSPPILSLAYMLANVSAALTSILIGAA
VYSMFSGDEVIEVSIHRSAASSLSSLLGSLVMTYVSAAYTAPSSYYLLYFTALLVGLSGS
MLLMMTPIPRSISEPRSSVVEEVKIRSGTALLILSLMFAGSNMLGIAWSPLLKELGAPVY
ITVALTITGNVGGILGSYVWRGYKAYITAMLLNSLLTAAIPFIAVPTYHIAVSFLTSLTF
LGVNLLGMHVFSEVNDRIGRIRASAYLVSSNYIGLLAASLISTFLQSPSQNLILAGSIKM
LSTLIALITIQEAAIVPAKRAYEISKIIYSTSLLGYSFTLQASRELLKTFISALALTALL
LVLYILYRVALTLIGV
>fig|374847.3.peg.535 Daunorubicin resistance ATP-binding protein
MELAVSTEELVKIYEGKVRALDGVSLSVEPGKSFALLGPNGAGKTTLMRILTTQIRPTSG
KASVFGFDVVHEGSEVRKLISYVPQEMSVWTDISGYENLLIYSKIFGIPRGERERVIEEV
LEHMGLIDVKDDLVRTYSGGMIRRLEIACAMLIKPKIMFLDEPTIGLDPGARKSVWERLN
IFKREHGVTIFFNTHYMDEADLYSDEIAIINRGRIVARGTAEELKRSLGGEMITLEMKGN
DNQEIIQELRSLSFVLDVVSEDGRLSILVRDAESTLPQLIDLVRNWASVGRISINKPTLD
DVFLKYAGERLEGRGRIGEIVHVRRMIRRG
>fig|374847.3.peg.554 Multiple antibiotic resistance protein MarC
MCIEEVGISAIQIFAILNPISVIPIFLSLTEGRDEGEVRRIVGVVSVAIFIMMSIFSLAG
ELILKLMGISVRGLKIGGGAILMVLAVDMLQGMPRTKSVEEEELAIVPLSTPLLVGPGTM
TTILLLSNKYSGTYGYLCSSLILTLASALVTVASYLILRNSGKLRKVLGVNGLRGLGRFM
AIIVAATAADMISSGILDFIKS
>fig|374847.3.peg.592 Efflux pump antibiotic resistance protein
MSSEKLEELRSRVLISCAIASFLTPFSSSSIAFLLPEISSYFGVEVALSNWSATAYLLAL
ASSMVPFGRIADWKGRAKVFRAGLVIFTISSIATILVRDFGSFIALRVLQGLGSSMISAT
SVALISSIFREGRGKAIGINTAAVYIGLSLGPLSAGLLSDLISWISIFPLMGTLSGVSLL
LSVNLPELGEGGSRPSYSSSLLFSASMICLIYGISNLDNILVLGFIIMISWLLLELRRGG
LIDPKLLRNRSYMASSTAALLNYSATYAITIILSNYLHGFLSPSEAGLILTIQPVIQAAL
SPIAGQASDRRSPHLIASLGMIVIALGIALLIPLGSEGLLRVEISLVILGAGFALFASPN
TVAALNSSPPKLYGSATAFLGSMRFMGQAISSSIITALMMIEEPLKAMNSALIIYVAISI
SGAILSIIARFWRA
>fig|374847.3.peg.636 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSESRVSEYREEIVNGPIVRTFFRLGIPPLINQLIAVAYNVLDALWLSIYNDLAVSVPRQ
VWPVIFLFNAPMQALTTVGMSTISQYIGMKDYREAEISASKLLTMASSLGIFLSISLFSL
RSFIFSQVIGTPEEIAGWVMDYSAIMSVNILLNYIVFSYNTVLQAIGDTKRPAIINAFAV
SVNTVLDPFLVLGIPPFPRTGVIGAALTDVLGSIISLVLLSSLLRKYELRMGFTSLGWDW
IKLSIKIGFPVFIMASMNSLAFIAQLRLVNAFSIVAVTAYSIGFVVADIADAALFGLVSA
SSIMIGQNLGAGNLNRAKEISLKAAASVFSLLVLGILLVYPLRIGIVRAFTEDASIIGET
DKFLQYLLPTLPFFGLFMIGMSAGRGSGRTLTPTIIGIFRLWVVRIGLGYFLSLSMGVMG
IWISISLSNLLAGVAALIWLIYGNWNRPVIRRGEFEVSTT
>fig|374847.3.peg.794 Quinolone resistance protein NorA
MSSRNVSVLSITSFAIDVAFSSWWMILPLYLERLGAGVAEVGISFSLVNVAWALSQLPGG
LLSDRFGRKVIILLSTSTFIPFFISMLLLKDWLAVALAVAISSFFAGLQNPSFSSMIAES
SEKLGVARAFGFYNFLLNLGWAVGPLLGSLIIPSYGFDPLFILGIVVSLSCLAARAALLK
EPPKMEESSSFGLTLIPLLISLSVFQLANGIISPLIPIYAEKLMYFSLEEIERMFFSAQL
LTSIASIAAGSLVMKIGGLRGLMLSFVSSGIFSLLWIFSRAYAAFILISLYYIALFSLAE
VSFGTAISELTARDRRATAFGTVTILTGLSHSAGSYLGGMLWEVSGPEIPFFLASSIMLL
SSIPLRALSNATPPPRCTTSPSSLS
>fig|375286.6.peg.55 Acriflavin resistance protein
MNFSSLSIKNPIPAIMLFVLLGLGGLLAFKSSAVQDFPDIELPIVIVNASLPGAAPAQLE
TEVARKIENSVATLQGIKNIYTKVLDGTVTVTVEFILEKNISDAVNDVRDAVALVRADMP
ADLRDPSVTKVSTAGRVITTFTAAAAPGSQVDEQELSWFVDNTVSKRLLAVPGVGSVKRV
GGVTREVRVELDTAKMAALNVTAADVSRRLRQVQQEAPGGRGDVSGAEQAVRTIATVKTA
DELSKMDIPLTDGHHIRLDQVATVTDTIAERRTSASQDGKTVVGFEVFRTKGGSELAVAK
GAKEAVAELQKNHSNIVFKEAIDNAKPIKEDFDGSMSLLYEGALLAVLVVWWFLRDWRAT
LVASAALPLSVIPTFLGLAYFGYTLNMVTLLSLALVVGVLVDDAIVEIENIERHLSMGKT
PMQAAMEAADEIGMAVIATTFALVAVFLPTAFMAGIPGLFFKQFGWTAVLAVLASLVVAR
LLTPMMAAYILKPKKQHVQEDGWLMQRYIKVMRWCLTNRLKTAIASAVFFIGSIMLVPLL
PTGFVPPTDRAQTQINIELPPGSTLKETMAITERVRLAVAQDKNILSIFSSIGGGSSGDA
FAPGASAEARRAVMTLTTVHRNDRKEKISDIEAKIRERIADIPGARFTVGTPDTGVKMQL
VLRSEDPVALSEAAKKVERELRGLKGIGNVTSSASLVRPEIIVRPDPARAGDLGVTTASI
GETVRVATAGDYDMNLPKMNLSERQVPIRVKLPDNMRADIAAIERLTVPGRNGPVMLGNV
ASVYMDSGPAQIDRLNRSRNVTLDVELGSRSLGELNTEARALPSMRNLPPAVKIAELGDA
QEMMLLFNSFGLAMAIGVLCIYCVLVLLFKDFMQPITILAALPLSIGGAFVALLITGKAL
SMPSMIGLIMLMGIVTKNSILLVDYAILARQQGMNRFDALVDACHKRSRPIIMTTIAMGA
GMLPLALGWGADPSFRSPMAITVIGGLITSTLLSLLVVPAVFTYIDDLEQWVKRMMRKAR
GIGHHDAHPTSTPAEQLGTEKH
>fig|375286.6.peg.1025 Acriflavin resistance protein
MSGFNISAFGVRERAITLFLIIAIAVAGAFAFIKLGRAEDPSFTVKIMTVTAIWPGATAQ
EMQQQVADRLEKRLQELDYYDRVETASRPGIVTMKLYLKDATPPALVPEQFYQVRKKLGD
ESINLPRGVIGPVINDEYSDVYFSLFALEAKNYPHRQLVAEAEVLRQRFLKVSGVQKVNI
LGEQQQKIYVEISHARLATLGIKAQALFEALNQQNNVTASGFVETAGPRVYLRLDGSIDS
VEAVKQIPIAAGGRTIKVGDVADVKRGYEDPKSFAIRTQGEPTLMLAVVMKRGFNGLTLG
KSLANEEASIKTTLPLGIELSRVSDQANAIEASIDEFMIKFIVALAVVIVVSLLTLGFRV
GIVVAAAVPLTLAAVFVIMLATGRDFDRITLGALILSLGLLVDDAIIAIEMMVVKMEEGM
DRVAAATFAWGATAAPMASGTLVTIIGFLPVGFAKSTAGEYAGNIFWVVAFSLITSWFVA
VLFIPYLGVKLLPEIKAHHGDHDGIYETQNYKRFRSLVQLCVDRKWITAAITLGLFVLAV
VGMGSVQKQFFPNSERPELTIEVNLPSGSAFSTTDATIAKIETAIRKEPEAKIVSSYVGQ
GAPRFFLSVNPELPNPAFGQIIVLTENSAARDILKAKINAMVTAGQFSEARVRVSQFLFG
PPVTYPVLFRVVGPDIEKLRTIAADVRAIVEKNPNMRDVHLDWGDRVPTLHLVLDQDRLR
LLGLTPNESATQLQVLLNGSPSTQVREGLRSVEVVIRSPSKDRRGLGDIGNLNLTTRDGR
AIPLSQVAKFETRMEDPVLKRYNRDTYIAVQGDIRDGVQPPDVTKAILPTLDALKAKLPE
GYRIDTGGSVEESAKADVALGALFPLMIILMLTVIMFQVRSFATMWMVFATAPLGLVGAV
PTLLIFNQSFGFNAILGLIGLAGILMRNTLILVDQIKHDLDAGLSPYNAVVESTVRRARP
VILTAAAAMLAFIPLTHSTFWGPLAYVLIGGVGVGTVMTLLFLPALYSIWFRVGRDAPKK
PSSNADQHHVTEYLI
>fig|375286.6.peg.1905 Aminoglycoside/hydroxyurea antibiotic resistance kinase( EC:2.7.1.87 )
MLEPYLKRWQLTPDGTAIMTPGSQLLPVRMAGMPAMLKVSAEEEEKNGALLLAWWDGDAA
ARVLACEGDALLMERAEGQSTLLEMALHGRDDEASRIMCKVTAQLHAPRNKALPPLVPLT
QWFQALEPAAAKYGGIFTYSAAVARDLLAKPQNTVVLHGDIHHGNILDFGARGWLAIDPK
GLAGERGFDYANIFCNPELANAIVPARFLRQLEIVVANSGLERTRLLQWILAYAGLSAAW
FFEDGMEAPTALAVAELAISELNR
>fig|375451.6.peg.1053 Permease of the drug/metabolite transporter (DMT) superfamily
MQRKLYKNREVLAGYGWMSVAVLIWASWLVLTSSGRVTALSVVDLAWFRAAIPAAVLLPV
LWRNREHVARLGVKRCVLLSAYGAPFTLCVGYGLTFAPVAHAGAMVPGLMPVFAIALGAI
FLGQRISPRKAVASLFILSGTGVILWYTSSAPEGDAVWVGHVLFLLGALCWACFAVTLGR
SDVGPFVATAIVAALSVLVLTPILAFPGVSQISSADLRDVTFQAVFQGVLAGLVSLFAFG
RALQLIGSRAAALTALTPGIAAVLAIPVLDQFPHGAEAAALILVILGLFVQATDAANAPK
ANHQTHARRD
>fig|375451.6.peg.1599 Methylenomycin A resistance protein
MTSHIPQIDKASAAAVSPRGMIIGPVAAHVAFVLELTLVPLLLPAMQSHLGLSVGDLAWI
FNSYGIAVAVGVLLSGWCGDTFNPRKVFGYGVALFAVGSLLVAASNSFEMLLFGRAVQGL
GAGVFSPLLPLLLTRASPLKPGRMLIVWGSIAGYVSALAPFFYGSFFSKFGWNIAFVFIA
LVALVALILLNRLRDPDEHAATPPAPKDYTQILRARYLWITFAYVFCTYGAITYYLFRLP
VWLSDNDVRTASVGLALTVLWLTFSGLSTLLRNMVDSPHIRTIMFASPILIVVGFLLSYG
NENLFFIVLSCVFVGAGLACSNAPSTQLILRFAPKGLSAASTSLDITFARLGGIAMVALL
ATAGFAFAFYATALSCFIAATCALIASRGLGFPPSPAARSTL
>fig|375451.6.peg.1879 Permease of the drug/metabolite transporter (DMT) superfamily
MTRRETVFFTCVLVLLGAGWGVTIPLTKIAVSTGFGHFGLIFWQLCIGSVLMAILCALRG
KGVPFNASTLRVFALVALIGTLIPNTASFQAAVHVPAGIMAILLSMIPMFAFPIALALRL
DSFSWRRLSGLFAGLLGVLIIVMPGVSAALAAPVFWLLVAMIAGLCYALEGNAVAKWGTA
GLDAIQVLFGASLLGTVAILPVTLASGQFIPPADLNSSAGHALVAASVAHVLVYAGYVWL
VGRAGPVFTVQVSYLVTGFALLWAKVILAEAYPPAVWAALALMFLGMYLVQPRGKGGLAQ
V
>fig|375451.6.peg.2299 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTFGILAVLSVGLVDAFFLGQLGNAPLAAVGFIYPLTTALTSLSIGMSAGANAAISQAVG
RGGSDDHPQRLAIHAVAVGLLLSVAVALGFLFSAPLLFSWMGASDQPLTEAVSYVPFWSL
SFPFLVVMMVVNAIFRAYGDGGTSSLIMIGSALVNIALTPLFIFGWGPVAGMGTEGAALA
TAIGRGLGCTAAIYWAWRTGVLAICGDMLKGIAFSLQEIFKVGLPAAFSNAINPAGIALV
TAAVATLGDEAVAGFGAATRIQSVAVVVLLALSAGIGPVVGQNWGADKQERAQAAMRIAW
MACVAYGLCLGVVMALFADQLAGLFAQGDAAAYAAQYLRIVGWSLFGYGIVITTNAAMNA
RSKAGYSMGLSIGRIFFVYVPAAWVGALFLGFTGVLFAAVAANLLAVGAAYFCARKTKIV
TALI
>fig|376686.6.peg.857 Permeases of the drug/metabolite transporter (DMT) superfamily
MKITKPRLALICGILCISIFPILVKLRLTPGLISAFYRMAFAVTLLLPYVLLSGNFKIPT
LKFTLLAALCGILFASDVAVWNIAIQESSATQASLLTNLSPVWVGVGSFFFLKAKPAANF
WIGTFVALLGMITLVGFEFFIDLNFDKAFLFAVLSGILYSVYMLVSKNVLSAVDVLSFMT
ISLLASSIYLGILCYSLDEPFTGFSNTGWFVLVLQAVICQLCAWLSISYATQHMRATRVS
LSLLSQAVITSILAWLFLEEQITLQMVFGGIILLFGIRITFYDKTISLKRLFSK
>fig|376686.6.peg.1347 Outer membrane component of tripartite multidrug resistance system
MFLKTTNSTDDCFPRILLLFLIVLAFNGLQAQEVHAVSLQEALKLAKENNKKILRSQLEV
TLSEQNIKERKELRLPDVQLNGMYSRITNITEFKGSGFLKDKEVTPAIPEIYEVNSTFKM
PIYAGNKINNAIKIANQENEIAKIKTEKAENDIELEVVANYLAIYKMMELQKIFEENIKE
EKSRLKEVQSLQKHGTVTKNEVIRAELQLSDRELNALTNSKNIKIALHDLKTLIQIPENE
EIAIDTTSSLDEMNGLDPYDFYMNKALQNEEMRIASQELNISKTELKMVKGNYLPSVHFF
GNYGFYYPNYKFFPPNPYLYTLGQVGIEATFDLSSLYKNKTKMEQASTKIKWQEMQNEIV
KEEIQDKLYKEHTQYQEILEKFVVVDKALDLADENYRIVKLKYLNQLVLITEMVDADNAL
LQAKYNKISTRLDAVLKHYELLHTAGMLPQS
>fig|376686.6.peg.1348 Membrane fusion component of tripartite multidrug resistance system
MVKIKNETRRNKTFHILITIIACVLVISGVILGIWFYVFNRNHEETNDAQVEQYVTPIMS
RITGYVQEVRFNENQFVHKGDTLVVIDNREYKSKLNAALADVQNAQQNSVVAQKNAINTA
SATAINEAQLEAAKSNLWKTKLEYERYKALVSEEAATSQQLEKVKADYESAQAHFQEMKN
RIHSSALSTSVAEANVPTTQTNIASKQAVADNAALFLSYTIITAPYDGWVGKRTLQPGQL
VKEGQSLLSIVSKEKWITANFKETQLQYLTVGQDVEIKADALSDKTFVGTIASLSPASGA
RFSLLPPDNATGNFVKIEQRIPVRIQLKDSDKQADFLRAGMNITVIAAH
>fig|376686.6.peg.1349 Inner membrane component of tripartite multidrug resistance system
MEDKSIFKSWVPKWAIITILFVCLLHSMILLGVYTSNVTYAASFLDIEPEDLQYAMCVTY
GTLLATILIESRFSSFFPAKNYLMGVYSLIGVTIVTSGYVDNFAVFLLLRVAEGILMALP
AITIRQLLIEQFDSKNAIIIGFSFYYGSLLLSTPFIMNIAVWFLDHYDWKYMLYVSGGLQ
VLNVFLILVTFRGHRTTKKIPLYQIDWMSYFLVLTAILCGAYFFVYAEKKYWFESSQMVL
MLITALITGGLFIFKELLVKRPTFNFEVFKYANLRIGFLLFFLFYISRATLSLCHSAMYS
IWNWDPSRVAGVQYINGLGNIIGLVLAAFFLMKSLSTKIIFLIGFSLIALYHFWFTFLFV
PDVALSDIIVPYFLQGIGVGLLFVPLILFTTSSVPANMAVSSGIVGVSGRFWGSTIGFCV
MQNATVFLNKKHFLKLSQFVTGENPEAQQNIANATQSFIAKGYSADNANVLAMKKIFGSI
TKQSTLLADMEIYTIVGYGLLVLIILIACNQHLRQTMTLVKSKIWIG
>fig|376686.6.peg.2757 Multidrug resistance protein B
MLKTAFNHYINNFKGFTREIWILTLITFINRAGTMVLPFLSKYLKEDLHFSYNQVGWIMV
SFGLGSMLGSWLGGKLSDKIGFYKIMIFSLFTTGISMFLVQYITTFLGLCAAMFVLMAIA
DMFRPAMFVSLGAYAKPENRTRALTLVRLAVNLGFAAGPALGGLIIMGMGYSGLFWVDGA
SCILSISIFALLVKEKKKTDHGDKTESASNTKSVFHDKIFWVFLFVSFVTAMIFFQLFTT
LPLYHNEKYGLSELQTGLLMTLNGLLIFALEMPTVGFMERKAFPKIRIIIIGSFIMAFSF
ILLMINIWGGILVISMICISVGEILTFPFSNAFALSRAPRGQEGRYMALYTMSFSLAHII
SSKVGFEIISDFGYQINWLFMASIGIFATLCCIWIKKALLQEKK
>fig|376686.6.peg.2836 Multidrug resistance transporter, Bcr/CflA family
MTTKKYLKLILILGSLTALGPFSIDMYLPGFSGIAKDLNTSVAKVSMSLSSYFIGISAGQ
LLYGPLLDRFGRKKPLFLGLMVYILASLGCSYVTDIDTFIFLRFIQAIGSCAATVASVAM
VRDLFPVKDIPKVFSLLMLVLGLSPMLAPTIGGYVTEDYGWHTVFSILMFMGIAILIAAQ
IGLPNSYKPDTSISLKPKPIISNFLKVLKEPQFYTYAFTGAIAFSGLFTYVAASPIIFMD
IYHVDAKTYGWIFAFMSVSFIGSSQLNSVLLKRFSSEQMIFGALILQSVVSIIFLILSLN
NLLGLYETIAILFIFLGCLGISNPNTAGLTMAPFAKNAGSASALMGAIQLGLGSLASFAV
GIFVKDSVAPMVLIMTVTTIIAFIVLNIGKRFIKNKVEIAADDDTILAH
>fig|376686.6.peg.3154 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKVVVLRLQSYTDLFFTAVLGREKKFTSGSINRAIVLLAVPMVLELVMESVFVCASLFFV
SKLGAAAVSIVGSTESVISFSYSVSIGLSIAASTLIARRVGEQNFKDANITAGQVINISI
ICGILISIICFIWSNEILGLVGLSPAVIEQGSLYAKVMFASCGFIIIRIALNGILRGAGS
ASMAMRTLWLSNALNILLCPLLIFGWGPVPAFGLLGVGIATAVARFIGVCYQAFHLIKGT
TIIQIGKEQLALHHETFKKVMRLTFGGMLQYLIPASSWLFMIKIVSHFGGNALAGYIIAQ
RVASIVTTPAWGIGNAAGILTGQNLGAQKPERAEKSVWRAGMINMCFLITVAIGWIFMAD
PVVRIFSDVPEVIDNSTTYIHIISIAYVLLGYTMVISRALNAAGKVMIVTLLYILMFYVI
QIPLSYVFAVALGFGPKGIFAAILLSELVLAFGCITIFRTGKWKLTKV
>fig|376686.6.peg.3279 Permease of the drug/metabolite transporter (DMT) superfamily
MNKRQILLVLLIIGTAFWGISYSVTKLAIGNFSPSTFLFYRFLMAVMVLTVIFWKYVRNT
NLESIKTGAVLAVPMFLGIHLQTVGLKYTDASQCSFIAGLCVIIIPLIKLSIYKTSPPLK
IWIAALTALSGLFIIAVKDKFTINLGDLYTIAGAFAFAVYLISVEKHSAAKNLLTSIVPM
FAFCALFTFILALTDQNADWFPERNTFWLGVVYCALFSTAYMYTISNISQRYLSAERVAV
IYLFEPIFGAIAAFFILGENLSLRLLLGGSLIFAATLISEVNLKNSNYRLGIKKTS
>fig|376686.6.peg.3353 Multidrug resistance protein B
MTPLNRNLLIITVILAAIMELIDISIVNVALSHMSGNLGATLEDTSWVITAYAIANVIII
PITSFLSANLGRRNYYIGSVVLFTFCSFMCGHSSNIWMLVFFRFFQGIGGGALLSISQVV
VFELFPKDKQSTAGALFGAGIFIGPTIGPTLGGYITENYDWPWIFLINIPIGILVTISCY
FLLREPTVKPEITKVDWTGIALLAIGVGALQTVLERGEVEDWFETKYIVVLTIIAVTTLL
AFIYWELTIEKPVVNLRVIKSKSLSIAAILTFVTGFGMFISIYISPVVAQRLLSFSPYQT
GLLLLPGALFALLALKICGTLLQKGVSPVIIIAAGFLLFIYFNWRMSGMTLNTSAAEVAT
SLVFRALGMALLTVPLTMLAVSSLDDKDVGQGAALNNMMRQLGGSFGVSIINTYVAHRFA
AHRNELISEVTPSNTLAMDRINAYIKYFQYRGFTYNEARAKALKLMENIVMKQSSLLSYR
DAFFLVGLFFVVTLPLLLFVMNKSKKPKTNMVISDH
>fig|376686.6.peg.4863 Outer membrane component of tripartite multidrug resistance system
MKISQLMLFGVFFIGISSIEAQEKTSLTLDEAVKMAWEKSNEVTLANTKVNSKKYELQSV
KNNQYPDLKISGQYQRLTKASIDMPGQGEGASLASPDRAMLGMANLSLPIFAGFKIQSSI
DAYESLYEAESVNAAKTKEDVALKVITYYTALYKAQKTLDVLNENQKSAKQRVTDFIELE
KNGIIPRNDLLKAQLLVSKTQLSIDEANNNINNINFYLTTLLKLEPSVKIQVNEDDFFNL
KTTNAPTSDALALENRKDLEAIRLQQRASEANVKIAKAGYYPTLSLLGGYTALDLKDIIT
VKYAMNFGLGLSYDLSGILKNSSHVKEAESKALEVKNTEAIMTDRIKVEVQKSIEDYDLA
INQSVVYEEAFQQAAENYRLVKDKFDNGLADTNDLVEADVEQLSAKINTAVAKATIIQKY
YELLSVSGQLSQSFNLSKI
>fig|377629.3.peg.2117 Drug exporter-1 ABC transporter (DrugE1) family, ATP-binding protein
MDSVSISEVSKKYIYKGKAHLVVDEISFDIRPGEIFGLLGVNGAGKTTTIKMISGLTIPD
SGTVRIFGLDPSNSKTQKLIGTILEGNRNLYWQLTALENLVYFGVLKGMSIAAARKKGAA
LMEEFQFDQYKDLLVQNMSRGMQQKLAIKVALMHEPKVLILDEPTLGLDVPTKDFFSRFI
SDIAKNMGISILLTSHDLEFVGRTSNSFGVIQNGKLVKYGKMQELNAWIDDSGYRVILAD
ELGGDEAKQLEKFGGKVIQENHANFLVSKEHLYQFLDAVKPANIINIKSLANDLEELLLN
TRLEK
>fig|377629.3.peg.3265 Bifunctional polymyxin resistance protein ArnA
MNDNNTKPLVVFTASSLALPLLNQLQKNGQLTTVVLPALESSSPFAHEVFNLRARLQEKG
IPYLNCGKEQLSELVHDLDRMQVEVGVIFTYPHVLPEKLLAYFAHGVFNLHGSRLPAYPG
PCPLYWQIRNREPVLTLTLHKATNEPDQGDIVATREIPIHPLDTLQSLSNQMAWLALPLI
AELQQVLAGQKLTYQPQLTADKNWESMPGKNYARRPRASDLQIIWHNMSAEAISAMCRAG
AGQPFSALFYYNNCPLLLQQATPVDYPQFGITAGTILFIGEPEGLIVATRENAVRLDIIS
CADGLFTGYAFAERFSLDAGIQLKS
>fig|377629.3.peg.3439 Permease of the drug/metabolite transporter (DMT) superfamily
MTPFLSIQLSFFMSRFFLPLNTGFGALYLSVFLLSVNGLFARSIELDSTSITQLRSVIAG
GAIIALCLLQKRSLLVAPRSLLVVYFLGVLLGLHWVTYFQAMQSSSVAVGILALFTHPVF
TVLLEPIFQGRRPEGKDLLAALVVAGGITVMVSAQLGGSDQLSAEQIRTGVFWGVGSALL
FAFRNTAQKYWLHHVPSTSLMFHQVLVVALMLAAFTDWSAVSGMAPINWLLLLLLGSFCT
AGAHTFVSVALKHLPAKTVALISCLQPVLAALFAWLILSEKPAIQVLLGGAIIVAVAAFE
SRTQHKSE
>fig|377629.3.peg.4105 Acriflavin resistance protein
MNENKGFLAQFIAHPIASKTLLAIFILLGVLGAFSLRQEVFPPFAPNRVDIFVAVRGATA
SEVEELVVRSVEQKLVELTEIDRIIATAYQDYAQFQLELVPDVDPYKALTLIKSQVESIR
SFPSYAEPPVYSVPKTTGPLLLVNLYGDLPVRVLYGEAIALRDSLALLPGITQVEIEDAP
EIEVAITASPEQLRKYDLRFSDIADVISANALNLSAGELSADNGRILLRGDTQAVSEEDF
GELVVAAFAGGNKIYLQDVADVRIGPVESYVNSRFNSQPSFTLSVRRDKYLSLSTASERV
REFVTSYQTRLGSEVGLTVWADDSREFSSRVSLLLKNGITGFLIICIVMTLFVHIKVAFW
TAVGIPVSMLGALGLLYISGTEVSLNAITLFGFLIAAGLIVDDAIVIGESIHEETLAKGE
GMQSAISGAHKVAMPTVFGALTSIAAFFPLTLTEGKMGSQMAGIGTVVICCLFASIIESK
LVLPNHLAGKWRSGFRGLDLSKIQARSNGLLNRFTENTYSKGLVFSLRRPWLVIAFALFL
LFASVGILVGGVVRTVTLPNIADYEVEGSFTIDANLSPVQRSQIADALEQSLYATSEALK
KEHNLEFDPVMMNAITVDTTRIVIAVEISHRDDAPFDAHQVANLWRNKLPLMPGIESANI
ASGPNGDEQVAIQLSGNDLETIYAAKEEVKSYLGEIDGVVDIRDSALTKSTELLLQVNPF
GESLGLTQAYLLAQIRTGFYGLEAQRVQVGEQEWRVMVRLAKNHRQTESDLANMEIQLPN
GRFLPLERVATIKSTRTETMVQRIDGQRAVTVYANTLGNVDAEGVAEGIVEDFLPGLQSR
YTGLSYSIEGEAKDAAKSIRSLINGSIIAVFIMFVLMAIPLKSYLYPAVIMLLLPLGFIG
TIVGHLLVPIDYSLISMFGLIALMGVMINNGLLLIDQYLVNIEQGMEREKAIVESCTRRF
RPILLTALTTFAGLMPLIWESDPEALWLVPIAVSLGIGILVSTGLTLIVLPVVLVLLPMK
QQRSINTTSEAVFTPVKTSEVVQPSISSVKYRYSDHAPS
>fig|378753.3.peg.181 Drug resistance transporter, Bcr/CflA subfamily
MIPAPAAPPRSFLLSLAAVLGVGPFAIDMYLASLPEIGANFAAPSWTVQLTLTGYLIMLG
AGQLVAGPVTDAFGRRRPLLLGLSIFIAACLLAAAAPSMAVLVVARMLQGAGAAMAFVVV
NSAVRDRVSGDAATRAFAVLVTVTSVIPMISPAVGGWVGELFGWRPVFLVLALIGAVSLG
IVFRWLPESLPAQRRVPLAFAPVLRAYAGHLRSRRMLVPLGALAGTFVYLFCYLGGASYV
YQGHYGVGQADFGMIFGVTGFASVGGAVIGHRLAHRLTTGQLGVLGMLIMVAGGIMATAA
ALCTDSLFLLALSVGFGLLGLGACEPAFMSLCMSSATSNVGAASALLGATQFLSGALTTA
LIAFPATLAPWAWAATMLGVAVVSLGFALLASRWSVPVRQV
>fig|378753.3.peg.390 Bicyclomycin resistance protein
MPQDHEPPESPPGDPRKRDPDERDARERDSDERDPHERDPRKGDPDEQGPAMQDPGPRDL
LRSRLGLRPRGDAVVLVGSLGVLSAVSPMATDMYLASMPEMAQWFGAPASVIQLSLTAYM
VGMALGQFLLGPLSDVLGRRRLVLGGNLVFLLSSAAIIVAPHIGLVLGLRLLQGAAGAAG
VVIARAVVSDIARGHRAAQLYSVLSLITSLAPVVAPLAGGVIATVADWRTAFAVLTVFGA
VMLGCSLLVIPETLPPEARSRGGIGRILRNARAVLGDRRFTLHALSFAFAFGALFSYISA
SPFVIQDVLGFSALGYSVVFALNACGSIATGVVNTRIVGSRAPESLLLAGVTGLAATSVL
NLVLALLGVVGPATLVLIFLSQSCMGFVLGNAVALAQRRAQARGLAGTGAAVVGTAQFVM
AGVVTPLTGLAGESTAVPMLACMASCAVVSVALVLAARR
>fig|378753.3.peg.434 Probable multidrug resistance transporter, MFS superfamily
MTAAAPRTWWRVGAAMFTVGFGANLFAPMLEVYRSQDGLSESFVTGMLGIYAAGLVPALL
VFGPVSDHRGRRAVMRPALVVVIAASLVLAAASHTSDWLLYAGRWVMGFGVGMAMASGSA
WVKQLSTDRPGSGPRRATVVLSAGFGGGPLAAGLLAQFLPAPQVTPFLLHVLLAGCAAVL
VWRVPETQPPASGPRPSRPLVPAVARTGRFFWVVAAWAPWVFGTATIAFASIPSFLLTTV
RFPVAYLGAVAATVMFTGVLVQPLAARLARSGWLPLSVTGLGAASAGLVLGALTVTWHLS
WLAFPTAVMLGVSYGFMMVAGLREVELMARPHELGALIGVFYTLTYTGFAVPFVLSLVAP
AVARWAGVEPTTGFVWCLLFGVLVCAASAVPVARAAARGVPDPGTTTPQG
>fig|378753.3.peg.1173 Drug resistance transporter, EmrB/QacA subfamily
MTPARQPTSRTRPARTSEQEHRDVLRALTGILAAFFMAMVTLTIIGTALPVIMADLGGDQ
TALSWTVTGTLLANAVTTPMWGKLADLFDKKKLLLMAIAIFVIGSGAAGIAGSIGMLVVA
RVIQGVGMGGLMALAQTILGTIIPPRERGRYAGYMGAVMAVATSVGPLLGGLIVDAFGWR
WCFLIPVPLSLVAAVIIVRTLHLPEVSRDRSPRVDFLGMGLLALATSALLLWVSFAGKLF
AWGSWESVLLIVLALVTAVAFVAVERRASEPTMPLHVITERTTVLAIIAAIATGAAMFAS
TTYLGQYFQLGQGYTPTESGLLMLPQVVGSFLGSTIAGQLISRFGRWKRILVVGAVVLAV
GLFLGAGLTHTTPAWLVGIFICLVGLGVGTLNQNLVLAVQNTVGLKDMGAASSAVAFFRT
VGGAVAVSMFGALLTRHMATQMSRFAAEHGMDSSATPDAASIDLAGLPPEVLGAVREAYG
TGTGLLFLVAGIASLVTLLCVLLMKETPLRTTVDVAEVDPETGQITLVTREVNPVEAAGL
RMQHAETGQIPVVDPTATGLRRGAGEEAAAHPRDEGATPHVGDPASSSPGADGGRTDRAV
HETAQPREDDAARGPGRASGGPRHRA
>fig|378753.3.peg.1735 Methicillin resistance protein
MEGGRTGRYLYCPYGPEAETPQAFDLALADLVAQAKAHRCWFVRVEPVNGHTVDGLETPE
ASLVRRGMKRAPRQVQPGHTQLIDLRRDPKDLLKDMKSTNRNLYRNIHKKGVRIERSEDP
ADVRHLLRFLDETAARRNFNRQQDDYLRAAAESLMPAGAASLYLATLDGEPIAASLVYDS
EDTRTYAHAAMDQEHRRLSAGIPLVVTMIMDAREKGLTWFDLFGTAPEGAGPEHEWYGFT
SFKKSFGGEPVAYPGTWDLPVSRAGYAAYSGVRAAREAVGTARGKLRELRERRAAA
>fig|378753.3.peg.1832 Methicillin resistance protein
MREFTARFATAQEIAEWDAHVTANPSGGNLLQSEAFAEVKKDHGWTPRHVVYEPSDGSRA
SYNLVLEKKVPALGRLWYMIKGPDVESVEDVPGIVAANERFVAGAAKGVFAIKYEPEILA
SDYAAGVLARAGLVKSFEIQPNDSTAVLNTDMDEKALLKSLHSRGRNAVRRAIREGCEVE
QVPLTEENMRAMYALMDSVGQGHAQVNLRSYEYYRAFWTNFAERGQGRLYFTYEDGKPSV
GAYVIAYGSKGTYKDGGSKPRRKQYGDSHLVQWSAITDLKQDHGIVQYDFCGTPPSDQLK
NKEHHYYGLGLFKTSFTKTVVDYAGVWDQPLSRAKYAVWTSVAEKVQRQLWVRRTGQPFY
>fig|378753.3.peg.1947 Methicillin resistance protein
MLQSEPWHRFQAALGRATHLFSGPGWHALVVEETSRAGRLWYAPYGPVLSHPEALPDALT
ELRSAARAARIGWLRVEPQAAASSGEGFTDAVRRQNATAPVLAAALTAHGARPAPRDIQP
AYTRWVDLTREPGGILGAMTGTNRNLWRRHRDKGITLESSTHPSGADAVIELLHRTAGRR
GFTAHGSDYLRTAARVLRETGSCTAYMSSVDGAVVSALLTYDSPTTRVFAHSGMDAALRK
LRPNQPLIVQALLDAAAQGQRVADLFGVASANDPGHPWTGFSAFKRSFGGADVALGGTWD
LPVSAPRYAAYRVARRARDEVSTVRGRARGAADTARARLLPER
>fig|378753.3.peg.2211 Drug resistance transporter, EmrB/QacA subfamily
MALGALAAGLGMIVLDGTIVGVALPAIIQDLGLNLTDAQWVNSLYAVLLAALLLSTGKLA
DRWGRKTMFMVGLVVFAGGSLLAALSGTAGALIASRAVQALGAAFIMPSTLSTVNALFRG
KYRGPAFGVWGAVMSGAAAIGPLVGGALTHWASWHWIFLVNLPLAAIIAVVGWSSITNTR
SDVRERGADVDGAMLSAIAFGALVFAIIEGPAIGWLTPTADFSIFGWVWPATAPVSIVAI
ALVVGLVALALFGVWERHRAKVRRSALLDLGLFQVRTFSWGNLAAAMVAVGEFAIIFVLP
LYLTNVLGLNIMQSGLVLAAMAIGAFISGASARHLAAKFGAPGTVLIGLGLEVVGVVVLA
LVMGPGTAAWLVALPLVVYGVGLGLASAQLTGTVLRDVPVASSGQASATQSTVRQVGSAL
GTAFAGAALSVSMSLTLPAALDATGLDAAQADQLAEATRQSAGGMIPQLQAQAEQHPLGP
ETQHVIDALSTGFTHATQWALVIATGFILLGFLGALQVRRAARRDDTPAA
>fig|378806.8.peg.924 Permease of the drug/metabolite transporter (DMT) superfamily
MAGGGLKVGDVYVVVTAAVGEFTKSMRQVVKDVAETADKVAQLGEKIGQIGAVVSAGLYG
ALAAAASFDKSVTERMDRIKLVFTNVGAAIGDAVLPYLERLSDALEHALGWFQRLDPSVK
EGIGSFLVWGTAAGLAGGALGKVAGVAKTAAEAFNYFVIPALGSAGRSVVSFSALMRGAG
PEAETALKRVARGADQVDASFLTAFRNAAARVLLIGAPIAAVAAAVAALVLLAGALYKAW
NDSSTGMRATFQSLWQTVAGWAAQAGEFFGRVFRGLADTVTEWARSTLDAYAFVVRNLAR
IGAPMARALNLEGAADALDSFRDLTGAALGGALKGLVTDSTKTLATGLGGIWEGVSYGAG
YAFDGVKALGSDTADYLQKRFGDVFGDVLGGPKGILRKPDDTKEIDVASVGSFDATAFIK
RASNTTGILEEIAIRKAKELADALARAADEAKQALTQKFTQAFGRVSDLIQDFQEGFAAG
GIWGGIGAVAADLLSQSATFASLIQMATNYIQTVANVIGSVLAPVLPLVASVFNMVTPLL
ESLVPVLTAILAPLQAIAPVFELLGVLFRGLAPVVSILGQILVVLVEPLTLLAGPIMKAF
FAVVRILAIGILYVIKGVGTVWNALVGFVQSVFKALSKIPLIGGAFKGMVKDLEKMKVPM
DEVNGALDTLKNTSYESAAANSAASVATWQNAEATQRATEALTNVPQGFKVALARLTSQD
PVIGSPTAPLSPSPLSPSPAAPVSGAGNVTVGQIVVEGVEDPEETARSVWNEIRREQNRR
RGTSEWLTGRY
>fig|378806.8.peg.1605 Permease of the drug/metabolite transporter (DMT) superfamily
MVPTALPRLTPATNPLKLVVAYCTCVLLWGSTWAVVKAGLEDLPPLRFAGIRMLVAGLML
LPFARAQGAQLGARTTWRVVGLGCIQLAIPFGLLFIGQQWIPTSWSSLLFSTFPVWLLLV
GRVLMPDQPLTVPKLLAAGLGVVGVMALQHSQLGQMEMSSLVLLGALLTLGATALMALAN
VLVKQHMAHVPPHVLVFIQTLSSAVPLLGMSFLLEGAQPVNWSSRAILAVVYLALGGTVL
TYQCFYWLLQRLSLTAIGVMSLMDTLVGVSLGVVMLHEPLTPSLMVGGTLILSSAALAQF
TPDRQSAPARTPQPDGG
>fig|378806.8.peg.4898 Glyoxalase/bleomycin resistance protein/dioxygenase
MDVQGFHHVAIQARDVERVTAFYRDLLGFPELTRHLRPDGTLRSIWVGVPGGGFLAIEAV
SGPPEASPFRHEQPGLLLLAFRMARASRAGVVETFARAGVPLEHETRWTVYVRDPEGNRV
ALSHHPED
>fig|378806.8.peg.6115 Glyoxalase/bleomycin resistance protein/dioxygenase
MPPPTSSAAPTFYPVLRYKNAPAAIWWLTTAFGFEEHRVVPGPNGTVAHAELRFGTGIFM
MGSQKDDLFGNAGMAPYVYVSDIDAHCARARAAGAVIEKEPFNTDYGSRDYAARDCEGHV
WSFGTYRPAP
>fig|378806.8.peg.6863 Membrane fusion component of tripartite multidrug resistance system
MAATLAPAPVDTSPSATAERVKPKGRARIVLPALLGVALLGGLIRFLFTHGRESTDDAQV
EGRIGNVAPRVAGQVMKVLVKDNQPVKAGDVLVELDRSDLDAKLQVAQADVLSAEAQLSN
AQAQLALTEANAGATLRQAQAGVTQASSGISSSKAALEQARADVASVEARFRLTDTELAR
VKRLAAEGALSPAELDTRQAAYDQAKAALDQAKARLASTEAGITSSSGGLEAAQGKLVAA
QTGPVQVQAAQAALKLAEARLQQSRASLHLAELAVSYTQVRAPINGVVSRRTVEVGQMVG
PERPLMAIVPQDDVWVVANFKEDQVGGMRPGQPVDVKVDAFGSQHFRAHVDSLAGASGAR
FALLPPDNASGNFVKVVQRIPVLVRFDGDLKELPLKPGMSAVVTVDTREP
>fig|378806.8.peg.6864 Drug resistance transporter EmrB/QacA subfamily
MKSDAITGSKAGITIAAMAAALMSVLDISIVNVALNDIRASFGTPLDQIAWVSTGYMMAN
VVVIPMTGWLQRRFGFRRYFTFSILMFTAASVLCGLAWNLPSLVAFRVLQGIGGGAIIPT
SQAILFARYPREEHGMAGALFGLGAVTGPLLGPTVGGLLIDASSWHWIFLINVPIGLFAA
FMAWRNIEQKDFEPSTERVDRYGIALLAVGMAALQYVLEEGNRHDWFDSQEITALAVIAG
VALITFIVHELETPSPVVDLRVFANRSYAAATGINLMVGTSLFSGTFLFSLFLGSVAHYS
ALDIGLLFLKGSVVQILLMPLVGRFGSKIDGRVLVALGIVGVSMSLWTNGHLATSADEAA
LITPIFIRSCSLGLVFVPLSVIALSDLKPEQRGNAAGLYSLTRELGGSIGTAWMSSSLSR
TTQLNVTTLTSKVDVYSQQTAEQLAALQGAMTGRVSDPTGAAYGLLNMKITAQAMVRAFN
ANFMVLTALFLCTLFFVLMLKKPARGVKVEGAH
>fig|378806.8.peg.7950 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQPGFGRDLTTGSIPRHMIAFSLPMLLGSFLQTAYSFVNAIWVGQYLGTSALAAVTVSFP
IVFVLFAIGMGLTMATNILVSQSFGARRMDELRKVVDSSTVLIGSLGIVFTVLGELFAPR
VLRAMDTPPEILEASTHYLRIFLLSLPLGFGLFLTRSLLQGVGDSKTPLYFQLGSVLFAA
ALDPVLMFGWLGFPRLGLNGTAWSTVVSQILAFSALILYLRAKKVPVAPSWPRFNHLGPI
TWKTLRIGLPSAVQQSLVSIGMVFVTGIVNGFGEVATAAFGAASRIDQIAFLPAVTFGMA
ISTLAGQNIGAGRLDRVREIFIWGCLFSGGITLIITAVTVSIPGALLRIFVTDATVIEPG
IAYLRTVGACYLFFALVFVSNGIINGAGHTLTTTVISLISLWVIRVPGAYWLSRRMESVK
GVWYAIALSFAVSLAASMAYYVSGRWKRPAGKKPPGPPAPDVTETFGHSTGEA
>fig|378806.8.peg.8086 Permease of the drug/metabolite transporter (DMT) superfamily
MLMSPRVKGAVLGLSAAALFGVSAPVAKLLLPSSTPLVLASLLYLGGGLGLLGLEALRRL
SPSGIQGREATVGRKDVPLLTGVIVCGGILGPVLMLVGLQRMSGVAASLMLNLEGPLTIL
LALLVFGEHLGRAGALAAGFVMAGAAVLGLQEGELHGDLLGVLALAGACLAWAVDNNLTQ
RLSLKDPLTLVRIKALGSGVCMLVLAWVTGQPFPSTPVQGGALVLGFASYGLSIVLDAYA
LRLLGAAREAAYFATAPFVGALVAVPLLGETLRPLDLVAGGLMATGVILLLRERHGHVHM
HAALEHEHVHVHDTHHQHAHPLDLPTTEPHSHPHQHVPLTHDHPHVSDLHHRHKH
>fig|379066.3.peg.545 Inner membrane component of tripartite multidrug resistance system
MASPSALADSPSARGTSGAARAVADDPYKNKYLIAIAVTLAAVLELVDTSIVNVAIPHMM
GTLGATLDEIAWVSTSYIIANVIVIPMSSWLSGFFGRQRYLTGSIFIFVIASFFCGAATS
LWGLVFWRVLQGLGGGALLSTAQTTLFEAFPPHERGIGQAIFGVGVMVGPTIGPTLGGFI
VDAYAWPWIFYINVPLGLIAALMVWTYVKDAAHQVRTRTIDGTGILLLTLAVGSLQWMLE
RGERYDWFESRFVLTLAIVSGVSAILLVWRELTIEEPVIDFRVLKSRQLAPGVVFASFMG
VALFGSVFVLPVFLQSLHGYSAQQTGLVILPGAIASAFTMAIMGRFGGKIDARILVTIGA
FLFLASMTKMSQLTLDAGQDDMFWPLILRGVGLGCLFVPLTGASMAGIPMERLGQATGMF
NLMRQLGGSLGIAIMATMLSRLTKTEKAVLTEHVGAYDPATLERLNGLTHGLMGRGIDAA
TAKQQALMLLDGQITAQASVMAFSRIYLISGLLLVSALPLLLIWKTGRAVPVKADGH
>fig|379066.3.peg.546 Membrane fusion component of tripartite multidrug resistance system
MARPNIRLLIPIAALVAVGIWGYQRWSFGRSHESTDNAQIDGHIVPVVAKVGGYVTAINA
IDNGHVDGKHVLVKLDTRELEVKLAQAEAELAAARASAGGRGLEGQAVTVVRTASSQRDV
GSAQVDAAKAQLIRAQADLTRAKELAGKQIISMAQLDGAQATFDAATANLEATQRQVLAA
TGSIANAQAGVRLAQARLAAAEAARDNAALQLSYATVEAPLSGIVSRKQVELGQLIQAGQ
AMMSIVADTGLFVTANMKETQLARLRVGQKVDLEIDAYEATAEGEVESIASATGAKFALL
PPDNATGNFTKVVQRVPVRIRVTKDLGKDRPLRPGMSVLASVVVR
>fig|379066.3.peg.924 Glyoxalase/bleomycin resistance protein/dioxygenase
MIETGSTAETAAIFGSLQGRRTLVPGERMTGFECTISVPDIHAAQQAIEAAGGTILMPVA
TIPTVGHLLWFRDPEGNVAGAMQPDARPLPDEV
>fig|379066.3.peg.1953 Transporter of the drug/metabolite transporter (DMT) superfamily
MSNRSPHAPSTTTRTPYLVLAASLIGISFAAPLIRLSEAAPLVIATWRLGFSLIIVAIAL
VIGGGWRAWRTLARADLLLAGGAGVLLALHFWTWNTSLRYTSVAASVALVNLQPVIIAAI
SGFWLREPATRRQWFWIVVAVIGALIVGLADVPGGLRAIGPALLGSGEGSRALLGDGLAL
LGAVTAAGYYLIGRRLRQHLALWPYVGLVYGAAFVACLILCLVTQAPLTPQPPRELAIFA
GLALGPMLLGHTGMNWALAHLPAFVVNLTVLGEPVGATLLAALLPGIAEVPGPATIVGGI
LVLTGAILAARR
>fig|379066.3.peg.2732 Glyoxalase/bleomycin resistance protein/dioxygenase
MIKRVKFISIPVHDQDRALAFYTEKLGFKVVTDAPMGPGMRWIELRIPRAETGVVLFTAP
GQEQWIGQFMNLSFECEDVVATAAALKAAGVELVQEAKVESWGTSAIFRDSEGNQFVLST
G
>fig|379066.3.peg.3448 Bleomycin resistance protein
MQPLSAAVPEIPVGNVATSTAYYRDQLGFDVDWHATDIDLAGISRDQCRLFLSGPAFREQ
RGNTSPVVIWLNLDSIEAVNDLHSLWHAANAIVLAVPESKPWGLHEFTAADPDGNRFRVF
HDFATPERLTESSQ
>fig|379066.3.peg.3882 Permease of the drug/metabolite transporter (DMT) superfamily
MSTPTQTPDTTAPVVPRWQLVGGFLIIYVVWGSTYLAIKWGVATIPPFVMGAARFLLAGG
ALYAFMRARGAPRPTLPEWRASAVIGALLLFVGNGAVSWASQRVNSGLTSVIVATVPLWL
VLCEAWQGRPPRLAQVIGVAIGLVGVGLLVLPVGGERQAAVDPIGAAVLATGALSWTVGS
LYSRTAKQSSSAALAIAMQMLIGGACMLVLSLVLGEWQRVSPESVSTASLLSLLYLATFG
SLIGFSTYMWLLKVASPTAVGTYAYVNPVVAVLLGVALGGERLPSLAWIAMSVIVGGVAL
VSLVDGRRRSA
>fig|380394.3.peg.40 Outer membrane component of tripartite multidrug resistance system
MHRKRWIAACAALGVVALGGCAPTIRAPNPADVKAPAWAMSVQRMDGAQALPTGAWPQQD
WWTGLASAGLDQVMTRALSPANPRLAEAVDTVQWAASVSTWRAAALGPQLSGQAAITPLQ
FSGNSPLGALGLGNKLYDSGDIGLGFTQALDFWGKYADRLKAALGEQRAAEARLADTRRL
LAAAVVNAYLRWAEAEQQLASTRRLQHLYQQRQALIRTRRYLGLGTDLSIASLSLQIQQN
TARLARWQQRAAAARFAVAELAAIAPDALPPRPVAPASAVIPTLPPHLSLDLLAHRPDVQ
AARALARASVQQTKAARAAFYPDISFSALLDMNSAHLATLLNPASFAYSFGPALRLPIFT
SGALTGRFRGAEAQQAKAVAVYQESILQSVRQVLTALSGYQHGRQVWQAEVVGTGATREQ
EKLTATAQALGLSDRAALLQRQIALIHQQMTQRLAHYAALQAWAQLETALGGGYDQSRQH
P
>fig|380394.3.peg.41 Multidrug resistance protein B
MLLLLGLSSGLLLASWSLAWSIPMLPYIAGAYSTSLDHAIWSLTFYLLAWALAVVPATWL
YQRFGELRMFQISLTLLMVATLPDVFSDHFGLFLGGRFVQGMAAGFLTPLTRRLLIRYAP
LRWQKTAADLSIVNLVLPLLAGPSLAGWIAYTWDWRAAAVLTFPVGLLALGMVSALLRDN
PEEHLRQPFDWIGLVLLAAWSATFQIVLNRGEDWNWWDAPAIRWLTALGAVLLVAFFLWE
RDQPHPCLDLRLLRRRNYVLALPALVFGWGLLLGGNSLFVSALISHANYSAFWAGVVLLP
MALGGVPLIAVMGPISHRVNPRWLATICFGFVAIYGFTTRLNLHSNLRSLLLSHLIEGVA
IGFYLVPLSLIMFSRLPQSRLPAAATLQNFVRILGGAYLSSAFSALWMRHGDTFRAHLTW
QSPTLPLQSMLEHWPVRGSAARALSIQHLTTQSAALSMQSMLWLWGWMALVVLALVWLTK
GPYRRRAGQVRRVTIEQQIMESAGFDAEPSRREDVERAP
>fig|380394.3.peg.55 Multiple antibiotic resistance (MarC) -related proteins precursor
MQMPVAAELHSALQTLIALLAILNPVGAIPIFIALTSDEDPQQRLATAKLASRAVAVVLL
TSAFLGEYILQFFGISIAAFQVAGGMVLMLLAFNMLQAKSSRYRHTPEEAAEGMQKEAVA
VVPLAIPLLAGPGTMVTVIIAHHKNASWLASGLLIIDILVIAGVAYAALRLAEPLSRRLG
VTGINISTRIFGLVLAAIAVTFIANGLAALFPGLVHIRMS
>fig|380394.3.peg.112 Acriflavin resistance protein
MHFTEPFIRRPILAISLSLVLFFFGLRSLGLMPITEYPPTNSSMITVTTHYFGATPKTVN
AFITAPLEKAVGQAPGINYMTAVSEDGISILTLYMRMGEDPNAALSQVQSKVNTVLNQLP
KGVMQPVVQEMSGSGAYLMLLSYHGKGFNQQQITDYLTRVVQPAIQSVPGVGLTSILPPG
TGPNGNTYAMRIWLDPQEMSVLGITPEQISTALKQNDFVAAVGRLRGQYTAVSLSANTAL
HSAAEFRNLVVATVHGVPIRLGQVAKVSLGAQTYDSSVMVDGQPAVNIGIQQAPGSNALN
VSQGIQKVMAQLDSTMPPGMKGYTIYNGAQFVKSSLQEVEVNIALALLVVILVIYFFMGS
WRALIVPVLAIPVAMVGAVTILHALGYTLNLLTLLAMVLAIGLVVDDAIIVVENVHRHIE
NGATPLHAALLSARELASPILVMATTLVAVFAPMAFIGGLVGHLFSEFAFTIVATVLLSM
VAALTLAPMLASRVLKAGHEGRMAHLVDQLFGRLKAFYGRVLFASLRVWPATVTLALILT
VGIYFLFSISQSELAPPANQGIVYVNGVAQPTATLEYMNAYDRYLTKTVFNKIDSRSHSF
AVNGVGIGGMLLNNEVMAGVVLKPERGSVTTQQVKEKVQKLAEQVPGMKLSAFGLPPLPG
AAVGLPVQFVLTSTGGGYHQLDAVSGKLVREARASGLFSFVCKNLKYNNQIQELHINRQM
AASFGLSMADIGQNLETLLGGNYVNYFDMDGLSYRVVPQVPPALRANPDFLKAYTIKTPS
GAQVPLSTFVSLKSRPAPTFLPQFQQLPAVFIQANPAPGVSLGQALQFLRNHAQKILPAG
DQIHYAGVSRQYMHQGSALVVTFGFALLMVLLLLAAQFNSFRDALVVLTAVPVALFGALL
PIALGASSVNIYSEVGMVMLIGLIAKQGILIVQFARVMQEEKHFDRRHAVAEAAILRLRP
ILMTVAAMIAGAIPLLFASGGNADARFSMGLVIVSGLGFGSLVSLFVIPAFYVWFGQVVR
QPESDLVG
>fig|380394.3.peg.336 Multidrug resistance protein B
METLPSLSQIWPLFAGVGLALGMGSFDGAALQGIFPYVAGGLSTSSDHALWTLTYFIVHW
SLGISLMPWTTARFGMRRVFQVAVIVAMAGTLISAVTDNLWIMLLSRALQGIAAGILVPL
SQSLFLRHSPKAHHGMVTIFWSNAMLVPFFFGPAIGGLLATELGYRSIFLLSLPIWGVAL
FLGSAGVPKDRGDPRTPPFDGWGFGLLYGGLMSMQVVLDQGEQYGWWHSAFILKTTLFAF
IFLLLFAWRESETRHPLLQLHFLRRRNYWLGLLLLCLGWAMFMGWASLLPLWAEETLGFN
GFWGSAVLVPLALGAIPLSTLMDRLHGLLGLRRLTTLCFAIFAFAYGSAYLSPISSLGDL
FWPVLFIGMGVGMLFVPLTMVILSGLSAQEIPSAATTSNFIRVFSANIGVSLLSVYWTRY
SALAGDHLRSHVSRFGGHTTLSAQHLHALISAQAGTLSIDNLLRLSMWACLAAAIAAYVF
IIPPSTLRSTDGPRNYVEEEEDEFPITAGAPMGEGAGISS
>fig|380394.3.peg.419 Membrane fusion component of tripartite multidrug resistance system
MRWLKRLLVLVIIVVVAFGAYAYFQISDYYPNTDDAYLHAHVVNIAPRVTGHIVAIYVHD
NQVVQAGQPLVEVDPRAYVYDVQKAEAELTQAERQTAAIQANIAGARANISADQVNYQNA
RHNAQRAAALAAQKYLSAQQADNEMTAAKSAGARLTADQAALAETQAQQVLNGARIAAAK
AALRTARLYLSETTLYAPIAGVVSKVDKIHVGDVVNVNQDLFPLIGNAEYWVEANYKETD
LSRVHPGQSAKITVDMYPDHPFKGKVVSLSGGAGNAFSLLPPENATGNWVKVTQRVPVRV
LITNPDSRFPLRIGTSASVTVDTGGAPGWVKALRPIF
>fig|380394.3.peg.992 Multidrug resistance protein VceA
MSMQKPEHSGSPIQPEKRTRLLVLVTLIFVLAGLIWAAWWFLRGQYWIETNDAYVSGNIT
PVDSQTAGTISRVLVENTEFVRAGQVMATLQAHRSQIALQQAGAHLAATVRQVRRDFAKV
TALQQTVSAKNAELRKLNADFIRYKQSLPSGAVSAIRLEDTQNEIAAATAQVAAAQAALK
GTQAIIAGTTLQTNPLVRQAAAQFEQADIQWQRRVVRAPVSGYVAERTVYPGLMVHPDQR
LFSVVPLNDLWVVANVKETAMRHVHPGQCVQLTSDYYGGDVRYHGEVLGLLPGAGSAFGI
LPPENATGNYIHIVERVPIRIALSAAELAQYPLRPGLSMVAGIHWTRSQKHSVLKPLTTT
PIRGYQTHIYNGELRRARQRAAAVIRDNA
>fig|380394.3.peg.993 Outer membrane component of tripartite multidrug resistance system
MKRRIALILPLLLLGACARLPPHLPGGKMAQNTQISGTLAYVDGHNGVLTGTWPVSNWWT
SAQLPALNTLITEALRDNPSLQVASARILQAKAAATDQHAALLPHFSAAASVTQEYFSRQ
GLHAPLNGKTITYGALNPLEMRYHLDLWGRDSDRVRAALGEVRVHQADYAEAKLLLSTQL
AWHYLLLAGDVQRLRQLVRAEALHTSLLHLEQQRWHDGLSDARAVYLQEEARAGARQSVA
DMQAAIAQQRYILAALVGHGPDWGRDIPAEPLPTLSTITMPRNLPLRLIAHRPDIVAARW
ETEVAAQQVGAARAAFYPDVNIALFAGWNSIHLGDLFSPGNLAHALGPVISLPIFEGGRL
RAQLKEKNASYIATEDHYRATILGAVREIAGRLATWRQIRQKLRAQRQMIYAAEHTTALA
ESAFHSGITDKAEAYGAQIQETEIRNQLLALKMQNAQSWVLLHSALGGGYTSRKNPA
>fig|380394.3.peg.994 Drug resistance transporter EmrB/QacA subfamily
MVILLNLAIGLGHLLVLFNTGAYLPMIPRVAGSLGVNPAYADWTQANFFLAMALAFPTAT
WFLNRWGEMRSLLGAFLAFALASAVCAQTSNYDWFLAARIVQGYAGGLTIPISLGVILRH
YTPQRRNIGLTLWGVAAITPFTLGPTIGGWITDALGWRWLFYLNMPIAVAVALISAILLV
GREADHRHPPLDWPGLIFLLIALAALESALNSGEIISWWRSNTIIFLTTIGAAALVFFAL
WEWHSAHPLLELRFLRRRNFLIGAIGLFITALFFQGTMALYIVGFQLTMGYSAWMVGLLL
LPMAIFSKLSATLTQRFLNHIDARILGMISLLGFSAGSFWVSSYNRTASFDELLWPQILV
GMFLGGLFPALIAIALSGLRGAAEMRGTAFLNLLRVSGQAMGIPIIATLFDRRMILHAHF
LAENGGTITSMLNTSVKNARTSDYITHHAAMLAFNEIFYIAAWGFLIVAGLLLLAKRVVF
AEPDVRVRQALEELVEP
>fig|380394.3.peg.1477 Multidrug resistance protein B
MEGSLHANSDQITWALTTYMLAMVIVTPLTGLLVERFGQRRLILWSVAGFLVCSVMSGQS
HSLTEIVLWRFLQGALGASLVPVGQAILVQAYPREKRGVAMATLGMGTMLGPIVGPVLGG
YLTENLSWRWCFYVNIPIGIIAFTMLIFYIPRFGKSEHPRPIDWLGFVWMAIGLGALQMM
LSLGDQDGWLSSDFIIILMLSAGTGIFLFVLRSLSVAHPLVDLRLLKDRSLTLGSAGIGL
FGLALYGTMVILPIYLQDYMGYEPQTAGLAMAPQGLGSWISMWMAGRLLNRGANPRWMIM
AGVFLGATGTWISLSYNLQVSPAWIIWPGVIRGLGLGLVSIPLFTLAFATLSKEQTPEGS
GIFNLMRNLGGSVGIAIVSTIMTEEAQAAWNQMGGHISPFNAALPRYLGGAGLRQGNLTW
QVLGRVLAQHAAMRGILDAFMFLFWSFLVVMLIALLMKDKS
>fig|380394.3.peg.1564 Outer membrane component of tripartite multidrug resistance system
MQKPLPRPVATVLATALAGSLAACSFEPPLRVPQAPADKTPYTAGISPKETVAPGGPSGH
AQKIAYGKELHEEWWKLFHSKALDELIATGLKNSPTIAQAQAQLKQAEATARANASIFYP
QVTGNLQANRSKASAAAFGGSSGFHYSLITGSVGVSYYPDIFGVNRLVYRNSEALVKYQQ
WELEAARLTLTGNIVTTAVSEAATEGQIRATRAIVAQERQLLELTENQYKAGAVDYLSVV
TQRSQLASELATLPPLKQQLAVYRHELAILVGAFPADARRQPFTLTELQLPEELPVSLPS
QLLKQRPDIRAALSQMKAANAVIGEARAQFYPTVQLTAAFGDTASHPALFFNPVSSIWSL
VGAVSQPIFEGGKLEAQKAEAHAAYDAVYAAYRSTVLNAFDQVANALRAVEHDAQTLAAQ
RAALQAAAEALRLAQASYRAGASDYLTLLTAEVQYDNAKIAEITARSQRYQDTAALLVAL
GGGWWNKADRKSTPVNTQGKPHPSAGALPVTQVKP
>fig|380394.3.peg.1702 Acriflavin resistance protein
MGAWLLRHRRSLLFLLLVLVLAGLLSAMKMPVALFPNVVFPRIEVSVNSGNMPIQQTDIA
VTRPLEQALRAVPGVERIRSTTARGAADISVQFAWGSNMTEALLQAESAVNKVMPLLPPD
TRFTARRMDPTVFPVLGLSLTSDHLDPVALRRYAEYDLRPLLLAIHGVAQVEVQGGAREE
YQVVVDPMRLQSYGLRPADVERALSNGNVITAVGRLQRHYRLYQILSESPLKNVQDIRHI
VLKTGAAGVVDLADVAQVRVGTAPQWTTVTANGKNAVLVNIKQQIGANTVAIDHAIRTLL
RKDAKSIPAGINLSTWYDQSQLITAAASSVRDAIFIGAGLAAMVLLVFLRNLRLTFIVAV
VLPSVLLASVLILFVMHQSFNIMTLGGMAAAVGLVVDDAVVMLEHIMRRITEHPSEDEPV
SVLLSALEMSKPLAGSSAATIIIFVPLAFLSGVTGAFFQALAISIAAALLVSFLVAYLAV
PLLADLLLRPRDAEQAEHQGRFLAWISSIYGQYLERILQRPLFLSLIVLTFLLLGGWSYT
QVGSGFMPAMDEGGFVLDYNAAPGTSLAETDRLLDQVQQILAKNRDVASYSRRTGLQLGG
GITEANTGDFFIRLKAQRQHSIWQVMKTVREQIHHQVPGLRVQTGQLMEDLIGDLTAVPQ
PIEIKLFGADPQTLQKLARQVAGQIRQVPGVVEVFDGIIIAGDAVDIHVDPVKAALAGMT
PGQVTNQLQTLMEGRVVSRIPQGQEMIGVRVRAPHALWNEINRLRQLPIIAPDGHYLTLG
QVAEIRMQSGQAELNSENLKPMVAVTARIEGRAMSTVMGEVKGRLAHVQLPQGVYLQYGG
LYREQQQSMRELALVLLAAILLVTVLLLFLYERFTVVLSILATALLALGSVFIGLWLTGT
ERNITAMIGITMIVGIVTETAIFFFAEAQSAERHELVRAGKARLRPVLMTAIIAILALMP
LALGLGAGAQMQAPLAIAIISGLLAEIPLVLVVMPGIYAWLERVFKKG
>fig|380394.3.peg.1751 Drug resistance transporter, EmrB/QacA subfamily
MAASAIHATTPPESSQEHRWLITIAFMLAMVMVLLDMTVVSVALPYMMGTLAATPNRITW
VLTAYLAANAVTIPLTSHLAALFGRRRLFLISVSGFVVASGLCGASQTLAEIVFLRTLQG
GFGALMVVLAQSTMVNLFPGKERGRAMAIWGMVLMVAPAMGPVFGGYITQHMGWRWLFYI
NLPVGIFSLLLGAATMRKSERKNLATDWPGLLLMAIGIGSLQIVLSRGNEDYWFDSRLIV
ALSILAVFGILTFLLRGWMIADNIIDLHLFRDRSFATATLITGVFGLGLFGTTAMQPLML
EGLLNYMPETIGWVMFPRGVASAVTMMIVGRFINRYQPRLFIVAGVLLTGISTWIMTSYS
LYISPVWVIYPGIIRGIGMGMIFVPLTVIAFDTLPLAVSAEASGIFNLARTLGNSIGIAI
DGTVLTNETQINWNQLGGHINTFSATLPNWLQASGLAPQDPRVWALLGQTLFSQAEMIGF
LDVFQWITIIFFCLLPLILLIPKRILPTG
>fig|380394.3.peg.1764 Acriflavin resistance protein
MALLGLFAYLQLPTALLPNVSFPMVMVTAELPGASPKTMSSAVATPLERQFASIPGLNSM
SAVSQNGVTQITLQFDLSKSPLGATQQVSNAVSQAQHFLPPGMPEPPSVRQMNPSAQPVF
YIGMSAPNMPLYDLDKYAQTKVSTALSGISGVSDVQIYGAQTYAVRIYVNPFALSARGLS
LQAVQSALGNANVNLPGGTLDGGDQAFATQVHGQLHTAEAYNHLVLAYEGGQAVPLSAVG
KAVNSTQDNQQETWINKTPGIVLAVTRQPGSNTVAISNKIRAMLPQLQAAMPGGVHLTNV
FDLADYIRAAVHEVLMTLILASILVAGVMWLFLRRPSATLIGAVAIPLSLLGTFLVMMLL
GFSINTLTLLALTLSVGFVVDDAVVMLENINRHIDRGETGMTAALNGSREISFTVLSMTL
SLSIIFLPLIFLGGFVGHLFSDFGVSIAVVILISGMVALSVTPMLCSRYLKPNHAHTPTD
LHDTGHLPEDGIFQRFFKGSRDFYIRTLKVALQHKYWMLALAGLSLAGSVWLVMIVPKAF
LPSQNSGMINANIEYPTGMTFAEVSHEQSEIARVVKSNPRIQSVVSSAGQGPGGFGSSTS
GHMFIHIRNGYAPETEEIIEDLNRATQGFHNAQVVFQGPQSAHSGTASDNGSYVYELIGN
NWTDLNAATLRMTAALRRLPQLSSVSNSLQNNNPQVAIKINRPWATALGVTPAAIENTLG
LAFGGHEVGTIYGANDQYEVIMELEPRYQHNINALSTLSVAGAGGTLVPLSAVAEFHYDA
APLTLMQHNGQPSTTISFNLAPGANLGRAISALQSKAKDILPAGIAGHLGGTAAQFQSAF
KSLPFLLLATVLLIYVVLAILYEHFLHPLTILTALPLAAFGALLSLVIFNEPLELYSFIG
IIMLLGLVKKNGIILVDFAVSRRREGASAYEAIVDACTIRYRPIMMTTFAAILGVLPIAI
GFGAGADSRVPLGIAVVGGLIFSQFLTLYITPAFYLFFDELQAAPKYFNWLFGR
>fig|380703.5.peg.42 Permease of the drug/metabolite transporter (DMT) superfamily
MSNTVSRLRSRRERGSSIDIGHGWMTTIHFWHSSRLHRMRRRITSEIKMRSYLLLLAIGL
LWGSQFIFMHQAVTELPPIMVAAGRALCGSLTLGLLCLFMRLKSEHTPWRTYMLIALLDA
TLPFIMVAWGQQYVDSAIAAVVMGCIPFVTILMAPLLVSGEKITKGGLVSVVIGFVGVLV
LFWPKLTSGMNAGLLGAMAILFGASCFAIGLLMIKRFAKDHPVVVARNILISSAIQLLLA
APFVTDLSALTMPSQHAIGAVAVLGVFCTGLVYFLYMALIQKAGPTFASFSNYLVPLFGV
MLGALFLGEKIQSTTGVALALILGSVALNQWAQQRRVQREAALCQAS
>fig|380703.5.peg.389 Multiple antibiotic resistance protein MarC
MMFFQVVFLALLALLPMVNPPTTATLLLGLSKGMSREHVRRQINLAAIYLFCTLCVSFFI
GSSILDLFGISIPGLRLAGGLIIAFIGFRMLFPAPSQAAGVDINQSIAFVPLTMPSMCGP
GTMALVISGAAQIAELPDEYNRFTIYAAMVTAFALMSLLSWGVLKLADPVCKILGATGID
AMTRIMGFLLVCMGMQFCINGIKEVAQDPVFHGAPAAQTAPALPHVSGALDQLPDPRQP
>fig|380703.5.peg.1013 Permease of the drug/metabolite transporter (DMT) superfamily
MSAASWWDKSTGLALLTIVLWASLAALTSRVTSVSPLVLVGLVLFFCGMGALPFWRQWRA
RPVNWLVTISALLLYHLLLFMSFRHAPVLEANLINYLWPLCIILFTPLLLPGHPLHGRHL
LAGAQGLAGSVLVMVNGELQLQQAHLPGYLLALGAAIIWGAYSVLSRRLPPAPAVMTAAA
CLPAGLLALLLAWLLEGPLPVARIPTGDWGLIIGLALGPMGAAFVTWYLALRDGDPRRIG
ALAYLTPLLSTLLLVLLNGEQLTPRHLLAGALIMGGALLGMLGKPPARQQQEAPAPQP
>fig|380703.5.peg.1144 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSAYFTLRQRAMTRRFWGYALPSIMAMLVSGAYYLVDGIFVGHYVGAAGLAGINLVYPVI
MVLIGLAAMISMGAATAISFQQGARNFGLARQALVNALWLLGLLGAVAPLLLHYWHVDIL
LALGIEQGTDTWQQASDYLYWIGGGTLLLACNLAVPYLLRNDGRPRLAMLLVSSGAILNI
ILNYIMVGRLGLGLIGTAQATLISEGVVSLLGLGYFFTRHAKLRIEWRHLVPDFPAMPNL
LFTGLPSLIAQFNLGLLLLLHNSQLMVHGSVKDLAGFTVAGYTEAVFIVILQGLAFGIQP
LVSQAAGAKRHRDLKFLMEMGLKITLVYGLAVWLLIQLLPRQVAMLYTGDQDGELLAAAI
SSLTLNLGAIPLEGIIMFGIVLLQSMARTRQALLISAAKTLLLLPLIFMLPLWWGRDGVL
LAQPTTVVLLTLPLCWLLWREWRRLKLACAPLSRPGRKPLGARQQVQLARRAG
>fig|380703.5.peg.1568 Bicyclomycin resistance protein
MDNQECLDQAGLWSRSARIMTLACLIVFMAQMATTVYLPSLPVVMTDLAMTRQGAELSIS
LFVIGAALPVLFWGAAADRYGRRLPLALSLLLFVGLSLLLATTSQGPLLLILRTLQGVAA
GGAAIIARILVRDHWHGDELARRLSVLSIAFITALGGGQWIGGLISRYAHWQLGFVLMAG
VGVLALLLMSSLPLLGPNPAAASGGMWARYASLLRRPGFFWPACAVGIGFAITVTLQEVS
PFVLQQGFALEVTTFGSLGLLIGVAYFAGAMTVNRRVARVGGRQLMRQGAALILLAAGGM
LLLWALGALQGSSGLLAMMTCYCLIIFGQAVLFPNSMALAVSDGREHGAYAMALCGFLQQ
GVAGLAAAGATLVSHHGAWAPLVFTLALITLLIVRTRVR
>fig|380703.5.peg.2310 Multidrug resistance-like ATP-binding protein mdlB
MNPTIKRLLGYCARYPRWLIQAGICLLLATGAEVAGPLLIKLFIDDYLAPRQLVWPAITA
IAAGYLGLQVLSAAGFYLQSLRFNRIAQAVVQRLREQVFATAIRLPARYFDQHRSGSLIS
RITNDTEAIMNLYVQVIGLLVQKVVLLCGILISMALLDLRLMLVCACLLPAVGGVMWLYQ
KLSVPVVRATRSLLSDINSRLNESLQGMPVIQAMVQERHFANAFAEVNQQHWAARLKSLK
INGILLRPLIDLFYMMVLIGLLALFAREGLSAEGAIQVGVLYAFISYLGRMIEPLIEMTN
QLNQLQQAMVAGERVFALLDEARESTEGEMRPLQGQVSFERVSFSYDGEQQVLRDVSFTA
KPGQMLALVGHTGSGKSTIISLLMGFYPLDQGLIRFDDHPMASLSLSAVRRSIGLVQQDP
FIFVGTLAENLRLGRDGIDEARLWQALTEVQLAEFVLSLPEGLNTLMEEGGKNLSAGQRQ
LLSFARALVGDPRILILDEATASVDSQTELALSSALAAARRGRTTIAIAHRLSTIVDADE
ILLLSRGQVNERGSHGELMALGGHYAQLFEMQSQGAWLEEKRA
>fig|380703.5.peg.2433 MFS family multidrug transport protein, bicyclomycin resistance protein
MPHAPLSPRFLFILLGALAGLTPLAVDMYLPAIPAIARDLATSIDGAQLTISAFLGGFAI
GQLFYGPLADSYGRKPVILAGLSMFAVASVGCAMADSLPELLAWRMLQAAGGAAGSVVVN
ALLRDLFEKDAFSRAMSFVILVMTLAPLVAPVVGGYISAHSDWRVIFWLLVGISLFICLV
LQWKIPETLKPEHKQPLRLGQVLRNYWGVLSHRGAMGYVLCGALSSSGMFAFLSASPYVY
IEYFHVPTEHYGWLFGLNILLMMVVTFVNSRLVKGVGAERMLQYGLTMLPLAGALLIYNA
WSQTGGLWGIVIPVVLFVGHISLVGANAMTGLMGHFPQSAGTASALAGTLRFGVGALVGI
LVNLDPPESPLPMAIAIASCGFGSALCYWLLTGKKK
>fig|380703.5.peg.2503 Multidrug resistance efflux pump
MDLLLILTYTAVCVAIFKIFRIPLNKWTVPTAALGGVLLIGTLIMLMNYNHPYSEMARNY
YVSTPIVPLVKGRVIEVPVQANQPVKKGDVLFRLDAAPFQLRADSLTARVESNRNHLKSI
EARLRSAKLDRDRASDLMRRGVGKQRDLDVTQANVDDIVAQIEQQQATLEDLQAQLDEAR
YQVEQTVVYAPSDGHVVQLALRPGMIATPFMYRPVMTFIHKDETAYVGWFWQNSMQRLAV
GDEAEVVIDGIPGKIFQGQVTAVIPAIAAGNVQANAGLLDQASAVQPGRLPVLISITDPE
WPKYQVIAGASGQAAIYTKHFHHVSVMRKVLLRMASWMNYVFPFH
>fig|380703.5.peg.2513 Permease of the drug/metabolite transporter (DMT) superfamily
MLISTVPTNKSRYSVIAGWLSGVKAAVLSDFRCLLTTARPHGYYSNGQFHGGNVRPLPIF
TLTLAMLLWSSSFIALKHVLGVWGFGQVLFMRMSVAALCWLCCYRYLGNFRYQKGDWRWL
ALMGALEPCLYFLLEVNALRYTSAGQAGMVCALLPLIVALVAFVLIRERVSRRQLLGFAI
AIFGIALLGFGSGTDEFAPNALLGNSLEMAAMFCAATYSVVFKKLCSRYSVLTLTALQAF
VGTLFFAPFAFGEPWPTAWVWQDMAVIVFLGACVTLGAYLLYNWSVTQVKVTLAAAYVNL
IPVFTLLLAYLLLGETLNALQWVACGAVLLGIAVGQLPARRVRMPAATTGS
>fig|380703.5.peg.3309 Multidrug resistance-associated protein 7
MDHPEISAGWLSRLFYHWTGPLQRKGLSEPQVNLDDLYPLLPEDRRDGRADAFLALTAAQ
PVRPWPITAFIWRHYRGRIGLLTLLQMLGMLATLASPWLLNHSMTQLGAGAPTEQKLLLA
FALFASVLASGMLAEHSLQLALKMHVPIRRLLAESLLAKVMKLGGKSFDDRAGGRVQNLI
NRDVWDITWILADPAMPLTMLLQLLGTIALLVWQVGSAGLVGFAVLTLLLLISTRVVRRM
NQQEQQLKRQQDERNGILAEYIKKLRLVRQNGLGAFFTRAAGHKRQQELGVLGRVLRLDA
INESLMLSTPLLVTLATFTTYLVSGRELTLPQVFTTIALFTVLRIPMMRLPYLIRTLINF
NTGFNRLCEFLNSPEQHRDLTDPSLPVGGLRLDNVTALHQQKPVLEGISLHIEPGELVGI
TGATGAGKSCLLHLIAGFDNGFEGSIRRHGRVAHLGHKPWLMNDTIRNNILFGQPWHGER
YRWVLGACALGADLTLLSHGDQTLVGELGTRLSGGQQQRVALARALYAQADILLLDNPLS
ALDPIVSAQVLEQGLAFKPGPTRLLVSHDPDVLAHCDRVIRIEQGRLVELDAHQLADLIQ
HPRPTPPVPPQEAEQFSEEKMVEGKVDWGLFGFMWQRLAAPGAILLALLLTLGQEGLRIA
SDLWLGGKAGVTGVSELLGIYVLLGAGSLTCIMVVRVINYKLGLKLAWTLFDGMLGRISR
APMAFFDKVPQGRILNRFDRDLGEAQEILLSMLMGLFGMLVSVVLQVVVIGVNMPLLLLI
APLVGWALYVLQRRYRAVQLKLRRQASVLRSPLYISISETIRGAPALRLAGAERFALDQV
LLHYDNNLRSWYTTTSINRWLGMHQTLLSAALVGAVALMVAFGNSSLLGAVAITYAFTAS
AMLNSLIRTFAEVEQVMNAVERVREYSEIESERQEGEALATPHPAVRFDNLGLRYPQASQ
WALHKVNFELAPGEKVGVCGRTGAGKSSLLGVLQAMYPASQGEIYYGEQPLSRLAPEAVR
DLYDTVSQIPLTFFGTLRANLAPLTKHDDAALEQALARVGLAERCAGRLDEELDKLQLSA
GETQLLVIARILLSRRPLIVLDEATSDLDHIGMRKMAELLYRYRPEASYLVIAHHLEPLL
SVDRVVVMEAGTVVEQGSPVSLLANSHSRFHQLFVGQVNRQVPQTV
>fig|380703.5.peg.3640 Probable antibiotic-resistance protein
MLLDGSPQPEIELVSRHPGAQAADGVGHDGAGGEMAIAERIQHGGVGAQEAAPAHAHGGE
HRHLVAGDPALADEGRHQRHGGPDRPQRGDREGHQLGVGEAEQQLEQPAHLGRQHRQQRH
PLEGFTAVALLARAEGQQHHEGADDEHPGDHRHPQLHPGLATVQQGVEHPQPGRGGFLAQ
TRFGPHARHLVGDRGLPHQRADHPLHQPGRHHGADEGAEQTDQRRAGGGLAARQLQGRHE
GHHDQPHAEGGAEVGERHQLPGGEALAKTAVLGEADHRRVVGEEGHQGRQCGAPRQPEHR
LHQRCQQHLQQADHPELAEQLAECARQHGNAHDEEHCVEQQLVSGVEQGVDQGGEAHLAA
EVAKQAAEDNQHQYRLQPAAKGGRPLVRIFNCLIFHTNPEICRCVVSIVVMAPIKQEPLS
CDKGSLNDSSCRLQTRVIRIDASPRQRLNQGGNTGGRTILSSLPVSRQHAGPRPARRRNG
AAV
>fig|380703.5.peg.3899 Multidrug resistance protein B
MSSSPLCGARIMSSFTRVLTPAARRLGLLALGLATLLPMLAGSMASMLLPALGADFAVPF
ASLQWVLVAYLLGLTCLTVVAGRLGDRFGRRRLLLWGMGLFVLASLLCAQASTIGWLLAA
RVLQGGGAACMLVLSLAMVGQLVSPARRGRGMGLLGTLSACGTALGPSFGGLLLDVAGWQ
PAFLALLPIGLLALVCGLFGLPRDAACTEGERLNLASLSLLLVALLCYGLALTSTGALAL
WLGGGALLATAWLVRSELGAAAPLLPLALLGTRRLRGGLAASALVAGIMVLTLLIGPFYL
QGVFGLDPFTSGLLISGGPLLAALTGLPAGWLVDRVGAITVVRLGLLLMSGAAALLAVLS
PALGPLGYLLPILLLTAGYALFQTANNSAVMGGSGGQARGAVAGLLTLARNLGQLTGAAG
LGALFAGLAGGGDPAVASASELHFAMQASFALSGLLLLAALWLAGRDQCSAPGEATRAGC
ESGGG
>fig|380749.4.peg.571 Multiple antibiotic resistance-related protein
MDRKQAIDIIYFIIKFSISIFAILNPFGALPVLVSLTKGYTKEDRSYVIRTSSIYAGLTL
IFFVLFGDLLFEIFGIGLGAFQIGGGIILSFVSINMIFGQPHRERASNQELEEAEQKENI
AIVPIAIPLLAGPGAISTVITIASSYRSVFYHVLLILSILVACIGVFLVFKSVDKIVKIL
GKIGINILSRLMGILLMSLAMQFIIKGIQLAFPTLGK
>fig|380749.4.peg.781 Acriflavin resistance periplasmic protein
MKFYVFGLLVLMLSLFSCEKPKTKEISKGIKSPNIALCKVVYGAYQVKTPIYGEVQNQAA
TYVSSPIGGILKSVYVKNGDFVKKGQVIAKLDTKVFQDKALSIAQDIEASKKKLKYYMSR
YERAKKLYKLGSMSYQEYSQIKTDLALAKGELDKNIYLKKSLEDEASYGIIKAPFDGIVS
NVVPSGSNVNPGSPIAFISAKKLYGEFFIPFNMKISHTDKILFENKLYPINAFQDDKSRL
AVILPISSYENPGSSLKAFIVKTIQGQRIPSKALVLYNNRPSVFIEQGDKVKNIPVKILG
NMGQYYVVSGVIGDSVVCKGAKLLKDGEKVK
>fig|380749.4.peg.1480 ABC-type drug export system, membrane protein
MWFLAFIRGSFVILEIELRKMIRQKVDIITRAFQPLIWILLFGNVFKNIKSIPIKGDYLS
FMTPGILAQSVMFVSFFYGISLIWDKDQGQITRFLSAPIPYSSITTGKAIFSGVRSLVQA
FLIMILSKAINVNIYINIYTILLSIVVIMLSGICFASFSMLIASIFKNVERFMSVIQIIT
MPIFFSSSALYPISLMPRWLKVVALLNPLTYSVEGLRLLLYKNSLDISIPLLVLSSYSIV
LLVFSAYSIKKLVN
>fig|381764.6.peg.333 Fosmidomycin resistance protein
MSISVLSFLSIASHFLLDFLVSFFNPLGPYLIQKFGIEIKLFTTFLTLSSATASLLQIFF
GFWFDRVTSTRKYLIAMYFLEALGIAILGIATNFWIALISIFAIRIANSAFHPLGAAMAG
EGTGKTVAIFSIAGTFGAALGPVFISYYVSKFNSTQTLWIISIPFVIIAFIILRINLPQK
TSKKNEKITLKEASILLPILLVVTIRSFLMSIVHTYTPIFVTNVLKFPITVSGTLITSGM
IAGVPANYIGVLLMEKIGVKKQDLVAFAGMALSVFFLVFSKTLIAIFVSFIMFDFCGFLL
MSANVVQAQKIMPHRKAFASSVAMGFAWSIGDFIASGYNSIFGNNVKLSLILVIPIAIVS
SIYFGITQKFDTK
>fig|381764.6.peg.883 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAKVNVLNERIEYSLFHLAWPLIVSNALQTIYNIVDSYFLGKLGPVQFSASTITWPVIFT
FISLAMGFSNAGIAIVSQSYGKMDIQKVKKSMGQLYLVTISVGLLATVLGIAFAKPILNS
IAGSESRDVVPYALKYYIVDMLGLPLVFIINSTTSAIRAVGDSQFGMRITLYMNLVNMFF
DPLLIFGIGPFPKLGVAGAAWATNIGRFIAAGISLYHVASKQAHVKISKSDFKPDWKIIG
LIFKLGLPSALGMSITSAGFAVIMKYVAMFGPAVISAYGIGNRVTNLVSMISFGLAGAVS
TMVGQFIGAKRYKDAEYTVLKAFYWNITIIGVLSLLTFIYGKQVTQFFINDPKVIQMGEI
YFKYISFSMPIFTAYMIYNNALIGAGKTILTMVGDILRLWGIRIPIIATLSLTFGFKGIF
VGMIISNLIVFVITYLFFRLSNWKKSVV
>fig|381764.6.peg.973 Permease of the drug/metabolite transporter (DMT) superfamily
MLSSYLYLAFTLFAFSSIEVVSKPLMGIVDPFFMTAFRFLLGGLVLMIFVKDDIEIKDFL
PITLVGILNSVISMTSLQLAVKYSNASTAATLVASNPIFVSLFAWIILNERYKLRKYVGI
GLGFLGLVIFSFGKISGDSWLGIFFGVVAASTFGLYTVLMRKYTKKYNSLVVTAYSSLSS
GLIYILLLTIFRKFEIPILSINQWFILIYLGLIVTGVAYLTFFKAMEKIGATQSSRIFFL
KPIVATLLAIVFLGEKLSLLKIIGMIIVLFSLTL
>fig|382464.3.peg.63 Glyoxalase/bleomycin resistance protein/dioxygenase
MSEPTVSFSLTVKDGNKALDFYAKAFGAKELYRMATPAGGVAHAEFQIGETKIYLSDESP
EWNAFAMEEGAKASCLFSIATESCDDSFQRASEAGGEVLSEPTDMFWGARSAMIRDPYGY
RWSFTQIIEEVSPEEMERRAKEAFGI
>fig|382464.3.peg.570 Permease of the drug/metabolite transporter (DMT) superfamily
MTSSSPVIISKVQPLLRIGLLLYIVLTASFCYVFILRGLEYAPPLAFAGFRTFIGGVTLL
GISALRTGRILPERRLWKWVPCVALTATSLTFGTMFLSPGFAGAGIASILGNAQPLFIAA
IGFFFLQERLSPLRALALLFGLIGVIVIVSPSFGAKENALLIGSLIALMTSLSAAIGTVL
GRYIKLGDSIVAFVGTQLATGGIILLFASLIFENDSIEWTPAFLGILLFLAILNTAFVAW
AWFYLLQREQASGLGMYLFLVPVLGVAWAYVFAGERPEPTSFLGGAIVLLAVFTQEFEGF
RRRVR
>fig|382464.3.peg.964 Transporter, drug/metabolite exporter family
MLRFLLLLSGVFFCSTSVIIIRSSELPPSLLAAYRLIFAAVLLSPPFLLAWKKHRNAFPA
RQFLRCILPAVLLATHFISWAWGARLTYIANATLIINLTPAVMPFLAHFLIREKVTRKEI
LGTLVALCGVFILSYSAFSIDPQFLLGNVVCFGSMITFAAYLAFGRINRDFPSIWLYMIP
IYVIASVICFIFSFFTLDSLSIRSTDEVGWMLAMAVLPTILGHVTLNRSLRYFAAQTFAV
VNLHQFVFAGIMGWLIFKDTPPTIFYFAAVLCISGAVIVVHEAARIRKTATQ
>fig|382464.3.peg.1478 Acriflavin resistance protein
MAEDPIKKHPIIAWFADNSVVSNILMFIILGWGIYSAITIRKEAFPSFAADSVTIQVPFN
GGAPEDVERGVAIKIEEALQGVDGIDRIRSTSTDSGATVTVDSIEDYPITKLFNDIKVQV
DAISTFPGEAEKPIITENKARNSVIWIDVHGEVDEALLKETARDVRDQLLKLSDVNQVNT
YGDRAYEISIELSENKLRAYDLTFDEVATTIRNNSVDLSGGLLRSDRGDIALRSRAQAYN
KDDFAVIPLRTSSDGTRILLEDVADIRDGFVDQQYLNRFDGEPTVSLQVTTDGDKDIIKA
SKQAAELAATYQDRFGLPEGITLSAWNDGSESIRSRLELLTRNGLQGVLLVLLSLSLFLN
VRLAAWVAIGIPVSIAGAMLLFNLPLFNISLNLITAFSFIIVLGIIVDDAIVLGESIYTE
KENQEHWKDDQANIRATVRGVSRVITPATFGVLTTIAAFFPLTQVSGRMGNVFGQIAIGV
IFCLIFSLVESKLILPSHLAHINVHKKPNNPISKFWARFQGLFASSLKFFINKTYRPTLR
QAIEYRYLTLATFIGLLIVIGSLLPSGKLRFVFFPDIFQDNVSANLELEEGLPVSHLHAN
TLQIAEAIRLVNEDIIAETGQSAVRHIQISSRSNTASSVSASLTSSEDREINTGQIVNRW
RAKVGQIAGSKALTFSGRAGPPNQGLSIQLESKNLDALQTAADAMKEEVAAYPGVYDVKD
SFSSGRPEIQVNLTPAGQASGFDRRELASAVRSAFFGMEAQRIQRGRDEVKAMVRYPEED
RGKLDTLRDMRVRSADGTAIPFSIVAETEFGKSLAAIERADYNRIVSVSAEVDKSITSGD
EVLSALTIEYFPVFAASHPDVNIALRGEAEQRMKSMQSLFTGLMVSLLLIYILLAIPLKS
YVKPLFIMSVIPFGIIGALLGHFVVGIPVSILSLFGVLALSGIVVNDSLVLIARIDDLKA
EGYTLRDAIIEAGPQRFRAILLTTLTTFIGLVPILLEPSVQAQFLKPMAVSVAFGVLFAT
TITLVLLPVLLITFDETIASSFRYYKKLIAKKWG
>fig|382464.3.peg.1976 Acriflavin resistance protein
MVSIVALGIYSAFNVIILQEHPDYPSRNITVSVPYPGSTPREVEQAIITRLEEELYDIEG
IKEMTSRATSSSGTVTLEIEDGYSLGTALDTIKNRVDSIRTFPVEAERPRVSMPEHRERV
ITAVVSGDLSEMELKRLGEEIRDEITNIPGITVASLKATRPYEISVEVSEHTLREHGLTL
ESLTNAIRAHSLDLSAGRIRSEGGDIMLRTSQQAYTQEEFESIVVFTRPDGTRITVGELA
KVNDGFDETPIVSRFNGQRSVAIDVYRVGSQNILELGAAVKDYLKLKQEQLPEGISLEYW
RDDSDRIAERLSTLKGSAIFGYILVVAVLSLFLRPSLAFWVALGIPIAFAGAFFMLPLMG
ISLNLITLFAFILVLGIVVDDAIVTGENVYQRMQAGEDSLTATIKGTQEVAVPVVFGVLT
TIAAFYPLINMTGWRGNIFKQIPFVVIPVLLFSLVESKLILPAHLKHCRPINNAHTASKG
ILTRMQRRVANGLERFVEKYYRPSLELCLRYRYAVLVVFIGLLGLFVARFVAGHLPYTTF
PRIPRDSVTVTLNMPIGTSFDATQKIVDRIEKSAMQLRSNLEEEHGVDIIHHIFATAGGR
PFSSWRSTAGVAEEGEVILELASSATTGVSIGTREVSMGLRRLIGPVPEAESLEIAFSWG
GGDAVNVQLEGPRIEELVEASRELQRKLATYEGLYDIEDSFQRATEELELELKPQAVHLG
VTARQLASQVRQAFYGAEAQRIQRGRDDIRVMVRYPESQRKSLAALHSMMIRTQDGTQVP
FEEVAEVVPGKSLPSIQRFDRNRIIRVTAAGDENEIDEEAIQLDLEKNYLPELISKYSGM
GFTMQGNAAATRDNNAELVNGIYLVLLVIYVLLAIPFRSYVQPFIVMTAIPFGIVGAVMG
HDLMSFVYTTLLDREINPVGNVTMMSILGMLALSGVVVNDSLVMVDFINQRRKEGMALRD
AVRLAGAKRFRPILLTSLTTFAGLMPLMFESSRGAQFLIPMAVSLGWGILFATFITLYFV
PLTNLVVNDIGNFFKWVYGKQEAIGSSSGHATTPEAAARVGE
>fig|382464.3.peg.1982 Acriflavin resistance protein
MFVFIIAGLGAVATTKRELFPDFSLDMITIRVPFLGASPEDVEELVIVRIEEALQGVNGI
KEINSVATEGYGSVTVTVDKGYSASRLNDDIKTRVDAIPSFPENTERPIIEEILIPKDVI
RVSIYGDASESEIKKMARRVRDELVEINGISQALVQGARDYEVSIEVSENALRNYRLTFD
QVVNAVRSNSIDMPGGTIKAQGGEIQLRTKEQAYRGDDFADIVLLTSPDGAKVYLKDIAA
IRDGFAEQDIATRFNGKPSTDVLVREVGDENPLQISRDVYDYVDRAMETWVPEGVYLEAW
ADSSYYLQGRIDMLLKNGLIGFILVLVSLTIFLRPTLAIFVAIGIPVSFLATLAVGPFVG
ISINLLSLFAFILVLGIVVDDAIVVGESVFTEFQKGGPGVQSAILGTHRVSTPVTFAVIT
TMVAFIPIFMLPGTIGKFMGVIPFVVIPTLAFSLVQSKLVLPYHLSLCHVGDKHARGKLN
WFSRMQRAISDGLERFIETRYRPIITFAVKWRYYTLSTFILFLVIAIALPVSGVIRFVFF
PSVPSDYLSMGLTMIEGTPFSETERALKRIEDALEEIRAEDAAKGLIDPVKNKAVFLGSQ
PNSGGPGGGAGASSGSNVASIILELAKSEVSDSNATEIGERWRAKIGEIPGARRLNVQSS
ASGPVGLPVDVRLTGRDFTQLKAASLEIQEKLKEVTGLFDIRDNYSEGKRELKIRLNENA
RALGINAFDLGRQVRNAFYGAEVQRVQRDKEDVKIMVRYPRSDRESLGNFENMRIVAPNG
ARIPISEVAELEMGMGYPAITRLDRNRVINIQADADKRAITTNEINFEVYEVILPEILAK
YPGVTPAIGGEAKDLAEAGPAMIGGALIVIVLIYALLAVPFKSYIQPLIVISVIPFGIAG
SIFGHLSGPGFKIQDLSLLSILGIIAMAGVVVNDSLVLVDRVNRLRAEGMDMHKAVINGG
QQRFRAILLTSITTFAGLMPIMFETSLQAQFLIPMATSLAFGVAFATFITLLLVPSIYLI
LEDFKWIVCAWWRGLSRGFAR
>fig|382464.3.peg.2382 Glyoxalase/bleomycin resistance protein/dioxygenase
MVLLGVQSVPRSAAFYESLGWKKSPTGHDGFAKFDLGGYSLSLISREDLAKDARYESAEG
SGFPGIALIYLAETPEEVPLILNRAVKAGGSLLKKATRTEWGIAGYFKDPDGHIFEVDYE
DAWVFDEEHRLVVDKMN
>fig|382464.3.peg.2393 Acriflavin resistance protein
MDFARVSIKKPVITWLLVAGSVLGGWFGYLNVGRLEDPAFTIKEAVVVTQYPGASAAEVE
REVTDKLESAIQRLDSIKEVRSRSYAGRSEIEVELVWTMGPDEIPQIWDELRRKVGDAQA
SLPAGAGPSLVNDDFGDVYGLLYAIYTDDVEPADLRDYAKRLRMQLMQVQDVADVSIVGA
QSEEFHVEFSPEQLARFGISPQEALSGIISQSAVVQSGGLRVGDRYAAIEPTDMLADVDS
LSELPIGRKGTDAFLALGDVAKVERGYVERPTQFVRFNGHDAILVGVSGRPKVDIVKVGK
RVDARLSELESDRPLGIEIAPVYEQHVVVETAVGGFVVNLIMSVTIVVGVLCVFMGWRSG
IVVGAVLFLTVSATVFGMYVLGIEMERISLGALIIAMGMLVDNAIVVAEGMLVRVQRGLG
KLDAASEAVRSTWLPLLGATVVGILAFSGIGLSEDATGEFTFSLFVVIAVSLLLSWVFAV
TVTPLFGYYLLQKPAKESESEDPYKGFVYKIYRSALKLSLHFRALTVLVLILMTLGSLFA
FTKVKQSFFPDSNTPIFYLNVWQPTGTDIRATNATARELEKLIQKDERVNTVTTLVGAGA
PRFMLVYAPEHPDSSFTQYIVRTKEADEIDGLIADLRSLIADTQPDLFVKTERVKLGPGG
GAKIEVRIVGADTVVLRELGDDVMDVLYADDGLRDIRTTWRELRPVLQPVFDPQLGMRQG
LSRQDFAQQMQLLSDGAVYGVLRDDDELIPVRVRLPQEDREDAADLGQRLIWSSGLNGWT
PVESVVSEIELAAVEGVVHRKNRERTLTVQAEPVPGELASAAFARIRGVVEGLSLPVGYR
IEWGGEYEISTDAETALFKGLPVGYLGMLVIVILLFGRLRQPLIVWSVVPMSIIGVSFGL
LSTGVAFGFMSLLGFISLTGMLLKNSIVLVDEIDARIASGQPRYDALVEASISRARPVAL
ASVTTILGMAPLIFDAFFIGMAVTIMAGLAFATLLTLIVVPVIYDLLYRIHPDETEV
>fig|382464.3.peg.3260 Permease of the drug/metabolite transporter (DMT) superfamily
MAFAALYLIWGSTYLAIKVAVETMPPFLMATGRFFLAGLVLYGVARASGAARPSGGQWKH
SWIVGGFLIAGGNGVVSYAETFIDSSMAALIIASNPLFMTLFGWWGGVQAKPGRMAWLSL
AGGFVGVATLIASGSGIEWGNSLFGYILVVGCVLLWTVGSIYSKRNPQEMNPWLQSGMQM
ICGGAICLLAGGSMGEFSTLDFAAISSRSWIAFGYLFIVGSLIGFTSYVYLLKHCVPSTV
SSHAYVNPVVAVILGWLILGETLNMGGWVGSGMILVSVFILLRQGRK
>fig|382464.3.peg.4538 Multiple antibiotic resistance (MarC)-related proteins
MGLLEYTLLAFVTLFVIVEPISIAPIFLAMTAGNDRSARTRTAKIACVTMVTVLLLFAVV
GMSLLEFFGISVAAFQTSGGILLLLIALDMLQAKESSRKITQEESDAGTAKEDIAITPLA
VPLLAGPGAITTCIVLANQAEAWDQRMALYGVIIFICGLTFLILKLADKGAAWMNPLFMR
VITRLAGLLLAALAVQFIFNGLRDSGLFPLSGGAL
>fig|382464.3.peg.4822 Glyoxalase/bleomycin resistance protein/dioxygenase
MKNRTVTITVSASVDEVFSFLANPEALPLWAVSFCKSIREEAGRWIVSTGQGELAFAIEA
DRASGCIDMLAGPTLETVESFPIRVFKADNGQTAASFTMFKSQRPDMTDTLFEMHYRGLV
KEVGTLVERFGGGELSSGLPEASKLTVGLVSDDIGATRDFYVKHFGFQAVFDASCYVHLS
REIGGEQIGLMAATAEAGQAEFESATTGQGVWISLEVEDVDAEYERLKGEGLVFRESPAD
QPWGERTCVTSDPNGVLIYVSQPNGKMDESLKQFVVEEGAELVS
>fig|383372.4.peg.1577 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MATAPGADYAAMLKRWLSQILWIAPEGVIIALLLAINAIVPSIWIGAGMTLLVVTFISRI
TALYLTSRALFQARWEAADALATVASMLHPWSPDALALRGAIALARSDSATAVRLLQRAQ
RLAPNRSAITAALSGAYLEEGEPQAAAVAARRALELDPANAAAHLHLAQALAAIGARAEL
IEDQLRAGLAHHPEPDAEASLRCALAHHLAQEERWAEAALALSAARAVLPHCSAAQRAIV
SQRIAEIDRAIHSAREDHAA
>fig|386415.6.peg.420 Drug ABC tranporter, ATP-binding/permease protein
MTIFISNLKRIFKSKTNIFFMVILPVVLIIFMISINRGGRRFSLGIVDYDNTSFTEILAK
EIGKDSKINYLNQKDIDKSLVNFQNDYIIEIPKGFTKEVINGHDKKIKGYEIDGINASSA
LKFNIENFISTSKDIGKYVKGNEKLFYNALEKYREGILDVSLENMDKSPINQNNIEFCVG
ILIFNMLMLGINMAPIIIKDKISRVYYRIFVSPIKPQNYTLQNLMSFFVVLIIQIIILLT
FIVAILNISIPNLKSIFLMFLIFGVFVVAYSLFISNISDNSRTVSIISRGTAIPMAMLGG
CFWPVEIMPSVLQQVSKFIPVTWMMEAINKLLYNNSLLSILKEISIIVLFSIVFLLLASW
RRKDIVNL
>fig|386415.6.peg.505 Vancomycin B-type resistance protein VanW
MARKKGSSTNAKSNKKIFKLSIAIILVIVCAVVSYVYFTVQKFNDSIFPGVQVEEVNLSG
ATKDEAMKILREKYSDAMLNKKINIKAKDKDYFINYPELKARYNIDDTVNHAMNYGKDKN
MFSKYMIIKGKKSKIYELELSYDVKPIDKMIDKIAKETNVKPVDAKLSFDGGSFGVKEDK
KGVELEKEKLKKEIISNINDKHQDVVVINAPFKVIASKVTAEVLKSVNSKLGSYSTNYAT
SSEARATNVAVATRSIDGKVVMPGETFSFNEVVGERTRARGYKEAGVIVNQKLESGFGGG
VCQVSSTLYNALLRSNIKMTERVHHTFPSSYVPTGLDATVDWGNIDLKFKNTFKYPIYIQ
GYTGGREVGFNIYSNSELARTRCEITSEVYKKIEPRTEYINDSNLPAGAMEVVKSGHTGY
RVKSYRSIYKDGKFVAKELIANDYYVPVNGVVKRGTRK
>fig|386415.6.peg.539 Antibiotic transport-associated permease SpaG/mutG
MKILRLMKADFIKMKHTSFYWIHICVPIIGILIFLGYYSFSIAGSIGKVNGYLDGLSLVF
PVVIGIVCSMVIEQELKAGKFKEMLSVEYGKGICLLSKVLVVLVMGFFSLSLAVGGFFIG
FEYILRQNILPFKFYAVLTLLIFMAQIFIYLFHLWLSIKFGSGASIGMGIFESLFSALII
TGLGDGIWQWIPCAWSIRFCNNFFIKKANSIDIFNKLADFNTGLSINAIGFRNCIIYTII
LGILFGIWFNFFEGRKSE
>fig|386415.6.peg.658 Acriflavin resistance protein
MDKLKNYPISLEDVTKALKVQNVKIPPGAIESKTSKIDVITSNGFDSIKDIENVVVYVSE
DTGAIVRLKDIAKIYMDYDQDDVKYKQDGKKSILLTGHFEDNKNVVLIGKDVRREIESIK
KTLPNDLNFYEVLYQPTDVDNAVSDFMTNLIEGIILVIVVIFAGVGVRNSIVVSTALPIS
ILLSFIMMHFAGIKVHQISTMALIIALGILVDNAIVISDVVQVKINQGVDNVRAALEGAK
ESSIPIFTSTLTTVASFAPLLTIPGVPGKYVESIPKVVIISLIASYICAMLITPALAAVC
YKKTSDAKQGKIMKKVEKFFENALSFGLKKRKLTILISLGMLAVAAFITTTLGLQFFPYA
NKNMMYINTTIEKKGDIKATENLSKVVEKVLKAQPEVKSYSTGIGDGLPKFWVAMPPSVP
SNDFAQTKIDFDLKKGGRFKDNAEFANFLQEKLDSEIVGAKCTVYPLQYALPKEAPIGIR
VIGDDMEKLYAASEKLQGLIRQIDGATKVRDDAADRTYQYKVDIDSDMASQLGIIKYDIE
RQINIALRGTEGSVYRKNGKEFSIIVKSNIDSKEKLENLAVKSTLAGHKVLLKEIATINL
QTQIDTIKRYNKEDCINVYADIKPGGNAVDLQDKIEEKIKTTDLPGVRLEFFGEKADIVK
YFGTLGQSAGVAIFFIYIILLIQFNSFMQPFIIFLTIPLSLIGSALGLFIFRQPLSLMAL
MGIVSLVGVVVKNAILLIEYINKARKEGYSLNDSCMDAMKKRFSPIILSAFTTVMGLAPI
IPSGNPMFVPMAVALMCGLIVSTLLTLIIIPVLYNLIESSVDKFNNKHKGGFKFNFKFGG
RKIKKENTLEG
>fig|386415.6.peg.1814 Ribosome protection-type tetracycline resistance related proteins, group 2
MKNIKNIGLVAHVDGGKTTTTEQMLYISGAIRELGSVDKGSAKMDYNSIEKKRGITIFSD
QTSFTWKDACINLIDTPGHIDFSSELERSLKALDGAVLIVSAVEGVQAHTETIWNLLRKN
NIPTLIFINKLDRVGADIKEVFSQIENNLTEKYLKIQRIDGLEENFNETIDLLVNEQFYN
DSKEKIELIEKFAEINEEVLEKYLEGEEITREFFIDNLKKSVEEGEVFPVLFGSAINGIG
IKELLNSIEELLPYSSGNDEDEFSGVVYKIKYDDKIGKLAYVRVLNGEIKVRDTIINNLG
EEEKITQIRKYNGDKYNTVENLTSGEIGVICGVKDIKVGDVIGNKDDINIINENNESALI
SRVVPQNEEELPSLLKALQILNEEDPSLQLEYNPENKELSISIKGIIHMEVLKELIKERF
NIEVEFLEPKVNYLETIGEITNGFCHFEPKKHYAEVEVEIEPNERGKGVEFISEINGDIL
PYQYQNNIEKASYEAVLHGPLIGGKVTDIKIKLTNGKHHLEHTHGGDFRIATIRAIYQAM
EKNKNIILEPIYKFKIVVNKEMGGKIMTDILKMGGSFNEPEVKGEKIIITGEVPVATSMN
YKLELLSSTSGKAVFNMQFSKFEVCHNQEEVVKNSENIVEKEDSIYNGVSLFREKKKMKK
VVLNEN
>fig|387092.5.peg.77 Multiple antibiotic resistance (MarC)-related protein
MNSIFISILLHDIIALITIINPIAAASIMISMISPPTASAIADVARKATLTVFAASFVTL
FGGEVVFQFFGINIYSIKIIGGIILMLIAINMAYGHGAKNRHSPEEAQEAQEKEDIAIVP
LGIPILFGPGVIATIVVLSHNNSSQLHPALSYILLSIAILIASLATYLTLRYASIINKAL
GVTGIKILTRIMGLIVGAIAAQFLISGIKGLWEA
>fig|387092.5.peg.81 Acriflavin resistance protein
MFEYFYQRPYLLFSLIVGFFAMGIIGLKSLPKNLFPDANRPQVVVITSVPGATAEVAANT
VSKPIEEEISRISLVRDVSSVNVANFSIVKAEFEYEKGLEAAAVDVANALSIARGKLPKN
ANPSVYTVGDFTLPVEVVALSPKNSNISLQEIRKIAESHIKPYLLANPHIGNVEVFGGYQ
SAINIEVDPFKAKKYGVDFDTLAKVLFALNKDIPIGFTKSKESFYTITYYGEKDNIEKLK
NLHILPNVKLSDIAKVSWSYKKRTSGYLGNGKNAIALSIQRAPAGSVLDVSDAARAEIKK
LQKLYPNIDFQIADTQRTLIETANENMLEALRDAIVYTLLVLLFFLGNFRAIIAAGISIP
LVFFGTIAIIWLGGGELNIVIYTAIILALGMLVDDAVVVLENIERHLELNEDMQTAIVNG
TKEVLGPVFAGTVGTIAIIFPLMFVGDFPEHIFRPLISTLIIALLVSYFLSITFIPRFSA
VLYKNGTGKTKIEQWFEDVYKYTIGQLIGPYISVLKFSNGKWWALRRMLLTAAVVLTFVL
SLKNVMPLIGKDVMPPMDTGIIKAQVAFSANETVDSAEKKLHKFLVWLHKQPWVKSSSVA
FGSESGVLSLGSGNLPSEATITINAVDRFHRNKTIWQLEDEIRDKIAELPGVKKNDVFDF
GATALSTIKAPLDIRIKAADYEKLPDKAKEIIDAIRNVKGLTSISQSWDKDFQEVVINID
KNRALSYGVTPYQIAMQIPLKGQVVSLAADMATMNTQFVRMYLKGKFNENIQSLKLLPIK
TKFGEIPLSELAKVSYQLTPAKIERDKLLYSVDVSGYRSKRPVTHITDDANAALAKVDTT
GFVVTQEGDIAQLHDSFKRMIKAIAIGVIILIMTLTAIYESVRLAIIMILVLPLSMIGAA
WGMLIFHKPSCMPSMVGLLLLFGIIIKNAVLLIDFYKEYEKEGKSPFEAAIESVRVRFRP
VMMTAFGTIAGMIPIALEQAVGLERLSPLADVAIGGLLVGTLLTLIYVPMYAYATDPRNR
KTNPIEKVEEYIEE
>fig|387092.5.peg.703 Acriflavin resistance protein, AcrA/AcrE family
MKKIILFCLMSIALLAKGLELSGYVKSDDTKMIGTRFMGYVEKVYVSEGDWVKKGQILYK
IDSKEIDLAKSQVELMISQARLAIAMNENMYEFAKVNYMRHQKLYKKGMVSKFELEQMEL
MYKNTKNMVEIAKKQLAQAKAKLAEVLHQYEYLKIKAPNDGVIIQKMVKEGQLTVPGYPG
MVLTTLDNLKIEAEISESNLKNIHIGQEVTVEVPSVGFETVGKVSAIIPAANPMTHKFKI
KVSFDKKGAELIPGMYAKLIWK
>fig|387092.5.peg.704 Acriflavin resistance protein
MKCAYKPKDIAGKLALTFLHNPLTALLAVFILAIGYLSLEVMPREEDPQIAISGGTIIVP
MPGATPKEIENVVVKPLEEKIREIKGVEHIYGIAMENVGIVNVQYFIGQNREISNMKLYD
KVMQNMDMLPKNAMHPLVKPFDIDIDIPILTFAFYKKNPNLSDGEFYKIIRDIKYRVNGV
KDVSKTNLKGAHKRQFNILVDLGKLSGYHLSLGQIMQAISSVAKEVPEVKNRTKNSKIVI
FGVPNAIESVEDVKNIMVANYMGSPIYVKDIAKVEDGINIQDFKQAQIWTKKLHTKPQYT
LEVSKLKGTNAVFVANDVLALINELKPYLEKKGIGYVLTRNYGKRANDAVNELVDHLLIT
IAIIAVMLVFFLGFKEALIVTFTVPAILALTLFVAYITGQTINRITLFAFLLSLGLLVDA
AIIVIENIHRHLHEHDAVYKDMDTILVEATDEIGAPTNVATVAIILTMVPMAFVGGMMGE
FMKPIPYNVPVALLSSLLIAYIFTPYLAKKLLKKPHMHHHHHHFQKHEKLPSECDIDGGK
S
>fig|387092.5.peg.1069 Acriflavin resistance protein
MKKFLEFAIEKATLNHLFLLFIFILSIFAYKSVPKEIFPPATLDKILISGGYAGASAQTL
DKMVVKNLEDELKNVQNLYDIDAIIKNGSFTIVSDIKEGANNLLVLNDVKDKIAKIRKDL
PPDMDEPIATILTKSFPLVLIAIATDANEHKLLDVADRLKSDLTSLKNLSEVDIRGWRED
ELQIAIDPQKINALGLGLLQVSDLVAQLSTIFPIGSIKQRGNHFFLTTQNGKKEKRALEN
TILVIGKKRVRLGDIANVSFTLSEPVTLSHFNGKPNVSINVTKTKNGNAIELVKKIKKLL
LTYKNRYPGFEFKIYTDTSIWIRNRLNTVTSNLIFGLILVFTALLLTVDWRIALVVGMGI
PVSFMIGLISLEMLGYSLNMLSLFGALIALGMLVDEAIVVAENIYRHLEMGEDAKTAAIQ
GSLEMFPAVLTATATTIFAFLPLLIISGEMGIFIRILPVIISILLLSSLFEAFYFLPLHA
KEILKVGKKKKPSRLWQFLGDLYENVLRFLLERKRVSTLLLVGSILFGTFILLKETKFQL
FPAFDTTQIYISGSVNVNSDVEDTQKIVSKLEQAILHSVKKDEVSSVTAIFGMKLDAKNN
AQTGSNLFHIFVNLHELKPQNFVDRYITPLFSIEYDSSDMVRDRSARAIAEDIKRIVETF
RHPPFEEINVIVPQAGIVKSDIEVSLEYEDPKQVLKAIHMLENGLKGIKGVYNITDDAKE
GEKELKLILNDFAERLGITEGYLASYLKSLYLDAEIAKMFKNSKLIYVKLKSIAKDSVES
FKNLVIQTPNGQKVLLKDIASFWTQRHFYNIIKENGKKIRTVYASLNKKVITTAEVYDKL
DPLLRKIEKLGVKVKIKGEQKENKKLIREITRAFVIAVFLIFGALVWMFNSFVYSLIVLS
VIPLSLFGVLVGNKIMGINLTMPGMLGLVGLAGVVVNDGLIMLDFIRSCNDIECVIQRAK
LRLRPIMLTSITTILGLSTLMFFASGQSLILQPMAITLGFGIGWATCINLLLVPLLYSVV
KKVQRKV
>fig|387092.5.peg.1800 Drug resistance transporter, EmrB/QacA subfamily
MSERSPKPYDLTNRQRALYTFIVMLGAFMAILDTTVVDVIVPKLTGPLATDMYGVQWIIT
SYMVSAAIGLLVCEYLIKRYGAKKIYLIGVATFAIASFVCGISSSLDSIVAARIFQGMAE
ALIMVTSHVMVFSYFPPNKKGLAMGIFALGVSFAPALGPTIGGYLTEYYNWRMVFFINVP
IGILLTIAGILYLPKEKFFEKLRFNLVSFIFLAIATVALLVMLSRGQQLGWFSSLQIGIL
FFIAILGYLMYVLSELYSKYTLIDFSLFRKSDFTNGILIYFFILGFSMYQYFYLLPIYYE
HIKGLPTLDAGIAVFAFALFIGIFSPVAGTLSDRIGAKKTVAIAAIIYLVTALFLLPHLN
YYTPLSQAILITIPFGIGMGMFFAPVTVLLLQSAPANKSELAIVLMDYFRFVGGSFGTAL
ATNNMEFFKNFHFDRMSEIQNREFLSIMLHRFQELLGVSFDQIKAIFRNYELFMSYNYGF
YNTFMHAGYWALLGSVFVLLLFIAPKNLQRKSV
>fig|387093.4.peg.273 Daunorubicin resistance ATP-binding protein
MADLEVRNVEVSYKKQVGIKEASLQANAGEIIGFIGADGAGKSSLMHAVAGVLRFEGEIS
YFEQVYHSPKEAEKIKPYTGLMPQGIGLVLYETLTVGEHLSFFANIRNLRQDASFKTYRQ
KLLHMAGLSDFTNRQAGKLSGGMMQKLSLICTLLHRPKLLILDEPTTGVDPLSRLELWEI
LDNIRKEEGTIVLVSTAYMQEAAKMDRVLLFDEGEIIARGTVPELIDSVREYTFEGGACP
EKENAESDCFTFDKRSYSLDVLSSSHAEPTLEALFFVNALRKKRTLPKIEIDAREGETKI
PETVMEAKGLTKRFGDFTANDHIDMRLKGGEIVGLLGANGAGKTTFMKMLLGLYPIDEGE
LTLLGRSIQSSDDRQALKAKIGYVSQHFALYKDMTVRENLIYFANMHRIPVATAIKRINR
YARELGFDAYMEHLPGELPLGINQRFSVAAALLHEPVILFLDEPTSGVDTIARAQFWEML
HRLKTSWGISILITTHYMSEAEYCDRVVLMRQGRKIADDTVKALYAKHPEARNFEDIFLS
YYRSES
>fig|387093.4.peg.463 Acriflavin resistance protein
MFEKLLRFFVENSRLNYFLFILIFLTGAVLYTKTPKEIFPSFELDMVSVNGHYAGASIDM
LNKMAVKEIEQELKNIDGIDKMATIISAGKFNIILELEKRVDKYNTAEKVKNAIALTKQY
LPSDMDEPVVNVLEVKRDLMRVAISSQKAPHSALIEAADRLKDKVSALKNISEVKIFGDS
DKYYDIHLDTQKIRAYGLDESTVVAALTGLSYIFPVGMIEESDAKHFYLSTYNGPKDAQK
MLQSQLDIGGKTLYLKDIATVSKRYEDAATIYSIDGKNAVDVSIKQSSEGNALKLAEQIR
EIVARMNQNSKGIYFTIHNDRSEKIKDRLNIVISNILLGLILISLLVGILINWRMSLVIT
LGIPTSFVMGVIYLYLAGYTINMISLVGVLIALGIIVDDAIVVSENIQQHIEEGLEPKEA
AIQGAKEMFKPVTIASLTTLFAFIPALMMSGNMGEVIKLIPIAVSVLVLASLIESFLFLP
IHAAHLLNKNEKTTSWERANRIYSKLIHKLMYYRKTFLTLFLILVPLLIVIGVKSSKFQM
FPKFDASTIRITLKANVNTSTEETMRALKAIEKDLYAHKDEFYIEHIGSVAGWRRDSAGN
SESYPYVGNIDIELQKLKAQNLVDRFITPTLSFYYDSEGRTRKEKSAVISEKLRAFLKQQ
HYKKRFGLSDLAIVERKVGPIKSDLKIGLVSDDSQKIMKYAKKIEEKLSSLKGIVSVNDA
MHYGVDEIKLKVNSYGESLGLNEKKLGALLSNFYLEKRIGFAFDSSDLLELKVRSSQKDS
LEALKQFQIRLDNGSSVSLEDVADFHIIRSFEKVIKDNGLTNFYIYANVNSKVLTATEAI
DAIKPILEKAKKEGIKIIFKGEEEKKKELKHDMMLASAMAMLLIMLSLLYLFNSFRETFM
IMTVIPFAFLGVLIGHFVMGLNLSMPSIIGMLGLSGVVINDGIIMLMNLKRAKDLEGIYY
YASKRFRPIILTSVTTLIGLASLVFFPTGQAAIFQPMAISLAFGLAWGTVLNLLYLPALY
TILNQKKLGM
>fig|387093.4.peg.888 Antibiotic resistance protein
MNPHFEIKNKEVIYDVLDQAAYGTLALSVDDVPYAVPVNFVRIEDDIYFHGALKNKKMKM
LSKNPKVSFSVVENYALIDSDFSTTEGLACPATQFFKSVSMDGVVTVVISREEKANVFTS
LMKKLQPKGGYKPFSDSEYDAAIKATAVMKIEVTHIRCKFKFGQHLSEERFEMIVSHLQK
RGTQIDKKTIEVMKAQRGEKSGI
>fig|387093.4.peg.1918 Multidrug resistance efflux pump
METLMVLTYATFCWIVFKVFKIPVNKWSLTTAVLGGVIMLAVILMGMAFYHPGSKSARNY
FVTTPIVSNVRGMVTELDAKPNEPVHKGDILLKIDDTPYKAVLKDLEAQLEFAKKRLADY
IELRKVAGGSKFDIHEYEMQVDSLKAKVEKAKFDLDSCVIKAPNNGYVTQIRVRPGQMAV
PFPAFPLFTFVNTDSIAFIAAFAQEPLTNIKKGNLAEVIFPSIPGRSFQAHVEQVLPTMA
EGEISPDRAMFSFNRQLPPGYIPVVIKIDDNLSAYNMPLGVDAVVATYDMSSPFWSHVAI
IRKILLRMQSWQYFLRFH
>fig|387093.4.peg.1919 Outer membrane component of tripartite multidrug resistance system
MRRCMMTIHKRTLLSSSLLLLLTGCAQNIPGYDKAVADIKTGKDTLKTPGKYSQSINSAK
VNDGWIRTFKDKKLDRLVDEAQRNNPSLKIAASRVERAEALTQLTESNLMPTVNMRGYYR
DNNAEGAQEIAFGGFGVSWEPDVWGRVGNLVAADRELTAAQLADYDFARQSLAANTARAW
FLYNTNSRIYSFTKKIISLQEKTLKILEAREKIGQGNKRDVHLARALVASAKDSASAALS
AKERSQRALEVLVGRYPSGKLSSGKLDTVLPRIPNGLPAQLLERRPDLIAAEQRVAAAFH
QKASADLLHMPNIRLNLGLGPNSLNDAITSLAGGILAPVYTGGAIEAQVAVANAEQKEAI
AQYAKTTLRAFQEVENALAGEKHLATRYKATQEMVKEYKAAYTMTVEKYRIGQSTVLDIL
IIQGKWISAEIQKLQVTKKRLINRVNLYLALGGSFDTKRMHYTAPKKAK
>fig|387344.13.peg.265 Permease of the drug/metabolite transporter (DMT) superfamily
MVSMTRQHHLRGVLLASIACMLWGISGVAASTLFTLNHHVTALWLTQIRMISAGAILLIW
GQLIHAQPFQIWRQRATGLRVISYGLLGLVPVQLCYFEAVKFGNAPIATIIQFLGPFIIS
IYYFLFKHMTPTRPEGIGMVMAFVGTLLIVTHGHLTSLAISPVVLIWGGLSAIGVATNTL
IPRPLLPKFGAMAVTGWGLFVAGICLNVFGPLWRVHVTLTAAEWGLVLLIIIFGTVIPFL
MFAHALGYILPTTASLLDAFEPLSATVFSVIFLNVQLTTFDLVGGALIILAVMVLSLNGR
KMMNFFRRRRAET
>fig|387344.13.peg.549 Permease of the drug/metabolite transporter (DMT) superfamily
MSFKEERVLVLRKTLLYIAFSTLMFSSMEIALKSAGGAFNPIQLNLIRFFIGGVVLLPIA
LRALHKQHHRLTKSDWGLFFLTGFVCVIISMTLYQLAISVDEASTVAVLFSCNPVFALIF
SYLILHERLGRANLIAVIVSIVGLVVIVNPAHLTNPVGLILAIGSALTFGLYSIVSRWGS
VRHQFNGIIMTCFTFFAGTLELLVVMLVTHIPVVAGGMRQVGWLHQFAALPILQNVSLQY
FWILFFIGVCVTGGGFAFYFLAMERSDVSTASLVFFIKPGLAPILAAVLIHEKILTNTIV
GIVIILIGSVITFMGNRVKARESALAEEDAREFQEADDEVPAKLAAHSESPID
>fig|387344.13.peg.564 Tetracycline resistance protein
MRIPAGELLRDIERAQNEVKQTAREFADRGLVRKSPWNDQQLYKLEKLRDQMMARPPKKK
KD
>fig|387344.13.peg.1846 Permease of the drug/metabolite transporter (DMT) superfamily
MRIMMHTAVVWERKDYQGLENSKATTENVMKGIFWATMASAMWGISGTVLQFISQSQDIP
ASWFLSTRTMGTGIVLLVVSLVMYGKKTFAVFRSGREIMWLLTYAIFGLGANLLTFYIAV
QTGNAAAATILQYLSPLFIVVGSLVFKHDRPLRSDLIAFVVAMVGVFLAITRGHISQLAI
PLNSLLWGIGSGITAACYVVLPRPLVKDEGHAPIVVLGWGMFLSGIVFNLYHPFFLNTPP
ITGGLVASMSTVILVGTILPFSLVLYSTHFAPSDVISIVDATQPVMTFILSIIFLSLKIT
VAEVIGSVLVVVAIYLLQRGRRKIETPFDEVS
>fig|387344.13.peg.2042 Quinolone resistance protein
MNDPRILPATLTAQSFLAITADEDRQLQMAHVQQQTIADQSLEHPLIDQCLFEGTTFIND
NFYRAELTDVIFKNCTLVNCQLEAASLYRVQLQNCKLVGTTFDHAVFRDVVITDCDLSLA
NLNEVKFTSVKIIASRLVEVNCLDSVMIKTQLTRCDLNQADFSGTGLKALDLSTCDFDEL
RLTANDLRGCHLNTEQAAYFAQQLLGVQLA
>fig|387344.13.peg.2112 Permease of the drug/metabolite transporter (DMT) superfamily
MKKIAPLFVGLGAISFGIPASLFKIARHEGVVNGPLLFWSFLSAVIILGIIHVARHHWLR
DQQTSWRQIVLVMAAGTASGFTNTFYIQSLKLIPVAAAAVMLMQAVWLSVLLGAVIHRRL
PSRLQVVSIILVLVGTVLAAGLFPITQVLSPLGLFFSFLAACAYACTMQFTASLGNNLDA
LSKTWLLCIGAFLLISIVWGPQIMTAPVTGATIKWGVLIALFSMVFPLVAYSIFMPYLEL
GIGPILSSLELPSSIVVAFILLGETVSWAQIVGVAVIIFAVILPNVWGVWHQRQLE
>fig|387344.13.peg.2190 Drug resistance transporter, Bcr/CflA family
MSSKFASKHHCRLQIHLNPAIMEEYVYARPSFRCVKWRSNGILAIIILSILKGLTALNPV
LTRRRRIWLTLLLGTVSATGPLAIDLYLPALPQMKAQFATTASLMQLSITACLIGLALGQ
LIAGPLSDQYGRRKPLIIGFVIFGLVSLAMAFIHSVTLLIALRFIQGLAGATGQVLARAV
ARDLFSGKKLTRFYALLNTVNGVFPIIAPIIGGFMIQYVDWEAIFILLALIGLLIALAVT
FGLHESLPPEKRQTGGFHTSLLAMGKLVVQPSFWPLILATGLVYGGLFSYISASTFVFQT
GFGMAPQTFSLLYAFNGLGIVVGSNLPGRLASRFSNRQQVTSMLAIAAGVSALLIISLLF
PANVWVVSGLILLLVILIGALLTLTVTIIMDQATSNAGGASAVIGLSQNACGGLASPLVG
LSGKSYAAMAIMLFVCNVGAYGLVKAQGQKAQ
>fig|388399.4.peg.720 Membrane fusion component of tripartite multidrug resistance system
MKHLKLIILAVAVVAAGGGLWLWWQHETIHPSTDDAYLKANVLTIAPQVGGAVETVAVTE
NQHVKAGDLLFQIDTNDLAAQVAAAQASYDAAVQQTKASITDLSSVSAQVDSARAALTDA
QDSYDRTASLFKKGDVAKAALDQATTTRDQANAALDSAQSALASARERAGQAGDDNPAVR
AAKAQLTLAQINLARAKVTAPVPGWVSNLDLRPGALVSPGMAVFSLVEDGDWWIDANFKE
TDLARLRPGQPVTVDIDMYPGLSLDGTVKSLGAGSGSVFSLLPPQNASGNWVKVTQRFPV
RIALDTRPDDPAMQLRVGASTSVTVDTSGLDNAK
>fig|388413.5.peg.188 Permease of the drug/metabolite transporter (DMT) superfamily
MLLAGVFFALMNVSVKYIPHIPAIEIILFRSFFSLIFSFMLLRRQRVNIFGNNRKLLVLR
GVVGSVGLISFFFTLQNIPLASAVTLQYLSPILTTLLGIFIVKEKVKPIQFVFFTISFLG
VMMVQGFDTRVNLLYAGIGFISALFSGLAYNVIRKLKNTEHPLVIIFYFPLVTLPIAGVI
SFFTWVQPVGWDWLILLWIGLCTQTAQYFMTVAYQNANVSKISSLSYLGVFYALIFGFFF
FGETYSLMAYIGMGMLLLGVILNYRVKNAA
>fig|388413.5.peg.948 Glyoxalase/bleomycin resistance protein/dioxygen ase superfamily protein
MENQDNFSHAATIFPVEDLQTSIDFYTQKLEFKLTFSWGEPTNYAVIKKGGVSIHLVKKS
DDRIPSKKHCALYIFVYDIAKIYKRCVSEKVSIINTPETRDYNMKDFDIKDPDGYIITFG
NGG
>fig|388413.5.peg.1620 Glyoxalase/bleomycin resistance protein/dioxygenase
MKMDSLKSIGRLLIPILIMAVFFSCQKVDFQKEAGAFESFAEMVHAGVKPIALSEPMEPA
ELDLFMPLAEKLSEKYDISVYRESDLIGTSLFDSSVVQDKEVLILYTGNHLEAYQMLKTK
ASELVNSNEYSGKKKEEVSRSFGRLLGYPESTINDLLSQNSTFKDLEDFGIQGQELIWFY
KDLPAAKTFYRETLGLKLLEEGEGAVTFQIAGDSRLVLKSLTGTEYSGGEPKSVALALLT
DHLEIWYDHLQASGVKIKYTLKVNPEGAHDGFVAVDPEGYLLEFEMFRMHPENEKFIPEL
KSMQPMVTTLGQGFDFYASITWLYYQDMLPMENFMNQNLGLEMSADQGWAKIYRLTGNSY
IGLVDEKRGMNSFSEEKLVEVKINLSDPDSWEEYLKNQDAGMERDAGTFEDPGRYLFRF
>fig|388413.5.peg.1682 Permease of the drug/metabolite transporter (DMT) superfamily
MLILLALVWGSSFILIKRGLEVFTPGEVGAYRIVAAASFLLPLSLPRFKNLNKHQLFYLV
IVGLVGSFIPAFLFAKAQTQLSSSLTGVLNALTPLAVVVIGALFFGSKITKRNGLGLAIA
FIGVFILVIVKEGAGLTSFAGINTYALFVILACICYGFNLNIIKFKFELLKPIEITAISL
LLVLPVALFYLILGTDFSYKVANVPGAWKALGYVTLLGVLGTALALILFNMMVKRVTPVF
ASSVTYLIPIVAIIWGVLDGEVLLFGHYIGIAAVILGVWYGNRK
>fig|388413.5.peg.2190 Bleomycin resistance protein
MKTEFLSTVPVLPSNDIERDLIWYEEKLGFKKIFGDSMYVGIHYKTVWLHLQWHADTEDD
PLLGGSVVRIFVKNIDKYFNKLVAKGVVPKDKLRKNTPWGTHEFGLYDLNNNAIFFVEDL
>fig|388413.5.peg.3635 Glyoxalase/bleomycin resistance protein/dioxygenase
MFTHTKAFGGFSVDDLQEAREFYDQVLGVEVKKLPMGLLSLKFQEDNQVLVYSKGNHEPA
NFTILNFCVEDIEEAVQSLSEKGVVFEAYDGNIQTDANGICRKDEHLIAWFKDPAGNILS
LVQEDKS
>fig|388413.5.peg.4024 Glyoxalase/bleomycin resistance protein/dioxygenase
MRHLFTFLILAFATISCTPGVSPPITSEISTSDYTPGRVVWHDLASPDPEVSSQFYKAVF
DWDAVPYGEGSKKVWIFKKGNTPVGLMAYYDSKNSTGEWIGAISVPDVEAATNTAKSQGA
TIMKSAMNVENRGMISFIQDPQGAHISLIKLSNGDPEKKPAEVGTFLGQELWSNDPSNSA
GFYSSTIGYSTSESEMGDGEYTVFQFNGENCAGMLQNPAPTLRSHWVPYIRVSDVNETVA
KAKSAGARVLIEPAPEIRNGSVALLLDPTGAPLAVQVYNP
>fig|388413.5.peg.4111 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTIKEHFKITFTLAFPVMMSQLGQVSVGVADSMMVGRLGAVPLAAASLGNSIFFVILMFG
MGVSMGITPLISVAEGKGKNKRISNLFGHGLWINVFTSLILTFIVIGLSQGLHFLDQPEE
VVNLTIPYLLVITASLFPFMIFQNFKQFAEGMSQTKQAMYITIFCNVVNVFLNYLLIFGK
FGAPEMGLMGAGWATLISRIFMPIMMGWYVLRSKRYQIYSLSLRLRKWSFPMFSRILNVG
IPTGFQYIFEVSAFSSAAIMMGWLGVNALAAHQIAINLASVSYMMVAGLSTAGMIRVSNQ
IGRGNLKAMKEAGLVVYAMAMVFMFATALIFVVFRDFLPTLYIDDPEVITLSASLLIIAG
LFQLSDGAQVIGLGVLRGMEDVKVPTMVTLIAYWVIGLPLGYVLAFEMGLEEKGIWYGLF
IGLSLTAVMLYMRFQKLSAQRMKMSKPIAPLV
>fig|388919.8.peg.349 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MNKIFHYLDKKTKFYTIIGALANGGLALAQPLVVSQALSLNQGELTYSKIIQFAVFGFTV
YFVLYSLMLFCNHTHNVFRREIQMNMRADLFGKLMTNKDFSEDEKITMLTQDMEYLGDNY
LEKYVNIICWSFVALLTAIYIISQNLLLGSIFVFFTILRPIPQFLMNKRLKHTGDDMAQG
RVDVHNQVSDSIRGAHTLLMNQAISENQNRFWKINLNYQRAIQKFCFTHNIIFFCNGFMV
FLSQVLPLVLGFYFAMAGQKVSVASLVAMYIAAGQLVSPIQTIMYDAVDIQGAKTTADKI
FGILEIGDVKQIDKKDAQELHALHIKNLSKSYGDRQLFTHLNLDVQAGQKVLIKGPSGCG
KSTLFRLITGEEIADEGEIIGVTTVNECTSSFVSSIGIINQHPFLFNDTVRYNLTLGQEF
SEEELLAVLKQVKLDFELTGGLDFIIKNNGENISGGQRVRIELARFLLRRKNLLLADEVT
ATLDKENALMVRELLFSLPVMMLEIAHHIDDESRYQQVVDLGKY
>fig|388919.8.peg.1468 Nisin-resistance protein
MENVSLFCYNQIRNPNKKGCVIMKKVLLGCLGTVLVLLALLIGFLAYFGPDYGIFLFPPS
PQDYARSVVKKLDFGLYTDKDWENEKKKALEKLESAKTYQDTYPVLEELTKEAGGKHSYF
LSPQDNPENSPESKNQPEVQNREGILYLKVPAFTGDAQAAKTYANKLSAALKKDDYQAVL
VDLRDNTGGNMYPMIAGLSSLLPDEDLFQFVEKNGSKSAVSRSDVLKQLGLEQTDEKAKK
VQIAVLINGKTGSSGEMTVLAFKGLENVKIFGQPTASYTTGNNYYQLYDGAVLLLTTSSI
LDRTGKLYENEAIQPDIQTDQPLEEAESWLKEQLGE
>fig|390236.5.peg.976 Tetracycline resistance protein tetA(P), putative
MLIYLISSLITIFFIPNDKNTDHKHNKEDLTLYLIKFFKKIIILLKSKELLAVFILNSSI
QFFYQPFYLYWQAIFIDKNISISIFGIIYVLFRVSDIIGAWIFRKIKHSKYDIYVILAII
FLLSVLIKIVLHIYIFITIIIFLVILISVYSNNLEYFLKKNVDSKVLGTLTSINSTLSRI
FSFLALGICSILTNFISAIYTFVLLILIFCTLSIIVTYKFKNNKKS
>fig|390333.6.peg.28 Multidrug resistance ABC transporter ATP-binding and permease protein
MKLLKITPRLLWGILLSMIASLLNLYLPLLVRHFINLKQFAWSGLSKKVLLLGGLILIGN
LLVSSLSDYLISSEGDRQVRQLRLRLQKQVLRLPQKYFDQQISGNLTSRIINDVNVLRSF
LTETIPAVVTGCLTILGTMLITFSLDWKLTLLMLLVFPIDGLVTVPLGKISEVIADQTQS
SLAALTGVTSESIKQIKTVKLNKTEEDVFAKNAREINKLYRLSLKGDRIAAMIGPLQSML
SFCLIMAVVLYGTLRVKSGSLSTGTLGAFMMYFFQIIGPINNVALFYSDRKQMLGATRKI
SEIINETAEETAGKEQLAVAPGSSLLRLDQVSFAYQDLPVLEKVYLEARSGEKIALVGAT
GAGKTTLANVITRLYPVAAGRISLNGQASTDFSLEQWRGFFSVVLQENTIISGSIRDNLT
LGLNRKVTDQELWDALALVRLEEYAKKLPKGLDSLLGESGKQLSGGQRQRMQIARACLRD
FKFLLLDEATSNLDADTEKIIMTALDRLKRTKNCGQITIAHRLATIANSDRIYFIKNKTV
VASGSHEELLEKVPDYRRYVHEQQLKEKR
>fig|390333.6.peg.929 Permease of the drug/metabolite transporter (DMT) superfamily
MKSNSKWAGLAAAACILWGISGLFAKGLFNLDPRITPIWVTQMRQVCSGLILLTVAQLTG
KHPWQVWKDKKSAVQLLAYAVIGVLPFQYCFFLVVAQANAAIATVIQFIGPFFVLAYLTL
TKQEALRLIDVAASLLAFGGVFLLSTHGNIHDLRIAPLTLLFGIMSAVGAAANSLLPQAL
VTRQSTISVTGWGLLISGLILTAIHPVWPSLPSSPTVYLNLSVVIVMGTIIPTLWQNHAL
GHISGMTVAFMDAFEPLASMIGSIIVFHFQPQMMDYAASVMIIFAVLVLNWTPRSKIKSR
VEK
>fig|390333.6.peg.1686 Glycopeptide antibiotics resistance protein
MYHELALQIRFVVIAVCVLAGYWAIRTGNSFLRLVVTVIYGCALIYYVFASRMLTVAVYY
WQHPAQMAAGSEVLKDPAFWKWGLKKVFASSNYGGRYGFLMNVLLFVPLGYIIPSWSKWL
HSIMITTFMVFCLSWFIEHFQRMTGLGTYDVNDMIANTMGAFLGAVAIMPTLWMRDIQAR
KLRKAREHAEAKAKGEAEAARLDRVSRQLANPTEKVPKVKMSRKDYRQRHGDQAD
>fig|390333.6.peg.1857 Permease of the drug/metabolite transporter (DMT) superfamily
MKDKHLGILLAITGAALWGTSGTAAEMLYQSPNINTFWLVDVRSWLAGASLLLISLVHKG
KGTFAIFKNHRDLLYAALFSMLGITGAQFTYFYTVAASNAPTATVLVFLAPVLIICFMAA
KTRQMPRRIDLIAVLLAVVGTVVLVTNGNFSHLAVTPKTLVWGFFSALTQALAIAMPAKL
FKKYGTITILAWGMLLGGIILSPALAVMPATGVTVKEWSLVIYIVIAGTVFAYSLYLSSV
MYISAGLVSMLEAFEPLVATILSVTLLGSDFGIMKMAGGVLIILATCLQVVPSPRRGKLQ
RKL
>fig|391008.3.peg.76 Methicillin resistance protein
MRGKTIGDQELALLQYIDEHAPASVGEVASGYGEARGLARSTVLTMMERLRAKGYLRRQQ
QDGVYRYQATRGPESVLQGAVAQFVDNTLQGSVSPFVAYLSQRQQVSDNELAELEALVAE
LQSRRQEG
>fig|391008.3.peg.1249 Glyoxalase/bleomycin resistance protein/dioxygenase
MGENGQPSNGSTIIPCLRYRDAQAAIEWLQRAFGFHVQAVYADGDTVFHAQLTYGNGMIM
LGSSSSSGEWSKLAVMPDEVGGRQTQSACVIVTDADAHYARAKAAGARIVIDIADQDYGG
RGYACADPEGYMWWFGSYDPWRADHGQ
>fig|391008.3.peg.2041 Acriflavin resistance protein
MARPRLTLLAIVAIVLTGLILALDFPSTEEPPITIRTATVLSFMPGAGVDRVEQLVARPI
EESIRGMPEVKRIRTTVRPGFAFTYVDLYPTVESEKIPIVWQRLRSRMGDIQSQLPEGTI
GPVVDDEFGRVAVMTMGLTGDGYNAGELRAAARRLRDELFRLPGVERVSLHGVRDEQVQI
ILDVPSLAARGLNPNVIADAVSRRNVIAPAGYVEIGGSEIALNVSGDADNPSQLKSTPIP
LPRGGSVPLGALARVERVTQDPPMTGAFVNGTPAVVIAVSMAPGLNVVSFADLLRGDVER
LSETLPAGMQLVQITDQAEVVSTQLLRVAKVFLETLAIVMAVVVLFLGMRTGLIVSAIVP
TTVLGTMAIMKILNIDLHMISVGAIIIALGLFVDNAIVVAEDMERRLSLGETPDQAAAHA
GSTMFVPLLVSSLAIILAFMPLAISSTETGEYLRSLGIVMAIALLLSLVIGVTLIPLLCK
HFAHHHAELSRTARAVERLTGWYRGKVRWILGHKAIYIGVMVALLATSGWLFTTVPNELM
PPSERHQLQMAIELSPDSSPANTMAVAQQISKVLADEKLVPEISSHALYMGDGGPRFILA
LNPPTPAGHRAYAVLSLAKGVKHEAAIERLRSVMATHFPDVRVEPKRFSMGSSDAGVATF
RISSSDGAHRIAAEKLLRTLQDTPGMVDVSSDAERQVVQLDVDVDQPKAQAAGISSADIA
KSMDMLLTGATISRYREGDTVLPVILRGEAALRTDIVQLEALPIQKADGSGSVPLGQVAK
LRLAPQLSSIQRVNQARAVSVLAKSSELTAQGIADKVEPLLSEFRKQGVRVELGGEIEES
KSANEGIEKLLPLCLAAMFLLFVWQFESIRKSLIVLASIPFVVIGATLALKLSGTSLTFI
GTLGLLALAGIIVNNAILLIDAIDEGQRDGLPPLQAIEEAAAKRLRPIVMTKMVCILGLV
PLLLFGGSMWTSMSIVMIGGLALGTLITLGLIPALYAALYRIHPTEEA
>fig|391008.3.peg.2096 Glyoxalase/bleomycin resistance protein/dioxygenase
MNTVGLYVRDQDEALAFYVDTLGFEVHTDVRNGSYRWLTVRSPGQDGFQLGLFVPGPPTH
DAATALALQQLVAKGAMPPLVLAVENCRARHVEWQAKGVEFTQEPIERYGAVDAGFRDPS
GNGWKMIEARSEARRQQ
>fig|391008.3.peg.2270 Fusaric acid resistance protein conserved region
MLFSLKCLLAASLGLYVSLRIGLNRPFWVIGTVYLVSQPLSGATLSRGLFRLLGTVGGAI
ATVALVPRFANAPLVLSAALATWMALCLYLAMLDRTPRAYAFLLAGYTTSLIGFPAVMVP
GDVFTIAITRVQEISIGILAATLVHALVLPRRVSMRVHARVAAVLDDAERWTRDMRAGAS
DTVLASDRSKVAADLLELHVLSIHLPFDSAHGVAQVQILRALHDRMLDVLMLSSAVEDSL
ARLRSPQASAMDATGWRDLLQAGLAAQQAELDLAHADCRVLQAQLHTARPDWHRHVPARL
ARHAQGAVLHRDHRLALRSALGAFVGILLSCVLWIITGWSEGATAVSIIGTACVLFGTLE
APAPHVMRYLLGSLIGVAVGLLYGLLIFPALSDFVGLIAALAPALLLCGSFLARPSFIMA
ALGVVLTFPLIAGLGATNTVNIVGALNNSVALFVGTAMALCSMQLFQTADAGRNRARLER
SIRRDIARHAAGQGDMTRAWLSRMLDRIGLLAPRLQGRSNAAHDLRALFADVRAARASSQ
FRTLNKCLDDPHVRALHAALIERVTAHFRIRAHSPRSVDAHLLELVDRVREAAAASAEAD
QGYLLHLLCGLRRDLLVPPLAHRH
>fig|391008.3.peg.2700 Multidrug resistance protein D
MSRRLLLLAIALLMFPQLAQTLYSPALADLAIRFALPPSAASQAMSLYLFGFAAGVLLWG
RLADRIGRRPALLCGLCVFAVAALGGLMAGSFGQVLLAQALAAVGAAAASVVTQTVLRDH
LQGPALAQAFSWIGMALALSPAIGLALGTLLVAANGYVGVQSGLLLIAALLAVACLAGLR
ESRPVQIPHTPMLPLLRELLRDRWIWSHALLVMAFNVAMYSWYVLGPFVFARLHWPATWF
GASGAVLALGSALGAWGNGRLLRAGVATTTRIRIAAGLVLTGGLLAALLHDHPALVAAMV
PVVTGFGLAIPNVLGQALRGYPHCLGSAGALFGLLYYLLIGAAMALAGAVQLLAPTLIVC
GLLALWLQRDRAVDGGRPGCGSQR
>fig|391008.3.peg.3526 Glyoxalase/bleomycin resistance protein/dioxygenase
MELHRGRLIDHIQLVVRDLAASRRFYQAVFDTIGIPIAGEGDDYFWADELFISSASSEAA
AGQLTGRHHLAFQARDSATVDAFHTAAIAAGGKDNGAPGERPYHPGYYGAFVLDPDGNNI
EVVYHGPANYSADSVKVTF
>fig|391008.3.peg.3629 Probable multidrug resistance protein norM
MSTATSTPRFSKEVGATGLLALPLVLGHVSTGLISFVDNVIAGHHATATLAAVTIGTALL
WLPMLIPIGTLISLTASVSQLHGAGREREIGPLFRQALWLALGLGLIMFTFLTVVPPLLP
AFGIAPDIVPGATAFLHAVRWGGPALTLYFCMRYLSEGMHWTLPTMLIGFGGLLVLAPMG
YVLANGKLGFPEMGAEGLGIASAVMMWLQAIAFATYLWFTKRFAHLQLFSHFEGPRWPAI
WDLLRTGLPIGITVLMEGGLFIVTALLIGRLGANEAAAHQIAINVAQLCFMIPMGVAEAT
TVRVGHAVGRGDGFGVRRAAWAGYAIIMGTQTLSAAVLLFGHDAIVGVYTNDLAVAGLAS
TLLLYAATFQFPDGIQVLSAGALRGLKDTRVPMFIAMFAYWGLGMPLGAGLGLGLGMGPQ
GMWIGLIVGLTAAAILMGWRLRRSSLRIGQSSLS
>fig|391008.3.peg.4059 Fusaric acid resistance protein conserved region
MNALTDRQAWLFSIKTYLAAVAALYIAMAGNLSRPYWAMGTVYIVSQPLLGPTRAKGVYR
IVGTLVAGLATLLVLPALVETPLVLSAAMSIWLAGCLFMALLNRGPRGYAFLLAGYTTAF
IGFPAVTSPETIFDTVVARSEEIILGTVVAVLFASLLFPASVRPMLRARIGNWMEDAAQW
CRQILERGRAHAPRNRLAADLVQFEALIEFLRRDDPRHAGSAVSMERLRERMLLLLPVLS
SIADRLSALRSDGQALPEGLPALVDDIHNWLDGPTNASEYARLRARISALKPQVDRDLQH
LQLASLLLRLEELVDLWQDCRTLQHAIDHGTAPLDRAHYRIRTERVAADKHVDYGMALFS
ALSAGVALMSYCVLWIALGWEGGGNGAMMAAVTAAFFAAQDDPAPSMVSFLVWAMVASVV
AGVYLFGVFPAVHDFGLLALVLAVAFLPLGLMLHHPKSALFALPLTVNLAALLSLQNTYS
ANIQTFLNSSIAMFIGIGFAVVMTRLFRSVGAEWTARRLVRQGWTTLAEAAEGRGQQDRQ
RFAARMLDLLGLLAPRLAATPEGSDIASVDMLNEARIGLNILQLRRARLELPERSREAVE
HILEEIAVHYRRQIAARKPIVAAEALRERLDTSLGRVGSVAACKARDEALMGLIGLRFAL
FPEAKALAPGLADAGAPSM
>fig|391009.4.peg.98 Tetracycline resistance protein tetA(P), putative
MIKKDKQFRKFQMYGFLKNLRFFEPFLILGFLSSGLDYLQIGILYSIKSIATNILEIPTG
VFADLYGRKKSMIFSMISYIISFSIFYFCNSFYLFMLAMIFFSFGEAFRTGTHKAMIFQY
LKLNNMESLKVQYYGATRSASQLGSALNSLLSALIVFFSGNYKLIFLMAIIPYVLNLINL
STYPDELDGNIKKTKKDTLKDFLGAISNWKTFKLLLNATSYSSVFKSIKDYLQPIIESFA
LAIPVFLGLNSKKRTAILVGIIYFVLYLLTSIASRNSWKFKKKLNLTLFFGAIVIMLIGI
TYYFNFYYISIILFVFVYLIENIRRPIVVSYISEKSEALASVLSVESQITTLLTAFFSFL
MGLVSKKYGIGMGIFVIGLILFVFSQIFWLKEKDLLIKEKVSILKK
>fig|391009.4.peg.207 Quinolone resistance protein NorA
MKFHRYHFVSMIYSVLFYLIVSYVNSMGSRLGLLYSQIGFINFLGALSYVIASISIGHIG
DKVGYKNVLIIESVLYFVFLLISLNFSGVFYLVFLAVISNLFFGSFYPQIEGLIAKSESI
ANYPHSKTIMRFNISWSFGNILGMALGPFMTVRYPKTIFVFGLFLSLAIGLFIWFDYKKI
GKLIKLSKVPFKRENLVENINKFRWVYRATLFFSGLLYTAILALFPKLINSYGIDLSLTG
FLIAFANVSVFLTFLFMGKFSFWVGKPRVSFLFLIVLPITSILLFLKPSPILFLIVSFLG
GMCYAVPYTFAIYYGLHSNEDDQGKQGGFHEATIGLLFGFGPLIGGVFLDAFSGIVGLAI
FGILLTSITLIIQMIFLLKK
>fig|391009.4.peg.604 Permeases of the drug/metabolite transporter (DMT) superfamily
MEWITFRIVLLGFERIFGKIITRKTSPILSAWGFFSFSTLTLLPFLGKVNFNIIKVSVFS
GTIYALSFFLYMYALKYEDVSVVAPLYNVNAIFLIFTTSIFLEEKITIQKILGSLFMIYG
VSYLKKDVNLKLSYKNLLKSKGAISMIISSFLMAIGRTIDGFLTKSFDKLGYSLGVYLVI
SVYFFLISFFKNRNLRIYVQIVKSKIIALVFGGVCNAYAYFALLMAFKKIDVSIAEPISM
LSSLVSILVARFIFKENIKLRFFGATILISGAFIIYI
>fig|391009.4.peg.1077 Fosmidomycin resistance protein
MKRNKGGVAMEFIAAIFHFFADFFNAFVKPLAPYFIDNLGIDNKTFASFMALLGGVTSLF
QVFFGAYFDNKKRDGLYITIIVLLEIFFVTFLGIVKSVLLFFMLVVIIRMLNSIFHPIGA
SFAGKREEGKHVAIFSVAGTLGAGIAPLFITSFQDLFGIEKLYILTVTMSVVLLILSRKI
IGYEKKTVKKTLSFKGDILKLWPIFLVVASRSFSMDIFHTYIPIYVNEIGKSLIVGGSIL
TFGMMLGVFTNFFGTIVLEKTNDKITNAIGFFGMGIFGLLFVLVSDIYFKVFSFIIFDGF
SFFTMSSNIVSAQKLLPNNKALASSISMGFSWAVGILLSSGYAAVFGNNTMFMFLSASIM
PIVTVIVYLISLRRE
>fig|391009.4.peg.1159 Permease of the drug/metabolite transporter (DMT) superfamily
MIYAILSAVLMGSTAIFNKLALKEFNPMFATIINALVASIFSLFFVKKFRKLRMNFYVVF
VGLFNAAGLLFMFIGLSKLDPGIAMVLGTSYYIFTSMYSVLLFKEKLSVNVLLQIIINIF
GIILIIMPSYRMEIPNLIGGIFAVSSALFFATSNSIAKLSKIQADFLVFANNVITFLVIG
VLYSTVYGNNSISFSFRGIFFLSIAAFIGSFLGLYFYYKSLSRIDFSIANIVRTLNPITA
LLLSRLFFPNVITTRQWIGIIIVIFSIYRLNVLINNSRIKLNSEN
>fig|391037.3.peg.484 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTQQTWDVPGANGASVRRAIVRLAVPMALAEVAGLVVLVGVMALMGRMGEETLYVRALYL
PIGHLFIAVYVAFGFSNQVAAAISRGRGRPEDVAPMAMSFVRMWAVASVVLVAATLLAAP
LLAAAFDVPDASRSEFMAFLRWMAAAELLQVVAILCASGLRGYGHAGAGAAVVVVSAAVQ
FAGVALLGLAAGMGAMSVPLSIAVGSVVGALLGVWLMRRHGLIRFGAELTRWHPESARHI
RSVGLPVATTQLILFGANFGLLWVLGDFGPRVIAGFSSAVTLQFLVLMPAIVLGSATAIV
LNQQRGAGRADWLPGTMHNGLAITVGAYLLLSVVMWAGSDLFGRLMTDSPSIADQTALYL
STVGLTYVLMGPVLTSLTVMEQIGSGLLAVVLNLAYFAAIVVIGALVVAAVPEPVALYRT
IAWCNLAGVIVVLAGLHAVRRASRLPAPTGAAPVPVGGGPA
>fig|391037.3.peg.2383 Drug resistance transporter EmrB/QacA subfamily
MELVVFLEVSIVNVALPAMGAALALTESGLTWVVNAYQLTFGGLQLVAGRAADVVGRRRM
FQAGIALFTGASLLAGLAPDASTLLVGRAIQGVGAAIVVPAELALIAAIFTEPAAYRRAF
AVWSAMAAAGAGSGVALGGVLTQTLGWPWIFLINVPIGVVALVLSPRLLPADPPWAGRAS
GARTQLDLIGGLTVTGSVLAMVLLATELPTSGWTPLTYTAAVATLGLGTVFAVNQRRHPA
PILPPQLLRIRQVRAGVAANALVGASHVPAFVLLSLMLQQAMGYSALAAGFAVLPIAAVN
MVTARTALPWAIGRFGSRVVLAAGMFLVALGLAGYAILLHPGAGYLTAVLPASLIFAAGL
PAVFVGSTAPAVRSAPENQQGAASGLVNTAQRLGAALGLTALLMASAAWTDNRGSGDRAT
ALADGLRVGFAGAAAIAVLGIVCALSTGTRVPKKPASGDTPPQEAVAR
>fig|391037.3.peg.3976 Drug:proton antiporter
MRTVLRRPDFRLLFGGLLASMTAESILLLALAVWVKELTGSSGLAGATIFAIIAPMTLAP
LVGWIVDRYPRQPLFVAVNLVTATLLTPLFAVRDRTDLWLVYLVAILYGLSYVTLSAVLS
GLIRSLVPAELLADANGVLQTVRQGLRLIGPLAGAALYSTAGGGLLTGVAVTGFVTAAVL
AGLLRVTEPPWSRPEPRRCVRTRSSPRSAELGAGLRYLADEPALRRALLGYGLGSLVMGF
SESLIFAYVDQGLRRDATFVGVLVTVQGAGGLAGGLVSPGVIRRAGEVGALAVGVALFGV
AALALSYPNLWLGCTAVLLAGASLPLTMVGLHTLIQRRTPPRLIGRAAAGAEAVVSGPRA
VSIGVGALLVGVIDYRLLFVVVSLVTLLAGGYLWGGRRLSRPPQPPPPAGRTQVSQQSWT
GAP
>fig|391165.8.peg.1 Drug resistance translocase
MVRQGRPSQSREQEDISEPGTQGRGWMQARHVHHWRFHHRRAVHKDLMTQPRSSRPVSSR
ILALIVSAALFMELMDGTILATALPQMAQSFDVAPLQMSVALTAYLLSLAVFIPASGWMA
DRFGSRRIFMGAIALFVTGSMVCGMANALPEMVIARLVQGAGGAMMVPVGRLLLLRNVPR
HELVSAIAWMTIPATLGPVLGPPVGGFLTTWLSWRWIFYINLPIGLIGMGLAARFVPNVT
EAELRPLDVKGLLLSGTALASLLWAMETLGRGPSGTDGMALSSAAILTLIGLGSGWLYLR
HSRTIPHPILNPMLMRIRTFRLSVLGGACSRVVAGAMPFLLPMTMQLGMGMSAAESGSLT
FVGAAGSLLIRPWAAGILRRFGFRRVMIWNGALSSTAVLLCATFQPSWPHGWFFLVLAPA
GLFQALQFIAYNTIAYADVPRERMSEATSFYTTFQQMTLSAGICIAGISVSLSMLAGPRT
QPDMTDFATGFVTIATISALAILCASRLNSTDGQDLSRKA
>fig|391165.8.peg.61 Bicyclomycin resistance protein
MPSARLSVPLIILLGLVTSVGPMSTDMYLPAFPQLQADIGGHYQGAAQITLAAWFVGLAI
GHLTNGTLSDRFGRRIPLIAGMLIYTLASTGCALATDLWSFTLFRLIAALGGSAGMVTPR
AIVRDMSDGHEAARLISRLMLIMGVVPLLAPTLGGMMLSVMSWRAIFWLGSLYGAVCVVL
VIMFLPDTLAPEKRLMLSPGSIVIRYGTILRERVFITHAMLSGFCVAALFTYLAGSPAAF
IQYYHISPTVYGMIFGMNAVGYIGCSQLNNLALPRLGMHRVLRIGTTLYLWLVSLLIVNV
YTGLGGLIGMMILLFLAQSIQGFLTPTAAVGALSPHAAHAGSASALMGTLQYVLGALFGT
GVAVLADGTPRPMVVFMMLGGICSLIGDRLRPGSRHGGPRLFRLRWSMPSRH
>fig|391165.8.peg.189 Permease of the drug/metabolite transporter (DMT) superfamily
MTKYTAPSVSPDNALPSAGPPGTVIRGSRTGPLLAVTACVLLWSLIGTVSKLTQAQIDFY
QMMSWSNLLSLLAVLVVHRLSGRAWRNLLPKRADISRVRLLMLPALLGMLDCFFYLAVYY
GYGHANGVAVLVTQSSWPLMIVLLGMAVFSERMSLRRWVGMALGFAALLVTASAAGHAVL
PAGSETDASTAGAGFATLCVVLLGAFSFTLFSVLSRFLRLDAFAGTVWVFLFSLLCSLVP
LLLFSRLTLPPRSAWPALLLNGVLINGVSYILWIYAMSSVHAARLTALAFAAPALSTIWL
VVFLHEPLIPAYLLGLGMALAGGMLCLSGSDAGHA
>fig|391165.8.peg.1306 Acriflavin resistance protein
MNVSMPFILRPVATILLSIGILLTGIIAYRFLPVSALPSVDLPAIVVFVNQPGADPETMA
SSIAAPLERRLGEISGVMELISTNSVGASNIVVIFDLDRSVDSAAQDVQAAINAARADLP
SDLPVSPFIRKFNPAEAPVMMIALTSDSHTIRELYDLADSMLGQRLAQVNGVSQVQINGA
EKPAVRISTDPMRLAAASLSGQDLYNVVRNTNVTQPTGVIENGDVRRAILINGQIDDAES
YRKVVLKASNGGFLRLGDITDIVDGVANTRLSATSNGKPAILLQISKQSGANVIETVDGI
KKILPQLRSWLPGDINMAIVVDRTGTIRASVDDVQFTLLVSIALVLMVVFVFMRRLMPTI
AAAVTVPLSISGTLGAMWLLGYSLDNFSLMAITIGVGFVVDDAIVMIENIVRHMEMGKSR
LRAAIDGASQIGFTVISITLSLLAVFIPIIFMPGIQGRLFHEFVMTLSVSIVISAVVSLT
LTPMLMGVFGRQVHALDNPLLRRWDERVEHLLNGIERFYLRTLGWALKHSALMLLSMVLT
IAVTVTLYRAIPKSFLPIQDTGLLQGSTIARPDISYAAMRDLQHRAEAIIRADPAVLNVD
GRVGVSNGFNALNRGMMYIQLKPLEKRHVSSEQVIARLRPKLGTILGLETFLHSAQDLRM
GGREDSGQFEYVLQADDIRELRSWAQRLQKRLQSVPEIADVSSDQDHAGPEIDIMIDRDT
ASRLGTTVSGIDSALNNAFSQRQISRIYTDRNQYQVVLQALPSLQSSPAGLNTLYVPATN
VNGTAAPATASRATLQNATGQVTLGSAVGGTQIGGNQVPLMALALTQYTTAPLSIDHEAG
FPSASLSFNIKPGIPVSTAQDAVLEAVRSLGMPASIRGEFGGNLALFKKAGQAMPFLLIG
ALAAIYVVLGVLYESLIQPLTILSTLPSAGLGALIALLLAGVDLSLISIIGIVLLMGIVK
KNGIMLVDFALEQQRDAGLDAASAIREACAERFRPILMTTLAALLGAVPLAFSFGTGAEL
RQPLGISIIGGLIASQILTLYTTPIIYLALEKLARRGKARPAINPS
>fig|391165.8.peg.2073 Fusaric acid resistance protein conserved region
MPVASHTAGQDGFDMGAWLPGFLRSAAFFYALRLALSGSLALYCAYFLQLQNPSSALVTT
IIVASPMRGAILSKSLWRFLGTILGCVASIMAVALFVQSPLLYLSAFAVWTGCCSYISNL
LRYFRAYSAALAGYTIALIGFGDVLAHPDTIFSVALDRLSVVSLGIVCSALVTMLLQPAT
SENKLQADSMQSLRDLSELLTMVRDGASEEKILDTRRRLLFRIASYDQAVEFGAAESSEV
ARRANAFRQLFGLMTSVTASSMRIGERLQALSADPQTAEAAARLRRILSNLIQHIPDNVQ
ELRHLVAASSHMHVELRHFANHTQCLKSLGLVNLLDDAARQLRMMARLADPRVQKIRRVR
LPLWRDHVTALRSGLRAFLAAELLGLFWIYTEWPSGGSAIVMTAIIVALAATGDNPSGMM
KAFLQGTLIASVLSFVLVYGILVHMDGFPLLLMAYMPIVILCGYMQASGRNPALAMSIML
FYAVLSPIANPIHYNLTGFLNSVFSSIIGALAANIAFMILVPPSFEMSIRLATLSLWRGV
SDAARKKMPASNLTWEYPQYQKLMRISARLPPAGPERRRIGRGSAALVLTGREIFKIRHA
IEHGIVPVSARPAVQRLLAVLRRQPQRAAEFADHACREVVAAGVHDPQLLRTAASLAELH
LLLLEGGRQVSQS
>fig|391296.7.peg.43 Multidrug resistance ABC transporter ATP-binding and permease protein
MNKRLVGVLLKSLNKTMFLFGIVLSALGVGMGLFLPQFIGKLLDQTYLSNLLTRPELLAG
FILFFVSVYAVQALSNYFIGRSGSNALKQLQQYIYESLLTTSVKDLDQYQSGDLASRLTN
DMSVVLNFITVILPNFLMNGLMVMGSIYFLWTISPWLTGLSLFLLPLLSMVMIPMNQRLE
GYYSAYQEGLGQVSSRISHKFTTIRLMKAFQGEKHEQREMGKSFQYLSQTFEKMIGLSAV
QHTLVSSLMTGFIILMLLIAGIEVTKGVMTMATLTTFVLYMMQLIDPVTDIAASLNELTE
FHAVSKRLVELLELNKEEQVDTELVDATSIQLEKVRFSYHTDPILNGVSVRIPEGAHVAI
VGPSGAGKSTIFALLMKYYQDYKGKIRIGQQCLSDISTKEMRRLISFIPQDNTLFHGTIR
ENLLYGKNESVSEERIAYILKELGLSPLVAELEDGLDTRISENGTGLSEGQKQRFSIARA
LLLEHPIYLLDEATASLDTVTERVISKAIDRLTAGKTRLTIAHRLHTVREADAILVLDKN
GQVADYGHHQQLVERNHLYQDFLRGLPQAS
>fig|391296.7.peg.235 Daunorubicin resistance transmembrane protein
MRKYLYMTRLTMMNAMQYKAFFLATFVSLAVKILVALYVWKTIFFTQSEVNGFTLQTITT
YIIFANLLASLNSFSLGEDLSYSILKGSIAGEFLRPYSFILALFFKDLGNKLLELIKFAI
VFIGILLVHQDFYLPDGKTILLFLVSSILGMFIVQLLDMAFGFLAFFTVNAWGVMLLRMG
LFNLASGALLPLSFYPQAVENFLKLLPYNYAVNVPVSILLGQESDLTALGLQVIWIPILA
CFIAALWSQAKRRIVIFGG
>fig|391296.7.peg.236 Daunorubicin resistance ATP-binding protein drrA
MIQAEHLSKTYSIIDKEVGLKGSIKAFFKPKKKSIPAVQDISLQVGKGKIIGYIGSNGSG
KSTTIKMLTGVLFPDQGQVRINGLNPQENRKAVNKQIGVLFGQKSHLDWNLPVQESFILH
AKIYDVPDKVFKERLAVLIELLDLADIMKQPIRNLSLGQRVRCEFAAIFIHQPAVVFLDE
PTIGLDASVKETIRSFIRYMNQEYQTTFLITSHDMKDIESLCERIFIIDKGKKVYDGSLT
VLKERFSTVKTILFSTEKPIEKDLQLEGWEFIRKDDFHFEIHYQSKVWTSAQVIEQVFNH
YSIEDVTMKELEIETMVRQIYEEGIHA
>fig|391296.7.peg.691 Glyoxalase/bleomycin resistance protein/dioxygenase
MLKAMEVYLVTNGNGLEAIEFYKNALGATVEQVNLFKDFLPDCPC
>fig|391587.3.peg.1222 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily protein
MKAAFHLALPCDDIQKTKEFYVDILGANKGRGTNTWIDIDFYGNQVTFTNAGSFNFDFKN
YRLSGQILPSFHFGVIVDMETWGKIYTKLFSMDIEVTTEVTFLENKAGEHISFFVTDPDG
YQVEFKSFKNEKEIFTSI
>fig|391587.3.peg.1302 Glyoxalase/bleomycin resistance protein/dioxygenase
MNAFHYAFKIKDIASTRTFYVDILNCKEGRSTENWIDFEFFGHQLSGHVSSNFPELDYCG
KVDGIHVPIPHFGCLLTISQFEDIQQKLEANNIEFVVKPQTRYKGQTGEQRTMFVFDYSG
NPLEFKAFSDESEVFASN
>fig|391587.3.peg.1506 Multidrug resistance protein
MAFFQLFTTIPLYYDEVFHLNEFKIGILLFLNVAIIVVFEMPLLNYLEKQRIPIVKYIIM
SCILLTVSFLVMYQNFWIGILIISIILMTLSEMLGFPYTNRYALNRAKDGLEGSYMAMYA
MSFSIAHIFSPKIGFDIVEKFGYQANWLVSGLYGVIGIILAIWLSKRTQKGL
>fig|391600.3.peg.514 Permease of the drug/metabolite transporter (DMT) superfamily
MTAATPAPPSHKPHALTGLEIAAIVAIIVVWGVNNAGAKLATETLPPLLVGAIRFGLATA
CLIVFVRPPFPDWRSLLLIVIVGGPIQYGLAYTAYWMATDVSPVTVANQLWIPFTALFAF
LILGERLSRAALVGMGVAFVGVAWMTLDAHALQDWKAILVAIAAGAAWGVTTVVARRTTS
IPPLKMQGLLALGAFPVMAFGSAVFEHGQWAAVKSATPMVWASLLWAGIVSSVLATTLLF
WLVQRREAGRVTPYLLVTPVVSMLIGWGLMGDVLTPQILTGSAITMGGVALVALAERGLR
AGAAKA
>fig|391600.3.peg.1255 Permease of the drug/metabolite transporter (DMT) superfamily
MSRPITILAIAICALIWGTTWFAITLQLGVVDPIVSIVWRFGLAAVVLFAFCALTRRPLR
LTRAQHLAAVGQGAFVFAVSYGFVYAAEERVASAVVAVIFAALAFVNLILFRVLERQKAA
AGAWQGAILGVCGVAVLSFGQLSGAGVSAGVAPVLGVVFALIAVLASAFGNWFAWRGQQA
GAPVMAATAWAMAYGTAMVAVYGFATGVEWRIEPTPAYILSLLHLSLFGSVIAFGLYFTL
ARQRGYALASYISALTPPIAVIMSVLFEGAHVGVTMLIGLILVLGGQVLLIRAPKA
>fig|391600.3.peg.1715 Glyoxalase/bleomycin resistance protein/dioxygenase
MQIIKRMDHFTVTTDRLDETLAFYEKLGLRSGPRPEFDMPGLWLYAEDHPVLHVVEASVL
PDTRRGVIDHMAFAADDLNATIDMLKREGIGYKIVRTPRPWSFWQLFLEDPSGAEVELQF
DPASDTPAEVLEARAARSRDRGPIA
>fig|391600.3.peg.2044 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIALSFQTRSAFRDLLHLAWPVILARIGIMTMGLTDAIVVGNFSSKELAFHSLAWAPTSI
VVTTAVGLMLGVQVMTARMLGEGRRHAVGSVLRRGMTYSLQIGVVSMIALIAVGPWGLGK
IGLEDGLAEGAGPALVVFALSMPFYLISVTGQFFLEALGRPKPGMVAMWIANGVNLALNI
VLVPDLLGIGFDGAFASAWATFGARAALAIFLVVYILRLPEARALGIFDKPERDPKAARE
QVKVGLGAGASYFIEVGAFSGFTFFAGQIGAAETAAWAVVLNVSAIVFMLPMGLSSATAV
LVGRSYGAGDGRGVLRAGLVGLGVVSAMTFIVALLVWPSAHLIVGAYNRDPVLLAIAAPA
LVLATLFFVADGIQVVAAQANRAAGDVWWPTIMHFVAYGAVMMPLGWILAHRMGVDGLVW
AVVIASLASSVLLTGRFVRVARRLP
>fig|391616.3.peg.140 Tetracycline resistance protein
MQNRAYLFILMTLTIDAIGIGIVFPIMPDLMERVGASGTGEGALWGGILMASYAGALFIF
APIIGSLSDAYGRKPVLLLALAVLAVDYVIMALAGVFWVLLIGRILAGVAGATYTTATAY
IADISTPKERAARFGMVGAAFGIGFVLGPAIGGIAAEWHISAPFWIAAVLSASNVLFGLF
VLPESLAPAKRRRFGRRDLNPFNAIIAAFKIPGLAIPLICLFVFEFANMVYPTLWAFFTR
ELFDWSTLLIGMSLAGYGILLAGVQGGLMPVLITRFGEFRTLQLGLISALIGFIGFGLIS
TVTGLIIVLVFAALSDLSPPMMTAMASNMADENQQGLVQGVIASLASIAAFLAPLVVTGV
FEVFVDDNGLYLPGAPFLMGAVMLLLLIPLIMRLRGHAQS
>fig|391616.3.peg.217 Permeases of the drug/metabolite transporter (DMT) superfamily
MFVLGVTDNLIPLISENSSLWLFQAARSAATLPLLALLALFGLGTLRANRPLHVLARNFF
TGTALLIYFGCLAFLPIGVVAAGLFTAPIFVLILSVLFRGQSVGFWRWAAVAVGFGGAVL
VVWPQDGSITVLAFVPIIAGLFYAVGAIGTRAWCEGESVLVMTLAYFAILGVYGLVGVAA
LTIWPMDAPPGVDGWLQRGLVPMTTTMFWVTIGQAVGSITGVGLLTRGYQLGEASYVAIN
EYSLIVFAAIFGWIIWDQTLGVLALVGIACIITSGSIIALRSK
>fig|391616.3.peg.3698 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLFATLYNVVDVYWAGRLSTDAQAGLAIGYQAFFVLMAIGFGLSSALSALVSNAKGSGDN
SQTQRLAAQGLSFGIIATFVSMVIGWFIGPLLINLVSEPGAYRDAALGYFKFLILALPGF
FLAYGGNGILQAHGDSRTMQRAMMVAFLANIGLNPLLMFGIDGIWNGIGFNGIAVATIIS
QTGVMIFIITRILKLEMMRSVNLAAFWPDRASFMQIIGQLIPASSAMMVMFVSGFVVQFA
LKEFGGHAVAAYGIALRIEQILLLPVLGMTGALLPIAGQNFGAQDFDRVRAAVLFCWKTG
FAMTLIATPILLFGGGKAMSLFSDDPEVIRVGFSYLRVDAFLFPIYMMLFSINSLLQALK
KPIWTLWISIYRQGFGVAFFVWMFISVLDFSVWGVWLGIATAVTSGWVLSLVVAQRVARS
TMGGLLKSASGPPFTLAAVLSDK
>fig|391616.3.peg.3940 Permease of the drug/metabolite transporter (DMT) superfamily
MSEESNNMKRVGLAPAAATMASIFFGASVVATKYVIDQTTPVQLAFLRYLIGSLCLTPFL
IWPKRVNIPWRDVLPIMGLGIVFFGIFPWTFSAALQHIPASRGAVVLATMPLLTLGIASA
VGYEKITRTLLFGVALTHLGVAIALGASVQTGLSTSWLGYFLMFLTALCGAIFSVFSKPY
LKRHPTLHVTALSILAGTLFLAPAAIWQISGTGLPEINESGWMAVVFIGTIGGGIGFFLW
IWALERSSPTRVAVFVTLNPLAATALAALLLSETITVSFTIGLSCVLLGIILANRRKPVL
TTHSPSNDMENVS
>fig|391619.3.peg.726 Permease of the drug/metabolite transporter (DMT) superfamily
MSARHTELGALAILSWGTLGVLGAFSASLPPYLVLTFCFAIAAGMGLAICAATGRNPVRL
LDRHTILFAGLLTAYHLSYLEAFHHAAPIPVSLINYLWPACLIILGNLFFQLRSGFPGYL
GAALGFVGVLVLIGKDGFALQLSETLGYGLAFVGALLWATFSNLRRHEPSDAISAMTTIC
FASSLICGLWWITKGANLPALTASDVWVIAALGLGPAGGAFFLWDLGMRQGHAALLGVLG
YSAPVFSTILMLTLGLGQPGWEVFAAIALITLGGIVVHSGSKGPTKCVANAETR
>fig|391619.3.peg.2635 Permease of the drug/metabolite transporter (DMT) superfamily
MALKYWAAIFVLGIGWGMSFMFNAVLLRELGPLSVSMGRVGFGALGCWIYVVAARKQVPD
RPRRWLALFGFGVLSYAAPFAFYALGQQHIASGVAGILNAFTPALAVMVAHFWPGGERAT
LQKSFGVVFGFLGILVLSWLLLQGGRQSEVWAVLVTLCAPLCYAFSVNIARQFRDIDPVV
LVAVALTGATAAITPLAIWAEGLPVITRLETWGALFIIGFILTSAAFILFYWVLPRVGPT
NITLPTLIAPVSALAMGAWVLQEPLKLEHLTGMGLILIGLVLIDGRLLRKIRRRSAL
>fig|391735.5.peg.80 Permease of the drug/metabolite transporter (DMT) superfamily
MNQALSRPAASVEMQAYLLGLMSVAAFALTLPCAKVLAGPLSAMQIGLFRSMLAALAALP
ILWFTRSARPNASQVKRLLLLSLGIVYGFPILTAVGMRYVPVGHGGVVLAALPLATAIFG
SLITKDRPPLLFWLASIGGFVAVALFAAWRSGIGGGFYLGDLALLGAVALAGFGYAQGGA
LSKEMQGWEVMCWALVLNLPVLLPLSLLYFNAADFAGFGSVSWAALAFLAFVNSLLGFFS
WNRALALGGIQRISQLQLLQPFFTYGYSIILMGEAFDPLALLICVAVIGLVVVSKRALLK
H
>fig|391735.5.peg.669 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MRRRRHWPMPRCSHETHPLVLRCLSQCRAGLARRDRRRARQPPFHPGQQGARVRAGLRQL
PTDRPLRQRGQRLGRAGTGLARARNRRASARRHSGECGLLCQHGRACRRGQAAVCRCHRR
HAHPVPRRIGPGAGAGAETGGRDRDPLVRPDGQYAGHCRAVRQRRGGADRGLRPGPWRRT
ARQKSRRLGRSCLPELLPDQEPGGLGRRRGGADRERGAGRQAAPTAPIWLVRQIPCRHPR
GAQQPARRIAGGGAAGQTAAARRAQCLAPSGRRPLQCRLGGAAAALSGAAGAGFRGPPVR
AAHRAARRTGAASASASGRLRAALPGGGPPSARLPGRGLLRPADGDAASLRPGPVPALLP
RSVRRGCGPGQRRSPLFLCPGLKMLSLLIPVYRNETGLPDLLAAVQSLHARLEGAMETVF
VVDGSPDRCYEILRERLPHCALRARLVLLSRNFGSFAAIRVALQRASGAYFAVLAADLQE
PPELVLRMHAALLRADCDVVIGVRQTRHEPLTTRLPAQIFWWLYRRYVLSEIPPGGVDVF
ACNRAFRDSLLQLQERHSSLIAQMFWLGFRRQQLSYVRQPRQHGVSAWTLRKKLGYMADS
IFSFTDLPIRWLLRAGLGGTLAATVVGAAVLAAKLLGAITVPGYAMIMLTIVFFGALNLL
SLGVVGSYAWRAYENTKARPLAVVLRDEQFGPPGVSNPGERPHA
>fig|391735.5.peg.816 Permease of the drug/metabolite transporter (DMT) superfamily
MWRSRPGIAGRGSTGPESPWPVADGHMAATIMPSPFGHALRLNARHPHARPRNPALKEPH
GQIRTSIRPPGAGAAARRSAGADRGACLAQQGGCVSAARPPEGAHTVAEGEGAPSFAARP
PEGAHTAAKGEGAPSFAARPPEGAHTAAEGEGAPVSAARPPGGAHTAAEGEGAPVSAPDE
AQQAAAAASAARTRGIGVSCGLAVALIWSGWSVATRFAMKTELAPADVTFLRFGVAAIFL
WPVLLRHGFGFKRIGRLNVCIMLIGAGVPFMMLAATGMRFAPASHVATLMIGMMPIFVAL
LSALFFRERFSRVQLGGLATVIVGAACLGGHALIADRGAGEWRGDLLFLCAGLCFASYTV
VQRRSGISPWHATALVNVGSALVFAPIYWLFLQPRIFTAPVSDLLFQVFAQGVCAAIVAM
FFYAEAVRRLGAPRAAIFGALTPAFAVLIGIPALGEIPGGVGLAGIALVMAGVVLVVTGA
RPRPA
>fig|391735.5.peg.979 Probable multidrug resistance protein norM
MTTATRKLDLGLAREVVRMSLPLMGTMAGNLLMMLVDRICLAQYSSDTLAASGPAVFTAM
TVITFFTATTNLSRSCVAQAFGRSGEPAARAEGVLGMLIAAGLGLILLCLSPLLGMIPSL
SDRPPAIRALESSFLELSALFGAVMVLNVSMSAYFNGIGKTRISLYVGLLGQVVAALAIY
GLVFGRFGLPELGMRGSALGTLVGCVSMLVCYAWQLPHGFLREGLKHWADAGKAALRAQV
VLRLRRGFASGTAAGMDELGNTSFVWLAAVLGPIALAANNVNLTLNYLAIIPIIGLGIGC
SVLCSNAIGRNEYEQIPPILKVTLLIEGAYVLVVSLAQLLAPMMLLEPFGLSTTDVQIQT
TAVDTTRVLWTFSASFVFSMTGAAVLEGFGMTRFILVTRIGLMWGLSLPLIYLATHHGAG
DPAWLPRIWIIGSVFEFAIGCIYFWNIRQATRKRLNYLQVQHAA
>fig|391735.5.peg.3130 Glyoxalase/bleomycin resistance protein/dioxygenase
MRVAQIDHFTLRVAQDMLPVLLDFYSRVLQLRAGARPAFSFPGYWLYAGDQALVHLVGNA
PGGEPATTDFLPTGKFDHVSLRTHGLKSTREHLQAQGIDWQEAQVPGIALHQIFLRDPVG
LKIELTFDAAELALAGPSTRPTAY
>fig|391735.5.peg.3631 Multidrug resistance protein
MGIMQTQQIAALFACLFLIGSAEVVAGPMMSAMSVDFGVRSSAIAYLPAAYGLSYGAVAL
IAGPLSDRWGRKLPLQAGLLGFALLNASIPGAAHLPAAIVLSALAGLCAAIIQPNALSLV
ADESPPEQVGRRLGQVFIGLMLAFVLTPVLAGQLADTLGWRSAYYALALLSVLAWLAVTR
AFARRPPGAGARTDFLSTHRQAWRTIDVRRRLSVSYLWLGWLAGFGAVVAEVAARKLPLS
PTDTGLIAGFFGLAVIAGNLAGARLHRALGQAALPVMAIVAALGLLGFMLPVESMAQLLL
LGLPWAFGYGCAGPLHHARLSALSERYRGTINSYHASLLNLGIFSVSFLLGAVVPHFPVT
LFCALVGAVTLVGACLLLPWPRLSITTR
>fig|391735.5.peg.3922 Permease of the drug/metabolite transporter (DMT) superfamily
MAALLAQCTGQTGQTGQTGQTGQSHDACGPGDPVSVPRGCRLASGCALSQARAIGPRTAH
QRAMTSQRRLHNLMRRPGLQPSGGHCLRPSHHQESCKPREATMKALRTGYLSIAVYCVST
ALSAVWVTFSFSQISGAALTFITLLTAFVIFFGAHLLSGGRPSRLLRTHLADVVILNVLT
VAAWFFMFLALQRIEASVESAIYQGCVPVAVLVCVVYTRQVPFQSLRTLGCVLISLCLFG
LVAARITTAGAIVIAPARLYAGIALATVAGLAGGLYVYWSGKVVRQSQCATLDILSNRFY
LLLVVTGATGYAQFSGATAESFAPALIGKLVLLSMVSVVIPAFTLQHAIGSLGASRVSII
TPFVPALALVVEQRLAGWPSPVVPALIVATCVAIVLSNVWLTVQASAKIPVR
>fig|391904.3.peg.549 Drug resistance transporter, EmrB/QacA subfamily
MMALGLAMIVLDSSIVNVSIPTIIDDIGINLTDAQWVTSLYNIVLAALLLPFGKLGDARG
RKLVFQVGTVIFVASSTLAAASQGAVMLLAARVLQGIGGAMIMPNTLSTVSALFRGKYRA
AAFGVWGAVMSSAAALGPLLGGVFTETLGWRWIFLVNLPLGIAVFVSAIFLVPKTGGNAS
VAGAADAAQDARSRRVGVDIPGVVLSALTSALLVFGLIEGETYGWWKQTSTQLKLGGLSW
NRDWLSPVPICLIAGALLMAVFILFESARGKAGRPVMLDMTLFRIKTFSWGNLAAAAIAA
GEFALVFMLPLYLINARGLNTLQAGAMLAVMGLGSIVAGAQAHVMAARLTPAGVIQLGLV
IEIIAVALVAVLMPVGFSVWWQLVPMAAYGLGLGFASAQLTSVVLSEVPVMQSGEGSATQ
STVRQLGTAVGSAISGASLAMAVNGTLPARLESLGLPAKVGDGLAQAVSGSAGGVIGVFR
SGDGPAARFGDEAPKIADAMTSGFVEGGQWTLLVAGIMLFIGLLASVAVRRAASSHNVR
>fig|391904.3.peg.1002 Antibiotic transport ATP-binding protein spaF/mutF
MNNVSITVRRGSIYGLLGPNGAGKSTTLKMITGMLRPTSGKILFDGHEWSRRDLEQIGAL
IETPPLYENLSATENLEVRVKLLDIPKTRIGEVLRIVDLQDTGRKRAGQFSMGMKQRLGI
AIALLNSPELLILDEPTNGLDPIGIQELRSLIRSFSSKGITVILSSHILSEVQLIADDIG
IISNGVLGYEGPMNKDQNLEELFVEVVRKSQEER
>fig|391904.3.peg.1087 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAHTDALDSGLGVTPVPRLALTMSFPAIVAQAANASYTIIDRMFIGHIPEVGNAAMTGVG
ICFPILLAVTAFASLIGAGGAPRASIELGRGNFKKAERILGTSTAFLVVIALTLTAVLQS
VKRPILYAFGASDATIAYATDFITIYLIGTVFVQLTLGLNSFISAQGKTTVAMVSVLIGT
GASMVLDPVFIFVFGWGVRGAAAANVIAQLISTVWIVLFLSSGRSAIRLRPANIRIDRII
IPVLTLGLAPFIMQITECLINVVFNVGLQRYGGDDYVTSITIITSLIQVVGVLTGGFQQG
IQPIIGFNFGARNMRRVRQAIRMAFVTQIASATALVSVLAAFPGFFASWFTTEQTVIDIV
TRMMPIFVCGWGVFGIQLGAQCAFVGMGQAGQSVFLAVFRKVILLVPLALLLPHWLGVDG
IFIAEPISDATSGMVAGLLFLITYRRIRRNLV
>fig|392499.4.peg.890 Drug/metabolite exporter
MSQATAHTARWRLIGFLLSAVGSMLFAIKGVLIKLIYVYQIDTTALLAVRMMLSLPVFFG
VGLLEWRRRPAAQRPDARSVGLAALVGILGYHVSSWLDFAGLQSVEAQAERLILFTYPFL
VILFGRLIFGHRLRFHALAGAGLSYAGLLVMFGSDPARLTPAMIGGAGMILAAAGTFALY
QLFARELILRCGPALFTAIAMSAAGLSVIAHFALTHGIALPSAPPRAWALMIGLAVFSTI
VPTFMMSAGTARIGAQGTAIISTISPVVTIALAIVVLGEPFGIGEAAGTLLVIGGVGLFT
WIESRPGRRRSKSVMPAEAGISGEGRRG
>fig|392499.4.peg.1563 Permeases of the drug/metabolite transporter (DMT) superfamily
MSGCRSGSSISTTSSPISTRRCARPADRHTPAMTTDRRRTPLYSYATLAAVMLFWSGNFI
VGRAVQGAIPPFTLALVRWSGAALVLAPFAWRHLRVDRALLAAQWRIVLLLGLVGIAAFN
GFVYAGLQYTTATNGLLLQAAIPALVLLFDRMLFGQRATWAQMAAVLLSIAGVILIVLRG
DPFAILSIGLNIGDLLVLGGVIGWAAYTSLLRLRPASHPLSFLFVAFLIGIATMAPLAML
EWARGARVVMGWGTVGAFAYVALLPSLAAYMLYNAAVHDLGAGPAGQTITLMPLFGALLA
AGLLGETLHAYHLTGMVLILGGILIGAWMRPGPARGQRSGRP
>fig|392499.4.peg.3366 Inner membrane component of tripartite multidrug resistance system
MSAAASAEPAPLGGVALGAAAVALALGTFMQVLDTTIANVSLTTIAGNLGVSSDSSTWVI
TAFAVANGVTVPLTGWLMRRFGVVRTFVVSVILFTLASLLCGIAWSLPSLILFRVLQGAV
SGPMIPGSQALLISIFPPERRSTALGIWSMTTLVGPVAGPILGGYISDNYHWGWIFLINV
PVGLASAFISWRFMKSRETATAKLPIDAVGLGLLAFWVGCLQVFLDLGKNEDWFHSPFIT
TMALLAAIGFVAWLIWELTEERPAVDLSLFANRNFALGTVALTLGYAVFFGNTLLLPLWL
QQQLGYTATWAGLVSAPSGIVSVIATPFVARLSGKVDARWLASFAFVAFAASYLMRSGYT
TQTDYFHFMLPMLVQGLGMSTFFVAMLSISLDGVSAERTPSATGLSNFARITGSSFAASL
VTTMWDRREALHQSRLADASSPFDPVFRHAADALGQLGLTAQQGYGVLTREMVGQAYLLS
SNDIFRASAWAMMAMIAIVWIVRKPAPLTGPVAAD
>fig|392499.4.peg.3368 Outer membrane component of tripartite multidrug resistance system
MPRSIPLRRPALLAGLVATLLSGCAAVPQVRPQVQAASAATAGLDGGAALAPVGDWWHGF
GDPQLDRIMAEALAGNPSLDVAMARLARAQAGIAANKAGLLPQVGVDASAIRQRLSEKYI
IPPPYGGSNRWIGDAQAKLDWSLDLAGRQKALVAQAGASADAAALDVEAARVTLSGAVAQ
SYVDLARATEQARIARRFVASREEQLRLAGTRKRTDLGSDFDLRAAETLLAEARQAGIRA
EGARQLMVHALAALAGRGADYHAAIADPTIRLDAALPVPDALPADLLGRRPDILAARARI
EAAEAGRKVARADFYPDIDLKGFIGLQAIGLGALFTGGAATYGAGPALHLPIFEGGRLKA
NYKGAVAGIDEAVASYNGAVVGAVRETADALSAIATNAADAAEQHKVVAGLGETVRLDEV
RLRTGLGARLDVLDAGDRLLAANQREVDLAADGAAARIRLLVAVGGSFDPHSRQNLASAA
GADAAGR
>fig|392499.4.peg.3532 Glyoxalase/bleomycin resistance protein/dioxygenase
MSGPSTNSLFCMAMAMGIRVTLRFEDTASKARLQMETNIQRLYHFAFPCRDAEETRAFYE
DLLSLPLVHCMQVDAVPSSGDAGPYAHIFFQMRDGSYIAFFDLGGDEPPEPSPNTPRWVQ
HFAMEVPDLADVLAYRDRLVAAGVEVTGIVDHDFIKSIYFFDPNGLRLEITTRTEKPGFN
EKAAAEAHAKLAAWSRFKHGRN
>fig|392499.4.peg.3642 Multidrug resistance protein B
MTESETNQQHDVAVVPIAPLPKMIVTTAIMAATILVVLDQTIATVALPHMQAALGATPDT
VTWVLTSYIMATAVGTPLTAWLTGRFGRRQVFLVCVLGFTISSMLCGAATSLPMMVACRL
AQGFFGAFLMPMSQAFLYDMNPPSLQVRAITMWGIGAMVGPIVGPVLGGYLTDAFDWRWV
FFVNVPVGIVALAGVFFGLPEFPSARRSFDHVGFIMIAVALCSLQLALDRGTQQDWLDSP
EIIAEFGLSIAAFWMLIFHLRRSRHPIISPGLFANPSFSGAMVLAFVLMPTIIASNALLP
QLFVQLLGYPVATAGEMMLPRGIAMTIGIFLGGQFTRWMDGRLQVALGVCIVIASLYVQT
GFNMEMDQHLIIWAGVLQGFGTGLSMTVLNFTAMSSAPLSHRTEAAALYSLSRNTGSSIM
LAIFSGLLAHDVQVNHAELGARISSGGGMSLHLSRIWAGNSLDAPIAAMAEVEVNRQAMM
IAYINDFWVMMWLVAAMLPLVLLLRPGKAPKGSGESLAALAD
>fig|392499.4.peg.4128 Multidrug resistance protein A
MNEMRSITGDAGVAAPALDGERRLGRLAAMLSVPALLLATGLYLWLTGGRTVSTDNAQVN
AHVVEVSAEVAGRITDVYVSENQLVKKGDLLFRVDPQPYRIALMQAEAAVGNAELTVAQL
ESTYHAKQADTAKSLSDVSLARDTFARQQELLARGFTTRAAFDAAKAALAAAQAQQASAR
SEAESARAVIGTSRNGGHPQIEAAIAARDKAALDLARTEIRAPIEGRISQADKLQPGTMA
IQMLPMVNVVSNQGYWIDANFKETQLDKVRIGQRADIELDAIPGRTIKGHVIGINAGTGS
QFSLLPPQNATGNWVKVTQRVPVRIQIDDRLDRPLVAGWSAHVTVHVAD
>fig|392499.4.peg.4165 Glyoxalase/bleomycin resistance protein/dioxygenase
MEIAQTALGWRQERKTMARLEHCNIRSFDLAATIRFYEEVIGLRAGPVPGMNRGAWLYDD
SDVAVVHVIDLDTDNRDASLGEIRHRLGELAGPLDPDAMRGGGAVDHIAFHCDDYDAMVA
RLEAHGAPYRTFDLPAYQLRQILVNDPSDVTLELNFRD
>fig|392500.3.peg.109 Permease of the drug/metabolite transporter (DMT) superfamily
MSNTQKGWLAAIFVGLLWGIPWIVGTPILEVMDPQVLVWLRYTVAFITLGLIFNIGLASG
KMTKKADFKLNWQNRNDIFWAACCGIIGQGSFSFLSFLSLDYITASENGVIQGLIPILIL
SVGFLRHNERFTVMQMMCALGAFLGVAILVMDPQSETQGFNIGHLICFGSAASFACMAYA
RAKLAEKYGSVATMFHQFVFASLGFGLYLFVVGADFSSALNVFSSPLRIMCIVILGVCIS
GMSYLVYIYGMERVGVDGTGMALNLMPLSSFILAVFALGEQVTPMRLVAIAVVITSMIAF
MKLGNQKKDKPVEQAALNTTKPCRSQ
>fig|392500.3.peg.110 Permease of the drug/metabolite transporter (DMT) superfamily
MTVTNKDNLLGWTAAIAVAGIWGVTGVVSKPLSMAVDPMTLVFFRYVTAVIGLSVIFMIT
SRFTSLSKDLGSSLKIDKGDIAKIALCGIIGQGVFSLFNFLSLSHIGATENGVIQGMQPF
ATVFFGMMFMNFKMSKIQWGAFIASAVCIYAMSVGPTNQVENGSSVMGYVYVTCSMLSLA
WTAHLRASLAEKYGSVVSMLYQYISVAVMGIIVVVAMDLDLSQINIILANPLLLGLLIFL
GMGISGGSYLIQLYSFKKIGVEKATMALNLMPLVGYIVAVLTLGEQLHLSKTIIVSLIVV
ALYVFTKFEAKPEINKSLKPQEA
>fig|392500.3.peg.2000 Acriflavin resistance protein
MASREDLIKQLDASDDVDTTSNKFITLKSLSITALIVVSIIFSISKLAVEGDKSEEYPIT
PQGAVEGESIIDAQVSSPVTETVVLQASGYIMAKKMMTVSSNVSGRLNSIMIEEGMRVKQ
GELLATFDDSIPQTELKMLESQYSYGLARLKESEAEYTGHQVSLRRIQRLFDSGNGSVAE
LDEMKTKANILEARVAVASRELEIAKENINTQLRRLLEYKVYSPMQGVVVDVMAQAGEVI
SSLTTFGTDEQSGICTIVDMNSLHVEVEVSEQYISRVAVGQRALAKLNAYPDLPVDIEVA
LIVPTANKDKSTVKVWLNIIKNDPRILPEMGVEVSFFPPDEEEEQGHLTSKLSDVAA
>fig|393115.8.peg.29 Multidrug resistance transporter, Bcr/CflA family
MQIDNKNLKYIPLLVLLTWFLGNMGVHFLLPLLPLLSNNLDASVKLTQYVIAFFLAGKAL
GMIVYGPLSEIYGRRKFMLFGLILYMSSSLLCMLTTDIYWLIFWRFVQGLGVSGTILMGR
VIINDSYPNDKAANIFGYLFALAAVIIACLPTLGGIIAIFKNWQLAFATMMIYSSLIFVI
MLKFLPETQSEQFQKSFSLIGIIKDYSNILRNRVFLGYLMCTSLMVAGESAFNTNAAFLM
IKTYGVSPKIFGMMMSSLLIAHLLGAAICGRYVVKRGISKLTGVGALILVLAAMFLSVTS
ILKFDGPYLTITAMFIYFLGTGFIMTTAAVGVVSPFPKMIGTAMAFALSLEFLLSALSSF
ITSHLSISSLFPITVLITLLSLGSFAMWFFCIKRDK
>fig|393115.8.peg.287 Bicyclomycin resistance protein TcaB
MLKAYRITLIFSGLIVLIGLMSIDFISPSLTYIKSDFETSQTLLKNSVLTYMLILGIFQL
PYGFLSDRYGRKKLVLISLSITILGILISAFAQGIVPFYIGRIVTAIGSAGCPVISRSII
ADVSHNPKRLRKSFSLYALASQISLCIAPVLGAFIQSVSSWRFSLITLLLINIVVFLLIL
LIMPETSRRLEYKINYKTTLDKYLYYFKNRYFFIMSLLSALFYVYSIGFYNMLPFVLHHL
GIPVITNGFINSFYAIKFGHWSFFITTFLI
>fig|393115.8.peg.805 Fusaric acid resistance protein fusE
MGINMSNKNTKSIISIIIILFALFSLYAMWQYYLYSPWTRDGRIRAKIITIAPDVSNMYV
SDNQKVKKGQLIFTIDDQRYAATLEGKEAELKHAMIEWQLAEKQYLRRIRLGRDDSISRE
ELDDYAMQEKLRKADLEKAKAEAELAKINLDRTKIYAPADGTINNIDLRQGNYVVSSKPV
MSLVKAGSFYVTGYFEETKLPHIKIGDKAKIILMSGGEPLYGHVISIGKAVTDNNTDVNN
QLLPKVQETYDWVRLSKRIDR
>fig|393305.7.peg.1415 Permease of the drug/metabolite transporter (DMT) superfamily
MAMPAGLPPSIIRAPLVGSGFLTGKRQGYVLALISAMLLGFTGIIIRILTAHYHLPTSVL
AFWRAGLVAAVLLPILLVIKPEWAKLRRDQVKFYLAYGLLLAVFNGLWTESVALNGASIS
TILVYCSVGFTVFLGWIFYNEYMGWREFFVIVISMVGCFLVSDGVNITAADFNFVGLFIG
LASGIGYSFYTLAGRIATDRRYPVWNTILYVFGLSAVYQLIFNQLLLWFPIQGLQQMVGN
LFFLSIGTEGVQWSGWWLLLILAAGPTLLGFGLFNLSLKTLPLAIASLILTLELVFTAVI
AYFLLDEILSASQLLGSALVLLGVLMLHRKDNTQGEIATPNNSAISP
>fig|393305.7.peg.2200 Tetracycline-resistance determinant tetV
MAFAVLDIGGSATDLGLVVAARSIFNLAFLLIGGVLADRYSRSIVLLSSATIAALSQGGV
AWLVLDGSATIMGLAILGTINGAAAGIALPASSAMVPQTVPAHNLRAANAFIQVGVYAGT
IIGASLGGILTSTIGPGWGLAVDALGFAAAAPLYFFIRVNSPLSLESNTNIVQDLRDGWK
EFIARSWVWAIVAQFTIINAAFSGVVMILGPIIADASFGRAGWGIIVAAESVGLIVGSFL
ALRWRPRRDLFIGVILVSLCAVPIVLLSMISSTFVLMAGFFIAGIGFGQFGVVWANSLQT
HIPADKLARVYAYDAMGSFVAIPVGELAAGPLAMHYGNSTVLLAAAVAVVIATIAASFTP
AIRQLDNGPKVKPCDE
>fig|393305.7.peg.3445 Outer membrane component of tripartite multidrug resistance system
MLDNQQLQLAQPKVSSLALSPQWWRVLEDPQLDALMSQSLQTSPSLKQAAARVREAQSVV
GQADAANGPNLDLNGSSKREKVSQNTLQPFLQSYPDKPLYETSNTLGLNLSYEFDWWGKY
RNRVNAANAQVNAARAEQQQAALTLTSSVASVYYQLQSNFALQNVLQQEVDNNDRLAELR
TKQYQAGIYGIEIPQQTKAQADTAKQQIIQLQSQGEQLKHQLAALTGQGPNATQNLRQVP
LPDITRLAPKGELTTDLLGKRPDITAQRQLVESYDQRVKAARKEFYPSLSITGFAGLSTT
NFQGTNPNLLEAASQAWNFAPAISLPIFHAGALRSKLGEESALYDEAVESYNQTILNAVR
ETADAITIQQSSQLQLQQAISASQSIQKVYNVADARYTAGIIGRDELLISQSQYLQQQQS
ELNASNNLLQAKIGLIRSLGGGYQAPVSDGSQNKTI
>fig|393305.7.peg.3937 Permease of the drug/metabolite transporter (DMT) superfamily
MKLTDFLIALLITAIWGVNFSIIKLGLITADPLILAGIRFTLCALPAVFFIKKPDTSWRY
IIGYGLLFGIGLWGIVNLGIKAGVSAGIASLVLQFGAFFTLVLGALLFHENLSKYQYIGI
IVALLGLTSIIFISDGSVTFIGLALVLCGAVVWGLVSIIIKKSDTKQVFSFLVWSSLFSP
VPLFILSYLFNGPSGFTELAIHFNTTTLFSILFQVYPNTLFAYWVWNSLLTKYPVSVVAP
LSLLVPIFGMLGSVMIFNERIPSGKVIAMIFIISGLIIGLYGKRLMGLLKRKSSVALIE
>fig|393305.7.peg.4259 Multidrug resistance protein
MLPIATIFVFKNRNYCRFLLVNSLLWMLHAQLYSTIPLYTRETLDDESHLTLFFMVEALC
VMVLQHWVNLYINQHIPSYYPAVTLMLFSVSFFLIYLAQDRVLILWAAGVFSLALMVYMP
SADANNAAFADHGSFATYFGLLSLSVTLGDSLGNMLGMRLLAFLLQSGNVSQYFLWLAGI
TAVLAIFYRNPYNCPL
>fig|393305.7.peg.4426 Multidrug resistance protein B
MIINDASRWSDLFSGKNAAFAIALSGGVVLHAINIYIATTILPSVVLEINGLNLYAWNTT
LFVTASILGSALSARLLSGYGARSAYLFASLTFMLGSALCAMAPNMPLMLVGRTVQGLGG
GFLFALSYAMINLVFPQSLWPRAMALISGMWGVATLIGPAIGGIFAEMNAWRFAFWTLLP
VTLIYTIFTWRILPQGRSSTAVTSALPVTQLVLLTAIVLTISASSIASSIASSGLTNLVG
IVLAVLLLVLLLRIESRATSRLLPKGALRLNSPLAALYITISLLAIGITCEIFVPYFLQT
IHGQSPLISGYIAATMAAGWTISEVMSAGWKKSGIRWAIISGPIIVLMGIIALAILMPVS
SLGSWQQMAPIAIALTLVGFGIGFGWPHLLTRILQVAAEEDKDIAGASITTVQMFATAVG
AAIAGMVANLSGLNAPGGVAGAENTAHWLFTLYTIAPALAIITALRCAAIRSQPQTVNSV
TSHEIL
>fig|393595.12.peg.16 Fusaric acid resistance protein fusE
MKTMKTQSLIRASVTLLTVALASLLAWALWQHYMYSPWTRDGRVRARVVQVAPDVSGLVT
EVPVADNQAVQRGDLLFVIDRSRYQNALLQAQADQQAAEAAARAAGADIRAAQASAAKAR
AEFAMRQAESRRRDRIAQAVSREVRDNAHSSAEAAEAQLQAAQASHQRATAGQQQLLARL
QQANAALALAQLNLERTEVRAPVDGYVTNLALYPGDYAHAGQARMALIDRHDFWVYGYFE
ETKLPNVHVGDPVQVRLLSGIRANGKVHSIAHGIADRDNPTGADLLADVNPTFNWVRLAQ
RVPVRVSIDADSLPENTVLAAGMTATLTLNPS
>fig|393595.12.peg.1210 Permeases of the drug/metabolite transporter (DMT) superfamily
MPMNDQPLKGALLLVLGEGLLAVMAAMVKHLSDHLDTEVIVFARNLFGLMFLLMIISTRG
GFGQLRTRFVHLHLIRAFTGVSAMFCFFYAIGHIALTEAVLVKMTVPFFLPVIAWLWLSE
RIGLHTWLAIIAGFVGVAVIMRAGQGEIDPVMWVALAGAAIMSIAKVSIRRMAISEPAQR
VVFYFALFATLFSAFPLFWANTIPAGSDYLWLLAIGLVATGGQYAMTTAYQIARPGQVGV
YNYSSVIWAALLGWMFWGETLVLTTILGTLLIVAAGIWNLKSR
>fig|393595.12.peg.1410 Multidrug resistance transporter, Bcr/CflA family
MTHRRTSKLYQDVPMQTLSPGRLAFLLASLVALGPLAIDTYLPALLAMSGHFAVEIHAVE
VSVSVYVLGVAAGQWLGGPLSDQFGRKPVAYVGLCLFILGCLSIPLSSSIDMLYVLRFLQ
ALGGGATVVIAAASVRDHFTGKEAAKVMTTIGLVMLMAPLLAPALGALLLKLFGWQSIFY
MLALYGLMLFGIVRFMLPSVAVKPSGEPLRQRMFLAYGRVLRNRPAMGFILANGLAFAAL
FTFITDAAFLYMEYFRISPEAFPLYFGANVVTMLGMNRLNVLLLRRYTSASIMRVALALQ
MTACVTLLVLTLAGLLTLWLVVPLIMVAAGMVALIMPNGIASFLDLFDHDSGAATGLNGA
LQFLLAGLIGIVLGILHDGSTLPMTALMATSSVAAWAAFSLVARR
>fig|393595.12.peg.2053 Permease of the drug/metabolite transporter (DMT) superfamily
MSLKTCGSFKENGMPTLAAYLIVVAVWATTPLGIKWSGDAMAPLAAAGVRMGIAALLGLG
WLWIKRQPLPLHARARLSYLASLPGIFGAMGCSYMAAVHLPSGLISVIFGLAPLLSGLML
QALPGGLRLNRWHWSACLIGLAGLVLVFDDSLQVLVAGQGMGGRGVGLLWMLSAVTLFAG
SGIAVQRVGAGLQPMQQTVGGLLLSLPCYAIGMAITGQTLSFSGDYRGLSAILYLAVFGS
LLGFYCYYQVLARLSAATVALVTLITPVLALSLGSLLNGESLGVLVLVGAALIVLALSLF
LLGDHKIRRQLKQLTKADA
>fig|394503.6.peg.133 Permease of the drug/metabolite transporter (DMT) superfamily
MPLKDLLLLTASSFFGIVLYFIFENTGLKYTTASNASIIVAAVPIFTLISESLFYKLKIT
GRLIICVIVSISGVFFVIFEQGSLDFTGNLLKGNMLIVGAMVSWVIYTIICKSLTQKYEG
IVVTTYQMIAASILFIPLVLNEVDTWHIISGSGIANLLYLALFCSALAYYLYNVAVTNLG
ATFSSMFLNLIPVVSIIGGVLVLHERISAFQIAGMLLIMVSLFFVGRNRDRK
>fig|394503.6.peg.421 Drug resistance transporter, EmrB/QacA subfamily
MHQLTQKRKTTVMIALMATMFFAAINQTIISAALPKVIAQLGGMDYYSWVITGYMLTSTI
STVIFGKLSDIYGRKIFLLSGIIIFLIGSFLTGLSANIFQMIAFRGIQGIGGGILMSISL
TAVGDLYPPQERAKWTGVMMSIFGISSILGPVLGGVMVDYVAWKWLFWIFLPLGVIALIM
IWSLFPKLSGNSSESIDYLGSIFLALSITSLLLGFSWAGTKYAWALPQSLGLFAATLVGI
LVLILIERNAKSPVMPLSMFKNKGVTISFVASFVMSGGMMGAMSYIPFFIQGVKGHSATT
SGLLNIPMSLMMIIFSTLVGRWMSKYGNYRLFAVLGLGIMSASMIIMANMNNIVWAAISL
IIFGVGLGFGMTVFTTTAQNSAPTSQLGVVTASCTLFRNLGGTIFIAIFGSIMNTSMARN
MEKVMSSGSGIDLTKLDVETAEKFKAMANPQLLLDNTKLEAIQASMPEQVQLLFSKVMDL
VRTVMGDALTSVFYIGALLLLVGVVLSLFLKVQTADKDNNEEFEEKEEAAA
>fig|394503.6.peg.1063 Glyoxalase/bleomycin resistance protein/dioxygenase
MKLIGIDHITINCTDINASFSFYEEILSLKRLNDVDLGDHVLHYYQLPNTKLELIEYKEP
QRTIIAGNTDTGIYRHFAVGTDDLMEIKRRCDEKGYKINLQPTYIPQIDKKVMLIVDPNG
VEIEIIQL
>fig|394503.6.peg.1206 Permease of the drug/metabolite transporter (DMT) superfamily
MLLGFLPQFSILLICAVLGLCSTIILFRKKLQGFNKKIVVTCVLISLISVVSNTFCMLAL
KKTSGSNTAFIVQLSIVITPIIMAVLERKVPSRKTILPAMAAMVGIYLITFAGKGMSVNP
GDIFALCNAIFFSLFIALQNKFSNVFTAVQFTFVQHSTNIVCFLALALIFETGKIVFSNA
VNPLFILLICLNATVTIFTSLFQSSAIKFVRPENAAIMYALEPVVTTVLGILLLGESFSG
ILTVLGCVIILFTIIISACKKGRFYSRESLKLRITTKA
>fig|394503.6.peg.2590 Daunorubicin resistance transmembrane protein
MRAYVEFAKKAFQNNIAYRADCVAGIINAIIMIFVNICVWKAIYEDEQAVAGVQFKMLIT
YVVLAFLMQCIYAMDEYRIENKVRSGSIGLDLLKPINFSGYTFSYNVGILIFRVVMQLTP
ALIISIFLFKMLPPFSLTMFALFLVSMILGYLVLYCLNFIVWISSFWFYWTFSLVTIKDA
AVMILSGALLPLWFMPQAMVDFINLTPFASIYYVPITIYLGQMPMEEIAFALIKQLIWAL
GLFIIGRLLWRSALKKLVVQGG
>fig|394503.6.peg.2697 Antibiotic ABC transporter, ATP-binding protein
MNVIEIKNLTKVIKGQKVIDNVSIDIEGGKTYGFIGYNGSGKSMLFKAICGFVKANEGEI
YIFGKRIGKDIDFPEKVGALIEHPGFLPDINGFENLKYLSEIQNIITDKEIKDALAKVGL
DQEDKKKVKSYSLGMKQRLGIAQAIMESPEILILDEPLNGLDKEGVESIRNLLLNYKKEG
RTILIW
>fig|394503.6.peg.3306 Drug resistance ABC transporter, RA2 family, ATP-binding protein
MSLINVTNLTFSYDGSYDNIFENVSFQIDTDWKLGFTGRNGRGKTTFLNLLLGKYEYRGS
ISSKVPFEYFPYEVKNKEANVIDIIEEAFPNYVLWEVMRELSLLEVDDDVLYRPFDTLSN
GEQTKVLLAALFLKENSFLLIDEPTNHLDINARMVVSDYLRLKKGFILVSHDRAFLDNCI
DHILSINKTGIEIQKGNFSSWFENKEMQDNYERTENDRLKKDIRRLSEAAKRASDWSNKA
EAKKIGFDPTQTEKSIGRRPYQGAKAKKMMSRSKSIKERQQSAIEDKSKLLKNIESSEKL
KISQLNFHTNRLVELENVSIFYSDKKACDNVTLTIEQGDRIALMGRNGSGKSSIIKLICG
EDIDYSGIIRKPNQLKISYVSQNTAHLYGNLSDYARANEIDESLFKAILRKLDFSRIQFE
KDISAFSGGQKKKVLIAKSLCDKAHLHIWDEPLNFIDVISRMQIEELLLEHRPTILFVEH
DIEFCNNIATKIVQL
>fig|395019.3.peg.4257 Bicyclomycin resistance protein
MRTASRACAEGIRLQSNPSNGPASGAPARTTLMLLCAFSVLPLSLFLPSLPAIARELRAD
YALVGLAIGVYAALAASLELLMGPLSDRFGRRPIVLTSVGVFTLGAIGCALATDIRTFLA
CRLMQAAITSVYPVSMATIRDAGGGSRAASRIGYAAMAAAFAPMIGPTLGGALEQAAGWR
ANFWLLGAVGVALFAWCAFDFAETHTHRSPTLARQFRAYPALLRARRFWAYALCMAFSTG
TFYAFLAGAPLAARAVFAIAPAELGVCMGTITAGFVCGSFLAGRVAHRYPLATTILYGRI
VACAGPLIALALQVGGATHAAAWFGPCVLVGLGNGFTNPGAHAGALSVRPELAGSASGLA
GAMTIAGGAALSSLTSAVVTSRNAGYAPLAMMLLSAAAALAAACCVRSFDARDPAGADAI
AVE
>fig|395019.3.peg.5327 Multidrug resistance protein B
MMRPTRTASRDAADEARPARHRLVLPTLCIAVLIAQIDTAIVNLATGAIGATFGARVGAL
QWVIDAYNLAYAVLLLTGGLIGDLYGRRRAFVAGAALLSGASVVCALAPTLGVLIAGRAL
AGAGAALLIPASLAIVRVTWRDPAERARALGIWAACGGIAMIVGPTLGGVLIRSFGWPSI
FGIVIPFGVAAIVLAAVAVRESADPHGRRFDVVAQVLGALAIGGIVFATIDARHAPLHAA
LLVAASGVAVALFVRVERRLGAAALVPLDLLANRPFRGMLIANGAMTFGGYGMLFVLPLA
WQSHRVLDAAGAGVALLPMSVPFALVSFGSGAVAARVGARTAGAGGVALMGLGLAVIGIG
AAGSTDARAPMLAWAACGLVLTGTGLGLAVGSLAATAVGAVDAARAGTAASLMNVTRMIG
AVLGVAALGALYDAFGGGAAALRIAMGAGSIVQLGCAALAWRTSGGGRAPARASRAIG
>fig|395493.3.peg.118 Permease of the drug/metabolite transporter (DMT) superfamily
MLSIPVPLAYISVILIWSTTPLAIKWSNETAGVLFGVTGRMLCAAIICVLLLRVLHQPFM
WDKAARRIYFATSLGLYGSLMVTYWGAQFIPSGLISVLFGLSPIVTSLLAMHLLVGERQL
NFIKWLGLLLGVLGLWIIFRTEMGVGTDSLKGLFAILLAVFLHCLSAVLIKRLKVTLSPL
MMTTGGILCALPMYVLTGLILGVEIPHAISLKSLLAILYLGLFGSVLGFVLYFYLLKKID
AGRVALITLITPICALFLGQALNNEVIHFNMWLGAVIVLTGLSVYQWGDKRQVMGLSLNS
VKNI
>fig|395493.3.peg.183 Permease of the drug/metabolite transporter (DMT) superfamily
MTIKPLHATLLLLLASFIWGTTFVAQRISMGHIGPFMFTAIRFALGGLFLIPFFLVLHRK
RQIMPLPDDKRLLVWAGLCLGSLLFSAATIQQISLIYTAAGKAGFITGLYVILVPLLGLL
WRQYPDLGTWLGSILAVIGLYLLTVNADFSLAYGDFLLLISTIFWALHVLAIAWFVQRIE
PILLAIMQFLVCAFCSFWVALFLETTTIQSIIGAGIPILWGGLLSVGIAYTLQIIGQRYI
APTNAALIMSTETIFAALAGWLILQETFSTQGLIGCCLMFFGIILSQLQITTTRLQQWFF
MAKSF
>fig|395493.3.peg.480 Daunorubicin resistance ABC transporter ATP-binding subunit
MSQFIEIIDIYKHFPVIRGYRDFLWHSIRPRYVTALHQVSLSITQGELFCILGENGAGKT
TLLKILCTLMLPNSGRVLIQGLEVTQHARQIKALIGYVLSDERSFYWRLTGRENLQFFAT
LQNLSKAVAKARIQTLSEQFALTAYLDKPFQTYSTGTRRKLAFIRGLLTDPPLILMDEPS
NALDSLSAMQIWQYIQQTLVKQQGKTVVVTEHNLQKVEQFADRFAILKQGQVKTVETLRS
LRQQLQSTTRYQLSLQTSSPTVMNWLKQQGVIHQQIPLAPDQYTIEIELNPQVITPSAFL
TQLVGLGASVSCFVSITPSLETLFTAYYQHV
>fig|395493.3.peg.596 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQSVDVGNTGINPPSIGEILRFALPLILGLMTNALMTLTDTVFMGWLGTAQLAAVPFASG
IFLIGWVLMVGLMRSSIAFIARLYGAGDFTKIGHVLFHYQLLAILGLPLLLLYVQLFPFF
SELAQLSDVVAAYADTYLSILVWETAFTLLFILYASFYQALGNSAFPMRISLITLAINVV
LDYALIFGKFGLPALGVAGSAYATVLSQAIAVLIMSVTLFNSPMCRRFCLSIWQKVDFQL
IKQILRIGIPQGLGDFVELIAWVGLSVIAGRVGETALAANNIGMQFTLVLFLPGLALGIA
AASYMGRFLGENRPVLARLTTYKILWIGCSYMGLLGIPLWFFGADIARLFTDDAAVIAEA
AAMFKVMAIYQLFDCLGIITRTALSGAGDTFIPSILLVLCIVAILFPAAISLSTFIQPPL
VGIWLGAFVYMIVLAGFMLYRYRSNRWMHIHLHPQAMTA
>fig|395493.3.peg.2054 Multidrug resistance transporter, Bcr/CflA family
MRNPQSLTTAMILAACVALGPLSTDMYLPSLPMLVGVFSTSIDQVQLTLSVFLFGFAVGQ
LIYGPLADRFGRKPIMLLGMFIFTVATIICIFVQTIDGLIICRFFQAIGGCVGPVLGRTV
VRDIYGAVKAAKMLSYIATAMALAPAFAPIIGGYLATWFSWHAVFVLLSIYGVLMLWLVW
AYVPETRPEESQAVLNPLIILKNYTVLVLNRQYNGYVLCCSFAYGGLFAFISGSSFVLID
FLGVEKQHFGYFFGVIIIGYMAGTLIAGRFSLRWGINRLVLLGVVLMTGAGLTMVTAAIL
QIYTVWVVILPMMFFSAGGGIVMPQAMAGALAPFPEMTGTASALFGFTQSMMAALTGMLV
GHLHSGTSFVMASSIALMGIASLVSYFSLIHFQRPVAH
>fig|395493.3.peg.3266 Permease of the drug/metabolite transporter (DMT) superfamily
MRILNFSISPYVLPVLSTLFWGSNMVIGRAVMAEMPPMALAFWRGIVGLLILLPFAWRYM
SAQQALIRQHWLILLVLGALSVGGFNSFLYVGLQTTTATNAAILQSNMPILIIILGYFWF
RQRVTHFQFMGILISTLGVLVIICQGSWQVLTHFQFNQGDVWVLGAVLIWAVYSLLLQWK
PMDLHWLGFMGVIVILGVLVMLPFYIWEFMYSPRTWSPNLPTISSIIYVGIFPLIVAYIC
WNQAIFEIGAQKAGQFIHLIPVFGTVLSLIFLGEQLHYYHLIGIIFVVIGIYLALFWHKS
VA
>fig|395495.3.peg.430 Permease of the drug/metabolite transporter (DMT) superfamily
MKTSMATPPRGPALRGGVLALLASALFGISTPLVQHFGAGLGAFSTAALLYAGAAVLGAA
LRQPVEAEARLRRSDARRLLAMAGFGAVIGPVALAWGLQRTSGTSASLMLTLEALFTALL
AWRLYHETLDRRVRAAMALLLAGGMVLVLDQGRTGGTQLLGLLAVLVATAAWGIDNTLSR
ALAERDPAQVVMAKAALGATATTLLAIASGEPLPGVVAALALLAVGATGYGLSLRFYLLA
QRAFGAARTGSVFAFAPFIGAVLAVVLGDRSASWVMALGSVLMLAGVLLHLAESHGHEHP
HEALDHEHAHRHDDGHHEHRHDPMPAGEHSHAHHHEPMRHGHPHVPDAHHRHRH
>fig|395495.3.peg.783 Glyoxalase/bleomycin resistance protein/dioxygenase
MTSTGFHWCILYFTYASFASSLPVNESLHRPLCASLSPLLDPRPPFALVTFLHPPRISMN
FKFHHMNLCTDNLPRLTKFYKTLFELGTISDKEHTVVSGVRQDRAYTGNVDFLTDGAIEF
HWAERDLDTGFKMKQFVNPMGHGHFCFRTDDIKGFMRKCDQLGIRYSDYGCWAIPGWYQV
FLQDPDGQVIEVHQPGVF
>fig|395495.3.peg.1174 Permeases of the drug/metabolite transporter (DMT) superfamily
MTLTPRLILLLTVPPLLWAGNAVVGRLTVPLVPPLLLNAVRWAVVLLVLLVLGWRAIASA
QQRREVVSRWRYLGLIGLLGVGAYNALQYLALTTSTPINVTLIAASMPLWMLLVGVLFFR
EHPRWQQVAGAALSLAGVATVLSRGNPAALADVHFVQGDLYMLMASASWAGYSWLLVRPP
PSMQGSARPMVPGGPQTQGAPRPWNWAEFLLVQTLFGLLWAGSAAGLEAVLTPRQPQWTP
WVGVAIAYIVIGPSLLAYGFWGRAVALAGPATAGVFANLTPLFAALMSTALLGEAPHLYH
GAAFALIVAGILVSSRR
>fig|395495.3.peg.1797 Permeases of the drug/metabolite transporter (DMT) superfamily
MNPLPLERRAAAAIAAITILTGAAQMLAGGPLLALIATAPPDRTGAHLFATVGMFMVLFG
ASLLHAQSRREALAVVLLWAALQKLLAAVMVGWGVGRGVFVEPALLVAGFDLASGLLFLD
LRRRGG
>fig|395965.4.peg.309 Permease of the drug/metabolite transporter (DMT) superfamily
MTLQKSGDSTQGLALYYAILVAATFLMASSFIAGKILLAHDVPAFLLVGWRFVLAALAAA
LVLYLTTDDFRAALLPRRLDVADWMTVAAIGVLQTAMAMGLLFWAMETIAPPTAAILLFT
NPLWVALIGHAVLDERLSGLRLTGLALGVGGVALALGGGFSLREGAIGGELLGLGAALSW
TGSTLLNKRARLPIETWALTFWQMLIGALALLIVAYARGENWPQHLPLSAWGWFLWLAIP
GSTGSFGLWFLALTRGGATRSSGYLFLAPLFTVILSAALLGSTLSAAQGAGGVLIGCALW
MINQSPRKSGAAAKLDS
>fig|395965.4.peg.1113 Drug resistance transporter, EmrB/QacA subfamily
MVGLVCIGAFLGQLDATIVQLALPTLGKTFAAPLQQVSWVALAYLVAFASFLPIFGRLCE
IFGRKSLYLAGYALFVIASALCGLSTSLSELIVFRVLQGIGGSLLGANSISILVAAIGPK
QRGKALGIFAAAQAVGMSAGPAIGGLILAALDWRWLFWLAAPFGAAAIIVGWLALPQTET
TEQDMRFDWRGAVLIGPALIFLIVALNHLSALTSPLTMAFLAGSSALGWLLIRHERASPR
PLVDLLLFRSRAFCCGAIAVALAYALLYSMFFLMSFALEHGYGDSPAAAGLRLAIIPVAL
GATAPFSGALSDRLGAPLLSAAGMACCLVALLMLVISGQDSGGGHLVAAAAFALFGVGLG
AFIAPNNHSTVEAAPARLSGEAGSMLNLMRVLGASLGVAAATASLSWRLEDAGAGQSWLG
ATGPSLLRAVEASLMIPAGLAALAAAAALCAASPRAPKTA
>fig|395965.4.peg.1592 Glyoxalase/bleomycin resistance protein/dioxygenase
MFSFYVQTPSGVLIEYGHGGVVIDDLNWDVKTYSQLSDWGHSHGH
>fig|395965.4.peg.1888 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTGTEVQTAPEGAEAQTCPAAEVKSGVVPYLMVEGALKAVEFYARAFGTETAAIIPPDA
QGRTMHAHLYINGGSIMLSDFFPEHGCSQASAQGFNLMVQVDDIDAWWKRATDAGAEVVM
PVAEMFWGARYGQLRDPFGIVWALNQPLG
>fig|395965.4.peg.1937 Multiple antibiotic resistance (MarC)-related protein
MTKEWALFLSTFATLLAIINPFEALPIFLMLLEGKDLSEHRRVAARATLYATLLLFFFLI
FGSLIMQLFGVPLSMVRIVGGIILVKIGFELFSPSPNGGSIIPDASSKTANFAFVPLALP
IMCGPGAIATVLGMQSEIKEAPEHIGRFAATSLAILCAMFVTYLCLAYAGKLVDKLGPMG
IDATTRIVGFFVSAMGVGLVFNGVLQGLHEHGLIAPP
>fig|395965.4.peg.2627 Outer membrane component of tripartite multidrug resistance system
MVMTTRKATGLAAAMLACLTIGGCYSVGPDFTAPDPLLPRTSFLGKPEPRAEPEPPRLSE
QGSGADWWRTFHDKTLTSLAERVAGANLDIASATVRLGESRAQRGVVASAAFPSINGQAS
YQRELYSKNGILSLAGPNINAPPISVWQTGFDASWELDIWGRVRRQVESADASLEASEYQ
RRDILVSTLAELARDYVTLRGAQAQIAILTENLKSASDILELTRTRTAKGLTSDLDVQNA
AALVESIKAQLPALQNDVDVNANAISFILDEQPGSLKGELMQAKSRIPAPPRPPLGVPSE
LARRRPDIRAAEAQLHATTADIGVAVADFYPSVKLNGNLVLNALDAKNLWKGSSLQYQFG
PSVSLPIFEAGRLKSTLDLRSQQQQEAAIAYHKTVLSAWHEIVNALNAYSSEQRRRDSLK
AQVDHASQALAISRTRYNNGVADFLTVLDAQRTVLQAMQQQAQSTTNVSISLIQLYKALG
GGWQTTFPTEPPPPMEAAFAPL
>fig|395965.4.peg.3576 Fusaric acid resistance protein conserved region
MTPYTVRDWLFALKTFAAAAAALYLCFWLQLQRPYWAVATVYICSQQLSGATRSKAFYRA
CGTVLGAAMSVALVPNLVNAPELLSLAIALWIACCLYFSLLDRTPRGYMFILAGYTAALI
GFPSVDAPGMIFDVAVARVEEILVGIACATVFSTVFFPRQVGPLAAGRLKAWFTDADLWA
CDALEARIGDDVLSARRLRLAADATQLDALSIHLAFDASIQSYAARAIRLLRLRLLMLLP
VISSIEERMRTIAGGGRLALAETQALVDSICATLRDDADISAEQEAQTDDLIAAYERRLD
AGSCAREIVEAGLLLRLRDFVNIRRDCRLLCGQIETGARQLKRPLAFQSPAGVVDARHRD
RFGAAVSALTAFVCVGGVCLFWIATAWPDGATAAMIAAIVCCIFASQADPAAVLRAFAVW
SVVAVGVTMLYLFAILPRIQTFEMLVIALSPAFILFGLLATRPKTAEASVALSLWTATLL
ALQDNYSADFSAVANSGAALLAGIWISTLAFQLMRVTRADWRLRRLVEASRADLASAATG
RGKRDRAHFAAIMLDRLGLAASLLASSGAMDATAVALLAELRVGLNIIELRYARHGLPST
AVIKVDAMLIELGRYFRGRSAPPAPRLLALIDDALHAVASSPPGKHRRAALLGAGGVRYT
LFATAPEPGAMSVARVLTLDMFFARRVQ
>fig|396513.4.peg.1855 Teicoplanin resistance associated membrane protein TcaA
MAQSQDSNRDDSNKANSKKKKTNKTTNENINQSIRKMVPWGIGTFIIILLIILFFLLKNF
NSPEAQAKIFVNAVKNNDTQRISNILSTRDNKVGGDEAETYIKYIKNEIGLKKFDKELND
TVHDIDKKNKDAGYIKTPDGNNILRVTMNGRRYIFFDNIGFSTETKKAIIKKKAKTTYVF
RTDDKKRKVIAEPNETTMLGYFIPGDYKIPATKETDNGKFVGYLTFSFKGSNSETVDVHE
NFPEANLNIKLDGADQLDSKHTKVKINGKQFSYDNTKLYGPYPVTDEIEVSAEGKVKGKT
FKSDTLKLYPNELKENTPVRLKFEKDKIDKYVKEKEKEENSLKNKVNKFFNKYTSALNTA
AGANNFSSISNFLKPDTDNYKTMKQSFQNGQGAQSMMQSPQVTDVSQDGSDIYAKVANIN
SQGFWVTSKYKLEDTSKKDGDDSDLKIISNQE
>fig|396588.3.peg.308 Acriflavin resistance protein
MNWPEWVLHQRHTVIALLVGALVLGVQARFQLPVQLFPDTDPPTVTVITEYPGMAATDVD
ADLTRLLEEEFASLDGVTRISGTSQAGLSVVRVEFDYGMLATLAAVDVQNAVGRVRRDLP
GTIGEPRVLEFSTADKPIVTVALRSDTLDLADVREVADNAVRERLERVPGVAAVDIIGAH
RRELHVALEPDRAESLGVDLEQVVAALDAWNLVAPGGRVRHGALESVIRFDAPIDSAETA
ERIVLRSDAAGQVRLGDVATVSLAPGEIRNAYRFDGLPAIAVQVLRRDDANTVEVAARVR
EVLEALRAEHPALEIVVADDDSVFTERVITDMTRTVLVAVALTMAVVLVFLADLRQAAII
ALSIPAAFLATFALMQAAGLDLNMVTMSALILAIGLLVDDGIVVLENIHRHLELPDTSAR
SAVVNGVGEILSAKLGGSLTTLGVLVPLMFMGSFIGELFRPLAMTLAFALASSFVMAVTL
VPLLGVWWLRPGRPQAPNRLVVWLGRAGGAVRVNYLAGLGLALRRPVTILVTSVLLLAAS
LGMLRMVGSEMMPRFDSGSFRVVVDLVPGATLEETVRAVARAEDVLVGREHTLTVSTRAG
HEAGARAMGDRGAMSVNQAEITVNLVPRTEREADQWQIMDQVRQVLEQTPGVMLGVPREM
GGTARASTSAPIVVRVSGESPTMLDRTAQALLDHLRGVPGMTDLYKDWALDTPELRVRLD
HERVAELGLTGAQVARAVHRAMDGAVATRFRQPPLRDLDVVVRYAEPHRLHLEDLENVTL
VTPAGPVPLREVATLEHDLGPRVLTREDGQRTLDVLGYHLGRPLSEVVADVEARLATFEA
HDGYRVFLVGEQADFDEARAHMLRALVLAALAVYLLLVVQFGSFAHPLTVMSAIPLQFIG
VTAALLVAGKYISMPALLGIILLIGIVVNNSIILLDLTRRRMAEGLEIHAAVTEAVDTRM
RPIMMTALSTVAGMFPLALEMAVGAERFSPIATVIIGGILAATVLTLVVIPALFVVMERG
GRRRRLAG
>fig|396588.3.peg.1380 Glyoxalase/bleomycin resistance protein/dioxygenase
MKQKVFDADLDALHHVAIPVENVARAVDWYRNQFRVRIAYQDETWALLKFANTSLALVVP
GQHPPHIGVVHPDARSFGELKTHRDGTASIYLKDSEGNAVEILEDNAYV
>fig|396588.3.peg.2747 Drug resistance transporter Bcr/CflA subfamily protein
MSPALPRWRVALLVASLAMLAPFTLDTYLPSFPDIAEEFGAGPARMQQTLSIYLLGFAVM
TLVYGPLSDAFGRRRVVLVALVGYMIASIGCALAQSMETFLLMRAAQGATAGAGTVIGRA
LVRDIYAGHEAQRVMGLMMVMFGAAPALAPVIGGLLHDVAGWRSVFVFLSLFGAAVWLFT
FRRMPETLPPVARVSVAPHFVLASYGRALANARFMALVLVLALAFAGMFLYIAASPELIY
GLLGYGVNDFWRLFAPLVCGIVLGGWLSSRLAERIPPVTMVTTGFAVMAVAVSLNLLQAH
WLPVQPFTALAPLPLYSLGLALCMPNVTVLALDCYPHQRGMASALQAFLQLSANALVAAL
LVTVLSRSLAWLSLGMTGLYLAAAMLWGLWWLIYGRPVSIDPRGGGPENPA
>fig|397945.5.peg.1692 Permeases of the drug/metabolite transporter (DMT) superfamily
MRRWPARGELPRPGGPGSRDTAPLEEGTGMHAIAPLLFVVIWSTGFLVGRGVSAHADPFW
FLAARFVGVAVLFGAAAWWARVEWPRGPRRIALHLAAGALMNGLYVGPSWWAMSRGLPAG
VMALIGALQPLFTALIAVAVLRRRLGPSTWAGLALGFGGVAMVLWPRLSASAGVAALSLP
VLLAAAGSILALTVGSMVQKSPLAAGDLRSASAVQNLGSIAVLVLMALCLGEARWDGSPL
LWGYLAYSVLVLSIGGATLLIWLMRHGEATRTAALVLAVPPLSALQAWAIFGETLTALQV
VGFAVAIAGVALARR
>fig|397945.5.peg.1764 Outer membrane component of tripartite multidrug resistance system
MTFDPSAPRPAPAARPAARAPSAPRMLRACAAALLPAWLAACSVAPAYQPPALATPMPTA
FKEAGALWQPAAPADAADRGDWWTLFGDEELNRLAARVQVSNQNIAAAVAAYAQAQALVR
EQRAGLLPGVSLSAGETRAGGETRAGGEGSARRGTTAQAALGASWAPDVWGRLGSAVDSA
RANAQASEADLAAARLSAVGSLVAAYFQLREADAEAGLLRDTVQAYERALRIARNRYDAG
VAAQSDVLQARTQLANARADLATAQRNRAGYEHAIAVLAGQPPAAFSLPAGTWVARVPEV
PAGLPSTLLERRPDIAAAERAVAAANAQIGVQRSAYYPSFSLTASLGRSGTGLGDLFSAS
GALWSLGLSAAQTVFDGGAIAARVEQARAARDARVANYRQTVLGAFQAVEDQLTAVRTLQ
AQEPLRQEAVSAAQRAEEQMLNRYRAGQVGYTDVVTAQVAALSARRALLQLQVNRQLAVA
SLVQALGGGWQAPWMDGAAAATAGQGAAEPR
>fig|397945.5.peg.2166 Outer membrane component of tripartite multidrug resistance system
MRTVAMMPLLALLSACTLTPPLERPAPPVPAVFPDYGGRAGAAASLSPGTSVRPDVPVAD
LGWRDMFEDPRLQRLIAAALEHNRDLRLAALQAEAVQAQYRIQRSARWPEVALDASASRE
RGARSGTGAGAAGSAGAAVSGQAALGVGVSAFELDLFGRVRSLSDAALARYLASEHGHRA
AQITLVGAVADAYFAQRLAQEQLQLTVRTLSDWRQSLELARLWRQAGQNSGLDVVQAEGQ
VAAAEADLEARQRALDQADNALRLLLGSDPPAVLPEPLPLEARPVAARLPAGLPSGLLLA
RPDLLQAEQALVAAHADVGAARAAFFPRIALTASVGRASDSLGGLFDAGWGTWRFAPQIT
QPLFDRGRLRGELRLAQVRRSEAVVQYERAIQVAFREVADALAGAATYGRQIDAQARTVA
SAARRVELSELRYRAGTDGRLELLDARRQQYAAQQALLDLRRAELGNAVALYKALGGGLV
ERAHR
>fig|397945.5.peg.2590 Glyoxalase/bleomycin resistance protein (EC 4.4.1.5)
MAIHSINHVQLPFPAGEEGAMRAFYAGLLGLAEVRYPAENALHFAAGRQRIALVPTTRWQ
PAPAAAHLAFEVDNLPELRGRLLRAELPLVENRALPGYLRFYVKDPAGNQLEFLEPDAEA
GALA
>fig|397945.5.peg.3242 Probable multidrug resistance protein norM
MTEPAMRPTDPSSQHAPAHAPWRSEARASLSLTLHLLIGQTALMSLPLADLLSVASLGRH
ALAAVGLVNSVAALLTLVCFGVLQAVAPLAGAALGRGGGPAVARKVVGDGLRIASGLGVL
NSGLLLLFAVLLPGLGQEPEVARQAQHYAAALAPGMLAAAWLAAWRVGLPVLGRVRSLSI
TLSACAALHFAANHVLVHGMAGLPALGMAGLGWSYAVTYGTGVLVLHLLDRRPVPQGAGQ
PHAPSSARALLRIGLPIGAVMGIEYMLFTGSTVLMGRHGSSALAAHAVALQWVTLAFVIP
LAASHTVLTRLSLAIGHADADAARRSTAAACVIAGVFHALVAGAWLWVPEAFASALLPVP
IRDRDDLVATAAALLRVGALLQALNGFVVVLAAVLRACRDTSAILWQVLFGYWVIGLGSA
ALLGSMAGPAGIWWGMALGFGVALVLVLHRVRRRLTRLNDVFQPTEEIHAQSR
>fig|397945.5.peg.3315 Probable multiple antibiotic resistance protein marC
MARPAQRSPRRAVPRASAKPAHEGVRRPDAPHLNRDTVTLELLGAFGKSFLFVIAALLPI
VNPAATAPIFLGLTEGASPTTRALLARRIARNMFWLLLGAMLVGSYVLEFFGISLPIVRV
GGGMIVAATAWRLLTATQATVDSRTELAESFTPDMARRQAFYPLTFPVSCGPGSIAAAIT
VGVSLADARLSMSLARMGGGVLALLSVAVLLYFAFRYAQQLLKPLGEAGSVIFLRLSAFI
LLCLGVQIVWDGVYELGVAMLRDGMLPLNS
>fig|397945.5.peg.3717 Permeases of the drug/metabolite transporter (DMT) superfamily
MRRFYAIGFLVLVAFDTLAQISFKLAGEHALPLEFSSAWLARVFGQPWIYGAFVGYVGAF
FTWMTLLEHAPIGPAFAASHLEVVSVLALSAILFNEPIGWPQLLGAALIAAGIACLARSE
AEEQAPPASVPPSPHGA
>fig|397948.3.peg.379 Efflux pump antibiotic resistance protein
MESIRVMRVLILFTTSLAAFQTPFNSTVLSFIVPVLGKYFHASLYTLVYVPVVYLIPLPT
LMVLLGRIADIYGRERVFRIGFALFIVGSLMGAFSPSIYVLIASSLVMGLGSSILSPSST
AIVSQVFPEGERGFALGINAMAVYMGLTSAPFLGGLITQFLGWRFVLLVTTLLSVIGLAV
SFVSMRGIDLPRRGIPIDAAGAASFSIALLSIVIFMILAATGDWLNYLYLPVISAASFAL
FIVIEGRVKDPMLNLSLFTRNISFMAGNVTALLNYISTYSVPFLFSLYLQSILGYTPFEA
GLILIPEPVFMVILSPISGRLSDIYGSREVAALGMGLIGLAFIMLLILNLRSVVNVVLAL
SVLGVGFGFFSAPNTNSVMGSITRDKYGVASGVLGTMRFTGQLLSITLASAILAKYLGKY
TALYLFTGVPLMSTIVYGLFTAGLRIMFIIAAALSFIGAYTSLLRER
>fig|397948.3.peg.460 Quinolone resistance protein NorA
MVDNRGFNYFMVNVLYSLVSGLIYPSFPLYLRMSGLNVEFTSYALTSMNIAGFASSIMWG
RVINRPENRRIAVLIGTIGGGLGYLTLAYIKGTLTIIAALVVLSIIAGGIYPTVMTLISE
TGGVEHMGYFWAGGSIGYAITTSFAGYVLEHMGIRPLFIISAIIYVSSAAILLNIVNYST
HRKPSDHATPLNTNDESFTLSLSALYIVSVFILLFIDAVKNLYMPMFYVYEANVNMAYAT
ATLSVEAFLEVPFIVMFVQLIRRNKADSWTALSLSLALGSLYLVANALLVRGTLSAFAAM
ASYSLVWASYSVSSSMIAPLISRGNRGLAYGIYNSVFPLANIIAPLCMGYSIASLGYRLS
LILLSAVALVIALIAFLSRPLRSRINKAVVNSP
>fig|397948.3.peg.1126 Multidrug resistance protein
MVSKASAVVNIMIARFIYSVYWYYLAPALPLIKLEFTVPNYELGLVPLFFIIGAGSFQIP
ASVIARFIGNVKTAVLGLTLLSAAGVATAFSVSFNEILALRLLAGIGAALFFSTAATVVT
NLYPGREGLMLGIYNSVFSAGAGVGLVYGVVYTIVNWRVAVLIISVVGLLESVILLKTCS
PLNRPIDTGLSINKGAVLVGLATAGYWGANYAAGNLLPTYAVNHGVGLVNASLITSLLLF
SSLVGGLSGKLADLTSRRELLIIAPAVLGSLSFLLIITLNPYAMIASTLIVGYTNELMIT
ASYALVVNDSNPTMSLATVNTLNMVVGMWLSPLFTAVMGNSTLPWITMIIASVAPLPLLL
VRRRVVG
>fig|397948.3.peg.1265 Fosmidomycin resistance protein
MMQEGKGKDRATILGLTSIGHFINDGNTWLIPGIILPVLSEMGVNYAVIGLLSALYSAIS
ALASPLVPLSIKWLGGHMKAMALGMFLWAFAIGLSSIGFLIHDLPLVYVGVVLAGVGAAY
YHPIGSALLSATYGGTAGSALGVNGAFGSLGRTLYPLIGSLLIFAGSVSEAYNLWVLAFI
TFIVGLSVLLYGVYRFDVHAYGKSTSRSDPSSNSMTLKVSVMLIILLFIITLLRNTAGQG
VQTFLGIYINKVLGIKLSVTYGEVLSMILASAIVGQPVLGWLSDKVGRRFMASLSTFAFA
VLFIIFIYTGNLIAVFLAMLFVFSNFPLIMAVLGDLFPREQVSWATSIIWNGAVTGGNVL
GSLITGLLAQYYEPIYGEVGALEHALLIVLILAFISSALWVVVPKPPKRSRIPLFG
>fig|397948.3.peg.1339 Multiple antibiotic resistance protein MarC
MVAFSLFDSLVAAVQLYAIIDPLGAIPLLVSVPDYEKMMNKFLRLVAVTVPLLLLLFAFA
GPFIFYVFSININDFRVAGGIILLIIAIDVLREGTPKTMGINPEDYVIVPIITPMLVGPG
AITSVMVMVTYYNIFSVITAVLIASLATYITMKYSVYLVKLIGNNTLKIFARFFSLIIAS
WAIQLIASGIINIVKAI
>fig|397948.3.peg.1731 Permease, multidrug resistance protein
MDKVQFIVLLLLTLSSFMVALDSTIVILALPVMLTALHTDLSTLIWVILIYILSVTIFST
QLGKLGDIKGRAMMFNLGIILFGIGSALCGLSTNAVELIGFRAVQAFGGSLMSSNTMAIA
SDYFPTSSRGFVFGTTSMGWNLGAVAGILAGGVITTFIGWRWIFYINVPVAIIGFIMGLI
YLKDRGIRTRQGFDIPGSITLGLSLGLYSMAGITYSGIGYTEEVGLMLATATVLLVLFLY
IEMRAKYPLIGLSLFKIRMFTLSSLSYFFQYMANNAILFLIIMYLQGVRGLNPFEASLWL
IPGYLIGSLSATLSGRLADRFDARIIASTGLTLQAVAYILYDTLLTLNTPLYLIVVITTV
SGTGAAMFFAANGKMVMHEVPSNLYGVASGTNRTIGNIGILLSFIVAIVVSSAAVPRSIA
FQIFVGASALTPSLMEPFINSLHMAFKVSLALIIIAIATSWSRTRVPMTQRREIINK
>fig|397948.3.peg.1930 Multidrug resistance transporter related protein
MLINNAEYDLKYAYRAMVILASLAVIVMYIEGMLIPSLTEIEREFGVTSSQVSWVLSSYL
LSGTVLLPIVGRLGDIYGKKRVLSAVVIIYAVAVTLTSVSPSFTYLIAFRGIQGIGVTMF
ALAFSLIREEFPRELIPRAQGLVSAAFGIGAAIALPLGAYISQYFGWRTTYHTAIPFVLL
VAYLIVTRIKESRYRNPSAKVDLPGAAVLGIGLGLVVYGLTEAPIWGWTNPNTIITFLAA
LIFIGAFIAVERRREQPLINLSLLTRRNVLIANLAAMVAGFGLFLFEQSLIILLEEPKPV
GFNLSIFDTGLYAIPMAVAQLIVAPVAGILITRIGARRMLMTGASIAALFSLITAAVAPL
GLGALITSTTLAMAGVAAMNVSLINILVFSVEPQVMGVSTAMNSVFRNLGGTLGPAVAGS
LESTFTSLVLMGILPGRNVPLLVTVPSMYAFQIGAVISALTVVTIGILAYFSVEVITWRN
ESQTVASLSQE
>fig|397948.3.peg.1942 Permease of the drug/metabolite transporter (DMT) superfamily
MWVIWCREMSRLSGGLIYSIALALVWGVAYPLTRMAEAYASPMVISVVRVGAASLLMYPL
ARRLILNSRMLIVSVLNMGLFLVLINMSILYSPNPGLAALMIYTQPLFVAVFEWLMLKRR
LSLMRIGGVLLGFMGVAVASLSSLSLSLGVVVGLMAGLLWGLGTVLYSMWFRDVNPLVAN
ASSSVLSIPVTALALPIDPALSLTIKGILLILLVVLDAQVLGFMLWFKAISSERPSTVSS
ILLLTPILALYFSALMIKSSVTPLEVVGAVITIIGLFMVVKSS
>fig|398578.3.peg.1858 Permease of the drug/metabolite transporter (DMT) superfamily
MNRYEHIVRAMNFQRFFGPHLRLVGMALLWGASWPAGRVVAQNMPPLAAASLRFLLAAAV
LLPWLYWAGGMAGLRHWSAKRWLGMAAAGATGVFGYAAFFLMGLQHVPAGKAALVITLNP
VLTLALAVWLFGERLNRTIALGMALAACGAVVVISHGQPLALLQGSVGAGELLILGCVVC
WVTYTLIGRWLLTGVDALSATAVTSTMGAAMLLVASLVVEGPAGLQAAVLGNATAWGALA
FLAFGATALAYAWYFDGVKALGAGAASGYITLVPVIGVALSALWLGESIDASIVLGGGMA
VAGTALMNWGRRPAAAVHVVAKRTAVQS
>fig|398578.3.peg.3319 Multidrug resistance protein B
MTPTPTTSLTSPPGRRNLPRLCFAMLVLTLVLAALDQTILSTALPVMARELPGHWPLAWV
FSAYLLAATVVIALYGRLADVLGRKPMLLLAIGLFLAGSLACGASHDLQQLVLARALQGA
GGGGLMTLTMLTLADLFAPEQRARYQGLLGAAYGVSTMVGPLLGGALVEHLSWHWAFWLN
VPLAGLAWGVLAWALPARAAAPEAAAEPRPRQRIDWLGAVLLAAALVSLLLATQHSHLNL
PEQLSLWVLLALGAKFALAFFVRQRRATHPLLPLSLFAHPAYAAVSFLALSTGVALYAAV
VFLPQYLQIGLHLSPTGSAWHLAPLMAGITAGAIGSGRRLRAQTPAASLARVACVLMLLS
FGLITAALHWLPQAPLALSAGLLPLGLGLGLMFPIITVVAQRVSPARHLGIATAAPVMLR
SLGGAAGVALLAALLTHLMKQELAAASPLAAQADAVTAALGHGLQAIFGCAALAVLAALA
ACRWLPARKAAARDGQGAPAAQSAAIRRGAEGA
>fig|398578.3.peg.3325 Permease of the drug/metabolite transporter (DMT) superfamily
MSHSPSLTSATSPTRPRTSQGGTWRMLLAMALSGTIGLLVVESALPPLLVVFARCVLGAL
GLGLWLAWRREWVAPQGREWLWLAGGGIALVLNWVALFSAYHYSSIAVATVVYHVQPFML
LALSALQGEPVERRKLPWLLLALLGVALSSGLVGLDGMDASHAGTGAWVGVALALLAAAL
YAGTTVATRRLGHMPSAQIAMLQMLAGGLVLSLWALPLLTHIAAASPQLLSARAASMVLT
LGLVHTAFMYTVMYAAFQRLPAPAIAALSFVYPAMALLVDLVWFGAVPSAAQWAGMGFIL
VAVVGHRAGIALRRH
>fig|398578.3.peg.3729 Outer membrane component of tripartite multidrug resistance system
MPKSFVSVSAAPRRVAAAAATLCAALALAGCASQGPAHEPLARLGASDLGLTAQSETGSN
TSLPAADWWKSLGDAQLDALIAQALQGSPSLAMSRARFDKAAALATATSTATDVRGTLGV
DATRQHYSANGLVPAPIAGHTYNTGNLQAGLSWTPDFFGRHAADLQAALGQARAAQADSA
AAANQLAAQVARSYVALARLIAQKDVAGRTLTQRQSLLDLSQQRTRAGLDSQVELTQAQA
GLPDAGTQIEMLDEQITLARRTIAVLCGQAPEAQLQLSPRLAALQIQAVPGQLGADLLGR
RPDVVAARWRVESATQGIESARADFYPDINLTAFIGLNAIGLDNLFKGSSRQMGITPALR
LPLFDGKRLRAQLRGTQADLDTAIAQYNGVVLDAVKEAGDAITSVQSLVRQQQLQAESLE
KAERAYDFAVQRYKAGLASQVTVLNTETQVITQRRLDVDLRARALDTRVSLMKALGGGWT
DGTAAVQVSQH
>fig|398578.3.peg.3899 Permeases of the drug/metabolite transporter (DMT) superfamily
MQDRTHSLQAASVASTAPAPTPAQAAPTAQETRGQWLMIAGGVLLGTVGIFVEEARQHPL
VTVLFRCAFGALALLAWGLATGRVRELRVRGRSWPVVVATGLLMVLNWALFFAAIPLTSI
GVATIVFHIQPVWIMLFGTLVLREAVAPRQVAAMLAALLGLVLATGLLGGDAAAWGPDHV
SGLLMCLAGSLCYAAVTILAKTEKVVTPFALAWWQCAVGTVLLLWVPLVHGWPQAPSSWA
WLAGLGVLHTGLAYAILFAGMARLTLGRIAVLQYVYPLTAIVLDWAVYGRALGAVQLAGV
GLMAGALLVVKARQLR
>fig|398578.3.peg.4416 Multidrug resistance transporter, Bcr/CflA family
MNFADPGPRRSVSFLLLLPLLLAAQPVATDGYLPALPEIARDLGSASSSLTVFMLAFGVA
QLVCGPLADRFGRRPVLLTGLACYTAAAAGCALAGSADALVAWRAVQGAAMAAILVCARA
AVRDLYPAHEGPRIMARGLTGLGLVALVAPIAGAWGVQATGWRWVLVAMGVYSLALLALC
WRTFSETRQAPAESAPVLVPVSVSAGGVRQVIADPGFCAWTALAAATYGGIFCFLLLSPM
VYVDLFGLSPVLYGWIPAGGSLVYILGITWCRRLLSRHGPVRTVQLGASLSLLGPCIQIA
GCVLAPASPFPLLLGHAVYALGHGLHQPCGQAGAVGGLPPQLAGRAVSCSGFAIMCVAFC
AGQLAAQFVDPTMRHGAWPMVLPMALAGVVLVLIAFVWLPWLYRLRSAQRVQPRS
>fig|398580.3.peg.811 Glyoxalase/bleomycin resistance protein/dioxygenase
MGWSIHHVNLQARDVRKTAAFYTQILGMTERDWVFPESRGYLPGDPDKLALLGDGREGHT
GLHLIAPDPEFASKNNLIHNPSEGGHVAIHVDDLQAVIDRLTAAGVPFSVTGEFAIPGLR
HVYVTDPEGNLIEVNGRV
>fig|398580.3.peg.949 Probable multidrug resistance protein norM (Multidrug-efflux transporter)
MPMSHASPIPTTISELAPLLRLSIPLMIGLAAPMLIGVIDTVMIAPLGTEPLAAAGITTS
VVIILLSSLWGLVTMTGIRIAQAEGAGDRPGVAIELKTGLWLSLAAGGLGMALMLAILPA
LGLLGQPDSVRAILPGYWVSMAVWLLPFTAFYVIKGLFDAVDRPWAGVALSYLGVVVNLP
LNWLLIYPAGLGLLGAGLASILSQTLALGAAWLVWRRAKGLAPWRVPVPAGALRLRAQIR
DGWPLVVGYAGEGGAYALIGLMMGWVGATALAANQIVHTVGAVGYVFPLGMAMAASIRVG
LAHGAGQTGRLRAILRAALTVVTGWMILLMAFFLIAGDWLSGLLSDDPEVVALAATLFIA
LACMQIADGVQSTSLGALRGMGDMRWPTAMSLIAYWPLALPAAYALGFWAGLGALGLWVG
FGLGLAIAAIMLPLRFWHLTGRAPAMQIGH
>fig|398580.3.peg.2126 Drug/metabolite exporter family protein
MPPRESIDAFGAVALVGFALLMGLNQVAIKIVGDGLQPVFAAGLRSLGAMICIWLWMRFR
GLPLKVAPGTVKAGLAIGALFAIEFLCLFIALDINNVTRVSVLMYSMPVWLTLIGHWVLP
GERMSLSKAVGLALAFAGVIVAFASRGSDLVTGSFWGDLLALGAAISWAGIGLLAKASAL
KTVRPEMQLMWQVAVSAAVLLALAPFFGPLVRDLAPIHVGSLLFQIVVIVSAGYIFWLWL
LSIYPAGGVSSFAFLMPLSGFGFGWLLLDEPLSASLWLSLGLLLVGLVLINRPRRAR
>fig|398580.3.peg.2280 Multidrug resistance efflux pump
MSETQTSPPSGGSPARTVALVVVVALVLIAGLYALMDRYVPSSPRGIVSANVVQIAPRVS
GTITRVHVADDAIVEAGDPLFSLDPRPFELAVRQAEANLNTALQTVDASGASLVAAQAAV
TQARTALENTQAEADRTFQLEERGIVATARGDDARAAVESAQAQLDQAEANLDSARAQLG
PEGADNPTIQAATAQLEQAQYDLASTTVTAPHLGVVTNVTLSEGQFIGAGSPALTFIDAE
AGWITVDLRENQLQKIEAGDPARVLFDALPGRIFEGRVQSIAWGIAPRRTVQGGLVANQQ
TTQWFEPARTIPVRIELEGGMENWPYAVRVGGKVHAVIFSESETGPIAWVARGLQRLRSW
LSYLH
>fig|398720.4.peg.40 Outer membrane component of tripartite multidrug resistance system
MRLTEAWEYAAQYSKEIKLKQLEEKIGAEDVLDAKNQRLPELSTHASYGKLSNIPVFTNG
IREKANFIPLEDHSTYGAGVEAYFNIYNGGKTNIHIDQAKTKQRLINYLAEESRDQIKYE
VASAYLSLQRGLLFEKLIAKNIYSNQELLDQITKLYENGVVLKSDLLRAKLQLSKQQTQL
LEVTNNAKLAHQHLNILMGFSEETPVKPIDTVKVELIQEDQDYAYYLNEAKSAPLSKAAE
TQVTLSELEEQDLKAGKLPKLGLFGEYMYSYPQIRLYPYETAPYLLGIVGIRASYDISAL
YNDKHKELAAALEVERQEVEKQQVDDDLRKGIKAAYQDYHEDLQNIEVALMSIEQAEENY
RIVRQTYFNQLSLLTDLLDADNQLLQARFELVNSKIAARLHYYQLLKITGNL
>fig|398720.4.peg.41 Membrane fusion component of tripartite multidrug resistance system
MSNTIKNYQKIDLIAVKSTYVVALLILIGLLIWGVSSAFHFMNYEETNDAQIKEYINPIV
SRTGGYIEKIAFEDHQYVQQGDTLVVLETNESEVSLQEAKAALAEAEAQLMVLESNVNTA
NSNATVNQAQIGAAEAKLWQQQKEYERYKKLHEAEAVTQQQFEDVKTRLGVAKSNLEAVK
NTFNTSQNRSNDASTQIAVAKAHIEKQKSVLDRIQLELNYAVILAPSDGYMGEKRLQAGQ
FVQKGQTLSFIVDQTQGKWVIANFEETQIANLREGQPVNIQVDAFPDEAFEGVIESLSPA
TGSQFSLMPPDNATGNFVKITQRFPVRIRLKKEQQDLSKLRAGMNVEVAIPKA
>fig|398720.4.peg.42 Inner membrane component of tripartite multidrug resistance system
MSNNTVFKSWVPNWLVLVVIFLALVPIASVLGIYMSGINSAASYYGADPTDIQYSVIIFY
LAIASAFPLERRFFDYFAPKPYFVVCAIIYVVLNLILYSTNSIAILFIIRFLGGMLSLGF
IGVIFTLIFRQFSQQRSRVLGYATFYGALFSTMPLAQILDAYVFSYYDFNVIFLIKIFMV
IPGFLLLLIILKRNVNLRNTKRIPLYSVDWASFVLYASALMLLAYVLLYGLYYQWYSSGR
ILICSIAFVFLMLLFVFRQLKLKRPYIDFSLYKHRNFRIGMLLLIVFYFCKGDMSVINGF
LNNNVNLDVYHKGYIMLFNALGIIAGVGLTARFILTGTNIRLIWVTGFLALLGFHVYMLL
LLGNQAELSDLIIPLFLQGFSNGTLLLSIVIFYVTGVPSAIAFSASVSGVAFRFSSFTAS
MALVSYMGLNRQKIHASAFANQIQQTNDLVGARISGYKEALLNQGASAFQANAGASKMLG
QALNNQSNLLFARDYYLYVSVVIVAVILAIILIPNFHYHMRKIGAKLIPF
>fig|398720.4.peg.735 Tetracycline resistance element mobilization regulatory protein rteC
MKEAEARVAAFTRELQALQEAQATPLKCALEAIAVCNKTLSSLQHWVDTHDFESIPSEIY
FFKSLKSEPMSHLIYYTEVRTCELQKPKAGKHYQVSFLQKELKKLNKFFYRNADFVHYME
LGHTYLDHQYFSRTQNPEYPVNPLVHYYQFPEFTTSHDMLWAKVKAMNRYIHYIREQLEA
LQPGQNFKWKQDKHKVLVWTGSKTALVELIYALYSDQVINHGALDLKQLTSGFEDFFNIK
LQHPYKTYTELKERKGSRTKFLNELILKLEQKMLAEDA
>fig|398720.4.peg.2636 Tetracycline resistance element mobilization regulatory protein rteC
MNSQLLSKKLLEDLDEIRVQNENILECAWRSIKACRNLLTVYKNEILSKEFKTIKEEIQF
FKETKQVPLIRLIYFSEIYSFEVQFPKGNKDCQLKFLKKKINKLNRFFLYNIDFGRYVNS
GATHFDKEYYTRDYLETFHITTSKFYFQDPDFCTPRDMLLGKYKAYDCLVTYFDEKKDRV
HNGLNGKHERIKPMEKIDWPFSNTDYVELLYALCSKGLGKRNNQGIMQVSKKLEQIFNIE
PKDIYKTFQDIKNRKKSRTLFLDDLSTSLLSEMNRSEE
>fig|398720.4.peg.2913 Outer membrane component of tripartite multidrug resistance system
MATAQDLSGYIAEVETNNPEVQAYELRYSIAQEKVNEVNTLPDTEFGVGYFVSTPETRVG
AQRARFSVKQMLPWFGTISKREKYQDALVETEYLEYVIAKRKLGLAVAQGYYKLYTIEAQ
SKVVQQNVELLERYKELALNAVEVAKASVVDVLKLEMRQNELKAQQQILEERRIAAEIQF
KNTLNTASEGRILVVDSLSIPIEDEQINSEDLSANPELLKYDKLYESVTQAEILNRQEAA
PKWGVGLDYIPVSERTDMFPADNGKDIVMPMVSVSVPIFNSKYKSVSRQNELRQQELDAQ
KAQRLNTLKNLLAEAKQHKNTARINFNTQKQNIAQAQDAEEILLKSYETGSIDFNDVLDI
QELQLEFQLKQLQAVQNYYEQAALINYLTNI
>fig|398720.4.peg.3496 AcrA/AcrE family multidrug resistance protein
MAQAVPQYPVLKITEAPTTLQRKYPAVIQGEEDIEIRPRIDGYLQKIYVEEGSRVKKGDL
LFKIDAPQYNEVVKAAQSAVKNAELKVQKATPLVEEGIINQYELDAAKLDLEAQRASLAQ
AQANQGYTFIKSPVDGVVGAIPYRTGSLISPQVVAPLTVVSDIDNVKVYFSMDEKEYLEF
YADHEGNSVDDKLKSFPKVKLQLSDGSILESEGEITAISGLLNQQTGSARLTAVFPNANQ
RIRSGGSGKILIPQAFSSAIMVPQKSTFELQDKRMVYKVKDDRVFTSEIKTMPTTVDNKF
VVTEGLSEGDIIVFEGAGTLRDSLQIKPNIITQ
>fig|398767.5.peg.2582 Permease of the drug/metabolite transporter (DMT) superfamily
MSLIIFGKSHVHRPLFAYLLLTLSALIWSGNFVISRAVASLIPPVGLLFWRWVVALAVLC
PIVLPRLKNQWPLIRANLKIFPLFGLFGVTLFNLLIYLAMHTTTAINAALVNSAIPILII
LFTRIFFRKGVSARQWVGILLSLGGVCIIILRGNPATIAHLTFSAGDLLVLGAATSWAAY
SVCLRYYPEGLDPLVFLFCIALCGQLFILPLYLLEVINGATVPVTAASLASIGYVGVLAS
VVAFVAWNSGIRSVGAQVGGQFIHLMPVFSTILAVLFLKEHLQGYHLLGILLIVVGIIFA
TDLLRLRKS
>fig|399549.6.peg.312 Multidrug resistance protein
MDKRGREVLLLLVWGDLLINYVETMVVPAIPTIQSDFSVSSTLASWITSAFIIVGAVVSP
IFGKLADMYGRKRMYLISLGGYLVAVALAGFSPSIYALIAARAIQGIGYGIFPVGLAIIT
DVLPPQDVATAQGLLSGSVGIGTALGLIVGSYIDQNFGWQYAFHTAFILSLLFFLLILTK
LKDTGVRVKESIDYVGTTLLTVGMVLILVYITEGPSLGWLNAENLVLLTLGVLLVLVFIP
VELRVREPLVDMNLMRIRNVMVANLVGVVSSIALMIMYFGIIYYAQLPPPFGLGLDIFSA
GLTLAPATVVMFVVGPIVGKLTGDAGPKPLLVFGSLTSILGFILLMVNRGTSQALVEDVI
VAGTGMISIIIPLINMIAVSLPETARGIGLGVNTLLRNLGASIGPVLATSIMSSYKDPYV
LIVDNQFLISFYPGSEAFNVMFEVAVLVILVNLGISLLTRNYKLKGKGRNIVL
>fig|399549.6.peg.419 Fosmidomycin resistance protein
MILIMESKSLRALIFTSLAHFSNDGVFLIFPLLIVYYTTDERISVVFLGALAIVYTLLSG
LLSPLIGDVADKRDSDAELIALGIFLEALATGLFALSFLDRGLAIPLITLGVVLLGSGQA
FYHPLGGAILARIFGKSSGRALGINGAMGSLGRAVMPSIITFLILGLGEVLGLGIFTVYM
VLVTLVIYFGLMNVRRGSMSLVRKATEKLDRRFYRFLIILGALVFMRSMFISGTTTFLGE
FVYQVYFSKAFTGIFLTIGFLGSVFGQPVFGWLTERLGGRTTFLLSSILSLVFFGLFLVF
PRNLFISLSSYTLFTFAAFTGFPILLGYIGQVFPKNFFTVANSYVWGIGNTVGGAAGTAL
VTWLLDLHYDLIFSFTVLFVIAVISTVLTPLIPKKI
>fig|399549.6.peg.1340 Multidrug resistance protein related protein
MDSFNWLLLSRALRSIGIMFVTISSSLYLSTLGLSPVIIGLVFLGMTGYIAGFSLSLGML
GDRVGYKKSLILGDLIPAIALILLISTRNPLVVIPSAIITGLGGTAGGARGAFSPGLTAL
VARNWKEDQERVRRLGKLTSISALAGAGGGILLSFHDYLPFGNVNDFRFLFGVASGLLFA
SALCILKVEERRGEKKSTKFMRKGSLRYISKVIVSNTLSGAGVGLAIPLLPLWFNLRFHA
SPLIIGVIFTGASLSTSLGSYIATRISRNPLRLASLTRIMNGGFLLAMAISPFLPLAGAL
YVVRGFNAGVGMPNRTAINVRGVSEDDFGTASSLQGVATRLSQMSSGLSGYLLEESFALP
LEVGGVMQALGGILYYTLLRGKEERREEKPKTV
>fig|399550.6.peg.126 Multiple antibiotic resistance (MarC)-related proteins
MLNGDNNMFDLLFAYYIQLLAIMNPFSALPTFLSLTDHLDEIERKDIVRKAFITSIILVI
LFSLIGNYILLAFGISIASLRIGGGILLLVIALDMLGGMPRTKQIEYSDIAVVPLATPMV
IGPGTITTILLLTSREPGFLNIFLVLIASILAATTTFIMLRYSTKLVSILRVSVIRAIGR
FMSLIIASVAVEMIALGIISFYHTYFC
>fig|399550.6.peg.291 Multiple antibiotic resistance protein MarC
MVVNMEIDVYQLVSAILMLFVVLDAPGNAPLFYFFTKDMEPWKRIYTIRKSIIVAAFILL
LFGLFGDYILLYFDITVNDFRIAGGIILFIYAVLGILGHTTAEEVSGEEIAVVPLATPLL
AGPGSITVVIYLKYSMGLLLTMLSIAINMIIAWILLENGGKLLQLLGKQGSTVLSKILAI
LLAAYSVAMIREGIISLINI
>fig|399550.6.peg.569 Permease of the drug/metabolite transporter (DMT) superfamily
MRNNYPSILKHYLALLGTVILWGTSFPVIKILVSNVDEYTYVWVRGLLSIIFLTPLILFY
ISKKYVSKECVKGGLLAGIFYGLGLFFQGWGTSYTTASNSAFITGLNVLFVHLIVASMYK
RYSIRLFASLVSGILGLYLLSSPTTIGRLGDFLVLIGAVMWALQIIVFDKYSKCNPFILV
YFMFTPTQTFILFDPSPADILETRINVLLGFIYLAIFCSIGAFALQAYGQKKVPPETAAT
IFLLEPVFASIFAYMFLGETLTFKQLIGASFILLSMYLASKHLLK
>fig|399550.6.peg.720 Permease of the drug/metabolite transporter (DMT) superfamily
MMVMQMEVIGVLSALTASSIWSLSPGLISRYGKGVDAITLNMLRSLHAVFVLFFIFLLTI
NDRWFVPEGILIVYISAFFGPLLGDTLYIHSIKHIGGGNAVSISYTYIFFAQLYSYLLYG
EQLRIQLILGSFIAIIGVYLVYSGQRNDIKIIGFLAALGAALSWGMGATLSKLALNYGDP
VTIALLRNLSTTISLLPITYNSVKKVFLDKEVQITAFITGGIGFGIGMTLFLTAINTIGV
SATVLATSLTPVLGRILAKYIAGEKPSPKTYLGTIITSTGIFIGLYF
>fig|399726.4.peg.889 Multiple resistance and pH regulation protein F precursor
MFFMEMEILKTLGGIILCITIIISILASINRKGVLEKVVITNIVNTKTVALIFILSYIRN
KPVFLDVAVVYALINFIAAIAVSKFFDGYHKQGD
>fig|399741.3.peg.1579 Multidrug resistance protein B
MKGFPPLINTLLASSLVLTIGRGVTLPFITIYLTGHFHLLPKSVGIILGISLMIGIFASL
YGGYLVDKFNKNTLILTAILLFALSFFAIPWIPRPGGIIVVLAILHTAYSVLGITIKACF
ADWLPVAQRIKAFSINYTLVNVGWAVGSSLGVMVAGLNPLLPFYLSGGLALCTVTALSFS
LHRQRTTPPAATEAVPSAPPNFRQTLTILRNDHRLIYFTLGSTLGAVVFGQFTGYLSQYL
ILVSNAEFAYQVIGAVMIVNACIVIALQYLLSRGMRQENMLRWLALGTVFFILGLIGFSL
AGQSLWLWAIAMAIFTLGEIIVIPVEYMFIDFIAPQHLKGSYYGVQNLSALGGAINPVLC
GFILSYAAPQMMFVMLIAAALFSLLFFFLGHRLAQKQQYRAGIISTK
>fig|399741.3.peg.3399 Permease of the drug/metabolite transporter (DMT) superfamily
MMSARKNIDSRAAAAMMMICAIWGLQQVAIKAAEPDISAVLQIAIRSGIAALAVYLLARY
RREKFVFDRPTLLAGLCVGFFFALEFFFVSEGLRYTSASHMAVFLYTAPLFSAIGLHFVI
RHERLSLIQWVGIAIAFGGVVLAISGMSDSSGAENSLRGDIYGLLAGMSWGGSTIVIRTT
GLANCSSKQTLLFQLSGACILLSLLAITTQSVHFNLTALAWTSLIFQTLVVSFISYLIWF
SLLRHYQASSLGILTFMTPVFGILAGVVILGEPLQIEFVLGSVLIVLGLIVVSCSYLFYL
NRGIVPKI
>fig|399742.4.peg.891 Multidrug resistance protein B
MESWKVNLISVWFGCFFTGLAISQILPFLPLYVSQLGVSSHEALSMWSGLTFSITFLVSA
IVSPMWGSLADRKGRKLMLLRASLGMAIAILLQAYATNVWQLFLLRGLMGLTSGYIPNAM
ALVASQVPRERSGWAISTLSTAQISGVIGGPLMGGFLADHVGLRAVFFITALLLMVSFLV
TFFLIKEGVRPTISKAERLSGKAVFATLPYPGLMISLFVTTMVIQLCNGSIGPILTLFIK
SMAPDSNNIAFLSGMIAAVPGVSALMSAPKLGKLGDRIGTARILMATLIFAVVLFFAMSF
VTSPLQLGVLRFLLGFADGAMLPAVQTLLVKYSSDQVTGRIFGYNQSFMYLGNVIGPLIG
ASVSAMAGFRWVFAATAVVVLLNIIQLAIALRRRHQKAASAGAR
>fig|399795.3.peg.18 Glyoxalase/bleomycin resistance protein/dioxygenase
MPFEIVHGIQPYEALEVRPVLKLNTGRIKRRRGEFQRPRLEPAAILRLGHVALLTNDFKR
NFEWMQSRLGLRPSDIMYGKDEDDLVGSFMHLSGGGEWTDHHSLALFPDPHPRVHHFSFE
VEDIDAQGMGNQWMSKQGWKHSWGIGRHIYGSQIFDYWFDPDGNIAEHFTDGDLVRPGCE
PNFALLDDESLFAWGPPMQAAKFVNMAARHG
>fig|399795.3.peg.2911 Outer membrane component of tripartite multidrug resistance system
MEHAKTCQRPISLERRLAATYLVAGLVTAGLAGCAAGPDFQRPTAPDVARYTATPVADRT
ASAPTQFGETQRLVEGLPIETQWWQSLGSSTLDGLINEAFHVSPTLASISANLRQAQELL
AAQAGSTQYPQVDVALGSQRQQMSPSSQGLSGDARQFSLYNASVGVHYNLDLAGGNRRAL
EALAARADYRRFELNAARLALAGNMATAAITRARLAAQLEATTAILRVQDEQLRLAHERV
RIGQASPDEALSLQAQAEQTRAELPALRKQLQQTEHLLAVLAGRAPGTGGIPAFTLADFT
LPVEMPLVVPSELVRRRPDIQASEALLHAANADYGVAVAKLYPQINLSANLGSQALTTGT
LFGGGSAVWGLVAQLTQPLFNPGLPAEKRAALAAFDAAAANYQSVVLESLRNVADTLRAV
ESDAQTLTALAAADMAAQASLQSVERQYRLGAASYLQLLIAQQQAQSIRINMVAAQAQRL
VDSVALYQALGGGVS
>fig|399795.3.peg.3423 Glyoxalase/bleomycin resistance protein/dioxygenase
MNQPYTANLSHFGIFCRDLEVMKSFYTGVFDMQETDRGEGVTFRFEIVFLSGRNDQHHQL
VLAGGRGADSPSTVMQLSFKVQSIDQLREARRRALALGATKMRGLNHGNALSIYCMDPED
NTVEVYLDTPWYVSQPHGDPLDLEQSDEAIWAQTERVVRTDPSFMPVAEWAAQFEQRRQA
TGNA
>fig|399795.3.peg.5181 Permease of the drug/metabolite transporter (DMT) superfamily
MSVASLIRLMTLAALWGGSFLFMRVAVPHLGAVPTAVGRGLFSALGLGAALFAMGYRPKI
GRHLWPLLGLGVINSGIPFLMYALAAQVLPSGYSAIFNATTPLVATVVGALVFAEAITPA
RVAAVLLGIGGVAVLAQAGPLDLSTAVLGGMAACFVATVCYAFSSYLTLRLAGANASVDT
RAAVFISQLGALMVLTPALLIDMALEPGMLARLEAAPLLAWGNVALLGLLSTALAYVLYF
RLIADEGPQKALTVTFIVPVFAVLWGWALLDESLTVAHAMGGGLIALSLWLVLRPKAD
>fig|400667.4.peg.956 Multiple antibiotic resistance protein MarC
MVSPYLHSFALFFSLLNPFLMSIYMIGLIRHSETKVFNKALIQGSLIAYIVFMLFAWGGE
AIFSKYLNVRFEAFQIFGGLIFLVIGYRYVFQGADTIGEMRGAPEHLAGTIAMPFMIGPG
TISAAVVTGIEMSIGAAALVIGFTMFLTCSILILMKFSHDHLRYKHAKYIDRYFDIVGRL
SALLIGTIAVDMIINGVTGLIHKV
>fig|400667.4.peg.1559 Permease of the drug/metabolite transporter (DMT) superfamily
MITQNKDILFRSPIMNKSMVYAYTGVVITMLFWGSAFNAMSYVIQYMPPLSAAAERFTIA
SLGLFILFAAIGKLRWAALRQNLAIYLIIGIIGIAGFNLGCFYGLQTTSAVNGALIMATT
PLITLLLTILLDGEKLTLNKSIGVVFGLSGVLFVISHGHISTLLHLKIAIGDLFILLGGV
SFCLANMLSRRYVKNATPLETTTFSMMSGALTLIILSVIFEHPSQAIAMAPITAHLAMGY
VIICSTMIAYLFWFNGIQKLGAGRASIFFNFVPVFSMLVALLAGQSLNIWQLIGTALVML
GVMSSGGFIQIKRPTLIAKPCTK
>fig|400667.4.peg.2312 Permease of the drug/metabolite transporter (DMT) superfamily
MSKNLATLIGLSAILMWASMVGFVKHITTAIGPDVGITLIYSLSALLLLIIFRVPNFKLI
SKKYLILGAILFIAYELCFSFALAYSKTAQQAIEVSIVNYLWPSLTVLAFVIFRELKFNV
FIILGLLISISGIIFIQTGNGDFSLGRVVDNFHSNPLSYILAFIGAIIWAFYCVLTKKMG
KGQNPISIFFLGVAITLWLKLLFSGQVSLPSLDLNTILSLIVASAAIGLGYAAWNIGIIH
GNITMLVVASYFTPIISSLLAMLVLQTELSISFWQGTAMVTAGSLICWLSTNWAVIRSYF
RIN
>fig|400667.4.peg.2319 Permease of the drug/metabolite transporter (DMT) superfamily
MEKFVDDHHLKRKVGTLEMVIAMLLSGSIGLFVIKSGQSPVNIVFFRCLISALCLIPICY
FYGHFRKVYFGKKELFLMVTSGLLIIFNWVLLFAAFPKTSISLATIVYHVNPFVILFLGA
LVFHEKLNKNDVLWTIVAFIGLIVIIGLGSASVNSNELVGLGLVLIATTLYSISVLITKK
LSNTPPLLIVFIQTLSGAIAMTPFMSVFENPPIGQQWLFVVGLGVLHTAFLYYLMYSAIK
KIPLNNIAILSFIYPISTIVIDYFFFDHVLTSTQVLGAGLILLGVLGVKLHWNIFALKNA
>fig|400667.4.peg.2665 Multidrug resistance protein norM
MNMLKDISLPILKLALPLILIQICQASLGVINTMVAGRYHYIDLAGIGLGSNMWTPVFIL
FTGILYVLVPKISAMQQANKAEIATLIQQGKKVAFLLSIFGFILIQLLALLCPWLIENPQ
VASIAKQYLHFVAFGVPGLVYMTLFRFISEGHSLLKPIILTYLILLFCDALLCVVLVKGI
GFISEIGGAGTGLATAISAYIACFCMYQLVAKAVPELKTNKAKVNIQQSLQLLKQGLPIG
ITLVLQILALATLAFFASQLGAKAIAAHQIVINIAMLIIMIPIAISSATTIRVAYFSATH
DHQSKLATSAAVAVITLIYGVVIAGLLVAFAEPLTGLFSNDAEVLNIAAGLMSFIAVFLI
FDAIQTVASGVLRGLQQFMQPLFVILFCYWLVIIPLSYLMGVRGWLQERANVDVIWLVLT
CGISLAAILLVIQSYRYLKKGELPVGETIST
>fig|400667.4.peg.3143 Permease of the drug/metabolite transporter (DMT) superfamily
MEERKNLDTRASALMVLLCMVLGLQQVVLKIAAPDISPIMQIALRSGLSAVLVLPLLWRD
HSIHLFSYRQCKAGALVALFFSLEFYFVTQALKFTSTSHTVVLLYTAPIFVALGLHWKFP
TERLNRAQWGGITLAFMGIILTFYPTTTATNAPALAQVLLGDLYALMAGLAWALSTIIVR
LSPLAQAPATQTLFYQLFGCFVLLLLIAFLTNQTTIHFTTLAILSLSFQTLIVSFASLLL
WFWLLRNYLASRLGIFSFLTPLFGVLFSILLLEEKLEIKFIFGSILVLSGIVIMSLKQGK
ANSS
>fig|400667.4.peg.3527 MATE family drug transporter
MMNQIFKLFIPMLSSNLIVVLSGLIDIAYVGHFSNDHVAALSVTLSLYTVVYVIGMGILQ
GVMLKLSEAYGCHDIPRIRQIFIQGVWLMLGSALVSIALLYLFRDLPKLFGASEHVVLIT
KNCIWALVFILPAHLLMRLFTALSQVTENAYKVLLSDSLFFILKIILSYLLIYGVALFSI
PPLGAIGALLATIIVRWFMLTVYYLFFLEKKYIFIEHPERSVEDSWQSLRMILKIGIPTA
IMALMDVIAFCSVAILILPFGSVVSAAHQIVASTGGFMFIFPSSIASAYSILVSRTMGSG
NMKEADKIARQSIWVIMAVSGSLSLCLWVERGLIVTFYSDDLAVQILAASLLLIVCMSHF
LDGLMTLLTSLLRCWDVSILPMLIFLVVVLCFGLGGGWWMAYKGLHWGSHSISAMGIYGF
WSMAAISYLVACVLSAFCFRFRKQLRGF
>fig|400668.6.peg.102 Multidrug resistance protein A
MSEQENNPSLPKQVEKRTTRRVLLVALPLVVILASVFVYMKGGRYVETDNAYVQSDITTI
NAEVSGAIQTIAIKENEKVSKGQLLFSIDATPFKVAEAKAQAQLQQVRLNILEQKAAYEE
KKAEINQAENEFAFNQREEKRQANLLKQKFISDTQFDQARQAAEVSELKVATLKKDLFRL
KEALGGDPSAPLEDHPSYQAAQAALDQTRIDLGHVNVRAPASGVVAKVPNSGEYVTAGST
TMVLVSDERQWIAANFTEKDLTYVQPGQEVEIEVDAYPGVSLHGKVESISPATGSEFSVI
PAENATGNWVKVAQRLSVKILVDTDQDTPVLRTGFSSNVTIDTEHQRRLFGLAL
>fig|400668.6.peg.148 Multidrug resistance protein B
MIYLIRFLSSSAWSCFYPFMAVWLHGVVGLTSSSASVVVGFAIVANRVGALVFYGVLDKV
SHRYEIIFSLFLMALFASLMLASAHLKITNIAIWIVIVSLFGISNSVSTISQISYIVHNF
KEGMHEKALAYENVAANAGSGIAPFVASILLTFSGSLFAALPVGLGVVAACCAYYLHNSR
LVHKRDTKTANINSTFTQLRDRALIIFMVINFLTMIGYAQFYYVFPTYATEQFSSETVGQ
LFLLASAIIIIAQVPITSFFQRVTKLWRVIISNLLIASGVLLLSNSSGGQFSLYIVVPLI
VIGEMICGPLYQAQAVKIWSGSSSTIMSIQTCIWGAAEALAAVAGLLLVAHGGGVASFII
GGGACILVTFTAWMSISSKKAIIGINLTEK
>fig|400668.6.peg.174 Permease of the drug/metabolite transporter (DMT) superfamily
MRLISLGVSVLCFLCAVLGTIRSHHPCASYYLEKPKMAGTFFIMIACFTWALDTLIRYPL
LGAGYSTLQIVLIEHLTLVLFVAPLLWRYRHVYRHMSIGGFSCLFFIGGIGSAMGTLAFT
EAFHYLNPTVVILLQKLQPIVAILLAYWLLKERIEGHFLQWAAVILLGSFVMMWPDLRQL
GDAQWHYSSDTTSILKGYGYTLIAVVAWGAATVCGKYLSHQHMPANAIMSGRFVAGLLVL
LPMALAQSDTLIAMKPVDLSLAVAMALLSGFIGMWFYYQGLKTVPAQLATLAELSFPVFA
AAINWLFLDMGLTGYQIIGGLMLILGNIGLRMKELRKEELTPAVQ
>fig|400668.6.peg.297 Resistance-Nodulation-Cell Division (RND) multidrug efflux transporter MexD
MSNFFIARPNFAWVMAIFILLAGLLALPTLPVSQFPVVAPPQVEITATYPGASAQVLVDS
VTSVIEEELNGAKGLLYFDSSSNANGIAQITASFEPGTDPDLAQVDIQNRLKKAEARLPS
SVIAQGVQVDQASSGFLMIYALTFKGDDSSKSIIALADYAARNINNNIRRVKGVGKLQYF
GTEAAMRVWVSPEKLLSYGLSIGDINNAIRNQNVQVPAGSFGGRPADDAQELTASLVVKG
FLEDPEEFGNIVLRSNVDGSAVYLKDVARVELGKQDYNFETRLNGHKAIMGAVQLSPGAN
AIETVKAIKARAAELEANFPDDIQISFPYDTSKFVSAAIEKVIYTLIEAIVLVFLVMLLF
LQNLRYTLIPTIVVPVCILGTFAVMSLMGFSVNMMTMFGMVLAIGILVDDAIVVVENVER
IMVEEGLPPKDATIKAMGQVSGAIVGITLVLSAVFVPLAFMSGSVGIIYQQFSMSLAVSI
MLSGILALTFTPALCATLLKPINKEAHHEKGGFFGWFNRKFARLTHRYSILNGMLVNRSG
RFMLVYLVLIIGLGYAYLRLPESFVPTEDQGYMIVDLQLPAGATFSRTNETMKDAEKFLG
QRDAVENVVTVMGFSFSGMGANAGLLFPTFTDWSDRQQSLFDETMAYNQFAGSITDGRSM
AVEPPSIEGMGNSGGFSLRLQDRSNLGREALTNARNIVLGQANASPIIAYAMMEGLEDAP
QLRINIDRQKATALGVGFESINNAVSTAYGSASVNDFTNAGRLQRVVVQADVADRMTPER
VLELQVLNDEGNLVPMRSFASSSWEIGPVQVSRYNGYPTYKISGSPMPGHSSGEAMAEIE
RIISTLPKGIGYEWTGLSYQEKAAGSQAPMLLTISILVVFLLLVALYESWSIPFSVILII
PIGALGAVAAVYLMGMSNDVYFKVGLITIIGLSAKNAILIVEFAKDLYQQGHSLKESAIQ
AAKLRFRPIIMTSMAFILGVVPLTIATGAGAASQHSLGVSVIGGMISATVLGVLFVPVFF
TWVLGRFKASNKTV
>fig|400668.6.peg.422 Permease of the drug/metabolite transporter (DMT) superfamily
MNRSSNTIGSIELILAMMLSGTIGYFVISSGQAFWNVVLFRCVIGALVLGSYAYYAGLLR
REYFQRNVLLMIILGGITLVGNWIFLFASFNYIPFSIATVAYHMQPLFLVLTGALLTKEK
LSGSLLFWLALAFVGLFLIVELDLSEISALFTGEASSDGSSALFGLLLALGAALLYTVTT
LVTKKVSQVPSTFVALVQVIVGVFMLLPFADFDNLPTQTSQWIDLLILGAVLTGFMYIIM
YDSFQKLPTSLIALLSFIYPITALFVDHLAFATHISLMQILGVILILLAVSAVKFNWALP
RKEPKQAKREKP
>fig|400668.6.peg.496 Permease of the drug/metabolite transporter (DMT) superfamily
MKNKYFLLLLIGLIWGSQFIFQKIALSTLTPQLVGVGRAVVGFITLFTICKILKVTSKGN
TVWTIYMLIGVLEASIPFTFVPWGQQYVSSSIASVLIGTIPFFVILFTPLLSVGSKISRS
SILSIVVGFLGLLSLFAPDIIEDDRSLSFLGVIAILTAAASFGVALLLLSKCGNEHPLIV
ARNVLGSASLQVLFIYLFTDGQIPNHVNLDTVLSIIYLGVMCAGVVYFLYMILISETGAV
FTSLTNYLVPTFGVLIGVIFAHEDVGLNTWVALALILLAVALNQGKGIKVNQWVK
>fig|400668.6.peg.865 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVKRFPVLKEVLHLLFPMILTMTLELSISVVDTIMLGHYSALHLAAVGLASSLWLPVGCF
LIGVTFGLTPLVTRHLHGRQPKLVNLYMSQAVGLSVGLGLLASLVAIFLLPYFAGLMATE
EETRQVSISYLYIFAPALPMLALMTAYKNLFEAAGRPGFPLFVASFGLVLNVLFNYVLIF
GKFGFPEMGAKGAALASALSLYLAVTLFFVYDRFINKTPLFTRLVWRYTRKFSILLNIGA
PAGFAFAFEVGLFSSMTWLISSFGDLALGGGQIVMSYTSFLFTPMMAMSAVTAIVVAKAM
SKEGVSGVRKRIRVIVLLGLSYVSTCFIITQVFHNQIPYIYSNNAEVVALAASILLISSC
YQFPDMLQTVFTGALRGFRDTRSTMIAFAASLFGLSIPFGFWLSHYSPWAETLSLRGFYI
GLGAGLTLLAVILIVRFRVILARYEGRRIASPREVA
>fig|400668.6.peg.1008 Permease of the drug/metabolite transporter (DMT) superfamily
MKQGSHLKAELILVFVTILAGFGWIFSKEALAGLPPLFFMGVRFIVAGFVLFLAGQKYFR
GLDWQNVKQASLVGLVMGITMMFWVTGLDQGSNLGVGAFITSLGVVLVPVVARFLFGARP
PLSIWIALPIAVVGLGFLALNDGLNFEFSHLYFLGAALGSAFQLNLLSRFSMRMHALVLT
AIQLSVAGCFLLFLSLLTETLPHSISIPVAGWFLVSTLVASSLRFLLQTYGMSMTPVSHA
AVIMNLEPVWTAIFAVFWFSETMASGQVFGCFLIFIAMLVSRWSQIRAIFKPVKSF
>fig|400668.6.peg.1342 Permease of the drug/metabolite transporter (DMT) superfamily
MSIAHIFLWATAAIWGFAFVAQSVGMESLGPHSFNAMRFLLATLSLLPLLFIFKPKQSQS
NRKLWLGGLAAGICLFLGFTCQQIGLQYTTAGNAGFITSMYIVFVPILGLMLGHKTERHT
WIGVGLALVGLYSLTVGPSLSINKGDAIELLGTLFWTGHVLLIGYLSRYVSALPLSIVQF
FIATILASITASILETPTLEGIKMAWWPLVYAGVASSGIAFTLQTLGQKNVSPSISALIL
SSEAVFAVLGGWIFMEEILSTRALVGCGFIMTGMIISQWPRQAKTTIKLAQQP
>fig|400668.6.peg.1466 Fosfomycin resistance protein FosA
MPFIAFRKRVREMNINIKQKILSVCAEKIKQKGDGVQVSFYAFFANKNDDPITLMAVARW
WIEEQQLNHFEKASKIYAMVVSLDDRSVFQSSYAEQNKGFNHLTLSVANLDSSLEFYCHL
LGFKAEVRWNTGAYLSYRDCWLCLSLGEAKPSRDYTHFAFSFDLSAMSRVQQKNAFQAVK
QWQVNSSEGDSLYIEDPDGHKLELYSGSLATRLESLKTKPYEGLEWLH
>fig|400668.6.peg.1829 Permease of the drug/metabolite transporter (DMT) superfamily
MTMLLTLNQDNICLIRLDQDSGNNKMTTHSPQATLIGSIAILLWSSLALFTTQANLVPPL
LLLSLTFGVASLLFFIVYLIKGELKSSWSKTPTSAIVMGGLGFYFYHFCYFYAFQHAPPV
EAGLIAYLWPLLIVLMAGMTKGNTLSWTHLVGAVIAFIGTGIMLQSRASISTIEVNTTYD
WTGYAAAFACAFIWSSYSVANRRFQSVPSSAVLWYCLVTTVLAALSHWMIEAQNTATSLD
YPASTWIAILGLGFGPVGIAFFCWDFGVKKGNLSLLGVLSYTAPALSTAWLGLFTEAQLT
TGQIIACLLITAGALFASLMRNKRVRPNDEHLASLEINK
>fig|400668.6.peg.2040 Multidrug resistance protein A
MSELDPNSLKKKRTVFVLILSAIVACIAIYIWWANIGRYYEKTEDAYVSGNVINVMSQIS
GTVTDIMVDNTSSVHESDLLVQVNPVDAKLALEQAEANLASTIRAVRNDFASLEQQKASV
ELARIALEKAQQDYKRRVNLKKNNLISNEDLSHFESTLTSAQASFSVAQKSYEASKTKVD
NTTVLTHPDVLKAISALKTAWLALNRTQILSPADGYIAQRSVQVGQHVSAGNALMSVISL
KNVWVTANFKETQLGNLRAGQAVTLTSDVYGSNVIYKGTVKGIEPGTGSAFSLLPASNAT
GNWIKVVQRVPVRIVLDPETLAAHPLRPGLSMSVTVDTHNAGESTLTPLADTKAPWRTKV
FDHNDAKVDVIIQKIIKESM
>fig|400668.6.peg.2704 Permeases of the drug/metabolite transporter (DMT) superfamily
MWIFITLFAAGCQSVRTAYQNTLARETGFLHATMSRSLYGLPLVTVYLVICWQLFGWVSV
EKNLVFVIAASTCAITQIMATYFMLRAFQAGSFALGTLLSKTEAVLAALIGLPLLHYTLT
MGAWFGIAFGVLGAVVMSVKWGNIRQAHKDVSLLLGLASGLCFAIASVTSSIASHSLSGS
LITSAGVTLWYVLALQSIILCGIQIYKSKDILAPFKHEFALSCKVGVLSSLGSIGWFTGF
ALVNPALVKTLGQIEIIGTLYYSKVRFSEKMTTQQWIGGAMIVISVVLVVTSTIK
>fig|400668.6.peg.3254 Multidrug resistance transporter, Bcr/CflA family
MIPFPYFILMAMCSPIALNAILPALPDIAKQLGIDSSTVQLNYSLYLAALALGQFSVGAV
IARLGNRSTIILGISFFVVGGLIALATEQLFFMLLGRVLQGIGGAFTLSMSRALLVASSG
GKRASQQMGYLVMAIALSQGIAPLIGGSLNTHIGWQAIFALSAIQGAILLFFSLKLIQPA
AQKPPKLPLKMLLSHYMSLIRLSSFRHYAMANTLIALCFYLFISASPYLTKDLSDNRLAY
GYWFILVSGAFMLGGYLSTLFNKRLALDKSIQLGNYLCILGATALLILQLSMPMSFASLF
LPMSVITLGRGISQASYQSAAIATADKLSGMASGLLGFLQLSFGAIFSQVVPLLIDLHPH
AIGFAILGCTLLATMVHRNIRTMK
>fig|400668.6.peg.3533 Permease of the drug/metabolite transporter (DMT) superfamily
MPAFIYLLLPIFFWSGNYILGRLTVSNGIDPFSISFLRWSLACLIILPFAYKKLWRERNI
IAKNWPLLVLFGWLGICNYNLFLYIGLGTTSVTNAVLLNSIMPVMILITARLLLGNKTSW
LQNTGILISTLGAITIVSRGSLETFLHLSFSQGDLWIITAAISWAIYSVLIAKRPKEMSL
IGFFACTAIIGTLFQAPLFFLFGHSQLTDFTASNWGAIIYMGVFASIGAFLCWNTGVQKL
GAATAGHFIHLLPVFSIGLSVIFLGEKLLNFHYVGITLIFSGIFVATILNKKKPQTT
>fig|400668.6.peg.4136 Permease of the drug/metabolite transporter (DMT) superfamily
MDEFIRIYMPFAELSGLVAALCWTISSLMAPNLIQRFGTMRFNTFRIVIASSILLVICLI
TQRFNATLWQHAEIVMLSGLLGIFIGDTMLFTAVHRLGPRRTGVLFATNAPMSILLAWLF
LGEDLTLSQLFACFLVLIGVVIAILFGRKNNLHAWEQTKGKLSVGILLALGAALGQASGA
LLSKPALIDGADPIAVSALRVGTGALALVLAYSLYYRHKQPADAIPFGQLTRADFMGIAT
LATIGMVIGMSVLVWGVGNANVGIVTTLSAVVPVLILPGLWITTGQRPAFGAWIGAIFVV
AGAALIILK
>fig|400668.6.peg.4140 Permease of the drug/metabolite transporter (DMT) superfamily
MVMPQTVTQHTSSISAQEPPKYKQYATGWGFRLGLLAAFVSILIWASWLVSMRAGMTNTL
TAFDLGILRFSPPALLLLPFLWRARAQVKTVSPILLLGIVCGAGLPFFYLSATGLKYAPA
SHAGLLILGAFPFFVTLLAVLFYQEKVSRERKIGLSLVSVGVLVLFSLSLLTAPENTWKG
DLLLLAASFFWAVYTVSLRIAGLPPLVSTALMGLVSLIALVFLWASGLASSGLADASWDM
LAGQILVQSLLVGLMTGFSYGYAIQKLGAENMAAIGAFTPVLAALIAIPVLGEHLEGYSI
AGLIFVSVGVVIASGIFKKR
>fig|400668.6.peg.4222 Permeases of the drug/metabolite transporter (DMT) superfamily
MAFLYVLLVVIWSTGFITGKFIVGLIDPNVFLSIRFVLSGLLFLAIALWQRRRFPPIKEL
PKHIIAGMLMNGFYLGFAYVAIAKGLPAGMMALIGALQPALVTLLAFLLIKEKTSLKGIV
GMLVGIVGLLLVVSPALELDMTHGGVTLLTFTLACAAIFTLSLGVTYQKMSISSSDIFSS
MAVQNLAASVVSIGFMLLLGETLFKVQLESFLLVIWGVLVLSGGGVFLMVWLLRKVRASQ
VTTMLLLAPPLAAVESYFLFSESMTMIQIIGFVITIVGVYFSRVNPSEK
>fig|401473.3.peg.1002 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKNLTSGSVFKTIVTFALPYLLSYFLQTLYGMADLFIAGQFIGVDGITAVANGSQVLYM
LTVVIVGLAMGATVTIGRTVGANRLDDAAEAIGNTITLFAGVALVLTAVLLLNVQGIVTL
IGTPAEAVCGTTQYLAICFIGIPFIVAYNIISSIFRGLGDSKSPMYFIAVACVCNIALDY
LFMGHFRLGPSGAALGTTLAQTISVIVAFAAIRHKRTGIRLHAANLRPRRDVLGGILKIG
VPTAVQDGCIQVAFIIITIIANYRGLNDAAAVGVVEKVISMLFLVPSSMLATVSAISAQN
IGAGKPERAIRTLKYATAITVAYGIAISVVVELTASSIIGLFTTDATVIVLGVQYIRSYI
VDAIFAGVHFCFSGFFAACGRSYIGFIHNIIAITLVRVPGSYLASKMFPHTLFPMGIAAP
AGSLLSVFICLGFYAWLRRRSVLEAK
>fig|402612.4.peg.499 Outer membrane component of tripartite multidrug resistance system
MKIKAKLLIVISFLGVTFGYAQEKRVLSLKEAISLVTNNSNEAALANIKVSTAKLEMETL
KNNQYPSLKISGQFLQLTDANIDPKIKLGASGTAVKVNQLFLGQANVSMPLFNGFKLKNS
IWASENLYKAETANAANTKEKLSLYVVELFAKLYQSQQTTTLIEDNLKSAQQRTKDFSAM
VHNGLMARNDLLKAQLQESNIQLSLDTAKKNVNIINYQLVTILQLPENTQIDIDIETIKN
DIVRNKNIEIQAKRNDLEALTYQQKASEAGIKIAKSGYYPALALVGGYIAFDLKDVMTVT
NAMNVGVGLSYDLASVFKNGKEVKLAQSKSEQTKTAVTILTNKIKEETHEAQENYNLSLN
QNVVYKQAVEQATENYRIVKDKYDNSLSTTNDLLEADVQQLQTKINLALSQADIALKYYQ
LQFAEGKLINSFNTPKN
>fig|402612.4.peg.564 Multidrug resistance protein norM
MNFSQYTKEFSENIKLAYPVILGMLGHTLIGIVDNLMVGNLGSTELAAVSLGNSFIFIGM
SIGIGFSTAITPIIAEADAAKDDKKIRSTFHHGLFLCTIIGVILFMLIVLSKPIMLLMHQ
PKAVVDLAAPYIDWVAFSLIPVIIYQGYKQFADGLSKTKYSMYAIFFTNVVHVFFNYVLI
YGIWIFPKLGIIGAALGTVISRIIMVVFMHFMLRKNHEMKKYFKHFSFKEIRKSAIKKII
NLGFPSAMQMLFEVTLFTAAIWLSGSIGKNHQAANQIALTLATTTFMFAMGLNVTAMIRV
SNQKGLNDYKNLIIVAKSIFILAIILETIFALVFIVFHNFLPHLFLNMNDANQALDNIEI
IKITAQLLLVAAIFQISDGIQVVVLGALRGLQDVKIPMYITFIAYWVVGFPISFYLGLYT
NLKATGIWIGLLAGLTVAALFLYIRFHNLTKKLVRENHK
>fig|402612.4.peg.2247 Tetracycline resistance element mobilization regulatory protein rteC
MNVFCNPFFIDFENEFEIIKNSFTDAIIQANELIRFIERKIKELYNWLKTYAFESLSEEI
YFFKELKPKLVSRLIFYKNILKLESNLPIGIKLKKKCFEKSLDKVYLKSRKDKDFYQYYR
SRATSKDEQYFIRSNEKSIDNDCHYQINYDIQLCTSHDYKVAMIMADDSLLAHLEDKLEE
INNSCNLKHPSLKTNLNWTGNKIDLIEVIYALHHQKVINGGNIDIKDLAVHFGFVFNIDL
EENIYRSYVDIKNRKTVKTKFLHHLSENFNTKIIEEEH
>fig|402881.6.peg.9 Multidrug resistance transporter, Bcr/CflA family
MKLAPGTAAFTVFLASLTAVGPLSTDMYLPSLPAIGEDFNADAGTVQLTLSTHLIAFAGS
QLFYGPLSDRYGRRPVLLGGFLLFMAGCFASLFVTSIEQLILARLLQAVGGGASVVLARA
IVRDLFEGPEAGQMLAKMAAIMGLVPALAPMLGGVVQDLYGWKANFIAMGAFGAVLALMV
AVNLDETLPRDRRQSAAPLSILRSYRRLLADRHFLKYLAIATVAFCGLFAFVSGSSFVLQ
GLYGYSPIAYGLCFGAMAGGFVAGSLAGGRLVRRRGIDGTLRFGGFCAALGGLLMLSGLF
LTPSAMAIVLPVVIYGFSMGVTMPQAMAGALTPFPDIAGTASSLLGFLQSFAGALAGLYV
GYGAEASALPMAGTIAAGGVLSFVIAMSGRRKTI
>fig|402881.6.peg.558 Multidrug resistance transporter, Bcr/CflA family
MNASSPRGSRIGFVVILGALIAFAPLSIDMYLPAFPAIAAHFNTTAGAVQMTLAVFFIGL
SVGQGVVGPITDRVGRLPPLLIGIGLYVGASIWAALAPDIESLTAARLFQALGGCAGIVV
SRAMVRDLFDERGSAQVYSLLMLVMGLAPILAPMIGGFIILHHDWHMIFWVLAAFGLACV
PAVIFGLGETLPRERRQHGGLRPVLGAYLALFADRPFMGFALANAFISAAMFAYITGSPF
VFIELHGLDPSGYAMLFGANAAGLIFASQVNAFLLRRISGRLILKIAMGVHLAAVVALLG
FTIFMPGAFYPLAACIFVAVGCLGFVGANATAAAMARADSHIGSASALTGILQFALAAVS
GGLVGAFNDGTALPMALIIAGASIAATLARLSARERVPA
>fig|402881.6.peg.1511 Acriflavin resistance protein
MNISSISAFSVRNWQFTLVVFGMLIAVGLSAFNSIPRAEDPDMKGPFAIVNVALPGADPA
DIEKLVIRPIEDAINRLDDLDEIKSRAEDGLAIIQVQFDWSTDPDKKYDDVVREINALRP
TLPAGIRRLDINKFRTSLTNVVQVALVSETAPNRVLEDLADDLTDEIYRVPGVRDAEAWG
LPRSEVRVSINFGRLANLGIPVTAVANAVGADASELPGGPIHAGARRFNLKTAGGYDSIE
DIRNTVIGYFGGNIVRVRDVAEVSWATEEATYLGWYNGERAVFVTANQKEAQNVFDVRNG
IYEVLDEFEPHLPADVRMERAFDQTVSVSHRLSRLYLDFAIAVSLVAITLLPLGFRAAGI
VMVSIPLSLAMGVALLDFFGFSLNQLSIAGLVLALGLLVDDSIVVVENIERHLREGKKRY
EAAIAATSQISLAVVGCTVVLILAFLPLLFLPGGAGKFTRSLPVSVLFTVSASLLVALTI
IPFLASRLLSDKAHPEGNIFLRIVMRGIHTIYRPLLHIALGWPRATTFAAMLVCVTSLAL
VPRIGFSLFPPADSRQFLVQIETPQGTSLQETKKVLDYVTETLRARPEIDWVISNLGRSN
PQIYYNENAREQRANKAEAFAQMAEFDQERTPILQDELRAEFNKYPGAQIVLRVFQNGPP
IEAPIAVRIFGPDLRVLKELAADVSRIVEDVEGTRDVVNPVRLDRTDYNLGLNTEKAGLL
GVPPGEIDRTVRLAIVGETVGAFREADGDEFPIVARLPLEEHHAIQALQNVFVPTASGAS
IPLNQLSSPYLESSPGRIDRFDRQRLVTVTAYTRTGYNTEKVTNEVFEAIASLPKPPGYD
FRAGGEIEARQEGFSGLTNAVLIAIFGILGVLILEFRSFRTTLVVAGVIPLGIVGGLVGL
WLSGYSLSFTAVIGFIALIGIEIKSSILLVDFTNQLRRQGVPLKEAVEQAGEIRFLPVLL
TSMTAIGGLTALALEGSGLYSPLAFVIIGGLISSTVLSRLVTPAMYLLLAPKELDEPERA
HAQMQGAPAD
>fig|402881.6.peg.1990 Multidrug resistance protein 2
MAEDEDIRTAETAAPAANRPLRPSDPDRQTTPQERKRAFFILFVCLLSVGMGQTLVFAVL
PPIAADLGMSEFETTMIFSLSAALWVLTSTFWGRRSDVMGRKPVILIGVFGFAFSTSLVG
FVLLAGYQHWISMVLMFPLVMGARAIFGIFGSGSMPASQAYVADRTTRAERAGSIAQIGA
AFGLGTVVGPGIAAAFAEIHILAPFFAVGALAFVSGIAIWILLPERTRPKKMLSEKQEKQ
AALKWSAPNVMPWLVIGVILSLSQSIMMQLFAFYLMAELGMQGSEATQLVSVGMMAMAMA
TLVAQLGLIQRFDLSVQFLLRWGAVTMILSFAMLVFGGSYGVLVSALALAGLGFGFLRSG
LSAGASLSVSLKDQGAVAGLIGSTAATGHILNPAIGIPLFYLLHSAPFMLGIGLMVMILA
FAIFHPVLKNLRSGDTGLVDEEEEEIGLH
>fig|402881.6.peg.2107 Permease of the drug/metabolite transporter (DMT) superfamily
MEPAEFCGINKGKSRFRRTLRPRATGESPLHSRKTTNWLMLAALVVLWGSAFAFAKIAVE
TIAPEWTMAGRLAAAALLLLPVAALAREHFPRNPRNWGWLAALALVGNIAPFFAISWGQQ
HISSALAGILIGFTPLATLLIARFFLPDERITPLRLIGFVTGFAGLVIVIGPGALMDFNL
GETLLAQLAVLTGAVFFACNNVLARLAPDMPLLAKSSGVMLAGAVMGSAVSAVMTPPAEL
LEASTASLLGLAGLGVFATGMAAVVFFKLIDRTGPTFVSLTNYLVPVFAAVAGYALFSEE
LRFTVIIGLALILAGIALSEWKRDAD
>fig|402881.6.peg.2121 Bleomycin resistance protein
MTDPARAIPVLASLDLAQSKLFYEEKLGFKVELFGDYMIARRDEMEIHFWLANDRIYPEG
TSCYIRGGQVPALYEEYARKGIGKAPIDGERISDFAVRPWGMKEFYVWDPHGNLLKFGMS
ADEA
>fig|402881.6.peg.3284 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MSTKSQIDLSVVLPVYKCGAALSELHQRLTRILATMSVSYEIILVDDGCPDNGWRGIVDL
ARQDTHVAGIRLSRNFGQAIAIAAGLAESRGEKVIVMDADLQDPPEAIPILWDKAQTGAA
LVYGRRDEEHQSMMRMAAGKLYFAFLRMISGRAIDPRYGTFTLLSRPTVDAYLRFTEPNR
HYLFILYWLGFDGVDADYKRHKREIGQSSYRFGSLLRHSFQGVLFYSQSLRRLLAACAIG
MGVTALLLFGGAGSRRRGLVLETAGGTLWLAVGGGSFSYGCARRPSIRTDQATAALCCHE
KDNSRWL
>fig|403833.5.peg.168 Permease of the drug/metabolite transporter (DMT) superfamily
MNKMRDYRLIRAFFWLLLATLIWGTTFPIHKVVLTDLQTLPYLFIRFGIAAVLSFLIWKK
HSFKYGATLGVILGLAHALQTYGINFTDASKSSFITSLYIPLTPIISYLIEKEKPNFIQW
VCFPLSLLGSYMLFGGISGFNFGDFLTFLSAVLFAVHIVLITKFSKVVDETSLLAYQFLF
AAIINLSMSFNSNWKLGVPIWLTVIYTAIAATIVVNFLQVKYQKVIGSNSTVLIFIGEPI
FASLFSFIFLGERFSGLQIVGASIMIGVIILTTFSYRVNKYLKKKLDLKEL
>fig|403833.5.peg.219 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKKRVIITISISDIDIRYKEGIILIEFKNVSKKFQDKYVLRNFNLKVQEGSKTLIFGKSG
IGKTTIFRLLLGFIKPDEGQLLYKNEELNGKNVWDLRRDAVYIGQELDISDGTVREIIRT
ILNYKINLKVPFEESKLIKLFDFFELPANILDKDFQSLSGGEKQRVLISIFTLLNKKLYL
LDEITSSLDREMKNKVIEYLLSKKEWTLIAISHDQEWLNKEGLNIIEMGGNNNGTYN
>fig|403833.5.peg.723 Multidrug resistance protein 2
MRRFGKSIKLDSTIVKYYFIIILYESIDKLFGTVYVAHMGIRGLTSFQIGQVLAIASIAL
SIFDYPTGNIADRYGRKRSLVLGFFIWSIGLLVFFQANNLFTFILSILLWAVGVSLISGT
PGAWFVDEITKEGRAHLKAKVFPNANAISLIFGAIVALLSSALAIGRPDFPLLVAGIMAL
GTSIILIFILNENYGDRAISFRKALARNTIDIFKSTTMRLILIYSMSGRIAFQTFVMIWQ
LYMVKELKLPTAYLGFTMAIFLVVLAIGNSLAGILLKRFEGVKVSIMGQGLIAIGSITIA
SHTSIVAFYIGACLIELGLGIDMSASSVWVHDFIPSERRASYISAISAAGSLFGFTIPLV
SGYIADQIGFRYNWLLAFIGSIITITLLIKIGTKIRTVREVIENVEESN
>fig|403833.5.peg.1099 Multidrug resistance ABC transporter ATP-binding and permease protein
MKNINLSIDKNEKVALVGTSGSGKSTMVSLLVRLYDPTNGKILLGNKNIIDYKLQEIREK
IKLVRGNEPLFNMTVKENIMLDDEFTEEEFMKAVKKAKVDKFIGLLDEGYDTVVGERGSK
LSDGQRQRVAIARALIREPKVLILDEATSGVDSQTEEEIFDELKEYEMTLIIISHRLSTI
RKADKVILLKDGEIMGEGVHEELLKNSPLYKEIIESQLVV
>fig|403833.5.peg.1234 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKIKDTGKVDVLKTSIWKALFTLAWPIILTNMMQAIYNITDAYFLGKLGPLELSVPTVVW
PLIFVFISFATGFSYAGTSLIAQYTGYGDQRRAEKSAAQTILVMTFVALSIMAIVLIFSK
QLLSLLQLDKNIFELSNTYLKIMAFSLPFIFLMQTVAGIFRGWGNSFIALKYNGISILLN
VALDPLFIFQFNLGVFGAALATMLSQVIISVVFLFVLFKGREGFKLHAKDFVPDPKLIKK
VLSVGLPSSIGESFTAIGFAIIMGVIAQFGPIVISGYGIGNRMNNLIIMFAMGISLATAT
MTGQYVGANQPERAEETVRKASLATLLIVGSASMVMFLFGHNITKFFINDPEVIKVGEEF
FRYVSFSLPFFSLVSVFLGTLRGTGHTIQSTIIDMVRLWGIRVPLVFFLAQTHGYIGVFI
AMIISNFSAAILALGFLIFGNWKKPVIEEASQRNA
>fig|403833.5.peg.1423 Multidrug resistance ABC transporter ATP-binding and permease protein
MRTILSKYLKQYYKEVILALVLLTVQAVSNLYLPNLNADIINNGVAKGDLNYIMQAGGKM
LLFSLLLVGAAVGATFFASRISAKFAQDLRRDLYYKVMSFSQNDIDKFGTASLITRNTND
VYQIQMLVLIMLNVMILAPIMAIGGAIMAIRQDVVLSTSLLVIIPLMGIVVFFLMRKAIP
LFRSMQVKLDNVNRVLREKLMGVRVIRAFVKEKSEEKRFDNVNDDLTQTAIKVNRLLALG
MPLLMLIMNLSTVSILWFGSMRIDSGAMPIGNLTAFLTYIMEILISIMMAMMMFVMWPRA
EASADRIKEVLETEPTITESDNPVILKSKKGTVSFKNVTFRYEEAERPVLRNISFEAKPG
KTTAIVGSTGSGKSTLINLIPRFYEVTDGKIEIDGVDIRELSMEDLRDSLGFVPQKAYLF
SGTIASNLAYGKKDATEEEMWHALEIAQAKDFVEELPDKLQAPVDQGGTNFSGGQRQRLS
IARAIVKKPKIYIFDDSFSALDNRTDANLREALKEETKNATVIIVAQRVSTILNADLIIV
LNDDGTIAGQGKHSELMRSCEVYRELVKSQLPEEETA
>fig|403833.5.peg.1604 Daunorubicin resistance ATP-binding protein drrA
MKGQSSIGFMGGKWVANKLLNELKSSERISVLLPTHFLKKIVVYAYIVSSNIIEERIKYL
LSLFNLEDAKDLKYMKYSTGMKKKLSLARALLHEPDVYIFDEPTSSIDPISANEIRQIIS
SLKNKNKSIVLSTHDMHEAELLGDRIGILNKGVMLAVDEKGNLKKLLKKEIIKVKTDKFV
SEEMISKDGIKGKINHFRSLKEDEFEIEVENSSEVLDPLIEKLKKENRKILTINVEQPSI
EEVFMNFVRNDKR
>fig|404380.3.peg.419 Multiple antibiotic resistance (MarC)-related protein
MEEKSMIQSAATHMEQLIVFVVQLFVIVDPLAAVPIFLAITVSHTKQERRSIARRGCSIG
LLAIVFFLVAGPSLLRYFAINTSAVQISGGLLLFVIALELLYGNPTGTQTSSKEERLAEK
KEDVSVTPLAIPLLAGPGAIVTCLVFSSQASDALSVLILIGGAVIVFSAAYLLLHWADEL
ARIFGELGMKVAVRIIGLILAFIAVQYVINGITALWPAVKVPSA
>fig|404380.3.peg.2141 Glyoxalase/bleomycin resistance protein/dioxygenase
MDLALLYLAGKGIEPTWGPVTLGPSKKAEIHDPDGLPIELRQW
>fig|404380.3.peg.2320 Fusaric acid resistance protein conserved region
MQWPRLLPALRATAAALAALVVAHLLRLENPYWAAMTALIVVQPTRTLLFEKSYYRLVGT
AIGSAAAWLLLLQTTSPLALTAALSIWIAACVGIGNLLHGLRSYAALMAACTCAVIAMSG
YQNPGHLGGMAFGRVACIIVGILVTTCVTALFTPSHSMDELGDRLNKVAADAVRWLAQLA
EGAGKQAGTDLEQEILCEAAEIEALLDAGGISSSFRSHRRNARNVLGALLSMLAAGKLDT
ESPERLQLLQRAASGWSEALTRRLQELAAGLERDPGPEWCGKAKALAAETTLHLPLLGRA
LYHLTGTLEVALASHADDGANEATLHLIRHRDWQQAGRAAFRGGIVIAVVGLVWSLTGWS
KGPLMLMALSIMISIFSSKEHPARFVGLIFIGAATGSTLAVFCRLVLLHGVGDFAVTAAV
IAPFILLGAYAMQHRRTVIPATDATLFFIFVIQPGVSVTVAANDLAIGAVAMVLGVASAW
MGYTFLVPVNPALRMRSLLAAMAKDIAQMSAQANRGSRVRIRGKLQHRVIRLVALARNFD
ITPAAAVSGAIGVLALTATIERLREKLEYEELSPESARQLRETLDRIACMAQTPALESRL
LQGWADDLSAVLKPLPPTEDRVGATDEGAAMGAVMVPAS
>fig|404380.3.peg.2409 Glyoxalase/bleomycin resistance protein/dioxygenase
MADQFKEQGAFSWLELSTPDLAGSRAFYSRLFGWKTEPWSGAEDYALIKVGSREVGGMTP
LRPGQRKPAGWGAYVTVTDVDATAAKAEELGGKVLVPPTEITRVGRFCVIQDPQGAVITA
ITYRRP
>fig|405948.6.peg.385 ABC daunorubicin resistance transporter, transmembrane permease component
MTTTLEPTPGATSAAPAPAAERVGPLRAVRHGLTLAGRSILKIRKSPAGLLDVTLQPILF
LVMFVYLFGGAISGDTGTYLQITLPGVLAMNMVFASLGTGMQLNTDITKGVFDRFRSLPV
ARSAPLIGAVLGDIVRYVVSIAVLLVFGTIMGFRIQTDAVSALLAVVVVIAFSLAMCWIS
VFLGMLIRSQQALPGVAMSFMFPLTMGSNVFVPLETMPGWLQAWNGINPVTKLADTARGL
MIGGPVAGPLTATLIWMVVLVAVFFPLAMWAYRRRV
>fig|405948.6.peg.747 ABC drug resistance transporter, ATP-binding protein
MGMSRARQHDRQWSNEHPMVNLINLESVSKSYGVRPLLDEVSLGVGASDRIGVVGLNGGG
KTTLLEVLSGSVEPDSGRVSHSRDLRMAVVTQRTELPEGSTVRNAVLDPHGFTAEHEWAA
DAKVRSVLTGLGMTSLGLDTPVADFSGGERRRVALAAALVRELDLLVLDEPTNHLDVEGV
RWLADHLLQRRCALVIVTHDRWFLDTVCNRTWEVVQGRVEQYEGGYADWVFARAERARLA
QQAEEKRQNLARKELAWLQRGAKARTSKPRFRVEAAEALIADVPPPRDTVELVSFAKRRL
GKTVLELENVDLRIADRVLLEDLTWLIGPGDRIGLVGVNGSGKTTLLRLLAGEREPDAGR
RIEGKTVRLAHLTQELHDLPGDWRVLEAIEDVAERVTLGKYELTASQLGERFGFGKGRQW
TPVSDLSGGERRRLQLARLLMAEPNVLVLDEPTNDLDIDTLQQLEDLLDTWPGTLVVVSH
DRYLVERVCDSVHALFGDGRLTHLPGGIEEYLERRRSLLASAEESVGKQAGDAAEATRAA
GLTGAEERAARKELGRLERQLDKLGKRESELHEKLAEAATEPDRLQSLNADLRALEQEKD
DIETRWMELADQLG
>fig|405948.6.peg.1225 Drug resistance transporter EmrB/QacA subfamily
MFRLEYKWLVGITFVLGLVMQILDITILNVALATLGREFGVDASTLQWVLTGYMLSLAVF
IPSSGWIADRFGSKRTFLLAVVIFTTASVLCGFAGSIWMLIASRVLQGVGGGMLVPVGQA
MLFRAFPAHERAKASAVLAIPITVAPALGPMLGGALAEYASWRWIFFINVPVGALTLVFT
VLFLKEERRGRPGRFDLPGFVLAGGGLATLLYGLDQGAQAGWSVPTVWGSLLAAALLLAG
LTWRELSVDEPMLDLRLLRNRLFGTGNALLVCQVASLFGVLFLVPLYLQDVLHVSPFTAG
LVLMPQAVAMLLATQVVSRMYGRIGPRRLLLTGFCLEIPVYLCLQLLGTGTPLVVVVVLL
ALLGTSVGILMTPMQTAAFAQVSVAEMGHASSMYNVSRQVATALGTAVFATTLVVVTDAA
GGGAPAHAQMAGFHGAFLVAVVFGLLALALSTRVRDSDAAASLDPSHPEAARAASPTGEV
R
>fig|405948.6.peg.2441 Glyoxalase/bleomycin resistance protein/dioxygenase
MGTARSRSPATPHRDSILVQQPRSTAVPAPGVSRPQRPDHRTKRTPMAEKDDYLAGAPCW
VDTLQPDPRAALRFYGQLFGWSFDEATPMPTGLVEGEYFTARLGGHRVAGIGQAPPASPA
MWMTHVRVDDLEQAVVRAEAAGGTHLLRPTDTGSDGRLAVLKDSTGVPFCLWQAGARTGA
ELVGEPGTWAMSSLHSTDPEQAQSFYGAAFGWELEPVPGAPFSKWLLAGQVVALLTATDG
LAVPPHWSINFAVRDADAIAEHATSLGGKVLMAPFDTTGFRNAVITDPQGGVIAVSAPA
>fig|405948.6.peg.3486 Glyoxalase/bleomycin resistance protein/dioxygenase
MRPPPRNTRKTSTQWTTSTTPGQDGPGPRGADMPIQHLPAVVPVSDIDTADAWSERLFDR
PADNRPMDGPVEWRITTNGWVQVHRDPTRAGTALLNLAVDDLDQHRTALDHRGLTTGPVE
TAGKDVRLSTTTDLDGNRITFIGNFRTDY
>fig|405948.6.peg.3660 Fosmidomycin resistance protein
MGPGRARPAARGGRRRAQGGALSEGSAQRPAGTGSVAEGAAEHVDEGTGRGPPAAARDLG
DRAALGEHPQRVVQTQLGSPLRERHAHLGAEEPAQRAVARPDLGPQRGEGARVGGIVVED
RADGRQPRVPGGREADRLPRSVPELVEQHGAHPRPLAVVVVLAGGVGQDQLPQQRSDGDD
RGAAQAQRVVGRRQSHRVQVRFAVGAVLVHRSRGHPDRPGRGRDPAAGLGGHRQHAASGV
DDLVIVMPMRVHARAGGQVPERGGRLRCVAHPPAVRGLLAVFRHNMAVYRKRDSAAWSDD
RGVLESDKKAVRLMAAGHACVDLYQGAVPAVVPFLVLERNYGYDAVSGIVMAATLLSSVV
QPLFGALTDRHRLSWLIPVAMTTAGLGVALAGPAGSYPLTWLAIALSGLGVAAYHPESAR
LVRSVSRGDHLAMSWFSVGGNIGFALAPVIVAPLLSAGGLRATPWLLVPALLGAALTTAV
LRSLSRPVAAAGQAVARRGSDDWPAFARLTAIVVFRSIVYIGLSAFVGLWAQQRVAGGET
AGAVALFVLFAGGAVGTLLGGRLVQVWGRVRTLRIAYAASVPAVAGVVLVPGHGVYFFVA
ASAILLYVPFSLHVTLGQDYLPNRVGTAGGVTLGLAVSVGGVATPAVGAIAEHASLQVAL
GVLIAFPVLAWVFARSLSEPRSLESRSAGHAPVASTSD
>fig|405948.6.peg.5191 Tunicamycin resistance
MLIWINGAFGGGKTQTAHELRRRLPGSLVCDPEEVGIGLRRMMPASLRGDFQDLTAWRQG
VHEVLDLVLHKHEGPVIAPMTLVEPVYFDEIVGRLRDAGHDVRHFALLADRQTVLRRLRG
RGLGIFREDFAVSKVDLCLDRLRHPEFAEHLWTDHLSVAQVAERIAESVGVALEPNRDVA
VLAGLRRSWTALKQIRLG
>fig|405948.6.peg.5310 Permease of the drug/metabolite transporter (DMT) superfamily
MSTLESGAGERTPDGGRAASDTSTGERVVGVRTLLPLFSLVAVTAVWGGTFVVVKDAVSQ
APTMDFLAMRFLIATAALAALRPSRVTTLSRAGVKRGILLGMALGVAYIAQTFGLEHTSA
SLSGFITGMLVVFTPVIAGLVLRQRIGKVTWTAVAIAVAGLGLMTVHEFAVGPGELLTLV
CAVFLALHIVGLGVWSPGHDAHALTVVQLAVAACICFAFGWWDGIDLPSDGGFWLALVGT
AVIATAAAYVIQTWAQARLSLPQAAVVLTLEPVFACIFGVVFDHDELTTRIVIGGALVVG
AMYLAELRSGSR
>fig|405948.6.peg.5487 Probable multidrug resistance transporter, MFS superfamily protein
MNSRWRYRRLRLLKGRCAFHSAPPRSGYVRSAWVRAALLLTAAGWGANQFSSLLGAYGTH
LGLASTTVTSLFAVYVVGLLPGLLLGGPIADRFGRKPVVLGAVAVGVVGTAALMAGAVAT
PWLAVGRLLTGVGTGAALAAGSAWVKELSYAGDVVDEGTGARRAGLFLSAGFSVSGLVAA
LIAQWAPHPMVIAYVPHLVLCAGALTAAVAAPETRPHSLPVAASGSGLRDPRFWWLVVPV
APWVFLAPSVGFGVLPGLVDGRLTGSETVYAGVATLLTPGSGVLTQPLARRLAVGNRIVP
ALAGLWAVAAGLALAVPAIVLEQPWTALCADVLLGGGYGMLVTYCLTEVGRIAPPSRLAR
LTAVFWALAYLGFCAPYVFDLLTGVATPPVIFSASAVLALLTCLLVAARGRSARDEPDRD
RQERRGADHVERLGDPRVP
>fig|405948.6.peg.5685 Multidrug resistance efflux protein
MSTETRAKTSALWAPERRNFTVGLILIITLAAFEAMGLGTALPTIVAELDGHRYYSWPFT
VFMAASAIGTVLGGRLADRRGPAVPLLLALPTFALGLVVAGVAQDMPTLLVARVLQGLGG
GTQIVALYVMIARAYPEEHRPKAFGAISSAWVVPALVGPAIAGFLTEYLSWRWVFLGLAP
LVLLGAVLLAPTVRRFGSGAEEGAAPRRKGLPLAALGASAGVVALTWSAQNPSLFSLSLG
VAAVVALGASIRVLVPAGTLIARPGLPVMVLARGLMAGVFFTAQAFVPLTLSTVHHYSPA
MAGVPLTVGSLGWSAGALWQGGQRALSREAVVATGLLLVGAGVAGLTLIAPEWGPHWLVF
GLWFVAGSGMGLGMASTSVRVLELSPADERGFNSSALQLSDMLGQAAMVGLGGVLVTSLA
ATGSPAAGVVPLDLLLTAAACCAAPLVLRSRREQMA
>fig|405948.6.peg.6374 Permease of the drug/metabolite transporter (DMT) superfamily
MGSVIITGVRYERAAIAGAAVAAAAVGAAVPVNGLLRDYPMWTGQGFRYALAGVLLLGWA
RVRGRSLPVPRVRDLPALAGLAVSGMLGFSLLQIHAQRYADPGFVAAVVGASPLLLGLAA
PLLSRRRPSPPVVAGAALVVAGIAALSGGGAWRGAGLALSVGSLLCEASFTLLAVGVVAR
LGGLAVSMWCCLIAGGIGLAAGAATEPLRPPGAVELAALLVVAVVVTAVAFCLWYHGLAV
LGADRVGVLIGLMPVSGFAVAVVLGTQQPTSASVAGTAVVAVGCGSACAAGARQAAAARE
PFGLFTGSRARPVTAGSALLAGVARLALLLAEPAQELGVVVRRDRGTAAAAGRAGGGVRT
ERLPEQHRDRDETDRRQHVDHLGATSTRHPRD
>fig|405955.9.peg.4404 Tetracycline resistance regulatory protein TetR
MNKLQREAVIRTALELLNDVGMEGLTTRRLAERLGVQQPALYWHFKNKRALLDALAEAML
TINHTHSTPRDDDDWRSFLKGNACSFRRALLAYRDGARIHAGTRPAAPQMEKADAQLRFL
CDAGFSAGDATYALMAISYFTVGAVLEQQASEADAEERGEDQLTTSASTMPARLQSAMKI
VYEGGPDAAFERGLALIIGGLEKMRLTTNDIEVLKNVDE
>fig|405955.9.peg.4712 Polymyxin resistance protein PmrG Ais protein
MRLSIGGVYVLAFCRSSLKSKKYFIILLALAAIAGLGTHAAWSSNGLPRIDNKTLARLAQ
QHPVVVLFRHAERCDRSTNQCLSDKTGITVKGTQDARELGNAFSADIPDFDLYSSNTVRT
IQSATWFSAGKKLTVDKRFLQCGNEIYSAIKDLQRKAPDKNIVIFTHNHCLTYIAKDKRD
ATFKPDYLDGLVMHVEKGKVYLDGEFVNH
>fig|406327.7.peg.1257 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNTELATESINKLILKYALPSTIGFVVLGIYIIVDGIFLGNYVGSDAIAAVTVAIPFSF
LLTGFGLMFGIGASSHISMNLGAGNQKDAENILKTVFYLIFITGIILTLLSLIFIKPLLA
LFGVSENLLNLSYDYLNLIYLFGIFIMFKVGLDPIIRNDGFPKKAMYAIILSSLLNILFD
AIFIVIFGWGVFGAALASVIGETFGALIYIHHFLAGKSNLKIKLFEKVSDIKYEIKNVKK
ILSVGFSPFILEMSASIVMLIHTIQFLRYGNELDVSAYGIVSYIFAIIMLIFIGLGNGVQ
PIISYNFGAKEYFRVKEIIRTSSILCSIVGILVFLLFSIFPKIPVMLFNQTDSLLIETSI
FGLRYFAYGLSVFGLNYLIITYFQSIGNSIVSNTLSLIRVFVFLIPLLIILPKNFGINGI
WASQPLAEILTLIVGFIFIKVAIKRTLNTVNV
>fig|406818.4.peg.441 Permease of the drug/metabolite transporter (DMT) superfamily
MSHDALPLSRRRLYLLDLGLLAVALSWGASYSLMQLIIQAGVTIPLFLMLRFALAVPFMF
FGTRIRLHNIKPGEIINGLIFGCLLYAILTFETLGVKYTTASNAGFLIALSVVIVPFFER
ILGKRKQSKFIYFTCFISLVGGGILSFSNTDNFGFNNGDWLILLAALIRGFQIFMFGKQT
SGKSYSLVNITLIELVTVSVLGLAFVLMTDSASLLLIPTITFNVWGYILFLSLLATAFAF
LMQLYAANITSPTRVGLILSLEPGFAALFAVTIMGETIGILQGFGGAIIVCAALLGRIVE
GKRYE
>fig|410358.8.peg.217 Fosmidomycin resistance protein
MNDLTKRIAGLAAGHGAADFYIPVVPAILPALIPIFTEQGITSYAMAGCLFTLVTLTMVI
FQPLTGWMIDKGRWVPGISWCILITGLAIAVFGFTQNYWVLLTMAVVAGAGNSMFHPNAY
QQIHQFTTSANRGTFLSLFSVGGSFGYGAAPLVTGALFAWGGFPALIWLIIPAVIVAVLL
RKHQQKPAFLPPKSVDTETVKPKWRNAVFVLGISSLRTWVYYGFLAFAAVYLTTYAGVDY
LLATGVVSCMIFAGMFGTLIAGPLSDKIGRKEVMFTAYIGATAAYFGIFLLSGVGSVISL
VIAGFFMMATASVEIATVQELMPGSVGLASGIIIGIPQGLAAVAIMVIGIMADAIGMPTA
LFSQVWLMVAAIVLCIALPYPLKLLNRTHKPVE
>fig|410358.8.peg.396 Efflux pump antibiotic resistance protein
METLRLSAKQYIIAITVGIACFLPPFIGEATNIALPNMLVGLGYTMGADYWNLYGWILTV
YLLTSTIFLIPAARLADKFSKKWFFSIGVLLLGVGSLGVGMSTSGEMVLAMRTIEGIGNA
LMFGSAIALLASAVKVELRGTAIGIAMTGVFLGQLAGPLLAGALTDVFGWSMVYLILCPV
ALLSFFLAIPFIPRDQPTDKGPYDWIGALLFMGGMGFALYGFSKQPNTEALALLVSGIFL
LIAFFFYEKRNKNPLIPVKLILRNRGFTFNNSANLLYYVAIYAMGSLVSLYMTNVWGITD
ALPRALIVTTQGLILVLFTIVAGRFYDHLLPRWLLAFGVLFTIGGIAGAWIMGVPSTGTL
WLIGAILCASVAAFGLGSLILAGIDRYIKNAPPKYATTTGLILISIGMIILLTCGTETAI
WSMIAVQAFFGVGIAIFVTPNSTAIMNSVTPQEFGMASGTLSTTRMLGMAISIGIVSILK
NIFLSGTSDDYAASFLQMMDGTIIAALVVLVLAMIFSWTAGSRRRI
>fig|410358.8.peg.448 Multiple antibiotic resistance protein MarC
MIRQAFVATGVAGVLMLTFLIFNNLLFDLLGIELESFKVAGGIILFILGLQIVLGLEIGG
SSAGHKSLESSDRIGKKSMAGVIIGTPVMCGPGTITTVMILGAQDGIILTLVAVILALFC
IWLILIFSAQIKKLLGETVLVILSKIVGLLLTAIAVHTIWTGILGLIALSVA
>fig|410358.8.peg.1020 Efflux pump antibiotic resistance protein
MTEISVHERRMILFATSMGAFLNPMIATMVILALPAIGLEFGVSARDLGWMSTAFILATA
ILLVPASRLVDSIGYKKSYIIGGIVVVITCFFSVFAPDYTTLIILRIIAGMGSSFIMITG
LAILTRVYPANKRGMVIGINTAMVYVGASMGPIIGGFLTEYTGWRSIFLLMIPLLLISAG
LMIIFLKQEFKNPGKSFDFKGTILYGAAIFCTMYGLSTITDTGSLYLAILGACLIVIFMW
YERKVPEPVLHVDLFFKNKRFARSSYTALLNYGCTYGAVYMVSLYLQSVGALSALEAGFI
IFFQPLIQAIMTPIAGKLSDRFDPRYLVTFGMALSAIGVTLLAGLGLTAAVSYIAITQVF
IGLGSALFSAPNTNAIMSSVPQNEYSSASSIVAVMRQLGMILSMAVCMAAISVFVGGLDM
LGPDMYPEFVQALQISMLVCAGLAVIGILFSWFRGNAPTGADA
>fig|410358.8.peg.1115 Permease of the drug/metabolite transporter (DMT) superfamily
MDLRLLIFPLLVFLGGCCYGPSSPTIKLAYAAGYSWTDVVMSQYFYGWLILFVIFVGLFL
LRLIRKQQTIPAKNPRPLLRRIPGLALAGTCISLVTVTYCLSLQSVPAYISVILLFQFTW
MGVLIQAITEQRLPEPKMILAVVILVIGTFLAAGFAGLDGPLDPSGVIFGLLSALLYAMY
MFMLGRFEIGMHPLNRSFLILSCALLLLTFLFTPAYFMQGTFVTGIWQYGIILGSIGCIL
PMCLFAIAAPRISTGATTILSSSELPASIICAVLFLGETVSWIQYAGMVLLTIGIAYPQY
HPHPRQKQIRKGVGMQRFLHPHARAKIR
>fig|410358.8.peg.1268 Multidrug resistance ABC transporter ATP-binding and permease protein
MNHIIERLAGSIREFKKDSLITPLFVSLEVVMDVIIPLILASLIDDGITAGNMGVILRLG
LVLFLSAIFSLIFGILAGKFAASASSGFARNLRHDIFYNVQSFSFANIDKFSTPSIVTRL
TTDVTNVQNAYQMLMRVAVRCPLMLILSYVMVIIINPELSIIYLVLIPILGVGMYLIITR
VQPIFEKVFKTFDRLNKVVQENLRGIRVVKSYVRDEYEVEKFKDVSKDIYGYFSHAEKLL
AFVSPLMQFVVYAAILLVSWFGAQFIVAGTLSTGELVSLFAYTMQILMSLMMLAMIFVMI
TMSRASAKRIVEILDEESNLTNPEDPVFVVENGDISFRDVDFSYSTDAERICLQKINLEI
KSGETIGILGGTGSSKTTLVQLIPRLYDVTGGSVMVGGVDVRKYDLTTLRDQVAVVLQKN
VLFSGTIKDNLKWGNPDASDEELIRVSKLACADEFIQHYPEKYDTRIEQGGSNVSGGQKQ
RLCIARALLKKPKILILDDSTSAVDTKTDAQIRQALMTEIPDTTKIIITQRISSVEHADK
IIVMDGGHINAVGTHAELLQNNPIYQEVYSTQQKGGEE
>fig|410358.8.peg.1297 Multidrug resistance protein B
MIQTSSLQQYFLMILASTAVFLDYLDTSIVSIALPTISADLGIGSLTASWVMTSYLLALG
STLLLFGKLADRTGRDREIFIAGFVLFTVSSFLCGVSANIEVLIGFRVIQGIAAGMMVST
ATMLITTRLPSGIRGMGMGVIATAGGIALALGPGLGGLVTEFISWHWIFFINVPIGVAAV
ILAVFLIPGSEIHSVAKQPFDCFGALLLALTLVSLLMGLELVLSDGWTLWVIVLFLIVPI
FGYVFFRRELRHPDPVLSAKLFLNRTVMWASLSTLLVTLVYLGIVYLIPFYLTGSIQMSV
AAAGLVMLLAPVSMALIGIPAGALSEKIGCMRLCNLAAVLMAGGLVFLVFSVVLSFLPLL
FVGLLLLGLGMGLNEGPSMQRITLHCPRELQGSSGGLIFTVMNIGCILGVAVFSAAASLG
SGGSDIYTDQGVIAACIAGIIAAVCAYLSSRLARDQILC
>fig|410359.7.peg.194 Multidrug-efflux transporter quinolene resistance protein NorA
MSDKFLKGGHRNPTSMAGPRAVRYVLLTAAVLHMMGFSAVVPVTSTLVKSLGGDSVVQGL
LASAFTLAQLVSAPLWGWASDRLGRRVIIAVGLGLAAIGHAGLYLARDLPTAFVARAVSG
LGGGTLPVIQAAVLELSRPEERAASMAQFGAALGIGFVAGPLLGGALSILSPRDPFLAAA
VLSATAALWSTAVYESAPTAAPQPKAEGRGAGVNPLYLVVFFLLNASYAQLEAFISFYGG
DLGLRPMYVGIAMSLASAAAVTAQTVVKRLEKERPTDSDIAIGLAVMAAGLATAAVPTPY
TYFTGVVVSAAGQVIATAFISKAVATSANRVGLAFGEMQAAGSLGRLAGPVDEGLLYKTL
GPTPSFLEGAGLAAMGLLLIIGATRLNLTPTLPTLSQDKREKA
>fig|410359.7.peg.451 Multidrug resistance protein NorA related protein
MAVRRVVAVVGVARFVRYFILGHLAVSLPIALEASAGGAAGAGAVLSLAGLISLGASIAY
SVVGDVVRHARGLAISETAFALGLLALAHVKNPWLLALALGLGGMGTLGPGATRGAFVPL
ILAVIRDHSKSHVESAKAIGVVNSISTLGGILGSATAGFTDLRHSIPPYSAVALGTALLI
AVALGRGERVRAVNPLKRVATRGREVAGYSLSQFVAGVGIGLSMPLLSLWLHAYMGLDEA
TIGLIFAVGNGAFMVSSLFAYRLVEALGLVRAAVVSRVASGMLLASLPIFREVVPFAVAF
VFYNAAVGIGGTARSSYISSVAPVGSEATTPAVSNIAIRASSVPSVALSGYIMELEPAAA
MPLAGLMLIAAGAIMWKMLKEPEEFTH
>fig|410359.7.peg.710 Multidrug resistance protein
MRLAASYTPIFVARIGSGASAFLVVKLASGGALEAGAVLAAYPFLEAIGALIAGRWSDLA
GRKKTLLVGYVVRSLAMLALAWAFFVHESPVLEAVLNGIIGFTTAFILTASLTMATDLTE
VRNRGLGMGGFEFVNLGSYGVGYLLGSALYIIFPDARAYLVIAVLTALSTPLFAMFLQET
RPVAPAEGRLLFSVLPPSAVALLPVWFALTTIIGLAMYTPRILDVEAGAHGAVQQIVDKL
GGNLVVGLLFIGALALLGAGAIFFGRLADKWGRLKVFYLGLVGGLSALVALNAALHLGLG
PVEAVALTAPLLFLTSAIGPSILALIGDEADIRYRGTVMGIYSVVLGLGIGFGSWLAGVI
SWAFSGYEINGLAAAALGVYAAMTSIHIAFAKRQGLLSQLK
>fig|410359.7.peg.1321 Permease of the drug/metabolite transporter (DMT) superfamily
MKGLALALFSVAAWSTNYVAGRRLAAAGADPLALSLVRFVAATPIIFALARAPPYRGALA
QLAVAGLLGVAAFNTFLYTALHYMTAAAAALFVVLAGPATSLIEAAAGKRRPNPHVLAGG
AAAVAGAYLVLAPQAQVRAVEGPLLAAAATLSWSLYTVYVRRVYARYSPAEASAWISLVG
TAELAPLAPLAHYGWLAHWETAAWVLYVAAVPGALAYTAWNTAVREIGPQRAAAVLPLMP
VITTAISAAALGEAVTPLQAVGMALAVAGVYYAQNPTLLPRIAGRPKSNRSSRQGSPLSE
>fig|411154.5.peg.1864 Permease, drug/metabolite transporter (DMT) superfamily
MEKKAIYAVILCAILAGNNGLLIKSMNSMSTGGIAWFRTGIPVLFLIPFLIKDKEFHFRG
NTKKMFLASFINAIRMYLYLLAFIYTSIGNAVVLFYTYPLFVTAIEYLFFKQKLQKAQTG
FLVLAFIGIVITYLGKPFSFASNDFIGMLSAIGASIGYAVTVILFKSETPNYSKNQLIFY
QNLIGALVFVPFLAFLPDVELPQIGVGILYGLLIGIVVFKLFFYGLKELTAATATTLMYL
EVVSAIVLGYFVLDEKLSWNILAGGSLILISSFFISKLNRKKVQESLSTSAS
>fig|411154.5.peg.3203 Outer membrane protein oprM, multidrug resistance protein
MKRIINYKFLIAGIGLLNLQSCFVAKDYDQPEVVKEDYYRTDNIEQDSLNMATISWTEMF
TDPILQDYIEQGLQNNIDIRIALQQIIAAEAYVKQGKAGYLPTINGNASYTHQKLSENSQ
FGNQFSSLDQYQLSADLSWEADIWGKIRSQKRAFDASYLQSIAAHQAVKTRLIANIASTY
YQLLSLDEQIKITEETIDNRENSLETTQALKEAGNLTEVGVKQTEAQLYTAQGILIDLKN
QERLLENTLSILLGVAPIQIERSELEEQEITTDLNIGVPVQLLRNRPDVIAAEYDLVNAF
ELTNLAKSNFYPSLRLTATGGLQALESGDLFNASSLFATVMGGLAQPILNGRRIRTEYEV
SVAQQEQARLEFRRAILTASKEVSDALYSYEAATNKIEVKQKEYNAYDLATEYSEELLNN
GLANYLEVLTARENALNSSLDLSNAKYNQLKAVVDLYEALGGGWK
>fig|411461.4.peg.256 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGKKTIEENTITEGIIWKQLLIFFFPIMLGTLIQQLYTTVDTIIVGRFVGKAALASVGGP
AAVLSTIVVTFFNGLANGAAVVIAQYYGAKDKGRLHTGLHTAYLFSIVVSLVISVVGAVL
TPWLLKIMNTPQDMMASSTTYLRIYFMGILFTLVYNMGAAIMRAVGDSKRPLLYLVVCCV
LNIGLDIFMVVILKMGIAGAALATVFSQCVSAFLVTWSLTKDYDSMKLQFRELRMEACVL
KRELKIGIPGALQACAYGVTNVVIQASINSFGTDTAAGWAAYGKLDLIFWTVSSALGAAV
TTFVGQNYGAGKWDRVYKSIRVNIGISYVFTGMIIFTLYAFCEPMYHMFTTDPKVIDIGV
YMLRFLVPSYLLSILLENLDGGLRGVGDVLWPTIFTFGGLFLIRLPWVMILTPIYHKVEI
LLISYPIAWGGTLLFVIPYYFWKKKKCFNKICSEK
>fig|411461.4.peg.392 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNDTFMKEKPILPLLTSMALPMVISMLVNSLYNIVDSFFVAQINEQAMAALSLVFPVQNF
VNATAIGFGVGINAMIAFHLGAGNKENANASATHGMILSVIHGFLALIISIAIMPTFLGA
FTKDENVIKLGLEYSRIVFLFAPVIMISLAFEKIFQAVGRMNETMFALLCGCISNIILDP
LLIFGIGFFPKLGIKGAALATGIGQIITVIVYLIYYVKKPLPVKLKKSCLPLQRSLDFRL
YTIGIPAILNLALPSFLVSFLNGVLSAYSDIYVVVLGIYYKLQTFLYLPASGIVQGMRPV
IGYNYGAGEMDRVRKIFRLALLMCGGIMAGGTLLCLFFANDLIGMFTTNPETIQAGGLAL
RIISSGFIVSSISVTASGALEGLGKGVQSLLISLMRYVVIIMPAAFILSRIRGAVGVWNA
FWITELISAIASVWIYRKSLKH
>fig|411461.4.peg.953 Vancomycin B-type resistance protein VanW
MRRRRIRIAGFCLAGCILILGIVCGAFHHYVSQFPEDKIAENIYVGTVDLSGLSKKEALE
KLAGQKKADQKQTVSLTVEGQKAEATLEECGFDYADVKANVKAAMDYGKSGGLFGRYKSL
RKLSKEKVVLSPEYTLDQKATENILEERAVPFAKHAQNATITKSGSGLQINKEEIGETVD
KSGTIKAIKKHLNDSWDHGSFAMEAKVKEEQPSVTEADLSTIQDELGSFSTDAGGGERWK
NLKNGVEKLNGTVVMPGEQISVHDVTAPYDEEHGYVQAGSYENGQVVDTYGGGICQVSTT
LYNAVLFSELKVVKRYPHSMLVSYVPPSRDAAIAGDTKDFVFENNYDTPIYIFGEIDDDN
QLCFAIYGKETRDKTRKIEFESEEVSTEEPGVKYKADAELALGEMEVTGSAHTGKEVKLW
KIVYENGKQVSKDVINESTYSKADKTISVGIKTKNSSAAAVVKEAVSTQDKVKIQAAIGE
ASSMESSSEQ
>fig|411461.4.peg.1499 Permease of the drug/metabolite transporter (DMT) superfamily
MAVGFIFVALSATCLGVMPSFQKQVLLDGLPMNSLMFYVNWIITLVCLVMALVKKRSFRA
LKIQIVQSLLMGVFGLLITALLLNNSYLYLPVGTAIMLNFLYPSIVCIVMGIVFKEGFSK
YQIAAIVVSVIGMGFLTGAGGNMPMIGIVLAVASAFVYGGYLIANEKGPANELPIEVKLF
YVSLPGTILYCFIAPMTGTLVAPPKSIDVAFIIAVGLFNAGGYFFMMYGISKLGAAIASF
VSMLEPIVSVIFSTLWFHDPVTIGIVVGGGLVMASILLIAIDGAKKGNSA
>fig|411461.4.peg.1875 Permease of the drug/metabolite transporter (DMT) superfamily
MSGERKNTITKSATANTTTKKGLSQGQADILIAIVAMTWGSSYLMMKIGLTGMPPFSIIA
LRFCIAFITVALVFLPKMKLMNLRTLGYGSILGLLLFGVFAFLVPGMKYTTASNAGFLVG
IVSVFVPVVHSFLKHKLPSKRTTLGVLLALLGICLLTFLSTFTINLGDILCILSAFSYTI
QIILMDHFTKETDSFLLGIWQLGFTGLYGVIFTFLFETPSLPGSGAQWGAILGLAIICSA
FGFIVQPVAQEYTSPEHTSMLFALEPVFSMIFAYIFLHEKLSLQGAIGAFLIMVGVVIAA
STHEE
>fig|411461.4.peg.1892 Permease of the drug/metabolite transporter (DMT) superfamily
MRMTQKQNILTKTGIVALLACVCCILWGSAIPVIKTGYRFLHVDSSDIASQIVFAGVRFT
LAGILVLIFASIREKKVMIPDKEILKYAVPVCLAQTVGQYFFFYIGVANTSGVKGGIITG
LGNFIAILLSCLVFRNERMTRRKIAGCVLGFAGVVVINLLGNSLDMGFKLIGEGFVLIAQ
LSYGISTVLINLFSRKVSPVVLSGTQFTMGGIVLMLIGAGMGGHLENVTTGGVVIIFYLA
MVSAVAYTLWSVLLAWNDVSKVAIFGFVNPLCGVILSALILGEVKQAFNVGSLAALILVC
AGIYIVNCKENKKE
>fig|411461.4.peg.1996 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAESNKMKEMPVNKLMVQMGIPMILSMALQAVYNIVDSAFVGNMREGSEAALNALTLVFP
VQMLMVAVGIGTGVGTNALLARTLGQGNSKKAAKVAGNSLFLGVIIYVVCLLFGIFGVKA
YISSQTVDAEVLEMGVSYLRICCVISFGIIFFSLFEKLLQATGRSLYSTIGQVVGAVVNI
ILDPIMIYGIGPCPEMGVKGAAYATVIGQVASAVLLLIFHIKLNKEFEHGAKYMKPDGGI
IKEIYTIGLPAIIAQALMSIMVYVMNLILKFNPSAQTAYGLFYKVQQFVLFLAFGLRDAI
TPIIAFAYGMRSKKRIQDGIKYGLIYTVILMILGIVITEIFPGGFATLFNAGPSREYFIG
AMRIISVSFLFAGINIAYQGIYQALNGGVESLVISLLRQLIIILPLAGIFSVFARNGQMT
VSLIWWAFPITEIISCFVGYVFLKRISKNKVDVLN
>fig|411461.4.peg.2038 Drug resistance transporter, EmrB/QacA family
MMLSVAMYGLVFATLTSPILESVNAMGYVSLFSIFAGMGVSIMTPIGGKLGDLIGRRNIV
VIPGIICAVCGIAFAFVRSLVPLMILRLLIGFAQGAFTAAPYIIAGLINERKDVPKAMGM
LATAIAVGGFGGSIIAGILTDMGLLKVAILMPAVPLILGVVLIGMNMPNVKREGKVSIDI
PGIIALVVALAGILLALNFGSSMGWGNPAIIAGFVIGIVALVVLVKIEGKSAEPLIPLKL
FKNSQYTVLLIVGFICYFYQSAMNVYAPIGAMRVMGASTSAAGALQMPRTIITIFLPTMA
GVWVGKKASNAWKAMVIGTLFVAVPMAVMGFTTPSTSIIIYFVALTITGIAESYRSVSIT
PSAQATLQPADMGVGTSLVNFVNSLANTIAAAVFGAAYNLSTAADPTNVAYIQNGVDSVF
RLAAIVAVIGLVLVIFVVRPKMTAKKAE
>fig|411461.4.peg.2733 Permease of the drug/metabolite transporter (DMT) superfamily
MKPKNAVMLLLTSLIWGTAFVAQSVGMDFLGPFTFNGVRSFIGGVTLLPCIWLLEKMNGK
PEVDGTRKDLIQGGIACGLLLFAASSLQQMGIQYTTAGKAGFITAFYIVFVPVLGIFLKK
AAGWKVWMSVFLALIGLYFLCIKEGFSIGKGDIMIFACALVFAVHILVIDYYSPKVDGVK
MSCIQFFVCGIASLPFMFLTETPQIGNILDARMPILYAGVMSCGVAYTLQILGQKHANPA
IASLLLSMESCFSVLSGWIILGETLSAREGIGCVLMFVAIILAQLPDKREKLKNGQA
>fig|411461.4.peg.2944 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MATSLIQMAYNMIDMIWIGRLGSSAVASVGAAGMYMWLSNGLVTLARMGGQVHVGHAVGA
GRTDFAGRYAATTFQMTLLLGVLYGLVCTIFSKPLIAFFHLTSRSVINDAVSYLMITCGL
VIFSFLNQIFTGLFTAIGNSHPAFLSTSVGLVINIILDPLLIFGIGPFPALKVTGAAIAT
IIAQMVVTLLFLFFASQDQILFHHIHLLQAPDSKKASEIFRLGLPSCLQSLVFTGISMTI
ARLVAGYGDAAVAVQKVGAQIESISWMTSDGFASAVNSFIAQNHGAGKEDRIHAGYRSAL
KIVLPWGLFCTILLVCFPTPIFKIFITEPDVIPMGISYLMILGFSQLFSSLEITTSGAFC
GYGRTMPPSITGITLNLLRIPMALALTATPLALSGIWWSISITSILKGLILFIWFQITIK
KK
>fig|411466.7.peg.447 Multidrug resistance transporter, MFS superfamily
MTNHDTQDRGGIVGGALTVALLITLAVQNAVPPMATDMYSAAFPQITADLATNSTMLGFT
LTTFFVGYASGQVLGGAISDQIGRRRPIIAGGIIALVGSMICVFTPNIWVLLVGRVFQGL
GGGVASSVARAILVDVAHGKTLARAMSLLQAIVGFAPMLAPVLGAFIITHATWRVVFWAL
AGFTLLMAALAWFVVPESLPEERRHPGGIPRFFSGLVQVVRIRPFVGFMLTNAFSSFCMF
GYISNATYVLQGPLGLSPMAFAWVFAFNALLSTGFALVNVRLISHFTPRTLIITGLTIAA
TGVVTLAISTFVLDLPLILTCVGFALIMTATAFIFGNSGAQAMSEAREHAGTASSVMGVF
QSIANGIAAPLATSGGDSAVPMVLVMIVGSVGAWFAFWVIARGGKHTPRHLSLD
>fig|411466.7.peg.806 Glycopeptide antibiotics resistance protein
MYTAINWALDLGLYVTVCTITCALWWWFGRRSEPSVTAGRAEASTDSVQSAGQVSRARLT
VVQALPLIYRRSKQTSALLPREENPDTPTTAEIPAVAVPASSKWRLPRALPLAWILYVAG
LLIFTLLPLPSDPVAACAAIIHWDNYTPFGSFVAVADQFRDGESLRGTLYALSILLNIAL
FVPLGSLVETTWRIRRVRRAPEGAPADGSRLARSIPHRRVLAWVVIGCAVSCLIELTQYT
GLFGVVPCTYRVVDIDDVIMNTLGTYAGVRLLPFMARNSRFMGA
>fig|411466.7.peg.1735 Multiple antibiotic resistance (MarC)-related proteins
MMTVLAGMSAAILALAPITNPIGGLAAFAGLTAGNAAAAVRSQAWKTGIYVFAILTVFAV
SGSLIMRFFGFDLPSLQIAGGLVVSHSGFSMLENKRRATHEETQHATSKPDVSFSPMALP
LIAGPGSIGVVIALAARNTAIGFHVGIVLGIAVTAAVIALLLRYGTPWIDKLGATGVGAI
VRIMGFLILVIGVELIIHGVRALQLF
>fig|411483.3.peg.390 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTQTAKKSPFSMNVDLMHGPIFKNLLLFMLPIFISSLFQQLYNTVDTMIVGNVLGDTALA
AIGSCGSIYELLVGFGLGIGNGLAIVAARSYGAQDHDLLKKTVAGSLVIGLVASLCITLA
GVLGLHPLLLMLDTPAEILDDAYRYILTIDLGVLVMFAYNLCAGLLRAIGNSVMPLVFLL
ISSGLNVVLDLLFIARMGMGVQGAAVATVISQGVSVVLCILYIFLRVKILLPEKQHFRVG
SHLYWELFSQSISMGLMSSIVSAGSVVLQYGINGLGTLVIAGHTAARKLFSFTSMPVMAM
ASACSTFVSQNCGANQPERVRKGMKEIALYSVAVAVLAVLLMQLGAEWMVQLISGSNEPV
VLENGARYLLWNAPFYSVLGVLLATRYALQSLGQKVLPLFSSVIELVGKVVFVLFFIPKF
AYNAVILCEPIIWCFMAAYLVLVYLHDPFVFPKKAE
>fig|411483.3.peg.529 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKDEYLITDAPLKALTVFAMPMILGSFFQQIYNMADSIIVGQFVGSSALAAVGACAALT
NVFICVALGAGVGAGVLVSRYFGAKEYGKMKTIVSTSLLSFLILSIVLGVFGLCFSLPMM
RGLQTPPDILDEAVLYLRVYFAGFPFLFMYNILSNMFTSIGESRIPLALLIFSSVLNIFM
DLWMVAGLGLGVFGAALATLIAQGISAIFSFLIFLHRMRRYESPFQRFDWRGLQSMLQIA
VPSILQQSTVSIGMLIVQAVVNPFGTQALAGYSATMRVENVFSLIFVSIGNAVSPFVSQN
LGAGKPQRIKKGYHAALVLDLCFAAIAFVVIEALHTQISSLFLGKDGTVLAYQVSGDYMR
WLGYFFIFMGIKMATDGVLRGLGIMRPFLVANMVNLAIRLSVALICAPRFGIAFVWLAVP
AGWLANFLISYGALRRSWPTDKMASTR
>fig|411483.3.peg.879 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDSIFDLDHLYRTYFKMALPSVFGLMVSVVYNLADTFFIAQSNDTALIAGVSLCAPVFTA
LMAFGNIYGQGGSSLISRLLGQDDREGTGRVSSFCFYVALITGVVLAVLMMLFRVPLLGI
LGATVETMPHAQAYYTVLAIGAPATVLNFIHSNLIRCEGMATQSMIGSIGGTVINIILDP
ILITTVGWGAGGAAIATIVGYLCSDLYFLWLLHKKSRCLSVKLSQCHVTGKELQQVLGVG
VTAALSNLMQSLTVIVMNQFLLPYGNDKIAAMGIASKVSMIAQLVLVGFSFGGIPLFGYL
YGAKKRDVMRKLIRFCLTFLVSIAVVLSLILCLNSGALMQLFVQDAGMIATGAQMLRWQV
YTAAFGGVALLLTVLFQATGKIMPSFLLSISRQAWCFCWHWWSAYTCSSIRAC
>fig|411483.3.peg.905 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MANADRSAEQFRKMTETPIPKLILSLAAPTILSMLITSIYNLADTFFVGQISTSASGAVG
IVSSLMAILQALGFMLGHGSGSIISRSLGSQNTDAATRFASTSFFTALVFGGIITAAGLL
TLPDFMMLLGSTETILPHACAYARYILLAAPIMMSSLVMNNILRYEGKASFAMIGLVTGG
LLNIALDPLFIFGLGMGTAGAGLATALSQTISFCILLSMFLRGKTVSQFRITAVTHSPAE
FGTILMTGMPSFGRQGLNSIGGMLLNIAARGYGDAAVAGMSIVSRIFMFIISVAIGTGQG
FQPVAGFNYGAQKYRRVQQACLFTMAASFCFLSVILTVCWFNAETLIRLFRDDPEVTAVA
LPAFRYQCFAMLLQPVIVAGNMLFQSIGKSGRATFLACCRQGVFFIPLILTLPRAFGLLG
VEICQPIADVLTFFVTVPFLFPFLRQLVRMDEAEAAEV
>fig|411483.3.peg.1176 Permease of the drug/metabolite transporter (DMT) superfamily
METQLSRAEKLDRLFGTPVFAVIIAILCNAMWGSAFPFIKLGYRLFAIDTADTASILCFA
GVRFMLGSVLVLGGSLLLEGRLPAMPKGKILAECCALGLWQTTAQYAFFYSAVALLTGAF
GGILNSTQSFLGVIFAHFLYGRADRMTPAKALGCGIGFAGVLIATLGNHGGGSARGVAYM
LIATVLFTLAGPWNKSVTRRADSFAVCFVNLFVGGAALFLLGAVLGGRLEHWSVLSVLDL
LALAFICGAGYIVWALLMKNNPVSRIAIFGFVNPVVNVLLSALINGEPLFRWQYLGALVL
VCIGIWLVNKAPAKKERAR
>fig|411483.3.peg.1321 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNDKTDFTQGSIPKKLALFMLPILGSLVLQAAYGAVDLLVVGRFGSTSGLSAVSTGSQV
LNLVTFVVTQLAMGVTVLIARYLGEKKHEFISPVIGGAAVVFALLAAVLFGVLVFLARPI
SSLMQAPAEALDLTTSYVRICGAGIFFIVAYNMLSALFRGLGDSRSPLIFVLVACVVNIV
GDLVLVAGFHLDAVGAAIATVAAQAVSVVCAVVMLLKKSLPFSIKKADFRLNFQCKKFLA
IGLPLALQEFLTQLSFLALCAFVNRLGLEASSGYGVACKIVNFAMLIPSALMQSMASFIS
QNIGAGKHQRARQTLRTGIGIGLFFGLFVFALVLCKGDLLCSFFTTDAPVIANGYAYLKG
FALETILTAILFSMIGYFNGSGKTVFVMAQGLFQTLLVRLPMAYIMSIQPNASLTMIGLA
APTSTAVGVLLNVCFFLYLDRKAKKQG
>fig|411483.3.peg.2011 Permease of the drug/metabolite transporter (DMT) superfamily
MNTQTKHSLMLMLCAFIWGTAFVAQSAGSGMGAYSFLAGRSWLAVLVLLPTVRAFDALHR
RHGAAYGWPKAPADRRHLLAAGFCCGTLLFAASAAQQIGITLNPSTAKAGFLTAMYVVLV
PVFGLFLGRRGSARLWLSMVIAVGGLYLLCMKNGFGGIEASDWILLSCAVLFSFQIMTVD
HFAPQVDGVRLSLLQFFVVAVESTAAALLFENPTLAEFGANWLPLAYCGVMSSGVAYTLQ
ILGQRDVNPAIASLIMCLESVFSALGGWLLLHQSLSMREVFGCTLIFAAVVLAQLPVEDW
LKCRSASRK
>fig|411483.3.peg.2456 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNLTKQFFKYVSQNIFGLIGTSCYILADTYFIAQAAGTDGVTLLNLCLPMYNLIFAFGSM
IGLGAATRYAILQAQGEARAQRFFSNAILCACLIAIPFMLAGAFCPGTLLQLMGGDADIV
ALGLNYTRIFLLFTPFFMCNYIFSAFVRNDGDPSLAMVATLSGSLFNVVFDYIFIFPMGL
GLPGAALATAISPVLSIAICSRHFFQKSNTLTFVRQAPSARLLVQSCQLGISGFVGELSS
AVTTTVFNFLLLRLAGNVGVAAYGVVANFALVATAIFNGVAQGAQPLISQCYGKNEMAGA
KKLLLLGCGTALALAAVLYGAVFGFTDTFVALFNSESSALMAEYAHSGMRIYFLGYFFAG
CNIVAAGYLGAVNRPTEATITSVSRGVAAIVTCSLILSALFGMNGVWSAFPAAEAITLAL
TVFLLKRPQSVCS
>fig|411483.3.peg.2541 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQKYAIPCIISLLVGALYNIVDQIFIANASYLGSYGNAANTVVFPLTVVALAIAVMIGDG
CCAFVSISLGQNEVPKARRSVGNAVVMCLVSSIVLTAVYLIFANTILAMFGGTVNAETYH
HSQEYFFYITLGIPFYMFGQAMNPIIRADGSPRFAMVSTLAGAVLNIILDPIFIFGFRWG
MMGAAVATVIGQVVTAALAVWYLLHMKIIRPAWADLR
>fig|411483.3.peg.2542 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTSFLSQISLVAAMAAINNMIRKYGALDAVFGQEQYAQIPMAVVGIVMKFFQIVISIVVG
MAAGCIPVVGFNMGAKSPPV
>fig|411483.3.peg.2543 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFTKLLLAEAAVGVVALVLVELLPRQLIALFGAANESVYYTDFAVKSFRIYLCMIILACV
NKACFIFLQAMGKAAESTALSMVREVVFGVGFALLLPRFFGLDGVLYSMPLSDILTFLIA
GYLIHKTYHEFNYHIALDSGVIGIEKCAEIMESLV
>fig|411490.6.peg.66 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNHKNKMETRQMFPLIVSMAVPPLISMFMQYTYNFVDCMFVSWIGEKELTAVSLAFPITT
LMIAMSIWIGVGVNVLIADNLGQKNQDRADSVVTNGILLSAAMGIIVTGAVLVITKPFFS
SFTDDPEIYNLAVRYMRICAFLEVSSMVHICIQKILQGTGNMIAPMWFQIAGVVLNFILD
PILIFGYFGFPKMGIEGAAVSTVCGYTLSMILAFMVLILRKQKVRLKIKGFHVDFQIIKE
IFVIGFPSFIMNALGAFMIYFTNIFLVVYSTTAVAFFGAYFKLQQVVIMTLNGLVQGCIP
IMSYNYGAKNMPRLRQAFKYGTIIGIVLTGISIVLFWTFPEQILKIFNASDEMMTFGVPA
LKIMCTSYVFAAAGTMTASFMQSTRRVGFSLIINILRQLILLLPLMWILSQVIGMEGIWW
SFLAAETITVFISIYLYRRYPVKFSDNPV
>fig|411490.6.peg.151 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKHKFYQFVIPSVCASMVTGLYFVVDGIFVGRGVGSNGLGAINLAVPFICILTAVAMMI
AMGGSTITSIFIGQGNEQKALRSFMNSIYLVLIFSAFMTVFSFLFSDQIARLLGARGDLL
SLTSDYLRYYILFGIFFCMAMVLAAFVRNDGNPKLGLAGMAAGALSNVFLDWLFIFVFHM
GIHGAAVASGLGQVISCMIMLPHFIHGKGRLKLKLLPIEQYYTSEILRRGIPELITQMSQ
PVTIFCYNLIVIRYLGNIGVSAFSVVCYLLTLVFSVFIGVSDGIQPLISRSAGEGKKELE
RCFLKKGIAVNFLLAFLLYAVLLLFGEPVIHIFNREPALVKLAGESLSVYGVSFLFAAVN
MIFTTYHLASKRTFKALTIASLRSFIINVAFIFLMPAVFGRQALWTGIIAAECTVTFIAV
LMMKKTSDSHTCSAAAAEN
>fig|411490.6.peg.893 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MILDPIMIFVFHWGMMGAALATITGQIVSAILAVYYLCHMKSIKMETECFRVNPIISKKV
LSLGISSFLTQISIVAIMAAMNNMLVIYGAQSRFGSDIPLTVVGIVMKVFQIVIAFSVGI
AAGSQPVIGFNYGAGLNHRVKKIFKLMMAAEACVGVFSMIIFECFPMEIIKLFGNESVLY
NEFAVLAFRTYLCTIVLCCIQKSVSIFLQALGKPILSMGLSLLRDFILSVPLVLFLPKLL
GIKGTLYSAPAADMISFIAVIAVTRYLFGHLKKDEKEERETAFNRGEETINLVSE
>fig|411490.6.peg.1716 Permease of the drug/metabolite transporter (DMT) superfamily
MSKNQKIRGIICIVLSAFCFAWMNAFVKLSGDLPSIEKSFFRNLVALIFAFVMIKRSGAG
FRFQMKNLHWFILRSLAGTLGIFCNFYAVDHLVLSDASTLNKLSPFFVIVFSYLILREKI
TVFQLTCITSAFIGSMFIVKPSFAAVSVLPALIGFLGGMFAGCAYACVRKLGTRGERGPF
IVFFFSTFSCISCIPFMIGNFHPISGLQLVYLLLAGLAAAGGQFAITAAYTYAPGKEISI
YDYTQIIFSTLLGLFLFGQMPDGFSILGYVIIITAAVVMFFYNNRRNKTE
>fig|411490.6.peg.1729 Glyoxalase/bleomycin resistance protein/dioxygenase
MASYLEHMALRVKDLDWHIRFFEDVFDMPVRMELGEAPNRKVWLHAGIQLNEAVDYEGPE
GRADHMGIMTEDVDAVLEKAYRLGVKELPQGHNWFELPSGLCIEVIAGKTDVLKEIIEKK
PWIE
>fig|411490.6.peg.1926 Permease of the drug/metabolite transporter (DMT) superfamily
MNQNTKGVIFTMLGGIFWGISGIIGKYLFDEKQLTAVWLVTLRLLSAGLLMLMLAAVQKK
GDIFRVWKKKRTAVSQLVFCLFGMTACQMSYFLAIQYSNPGTATVLQYIAPALIMLFCLA
VEKRKPKRLEVIVLVCVIAGVFLLATHGDPGSLAVTGRALFWGLAAAVALAVYNIQPEKL
LNEFGSMETVGWGMFIGGLLMIPVTGFFHVPGIWDMTTVLLALAVIIFGTVIPFGCYLEG
VCLLGPVRASMFACVEPLVAAVMSALLLGEVFVGVDVLGFALIIGGVTSLAVFDRS
>fig|411490.6.peg.1989 Vancomycin B-type resistance protein VanW
MSKRMKAGIAAGILAVICIGIFVYISQTVKGATKDHKIVQGVIFEGKSLGGMTKEEAKKE
IEDYIEKEQAKDITFYVDGKKAVTKLSKTGVAWDVEKTVKDAYDVGRSGSIINRYSQVKK
DKIIVKIERSYDQKIFDRELDSAAKKIVSEPKNASLKRKNGKFIIIKEKTGYALDKKSTF
KAYKKQVEAESFKVPLKVTRKKAEYTSEDMAKVKDKLGTKTTYYGSSAPGRKGNVANGAK
MINGTVVYPGETFSVYKAVSPFTSENGYYLAGSYENGQTVQTYGGGICQVSTTLYNAVIR
AELKIKERHPHSMTVSYVPRSADAAIAGTYKDLKFENQYDFPIYIEGIADGSNITFSVYG
QKTNPNRHVEFVSETTSVRNSSGEKAIKDPTLEEGKRVVEQVGHTGYTAKLWKIVKEKGK
KTQKILFNTSSYMATPNTVRVGTKKKDKDKDKKKKDTDKKKKDSKPTEKSTEKSTEKKKT
PAKKSTEKKSTQAAQTSKEN
>fig|411490.6.peg.1996 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDNKVFESYPVPKAVATLALPTVLSMLVTIFYNMADTFFVGQTGDPNQVAAVSLTTPVFM
LLMAVGNIFGIGGCSYISRMLGEGETEKVKKISSFCFYGSIIAGVIMMIVFLGGMPVILK
LIGCSPNTEEYARSYLTYIGLGSVFVVISMAFNNVVRGEGAAKISMIGMMIGTIVNIVLD
PVMILGMNMGVAGAAIATIIGNICTVVFYLFFFAKMKTGLSISPKHFTAKERILSGVFAI
GIPASINNILMSTANIILNNFLASYGDIPVAAMGVAMKANMLVILVQIGLGSGVAPLIGY
CYGSGNLEKMKKTMKFSMACNVIMGTVLSLLYLLFTEPIIQAFINDGSVVAHGVRMLRVL
MISGPVIGIMFVFMFGFQAMGKAIPSLILSLSRQGLVFFPVLLITNYLFGLEGIVFAQPV
ADLASLGVSFLLFIKIAKELKEREKELELQKAEA
>fig|411490.6.peg.2551 Permease of the drug/metabolite transporter (DMT) superfamily
MNQKNKTKLGKAALFGSALIWGSSFFIMKNTIANVPENFLLGTRFLAGALLLCIFFHKRL
GKIDKSYFKTGFVLGGFWFWAYWFQTEGLYHTTPGKNAFLTAIYCVAVPFVTWIWQKKKP
TKQNFLAALICITGIGLISLDGNLSIGIGDGLTLVGGLLFSLHIAYLGMKSGQKDPVLLT
IVQFLFAGLWGAGISVFTEDISAIHWTVGQAGSLAYLVIMCTAVAVTFQSIGQSRVSSSS
ASLILSLESVFGVLFSVIFYGEKATVKILIGFALVMAAILISETDLGRKSGHTENNDKKR
INKKTANVV
>fig|411490.6.peg.2669 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRAKREENMKDLTVGKPFEVIGKFALPMILSMIFQQVYSVVDSIVAGRFIGVSALGAVGA
SQPITVIFIAIAVGTGMGINVVISGFFGAKKYKRVKSCISTAVITIVIMSAVLTFLGLLG
CRWMMGAMSTPGDIFEDSALYLRIYIMGIIFLMLYNGANAIFTALGDSITPLIFLIFSSV
LNIILDVLFVTAFSMGVAGVAWATFIAQGIASVLAVVTVFKKNSKIQAGNYRRFSPLLLK
KMTWIAVPSIMQQSFVSVGQLFVQGRINSFGSVVVAGYSGGFKIQIFILSVLGTVGNAVS
SFTAQNAGAGKWERTKEGTNAGIKMIVAMAAVFSVLCLVFSRQAMGLFLSGNSAEAVRSM
GVGVDFLRINAPFFALVSVKFVCDGMLRGMSEMKGFMASTFADLIARVSLSYVLSVPFGA
TGIWAAWPVGWVIGTGVSVWFGKRAQKKYLK
>fig|411490.6.peg.2681 Permease of the drug/metabolite transporter (DMT) superfamily
MKIIKRNNETKYVLLELLAVAFLAAGGIFVKLSSLTPVSTGFYRVLFSLPLLLPLAFRGL
RILTKKDVLILFLAGVFLAGDVALWNLSFSYTSVANANLLTNLTPFTVIPVSYFLFREKI
PKLFLAGAAVTLIGVFVLLGGKISPLQSNYFGDFLAFSASFFYAVFILISYRLRDRYESS
VIMFVSGFGSALALGVTSVLTEGIQIPHGTEQLWPLLGLTLCLQVIGHNLLAHCQGKLSV
NLSSIVCLCQPVIASLYSYFIFSEVLSLREVLGIAIVIAGVYLVKAQYSNKIKK
>fig|411490.6.peg.2995 Teicoplanin resistance protein
MGNHRNRKLRDGIFNGVFIFYLAFLLENILFKYVQPWQLFQHGRYFSRSLNLVPFRQIMS
SSGIGDLNIYGNIILFLPLGIYLMFFMKRRKAVKSLLAVFGISLFFEAFQYAAAIGATDI
DDIILNCAGGLFGVMCYKVLLFVCMGKEEKAKTAVAGTAAVVGMITAVLIGLLIAFN
>fig|411490.6.peg.3113 Permease of the drug/metabolite transporter (DMT) superfamily
MGYEIFKIQGDDIGSKLLFAGIRFAAAGLMVLAVLGVQTRQRPLPKKGAFKHLLTLGILQ
TTIQYYFFYVGLAHTTGAKGSIINSFTAFFPVVLAPFFFKSDRLTAKKIIGCAVGLSGIV
LINLKGGSLGGFAWNGEGFIVLAALSQSLASIYSKKLAQTMNVMLIAGYQLLLGGSLLLI
FGYAGNGTLTFQTSGLILLLYMAVLSAVAFSVWTWLLSHYQVSSISIYNLLIPVFGTLLS
GLLLKENVFTAVNIASILLVCGGIAAVNKQ
>fig|411490.6.peg.3257 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKEQLTNDMSVGNPAKKLFFFAVPIVLGNLFQQLYNIIDSMVVGRFVGAQALAAVGASTA
IVFLFVAVATGSSIGYSVVISQLFGAKDQDRMMTAIYTALISTFVLGLILMIIGAAGTGG
ILVLMRTPADIYRDAADYLRIYMFGLVFLFMYNTLNAVYNALGASKIPLYFLAGSSILNI
VLDLYFVIRLQMGVTGVAWATLIAQGLAAVISFINLLFRLKKIETETKPVLFDRKILFQM
GRIAVPSMVQQSIVSFGMVFVQSLVNSFGSVVLAGYTAATKIDSIAIMPMVNVGNAVSTF
TAQNIGAKKPERIREGLRAGRLMAAGIAVVITGILFFKGDVLVAQFVDEAVNAEVIAIGV
DYLRVVSVFYALMGLMNVVNAVLRGAGDVGVFMAGTLCNFGCRVVFAYILAHFLGASGIW
WSVPIGWAAAFTIGTLRYRSGKWKEKGIVEREKDCKETGESI
>fig|411684.3.peg.443 Permease of the drug/metabolite transporter (DMT) superfamily
MQRPPAHPLAGLALGFVGVVIFGATLPATRIALEGFSPAFITFGRAALAALVAGIALFAL
GKHFPRQHALSFLAAGVLLVYGFPGFSSVAMQTVPASHGGVVLGVLPLMTATFAALFGGE
KPGLAFWAWSITGAALVVIFSLSGADIEPGLGDVWLGCAALSASCGYVICGKLARTQPGW
EVISWALVITAPLSLAGALYSWDSGVTNPDTAALMGFIYLSLGSMFAGFIFWNWGMAIGG
IARVGQVQLLQSFVTLALSALLLGEQITWVTLGFAVAVALVVWFGRKAKVG
>fig|411684.3.peg.3754 Permease of the drug/metabolite transporter (DMT) superfamily
MTNASLFAGSSGASRFVPLVVMILTPLFFSTNLIFGRTTIPEVAPFTLAFLRWTAASLAL
APFVWVARHHVRAYLTSSPRHWLLLGFLGMWICGAGVYYALQFTTATNATLIYTTSPLMV
ILLERLFFARATGWRELAGIAIGFFGVAIIVLQGDLDRLAGLDLNRGDLMFIAAALSWAV
YSVLLKGPRTSAMPVSALFGAITIAGALLLAPFALWEWMSGARMPSTVSAWGGIAGIVVF
SSLLAFGGYQYGVARLGASTTSIFMYLLPVYGVGLAVLVLGEPFHAHHMVGILTVLGGLV
LATAPIGRPPKTRP
>fig|411901.7.peg.2693 Permease of the drug/metabolite transporter (DMT) superfamily
MNRIKGILYAAVSSSTFGLAPFFSITLLLAGFSAFEVLSYRWGVASIVLIVFGWLSGCNF
RLAGKDWGVVFLLSLLRAVTSFSLIIAYQNIASGVASTIHFMYPLAVALAMMFFFREKKS
LLVILAVLMSLLGAALLSLGELEAKSGNTMVGLVAACVSVFSYAGYIVGVRTTRAVQINS
TALTCYVMGLGTIFYLIGAYCTSGLQLVSDGYTWLIILGLALPATAISNITLVQAIKYAG
PTLTSILGAMEPLTAVVIGVFVFKELFTVNSAVGIILILLAVSIVVFRRQKS
>fig|411901.7.peg.3625 Clindamycin resistance transfer factor BtgA
MPNNSRKTIFTTISIDKETAALVEKICKRYSLKKSEVVKLAFGYIDKAHINPSEAPESVK
LELAKINKRQDDIIRFIRHYEEEQLNPMIRATNSIALRFDTIGKTMETLILSQLEASQER
QTAVLKKLSEQFGNHADVINNQSKQINALYQIHQRDYKKLLHLIQLYSELSACGVMDSKR
KESLKVEIINLINT
>fig|412965.6.peg.270 Glyoxalase/bleomycin resistance protein/dioxygenase
MNIRFSHIALRCNNINTVAIFFTEVIGLEKGFRPYFIFPGYWLYSPENKQEAIIHILSKK
AKFSIKTNNYNNLLDHIAFVRDDYPIFIKHINKLKINFYEKFIPNLNTKQVFLKGPENIT
VEVNFII
>fig|412965.6.peg.326 Acriflavin resistance protein
MDNILIFFVKQKKLALVLTISIIVLGLFTLNSIQRDKFPAVDFEVMTIVTAYPGASPEDV
EQNVTNLIEDELRSISGIDKFSSTSKEGKSSIVIILSQDVDDIEPLKQEIRNVVNRIKSL
PEEVNGFPWIVDQKNSLKSILKINISSDNLSYQVLRDIIDDMSESLSLVKGVSKVIKEGY
LDREFQIRVNPDSLYQHKLSLPQVIKAIKNRNKRYTVGNNNDINEKTIVVLAKFDEIEAV
SNVIIKSTFDGPVIRLKDIAKITSENKKETSIIRVNGTKGFILSIHKQEHADVITTVDLV
KDKVLELEAKYPTSLKFFYSSDESNHVRNRLNIVTNNGLIGLLLVLIILALFLSFKTAFW
VSIGLPVSLLGTVSLLGVTGETINLVSLAAMILILGIVVDDSIVVAESIHHYKQLGKDRY
QSTILGFKRVIAPVITTILTTILAFSSMFFMSGTMGKFIYVIPLVVIFSLTLSFLEVSLA
LPAHLASSDEKTKEKIWFMRIEVWFEGFLTEVLKWRYSVVFIFSIVLIGSLYFAKTQMKY
VQFPIVGADSIDARLNMPIGTSLERTESISKQVEKIIIEVVGEDLDSLTNNIGHYFTNVA
KFSIELVPSSIRVETSKSLLAKLKKRVKDIKFAQELKFSISRPGPSQGEDVEINLIGSDN
IQRQNAADTLEKILLGIDGIDNIERDDESGKARIEVVIDFEKMSRFDVDFSVVDDYLKAV
FTGTNVTSVRYGDNNVYFRIYLGSDKQSKNFLTLLKINNRQGRPIPLKQFVSLKKIKGEP
NFNHFNGQRSVMFSGSVDDEVTTSGEVISQALKQLDLVSKYPAIQMTSEGGNKDTKKTMD
SFKKAFIMAIFSIFLLLILLFNSYSQPILVLIAVPFSIIGVIWAFFLHGETLSFFAILGT
LALVGVIVNDSLIMVTHLNYLKVKLASTMSVYKWVAQGAKDRLRAVVLTTLTTLAGVIPL
AYGIGGTDFILQPMALSLGYGLLFGTLMTLVLLPCLYLINHELINWLKKTFG
>fig|413999.4.peg.218 Vancomycin B-type resistance protein VanW
MKNRKAKRILIFIFLLMSILFGVFYYIYKEVSGFDSVIYPGVFIEGIDLTAKTKNEAKNI
IESKYSKVIVRKNITISWNDKKYNLSYAKLNPRYNIQETIDNAYSYGKNLSIFSKYKIIK
SKSIQNYLLKFSYDKKAMDRFIDSIERDINKEAENAKINVNKGSISIVQDKKGFKLEKDK
LKKILYSKMDGKNLKDINEKAPVKTQEAKIKKKQLETVNSNISSYTTNYGSISSPQRANN
IVISTKAINGTLLMPGESFSFNNTVGPRTEKRGYQGAPVIIGNKIESGLGGGICQVSGTL
YNAMLKANINATERVRHTFPSTYVPIGMDATIDYGNIDYKFKNTLTYPIYIEGITNGANV
TFNIYSNSSLKNKTYNISSEIYETITPKEQYIDDASIPLGKTEIVQEAHTGYKVKVYKST
VENDSVVKKELLYTDFYKPVDKIIKRGTKK
>fig|413999.4.peg.316 Multidrug resistance ABC transporter ATP-binding and permease protein
MCAIEGKGGSRYMRTTLRIFIGARRYWIHLILALIAVIISTIAGFYNPWALRELTSIATE
GSANFGGQSLRIGLMLLVATILQSAGSAISGYLNHHAALHYVADMRTELYSKLQHMGLRY
FNKSRTGDLTSRVINDVMEVEILLAHIIPDFVVNILTFIGVGILLFSINVKLAFISLVTI
PFIIMITLWQSKHLSPIWKQNSMIRGELSGTVQDNFSGIKEIQIFNQQEREEKRIKNLSI
KHSKAYLKASFFFETTFPLLAFFTALGSVIVIIFGGFMVSRGEINIGDIVGFSMYLSMFY
GPIKSFSRLMEMAGNAVAGCKRVFEVMDEVSDVQEKVNAKKLPRVKGEVEFKGISFSYND
EIKVLKNINLKVNPGETVAFVGATGVGKTTIASLLNRFYDPQSGSILMDGIDIKDVTLKS
LRDNISMVLQDTFLFNGTIYENIVYGWKEATRNQVVAASKAANAHNFIENLEDGYDTIIG
ERGVRLSGGQKQRISIARAILRNSPILILDEATSALDTRTEKEIQAALDEISKDRTTIVI
AHRLSTIYNADKIVVLEGAGIKETGTHDELIRSGGTYAMLYKSQVS
>fig|413999.4.peg.576 Multidrug resistance ABC transporter ATP-binding and permease protein
MKKILNNVWGVAKKYKGKELIGLIFTILYTVAIFISPMVSRYLIDSVIPSNSIYKLKIGI
LIFFGGCICQPIFGYLKNRVFMGISENITIMFREKMFNKVIDAPMEFFDGCSNGAIVSRI
SNDGRSVSEFITNFFVVVVKNIVLIIMIIIGMLMLSKEITLMVIFLYAIYFFINWKISRK
FNPMSKSIQESYDQICIKINRSVGSINTIKAFNQEEKVKREFKEIIEKNYTNNLKFRKLS
MLMNSISNGIMIASLSIVYGMGSLLVMDGKITIGTVVAMGLYFQLLVQPIYELLNSNIDI
HTIVPIFNRINEYINLKTERVNKENNELSFLKEIEFKDVSFKYNNGSQAINNINFKLPSK
GIFAIVGDSGAGKSSLIKLLSAFYDSYGGEIKINEKELKEYGAKDIRKVISLVSQDIELV
NESIKNNIKMGRNIKDSKIKEVVKSLSLEKTIEKLELGYDTIVNERANLSGGEKQRLSIA
RALVKESLIYIFDEPTAALDTINEKRVKDILEELSKEKLVIIITHNLSLLNKAQCIYTIK
QGEIVEEGDYEYLTKQDSYFSKLMKELSKK
>fig|413999.4.peg.823 Quinolone resistance protein
MSISNPRIPADLIMVDDFSSYAQGYLYEEIPITQIKIYGEHIEHFDFSKSEINTSIFENC
TFLDCSFEGASFVDVVFQNCNLSNSNFTDAYFERCQFIACKCVGVNMIDTIFKQTSMQRS
NFQYSYFDKAKMTDIAFEDIDFTEVSITEAKLKRFKAKNSHFIKNNFFKTMLTGVDFTKN
ELVAPTVSSPPIEFQGAKISMVQAADLIGIWGIIVDQ
>fig|413999.4.peg.981 Transcriptional activator BmrR for multidrug resistance transporter
MKDLFTIGEISKLFNINIRTLRYYDEIDLFKPIFIDKANSYRYYSTDQFEQLNTIKYLKA
LGMSLDTISYHLKKRSVDNIIELFEKQKKITEEKIKELELTKQKIQNRINQINYARQYHN
LDVVQEIRLQERRIVLLKEKIKSNNDLELSIRHLENKANKNASIFNGKIGVSISIDKLKN
KEFGEYDSIFLFTEGERYNKNLIKVLPEGTYASIRFTGTHKNSPIYYDELLKYIEEKGYT
IIDDSIEITLIDFGLTTEKSEFVTEIQILINKS
>fig|413999.4.peg.1116 Permease of the drug/metabolite transporter (DMT) superfamily
MKDSRIYFLMILSTLFWGGAFIAAKLSAPFIPPFTLTFLRFLIATLVLFFIIMIKEKSIY
KLKKEDIPVFLFTGIVGMVGYHIFFFKASTYTTATNSSLIAASNPIITCILSVIFLKDKL
SSKGIIGIILSFTGVLLTITNGAIANILNINFNKGDILMIIAVLCWASYGVFSKKVMPRY
SPMTLTFYSFLFCTLFLIPFVIYEKPLSLINKVPYYSYISILYMSIFASVIGYLVQQISI
KQIGPSKTSIFVNLVPISSIVLSSMILGEKITIITLLSTALIIAGVYICQKSN
>fig|413999.4.peg.1961 Teicoplanin resistance protein vanZ
MYVAHTDYLINIIRICILCIVFQKGFYLRAKKREGGVSRKHLLWVFIFLLYLGAVYGVTG
IGTIWDVQRFVTASTSKFDRIYLVPFSSSEVIMPYVLNIIMTIPLGFLLPLIWKQFRTIK
KVALSGFLLSLCIELSQLFTQSRTTTTDDLIMNTLGAIIGYFIFKAFFHIILKKNSNEKD
EITSSSVVIKHEAIFYLVLSFLGMFLFAI
>fig|413999.4.peg.2463 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTKNIEDKQGKFEELTKTPISKLILKMAIPSIMAMLIGIAYSLADTYFISKIDTISTASV
GLAFSFMSVTQAFGLLYGHGSGNYMSRMESEKNRTESSKMAIDGLVISFLTGIIIMIFGE
LYLNELALFLGATNSLLSSTKEYLLILLIGTPFMISALTMNNQFRLQGNPSLGAAAITSG
AVINCILDPIFIFYFNLGIKGAAYATVIGEIISFIILIVVSGMRENIKFNLKNFSINKKI
LSELYGGGIPNFTREIFIGISLMLLNNELKIFGEEYIASFTIVNRLVLAGTYLMVGLGHG
FQPVCIFNYGAKLYERVEKALKFTLRSAIIFMVFISIIFLMYSENMVMLFRNDNEIINIG
SQVLSIQSITLPLIGYITITGMFLQSTHKFKEATLITSSRQGYIYIPLILIMPKMLGVKG
ILYVQPLSDFITFVISVVLVAKYKKELKC
>fig|413999.4.peg.2673 Teicoplanin resistance protein vanZ
MRDIVTPIIINSIIIFILSKINKKQQNKTGHITGVLFFTFIMTIVFELTGISPISGFHTD
IRINEISYIPVVSTLDMVKDVFNTAHVENIPGNEVMLYLGANIFGNILMFGPLGLLLPLL
WKHFRKFSKTVLFGFIVSFTIESSQLFLARGTDIDDLILNTIGTMLGYLAFVILRKLFPK
FTAKFTLEDDAEKSSWSILPVICVIIPYLVIVAFGFYDRAILFAR
>fig|413999.4.peg.2677 Teicoplanin resistance protein
MKKKIINILFTVGFVFYISFLLWNIPFKYVSPLEVFSTNRYFSRILNLIPFYDIFNGNYN
SLDIWGNIILFIPLGIYMNIINKNNAIYKRIYKIFAISLIFEASQYIFGIGASDITDIIT
NTIGGIIGIGIYMLIKRVFKENKKVKNFVTICSIVIMIPVAIILIALFIYN
>fig|413999.4.peg.2723 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKNREELINGNMFTLLLKLSIPGIIGMLVIGLYNLCDAIFVGKLVGETALAAVSISSPF
TFINNCIAVLVGVGSSSILSRAIGAKDDKVVNEILANLILSVLVLSLTVTVLGCFFSENL
LRFSGAKGEILQSGINYLRIVYIGSFFVNFSQSANMLIRGEGKMKEAMGIMALGAVLNII
LDPIFIKTLNFGVEGAAIATVIAQIIQALVTFMYFKCNKSILSVTKLKFAFDLMPEILSV
GGSAAMMQLMYLVQQTALYKLISIYGGDDQLVLMGVALRILMFTFIPIWGIGQGLQPIVG
MNFGAKKYDRVKDAVKIFSIASTIFIGVLWGFYMLKPRVVLSWFINDRTIIENGYEFFRL
MFLTFPVSGLIVMSMTFFQSIGKGGKSALITVLKQVILFMPIAIILTKIIGIKGTWLASS
VTDAIVFVLSFVLLAIEFKKLYDINSSENQNITYIK
>fig|413999.4.peg.3512 Multidrug resistance ABC transporter ATP-binding and permease protein
MGKLRSLLKLKPFLQKYKLLLFFALIGIILGSIVAIPVPYIIGKIMDDVLIGSKSFNEFY
FYIGIITILYVLKYFISITSNYLSSKFNNFMSNDLRFILIDKVMDLPMDYLANVEKGYLQ
GRISECDSITAIFSGTIISILLSTVNAVLSVSTMFVINYKLAIAVLILVPFFFILAKFSN
HALTKNTKKMLEDSAILNAECFEIINGVEDIKILNGKAYSLGKFKKKLDQFIKITLKQNK
TMLLLSQNVVGVNDVGTLLILLIAGNLIIKGEFTVGLYTTFSLYSSKIFSSTQLLANIGP
SLKQACLSIERLYELIDMDDENKGKNKHLNKKIESIKLENVTFKYKNSIKNVLDSLNFEI
NKGEKVLISGENGTGKSTLIKLLVGLYEPTEGRILYNNLDLATINNESLRSRIGIVSQNM
FLFKGTVLDNILYGQNQKKRKDVEKLIIKLNLENYISRLPEGLDSKIIQNNNGISGGQTQ
VIAFIRAVLSNKDIIILDEPISNVDAETRNIILNILKESKFDGILIIISHFTKGMEFINK
TIKVGKK
>fig|415426.7.peg.1 Permease of the drug/metabolite transporter (DMT) superfamily
MAAGWGTAYTTASNSAFITGLNVVFVHLFQALVMRLYSVELAFSLVLAVGGLYMLTGPTG
GFSFGEFLVLLSAFAWAAQVLIVSRFSGSDPFAFTFFEALTATVMIIPDMLVYGNSLDVP
AQALPYLAYLGLACTDAAFVLQVYGQRGVSPATAAIIYLLEPVIAAAIAAAMLGEHMSTL
QAIGAAAILASLAVAARAEARREG
>fig|415426.7.peg.249 Multidrug resistance protein
MFLRVLASGLFGRGGWRRGMGRLLWLLVAVFLYSAAAAIANVAAGLYVLDLSGSRFYLVL
SVLLFNAGFAFSSLVVVHVASRRLSGHFVLAAGLVGVAAAVAGMAFARCVVVVAVLNLVY
GVFAALIQPVAVSAASRVGGDVAVPRVNMASSLGIVAGDGVAALFAGSIGVQGLLIVAGF
LAAAAVLPVLYGPRVQAGVRGYPSPSAPLVTGRARYTPPHVARSSLPMPACRGGVPWQVY
AGTLVLFSGVALFFSPMPAYLREAGISDSGIYLLSMEALLASTVAYELLRRLELGVAVAA
RLLVAASASRVAVFMLPLAGFGGFAPVGAVMALVYLLVGVTWAAISTGLPLLALRLGGGE
AGVGRVNAFMSFGLVVGSLVAAPLAEAYGAVATCAAASALAGLSTVFFAVASGRLAGCGN
TFKASA
>fig|415426.7.peg.307 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MADAGERLGRLRERVLSEENIVRLLVWLAVPLMASSSVRILYEAVDAFWLSRLGEAALGT
PIVSWPYPDIVFAVAFGLSGSVSAIAGQYIGAGLYDRASRSAGTVLGLIMIVAVPGSIAI
AATAPLYLDAIGVPETVKPLAEVYLAIIALGTPFSALFLFFNMLLGAAGDTRTPVKVSIA
ATAINAVLDPILIFVADLGVLGAALATFIASLFSASYAAYSLATGRHGFRLGIRDLIPDR
SLLPLVAKVSAPLVVQRLGMTLGFMVMAGIVAGLGEVVLAAYQVGHVALSIDSIISMPLA
RSVGIVVAQSLGAGQTWRARKAVKTGLLLLAGFVGAYIAAIVYFAEEFARIFTSNPETVK
VIVDMLHVFGPSILSFNLLTLANVVARSSGHTFFISALGIARLWFLRIPLSWLLAYQLGL
GEKGLWAGMAISNHVAGGTALAWLAYGNWAKPVITQEQREHKPGHMKTQSQQQG
>fig|415426.7.peg.585 Permeases of the drug/metabolite transporter (DMT) superfamily
MTRALLGYAAAFTAGVLFGVSDVLVRAASARLSPLANLLLSLLIGTPLLWLTVAATNSFT
ADRSALLAYAVAGLLNFVVGRLLFYVSISAIGATSAAVASSPTVLFSALLAWVFLREPID
AERAAGLTAATLAVYLASSRPSGRPLHGEKLGLGVVAGIASSLVFASSTLLVRYAGGYSG
GNPVLGTAVSYTVALPIAATLAAAAGRLKEITGLTRHHIFMASAAASVAFAQLLRYIALS
IIEVAPAVILIGLYPLHTLLLAATILPGEAAEKPTARHAVAATLAVIAVALAA
>fig|415426.7.peg.623 Multidrug resistance protein B
MVYSGSSEYLVMLAAAETIPTIAGVLGAILAERLGYRPIFLLGIAEGLFLSLTGIWLHRP
ELLWLAALIASFSWSLAGPQILGYALTVSGLSARSLGIVLAGGTIGWSLGGAAAPILAAY
VGADVVLVVSGIIVAAIYLVLGLMPQARPSRKGGKGLTRLRYFAVAIIPASLAFVGTEIV
GTIYMAKLSVEMERLGYALGIALSGFIGAAVRPYAGSLVDRIGEARVLPLVLILYAGYIP
LLASTHGPIFMAVWLLPLYPLFDVAIYKYAARLVGEAMGSAAVSSAYSIAGIVLLSAARL
RGETSTYNALAVAAFLAAATAAAIGSRVVPERSHGEHLIRGPVERGAGG
>fig|415426.7.peg.906 Aureobasidin resistance protein Aur1
MNMWKLRLDRPYLRVLLYMVPFVLAYAGYEMARGIAFRLQSYAVYAPYVDLEVALFGVPL
AVYFQFHRLLVLDIYTGIVYALHPVYFFAFAVLLAFREPKLFRRLLAAFLVASAVAITVY
VLSPTAPPWIALPCIERPPNLVLKLVELVMGARIDPNPYAAMPSMHVGMAVIFGYYYVKL
YGGSRRSLLVAVAWVASMSFATVYTANHYVADVAAGLALGYAASLLGDKLGGLSLH
>fig|415426.7.peg.1265 Multi-drug resistance efflux pump pmrA
MATRVIRMNVAALSLYSLFRGFSVSGYQVLFSAYMRSLGYSMTSIGGAVTVSSLAGALLA
PGFGAVIECYGARLTTTLTGLMLVVSLLLLSIPEPGYAAFVASYVLYMLAFSLGQPARST
LLAKSVPGELHGYYTGVTMAVFATARIVGPLTAGWLAARAGYPQAFTVLTLSAAVGVTVF
HILSMEPSEPACKNTLQKLRSAYTSALKPHKELRRLYPLLVVDRSGWSLWFPLLSAQLKA
VGYTEDQIGALYTASSLLQATTSMVWGRLTDRLGPAKTVASSELLGAAALPLLANPHPWI
NAAAGMALIGLSIAAWVPAYNKLVAQLARGNLGEAYANANAVRSLAGTPTPTIGGIIYET
LGPAALYTLSATLLTTSAAYALKTLDTKTTK
>fig|416269.5.peg.1034 Permease of the drug/metabolite transporter (DMT) superfamily
MNRYILFVLFSICCLALGGIFVKLSQFPPITTGMYRVLFSLPIFFLLSKYNKDEYKMTLS
EKLIAVCAGAFLAMDLILWNISFSYTTVANANLLANLVPFTVVPVLYFIYKEKVSKAFLI
GEGIILIGIFVLMGGKVNPTAENFKGDGLAILTSIFYGLFIVTVYKLRSKVSTIYLMRYA
SIGCLIVLLPISLLLEGVYVPYTFKDFYPLIGLALLSQILGQGGLSYCLGKIKASYASLL
VLTQPIISAIYAYFIFNEHLSLKEITGIFVVLIGLYIANKKK
>fig|416591.4.peg.1388 Permease of the drug/metabolite transporter (DMT) superfamily
MVYVYLLFSLLMWSSMEVLTKPLMQQVDPFFLTFFRFLVGGIFLVIFAKKKISLKDAGVL
ALIGCLNGVVSMSLLQLSIKFSNASTAATLVATNPLFVSIFAFALGKEKLNFKKFVGVVV
GLIGIFVLSYGKVEGDSTFGLICGVGAAITFALYTVLMKDFTLKYGSMNATAFSTLFAGI
VYGAILLLAGKLDIPEVALNGWIILLYSAIFVTGLAYVTFFKAVEKLGPSRASLVFYLKP
AVASFFAFLILSEPVGIFKFVGTAIIIVALFIK
>fig|419610.8.peg.1526 Permease of the drug/metabolite transporter (DMT) superfamily
MCRKWPAMPASTITSDHPALQAQAVLAGRRCMPPAGLAVQPLRKRSGSVLLLGAAILLWG
ANWPVMKLGLGHVSPLWFSAARFATGAACLFTWQALRGEVWWPQRRDLPRVASIGLFQMM
LFTALGTVAMMHLPAGRSAILSYTTPLWVLPVAVLVFGERIERRHWAGLGLAGLGVLVLL
NPHAVDWGDGQVVGANAMLVAASLAWAVCILHLRYGRASASAIQLAPWQMLLAAATLAPL
AYAVEGPFTGDGTAAFWACLGFVGPVATAFCFCAVNAASARLPASATATLMMAVPVTGLA
LSTATLHEDPSLDLIVGALAIVLGIAASAQRSHP
>fig|419665.8.peg.1248 Multiple antibiotic resistance protein MarC
MILYFPTRGRNMAVGYSFFSFFIYSFTSIFIIMNPIGLVPLFYIWTSESEKTEKIELLRK
SAIAVMLTLLTFALFGGSIFKFFGITLDSFKVAGGILMLKIAWDMLHAQVSKTRHNLKDD
EEPISLEDIAVVPMAIPLLAGPGTITTSIILMEHSITTYDTLIIMFSIILATLISVVILY
LSDNIARILRVSGIKAIVRIMGLILAAISIEIISSGVFGLIKSAGLMY
>fig|420246.5.peg.393 Permease of the drug/metabolite transporter (DMT) superfamily
MKKLSGQYLYIFLLVTIILLWSYGWVLTKMGLSYMGPFTFAALRFLLASLTMIIILFFLK
TPRPKGKEWMILFIIGLLQTTAMFLFINYGMMFVNVSKSSILIYSMPIWSGILGYLFLHE
SLNYYKVVSLILGISGLVSIIGVDFFAVQNKSSIFGECFLLLAAISWAGANIIVKKYFSN
HNKIVVSTWQMIFGTIGVVVAAILMEWGQPIQFTTMSMFILIYTGVIASSFCFTCWYVVL
TKLDTTVASISLLFVPIVAIFLDWLLLNEKMTVNIAIGALLITIGVYLATVAKPKKKSIK
RFSTEIKS
>fig|420246.5.peg.1132 Drug resistance transporter, EmrB/QacA family
MNSRLSVMVSIVLAMLVASMDTTIMNTTMPIIAKELEGFSLYAWTFASYMITTTVLSPIA
GRLSDLFGRKKVFSFGIILFLIGSLLCGLSQNMVQLVLFRALQGVGAGFMMPFPAIIAGD
LFPVEKRGKIQAFFTAMWGLSAVLAPLLGSLFVEYATWRWIFYVNIPICVLSLLTLLPYK
EVYEPKRAAIDYVGAALFATAISLLLLVTVVEQGQWWYGAAGVLLLVIFYYFEKRQPSPL
VPLSLVHHRTLKWMNINGFVSCVALFGTSSYIPLFLQNVAHLSVFMSGVALLGSSVGWMI
AAVPAGKWILRYGYRSLLIIGNVLLVASGLFLALLNESHGFWYVFFIMFLQGLSFGLTST
VGVIGSQQLADAHEKGIATSFFMFCRNIGTAIGVTVMGAFLAQASTFMAGIRHLFLFGLI
GSIIAMITSLFIRDETEADRNNQQSEGMA
>fig|420246.5.peg.1258 Permease of the drug/metabolite transporter (DMT) superfamily
MKEKLFLVLANLFWAGNYVVGKAVITETGPFWLTLIRWCAAFIILVPVSYWLERPRYWDV
MKQYWLPLVASGALGIIGYNLLLYGALAYTSSMNAAIVNSLNPAIIVVLSYMLLRERLST
VNIIGFLLSLIGVLFILTDGHIGHIFQTNYNRGDLMMLAAGVVWALYSIIGKKLPVPPIT
ATACSVFFSLIILWPFAMLYPFPSDQLSAAGFAGITYICLFPSVLSFLFWNVSVQKVGPS
HAGVYLNLIAVFTALITFLLGGTLSVSQLAGGAFVLFGVYLATKAKSKQTDITG
>fig|420246.5.peg.1900 Drug resistance transporter, EmrB/QacA family
MSDSGLARRFLFWAWRRFIIFPKRSGGAASSTSSFVRSLGMTVGITVFGIIQRNLFTNQL
AEQFSGMAQAGFGGAAHDPRAILSPEARAYIPAPVLDRLTEALASSIADTFLWALIPAAL
TVVCVLLMSNERLAIPSKDERVEVIENASSPR
>fig|420246.5.peg.1941 Glyoxalase/bleomycin resistance protein (EC 4.4.1.5)
MIRVKRLDHVQICIPFGAEDEARAFYTGVLGFKEIEKPESLKANGGLWYKVGDIELHIGT
ENRDGYNSKSHPAFEVEDVEAARRYLEARGVVTQDEKPIPGVKRFSFRDPFHNRIELLEK
G
>fig|420246.5.peg.2466 Vancomycin B-type resistance protein VanW
MEKATPWKLFAVMAVCTIYFITFSHFGTFAYNALIPDDGRLSAGTAVGPVSLANMTVPEA
HEAVTSRVNQWKATASIPLRYQEKQIDLSADVFTFRLEESMKRLIDGKHTPLFVIMDLEK
CLKAVEAVVPLAPLEALDVKRLGEDLEKRAAQLQSPSSPIDLAGYISFPDGNEPVVSEAA
VPLSDAAAALWLSTERRATIKAGQLFSLDDWLKKEKADFSDGAADLIASAVYQAVLKTNF
AIAERYTSRTLPDGVTPGFEAAISNGRDLEWLNPNTTDYTLWLRYDGQSVHAEISGLPFV
YQYIIRTGEAVNIEPRTVVQYDARLAPGDKQTKQMGRLGLFVEVTREVRDGPRLVRKETV
SEDFYPPTYTIEVRGLEIPKSSVEPSSDEEGESGESTESENGESMESPNPTATENSEENT
RDKPVPKEGDEADSRENAPTASGKGETEASGGGEK
>fig|420247.6.peg.1430 Efflux pump antibiotic resistance protein
MFFMNANKKRDFIVITVASLATFYGAYMGNVTPVALPKMAEIFGLSNIMQNWVTNIFLLT
MGVLAIPLGKLCSRYGVKKTFIYSVILMLIGSIGTPLSHTIPELLIFRVIQGIGGAGLCV
DSMLIIAEAISPEKRGQALGITVSCTYIGIALAPVLGGSLTYNFGWESIFWVMIPFILLN
LILLFTIKEEWFKYQNEKFDLKGSIVFAIGILLLIYGFSIFNTTIGFIITVAGVLLLILF
GKIELNSKYPAYDIKLYKNKKFLSSNIASILSYIATFVVTTIVNYNFQYVRGFDSQLSGL
ILITFPLLMAIVAPAAGKLSDRIDPQKIATIGMIIVTVGLILLVPLDKDTSIVIVLVSLA
LQGIGYGLFASPNINTIMSSVPPKDTPMASSAVATMRILGQTLSTGILTVIFAIMMGNVI
IQPSNYPQLISCSQITLLIITVISALCFIVCHIGYKSKDKLYF
>fig|426355.14.peg.105 Drug resistance transporter, Bcr/CflA family
MTIAIRPVPPVQDVRAPRPWSGPGFAEFVAIIALMMAVTAISIDNLLPAFPAIEARFAVP
DPNRLQLLVYVYMIGFGFAQIVYGPVSDALGRRPVLLASLAIYVVGCGLAMVAPSFGWLL
AARIIQGIGAAGGRVLSVAIVRDRFAGREMASVMSLTMMVFLIVPMIAPAIGGMMLALGS
WVYVFVSMLVLAFWLTLWFSLRMPETLHPEYRRPLSPAATWEAIRLTLKTRVAVGYATAL
GLMTGCIMGYVGSAQQVFDTGLYHLGPLFPLAFGLVAGAMGAATLINARVVRRLGMRAMS
HSGVIAFTLVGLVQVGVGLAYRGHPPLALFLSILAVNQFLISFAMPNFNALALEPLGAIA
GTASSFLGFYTTILGALCGFLIGQSFDGTVLPVAIGYASLGALALLVVAWTERGRLFRGG
VGG
>fig|426355.14.peg.1648 Membrane fusion component of tripartite multidrug resistance system
MDARRSDSFKSADPVAGAPVSPPATAAVTPPVSTPVPAPVSPPAPRRRRARTVLPLLGLL
ALGGAGTYGWHWWTVGRFLEVTDDAYLQSDKVTVAPRIAGTVAAVLVGDNQPVKAGEVIA
RLDDRSYRVQLKQAEAEVEKDRAQILGVASAIVQQRAQVASSRADLANAEAALTFAQQEY
TRYQNLLQTGSGTVQRQQQADADLRQRHAARDKAAASLDAAQKQIDSLKALEASTRASLE
GAQAKVEGVRLDLSYTTIVAPIDGVAGDRALRIGQVVSAGTGLLTLVPMGRDIYLVANFK
ETQTGRMVEGQHVTFTVDAFGDHEFQGRVESFSPGTGSQFALLPPENATGNFTKVVQRVP
VRVALDPSDPLIARLRPGLSVEATVHTADPVEPVDPARRRPRPAPALVSEALPR
>fig|426355.14.peg.3727 Multidrug resistance transporter, Bcr/CflA family
MAERRAPLPLLVAVTMTGTVALHIFVPALAAAAVDLGTNAAGAQLTITVYLIGLAGGQLL
YGPLSDRYGRRPILIGGLGLYLAGLLLAIPAPNIGVLLVARVLQSLGACGSLVIGRAMVR
DVSTREDAARKLAILTTAMTLTPALAPAIGGVVNEAFGWRAVFVVLAGLVAVLGALVVFT
LPETNRHKVALPGFVAVLSGYLRLVRVPVFRAYLVAGACGGTSLYAFLAVAPFLLVDRLG
RSSQEVGFDCLIVVFGMVGGAVLASRLAARVPIRKAARSGNLLCIGAALSLLLVDRTGML
GVVSLIVPLFAYAVGVGLLSPNAVAGLMNVDPHAAGSASSLYGFTQMTFGALFTVAASAW
PATSATPVALALLAAGLIAALALRRA
>fig|426355.14.peg.4496 Fosmidomycin resistance protein
MSVASDLTASSEPVSLPDARRTLVATGVNHALHDGYTDLIYVLLPVWQAEFGLDYVALAF
LRSLYNGALAALQMPASRLAQAWGARTVLVLGTVLSAVGYAIAGASGGLVGLGIGLLLGG
AGSSTQHPLASAVIARAYGPGARGPLGTYNFTGDLGKAAVPPLVGLLLTLTGWRHALWVI
AGVGILVALAVARLLPREPASRTGVAAARPAPHRAATGPGRGTGFRLLVAIGMLDNAARP
AFLLYLPFLLQEKGAALTTVGLALSLVFVGGALGKAVCGRLGEHLGVTRTVILTETGTAL
AILAVIGLPLAPGLILLPLLGVMLNGTSSVLYGTVPELAPGGQVERAFAVFYTWTLGGSA
LAAPLLYGRLGDAAGPHWAAAAAAGTALAVVPLMLALAPRLGTERQRA
>fig|426355.14.peg.4927 Membrane fusion component of tripartite multidrug resistance system
MAANPRSSLRDWQPPPAYNVAATLLALAAAVGLAYLAFLYYAYTPWTRDGRVRVYTVQVA
PEVSGTVVAVRVRDNQFVRKGDVLFEIDPGTFRNAVTQAEGALASARAQAGYLAGIARRT
ADLDDLATTPEQKQTTSGQAQAAQASVVQAEGALAQARLNLERTTLRATVNGWVTNLLLQ
EGGFAATGQPALTLVNGDSFWIEGYFEETQLPRIGEGDAARVSLMAWPDRPIRGRVTGLG
RGISVADAAPGVQGLPTVNPIFTWVRLAQRVPIRVELDDVPCPIVLAAGMTANVAILAEK
AGPPDALPPDRRTGAAAGRRCDGAPVVESRR
>fig|426355.14.peg.5304 Outer membrane component of tripartite multidrug resistance system
MITAGLLGLAGCTVGPDFAPLATPLADAGDYLDTGLVAPTPRRLLARTIDAEPDVAWWLA
FRDPVLAQLEDRLAAQNLDVQTTTARLFQSRSQINTAAAAGLPTLNGQGSAYRQQFSKNG
TIGLLSNSLGSLTGGSSGASSGNLTAPLTNGFESYTLGFDASWELDLWGKVRRSVESAEA
QADASAEARRDALISGQAELARAYVQLRGTQELIRIDLANIRVNEQILDVVRVRQQKGLV
TGLDTSSAAQQVEAIKAQLPQLQQQEIQQINAISLLLGEPPLALSQELVAGPSIPPVPPR
IPIGVPSSLVMRRPDIRRAEANLHSAVAEIGVAEAQFFPSVTLTGSPTVNSVDPGKLFRG
SSLQYMNIGPSISIPLFEGGRLKSNLVLQRARQQEAAIAYQKAVLQGWHDVVNALAALRG
DEARRARLARQVADARQALALSRARYVQGVEIFTTVLQASQTVLQAETSLSQATAAISTD
FVALSKALGGGWETTFPVGRTPPLSLAKVGIPLTDVVHDGALGR
>fig|426368.9.peg.1224 Permease of the drug/metabolite transporter (DMT) superfamily
MKKLLKKYELFLLMIPAVSFGAGAFITGKIGILELSWDELTFLRFLIASVIILPLVLKTE
RKNLKLNKSDAYLVILAGLLGMFGYHALFFMSLEYITAINSALLMATTPMITSIIAAFVL
GEYFGIKRIFAVIIAFFGVLLTITNGNLEVLKSLSFNIGDVIMFSAVLCMALYAVISKKV
AQNYSPSVILTYGYILTVVLLIPYMILKNPVNAILNASFETWLSIIYMAVFASVLAQLLQ
QISLKYYGASKTMLFYQFVPLIVIVLSAIFLKEPFTKITVISTLFIMTGVYINSTIKKD
>fig|428406.5.peg.3692 Bacteriocin resistance protein, putative
MGRVMLCLFCAGSLWATQASAQEGAIALRADSEMPLNKPVKSMAELRYRSVMRQQQDFSC
GAAAVGTLLRYGYGLDIDERRVIADMMKVSDPKQVAEQGFSMLDMRNYVQTLGFRGRGYR
VDMAALRDLAIPVIVLLSLNGYQHFVVVKRAAQGRVFIADPALGNRIMQEWEFAPAWNGL
VFAIVGDVSVQADSGLLQTNAPSLRARENAAFSGGMLPIQMEFGPARWDLF
>fig|428406.5.peg.4053 Glyoxalase/bleomycin resistance protein/dioxygenase
MCGSPAVARQLPTKEIRTIDHTGVVVSDFEARRRFYEQALGAVGLAKVLEFLAAVTDHAD
VAGLRPPGTAAW
>fig|428406.5.peg.4417 Outer membrane component of tripartite multidrug resistance system
MIVSLAGCSLAPTYERPALDVPAHWQTEAPWRAAQPADAAPKGPWWQRFNDPQLDKLITQ
ALAHNQSLKVALSNLEQAQAQTRVARASLLPTITANNNDSRTRTSSERPLSSYTSPTMST
IQSDLVLRADASYEADLFGRVRNTVANAAASEEQAGANFENFRLLLAAQVATTWYNLRET
DAEIAVVQEGLALQRKALDFVTSRHQDGVASGLDLAQQQALVDSTATQAELLTKQRAQYE
HALATLVGTPAPAFHIDPTPLKGTAPQIPVALPSDVIERRPDVAAAERGAAAANAQVGVA
RAAFFPSVMLNGGAGWESRDLALLFSAPTLLWSFGTQIAQTVFDAGRTRGRVDIANAAYQ
GAIANYRQTVLGALQEVEDGLAGLQSLDRAANQARHAVESARKVYDIASVRYEGGLATSL
DVITAQQSLLNNQRTAVQILGQQMTTSVFLVKAVGGDWNQAAAAPTAAR
>fig|429009.3.peg.98 Membrane component of multidrug resistance system
MEKERALPWGSLGVLVLGTFMGVLDSSIVNVALPHLMALFSATEDQIQWVMTIYLLVGGM
VIPAAGFLGDRFGYKKAYLGSVLAFVLASALCGLSWNTTSIIVARAIQALGGGMVIPLSM
AYLFRIWPREKIGVATGLWGMTITVAPAIGPTLGGYLVDYVSWHWIFYINLPIGIFTVLW
GWLALKETPIQEDLKLDWLGLFLIAGSAFSLLLALSKGQDWGWTSPSIVFLVVGALFGTL
LFILWELSVPNPVLDVRLILNPTFMASLVASNLTSVALFVGIFLVPLFCQNIQGYSAMQT
GLILMPAALTTAFFMPIAGKLFDTVGAVFPGLLGMGIVAAVTHALIHLTADMPIHHLQIL
LCIRNAGLALAMMPLMTAGINTIPTARTGQATAIASVTRQVAASFGIALVSYVLTNRTVF
HAERLAEEVSLINPLGYHYYTQLKGLVAGMGGGDGLVQTLLSGIVQKQAMVLAMGDAFWV
AMWLVFLAFPFIPWLTPRRVKEELKRQEERLKREEVSLGSSSNL
>fig|429009.3.peg.765 Permease of the drug/metabolite transporter (DMT) superfamily
MSGSFSTWLFAALAVILGSLGQVFLKMGAGHDLLRSLADRHTLLGVLLYGGSFLCWLKVL
AAWPLSRAYPVLALNFGLVALLSALVLGEDLGAARVLGTVLCAVGVVLVSLGS
>fig|429009.3.peg.1067 Membrane component of multidrug resistance system
MTATLDVVPPELNNQATSILNMLRQVGSSFGIALMSTVAQTHQETHFVHLAEKFTYNYPM
LLELLTQLSWTSIGPHDSSVVWALIAAQLQLQAFVYALDDAFVLAVIFGVLAALGVIVLC
CFRKVGPGKTKQEEGTNGAHFNQAFTHF
>fig|429009.3.peg.1442 Vancomycin B-type resistance protein VanW
MRRAVWVGAGIFFLLLLATAQLTYYDKTGCPAGTIPAGVYIDGHYVGGKTAGEVAAWLNR
REKDLLARTVKVECASREWRVPLAELGVKLDRSVLEEALAVGHRGWLGQRLWERWRVGRE
GLHLPLKFSVDRQRLVSTLQDLTRELTVPPQNAAFRVLPDDTITIIPSREGKCADVEVAY
PQLLAILNEGREPVIKLPLKPIPPAHTTEDVKNMGLDCLLAQFTTKFDPSNANRVYNISV
AATAFNGLLVAPGEVVSFNRVVGPRSTKAGYKEAPTIIEDRFVDTVGGGVCQVSTTLYNA
VLLAGLKVVERYAHSLPVGYVPLGRDATVSYGGFDFKFQNNTNKYLYLRTLVGPDFLTVK
IYGNHNFKRRVEIRTWVTEEIPFKVVRKEDPDLEKGKEIVKQKGQKGYRVSAERIVWEGG
KARREVLPSSYYKPVDEIVVVGTKAVPRLVVPERSEGKVSDENPPASTEVPASS
>fig|429009.3.peg.1606 Multidrug resistance protein
MKRQGAWLLAGVPFVMVLGNSMLIPVLPSLKKALGMSTFQTGLVISLFSLAAGLSIPWAG
LLADRVGRRRVLLPALALYALGGLGAGFSCFLSSALAPILLLLSRAVQGVGAAGTAPVAM
VMVGDLFQGGKRSRALGIFEASNGLGKILSPLLGAAAGLLGFFWPFFLFPCFVFPLLVLL
WWLVPEPESRPKAVSSQTYWEILKSIGRQKGVWLASIFLAGLTTLLTLFGFLFFLSEHFE
TAWRIKGLLKGTLLALPTGCTCLAAFLTGKLIKPRSRLPRLFALSGMFLMALFFAGLIFF
QQFWPLVALSGLAGIGAGATLTSLNTLATSSAGPQARGLVTSLYGGVRFLGAASGPSLFS
LLVPHSLPLTFGLTAALCLLSALVLFLVKPEATGPHP
>fig|431943.4.peg.94 Teicoplanin resistance protein vanZ
MNLMFIIIVSITCFISTLPFLIPYHILLTSQSKKIGYKLSIGHIIIVYIFVYYLTVVLSF
TGIPSISDIVDNSFGIITPKGFDFPLGEINLIPFRWITEGVRPYIENILLFIPLGFMLPC
IWKKYEVLWKTTLSGITLSLIIELSQLFNRRITDIDDLLMNALGALIGWVFFRLLKEYLS
KLQYKLSVQNTNIERIPLLLCEEARFYMASAFAGMLFVFYPFLISSLQFVLKIKVNI
>fig|431943.4.peg.723 Permease of the drug/metabolite transporter (DMT) superfamily
MKISKIINKAIIADLSLLFAAMLWGGGYTATKNALNNVTPFYMMAIRFLCAGILISAIFF
KIVIKTSIEDVVRGFVIGIFLFLAFATQTIGLNYTTASKQSFLTSVYVIILPFIYWKIFK
TKPKLNVLVSALVSLIGIFMLSLKPGMHLDMTIGDWLTLLSAVLFASHIISIACFARKSN
PIILSVLQMFSAGILSIIFAVIFEPNLNKIPRNALFSLSYLIIFSTMVAFLIQNIAQKYT
NPNHVGILLSLESVFGAIFSVIFLKEIFTLNMVLGASIIFLSVIIAEMDFNISSNK
>fig|431943.4.peg.804 Permease of the drug/metabolite transporter (DMT) superfamily
MKKEEVNNFMDYKRKSIMSSIALGLIALLWGTSYAIIKDILSDIRPFTLMSLRFGISTIF
LCVIFPKKLRNIRKKDILHGSIIGIFLFLAFLNLVTGIFYTTASKQSFLVGSYVLIVPFL
GWIIYKKPPNIYSVFGAVLAVFGIGLLTLNGSFYINKGDSISILCSLSFACHMIAIEYFN
KDSDPIVSTIIQFLVTSILFIILTGIFESFTIYLSSKVLKSIAYLTIFTTVIPFVVQNIA
QKYISSTSTALILTLESAFGGIFAVILLNEILSFQMLIGCVLIFTGIIIQTTRLAFLKKM
KISCKN
>fig|431943.4.peg.968 Permease of the drug/metabolite transporter (DMT) superfamily
MKLIIKLFKAKKFNAYINLALCVLLWGSIPVATKKILVELDNLQTLFYSTILSTLVLGLI
LISQKKTGDLKKYNKNQYGSMIFLGFLGNYMYYVFLYGALSRTTASEGFILSYTWPILVL
ILSFIILKDKITLQKLVGILISFLGIIIITTKGNISAFNLTNLQGDILALIR
>fig|431943.4.peg.1538 Efflux pump antibiotic resistance protein
MKKKEITSNNFKEVVNMERSNSQTRITLVIVMITSFITPFISNAINLAIPSIGIEFGGNQ
NLLNWVVCGFLLSSAAFLLPFGRLADQFGRKKIFLIGMIFLAASSLACALATSLVALVYF
RILQGIASAMIFSNSMAILTSVVPPESRGKALGLNAAATYIGLSCGPVLGGLITSVFTWR
GVFYFNLLIALIIIVMTVWKLKGEWIGIATKFDIWGIILCIAAQVLLLFGLTALTNGLLY
QVSFAVGILLLIVFFLYEKNHSNPLIPIESIIKNRPFVFSNLATLINYSATFALSFMLSL
YLQTALKIDTATSGLILLVQPIIMAVLSPVTGTLSDKIKPAVLASLGMGISALGLFFFIF
LSTQTPIVMIILNLAFIGLGFALFSSPNTNAIMSSVDRTLYGVASSIMGNMRLLGQSISI
AIISLITSILMRNLSIGSAGYVDQLMLSLRTAFIIFVVLCVLGVLASLARGEVNREAEEN
>fig|431943.4.peg.1725 Teicoplanin resistance protein vanZ
MFITIIKALVYEYLCVIFFCVIFQIIMIKKEHKNGHRYSLNHFVWVYIFYIYITLVLICT
GIGTIYEFTRYTKLHETISILTQFNLIPFNSISGGIMTHLANIIMFIPLGFLLPFIWRQF
KSPWKVIGTALLFSLIIELSQLLNMRSTDIDDLIMNTIGAFLGWTIYSLLKKLFKNRHEK
EFNNSDKTQLSFLAHYEACFYLILSFAGVFLLYNPLLF
>fig|431943.4.peg.1766 Lincomycin resistance protein lmrB
MHFILTSLNIIRSVDFVKTEIIKFEETKKKKEYNVKVIMAVLLFGGFLSLFNETILNVAL
SKLMAEMNVTAITIQWLATGYMLIVAISVPTSAFLIHTFTTKRLYLGAMTLFLTGTVLAV
FSTSFPMLLFARMVQATGTGILAPIMINTALAINPREKHGFVMGICTCIILVGPSLGPIV
SGTLLQFFNWKSLFIILIPMIIICMIGGALYLKSAIDLTKPKIDYLSVLLSIIGFAGIVY
GISIIGSNSNMLNIILIFTVGIIALILFSKRQLSLQQPMLDIRVFKHPYFTLGAILVIVI
QMVQFSMNMVLPMLLENGLKLSSLMSALVLFPAVLVCSIMTTISGKIYDKVGGKTLIPLG
ILIMCIFLEILSRIQPSTSIITIAILNIFLYFGISLAWSPNQSNALNQIPMRNQADGVAI
LNTFIQLGAAFGTPLFIGLMSAGQKGYLNNIGNLNDPKSQVQALYSGFSYSITVAAMIIA
IVFILSLSLRHKTKKYS
>fig|431943.4.peg.2252 Fosmidomycin resistance protein
MNRFYGNLLTFGHFVADFYQGALPALLPFLVSDKHFSYAAAAFLIFSANVSSSIIQPLFG
ICSDKISVPWTLPLGVLLAGISFGMSGVVDNYWVMAVFIALSGVGIASFHPEGVKLANTF
AGENKATGVSRFAAGGNIGFAVSPIITTEVLLLFGLKGTIILSLPALIMCIIFLIQLPKL
TKNKAQVTVKREVQAKNTADEWKPFSRLTATLTCRAMIFFGLNAFLPLYWIHVLNQSKRG
GSIALSTLIIVGAVGTLIAGRMADKFGNRKVIMTGFLTLIPLLFVFINVRNVILATLLLI
PIGLSLYAPYSPMVVLGQKYLPNHMGLASGVTLGLAVTMGGVISPVLGWISDNYGIHTAL
SSLTILPIIAVFLTLTLTIPKVDLNRDSVNKVKFNVTRSGN
>fig|431943.4.peg.2305 Bicyclomycin resistance protein
MVLKFTDWKGIFIVLGIIGTILFLATLLYFKETLTIDYSQENDPKVIFTALKSLISDKIF
MSYALVQGLVTGAMFCYISGSSFVLQNMFSLSAQGFSLVFAINGIGIVFMSQAAGRLSYR
LGEKLLLQIGLSIAVFGSIALFISLFLPKHLLAVTIPLFFIVSMVGMVNPPAFSLAMQNQ
KKWAGSASAILGLGMNLIGGLLSPLVGIRGNQTYVPMALLILICNIGAFLIFYLYLNRQI
PYNSSNGI
>fig|431943.4.peg.2544 Multidrug resistance protein B
MLSYSKEKRYIMKVWKRNLIVCWFGMFVTSVGMSQIAPVLPLYIKHLGISNTALIEQFSG
IAFGITFIISAVFSPVWGHAADKFGRKPMLLRASLGMAIVIFSMGFAQNVYELIILRVLQ
GIITGYSTACITLIATQTDREHAGWALGTLSTSSIAGSLLGPMIGGYIEENFSLQNVFFI
TGVLMLITFTTTALFVRESFTREDKKVSSIKEIWSIIPNKSLTIIMFVTSFILTLALYSI
EPIITVYIAQLSRNSNHVALLAGMAFSVSGLANIIAAPRLGKLSDKIGAQKVILVALVAA
GIIFIPQAFVKNPWQLMGLRFLLGLAMGGLNPSVNVLVKRITPDSLTGRVFGFNISAQYL
GIFGGSILGGQVAAYLGIRYIFFITSTLLLLNAVWVYFKVYKRLSLN
>fig|431943.4.peg.3661 Permease of the drug/metabolite transporter (DMT) superfamily
MELPFLLTAPIFYKKLCNIDKKTLLYGTILGLALFCVLSTLMFGLKTTSASSAGFLAGTT
VVFVPLLQIIIHRKRPTLPITAGVILTIVGIALLTIDSTFQLDTKSLLCVLAAFIYAGQI
LLTSHFSKMVDPLALGVLQLEFAGIFGLLFSFIFEQPRLPNNSVEWIAVLSLSVICSAFG
FVLQPVAQKYTTPERTGILFSLEPVFSAIFGFAFLDEILKIQGYFGAIFVLAGIIISDID
KKVSLKTNYQRGILNKR
>fig|431947.6.peg.6 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSSQQIQALESEKIPKLLFHYALPAVVGTAVNSLYNIVDRIFIGNGVSEYALSGLAITFP
ILIFLMAFGMLVGAGASVRVSILLGRKDIKEAEHTLANAIFLTFFTQALTIIPCYIFMEP
LLRLFGASERTLPYAMEYLQYVVPANIFSALSFGYNAIMRASGYPRKAMITMIIGAMTNV
VLDYIFIYPLGMGISGAAIATVISMIVCSVYVLSHFFRKDSIVRFHRSAFRLSLPVIGGI
TAIGVAPFAMHLTGSLVNIIMNRSFVSYGETADATDLAIGAFGIINGYAMLFFMIIIGVA
QGMQPIVGFNYGAKNPGRVKSAYRYSCGVNLLVSFLGFALAMLMPRTIVSLFTNSEQMIE
LSASALRTALIGLSLVGFQVTTTQFFQSIGFSHKAIFLSLTRQIIFLIPCLLIIPRFMGL
DGVWWSLPISDLASVVLSFVLITIQMKHFNQSKKTTFAE
>fig|431947.6.peg.326 Multiple antibiotic resistance protein MarC
MDFLDKVLQDLSLIDLKEIIGSFVILFVAIDIIGAIPVVLSLKDRGQSFHSGKATTFSCV
MMLAFLFIGEPMLNFFGVDVSSFSVAGAIVLFVMAVEMIFGVQIFKDDGPAGSATIVPLV
FPLFAGAATFTTILTLRADGIAMTNIAIAILINVAMIYLMLRFVNQLERFFGKGGIYILR
KFFGVILLAISVKFFTGNIVKIIETMNEALQK
>fig|431947.6.peg.1518 Drug efflux protein
MGNLLPVKLHPDHSMPELTISFSMPKASASLVESELSSPLEKVLSGIAGLTGITSHSSDG
MGVIRLSFDKYVDIERARFEASTRIRLIRSELPHTAGYPTIRTGRTSDQDAKTVLSYSIG
APHASSDIETEVERHILPLLREVDDIGDIILTGGRKQEYLLAYDPEQIRILGISPDDIAT
AIGSHFRNDFIGLAGIPDSVGGENHIRIRLSEEANNVFDLSRIFIPAKDKSLIPISRLLT
IRQKEIPRREYYRVNGLNSIYLRVLSSSSANQIALSKQIGRIMDDVGRELPEGYRITKLF
DSAESISLELNNILVRSGITILLLLLFTLITTRNVRYMATVTISLIANVAIAFAFYYLFG
LEIQLYTLAAITISLSFIIDNSIVMIEHLLRRGDRSAITAILAATLTTVSAMIIVFFLPE
AQQKNLGDFARVIIINLCVSIIVALFLVPSLFERLSFSSRRTGRSPHKMVVTIRLLSFYS
TLSSFLYRRRRWVFIGFAFLFGLPLFLLPKEIEGDTDLARLYNNTIGSTAYRKIRPYTDV
ALGGTLRPFLMQISSGSEKKWEKPVIHVNVQMPVGSTADATNEYVTKLERFLAQAKGISY
FETSVTGERAASIGIHFKDSHARGNYPYDLHQGLVGRILSIGGGYCRTYGLENVSFSNIR
EKEYGSNAIKLTGYNYDALLAQARLEAIRLSAKAAIRNVSIASNRYSLSEEQELHLSPYE
GSHAFLGISPHDLVAAVNEQSRTEQPLPEIIIDGQPVQLAMAARTHHAGSKWMLENSPLY
VGGKTIKLKDYGEMQVVLQPQAIVRENKNYVLYVLYNHMGTIRQSQAFIEKEIQRLNAEL
PIGYKAMEPEYKEWENERGKLVWALIGIIVLIFFITSILFDSLYYTWVVLSIIPISFIGI
FIVFSVFRLPFEEGGFAAMILLCGITVNASIYLINDYLHRRRKHPSISPLDAYRRAVHNK
TFAILLTVISTVLGFVPFVVDKGASLFWHSLSMGVIFGLLFSTLMLFLILPCFLGRD
>fig|434923.3.peg.138 Drug resistance transporter, Bcr/CflA family
MSSSKLLFFVIALAACLTQFAADIYAPSLPAVALSLNTTIDLAQWSMAIYLFGVALILLI
YGPLSDAVGRKQPMVIRLCIMAAGSVVAMLAPNIKLLILGRFIQGCGAGACAGLWRSIFR
DVFTGEELAKYGSYFAILVMFIVPLAPALGGFLQHYFDWRANFVFMTIYTLFALLTVAFG
FKETSRHHHLENLRLPYVINTFRRLVKSPIFMGITVSTFLSYGAFFAWITSGSVLLIHVL
GMSPLTYGLFVFFGGGIAYALAGFLNGRLVSRFSMPTMMRFGWSVMVLSGILMALGKLAD
INVWVIAIPIILFYFGSTFIWPNAFATAFTPFGDIAGYAGALYGFMQLSGGAVIGSLMAY
LPHADQLPLALVIIGTSLLAWIIYERVVVKHQQ
>fig|434923.3.peg.663 Permease of the drug/metabolite transporter (DMT) superfamily
MKLSVRAHLALFFITLLWGLTFPLIKDALGSISPSLFVVLRTSVASLILLPVIFLQRKKT
TFTMIKWTLVLGFFQSATYVFQSIGLESISSADSAFITALSVVVVPFLALIFLKSKPRWF
DFVTALLCLGGIFILTGANIFNMKGGDFWTLGCAVAYALYIVTLQAFSKKLKPEDTILAL
SYQILFSLIFPLLTAFYKTTASIFSWPVIIAVLFCAIFATGLVFYLQLRYQRYIPVSRAV
LIYAFEPIFAALFGYLLNGEAIYLNTVIGGFLILVSFVLSELFPSKKSSQDNNPLSETYA
SESKS
>fig|434923.3.peg.717 Drug resistance MFS transporter, drug:H+ antiporter-1 (14 Spanner) (DHA2) family
MASGISNGIRQLGRVLGVAMIGSVISNIEHSRLIHSHLDTTGKLSQVSDQQLTHLLSNPA
AAKHFLSGLSLSEINHIHLALKSVFTFAFSMGMILAGFLLILTLGISFFLPNKPLRLLWD
EKSKLV
>fig|434923.3.peg.758 Drug resistance transporter EmrB/QacA subfamily
MKSYYLEGNPLRKWLVLTAVCLAVFTITVNTTAVMNALLAMSNELHLTPIALQWIVNAYM
LACASFIVVGGQLGDLFGRRNMFFVGAGFFIISSLIIALGHHPTTLIVGRALQGLSAAIV
VPMTLAITKFAFLNEKESFAIALWTGAVGLGFAFGPVISGIFSTYLSWRYIFWANIPLMF
IAIIMARLFARKSRGAREDIRLDLWGLAFLAFGLITLTLGLVEGNVWGWSSLKTLILLIA
GVFLLLVFWFLEHHVRSPLVHFSHFRKRLFIAGNIGIAASLFTMMGMLYFFNTFIQNPFL
LHYSALRAGIAILPISVSIFLLSLVASTITKHWGYRLPMALGLVLIAIGTFILHNVTIYT
TYYALWFPLLLTGLGLGLVFPNSPSLGMQALPKEKLGEGAGIINTINYYSGILCVAIGTL
ISILLGREKFYQSIAPTELPSITLSQIDRAVFGHQGNLQQILSSLSDSTQNQLIHAIQLS
TVKSFTAVMLMCFTMTIIGLIGICFFARSKT
>fig|434923.3.peg.822 Drug resistance transporter, Bcr/CflA family
MSVPSIRKTVWTLAPMAMALALAMDVYVPAVPHMATLFHVSAGQMQLTLSLFMFTCGIVQ
LVIGPLSDQYGRRRVSFFSIVIFSIGSILCATAHSVPELIVYRIIQAIGAVGMMVCGFAI
VRDRYHGEKSGKTYSYLNGIIAFSPMFAPFVGSYLDVHLGWQSTFLILLLISLWAFLSLF
FSLPESLPRNKRIKVDRRIFHEYKTIFTNRVFLNYTLSTAMGLSYLFIFCSISPYIIIQL
LRIPELNYGYYFAFMGISFFVGSLLSGYFVGKIGIYKTVVVGFFISLIGGTIMALWYFIT
GLTINNFIWPMLLIGIGGTFGLGAGSGGAMEPFGDTAGAAAALSGSFRFLFSAILGMVVI
NKNISSTLPLALPAVLFSLVGLILFLSQRKGLIIIHRK
>fig|434923.3.peg.969 Acriflavin resistance protein
MPGADPETMATSVATPLEKELSTISGIESMSSVSSSGSTKIIMQFALTRNIDSAAQDVQS
ALLQVARRLQSQMPDPPTIRKMNPADSPVLYLALSADHLSMTKLDDFAENYLAPNLSMLN
GVATVNVFGAQQYAIRIHLNPNAVKSRGLSLDDIKQSIQNLNSNQATGTLQTDGFYHLIK
VDGGLDNAKQFGNAIISYQNGSPVRLKDIATVKNSIANDKAVTEYNNKRAIVLAIQRQPG
SNTVSVVNEVLKSLPGLNQKLPGDAKLQVVYNKAVFIQSAIDDVELTLLFAVFLVTVVVY
LFLRNFSFTIIAALSLPISVIATFAMMYLLSYSLDNLSLMALVLAVGFIIDDAIVVLENI
VRYIEQGMDKLTASLRGSKEVNFTVVAMTISLVAVFIPIFFMGGIVGRLFHEFAAVVGIS
ILFSAFVALTLIPMLCSRLIKEKSSQEEKKPTWFGLFFAKCHSSYEASLRWALDHYGILL
GIAGMIIVATFLLFYLVPKGFIPSQDSGMIFGSVKTPEGIDYKNFVTEQTQAKNIIQQNP
NVAVVVSSVGQGADASASTNTGIY
>fig|434923.3.peg.1052 Drug resistance transporter, Bcr/CflA family
MSFLSFKLVDPQISESQRYWYAAIALFIVPLSGLSIDIFVPSLPVISHYFGATKSLAQLS
ITMYMLGMGVMQLFSGSISDSFGRKKPFLIAMLINIVVTLLIPLSHTIYELLFLRLMQGI
LVAILIVPIRAIFADLFSGVEFHKMTTYSTVIWSIGPVVAPAIGGYLQHYFGWQSNFYFI
GVYNIIAFLLILFFMPETSRYRHSFQTASLLQRYKEILSHSEYIRMLIVNCALYSIVILF
SIVGSFLIQKVLHYSPVDFGHMAFLTGLAWFFGAMTNRAFIHAPYNLKVKIGLWSLLIVS
LISIFAASILPLTIYAVMIPTFILVYLGGTVFPNNFAKALSLFPKINGSANSLFGAFIFL
LPGLSSALGTLLKTNSVIPLLTSYLGLIAFSLIIFYARPVGVTVRKRML
>fig|434923.3.peg.1212 Multidrug resistance protein A
MIKKFVKVILPLFIIAILSIGGYFYWQHQNRYPSTDDAYIQADVINVASRVSGTVSEIDV
RNEEHVQKGQLLFTIDPAPFTIELNKAQAQRDATRQKIQAADTAVKSARATVVERKAELT
HTRLETKRILTLMKKQFVSRSDGDLAIKNLHVAEAALNAAQNQLEEMIEKRGELGDKNAQ
LRLAQAAVEKAKLDLQYTRVFAPTSGYIANFNLRHGDVVSAYQPLFALIEDQTWWAQANF
KETQLARIHTGEQATIKLDMYPHQIFIGKVVDVNKDSGSSFSLLPPENASGNWVKVTQRF
PVKVIITQRKSGYPLRLGASSTVTIDTTSPK
>fig|434923.3.peg.1213 Drug resistance MFS transporter, drug:H+ antiporter-1 (14 Spanner) (DHA2) family
MNTTALTKNEILYSRRWLIIVTIMMVAILEVLDTTIVNVALPNMMSSLGANQNQITWVLT
SYVVASAIMLPLTGFFSNRLGQKQLLLINITGFMITSFLCGIAQSLPEIVFFRIFQGLFG
ASLIPLSQSILRETFPLEEQGKAMAIWGIGIMAAPVFGPTLGGFITEHMNWRWIFYINMP
ICLLGLMLTLFVIPSSERHYQRIDWGGLLLMITGVGALQVFLDKGNENDWLNSNLILALF
ITAIFCLVFFIIRSLIHRYPVIKLKIFKDRNFRISCLALALFAGSMFALITLEPIMLERL
FNYPAVTAGWTMAPLGIGGAVVMMFVPFLMKHLNIKIILTVGILCCFYGAILFAGVNLNS
TMQEFLINNTVLGFGMGFLMVPLTTYSLATLPAKDITEAAGLYSYSRMLGTSIGISLLST
LVSRTTQIHWHFLTTHINVFNTNFHNWFTFQKLPFMDPVGIARLGVQFQRQASMLGFLDG
FRTIAIVFILLLPLLLTLKTIKLQGSPAAPVDDPVIPASTGITEKI
>fig|434923.3.peg.1804 Permease of the drug/metabolite transporter (DMT) superfamily
MEFSKKSWQGYSLLLLAQLMVGVGIVGCKSLLQTIPAVIILAIRFTIGSTFLLLVHLAVS
DQKFRPLKQLMRLDWGFIISQALCAGAFFNILLLLGLKYTNANVAGIITSALPAIVVIFS
IIFLKERVTISTLLCFGFAVIGLIIIKFHSLQFGSRYQIYGDILILASLIPEATYYILSK
LRPNKLPVFLVSALMNGINVLPFLLFLFLRHQSLLMQIAPEQYILLFIVGISSALFYVFW
FSGCNHVSSSSAGLITAFMPIATLIIAYLFLGESNSQYHRHFSYQGNWQ
>fig|434923.3.peg.1978 Drug resistance transporter, Bcr/CflA family
MALYLPALPALTTYFHTFPGVIQLSLTLFLIAFGFSQLFYGSLSDCYGRKPLLLIGLVIV
MIGFLIAVFARHLSLLLIARVVQGLGAGSVSVLARAVIRDRFEGKKLVQALSLLIMAASL
APMIAPFIGGHIQRRLGWHSIFIFLFFYSGLILLGIFFLLPETKKTESVPFKMGALLNNY
KLLLRHPIYIKYVVCIIMAYACQILYLSISPFIFQNGLKLNAAQYGTIITLPAIGYFVGN
FLSTRLIRFFDSNHLVFVGALIVVMAGIALALEAAFNGLSAFSVITPIIFCVIGIGLIYP
NVISGSLSPFPQMAGTAAALSGAIQMAGTSSIAGVTNALHVVSVLGLGISFLLCGAVVLL
MIFRIMRTSVQ
>fig|436114.3.peg.362 Acriflavin resistance protein
MISKDFFIFIIKRKFAIMLIFLLLAIIGYSTSNSITKDIFPNVYFPRVEVAIENGYTPTK
QMLLEITKPAEESLKTVQGVEKIVSKTSIGSTEINLYFNWSTNPFTAYQLVLARVSELKN
VLPPTAKVVVRQATPSMYPIGIYAIGSDAKSQTQLTDILYYKIKPLIISLPGVYDLEIKA
PQWQEFHVVIDTDKLNSYNISLDYLKSVIYDQTKIDFLGITEMLNKQYVITLYQKPDDVY
KLLDVKIPLSGGRYINLSEVATIINSKYPSRSISGFSHAKNAVVFNILRQPDADTTTVIQ
NVDSQIESINKSLEKEGIRIYKSYDSSAFIKESIKSVRDAIVLGSIIAVLILFIFLRKLK
LSFATLLTLPVVFFTTIIGIKILGLDFNLFSLGGMAAAIGGLVDHLIIVIENIDRHLKMG
KDKLNAIIDGSKEILPIMTAATLISTLVFLPLLFVPGVVGVFLKQLGLVLVLTYIVSQIA
AIFLVPIMAYILLPSRFKSQEDFISRLEKRYETFLERLFKYDFVSVPLVLIIALIGFLLF
RAIPTTFLPKWDEGNFVVDFTLPAGTPLEESYKTAMEMGKILNSIPEVKSWTLRIGTSLG
HVAEQPNIGDFLVVLKENRTRSIFDIEDEVRKKIEAKFDNLEEFDLPQVVEDRLADILGE
EAPISVILYGYDPDKLVKYGFKLRDLLREKPILTEVNLKTTFASGEIRIRLKPEAQSIYG
LNLNDLYQQLYNAYWGNVVGNIVYGEKIINLRLISIDRQQFLNPENVKIYSPAVGRFIPL
SQVAEVSYMTNVPEITHYNLSPVAVITVRFKGNDMSKAVKVVSQTIQEANLPSDITPVIS
GFYKQQQKSFKSLMLVILAALTLMGIFTMILFVDTKITVSVLLAVILTLTGVLTALFITG
KPLDITGLIGMLIVLSIVINNNVLIFDFYKNSTEEKLEKRILYATASRFRPITMTMLSNA
FAMLPIALTIGSGTQILQDLAISTIGGLIFAIFLNLLIIPMLFHFLSRIRISKT
>fig|436114.3.peg.1184 Acriflavin resistance protein
MLKWYISKPHLIFSILIAFAFMGIIGFFSMPRDLFPPADRPQIAVVVQEPGATAKYIADH
TASIIERQLYTISGIRRVYSTSNDGFCTVIAEFHYSKPLAEAKTDVANALSKVQNLLPKD
ILPPQIYEITSYTPPVMVLIVSPKKDSHPSLEDVRYIAENQIKNEILRTNAVANVDVFGG
YTKEVHIQIDNAKLSSYGLSPQDIINAIQKSNNDMPLGIMINKDTQNTFILKTEAKSLDE
LKNIQITKDVKLSDVAKVEFGIKPPTAMYQGNGKEGIALAIQRPYGGAVLSTISAVEEVL
PKIKAQFPQLNIDISDTQKELVKQSNENMLEALRDAIIFTSLVIFLFLANLRMTIIAGLS
IPFVYLATIAFMWLFGIGFNTVSLTGVILALGMLVDDAIVILENIERHLFELKKSPVEAA
IDGTKEVMLVVFGGTVATAAVIFPMLFVGDFPEKIFRPLAGTLLIAILVSYVVSITLIPI
LAIKFLKNADKKSAWELKINQLMLAWLNPLKNIYTDWIKTLIHKKKIRPLAVLPLTVLFV
ISLKLIPFTGRDLMPPMDTGIVKANVVFNSNTSIWQVNQEVKKIQDYIYSLGNVKRVSVA
IGTEPGVLTISGGTPQTASFTITFVNRFERKETIWQLEDKIRDYIHTLPNVKYTDVYDYG
ATALSSIKANLDTTLYSDNLEALNKTGNTILEIANNTPGLKSASKSWDMDKIEYEFKIDK
QKTALYNTTPYDVAVQVSAGLQGQISSVLTIPNETGFLIRVILSQEQRSYIDQFKSYLIK
TPKGFVPLEALGEFTQKAEPTIITRQALDYTQDVYGYRGTNAISHIMENFQKEFEKYAKT
HPGFPLPNIKIEQTGDIQQMMDSMGRMFKAILIGLVILYLVLAAVFKSWKDPVAIMLAIP
LSVIGGSWSLLIADKHMCLPAIMGFILLAGIIVKNSILIIEFIKTYREKGYSKEEAILES
VNIRTRPVMMTAFGTAVGMIPIALEWAIGLERLSPLAVVAIGGLIVGTFLSLVYVPFFYY
LIDRGEKNEKTANT
>fig|436308.3.peg.459 Permease of the drug/metabolite transporter (DMT) superfamily
MSVVSKFQPTYENLRKSKINKISLFSKLKSKTVGVGFLFAILAAAFSALPNVIPKSFLDA
HAVDTSTIPNPLMLVFVIYVVNSLLFSPFRKSQREHEVKKTSRMTLFLLILLGAVEASGT
LTYTFGLQETSATNASILVNSETVFAILLGIMIFREKLSKQEVLPFFLIVAGSILIPVGA
DIQNNEWELSDFMMGDLLIVMSGFFYCLDTFIAKKLDDSIKTRHIVHIMSCTGAIMTLGL
MLFFEIPFDISFEELSVMSFVGFLGIGVTMMFFVIALRLIGAVRTVLIYSSTTIFSIVYS
ILILSEGLTILNIVSTSSVLIGLFVLRNRVGSD
>fig|436308.3.peg.1102 5-nitroimidazole antibiotic resistance protein
MQILIDLKLVGRLEIKSYEKIKEFLSQEHVGRIASIDENGYPQIIPMNFVFANDAIYMHS
YTRGEKLDNISRNDKVGFEVDRELEFLPSYFSHPTDASQADTLYISVVIKGKGVFVEDDD
EKAFGLNELMKKYQPEGNYIPIQNNDLVLDEVAVIKVIPVSIKGKYKIGQQLRSDSRQIL
AQKILERKSPTSKQTLKIMGFEETPDGLKMVDEPVW
>fig|438753.3.peg.1109 Multiple antibiotic resistance protein MarC
MLEDYDLFITQFVTLYALLEPIGHLSLFLALTGEHSKADRLRLAILSPLFAFAVLSFFAL
AGQTLLNAMNVSILSFQIAGGIILFSFSLSMIFGEAKKPSGVPEEKNLISQAIYPLATPT
IAGPGAILSVVLLADNNRGSLIAQSMTVLAVASMMLLLMGAFLAGDIITRLIGSGGTNLV
RRVMGILIAALSVDLVLSALAKWLHLPPI
>fig|438753.3.peg.1605 Multiple antibiotic resistance (MarC)-related protein
MSQFINIFVAVFAALFPIVNPLGGAPIFYEMTRACAPQVRASLAMKVAIYGFILLVVSLV
AGSRILTFFGISLPVLRVAGGLVVTFVGWNILHQGDASAEKAPDATATRDVDVLRVEQQA
FYPLTMPLTMGPGSIATAIALGSQGTFNPADGYGHMIIEAMGALSGIAAVSASVYFAYRY
ASDIERFLGPNGTNVLVRLFAFILLCIGMQIMWLGIRDLVASLPVHG
>fig|438753.3.peg.3355 Glyoxalase/bleomycin resistance protein/dioxygenase
MSAPLPGAGVHGLFHVAIKTADLEATRIFWRDIIGLKEIHRPDFGYPGAWLGCPQPGGLG
IIHIYAGGPALGPSGMAPYGTGAIDHISLSCSGYRAYIARFKAAGLDWREFIVPGTSLWQ
LFVYDPSGMQLELTFEASIEGAELPDVSEARVYRAGRSFFDPDTYPKLARQAAARA
>fig|438753.3.peg.3685 Drug resistance transporter EmrB/QacA subfamily
MGVGSIDSRQRWCTVFAAAGALGMIMIDATGTAVALPSIQRDLVLSHGAQQWIITLYALT
VAVAIATGGRLADVYGRARVFRVGVMLFAFGSVVSGLAVNLPMLLCGRTLEGLGNILMAP
AAALLATEAFGPTERGRAMGLYSGLGGLAMVIGPIVCGAVVQVGGWRWAFFVNLPLALAV
LLLLRAAGPAAASPRSGTFRPAHSLLLVAALGPIVLGLQESHAWGWTSPLTLSLIAIGAL
LLVLFVATQARAADPLVDVRLFTRRQFCADGLVLFCAQCAIIGQSAYGAIYLQRVLHFAP
LQSGLAMLLFLGPMMVCAPLSGVLYDRHGVKVPVVAGLTLATLGFVLEVHALPRMDFLYM
APALVMLGAGMGLALSQTYTDGTAQVAESHRGRAFGALDTVRQLGGAIGMAAIGTVVVAL
ERGRVLAIAAEAAPEGAARAQLEALMADAAYGKDEAVRTLAEQWPAVGAALRLSAARSIS
EGYYVGAAMLALALCAAVLVMRRPPHAPREIAKGAS
>fig|438753.3.peg.4302 Permease of the drug/metabolite transporter (DMT) superfamily
MRLSAPSAGPAPSFRLGLLGALVTVAIWTTWITTTRVAMHGRTPLAPELLAFIRFGTATL
LLAPFWWRFRLFPRQSPPLALLGLMAAGLPYQFLVLWGLHFAPVSTAGPLLAGTLPLFIG
ILSAVVLRERLTPLRILGIALITLGVLAISGEGIASLTGDTWRGALAILGAAFAWSLYTV
AFRYSRLSGIEAAAFVGVWSLVVLLPFEAGNIWTAVQATPVTLLAQQLVTQGLLAGVVSL
LTYTTAVRHLGPARATALTALTPPAALLTATLLLGEHPQLEELVGCGFIVAGVVAASGAL
SRARA
>fig|438753.3.peg.4408 Fosmidomycin resistance protein
MSIAAVRTPPSREMATISAVGTAHFTSHLLQLAFAPLFLTMRDDLGVTFTELGALLSAFY
LASGMGQVTAGILVDRFGAHRLLLAGMALQASSVAAIGLAPTYGLMLPLAFLSGLGNAVY
HPADLSILSHRIRPERLGRAFAAHVIAGNFGYAVSPLMSGTLAIAFGWRTALVVMGGAAL
VATFALIAVRPVLHSPTIAEQAKAPGGVAPISFGQVLTTPVVLLAFFYFLLSSISLVGIQ
NFSIAALQEGYAFTAAMATLTITAYQLATAAGVAIGGYVADRSTHHHRIAMGGLAAAAAC
AALASLHLPLALATTALVVGIGFANGLTLPSRDVLVRRASPAGATGKVFGVVYSGFDIGS
LFAPLIYGLLMDHHLPHGVFLTAAVPLALGIVTVLGVRPGKR
>fig|439235.3.peg.1331 Permease of the drug/metabolite transporter (DMT) superfamily
MNLKVLKANLILLTAALVWGSTFVFQRSAMQNMDPVSFSGLRFALGALCLAPIAYFRSKR
PTLPLPGVPRWLPLLGMVVAGTVMCFGINFQQVGLVETTAGKAGFITGLYVIMVPILGLA
FKQKPDLGLWLALPLAVTGMYLLSVTDAFNLAPGDGLVLICAFMWAVHVLVVGYFSPRMD
SFVLGFGQAFVCAVLSLIYALCCETITWEGVWASRYALLYGGIGSVAIGFTLQIIGQKDS
PAAHAAIILQLEAVTAAVSGWLFLGESMTTRSFIGAGLMLAGMLVAQLWVFVPKRKPQGN
NGTP
>fig|439235.3.peg.1525 Acriflavin resistance protein
MKGMVKWFAENHVAPNLLMIFFLLAGVFTALNIKMEVFPETSLDRVRISCSYSGASPEEV
EEAIITRIEEAIAGLAGIERIDSSAREGAGRVTVEVMKGWDVGKLTDEIKSAVDRITTLP
DEAEQPIVAEMTRSREVVNVAVYGDVPETTLKQIAERTKDAITALPDVTLTELSGVRETQ
IHVEISEDALRRHRLTLGQVATLINNASLDLPAGSVKAKGGEILIRTKGRRYYAEDYADI
AVLTNPDGTQVTLGQIADLKDGFEDVDYRAYFEGEPAALVKVYRVADQNALTVASQVREY
VESASRSLPAGVKLRVYNDSSTILKSRISLLVRNMGIGLVLVIVLLGIFLNVRLAFWVTL
GIPISFAAAFIFLPYFDVSINMISLFGFILVLGIVVDDAIVVGESIYHKQEQGMPRLKAA
IEGALEVGRPVVFSVLTTMVAFLPLLTGSGRMGRLLRNLPIVVCLVLAASLIESLLILPS
HLAIGKSKIKSVDPANPSGRKRSPIKKAFKTAFRPLTIWRDVLTWVINKPYAWLVDFCVT
WRYVNVALGVFVIFLTFGVLKAEYVRETFRPDIEGDTMSCMITMPSGTPKERTLEVMALM
EEKARQVLAEKDKTRPEGAKPLLEHTIGLLGAHLGDGKPDTGGHMGQLWISIISAEEREE
GISTAGLTSRWSEAVGIVPDAESVTYSSALHSAGKAVEFHLSSSDNEQLSAAAEDLMKEL
ETYPGVYGIEDSFLPGKKEMQIKLKPEARSLGITLYDLARQVRHAFYGAEALRLLRGQDE
VKVMVRYPEDERRDLSNLEDMRIITPQGDLIPFSRVAELQLEEGYSYITRAQRKRVVQVM
ADVDMEQNNPNRVRDTVTNEFMPELKAKYPGLNFTVEGRGRHREEAFKDINRGFLIALLG
IYALLAIPFRSFTQPLVVMCAIPFGIIGGVFGHMIMGIDLTIMSRFGMVGLTGVVVNDSL
VLIHMANRLRDEGAAAHEAVVAAGARRFRPIMLTSITTFAGVTPMLLEKSIQAQFLIPMA
VSLGFGVLFATGITLLLVPSGYVILDDIQRFFKWLFGGDYGRYHASGGDETELEEEQTPD
LPPPLPQKD
>fig|439235.3.peg.2416 Drug resistance transporter, Bcr/CflA subfamily
MLVRPIKPQSLLYTGMLAGLASLPPLSIDMNLPAIPAIEASLGVASGQGALTFSLFLLGF
AIAPIAGGPAADRFGRRPTLLLSLLFTSIAAFSCMIAPSFQALLIFRLIQGIASGICILL
PLAIVRDTLSESEAPKLLSRIMLVVAVAPLIAPIIGAWVLSWSDWRTIHAVQGGLSTLLL
LLTAMGFEETLEEDRRTPLSMRQIGSAYAEIATSKTFLGFSFLMAFTFGCMFSYISGSPG
LLQVQLGLSENLYSLVFAFTSFGIMCGSYISYRLGRRDVPARSIINRGLTCMVVAVAAAL
VLVLNGFVHLETMAPALFLIMMCAGTIQPNCMAEAVAPLPHIAGTASGALNSLQMFIGSA
ASAFVTFLTGYFTPALAMMISMACSIALAFAIYHGLRTGRTPGKLEMSPETD
>fig|439235.3.peg.2476 Drug resistance transporter EmrB/QacA subfamily
MSTLDGSIVNIALPSILKSYGVSLSTIRWVPLVYLLTISCLLLSFGRFSDMIGRRRVYTR
GLFVFSLGSLLCGLAGSAGVLITARSLQGMGAAMIMSCTPALIADNFPPEERGMAMGMIG
AVVASGLTVGPALGGLILEHFSWHWIFFINLPVGLGAIIAANRVLKESQASGPRESFDWI
GALLLALVFGSFTLAISMGKEMGWTSVPIVGLIAAFAVGAVFFIFVEVKAPHPLVDLELF
RIRLFACALCAAVTLFISLFCLIFLMPFYLKYPGGFSDAGAGGMLVVPFLFMLVGAPLFG
AMSDRLGSRLLCTLGMLMLSASFFSFMFMEPTTDIFPIFWRLALAGFGTSLFTSPNNAAA
ITAVPVNRRGIASALIATARNMGMVMGIAMASTVFTAVYVSIYPGATLDSYSAEHMEGFM
AAFHQAMMCGGFAALTGAVLAALRGKGTVSEE
>fig|439235.3.peg.2725 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNVQTRGGMLAADSIGSLLMKLSLPAIISMFVQAMYNTVDTIFIGRWVGTLGIGAISLVL
PIVFLIMAACQAIGVGGASIISRRMGAGDADGVGRTFGNMTLLALLLGVGVQLAGLFAIT
PLLRIFGASDTLLPLTWEYFRIIMLAGPLMTFAMTANNAVRAEGAAKMAMLTMMSGAVLN
TILDPIFIYVLKMGIRGAAWATVASMFLSTVMLLLYFKSGRSEIPLGARYMRLKFFIIRE
IAAVGSSAFVRVGAASITVAILNHTLSYYEGDVGVATFGIIFRVLSFILMPVMGLSMGLQ
PVVGFNYGARSYSRVREAVKLGVMAATTVAASGFLVIFLFPEAIVSVFSKDPLLMEYASN
AIRLSMLALPVVGCHVVGTAFFQAIGKAAPALMLTLCRQVLVVMPLILTIPRLCGAEYIW
FAFPIADAVSFTLTTILVWRVLKKIPKIEASSSA
>fig|439235.3.peg.3636 Acriflavin resistance protein
MEAFARNRVFANVILLIILIGGIVAGFRMIKETFPEFSLDMITVEVVYPGADPEEVEEGI
CRKIEEAIDGVEGIKQYTTYSVENAGTALIEVKENWDVQEVLDKVRSKVDAISTFPGDAE
KPVITDLPLKDIVCLLYLSGDLSERGLKEWANDVEDEIKNLPGISQVGVFGAREYEISIE
ISEERLQEYGLSFDQVAGAVARSNLNLAGGAIRTQGEEIRVRTLGRKYTGKELSEIVVLA
SENGDIITLDRIAAIRDGFAEDPVEATIDGERAVLVHIFKTSEEDSLGISKTVHKFLEEK
QKVLPPGAKIGLLYESTDILKARINLLLKNGLVGLILVLILLFLFLNARLSFWGGMGIPV
SMAGALIICWSLGATINMISLFGFILVLGIVVDDAIVVGESIYQHRQNGEGPLEAAVNGV
LEVGMPVTAAVITTVVAFIPLMFVGGIMGKFIAILPVVVIACLAISLFECLFLMPAHLSH
LPDPNAEDKSRFAPIRVWNAFFKGFSRGLEGFVKRVYMPVLEKALTWRYVSLCIAIAILM
LTMGLVAGGLIKFQVFPDIDGFVMTANVELPQGTPPAVTQEAVKRIDDALLRVAERTPTL
TGEPMIKSRLSLVGQTLEDIPENGPHLGGVQAIMLESEYRGVHSKDLMVEWEKEIGLMPG
VKSLTFTGLSAGPPGAPIEIWLQGKDMNEIIAASEELMEKLATYEGVNQIRSDYAAGKNE
MRLELKPEARTLGLTVNDLARQVNSGYYGYEAVRLQRGRDDVRVKVRYTQDERSRLSDFK
EMHVRTPDGSEVPLYSVANVSFSPGYSRITRTDGLRRVAVSAGVDSNKANTTEILVDLNR
SFFSGLKEKYPGLLVAVQGEQKKMRESFGSLMIGFPAALLGILVIIAIMFRSYLQPLIIM
VTVPFGIIGGIFGHLLLGYDLSMMSAFGAVALAGVVVNDAIVLIERINENIAEGMGFREA
IIKGGGRRFRAIFLTTLSTVGGLTPLLMETDLQARFLIPMGISLAAGVAFATLLTLLLIP
CLLMILNDFRRTVHFFWRGYWPTRREVEPAINRPVQSYALKEECEPAEQESPLPSPLPHE
EEPPPLTL
>fig|439235.3.peg.3967 Acriflavin resistance protein
MEREIAITRISLNRPVTTIVLVLAAIFFGFYSYRNMGLELYPNVDIPVVSVSTILTGASP
EIIDRDVTDVLEEQLNTIEGIKNLTSSSYEGRSVIVIEFVLERDIDAAAADVRAKVNLAQ
YYLPNDCEDPIVSKLDVGAFPVMNIAVKGGEDYRTRSHFVDKVVKPRLQTLSGVGSVDLV
GFRDREIRVWLKPADLEAQGLTASDVAGALARRHLELPGGRIENDTQELSIRVEGEYATV
EGLSQLVVKESLDGRLVRLRDVAKVEDGFEDVRTGSYLNGSPVITVQVKKQPGVNEVQVC
NSVKEVLKDLRSIAPAGIEMIISSDTSDFISRSMNGVENDLMIGVVLTALLMFVFLRSIR
VTLVAIISIPTCLISTFLICNALGFTVNNLTMLAMSLAVGMVVDNTIVVIENIFRHLEQG
KPVRQAALVGAGQVGFAVLAGTATTLAVFVPVATMKGVIGRFFFSFGMTIAGAMLISLLV
SLTLTPFMASHLMKRQTSEGTFSKILDLPMKALEALYRRVLGWAVRFRFVTILFALLTFA
AGIMMAKQLGMDFAPEEDQGETTLQYELPIGTSVEESARMTRELSAIVQEQPEVTLVLAT
FGGGSGEEIHKGNLYIRLVGRKERSVSVAQFEERLRDLFAGYRDVIFQIQQGGGGPGSSD
AEQSIQADSLEDLARVTEAMVEDLKKAPGLVDVNSDLRLTKPMVKIHINRGLTDSLGVDV
KDIANEVNTYFGGTDASVFKSEGNRYDINLKGAPEDRLVADDIGRITVKTSTGDTVRLGA
MVDVETTVGPNVIKRYNRRYSASVYANVQEGYSTKQATDDIQAAFDRHAPSDKSMATVIT
GNAQMMMESMGYLVEAIIIALIIVYIVMAIQFESFLNPLVVMFSLPLAFSGVFGLIWITG
GTINIMSMIGMILLVGIVVNNAILLVDFANQRRERGLGPVEAMLEAGPLRLRPIIMTAAS
TMISSLPIALALSEGSEFRQPMSLAVIGGLFTSTVLTLVVIPVGYIWVENISSGAGRLYN
KLFTRKKSQPEPAELVETPPDSEEK
>fig|439235.3.peg.4982 Glyoxalase/bleomycin resistance protein/dioxygenase
MKPRISMITLGVRDMDRAVKFYEEGLGLPKMDYDPAVAFFTLNGTWLALYPWDLLAEDAQ
VPPEGTGFRGVTLAHNLASEAEVDAFLAQALEAGATQVKPPQKVFWGGYSGYFADPDGHL
WEVAYNPYFWIGPKDEEA
>fig|439292.5.peg.521 Drug resistance transporter, EmrB/QacA family
MDTYQKKIIVALLIATFLAAVEVTVISTAMPSITSDLGGMDKISWVFAAYLLTYAVMTPI
FGKLADLFGRKRVFIGGVSVFLLGSVLCGFSQSMEQLIFFRAIQGIGAGALTPMTFTIVG
DVFQYEQRAKAQAIIGSIWGVAGIFGPLVGGFFVDFLTWHWIFFINVPFGLVAMHLVGRH
LQEQIEKKKRRIDYKGALTFIIGTGALLYALLSGGTDIAWTDPLMYSLFLIAGLFLVLFV
RIQIRTAEPMVPLHLLKNQHLLTANLASLMLGMILIGLTAYLPLWVQGVLGLAAIFSGLT
LIPMSLGWPIAAFMSSRLLKQFGAKPVCIGGTGLIMLSTLAMTFVTAATPNWLLVIIMFF
VGAGFGLAMTMFTVIVQSSVDWTNRGAASSSNAFLRTLGQTLGITILGATLNQYIGGYGG
EASAPADVLASGLSTVFLLLFIIATVAFLITFRLPSEEPEHARSS
>fig|439292.5.peg.3021 Permease of the drug/metabolite transporter (DMT) superfamily
MFTIEVFILAAVFGLIYGFLLQKADFCFVASVRDFVSVKDSRVGKGILVLMATAMIGWGL
SLTLGIASVDQLWAVPIGFQNLLGGLLFGIGMTIAGSCASGALYRSGMGYIQFWIVIAAM
ITGNLLFAFIYDPWANDYMMEPLTMAEGYSLYEIGLPFMTLPLLLVGLLLFVTIRKFGWA
GFWQGVKNSFTDWKGNPFTQQHWDVRFVALLMGITATVQFITLSSISVTGPETRIGGVFL
ASIFGEQAVYNNLYLNNMFAAYPTVGIGPEEVLVIMIVVGAFISSVLSKSFKIRFPKAKR
LPAAIGGGLLMGVASRIAPGCNIANVVAGVGGLSIASFLVIIGMMVGVFLVTKYYFKMPI
MLFYREKDAA
>fig|439375.7.peg.1678 Permease of the drug/metabolite transporter (DMT) superfamily
MTAITETTPTSSTSDTIRGLAWGLSGVLVWSGSFVLTRFGFKTALTPFDIIALRFGVAGL
VLLPVVLVKGFGFRKLGPLGFVLLVSGAGVPYALLTTCGLQYAPASHAAALIPGLMTAMV
AVLGMALLKERLAPSRWSGVVLILIGAMLIAGLSQLGGPEMLGHFFFFVAALVWAIYVMV
FRRKGMDGLHATAIAAVTSAIVYLPIYMLFLPKGLGATSWGDIALQGFYQGVLTSAFGVF
AFNRAVVLLGTAAGAALSALIPVITLVLALVLLGEVPGWTDTLAAFLISLGVLALNRKGR
KRIAS
>fig|439375.7.peg.2703 Permease of the drug/metabolite transporter (DMT) superfamily
MQSEATMQPGVASSFKSLSAMLGLAVMWGLSIPVTKLGLQTMPPLTLTALRFGIAVPLLL
LFVLGKQRLPLKAFPRLAGLGVLGIGIGQVSQTLGVAGTSASVGTIISATIPLFVVVFAA
LRLKQAVSGVQMLGLFAAFVGIGLVALEKGDPSAVGTQNSLVGASFLLLSAVAIAFYYVW
SVQLTVQYGTATVVAWSTLFGLLALLPFAGWEISTVDFQLNYVAIVSAIYLGFIVSVAGF
FLWLHLLRTVPARTAASVQYLQPVFGVMASSIMFGDTMGWYFAAGVTLVLIGLALTIFTK
RQRQ
>fig|439375.7.peg.4164 Membrane fusion component of tripartite multidrug resistance system
MNKPVVLFQQPAPVKDKPEPLKAAGKPRRRAYLSLARASVIVAGIGLAIVIPLGWGSWVA
GMTNQTTDNAYLRADTTPVSAEVGGRIVHLLVEDYQHVKTGQLLMQIDPTQYQAQVDQAG
ASVAAAQAAIRNAQSNITLQQRVIEQAEAGLAALNADRERVVSEGHRQTSLTKDGWSTAQ
KLEAAIADVKRIEAQIAEKQAEIAAERQKLDVLATQSDQAQAELSNQQAALRLAQIDLDR
THITAPMDGVVGVSGAREGQYVRAGSQLVSVVPVSKLYIVANFKETQLAKFRPGQVVSVT
VDTFPGKELRGYVERLSPATGSEFSLLPPDNATGNFTKVAQRVGVRIALEQNGELDELLR
PGMSVVATVHTDQSIETTASLIK
>fig|439375.7.peg.4165 Inner membrane component of tripartite multidrug resistance system
MRALIGVAAVLLGTTTSLLNSRLTDIGLADIRGALGVGMDEASWLTTAYVVAEVAAIPSA
VWLRSILSPARGVMIGALIFTIASMLAPFSPNLQTLISIQAIRGLSAGILMPMAYAVIMR
HLPQHLRLYGLSLYALASSLTPNLAVSIEGWVITHLSWQYLFWINIIPGSLTLLAGAYGL
ANDPIKFLRFRRHDGFGLLALSFGLAALVTALDQGNRLDWLGSGLIVGLLASALFFLSIY
LIHALWHPDPVVSPRLLARRNIGFSLFLMFAMRIGLMTSAYLLPQYLIRIQGYRALESGT
MFWVSVLPQIVLTPFVAWLTYRMDPRSLAAFGLMLFGAGVLMLSGLTHLWTSDQILPSLF
VQSIAAPFTAIPLMVLITEDISVREIPWIASLVHIVRTVGTAIGLAAVSTFTRVQEQLHS
NLLGLHLERGAADVQGHIDRTAAMLEAHNSDPTRVTAQATAMLARTVQREAFVLAYSDMF
VMIGLAIALAALATLFMRQPKLPGKFL
>fig|43989.3.peg.1177 Quaternary ammonium compound-resistance protein
MKDFVGFDFSSPTIIFYLIAHILTNYWILMGLGILVISLSLYLSAISKLDLSYVLPIHAS
SYVLNGLFAWAILGEDVTGMRWLSTLIISCGVLFVGLSDSQTSQFSEDYHSNIKSRNLPL
FFLPFSLAVSKTWLAIMISSVSDASGDVLLALGMKKIGELKKITFLEVTKMVIKVITNPI
IISGIACQGIAFFSFISVLSWADISFVRPATALTYIISMLGARFLLKEDIREQKLWGIVL
IGLGVFIHR
>fig|43989.3.peg.1358 Permeases of the drug/metabolite transporter (DMT) superfamily
MMQLKLTSQNNNAVNLLPFVTLVIALISISFAPIFIRFSEIELGANGTVFNRLWIFFMVF
GFAQTIRRRFYSPENIEIQSPLTVKHSLLLLLVGIISITSLGLWAISLQYTSVANCMLLN
NMTPIFTSIGAWLYFGKRFDTKFILGMILALSGAIFLGLEDLQGTNSHLIGDFYALLSAV
FLGIYFLIVEQLRNRFSATTILLWRCGIGSFLLFPLVLWTEGKLFPTAWQTWLAVIGLGV
ISEGLGQRLLADCLDKFSSSFVTMFLLLEPIVSAILAWIVFAEGLTSITGLGFVIILTGI
YLAQSSHSAVHEL
>fig|43989.3.peg.3572 Multiple antibiotic resistance protein MarC
MKSKVFPHFRLTKHCLMAVILSLVTLLTLWFSVNFPVVATLPTDRVIETATPLEQPFLLA
QAESETESPKTDPDRYQSWEKQNLSELQQFRGVLSAGNIFIIFFVTLGPIKIIPTFIKLT
QNADDDLRKSLALNGAGLATIVIVLVVLIGGNILTRWTVSMSALLMAAGIMLFLASLQAV
MSQYKGSAENEPLLEPSMKLLINPLTFPTILPPYGIALALILMVFNNRISDRPFIVPVML
ILVMMLNLLAMLFARPILKTIKLPTLRIAGLVLGVMQLALGIEIILIGIHIQALILEDLL
KLN
>fig|441768.4.peg.1133 Glyoxalase/bleomycin resistance protein/dioxygenase
MDKSLAFFKALGFKTNAQFGAPIVFFNNNGTKLELFPVEELAKDINDNNPPVIQTTGFSG
ITLACNMKTKEAVDELMALVKHHGGVIIKKPQTTSWGGYSGYFRDLDGYYWEVAYGPMWK
FDAQDMLIID
>fig|441768.4.peg.1136 Daunorubicin resistance transmembrane protein
MKINKYKKYLAFSKAGILDGFAYKFSALGWLLGDLVSIIILFYLWQAIYQNSPTETINGM
TFKDMIAYLIFARVSTTLIFSSSSFWNIGFDIYEGNIAISLIRPINYRYRLLASSFGNFL
STAILMFIPLFIVSIVILNLSLGIGFPELAHLLLFLVSVVLSFVIVDSMNFLIGEISIFT
NALFGLMIIKNIILSFFSGSLLPSSFFPDWLNAVLRFLPFQSMVEKPIMILLGRLEYMDI
LMTLLIQLMWVVILSVLCNFSFNRLKKHVVSVGG
>fig|441768.4.peg.1137 Daunorubicin resistance ATP-binding protein drrA
MPIIEVKGVKKVFKKPVREPGIFGMFKTLFSFKYTTVAAVKDISFSLEPGEIVGYIGANG
AGKSTTIKMMCGILTPTDGVITIDGYKPYNPKERKHVLNKIGVVFGQRTQLWWDLPLIES
LVILKEIYDVPKDAYEERFKFLSTVLELDPFLNQPVRTLSLGQRMRADLAASLIHNPQIL
FLDEPTIGLDVLVKDRMIEAIKEINKKYHTTIVLTTHNMEDITDLCKRVIILDEGSILYD
GPIKKIKAKFGDMRHISFLTKERNILLELKEMLPKDCLIEEIEGYIHLSFDLEKMSVNDV
LKTIIDTYTIEDIKIEENSLESIVKKIYENKQI
>fig|443906.9.peg.752 Tunicamycin resistance
MIIWLNGTHGAGKTTTARLLQERIPDSRVLDAEKVGEVLMDIRPPLPQLDDFQHWTPWRP
LVVETARRVLDYAGGTLVMPMTVLVEAYWREISGGLAGHGIPIRHFVLHADTATLRDRIQ
NDQDLGPSAFRFSRVEPYAEAARTWLHAEAEVVDTSRITPAEAADRIAGAVLAGAPGA
>fig|444157.3.peg.40 Multiple antibiotic resistance (MarC)-related protein
MELLTAVVALYVIVDPLGNIPLFAALTAGLSEAQRSRVLLLSVLVASAVLVLFAVFGVEI
FGYFGVELGDFMIASGLILISFSLHQLIRPYEQRPATDGLEVAVVPLAVPYLAGPASISY
VLLMSKHMGVAPTLLAVAAVSLLTFATLRASGFIMRALGVLGIRVVEKIMLILSVAIGVS
LVRRGLEAGWSLGASSRG
>fig|444157.3.peg.1923 Bacitracin resistance protein BacA
MDLLAALVLGVIQGVAEWLPISSKTQIMFASQVLLGAGPELAYSLGLFLEAASVLAALIY
FRGVYLEILRGLLGDAEGRRWLKYVVVTTAVTGAVGIPLYLAAKRYLLLGASAGWLMIAL
GLAVILNAAILQRARAAAGLKTFGEMPLSHMALVGLAQALSVLPGVSRSGITTTTLLLLG
YRPDEAFKSSFVLVPIAGLGATALAYLSEGNAVATPEAATAMAVGLVVSLATIRALLQFA
KSRHVALVNIAVGALAIAGGLAKILTP
>fig|444177.5.peg.2450 Oxetanocin A resistance protein
MSNRTIRDTSFGMTIRESLQADCPSCFGLCCTALNIVASSDFAMHKPAGKPCSNLTEDYS
CQIHSKLRMSGYKGCTVFDCLGAGQHVSQVTFKGQDWRQSRELADKMFQVFPIMEQLYEM
IAYVAEALSYQIDSMLHEQLLVQLEQLQQAAELDANGLLALDMMAIRMPVNALLLKTSEQ
MRQHLVKGKASLKLNQRGVDWIGKNFQGKDLRATDLRGGYLIAANLQGANLQGVDFIGAD
LRDTNLRGADLSTSLFLTQMQINAAQGDNTTKLPSYIKRPAHWQ
>fig|444177.5.peg.2530 Antibiotic resistance protein
MKKQTIFTSAFLLLFMSNFLTFIGFEMLLPILPAYLMSLHASPFQVGLVTTVFTIGAIII
RPFVGYYLVDNNRKGLAMGAGITLMIITIIYPFMNTIWLILLLRFFHGATWGVSTTANST
MAVDLIPKTRLGEGIGYFSISTTVGAIIAPSLGILIYHSFSFSILIYSSCMLCLLAVIAL
QFVYSAEPVKHEKQPFQFMEAIFEKEVWFQALLTVMTTLGFGAIITFLVLYGEQRGLDHI
FLFFLINAIVSTLLRPFTGKWFDKTGPWSIIIVSAVVGFLSLMVLSYATNSWLLIIAAIL
FGAGYGTVMPCLQTWTVQKVSEAKSGAANATFLSSFDSGVGISAFLLGLLAEWMSVEMIF
RLVSLSFLLVALFVYIDAKRTRKNNHIQTTKF
>fig|444177.5.peg.2627 Permease of the drug/metabolite transporter (DMT) superfamily
MRIKIIGALFLSLAASIWGAMYVVVKVVVEVVPPLELVWIRYLIAVLALGLIGIMMKQSW
KIAKKDRLLIILVGLIGNTISIVTQEMGTMLSTAQMGAIITATTPAFMVVFARIILKENI
TPKKGLSIILATIGVGAIVGHGGINLTQQLGGLYLLVAALTWALMSVLVKKVPSHYSQIV
VTTYSSLIAVILLTPFVIPRLKDLNLSVVLQPTISGGLLYLGIVSTAGGFLLWNKGLQLM
NASSGGLFFFLQPVVGTILGWLLLGEAIGLSFWLGSLFIFSGVFMVIREE
>fig|444177.5.peg.2682 Permease of the drug/metabolite transporter (DMT) superfamily
MMKINIVGIFYAFIWASGAIATKIGLFSASPLIFASVRLLCAGIILFLFVYIFRNYRYPK
GSEWANLIILGILNTTLYVGCSFLSLAYVDSTIFNLFITINPFIVAFLSSIFLHRKIGQK
EILGMAISAFGIMIAIIPYLESLNATLFGLITLGVGVLSMGIGSVFYNKIQLNLPQIVVN
TWQIIFGSLIAIPFVFLLEPNFYIQFDPYFLSGLFWQVVMTSIIAMILWFYLLEFDAVRA
NNFLFLTPIFGYILSAIFLNEMLTVYHYVGALFVIAGTFFSQSMKKRQHGNS
>fig|444177.5.peg.3957 Drug resistance transporter, EmrB/QacA family
MDDTMNKVFIALLLVTALAAIEGTIVSTAIPSITADLLGVDLISWIYSAYLLASAIAAII
FGKLADLFGRKRMIITGIIIFLMGSMLCGLAQSMEQLIVFRAIQGIGAGSILPITLTMVG
ELFTTEKARAKGQSYLSMVWGVSGVVGPLFGGFIVDQVSWHFIFFINVPFGLASIYLIVK
HYKEQLEAVKRKIDYLGAGLFTIGMVSLLYVIIENSKTQAWLSNQSLIMYAVAAIFLGVF
VWVELRAEEPIIPLTLFKNGRLMVINSLTLSTMSIVIGVTVYIPIYAQSVLGKNATQAGL
LLTPMSIFWTMNSIAAGYLIGRLTNKRIIQMGTILLVIGTIMLARLSSGSSDISVYLGSS
LIGLGMGFIMPMLMISIQKVAHPKQLGISIGLNSFTNTFSQAVGAALFGMIFNLATNEKM
ASLGKGEIQLNGEFAKGGFSLEEISFLKGTIANGVSYVYITTLVFAICALILSFFIVTKL
KDKA
>fig|444177.5.peg.4298 Multidrug resistance protein B
MKLSNLFHPLVWIILGGTVFTRIASFMAMPFLAIYLHNEIEATPLQIGLTIGIAPLISTV
GGFFGGYLTDRFGRKSVILITIIVWSLVFFGFATVHTVWLFILFNALNGLCRSFFEPSTQ
ALMIDFTPADKRKRLFSLRYTAINIAAVIGPIIGVYISQLASPSIPFMLTGIMYIIYAVF
LFFVLNRYQMQQQKAVTQTKILHTFTILLTNRVLLSFIFGAILINIGYSQFDSTLPQVIE
LTVENGTKLYSLLISLNAAVVLLLQLPISIVSERFSSSATLLVGILFFAIGLFMFGFSSN
YTLYIIAMIIFTIGEIFAFPTMNVMIDEIAPDTQKATYLGAAQFKNLGGFIGPIIGGWLL
THYMGAMFAIIAILVLCSCIFYRSKTSTH
>fig|444177.5.peg.4306 Permease of the drug/metabolite transporter (DMT) superfamily
MKQLTIYMILFSCVFFWASNFIIGSILIEHWSPIMVAIFRLIVIVLFLGCISWKAIIRTR
LTRNDLLLLIIAGILGVSINHFSFYASLQHTSPITAALILACAPIVTSLLNKMMYQESRN
GIFWLGAIISFVGVGLIITKGALITISIGKGEVLSLITMLSFALFLIIVNHLSLKLSAQS
ITFYTNLIGLLVLVPFSFTMWTQTNWQVAYPYWILLILSAVIIHGISNLLWNQKMKEIGS
TNASLLLNFEPAIAMLLSAIFLKQFPTSVQIYGSLLILLGILLCIYYKEIRTLLFMKRKI
T
>fig|444177.5.peg.4581 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTTINPIETRPLKPLFLSYLFPAMIGMLLMSVNILVDGIFVSHGVGPTALAGVNIAVPIF
SILLSISLWIGMGGATLYSISLGEGNKQRAHQLFTLAFTTMLVVVLTIIGFLAFNLKDIS
YIFGASDDTYPYVQEYLHVILLFGVFYTIENLLSIFIRNDGNPKLAMLGLITTSVLNIIL
NYIFIFVLDYGVTGCALATAIATIIGTAVLCLHFFRPQSELKFVSSFFNKTDLRKIFAIG
LPSFIVEASVAVIIILYNVTFLHYLGASGVTAYAMVNYIHTVLLTIFLGIGMALQPLVSY
HHGARLLERLTALLKIGLATAFILGLTTALIAMLFPSQLMALFGDSSFEIRHMATQGFVH
FAIGYVFLGINMVLAEFFQSIEKIRIATTIMLLRSIILFIPTLILLPKVFGSQAIWWTFP
VAEGITALLIYGYIKKNPRIIASPGDA
>fig|445932.3.peg.73 Permease of the drug/metabolite transporter (DMT) superfamily
MTQFYFLALAFCWGSAFLATKNIVTEVDPYYGALSRVFFGLLFFIILFIVRRKSIKIPLK
EIWKPWVLSSLLISLPFMLMFWGQQHIPSGVAGIFNGTVPIWAFVMGAAFLKGVDSFTWR
RAGGVLIGVGGILCIMLPKVHFSGQMSEFYGCLALVGMAISYAAGNVATKHLMVDHNTIS
IEGNIFHQYVFSAVILAIISVCFGTMPSAETLTQPKVLGSMIYVGVFSSAIAFLLLLELI
RRLGALRASAVTYLVPIVALILDFGSTGRIPAGNEFFGVFLIFISLLMIQKPIKK
>fig|445932.3.peg.126 Acriflavin resistance protein
MSDNNKENVGGEVPQTGATVASFFIKRPVTTAMLSIALLVLGVIGFKSMGIDMYPNVELP
YVAIQTVLPGASPEEVETSITKIIEESVNTVSGIDEINSYSLDGLSITVIAFELEKDGDV
AAQEVRDKVNQIQANLPEGTEAPVISKFDLSSLPVLTIAISGERDVIELTEMSKKLVKES
IESISGVGSVNIVGGRKREIHVEVNPFKLYSLGIPISEVKGALQEQNVEIPGGRVEQPSK
EFDLRILGRIPTVADFLNVYIGTRNGRPIKISDVGTVIDSGEYERQSTWLNERRTISLEV
QKQSGTNTLAVIEGIKARIEEIKPILPEDFQITFLMDQSGNIRESFYSVIEHLILGGLLA
AFVVFVFMGSLKSTIISSIAIPISIIGSFFFMWQFGFTLNNMTLLGLTVAVGIVIDDAIV
MLENIYRHKEEYGKGAVKAALDGSKEITGAIIATTASIVVIFLPLAFMSGIVGRFVRSYG
ITVAVAITLSGIVALTLTPMLCAKLLTGDEKKSKIEVYVTKINGWLVAKYLPMLEWALRN
RKTMVLISVLLMVSTIPMLVGLEPFIKIVKPSFSVNTQNIVVNTIFKGVGKDFIPQDDSG
KIRATIKAPVGVSYEDSMAIFNTLADDLRQLPYIKNMFVSVGVPADSMIGSSPVNEGSIL
LELEDRNTRNKITTFKYRDEVREIIGKYDGLRTMVVIVAEGPSSGHAQMQYLISGPDIEM
LTKYSTAMADKLRKDPRFIDVDVSFSLAKPEYRVIIDRDKAQDLGVKVLDIASALRTMVS
GEEDITKFKDGDELYEVRLRVQGEYRANVATVSALLVPSKNEPVRLDSLAKIEEGFGPTQ
IDRYNRQRQVTVSANPTGGMDIGTGSKVMEEVFRSLNPSEEYNGRIIGMGKEMGKMMSSF
IMAFILAFLFKYMILASQMESYTHPVAVLVSLPLTLPFALISLIVTGQTLNIFSLLGLFM
LIGVVSKNSILQIDYINTLRSEGLHRLDAILEGNKVRLRPILMTTIALVMGVVSMVFGTG
SGAVLRRSLAIVVIGGQTLSLLVTLLMTPVTYTLLDDLGRWIGNLFYKEPKKD
>fig|445932.3.peg.254 Permease of the drug/metabolite transporter (DMT) superfamily
MIYIKLFASILFWSLTFYFVKTALAECGVTTLVFARSVLGLLVVTLFLREFKWLKTLTKK
DWLRFFFLAMVGVVIQQNVQGYATMHTSTNHAGWLVALSPIFVAFTMVAFFKERLPKDKM
MGFIICILGVLLIFLSKQTFVDGSSMSTLKGDLIFVATAVNWVFYVVPMSIWFKNMPNLR
ITFCLFLAAVTIMLPIEIVSGSLKDFAHMGPRALSALAYLGIFCSGFAFIFYNEGIEKIG
PSKASAFIYAQPLFTMVFGYILLGEVISKEAFIGGALILCGLYLINVRRKRLKRFYITLI
RYFRV
>fig|445932.3.peg.410 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSVDTISSATEIVKEKNPFKGKTLQGILFKFSAPAVVGIIVNALYNVADRAFIGHAMGPD
GIAAITISFPLILFIMACSIMIGVGGSVLFSISLGKKGYKLAERVLGNTFVLLFIVVSLV
VGIWELSMDHMLKLLGASKAVAPLAKAYMRIILIGAPIQAVGMGMNNFLRAQGRPLLAMF
TMLIGAVINCILGPLFIFYYQWGMEGAAWGVVLSQLVSAVWVCWHFVGKKARFKLKFKNF
VLKAKIVSKTLTIGSSQFVLNTAVSVLNVILNLTLVGFGGDLAVSAMGIVSSVNTLIIMP
VIGIGQGLQSIIGYYYGAKYYKRMLQFLKMGINWASGITLTGFIIVMLFAPYIVALFHRG
TPELTHLASYALRVFNICIPLVGFQIVASTFFQATERAGKAIILTLSRQILLLIPLILIL
PRIFGLNGIFISGPVSDFATAVLSFVFLRREIKRYL
>fig|445932.3.peg.420 Permease of the drug/metabolite transporter (DMT) superfamily
MHISPYIYALLSNLTFGIGAQIFTKFSRKISPVWMTVFKGSLACLFFFLSVMLMGGFHPI
PLKYMATFILSGFIALGLGDILLLKAFADMGPGRTMMLFAFQPLIVGVFSYFLFGQAVNA
AKFFSIIFFIICIFIFAFENFKKSGKWSFTSMLIAFCGMTVDAVGILITRYSFNGSNAAA
LEGNFYRALGAVLSFILVCGVFKINFFAKFKILTKKEIALSSLGVFMGCYLCLLFYLAAI
KTGHLATLSSIAITGVIFAGLFECLFERKLPSKYLMTAFFFFCAGMYILLRY
>fig|445932.3.peg.426 Drug resistance transporter, EmrB/QacA family
MLALDSVAGRLRGSKKVIAWLVAVAFFMQMLDGTILNTALPEIAKSFGENPLRMQSVVIS
YMLTVAFILPISGWLADFLGTKRVFISAIFIFSLGSLCCALSNTLTQLVLSRVLQGVGGA
LMVPVGRLAVMRIFPKKELVSALSFITIPALVGPIVGPFAGGVIVQYVSWHWIFLINLPI
GVVCAVFTYIAMPKVTPVKFKFDWIGYLLFSAAVILISLSLGSVDEATLGRRAAVLMFLA
GALCLGAYARLSIAKPWSALFKPRLFYERSFTVGIIANLFIRFAGGSLPFLAPLFLQTAL
NYSPLKAGVAMLPLGVMSIAAKTFVEPVLNKLGYRRLMTYNAIIIGIMLCFLAFIGPNTS
YLFILVYLGVLGIFNSMQFTSLNTLTLIAVPPRDLSQANSLLSAVMQISMGLGVSLVSAA
LAYFGAHTAKIGSENILYSFHATFVFIGVISILGVILFQSKFARGIVDKPKNM
>fig|445932.3.peg.819 Multiple antibiotic resistance protein marR
MADFRDYGILPEKGRQYEEVIYVMALIYNIINNEASNYLARFDLTPAKFNILMVIKYSGK
NDGLTQVEIGKRLIVSAGNITKILDRLSAQGFITRAPSKTDRRANVIKITKIGSDTVEEA
WGGYDAILKKASSFLTASEQKNTAFVLKKWFNSLIKGA
>fig|445932.3.peg.956 Outer membrane component of tripartite multidrug resistance system
MNINFVLKKIFILLFLLAAGCNFAAKNKLPETDLPNQYKIEDYSVFDNEKWWEIFEDPTL
NMLEETALEYNKNLVIAFERVNMARAEAGIISANSMPQIGFNVGGMRSGGYRVRTNNRFS
AGVGASYEIDLWGRQRNLQAAMKARLLSREAQKDVVRLTITADVAKTYFTILAYDSILAK
IDAAIKDKDDNIALHKSKFLKNASTELSLRRLEAEKDNMKAIYLEYRIALSANETALSTL
IGGSAREIIEESIPRERPLEKMAVVEKMLSQVPSSILHNRPDIRVAEMDLYEAGANIGVI
RAGFFPSISLTTATVLVSESMKRLFSGGTWNFAGIITGPIFQGGRNRFKLEELQAQQRIL
VSTYELTVQKAFKETYDAITSNNINHEILATREREVVTLNRSVTLARKSYLSKKITLTDL
LEIQRRALDADIDLSLTLRNQLYFIVDICKTLGGGLRYDHAPGEEPSDAKPEVEKEPAED
TDKEIKK
>fig|445970.5.peg.789 Permease of the drug/metabolite transporter (DMT) superfamily
MKLKDLAFIGAVVLLLAPFFLSNDLYAAYLACNASHPYLMALLKFGILSTAGEVIGLRIK
TGRYNEPGFGILPRAVVWGFLGVWIAAMMKTLSIGVPAVAESFGIEGVAAAMKGELTPLK
FIGALLISLTMNTTFAPVFMTLHKITDTHILNNGGSLRALVRPIPMRRIISSLNWEVQWG
FVFKKTIPFFWIPAHTITFLLAPQYQVLFAALLGVMLGILLSVAAVAGRK
>fig|445970.5.peg.1605 Permease of the drug/metabolite transporter (DMT) superfamily
MERGALKGHGALLLANVIWGLNSPICKTVLLSPENPEGLNHFALTVYRLVGAFLLFWLAS
AFLPRERVAWRDLGGLFIASLFGIQLDQILFLWGLSLTSPINVSIIATTVPILTMILAMF
FLREPITPLKTGGVLLGAAGAVLLILISSRGESGGGSIAGDIITLVSSVCYAIYLTACRK
VILKYSPVTTMKWMFFFAAIVVVVLYHRPALEVDFPAVPARVWGGAAFAIVLSTFLAYLM
VPIAQHYLRPTVISMYNYVQPVASVLFTVVLGLDVFGFTKAAAAGCIFLGVWLVTMSKSR
KDLEAEQAVKMTDKK
>fig|445970.5.peg.1638 Permease of the drug/metabolite transporter (DMT) superfamily
MAPIALVTASLCAAALFSLVPLLWSKAKPIARKDIKTMIGAALLIGVIRKVLLMYGLSRT
SPIDGSIIDTITPLLVLLISVVLGIDKFTRLKIAGLVLGMAGAVGVVLLGASGGHTHSGL
VGNLMIAGCALATSCYMVWFKKLIARYDVVTMLRWVYCLAALMVLPFGARELVHTDFAAM
DTDILLATLFVVFVPTYVPNLLLNYSLKYVQPTVSSIYTYLQPVLAVVLSVAMGLDRLHL
DTALCALVIFFGVGLVIRSYRGPAVPSAPLPVHTH
>fig|445970.5.peg.1845 Tetracycline resistance element mobilization regulatory protein rteC
MPVTLCFIKDKHKVMEHKILLETYFAGLLQKVEWQIQEYEDTATDTLTLCRLCVDYLQEI
LGELKTFIISYPFASTEEEIHFFKELKPLLASKIIYYNTVYKIEVRFPSGSEDVQRDYLL
SETDRISKSFQRNLAFYQYHRTKATYLDRQYFMRGKPDIQIIVDSFYYETDPQFSTSHDF
KVAKILANELLEIYLTNRLHELERREQRKRVKNGFTGKVLRWTGTKRALVELVYALHACG
CLNKGTVDIKEIVAYFEYVFDIDLGDFYHTYMELKAKTKDRTGFLSTLKDRLLLRMREQD
>fig|445971.6.peg.72 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSEDLTKGNINKTLIKFAFPIFIANMLQSVYGIVDMIFVGRFVGGKGIAALNSAVMITFI
ITSICMGITMGGSVLVSKYKGENNGNKIKDTISTLFSISMIFALIVTLISLIIYKKIFIF
MNLPSGSLQYANSYMKIISFGIIFIFGYNAATSVIKGLGDSKSPLTFVFIASIVNIILDY
ILIGLLHIGVNGAAYATIISQAVSFIISIIYLNKHDFIYKLKITNLYIKKDKAIKIIKIG
FPCAVQMTILNVSYLIITKILNGYGLEITSAAGIGLKINSFAAMPCWAIGQSVTTIVSQN
IGAEKIINVKKTVKAGIIYTLISSFLLIVLIQIFSYEIIELFNKDINIIKEGIIYLRICC
SINFVAYGIMYTLDSFMTGLGDSFIAMLNSILQSVIIRILFSIILIHYFNLGYIGIYIAE
FLSPILPGIFGIIYYLHFIKLNKAKEKEIE
>fig|445971.6.peg.223 Permease of the drug/metabolite transporter (DMT) superfamily
MSNNKKIMPYITGFLYSFIFGISFAFTSEVLTVLHPLQLPAVRFLFAALFITLLYFFGAF
KLNYKGKDLKLLILLAMFEPLLYFIFETYGVKLTTSSLSGTMIATIPVVVCILAVIFLRE
RPSFLQWVFIVLSVIGSVIVVTGSGSSGGTSETIGILCLLGAVISGAGYNIMNKIVCEKF
TAIEVTFFMMWFAAISFGIISIFYSKGFGGYIAAFTNVKVLLILMYLGTVSSVLAFFCYN
FTLHNLPIAPAAAFANLITVISVIAGVFVRKEPFTLIQMLGAAIIVAGVFGVNLLGKDED
NGGKSFETDS
>fig|445971.6.peg.230 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKDMTKGNIFKILIMFSLPLILSGILQQLYTIVDSVIVGNVVGENSLAAIGATNGITFLI
PNLLMGFTTGVSILVSNYYGGDKKEFIPKITASFVITLTIIFTLVSGVCAVFTEGIACLL
NTPSNIMDLTVSYLRILFLGVPFLTVYNIYSALFRGIGDSRNPFIAIVIAAFTNVVLDLI
FVINFHMGVSGAAIATITAQCFSAVYLVIVAVIKYKLLHFKLSFKSVNSNMLRAGFSLGL
PVALQSSIVSFGSLLLQNIMNGFGSNVVADITTAYKVDSLSLLPVINVSSALSTFTAQNV
GAKNRERVEKGFKVGAIIILPVSILTALIVVLGGSSFLYMFGVSDEVCYIGKTFLYTCSI
FYIFFALHNLFVGFLQGTGSVVITAMSNVISLFVRLVLSYIFASVFGFRIIAYSEIISWI
VGALIVFVYYKKKTWLKRVEISGVK
>fig|445971.6.peg.258 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNSISKEFNLSSLIKFSLPTIIMMLFMALYTIVDGVFVSRIVGINGLSAINIIEPLMNL
FFGAAIMFGTGGSAIIGRKIGEKKDDEANGDLSLIVLTVFIISAVMSVISLLFLDKIIYF
LGASDVLFKYCYDYLKICLTFIPLLMFQLVFSSLFVTAGKPALGLAFTIIAGITNIFLDY
IFMVPMDMGISGAALGTTIGYMIPSAAGLIFFIFNKKGLHFGKIDKNLKVLTKCMTNGAS
EMVGHVSMCITNWMFNVTLMRMLGEQGVAAISLLLYAQFLFNSMYMGFSSGVAPIISYNF
GSENKLQLQRIFKNSIKIIMVSTVTIFVMSLVFAQDVVSIFIPKSSDTYGLAIRAYLLFS
VTFLFSGFNIFASSMFTALSNGKISALISFMRTFVFIAGAIILLPLIIGVDGLWLAIPIA
EVLALIISIICIVKQKDRYNYIN
>fig|445971.6.peg.561 Glycopeptide antibiotics resistance protein
MTLVPYMGEYTYERNYNLIPFASIKSYFESLRYNGFFSGGQPSMVAFINLFGNIGLLLPY
GFLLPLAFPGKITFKKTVFTAFLMTTFIEVSQFLFLVSRRADIDDVIFNTLSAVIGYILY
FIICHRHYKYYKKHKPNGKYFS
>fig|445971.6.peg.1507 Permease of the drug/metabolite transporter (DMT) superfamily
MKINIKNKSLCADFFLLVMAFIWGSGFIVTKNGLDALSGTQLIFTRFIIAAVTLFIINFK
KLNLITKKTIMKSAVIGFVLFLGFTFQTYGLVQTSAGKSAFLTAVYVAIVPFITMFVGKQ
KPEKHNFIAALMMIIGIFLLTMNPREGLNINYYDGITLIGSIFWAFHVFFVGIFSKDEDP
IILCMMQMAFAGLFAFILLIFNGELFTFDITGSIVPMLLYLGVIASAIAFLIQNVAQKYT
TPTHAGILMSMESVFGTILGIIFLKEIFTIQMLFGAVIIFTALILAETKFAFLKREKVKI
ETEDV
>fig|445971.6.peg.1786 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNDNILDQKWSAGSLLRFAFPTIVMMIFMGLYTIVDTIFVAQFVNTDALSSINIVCPIIN
ITVGLATMIATGGNAIVSRKMGAGKNQEAKEDFTLLILTGAVIGFLILLGGTIWIDNIIY
ALGASDLLFPYCKDYLMVLFLFIPANILQTLFSNLFVTAGKPGLGFGLSVLAGVANIVFD
YIFIVPCGLGIRGAALGTGLGYLIPTVAGLVYFARSKGTLSFTRPKLKWAVIGESCFNGS
SEMVGQLATAVTTFLFNRTMMKLLGENGVAAITIIIYSQFLLNTLYIGYSMGIAPIIGFN
YGNRNHIQQKKVLSISMRFIGLASILIFAVSMFGGSYIVRLFADDTSEVYQIAANGFAIF
SYSFLFCGLNNFTSAMFTALSNGKVSAVLSFLRTFGLLAGGILLLPRIWGITGVWLAVPV
AEGIMFVVSAICLIHYRKKYSY
>fig|445972.6.peg.159 Permease of the drug/metabolite transporter (DMT) superfamily
MKRERLYIILALVTICFWGTTFVSTKILLGVLSPIHIMLLRYVIAYVSLLAIHPKIHRPE
SLSLEFRYVAAALFGSTLYFLAENFALSFTQAANVSLLISAAPILTSVVAHLTTRDEHLT
RNAVGGFFVAMTGIALVVFNGSFVLKLSPKGDLLAVAAALSWAFYSVILRGIRSSYPPVY
VTRRIFFYSILTMLPCLLFDAAPFDMAVLKEPLILGNLLFLGLIASSLCYVLWNYVVAGL
GAVRSNNFVYLNPLITMIASVIVLHERITPLMIAGAILILLGVIVSEGTLLKRQDTAAQR
>fig|445972.6.peg.662 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTKDLTCGAPAPLLFKFSIPVILGNLFQLFYTLADTVIVGRTLGPEALAAVGATGTIIYF
ILCFVQGLTSGFAILLAQYFGAGDEKNVRRCVGISTLLSLFFSIVITAVICILARPVLAV
MDTPGDIFELAYDYMIVIFYGAFTTIFYNLISNILRALGDSRTPLYFLVFSSLLNIVLDI
VFIVPLDMGVGGAAWATNLSQLLAAVFCAAYAVQRFDAMRLKRSDWNLDRFLVLQHLKIG
FPMGFQMSVMCIGQMAMQAAVNAIGTNAVAGYTAATKVDQMSVLVNNAFGVTLSTYVAQN
YGAGKIDRIKRGFNACFLMTECANLLMGALILLIEPVIVPLFVDSPGLEILSFARTYFLV
VIPFYPVLGALLCYRTAVQSMGNPKAPFLACVIELVLRVVCALLLSRFWGYPGICFSTPM
AWIGATALLIPVYYAMLRRLLNIQPPQCEN
>fig|445972.6.peg.1074 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRQDGRFLHGVFSRFLFPTVLSVLGGTVNVMVDSAIVGNMMGAQALAAINLCGPIFLLCS
TAGSLIGSGAGLLAAAQIGRGESERSCVCYTLCVALQFLFGFLLTIGGLLFLRPVVRLLG
ADDTLFAMALSYARIAFWGAPVKCLLYVPFNFLRLDGKPAMVSVSLLAMTALNGVLDYLL
IKVGWGLAGASLASVLATCLGVAVGFVCLHGGSFRLIVPHGGASILRELLVLGTPPALNN
LLSVVRMILLNRILMAAGGSGFVAIFTVVGSVSDFTLCVISGVPQTASPLVGIYSSERNN
PGMRLLVRMQLCYGGVLIGGMAAAIILAPGLICTLFGLTQTAQAVWALRLFALSLPMAML
CSILIFFYNASGQVPLANGVTVCRVLLFAVIPAFVLSRAGFPVWWFFPLSELLTLAALFV
ALWRKARPDTLRSPILLLDEAYDRMGKVIDFSVEARADAVGRAAELIGGFCEQNNLTARQ
TMAVSLSIEEMLTIMMKHCFKEQSQATVDVRVFVIQGEVGLRIRNAGKQFNPIDYYQAHQ
AADEMGEALGIRMILKLAQSVCYQRTFGVNTLTILL
>fig|445972.6.peg.1397 Phosphotransferase (aminonucleoside antibiotic resistance)
MINYLHKYPVEVVVLCPDVETIKERERYREKTGYSGFTVETLYDTFMQTTPRIGFWLDNS
NQTPQQTAETILNTRKPV
>fig|445972.6.peg.1450 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVKQFFKQVLPAMAAFAFSGLYTIVDGFFIGRSVGDVGLAAVNIAYPLSALLQAAGTGIG
MGAAVCISVCRGRGDTRGERGHLGGAFLLLAAAGVLLAVSLFSFGTPALAALGARGEVLE
QAIVYLRVILLGIPFQLAATALAPLIRNYDGALAAMGAMIAGFVTNIVLDALFVSVFGWG
MAGAAGATVIGQIVTAVPCAFYLWRVTFRIGSGPVRPAGHMCGSILRTAVSPFGLAMSPL
FVIMLLNKAASVYGGESSVAAYAVISYATAVVMLLLQGVGDGSQPQMSLYFGMDRPERTK
AVRNLAYAFAAVTAVANIVALCLLRAAIPVFFGASGEAAAMAAKAMPVFTIGFIPIAFCR
VTTAYFYATQHNRPAYVMVYGEAVLLALLLAFVLPRMIGMDGVWISLPVAQILLMLIGCG
LLWRSRRNRVKDSGKVSNETVCDTPAL
>fig|445972.6.peg.1513 Methicillin resistance factor
MEILTPEQYGEFEAFVSAHPQGCFTQSVNWQKVKNNWGYEAVVSRTADGTIQGAVSVLVQ
KIPLIGTSFLYAPRGPVCDPHDRAVLADLKAGVDALAKKYRAHAFKMDPDVLMSDAEFIR
IAKDMGFVQSYGPDGFEGIQARFNYRLYLNGRTEDELFANLTQGTRRKVRIAIKNDVQVR
PVGPEYLDEFVRIMRVTGARDGFNVRPRAYFERMLDALGEHVRLYMGFYQGTPVCGAVTT
NYAGKCCYVYGASDNVHRDVMPNYLMQWEMIKWAVQTGCEVYDFQGVSGDLEGGHMAGLY
QFKRGFNGQLDELAGEFDYTYKPIKAKLVDRAIDLNGKLGQLKKKLRRS
>fig|445972.6.peg.2287 Permease of the drug/metabolite transporter (DMT) superfamily
MANKLGSTSMHPLMVGAVRFTVTTLLIALAAAARGVPLRITRRDWKTLGTGSFLMYFLNT
LLVLFAAVRVDASISTIVLCLIPVGLVLVDSLAQRHFDVGPPGVIGMAGGFAGVVIASAS
GLLGGGADIGGITLLLASVCVWSVGTIYLKNRTVEAPFILQIFVQSAVPAAAFLLTALFT
GTLRPSTLNLGGVLPAVYMGVADSIIGLGSYMYLLKRWPTSVVSTYAYINPIVGLMMSHL
VLHESMNAQKMAGAAVILFSVLLIREDGRLTAWLRARRRAKAG
>fig|445972.6.peg.3588 Glyoxalase/bleomycin resistance protein/dioxygenase
MRIKGIDHVTINLKDVARSLWFYGELLGFERLPDVDMGDHLLRYFALPGGGRLELTEYRY
ETADCGNTATDKGRARHLAFEVEDVYALEKKLTDAGYLFHVPVSHVEKLGFSGGLTRDPN
GFELEFLQYD
>fig|445972.6.peg.3789 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTGKNAARAQRAEIRSEYFRYLVPTIIGQVAHCCYCLADVFFVGLGVGKDGLAALNVALP
IFTVYTTFSIMVGVGAATTISVCRGRGEDENVDRVFTMAVVTVLILGALLSVFGTLFLRE
IAYLFGATDLIVGHVVGYLAPISPFSFIYMLSSAMCVIVRSDGNPRLVMVAATTGNILNI
VLDYVFVLPLGMGTFGAGLATIIGPVVTCLLLSMHFLRHYNQVHFTRRFFSPRLFARMVR
NGAGSGVLETSSGFVILMFNLTLLRVSGETAVAIFSIISNIGYVGKGIFNGMAQAAQPII
SISYGSGTYSRMKTVNRFAMLTALSFSLVVFGLIVLFPGQIITLFISSDAQIIAMGAPAV
VLYFLSLPFTGLNTILMYYFQSTEHARITALVAVLRGIVLVYAALRIFSSLWGLTGVWLA
LFAAEALTFLAFYPVKLHLDARLSDGKIV
>fig|445973.7.peg.607 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKTNQNQMGTKPIASLIFTMGCPPIVSMFVQSMYNIVDSIFVAKLGENALTAVSLAAPI
QYILLAVSVGVGVGINSYISRNLGADNIDEANNTVTHSMILALAHSVLFIILGLLFIKPF
FRIYANNDAIFSDGCSYTYIVVLLSFSLFFQLTFEKVFQATGKMLLPTISQIIGAILNII
LDPIFIFGWFGMPKLGVTGAAIATVIGQIVSFLILLIFFIRNDSVLKIDLKLFKFDWNII
KQIYAVGIPSALMISISSILTISLNSVLVKFSNTAVSIYGIYYRLQTFITMPVNGLVQGI
RPIIGFNYGAKDRGRIIETLKISLIVSVVLMLIGLLLFMFIPRQLLSMFSASENMMSLGV
VTLRIMSLGFLFSAISFIISAMYESIGKGTYSLAISLVRQCIIIIPVSMFFYKIIGLTGI
WITFPVSEIAAALVCLWMFIRTCKKDEVFIKNND
>fig|445973.7.peg.770 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQKKINLTEGGIVEKLVKIAIPIMATSFIQIAYNLIDMMWVGKNGSNSVAAVGTAGFYPW
LAMAFVMFSKIGGEVKVAQSMGEKNIKEVKSYIKSSIELNVFLSVTYSLILILFNKQLID
IFNLGNAEVISMSRQYLVILGLGMIFYFINPVFTSIFIGLGNSSIPFRINTIGLIANIIL
DPLLIFGFGPIPALGTNGAGIATISAQIVVSFVFIGYIIKNRIEYFKVTYFRKIEFKYFK
ILYKLGFPVAIQNALFTLISMAMGVIVASFGPVAVAVQKVGSQIESISWMSADGFASALS
TFTGQNYGAYKFDRIDKGSKIGLIGAIIWGSITTVVLVFFGEIIFRAFINEQDAIIKGID
YLRILGYSQLFMCIEITITGILKGLGRTYIPSFISIALNLARIPMAIVLSKPDILGINGI
WWSIAISSIFKGLVLLLIFAILYKAKKLYKIEEGKKDLNKDKELCS
>fig|445973.7.peg.802 Multidrug resistance ABC transporter ATP-binding and permease protein
MTKLFKYLKQSWVAIFTILILLALQATTELSLPTYTSNIVNVGIQQSGIENATIKAIRES
EMNKLTTFMNDSDKEKVLDNYKLVNKDNLSKEEFNNYKKEYPVIKKEIFICIIN
>fig|445973.7.peg.883 Permease of the drug/metabolite transporter (DMT) superfamily
MKNNKELLYKLCLIVCSIIWGSTFVVIKDATNTMSSGFINASRFTIAAVILLAVYFKKIK
NINKSELKHGIIMGVALFGGYYLQVLGMEYGSTAGKCAFLSATFCVMVPFLSWGVFKKVP
DKYSVIAAILCIIGVALVSIENGAHITVGDGIILISAFFYAVNIMFTSEFSTRENNDTII
LAFLQIAVVGILSWIVVLIKGEMPQVYHARAVMGVVYLGIFATALCLLMQVIGLKHINST
SASIILSLESVFGVMISIAFYNEVVTPKLMAGFVVIFIGIIVCETKLNFLKQKISIKKSI
TGNYKNNNNSKHLDANESAL
>fig|445973.7.peg.933 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKLNLLRDKESKVFFHYLIPAICSTLVTSVYLLVDTLIIGQGVGALGISALNIFMPFFL
IFNGLGLLFGIGSGILISAEDGMGNKKKSNQYFITGLVSVVSLALVLSLIWNHYLESLCI
FLGANDDTIGLVLEYGKCIMMFAPVFIMSNYLAPIIRNMKNPKLVMCGVLTGSFLNIILD
YVFVFPMDMGMFGAALATVIGSVTTVLVLSTHFIKKQNRVKINKETISLKLVTPILKCGF
SSLIMEVANGFVIFIFNIQILKYIGNNGIVVYGIISNCVLVGLALFNGVAQAAQPIIATN
FGAKESSRVKKVLKYAMITTTIIGISLFAVVFLFTGQVIQIFVKANAEILSVGIPALRLY
LSAFCIMNINILISGYFQSVGKEKIAIYVSIVRGFLLNIILAFVLPSVLPATILWAIVPL
SELITLIGIAFYAKNSSTIENTALNEEFISA
>fig|445973.7.peg.940 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTNDMTKGNPLKIFIYFTIPLLIGNIFQQLYSMVDTIIVGRFVGVNALAALGACNSLFFL
VNGLVLGLTSGFAVLVAQKFGAKDEKGVKKAVASNITLTIVLTVIITIVALLAVKPLLNM
MNTPENIYEDARVYITLIYAGIITQTGYNMAAGILRALGDSKTPLYFLIVASILNVILDL
IFIINFNMGVAGAAYATNIAQGVSAVLCFIYSYKKFKILRLKKEDFKVEKEYYTTHLKIA
IPMSMQFSVTAVGIIIIQSAINTFGSVVIASYTAASKVLQLVMQPSTSFGVTVATYAGQN
LGAGRFDRIKHGIKIMNIVSIITSLIAGVVLVTLGKYFVMLFIENPTPEIFAYAQQVLNY
SAIFFIPLGFIFVYRNVLQGMGESFVPMMAGFFELAARATVAFTLPKVIGFTGICLSDPI
AWISACVPLMLTYYIKMKKIDKKNKLNEEINNPAGVL
>fig|445973.7.peg.1036 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAVTQMTKGSISKQLILFSIPILISNLFQQLYNTVDTAIVGRFVGANALAAVGTCNLVVV
FMIYFFIGLSNGSSIVLSQCFGENDEEKVFKTVHTTMGLSFISGIVLMIVGLLCAETILK
MINTPDDVIGYAVTYIRVYFLSMIPMMIYNMGTGILRAMGDSKTPLYYLGAAGILNIILD
LVFIIVFNMGVMGAALATTLSQTLSAILILIKLISSNEVYKLHISKIKIDKDILKHILVI
GVPTGLQSVLVCFSNIIVQSKVNLFGLDVMAALTVYYKIEGFIYMPIEALAMAASNFIGQ
NIGARNVERVKKGKSLSMKICVGMTVLIGGLIMIFKTPILHVFTTDSEVVKYGSQFIMFI
VPLYFIYAMNQILSGVLRGAGKTFVPMLIGLVCMCGFRVGWLVVMMGIVKDVRIIYASYP
LTWILTNIAMTAYYYKSSWIKKRH
>fig|445973.7.peg.1099 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEQTYDLTQGNIKRQLIYLSIPLLIGSIFQQFYNTIDSIIVGTYVGHDAFAAIGISGTVM
NLFIFIIIGCCTGVSIITAQLYGEKNYDKMRNEIFLSSILGIAVTIIISILGILFMPIIL
NIIQTPVELTGYVTQYMNVILGGLITTFLYNFLSSILRSVGNTRMSLIFLVISIFLNVIL
DLLLIKQFSMGIMGAALATVISQAVSALLCYFYIIYKIPFLKVKKIDMKYNSGLIRLTCQ
YSFVSALHQSSLYIGKLLVQGAVNSLGVDAISAYTATGRIEDVILAFGNSGSEATSIFIA
QNTGAKNQKRVLEGFKDALVLIQLVCIGLILFIFFRSDILLNFFVFDEGKTVLNYGVQYF
RILSFFYIISLVGSIFVGFYRGTGHVNIPVIGTTLQISIRVILSYLLVKFMGIGGVALAT
GIGWIGIVTFQISVFVIKKYYKVKEEEE
>fig|445973.7.peg.1214 Vancomycin B-type resistance protein VanW
MQDINLSDLTKEEATKKINSYIEQNNEFELFYNNESILVNKETLGVDYKVDELVDRAYSI
GRDKDLITDMKTKISLKKGEKKIIPLTCSYNIKKVDNLIDKIYSKLYISPKDASAKIVNG
NIVVYEEHKGQAVDKENLKDIIVYKIENLDSSQSEIPLDVLNPKYTYDQLMKIDTLLGSY
ETYFNPKRKNRVNNITVAAKSTSDILVNTNEKFSFNQQLRDNDAYNKLKVASIILNGKHD
KGVGGGICQVSTTIYNAALYAGMDIVKITNHSIPSPYVTKGRDATVSNGSMDFVFKNNNN
NPIIVHNEIFENKIVSKIYGCSSDKRNIEIETEIVETIKNKKIYKSDSKLQKGTKVVEQE
GRLGYTVNTFRLYKSNNEILKKELVNTSYYPPCDEIILKGTKDNTLYK
>fig|445973.7.peg.1227 Erythromycin resistance protein( EC:2.1.1.48 )
MKAKSNNYRGKVDISVSQNFITSKNTIYKLIKKTNISKNDFVIEIGPGKGHITEALCEKS
YWVTAIELDRSLYGNLINKFKSKNNVTLINKDFLNWKLPKKREYKVFSNIPFYITTKIIK
KLLLEELNSPTDMWLVMEKGSAKRFMGIPRESKLSLLLKTKFDIKIVHYFNREDFHPMPS
VDCVLVYFKRKYKYDISKDEWNEYTSFISKSINNLRDVFTKNQIHAVIKYLGINLNNISE
VSYNDWIQLFRYKQKID
>fig|445973.7.peg.1251 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MANENKILEEEKISKLLLKFSVPCIMGLLISAFYNIVDQIFIGNSTLGYLGNAATGVSFP
VICIANAFAWCVGDGAASYLSICAGRKDTDSAHKSVGTGITVTLLISIVLMLICEIAAVP
LMNLFGASDQTLGLSVTYFRIVAAFFPFYLLLNVMNSMIRADGSPAFAMKAMVMGAIINI
ILDPIFIFLLKWGIAGAAWATAIGQVVSFAMCAVYFFKPKSFKLKKSSFIPNITILSKMI
NLGAATFITQISIVAVTLVSNMTLARYGALSKYGPDIPISVFSIQTKVYTIVLNIVTGIV
LGGQPIFGYNYGAKRMDRVREAYKIVLRATLITGITATIIFQLWPKAVVGIFGSGNGLYQ
EFAVKTFRIYLSLMTVTCLVKMTAVFFQSIGKSKYAVMASVIRDIICFAPLAIILPAILE
GSESGTGINGILYAAPISDLVAIAVIFVLTISFFRKLNKEIVIEEQKELAS
>fig|445973.7.peg.1278 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNTLQNRITFTSLIKYTLPTIIMMICFSLYTIIDGMFISRFVGADALSASNIVYPIIFL
VLGVGTMFATGGSAIVARKLGENNVDEARENFTLITLGALMVGMIIEIITIIFMKKIIYL
LGSTDALYFYCKEYLLYMILFTPFIILKFFFDYFLVTAGAAKLGLFSGLLGGVVNIILDY
VFMVNINMGIKGAALATCIGYIVPSFIGIFYFLNKKHTLHFVKPKLTLNVLANCCSNGYS
EMITQISNCVTTFVYNVVLMKLLGADGVASITIILYIQMLLNAAYMGFISGVQPRISFNY
GSKNSEQLKNIIKYSLMIIYIFALFTFSLSRQNANFLISIFTSKESSLFGITHNAFMIFS
FGFLFNGINIFTSGMFTAFSNGKVSAIISSLRTFIFFIIGMMIFPNLFGVNGVWMVVPFA
EIITLIVSLVYIYKYRKEYMYENIFTKESVAV
>fig|445973.7.peg.1290 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQAKCQVDMTYGDIPKQLFMFTIPILLSQILQQFYNIADTAIIGQYVGTDALAAIGSTGL
LIAVIVNFFIGLSTGVSAVIANQFGAHEYEKLRKSIATSLLISIVLGIVFTIGSLIFMKS
IINLLQTPKDVYYLAVDYLKICFLGITFQLLYNIGTAILRALGNTKDPLYFLVFSCVLNL
ILDILFIVYFGWGVKGAAIATLVSQILAALLVLWKIMHLDDECRINLKQIGIYKGYIEDI
FLVGIPAGLQAIFMSISSLIIQSSINSFGAEAMAGMTVFGKVEGFLYFPLFSLGLAVTGF
VGQNFGAKEYERVKEGINISLKLSVYISIIFIIILNIFAPYILRLFTHDLQVIKVGLESI
RIVFPSYVFYAINQIYIGSLRGIEKTFEPMIIALFAHCIFRVVWCSVLLKYFHDMKVIYS
SYSVSILIMFALLYFSYKKHICKKYFKQEVSNID
>fig|445973.7.peg.1429 Vancomycin B-type resistance protein VanW
MSEDTAVKQKGDFKSKRNIILIILIVIIIVFVGILNYFTSKNLYNGKIAQNIYIEDVNVS
NMTKQEALETIDAKYPTKKVNLSYNNEYYTIEPNQVDLSYDTKDVVDSAYNLTRENSYFS
NIVTYISTKFKGHDFSIKVSYDEDKLDKKISSISKQINKSSVDASISVTSGIYVKESQTG
LKCDDKENKKLIEKAYKDKNYETIALKVDVTQPKIKTEDLKSIDSVLAGYSTTFNSSIYG
RSYNIALALKRCSTVVMPGETFSYNKATGPRTISNGFQNASVIVSGTYQDAPGGGVCQGS
TTLFNAALLSGLDITQVRNHSKTSSYVPRGRDAMVNDSDSDFKFTNNFNHPVYISAYAGG
GQASVKIYGSSQDKVSVSIKTDNFIYNGLPGAKTYRTITKNGKSETKHIYTAVYQE
>fig|445973.7.peg.1504 Permease of the drug/metabolite transporter (DMT) superfamily
MFSKYKGEIGLGLTALIWGSGFIGVSISLSGGLTPLQIMTIRFFIGAVLLGIIFFKEIKN
NITKEAVKAGSMIGVFLFIAFAFQTIGMSYTTASKNAFLTAINVVIVPFIGFVLYKRPLD
KYGIISSIIAILGIRILSLEADFSINFGDFLTIICAFGFAFHIFFTGEFVKKHNAIVLTV
VQFSVATVLSLIVQILFNEIKIEVQISSIIGVLYLGIFSTTVAFLLQTVCQKDVSETKSA
IILSLESVFGSILSVIILHEVLTFRMVVGCLVIFCAIIISETKLSFLKKDKLKEEKTNSM
N
>fig|445973.7.peg.1505 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENYMTEGNAAKSIAYFSIPLVLSSVFQQLYNLVDSIIVGNYVGEDALAAVGASYSITMV
FISIAIGSGIGCAVVISQYYGAKMIHKMKTSIYTSIIAIAILSVFLACIGWIMSDFLLQI
MKTPDNIFYDALSYLKIYFLGLTFMFLYNIITSIFNALGESKIPLYFLIFSSFLNILLDL
IFVVKLQYGVVGVAIATLIAQGISAFLSITYLLFNLKKFKTEDEVAIDLGLNNKSAKVKT
NKKENINKRKDSKDIKLFDFAILKNMNKIAIPSIFQQSFVYISIFLVQIIVNTFGSSIIA
GYTIATKIDSITMIPLASFGNAVGTFTAQNIGAKKIERVKEGLKSSLIIITLMSLAIFAV
LFIFGQNIIELFLNKSQSEDAIDFALKYLRIVSGFYIVKGFMNAYTGVLKGAGDIGVFVL
STMLNFLVRLIIVYVFANTIGVSVIYYGVPIGWFVGLLIGYIRYKSEKWKFKSIVK
>fig|445973.7.peg.1527 Vancomycin B-type resistance protein VanW
MYKRIISVILIFIIMICCLGNNKANNNKQEKIYKNIYIEDIDMSNMTKKECIDILKEAYP
LEDINLKYEGKTWTIHPKDIDFRYKIEEATDIAMKYTKTDKRLENLKRKSKLILNERHHI
PLDEEYDKEKLSAVIDCISNQIDREYVNATLAIEKDGTFKRLPSKEGKKVQKDELQKEID
ELIQNKNITDLNIPVKTTLPTLNSDDVQSVNSILGQFSTAFNNHTSRGSNIHTAGESSGD
IILMPQEIYSYNKATGPRVLSKGYKYAPVIIGGKYRNGEGGGVCQVSTTIYNAALLAGLE
IVEVHNHTYISHYVSGGRDATVAYGYYDLKFKNPYSHPIYIKNIVGDGAITTKIYGCKDD
IKRIYVRTEYEYKKQKIIVKTYRVYLDQNNQKIKEELISTNKYDQK
>fig|445973.7.peg.1907 Permease of the drug/metabolite transporter (DMT) superfamily
MEEKLSTEQNKNFFQKNINIVICSIFCTALWGSAFPCVKLGYELFNIGVDDTFSKILFAG
WRFFLAGILVLLIATCMQKKFPKLKKESVKGIALLGFVETTLEYVFFYIGLSYASGFKGA
ILNPTSTFMMVILAHFFYKDDRLNFRKSLGCIVGFLGIIIVNLTGDIDSSFSFLGEGCLL
ISALAFALGSIISKEVTKVEDNPMTVTGYQLSIGGIILIALGFIGGARLHVTSTSAMLLF
LYLALLSSIAFSLWTTLFKYNPVSKVSIFNFLTPIFGTILSALILSEDVFNLRNLVALIL
VCLGIYIVNKPKEKETSIN
>fig|445973.7.peg.1934 Vancomycin B-type resistance protein VanW
MTGLGVYCINGDKISKNVYVQNINIGDLTKDEAKDKLSSEYKIQSFKFNYKEKTWDIDPK
TLDINYDLDKTINKAYDVNRKGNIIQNIFKSLQNLAGIKTKVNLVMNCDEDKLKSELEKI
SKEVNKDSKDATIKIEKKKVKVVKEETGLKLDIEKTKENFIEDINKGKSTQKLVVSQIKP
KIKSSDLKGIDTLLGSYSTTLYDSGYGRVQNIKLATKKTSDVILMPGETFSYNKHTGVRS
AENGYKLAHVISSGKVAYGIGGGVCQVSSTLFNAVLYSGLDIVSRTNHSIPSTYVDLGRD
ATVSDSGIDFVFKNNYKHPVFIKNNYKDGVIKCQIFGHKSDKKNIEISTKYGYNITTYRT
YYDNNKKEIKKEAVCTSAYLSRSH
>fig|445973.7.peg.2269 Regulatory protein, MerR:TipAS antibiotic-recognition
MKDLTFNISETSRITGLSIDTLRYYDKIDLIKSKKNPNNRYRYYTIEDISIISHIKNLRD
LDLSICDIKSLLHSDPEVQRQILKNHHKVLLEKVATIKKIEKVFKDTLKEVNSSDLMINV
PVIKSYTDRYFKKLKNNVKTNKCSISKKNLLDTSTNFLDILDKFVFSFSDKNFDSTNLFD
FFEYGKVSENQEYYTEISHEEFEVMEDTKDILVVPHSNYIETITKLSKDNFDEYFENLIG
WIDFKNLNPIYPGFIKYLDTSLYFMNEGECLVQFQIPFKHKKYE
>fig|446462.8.peg.4399 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRESAEALGTAPVGRLLWRACSQTTLSVGVYGIYALTNAWFVARGVGAEAMAAVNLVAPV
LLVLGAVSTTVGAGGASLVSRALGAGDAATAGRAAGNAFTVFWGAAVVVTALGLLGVEPL
LTALGARDGAREVAREYAVVILAGSVLSTGFSSLVRAEGRLRFSTLLWLAPVLVQISLDP
VLIFGFDLGVRGAALGTVGGQAVSALLSLWFFFVQRERPYRVRAADLLPHGPTVRALLGI
GAPSFLAGFGTTLLAVLVNTALAGAGAAALAAYAVAARVQTFATMPLVGIGQGLQPVVGY
NAGRGLHARVVRAKDLALRVAVGYGLVASALVVVFAGPLVSVFLDDPAVAGQAATALRFV
AVGFAAAGITPLVAGYAQSLGATRQAWALAVGTLALVRAPLVVVLGGGGTTGVWVALAAG
EVGSALCALVVLRRLRPGGVSAG
>fig|446462.8.peg.5925 Drug resistance transporter, Bcr/CflA family
MGVTAVQGRGKLVALLGVLCCLGPLSIDAYLPAFPDMAKEFGAGESQIQLSLTTFIIGLS
VGQLLIGPLSDSIGRRKPLLFGIGSYVVLSLVCAMAPSAVALAAFRLLQGLGVAAGFVVA
MAVARDRFSGLAMAKFMSLIMLVNGLGPMLAPVLGGQVLRYASWRATFVVLAVIAVVLLV
LMAVGLKETLPPEKRRPLDLGGTLRVFGGLLTDRVFVGYVLASAFALGAIFGYVSGSSFV
LQGVFGLSPQEFSLVFALNSAGIFVAGVINTALTGRIMPRGLLRIGLSTAVLAGVALVVA
GALGGGLVAFLVPLFLVTCSIGLLMPNAATLAMARHPEAAGSSSALLGVSQFLMGGLMAP
VVGAGGSTSVLPLALVMAACTALALTSFLVLTRGDKGITKDEPEVVEAEQTPAASAV
>fig|446466.7.peg.991 Vancomycin B-type resistance protein VanW
MRAHEQLGGSIMHGTDRDTPTGGADRDSADVPRGGVPQPHDAPEATVPEPPTSDATTDGS
TGTDAPAADADGTAEATDAPAADAATQDAPAGADAVDAPVTTGEDGPRGSTPPPAVPPPV
TRARPLAPEPAAPLAAWPSWDDVAVTAPPPEPAPPAAGSAEPAAPEPAAEPSATQASDAG
QEPTAQAPARPGRADERADEPEAPAAGPRSGSVPTGTASAGTASAAPAPVPGAPGPLPPL
DLGSLSALAFTALNAASVGVPAHALPKDAPARPGDADADGPDGAAAAGPEASGPAADTEG
SATENEAAAAPDDATDASAQAAGEQGLAGDAAPGAGSATGAPTPVDVERVAAEPVDAEPV
AAEPVDAEPAAERADEVEAVPSVPRTDDTAVVPPTPRPDETTVLPAAGTDVATRATPAAP
TVPPRRTSALAAPQAPAEPVAPAGPEPDDASPLAVFEPEESDRRWPRALAITGGALALLA
AVYVGSSFALADRVPRGATVAGVEIGGLSSAQAEQHLRDELAERTTSPVAVVAQEVQAEV
DPVAAGLELDAAATVARLTGVDLAQPARVWRHVVGVGEQRPVTVADESALDTALTQLSGS
LVLAPVDGTVVFADGAAHSTDAVDGWELDTAGAAAVLEDGWLTAEQPVELPTSAVPPAVT
QEETDRALAELAQPLAAAPVTVQVADRQAVLDVATLTAHAAVVPVDGQLQLQLDGEALSQ
SVLAQLPDLLTSASDARFEFQGGAPVIVPGTPGTTLDPATLSASVAQAATAGEGRLAAVD
LVESDPAETTAALEALGVKEIVSEFSTPLTSEPRRTSNIATGLRNITGTLVRPGEVFSLT
EALGPVDAAHGFVQAGAIVNGEHTDAWGGGLSQVSTTAFNAGYFAGYEDVEHKPHSEWFQ
RYPEGREATIFTGVLDMRWRNNTPYGALVQGFVADGRAHVRIWSTKHFTVETEKSGRSGV
VAPTTVYSQSPTCEPQSAGNPGFTVTNTRKVYLNGELVATEPFTWRYKPQNKVICGTAPA
PGASPTP
>fig|446466.7.peg.1045 Multidrug resistance transporter, MFS superfamily
MAGMHEPDPTADARSDAPVPDALSATDATPRSRAPVTSRVPATPDAPAPSDARAPAPAGD
PVHRPDARHVLLLGTMCALPAISTDIYLPSLPEVAQDLGTSAAAVQLTMTGMLVGGAVGQ
LVIGPLSDRFGRRAPVLVGVALHVLVSLLCAVAPAIVPLVALRVAQGFFNASATVVAMAV
IRDRFTGADASRLMSRLMLVIGAAPLFAPSLGGLIAGQWGWRAVFVVLAAFGVVLWLIVL
RRLPETLPPARRRPGGVRTALSGYLALLRDRHFVALAVLPGLTMAVLMTYVVASPFVLRV
GYGLTEQQFALLFAVNGIGLVLGAQVNAAVVRRVAPVRILRVALVATVVLTGVLLGVALT
GVGGVWSLVAVLWLVLALVNFAPPNATALALGRHGAMAGTAAAFIGSLQAGTGGLVANVS
GLLGGGAVAMAAVMLASSTVALAVLALATPAFWRGGAWQAS
>fig|446468.6.peg.1311 Glyoxalase/bleomycin resistance protein/dioxygenase
MFDTTRAFGSFAVRDPDRAREFYGTTLGLTVGPVEGMEEHGLLSIDLGEGRAVLVYPKPD
HEPAGFTVLNLPVDDIDAVVDELARRGVGTLRYEGFDQDGKGISRGVPTVAWFADPFGNV
CSVIQEA
>fig|446468.6.peg.1329 Glyoxalase/bleomycin resistance protein/dioxygenase
MYVKFAELPVFDQERAKAFYTDRLGCTVVTDAPMSDDGWRWIELGFPGSRTHLHFQRRAD
EDPSAEPVMVLVTEDVEGTVEALRAEGVEIVTEPQEAMWQPGVTAAEFRDSEGNRMVLSD
S
>fig|446468.6.peg.4421 Small multidrug resistance protein, SMR family
MAWFFLVATVVTEVLGAFATRASDGFTAPVPTVLAVVSVVAAYYLFSLALRHGMPVGVAY
GLWTALGVAAVAALGVALLGEALTWPRVGGLLLVTVGTAFLQMGGREEGERAAAGPTPGP
GE
>fig|446468.6.peg.4956 Phosphotransferase (aminonucleoside antibiotic resistance)
MAPLVAARYPRAAHISGDVLSYMVVQGRVGFNGRPAEEARRQLRLCVRNMCDLAANFADN
GVFPVVEYTIDNRRMLDAMVEMLRPRPVMFVALFPPLEVCRRRNATRDPGHRVDFDFAPH
YRAMREDLGGVGWWLDTAALTPEETADLIRARAHEEALL
>fig|446468.6.peg.5195 Glyoxalase/bleomycin resistance protein/dioxygenase
MRPSRESSVRLHYGSSGCGRSRPVGPERKPMLTHPRLSVLYTSDQQRTLDFLTEALGFRL
EVDTVHQGGQRWVEVHLPGSQTSVALAQVDSGLLEEVRSRVGRMAQGWFNCDDLDAVCEN
LRGQGVEILTEPQDTAWRKGNRWAQISGWDGNVYGLIEGGR
>fig|446469.4.peg.296 Probable drug transporter, MFS family
MLGERRLAAALWCAGLATFALLYAPQGLLTDVSASLAVSPSRAALLVSGATLGLAASVLP
WAWLSDRIGRPEAMRAAAVASAVLAVLVPWLPTFELLVVGRFVQGAALGGIPALAIALVH
DCALPTRAAALAGSYVAATSVGGLAGRLLSVPVAQHLGWRMGLVAVGACLTALMALLVLL
LPHGREHRARRAAARLAVAGRAEPTRSGAHLRAHLRDGTLVSLFCIGGLLVGGLAAVFNY
LPFRLEAQPYGLAPTVVSLVFLTYLAGTVGSRLAGALSDRWSPRVVLVLACALMGAGALV
TLARPLVVVVLGVTVLTTGLFVGHAVAASRVGARATTGRAQATALYTVVYYAGASLFGWL
AGHAWDARGWPAVVALVVGLAAVALVLSARPAPSERPVTHTTD
>fig|446469.4.peg.786 Aminoglycoside/hydroxyurea antibiotic resistance kinase( EC:2.7.1.87 )
MPPDEHLVTEHLQRHLERWGLEPDGPLTETATSVLLPVRRGPDLALLKVARVDEERVGGQ
LMAWWDGRGAARVLEHDDSAVLLERATGPRSLTVLAGTDVGSPGWVREDVRATQVLCDVA
RTLHAVDDVETQRPEHLTPLTTWFRDLLALEGERRGFVHRSAVVARGLLADPWDETVLHG
DLHHGNVLDFGTVQGAQWRAIDPKSLVGERGFDLANILCNPSTAVATAPGRLSRQVVAIS
EATGIDRVRMLQWVVAWTGLSATWHGESTDAGRAARAVTIQVGRTAEDLLRAM
>fig|446469.4.peg.1630 Drug:proton antiporter
MRSTPTPASTTARSALRSPGFRLLTVAWGFTNFADSVLALILAVWVKDLTGSDSLGGLVF
AALGLPALVSPLLGQVADRVSRRRMMTATYTTGAVSLLALFAVQGPRDVWVVFAVTVIYS
LVGFATTAAQSGLVRDMLPDEALAAANGRLTTIDQVFRLTMPLLGAGVYVATGPLPLVTA
AAASFAVAAVVVARIRLVETPPTARDEREPFRTEVTAGFRHLLRTPPLGALTVALLVACG
AVGLLNASSFAIIDQGLGLGPEMLGPVSSVQGATAIVAGLTAARLVARWGSPRLVTVGLG
AVALGVLPALGSSLVGVLLGLGLVGLGMTWAIVGFVTERQLRTPPRLQGRVSAATNMLLN
VPQLALTVVGASLLGLVDYRVLLVVTVLGITAGAAVALREAARTHRAPPSVAADPPATDP
RTTPATPDRAGSGPL
>fig|446469.4.peg.2197 Drug resistance transporter Bcr/CflA subfamily
MPSTPPPHAAARPAVARPDRISAGLVLLLSALTAIGPLTIDLYLSAFPEIVAEMGTTESR
VQLTLTATLAGLAIGQLVIGALSDAVGRRAPLLVALTVYVLASSAIVAVDGIVWLTVLRF
VQGLSAAAGMVLSMAVVRDTFHGFQIGKVIARLMLVVGVAPILAPTLGAQFLRLGSWRLM
FVALAVVGAILLVVVALRLEESLPVERRRTGGLGEALRSYADLVRDWSFFGLALLAGFYM
AAMFTYISASTFVLQGQFGLSAQTYAVLFGVGAVSVTAGSQINGALVGRVAPTTILTGAV
AAGFVLSGALYAAAAAGAGLAVLVSLIVLTLGTAGFVMPSVPAIALERNAHRAGSAAALV
GALQFGVGAGIAPVTGLLGGTPSVTMAVVMFGVITVAGVLLLSLRPGWRRLAAAERETPE
TALGETAERVVKAVPQG
>fig|446469.4.peg.3197 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSTSATTNPTGGAGTAEPVGTNRWYLSSAPMLRALLHLCVPMAAAMVVSAVYNVVNAGFI
GSLHDSALLAAVTLGAPLLAVVMAVGGMFGVGGGALISRLLGATEHDPTQAGQIRRVSSF
ALWGSVVTGAAISVVGLVLLDPLVSLLGADSAAAPATRAFVGTLLVFVPVFAAAFCLEQL
VRAEGAARQVMTALVVSTVANVVLDVLFILVLHRGVAGAALAMGLSNVVTVVYLAGWLHR
SSQHVRLSPRWFTLSSTVLRPVLGVGVSELFQASFLVVTSLVLNNLAATYGDTALAAMGV
AVRVAQVPEFLVMGVTLGVLPLFAYAYGKGDRERLASALRVSAITVGSIVLVSAATAVVL
REQLVSAFTADRAVLAVGVTVLTAQVVAMVANGFAGLLTSYFQATGRTVPAIVMSTAQGV
LFVPVVLAGHVWFGLPGIIWSLTVSEGVVLVVGIALWFGYRRSIDRGLAEGSPERAEAAL
EQADA
>fig|446470.6.peg.510 Daunorubicin resistance transmembrane protein
MTPRIAYLGTRFKALLAYRFEIIIWLIGPLLQMLLLATVWRAVYDGRSTVDGVSLAVMTT
YVTISTIHSLIAHDDMDDWVHERVNTGGVGVDLLRPLPFMEQTLWGSVAQLGIKLLMIVV
VLPVGAVFAGLSAPAHLGLYLIAAVLAWLVNLCMYLLLSSIVFWTLEVHGLNFMYFVVNA
FLSGALVPLWFMPDWLATALSWLPFQAIVFTPASIYVGQLTGTAAWQAIGVQFTWLVLLS
ATAVLVWRRAVRKTVVQGG
>fig|446470.6.peg.938 Permease of the drug/metabolite transporter (DMT) superfamily
MLPWLALFTVWIFWGSTYLGIQFAVETIPPLLMAGFRYLLAGAVMFAIVGPRHARGPNRP
TPRQWRSMVIVAVLLLVGGNGLLSVGETSIDSGLAALIVATVPVWMLLIDAAVNRSRITV
TMAIALALGTAGVGVLVGGPGSRVDLFGAIVVLIGALSWASGTVYARRAPQPKHPLVVAS
LQMIAGGVVLILVAAVTGEFGRLELAAISARSIAGFGWLVVAGSMLAFTAYGYANANLPT
STVATYAYVNPVVAVVLGVLLGDESLSANLLLGGGIIVSAVVLIVGGQAAKRREKPRPRE
VHRQALRWYRRHPEAQRSRRHMFATRHTTKLPADEALPGRPGPLLDPSDRNAALGTPLLG
PYPDGMEIAEFGVDCFWGGEAQFWDVPGVWTTVAGFQGGHTPNPLADEILSHRTGHTEAV
RVVFDPAKTSYEKLLAVFWCSEDPTRRVDMRGHGRSAIFTQDAGQLAKAEASRKVYQREL
DRRGYGAIITEILSAQEFPFYPAQLRHQQHLARH
>fig|446470.6.peg.958 Glyoxalase/bleomycin resistance protein/dioxygenase
MLSDIMYVTVYVTDQDRALEFYTEGLGLEKGLDFSGPDGRFLTVGVPGGSVQVILWSHAA
AAGQPGEVGVPGPVILESDDLRKDFEAMRQRGVTFEEPEPVDYPFGVRIEAVDPDGNRVS
LRQQPKR
>fig|446470.6.peg.1224 Antiseptic resistance protein QacA
MSANEKASPRQWLGLSVLLLPTMLLFLAMTVLFLATPYITADLKPSGPQVLWINDIYGFI
MAGFLVTMGTLGDKFGRRRILLSGAALFGAASILSAYAPNPDVLIVGRALMGLGAAALVP
ATLALITNTFTNARQRSVAIGLWAASVSAGVAIGPLVGGLLLESLWWGASLLIGVPVMAL
VLVTVPLLIPEYKAPNAGRLDPLSVVLSLAALLPFVYGVKALAETGLDAITAVTLVAGIG
LGAVFVRRQLRLPEPLIDMRLFRNRTFGGALAVYMFATVALGGVYLLFTQYLQLVADQSP
LAAGLWILPAAIALVVVSIVAPILARRVRPAYLIAAGLLASAIGYVVLTQVDSTAGLPLL
ITGFYILYPGIAPAMALIPDLVISSAPPEKAGAASAVEGTISDLGVALGVAILGSVGTTA
YRSHMDTVEVPGEAAAESAETLPGALDAAQKLPDEVGGTLVDAAKTAFTEGLNLAALVAA
VLTVIGAVVAVTVLRRGEPAEAADETETDPDTELAEVA
>fig|446470.6.peg.1673 Permease of the drug/metabolite transporter (DMT) superfamily
MATFAVTTDSLVIAGLLRPIADTLDVSVSTAGQLVSVFSLTFAIAAPVLGAATANLDRRT
VLLLAIGVFVLGNVVAAVGTEFAIVMAARVISALGAALISSIAMATASALAPPDKQGRAL
ALVTAGMTVATTMGVPLGTLIGGADWRITLWAVAGLGTLAGAGIWLGLPKVELPVAPLRD
RLKPLGDPGILAILAVTLMILTSGYTLYTYIGVATDAATGGTASGLMAVLIAYGVGSILG
NVISGFLTDRYRPVRVLLVGLVMLTAILAITPLVSAAGLFLTMAWATTWGISGWLTGLPQ
QHRLVTKAPESSAILLGLNASTLHLGIAIGGGIGGLILNWGNTVLLGLMSAAIVAIGLAI
TLVSTRGRVTEPEPVPASAD
>fig|446470.6.peg.1933 Antiseptic resistance protein QacA
MNTTGETLPPPKATSREWIGLAVLALPTLLLSLDLSVLYLALPQLSADLRPSSTQTLWIL
DSYGFMIAGFLVTMGTLGDRIGRRKLLLIGAAAFGVASLAAAYATSPEMLIAARVLLGVA
GATQMPSLLALIGNMFKDAKQRSFAIATWMSCFMGGMAVGPVIGGFLLENFWWGSVFLIG
VPVMVVLLVAGPFLLPEYKDGSAGRVDLISVALSLLAILPFIYGLKEIAKTGVQVSHVAA
IAVGLAFGAVFVRRQRRLKDPLLDLRLFGNRTFTAALTSMSLGAGIMGGVMFLFNQYLQM
VAGLSPLEAGLWMVPPSVFMITITQITPAIARAMRRDHLIATGFALAAVGIFILAQVEAD
SGPLMLVAGMTVTAMGMAPLGMVCTDIVIGSVPPEKAGSASSMSETSAEFGIAMGVAVFG
SLATAVYRGGIDIPEGTPDAAAAAARESLPGAAEAAKDLPGQLGAGLLDTAREAFTSGLG
VVATVGAIVMVGLAALGLVMFRERKTTPEPTAEQQDRETELVNA
>fig|446470.6.peg.2593 Permease of the drug/metabolite transporter (DMT) superfamily
MRTDTTAANPYLLLMTTMMLWGGAFSSSKVVVDAVPHTVGAFLRFGGGALALLVVVRLYD
RRQTPVPARKLWLGAAAGVLGVFAYNAFFFWGLSLAPSLDAGILIPVLSPVLTTAFLLVS
GREKANRARVVGLSLGLVGAVIFFLGAGGATSAGPQRLPGDALFLLSAVCWAAYTLAGPR
VMAGIAPLRATTYATCAGAVMLGALAVPDMATVDWTALPSLVWANVGYLAIGGAAVANLL
YYRGVAAVGPARASLMMFSVPVVNTLCATLILGESLGWLQAAGACVLLTGAFLALTQGRL
PGLRRPVSP
>fig|446470.6.peg.3608 Glyoxalase/bleomycin resistance protein/dioxygenase
MNMTTTISDAKTAARVLRQCLADDGFELSHSRALEIVAQQLGFADWNTASASLTAAQTDS
GSAVAVLRIHDTALARGFYLDYLGFTTEWEHRFEQGMPVYMRIRRGETVLDLSEHHGDGT
PGSVVWVPIGDLRSFHAELSRRAHPNLRPGIERDAPGGPTMEIIDPFGNVLRFCQPSE
>fig|446470.6.peg.3759 Drug resistance transporter EmrB/QacA subfamily
MIAARVVQGGFGALLFVLMPVLASAAVRPQLRGRAMGWMFAIGPLGAIAGTAAVGVMIDN
IGWSSIFLPHLPLAAEGRYAWLAVALLAIPPVLAWRRMESGRLVLSLLRVPGVRAPMTAL
WTQVTGQLAVSFLVPFYIQRYLDADSALAGLVLLVLPAGMVLFSPLGGWLTDNWGARRTA
ILGLAVPLAATGSMAWFGETWTIADLAWRLGLLGVGAGLFTGAQTAMAMAAAPADMMGSV
SAALSFARQLGLGTAPALATILWGLTGYGLAGMRLAIAVITALGLGGLYALWRARTVAPL
PTAPEPARGRAA
>fig|446470.6.peg.4285 Antiseptic resistance protein QacA
MSTVTIAPTTTTTTPDANPRRWVGLAVLCASLLIVVMDLTILNVALPEIDAALRPSSVQL
LWIVDVYGLAVAGFLVTASGLADRFGRRRMLLVGYAAFGTVPLIVLFADSAPWLIAARAL
LGLGGAFIMPSTMSMIRDLFADPKERAVALGLWGSMAAVGAGLGPIIGGILVQNFSWHAA
FLINTPIMVLAIVFALWLLPESRGGAVPWDFLGIALSIIGMISLMYAIKTIGKHGITDPT
ALLTGTIALVSLIWFARRCLNRREPLLDLRLLRRRPLSAGLMCALISSVAMAAMMLLLAQ
WMQLVMEYTPIQTGIHLLPVAIVSGVISPLAPRIAQSIGTRTVMAGGLAVGGLGFAILYL
GGDHLDYPLVALSQSLVGVSMATLAIGSAVIVASVPVERTGNAAAMEETSFELGNALGVA
VLGSIAAVVFHNLMAATRLESLGLTGSAASTASDSIGGALSVASHTGNTALADHARAAFT
ESLGIVGLAGGVLMLLAAVAVWYLTPRGLTVEGGHH
>fig|446470.6.peg.4571 Glyoxalase/bleomycin resistance protein/dioxygenase
MDWKIEVVPVPVTDIERAKSFYADKLGFNVDIDFTLPDDTRIIQLTPHNSGCSIALGAPT
SMPPGSLHGVQIVVDDIATARQTLLTNGVDITPVQHFDGKTYVDGPGDDWNSWAFFADPD
GNKWTLQERPATTT
>fig|446470.6.peg.4685 Phosphotransferase (aminonucleoside antibiotic resistance)
MNARLILITGAQAAGKTTIGNALARLLPKAVHVDGDAIAEFVVSGAIGMDLPPPPGAMEQ
LYLRYRGSIAVANVYRDKGFDAVVSDNMFGETLTDVIAMGHETGDVHVIALDPDIASIEE
RELGRGKSGYTETVTPQALVDALRNETARVGLWHDNSGETVAETASRLLEKLDAALVPRP
ASA
>fig|446470.6.peg.5319 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDHMAGSLRALHLVVADVRATREELVEKGVEMGEVDEHEGSMFYVPFVDPDGNTWTLQE
MPWRVGDFAD
>fig|446470.6.peg.6302 Glyoxalase/bleomycin resistance protein/dioxygenase
MARLHDIVFDCGHAASLARFWAAAVDGYAVAPYDDEELARLRSFGITDTEDDPTVLVESA
AGGPRLWFQRVPETKVVKNRVHVDLRTDDLETEIARLTALGASVSERFGDNVVLLDPEGN
EFCLAVN
>fig|446471.6.peg.485 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQNLTVGPPTRLILAFTVPLLVGNVFQQIYVFTDAAVVGRLLGLEALAAVGASGSLMFLL
IGFSWGASAGLAIPVAKAFGAGDMRGVRRYVAAGAYISAAIAAIVTAVGVIFAKDLLALL
NTPAEIIDMSATYLAVTFAGASVTVAFNFLSATIRALGDSKTPLYFLMASSVLNALLVAL
LVGVFHWGVAGAAGATILAQGAAVAACLALVIRRMPALHLSREDWAAGRRALREPMRTGL
PMGFQMSVIAVGALVLQLAVNGLGATAVGAFTASMRVDQLAVAPLNSFGIAMVTFVAQNR
GAHQWHRIRVATFRTSMVAVGVALALGAVLVTFSQPIIGLFVGPDQPEVMAMARTFFLVS
GGLYPVLALLFVLRNVVQGMGLSTVPTVAGALELVMRALAAIVLVGAFGWVGVAWAAPLA
WIGALIPVALAWFRQRGLLLERERTDHATPRPPHEAAEPAAPAPAPALAVAAAPAAAVID
VAAPPADALPTLAGPVPADT
>fig|446471.6.peg.526 Truncated tunicamycin resistance protein
MLIWINGAFGAGKSHTAFELRRRLAEAHLADPELLGSALHRMLPQAMRGDFQDLPLWRSV
VVETLHQAAASHAGPLLVPMTIVNDDYFDEIVGGLRERGVDVRHYTLVASPATLRRRLGT
RLGFIRSGGRRETWAMRQIPRCVEQLAQDRYGTHVRTDDRPLDEIVEWIAADAGLDLVGP
RLSPVRFQMRRLQVAAQLIR
>fig|446471.6.peg.901 Vancomycin B-type resistance protein VanW
MSHDSPTEQARRTRRLWWTAAGVATLAAAYGAAQWSLADQVPTGATVAGIDVGGLRHDDA
VAALDDAAALLADQPVPVTAGTAETTVLPTDAGLALDAAATIEPLTRFTLHPARLWTHLR
GAAEIEPAVTIDRDLLDAAASRLSTELVREPVDGAVVFADGEPVVTPAEPGTQVDPDAVG
QVLATGWLAQDHPLELPHEPVEPAITQELTDAAYAAARQIVASPVVVDAAGQHAELPASA
LADATAFEVVDGALVPTFDGDALLAAVVERTQNLLDAPVNARFQVTGGRPQVTGGTPGTT
IDPAALVEAVQAAALGEDRTAVVDVVQQDPEVTAESLEALGVNEVVARFSTSLTANRVRT
DNIRLGSERITGTLIRPGETFSLLEALGPITTANGFGNAPVIVGGQFVPGVGGGLSQLAT
NVFNAGFFAGFEIVEHRPHSVWIPRYPAGREATIFTGSIDLRFRNNTPYGAVLHAFVADG
QLTVQVWSTEHFRVETTQSERRNVVPAVTNHSTAAGCTPRAAGSDGFTITNTRRVYRGST
LVIDEAHTWTYRADHGTSCGPAEPPPAPEADAAPEDSAPE
>fig|446471.6.peg.3360 Glyoxalase/bleomycin resistance protein/dioxygenase
MSVPAASVPAAPAGSATLAPFIMSDDAEGLIAFLVEVFGAVEVPQARTQDVDGLVLHSEL
LVGDSLLTVADRKPHWPYTPAFVRVYVDDVEATLERAVARGARIVTEPTDVWGDVFSRFA
DPYGHLWWVYKHNPTTLWDEPAGEEVWTEEVDLSWEAFATPELTYLQATLLEAMDTLHDP
RTQK
>fig|448385.11.peg.1021 Drug resistance transporter, EmrB/QacA family
MMALRTSIAGAPLPSEAPDQAASGVRGPARAEAIACVLAAMVLVVLSAGIANVALPALAH
ALQVTPAASVRVVSAYQLGLVMALLPCAALGESLGYRAVFTAGVGLFTGASALCALAPSL
HWLVAARFLQGLGGAAVMALGVALLRFVVPQAQLAAAIGWNALAVALSSAAAPTVGAVLL
SSASWPWLFAVNLPLGVAVLLASRGLPEVPGTARALDATSMALSAGAFGALIAGAELLPA
APALGAGLLAAAALSATLLLRRELPKEAPLVPLDLLRSRSFRVSVIASVACFAGQTSALV
ALPFYLRHGFGQEALTTGLLITPWPLSVALLAPVAGRLADRISTAWLCATGAGCLALGLA
ALALSPAHGSALSLVPFVALCGAGFGLFQVPNNRNMLLAAPRARSAAAGGMQGTARLAGQ
TAGAVVMTLLFTLMPVDAAPRIGLGIGAVLTLSAGIVSALRAGSHRSHDGGRMGS
>fig|448385.11.peg.2619 Outer membrane component of tripartite multidrug resistance system
MARRAARAALAAAAVSLAVRLAPLPAAAADTGGAPGRRAAVVHDLPGVLALADRNHPNVA
AARAKLDQVRAQLDEARYAPFSQFKLTGGVALAPTVRGNNVFSPNTDVSLTSSLGVGWRV
NIDGVIPLWTFGKITNLWDAAEANVRVNQASVEKERDAVRLDVRKAYFGLQLARDSRSLL
VDVRAEMDKALRRLEEQVEREEGDPIELLKLQTFGAELEARGAEVDKYISVALAGLRFYT
GVADLDIPDVPIRPPNHRIGHVTRYLTAARLYRPELAQARAGFDARSAQVRLARAQLFPD
IGIAVQVGVSAAPEVADQLNPFTSDPGNFFHYSAALAVQWKLDLLPQSARIRAAEAQLEE
MAATQRFAMGGVATEVETAYAEVVEAQKRLDAYTKAAKYGKRWLVMVQQGIDVGTMADKD
LIDPAKAYATNRFNQLNATMDLDMAMSRLAKATGWDAIAPDGT
>fig|448385.11.peg.3402 Permease of the drug/metabolite transporter (DMT) superfamily
MGDGSLAQGSRGARRDLASREAGAGEVETATQTGDRPLPEMCPPPSRQPRAVANARSCAQ
CRRASRRRSAPARRRAVGDGVRSPGGASLVKSREAEVMSPHEGVGALTGEIRTGLLDDGR
TFAVLSAATFALKAIFVKLAYAAHPVDAVTLLALRMGIALPFFLWLARRERGAAEGPLTP
GLWGGVLIVGFLGYYLSSLFDFIGLTYISTGLERLILFVYPTLVLLIGAAWLKQPVRGKA
WGALAVCYLGLGAAVWHDLEQSGDARAVAIGGAWVFASSVTYALYYIGVGKLASRVGSTR
LAAYCGAASCLMVLAHYAAAGSPVRLGELPASVWGYAAAMATISTVLPIVLLAAAIRRLG
AGRAATFSTLGPVLTIAFSWVILGEPATWQQVVGLTLVVGGVSWLGKSK
>fig|448385.11.peg.3735 Outer membrane component of tripartite multidrug resistance system
MRPRSVMLALMGAGVASVLAAASGAPGAQPGSAPKAAASATQPGGASKTAAGAAQPGGAS
KAAASATADAGAPRAAASAATDAGDELPLDAAPFPPEPSKQPTAAEWKAAPRVRLSRAGP
AAAGCRAYRAREWLRIRCPELTVSAISLLGGKTEGVAFWIDPPRGGSELPRGGEVMFPIR
RGDRRVIQILTFGPGYDGPFTLLPAIVIQEQWLEDEPAPTVTAS
>fig|448385.11.peg.4873 Vancomycin B-type resistance protein VanW
MDTRALVLVLALGGSAGVGAAVGVRHVLPTSPVVRGLSVGERFLPDGAAPAAWLAARRDA
LRERVVRLRHDDVELTATLGEAGVEVDVDETLAAARRVGHEGPWARRLREARGARRGEID
VPLTWAVDEPRARAFLERLAPQIYRAPVDARLDLANRRKIPEQAGRALDVEASLAALRAG
EHGDEELIELAVRQILPQVVVADLVSVDVTRVVAAYETKFKHHGKEAGRARNIRNAASKI
DGTILAPGDTFSFNAHVGPRTAKNGFTIAPEILGDETVPGYGGGTCQVSSTLYAASLFGA
LDTPDRQSHSRPSAYIPMGLDAMVTYPESDLKIKNTLPFPIMIHAYLPEPTVLRVEILGG
DPVAEVQHHVSAEHTDDFIRRIYVKSELAEGKVKRHQKGSCGYDVRSFVTVRYKDGRASE
RSYSSEYRPAPEVFWVAPDYDPQALPALSEHAKAVEELREGESPAEAPAAAGQGGAYSM
>fig|448385.11.peg.6188 Acriflavin resistance protein
MSDQLSSDLASLRIQRDVDPDRRSPLRTVLVAAVVLAAIAGAAAFAVPKAQSALFKTEIT
TTEVALVSPAQASISVTSTGYVVPQVVSKVGAKFPGRIARVHVKEGDVVKQGDLLVELDD
ADQKSLVAAAQAKVAAARARATASRASIGEVEQQLARERLLVERQVTGRASMDDLTARMH
SLTQSAAAADAEVKAAAADVESLRVTLADRKIVAPIGGTIMSKPPEVGEVVGLELPHLVE
IADFTSLVVETDVPETRLYLVEPGKPCEVVLDAYPSKRHRCTTLEIGKRVNRAKATIPVK
VKFVGEPKEALPEMSARVSFLSEALSEEAMKEPPKRVVPEAAVVERGGAKVVFVVNEGQV
KMVPIKVGGPAPGGLELLDGPAPGARLVARPSPELADGQKIKEKEKGSE
>fig|448385.11.peg.6612 Membrane fusion component of tripartite multidrug resistance system
MSYVRLRKNERGHVVSRGIARRLDTAILLAIARRPRLNSEFHVVVAVGGVLHGDVLVPVR
GVLEGLVDAAGFDAGPDALLIFQVASEEGHRLRLLRLLVLLVLLAITIDISHGRPPDGMT
ALRRSRRGEHSFNRPALHVKFCQAHRLYPGDGCDFLRILRSCTLARPLMPAGFSRSIHAI
ATDGHRGSIVGAALGALLLGGWLAWFFLARVGQYEASVSARLEVGQAAHRVETPLGGRVA
AVRLDLLGAEVAAGDVLVELDVEPLRRDMDDKQARLSAIAGQMGPLRAEIAARSRALRDG
AEAARARIDEAKARLKEAEAGARFQELEAARAVRLRQDGLVSEAEAARLAAEALSRRSAT
EALDRAAARADVERRTGQSEQQAELARLDREAASLEGERLVLEATIAGLLAEIERRKIRS
PIAGRVGEITVLRAGSFVREGDVVAAVVPPGELRVIAEFPPSSVGRIRAGQAGRLRLDAF
PWTEYGTLATTVERVASEAQEGRIRVELGVRPDPASPIPMQHGLPGNVVIEMERVSPASL
VLRAAGQIVRVRGGADG
>fig|448385.11.peg.6814 Vancomycin B-type resistance protein VanW
MDLRRSPELWRFAALVAIFVTSGLAITYLVLPPPPDDGPKPPPVLRVAQVPVPTGGDVVA
NALDLVRRYATGEIRIVLPDGSARALRRNDLGVEINRVRLAEFVREALRPESALRRAHER
AAQEDAPLDIPIPLLLDSERAISKLLDLKVELDAPAVDAYVDLEAKQLKPEKIGYRLDVY
GTLARIDAALRAGEDTAQASVETIAPKLVADQLGNVKFDQVLGYFETRYATGARSKERTY
NLRLAASKLDGVVVMPGEIFDFNETVGPRDEAHGYRVAPVIAQGELVDGLGGGTCQISGT
LHGAAFFAGLEIVERYPHSRPSYYIKLGLDATVVYPTINYRFRNPFDFPIVLHETVAGGV
VRAEILGPSRKLTVTYFRRIDEVVPFEELERPTPKLPEGKRALAQRGIPGFKTTSSRVVR
DGAYAVREKWSDSYPPTAQIVHVGSGPRDPEAKTADDNHPEYVADEYLVVTQGPDVRTPG
VTGPEPGGGTVESREPGLTGERGWTERAGFGTFRAKGEERAEGEGGRARGEDAPPAEGIA
VAHAPGAAAPEARGQRDPAGDEAKGGKGKKRRQNQKKTTTTSDGG
>fig|448385.11.peg.8274 Permeases of the drug/metabolite transporter (DMT) superfamily
MASSSLGFAESRQRRTAQVLLFVTPALFTANMLLARATADFIPPVALAELRWTGVVLVLL
PFCGRELWRNRAALRRDWARYALLGLLGMGICGAGVYYGAATTTATNIGLIYAVSPVIII
LLSRAMFGERLSRRQGLGAALALTGVLVIVLRGDPAALLALSFSTGDLMILGAAISWALY
TVLLKRWPDPLGVQARLTAIALAGAILLLPLLGWELASRGAPHFDLRTIATVVTLVLVPG
VGAYATYSYITEHLGPSRTGLLLYLSPVYTAVLAWLLLGEAFALYHWLGAALVLPGLFFA
THKPKAT
>fig|449447.3.peg.3112 Glyoxalase/bleomycin resistance protein/dioxygenase
MRIFIQFTAIIPQKTVISSDSAITLPLMNRPPIDSQITFIYTRDLTAAADFYERVMGFPL
WLDQGSCRIYRVSGDGYLGICRANESRASGEGRQSNVIFTLVTERVDEWYDYLKQQGVTF
EKPPLFNEKYRIYHCFLRDPDGYLIEIQRFESSEGGN
>fig|449447.3.peg.3852 Glyoxalase/bleomycin resistance protein/dioxygenase
MNQPAIFHLAIPITDVSTAKSFYCDGLGCLAGRETEKAIILNFSGHQVVAHVTEMPLTPQ
NSIYPRHFGLILPDASDWDNLLEKARVNQLKFYLEPKTRFTGEITEHKTFFLEDPFYNLL
EFKHYRHYEAIFASRELTAIGDRA
>fig|449447.3.peg.5341 Glyoxalase/bleomycin resistance protein/dioxygenase
MTISPSVTAKKLKIGQLRKVHHIAFNVKDMEASRHFYGEILGLEELKGEKIPSTLKELVA
QGKVANFITPDGTVIDLFWEPDLNPPDDNPEIAFTRANHLAFDIAPECFDFALEVLQSQG
ITIASGPVTRPTGRGVYFYDPDGFIVEIRCDPAF
>fig|450851.6.peg.2493 Glyoxalase/bleomycin resistance protein/dioxygenase
MSRVVGIDHLSVRVSDIERSRAFYGRLFEFLGFEVLEDYGDQIGWTNGKTRYWIGQADAE
GRGRRHRIGDVGFHHYAFELRSRADVDDLQAFLEREGATIVDPAGEYYPDYYAVFFLDPD
GLKLEGMKYGKV
>fig|450851.6.peg.2954 Permease of the drug/metabolite transporter (DMT) superfamily
MSFRDFGLLALVCLLWASNNIVSKYVIATLGVPPLFYAAVRFGVVALAVFPWLFPMPRPA
WRLIVVALLMGGGNFALLFMGLQTATPSAAAVVGQVGVPMTTLLSVLMLGERIRWRRGIG
IALTLAGALTVMWDPGGFALSGGLLFVVASAFAGSLGAVMMKQMEGVKPLQFQAWVGLAS
VAPLALLSALLEPGQVEAGLRAGWPFWVGVVYSAVVISVGAHTLYYALIQRYEANLISPL
TLMTPLATIALGVALLGDPFGPRMAIGTAVALAGVLIIALRRNQVMPLLLAVWNRSQ
>fig|450851.6.peg.3120 Bacteriocin resistance protein, putative
MRRRRDRSRIVALAAALTALAAAAPAVAQVQFYGEASGARVRVMTWRDIPFRTVVRQEHD
YSCGSAALATLLTYHYGRPTTEAEAFTRMYAAGDQETIRRVGFSMLDMKRYLAAEGLRAD
GFRMSIDDIGKEGVPVIALIQMGAYRHFVVVKGVVGDRVLVGDPALGLRIFTRAQFNAMW
NGIAFALHDTPAVGRGRFNVANEWSPWSTAPLRARADATDTLNALTLHQLPFYQITPIMV
LGSVAPGGGL
>fig|450851.6.peg.4058 Glyoxalase/bleomycin resistance protein/dioxygenase
MLGGERPVGFIATTDYERARAFYVGVLGLEFVRQDDYALVVRSGGVTVRITRLPEVHPPR
NTVFGWEVADVREVAAALADRGVTFERYDFLGADQGADGIWTVPGGAAQVAWFKDPDGNL
LSISSAGG
>fig|452471.3.peg.76 Permease of the drug/metabolite transporter (DMT) superfamily
MPTLFMIIATLFWGASFLFIKLALQEISTASFIFLRFLVATISMAPIMAFSSISLNRKVV
KQGIILGLLQLGIIFLQTLGLETISASLSGFLTGLYIVFILVIQFIRQRRIPSFTDIATS
VACLGGLGLLTHNFEVTNGVGVLYTIGCALCMALYIYALDAYSANNNAVLSTFIQMASIT
AFSSILFLLPGNNLQIPTQPITWIAILFCGICCSSISFWLQNKAQRHLGAFKVSIILMLE
PIFCTIFACFILGEKLYAEAYIGIIMILASIAVINVRLKEVE
>fig|452471.3.peg.607 Permease of the drug/metabolite transporter (DMT) superfamily
MRNQTRIPNNRIIAWVLLITLSCIWGSSYILMKKALCFFKPQEIAYLRICSAAIVLLPYS
LPQLKKLTFRHYKLLALVGVVGTLLPLFCFATAQLHINSGVHGVLNSLTPVFVLMVGIIF
FKKRLFKNEILGVSLGILGTVLLVIIESRFFAGSFNYYILLSLLGSCLYGNTTNLIKYYL
NDIKSTTIVSVSLLLIAIISGIYLATHPNIFIKMDTSIESYQALAYVLFAGIVNLGIANI
ILTELVKITSPVFTSTEALLAPIVSLSWGLVDGEQLLWEHYVGATIILLGVYFINKPKKE
IPKQPVFNAEV
>fig|452471.3.peg.784 Glyoxalase/bleomycin resistance protein/dioxygenase
MVLLPVGRLKDDFVRFLQVRVYQRSDFCYLKLNIMKQIIFILIILSISIMSCSQPNSNLK
INNKMKLNAGIITKKMSETKSFYTTLFNFGVTFENEFYLLLHTPNHESEISFLLPNHPSQ
QPLFHKPFQGQGVYLTIEVDDVDKVYNELKEKNIPIRIELRDEPWGDRHFAIEDPNGIGI
DIVKYSPQQDQ
>fig|452471.3.peg.794 Permease of the drug/metabolite transporter (DMT) superfamily
MKRISKGVQYMLLSTICFALIGLIVKLLVHIPPAEIIFLDSLVALTISCFMIGYQKMCLW
GNHRRILLLRGLSAGLGVTLFFITLVRLPLSAANVLQNTSPIFTAILGIFMLKEWISLRR
WFFFILTFIGVGLTYMTDFSITNQSAYLVLLGLISALLMGISNNFNAKMKSGEHPLVIFS
YSTFCTVLITGCICLYAFVPLTIYDFLLLLAMGTLTFIAQYLAIKAFQNAPVAHVSAISY
LGIPYALIIDLLLGERIHWISYVGMCLVVLGVILNLFYGYSKRVGA
>fig|452471.3.peg.811 Permeases of the drug/metabolite transporter (DMT) superfamily
MSNKTKAIAFILLNCISFTLSMTINKLVNPAIPVALKVLIRASFGLLFFSPLILKSGFRV
LVSNKLSLQILRIFLMSIAMGATYFTYTNMPFTIAISIGFTGPIFTAVLSYLILKDRLKI
GQWVAIFIGYLGVLLIIKPHGEVNYAIYVAILGNVVVGLSLIFTKRLVKIDSKNTILILG
NIGIVATSSLWAFIYWLGSKYENLWLHAVWVCPSWKDFQWLIIMGFLGAISQMASITALK
YASPSFLSPFEYSRLVLAVPIGIFLGEALPGYREIVGIIIILISTVYNSWQGDFHAKSKK
>fig|452471.3.peg.1147 Multiple antibiotic resistance protein MarC
MNTLYSFFIAFNIKKFLTAFFILFAVIDVLGCTAIIINMRNKIGYIHARKTATVAGVIMV
TFLFLGQTILDLFSIDMSSFIIAGSIILFLLGLEMCLNISIFKTDTDANSSSIVPLAFPI
IAGTGTLSTLLILRAECETINVLLASLVNLVLIFLVLKYSEWIEAKLGRLGVSIIHKMMG
IILIAIAIKRFKMYLFI
>fig|452471.3.peg.1261 Permeases of the drug/metabolite transporter (DMT) superfamily
MSCGNDAITKYLGYTFNPWQITFFRFAFGILTLLPVMLYQGKSAFITYRWKLHFLRGLFV
FVAISLWSQGIKVSPITTSTIMSFTVPIFVLVLAPIFLKERVTWPMWLATLGGFVGILFV
LQPDVHTFNQGSLFFIIAAILFGMLDILNKKYVTQEPMLCMLFYSTVVALILVTFPAMQV
WRTPTNYELMWLLVLGIGSNLILYCILRAFSLTDASSLSPFRYIELLISMVVGYVFFHEL
PSSYSYLGAAIIIPSTLFIGYYQTRNQPKA
>fig|452637.4.peg.119 Glyoxalase/bleomycin resistance protein/dioxygenase
MRASAQLAPLDLYAFAKNMKFRSNNCVRVHLPDLKKAEAFFTGVLGFRLTDKSATQLEYD
TGRFLLCVNKSEQPLPPIPSFTVISVKDAKEHLLAHGCEIVEDHGTSLYFRDPFGMVYDV
IED
>fig|452637.4.peg.950 Permease of the drug/metabolite transporter (DMT) superfamily
MMLLLANLFWGLSFPVIKSITLLHAQLLPDAGTWFSTAYTIAPRFLLAVIVLLAWQARSF
WRITRAELKQGVILGLFAAAGMLFQVDGLQFTAASTSAFLTQFYAIMIPVYLALRSRRTP
GALVWISCSLVLAGVAILGRFDWRELTFGRGEWETLLSSVFFMGQILWLDRSEFVGNRVE
KFTLVMFLTEALVFLGLSAATAPSVDALVLPWTSPGWLGLTASLTVFCTLGAFLIMNRWQ
PKITATEAGLIYCVEPIFGSVMALFLPAMISAWTAINYPNESATSHLLIGGGLITLANVL
IQLRPPAKPAAAASK
>fig|452637.4.peg.972 Acriflavin resistance protein
MRFTDLFIRRPVLATVVNLFLLIIGGLAIKSMVIRQYPQTNNAVIRVTTTYPGASADLIR
GFITTPLEREIASADGLDYVESVSAPNVSIITAKLRLNYDPNDALTQITSKVNRARRELP
VDAEDPVFDVSVGESTASMYLTFSSAVLGANQVTDYLTRVVQPKLSTVEGVQKAEIMGAR
TFAMRIWLDPEKMAAFGLSASQVWAKLSTQNHLSAVGKTKGSMVSVNLTAGTDLQSAGEF
RQMVIRENKGEIVRLGDIANVVLGAESYDVDVKFAGQETTIIAISVLPTANSIDVIKGVR
AVWPEVVSQLPAGLDAGIAYDATEFINDSITEVMETLLEAMLIVVLVIYAFLGSFRSVVI
PIVAIPLSLVGVCALMLSLGFSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGLSPL
DAALKGAHELVGPIIAMTITLAAVYAPIGLQSGVTGALFREFAFTLAGAVIVSGFVALTL
SPMLSSKLLRHNPNPRGIEHFLDVAFTKLRDRYEHLLDQVLNTRPAVYLVAVLIVAAIMP
FYALTKKELAPPEDRGFIVTISQGSPNGTLDQALRYSERFNELLKQIPEVNTFFSIAGFD
MVSGMASPSSGLTGVSLVPWSQREASAADLIPQILGRASTIAGVNYAAFLPPSLPGAGGG
LPVQFVVSSTANHDRVAVVTQTLLQRALASGNFLYGDTDLKFDQPQADVKIDRDKAALLG
IDMKQLGTDLGAMLGGGQVNRFAIQGRAYRVIPQVTRSARLTPDQLADYYISTGKGELVP
LSSVAEIVPTTQPRDLRRFQQLNCATISLLPRPGLSMGEALDWLNAEAKTVFPEGFASEY
KGESRQFVQEGSSLMATFVLAIVVIFLVLAAQYESFRDPFIIMMAVPLSIAGAMVFLFLG
VATLNIYTQVGLITLVGLITKHGILMVDFANKLQEEGHEVRSAIEHAAGIRLRPILMTTA
AMVLGVLPLLVAQGPGAEARFSMGLVIAAGMAIGTLFTLFVVPAFYVLVAHRRTAIPAGA
PASPTELAPAHHS
>fig|452637.4.peg.979 Multiple antibiotic resistance protein MarC
MPSAHHFWELILGTVIALLPLINPLASAPTFLAITDGDTPERRNQQLRMACLYTVGILVS
FLIGGTFIMGFFGLSIPGLRIAGGLLVAGIGSHMLMSPPKPATDDPVHAAARAKRDISFS
PLAMPMMSGPGSIAATISFTSLARGWIDYVAIILGIIIVTVITYVTLRISDRVVRVVGFN
SMNALSQVMGFLILCIGIQFVVNGVTEIVTDPVLLGSIRDAFQQS
>fig|452637.4.peg.1470 Polymyxin resistance protein PmrJ, predicted deacetylase
MPLRLALKVDVDTDRGTRDGVPNLVADCRAIGAPACFLFSLGPDQTGRAITRVLRPGFFK
KVSRTSVVQIYGVRTLLNGTLLPAPHIGRRHAATMRAVRDAGFEVGIHCYNHYRWQDYLQ
RMTQPEVDAEFLAARAEFRRIFGAEAHTAGAAGWQSNARSRHAYDAAGLRYASDTRGGAP
FFPRIAGQVFRTLEIPSTLPTFDELMGRPEYPDDAIVDHYLSLLRDDLVNVLTIHAEIEG
MGRRALFGELLSALRRTGVEFVRLDDYARELLANRAAIPVREQVMAEIDGRSGLVAAQAP
D
>fig|452637.4.peg.1929 Glyoxalase/bleomycin resistance protein/dioxygenase
MKIRGVDFVMLQVSDIVAATEFYRDLLGLRCAIYSAEDRWAEFDCGNVTLVLHGGETVAA
GGTGTRVALAVADIDAAHAELDARGARLLSPVQDYGVCRAFEVLDPDGNPLLLHHRADGT
FGP
>fig|452637.4.peg.1946 Glyoxalase/bleomycin resistance protein/dioxygenase
MPSPSSPLFKDVAFVVYPVANVKTSRSFYEDTLGLKVTANWDDQWVEYDIGAGTLAITSA
DEKHRAGSHGATLALEVVDFDATIAHLKANAVSIADGPFESPACRGCIIRDPDGNELIVH
ARK
>fig|452637.4.peg.2063 Glyoxalase/bleomycin resistance protein/dioxygenase
MRVNDLERTVKFYQDVLGLKVVRRHTSPRGAQLVFVATPNSDEEIELTYLPNSPSVQVQP
DLMHLAFEVDDLEKFAAELKQQGYPLSDGPTRTDSGAVIAFIDAPEGYEIELIQKAP
>fig|452637.4.peg.3498 Acriflavin resistance protein
MILSDVSIRRPVVCLVASILIVLIGLLSFRRLPVREYPDIDSPIISVSTTYPGASAEVIE
SKITEPLEKEISSIDGIRVVRSLSLEQRSEITVEFNLRRDVNEAANDVRDRVSRARRQLP
DEVLEPQVTKTEADADPIMGFSLASDRYSRQELYDIADRFVVQRIQTVPGVGAVQIRGPR
YAMRLWIDSDRLAAHELTVADVERALQQQNVEIPGGRIESVTREFTVRTQGSLVEVAEFE
NLILAVRNGYQVKFSDIGRVELGQNDYRGESYYRGVPTVGVQVFRQSQSNLLDLADGVKA
QLPLIQASLPKGVTIDIGFDSSVFVDRSVAEVYKTLWEAATLVILMIFVFLRDWRATFIP
LLAIPVSVIGSFAIMSWLGFSLNVLTLLALVLAVGLVVDDAIVMLENIYRRIEGGEPPIR
AAVHGARQVAFAIIATTLTLAAVFLPVAFQSGQTGRLFFEFGVTLAISVLVSAFVALTLT
PMLSSRMLKARLVGGHVKHGWLYEKTEPFFEGMNRRYAAMLNWTLRHKFWVLLGAGAVAA
LGPIFYLQLQRELTPLEDRSAFRAYFIAPVGSTPEFGHYYAGKMEQMLLDVPEVERTFRR
SGDSNRAFMFVTLKPWEQRERKAQQIIAEMREKFRREITGGQAFPLAPRPFGQRGGSAGI
QVVLQGSDFDQLQQLGDRMIAAMRERTDMFYLPRVDPSPTKPQLDVRIDRAKAADLNVPI
SEIASTLETLFGGKRVTTFQRGSQEYDVLVQVADEDRTTPSDLSRVYVKSSTGHLIQLTN
LVQANEAVVPENYPHFMRLRSVTVSAQLVGNATIGDGVDFLQVQAEKLLPAGYTYAWDGE
TREYVESASDTWMLFTLALVFTFLILAAQFESWIHPITIFTGIILALAGGVIVLYCTRFW
GTAMTDNLYSRFGLIMLIGLVAKNGILIVEFANQLQLEGRNAFEAAYEASILRFRPIIMT
AIATILGAVPIAFASGAGAETRNPMGIVVVGGLSIATFLTLFVVPIFYVLVDHFAVKVTG
HSSAYGLKKAEEIRHETAEEVEVAAPAK
>fig|452637.4.peg.4187 Tetracycline resistance protein
MNPPAAAPQPSRPLSLGVIFLTLYIDLIGFSIIFPFVPDLMEYYLRGETPGGLLAWLLAQ
TNALAALLGNHDHLADVLFAGVLTSFFSILQFVFAPFWGALSDRRGRRSVLLLTVCGTAA
GYALWVFSGSFWLFMLSRVICGAFGGNLSVATAAVADVTSRQERSRAMGLVGAAFGLGLV
TGPMLGAISASHNLLASYPSLARFGINPFSVPALIALGMSLVNVVWIALRFRETVSTATR
DESAATRLRNPLRAIFALPSAAVRRANLVAFIFSVAFVAMETSLTFLAAERFGYTARQNG
MLMVFLGVCSIITQGMIVRWLLRETSELRVLAGGLIAAAAGLVCIGLAPAPWLVFVGLAF
LATGSGLVNPSTTGLISLYSHTAEQGRALGVFRSLGSLSRAITPVCAGTAYWIFGGGSVF
VVAAGFALAALWLSRTLPLPDK
>fig|452637.4.peg.4266 Glyoxalase/bleomycin resistance protein/dioxygenase
MTEIAFTGYPVTNMARARVFYENVLGLKPGATFGEGDKQWVEYDIGAGTLAITNMAAEWQ
PAAQGPSIALEVEDFDAAIEALRQAGVTFTVPPTASPVCRLAVCLDPDGNSLAVHKRNPH
>fig|452638.3.peg.1936 Acriflavin resistance protein
MGVILLGGVAYLYATARAELAPTEDQGIVLMQASGPSNSTVTQMQTYVDQIYAIAAAEPE
YEQAFQITSPTSSFGGILLKDWGERSRNATKFQEDMQQKWNTIAGARVAAFQFPALPGAQ
GLPVQVVINTTEPYAQLNEVSQAVLDRARRSGNFFFVDSDLKIDKPQDVLEIDRENVAAL
GMTQQ
>fig|452638.3.peg.1937 Acriflavin resistance protein
MCSRIFTEEQEASSCVQKIDRIFDKIHHSYQATLRDLLST
>fig|452652.3.peg.4579 Permease of the drug/metabolite transporter (DMT) superfamily
MAVALGLALSALGTAPVAAADRTGHGGRAAQGHPAAGAVRVAGVPAAPIPVYAEDFENVP
AGSGPVRITSYTGTSGETYTADPVWLAYCNGWVMDDVDRGTVPTECGAPINWDTLANVTR
AMGQYSGEDDTAAGLNHGVAAWSEDGSYTANDVQFRTVQQIPLVNSNRFLTGSGTSGAVC
YDGAYADPLTNFYLTDGTTEYPVSATPINPCTNPRAQRFTYPTGKQYPIGVVHGAADKPI
LYSGSTVGVIMRNAAATGAGNDAAFDDIEILDVTPTATKAFSPAAVVVGGTSTLTITVTN
TTDLLEKDGWSFTDDLPAGLVVANPANTSTTCTNGAVTATAGGSTVGLSGDLVKGQAMCT
LSVDVTSSTAGTYHNCPDANSNLIGMNWTECADVVFAVPQYTITKTATPASGSSVKPGDQ
VSYRVVVQNTGAVAVDATAADDLTAVLDDAAYDNDAAATAGTVSYAAPTLSWAGTLQPGE
SATITYTVTVNTPDTGDGQLDNHVTGSSASNCPTGTEPGCTTHENVNSLQITKTSDTATA
KPGQKVTYTVTVTNPNGHAYSGATVADDLSAVLDDATYDGDASATSGTVSYAAPVLSWSG
DVPAGGSVTLTYSVTVNNPDAGDGKLANTVTGPADSNCPPGAPDGSCSASVPIAELHLGK
TSDAKNPVKAGDKVTYTVTISNPGQADYTGAVVTDDLSSALDDAAYGGDAQASSGTVSYA
APVLSWSGDVPAGGSVTVTYSVTVNNPDTGDKQLANAVVGPPDSNCPPGSADAACSTSDG
VAELVIAKSSDAKNPVKAGDKVTYTVTIGNPGKAAYTGAVVTDDLSGDLDDAVYGGDAQA
SSGTVSYAAPVVSWSGDVPAGGSVTVTYSVTVNNPDTGDFELKNAVVGPSGSNCAAGSAD
PRCSTDDKVAALVIAKSSDAKNPVKAGDKVTYTVTIGNPGKAAYTGAVVTDDLTGDLDDA
TYGNDASATSGTVSYAAPVVSWNGDVPTGGSVTVTYSVTVNNPDTGDYQLANTVVGPDAS
NCAKGTRDPRCSTRDRIAALRISKTSDSRRAPVRPGAKVTYTVTVTNPGTAPYPAAQLSD
DLSRDLDDAVYDNDAVVVSSTGGDPGVATYAAPVLSWTGGVAPGETVTLTYSVRVNRPDT
GDKELANTVVGPDGSNCQAGSTDPACSTNDDVASLVIDKTSDAKNPVKAGDKVTYTVTVT
NEGTADYPNAVLVDSLTGDLDDAVYDGDAQASSGTVSYAAPLLSWHGDVAAGQTVTITYS
ITVGNPDQGDHRLVNAVSGPIGSNCPPLRSAPQCSTENGVAELAITKTSDAEHPVKAGDK
VTYTVTIGNDGAAAYPGAVVTDDLSGDLDDAAYGGDAQASSGTVSYAAPVLSWSGDVPAG
GSVTVTYSVTVNSPDGGDHELKNAVVGPDGSNCPAGSTDPRCSTADEVAQLAIVKRASTD
RVDPGGTVSYTVTVTNTGTAAYPGAAFQDDLGGLLDDAAYDGDARASSGTVSYAAPVLSW
TGDLAPGAQAVVTYSVTVDDPDNGDHALDNAVVGPAASNCPAGGKDTDCATHGEVTPANP
APGPHPGPAPLPDTGTGGLVWYAGMAAALAVATGTLLTAGTLRRRSRRS
>fig|452652.3.peg.4851 Permease of the drug/metabolite transporter (DMT) superfamily
MTAVSTTAPAAPPVPGERRQLPRTDLLLLAVSVAGISLSAPLISATAAPALAIAFWRNTM
SVAVLGPYALWRHLGELRAVSRRALLLAVAAGVLLALHFALWMPSLRMTSVASATALVTT
TPLWTILLMRACGVRAPRLVWAGTGLAFAGVLVLTGVDLSVSPRALLGDGLALAAGAAAA
GYMLLGAEVRRTVSTTAYTLVCYATCAVALLAACLLTGVRLGGWPAGAWWQIFLLMVAAQ
LLGHSLSNRVVRTLGPSITSNAILLETPGAALLAAVWLGQWPPAAAYPAVGLILLGLVLV
ARAERR
>fig|452652.3.peg.5102 Drug resistance transporter EmrB/QacA subfamily
MSENSSRARWLALAVVCAGMLMVILDGSITTVALPAIQADLHIGTAGLTWVVDAYVVAFG
GLLLLAGRLGDLLGRRRVYLAGIAAFTAASVLCGLAVNSGTLIAARFLQGAGGAMASAVG
LGMVVALFPDPAERARAFGAVGFTGAAGASLGQVLGGVLTQGLGWHWIFFINLPIGAAAL
LAGRRLLADDRGPGLKAGADAPGAALVTAGLMLGVYTIVEGGPAGWTSARTLATGAAALV
LLAAFLLRQARTATPLLPPRILARRTTALANLIQLLMLAALFGFQILLALYLQQVQHYSA
LATGLAMLPAALTIAAVSLLLAARTIARLGERRTLLLGLILLTAGIALLTRLPAGHLSYA
ADVLPTLLSAAGFGLAATALTALGMADARPEDAGLLSGLLNTTQQVGAALGVAVLTALAA
GRGTGGFHLAFGTAAALLAAAFLLALALPRHRAAPPAGAAAAGAGAAAEPPVLTHG
>fig|452652.3.peg.5804 Probable multidrug resistance transporter, MFS superfamily
MPTETPPHPSPRPGPTPSGLRRLTRGALADLTPLRDSPDYRRLWFGQTVSSIGQQMTTLA
VGIQVYDLTRSPFLTGLVGLCSLVPLVVFGLYGGAIADRVDRRLLGLVGSAGLAAVSALL
AVQALLDLRSIVLLYTAVALQGGFFAVSSPARSSMIPRLVPREQLPAANALNTIGMNLGQ
TVGPLLGGVAVAAYGAQSAYLADTVAFAATLYAMWRLPAMRPQTTSGKRATVLDGLRFLR
GQPNLRTSFAADLAAMIFGLPRALFPAIVLPFYGGDAGTVGLLAAAPAVGALAGGLFSGW
IGRIHRHGVAVLGSVAAWGLAIAAFGLVHNLPLGLLLLAAAGCADTVSMIFRNTMMQVAA
PDEMRGRLQGVFIVVVAGGPRLGDFESGTVAALTTPTVSILTGGLACVAAVLYLAARRPA
FLRYDARHPTP
>fig|452659.3.peg.1386 Multidrug resistance protein B
MLPAAVFALIASLVMPYLFTRFIARVIMFSRLIFTTI
>fig|452662.3.peg.3420 Outer membrane component of tripartite multidrug resistance system
MRRIAILVLVGGLGGCATVPDLGPRPDPAQPGAFAATRSLAGTSQAWPQDDWWRTFGDTQ
LDTLVGEALQGSPTVAQAAARIRIAVSQADLARAALLPSVGATATARDSRLTQSIGLPTD
GDWHWLLAGLVNMSWELDLWGKNSSALRAAVSARTAAEADEAAARLALASAVSTAYVDFA
QLLVRRDVAADAVRIRRETRDLVVRRFDAGLEPRTSVEQAEGGVDAAEAQLAAINEAIGL
GRNALAALVGAGPDRGLAIEPPSLTTRRPDALPANIPIELVGRNPEVVSARWRVEAAAER
IGVARAGFYPNVNISGLIGLASFGLDNLFRSESVIGSVGPAISLPIFDGGRLSARYRGAR
GEYDTAVATYNETLLQALHHAADAATSLRALRERVDRTNASVARQEAAYRLAKMRYEGGL
SDYQRVLISEDALLSAREQAAALRLRGFILDIALAKALGGGFRAAVPARDTNS
>fig|452662.3.peg.3422 Inner membrane component of tripartite multidrug resistance system
MAAAALSFGNFMVVLDTTIANVAMPTISGDLGVSTTEGTWIITAYAVAEAITVPITGWLS
RRFGEVRLFTACVVAFVICSILCGLSGSLGFLVLFRILQGFAGGPIIPLSSTLLISIFPK
DKANIALAIWGMTTVVAPIFGPILGGYISDNYHWGWIFYINIFFGIAVGSVAWWLMHNRE
TAITRSRIDIVGLLLLVVFVSAFQTMIDKGRELDWFSSSFIVWMAIVAGIALGALILWEL
TDDDPVIDLSVFRNRTWLVSTLSLGLMFGLFFGNIVLTPLWLQQMMGYTATWAGFATAPM
GILAVLTAPIVGRLMSKIDPRLIVTYGMVVLAISFFMRAHLNAQADFMSVAIPMFVLGAG
VPACLVTLTSLGVSELPPEKIANGSGLQNFIRIMAMAVGASLTSTYWENATKGNRAELVA
IIDPSTAPAALPGLQSGSGLAAFSRMVDMQAVMLATNDFYAMATILILVFAAVVWLAKRP
KGPLKQVSH
>fig|452662.3.peg.3666 Permease of the drug/metabolite transporter (DMT) superfamily
MPAQALAEHRAAAGLLWPLLVLTCVLLSSGSQVLMKIGMNGAPVQNALARGSAIEIAATI
ATTPLVIVGMAMFGLSAGAWLMVLSRMNLSQAYPCVALGIVVTAICGFWLLGEAISPARL
GGIGLIVAGVLVTGLN
>fig|452662.3.peg.3903 Glyoxalase/bleomycin resistance protein/dioxygenase
MAHFVIRTSRYDESLAWYQRFFDTETVYAQDGLTFLTFDDEHHRIAIGRIPDLEDHRENI
AGVDHIAFSMQNLEDLVTAYERNKAAGIVPFWCINHGPTTSIYYKDPDGVKIELQVDNAT
FPGGARAFFSSDEFARNSYGIEFDPDDFVARFRAGESTAALLARPDTLSAGE
>fig|452863.6.peg.1914 Methicillin resistance protein
MIPAVVPCTDRALWDESVDTFNGHPQQLWGWGETKAMHGWSVDRVLLKDGETTVGAAQLL
VRPLPLPFRALVYIPRGPMCSVADTQAVLNSLADHAAIRHRGVALSIEPDWDRDSAYAGA
VAGAGFRESSNTVLIPRTLILDLARTDDELMAEMSKSTRANIRKAMRSEVEFRKVKNESE
LEQVLAIYHETAERAGFGIHEDQYYRDIFRNLGDGSPIIGAFDGEQLLAFVWLARSGATA
FELYGGVSAEGQKQRVNYGVKWAALQAMREDGCSRYDFNGLLNDGISDFKKQFAKHENML
LGTWEKPLSPFYPAYSKAMPLARRGLQTARRLAKAAAGRAQTLLRRG
>fig|452863.6.peg.3284 Permease of the drug/metabolite transporter (DMT) superfamily
MRAAFFLILATLFWAGNFVVGQAAVQSMAPLQLTFWRWTLAALPLLFLAHMVDRPDWRAA
LRHWRMLLLLSALGMTAYTLLLYSALQHTSALNASLVTSANPVLIMVLAAVLLKDKPRPL
GWIGLALGLAGVLLVLTGGQLQRLLTFSLGAGELLILAAITVWALYTVLARRVAVPAVTS
TALQAAMAAVALAPVAAVTGAGFPSTQSGAWSLAFIAVFPSLGSYLLWNLALKRTGAANA
GNYLNLIAVFTAIITILLGQPITAAQVAGGVLVISGVLLTGAAQRPQRPKSSKPTSSPPS
EALPRLRAR
>fig|452863.6.peg.3728 Glyoxalase/bleomycin resistance protein/dioxygenase
MTLKMSTATTILPVDDAARARSFYTGKLGLPHRGMTDDGSELLGTDGGPMLQLMPVSDGK
HSEHTALSFEVTDIERTVRDMEAMGVRFQDYDLPNLRTENHICTTGSEKCAWFMDTEHNI
LCVHERLNGQPDYQV
>fig|453591.8.peg.383 Permease of the drug/metabolite transporter (DMT) superfamily
MIEALVPLIPQFLWATNFVVSKVVISKGLHAMTLTALRWAIAGALLYAYSRLKGLRVVLS
KELLLPSLTGITGFSALTYLGLTYAKASVVGLTMALIPIFTSVLAAAFLKERLTPLLIAS
VAAGSTGVTLLTLDSSGLSWLGALLGSLAALDWAVYTVASKKAMRELSPIESLTSNALMA
QPFNFLLALPFFSLAPMADPEVLAGLLYVSLVPGFLAYFLWLYSVNLVGAARAGVYINAL
PLLTLALASASLGEALSGPQLAGAALILLALALVTLDYLKRLSTS
>fig|453591.8.peg.394 Multidrug resistance protein
MWTKLVALSAIISITFSASNVALPYFLMYLKGELKTLNAELLNASKVALEFGALTSTFMG
TRVVIAFLSGYIAERIGMKRSVVVGLILYLVSGIWLIVTENYWEVLVSRALQGVASAMVW
PVAESMIVEFAGGKKTRALMLYVMAFNVGMILGPAVGGAALQASSSLPLPVAVRVPFALL
PLGALAGLLLIFKLPDVRYKTKMKVRELHAKIKSALYVFFFNAFANGFSAGIFMSVLIIY
IMQYVTSVPIKLSSLVALSGLLGMALASPLMKRLDEFDFTNKLKVAIGLGLLHKLALAAV
GLTKSYFILLAILTVQNFAITVVIPLIRSLVSDLVPRELTAKVFGMQQAYFNLGMIVGPL
VGAALYKWLEASGVGGGLAFPVAAALGAAGVLTLLRVDGREVEGMKGEPVKAEG
>fig|453591.8.peg.412 Fosmidomycin resistance protein
MRKRLLLLGIALLSLGYGYYTTAARVSGDVSEAGAVAVAELASAASATFFGWLADKKGMR
KASLAAPLAGPLSALGLDPLSVFLTLSFFYSAFVVALLAANEAGPEELGASVGALSLGWG
AGVALVPYFRGPQVPAASFFAGSLAVVAAVPDVPGRANFLAAVPKLKRLVPPLAAFMGAE
YLSYALTAWRFYELADPTTFVLSYAVGPGVTAFLGGLVAGRALERFGPERVLLGSLLAYP
FVVALALLAPPPACFFAWSVPVYPFYEAGLVATVTKFVPEAKGASLGLTYTTMALSSFLM
APLTRFKDVKVIATISITLMLISTIIIKRIICPPSRARRRASPRP
>fig|45361.3.peg.236 Multidrug resistance protein homolog
MSDQFSNIHQELSQYSNKHIQTFKTFFLHNQIFSFKNLIEHGFSKFTSKRTKILKKSSSI
SLIATFVTTMFTGILLLEVTLLTFYNYYDVSIFLSLMLYSLDFSGSFGDIIVQTFMLSIR
GQYLSNIISKVPTTTVNRELNKAIEKISISNLSFVFEDKTVFSGINFDILPGKKYLIDGP
SGTGKSTLLKTILGVYPDYQGNILINDELEINQVSSSSLRQQIGFIDNQNIIFDASLQDN
ITLFDTQVDLQKLNKILDTLKIDWLKLEDNINVNKLSEGQKQKIVLARLKYSNIKFWVVD
EALDNIQKDHAELTIDNLLGDPDLTILFVSHHISADLREKFDEVIAIRG
>fig|455632.3.peg.531 Drug resistance transporter, EmrB/QacA subfamily
MLFAVSMTFIDQTIVAIAAPNIIDELGLTSSQMQWVVNAYLLTLAAFFALGGRLSDLFGH
RRVMLIGTLVFVIASALCGAVPSGDFAQAWLIGFRAVQGVGAALMFPAALAVVIAVFPVE
RRGRALALFFGVSGALTAVGPLLGGWLTGWTWRAIFWVNVPVAVVAIVLAVLARIPDRPR
REPLDLPGAALVAVGMGLTVLGLQQASTWGWDSVATWACIAGGLLVLAAFCRLELRTRSP
LINLRVFRDLAFRVDNAVLFFAMMAFVPVFFFASVYAQVSLSASPNQAALYLLYFFIGFG
LASQWGGRILDKRGARPAMKLGTALGAVGFALWAGKLTTLSMHDQWLYAAMAGAGIGLLL
APASTDAVNRAIDASYGEVTGITQTVRNFAASIGLAVFGTLLTHTTITKVDATLRAKDVP
PGESRDIAESIAQSVTGQADSRGPSGSGPVAETVRDAMSAIRMDFAEANQWVFYGMAIAL
GVAFLISLRHPGTRVTQESSD
>fig|455632.3.peg.3289 Drug resistance transporter EmrB/QacA subfamily
MIALTQLVVVLDATIVNVALPQAQLELELSDTERQWVITAYVLAFGALLLLGGRVADYWG
RKRGYLLGMLGFGAASVWGGLAQSGTELIVARGFQGAFAALLAPAALALLTVTFPAGRER
GTAFAVFGTVAGTGAAVGLALGGVLTEYADWRWCLLVNIVFAVVGLIGALLFVSESRVEG
DNRYDIPGALAVTLGLAALVYGFTLAESGWTEPDTVGFLAGGLVLLAVFGWVETRVAQPL
LPLRIVRDRARAGAFLIQAAIGAVYIGMTLYLMFHLQIVLGLSPLLAGLASLAMTFATMI
TAPVAARLLPARGPRVLMTAGPLIAAAGMVWLTFVTPDGSYWTEVFGPLVVVGVGIAFVI
IPVQNVALVGVARHDAGAASALVNSAMQIGGCVGLSVFTTIYLGAVERSGAAGSGRGAAL
TEGYSAVFLATAVTLVVAAIVAATMLRGPRPAVTPDRVAEVPAHVG
>fig|455632.3.peg.4302 Glyoxalase/bleomycin resistance protein/dioxygenase
MTASTDDSTGTTDAAGITGLGVVLGSTDSDALIAWYRAALEPLGAHWAEHLLVIGPGAII
GFDERDDVADQAAEPGRQLINLTVRDIRAAERHLNALGVTWVRPVEEVGGGWYFSTIVDP
VGNYLQILQGPGAP
>fig|455632.3.peg.4494 Drug resistance transporter, EmrB/QacA family
MGTAPTPGADTGSGAEAGAGSGADGAGGPSALTTPRGRRPVVAALMLGMALAAIDGTIVS
TAVPQIVGDLGGFTVFSWLFSGYLLAVTVTLPLYGKLSDTFGRKPVLVAGIVLFLIGSVL
CAAAWNMGSLIAFRIVQGLGGGALQGTVQTIAADLYPLKERPRIQAKLSTVWATSAVAGP
VVGGLLAGYADWRWIFLINLPVGAIALWLVVRHLHEPARPRPAVRPRVDWAGALAVFATG
ALLLTALVQGGVAWPWLSAPSLGLFGVSAVLAALTVVIERRAAEPIIPGWVWRRRTIASV
NLALGALGLLMVAPTVFLPTYAQSVLGLGPIAAGFVLSVMTLSWPVTAALSDRVYNRIGF
RLTAIIGIGAALLILLAFPLLPYPGEPWHPALLMLLLGAALGLFQLPLIVGVQSTVGWAE
RGTTTASVLFCRQVGQSVGAAVFGAVANGVLAARLLDAPVTGLPDDLDAVARALEDPGAL
SAAATDYLRRAVDAAVDHVYIGAAGAAALALLALVVLAPRRFPVITETAGAPRAAATAAD
RQDSPS
>fig|455632.3.peg.4936 Drug resistance transporter, EmrB/QacA subfamily
MALGVALIVVDLTIVNVILAPIIEDLSIGSSEAQWIQESYAITFAALLLVTGRLSDLYGA
RRIFLLGLAVFGVTSLLAALAPGGGPLIVARFVQGVGGAMMLPTSLALLNATFTGRARGQ
AFAVWGSTIGAAAAVGPLLGGWLADISWRWAFGINIPLVALIVVGVLRYLDVSPRTRGRI
DGVGAVLSAVGLGLLSFVLIEGRTHGWLMTTEPLEIGGLSWSGGLSPVFVALLLSVPALA
VFWRRQAVLSRAGDEPLMDVGLLSIRSFRNGNFVTLMVGLGEFGIIAVLPLWLQFALGYS
AFEAGLALVALAAGSFAASGASFPMAAAVPALAQVRIGLGLEAAGLTMLALIASTDSSWW
LISIALFVYGIGVGFATAQVTNIVLVDVPERSGGQASGIQSAARELGSALGIALLTTLFF
STLASGMTDRLTREGVPADEAERLGGVVTDSAGSVIGSLASEPRTASAAEAAREAMAVGV
QVSGYVCAGLLLLALAATLFMSPRGPRTPKTPKTPQNQGPSDPKAPHGPVRRTV
>fig|455632.3.peg.5255 Tetracenomycin C resistance and export protein
MTSQTTVEKAPREPEDNAVPAPVKGLRGHPWLTLFAVAIGVMMVALDGTIVAIANPAIQK
DLGATLADVQWITNGYLLALAVALITAGKLGDRFGHRQTFLIGIAGFAASSAAIGFSKEI
GLVVLFRVLQGLFGALLMPAALGLLRATFPAEKLNMAIGIWGMVIGASTAGGPIVGGLLV
EHVSWQSVFFINVPVGVIALVFGLVILKDHRAANAPRSFDILGIVLLSGAMFSLIWGIIK
AGESWGWGDGRTWAWLGLAILLFVAFGLWQNKVKEPLVPLGMFRSVPLTAGVVLMMLMAF
AFMGGLFFVTFFLQGVHGLSPVDSGLHLLPLTAMMIVSSPVAGLLITKFGPRVPLVGGMV
CTATAMFGMTTLSESTGTFAMSLWFALLGCGLAPVMVGATEVIVGNAPMELSGVAGGLQQ
AAMQVGGALGTAVLGAVMSSKVSAEFADNWAGAGLPGAPDPKLEEAAEFGMVPAEQLAKA
PGMTPDIIDRIGGVIHDTFMSGMGLAFTVAGIVAVIAAFVATLTKRGENAEAGAGVGHI
>fig|455632.3.peg.6397 Phosphotransferase (aminonucleoside antibiotic resistance)
MAWADVPVDTGSPAVGAVLLTGIPGSGKSTVAAALAARFAASAHIEVDALQELIVSGGRW
PSPEGDEEADRQILLRARNACLLADSFAAAGFLPVIDDVVVRRAHLDFYRATLTGGPLHR
VVLAPGAAKAMERNLARDKRLTTDWSFLETAMRAELADEKIWIDSAELTVAETVDAVLSA
TGLTPAPA
>fig|455632.3.peg.6546 Drug resistance transporter, EmrB/QacA subfamily
MTILDETIVNVALPVMREELGFSQGGVSWVINAYLIAYGGLLIFAGRLGDLIGHKNVLLL
GVSLFTVSSVVAGFSQNAPTLVAARFGQGAGAALVTAVTLAIIVMMFQDPGEQTRAIGFY
SFTFAGGGALGLIAGGVLMQLTTWHWLFFINLPIGVVSVILGWKLLPSGKGLGLSAGLDV
SGAALLVSSVSLLVYGIVNAEHNGWTGMTLAYLAGSVILMIAFVIRQKKAKAPLFNLNIL
SDRDVAGANIVQFLVSGGLYGSFFVATLYLQQVLGYSPMEMALAFLPLTVITALGSIALS
PYLTAKLGERIGLIIGLAIFVAGALFLARTPLEATYAMDVLPSMLLLGLGIGLCLPPIMS
LAMSTASEDEVGVISGLTNSTGQVGGALWVAIVASAAGSITASRMDGGTNERESVNAGLM
YGSLVLAGALVIAIAVAAFVIRKRSVDTPTDGADAKATVHAV
>fig|455632.3.peg.7153 Daunorubicin resistance transmembrane protein
MADAAAKQPVVTLLRAHLACARMEFRAALTYRTAYLSSFAMMLLQIWLLTVVWKALYDGR
EEVDGLGLTTMTAYATLTTLQYHLVSPWRSSPIDQRVREGKVAVDLLRPVGFPGQMLAGQ
LGWASAAVPVLLVALPFALLIGAGQAPASTAAGFAYPVALIGALLVNQLLGLLLGMVSFW
TLEVSGALMAYRFVAQFFSGALVPLWFMPGPIRAAAEWLPFQATAYTPAAVYLGQVEGVG
IAAALGVQLAWIAALGTLASFVWSRARRRVLSQGG
>fig|456827.3.peg.930 Permease of the drug/metabolite transporter (DMT) superfamily
MSNQNKAYLFAGASILAWSTISTAFKLALNYLTPVGLLFFASLTAFLFLGIVNAVSNPSL
FKTKELFKTVGRNLKISLMRGLLNPFIYYLMLFEAYSRLRAQEAQALNYTWAIVLALFSI
WLLKEKFRIIDFVSLLISFFGVWVISTKGQITSLQFDDALGSFLAVSTSIIWAFYWILNI
KDKRPALTKLNYNFFLGFLFIALFALFTHKSLFTPQAIYGYGILGGIYVGIFEMGLTFLL
WNKALELTDNTAVISNLIFFTPFLSLLFISSVLKESIHYATFIGLLLIVFSNLLQKGLPA
ILKRNE
>fig|456827.3.peg.1093 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKHSKIEILEKTPVAYSILYLALPSMLSMLVNILYNLTDTFFIGKLNDPFKVAGVSIALP
YYNMLMAIAGIFANGGASYLSRLLGKKDLKTARETTTTAIFTVAIVSIFAAALGVLFIPT
YLKLSGASALTALSARQYLTAIFIGSPIIMIKFTLIQLLRAEGAAKEAMLGLFIGTGANI
ILDPLFIFTFKMDVTGAAIATVIGQGLAMLYYISYYLKKKSLASPGRKYLHPRWSCYKEI
FAIGIPSSLSQVMMSIGNAISFKLASAYTDHTIAALGVVSRVFSIAIFAFIGLSIGIQPL
IGFNYGAQNYTRMKKIIKMSNIICLGMSAVFTLFFALFPGELIAVFIKDKAIMKIGTQIL
NAYVFAIPFAGLGMILMAALQAMGKAIPAFIVSLSRQGIVYIPMLYLLNYLFQFSGLIYA
MPIADVITTILSFTFVYHITKRLKSSP
>fig|456827.3.peg.1648 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MKLWITYLKAVLAMLFWSATFVWFKIAYKTYLPYEVTFLRLLLATILLFPFVWLTGKREK
VPKKDLLHLMLVSFCEPFMYFIGEANGMRIVSSTLGSLIISTIPIFSAVGAWLILREKLP
LLVVLGLILSTSGVAVMSLGSDDFSATFKGILLLLIAVFSGVFYGITVRNLTLRYNPFTI
VAWQNFFGMLYFLPLFLVVDGKHFFSVQHSLEGLATIAAMSIFASVIAFILYTGVIRDLG
VAKSNIFTNLIPVFTVALAYIILGDKLGLPGWIGLILAIIGLFLSQYPDWQKYRKQEKTE
LLPVVENAETNISDEL
>fig|457570.7.peg.298 Glyoxalase/bleomycin resistance protein/dioxygenase
MVKELLYCYLRTQVFSLLTSLLNLIFLFRTVSVKLLIFLQKIKERWYIMWSGSVIFLGTN
DLEKVHDFYHNVLQLPLFKDQGACRIYEIPGGGMIGFCTHMEVKSEGKAPIITLLTEEVD
RAYGSLIDNGYQPFNKPKTNPDFKIYHFFSEDPNGYSLEIQKFLD
>fig|457570.7.peg.602 ATP-binding protein involved in mithramycin resistance
MGLASLFPLTTLMFLNFFTDNPSSGQMAHIITGNMMFALVITGLNVVAQNISQQKHQGHF
TFYASLPISKINFILANLARGAMTSLPSFCILFVIGRLVYDVDFYMTWALFPATFLIIMS
VVGIGAYIGFWSPNQQLTSMLVQALMMLISFLTPVMVRIEDLPSLLQLISRLLPTTYAAE
TLRILLISGLTQEVLFNAAILLVFTCCFYILILNNLDWRIEE
>fig|457570.7.peg.1509 Vancomycin B-type resistance protein VanW
MHSYNHLAIHYVMSRIFIAGWFYMFKKYYDNFDKKSKKLISIVIPVMIFFMFMMLGLGGY
QQYRYQNTFIPGISIAGINISEKSHTQVKKLLEQELENMSDQKIILEHQENTWEYNFHEL
GMDWMVKASFDKALDNDELSFFEGIKLLLAEISQDQEIQLEHELDESKTKSIVSNLRDEI
AQKPQDAEYQVNKYAQSVSIKPHQNGKEIDESKFISELNYLLEQISQDLRSFTDAEFVIE
IPTTTVEPDTLTEELQELGIDTLISTFETHYDEDDEQRVTNIELASEKLDNKKLEPGEKL
SFNEVVGPRTRERGYQEAPVIIDGELVDGLGGGICQVSTTLYNSVLKAGIIPIERSPHGI
PVEYVSLGRDAAVAYDYLDLVFENHRDNGILISTLVDENRLRVDIYGSQESHDYTIRTED
YQEIHPDTIYFLKTDDGERVEISQEEKQELLDTNESDENVNENDYDNEENDLEETNTNND
DKEHIEDTNYEITELQRGRLGYQIEVWLLTYKNDEKVDKEHIATDIYPSRDEKYLIELED
SDQ
>fig|457570.7.peg.1957 Acriflavin resistance protein
MFLSKIALKRPVTIIMAVVIILLLATVSFSRIPIDLYPDMELPVLFVQTDYEGAGPHEVE
NMVSRPLEETLSTVDNLSQITSISQQDSSQIIMEFDWGTDMDFAALDTRELIDMIGEQLP
DDAGDPTVMQLDPDMMPILQVGINAPEMDLQEISELAEGTIQTQVERIEGVGEVNVMGGV
EREIKIHVDPYLLSSYQEVSYENIREAIAANNMDISAGEIRDGDGKYAIRTIGQFEDPDE
IKDIQIGVEGESPVKLGDVARVEDTVEDMEPLSRINQEPSVSLGIRNQSDANAVRVAQDV
RAELANLEESLPGNVQFEIVTDQSTFIEESIDSIIEMGIIGAILAMIVLWLFLGNFRTTL
IIGFAIPISIISTFNLMYFQGYTMNLITMGGLTLGIGMVVDSSIILLENIFRKREQGLSS
YEGALQGSKEISGAIIAATLTSMAAFLPAAYTEGIAGIIFEPMAWTVVFALFASLLVALT
LVPMLTDKVMGEGVDFNRKSYLPRKMDQGLQWLTNKYGQLVDWVLSKRFVVIVSFIGLMI
ITVLIFPLMGFEFFPPEDSGEITVDIQYPVGTPLDTTSDNLLELEEEISQVEGVETVFAT
AGGGGDFVVGGDSRSGTINVIMEDDHQRTTFEVVDEIRGLIPERGGVDVTVSADDMAEEG
GGMEGEEDLTVLIKGDDMEELESISDEIAENALTVPGVVNTTTNFEDATMEIQIDVDEAS
ADSYGLTTVTIGNFVRQVSEGELVSFYREGGEEYDITMEMEPSQGISVSTLESLLINTPT
GEQVPLEEVASLEMAETPRQIEREDRVRTGTVGVQIEGRDIGRTAGDIREVLDESIELPP
DYTMDFGGTYEMMMESFEGLGLALILAVLLVYMVMAAQFESLLYPFIVMFTIPLALIGVI
LALLVTGHSLSIVAFMGVIMLAGIVVNNGIVMVDFINKLYHEQGYNRIEAIVTAGKIRLR
PILMTVLTTILGMLPMASGAGEGAEVRAPMAIAIIGGLAVSTIITLVLIPVVYSLFDDLR
LRFHSKLARKEESGDLIVKN
>fig|457570.7.peg.2311 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRGMAGGAQLAQQNKRDLTTGSIPKKLIRLALPIMGGMFLQTIFNIVDTFFVSQLGHNAI
AAVSMNMPILFILIAMGNAVAVGTSSYIARSIGAGEDEKARKTASQAITLAVILGIVATI
IGVSFAPYIISFMGAEGELYSLAVEYTSIIFWGNLIFFLFLALDGVLRGEGDMKTSMMKQ
VVGVGFNILLDPIFIFGLGPVPAMGVAGAALAIVLSRFLGLLFLVWHFSTGRSTIKFNMT
KFVFESEIIKQIMAVGLPTSASQAMMSLTLFVYNRLASGFGDEAVAALGLGFRIDSLAIL
PGIAIGISMVTMVGQNYGAGELERVRRSYWTAQAMAAGFMASVGVFLFAFPEFFIGIFSQ
EQDVMSHGVSYLRILPIFYPFLGSGLISAHSFQGLGKAIPALIISLIRVGLVGIPLALFL
TSQTGLGASGIWLALGLSDFTFFGVGMLWFKSTFKRMTRFVHS
>fig|457570.7.peg.2642 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKVSSSDRLGTDPILPLLLKLSLPGIVAMGIQALYNVIDSFFVAQVNEEAIAGLSVAFPM
QLFLIALSVGTGVGTSSLISRMLGKGDRNGAISVVEHVLVISAIYSVVVFLIGFLLPESF
IYIFTDDHLIAQYAFEYGRVILMGASPLFFGFLISDALRGQGNTLIPMIGMVSGAITNIL
LDPILIYGMGPIPRLEVQGAAIATVISKTVTFAVVFYELLIGENEVKPKFRDGLKNFKFN
KEIIKNIYAVGLPAAVMQMLASIMISGLNIIVGNLNALALSATGIYFRIQSFVFMPVFGL
NQGYIPLVGYNFSNGNAERVKKVIGYGALIACGFTSLGFIGFQFIPEIIAGPFVESQELM
DIVVTAFKTISIAFPIIGPAIIGATTFQAIGKGIPSLTLSFFRQIILLLPIAYFLSLTGN
LDLVWFAFPISEFVSFIFMIIWLYITLKKELIFAKFQRG
>fig|458233.11.peg.254 Multidrug resistance protein
MKQQFKLLMMIQFFIYFGFSIVIPVIPALVHSLNLNAFHMGLLLASYSIVSFIVAPMWGY
LSDKYGRKKILIIGLIGFTLSFVLFGLFIDNLPMLYTSRILGGLFSGACFSTTTSMVSDM
TTHEERNKYMGLMGMMIGLGFIFGPAVGGLLSGISYQIPYFVTAAILTVIALFCLFTIQE
TLQHSTDSEQATVNPKLLTPAVYMLLLSTFIVTFTMSGMESSFQLFEIEKINITATQMGM
LFMIGGLVNAGLQGGYLRKVKHGQEKPVIITGQLITIVAFIMLPFSMNLFYAGLCLVLLM
SGNALVRTLLTSQLTKETSSNKMGKLTSISYSMDSLGRILGPLLFTALLSRHLEMPFYFG
ALTSVFGLILLFIYYKKGRVV
>fig|458233.11.peg.353 Chloramphenicol resistance protein
MKVNLFLLAMMAFLAGLNELVLAGILPFVMDYFNINTQEAGYLITVFALIFGLAGPVLMS
VTMNVNRKTLLLVFLSIFIVGNLMSVFAQFYWMMMLSRIVLAASVSMLIGLALSLSVKVV
PEYMQARAIGIIMMSISGSLVLGTPIGIYIAELTDWKVIFILISVLSAILMLLLMKYFPK
NIQVERVSMARDWKFILKKEILSVHLFSFLFFVGQGMFFVYLTPYLMDRGHSIAVVGLIY
LVFGLAGILGSGIGGYMTDKFGSTNLLVVQSFLYVFLMLMVNFTAFSAVLVCINIAIWAM
TGWMVNAPTQTYLIQAAPKFSSINQTVSTSSTQFGISLGALLGGICITQTNSYPALIYYG
CCVLVIAFLVTLYIRRLNTK
>fig|458233.11.peg.644 FmtA protein involved in methicillin resistance
MKIALEFLFSRNRNISYTAIDKYLDDINFNGQIRISHEGQGIFHQSYGYKNLIQDPITYD
TQFLTASIQKFITGIIIEQLIDEGKISRMDKIVKYINGLPDFITIEDLLLHISGLSPYKV
HHNFYGLDQSVDMIRASGAKLPFHKFDYNDANYILLAKLIEIVENQTYRAVVYDRIIDKY
QLAHSCFYDEVNDATTGLHQFGSVLIEDWHNDLDKYYGAGNMYMSLKDIDILSRLFANHL
IFNKPKTEFILAPDRYKNQKYRSGISLRDNYLRLRGSLYAHDVVVYFNGTSFICVASNRE
SKLYQAEKILLNILNSNKYC
>fig|458233.11.peg.645 FmtA protein involved in methicillin resistance
MRKLIVLLLIIGLWGVLIYELTGKNNETHEVNGKQNTGVQTNVSKTSQNDALKIQVDQLI
KKNHFNGSVFVAYNNDTLLDQSYGFKDADQTKKFDENSMYLIGSCQKLITGIITKQLVDD
RKINVDVSVKQYIPNFKYPNIKIKDLILHRSGLVKYAFHGDYHGLDASVDNINATGLGPV
PHGSYLYNDANYILLAKVIENVTGKSYQQNVEQRIFKKYHLKESSFFDDEKLSPYFVKGL
KYVNHNWKAIEPTGLDKFYGAGNIYMSPKDMGILLNDVMQYRVLSKSQLDSISKPMIFNI
HSKYRYGMSLKKEYYRSRGYFFGIDFVSLFNHNKVVVVATNKLTQNEIPNNEKLAQQIYS
LLK
>fig|458817.3.peg.2404 Chloramphenicol resistance protein
MNPKVYLLALITFATGMDENIAGGIVPFIAEDLGVSISAAGQLTTVFSLTFALAAPVLLF
ATAKFNRLRLLQVALFTFCLGNLFSALSPSYAFLFGMRIISAASCALIVVLVTTIATEMV
EAEFKGRAIGIIFMGISGSLVLGVPVGLLFCNWLGWRAPFAFIALMALLLCIIVPLMLPN
VSSNGQRIPLSKYAEHLKNPKLLTAQLVSILMIGGHFVLFAYLAPYLQATIGASKSELTF
YYFLFGAAAITGGYMGGWLSDKLGHITAIILIPSIFILFLGAIPFTLNSLVLFIPCMMLW
GGLSWTISPIVQNYLIQSDHANAGVSIAVNNTSMHLGVALGSLLGGVVIKYSSVNWTPAI
GVFVVVLSLLCALYSTRCQEITREECKEKLIQP
>fig|458817.3.peg.3313 Permease of the drug/metabolite transporter (DMT) superfamily
MFHSRANALIRLAVFPVLLLYWQDFYGTRLPLLGPALVAVLFCISSQMPSAKMILKLGVI
LFVCTWAQGQISLYLFDDPLIYYLLLFVTFYWCMQRARENPTDIISSFMLLSLVLVTVFS
RQKGLDITQLPKGLFLELIYAGFTVFIAFLLFPGGEIIATTQTIPEGGAQTEIWHLLLKA
ACSFICLWVFIDLNLSQAALMAITFTNVIKDPNPMKGVNYGISRFIMNSVGLLFALPPLL
AAAFEVNIIVQLGVAIVCAMLMGIYAMKKEASINSFQVLYCAYVILLFKGITESGGNALH
NDFIRIGSILFSVMLGLIILLLLQSPTKTEQVP
>fig|458817.3.peg.3314 Membrane fusion component of tripartite multidrug resistance system
MPTSKDTASTGDSEITQKKTVASSKRVTWILLVIVFLLWIYTLWADRVTPMNNHARVNAQ
LIQITPQVSADIYKVSVLNNAEVRQGDALVDLDNAPFLLKITAARLHLQQTTLSLGADSA
GIQEAQANLVASEIKHDNAFKHTQRMAALGRTGVISKQSLEDSQDQLKDAEAQVVQAKAA
LERAKKALGPKGENNPQLQSALNQLHQALLEESYCHLRSPGDGVITHLNLAAGNFAVAGH
PLITFINNKHTWITAMLRENSLIYLKPGTPVKIVFDAYPGQVFRGEVQSIGWGSSGNGNL
QTDQTTGLLISPDGLQHSQRFPVNINLGPEASALQQRYGARAMISFYPGESGVGETLLNI
WTWTWSYLSYVS
>fig|458817.3.peg.3711 Multidrug resistance efflux pump
MKEIMLPYIFIVWLLFKFKVIKARPRNYFISVFVGCLIAVALFLAHRFYSPADLTNSTTV
RAPHAILSPAIGQQIDTISIDHNQHVNKGELLYTLVDDKVSSAIDEINARVQEVKRNIEA
TEVKLAQAKRNHQRKINLGDHVSERDLENAADKVEITTAELKVQYAQLEVQYAQLRKQEF
ELKRLEVRAPFDGMVTHVYIADGSRVGAMHLWDTGRKFVEMRIPDQSFAYIQPGQFAEFY
INAYPGQIFRARVHSKVEATGEAQGDILPREQMVSRHINLGSMPVGRTVVLEVDDATMAM
LPIGATGSAWISADKPSSILGFLDIIGAATVRLTAVKAYLNPL
>fig|467705.8.peg.1783 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MRLNIKEEYLVKKYLEFLSKDRNMTLKAYLFRCKRSNSIWLFWIFINSLCVYLNGILSAK
AISTIVNFDLQSFLYLSGAILAVNLLWVLQIYQNSKASEKAIQEMCTEIRKDIVKRIEKN
GGVHFASKSISAYTSWLTNDINTIRDLGFETLELMISQALNIIFAVIAFFSFHYSLLFTI
FIFFILMVNLPKIFTKKMEKKAVYFTEKNEELVKAIDDSLSGFRMLSNANQLHFLLVKIL
SYSKQYSRSRVSYSKTFGGLMSVQNGTSFVSQIAMLTHAGILYFNRLIPIGAVSSSQYFS
SIIFAGLTGLTANYAEFKTVNKIFEKFELTNDHSINETQNKKQPWKKFIDKLEIQAVTIE
REGKLILDNLNFKIEKNKKYAISGTSGSGKSTILKAINGEVLISKGEIFYDNVNSQNIDL
VDLHKQISYVSLDDHIFNESILFNLTLGRQLEDTKIEKALDLFYLRDWVSGLRHGLDTTL
SEISQDISSGQKQRISLARAYLEEKPILIIDEATDAIDKERRYQIEKYLFSLPDKTIIFV
SHHLDENIKSLFDKIIYLD
>fig|469378.5.peg.316 Permease of the drug/metabolite transporter (DMT) superfamily
MCWKGMLPNVQSKQGIVIMLVLIQAAIYGLGNVLMKIAYLGISPMWCAVLRFGLAFVLFM
LFFGRRVISTFKGKRLRTWLPSCLLMAASFLLCGLAVNLTSATNAGFFMALPMLFTPVLS
LVVLRRAYTLQTVLLQGVVIAGLYLLCCNGGALSFGPGEFCGLASSACFAASIVMAEHGL
GEVDAIAMSVAQIGVTFVTATGAAIVFEVPPVLDAVPLESWVAIAFLAVIGTCVAFFLQN
FALSRIPSATVSVLLCAEPVFTAAISAVALGEVLTSVGIVGAALIVACTMAASLEDTQIT
LPHRIVHEHVQRLSSVRR
>fig|469378.5.peg.357 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLDRADFKVYIHYIIPSIASFLLTGIYSIVDGLFVGHAVGDAGLAGINVAWPLVAFMMAI
GTGVGMGGAVISSIYAGIGDLRSSNRAIAHTLSMLALATPLVMVVLFCFGQQLIYLFGGR
DEILSQSQSYLSVMTWGSLFQIMASGCIPLMRNKGRVVAAMVILVISGLLNVALDFALVM
LAGWGVAGAGLATVIAQAFVFICGLAFFLKRENRPRSRDFALDGEFLSRTLKGGFAPFAL
TLLPEVTTIVMNMATEAHGGATAQSAFAVISYVAVAIQWIIQGVNDGSQPLVSLRFGEGK
LSTMRALRHTNYVFAVGIGLAGMVALYVLRVPLAVVFGISPQTSEVFYHGVALFSLALGF
YGITHATTSFFYAVESSRNATIVILGEVVFVVFFAAVLPLFLGLDGVWLAVVATQACLAV
LAVALLRHSRGNIAQAAARHVEKHAELAGQAAESNA
>fig|469378.5.peg.782 Albicidin resistance protein
MKFLGIQLDDIKRDQDDYRTIDSVKQLFSEKSKTMEAEFNELLRHFTALKNLAATTRDDD
SIDWSRYARIIQDFEDGGKYFWQLSCVYEENASREVEAAVQRNIEEKQRHHEKMRAMHEL
IAQAIVLMHDGVPADDERAQELARKFNSIQDKTGWAMPVNHFILGDAHSSHSGDHAHTNH
HASDSMPPSLAEANTSPFGELRNDVGAYFLKASQALQKQQKRKEL
>fig|469378.5.peg.1150 Multidrug resistance protein B
MRAHAVQTNSLYARQPSAKRPAAQQVQHSRRVSPIQQAKQVRQRPTHCLAGLIHRAASPV
AVLLIFLCMALMLHFLFLPQFAGLPFVGFTYDGGDASAQLIPAVSLLERSLMDGTFFWSW
DYGLGGDLFSEFSYYYSTSPLFYLQFSIKWLFGAAGGDFATTQAWRVVFSIIKQILCMLF
MYLLIRREGKGRLAALTAGILYGCSFWYIDNSVAFDFMTDAMLWPPLLVMAFNRWNRTGS
WMPLCLVLALSIASNFYFGYIVCVFCILFALVFAYRGENGQKWAAFIRGYLRRLGVLALV
AIGAILLSSIAFIPSVIALLSADRAQVPLQVGIFPSLHFVKALPEILFFKGGMFSANDAQ
TYAFPLIAMLAPFLFKHLSPAGRKRTIFAALLVLLWLLPVVSSLMNGLSYPSNRWCYLVV
FAVAYAVPDWIECLATKGIRAVRPVVFVGLAVLALVVLATHNVRVQDLSGAPGYVFQLLG
ISDLVFFGLQVAFIAVILLKGTRQQTNGAARVHGVPLSAAALALLAGAVLLAMPFGPYAA
YAGFRDMGGAVTFSSPEQLNKTFEGDTSNQETYRLLAQAGAEFEAGVKTKTEPRVAAHVQ
IDTDANAGVDANSGTDSIDANNTFFRTADEETYQDDANYRRFENRSWILGTHPVSVYNSL
ITKDISQWIKRERQVTPTTRSASQYRGFGHRLFIENAWGIEYKFNTTEASNLYGYEPLDD
SSHESLGDTSQVLGAQDASNENASQTNISHTNTSQTNAPSSDEATEGKTTEGKTTADKTT
MDKVTASTKEIWRNRYATGIDLWYSTATAKSSTPTWSFEESDAALLQTAVVDDDVANRLA
LPSGTLESTVTVLPLDNSNTHFDNCSLSNGILQVDSGGGSITIDLPDNLGSGECLLSFTL
KNTQEESFTFRVNGEEYWQGGKTHRWRYPIDNYSLCFPEPEGSLKVNISAGTYTVDNVQL
EFGSYSRLADWTNSVNRYGLADLTVGKSSITGTIHTDEAGILALAIPYKKGWTCLVDGKP
ADSFVVNGIFAGVFLDAGDHTVQWSYANPYFPFAAGLSILTGMALAAIWYFRRRKSGSNV
LTRKQIARPSVPSCSQSRVRSHSPHLLENDLAKQHEVPRHNADHSSELSNKRHNADTSHI
>fig|469381.4.peg.255 Acriflavin resistance protein
MEWIVRILRQRKVVYSLFLGAALLGVLAWVSMPREEDPPLSYRAGMIQAVFPGADAESVE
RLVVIPLERRLSQVKEVKRVKVTARRGSALFLIHLHDEVMDSIAAWDEVRRAMEKARPDL
PSEVTGLVLDDRMMDYESIVVAIGGTSDLLELRNGAIALEKELLRLPSVSRVLRIADPGE
QITVAYDDSTAERMGLSPRNLRQALSMQNRTMPGGSLVMGEKSAALQAHTEFKSIVEIED
TPVRLPSGETVPLKTIAKVIHGPSEPARDRMRYMGNPAVGLGIVPVTPVNSIEFGKDVRK
ILERMREKLSPLEIEEVSFQPHYVDLRLKGLSNSLLMSMVLVGGILCFSVGFRMGMVVSS
VIPLIVLSSLGFYALCGGVLNQISIAAFVIALGMLVDNAIVMAESVEVRMKNGSGGMDAA
VDSVRELGSPLLAATGTTVAAFLPLWMAHGQAAEFLRAIPQVVTLTLFLSLLAAMIVTPT
LAALAFRKSRGNTADYGGRFNLGRAIGAFSSKHAVLILLMSLSLLLVVGGYGKHVRKNFF
PGADRNVVMVDLFLPEGADIHAIDGIVGKVERHLKNEVPSVSRVASFIGRGAPRFYANIV
PAPRNPHRAQMILFTTSQSQNHSVVGEIRSYLGEEIPQVNSVVQELVLGTPVDAPVEIRL
YGNSLKDLRFGAERVMEAMKRIPGMVDLRHTLGNGNPSLEFDVSSGAAFRYGLYRDQVAQ
VLSGRTLGLPAGEYRQEEEPVPIVLRSEKGVFFGADRVSSVLMDSSTGVPLQTVAPTEIA
WHPSAISRRNRERYVAVQSNLEDGYVYSDVMTRLLPILSETDLPEGVRFEIGGEAEASGE
AQGSFSLAAPFGLIVLVGILLAGFRSFRKVGMVLATIPLASLGVIPGLLLSGEPFGLMSL
LGVIALAGIVVNNAIVLLDVVELRRKKGLSVHEALTKAVEERIRPILLTSGTTAAGLFPL
AFSSSNLWPPMAWAMISGLCASTALTLFVIPAMYRVLYPEKSVFARLLGLIRVLVGTKAV
RNDQI
>fig|469381.4.peg.339 Fosmidomycin resistance protein
MTTAGKALSSKTKVALLSTGHLVNDVHTAFLDTFLPYLVKNLGLSYAQAGILTSLSGVIH
TVFQPIMGHVADRHTRPWPIMFGPIAAALGASMIPLSTSYAMALTMVTLWGIGAATFHPQ
GQGSLGYVAPPSELAFAISLFGLGGMSGGTISSIYAIALYRYFPHWAMPVIAVIPPLILA
AVYYKTMPKIRDRSPEEDSDDIGMIKNLSSVFKRIYPIWAVTILRECSQKGVRFLLPLLI
VSEGGSITKVGTFLFFLSLTASILPLIAARIAMEVGNVKIVKIIIPLASTFLVIGWATEG
FLSLAMIVIGGASITACNPATDAMAQELAPDKRSTASSLMMGFSFGLAGVAMAPLGWFTD
AAGLRAALGIVAFLPFLSLPVMYLLWPKKGLIR
>fig|469381.4.peg.368 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAKVPKGKKAEMMGSYPVGAILWKLSLPTITGMVVQASYNMVDAAFIGKGVGTLALGGTT
ICLPFQMLMGAMGGAIGMGGASLVSRALGRHDRELASRALGNVVALALILGIAATLLGKA
SAEAVVTLFGASEEIKPYALEYLGIILLSCPLTLLAMSSNAVVRSEGNANVAMLSMVISG
LANVFLDWLFIFHFHMGVAGAAWGTLISKLLVVIWLVSHFTVSPHKVIKLSPRRLRVDRD
IVSEISSIGVSAFVRMAGTSLVMASVNNAMGIYGGPYYVAAYGVINRVMSIVYMAVNGVA
LGMQPLAGYNYGAGLFDRVRSSIKLSIIWGTGGCVFFFLLLFFLPERVFSLFTNDPDLIA
AGVVSLPTIVAGTSLVAIHRIGATAFQALGKGKPAFWLSMTRHVLVFLPLLAILPRFMGL
TGVLLSFPLADAIAAGITLLPLRKEMRQLKKEVLSTL
>fig|469381.4.peg.925 Multiple resistance and ph regulation protein f
MIYTVLWGLLFAGLVGFYRVVMGPTVPDRIVAADTVSTILTTFLAVLYLLFDDMVFLDVA
LAFAVLSFVDVLVMAKYFEHGELHL
>fig|469381.4.peg.949 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTSKERSERMGSDPIWRLIFQFSLPAIVGMVASALYNIVDRMFIGHAVGPNGIAAITVAF
PFFLLVISTGILIGVGTSSQISRRLGENEQDRAQLAMGNGFLAILVFSVVLMVLAFFFME
ELMYLCGASETLMPLTRSYMLVILWGVPFQLISFCCNYFIRAEGHPRYAMWTLILGACAN
VFLDWIFIVKMGMGVKGAALGTVLAQLGAACWVLLFLP
>fig|469381.4.peg.1009 Permease of the drug/metabolite transporter (DMT) superfamily
MAERIYDKKKMALGDLGILTCALLWGVSFAATKEVMKYMGPLWLLAFRFTFSFLLIAGLS
PKRLKKLTARDIKVGGIIGSLLLVAMALQTIGLQYTTTGKSAFITACYVVIVPFITWAAD
RRSPGFKAFVASGICLLGMGAITLDGVNMGIGFGELLTLGCALAFAIQLVVIDRMAQESD
ALTLTMVETALSAVACVVGALIWEPMPQVRSMAVVGWMAYLVVGCTLIPYALQIKSQQLT
SPTHASILLIMESVFAMTVGIVFLDEPLTSRLALGCGLIFFSILLTELDLASLSKKLRRQ
EA
>fig|469381.4.peg.1064 Acriflavin resistance protein
MGDRTGTPQKNRGEDPMRKLIETALVRPVTVVILTTALIVFGVYAFANMGMERMPNVDLP
YVMVQTTMEGASPSVVDNDITDVLEEQINTIDGIKNIDSSSYEGRSVIAIEFQLDKDVDV
AASDVRAKVNLARGSLPDEADDPVVDKFSFDDMAIMTIAVNSTADMRSTSTYVDKIARQR
LQTVKGVGNAQAVGLREREIRIWLDPIALQARGLTATDIKNAINEKHVELPAGRIESESQ
EFGIRLAGEYGSIEALSQMAVARRNGALVRLKDVARVEDGFEDRRSIATYDGKETILIQI
RKQRGTNEVALAKDVKAMVDTLNATAPKGISLKIVQDTSRFIIRSMNGVRGDIIMGIMMT
SIIMFLFLRTIRATFVAVITIPVCLIGTLIVLDGLGVTINNMTMLGLSLAVGMVVDSTTV
VMENIHRHKEMGKTAMRSSADGGSEVGFSVLAGAATTMAVFLPVAFMSGIIGRFFYAFGI
TVAMTILISLILSLTLTPFLCSRILGRQTESALTRAMEAPFLVLERLYTGLLGAAVRHRL
ITLIVAVAIFASGLWMATQLGSEFFPNEDRGRFKINFELSAEASLQQTEDFLLELGKLVR
QDPRVVYTYGTVGSGQGGEVYKGTITVELVPRDERAPFYVIMGEYRKKLAVYRDVDITLG
RWGGSDISLVLQGDSTEELADIGEAMKAELEQKSVGLVDITTNLRMNKPRINLDIDRNLA
DDLGISMRDLSTEIKTYFGGTNAGSFKEGGYRYDIRLRAGAEDRDAPEKISDIAVRGGDG
ELVRLPGLVTPRIELAPNVIKRHNRQRSLGIGANTDGISPGEGIVQLEEIFDRYAPSDGS
VTMFPSGDTENMRESFASLTTALAFAILLVYMVMAIQFESFMHPLTIMFALPLMTAGAFG
LLLLTGIRLSVMSFMGIILLVGIVVNNAILLVDFTNQQREQGMDKISAIMKAAPLRLRPI
LMTTCSTMVGMLPIALGLSEGGEIRQPMSITVIGGLFTATLLTLVVIPVIYLIVDDMTDR
VKRVFSRAGAIVRGRRMAASGRLPGQTTERGKTAR
>fig|469381.4.peg.1072 Glyoxalase/bleomycin resistance protein/dioxygenase
MRSAHVGIRVSDLERSLSFYVDKLGCRLSHRIDTQTSRLAFITAGETTFELVEKAPMTEH
NGAIHLAFVVEDMDETVKKLEESGIHLDKNGINSFQGGKILFFQGPDGETLELCQDVGTA
I
>fig|469381.4.peg.1119 Permease of the drug/metabolite transporter (DMT) superfamily
MDRLGFVLILGSALTNAAGSSMMKVGFGRRGDLMDGGALRALFQIVSNPWAIVGVLLFGV
SFIFMSAALSRVDLSVAYPLMSAMVYVLVLAVSVFWFGESMGLSKLLGIGAILFGVAALS
VGG
>fig|469381.4.peg.2159 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKDRTEFLGKEPVGRLLTKLSIPAMTGMLVMASYNVVDTIFVGRGVGPLGLGAIASAFPI
QFIVHALAMMVGVGAASLVSRSLGAGDSERAEVALGNAFFMALVAGLFVSAAGRLSMPTL
VALTGAPSELAPLIRDYLGAIFLGSSLLVCGMTMNCVIRSEGSAKVAMMSLILSAVTNIA
LDPIFIFVLKMGVTGAAVATVIAQGVTFLWAVAHYLVPGRSSVRLHISNLRPRWSILKEI
MTVGGSEFARLSAQSVAGVLILNRLSFYGGTDAMAAQGIVQKMLSLSIMPIFGIAQGLQP
IVGYAYGAGDNMRAKKAVELALISASIISLGTSALLLTVPGPLVRVFTDSPALIDTTKSF
IRVAISMYFVVGFQIIGTATFQSLGFSRPSMVLSLSRQVLLLIPLALILPPYLGLLGVFL
VYPTADIASASLTMWLLARYRKRLIPSQVN
>fig|469381.4.peg.2178 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQLVIIALAQGIGIGGSSLIATELGAENEKGAEEILGTMTMLISLGSAFIVALSLAFISP
TLSFLGASELTLPLAKDYGVIVLLGSPMLAFSIMANGIARAEGEAVMAMKTLAISAATNL
VLDPILIRYFDLGVSGAAWATVIAQAGSASWMALYLGGKSSINIRPRDLKLRRSVVSSIV
SVGSSAFVRQGSASITAVVLNRVLLSMGGDPALAAMGILNRISTFVTMPLYGLVQGMMPL
ISHNTGSGDQCRVLRTMDLSALWATAVCLAGALPLWAFPLATLSPFCSGETLEIAVAAAP
YVALGMPLGGFQVVLSGSYQALSRGRDAFLLDLLRRIVLVVPAIYILSHIAGLKGVFMAI
PISEVISGGLSILLFREVRRCSKKRCLVSSQDSI
>fig|469596.3.peg.151 Nitroimidazole resistance protein
MFKEMRRHLQKLSLQENKDILTKATSGVLAVSGEDGYPYAVPMSFAFDHKRLIFHCAKTG
HKLESVLRNDKVSFCVIDQDIIIPKEYTTYFRSVIVFGRTHILLDEKEKQKAFEILAAKY
SPNDQEGRLAEIHKLFKQTVIIVLDIEYMSGKESIELKNKT
>fig|469596.3.peg.152 Permease of the drug/metabolite transporter (DMT) superfamily
MSEGKAHFYCGIVAVIWGLGFIAVDQALLSFSCFDILLIRFLGSSILAWLLIIKDIKKIH
IKTVKKGVINGTFLFIAYALQTYAQTLTSVSNNAFLSASGVVMVPYFCYLVFKKKPNTIQ
ILSSCLCLIGIAILTSSKMSFQVGDILALGCAIFFAIHLVSLQYTCVLEDSRVINAVQLL
TSAILSIPCTLFFSRTPTDISLMSIMSCLYIVVFATFLCFFLQTKAQQAASASSCSVILS
TESLFAVIFSVILLNESIHIHLLVGGLLILLSVILVQTSSLKIVINKVMKKE
>fig|469596.3.peg.752 Permease of the drug/metabolite transporter (DMT) superfamily
MNIKKKGIIFTVIATLIFGITPVIGKMTYAMGSNGIQLAFLRHLFVVPLFLFIVVYQKLS
LRLTKQQYLDVFKVGFFGNTLTVVMLYMSYSYIPVGSATVLHFLYPLFVCLFNFLFYKQT
LNQKQMLCLALAIVGVFCFIDNTSSSMIGFVLAVTSGIFFAYYMIGMDHSSIRNISPYVF
NFYLVIMNTVVIFLLGLLTKSLSIMPIEGYILSAIVAIFASLVGVVLLQLGIRCLGASLT
AILSTLEPITSIVIGFLFLGETLTVLKIIGCLLVLLSTFILVKNQTAAGE
>fig|469596.3.peg.888 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKSKSTDLIHGHIAKSIFWFSVPLLIGNLFQQLYNTVDAYVVGNFVSKEALAAVGASSP
IINMLIGFFMGLATGAGVIIAQYFGAGDNGRLKKAVHSSAALTLVMSLLLTVIGMIGTNP
MLHAIGIPADVFHDSSTYLMIYFAGISFNLIYNMGSGILRAMGDSKRPLYFLIIACIVNI
ILDFLFVKYLHMGVAGAGYATLIAQAISAILVVIVLVRSEGPHQLFWKQIRFHFPILKKI
IMVGLPTGIQQSIVSLSNVIVQSYVNAFGSSVVAGYSATIRIDGFVNLPLQSFNMAVTTF
VGQNIGAKQYERVKKGSRIALWMTMAVITTMAISLFFFGESFIAIFNSEPDVIQAGRTMQ
LAFVPFYIMLPVVQIYNGVLRGAGKSSVPMYIMVFNFVILRQIYLAIVTQMTSDVYFVFM
GWPVTWVTCAIMFIIYYHKVNWLNQDSVS
>fig|469596.3.peg.2163 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNRKNIFATFIKYTSLSMLSMIGLSCYILADTLFIANGVGPLGLTALNLDLPIYNIIFGL
GTMLGVGAATRFSILKSQDKHHEANQYFSQSLIVGLIISIPFMIIGIFFPATIVQLLGGN
SEVLPIAVDYLRTFIIFTPFFILNQIMVTFVRNDHNPKLASIAMLMGTLFNIIFDYILVF
PCQLGMFGAALATGFSPVVSLLICMFHFAKKRNNFTFVKTKLYYEHLYHFITIGIPSFVT
ELSGGVIIFIFNIVILNIGGNIAVASYGIVCNLALVVTSFYTGIAQGIQPLLSQCYGHHQ
NELIHTITRYAIVMSLIVSGIVYILIFMFPENIISLFNSENNIVMTEIAKNGLLYYFTGF
FCVGINMIAVSYFASVEKVKPSFLISILRGGLLIIPIVLVTSQFFSLTGVWLAFPLTELI
VLFIAFLLHNKYHLIQTL
>fig|469596.3.peg.2332 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQNEEKIELFEYIPVSKSVIKLALPMILSSLTVIIYNMADTFFVGMLADPIQNAAITLAA
PIMLAFNVISNLLGVGTASMMSRSLDAKDYKTVKQSSAFGFYGTLFSGLLFFIVYTIFKQ
PIMELMGVQVNTEFATNIYMFWTVTLGALPTILHIVMLNIIRAEGKSVLASAGVAVGCIL
NIILDPIFVLPWGLNMGASGAGCATFLSNCASCIFYFIILFKKREKMFASISIKDLVLNK
KVDYGVCSIGVPASIQTLLNVTSMTILNNFTVIYGATAVAAMSIAQKINSIPLNIALGGS
QEIMPLISYTYASKNYKRMKNAVNYTRNVMLIFLILCSSVSFILAKSFVGVFMNSSDIST
YGSQLLRGFSLGIPFLCLDYLSVAIFQAVGMGKYAFFFAIARKIILEIPSLIILNSFFPL
YGLAYAQFVTEIILSIISIIVLRRLFHNLI
>fig|469596.3.peg.2340 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNVDMSKRQDLFETMPIMKAIMIMSLPMVLSSLVTILYNLSDTFFVATLNDSLQTAAVTL
SAPILLSFNIVNNLFGVGSSSLMSRMLGIKKFDIVKKVSNICFYCCVGCGVIFSLLFIFF
EHEFLVILGVDLQTMAATQEYMFWTVKLGATPAILNVVMAYLVRSEGASLQASIGTMSGC
FLNIILDPFFVLPQYLNMGVAGAGMATFISNCIACLYFIVFIMLKRKQTFIDISLLSFHW
DWKIIKEIFVVGIPAAIQNLLSVISMTVLNHFTVFYGVDAVSAMGISHKIVMIPLQVVLG
FSQGIMPLISYNYANRNVQRMRNVLYVSLKFSISILIVLCIIFMMFASYLMSIFVDIPHV
IQMGSVLIRFSCVQLPFLCIDYVTVCVFQACGLGGYALIFAILRKIVLEIPFLYLWDYLY
PFYGLSIATPTTEVILAIIAIIKLKKILTEQTKRL
>fig|469596.3.peg.2712 Permease of the drug/metabolite transporter (DMT) superfamily
MSIYIQLLLASFFWGSNVIVMKLLLDEIPFLLLATMRVFLSLIFLGIYLKWKNISFEYNY
KNKALAIGILAIYLNFFFTFLGMNQVKGIDNAFMNALAPILTFVFSLLLLKQKGNMKEYI
AIGMTVFAFLLSIRFQIFSIKIGFWYLFLGMVLYMLANVCIQKWKLHNSLILSFYELLFG
FFFLAIHCFVQGQFQLQPLFEISLFHWLLFLIISGIGFAFIQVTYMRSIGVIGALKTSFF
LSLNPIITYIESLLFLNEEFDIIHFIGFVILAIAIYMMNGQKEKRTNSLSHNDE
>fig|469596.3.peg.3001 Teicoplanin resistance protein vanZ
MYILSIELKLTLMQKVILIMIQTTSIVGYVYFDSNYQNQEKRKKSFLQMHWVLFILYCLN
LFYILFLDPDFGRKVMKATLSFEDYFQYNVNLDPFETIHLFIRGYQKGVVTLEALLGNLL
GNMLVFMPMAYFLPVLFPKLRKIRWFILTIIMMVLSVEILQVYLRIGSGDIDDFLLNVAG
ATLMYFLLKCFPLSHIYCLVGKE
>fig|469596.3.peg.3637 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKEKMETGKILPLLVELSVPAMIGMIVNAIYNIVDRMFIGNAPHLGSIGLAGITISYPV
TLVLMALSLMAGVGGATRFSIALGAKQDEDAKFYQGNSLMITVIFGLVFMIFGNLFMDPI
LTVLGASESVLPHARAYLSIILYGAVFQCVAMCGNNFSRAQGNARNAMVSQLLGAGFNIV
FDYIFIVQFHMGMEGAALATIGGQFLSMVWQLAFLFGKRGLIQCKLVHMKLKKRFTYMIL
KTGLPAFLMQMSASVLNIVINGTLGTYGGDTAISTVGIITSVQTLMLMPLTGMVQGQQPI
ISYNYGAKRYDRVKETLKYTVIGSTIIAFIGFLIIEIFPAMIISMFNQEAEIINLGSISL
RIWFICLPLIGCQTMCANFFQAIGMVKQSSFLNLLRQCLLLIPLILILAMIFKLYGVFIA
VPIADLIAFLITMYLIRREMKTFVVEEVS
>fig|469618.3.peg.230 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKFENDLSKGNVVKQLIKFSIPFLISNLIQTLYSVADMVIVGRYASTTSMSGVANGSQV
QFVITNMVMGFTVGGTVLVAQYLGIGNRKAMKETISTLFTTLLLIAVVITTLMIFTMDPL
LKLIQTPAEAFFETRAYFFVTTLGTIFIFGYNALSAVMRGMGDSKNPLYFVAIACVTNII
LDLLLVAKYGMGAEGAAIATVISQAVSMILCIIYLKKNGFIFDFKLSSFKFYKDRFDLLL
KIGIPTSAQNAIVSVSFLFLIALANTFGVSASAAVGAVSKLNSFAILPTVAVSASVSAMS
AQNIGARQIRRAVQTLKTGIIFSLAISFIIFLFMRIFPEDCLSMFGEDKEMIKCGVEYLS
AISYDYLLVPFVFCLNGLFIGAGHTKFSFINSASASLFIRIPACYFLGVFLNKGLYGLGL
GAPLASMFGVIMGVVFFLSKKWMRAVIVKE
>fig|469618.3.peg.238 Acriflavin resistance protein B
MKSISEFSIRKPATATMFIISMIFFGILGLKKMPIEMLPNINKPTVRIRIKWDGATPSDV
DKMITRKIEDVLPNVEGIVEYTSESSAEQSLIFVKFKYGTDVETKITLIQNEINQIRNKF
PDDMKEPSIRKSSMSDVPAITFSMAGGDRMEMRSYAENNLKPMLERISGVAQIQVFGGQE
QEVSVEVDPNKLENYNLGIMDVYNKMNKASVNLPGGILREGEKEYLIKIEAEIETADQIK
EIVLSNKNGHLLKLKDIAKIQVAPKDRTSIYRKNGKDSIVVIVSKTDDGNSVAIVNETKK
IIESNRGSLPINTVLNYEFDSSVTILNSISNVKSSGLQGLVLASVILFIFLKSVSATLII
AVAIPISIIFTFFLLNIQGISINLISLMGLSLGIGMLVDNSVVVVDNIFRHMTELGKTRL
QAAKDGAEEMALPVLASTMTTVAAFLPLVFQEGLAKEQFNNLCYAISYSLLASLVISLTF
VPMIASKVMDSKKDLNAEGKIMINFRKIYVATLKWAIRHRGAVLGILAVLFAGSMFIASK
IGGRYIPTVDEGRYAVVAKLPSGADVNKADRIGKVLEEKAVILPFVKDYTVSGNSSNTIL
NINAGLKTSRNESLQDIMRELRKTFVEFPDVELTITPGYKFGTRGIYDLEFELYSDNESQ
LQMISQELKEKIKEIDGIYDVTSSFEGGKPEGKFYIDREKAEYYGLDAKTIATMIQTQIL
GGTPIKINSDNSEIDVTLQLQKKYRESTGLILDSRITLPTGGNIRISDVAEFRAEEGPSK
IEKKDKKKKIVIYANLKDELDLETAQKLVITTLEDMGYPDGLTYGTGGKSADMAEMGAQL
KSTFAIAVFLIYFILVWQFESFIMPFVIILSIPLSTTGAFYALYAAGLSIDAMVSVGFVM
LAGIVVNNAIVLIDFINIRRAAGDNMNKALITAGKTRLRPILMTTLTTVLGMIPLMFSNG
EGSEIYKGMSFVVVFGLSTATLLTLVVIPVFYYLIDDFILVMRRFRKKLSKKS
>fig|469618.3.peg.242 Acriflavin resistance protein E
MKKTGYLILLLILIMAGCGKKQEEVIEKKVKYVITEPATMRKMSQVFKSDAVLEPKNKVN
HKTEKGGTIEKILKRNGDTVKKGELVMELSDAATESSYFTAKANYTSALSSLNIAKSNYE
KFKNLYEKELVSYLEYAGYENTYVGAKGNYEAAKASYENAKSDYNKLFRKAEIDGVIGNL
FGKEGNEISASDIIFTVVDDNSMETYVGFPAEWLTQIKVGQELEVEVGALGKKFTGKITE
INPIADSSTKKFMIKVAVANPDKAIKDGMYSYVTIPVGEINVLSVSDEAIFVRNLLSYVF
KIEDGVAKRVEVKTGATNLPYTEISSEDIKEGDRIVVKGIFGLEEGNEVEENTEAK
>fig|469618.3.peg.287 Permease of the drug/metabolite transporter (DMT) superfamily
MDNKKTSLLQIHIAVFLFGISGLFAKFIVQPSIIIVLGRVFFSSIFLLLGICISKEDLKL
KNKKDLIIIFIMGIILAIHWCTFFQGIKFSTVAIGLLTFSTFPIFITFMEPFFFCEKLKK
EDIFLAFMTFVGILFVIPSFQIKNEMTMGVIFGIISSFSYAVLSLLNKKYVKEYKGVIIA
FYEQFISFVILLPFFFIIKPVIAEKEILLLLLLGIVFTGIAHTLFINSLKNIKTQTAGII
SSLEPLYGILLSIFFLNEIPSIKEIVGGIIILGTVFYSTMKNLKNKN
>fig|469618.3.peg.602 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKQNLNLETGKISELFFSFAIPSTISMIVTSLYTIADGVFITRGVGSEGIAAVNIGYPII
NFTVALSLMFGIGGATLIAFKKDDIKYQNKCFSHIILLNIFVYIIVASMIFLFTKPLMMA
MGANEKLLPMIKGYMYPCTVSTFFLMMSMSLNAVVRNDNAPRRAMVSTLLGAGLNIVLDY
LFIFKFNLGIEGGAYATAISQIISAIYLCRHFIGSTFKLNLSLKKIDFFLLKKLLSIGFP
SFVLEFAVAVITVLLNIAFMNAVGVFGASAYGIISYSFMFFRMLFTGLSQGIQPIVSFNY
GRKNLDRVKKMLIFAHKITFGASIASLIIIFFLATPVVRIFTHDAPLVVESAKGFILYSI
ALSFLGFNFVNIAYLQAVDRPMFSNVICMSRSFLFVFIGLVILPKLIGVNGIWLALPFAD
FMTAILTIPFMKKLTINYVEASV
>fig|469618.3.peg.661 Inner membrane component of tripartite multidrug resistance system
MGISFELILATLALAIGSFMNVLDSTIVNVSLTHIAGDFGIAPTQGTWVITSYAVSEAIF
LPLIGWLTKRFGIVKQYTVATLLFTTASMLCGISFSFGFLLFARVLQGIVGASMIPLSQT
LMLSFYPKEKKAMALGIWSMTVVLAPVLGPVIGGWITDSFSWRWCFYINLPFGIISTFIV
HSIFKKKGYKDKTEKVPIDKWGLIFLALGISSLQIMLDKGNDLDWFSSPFIIILALTSFI
FIVILVIWEWHQDNPVVNVKLFLNRNFAIGAVSLSISSIAFFSSVVVIPLWLQNYMGYTA
LQSGMTTSTLGLSILFTAPILGSILNRLDARKVVVAGFILFSITAVLTGNYTPDVTPAYI
SVSRFLTGIGLGMFFIPLNTITLSNIQPEDMAGASGLYNFTRNIGNSFGTSLAINFWDHR
ISMHHQDLVASINNGNPNYVNYIHQMNGPIQTKLALINQMITEQSALMGVNDIIIGSGLM
ILFLIPLIFMARKSIVK
>fig|469618.3.peg.920 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLKIILEILKLALPAVGEMILYMMIWVLDTIMVGKHSGQLGVSAVGLSSEVMYTFTNIII
AMGLSISITSIISRAIGGKNYEKARLTSDIALRLGLIFAVLMWGIFFCFPEKILTIVGAE
KDILSLATKYMRICSFAVICNMTTNIFNGIFRGCKNTKTPLFTAIIVNVVNLSLDYILIF
GKLGAPELGVVGGAIATVTGNVCGLLFTLSQLKKIPFKLSPLAPFNKEYFKELVRLTIPS
SLQEGAFSINKLINVAVIMTLGSLSFASNQIAITIESISFMPGWGFAIACTSLTGYCIGQ
KDYEKAKIYINYSIYLASGIMGLFSVIFLIFPEKLISLFIKSSETEVIALGTACLMLASI
EQIPIAISMVLGGALKGTGDSKTPFKIVLFTNWIIRLPLVYYYIYLKRSSVTYFWKITAL
QWIIEAIIIFIVYRHKWKKYYQVTDLKEEIV
>fig|469618.3.peg.1482 Permease of the drug/metabolite transporter (DMT) superfamily
MQKKTVCKIALVCVAATWGGGFPITKIALDSGMAPNAIMSLRFLIASLLIFLFLFIKKVK
VTKAEMKLGLGAGLVLGTAFSLQTVGLMHTTSSKNAFITGAYVVCVPFMLWILTKKRPKW
ITYLSSIICFTGIGFLSLDGDLSMNYGDVLTLICAFFFALQISIIGARIGNMNPVVINAF
QMFSGGLLTLLLNITYENFSIVTTKLTGIQVMAVGFLIIFNTLIAYLVQTTAQKYVESST
ASLILSTEILFGAITSVILLGDPITIKTVLGGLLIFASVVISETELKFFTKKYIEN
>fig|469618.3.peg.1693 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSNELESKNVSRLFFKFAIPSIVGMLIVSIQMMVDGIFIANTQGASGLAAINLSMPIILF
TNSIALMIAAGGGVYCSIALGKGKFKRANEIMSFTLQIFVIFLGSLSLLGFLFINGIIGI
LGATEILAPLVKSYLLTMLILNIPYNIPIFTEGFIKIAGKPNLVFLSCIICLTGNVLMDY
LFIVKMDMGVFGAALATSIANGTAGAVLMWNYFKNRSRLKLVKPNGNRILLGKILYNGSS
EMLTMVSSALATFIFNYILIRRIGEIGVSALTIVFYVNTVVNICLFGLSQALQPIVSYNL
GARRMEQIYKVMRTAFFTGGSIGFFFFFVMKFNSSPIIKVFSKDNSDLMNLTGRALNFVV
FQYLFSFVNVIISSFLTAVEKPMESAAVAMCRSLICVAGLLFILPIFLGEKGLWLALPLG
ELLCMVMSIPLLVVSYKKIKIRINKNK
>fig|469618.3.peg.2267 Multiple antibiotic resistance protein MarC
MGVNTIFINALMLIAVLNPFGNVPLFIGMTEGMEKEIRKKLFKAIALTGFFIIFLFSLVG
EFLMINFYKIDMNELRMAGGLILVLMAVKNLIFPPMKKEREEAHISPEEQIKQAVIPMAF
PMMVGPGSLTTALIGRSEYGVVYNSLSILTAFAVIFMIFVIGNYLEKIFGKLVLYILSKV
MQIFIMSIGFRIFFDGFFKMLELKYGL
>fig|469618.3.peg.2404 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKSISLGKDPVWKLFLNFSIPAVTGMIVTAMYSIVDGIFVGRGVGADGLAALNLGYPIV
NFGAALSLMFGIGGATLISLNPKDKEFCNRCFSYIIVLNVTAYLLILLLVVFFNERIIRL
MGANDNLLPMVKAYMYPCTAALGFLMISNSLNAVVRNDKAPAYAFISMVIGAVTNIFLDW
LFIMKFGFGIFGAAAATGIGQLFSMLFLVKYFMKPGSRFKFSFENRIKIDIMKKIAAIGF
PSFIMEFTVALITILFNISFMKYSGEMGVSAFCIVGYVFYIFRMLYNGMGQGIQPIVSYN
YGEKKLDRVEDTFKIGHKISFGIAIVILIWVNFFGSSLIRLFNEDPELIKTAVHGLRLYA
SAIIFVGANFINISFLQSKDRAKAANILSVLRSTVFVLIGLLILPKFLGENGIWLALPFS
DLMTFLTTLVLKRKTDIF
>fig|469618.3.peg.2579 Acriflavin resistance protein E
MKNRRIKSLILITASILLISSCGKQKEVEKIIRPVKVIEIKNSDSIEYFSFSGITTPSKE
TILSFKIAGPIESMNLTQGQTIKKDEILAKMDSRDYEINLEVYKKKYEASKASADNAVLQ
YNRAEKLYKADAMTKKNFDIITAQKKAAVSLLKEAQQGVENARNKLKDTELKAPYSGYIS
KKFVDAGTVVNAGTPIVSLSADVNPEVTISIASKDIDILKNAVSFIFVLNDNTEKKYELK
LKEIGKNPEFSKLTYPATFELLDGKDINMGMSGKVIASVKRDDSSPIIIPASALFEDNGS
KVYIYDNGVAKTREVKIGNLYPDGNIVILEGLNKNEKVITAGVNTIIDGEKVKLIPEESE
TNVGNVL
>fig|469618.3.peg.2604 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSYTTTKKFTFLSLLKFTVPAIIMMLFMSLYTIVDGIFISRFIGTTALSGLNIIYPFMSF
IHAIAIMLAAGGSAIVAIRMGEGKNEEARRTFSLIVYSGIFLGVFVAVFGSIFINEIIRF
LGASPALEKYSYDYLKIIILFAPFSILQTLFQTFFITAGRPELGLRMTILSGTANGVLDY
IFMKLFGMGMTGGALATVSGYLIISIFGIVYFIKNKKSLYFVKVKMELETIKESCINGSS
EMVTDISSGIVTFLFNIVMMKYMGEKGVAAITIILYSQFVFIAVYLGFSMGTAPIISYNY
GNKNQKQLKRIFNICSKLIMNSSIGVFIISLIFAKYIVGFFTPEGTEVYEIAKKGFSLFA
IGYIFAGYNIFSSSLFTALSNGKISAVISFMRTLVFIVIGIFFLPMVFKVNGIWLAVPFA
EILSILVSLYFIRREKNNYGYV
>fig|469618.3.peg.2611 Permease of the drug/metabolite transporter (DMT) superfamily
MNRQLRANFFVGLVALFWGSTYFLTKIGIGMLEPFNLTSLRFATAFLVTALFFRKRVLKV
DKVTLKYSIILGILAFISVLTMTIGVKYTSASNAGFLISLSVVMIPLISVIFLKKKIKFK
LLVSVILATIGIVLLTLNEQLTINKGDILCIICALAFALQVLVMERIPKNADSVAIGALQ
LGIVGVMNGIISFTIETFKFPHNLKLWGVIMLLGIFCTAVCYIMQIYALKDTSAIQAGII
LSLEPVFSAIFAFVFLGELLSTKGYIGAVLLFISVILAGVI
>fig|469618.3.peg.2675 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVGYALEIYIKVDGNPVYPAICVMTGGIVNIFLDYLFVAVYPYGIKGAAFATGMSQLTST
SMLLFYILFKTKKIKFIKLKYSFKDLLKISKIGFAEFLAEVSTGIAIFIFNIVLIKELGE
KGVSAFGIIGYISSFVVMTMIGFSQGIQPIVSFNLGAKKYTNVIKTLKISLLMIITTGIV
FYGSINIFSEKIISTFLNDIETFKMTKYALAVYSFAYIINGLNIVTAGYFTAVKKVKIST
TITILRGVILIGIFLIVLPRLFGTVGIWWSVPAAELVTLISSIYFIKKYMHKYENIRA
>fig|469618.3.peg.2728 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTQQEKEFRDGNILSLLIRFSIPATFAILIGIIYNVTDRYYIGQAVGRNGISALAVTFPI
VLILSATGVLFSIGGCALAGIKMGENKIEDARRVLGTCFYALIVIGGIYTVLGMLFLEEI
VSFMGATKNSFAYAVEYNKYLFPVTIFQLIYITYCSFVRLEGRPMESMVINLASAIVNIV
LDYILIMRYGMGMKGAAIATAIANVVPGVILIYHFLKSDILTLKLKYIKYNHELLKKVFY
IGNSGFLNQFLNGAYVYVLNIQLAKYGGDVALAGMGILSLLRTCINTGYMGLNQGRQPLL
SYNWGAKNYERVKKIFYSSITLTAVISLFLLFVVIVNARTVVNFFVKNDLELTEYTIRGT
YIHLGLMISTAIYLSCTNYFQAVGKGMITTRFIILRLAVLSIPLAYILPVFFGADGILMS
FPVADTISCIGAAYVMWQEIKLLTKRAEKQKRYIK
>fig|470146.3.peg.70 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKPLLYTFGANSQTYEMAKGYIFHVSYGAPFIIWSAAASFIVRAEGASSEAMIGSMIGTV
ANIVLDPVFISGLGMGAAGAAIATTIGNILASIYYLWYFMKKSKSFSVSPKYFKCGEQVL
SRVCSIGFPTAIFSALMSVSTIVLNQILVKYGNAPVAAIGIVFKANMFITFLQMGLANGV
QPLMGYNFGAGNQKRFMEVDCFTKKCCLVVGILATALFFFFREPIIHLFINDKDVIYYGV
KMLVAYMVSGPFIGILFVNMNCMQSTGDALPATILSVLRQGLLLIPLLYLLNAVFGLNGV
IYGQALTDCVAIVLSMYIWGRKKRKLKSE
>fig|470146.3.peg.143 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MILAISVALNIVGDLLFVVVLKSGVRGAAIATVLAQAIAFVVCWIYMVKRYELLRLSRED
FKDPNPVMVKNMLGAGMSMGFMSSLINIGSLTLQTAINKLGNDYIVAQTAARKLTEMFMI
MFTVFGNTMATYCGQNLGAGKIDRIKKGIWLAIFYTCIWCTLVIVASYTIGDKLVYLVTG
THNENVILNATRYLKFDTLFYYVTAVICIVRNAMQGLDDHITPIVSSTLEMLGKIVIAFT
LVPHLGYTGVIIAEPIVWFVMVIPLIVQIFRMPVLKQTSLS
>fig|470146.3.peg.423 Probable cation efflux pump (multidrug resistance protein)
MTKDLTTGKIMPILVNFTVPLVLGNLFQLTYNAMDSIIVGHFVGKEALAAVGICNPISTL
MILFLNGLCMGASILMGIQYGAKDYKTLHRQISTTMLSGVVFSFFLTLLCVVFAVPILHL
LQVDASIMEMTRQYLRIIFLGLMFTFLYNFFFQYLKSFGRQCIAFVFLNYQCSPEYIRRS
VFCHCTKGRKQWMRHFNSA
>fig|470146.3.peg.756 Vancomycin B-type resistance protein VanW
MDEEYICKNVFIGKTDVSGMTKEEAVKAVDNTLGDYRNKQLVLKVKDQGADVSIEEMGAE
VENIDKLAEKAVGYGKNGSIWSRYQKIHNLDKKKYVIDESFKVDEAKLRELIQERAVPLE
QKAVNASASYNGSGFDLTDEAEGYTVDVDKSVKKIKNFMNKKWNYEDAEVELKLDMEKPT
IKKADLESLQDELGSYTTNAGWGDRVQNIRRATELINGTVVMPGEEFSVEQATLPYTEEN
GYVAGSAYENGQIVESIGGGLCQVSTTLYNAVLYAELEVTRRAPHSMSVSYVEPSRDAMI
AEGISDFKFVNNYDTPILIEGYIDGNNQLGFYIYGKDTRAAGHSVEFESETLETTEYTKK
YVEDTESAVGSQETEGAGMDGSTARLWKITYENGEEVSREVINNSTYQTSDVTVKVGTKS
DNAEATKLVEEAIETQDQEKINAAISKASALK
>fig|470146.3.peg.2511 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKTKTIDLTSGPILKTLAELALPIMASSLLGTAYNITDMAWIGMLGSKAVAGVGVGGMY
VWLSQGLVALPRMGGQVNVAQACGRGDYEQARGYAASALRLTFLLGILFAAVCIVFIHPL
LGFFNLGDAETYTAAKLYTLITCGLILFSFLNLTLTGLSTAQGDSKTPLMANLLGLVGNM
ILDPILILGFGPFPRLEVVGAAVATVTSQILVLIVMLIRIMHSDLEPNILQNTHVLSRFP
AKYYISIFKIGFPTAVQSSIYCMISMILTRMVSAFGAGAIATQRVGGQIESVSWNTADGF
AAALNAFVGQNYGAKKPDRIRKGYNISFKILAVWGLIVTGAFVFLPGPIASLFFHEKDVL
AIAINYLIIIGFSETFMTIELMTIGALSGLGMTKLCSIISIVLTSARIPLAMILTQTSLG
LNGVWWALTITSITKGIVFYFTFHHTSRHLPDANDN
>fig|470146.3.peg.2534 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKTLQKDLTTGNPGKIIFNFTLPIFIGNVFQQFYSMADTIIVGKFVGTKALAAVGSTGTI
MFLINGFILGMTAGFTVLTAQKFGAGDMKAMRKTVGNAAILAIIMSLIMTVLGMMAMKPL
LGIMKTPDDIFKDAYAYIMVICGGIAAQMLYNFLSSVLRALGNSKVPLYFLILAALLNIV
LDMVFIIAFHMGAAGAAWATVISQGISGILCLVYIVKAVPILHLHKEDWRPSGHLLKIQL
AVGIPMALQYSITAIGTMMVQTALNLLGSTQVAAFTAANKIEQIVTQAYVAMGTTMATYC
AQNIGAGKIKRIRQGFRSITIMGSIYSVVVAAIIMTVGKYMTYLFLSGDLTEIMHSVDIY
LKCVGTFFIPLTVVNVYRNGIQGMGYGLLPMMAGVAELVGRGVVAMIAAGQKSYFGVCMA
SPAAWILASALLIVMYYYVIHQNEKRFAKYADEE
>fig|471821.5.peg.955 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIVFGLNQGMQPIVGYNYGTDLYERVTKVKKTIIITVAPMTFGSVLVELFPHSVASIFAD
EKNLIDVTATGLRYAFMFSLFIGF
>fig|471852.6.peg.226 Multidrug resistance protein B
MLGGMFLSMLDQTIVGPALPDITADIGGENLYSWFVSAYLLTTTVSVPLYGRLSDVYGRK
PLLLTGLGIFIAGSALCALAQTSWQLIAARALQGLGAGALIPLSLALLFDLFPGRAMGKV
QGWIGAVMGVSYVTGPMLGGLLNDHAGWPWIFLVNVPIGVVLAAVVVIRLPHRPGTAERA
RPDYLGIAVFSAAVSLLMVGLTQKGLTGADGRLHHWTDWPVLGYLLAALALLAVFLLIEL
RVSEPLIPLGLFRNPVYTATNVASFATAFAMYSAIIFLPRYLRDARDYSAVASGVLIYPL
LIGIVVGSFAAGAIIGATRRYKLLLASVQLLTGIGAVCFLWLEADTPLPVLSVWMATLGL
GIGPMLSGLTITVQNSVPIEHIGTATGKVTFFRQIGGAVALTFAGSIYMETMTDHAPAVG
PQQAAAEAAAQVLPLLGALGAGTAFLAMLLVPRRPLWLLGDGGD
>fig|471852.6.peg.458 Permease of the drug/metabolite transporter (DMT) superfamily
MAITAIWGSTFPISKDLLTRLPVPDFLALRFLTAALVVGLVRPRALPRAGWRVIGVGAAL
GLLYFIGQYLQFVGLQHTAPTVSAFVVSMYVVFTPLLAALLTRKPPSRRTVVATLLATTG
VAAMSLRGLAFGWGEMLTLFAASLYAAHILALERWSRAQIAYTLTVVQLGTMGLAFLAVA
SIDGLQLPATRDVPVFLYLALLAGGLALLGQTWAQAHLPAPTVSITLVLEPVWAGIISVL
FFKERLDARIIIGAALILCALLVITGRARNAPQDGLRRPQRRKVPRVPLLRRSR
>fig|471852.6.peg.2717 Glyoxalase/bleomycin resistance protein/dioxygenase
MDVLSSRILLRPADPARSHRFYRDVLGLAVYREFGPPEEPGVVYFLGQGLLEVSGRSAEG
PGAALMLWLQVRDVHAEHRRLREAGVTVLREPRQEPWGLIEMWIADPDGVRIALVEVPAD
HPLRRDPRPLPS
>fig|471852.6.peg.2792 Glyoxalase/bleomycin resistance protein/dioxygenase
MELCTPRPEVAEKFYSALLGWSVRHERLGRSTYRMCGIDGRDVAGISESGLHGGRPHGWL
TYFAVDGIEDAVRRAVALGGEVVTPPRHLPAAGTGATVIDPFGAVFGLYQGEARLGVQLL
NLPGALCWNELNTGEPQQSVTYYRSLFGYGTHLRTDTPTGRPYTVLTLDDVPVAGVLELD
NAWPNCVPSRWITYFGVTELDAAVAQAVELGGAPLIGPIDGPYGPLHLVKDPAGHTVCLI
QLKDRLRPDYPSPAVTR
>fig|471852.6.peg.4324 Permease of the drug/metabolite transporter (DMT) superfamily
MPSPRSRSSLGALLCLISAAGFGLSAIFAKETYRTGAGVQTMLTVRFAVAAALLWLLVAW
RRPALPTGRALLTCIGLGAIGYACQAMCYFGSLARIDGSLAALLLYTYPPMVTAIAIALR
REPVDRRRLTALACSVPGVLLLLGGGVRPGAASGVLLALAAAGTYAIYLTVAAGLPEELD
LITVSAVVCTSAAVSMVLITAGTGSWQPPAQASGWAWTTMLAIFSSVVPIVCMLAGMRMV
GASTAAILSYAEPAVAVASTALVYGERLSAAQLLGGLIVLLAVLILSVERPGTPPAPRRV
LDRIAPGRRSRRPEREEPEHEGRAQRTGDRACV
>fig|471853.5.peg.1150 Vancomycin B-type resistance protein VanW
MTESETGARATDAPDEESTGAAPETEPEQGVDDAAGAAQHGPSAEPAAAEAAAETQVRGI
PVVPAQEPAEPAEANAAEPPEAGATEVAEPADDQATEAEPEPAEPVEADAAEPPEADVTE
VAEPAADEATKVEPEPAEPMDEVVAEPADPTEADATEVAEPAADGEATEVMAEPAALAAG
ATGGGDSPLDELEGEPPSHRGRKIALGVGIGVVVLAAAYAGAAWFVADRVPRGATVAGVE
IGGLTTDDAVARLTDDLADLATEPIDVRAGDAQTTIDPAAAGLALDAQATVEALSGFSWD
PRDVFRHVLGTGEEPAISTVDAAALDAALVAANDDVAIAPTEGSVVFANAEPVVTDPVDG
VGLDLPATEELLVSSWLTAERPLALPTESVTPNIDDAAIEEALSTIAEPLVSAPVSVVAG
EATVPLSVEQLTSVATLVPEGSRLVLELDGDALAQLLGEAAPDVGTAPQDARIELQDGAP
VVVPSVNGTGIDPAALADAVAAAATSTTERTATVELSETEAEFTTADAEALGVVERISEF
STPLPPYPDPPRTENIQIGASRVTGILLMPGDTFSLLDTLSPFNAANGYHQSGVVENGFE
ARAYGGGLSQLSTTLFNAAFEAGLEDVTHKPHSRWFSRYPEGREATLFEGSVDMQFRNTT
DHGILLQAWVAGGRTHAAIWGTPTFDVDITTGERYAFTSPRTVYNTSPECIAESGGSNGF
SVQVRRVVSLDGAVARDDTYTWSYQPWNTVVCGPDPATQPDPPTPTPDPGGG
>fig|471853.5.peg.2555 Drug resistance transporter, EmrB/QacA subfamily
MSDNTAPATAGPATAGDPAERPDPRRWRILWLVGIAQLMLILDVTVVAIALPHLATDLGL
DRATLTWVVSGYTLAFGGLLLLGGRAADLFGARRLVLLGLGLFALASLVAGLASSGPMLL
GGRLAQGLAAAILSPAALSVVVTTFEGDERNRALGIWSALGGSGAALGVLLGGVLTAGPG
WPWVFIVNVPVGIVLLLTLRTHLPAHPRPAAGGRLDVLGAALVTAATGSLIYALVQAGDG
GWATPTTAAFLLAALVLYGGFVARQLTATSPLMDLRLLTRRPVATGTVLILVATALMIMV
FFLGTFFLQHHQSYGPLVTGLLFLPVAIATMVGANVAGRVLGRVGPRLLGVVGLLVAAAG
MSVPAMWEGTTAMVVGVSVAAAGTGIAFVVASATALGQVEPQEAGLASGIVSTFHEFGAS
VGAALASSVAAASLVGPGSGTSTVGFDRGFTTGAVIAVVAALVTLVITPSTRRVGAGRRR
>fig|471853.5.peg.3859 Ribosome protection-type tetracycline resistance related proteins
MPSPLPYLNLGIVAHVDAGKTSLTERLLYDAGVVDAPGSVDAGTTRTDSMDLERRRGITI
RAAVTSFPVDDVTVTVIDTPGHPDFIAEVERSLAVLDAAVLVLSCVEGVQSQTVVLWRAL
RRLRIPTALFLNKVDRAAADVERTLAQVRRRLDADLVTLTRAEHVGTREARVHAVPLTDA
SVVEAVAAADDSVLARWVDGAPVRARQVRHALRRGVRAGTLVPVVCGSAITGAGTGMLRQ
VLTDVLPRAPRREGPDDGGPAATVFAVDRDDRGRRAWLRSWSGTIRVRDRVSLSGRAPEL
VTEIAVSGASGLHAADEVRAGEVAVVRGPTTSRIGDTVGRPPVRQEYRFTPPTLQSLVEP
VDPAQRTALYAALTDLADSDPLIGLRLDETDGEAAVSLHGEVQREVVAALLEEQFGVRAR
FTSTSTICLERVVGVGEAVEQISAGGNPYLAGIGLRVEPLPVDSGVRFSPGIERGNLPPA
FIAATEAGVRAGLRAGPSGWAVTDCLVTMTASGYYPRQSHAHQKFNKAMSSVGADFRNLA
PVVLHAALASAGTQVCRPFDAFELDLPERTLGSVAALLGRLSAATTASTAERGSVRLLGH
VPSAHVDALARALPDLTAGEAVLVTRLDHHAPVPRGTEPPIRRRTGPDPRDREGWFRDVP
R
>fig|471854.4.peg.394 Permease of the drug/metabolite transporter (DMT) superfamily
MVVLAFATVYIVWGSTYFFIQRALEGFPPFFLGAFRFIIAGLLMLGWSLLQGEQVFSWKV
MKPALITGLLLLFVGNGVVIWVEQFLPSAMVAIMVSSAPLWFVLLDKPKWSENLSNKSTI
LGLVVGFAGVILLFYEKIMATMSSLNSGRDLFAMALVVLGSMAWAGGSLYSKYNSVSKSA
TVNSTWQMLAAGIAFIPGTLLTGEYTSVDLTAIPLNAWLATTYLIVFGSIAGFSAYVWLL
KVQPATKVSTYAYVNPVVAVLLGIFFAHETITMMQIAGLVVILGSVLLINLHQYRKPKQV
TATC
>fig|471854.4.peg.418 Outer membrane component of tripartite multidrug resistance system
MVCLATGIVWFAVTGHSYAQSARTIRLEEAISMSLQNSKQLKLSQSNVDLAGLGIRQIKE
NQLPSLSVSGSYLRVNSPNVNLKISREGNDSTGNSGGLPNVHQAMYGMASASLPLFSGFR
FKYGLESAKYVEQAVKLDADANREAVIQNTVAAYGNLYKAQKAVDLVTENLVSERERVQE
FTNREKNGMLARNDLMKAKLQESNVELALLNAQNDLKITTINMNLLLGLPEETVIEADSA
SFTTLKAEGNAAEWEQTALSHRKDFAANGIRQKAADSDIKVAKADLYPSVALSAGYVALN
IPGVVTVPNAVNAGIGFRYDVASLWKSHSKIAEARTKAYQLKTNEQIILDKIHLEVNTAY
YNYVLSKRKIDVYAKAVEQADENYRITKNKYDNSLVTTTELLDADVAQVQSRIDYEAAKA
DAVVAYKKLEQTAGVIN
>fig|471854.4.peg.1283 Permease of the drug/metabolite transporter (DMT) superfamily
MKSNLTAYIALLMVCFFWGTTYLAARIGVSGFPALFFMGFRNVVAGLLLLSFLVLKNRSF
PWTLRDMLLQLVPGWCMITFGTGLVGWCVQFIPSGLAALLYATVPLFTIVINLLARKDER
VNAHVAAGMLMGLAGIMLVFRDNISYLADRASFVGICVTLASCVSWCIGGLYTKSYPGKT
DSFFNAAIQMTAGGVGLFTLSAFNEDWTSLPVMQTKSLLALLYLIFFGSILAYASYLYAM
SRLPAGLVSIYAYINPLVALILGFFVLDEQVTWLTVLAFVVTLGGVFLVNKGYQLQKRKN
SLTLINSHE
>fig|471854.4.peg.1305 Acriflavin resistance protein
MDLIRFALRKPITIMVIVAALFFFGIDAVRKIKVDIFPKLDLPVMYIAHPFGGYTPDQME
TFFAKQYINILLYVNGIKSIETKNIQGLTLMKVNFYPGTNMAQASAELSAFTNRAQAIFP
PGSNPPFIIRFDASTLPVGQLVLSSEKRSNNELLDLANVYVRSTFTSIPGLVSAPPFGGN
IRTIVVKVDPELLRSHNLTPDQLVEALRVNNQTAPSGNVRIGDKNYITPTNTTVRYVKDF
ENIPLFKGGVQNLYLRDVATVEDGADIATGYGLVNGKRSVYLSIAKGADASTWEVVQNLK
KAIPRIQNTLPEDVKVSYEFDQSTYVMNSVKSLLTEGAIGAILTGLMVLLFLGDARGALI
VILTIPTSIIAGVLFLNLFGQTINIMTLSGLALAIGILVDESTVTIENIHQHFDMGKPKA
LAIWDACKEIAFPKLLILFCILAVFAPAFTMGGIPGSLFLPLALAIGFSMIVSYFLAQTF
VPVMANWIMKVKHHQKPDGTEMTDAEEFAASGLSKNPDAQKEALIHRADADQNGKISVFE
RVRARFMRFINRTMPFRKPIVVAYLLVTTALAAFLLNSIGKDVLPKVNGSQFQVRLRAPE
GTRMERTEEKTLKTINIIKKIVGPENVSVTSAYVGQHPGLFSVSPIYLFMAGPHEAVLQV
GLHEGFHTNLDELKEKIRTEMKQAMPDVTTSFEPIELTDKILSQGSPTPIEVRMSGRDKK
LNEQYAQKVIAKLKEISYLRDIQLGQSTKYPAIKIEVDRIRAAQLGVDMNDVSRSLIAST
SSSRYTDKNIWVDEKGGFSYAVQVQVPESKMNSVQEMGEIPLLRNANRPVLSDIATITPD
TTYGENDNLGAMPVLSVTANLNNTDLGVAQADVRQALASLGELPRGLTVELVGLSQTLTD
TLDSLQNGLVVAIVVIFLMLAANFQSFKVSAIVLATVPAVILGSLALLMVTGSTLNLQSY
MGIIMSVGVSISNAVLLITNAEQLRKHSGNAIEAAKESAGLRLRPIVMTAVAMVVGMIPM
ASGLGEAGDQSSPLGRAVIGGLVASTFAALFILPLVFAWGQGKASTQSVSLDPEDEESKY
YVPMTR
>fig|471854.4.peg.2147 Glyoxalase/bleomycin resistance protein/dioxygenase
MENRINGIHHITAIAGDAQTNYDFYTRVLGLRMVKKTVNFDDPNTYHFYYGDENGTPGTI
LTFFPWGNQIPAGRRGTRQATEIGYSVPEGSLDFWLKRLEANKVTYNKPAEKFGEQYLTF
LDPDGLKYELTVPKVADNRTPWTTPEVTAEYATRGFHNVTITTTNIAETAKVLTDIFGYR
LVEQHVNRFRFVTDAVDNANIVDLVEAPGERAGHVAKGSVHHIAFRVANDDILMEFRQKV
LDAGLQITDKIDRNYFYSLYFREPGGVLFEIASDNPGFATDETVEQLGSGLMLPPQYEPR
REQIVKVLPVLG
>fig|471854.4.peg.2458 Acriflavine resistance protein E
MFLNTTKYYSAALLALTIFSCGKKDQQQQPTGPMAVPVTLTEVKSSEASYYDEYPGTVVP
LNEVELRPQVTGFVTGIHFTDGARVRKGQLLYTIDAQLYDANYDQAVANLNVQEANLARA
QKDADRYHELEKNDAVAKQLVDNADAALEVAKRQVDAAKASIKASQTSVRYTKVMAPFDG
IIGISAVKVGAPVSAGQTILNTVSTDSQLAVDFNVDQKEIYRFTTLMKSQKASDSTFSLK
FGTDIYPAHGKIALLDRAVDPQTGSIKARLVFPNKDNQLRAGMSGTVRVLNNAGSKSLVI
PYKAVTEQLGEFFVYVAGDSSKVTQRKVVLGTAIGPNIIIREGLQEGEKIAVEGVQNLRE
GAVIQEGAPAQGGAPKKQ
>fig|471854.4.peg.4181 Glyoxalase/bleomycin resistance protein/dioxygenase
MPYLMLDGAPKFRDFTTTVFGGTIGATQYQEDHPEQIRHSEVRIGDSTIMFCDSRPEWPA
QPANLFVYVDNADDTYQKALDAGGTSVMPPADQDYGRSCGVADPCGNTWWITSVL
>fig|471854.4.peg.5813 Nisin-resistance protein
MKQSLTHFIVLALSLVMAVSAARPGPGAGPPSREASAYFEQAFAFIQNNAYFHKHLDFAK
VKQQALAKMQHAQSAADTHDAIRFVLEQLDDRHSFLQPARPAGAPSGSISARSVMPFEVS
VEGNYGIIKLKSYNSTDAANAHRIADSLYNCLLDFDKKHTKGTIIDLREMEGGTYIPFVT
GLAPMIDAEQLIGFVDRKGKKGRTVRYQNGIYYQQGRKKARLGYLTRYERPNAADRPIAV
LTGQYTASSGEMILLSLKGLPRTRTFGAPTYGVPTGKANFFLPDSSMISLTNTACFDRQK
QIHSGAIQPDVPCAEKDAMREAKNWIDHF
>fig|471855.5.peg.1773 Permease of the drug/metabolite transporter (DMT) superfamily
MSPLQGNICLLAVTFVWSFEVIVHAAIPHGISPFATSCVTSLIGAVLLWGYFFRRIILVL
KWHRDVYARRLLLLGVLNAIYNVLYLIGLEYFNVSVGAFTASMTAVILPVMVLVMKHSIS
ARSWISAGMILFGILVAVSPNVGQNEIPGLALMALGAMFRALFIVKLNEYAQVYDPVTLA
AGLTGVSAVLSFIPWAIVQPATFLALPWSGRLIATYFIYGYFIVAFATVLNIYAQKRTSA
THATIIYSTEIVFTTVWAMFLPSVIVHHVEITLPVVIGCLFVVAGNLIEISPSKDDEKGH
WKKDAEDDVMIRVSHPYARLLDSTKTPFGRSVLLFAALLVVYLVIALPFKVLLVIPGFSD
IRPVYMLYPVYGIFFGVPGCLATAFGNLICDVVSDGLRLSSISGFIANFLYPYILYILWT
KVPKTRFCLRRRRMLTAFVASFAICSVLQALIITPAVAHFYPDVDAGLFALSVIGNGTLF
PFFFAVPFIMLMQEELGYKPLTGPRMAKAQEA
>fig|471855.5.peg.1832 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MYQGSAAKVFARYAIPQMIGLLFNSVYIIVDGVFIGNRLGSMALAATGVAVPVVELLIAL
SMAVTAGAGVVVSTRIAKREHEQAVRAFHTCLVLQGIIGLSVVILGNLFIHPLAKLLGAT
PDIQAMTVTYLRYVLSFAPFLLFGYLLGGLARNDGKPKLAMVALSAGSLSNILLDYVFMY
PLNMGIAGAALATGIGPIVSMAILLPHFFAGKGVLRFQKTALSGNDARSFLRLGLPSFVM
EFSIGMVTFLMNFGIVRYGFGENGLAAYLIIGYLMLIVFTLFLGMAEGLQPAFSYLHAAG
DHTKLKALLRFAACVFTAVGVVSYVLVLFFSIRFYSIFTPEAHEVAVMAAQKSTWYFCGL
AFAGINILSISYYQATAQTGNALLISSLRGFVLPALLILILPAACGPELLWICHSTAEIM
TTLVCLACATHLLRR
>fig|471855.5.peg.2466 Permease of the drug/metabolite transporter (DMT) superfamily
MKYKLLLVLATLIWGSSFVMVKDLTDVMAPAWLLAIRFVAATVVMAAVCLVRREPLFDRE
HIKYGIIIGLPLFMGYLFQTIGITDTTPGKNAFLTATYCVIVPFLTWAVDRKRPNRFNIV
AALLCLSGIGLISLTGSFTIGFGDAMTLCCAVFYAVQILFMSKFGKGRNVVVLTVWQFAT
VTAGSLMVALVSAEPPTPAAMTPGVWLSFAYLAFIVTALAVFVQNIGLANVEPATGGLLL
SLESVFGVAFSIALGREPLTPRILVGFVVVFVAMVASEYLPAKLERRRTS
>fig|471855.5.peg.2689 Permease of the drug/metabolite transporter (DMT) superfamily
MNANKERHLHLPVWVYKGMLLLAAAVWGLGTVVLKDTVDALPPLWLIAVRFVLAGIILGA
VCYPRMRDHLDRDTLLAGAFLGVFVGVSYGLNTIGLLYTTAAKSTVLTSAYCVMVPFVAW
AASKIKPSLFNLVAAALCLSGVGFVSLQGSTEGLFTIGLGESITLLAAVFFALQIAYMAK
LGDGRDAMVLTVVQFLVGGGLCAVGGLLFEGPLPLEAFSDPAVVRNLAYLIVVASCLALS
LQNVGLAHVSPAPAALFLASESLFGVIFSILFLGEAVSANVIVGFVLITSSIVISETFPY
LRSRSADNR
>fig|471855.5.peg.2709 Drug resistance transporter, EmrB/QacA subfamily
MQKTNYKPMLVILYLAAFIAAFNENIINVAMVDIMAEFSISYSAAQWLVTGYMIVTSIIV
TVMSFLSRRFTLRRLFYVAGACFLVGEAASFVMPNFPLLLAARLLQAVGSGVFIPLMMGT
VLAVAPREKMGTYLSIGSAAITLGPAFAPVVSGVAATFIGWRAIHVVPFTVVALLAVAGA
KLLRNIGEPESVKLDAPSLALASVGLTVFVFGLGEITTHLPLALVCIAVSVLVIAAFVRR
QFVIPNPMLTMRPMTDPRFSVACILVIVAMMTTFSMSVLLPLYFEGTFGHTALLAGLLIL
PAIVVNAITAVIGGRIMDKSGPWPLIPVGFLLAAAGQCAIAAFSASMSLVVVVVASVAVY
AGVGLMMSPSQTAGLRTLPREEHGAGVSIINTFNMVAASIGPSLFIGILSSGAAKASAEG
TSANVGNAAGFSQAVLVAAGIAVLGLVVAVVYSYKERGAAPAAVHASETEIASGATVPSL
ADVMKRDAYTVPASATVADVARILVANKTSGVPVVGKAGAVLGFISDGDIMRALSKSETQ
AVDLGYYLAAMAEDEAFGDRVHDLLGRNVMDYATENVVCASADEPIDSVCAKLNGRRIKK
MPVVENGRLVGTVSRSDIVRYLMESFVA
>fig|471857.5.peg.1573 Permease of the drug/metabolite transporter (DMT) superfamily
MTEPPERAPIPRTDATKAALAAAVTMVLWSSAFVGIRAIGEVFSPAPLALLRLAVASVTL
TVLIGSSTRRLPPLPRDRTSWLFVASYGVLWLCCYTVALNAAELHLDAGTAALLVNIAPL
LVTFGAGVVLAEGFPRPLLLGGSIGMSGIVIIGLGTDGEGDWIGVALCLLAAVLYAAGVL
IQKKALDRIDATTITWLGCLIGTAVLLPWTPRLASELATAPTSAVLGAVYLGVFPTAIGF
STWAYALKRTEAGRLSVSTYAVPALSVVLSWVLLAEVPTGYGLVGGVVCLAGVAVSRYRP
RRAVTGTNTVAPDTATRPCEPPERQPR
>fig|471857.5.peg.1955 Multi-drug efflux transporter
MYLLVVLTAGAYLPSPLYPQYQVAFGFSDLMLTLIYAMFALVSAPALLLFGPAADALGPR
TVLRVGVAVAAFASTCFVLADGVGWLLVGRAAQGLALGAVTGAATMVITDHTPSANRGRA
SVVASMAFVAGTAVGPIAAGVVAQYAPQPQVLPYLVHLGLLAIGWHRVSALPAPPQRARR
WRPTRPRIPTGMRLRFTTAAATGFLAWAVAGLFLAVIPAVLNRTAGINNLAVIGGVVGAV
LVCSMAAQPFVARCGAGPAQLVGLSALLLSLLALAVTGGGSLSITMVAAAAAGVGHGLAY
SGAAAAVEAIAPEDRRGAITSALYLAFYVGSGGPSVVVGLMTLWHPLDTAVSWLALVATV
LTPLVGLAVVFTGRSFVPRWSLPTTTSRPHPGPEQKGAVDRNDRSTPTVSSVSSASSVSS
ASTVSSASTVSSVSTVSSSNTVWQRRHLCHRHPGVARPGFALDDSSDDAGIGTAAAEAAV
SAHQPHRPDPQKRF
>fig|471857.5.peg.2077 Multidrug resistance protein B
MMSSGVRGGGTLERTGAPLLGVAFILVLGTFMASLDATIVAVGIDTLVEEFDASVADIQW
VTTAYLLAIVTVMPMSGWLADRFGGRRTWLTAVAVFLLGSVACAVAWSVPSLVVFRVLQG
LGGGLLPPTGQALLARVAGPERIGRIISVVSVVPLLSPVLGPLIGGSILSVAEWPWLFLV
NIPIGLVAMVLAWRYVPVVAPTDRSAPFDVRGAMLLPPGLAVLVFGLTELADTGQGGTFD
VAIVALAVGVGMLVAFGVHGMRSRRPALLDVRLFTRPPFGAAATALLAVAASVFGTMFLL
PLFLQAGRGLSAWEAGLLLAPQGVGAAVGALVVSRIIGQFAPRTLVLTGMALIAIGTVPF
TQLPDLGDGVIAVALLVRGMGSALIGAPTMNIVYSRIEATQTARASSALNLMHYVGGSLG
TAVLAVVLQTRLSAEGVDVTSAFAGCFWWVLGLCVVAALWAVRLPRRVERARSS
>fig|471857.5.peg.3286 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDEAPRYLGLAPYLYYTDATEAVEWLTRVFGFREKVRYVDAAGEVFQATLLAGDAEIQV
TAVDSTYWEAKGVDGPVGQLNVVYVDDVDAQYERVRAAVGESVELTTPQDQPYGARLFTV
QDVGGNSWTFWQHISDVVDLPVGWQEIRAEDGQNAVTRKNIEQSEREHELG
>fig|471870.8.peg.467 Permease of the drug/metabolite transporter (DMT) superfamily
MKNSTSAVVYACIAVLSWSTVATAFKIALTHLTHFEMLLIASCTSLVIFALLLTFQKKWR
LVSELSGRQWGYFALLGLLNPVAYYLVLFKAYDLLPAQVAQPINYAWPIVLLILLALFAH
QPIPQKKYIGMFISLGGVVLISVGTGQSGGMDIPVHGLLLAALSALLWAMYWMINNKFKD
KTDGSIALFMSFLFGTVYLLIGAVGVGVHLNTLPGILSGMYVGGFEMGIPFIFFSLAMRK
TSNPALVNQLCYLSPFLSLFFIAIILGEQIVFTTYIGLALIVMGIMFNQYLVKK
>fig|471870.8.peg.1722 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVQSAQPIVSYNYGCGQLLRSNKALRLCIISAVVFALLISGVFVCFSGDIVSLFLPDRTS
HAWQYAVAGLPLFAVDYIFFGINVITIGYYTSIERINLAMRLTLLRGILPVLFFFILPAW
FGVTGIWLAVVAGDITTTVVIVFLNLKDKNSKKGTSNVDDHFREVTKMIEIGKRSVSK
>fig|471870.8.peg.1960 Tetracycline resistance element mobilization regulatory protein rteC
MIVFIEKLNSEVLRSIERIESRDTDVLKKSLEASRVLGEAFDRLKQYIIGYRFQNDDEEI
TFFKEIKPRLFCRLIYYRKLYNIEMNRPVGSIEAQREYLDAHVRAINAYTQKRLDFIRYF
RSGATHLDSLYFLRGQTDTEQYLETFYYELDPQFSTNADFKVAKILANDMLSVYLMGELE
SLESTNLRNMVLPLSDVRPTWQDSKTDLTELIYLLDSKGCFGNVPLTQLASYISNAFNVH
LDMNLSRTFCDMKIRNNPTPWLDKAKEALLKRMQTWKRNKKNGNSE
>fig|471870.8.peg.2068 Permease of the drug/metabolite transporter (DMT) superfamily
MKNLKYIFMVLLGGTMYGTMSSFVKLSYTKGFNAAEISFWQAFIAALLLAIYAFFTRKNI
KGKLTFGNFIFLLFTGSAIGLTNFFYYESVSYISASLAIVILMQFTWFSLLLEWLIFKSK
PSKPELITVSFILVGTIMAGNILGAKAWEFSMKGVLFALSSSLTYTVYIIANSRVSKSVR
WQTKSMVIMMGSSLCLFSINSEIILSSDYLNDKFFCWAIFLAVVGTTVPTALFASGISKI
GVGISSILMTVELPVAIICARIVLKEQIGSLQIVGIVIMLASICIMNYYKVYKSKR
>fig|471870.8.peg.2492 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIHQESLKKRLAKLAAPIFIETLLIMMLGAVDTIMLSRHSDSSVAAVGVVNQIIMLTFLI
FEVINLGTSVLCSQYLGARLQKKVVQVVGVSILVNIVIGVSVSLFLFSCAGPILRLMGLT
PELMTDGMDYMRIVGAFAFFQAISLTLSASLRSANKAIYPMLVTVVVNILNIIGNYSLIF
GRFGFPELGVEGAAISTAFSRGVSMVLLFIILFRKHIHRFPVAYFRPFPWPELKNLMKVG
LPSAGEQLSYSSSQVVITFFINMLGVEALATRTYCVNIIMFAYLFSIAMAQGGAICIGHL
IGEGKPHAAFLMGKYVMKKSVMITVILSTVLAVFGNTIFHWLTSNEEIIRLGTTILIIDV
ILEIGRPINIFATNALRAAGDVNYPFYVGLVVQWSVAVGLGYIFGIPLEWGICGMWVAFL
LDENIRGAIFVRRWYSMKWTTKGFVAKH
>fig|471870.8.peg.4347 Drug resistance transporter, EmrB/QacA family protein
MHETGPFSIPAIRDFVPPKLRPWIIIAFVIVFQFSGGLYLAAVNEMVGSTALMQEDIMMA
GYASMVGMGLTFAIMFRLKFRFTSKASLMTCSIALIISNLICMHTHSIPVLVITCFFAGI
FRMWATFECNSTIQLWLTPKRDLSVFFCFIYLLVQSCIQLSGLVTIYTAFWAKWEYMHWL
IIGLLLLVMLVTLWLFRSYRSLPKLPLFGIDWLGALMWGLVLLCILFVCVYGEHYDWYQS
FQIRVATIIGTLILVLNLWRASFIRHPFIALKTWTYRSVWLPFILYIVIDILLAPSHLFE
HVYMEGILGYDALNVISLNWVVLLGIVVGAGFTFFTFSRRKWRYKTMTVIAFSSITGYLM
YFYFGIEYALPKETLFIPLFLRSFGYVMIAICFLTVLSRVPFQHFFQAVSVQSFVSAGFG
GALGTAILGHALNGAMKKNAMLLGAGLDHVNPFASRISAGELYGVVQQQALMISMKELYG
WLILLALFCLLVFLVYESDIRPYKVLHPTYRSIRRFVKHELRMDKKLEATG
>fig|471871.7.peg.1957 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKKLEKDFTTGNTTKKLIGITIPLLIAFIFNMAYNIVDSVWIGNLLGEKAMAALTISMP
PILLFTSVAMGATNGIAILLSKNIGAKEKNSINKVISTSFVGAIIFSIIVTIVCEFGTNI
ILNLLNTPYSIYSMAKDYFVIYMLGYVFVFMYLYFTAILRSFGNTIMQMISIILCTLLNL
VLDPIFINKLGIRGAAFATLFSQGIMMGIMVIYIIKKKIIIIDFKLFDKNILKEIVKNEV
PSIIQQSIPAISTSFITSLVSGFGILPIAAFGISGKLETILFYPAMALNMTITTCTGQCF
GAKNTKKAKEYLHSGMLLGSGFLIILTVIVVVFSKNLASIFGAGESVGKLVKVYFSIISI
GYICNTITNCVLGTVNGFGKPRAAMYLMIFYYIIIRIPLSKLLSLTVLGLNGIWIAVLLS
HILASIAGIWYFRLLLKQEVIETHMKFGI
>fig|477641.3.peg.62 Probable multidrug resistance transporter, MFS superfamily
MTAVEAPVRATPEQARTLLMASLATLLVLVTFVTPLATGVRTTVDLAAGPGAQAWLLSAM
SVGLAAALLTAGVLADDLGRRRVFAGGLAVVGAGAVVVAAASSPGVFIAGRLLQGVGGAA
VLACALGLIGHAFPPGPARSRAAAVWGASVGAGTGLGGLVTVALDHGQGWRTTYWATAAA
ALLLAAVARWTLAESGGNADRRVDVAGIVLLAGGISALLAGLVQSRTGWGQLPVVVLLAL
GVLLLAAFVPAELRQAAPMIDLRLFRIPGFLAATVGAFVTGATVVGLSSYVPTVLQRGLG
ESLLTATLLVLVWSAVSTVTALSVRFLPGLDGRVLLALALAVCAVGLGGYAVLGVDASGA
RLLPGLVVLGIGYGAANAALGREAVAHVPAARAGMGSGANNTARYLGAAIGVTLVVLVVG
AGDPAGTTEGLLAGWDRAALGGAVVTLLGALVVAVIRPARTP
>fig|477641.3.peg.2332 Probable multidrug resistance transporter, MFS family
MTDEANDPVAERAPPSSRLALLLAAAMFVLVVDTSLMNVSISAVVDDLDTTVSGVQSAIA
LEALVSAAFILINSKVADLIGRKRAYVLGLLAYAVGAAAMTVAQGLTAIIVFWAVVGGLG
ASLLLPAMQSLIHGNFDGAARKKAYALVGAAAAIAAAVGPLLGGFVTTYLSWRVGFLLEV
VIIAVVLANIGLVRDVAYTGPRQIDLVGAALSVVGMGGVVLGILVWQEGGEAVGALIVVG
VVGLAGLAYWLVHRKRQGKPTLIDPDLFGFPHFRLGFVQQMLQQVTLGGAMIVLPIFLQM
TLEYNAMQAGLSLAPLSLSMFAVAVLAGRMVGKRRASTVVGAGFTLTTVGLLLVIPIVPR
ADFGWWLIGPLVLAGSGLGLLVSQLNNYTLAPIQEERVSEAAGVNSAAGSFGLSFGLAVA
GGIMLAALSLGFTSRTEASTVLSPGQQEQIAEVLETDAQVMSDTRLDAALDGQPDDVRAE
VLRINSEARDVSLRVALLVPVLAGLIGVLNSFRMSRLPDITPAAPREGTTLG
>fig|477641.3.peg.2754 Glyoxalase/bleomycin resistance protein/dioxygenase
MDWRLEVLVIPVGDVDRAKEFYTGGLGFALDTDFTPNEHFRVVQVTPPGSACSIVFGRGL
PTGAPLKGCQFVVADIAAAADHLTAAGIDHSGMVHFADGVQTAGRDPQDADFGTFVFFDD
PDGNTWSVQQGKR
>fig|477641.3.peg.2957 Drug/proton antiporter
MFSALILFAGTFSERIGAKRAYGAGTVLFVLASAACGLAPDLGTLIGARFAQGLGAALVT
PTALAIIREAYTDAGARARAIAYWAMGGSIAAAAGPIVGGALTQVDWRIIFFLNLPVGAI
ALLVLTRVGTSPREAAPFDWTGQVTAVLGLAALTYAIIEGGEGGYGRPTILTAFAVAVLA
LVVFLLAQSRGRHPMVPLELFRSTRVIVALAAAFIGMSAFYGVVFVQSLYFQQVRGESAF
STGLLFLPMTALVAAISPVVSRVAAHYGLRVPIIGGQIVLVAGLIALACVPASTPTWVVA
VLMVPLGLGGSFTVPPLTTLVIDSVPARRAGTASGVLNLSRQMGGSLGVAAVGSVLAVQA
TFMTGLRIGLIALAALVVVTIVASLTLRDVDGPAAH
>fig|477641.3.peg.3390 Glyoxalase/bleomycin resistance protein/dioxygenase
MSASPPFASVTDVFCFVPDLAAATAWYTDRLGSPPVLVARQLARFDLGGSRLTVHSIDEF
NGGGPAGCVACWDVEDVDALVAEWVRHGAVAHRGPKTIMTGERLCQLRDPFGNLLGVRQA
PAPAAPLPSGGTDVAAG
>fig|477641.3.peg.4906 Probable multidrug resistance transporter, MFS superfamily
MTWRRGVFALFAVAAGTNVPTPLLLVYQERLDLSPQVLTALFGSYAAGLVPALFVAGPLS
DRLGRRRVAVPGILLSAVASLAFAAAGESLGLLFGARFLQGVVSGVVFSVASAWIGELSL
ASGDGAGGRRAAFAMTAGFSLGPLVSGVLGQYGPAPTVLPYLVHAVLATAGLVLALRLPE
TVDLLPVPAAAGLPVAAPVPLVRPGDGLTVLTVLAPVAVCVYAFPSAVISAVPLLVELPA
AGVAVTGVLAGVTLGAGTLVAGLQRRFGRWTAVIGVALGTVGFAAATAFTATAALPWLVV
AAPVLGAGSGLCLAAGLTLTARLAAPARLGALTSLFLAFAYVGFAAPFVIATVAEATGPT
LPLTVAAVLCGLLALRLLPAVRRHQL
>fig|477974.3.peg.861 Vancomycin B-type resistance protein VanW
MTGRRLLLLVLSGLAALLLTVTGTFWGIVTVEGRSQTVFPGVSVYGLDLGGLDQAGCLEA
VGSLEQSLRCTPLTLVYGSRSWRVELGDLGLVVDGDKITSEALKAGRSGFFVSQWLERGE
ISRNGFKLDLCADFEEPRFRTVIDEITTEITRAPVDARYHIGNDDTVHIIPHQDGYQVDH
GRLKQRILQQLETGRLAPVSIPVVHVVPEYTTSDVEAMNLTGLLAEFGTNYDPAVVNRSY
NISVAAGALNNLLIPPGEIVSFNRIVGPRSSEAGYRTAPVIIENQFQEGIGGGVCQVSST
LYNAVVLANLEVLERKNHSLPVTYVPIGRDATVVFGAIDLRFRNNTGGYIYLKTSAANGR
VSVKIFGDHRYHPRVEIKSWITETLEPRTVYEDDENLEKGKQVVKQAGLRGYRAQAERWV
WQNGAAEKEPLPASFYHPVPEIIAVGTREPVPALIVPPESGVPIWIPDPGNPLSPPGSIP
PREENRVLQPE
>fig|477974.3.peg.1070 Daunorubicin resistance ABC transporter, ATP-binding protein
MSEVLLELESVTVNFGGLTAVHRLDMNIESGSIRALIGPNGAGKTTVFNVVTGIFRPTSG
SIRFRGREITRLNPYDIAAAGIARTFQNIRLFKNASVLDNVKVGRHSRGKSNVLGALIRH
PGFKAEERDTTEASLAALELVGLSRKKDELAKNLSYGEQRRLEIARGLVSEPALLLLDEP
AAGMNPQEKQSLLQLIKRIQEQGITIFLVEHDMKFVMTLSQKITVLDYGREICTGTPAEV
QADPRVIEAYLGKEVG
>fig|477974.3.peg.1963 Vancomycin B-type resistance protein VanW
MRWFPLMFLLLITLFLAGVGPAGAAVMVPLRPVLENRGITISWDGEAATGYCCGRLLRVV
PGRDTAEMGGNEVLLDVPAVMLGGMTFVPDTLLAGFLDSPPPVVGFHAFTRVRIGEQLWL
VGMLGESLEAEPEDFRIPSDLVPEEPDTIIPEAPGPARIWVLPGTGEDMVLEGLVSLMGA
ELSSGALGFTLAPGASGILRDALTQKLDSVTLPLERRIGSCLVNFNPGGGDYNNMLNAVQ
AAAYLNGITVQPGQVFSYNQTVGPRTAERGFVIGYAISGDRHVPARGGGVCRTSTVLYGA
VLNAGLPVIERHAHTRPVGYVPMGRDATVSYGTADLKFRNDLPRPVRIKAGGTVRQLQVT
LWELWG
>fig|478749.5.peg.457 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKITDDLTKGNIRNQLVVLALPLILGNIFQQLYNTIDSFIIGRYISHTAFAAVGVAGNIM
NLFTFVISGGCNGISIIFAELYGERKWNTLRKESFLSFSFGCFVTAGLSIIGLLTLVPLL
DVLQTPLVVRIFAQDYLRIIYLGLPATFLYNWCSCVLRAIGDTKTPLWILVFAMVLNFSL
DYLFVVCCKTGIFGTAAATVVSQLFASIVCFMYMKVKYPCLLFGRRDMAFDRRLLLKTAN
FGLVSALHQSSLYIGKLFV
>fig|478749.5.peg.837 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRNNVKEEKKQMMLNENIMTLLPKMAVPTITAQLITTIYNLVDTYFVSTLGTNATAAVGV
NSSLERMITVIGSLIGAGACSYISRLLGAKKEEHANRILSTSIFTGIGLGILFMIFGKLM
LGDIVYWLGATEECAEYSIQYGTYVLYAAPFMIGSFILNMCLRSEGSATYSMIGIGFGGI
LNCFLDPLFIYKFGLGVAGASMATAISKCISFVILCWPYARKTTIVEISIRKFSLVWNDV
KEVVAIGSSSFFRSVLTVVASIAINRVAGSYSTASLAALSVANRIMEFPFAFILGFGQGY
QPVVGFNWGAKVWKRVKDSYTYGCAMAVGGSIVMGIIIFIFASPLIRIFNSQADMEVMEL
GMLCVRLQCFGLIMHALSSQVNMFFAGIGNAKLALVANFARQGYCFYPVLLIAPRIWGVN
GVAATQALADLLSAVVIIPMFFYGLKVIRLAQEGKVETDVHKHSHRRKAEQHS
>fig|478749.5.peg.1176 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAKTIDMTQGKPSKLLLQFAFPVLIGNLFQQLYTLVDRVIVGQFVGADAFSAVGSTNALS
MMFMSMCMGTAIGTGVVVSQYFGAKDQKNTAKAIANGAYVNVIVALIMTVIALLATKPIL
ILLNTPATLMDDAVSYMRVFMGGLLAVSLYYTPFSILRALGDSKTPLIFLAFCSILNIIL
DIIFVVPLGMGVEGAAIATVMAQAIAAVLCMIYAFKKVPQFHDAVHYMKPDSNIIRQTLK
VGIPTGFQYSLMYISSIALQRVVNGFGESVIGAFTSTTQIELLVQQIYAALGTAMVTYTG
QNIGAGKTDRVKQGMCSAMKISGIVSVILLVVFWLGGRLIMSIFVPDKDIIALASSGIRI
TSLFFMALGVVQVLRYLLNGAGDSVYALVNGIVEIIARIGFAFLLTAVPFIGMWGIWLTT
GLTWLVTAVFALWRYRSGAWMSKSLVKGKENE
>fig|478749.5.peg.1432 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKTQNQLTEGNILKTLLVFAIPFLIANILQSLYGAVDLFVIGKYCDAASVAAVSTGTQV
TQIVTSLVTGLTLGSTVIIGQYMGQKNYRRAAQTIGTTLTVFALVAILLTILMLAFERPL
LELLSTPAESFELTMQYVAICAAGNLFVCGYNAISAILRGYGDSTRPMIFVAVACALNIF
LDFVFVKYMGLGVSGTALATVISQAVSMVCAIIYLKKSSFIFDFKLKSFRPVPALVRELA
VVGIPISFQELMIRISFLYLMTVMNGCGVYAAAVVGISSKYDVFAMLSGTSVANALAAIT
AHNIGAGKPERARRSLWYGLSFALCAAFLFWLWAQLSPQSMIRVFSDDEQVIAAGVPFFR
SNSYDYLLVTIVFCLNGYLNGRQKTVWTMISSSAGALLLRIPLVYLFAKYFGDNLGMLGR
IAPTVSGIMACYTLAYVLYEGRKSRQRT
>fig|478749.5.peg.1522 Vancomycin B-type resistance protein VanW
MKLKKRFLGTLVFAFVMTGAFCAAAEDDVRIDNGICIGDIDVSGMTYDEAYALVKQRIGE
MRSAVITVQVGEDSIETTASELGLQWNNKSVVQDAIDLGNSGNPVKRYKERKDLDQETQV
LSLEFSANANAVRDFIEEKCKQFEKEPQNATISADGSGGFDLQEGVTGQVINVDESVKAV
QDYIANEWQGEDGTIALSVEIEEPEGNTEDLESIQDMLGTYTTYYGSTAGRNMNVERGAE
LINNHVVWPGETFSVCDQLVPFTAENGYELAPEYSMGQVVQGYGGGICQVSTTLYNALLL
AELEIVERHNHTMTVSYVPYSMDAAIAEGSMDLKFCNNLDTPILISGYAYGGELTFTIWG
KETRPADRTIYYYSNTLSETNAEGVALYAAPDQPVGYFNQVQSAMAGVSAECWKEVTYNG
ETTTELVNTSYYQATPASWEVGTLGASDALLSAIYANDLEAAQAAALGVTTQTESETQAT
DTVVTETPATDTPATDTPATDYIDPNAGANTDAGSSDGVVIWE
>fig|478749.5.peg.1783 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNWSKYFGDRKFYRSMLTVAIPIMVQNAITNFVALLDNIMVGQVGTVQMSSVSIVNQLIF
VYNLCLFGGTSGAGIFTAQFVGKGDQQGIRYTMRFKLWIGALISVLALLIFGFGGSFLIG
LYLKGQAEAGDAVRALQYGRSYLSVMMVGLIPFCLTNVYASTLRENGETMLPMKAGIIAV
LINLCLNYILIFGHFGAPELGVTGAAIATVVSRFAECLIVVSWTHRHREKNRYIVGLYQS
ARIPAKLTRDMIAKGTPLLLNETLWSGAMAMLLQCYSIRGLSVIAAMNINSTLSNIFNIV
FIAMGNTVSILVGQLLGAGKTEEAKTAASRMTVFSVLCSLATGLVMAAFHDVFPQFYNTT
PEVRTLAGELILVTALLMFLPAFTNATYFTLRSGGKTLLTFFFDCFYVWVVNIPIAYCLC
HFTDLPVVLVYLVVQASELLKCIIGFVLVKKGIWLNTIVDN
>fig|478749.5.peg.2724 Acriflavin resistance protein
MLPRYSVKRPYTVLVGVVLILILGYVSFTSMQTDLLPDMTLPYAIVYTTYPGASPEEVET
MVTRPVEQSMATISNIENISSISSENISMVILEFSQSANMDAVTIEMRESLDQIEGYWDD
TIGSPVIMKLNPDMLPVMVAAMEDGDMSQSDLTDLVNNTILPELESIEGVASVSTTGTIE
EQVQVTLREDKIRAVNRKVRNALDDKFAEAESELEEAQKKLDEGKEELENGQTQLADQTS
SAESQINAGASQMITGQVQIDQKLAEVQSGLEKMDASEQELLAKEQELLAGEETLQKLPE
QKAALEAQKAQIDAGISQLESAPSQLAELDAAIAGVKGAIEELEAQIAGLQGAPSETETD
GAQTDAGEETEGAQTDAAAQTQLYSGARTQTNAEGKNSAGTRTQTDAEEKSAADVREPET
SGMKNNETENVRSAEEPSVPEPQTETGLVVPAQDAGAEAELFAQDDGELILDGENTGSAG
ETQSQPEFSLPQVNPGLSQEEIDRLTQEAQQEAVIAALQKQLLELQAQQLTLENTKAQAL
ASLAVLGVNTGGTAQERDESIDTVKSELVARRIQIEDGIAQMQTTIDGMPEQMEQIIAGK
AQIESGKAQLSEGRAQLLAAQKQLETAKAQIASGQTSVSAAVGELNKAKISATIEMAAGK
AELSAGQKELDAALEQIEQQKDAAYDQADVTEIITADMVKGILAAQNFSMPAGYVTEDGV
DFLVRVGNKLEDTEDIGNLLLLDLHMDGLEPIRLSDVADVVTLDNSSEVYAKINGHSGIM
FTMQKQSGYSTGEVSDRIKEKFAELEESDENIHIIELMDQGIYIDLVVDSVLENMLSGAG
LAILVLLLFLKSVRPTLVIACSIPISIMAAVVAMYFSGITLNIISLSGLALGIGMLVDNS
IVVIENIYRLRAEGYSVKKAAVEGANQVAGSIAASTLTTVCVFLPIVFTEGITRQLFVDM
GLTIAYSLGASLIVALTLVPAMGAGLLKNVKQKRSRIFEALQNGYAKLLGWSLKVKFLVL
LLAVGLLALSAKLALSKGTAFMPEMESTQVSVTLNMPEGSQLPETAAMSDAVMERILTIQ
DVTDVGAMAGGTGAMSMMGGSQSSSADSVSLYVLLSEEKTITNDELKAEILEKTADLNCD
LDVETSTMDMSALGGSGISINIKGRELDELKRIAGEVAEIVESVEGTADVSDGIAEKTLE
LRLVVDKDKAMSYQLTTAQVYQFLQAKLADASSATTLSAPSKDYPVLVVSDADETLTRDK
IKKLTITGKDEDGQEVEVPVADLVEFVDTEGFSSINREAQTRYVTVSAQIADGYNIGLVS
ADLNAALENYELPKGYSLEMAGEDQTINEAMTEVVKMLLLALAFMYLIMVAQFQSLLSPF
IIMFTIPLAFTGGLLALYLTDNPVSVIAMIGFVMLSGIIVNNGIVLVDYINQLRRGGMEK
RAAIVEAGRTRLRPIIMTALTTILGLLTMALGNGMGADMVQPMAIVTVGGLTYGTLLTLF
VVPCIYDIFNRKKDMTEEEI
>fig|478749.5.peg.3433 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDSVKSMTSGSPGRLIFSFALPLMVGNLFQQLYTVADAMIVGQVLGVGAIAAVGAAEWMI
WLMQGMIQGFTQGFSIWMAQAFGAGKTDELRRVVANSAVLSAAIAVLMLLCGQLVAAPIL
HILNTPATVFPEAEIYMRTMFAGIPVVMVYNLLAAILRSLGDGKTPLYAMIFASVLNIAL
DLLFVIVFHWGVAGAAAATVTAQLASAIFCLARLRSIEMLRLAKTDFVLTPATHGKLLQL
GFPMAFQNAVISVGGMIVQSVVNSFGVHFIAGFTATNKLYGMLEVAATSYGFAMTTYTGQ
NIGAGKQERVRSGYRAAMGIAMLTSLVIMVAMILGGRAILRCFISGDAQTVEDTLAIAYH
YLFIMSVCLPILYYLHVTRSCIQGMGNTVLPMVSGIAEFLMRTGAALLLPLLMGQEGIFY
AEISAWAGADVVLFFSYRYCMKKQKG
>fig|478749.5.peg.4052 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
METVTQHENPLGTERIGRLMLQYSIPSVISLVVNSIYNMVDQVFIGQGVGYLGNAGTNII
SPMTTILLALTVMMGAGAATYMSLHLGKKEPEKAAVGVCNSMTVTVLIGIVCAVLLEIFM
EPMCRFFGCTDNVLPYATAYGRIIVLGFPVAAIGCGFGDIIRADCRPKQSMAGLLIGCVA
NLILDPLFIFVFHWGVEGAAWATIIGQLLTALYFIRCCFHFTTIQLKKSYFRPQWKVVRR
VATLGISNFITQISSVIVMTIVNNLVRIYGAASEFGSDIPLAVLGIIVKINGLAASIVMG
VSTGVQPVMSYNYGASQYGRVKKTYKITLVVNTIILTIARILFSLFPEEIIGLFGQESEL
YVTFAVKCFDIFLLAIPLVGICVATSIFFQSVGKAGVAAILSLTRQVLYFVPAMLILAPI
LGLDGVLWGAAISDTLACVTAVIVVLALWKRIFKERK
>fig|478749.5.peg.4055 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFSAKKIDMTEGPVMKLIFLFALPMCVGNILQQLYNTVDTFVIGNYCSSVSLAAVGTSSQ
PVEILLCVFVGLGNGVSILAAQHTGNGNIENLKEVVSTAVSFLYLCAIPVTILGLLAGAD
ILKVMQVPESTWELSVRYMRIIFLGVLGNLGYNMNAGILRGLGDSRSSLLFLVISCIINI
VLDFIFVAGLGMDVAGAALATIIAMFSSWLFSILYIRKKYPELAFTILPRRMKKEILLEI
IRIGLPLGLINSIYSIGHVLLQSLINMQGAAFMAACAVASKVTSIANVTINSFSSAATTF
SGQNLGAGKYVRLCKSSLKIPLVSGAFSFAGGMIVLFFGREILGLFTSDAEVLDMALIYL
RVTLPYFWAYAIFNGFICFANGLGEVRYPMIVSILALWAVRIPCAHLIARFFDGRYMMAC
FPASFLFGMCAMLLFFRSKRWKEIKRLAKEEQQDT
>fig|478801.5.peg.1878 Vancomycin B-type resistance protein VanW
MASLFLLMGLVALIYLALVFVVGRTTPSHLTVGGVDVSSMAPDEAERSLEQEAERLMQQP
VTVVAAGEEHEFTPQELGLGYAVARSMRGTTGRTWDPRDLWARATDQVDRDWAVTLDEGR
LHDRLRDLSAEIDVPATRATIELRGAEVEVTEGSTGSALDVRETGESVQDAWPREHRVEG
TVEEVEPEVTAAVLRRFADQVVEPALSAPVTLVAVPVEGPRQGPSGESADPASPEPSDGS
SASASAQDELTATHRVTIPADQIAEMVSIGGTAREPALEVDATRWRDGLPDDHPFSDREA
REASLRLEDGSVRIEPAQVGRSVSTGDIEQGVRDAVRAQEREARVTVSVTRPYELGDGWT
AQHLSTFTTMLPGGEGNEGRTRNIRTLTRKIHGTVVPAGEQFSLLEVMGEPTKEAGYEEA
HVISNGTLSHAVGGGLSQVSTAVYNMAFIAGVQLDEHKPHSYYIARYPEGREATLWYPAI
DNAWTNDTGSPMIISAQLDGRELIMSLYGEKQYDVDATTRPRQNVVPFRKYHSNDPECVD
QGGVDGFDVTVERILTPYGDHDGEERTEVIETHYDPSDEVFCTNPESPEYSGSQEPPSDE
YRPFSQREQDVKDDARAEAERELREDEQADAEAQEEDGRPEGTPSSSAEPEPSGSSTPQP
SGSASGD
>fig|479431.6.peg.1276 Bicyclomycin resistance protein
MTRDEHAAGRSRVWLIVALGSLSAFGPLCLDMYLPALPVLPGELNSTAAAAQLSLSACII
GLAVGQVITGPLSDRLGRRRPLLLGVALFALVSALCAVTTSMTLLIGLRLVQGAAGAAGI
VIGRAVIADLFTGKAAASFFAAVASINGLAPILAPVIGGQILRVGTWRTVFWVLAGIGVV
LLVLAFFVIRESLPPSRRSAGGLGATRRAFGTLVRDRGYVGCVLAGSLVTAAMFGYISAS
PFLLQDRFGLSAQWFSACFALNALGIVAATQVGRLLLRRVSSLWLLSLGVVQGLLGAMLL
AVTVAAGWGLAMVLVSLFVMVSAVGFALPHASAIAMDRHRRIAGSASALLGLTQFALGAV
TAPLVGLGDPASGVALAGTAVIATGLGALALLVGRSAVGGPGPARVVGAG
>fig|479431.6.peg.1519 Probable drug transporter, MFS family
MTPSRRLTAALFAGGVATFAELYAVQAVLPGLAAEWSLTESRATLAVSVATGALAVSVLP
WAAVGDRIGRARAMRISALVAALSGLLVAIAPTFEILLALRAVSGAALGALPALAVAHLV
SAAPPARVAAAGGLYIAGTTIGGLSGRVLTGAVGGVFGWRWGLVTTAAFVVVAAVVFVVL
LESPATARTADQLGGRPAGGEAAKVRLALSDRVAWVFYAQAFLLMGAFVTVYNLLSFRLL
ADPYRLPASVVSLLFLTYLVGTIGSSGVGRLVAGLGRRRVLAGAGLTMAIGAAITVPAPL
WSVLTGLVLLTFTFFVAHAIAATWAGERVPAARSQASAIYSLAYYAGSSVVGLVGAALYA
RGGWPAAMTLVVTITAAAAVLAFFGAPRRDRPAERQSSSV
>fig|479431.6.peg.2253 Permease of the drug/metabolite transporter (DMT) superfamily
MTAAAEAGVMTMRVGWAGQERSGALLAGGAVVLVGGSVAASSLVGDYPVLGGQGVRYLLA
GLLLAAWSRLRGEPLIRPTGREWGWLGALAAVGLAGCSVLMIQATRVADPGSVGVVIGAA
PLVIVLAGALVRRRRPATRLLVAAAVVAAGAAAAQSGSGAGSFSLLGFALSLGALAGAVG
TTVLAAPVLPRLGPMTVTVYSCVLAGGLLLVLAVQDGLATGATVLRMPTLVEFGALAYLA
VMVTGVVCIAWFGAMQRLGSERTGLFNGLIPVASLAAVLLVGAGQVGAWQLIGALAVLVG
VVLGLRRGPVVTATASGPTIAGAVPVGR
>fig|479431.6.peg.3202 Glyoxalase/bleomycin resistance protein/dioxygenase
MLRITVTSVLVDDQAKALAFYTDKLGFRPGYDVPAGDYRWLTVGDDHSDVQLLLEPDAHP
AAKAFKAALVADGIPYTQFAVPDVHAAHAELVERGVVFTQPPVEMGPVTMAILDDTCGNL
IQLITMTGTPG
>fig|479431.6.peg.3912 Multidrug resistance protein
MTLEVKVGRHRRSEPTQLRHNRTYLLLWTGAGVSMLGSRMSAIAYSLVVLWATDSATSTA
MVTFAALLPFLVTQLPAGVLVDRLDRRRVMIGCDLGRVLLIGIALTTVAMGHVWVPLLMV
IAFCEGSLTEMYSIAERAAVFTVVPDEQLGVAVGANEARSEAAGLIGQPIGTFLFSALRW
LPFAATIVSHLLSLFTLLLIRRPLQGPRPDGPRPSPVQDVKEGFDFVRSQTYLRRALGLI
AASNLLFQVLALGLLVIVKDQGGGPDTIGWILLASGIGGMLGALSSNLFMRWVGVRWIFM
GVNIFWTLLMGSMVFFQQPLALGVIFSLLLFGAGLANVAGIVYTMKVAPEDMQGRIGSIV
SLLSSGANALGALCAGAILDALGVRTTMIIVGCSMLVIAIAAVLAFGGRKAAAAEAALGD
LTE
>fig|479431.6.peg.4270 Antibiotic efflux protein
MTVPPPGDAAAAPRVAGPGPFRRLLVATTSANLADGLMVVAVPWLASAITRDPVSIALVT
AATRLPWLLFSLPVGAITDRFDRRRLVGLAATARAVLLLGFALLLVAVGAPAADPSAGAD
PAAGAGTGTVAGGDHSGVLLAGLVVLALLVGLAEVVGDNSAQTLIPSLVPEQRLTTANGR
LWAAETVANQFVGPPLAGLLIAVGIALPFFVGAGGFAVAAAMVFTIAGSFRPPRSDGPPT
RLSAEIAEGVRWLMGHRLLRSLAISLGVLNAASAMGAAVFVLFGQEVAGLDATGFGLLMT
GSAVGAVLGGIAGPRLIRRWPPGTALAAAIVGMGAGDLLFGLLSQFAALWAVSLVTAVFI
VVWNVITVSLRQSLIPDRLLGRVNSVYRFFGWGTIAIGTLLGGLVVWAFEPVVGREWAVR
LPFLLCGLSYLLLLAWAWPRINNEQIARARAQAGEGGAAGADGPLAR
>fig|479431.6.peg.4833 Antiseptic resistance protein QacA
MMTSADMTTPGTPPRRATTADWVGLSVLALACLMYVMDLTVLHLAIPQISEQLAPSSAQL
LWIIDVYGFLVAGALVTMGTLGDRIGRRKLLLIGAAAFGLTSILAAFSTTPEMLIVSRAL
LGLAGATLAPSTLSLIFHMFADPRQRSVAIGIWIGAFSAGSAVGPVLGGLVLEHFWWGAV
FLLALPVMVALLILGPIVLPEYKDPGAGRLDLLSVLMSVAAVLAMIFGLKEIAQDGVTPL
PVGLIVGGLVIGLIWIRRQRRLTDPMIDVSLFRIGSFRTALSVNFLAVFISVGYFLFLAQ
YLQLIVGLSPLQSGLWSLPSAAGFIVGSQLGPRIVRRVQPATIIATGLGLSAVGLGLLTQ
VGVTDGLWIIVTSSVIISVGLGPVFGLTTELIVGTAPPEKAGAASGISETAAELGGALGI
AILGSVGVAIYRGQLATTLPAGLPSAAADAASDTLGGAVVAAASLPPAQGVAVVDAAATA
FVTGLQVVSAVATVIAVIIAVVSWFALRQPRPAAGGDPAADGGASSGDAAAADAVGREAE
RPPAPAHPSPRSGPDDRLCCADC
>fig|479431.6.peg.4921 Drug resistance transporter, EmrB/QacA subfamily
MSAPTPPSVTVTGVPIHGRRPVRPTLVIAVFCLGLFLTLLDITIVNIAIPDLVTDLNATL
ETVLWVGSAYSLTYTVLLITAGRLGDIHGPRRLFLIGLAVFTLASLASGLSQTPGQLIAF
RAMQGVGAALLAPQGLPIITSILPPAKRGPAFAATGIMSGLGVLAGPTLGGLLVTHVGWR
WIFFLNIPIGVAAFALAFAVMPDVRPGRRHRLDLVGVALLTAGLLGVVFGLIEGERYDWG
TVAGFVTIPMIIAGGAVLLVLFLWRQAVTQDREPLLPFAVFADRSFTVMTLVLLAMGFAM
VGMFLPLTIYYQSVVGLTAIAAGLVIGIQSMAMMITSGIVGGLSGSGRIPMKWVLFAGLL
LFAGGMVEIAAVATPDSAWWVFVPGLVAAGIGLGCVWTPVFGLATRDMLPARAGVGAGVL
DTVQEFGAVLATAILGAVLANRLADAMVAQAQLVAAGLPAAARAPFVDGLTQAAHGGLSV
GAGQAQSSWPADVPAALADQLAAAAQQTFAAAFTDAMGPVIRVAIGVVLAAAVAVLFVRS
RSTVAGAGAGAGAGAGAGPVAGAVAGADPAAAPERAEAS
>fig|479431.6.peg.4957 Vancomycin B-type resistance protein VanW
MALPVAAAPAPENGSGVDSARRNKIIASVVGGVVAVLAAVYLVDLLMTSGTIERNTSVAG
VAVGGLTPEQAAAALTEQALPEYSAPVVVDVHGVATQIDPTQAGLSTDVAATVQALGTRS
ANPFVRLSSFFTSIEQPLTDGVDETALTAVVQGIATSTDLAPVEGSVAIDNGQVTTVQPV
IGRSLDVAGSVESISAAWISGGPGGLGGLVLPVSAAPVRASVEGTERAAAQAATIVSAPL
TLTGGGATVEVGAVELGAATTITPDSADGFVVAVDPAAVLDAVRPAVEATQSAPVDAKVV
IRDGAPVVEPSAAGRALDAAATEAAVAAAVTTPNRTVELAYQLSDPAFSTEQANALGIKE
VIGEFTTGGFAAASGENIRVVAEKVNGALVMPGATFGLNEFTGPRGTEQGYVPAAIIQEG
ALSTAVGGGISQFATTTYNAAYFAGMGDVTHTPHSFYISRYPAGREATVFDGEIELAFSN
DYDTGVLIETIWTPSDITVRLWGTKHVQVESVSSDRFNYTSAPVIVKPYGTACTPSGGST
GFSIVNTRIIKDLAGNEIRREDFTTVYNGQQNVICSPAPAAASTAPATMDAAAAPAAEVP
AGG
>fig|479432.6.peg.610 Permease of the drug/metabolite transporter (DMT) superfamily
MKLAVVGAAVLWGTAGTAGLLVAGVDPISLAAARLVVGGLVLAVAVGPAIRSLPRPALLL
PAAVAVAAYQLCFFAAVSRTGVAIGTVVAIGSGPVFTGLLSWALDRVRPTRRWAGATAVA
IAGCAVLTGGGGEVRLDGVLIALLGGLLYAFYAVTAARVISAGASSDAVMGAMFGGAAVV
MLPVLLWTGTAWLTEPRGLLTALYLGCATTALAYILYGRGLRTTPVATAATLALAEPAVA
ALLGVVVLGEQLTLTSAAGLLLLGGSLAVVALPERWSGRRGRAAAIESSA
>fig|479432.6.peg.2021 Drug resistance transporter, EmrB/QacA subfamily
MTHHGPDGRRLPYLAVFGLLLGMFLAMLDGLIVGTALPTIVGDLGGLDRLPWVVTAYMLA
GAATTPIWGKLGDLYGRKATFITAIALFQVGSLLAGVSQDMSQLIAFRAVQGLGAGGLMV
GALAIIGVLVPPRHSGRLQSMIGVIMPIAYIGGPLVGGLLTDHLSWRWTFYVNLPLGAVA
LLIIATRIHLPPAERVRARIDYGGAALLTTAIVTLTLLAGWGGSTYSWASPQILTLTAVG
VFSLAGFVAVERRTAEPIIPPRLFHDRNFTLAQILSFLVGAVMLSVTNYLPQYMQFVQGA
SPAASGMLLLPLMFGMLGAQLLTGHLISGNGRYRVYPILGGALMIAGALALLLLDVDTAP
VTASALSLVIGAGMGLVMQSTTLITMNSADPRDMGAASGTVTLLRTIGGSLGIALLGSLY
AVRMRDGLSAHLGPAAADQLTVGGDLTPGLLPGLPAQAGAAVREAVTGGLHGVLIGAAVL
AVIAFAASWLIREVPLRDGPPVQAGPEPDTHAAATR
>fig|479432.6.peg.2119 Permease of the drug/metabolite transporter (DMT) superfamily
MLSFSGSFPATVFAMEGFDPYLVAIGRAVIAAVPALVFLVAARGPLLPPRSHLRSYLVIV
AGVVFGFPVFSGLALDAGASTSHAAVVIGLLPAATAACAVLRGGERPKPAFWAACALGAV
SITAFTLSRGGGHATGADLLLVGALLSAAVGYTEGGRLARETPGWRVISHALVIAAPLTV
PVTVALALTTDVRPTATSLAGFAYAGLISMFLGFIPWYAGLAAGGIARAGQTQLAQPLLT
LLWAWLLLDERFGPLTVAAALAVLVCVAMSQRARS
>fig|479432.6.peg.2907 Permease of the drug/metabolite transporter (DMT) superfamily
MRPADILGIGVLASVWGTNFLLVEEALEGLDPIQIVLIRLVLGAAALVLLARARRTALPH
GGVVWLKLAGMGLLGQAVPWLLFAWGQREVTGALAGVYTGLTPLMTIPVAWLLLRERPTA
AEVGATVIGFAGLAVVLAPWSGGERAPLSGQLLCLAGATCYALAYSYAGRLMRTLPDGKL
SLAAAQALAASAIMLPAGSGQLAHPVRLTWLIALCLVLLGAGTAVAFLVNYWLIARVGPV
RASLAFYLIPVVAVVAGLVARGERLNPNEALGSVLILSALAALYAWERTREAGPAPVPDP
AETR
>fig|479432.6.peg.4315 Permease of the drug/metabolite transporter (DMT) superfamily
MAVTPAVFVVLWSSAFIAGIPGVAAAPPLLLMFARFALAGVLLAGYALITRAPWPRGRAA
AHIAVAGLLMQAVQFGSFYTALGMGFPAAVVSLVQGLSPVVIVLAMRLLGETVTRRQALG
FALGAAGVVLAVADRVSLSIWGVVLCLAGLLGLSAGTLYQKRFVPYMDVRTGTAVQLLVS
APAVGLVCVAIETPRVSDWAAFGASVAWMVLVNSIAAFILLNRMLLRFSASRVSTVFFLT
PSVTAVLAWLLVGQSLHPLAITGLVLGGAGVLLANHRAATA
>fig|479432.6.peg.5300 Mitomycin resistance protein mcrB
MSSPHRRDGTAGQTDLLELVNVGPAVVRHLARVGITRTGQLAGLDPVEMYDRLCALDGRR
YDPCLLDTFMSAVEQAGGGPARPWWDYTAERKRLLSERVR
>fig|479432.6.peg.5686 Multidrug resistance transporter, MFS superfamily
MSAPPTAPPRHAGVSAVWLAVLAGPMSFGIAGPALILGEVAGGLGVSTGEATWLVTVFGW
GIAVGTPLMSGLVGHRGMRGTAAVCALLALIGAGLALVAPSLPVLLLAAAAQALGAAGLT
AIAMQLADSPRRMGVATASLAVVGSVSPLAGSLVSDLLSWRVVLALPVVAVLAVPAVLRQ
EVRSAPSAGRFDVIGVVVLTGLVTALVAVPHQPVAAGLCAVAAATALGMHLRIRPAGFVP
AALVRAPRFLGAAGLAFALAVGNFGLVYALPVRLSELTTWSSAQIGVAMVWPLLFGGALS
WFVVAASARIRPHLMIMALAATGVAAALAAVSVSWVPGLLVAQAAASIAASSGQGVLAVR
ATSAVPEEHRPAAIGLFTLCYLLGTAFGPAVVALPAG
>fig|479432.6.peg.5895 Glyoxalase/bleomycin resistance protein/dioxygenase
MSERSGYKSGVPCWVDLSSTDVTLSVRFYREIFGWEAVFDPRPEAGGHGRFTLRGKAVAG
IGPSRGDGGSSVWNTWVATEDAGLTAARVREAGGEVVVEPAGVFGEGAMTVVRDPSGASV
TAWQVGPRQGAEIVGEPGALAWNELVTRDTARCGAFYPAVFGWGVKDVDGAGGRCVEWQV
DGHPVAGMTESGPRVPPDTPPHWLAYFAAEDVDATVARAEELGGTVVLPRTPAPRGPVAV
LADPQSALFAVVGPDRPPAVSPAVRRPADGPPARAGHGPAGTGPARAEHESDPAPSPGQV
DLSCGVS
>fig|479432.6.peg.6721 Permease of the drug/metabolite transporter (DMT) superfamily
MSVSVAWGSAFPLMKDLIARMPVADLLAERYGIATLALFALRPRCLRGLPESTWLTGLLL
GLLFGVGQTAQAVALHDLPSSVSGFTVGSYVVITPVLGLVLLGARISGRTWGAVALALAA
LTVFTLLSEAEGGAVSLPALAVTLLSAVLYAGHTLVLGNFAGARRDAYAVTVIQLGTIAL
MTGVLAAPDGLTLPRTTGDWALLGHLSIVACALGFLARSYGQLHVPPVPAAVILSAQPLW
VTALAVVMYGEPLTWAVFLGGGLIALAMLLVVLPGGLFRTARRGTGPAPPR
>fig|479432.6.peg.7920 Vancomycin B-type resistance protein VanW
MATPPERPLQERPPREEPPAASGGDPRQPESSRYEEPSRRGRRLTVLLLLLLLLAGLAYA
VPAIVMSGKMLPGTRVHGVDIGGLTATEAADKLRDRLPGKAGEEMVVRAVDRKYSIDPEK
AGLEFDVVATIDQAHSGFPAPMEVWRALTGTTELAPKISVDSERMQSTVTALARKIDLKV
REGAVTFEGGKPVVVTPRDGRELEREAAARAIRNAFLGPVGEVELPVSVIKPKVTAEVVR
EAAADAGKALSGPVTLTYAGRQAQLPVETLAAHLSFEPDSSGGMGPVFDARSAVATVENR
LVDPALAPREPTFQIVGAAPKLIPGRKGKGIDDDKLAEAVARMVAEGGSRTIPVVLTTVQ
PRVSEAEVRKLGIKEKISEFTTPYDCCLPRVTNIRTIAKLLDGYLVKPGETFSLNGVVGQ
RDTARGFVPAPMIQGGRLVDSVGGGISQFVTTMYNAVFFGGLEDVQHMAHEFYISRYPAG
RESTVSWPAPDFRWKNDSKYGVLVKTSYTDKGVTVAFWSTKRYDIESISSDRYDVTPFKS
ATDSGPTCIPMVGQQGFTIDVTRVFKQDGKEVKRETKKTVYKPETDLKCVPSTTPAQDE
>fig|479432.6.peg.8258 Multiple antibiotic resistance (MarC)-like protein
MDVQFFVEAFVTMFVIMDPPGIIPLFLAYTRGRTERERTRIAWQAPIVAFCLIVVFAVFG
RAILGYLHVEVAAMQIAGGLLLLLVALQLLTGETGPPPNTMKSNVNVALVPLGTPLLAGP
GAIVATIVFAQQAGQKNGGILALALAIAAVHILLWVFMRFSVTILRVIKENGVELVTRVS
GLLLSALAVQLIITAIRTLLATG
>fig|479434.6.peg.178 ABC-type drug export system, membrane protein
MGFVMDTLYLLKRHTLATVRIPIWVFMSLVSPLIWLVLYGQLFRRIVELPGFGSGSYIQF
LTPGVVVMLALFSAAWGGMGTLQDLTDGVMDRMLVTPVSRAALIASRVLHTALTVAVQAA
IILVVGLVMGARVPGGILGAVSVLGVSALLAAGISALSNGLALITRREETLIAVVNFFAT
PLVFLSSAFIATALMPGWIRAIARANPVNWAVQGARNAMEAADWGAVASYGLLLTAFTIA
CVLFATQAFRLYRRAM
>fig|479434.6.peg.438 ABC-type drug export system, membrane protein
MMTALIHTMDIAGRHLRNFSRQPWYIAFSLVQPIIYLLLFGALFKRVVELPGFNTGSYAT
FLTPGVVAMSALFSGGWLGVSIVSDLERGVLDRFLVSPVSRSALITGRLIQTGLVTVIQS
LILIGLGLLVSARFAGGVAQVAVLIAAAVLLTAIFGALSCAVALVVRKEESIIGVVQFLL
LPLTFLSSVFMAPALMPGWIRQVSRFNPLNWAVEIGRSAPEAASMDWSLVLTRGAGLVAL
AVVATWLATRAFGAYQRSI
>fig|479434.6.peg.1587 Vancomycin B-type resistance protein VanW
MITDGTQQHAMVARGHVPVIRFAAPVLTGVAVLAAVIALAGIAVLAYGRMHGPTIYRGVS
AVGVPLSGLDQAEARARIEAAVQGSLPAAVELEAGDARWQVPLMDLGIEVDPAATAEAAW
RWGRSGDLWADSRAWLLGLLGGYEVPLAVSLDEQAVYRTLEAIAPEVTRPARDARYDEGS
DGRLVVVPEEDGVAIDVVATANQIRRRVQQLSTEPVPVVTISISPKVDTEALERELDRAE
KLIAEPVLLTYGGRSWVLDPETLRAMLTVANDGSRKNAELTIDRERLRASVASLAEGVGL
PGRDATPVWDGQRFVVESAGMGEALDVDATVDAILAGLEDGERRFELRTRQVAARIGNAE
AEVAAERATALVASGLTVTWPDGSQHLAPGELAEAIRFTAVLDDEPRLEPEVDMDALRQV
LERHAPAIEIPMRNADLRYIDGQVVVRSPEQAGRALDLDASVANVARALETGQSQAELVT
IPVEPQVTAAMAGSVQIREVLASAATYYAGALDNRRHNVELGVERANGALIPPGGVYSFI
ETVGAIDLNSGYKVGYGIIGTSNGSVSTVPSVGGGVCQVSTTVFQAAFWAGLPIVERNWH
LYWLPFYGQPPSGLTGLDATVDTDWGLDLKFKNTTDDWIAIVATADGEWVRVEIWGTDPG
WTVQVDEPVVTNVVKADETMQYRESDQLPTGTSLQVERAQDGFDVSIHRQVLRDGEVIDD
LTLRSQYLPSANVTLVGTG
>fig|479434.6.peg.2471 Permease of the drug/metabolite transporter (DMT) superfamily
MERDTALDTGAASERASEEPQAGRGGQRALSTRALLLVHLSLLFVAVSWGSNFVSIKYLL
RRVDATEVLMIRLTLASLCYAGFLLLSGRGFARFSRADWRKAALMALLGVTINTGAVAYG
VQMIPAAVASLIVTGNPVFTALIARALGQERLTPRKLGGIAVAFTGFLVVLFYGGPEAQF
SVRNALGILITLLGPLAWAFYTVLSKPLLVRYEPVQFAGTVTILGTLPLLPLFATRPGVV
REALRFGPAEWLAVLTMVVFALVLAYALWYRGLRVLSPTQIAVYIYLVPVFGTLGAWLLL
GEHITIYLLLGGTLILLGVILTNTARRGPVEHGERARRRAR
>fig|479434.6.peg.2562 Drug resistance transporter, EmrB/QacA family
MRQTNRRVVVVAVMLGTFLAALDTSIVGTAMPTVIGQLGGMSLYSWVFSAYLLTSTTTVP
LYGRLADLYGRKPLFIAAAGIFLLGSMLCGAAQSMPQLVAFRALQGLGAGGIIPVTLTIV
GDLFDVEERARMQGLFSAVWGTSAVAGPTVGGFIVDYVDWRWVFYINLPFGIAATILFWL
FLNEQVERKRHAIDYAGTVSLTLGVTALLVALLEVGEGRAWTDPIVVGSLALAVVLLVFF
VRTEQRAAEPILPLHLFRTRVIGAAFLAGILVGGAMFGVTSYLPLYVQGVLLGTAVTAGM
VVAPNSIGWSLASILSGRIILRFGYRTAVVAGLTAIVLASVVLQLVPHGNSLWLAVVAAG
TFGIGMGLSATAFIIAAQNAVGWAERGIATASITFSRTIGGAIGVAALGTVLSASMATRL
SALPETARDVNALLDPAVRSTLSPAMLETMRTALADSLVYVYLGVLSIAVVAFLVVLLGF
PRGSIKDLQAAEAGESAPDAGEEPAALPVGSSEEVQSTEAR
>fig|479434.6.peg.2705 Fosmidomycin resistance protein
MAETQAVPAAAGSIVRNRPLITLALGHFTIDLYAGLLPVLFPLLASRFGLDLKTVGLVSL
AYSGVGSVSQPLFGYLADRFGTRLIGFALIWTAVTFAGIGFAPSFPVILTLAGLAGLGSG
AFHPFGALNANAVITDQKRNAAMSVYASGGTIGFALGPLIGVGLLALFELRGVSVMLFPG
TVIAFWLLYEMRAIAVRPAVRAGHARVKPAPIPKLAMAAVILIMMARSWSMSSIQAYVPT
WYESLGYSKGFYGALATVITLCSAAGTIGSGNLADRYGRRAVILVSLILTIPTVLLFAQF
TGPIAFVTGALVGLLAASTAPLLLVMAQQLMLGRAGIASGLILGLGFVTGAIGVPITGAV
ADALGIQMAMRLQVVLALIAIPLCLLLPTERSLQAAKRE
>fig|479434.6.peg.2980 Glyoxalase/bleomycin resistance protein/dioxygenase
MIAYVHSATIIVSDQEKALDFYVNTLGFEKVFDNQLDPNMRFVTVVPPGAQTQVALGLPS
WYEDGRKPGGYTGISLITRDIDEAYKTLTERGVTFTKPPEMMPWGQRATWFSDPDGNQFF
LVEE
>fig|479435.6.peg.247 Drug resistance transporter EmrB/QacA subfamily
MQNPPDPKRWFALALLCVTGFMIILDASIVLVAVPSIERDLTFSTGGVQWVPSGYALMFG
GLLLLGGRVSDLLGRRRVFLAGLVGFAASSLLCGLAWSGDALVLARGLQGIAAAVLAPSA
LSIVMTTFAGGPERNKALGIWGATSGVGGTAGSLIGGPVTDGLGWPWIFYINVPICVLVL
VLAPLVLQDSRGPAQRTFDIAGAVTVTAGLIVLVYAVIEAPGSSAGRTAALALLSAALFA
AFVLIEQRSSAPLVPLRLFRSRALVGGNLIGIAFGLGVFGLNILYTQYAQLVAGYSAIKY
GLVSSVLAAAAVGGSMIGQHLVTRVGARPVAAVSLLLTGAGVTVMSRLTVDTGYFELAFW
GLTIYGAGLGAGTVAGSIAALGEVAGNDAGVASGLQNACFQIGGAVGIAVISAVAVANTN
GSTPAALTAGYRVGFAACWAFVAVGLVGAALLVSRKKAPQPVAAGQGAA
>fig|479435.6.peg.927 Permease of the drug/metabolite transporter (DMT) superfamily
MFWSSGFIGARWGTEYSSAFDLLAWRFLLAGTIAAVALAIRRPRITRADLITHTGMAVLT
QFVYLGLIFVGIDHGISAGITALIGSLQPILIATVAGPLLGERVSPLQWAGLALGLGGVG
LVVADDLGSGHGSPWLFALPVAGLLGLAAGTVLERRRKPQTNLLDALCLQSVVSGVLFIV
VATATQQMTVPGELGFYGAAVWLVVFSTAGGWGLYLVNLRLSGATRVSSMLYLVPPTTMV
LAYLMFGETIGPIALAGMLVCAVAVLLIRRPARAR
>fig|479435.6.peg.1222 Drug resistance transporter EmrB/QacA subfamily
MHALTGNKTRAGQGSGVTAGLAVLCVAQFVVVLDVTIVTTALPVLGADLGFAAARLSWVI
TAYTVVLAGLLVLGGRVADLVGAARMFRVGLALFSVASLACALAWSPDALIGARIAQGAG
AALLSPAALAALTDLVPPAQRRTALGWWTAAAAGGGASGWVLGGLITEYAGWRWVFAVNV
PIGVIAYLVSLRAVRTRAREDRAATTLDLPGAVLATTGIAAAALGLTWLAEAPTQWHGWA
SVVMAAALLGLFVRTERRVREPLVPGSLLRTPGVVAGNLTAAALTASTTPAMFTVTLYVQ
ETLRLSPAKGALLFPALNLAVIGGSLVGPVGLRRFSVRSILFGGFGLVVAGIGLLFALPP
RGLPVVLLVGALLLMGFGLGCASVASTTVGTAHVRPGERGIAGGVLNSSAQLGTALGLAV
ASPLIASAAPMTGYRLGFAVAAVIAASGLLAALTTPAGPSTADAAEPAEAADAPGRTSPG
RLG
>fig|479435.6.peg.2365 Aminoglycoside/hydroxyurea antibiotic resistance kinase
MPAVEIPAGFLVVGTRGPDWRAWLDRLPRLTQELLAEWELAVDGGTAYGNCAIVLPVRTA
DGQRAVLKVQFPHWEAETEHLALRAWDGNGVVKLLRADPRRFAMLLERLEPRDLTGVDDR
EACEIVGSVLPRLNVAAGPQYRTLSGELKRWIEDFRALPASAPVPHRYVEQAISLAQDFV
ADPACDGRLIHTDLHYDNVLAGEREPWLVIDPKPLSGDPHYEIAPLLWNRWPEVVASGDI
RFRVRSRFYTAIDAAGLDEDRARDWVIVRQMLNVLWTLKEAGTDESLPQDWLTRNIAVVK
AIQD
>fig|479435.6.peg.2894 Drug/proton antiporter
MRVSTQPVLALSAAASSFFLITLNSSLVTTALPSVGRELGTGPALAWVLTGYSLVFAVCL
LPAGAWSDRIGARRTFGLGMVAFVITSAVCALADTLALLLAARAVQGAAAAAILPSGLAM
LTAAAPDQVRRTRAIAHWTAAGAVALVVGSPVGGAITTAFGWPATFWLNVVLGIAVLVTA
LALRPADHPVRRPAGAGTKLRSRAVVVSAVTGFTVNFASYGAIFVVTLFVQQLLDRSAWT
SGLVFVPMTLLIIPANLLAARLTTRHGATRVLVLGQTLMLVGLLGLCSVDDRIALWVVIG
WLLPIGAGAGLVAPAMTAMMLDGVPSSRAGFGAGLLNASRQTGSGAAAALFGLLLGGSQF
LTGLRTSLVLAAAVVAVSTLTAVGRRKVHLTGVPTRSPDRES
>fig|479435.6.peg.5531 Vancomycin B-type resistance protein VanW
MLVVAYGAAFALTGDKVPGDTTVLGISLGGLSEQEAKAKLQAGIKDRLNLPIKVKAGKTT
YEVTPADAGLSLDVDATVEAAGAGRSLNPARMWQVMTGGDAVEPVVVKDEGKLKAAVDKL
AGRVNRPATEGTITFPDAKAVQHAPADGLQLDKTKATDTVVSAYPSDGNPKDLPVSVTKP
KAGTEAIGKAMKEYAEPAMSGPIRLTVGDKGVNLTPAELAPALKLVAKDGKFTPSLDIKK
LEPLFAKRFKGLETPPKDAGIQIVGGRPQVVPAVDGQVVARDKVAPAILSVLPKPEGERK
VAVGLAKSKADLTTEAAQALGIKEVMGQFTTRFPHAEYRNVNIGTAARRINGTLLKPNET
FSLNKIVGERTKANGFTEGNIIDGGKFKLDLGGGVSQSATTTFNAAFFAGLKDVEHKPHS
VYINRYPAGREATVAWPSVDLKFLNDSGHGVYVQTLFTASRPGTQGSITVKIWGTKVWDI
TAGQSARYNFRAPGLVYSQEAGCRPQAPTGGFDIKVYRYFAKNGQRVKTETFTTNYNAAD
DIRCGPKPGTTPPPNTPDAPPSPGVAKPSGTTRAPS
>fig|479435.6.peg.6201 Glyoxalase/bleomycin resistance protein/dioxygenase
MRTVLAVVPVAEFEKSCAWYEGFFGQPPDTRPMDGLAEWHLSELGVVQVFQEPDRAGRTA
VNFTVDDLDAARSELSGHNIASTDPQVVSAGRQRLSIIQDPDGNQLGLIESLS
>fig|479435.6.peg.6916 Permease of the drug/metabolite transporter (DMT) superfamily
MTAAPTSRNGITLLVLAGVLWGTGGLAGSILASSTGLTPVAVAEYRLLTGGALITGYALV
TRRLAGAPRGPEALFRIATVGLLLACFQAAYFAAVAATSVGLATLTTMVAVPILITAGTA
LLDRRRPARRAVISLVVALAGLVLLIGTPTAGAHRLAGTGLALLAAAGFAALSLDRREAL
PGLDRISTIGLGFLAGGLLLLPVALTVGMSIPVQPAAIGAVLFLGLVPTAVAYGSYFTGL
RYAGPRAAIIAVLLEPLTATLLAALVQQEQLSGPQVLGALLILLSTTIRHNAAG
>fig|479435.6.peg.6956 Antibiotic resistance protein
MSPQLSLQQVSKAYDHRVVLDQVGCAFPPGRISGLIGENGSGKSTLLRLLAGVEQPDDGT
VTVVASGGVGFLAQDNPLPLHLDVAAVADHALADLRAIESRLHEVEQLLADGNLEVLDEY
GDLQSAFEAREGYDADARLARAMHGLGLSALPGDRRLSELSGGELARLHLAAVLAASPEV
LLLDEPTNHLDVAATVWLEDHLRSRSGTTVVVSHDRAFLERVASTLFEVDGDTHRVTRYG
NGYDGYLSEKAAERARAEQTRQLWEDEVAAMKLAVGTAADRVAYGRPMSDNNKMAYDRAG
GRVNEAERSKTRNAKERLRRLEADPPPVPAKPLRFAASLRTAGATSGVLVNAVEVSVQGR
LAPVSLEVPAGGRVLITGANGAGKSTLLDVLAGRLAPDTGFVEHRGRLGYLSQEVVEPRP
DERLRTALARHRGAGGLGLFRPDQLQTRVGALSTGQRRRLALARLLTAQYDVMLLDEPTN
HLSLVLVEELEAALDAYEGALVVVSHDRRFVSRWRGEILELKENTLVSQ
>fig|479436.6.peg.148 Permease of the drug/metabolite transporter (DMT) superfamily
MEEKQWKGMGLAIMGALFWGLSGTSVQFLESAKHINVEWLLEVRLLVAGILTIGLAYLRE
GKRIFSIFKAPKDIGKLLIFGVLGIALAQYTYFRAIAISGVGVATVLQYVAPTMIIIYLF
LRYFKKPSTPELFCILLALVGTICIVMQKGLDISSFNEKALFWGLVSAASICVYTLQPIE
LLKTYGTTAIVGFAMFICGILSVIMFQQFDSEAIVDSMTLLGLFAIIILGTVVSFNAYME
GVRLIGAVQGSILSSLEPISAALFGWALLGNEFTVIGIFGMICILATVFIIAWDRQRTIK
REVLAKLNKTILE
>fig|479436.6.peg.249 Permease of the drug/metabolite transporter (DMT) superfamily
MGTIYSVRRHREFCYQVVFNEGLRTIPAATSSIIMALTPMTTALMAMIVYKDKIRPIGWL
FTITAFIGVAIIILWNSTLTIPTGALWTLLGMTLFAVYNILNRGLSLKGYKPITIAMWSM
FTGAIMALPFAEHAIEMIAVAPISAKFAMAYLAFLSSALSFVLWSYALEHAEKVSDVTNF
MYISPIVAAIVAAFLLGEIPNMGLYIGAPVILGSLYLFNRYR
>fig|479436.6.peg.915 Vancomycin B-type resistance protein VanW
MTKKYILVGTVLVLLGTSGCSYIPTENISYGVYYNDTDLSNTPKNELQARLQEVNDKIPQ
TISIDMGNNKKQQVTYHDLGIQFDTEAMVKAISTYGYEDDMWTVLSHRFNGLFYGHHFKP
QYKLDEVKGKTYLTELAKTIDTPGHDAYLTVENGQVVIHPSKEGKRIDIDATLKKLKDDL
QSGDSINSLSMVFTTQNTVKVTNTDLKPLNTVLASFTTEYNPSNESRTHNIQLASDKING
TLIKPGAQFSFNDVVGERTAEAGYDDAPVMIDGKLVPGIGGGICQVSSTIFNTALLSGMN
IVERTPHFEPVGYIQAGRDATVAWGYLDFKFRNPYQHSIYILSVMNNGTLTIYIIGTAED
KPKNVSISVGDYGEIPNKTITKVDPSLKEKEVQEGHVGLKMNTYRTITYGNWVTQTDSFE
SVYDPVDTIITMPATPEVPPKKTDKKKS
>fig|479436.6.peg.1559 Bicyclomycin resistance protein
MTQESSAKVSFILVVFLGLLTAITPLATDLYLPALPIMPSELNTSASNIQMTIGVMTFGV
ALGQLFGGPISDTMGRKLPLITGNLLCVISSIICAYAPSIEILLLGRFLQGLTGSVGVVI
AKAIARDFAFGQELTKLFALLMMVNGLAPVIAPLIGGQLLLFTTWRVIFVILAIFSAILL
VGSLLFRESLPKEKRVTGGVATATKNYITLIKDKRFLGQTLIQFFAFGGFFAYISGSSFV
YQNIFQLSAQEFSYLFGINSCGIILASAISARLSNVITVRQLLTFALWQLTIGSLLFLIA
MLFEWPLIPVTAILFFTVCTVSLFGSASFSMAMAKYGKMAGSASAVLGFASMFSAGIVSP
LVGIGGEYTGIPMGITMLVCAALSLLCLYRLVEKE
>fig|479437.5.peg.100 Permease of the drug/metabolite transporter (DMT) superfamily
MSALLFAVHIVYVSKFSGTNDVLVLTVMQFFIGGACGVACGACFETLSPAWALTPEFFWN
MAYLVIFASCVALVIQNVALAHVPPAQASLFLRLESVFGVLFSVLLYGEQVGLKLIVGFV
LIFGAILVSEMFPLKRKDVATNQLEAVPVELP
>fig|479437.5.peg.710 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDELLIEPEPTERELRTAPIKPLFARYAAITFAGMLAQMVMVVLEGLIIGNGLGPLGLAA
VTVILPLELLNLALGGALGMGTAAAAGQRLGSGDTAGAQKVFNQGFWLAAYLLVALSAAI
ALFAPQIATMLGATPDIHDDVTAFIRLLMCFYPFCTLGQLLCSLLRTDEKPSLASALAVI
ASATSLLWLYLCVYVLDLGFAAAGAYYGMSTGLWFLAILYFQLNKQSTFKLTFGGMKLDP
AICRAILWQGLPLFLVQAASLVYTIAINNYLGSLGGDADLAAFAVINGYVVYLLDILCLS
ATYGLQPIASFNCGARRFDRLSELVKVSLGGTLAVLAVVCGLVIAFAEPISAFFIGDDPQ
LIELTASHFLPLLACAPFGFLAQVASAYFQAVGQERISILLGVCRYLLFAIPMIVVLAAV
EGLTGVWWSQPPADLMAAALAVALAARECGKLRRAGAAQTKPAPESEPLLEAE
>fig|479437.5.peg.1216 Quinolone resistance protein
MTESARRSADTRPPRPARPDIPGELTEVDDLAGWIERDNGGDLRVSHVLVRRDAAEGADF
SLVELTESRVEGCSFVGCDFDRAMASDVAFSNCDFSNSTFSQANFTRCTFSSCKFTGADL
LEAVLSRVEVRDSTFAYASVAKGKLEDVSVRSTDFSGADLAELRQRRVELDDVRFAGTSF
FRASLDGVDLSSCRLADIVLSDTMEELRGCSMDLFQAAGIARRLGVNVKD
>fig|479437.5.peg.1621 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MHGTEEAVDGEGVVAEIAPKSRSDRKIDRLGTESTFKLLLEFSIPAVAGMLVQMLYNVID
AVYVGHAVGADGLAATTVANPMMTAMVAVAMLVGVGGNALAAIKLGERKKGVAERVMGNS
FVLLLIATAVLWGIAIFALEPILRYSGADGSVLPLALDFMTVIVAGCPLQFIAFGMNNFI
RTAGHPNRALGSMLVGTGANVVLGYLFIIVLDGGMRGAGLATVCSWALSALFVMQFFLKK
GSPMPLRRPSLSLDPRIALRVCALGIAPCVTQLGFAVSSLIENNLLVLYGAADALGVDGA
LAVMRVLSAVGLFTFMPAMGIAMGAQPIVGYNYGARAYGRMKLVLVQAIVLGIAITTPLW
ATVVLAPDLYAHLFGLPEIYMKETAWALVLYLMFIPILPIQTIGSNYFDATGQAAKATVL
TLTRQILFLIPLLVFCPLVLPQVLPITALESVWLAPSISDITSTLIVSGFLAFEWRRLRA
AEAGEGSNGLHRA
>fig|479437.5.peg.1629 Vancomycin B-type resistance protein VanW
MFRALAALVARSRIALAVVFVCAALLVFGVADFAVNANKAYPGVRVGQIDAAGKTADELA
ALIDEVYGARLAQGSVTIYANDEAEARIADETAAAQDAALAEQLALEEARANKLAWTADA
ASLEARVPSDELAAEALAVGREDGGILARLAALATGRELKPRAAYAETAVESLASDIDAA
IGDPRVDYGIVVEDGTASVTEGHDGFMVNRDELRRTLDELLLGQEDGSRSFVARAEHAPL
RIDESAAQDACDAVNAAIADGARFTYEGAAWSASASDVGSWVSTRIDGSSLAAFVDAAKA
KPALLAHVAEVGKGDPVHVSFEVADDDVIVRTDGEGAIPLVAEATGLLDAALFGDDGKAR
TGVGAGAPVEVAIGSGPAPEAMPFDEAMDLGVIGAIASYTTEYATGPGTEARNHNIALVS
QYLSDSVAKPGDSWSFNGTAGDCSTEERGFKGAGAIVDGEYDDAIGGGICQVATTVFNAV
YDAGFPVLTRHNHSLYIASYPTGRDAAVSWPDLDFVWQNDSASDVLVRLSCVDGSVTATL
YGVDPGYKVSTTTGDWGEGRKYETRTTIDDTLAPNASYVKTRGTDGRTITIIRTVKDESG
EVLHEDPFSSVYDPVTEVVVEGPKVAGDGKSDAATEGSSSNVTSN
>fig|479437.5.peg.1959 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLKEYLKYIVPTMITFTLGGVYSIIDGVFVGHAVGDAGLAGINVAFPLVAFIMAVGTGVG
MGGGVISSIARGAGNEAKARRAMGTTLTMLALSAVPIMALLFTLATPICELLGGQGETLA
QAAAYTGVIAWGVPFQILVTGCTPLIRNQGKVAYAMAVQVFAGLMNVALDYVFVILLGMG
TAGAAAATVVSQVSAFLLVLGFFLKRENRIAVADLRPDRHIALHALRLGLAPFGLTLLPE
ATVVAINVNLSMYGGEQALAAYAVVSYTACVIQMLIQGVGDGSQPLISKHYGAGDADGVR
RFRNTNYLITISLGVLGLAAMYLLRNQVPLLFGASDETAGLIAYALPVFSTAYVFYGFTH
ASTSYFYAVDDAKASSAIVYGEALLVVLIVFGAARLFGLDGIWLSVTAVQMVLSVAAAAL
LRYRHRARRPDRAAEPAASEAC
>fig|479437.5.peg.2733 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MARGAGMAGSSSMARPFARYVSFNVLGMVGVSVYILADTFFIANGVGSDGLAALNFSIVL
YTVLQATGLMLGIGAATEFQVCSARGDRTGANRVFTTALVMAGCAAAVLLAVVEAFATPL
ASLLGADEATLPLTVTYLRTIFAFAPLFLLNNVLLPFVRNDSSPQLAMVAMLVGSFGNIA
LDALFIFGFGWGMFGAAFATGFAPLMSMAVLLIHFLRKRNTFRPVRLHLRARLVGHIAAL
GFSSFVVELSGGLVLLVLNLVILAFEGTIGVAAYGVVANFAFVASALFVGIAQGIQPLAS
NAYARGSDRDVRAVLRLALLTALVIATTTYAAVALAAEPLALAFNRDNDPQLTALAVDGM
RVYFLGYFFAGANIVAAAFFSAVEKPAYGLAISIVRGLPAMLAFAAVLAALFGMAGVWAT
FPAAEAATFALTAVLLVRFVHGPRRRDREVVA
>fig|479437.5.peg.2875 Multidrug resistance protein B
MAPSSSSSASSASRGRGKGFALVAAVYLLGLFIGALDTGIVTPARTVIQSDLGIGEQMGV
WIITIYTLAYAAAIPVMGKLADRSGRKYVYLASILLFGVGSLLCGLAQDVGSFWMLLAAR
AVQAVGGGGIVPVATAEFGTTFPPEKRGLALGLVGGVYGIANIFGASAGSLILSVFGQAN
WQFIFYVNVPICAFIVVAGLFVLPNTRAEQVKPIDGWGIAVLVAMVLSLLYGLKNLDFFD
LGASATSSDVWPFLLAFVVLLPVFVLIERRAADPVLNLSYFRDRDIVITLVLSVITGVIL
MGIIFIPQFAENVLKLPSGSGGYVVIVLAAFAGVGAPVSGKLIDRFGVKAVLAFGLAASA
AGAMFLALVATQFANMATLIISLVAIGIGMGFTIGTPLNYMMLAKTKEREANSALATLSL
VRSVGTAVAPAVLVAFIAHAGMAIPDRIMGVLPDAPGGQSIAQLASGQAQGGDGAGLPDD
LQQLMKGSDVTTIVANVKTLAKTEIEQEAASAGMPAEAVDAAEQQYLAAIDDRAGDIEST
FQSTVDEGFRGAFLLVGICSLVGLALLALYREDRPRPGQAKGEPTR
>fig|481448.4.peg.325 Drug resistance transporter, EmrB/QacA subfamily
MDGQSTNELAWKPRHNPWIIALSVMLATFMEVLDTTILNVALPYIAGGLAASNSQATWVL
TSYLVSNAVVLPMTDWLGRTFGRKRLLIGCIASFTLSSALCGAAPNLGILILGRIIQGAG
GGGLQPISQAILLESFPPEKRGQAMGLFALGVVVAPILGPVFGGWLTDNLNWRWCFFINL
PVGILAIIASKITVEDPPYLQRNATKKLDILGFSFLCLWLGCLQVLLDKGQEDNWFDALW
LRWMGGLSLLGMICFIYRELTTDNPIVDLKIFKDKNFAVAIFEIFIVGIVLYATLSGLPL
FLQTLISYTAYQSGLAISPRGIGAVAGAIIAGRLLGVLSGRLIVALGFSMLALSSLQIGF
FNLEIAKINIVIPNIINGIGAPFVFIPLTTAAVVTLRQEQIGAATGLFNLFRNIGGSVGT
SMVQTFIQRLAQAHQTILVGYYTPDNINYNDRLSAIESYIAMMHGTVTGASQTLRLFYTT
LINQANLLAYMEIFQFMGWICIFSIPLAFLLAKDKRGTRPGAGSLH
>fig|481448.4.peg.433 Multidrug resistance protein A
MDYRLLNRLKSPAYKGLTATLTEEQEKKEGERIESVHAKTGGSQTGLGMLSSFLFGLIGA
LIFFLLYFVYTYFSSYETTDDAFIAGHIIRISPKVAGHVVGYYIDDNMDVKKGQLLIEID
PRDYQSRVALAQANRDLAETEWKRMKEILRSSAVSQLQVDAAWAIKLSTEAYLRLNELQL
GYTRIYAPEDGRITMRTVEKGQYVEVGQTLFDIVPPELWVVANYKETQITYMRPGQPVTI
RIDAYPHRRYKGHIDSIQRGSGAQFSLLPPENATGNYVKVVQRVPVKILFDEPLNKEEIV
GPGFSVVPTVEVRKFRLDVFWSLALLLIGFGAGLLVGLIRKLKKKEQ
>fig|481448.4.peg.735 Multidrug resistance efflux pump
MVFSKTSYRFILVCLIFSGGLFFSWKSLLERSSYQQTEDAYMNSHVLRISSKVSGYVEKV
LVDDNLKVKKGELMVKIDPRDYLARVAFADAFRILAQTEWLRLRQLSVINALSSFNYDLT
LASNLITRSILRLESLSLGYTDIYCPLEGKITNKRVEPGDYVSTGQYLFSIVSDDSWVVG
NFKEKQLNKIRPGQPALVKIAAYPQKWLTAHVDSIQKGTKNAFSSYSPEDLTLNYVKTSQ
RVPVKVLLDEPLPKDYANLGPWMTVTLRVQVGKDTPIYPLSLLYSLLTLTLIWFLWKMAK
KFLPGKFQKLDSFTS
>fig|481448.4.peg.947 Outer membrane component of tripartite multidrug resistance system
MIYLVIERSVKDRAFSSWILLILLGVTLFLCGCATLPKDTRISTPIEPPQIKQTLSTEFD
PSSEKIVKKWPLNNWWEGFHSPEMNRIITIALGKNPDLKASLARIHQAWAVAAGARSRYL
PSFYSTQFLFPVPFGVLQLPGSSFFGPFGDNSFFFWSVIPALANYHLDLWGEDKARVRAA
IGMARATEAEFALSRLFLSTTLASRYIRLASAEEELELARSGQQIMQELLKLVQMRKKSG
IENLLPVHTIEQRLQTVTQQVNSLERETKILRDEIARLAGQSPDWGKTILAKEPHFPKRF
PLPQSLPLDLLGRRPDVAVSKWRAEALAHQVKVTKTAFYPNLDLVSLVGFETLNFATLFL
NPALPLLYIAGPAWNLPIFTGGRLSAELVVAQEEYNIAVENYNSTLLSAFQQVADALAVW
KETDKNLESQEQSTHAAKSNAELSARLFSAGINTKTDLLDLQYTLIQSQITLSGRTAEHL
EAAVGLFLALGGGYDSIE
>fig|481448.4.peg.948 Inner membrane component of tripartite multidrug resistance system
MPLEPQKKVRPFFLILLQAVLSIEFLLGTYSPPAYATFNLYPAGDLGVSPSHASWISTIY
FAGQAFGLFIGPWLDRALGRVRSLLWAICFFALFDFVVAVSTDYYLSLFYRLLLGISGGS
TMTLCQLNLLDYYPINRWPFVSAYFGFLQVSVFGFGPVLGGFINENFGWRAYFLTSFSLH
LFCGLIASWIMLFLPEKPPEHKREKVSFDWVGFMLLFFSALCFQTLVTRGQDEDWYNSTF
IDLLFIFGTISLVYFIVWETGEKKPFVNVKLFLKPTFVVSVIVAPISFALVYGLFSTLVF
NLQLLKSATNFSSFQAGLAMAPLLFFLPFLYPASVFLSPRMDPRLLASLLLAILGIFCYW
TGYYDFFRKRAFFDQFFNQYVLLSQVLNGAYVGLIPPLNAMAIHRLSRKNQESAVNTGIL
LRTYFLTWGGGLLGTMVMEHRRDFQQTRLVESFSGQNPESMQLIDSLRGLGLTDLQIQSK
LVEQAANHSVILALDDTYRLCSWIFFFMALLVWFPSLGKRNKEKFS
>fig|481448.4.peg.949 Drug resistance transporter, EmrB/QacA subfamily
MNKPHAVASRRNLSQKFPFAFVLLHFVLAAEFLLAVYSSSSYAVMNRHAVGELGQSPSHA
TWTSTIFFVGRALGMFLSPWLSQAWGRVRSLLSAVVVLIVCNFILAYTGDFYLFLGMRLP
LGLAAGAVMMLCQYVLMDFYPVNKWPFVTTLFGFLLMTTFGLGPTVGGLMQELHWNWRDY
FTANFALHGLCLMFLWVFLGKREEKISHVHFDGVGFLLITLCFFSFQTLASRGQDEDWYN
SLFINVLFFLGVVSLIFFFIWELAEKDPFFNVRLFLIPNFLIANLIGPLSFGALYGAFSI
LIGALQQVGYSSFLSTLALPPMLLVLPFLYPLSIYLSNRSDPRPIASFCFGLLALFCYMT
STYDFFNRRSFFVQSVLLSQIFLGGMVGILPPLNRICIEGLSPRHQQMAINCGILLRTFS
FTVGSGLLGTLLEHRSVFQLRRLVETRSMFDPQVVEFLQKLRDLGLDSLQALKVYAETVI
QRSYILAVDDTFRFCAVLYLIITFWIWATKIKKLRKESS
>fig|481448.4.peg.1381 Glyoxalase/bleomycin resistance protein/dioxygenase
MIAIGSIHHVTLTVNDLDISIRFYTQLLGLQPIERPSFPFKGAWFKVGTQQLHLIEREEK
QRTSSLVINPQQQHVAFRVKNIQKALQWLRTNGYKEDHPDPTQRLLVNLESRAGFPQIFL
FDPDGHLLEINAEDKGD
>fig|481448.4.peg.1449 Acriflavin resistance protein
MSFPEFAIRRPVAAWMLMAALVFFGLLSLFSLGISRFPDVTYPVITVVTQWPGAAPEVME
SEIVDPLENVLVSVQGIKDIESTMLPGIANIKLEFYIDKDIDAALQEVNSKVRSVRLPTD
VNPPQIFKINQDDNPIMWLAVTWDKPFKNLVRYVDNHIRDRFMLVHGIGDIQLGGWADRN
FRIWLDRKKLDLFQLSPTDIRDTLQAENLELGAGYLESKTNEINVRVMGEARSEYEMRSL
ALNHRASGAGGIPITGVGGSQGGGMGTTGAGSNQFLTNPAMTSAASNLLSNTRGASSVYL
PLSLVAEVEDGIMDPTRLSRSDGKAAIGLGLQKLRGYNEIAVAREVKELVKELKKELPEG
MSIGPRFDSSVYTQEAVHETEFTLLLTIFFTASVCLLFLGSLRTTLNVLFSIPISILGSF
IFFKFLGYTLNFFTLLALSLAVGIVVDDSIMVLENITRHKNLGKDPRSAALDGANEVSFA
ALAATLSIVSVFCPILFVGGVVGKFLSQFGLTLSIAVLISLLEALTLAPMRVAEFLNVGG
EERRNFFETWLDHFFWKFAAVYKRLLALALKKRGIVLILSFSIFFLSLRLFPVLHKELSP
SEDMGIALIRIETPVGSSLEYTGGRVRFLEDYLRKQPYVAHVFSSVGGYSGGQVNFGALF
ITLTPRKERKLRLQEIFKIWRKEFKKAEYQDLHIKIIDISQSAFSSKRGTNIELSLLGSE
YSVLKDVSQKILGELDKSGMYTDLDTDYREGMPEVQIIPDRDKCALSNISMQQLVDAVRY
SIGGGRQGMYTNEKDIRRYDIRIRFIPEQWREPRDLEDIPLWTNYGGEPIHLKDVASLRI
VPKLMNMTRENRRRVITLFANVKPEYSQARALDYAMEICRKYLPPTYTVQPAGASQTAKE
TFSAFPYALGFGIIIAYMVMGIQFNSFLFPLIILCAIPFSITGAILFLYLSHLSLNLYSG
IGMILLMGLAMKNSILLVEFINKKRFEEGLETKEAILEASYIRLRPILMTSLATISSAIP
AALGLGPGAEVRVPLVIVVIGGILVSTSFSLFVVPCIYSLVSKVGGKPPIDLEEWLQEEK
VSSY
>fig|481448.4.peg.1450 Acriflavin resistance protein
MTLSDLSIRRPVFAWMLMIGLIFFGAISLGRLGISQLPEIDFPIITVNLQWNGASPEILE
TELVDPIEQAVISAQGLKGVSSYIQLGQASIILEFELGRNIDSALTEVQSKISSVKLPMD
PTQQVGMQQVPTPVPQPILVKDNPEEQPILLIGVSGEGKSLHDLVSFVDLVLHDELQIVP
GVGQIVLAGYNIRNLRIWVDGQKLASYQLTVQDVQTAIMQEHVEVAAGDLENSRNQFNVR
AMGEGLTPEEVGDIQIKKRGSELIYRSNIRIKDVAKVEDGLDDIRRIAATNGKTSLGIGI
KKQPGANSVEVARLVKKKLQELQPFLPKGIHTEVVYDRTQYIEDSIKETLFTLLLSAVIT
SIVCYLFLGSWTATVNVLLSIPTSVLGTFVVIYFLGFTLNFFTLLGLSLAIGIIVDDAIM
VLENIYRHRDLGKNRVIASRDGAREITFAAMAATVAIIAIFLPVAFMKGVIGKYFYQFGL
TISAAVALSLLEAITLTPMRCSQIMDDRNKRKGLAFLVDYAFKYLAKFYKYLLKFSLSYS
WLVLVVALGLFLFSLKLFSFLPQELIPTQDESSFIVRIQTPVGSSIYFTEEKLKECEKRI
LAHKEVDKVFGAVGGMIQRTGATDGNLVDSEVNVGTLYVTLKDRRERAISQKLFMEKIRK
ELNSIGDLRAAPQDLSIRGFTTGRGFPVELTIRGEDYKVLQKIVQQDIEEMKQSGYFVDL
DTDFRDGMPEVRVYPDRFAANACSIPIQNIANTVAIAIGGVAQGQFTNGERRYDIRIRLQ
GKERVGPEDIARLGVRTNTNEFMPITAVAKLQTVKTYQTLTRKMRERAITIFSNVATDKS
QAEALAVAKKICSKHLPKGYRLYLSGGAASFEETFQSLAFALWVGVVIAYMVLASQFNSF
VHPFSVLLALPFSLSGALLALWFTHQSINLYSMIGLILLMGIAKKNSILLVEFTNQLREK
GMPIKEALLEAAPIRLRPILMTSMATVAAALPPAFALGPGAESRIPMAITLLGGIVVSTV
FTLFVVPSAYLLLSRFEKPSPFKAPPKGPMAEEKVLVEKNGEITKARR
>fig|481448.4.peg.1641 Glyoxalase/bleomycin resistance protein/dioxygenase
MVHRFLHTRYRVSNLEKAVSYFVNVLGLQEVGRITSPRGSKLVFLKAPESQELLELCEYP
GSGNVVVPPDLTHLAFSVPDLKEARIRCDKMGWPFTDEIQQAENGQYFTFIDAPDGYEIE
LIEEKKDNPS
>fig|481448.4.peg.1828 Acriflavin resistance protein
MWLVKLSLKKTYTIGVLAVLIFFLGFFTLKTTPTDIFPEINIPVVVVSWQYLGLVPTDMA
NYITTFSDYQIANYVDGVKRIDSNIYFGFSVSKIYFQPYVDISMAVAEITAVLQPIIKRM
PPGTTPPLIFKFNASSVPVLQIAVSSSSLSEPALYDYTIWQLRRDLLSVKGTMFPPPWGG
IVRWMTVDLDPHQLLARGISAQDAVDALTGQVLNYPSGDVKIGDRDYFVTLNNVPKNLFE
INDFPIKRVFDTDFAYVRRNINDRVIYFRDVGTVHDGGVPQVNLVRLNGVHGILMTTLKT
MGASTIQIVDQIKSLLPEIRKANPDKKIQELFDQSIFVRAAIKGVVFEAGSAAILTGLMI
LLFLRSPRSSFIVLTSIPLCIFVALFLLKLLGHTLNLMTLGGLALAVGILVDDATVAIEN
IHRNKELGKPPLQSIMDGSQQIALPALVATLSISIVFTSVIFLDGPPRYLFIPMALAVVF
ALLFSYVLSRSLVPAMVLLLESKEDKESRIDRLFSFFYPIQASFYRNFERLRLSYATILR
MVLCNRKKFYIGVFFFITGSLLTLPFIGRDFFPTVDAGIMRLHVYTPTGTRLEKTEEYFS
RIEASIKKIIPPAELETMVDNTGLPIYFMATLAMSDSMNQGSFDGEIMINLKEKHRPTAF
YMKKIRKILRKEFPDCIFFFQPADMVNQVLNFGVPAPIDIQVIGTDDKLTYQFALESLSR
IKEIPGIVDGHIHQRFDYPTLHLEVDKVRAVEMGLFQIHVANNVLNQLSTSYMVKPTYWP
DPKTTINYPLLVFSPQMKINSINDLLNFPLTSITTPFLVGASPPVESTQTLLGNVLNPEL
LANVAKLIHTTEPAMVSHSTMKPVFDILCNVQDRDLGAVASDIEKKLDPLRKKLPPLYRI
ILSGQASSMNSAFQQLEFGILFAIILVYLLMVVNFQSWREPFIVLTALPIGACGVLWMLF
LTRTTFSVPSLMGILMAVGVITSNSILLITFANQRVREGLSPLEASLEAGFTRFRPICMT
ALAMIIGMLPMSLGLSEGGEQYIPLGRAVIGGLLLGTAGTLFFVPSMFTTIRQRKP
>fig|481448.4.peg.2221 Outer membrane component of tripartite multidrug resistance system
MHGPPPLLLLFSPWILGSTFISLVGCSVGPDYKPPKLEVPQNWKWGEQKPDPKGSHSREK
PQIEEKKTAWGGNDLQGEENIKRAIEEARKNPGKWKLAAPKDFVKKGQWWKIFNDPVLDQ
LEAEAEVANQQIKMAMANVIEARAGVGAALSAFFPHTNFTPSYQRWKLKTHLPWLPFILP
EPIFSTVPLLGQNGIPIPSGSIIGSTQYYGFQPTLNMWQVYLNSNWELDIWGKLRRQLEA
AKAEAQASQAELEGMKLTIHADVAQAYYLLRYIDSQLEVMERMIHVYEDNLKRVEIRFKS
GLSNELDLARAKTDLSRIKAQYIALESHRAKVENSIARLLGQPASTFHFPRKPLKEDPPH
VPQSLPSDILEQRPDIAQAEREMAATNAMIGVAYAAYFPSVNLNAYFGFFNTDFGQLFTW
PSNSWIYGPLIDLPIFEGGRLLANLMQARAAYEKAVASYRETILSAFEEVENALIGMRLL
EEEQKVEDEVVASAKKQYDLALDRFQRGLSHYIEVDTTESVWLNAILTDIALRGERFIVR
IALIRAFGGGWADSSMKKPSFQQNQSKN
>fig|481448.4.peg.2223 Inner membrane component of tripartite multidrug resistance system
MATPLSLRYGRKKTVLFFSSFLAASSLFCAWAPDFYLFLGGRFLQGLSCGLLIINSQSLM
FENTPDPWRVFPLMLGAVASVLPFTIGPSLGGYGKEYWGREASSWRYWFYGTALLFVILS
FLFHILFKETEAVAKKKPWDWAGFILLFLSLGAAQTIFNMGDDYEWFISPIIKFLFLLGI
GCLLSLFVVELNRKNPFIPVRLFLRKNFFIGSLCLTVGFLFFYGLWTTLLVRLQNQNLFP
PHRAGTLFVGMALFSTPISFLLPRLAGKMRSPLYAFIVFVLLGVLYTWMGYFDFYQKRWF
WMQSPLIFVIQGIALGLFFIPLTNLIISGLCPKNQLQAIELSSSMRIIGQGWASPIIGTI
LYHRIVFHKMRLDEWLHAGHPYLMEYYSKFKEQGIGREIALKILDQSALSHAFILSLNDA
FRFCGIGFLVLSGVILLAKERRDQI
>fig|482234.3.peg.321 Glyoxalase/bleomycin resistance protein/dioxygenase
MLHHVEVYVSNLAKSREFYEPLLIKLGYYPYQEWENGFSFKKSEHYIVFVQTPAEFLEVG
YHRCRIGLNHLAFYGGSRKQIDQLRKDLITRSVNLLYEDRYPYAGGENHYALYFEDPDGI
KIEVVGN
>fig|483216.6.peg.188 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MKKVTLLIPVYNEEAMLPTLYQRLIELINRNSAYEWEILFINDGSSDRTLEVIRRLRQTD
SRVNFVNLSRNFGKEIAMLAGFDYATGDCCVVMDADLQDPPELVDQMLQYWEEGYDDIYA
KRRNRGEESWMRRRLSLAFYKLLQNMSRIDILPNVGDFRLLDRRCILTLRQLREQERYTK
GLFCWIGYQKKSIEFDRGDRLAGHSSWNFFQLLNLAIEGITSSSTAPLRIATVCGIICSI
SSFIYAIYFLIKTVIYGDQAAGFPTLIVVILFLGGIQLFSLGVIGEYIGRIFKETKGRPA
YIASDYNEKKLGYDE
>fig|483216.6.peg.650 Acriflavin resistance protein
MKFVKYFLQKRSVTILLLALVLAGGLFSYIKMGKLEDAPFTIKQALVLTPYPGASPSEVQ
TQVTDILEEAIQSMGELYYLKTENRAGLSKITVYVKKEIRADEMQQLWDKLRRKVNDVQG
KLPAGAGASIVNDDFGDVLGVFYGLTGDNYSFRELEDEAKLIKNELLKVKDVAKVEIYGV
QTPTIDVTISPAVMAQSGVTTADIAHAFEAQNKVVDAGGVDAGSNRIRIESTGNFYSLDD
IRELTIVSRTGEHFRLADIANIEESYQNPPGNIMRIDGSPAIGIAISTVPTGNVVDMAKA
VQITLDKFKETMPEGFTLTAIYDQGYESDIANQGFILNLIISVLTVVAILLFFIGFKNGI
LIGSGLVFSIFATLIVMMASGIALQRMSLAAIIIAMGMLVDNAIVVSDSALVNMERGMRK
RVAIMRACSSTALPLLAATIIAILTFLPIYYSPHITGELLSSLVIVIGVSLMFSWVFALT
QTPFFIQEFVRRPRPEELKAGLFDGKYYNIFRNALRWVLRHRTMAVASLVVMLVLSAWSF
KFIPKVFVPALDKQYFTMDMWLPEGTNIYETDRIADEMADYVRGHEEVEMVSNYIGRTPP
RYYLSNIAFGPQSNYAQLLIKCHTSKDAVAMHALLQDSIRLKFPEPLIKVNKFELSPLTE
AMIEARFLGPDAAVLDSLVNVATSIMRRNPKAADVRNEWGNMTLVMRPIYDPVKAGALGI
TKAQMMQSVKSVSDGLPVGIYRDDEQKVPVLLKSDNTSVTDAHSLENLSVWNGKHSAPLS
QVTKGVETAWEWPQIRTYNRQLSMAAMCGVQPGHTMAEVHGEIRKEIEAMELPEGYTFFW
DSQYKDQNEGLQALAKFFPLAFLMLIVILVALFGNFREPGIILCILPLSLIGVAVGMLLT
GFDFGFFPIAGWLGLLGMIIKNVIVLLDEINVQRHDGVIPYTAVIEATVSRTRPVLMAAT
TTILGMVPLLFDVAFGGMAATIIFGLTFATLLTLFITPALYSMFYKVKES
>fig|483218.5.peg.1609 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSMSINQHFTPVKLIRFAAPSIIMMIFMSLYTIVDGIFISRFIGSNALSSLNIVFPVINI
AIAISTMLATGGNAIISKYLGEGRRREASECLTMFVVVTVSASIVIMVLTFAFLTPISRL
LGATDILLEDCRSYLATAIAFAPACMLQALFQSYLVTAGLPALGLCLTVIAGILNAVLDY
IFIVVLGLGIGGAAAATGIGQCVPAAAGLIYFTFIGKTIHFTRFHLRIKELLAACYNGSS
EMVTQLSNAVVTFLFNMVMMRLAGENGVAAITILLYGQYLFNAFYLGFTIGISPVVGFQF
GAKRKNELKNIYRVSFIFVMCSSLLLTLAAIRLSTPIVSVFTHDAGTFALASSGFRIFAF
NFLFSGFNIASSGFFTALSNGRVSAVISFARTLVFTVLSLLILPQIIGINGAWTAIPAAE
FLTLILSAGMHLKYFIRNNKYNYFE
>fig|485913.3.peg.729 Membrane component of multidrug resistance system
MVIFGIFMSILDGTIVNIAVPRLETAFGSDLNSVQWVLTAYTLAQGVATPLTAFLADRIG
TKRFYILSLAGFTLGSVLCGLSWSLPMLILFRIMQGVAGAFLSPLAITLLYREFPPQERG
TVMGALGIPILLGPALGPTIGGYIVTYMDWQLIFYINLPIGILGVLLAFFFLHEGEIVPD
KKFDIPGFLCSGIGLALLLYGLSDASTDGWTSPIVMGSLIVGIVLLIAFVLVELRLSRRG
KQPLLDLTVFADRSFSTSSIASILVVFALYGGLFLIPIYLQNLRGLSAYQAGLVLLPQAL
ASMVAVLVGGRLVDRIGVRAVVIPGLIILAIAMWLYTSLNTSIPIGDFQWLLILRSFGIG
LCLQPLSVSALSNIQPRRLSQASSVSTTIRFVGSSLAVAIIATLVQSQNKVHYAHLAEQV
TPTSSFGHLVMMIQAGLMGKGASAIAAYAYALKTIGGLLQLRSYMMAMQDAFRVSFFLAI
VAIIATLFVTGNKKKAVVVDEASMSAEERAEAEKAREEASMAL
>fig|485913.3.peg.1696 Permease of the drug/metabolite transporter (DMT) superfamily
MRMPDRRDIPAMILLGFIGITVYQLGLTYGETSVSAGTAGLLIATVPCFTVILATVFLGE
HFSVWGWVGLLVSFTGVTLISLNGNGGLHFTPGALLILLASFSESVYFVVQKRYLRKYSG
LELATYNLWGGTLFMLIFLPTLWQELPHAPLGATLAIVFLGLFPAAVANLVWTFALSRTS
ASAAISFLNISPVFSLIIAWLWLREVPSALALGGGLVVILGVLLINLKGKVSVRAEQPAE
LAEAEVPSQEISASL
>fig|485913.3.peg.2375 Drug resistance transporter, EmrB/QacA family
MPSIVGKLGGVTLYAWVISIYLLTSTVTVPIYGKLADLYGRKLLLLGGTAIFLAGSIACG
LSQNMVELIIFRAIQGLGAGAVQPLVLTIIGDIFVLEERARVQGLFSGVWGLSSIIGPAI
GGVIVDRLSWSWVFYINIPFGLLSALLLIIALKENVTRSKHRLDYMGAATLTGSVVALLF
AIQEGGSTWAWGSPQSIGLFAVAVLLLALFLRVEARASEPVLPLALFKNRFVTLASIGGV
ILGTVMFGVSSYLPLYVQGVRGGSATEAGLILMPLLVSWPIAAVLSGRLVMRMGYRFPAI
LGSLLSMVGALCVALFNTQTSYILAIFPIIAIGAGLGLISNVYILSVQNSVPWNVRGVAT
AATQFFRTMGGTIAIAVMGTVLNAQMGARFATILARFPGGISHAAAQDSPANLLVRPETR
SLFSPSLLAQLQDALMQSLFWVYLLTAIVAAGAVIVALYVPRGRAEEHAYREASVDEVPV
SAPVVHVDMG
>fig|485913.3.peg.2691 Glyoxalase/bleomycin resistance protein/dioxygenase
MSNQQIQKVRVKRLVHIGLWASDVQAQARFYHRVLGFDLYTHADGSLEQHLEEEDAAIFL
ALGEEMHALSIFNDTRVFPTNGRRPVVRSTLHHLSFAVDTDAELAAMAARLQMSGIELSF
EPRDGAPDLGDALWLNDPDGNRVEISVMPDELYTAISSNRKTRRALLRPYGLQHVALKTS
RLEEMVEFYTESLGFDISDWLLRERAWLRCNNDHHSLILSEGQTGIEHVGFTIADGSELL
GWADYLSHQQVPLLWGPGHHGVGDDLFLQFPDSDGLHIELSAGLSQYYDRDVTTPPRLWH
TRETALNLWGAIPSWLREESHV
>fig|485913.3.peg.2731 Drug/metabolite transporter (DMT) superfamily protein
MLAGASFGILSTVVKLGYHAGFSVAEITSSQVLFGCLGLWLLSLPSLKYLRYIRKLTLGQ
LLLSGLFPGLTGVFYYMALQTISASLGVVLLFQFVWMGLLVDWILQRKAPTLSRWLALVA
VLIGTVLAANYQVLLTSHLDLKGICLGLLAAASYTGNIVINEHVAPEVPPTLRSTLIMTG
ALFITLVIFPPQFLFTSALSHGLWFWAIILGCFGVIIPPFLFARGVPVVGAGVTTILGSI
ELPVVIIMSTLILKERVELIQWAGVALILLGITLTQQSNLLQKSWRKRLAHNINK
>fig|485913.3.peg.2853 Methicillin resistance protein
MTLTIQEINDREQWNNFLTSQSRGHLLQSYEWGELNKYLGGRIYRLGALEDGRLTGVMLL
TVNPVPLPARIPGLKLSWLYSARGPTVESPDSPALPALIEHAHKVARKERAVILRIEPNI
ADDDPNEHTWLAAYSKIDFRTNPIAVHGRRSWVLDIRPSAEELLTNFKMTWRQNVRAAGR
KGVIIREASSDADFEAYYELLKVTSERDAFFIHSLDYHKEIYRHFASKGDAVLYIAEHEG
TAIAAKMLIRFGDWCWDMFGATSNEKRNLKPAYLLQYTCFQWAQARGCSYFDFRTIPEIL
EPGEEMWGVYEYKKGFGGFSRLNMPTQDYVYRPLIYTLWSRLVEYRRAKRHQERQKIELE
RSARGQAQRKDEEAKPAEQIPATPKEQPQPAKAKQKQQAGKNGKKPQEAGNSPIADTPEE
TSSPVS
>fig|485913.3.peg.2854 Methicillin resistance protein
MEARIITDRQQWNDFIASSPCCNITQSYEWGELPLLGVQEVLRVGVLDDSGKLCAGMMVL
VSRAPVIRQVYLYSPRGPVITDPQSPAMTVLLNFVRAEARKRGAFMLKVEPSVATENREW
QTAMQRFGFRTNPHHMHIRHEWVLDISPAEKGILSGMKEKWRYNIRLAGRKGITVRRGET
EADLEKFYSIYEVTSERDSFFINSKEFYRQYLDLYKEGDRVALFLAEYEGKPIAGTIISV
LGEWSWYMYGASSNEQRNLMPNHLLQWTSMQWAKSKGAKYYNFRGIPDVLEEGQELWGVY
QFKRGFGGYPIRFFPTQDLIYNPIVYQAYRALLDFKHWRDERQFKKAAVESAREREPQKP
EEKTPVQA
>fig|485913.3.peg.3159 Drug resistance transporter EmrB/QacA subfamily
MQTSQSSSPENVQPEVAVDESASQHGGYQWTALSVTTVGALLASIQGSALLIVLPNILED
LKVSFFIIMWVLLSYLLIMTVLTPIVGRLADIWGRKRLYNSGFFMFTLGSLIAGLAQPQF
HGADLIAGRVVQGVGGALMITNSTAIVTDAFKKGQVGLGLGVNQIAGAAGFLLGPIIGGL
LAQFSWRWVFLFNVPIGIFGMLWGIWRLREPVRLKAHQHIDWVGALLLALGLTGVFLALT
MLAFPMLPMPVITAMFVGGVICLALFGVIEPRVKEPIVQLRLFGHRLFTMASLSGLFNGI
ARGAVLFLLIFFLQGPYGQDPLTAGLMLTPFGLAFMIIGPLSGRLSDRIGSRLLAPIGLG
VSALGLLGLVFVEPTTPFWLLCVFMALMGGGSGFFTSPNTNAIMSSVIPQMRGAAAGILN
MLNNTGQMLSIAIVFPIALSKVPQDAMMAIFIYGGGMSKYPQALAIFMSGLHSAFLVCCI
ISVVAMVVAALRPAH
>fig|485913.3.peg.4251 Permease of the drug/metabolite transporter (DMT) superfamily
MKTRFSASPEASGTSTAPGTSPELARRGLLFVCIAVIFFGSNPVFVRWAAPFSSLEIAFW
RLAIATLLVALMGLITHQPLRIARGEIRNFAFYGLVTALHFVFYISSLSFTTIAHSLALT
YTSPIFVTLFSVIFLKEPLPKRKYVGIGVAVLGVGILAGFEPNYTTCNLNGGRCMILGDG
LAILSALCFGIYSIAGRSVRDAHPLFRYTTNVYGFAALWLLPIGTYLAFQHSYSPLAIAS
VVALGVFPLGLGHTLYNAAIRYVHATYANLIATQEVTIGIILGIIFFHEIPSWSAVIGII
ITLLGITSVIF
>fig|485913.3.peg.4421 Permease of the drug/metabolite transporter (DMT) superfamily
MKVAWRDFGALVVAGMLGFGAQQICFLYGSYFAEASMGALLSAFTSAIMTLVASLVARER
MTGLMIGGLLAACGGMVLVVLGKGSLGAITPASWIGLGLYFVAGLLSGLMPLLTRRSLTR
YSSLRVTTWTLFVGGVFFIIPGGMNVQNAHISVLPPVVIPALLFTAIGATAVTNMCWNYG
LARVGVVRLSIYGYLPSILGVLMAAALLGEMLTPAQWLGTALTMGGVLVSQIKGLDIRKF
GKSLFSRKEELALLVDEYAGGD
>fig|485913.3.peg.4446 Antibiotic acetyltransferase( EC:2.3.1.28 )
MKRFLNAALRYATNHLINHIPSHTLRRAWYRHMLGWRIGPGTHLLLGQHIMFGGLRSGGS
KVSIGHHTIINHDCLLYTTGGLIIGNNVSISSGTWLMTGSHELNHPAFPDIYKPIMIEDH
AWLGLRCTILQGVTIGRGAVVMAGAVVARDVPPFAIVGGVPAKVVKYRELQDPSYTLEFS
PLFE
>fig|485913.3.peg.5070 Permease of the drug/metabolite transporter (DMT) superfamily
MDGNISTANPFSIHIPLPVGAAGAKALLGKRSFPHTLTSERCVYHYHNRVILSFLYRHRK
AYLTTMQEYQELSPSTTQSVSTAADPRKARMLTLLGFGAMVLVWGSFPVAAKIGTEHVPP
LLFSAVRFLLAFLLLLLVARWRRISLRITRTQHLRIFQTSLFMVGIPAAIFFASIPYAPA
GALTLMWATAPLFVSLFNFRGVGEARGWRLPVSLLIGIAGILLVLLGRVPFLPNQGASIP
GFAMSGPALIAELMVLASAAVYGFGMLLAKRYSADVPVLVMTAWQVFYSGVVILLASLIF
EHGGPFAPTWATLEALLYLVVFCSCISFFLTFWLIRRIGAIRTAYSDFIIPGVTLLLSYW
LLGEELSPAKLGGFLLVMLGCALVEK
>fig|485913.3.peg.6291 Permease of the drug/metabolite transporter (DMT) superfamily
MLGKRQAFSFLCRSYGFENHQENESLAIDLTRGGNMTRKGWLLFTAMSVIWGIPYLFIKI
AVQELDPIVVVFARVGIAALALLPVAVHQGVLRRLRERWLTVAALACVQIAGPFLLISYG
EQLIASSLTSLLIAADPLLVVLFALRFDPSERVSGSRLIGLLIGLGGVVTLLGLDAGGDM
QQLLGATLVLLAAAGYAAGALLIKRPTIAALPSLGVVTVECITATVVLAPLAVTRLPSRI
PDLEVIASLLVLGLICTALAYLLFFALVAEVGAGRGSVITYVNPAVSVLLGVTLLAEPLN
AVIIAGFLLIIVGSWLSTGGVLPPQLKHLLRTTRQQPISRDTEVSELAAPPRK
>fig|485913.3.peg.6596 Antibiotic resistance macrolide glycosyltransferase
MKKYIFLNVPATGHVNPTLPIVQELIQRGEQVIYYLTEEFRAAIEATGAIFRPYESFLEG
IGPGPMPLKMAEESRRVLPQVLESIRAEQPDALLYEAMCLWGRIVAQVLQVETIVLRASY
AANEHFGLFTARSDASMPFPSELLERFQVSSAELSATYHLPPFDLRQFVAHAEGLNVVFL
PRAFQPAGETFDERFVFVGPSLLPRQDAPAFPWERLGDQPVLYISLGTAFNHRPDFFRLC
FQAFGELPSQVVLSHGKRLDPAVLGPAPANFLLAPSVPQLEMLQRTSVFVTHGGMNSIME
SLYFGVPLVVIPQMMEQEITARRVEELELGAALTQENATAEHLREAVARVQQDPSITQYV
QAMQQQVRAAGGYQRATDAILDFAYKRASLTHSRSMEA
>fig|485913.3.peg.6644 Aminoglycoside/hydroxyurea antibiotic resistance kinase
MITIPPAFQRFMFELHEEEGQAWLERLPRILATCAELWGLVVEEPFSNLSFHYVTRARRR
ADNTPVVLKACSPTGEFRMEAATIAHYEGHGMVRLLDTFPEGEVMLLESLTPGKTLNTLT
DDEQATRYAARVMRELWRPAPEQHSFPSVADWGRGFQRLRQQYGGGYGPFPPHLLDEAKR
LYAELTASMAAPMLLHGDLHHDNILQAEREPWLAIDPKGLIGEPAYETGALLRNPLPNLL
HRPDPGRIQERRVAILSEELGIDHARIRGWGLAQCVLSAWWSIEDTGQYPADTIACAQLL
ADSKV
>fig|485913.3.peg.6876 Tetracycline resistance protein
MGFTIIGPVVPFMTRQYLGNPNDLAVVVGWLLSIYGICQMLAAPGLGLLSDRYGRRPVIF
ICLLGSAIGYLLFGLGGALWMLFLGRIIDGLTGGNFSVLFAYVADITEPEERGKYFGIFG
GISGVGFIVGPAIGGLLANVSYSMPFLVAAGVTLLNLVWGFFFLPESLNKEHRLTTMRLR
DLNPLAQLGTVFNMANLRWLLLAGFFYAFPFAILQANLTILMRDSLGWNATDAGLVSTLV
GVVDILVQGVLVGKLIDIFGDIKVGISALVLVAISYLLLGSIALIASPILLIAGVILFSG
SGGLVENALRGLTSRAVGPKQQGLVGGASQSMQSLALILGPILGGVLYAQFGHATPYWSG
ALIIGLAILSVVLALPALRAAKA
>fig|485913.3.peg.6951 MDR-type permease, probably tetracycline resistance protein
MLWFGILSAVGSLLGIATTELVNRRLNMNHAPSLLHALAIINLLLILGMVSFALAGNFYL
ALLSVWGVGIMRTASRPLYNTWITQNSDSRVRATIFSAAGMIDAMGQIGGGPAIGYIGER
VSIRAALTATSLLLSPILFFFLRGFRLLQRSDGASLENQTLEAATEIEG
>fig|485913.3.peg.6987 Drug resistance transporter, EmrB/QacA subfamily
MTGTYDPKKWGILQIINIGTLMSTLDVGIVNVSLPTMAKEFSVPLAQIQWVATAYLLTMV
ALLPFLGKLSDIWDRKKIYSYGFLVFSIGSLCVAVSHGIVSVLLSRCLQGIGATMIMANS
QAMLRQVFPDHEIGRALGVNAIVLAAGTLAGPAVGGLLLNFVHWTWLFIINVPIGLAAFL
LGRRWFPQAKSGGTRTAFDIAGSFLLAAGTCMLMLASEASEQGGGFTPPIVFEGVAGLAL
LVILWFYERHISYGILDRELFSQPKIALGNTSAFFINMAQTATMIPITFYLQEQLGFSAG
VTGMLLILQPLLMGIVAPFAGWFRDKHGGFVPVTVGSLFCAASMLLIACSQHVTAISVSL
QLVLFGIGMGLFHATNNAEIMSASPEAKISLSSSLLAMIRYLGQIAGIGLATLLVGSMGK
AGATVGIPLQILFWICFLCCLGVAIIRWMSLPNKLLPFQKLIRPW
>fig|485913.3.peg.6988 Permease of the drug/metabolite transporter (DMT) superfamily
MALLIKKKVPVRAYSALLLSTLCWGLAPVATRYLLISFTPLQLVLIRFVIAALFFLPLLT
PLRRFHWSVKKVSWVVFCGVAGVIGYNVPVAYGLRVIPSSLAGLLIASEPIWILLIAAFV
LREKITWTMVIGLLLSVLGITVLFGQAYVDATWNMRNFAGALLILLAAFMWAMYTVSVRR
LSKEVGARTATALTMIVGTFPLLTWWDSHTWSLLRYLSGAAWIALVLLTVGSTVAATILW
NYGVAYTTSSQASIFLYLIPLISIIGGTLFLHEHTSILTLLSGLLILGGIALGQLVRPGR
AKN
>fig|485913.3.peg.7042 Drug resistance transporter, EmrB/QacA subfamily
MALPQIQKAFNTSFDTVTWVSTGYFLSQAAVIPIIGYLSDRLGTKVVYLTALGLFTVGSA
LCVFAPNEELLIVFRVIQGLGGGAMMPTAFTLIYRLFGPTERGPVTATVGIPVFLAPAFG
PTIGGYLTTTFDWSAIFTINLPIGLIAIVLGLFILHNRAQERAAAGEEHASQGQRVDIAG
LLLSMLGFTTLVYGITEAGTRGWVDPIVISLMAAGGVILIVFAIVELFIASDPVINLRLF
AQYTFAISNLLLWVVSAVLFGSLFLLPFFFENVQGNTPLTAGLWLMAQGIATAIGMVFGG
QLYNRVGPRPLAFVGLILLAVGTYGLTQLDVSTSGGALQGWLILRGLGLGLTNTSLQTVA
LSAVSNKAMARASSLLNVMRMVFSAVGVAVLTTYLSQQATSYAITAKQGVQAIPPSGIAM
TCAATVGAHAEALKNCVTQHVTVMGLNDTFWLVLIGCVICIFIALVLGRDPALEAAKRAR
AHGEVVQAEVPVAIGE
>fig|485913.3.peg.7939 Glyoxalase/bleomycin resistance protein/dioxygenase
MNKLGFEKVDDQPMSETERWLEVAIPGTQTHIMLGLRGQSGGNQTGMTGFVLHTDNIEET
CAILIARGVTITQELTTEPWGKWAQFSDPDNNEFGIWAPAW
>fig|485913.3.peg.7981 Glyoxalase/bleomycin resistance /protein_id=
MIKLGINAILLFVRELDKCTVFYRDVLKLPFVGSDPGVATFKVQDRYLTLLSPEGVAKLF
GIEPDAVNIEGNPRAMIASRVEDVHATYETFQAAGVTFLRPPTDHPWGVRTAIFVDPEGN
LWDINQDIE
>fig|485913.3.peg.8497 Glyoxalase/bleomycin resistance /protein_id=
MTTTNENILMLSVAVTEMAKAKAFYAEQLGWSVTTDKGQGDHHWVTLELPGGGASLTLTT
FHENMKPGTMKLYLSASNIEAAFDELKAKGIKVNDVKDDLYGPGSGVKWFDLHDPDGNRW
LFVQSSSR
>fig|485913.3.peg.9051 Permease of the drug/metabolite transporter (DMT) superfamily
MDTADQARAAQQEPSTDFSRQDESTVGKVASPTRRSPLIVVVALFYILLWGSAFIATKVG
VTYSPPLTLLSVRFLTAALLMALLAWVYRVPWPRGWAAWGRLSIFGLLNCAVYLGCNYEA
LRSLSAGMGSIIAATNPLLLTLVAPFVLRERLTWWRVLGLLLGFGGVLFVMGARLNGHGQ
LDTASGMLISFIGVIGLVAATLFYKRYPPREHAFVVNTVQLGAAGLALALPALLFEHPEQ
FSLNAPLIESFLYLVLVISIGASLLWFWLLRRGEASVVSAYYFLTPIAGLALAALLLGEP
FTLRDALGLVAVAAGIALINRPVRARN
>fig|485913.3.peg.9118 Permease of the drug/metabolite transporter (DMT) superfamily
MKSIQKQQATEILAHETIPAHKSQTHLGRGTLLALVITIFCWASSFVGIRAGLHGYSPTH
LALLRYLVASLVLALYASVKRMPLPQWRDLPGLTLTGVVGIAFYNVVLNTGELSVSAGIS
SFLVNTGPIITALLAMVLLKERLRPLGWGGILLSITGVSIITLSTGEGIHLSVGVLFVLL
AALAQSLYFVWQKPYLARYSALQCTTYAIWTGTLALLIFSPGLIPEIQAASWSETTAVVY
LGIFPAAIGYVSYAYALARIPATRAASFLYLVPPVTLGIAWFWLGEWPTWLALVGGVIAI
SGVIIVNVFGKTQTRRTDGVDPS
>fig|485913.3.peg.9270 Permease of the drug/metabolite transporter (DMT) superfamily
MRMKLLACGAFFLNTFLYGTYYAVSKGSLGRIDPIVFTFFVMLALLPLALCIIIYSWHEI
NREVIKSGVLLGSCICIGLFTLSVALKYNSATSTAFFPSLNGFLAAICVWLFMRQPLHKA
TWFAGLVSACGALLLILNSPIGGLRGALIAFIGGLFCTFYVFLADHEQRGKAYLPLFGIQ
LLTMAIWGNFIALLFGNWQDVHPLLPNDLWSVLYIAFGTTCLPTLITVRLQNYISPITVS
FIYILEPVLGAAFANYYLHEVLPLDGYLGGALIVAGALINTWGSAERPATQGKRSMALFG
DRLMQTWRGSDGGLILPVLGVIAGAFALLRLGGFPPAAWILLAQVWPEYQTIVAHGHGSM
LALVIGQALCWLLAWIAVAGLSMLSLRRLIRLFNTPTAARSIPSTIPREHEANTQEVSDM
DVLARSFEVEDVPMEQAPTVAYTLETWDEHARHQPGTTPASIYWRPRQRERKRLLHQHHQ
EARASAGLANKARLRRQTVDLSGLHADAIFGEELPAYDRLDR
>fig|485913.3.peg.9741 Multidrug resistance protein
MLVCTCCLMLCALLIVVCLVLQFPLAIMLGCLYVLSFLIGTSSVFYGLAEVVALTRVVPK
SQIPLALTQNEITYSATTLLAPPLGNFLLTIGRALPFLADAISYIVLLISLLCIRTSFQE
QRREATQGIAREILTGLQWLRTHPLVGFLAFFSGFLEVIVILNVLLISAIRLEAGFPQGI
VGVILAGAGIGNLLGNALGTYLQPRLRFGWGLCAVSIVFVLAWPLYGLYTNPLWLGSIVA
FLALIDSVAYLLTASYRLAVVPDAFQGRVSSLYRLILFGFASLGPATIGVVLQVYGIATA
INIIWGALFCFSCVIILSPQIRRATFPQDENSTKNL
>fig|485913.3.peg.9795 Glyoxalase/bleomycin resistance protein/dioxygenase
MVQAAEWLCKTFDFKERLRIGRHRVQLAVGDAAVIVNEGKSEAPSRAENHSVLVRVEDVD
RHYEFTRGRGAHILRPPTTYPYGERQYTVEDPGGHCWTFSQSVADADPEEWGGTWPSA
>fig|485913.3.peg.10066 Permease of the drug/metabolite transporter (DMT) superfamily
MTTSTPPPVIEDSVASTLLPLTPRRKYLYITLMVLATIVWGSTFLVVQETIKLTGVFTFL
TLRFSLGALTLILIFHKRLRHLNRYELGAGSCIGLFLFAGFALQTWGLRYTTSSEAAFIT
GLYVPFVTILSLFILKQKPTRMALTGVVISFVGLTLISFNKDLVLTFGLGELLVLGCAVA
NALHIVTISKFAPKADPMNLAIVQILLTALLSAVAIPLAGEPLVLPPAPVWLSVLFMGMI
ATAFCFAVMNWVQQSVSSTQATLVYALEPVWAGVFGYAVGEMLTPLGWFGCVCILLGMVI
GELRLWPRRSRS
>fig|485913.3.peg.10601 Daunorubicin resistance ABC transporter membrane protein
MLKMTEPAIMPEIMPESISANARFIDLEGIAMIWRRDMVRLWRQRSRLLGAVARALVWLF
ALGFGLRGSLGSIAGFSYEQFVFPGVIAMTVIFSGLQSAISIVYDREFGFLKEVQVAPTP
RSTLVIGKCLGGASSSTIQALIILIFAPFAAVHLTPLNILATFVATFVTALAISGLGVVI
AMWITDFENFGTIQNFITLPLYMFSGAIFPTRQVPGWLHAVLLLNPLSYGVNAIRGALLG
YEASSIPFNLGILLLFTVVMVGIAIFMSRKEV
>fig|485913.3.peg.10622 Permease of the drug/metabolite transporter (DMT) superfamily
MRTKEVGVLLVLAALWGGGFLFIRIATPAFGPVALMAMRVLLTGLCLFVFALVTRTRLEL
RTYWHHYLVIGIINAALPFLLIGVAELYLTSGLAALLNATTPLFGAITAVIWMREAMTIK
KVVGLGLGLLGVVIVAGWSTLPFSTTLILAVGASLAAAASYGLASVYIKVSLGNKVSSLA
TATCSQFFATLFLLPLTFVAPPTRVPTLTEWLSVAALALLCTAATLLLYIWLIAHAGPTK
ALTVTFLAPVFGVFWGVLFLKEPLTLSPFVGLVVILVGAGLVTELLLPGWPRRVTETLSE
PGERHVAAEMKGEHL
>fig|485914.4.peg.157 Glyoxalase/bleomycin resistance protein/dioxygenase
MTELQFITFACDAPERLATFWEAALDGERRDTEVPETALVDRPGDGPDLLFKRLQAGTKW
RMAIHLDLSVEDRAQSVERLRELGATVRETKTEHHDGTTAEWTVLEDPEGNAFCVSEY
>fig|485914.4.peg.734 Transporter of the drug/metabolite transporter (DMT) superfamily
MSDSVARPRLALAVAVVAISTSAILIRWSTAPPVVAAFYRVLLTTALLAPVLLARHADAV
GDLSGRHLLAAGLTGVALAAHFAAWFESLSWTSVAASVTLVQSQPIFVVTGAWLLLNERV
TGRTVLGVVVAIAGIVVMSLGDLLGGTAVGPRPLYGNALALVGGLMAAGYVLAGRSLRQR
LPLLPYVTVVYGVAALALLAVVLAQGLPLTGYESREWLLFLGMAVGPGILGHTLVNWSLA
HVESSLVSVTLLGEPLGSALLALLLLTEVPSSWTVAGGAVVLAGITLTARSSE
>fig|485914.4.peg.2042 Multi antimicrobial extrusion family drug/sodium antiporters
MGLLDRIRALFKGPEEFDLTSGSIGKPLFFLSMPIVITNLFQTAYNLADTFWLGQYSTDA
LAAISFAFPMVFLLISLGMGISVAGSVLVAQYTGAGEEREAEYAASQTVTFAAIASVVLG
VVGFFAVEAFLGVMGASADVLPLATSYMELISLGLLFMFGFAVFIALMRGYGDTITPMVV
MFGSVVLNIVIDPFLIFGFESNPLFSMLDLGSLEATLLAATGYTGSGITGAAIATIFSRA
VALVVGLTIMFRGRRGVQIHLGDMVPDLDYLPRLVRIGLPASVEGMGRALSMNLLLFIVA
FFPDAVVAAYGIGTRVFSVIFLPAIAVARGVETMTGQNMGADKPDRAQRATGLAATVLFG
VLSAAGILVFFVAAPIADVFTTDPEVVAVATQFLRYVALTFGFIGIMRAYTGSFRGAGKT
LTAAAISVLMLGVIRFPIAWFAAGEIGETGIWLSFAISNVAGAVIAYGWYRRGTWRDNDL
TEDGIDLDDAGMEPATTDD
>fig|485914.4.peg.2219 Glyoxalase/bleomycin resistance protein/dioxygenase
MTDAPPTPGIHHVTCIAGDPQRNLDFWVETLGLRLVKRSINQDDPETYHFFFADAEGTPG
TSMTFFPWENLRQGKVGSGQVSRTAFRVPEGSLDYWEDRFEEYGVDYDDRVERFGSETQR
ASDSASGDEPRAETVLPFRDPDGLPVELVAVEIPDDDPTVPWTEFVPESAAIRGFHSVTL
LVADPQPTMELLETMGLERSDTEAAQGDTPGDERTRFEAAGTVGRYVDVLPTIEGGRQGH
GTVHHVAFQTPTDADQEAMRQAVQSAGLRPTAQIDRHWFRSVYFREHAGILFELATSGPG
YTDDEPLDDLGGRLVLPGEFEDRREAIEAALTDVTVPRGESAAAED
>fig|485914.4.peg.2386 Glyoxalase/bleomycin resistance protein
MLTDTPGIHHVTSMVGDPQENLDFYADVLGLRLVKRTVNHEDVLRYHLYYGNGTGDLGTI
YTCFPYPNEPPGRRGRPGIDAAAFAVPPGSLDFWADRLAEHGVDPERRERLGESLLRFED
PAGTRLELVAADAPVDSWQASPVPAEHGIRGLHGVTTHPVDPYQTASVLETLGLEQVAES
DDRVRYRAPGDHATVVDLLDREGGFGREGVGTIHHVALRVDDEDLREWHDLFRERDLRVS
RIRDRHYYRAIYVREPGGVLIELATESPGLTVDEGAADLGSSLVVPPWAEEDREMIEGQL
PPIEVPYRDG
>fig|485915.5.peg.1397 Permease of the drug/metabolite transporter (DMT) superfamily
MSASSLLSTPKTMQPSQRQLGADGVLLIVALIWGITFTMIKDALVHVSVFAFLGQRFTLA
SALFVPFLVWRWRCFAWRAVAHGAILGIFLFGAFAFQTIGLAFTTASNTAFVTGMNVVFV
PLINGLLFRVHIPVPVRSGVILAALGLAGLTLNTGLEINPGDLVVLLCAVCIALQIIFTG
RYAGRNDVYWLTAVQIAVVAVGSTAIGWIRGEEVFFWEPKIASALVLCAPLATVFAFWAQ
TAMQRFTLPSRAALIFCMEPVFGALYACLVGGEHLGPWAGLGAAGIFLGMVCAEMPETWW
VRLKAGWGSREAGS
>fig|485915.5.peg.2512 Permease of the drug/metabolite transporter (DMT) superfamily
MQKTTFSPSVLPTLALLGAVFLWGSSFSAMKVAVAAFGPLFTVWSRMCISTALFVPLSWK
LLKNGGPGRDWGWILLVAIFQPCLYFLCEGFAVHYTTSAQAGMVSAVLPLLVAAGAHLVL
KETSGPGIWIGGGLSCLGVVWLTLASSPSATAPNPFLGNTLEFAAMLSAAGYMLTVRRLA
GRYSSWLLTGLQFSLGVLFFLPGGMQGPSGGWPETVWPYLLLLYLGALVTLGAFNLYNWG
IARVPAGRAATFVNLVPVTAAVLGALFLDEVLSTSQIAASILVLAGVALAQSTFLERTAR
RQR
>fig|485916.5.peg.1840 Drug resistance transporter, EmrB/QacA family
MAIVLAAIEVTIVSTAMPTIVRDLGNIHLMSWVFAIYLLATAITTPIYGKLADLFGRKKV
FTIGIVIFLIGSSLCSLAHSMAHLIFFRAIQGIGAGALFPVSLTIIGDIFNIEERAKIQG
LISAIWFISGILGPLVGGFIVDLLSWHWIFLINIPFGLLSISLIKLFFHEQFTKKKRYID
YPGAITFTIGMTSLLYAIILGGQNKAWISPITLSLLINAVGFLSLFYFIELKSPEPILPL
NLFKLPMVMVPNLATFFLCTVLIGLNVYLPIWVQGVLSYKATGSGIALIPMSVGWTLGAF
YCGKLLMKFSVRNTTSLGAGAILAGCSLLVAMGFSIFELIFGMFIIGLGFGLALTSSGIV
IQSSVEWNLRGSATALFTFTQALGQTVGVAMLGVLFYHTVSTGSATLNKEVLTFGLHNIF
IALSVISVLGLFINLWIPKQKLSGSKLL
>fig|485916.5.peg.1946 Acriflavin resistance protein
MGLIEAGLKYRKITLMFFIMAVILGIISFINMPRFEDPQIKVFMAQVQTVYPGASPEQVE
ALVTKPLEEKIDELKEVSKITSSSANGFSNIMVEIAPESDQKKAWDNMRQKVNEARLLLP
SGAGEPEVNDEVNKTSCLIIHLIPPANLPVASIREIADDWKDSIKQVPGVEKIEVMGLPE
QQVQIILDPSALAARRLSWTHLADALQKRNVSIPGGTLREGETGFMVEPSGEYSNLEEIK
DTIIYQPVGGTAVKVKDVASVKLVHARNDVLVKSSDNSAVALAIFPKEGHTVFDVNEKVQ
AKIKEMKKDLPSGVEVQSVYDQSESVKKKFDELWRELLTGMGMVLLICVLGLHWQTAVMT
ALAIPVSVAVGFGPLASMGVDLQQMSLAALIIALGILVDDAIVVNDNIERHILLETDRYT
AVLSGTREVAVSILTSTIATVAGFIPLILLRGNIGEFIRSLPLVVAVTMSASMVVSLWLV
PIMRYWTAGRVKKNIREKAFGQSGPLGPFLNRLSTWYEALLSKCLKLPFLTVTVALLVSA
STFMLIPIMGIQFFPYAEKSEFIIDINTPKSSSLHETEAVVGQVVRKVKEQIGVKEVFVY
IGHQLPKFYYNELSGGRGETLTQLLVVSNQEPKETHQLAAKLRGELTGAIPGSRVTVREL
EQGPPVGPPVSIRIKGDDLSELRTLADQVIDILKQVPGTVNVHDDMGSDTYSVKVNSSPE
LTARWGVAEKDIANSVRMAVDGLEISNYRKGDKLYPIVLRTSEAEDASLSNMSSIWVPSW
KTGSILPLAQVATVDVGWNTGTINRHNLKRVINARAYTDGTLPDNIIKAASAKIAAIPIP
KDYKIEYGGENEERDLAFAKIGKLSIVVLLLIYVIIAIQFYSLTKPAVILLSVFLAISGA
VLGLYVTGTPLGFMALLGVVSLSGIVVRNGIMLVEFIEVGLKQELPLYGAILEAGKVRLR
PILLTAATAVSALLPMAITGGSLWRPMAVSIISGLIFSTVLTLIVVPSVYLLITKRKLAG
>fig|485916.5.peg.2301 Vancomycin B-type resistance protein VanW
MSKISVKIFGFVLIMFLILFYILFPDLFYPAFISQKVVQGVTIRGIDLSELSLQEGLNKL
QSLEEKIRETKIFLKYEYQTYRLSIDNSGVRLDKQAIMNQALSAGHSGSLFRRWSEQYHI
EKYGLEIPVKINIDKHFLEASLARITSDITIHPRNAAIHINERNEIEIIPSAAGLKADPA
QACIKLIGALEADRSEEIIDLKMVSVAPEHTTDEIRAMGINTLLSAYKTEFESDNLSRSY
NITVAAAALDGLLVPPGKTISFNEIVGPRSTEAGYKDAGVIVNNELVQGTGGGVCQVSTT
LYNSVLLAGLEIVERTNHSLPVSYVPIGRDATVVYNSVDFKFRNNTNKHVYIKTITGNSS
LTVKIFGSNKSKRDVELRTWITDTIEPQTVYKIDTALLEGQESVKQEGSKGYYAEGIRVI
YNNGLMEATKPLPQSKYKPVNKVISVGSLKKDK
>fig|485916.5.peg.3289 Vancomycin B-type resistance protein VanW
MNKTRLTSKVILITVFQLIVCISLSSFALKFYYSKVVLPGITVQGVNIGSLTYSQAVEKL
KQDLPYPSPKMILQVGLIKYGEIQYTTDYEATVREAIKYSQKLSSRQIIKLMFSNTKTHD
FVLTKTYNDKILNEILDKAASQYYEAVQNAYISFDEKTATVFQDTYGRKLDKEASIQKFI
SSPYGNTYLALSFQITEPTRKTPDYDGINSRLSLFVSDFDVNETDRTRNIELASESINNV
IIRPGEVFSLNKTLGKRTSEAGYRKTLENTYDVDLIASHEAGICQVAGTLYNAVCRAGLT
VVEKRINPVPVPYIPENMESVIADENNDFKFANNTSKNILIASQIHQGELKICIMGHKGS
TPVRQIKTEKERYVTSPPKQYVLDPTLPPGLVIIRNPGSNGYAMKIYEVILKNEREIDRI
LTAAIEIEPEPELLAISPMRSTIANLFRKEPLKFK
>fig|485917.6.peg.2445 Drug resistance transporter, Bcr/CflA family protein
MASTLQVSSLQVQLTLSLFLISYGISQLFIGSVLDSFGRYRLSLICLLIFAAASIVIANT
HNIYLIYLMRIIHGFTVGTIIVAKRAYFVDLFTGDQLKHYLSLFSIIWSTGPIVAPFIGG
YLQTAFGWESNFYFLALLAIVLAVLEYIYSGETLSHFSAFSLKKITGIYITMIKTASFSL
GIVMLGLAYTMVMIYNMTGPFIVEHHLHFTPVVAGYSSLILGFAWMVGGFIGKATINRPF
FKKMATNLIFQVIFVSTMLLSIQFISSLYTLILFAFLIHVTAGYIFNNYFTFCLGLFPKN
AGIASGLTGGITYVIVSFLSYSIIAILPAKDEHHLGASYLVLTILSALVMFTIYSRHKKA
GTQVTE
>fig|485917.6.peg.3534 Multidrug resistance protein B
MSLPKQIAGHYKESFSGLSRETWILSIVMLINRSGYMAVPFMGLYVTQSLHRLPSDAGLI
ITLFGIGSILGSAVGGKLTDVIGFRPVQIIAAIVSGIFFLFFASVTHFQTLCVLALVISF
FSEAFRPANFAAIAAYAKKGLETRSYSLNRLATNIGWAFGVSMGGMIASYNYRLLFYIDG
AVSIFAGLCILFFLPRIRNYSKTIKEKVKGVVVRKPWQDTVFVKFILLTTVFILGFFLVF
RVVPVFFKEIWKIDEFMIGLILGLNGVIIALFEMVMIHKIEHKKSPMFFIVIGVLLIAAS
FLLLMLPFGNPVFLGALCLILFTLGEMFTLPFVNTFVMSRANEFNRGLYAAGYMLSWSVA
QVVGPTAGFYIAEQYGYNTLWIGLSTLMLLTAYFYKRLKTV
>fig|485917.6.peg.4333 Outer membrane component of tripartite multidrug resistance system
MQEAIALGIENSKNLKLSQNKVEQAIAQLNMVKDNALPSAKASFLYNHAEIPTNTLSIGG
GNPIHLPKRADAFIGTAAVEELVYGGGKLKYAEESTRLLSDVARLDADKNKEEISYAVIN
TYYSLFKVMQSKKVIAQNLESIDSQLKQAQRFFEQGIVTKNDVLRFQLQQANISLTDMEA
ENNRKIINYNLDILLGLNENTQIEIADPDAAAKAIGPLSSYIDLALGSRQELRQLDLQNK
VADVNIKSVKANTLPTVGVGANLYYINPSGKFVPPTDQYIMPVTLGANISWNIGNLWTNK
HKVTDARIQQKEVELQKDILSDQVKTEINSNYQRYQLALNKIRVLETSIAQATENDKLLA
SKYKNNVASAIDRIDAETLLYQAKINLELAKADAGLAYYTLLKSTGKISQ
>fig|485917.6.peg.4334 Membrane fusion component of tripartite multidrug resistance system
MTTEKKKKNKVIPIILGVLIILGAIFGTKEYLYYSKHVDTDDAQIDGDISPVVSRVGGYV
QEINFEENTHVTEGQVLVKLDDRDYKLKLEQALAGQKGASAGVGVSESQIAATAANTSTA
KANIEAAKVKLNLAQKDYERYANLVKDGSVTQQQFDQAKAQKESAQAAFTAANDQYNAAV
KQVGTSQSQLAVSSNTVTQHQADVDFARLQLSYTEIKAPATGIVSKKNVQKGQLVQAGQA
LFSIVNDNSIYITANFKETQLEDIKTGSKVKIDVDAYPSDEVLGEVYNFAPITGAKGSLL
PPDNATGNFVKVVQRVPVKIKITKAPKEILAKLRPGMSVKVSVSIKD
>fig|485917.6.peg.4335 Inner membrane component of tripartite multidrug resistance system
MAEKGLKKWIITFTVITASLLELIDTTIVNVAIPQIQGNLGATLEDVAWLSTGYAVANVI
VLPMSGWLGSRFGRKNYFLFSIVLFTVASFLCGNATNLEELIAFRILQGLAGGGLISTAQ
AILIETWPREDVGIATALFGLGAVVGPTVGPTIGGYLLEISTWPLIFYVNIPVGILAAYC
TYMFVRETPKDGKGMPVDWWGIVLLAVAVGSLQTVLEKGESEDWFATPYITALAVTSVLG
LLLFIWRELSTDHPIVNFKIMRHRSFSVGMFTSFILGFGLYGSVFVFPVFCQNLLGFSPL
QTGELLFPGGLCTIVMMPFIGIMLKKNIPAQFMATIGMFLFFVFCSMLSKSTLQSGTNDF
FLPLMIRGVGMALLFVPLTTLAIQDLKGAEIGQGSGLNNMMRQLGGSFGIAALTTLIHVR
QGFHRSNLLVNINEYNPAFTDRFNGFIQNFMAKGYTYLDAKALATKAIEGTVTKQALLLT
YSDAYWVAGLILLCSIPLLYLQKFKKNVAVPADLH
>fig|485918.6.peg.141 Glyoxalase/bleomycin resistance protein/dioxygenase
MKGLKHSIIILVAALTLGSIEKASAQTKAGILGIDHIGVNVPDMSQAVAFFTDVLGFTPV
TQIGPIPLNDAWKTANHMQSGTGAVSIKMVHAGSGANIELFYYENNKGAQQQPGGDDAGA
THIAFYTTDINAAVAYLKSKNVKMLGEPFHTTMGDTAGETWVYFETPWGAKMELVSYPEG
KEYEKNHPKELLWSPKTAVNNLNTITMDTKDLLAIVEQHLLIWNEKDAAKRSAIAQKVYA
ADIEMVDRHFTATGYDSINEFVNKLQKDNPSARFTHVKAINAHHNIARLFWQFGPKEKPD
AVTGMDLFVIENGKVQKLYVFVDEAK
>fig|485918.6.peg.384 Permease of the drug/metabolite transporter (DMT) superfamily
MNNRAIHWSIFLLLSLTWGSSFILMKIGLQALSPYQVASLRLLSAGVALLPFFIKFIRQT
PLNKIPMIILSGILGNLLPAYLFCIAETRIDSALAGILNSLVPLMSLLAGFFLFRAPIVK
QQLLGICVGLLGVVMLFAVKGVDAGYWYYGLWIVVATICYGLNIALVHHHLKGYSSLQLG
SIALFFCAVFALPVLLFSGFFGILSGPAIPWSSLAASVTLGILGSGVASVLFYILINKAG
AMFASMVTYALPVVAIGWGLLAGEQISWLQVLCLCIILLSVYTVNKAKR
>fig|485918.6.peg.1763 Outer membrane component of tripartite multidrug resistance system
MSRLRVESSEEALKDAKAERLPEINAAGAYARVTNMPVYEDGLFHTPDQFPVLHNFYKVG
GEAYFNIYNGNKTNLEIKKGATEHAIAEEQKNLTVSEVKFNAAVCYLDLARSCRFKELIA
KDIEEQERQLVHIQELQKNGVVLKSDVLRATLKLSRQKMGMIQIENDIAIASQKLDLMIG
IDEHVLIQPDSSMTTDLAVPGTYDDYLVAAAEHAHEYRISERETALKELSLKQVKANVAP
RIGLFAEYNWSYPQIQFYPYGDAVYGLGMYGVKASFPISSFYHNKHKEKAAKLQLERQEV
EHKETGDVVRQQVNEAYLRYKEALTRIDVAETNIKQATENLRIVNNTYFNQLSLVTDLLD
ADTQMLQTKFDLVSANIAARVRYYQLQKVIGNL
>fig|485918.6.peg.1765 Inner membrane component of tripartite multidrug resistance system
MANSTPIFKPWASEWLIRIVIFLNLMPSMLMFGISTASGSNAAGYYGIEPADVQYSMVLF
YASLAGFFALERRFFIYIASKEYLLIGVIIQIVTSYGCFVTRDLYVLLPLRFIQGMANCI
TTSVCITLVFSRLRTNRAREVGYSLFYGVLLGITAFTTLVTAPIIDAFDFNVLYKWMIFT
YIPGAILLVIIMNRIRLNRKIPLYQLDWASYVVYTTMLCLIGYILLYGQQYYWLQDERIM
AASIAAVVLLLIHIIRQRSLKRPYLSLDVFRYRNYVIGVSLITVLYVCRGAFNITTNYFI
TVLGLDPRHLSYILLANIAGIILGVLYSSRWILMKRSVRWIWMAGFSLLLIFHLWMHALF
ATQADVPTFIIPLILQGIGVGLLMAPMIIYTISSVPAHLGGTASATGVLFRFTGFCISIA
LINYFQLFSRKVHYNRFLDLVTSLDPLVTAKLVNYKTAVAAKGLPADQAAKIANGLLYRS
ADMQAQIRYSMDYYYLISCALVVIILLIAFVPYLNRTVINLRNNQPAPASY
>fig|485918.6.peg.1959 Acriflavine resistance protein E
MKTKQHILLIGATGLFYLASCKGPAQKAAMVLPPTPVSVVPAVTGTAIYYDKYPATVVAL
NQVELRAQVSGYITGIFFKEGEVVQKGKPLYEIDRRKYEATYRQAEASIAQAKANLTKAQ
KDADRYHKLAEQDAIARQTLDNADAALDVSRSQLAAAEASLLSARTDLDYAVIKAPFTGR
IGISQVKLGAQIGAGTTLLNTISSENPIAVDFVVNENDIPRFSGMQGKAVTPGDSTFRLQ
LPNGQAYTEPGRLTVVDRGVDNQTATIKVRIEFNNPKNELKEGMSGVMNVLNDQSGDRVI
IPYKAVVEQMGEFFVFVAKDTVAEQRKIHLGPRLRESIVVMDGVKQGELVIAEGIQRLRD
GGKIDTTTVKKAPDAAAKK
>fig|485918.6.peg.2478 Inner membrane component of tripartite multidrug resistance system
MSAEVYYLRCIIYPVLIPMEKSASFTGYGFRHACITLIAFICVLVAVMNCTVTNVAFNEI
RGNLGVSLDEVSWVTTVYVLAYIAIIPFSNWLSRKLGNKKYLIITLILFIVSSFLCGNAT
SIEELLILRFLQGLGGGAMLVLSHTMILENWPPQRRTTAQAFFILGMLGGNMLAAPFGGY
ITDNYTWSYIFYPNILVGILLCILVLVFVENKRYQQREDWLGTIMVSIGASCLYLALTRG
QQEEWFKSPFIIVLLLCGLVGLVIFIRRELEWITPQGENGLLRNVSLRNGLILAFVAALG
IAASSSTITIPLRWHAQLPKISPWLVIVCIILVMALITILIEEKKALKYILAAGPILLII
YNYMVFQQPVAPKYTTYIYYLLAVRILAVILLSISVSTFVFSKLENKEIGPGVRMYHLVQ
QLGLALGIALFSAFTYKAPEPDYTRFLGHLDLKDPVVQKAIRESTTSLDQVRAEAFVRQA
HDTQVGVVKANFMLMIIAGIILTVLIFSVRQRIKINSKNDSK
>fig|485918.6.peg.2909 Permease of the drug/metabolite transporter (DMT) superfamily
MKKSNTNAYMALVLVSIFWGTTYLASRIGVRHTHGLMLAGVRQTIAGILLTGFFLLRGFK
FPEKIILSRLFVIGVMMLCMSNGLITWAMQYIPSGLCAIIVATVPIWITIFSYFLVQRTK
FTILLITGMLVGLLGVGGIFYDYLPSLANPEFRFGIFLTLISCISWAIGSVLTARWALKI
NFLYGAGFQMLFSGIVMTGTAILMGYSLPLDGFNRELWGSIFYLVFFGSILGYSSYVFAL
NNLPTSLASVYAYINPIVAVLLGWLILQEHLNWTTGLSCLVTLGGVYMVNMAVNRNKKEY
GTTKS
>fig|485918.6.peg.3048 Multidrug resistance protein B
MTVYLTHELHFSIEQAGIVMACFGSGAICGSFIGGRLSDRIGFYPVQFWSLLLQGLIFLV
LGQMRTLPQFCVCIFILSCVGDAFRPANVAATAYYSTAVNRTRSYSLNRLASNLGWSVGP
ALGGILAGYSYHLLFWVDGLSCIIAIIIMRVLLPPVKVAPKPPKPVDCVKSNESDSVYKD
GVYLAFVLLIVVFTTGFLQLSTMVPLYLKSVVNMQEAHIGMLMGLNGLLVAFFEMVLVYK
LEGKMHSLQFITRGVILAGIGYLSFNLLPPVAAAGVVFILLFTAGEMLSIPFMNSFFVMR
SSDHNRGQYAGLYTMSFSISSILAPTLGSFMVGHYGFSSWWYCTTALCTLTGIGFYILYK
KTADNKEVEILVKS
>fig|485918.6.peg.3384 Drug resistance transporter, EmrB/QacA family
MLRYKKYVLATLMIGTSMAAIDSSIVNVSLPVIQRQFDVGLDDVSLVITAYMITFLLFIP
LTNWLKNRVGYYHLYMASIIVFVLGSALCSIAGSIDMLVWSRVIQAVGGGSIAPVSLAIL
SESFPQDERGSAIGWWGIGNVMGPALGPTLGGVLTEYLGWQAIFYVNIPIGIIAILMNMR
YLNFLKSRKRYSEPFDFKGYFLFICFIILLQFTLTSTSDKFGFTSWQFISGVLLTVLSLW
LFIRSSRKPSALLDLSVFRVAAFNRAFIIVALRSLALFGGMFFLPFLLQGYLKYTEIQSA
LLILPNALVMLLTRPLAGKMADAGEIRNISVFGIVLVSASFFLFAQINTGTPVWFIVLSM
IVRGLGISFLIAPVSTAMLNAVSPSQTATATSLNSLMLQLGGSVGIAISGSMHTYINDHY
LAKGYDTMLAEHYALRDGFLFTAVLMLVTLIPAFKLPHKVERELKHKEALG
>fig|485918.6.peg.3482 Drug resistance transporter, Bcr/CflA family protein
MAKGLQVEESSIQLTLTCFFISYGISQLLVGSLLDSIGRFKPAMYALVAVIITSMLIGFT
SNVQLICLLRVIQGIAVSFVVVSKRAFFVDMYSGDKLKNYLSYFTIIWSCGPIIAPFLGG
YLQKYFHWQANFWFLAAYALVMLIFELIYSGETIKARKQFDIARVKKDYSMALGNLNFVL
GIVTLGLAYSVVMVFNIGGPFVIENGYHFNSIVTGYCTLILGFSWLVGGVIGKRLVAVDF
VRKITVASATQLLLIVILMFIGFGYPALWCFMLFAFVIHICSGFLYNVHFTQSMLYFPEH
AAMASGLLGGSVYVITSFSSFILSKAGKMGHQQDITLRYLVVSAILSAVVWYAVKRRRTL
RKVNTAIAA
>fig|485918.6.peg.3966 Permease of the drug/metabolite transporter (DMT) superfamily
MLRNSGLIFSALCGISLPFMLIHVKTDTVQDKPDNTKLWLFLFAVYIIWGSTYLGMKIAT
EVVPPFLLSAFRFLAAGTILGLISRGSERQWPTKQQVGSAAFVGLMLIGIGNSCTALAVH
YMPSGLVALIVAAIPVWFVGFDWAFFSKQRPTIMTFTGILVGLVGLFLLFNPFGADHQSR
PYPLWPIAVLAGGCACWALGSLSVSKLSMPAPMTSAALQMLTGSVFCFIVSSVMEPGAWN
TLAHLSTRTISAYLYLVFIGSLVGFTSYSWLTRNAPPGLLSTYAYVNPVVALFLGWAIGH
ENLTSQALMACGIVIGGVVLMTLGKRKG
>fig|485918.6.peg.4102 Permease of the drug/metabolite transporter (DMT) superfamily
MKKYILFVLTGAASYGMLSSFAKTAYREGYNAAEITFAQAAIGALLLWMPVLVKRIRERQ
APSLANWRLLLAGMGIGISTYTYYLAVQYIPASLAIILLMQMTWMSTFMEWLLFKRKPLT
IELYVTAVILAGTVLAGNLLQVGTFEFSLIGIAYGLLSALTYAIAVICTSRLGTKVPMFE
KSAMMITGSAAIIFMINFNSLRLSEHFDGRLLQWGTFLALFGTVIPPVLFTKGMPKIGAG
LSAILVTMELPVAVLCAHFILKEEVNSLQILGILLMLGAIIYLNIYKEKKPVQEFAEL
>fig|485918.6.peg.5218 Multidrug resistance transporter, Bcr/CflA family
MQNKQHTIIILILGLLIALSPFSIDMYLPAFPAIASALKTDIAHVGYSLTSYYAGLCAGQ
LIYGILIDRLGRKKPLYAGLLIYLTAAFACAFSLNINMLVAVRLFMALGGCVGMVTARAI
VRDLFPPKDTARVLSLLVLVMGIAPIIAPTIGSIVNTIAGWRWLFGVMALIALALLIATY
TLLPETKTPDPDVSLRIKDVLPEYIAVLKNPAFLVYTLAGGISYAGLYAYIAGSPFVFMT
RFGFSDTAYSWAFAFNACGLISGSQINRLLLNRYDSIHISFYAAILLFITGLLLLISTAL
GIAGAPMTLCFTFLFLFCLGFLNPNTTALALRPFTAAAGRASAVLGSIQMIAGVIASWTV
NFFFNGTANVMAAVMFGCTALTLFLLVFFTGRRRTKQDLQPA
>fig|485918.6.peg.5230 Outer membrane component of tripartite multidrug resistance system
MRKVIIISLLSLAGLQSYAQEVSSDLKELINKSFTYFPRFSELEQSVKTEEERVTLAKAN
GLPNLTCSAGYRYSHPVSEMTIPINGQLSTFKIMPNSNYNTGLNASYVLWDFGVVKANVE
SAKRAVQYAKDNIEYNRAQMAYQVAVIYYQIVYLQKAIAIQDSVLAFLKANKEDTEIKLK
HGDALRYDVLSIQSTIDQENNTRIDLENSLLKQYNLLQYSTGSTAANGKDFDFMQANENK
QEALNIAQQHNPEYTLLKDRISQSEAGLDISKKAGLPSLSLSASTGFANGYMPDLNQFRY
NYAGGVTLSVPIYQGARARRQRSLAQSQLKEANLGMQTLNNTVQNDIKQAYTDIESNQSR
LVNAMEQVEEAKEAQKLAQSRYRNGTGTNLELTNASTNVQRAERSTLQYTYQLCLARLEL
ARVLGTKYW
>fig|485918.6.peg.5232 Membrane fusion component of tripartite multidrug resistance system
MTQEKTQPSKGPVKFIVLGVAGIAILYFGGKKIMHAYTHESTDNAQIESNAIPVVSRVGG
YIDTFALQDYQSVKGGQLLLTIDDKEYKIAVQQAEADLSAAKADLIFAEAQITNIGSDKN
VADAGVSVEQVNLEKATRDLARDQALFNDGSITQHQLDNSQSAYKVALSQLESSRKRVSQ
VVTQHGTANAQIEKAKANVALKEAALESAKLKLSYTQVIAPVAGRIGKTNLQKGQLVQAG
QQLFSVVNNERYWIVANFKETQLEKMKIGQVVKVEVDGYPDKEISGKIVAFSDATGAKFS
LLPPDNATGNFVKVTQRVPVKIEIDRAEELKSILKAGLSVTVDVQVD
>fig|485918.6.peg.6005 Glyoxalase/bleomycin resistance protein/dioxygenase
MANTEHPTLGHGKICYIEMPAIDVNASATFYEKTFGWTIRTRGDGSVAFDDGVMEVSGTF
IEGLPPHNGEGLTIHIMIDDMDSILEKITANGGVITVGVGAHPGELTAKFRDPAGNIMSV
YQQRG
>fig|485918.6.peg.6024 Outer membrane component of tripartite multidrug resistance system
MRIKHTNTGYSCLLLSCLSAAILLMHITIANGQTANNNTYKISLNEAVEFAKIQNKLVQA
ANFEETAMSEDKKDVYKAVLPDIRVNGSYQRFSGLTLFNDGLRHANTEARRPTSTSAALG
IEALFNIYSGGKQKALQREYTFREKLEQLNTKDQSGIIAYQTAAQYLELVRLNEQEKFIH
EQVKRAAVRVKDIHALYDNQKVTRSDVLRAEVNLSNVRLSLEQNENDIAIANQKLVVLMN
VPDAIHIIPLDSAGMLKPDIHSLLPIADAAETSSYSVLKAAKNVEIQKEKVKGVRSNNKP
NLSFYSGYGINYPNYLFFPPVDQAYAIGFAGLKAQYSISSVYHNKSRIAAAKLRVKELEL
RQQASADNIRSEAKAYYAKYAEALSRITVNEHSVQQTEVNYRIVNNKYLNQLALLTDLLD
ADNLYQESQFNLVKAQTEALVIYYRLLYTSGNL
>fig|485918.6.peg.6025 Membrane fusion component of tripartite multidrug resistance system
MVKEGDTLVILDDREYRAQLQVAEAATEDAHAQLTVLTANIAAAVTSTRVNQDQIKGAAA
KYVQQQLDIKRYTNLVKEEAATGAELEQVKARYDVAESDYSAARNSLKTNEARIAELRTH
FALLQADIKRKKAALELARLNLSYTVIRAPYSGRLGRKNILEGQQIQPGQPLVSIINEKQ
KWITANYKETQVADMYVGQSVEIRVDAIDGKVFPGRIMAIAGSTGARFSLLPPDNSTGNF
VKIIQRVPVKIAFEGPGTGNVVAGMNVTVAVKKRA
>fig|485918.6.peg.6026 Inner membrane component of tripartite multidrug resistance system
MKPAYFKPWVQDWDWGIRIALLLLLLSSLMQLGVFALTGSYIIAYLGAQPEDISFCLLST
YAGIVASIPMQFRFIRHFEIRNYLATNVILAMLLNWLCVGCQDINLLLFIRFLQGVLTGG
ICVSTLILIFSRVPSHRAQLMGAAVFYPTILGNIIVAALIAAIFIDLSEWKASYYCLMAI
QLLTLLIVITMLQRHSGHRKIPLYQIDWAGFILFAFSLLTLAYTFIYGSKYYWFNDKRIC
YSSCMAGIGTILFLYRQSLLKRPLIHPGVFKSLYFLTGLCLLGLYYGGKDSINLVYNYAF
STLKWTPLQVATLGFCNIAGVVSFAIFSTRLIMFRKHHFQVFLVTGFSLMALFNLWMWYI
MTPDLSFTDLLFPIFIQGAASGLLFVPIIIYILTSAPGFSGTSGIVLAACTRFTATLQSI
AGLYNLQLYHNQYFKESFLSSLTADNPTTTSRLNIYQSLYTSKGFSTEQGSYIAKTIIWQ
NLGQQSQLLTNRAVFMTFALLMLAIAILSLIIPAISKTWNYWSRCYSTK
>fig|488538.3.peg.3 Permease of the drug/metabolite transporter (DMT) superfamily
MGVGLLLHGLYLGGVFYAIKQGVPAGISAVIVGLQPILISVLERVFLPQPARAQPYNSAH
YRSQYIGLIAGFIGITLVVTGNGISGSGISGNGIAGLGLPDMSIIGLIANVIALFGISVG
TIIQKRIGRDVPLLSGSLYQYLGATVMMLILTFTLETQAVTPTIELALALLWLVFGLSIL
AVILLMYMIREGEVVKVTSYFYLVPPVTLIQTWWLFDEQLNAVALVGCALTVFGVYKVVR
APSAPA
>fig|488538.3.peg.348 Acriflavin resistance protein D
MGGLIKAAIERPVAVLALVLLAVLFGIVAIRDIPIQMSPDIEKPILEVRVNWPGASPEDI
DREVVTRLEGELASLNGVEELQSRSSFGRTRITLTYNVKQDMDKALVLLLSRLSAVNDLP
DDAQTPRVRTSNSDDSPIARLALVAKDDNEVNLETLGAFLETNIVDPLGRIEGVAEVGFN
GGGRPEMRVIIDPDKLIQYKLTLTEVITALRSSSSMMSVGVITEGKRTYAVRTESENYTP
DTAGRIVLRTDVSSSGTIVPILLSDVASVDLRVQKRTSFRRLNGKEAIIINALREQGTNV
VTTMQRLREEIAVLNKTELSPRGLELNLVYDETKYIESAIDLVQQNIWIGGVLALFILLL
FLRSLLPAAIIFAAIPVSIIGTFVAIAGLGLSINVISLAGLAFAVGMVVDASIVSLENIF
RLRQRGMKAQNAAFLGARQVWAPILGSALTTVLVFVPILMLDLPVGQLFRDIAIAISVAV
LISVVVSVTVIPALASRLLAGAGDKYERLFPIPGIDHAARFFSNLILRYVRVTVKRGYVG
ALVVVAILLSAGFASYRFAPQLDYLPDGNANFAFGRIIVPEGYSIDETLRIAEKMEAAAR
PLWEGNTEPGGPPAIERFFFVAYSGGAFAGASSVDPSRVSDLRMVLMRPIFDVPGARAFV
RQASLFGRSVGGSRSIRVDISGNNRDDIMPIALALNNALEAKFTRREGNQLRAIPSLSSG
APQIRITPDLTALARAGVTVRELSAAVDIFNDGANVIEVPIEGELIDMVLSGKEAQNMSA
DALNTIPIVTRSGNIIRLEQLAKIDIVSAPGNINRLGGKQSLSLQLRPNESITLEDAVQQ
IETEILPKINDMARDAGVSISLRGAASAMDQTWKAMQSNVATAIVVIFLLMVILLRSFVM
PLIILLAIPVAAAGGIGGLALLNLFVRQPLDMLTMLGFVILTGVVVNNAILLIEQTVLHL
REEGMSPTDAILEATRNRIRPIFMSTLTSLFGLVPLVIFPGAGSELYRGIGVVVFGGLAL
STLATLLIVPPLLGIALQTRLGRNTGQKIVIDV
>fig|488538.3.peg.1570 Permease of the drug/metabolite transporter (DMT) superfamily
MSEQKRNVALLILLALVWSSSFSAIKLAVVETGPLTLVGLRTLIGFFVVLLFIQFQADFV
WRPYLRHLPYLFVMSVVGMSLPFYLISDAELVLDSSLTGLLMSVGPLLTIIGAHFFAEDE
RMTVSKIIGVLIGLSGVMILFGHAAMNAGGAHIIPQILVCCATGCYVSAALMARRLPQVP
ALFIALVIMGFVTIQILPLAFMFEQPLAWQGWSSNAWLAIIWLGALPTGFAFFLRYHLIK
RAGAGFTSFIGYLIPVFSVFLGALLLGESLGLDKFIALGLILTGLAVAQRTAQT
>fig|488538.3.peg.2093 Permease of the drug/metabolite transporter (DMT) superfamily
MTNKDWLRIVTLGVLWGSSFLYAEILLRYLNPLMIVFLRVSLAGLILLLICLIKRMPIQL
TGTDLFTIGVMGALNNVIPFSLIVWGQQTTTGGLASIINASTAFFSILLAALFIPQERLT
WNRVGGVLIGVTGVAMAVGPANILQFSGSDSGKYMILLATISYAIAGVWAKMRMQNLPSM
ISATGMLVASAMMMVPLLFVTDTFQIAPIDLYVFFIAFQFAVICSVLAYLLYFKILETMG
AGNLLICTIIVPPSAILLEVLVLDEVIGLNELAGLAIVTAGMIVLDGRLLPRR
>fig|490899.4.peg.9 Permease of the drug/metabolite transporter (DMT) superfamily
MNKRVAGVVSLVVATILWGSSFSFIKLSVTDVSPLTYSSLRSFIAVILLTPIILLKMYRG
VLSINSLYKGFIVGIAYFLGLFLQAAGTVYTTPSLSAFITGLNSVHVHLYIALVERNYGL
IDGIALLLALSGLYVLTSPSGGLTIGVLLIFIGSIAWAAQIILVSRYGSSSIIEILYGMF
LPGALTYPFALILGGAVGIEALIYITYLAVACSVLATFFQVWGQRYVSPLTAALIFLLEP
VFALLFSLAMGLEGIEPYKVIGGGLIVIATYLSSMAELSSNWLK
>fig|490899.4.peg.982 Daunorubicin resistance ABC transporter, inner membrane subunit B
MFFLSDLRDLIHIIEWDLERLKTQKVFVAMRLSWFVIQVFIFARAISLIVRQLTGINYYE
FYLLGVYVSILYSTSISRGYVIADEFDDGIVEYHLSLPIKRNIFVLGRILGCSLAALLFT
LPMMLIVLIAVNALNLTGLLVSMIMAYIFSIGVVGLVILVVVNVKSTDATDILFGTIDAI
LVRLSSIFYPLPIIQAIGMAPYYYAALFNPLTSIADFIRLLFIPEFTLYTVSPYALVLYI
LGFSIGMIVLAMEHYTKKLEAGGWK
>fig|490899.4.peg.983 Daunorubicin resistance ABC transporter ATPase subunit
MSGIHAVEIRSFTKKFGDFTAVDDLNLDIYEGEIFGLLGPNGSGKTTTLLTIATIYKPTS
GDIYVYGHSVTREDYAVRKITGIAFQDPKALWVDKPYDLLMWHAKVVGYSGEEARKVVRE
VMETLGLWEHRNKYFYQLSGGTRKKVELAKVLIQKPRLAILDEPTAQVDVLAKHALWNII
EGLKKEGTTVIIATNDMFEAERVCERIAIIYKGRLRALGTISELKDMIPGGDVVEIQVNN
DKLPNNIVERLNEYGRVEFKNRVLRVYLEKGEEKVVDIVDLLKKNNITVSRLMIKEPTLD
DVFTYLTGASLRGEG
>fig|491915.4.peg.1458 Permease of the drug/metabolite transporter (DMT) superfamily
MLTKNIKTYILLFLAATIWGGAFVAGKIATTTLHPVSVAFFRFFGASLILFPLLYWKEPN
RPTPTRKDWIVLALLGLTGVFLYNIFFFIATKYAPIVKSSLVIAVNAPLITLLSALFLKE
KLNGRSIFGMLLAVFGAVYIITNGHPSVLIEIGVAPIDLVLVGACLSWSTYSVIGKVAMK
TYSPLAATTYATGFGTLFLAPFALYYTSFTSVKMSGWDVWLSVLYVAVVVSAISFVWWYN
GIQKVGASTASVFINVMPISATVMGTIFFNEHLSMTHIVGAAFVFSGILFNIYSKQEKAM
FPLIKKGANI
>fig|498211.3.peg.394 Permease of the drug/metabolite transporter (DMT) superfamily
MSHTSSRLSPEGILLLLGIGFGWGLNWPIMKYIISEIPPLSFRGFCLLLGGLGILALARI
GGHSLRIPRAYWGKIFWVCLFNILAWNIMATFGLSLLPAGRSALLGYTMPLWTVLLSVLI
LKDSFSVRIGLALVLGLGGIFALLSDSLLSWFGGPLNSSLLLGAGLMVGAAWGWALGTVL
LKRWKIPLHSVVLTGWLLLLASLPTLVAAAWFDGIPHSMPDQWALWGVVYNVFIGFMFCY
WAWVRLVELVPVSVSSLSSLITPLIGVASSIILLGEEPGWPEISATLLILGAVAVVNWKP
GNAKQKY
>fig|498211.3.peg.748 Permease of the drug/metabolite transporter (DMT) superfamily
MRRATRSFAVTTFFAYFTVVLIWATTPLAIQWSGDSLSFMAAVIARMSIALALALLIHAV
WRHRLYFARDNAAIYFAASIGIFPNMPVVYWAAQFIPSGLVAVIFAMSPFATGLLSMLLL
RHNPFTPKRVLALLLAVSGLVIIFWHQIRFDRASIYGIGGILLSCFLFSFSSVWVKKLSS
HLSVPIGAFQQATGALLFSLPGLLLFWWVMDFGVADVGLPVTISVKSACAVLYLALIGSL
LGSMLFFLILQRLSASIVSLITLITPVLAILIGRWIANEVLTLETLVGVAVVLLALLLYI
PWSLMSVVRHGRCWLSACFFRRLAKGALSDSHHPETGLEAIRDDMIRYK
>fig|498211.3.peg.925 Permeases of the drug/metabolite transporter (DMT) superfamily
MSSHKSAWISLHLTAFLMGATGLFSKIIALPAWDITGYRTWIAALVLFAWVAWRERHIRL
NSGRDYWRMLVLGILLALHWVSFFYSMQVANIAVGMLSLYAYPVVTVFLEPWIKRTRLDW
RDVVSGFLVVIGIYCLVPEFDISNNMTQGVIWGVISALTFAVRNLLLSHWFSGQSASRSM
SYQVLIVALVMTPVIWLSPHQPTSQDWWLLILLGVFFTAITHSLLGHSLRYLKAKTVGLV
TCLQPVYAVGYEIVILNEYPDQATLIGGAIIIGAAIYESVREHRRG
>fig|498211.3.peg.1033 Permease of the drug/metabolite transporter (DMT) superfamily
MTRLPEVFCGAPMQVSPSKSGYFFVAGTILIWSGFVLVARMGGTSVLNAFDITALRFGVA
AIVLLPLWLFWKPVPLLNKTMLSLALTGGIGYSLVVYSAFKYAPAAHGAVLISGLLPFFV
PLMAYAFLKEPLRRHLYLALPVIAIGIICLGIDIFSRSENTLPGDLLMITSSLIWAAYTI
LAKRSGLGPWEMAIGGALLSAMIFLPIYLLLLPKAIGLASTNDILVQGIYQGIIVVIIAM
LFYMAAITRLGPARTGACMALVPAIAGIGASLILGETLNAWLIAGLLATSTGAWLGAR
>fig|498211.3.peg.2149 Multidrug resistance ABC transporter ATP-binding and permease protein
MKNLWRVIQFIPEYRGRVAGVILVGTFLGFIGTATPYIYKGIVDVISQLFSGKITLDSAT
ASVIWLLLGFFALRLGVVLFGALQNKQADDLWLDTVSTFRQRVFDNMTQKSIDYFEKTRV
GEIMDRFGNITTITMWLSSLTEGTLANILQMFFILVVLTLKVPVVGLMMTGILLFNFWIS
YRTIGWTKPHRRGWQEFAGRMTGLLAEMVGNIATVRSFGGEPAVKQRYDDTQAQWKVARD
NLHKTQWRSEQALNVVNTFGVFIAVAIITHGALHGRFTTGDILLVLTLTQTLITSISPIS
RQINQASEIESASERLVELLDVASEQADKPDAIPLTQLKSITFADVSFRYPGTEEYALKR
ISFHLDAGETLALVGSSGSGKTTIVKLLMRFYEPTKGVILINGRDLRDYQQRSVRAIMGV
VLQDVALFNDSIGENIAFAKPGASELDIKAAAEAANAHQFIARMEKGYETMVGERGIKLS
GGEKQRVAISRAILKNPQLIILDEATSALDSESEYLVQQGLEKLMSERTSIVIAHRLSTV
MNATNILVLRNGEILESGTHAELANKPGGLYAHLFALQTQGRKPLVGIS
>fig|498211.3.peg.2214 Multidrug resistance ABC transporter ATP-binding and permease protein
MFMTMPASPSPLSSSLLNDQPAGRFPGGGGRLGTPDQDGVNLDDDIFIRFDSGIMGRLWG
YIRPYRLPLTGCMLAVVLYALVQVAIPLAIRGVVDNAAETAALSTVLPLSTALPFALAIF
AVLVLLNFAFNFLQEWGTARIAQRVIFNLRRAMFAHLQQVSLGLLDQTQVGRLMARLQGD
VNALQEFMESSISALGDLCLLLGIVVVLLVLDWQLGLLTLAVLPVLVLIRLVWLPWARRQ
FRRAREASSRVNSALAENINGIRTVQENRRESFNFNRYEPIARENLDAQLGSSRASQIMV
PSVDILTGFAMAIVVVAGGVAVLHSRVEVGVMVAYLFYVQRFFDPIRTLSMQYTVLQRAM
AAAYRIFEVLDLPVTLQDKPNARVLDNPVPDIEFRAVTFGYKPNQPVLHNISFHIAPYTT
AALVGPTGSGKTSITALLHRFYDVWQGQVLIDGQDVRDLTQDSLGHVIGMVLQEPFLFSG
SIMDNLRYGSTNASDEEVIAAAKAVRAHDFIERLPQGYQTPLGQRGRNLSIGQRQLLSFA
RTLLMNPRILILDEATANIDSFTEAEIQRALRVLCAGRTSIIIAHRLATIRAADQILVLN
HGRLVEQGNHQQLMQQGGLYYQLNTSNQSSFDELAD
>fig|498217.4.peg.1861 Permease of the drug/metabolite transporter (DMT) superfamily
MLRVALFPVLLLFWQYVFGTDLPLLAPAMCAVFLTTTHNPPPLIMVFLMAVVLYLTSWVQ
AWLATLLLDYPQVYYLALLGIFYWCMDRTRKNAQDLVAILLIVATAMIAVFVKQKAISVD
QIPLALLKNIFVAGFTAYLAYFIFPGGEPLTDACAAANSASTRPHRRWHTLFKAALVLTI
LCTGISLDLEQSTIITIVVALIIKDSNPALGHNYGIRRLLTTYASVLYAVPPLIMCVLQT
NLIGQLGVTVVCALFMGIHAVKKKASYNSIQLLYSSYVVLVFYSITSTSIDAFSDGLIRF
SSVMLAVALGVMALIIMQPAPSAEPEIR
>fig|498217.4.peg.2135 Multiple antibiotic resistance protein MarA
MYNTDFISALRTWIDSNVAAISSLDDVAARAGYSKWHLQRMFKAHTGVRLGEYIRNKKLD
ESARRLKVCQGSILDIALSMGFDSQRSFTRSFKRRFDVTPGVWKKEVTAGKPLDRAA
>fig|498217.4.peg.2337 Permease of the drug/metabolite transporter (DMT) superfamily
MGLKDTLLALLVVAIWGVGFVVMQTGLQHLPPLLLGGLRCLLLALPAVFLLPRPALPAHT
LILYGLLIGFGQFAFLFFALQGGLSAGVAAMLLQLQLLFTLLLGALLFGERIRTSQIIAL
LFVLTGLALLLHPGLTGLPLSRGVILLALGAALCLALGNLIQRLRIRDNIQGSLPALIAW
AALAPIIPFFLAAWLFNGAQATLTSLRTLDFSALLALIYLAYIATHLAYAIWGRLLLRNR
ATHLMPFTLLIPLVALGADLLTYGDRLSPAQLYSLLLILLGLALAVLGNRLVDFRLVRH
>fig|498217.4.peg.2646 Multiple antibiotic resistance (MarC)-related proteins
METWLIHFLLTYVTFLSMFCPPATITAATILLGQTPPHTLRQLAWKVALEYVAVMLVAIW
IGNYLLMALGLNAHALTATGGAALLFQGWPLMTKGTKAEPARMVVTPDARPNVQDMVLVP
LLFPLTIGGGTIAVGISLASHDGSLAGLLQLSAVILLMAPTIALTFLAVGPLHGRLSSGA
IDAMARIAGIVLVTLSLQLLASGLTQLVLQYGLAK
>fig|498761.3.peg.128 Vancomycin B-type resistance protein VanW
MNLIARRAALCAAMVAGALTLQGLQSATLTGTEACAPADSTAQAQPQWQPQPAVKTPKAG
TITFLIGKERFTFVPGQGADYLEPGKWSYLPTLDLETARQTAVLFADALPKDLRLRDGGL
DRITSAILEGEDATVAVPSWVIAAEIVIPLTYVSYNGGRNASTALDYLDGYVLKANETFS
FNEVVGPRSAERGFITGMSLIDNRFVQEQGGGICFASTIVHQAVSRTDVEIVEQNHHSRP
VAYVPRGGDATVYYGELDYRFRNGDALLAFEKLQRPNGLGLRLWKSMH
>fig|498761.3.peg.191 Membrane component of multidrug resistance system
MTSRENGHPGVLVVTMVVVIGTFMAVLDTSILNVALPKLMVLFSVDTKEIQWILTAYMLV
SGAVIPIMSYLGDTYGYRSLYAYCLAAFTAGSLLCGLAWNNESLIVFRVIQALGGGLIQP
ASMALMFRFVPKEKMGMAMGLFGLSIAVAPSIGPSLGGFIVEDFSWRWLFMINVPLGVLG
FVLCQTLLPETEKIPSAHFDFWGLLLSSGSAFLYLLALDKGQDWGWSSYTVVMLLLTATA
MAALLVVVELNHTHPMLDLRLFKIPQFTYSVVISSCLYIILISGVLLWPIYLQNIRGYSA
VQTGLILMPQAIAMGLMMPVAGKLYDKIGARPIVMVGLPLIGVSTYLMHTLTVDTPQSVF
NLWLILRGLGLGLTFMPVNTAGVSAVPLMKAGAASTLNNLVRAVAGSFGIAITTSMLENR
QAFHAHRLVEGLDLFSPSWTMMQQSADGILGATGDRSPLQPTTLTLMYGQIQLHSNTWAM
ADVFFVFALLVILVIPMALLLKKRGGKLGGPPVVAE
>fig|498761.3.peg.857 Permease of the drug/metabolite transporter (DMT) superfamily
MFRVNLWANLAMLVTVLFWGISFISIKIAVTEVPPVTLALLRFVIASAILWGALRLSEPG
AKLEKADRLRMLLAGALGVTFYFYFENSGVKLTTAANASLITSIVPVLSIMLDIVIYKTR
VSVIQWMAIAASLVGTYLSVTANGQMDLSSDTFVGNLLVLGAMLCWAGYTLMSKSLARYS
GLALTTYQTLLGTLLLVPLSLLEREQWEFFSLTAFYHTLFLALCCSALCYFLYMYALQRL
DVTITTLYLNVVPVVGVLCGYLLLDERVLPVQIAGGAMVILSIFLVNWEKGRSQTESAVA
EVQHGLGEQQKA
>fig|498761.3.peg.1279 Permease of the drug/metabolite transporter (DMT) superfamily
MQQQRTSRVSPLTADLILLSVAAVWGGTFVAVKEAIAFMPPYTFLAIRFFIAGLFLAAIA
GRRWQRLTGAAVRHSFMLGACLFGGYALQTIGLQYTTSSHAGFITGMSVVLVPLVGWLVH
KQAPRSGVLAGVAMAVTGLGLLTLTDDLTVNPGDLLVLGCAFCFGLHIFLVGQVTHRHDP
MLLSIMQIIAVGIACTAFSCFFDPPLAYDQFRSEVWTALALTAIPATSLAFLAQMYFQKF
TTATRTALIFATEPVFALLFGIALAGETLTLRGAFGGILVMAGIVVAEMVGAGESEEVEQ
DAACDGVDGRAA
>fig|498761.3.peg.1770 Permease of the drug/metabolite transporter (DMT) superfamily
MWLFIAVISAVVFGLAGFGMKVGQMQGVPSSMVLIGLYLSGTLGFLLTWLGGGAAAGMLI
LLAGLVIGLGSAGGNFAFMRALETGPASLASPIVNMNVVLVILLSVLVYGETLGWVKAAG
VFCIVVAIILIGLRPGGAGGAGGSLRWLALVLLSTLLFAVRNGGLKVTQEMGLDNSAVLF
FSYLFPLIYFIFRHREELSAITPKKRLSTLGWGLASGVGSFGGLQLYAYALSQGPASVIS
PVFSLYGLVIVLLSVWIYKERLTALQSLAVALTFAGLVLVRF
>fig|499177.3.peg.1090 Vancomycin B-type resistance protein VanW
MKKVGIILVISFILIATSAAMYLNSLTQDNFIYPGISINGVDVSGLTVTQAKEVLQDRAK
VGKVSFTHNEKKWNYDLKELGFEYDYDSSIDEAFKIGRSDNILENWITVLKLNNNKQINL
ELSRTDKYENFDEIFSKIKSEVDRQAVDADISINTAISITPEQDGYEVDIDKLKNLLITE
LKDKNEDIIIEVPVKVTQASVKREQLSSINGIIGEFTTTFNAKVAGRSTNIRLASSKVDS
VLLMPGQEFSFNNATGKITLAAGYKNAPVIVKGELQEGVGGGVCQVSTTLYNSVLYAGLD
VVQRRAHSIPSSYVSIGRDAAVAYGSLDFVFRNSHDYPVYIKAFVSGNKVTARIYGDTTK
HKNKTLSSQVVEQIPRQVKYVNDPTLPLGKEVIDDPGRDGIKSVTYENVDGQTKVVSRDH
YPAKTKVIKVGTGPAEAPAVNLNPEAINESVNTQNQENTIIDSIFGGR
>fig|499177.3.peg.1606 Permease of the drug/metabolite transporter (DMT) superfamily
MNKSKAIGLILLIITVVMWGISFISIKISMDVFPPLSLAFYRFVIASIILFPIMKYAAPK
EKLLKKDIPLMATAGIIGITIYFFFENNGILRISASAASVIIAFMPVVAAFGEIFFLKKI
PKLTALFAVALSILGVYLVIGGDLSSGGSLLGYLYMLGAAISFSIYLIITKPLFDTYSDV
TVSFYQSLFGCLAFIPFLGFEKVNWSQLNPEISMHFIFLAVFCSGIATYFYMFALNNLGV
TISAVFMNLIPVVTFIVSYFWYEEIPSSIQLLGAAIVIISVSIVTLSEKNKEINN
>fig|499177.3.peg.1863 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNQDLESKKIPALLFQLSLPAITSMLISAVYNIVDRIFVEKISPLALSGVGITMPIQILQ
MAFVLLIGIGSSTLISIKLGEKKPHEAEVILHQAYKYIMIAMAIFSVIIIVFMNPILNIL
KVSSDVYPYAKDYIFIMVIGSIFGLPGFCLNNSLRAIGKASVSMKIVVSSALLNIILDPL
FIFTFNMGIKGAALATVISQTYVTVLVFWLFAKSKNFPINLKFAMPVEKSFFKEIIENGA
PSFYMQIFATFVNIIFNRSVVEYGNDLYLAAMTIVQAIYSFYHMVVVGIIQGAQPINGYN
FGAKRYDRVRETLILTLGSSFIISISIFAIIQFYPSLLSGIFTSDKELLKLTNYSMKLYL
FMLPLIGLHTVSSQYFQAVSKPKKASILSLLRYGMILIPLLFILPRFWGIQGVFISNVIS
DFIASSVAIFFISKELYYLKSNL
>fig|499177.3.peg.1994 Glyoxalase/bleomycin resistance protein/dioxygenase
MTYNRLIPEITVTSIKESLSFYCDVLGFEKTYEGEDKDFSFISFYGSQLLLQENSNEAWK
KYELEYPFGRGVNFSIETDDIDKLVSNLEKANISLLCPLEERWYKKDDMEHGEKHFIVMD
PDGYILRFMQDLGQKTI
>fig|499177.3.peg.2445 Quinolone resistance protein
MNTKKDIVKVAKPKLMRFMEEINSEAIDIEDEYEMNNISFSDCEIRTKTADKLKVDGVIF
SKMDFKDIFLKSLELTDVRFENCDLSNADFSGAVIHRAEFINCKLMGLNLNEASLNHLTI
NQCNCKFILMNYVKMKNIIISDCIFESSYIQESKLDKVEFRNCNFKQSQLSGTSLSGVDL
SDSEFEGAGFRAEDLKGAIVSATQAVDFSKIFGLKVKG
>fig|499177.3.peg.2518 Permease of the drug/metabolite transporter (DMT) superfamily
MHLNNLSTEELKKRRLYSNLALFLVAFLWGTTFAVSKYAFAYFTPVYMIAFRFTIGVLAM
CIFFWKKISKITLKDLKGGIIVGIIFFIAFVTQLIALQYTEAGKQAFLAATYVVMAPFLY
WIIYHKKPDFRTLAGAFICFLGIGLLTLNASLSISFGDGLTLFSSLFYALHIMFNGYFVE
KQDPVILSTVQFAVVAIISWIFAFFFEPFPTAIGFEGIASVLYLGIFCTGLAYFLQTAAQ
RYTLATHAAIILSLESVFGILLAVVMLGEIFTLRMLMGCIAIFGAILITELRPSSD
>fig|500635.8.peg.777 Permease of the drug/metabolite transporter (DMT) superfamily
MTITAMRYYLIGTTLLALSVYRGEHLLPPRDCVLGLILMGATGIGLNNVMQFTGLAISTV
TNCTLIAAASPAITAFMAVIFVRERLSLLAWGGIVLSFLGALLVISHGSLAVIETTSFNE
GDILFLLAQVAWTTYSLIALKIMRRMSALQTTGWAGLFGAFIVTGYGLATGQFAPIMLTP
SLWVAFLYTVIFGGIMAMLFWNIGVHNAGASVTSIFQNITPVVGMIGGVLCFGEIIGIEE
LLGAAAIFAGVYLTTHSGLR
>fig|500635.8.peg.783 Permease of the drug/metabolite transporter (DMT) superfamily
MAKALCLIYLIWGMNWVVMKTANTFFPPITFVAYRFLFGALVLLSVWFWLHLPLPKKKYW
PWIFLTGILQMGLNNIAAQTSMLTLGAGMVSVLNYSMPVFAAVMAHFLLGERLTWRKGAG
IVLAIAGMAVLMDVHAGGDATAICIGLLSAVFWGLASIFVKLKLSDVNPISLTTWQMVCA
SLSLLVYTAIVPQGEVVWNAESVLCLIYNGVLASALAFFLWSWILQHIEVSKASVAVLAV
PVVGVVGGILCLGEPMTLHIFFGMIMIMAGIYIVVTHKRQPA
>fig|500635.8.peg.1167 Acriflavin resistance protein
MNMTRLSIKRPVGISMIVAFFVVLGLYSYYRIGVELLPALNTPYVTVSVKYPGASAESVE
QEVVKPVEDALASVSGVKKITSTASYERARVTLELDFSTDADTAAIDASKKVEAIANKLP
DEADSPVVIKRDMNAKPVVELAVLSNHSLADTYTATDNVFTEVLQQAGGVSEVELHGGRD
KEVAIDVDREKMAAYKLTLAKIASAIKNENQLVPSGSVFTETTKSDVRVVAQFQKPSDIE
KIQVQNTAGKMIPLTAVAQVREREARTVRYGRLNGEDAINVLIYKNSDANVVETADNIMK
SVEKLRKTYPDYQFVVVSNDADYVRDSLHSTMNTLIEGLITTGFVLFLFLRGWRSTAAVM
IAIPTSLISTFFVMYLAGFTFNMMSLMGMTLCVGILVDDSIVVLENIVRHLKMGEAPDTA
AEKGRTEIGMAAIAITLCDAAVFMPIAFMQGMTGQYFRQFGLTIVFAGLFSLFVSFTLTP
MLASRFFRKGYHPGTNRAFAFMDRVEERAQRLYVEILNWSLRHTKKLLVSILAVFVAVVA
LVPLGFVGMEYMPQTDESSFTINIQAPVGSSPEETNRVAERIEGKLAELPEVKYYMTQAG
GSTAYEGRIKVQLVDRRERSRTVWQVANDVRKFAATIKTADVRVSETQTNVAGIAGGGRA
KNGGGALQIELRSNDGAALDDAAEKAMNTLRAIDGVTDVNSSYVEGMPELRLTVDRQKLK
AYGTSLQDVDTAFASAISGLSAGELKSDPNNGGQDTDIKVRFKDADSYKASDAARVPLSA
SGKLIYLGDVATIQNGRGPVTIRRVDKQRSVAIGANLSGRPMGAVTSDVKKAFATADLGP
NVTYQFKGQATRMNETFSELLSALFLALVLIYMLLAVLYESTITPFIRMFSLPLGLIGSI
LLLFITHNTLNLFSMIGILVMDGIVAKNGTLLIDYTLTLMDRGHSALEAVIEAGRVRLKP
IFMTTITMMVGMTPMALAMTPGSESRVSMAWVIIGGLLTSTVFTLIVIPIIFLFFANHKK
KKKPSRGET
>fig|500635.8.peg.1421 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSSPAKHMQYKQKARRFFSVLLPIFVTQVALTATGFFDTVMSGHVSEQDLAGVAVGSNLF
MPFFGSFLGIISVLTPTIAQLHGAGRQERIGFVVRQGFYWSLGLAGAFLLLGILFVPTIL
EFLALEPKVERVAAGYLAAIAFGIVPIFLAGVLRNLIDAHGYTRLTMVITLVTVPINVIA
NYIFMYGTLGIPAFGGIGAGIGSAIAFSLNLLFNAIVVVTVEPFRSYHIFRSLPRPDLAE
WKRSLSLGIPIGSTMFCEQSIFSAVGLFMTVYGTTVVAAHQAAMNFTTLVYMIPLSASMT
LTILVGFEIGARRSEEAAAYIRLGRLLTFVFEGSLAILLVQFRETIAALYTSSPDVQELL
VVFLVFAVFLQLADSIDAPLQGALRGYKDVHVTFLLAVISYWVIGLPAGWLIANYTSVGP
YGYWCGLIIGIAFGAIFLSLRLRAVQKRYQGA
>fig|500635.8.peg.1554 Permease of the drug/metabolite transporter (DMT) superfamily
MLLLAAFIWGTTFVAQMVGMDGLGPFTYAAARYLLGFLFLVGLWYAWRGQREGAKRAGTY
RAGWKAGLGAGCIMLVATSLQQVAMLYTTAGKTAFITALYIILVPLGAVLLGKRIHLENW
IGALLALAGLYFLSIRGAVSLSFGDGLVFISALFWTGHILFIDRFASLVDPIELSVTQIG
VCAAGSLIAALGFETVAVQPILDAWFAIFYGGVMSAGVAFTLQILGQKYAEPGQAAIIMS
FEAVFGALSSWLLLGEHMSAVQVLGCALMLSGMIVTQVRPLLEDRRHAS
>fig|500635.8.peg.1650 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MHFGKHLQIDMLHGPIIGPMILFALPLAMTGVLQQLFNTADVLVLGQFVSTEALAAVGNN
SPIIGLLVNLFMGVSLGANVVIARFIGAHDLKETIRAVHTSFLLALIFGVLVAVIGELMA
RPMLEALSVPTSVMPLAETYLRIYFLGMPAIGLYNFESAIYRSRGNTWMPLQALAAASGL
NVVLDLLAVLVFDWGVAGVAATTALSNYLSAWILYRGLCHEHGIIRLEPGAIRLERSYAK
EILRIGLPAGIQGMVFSLSNLVIQAAINSLGAVVMAASTAAFTIEINIYVLLIAFGQAVT
TFVSQNYGAGNLPRCRRVTQLGLLVTMVVTVVLSALACIFADPLLALFNDNPAVIDVGRI
RIYYIIGFYFLCVFIEILSGAMRGYGHSLPPALLMLVTVCGVRITWIYTAFVAEPTFATI
MISYPLSWAATVILLVFIYLFYRRHITARKVLI
>fig|500635.8.peg.1942 Fosmidomycin resistance protein
MDYTAIAGLMFASSFLSSVIQPLFGYLADKGSRQWFMAVGVFFAGTSLAITGFVSDYWLI
FAAVTVMGIATSIFHPEAARCVNGVSQGARGKGMSIFSVGGNGGFGFGPLLAVFLVTTFG
MHGLAFYGITAACMSLLLLLAIPHLRRAIEANASAAAEAASAKQTSSSPAAMNDWHAFGR
LFFVILFRSTVFTGISSFLPLFCIQVLGSSEAIGSMTLSIISIAGVAATLFGGWFADRHG
YRRTLRLGSVLLVPFLAIAVFSHSIYAVYAMLLPMSVAMLAPYSSFVVLGQEYLAKNIGF
ASGVTLGISMSIGGIIAPALGHYADTYGLTAVMGLLVLIAAICAGATFLLPAKKQTS
>fig|500635.8.peg.2066 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQRTTTKHSPLARRFRLGSLLRFAAPSIGMMIIISLYTVTDGIFIGRYAGSDALAASNIV
YPAINVVFGLAIMLASGGSALVAKNLGENKPQLARQHFTMITVTTAVLATVLATLTIAAG
DSLLTLLGASPELMADCRSYLYSLLPFFPFAALMILFNAFFIADGRPMQGFIVSVLAGLT
NASLDYLFLAHLGLGIFGAGLATGIADLIAGVIGLVYFYRFSHLIRFAKPRLEWRALGQA
FYNGSSELVTQLSVGITTFLFNILTFRYAGADGVAAISVILYAEMLLTAVYMGFTNGVAP
IFSYRFGARDFGELRRLVRLSLTVIAGGALISFSLSHLLAEPLVSLFLPQGGHVYELTRQ
GFALFSFTFLLCGFNLFISGFFTAISDGRTSALMSFARNLLGIVFFLLTLPRMLGLSGVW
LAVPAADVTALLFGLFLLVSRMREFKNMDAAQKGIRLTDINGRNA
>fig|501479.3.peg.272 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDLDASIAWYREALGFELLSSYGWPGVRAAFIGRGDIRIELFQNEEAAPMTDDRRKPET
NLRIGGIGHLALAVADLDAAMADLRDRQVEIVAPPREVPDGSGSRFAFIHDNEGMLLELF
QPG
>fig|501479.3.peg.2059 Glyoxalase/bleomycin resistance protein/dioxygenase
MSYKPDGYTDLAAYLLVTDPEDVLRFCETVFGAERLRVMQDGERIMHAECRIGDTVLMMG
GVEEGNPTMLHLYLDDPDAAFARALEAGAEELQPMRDGRDGDRRGGFRTPCGTQWYVSRQ
IGD
>fig|501479.3.peg.5005 Probable multidrug resistance protein
MTGTAATDTPIREGVKWTIVLAVVLTAVLEVLDSTIVNVALPQIQAAFGITNDQTVWILT
SYIVASVVVMPLTGFFVRMVGRRRLIISAITGFAAFSALCGLSWSVEVMVACRLGQGIFG
AFLIPLSQSILFDSFPKEKRGQAMAFFGLGVVVAPVLGPTIGALLTEYFSWRAVFYVNLP
IAGFALAMMSGELKSEDTKMLKVDWSGLALMVGAIASLQLMLDLGESRDWFASHLIQIAA
ITLVCCGMAFVLRGIGRADNIIDFSLFRDRSFAGANVAILGFGVAMFGSIAILPLFVQGL
LGYPVLDAGMLFIPRGIAAGFSMVLTGSVLVTRFDPRKLLVLGLVLTGTGNVLLGMLNLN
AGFWDLALPGIVSGLGMGLFFVPMSTLAFQNIGPEKQDEASGIYGVTRSLGSSVGIALVG
WQVASRMQFHYAMLASGISPFDEAARAYLAPLGLTPTSAEGAAQIAGLIQQQASLLAFQD
AFWLTGVAAFLMLPVVLILQRPTAGADPAKAH
>fig|504472.7.peg.382 Multidrug resistance protein B
MIQRTVHLYQQAYRGLSPSVWLLAGVMLINRCGTMVLPFMTLYLTQHLHYSVERAGVVMA
IYGLGAFVGTFLGGRLTDRFGFYYIQLFSLLFGGVALLGLQFVTDFYMLCGSVFMFTLLG
DAFRPANQAAIAYYSEVGNRTRAFSLNRLAINLGWAVGGGLGGWIAGISYNLLFWTDGLT
CLAAGIVLWFCLPVPARIPAPNANPDDLHSVTIGTKSPYRDGLFVAFVICSCLYLITFMQ
LFSIVPLFFKEVMRMSEGTIGSLMALNGLIIVCLEMALVYSIEQKKRAKTSLIVAGVLLT
TLSYLLLASTSKIALPAMTIALIFIVFGTFSEMLAIPFIQSFTVERASPATRGQYLALAG
MSGALAQTLSPAIGSQVVAHFGFSIHWLVIAGISLLSASGFWWLGRKLATKPLPEADALV
>fig|504472.7.peg.495 Drug resistance transporter, EmrB/QacA subfamily
MSAPPISAGTSSPNKWIILGTVMFGTFMSTLDSSIVNIALPTIRRELNAGDSVEWIVLCY
LLTTTSTLLIMGKLSDWIGRRQMYITGFFVFVLGSLLCGLAWSLWSLVGFRVVQGLGAAM
IYSIGPAIISDAFSSKERGQAMGLMGSVVAAGSSAGPVIGGLLLGKFGWSSIFFVNVPIG
LLAIWRAWTILPESPKVTGQRFDLVGAGLFLVGVTTLLTAIEFGPEPRYGWDNPLVIGLL
SVGSILLVSFLFWEMRVKEPMLRLSLFRIRPFTMAILAAFCGFLASGGNLFVIPFFLQQL
LKLNPERAGLVLLAGPLTLSVVAPLGGYLSSRVSTRWLSSFGLLITATGYFAFSFLDTSW
DWKDVVWRSSLVSLGFGLFQSPNSSSALNAAPLDQRGIASSMIAFMRNLGFVVGIALAAA
VWYSTRNRFALANGVTPEATDAQLLGMHYAYLVMASLVLTGAIISFSRGKYQELGARS
>fig|504472.7.peg.615 Permease of the drug/metabolite transporter (DMT) superfamily
MNKSIQSWSILFFCNLIWAFHFTSIKLTQAQVGPYFTVWAPMLLATIFLGPFVIRDFRKG
GKKLTDSLIFVQLAALGAFPSQVLMTWGTQYSLASNAAILVMTLPVITAVFAFLILKEKM
NAARWISFAIAIIGVALCSTDDIKRVDLSSRYALGNALIFLAILGNAYYNVGCKKVSGQY
TEMEMVFYTYLVMSILLTPLVLYYEPEMFARVPFFTTNTWIGMISLTLFHNFLSMLLFFK
ALKNLDATQVALSNYLITFMGLPIAAIWLGETLNQQAIIGGLLVLASTLILSIVDTKVQQ
KKVANQNQEPAKL
>fig|504472.7.peg.2819 Acriflavin resistance protein
MKFVETIIKRPSLIIVLFAILTIGGLFSYRLLSYELLPEFSTPVITITTIYPGAAPSEVE
TEISKKIEDAVSGLDNLDDVKSNSFENASVLVVQFKAGTDIDLALQDAQREIDKMVSDLP
DDAEQPSLSKISPSDQPIMQLLATSTLPNEVFYQQVEDKYLPVLQQIKGVADIAMVGGDK
REIRINVDDDKLNYYGLSLLQVSQAINQANLDFPTGKVKSTSENMTLRLAGKFSSLDDIR
KLVIATPANGSPIRISDVANVTDGLTEATSISRFNGQDGIGLFIKKQSDANAVEISRIVQ
EKLAQIEKENTKDKVHFAIAYDSSVFTLASVEAVTHDLLLAVGLVAIVMLLFLHSFRNAF
IVMISVPASLISAFLFMFVMGYSLNLMTLLALSLVIGILVDDSIVVLENIQRHLEMGKDR
WRATLDGVSEIGFAAVAITLVIVVVFVPITFVNSVIADLLRQFSLTVAFATMVSLVVSFT
LTPWLTSKMARLEHLNPKNPFQAFLLWFEKGLTALTSVYHRSLGWVLTHKLAFTGILVAI
FVFTGWVMNLGIIGSEFVAQGDQGKFLLTMKLDKSASLQQNNLMARNIENYLRKKPEVET
IFANVGGASTGMNSTGQGETNRTELTVQLADASERPGHKLTEQYMIDVRQELEKQFPAIE
FNSSVVGMVNSGSAPIEIFLSGNNVSQNLAAAEELANRIRRTPGANDVNVSVESGNPEVR
VDIDREKMAKLGLTIQTVGGTLQNAFAGNDDSKFRDGGEDYDIRVMLDAFDRKNPDDVKN
INFFSPSTNRPVRLAEFANVTLSNGPSLLERKNRRSSVTVTANTLGTGSGTLTSVIQADL
AKNPLPAGVTVSWGGDAKNQSEGFGSLGIAMLAGLMLVYFIMVLLYDSFVYPFVVLFSVP
VAVIGALLALALTSSNIGIFAMLGMLMLIGLVVKNAILIVDFANQQKEQGVPFRQAILHA
GEERLRPILMTTIAMVIGMIPIATASGAGAEWKNSLAWVLIGGLSSSMLLTIYLVPMMYY
VVDRIGEKWTVFRSKKQIDQPVQAEPIQTEPIH
>fig|504472.7.peg.5208 Tetracycline resistance protein
MTVGTALMLGVQLAGSPAIGRWSDLRGRRPAAIATTVVSLLSSLFLLPVQTWGYVASRWV
KGGSNGLYSVMRSAVADLTDKDELLKYGGLFSFIAGSAPVIGPMGAGWLMLVVHEARINP
LPTVLLLLALGLLNIRLAMLFRETNPKKEAVDYTELADKARNSLKVVSIWRQLLEADKQL
PGIKSILILNLLATLGMGYFAFFVAFLTQSELIMTPAETARFFLYYGGLALAANFIFFTY
IVQHVNKRIAILVMALISIVLQVVYTFSESSVELFYVVAGVDALTVSIITGLTGGILSQV
IKEGSGQGEMFGNIQALGGLASFATALVNSLLSGVSLKAPFIFCAISMIAVVIWTIRLPK
AARQHTDSKTPAT
>fig|504728.4.peg.32 Drug exporter-1 ABC transporter (DrugE1) family, ATP-binding protein
MAFAVAIAHDPPFVLLDEPTLGLDIDAAEVLEAQILGMAKAGKGILLTTHQLEVAERLCT
RVAILSGGRIVVDKAKEELLEMFDLQSYRVTFKEPVGLPELPFQHTLDESGRVLEVILDY
PEQLYELMRRLHPRPLRSIEKREVELAEIFRSYTARKESHSA
>fig|504728.4.peg.467 Daunorubicin resistance transmembrane protein
MVMALPAYATAAFVSGAWSAGEWRLGWFFLSLVVGFACAYFFEFLMSLSAFYTSAQQGIN
EAKALVVALLSGAFFPIDLLPDRYALLASLLPFQAFIYLPARMLQPSMPESEIFRGLAVQ
LFWLLVLAASSRFLLGRVRQRFNVQGG
>fig|504728.4.peg.1514 Glyoxalase/bleomycin resistance protein/dioxygenase
MFELRPHHVGLSVPDLEASRRWYSEMLGFEPEKELFIEQIPARVAFLRRGAFRLELFEVV
GAQALPEERRQPHTDLRTHGTKHLAFAVPDVDQAVEALRARGVRVLLHQRIGGEPMAFIC
DNAGILLELVQAASFGE
>fig|504728.4.peg.1730 Drug exporter-1 ABC transporter (DrugE1) family, ATP-binding protein
MNAVLEATGLRKRFGSLVAVDGVSLHLAAGEVLAFLGPNGAGKTTTIKMLAGLLWPDGGQ
VQLLGQSPHQNPWALRHLGAVLEGNRNVYWRMTALENLVYFGVARGLRYQAAQRRARALL
EQLELGAKSHTEVRHLSRGMQQKLSLAVALMHDPELLLLDEPTLGLDVESALRVEGMVRE
LAQTGKAILLTTHQLEVAQRLASRIAIIQQGRIVLEGRTPELLGRFAGEHYLIETETPLS
PAQLGHLRSLGLEGEGPPYVYQGDSDGLWRLLEALKPTPLKKVARAEADLLEVFLKVVGR
A
>fig|504728.4.peg.2431 Multidrug resistance protein-related protein
MNALDKLPWQRQDLPKFIVMLSTLGLLEFTRSAFFWVYMPFSSKELGLSLSLVGLAWVVH
SLTEALSRGIGGFLVQRIGFGAVGVLSGLVGLLALSGTILNPNGWFLLVSMLLWGVSISG
LQPGYLSFSSRIAVPGREGRAIAYAQFLVIPWIGLGWVLGTFFIRNLPESTSLLLFAALG
LVTLLGLASLGVREPLPKQSLNIRQLMQVLIIVPTAFAQLFLQNLFNLVILKFTLTHLKL
TEWQLYLAMGLAAAVVFLGAGILGRLPDRKGVWLPLISSLGALAAIFLLIAQQPSYPYFL
LLCLLGGIAFATFVPSWNALLVRLLPTENRAAIWGSLMVVEGLGAATGPAVGGFLWDWLG
PRGPFWGGAAVCGLLIAFYGFVYWRLRRGLSVEAS
>fig|504832.4.peg.1787 Glyoxalase/bleomycin resistance protein/dioxygenase
MFCHVMVGSNDLQAAKKFYDAVFTAAGGAAGEIDAKGRVAYSKDGARFLVTKPIDGKPAS
SANGGTIGLLMKDPAVVDAWHAAGVANGGTSIEDPPGVRVSGGKKVYLAYLRDPDGNKLC
ARAPFPG
>fig|504832.4.peg.2238 Multiple antibiotic resistance (MarC)-related proteins
MLVDFTLNALVTLFVVVDPIGIAPAFLSLTHGLPAATRRNVGYRAAAIAALILIGTALGG
NWLLTRLGIGLPAFRISGGVLLFFIAFEMVLGIRPTREARQAEQAIEEHVRNIAAFPLAI
PLIAGPGAITATLLLAGQGGGSAVSLAALVAIIIVIAAACAVAFLFAGSVARFLGVTGNI
VLSRLLGVVLAALAVQFVIDGGRAAFG
>fig|511051.3.peg.223 Daunorubicin resistance ATP-binding protein drrA
MDKAIVVENLKRVYKKGKDSFFALDGISFEVHYGEIFGFLGPNGAGKTTTIKILSTLLYP
TSGKAFVGGFDVEKEVQKIREIINLVSGGESAGYGILTVKESLWMFSQFYGIPTNEASKR
IEHYLKLVGMWDSKDTLLNRLSTGMMQKVNLVRGLITDPKILFLDEPTIGLDVEAARTIR
SIVSEWVKEKPTRTVLLTTHYMAEADELCDRIAIINKGRIVALDTPENLKKAISDEIFFE
IETSIVPKETSQILTNDLKEFGINCLIKDHIERGVSTLSVILKEEKDIAKVIQKIVEVNK
EILSLRKIEPTLEDVFIKLVGKRLEDEETN
>fig|511051.3.peg.595 Permease of the drug/metabolite transporter (DMT) superfamily
MEKKTGLWVNVSLFLLFLVWANSYTFIKIAERQLEPVSLVLARFFIIFPFLFLFKDFYTG
LKKIQSIADFLKILFVGLLIVPSYHIFLNTAETMINASVAALVAGFSPVITGILSSIILK
EKLEKKRIVGLIISLVGVITLTYGISHKFEVKNSLGVLLSLSSVTSWALATVTSKSLYKK
FKPIEVNTLGLFFGTLALIPFAKAMFVQQIFTMNTQTLIAVLYLGVLCILIGYAVWFKAL
EYKEASTTATFIYLNPIIGSLSGVIFLKEPMNFVMILGGVTIILGLFFVNPLKMEKK
>fig|511051.3.peg.685 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRKVSREEILSGNPVKIMFQLGLPIMISQILFTFYNMADTFWLGHLPSAESGSAVAGLQV
AFPIVWFLISFTLGFGFAGVALVSQYTGANDHKNANHAASQVLSFLTIAGILVAIFGYFV
MPIIAHLITNVANVSATAIKYMKVYVIGIPFLFVSAAFQNILSAKGDNVTPMQISLVTNV
MNIILDPFLIFGWWIFPRLTVVGAAVATVITEGVAAIIAVYFLFKGTKGIKVSLSDLKIE
LSWFLRIFKIGFPAAVGNSGTSLGFVVLTALIGRLPNAEIALSAYGIGDRAIHIIFVVVE
GIGAAIVTMIGQNLGAGLIERAEKISKEGIKLEFVITLIESAFIFVIRNAIYKVFIPGNM
AVIQEGSKFLTIFILGLPFFGLFSAVSGVFRGSGHNVEPMIGDLLRLWGLRLPLSYLLSR
FWGSSGIWWGMTLSNIIAAVVLYVFYTFGKWKVPIIKKEEIFIEESAIITGSE
>fig|511051.3.peg.1065 Permease of the drug/metabolite transporter (DMT) superfamily
MKRRKIFSILLLIFATLIWGSTFTLVKSTLRFINEFQLLFLRFGFASVVALFVVLRHRKF
LKNPKLLLLLIILGISLFVAYAFQTIGLKYTTPTKSAFITGLYIVFTPIFSTIYLKEKPR
NFEIVALVLSFVGLLFLSQIDLRSLNSVNFGDILTLLCAISFAFQIVLTEKLVKDLPSLL
VTSIQMIVSFALSFPFAFLNQHFNLNRFVMFSTLFLGVVASFFAIQTESFALKYIDSTEA
SLIFILEPVFAYLFSFFILGERLNFGGIVGATLILTSMVIIAIYNKE
>fig|511062.4.peg.596 Drug/metabolite transporter superfamily permease
MPYLVFVTLLWAFSFSLIGVYLAGAVDSYFSVLTRIALAALLFAPLLRWRQPPRLAAGLM
LCGALQLGIMYLFYYQSFLLLTVPEVLIFTVLTPVYVTLVYDLLHRRFNPGYLFTAVLAV
LGALVIRFDALTDDYLLGFAVVQGANLCFALGQVGYKVLLERYPSTEPQHKRFGYFYLGA
LLVVTPAWLGLGGEQYPATPLQWGILLWLGLGASGLGYFLWNKGATLVNAGALAIMNNAL
VPAGLLVNLLIWNRDADLPRLALGGAILLASLWLNEAWIKVSRPAPSE
>fig|511062.4.peg.715 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTTSSNPMVHTPVPRLFFQFAGHALVSLLAITSASVIDGLFVGNLVGADALAAVTLLVPW
LTLLFALGLVLAIGGSVRAGHLLGQQQRQAAGRLFGAAVLAAALAVALAGLVITLWPELL
YRALNVPATLRPLVAEYLGVMKLALVVQIATMVAYYFVRADGHTGLATRALIAGALSNIA
LNALLVGGLKLGLAGAAWATLLAQLVQAGLMARYLRRPGAMRLRFRGWPWQDLRAALANG
LSEGINEVSVGVMIWLVNWLMMRAQGADGVAAFSIVNYLIFIGVMTCYGIVDGVHPLVSH
NLGAGQAQRARQVVKLAAITLAGLGLAMSTLLLLAGHRIPALFLGSGETAAMAQATTLIA
IIWPLFLFNGFNMLIAVTFTALQRPLPSAIIAFSRSLVLPAGLMLWLAWAFPSQPFLLAL
PLAEALTLVLALGLAAQARSQSQINQRCRP
>fig|511062.4.peg.1899 Acriflavin resistance protein
MNDLGHKGWVAWFAANPVAANLLMLLILVAGVMSALNLRVEAFPPVPPNSVSISVSYDSG
SARSAEEGITLKLEEALQGIQGIKKISSISNTEGSSITVERSSGYDLDTLYRDIKNRIDG
ISTLPAEAERPVITKATYLEDAVSVHLAGDVPQDVLQETARQLRTLLLNNPAIERVNTNG
RETPEISIEVDEHRLQALNLTISDIAEKVAASSLTVAGGELFSREGSMIVKADQQLYRLR
DFEAIVIRQTRDGQRLTLGDVATVRDSYEPSGVLSRFNGERAIWLDIKMYSSSNIMAISE
AVQKEIDSFSGSLPQGITAKIWNDQSLYIGARLNLLLKNSVMGIALVMLLLALFLDIRVA
FWVGAGLPVIFAGAMLLMDARLFNMTLNEMTTFGFIIALGIVVDDAVVVGESIYSERQRY
GASLNSTIRGAQRVTTPTVFGVLTTIVAFLALALVEGEMGKIFSFFAYAAAFCLIFSLVE
SKLILPAHLAHLKMDSGAARNPVSCGWQWLQTQVSRGLTYFTRNIYRPFVHQVLNFRYVA
LMLAISLFIIVGGMVPSGQIRAVFFPDIPSDFIEVQLELDPQAGYGLVQKQAIEIEQTAA
RLNQRLQDEYQLSQPPIPNLMTLSGDSSASVIAGLSPRDQRPFGTQEIADLWQQEVGALE
AVRKLKFVTTWEGAADISIELAAESPQTLQQAATKVQEALALYSGVSGIENSMKTGQAQI
DLQLRPAGEAMGITTALLARQIQQAYQGYEVQRIQRGRDEMKVKVHYPQDQRQQLDDLQR
ARIRTPDGRTVALSTVADISTRYVADEIKRTDRSRVAVVTANVNKAIAAPAEIIASIDAQ
LLTQLQRDYPGLTIRFGGEAQEEAETTNSLKGAFLVALIAIYALLAIPLKSYLQPLMIMS
AIPFGVIGALLGHWLHDIPLSLLSLFGILALSGVVVNDSLLLISRYNENRLQGKPTRLAM
VEAGCSRMRAIVLTSITTYAGLIPLIWETAENAQFLIPAAVAMGYGILFATLITLILIPA
LVLISEDLTIRQWRKKRRKHSTTSKTTMETMS
>fig|511062.4.peg.1904 Small multidrug resistance protein
MAAIAAEVIGVFTMKIVSDSASVPALLFMYTMIGLSFYFLALAVKHMPIAKAYATWEALG
LISITFIGVQFFNESLNFIKLLGLTVLITGVVLTTLGAPSAEANNRQER
>fig|511062.4.peg.2639 Multidrug resistance protein D
MPGLSLVLLTVLMVATGQMTQTLYVPAMGDMADALQVSHQALPLVMAFYLVPYGLFQFVY
GPLSDRHGRRPVLLVGLSVYALGSALILLVPVYSMLLLGSFIQGAGTAAAGSLCRSLMRD
RFEGTELVRYNGYVSMGIMLAPVLAPLAGGWLNLHYGWQSMYGFLLATGLVILLVMVVWF
RETLPRERRHVQPMLPAYQHVLHHGGFRRQLGMLIATFAGLILYEAVFSVLAARHQLTSA
EISLLFVLPLPLYFGGAMVASCKSAQWSVRRMQWLASLSLLAGAGLVLAGGFAPGLELAG
LVAGGGLYFAGAGLLFPVATSAAVAPFPQHSGTAGALLGGCANLGGGLFLLGQGALPQMS
QPVLGGLLLACAGLVVWFLLPAEAALPEPGV
>fig|511062.4.peg.3198 EmrB/QacA family drug resistance transporter
MSETIQDRQSRQAHRVFAGVALAIMLGALEITLLMPAISRLGQIFDSPALAPLLVSSYLF
AMTLTMPVYGRLSDRFGRTPCLAAALGFFTLGSLASALTDSLPLLLATRLLTGLGGGGLI
ALSFAVIADVIPPRQVGRYQGLISTLFAVSSVAGPLLGAFMVARFDWRWLFLFKLPLGLL
AMAVSYWALKGLGHKGAHSTPDHWGIGLLLLAGTGWGLSTNTAELLPALAPFQPALLAGA
ALLSLVLLIQQWRHPHPVLPLRLLGGRLMAIAVLLLALSEGVRLGLLVYLPLALEQQQGL
SPDDTSRVLLWFILSVTVGTFVSGKRISHAGYCRPFPWSGGLLLGLGCVVLWGLFSQRLN
GVWLHGGLIAGGIGIGFLIVACSIAVQNALPSNQLGAGLALMNFCRSLGGTLGVIWLGWQ
YQQQLTDWATPVYASLSAYGLICLLLGFAMPDRELGNQAKNQPG
>fig|511680.4.peg.955 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKAKDLTTGKPISLMIKYAIPVLIGNLVQQIYNFADTIIVGQCLGNSTLAAVGNTGSMF
FLVNGFVIGITSGFSVHIAQCFGAKDYDRMRNSVCNAIMLWSGITLFITLLSVLITKPVL
RLINTPDGIFDMSYNYIVIIFAGIAAPMLYNAVSCILRALGDSKTPLYFLIFSALLNIGL
DLLFIVVFNWGVAGAAIATVLAQLVAGIACIVYISVKFPVLHIKKEDFKINPGIIKTHLT
IGLPMAFQFSVTAIGTIILQGAVNVFGENYIAAFTASSKTEQLIMQFGISGGVTVANFVG
QNVGAGRYDRIKNGILKWSLFTVGSAVLCMGVIFIFGRPISRLFIKGGDELILSYAMTYL
HISMFFYIPLFQIFIFRNALQAMGKTTMPLLAGFFELGARSIVAYTLPKAIGFSGVCFAG
PVAWVCAAVPLIITYIIYMKKFKKKGYFNTQFS
>fig|511680.4.peg.1147 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNGIDFGKDGIWKILFKLAPPVMAAQLIQALYNMVDSIFVGRYSEAGLTALSIIYPIQL
LMIAVAVGTGVGINTLMAHYLGMGKVKEKDETAGTATLLALVMWAVFATVSFFLMPKYAG
MSTKSPEIIKEVVTYGRIVSVLSIGLFLESAWTKVLQSEGNMKLPMIAQIAGAVINIILD
YLLIFGIGFFPALGIAGAAVATVTGQIAAAVIVMTKGFRKSPPLSVYKKYVKKIYYLGFP
NILMQSAYTFYIFGLNMILKGFSDQAVTTLGLYYKWQSFFFIPLGAMQTCIVPVISYNYG
AGMYDRCKKTLKDAVIFGWTLMIIGILCFEIIPGPMLRVFSRDAKVIEIGVNAFHIIGMS
FILLVTSLTFPVYFQAIGQSVKSSLLTVLRTVVLFVPLGWLFSKLGLKYFWCTFPVTEFI
TTAAGLIMLKRFRGNYE
>fig|515619.6.peg.2461 Multidrug resistance ABC transporter ATP-binding and permease protein
MNDKKYSLRPYLLAYKWHYAIGIFVLLAVDLANLYIPQFIGEIIDGITAGKLDMAGVGGI
IFKILITGLIIMAGRFGWRYFIIGASRGIEYRLRDDMFSHMETLSARYYNSHKTGDLMAY
FTNDLQAVRMGTGMAVITVFDAVIMTVMVLVKMVVYVDFKLTLFAFIPLIFIAIGCYFYG
IESKKRQVKRQDAFSYLSDKVQESIAGIRVVKAFAQEEEDFKQFEKACENSREKNLAVVK
LRAVFGPTLDAVIGISVIVTLLAGGRMVLDGQVSIGQFVAFNSYIDMLVWPMIAAGDCIN
TFSQAAAAWGRIQTIFEEKPDIVDMVPPENVIENDGMAGRNADNLAEGIYDKIQIHGDIQ
LSHLTFAYPDGTKPVLSDVSIHVKQGEMLGILGRTGSGKSSLADLLLRVYDCENGMILLD
GRPITDYPLAVLHRDISYVPQENFLFSDTLEENIAFGLEDRIADNPAILDAVKQAAKDAC
IHDNIMGFPDEYKTMVGERGVTLSGGQKQRSSIARALLKDSAILILDDSLSAVDTDTEEQ
ILENLMETRQGKTTIVIAHRISTLQKADHVAVLSDGKLTEYGTPEELLELGGFYADISHK
QQLESELGS
>fig|515619.6.peg.2615 Vancomycin B-type resistance protein VanW
MKINKKALLLGTMAFVLVAASGMVSAYASGSSGTKKAKVQTITEGVCIGSVDVGGMTKEE
AKKAVDAYVDSIKDTSFSLKGANGSFDATAQEMSVSADSDAAVDEALSVCHEGSLIDRFV
ESEELKKGNVAVKMYLSVDKQKTANMIYDKSDELNIKAVDNSLQRNGDSFDFVPGQEGKE
VDVVKSVYAINDFLQNSWDGSANEIELVTNTVQPRGSKEELSKIKDNLGGFSTDFSSSAA
GRATNVKNACSLINGSVIYPGEQFSVYEAISPITTDNGYQIAGAYENGQVVDSVGGGVCQ
VATTLYNAVIRAELEIVQRYNHSMIVSYVKPSDDAAIAGTYKDLKFKNNLDNPVYIEGYC
SGGIITFNVYGVETRPANREISFRSETLSEEDPVTQFNFDAGQPVGYFNTEQSAHKGVTA
RLWKTVTVDGTVQSDEVFNNSKYKSSPKIVTVGTAGASAEVVAQLQAAAAANDEGSVKSI
AASAAAAAQAAQAQATQTQDPNAAAQTQSAQTQTTDPNAAGQTQGAQTQLTDQNAAGQAQ
GAQTQ
>fig|515620.4.peg.1263 Multidrug resistance protein, MATE family
MENANTMDNAKMTNGPITRILLSFAGPVLLGQLLQQLYNIADAAIVGQFLSSKALAAVGA
TSSLTYIVCYFCIGSCIGISVPVSQAFGAGKNDDLRKYFVNGVYFALAIAVIMTAVTASM
SGLFLTWLKTPENIFKDAHVYLVIIFLGLPLTVLYNFCFGILMAFGDSKKSTMFMAVSTV
INIFLDLFLVVVVKWGVAGAAVATIFSQGIAGVLSAVYIFKKYKLLFPVNADERKFHPYY
MKNIIKMCMPMGLQYSITAIGAIILQFYVNALGEDAIAGFTSGYKIKNLILCPLNALGTA
LSSFIGQNFGAKRFDRISEGFKRTLEIGLIYSVITMVVCFFTGKYMALIFVDAADTVVVG
YTVKFIKYISVFNAELALLFTARYSVQGMGYGKYSILSGLAEMAGRAAVAVLLIPHFGFD
AVCWNEGLTFLAGIAVILPIYIKLFCHLRKSMI
>fig|515620.4.peg.2417 Permease of the drug/metabolite transporter (DMT) superfamily
MNNIKGSLILLLTAFIWGTAFVAQTSGAGAVGTFTFNAARSIVGALFLAVVIVIKNVLDK
RNNSGKVINTENESHLQTWPLGAGIICGIVLFAAMTFQQYGISVYPQGVAASGRSGFITA
TYVVMVSVVSVFMGKKMHWITGVSVAGCVAGMYLLCMSGGVSGIYLGDVLVFLGAICFTT
HILVIDKFSSADSMKMSCIQFMVIAIISTFAMIFTENVTFAGIKVALIPILYAGVLSGGI
AYTLQMVGQKYAQPSVASIVMSLESVFAVLAGWIVLGELLKPKEIMGCVLVFTAVILAQI
PGMKKGDTK
>fig|515622.3.peg.253 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEQKRNSYLVSSSMKKFLTASIAAMLIQNVNAIVDGILMGRFLGTEAFSAVNLCLPVVGL
LTTIAMLFYTGANVLASVALGAREEKRANSIYTVSMTSVGILSVVVTITAILGVNLVTAV
ICREEALREYTRDYLLVYFAGTAVIMLVSALLGFGNVGGKPKLVTRASLTNVITNIVCDV
LYVKILGMGIKGAALATITGALLSAIIVIADWKIKGSPFKFCRVGSETGPILKEIVHYGV
SVTSQTFAIVIYSYVCAILAQIYCGVYGAFVGSLLAQATSLGQGVSGGMGKAFNAIGGML
KGQKDDAGVLMLYKKGMKVAVLVAVVFVAVFMILARPYAMLMGAEDEELLRYSVRSLRMA
LPFIIPVSFVWIIPNIYALGGQLSILPIISISQPVLTGLGLIACGSIIGNDFMWIGYPIS
AVLIFLLVVCLSESVRKKASENLGFISLLPVPENKPNVYDISVPCDKDGLVDTLRELNTF
FDGQDIDKKLGMRVRLCIEEMVSNIVEFGGRKKNQFLDLKIVVDEQEISAIIKDDGKQFD
PITAEKKGSGLKILNGLCPDLDYKYSYGQNMLFMNWVK
>fig|515622.3.peg.650 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTNIEQTTQNMTSGNSMKQIILFFLPLLWGNLFQQLYSLVDSIIVGKGISDQALAAVGAT
GTLNFLILGFVVGMTRGFGITFAQSFGKNDMAMLNAYIRAAKKLSIMFGMAFTVVCVSLL
NKMLTFLNTPEDIFDDSYRYFAVILLGIVVTVMNNLEITILQSMGDSRTPLTAMICSSLV
NIMLDIIFIMAFGTGVVGAAVATVVSQFVSYLLCLKKLRTIDFMSLGKDTSEIADEKNIL
VELMKIGLPVALMNSVTAAGAMVLQYFVNLMGSAYVAAYSACMKFASLFEQFGMSVGLSM
MTFVGQNKGAGKYDRIRTGVRQGLMLSTLVNVPISLLMIFVPGSLARMLLTDNMIIGYCT
DFMPIMGISFFALGWLFVYRYSVQGLGNTFIPMLSGGLEVIMRLIFGFLVGRNGFKGIAI
SEVSAWIGAFLMLMVTYYCLIGKRTKAIA
>fig|515622.3.peg.720 Permease of the drug/metabolite transporter (DMT) superfamily
MLAGVMTIIFGSLVSRQVLTPKIESLKYIGALALCQTIGQYFFFFMSLANTSGVRGSIIN
ASGNFLAPIFAIFLFRLEKFEVKKLLGCFIGFFGIFLFLGGSSVLAGGKMTMAGEGAMLM
AALFYAISGCSIKIFSKFENPVVLSGYQFTLGGIVLLGIGLLMGGSLSFTSMGCYLNLIY
MGFISAGAYTLWGVLLKYNPVSKVSVLGFVNPIMGVLLSALFLGEESQAFSIVSVISLIL
VSAGIIVVNAKRN
>fig|515622.3.peg.1065 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MANPMADKYAKDMTQGDPTRLILAFMLPMMMGNIFQQFYNIVDTIIAGRFIDAKALAAVG
STGHVTNLFFALGNGLATGIGIVVSQFFGAGNMKGVKKVITNALVIVTATSVFVGLIGFV
FSRPVLTYVMKTPEDILENAVAYMSITCIGFFGTALYNTISYIMRGIGDSKTPLYFLIIS
SFLNVAMDLVFVIAFGMGVSGLAIATITAQILSAVCSITYAFFKNPVFKIDKSDWKMDPH
IIIKCYKIGGSMALQSGLVALSFVILQRVINSFDSVVVAAFTTTSKIESLVNMQFKALQD
SLSTFTGQNIGAKQGKRVRKGFQNGMKMMILYAVVMIIVMGLFGDVLVKIFIDSSETDII
AYGSKAMRILSYFYLPLGMIYVCRGTLNGAGDAKFPAISGASEMIGRIIFPALLCSLPFI
GAWGLWISTGITWTIVGVTAFIRFNMKDWRGGLDI
>fig|515622.3.peg.1671 Multidrug resistance protein B
MSETKVNYMTNEKKWYVPVIVFFSAFLMYVISALPIFIGRGLPFFYYGDYNVQQIPFYIA
AHRAVENGDFFWNWNIDLGGTMAGDFAFYLWGSPFFWITMLFDESMIPYLMPFLMALKYA
CAATCAYLYIRRYVHKYSYAMVGGYLYAFSGFNACNIVFNHFTDSVAFFPLYLLTFENLM
AVDDQEEARYRYSGSKFVAFALMTAFMATVNYYFFFGQVVFLLIYFVVRYARNNKLLSTF
VMFNKALFGGVLGIMIAAFFLLQAYAGIKGNTRLDNYINGYNMLIYPSEKLLWDIVKSVS
MLPDIIGKGTLFYTGTVKNASLAAYIPMFGMSGVIAYFLLNRKKKNWEKTMLIICFVTAF
MPVLNAAFSMFNSAYYARWYYMPILIMCLMTAQVVERGKSPQLKKGAVAAVLMFLFFLGV
YFLPSKNDDGEMVMFNMTENKTIFLRDVLGTAILCLMLLVIAFVIPKNFRKTSENGNERR
FVTGIRDQIILWAVVVSCIISTFIPLKNGSGIISDRGKTMWQTQMLFNKVEVDQSDFCRG
EVDSTSTNYDMVWGIPSIHCFLSTVPSEIFDFLYGSCGITRTVETNLPVERSGARAILSG
KYYFENAEISKNRVFHNGEGTDGYFYLKNENGFDVFENLNFIPMGFTFDYYITESEWEDL
EAKEHDLDLTRVLILPDDVADEYGDKLIMTEMTAEEISENPISYLEFTDECTKRAQTSCT
EFTTDTYGFTARTAMLKDNTLVFFSVPFTEGFSCTVDGVDTPIIKADYGLMAIPVSGGSH
EIRVTYTPEGFRSGLALSIAGILLLAGYILVLKNIKKND
>fig|515622.3.peg.2399 Multidrug resistance ABC transporter ATP-binding and permease protein
MGKFDKLKKYWNKRDDAKEYLKWCLSYSKPYIPQLLLLMLFDLAATLMSVGMAIIGKKMI
DRASEGNLSDLWKIIAIYVVVILGSQFLGIVSSLFSVIVYEKFGFGIRKKVYRRILDTCW
IDVSKYHTGDLMTRLTSDVGAVSDGISSTIPTIIRLVVELLVTFCTLAYYDLKLALFALL
VAPIALFASVVLGRKLKYLTVKVQETESKYRSFMQESLANILIEKSFCLEDYSEERLTQL
RDERIYWVFKKNRTNMFASAAMGLSFQLGYIVAFAWGAICIANRTITYGTMTVFLQLVNR
IQAPIVSLAQLVPRLISMLASAGRIIELQNLPREEYSGASIKQKNIGVKVDKISFGYTDE
LVFDDASIDFKPGEFTAIVGKSGIGKTTLVRLIMAFTNKMKGNIEFYNDAGETMQASPDA
RNFIAYVPQGNTLFSGSIKDNVLMGKKDATDEEVIEALKGAAAYDFVMDFPRGIDTVIGE
KGVGISEGQAQRIAIARALVKKAPFLILDEATSSLDESTELSVLEGIRKWNPSPTCLLIT
HRRSVLQYCDREIQIVDKKMASIAG
>fig|515622.3.peg.2483 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKKTTTKNNNIIEGSIWKSMLAYFAALLLGAFFQQFYNTVDAIIVGKAVGSDALAAVGG
SAAMVVNLFVGFFMGLSSGATVVIAQFYGAGRRDEVKKAVHTAIAMSIAGGALITLIGLF
IAPWIINAMKTPTEVIEASTIYLRIYFLGMIANLVYNMGAGILRAIGDSKRPLYVLIISC
FVNIFLDVLFVIWMGLGKMGINQGVMGVAVATVICQIISAVIIVAMLMMTGDSYKLILRE
IRIDAEMLSRIVRIGFPAGIQTTMYTLSNILIQASINEFGKDATAAWAAYGKIDVLFWMT
IGSLGTAVTTFAGQNYGAGKYDRVRSSTRQAFIIAACITIPLSTVLYLWGEGFLYIFVNE
SQVIQIGIQMIKFLAPFYCLYIGVEIFSGVLRGMGSALIPMLLTLSGICLLRVVWIMVVF
PLNRTIVTVETSYPITWGVTSFLFLIYYTYYVRKNKIKGDADSVK
>fig|515622.3.peg.2571 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MAEKVISFVIPCYRSEKTLGSVIDEIDRTMATRDDYSHNIILVNDGSPDNTWEAICQEVK
KASDGHILGINFAKNFGQHAALMAGLGRANGDYVVCLDDDGQTPADEVFKLIDALENGAD
VAYARYEHKQHNVFRNFGTFMNESMATIMLGKPKDLYVSSYFAARRFIVDEMVKYESSYP
YVIGLVLRTTKNIVNVDVHHRKREVGQSGYTFSKLLGLWINGFTAFSIKPLRIATFTGCS
FAALGFIYGIYTIIKKFVRPDVPVGFSALMSAVIFIGGMLMLMLGMIGEYLGRVYISQNK
NPQYVIRETTEDGKK
>fig|515622.3.peg.2872 Vancomycin B-type resistance protein VanW
MKKFLGGVLLFIGVLLLLPGIRTKAADGRTIANGVYIGDIDVSGMTVSDATAAVHSYFDK
MAGAEITLDAGEGRSLQVSGEDLGISWKNPQIIEDAYSLGHKGNVIQRYKALKDLEKEGH
RFDIEYGFNDEHLQEIVGDRCSSFNQDKVNYTLKKTADGFTVTEGQTGYVVDVDQSIAAI
KNFVTSGWNGDNGAVSLSIKEDAPLGSAEDLSKVRDVLGTFTTSYKTSGSSRSANVANGC
SLINGTTLYPGEEFNVLDTITPFTEANGYYPAGSYLNGIVVESIGGGICQVSTTLYNAVL
LAELEVTERHNHSMIVNYVSPSADAAIAESGGKNFRFVNNTEYPIYIEGYTSSDKHITFT
IYGVETRDPGRKVAFKSEVLETTPASEDQYVTDGSQGIGYVGTQSAHIGYKAQLRKIVTE
NGSEVSNEVINSSTYKMVPRIITVGTAGADATALAQLQTAIATRDVGTVKAVAGALKAAR
DAAGTENAEAAAQAAAAAVDAANAQIQQQAVAEDMESITTNG
>fig|515622.3.peg.3003 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSRTSTMDMTQGSIRKELILFAIPLLAGNVFQQLYNTIDSIIVGQVVGPDGLGAVTSVAP
AINTLVGFFMGFSAGSSVVISHYFGAKNTEGLRRAVHTSIICTFILGLVLMVVGFFLTPP
LLVFMSTPETVMPLATQYLQIYFLGIVGLMMYNIGSAILRAVGDSVRPLIFLIITSILNI
FLDLFFVINLHMGVAGAAYATIISQFISAILTIAVLFTSKECYNLRLKEFAIDKSILSQI
ITIGMPAGIQSAVISFSNLFVQSYINRFGESSTAGWGAYGRIDAFVMLPMQSIALTATTF
VGQNAGAGNVDRIKKGIREALFLAAICTIALVIPEFLAAPKIVSMFNSDPEVVRYGTLFI
RMNCFFDILCCSNQTHAGVLRGVGDAKAPMFIMLSSFVVFRQIYLFIASHLTSSIYPISI
AYPMGWLVCSIIMLIYFKMSNWELKVDASYRNHAMN
>fig|515622.3.peg.3067 Permease of the drug/metabolite transporter (DMT) superfamily
MKQNTKIYTLTHTLMLLVASFFWGTTFVAQSLGAEYVGAGTYLALRTYIGIIFLLPFVLY
RDKKEVNNLGLGLQELQDKRSREKQAFIKGGMLAGLFIFLASFAQQYGIAYTSVAKAGFL
TTLYVVFVPIISLFFGRRFDNKLWISIALSVLGMYLLCMKGSFYLEIGDALMILSALGFS
IQILAVSRYSKRIDPVKLTLAQFIIEAILATIVMFVIEKPDLSSIYSALPAILYAGIFSS
GIAYTLQALGQKNLNPAIASIAMCLESVFGTLSGWIVLGQQLSLREAAGCILMFAAIVLT
QFLGNS
>fig|517417.4.peg.1834 Fusaric acid resistance protein conserved region
MVAGFTLALIVLEGWGHQEQIDALVVARIDCIFIGIVVTTAINISFTPRNGMKNLNRSIR
NAVLASLKLVSLTLQSSEHAKAERGRHNLLFMLADIEKKLDSAGAGTLALKRRRFHIENL
IVDLLSLLETSVLLEQQLNPNDEKSIMIRQTIAERLDAVTSRLEGSWRPVGTDKEFARLV
AEVGAKLPVLASPLLSLSASLDLLLDQRKKSKLPNVPVTAPEPRLRERNWQEAARASLRA
VIAVGITGTIWQLTGWREGPVMMMATAIMVSIFSTHDHPSVLLSHIFGGALVGVLLAFVV
RLLLIPGQSSAFTQGLLTLPVLLGGMIAKNRRKTALGAMDTMMFFLFVMQPGLPVVASRI
QFVAGGVAGLAGIVLALLSFRYVVPVNPALRLRTLLISIAKDLLLMTETNSPQILERGLN
RTRYRVLRMLDNASLMNRDMSDVVDGSLAALAIGSFLKRMQEERAHTPLSEKRSLAMREF
GAKLSSSGMNSEAIISLLKDSSFHFSRLDQIASN
>fig|517418.3.peg.1058 Drug resistance transporter, EmrB/QacA family
MESTTKQRLLTAGILLVMFLAAMDNMITSTIMPSVISSVGGLSLYPWIGTVFMLTTTITT
PLYGKLSDLYGHKRFVLIAIGIFMLGSMLCGMAQTMEQLILFRGIQGIGGGGLVTMSFIV
FGILFSPEKRAKMQSALSSVWAVASVVGPAVGAFFVETLTWRWAFYVNLPIGLLSAWTII
MFLKVPKEQHTDHRIDYGGAALFASGGILLLFGLLETSQGMSEWINYAALGLGILLLIWL
VFHERNEPEPIIPIALFSNKNFLAPVLLGFIAGSTLFSISNLTPLFIQGALGESAGISGR
VVTGISFGWVTGSLICGRLLNKTGFRTISIFGALFMLVGLFLMKDISLASAWWHLFIYNI
ILGFGMGLIATTTLVAVQSAVSKRTIGAATSTNQLFRSVGGTIGLSVLGGLQLGHFQQSL
TKTFSTNAGEDLQKLVHQPHLILDPANRAILPADALEKVSQALSDSVQEVFLIAFVVSFL
VLIWSWQMPKETPEMLAATVEAETKKSTKNPYSASENTAEISISSAE
>fig|517418.3.peg.1174 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MFPFALREKKIGEIHRIGKKNLLRLIGAIGFGGIAGPVLLLLGLQKASASSVSLWLNLEL
VATALLGVLFFKDHLGRYGWIGVIGTVAASLILTWHEGNIGLLALVLIGAACIAWGLDNH
LTALIDGITPTQSTFWKGLVGRTTNFAFGLLFEPNSIQGNSLFLALVVGVFAYGISITLY
ITAAQNIGATRSQMIFGSAPFWGVILSFVFLGEQISHFQIVAIVLLIASLITLFLEQHSH
PHTHEAITHKHLHHHDEHHNHPHVENPSSYHSHWHTHEKITHSHPH
>fig|517418.3.peg.1901 Permeases of the drug/metabolite transporter (DMT) superfamily
MWFALSLLSAVSKSASQILTKKLHALGTLELAAYSHIFSAVLILPLFFFVEIPLTGAFLY
PTACSTVMNVVAILLLIQAIKISDLSYSIPFLSLTPVFVILVAFVFRGEVMSPLSASGIF
LIVLGAFVIDARSLPDLARFGGARIFKDKGVLLVLSVALIYSVSSVCDKSATLASSPLAY
VWLFTLARAAIFGLLLFLSRLKHGAKKSPAFERRNLLVLIFIGLIYFLEASFQMQAFEYG
NVAEIIGVKRVSILFTSLSGFMIFKESFTRYKLIGAMLLVLGAVVIYVFR
>fig|517418.3.peg.2143 5-nitroimidazole antibiotic resistance protein
MNTALEGFPHAAMRRKDREIVDRLEIDAIIHSATVMHLAMSDNDVPFLVPLFYAYDGQAI
FFHSAHAGTKMEILKRNNKVCFEISVDHGVIESEQACDFEARHRTVIGFGSASFIEDEAE
KTSALDLIVARFSDKKFDYPKAAVNRTAVIKIEIESIKGKRHGF
>fig|517418.3.peg.3159 Acriflavin resistance protein
MMSMFLIVFALFGSMAYFGMPLDLFPVVNIPYITVKTTYAGAGPKEIETQITKKIEDAVS
SVSEIDQMISYSMEGVSLVMIKFELAKDPDIANQEVKDKVDAIVNNLPDDADIPIVQKYN
VNEKPILEVVLSGPLTQTELYELADKRLKDRFAQIPGVAQVNLSGGQEREVQVILDDRTV
FQNTIDLNTLSQILSAQNIDIPAGNFKRGNQEYTVRLSGEFEDPKEIADLEVPTSFGMKR
IKDIAEVKDTGEEVRQRVSYFNNIEKAGSPDAVLLSLVKNSEGNSVEIAKDVKKVLPEMQ
ASLPAGTQLEIVTDKSVFVESSVEDTLVNILLGIVLTSIVLLFFLHDLRSTTIVAISMPM
SILSAFMIMQASGFSLNMMSLMGLSTAVGVLVTNSVVVLENIFRHKEMGNGRVEAASKGT
NEVVVAVVASALTNIAVFLPIAQMTSIVGQFFREFALTVTYATIFSLIISFTLTPMLASL
LLPEEDKKKHPIGEALEKMFHFWETLYKRSLEAILQSKWRAVGVIATAIILFILSLPLAG
KIGFEFVPLTDEGDIDIELELPEGTNLEKTAELLSSVEARLREIPEVKHLLMNLGRINDY
NVGTNLVLIKLKLVSVHERSESSEAFTSKIIQMLSDFPDIRLRVRAVSSIGGSEQAPILF
YLMGQDNDLVNKYKDEILAKISDVPGLVNLNSSSRSGKPEINLTPDRKKLSDAGLTIYDL
AMNVRGAVNGLVSTQYKEQGEEYDIRLMLDDAAVDSPEKIANITLSTSMGSLRLSQLCDI
EFKEGYSKIMHKDKFKAVEFSASSAPGVPMGNVVSEINAKIAEIDLPSGYKITWGGDAEM
MQDTAVDMLRTFIIAIILTYMLLAAILESFTQPLIILGTVPLAMIGVFGSMYITGKSMNI
ISMLSIVMLLGIVVNNAILMLSYTNELREKGMSIYDALIEACPTKLKPILMSTIAIILGM
LPMAMGFGDAGREIRQPMGIVAIGGLVVSTFLTLFVIPAIYDLTSREKKAQS
>fig|518766.5.peg.517 Acriflavin resistance protein
MAILSWATALLLAGLWVGRQIPIEWVPRVELAEVHVAAYWPGAAPRQVEQYVTAPIERAV
QRVPGTVHVESLSEEGRATIILQVAPDVPLGPYVAQVREELARLRNVLPDRVVPQLTRAV
PEQLREQQGFLTLQLVGPLEPEALRRLADELVAPRLRSVPGVAFVRVAGGRERELLITLD
PDRLEAYGLAPVRVQQQLIDALRDRSYGRWQTGRNSWLLFTPPETDLDAIRNLVLHQAGP
DAAPFRLRDVARIRLGPAPARSISRVDGQPVVTLSIDRKPGSHLLTVAEAVHATVERLRA
ELPEGVRLLVVLDRSEDVRKQLRDLMVRGGLGFALLVLVLLALLQSVRACVAVLFSVGVA
VAVALLLFRPLGLTLNLITLAGMALVAGLLVDNSVVVVEQLLVQRQRLRVRGLQGLALDA
EATRRALQTVWLPLLGGTLTTMVVALPLVYLSGELRTLFLPFGVLVAFTLGASLLSAVLI
VPVLGRFLPTPPPVPVRQRRRLRRLIALPYWLAARWPRLTLLVLFLAVGIPLWMLPDTWK
LPDEDEQEVVEDTAWQLAKERLARLYNATLGHDRVQEVRRLVEPLLGGVLLPFFQKTTFG
RRWHFEVRPEVYVYMAFPPGTPIGRADTLMRRFEAVALASPSVARTVAQITEQVAYLRVR
FTEASLRTIEPYLVRERLIQQAVQLAGLRYLSVSGLLEQGYYSGSGVNISEFRIAAYGPS
YEDLEALCERLAQRLKAATPRVAAVNYNVDRYGRPDAREVLQFRWTPEAQLRTGLTAGDL
AAALRPVFNTRFPFFRAPVADEPYLPVRIEVAGAEQIDVARLITQPLPVTDSVQVQLAAL
APPEIVPTPSAIERFDQQYRRYISVDFRGPWRLGDRVIRQVVESMPLPPGYRLQYPTYAI
FGERELKRTAGWMLPITIALVFLIAAMVFESWRLPLVMLLSLPMAALGVAVGFLWSGANF
AEGAFIGLVLLAGVAVNDSLLLLDRYRQLQAQRPHGRPDLLIRLAVRERLRPMWTTTLSS
IVALLPLLLFPDEEGFWLGLAVTVIGGLLAATLLAPLATVALISRRRG
>fig|518766.5.peg.518 Acriflavin resistance protein
MRALVGWCLRRPVAVTAWSLLALGLAAIAYVRLPVALLPELRYPALAVWTAYPDVPPERV
ERAVTERVEAAVAGVEGVVEVTGRSLLGGSLVVLRFGWNTDLNLALLNVREQLDQLGDAL
PDEAERPVVLRLDPSDRPIMLLALRQALPRDTLRRVAAGESFQDLVALKRLARDVVARRL
EQLEGVARVRVTGGYEPEVEVRLDPERLIRYGLTVAQIEQRLRAANATLPGGLIRRGPFR
YAVEVSGAFTEPADVAETIVGYAGRTPLRLADVAEVRPGVAERRGLVRFDGEEALLLLVE
RAADANTVVAARQVRRTLRELEAEVPGVRLDVVVDESLFIRQAIAGVQQAVLLGGVLALV
VLLVFLRRPRVLLAVAVAVPLSLALTLIAFEVADITLNLLSLSGLALGVGMLVDNAIVVT
ENIARLREQGYAPLDAAREGTVEVAAAITASTLTTIAVFGPLAFVEGLAGRLFRDQALAV
VFSLLASLVVALTVVPVLASRDRRSGRLEPFGTRWLLVHYEALLRRALRRRGLVVLLTLL
ALAGAALIAWHLPRQVMPHADLKRLTVHLSAPPGTDLPQLSRWAAQIETAALRLPAVQHV
LADLGERDEARLDLDPRPPYEGTLTVLLDERARSETVAGQLRRMPMPPALTVEVLLERTQ
LEALLARGEADLWLDLQADLRAEAEAAADQVLPQLRREPALVNVRRAFAEEVPGYALHFR
RDVMARFGVDARQLADWLAAAARGLEATALQTVNETIPIRLRLPEAQALQRLLQTEIPTA
QGLKPIGLFVEARPVSLPASLLRAGQAPVVRLLADVAPGADLAAARDALARALEVLPPGV
RGTIGGATDAFREGLRGAAWSLLLSLLLVFLILAAQFESLRQPLIILFTVPLATIGVVLT
LTLTGQSVNLMSLTGLVVLVGIVVNDAIIKVDFINRRRAEGMPLLEAIEAAGRDRLRPIL
MTTVTTVLGLLPLALGLGAGAALQQPLAITIIGGLTSATLLTLIVVPVLYVLVAGSERRT
L
>fig|518766.5.peg.2614 Drug resistance transporter EmrB/QacA subfamily
MNLLASPERRYTLAGVLLALFLGALDQTIVATALPRIVADLQGLDRYAWIVTIYLLTFTV
ATPIYGKLADLYSRKAIELAAIGIFLGGSFLCGLAGEFGPLPLLGDGMNQLIVFRALQGL
GGGGLFSLAFIIIADLFPPAERGRYQGFVGAVFALASVLGPFIGGVLTDHGDVLVPGIEG
WRWVFYVNLPFGLLALGFIWSKMPTLQPPATHRALDWNSTLLFSGALAALVLALQLDKQA
HPWDAPETIGLFVLAALLLVLFVRQARRSPSPILDLELFRGRVFTTSVLALLFMGAAFLN
IVLFAPLFLINVAGVSATVAGLSMVPFSLGVATGSTVSGQLVSRFGHYRRFMLGGELLVL
VAVGLLTTLTPETPPGLVALYLALCGLGLGPTMPLFPLAIQNAVDVRRLGQATSAAMLAR
QIGGVVGTAVMGTVLAISLAAYVPQEATAQLGFREGQRGGLEAVQARFDSLAVQIETALE
SHDDGRLARTLQAAPLPPTVKARLQEAARHEVSTEALQALVHREIDRARQQVVQQLRRAF
AEAIGRIYRYVLALVVAGLIATWFVPELPLRRSYD
>fig|518766.5.peg.2743 Permease of the drug/metabolite transporter (DMT) superfamily
MSQSRLKYELALLFDVLVWGINFPILKVALAAMHPFVVNLFRFIFSLLVLGALHAWTHRR
DRTPFFEPLRTHGRAILLLGLLGYVIYQLAFIEGVNLTTSGSAALIMASAPLWTAVISQL
RGYDRLNLLGWIGLLVSLLGTAVVVLYGPRALDFSEDALLGNLLMTGAAVAWGAYTALSQ
PFVHRMDPASLTFFSLLLAYPILALLGLLHIDAVVWADVDATIWAALIFSGALSTGLTVA
FWNHAIRHVGPSHTAAFGNLVPVVALVAGYLMLGEPITPAQLLGGAGIIGGLLLMRRARR
MPLPS
>fig|519441.6.peg.354 Permease of the drug/metabolite transporter (DMT) superfamily
MKNLKSELILFVVAIIWGTGFIATKIAVDSGMETYNILFVRFLISTILLYIMLKIKKIKI
EKSAYVSGFILGSILVLAYMMQTFGLYYTTPAKNSILTGLCVIFVPYISHLIYKVRVDRY
TFIASILAFIGIYMLSGNFLESIEGFNKGDFYTVICAVLFAFHIVVTGYYVNKINTVALA
YTQFLIATLLSLILATYYGHLKVISTFGILSSLYMGVFCTFVAYTLQIVGQKRVNSSTAA
VILSLEVVFATILSIILGYDKFHIIILFGSLLIFLGIIISETKLDFIFKK
>fig|519441.6.peg.427 Daunorubicin resistance transmembrane protein
MKVISIYSRNSLKRSLVYKWDIWISVLSGIFNILGMLFLWSVVYKNSGKSSIGGYNFNSI
VLYTLMSNLTAMIINVDIARIISNEVKSGEITNSFIRPVSYITKLVGEGIGHILFNLIML
FSPIISILIIYMNIFNIKSEITLGSILFYTVSLLFSIIINFEISILVGFCSFYVNYIWGF
ILLENAILTIVTGQLFPLNFYPDKVVKFLEITPFYYINFGPVSILLNKFSKYNSIRILLI
QSVWCIILAIFVSIIYNKAKTRLQINGS
>fig|519441.6.peg.643 Permease of the drug/metabolite transporter (DMT) superfamily
MNLSWLFIILGAMMWGIDGVLLTPRYFQYGLYNVLLIVFIAHLLPFLFMLITQRGSIKEI
KKMNFYDKSYFLLIALFGGTIGTLSIVKALQLSEFNPYSLVILIQKSQPIFAILSAYFIL
KEKITHKFKIVFVISLISLYFLTFGLNSPFEIELKSIYSAIYSLIAAISFGLSTTFSRKV
AIKYNANLSTFIRFMFTAIITFILLLLNIGQSKSDIIYVVKNNHIMLLALFIAIWNLIAS
NLYYKGLQKTKAIYSTVSELSFPLTSVFIDMFILGNVLDPIRILAGSVLLLSIVYLNLNN
E
>fig|519441.6.peg.1099 Tetracycline resistance protein tetA(P)
MVIITFILIYKFSSLYILALAWFIYGFYEATISGTLDAQIINDIKNEDETLLNKFIKTSQ
QIMFIGMMMGSVLGSFLYFKIGFKIYLLGALFIAFSFFIILLFFKNNQKSLNENVKIKIH
LFQVINELKVNENLRIYIFLCLVSQIYFQTHFQLWQALFLTKGIKQENLYIYYILFQLIG
FISYYFPIEKAKNNMRYIYFSFSVLIIIPLIILSNNKYLVIVIYLLICSIFTILDYFIIY
NFSKIVSKENISSLISLKSTSSRIASLIMLILFSFILKFVSLQYLIISNFTIVFAILLIS
IFKFHNKLFNENMQLIFGEVKNALLLFFNFRHLNILQYLEILKKM
>fig|519441.6.peg.1147 Transporter, drug/metabolite exporter family
MKKLGIIMAFIAAFLWGVSGSLAEYIFSNSNFNVNTYTFLRMFLTGIILVGYGVYTKGTK
GLNKILFSKKYLKKIIVYGIFGIALLQYSFAQTINNSNAAFATLMQYITPTIVLVYLSYV
TKTLPSIKKSILVSVALYGMFLMITSGSLNNLNVSPISLIYGLIAAFTFAFYILYISKFK
KIDNTIVIGCGMIIGSLIFIPFIDYSNFRELLKLDIFITFLSNVVLGNAIPFYLFLESTK
YIHPATTSLLGAVEPIVAIIIGIIFLGTHLTLIQLIGAILLIGSITIISIFED
>fig|519441.6.peg.1504 Daunorubicin resistance transmembrane protein
MDKYIELIKIGGKKILSYKGLITTLIIKNYIYIFLQYSLWLSIKENSSINIDIKNILVYF
IIIRSVNSVNFNLSQYMSYDVKNGNIVGILTKPITVEKYYFFDILGNTIAKVLAILIPNI
LIALFLIGKFNIFFIFKLIIIIIGSYVLNFVIELILGTFSFFTQSIWGIESLKSIFMLIL
SGSFFPIEYYPEWSKKMLDYNPFVYIYGKIADFILYEKNFLKILFFQTFFVLILFCVYKS
IFKLCLKKISINGG
>fig|519442.4.peg.1188 Daunorubicin resistance ABC transporter ATPase subunit
MGTKRSNPTDEQSPEKTAFAIEASDLELTYADGTEAVSGVSMTIPEGEFFGFLGPNGAGK
TTTIKVLATLLSPTAGTVRVNGFDVEADQQAIRESIGYMAQETSVIREMTARENLRFACD
AYGVSRGDRSDRIDELLDLVDLADVADKQAEGFSGGMKKRLDAAMALVHRPPLVFLDEPT
TGLDPKARNRLWDYFEEINDRGTTIFLTTQYLEEADHLCDRLSVILDGEIVAEGSPETLK
REVGGEVLDVELEDGSGARERAAAIARDGELFSDDPTVDVTDDGITVTSRESRKRGPDLL
VALRDAGITVTGFNVRSPTLDDVFLAITGEHLDDGDPAESDLDAVESAAGPTTAADGGDP
>fig|519442.4.peg.1733 Major facilitator family transporter 10 (probable multidrug efflux transporter, probable tetracyclin resistance protein)
MTERTRLAVVVWAVLVSQVLLYPGLEDTVIALGGGDHLLAGTWFLVAEFGAFVGMAVLWG
LLSDALGRRTPLVVAGAAGGAVSYLAVAAVPGLGGSFDVVLVLRVIGGGFTIGAFSLSIT
KLMDLAGGHGRNMGAAGTAIGFGAALGSIVGGGLATLDPLAPLYAGAVVLAGAALLAATV
PDRGVGGGLALETVFARIRTRPALLVPYAFGYIDRLTAGFFALAGVAYFRDAFDVGPALA
GVTLALFFLPFAALQYPMGNLSDRIGRFVPVVAGSLCYGVAIIAVGLAPVYALAALLMVV
VGICGAAVSPATMALVTDLVPASERGAAMGGFNVFGSLGMLTGFLLGGVVSGVFGYLPAF
VAVGGLEIAIALLAARAVFRMTAGQPGAEWFRHAIRDG
>fig|521003.7.peg.242 Nitroimidazole resistance protein NimB
MRESGELIGAIGLLTGDACDYLEADDEYSVGYWIGVPYWGQGFAAEALQRLIDHARDSLG
ARAIYADHFLENTQSHRVMEKCGLSPVRTQTTGVLYPAGKRDVLIMRRLLVPHIERNDMN
HPMKQLPERAIDEQEARDILRMGEYCVVATVDEDGHPYATPLSYVLDGDSLLIHTGIAGG
QKTDNWTRDPRVCVTVAMDMEPVYVKENGEPGFFATRYASVIATGTVRRVVEPACARRAL
AQLCLKYCPEHRDKIGDAIEWELPATAVWAIDLEHISGKAGRRIPNGKGAVSPH
>fig|521003.7.peg.379 Permease of the drug/metabolite transporter (DMT) superfamily
MTGIDRERGDDITTVKTIEDVRAMKRAHKDGTWKYACACRSGVRYEGESEAWAQLKTVIE
EQVAKTTAGIEENDPFASKDAVPVPPEDRAPGKLRGAGARSPLFWKLMLVAMALIWGYSF
LTMKTVLDTVPTFMLLACRFLLSAVIMFTIFRKRIKAHFNREYLGFGVLMGCVIWSAYAA
QTLGLVDTTPGKNAFLTGTYCILVPFIALILFKERVTKWHIASALLCLVGVGFVALDNFS
IQMGDLMTLVGAVFFAVDMAVVGHIGRTRDVSVLTSWMFLFVGLFSLAATTAFEPRVPAG
QWTPEIVGQLVFLAVVCTTIGLLLQNQALSHVPPATGSLLLSLESPSGVLFSVLMAGEVL
TGKLIFGFVLIFLSIVLSETHFSFLRKWFPKK
>fig|521011.3.peg.765 Drug resistance transporter, EmrB/QacA subfamily
MSDAEPVRNVPMIMGSVMLGLFLSAMDGTIVSTVMPTIAHQLQGMDLYVWPFTVYMLAST
VAIIIFGKISDIFGRKPVYLLGIGIFLAGSMLSGLSATMSEMILCRGIQGVGGGIIVAIS
FVMVSEIFPVWERGKYLGILASVFGIASIIGPILGGVITETIGWPWVFYLNIPIGLLSAV
LIKTKFPNMPAVSPSGDIDYRGIICFIALMIPLFLGLSLAGVVYPWVSLEIIGLLGLSVL
LLFIFIRIERNARHPILPIDLYKNRVFQISMGAVFLGNSLFYAGIIYLPLFVQDVIKTTA
SGAGLVITPMIISLILSANITGRLIARTRRYKYLALSGFLFLGIAISILTMVRIDTPITV
LILASILLGYGMGVMFPTFSVAAQNAFSVKEIGVITSSLQFSQNMGATLITPLFGIIIST
ALNSSKKLTDYSLVPADLLSHAISLVFDACLGIVILAILVTLLLKNDLIAPRSPQA
>fig|521011.3.peg.911 Drug resistance transporter, EmrB/QacA subfamily
MIKKSTDFVSPQREKLDPKILRVSVIMVIGALAPLLDSTMVNVAINIIAGDLNSTISIIQ
WVITGYILAMALAVPVSGWAVNRFGGKRVYMFSLFVFFAGSVLSSLSWNIDSLIGFRLLQ
GVGAGLMIPTLQTVLVHIAGSRNLGRVMSIVSIPALLGPILGPVLGGVIVNSLNWRWIFY
VNIPITIIALLLTWRGVPTDEPSTSKQSLDIIGILLVSPGFALLIYGISQISSHGGFTSS
AVLIPLVIGLLLMVAFIVYALRTKNAPVIDVRLFKSRNFSASTALLFLSGIITNGAMLLL
PLYYQQVRGESVLFAGLLLIPQGVGMLLTRNWVGRLADRIGSRSIVAISLVVTMIGTVPF
ACAGPETNQILLAVALLIRGAGLGGLLIPIMASAYQGLSRDQVPHASSATRIFLTIGGAF
GSAVLAILIEHQPSGLSVLDIHTVVSAYNGAFWWLIGFTVIAIIPALLLPLRKFESVIQ
>fig|521011.3.peg.1160 Glyoxalase/bleomycin resistance protein/dioxygenase
MNNQAEALKFYTEILGFEKMADIIADNYRWLTVVSPEDRDGTQLVLEPNENPAAKAYQED
LFRQNIPAASFFVDDIQKEYERLKKRGVKFTLEPTELPGTPSTIAILDDTCGNLIQITHL
QNF
>fig|521011.3.peg.1174 Daunorubicin resistance ABC transporter membrane protein
MRTLRKQLKATYTIWLRELTKFYRERTQFASTMVTPVLWLIVFGGGMGINLRTGAINTSY
NAFIFPGIIGMTLLFTSMRSGISIIWDREFGFLKEILVAPISWTSIVMGKALGGGTNAMI
QGTILLLLSVFVGISLTPLQIVLVLPLMLLISLGFDGFGLSIASVIESYEGFQTIMSFVI
MPTFFLSGALFPLTNAPRWLQIVSDLDPMTYGVDAMRQVILRGGQFPMGLDLCIMIAFTV
IMLVFTSYRFTIKN
>fig|521011.3.peg.1276 Nitroimidazole resistance protein NimB
MKDMRRKERQLTPEETDRLLQTGVFGVLSTVGSGGVPYGVPLHYVYHHKVIYFHCATDGL
KLDLLDQNNRVSFCVVVDAVVLPERFSTRYSSVILSGRAFEVFDLEKRAGLVALLGKYSA
GYLDQGTRYIEKAWERTKVYRIDIETCTGKGTITSKSSRD
>fig|521011.3.peg.1297 Drug resistance transporter EmrB/QacA subfamily
MNRLSDNTSDEKYKRVALAIAALGTLVGVLNGSTLIIALPTIMVQLHTTLFGVMWALIVY
MLITTILAPAWGRLADIYGRKRLYVWGLVTFTIGSILCGFSADIGQLIGFRVIQAIGGSL
LVANGTSIVADAYPRGELGRAMGVLSMIMAAAFVAGPILGGVLTVIDWRLNFFFNVPFGI
AAIIWAQWKLKDIVALDRHKHFDLLGMVYFTVSVIALMVYVGAGFIVGLLSPAMLATLVV
GLISTWAFIRQEQKSQSPLIDLSLFKIKIFTYGQVSALLNSIARGAVMILLILFFQGVKG
EDPFTASIMIAPLAIALTISGPIGGRLADRYGSRLIATVGLILSLVGLFGLALMHYDTPY
WYLAVCLFINGFGSGLFQPPNTSAIMSSVPPDRRGVTSSIRAFFGNMGMMVSMSFATPIL
LGTISMDEMMQMFVVGGSSIPVAVQQTFTGGITMAFLLASLITVPAIIVSALRGKDDLHH
LHSIPAE
>fig|521011.3.peg.1329 Multidrug resistance protein
MIETRDSNQPDLPPLGYNTRHIILAIVLVGLFMCVLDVQIVAIALPTLMQSLGAGIGEVQ
WIATGYVIVVLATVLLFGSLSHSLGNGRLFKAGLLLFTLSSLGCGLSQSIPELILFRILQ
AVGASMLMGVSVAIIIQVFPPGEQGRAMGYYTAVIALGLIVGPSAGGFIVDLLSWPFIFL
VNVPIGLVLLVCTLRYLTVDRDPPAVQHFDYHGAFFLIGLMASLSLALNTLSNPPIRLDF
FGIWSGIFLLLLIAFVARERSVDNPILPITIFCKRSFLLPTISLILYIMAVFLLLTIQPF
YFEYVMGLRPSHIGLIALILPLSMLFASPVFGWLYDRYRSSRYPFIGIVIVGSAFLGCGA
AFSCMDFGLIIALFIIGGISRSIYQGPNSIEIMTALPPAQQGIGSSLLTALQYLGILLGI
SFATFLMTAQLDVAGYSELTDAGPTFLAAIFGNCLYIAGLLCLAGAVCEYKV
>fig|521011.3.peg.1412 Class H tetracycline resistance efflux protein
MTDLRITPLLALQVVIFTDTFSFGVVLPFMVFLVSGFGGDALAFGAIGAIYPFFQTISAP
VLGRWSDKVGKSRVLLISQAGTALSWLLFLGIFFLPSTEVFGLPLPIILMLGARAVDGIT
GGNVGVANACLGDLIPEAERTMAFGRLNVASNTGYILGPAIAGVVAWSGGSLMVPVLLAL
MVSAAGVVMIRVGLPDICRTRATGEAGTGLFNLFRRRGVRSLLGLTLLYFLAFNIFYTAF
PVDAAGRLGWSAATLGLYFAFLSGVMVVVQGPVLKRAAERWSPRTLLIGGALVLAVGFAL
LWFGQTTTGISAAILFSLGNGLAWPSFLTLLSLSVGPDEQGAVQGAASGVGSFASIIGLL
LGGVLYLAIGPSTFLFCTGIVLLTAGLFIAGHSTSEERVQ
>fig|521011.3.peg.2592 Drug resistance transporter, EmrB/QacA subfamily
MGFDTLGSVLIFSGVGTGIAALSMGKERGWTSGPILLLLLSLLINSAFLFREWYQPSPLD
LHLLKQPQFTMGIGTAFINRMVVSGTVFLLPLYSELVKGYTANFAGLLLVVSSLLIIVFG
PVAGTLSDRIGSRWLCTLAGILLLFVIFDSSMPLILILIALGLRALSMGFFSPPNLRLVL
SFSQKDHQGSASALWYFSRYLGAPLGSWSLRFSSITGSGSLRNPGPPVRSISIRWPARC
>fig|521045.3.peg.190 Permease of the drug/metabolite transporter (DMT) superfamily
MNKRVTATLLLATTAIIWGESYLFTKVAVESMPPMTLALFRFIVAVAVFIPVQIKKGVCP
KRTTKQRFNIAMAGFFGVTLYFLFENYGLRLTSASDASLLVSSAPILTMILYDILHRKFD
GLEYLGSTIAFIGISIVIYGGQFSEGSSVLGNSLSFLAALSWAGYTYFFDKVKDSSIATI
VQLMVWGIVFITPFSIIEVFFLKDPVIFSVEAVSGVLYLGILASALGYLMWGKGIHLWGG
KAATLWVYTIPVFTILGDIIFLKHRPSLFFYVGALLVGMGMSIAIWRQRKHLQVQEENAS
TQGLH
>fig|521045.3.peg.378 Probable cation efflux pump (multidrug resistance protein)
MIGQLGSAAIAAVGLVNQINFVLILFLFGASSGTGVFISQYWGNRDLKNIGKTISHVLKI
TYVGGFVFFMLLFFFPQQIISFFSRDITVVTAGVAYSKIISFTTFLIPFTFVMAMALRTI
EKPKIPMYISFVVLAFNTVGNYLLIFGVGPFPEMGVKGAAIATLLSRIIEFFLYLYVLLK
PVTALTISRHEFLDFDTVLFRKLMVVALPVIVNELLWSVGMTTYSFIMARIGTEALTVKN
IVSTLESFGFIIFGGMSAATVVMVGSELGKKNYEKAFKNAIKLLNLMVVIGVITGIGIIL
LSRFLIRMYNVEEVIKSTVVMVMIIVGLAQPVKMFNGLNIVGVLRSGGDTKTAMFLELFS
LWGIGIPLVALSGIVLKWPLPFVFLMMLPEELFKASLGMLRVHSRKWLRNVID
>fig|521045.3.peg.955 Permease of the drug/metabolite transporter (DMT) superfamily
MLSKKILANIYLLLVVVFWGLTFPLQKVILINSLSPAFYNALRFFMAIIFLIPFKAFRKN
FFSSLKEELFHGVILGLFLSGGYVFQTWGLVYTTASKSAFITALYVGLVAIMAPFLERKA
PTFLQIVALGISIMALYFLTSPAGGGFNLGDFLTLLCAISYALHVLFITHFTRENESELS
LLLPQLVTVMLVNVILIPVIPGKVILNREIFFTAVFAAIFATIFAIAIQLKYQKYVGSLG
SSLVYVGEPAFALLFAVILLGEKITMIEGLGLIMMVVGIILGSLSTIKEKEQESEVG
>fig|521045.3.peg.1169 Daunorubicin resistance transmembrane protein
MVSFVMYDFFYWKLDVIISFAAAFCVFDKFAILLEHCVIYPFLHLGNRSVRKEEFFVRGL
AIARASFLRNQVYLLNHVAANIGSFVFGYIFVCIWKAVLGDSPEASTMITYVMVNQSALW
VTMFLPRGAFLIRKVYDGTIVFDLIRPYGLMYQSFFEVLGHIVYNFVFRSLPIYLLGVTL
LGVKFPDAGRIIPYMVSVSNAFVISFFMNYFVGLWMVKFLNYTAAQGMYYFFMNLFGGYF
LPAQYYPAFLRKIMPLLPFASTSYIPGSVYLGKIDPIKAFGIQWFWILTLGLTAFGLTEL
IKKEIRIQGG
>fig|521045.3.peg.1254 Permease of the drug/metabolite transporter (DMT) superfamily
MKERLKNPLIAALLATAASVLWGSAFPVLKIGFREMGIGPENVAEKLVFAGIRFLGSGLL
IFIFSPLIAKGKFWPGKRVFKSLLLLGLLQTALQYTLFYNGLSNTTGVKSSIIISSGNFF
VVLIAHFVYKDDRINWKKTLGLAAGFSGILIANWSKGISYDFKFEGEGLLVLSTLVGAFG
TILAKKVSRQVNPFFVSGWQMFLGSIVLLLLGMPGMKNGLKFTPLATVLLIYSSLLSAVA
FSLWYTVLKYHKAGEVTLYRFMIPLSGALSSAAFIPGETLTPNTLIALGLVIFGIVVVNY
RNS
>fig|521045.3.peg.1750 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQRVYILNEQMTPALFKLAWPTILSMLFQTLYNVIDAFWLGKLGKIAISAPTIAWPAIFL
LISLGSGLGVAGLAMVSQYVGAGDFKKASKAAGQIILISTIFATVIGIIGGIFSGGILKL
MRIPPEMFDSTRIYMQTIFFGAPLTFGTFAIASLFSGWGDTVTPMILTGLSVLFNAVLDP
LMIFGIGFPRFEVFGAALATVISRGVVVIFALYILFSGRRGIKLTFHDMVPDVYMIKKIF
SIGFPSSLGQSVTAFAFLIIMAIISRFGPVATAAVGVGNRVTSIATMFSFGLAQATSAMV
GQYLGAERNDDAYRVVWKSAGINMVIVGAMCTGTFFFGKEVTAFFINEPDVLVEGFRYFR
IVSLSIPFYATFNIFDAALRGSGYTVASMILNIVRLWGIRLPLIYLFGLSMGTLGIWYAM
LISNISIAIAAAFVISSKKWLKKVI
>fig|521095.6.peg.367 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLASMLYDTADGILVGRYLGQESFGAVTIAVPLVILCFAIADLIGVGASAVIAVEHGKKN
HQTANNIFTIAFIMLITTGVISGIFFFFFAPNVLALMGAQGKIAEQGTIYLRVWTLFLPV
MCISYAVDNFLKICGKIRRSTSIAFISAILGTVLEYYFLGVLGLSVEYAALGYCISITFS
SLYGVWPFIGNKQILKFVKPHFNWTHIREIFVNGFPIFMQNISSRIYSLLMNAALLTLGG
DIAIASYGVLLYSGGLIQPLIYGQADAMQPAVGYNWGAKKKNRVLAIEKYIFSTGIIIGI
FAFCVSFFFSEFLVKLYLPDGTQELLNIAIPAMRIHAFIFIFSWITMCTESLAIALKQTK
ISNLLSIFMALIFPISSLLILKPFGLDALWYVSVVSNILSALLSVGCLIHIYRKYFTSVD
KDDVGAASDASQEEDAELTDAALATSELSSPEDHLDPESISRAQ
>fig|521095.6.peg.501 Multidrug resistance protein MsbA
MKESFLSIKEIFHIGNGKINVLVFLAVLAVISSFLEIYSIQYMQSLSKVFSTTVSNDLFQ
IGFICAKFLMLIVLSTIVRNYFCFRVSVFSNDIIKNVRDKAYSKLTDTEYELAIIHDNAF
YINLIDNNVNKLSLIFSTSFFTLCSDIFDTVWICFFMIQINITSLLILIVGILPLVLIGN
ISASEQKKFAENTIKLNEDLIEKINETNDNFSYIKLFKGKEREANRFNRINIDILENDNL
SSAALSIFFVIEKSIRYLFVAISLFFLCKDVLAQDGNWMILIPFLLYVQRFYNPFSNLNK
YSQLIQKSVSSADKLIDFIISKPTEEISTIQFISDSSESEIVLSGISKNYESETILEDVT
FSFKEGINLIDGKSGVGKSTLLKILLGLIKSSSGKVTIYSRADDLNLYAYSGQSNKLFNL
SVIENLIYPKTVDHLSSSERMKLESLLDEFGFRKSILNKDIAKEGENLSGGERKRLSILR
ALIRPSKVVILDEPFANLDSNNIEIIARKIQDLSKNRIVIIVSHETSFPDSLKFNTHLTI
SGT
>fig|521095.6.peg.1090 Permease of the drug/metabolite transporter (DMT) superfamily
MSSPTHTPSHILTHNSSQTLIWKGALLFCALVWGGSFVVIKDAINFIPTAWLMTLRFVLS
VVVVGIIFRKRLKENLDIRHLTFGALLGILNGFGFLFQNGALAYTTAGKTAFIASIYCAM
IPFVNWLIAKKKPHISSIIAACMCVAGIGLISLGTDFSFSFGIGEQMALISAIIFAFVFV
LTAELSHKLDIITLTIVQLGVSTLPCLGWALCCETMPNFSQIPSTAWMALAYIIFIATAL
TGVLQNRSQKSVSPVQASLIISLDTIFAAVFGVIFLAEIITPTIFLGFIVIFVAIFISEL
GEKPAEPQTTSES
>fig|521096.4.peg.539 Bicyclomycin resistance protein
MVSIGIVDTKAAAETPRRWTTVMLLVAVTAPQLGLSLLNPSIPQMAVDLHTTVSAVQLTL
SGYMAGYAVSMFAAGILADRFDARTVQALGLLLFAVGGVAAAAAPSVAVLGAARFVQAIG
GTSATVLCRLVIQRRYPADTRMQLLTSLSIVIAATPAISPFLGSALVQVLAWRALFLGLA
VVGVMLAVAFLLLVPAAPPEVPVSPTPRMVGRGIAEAVRERGFRRHALVISLAWMGYFLF
IEQSSFVLQELHGATELQYGLLLVVPAIGYIAGSVLVRRAPAVVRAVRFGAVASLLGAAA
LVILAAVGVHNPAAVVVPLAVGFVGVGAAIPFSQAGLLELDLAAQGVGAGLFFFLQMASG
AVYSVIVEGLRLRGSLSVSLAIALPLFCLAVTVAITTRARNRQGENANA
>fig|521096.4.peg.713 Probable multidrug resistance transporter, MFS superfamily
MQLPSNPMTDNLRRNRPADGVLIAVLCLGGLLASLMQSLVVPIVGQLPHLLDTTTDNAAW
VITATLLASSVAMPIAGRLGDMYGKRLVLLTSLLSLITGSLICALSHTLLLTVVGRSFQG
FAMGLVPVGISLMRDELHARKIPGAVALMSAMLGVGGAIGIPFGAYISEHFDYHTLFWFS
LALGVVTLGLVFVVVPESPNRHPGTFDVVGTVGLTVGLVSVLLSITKGQSWGWTSAATLG
CAIGGALVLIAWGFWETRTRDSLVDLRISARRPILLTNLASIMVGFAMFSLMLTMPQLLQ
IPEATGYGLGQTMLNAGLWMVPGGLVMMALSPVSALLTKRIGARLTLAIGATMSAIGYFA
LLGLTDATWKMSIGSMIVFGGVGVAYSAMPALIMANVPDTESAAANGLNSLMRSVGTAIS
SAVMATILTRSTITLLAGTPREVTLPAEDAFTSGFVIAGVVAAVAAVVALAIPRATKGGE
TTSAAPEDREIQEAGARTA
>fig|521096.4.peg.1480 ABC drug resistance transporter, ATP-binding component
MAEFIYTMKKVRKAHGDKVILDDVTMSFYPGAKIGVVGPNGAGKSSILKIMAGLDQPSNG
EAFLDPEATVGILMQEPQLDETKTVKENVEDGLGQTMVNLRRYNEVAELMATDYTDELME
EMGKLQEQLDAVDAWEVDSQIEQAMDALRCPPGDSPVTTLSGGEKRRVALCKLLLSKPDL
LLLDEPTNHLDAESVLWLEQHLANYPGAVLAVTHDRYFLDHVAQWICEVERGKLHGYEGN
YSTYLEKKAERLEVQGKKDQKLQKRLKEELAWVRSGAKARQTKNKARLERYDEMAAEAEK
HRKLDFEEIQIPTPPRLGNVVVEVSHLDKGFDGRVLIKDLTFTLPRNGIVGVIGPNGVGK
TTLFKTIVGLESPDSGDVKVGETVKLSYVDQNRANIDPKKTVFEVVSDGLDYITVGQNEM
PSRAYVSAFGFKGPDQQKPSEVLSGGERNRLNLALTLKEGGNLILLDEPTNDLDVETLSS
LENALQEFPGCAVVISHDRWFLDRTCTHILAWEGNVEEGQWFWFEGNFEAYEANKVERLG
ADAARPHAVTHRKLTRD
>fig|521096.4.peg.1761 Drug resistance transporter, Bcr/CflA family
MTPTERPAPPKLRIALILGSLSSFGPITTDLYLPGLPSAAEDLGASQPAMQATLTACLVG
LAIGQIVVGPLSDSIGRRRPMIAGMALFIVSSLLCAVAPSVYLLDAARLLQGLAGAAGIV
LSLAIVRDLFHGVAAARMIAALMAVSGVAPIVAPLAGAQLLRVLDWRGLFVVLAVLGVAL
LAVAALLVPETLPTADRRPSGWRAVGAGYYSLARDRRFVALTATSGLAFAVMFAYISTSS
FVFQDHYGFTATQFSVVFAANAVGLLVTNLIGGRLVGRVSTSVLVWTGLAGMALGSCVAV
LALSADLLPLLVGSLFLAVSSLGLVMPTVAALALEDHGALAGTASAALGSARFVFGGLAA
LVAGIGGNPTVLGVVMVVCAVGALMAFVAAKRAPTAAR
>fig|521096.4.peg.1907 Permease of the drug/metabolite transporter (DMT) superfamily
MRIPPVLAVSVVLLWALGYPVAAIGVASMSPFLLLLLRFAISGVLMIGLVRATHRTLPRG
ADLTHAAVAGLLTQAVQFLGCYLGLQAGVPAGVAALILGVNPAATAVVARIALGERLTGR
KVVAAGLGLGAVVAACWSTVPQLAHAGAGIGFTVLGLAGLAVGGVYQQRFCRNVDPVAGN
AVGLLVAAAPAAALTAAFGATVTDPGRAALVLVVMVLVNSMVATTLYLRVIAVAGAGGAA
MLFALIPAVAALLSAVLVAESMRPGAVIGVVLGSIACLTASWGSRRPPLAGVGGPSSEGD
RLRGEDRRGLGGTLQVRPAGRGYR
>fig|521096.4.peg.1947 Permease of the drug/metabolite transporter (DMT) superfamily
MTVLMNIAFYESIAHIDLGTAVAIEFLGPIAVAVAGSRRPLDLVAAAAALTGVICVAGVN
IGGVAGVDGALGVGCALVAAALWAGYIVLGKRVADAGGGIEGLGVGLAAGALILALPALG
TDVLTRPESFLGWKVWVLGLGLGLLSSVIPYALDQVVLRRVGRARFALLLALLPVTATAV
GAVMLGQRQGWLEAAGIALVVGAIVLTSRDVAAEAAPTSGG
>fig|521097.5.peg.1814 Permease of the drug/metabolite transporter (DMT) superfamily
MKDIVKGYLAAFISAVTYGMIPLFMIPIKQQGFSVDAALFYRFITASLFIMFYLFYRKET
LRITPREVFIFLILGLLYALSAEFLFLAYDLLSPGIASTIFFMYPLIVALALGVFFKEHI
TFPTILALFIVLIGVFLLSVKDVTNFSINYVGAGVSLLGAVSYALYMLIVNKSKISASGI
KVSFYSTLFSSVYFLVKLWVIGTPLPIPEVKMSLLLTSFGIVTTLFSIITLIYAIRMIGS
TPTAIIGVMEPIVAVAISIWIFQQESLTTNLIIGVLLIIIAVMIDILKRKK
>fig|521098.5.peg.212 Fosmidomycin resistance protein
MAVVQAVREQGRMNRDAVWSISGSHFLNDLSTTGLVPALTQLYKPLFHLNYTEISLIVLV
SYITSSVAQPLFGAWADRHPKAWMLPLGLLLSTLGITLTGVASSYGALLLMVAVSGLGSG
AFHPEASRVAHLAAGRAKGLAQAIFQVGGNGGQAIGPLIVSLFILSAGLHSILWMFIGVA
LGLVFTLRLYPWYKAALRDYAKVRKTIEGENRIGAVALLVVVIVLRSWCQIGIAQFMPFY
YAHKFGMSYQLSDALMFVFLGAGALGTFIGGALADRMPKQRILLLSMLLSIPFGFGLPFL
HGAWAAVALLPFGFFILSSFAVTVVYMQMLLPRNVSLASGLTIGFGVGAGGIGATFFGVL
ADHVGLTSVLYILMVVPIVGAILSAFLPVDSKGGFARA
>fig|521098.5.peg.286 Multidrug resistance protein B
MRLIVGSLLLTALAQWSLMLAHSLPPYAVAIAANSFLISATQPALNAFVGNRWKSVSARL
FNTMYVMNNIGIAVGTALAGVIASISFLLTFFLNGLLTLSFAAFMWRFLRRLGPESEDAP
VDAMPQVGASAWQLFRNYQVYALLGAGMLALSLALAAWNSGVAPYLNQTGHRPDAYSVLW
TVNGLLILVGQPVTGWLKRRVTQAPTAQLVASSVLYAVAFAGMAIAHRAYPALVAGMVVA
TFGEMLNAPTVPELVTRMTGPHAAFYLGLIGAIGNVGSLLGPVVFGHLFDLAGISPILWV
ATGACAAATVAFAGHARVVRRLGGTQGVTNGMHTSPADEGTQFTK
>fig|521098.5.peg.919 Permease of the drug/metabolite transporter (DMT) superfamily
MFSLLIFANLIWSASFTATGLAAESFSPPLIVMARMIIGGLVLVPFVMRDVRLGVWTWKK
VLRISLLGLLGFTLPVTMETEGIRASSPALGAVSIALEPLLTLVVSAVAFRTPLGPRRWF
AMILAATGAWVVAGCPRPGFAGYLLGDLLMLGAVACYAIYNAISGRLTADVSAASATSIM
LLAAGIGCLPVYAWTGHAWPRHVTPASLWSLVFLAFFATAAAYLIWIFVLQDHDVASAAI
TLYLQPVFGVLISIVVTGERPSVLFYAGGAMILLALFLGQHRGQPSISSAAADPPSAP
>fig|521098.5.peg.1554 Permease of the drug/metabolite transporter (DMT) superfamily
MQRSRAAGVWAARGLLVFVTLVWGATFTLTKQALAVLPVHAFLTLRFAAAAIATLGLAIL
SRRRSSAWNDARTWAVGVLAGIPLGASFLLQTEGLRTITPGLSGFLTGLNVVMVPILASA
MTKRRPGARTWWGVALACTGLLLMCAGTPLAGRFPGVAETILCAMCIALQIVVVDRWAKG
LDAFAVAAVEVWVTALLTWAAALFAGQWAPLADVRTWTQPVTWAAVLVNGLLGTAFALWA
QNWAQERLSSAQTAITFALEPVFAAAIGWMVLGEAMTWPGILGGLLIVASMAVAPA
>fig|521098.5.peg.1808 Drug resistance transporter, EmrB/QacA subfamily
MQQQATLARKEHRLPLEGVIQRPEGMWFIVGTVCFGAFMAALDASIISIALPKLEQAFHT
MMNRIEWVSLIYLLALAGCIVAFGRLSDLIGRRPMYTMGFGVFIIGSALCGASWNLSSLL
AFRVVQGIGASLLQANSVSIITAAADAERRGQAIGFQALAQGLGLSLGPLVGGVLTHIAS
WRLIFYINVPVGILGTISALLFLPRDRREGPRPRFDLVGALVLAFLLIVTMYVLKEGFRP
ESRPTITAMLLAVAVLAAASFVAIERRAESPLVPISYIREPVIWLGNLTSILSFSVMYAI
TLVVPYWFVHVEGLSSAKAGLLLTALPVGMALCTPFAGRLADRWSKVKVSAAGMVLAAMG
SASLFAFARVTPAFLAGLFLVGCGIGTFTPANNARVMNATPAAHLGVAGGILNMSRSLGM
GVGVTAGGVSVELFTAAFGHHGVALAYRCSFLVAAALALIALGLTLLRQKQSREAA
>fig|521098.5.peg.2591 Multidrug resistance protein
MRRPAWLGILAASLIPFVLTLGNSMMVPVVPVMQSTFGVTPTAASLLITAYSVIAVVLMP
VAGFLSDRMSRRRLAIAALAVAAAGGGVAALGASAAHSYAWVLLGRIVQGVGAAFSMPLA
LPLASDLADPHGRGRAAGFTEVGNTVGKLMSPILGALLATWAFFAPFWAVFALCGTLSAT
IAWMVPERRAPVPRSHLPAAWRLAFRAHAKLLTATYLSGAVSMLCLFGGLVSLSESLADS
AHVPEWQNGLLLSIPQAMLCLASLVTGLFSDRWKAPSRAAIALGLAWTAASFGAASASQD
MAWQIAAVSLGAYGIGTAITAIDASLATALSHEVRGTLSSLYTSARFLGPTLGPPLASWL
QGFGARTPYAVLSAIALAAAIAIAPLLRRSTQDGESAAREQRQAAHT
>fig|521674.6.peg.126 Glyoxalase/bleomycin resistance protein/dioxygenase
MTIVVKDLVRSRWFYHEMLGMAEVSRPAFSFQGQWFQAGSTLIHTILEFEGSGPAGQSGG
RSSRGHHIAFAVPDVRIAEKFLQQEGVPIVVPCKLRPDGALQTFLHDPDGHLIELTSPPE
SLFRPGASLAVDVSSQVMLDGVFSLLT
>fig|521674.6.peg.4456 Permease of the drug/metabolite transporter (DMT) superfamily
MPYLLFLLICTVWGGSFILMKKANPVLEAITIGGWRVAGGAIALGLIFWWLGPSRTLRRK
HLGALVIVTFLGFTWPYVVQPWLVERNGSFIVGGSVSLNPLMTIFIAIPLLGVWPTQRQF
WGVLAALSFLIVLFAGEIHKNLPLLDLAVLISVPLGYAFSNVIIRRTMKDANPLELTLVA
LAAAAIILLPLAWFTESAAPDATRIDWITAIGAVAILGVAGTGLAMYGFNILIRDQGPLF
AGMVTNLVPLWAFYWAWLDGEPLTLLQLVCVVGVLGSVLVVQYRAAGAKTPAHPPVAAPA
IPPLEVTDEATELVTVRSVPTNTLAPAREQIAAGGENG
>fig|522306.3.peg.401 Acriflavin resistance protein
MKSFNLTEWALNHRAVVLFLILAIAIGGVLGFTKLGQLEDPNFSVPSMTVIVIWPGATAQ
QIQDEVLNRMEKKFEQIDHFDKVKTYARQGYGGMTLSVVGGTSHADQREAWYQARKKFSD
VKLELPDGVIGPIFNDEYGDVTGLLYAVKGDGISHAELSDTAEDIKRRLLKVPMVKKVDI
YGKQAKKVYVEFSHQRLAALGITPLAIAESLRSQNSVLASGSIDTHGDRVLVRVSGQFTS
LDDIRNVPIAAGGRLIKLGDFTTITRGYEDPPMYTVRHNGQQVLMLGITMTNDGNIVEFG
HAIAKAVANVQAELPHGIELERVADQPTVVSESIWEFERSLMEALAIVLAVSLISLGWRI
GIVVGLSVPLVLGVVALVMLAMGWNLERVSLGSLIIALGLLVDDGIIAVEMMVVKMEEGW
DRLKAAAYSYSATAMPRLTGALITVAAFMPIGFSRSTTGEYAGGIFWIVGTAVLFSWVVS
GIITPYLAVNMLPKDFGTHHHGADPYDTPSYRRLRGWIDLAIARRWWVIATTVVALAVAV
VGSRFVPQQFFPNSSRPELVVELRLKEGASFAATTEQVKKMEAVLKKDEDVRFFTAYTGA
GQPRFYLSLNPELPNPGYAAFIVMTRDMEARERVRSRLMTSVNEEFPEVWVRVTRLELGP
PVGFPVQFRVVGPDTQRVRSIAREVEAAVASSPKVRDVQLDWNDPVRTLRVDLDQDKARA
LGLAPADVAFVTQTVMNGATVSQLREHEDLIDIVARAVPSERLDVDTLKDVNLYTREGTV
VPLSQVARVRYELEEPVLWRRNRDMAITVRADVKDGEQGVSVTQEIRPMLKEIEAQLPFG
YRIDVGGAVEESDIANRALMAVFPVMLVTILTILMLQLQSFSRMFMVFLTAPLGLIGVVA
ALLIFQAPLGFVAILGITALCGMIMRNAVILVDQVQAEMAEGRDPWNAVLEAAVHRTRPV
ALTAAATVLAMIPLTRSVFWGPMAIAIMGGLTVATLLTIFFVPALYAAWFKVERASAANP
EMPPAAAPA
>fig|522306.3.peg.1157 Polymyxin resistance protein PmrJ, predicted deacetylase
MKRIALKIDVDTCRGTLVGVPALIDLLQRHAASATFFFALGPDCSGREAHKSSPSRHYDL
TTRLSGLLLPAPDIGARAADSMRQTLAAGFEVAVHAWNRVLWERRVLSADNAWVEAEMAQ
AWRRFEAIFGAPPLAHGAAGWRMNRHALRLTQRLGLCYASDCRGKYPFFPVIDGEIVRCP
QIPTTLPTIDELLLLGAASADQAVEQVIEASTTISGDHVFTLRAELEGITFCDAFERLLA
TWQEKGHRLVALRDLLAARNVAQLPRHTVAFAEIAGRTGPRMLQGRAFLEE
>fig|522306.3.peg.1583 Multidrug resistance efflux pump
MIAGLVMVFGYALIVWAVFVKFKWLKFTIPWGVISAFVGVHLLIIFLIGLRFMTPLATEA
KVIQHTIQLTPRLPQPTLLMAVLAEPNVPVRKGQPLFQFDRRMFEYQVRQLEAQLAKAKQ
NVLVMKADTGIAAQKVIKLKSHLEFARYQQALSAKLAKQGAGPEEDAQKWAAQVAADVAA
IKEAQAEEQRAILNYTSEINGVNTSVAAVQAELDQARFYLDNTLMVAPEDGYLINLQARP
GMVAGDVRIGAVASFVCDADRYLLANFFQENLKYVKPGNEVEAAIDLYPGQIFKGKVLAI
WQGSGAGQMLPSGVLPNFQAVPTDRPQGQFAVAIRLDDPDQAKFPIGTQGRAAIYANPDS
WFVPLRKIMLRAYSWFNWIYPFSG
>fig|522306.3.peg.1780 Permease of the drug/metabolite transporter (DMT) superfamily
MKRSHANLLLLVVAVIWGSAFVAQVVGMTGVEPLTFTGIRFLLGAAIVCPFAWREWRALS
AHGAQPLPGDALSVATLGVLLMLGAAFQQIGMTSTTVTNAGFLTALYVPLVPLLAWLILR
TRPHWSVWPTSIGCLGGTWLLSGAQALDPVVGDAWVIASSLFWALHVLLVGRIAERMAAP
FVVACGQFLVCGLISLLWAGLNETITLAGIRQASLAIAYAGVVSVGIGFTAQVIGQRYAQ
PADAAIILSAETVFAALFGFLLMGDRLNASGIAGCALILVCIIAVQLAPLTMAGRRSASR
SDTAEAGR
>fig|522306.3.peg.1941 Acriflavin resistance protein
MAEPEKLPAASLSQLTIDRSAAPARRRRRSWVGWLAGALVAAGIAAFLLVPGKTEVQVTS
VLSAYPSQQYTQLTASGYVVAQRRASVASKGTGRLIELRVREGSPVQQGELIGRLDASDV
QAALLVAQAAIGQAAAGVRQAEANLEQAQAEAANAEVEFQRQQTLRTRGFVSSQAVDAAQ
RRALAARAGVGAGRAAIGSARAALAQAQAQVSVQRVNQDNTEIRAPFDGVVLVKNANVGD
MITPFSAAAGTSGAVVTMADMSTLEVEADVSESNVARVRVDMPVEITLDAIPDARFRGSV
ARVVPTVDRAKATVVTKIRFEKIDARILPEMSAKVNFLSQPASDADQTPVVAVNPRAITE
RAGSKVVFRLVGETVEAVPVTLGRKLGDAQELTGSPLQPGERLVLAPTERLAAGASVVVS
GK
>fig|522306.3.peg.2883 Permease of the drug/metabolite transporter (DMT) superfamily
MDKAPPRWLPFLVLGIGLLAISFGAILARIAQGYGLPSLTIATLRLGLAALLITPLALWQ
SGSALRMLKPRQGLLTGGAGLFLALHFATWISSLEYTSVASSTALVTTNLLWIGIASFLL
FGDRPSRLMVIGIVLSLSGSLLIFWSDSRTSAPGTNPLLGNFLAIAGSWCFSAYLLIGRR
LRASLALPAYVWLAYGSAAILLLLACQASDTAITGYADAAYLVALGMALGPQLLGHTSYN
WSLKHVSPTFIAVVTLGEPVGSAALAWLFFGESFAPLQATGFVLLLVGIYLAARGEGK
>fig|523791.5.peg.246 Permease of the drug/metabolite transporter (DMT) superfamily
MTKLPQKQLAMAGLILAVVLWSASFVAMKLAIAEFGPIMTVFLRMILATAVLIFFLPPMA
KKQQYQKGDWWLLLLLALCEPCLYFIFESYALTYTTASEAGMVTALQPLMVAVGAYYLLK
EKLNSRLLIGCIIAVVGVVWLTLAGTSSEHASNPMLGNALEFGAILAATGYCLLARKLAQ
RYSPIFLTLLQTVMGSIFFLPLIFVQGAPLNFDVSAEAVLAIMFLAFGVNIFAFTCYNFA
FKTMPASQVGSLMNLLPLGTLFFGWALLGETLSGMQYLAAGLVLFGVIWSQTKPRPKTVF
IEQDMVTRSLRHKAKQKIRKSFGLVETP
>fig|523791.5.peg.1035 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAHSADNNSTSSSGHSWQDIRHETTAIIRIAIPAILAQLAQMSLGVIDTLMAGNYSSNAL
AAVGTGFNAFMIIFSLFMGLMMAINPMVAHFNGQGKMDSIGKTFQMGMFLAVIFGIITFI
LLRNVDPILYLLGVEDAIVETTSGYLKALSWGCVFAFLFIALRSGNEGLFSTKIVMFCSF
MVIPFNLLFNTWFIYGGLGVPAMGAVGVGYATSVVWTLLFLFLLFFTWRNPSFASLNIFK
KIRWPTWALIKEFFSIGTPMSLGLLMEVSMFGMIGILVARYGVDLTGAHQIAMNIATVAF
MVPWGLSIAITARVGYWMGRQDYRQMRLSGFCGIGTSLFFQAVSVAIMLLFRYQLVGVYT
DDQAIIEISASLIFLAAIFQLSDGLQVNSAGALRGMKDTKIPTVYMAIAYWFIGFPVGIY
LADYMDLKVKGFWIGILVGLTVAAILLLGRFIHRSKQTLAFAEASRS
>fig|523791.5.peg.1531 Acriflavin resistance protein
MVKQYDTHTGIISWFARNSVAANLLMIFIIVAGFIGLSHLRQQVFPDIVINSVSIQVPYP
GAAPQEVEEGIVILIEENIKEIEGIKKVTSTASEGMGSINIEIQDNYEVSEVMDEIKVRV
DAIPNLPDLAERPVIYENRMQRQVMRLNVFGDANERTLKEYGKDIKNELLALPNVGLVEV
EGARPYEVGIQVSDHQLRKYGLTLQDVANAVRSHSLDLPSGTIKTLGGDILVRTKNQAYD
AYDFAKIPVITRPDGTTLLLADIAAIDDGFAEWNFLSRFDGKPTVSLRIRSSLESDDLLI
AEQIYDYLDKKTPTLPAGLSIEAWGDGTYYLKGRLEMMQKNMFVGILLVFIVLALFLRFK
LAFWVMIGIPLCFLGAFALMYMYPGFAMTINMITLFGFILVLGIVVDDAIIIAESAWASI
EEKGHSIDSVVEGSKRVALPATFGVLTTIAAFYPMLAISGPWSNAMASMGLVVMFCLMFS
LVESKLILPAHLAHMKLNKLEDTKNPKVRAVKGFFRAIRLKVKDLLSRFINNVYRPKLEM
FLKYKGLTILSFVCILFITTIGFIGSGWVKTSLFPNIPNDGVFVEIKMAEGATAEQAMSN
VQIVWDKLNKLHKEVEAEHGIGVFQHAFMWTRENTGGYMWTELVKSEDLPIHQFELIDRW
RDMVGTLPAVEEISFGGGGGGPGGDGVGYRLVGTDIDELQIVTEKIRAKLAEYDGVYDIS
DNLSGGKEEIVVEVKPHGYNLGLSTQILSQQVRNAFYGSEAQRFLRDNEEVKVFVRYPLE
DRRSIGNLEQMPIKTPSGEYVSFTDVADYQVQEGYSRISRIDGVRANRISADVSPQATIT
SGEIHEDMMQNVIPGILAQHPTVKLEPGGPSEDQQKLSKELGIGGLIALILIYGLMAIPL
KSYIKPVVVMSAIPFGIIGAMVGHLLLGINLSMFSFFGIIALSGVVVNDSLLMVDFIGRA
RAEGMSRIEAAVNAGTRRFRAIILTSLTTFFGLLPITTETSLQAQLVIPMAVSLAFGIVF
ATVITLIWVPCLYVTLGSVKDWFLGRDAKSLSKEQEAYENN
>fig|523791.5.peg.1746 Permease of the drug/metabolite transporter (DMT) superfamily
MAFIMSTPVLYALCVLIWGSTWFAIEFQLGVVPHEYSSFYRFGLASLLLFAFCWFKKLPM
RYGLLQHAWLVLMGITFFGLNYLLVYEAQEYLTSAMASVIFSAVLIVNIFNSWLFFKAKI
TARVIIGSALGLIGMVMIFWNELTDFTLENAKLYGLLIALLGVLCASIGNMVSVQTQKYD
MPVIQMNAYAMGYGSLFSLIVGLVQGKALIYDMALGYSISLVYLSVFGSVLAFGAYLTLL
RRIGIHKATYAVVLFPAVALIISTFFEDFIWTWIIATGIVLIGLGNVFVINREDIKKQ
>fig|523791.5.peg.1995 Outer membrane component of tripartite multidrug resistance system
MSIRFPFALLLLSTVASCAVTPDFKEPEPPSVSQYTGSDDAVVIGSNKKLATGQTLQWVD
ATDQQWWQQFQSDSLNLLVEKVLTQNPSLLAASAQLRSAEELYQARVGTTRYPKVSADVS
AQRQRFNPGVFGQQATPQEFSIYNAGVDVSYQLDLSGGNSRALEGLASRVDYQRYELEGT
QLALVATVLNTAFNQAKLRSQLEVTEQLVAKQEQQLDIVKQQLELGQVSKHEVLMLQSEV
ELTRANIPVFRNQIQKTEHLLATMAGETPDSENIPDFNMQDFGLPESLPLIIPSELVRQR
PDIQAAESLIQAANAEYGVAIANMYPSINLNGQIGSQALSAGSLFSSESAVWSLIGQLTQ
PLFDPGLPAEKRAALAEFEAATSNYQYVVLEALREVADTLRQLENDAQKLNALSDSNQSS
EEAMQITARRHELGAASYIELLLAQQQYLSTRMQLIDAQSQQLINSVSLYLAMGAKPSLS
QPDVQ
>fig|523794.5.peg.165 Permease of the drug/metabolite transporter (DMT) superfamily
MKQYLADFGLLFVGIFWGLGFVFVKIGLNTGVDPFYLSAVRFLVGGLILYGIFFRKVGRF
TKKDILAGLIVGIFQFFGYAFQTYGAMLTTASKNAFFTSINVIIVPYIFWFLHKKRPDIF
AFLASVICVMGVAVISFDRKMNLANLNFGDILTIISAVFFAGQIATNGYFSKKVEPLKLV
VMQMFVAGILFVINVFIFSDISKIEKPAGMTLVAIIYLTLFSTAIPTVLQTFCQKYTTST
RASILMSTESLFAPLFAFFILSERLSLRVAAGASLVLFAVLVSETKLGLKKIEE
>fig|523794.5.peg.319 Acriflavin resistance protein B
MTVAEFATKRVVSTTMILLFMIFSGFMTMRSMKKELIPDFKFPMVVISTSWTGAASEDVK
TQISKKIEDAALNVDGIKNISTSSTYGNSNVIVEFNFGTDTDIKQVQIQSEIDKIKRDLP
SDANDPVVSKMNMAGGNSDMALMVAIRGGDEATITSFIEETLKPRLKRNRGVGDISVFGN
ATRQIKVKLDPYRLQAYNLSPSEIYAKIQAANTIVPGGTVKDGSKEFILKVDGELKTLEQ
IQNIIISNKDNQVVRLNDVATVEYGTKDKTSYSKYDGQDMISVMIQKSKDGNLVEIASIA
RKALEEMKPLFPSGTSYEIITDNSIRVKEAISNVTSTGLQALVITIIVLLVFLKDLRAAL
VVGMSIPISAMFTFFLLGTQGITLNMISLMGLALAIGSLVDNAVVTLDNIFDHIQLNKEP
AMVAAIRGTNEVILPMIASTATSVCVFLPIVLFPGFAKEVFSGISFSMMFALSTSIVVAM
LFIPMASSIFLNIEKISGAAGKAHRFNAFRDKYKELVKKALENRKVVIIGIAVLFVVVVF
GLGKTVKSAFFPTIDNNEYSVVASLSTGLDVEVAHEISKQMEQIVKEDPVTKNYTTIVNA
QAAIVNVDVKKDTMKAMERVRQKMSNIPNVTIAVSPQKAGGRAVSKDYSFQVEGDNAEEI
NRIANAIMADMKQQSWFKDVKSSSEGGYPQAQLEVDRVKAESYGLSVTDITRMLNQTVLG
VDPIEVTQDTETLKVYMEFEDEYKNSLEKILNIMIKTSTGQFVRLGDIATMKEVEGAASI
ETYNGAQIVTVGANMDKSKGLNDAASFVNASFQKTNPAAGYKIAPAGNAQSQKEMGGEIM
NALALSIVLIYIVLAVQLESFVLPLIMMLALPLSMIGVIFGLAVTRIQLSMFVMIGILML
FGMAVNNAIVLLDFVSGLRQKGMEIREALVEAAGSRLRPILMTTLTTVLGWIPMVFSSKG
SSGYYQGMAVAVMFGLSFCTLLTLFFIPVAYSIVEERKEKRQKAKEEKRRAKKINERN
>fig|523794.5.peg.1291 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKKREELLNGSIIGLFIKYFIPTLIGSAAVVLYNIVDRFFVGKISEKALAGAGIAFYIV
MLIIAFSMFIGVGAGTIISIRLGQGKKGDAKKILGNAVTLFAILGIALYVLLMLNIDTVL
RYSGANNETLPYARAYLQIILLAILPLFYSFGLTNVLNAAGAPRVAMFSMLIGAVVNIVL
DYVAVMIMHTGIEGTAYATLIGNVLSAVFVLWFLIAGKSPFRIDMFGFKLEKESVITIRF
SKLKLEPKIVKDIFSIGMSPFLLQAASSAVGLVTNKIVDTYGGTYGVAVMTIINSYLPIM
TMSVYSVSQAVQPIIGFNYGAKNFRRVKKSLMTAINAGVMLSFVFWVIVMLIPKELILFF
NEKSTPEGLREGVKAIRIYFSLVIISSFGITVPNYFQATGRSKYSVTLNLLRQVVIFLLI
VIIFSNIWKLDGVWYAQPFTDLLFFVILLGFLYKEKKFFDKMIQSENNILEYKEMIENKK
DKKNENIK
>fig|523794.5.peg.1799 Vancomycin B-type resistance protein
MSNGNRRRNFCDIHPFYYTISLHKEIAKRNIKDFFSKEKFAKTKKEEKLPNIISTHSSNI
IRKGKGIDPILQENKAVNLELASSKINGIIIRPGETFSFWKTVGKATRKKGYKAGRIISK
GKIKPGIGGGLCNLGNTINWLILHSPLEIVELHTHSDALDPSAEKNRIPFSSGTSVSYNY
IDYRFKNNSDQNIQLFVWCEDGKLKAELRSETEFPWKYELVEENHHFRKKGDKYYRSSKI
YRNAIEKTTENILSKELIWDNNSMVMYDYDLIPKELIKEEK
>fig|523794.5.peg.1980 Permease of the drug/metabolite transporter (DMT) superfamily
METKLKLRGMLLASLASSFWAISGISGEILFKQFNFSSDWLVSTRTLVSGILLFMIVVFI
EKKSILRPLKNKWDSMGIILFGVAGMYLVQYTYFKTIELSNVSFATILQFTAPFFIFIYE
SIKNRKLPSISTVTLLFMTILGVVFIATKGNFSNLSVSLEALLFGLVSAVMIAFYSTYPK
KLLKKYGSITIVGWGMIIGSVISNIIHPIWEIQGDINTKSIIQVIIVVILGTSIAYLIYI
ASLNYISSSLAGILTAFEPVLAAVLSVVIFGLKFSIIELIGFVLVFVSIFILEKRL
>fig|523794.5.peg.2111 Quinolone resistance protein NorA
MKKNINRMIILMFLCIIVYNLGHPATPALIELRGWKKSISGELLAFMSTAMFISSPYLGA
LADRVGMKRIFVFMPFCYGMSQLIFGFETNLPLIFLARMISGFASGGTFAVAFGYVSQLS
EKEEKAKNIAKVSSATVIGGAIGQKIGGYVATAMNDPRFSFALQFIGGSIVSIIILLIMK
EIVKKDSNSEEEKSKKDLNPFATFRYIKELDGYSKFFCLIILLSGIGIYSYGSALNYFFK
FYEKVSSDTIGTFVMCSSLLAFFGTAFLLGKLLKKFKEKSIYKFLIFTGIILMSVILFRV
KFGVTPYILMAVYTMTYEIVRSLGNTIIAQRYKENQGKILGVASAVGSLGTAIGSLLSGH
LLNFNPFFPFVVNIIVMSFVLILILVKKL
>fig|525146.3.peg.1155 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MTPPPARTHGPAGQASSGPSTPGTTRGDAANALAAPKGRRAALARAHGATLLFGASGIFG
KLCQCSAPMLVCGRAIFAVAALTLAGLGKKQPPWRGLHACDLLALTISGTLLAAHFVMFF
MGIHIGGVAVGTLGFACFPAFTTLIESLIYRERPSFAEMRGLGMVTLGLVCTTPSFSFAH
EGTVGLLLGVASGLAYALVTVGNRRFAGHLPGLQTTWWQNTVTAVVLLPFVWRQFSTVST
LDWLWIASLGLLCSALAYVLFINSLTVLKARQAALIITLEPVYAIAAAWLVLGDAPGGRV
FLGGGLILGAIFLANRR
>fig|525146.3.peg.2568 Quaternary ammonium compound-resistance protein SugE
MSWVYLVMAGLLEIVVVAGVRDIAFRRYARGFVVYGLGLTSSLFFLYLALRQIDVSIAYT
SYTGIGVIGTVASGLLFWGEKRSFRKACYVGLIVAAIVALKISG
>fig|525280.3.peg.502 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRKDFYRNVLPAMFAFAFSGLYAIVDGWFIGQNVGDLGIAGINLAYPITSFIQALGTGIG
LAGAIQIAIALGSNDHEDQARYLKTTVCLLIVASLVAFVLLFKTYPQILTFFGAQGRLFD
YAADYIRIIILFSIFQIMATGLVPIIRNYGGTLFAMVAMITGFITNVILDGYFVSVLKLG
TAGAGYATIIGQALTMLLCVGYMFKHVPFGGSEKIKVKMSSVVQVLKVSLSPFGLILSPN
LMIIVLNQSAIQYGGDIAAASYGVICYVVFSVQLLLHGIGDGCQPLISRYYGNDSMDKVH
EIVSIAIRFALGVALTCMVILYSLRFMIPGFFGASEEVALMIAEVMPLFLLGLIPIAFLR
VSTSYAYATRDNHTAYRLIYSEPILTTVLLLWVLPGMFGLKGVWLSVPLAQYCVLMYSIV
VYWKQVKQYKHDFHV
>fig|525280.3.peg.507 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNTITTRKQLRHNLARYILPSIGAMIFFSLYTMVDGMFVGKGVGPQALASVNLSMPYINM
IFAFALMIAVGASTRITYYFGKKNLYESNVIFSLGFWFLGLFALALAILMGLFRDSLILL
LGATPDTMHSVSQYLSMMILFSPFFMLTYYLEVLVKADGAPGLSLLGIILSAFVNIILDY
LFVIQFQWGIQGAAIATGIAQVFGFIFFLSYFLSSKSTLKFIKPTWNFQTLIKMIQIGIP
DALTELSSGFITFVFNLGVAFYFGSNGLAAFGVLMYLTNLVTVTMIGINQGIQPLISYYH
GQKQPKLINWILNDALFVSVLCGLGFFILCQAFPKVLVSGFIDAKNIEPFNLAVEALPIF
SFGFLLSGINIVLAGYFAALERIRPAMLISMMRGYLLVALCVIILPYLFGASGIWFAPLT
YELLTLVVSLILFKHYKKTA
>fig|525280.3.peg.647 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKIHKKTSMTEGVIWKEMLLFSIPLLIGNLFQQLYNTVDSFVVGNYVGEEALAAVGASTP
LSNVIIGLFMGISTGAGILISRYFGAKKDEELHDSIHTFMAFSLIVSIFLTFFGSVMSPI
FLGWLKTPANIMEPATLYLRVYFWGVTGLVIYNSGAGILRAIGDSRNPLIYLCISSLINV
SLDLLFVIVFDMGILGVAVATLIAQLTSAILVWIHLLRVEDIYQLKMADIRIHRDKLYEI
IRLGIPTGIQQTVVSFSNVLVQSYINAFGSAAVAGFSAADKFNAFLSMPTQSFSLTITTF
TGQNLGAGRKDRIMEGVRTALILAVGIVIVIGIPTFIYADQLIAFFSPEPMVIMYGARML
RIMVPFYFALSTTSILSGALRGAGLTMVPMIIMISCFTILRQIFLFIMMRINHSIDWVYW
SYSVTWISPMVLTLLYSKASHWLEKA
>fig|525280.3.peg.926 Teicoplanin resistance protein vanZ
MFERYLSPIINNTQGVSINSGIIVYILVAMIFLVKFRKTTVKNKILGLLFILYLGKVMDL
TLFPLPLNQKEVQNAAIHFSLENASIDYYNLIPFRNGISLKNLKEPLLNVLMMVPMGVFL
PVFFKRFRKVEKTVAGTFMISLMIECAELLLTLSFGVILWHFDVTDLITNTLGGFFGYCL
YYHAVRHVLVYFDQKESHWLHRKGFGVMSILLLFIFMMSSIYLEVSANDSITYRLNMRNM
ISNGKANRRYYSFDQYAVSMEGSMKLKRDDFAGSHSDNPTIELKQKVLFLDYSFGKYNVG
GIYLDAHHNEGDARLFSIIWDLDYGGDYFYFITESKIATARKVGEAKITNP
>fig|525280.3.peg.1495 Quinolone resistance protein
MKRPQFIEEFVVSNARVLFSELKRNTRYESCLIYQDHALVKCEQVCFSKCEFEMDACDRA
EFLDVVFDRCDLSNHSLQKSYLYRCEFLSCKLMASEIYDSKVKDVVFKDTLMNFMNLSQS
SFENVLFDGCRLNESSLMMAKYKNMKFKNCELTGLNLSDTRCNALDLTSCTFDTIVYSPS
LIKGMRIRADQASALIGYLGLIID
>fig|525280.3.peg.1535 Multidrug resistance efflux pump
MKLLIEKYKMSIFVVLNLLLTIGMNLGHPVTPTLLKSLDLPPHVFGLSFAAMCLTNFIFA
LVWSNVANGMKKTRILMISSIGYAIAQLLFGYALNRYSIYFARLLSGIFAGGFQVGLMSY
VVNEAPEDRQSHYITISSIIVSVGAALGFFIGGYLGDVSVRLTFVIQALFQIVLGILFYL
ILGSHENIEEKMEWSMIRNSNPLKVLQSSRHLMKDVVLILLIVTFTSSVGTTLFDQSFNY
YIKDIFNFVPSQNGIIKAITGLFAVVLNVILIRRRNRKKQGVELGLLKTVFIAMGSLAII
VSFSQTSKPFVGFALAWFGMYTVMIPILQNSVISNKHSVEEGNQLAGLYNSLLMLGKIFG
ALLTSLIYTISPSSTFMFAGVIFILSFIILLKPEKRMK
>fig|525328.4.peg.860 Permease of the drug/metabolite transporter (DMT) superfamily
MKQQKKLWIFLVIISCNLWGISGLCAKRVFDLSTQVSPITITQIRMLISGLFLLLLAQLT
GKKPIKILYSRKNIIDIILYGLFGLIPIQLFYFIVVQKSNASIATILQFMGPFFIMFYMV
VFEHQFLRRLDIVAALVAFMGIIFIATHGNFSKISLSPEVLFWGFLSALGVATNTLIPRP
LLKRMDSVTLIAWSMIATGLMMLIAYPSQILIPKDSRVIILLVVIIILGTILPFYCMLNS
LRYIKPSTASILDAFEPISATLGSVFVFNLILKPIDWLGTILVILAVIAICYQPKSKIES
IQK
>fig|525364.3.peg.847 Permease of the drug/metabolite transporter (DMT) superfamily
MENKKKFWTIMIIISCTFWGISGIFAKFIFNLDRSNTPIFVSQIRMIISGLVILFFSWLN
KDKPMEIWKTKKSSFTIIMFGLLGLIPVQYCYFEAIKYGDASIATILQFIGPFFILFYLT
IVKRQAPRRIEVICTIIAFIGVFILATHGNINHLAITPQVLFWGLLSAIGVATNTLIPKS
LIHEFSPTAVTGWGLLIAGVGLFIIHPHVSASILAPQAIVPLLCVLVIGTIIPFQLFTSA
LRYVKATTASMLDAFEPISATIGSILVFNMHFYLADMIGSVLIILAVILLNWQPKGKIQ
>fig|525364.3.peg.1503 Quinolone resistance protein NorA
MLHLDNSVFGTAFAVMSFGIFIASPFWSKIAGLVNSKSVIAIGCIGYAIAQFLFAVGHTT
SLILIGRLLAGLACGAFFVGVLNYIVNLSSETNRGANLTLNATIQTVASALGYFVGGMLG
AYNVYLSFAVQVIQLTLVGILFYLLLEKDSKNTDSLQLSLILKESNPLKRLEDGRLFMNK
AFALLFSVSILLYLGYTAFDQSFNYYLKDIFNLSSSFNGIFKGAIGIISLIVNTSIGLYL
MKNTKISKSLIYVLLGASTLMVLILFSHHLTAYVISSCIFYGFYALSTPLLQDLITQEAQ
VETRNLVLGFYQSTQSLGQILGAYLAGIIYNFSPQAPFSLAFLALLGAFLCSIFYRRMYR
I
>fig|525364.3.peg.1714 Permease of the drug/metabolite transporter (DMT) superfamily
MSMKTKGILLAAGGASLWGGSGAAAQQLFMTHAVTTEWLVAVRLLGAGLLLLIWGLIKSS
KQINEIIHDRKNMAMVLAFAIFGVMNSQLSYFFAIKYSNAPTATVLQYLQPVLIVLWMAF
GQKIRPRRVDGISIAVALMGTFLLVTGGRLDTLTLTPIALAWGLWSAVAATLYTLLPSGL
LKKYDAMVVCGLAMFVSGIIMLPWFLTMEQPHLSLFNIVLVIYIVVFGTMFAYTLFLQSI
RYIAPSVTGILSAFEPLIATILAVTLLGTKLSTAAIIGSLLIILTTVIQAVPFNVIWRRF
KRAK
>fig|525897.5.peg.1796 Acriflavin resistance protein
MIVNEAAQRRQPLVLVSLLLIIVAGLYSYANLPREAAPDIQIPYIFVTTDYEGVAPEDME
KLITVPLERKLKGLEGVEELTSQSDDGTSTIAIKFLPSEDIDDALQKVRDKVDQASGDLP
SDLEDDPLVSEMNFSDMPIIQVVLSGPFSLKRLKVFAEDLEDRFESISGVLDARIIGGLE
REIHVEFDLDRVGAYKVPFAAMLQSVERGNVNMPGGSMDIGDMRYQVRVPEDFRSPAEID
SIVAFVRDGKPVYLRDVAAIRDHYKDITTLSRLNGENAVTLQVIKRSGENIIDINDRVAA
VVEEMRLLLPPTLTISLTADMAEDIRNMVADLENNILTGLILVLGVVLIFIGGRSAVFVS
VAIPVSMLITFALLRLLDITLNMVVLFSLILALGMLVDNGIVIVENIYRHMQEGKDRFQA
ALDGTSEVAWPVITSTLTTVGAFFPMIFWPGIMGGFMSFLPKTVILALAGSLFVALVINP
VLSARYQTAAPALAVDGNVVRSRSKRAYLWLLEWALNHRALVLGVCVVMLLGSALAFGKF
GKGVEFFPETEPKRAYANVKLPVGTNLDATDRYIRIIEDVCSEYADVRYVIGSTGAATGG
DFGGGGSGTHLGSVTLDFVPIGERSRHSSEIISEVRDRLSALITGAELRVEKEDEGPPTG
DPVSLEIYGDDMQVLAGIVEQVRALMRDIPGIVDMKDNLVTGKPEIQIRVDKEKTSLLGL
DTYTVAYTVKAAINGAKVGVFREGKDEYDIVAKLPRKDRESVESLRRITVSGLDGEPVPL
TTLARVDLASGLGAINHKDQKRVVTVSSDVSGRLANDIIRELDGKLGALAWPRGYTYSFA
GEQEEQRKAQEFLSEAFVAAIFLIFMVLVAQFNSMVTPLIVLTSVVLSFIGVFTGLLITG
TAFGIIMTGVGVISLAGVVVNNAIVLIDYFEQLKAKGMQTREALLEAGLTRFRPVLLTAV
TTILGLLPMALGVSFDFFKWKLITESESAQWWGPMAVAVIFGLLVATLLTLVVVPVLCSL
QDGGRAWLTRRRSGKAGEAVART
>fig|525897.5.peg.2398 Efflux pump antibiotic resistance protein
MHIRTSALAAASVASFLVPFMMSAVAITLPVMQVELGATAVELSWIAGSYILALAAILLP
VGRLADILGRRRTFVWGTAAFVIFSLCASLAWSVTSLVALRVVQGVGAAMILSTGVAIVT
ELYPRTERGRVMGIMVACVYLGLSVGPLVGGMMTSLAGWRSVFFLCLPPGLLAWIMARRI
KDEWRPAHGEGFDLIGSLLYAAFVVCCVNGLTGLARPERGLPLLGAALILGVFFVLRSRS
VAHPLIDLSLFTANRVFLLSSLATLVNYAGTFAVGFLLSLYLQVVKGFSPMHAGFILIVQ
PVVQSLLSPLAGVLADRFNAAWLASLGMALCALGLLGMCGVDLHTGLLEIGAILALLGLG
FALFASPNMSVVMGSVEPRHYSIASSLVATMRTFGMTLSMGIAAVVFGFLLHDRQIAPET
IPEFLASMRIIFAVCAGLCVAGVFCSLGRVGKR
>fig|525897.5.peg.3000 Permease of the drug/metabolite transporter (DMT) superfamily
MKHSTSSKSLQGILFALGATVIWSGNFIVARSLNQSIEPATLSMLRWATAFVGLLPFAWR
AAWAERAAIRRSMPAMIPMALLGVTTFNALLYKAAHTTSTLNLSLIATSTPVFIILLARI
FLHERLTTRKMLGLTFALGGVLLLITGGDLGRLTGLDFAIGDLWMSLAAVIFAGYSILVR
RFPGGLSQPVFLLTLFGVGIVFLAPWTGWELLTAGAPTITLGAAGAILYVGLGASLAAYA
MWNSAVASIGPSLAGLIYYSLPLFSGVMAFLFLGEPMGLIHLLSAGCILGGIVLATRR
>fig|525897.5.peg.3201 Permease of the drug/metabolite transporter (DMT) superfamily
MKPYLYALGAVLCWASLPAATGSGLERLSVTELLFFSFVPAALYLTVQEMIISRRRAIPW
PGLRLVALGLAGIFGYHALYYLALDHTPLVEGAILTTTWSFWIVVFSSILDKKRLSPPVL
AVALAGLAGAGLVVSGGQSLQFEARYLPGYLMALGCGLIWSSFSVALSRLKPTRDYMPAF
TVLAALFSTLVYAASAPQALPPAGALFSALYLGLVPLGLSFTLWNRAVTAGNMTLIGYLS
YLTPPLAVLLAALVRGAAVTPHAVIGMIVILAAAFVGRRMS
>fig|525898.7.peg.13 Multidrug resistance transporter, Bcr/CflA family
MPHTLTERQIVLILASLSAITPLAIDMYLPAFPAIALDLHSAIPHVEFSLSLYFFGMAMG
QLFGGPISDAYGRRPMILIGLSVFALSSFMLSIANSIEMFWILRALQSFGGGVATVNVSA
IVRDKFDGKESARIFSMISMIMLMAPLLAPTLGSAILKLLDWEAIFIGLGSYTLITLGVY
LFCFPKTKQIRTKITPIQNYKTVLSHKLAMVFVISQILCTSGMYTFITSSSFIYMEHFQL
SAAQFALFFSSNVTMMMFFGWLNASLVKRREPLSLLRFGMSVQALLGILLFTFQDGSLYL
IFPLIGLYIGILGFIFSNSIALTLEFFPTISASANAIIGVLQYSVGALMGFVASSFHDGT
LFPITTVMMSVSLCGIILLLTGSRGYAPRHHIKSA
>fig|525898.7.peg.44 Multiple antibiotic resistance protein MarC
MTEFFNLLLQHTITMMAIVDPLGVSAIMLSLLPQSTTKEHIDKIARKATLTIIVAFFVVL
ISGNFLLNLFSIEIDSLKVMGGIILLFTAIKMVQGSMESKNQTEEEREEAIKNDEFSVIP
LGVPITFGPGIFATIIILRGHSEGFISIAALIMAYLIVALSVYLAFKNSIYIRKYLGITG
QKIVSRLMGLIVGAIAVQFIVGGVSVLVKHYM
>fig|525898.7.peg.131 Permease of the drug/metabolite transporter (DMT) superfamily
MINYKLKELIADFLLLLVAVAWGSTFFVVQAAVNETPVYTFLFWRFFVAAVLMLLLSVRA
LRYFNTEVLKAGVLLGTFMFLGYAFQTFALTYTYSSTVGFITGLNVIVVPFISYLIFKHK
ASLFSSFGAVVAAIGLYFLTLNSEIGFGLGEGYAFICAMMFALHIVFTGYYSTKHNVYLL
VCIQFFTVALGSFIGGFVLEGAIMPPRIDGLFINAIAITVLFATIFAFWVQTAVQRFTTA
AKTAIIFTMEPVSAGLFGYWFANEVLSLSQIAGAFLILSGMLIAELGAYMVERRRLKRKP
L
>fig|525898.7.peg.836 Permease of the drug/metabolite transporter (DMT) superfamily
MNQPKTDPIGILFLLIAMLTWASSFIALKSAIGPLGPMSVVFGRMVIASLCFVYFIKQFR
ALSFTRHDIKYILLLTLFEPCFYFIFEAKALQLTTASQAGMITSMMPLMTAIAASFVLKE
YLSKRIVIGSVLAVVGAIWLSLGAQSSENASNPLLGNFLEFCAMICGTWYAISVRYLSQK
FSALFLTAIQAFVGTIFFFPLAIWEYFTLPMHLSLEVFGWLCYLGIVVTLGGYGMFNLAL
SRIEASKASVFVNLIPVFTVLLAYLFLNERLSQTEMLASFVIFGGIIISQLPNLTKKKES
I
>fig|525898.7.peg.1089 Modulator of drug activity B
MKNVLILNGHQYYPNIAEGKLTQLYIDTAEAFLQSKGFNVKHAKAESNYNALEEVEKFKW
ADFFIIQYPVYWMGVPWMMKKYIDEVFSAGANNGIYANDGRSRSDATKHYGSGGLMQGKK
YMLSLTYNCPTSEFSNKEGFFDGLSLDEANIATHKTWQFCSATPMQTYSVHDIFKGDLNI
EAQKAKFIAVLSQNFLG
>fig|525898.7.peg.2219 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNVTKDNIASIFFQYSIPSVMGMLAISSANIVDGFFIGNYVGDFGLAAINISLPIFSFLF
GFALMLAIGSSVLAGKFIGEENVKNASLIFSKTIVTITLFSFLTSSVLFLNIKTLLHFFG
ADENLAKIAIEYLSIMLLFIPFLMIGVVLDYFVRVDNRPNLAFIALLFSALINVLLDWFM
IVYLQKGIFGAALATGISQLILLFILLPHFFSKKATLQFVKPIGSYAHILKAFYNGASEF
VNEISIGIMTLVFNYVMIKNFGMEGIAAFTVINYLLFIGVMISFGISDSLQPIISKNFGA
KEHKRIGAFLKLAFIATSLVGVVMILLLLFVPDTLADIFLEESNDTTKQIVLSFATYLWI
IFLFDGINLVISAYLTAIHKPLASMVIALSRSLIFPVFFIVMLPFVFDKNGIFMAIPMAE
AVSFIIAMSLFRKFSPQNLGELNESS
>fig|525903.6.peg.33 Acriflavin resistance protein
MLHRASLRRPIAMGCLLIALSLLGINAYRKMGLELMPKADVPYVTVVAIWPGASPRDIET
DVAKKIEDAVSSVDGIKHIKSTCMENVAVVSLEFELGTDVNVAANDVREKIDPIVPDLPE
GVEKPIIQKFDINASPIITMALVGDMRLDELYDYADSRLKDRFSTIPGVAEVRLTGGSKR
ELHVLLDPFRLAERGLTSSQVTRALAEGVRTIPSGRIKDGEDEWSVRFDGDYRSVQDLAM
MPIAARNGARVYLRDVAQIRFDTAERRQAVFLDGRQAVGIRIVKKADANAVELVDRVMRT
FESLKGELPGGMRLVWVTDEGTYIRSSVRNTISSIVQGIVLTAGILFFFLYNLRSTLVVS
VTMPLTIIMSLFFMQLMGYTLNTSTLLALGLSVGILVSNSLVVLERVLSKLKEHGDPKRA
ALEGTSEVALAVLASAGTNVVVLLPIGLMGSMVGLFFRPFAITSLTVNAMSIFISFTLTP
ILSAYLLKVTSGGRLERLEERFNRWLDRLSDRYVGAVRHLVSSRARATGVLVLVLVLFLH
AMTLPKRIGFNFAPDVDKGNVYVKLEFPTRQNLDATVQGVREAEERLRDLPHLRHVFSTV
GTVEGIGENEEGVYLAQLLLNFSDKTERRESIFQLVEEARRRMRDFPGAKVSVSIPSFIG
GQNVPIQMDIMGDDFEQLDRIALEVQRRVQEKGGFFDVDTSVREGKRELLVRPNRAVLAD
LGVPPLAIGGMLRNNLEGQKAAVFKTLDKNYDIRVKFQEVSGTQRVASFQLPGPGGSTVP
LASVAQVSQGLSPIKVYRSDKMRTSKLFASLSPGYPLGTAVEDVEDMVKRENLLPPGYTV
KFRGDYERMADANQAFLEAGVLSVILTFLTLSAILESFKWPVLILTTVPLGMVGVFWALW
LTSTGMNIFVLLGAVMLIGIVVNNAILVVDQFRSLRAQRPGLDSAELMLMALKESFRPVL
MVTLAAVLGMMPLALSRGMGSEFTTGIGIASAGGVAMSGLLALFVIPLLYIVHLEWKSRR
GGDGGKG
>fig|525903.6.peg.259 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRDEILGRDPIPSLIVRFSGPAIVALLAHALYNITDRVFVGRAVGSSGLAALSLAFPFML
AFISWGLVCGVGTSARMAISLGASDREGARRYLGNGILMALVGSVVMLALGFWGMEGLLR
SQGGSGEILPMAQRYLRVILLGAPFSVLGMTFTPVLRPMGRPNAAMGIQLVGAFLNIALD
WWWVMVLHMGVEGAAWATVASQAVQALLGAALVLNSSRIRPRHMVPEPSRMGRIFSVGLP
SGLTEMGFTIVIAIMNRQVKLYGGDAGLSALGIFFGLDALFFLPAIGVGEGAQPIIGYNY
GAGNLQRVRRAIWTAVGYAVGYFCLSLLLVQIFAPELVSLFVKDDPVLLDMAAWGLRVSY
AGAPMAGMSITAAYYFQGIGNWRAGLITAMCRIVIFVMIPLMILPPIMGITGVWASLPVA
DVGGCMLGFLMVRRSLRSIGACDPSGPA
>fig|525903.6.peg.406 Permease of the drug/metabolite transporter (DMT) superfamily
MMNKGISRRAVLLADGAILMAAAFWGVGFAVLKDTLDYLPPFTVLVVRFLIGGLMLGLVF
LRHFRGLSRTSLKDGLITGILLFCAFSLQTVGLMWTTAGKQAFLTATYVVLAPLVSWGIS
RVFPGLRAMVASLTCLTGIWALSSADAVVLNRGDVMTLMSAFFYACHLIAVDRFTKRTDP
VALAAMQMVVLGLISLPFAAFEAPSFHMPLRGWMSLLYMILFSTVGAFTIQNVAQKYTSP
THAALLLSTEAVFGAVSGVMILGERFTLQMVLGGSLVMFAILLVEMPWPKALSSQGEATD
P
>fig|525903.6.peg.1384 Acriflavin resistance protein
MKLWEFSVRRPVTVTMLTGAMVLFGLMALSAMGLQLIPDIDLPVVTVSTSMTGASAKVMD
NDVADVIEDKLSTLSGVESMSSSSYQGVSITVLEFQLGVDVDRAAADVRDKVNLAARSLP
SEADTPVVQKFSIGDRAIITLALVGGSDPKGLATFADKVLKPRIQAIEGVGEVGTPGLRT
REIRVWLDPVKLEARNLMVKDVIDAFKAKHVELPAGSVKNSRQEIQLRLIGEYQTVEDLS
SMPIKVEGNAMVRLRDVARVEDGLEDKGSAALYNGSDTIFITVKKQRGANEVAVCRRVRE
AVQEMRRQAPAGVNIMVIGDQSDYIMRSIRGVFSNVFQAVLLCALVMFLFFKTLRSTFIT
VISIPVSLIGSFLVMRALGLSINNLTMMGISLAVGMVVDATTVVLENVHRQVEGGLKPLE
ASIKGTQEVAFSVVAGAATTMAVFAPIAFMGGIVGRFFYHFGITVVVTVGLSLLVSLTLT
PFLCSLALKHEPEPGRLGRAFDRFFARLEAGYRRSLFWAVGHRKAVVLAAFGLFVLGLGL
AANIGKGFFPTSDRGSFSVDVELPPGSSLERTQEFIAKLDHRIRRNQYVKYTYGDAGSGI
GGEANKGSISVELVPIKERPPIDQVIDQVRKDLSSFREGKLTFSQEGRSGVTMMLVGATT
ERLYQIAEQMRRDLEATGKVSDFDTDVRLNIPQLEILINRPMADALDLSVKDLAQEIQAY
FGGTKVGVFKEGGFRYDIRIMADQMARTSAEDVKDVAVRANGSSIRIPGVVDVRKVLAPN
VINRYSRRNSVEISVNGRGISTGELMTMMEGSFRKFVRPGEGVQIMPSGRSKSQRDDFKR
LFTALAIAIALVYVVMAIQFESFLHPLTVMFSLPLLTPGAFGLLFLMGNELDMMSFIGII
LLVGIVVNNGIILVDFINQEREKGAPKTAAVLTAGPLRLRPILITAVSTMVGAIPTALKL
SEGADFRQSMAVAVVGGLSTSTLLTLFVVPTVYLILDDMKDRARALLRYLRGAKAPRLRE
GS
>fig|525903.6.peg.1388 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGSEPVGRLLMRLSLPAMVGMFVQATYNMVDALFIGWGVGPLGLAGTAMAFPVQFLAMAF
ATMGGVGGSSLVSRSIGAGDRETACYAFGNLMWFAWTFGLIMAVGCHLALGQILGLMGAS
EDVLPHGRAYLEVIIWGFPLIMAGIGMNSTVRAQGRAKLAMATMLVSAGTNVVLDYVFIF
PLGMGVRGAALATVISQGVMVVWLMVHFALSGGRMLSIGVRHLVPRWGVLRQILGVGSSE
FVRLGASAVVVALVVRSLQRYGSSDAVAAFGVVNRVVALAFMPIIGVGQGLQPILGYNYG
AGKMDRAIRAIKLSLLMASGLSTLAFVLMMIFPREIFSLFTPEEALIGVGERTLRTMGLG
FPVVGFQVAGTGVFQAMGKGLKSFVLSLSRQVLLFIPLLLVLPPAMGLKGVWLVYPLSDL
ISAIITGVMLALQLRALGRIEDGKVM
>fig|525904.6.peg.24 Permease of the drug/metabolite transporter (DMT) superfamily
MVTVGLLIVTAIWGLTFVTVQSAVADYSAFSFLTLRFALAALALLPFSANRIGKKELFVG
VPVGATLGLGMLLQTVGLRSTTATNSGFITSLYVVFAPIISALCFRSRFHPRIWVAVILS
TIGLFLVSKAGLYGVNPGDALTLGCAVLFGIQIALLSRYSPGLDSAALAFIQTVTSVFMY
LPVVFLTRTPLITNDLDVWLALLITGLGASAFGFWMQTYAQQRMSAARAAVIMAMEPVFA
AIGGYTFAGDRMTILQWFGAAFMMAGLFVAEILPYLKHRVSMSQRLGETLSEKDLSA
>fig|525904.6.peg.365 Vancomycin B-type resistance protein VanW
MEYVRTPLVLTQGEHTWKITPAELGLQPNVDPAVQQAYKYGRDGNIFHQFAERIPIGRRT
VRIQYVLDKSKIDNYVNNKLAPQIARPATDSKLTVSGDGTILASKEVDGQKLNTSMAIQQ
IYSALVNLRKGDIALPVVTVKANITQSTWRDRQNLVLKLSKPVTLRFENRSWTITSDEIE
QAIVAESGAEGVVGKIEPSKLMPILANINKDIALPPEPAKLEIKGNQVALTPEQPGRRVD
YSATLSAIYAALQSSGETDLATKEIEPIVTTSVLENARSQLEKLLASPLKLHFKDQSWEI
PTSTLADWTSIDIDKANRTSSVKLDPNKVNEFVDNLASEINQNPINGELTWRGKLVVLRE
SQDGQDLDTEKTKDLIAQAAFSDDRDVDLPVKVTKPKIPTDNLAALGIKESIGWGSSEFT
GSPPERVHNIQTAAGYLNNTVVAPGETFSFEKAIGEISVERGYQEGLTIVADQTVPGIGG
GVCQVSTTMFRAAFWAGLPIVERHQHSYLVPYYQLDGDPPGFDAAVYFPYKDLKWKNTTG
HYILIEAKWTDTKLTITLYGTDPGYEVTRGKPVITNIVPPLPDKTIYDPTLPPGTKEQVD
WAHEGMDVTITRTVTKNGKVVLQDSFFSRYKPWGNIYRVGPPKKEPSKKEPPKKETKNKN
KESENKDKQQKKDVNNSKDSTKKIEQR
>fig|525904.6.peg.845 Permease of the drug/metabolite transporter (DMT) superfamily
MKQGTKDRTKQLSGIALAFVAVSMFSTSAVLIRVIKDISSIEITFWRMLIAGLLVLGAAL
ISSQLSLKHNPFNYRFLAYGLVAAMHFFFYIASLEYTTVSNSLALVYTAPVFVALFAALA
LHESINWRQWLGICIVVVGVMIFSGFDLGLDKSRLIGNFLAILSAAAFGVYSVMGRGERN
KYPLLVYAGGTYLTASLWLLPLAAHSMINSSYSMTNIIALLALAIVPLGMGHTLYNAALR
RIHAAHANVLSTLEVPGGTLLAWLFVKEPVTLRDMIGMFIILFGVLTVILTADRTP
>fig|525904.6.peg.1524 Vancomycin B-type resistance protein VanW
MEKILAREIESWREEASELRNYPHGRSFLLRLIRAALPVLAVFVVVLLGSAFLITRAYSD
RIYPQVVVGNIAVGSLTQDDAKEKLESSLEDYLNNPVVLTFGQLQWHPAAEDIGLTIDVE
ATVNRAMRAGREDPVILVIARTLVGQQSPEVVPIVMRIDESRLSSYLSDIGRQINRDPLN
PSIQVSEGNIQIEGGGAGYTFLQPETESKVLTSLRKMSKGPVSIAVYTTAGTISSQEVSK
AESLAKSMISSPITLVGDNQQKWQITTDKLQDWLRSKPVKVKGNTELDVYLDPVELENYL
DSVAKDINSEPVNARLRWDNGHLSVLAPGKLGRRLDIDRAIGLIQEAAKSNSRQVQLPIS
RISPSVSENNIASLGIKELIASGVSGFRGSRPERIDNIKKAAQAINGYVIPAGSDFSFAE
AIGKISESAGYKPELVGDNRLELQGWPGGINQVATTVFRAALYAGLPILERHSMPYRLDF
YQQENQQPGTDAMVLVPGTDLRFTNSTPAAILIQVSVSEQDQTVQVNLYGTDPGWSVDVK
PPIIENVVQPIGDIYWTDPTLESGKTETYLYASAGADVVIERTVRKGTEVILDDNITSSY
DPLPTVFAVGSANSDNG
>fig|525904.6.peg.2343 Aminoglycoside/hydroxyurea antibiotic resistance kinase
MSLVPDSLVRVMQDLHGDAGRQWVESLPAILWELSSRWGVEVGAPFPELSYNFVCEAVLP
DGQPAVIKLGHPRDEAFWHEAEALRAFDGRGVVRLLAEARDLTAMLIERALPGASLLSLG
DDEAMTEVAARLLRDLHVPPPDAHRFPTLADWGQGMRRLRERYGGSSGPFPPRLLEAAEA
CWRELLASQVRPMLLHGDCHHYNILSTEGGWVIIDPKGVVGDPAYEVAPFMLNPADVARS
PRRVFERRLDIICDLTDLDRQRIVRWTVAHSILSAWWGVEDHGEPWTDALAVGEIFCSML
>fig|525904.6.peg.2894 Tetracycline resistance protein
MSAYRLYLIYSGALALLITGIYSLSNVYRLEVAHLNPLQLVLVGTALEGTYFALNLPTGV
IADTYSRKLSVILGPCLFGVGAVLEGLLPVFGWIIVCQVVQGAAYTFIEGALESWVTDEV
GEEMSGHAFLHAGQVEAAASFVGILLGVGLSSLELRLPFLLGGALLLSLGVALVWLMRES
SPPYSTRRAQVGLQGYLGAGLRDMSDTLHGGMRVVRTRALAGTILLVAAMMGGFSEGFDR
LWQPHFIQDIGLPSVGGLDRLVWLGLAMAVNPLLASLVLRSVRSSLSDTSPRTIIGLLMG
TDVVVMLGALAFALAPNFTVGLLAYWVMTVARRVHQPLYLAWINQGIEGRVRATVISVSG
QVDSLGQFVLGPLVGGLATLLSLRVGLALSSCFLAPLVALYARSLGKVRVDVASTVE
>fig|525904.6.peg.3028 Multiple antibiotic resistance (MarC)-related protein
MNFFLKALVALFTIVDPIGMAPIVVGLTAHLSPAVRRRVVTRATLIATGVVAVFALFGKP
LLEFLGITPEAFSIAGGALLFLVSIDMLFGRESGARETGREAREARTREDISVFPLAIPL
IAGPGTITTVILLMDSAQGHASRQLAVAAAVAIVMFCTWVSMSLAFPIQKRMGTTGTLVL
SRVLGMLLAAIAIQYILNGLSSFAESLRTILS
>fig|525909.11.peg.619 Permease of the drug/metabolite transporter (DMT) superfamily
MERRSLAALGVLSVIWGCSFLFIKVGLATFSPDLIAFVRTTLGASVVLATARLRGWALPR
GWRLWAKLAVAALVSNTLPFILFGYGEQHVSAVLAGFINATTPMFTFPLAVALKLERVSV
GRIAGLAVGIVGVGAVVGIGTGAISGASGVGVLACLAAAALYAVGFVYVRMTLGLTGANR
TGLAGGQLAMAALETGVVVLVMRQGIGTVHPLALAAVATLGVAGTGIAYIVNFALIHRSG
VVGASLTTLTMTVVSTVAGVVVLGEPLRWYQPIGALAILVGAWLVQGARPVSTRLVPATE
>fig|525909.11.peg.899 Multiple antibiotic resistance (MarC)-related proteins
MVTKFFVEALVTLLVIIDPIGNIPTFLVVTRGRDQRARRRLATEAVLVAAAVLAVFALAG
SQILDYLGISIPALEVSGGLLLLIVALELLTGRGGSIGTTEEGISVAVVPLATPLIAGPG
AIAAVLVLAKRAATAPLSVALAGALVGSMVILWVVLHYASALVRILKESGIALLSRVFGL
LLAAIAVQLAAEGIRGFGL
>fig|525909.11.peg.1172 Permease of the drug/metabolite transporter (DMT) superfamily
MGVTAIWGVTFPLNERALGSLGPVELTFGRFSVAALVLWVLALARGHRIDRRSVVAGLAS
GLALFGGYLTQIEGQRYVSPTIAGFLTGLSVVVVPIFVMALGRRPSARQLVGIVLAALAL
VVLSAPRGHASFVGIGLELACAGFFGAQIVVLEELGSPGDAMVTAALQMTTIAAATVVAA
PLVGAGLVPTHLTPIAVTAIVYDGVLASALAFVVQAWALAHADSVQISVIYAAEPLFAAL
ASLAFGYASLGLPVVVGGLLALAAMVLASVPPAAARSSDPTG
>fig|525909.11.peg.1186 Drug resistance transporter EmrB/QacA subfamily
MTQGSHRHRSGLAIAVIAGAQLMIVLDLTIVNVALPTIQHALHFSPTGLSWIVNAYTLVF
GGLLLLGGRSGDLFGRRRMFMVGVALFAIASVFSGLATSQAWLITGRALQGIGAAIASPT
ALALISATFTEARERGRAFAIYSAVSAGGAAIGLLAGGLLTQYASWQWVFYVNAPIAALL
LVAAPRVLAETERHHGSVDVPGALTGTGGLALVVYGLIHASTTSWSNVTTIAVLAGGVVA
LGAFIVIERVRREPLIDFQILAKRERGGAVAMILFVAASMFSVFFFVSQFMQDVVGYSPV
RTGLAFLPMTLGIMITAQLVSRNLHRVGPKPFMVGGSVLIAVAMGLLSQMRASWGYLDLL
GPLVILAIGAGSSFVSLFPTATHGVEPRRVGMASALVTVGQQVGGTLGLSILVTVTVAAA
KRHAAALAPRLASGHLTPQALTILAEVHGWAAGFAVATGFGVIGLLIGLIVVPHLGPTAT
EGAAEGSAVAA
>fig|525909.11.peg.1745 Permease of the drug/metabolite transporter (DMT) superfamily
MNHLDHRQRTLGIIALAGASAIWGGMYVATAALMRQTPPLVVLELREAIAGLILVPIAWR
SGRLRIARGDLALAAAIGIVGFTVSIGLQLEGTHIAGAALGSLITASSPVLIALLGRVWL
RERLPWPKLVAILVAVGGVALIAGHPPGGPQVEPGIIDLAGAALAWAIYTVGSAHLTRRY
DALGVLAIACIVGSVTSLPFALASASHAAHPLPTTLVAWLEVAYISIAGMALAFFLWNWG
FGRVDAAVGGSMLLFQPLVGVVLGIVLLAEPITLTLVFGGFLVVAGVSGAVAIATPRVQL
ATNASPEAPQSGIRT
>fig|525909.11.peg.2144 Drug resistance transporter, EmrB/QacA subfamily
MVLCAVMSLTFLDTTIVAVALASVQTSLHAGVAQLQWVIGGYALAFGALMLPFGALGDRF
GRRRAMLVGLALFAVGSATAALAHSPAQLIAARVVMGVGAAASEPGTLSIIRQLYTEPGS
RARALGVWSAVAALALAVGPVIGGVLVGIGGWPAIFWFNVAASVVVIVVTAIVIPESTDP
GVGRIDWGGAALGLIAIGGALFGVIQGEARGYGNPLIVAVFVVAAVGLAVFSVLEAHVPN
PMLDLHYLRRPGFSGSLVLAFSVYFSIFAIFFFTALYLQIVEGYSGYRIASVFLPMALAM
ILTSLATGRWVARIGVGMPIALGSLLAGLGVLGADVGLSGSTHPLVLALSLTVAGLGFGT
TVVPVTSIALAVVPQQHSGMAAASTNTARALGVIASVSVLGSYLNAQLTSGLGTKLARLG
VPPVFRHVVISAVETGGVPGGSSIAADTKTFGPLVAKVVTAAYGAFHRGLTISLIIAGAL
IIVSGVLSAVAVRGARTRPDGETSQA
>fig|525919.4.peg.36 Multidrug resistance ABC transporter ATP-binding and permease protein
MTEKKYTNKYLLKRFIPYYRPYKKVLTIDLLSAALTTISQLVLPLLLSYLTDWAQLGLLD
MPRLGKVALIYLATKFIEVVSRFIMQSYGHIMGALIEKDMRGDVFSHLLTMDTEFFNEAK
IGQLMARMTTDLNEITEFSHHVPEEFLVAAIKLAVSFVVLLTINWQLSLIIYILIPIMYI
FSRKSRQKFRQATMNTRKQIGAINSGIEDTLLGINVVKSFANEDIEKEKFGRENEKFADI
KKDQYFNMAKYFCVKDAFSGFMYAVLILVGGIFVIQKQITAGDLIAFTMYLNMLVATIER
LINFTDTYERGTTGIERFVQIMNLDRDIYDKDEARDLEDVKGKIEFDHVYFKYPETKEED
PYVLDDMSFTIDVGENIALVGPSGAGKTTISKLIPRFYDVDDGAIRIDGDNIKDLTIDSL
RDNIGIVQQDVYLFSGTIKDNIKYGKEDATDREIEKAAELAGALEFIKDLPYGFDTYIGE
RGVKLSGGQKQRISIARVFLKNPPILILDEATSALDNKSEAIVQSSLEKLSKGRTTLTIA
HRLSTIINADEILVLTYDGIVERGNHKDLLAKKGVYYNLYNSNNTDLFG
>fig|525919.4.peg.1350 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKTISKKENIMGTMPVGSLLIKMSIPMVISMLVQSIYNVVDSIFVARISEEALTAVSLA
FPVQNIMLAFAIGISVGASALLSRYLGMDDKKRVGSVAMHGVVLSVVGAIAFALFGIFFT
DFFADSQAASPEIVAYTRDYLWIITIFGFGLFFQVLCEKLLQATSLTFYTMIVQVSGALI
NLILDPIFIFGLFGFPRMEVKGAALATVIGQIGGSIIGLIINKTKNTDIEVDFKHFRLHG
DILKQIFWIGLPSIVMSAISSVVIFILNAMLRAFGQSAIAAYGVMFKLQSFAFLPIIGIS
NAMVSIISFNYGARHVARIRRSIKLALISGMVLVGIATVSLWILPNQIFDLFNATETMRE
IGVPMIRIVSLSYIVASVSIISVGVFQALGNWQSAILQSFLRQVFILLPTFYLFSLTGNI
DLVWWSFLISEGLNTIMCVYFLKRDIKNKIDVL
>fig|525919.4.peg.1551 Multidrug resistance ABC transporter ATP-binding and permease protein
MFIKFNDKQMNLKSREIVALIVSTCIFILSNILAIYVPSILGKIIDIITSTNKSNSVRDY
VFIFAIISLLIILLQYISSKILNELNKKINIRMCTYVFSKIRKMNLIYWFKESKGEIITI
ISNDIYNITDFITNSIPNLFSLIISTILIFIYIMRSSLWIAFIIFLLNIVLVVIQYMMSR
VVKIKSRDVRNLNAEVNSKVQACINNVENLLLKDYLKSSSENYNRSNKKLFIANNNLMDL
ILRSSTLNLLASLCSIFIIIAIGGHLANTGNISTGRLVTLILYSQKIFSPITNITKILMK
FNTILPKKTKIDQLLDNQDMIEDFTNFDQLLEHKLNFKTIIANDLETGYLDDNIKIENLS
IDFTKSNVIGIIGDNGVGKTTIIKLIRKLLPIKKGKIKIDNTPLEDIGIGELSRNIQIMP
QTDSLNQYDIKYIKSKLQEHYLNVDIEMFIGDISKIFKSSDKYEYNINSKGELQKLSFLN
TIFKDAKLYILDEPSASIDLKSEKYMSKIIKALSKDKKFIIITHRPELLNICDYIINL
>fig|525919.4.peg.1665 Antibiotic ABC transporter, ATP-binding protein
MKNIRKLFKEIDKVHPGFSVRVIITNLILGFLPLINIFAPKLIIDELMGQKRFSYCLGLG
ALVLILSFIKEVTYRGLNNYLTLTFEDMSDKLTFKIAQKSLRLPIEKSDSKEIQDMMEQA
HYAVWEMYTLYDIIVLVISAVITGILSLGILVRLNPAILILLLLLILINKKLVKLIKENE
LKYQENNISDLRSYRFFSNFAADLRYFKDIGIYDGQDLVLEKADYYQKEMIKSSTDYFNK
NGIYTGIMNVSANGSIILTLIYLTYKLIDKTISLANFTMYFNSLIQVINATNLIQQNYAK
VISVNAQLKVFFDFLEMEEGLLDKGHIDHIDTSEVRIRFDNVSFKYPASEDYVLKDATFE
IKNGETVALVGKNGAGKSTIVKLLCKFYEPSEGNIYLNDINIKDINTKEYYKILSPTFQD
FRLFPFRISENITGMLKDEIEDKDYEKMDKSFDLLKLASWIDKLVDKEDTFLTYLFSDES
VEPSGGIGQKLALARSMYHEGKFFIMDEPTSALDPRSEEEIFENMLKISKGQTSLFISHR
LSSTKYADKIIVCDKGCISEEGSHEELMKKDGLYKEMFTSQADLYL
>fig|525919.4.peg.1849 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNTLLKSYFKYLIPTILTMILFSTYTMVDGIFVGQGVGAEGISAVNVAMPFITLTFSLS
ILISIGSLNLITYQLGKDDKEKADEFFSIGLVLSLIVAISISVFTYIFMDPLIKVLGASP
EISHIVRDYLSVIIFFTPFYVMAYVFEIMVKADGRPIISTILMIVSALTNIILDYVFIFR
FHMGVRGAAIATGIAQVLPTIGYVAYFMSPKAKLKFRSFKLKFYKIKEIISYGFPASLNE
LSSGFVILLFNNVISAYYGTEGLAAFSVISYIMIFVVNTMIAVNQASQPLLSFYFGRESY
EDVLRIRKYMLRTVALLSLMIFVIIELRPEFFVNVFIADYEEAFLPFAVRALRIFAISYL
IMGFNIINAGYMTSVKKPRYDFYITMVRGYVLMAILVYALPLALGKEIIWHVATITEFVT
MIFSIFFIRDEIKEIHKLERIRDKHIKKKYQ
>fig|526218.6.peg.332 Nitroimidazole resistance protein NimB
MFREIRRIKKKLPESEAVRMLEQLSCCTLALSGDDGYTYSVPVSFVYDNGKIFFHSATEG
KKCDSILQNNKISFSAVEKDDIKPAEFTTHYKSVIGFGEITLLEKREEIQHAMELILKKY
SPDYMKEGKDYIERAWGHFYTYVIDIHHMTAKGTEKQKE
>fig|526218.6.peg.486 Multidrug resistance efflux pump
MNNKRRRGRKKKKIFLKKKIEFFNENKGIKIFCITLIAMISFYIIYSIRMDYITPYSSNA
VVEYDVIPVYSRVNGIIKSINVKNSDIVKKGDKLFDIESEQYRILYELAVANKESAERHI
DTMDKEISVEKAQIEKAQKNLDTLSKEHEKYKMLFEKEMISEDLYDDIKIKYDNAKNDYE
IAKRQLKQLEVSKGKEGSDNDLIKVSDSQISKAKLDLEYTEIISPINGIVEMKQLYSGNA
VNTSVPLLYIINKDELKISVETKEKTINAIKNSDLILVVFDAYPNKIFHAKLVDITKISS
SSYTKPGNLEDVEQIDNKVVRPQGFGKVNIKITDKIPENYDIMGGGKASVLFFSKDVGKP
MKLFGKVWIKAVQLFKYIQ
>fig|526218.6.peg.565 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTVTKIKNGSMSKEFIKFVIPAIISMVVTSMYSIIDGIFVGRGVGENALAAVNIAYPLIM
LHIALAMLVAIGGANAFSINKGRGDIKNANRIFLQSMILIVGISVILNVLILVFPTQVSR
LLGADDMLLPYVRDYIKWVALFAVIYMPGLALSIFIRNDDAPKREMTGTLIGAVTNIVLD
YLFIMVFDMGVSGAAIATGIGQLVSTFIFMTHFTKKNRLLKIEKVKFYIDDIKYIFINGS
PSFLMEFSQAAVAFSFNIVLLSRIGALGVSAYSIVMYICSIFNMILIGLVQGIQPIMSFN
YGKGNRENIQKVYKMAVRTSLCLTVIVYIAVFIFGKALSDIFIRNNTQVTNMALNMMRYY
FLAFFPIGISLINILYFQIIRHEKWAVFLSFIRCIGFVQLSLLIMPELFGITGIFLSFLC
GELANCFISVILYKYAEKSQSNTVKISDKKVLFRNIETD
>fig|526218.6.peg.745 Permease of the drug/metabolite transporter (DMT) superfamily
MNKGDIYTLFCALFFALHIIALDYFTKIYDTLILAFLQIIFAFLFSAVSALITGQVSFGI
SSQGLLATLYLGIFSTFLAFTIQTAAQKYTSSAKTVVILSTETVFGAVFSILILNEQFTT
KLLIGCLFIFAAIIISETKLNFIYKSRRNII
>fig|526218.6.peg.1138 Vancomycin B-type resistance protein VanW
MWKKVTLIIAGIFLLFGGAFFYFVKDTDKIYNNISVSGVDLSDTSKETAKKKIEEIKLEN
VKLKYEGKEFMISGDSISYKVDSDTIVNEAYNVGRNGNFLKNKAKIFALKALGKKVSLPL
HYSINEEALKNELVKIASEVDVKEQDARLVINNDQISVIDEVNGKKINIEKTLSAVMESI
KYSKHDDINLVAETAVPKVTKEKLGSVNTLLGEYTTTFNSGVYGRSENIKLAVKSINDVL
LEPQDILSFNDSTGMRNPKNGYKSAPVIVNGEIEQGLGGGVCQVSSTLFNAGALSGLKIV
ERSNHSIPSSYVALGRDAVVDYGNLDLKIQNNFQNPVYIAADVVGSKIIIKVYGNQKDKA
DEVKLYAVVNGSIPRKTKTVKSGKATNGRDGIKATTYRVIVKNGSETKEVLSSNYYPPKA
RVVVLTPAPAVVSEEAPSL
>fig|526218.6.peg.1373 Permease of the drug/metabolite transporter (DMT) superfamily
MKFKDSYHPYAIITIVFWSLAYVLTRLTLQYFSSFSLGFLRYFIASCALLCIAFITKMKF
PSKKDFPWFLLAGAVGFFIYIITFNKGQESISASTASVVIATVPVITAVLARFIYSEKLS
CIQWGAIIIELIGVCILTLLKGIFSINIGLLWLFLAALVLSIYNLIQRRLTKKYTALQTS
SFSIFSGTILLAVFMPASLREVLHVPFIQLFYVVLLGVFSSAIAYIAWSKAFSKARQTSD
VSNYMFVTPFLTSILGFFIANEIPEYSTLIGGAVILFGILVFNFGDKIYGLLYK
>fig|526218.6.peg.1614 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MERKKNLKNMLRYVIPSVTALMVNSVYIIVDGFFVMKGVGEKALAAVTLSVPFLEALIAV
SMLLSVGAGIYISYYLGKGSKNTANTVLNTSLALLFLVSAVISISGIVFLKDLARILGAD
ETMTELVCDYLKYLLYFSPALILSYALATFLRNDNKPGLGMIAMIFGGLANGILDYVFIF
VFNMGIEGAGLATGLGPVFSILIMMPHFFLKKGDLYFRLSAFSFRYCKKILTAGIPAFIT
EYSLGIVTYLHNFVIIRILGEQGVAAYGIIGYVALIVLTFYLGISQGIQPLISMAYGAGK
DRELKFYTRVSFIFAGIIGIVSTAVIIVFARPITEIFSGNNSELTAVTVYGLRIYSVNFI
LAGINILAISIFQSVQKVKTASVIAVIRSTVFVYAALMTLPVFFGSLGIWLSMPFAEAGA
FLVILGICIFTLRDEKEKRAEHVIL
>fig|526218.6.peg.1835 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKIYRKVILMEKYGKLGNENVVKLLFEFSVPAVIAGMIAALYTVIDRIFIGRFVGEIEF
SGVSATFPIMIFYIAFASLIGIGASASISLNLGRGNKKRAEHILGNAFSCFNILGILIIV
FNYVFLDQILRAFGVTENTFIHAKSFMIYLIPTCYMTFLTYGFAGVIRAEGNPKTAMNIN
IAGALINIILDPLFIIVFKMGVAGAAIATLISNLAAALLVIYHFTYSKKSSLKIRRKYFK
LNAKILNQIVKIGISPFILQVSLCLVGLAANNMIKIYGNDYDFGIYGVLNTYLIVIFSVV
LGISQGAQPIIGYNYGMKNYRRVEEALFKSMSFTTVFSILCLVITLIFSRELSGIFVKDE
IIINRTAPALIMFLMSLPVYGILIIGVDFFQVVEEAKTSSILFFMRHFVLALGTMFLLPV
LIGISGVWLSRTISDFIYLPAVLYCQWKWLKKLKFKIKEQQQNVK
>fig|526218.6.peg.1960 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRRKANKTNILEGSISKGLFKLALPVVLTSLISIGYSLTDTWFIGKYLGDKYVSAVAAGA
FFINFGMCFCNIPKIGAQVLVAQSIGARKITTARKYVRTALYLCVAFGLMYCAFVMVFHN
YLIKVIKVQDPVIVSAANQFLMISAVGFVFLYLVITVSSIINAEGDTLGPFIFNSVGLLL
NVLLDFIFIKYFKMGVIGAATATVTAQIIACIGILCYLFRKTSRFRKLRIWRLDPAHYYR
RIVKLGIPNGVNQALFSVFAIILAGMIASINETALGVQRVGIQFEAFSWNISIGLASAIS
AFVGQNYGARNLERLKAGYFIGLKWIVSIGFVISAVFIFGGKYLYGFFFENPETIAMGQD
YLRILGFSQMFMCAEITTTGAFNGVGRTLQPTVNSVAVTSLRIPLAYILTLLMGLTGIWW
SISGTSILKGIISVAWFLWTLRKIKNSGEMLKELAA
>fig|526218.6.peg.2698 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENSISLEKDSIGKLLFKFSIPAVVGMLVNALYGAVDTIFVGQFVGTNALAGVGVTFPIT
NTIMAVGMLVGIGAAARISISLGQKKKNRAEKYLGNAVVLMIIGYALVGILGKVMITGIL
GYLELNPEVAAYANKFTNIMLIGSIFQIVGLGLNNVIRSCGSPKIAMFTMIIGGITNIIL
DYIFIVPFKMGVAGAAWATIIAQAVSCIWVTAYFFGKSSLLKMKLKNFKLSSYIVWSIVS
IGFAPFMLQMAGSLIQFILSKQIVYAYSSGESDLVIGVMAVISRVTIILLMPVFGVNQGA
QPIIGFNYGARQYDRVKKTLKLAMIVSTVLCVSSFIVIQTMPEVLLGLFISKNDMKAIEI
GTHAIRIYCLGFAVVGFQVISSSFFQSIGKAAISMVLSMSRQIILLIPFLLILPRFMGSE
GIWIAAPMSDFLAFILSVTMISWEMRKIRRMELSV
>fig|526218.6.peg.2852 Multidrug resistance ABC transporter ATP-binding and permease protein
MYIWKQLWAYTKPYKRFLFYSLFALMLSTTIFIVGTMMTKIIIDKYIMGMFRPVSVSNTI
QDEKKSVFYKGKYYTRIEENSKLNILEKNSIILTKEGYVLINSDIADEKAEIKDNRLFIN
NKESNVGFNILTKDEVWNFYEPYVGSATLAVLSIFILYMAAACLMYTCGYSLRILATKVV
FDLRKDAFKQLQKLPVQYFSDYPDGKVVSYIVHDSNAIFGLYENTLLEIVKAVVQVVFIY
IAMFLLNVKLASYALLILPIIAVWLYLYRKYVSENFKETREIQSNMNAMMNEQFQGIEVV
QAFTHEDESIAEFDVLADDYLEYKRKFAVLSALYTDGMAHTVRRLAITLTLVYFGREFLS
GSMILSVGTVFAFVQYVDSAFAPLFWFFGVLNRFERAIVSARRIFDMFLNVPSKELEFST
ENLELKGNVEFKNLSFAYDNENYVLKNINLIIPAGNTIGIVGHTGSGKSSLMNVLLRFYD
YQKGDIVIDGRSLRDYPVQTYRAHVGMVLQDPVLFSGTLFSNITFNNNDVTEERVLEIMS
QIGAQSFIDKQPNGIHESVEDMGRNFSVGERQLIAFARVMVYDPEILILDEATANIDTET
EIMIQKALNVISQNRTTFIIAHRLSTVKHADQLIVLNKGNIVERGTHEELVEKDGLYAKM
YQSQMREEYTHEVLKNSKENFVLNM
>fig|526218.6.peg.3602 Permease of the drug/metabolite transporter (DMT) superfamily
MKKYSADLGLLLVGFIWGTGFTATKIGLDGGITPYYMMFLRAAFASIFISVIFFRELRNV
TRREVLAGVLLGVFLYLGFSFQTVGLVYTTASKNAFLTAINVVLVPYLYWMFYKKRPDIF
AVLSAVLCLCGIGLLSLTGTDFSLNKGDILTMICAVFFACHITFTGILSKKVDAIRLNLV
QMYTMTVFSFITCVFNGSITLNVTQTQFLAVLYLGIFSTGICFLLQTTCQQYTTPARASI
LLCTESLFAPVLSFLILHEVLTPKAIAGAALILISVIVSETKLGFGAKKEQST
>fig|526218.6.peg.3746 Glyoxalase/bleomycin resistance protein/dioxygenase
MIFAGICLMTEDVRKLADFYKEILQTASDYDDEIHQEIFTKGASFAILKNDGITQAGNSN
MTMIFTVDNVDEEYERLKKIGVKILDIPTIQPWGAKNMRFSDPDGNFVVFRTFL
>fig|526222.3.peg.325 Multidrug resistance protein
MNFRKALSESIETKQGTVMAVLATAFFSTFGVGAYTFSLSLSADSIGLSASWLGLAFSGY
FLARLVLAPLAGCSADYFGPIPLLRWACGIGTAVPCLYHFFPMVESLGLIQICLGFCAGI
VKPVSMSLLGQCTRQKERGRLFALYNTCLYSAFIIGPIVGGAGIGFQGKLGFVSLIWPAL
GMGLSFVALLMNSSEDAPASKEKQKETEGLPWRKAGFLPLLLAVLGRTAGASVVITFLPR
LISEHFGLSGYLAGFLFALPNLAIILAMPATGRWADSRDRAGLTFLGMGFCAACLFGLGQ
PVPLWIFCLLVAGMGFGSALSLPASMSLAADMGGAKGRVMGVFLGVSNLGFVLGPGIAGF
AAEAGGMADAFELTALFGGLCLLPTLISMSKRLYAD
>fig|526222.3.peg.1330 Glyoxalase/bleomycin resistance protein/dioxygenase
MHNDSSSHGFFSWNELLTSDLEAAKKFYGDLLGWTFKESKTIYGDTYLTAFKDGRMAAGM
MIKPADTPDHIKGCWDPYITADDVEAAAEQVEETGGKVMLPPTKIEGVGRFCVIQDPQGI
YLNLITYDQED
>fig|526222.3.peg.3553 Permeases of the drug/metabolite transporter (DMT) superfamily
MKWSEFKKTEKAGYIFIVLGILNWSGNFVAARGLAGTIDPATLNLLRWVLATLIFLPFGI
KAFMKERHLVARYWKELSVIALCGISLYDTLVFIAGATSEALNMSLISTMSPLLTALIAQ
FFLKEKLKPSMYAGIAVSTFGVALLVTDGSLEALLHMRLAKGDLLILCTAMMSAIYNTVV
NKVAGKISQTTLLMSCCLFGTLYIIPLYFWETGGQIVMPEFTYNLVVSLIYLSVFASILC
YLFWNMAVEAIGASKAALFYYTLPPASAVVAWFVIHEPVNMNQVFSGMIILAGIIFALYG
GSLNFMRRKAHNYG
>fig|526224.6.peg.74 Acriflavin resistance protein
MNRIIELFAKNRLLVNVIILITLAVGIYSYLNIKKEAFPSTNFDVMIVQVIYPGASPEDV
EQYAMIPIEDELQTIAGIDEFYSIIIENAGILTIRIDMNLKDSRPVKDEIFRRLQNAPNV
SKDVSEIKIFEANANRMPIYNLGIRFKEGQEGSEKELYDISKRFEKELKYVDGVANIEVY
GRTDPEIQILADPYKLREYYTSLTEIIQALSLRNIRSTSGSMKPSESDNLEDKNKLLVTT
GQFQDPLSITNVIVRSIFNGQPVRIGDIARVEELFVDKSVYMRVNSKHGYSINIIKKEDA
DILKTIDNVNQYFEKNKSTIPSNIEIVPMADNSRTITDLLNAVSSNIITGFIIIFIILII
FLDFKSAIFTSLGMLIVISVSLIYMTYSGITFNIISLGGIITVLGMIVDNSIVVSENIFN
YHQKGIRGLEATKNAVGEVFMPMLVSTLTTVASFAPIIFVTGTMGRLINQYPRVVIVALV
VSIFQAVLLLPNNLITKEELTGEHKRKRFNFKNPLDFDKDKLFDKLKIPFIKFLRFTLKF
RYIVLIFFIVTLLITLLIAKSIFSKFTLIYDTSADVIVVNIDTGVGSSIYKTEKYLQKVE
NIIYETINTNDIVAVYSLLGKQLDKNTVEISEEMDNIAGTMIYLVPANNREKIAYDIADD
LNAAIEKSSIKDELELITVNTKLPINPGKAVDIKIIGNDTAMVKEVKDKMKEHLLSLDGV
VNYDDDDKIGQEELRVIFDYDRMSELGVNVAYAARELRAAYSGIVATSIQEFENKLDFRV
RLDKKYTYDTNVLNNLLIPNTYYRLIQLKDIADIYITNNQSSIRHYNGKKSITMTADIEQ
GKNTAIQVTYEMQDYFNSIAKDYPNISVEFAGEVKETRGSIIGIAWGYLIAIIAIYVILL
LQFNKFVQPFMILGIIPFGIIGVILGFAAHRMPMSFVGAVGIVGLAGVVVNNGIIMVELI
NRILEKGNIRNKQDVLNAIVEGTGDRFRAIFLTTVTTIFGLLPTVYGIGGRADLIVPMVM
SMAYGLLFAALLTLILLPSLFMISADLKLIKINYEK
>fig|526224.6.peg.419 Permease of the drug/metabolite transporter (DMT) superfamily
MANKERLGTIGIFLTALIWGYSFVAVKVVVQEIEPFYLVGFRNLAGGIFLSLIFFKRMKK
ITKRDILLSIPVGAALFLGFFLQTMSSKFITASKVAFFTGSYVIFIPFLAWALYKKRPHI
AAFIAAVITVIGLYLLTSFDGLGSIKAGDLFALLCAVVFAVHLILIDKMLEYVDGIIMAS
LQLIVAGIISLSAGIITSTPFDINAVSKESMYSLIYLSIGATGIAYLLQTVSQKYVNPNK
AGLILSLESFLGALGGIIFMKDPLTVNFVIGGICMISAIFICEIGSTIKKTD
>fig|526224.6.peg.864 Permease of the drug/metabolite transporter (DMT) superfamily
MLNVLLVIIGSIAYGFLPIFVKNIIAYNYSSLSIVFYRYFFTAVFLFIIILVTRKSFKIT
KRQFIELLIFSITGLGLTFFFLSQSLLYISAGLSNMIHFGYPVVVLLIMIFLFKEKINIL
KILSMLFAVSGIVLLTKVVRVESFLGIIYALVTTVTYGSYIVANKKCSFSSIDTIVSLFY
MSLIVSLTFFIAGIFTNSLQVLNNINVFYNFIAVSLLCTIFSLGLLLYGVKKLGSSLASI
LNMFEPTTTVAASIFIYNEDLTFNIVIGSVLIILSTITMVIGSKR
>fig|526224.6.peg.1035 Acriflavin resistance protein
MRNFIELVVKRPVAVFMCMIAVLILGFVSLSKLAVDFLPDMELPYITVRTEYENAGPEEV
EKSVTRIVENAVATVSDINTITSTSQEGESSVFIEFNWGTDLAVATADIREAIDGVKNSL
PDDADSPTVFKFSTDMMPVMEIAFFGTDNLGALYTLIDNQILNKIEQASGVARAEIRGGL
QTEMKVDLVLNRLHAYGIDINTIVSLLSSENQNLSGGETYEGVYKYTLRTMGEFTTVEDI
ENTVVALKTNDTPIKLKDIGRVYQGYSDDSEIVKINGMPAISVSVNKESGGNTVNVSKAV
QKQLANLTLPEGVEYEILFNNADNVNESINGVLDTAWQGGLFAVIILMLYLWNIKTVSII
AISIPISIIITFTLMYFMGITLNIISLSGLVLGIGMMVDNSIVVLENIFYYRNNGYGKYS
SAINGTSSVALAISASTLTTIAVFLPFLFVEGQTGQLFRDLCITVTVSMIGSLFVALTIV
PMLGARLVTNKKTKFLIPIENFVNKNFHNRVNNLYSSVLHYSIKNKKKVLISSLSVVFVI
IALGLTFIGKEGFPTSDEGQFKIDVEMPVGTKSEQTQSFVTRMESDIQNLIGEDFDRMQS
RVQSGSDENKAEIRVQLRDKSEGRKKSVDEYIEFTRNALVSYPAQINIAAITSSAINSGG
RDGGTGGNEIEIELVGDDLDKATEIANNIIAAISDIEGIREPRLTRDDSNPELKIYVNRE
IAAKMGINVNTIANIVKTSFAGTTATTMTPANSDVTDIDVNVQLGEPDRLNIDDISRLMI
PTTSGIVPISSIATVEKSYGPTEIERKDSTRITTIKASGYNRALSEIMTDVQEKIKQEVF
IPSGFNINYTGDFEDMNDAFLQLLQALILALVLVYAIMASQFESFIAPFVIALAIPFGFA
GSLIALFIGRQTLSVYSGIGFIVLIGIVVNNGIVLIDYMNQLMHEKNISGDEAALESGPR
RLRPVLMTTLTTILGLLPMALSGGSGNEMYQPLSLAILGGLLLSTAFTLVIVPTVYAAIR
NKIPLKDYEQKDLESRDDFSNYDTINATGK
>fig|526224.6.peg.1064 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAVYLIFIKDILKISGASSNTYQFSKDYLVIAAFGAPFVVNQMAMGQIVRAEGSSKEAMI
GMMIGTVVNIVLDPIMILYMEMGVAGAALATIIGNACSTLYYIYHILRKKSFLSIHVKDF
SMHKDILINVFSIGIPVSINNILMSASNILINNFAAGYSDNVVAGLGVAQRIFMLVILVF
IGLSQGLQPFVGYNFASKNYKRMNAAIKLSCVVSVITGFLLLALSLIFGRVSVAVFINNE
EVIDYGVKFLVASYAIAPIIGFQFVFMSTFQALGKSIPSLILSLSRQGIAFVPTILIGTK
FFGINGIIWSQPIADIVSVALATVMYIYIYRKMKRKALEEENNNMEAAYNNA
>fig|526224.6.peg.1830 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MINMTQNTKNMEKSFFKYVLPAIASTMLGGLYIVVDGFFVGNSMGDNGLTAINLVYPIGT
LIAACAVMLGMGGSVIMSTYFGGGDSKGFNKAKSNTFITLILASVILTVILLLLKNKLIY
LLGARDNVFKLADEYITVIILGGSFQIISYGIMPMIRNLGKTIHAMAFMVAGLITNIILD
YLFLMVLRLGMFGAALATIIAEGIVALISLYYLFIRKKYRIKLSDFDLSMTKRAIQIGLS
PFGLVMAPSLIVIFNNWQCIKYGGYTAASAYSVINYIYGSVIYLFEGIAEGCQPMISYFK
GAKRNDLMKKVFKKGVLFALIIASIILSIILIFKNNFGILFGASIETNDIISKGLILISV
SFILQPIVRLGTAYFYSSGESRYSALLTYIDPLFVSPLCILVLPLFFNLDGVWLALPFSQ
FILIVLFIFIFYNTNIKDKDFIKKTVY
>fig|526227.6.peg.793 Permease of the drug/metabolite transporter (DMT) superfamily
MYVVSKVVLEVIPPITLVALRMVVAFVCMVLWLRLLGRDWRLPRKLWAPVTAMGLIGYAL
SITAQFIGTGLAGAALGSLITTASPLVTVALAALLRIEKVSARAWIGLGIALGGVWVLSG
SANANLAGVLWLIVAAVTWGILGLIGAQTVRQHDPALVSAWASLVGGVALLALVPGELAR
APIGEISLGTVAGVLYLGVVSTAVAFTFWVYAVAKAGSVLSGIAFFAQPVVGGLLGWALL
EEPLGLSFLLGATLLFIGALVARPS
>fig|526227.6.peg.1407 Permease of the drug/metabolite transporter (DMT) superfamily
MRLPPLIYPLFSILAWGSNATALKVLVAYLPPHAMNSLRVLVASLVYAALWALFSRERLG
WRDWVVIAGLGLIGNSLYQWLFLEGIPRLPASYTSIVSSTNPIWVALLSVIWLRESLPKM
AYVGLVLSLAGVMILSAETLEQGGAQWLGIAFVLLSAVSWAVYTVGARRLAGGYRLLTWT
GGSFVLGMVPYWLLHTPDMLRLASAAVPVWVWVLLIASGLLANTLAFLTWMHGVRQLGPV
RVAVFSNLTPVVGVLAGVVFLGERLPLQALLGGLLTLWGVLIAQRAQRM
>fig|526227.6.peg.1876 Multidrug resistance protein-related protein
MPWKITGLLPLLSFVLLLGLIEAVRSGFFAVYLPNFAKSSLGFSAAVWGASWTVHFLAES
LFKGPGGYLVQRLGLGVATLIAGAAGLLALLLLPYISAPWMLWALTLLWGLSLSAVSPGL
MTLSSRLARPGREGRALAYTTTLILPWAGVGFLLMAFLVPKDIGAAYTTLLIGQGLVILL
SLPLLSFRERISLPKQEYYPWRQLVLFIPAAFGQTFAPAIISQLIQKFASNELGLGFLEL
GAVILVGGVVAFSSMGWLGRIPDRRGPKVPLIVGLSLMSATMLLVAQKPSFPQLLAIAAL
GGIGFALFVPSWNALVVRVLPQNNRAAVWGTLMMIEAWGTAAGPSVGGILWSTLGVTAPF
YASAAAFLAVAVFYVFAVRREI
>fig|530564.3.peg.271 Multidrug resistance protein
MSRSPKTPAPQSADDSSQLASTSTGRGSLLVIFLTVFVDLLGFGMVLPIVPLYAKSFSEK
YALEAWQTGLLIGALMSSFSLMQFLLVPFWGRLSDHYGRRPIILIGLAGATFFYALFGVA
TAMQSLTLMFVARIGAGIAGATIATAQAYIADSTTTKNRNKGMALIGAAFALGFTLGPTL
GGVAILAGGAIHLSPWPGYAAGLFSGVALLLAIFCLPESLRPGSEKAHSKLFDREALAAA
LRIPTIGTLLLTSFLAVFSFGNFESTLSLQIDTMVQKQTSPETTPAFLASLLRFANWLGH
ESPDNVKLIVVLAVFAYLGLVLTIVQGFVVRRLAGKVPETTMAIIGSVLATVGFLILGLA
AMRADFHLLLIAMAVEVSGFALVNPSLQSLISRRSDPAVQGGILGLAQSTSSLARILGPV
FGNYLFSRSVGAPFWAAAVLMVLAVVMMFFTIGAKQDFTPETKAV
>fig|530564.3.peg.2091 Permease of the drug/metabolite transporter (DMT) superfamily
MLALATFFWGSNYLVGTIAIQYTPAFTLTYYRWLLACVPLMVLAQVLERPDWRAVWRNLP
LLAALAICGISVYSSLMYLSLVYTTPMNAALINAVNPSLIVLAASFFLRERLTPIGIVGI
ALGLVGVAVVLTHGNLMAILHHRYNVGDLMMLGCVCFWTVYTLIARRLHGVRPITSTAVQ
SVLAVISLTPFALYFDNYTLSLEPTAITCIVYVVLGPTIASYLLWNIALTRIPASQGAVF
MNLIPIYAAILSTMLGKPVTMAQICGGLLVIAGVLLSSQSSHRVEKSIGKAATS
>fig|530564.3.peg.4276 Acriflavine resistance protein A (precursor)
MTEPVVDNRPPVPIITCKPVVKPIVEWDEYVARFEAVEAAEVRPRVSGLLQSANFIEGQI
VKKDQVLFEIDPLPYQAEADRAAAAVNEAKSQADQARAAVAETTAGILVAKSDFDLAKKQ
YDRALQLRSQNAISQEDVDIRQSSFENASANYESANAKLVSAKAAVVAAESAIKTAMAFQ
QIADINLGYTKVLAPVSGLVGQRLVTDGNLVTGGTGNATLLTTIISIDPIHCVFDADEQS
YLKYTRLAENGKRTGSRFARNPVYIALADEQGYPHLGQTDFVDNVIDQNTGTIRARAIFH
NTKDMLLLPGLFARLRLPGSARYEAVLLPDLTIGSDQSEKYVYIVGADERIERVSVKLGP
SVEGLRVIREGLTGSETVVMGGMQRVTPGQRVTPENKPIKAGSSDLPDDFKPVPRAEWIM
TPRTERILKDVEGQTEINPPAVPLEAPPTPAAAAPTEPAPAPKPPAPAEGVAPPAEEGQN
>fig|533247.5.peg.1870 Multidrug resistance protein
METTSKKFKSDLILEARASLKLGIPLVISQMCETGIYTANAVMMGLLGTQVLAAGALGAL
AFLTLLFACHGILSVGGSLAAEAFGANKIDEVSRIASGQIWLAVTLSLPAMLLLWHGDTI
LLLFGQEESNVLLTKTYLHSILWGFPAALSILTLRGIASALNVPRLITITMLTQLILNTA
ADYVLIFGKFGLPQLGLAGIGWATALGFWVSFTLGLILLIFSLKVRDYKLFRYLHQFDKQ
IFVKIFQTGWPMGFQWGAETALFNVTAWVAGYLGTVTLAAHDIGFQTAELAIVIPLGVGN
VAMTRVGQSIGEKNPLGARRVASIGITIVGIYASIVALVFWLFPYQIAGIYLNINNPENI
EAIKKATTFIPLAGLFQMFYSIQIIIVGALVGLRDTFVPVSMNLIVWGLGLAGSYFMAII
LGWGGIGIWLAMVLSPLLSAVILTVRFYRVIDNLLANSDDMLQNASVTTLG
>fig|535289.3.peg.2346 Outer membrane component of tripartite multidrug resistance system
MATPAAWAGQGAVQGGAAATPQDLAQWWRQLGDAQLTGLVERALQSHTSMRSARAAVEQA
RAQRDVQAAGLLPSVNASGSAQRSRSNGSTGNTFQAGLDASWEPDLFGRLSSGVRASEAD
LLAAEEGVAAAQVALAAEVAVNYISLRSQQQRLQIAQQNLAAQSETAQIVQWRVQAGLAS
SLAAEQARAAVEQTAAQVPTLQAGIAQARHALAVLTGQPPAALDEALAAHAPVPQPPADL
ALAFPADTLRQRPDVRQAEQRVRAAWERVAQAEAQRMPSLRISGTLGLRALTLGALTGGG
ATVASLLSSVSLPVFDGGALRAQVRAQEAALQQAQVGYEESVLGALKDVEDALVALQGDR
DRLQRLSAAAEAAGNAALLAQNQYASGLVDFQTVLDTQRTLLSAQDSVASTAASVSTDHV
RLYKALGGGWPAP
>fig|537021.9.peg.896 Drug resistance transporter, Bcr/CflA family
MKKKLPLKLRNSNISHMEFVIVIAMLMAINSLGIDIILPCLPKISDSLHLSNENYGQHLI
SFYLIGYGIAQIFYGPLSDRFGRKIVMMFGLVIHIISTFIMVTINSFTGMLCMRLIQGIG
GAAPRIITISIIRDIYDGRDMAKVLSIAMMIFMIMPILAPSIGQATVALSGGWIGIFVCM
GVITTFITLWYYIRFPETLDPRDVRPLNLYAILHSFSLIFKHRASTLYNIANSLTMGAIL
GFVNSSQQIYVGIYQLGNLFPIAFAVGGFAMSIASFINSRLVEKFGIRRVSHYSLLIFFM
ITGSWLLVQITSNHPIHLLIFIAFFFLASFQFGLINSNFSSISMEPFSHLAGTASSIFGF
INTVISTILGIIIGQSFNGTTYPITIGFFGIAVSSFICILIVEKNQMFRKTELR
>fig|537970.9.peg.38 Membrane fusion component of tripartite multidrug resistance system
MKKRLQYSWLPSKPKLYVIVLTTFGILAGVLSILYAWQLSPFFLNVVVTNDAYIQSKTTL
LSPQVSGYITEVYIKDFALVKKGQPLFQIDNRIFTQRVKEAQANLQSAESALLAYEENYR
LYEANIAEKEAQIKSVEANLKNAQAENDRATTLIKNKALSKRDYDNAKAQFLSLQANYVQ
AKAQFQKAIQELEAHKTTKSSLEAGVKRANALLELALIDLDNSVIKAPVDGQLGEILAHI
GQFVSQESALAYIVPQTHWVVANIKETKMDKVALGQKVHFSVDALSGKEFSGVVEEISPA
TGSEFSPIRVNNATGNFIKVIQRIPVKIKIDSTNERLEELRAGMSVVVEIETK
>fig|537970.9.peg.1324 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPKFLHFYSNQRSKKILNIAIPSGLNSLLDIINLSIDLMFIGVFGANAIVAVGVSLNYMM
LAFAFTTIIFVGNSALVSRFLGADQKKCADEVILSLTFAAFCLSIPLCLLAFLCYDYFFS
WIGISNEAKEIGSSYLSLTLFGIPLLLIKQVSISSFSAAGATKIPFFIKIFITLFNPILK
YIFIFGFLFIPEFGVIGAAIATLIINFIETLALFLYLLCYKKSPISLRGKINFDYIKRAF
IVGIPSGCERLFTLLSMILMAKFVALYGTFNLAGYQIATRIEGFAFMPGFGFMIAAMALM
GQNLGAHKPLEAKYSTLNTLLLGGVFMGVIGLIMTFFAPLLSSFFTHDIQTIEASTKYLI
PIGISQIAFAFICILDGALRGAGITKITLITNTLMIWGLRVIPCYLIAKFHYPISYIYLC
ICLETFLRAFVYWKIFQKGAWRKNKV
>fig|537970.9.peg.1566 Permease of the drug/metabolite transporter (DMT) superfamily
MQKLSNEQIGILWIISASIAYGIMPIWSVISQNNGISTDFILFFRFLCSAFLLFLWALYR
QISLKLTKLQYLQFFFLGGILYIIQSFAYLDSLRYIPASLSVLIYHIYPIIVALIALIFL
RQKLQAKTLFSLFLCFAGLAIILQPPKDLELSVYGVILSLIGALFYGLYVVFSKSYTSNL
SSVVYSFYICLFAALMILGFMIPNPPQFDNFNINGILSLLGLTFISTLFPMMAYFLGMPR
INVTKTAILGMIEPLVGVLLSLWLLGENLNLLQYFGGFLILFGSLVLFIKR
>fig|545694.3.peg.553 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLVNAIYNIVDRIYVGQGVDPLGIAGITIVMPVMMVLMAMSILIGIGANSLFSIRLGEGR
RDEVEKIMGHAFFLLFLVPGIAIVVCLIFLDDIIIHILGASENIFPYAKTYLQIILYGGV
FSAMGPGINHFIRSDGHPRTSMVTQLIGAVINIILDPILIFGFKMGIAGAAWATIISQFI
SFVWVLGYFNSRFTTLRFRIQDMKLELGLTLKIMAIGFAPFAMQLAMGLVGVLQNHALNT
YGGDTAVTSMGIVFSILIVIFMPLQGINQGAQPIIGYNYGAKKYQRVKKTYKWAVIAGTI
FISAGFLLIHLFPHFFISVFRNEEGPLMDMGVYCLRVSSAMFPIVAFQMFSSSYFQAIGK
PVQSTILSLSRQILMYIPLLLLLPRRFGLHGVFFAMPASDILSAALTLIVMLIEFKRLKK
LIAEGEVRRR
>fig|545694.3.peg.589 Drug/metabolite transporter, DMT family
MWVFFALSSAVFAALTSILAKVGIANINSNLATAIRTVVVLIFSWGIVFITGKQNDIVNI
GHKNLLFLILSGVATGISWLCYYRALQIGEASKVIPIDKFSVVIGMVMAFIVLKETITIK
SIIGGILITAGTFVLIL
>fig|545694.3.peg.672 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSASAPNKYSLTEGGILSKLLQVALPIMGTQFLQMAYNLTDMFWLGRVGSDAVAASGAAG
MYMWLSMGFLLIGRMGAEIGVSQALGRGDKKAALGFSQNAMLMALFLGLLYGLCLFIFNR
ELAGFYNFREPNVAGDAAAYLSIVAWAIPATFFTAVITGSFNASGNSRTPFIINGIGLAA
NVILDPVFIFVLRLEVRGAAIATVISQLVVAAGMFAGVNWLKGRPFERYPIKIRIEKEKI
AMMLKWAVPIGVESLLFCFLSMVTSRIEASFGAFAMATGKVGSQIESLSWLIGGGFGSAL
IAFIGQNYGAGKWDRIRRGVRISALLMTAWGIFVTLLLYFAGGFLFSLFLPDPELVQFGT
KYLRILAFCQLAMNLEAVSAGAFKGTGRTMAPSAVSIISNLIRPFLALILSRTSLGLYGV
WVAVSITAIIRGAWISLWYVFRKKAREQSTGQ
>fig|545694.3.peg.1340 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSDLANDNVPGNPSIQADAAERLGTDGVGKLLLRFSIPAITGMIVNALYNVVDRIFVGRW
VNEMALGGLSLVMPLMTVSMAFAMLFGVGAANMISMRLGQGRKSEAENALNHCFWLLLIS
GIILMALQLIFLDPLLSILGAQQGSASLPYARSYYLIILYGQVFLSVGFGFSHCTRAQGF
PAISMISMFIGAGINFILDPLLIFVFRWGVDGAAWATIIAQLAQAIWILAFSFSKKAVIR
LRLRLLQRSSPRSFKPSPGIVTQIMAFGSAQFFLQFVMSAVQLIYNTSVGRYGVASLGVS
NGGDIALSGMNINGSMAMLILMPVFGISQGAQPILGFNYGAKKFDRVFKAYRAAVVVATV
ICVLGFAMTELFPLQLVKLFAPIGSPALLRFTPWAMRVMMLLLPLNGFQIISANFFVVTG
RPRTSIILSMLRQCLALIPCIFIFGRIWGLWGIVAAAPVADGVSFVATSIMILFEMKKLR
AQMATS
>fig|545694.3.peg.1375 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MESTPVWTAIIRLALPMMFSMIAQLVYNMTDTFFIGQTGDPNMVAGISLAMPLFMVSQGI
GNIFGVGASSYISRMLGAREAETAKRTNAVSFYTTIMAGFVITIALLLFRKPILHVIGTS
DATFVHADSYFSIISSFIVIALLNISLAGQIRSEGATDKAMVGTLIGIIINIILDPVFIS
VLNMGTAGAAWATVIGQAASLGYLLWCFISPHTMLSIHPRDFKPSGKIYREILKIGLPAA
LSNIVMSLAMAVRNLMAASYGDMVIAGMGVTIRVESLSFMLIMALAMGYQPFAGFNYGAK
NYGRLKKGMKITLVYTTALALFFVGVFALAGRSIIALFINDAQTIAAGATFLHAFLFGLP
VMGIQMTIMITFQALGKPVLGTIVSLGRQCLFYIPLVYVLNHFSGFEGFVYSQPLADIAT
TVVALILVSGLLKELKHHEK
>fig|545694.3.peg.2801 5-nitroimidazole antibiotic resistance protein
MRRSDREITDVEEKLKILRKNKVFRLGMAEQNQPYIVPLNFGFEFDGGLLTLYFHGAREG
KKADILARNSQVCFEMDGEHSLVTGEEAAAYSFAYESIIGFGTAELLTKDEEKIRGLDAL
MKHQTGEDREWHYTESQLKAVAVYRIRVSSFSGKRRPQK
>fig|545696.5.peg.331 Vancomycin B-type resistance protein VanW
MQRLHLYQLGPQAYALSRKKEILKRKFQDQIHQIHFAQTRSEALLPVVVNRHNSLIRRKL
GNVDQRLQENKAVNLSLAAPKLTHLLIQPGETFSFWHCVGECTAEKGYREGLTISGNHPS
SGIGGGMCQMTNLIHWMVLHSSLTITEHHHHGRFDLFPDFGRQVPFGTGTSIVYNYLDYQ
VENRTSDTFQLVIETNERYLCGELRCDHPQLLKYHIYEQDSGFTWEKDGAYRHNIVRRKA
INKASGEVAFDQELIVNHAKVMYDPKLIDPALFRESGFWNQKQ
>fig|545696.5.peg.745 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKFNSDKMGTMPVGKLLFSMSVPAIFSMLVQSLYNVVDSIFVAQVSEDALVAVSIAFPL
QMLIIALALGVGVGTNALIARRLGEKRREEANIAANTGIVLSLINMALCMLVGLFLAKPF
VGLFTQDAAVFTMGSQYLMIVMVFSVGVMIEMTCSRVLQATGNMIVPMISQLIGAITNII
LDPIFIFGYFGVPKMGVAGAAVATVIGQILAMIFVLIVLKVGTHEVDIAPWRHHPQMQAA
KDIYRVGIPTFVMNAIGSLTTTAMNAILMGFSATAVAVLGIYFKLQSFVFMPIFGLNQGA
MPILGYNYGAADEKRFTRTLALSFGVALAIMVIGTVLFWTMPEMLLKLFNGSDQMLQLGS
YALRVLALCFLPAACSIIMTTMFQALGKGMMSLVMSLLRQLVFIIPLAWILGQLGGLGAV
WFCYPAAELLVAVIFVPIALKTIKKSFDQERQETGVY
>fig|545696.5.peg.776 Methicillin resistance factor
MLRLIEHEQPQLFDAYAANGKIPHYSKTHFYGELCRRKGIEIQLVSAHNEADEIAATALI
QWEKSGGEEYGYLCYGFNLDYTNTETLQIFATALTELAKRRGAAYLRMELNIPRIEHEKD
GRIKPGGFNNEFVTAQMEACGYHHLGYTYGYSGNRMSRFTYCLNLDQPLETIRKQIKHYA
AYQKKNIQRAVSVKLSDARDLSILVEAERELAHKLHFLPKKEKDFRQLMECFPDQARLYV
VSANVDQALSHLKILREQLICQQGKLINAQRLAENQKQIVALDQEIAELMRDYQGLGEIK
LGAKLIIQQGEHVYNVNMYTKKILPNFRAAFALHSAVIEDCWKRGAKTYDFEGVSGALNP
EDPYYGIHDFKKSFGGEFIEFLGEFDYIQDPQAYQRILKRQRRRRKLRRGLARVLYR
>fig|545696.5.peg.1300 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRKHQHPTVNEITEGVIWKQLLLFFFPIMLGTFFQQLYNTVDAIIVGQFVGKEALAAVGG
ATGTLINLLVGFFVGLSSGATVIISQYYGARKVEQSSDAVHTAVAMSLIGGAIMMVIGIF
GAPVALRAMGTPENIMNYSLIYMIVYFVGLIPNLLYNVGSGILRAVGDSKRPMYFLIVCC
LANVVLDLLFVLVFQWGVFGAAAATCLAQFISGGLVYLSLSQAEDDRYRLIRKRIRLHGE
LLKEIVVIGIPAGLQSVMYSVSNIVIQASVNTFGTDTIAAYTAYGKIDGIFWMIMGAFGV
AITTFVGQNFGARKIDRIHKSVKVCLAMAFGTALGMSGILMVTSRWIYHLFTQDAAVIEV
GMQMLLYLAPYYFTYVCIEVLSGAVRGTGDSVIPMIMTCMGVCVLRVVWIWIAVPLNPTI
ENVLFSYPLTWSLTSILFVLYYLQGGWLKRRLKKEERKGLQN
>fig|545696.5.peg.1849 Vancomycin B-type resistance protein VanW
MSRRRVTEFLPFLLPLRRKQKIWCFYQKMKHDGNRYARRQAEERLPYIQYECTQGLINPD
SGYDIQYQYNKAHNLKVVSRRMQQLIIEPGEVFSFWQLARGADHDDPYRPGLGLHDGKIV
PVHGGGLCFMSELLYWMVLHTPLTVIEKHPHLVISLPANPNAEMPAGIDATIQEGWSDLK
FRNDTDQPFQLILDFDEDSVHAQFRCAQPPCYRYEVTGSALVYSRKKGKIYRTQDISRTL
YAAADGELVREEACYTSRSRIDYPLPPETEITEED
>fig|545696.5.peg.1863 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSLKRKFIRFVLPSIASMLVFNLYTMVDGIFIANYAGETALAAVNLAMPFINFMFAFSLL
LSIGASTLISIHRGAGRTERANQLFSMNTAVLSVLALLISVSCVLFAQPLAVFLGAGSDT
LNYVTEYLRIIGGFGFFFIVSYSFEVLIKADGFPQLSTFGVLLGAVTNIVLDALFVFGFH
WGLAGAAWATGISQLLTFLVFFSHFLFSRKTHFHFTRFTLDLSQYQRIVPIGIADCITEL
SAGVIVFAFNHQILSIIGTSGVVSYTVMTYVYNLVLMAFVGIAQGCQPLVSYAVGQQDSK
TIKLVYRYGLTAVALTSVLCFGGCWIFTPQIVSVFIRPQETALFGSTIAAFRLYSFCFLI
MGYNVLTSGFFVALAKPKAALMLSLARGIVVILACLLAMSSVFGALGIWLTPTVSEGLCL
ILSFILLIKAKSWAAA
>fig|545696.5.peg.1865 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTKTFFKYVIPSMLAFALSGIYAIVDGFFVGNSVGDQGLATINLVYPLVALIQAAGTGVG
MAGAIHFAIAEGGKRINERNRYFWITCGLLIAVSLLLTLVYLPLNKTLLHLLGMQGQLEI
YGLQYMRVITVGILFQVLGVGLVPLIRNMGKSLQAMAAMIAGFLTNIVLDYLLVWILPYG
LPGAAAATVLGQAVTVLWCAAVLFPVRKTLKAQWDKGWEYQTTRILKLTPSPLGLTFVPN
VTLILINWSAMQFGGDPAVSAYAVISYVCCVMLLLLQGVSDGTQPLFSQYYGEQKPDKVR
RVRRLAFQFGLAIALASVLLLYGLRYEAAVLFGASEEIVAMVGESLPIFILGFVFVAISR
IAISYFYATEKNKYAYLLIYGEPLILAALLLILPQRCGIAGTWAAVPVSQLAVAVLSLGL
LKKVQRKEEKFRIEQRNQTVERSC
>fig|545696.5.peg.2290 Multidrug resistance protein B
MTGVLTLPTMAYILHNDRVGQFSLKLFFEQPSIYLHELCARLVPNYIYIYRTNVFETTAH
TTRELCLYSGTLTAVLLPQIFSDKDKKFRKATLIFYIILNLFLIFPFLSSMAHGFSDPTF
RWTMILILVQILTVCHYLENINQLNTKNLKITMGISIFVLIAVIPLTVILSKGNTISAYR
NQILLFLSAIIFVVINTWLLLNKKSYIWFLTVLCIEYSISGFTLYYSRMRSEGITYDFIK
SATHVLQDKDHELNYFLENIEPVNSLQYYRTYIPLESIYWDFSHNMSLMVQLQGTMTYDS
TYAPSFNKMKEIAPEVKDYDSEWIFNIKNPDILQFLSVKYAIVTNPSELPEGLSWRLLTD
NYRSGLLVYRNDDYRSLGTTYNQIITYEEIESTKLITHLSDIVACESSDLMEIQNMMNSN
HSVELENIAHQGNYLTGTCNTDESSFLVLSLPYDKGWKVFVNGQNVKTYSVNGGFVGFGV
EVGNNQIEMYFTPVGFKQGAIISLIGIMGYVALIVYEKLKIRNSRRYKNEQSI
>fig|545696.5.peg.2775 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTMNKNADRSLILDSMPVKQALIRLAVPSILASMVTTIYNIADTFFIGQLHNTAMIAATT
VAMPIMMLTHAFGESIGVSAGSYISRQLGAGHRDQVSRIVQTTMTLVVLISIVLPILFIT
FLGPLLGMFGAEGDVTMYAAQYVTILLVFAFSQIIKLTIVHLLRAEGDVNFPMAAIFAGV
VANLILDPIFMFDWGLNLGIAGAAWATAAAQCLSLVMLLGRLLFKAEAVRWNPRVWMLDK
AAVQEILSLGVAVFARQALPSVTYSCLAMQASVYGTDFLAGIGIAKKCLNLVMFAIIGFA
QGFQPFAAYNYGAGNRPRLKQALKSALTWVTVYGCFAAVFYLTLAPQIVQIFSREAAVIE
MGRMMLYGYAVSMPVVGAYNIAAVLLQALGEKRSAFFLSIARQGLFYIPIIWVLPTLLGK
LGIFMAQPCADYLTILTVIFLCRHLFVDLMKG
>fig|545696.5.peg.3413 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSQSQNSILGELRPSKAIVKLAVPATIALLAKAVYNIVDTAYIGMLHSDIALAAVGVTLP
LLLIMVSVENIFAAGAAVLAGRQLGAADKKGANTTVTTVIGLSVLIGALLCVGGIFFMEP
LLRSFGASSAVLPQAKDYAFWMFIAALANLPAQSLNCAARAESSVRISSIAVITGAVLNV
VLDPIFMFDWGLGLGVGGASLATTVSQFVTFAILVGFYASGRSIIKIHPRYFKPNWKLIK
TVTLIGIPTAVIQICLAVATSLTNMAAKPMADADLIIAAYGVVQRLVLIGCYVIMGFMQG
YQPVASYAFGAKNEDRFHACVQFALKASLLLTVIVAALYIVSARPLIQLFNSNPAVIDYG
AKLLISQVALYPAFGLCYMMTITFQTIGASRYGLFLSLIRQGLFYVPFILMLPRWLGVNG
IYFAQPAADLLTLLVCVLSVKSMKKIASRNMQLDVSVA
>fig|546269.3.peg.371 Vancomycin B-type resistance protein VanW
MKKMVGIAVGVIVIGIAGVVYLNHYMQKDIIYSNVFINEVPVENMTKQEALNTVSQKERF
QSAVFQFQDREFRYPVEELGFSFNYEDAVEQAYSIGKEGTFFDRIKSIFSLKVLQQKQNI
TLQYREDSSKLEEKASEINGKIYQQAQDATISVETNFEITPEVVGRKVELDKIEGLVKQN
LKSNEDIVISLPVKEVIPKVKKEDLEHINGKLGQFSTRFNSSLTGRTENIRMATSTINST
ILMPGEEFSFNKKTGNRGLSDGYREASIILNGKYEKGVAGGVCQVSTTLYNAALYSGLEI
THRQNHSIPASYVDIGRDAAVVSGDFDLKFKNPYDYPVLLKGFVSGNYVTFQVYGDVSQA
PKVVLSSKVVSSIPKKVIYRNDPTLPMGQEVVEEPGRPDIRSVTYMNVNGESKIINRDRY
PGKTEVIRRGTKPVDSTDNPDATPGMLPSPTNEGNGQSSIVG
>fig|546269.3.peg.1217 Permease of the drug/metabolite transporter (DMT) superfamily
MQPKDNQKVLALMLLLFTCVAWGGSYVSIQICLDAMGPVYLPFFRYLLSAVLLFVVLKGK
GMSLRLEASDWVKVGLTALFSITVYFYFENSAIKKIGANEAAILVAMLPIVALIGNRIFL
KQKLLRRNVISAVISIVGIYFVIGGVQFGQNKLGYFYIFLSNLSWSAYLINTKPLLKKYD
GLVLTFYQCLIGSLAFLPALPMDYFYIDKITTGIILHFLFLALICSAVCTVCYTFAIKHC
GVGISALCLNFIPVATFFFSFLILREVMRPIQLIGAFVAISGLMLMKEDQAIDG
>fig|546269.3.peg.1336 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVDGFFVAKFVGEQTLSAINVVLPFINGIFSIAILFSTGTATLVGISLGENNHKKANALF
TFTTVVELLFSILLYVVCRLNIIHLASFLGATPSIVSDVTTYLKIILLFNSFFIISYNLE
VLVKTDGFPALATIGVLLSAFTNIFLDYLFVGVFHWGISGAAWATGIAQVFSTALFMTHF
LSKRSVLKFRSFEWDFKIYAKILFIGFGSFISEISTGVIIFLYNNHIVKVIGETGLISYT
VLSYINLFVSMSMIGLTQGMQPLVSYYYGKKDPDSYHKFLKFSFIGILGLSATFYVITLL
FRQQLTGIFIRAEHAELFAYTQRALFYFAPSFLLIGFNLLISGYFASIGYAKHSLIIAIA
RGFLFIWIALSVATYLQKDTLLWLSSFFSELITLLVSILLILSIMKKKNLSSINEEQTS
>fig|546269.3.peg.1714 Vancomycin B-type resistance protein VanW
MQLKKIISATLLLGLLGSSAVFADVEPNPAETPNPTATDEQSYNSETEPTENTSDDTVPT
DLEVLDSLDENYYNQEQVTPPVLKVISLGKSTSNFASSPSNRKFNIKKAVNALNGKVIQP
GEIFDFNRIVGPTSQATGYRNAKVITDGEFVDGYGGGVCQVSSTLFNAALNSGMDIVQRR
NHSLRISYYPAGYDAAVNYGSLNFKFKNTYKVPVKIKATADNKNITIELVALQDTTKKVV
SLSREKKGDNTFVISRKIKENNVIIKKDTFRSTYGIKKK
>fig|546271.3.peg.943 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKILGKLRALRHRERIYGVHNPLTYDFLHHNLHHLHVLLFHSADQQDFTRGAIPRQLLV
FMLPILLSQLLQQFYTIADTALVGQVLGAQALAAVGTASLILSVIVNFFIGFSAGLSVLV
SHLYGKKDYARLSALVQSIFITVALFAALFTAAGIILTEQLLAALSTPAELIPAASLYLH
TMLYGILAQLLYNTASAILRALGNTTSALHYLAAAVVLNIALDVVLLIVIPCGIAGAAAA
TVLAQYAAALLALWKLFHLHGTWKLRFSRPFFALSHLLPILSTSIPAGLQAVFMSLSSLV
IQTYINSFGYAAMAGMTVYARIEGFLYYPLFAFGIALTSFIGQNVGAHDLTRVRAGLRIS
LRLAAGGAMGMALIAGLAAPALVSLFTDDPAVAANALDAVYYTFPFYWLYGINQIYIGAI
RGLGDTLYPMMTALAAYCFFRVAWCWGWYMIGIHSMHIVYSAYSVSFFVMAGLLWFGCRK
ALCRVYRDFSYEYLKGRD
>fig|546271.3.peg.1026 Vancomycin B-type resistance protein VanW
MNFILAVSLLVVLTLLASGIFAYHTSCRGRILYGVQSEGRSLFGLTQKEAEQYFTQLGKK
KLASQTVSLRSNGAVWKIQPQEVNLQPAAAAAAEEAYNSGREGTFVLQAVTQIKNAIYGC
NIPFTASYDESLLQAKLEGIAEKLLVQPVNAACEISVNGAIHHIPGKSGKKLDIAASLKA
LDKPLKEMQAANLELPLEENPPFVRTEDVANVNAVLGTYTTYYRHGARGDNIAIATQQLN
GVLIRSGANFSFNNIVGTRTANAGYKNAAVLVNGKSVPGIGGGVCQVSSTLYNAILLAGL
NPTERFSHFIPSSYCPPGLDATVADNLIDFQFMNPLPHNVYILASADGRKITVQVLGTQA
DLQGKHISIETVGSSRRPSVYRVYSANGQVVEREYLHTDSYS
>fig|546274.4.peg.1055 Nitroimidazole resistance protein NimB
MPLPAAALFSGSLQAFWGQHSGADFGIIPLLATGYLKPAGLNLTEEKIMSFREMKHANQQ
LSNEEAIAILQRGKSGVLALHGDNDYPYAVPISYVYHEGKIILHGAPAGHKHELLARDNH
VSFCVVDLNDIVPQEFTTYFRSAIVFGTVRTVTDPAEKQAALEAVGHKYSPDQNGLLPYI
GKHFDYVKVMVLEIDHLTAKESIELVRAKTSHS
>fig|546274.4.peg.1303 Bicyclomycin resistance protein
MNSPASSRLSDKQMALLMAAMAAVMPFSIDTYLPAVPAMAASLGVGETDIQQSLSIFLVG
QSAGVLLGGVFSDFKGRRPVVLAGLGVYLVASLGLILLQTLPQLMLLRMLQAFGAGMVAV
SGGAIVRDHYEGRRAAQMFALIGVIMMAAPILAPMVGWLMQIIGGWRAVFGFLLGYAALV
WLLQWRFLPANRPAAKPAGSPLSIIFTGYRSVFAKPQSLGFLFFQSFSFSSMFVFLTESP
SVYMKFYGLSNGFYTLLFGLNIVTMVFFNRITAWRLKSGSEPANILLIGIAVQFCANFLL
MLLSQSTAMPSLWLFAPLVMVSVGTQGLVVANTQACFMGYFKAEGGSANGVLISSQVLIG
AAMGFLTTQLHDGSARIMPAMMLASTLCGSALLFALSRHVWLDKARQ
>fig|546274.4.peg.1590 Drug resistance transporter, EmrB/QacA family
MQHTDSANTQHEYFANRPGFPAKTIVATLFIGAFFGYLNDTLLNVALTPIMRDFHIDKTT
AQWLTTGFLLVMGVFTPITAGVIQWFETRRMVLITQATFLAGSLICALAPNFGVLLAGRM
VQAISAAFFVPLLFNGILNIFPPNRHGTAMGVITMMFTAAPALGPTLSGIIINHTHWRVI
KPHSKSSD
>fig|546414.3.peg.3245 Permease of the drug/metabolite transporter (DMT) superfamily
MVIWSGFILVSRLGAQGTLSAFDVAALRFGVSGLVMLPYLLRHGTGGLTLLQVAALGVTA
GLGYALLAYSGFHFAPAAHAAVFMPGMLPFFTAALAWWLLGERWTRGRLLGLAVVAAGVA
LLVADELGRGGTTWRGDLLFLSASVSWAVFGVLARRWRVQPLQATAVIGVFCLVTYWPPY
LLSGHSNLLEAPLAEVVIQGVYQGLLAVVVALITYTRALQILGPNLTTTITSLTPALAAL
SAVPLLGEELSALAVLGVMIVTLGVLVSVIRPRSTPTAQVSDED
>fig|550540.3.peg.1215 Membrane fusion component of tripartite multidrug resistance system
MKKPLIAVLALGLVGASALYYGIGSSGVSTDNAYVKADLTLIAPQVSGQVVGVAVSDNQW
VEQGDELFRLDDRDYRAALSQAQAAVALADAGLASNDSRTALQRVQIEQARAQIASAEAN
ASLQQAELKRYRQLVTSGSVSQTQFDVQSARAVEAQTGLDNARLALKAAEQQLATLASER
VQLEAQRQQAEAQHQLSAIALERTIIRAPMAGRVANRQVQIGKLVQPGMAALTLVPEAVW
LEANFKETQLAQMAAGQAVEVVLDGYPDQPISGEVDSVTHATGAQFSLLPPQNATGNFVK
VVQRVPVKIRLQLPAELKDRVYPGLSATVTVKP
>fig|550540.3.peg.1780 Acriflavine resistance protein a precursor
MNAWRYRLWAGLLVGSLAACGGEAPQQGPPPAAEVGVITLQAQPVTLSVQLAGRTKASLE
AEVRPQISGIVLERNFTEGSMVQEGQQLYLIDPAPYIADLNRAQADLSKAAANVKTAKNR
ADRYETLVAARAVSQQDYDDALANYQQAQADVATARAAVTSAEINLDYTKVYAPITGLAG
RSTVTVGALVTANQGDPLVTVQQFDPMFVDVTESSRALNRIRRQWASGELVRQDSAKVRL
YFDDNDLYDQEGVFQFADINVDTGTGTFTIRTTFPNPDNVLLPGMFVRAEMVKGIVPNGL
LVPARGVTRNAKGEATVMVVEDDKVAQRVVDAEQMVGQNWLIRSGLKAGDKVILEGLQFV
RPGVPVGTVRELDQKQQG
>fig|550540.3.peg.2205 Permease of the drug/metabolite transporter (DMT) superfamily
MAHYIPAILFTVFTNFLSQIMLKKGMTVIGPVELNPTGLKQMGASVLLNGYVMGGLLVMV
ISMASHLYVLSKVEISYAYPFLGLSFVLTTAYGYWVLSEGVNAWRVLGVLFICTGVAIVA
KN
>fig|550540.3.peg.2592 Tetracycline resistance protein
MSPYRILAATALVTLISVSGVALPYPILAPLFLDLAHPVSQFANLPPKLLLGAILAIYPL
GILIGSNLIGAWSDRFGRRTILLWTMVGSALGYFLSAQAIAQGNFLLFALSRLVTGLFEG
NLSVARAIASDLHPKIDRTKAFSWLSATTYGGYLIGPLLGGVLLPLGAPVAFTVAGIACA
IAVGVIAVALPKDRPASCGQRAERHSLALLRDPRIRAFFTLYLLLMLSVNGFYEFYPVWL
LEVRQFDSLDIAGATVLLTSTMIAVATLVNVRAKQRLGLARAGMVGMALFSLPLLLLPLS
AGHYVLSFILMGAGIALYNAMLPSFLAERGGDYGQGALMGLMATTFFLGNVIMALLGSAL
ALLDTRLVLTLSGLFGAVAMAQFGHLHFRRTTWPRPVSQAPAEKPAAGGL
>fig|550540.3.peg.3019 Multidrug resistance transporter, Bcr/CflA family
MTRPVPFVLLMLLVAFSPLAIDIFLPAVPAMADALAAPLPQVQATVAVFLLAMGLGQLLA
GPLADRYGRRPLALSGVALYLAGSLMAAWANQIEVLWLARLLQGFGACAVVVAAMSGVRD
SYGPERAGPIYSYLNGVICVVPALAPLLGGMLAALWDWRATFYFMAAYALLAGALVAWRL
PETRPADTRSEGALVSWARYQPVLSHPVFQYHAGFIMLAMAVIIGYVSLAPVQLMVAMKQ
SPMAFSLWFGANAAINIAAAFAAPSIVARVGKRAALRLAIGLCLVAAIALLLLADLSHPA
AFMGPVFISSIGFCFVFAVCGGSALAPFGERAGTASALLGLFQMTGASVLVGLVNLLPVA
PVASLAVLMLLPLVWLGLARLNRAGHQQVQAAMVSVSDNAPAN
>fig|550540.3.peg.3034 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSANLSRQDVNRQFWRYVLPTVAAMLVSGLYQLVDGIFIGRYIGADGLAAINVAWPIAGV
LYGLGMMVGVGAGALSSLSRGEGKLARARAQLGNGLVLMALMALAATGLLWVLGEPGLAI
QNAEGNVLALAQDYLHVLMLAAPVALGSMAMPFMLRNDGAPNRATALIVAGAVTNIVLDW
LFIAEFGWGLTGAAAATALAQLLVTLMGIAHFFSDKAQTRLTLADLKLRPYDAWRSCAIG
LSSLLMYGYYSVVVALHNGLFLHYGDATVVGAYAIVSYLMAVYFLFAEGVASGTQPLISY
HYGAGEYGLMKRYIRLMLKVAVGSGVVALVLLNLASAPVISIFNSADADLFAATEHGLRL
HLIALYLDGFIFCVGVIFQSFGASGKATGVTLANMGIQLPFLLVLPQWFGLDGVWLALPI
SNVALSLVAGALLWREWRQLEARLG
>fig|550540.3.peg.3276 Glyoxalase/bleomycin resistance protein/dioxygenase
MTQFKPEDVPTLMPYLMVKNVSQAMDFYQTAFGFERAGEPLVEDGVVLHGEMTFGDARIM
LGREGAFGSEAKSPASSGHDQGMGLYLYCPDVDAHFEQAQEAGAAIMQPLNDMFWGDRIY
TALDLDGYRWSFATHTATQES
>fig|552396.3.peg.192 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNMTQGNVMKLLLSFAVPVLLGNIFQQFYTMADTMMVGQILGVRALAAMGATASLSGLV
IGLVSGVSMGVSILIAQYYGARDQEGMKMATYGCILLCMSSVVIIVLAAMLLKTPILSLL
QTPKSILSMADGYLTIIFMGLFITMAYNMMASMLRSIGDSKTPLYFLIIASLTNIALDYL
FIAQLHLGINGAGYATVLAQLLSVVLCFLYMRKKYPMFFLKKEECHVEREVFLKQMSMGI
SMGLMNSIVSIGSVVLQSAVNSLGEMTIAAHVAARKIVEMFMQPLISIAIAVTTFVSQNL
GAKQYHRIREGMKKSVWISFGWVGIVILLSFTCIDFFIGFLVNKQQTQVVSLAAYYTRIS
SVFYFILAILFIYRNGLQGLGNGRSPIVSSCIEMGVKIIATFALIPFSGYTGVCFAEPIA
WSLMGPFLFIFFYRDLKKKERMLI
>fig|552396.3.peg.451 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKLHASGEDYLETILVLQKKLGMVRSVDVVRHMEVSKPSVCHAVATLRDGGFLMMDEDHF
LHLTDVGREVAEKIYERHCFFTEQLITAGVDPKTAEADACRIEHIISDESFDRLKEAVEQ
EQD
>fig|552396.3.peg.1558 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNDRVHRLYLHYLFPTLIAMASNSLYCLADVFFISKGAGSTGLAALNIAMPLFTLYSAIG
LTFGVGGATIMSIAEGTGHMQERNQAFTCSVLGMSVIGLFIAVFGTIFAQPFAYMLGSSQ
ELLPHVMEYMRPINACAMFFVINYAGSILLRNDHAPKLAMQATLCGNITNIILDYLLVMV
FGMGLFGASIATALSAVLSLLFMLPHFFFKQNTVHFCKDIFSIEVWKRMLMNGAGSGVLE
ISAGSVVLIFNYVIVQEADQLFLAAYAIVTNIAYVTKGLLNGFAQAAQPIISTNYGARQK
KRTQQAFHISLIASSLFALLLYILFLLFPNTVAAIFSDGDMQLIASAGDGIRFYFTSLFF
TAIITMILYYLQAIECSRAATILALLKGFVFVIISLFIMVHLFGMNGIWFTITLAEGLAV
LSGFWLLKKL
>fig|552396.3.peg.1861 Permease of the drug/metabolite transporter (DMT) superfamily
MKKQYANLMLVFVTIIWGGGFLATNGALAAISPFYVMMIRFVGAAIFPVCFCWKKLRQLS
KDEIRHGIITGVFLFLAFAFQTFGLKYSSPSKNAFLTATNVVFVPYLLWFLFHRRPHKKE
IIASLLCVSGIALLTLRVDAIMIGFGDLLSIICALFFALHIIALERYSAHTDAFCMTAMQ
MVTAGVLSTICALAFEQAPATLGLEALGNVGYLIFISTLLAYLLQTYAQKYTTANTASLI
LSMEALFASIFSFLILHEMMTLPMLVGACMIFGSVLYMEYKPTKKE
>fig|552396.3.peg.2238 Glyoxalase/bleomycin resistance protein/dioxygenase
MKITWVTLSVSDIKKSIAFYTEVFGMQVVSRFHGGIHEIAMLKTKNEVLIELIQNRREAD
KEVGNGVSIGLEIENLDAFVAMLRKNGYELTGPIAPNPTICFYFIKDPDGYTLQLLKRS
>fig|552396.3.peg.2835 Drug resistance ABC-transporter,membrane protein
MKRFLTLFKIEGKLALRCPDGIIFGVIMPVGILFLIGFIAKDQQAGNSGYTFMQSAFPSL
ITIGICATAFMGLPTTFSDYRDKKILKHFFVTPVSPRVLLLVETLIAALTAIVSACMISL
CAILFFDYHMDEIPSYF
>fig|552526.7.peg.735 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKKLLSYLGRFRYFALLVFMLGGFSSILQSLVIQRVIAIDTVSDFRSLWKLFIVGLLTYL
LFYGLEFGANVVYDVACKRIMLALRDKLTRKLLLSGQAIDQHEATNFLSQDLEFFYDNYV
TQVMRLPKDGMIFLVVAIYLITLNPLLAFLFIVGSLLRPLPQLFLTQTTESLGKRQSDER
ERSMSLIMDYVNGSSTLLHHQAFESTYDQLANQVLTYETARRNYYYLSNFLFFCNGLTQF
LGRVVPIGLYFLLPMVFGHIPVSSLIAMFMASNNLANPLQNMMYATFSMQAAVSVKAKID
DMMDQVADEAKVPYLPHFKALALEGITKSYGAKLILKDFSYTFEQGKKYLIKGTSGRGKS
TLLHIIKGATVDSGKIAFITKDKQSFENYQANVGMVNQAPFLFNGTLEENVCLNQEFSKE
DILAVLDQVHLLEELPAGLGFQIENNGTNISGGQRVRIELARFLLRQKDILLLDEVTAAL
DKDNARRVRELIFSLPITIIEVAHHVDQAIAYDDMIEL
>fig|552526.7.peg.736 Multidrug resistance ABC transporter ATP-binding and permease protein
MFKYFNKYLVTLTLVACALNSLVFLIEPLITSKIFDLTSLNNHQDTLSFLGYGLTLYVVL
YSVMFIANLLINHIMTIGCGRIRLRLYQNLILNHREMSHDKKISMLTQDVEYYLWNHISP
SILLVSHVSNVLLLSAYLLSKNMLIGLIFIACAFVFLVVQHVIGQKAEQKGSELAVARQK
LLGLLSDVVAGHSTLIQNQALFASLKQVKKQSEHYESSRQAFEIFRSFFTLLAHLMLFIS
QFLPIFLGLALTLLGVKLRTTDLIAMFIAATRLEQPLKNIVDDMFRLNGAKAIAKHFETL
LEQPIPKYQSHAMTGDPFECLDGHHLAKSFAGRTLFFDLSFHFEKGKKYLIKGPSGSGKS
TLFKLILQEMSPDEGTLDMVLAGGRTTDNYHHRIGLIAQSPYLFNDSIRYNLTLGEAFSD
ELLLEKLEQVGLTNEFDDILNYQIVNNGENISGGQKTRLEIARSLIRQKDVLLADEVTAP
LDVNNAKTIRQLLFSLPVTVIEIAHHIDDTFIYDGDIDLS
>fig|553190.4.peg.462 Daunorubicin resistance ATP-binding protein drrA
MNNNIENATDSRDNNNKQSASNLILRIDNITRSYSRGFGRKKTTRQVLHNVSFDIHSGEI
FCLLGPNGAGKTTTVKIVGTLLAPDSGSVRIANIDAVSNPREARKHVSLLLGGERGFYQK
LSALDNLRYFADLSAVPYREQGKRIHDALEQVDLLDKAHDAVQTFSRGMWQRLHIARSLV
ARTDLMLLDEPTTGLDPENARKVREIIHALRDQGIAILLTTHEMSEAEKLADTVAVINHG
NIIAQGSVQQLASLQHIDHVTMYAYEGETSSGTPSVKEELQKLDGVLWCDVFESHGVLNI
TIAWSKALSQERNVKIPVDGITRLGDRAASLEETYLAIVQNDNISASNTSTSSAATSSSS
SSSLSLSK
>fig|553217.3.peg.11 Inner membrane component of tripartite multidrug resistance system
MSKHTPQSLSNSAVIFSLLLGGVVVSLSNSALNPAIPLFMQVFGVPLVSASWVLNAYVIA
MAIGLIMVSYLATIFVRKTLYLTALAIFGLGSMMGYFSPSIDWVSGARFLQGLAGGILIP
LSVGILYQIVPHQRQGQTMGLWGMVVMLGLAIGPLVGAYLLKWYDWDVLFIINVPLMGLA
WALVWHYLPHQQAKIQQRNLDKKGLLGLCLLLLGGFVWERMAHQYTAQFSEWMMVAMIGL
GGILIYGSYRWWLYEYYHATPLLQVNIFDNRIYRYCTIISVTQTIGLMLYLILLPMLIQQ
VMHHPATWTGWVLMASTLIASVTTQLVGKIVDKQGARLLGCWGVILTASASFGLAWQLVD
ISIIAVVIWVCVHGLGVGLAYIPTTTVGFSQLPADKVTEGASLNNISRRICSGLVIWLAM
AYVNYRQTQAVNEVGILQELLLLIGGMLLLSLPFAFALPRTSSGFINQQQS
>fig|553217.3.peg.755 Outer membrane component of tripartite multidrug resistance system
MTGKTMKQSTLSHLILAGILTTAFTASLTGCQNTPVKSQSQVVMPQKFNYVLPVGEQSNI
STWWQNFHDPVLTSLIEHALQTAPDIREAKARIDEASAVANLANANKGIMVGAGGSITGV
NSDVDNPLPSKVRKPLGMLGSDWGDSSLDVDGHAYHLGILASWEPDFFGKKQSDADAAGY
AYLATQEKIHGAHMLVAAKIAQAYFQARSKEQEALILKQTQSSLSELRRYAKARFDLGQA
TRYDIDDIDIKLQGIKAKQDNLSAERQANIRQIAVLSGKTSQDFDLPPSPVNVLKHLPPA
PQGYYPSDLLTRRPDIRAKQAQVNALAALHGSAVADQYPRFGINFGALNGGLSISNNDLD
STGITAGLINANVSVPLFTNGRIKHNIEAADARVQAVMADYDKTLLTALAEVDNSSQLNT
ALIRQHRNLQNAVKDAELQADHAKKLFNYGRLTFDDMPKARITAQEYEQNLIQNELGQAL
NLIALYNSLGGGW
>fig|556268.6.peg.1192 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSRNTKDTGYRPDCLCRSRNPSGKARVGVLSAIKGHSLQTQFKSTAFRFTDALRQGMRHT
GRQNRGVFKSIQKAGQKMEQAKKQTGIPSRGEKELATGPIPRLFVKFVIPGMLALFLLSA
QVFIDGILVGNFVGANAMAAINLVIPLYSLLIAFAIVMCVGCQCTVGMKLGEGDLHTAND
ALKTGLVFAVAVSWAAGLVICLAAPRLITVMGANDVLSGDAVAYIRVLAFFFPLPVAMFM
CDAVVKATGRPIYATAGMLTMVASNIAFDLLFIVAFGWGVAGAALATGISYALGLCVYLP
ALLHRHTPVNLFAGRFRKALVGKILYIGSAEGVTELSAAVVTLMFNITLINTVGEKGVAA
FTAINYLHFVLMACIIGMSEGIRSIISYNHGMGNPERIRATLKLAARVTAVFAVVTFSSF
AFFGRELVSSFFSTQESDIITLAANGTAILAFAYLFNGFNILIAGYFTSIGQARRSLVIS
LLRGCGLLTVLLFTLPPLLGIDGIWATVPVAEALTLCVAGLMYLKHKNAAATVAAKQAKA
VMPE
>fig|556268.6.peg.1374 Multiple antibiotic resistance (MarC)-related proteins
MHWGFLIKKTLTLLALVDPLMAIPLFICATAGLDTGFKDKYSRQLGITVALSLLIGGLFG
LHLLDFMGVSLASIQIGGGAIMFIVSLAMVIAKEETIKYTPRETEEAASGPSIVPLGIPL
LAGPAALSYVMATSQITQAEDLLSVILPPVVVGAATWLCFRFVGRGGRILTPSAIKVIER
LAGFLLTAISVEMMATGFRHVFPGLSS
>fig|557598.3.peg.1124 Polymyxin resistance protein PmrJ, predicted deacetylase
MAGRWWPGRQPGRAGRQVCQQLQAAGFELALAAWDQAAWRQEALTGEAEWSRKTLEHART
AFSQLTGQPAAGIASPGWRINWPAMRELQQQGFAWASDTRGSRPFIPVHHAEIVAVPQLP
TTLPTLDEVLADIGNDEAHAAERLLGLSARVPAGGCHVYTLAAEREGGAFAAVFEALLAG
WQEQGWQLVSLGELAASLDMDSLPRCNLKWEAWPRRPGERTQQGDPAFAG
>fig|557598.3.peg.1269 Transcription repressor of tripartite multidrug resistance system
MTSCNPLLHLEDAIGEISRKMPGSPRTEIMLTRLHFYVQLQLGAWFESSLKPYGLNHSAW
LALMLIYSRPQERVSPSDISATLAFSRTNATRVVDELEGRGWIQRHPCPDDRRKTELGLT
EAGYQLIREVMPVHRQRMRDAWQDFTPEEQAQFIALQRKLLTRLETGS
>fig|557598.3.peg.2173 Bacteriocin resistance protein, putative
MPILSRLLPLGLSLVVSFSALAENSLPVPAYTGLNEGLTKHVTSLREARFDSVIEQKTDY
SCGAAALATVLRYAFGRPLGELDVMKGMLVGADPATVQQYGFSMLDMKRFVQNQGLRASG
FLADKTRLAQLRIPVITLIDSGGYKHFVVIRRVQNDEVHLADPAMGNRSMPLEDFARQWN
GVLLAVAGPGYLRDTPLLQPRRVFSARTSINNSQPVPIAELLEFGFQHSDFF
>fig|557598.3.peg.2672 Outer membrane component of tripartite multidrug resistance system
MMRRHFAIAPVALALLMTGCAIGPDYQRPVMELPDSYGTPAGSPELRISRDWWTQFNDPA
LNALEDRALNYNRDLAAAVARIEQAQAQLTSATADLLPQLNAGADATRGRNSLYSSTTGT
NPVMDSYQASLAASFELDLWGKLRRNREAALASLRASEAARDTVALSVTSSVADAYFQLR
TYDEQLDISRRTLKSREEALQIYAKRYHGGLISELDYRQAEAETATARVAVPRYEQAVSQ
AETALKVLVGANPREVFEAEVPRGEELSRIVVPPVLPDGTPSTLLLARPDLVSAEQQLVA
ANARIGVARAAYFPSISLTGAVGSASLALGELFTGPAALWNYGGALAMPIFNWGKTGAGV
KAATAQQKEALANYELAVQNAFRDTRDALTAQQKSAEQLAAQDTQVNALQRTAHLARLRY
ENGYSSYLDVLDAERSLFSSELDRANARLARLNAAVSVYRALGGGYDQPGAREIPPPVLV
Q
>fig|557723.7.peg.489 Transporter, drug/metabolite exporter family protein
MANHQPVKGSIAIITAGFLFACVNTLIPKLTSVSAIDASVIALVQYLVAFIFLMPSMANM
GFFQSLKTKHFGMHCFRVFLSAIGIQCWTMALAYLIPIWQGIALLMTSPLFVTIGSGLFL
KEKVDTKRWIATFLGFVGAMIILEPWSENFEWVVLLPVAAAFFWACYSLMVKKLSNEDSP
TTMVAYLFILITPFNLLIALTNLSPEGFSLPSFSDFGFLILLGFFTALAQLAVAKAYSLA
DASYIQPFDFIKLPLNVLAGWLVFNWVPPGKLWLGAAIIIGATMYITHAEAKQSQQK
>fig|561229.3.peg.74 Permease of the drug/metabolite transporter (DMT) superfamily
MKLKDFAFYAPCVWGTTYFVTTQFLPADKPLLAALIRALPAGLVLIFGKKLPPVSWLWRL
FVLGALNIGVFFVMLFFAAYRLPGGVVALVGSLQPLVVILLSLLLLTQPVLKKQIMAAVA
GGIGIVLLISLPEESLNPAGLAASVLATVSMASGLVLTKKWGRPAKMTMLTFTGWQLFCG
GLVILPVQMFLEPLPDAITWTNLAGYFYLAIPGSLLAYFMWFSGLEVNSPVIMSMLGFLS
PMVALLVGFLFLHQGLSGPQWVGVVLIFSAIIIVQDISLFFRRKNQCS
>fig|561229.3.peg.82 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MALAWPMMVTAVVVSLSQNMQIAILGNGAESQTLLTLSFLQPFNFLFIAILECLAITNQV
FSARSRHDWPRQRIRHSTLLLGGIGILATALTALLCRVLALPLSNWMNSPDLALMQNAAP
GYLLSMTPFLALEMCNAALRGQGKTVPAMTLMCGYVLLSAAGCYLGFHVYQLGFDAVLLA
NSLPALVLLPLAVRSLRQVARPVPDERPHAFLPRLLALLTHAGLPVGFSMLVVFFSSMVI
FPLVAALGAGFLPAFLIVIKLRAFFIIPAVATGSAIAILLNQHRKTHSAPRQVSLLNNGV
WLIVLAYLALTLGVCWARNGILAGFSNDELIRQSSQLLLLLLLPTFFLTSLVAALQTLLE
QVDRGKRVLLFTLALELLMVAVALGAHRYFNDVQTIAGLIVAFSLAYAVVFLREYRLLAC
ALGEQDAAV
>fig|561229.3.peg.213 CpmF protein involved in carbapenem resistance
MKRNVVLYAVLLLSQFAHAVQPNVMPDEIAIKGGAFYVGNIFGNKDYASHTNTTLKPFYI
MRTEITYSQYQHVLQWAESHGYAFENGCNGGHFDDCLPAEQDNGRHPVTTLSWWDAIVFA
NALSASQQLTPYYLTADGRPITSVPQDQALNVVRNTAATGYRLPSLNEWQVAARGGEAAL
RQGLYGRIYSGSDNPDHIANMPKDNSTTFSTQPVARQQPNALGLYDMTGNVWEWIDDDFH
MTGLNNMHYFCGGSYLMHISNLSECDVHTPNFPTSDIGFRLVRSAPL
>fig|561229.3.peg.2192 Permease of the drug/metabolite transporter (DMT) superfamily
MQAENVKNPRTAQSYQPVQPQPAGLLLGYVAMAIAVIAWSLFAVSIRAISASPLSIADVA
LFRFGIPALLLLPWLPARLHQLSNLRLREIIAILVGGGVPYFFIASLGGHLTTAAHVAAL
IAGTSPLSVALLAFVLFRHRVGTTQLRAILLILLGVVAMVLPGFSTTMMNGSAMLLLASL
LWGGYTLAIRRSGLDTIGCVLLLSLPSALLLLGLMTTGVVESHLRSVTLHEMLPFLLIQG
LGTGIISSLSYTVAVQKLGPSRSALIGSLCPALAYLLAVPLLGEHFSLPNVIGVVVITLG
VILANAPFTAYAKGCPPQNRLTPAPRR
>fig|561229.3.peg.2802 Multiple antibiotic resistance protein marR
MLIHLSNQFKEHLLNEYFADTDITAPQFKVLISIYKGITSPVEVSKNVMVDGGGLSRMVE
RMVKRELIVRQPHPDDKRQVVLALTEKGREICRYFEQEGMQVIPAQLTARLTPQETEQLI
RLLTKMLPDEVVARYLPY
>fig|562970.4.peg.230 Permease of the drug/metabolite transporter (DMT) superfamily
MASWRADLLLLMVVAVWGSTFVVVRDAVAEMGTMGVLASRFTVAALALGVFGFKSVRTAR
ISEIRAGVAVGLAYFLGFALQTAGLASTTASKAGFITGLSVVGVPFIAYLVWKVKPSVDA
VAGVIFATAGLAFLSLADVRGVGIGDLLVLGCAVAFSVQYLLVSHFSVPCRIVPWTFYQL
VTVALLSLMGSALSGTSPLPASTRAWSAALFLGLVATALVTVLQNIGQRYTTATRAALIF
SLEPVFAAIFGHFIQGDQLTGRMAIGAALILLGMITAELQWVTHWRLRREEQRMITR
>fig|562970.4.peg.565 Drug resistance transporter EmrB/QacA subfamily
MATIRSSVCNSVLFVLCAAQLTILLDTSIVHVALPAIQADIHIPTHQLQWVVTAYALSFG
GFLLLGGRMGDLFGRRRMLMAGMALFTAASAAGGLASGTGLLIAARALQGLGAAMIAPAV
LSLLAMAFPEGEERNRALGVLGTVSAAGFTVGLILGGILTGAFGWRWIFYVNIPIGILVI
ALAPRLLRESERLRQPVDVPGSVVATAGLTLLVYACSAAGTSGLFSVRTWSFFLPALFLL
LVFLFIESRIGNPLIPLEIFRNRTFVGAWMAGGVFGSVMGPTIFMLTLYLQNVLGFGPLA
TGFAFLPQEITVLVAANLIGRYVSRVGVKAVLSGGMLGFGAGVLMLARISTEGSYWSVVL
PGMMLIGFGVSCVIVAGAIAATAGMAPQEQGLASGLWNTAPQIGAALGLAVLVTVANAFS
DGALRHEPGLSTPVSAAGVTGFKAAFFASIGFVAVGLWSVLALIRKTNPFEKPDHND
>fig|562970.4.peg.1476 Daunorubicin resistance transmembrane protein
MFIRQAFLKWTAYRTAFWVDVFSRLLQIYVMYAVWSLLYKEKPSAFGALSFEQVFGYAVV
GILLGAILSLDEGPHIRIAERVRTGMIAVELMKPISFVRLVALESFGDLAIRAALYAAIP
YLFALIVFRIPVPQTPGQAALFLTSLVLSTVVQFFAHFLFGLISFYTLDLVGFQFAYWAM
VRFFSGQWIPIYMYPEALKPFLYALPFQAMFATPQSIYVGQLHGWAATTAILVQGIWSLV
LGGAALWAWRSLQRHVVIQGG
>fig|562970.4.peg.2221 Drug resistance transporter, EmrB/QacA subfamily
MESNGMPRASLEKAGQSHEPAAHRWLVFISVVIGTFMVNVDSSIVNVAVPVLQRDFHVGP
GALQWVISGYLLVVTAMLPMIGGMSDRTDRRTCYIAGVTVFSLGSALCAWSTDVDQLIVF
RLVQALGGAAIMGNVMSIISYTFPAGQRGRPLGLVNSVVAAGTIVGPALGGALTAAVGWK
SIFWVNIPLGMISIVMSLAFLRRMSTNRSMARFDWMGSLWFFVAMAGTLLFLSNGNSWGW
MSGRSIMAGGLSIGAWLLFMMRESRIREPLIDLRLFRSARFAIGNVAGYLSYVIMMFPTF
ILPLFLHQVMHEPIAHVGLLMTSQAVAMILISPVAGWLTDKYGPKWPTTVGMAIVTAALL
WMAGFGSGTSKPAVVAAQALFGLGMGLFTAPNNVSILESVPVAQTGLIGSLLATIRNFGR
VSGVALAVVLLETAIGTSSHYSESALVIGSRIAFGSAAILGAVATLLISTRMAASSKTTV
I
>fig|562970.4.peg.2519 Multidrug resistance transporter, MFS superfamily
MKQTNRKWVTVCLMAAMFLSAMEATIVATAMPTIVGNLGGFSQFTWVFSIFLLTQAASIP
IYGKLADLYGRKPVFAVGTGLFVIGSALCGLADSMPTLIAFRALQGLGAGAVQPIATTII
GDLYPGPERAKVQGLLSSMWAIAAIVGPALGGLLVQTIGWPWIFELNVPLGILTIIGIAL
FLHEKVERRGHQIDYLGAITLLIGISALLTALLQGGVAWPWTSGKILGLFAISALCLALF
IWIETKAQEPMLSLPLLRRPVIAAANIAAVITGGITLGASSFLPTFAQGVLGTSAIVAGG
TIVTVSIGWPVASTLSGKLIWRWGYRALEVAGLLFCTLGAILYLTISPSTPPWHMAAFSL
VLGVGLGLASTTQIVAIQTSVPWQQRGIATGANMFARILGSTLGVAVMGTVVNAGLSRAL
SATPIARKYETADPISVTNLLLDPVRRAGLPPADLRVLSDALAHSIHSTFWVLLVAGILG
TLIAFGMPGGVSQSAESGEQPETGHKSG
>fig|562970.4.peg.2662 Drug resistance transporter, EmrB/QacA family protein
MEQVRREHSLLDTSGGSEDIGGVRKWLVLANVAVGTFMANLDGSIANVGLPTISESFHVP
LASVQWVVTAYLLTICALLPTVGKLSDLLGRGRLYNLGFALFAIGSALCAVSGSVGMLIG
MRVVQAVGASFLMANGQGLVATTFGPRERGRALGMIGTTVSLGTLSGPAFGGLLIEHFGW
PAIFWVNVPIGAVAFFAGWRILPRERGGGREPFDLVGAGMFAVGITALLFAVSGAEGRGW
TSWPTLGGIGASLLVLVLFYLREVHIPHPMLDFSLYRIRMFSTGSAAAFLSFVSLFCVNV
MMPFFIQTVMHQSPAVTGYVMAANPVVMAVTAPLAGWLSDRIGPYVLTTGGLTLNALGFV
ALNMLSPEVSPWVVAGHLAVFGLGQGLFQSPNNSSIMGSVPRSKVGLAGGLNALTRNLGM
VFGISLSVSLFTYRLGVLSGATDAGPGDIGPVEAGGVVQPSPEVFMGAMHTVFWAAAVTC
VLGAVVSSLRGGRRTAGGSAKTAE
>fig|562970.4.peg.2717 Drug/metabolite transporter (DMT) superfamily protein
MMGQPRGWRPTRVQALWMIGLGASCYGLISPVMKTAFAQGYTMEGVTAAQYFVALLFWVV
AGLAVRTGTRPTGREVIQLFMLGLIGSGGTTVLYYRSLVHLPASLAIVFLFQFTWITILL
EIMLERKSLTARRWQALLMILLGTGLAVGLLHDQWEGGVSWIGVAMALGGAVTYSVLLYG
TGRIAVQTSPVRRSLFMSLGAGVPILLTTPLAAYYTAPSLAGLYGWGVVVALLAQIAPPL
LFAVAIPAVGGGAAAVLGSMELPVAVVAAAVILKEPVGWDRWLGVALILVGVIWSERVNR
RGRESPGI
>fig|562970.4.peg.2759 Daunorubicin resistance ATP-binding protein
MIELRRASIIRNGRILLYPVNLTLESGVLATVTGPNGAGKTTLLRLMSGLWRPSEGEVLL
DGESPSARHRGQIGLVLQESMLYGGLTVRENLRFFGRLYRVSDLENRIHDLANELRFERR
LNDPVSVLSKGYTQRVTLARALLPKPRLLLLDEPFDGLDPSVRGLVKEVLALRVAEGATA
VVVTHDLKLTPHADVQIQLNRGRVAVVSPGNKVS
>fig|562970.4.peg.2939 Permease of the drug/metabolite transporter (DMT) superfamily
MTRKLAWPVVGYIAALVLTWGICWPVYKFGLNYTPPLLYAGLRTFLGGVLMAALALPRWK
ALQWRRNWRIYAISSLLNVFLFFGLQTVGLVYLPSGMFSLLVYSEPVFVGLLAWKWLGET
LAPTKVVGLLLGLLGVAACSFDRLPGSASGLGILLGLAAAISWAAGTVYLKRVQAQVDMM
WLVAIQCLLGGAGMMGAGSLFESWSEIQWTWPFLATVAFAMFFGVSSSWLIWFRLVQMGE
VSRVAALTFLVPVISVVLSALFLHETISGWLFAGLLLIAASIYLVNHTPHPHRAAGEAPR
TLG
>fig|562970.4.peg.3168 Permease of the drug/metabolite transporter (DMT) superfamily
MRGYVYLSAAAAIWGGMYVISKVALDVIPAFVLLWLRYTVALVVLALVLKVRHQPWPRDR
RTWLWYAAVGGVGYAVSIGAQFLGTAWTSAHLGALVTTSSPVFAALMARWSGEQVGGRVW
TAVIIALAGVGLVVGGDVIPGSAVATAGALVNPGTTASSLGSLLLFWAGVGCLVVAAATW
AGMSVLVQRAESRLPASESDPLVLTAGALVTGWVMVTPIAFMQGMAVGWPALWRILTTPE
ALGSVLYLGLISTALAFFLWNAGVQYASAARANLFLALQPVVGGLLGHWTLAEPLRLTFC
VGGAAVLVGLWIAAGTQPGRSES
>fig|562970.4.peg.3358 Fosmidomycin resistance protein
MEPSTAEQSLARQPVWKALWIVSLGHFLNDTMTTLVPSLLPLFQSHLGLSYIELGVLVLV
ANVTSSMVQPIIGAWTDRHPKAWLLPAGEFVVGAGAAAMGFAPSYGWLLVLVALLGAGSA
AFHPEASRAAHLAAGAQKGTAQSIFQVGGNAGQAIAPLVVSLLFVHTGLHGSIWLLVPAM
LAAGALATIVPWYGAKAKVKVPRVVRTASGTGAAGAVVLLLAVVTFRSWMQAGLSGFLPL
YYVNVRGLSTSVAEVYTALFLLAGAVGTFIGGPLSDRIGKRRLILISMAGAIPFSLVLPY
AHGIWAAVDVVLLGFIVLSTFAVTVVFGQELMPGRIGLVSGLMIGLAVGMGGVGASLAGY
VADRFGITTAIEILAALPLLAAVLAWWLPEDRPLSPRGRPAPKPHH
>fig|562982.3.peg.748 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MYQGKNIKEQSKIFVKLLFPVLIYQIISYSSSMIGTFMAGHYSPTDLAGVSMGVNIWNPV
MYTLNSIVLAIVPIVSQLMGKGREQEIPTKVRQFLYIAVFISIILIIGLNTLAEPIVNGL
GMDENIARVTKKYLFYESIGVLPIFLYVVLRAFMDSLGLTGLSMIMMVISVPVNVLLAYG
FIFGKLGMPELGGAGNGMAVSLTYTVLFFIALFLTLKHPKINKYKIFEKEGIKFSYWGEI
FKLGVPIAIATALETVVFSTLSLMVSRFDTTIIASHQAALNFSGFLYSLPGSIANTVTII
VAYHVGAKNYKMARRYTILGVIMGMIFAFLAGLIVWIFDANIPYLYSKDLGVIALTAHLL
LYAIGFAICDSFASALAGVLRGYKKVVPICVAMFIGYYLVGIPVAYFLVFKKGIGIDGLW
IGWIIGLGTYALGVLVYYMYMKKNIKKQLA
>fig|562982.3.peg.1291 Daunorubicin resistance ATP-binding protein drrA
MDKVLLEVDKLSIWYETKKYIVKDSKLSISENEIIALVGVNGAGKTTLINTLVGIHSKYS
LGEFIFRNEKLEFDDESFKMNRIAVFSQDESFRYWNFVEYMKFIFETYNIPLDSKYIDYL
IDGFSFRKYINYMKKDLSMGNKKKFSLIVAFGLRLPFLILDEPVDGLDFESTAFLYKIIK
EYKAYGSILMSTHVTESINESCDSVVILNGGKIGPKNQIQSKLSISDILYITRE
>fig|562982.3.peg.1339 Permease of the drug/metabolite transporter (DMT) superfamily
MRRFISELILIGVVIIWGLAFIWQNIASKVLGPLTVVGLRSLIAVIFITLVAILVPTLYK
SQEPKWIGQISSSKKLWLGIMCGVVLFLAMYIQQIGIGMTTAGKAGFITVLYICIVPFIG
VFLGNKLNKFFIIGLILAVIGFYLLSVKEEFTLELGDVIVFISAIFFGVHIIVIDYSALR
VNSMFLSIIQLVVVAIFSLGLAMIKETIILADILSVAAPLLALGILSSGLGYTGQIIAQR
EIPPHTTSLIMSLESVVAAIGGVLILNEHIGLREGIGMAIVLVGIIISQLREKKSPKLEQ
K
>fig|563041.5.peg.599 Multidrug resistance protein (spaB)
MPKPETQIKLEEKIHSITFENISFSYPNSKLIFENFNLSLHSDKIYALVGKNASGKTTLI
KLLLGFYIPNSGQIIINNKYSLQDLELNSYHQQMSAIFQDFSLYAGYSIDDNLFMQNNIT
KEQLKQKREILKSFDENFQNCLNDYSNALFGTQYNGIDFSLGQKQRIATIRAFLKPSHCV
VLDEPSSAIDPIIEKEFLDFIFKKSQSKMALIITHRMNSVKQADEIIVLDQGKLIEQGNF
ETLMKKQGLFYELFLKQQY
>fig|563192.3.peg.304 Probable antibiotic-resistance protein
MVIDFRIRPPYKGFMNLGIVRNWQSVPDDPRKMRPTGFERLPVPSMEHASVDMLVDEMKA
AGITKGVLHGRHTGNARYGDVSNAEVNELLLRYPGLFVALAGISPNAPDALEEIEHCVRD
WGFKGVALDPGWCSPAMYATDPKIEPILDLCQQLGVFVSITMSAYGGPDLSYCDPTPLVP
MLRKFPKVNVVIPHGCWPKVQEAVGVALLCPNLYLAPDCYFFLRNMPMRHEYANAANSFL
KYRFLFSTSYPIRGFAQAIEDWKNAGLEPESLQRSLYDNAAELLGISG
>fig|563192.3.peg.543 Permease of the drug/metabolite transporter (DMT) superfamily
MGFFLGLFSSATFGLIPLFTLPLIHDGVSPASVLFYRFLIASLTLGGVLVLRRERFHASA
IDLCKLAGMSFMYTAAALLLFYGLNYMPSGVATTIQFLYPVMVMLLMIAFFHEQFSMITA
CSIVLAVAGVALLSIGGDSSRPVTLLGVGMMLLSGFCNALYITGIHVAGIRNMNGLVMTF
YVLFFGAAFAFANAVGTGTFQPLSSWWEFMMAALLAVITAVLSNLTLVLAVQRIGSTLTS
VLGVMEPLTAVFVGILVFNEPFTPALVGGVILISSSVTLVMLGRQVQAIARRFQRKAA
>fig|563192.3.peg.2003 Outer membrane component of tripartite multidrug resistance system
MPASLIAAGDALARFFAAPEIGSVPHRSARQGILILVAFIGGMLPISNMAMLSSAYLALS
GDFNADLIDLGRLALGNLLIMGLVQPLVNHIHAGLGLRGALFLALCVVSVAGVGAASSGS
LTEMTLWYALAGFGGGLFLSLSARILFVAVPPESRRLMMAIWSFFIGFGSNLSPLLGGFL
VEFLTWHSLFLLSPVVALPCLVILFFLLPDSRPAGMPPFDWCSFAFLVAFAVPTLIAVCY
GQTFGWNSSFILIMIFCAVSALFLFLVSCLSAEAPLLHLRNLRIKGVGPAVMAALLLVIS
HVGMRIQMILFMRNVLGYPPSEIGLMFLLPLCVFVLTVVPTGIMVATHGNPKPFLLAGIA
CIAGAGLLLSRLDANADWWHMAVPLALRSFGYAMGSASATPFLLRNVPPEKQPQTLPAIN
SVRFFSMCLCMGSITTLSVLLNKWYFALIAAQVTQGSSAASASISRWSALFAGQGLSPSQ
SRHDALLIVSSSIKKQASVFTFDHLFLILSLVACVAFVCALLSRRVDPHPHAVRAHARNS
LSRLWAAVRSRLPRPAFPLAGLLLCCLLAAGCTLGPDYKRPDLDLPAASVAADEPGALFT
RERWWEVFHDGALNRLEEAALAHNSNLAQAMARVEEARAAAGVAFADRLPAVGLRSQDGK
RLMTEGEELAHHYASRTQEAYKAVGFLSFELDLWGKYRRLDEAARAELLSTEAARDTIRL
AVASETALAYFQLRTLQEQERIAADMLKSYERTCKVYETRYRLGQSPETTLRRFAAERDK
TQAQLYDLEERRIRCEGALAVLAGFSPAGIVDGAGRAFQEGRTLGELAPPPDVPSGIPSD
LLQRRPDVRSAEGRLMAANARIGAARAAFFPSFSLTAEGGYSSTHLDRVFLDPARIWGVM
GGLAQPLFEGGRLTAKQRMAEAKYEEARAAYVGSVRNAFTETRDALAGNRISRKALAAST
ERVKELTRSNEIMEKQYDAGLSSVMDLLDVRRQLLAARQEQAEARRRQLAAVVGLCKALG
GGWTEAKGFE
>fig|563192.3.peg.2245 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MHGLDLMLHGPLVRTFLRYCIPWTLAMLLQSSAAIVDGFFVGRYVGAMSLAALNLVMPMF
SLFFGVGVMLASGGAVRAGKYLGEKRPEAASAIFTKTMLSLLLVGLAASAGMLLFSGELV
RFLGADEELRGPAEAYLRGLMFFGPMIPCGLALSYFVRVNGKPALASVGLMLSALINIVL
DAVFIPVFGMGVEGAAYATGIAYTITTGVLCLHFFTPEAKCRFTRAIGAWKEVGQACWNG
VSELINETSIGLVILFINWILLARIGSYGVAAFTIINYAAWFGASVSYAISDSLSPLVSA
NFGARNFARARQFLGLALGMVFGIGLMLYGLFALYPEMLLKIFLPGEEKVVAVTLEFIDW
FKLAFLFSGLNMALASFFTALHMAAASAAVALMRSLLFPVGFLWLLPQLFGNVGIYVAIP
LAEMCTLVVASLIFAASRKHFADRKAHHGPERAARGGKNL
>fig|563192.3.peg.2731 Multiple antibiotic resistance (MarC)-related proteins
MDYSIGDFFSSVIKLFALLTPPAALSAFLSGTQTYGGRRKRRTALRTGTAVFIVGTVLYF
FGESLFSVFGFTLDAFRIGAGALLFLTSVALMGEQRESHTPDSPDEDISVVPLAIPICMG
PASIGTLMVLGASAHSMTERVIGSAALFVASALITLMLLMANHVQRILGKTGLAVLSKLT
GLLLAAIAAQVVFTGVKNFLIVG
>fig|563192.3.peg.3269 Permease of the drug/metabolite transporter (DMT) superfamily
MTVSKNVLMALLILSYATWGGGMIAMKYAFESFTAMQVVFARVAFAGVIYLALYRLWSHI
PYQKGDWKYLLAMVLFEPCLFFLCETFAMTYTTASQGGVIAACFPLCTAVAAWLFLGEKL
TKKTIIAMLLAVAGVAGASLAAESSDQASNPILGNLLMVGAVLSATGYAVCVRFISRRYS
FLSISAIQALGGTIVFLPFVFTTPMPVNVTMPAIGGLLYMGLGVGFLVYLSFNFALKHLE
AGIVALFGNLIPVFTLIFAFTILGERLTLAQTLGVGLTFVGVIIAALPEKQRQ
>fig|563192.3.peg.3341 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAHADPSSELATKPLGRLLLRFAIPSIFAQIVNLLYNIVDRIFVGRIPEIGPLALAGLGV
AFPIILIISSFSFLAGMGGAPLASIAMGRGDNAKAERILGSACVFLLAMSVVLTVLCFWA
MRPMLLMFGASEQTIGYAVDYFSLYLLGTPAVQLSLGLNYYISCQGFAKTSMMTVLIGAA
LNIILDPIFIYGLDMGCKGAALATICSQAVSAVWIFAFFFGKRTILHFRRQYLRLDLKEL
VPVILLGLSPFFVQVTDCIVPLVMNAGMQQYGNDYYVGTMTVMFSIEQLLRLPADGLCQG
AVPIMSYNYGAGKPERVKKTFFLILAFSFGFTTIASWLILLFPKTFIMPFTDSQRLIEIT
IPAIRIYFGGMMFIGVLYACQRTFMALGRTKLSLLGAMMRKLVILLPLCFILPRLGYGTD
GLLYAECIADVLGSAIVFAIFIWNFKSMLKTP
>fig|563192.3.peg.3739 Membrane fusion component of tripartite multidrug resistance system
MTTDENLSMTPDNDKAPQRRKRPRKGPIVGFLLLLFLLAGIGAGAWWYLFLRFEESTDDA
YVAGNVLRIMPQVSGKVVAVDVDDNDMVAAGQTLVRLDPVDARLAYERSLVALASAVRDN
CRLQAQLRETEAAIRMRRVDLRQKADNLTRREALGKAKAIGAEELKHARDDRENAAVALA
AAEEERNALAAVLLDTGLAEQPAVRQAAANVRDCWLALQRTTVLSPAAGQIAKRGVQAGE
VVSPGTPLMTVIPLHRLWIDANFKEVQLHKMRIGQPAVIRVDMYGGDVTYHGRVTGFSAG
TGSAFSLLPPQNATGNWIKIVQRVPVRIEIDPADLREHPLLVGLSAVVKVDTSDTSGRLL
AASARTEPVPGDLVSQAPAVDFAPVEATISGIIRDNALPGVCPVQGKP
>fig|563192.3.peg.3824 Permease of the drug/metabolite transporter (DMT) superfamily
MQSKIGCYIIAVAVITVWSTTFVSTKILLRSLSPEEIMFYRHVLAYLVLLAAYPHRHPSG
GFREELLFAGAGIFGSTLYFLTENYALKYSMASNVGLLLATTPMLTAIVARFLTTGEPFN
RQLAAGFCIAFLGVFLVIFNGHFILKLHPIGDFLAIAAALSWAFYSTLVKKIGNRYNGIY
ITRKIFFYAIVTMLPVLAFGDFRYDFSRLWQPTTYLNLIFLGVIASSLCFLIWSKIIWKI
GPVAVNNFIYLMPLITMLASWLLLDEHLTPIAIAGGLVILAGVYVSTKAAHRKK
>fig|563194.3.peg.254 Transporter, drug/metabolite exporter family
MTRKYALGLLLCLISVLSWGGMFPIMEPALKVMDPFYFTLFRYGSVAIIFALILFITEGA
HAFKTEGHVFKLWVFGTAAFAGFSFLVFLGQQLAGASGSIIASVMMAIQPLLGVLVAWIY
RGIKPTLASLVSMIVAAIGVFMVVTKGDFAVLFSGQNTLLAVTLILLGALCWVIYTAGGA
DFPGWSILRYSTLTALLGVCSVIIALTIATILGWLHFPSLNQIAEVHSALIYMVTFAGVI
AVFTWNLGNRIITPINGILFMNLVPITSFIIKIVNGYQVSLFEVAGCIITITALVGNNLY
NRYKAKQSDTTELTSTH
>fig|563194.3.peg.759 Bicyclomycin resistance protein TcaB
MEENLSTKPKTKGIVYLFAILGGFAGLLYGYDSGAISLALPSITTAFGLDSVQKGLVVSF
LLFGALPSIVVFTALEKKIERRNVLIVAGVVFLAGSLLSAIATGTVFLMMARFVLGIAAG
IANMYGLIYLSELAPAHIRGLMSSLYQLSVNVGILVAYAVGAYNLPQDDWRWTLGLGVVP
ALILTIGMVMSPQSPRWLIRDGKVERARKVLTKVRFTSTEVESEIKDIQNSLKTKEAGLS
ELFGTFRPALTLLIILTIFQVFTGINAAVYYAPEIFHNLGMANSSIVADFGVGIALVVST
FVSLPFIDKLGRKNY
>fig|563194.3.peg.812 Glycopeptide antibiotics resistance protein
MFIIKYIPFLGLALIILIGCLIAYERRPSLDRAIVFGSLAVYLVCVAWLLFTPGQYFFDP
YAYYARYFYWHHAKIIYYPSALRSMGSYMNIVMTIPAGVYLGILFHRHLNWLTVILCAGL
VGIFNESNQLILDMIINIQRTVDITDVLTNAAGVVIGYLAFYCLVRPWLKNTSFA
>fig|563194.3.peg.966 Multidrug resistance protein B
MEAQNTRHTNPMIVVAVVALMSFMGILTETSMNVTFPALMKEFHVPLNTVQWVTAGYLLM
AALVMLTSAYMKRRFTNRQLFTAAAILFSSGDLICGLATNFWVLLAGRLIQAGCVGLCTP
LMVNIILDVVPQHKLGTYIGMANLIILVAPALGPTFGGAVVAFNSWRMIFWSTLPVALVL
MLLGMKVIKQYAPTDQHYAFDWTRFLLLGMALVSLIVGLNALGEMQLGTFVGLLIVSIGL
TILFVKRSHTATKALFSLQVFKQPAFLYSFLPYIMLQFANVGINFLLPNYVQDVFQATSL
VGGLILLPGSLFNGFGQPLYGWLLDRFGGKVPLYTGDILFTLALVGLMCWGPQLGVVGIT
IAYLIFAIGRSMAFGNSVAYGLKHIDKEFQNDANALYNTGQQVTGAIGTTVLALLMGSVK
RPGYTHAQNVSAGSQLAFILLVIFGCVIFVFFHHLVNLKNLPEDKGVDL
>fig|563194.3.peg.1778 Permease of the drug/metabolite transporter (DMT) superfamily
MYIIILEKEVFLVKLRTLLYVVISTFLFSSMEIALKVAGGTFNPIQLNFIRFLFGGLLLL
PFTMKTLKKQGRRLKGRDIAAFSMTGFSCVLVSMTLYQLAIQLSLPATIAILLSANPAFG
MLIGLVLLKEKMSRTNTLAVILTLAGLLVIINPFNLTNPLGITLGLLSSITFAIYGILTR
LSSNKLGFGGMTMTCFSFIAGAIELAIFMAITHIPVVSRAFSGLEGFSDIPFFQGITLSN
ILLLAYISFLVTGVGFGLYFVVMGEAGVPIASLIFFIKPALAPILSLLILGDPIHLNTIV
GIIIILIGSVVTLVGEKIAMRMSK
>fig|565045.3.peg.220 Permease of the drug/metabolite transporter (DMT) superfamily
MRHSSAIIMAMLPPILWGSTYLVTTELLPPDKPITAAVLRVLPVGLLILLMTRFRPTADQ
FKKLVVISLLVISLFHWPLFVAAYRLPGGLAAMLISSQPLIVALLGFAFFGIRVQRNVTA
GIALGLSGVVMVLIVPSKLAWDTVGVIAAFSAALSMSLGTLLTKRWALDMPVLAFTGWQL
LLGGLFLLPLALLFELPMQSLEVRHISGYLYLAFVGTLLPYFLWMSAIRHLEPVIISTLI
LLSPVSAMALGYVVLNQALTPWQLLGAGTVLIGILITSVPPSKYIFWRSGINEGGGPTTA
AAIKQTNERGSKL
>fig|565045.3.peg.807 Bacteriocin resistance protein, putative
MVKQQWDHSCGVAALATLLHRLGNDAVNETGLIKQLDTYNPDLPENGYSLDDLRWLAAQY
GYRASGLRVDASLLEQLKKPVIALLHLPRGPHFTVVIPTSDRWIHLADPSWGNRFLLPHQ
FAQLWLQHDQRGTLLALMAND
>fig|565045.3.peg.2298 Glyoxalase/bleomycin resistance protein/dioxygenase
MSQNVPMFRKVDHVSLTVEDIDEAIEFYTRVMGAELRYRMGPFDAREIPRGEDGRDWTDA
HVQVPDARLNIAMLKLCENLGMELFQYDRPEDAATVPPRNCDVGARHICLQVDDVEAAIN
YLAENGCSAMAGPIVSEGGPAPDSLSWYVTDPFGHQMELVQYT
>fig|565654.4.peg.648 Nisin-resistance protein
MKIVKRILLAVVTICVLFLGIIYFWGYKLNIYLVPPSPQKYVQVALNNMDELGLFTDSKE
WVETKKNTIQETSNAKDYAETIPNLKKAIKVAGGKHSFIEYEENMSKKSIEEYIKPKAEV
ENDIIVLTIPAFTGSDKEAEEYTTILETALHKKIYKSVIVDLRGNTGGDMAPMILGLSAI
LPDGKLFSYVDRNNDLEPVTLKSGKLNSNISTIKISDNKKIKKVPIAILIDSNTGSSGEL
TALCFKGIPNVKFFGSDSAGYTSANQTVYLYDGSTLQITSAFVKDRTNKIYKNVPINPDV
QTNNSKSSAIEWIKSQLK
>fig|565654.4.peg.720 Permease of the drug/metabolite transporter (DMT) superfamily
MKKTVGIVYACSAAALWAVSGIAGQILFTKYSISANWLVSTRLVLSGCLLLSIGLKDRAR
LISPFREKKDFIQLLLFSFLGMFLVQFTYFKTIEQSNASFATIIQYTGPFFVLLYAVIAK
RQFPSLKTCFWLLVTLLGVTAVASKGQIEQLATSQSALGWGGASAISLAFYSIQPRKLLQ
KYGSLPVVGWGMLIGGGLANVVHPMWQIDSQLNVQVILYLLVVILFGTALAYLIFLTSLR
YLSSTLATVLTAVEPLLAAFLSIIVFHDHFAVVELVGFMAVIGSIMCLQKNME
>fig|570509.6.peg.1098 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNKTVFSKNEIKLCYDNLWKTIFIFSLPTVLVMAMTALYPILDKFIALTFVTPNVFHHQP
YLDWYKEHISINNGELTYESAKIFVNLSTHFAMQIYNLLFAFAILFAIGTSITFAIKSGQ
SNKQQTQSLAGNALTITVLFSIVAAFFVFCLVFPQWDNIMILIQLSKKGTWIVQDLTWHY
VFPMLLASPLMFVSYLLLTLLRTDGKSHAAIYITIGAIAINALFSIIFVKYGQMLLEGTM
LGTIIAWIFIIIVSLICIYYNKNSYLRFHWRDLFYLHKTTIKEIFRLGFSSFINNLGAVL
VSILSSAIISSLPGQFAQRQQYGLASFQLFNSAVSPWIAFFTAIALGIAQGMKTIIGYNY
GAKKYLRMYQTCWYGLAIISGWLFFTLLLFIALGPQLLMAFAFPSDLVDEYRWIAVLMLM
SYPCAAISFLGVSLFQGMNNARKAALCSSFRAFIVLPILMLCGYFLAHGLSDGTDQSNIY
YFILLGLNDLISAIVVGIILYFFWYKHRHHIFNEVDEKDQEYLQSKKQQTSY
>fig|572477.4.peg.746 Bacteriocin resistance protein, putative
MIQEWDLSCGAAALTTLLHYQYNDPVSEKEVATALINRAEYIENPQLVQVREGFSLLDLK
RYVDSRGYTGIGLGKMSLSDLERRAPILIPIHTRGYNHFVVFRGRLGNRVLLADPAWGNR
TMTIEQFNRAWIDYPQIGQVGFVVDSHTENTHTPGTLKPRPSDFVTFN
>fig|572479.3.peg.38 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEVKSKSSRMGEEPILKLLFKLSAPAIAGMLIQALYNIVDSIYVGRLSTDALSALSISFP
VQMFLIAIGVGTGVGTSSLISRLLGEGNKCRANNVAEHVFFIAIIYGILGGLVGIFFSED
IVRLFTDDPVLIDLGYQYINIILTGSIAIFLPAIFNYTLRGEGNTFLPMLTMVIGGVLNM
ILDPFLIFGLGPFPQLGVAGAAYATVFSRIIGGIFISFILFSDKNELTLKLKDFKFDFQI
IKEIYNVGIPAMANRLLFSMAIVFINLILGAFNSTAIAVMGLIFRMQSFFLMMVFGLTQG
YLPIVGYNYGHNNPERMKKTILVGNAVALSFGVFGFVIFQLFPEAIISLFNSDPKLLRIG
IDAFRKVSLSYFFLVLNIVGVATFQAIGRGMPSFILTFLRQAVFLVPGMYLLGEFFGLDA
VWFGFPIAELTSFLIMLFWLTIAIKDAMANMRKAA
>fig|572479.3.peg.415 Multiple resistance and ph regulation protein f
MIIGLAIFFTILSLIVSYRVVIGPTITDRLIGADTIGIFMSIVMLMIALEYDIALLVDIV
LAYAVLLFIDMLIYAKYFEHGELYK
>fig|572479.3.peg.1351 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVDDNKAIINENSSTKKVIFKLAWPVIAEQSLATVTQIVDMMMVGRLGASSVAAIGLTMQ
PVFFSTALASALGVGTTALVSRFTGSNQNKKAASVLQQSILMSLIFSVFFAFIFYLSAPK
LLIFMGGEAEVIKLGTGYLRMISPGFIFMVLAFIVTAALRGAGETKTPMKVNILVNILNI
FGNYLFIFGNFGFPKLGVNGAALATTLSRSLGGIILLTLTFTNYSVLKMKIEGFFRFDLN
LIKRVLKVGIPTAMEESVRRLAQLLFIRVIASLGTTAFAAHQISLNAESISYMPGFGIAV
AATTIVGQNLGAKNPEGAEKGTFEAWKIGSLIMGFMALILLIFPEQLVKLYTTDPEIITK
ASLNLRIIALAQIPMGTQFIFAGALRGAGDTKAVFYSTAISTWIFRLLLGYILVHPLGLG
LFGAWSAMVIDWIVRGSYVIYRFKKGNWKLINI
>fig|572479.3.peg.1372 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTKISEAKLTKGKIIPQLIKLTLPMILGMLGMVIFNLTDTYFIGKLGANQLAALSFTFPV
VLIINSFTQGIGIGTTSIISKYIGARKNNKVKKIATDSLILGLIISVLVFILGSLTIRPL
FSILGASGVILNYIEEYMTIWYFGSFMVVIPMIGNNIIRSLGDTKIPGLIMGLSALINVI
LDPMLIFGYGPLPILGIKGAAIATVLARAITTLTAISILYFRENIIYFSKFKLKDTFKSW
KQIIYIGIPNSLVQMALPLSSAIITKILATYGPNVVAGFGVATKIEFFAMSFIMALNSVI
GPFIGQNLGSKLFKRVNKGLKFGELFSLITGFILAIILSTFAKNIAALFNQNPEVIKTVT
SYLLIVSFTYGLQGILKIDSTILNVLNKPIQAALLIFSQTFLIYLPLALVGSHLIGVSGI
FIALSISYLISGFLAHLIVQKNFNLYKKNSLKKVS
>fig|572480.3.peg.18 Permease of the drug/metabolite transporter (DMT) superfamily
MMNIKLVLLVSLTLFFFATSSVLARAALINNSIDPYSFTFFRLFFGALTLVVILFLKEKK
LNLTLNKNWHTSFLLFLYAICFSYAYINLDAGLGALILFAMVQLTIIITALIKKESINLK
KALGITLAFIGLIYLLYPSEGFEVSLYHSILMMISGVAWGLYTIFGKKSSNATLNTTDNF
TKSLLFAIIFFALFVHNVKLSSYGITLAFISGGITSSIGYLLWYYLLPNMKIITSGILQL
LIPPLAIFLGVLFLNEKITSTLIISTILILLGILISIYKKDK
>fig|572480.3.peg.1254 Fusaric acid resistance protein fusE
MQKNKIVQLLRYIITFSVVTIAIVLGMKLWQNYVDSPWTRDGRVRADITLIAPDVSGMIS
KVYVKDNQYVKKDDKLFEIDKKRFEANLQRAQSIVQIKKANYLMKKAEYDKRIKGDDSII
PKDVKDDAKYNLLMAKEELNEALSKLDITKLDLQRATVYAPTSGWINNLLLKKGDFIQKG
QSHISMLNENSFWVYGYFEEHKLTKIKIGDKAIMNPLGTDLTIKGHVQSIATGITDRDNK
IGKGLLANVNPSFTWVRLAQRIPVRIAIDEIPKGYTLRAGTTCTIEINNNF
>fig|572480.3.peg.1328 Permease of the drug/metabolite transporter (DMT) superfamily
MQHTKGNILGLLTIFLWSTLALFTVYSGNIPPFELLSISFFIASLIGVLMLKKQKRSFAS
LKTIPLKAYIIGVSGLFGYHFFYFLAIKNAPAVEANLLNYLWPLLIVLFSALLPNEKLKW
FHILGTILALIGAFLLVLKDGSLEFDTKYTLGYAFALAAALIWSSYSVISKTLTHVPTFA
VTGFCIITAILSFIAHLIFEQSITPSITELLAAVMLGLGPVGGAFYLWDFALKNGDIKIL
GSLAYLAPLLSTLILVLVGVSKMTTSIALACLFIVLGSIISSKQYLKTIINLLFKS
>fig|572480.3.peg.1362 MFS permease (drug)
MSNVAIVTSLPHLKEYFNHIANIEFYSRLMLTLPSLSIALLAPVLGHLIFKFGKKKSVLI
ALFFFSLFGTAGLYLDSIETLLASRALFGLCVATLMIVSTSLVGDYFKEDERHQFMAYQS
SFMALGGVFFVIGGGMLSDMNWRFPFGIYFIGILLIPFVFKNIEEIKIENIEENETSNIN
KNILFVYFFAFFYMLLFFILPTQFPFLLIEKFKVSGSYAGTIIATAFFCNALGAIAFSKL
KKIYSYSTIYIIGLTLISFGLSLVGIITNVHFFFITAPILGFSGGFMMTNAVAWMLSKTN
PKMRVKSSGYFTSSIFLGQFLSPIVFHPLIAIFEIQKFFSIIGASLFVIVLLVLITKKFI
LR
>fig|572480.3.peg.2267 Outer membrane component of tripartite multidrug resistance system
MINGCALLPGEKELIKPNTISKYKSKESFDNKIKTQWPKESWWKVYGDKQLNELISEALK
DSPNMISAMARLNEADAYTQVTKSTNLPQISANAQVTKEKRSYNYITPRSVTPKGWNDYG
QATLNFSWELDFWGKNRATIAASISNVEAMKAELAQTRLTLSSAIASNYAQLARLYANMD
ELKEYLIVQNKLLTLLNQRYENGLENKSTVDDAKSLLANAQGDVLSLDEQISLQKNKIAA
LMGAGPDRGLKITRPTIDFYKIKFGLPDDLAVNLLGRRPDIMAARMQVESKEYLIKEKKA
EFYPNINLSAFIGLQSLGLNLLHEKDSYMGSVGPAISLPIFSAGRLKGDLRRNKSIYEQA
VANYNQTITQALKEVADAGTSQKSLAKQIFRSLEALNSSKEAYEIKTKRYEGGLSNYLEV
LYSQENLINAKRNFINQKSRALTLDIALKYALGGGYNQKLPMNEKGNNNGK
>fig|572480.3.peg.2624 Permease of the drug/metabolite transporter (DMT) superfamily
MLTNIILFIHIISATAWVGGGLLLFGMGIYFKDPKVQNVIYSHIGPFYGYFQLIWLTLLI
ITGLLLLNQHNLYSIILSEEFKNSQFGILLYRKLLIVLLVVIATAIHMYISLKAHGRERT
KKEKITSRASSMFIFLFNFSIIWYAINISQYLN
>fig|572480.3.peg.2687 Permease of the drug/metabolite transporter (DMT) superfamily
MNKKLLELRADILLLTVAIAWGVTFLMVQDAIKSVPVYAFLFWRFGIATILMAIIAYKYF
DKLNKQTILYGVILGCFLFSAFATQTFGLAYTKSSIIAFLTGLNVIIVPFLAYVVFKEHV
RKMVFLSSLIAVCGLYLLTMSGSLSLGEGEILGILCALLFALQILFTDKYSKRVNVYLLV
LFQFITVTILSLIFSLSLDSVTFNLDFNQTFLKALIITSIFATVYAFLIQTYMQQFTTPT
KTAVIFSMEPVSAGIYGYFVGNELLNSIQLFGATLIILALLLAEIKFKKK
>fig|572480.3.peg.2706 Permease of the drug/metabolite transporter (DMT) superfamily
MKFYIQKSILPFFFMFLYGSGFIFCEYGLQNASPMAFLEVRFFIAFCILFLITIIFKLPM
PKTKKEVFHIAIAGSLTVGTFSIGGFLAVSYGISGATNALIIALQPIVVTVLALKLLNED
INIRVWAGLIIGFVGVGFVVFSKLETSFSSLGLFWAFISLLGLSIGSLYQKKYCSHMNLY
SGGAIQTFSSTILVLPFLLFEDSHINWNIHFSIALLYMTVGVSIGALSLLYIMIKNGEVS
KVSSIFYLVPVSAAIVSYFLLGDKIEFSEIIGIFTIIIGIVLINKKKKGIK
>fig|572480.3.peg.3129 Permease of the drug/metabolite transporter (DMT) superfamily
MKNLAIIAFWALGIIWGSNFIYMKMAADYISPMQVVFFRVLFGFIPVFLYAIYTKSLKLK
DLKYSFHFIVMSLLATVVYYFGFVKGCALLLSGVAGALSGSIPLFSFLLAAIFLKEEKIT
KLAFLGVFIGFLGVVLISDVFNENIMASSMEGMLSMILGSLSVGASFIYAKKYVMPLKLK
AEALTTYQLGFGVLILLFITDFNGINNIWQDTHSALGLVIGLGLLGTGLAYIIYYYMIEK
LGALKASSITYIPPVVALIIAVFIVGEDIKLIDIIATGFIFLGVFLINQRKKA
>fig|572544.3.peg.910 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MERLEKYKKVLKLALPAVGEMLLYMLIWTVDTLMVGKYGGRVAVSAVGLSGQILYTVSAI
FSAMGIGVALTSLVSRKIGEENGEEANIYGSIGFFMGVAISLVLGVLFFTLPQEFLKFAN
ARGEVLLLGSIYLKISSFALLMTIWRGLLNGIIRGAQNTKIPLYTTAVMTVVNLGLDYLL
IFGKMGFPEMGVKGAAIATVAANLVGFLYTMFYLQKYSCISLGLCMGIKSSHLLYLKDKW
WEIMKIALPASFQEGAISISRLAAVFIIMILGETAFSANQIALTVESISFMPGWGFAVAA
TSLAGLKIGEKNYEEAEDMIGICLQMGIVVMGVIAFSFVLFPEFLISLFIKIEEKEVISL
GATCLMIASLEQIPLAYSMIVSGALRGMGDTKTPFYISVFSHWFIRLPLIYYLIYLKRYP
VYYVWIVQIFHWIIDGGLLYIFYKKKINALLKYKVKN
>fig|572544.3.peg.1266 Acriflavin resistance protein
MDITNFSIKNRATIIILYILVIFAGLNTFRGMQKGEDPPFTIKTATITIKWPGATAQQMS
ELIGDKVEEVVQDIEELDYVETKNSPGLSTAYVNIKPEYRNLQPIWDTLRKKVKYEVEPY
LPTGASVPIVNDEFGDVFGSVIMVTGDGYSYHELAVIAEELREYILKKVPEAGKVHVYGD
QQEKIYLNFDPAKLTQLGITTADIRNAISGRNQVTSSGNIVMGNDKMTLDTSGDFKSIEE
IGDTVINTPGSTGIVYLKDIADIKRGYVNPATYITRFNGKESIGIAVSLKDGMDDTKLGE
HLKAYVNSLEKKYPIGVDFDFVAYSPQRVEDKINSFVSNLTQAVATVLIVMLISLGFRTG
LIVASLIPTSIAMAFILMPHYGVNLDQMSLAGLIIALGMLVDNAIVMSESIMVAMEKGKS
RLEACLGSANQLKIPLLMSSLTTVAAFTPIFLIEESMGEYVGPMAKVVVFTLLSSWLVAM
TLVPLLCYIFLKVDHKEHEYKSRTYTNYRKILIFGLKHKIITVIFAFGIFCTGIFLFRFT
GNEFMPESDQKIMLTTMRLPKGSSVEATEKVAKDLDLYIKKNFKVPDEELKVGFFKDIIS
GFTIREYEKDGVLSWGTFIGGGAPRFVLAYSPEAPSEEYAYVIYNSTDHKIIPEMSEKID
NYMKNLYPDLDISTKKMKTGPSADRDVEYRISGNNLKDIFDKVDIVQSKLSSIPIAKNVI
NSWKNEVKKLTIDIDQERLRKVGLTSEDVSNSMAVNLEGMVIGTYREPESPLTDKSIPIV
LRTNEAHNTVFSKLDTMKIYSSVTGKFIPLSQVADIKMEFERGYIHKRDRTNTVSVQADV
ISGHTSNEIDRIMSPWIAEQVIEWEAENGEEVKVKNIAGIPASAEGLNYKYEIGGSSEMS
NKQSDALGQKLPYAGLFILLLLVAQFNSIRKPIIILLTIPLGILGVAVGLIVGNQNFGFF
AIIGLVSLSGVVVNNAIVLLDQIDIEINENCLEPDHAVVMSAQSRFRPIILTTLTTLCGL
IPLWLFGGNMWKPMAVSLIFGLIFATILTLGVIPVLYTIFFRVAYKDYEYEKLSTDTEVS
CTNSK
>fig|572544.3.peg.1735 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSHNNKIEKTKMMGEGEISKVLTKMSVPGIIAMLINAIYNIVDSMFIGMLGNTEAMGATS
VIFPLFMLIAALGQMFGVGAGSYIARLLGAGNKNQAEKVVSTTFYTTIIMSILFTVSVLT
LINPTLRILGATDTIMPYALTYGKILVTGAIFTIINMTLNNTIRAEGNAKYSMIAISLGA
VLNVILDPLFMFGFDMGIKGAAISTVLSTSISSIYLLRYYFSGKSFIKITREKFTPKLSL
YSEIMKVGGATFARQALASLSLGILNSKAAFYGDSTVAAMGISTRVTSAVLYIVIGYNQG
FMPIAAYNYGAEKYDRLKSAIRISLIRLTVFCTFATFIFMFFTEDILRLFSSDPEVIERG
KAILRAMSILIPTLGFQQIYAVLYQALGKSVGALVLSSARQGTFLILALMILPSLLNFRG
LIYSQASADIFTVITTLIFAIKISKEIKDKEDIYKPSNNLVLESNG
>fig|572544.3.peg.1758 Permease of the drug/metabolite transporter (DMT) superfamily
MNKNHNSIFADIALLLVAVIWGSGFTATQVSLDSGFLPFTTMAIRFGIAAILMSVIFIKK
LKYINKKDIIAGSVVGFFLFTAFASQTIGLQFTTPSKNAFLTATNVILVPFIYWFMSKKK
PDIYSVTAAFICVCGIAFISLEKDLTLGIGDSLSLLCAILFAFHISSTGFYSHKVDTTVL
SVTQMWFASILSFIGAFFTETFPNSVPVNGVLSVIYIGVFGTMIAFFIQTTAQKYTTPTK
TAIILSTEALFGTIFSVIILKEIITAKMIIGGISIFLAIITAETKWKFFYKGKAKIIKSD
L
>fig|572544.3.peg.1932 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKRRRLEEESIPKLLWEYSIPALAGSLVYILYNIVDRIFISFGVGRLAIAGLSITLPLF
TLILATGLFVGMGGGSLISISLGARKEKYAEKILGNAIALFVIIGIIFSVTGLAFLDEIL
SLFGATPNNITYAKSYMSIIFFASPFQLMFIGMNHIIRGEGNPKTAMTMSIIGCGLNIVL
DPLFIFVFGMGIKGAALATVISNVIAAFLQLYHFVGGKSKITFRVENLKLDFTVIKEIAS
IGVAPFIMQMSNSIVVIFINKNLNIYGGDIAIAAFGIINSLSTLFFMPLVGIYQGSQPIL
GFNYGAGIYTRVREAYKISLKTALLVSATGFIMAMFIPNILITPFIKNDPELFILTENAL
RIFFSMVLFMGFHTIGGSYFQAVGKAKITTLINMLRQFGLMLPMLYFLPKYFGLKGVWMA
APVTDFILAVFTSYFVFSEFKRLKELPVTSKEQEI
>fig|572544.3.peg.1935 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNKLETGDIKKLLVEFAIPSIIGSTIVMLYTIIDRIFIGQRLGAEALAGVTLTFPFAQL
SVAASILIGMGSSVLISIKLGAKKNDEAEEILGTQVLMFLLMCTSIVIIEEVFLIKFLNI
SGATKDTLEYAVSYARVFIPVIYFQSFTYGLNGVVRAQGLPKLAMKVSAIGAVTNVILDY
IFLYILNMGTFGAGLATLLATAFASCFNLYFFIYGKSKIKLLLKNLKIRKDYMLDMLKLG
ASPSLIQLSNSLVTGIYNNQLKNFGGSPAIAAFGVMTTILSLVIMINIGLSQGMQPIVGF
NLGAKNYSRVIKTFKLTFYAGFIISTVLLFIIGFFPKTIVRIFVDDPETIAVGKTALRLG
LCVIPLTTGSIIISNFYQAIGDAKRSIIFSILRKIIIIIPALIFLPKLLGINGIWLSRPF
SDTASFMIMGIFVIKTLKNMKSFSIEKNKE
>fig|572544.3.peg.1941 Permease of the drug/metabolite transporter (DMT) superfamily
MTLKKHHGIIMGILACFLWSSAFAWVKIGFKYVPAPLTFAGMRFTLAGIILIPFCWRKNL
FVLLATHRKVITYVALLNVGIGYALYYTAMKYVSGATAAIIIGTGPLITAVMTHFIMDND
RMDRMKFMSILLGILGIGVIILNTKPVTPVGRKEAMGIFLLLMNSSLSSYANIKVAQIKG
GIDGRFLTSNQMLWGGSMLLLMGRIFEQSYNIEVFNLPKEFYMSLLWLAFVSAAAFSLWF
IAIQIEGMKVSELNMLKFIIPVLGAVISWNLLPEESPNFISVLGMILVFTSLIVYNINNK
KSA
>fig|572544.3.peg.2156 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGKKSVKNLLTGSIPKHLFDLVLPSIGGMFAITIFNLTDTYFVSKLGTNELDAMGFTFPV
IMVIGSITGGIGIGSSSVVARALGKNNHHEINRTTTDGIILSIIVVVIISLIGLLTIDPL
FSLLGADNTILPLVKDYMSIWYLGVVAVIMPRVCDSSMRALGDMKRPLIVMLVCALTNLI
LDPIFIFGYFGIPALGIKGAAIATILSRILGMVTTLSFVHFHYKLIDFKYNYKSEIFDSW
KKILHVGIPGAIIRLFPQLLRAVLTSLGAKSAGIAGVAAIAAGARIESFSTIISMAVGAA
LVPIVGQNWGAKKYERVEEVKKLTNKISIVYGFILFVLSLIFTRKIATIFTGDPVVIDLI
YAYVNIVMLGSIGLNLYNWTSESLNATGKPKYVLIINGLGTCLIIIPSIYIGFFLGGFPG
MLIGISIGQIILGGVSVKIGKKELGMQAV
>fig|572544.3.peg.2316 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKIMHGDVSKLFLRYLIPSVTGTLSIGILIFIDTIFIGRGIGSLGLVALNTVIPAYTLY
SSTGMLLGIGGATAASVDAGRGDYDGRNKIFTHSVILALVLGCLYIIGQTVLLKEITFFL
GARGGAIPMTEDYLGILSKFTLFYLLPHCLNAFIRNDGNPSISMMGMVLCGIVNIILDYT
FIFQFNWGMKGAALATGIAQMSYTAVLLTHFISKKNSLVLQSHKLEILVIHRMFKVGLPS
FINEMSFGAVIFAFNYIFLRIGGENAVAAYSIILNINILLYLVFLGISQASQPLFSVNYG
GGLHSRVWETLKLSTLVSGLLGAVTILVTILYTKEIIGLFIRDDMELMKITGDGMPLFFS
ASIFMGLNIMMSTFYQSIESSAVSSFITTMRSCVLMVVGLIFLPGMAGIKGVWMTPLFAE
GIAFVISLFFLKNYFDKNKGSFQKSVNITPIYNK
>fig|572544.3.peg.2469 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNVNRLTEGPISRQLIALALPIMGSSFLQMAYGLVDMLWIGRLGSSAVAAIGTAMFFIN
LGYALNSMVVTGTGIKVSHSIGSKDYNDAAECIKNAFLINLIMFSCFISGLIFFRDNLIG
FFKLNDSNVENMAKTYLVITAFGLVFKFLNFLFTRILNSFGESKLPFKINAVGVVLNIIL
DPLLIFGLDMGVAGAALATIISQAVNMVLFIKASREYFSIKNIFQYNFKKIREILSLGLP
IAVQRILFTGFGILIAKIIANWGPDAIAAQKIGLQIESIAYMTAGGLYGAVASFIGQNYG
AKKYKRISKGFKTAFLLSAIIGGAATFIFLVFPEELIKVFVKDRKTIEIGVSYLRIVGIS
QFFMCIEIISNAAFSGIGRPKIASTVSIIFTGMRIPIAYYLSHESRMGINGVWVSIALTS
IFKGIILSGLFLNNLRKIYRKIKGEGLWI
>fig|572544.3.peg.2556 Multidrug resistance protein
MKDKNKMLLILGSMAFLANGDNYAAAPLLINISKDLNLTLSTAAMSVTAYMLAFGIFTLL
FGPLSDRFGKVRVINTAAIGTAIFSILGATTFNLSSLIFFRAMNGAFGAGIFPVTIALIG
ESFDPEDRQKALGKLMGFMFLGAATASAIGGAIAYFGSWRIVYLIYGVGELILAIMMLKV
LERDKPVVDRLNFFSAYKNALTNYRFMRTVIMVFLVGFSVFGSFTYSGKLIQELTGYNIL
SVGLILSVFGIGTVIGGRIAPEMRKMLRNGFLVISGLIGGLSMFVLSVFKNIWILSLGLF
GFGLAFVCIQSTLILMAQEKLPKMKGTAMSVVSFNLFVGGAIGTSANGVIMESHGITKIF
NNNSYIILTVGILTFIFVARFEMRKNNSTVT
>fig|572544.3.peg.2696 Permease of the drug/metabolite transporter (DMT) superfamily
MNSKYIGYTMAFITIFVWGTTYAITKNLLNYFTPFEVLFLRFLIAYLFLLIVKPTFNFKF
NFKFNFQEEKLFLLLGLTGGMLYFLVENMALKYTSASNVGLIVSSIPIFSSIIAHFTTED
EKFDKNLILGFALAITGIFLILYNGNKVLKINPIGDILAVVCSIIWAIYSNLLRKVDKSY
SGLLVVRKTFFYGLMFMLPGLYLLKVKIHFEYLFNKDVSFSIFYLALVASSICFIMWSRS
INIIGIIKTTNFIYLIPLVAMISSVVILDEKITPLMITGGLLILSGVLINDKKISFEKLF
KPKTTTL
>fig|572544.3.peg.2704 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKIKRLGEEKISKLLVEFSLTAIISSLVFALYNVVDRMFIGKCLGPYAMAGISITFPIF
TIYIAVGMLVGHGGGSIVSLRLGQGRKEEADRVLGNVFTLYGVFSIILMTLGYLLMDRLM
IIFGATENTIIYAKDYLYIINFLVLFDFIAMGVNNLLRSEGNPKFSMIIMIVGALTNVFL
DFIFIFVLDYGIKGAAMATAIANIVGSIMVLYHFIYSDRSNIKLKLKYLKPDFKIIKEIF
SIGISPFTLQLANSLVAVFANRALLIYGGDMAVGAMGAINSVFMFLMMTLSGIIQGAQPL
LGYNYGAQKYDRVKKILNMALLYGVIISLVLTALIMIKPEFFINLFNNGNEELLEIGKSG
IRIFMALVVFNAIYVVGANYFQAVGQANKSLFLNIFKQLGLFIPLIIILPKYFGLNGIWF
AAPVSDVIIFMITGVFLLKNNKKLKKLSVQYA
>fig|572547.3.peg.370 Permease of the drug/metabolite transporter (DMT) superfamily
MTSSTHPRLKVLLAVLFWGGSYTATKIAVSRVSPVAVLWLRFGIGAAVLGLVLFLKKRLQ
LLPLHQMTELCFLGFFGVFLHNYIQAWGLRTAAAGISALIIACTPVIIALLSAFLLKEKL
VQRQSLGIIMAAFGVLFILSKGNLAFLKEGNYSFGELLVVCSAFTWALFSVFSRKALKTI
PPALAMFYVILSGWFFSSIPFLFQGVREISKLDMAGWGSTLFLGVFCSALAYVFWYDALK
LLPASEVGVFLYISPIVAVAVAWIFLGEPLLLSSIIGGGLVLTGVSIVNYRKKS
>fig|572547.3.peg.416 Acriflavin resistance protein
MNIAEYSIQKRYVTWFFTVFLIIGGVFAYKGLGKLEDPAFTIKTAVVTTAYPGATPKEVE
EEVTEVIERAAQQMGQVDKVRSLSQEGVSLVYVDIKDTYTAKDLPQIWDELRRKINDVQE
HLPPGTSRSLVNDDYGDVYGVYFALTGEGYSYRELEDFADYLRRELLLVPGVASVEVTGI
QKEAIYVEISRTKLSQLGISMGELFQVLKAQNFVVPSGKVRAGAEYIRITPTGEFSSVEQ
VGALLLASSSRVLIRLDDIATVTRNYIEPTRAIMRYNGSPAVGIGISNVEGGNVIAMGEA
IKKRLKELEPQTPIGMNLGLIYYQSDTVQKAINNFLLNLLEALSIVIAILLIFMGFRSGM
LIGGVLLLTIFATFIAMKLVRIDLHSISLGALIVALGMLVDNAIVVADGLLVRIQSGEDR
ISSAVGVVTQTQWPLLGATFIAVIAFAPIGLSPDSTGEFCQSLFQVVGISLIISWVLAVT
VTPVAGVRFLKTSAKAEIPYDTKLYRVYRRFLKACIRKRKVTILVMVCLLGSALIGFTFV
DQSFFPSSSSPLFTVEFWRPRGAYIEETQREVEKVEAFILKQPETVSVASYVGQGALRFI
LTYTPSDSSDSYGHLIVEAKDLKSAESLRRKLGNFMNIEMPDIDPRVRSFSKGTGGGAKI
QARFTGDDPRVLRRLGEEAFYMMRNAPDSMNIRSDWGERVKVIRPVLDEVRTRQAGLTRQ
DVASALEMSFSGIQAGLYRERDKLLPIIARLPKADRARLGALPEVEVWSPLMRKYIALTQ
ITKSIDTIAEDPVIYRRNRMRTFSVECDSRSGKTGLLFARIKPELENISLPLGYSLSRGG
EYESSQKAQGGLVGMIPIAFLAMVAILVVLFNGFKQPIMILLCLPLSIIGVTAGLLLFHK
SFDFMALLGFLSLAGMLIKNAIVLIDQIDLEIREGKEGFSAIVDSAMSRARPVLMAAITT
VLGMIPLYFDILFSALAVTIMFGLAFATVLTLIIVPVLYSVFLKIPVFKDENVR
>fig|572547.3.peg.1318 Permease of the drug/metabolite transporter (DMT) superfamily
MPWLNRYKVLIADGALVLIALFWGVGFVAMKDALVSFSPFWLLALRFTASFILMAIIFKK
RLRKLTAANLKAGLLIGVFLFLGFATQTIGLTFTSPGKQAFITATYVVIVPFLSWGLKKI
FPGYLSFVASLICLAGMALLTLQGNGDTLSTFNKGDLLTFACAIFFACHILAIEMFASKM
DPLVLATLQIGTTALLSFACALLFEEWPGSIASSAWWSIAFTVLFCTVFALSIQNAAQKF
TPSTHAAILLSLESVFGALSSVLILGEVFTIPMVLGCFLILIAVLLTETGPTLLGKLQII
KTIFYL
>fig|572547.3.peg.1336 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKYTFDPLRGSIFSVFLYYSSLTVIGMLAVSSASAIDAAFLGNMDGEVALATVTLTLPFV
IFVGGVAFMMGIGGSVSCGKYLGAGDVQTASAIFTKTLLATLLFAVGVCFTATIGVDLLV
VLLGASPAIAPSVRTYTSILTLFIPFSVTGICLSYFVRVDGRPLLAAVAMTVGAIVNISL
DWLFVVKLHWGIQGAAFATGFSQITLLCMLFSHFLQKKGKLRFNMRGGSWKEIIRAAYNG
FSEFANEISAGFLTFLFNRIMIRRLGVAGVAAYTIVNYILYLGSMACYGISDAIQPIISK
NFGAGKAKRIKGFLWIAGGTVTFLGILIVSILLLMPNSMIKLFTNSEAEITICIARDFIA
HFWPAFLLIGINIVFSSYFTAMQKPVHSAFIAISRSLVAPATLLYILPLFLGNKGIYMAV
PLAELATFILALALFMPNSPLKLIRSDQIYKKLGEKRELFPQKGVPTSESRFS
>fig|572547.3.peg.1885 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDRRELLAKERVGRLLWRLSVPAVIGMLVQASYNIVDAIFIGRGVGPLGLAGTTIVFPIQ
LLASSLAVTIGVGGASIISRSLGAKKYEKANRALGNMVFLSLIFSTTILITGSLAQQRLL
RLFGASPTILPYAEEYLQVILMGLPFVGFGMSLNHAARSEGNARVAMISMIISAVMNMIL
DPIFIFVLNMGIRGAAIATVISQIAMACWMGYYFLLSGNSFLVLALRYGQPQLEYIKEIL
SVGAAEFVRMASGSMIIVFINNSLIHYGSDISVAVYGILHRALSFSFLPIVGVSQGLQPI
LGFNYGAGRYDRARDVARLAIIAASCIAFCAFMVGMFFPEKVVRLFTTDLLLIKEASASL
RIVITAYFLVGFQITGSSMFQALGKGRASLILSLTRQVIFFLPCVVILPRFFLLKGIWLA
FPTADALAFLVTVTLVSRQLGALKMERSEQNQ
>fig|573065.6.peg.1423 Permease of the drug/metabolite transporter (DMT) superfamily
MSVASLIRLLSLAAIWGGSFLFMRLSVGALGPVWLIAIRVLLAAVFLTGVGVATRKTLQI
KGFYKYFLILGLFNSVVPFVLFAFAAESLTASLLSILNAMSPLFAVIIMAVWSRRMPDIK
TVFGLLLGVAGVGVLVGLDATHLTLREAVALLAGLVAALCYAIASVYARHAPRTPDPLSN
AHGGMWASVVLIAPFVPVLAPTTTQLMTLTPVAAAGVVALGVVCSGIAYMIYFRLINDIG
AAPALTVTFLIPVFGTLWGWLFLHETVGLSTLIGGALVLWGTALVVGFDPRALFRAE
>fig|573065.6.peg.1435 Outer membrane component of tripartite multidrug resistance system
MLIGRWWDGYKDAQLTDLVQTALRDSPNLTAAAGRLLKARALEDTQKATLYPTATALGAS
LQMGGKDPAIDAVTLGGINFGWELDFWGKNRAGLKATVTAAEAARADGQQAVLVLSTSLV
NAWFELGHMYKDLDVAERNLAIRTDTQSLVAQRVEGGLRPRAELEQARANVANSKGEVAA
LNERILIQRHLIAALAGQAPAFGEALPRPVLPDTQDFKAPTRIDLELVARRPDVAAARAR
AEQAVHGTERAKASFYPNVNLMAFAGKVFLNDLSGSGIDAINAGPVISLPLFEGGRLRAN
LRGAEADQSVALASYHQSVINAMQEVADTGASQTALSERLSLSNEALASSEEAYRMARLR
YEAGLSDYASLLVIEQNLLSQRTANTALQSRALTLEVAMVKALGGSY
>fig|573065.6.peg.1476 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTRALYTAAFKELFHLSWPVVGSRLGFMLMGLMDTLIVGHYSAAELGYHSLAWAPTSIFL
VTSIGLLVGIQVKTAHFIGADEPHRIGPVFQRGMVYAIILGLFAAVVLFLAGPGLLHLAV
KPDMADGASGPLLVFALSMPFYMIAVAGSEFLEGLGRTRPGLIFTWAGNVLNGVLLLLLV
PGVITLPGIDSDGAMGAAISTLIARACVMVALIVYVLTLPGIAQYGLLKRHNPDPQGGRE
QRQIGYAAGASYFIEVAAFAGMTLFAGRISEEAVAVWAIVLNFASIVFMVPMGLAIGCSV
LVGRAYGAGDMPGLARIGRVSFSAAAAFMMGVCLVVLIGSQGIAAGYTSDDALRSGVQAA
LLLSCLFFVPDGVQVVTAQALRARQDVVVAPVLHYIAYGFVMLPVGYWLALHVGQGVPGL
IYAAALASWVSAILLQARFMWLDKKALTAMRAAPTE
>fig|573065.6.peg.2327 Multidrug resistance transporter, Bcr/CflA family
MSAPEAAPPALKNPFLVIFTLGALSTISPFAIDMYLPAFGQIAADFKTSSAAVGLSLSSY
FAGMALGPLIYGPLLDRYGRKPPLYAGLALFVLTSVGCVFAPNIDVLIWLRLFQALGGCA
ASVAAMSLVRDLFPPKDTAKIISLIILTIGVSPLLAPTLGGLVTTWLDWHWVFAFLAAIV
GLTLILVITVLPDGKPADPSVSLKPLPILKTFLGLYRNPAFVTYLFAGGFSFGCLFIYVS
ASPVIFMEIFHIKPEIYGLIFAGLSVGFIGSSQLNVFVNRRYSSKQILRVGLSVQCVFVL
AFLLAAANGWLNVWGTVIMLFLILSCLGFIGPNSSATAIGSLTRDIGSGSALMSFTQIGL
ATIVSAVVSALQAQTLTPIVVVMTMSVVIGRVVLFVGERLGSHSHD
>fig|573370.3.peg.242 Multidrug resistance efflux pump-like protein
MKTLFGLAAALLLAAALPASAETISFQGKAYCPIRYDINWPFSAKSKKAPTQGSGITANV
YEMPKEAVEEKSAADLGSDMRRLRIISAPVQIGQHVVEDQVLITYELPLENLMAEKQLVS
RAELNGLEHAMSVVQFQLATIQNRQRELENMAGNQAVAVNEVANNARDIENLLLQRDFLE
EKLELARQRYDNSVLLSQSKFGKEVDLKNLPRRGYVRAPGDGYILWLNSSLVPGMAFSKQ
APLVTIGKLDPIIVRASVHEIAMQKLKAGDPATVIFNAWPGEKFQTTISKVDYVAQPAML
QQPSFYLIELTLPNPDLRIKEGMRCDVVVDLH
>fig|573370.3.peg.728 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MSQAAASPTLTIVIPVYNAEQSIGRLVDALVAQPPLPGTDVVLVNDGSRDGSHRECLACC
DRHPGRVTYLRLARNFGEHGAVMAGLCQAGGDYVVVMDDDFQNPPHEAARLVETAVAGGF
DVVYGAFREKCHGTLRNWGSAFNDRVATWLLGKPRHLYLSSFKCLSRFLVERIIAYAGPS
PYVDGLILRVTDNIAQIDVEHCPRRAGRSGYTLWKLIRLWLTMFVNFSVAPLRLSAVLGL
GVSAFGLLMAGWSLLEKLLGLDVPTGWTTLYVTVVIFAGIQLVMLGLLGEYVGRGLLEAN
RAPQFVVREVHGGGRPPAREPRRW
>fig|573370.3.peg.739 Antibiotic resistance protein
MRKKEREIKDKAILEQLLMQSRICRLGLFDGQWPYVVPVNMGYEPGRIYFHSSKKGKKMD
ILRANPNVCFELDADVEIVTGDRPCDWTTYYKSIIGFGTAVILEDEAEKLAGLKVIMRRH
GGPADGFKPEVVPVTAVVRIDIASMTGKANPPHGEWD
>fig|573370.3.peg.2056 Permease of the drug/metabolite transporter (DMT) superfamily
MSQTNREMSWAAFFALVGASILWGSSFIAMKIAMREFSPLLAVFCRMAVASAVFALIWKR
MGGFAAGRADWKGIVFMAFCEPCLYFIFESQALTMTQASQAGMITAMLPVMTAVAASFVL
QEKLEVRAMTGLLLAVAGVAVMSLAGEAGPQAPRPILGNFLEFLAMCCAVGYIITCKKLA
ARHKPLYLTAAQSFVGMAFFSPALVFAPMPAKLTFGPVAAVFFLGLAVTFVAYGLYNYGV
CNAPAAKAAAFINLIPVITCLLSWLILDETLNAGQLLGGATVLGGVGLSARPARKGRKTH
GE
>fig|573370.3.peg.2365 Permease of the drug/metabolite transporter (DMT) superfamily
MNIRFLGYLAALSATVLWAGNFVVARGIAQEIPPVQLNFWRWLLALACILPFAWPKLRAD
WPAMKRHWRYLAAMGLVGVSLLNAFVYKAGQTTESLNMALLVPTAPVMIIILSRIVYGEP
LTPRRLGGVAIVLVGVLELVSRGDWSHIASLRFLPGDLWALAGAACFALYSLFVRKRPAG
ISVEGFNAATFAWGLVLMLPALAVEAAAGPTTSWNLRVLSGVAYAGIGCSFAAYTLWTKA
IGSIGPVLAGIVYYFLPVVTAVESVWLLGEAVTAAHVLGGALIVSGILLATLDVRLLSVR
PGKTV
>fig|573370.3.peg.4039 Multidrug resistance efflux pump-like
MRMIRRAVLLAVGISIFAATVAFAQTPAAPAESPERSSFRPADISFSGKLYSPVKLSVFL
PFNAKILTLSGQIGQHVKRGDVLASYEIPLETRMDEKTKLSPANIKELEHKLAVADKEID
RLSAKGRELEAMSQRNMTSQQAISMNAKEIEVVRKEKSAVLEQLSLARDLLTDRVELAED
HFGKGVGIGKVPKDGIIKAPVDGYVMWMNPELRAGVKLAKEAELFQVGLLNPMIIRAQVH
EIEAQKLKEGVPAVVTFDSIPGKKFNASVSRIPWAPMPAALQQPSYYEIELTIPNPDAEL
KEGLKAQITIQPGK
>fig|573413.5.peg.553 Permease of the drug/metabolite transporter (DMT) superfamily
MDSKKTAVLALFAAPMLWGGALVAGRVVSAEMPPISAAFVRFVVTTTLLALFLRIRGGKL
PKPEKNILPALIAAGMTGVALFNVFLFSALATVSAGRSAVIIAMTPAVVAMISAIIYKEK
HQKLFPLALILAFLGAAIVISEGDPPSLFRTPPGKGELFMIGCVFSWAAYSFAGKHVLKS
FPPLPAIMYSSFFGALLLAIPAFLEGGLPRVFSASPSAWAGLLYMSIGAAGVAHVFYYYG
ISKIGPSKSAIFMNLEPISALFFGMVLLGEEITMPLAIGSVLVLSGVSLSVKE
>fig|573413.5.peg.682 Glyoxalase/bleomycin resistance protein/dioxygenase
MLLPGYDIDGPTLEIFEYNENIRNTGKKINVEGFGHIAFAVEDVEQKLNLLLENGGSVVG
KLIDAEIDGVGKITVVYAKDPEGNIIEIQKWE
>fig|573413.5.peg.774 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDQLLLSGKHPVRQFLAYALPAVLGMFLSSFIIVVDGLFIGRFVGSRGLATTNLVVPFLY
LLLGISIMVYVGGMVPATHNLGKGDFEEASRIFSITFALGTVSIFLVVLTAGLFFEELLS
FLHLDGVLRSYGRDYLGILLYFYIFMTINIGFSIFLRAEGKPVLSLFFSLAGNCLNFLLD
YLFIAVYGWGMRGAALATGIALLLPFLFGLFYFLSGRSLFRLVVPRCRMREIVMLLYNGS
SEMIGQFSVSITTFIFNAVLLRRIGVDGVAAYTVAGYIIMLQGMVLTGIIQGLAPLVGRA
YGAEDTHSVKRFFRIAVSAACMVGGISFVACAAASSLLPRLYNVDTPRFLSVASTGLLVV
SFSFLLNGFNIITTAFFTALGKAGHSALIAILRGVVVINILVLIFPRFLGDLGIWLAIPV
NELLVAFAALYFLHLDNRTLVVKRST
>fig|573413.5.peg.1811 Acriflavin resistance protein
MKSFLRWFLDHPLSTLMLYLALILFGVVSFPRLKGEYLPTILFPEVRVVCEFENISAEEI
ERQVTVPLENVLSGVSGVKELESLSRQGISSILLRFSWGTDSYKAALEVREKIDSAYPYL
PHGIEKPLVFTERGENEALFILVLRPKEGTSIQELDRTIRYDLKTRLMQVEGIGTVRLRG
ITSPEVKVLLDPDTCTAAGLALNEVPSLLASSVFELPIGKVNEGGKEHLIKASTDTVDLS
ALQRIAVPVESGSFLSLGEIAEVRLGHAERTSFFSYNGEPCVGAFLWPSPEEGTLNASRT
LRRELTDIRRNYANDIEIIFLEDGAERIRSAFRELAISLILGSAAAFLVMVIFLRSLSSA
VILLSSLPAAIIPIFFFQYLFGLSLNVMSLTGIAIGIGMIVDNSIVVLERIQGRRDHAAI
AEGVLEMGSSTFGSTMTTLLVFLPIVFVPGIIGILFRELAITISLLLIFSFLVSMSLTPA
LYVLISPKTKESSSKKIFDRAESVYGKLLHALIARPFMIILLIIISFAALFGLAKVLPKE
TMPSVPEGRLQLSLSLPADTPFDGVEAAAERFLQAVGEAEGISGGYAYTGYEADNPLERA
KKESSLNDIFFTFFYAPQTYQREAILKAHIEREAAILSVGKLSWPDSSDPISRLLSKGKE
IRLRFSGRERENVLQEARAYRSQLLQEAPESDPRLEESGGYTELRLVPDQLACRNSGITP
SAIAGTLKGLVEGSLVGTITLRDEEIDIRVQIAGYDRLSRRQVEAIPLQTQNGFVKLGNM
VRFERLPKQRDLYRYNRVPSILLFVKDGNNTVQTGQSSTTGIKRERLDQSSFAESMRAII
GTFAIALVLMYLFLGAQFESFSAPLLLMIVLPLSACGSFLFLTVTGRSLNINSGIGILIL
FGTAINTTIILKASFLHSRNREELIRMAGGRLRPVFLTTATTVTALLPLMLNGSPEATLQ
AHTATSVIGGLLIGTVLSLLIFPALDYVTKHGNR
>fig|573413.5.peg.2158 Permease of the drug/metabolite transporter (DMT) superfamily
MKSKNSFLMTPIDWLLLISLSILWGGSFFFNRIAVTELPPFVIVTSRVSIGSVFLLFFVH
VKKQKLPRSIGIWSQLIFMGLVNNVIPFSLIVWGQTSIASGLASILNATTPLFTILIAHL
FTPDEKITIHKAIGLIVGFIGVFLVIGPTALSIADITPQLAVLTATCSYAIAGVFGRRFH
TLGLDPLVTATGQVISSTAILVPITLLTNYSFLRQATTSLPVFGSLIGLGLFSTAIAYTI
YFLLLSRVGATNLLLVTFLIPITAMVLGVAFFNERIVTRQVIGMLIVFTGIIASNRRCHH
QE
>fig|573413.5.peg.2260 Antibiotic hydrolase
MKEYKMMNNVMIPMKDDVKLAMDIYFPEGDSESYPVILERTPYGKREANDYDIDNPKGQA
SSRQKIASFYNKHGYVVIFQDCRGRYDSEGVFIKYFNEASDGQDTIQWIRRQPWCNGKVG
IMGFSYTSHAAMALGCLLSEGIDCMFIDSGGFSNAYFSGIRQGGAFELKQLIWAFLQAQV
SPAAVQDPIITESLKSEDIFAWMDRMPLKRSHSLLRNFPEYEDIAFSFWEKGTYGAYWKQ
LGINTSEYYDRFIDTPIFLISGWYDPYVKTILENYEAFSKRHQNPVYLMMGPWTHNNRAM
TIAGDVDFSAEALIHTGYANSYQELKLAWFDKFLKGKDVLPEDGKKVKIFIMGGGSGKKN
DNGTISHGGHWFSADSWPLPNTIFVSYYFHANGSLSDKKSTLSESFIEYTFDPKNPVPSI
GGTITSGEPIMRGGAYDQKESDRFFGSRKPYLPLEARDDIVVFQTSILDEDKVIAGPIKA
RLWISSDCKDTDFTIKLIDVYPISESYPQGFAMNITDGIMRVRYRNSFEKPELMVPGEIY
EVVVEAFSTANLFKKGHRIRIDISSSNYPHFDVNHNTGDPEGKGQVMLKAKNRLYVDKEH
ASYVDLPIVNSL
>fig|573413.5.peg.3063 Acriflavin resistance protein
MHIVDLSIKRPVTILMVIFALILFGVMAYMSMPISLFPNVTIPYITIQTVYAGASPDVIE
TQITKKIEDQVASVSQLKTLTSYSMDSVSAVIAEFEISKDENIALQEIKDKVEVILSDLP
DDAERPKISKVDIASAMPVMNIVLEGDMEPSALYTFGSTTVSDRFAQVAGVSSVDLSGGQ
KREIRVEFDRSTVFSHMVPLSQVAGILGAASVDIPGGNFQLEDQDIPARLEGEFDDLDQI
RNLDIPTGTGTFKLRQLADVKDSSEDVRVRTVLLDQKAGTREDNAILLGVVKNPSANTVD
VVDGVTEQIKEIEASYPGIRLKIVKEDASYVRESVAGTLTNVYLGIIFTGLVLLFFLHDL
RSTLIVVLAMPFSIIATFLVMKAAGISLNMLSLMGISCSIGTLVSNSVVVLENIFRHKEL
GHDRINSASLGAKEVTVAVFASTMTNVAVFVPMGSMSGMMGKILANFAYTIVIATLFSFF
VSFTLTPMMASRILPEKAKKELPISKALEAMFRRWEKAYGRILGGMLKNKGRSALVVFLI
IALFGFSMHLGGNLKFENIPQSDGGKIQVDVDLPQGQRLESTASILEEIEGRLSRHPEIE
SILTTLGTQGIMDEDVSLAQMTVYLVPKSERSQDSSAMASMVARELTDIPGVTIRVMPIS
ETQSSSVGGSVVDLYLKGPDLTILQESAEKIKSVMESIEGVTNVTLSSKSGKPELIFRPK
RKQISEDGISVQQVAISLRAAVDGIVATSYKDEGEEYDILVTMKDSEFTDIDDLKNIPIA
SAVGVYPLSRYANVSFGEGNSKIMRYNRLRTIEITADNLPGYAGGSLVNEIMAAIEQVDL
PPGYTIDQGGSTEMLSETVHDLIVVFFIAVILTYMLLAAILESFVQPLFILSTVPLSMIG
IVLICLATGTVLNVVAMLGIIMLVGIVVNNGILILDYYNQLKAKGKSTHDALVEASVVKL
KPVLMSNISIVLGMLPMALGIGGAGAEMRQPMGIVIVGGIVSAMFLTLFLLPSLEFLAPH
RSGASSSPLPASTEKRGD
>fig|573413.5.peg.3163 Permease, drug/metabolite transporter (DMT) superfamily protein
MLMASAGVFIKLAAVPAPLMSWFRTAVPLVALTIFYLLSGHRRLGKPSALILLGSFLNAV
RLLLLFAGYLFTSVSNGIMILYSWPVFATLFGALFLKERIPLRNRFLLLLAFAGIGIVYS
QSGFEIESRDFIGMSMLLISSALYSLTVIVFKAASVRYDQIATTFYQNLIPALLFTPALF
FWPFPTGASLAYASLYAVLIGLVAFLLFFTALKHLPASVTAHLSYLEVFGALALSVLVLG
ETLSWNKLVGGAMILLSVLFVSRGNQNKGGEDQKTEADI
>fig|573413.5.peg.3476 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRDLTQGSIPKHILSMSLPTMSGLMLQGLYDIVDMIWIGHISYQAVAAITIFASIFWIFE
VLNEIIGMSSVSLISQSYGAGDMKRTAVAAEQTITCKFLIASLAAILLCIFLKPMLHLFT
DDQLVTEYAKDYGYLRAATIPIFFSSFSVNTIFRCTGDAKTPMFLLIGSAVINIILDPIL
MFDSIPGTSLPGAGLGMFGAALATVLANMVALGIGMLLLLCGKSGVRISPKGLFRLVPVM
DKKLLTIGLPSGFEMLFRNTANTVFIKMVGVYGTAAVALIGVGLRIYSFIFMPIMGIVMG
SGTIAGQNLGANQIDRSRATAWYSSLIGSLLTAVLITLVLLRPQVVLGWFLTDLDEIRQG
VGMLSIVLPSLIIAAFSLGWSSVFSGSGYTMPFLISSFVAKWVVMIPYSAVVVYRFHASL
TYVWISFVLSEIAEMIILGRFFHKGAWKYRRV
>fig|573413.5.peg.3571 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNDKREMLLNQSMGKLFVSLALPGMAGMIVIGLYNLVDSIFVGQFVGPAAVSAVAMGYAV
ILVNQAILSLFATGASSLFSRAMGAGDQKTMDALLGNVFWPVALCSLVLTAITFSFAPGI
LFALGAREEILSLGIDYLRLLSLGFVFGAVGPALNFLIRAEGQMKTAMKIMALGTITNII
LDPIFIKVLGMGMEGAALATIIGQSLFLLGDFAHFRSKQSSINLSRKSFRINWPLMPEII
RVGFSGMIMSLAVAIQLSILLSLSSSYSINSNIVMSTAFRIMSFFYIPIFGISYGLQPVL
GANYGAGRFDRVREAFWYFGKVASAIAVGIWLFFQLFAPFILSWFITDGEIVAEGSRQFR
LFLSSFLFYGLIAVFIMLFMALGKAGKGALLTLGRQLFFFIPLALLLPYMFGEIGLWLSY
PLGDLCVVLFGMILVRSELKLLKRPHYAGQ
>fig|573413.5.peg.3742 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNSDRILNGGISRLFVRLSFPAIVSLLSLGLYQFVDGIFVGQWVGPAALGAVGVVYPFS
LINNGIFSLIGVGAASMLSRAIGRKDQKTIDALFGNLLLANLILSGAMILFGLLAAESIV
AFLGASGEIHRLGVIYLRILVLGSFFFNFASSANILIRAEGRMKQAMRIMLSGTILNIIL
DAFFLGVFDWGIAGAASATVISQGVMCCVSFFYFGKANGAITLRKSHIAFTGHLFEMLRV
GFSGMALPIMTVIQIIFVLKSVASYGTEQELIIIGAVIKILNFIFVPIWGICQGFQPLAG
MNYGAGKYKRLARAFTLFSFYSTIITLVIWLLIQLFPRVPLGWFIIDSDVLEAGVSVIRL
YLCDFPIYGYMLLVITFFQAIGRSIPAAFLVVSRMSLFFIPVILLLPRLLGLAGVWLATP
VSDMFVVVIGTILFGLELRRQRCLEAQEEEG
>fig|573413.5.peg.3855 Multiple resistance and pH homeostasis
MSWITAFFFLLGALFALMGNLGTLLFPDVYTRLQAASTCSTTTVFSIMVGSLFITGFSLM
GGKILVITLFFMVSSPVSGHIIARYAWRSGQVPWRRPTWKR
>fig|573413.5.peg.4052 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MADNYNNERIQLLAEGDIGSALFKLSAPAVAGMMVMAIYNVVDTFFVSLLRDTTAVAATG
IVFPLFQLIGSIGLTFGMGAASVISRKLGENDYKEANRTAATALYTSLGVGIVFALVGAT
FIKPLLILFGATDSILSTADLYGRVIVGGSIFQVSNMTLNNILRSEGAALHSSTGQIIGA
VMNIILDPLFIFALNMGITGAAIATVISQGISTLYLASYYFRDKGAVNPFKRSYFHPTVR
TYRNIMNMGIPTFVRQILGSISFAIVNNAAGVYGDSSIAAVSINSRLFSLLMMALFGLAQ
GLQPLAGYNYGARRFDRVRQTIRIVFSVASGIGLFAGILCFIFAPAIMRVFAPQDPDVIA
MGSEAMRMMALSLIPVGLVIMFGGIFQALGNGRYALILAAGQQGLFLIPLVLILPRFFGI
SGVFAAQPAGFVFALLVGMILFFRQSNVLKARETQMLEG
>fig|573413.5.peg.4208 Multidrug resistance ABC transporter ATP-binding and permease protein
MLKEFKTLLPMVKKYRWWYVAGLISLIITDAGELLIPQMIKQATNIIASGSFFPAAIATP
VLIMIALAAIVALSRFGWRFFLHGASRRIERDLRDKLFAHLLTLSPSFYGTMKTGDIMAR
ATNDMRAIRMATGMALVAFMDGLFLTLAILIILFTTNPALAAITIIPLPLITIIILAFGT
VIGQRFKAVQEGFSRLSEHVQETLSGIRVLKSFVRESWAQERFVDTSDAYMQKNMQLVKL
WGFFFPLIVFISGLTSLLLMRFGGVAVMLGSFTPGDFVAFLTYLSMLQWPVIGMGMTVNM
IQRGAASLGRINMILNEKPDIVSPPRGRTNIDHTGIEIKKLSFSYPDSEIKALDQVDLML
EEGKTLGILGRTGSGKSTLVRILPRLLDPPSGTVFLGGVDIREYDLETLRNAIALVPQDT
FLFSASVRENISFARPEADESEIMDAARISTIDREIEKFPKGWETEVGERGLSVSGGQKQ
RIAISRAILPNPPILIFDDSLSAVDTETEEKILNAFLEHRKGKSNILVSHRVSTLQWADY
IVVFDRGRIIQQGSHTQLLATEGLYRNIYLLQQEGSL
>fig|573413.5.peg.4209 Multidrug resistance ABC transporter ATP-binding and permease protein
MEEEKIVKGYDPVIMRRLLGFVAPYKKLVTIALLAMVLATLAELLGPVILQRSIDQDIIN
RYHRVSLSKMDDALAERLFAPPVLPQLFHKSDPPLFGDNRFITSSMLERLSAEERKKLFD
ANIVDTMEWYLSGKLNNAEELLSTLPAEAEAMLQDGWIAMPASSLKKLDKESLGLLRAND
QKSLSHKTGVYLIFLIVMLLFSFLQVYLMAYTGQGVMRGLREKLYHHVMSQNLGYLGNVP
VGTLVTRVTNDVETINELFTSVATGLLRDFATMGGVIFILFYLDPHLALITSASLPPVVI
LAVIFRNRARDAYRRVRIWTSKVNAFLSEHISGMDVVQAFHREKRSQENFQKINGQLLSA
NLAEMYVFATFRPLISLLTSISIGTVLYFGASMVLNSAVSLGVMIAFVNLMQMFYRPVMD
FTENFTILQSAMAGGERIFNLLDRNEVIPDNGTTPIPAPVKGKIEFSHVNFGYTNDEQVI
RDLSFTIEPGETVAIVGYTGAGKTTIANLLTRLWDIEGGTVLLDGINISRISLSELRSTV
VPVQQDVFLFAASIRENITLGRDIPEQRVKAAAETVQSAPFIESLPRGYDTVLSERGANL
STGQRQLLAFTRVVAQNPRVIILDEATGSIDTETEKLIQKAMERLTQGRTSIVIAHRLST
IQHADRIMVLSGGRLVEMGNHAALLAKNGVYANLYRLQYKDAVQE
>fig|574087.3.peg.151 Vancomycin B-type resistance protein VanW
MKNSLLAALVALTLLFSIGLGIYIGSYFFFKQHEDVIFSGVMIEGYDFSGLTKKQAKERL
KKLTEPLLQEPLVLERDNDKWLLRPDDIELKFKNRGALNKAFGIGRSGTLLQRSIAVWQS
AEYGKSLTVDISYNEDKLDEKLQQIANEVNISSSNAYLDLETEELISFQLGKRLRLEESK
QKIISRFNNFKKIPVKLVIEKKVPEVNREKLKEWNLTNQLSSYKTSFDTEKENRVHNIKL
AAQKINATLLKSGEVFSFNQTVGRRSLKNGFKQATEIVNQEFVTGVGGGVCQVSSTLYNA
VLLGDLKVLERHNHSRPVGYIPLGRGAAIYNGYLDFKFKNTSSDPIMILAKVLENSLEIA
IMGQSKDYQIEISTSQPKVLDYGQVKKKAKVEERKVVKEGKQGYQVKVVKKIIVDNELIN
KEIISQDVYQPVDKVIKVPVK
>fig|574087.3.peg.1814 Permease of the drug/metabolite transporter (DMT) superfamily
MEEYEEVSFKKRIKADLALLFVVFVWGTTFAIMKGVFDIVTPFYFLTLRFWTAVIVLVLI
FHRRLKKLDWETIKLGSFVGIFLFGGFAFQVVGLNYTTASKAGFLTGLSVVIVPILSAII
LKKIPSMLTVIGVTLATIGLGLLSFNGEFIFNFGDFLVFLCAVSLAVYILLVGKYVQQKD
SILLTIVQITTVALLSGFSSLVEGSFEVVLQPELWGAVVYMAFFATTLALVVQNKAQEFT
TPTRTAIIFSMEPVFAAVFAYFYLGEVISVNSYWGGLLIVVGMIIAELKLSKPKEEAV
>fig|574087.3.peg.1890 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MAKKFKKQLGKQVDSTKGSIIKSLFHLSWPIILSNLMHMTYNLVDTIWVGKVGAKAVAAI
SLSFPIVFVLLSLGIGFTIAGTTLVAQYTGAEEGEKVNHVVGQIFSFVLSIALFCSVIGI
IFTPDFLKWMGASKEVLPLAVSYMRVLFGGMTFMFIFFIFSALLRGSGNSITPMKLMFVS
TLINIILDPFLIFGVSFFPELGVTGAAVATIFSRAVVAVISIYFLWTGKYGLHLKWHHLK
FDFKLIKEIVVLGAPAAIEQSTRGLGMTVMMSIVAHFGTMAVAAFGICTRILSLVIMPSR
GFSTATTTMVGQNLGANKVSRAEKSAYISTGLNFILLSILGAIFFTVPQLVIKVFNDNPE
VIRIGSSFIQINGLFFGFMGGLIVINGGFRGAGNTLSAMFFSIFSLWIIRIPLANIWSKV
FEWGTNGIWWAFVISNVLGSLTAILWFKRGHWKKSIINKDKKA
>fig|575540.3.peg.1306 Permease of the drug/metabolite transporter (DMT) superfamily
MLGMAILGSTTAPAAKLAVAEIPLTVLPVIRFGAAGLLLLVWFWPRRRELIALLSERPGR
AWATAAFCVPINQAFFLSGTKLAPTSHVGFLYATCPAVVLVLAWLLGMERLKPVRVAGIL
VTVLGMAIITWGGLKDVSSAGLESLLVGDLLLMGAVVSWAAYMLCSKSLIESHGAFPTLI
STFLLGALLCLPFTLAASWDTQMLRAVSWTAWAGMIHLTVVVTVVGLALQNLAIRRLETS
QVAAVGNLAPILTLIWAVLLFGDAITPQLIVGGTATLVGVFLANRS
>fig|575540.3.peg.1410 Acriflavin resistance protein
MTTRANSGGETTHRHTHGREDILTGIVRIFLESNFSIILIIVAVLIGLGALLATAREEDP
QIVVPLADIMVEMPGHTAEEVERLATIPLEKALYQIDGVEYVYSMSRENRAIITVRFFVG
QDRERSLVKIHKKIDENLDLIPPGVTGWVVKPIEIDDVPIVSMALISDPDQAGPGTESAE
DGYPIRRVAEELAQRLSALPNVSRVQVIGGMPRQVRIDLDPERMRAYSLSPLEIQRALIG
SNLITPAGSFERNDAMVTVEAGLRLDRPEQLPNLVVGVFQDRPVFLKDVATIRDGPAEAS
SYVRHGFGPAREFAVEPGAPGYVLGAPVAHDQDGKAHQLVAQVEPPQTAVTIAVSKQKGT
NAVSVAEAVLNRVEELRADLVPSDMKLVVTRNSGLVANEKVNELIEALWVAIVIVLALLT
LSLGWRDALVVAVAVPVVFGLTLGVNYLAGYTINRVTLFALILSLGLLVDDPIVDVENIA
RHFSTRGRADREVVLEAVAEIRPPLISATLAVIVSFLPLFFITGMMGPYMAPMALNVPIA
MLMSMVVAFTITPWLAYQALRGHVKPMNGESPPVGHDHDPDDPDTIRRTMLYRFARPLMS
PLLGSKWRSVLFLLIMAGVTLAATALAAVRAVPLKMLPYDNKNEFLVLIDLDEGTTLERT
DAVVRQFETLLAVEPEVVNLTSHVGVSGPIDFNGLVRHYGLRAMPHQAEIRVNLVGKRHR
SQQSHAIGLRLHDRLTELADRFNARVKIVELPPGPPVLSSLVAEVYGRPDMTYDQLADAA
EVVARRFRVEPGVVDVDDTIETPARKLIFVTDQEKAALNGVSVEEIARTLALVLHGGHAG
TVREVGEVNPLRIELRLPRELRSTPEDLARVQVKGTNGRLVPLSELGVWEEGRVTQTIHR
KNLERVVYVLAETLGRPPGDCVADIALDRVEPQPGDSQGFVAEGTGKPVALRTFGLEGGG
VPWALPEGARVSFSGEGEWKITLDVFRDLGLAFAAAMVMIYVILTMQTNSFVVPLVVMLA
IPLTISGVMPGFFMLNALTGTTVEGYADTVDFTATAMIGMIALSGIVTRNAIILVEFIHH
AVKRGRSLFDAIIESWVVRMRPILLTAAAAMLSSIPITLDPIFSGLAWSLIFGLIASTVF
TLFVIPAAYWLINATQVDIDGSYSDQSEE
>fig|575540.3.peg.1561 Tetracycline resistance protein
MSQTRSISPQALLVMIVLVDLMGFTLVMPLLQRFASDYGFKPWQIGAILAAFPLFQLIAG
PILGRLSDRYGRRPVLVASQFGTALSFALMAVSREFWVLLLARAIDGASGGNVLVAQAYL
ADVTKPEERGKALGLLGAAFGVGFVLGPLLGGVLVKLPIDPDWQLRLPFVVAALFSTVAW
VLVWLKLPESLPREKRAARFTLSRGGPLSVVRVVRAPKIGRLVVVSALLTLTFSSLEGTF
SNYLKSRVGWDAAEAAWAFAFLGLMSAMVQGGLIRPLISRFGEPRLVIFGVTTLALGMVA
MALMSDWWGYLAACILIALGYGTSGPSVNGLLSRSVSPVDQGLVFGVVASCQTLARMINY
MVANLLLGSEGSSAPYWEAAFLALVALAVAWPVVVGVGPSTDHDATLPSETLWSSDAADN
LGRMPSLEPNGASNVPRQPSESPTSAAR
>fig|575540.3.peg.2494 Permease of the drug/metabolite transporter (DMT) superfamily
MSPHASPASVRPPTLAQVSSPTGRFTGWWVGLVVICQVIWLIWCLREPLPNASRNGQGPQ
ISRGLLLMVALPGPTPDLDWSDSILGSALDELSQWWRLGDRVAILAVAGLILAAIFGLGG
VILRLLDPDCRFARVWGPGLGPPIRFGIGAATLGAVVLGLGWWGWLGPTTARVLIGALAL
ANLTARRGWRSSSEEGRSAASQRIPWRSLWPLGFALPFLVPMFLGAMIPTIDFDALEYHL
QGPKEFYLGGRIAFLPHNVYTSMPFGVEMLHLLAMHALDDWAVGALAGQVTLAGVAVMAA
WAVGGLTARWAGTGSGVAAALAYLATPWIYRMGVLPYVEGPLCFFHAAALGAAVTAWNDS
DSQGRGRAWSVVGLLAGGAMACKYPGLISAVIPFGLAAAAAAITRRHPASLVGFVLGVAL
VVSPWLLKNAVETGDPVYPLGYAVFGSHQWDETLDAKWRAAHGRKPITLAELGRALVDVA
GRSDWQSPVYLAFAPLAWLARGRRGHAAVATAFLVWLFAGWWLLTHRLDRFWLPLLAPAA
VLVGLGWNGMSQRVWKIARVAILGVCMSVGLVQSLSPLTGPTNWTTPLDDLRHSIPRLLD
KELVEFAEALPPKARPLLVGEAAVFHLTVPVVYNTVFNRETLEVWTAGLDPVEAGRAVRD
RGITHIFVDWNEIARYRSPGNYGYTDYVTPELFERWVQAGWLRRLRGVPGRGVEVFEVRS
NSSPDLFPTETKP
>fig|575540.3.peg.3802 Acriflavin resistance protein
MRDHDLLPTPVRSMTVSDICIKRPVFTWVLMMIPVVLGSLSYLELGVDLFPNVDFPVCAV
VTTLPNASVEEIESTVTKPIEDVINQISGIDELRSQSLEGTSIVTVQFDLSKPLDVGVQE
VRDKVGIVVNQLPEGTETPVVSRFSTDEIPIMTIAVSGRRDLREVTEIARRQIKERLETV
SGVGTVGLSGGKVRAMNIVIDADKLDAYGLSIEEVRQALARQNVETPGGRIDQGERELVL
RTLGRLETEQEFNDLIVVNRGGYPVKIRDLGYAEDSNEEVRTLARLEVFENGISQGAKNA
VSLTIQKQAGSNVVAVADEIFKRLEKIKASLPDDIEIAITRDQSRFVRKSIEEVQFHMLL
AAILVSGTIYLFIRDWRTTVIASLAVPTSIIPTFAFMYVMGFTLNNITILGLILAIGIVI
DDAIVVHENIFRHMEEHGLDGYEAARMGTREIALPVMATSLSLIVIFLPIGFMGGIIGKF
FSSFGLTVAFAVAMSLFVSFTLTPMLCSRFLKLDSSQGAGGPQKAKSKSGLIYRLVDGTY
GLILRFALRFKFLVVLMTLVVVIATYPLALGVGFNLIPRDDQSEFEVVFTTPEGYTLKRT
DEVTAEIEARLREQIRDMKYMYTSIGNAVSGGIASSEGDVTKSSIYIRLKDLEERSPGVT
QFNQQEIARKILLDYPELRSSVNDVSPFQGGSRGQTFQVNLAGPDLEKLEELARQLADKL
AATGNVTDLDTSLTLRKPELQVRVDREAASDLGVQVGVVADSLRALVGGIKVSKFRDGPE
QYDVWLRATKIDRQDERALLRLTIPSTMMGLVRLESLAELEFELGPTEIERYNRERIVTV
LANPKQGMALGELVKLTTSLLDPNSTNPDRLELPPGYSFRFTGQAETLAELFRYFAIAFF
LSVTFMYLILAAQFESWSQPVAILMSLPVTVPFGLLSMILFQTPMDLYAMFGLFMLVGIV
KKNGILQIDATNQFRAAGMNRHQAILEANHTRLRPILMTTFMLVAAMIPLALGQGPGSGS
RASMAKVIIGGQVLSLVLALVVTPVFYVYLDQLRNLMRKSPFRLTVERQTHSLNASDQPA
RPVPVMARVFESSHSLPHDNGHGYGNGHGLRSPVEPSEPYERPVGSSAAKSSAD
>fig|575540.3.peg.4269 Acriflavin resistance protein
MALESASSAPSGSLREQLASLRIDRDRVVISRPKPATRSGRKAVPTNGTISALSGPEPPD
SRLVIDEARAAMIREAVEQLRLDRSSSFRPRSRRSSQPPLSGPSASSPANWSSSSPSPSP
ASPAAESDRNGRDVIPPKPPWERDTVQPAPRPATRSAPRPRRRRSWGFQLLSLMLWMIPL
AILAALASQAYRYYDARLPKFEVTVAVAQKMTQAEAQKILSAKGYIKARRQTMVGAMSPG
RIERILVSEGMKVGEGELLAVLEHNELDALLKSREAMIEQKKAELEEAQTALEDRRRKEE
RLRTLSSRRSVPIEEFEDAVYQTRMAASRVEALKAAIRLMEASAQETRETIRNMEIRAPF
TGTILTKDAEVGETLTPGGMGAASGRGSVVNLADLTDLEVETDVAESLLARLQPGQPAEV
SVAAVPNRRYQGRLRQIIQLGDRARGTIKVKVELLDEDERLFPELAATVNFLPIPPDFDP
NDPAASFERAGIQAAAEPEVFVPRAAVFDENGEPRVWVVDENSRVNKVALQVAPAPNAPT
QWKVEQGLQGGERVVLNPPAELRPGMLVKLPE
>fig|575589.3.peg.542 Permease of the drug/metabolite transporter (DMT) superfamily
MLLKDKLAAFAVVFIWGINFYFMKVGVSEIHPMLLGCLRYLLVLLPALFFIRIPSIGWKW
LLLYGFISNFSQFAFMFSAIATGMPTGLVALVVQSQAFFTVMIAAFFLREQAFWNQWLAI
AIAFMGLMLIAFGQQHSHVPLMGLALVLCSAISWACGNIVVKKMGPVHPIGLVVWGNILT
PLWFLLLAVQNIGWQGVVADWHALTWKGFGAAAFLAYFATIIGYGLWIYLLTRYPVAKIS
PLSLWVPVISMIFAYLFLDEQLNTLQWLGSCIVMLGLMVHLLGQKIQTLLLMQRASNT
>fig|575589.3.peg.2005 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSIATTTRFEIKKLFQLMLPILVTQFAQAGLGLIDTIMAGHLSPTDLAAIAVGVGLWIPI
MLLFSGIMIATTPLVAEANGARDFNNIPTIARQSLWMAFMLGILAMLVLQLMPFLLPLFG
VPENLQPKAGLFLHAIGFGMPAVTMYAALRGYSEALGYPRPVTAISLLALLVLVPLNMIF
MYGLGPIPALGSAGCGFATSILQWLMLIALAGYIYKGHAYRKTQVFSQWEKFNPVWAKRI
LKLGFPIGLAIFFEVSIFSTGAIILSPLGETVVAAHQIAISVTSQLFMIPMSLAIALTIR
VGMYYGEKNWHAMRKVQHLGLITATVFAVLTMLVMWIFRSEIVAVYTRDLAVTHMALYLI
LFAIAYQLMDAWQVSAAGCLRGMQDTKGPMWITLLAYWVIAFPVGIYLARFTRMGAAGVW
TGLIVGLSVACVLLLLRLYMNNKRLKLSTST
>fig|575589.3.peg.2028 Permease of the drug/metabolite transporter (DMT) superfamily
MSSTASGTPSASLLFTSSVYALLVLIWATTPLAIVWSVEEVHPMWVLIIRYFGASILAFL
ILKLMRAPLPFDQMAMKSYLAGSLNLIGAQLFIYLAANYLTSGLMALIFGFSPLVAGLIG
HVILKTQKLVALQWLGMAIAVAGLSFVFADQAETQVNPIGVILMFISMVSYISSIFWVKE
INAPLAPMSQATGSLLVSALASLLLVPFIYEHIPTAIPGTKTIIGFLFTMVMSSIVAMLC
YFWLIKRLNASTVSLSNVITPVLALMLGATLNNEQIGSHTFAGVSIVMFGIVLYFWKDWH
SQYRVKKY
>fig|575594.3.peg.122 Fosmidomycin resistance protein
MKVSKYIYSLSLGHLFVDFSQGALAALLPTLITQHHYNYAIAATLVFAMNLVSSVVQPLF
GFLSDKYNTGWIIILAVLITGVGFSSLGYVPTYALLVMGCLVCGIGIAAYHPDAAKLVNG
LAGYNPGQGMSIFSFGGNIGFAIGPITLTLAVNHFGIHGIGIFLIIAIIIMLILLKLYPI
MHRQSVAFWSSSKKDRNSKIAVHGHNDWFHFSLLSMVLFGRSIIFYGLNTFLALYWMHIL
KQSNTNGSIALSVLFVIGSLGTLLGGRLADNIGSIKVIRLTFCILPFLILALSLTRNVLI
GSLFLLPIGLLIFLPYSAIVILGQRYLPNNMGFASGVTLGLAISIGGIATPFLGYIGDAT
NLVKVFQILAGIGLIPLVFSFLIREPK
>fig|575594.3.peg.278 Glyoxalase/bleomycin resistance protein/dioxygenase
MPVIEDQTENNEHEHVVTLRCGHQLIRLQPTDRPKEQLQAAHPTPGSVDLCLVSGDDPED
VLHHLKSYYVDVIAEPQPNQGAEGDMTSLYLRDPDQNLIEICFYKNK
>fig|575594.3.peg.651 Glyoxalase/bleomycin resistance protein/dioxygenase
MQYNHLTLEIWTGEGAVRKTGAINHISLNTKDADAAFKAAKAEGFKLKDSEVQHLDFWDK
GIKFFNIEGPNAETIEFCEIVK
>fig|575594.3.peg.1491 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENNRLDLTTGKPLQRILQFSTPLIFGTLFQKLYSFVDSIIVGHFISANALGSVGATYSL
NFLIIGFMQSFCVGLGIPISQSLGANHGRDVQRFFWNGLYLSIAISIFFCVLMTYYTEPL
LIAMRTPQPLLHDAVIFIRPQFVFIWVTVLYNFSASVLRSLGDSRTPFYTLVLASLLNII
IDVVLIGIFHWGVIGAAVATIIAQAISGLMNIIWLVKTSIIIDFRHPQLKFSARHTYRLA
YIAFPMGIEYSISAIGAIIMQFAINSLGTVYVVSQTAGEKIRQMFTLPIESIGMGMATFI
GQNFGAHSMSRIRQGIKDGMKIQIIYYGICLIIIMLFADPLSELVIGHHPELIHLSSLYL
RLMSLTLFLHGTLMIYRYTLQGLGFSLLAIWSGVGELIGRSIVSLIAIVLNSFIAVCFIN
PVAWGLAGGYCCWMVYRQLKKIAVSFTREVN
>fig|575594.3.peg.1618 Multidrug resistance protein B
MTSNTINIDRHTRNIIAAILLLADFISLASQTMIVTALPIIQQDLHVSLTTAQWLTTGYT
LILGLTIPLFSNIYNKYTDRGIYLSTVGLFIIGTALGCIATNFPLLLLARLTQAAAGGVI
MSLQMTTMISIFPIEKRGTVLGMTSLIISTAPAIGPTLSGFLLEYLSWRWLFISVLPLMI
VCWLIGFWKLSNYSPIKDVRFDYPSILTSLIGTGLALGSLSVFQSNLEAGLAMLVSGCLF
IWWFVHRQLHLKRPMLKVTIFKYPSFRLMTLVGLLAFMIMLGTEQVYPIFTEKILHTSSL
TSGLILFPGALANGIVAFFAGRLYDQYGFKWLIISGSLLIALASIPLLFISSSTSILTLT
VIYIVRLIGNALIFSPALTEAFSDLKLEENSHGTALNNTVRQIMGSASVTMMVVITDAPR
SIVQGAHWAFGVTLLMVVVLMVVLGRYLTIKKQH
>fig|575609.3.peg.25 Permease of the drug/metabolite transporter (DMT) superfamily
MKSKFVSSILLIFSAAIWGFAFVAQSTGMEHIGPFTFSALRSIIGSIAMILTINVIPKIG
MLQKKETSVVVDKALTRRAGIINGIILFFAMNSQQYGLLYTTPGKAGFITALYIVIIPIM
RSFMGEKVSLKVIICVIFATFGMYLLSVKENFTVNFGDIVVFCSAIFYSIHTLTLAHYSP
KVDSIKLNAFQFLLSGILSLICALIFETFSLQDIVNSMGSILYVAIMSTAIAYSLQIVAL
KVLEPTIASLLNSSESIFAVLGGFLILNQHLTHRELIGCLIMFVSTLIAQIPIMSFRRKY
E
>fig|575609.3.peg.44 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKLKIDGNVNFTEGSIASGIIYFAIPLLLSNFLQQLYNTADLMIVGNFAGKGPMASVGAT
GPVANLLIGLFLGLTTGASVIVSQFYGMGNRKKLHSCIHTSYAVAIVGGIVLSVLGYFLS
PIILSNLNTPREIMDDSIRYMRIFFLGVTPLLIYNMGAGILRSTGDSRRPFNFLCISAIV
NIILDVVFVVYFKLSVVGAGWATFISQVVSAILVTYNLMVSDRIFKLNPKDVKFYRDTIG
KILKIGIPIGVQSSVISLSNVLIQSKINTFGANAIAGISAESRIDGFIFMALQAVSLSAT
TFAGQNFGAGRFDRIKKGIKTAMLLMVGTALFLSAISIIFAKILISVFNSDPEVINYGSE
CLYYIASTCFIFGISEVFGGFVRGAGKAIVPMAISIVSMCGLRMVWIYVALRTWNNIEII
YLSYPISWIVTCILNGLYYFFGKWNPQERFNK
>fig|575609.3.peg.1323 Teicoplanin resistance protein vanZ
MKLLLFFSMIGILVFVFTFILFSLIRTNFFKSLKRKSNPKRELILSIFVAYIAVMCLLLF
LPNVFMSNHGIDLTSQNFDFVGDFKDRISAGSWGVNIIPFRTMKSYIKYSGVFHVFLNIA
GNILIFIPFGTMLPMLYDDMRKFYRVAVLSATFSFLVEIVQFFVGRSVDIDDFILNTIGG
MIGYFVFKMIQNKYN
>fig|575609.3.peg.1384 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKDVDLLNGSITNLIIRLSLPLMGTAFIQMAYSLVDLIWVGKLSTEAVAAVGCCGFFIW
IAQSLILISRTGLSVGMSQAYGKRDNRALVEVARSGFQVNFLIWTALTFIYTVFRDDILG
FYRLDYEVEILAVKYFNIITFGLIFTFWVSAIESVYYARGNSTTPFKVSTVALIFNIIAD
PILIFGLGPFPNLGIEGAAIATVLAQAIAFFIFIYLGIKDREIYVRINYLKKVNINRIIY
IFKLGVPASLQSIIHALVGIRLNRFIADFGAASIAAFAIGAQIESVSWMSAEGFSTAFSS
IFGQNYGAKNFERILECRKKGLKILTTVGVLAASLLFLQESRFLKYSLMIWM
>fig|575609.3.peg.1437 Vancomycin B-type resistance protein VanW
MHFSNKRVISVVLAVVLLGIAIIYYSNESKSEKIHRGIKISNIDVSELSVEDAILKITST
KEEENKDAKLKFSTEEMNYFIPYKDLGYTLDVETAVKEAYLIGRSNSIIKNFFDIIYTSI
VHKNIELSESFSVEKVDATINFLVEKVYKKPKNAEISYSAENGFNLSKEEQGSYLDSKKL
KELIFHDIDKKEDIQLPILKSEPTVYIKQFEGIDGLLSEFSTDYSKSEDNRKDNIALGAS
HFNDFILKSGEEVSFNNVVGDISLLTGFKDAGIIINGEFDRGVGGGICQVSTTLYNALIR
ADLDIVERYNHTRPISYVPLGTDAAVSQGYKDLKFRNNLNHNIYFKAFADGNELKFQIFG
NKADRDYQVEIEPKLLAVTEPNVIIQYSDAIEEGKEEVKKPGAKGYSYVTYKNIIKDGQI
VETQKISSSNYIAQDKVVVIGEGDPDVIREKKEREKKNYNKEKTNKKTNND
>fig|577650.3.peg.3448 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTTLSLILHEARALLRLTGPLLLAQLAQTAMGFVDTVMAGRYSAVDLAAVAVGFSIFIPV
YVFLLGLLSAVTPLVAQAHGRGDGKAVRRAIRLGMGIGLVAGLLLMPLLWWTDPFMMWMG
VSPEVIPITGRYLFAISWGLPLGGIFFALKGGGDGLALPRLSMFAGFFGLGVNIVANYVL
IYGKLGLPALGGAGCGWATSFSILAMLGFMALLLGRSRIDGTARLFALHPDQAATTSVAA
FLRLGMPIGLALFIECSIFTIIALFIAKFGAQVVAAHQIALNFASQVYMLPYSLSTALTV
RVGFTIGRKRIRRLRRIAGTGLGMALIGAVLTCGGILLFSPQIAALYTADPAVRQLAVVL
LGYAALFQLPDAMQVNAGGILRGCKDTRVPLLLMLCAYWGIGLPLGYGLGLERLGNLEPG
PQGFWVGLICALVVAALLLGGRVRIMLRRLERQAGQGVRADRP
>fig|580327.4.peg.2708 Teicoplanin resistance protein
MGINFPIGLKAILFIFFIPLIIKQFKSTKNIVIVTFMAGFIIYAIELISIVFFPITFYPP
MPNYTPNVNIVPMKDIIILMRLQPINIVIKNVVGNIILFIPLGFFVPIIYRKMNKFNYTL
LLGLCVSVFIEIAQFIIDYLTKYPNHTCDVNDVILNIIGLILGFIIQRGIRKASFMANYI
NNVANKIE
>fig|580331.4.peg.397 Daunorubicin resistance ATP-binding protein drrA
MRVIEVKNLTKVYCAYEGKSLGRIFKRLWSREGVKEVKALDNVSFSIDLGESVGLIGVNG
AGKSTTIKILTGILEPTEGVVRVFGNIPSKHRMKNNYRIGAVFGQRTQLRWDLPAYESYG
LLKEIYNVDDKVFKERLDYFSEVLDIKKIMHRPVRTLSLGEKMRAELCAAFLHGPEVVFL
DEPTIGLDIFSKEALLHFLKEIKEEKKVTIILTTHDLSDIEEVSDRIIILDRGKILFDAS
KDEVLNTLEVGSQIIFTLKNKEAVIPQSVKSLPFSISKNFLKVDNVSKDLVPQVLTDVFS
YNTVLGVEINYPDFKDIVKQIYLQNKDRGRKNGDNLYKGKIGF
>fig|580331.4.peg.1775 Probable cation efflux pump (multidrug resistance protein)
MFIKRDILVLIMPVIVEQTFLILTGVINTIMASRLSKDVVSAIGMADSLNNMLINVFSGL
AIGGTVVVAQYIGQGNKKNANKTLKQILYVGVGISFLITILVWIFRYEIVGLLFKSAEKT
VIDNLMVYLQITVLNYPLIAIQLITLGALRGSGDTRTSMKINILVNILNIFLSYVFIYGI
KWIGFKGMGIKGAAIGLTLARVIGAIVTLAEITSCKNYLYLDQLTKFKLNIHILNAVFTV
GIPASIESLLFNSGKLLVQILVVELGTAAIAADSIFNSILSVFNIPGNAVRAVTTTLVGQ
HIGRKEINEAKEYIIYSAKATAIILGILGAISYPFAKSIASFYTSDETVIKMISDLIKLN
SICILLWSPSFVIPEGLKGAGDSKYTMVISMISMWLFRIGVAYVFGILLNLGLIGIWAGR
YVDWLARGVLYFLRLKGDKWNKILVKSEEV
>fig|580332.5.peg.1293 Inner membrane component of tripartite multidrug resistance system
MNSNRVLTGIAVMAATIMQVLDTTIINVALPNMIGQLDATPDNISWVLTSYLIASAIIMP
LTGFITDRIGQKRFLLISIAGFVVSSALCGMATSLAQMVLFRFLQGVFGASLVPLSQSIM
LQIFPGEQRGKAMAIWSMGVMVAPIMGPTLGGWLTEQISWRWTFYINLPVGILSFILAMR
HVHDTPTRERRMDWLGFASLGLGIGALQLILDRGNQDDWFSSQTLVFAALLSVAAFIFFI
VYTLTGKHHPLFDLRIFRDRNYLVASLIMTTIGIGFFGGMLLQSLFLQNFLGYPTFEAGL
YMAPRGLASFLVMIFVGKFVNRIQPRNFIFVGICASILGNYMMTRFTGDITANDLIVPMM
LQGMGMGLIFVPISTLAFTTLPKETAAEAAGIYSLIRAVGSSFGIAILATYFSRSTQQSW
SLLRGDITPYSEALRNYLAPLHLGAQDPQGVAMAARAVLHQAQNIGYIDSFWFATLNFVM
MLPLLLLVRTPKKGAAASAPAVSAE
>fig|580332.5.peg.1294 Membrane fusion component of tripartite multidrug resistance system
MHMDSIKAHKKKIIIGLLLIALPGILAFTYYYGRSRSTENAYINADVVNVAAQVSGRVVA
VHIKDNQHVHKGDALFDIDPQPFTIALERAQADLAQARQNARQDNAEVAAARAMVTQAES
DLGNARSTYTRDKELVAQHFLSQQSLDDAQTHMQALQATLEQAHAKLTKALSAPVKVGER
GDVLKAQAAIDQARLDLEHTHVVASQDGQISNLSLTAGSLVGVGEPLFALIADNSFHIDA
NYKETELPGIHPGQDVDIEIDMYPGQHFKGTVESISGGTGTAFSLLPPQNATGNWVKIAQ
RVPVRIKLAPTDAEHPLRIGATATVSVQLK
>fig|582744.3.peg.227 Permease of the drug/metabolite transporter (DMT) superfamily
MAGIAMVLLASVAVSSKAIIVKLAYVYPVDPATLIALRMAFSIPFFAALAWWSARQDSLA
TLSLRQWMAVLGLGAIGGYGPMWLDFAGLAYVSAGLERIILFLYPTMVLMFSALLFRQAI
GRRELFALITGYAGVGLVVGHDIEFVHGTADATLMGAALVFASAVLYAAYLVLSGKLIPQ
VGASRFTAYTMLVATFTSGMHYAGSQHVVSWSQLPGEVYLLSLLMAVVATVLPAVLLNIG
IQRLGSNRASLISSIGPVSTIFLAWVFLGEHITWLQLGGTALVMAGVLAVSLGRTPA
>fig|582744.3.peg.1091 Inner membrane component of tripartite multidrug resistance system
MNAWSLASMRRPLLRTRVQLRLCVLACARYARSLAHGISTLARALGMGATLGAREWWKLD
APIIAYVFKVLLASVLAVWISLRLEFDQPRTALLTVAIVMQFRSGMVLTKSYYRLIGTIF
GIIASFLLVAMFAQERVLFLLSMTIWIGLCTAGSVIFRNHQSYAFVLAGYTLCIVGLPAT
LAPELTFNIGVTRLSEILVGLLCATVVSDLVFPQRMWNVTLQTVRRRYTDFCDLLRISAR
EGVAHATLQAHMLRFIGDIFSLESFRASSGLETDESRGHRHRLSHLNKEFMEVSTTFHAF
SRLLQRQRNNSRAEVREALLQLYQWLADAVTVQYRSAQTEQETLEIVQKLKAFREDFSLR
LQAARHRLPATLQTRDLLDFDTGAAYLLRLAEELYVYSRTYGSIATGSAPDQGHAEELPA
QLEMHFDPLAVALAALRGSITLLILAGLWIFTDWRSGIEAITIGVITSTLFANSPSPSKT
IRHFMAGAFIGTVLAYFSNFWWLTQAHDFWTLIIAISPGILLASWLGSRPATAFIGAGAS
VVYLLHIGFNTVFSASPVTFLNDAVADLLAILVSGTMYGLIDLSGSAWSRQRVSNALRNL
VVAACRESTPLRRARFEASARDLVQRSGSVQRVGEAQDQVVVEWLFSALEVGHAVIALRE
QLPHVPVEMARALQHAIAQIASLYEEPGQAAIAHAAEAVDQALALAAPTAASEIPLHVRH
QLLTTLHFVHSTLLDEASVLAFSPSTFASTSPAGGR
>fig|582744.3.peg.1522 Multidrug resistance transporter, Bcr/CflA family
MHKASALTLSFLLAGLAALAPFTIDTYLPAFHTLAQDFHTDNLAIQQSLTAYLLPYALMT
LWHGAISDAIGRLRTIYIGLGIFTLASIGCAFATNVETLWFFRVIQGLSAGAGNVVARAM
VRDLFEGVMAQRVMAQLQMMFGLAPAIAPIMGGWLLGIHWQAIFVFLALYAGLAMLCVQR
WLPETMPPEKRRPLSARAVWQGYAQVFGDREYLKLVVAVGANFAGFFVYVLAAPVFLVEH
LGLGPQQFGWMFIPTVCGMMLGSYLARHSAGRYSAHRIIRLGYGWMAMAAILNLLVCWLL
PPQPLWNIAPIVLYNIGSALVLPNLSIAALDRMPKLRGTASSGQAFMQMVLATVSAGLLI
PLLWHHPAGLALGMAGYLLLGFLATRASLVWQPIKPASQDK
>fig|582744.3.peg.2224 Permease of the drug/metabolite transporter (DMT) superfamily
MSLAFTYFCVLFAAIQWGANFNLAIPVVAEMPPVVAGATRYLLAALIMLTLTYIRGEHVP
LRHARAYIVLGLVGVFGFNLLFFLGMQSTSAVNGALIMALNPLLTALIAWATIGERLHMR
QWLAFPIGLLGVAIVVLGAGAHLEISHGDILIFLASLSWAAYNVCVKKMMPTDTSGIAST
AAIMTVGALALTLVALLSGEQFVMPGQHAAIALLIMTIGGGVLAYLCWNAGIRRLGAGRA
AIFLNLVPVTSMVIAAMEGVPPTTIQLTGAALVIGAVSFASWPRQQPTASPSAAT
>fig|582899.7.peg.2348 Multidrug resistance protein B
MALSDTASESTASKVLTASAVLLAVLMVILDMTVVNVALPHMMGALGATPDQITWVLTSY
IVAEAIVIPTSGFLAARFGRKRVIFVSVAGFVVASMLCGQAQTLAQMVIFRLLQGAFGAS
VVPLSQAIMVDTFEARNRGKAMAIWGIGILLGPIMGPTVGGFITDHLGWRWVYYINVPIG
LVNLAMILVFLKQTPKSRAVADWIGALLLAVGVGSLQMLLDRGNGDDWLQSNFIIALIFV
STFCLVAFAVRSYKRSDAILKLSLLRDHNLSTATFMIMAFGVGMLSTIALQPLFLEHLLG
YPASTAGLVMAPRGIAVAMGMVFVATTINRFEPRWLVLIGLTLAAAGTYATTWYNLDVDV
FWIAPGIVQGLGMGMIFVPLSTLAYQTLPQDATDQAAGIFNLARTIGGSIGIAIAATVLT
RASHSNWQTLGAGIDPYNPALAQWQDATGLTVPDPSAMQVLALELSRQATMIGFLEAFGF
VTLSFLLLIPLVLLLKKQGDAPRRSPI
>fig|582899.7.peg.3057 COG1566: Multidrug resistance efflux pump
MIAFLFNGYLFLLFLLVWFKVVPFNLFWKISPVLVMLALLVGLFIPMGWGAPSGQLVVGR
HSVAITPDVAGEVVDVPVQPNAQLKQGDILFRIDPVPFEAQVKALEAQLKLSTQRLGQMT
ELVEKAAGRQFDVEQRRAEVDQLNAQIEGAKWNLEKTIVRAPADGYVTNLALRKGARVAS
LPLAPVMAFIDTSDTIVAAEIPQIYARYVMPGQSAEVTFKFLPGQVFTGKVETVLQAVST
GQTQVSGLAVTPKQVASAPFVVRIALDDPSLAASLPAGSTGDAAIFTDHAKATHVIRRVM
LRMSAIMNYVNPY
>fig|582899.7.peg.3321 Drug resistance transporter Bcr/CflA subfamily
MAQLERGDTAPSPADSPQALHNLSFVEFVVLTAAMMALTAISIDIMLPALPEIGEALGVA
SANDRQLVVILYMVGFAAGQLFFGPLSDHIGRKPALMAGLAIFIVGTIAALVSNGFSMLL
AARFVQGIGAASPRVIAIAVVRDLYGGRQMARVMSFAMMVFIVIPVLAPSIGQALIHLGN
WHWTFYALLAMAILIAVWAGFRLPETAAPALGLERAMTLRASLKAAIFDPQTMAYGAAGG
FMFGCLLAYVASSQQVFVEVFGIGEAFPVVFGAIASVMALASFVNAQLVGRLGMRRLSHA
SLLGFVGLSLCLAGAAAAGIAGIAVYAILLAGAFFLFGLIAPNFNAIAMEPQGHNAGMAS
SVTGSLSTAIGAMAGGLVAHAFDGTVFPIAAGFVACSLIATLIVFAVEGKRSFFGRNRLA
>fig|583345.3.peg.1946 Permease of the drug/metabolite transporter (DMT) superfamily
MRLHMSRQSLWIVLALFCTYFIWGSTYLAIRFGIESFPPFLMGGIRFTVAGAILFVVMRY
LGAAMPAGREWLGAGTVGLLLPALGNGTVCYVQQTISSSVAALSIATAPIWMAVFSSIWG
HKITLREWLGIAIGLVGIVLLNLGGSFEGDFTSALLLIFAAASWSFGSVWGKHLAMPEGL
MGAACQMLVGGLALLLASAYAGESWPQEVSHKSWGALLFLIVLGSLIAYSAYQYLLKTVR
PLVASSNTFVNPIVAFAVGIWWAGEHVTMVEMAALGVILVGVFLVLSVTNNKDI
>fig|583355.3.peg.33 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDGETNPSMLPGVIGWNEIITTDHAASVAFYTELFGWTSEDMPLPDGATYTIFKQGDRM
IAGCVEPAEAGVPTMWMQYINTDDLDASVERVVELGGQVLKPRMDLPMGSFAVVADPQGA
SFAFWQNSPDVAC
>fig|583355.3.peg.98 Modulator of drug activity B
MQHALIINAHQRYEGFAEGKLNHYFASIIQEVLEAASYSVQVSQLEQGYDLEQSIAQHEW
ADLIILQTPAYWFGTPWIHKRYIDEVFTTAMSQNRLAKDDGRTRSDSSQQYGSGGLLQGK
RFMISSTWNAPADAFNDPDQALLQGRSVDDVFYPVMASYRFCGATILPTFASHDVYKAPD
IQADAERLKKQLRSIIST
>fig|583355.3.peg.166 Multiple antibiotic resistance protein
MLATCLIAGNQIMHFFGLSLEGIRIAGGILITTYGFAQLNPNPERHHSPAEHEEAMSKRD
ISFTPLAMPLLAGPGAIASTVSIASTIPREHVLLAYLSSLLGIALTCVLCTLILSQSSKL
MRYLGVNGANALTRLMGFILLCIGVQLVIDGVLGLR
>fig|583355.3.peg.636 Membrane fusion component of tripartite multidrug resistance system
MIYAGVATAIFKIFKIPLNKWTVPTAILGGFVFLFFLLYWMNFNHPYAKYAKEVYVSVPI
TPAVKGIVVDVPIEPNVEVEAGTVLFQIDQTPYRNEITRLEAALEDAKQADIEADAAVRV
AEAVLKEAEAERDNAKLSYERYSESAGVSEIEKENRYQTSLAAEAMYIARQAELNQTKLA
AAANVQGLDTTVAQIQAQLETARYNLDQTTVRAPSKGMVTQLALRKGTYATPLPLKPALV
FVPTERRRVVASFWQNSLRVLEEGADAEVAFDAVPGKIFTGKLVEILPYVPEADFQFGGS
LVSSEYIKSHDRVAAIIELDEDLNDYHLPIGLQAKAAILNHSDKLHSSPVRRILLRMMSW
LNYLYPIKK
>fig|584708.3.peg.322 Permease of the drug/metabolite transporter (DMT) superfamily
MNPSSRRAVLAADLSLFLVAVVWGAGFPFCAHLLEVLSPLWMVALRLSLSALFLLVLFRR
RVREADREAWRGSLALGALMTGVFVLLALGLAASSPGKQAFISGTYVVQVPFLLWLLYRR
RPSLFAFGGALVVSLGLGIMAFTPGMRFVAGDLYNAVLALGCACQVLAIGWLARRIDPLT
LTTLHLAFAALFLTVLALLLEPLPSLALGAVAWGELLFVSLGGTVVAFLVQCTAQRFTPE
SHAAVIMSLESPFGYLIAVWLGLDPWSPRAVLGGLLILGGVLLTEWETFLRREAEAA
>fig|584708.3.peg.393 Permease of the drug/metabolite transporter (DMT) superfamily
MRSAETANLFRGRACALGAVLFWGVSFVAAKAALRELPPGLLVWVRCTLGAGVFTLAALL
RGSELRIPRDQRLYLAVLGVMGIPFHLMIQSVGLLTVSASATAWILAVSPALVALLGWAF
LGERLGAKGAGGIALAMTGVFLVAGGGKGPLGYTLGDGLVLLSALNWAAFCVASRRGLKV
LSPAQMGWAIMVLGWIASFPLLALPGCDLTVLARLSPAGWGAALFLGVGCSGLAYALWYD
ALLVLPVAQAGAFQYLQPLVAVLTGWFLLGETPTWPLLAGGGAILAGVSILSRSGRH
>fig|584708.3.peg.563 Acriflavin resistance protein
MNRILRRNILAGLTALLLLVPAGSLGASETPADLSLEEALSLGLETNLEVARAKEELDKA
EGLLTQARSALLPALSAVGSATGRNEDSSKPEREGTGSLALSQTLYAGGVIRAGEQQALL
NRQKAQESLEETRETVALKVYEAFCGVLLRGENLKTAEDALGYYDKATKDLRKRLELGLS
TRLDLSRMEQQRENARVDVITAANNLSAARIVLFTLLRLPPEAPTVVSGDLTVTAVSVDA
PSLAAQALNRRPDLLALRTAAAIQKQAVDIAKAGMRPTVTLTGSYQFVYDSNPSSNTKDD
DWIATLNVSVPLFDGGKTRGKVTQESAVLRQTEQSVSQKEDAVRAEVVDAGLTLNSAAEA
VTSARKNLDLARESLRLAEVGYREGVDTQLDVLAARTSVTEARQKLSGAQRDHRVALARL
WRSQGILVDQALKAR
>fig|584708.3.peg.823 Drug resistance transporter EmrB/QacA subfamily
MAFGAFMASLDGSIVNVSLPTIARVFRLGSGEAASVILSYLLSLSGCLLIFGRLGDVAGK
RRVFLWGQGVFLLGSLACGLAPGLASLVAARFFQGVGGAMLTVSSYALISQVAPRDLLGW
GIGILTTAVGLGATLGAPLGGFLTDWFSWRWVFYINLPVGAVSLYASHAYLQREGADRSP
LDLRGLLRRFDVPGALFSFLGILLLVFGLNRGREEGWTSPLILGSLLGAGIALGLFALAE
RRHPEPLLDRELLGRRGFRVPVLGSLPGYLFIGGNTLLLPFFLQGAKGLSAQGCGFAMLL
FSGVYMLLSGVGGRTSDRISPRILCAVSQVGAAGCCVLFASTLHVPGLLFPLLFLVGLGV
ANGFFYPPMGNLVLGGVPPEMRGSASGIFSVANRVCLTLGVCLYEALFSQWAPGGIEAPA
SALAGFRAAYLVAAALFVVGALWILLVPGKDALASTSPPSP
>fig|584708.3.peg.855 Permease of the drug/metabolite transporter (DMT) superfamily
MPIQPNPRPWQVLAADLALLVVAAVWGAGYPVSALAIRSITPLWLLGIRFAIAGTAMVVL
FRRHLRGFDWRGAIPVYALSLVMALSYLLHIYALTLSTAAKQSFIAGTSVAMVPFVSAAF
HRCWPSRVALAGSLVTSLGLSVLAFTPGMAFNGGDVLSLLMAVTIALHVVLCAACIRKHD
ALAVATIQILCGGMVFLLGAVLLEPLPDFRFTPGLWRSILFLALLATVFPFGVQCVALRY
THEVHAGILLALESPFGYGVAILMGQERLRGQGLVAGAILLAGVLLAESELWRGPSRERT
EPEEAEEAAEEAG
>fig|584708.3.peg.1260 Probable efflux protein (fosmidomycin resistance)
MVLSGLHFINDLHASFLPTFLPLLIRNLSLTLGEAGTLNALFGGIHLIAQPLAGLWADRS
ARSLLVFWGPVLTLWGACLIPLAPTLPLAFLIVGIFSLGTAAFHPQGHGLVGAVVPGNEL
GGALAIFAAAGTLGAALSPLYAVALWDTPGHLGLVGVSAGALLIPLLCRGIFPRRTPGAG
SQLPPFKQFLHVGRLVAPILALTIARDATSQGIRVFLPLWVTLRGGTLAQGGTLLFAYTL
GGMAGGMVAGRLSDRLGTRPFLTGSFALAPALLLGGLVTQGGISWLLLVLGGAVLSSSSP
VTTALAQKTTPESRSTASSLAMGVSWGLANWVTSPLGLLADAWGLNQALICIALTPWAFL
ALNPLVSRVSRGAPR
>fig|584708.3.peg.1569 Transporter, drug:H+ antiporter-1 (12 spanner) (DHA1) family
MKETWRMVATLGLGYFALFGVSNVYYLLPQYLSHAGVGSSQQVGWIVGAFYMATTFSRPF
GGGLVRRMGFRRLFRWGGLLGIAGALGFALVGSYTPGLLLFRVILGVSQTLFVVGFTTYQ
GLVIPESSRGVAFSAISAGGILPLMTLVPLGDLFLQRGYDVAYLLVPLAAALGVFYLGER
LPEQSLRGRGREGSLVGVLRNPSLRLLCLSSFCFSLGDACLVVLASLAQSRGVLVSAFFM
ANASVAAGIRLFGARLLDRLPRRHLAAPAMAGLALALFGCTWATGNGAMAFWGGVFGVAM
GWGFPLHMALIADLATPEERPHASAMVWFAMGGSFALVPVLMGYGVDWLGAEGSFRGFAG
FLLLLSLGLGVLWERDLRRHPGRPVPTGS
>fig|584708.3.peg.1814 Ribosome protection-type tetracycline resistance related proteins, group 2
MSGPTLRNLGILAHVDAGKTTLTERLLHASGALRIPGSVDAGTACTDDLEVERRRGISVR
ASLASFEWRGHRFNLVDTPGHGDFAGEVERTLSVLDGAVLVVSAAEGVQAQTEVLWEALA
ALGLPTLFFLNKVDRVGADLPGVLGQIRRLLTPRAVPLQTLAGAGTDRLLLRDLSDPGDP
EAAAGLFEALADLDEDLMEAYLEGRTLPPEELLRRAEPHARKGRLFPLLFGAALDGLGVE
LLLDGLVRFLPPAGGDPEAPTSARAFKVVHDPALGRGVYVRVHRGTLRTRDALPLPGREE
PGKVTRIRRAGAGRWEDVSSLEAGDLGLVFGLGEARAGDALGDPEGLPCGVPLAEPLFSV
RAVPPTPEDAPRLLAALRVLSDEDPHLGLVLDRERQEMHLRILGPLQVEILTALLSDRFG
LAATFEKPATLYKETLQEAAEGYVEYTLPKPCWAVLRFLVEPGERGSGVVYRSRVSTDDV
KLKYQREVERTLPAALEQGLLGWEVTDLRITLLEGEDHEVHSRPTDFAIATPMGIFDALQ
KGGTRLLEPVLRFALAAPEEAAGAVLGDLLRMRGTFDAPRVEEGVFRVEGTLPAEPCGDY
AVRLGSLTGGRGRFSTRFAGYRDCPEEIRAEAPRRSVSPLDRARYILAARGALG
>fig|584708.3.peg.1958 Glyoxalase/bleomycin resistance protein/dioxygenase
MGETPRYGGSVLLVGDLEASRRFYEGLFGMKVVTDYGPCVGFEGGLSLWLREAALALTGE
GPVPRGGRDLELYFETPELDAFAERLRTAGVRWVQGVHEAPWGQRSLRVEDPEGNLVEVA
EPLETLVRRLAEGGMGAEAIAERTSMALEDVRRML
>fig|584708.3.peg.2113 Permeases of the drug/metabolite transporter (DMT) superfamily
MTEGHRSLIRIHLAVLLFGFSGLFARLIHLPAWTITWGRVTFASLSLMVLFLLRGESLRM
RTPRQTALALGAGVVLAGHWSAFFQSIQTSTVAVGTLTFATFPLFAAFLEPLIFRERLRL
RDLTTASVLILGVAILVPRADLGDAMTRGILWGMLGSLSFAVLSLMNRSLVRDNRGTLVA
FYEQGAAALVLTPLVLLRRDPLPLPDLALLALVGVVFTAGAHSLFIGGMRKVTARAAGVI
SGLEPVYAILGALVLLGETPSLRECLGGAVVLAAAAASSLRSARESGGSPSPAVSATLSP
PWRLPTPPQGSPSPAVSATLSPNDPKEGSP
>fig|584708.3.peg.2136 Permease of the drug/metabolite transporter (DMT) superfamily
MTLAIILATLVLNVLANSFVKMGMTGFAGGVGGGMVMYMIRSPYMVLGVGCYGLAFVTYS
ALLTRMDLSVAYPLMTGCIAVTLAAVAVACFGESLTLWQMLGIFLVVAGIWLLAR
>fig|584708.3.peg.2260 Permease of the drug/metabolite transporter (DMT) superfamily
MGTETRPSRLLLLAAYGAIYGVWGSTYLAIRFTVRTLPPFLTGGIRFFLAGLLLYALVRP
RTEAPTPRGWLQAHRIGFLAFFLSYGAITWTMVRVPSGVVALIVALEPLCFLLTDWFCFQ
GPRPVRMELWGLALGFGGTVLLLAGDPNVSFHGTGGVYLLGALAVLATSFAWVYGSLLTR
TAPVHPDGVLAAAMQMIAGGSQLLLLGTLWGDWKHLGEASLLSVLSLAYLVVFGSLVAYT
AFTWLLKVEPVSRVATHAFVNPVVAVFLGWLFGGERVGPETLVAGGLIVGAVVLTLWARK
PEL
>fig|584708.3.peg.2396 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRHPDGHAPDSLRELQTQPIPRLLLRFALPALAGMLAQGLYNVVDRIYVGNLVGPSALAA
LSVCFPLTLGMLAFGMTLGVGAASRISLALGEGRVEAARETFRQTLLLAGGGSLGITLLT
ALGLDPLLRLCGAGRELLPLARTYLEILLWGVPFWILASCLNYVIRACGAPRYAMSVLLL
GAGCNVVLDGVLMLGFSLGVRGAAWATAVSQVLSALWGLRFFLRDRGGLGFPRLAGGLRR
QEVGAILRVGTSQGVVELSFMVFSVIFNRALRVHGGDEAIAALGVVLGWAAFLYMPAMSL
SEAAMPLVGYNYGAGRPDRVRTTLKYALGMSCAFFTLVTLGVALFMDPMIRLFVWDAPRT
NPRFLELTRQCMVSFNVTIVFTGTAIVTTGFLQALGRGGLSLLFTLVRELLVPVPLILLL
PRLYGLTGIWITYPALDLLVFALACALLLREDRRLARREPVWEGVAPEAASGAKRPRSGS
PLPQGRSCR
>fig|584708.3.peg.2412 Glyoxalase/bleomycin resistance protein/dioxygenase
MRASDDSPILGPLRLGVASVERSRDFYRAALGLETREVPGGAELFLPSGNLLATLEERPG
AVPESPAVPGLYHLALRVPHRPALARTFLRLKEARLPTDGPVDHGVSEAIYTEDPDETGI
EIYRDRSRETWPTRGGHLAMGSRLAPPQDLLGALAEEMEGPGSTPEMTLGHLHLRVSNLK
RSVDFYSSLLPLKVTQEDLPGAAFLAFGDYHHHLGLNVWSSQGGKPRDPQRSGLIELSFL
FPVPSAFQSWKDRLLSQGCPELLSVAPNESWLLVRDPDGWDVRIRQAS
>fig|585506.3.peg.1871 Multidrug resistance protein B
MNEEKVSSRVIWSIVAAAILGFSGILTETSMNVTFPELIQQFHQSMGTVQWLTTAYLLVV
ALLMLTSAHFNAILSKRQTYMIGWIAFVVGDIIAIIAPSFWLLLFGRLIMAVGTGFALPL
AFNVIFTSVPMSQLGKYMGFGTLIISLAPALGPVYGGVVTYTLGWRAIFMIILPVTIISL
LIGWFNLDNQKPTSKNKFAYGQFILIGISLVSAILALGQLESGRLTAAIIILALVAIVAM
IGFIQAAKRSTNQLIDVSVFRSKALVMALLIYATSQAINLAVNFALPQYSQLTLGTTTMV
AGFILMPGSLLGSAVAPVYGSMYDRLGANKPLTWGSLGFLVVMIIFSVMAPNIATIGLTV
VYVVFTLARNLTFSVAMTAGVAEVKPQQSGDVNAIFNTVQQFIGAVGTTVAALFIQTSGT
TKAAIATQTATGFSHLIWFSTVIVAISLIWLVIYMKTKTAK
>fig|589865.4.peg.53 Permease of the drug/metabolite transporter (DMT) superfamily
MISEQRKGELYLLAEEFLWGWFPIVTLLTYPYLAPLWSMGLTLAVAAVFFGLLMSKRLGS
NLWRELGNRRAWKDLAWSSFYIMLLFVLLFTGLAHTTAGNAALILFLQVFFAFLYFNLLQ
GEKMSPPHLAGAALMSLGAFLVLFPGEAGLNKGDLLVLLAAMVAPIGNRYQQRARRHVHA
TTLLFVRTVTSLPVVLLLAWAYANPPALADLQATWWLVALNGVFLMGLSKIYWIEALHRL
SVTKISAMTALSPLFTMLFAFFILQEVPGGWQVAGILPILTGGMLITRPLDPGEAVRGCR
PGR
>fig|589865.4.peg.600 Acriflavin resistance protein
MKPGVLDKLHSRPRITLAAVVLVALIGMLAGSQMPRQEDPTLRDYWGQILVEFPGADAET
VERLVTDVYEQYLQEVEQVSRLYSTSRAELAVLNLELADGTRDIEQAWDDVRLALERAEP
RLPSGVARPQLNRDLNEQDSVVLAVAGDNDLLVLRQAARQLQRRLLQLPEVGKVHLVGDP
GEQITITWDEEAVRRLGLDGRQLAALLAARNRVQGGGDLAVADSRLMLRPLSEFQSVAEI
KQTPLLLPSGGTLPLAELAEVRHGPARPAETLMRLDGRPVVGLGVVPVSGGNIMAFGEAV
RELVAAGAPEFAPLEIREMAFQPDWVRLRLSQLATSLLLGIVIVATVLIIALGRRPGLVV
AAVVPMVTLTALGIYALGGGVLHQISIAALVIALGMLVDNAIVVTENIQTRLDEGKPPAL
AMRSAVREVAAPLAAATGTTLAAFTPMLIAQGPTADFTRSIPLVIILTLGLSYLFAILVT
PLLCYYFLRPRAVAGGAGRQWRRLADGLGRVAVSRPRPVLAGAALLILVMIVLTPWVARQ
FFPESDRNQFTVVIKLPEGSRLEATSAAAGRLERELLALPEVAAVATFVGRSAPPFYYNL
PRIPRSPNLAQLAVTAAAPGSPDQLVAWTREWARQQLPGTEVVVRKLEQGPPVIAPIEIR
LFGTAPVEVTRRLDTANGPGRPGAYGQPALAELENAALQVMAQLNQIPGVRDLRHELSTG
APTKVFAVDDAAAARHGLSREDVALSLYGLSRGIAAGQFRGGDEPVPILVRSPEGEDYPA
ADLENILLLTERSGRPVPVPLSLVATAELQWRPAAIERQDRRRVAKVLAQLADGTTYSQV
LDELRPRLEKLTLPEGVYWELGGDLEGTGEANAAMAAAAPLGLLLLLAILLLQFNSFRKV
GIVLVTVPLAAAGVVPGLLLGGQPFGFMSLLGTIALVGVVVNNAIVLLAVAEQRQAAGLP
TAAALQVAVSRRARPILLTTATTIAGMLPLAFSPSSLWPPLAWALISGLAASTMLTLLVV
PALYLLLCKR
>fig|589865.4.peg.638 Outer membrane component of tripartite multidrug resistance system
MFRYSLMLFAILLAGCSLGPEYHRPEVAAPVEYRYAEGYEEIWQQGEPADELPKGQWWRI
YQDPALNELQERAAANNQQLRAAVARLDQARAVAGLSRADLFPRLDLQPSAQRGRTADDL
SPLGEGQTTTTINLPLDLGYELDIRGRLRRLNEAAAAEVDASAAEMESFRLTLHSEVART
YFTLLTLDRETALLEKTAQLRRQNQRLISSRYQHGLSDKLDLSRAETELAAAEAEVIMLR
QRRSEVEHALALLLGEPASNFAHAANEAEEFQVPEVKPGLPAELLQRRPDVAAAERRLMA
ANARIGAAKAAFFPSIRLTGAAGFGSNELSSLLASGNRFWNFGPQISLPIFDGGRNRAQL
EQARAAHEEALADYQQTLLQAMQEVEDALATLALLHQQQQAQQRALRHARETVGLAHQRY
RAGLVSYLEIIESERSALTQERAALQTSNQQLQANIALIKALGGGWDSVQN
>fig|589865.4.peg.1273 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPKPEPSISLAAGLTELRQLWRLSLPLILAQLSHMAMGFVDTVMAGRVSPADLAAVAIGS
SVWFPVMLFVAGVLMAITPIVAQLYGAANHDRIPTSLRQGLWMALVLGLGGFLLLGNMEW
LLKLLDLEPEVRRLAAGYLSAVAWGFPALALYQALRSFSEGVSLTRPIMLIGFLGLACNI
PANYIFIYGKLGLPPMGGVGCGWATALVMWVMMLALAGLILYGRGYRFLPPLFAWERPDF
KKIVHMLRLGFPIGISFFIETSLFAAIALLVASLGAVVVAGHQVALNFTSLLFMVPLSFS
QAITIRVGQAIGRREPAKARFAALCGALTTLTTAVLFATAILLWAPAIATLYTPDLEVRQ
VAANLLFFAALFQISDAIQVSAAGALRGYKDTRVPMFITFFAFWFVGLPLGYLLGLSEPV
GLHLGAQGFWIGLVAGLTTAAILQSARLWHVSHPRNRP
>fig|589865.4.peg.1646 Acriflavin resistance protein
MNNQIQWMAHNHVAATLLLLFFAVGGLVFAFNVKQEVFPEISLDRVNITVSYPGASPEEV
EEGIILQIEESIAGIDGIKEMRATAAEGIGTVTAVVDTGADVDQVLQDIKNEVDRITTFP
EDAEQPVVSKALIRNEVISVVVYGPTTERALRERAEMIRDDLLEMPEITQVELAGVRPYE
ISIEIEEEMLRRHHLTLEQVAAAVRRASQDTPGGVLKTEGGEILLRTKERRYTGPEHEEI
VIRAGADGALLRLGEVATIRDGFEDIDLISRFNGQPAAMVEVYRVGEQRPIEISELVRRY
VERQQPAVAGTVIDLALWNDNSEVLQSRFQLLLKNAAIGLLLVLLILSLFLEIKLALWIM
LGLPVSFLGALLFLPSFDVSINMMSLFAFIMALGIVVDNSVVVGESIHEHRSRGKERLRA
AVEGTREVAVPVVFSVLTTVAAFLPLVYITGTMGKFIRAIPFVVISILMVSLVISLFCLP
ALLGRRDHASPPGPGLIGRLKGLHRQADALLQRLINGPYRRTLEFCLTYRGLTLAAALAL
LMLAGGLVGGGLVQFRFMPEVEGDIIRVELEMPQGTLVEETARVEAFIVEQGQRTIAEFD
ARRDDGSTILRHLYSVIGGTAANEGPGGGGGDSGTHLATTTLFLQPAEKRGLPASEVSAR
WRELVGEIPGVRSLTFTTNLVRFGDHIDVQLSHHDFTTLLAARDRLQADLANYPGVYDIA
DNFPEGKRELTLRLKPEARSLGVTEEDLGRQVRSAFFGAEALRLQRGRNEVKVMVRYPEV
QRRSLSDLEAMTIRTPDGGDIPLLQAAEVIDGRGYAAISRSDRKRAINVTASVDDRLANA
EEVLAALRQGPLARLVADFPGLSYDLEGEEKERRESMGSMGQGFILALFAIYALLAVPLR
SFAQPVLIMMAIPFGIVGALLGHLLLGFNLSILSMFGIVALSGVVVNNSLLLIDRINRNR
RRQETRVDGPGELDGLAKTAATREAVIDAGCRRFRPILLTSLTTFGGLFPMILETSVQAQ
FLIPMAISLGFGVLFSTFITLVLVPTLYLVLDGTRLPSQ
>fig|589865.4.peg.1809 Methicillin resistance protein
MSETDSEWDVFLAACPLSHHEQSSQYAANRKAYGYHCDRVVVRENGDIVGGVQVLVQSTP
VGRFAHIQRGPLALDDNPLLMRRVVDKLEELVRERSYASVRVDLFPNQAVAAQALKEAGF
RPSKAWGRAGDSVIVPLTLSDDELMGKMDKKVSYNIRRSRRKGLSVQAEDEKSMDAFYGL
HQETASYQDFPVFSAEYFSYVQELFGRAGKAQLFVAWHNEKPCAAIYNTIVGDHMYYGWG
GMRRDPEAKTLRANYLLHMTAMAWAREHGCRLYDFVGNQPFKRWFAIEVISWPLPLRKFY
GPAQILRWKLLEGTDSSPLLRRLINKASRKFGIAQTMPW
>fig|590409.4.peg.3026 Probable multidrug resistance protein
MPGMTQWIISGFVLCLSLSQLFFGPLVDRVGAQRVLLGGCVVYALSALGVYLTSTISGFI
ALRLVQGCGAGAMAVAASASVPLRFQGAAIGKVFSLLNGVISLVPVLAPVIGGVLIVHYG
WRSSFYALGLFALLCGMLVLWKPLPAVCCGTSEGKGRLSSAAPLNVFSGYLTVFRHPEFR
LGCFAASFGFATQLIFFSSSPIVLIETLHIPVDQFGYYFAVNALAITTGSLLTARLLGRV
KETVILHGGAVLILLAMAGFILTMHVLTVSVWPYLISATLGSLGFAVLIATGASIALSPF
KSLAGQASALMAAIQMSFSSLVAWGVMNHWRDDWSPMIAAYFLLAVALLVQLQAHRLTRI
RRHQPEPAVFEKSSPNSD
>fig|590998.5.peg.57 Glyoxalase/bleomycin resistance protein/dioxygenase
MRQDETFDGGWRRVVVGPPDGGTGLVLALAPDDAPVGRQAGADVAFFLETDDFAAQHERM
VRHGVRFREEPRREPYGTVAVFEDPYGGAWDLIEPPSA
>fig|590998.5.peg.141 Glyoxalase/bleomycin resistance protein/dioxygenase
MPDVRPVIRQVVLDTTDARGLAEFYRELFGLEYRHGDEPPPAGEPDPNGADWLVLRGDVP
LAFQQVDALPASTWPDPGVPQQLHLDCTVPDKATLDAQHERALALGARLLHDRSDDPEEP
LRVYADPSGHPFCLFVG
>fig|590998.5.peg.273 Glyoxalase/bleomycin resistance protein/dioxygenase
MPTITGPDFVALQVRDVDAAAHFYETRLGLRRAPTSPPHAVVFATTPIAFAVRAPLPGTD
LASISPHPGAGVALWLRADDAQALHDELVAAGVVILTPPVDGPFGRTFTFADPDGYAVTI
HDRG
>fig|590998.5.peg.562 Glyoxalase/bleomycin resistance protein/dioxygenase
MHVRVHRAFLPHLDPAASLALYRDVLGLEVREDVGSGSLRWLTFAPAAPSDEASGSGGAA
LVLGPPIASHGVTQAEHRTVRELMAKGVYATVSLATGDLAGAFARVEACDVVDLLQEPAR
RPFGGVDFAFLDPAGNVVRVVEAP
>fig|590998.5.peg.1906 Glyoxalase/bleomycin resistance protein/dioxygenase
MMLSDFDAIPVLAVTDLQRARDWYEGTLGFTSQGDAVEGVMYSTRTGGFLVYPSGFAGTN
QATAISFQVPADRFDAEVADLRDRGVELQTFDVPEGTWQDGVLVSGDMKAAWFADPDGNI
LNVETGM
>fig|590998.5.peg.2309 Glyoxalase/bleomycin resistance protein/dioxygenase
MASTNSTLHPNLSVSGAREAIDFYVRALGAEVVSVIESGGIVVHSDLRLGGSTFTVAEPF
PEMGSTAPDPEQPVPASFTLEVADCDAAFARAVEAGARAVSEPTDEFHGGRIAQLRDPFG
HRWFLNQHLEDVAPEELQRRVDAWTAAQAPA
>fig|590998.5.peg.3424 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTARRPRGTLHHLELWCPDLAAAEADWDWLLRAIGCVPRDRWPAGRSWTTPDGSYVVLE
SGPDVVGTAHERRRPGLNHVAFVAGTRAELDRLVDAAPAHGWTLLFPDRHPYAGGPGHYA
AYLEDARGFEVELVAADGA
>fig|590998.5.peg.3434 Glyoxalase/bleomycin resistance protein/dioxygenase
MAHGDITHIDIPADDLGRATAFYRAVFGWDAQEMPGFEGYPMWQAPNKISGGGFGPRDDK
LRIPRSYVEVDSIDDALATVVAQGGRVVMEKSEISPTSWWAVFEDTEGNELGLYESDTHA
EPQG
>fig|590998.5.peg.3573 Glyoxalase/bleomycin resistance protein/dioxygenase
MTIATTPHLNFRGDARAALDLYAAAFGGTTTVVTYADAHAVTDAAEADQVMWGQVVSPDG
FRVMAYDVPSHTAYEPGVIPVFVSVRGADADELTRYWERLVDGATVVVPLGPAAWAPLYG
MLRDRFGVTWVLDVAVPWDAA
>fig|590998.5.peg.3697 Glyoxalase/bleomycin resistance protein/dioxygenase
MAVTLNPYLNFRTGTREAMEFYQSVLGGELNVSTFADYGMAQDPADADKVMHSQLTTPDG
LTLMAADVPAHMDLAPASSISVSLSGDDEAKLRGFYDALAAGGTVLEPLTVAPWGDSFGM
VVDKFGTTWLVNIAGTPAA
>fig|591001.3.peg.66 Transporter, drug/metabolite exporter family
MERRKKIGVGMVLLGATLWGSSSNSVEYLMVDQHFTWSAILFWRMVFTGISFLGISRFQK
QDLLAPLKQDGKWMMKFILLGLYLMQVTFFKAIYYSNAATATVLQYTMPAILLLMYLVKD
WRLPTRREVVAVVLALLGTALIATKGQGAALAVSGEALFYGILGAFGMAFYTAYAAVLLK
KYSCFLILGWGSLGNALLLQLFHHPTLEGAVLDIHTAAAFGILFVLGTLVAYYVYLESTK
YIPPAETGALAAFEPLSAYFFSVVVMGNRVGPVELVGALCIIVMVCVLTRND
>fig|591001.3.peg.68 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTRTTTKDMTSGNIPRLILEFALPLMIGNVFQMLYNTVDSIVVGNFVGTQALAAVSSTTM
ITNMSVFFFNGFSIGATVIIGKCFGAKDHGLLHRAVETTMAATFLLCVLFTVFFFTGTDF
MLHFMKTPADVFDQAALYLRIYFAGVTGLLLYNMGSGVLRAVGDTKRPLYFLILTSVLNI
FLDLLFVLVFHWGIAGVAYATIIAQFISAGATLAVLLRTRDVYRFSFRDLCLDGNLLGQI
FRVGLPTAIQSIITSFSNIFVQSYINFFGATVMAGWGCYNKLDQFIMLPVLSMAMAATTF
VAQNIGARQEERANDGTVSSIVLSLAITGTIAALLFIFADFSLRLFTGDEAVIRSGVDFI
HVNIFFMMFNCVNQVLAGALRGRGDSMGPMVIMLLSFVLVRQIYLYIMTRYISNTPLTVG
FGYPVGWATCCVLEVLYFWLYWKHKEG
>fig|591001.3.peg.758 Tetracycline resistance leader peptide
MFSMELEHLARNAEYGIPMTVEMEKEAETMCDYGRGLARKYAEKGRAEGLEKGLEKGIQQ
ERNSNILGMLREKIPMETIARITKVSVEQIRELGKLNGML
>fig|591001.3.peg.849 Permease of the drug/metabolite transporter (DMT) superfamily
METALKFFGGMFHPIQITFLRFLIGGLVLMPMAFSALKKKNVQLNGQDLKFFLFSGFLGV
VVSMILYQMAIVYGKASVNGVIFSCNPVFVVLFAYFLLGEPIDKLTIFSLMASFAGIVCI
VNPVNMTGSQLSIILILLSAMTFALYGIAGRKHAQRYGGIAMTSLSFLCGSLEMLVLIGI
STFAPVRDLMLSLGLKVFTDIPILGGLTAAHIPPLAYIAVGVTGLGYASYFLAMEYTDPA
TASLAFYIKPILTAFMAWLVIDEPITVNMIVGIALILFGSCLSIISKRKKAA
>fig|591001.3.peg.1060 Permease of the drug/metabolite transporter (DMT) superfamily
MTKNQKAIFCMLLAGVLFSLTEVAMKKINADLNGVQVNATRYFLCGVFLMPWSRARLKAT
DTHIHAAQMKLCALLAFSGITIVGPLYQMASATLGAGNTGVIFSSTPLFIIMLAALLLHT
PVTRREGIALALQVLAIAILVDPFHMTMEPVGVAALLVCVVCYSLYAVGGKKLITDLGSI
TVTAWSFFWGGVQLLLVAGLSHIPAVSQWLMAHGFANYACVPLFTGYTWENLPWVLVLYI
GITLVAFLSWFLAIEWGGVALGSLTYFIKPALSPLFALIFAGEPITTKMMIGMVLMIGGA
FVALKR
>fig|591001.3.peg.1239 Permease of the drug/metabolite transporter (DMT) superfamily
MLQQIPALWVLFIRYALSSVILLAAGYHTLQGRIAIARKDWGELFFVGVVGYFLSNAALF
LGIQYSSASFASLINSLTPVVISGLAIILLGEKVTKLQGLSLLVAVAGAGIIIGRPTQGV
TTAGMVICVFALFSWAYATIHLKKLTARYDPLLVTGYGMAIAALLSLPSAWVFVRATGAA
VSFTGTVWMPLLYTCLVCTALAHLLWNELLQKLPATYCASFYPLQPLTSMVLGVLLLGET
MTPSLITGALCIVAAMVLNTLAARRTRNRS
>fig|591001.3.peg.1295 Tetracycline resistance leader peptide
MPDNDLLFPVKFLNIQIRSLQYQSFEKTIDLRLEGKSIRLKEGSWKAWIRKSILSKVWIK
>fig|591001.3.peg.1322 Permease of the drug/metabolite transporter (DMT) superfamily
MCEKGNTMDQMKGNLLLLLTALIWGSAFVAQSVGMDYVGPFTFNAARNLLATGVLVPVVL
AFGGVRQGSLWQRLRPDAVTVKAGLCCGVIMGVASNLQQVGIAQTTAGKAGFITALYIIL
VPILGRFLGRTVRKILLLCVPMALVGFYLLCVTGDFTISFGDFLVFLCAVFFALHILCVD
HFLLKGASGVRVAWIQFAMTFLVSLLGALVWETLPAAGLGPALWAARWPLLYTAGLSSGV
AYTLQIVGQKYTDPTTATLIMSLESVFAVLAGWLFLGEVMTLREIIGCGLVFAAVLLAQR
>fig|591001.3.peg.1405 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQKDMTRGPIVPIILHFLFPMFVGNVFQQLYNMADMIIVGRYVGAGALAAVGSTGTLMFL
VLGFALGITAGFGILTSQRFGAKDEAGVRRSVANGTLLALLLSAAMTLLSTAAVPWLLDL
LNTPADIMEDARAYITIIFQGLFTNVFYNMASVFLRSVGNSKAPLFFLVFSACLNVGLDL
LCIIQFHMGVAGAALATVVSQGISVLLCILYIVQKVPVLVPWREDWKLYAHETREQLRMG
VPMALQFSITASGIMIAQAAINLFGSTAAAAYTAASKVSMLLTQGCLSMGQTMATYAGQN
FGKGDLGRIREGVKKGLRMMALYSLLAAVVLHYLLPFLTGFFFSGDVDAAALLPWARTYG
DIAMWFYLPLSMIFIYRNAMQGVGYALAPTLCGVIELAARGLTALVGMKTHSYAISAACD
PMAWLAAGIFGWCAWQWVMRDLERRAKKGAAA
>fig|591001.3.peg.1707 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSETTLAGTGTFRSRLKKILGVMIPILITQLCITGMSLFDTVMSGHAGTVQLAGVAIGTN
VWMPVFTGLNGILQALTPIVANYRGAREYHKISGAVVSGLALACALALTVIGAGSQLLPR
ILDTMSLAPEVRTVAFRYLGFVAWGILPLFCASILRSFVDTLGYTQVTMRLFLLTMPVNA
AMNYIFIFGKLGAPALGGPGAGVGTAITCWLLCLSFSLLVLRLKVFRDFHVFRISGFSFS
HVREHLRIGIPMGLAIFLETSFFGVECLLVSRFGTIAVAANQAAMSFCNMLYMVPLSFSL
SLTIIVGAYVGARDFVQAKAYADTGRLSNILIGAFFGCVLFLGRGLIARLYTEDPNLMEP
IMHFLTFAVAFQFFDSTAAPIQGVLRGYKDVKATFYSALAAYWGIALPFGLFLDHGLHKG
PDGYWLGLITGIFFSAAFLSLRLRYMERKKRETV
>fig|591001.3.peg.2015 Tetracycline resistance leader peptide
MTVEMKEEAETMCGIGHAIARKNLEEGMQKGLQKGRLEGKQEGIALVQRELLLNLFSSGM
PVEQISAGTKVPVSYVRKLAEKAGK
>fig|591365.3.peg.126 Daunorubicin resistance ABC transporter ATPase subunit
MTDISISNLKKVFHGKVVLDIPQFTASKSEIISVLGVNGAGKSTFIKTISGLLLQDEGQV
NICGYSNFSPKIHQVTKFVLESGKGYYDYLTANQNIDYFLKLNKASRSDLALNIAVLFQK
LDFQQHADTLVSELSQGTRQKLSLIIALLCRPEVLCLDEPTNGLDVIAKKQLAQILLGLS
KGKNTIVLLTTHDISFARDISSRVLVMDNGRIKKDDSFEHVFSRKNTWKKYEIVLPLSFQ
NIIERSFQNLHYVIQDEEMIIQTQEKDVKDRLLKETDIVRFEEIEQDIEEILYEVLSK
>fig|591365.3.peg.241 Glyoxalase/bleomycin resistance protein/dioxygenase
MTRKEELTKKNQELLFLGYHHIAFRLGSREKVDELTTRHQEDGYQLLSRPRLTGDGYYES
CILALEGNQIELTV
>fig|59196.3.peg.220 Outer membrane component of tripartite multidrug resistance system
MLGSLSACLVGPDFETPQPPKVNHYTNPPWPCRTVSAPGQGGASQTFVQCKTFSAEWWRL
FHSPKMNKLICQGIAKSPNLMAAKATLREAQENLSAGIGNGLFPSVSAQLTAQRGSNIGF
FSPSTVASNAVTTSGISQAIFNLFNASVNASYLLDFFGGIRRQIQGLRSQVDYHYFELRA
AYLSLTSNIVTAAITVASLRRQMDVTQQLIKEEEKQLAIMKKQFGLGGVSKIEVLAQQTQ
LAQTRATFPPLKKNWEQARHLLAILVGAFPSQQGVIPRLDLKELHLPTTLPLSIPSALVR
QRPDIRAAEALWEAANAQVGVATANLYPQIALSGSWGKSNTVGGRIFSSGGQLWNIGGGL
FQPIFRGGALLAERRAAIAAYDAAAATYQEAVLKAFKNVADTLRAIEADARTLRVQKQAE
LAANAHLNLVKQQFYLGGVSYLSLLDAQRQYQQVRIRLIQAQASRYMDTAALFQALGGGW
WTSNCLF
>fig|59196.3.peg.960 Aminoglycoside/hydroxyurea antibiotic resistance kinase
MQLPKELIKNILSIYGPIGREWLDSLPHLLSQYAKKWQLIIKDCFNNASFNVVAEVILDN
GHSAILKCGVPSKEFINEVAALQHFSGRGSVKLLDAEVGVGVMLLERLIPGTLLEEIFDE
TQRIVASVELIQKLHRPCQETTQFPSLADWFQGFQRFYHYFQGETGPFPKSLIERADAIN
QELLASMESPVLLHGDLHYGNILLSDKYCWLAIDPKGVIGEREYEIPFPRLKDEVNEKLI
KRRLDQFIEISGFDRSRVLGWAFCKAALAAWWSFEDQGEICQSFLQCAEIISTF
>fig|592010.4.peg.1894 Vancomycin B-type resistance protein VanW
MRKKKLIIAVYSVLVVLIVATAGLAVTVSALSSKQEGVICEGISVNGIEMGGKTEEEAEK
LLSDYTNRVKSKELVVSVTENGEEQGSESISFKDLGVKVKSNNIVDEIVQIGEKGNIIDR
YKAIKSAKENKPEYNIEFKYDSKKVDQFIKSIAEKYDVVPENATLRREAGKFIVSGGKEG
RSLNQKEAFASAKAVVEGYLNELPGKIEDETNVELALETKKPKYDKEALSKVTDLLGSYT
TRYNPSGGRGQNVANGCRLINGSVVMPGETLSANNKMAPYTVQNGYGMGTAYVDGKVVPD
MGGGICQVSSTLYNAVLFSELGVVQRFNHSLTVDYVELARDAAIAGTWKDFVFKNTTAYP
VYVEGITNGGQITFNVYGHETRDMAHRKVELSSVVLSRGNGSKAQLYKLVYENGVLKDRI
LLNTSTYKPHEYEIEAAKKKAEEEKKKKEEEKKKKEEEKKKKEEEKKKKEEEKKKKAPAE
SEDPNIDDDLEEEIEG
>fig|592010.4.peg.2471 Multidrug resistance ABC transporter ATP-binding and permease protein
MYQSNEQRFSDFLKPYKASYIASVIMAIFSVFFGLAPYYILYNLLVGVLSEFTYKNIITG
SLFILIAFTLQLVCHSLSTAISHKTAFKILGQIRIAITNKMLRLPLGYIQMRGTGHFQHM
LIDGTERLEFPLAHAIPETTSNILIPIGIIGLLFTTNFYLGLAVLLPAVLTLLFYLPMYV
GIMNEFANFYYLSLERMNGRVIEYIRGNKEIKIFGQESRAYSKYEKSITDYKDSTLKLYY
KMYIVSAPAMVFLSSILISVLCVGGYLYAHKDISGQVFLFSALLSMGIGSSLLKFTEFMD
NFYHIRNGKNLINEILSAPELEEMDSENNILNNSIELHNISFAYEKENVLQDISLVIEEN
SKVAIVGPSGAGKTTIANLLARFWDVTKGSITIGGVNYKNLPLSYLTSKISYVTQDTFLF
NTSIMENIRLGNLSATDEEVKAAAAKAQCDDFIKELEQGYNTIVGNDGTKLSGGQRQRII
IARAILKNAPILILDEATAYTDMENQNKIQESLMSLCKNKTLIIIAHRLTTVTNCDKIVV
LDSGKLDSVGTHDELLRNSALYKKMWEIYLSEIPAIQEKEGE
>fig|592022.4.peg.433 Membrane component of multidrug resistance system
MTQTEEKMSKRSKLILFILILGNFLCLISETVMNVALPSIISDFHVRTSSAQWLTTGYML
VIGISVPVSAFLIQRFTLRQLFVTAMSFYLIGSFIGFITPWFSLLFVGRMIQALGTGIVL
PLVMSTMLTLVPVSKRGTVMGIFSVAILFAPAIGPVLSGLIIQYYSWQIIFLGLLIAAAL
IFLFALFKLSNVSETSRPTIHMPSVILSTIGFGGVVYGFSAAGEETGWSNPIVWLTLIIG
VIALALFVRQQSKLNSPMINMKPFRSSVFSRSIFLMFLIMMIQFSMMLILPLYFQTAAGL
SPLQTGFLMLPGGVTLALTAMVGGRLFDKIGFKPLLLTGLVLLTIILSLFTTISSGTSTT
TAAILYAAFTIGVGLSIGPVMTLALNQVPKPLHAHGSAISNTINQVSGAIGPALYTSIMT
MASQHFIQQSNETNKTLLQIKSMTSGVHTVYYVAIAFAVVSFLLALTLKKKDQQLETQ
>fig|592022.4.peg.997 Acriflavin resistance plasma membrane protein
MSWLTKWSFKNKAAITIMSILILALGVISYFTLPMEFLPTADQPQVSVVVMGQGTDADSM
EKQVTSPIEEAVAGVKGKSNVYSTTGDGYSKIDISFESKTDMKEAKTNVQEALSSVQLPA
SVSKPNVIQLNTSMIPIADISLTFKEGLTRDNLDLAEKKLIPKYKDVKGIASVQTYGTAD
SYVSIKVDNKKLSQKNVTIDKAISVLEGKNTSLAVGEKVINNKSSNINVTGKIDSLDKVK
KLPVAPNVTLGDLAKVEVKKPEGVVTHINGKDALLLIVTKDSHSNAVSITKEVKKLSQQI
NKDYNNVNASVFFATGDSVQNSVHSMMKEVLLGALFATIVIMLFLRSVRSTFITIVSIPL
SLCFTLFLLSKSGVTLNILTLGGVAVAIGRLVDDSIVVIENIFRKMQKEEFSLGLIIDAT
KEVGSAITASTLTTVAVFLPIGLVNGGLQDFMLPFALTLTYSLLSSLIVALTVVPLMSAG
LLKNEKLRKHKQPVRFTKVITWSLNHKWVVLLLSLLLFVGSIGAYTMMPKGAVDNSSSDF
VGTTLSYPNNTPIKTVEEKSLQLERYILAQKEVKEVYMQLGNTDEGAKWGDVGSPTEATY
TIIVKDSGNTDSLMKRIQNQKKLYDGGDLSVSAASLMGASTTSITVDVIGNDMNKLEKTA
SSIKKEISDIKGVDKVSTNQDEKKTIYSLDVDPTKANAQQVAQQLGVMLNKTPIGAIDLE
GKQANVLLESVLNPTSPKELKDISIMTETGPSPVSKVASLTQAEKPTNQFHKNGDPYIQV
TADVNPEKLSEINKDIQTTIFGDGKNKGLSISKDVDVVIGGASTQQGEDFSDLFITMLVS
IGIVFLIMVITFKTIRTPFAILFSLPLAAIGAVLGLLISRIPVDVTALLGALMLIGIVVT
NAIVLLDRVKQNEKKMIMRDAIVEAAATRMRPIVMTSAATICAMLPLLFKQSESGSLVSQ
SLAVVVIGGLAVATLLTLVVIPVVYELLHFRKSKKQRIQQKQQENVTPL
>fig|592022.4.peg.2406 Multidrug resistance protein B
MLILYTFGMAVVMLVIPVLSTITQVYIIQVIMGLLGALQKTAEKIALSRQTDRAHTGKQV
GHYHLWTSIWAALAVIATGYIIDFLTIGSLFYITSFMYVAAGVLIWQKPKTVELERHHSL
>fig|592022.4.peg.3679 Permease of the drug/metabolite transporter (DMT) superfamily
MDTMIAKQQESLTTRKVRRGNGLYISASVIAVLLWSTSFVGTKIAYTSFPPLTLGAARFV
IAAVILGFILLIRKDKIKPSFKDIGLMSISGVLGTTLYFSLENIGVELTTASNAAIIVAS
YPAITVLMEFLFFRKKTSRVKAIGIGVAMIGVYQISYSPETQTDDKQLIGNIILILAGFI
FALYNFTTRKVVKKYSMITISFYQTLAGAITFIPLAFIEKSSWQTPDIRSFLTLLYLGVF
CSVIAFLLYNFGLRKLSSSSAMTLMNLVPIFGVLFSVLLLHEVVGINQFIGGIIVLLGVV
LSMRETRKKHVLENK
>fig|592022.4.peg.3836 Multidrug resistance protein
MKKEKLFANSSYKKLFISSTGASFGDLFDMFAVMTLFTYVWHANSLWITLIPVAYALPSI
LLSQAAGNLADRYDKVQLMFLSELVRLLFTCLLFFTNEPLLALGVLTLRSMGSVMKVPAQ
LAYVREVVKEDQLLQASTLQNIMFQIAKVVGPFLGSAALTITTPKACILVNAAACMISIG
VLFSLKKAGKNIQGQAARSSHQVKETYSNGWKIVFQHSILLRAVILFHLSYFVVMLVDAQ
ISIFLRDVLPHHPEMLGWLLSGIGLGALATGVYLNRKKQVHHPFRLLSLGLLLFGGALFF
ISCFNPAVMSRYFILIAAPIGGAGVGLNLLLTISFKHTATRNTSEKCTDSLTP
>fig|592022.4.peg.3837 Multidrug resistance protein
MYGFINTLTSAVLLTAPLLGGMLVKLAGAQTTFLTAAIIIGSVGFVSMLMPLRDKRERNI
QIDA
>fig|592022.4.peg.4461 Permeases of the drug/metabolite transporter (DMT) superfamily
MRRPFVKPLVYGLIGLGVIGFAFTLITDPAVLLRQAGYIFLFIILFYLVYRFILRPSQTK
GQDRGYVRAVKQSKLRQKEKERGSNKVDMHTYRSSNKRPVSKSTKPLKKKKNNSHLTVIE
GKKGKKKNRAFF
>fig|592026.3.peg.187 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MHNMTTGSPLKRIINFSIPLLIGNIFQLVYNMVDTFIVGRTMGRDALAGISASSSVMFLI
LGFAQGLTAGLTIPLAQAFGARDFHKVRRSVTIAWTIALCVSMALTFLSTFFLRQILEIM
MTPPEIIQYTYDYLIVIFSACTVTMLYNLLSNMMRALGDSRTPLYFLIIAALTNIVLDYV
FIVNVGMGVAGAGFATVLSQAVSVVLCLWAIHRRWPLLQVSWQKAMLVAEEIRYHLNMGF
PMAFQSSIIALGSISVTVALNQLGPLAIASYGAASKIEQIVILVLMSFGIAMATYVGQNF
GAAQFDRIRQGVRQMTFLSVGVALVSGVILALTGAQVVTLFAEGSQGLEMAHYGQVFFYC
SAPAYWLLALLFIYRYTLQGLGDSLIPTIAGIMELTMRMSAALILSQYLGFVGPAIASPL
AWLGACVPLFLAYHHHKHHLQERFNQKLAQN
>fig|592026.3.peg.429 Drug/metabolite transporter (DMT) superfamily protein
MTALWKGRLYTILGAASWGLSGVCGQYLMQTAQIPARIVVSIRMLLAGLIMTTYLLACQR
PQLKALSQDKRSLVQLVIFALFGIVLCQLTYLEAIGASNAGTATVLQYTSPILVIAYVSL
KTRQAPTGQLLAAIALAILGTALIATHGDITSLSLTPAGLSWGLVAAVGYALYTVLPADL
LQRHNATLVTGLGLLLGGASLFLANQTWTYPIDWQPLTILAMAGLVVVGTLLAYTLFLKG
VALVGPMEASLLGASEPISAVFFAFLLMSEHFYLIDLLGMVLIIAAVVWVSLHPKAAPHP
VND
>fig|592028.3.peg.289 Permease of the drug/metabolite transporter (DMT) superfamily
MKYRLLLLLAALIWGFAFVAQVIGMDSIGPYAFNGIRFLLGSLSLLPIIYYYPSGRNPKE
ASFSIWVAILMAGILLCGGATLQQVALQYTTASKTSFLTATYLLMVPVIGLFFGQVLRLN
HIFGVILAMAGVYFISITETLDIGYGDFLVLLCAICYAAHIILLNYLTQRFPPVTLSSGQ
FMVVGICNLILAFFFETVSISSILSSWWPILYTGILSTGVAYTLQAVGQKYLPATEATML
LSLEMVFGGLCGVLFLNESFTGKQLIGILCMTAGVFLAQIPSRTILPLKK
>fig|592028.3.peg.478 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKIGLYSDMKKLLSVTFPILVAQLSTMGINFINTTMAGHAGADDLAGVSVGTGIFFPFEG
AAIGLLMAGTPIIAQLIGKNEKSSIPFVVRTGIYIALALSMLLFAGYFFFADEVVSSMGL
TAEVEYIAKNYIFAMVVAMVFISLIIPLRSLTDVAGSTATSMKLFLSALPINAVLNYFLI
YGHGGLPRLGGIGAGVSAAITYFFVLLMFLYVIHSDERFMGKEIFASGKSRFCDWKEYMS
VGIPSGLSVFMEMGLFGAIIIFMARFGTETLAAYQVADNFANMAYMVPLSCSMALTILVA
RAAGAKDHALARRYAKAGILMSVGFSAAEVLLTTIFREQIGLVYTDDAAVIAIASQFLIF
ASGFQFFDSISAPVQGILRGYKDAKVPFILLLAAYWGACFPVALFLDHQLDMAAVSYWIG
LDVGVAASAVFMAIRLFTLESGFMENTAAVSLRGRLSLEPAYDNGVYRVKAEVLTGIKII
WQYCREIGNNLFVPQEKIVEIRGHVLTGIQRKLIGHAARAYVP
>fig|592028.3.peg.1701 Glyoxalase/bleomycin resistance protein/dioxygenase
MRISKLDHLVLVTSDLSRCVSFYRDLLHMEVEEKDGRFALRFGTSKINIHTCPGEFQPAA
ERPVPGSLDICFVTEEPLERLLDELKEEKAPLVTDIVERHGALGKMRSLYLRDPDGNLVE
IAEYRKGGQHAYHQSG
>fig|592029.3.peg.2232 Vancomycin B-type resistance protein VanW
MIRKLVPKSLKLQWQLFKRARSDKQSGFYKNLGAHKGNTSSFHHKVSVTQPIKNNAGAIN
KIHNIKLSYQQMEHLIIQSGEYFSYWHVVPAPIAKNGFKKGRNLLAGKLQEDYGGGLCQL
SGMLYIAALKAGLEITERHHHSIDIYTEETRYTPLGSDATVVYGYKDLRFTNNLNQAISI
ELEFKENSLTLHLISDQPFVEQEISWNLVSQTDFKVVETRNSNGEVLGVSRYRV
>fig|592031.3.peg.90 Nitroimidazole resistance protein NimB
MFRKMRRIKQQITEDECIRILKENPRGVLSMIGDDGYPYGIPLNHYYSEDDGVLYFHCAK
TGHKLDAIKTCDKVSFCVYDKGYRKEGEWALNINSVVIFGRMKLVTDEEKTREICINLAR
KFTDDEEYLEKELKYSLPNVQCLELIPEHITGKLVNES
>fig|592031.3.peg.251 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MYAENKMKALETGGSNLKLKFSKFILPTLFSMCFFSIYTMIDGAFVGRGAGNMALAGVNL
SMPFISFVFALSIMLSIGSSNIATFCLGRKEYKKASLAFSRGIEAILLISILIVALGLIN
LNHLIRLLGASYETAPYVKDYLKIIIPFIPFFMISYTLEVLLKADGNPHLSLFFVTLSAG
TNIVLDYIFVIRYNFGIEGAAVATGISQVLAVAGYCTHFFSKRANLKFYPVKLKLHGILS
AAKLGFPDFLSELSIGFVTFVFNIVTIKYFGSYEIASLAVIMYTYNLVVNAMTAINQGVQ
PLVSFYYGRRNHENIRKLYKYSVFSAATLGIIFVGFVYVFPNLITSMYISPDSGYLYGFA
IDSLKIFCFTFLILGINIVSAGFLNATRNTGKSLIISISRGYVLISLLTFTLPLLFSRSV
IWQSAGLCEGITLVISLMLIKKYLPSCDGRYSN
>fig|592031.3.peg.329 Permease of the drug/metabolite transporter (DMT) superfamily
MKHLKGNLLLFVTSLIWGTAFVAQSASMKHIGPFTFNFIRCSISILCITPVMLMSFKKYK
LTNSNAAPSDHTGLYKRISDRCDNLYDKEKSIKFKHVIVGIICGTALFIAMSLQQKGMVY
TSVTNAGFITAMYIVMVPILNIIFKRYPRPITVLCVIAAVFGLYLLTVPENGGFSAVNKG
DVYMIISALGFSVQIIAVEHLAKKLDGVTISWVQFIMCALLALPSIFIFNENVNLDSILA
AKVSILYAGALSGGLAYTLQIVGQKDTEPTIASLIMSLESVFAVIAGIIILHESPTTRTL
LGCAIMFAAIVISQIPSKKKNDKLTV
>fig|59374.5.peg.417 Permease of the drug/metabolite transporter (DMT) superfamily
MVLAAFLWGSTFVAQIEGNDVGPFAFVCMRNFIATGVLFGLAKVLDKFNKSPRKPKTKEE
NRALWIAGLFCGLTLFFAMNLQQTGLFLGCSAGKAGFLTACYIIFVPILSTFFGKKISPK
IWLCVAITLEGLYLLCIKEDFTIQPSDIILLLCALAFAAHILVVGKYGPYMDNVRLSAIQ
FLVVATLSIFPMFFVDLKGSFAGFGTVIEVYSHFKPWIPLLYAAILSSGVAFTLQIVAQN
KLRPTIASLLMSLESVFSVISGWVMLGERFTLQEAIGCVLMFTAVILAQVKIRRR
>fig|59374.5.peg.874 Membrane fusion component of tripartite multidrug resistance system
MNALKMIGKVVVVLALIVLVIMGISQLQQFATQPREQFLQGQMEARRVLVAGKVPGRIER
LLVHEGDVVYKDSLVAVISSPEIEAKKMQAQGALGAAKAQASKARNGARSEDITALKAMA
DRAQEAATLAKNTYNRVQKLYNEGVLPLQKRDEAETQMKATQSAADAARAQYNQAVAGAR
SEDKAAANALVMQAKGANAEVDAYLEETKIRTPITGEVSLKLAEEGEVVGSGMPIIAVTD
LNDSWAVFHLREDYLKNVSKGKKFYLQVPALDKTIEMVVSYIASVGDYATWRSSKESSGF
DLKTFEVRMRPTHKVENLRPGMSVLLPADDIQ
>fig|59374.5.peg.880 Fusaric acid resistance protein
MNKLEDLLDNFWNTHKNNAGVAYVYTHKLSIAWVACVVFAVMLGFIYQGKAAMFRGIAES
SETIISLPSPTEIVKIYVVPGQEVKPGDTIVVINRPDLTLRVAELTRELDALEGRSNLSS
AEIDQKVAEVKANLESRRLTLLAEIRNLEAEYESNKAISAKLKSLSNSKSKADGNDAMAM
RIKSLKNELAVATRSANEQIALLRGSNKLQKSSGKTEAANIRKELAELRKQQKELTQIAK
ENWVVGDVNVRDGEKVSSFAPIVTLAHKSPTLIRGYINEQIYENTNLGEAVKVTSLTGKG
KAVIGEVVGLSSRIVPFPTRMWKMPEIPVYGREVTIKIPEENQFLLGEMVTITETSKRNL
EKQQQKAKK
>fig|59374.5.peg.945 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDCVLKKYGSLSIEAKASLWYLFCNFAQKGISFIVIPLYTRLLTTSEYGTYTVFQSWRDL
ILIFATLNLSAGVFTRGLVKNDGSNDKYTAQMQGLSSAVAVLTFLIVLLFFDPFRRLTGF
DEKLVITLFVYYIFNPSFLFWSVRQRVENKYKSMVAITLLASLLVPAISLLMFFLTDIRA
NALIYGFLYVQIAVGMLFFVKQFVDGRAFFSKVVWWESLKFNIPLIPHYLSLIVLAQSDR
LMIDHICGTSFAGIYSLTYNIGQIILIVIASINGSLVPWMYKKLKSGEYHSIAVTSNMLC
ILLGLMSAIVMLLAPEVVFIMGGSEYMPAKWCIPPVVMGTYFTFCYGLFSTVEFYIGKTS
YVAVASFVGAVLNVILNLLFIPKYGFIAAAYTTEMCYLVFMVLHYFFMKKMTKERIFNIK
KMIVICSAFFASSLIFTFLYDYDFARWGVAVLVSLLVLFKRRTFMNMIKGLREK
>fig|59374.5.peg.1102 Permease of the drug/metabolite transporter (DMT) superfamily
MKPAPIKDFESSANASRGLALWHVLAIGTIAFWGTSFVSTKVLLNHGFSAVQIFTLRFTV
TYLLLLAMTHKQFRCENWKHELILCLCGLTGCTLYFWAENTALSISPSSNVSLIVCTNPL
LIMIFGGLIYKSERLVKRQIFGCVITFIGMVLVVLNEKFILKLSPVGDLLAFGSSCMWAI
YSLIVRPLNYKYSTLFITRKMFFYGALSSIIIMLGETAIAPNEAGAGRFLGVPWQNFAEP
VVSLNFLCLTVFSSMFGYLIWNKVLKQLGTVLASNYIYAIPLVTIITAVIALGERITSVA
IAGAVAIVAGMVLAEWKPRK
>fig|59374.5.peg.1934 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEDVINNKKLNAMGTASIPKIVLQFSVPAIISMLVEALYNIVDRYFVGQGVGSLGIGGIT
ICFPIALFIMAMSMMVGVGGNTLFAIRLGERKYQQAAIILNNSFVLLIIMAVSSFTLGQI
FMEPLLKLFGASDQLLPVASSYMRIILCGAIFQTIVPGMNHFIRSMGHPKTAMTRVMIGA
GSNVILDWLFIMKFNWGIEGAAWATVLSQFIGGLAVMQFFVKKTTPIKVNRRYMKLRLPY
VRKIFILGLPPSIMQISNSLVNAILARSLTSYGTRDLPIVNGMTGGDQAIAAFGILMSIV
SMIVLPLMGFVTGSQPIIGYNYGAKYNNRVRDALKFTMLYATAFIVIAWILMMTNTLAFV
APFVPNDQNMQQLTCKALRTFICMMPFVPLGMVSGNFFQGTGKAWRSMFLNACRQLILLI
PFLFIMPRFFGLRGVFMAQPIADFVTAFIAIIMLRAELKNIPRI
>fig|59374.5.peg.2385 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MFKTFLSRKFFSLLLSSTIGQLVITVLTLSDSMIAGVMLGEDAVAAICLVVPAYSLAGFW
GCLVALGVPIIYNRAMGEFDKKKADRCFAFGLFMSLLMGVILFVTFMVIGDAYLRFYEPS
SIVFGAAKDYFFWYKFTFLLLPLYTLMYVMVLADGDETLSMVSGIVQIVGNIVCSIVLVK
FIGIAGIGLGSFIGTVAAILVSFAHLLRQGNSLKLGFYFSFRWLIDVVKYSAVDAGSYLF
LAFYIAVMNRFITFAYGPEMLVLGAIVLFIKEIQVLFDGVGESFSPLMNIYLGEESYDAV
KKCYRLSQKTAVVEGLALTLLLLLLAPYVVKLYDISDPLMFSYAVGGARIEVLGLVFLSL
LYLLSSYYLLIDKIKLGFMMSALRDVLVVTPVCVFLGYFFGVYGMFAGIAVSPVLAYVIS
VLYIRIRYGAENYPLLLADKLKGFKHKFYELKLDPASIVKTQQQAEKFLCENGVDRKIVS
KVKLLIEDIYMLIYEKNGADKAVYAECTVIIRETGVQIITKDDGILFDLSSDDVIAGSIV
EFMVSGYMEKLKENKKYLTTMSYNRNTFKVNNEVRV
>fig|593907.5.peg.1658 Glyoxalase/bleomycin resistance protein/dioxygenase
MSTPTDPQTAVSGPRTDDVLDAATTMDAVTLHVGDLEGMTSYYTEALAMEPLEERSRGRE
VHRVLGRGTTPMMRLVHTPDLPGVDPHQPGLFHTAFLFDDQPGLAATVYRAAQDPRGRFV
GSSDHAVSEAFYFADPEGNGIELYTDRDRSLWLHARGQILMDTTYLDPNEFLRRHLTQDA
LDAGPALAGRVGHVHLQVGDLARAEAFYVGALGFEATMKEYPGALFASAGGYHHHVAMNV
WNSAGSGPRAATLGLADVAVSVPARDDLDALAARLRARGLAFADDGRAITLRDPWDTHVT
VSLPATTTQELLAR
>fig|593907.5.peg.1704 Glyoxalase/bleomycin resistance protein/dioxygenase
MERVLGIGGYFLRADDPAALTAWYRECLGLDAEAQELWRQDAGVTVFATFEPQSDYFGSP
DQRVMLNFRVRDLDAMLAQLRERGADVAPEVQDMEGVGRFGWVTDPEGNRIELWQPA
>fig|593907.5.peg.1855 Vancomycin B-type resistance protein VanW
MRRERQWRQDGVVAHPDRAEPDGFAHHVAAHRTPIFRELAGVDRRLQENKAVNLVIAAGR
LDGLVLRPGQRMSFWRLVGKPTYRRGFKDGLVLRQGQVDEAVGGGLCQMTNLLYWMTVHS
PLTVVERWRHTYDVFPDNGRTQPFGSGATCSWPVLDLQIENRTIATFRLSLGVERTDLAG
AWTSDQPPQHTYEVYEAAHVMTNDLPGVFTRRNVLRRRVFDLAGVEVADELLAVNEGRLM
YQPFLESGAAG
>fig|593907.5.peg.2940 Glyoxalase/bleomycin resistance protein/dioxygenase
MTDDTARTAGAPSPVRQLRLVVEAADYDEAVTFYRDVLGLPEQAAFEGDGDARVIILDAG
RATLEIANPAQKRMIDDVEVGRQVAPHLRVAFEVDDAVATTRALTDAGAQELAPPTRTPW
QSLNARLDAPAGLQITVFEELESLDARSGRPGFGTADTRD
>fig|593907.5.peg.2947 Glyoxalase/bleomycin resistance protein/dioxygenase
MPFASIRLVTDDVDRLVAFYERVTGEVAERPAPVFAQLGGPRAILAIAGTQTVAMLGGAV
TPASNRSVLVEFEVDDVDAEVARLQPDPQDVVLPPSTMPWGNRSALIRDPDGNVVNLFSR
PPA
>fig|595494.3.peg.238 Permease of the drug/metabolite transporter (DMT) superfamily
MNQSDYLTGLLLAILAATGFACKAIFVKLAYRYGVDGTTLVTIRLLLVLPLIATMRLLRK
SPATALSWHDRGMIILLGLLGYYLSSLLDFLGLETVSASIERLILCLYPTLTVLLSAWLM
KTSISRRMWSAMALTYCGMVLVLTPDFAGARLDLLGIFFVVASTVTYAFYLTWSPAVIRR
IGAMRFAELGLTISALAMFVHYLLTRPVETLLHQPLPVWGYGMIMALVATVLPIYALAAA
MARIGAGKTALIGSVGPILTIFLSIGILDEHLSPVQWAGVCVVLTGIWLVGQRKT
>fig|595494.3.peg.410 Permease of the drug/metabolite transporter (DMT) superfamily
MSPIFVALTPILWGTTYFITGRYLAEWPALWLSVMRAIPPGLLLLAIRPAKVPWRQVPYL
LLISFLYIGAFFPLLFISALYLPGSVAGTLAATLPLVLLGLQWLFLHKRPSRQALICALL
GLGGIILLLGPGAELNWIGVGAALTSVLLIGICSLLLQQRPWHGELISFTGWQLLLGGLM
ILPLAFWVEGAMPIPAGDDWFGLLWLILLNSALAYVLWLWGMANLPLNRLGLMTLLNPLT
AVMAGSILMHEALSYWQWLGVLTVFASLLLELLLRPKRYPAAA
>fig|595494.3.peg.1729 Multiple antibiotic resistance protein marR
MEPLAESLGFLLGHTNLLKDRLLDKHLEPEDITAGQAKALFNIYRFNKNRPSDIGKSLGV
DNSAITRMLDRLEKKELIKRYPAPEDRRAQLIELTDKGNETIERAMPLAKDAIAELTHAL
TEEEKSQLKHCLRKILASSGCAFAKEHYSVPDPSSESQE
>fig|595494.3.peg.1730 Outer membrane component of tripartite multidrug resistance system
MRRYFLLSSLTLVVLLSGCASPDDIRPQNTLFGNNVLTHSKSLTTDALSSANWPQQAWWL
DFGDQDLNALIAESLKNSPDMQLASARLNQANAQVATADSQFDPTLSADANMSRARFSRM
EDPLGEGNRYSTSRSLGLTFNYNFDLWGGKRAAWEASVNNQKAAEIDQQAARIALSTGIT
QTYIQLANAYALEDLAQKDFDRNQHIVEITDRLFKNGLTSEDRLYAAQSGAASAKQALKQ
RSLVVAQLKNALAALVGTGPDRALSIARPDVSVQADFHLPADLPASLISHRPDITAARWR
VEATSKQIDAAKTRFYPDFNLTAMAGFKSVLGDAVFADVSRSWNVTPAISLPIFTSDLKA
NLLSKTADYDAAVAQYNQTLITALNEVSDNVLALKSFEQQLIDAKESMELAEKSYQITEK
RYQAGMGSQLEVLMAEQQLLQAESAFTALKNQQQESQIQLIKSLGGGFLASQPPAAVKDA
QNS
>fig|59748.8.peg.125 Multidrug resistance ABC transporter ATP-binding and permease protein
MKRVLKYLKVFKVQIIISIFLILMVSTLSCLIPFLEGKYITNKIKEASASTPPDTKDAIK
TQIFHFLYLDLFFCFFVVLCRLIFNKLLIQSIHKSMRNLRQDVQKKIHYLPISYFSQNTL
GNIISRLTHDIEVISNCLQQSFAIMIDAFLKIFMVVIFMFHLHWFLALIVFTMIPLSFYS
TYRVFKSSQKIFIQRFESSGVYNGFLQEKYTGYKEILLYNQQKNTIKEFKTHNTNLQKLV
FKSHFLSGLSSPIVSFFVYLTLVVASIAGFYLIDSKQHFLNLTLPILQVGLFHTFIQYIW
RLGNPIVELGHMSVLLQSANAASKRVFSFLNETEEAPEAKKPIVLTDPKGQVVFENVFFS
YNNRDMLLKNINFTAEKDQTIAIVGSTGSGKTTLINLLMRFYDINEGSIKVDGVDIRELK
KDNLRKIFGMVLQETWFFKDTIWNNIKYGDKNASDEQISKICKQAQIDYFIKSKPLEYQM
IINEEADNLSQGEKQLITIARTFLSNPKILILDEATSNVDTRVEILLQKAIKELVKNKTA
FIIAHRLSTIVNADKILVLNRGEIVEQGTHQQLLANKNFYYRLYQSQFQK
>fig|598467.3.peg.545 Outer membrane component of tripartite multidrug resistance system
MISEARWPQEQWWRAFGDGQLNQLVDEALAGSPTLRGAAARVRQAEAMQGMAQAQLLPHM
DANVASTRQRYSENGTTPAVMAGTWQTVNQGTLNVGYELDFWGKNRAAVEAALGRSKAME
VDRYATQLMLSSAIVQAYIELQQGNEQLAIERQMLKQQEQVLSLTQQRFTAELDSQIDIK
QAQAAIPATRARIAALGESMELSRNRLAALLGKGPDRGRAIAAPQLKRLDTVTIPSNLPA
ELLGHRPDVVAQRWRVEAARHEIEGAKARFYPNVNLSAFAGYQSLGFDQFTEAGSRILGI
GPAISLPIFEGGRLRANLAAQNAAYDIAVEDYNQTLVDALHDISDQLSSIRWLRERIHQQ
QQAVQTADDAAKLVDQRYGAGLATYIQVLTTQSDALAQRRQLVQLQSRGLALEANLSRAL
GGGYVPDLPLDGAKE
>fig|598467.3.peg.2845 Permeases of the drug/metabolite transporter (DMT) superfamily
MLKTTGTAESEQQKGLIGIAMIVAALQILPFSDIMAKYLSLSIPIIQVIWGRFFFHCIIT
GIYSAVAYGPRYLAPNLSAMLLLRSTSLFAAVGLFYVTIHYLPLTTSLTLWFVEPFILTL
MAALILKEKVTAYQWLAIFIGFVGIVIAIRPTIVEWHWAYIVGLLAGFFYALFLFFTRFI
DNKIPSVVSVYHTGLVGGVLASVTVAPYWVAPTPSQWLLLVGCGAIAAIAHLLIIKSFEL
ANASTIAPFTYSEIIMGAILGFIVFADAPDIWLFIGLAIVVGSGIALTKIKQSLPKSSAV
NGG
>fig|598659.3.peg.834 Acriflavin resistance protein
MKRFIEFFIKKAVFTHVLFLIVIISSIIAYKNVAKELFPPATLDKILIQGAYPGASPKTL
DKMAVTQIEDDLKSYQEVSSIESVIRNGSFTITVNLKPNANKLELLSEYKTITSNLKKDL
PSDMNEPSVTIAKKAFPLMFISVASNVLNKDELLNHADNIKKILSQIKDLTQIDIRGDSD
KNIYFELNNKKIEALGINKSQLINVLSQVSTIFPVGKIEGSTHYFISMYSKNVNDFKNMI
INVGNIKVRLKDIADIKKKYETPTQIGKYNGIPNITIDVRKGESGDAIAISKKIRNILKN
YHLKHPEITFGISTDTSKWVRNRFNTVVSNIIFGLILVFFIMWIFLNWRISLVVTLGIPT
SFAIAMIALDYYNFSLNLLSMLGALIALGMIVDEAIVVGENIYRHMQMGKSKTEAAIDGT
VEVFWPVVAAAMTTVLAFLPMLLIKGEIGVFIKILPVMITILILSSLFEAFIFLPLHSKE
ILKVEESKKDIFWQKFSLFYKNLLKYFFKFRYIALFFFLVMVPVLIAIGMKHSKFQLFPD
FDASQIYVNGKFESNYTITQTAKAIKKIEEDLKKYVGKDVEGFTTVVGMQMNNKGEANVG
ENYFHIFVDLNDKKPTDVYNKYIAPIFQPIKVENQIRTHTAQQLSHMFKKDFADIKIPGM
VELNVIVPQAGVVKSDIVISIGGQSQEKIIEAIKKLETVMKKIKGVYNIYDDAELGADEL
KLKINSYGQKLGFTQVGLFNELRGFFAEAEFDKTFDKDGIVKIILKDKNKDSFNELKTFR
VTIPGTNRYIELNKVCDFIITKAFKKLHKYDGIAAKTVYATLNKKIITTADFYVKVNPLL
KEFKKEGLIVIIGGAAKTSKEFIKDLKEALVVAILLIFLILVLMFNSAILPFVIISVIPL
SFLGVIIGNMIMDMNMTMLGMIGIVGLAGVVVNDGIVMIDFIKKAKNLDEVLEYASHRLR
PVLLTSITTFFGLLTLMFFPSGQSAILQPLAIALGFGLAWGTILNLFYLPIFYYVLRRKH
LHK
>fig|608534.3.peg.2 Ribosome protection-type tetracycline resistance related proteins, group 2
MERLVIGILAPVDAGKTSLSEAFLYRGGLLRSPGRVDHRDSYLDTERLERERGITIFSKQ
AVFSIGEKTITLLDTPGHADFSAEMERALSVLDYAILLISGTDGVQGYTKTLFRLLESRG
IPCFFFVNKMDRPGTDRAKLLAELRESFGSEILDFSSALSEGEGELMPEPADFPSLPPEL
LESLSLTEESAMEEYLSSGKLPLSRIQELFQRRRFFPIFFGSALKLEGISPLLLGIFFLM
KEPSFPASRGLSARVFKISRDEKGRRLSFLKLRSGKIQKRQELLPGEKITGIRLYSGAGY
EELSEAEPGMLVALTGIRSLYAGQSIGEEGEESRSSSEAVLEYSLYPAEGGEEEIRELYR
RIRELSEEFPELHLSYDSELPEIRLRLMGEVQTEILGELIRERFGTEVCFGEGRILYRET
IGRIAEGVGHFEPLRHYAEVHLLLEPLPRGSGTELRTLCPLDTLSGEKQRQILELLSSEE
FPGVLGGFPITDLRISLLSGKASEKHTDGGDFREAAIRALRQGLRRAESLLLEPWYRYRM
ELPPESLGRAMTELSKRGLEPASPEIRGESAFLSGEGPLSSLFSYEREFREMSRGRGKLS
MDFLGYRGCPEERELLSEWGYDPDSDLRYPSSSVFCLHGNSRIIPWDQVEKYMHLPPYLE
RERREEESGEGEGTRRDPEEGFRKAGHYIGDQELEEIFVRTYGPVRDRAAEAEAAGKRTS
FEKTRAENLRREREIREEREKKGAPERGEEALIVDGYNMIHAFPALREIAEENLDSAREK
LLERLSNYRAYSGKNVILVFDAYRLERHPVETALRSGVRVVFTKEAQTADQYIEELSRRL
SEEGGRVEVASGDRLVQLIAWSGRGVSILSAADLERELERVEEEIRREHLRFDSAPRGSL
SGRGILPDEKS
>fig|608534.3.peg.6 Permease of the drug/metabolite transporter (DMT) superfamily
MNRRSRRKVLGFCMLFLTAAIWGLAFIAQRDGADYLGPFSFMAARNWISLAAMSPLSFLL
YRKNLRQRDGAGRGREGLLALFAGGAACGFFLCMGGAAQQYALPMSTAAKAGFISALYVV
WVPLLGLFLFRKKEGMRTWIGTGLSIVGLYLLCMKEGLRLGMGDLMLLLCAFLYAMQIIC
VEHFIRKAEGIYLALLQILASAFLSTILMFLLERPTASDFWAALPSLLYVGIFSGAAGYT
MQIMAQAYVDSTIASLILSLESVFSAVFGFLLLGQSLSGREILGCAFMLAAILFSQLPGI
GTKEELSSAG
>fig|608534.3.peg.873 Teicoplanin resistance protein vanZ
MREKRMTRNRWLGLLLFVLYLSLLFYLMFFSEMQERGVLVKPDYTYNLVPFREIRRYFLH
GKQIGFFGVLLNLWGNILGFLPLGFILPIFSRRCRRHWYNTVISAYLLSFSIEAAQLLLR
AGSCDVDDLILNSFGAFLGYLLFQLVQRLRELRRLWTSREDRA
>fig|608534.3.peg.1469 Vancomycin B-type resistance protein VanW
MILGALAAILVFCVAGVLFRGLFSHAGKRESTTAETTAFDPNIIHEDLYLDYSAFSPNAE
LLNMKGMTKEQVEDTLKKSYSWGLVVKNSNPNLKSFTMPALPSETTTAASAGETGADNEG
TEEVVKVKDSLSGITIQPDKTQFLVPDLIEENISSFVAQIFEDYTKKNEESSSESSTEET
KKAKKKKKGSTEESSESSSAPSADYVLQLPDFSARITDYMNQLALVWNMAPENGDIVSYD
ANSGEFVFGGTVDGYSVNAQSTAAKLMDAIERKAFSEAVDADGETVPASLSSIKDKYKII
GSYTTKTTANAVRNKNIKLAAQTVNGTIVKPGQEFSFNGTVGQRTEEKGYGGAPAYNAGE
VVEEVGGGICQVSTTLYNAVFRSGLTTTYRRSHTFAPNYVTPGMDATVSWPGPDYRFVNG
SRHAIGIRASYSDQKVTVQVYGIPVLPDGVSWELTSEKLKDLPVPNPQIITPDQGSESKG
TAGSEWQAYKIITKDGKTEKVKDHSVTYKGHPPKQYAGSAAKASSGSQGASESPSSSESS
ASEKTSQQDDKESKKQTQQGEKESKESKEGKETKSESKAETKSDNKGTVGPGSDIISNDG
PTVGSSSSDSIISDGPPA
>fig|608538.3.peg.1732 Acriflavin resistance protein AcrE
MRRYIKYIGFLVVISLVVLWLAGVFSHRERTFEVEKKAKTVEGLKIGKVERAQEVQVGYV
GNIVADHVAEISTRVAGKITSVRVKEGQAVKKGQILLTLDASDILAQASAVSEQVKQAEE
AYKSAISNYEAVKKTYERYLSLLKENAITQQEFDQIKAQYDAAKAQVEQAKAGIRAAQFQ
RKAVVSNLDYTTIRAPFDGYVAHKKVDMGDLAGPGTVLLVIERPPYKLEVNLPEKYVGRI
RVGDVYPVYIDALNKTVQGRVSEVSPSVDPITRTFRVKLSLESGDLKSGMYAKMLISEKL
SVILVPESAIFRRFDFTGVWVVKPDNTLELRFVKLGEKRGNMVEVLSGLSGDERIVVDGI
EKACDGCKVGG
>fig|610130.3.peg.385 Vancomycin B-type resistance protein VanW
MKKKTLSMSLAAVIIAAGIGFLSPTYVMADTLPDGIYVGEYNLGGMTEEEASQKIQSLVN
EMENQKVTLIVDGQPVETVAKELGFHWSNPEAVAQAASSWQGGNLIKRYLNKKDIEKNHV
IIPLETALDDGKVAAFVAEKCSQAMVEPKNATIVRDKGAFIVTPSSIGKNVDVAATKQAL
DAALANGLKEPVTATAVVSEVKPGITTEDLSTINDVLGTFSTSFSSSGASRSKNLQVGAS
KINGRVLMPGEILSGYECMHPFTLANGYATASAYENGQVVDSVGGGVCQIATTLYNAVLR
AELAVDQRQNHSMVVGYVKPSEDAAIAGTYKDIKFSNNYSTPIYIEGYTSGKTLTFTIYG
KETRPANRTFEFVSETLSVTDPGAPKEVVDPAMPPGSRKQVQSAHRGMKSRLWKVIYVDG
VEQSREILHTDTYNPSKAIIKVGPAAPAVAVPAETPGVPIETSPAAPPPETTPAVTADPG
PGAVEMPGEIPPEAGPGV
>fig|610130.3.peg.579 Acriflavin resistance protein
MGITKGVLKRPVTTILVVLCLFVFGLSSVLSSKMELTPEMNFPMLLISSVYPGANPEDVN
DLVTRPVEEAVGTLSGIKNVQSSSQENVSIVVLEYEYGSDMNKAYSDLKKKMDNLDLPDD
VETPSVMEFNINEMPVVTLAVKDPSQNNLYNYVNDKIVPEFEKISSVASVGMSGGQKGYV
SVRLIPEKMNQYHLTMNSISQAIKAADFTYPAGNTGVGKRDLSVSTGVEVGSVESLKKVP
VVAGDGKTIYMEDIADITSTSESQEAIGRYNGEDTITLSINKQQKNSAVDVSKSVTRTIE
TLKREFPNLDIVVIDDTSDQITSALNSVKNTMVMAVVISMIIIFLFFGDIKASLIVGSSI
PVSILVSLILMAAMGFSLNVITMSSIVLGVGMMVDNSIVVMESCFRSQKGTGFREYMQAA
LEGTGVVLQSILGGTITTCVVFIPLALLEGLTGQMFKPLGYTIVFCMLASLLSAITIVPL
CYSRFRPVEKQNSPMGGLVKALQNGYRRIVDKLLNRRAAVMIVSVLLLISSFVLATRLGF
ELMPEVDQGTITVTAEIKPGLKVEEADKILKKLEDIVTSEEDLKSYMVSYGGSGLSFSGA
KNGTLTAYLKSDRKLSTNQMVNKWKKAMNQLPDCNVTVESTSSMSRMSRMSRMSSKKDFE
VILQSSQLDKLKSVSKQMVDELTQNPQLIKVHSDLENAAPVVKVRVDPIKAAAEGIAPSS
IGSLLNGMLSGTKASTMDVAGQEVDIKVEYPEDSYDTLDKVEGIMIPNSSGGSVALTDIA
DIGYEDSPTAINRKNKQYLVTITGSFTDVVKTAKDKEAAKKNIDETIVNKYLNDMVTRAK
NSEDESMQEEFSSLFKAIATAIFLIFIVMAAQFESPKFSLMVMTTIPFSLIGSFGFLAAA
GVAISMPSLLGFLMLIGTVVNSGILYVDTVNQYRATMDKRTALIEAGATRLRPILMTTLT
TVVAMIPMAMAIGKNGETMQGLALVNVGGLTASTILSLLMLPIYYSLMSGKTDKNLLPD
>fig|610130.3.peg.728 RND family multidrug resistance secretion protein
MKIRLDGRKKILCFLAAGILLALAIGRTALKSFRGAPVETAAASYDTVEDRYTEEGTITA
GGEYRLVSDVSGPVKEVLVRENDGVKAGDVLFTIDDKDLLHEKSLCESTLAGYKAKLEQS
RIGQVMASSPQEYLDSVRADVAVKEADYQAAKTLSDASQSLYSAGSISKIEWEKNRATYE
YATLAWEQAKGRYEESRRFLESLKAGGIDETTINGRFYESVEEQLKAQIKSQETTMEQLE
DRLKKCVVAADRDGIITSLPVADISYIQAGETALTISGRGKVQIESDVLTSIAPYLSPGD
KVTVVLQLKNQDKIYGGTISQVYDYASKGTSALGMDEYRVHVKMDMDEDPDLEGKEGYGA
NIRFTLYQGENKLVIPSSAVFEVDDSNFVFVIKNGKAEKLPVEVEYKTASQTVIKEGLTK
GQVVIDHVDSEAIYEGAKVYAGS
>fig|610130.3.peg.997 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKKSNLLEEPVKKLFLRYLMPSISATLVTSIYILADTLMIGRGVGAIGIAALNLLLPLYS
LFFGTGMLFGVGGGVLLSISKGKGDEHGAREYFTSALYMAALASVFYVASGHLLFDSVTK
FLGRNETMDPYVREYGRILISGAPVFLFSSLLQSFVRNDRAPKTAMAAVISGGVTNVILD
YIFIFPMNLGMAGAAAATVTGTCLTLAILLVHLFTRGSSLKIVLRVKGRKAGEILVNGLA
SFLLETCSGIVMFLFNRQLLAYVGDLGVVVYGIISNSALIVASINNGISQAAQPILAMNY
GAGKTERLKETRRMGELAACFAGVVFAGAGMLFPALVTEAFVKPGDEILAMSVPAVRIYF
LSFLPMGFNILFSTWFQSVLKPGNALLICLMRGLILSSVLVFLLPMAMGVNGIWAVMPAA
ELMTLAVCFILLKKQKSVLPENF
>fig|610130.3.peg.1236 Glyoxalase/bleomycin resistance protein/dioxygenase
MIFVKNMDESIQFYHEILDLPVNKRFGGIKGPEIAFLGDSETQVELVCNPEKLDGIYGSN
ISIGFDVVSVDNLISDLQKKAIPIYDGPYQPTAKLKFFYVLDPNGVSIQFVERHH
>fig|610130.3.peg.1258 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNLESIQNNKIKTILQFSIPSIIAMMLTSLITVTDGFFIGNYVGKEGLAAVNLGLPIVYL
YLAVGLMVSVGGVAIAGMALGSKDIKKCNSVFNQTMCTAMAATILLSVIVWLCLDTMLHI
LNADVQVAGFFTDYYGIMLLELPIMVINASFGMFIRGEGKPQYFMLVNILNVLLNMLLDY
LFVRWFGLGVKGIAAASLLAAVVTLLCILYFFTSKSSVYKFGRFTFSGDVLGSTLLNGSS
EFVGEMSMSISMFAYNYVILKNIGVDGVTAFTIVGYICYIFSMVIIGFGQGASPLISFTY
GSKEHFLAVNLRRITNFMVLTAGAVVLLLVLVGSGWYSSLFVKSVVVEQMVHSGVIIYAV
SFLFSGINTISSFYFTSIGKAKESAIISSARGLVILLICIFTLPPLFGMTGVWLVSPITE
FLTLILSLFFIGRESKYLSRKLVQS
>fig|610130.3.peg.1764 Transcriptional activator BmrR for multidrug resistance transporter
MKDFLSIGEMSSLFGLNIQTLYYYDSIDIFKPRMREMKNGRRKYEFDQIYELATICYMRK
LGYSLEEITKQRSTQHAGSALESLKQRSEELHRQWKELISIDEAIQRKLRFIEEEMNQIH
TDEITIRHFEDRAYLVIGEEESLYRQNSFYFYPTIAFYQGEEKYFGAYLYPSEEPLPDHV
RKDQIRRIPSGDFLCGYHLGSYETVPATIERLRNARPDLDFEDLTINFNILDQFVENQSS
GYITHTQIRILKP
>fig|610130.3.peg.1836 Vancomycin B-type resistance protein VanW
MNQIDNRQRGGGRAYSSRKVSSKSASEASRRTGQAYRTGSPYQQRRGKKRRKGPQYNITK
ILLAIILAVASFICIMAAVKLMGGSRAKETEVNTTTVSDPELRKEVKVEGITITGMSREE
AREAIEKQYPWGMKVTYNQEEYKLKNLMDKKVDALLDEIYSGEPKESYTLDSEGLEEAVQ
AEVKAVAGKWDVAPKNGSVSGFDKNTGTFVYSGEKNGVVIDQEKLAADIMSQIKAKDYQA
VIQASGKEVAPKITEAQAKEMYKVIGTYTTTTTANSDRNKNIELASGALNGLIIQPGEEF
SFNKATGERSPAKGYRPAGAYLNGELIEEPGGGVCQVSSTLYNAVVFAGLSTTERHAHSY
EPSYVTPGEDAMVSYGGPDMKFVNNSSTAVAIRTSFANRKLKISIVGIPILEEGVTLSMT
SKKTAELDAPAPVYEEDQTLQLGEEKIVKAETKGSRWVTNLVTKKNGVVVSDELLHNSTY
RGKPATIKRNQSGVVIPATDPASSAAESTPAGSQGTAETTAPHNNETAGNSGGTQGPGTT
ETQPSQTQGPTSATEAADGDGGQNVIPPNPFN
>fig|610130.3.peg.2026 Permease of the drug/metabolite transporter (DMT) superfamily
MNKQAGKGIKALSAVGLVITTIIWGSAFVVMKNSVEVITPAYLLALRFTIASAALVAVFW
KRVRKICKTDVMCGGLLGVFLFVSYFFQTYGLQYTTASKNAFITTLYVILVPFLHWFYNK
KRPSGNNVAAAVIAVLGLGLLSLEGNLSVNIGDVMTLICGFFFAFHIVFIDRYTEDHDPI
ALTVIQMVVAAMLSWAMAPLLEGFFDFRVIGSSMMISLLYLGIFSTMLCFLLQNVGQKHL
SPNTSSIILSFESVFGLVFSVIFLGESVTLKLAAGCTLMFASVILSEYKRKSSAKS
>fig|610130.3.peg.2171 Ribosome protection-type tetracycline resistance related proteins, group 2
MMKITFGILAHVDAGKTTFSEQVLYREGVIRTLGRVDEKNACMDHDNIERARGITIFSDV
AGINHGDDTYYLIDTPGHTDFSSEMERSLEVMDYAVLILNGNDGIQSHTEAIWSLLERYH
VPVFLFINKLDVASSSYERVLTEVHKHFSPNILDFQGIGLENGKEGTFTDDFIENVSEWD
EGFMDKYLDGALAFEDLKPAVVSQIKNRKLFPCFGGSALKGEGIEAFLNAFYNLTEASYP
VSDPFSGRVFKIRYDGHGERITYLKILSGILHVRDPLLADEKVHQIRFFQGERFTSHQEA
AAGDVIAVSGLRTTRAGQGLGECRNKVVPTLKPTLQAKVLYPPEIPHRRILQVFHILEEE
EPALNVIWEESLGQLKVNIMGKIQLEVLEQIILERFEIRITFGQPEIIYQETVLEPVTGY
GHFEPLRHYAEAVLRIEPGERGKGITFESQCHVDRLGINYQNLIRTHIFETTHKGVLTGS
ELTDVRIILVDGISHIKHTEGGDFREAVYRAIRQGLMKARSLILEPYYSFTISVPDFLAG
RVLNDITKLSGRLEAPVPDENGRTVIKGLGPVSAFMNYGEELMIITGGRGRISMTFSHYD
RCHNEDEVLTRYQYNPNEDTDNPSCSVFCQKGTSFVVNWDHAEEYMHSLS
>fig|610130.3.peg.3052 Daunorubicin resistance ATP-binding protein drrA
MIVLEHVSKKYKGITITKDSGIALWVKNIANLTGNKATELMAVKDVSFSIDKGEIFGIYG
ANGAGKTTLIKLLSGLLGASSGTVQIDGQTDNKHIKDTVSYISTNGWMGLEWQLTARENL
ILYGNLFGISGMVLEKKCNEVLEAVGMTAAKDKLVSQLSAGMRQKITIARGLILDRPIIF
YDEPSVSLDVQSSRSLRELIKADAVQNNRTAIIASHNTEDLTICDRLMLLSKGEIIAIGT
IDELKKPLADIQIIEVKCPAIKREVAFEDICGIDSVRCASVDGKRGYQSIKINARKGEFS
LNDLIDFLIEKNIAVLDIKSKEITLQEIYEYYLALKGGGVPSEIV
>fig|610130.3.peg.3527 Quinolone resistance protein
MSQKLLPPILPGAMDVVLEDLEELFLRKDQEEAVTDVLIRNLHITEEDLSHMRFSAVIFE
NCIFQDCTFEKGEFSDVVFNACDISNCSFEDSYFNRAEFRSSKGMGAKFCGNTMLHTVVL
DCNFSYANFDSSRLEHIRFSDCRIQGGSLTQCRCKAVEWNRVNLENASFFKTMMKGMDFT
SSTIQGLTISDGCGEVRGAVVDLYQAAELAKYLGIVIKS
>fig|610130.3.peg.4224 Glyoxalase/bleomycin resistance protein/dioxygenase
MKFCWSTLNVKNLEESIKFYEEIIGLKVTRRFPAGPGTEIAFLGDGETQIELICGGEKEI
HVGDDISWGFEVESLDQTLFLAKEKSAVILGEPVQPNPQVKFAFIKDPNGLRVQLVENIR
>fig|610130.3.peg.4364 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGYNYGAGNWERVEQAKRFALKLTSGFCAFVTIEIIVFSRNIIELFSKNDAFVMKVGQEA
LILNSIVFVTLGFQLVYGTFFLALGKSKQGGILSICRQGVFFIPLVLILSRIFGVQGVLF
AQPIADIANVLLTGSFAYGINYRMQVN
>fig|626523.3.peg.346 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKTMTHQKQTKSIQKNLTQGPINRQILTFFLPLVIGAFFQQLYNTVDASVVGQFAGTESL
AAVGGSSGMITLFLFTFFINLATGATVVISQHFGAAETDKVDDALHTAYAFSILAGLFLG
IIMLFLTDPFLRLLQTPENLMEASALYVRTLMVGLIFTLTYNMGAGILRAIGDSRRPLYI
LIAATAINIILDLFFVAFLHMGVFGVGIATDISQGISALLVSWLLIRKTPGLRLSLRRLH
LNPQTLARILRIGLPTAIAGSMFTISNMILQASLNQKGVNAMAAWTAYARLDAIWWMIDA
SFSASITTFIGQNFGAAKPDRIKKASRNVLLIELAFALILTGLLLIFTPSLMLLFTRDAE
VIHLAEDICRCIAPFYAIYAFSEVLGSILRAENKVLITTLINLLGICGFRAIWLLVIVPG
GSVRQLFSCMPISWAIISASITIYYLLQQPGILHRLEGRSK
>fig|626523.3.peg.778 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MADRKAISLADHFDDRKLLRFTSHSILTMIFTSIYGIVDGFFVSNYAGEVAFAALNLVMP
LLMLIAAVGFMFGTGGVALVSLKLGQKEERQAKEIFSLTTYTLMVLGILLSLLGYLFAPQ
AAVLLGASEELLPYGVLYARISMVSMTAFMLQHFFQSFLIAAERPRMGFWITVIAGVTNM
ILDYVFVAGFGLGLAGAAWATVGSELVGGLVPLVFFILPNKTPLRLGKTGWMPWALVKTC
TNGASEFLSNAAASFIGMLYNRQLLCYMGTNGIAAYGVIMYVNFIFVGIFFGYAMGVSPI
ISYQYGARNQAELRNLFRRSLSLLAGASLILTLLAELSAGLLAGIFVGYNPQLYALTVRG
MRIYSVAYLFMGFNIFGSALFTALGNGKVSAVLSLVRSVLLQVVLVLLLPLILGGTSLWM
IAALVETGAILLTGFLVTRYREKYRLY
>fig|626523.3.peg.1117 Permease of the drug/metabolite transporter (DMT) superfamily
MQEAGIQMAGIQTAGAQTVRKSEFGNASLIFTATLIWGTAFVAQSLGANHLAAFSFTAVR
NLIGFLFLIPVTLLFRARGISARPERENRPDNVFIPGRRGQRALVTKRELISGSILGVIV
FVASNVQQLGIAGTTTAKAGFFTAMYVIFVPVLGIFLGKRVRKMIWGCVLLSVLGLYLLS
IKGGHLSLNVSDGLELVSGLCFAVHIMYVGHRSSYCDGAVFAMIQFAVSSALSFVFALAL
EHPRIEDIGLAIFPLLYAGVLSSGVAFTLQIIGQRGMNPTLASILMCFESVISAVAGWFF
LHQALSAIEIFGCAVLFTAILLATLFGE
>fig|62928.7.peg.107 Permease of the drug/metabolite transporter (DMT) superfamily
MQPARIPPRTLLALVLLTLFWGVNWPVMKFSLREITPLYFRALTVSGGLLLLIAWFRLRG
VSLRVPRREWGRVMLLALPNIAGWYCFSIFGVQALASGRAAILGFTMPIWTVLLGVLFFR
ERMNPRLWLATACAAAAVLLLLWHELGQLSGRPLGMAWMLAAAASWALGTLLLKRLAPAV
STEALTVGMLVCALPVLWALAVLKEPVPTLQFSLPMWVAVVYGVVIACAAAQVLWFSIAR
SLPPVASALSVMMIPVIGLASAMPITGERPHPQDLAAAVLIMLALSAALLPRRAG
>fig|62928.7.peg.583 Multidrug resistance protein B
MLLSAHPELRPLRVHAFGATLGLVAGVDFVAAILIAMAGTQVQHGLGVAPRDFLWALTSY
AVAAVMANLMLVQLAGRVNYRRFTLASLAVFIAGALGCAAADSLPAFTAARLVQGLGGGG
LFAAARILAQYSSQPQERLSLFWGFGVANFALVALAPWLAGWLVAHHGWHTLFLLQAGLA
LPLLPLVAWLYPRVERTPSRALGRLDWPGVLAFAGGALLLVHALEHLRYLSRAELPQLAA
YALLGLVLLGVVMRRFARHPDPWLDPRRLASRRYLAGLAFYGVFYLICGYWNFLVPAVLV
DGLGFGLDTVGGLLALGGLTTLGAVVVFHLCLPYIMRKRRYIALGYVGLAAAFTLMAVSA
RPGAGVLDVLPPIVLQGAMPVLALLQVAMMTFVDMPTEDFAHAYAFKNIVREILNALGTG
LAVLQLHHGTAAAQAAMQAATPGPLQPHLAEVVHRAAVGTAAGQMLSGLALACLLVAAVA
VWQRALR
>fig|62928.7.peg.2102 Probable multidrug resistance protein norM
MLIAQLLSMGMMVADTIIAGRYATSDLAAVAVGNGIYVSLVMLLVGVLQAVAPTVAHHVG
AGATGELVPSLHQGFWLAILLAVPGTAILLSPGALLDLAAVPPPLAAKVGDYLRATAAGL
PAVLLYRTFYAFANALGRPRVLMFISLATTCIHAPLAWALVSGAFGVPLGGTGCGVSTSV
VAWIALGCGAIALARLRVFRKLRAFRSWTPPDPVRLWALLRLGFPIGLSTFIEITSFTLI
ALLIARLGPDWVAAHRVVANLAALAYMLPLSLATSALVLVGQAAGGLDWTRAARYAKVAI
VLTCALSTLLGGVLWLARTPVLQLWSSDNAVRLAALSLLPYICLYQVFDAAQTVASHTLR
AYKVTALPMVVHTLAFWGVGLGLGYWLAFHAGARSAEASVAAFWQAAVLATALAALLFLG
LLRFVAGRSQRPGR
>fig|62928.7.peg.3182 Acriflavin resistance protein
MVLSEICIKRPVFATVLSLMVLLVGLMSYSRLTVREYPNIDEPVVTVETLYTGASAEIVE
SQVTKPLEDSLAGIEGVDVLSSISRQERSQITVRFRIERDADSAAADVRDRVSRVRRRLP
DDVEEPVIAKVEADASPIIWVAFASDRHSALEMSDVASRIIKPRLQTLPGAADARVFGER
RYAMRIWLDRDRLAAFGLTPQDVEDAIRRQNIELPAGRIESREREFAVVARTDLAEPAQF
EAVVVRQAGTPGGYPVRIRDIGRVEVAPADERTSVRFMGKPAISLGLIKQSTANPLDLKR
GLMELLPRLEEELPAGMTMSIANDSTVFIERSIASVFSTIWEAVVLVALVCLFFLRNWRA
MLVPLVTIPVSLVGAFALMLVFGFSINTLTLLALVLAIGLVVDDAIVVLENIYRHIEDGM
APLAAAFRGAKEIGFAVVAMTITLAAVYAPVAFMTGRTGKLFTEFALTLAGAVIVSGFVA
LTLSPMMCSRLLRHEPRHGRVYNAIEGFLEWLTAGYRRALEAMLGLRWVVMLAFVAVAAF
AGLLLTQMKSELSPIEDRGRVMAIFNGPEGATIDYMTRYAGQIEDIFSRTGDVDRYFVVA
GNPTVSQGISFIGFNDWSQRKRSAQEIAAELQPQLRAIPGLNAFPVLPAAFGQSPRTRPV
SFVIVTSASYDELAAYTERMLDEMHRHPGFVSPDTDLKLTKPELAVEVDRDRAADLGVSV
EVIGRTLETMLGGRQVTRYKKDAEQYDVLVQVAAGERAGPRDIRDIFVRARGGDMVPLAS
LVRVQETVSPRELNHFGQRRAVTISANLAPGFALGEALDFLDAAAARILPPGYTTDYDGM
SREFKTSSASLALAFVLALAFIYLVLAAQFESFRDPLIIMLTVPLSMAGALAALRLTGGT
LNVYSQIGLVTLVGLITKHGILIVEFANQLREQGRALREALVEAAVLRLRPILMTTGAMV
LGAIPLALATGAGAESRQQIGWVIVGGLSLGTFFTLFVVPTVYTLLARREREHDSDTVES
ASAGMAG
>fig|629741.3.peg.620 Permease of the drug/metabolite transporter (DMT) superfamily
MHHYRGELWLILVTLLAASGWFVSKAALQELPAAGFIGARMVGAALLFLPFALPQLRQWT
AGQFARAAAVGAAFSGNIFFWIQGVAHSTHFGEGALLLSSSMLLAPVLSWLLFRHRPSPM
LWLSLAISGCGMYLLNAGKSPLQMSLGSGLFALSALMSALFFVLNNQFSKGMNALPLTTV
QLACAGIVCGGYSLAFETWHFPLSAASWMWLIIGIVVITNTRFLLQTHAQKICPIGNAAM
IMVLEPVWTLLFSVLLLGEQLSWEKATGGALIIAALLLYRLPLRQWHQRKD
>fig|629741.3.peg.2580 Outer membrane component of tripartite multidrug resistance system
MLETRQRVAQRAQLNREREQVVRELIRAGQVAPSRLYAVQQGNSRFQAALSDLDGNIAQI
RHALAALTGQPAQALDNFAPNPAAAVPPAPVSQLTADLLGKRPDLAAQREALTARHHLVA
SAKTEFYPNITIKALAGLSNVEIGNLPHSSSFLAGLLPSVSLPIFTSGALRANLSRKEAE
FDEQAARYNKNVYTALREAADALTQYETAAAAVRDQTEMTALARKNAAAAQSRYRAGLDN
KLDWLAAADETLQNEAQLAQAQAKLFTAWLALNTAFGGGFAADK
>fig|63186.3.peg.1498 Multidrug resistance protein, AcrA/AcrE family
MKKLSILGLLSAGLLLSSCFGTTPTPPAGGATPPPPSLKVGELTPQDITIYNEFSTTLEG
KQNVEIWPKVSGFIQHVYVEEGQKIKKGQLLFKLETQTLNQDANAAKASVNVAQVEVNKL
KPLVEKNIISEVQLETAKAQLEQAKANYESVASNISYSRITSPVDGYIGEIPFKTGALVS
SNMGKPLTTVSDISQVRAYFSLNEKELLKLKESMPKNDKNQMDLEKAPEVKLVMINGKEY
PEPGRIAMINTIINSTTGSVTARADFENKNNILSSGSTGKIKIPTIYKNAYEIPQAATID
LQGKKLVYVLKDDNTITTMPIDIIANTQKGYIVENGIEKGTTIVLEGVTKIKDGMTISPV
K
>fig|63186.3.peg.3633 Bicyclomycin resistance protein
MQKENVRPNFEFIALMASLMSIVALAIDALLPALSHIGITINSLDPLKNQLLITMIFLGL
GVGQLFFGPLSDSYGRKPVVYVGFGLFAIASVICVLAPSLEIMIIGRVLQGIGLSAPRTI
AISIIRDTYKGDYMAKIMSFVTAFFILVPVVAPAIGKWIMDAFGWQSIFYVQLFFGLLVC
IWFWKRQPETLKPQFKVPFSMGVFASGLKEFLKYRETIAFTFASGFVTGAFLVYLSSSQH
VFEDQYGLVENFPYIFAGLAGSVGLSTFLNGTLVLRFGMRKLAFMAMTAFCIIALTYVVL
FWGRPNPSVPILVAFLFVQFLCLGFLWGNFRSIAMEPIGHIAGIGAAINGFVSTILSVPI
ANFIGGFVQDTVWPMFVGLAICGLLSLGTMLLVRRPKVVVTA
>fig|632292.3.peg.1889 Daunorubicin resistance ATP-binding protein drrA
MKAIEIKKLKKSINGKLILKEINLNIYEGEIYSLLGPNGAGKTTTIYTLLGLLKKDDGEI
KIFGEELSKKHFKEIGLMFEIETYNLEWSVIDNLKHMCYLFGVDEHRIYDYVEMLDLKRE
DFRKKFKQLSKGTKRKISLIGALIHDPKILILDEPTSGLDPEIQVVFKKLLLDLKKRGKT
VLFVSHNLYEVQEISDRIGFIKSGETIFEIPVSEKFYLVEGDYPEFQTYRVKNSKLYVFD
EKMFLKIKPKNYQMIEKLEDLYAKFIEGRVS
>fig|633131.3.peg.64 Glyoxalase/bleomycin resistance protein/dioxygenase
MKLEFHHINFVSEDVDRLHDFYTQVLGLDDIPIQSFPRPNATNSSGYDGKIRFATDGKMQ
MHLATKDLTVAFKNGEVINPIEKGHIAFKTDDIAAFMVLLDNKGIPYSDYGTAFAKEWHQ
VFFHDPEGNVIEVHQSVG
>fig|633149.4.peg.2119 Glyoxalase/bleomycin resistance protein/dioxygenase
MARVSDIRYVGYGVTDLEAERRFYADTWGLREVGEKDGLIHFAAQGDDELYVVRLRAADR
KQVDIIAFAADTREDVDQLHRNVVEAGCKVVFAPRDLDTLGGGYGFRFFSPDGLPFEISS
DVATGEQRTLARWEGIPQKISHIVLHSPKHKEAADFFTDVLGFRVSDWLGDFMGFLRCNE
WHHRLAVLPGPPCLNHVAYDVASVDDMMRGIARLKQHDIDIKWGPGRHTAGNNTFSYFVT
PGGFAVEYTSELEKVDDDTWVAQVHVPTPTTMDQWGIGIGGPQTMPHPEPDAGLFQPVGV
>fig|633149.4.peg.2378 Glyoxalase/bleomycin resistance protein/dioxygenase
MTNRLGYFTIDTPDLGKAKAFYSSLLGWTFDDANSNPTYAHVLATGAAGEVAFGVRKGER
KDFPNLYIQVDDIHAMCARVNALGGRASMPAQSDSGLSAVICDDQGVSLSLWQPAPGLVD
>fig|633149.4.peg.2443 Multidrug resistance transporter, Bcr/CflA family
MAEPGTAFRPETGRLELLLTLGALAAFGSLSIAMYLPGLPAMAQEFHGSTTGVQDTVAAF
SLGLCAGQLIYGPVSDRWGRRAPLLFGIALYLVATLACIVASNLSTLVAFRFVQGLGGCA
GVVISRAIVRDRFTPQESAGVYSTLMLILGVAPILSPLAGGWIIAGFGWRAVFWVLLAFG
VVLGVVVWLRLRESSSAESRRRARSEHPFRSYLAILGDRQVAAFVACGGFGAAGTFIYMT
MSAHLLIDGYGVPTTAFGWLYGAGSLAVLIGSQVNRVLLNRFSSHRLLVWSTRLNLAACL
LMLATVSRWPALIPAFLIPLCLAFSMNGLSSPNAAAEAMGAAGWRAGAVAAVMGFAQFGM
GALLATIAVRVLDGTAFEIAAMLCVTSACAVGCLLFAGKSRALA
>fig|634176.4.peg.691 Permease of the drug/metabolite transporter (DMT) superfamily
MSKKLTATLYQKAIICMVLAYISIALMGVFVKYASDELPSSEILFSRFLIGFIFLLPFMI
RDGDFKVELSQWPFLVMRNLAGIASMLLTFYAIKYLPISIAVLLMNTSALFVPLLLFVLR
TRTPLKVLACSFLGFAGVSIIMLTDSSKHFELQHIGYALGAAFLAAMAFISLQELNKHNS
PKNIVFYFHLLGSLLLPLFFATQWTIPSTQGFVLLLLVGGFGLVFQLLLTRAFKYAPANV
ITPFAFTGVIFSSICDWLFWHNVPTLNFWIGSLVIIVSVSLLAKIRR
>fig|634176.4.peg.854 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNLTTIKEYHIEAKKLIAIAIPILLAQIAQNSMGLVDTIMAGRVSSADMAAISVGASIWL
PLVLFGHGLLLALPPTISYLNGSGQRKRIAHQVRQGIWIVIFSCIPLGLLIQHSDFVLQR
MDMEPRLAEITSGYLHAMIWGLPGYLLMINFRCLNDGIAKTKPAMVITFLGLMLNIPLNY
IFIYGKLGIPAFGAVGCGIATAIVNWVMCFLMITYCMHARNQRDLKVFANIIERPNMHTL
IKLLKLGFPIAVALCCEVALFALTSLFLSPLGAHVVASHQIALNTSSFIFMLPMSLGMAT
TILVGQRLGEKSPRGAKLVSYSALAVGLTITIITAFLTVILREQIAAIFVKDTEVIAMAG
SLLLLAALYQFSDTVQVIIGGVLRGYKDTKAILYITLFCYWVVGMPLGYALARTDFIVPG
GIAAKGFWTAFVVSLTLAAALLIYRLRKTQGQTDDILLAQLEKLK
>fig|634503.3.peg.2232 Drug resistance transporter, Bcr/CflA family
MLTTKNMPANAGLAAFSAQQRIAFILIVSISFLMGISIDLYVPSLPAISHYYHSTIASVE
ISISLYLLGYGLGQTVLGILSDSYGRKKIFIYSSLCFLLSSIFCVLSDSSTMMNGWRFVQ
GVAVAGLASGMRAIIVDLFSGLTLKKMANYFALSWALGPIIAPWIGSNLSHYCGWQANFY
LFAVYGGVIFLICLFLFRESNHNPSRFELSSIKNNFIEIIRNKKFTLLSIIYGLSYSSVL
VFNTAGPYLIEVVMHHSELFYGYLAMFLGLAYFVGTIINRYLITKFDNEAILKVGGTMAL
IVAILLWLLLSYVPNIFTLIIPIFLMFVCIGLIVPNAIAITMVIFPEKAGFATSLCGTIV
GLVVFLVTYLIGHVKISALELSLCYFALFLLLNVIKLAVYHQKNRPSPPEHLPPC
>fig|635013.3.peg.360 Permease of the drug/metabolite transporter (DMT) superfamily
MNAVFFAALCLIWGSTWMAIKINLGSFPPFFSAGLRFLLAGFVLLAAMKFAKVSFPGEWR
KLSPSFVFGLLNGISYGLIYWGEQYIPSGLTAVLNASLPFFSIIFAAMFIGERITLRKVF
GSIIGFAGVLLLFYESLSELSSGKIMGEIAIVVAAAVYALAGVHVKKRSSVEPLAAVTVQ
MLTAAAVLLLVALPVEYGAAVHFTWRGLVAFMYLSLFGSAVAFYLYNHLILRMEVTALSY
TSLITPAIATLLGVLIMEEELNGFMIIGMILIFTGTAIINIKGAHRSRDKLPDLSADSEP
YRQSEELRQS
>fig|635013.3.peg.1191 Daunorubicin resistance transmembrane protein
MNTNKFLLYLELIRLEFIRMLAYRSTYLTGIFNYAIQIGAYYFLWEAIYINRKSLAGLQK
EQMLTYVIIAWVVRSFYFNNLDQKITKEILDGSVAIELIRPYRYDAVKLARSLGEALFRL
FFFSLPSGLFIYLLRPFSLPQSSTTWGIFAAAMFGSYLINAQIALLFGYSAFFTHSTSGV
LRAKRVVTDLLSGLILPISFYPDWAQKALAYLPFQTISYLPNLIFLERLQGLAALKILVL
QAFWVVVLYILNRIVWRIAIGHVVVHGG
>fig|635013.3.peg.1275 Permease of the drug/metabolite transporter (DMT) superfamily
MTKKRFWPFAAITLVMIFWGLSFLSIKVSVAALGPMSLALSRFAIASLLLFTFLKIREPG
TRLERKDTLLMAVSGIIGITVYFFFENNGVKLTTASTASIIIGTIPLLTILADFIFCGNR
VTWSKGFGVAMSVIGVYLIVKESGDLSFASRHFIGNLMMFGAAFSWVFYSLLTRPLGQRY
SRLAVTTYQTLFGTAAIVPFALFETNKWDALNWVVVGNVLFLGFFCSALGYYFYVYAMGE
LGVDISSLFINLIPVVTVVSSYFILGEKITSTQMIGGGIIVLAVYFADLSNWLKKDDRRK
QTGQKTNPIENVKA
>fig|635013.3.peg.2037 Vancomycin B-type resistance protein VanW
MSLSTLKVFLLAIIVVAISAVLSFFVAIAVSAQEDQIYSGVWVEDISLGMLTREQARNKL
EELNDQIRGKEVQVKYPGGEAAFKLAEIDASIDVEGILKKAWEYGRKGSLLDQWQERRRI
AREGVIIPLKINYSRTKFEKLAQKLGAGATIEPQDAKLVITRQDTIQIIPGKQGKVIDTQ
NALAQIEDILNEKQEPVLNLVLKTKEPEMTTQEVENMHVNGIISHFSTFFNVQKTNRVYN
IKVAAGALDGTFIKPGETFSFNKVVGPRSKEAGYKLAPTILNNEFIDSLGGGVCQASTTL
YNAVLLAGLPIIERANHSLVVSYVPLGQDAAVAYGGKDFKFKNNLSSWVVLKTEVVGNRL
TVKIFGDTALKKDVRITNQILKTYPFKVVYKQDATMYKGKQVIKQKGVNGYKVASQRHIY
VNGKEVRTEKLPSSYYKPLDQIILVGTKKVAAKTKTSISTNTNNPKKPVAGQGTLSPGQP
PAAPPANAPQPEAPQGNQNNTGVVNPAG
>fig|635013.3.peg.2550 Vancomycin B-type resistance protein VanW
MPSRKKVFTGILSLIAIQVAVSVFGAVFFLAPADNELIYEGVLVENIDLGGLDKSAAEEK
LTRALEPGLRNSAITLTFRSKQWTLPYSQLGIYADYKKTVEEAYNTGRGNNHFLKMFDSF
RIRMNEVELPLAFRFDEEKMRKSLQELAAEINRSPKNAGVILLDNKLQVTPEQKGYRLDE
EASLQAIKNAVIQRKESCRLTVRQVAAEVSAGQLKDVRDDLAVAVTGFDAADKNRRANII
LAAESINNSLVKPGETFSFNYTVGQRTVQRGYKNAKVISNSNLTDGIGGGVCQVSTTLYR
AVLMAGLHIVERHPHSLPPDYVPIGQDAAVADGQLDLKFKNNTAFPVLIAVSVSDSELLV
RLIGKKQGNKKYRLVSDIYEIIEPKVTVKKDGTLPKGETTVLVSGQKGYRVKVFRVTEPE
GKKELVSEDYYKPLATVVRVGTKTNKDLRNRK
>fig|63737.4.peg.1227 Permeases of the drug/metabolite transporter (DMT) superfamily
MSLHQSSGRWRLGLVLSLLTVLLWGILPIALAVILQVLDVYTVVWFRFSVSFLLLAVYLG
IRGKLPKLEQLRSASWKLLAIATLFLGSNYFFFTQGLSLTSPANAEVLIQLSTLLLGFGG
LVIFKERYRLYQWIGVSVMICGYVLFFREQLTNLITAHGTYLLGSVLIALGSTSWAIYAL
AQKQLLQSLSSASIMLIIYGGCALLFTPLAKVKSLLILDPFHLGMLLFCAFNTLIAYGAF
SESLEHWEASRVSAVIALAPIVTLISVAVVSVIAPNWIPSEHFSLVAILGAGLVVTGSVA
IALGKGN
>fig|63737.4.peg.2097 Tetracycline resistance protein
MESKNNSRPILVLFLTVFIDLLGFGIILPILPLYAEQFGAKPNEATLLVAIYSLMQFLFA
PLWGRFSDRYGRRPILLLTLFGSVIAYAGLGFANSLWMLFLARSLAGIMAGNISTAQAYI
ADITTPANRARGMGIIGAAFGLGFILGPAIGGFLIGSDPDNANFHLPSLFSGGLSLFALL
CALTLLPESLNSETKAKMQANRHRRRRLNLLQLSQRPQFCVLVGIYFFVTFAVAAMDSTL
ALWSKQQLNWGPQQTSYLFAFMGIVSTIVQGGLIGFLKKHFGEIKLLTLGILGLGLGLLL
IGFSQSLILLLVATTLVAWGISVSQPILNSLISQMTAPEEQGQILGIASSCSALARIVGP
TWAGISFMKFGSDSPFLSGFLVMIVALALSLRVTKSASESNKERIA
>fig|63737.4.peg.2362 Permeases of the drug/metabolite transporter (DMT) superfamily
MMNNGKVLHLSLIGIAIFTIVSGLLQMVLPSLVLYIVSAEVTPTSQHFFAIIGMFMLLFN
GALLQALISPQPQPIVLIWAGLQKFGASITVCLAVIRLIFSPFALLIAGFDLLSGVLIFW
YLFRLRTFTPGYTYEQPTA
>fig|63737.4.peg.3863 Probable multidrug resistance protein
MFMSTLDVGIINVALPTLVQAFGTSFPTTQWAVLSYQLVSSGLVLGATRLGDMWGKKSLY
QGGLVLFTFSSLLCGFAPSIEWLIAFRALQGLGAVFISGLGLAIITEVFPSSERGRAVGV
IGSVVSLGIAFGPSAGGLLLSLSGWHSIFFINVPLGIIASFLIARVVPPSIRIQGKQRFD
FFGAILALLTLGSFGLGMTLGQSQGFGSTNALVLLVIATLSFIIFLVVEAVIKEPLLELH
LFRNLQLSMGLLSGWLAFIVIGGSLLIVPFFLESVKHYPTVKVGLLLAVSPVLSGLIAPL
GGILSDRFGARLISPIGLGLMIGGCLGISTFDAQITELGYVSRYFIYGIGLGLFQSPNNS
TVMGAVPRERLGIASGLLSLSRTSGNTVGVSLIGAVFGALIASMSAGADVSVAPPDAIVA
GFQGTFRFAALILCGAAVASVLRIGKRKGAGLP
>fig|63737.4.peg.5432 Permeases of the drug/metabolite transporter (DMT) superfamily
MVENQLILTTEKSDKTLNILPIIIVIIALLALSSTAILIKIALREMSATATFFNRLWIAT
IIFGFWNGINQARTQIKDDQPVLPQQPYPIKEIAFLIAVGLVHVLGRLSWTWALTQTGAA
NANALGSLNPLFTTLGGWLFFNQIFGRKFIIGLILAIIGAIAVGFEDLLRSNNNFTGDAV
ALISSIFYAANFLLIEQIRNKFSIITILLWRCVIATSLMVPVVLIFEKQPFPVSLSGWLV
VFALAAICESLGHGLIVYSLKTFSSGFISLLLLLNPVIVAILAWILFSENLSIFNLLGLA
LIVGGIYLAISNKESIKSSVNPPIQSLQKSEF
>fig|63737.4.peg.5579 Multidrug resistance ABC transporter ATP-binding and permease protein
MRGTIPVVASEQASKQLSTLRRFLQYLLLYRKEIPIALTLVFIGAVTQAIGPFFLGWSID
RLIEKGNLQGLLLLLGLLALNYGLGIIAIRGQIIRVGWIMQRLLAQLRQDIFLKIQSLPL
SFFDRSEAGDLMSRLLNDVNTVNQAFGLTIAQMLGNIFSLVGIIIAMLSINLQLGLLSNL
VVPLMIFTTSLFARWARARFRVTRQTIGELSAKLEEDIGSVREAQAFNRVQTNIAQFDVL
NAANRDANVEAVAITSAFLPSIDFLNTLATAGVLAYGGYLAVTGAVTVGVVTSFLLYVQQ
FFRPIQILSQFYTQAQSAFAGLERIFLLLDEPSELKDAPDATEMPPIQGEVRFENVKFGY
NPDQLVLKGVNLHAYPGQMIALVGPTGSGKSTIINLILRFYDVFAGAVKIDDIDVRSVTQ
ASLRRQIGIVLQDNILFSGTVAENIAFGAPHTTQADIEAAAQLANVHEFITSLPQGYTTQ
LGERGAPLSQGQRQLISIARAVLINPRILILDEATSSIDTRTEALVQSAIARLLQGRTSF
VIAHRLSTVTQADQVLVIQQGQIVEQGTHAELIERQGVYANLYGLQLGAADTTVLQNEK
>fig|63737.4.peg.6218 Permeases of the drug/metabolite transporter (DMT) superfamily
MNLNSLMNVSNQRKIALAALFVGVGAISFGSIFVKLSETQLSPNATVFNRLWLASVFFLL
WHGYKAIRQRLSLDKPEEQQLYTSQDLWLLGSAGIFWAGTLVLLAWSLTETSVAISSVLH
NLAPIFTSLGVWLLYRKSFESQFLIGMVIALGGAIAIEFEELQIATDEVQGGFAAIVSAI
FLSGYLLIVEKLRTKFSPATIQLWISAISALIILPILLFTQDQLFPSTTSGWLWVISLAL
ICQVLGHGLLTYCLAKFSSVVVSLVHLLEPVFSGIFALIIFSEKLTFSNWVGFAVVLMGL
YLAVSSQGVVNLPIHKLVTNIVNTFVKSMTSKLSLLKQQFSETPALLGTASLLFALIPIS
LAPSLTKLCQQEIGANAVVFHRSWIATIVFALWNLLEAFRSQQSENEPIENEPFTSQEVW
LLLAMGTSAGTYLLLWAWSLSQTSVANVALLSNLNSLFVALAGYVLFGRRFDNRFVIGLV
IALAGAIAFELNKVQFATDQILGDTLALLTAIFMATCMLLIERLRTRFSTATIMLWRCGV
TTMFLLPVLPFLEDRLLPYSWTGWFFIIFQALFCQVLGQGLLAYSLSRISSSVVAVTLLL
EPVLASIFAWFIFSEQVGLFDWATFAVVLVGIYLAQSSQSIVQVTNEAS
>fig|637380.6.peg.4872 Permease of the drug/metabolite transporter (DMT) superfamily
MTRTYILLFICVVVWGSNFIFGAILVNTFHPVLLTTLRLLFINLFFLAYAIMCKKGLYIE
KNEMKGVLLIGVIGVAINQWSFYEGLQTADPTTAALILALTPVMTSILAVFILNEPLTVK
LVIGGGIATFGVFFVIGVGQRFVFSEGLIWIFITMLSFSLSIVLIRKLGNRDDMFFITFF
SSIFGFLIMLPFLAFTFSHITLKYSIESWSLLIVTAILMHGICTLVWNNQLRKAQASTAA
MFLNLEPFVTMVVGYIILQKSVTSIQIIGAVFIVCGVYTATFGYGKKSKGQKELFRKAT
>fig|638300.3.peg.889 Outer membrane component of tripartite multidrug resistance system
MPPRPLLLALTAALLSACQTTTITTASRVPLPTAYESAPARADNTDIRRWWQAWHDPVLN
QLITEALANNPDLAIARSRLKEAQATTRLADADRGATIGLGLNAGHLDADLDNPLGGTPL
ARSDKINTHRTLLASNLSAKWEADLFGQKQSDADAARYAALASAEQTHIAQLQIAAAVAD
AYLQARALEARQRLADENIVTLEKLAHYVEARYRAGHTTAFEKTEAQSHLSAARAARSTL
AAERAAQARKIAVLLGKTPQDYQLPASSADILAHPPAAPGGQTPQGLIERRPDLRARAAE
INARAAKVASAKADLYPRLTLNFLGNGILNIDSDNTQKSLISLLGASLQVPLFTNGRVQA
NIDAADARLKTALLQYDQTLLQALADVDNAYQASDALATQTRLLAQARDEAEKQATDAEK
LYRYGNKTLADTLSARLSANQAAENQLRSQLAQAQTLIALYKALGGGWAEK
>fig|638300.3.peg.1052 Permease of the drug/metabolite transporter (DMT) superfamily
MPRFHIGHAALLLTAALFGIAFIFQRHSATAVSALIFMSWRLPVSAAFLLAILALCRRPA
WGHWLRDGICCGILLFLGMYSQQWGLEHTTAGKSGFITSLYVILVPLLALLGGERLGKTL
ILATLLAFAGLTCFAAIHSDSAALNWNAGDSATLASAFIWALYVNYYGIAVRRSELLTLT
TVQITVAALLTLPAALATEGAGALTDPALLNYSKWDILYTAVASSGIAFFLQGWAQRHVA
ATPTAIILSMESIFALAAGWLILDEPVTLLMLTGCALLFAAMTIAQLEPGKTP
>fig|638301.3.peg.1411 ABC transporter ATP-binding/membrane spanning protein - multidrug resistance
MKVIFQKFKKEVFVTIAILTLIATSQLLTSIVNAEILDYLVKMDMNGFIRETILLVAIFA
LYLLFTYMLIRYQAFFEQKVVTWLRDRISHAIKNTSYERFYEKNSQTYISWFTSDMEQIR
TKAFTPTVEVVGGAISAVFSAVALFMYHWSIVLLTAFCIVLMAVLPALFSGELTAKTMKT
SEENEHFSKHVSDLLSGYDTLFVFRKLNYLTHKIHERSVKVGDTQRDFSKTMAKVAVSGG
ISNLFCQVSVFVLTGYLAYIGEVSIGSIIATTGLSGIIFNVLGNISQKIGSIKSTAPLFE
KYELLESAQNNENVDKEDSHTLIEVSDVSFNYGEKVILNHVSLGFNEGQKYAITGESGTG
KSTLLNIIAAKLTEYLGEVKFAGVDVKKQSYDELYRQMVYIAQKPHIFTTNIRENVTLTE
EYTDEEVWESLEKVGLATIVRNLPQGLDTVLGDGDSNLSGGQLQRIAFARGLIKKPKVFL
LDEVSSNLDEKTTIEVLKPILEDKSVTVLWVTHHLPEDLKETIDQTIQMSELNHVN
>fig|638301.3.peg.1641 Glycopeptide antibiotics resistance protein
MYLLGPFYRWIVEIFADRVNHLPLVRLFIFSLDHAIVLFIGWLIVWSISLLFRKRKRIVW
KWELYRNLFIFYLILLSQVTIFRNLDESFTVEFVMHPLSDIMWVPFVDSIKLFMQGSIFA
AYYNVVGNIVWFMPLGFFCGMLYGSKKGESRSLKYGFLTSFFIEFAQFIFYTGVSHIDDI
ICNVLGSWLGFLLYRLIKKRRKK
>fig|639282.3.peg.955 Permease of the drug/metabolite transporter (DMT) superfamily
MDNKELKGSLFIILAAFLWGTTGTTQGLAPSEANSAVLGTLRILIGGLALFFIAYIKNKK
LNLSNIPLMLTFLGMASVALYQLSFFYGVKLAGVAVGTVVGIGSSPISAGLLSIIFLKEK
IPAKWYFSTFISLLGLIFIGLGGSNSNYDFNILGIFLAILAGFSYALYTLVSKILLKSLD
NDTVMALLFLGGAILLSPILFFNDLSWVFTTKGILVTLHLGLFTTTISYIFFIRGLNYIN
VSKTATLSLTEPLTATFLGITVLHEKPNIYSIIGIILIFLGILILTYNKNKKS
>fig|639282.3.peg.1816 Permease of the drug/metabolite transporter (DMT) superfamily
MIATYRLVIASTILNIIYFRKGGKRFDFQKADFIYGFAGGLFLALHFVTWFQSLKYTSVA
SSVVLLSTGPIFVAVLSYIILKEKQSKEIIIAIILAIVGSAILALGDSNADFAFGEKALI
GDFLAISSAFFVSFYLMVGSKLREKMDILSYIVLVYTFAAIILLITSILMQIPFTGYSVK
SYIFMVLLAVVSQNLGHTAFNWALKYIKTSVVSLTTLGEPVIASFLAYIFFGETIDKFKF
IGIILIFVAIIIGSRKGEK
>fig|639282.3.peg.1818 Permease of the drug/metabolite transporter (DMT) superfamily
MREKLREYIADISLIFISLIWGSTFVIIKEAIEDVNVFSFLTIRFGLATIIMLFFVFKRV
DKLRDSFVPGLFLGLTLFAVFAFQTIGLKYTLASIAGFLTGLYVIFVPILSVIFLKQVPR
ITSIIGVIFALSGLYMISFYGEVAEFNIGIVFLILNAFFIAIHIILIDIYSKKYDVVILT
FIQFLVIFVLSFLFSLLFKENLFDITFNGELIFAFILTGVFATVVAFFIQILMQKYTTPT
KAALIFTFEPVSAAFFGYLIGAEILAFKQYIGSFLILLSIIISEVGPFLLRKYFNRGIND
>fig|639282.3.peg.1969 Multiple antibiotic resistance (MarC)-related proteins
MALTKGMTVKERKSLLNKSIIVAFILIGIFTVAGSSILWLFGIDVHDFRIAGGALFLLIS
IQIIFGNNESEYGEKISGIVPFATPIMVGPGVITATIVLTGTVGVLPTLISGIIAFILTY
VILYFGRQILELLGQNVADVITKVIGLILAAISIHYIREGILGVINQFKS
>fig|639283.3.peg.620 Multiple antibiotic resistance protein MarC
MNWSERVQEFVTLWVVIDPLGTLPVFLAVTTGLDAADRSQAAVLSIIVSFGVLTFFSLAG
HWLLKTMEISIESFQIAGGIVLFLFALTMINGTSHADTVAPAETNPVEIAIHPLAIPSIA
SPGAMLAAVVLTDNARHDVPDLMMTIATFGLVLLATLAIMLAGSRLVHVIGRGGTSIISR
VMGMILAALAVDLVLSATAQWLHLPPI
>fig|639283.3.peg.1367 Permease of the drug/metabolite transporter (DMT) superfamily
MPLRDKLLAIAVVGVWGLNMIVIKLGVAEIPPLLMSAMRFVLVAGLVLPFTRIKRADLPV
LALLSFTFGTLHFGFLFAGLRNAEAGTSAVIIQLGAPIATLLACLFLREPLGRRRLLGLL
VSVAGIAILAAGPTLPGPLSFTLLTISATGWAVSNLIVKNIDDISPMAIMGWSSLLSVPQ
LLLGSWVFERAEWPLVYAAGWHGWLCVLYSAIASSIFGYGIWYWLLRRHPISAVVPYSML
NPLLSVLFGIVLIGDDPSPVKVAGALVMVAGVALILRKRDAKLPDTA
>fig|639283.3.peg.2453 Permease of the drug/metabolite transporter (DMT) superfamily
MTGYAFGAAGAVLFASKGIIIKLAYAEGIDPETLLALRMAFSLPFYLVIGGIAIAQMRAK
GEALPGLRIVLQSLFVGALGYWFSSYADFLGLAHISASFERLILYTYPLFVVLFGALLFG
QPIRMKALWAFAAAYSGLALIFAQNFSANATNTVHGSLWVGAAAITFALYQLMASRLLKS
IGSALFTCIAMISASVVSIGQFVVVRPLDALAISPHGLMLAVMIAIGATVLPSFLMNAAL
KRISAQANSMISTVSPVVTMVLAVLILGESVSGIELAGAAMVLVSIGWFTLSDSRRRAIR
>fig|639283.3.peg.3038 Permease of the drug/metabolite transporter (DMT) superfamily
MEKPIHPAAAGAALEPSFRDRLVGIGCALLAVSIWGAWIVSTRHAVHGHLPPATVGWLRF
VVPAVMLAPAWWRVGLWPKRGLGPFALCFLGAGGIFFLVVANAMRFVPAADVGPLLPGTM
PLIVALISVFVFRERLGRLRAIGFICIALGVLTLGGRGVLAHEDGAWRGHALLLTGALMW
SGYTLAFRRTGMKPTEIVGLTGVWSIAILTPFGLPGVIDALQQGYGREVLFQLLMQGLLS
GVVALVAFGVAIERLGSTRAAAFTGLVPALAALIAVPALGEHPDLAAIIGVVATGIGVTL
ASGAFKAGR
>fig|640081.3.peg.13 Permease of the drug/metabolite transporter (DMT) superfamily
MLGEQADTHKVSAFFMCRHKKAHDRSGPAGKNGGSFRLRPQAMNAASLARLLLLAAIWGA
SFLFLRLTVPAFGTVWTVEVRVILAAASLTLFAWWSGEALQWRRHWRQYLIIGLCNSALP
FLLFAYAAQSLGAGLLSILNSTSPLFAVIIGALWLRQPIRAVTVAGLLLGLGGVAVLAWD
GLQSSGSPDAWLPMLAAALAPSAYAFASVYSRHHGQGITPLATTQGSMICAALLVLPLAA
PQGLPAAATPTAWGALLGLAVLCTAWAYQLYFRLVHEVGPLGALSVTFLIPVFGVLWGVL
LLGERLGGHLLLGGSLVLLGTALANGLLKWPRLARPA
>fig|640081.3.peg.1319 Permease of the drug/metabolite transporter (DMT) superfamily
MNAIAPPLPAGIAAAPSRTRVLIAGIAFSVIWSSAFVAGRIGLDHAAPLTLLAIRFLAAG
LLFAFLARSSGRSLRLPTMAGRALLAGLVCNAAYLGLAYWGLQGVPTALTAVLVSACPLL
TLLLAAALEGERLTPLRLAGILLGMGGVLWITRHRLTVEQLEPLYLAAIGAGTLALALGT
VLSKKVAAGQDLIAAVTLQFMASGLVLLPLAWGLEGFRLEAHPALWGSLAYSVAVSLAST
LLMLWLLRHGQASSASSFHFLNPFFGTLFAVTLLGETMYADDLLGVLPIALGIALVAWKR
>fig|640081.3.peg.1462 EmrB/QacA subfamily drug resistance transporter
MSFSSSPRSLEALQARHGGRYPWLVLAAMACGMVTAVLSSTIFNVAIPSLMADFHLGQDR
VQWAVTGYMAAMTVAMLPTAWLIERYSFRRVFLGAVLLIGIGSLGGALAWNFPSVVAMRI
VQGLAAGLLQPMSTLLVLRLFPLERQGRAMGILGFGIILAPAVAPIAGGFLVDHFGWRAI
FLITVPGSLAALAAGHLLLPHKPAARAEHPFDWTGLSLLTLAILSLLQTVGGLHAHGLLS
TQSGVGALVAAAGIALFLRHARRVPGPILALGLFSERAFAMGTLVSFIFGVGLYGSTYLV
PVFLQSILGYNAATAGLALLPGGIALALMTPGAGYLADRIRPHRQTALGLLLFAISFVLL
ALLAGISLGLPLLPTLMGTVVIGRIGLALILPALNLGALRPLAQRLVGQGSALLNCTRQL
GGTLGISLGAVYVEWRSNHLGQPAGSAQAFAEVFALVALAFFLALGGALAMGKPATAATA
AGR
>fig|640081.3.peg.1795 Permease of the drug/metabolite transporter (DMT) superfamily
MDNQHLRRGYFYAALTVAVWSGFILVSRLGGKSPLTAWDVTALRFGTAALILLPVWLWRR
PRLNFSWRMVILAVTGGCGYGVLVYAGFKLTSAAHGAVLLPGMLPFLVALMAWLVLGERP
SPQRWLGLVGIAAGIACLATDSFGSSVGDWRGDLLILASSLSWAIYTVLVRRWQVAPWDA
TLGVGLVSAALYLPVYVLWLPHNLAAASLSTIALQAAYQGVLAVIVAMMFFMRAVAILGP
TKVGTLMALIPAVAGTAAAPLLGEPLSPWLMAGLVLVSLGAWVGSQTRFFVRRNAVCPT
>fig|640081.3.peg.1816 DMT(drug/metabolite transporter) superfamily permease
MNAYRRWLPLLALVVLSLTWGYTWVLAKQGLAHAAPFAFAAERCIGAALALVVVLRLLGK
PLRLVAPGQTLAIGLTQVAGFMVFQTWALVEGGPGKTAVLIFTMPIWTLLLAWPILGERV
RGKQWLAAGSTLVGLLLIIAPWDMHSSLFSKFLGLMAALCWAVGTILIKRLRGAQPVDLL
VLTTWQMIIGAVPLTLLALVVPEHPTDWNLSYVGILMFMSVASTALCWWLWIYILDRVPA
WEASLSVLGTPVVAILSSRLTFGEAFQASEVAGILLIGGGLALLSFFGWLASKRNPIVVP
AAGPEGKNP
>fig|64091.1.peg.544 Daunorubicin resistance ABC transporter ATP-binding protein
MTDLAIRADGLTKRYGDEAAVDDLDLAVPAGSVYGFLGPNGAGKTTTMRLLTSLTDPTAG
TAEVAGVPVTDRAALTPRIGYLPADPPVFDELTGWEQLRHVARLHGLDDGEADTRIESLL
ERFDLLADADRRIESYSTGMTKKVGVVAAMLHDPDVLFLDEPTSGLDPRAARTVRDTVAD
LSAGDATVLLSTHVLPVVDELADTIGVIDDGVLVADGDPENLKSTAREGSAADLETVFME
VTADADAPLPDS
>fig|64091.1.peg.1222 Permease of the drug/metabolite transporter (DMT) superfamily
MSFRRPTLGETPTTVLFLLLAAIWGSSFVAIKIGIADVPALSFAAIRYSIAGLIVLAYAA
HTTDRWRPRGRREWVLAATVGLFVIGIYHGALYLGEHDVSAPIAAIVISLAPILTAGFAS
KLHENVTIDGTQAAGLLAGLAGVVIVANPGSAGSVDLGGLLLVFLAAASFALGGVLTGKL
PGGGGLPVETMEAWAMLIGSLALWVGAAVRGENVTAVHWTPTALASLAYLTLVCGAGGFL
LYFVLLERAGATEINLVSYLEPIGASVVAWALFGDVVSPRALAGFAVIFAGFALVKHRYI
GAAVRNTTDDAEL
>fig|64091.1.peg.2479 Permease of the drug/metabolite transporter (DMT) superfamily
MSRYRTTGRFLLLCAVWGTAFMATDVGLADLPAVPFAAVRFDIAAALLFAAVFVSDADVY
PRTMDDFVYVLVGGTLTIGAHHAFLFTGQQYVTGGVAAVLLGLVPVVTPALTRLVATDEQ
LTAATAVGVMLGFAGVVIIANPDPTNIADSVLGVSLVLASAFAFAVAAVVTHSRSPSLPF
LSTQAWLMATGAVVLHVAVLVLPGQSFAAATWTPSALGALTYLSVVAGVGGFLLYFRLLD
DLGPIEMSFIEYVIPVFAALAGWLVLGQEITPATVVGFAFILSGFLASKWRALRLRSVVV
TTISSFTGPRDD
>fig|641118.3.peg.394 Probable multidrug resistance protein norM (Multidrug-efflux transporter)
MVAALTLGWPLIFTNLSQAALTATDVIFIGRLGADTLASALLATSFYHTLMIFSMGLVSA
VMPMIAIALGKNRHSVRDVRRTVRQGFWTAIMIAVPVWVVLWHCEEIFLFLGQRPDIAAR
STDFMHTLQWALLPYLGYIVLRSFFAAMEKPMWTLLIAALAIGFNALAGWTLIFGHFGFP
RMELHGAGIATTASSTMMFLGLAFITLRHRRFRRYHLFGRFWRPDWARLLELWRIGIPMA
LTFVFETSIFYAAVVMMGRIGPTAMAAHAVAIQIASLSFMVPLGFGQVATVRVGRAYGAG
HPKAIAYAGWSAYALGVGFMAVMGLLMVLIPRLFIGVFLDLHDPQNLPVMELAVTFLALA
ALFQIVDGAQAVAAGMLRGLRDTRVPMFLALFGYWGVGLPLGALLAFKFELGGVGIWLGL
AAGLGIVAVLMTLRWRRHLAHVSAHPA
>fig|641118.3.peg.2806 Multidrug resistance protein B
MQSSIEETTPAGIAGHAPAGWGELLSGKNGLYALALAGGVTLHAVNMYIATTVMPSVVQD
IGGMDFYAWATTLFVVASILGAALTARLLKSAGPRGAYVVATLLFAAGTLISSLAINMPV
MLAGRSVQGLGGGFLYALAYGLTRVVLPERLWGRAIGLISAMFGVATLIGPAIGGIFAEY
GAWRAAFWSLLPVSGLFAVVAFATLPRSSWDRNERVSIPVLQLILLTGAVLAVSAGSLSE
ETLWKIVGLGAAIFMIAIIAVVDRDAKARLLPRRSFSLSTPLGALYLTIALLMLSMQPEI
YVPYLLQHLHGQSPLWAGYLAALMAIGWTVASFLSSRWQEKGGDRLVVAGPVLALAGLVL
LAIFLPIHGNGNWSLLAPVCLGLILIGFGIGLAWPSLVTRVYQSAPLTEQDLAAGGMTTV
QLFAIAFGTACAGMVANFAGIAVPGGVEGAANASLWLSVIFALAPAIAVAVAFKVIRITG
GKG
>fig|641149.3.peg.676 Outer membrane component of tripartite multidrug resistance system
MKFNQIHLLCIAAALALAACKNTEVPLNSQVQLPQAFTQDAAAKGDADIGTWWQQWNDPV
LSGLIAQGLAQGHDVKIAVSRLNEARAVAGAARADLGPTVGLSGKVGANYSKMDNPLDSN
ARALLSRYPQASSLNGDTIESTGTSMYGGLTASWEPDIFGKKRSDADAARYAALGQQELA
YGAQMLVAGDIADNYFKARAAQGRLKTADQTVATLRRMVRYIEGRFKAGHVSGYEVNEAK
VQLTAAEAKRATIGAEYAAYVRSIAVLTGNVPQTFTLPESSADVLARQPSAPGGQTPQGL
LERRPDLRAQAAQVNAYAAKFASAKADLLPRFTISFMGQGGRIGVDGDRSLTGWASLLSV
GIQMPLFTNGRIKANIKAADARLQTALLEYDKRLLTALGEVDSAYQGVESLSRQTELLQT
AHNQAARHAADTEKMFRNGYKTLDVALKAHIAEGQMQENLISARLARVQMLVSLYKALGG
GWSAK
>fig|641149.3.peg.771 Permease of the drug/metabolite transporter (DMT) superfamily
MIAAALCFTLMNLCIKAAAQKFGLYSGELVFWRMSFAAAVLGITAKAQGRTFSTPHWKTH
LNRSVIGSAAMLCLFYAVMHLPLATGVTLSYTSSIFLAVFSFLIFKERIAPYTQAVLVLG
FAGVVLLLNPSFGSGQETAALAGLAGGAMSGWAYLQVRELSLLGEPGWRVVFYFSVTGMV
LGAGWAAATGWHIPTADMLPYLCAVGLSALVAQLSMTRAYKVGNKFTVASLSYLTVVFSS
LAGIVLLGDKITWQEIAGMVIIVASGILSGIKPIWIKQLFTR
>fig|641149.3.peg.1286 Outer membrane component of tripartite multidrug resistance system
MKFNIAKWSIGVLTVCTLSACAQFGKQAPLEEPTAYSLSEGKSAVMAKDAWWLQLHDKKL
NLLIAQAIQTSPDLRVAKARFDQAQAQLGLTEAATKTQIGFSVRGAGAYVSPKPASRQGE
TDNTLLLANAALQGSWEFDFWGKNRNQIASVLGKRQAILYEARQTRIMLANAVAAQYFAW
QSLEEQQKLLARRTETADKTLQLMQRRVRAKLMPPESLYQIELLQHRLQLERLSLEQQTA
KVRNSLSALTGNAPYTLPVRFPEEMANVPNLPVDRIYADLLAVRPDIAVQKSLLESKYHA
IKSTEAEFYPNIELKVLAGMAHIDAFNVIHGRNSAMLGILPALNLPIFTSGALQSKLWGR
RAEYNEQVAIYDRTVLNAMRSAADAVVDYQSLQAKKLVWDKMLNTSGKSVRAVQNRVKVG
LENGLDVLQKQEERLQLQMQAVQYQAEYLTAWSNLHAQLGGGVK
>fig|641149.3.peg.1287 Transcription repressor of tripartite multidrug resistance system
MSFSQAELVNALRLLSGRLPEFSEQQTQVGRLLRIVTERLSDHLNENLKVLGINENLWFA
MMAVYVSPNSEILPSRLSDMMDLTRTSATRLSDEMVERGWVERHINQQDRRQIVLKLTPE
GEAFIQKVWPQVSSKSGEAWQDFTNEDYAQLQYLLSKLLNRLEG
>fig|643562.6.peg.316 Permease of the drug/metabolite transporter (DMT) superfamily
MTRPSLSPSLSPSGASRATPSPASAYACLALAMVIVGSSVVAGKIMVAELPVFLASALRF
VLALAILLPLLRIREGGLPRLSRRSWLLLAGQSLCGSFLFTVCLLHGLKLTTPASAGIIT
ATTPACMGLLAWVFLRDRPTRRTGAGMVLSVLGVLAVNAMGGEPGGIAPAPLTGNLLVLC
AVGFESLFLLVRKGVPEPLTPLAASTIISLFGLVWFLPMGCVELAATDLAAVSLIGWLSV
AYYGAFVTVLAYVFWFAGITRVSASTAGVFTAVMPVSALVLSATLLGEPVGWPQLAGCVC
VLGGIVLISRR
>fig|643562.6.peg.1245 Permease of the drug/metabolite transporter (DMT) superfamily
MFQGLVYAVISAVAFGSLAVLVKLGYDAGLSGSEMMQYRFTYAVVVLGTFMLLRDRSLLV
ISRSGLARCALLGLVVYWLQTTCFVRALETIPASTTALILYFYPVSVTLLSAVFLGMKLN
RVVLGSLALVLGGCCLVFYDAFLKEANPVGLLYAVGAMCFFSCYLLLVQVLLRKLKPLTA
TFYVMFFAAISFTLSGDPAAWLSPTWERVVFGVSLGVVPGVVAVSFLYMAVEKVGSAYAS
IFSSVEPVVTLAGAAILLGEQVALLQIGGTVLIILGIVIPNLRALLLRRRAATLIRSA
>fig|643562.6.peg.1424 Multidrug resistance efflux pump
MVQTILLTLGLAMILAACSENPANRFQGYVEGEFVNIASPLGGTLDALSVVRGQQVRQGD
PLFVLEHEYEQASVDDARHGLQRAQDSLADQETGQRPSEIAAIKARLRQARAAATLARIE
YDRRVKLIREQTISQEELDQAKNDFDQTTHRVREINAELETARLGARSGQVLVAEAEVRQ
AQAALDQALWNLGQKTRVAPADGLIFDTFFRVGEWVATGQPLVSLLPPENIEIRFFVPEA
VVGSLAPAQEVQVTFDGAPQPVAATITFISPSAEYTPPVIYSSQSRAKLVFMIRARPALA
DAPSLHPGQPVDVTIPALPR
>fig|643562.6.peg.1492 Permease of the drug/metabolite transporter (DMT) superfamily
MIPYQSPTMLQPQTLGYVYALLAVVIWSGNFVIASGFVDALPPITLAALRWGTATLFFAP
FVVGRMRREWPAIRANLLPLCGAAFTGVTVFNTLIYYSARTTDTVNLALLTGTTPIFVVI
LSRLFLGEKITPFRAAGLAVAVGGMVAIATRGDLDMLRTLTFRTGDLTMLLAGLLWAVYS
ILIKRRSPSVSLFSFLGVTFLIGLIPLIPAALIEQHFHPAWAMTPAIVGAALYTGLGASL
AAFFLWSSAVCLIGPGTSSLFQYLTPVFSGITAYFLLGQPITVWHGVGFVLIFTGVVLAT
RQR
>fig|643867.3.peg.1112 Acriflavin resistance protein
MAVSYPISILMLVLAVILLGTISFGKLPIELFPDLKNPTLFVELKAGIKPPSEIEKQFVE
SIESVAIRQNGAVEVSSISQTGYGRVTVQYDWGKDMDEAFLDLQKSLSSFSLDEEIEEFV
ISQFDPNATPIMILGIYNPNSNDTEALRKVAENNFRNEIIRLPGIAEVRLSGEQEKEVVL
ETDPNLLASYGLTVNDLVAKIENYNRNVSGGFIEELGRKYVIKGLGIIEDSEDLEELVVG
YTNRQSTSSNPNSTNVNAEMAQSTSNPQTSTTAQVPVLLREVATLKIMDKEANSIVRVNQ
QRSLGLSIFKETKYNTVNAVNELTEVLDGLKKSVPGYEFVIIQNQGRFIQGAIDEVKESG
LYGALFAVIILFVFLRRIGSTLIISIAIPVSIIATFNLMYFNGLTLNVMTLGGLALGAGM
LVDNAIVVVEAIFRRREEGMSVIDAAVKGTSDVSGAITASTLTTIVVFLPIVYLQGPSGE
LFKDQAWTVAFSLISSLAVAILVIPMLFSQIFRKDNRKQMEKPLKYKAYRNFLNKVLHYR
IAFIVLSFLLVLGSYQLIGIIGSEYMPQAGTKAIAVDLKLANGTPLTRTSSTVDQIEGQL
SILFEEQLDHVYSHIGPEKSQSGIDNENVYDENKASLKLIFKEDVELDINEVTSALSTYF
EGIPGLTASFSNDESALNAILGEEQMPLVVEVSGAEFEALSALSDSVMVILNGNEDIYEP
VSNLEEGVPQIKVDVDKYRAGLLSLSIEDVITQIKDQLEGKKAGTLERGGELQDILVKVP
KISLSGLENMRIKSSNREFPLSEIADISVQYAANSIYRKNQSRMVTVGARVNQDKAYNQI
VKSVDDAFAEMSVPPQYKISVAGQEVKRQESMNNLLFSLLLSVLLVYMVLASQFESLLHP
FTILLTIPLACVGALVSFWILGMSLNMMAFIGIIMLAGIAVNNSIILVDSINRNKRSGMD
LRDSILDAAQRRFRPIIMTSLTTILALLPLTFGFGESAALRAPMAVAVIGGLVSSTLLTL
IVIPCFYESIENLISKIKGTSSAKKEVSHE
>fig|643867.3.peg.2101 Drug resistance transporter, EmrB/QacA subfamily
MAKQHHYQLSSTTGKWTLAACIIASSMAFIDTSALNVVLPSLQEDLEATGTDLFWVLNSY
LVMLSSLIIVGGSLGDKLGRVKIFQWGIILFIAASILCGLATTINQLIWFRILQGTGGAL
MIPGSLAIISATFSDQEKGKAIGTWSAATVLVTMGGPILGGALADIGLWRLIFFINVPLG
IITVIMLFLKVPESKAPENKHRIDWKGAFFLAFSLATFTFGFLNIPELGISNIRSYLPLL
IGIVSFGAFLYVEKKVEAPMMPLEIFKNLTFSGVNLLTFFLYAGLSAVMLFLSLNMIQIQ
GYTQMQAGLTFLPFTLLMALIARKVGALSDKWGSRNFLIVGPLVTAIGFVMLGLVGKTSG
IEDFWTSFFPGILLFGLGMSITVVPLTSTVMLSIGNDQAGIASGVNNSITRISGTVINAI
LGAGAVFIFTVLVSNQVETLQLSSPLSNSIIQESINFGEAQVPSNVPSEHIRDVQQIYTT
SFISTYRWVCYISAAMAILAAAFAVFMLKSRSK
>fig|643867.3.peg.3246 Permease of the drug/metabolite transporter (DMT) superfamily
MNKTWQIHGALALVGLIYGANYVIAKGVMPNYMSPNAFILLRATVATILFWIYHALTSSE
KVIRKKDYWLFAKCAVFGVMGNQLIFFNGLSLTSPVNASIIMTANPIIVLVISFWLLNEK
ITWRKIIGILIGAVGVILLVLNKEVSIDNDAFLGDIFIFLNATFYAIYLVMVKPLMQRYE
PITVVKWVFLFGTLMIVPFGIVPIFDVEFQAFPSGIWWSIVYVIIGTTFLAYLLNAMALK
HVNSTIVGYYIYLQPVFATLITIILGQEVFRWEKTVFALMIFFGVYLVSQQKKTKNEEAT
N
>fig|643867.3.peg.3642 Drug efflux protein
MEKLATAPLENILSQLRDLDELNSQSRYGSGNITLRFSKNADLAYKRFEVATLVRQLYPE
LDENVSYPILQSSGGDDEEGENKTILRYTVRGPFASYRIKEITQESIVKPLQNVAGIESL
PVYGANSLQISINFHSEKLEAYGLSPVDLRAALQQGGQLRYPGLAQSASNEKYVLVLDQR
FTDIQQIVELKITQKESGKSYRLKDLADIDLEEQEPSSYYRINGENFVTLVVEARKGVNR
INLAREVKSRLNEIEDNLAQGVALRLVYDDTEYLEKELDKLYERSILSISILILFIFLIN
RNWRYLLVLFAGILVNVSLAIIGVWALDTEIHLYSLAGLTISFGLIVDNAIVMIDHIHKY
KNRHLFLALLAASLTTIAALLLVFLLPEEQKMNLVDFSKVVALLLGVSLLVALFFTPSLY
ALLFTTQNQKRKGNTMRQLRRKVRWFNRYSSAIHWSAKYRKAFFTLLLLAFGLPIFMLPA
KWEDQEWYNKIIGSDIYQDDIRPISDKWLGGSLRLFVRNVYERSSYRQNEKTRLYITGRL
PYGNTLEQMNTIMRDFEGFLLQQEGIDIFTTQIYSGQYGSIEIIFEEDYEKSAFPYQLKA
RLSSRSTNWSGVNWSVYGVGQGFSTGSSDRIPSFRVALKGYNYFELENQADKLAEMLLEH
PRIQEVNTNERMSWRDQKSKEYIIRPDLKELAFHNISLSDFTNAIRMHAPANGATAYLPI
NGEQFPVALASAKADDFNKFALEQYSLGYEGKRIPTGNLSKLQLESTVNAIYKENRSYIR
ILSFEYYGSSRFGSKYLEEVLTTYDQIKPLGYRAERQSFNWGSNTAKKQYSLLLLLIVAI
FFICSILFESFKLPFYILLLIPLSFIGLFLTFGWFEFYFDQGGYAAFVMLGGLTVNAGIY
ILYDFKNRKIQNSRSFLKSVSTKAAPVLLTIFSTCFGLIPFVMSGQNEVFWFSLAVGTIG
GLIFSMIGVFFFFPLLAVGKGK
>fig|644282.4.peg.2148 Polymyxin resistance protein PmrJ, predicted deacetylase
MAELMTMAARRPQGPLVALKVDVDTKIGMVEGVPRLMAILRRFGLKASFYLSVGPDHSGR
ALKRLFRPGFLRKQLNSGAAVAYGPVTMLYGLVLPGPIIARQAPELFGLLLAQGHEVGLH
AWDHVHWHDRVRGLSFEATKRQFDLGRELFTQTAGFAPMSFAAPGWQVTTQALQIMAQAG
VTHTSCARGGRPFRPLGPDGPLPLVELPSTMPTMDEVLGLGLAGPDDIGRWLAEQVRDDE
LNVFTLHAEVEGRALAGAFEEMLEALTARGARFVRLVEAARLAALEPLPVEGLVWGPLAG
RAYDVVMPASQNPGGEPA
>fig|644966.3.peg.116 Permease of the drug/metabolite transporter (DMT) superfamily
MDGRTLALAGLTLVFWSSAFTVIRAGLAYWSPGQLALVRFLVASVALAVGIGLQHAARRR
GQRAGACRGRGLRPDRVRWAAPGKPAAAANGRPGPHGPHDARRRLPLRDAGRFLVLGATG
IFLYHTGLNWGETRVPAGTASLLVATAPALTALLSRLWLGERLAPRAWLGLALSFTGVAI
ISWAASTGPVSPAGMAGAVKPLSASGPAGLAAQTVPGDGAGGGPMGSLQAGISAAAGFGS
PGAPAGWAGPAAVGGAALATSAFFVLQRPLASRYGSLELTAFYTWAGTLLLALAFGPGLV
ADLQAGRIPPAAWIPALYLGLFPSALAYWAWSAALARDSAARVASLLNLNPLLAVATAWI
ALGERPSWVELAGGAVALAGVLLVQGRPPTPQGQRPGSFRRQDPPPVPVAAEPAPPTPPA
AVPVEPGGSPAGPGDRPSPRPGGR
>fig|644966.3.peg.299 Acriflavin resistance protein
MAVWRWAIARPVATLMAMGVLVWAGLFSLRTLPVGLLPALDPPVLTVVTTLPGASPEAID
QLLAPPLTQALRTVRGVEEITARSGDEAAVVVLRFRWGTGLDAAREQVHQRLDALPLPPG
AGRPQVLRFDPQQLPMMEVSLAGPGDPVQRARQVREVLLPRLEAVPGVAAASLRGAPEER
VEVVLDAAALRRHGLAPGQVQAAVAAAAATVPAGAVAGGDGARRWPVEVEGGFDHLDDLE
RVVVGLSSPVAVVPPGPVPGLQTPERGAIPEPGAAGDTPVAASPGMEGSRDGTPDRPDGA
PGRGGAPGRRPAPVLAGAVPVRLADVATVTVRRDPPPDVERLNGRDGLGLVIYQEPGANT
VSVSRGVREALAGGLAALPGWEATVTYDAGLLVERAVRGVGQSLLVGSLLAVAILWLFLR
RGRAVAVVAVAIPISACATLAAMHLAGMTLNVMSLGGLALSAGVLVDQAIVVLESIAHRH
RQGLPPREAAEAGTAEVAAAVAGSTVTNLIVFLPVLFLGGLAGQLFHDLAVTNALAQAAS
LLVAVTVVPVLAAWWLDEPVPLPAKASRAQASSPPATGPVPATGAVPAPGPAEGPAPWAV
GHPGPDGAGTSATTLVVPPLPRPFEACLARPAVTLVAALVLVAASVPAAARLGTEFLPAV
DERAVDVTVTLPQGSSLAATTAALERVEAAVLRLPGVETVVVRAGGSAWPGMAGAQNQGL
VRVQLAEGAGSSAAWAERIRRRLDGARDPGLDRLGAQVTVQPRNLWADVGAGAPVVELAL
RAEDPATLAEAAAQARRVLAGMPGLADVAVDLDPTAPRLLVRVDAAAAAGYGLAPAQVGQ
QLRLALAGEAVARARVDGRWLPVVLRTAGMPARGNLPAVTGAGPSGAGSSAAPAGPAPAG
DQGARPALGAGVGQLPLAGGTGWTRLNDVATVRPDATPAALVRRDGWLSATVTARVDGTD
LGTAVTRARQRVAAALPPGAAVAPAGTAVLMEEGFATLVPAALGALLLIYMAMAAQFESL
VHPLLMMVTLPLALVGAVAGLAVTGYPIGLTAVMGGIVLAGIAVNNGIVLVDAARRYRAE
GLAPAAAIRQAWRRRLRPVLMTALTTLLGSLPMVLAPGRGSELEVPLAAVLVGGLFTSTA
LTLVVLPCAWLVVETRRRPGAPSRP
>fig|644966.3.peg.560 Permease of the drug/metabolite transporter (DMT) superfamily
MALFSLTLPATRLALEALPPELVGPGRAAGAALAAALVAACAGFARGARGPGRADAPAGS
GPRAAPEAAVTEGTAAAPGPGWLPPREDWPSVLLVAAGTVTAFPWLSTLALAQVPASHGA
VLLGLLPLLTSGYATWRAGERPSARFWWAALTGSAVVVGFALHMGAGRLQHGDLWLLAAI
VAAAAGHGEGGRLARRHGGFLPIAWGLWVALPVTLAAAGPALVHPGIAPPAGTYAGPGAA
PRLGPASPPGPGIPAGSPVLPAWPAWLAWFYISVVTQFAAFVLWYRAMSLAGVARTSQLQ
LLQPFLTLLAARAGLGEALDPVTVLAAGAVALVVAVGRRAPVHRADEPACRPAPGSAPAR
PHEVTAASVPALPREEPPQR
>fig|644966.3.peg.566 Fosmidomycin resistance protein
MKGALGYLLLLSLAHLITDLNQGGMPALLPQLKESYGLTYAQLGVVLLVLNITSSLIQPL
FGYWSDKRPQGWLVAAGPLLAAVGLALVGYARSYEGVLLAAILCGIGVALFHPEGARSAR
GVSGGQRATAMSIFSVGGNLGFALGPVAATAVVGLWGPQGLAWLVLPAGLLAAGMVAALP
GMDRLEQATARRGATTPGRMPGTRGPGPAAGSAPAGSSAGSGGGTGPAPADEAGKTNWLA
EVLLIGVVGTRSWLQFGVLSLMPFLYLEKAGPHGVSTGVLLFVFLAAGAVGTLVGGPLAD
RIGTRTVLIGSMAVLIPLHWGLVHGPAWATLPLLAATGFALVATFSITLVMSQDFMPRYV
AVASGLNTGFSIGLGGIGAAALGALADRWGLETTLSVMVLLPVIGLLLTLLVPVPERDRQ
QRRAGAAGRARPAET
>fig|644966.3.peg.610 Permease of the drug/metabolite transporter (DMT) superfamily
MHPLAPLLALAGAVLAISFSSILIRYSQAPSAVIAFYRMALTTLLLLPWAWREAGRVRRL
PRRLLGASVLSGILLAGHFLTWIASLRYTSVTASVLLVTSHPLYVMAADAWLLRERVPTR
RLLGAMLALTGVAVVTFAGAGAGDLVAGGRALYGNFLAVAGSWFFAGYILIGRRVRQVLP
VMPYTTLVYGVAAAVIAVGLALTGTPFGPHPWREMLLFVALAVVPTLGGHTVLNWALEYV
PASVVSVSILGEPVGASLLAWLLLGEAPTGVELAGGALTLAGLFVATQAAAREAAPAAAG
AGQSERQDPHAGPSPAG
>fig|644966.3.peg.1733 Drug resistance transporter, EmrB/QacA family
MQPGHGAGRQAGTRGLLLAAVAFGALLNPLNSSMIAVALPAIARDFRVPIGRLTWVIAAF
YLASAVGQPVMGKVADLAGRRRIFFAGLALVALASAVAPLAPTLGALVAARVLQALGSSS
LYPAGMAAVRDAFTGRTGQALGILAVFASTSAALGPSLGGFLVQAGGWQALFYVNFVPVA
LSMVLASRAFPAGPGGAGSSGGRSPRPAAPTGRPGGLRELGRRLDLPGMALFAGTVAFGL
AALLSLSEPQPAWWTMPVAVLLAVALARWEGRVKAAGWEPFLDLEMLRRDRARTAVYGAW
ILSNLAFYTVFFGMPAYFEEVRHLDPRESGLMMLSVAGFSSVASPLVGRWVDRAGHRPAL
WAAGLSLLAGALALLAVGPGAPLAVLFVVLAFLGASNGVNNLALQAALYRFVPREETGAA
SGLYMTCRYVGSILSSSLLGLVLSGPLNAAMLRELAVALLVPALGLLAFVRWIPARPAPV
ASR
>fig|644966.3.peg.1765 Multidrug resistance protein B
MKPVVRLAARLRAAAIPTGLPPSLYWLAAGQVVDSLGSGLVFPLTTLFVVQVLGRDLTWA
GSVLFFHSLAATLGATLGGRLADAHGRKPVLLASLAGAALCSLVIGWRQEAALYAATMAV
FGLVISLFRPASQALVSDLAPGRERQVFGLVYMANNLGIAAGAALGGIVAAWSFRAVFWA
DALTYAVFALVLAKAVPDPYGQRLRARRSQARAATDPAASQSRGHPVSTGGAGGDEPAPA
PGTPAAAVSAVPVPAGGTGAPEPGSGPAVAAPRTPAPAVQSPATRPRGGRQEHRADPPRS
LGSAWGTRLAVWHRQGLLTVVLLAVASAGLFFPYAQLHTALPVDMTRHGFSEAAYGLLWT
LNALLVVVMTPVASTWADRRGWTLDGMLKGSAALHAAGFALLLVTGVWPAYAAFALAMVV
ITAGEVLHAISYNAAVARAAPEDRRGSYQGLAGTLAGAAWMVGPLAGGAIVDRLGIHALW
TVTVAVALAALGVFRLAEAVESARRRASDAAVPTGSVPQGT
>fig|644966.3.peg.2017 Glutathione transferase fosA (Fosfomycin resistance protein)
MGILQMNLIHRGRRDAYLEWGSAWVCLQERPARRPEHPTPGVDHVAFFIGPDDLEPAVER
LRSCGVTIARGLMQRGTGWSVYFLDPDGTQLELHTSTLHERMQVWR
>fig|645463.3.peg.1336 Permease of the drug/metabolite transporter (DMT) superfamily
MGEKSKGYVFIAIAGLLWATLGLFGKFLMGNGLTSEQVAFTRLFFGFIVLGVYSSIRTPQ
ILKISKKGIIYSVIIGIICQAMFNLCYFKAIDIAGVSIAAVLLYTSPLFLAIFSKVCYKE
NITRSKLFSLILCFIGAIMAVTGGRLDFQGLNAFGLLLGVLSAIAYALMPTISKNALKEF
SSSTILVYSFLFGAIFMIPSSRPWEILNYAKDLDVLSCMLMLGIVPAALAYIFYAAGISK
GVELSVAGVVASVELVGSVIIGCTILGESFSLGKLFGVMLMLISAVVALNLSYDEIRIFY
KSNKLKQIEKTESI
>fig|645463.3.peg.1341 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDTKISINENMSLGKRFFKYLAPSVVAMWVFSLYTMVDGIFVSKGVGELALAAVNISMPF
INFIFAVSLLFSTGASTIIAIYLGKKDIKSANEVFSFNLVSIIILSIIILAITFFNLDRL
ALFLGATESTIGMVKDYLGIIIFFNGFFIVSYSLEVIIKTDGFPILATVGVIISALTNII
LDYLFVIEFGWGVKGAGIATVLSQVFSTIFFLIHFLRKNSTLNFSKFRIDFKTLRKIVFI
GFPDSTTELSCGIVVLLFNLSLTKYIGENALIYYSVINYINTLVLMTMMGITQGMQPLTS
FYYGAGNIDNVKKLLKMGIKATIIASVAVFAICMAFSGPIVSLFIHPEETMLFNEGVRVF
KIFSISFLLVGINVIISGFFVSVEKPSISTVISLGRGLVIVVLSLISMILIFGGQGIWMT
TIVSEFICLILSLVFLKKNFSTLDSNLNKVA
>fig|645463.3.peg.1363 Vancomycin B-type resistance protein VanW
MSNVNKKLVIAIGAVALVAIIFIGIMCMQFKGEKIAKNTYVNGVDIGKLTKSQAKQELAK
KYKLENVEFNYNDKSWKVKSKDLNLSTDLDKTVENAYNLNRKSSFFGNLSKTISTNFGKK
SNLVVVINYDKNKLKAEMEKIAKEIDVDVKDATLDISGEKVKVIPDSDGLKMDISKSMEN
FDNQTKKGNYKNELVVKATPAKVKKEQLTNIDTNLGTYSTIFKTSQINRSINIKLATDNI
SNVLLMPGETFSFNKHTGKRSKENGYKSAPVIMEGEMEEDYGGGVCQVSSTLYNSVLYAG
LEIVNVKNHTIPSSYVPKGRDATVADSGIDFLFKNNLKHPVYIKNYVSGNQIVCNIYGSA
EDKQNITISTKLDGVSQTTMKRVNDPTMPKGKEKVDKSGRNAYSVSTYRTFNDANGKKIK
TEKIANSYYPKKEGIILVGTMEPKPEEKPNTDENKNNQNTNNQNPNNQQKPETPPTDNKP
NETQPQPQA
>fig|645463.3.peg.1432 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENLFTRKFTTFEFLKFVSPAIISMIFISLYTIIDGIFVSTLVGSDALASINIVLPIINL
VCGFGIMMATGGGAIVSIRMGENRQDEANSTFSFIVLFSLIVGISFTVISYFFIKEISIL
LGATDKLLPYCITYGKVMILCTPFYILKFIFNYFARTDGNSKFSLFLSVIGGVTNIILDY
VFIKYFGMGLLGAAVATAIGIILTCVLGIIYFLSNKSTLKLRKPKTDFRLIRDTMINGSS
EMVTELSTGITTFLFNVVALKLAGENGLAALTIVLYAHFLMTSVYLGFAAGVSPLISYNF
GAENSDKLKETFKHSLKFIFVSSLLVFIIALVFAPFIVRVFVSPDNTVFKLALQGLKIFA
FAFLFVGINIFASGFFTAFHNGKISAIISFSRAFVFIIIGIIILPPMLNMTGLWLTVPFA
EVITIFISILFIKKYKGRYKY
>fig|645463.3.peg.2557 Membrane component of multidrug resistance system
METQSNNKKGNLIIAIVMTGAFISSLSQTLLSTALPNIMSDFKITADIGQWLTTIYLLIA
GIIVPTTAYLINRFSTRKLFITSMSIFSIGCIIALFSNNFSTMLIARVLQAMGSGSLMPL
LQVIILYLCPEEKRGAAMSLVGITVGFAPAIGPTLSGWLVDSFGWHSLFLFLSPIAILDV
ILSFILLRNVGETQKLKLDIPSIVLSSLGFGGLLIGFTNQGNYGWTNIATYLPILIGIMS
LILFTLRQLKSKEPFLELRVFKNKPFLISTILIMIVYASMMSATLMIPLYVQSVRGFSAL
SSGSLMLPGAILMVVLNPIAGRHLDKYGPHALSILGTGCLFLGTLSFAFLGRDTSLIHVS
LMYCIRMIGISMVLMPLTTWGIKTLDRELISHATAINNTLRQISGAIGSAILITIMTSAT
KKAHMSSNMLSNIHGIDVAFSIAATLAFTGLIVSICFIKRHQIIRS
>fig|645463.3.peg.3353 Drug resistance transporter, EmrB/QacA family protein
MKQKWIVLIIICIGVFMSTLDGSILNIANPTIAADFKINMSQIQWVVTAYMLVVTATMLF
FGKLGDKVGSNRLYALGFFIFTIGSFLCSMSNNLSTLISSRIFQAVGASILMATGLGIVS
NAFPANEKGKAIGITGAVVGIGNMSGPVIGGIILEHFGWPSIFIINIPIGIIAVFLGIKF
LPKPVLDEQNKSFDISGLLLFASCTTLILLAMNEKGNTRLYLGITALIIFLLLALREVKF
EQSFIDLPLFKNRNFTVGNIIGVACYFPQMAVSFLLPFYLEQLKNLSPMMAGYVMTVHPL
IMVLIAPIAGSLSDKHGAKNILTASFSFMTISLVGMALLKADSPLYLLIVCLVIFGLGLG
AFSSPNNSSILADVPPQKQGYGGSFLATIRNLSFALGTAFFSSFFAQSLTYNQKFKSHTS
AYVIASNQSYWIAASVCFIGLILTVFFMRKTDKSIS
>fig|645512.3.peg.1301 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MARNDLSRLGTAPLGKLLREFGAPAVVSLVVNSVYNIVDQIFIGWGVGYLGNAATNVSFP
LVAITMALALLLGNGSCSNFSLSLGRRQPEEAAFFVGNSLAVESVLGSVLAVFSWVFLTP
MLKLFGATPTVLPYAQSYGAICLIGTPFVMVTLGLVNLIRADGSPRWAMWSSLTGALLNV
ALDPIFIFDWGLGMGVAGAAAATVISQMVSFFMTVAYAFRFNSITLQRHHFRIQRQVMSR
ILSLGASSLLNNVTFIIVQICMNNALVSWGTQSPYGSDIPLSVMGIVMKVNQILIAVLIG
ISIGAQPILGFNYGAGNMGRVRRTYGLSVWTATVVCVLGWSVFQLWPDQVMELFGRGSDL
YFQFARRCFRVYLFTMPIVGYQIVSGLYFQATGRPGRSIVLTLVQRILFMVPAILLLPLA
WGFDGLLYTMPVADLAATAATTLMIVPELRRLRQLENSRPSE
>fig|645512.3.peg.1417 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPNETNMPQLAGDKNAERARMGTTPELRLIFQFSAPAMMGFLSNALYNIVDRMFIGHWVG
SPGLAALTVAFPIALFQGALATLVCAGGTSLLSRKLGAGDLEEAKQTMGNMMTLTATMTF
LLCLGTEFFLDPVVKLCGATPDILGLSKTYLRIVLWGMALQFGTIVQNETIRALGRPRRA
MESVVIGTMSNVALDWLFIAAFNWGVAGAAVATVIGQGLSLAWVSIDLWGKRAPLNLEPP
CWKLRWSTVRQIAAVGFSPFIGTLFFSILMVLFNLILSEYGGSLALSAQGIFFSLDSLLF
LPVMGLGDGVLPLVGFNYGAGNLRRVKRLVSIALWSSGIFLAATTIITEIWAESMVALFS
SGNPALTVAAARAMRLGYSAMPLAAISITASYVLQGLGRAKESLILTLGRQLIILPPVLI
LPRFLGTDGLWVSFPITDILGGVIAAWLLHGESKRWVEPAPRPAAQEE
>fig|645991.3.peg.1007 Daunorubicin resistance transmembrane protein
MRTYYEIMKIAWKNSFAYRLDTLIGILGSVIALYVQIYLWRSLYGDYSISVLSLQDMVTY
QIMGIVLSLLYADAVAREVGGKVLDGSIALELLRPYNFAAGMFFRTLGQTLSGFATKGAA
VLIFAALVFHFRLNVGLLDAFLLMVAIGLNIMIYWLLHYMIGLLHFTFLNATWFVRILRD
TIRILGGGVIPLWFFPDVLRKISYFLPFQLLYQFPQSLAVQKISTGELLFNLAMAGSWIV
LLGLGTFFLWKMGVKKLVIQGG
>fig|645991.3.peg.1969 Ribosome protection-type tetracycline resistance related proteins, group 2
MNMINLALAAHVDSGKTTLAEQILFQTGTLLKAGDVNKGSSRLDWTEIEKKRGITVFAEQ
AFVHRRGIKLNILDTPGHTDFYTELEMSLSVADIAVILISAVDGIQQNTEKIWDLAGKKK
LPVIFFLNKMDRTGSDHQKVITEIRQRLSPHALLVQEAKYGESDLAGIEDLLLQQTSDSA
ILEHLAEKDDSILEKYLSGTEVSADELLAAAQKLFLQRELYPVLLGSAAKGIGVVNLLDC
AVDLFQPPDREALSAQDLRARIYKVRHDPKAGRLAYVKVLSGQIQVKDSVILEENQVCKI
NQIRLYNGPKFILADRLEAGDLGVLSGLGTVKAGDVIGQNEITNENPELKPILLTKIELE
QEEDYPALLKALEILEAENPVLAAEIDSSAKEITIKVMGLVQMEILEEIFAERFGLQIKL
GKPYVMYYETVTAKSKGFCHFEPKKHYAEVEIELSPNERGRGNEFQSLVNPDDFPLQYQT
VIRKTVEEALKRGALAHLPVQDVVIRLIAGKHHLEHTHGGDFRIATIRAIQQALENNQLL
LLEPIMEFNLVIPNDFAGRILADILKMNGEYTTTESQGTEIMIKGFVPASTSMEYPLELA
GITGGAGRIRMKYHSLRECHNEEEVLDRIRARESSQDKNRDSSEDILYNSVSLFRAKRKM
KKVTNDQE
>fig|648757.4.peg.809 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MDTRRPTLISVVLPAYNESEGLPVVVSSILHALANTGFAHEIVVIDDGSTDGTREVMLDL
CAKQPSLRYVRFSRNFGKEAALSAGLRTAAGDAVILMDSDGQHPPALISVFLDKWREGAE
VVAGVQNERLESWTKRRFKAGYYWLMQAGSHVVIPPDAGDFRLIDRKVVDAINALPERNR
QMKGLFAWVGFRTVLVPFQPEPRVAGVTKFTWRQLFKLAFTGLTSFSVVPLRLVSLTGLV
ISSTAFLYGCYLLFEHYVVGGRVPGWPTLAVGMMFLSGVQLLALGVIAEYLGRTFEEAKQ
RPIYIVAEDSRVKSPPHAASPVYDASAFVADARASETETGRHS
>fig|648996.5.peg.926 Multiple antibiotic resistance protein MarC
MELFKYLISLLVIVDPIFAAVMVATLLPGEEEEIKRVAFKASATVLVASFVTLLFGQGLL
KIMGVNIYSIKIFGGLILLSMAFQMLQANPPKTKHTKREEEALQEKDEIAVIPIGIPILF
GPGTFTTLLIFREEVQSASQLAQLVAAVVLTVAVIYFTLEKASLLARKVGPTGIGVTVRV
FGLFVGALGSQFVVEGVKHLWSAG
>fig|648996.5.peg.952 Probable multidrug resistance efflux pump
MRRLFTLLGLVAVLTVTAWFGYFLYLHYRFVVTDNAFQSANFTAVSTEDVSGKIVKLYVK
EFQRVSKGQPLFKVDDSSYRERLRQVEAQLKAVDAQIEAAKLRLSRLQVQLPASVGEAEA
ALSGAKASVSALGRQLSEAEANYRATLAQAQAAVPAARSALEAAKVDLERWRRRLERYRA
LYERRVISLQQFEDVKAAYYKALSAYRAAESRLVQADSSLKKAEALKEQVKALEARLKAV
RAKVVAYGQRLKASEASLKQIEETRALLKELLARRKALVAQEAQVKLLLSHTLVRSPVSG
FVAKRWKEVGDFTSPGLPVFSVYDPSSFYVLAWIDEDKVRFIRNGTEGRVELETCGRSFK
ARVVAVGRSAGSVFALIPRDTSQGEYTRVVQRVPVKIKVFNVPLECVKPGTNVTVYLRKR
>fig|648996.5.peg.953 Inner membrane component of tripartite multidrug resistance system
MKRVFFLGGLIVAGMFMTLLDTTIVDIALPHMMSAFEVEPDDIQWVITSYMVASAVSMPV
VGWLGGRIGHRNTYLLGIALFTAMSALCGLAPNLDFMIFARTLQGVGEGLAVPMTMTLLF
ELFPPEKRGVAMGLFALGATFGPSLGPTLGGYITEHLSWRWIFYVNLLPGVLVVYLLTLF
MEDDRHLHRSDKPLDIPGLLLLAASLTSLIVALSKGNSWGWDSMKVVSLLYFFFISLVLF
VFYELRTENPLVELRIFKFPFFRYPVISLTLFGMGVYASYFLLPLYLEKLRGFPTITAGE
ILFWPSMATGLVSMVVGFLIDRKLLSKRTSIVIGVLIFTFGTYLQTALDLDMSKSEVVLY
LLPWGAGMGFFFPALSQVSLGSLKGELLRQASGLQNLLRLVGGSVGTAVSTYILVSSQPK
HFVHLTQEVSPQAPQVVYFLNRWKEHFLYDCSSVPQIASEQAKGVLAKLFSLHAFWHSFG
DAFFFALVCGVLTLIPALFVEESGESGVDSLNFKPSDG
>fig|649349.3.peg.468 Permease of the drug/metabolite transporter (DMT) superfamily
MNYRFFLLGILFAALWASASAAAKIALPYIEPLAMFQVRFFLAGVLLIAYSLIITKDRFP
KGKEWVQLIIFGGLNTTLYLSLFVLSLREISAGIGSLATSTNTLIISALSTVFLGQSLKS
KQWMALLLGFAGVGLACYPLWENHQATPRGLFLIFLSMLSYSVGTLYYSKIKWNLSRITI
NGWQVFLGGVLMFPLTWYFHVDGANQWNSIVWTSILWLIFPVSIGAVQLWLYLLKQDTVR
ASFFLFLCPIFGFIYANILLQEPLTWYTWTGTAMVLAGLYMGIEKKPR
>fig|649349.3.peg.644 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MSIIIPVYNGASSITSLVEILQKELNSYSFEIILVNDGSKDNSAEKCKSLATDHSEITFI
NLRKNFGEFNAVMCGLNYVNGDYAVIIDDDFQNPPSEIIKLYQKAQEEDYDVVYSYYEDK
QHHWMRNFGSKVINLLTTYLLKKPKDLYLSSFKLIKKDVVEEIIKCKTPHPYIDGLIFQV
TNHVGKQKVVHLERKEGHSNYTVSKLLSLTLTILFGYSLIPLRLTLLAGLLSIIFSLSYM
ILYALNIISTWGSPIIIFMCGVILCALSLVGEYVGKGFLMHSGKPQFVIRSVVKKQ
>fig|649349.3.peg.833 Florfenicol/chloramphenicol resistance protein
METQFGETPLPLKPTIIHSAEQVEKVLFETQSGAKIETVLSRYRAGWTSMCISPQSGCGL
GFTFCATSAMGLMKNLSADEICPQVFHSHWNNQVPDSIAFMGMGEALANPNI
>fig|649349.3.peg.1115 Permease of the drug/metabolite transporter (DMT) superfamily
MDNNKNSLAYGALFIVCIVWGTTYFAIRIGVETFPPFLFAAIRQVVAGGALLLGLKLTGS
LNMNKSDFLYQSVPGVLMVALGNGVIGWCERYISSGLAALILSLIPVFVVVISYLFGFDR
RKPHLLIIVGLILGCLGIVLIFRDNLKDLANPAYFTGMLIAFGACLAWASGSVLAKYKIP
NSKNVLQNAALQLFSGGMALFVISAFLDDYSELKTVTTSSIWALVYLIVVGSVIAYSAFV
YALKHLPIGISSLYAYINPFIAIMLGFLFLNENLTGITLLALVATLSGVYCVNRGYQKMS
KK
>fig|649349.3.peg.1785 Multidrug resistance protein, AcrA/AcrE family protein
MKKIILLWGFALPFLACKEEVKDDTGLSLPVKSLKKDSAVTTFTYLGAIEGKVNVEIRPQ
VEGILEKIYIDEGDFVKAGQPIFLINELPYQEQVKNARANVEVERARLRNAEIELDRLQP
LVDHEVISDVQLKTAQSHLEVAKASLARAQAQEATARINMGFTTIKAPVNGYIGRIPKRI
GNLVAKNDNQPITVLSDIEEVYVYFTLSESDYLFYKKMSSDSTAKRINPNVKLVLADGSI
YEYTGKIDADAGQVNRSTGAISLRATFPNPKKLLRSGNSAKILMEQYHPNVLLIPQVATS
AIQDRTFVFRLLPDNTVERVLVEIEGKAGKNYIVSDGTLKPNDRIVTSGLDKLTDGVKVN
PMGEKQILSQKLP
>fig|649349.3.peg.2735 Permease of the drug/metabolite transporter (DMT) superfamily
MNQKGILFTLLGAICFSAKAIMVKLAYLQYDASTMELLGLRYFFSLPIFLIIALWRYKNG
KFISLKIKEWAILLLSAFLGYYMASWLDFQGLQYVSAGIERVILFTYPTLVVLFSRLFFK
KAISRTSIWALVLCYGGIFIIAAEPKFFAGENVIVGGVLVFLSAVTYALYLVFSGELSSR
LGSINTNTLGMIFSSLFVFIHVAFTPAISWGNLDPGVYYYGLGIALISTVIPTFLMMEGI
RLLGANKASIIGSIGPVSTLIMGYFFLNERFTLQELAGSILVMIGVFLIGKK
>fig|649349.3.peg.3171 Permease of the drug/metabolite transporter (DMT) superfamily
MELFYISKKSEGVSRSSLSLIILIILAVAWGLSFLFIKKLTVAFSGVEIGAGRIFVASAF
LLPFALYNRKGYPVSKTVPIMLSGLFGYLLPAMVFGTAGSKISSSLSGTLNATTPIFVLL
IGGLFYKKVIYRYQYIGIFLGFIGSLILISNGEKLALDFSNPYALLIMIATMMYGLNTNI
LSFHLKEVKPIIISSFSVGMMIIPATAILLTTDFFGKILLEENRLYLLYFLILGMVNSGL
AAILYNYLLKITTPIFASSVTYLIPVVAIIAGMLDGEMIGVSHLVGMGIILLSIFILNKK
VSA
>fig|649349.3.peg.3491 Permease of the drug/metabolite transporter (DMT) superfamily
MKNNILKGYFFAAASAISFGLIPLFIIPLNEKGIHLDTTLFFRFLFAALMIGVYCTFKKQ
SLRVNQRDLFLLFVLGILYALSAEFLLWGYSAMSPGIASTVLYVYPLMVAILLYWKYSEK
ISNPTRWSMFLALLGVLIIGWEGENMRFNFWGTIIVLTSAMTYALYMVIVNKGKLQAQGI
VVTFYSVLFSSFYYLIKMSMGSFILPSLDTLGFISLFSLVTVVISVLFIILAIQWIGSTP
TAILGALEPVVAVGVSVAIFGEKATWNLFAGLILVLSALMVKVLGDTQSLRH
>fig|649638.3.peg.248 Permease of the drug/metabolite transporter (DMT) superfamily
MSAPLSPRLGLVLLVVITLIWGSTFVIVKETLATLSPALLLALRFSVAALLLVWVPLPRA
VWRAGLVLGVLSFLGFATQTVGMTMTTASKAAFITGFSVVLTPLLSALWFRLRVPARAYV
AALTALAGLGLMTSTGPVGVSAGDFWVLGTALAYALYIIYTGEAAQRHGALALSAAQLWP
MAALAWAWAWPQLGDLRGITPGAAFSVLYLAAVATALVAVMQIAAQRVVAAHVAALVFVL
EPVFAAGFAYVLLGESLGFWGWVGAALVGAAMLLSELRVRAEEPLPAPPTPH
>fig|649638.3.peg.1724 Multiple resistance and ph regulation protein f
MTTFFLVVALLLFGDILIGLLRVLHGPSAIDRMLAAQLFGTAGVAILLLLAEVASSPPLR
NVALVFALLAVLAVTAFVKHARTLPAAQSGTSGGTL
>fig|649638.3.peg.2148 Glyoxalase/bleomycin resistance protein/dioxygenase
MGFCQHDAALPEHPGLILTLVLDDVDGTYARLCERGVPTEAPPRENARFGIYHFFARDPD
GYRLEVQRFLEPL
>fig|649638.3.peg.2975 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLRPLRVNPYDRDILALALPALGTLAADPLVSLVDTAFVGRLGSVPLAALGVNTALFSLA
FVVFNFLAYGTTPMVARSLGRGDREAAGRAVVQALTLALLAGGLAVAFLQLFAAPLLRLM
GAGEELVGPALGYLRVRALAGPALLLITAGNGAFRGYQDTRTPFLLTLGLNLVNVALDPL
FIFGFGWGLAGAAWATVVAQWAGALGFVWVLFARRRALGISVALPRFAELRPFVRVGWEL
LVRTAALLSTLTLATAVATRVGVLEVAAHQVAAQLWLFLALVVDALAVAAQALVARYRGA
GQPLRARAVADRLLAWGFGVGLVLAAGFALFAPVLPRLFTDDPAVVRAVLTVFPFVALMQ
PLNALVFVWDGVLMGLEDFRYLALAMLVSAACGALVLLLVLPLGWGLTGVWWGVATLMGV
RLVTLSWRYARLGR
>fig|649639.5.peg.895 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENNSAKKLSLFAITWPIFIEMTLHMFLRTADTFMLSRVSDEAVAAVGVANQLIMFMFFL
FQFGSIGATVVIAQYLGAKKHDQIHKFSGNALSFNILFGIVVSVVIVSFTSFYLGFFHLT
DELFAMARTYMLIVGSALVLQAMMLTLAAIIQAHGFTRYTMYVSVGMNIINIFGNYVLIF
GAFGFPQLGVTGVAIATVFSQFLGVTANFIILYFKVKVKVRLIDYIKWKKDRLMKILSVG
VPAALGQISYSASQIVTTGFITVLGPDMLTTRIYTLNILFFVIVLAISLGRGTQIVVGHL
VGAGEMDKAYKEAFRSLKWNISLCLGVAVLLVIFREPLLGLFTSNPLIISTGAVLLIMGL
ILEPGRCLNIVLGQTLQATGDSRYVMLVSVIIIWAFSVPLYYVLGIHLGFGLIGIWIAFI
VDEWIRGIYLLQRWRSGKWRAKALVKQEEDLKESV
>fig|649639.5.peg.2076 Permease of the drug/metabolite transporter (DMT) superfamily
MYVLIIKRFVFRKKGSKLSKTWTYILVLFVMILWGLNVVAVKFLVESLPPVAMQGLRIFI
GGIIAIIVLFFLKDLRKLTKKEWGYTIVAAVFGQMLHHSLLALGLVQTTAGNASLILGLI
PLATAIFAMLFLKDSITLLRTIGIALGFGGVCLVVLQNAEIGVISPGDILVFIAMLSQAF
SFVIIKKVTATLSSRQLTAVMLLVGAVMLLILSFIFEPQGVGNLVHGNTIVWTVLVLSAV
FATGLGHILYNAAIQEIGAGQTAIFNNLVPFISLIGAFFLLGEAIYTSQIIGFVLIVLGV
LFGTGYIETRVLKKRMNSIGKKQKKQTA
>fig|649639.5.peg.2214 Permease of the drug/metabolite transporter (DMT) superfamily
MGMLNKKPWLIYLMLALATSSWGSAFIAGNYATRDFDPITVAFLRFFFAAIILIPLMLIK
EKNHVLPKGKEWFLLASLGLTGIALYNICFFIATKEAPIVKSSLFIASNPVLIIILSGFF
LKEKITSRNIIGLILALVGAAIIITEGNFMEVIRAGFQPIDIVLFIAVICWALYSVLGKV
ALQRFSSLESTTYAVVFGTLMLLPFAMIEGEWNEYIQATTLTWVSILHMSIIVSVISFIM
YYQGIRTIGAAKASIFINLMPLSAVILAILLLDEPLLPIHIVGAAFVLTGVTIGTRPKRK
KVNS
>fig|649639.5.peg.2939 Permease of the drug/metabolite transporter (DMT) superfamily
MKGNSIFYIGLTIISIIWGINFGISRWAMEVFTAEVFTLLRFGLAVPILFLILYKLEGSI
KVEKRDLLKLVIIGFFGVTILELLVMYSIKYTTLANASLLNVAPWPIFAALFAPLFTKEV
MTKRIVLGGAIALIGVTLIIGGGSDNLDLSGQYMLGNLLALAVSLIGALFNLACMPLMKK
YSPLRVSTWYILFGSLFLIPFTLGGWSDIHWSTLTLPVVGAILYNVILCTVVAFLVWNAS
MNRVGATKANFYRYVVPAAAAVAGALFFNEPIMIGQIIGAIIIMSGLVIIGAEKKQLEKE
GTVDSQQKVAN
>fig|65093.3.peg.2706 Multiple antibiotic resistance protein MarC
MFQHFLQDATTLFVVIDPVGLVPVFIAITQKEPQVSRQRIALLGVGISAIILFAFMIGGQ
TLLSALDISLPAFKIAGGLLLLIVGLRMVLNEDEHSASTDPESSIDLAVFPLATPLIAGP
GGIMTVVLLTDNTKFGAIDQAITSLALMTVLIFTYVALLFANLIQKALGRTGVNVITRIL
GLLVAALATEIILGGIQDYFLTL
>fig|651182.5.peg.497 Acriflavin resistance protein
MSGISAWFTKNPVAANLLALLVIVGGVFSLMGLRIEGFPKIPSSYISIDIAYPQSSSEQV
DSGITQKVEKFLEGLAGVKKISSYSSEGAAKILVQKETGYNMIRLLNDVKTKVEAIDNFP
DKSSKPVISVDEFKDFVLIVQVYGDVSEQTLQQSARFLEKELQSDPKISKIESFGKKSRE
MRIELDAQMLKAYKISIGQVAAIVARDNAEQGYGLLKNDTNRIIIRSDVKIEHYDQLMNL
PIITSSDGAKIYLKDVARVIEDYEDSDTKALYQNQNSVGIVLYSSNKGHMLEVSKAAYKV
VENLKKQVPDEIHIDIWADFSTYMKDRLILLQSNAWQGLLIVFAILAVFLNFKLAFWVAM
GIPFSIAGVLALMGESFLNYSLNDITTFGMIIVLGILVDDAVVVGESIFEERKKNLDRIE
GTIKGVHKVAVATIFGVLTTIAAFYPLMLIKNDFGKILASFSVVVCVALIFSLVESKLVL
PAHLASISITPEKPENIFLKGFYKVQESASNVLVFLNQQVYTPLLVATLKHRYSVLIIFI
SLAMAGGWLLKMNYVRTVFFPEIPGDVISVNVTMESGGSSKMTYENADAIDAAAAAINRE
LMEKHGTNEPPIRKIMTAVTGSQGIEIYAELQPQAMRVVNTLSLLKMWRSRTSNLEGVQT
IEFRGNAETGGGFVLKAESHNIVSLRQAIKKLKAGLKEMQGVHDLRDDFKSSEPELRLNL
KNEARHLGVTPEDLASQIGMAYGGFEIDKFQKDNDEIKLRIIYKKDQRKYIHQLLETRIS
LADGSLIPLTQVANIESRFSSGFIHRINGKRVAEVEAAIDKRIVSASEVFDALKQKVIPA
IERTFPDVKILAGGELEQEGEVKGGLVKALIMIMLLIYALLAVPLKSYWKPVVIMSVIPF
GFTGAVVGHLIAGVPLSILSFFGMLALSGIIVNDSLVMLTRFNDIMAQGKTVNKALTTAG
SSRFRAIFLTTATTVCGLMPLLFETSEQAQYLIPAVVSLAYGELFATFITLLLVPLLMNI
AYDIREVFASNQSAQYVC
>fig|651182.5.peg.1099 Acriflavin resistance protein
MVTLVFSTIIALGGIFSFLNIGRLEDPEFTIKETVIHTHYPGASAKQVELEVTEPIETAI
QQLKQLKEVRSISRAGVSIIFAETQEIYDKHNLPQVWDELRRKVGSVNGQLPAGCQTPIV
NDDFGDVYGVLFAITGDGYDKKQLKAYAEDLRRELLTCNDVGRIDFWGLPREAVFIEIDR
AKLTQLGLNPNTIFDTLNGQNSVTPAGAVQVGSEYIPFRITGDYTSIEDIANQLISGSEG
SMIRLKEIARIRHDIITPAAELMCYNGKEAVAIGISTISGGNVISMGDSIDQRLQELQAN
TPFGINIHTITSQSKIVEKSVSGFVSNLISAVVIVILLLVVFMGWREGIIIGFVLILTIF
ATLMVMKSYGITLQRISLGALIIALGMLVDNAIVVTEGIIIKMRQGIGREEAADQSVKET
MWPLLGATIIAILAFAAISLSKDMTGEWLASLFQVICISLGLSWFFAITTVPCFCVMILP
VPKNNGKKKHSQRFFKYYKTIVGKAIDHRWLTLTGVIGLLVVAVWGFSHVKQDFMPDTNR
SQFTVDIWMPQGTHINSTEKQLEQVEKYVARLEGVQNISGFIGRGPLRFLLTFSPEMPDS
AYAQLLIDVDDFRRVPELKKNIQQYLDKEVPQVIGSVDAFKLGPGGGAVIARLSGPETKI
LRNLAGQVKKIMAENPNSRSIRTDWGNQIKVSKVDFADLRAQGLGISRPEIGSSIAMNFT
GSVVGQYRHRDDLLPIILRPPKKQRNNIDFFDEVQVFSQAKNKWVPVQQVTNRTITGVED
SVIHRLNQKRTLRVLCKQREGTTDALFRQLSPIIEKKLKLPPGYNLEWGGEHEEQIEANT
KLMSNFPIAFAGMFLVTVLLFNSLRYPLIIFMGLPLVVVGVAPGMLIADKAFGFMAMLGF
LSLFGMLIKNEIVLLDQIKAELADGKEPFTAVVESSASRIRPVTMATFTTVLGMIPLLTD
AFFSPMAATIMGGLSFATLLTLFVVPVFFSTLFSVRRPGVKHF
>fig|651182.5.peg.2590 Acriflavin resistance protein
MKAFLNFILKRTAFANTIMVVIMIGGALSAMTIRQELMPAQETRMVELSVDLPGASPEEM
NTSILMVIENAVRGMDGIKRVDSRAREGGATITLTLLEHVNTQKMLGDIKNAVDRIETLP
EDAEKPVISIPSHVEKALSIIVFGDQPVMWLQKNAETVRDDLRTLKGLKNVELAFPREQE
ISIELSEHTLRQYGLTLSDVAEKIKQSSPNLPGGTLFTNEVDITLRTSERREWASQFEGV
VIGRTTEGIPIHLSDIATLKDGFGVSEIESWFNGLPAVQIDVYAVGDESPISVEAAVQEY
IETIVPKKFNGIQVVIFENQASAYRSRMALLIDNALIGLALVLITLGLFLTPSLAFWVMV
GIPTSLLGGLVLLPVFGGSLNMLSLFAFIVTIGVVVDDAIMIGEAIHVQLKNGLPPLKAA
AQGLEEMGGAVLLATSTTIIAFMPMFFVPGEMGVLFYQIPAVVIAVLLVSLFESVFILSA
HLSVGHPEWSWLKTLARPQQMVNAWLEHFIENRFRPFIQTSLRNTGTLFAMAFVLLLLTI
GAIAAEYLDFDFTPTIESDTVIAQATLPYGTPKKQSIKIQKQLVEAANTVLKENNMKSPG
VFSLIGTRLEEGEVEVESLAGFHYISVLMALPPEEERILSGRQFAAAWQQAFGDPGELES
LNFTGETNVTGGEPIMLEVFHPDPEVSRSAALSLGRRLRTISGLTSIDDGVRAGKPELTI
RLKESGQQMGFSAEMVALQIRHRYHGAEALRFVRDGSEVKTMVRLTQAERNSISSLQDIQ
LRSTSGKLVNLKEVADITQDRSYTSLARRDGKRIYPVTADIGFGIDDDLVEDALEEAIVP
QVLSDFPGVSIHFGGEDEENDEALGSLGNGFLIILGIIFLVLTFYFNSFTQPVMVLSTIP
FSLIGAIWGHIILGCDLSIVSVIGIIAMAGVVVNDSLVLVTTYNRYQASGQPPFKAIVDA
ACHRFRPILLTTLTTFFGLVPLLTEASEQAQFLIPAAISISFGLVFGTVITLVMMPGFLW
LFEKKQPKISNTDFLIKRLFIN
>fig|651182.5.peg.3918 Acriflavin resistance protein
MKALGNWSVEHRVSVNLIMIFLIVAGLYTILNMKREMFPQFSLDMIDISVAYPGASPEEV
EEGICIKIEERLKSLEDVKTMYSTALEGQGSVLLELKAGTDINEKLDEIKTQIDLIDSFP
DQAEDPVVVEIKNNDPAIYLAVYGDADERVLRHTAEKIRDDLVETDDISLASLIGVRDYE
ISVEVSEETLRRLNLSFDQVAAAVKTGSLDLPGGKIKTKGGEFLVRAKGKHYTGEEFEQI
PVVTREDGTTLRLGDIATVIDGFEDTDIKARFNGKPAVLVVVRRTDSQDNIAISNTVKAY
IENHKDSLPRGIVLGYWFDMADMVQGRIDLLLKNGIQGILLVFIVLALFLDLGLAFWVAA
GIPISFMGAFLVLDYLGASINMLSLFGFIMTLGILVDDAIIVGENVYTHYKMGKSAKTAV
IDSIGRIGAPVVMAVTTTIVAFIPLMHIAGIMGKFISIMPQTVICILVISLVEAFIILPA
HLDHALTTAKKNKTLICRVCFSWLDWLKKDLLDGHKWFRDRVEKALTGFIYSIYTPALKY
CVKNQYFTLAVGFGVLIVSIGFMAGGHVPFVFFPKTDSNWIVADIIYPLGTPFEATEKTI
KQIEKGAVELNSFFRHRVEGGEDLVVNHFSQVGIIPRRDWKPGVYGGHCGEAWIEIQPAS
KRPDISAPDVTAKWRELTGDILGAEQLSFSIIGGGPGGNPIEIQLAGFDLEQLELAATAL
KNEIAKYPGTFDVTDNFRPGKMEKRIHIKKGAGSLGITMADIATQIRQSYYGDEVLKIQR
GRDDIKVMVRYSQKERESESSIDELRIKTRDGRQIPLNQVADIEMKRGYSTIQRVDRKRI
ITVISDIDETAANARQIVEDLKENYLDTLVNRFPGVSYDLEGQARRTEESIDSLKLGFSL
AAMIMFLLLASQFRSYIQPVIIMTAIPFGLIGAVAGHYVMDLDITMISIFGIVALSGIVV
NDSLILIDFINSKIRRGAGMFASVIEAGQNRFRPVLLTSVTTVAGLFPLLLETSFQAQFL
IPMAVSISFGLIAATVLTLIFVPALYVVINDLTRLFVAGEDEVKVEDEIKLSKNKPSLYK
AIK
>fig|651822.3.peg.234 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLQPQRMGREPMLKLIFSFTLPSIAGMLANALYNIVDRMFVGRLVGTMGLAAISVCFPFM
LLLLSLSLLFGIGAVPMISGALGEKNDDLAEAVLGSALAAAALVSVLVSVVAFIWMDPLL
RLSGANEELLGPSREYLRVILLGAPFGMLSFVMNFAIRAEGRPNFAMATQVLGAVANIVL
DALFVWGLKWGVAGAAWGTALAQLASLLWVASFYWRRLGHLRLRLQHCRLQPRLLGRLTA
LGFPSALTEVSFSLFYVLFNQSLAKYSGPLAVSALGAFMGWDSLLFLPVVGICDGVQAIF
GFNWGARRPLRVLEALKLALILGTGYFMGSVVVVHFFLWDMMRLFSTDPELLTIAVVGGR
VAYAGVIFTGVAMVTNSFFQGIGLSGLSLFLSLCRQFVFLIPALLIMPRIWGAIGVWGAF
PALDAGGGALSILLLWGQCRRLGLLRCEARRLRLARLRRAGGGA
>fig|651822.3.peg.561 Permease of the drug/metabolite transporter (DMT) superfamily
MEKERAPLIKEGVANPTDETTAQGRISARAAALIADLALLLCALLWGGSFTVVKVLLDLY
PPNWLLFLRFSCGSALLLLFFHRRIGRMSRQAVAGGVVIGVALFGAILCQTLGLLFMAPG
RQAFLVSTYVLFVPLLLWLFRGLFPGWHTLAATCTCLIGMALLTSDLSGPLGRGEALTVL
CALFFALQIIAISRYSAQCDPISLTFVQFTVLSLLTLAAALLFERPLQFHWRRGLPELAF
AIVFCTFLCYLVQICAQRYTKASHAAILMSLESVFGLLWSVIFLGEPTSLRMLFGCLLIF
LSVLLVELEPLLKRGRCPGGPSARPDTASPRSPSAPSSGGPQGPGTCSAASGAEGAPAAP
AAPTPAAPRGRERP
>fig|651822.3.peg.1335 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRRQGLEFALRLRRFAAAGIIIIMKETAVGGICDEGRSRAVSGVRGAAQRGGGADMTRGD
VFRHIFYFSLPFLAGNVFQQLYNMADTWVVGNYVGDEAFSAVGTVTPVINMLIGTFMGFS
SGAGVVISQYYGAGNRQRVHDAVQTAVVMTAVLSVVFTIVGKAMTPLMLRFMRTPEDVLP
ESMAYLDVYFSYIAGLLFYNMGAGILRAVGDSRRPFYYLVAAAFVNVVLDLVLVIVFGLG
VRGVAYATVVSQGISALLAFSLLLRTDMSVKLTLRDLRVDLKLLWKIVRVGVPAAVQIGI
VSFSNVFVQSYINQFGKYCMGGWTAYHKIDQLIFLPMQSLGLAATTFVGQNLGRGLADRA
RRGVRTALLCAVAVTLAASTLVVALAPQLVAVFNPEPRVVEFGAMFLHFLTPFYVLCCVS
QVYTGALRGAGNSKVPMVMMIFSFVVFRQCYLFVVSRYVSNTPLSMGMSYPAGWMVSSIL
AALYYGHARLEATRLVERGEVLSAEEA
>fig|651822.3.peg.1846 Permease of the drug/metabolite transporter (DMT) superfamily
MDSRALRGNLLLLVTSAIWGFGFIAQQFGSRALPPFSFNACRFALGSASLLPLIVIFGWH
DPARRRARAASRRLSVQGGLLNGGVMFLGAWLQQAGIAETTAGQAAFLTGLYILFVPLLG
LFMHHRVPLTTWCAGILALVGLYLLSVREDLSVSRGDVFEIAGAVFWALHILCIDAYVKR
TDPLEFSFWQFAFCALFSVGTALSLEPGGFAHVGDALLPILYCGVVSVGIAYTLQVVAQK
DVIPAHAALILSVETVFATLGGAVVLGENLGLRGYVGCVLMFSGMILAQWHGLRGGMRPA
DVRT
>fig|651822.3.peg.1964 Permease of the drug/metabolite transporter (DMT) superfamily
MNLNRVVLGITLAAATGLIWGAGSPAYKLMGQQGVSMVTVTFLRCAVGGPVLWLLFRLLA
PRHLRAPRRDLLRVLLLSILAPALNYLGFMLSVVYLPVATANVLHYVNPFVIALGSALLL
HERPTACDLIGAAIVFAGVTCSVLTPEWRFDAGISIPGLLWGVLAIFGITAQALCGRAGS
GGGMSGLGFFCWSHLLGTLWIALYKTFAEGWGDMATLTPAQMGLIAIPLFGGTVLGFSAF
YAALQYIPAPTVTLLTSMEVPSALLFTALVLGARPTAPQALGCVLILAAIALSSFGARRR
GGEVSAPPR
>fig|651822.3.peg.1988 Permease of the drug/metabolite transporter (DMT) superfamily
MKEVHIDCGAAPSAEGKMARRDVLLLLAVAVVWGVNFAVVKTGLRSVPPLFLVFLRYLFI
VLPLIFFVKKPAVSWRTMAAYALLSGVGQFSFMFYSLKIGMPAGLASVVMQSQAIFTLIL
SAQFMGERIGGAQLAGIGLAAVGLGLIGGPFGAAAVPTAAFLMNLLAAFCWSSSNLIVKR
ASEESLRSGRSLDMMEMIVWSSIFVPLPMLGLSLVGDGPSAILQSLAQIDAAAVLSVLYL
VVLSTLFAYSAWNQMIAAYSAGRVAPFSLLVPVTGLLSGMLFHEERVAPLQWAGIAAVVA
GLAVFQLGERRPHAR
>fig|651822.3.peg.2127 Permease of the drug/metabolite transporter (DMT) superfamily
MKRSAIAGYAAALTSILIWGTTFIVSKVILEDFRPVEVILIRMVLGLVALFLVSPRLPRV
RTVPEELSYAVAGFCGIVLYFLLENTALTHGLASNVGVIISAAPFFTATLNRLFYRSDRL
QVRFFVGFALAMTGIGLISFNGVRMQISPLGDLLALGAAASWGLYSVLVRRAGGFGLSTL
QATQRIFLYGVLFLAILSPFLGLRPNLAHLVQPKFFLPFLYLGLGASALCFFAWNFAVEA
LGPVRTSVSAYLIPVVAVAAGALALGEPVTPLSLLGTGLILGGLAVSEWRAGRG
>fig|653733.4.peg.1680 Acriflavin resistance protein
MFELIQRKRLGVLFIAFAIVISGITSYIKLPKESIPDITIPVVNIVVTHTGVDALGMEKN
VTQKIENSVRSVSGIKRMTSTSSEGLSSISIEFMTHVNIRTALQDVKDKVDQIQSELPAD
ADTPIVSEINLSEFPIMFLNLSGNDQGLLEYLADMLDDELSAIPGVLGIDIYGKRDLEIF
VSLDLDRIEALGVDPIQVGQQILRESITVNNGKLYVDGNVFHVKTDGEFNSPDPILNLKI
PTSAGFTYLRDLGTVDFVEKEDRTLSRLDGKPSVSLSIKKQAGSNLLGIAAQVYAIVDYF
NEHRPDGVEEIAITGDQAVEIQMMLEDLENSVLTALLAVFLVTCFILGGRNTVIVSLVIP
FSMLCAFAILSAMNVTLNMIVLFSLILALGMLVDNAIVVVENIYRLSTTMPLSHAVIRGV
REVAVPITTSTLTTLCAFIPLLFWDGVIGDFMKYLPITLIITLSASLATAIILTPIISRI
FLHPHKRVFRKPPLLKVYEKSLLWSLHHRKTVITTAFGLFVATLFLYGTFNTGMELFPAV
ETRNAVIKLDMSKNTDRDTTDQAVRTIEGIVEGFADVESYVSTVFQGRAQINIQFYEQEL
RTQSSFKTIDDIRDALPAFAMGTTEVLARQDSPTSAYDLTIEITGDDYGPMEQVFEQLVS
RMERDERIVEIQDNYDKENFYLRVLPDRDMLYHHGLTTRDVSSAIDLFFKRQKVITIYDD
RNEEFDIVLGVQPEYSSIPRMLAHTIPNPQGQQVALGELIAIEYSNMLYQVNRKNNQRAI
TIESQVRDGINAFTVQQDLDAFIRTLELPAGVYVNFAGQAEDQQETMEFLVWAFFTALFL
IFTVLIFQFHSFMIPLIIGMTVIFSIMGVLLGLLIMGMPFGIVMVGIGVVSLAGIVVNNA
IVLFDYILRRYEKTGDMYKSIVNAGKIRLRPVLLTATTTMMGLMPMFFAISINFTGLSIA
HGTESSQWWQSMSVTIVFGLMVSTVLTLIVVPTMFYHHHLMKTAALQWIQQKRQQRQSAL
PMATPTPRSLRKWYNRRK
>fig|655438.3.peg.439 COG0697: Permeases of the drug/metabolite transporter (DMT) superfamily
MNKLLSSAWVLLILIVIIWGVNWPIIKIGLRSIDPLWFAAARLGIALVTISVLLLFLGRL
KRPHRQDIPIVLGVGVMQFAVFVTLINMGLTEVNAGRAALLAYTTPLWVTPGAYFVLKEP
VSRIKLVGAAVGICGLLILFNPLGFDWNDASVVKGNILLLVAAMVWAISILHIRQHKWKG
SVLELTPWQIMVALLIVVPYAWFSNTQAVVWSAELVLILLYNGMLATALAQWASIRATQI
LPAMTVSLGLLMVPLMGILSSTIWLGEPFTMTLGLGAALIVGGLLLQINFRKQR
>fig|655438.3.peg.548 Permease of the drug/metabolite transporter (DMT) superfamily
MSNAIKADILLVLVTILAAISWIFSKEAVLLMPPLLFICSRFLLAGLLLLIVGFNQLSVL
SWNQYRQAIIVGFIFALGMCFWVMGLHSGVSLSVASFITSSAVIFSPIISKIFFAEKVPS
TTWYAIPFALVGLAFLSLSGEFEIQKGQLLFIVSALFVALFFVLNSRAANHREIVVLGEV
TRVSKRVPALPLTAIALVTVGVLVGMLSFITEGWLEAAEGFSSTLLAWVLASAFIGTALR
FFMQTHAQSLSSNSHGVVIMIVEPIWTALMAAAWFGESLSEKELIGCVLVFISIIIIRWT
LIQRLLKRASA
>fig|655811.4.peg.958 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKRKNIDLTKENIGKSLIKLSIPLTLTAFVQIAYTLVDMIWIGRLGSNAVAAVGVSYFL
AWIAEALSLIAKIGGGVYAAQAYGRKDKKLTSLILQNGYFQGSITSIIYIILIFTFKTYI
IDFYKLGAEVSNFANAYLSITALGYIFVFLNPIFSQSFYSIGESITPFKINTIGLVLNIV
LDPIFIFGFGPIPELGIRGAAIATVTGQATVFFIFLFVMKRKVGVIKDSLENFTLSTKWQ
VRIFKLGLPVAFISGIHALITMILNKLMANFGPKPVAVYSIGSQLESISWKTTEGCQVVV
QSLIAQNYGAGLMDRVKKGVKESLKLVGAIGIIATIILFAFRNYLFEIFVPGDLETINLG
AKYLAILSASQLMMALEIGSTGIFQGLSDTRTPSAISIIFNAARIPISILLMPYFGVLGI
WLSMTITSIIKGLLSLFLLKKKMKKNLKVIDFR
>fig|655811.4.peg.1296 Permease of the drug/metabolite transporter (DMT) superfamily
MLKNKKNAVIFSLIAMFLWGSAIPLIKSTYQVLQIESSDTFAKVYIAGIRFFMAGILAFF
YAKIFGKNKISFSKVNIKLVIILAILQTFLQYFFYYIGLSNTSGVKSSIIQASNSFMIVI
ISLFLLPEDKISINTIIALIIGTTGIILVNSNQKMGSGFKLTGEGFIFTSTFINAFASVL
LRKYSKNSDPYILNGMVLLFGSLPLIILGRFLYINPVVINLKAFLMLFYGAFITATSFTI
WTIVLQNHSANQFGVFKLFIPIFGSILSVIILGENFTIRLFIGLILVLTGSLVLMKGKSK
KSGVTE
>fig|655811.4.peg.1379 Permease of the drug/metabolite transporter (DMT) superfamily
MKNKHRGELLLLLTSFIWGFAFIAQKLGSDYIEPFTFNFFRNLTAGIFLLAYSFFKKNKP
RKKVDSITKTATIRGGIATGLVMAVAVSFQQTGVYFTTSGKAGFITSLYVVIVPIFAIFM
GKKVSKKTAISIILALVGLYLLTVRVDDGFSINKGDILIFVGSLFFAFHILFIDKFSIRA
DSVKMSMIQFFVASLVSLLLMILFEKPNFDLLMKGMLAILYLGIFSSGLGYTLQIVAQKD
TDPTIASLILSLESVFAAFFGFLFLKERPVDREIIGGIIMFIAIILSQIPEQKIKKFLKK
>fig|655815.4.peg.1500 Glyoxalase/bleomycin resistance protein/dioxygenase
MEASKDFYTEKLGFEIDNSNPQAFVFKYNQGEASFAIRTPLEPIEDKELGVGVSLWFAVS
ENLDELNEKFIANGITTVDPIFETPFGRAFHVKDLDGYKLTFLDPK
>fig|657308.3.peg.973 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MGTERIGRLLLEFSIPAIISMVFNSLYNVVDTAFLGQAFPDGTGVAVTTLALPVMTILMG
FSMVAGQGGNALAAIQLGEGRKAQVEKTLGNSAVLLCGLAVLVAVAAVAAIDPVLALIGT
SAELWEPTKTFVQIICVGFVFQSLGMGLNNFLRTAGKPNLALGTMVFGTVMCIVLNYLFV
LVLGWGVAGSAGATVLGQACGMAPVVWYFAVCKGAPFRLRLSCCRPDARLMGRILTLGLA
SFVMQVASTVVSVVLNQVVGVYGSQDPIGVTGALAAIGVAQKATLFAITPLIGLIMGAQP
IIGYNYGARSWQRVLDALKWASVAGVAIGAFFLVLSHAVPVQIVALFGVTGDLESFAVTA
LQIYTLLYPLVGFQIVGSSYFQSSGQPLKAAILEMTRQVIFLIPLYLLLPPVLTSVFGLT
GLQGVVVSAPVSDGLATLMTTVFVVREVRKLRGLREASRVAVRPAVAAGELGDAAAQQA
>fig|657313.3.peg.94 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MITDLTKEHPNKTLWRFLLPMLFSVMFQQIYNIADSMIAGRFAGENALAAVGASYPITII
FMAFAVGMNLGASVVVSRLFGAEDRGGVKRAVTTAFLSSMVLGIMLTLFGYFFNHQMMRW
IRTPQNIMADGVLYLKIYIFGIIFLMLYNVCTGVFTALGDSKTPLYFLLGSSAGNIILDY
IFVAKFQWGVSGVAWATFIAQGVSAVLALVTLLGRLQKFAGKEKQPWFDKKLFAQIMAIA
IPSILQQSVLSVGNLFVQGIVNQFGSAVVAGYSGAIKLNTFAINIFMTLGSCLSSYTAQN
IGAGKKERIPLGFRTGLKLSEFTALPFVILYFVFSRQMMGLFLGAESAEAISAGMAFLKI
VSPWYFMIAIKLMTDGIIRGSGAMIYFVVATVPDLILRIGFALVLTKSFGSTGIWMAWPF
GWIVATTLTLIFYRKLGYKNDKSSDF
>fig|657313.3.peg.408 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSDNATMKNTTIHDMTTGSPARLIMQFMIPMFLGNIFQQFYNIADSIIAGQFLGVRALAA
IGSTGSLMFFVTGWLNGLSSGFAILVSQWFGAKEYERMRHYVAMSIYLSAGWAVLMTIGL
GIANEPILRLMNYKDSIMPDVKAYMGIIYAGLIVTAAYNALAAFLRALGDSKSPLYFLII
SAVINVGLDVAFIIYGGMGVEGCAYATVIAQGISAVLCFIYIVKKFPILHLKKENFRFSL
PACGKLMALGVPMALQFSITAIGTIIVQGAVNVYGEDYMAGFSAAAKIQNVICTVFVAFG
ATIATYVGQNWGAGKVDRVRQGVRCTQIMILAYSVIAMILVFFFSKYLTYLFISPSETKV
IEVSVLYFHTVFWCYPFLGSIFLYRNTLQGLGYGLVPMLGGVFELAARSAIVVLVAGKTS
FAGVCLSDPAAWISALIPLIPYYIYVTRKWKKQGKIAM
>fig|657313.3.peg.799 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MEKTLIFRSVDEIRLKKLLRFIIPTYLTSLFTTVYTIVDGIFVSAYVGTNALAAINVVYP
LVNILYGIALAFATGGSALAALHIGGKKNDEASRTFSVSMAAAIVIGALVSALILFRLPL
ILQMLGATSLLMEDCKAYIYWWLFGAPIVVGKEMFTYFIRVDGSPTYSFLTALSGGIFNI
VFDYIFIGQLHMGITGAALATFLGLLLSFIMGVVYFVTHPNFLHFTFHGLSIKEAFHSMV
NGTSEFVNQLAIAITTVVFNRSALLFAGEDGVAAVSIIMYLQFLCIGIYFGFSMGLSTPL
GYAYGDRNFSVCRVLEKYAYRFFAIAPIILYGCTYLLAPIGVYFFASPGSTVFDMAVSGL
RLYGLGFLFSGINIFAAIRMMTYGKGYISGMITFLRSFALLLLFLTVLPRFLELNGIWLA
VPAAEILTLIVALWTLRKKTVA
>fig|657313.3.peg.1343 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIGYSCYILADTFFVARGIGSDAIAALNLVLPAFSLLNGTGLMIGMGAAARYSLSSGRAD
SKIHRTIFTQALQLAFIAMLFFFSIGLFFARPLCVLLGADGTTLPHAIPYISILLMFSPL
FLCNNLLNCFVRNDGEPRLSMTAMLVGSLTNIVLDYIFIYPMQLGMTGAALATATAPLVG
MSILSMHFWKKKNQFHLVKTRIHLKTAIDICRLGVSSLVAELSSGIVILVFNMLTLKFSG
TTGLAAYSILANIALVLVAIFTGIGQGIQPIVSSHPGKNGAPVRHQVRHYALSTALLMAF
IAYLVVFVFAVPIADLFNKDKNPLLTSMAAEGMRIYFVSLFFSGINMVSATYLSASDQPV
PGFIISILRGLVLILPIAFLLAALFGMTGIWLCLPVTEAIVCVVTFFFLRKF
>fig|657314.3.peg.265 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MWNLLKSELLKLRRCQILLVGLVALALCPLVQYGSQLIVEAEYRNPNYDFSALFENVVWG
NTQIFLPISLVMIGGWLIDRESTHDTLKNIMTIPVSMPKMLGAKLLLVGMLAVLLGIYSV
GITLITGLTVGLSGLTAEVFFHGGTQIVLAALTTYLVCMPLILIFGQIRGAYLGGSILAF
FLGYSMLFFKSGILASIYPFSAALILVGFDMSEYAGTTTSSTPLLAVIGVGIMVLWAVLL
LLMSSNKKEMKSRKQANAKGKGKRTVRRKGR
>fig|657314.3.peg.1252 Antirepressor regulating drug resistance predicted signal transduction N-terminal membrane component-like protein
MVQRTESISILSVIWLAGLLLCFGFFAVSYIKCYREFRFSLPVENDILEAWKEKHPLKRS
LSIRQTETIAAPLSYGVIRPVILMPKNTEWKNIYQLRYVLEHEYVHIRRLDMLTKLIMIA
AVCIHWFNPLVWVMYILFNRDLELSCDETVVRRFGMDIKSVYATALISMEEKKSGLTPLC
NSFSKNAIEERIRAIMKIKKTSKFAVIISAVLVICVTGGFATSASSLEKKTETAQENGET
TVALNEVNIREDESLSSSDVEWWTAEEYAKWLDEEKEVLQSMIGEKAYTGGDGWFVWTQE
KVDETIALYEDNLQKIKDGMKLSKSSDDAVGITMAYSPENIEYAKQEAETVTENKDSNEN
VFSEEQLSEYAKAGITYQKETGFLMYDGKTIGYFRDEFKPGTYTISSKRGGTLRVEVQRE
NYGTITDVKAEPLSDDFWSEPAVLVESSGGEAVTADEMKGSVFEEGGSENIAADDMGEYS
SEEGKGLNIAVPQEYADYGVSCDAQGNWVYNGKIIADLYDEGRGIFSNSNGTMYIEVTRD
KSGKISSFQKVSKNRMQELFTEFNPEAETFDGYTSEAKH
>fig|657314.3.peg.3279 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MSLYSVVVPVYNSEHTLEELYRRLEKVFREVIKEDFELILVDDGSKDRSFEVMTELRNKD
QRVRIIQMARNFGQHPALLCGFAHVRGDFVVTMDDDLQHQPEELPKMVKVMRERDDVDAI
IASYEGRKHGFIRRLGTKFSVWATSRMLGKDPNLQITSYRLIRRFLVDAMVKTNTYLPQI
GNLLVLTSNRIINVPVQHAARAYGKSGYSFKRLLKDLIYDITAHTAFPLLMVRNIGIVSF
LVSMVMAVYFLVRYFAFGISVEGWTSLMLVMLAFFGLILLSIGIMGIYLMNILNEAKKMP
HYVIRREDTD
>fig|657321.5.peg.1384 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MATSIYAKPIKAKTILKFTLPTVLMMVFMSLYTVVDGIVVANCVGSDALSAINIVYPFTL
VFMAVGLMFSTGSNAIIAKKMGEGKQEEANRLMSGVAITATVISVIIAVLFTIFAEPMYM
MFGSNEKILPYCIDYGSVMIPYGFVMCWQMLNQSYLVTADKPHIMLVFSILSGCTNIVLD
ILFMAVWDFGIIGAGLGTIIGMAVGAIPLLLFFNKKQTLHFGKPEFKVSEILFAMANGSS
EAVTNLSTAVTTALFNIQMMHFAGAKGVAAISAILYIHFIFTAVSFGFTSGVSPVISFNY
GAQNHEKLQKLFKLCIKITLIISVAMITASEFFAEPLVGIFSAGDEKIQQIALSGFRIFA
INYLLCGMNIFASGLFTALNNGKISAVISVARTLVFECAAMLILPMFIGINGVWSALPVA
ELCAVAISVTFIIANAKKYHLVGVPPLPVRADSL
>fig|657321.5.peg.1859 Permease of the drug/metabolite transporter (DMT) superfamily
MKLLQNKKIAYLTAIFCTLLWGTAFPFIKVGYSAFKIEESDIGSKLIFAGMRFMLAGFMV
FLFLWISKRKPPTLSKKDILPVCSLGVVQTGLQYIFTYIGIGFTSGTNTSIITACASFFT
VLFVPLFFKNDRLTLMKIIGCILGFGGIIAINFGGTVSTDTWFGDMMILFSTISAAAGNI
IAKKVTTGRDPFPVTAFQLLTGGFILLVSGICCGGSIGLINVESVSVLLWLAFVSAAAFS
LWTALLKFYDASRISVFNLLVPVFGTVLSGLMLGENVFRIETLISLILISLGIAFVNMNL
KKSGGKI
>fig|657321.5.peg.2102 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSSTVLGRNAVTVNKKYTEYFLPTVLTAMATNIAMIVDSIIAGNLLGQNSLAAINLMSPI
SQFYFSITILFGLGASSIISFAKGRRDEKQANRVFTSTFIVLIALSVIFIAIQLPLADSI
SSLLTKDAELKSLLYQYYVPFIIGTPIYLLLMCSIHFVRADARPAFASNIVIVANAVNLG
LDFLFMGAFKMGIAGSSIATVTGYAVGFVMMSTHFIMKKSTLHFDFSILRNPVQFFKFLG
KMVTIGLSGALGTMLITVKMLFLNTIIQSIGGSAGMVSYSVCSSSQIFMSMFITGASQTM
IPIIGVCLGEKDYDGVRYAFRRAARVLAVSSVVIMLFICIEPEPIIKFFGITSPTDIANT
VPAMRINALSFPGLSFSFLLLYYYMATQKRAISTAISIINGIVILIPSALILGKFFGIMG
VWYSLVVAQVGTLVVVYFIDLAEKRKSGGKYKNFYLLEETEDNELLALSFKGTKENAAGV
SLYLSSFLSKNGIEESRANRIAVAVEEMAANCAERMEGKKKFADIDIRIFADKKETIISV
RDNGDEFDPLNDDKEFEMSPLTVVKAISDKVEYSRALGFNRTIIKL
>fig|657321.5.peg.2118 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNGSKSVRNLTQGKISSQILFFAIPVIIGNLLQELYNVVDTLIVGQTLGEIKLAAVGSTS
SLNFFALGFFIGLSAGCSVITSQHFGANDMERVKKSVAAHIIIGVVSAVVLTVSFVLLVN
PLLTMLGTTSDTFEYASRYLTIIYLGIPATMLYNLTASLLRSVGDSKTPLYLLLFSSVMN
VGLDLLFIIVFRWDVSGAAIATVISQLVSAVLCCVYIFFKVKMLLPNRNSFKNLTSTVRD
ELKVGFPMGLQNSVISIGMMVLQYFVNQFGSYAVAAYTIGNRVQLLIQNPMNSMSTVIAT
FAGQNEGAGRYDRIKKGVNFCLLICIAYSIVIGAVSMIFAQPITGIFTSGSSQQTIDYSI
QFMFWNCPFEWSLAMLFIYRGTIQGLKNGIVPMIGSLIEVVMRIMTPVIFSSVIGYASIC
VAGPAAWTGSMLLMIAVYYVKIRKLSKTKTVVAN
>fig|663278.4.peg.457 5-nitroimidazole antibiotic resistance protein
MRRNDREVTDPDEQIAIMQRCDVCRLAFFDADSPYIVPMNFGFEQACDTLLLYFHCAKTG
KKLDCLAADPRVSFEMDGAHRLLEADSACGYSMEYESVIGRGTARLLGDAEKAHALQCIM
RHYRPGKTFVFDLRMMDAVAVFQVSVQSLTAKRLKK
>fig|665571.4.peg.600 Multidrug resistance ABC transporter ATP-binding and permease protein
MKLLARYIARYWYFALGSLLFMGTEVAVNLAQPALMGRVVDEGIIPSDMGAIVRLGLILF
GIVLIGVAGGIGCTITASAAATRTARDLRDLLYHKVLRLSLKEESRFGAGTLITRLTGDI
VQVQTIVHMLLRMMIRAPLLALGGLVMSFLLSPRLTLIMLASLPLLAGILIFLIRKGIPL
FVEAQGEMDRLNTVVRENLEGVRVVRAFVRTDYEEGRFGKVNDRLKEVMTKASSLMGLAF
PLVFLIMNLSIVAVLWAGGFLVQEGTVQVGTIIALTNYLLQILFALMMIGFFFMGLSRAQ
ASLLRLSELIEAPEESLSLESVQILPSRSPASLVVEDLSVAYDGTPALSDISFEAPAGTR
IGVIGPTGAGKTTLVMALLRMTEPSGGRVLLDGEDIQALSLEELRARIAVVFQKPVLFRG
TVADNLRWGFPGATEEQMIEALKKAQAWEFVSRLPGVLEARIEQGGTNLSGGQRQRLAIA
RALVRPASLLILDDATSALDAATESRLLSSLRTLPVTTLLISQRMSAITTCDLILVLDDG
RLAGAGPHPLLLEQCPLYRELYETQIEGALHA
>fig|665571.4.peg.1503 Permease of the drug/metabolite transporter (DMT) superfamily
MDRDKLVGVAAMLFSVVVWGISFVSTKIVLAAFGPMMLAFIRFAVGVVVLALLLRLQRKS
LSVRRGQGALLIAGGVIGVTLYFYFENTGLLHLPASDASLIVASIPIVSLLVEAVVFRRG
MGVREVVGALLSFAGVYLIVREGLRLTGRPVGYLLMAGAAASWVAYGFLSRPVLEANDRL
VVVFWHFVAGTAAFLPFLPGEAQNLEAVHLGVIGHLLFLGVGCSALAYWTYQVALHRLGV
AVANVFINLIPFVTVLTAMVVLGEALSPLKWVGGAVVIVSVSIALLPAKPKKGRLPGEAG
PV
>fig|665571.4.peg.1981 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQQVRNSRFQDQMFSGPVLPLLVRLSLPIFAGMFFQLLYNITDTVWISWIDLEDPSLVGG
IGIIFPLLFFFMALGNGLMVGTASLVARAVGEENEEKLDAAADSGIFMAVLISVAMLAGG
YLLKEQLVGALGAEGDYYMRALEYFTYILPGAAFIFMQNTLIGVLQGEGLVNYVMRSMII
GTVLNIVLDPVFIFLFGWGIKGAALATVLAQGIGFLYVVYVFLAGKTRVPIHIRLSGIRG
KVMAEIFSVGFPQTLGQAIMSLSFLIFNRIVIAIDPLALTAFTLCGRFDQAILMPIFAVA
SALVTMMGQNFGRRLYDRMLSIWHVALRVSVATVTVIVLAIVVFAPRIFSLFTDVPEVLS
YAVAQVRTMEYAFIFASFGILGRSFFQAIGKGWAGLLLVLLRLVLLAVPAVLFFVYVLHL
GIRGVWFGLIFANLSTALTAALWVPRTIRSMMEREPMPALR
>fig|665571.4.peg.2047 Acriflavin resistance protein
MIALLLLLLGVLSVLFLPVDFLPPLTVPRLTVVCSYTGLPAREVRDLITLPLEDTLSTVQ
GLRHISSTSRDGFAILTLEFSWGTNMEIAAAQTKELIDVAYTRLPHEASKPMILPADPGE
QPVMILGVLPTGELSLERLTNLVERELSTAFQQIEGVGSVQVLGGREEEVHIIIDPHRLT
SYGLSFSSFVQALNSFTMEIPAGFMKEETTEYIVKVEPLAEEPEDLPTLFIPTPLQPVPV
TSIGEVHRDSLEQRSFFFYRGKEGVALLIRRQAGYSPIKIAQEIRTRIPALMESYSHDVE
IVVVQDNSILIQESLSSLLFSALLGMGAAFFLILLLMRHLLPALLLILTIPLSMTLSFLL
FPIFRLTINVMSLGGLAIAVGMVVDNSAVILENILRLPQKRTKEYILHATAEVAGSTLAS
TTTTIIVFLPLFFLPGIIGKVFSPLAASVCLTLLSSYLVSITIVPLFLFLIPGEISSPSL
SRTPKRVFKILFSLGTKAPVLTSIVVLLSMGIGILGLIHTPFLWLETPQSETYLLEYTFP
QNTKLESLKEVASELEAVCTAHDIEAYFLGGYNPEDPYAIAENPDAPTTLKVVAHLPPHH
GYTPRSLLSTLSVPLARTINITTSSNLLIEALGLPDTGRSLFYVSGKTPEEAEALAQHIL
STYSIPDVQVLPSEKRVSLVVSPIMERVLQYGLDVQTVASTLRTVLWGTYGGSVKEEGRR
IPIRIKAPPQFQEERALIEGISLPTEGGDSILFTQLVRFEQREDYPYLLRHDRKDIFILS
CARSKETLHLSHMLEREPRVIDVLKLQWSQQLKETMFLFFLAILFLYVLLGYQFESFFLP
FIIMLTIPVGFSGIGPFYLLTHTPLSLNTFLGILVLIGTAVNNGIILFEILSQRIKSPLH
LISRTYVGSLQRLRAILLTVGSSLLALLPLALDLFGKNAQRSMALSILVGLLCSTFFSLL
ILPSIFMRFFGRRRKNPPWKP
>fig|666684.3.peg.60 Permease of the drug/metabolite transporter (DMT) superfamily
MDKEASTHQARLGGLLFLACTAIGWGLNWPAMKILLRDWPPLFARGISGVVATLILFAIA
AANRERSAVPRKTWGALLLASFTNVFAWMGFTTISMTTLSISEASLLVYTMPIWATLLAW
PVLGSRPKPRDVAGLILGFAGLFVLFSDHPLGFASDKIVGVALALGAAILFALGSLLNAR
PVPVAPISFVAWQIGLGSLPMVVLGLAFEHPDMGALRIDSGLMLAYMTLVPMGTCYLTWF
ATIRRLPATTAAVGMLSVPVIGILAGALFLGDGIGWREICAIVLTLAGVALALSKPKPVI
EQGV
>fig|666684.3.peg.2412 Permease of the drug/metabolite transporter (DMT) superfamily
MGLGFIGIAIFGGTLPATRLAVEGLDPFFITAGRAAASGLLSAALLLMLRRRWPSMRQIR
TMLICIVTIVFGFPGLMALAMLTVPAAHGGVVLGILPLTTAAAASVILGERPSLRFWLLA
GLGTTVVVAFALRDSGGEIAIGDVYLFLAAISTSIGYVFSADLSHEMPGWEVISWILVLA
LPLTLPLAIWLWPTNPGAVPTAAWVAFAYVSVFSMFVGFFAWNAGLVMGGVARVSQVQLL
QTFVTLGLSAVINGEHVGPSTIAVAALVVAIVAAGRNARITQKVPEAV
>fig|666685.3.peg.637 Acriflavin resistance protein
MNIFAPLIRRPVGTSLLALGLMLAGLWAYLLLGVAALPSLDFPGVYVVASQPGASAQTMA
NTVLAPLERHLGRIPGVDEMYGNASEGQASVMVRFTFDRTADSAARDVQAAINAAAVDLP
SGMPSPPQYFKFDTAQIPILFLTLTSTGLPQDQLFDLADTMLKPAVAQIDGVAQVQVFGG
TPHAVRIELDNGALAAKGLTTNDVANALRAANVTSPQGTLSDGRTQMTVSASDGLQTPAE
FARLLISVKNGTPVRLSDVAKVYSGQQDEYQAAWFNDARAVGLQISKRPEANAVATVEAI
RARLPQLRASLPQNVTMTPVFDLTQTTKSALHEVQVALLISIAMVVLVMLVFLRRLRPTL
IATLSVPLSLAGAFVVMWALGYTLNTLSLVALVLCIGFVVDDAIVVIENIVRHMERGEPP
MQAALTGVREIGFTVISITLSLVAVFAPLLFGNNMLIMLLREFSVTLTAAVVISALVSLT
LTPALCAWMLTHEPERSRPPGRIEQAVENFDRKLLHVYQRALDWAMHHRRIMRWQPLTLL
VLTFVLGFAVAKTAGGTFMPDEDTGQLQVDISADANISPAELTARALAVAKIMQADPAVL
DQLTMLGRDGGGGGAVGNNAQMFVDLKPRGSGPGQRREGIKQVVERLSKQYDKLANVKVS
VSAAQFLGGGGSGDKGGQYEFQLVSSNGGDLQPWTLKMVRQLRGMQQFRDVSSSFDQVGK
QQLLRIDREAAARLHVGVGTIDSALYNAFGQRQVSQIYSDINQYAVVLSTGAAERVSPES
LLDVRVRNEQGRMIPLSALATIEPNMSPLRVRHHNQLEAATISYNLAKDVTQDVGVKLVE
QAAYAARLPAGMRVDFTGANQRLKQAQSNGMVLLLGSILAMYIVLGILYESLGHPLTILS
TLPAAGAGAFLAMLVTQTQISMMAIIAILMLIGIVKKNAILMVDFALVAERERGLPAPEA
IREAALVRFRPITMTTLVAMGAALPLAIGFGIGSEMRQPLGIAIVGGLLVSQLLTLLSTP
AIYLWNYDRKIRKAARRERKAEKKRLKTLGKVQTAS
>fig|666685.3.peg.2821 Permease of the drug/metabolite transporter (DMT) superfamily
MDTAERLDGRALVAIAIALLTWSSAYAAIAYALPAFTPGEVAFARLLIGSLCFAVLLRVK
RVPLPTRRDWPLLALLGVLGLTVYHLCLNYAETRIASGTAAILISLVPAATAAVSALWLR
ERLALRSWVGLAVALLGTVLVVLASGQRVEVDPKALLVLVCVMVSAIFFVGQKALFARNS
MLGVTAFAFFAGTLAALPFGWHLPQALLTASWAHIGALLWLGIAPTFVGYLAWNMAVNRA
SASRVSSFIYLSPPIALLIGWLWLHEVPNALILVGGAITVGGVVLANARRRAAPVSAAPV
EACEQC
>fig|666685.3.peg.3307 Outer membrane component of tripartite multidrug resistance system
MKDTPMKHAPLRGRTVLVAAMVLALAGCAAAPARLGTPALRDDVPLAGLQAPVRAGWPTA
QWWRQYDDPQLDGLMDRAMQQSPDLALAQSRVRNAEQSAKLAAAQLGLSVNGSAQVTRER
LSDHGLIPSQFLGFSWYNQADLGVQLQYDFDWWGKKRATMEAALDQAHAAEAQRSAAALA
IQYAVADTYFGWQADQARLQLADRLLATQQQFADIAELRVRQGVDLPDEAQKARAQLAAV
REMRVALDGSAQIRRAALASLLGVAPTELPELRARPLPAIERGVPANGGLDLIARRPDIA
ASRWQVEAALKQTDAARAEFFPDISLTALAGLSSIDMGKLLTAGSRTFALTPALHLPIFN
GGALEANYGVSKAQLDAAVAQYDSAVLAAAREVATQALSAEQVAARRHEQQAQLDADQRL
LANAQARARQGVRDLRESLGAQAALLQQRDAATQLQAQAVSTDLALIKALGGGYRATDAA
TSPSSSVTAGAAPHERH
>fig|66692.3.peg.94 Glyoxalase/bleomycin resistance protein/dioxygenase
MGNPILKQIGTVFIPVSDIDKAKDWYCDIFGFNGDGEILFGHLYVIQLEGTGIVLDSKIY
SPEKTFQTPAFHFNTNNIEEAYQYMQSKGVKLLTGIENNHYFNFEDLDGNRLMVCKC
>fig|66692.3.peg.323 Multidrug resistance protein
MNETTNSHWRKKMMVITVLAASFLFLFNQFLLITAFPTIMDEFSINATQVQWLTTSFLLM
ATMLIPTMGYLMSRFSARALTMTALACFVVGTVLSAIAPSFVLLVSARVVQAIGAGMMLP
LVQTILLHVYPAEKRGYAMGLMALVINVAPAIGPPISGYIVDWLGWRSLFWLVLPLALAI
FVLAAVFMQNVTEQKSVKFDLLSLFLTVVGFSGVIFGLSNISVAGFSSAIVLVPLSAGFF
AIAMFIWRQLCLDSPMLELRLFKLPLFVHGVILSFVISILLLSTETLLPLFIQDVQGRSA
FSSGMILLPGTVLLALTSFVSGKLFDSFGGRALGLSGYGILVLVFTVFMFMGDQTGIPLL
VVCFCAFMVGIGFTMTPATAIAMNALKQAELAHGTAIANTIRQFGAALGLTVLTTLVSLN
ANRSDIDYVEGTLAGLKLAFGVMAILALVAWVLVYTAKEKNARQQEQ
>fig|66692.3.peg.1303 Kanamycin kinase (Aminoglycoside phosphotransferase, gentamicin resistance protein) (EC 2.7.1.95)
MINNYMKNVKSFYPNISIENFYLNEMGQNNDVLIVNHSLVFRFPKYKNGIIQLKRETEIL
QYIKDIISTPIPNPIYQYFEELEPGKVFTGYHLIDGVPLWGESLSGIKNHELVKSLATQL
VSFLKELHSISEEKLSRELKLKVNNPREEINKLYSKIQKNLFAFMRKEAQKEISHSFEKF
LNGEALSKLHLSLIHGDFGSSNILWNPESSRITGIIDFGGSCLGDPAYDFAGILSSYGRH
FFDMCISLYPNDSELLDRANFYKSTFALQEALHGIENDDKQAFESGIKGFR
>fig|66692.3.peg.1398 Multidrug resistance ABC transporter ATP-binding and permease protein
MRGYFSSISLKGYKNIWMKQWKFTLEMKVGKKMEHELAGSLGARRFWSMVKPFLPKVAWL
VLAVVLVIGETSLSLIVPLLTMNFVDEMNAVGLNGQTVILLASVFFAQLVMSGFALYTMM
YIGQKVVFALRKEAWQRMLHLPVPFFDRHSSGELMSRMTNDTLVIKDFLTMQLIPFFSGI
VSIIGSIVLLLAIDWKMTLMMLTVVPASLLVMIPLGRSMYKVSKSLQDETASFQGDLGRV
LSDIRLVKASLAEGVEQKVGLSRMAKLFRFGMREGKIMAVIQPLMMSAMLIMLVVIFGYG
GMRVSAGTLSAGALVAIIFYLFQIAMPFTQMASFFTQFQKALGASERLETILRAEPEKNA
ENVDGAVAPAGTLSFQGVSFGYTADKPILKEVNFDAPIGKVTAFVGPSGAGKTTLFSLIE
RFYVPDDGTIQYKGHSIHRLPLHEWRQKIAYVSQDSPIMAGTIRSNLVYGLTDVPEENMR
AAVRHANLESFIASLPDRYDTEVGERGVRLSGGQRQRLAIARAMIRDPEILLLDEATAHL
DSSSEKLVQEALEVLMEGRTTLVIAHRLATVRHADQLIVLEEGNVTGAGTHAELLDTHPL
YKELVSQQLQFN
>fig|66692.3.peg.1459 Drug resistance transporter EmrB/QacA subfamily
MTDMQAFSIRTIIGPLIAVVVGMVMVILDSTIVNVAFPKFQQEFGSTLAVVQWTFTGYTL
ALSAVIPLAGWMTDKFGAKRIFLTTVALFTLGSVLCGMAQTIEQLIIFRIVQGIGGGMVT
PIGMAVIYRLTPSHKIGEVMGVLGIPILIAPALGPVLSGWLLDYVSWQWIFLINLPIGII
AIALGMKWLPAFPQGEVPKLDTLGMILAPLAFSMLAFGVGEGAVDWTSTRTVVALTVGAA
ALVGLIVTELRHRQPLLELRVFKSSDFTRGILLLWLVQIALFGVMVLFPVYLQTVRGYSP
LDTGLIMLAQAVGSILFTPVGGRMYDKVGARPLALIGLTAVSAALFWLSHVSPEAGLTML
LLPLFMIGSGMGLIMMALNTHVLNSAPRDLVGRVTSLTTAAQHVITSFAVAGLTGFLAYR
MNEMTMNVELQSIAAAYSDTFLLTAILAAIGIVLSLTLRKPQLLDSAVPTQGHDTNK
>fig|66692.3.peg.1656 Multidrug resistance protein
MKKNDYSGLFLLPTLIVLGNSMYVPLLPVIQQTYAFTQTESTWFLSTFTLAGVVAIPFAQ
QLARRTNIRKAMVISCFLVMVGSLVNVWAQMNEAATLLFAGRIVSGMGAGGATSLAYTYA
GAFAKGNEKLVLFGRLELSNGIAKVSSPLIGSLLLYLSWTLSPYLFLLLAVGSIFFVWRN
IAPLKWENPKVGQRSFRRYFFVAASEYMLSLVHLFLLYGLFFYASYLFSLFGFSPAVRGV
LLALPFLAMVLCSANIRFVANVGQTAIRGVLLSLLLCCTLLLLFFSEQAIVLCIVLLICG
GCTGVALPLASNALGEKTAGAVRERLIAYLSMARFLSIAAAPLFYQMWIGNGMVALGSLV
AVLAASLIIGICLHREKNQHITQI
>fig|66692.3.peg.2298 Multiple antibiotic resistance protein MarC
MVSFFIHAFVSIFAILYPIGNLSVRLGLAHIKGDTQRIHKAAKAILVVLGALTTLLLLEQ
WLLLLYNISIEAFTIGCGLCLLVIGCKLLQGKTRYRSKQKTIFATVASQGAAGATMCLTA
NQNHRWFYVPITFLAFVSVLVLSLLPLLVANWLRGRTGQKGLSLVKRATGVALTVIAIEM
VVMGFADILPSFEQEAA
>fig|66692.3.peg.3384 Vancomycin B-type resistance protein VanW
MKHFLALMAFASICVLAACGSGEERVAASVSTHENVVLEKTIPDLSVTVFLDEEEFDKLP
VELVNEDDLRKWARDLARGKDGFDQTMIPAKWNGQELVGGQDQVTLDEQKLVEDILSLSV
WEREVTLPINRQAISARAEDINNIENKTIGHGRTSYNKSVSGRVENIRLSTESVDYVVLG
SGDTFTFNGIVGERTKERGYQVASVIMDGDFTDGLGGGICQTSTTLYNAVLDAGLTVLER
HPHSLPVGYVEEGMDAMVSWGSADLRFRNDFDYPVVIRGGVDKEKGEVWFDIRK
>fig|66692.3.peg.3703 Ribosome protection-type tetracycline resistance related proteins
MKTINIGVLAHVDAGKTTLTEQMLYQAGVIKEAGSVDKGNTTTDTLAIERERGITVKAAA
VSFFWNDVKVNIIDTPGHADFISEVEHALTILDGAILIVSAVEGVQAQTRVLMQSLKAYR
IPTVFFINKIDRVGADYKRVIKQIKWLLDDHICPMCEQTQGDTAYSIKATCPQTAGWLDV
LALHNDELLAAYVENEPVSEMELRKELSQQTKKAVAYPLFIGSAAKGVGVSALLHSLSHW
FSHTTEEASERDLSGIVFKVTELPNGEREALVRLYEGRLVARKMVSVIRADHPSFSVKVK
HLQLLENGGRTGASAVSAGDVAVLREKSLQVGDILGKRVPQMKRFAFKKPPLQVQVHTDR
KEEAIALHRALARLAAEDPFLQYTQDAATGDHFIRIFGHVQQEVLLSALKNEQGLSVSMS
EPLVVCIEKPSGVGAAVEWIGEKGNPFYATLGFRVEPGPEGSGLSYQLEAELGSLPPAFQ
RAVRDTCRVVLQEGLKGWAVEDIIVTLTHTGYWSPVSTARDFRGLAPLVLMEALRQAGTS
VYEPLERIEVIVPERFLSTLLSRIVQLGGNVLEPAFHQAGVLIKGTIPVRTATRLKSSIH
ALSGGEGILISKPGGYERVAGKAPTKERRQLNPLERTNYLMRFSHTM
>fig|667014.3.peg.138 Acriflavin resistance protein
MTFVERYLKWPHLILALLFLGVVLGIKSFRELPLNLFPDANYPQIVVVLSLPGASAEDVE
KEVVIPVEKELATLSLVRKVRSVSRDGVGVLSVEFEYEKGLSAAQVDVSSALDRILSDLP
RGLLPPRIFKVSDVTNPVMTVAISPKEGSNLTLSEVRRLAEEYIKPSLLNVPQIGDVEIF
GGYQPEVRVEIERDTLARYGLSLANVAAALASQNTNWPAGIIRSNEQEIFIKIPGEIARP
EELKDLTIPLKGKSIRLGDIARITLSHEDRNSLFHGNGRPAIGLNVLRPENGNVMATIEA
AEKALKKLKVQYPELSFSIADTQKNIIKTSLSNLIGALRDAIILTVAVIFLLMARVRATL
LAAVSIPVTYFLTFFLMKLFGLELNIVTMTAVILAVGLLVDDSIVVAENIERHLREKGLS
PRQAAISGTQEIMLADLSGTFTTILVLIPIMFVGGYVEKILRPLAMVLTMALTASYIVSV
TIIPLLAPYVLRAGEPSRFEKFLSRVSEGFLEKFRAFYLTLFRFGVRYKVVLIMPAVLLM
VISVKKIMPLVGRDLMPPMDTGIVKISFEVTPNTPIEEAEKIIRKMENTLENYPGFIRMA
TVMGSEPGVISFGADRTPRQGMITVHFVDRFHRKENIWQIENHLYSEFLKIPGLKTLHVF
EFGATPLSSIAAPVDVMVSGSDPRILHKLALEIENRLYKVPGLVSLSHTWDFDRQEFLIK
PNLEKLSFYGLTPEILAREMAMGFSGGKASFWRVPEERPYVIKVRFLPYERDSLESLLNY
MVPTPKGPVPLKELATVEKDFVRSVIVRDNLSPVIDVLGYRRKTAISHIQEGVGKALSDL
KVPSGYKLSQEGEVKPMKESFARLKDALILSLILLYFSLVPTFRSFRHPITIMVAIPLAL
IGAIWGLLLVDRHFCMPASMGMILLSGVVVNNSILLLDFIEKARQKGKDLKEAVEGAIRA
RTRPILMTALSTITGMIPIAAERAIGLERLSPLAVVAIGGLLVGTILTLVYVPLFYVFLE
KVRALVSRK
>fig|667014.3.peg.1963 Multiple antibiotic resistance (MarC)-related protein
MEFIKGFLHIFIPLFIIIDPIGCVPLFLGLTNDLSPERRKKSAYKAAIVAALVLSAFALI
GDQLLFFFNISVASFRVAGGLILLLIALQMIQAQPRATKSRPEEEEESRHKEDVAIVPLG
VPILAGPGAITTVLVLTAGHKDFGFRLEVIIAILAVSLITCLVFLYSTRIAKILGRTGTN
LFVRIMGLILAVISVEYMAKGLGELFPGLLK
>fig|667015.3.peg.1981 Acriflavin resistance protein
MEKKKRNFVEWAMHYRQIVILVVTCLVAFGVYSLPEMRKNEFPDFTVRQGVVVAVAPGNT
AQEMVEQVTKPLEEYIFTYKEVKKEKTFSKSRDGIVYIQVELNDDLTNKDEFWSKFKHGV
SQFKAQLPGNVLALVVQDDFGDTSALLITMESEDKTYRELDDYMGLLQGRLRRINSVGRM
TVSGMQNEQISVYLDHDRLSKYGLNEQTLALGLMQKGFTTSGGRVKDGSMVEPIYVSRSL
NTVRDVQEQIVYTDPQGNTVRLKDVARVVREYPAPDSYITNNGRKCLLLSVEMKKGQNIV
AMGDEINKVLDEFQQELPTDVSIFRITDQPEVVGDSVSNFLHELIIAIVAVVIVVMLLLP
LRVALVAASTIPITIFISLGLFYAFGIELNTVTLAGLIVTLGMIVDNSIVIIDSYLEKLG
EGMSRWHASIQSTTHFLKSIFSATLAISVTFFPFLLTCTGMIHDFLVHFPWGITIVLAVS
LLVATLLVPFMQFWFIRKPMGAKVKDGKKPFNFLDLLQKHYNWLFGKCFAHPKITVAVGV
VSIVVGAVMLAGLPQRILPVADRNQFAVEIYLPTGTDVDVTAQVADSMEHILSQDPRVVS
IASFKGCASPRFQTAYAPQIPGTNYAQFIVNTTGVKDTEALLAEYTPKYTEYFPGARVRF
KQLSYSEAVYPIEVRLSGEDLSMVKQDAQTVLEVLKRMPGLILAQTDFNEPLPAIAVNLK
EDEATRLGVTNLGLESTLAMRYGDGLAIANVWEGDYDIPVKLKSEKADRALPVEVKDELI
PVAAGLADVPLRQVADVVPTWKEGQVVRRNGIYTATVQADLAVGENALRMTARVQEMMKG
VELSEGVTVSYGGEMEKTGEMMPQIMGGLMLAVAIIFFILLTHFRKISIALLIFGSMTLC
VFGTAFGVWIQGVDFSITAILGVVSLMGIIVRNGIIMIDYAEELRVTEHMTASEAIYHSA
LRRMRPIFLTSAAASMGVIPMILGKSSLWMPMGTVICYGTLITMLFILTVLPCLYLLTFR
GSSKKREKWDALEQQ
>fig|667015.3.peg.2043 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MHLTKEEQLLATGRITALFRKFAIPGVVGLLFIGLQPMIDGAVLGNFVGTEALASINIFV
PIYTFMSALAVVVGVGCQAIVGMALGSKDYVKAHSAFKTAFWSLLVLALVMGCTFVLAAE
PLCRFLGANEVLLPYTVSYVRAFSLFFPFLLLTFLCDYMLKAMGRPYFAMLVLGGTVVLN
LLLNLLFVGVFGWGTAGSGLATGIAFTTGFAVMAPALLKKNSLVSLRKGRLSFRLLGQMT
YNGSSEGLSELSAGITVFLFNWVMMKNWGEVGVAAFTAINYMLNLGVQMFVGLSDGIVPI
LSFNYGAGHLNRVKETLFLGFKTNATIGIILFCIMFFGNEFIVSQFFADGGSHVLKITSI
GAAVCAFAFLLNGSNILSSSFFTSLGDARTSVLVSLQRGLLFVVLGIMIYPVILGDNGVW
LTVPLAEFFTFVSTIYLLRKRLKKWSVSIHA
>fig|670487.3.peg.233 Permease of the drug/metabolite transporter (DMT) superfamily
MTPTALVLITLSVVAHAGWNFFSKTRPSLAFFAVSVLASMAALAPLAALDRTLLPAVPAA
VWGLVAATGLFQTVYFTGLAGAYRHGELSVVYPVLRALPVLGVTALSLLLGQGAPIAPPA
LAGIALVALGCLLLPLERFAVPRPRDYAGPALWLALVAAAGTTGYTLIDDAAQRFLRGEL
PGLGPLRVTAFYVVLQTYSTGLWMALALLAWPAERRRLRALGGRGALAAGLTGLVITGAY
ALVLAAMAFVSNVGYVAAFRQLSILLGAALGMALLGERPHGPKLLGLAAVTAGLVLVALY
>fig|670487.3.peg.1279 Multidrug resistance protein-related protein
MRRWLERAPWPPGHLAPLATLIALVGLVELTRTGLYTVYLPRSLGPVLGLGVVGLAASLQ
YLADTLGRSAGGHLGERHGLRRVLPVAAALAAVSALGVLHAPGVGWLLAASLANGLVIAP
LWPAMMTYSSRAARDGEDGRAIGFTQSLVAPFIGLGVLLTGFLFDHDPRLAAAALAAVQA
LVFLLGAAILLRFRTAAPQPKPTSPFPWRKLASLAPGALTQLLAFGLLAPVFFPFIDRLG
LGTRELVLALALGGGLEYLLLSPLGRLADRLGPARTLAPALLLAALALIGFAEVRGLGGL
IAAALAAGLAQALLIPSWGGLVSRTLPDEHKARAWGALMSLEGLGFALGPVVGGFAWELW
GPRAPFWIGAAAYLGVALFYAARLRRPAGA
>fig|670487.3.peg.1648 Drug resistance transporter, EmrB/QacA subfamily
MNRTQRLTLIGIFLGIFLAALDQTIVATALPRIVQDLGGMDKYAWVGTSYLLASTIAVPI
FGRLADLVSSRMLLLWAIVIFLVGSMLSGLSGTMEQLIAFRGLQGIGGGALFAVATTTIG
LLFSPRERGKFQGLFGAVFAIASVVGPWLGGLLTDHLSWHWVFYINVPVGAVAVYFIAVH
MPVLRPASTHRFDLGGALTLALWTIPLLLATSWGGHEYAWTSPVILGLFAWAAAGLALFV
YVETHTPEPLFDLTLFQNPVFRWASVALFFFGAAFLSAMFFLPLYLIQVKGISATMSGLT
ITPLTLGAIVGAIGSGQIASRWGRYKPLMIGGMSWLLVNFFAMHFLIQVDTPLWQVLALM
VSMGLGLGPGMPLFTLAVQNAVPPERMGTASSATQFFRQIGSTMGIALMGAVLAASLQTQ
LSANLPSNLTNGKVDLGAMRDPGALERSFDTELQATLDELERALSGDEAAKAALLKNPLL
PAELKQMLEGPPPPAAYREMVLAKVKEELAAQAEQLKRQVTEALNLAITEAMKQVYLYAA
WLVVLGLAATFLIPDARLEGRAHFSPGD
>fig|670487.3.peg.2330 Permease of the drug/metabolite transporter (DMT) superfamily
MEPSNTRLTPIDVSALLTLYFIWGGAYLANKLAIATIDPFIMLAIRLGASGLLLFVLLRL
LGWTLPKGREVLGSWLIGQLLLVGGMGAVVYAQQWVSSSLAAVIVSTMPLWNAFFANFLG
RRTRGVEWAGMLLGLAGVYLLAGEPDLKLDPGALLVFVGPVSWAFGSAISTRVPQAPGLM
SSAVHMMGAGLSFTVIALLAGARWHEPSVASLLALGYLVLLAGVVGYSAYLHLLARPLRP
ALVTSFAYVNPLVALALGIGFAGERLTQAGLAGVGLIVLGVGLAVSGRGR
>fig|671143.5.peg.813 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MTSDKPDLSVVVPVYKEEANVPPFLERLEAVLKRMGGSYEILFCLDPSPDRTEEVIMRAI
DRNPNIKLLVFSRRFGQPAATMAGLLMCHGASCAVIDVDLQDPPELIGDMYKKLLDGYEV
VYAKRRSRKGETLIKRIVARMGYWLIARLSDVEIPRDTGDFRIMTRRVIEELRRLNEMHG
FLRGLVAYVGFRQTFIEYDRDERAHGQGNYNRFVGSLKIGLNGLISFSSKPLQLMSITGA
LFAGFSFLLGAWYVLQKLIGVALTPGLSTTVLVVSFFAGIQLLSLGLMGEYIGRIYDEVK
RRPMFIIDRKINF
>fig|671143.5.peg.1070 Glyoxalase/bleomycin resistance protein/dioxygenase
MVRRIEHIAIAVKDAEASARLFETLLGVGRGQMETLPGERVKVAFFDLGESRLELVQGIG
DDNPMGKFIEKRGEGLHHICLEVEDLPETLRLLDAAGFPLIDSVPKPGSSGTRVAFLHPK
GCNGVLIELVEQPNRA
>fig|675635.11.peg.92 Glyoxalase/bleomycin resistance protein/dioxygenase
MDLFAGIAVRDLARAVDWFDRFFGEFFGAVETFAPNDVERVWTIGEHRHVYVVVQPAAAG
HSLLTLFVDDLDALLRDVASRGITPDLQETYGNGVRKAVFHDPDGNEIGVGGGPG
>fig|675635.11.peg.146 EmrB/QacA subfamily drug resistance transporter
MSTEAVAPQQSAAGAPAPSERSSGELSHRQILTILVGLALGMFLAALDQTVVSTAIRTIA
DDLGGLSQQAWATTAFLITGTITTPLYGKLSDQFGRKPLFLTAISIFLVGSVLCTFSTSM
YELAAFRAVQGLGAGGLFTLALTILGDIVPPRERARYQGYILAVFGTSSVIGPVIGGVLS
GQATIAGIDGWRWIFLVNVPIGAVALVVVAKVLNLPHTKRSRRIDWPGAVTLAIFLVPLL
IIAEQGREWGWGSTSAIVCYIVGAVGFVLFMLAERFYGDDALLPLRLFRNGVFSLTGVAG
FVIGMGMFGGIVLLPQFLQIVHGASPTESGFLMLPLVGGIMVGSILSGQITSRTGHYKIF
PIIGTALMVGAMLLLHFRVTVDIPLWELDLYMAMLGLGLGGCMQTLVLAVQNAVPARDMG
VATASSTFFRQLGGTLGVAVFLSILFSTVTDKISDAFRTAQTDPTFVAAVGDPAVRADPV
NAPFFAALNGGADTSGVLNDSSFLQKIDPRLARPFLEGFSNSMTLTFLVVACVLVIAFVL
VLFIKELPLRTMSGAQARAMEEAAGEGASVGAVTPTALEADAEAAPVPSANGNGNGHGNG
NGVAAGTVAAAVAAAAAKGSNGQGSRHALRAADGQVTVPADGQRADTAPIPVVADQAPTP
PSDGPAIEGVVRRADGAGLPGAVVTVTEPTGRQAARTTSDQQGEYRIGVPTGGTYLVVAA
SGAFQPHAAMVAVADRAVRHDVTLAGAGGLRGTVRVTDAQGQVRPASGVAVTLIDVQGNV
SAATVSDELGRYVLAGVPDGQYTLTAAGAGYQPVATSVVLPGGSEVVQDVELPRRARLLG
TVVAGSTGRGVPEALATLIDPSGNVVGSTVTDADGAFAFDDLAEGTYTITASGYAPTAAV
VQVTAGGASTTEIAFPPPVVAGSAPATPPAPQVQRSASNGTTPADLPSVPEEPGSPTAGQ
LR
>fig|675635.11.peg.343 Bcr/CflA subfamily drug resistance transporter
MMFTWLGPFSMDAYSPAFPAIQSEFATSDGMVQATLATTLIGLSVGQLIVGPLSDRFGRR
RPLTIGLAGYVVASVLCSFAWSIEVLIGARLLQGFSAAAGIAVARAVARDVHSGATLARF
YSLLAASTALAPMIAPILGAGLLELGLSWRFIFGLTLALGVVGLGLVVFVLPETHPDRIG
GRTPPTPAERARRKADGESHLGLWSLLRRRHVFVSALVLGSVGAAMIAQLAGLSFYLQTE
RGLGPGAYSAIFAVNAAGLVLANNVNRLLLRRFTAQRLLSVATPVMLLAALTFAALLRAG
APLPVALPALFAFMSCWGFVMPNAVSVGMAVERHAAGRASAILGVAQFGFSAFVAPVVGI
LPAVLGVPSMAVVMVICLAVAVTVQLVSRARLPRRPREVPVVPQELADSAAQPTCRAAG
>fig|675635.11.peg.495 Glyoxalase/bleomycin resistance protein/dioxygenase
MTSIDSVVIETTDPAATRAFLTALGLDGRLAVRGSDAPTDGFRACTLSLVVGRPSTVDAL
VASAVAAGATVVKPVEKTFWGYGGVVRAPDGTIWKIATSKKKDTGPATREVDEIVLLLGV
TDVKASKRFYVEHGLTVGRSFGGKYVEFSTPGAPVKLALYPRKALAKDAGVDMAGSGSHR
IAIAGDGDGFTDPDGFVWESAPVTSSPN
>fig|675635.11.peg.926 Glyoxalase/bleomycin resistance protein/dioxygenase
MTEPTHEFTDGVYGWITHTDFASDDVEATRAWCADVLGWSFRPPFPTGSGDYHLFAYSDV
GGGGIRRTAPAEQPGSTPTVHVRDTHAAFAHAVEAGAEPVTPPTKIMPGVCTALVRAPGG
VLIGFSGPTD
>fig|675635.11.peg.1387 Glyoxalase/bleomycin resistance protein/dioxygenase
MIDVRGVHHLGLTVGDLATASAFYASAGYQPADRISLTGPDGAVGNGLDAASLEIAFLIG
PTLTLELVEFDPPAPRRVSATDPGFGSVPIGRPGAGQDPDGRPVTFGTAERGLFLTSAAP
ERTVRLLDALGFDRDGDGAVAGHGVHVDVVGVAAPGRTPANAPGRVHLCCEVADMQKACD
ELAAAGFDLVSAPRVSGHLSWVFVAHPEGPGVELLEIGTP
>fig|675635.11.peg.1454 Glyoxalase/bleomycin resistance protein/dioxygenase
MNDPLDALREPVTPVDPDPAFAARLRARLERAVLAAPGPQEEPMTSTISRGTALALHSVT
PYLAVPDATAAVDFYVDAFGAVRRGEPIVMPDGRIGHAEVAIGDSVLMLAEPFPELGVVA
PRDGEATVSMRLEVSDPDAVVDRAVALGARLERPVGDSPYGRGGVVLDPAGHRWMVSREP
AAGAALQVGDVGYASLWRRDVDAADRFYAAVLGWTTEGARDGHARRVVGVGQELGMYGGQ
DAATTMCAYAVDDVDETVALVRAAGGSAEEPLDEPWGRTATCADDQGLPFAVFAAGRQNV
RPDTTRPGTLTYLTIEVPDAGRARAFYGTVLGWRFGPGRVPDGWHVRSASGDETSPMTGL
HGGHDAAQVVPMFVVEDVAGAVAAVRAAGGTADDPADAGYGVSARCTDDQGAAFWLVRY
>fig|675635.11.peg.2494 Glyoxalase/bleomycin resistance protein/dioxygenase
MSHIAVGVRDMAEALRFYRDFLGLAVSLDQHEQRGRERGDGSAQSGRRAVYLRLAEHDDA
SFLVLDQQLDHRADGEPRNLFDVGFHHIAFWAEGLDALVAAAPAAGVTIVHGPAWEDSTS
WGESAGRPIRTVIFRDFEGNIVQVDSRHDG
>fig|675635.11.peg.2612 Glyoxalase/bleomycin resistance protein/dioxygenase
MHHVGIQVADLDRSLAFYEGILGFEVITRQVRGEAYAGEIVGYPGVELHLAHLRPPNSSV
VVELTEYRGVERTPVDTSTANPGTAHTCYVVDDVEAVHAALLAAGVRPVSRTIVAPDAGI
AKGGKVVYVQDPDGVRVELLQPPPSQT
>fig|675635.11.peg.3631 Glyoxalase/bleomycin resistance protein/dioxygenase
MTPAPSRHGVATTPDVCPARSPAGWVRTVRTSVRMIVMDVGPPVIARIAGAMLAVENQDV
MVAFFEKLGFAKTVDRSLWPGARWVEVALPGAQTSIVLTPARAYHREPDRLYALTLSCHD
LLATAETLRAAGIEVDGPTHEPSGSYIQVVDPEGRVLFVNDKADPGS
>fig|675635.11.peg.3669 Antibiotic resistance transcriptional regulator, MerR family
MRWSTAEVARMARVSSRTLRHYDHTGLLRPAGTGNGGLRLYGRPELDRLQHILLLRELGL
GLADIAAVLDGQTDEVAALRRHHARLLSESRRLRTLAATVARTIEEREGGEEMAAEELFE
GFANDPYAAEARERWGDTAADSQRRVAGWDAGRQREVMAQGTAVNARIAELMRAGSPVDD
AAVQAAVAEHHAWVRHFWEPNREAYIGLGELYVDDPRFTTTIDRDAPGLAVYLRDAMRVY
ADRELA
>fig|675635.11.peg.3993 Glyoxalase/bleomycin resistance protein/dioxygenase
MATHEGQWKAGTPCWVDLNVPDVPTATAFYSAVLGWSFVDTGAEFGNYQIAQVDGRAAAG
IGPIMQEGQPSFWTLYLASDDADATAKLVTDNGGSLIAGPMDIPGSGRMVIATDTAGAVF
GVWQTLGMNGAEVVNEPGGLVWEDARLTDPETARAFYAAVFGYTYDAVDGAPEDYTTFAL
DGEIKGGMGGLMGAPDGTPSHWIAYFGAADVDAAVAQVQANGGSVMMAPQNTPFGRMGIV
ADPFGAPFCLHGEVTG
>fig|675635.11.peg.4078 Bcr/CflA subfamily drug resistance transporter
MTRQTRPAAAPERDRPPLRQVLALGGLSMFGPLSMDLYLPGLPELTTDLHTTEATAQLTM
SLCMVGLAAGQLIAGPLSDRRGRRGPLLVGVALFAVTSLACAFAPTIEVLLALRLLGGLA
GAVGIVVARAMVRDQWEGRAAARVFALLMVVSGAAPVLAPVIGSQLLRVTDWRGVFVVLA
GIGLVLLGAAATLRETLPAARRRSGGARETLRALGSVARDRSFLAPASVLALGCCSMFVY
IAMGSFVLQGTGYGLSPQVYGVVFAVNATGIVLAGRLSAWLVDRAGPRRLLGAAVAVAFV
AALTLVAGVLLTRSVWAVLPPLFVVVAAVGMIMPNATALAMSGQGAAAGAASALLGLGQF
LTGALVPPAASVGGVTPLVMAVTIAGTATAAVLAAVPVLRSRDPEPAAQPAVLAQPRTPP
GTG
>fig|675635.11.peg.4173 Glyoxalase/bleomycin resistance protein/dioxygenase
MISGLHTIVYAQDAARAREFLRDVLGLGWVDAGDGWLVFAAPPTEVAVHPTDAASSGRAE
LYLMCDDVTATVAALTSKGVEFTSPVADRGWGLVTSLRVPGAGEIGLYEPRHPTAL
>fig|675635.11.peg.4508 Glyoxalase/bleomycin resistance protein/dioxygenase
MEETVKFYNGLLGFPVVVTLQLPNPDPFPGAVPGNLGGSRHYFFRISEQDTIAFFEFADV
EVPADNSLLGAGNHLAITVPSEAELQKAKRLLEENGVKIKSELDHGFCHSIYFEDPVNHI
ALEFATWQHACDEEEPFLQDPAPVPAALAAIGAERYERYQLHYNPDGHGGEGPRA
>fig|675635.11.peg.4947 Glyoxalase/bleomycin resistance protein/dioxygenase
MGAPVIHFEIGATDGERSRRFYADLFGWKITPDPNGYGVVDTGAAGINGGVVQVPGQVRP
YVTFYVAVEDLDEALDRAEELGGHRVLAPSAVGDIGSMAMFTDPDGTMIGLFTERGTATV
>fig|675635.11.peg.5018 Glyoxalase/bleomycin resistance protein/dioxygenase
MTSPEDVPTVTLAVTYRDPKAALDWLARAFGFEVSMAIEGDDAMTSHYEMSVQGRGRIVI
GGEWADWTRSPAGVGGANTQSASVLLTGDVDAHCARARDAGARIVAEPEDQFYGDRTYRA
VDPEGHVWTFAAHVRDVSRAEAETVIGRRIDAPSWT
>fig|675635.11.peg.5041 Glyoxalase/bleomycin resistance protein/dioxygenase
MRRGGVMTGEFGFGQPHGGVIQTAFVVTDLREAVDFWTGDLRAGPFFHFPEWRGGDPVYR
GRPSTAAVTIAMGFAGRMQIELIQPLDEEPSVYKELLDRSGPGFHHLGVASEDIDADVAR
YEKDGWTLAFRAGVGNGEVAYLDGGPARPGMIELIEASPGLDASFTAMWRASLDWDGTDP
LRPR
>fig|675635.11.peg.5211 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTPENPARIGNVLHPVPDVAAAVEFYGSVFGFATKFVDGGRYAALDAGGTTLALAAPEE
DVTGGVPAASIKVADVAAALAALVEAGGTVVREAEQGPHEVRAVARDPWGNTVVVYGPRQ
DSPG
>fig|675635.11.peg.5391 EmrB/QacA subfamily drug resistance transporter
MGSSAFLASLDLFIVNIAFPVLRVDFGANLVGLSWVLSGYTVVFAACLAPAGRLADRVGR
KRLFVIGVALFAVGSAACAAAPSVGMLVAARVVQAIGAALVTPTGLALLLTAFPAQRRAF
AVGVWAALGAAAGALGPPLGGLLVVASWRWVFLVNLPVCVVVLVVAPRLLRESRDASGAL
PDLLGALALLGGVGALAYALVEAPTAGWTDGPVLAAFVVAAALFVVLAARSRRHPAAIVD
PTMLRIPTLSLSSVAMLVFSAAFAAMVFGNVMFLTGLWHDSTVVAGLEMAPGPAMVVVVA
MLGSRLVQRIGPGPTAVMGALSYATGITVWVLRMTAEPDFATTMLPGQLLTGLGIGLAMP
ALTGVVGAVLPPDRWGAGSSMVNTTRQIGMVLGTAVIVAIYDASGGPTTLTAFRHGWTFL
LCCAGLTIVCGLAVARRAGRDHDAAAQRFTGPVAAAPGRA
>fig|675635.11.peg.6174 Glyoxalase/bleomycin resistance protein/dioxygenase
MTEILQLTPKLVVADGAAALAFYTAALGAVVEESYTMDGRIVHATLTVGSLRFELKDAGD
GDPAPTPGQHPPVLMSLDVSDADAVTERLLAAGATVVYPVSDHEYGSRGGRVADPFGHHW
MVSAALETLTPDEVQARLDGVRQGQV
>fig|675635.11.peg.6266 Glyoxalase/bleomycin resistance protein/dioxygenase
MTVTGLARAIVSVADLDAALRFYRDVLGLPVVAPAPDVAMLALPGGTDLMLHQRPSRPSD
AGVALSFAVDDVDATVDAAVSAGCGVLDAPADQPWGERQAVLTDPDGHVVCVVARP
>fig|675812.3.peg.2704 Permease of the drug/metabolite transporter (DMT) superfamily
MARLTKVNPKNVLMAVIAMVFFAANSILCRMALAEGDIDPASFTSIRLVSGAVVLFVLAG
LAHKREGEHNACSLLRQPTEHWLAAAMLFLYAATFSFAYLYLDTGMGALILFAFVQLTMF
AYSHYKEGGASGVEYIGALVAIAGLGYMVSPGMNAPDVWGAGLMAISGIAWGIYSVLGKE
MKVPQLPANCINFRLSIFFVVPFFLLNIPMNSITSEGIWLAVASGAGASAIGYAIWYGVV
QRFKATQAGVMQLSVPIIAALGGYMLMDETLTLRMVISATVILSGIVVTFLGKQIKQSSP
V
>fig|675814.3.peg.2625 Inner membrane component of tripartite multidrug resistance system
MSTIALSKPESEVVVSRKEWWAIIGGLIGGFMAILDIQITNSSMKVIQGALSASLDDASW
LMTSYFTAEIVAIPLCGWLSKALGTGRYALWCIGGFLGSSLLCSMAWNLDSMIVFRALQG
FCGGALIPLSFRLIIEILPLEKRPMGMSLFSIIATFAPAIGPAIGGWLTEHFSWHAIFYV
NVLPSVVAWALIQRSMKHPIINWQIIRQGDFVGVVSVMMFLGTLEVILEKGGDENWFDSR
MICVLAVLSAISFVIFVYDQIVHRNPLINIRLFKEYQYSYALLIFAMLGSAIYGTLFLVP
YYLTMIHDYNATEIGHVVIWMGLPQLVILPMIPFLIRRYNPKYLIFIGFVGLAISAFMDC
HMNADFAGPQMIASMLVRALGQPFIMVPLSMLATQNIKAEDAASSAVLINVFRSLGGSMG
TAVLSTYFTTRIDFHLDSIKSTLLTGSQQFYHYLGEVKNLLVNQGLPSDSTNVQQTAVSI
LGERMAIQSQIMAFNDLFMIMGIMMLATAIMVLCSNRDFQLQLKKEETA
>fig|675814.3.peg.2628 Membrane fusion component of tripartite multidrug resistance system
MKKIIKILIPLMLLVLAGGAYWYYYGRFFQTTDNAYVQTDITNVSSRINAEVVKINIKDN
QKVKKGDLLAQLDDREFVIKEQLAEATLAQSQAEQSNADAAYKMQKSTIEEYQSKVTSAK
AKYQYSLQQYKRLQALEKQNYVSKGERDNGASAYKVDKAAYLEAKASLKTQQDKLSVLES
EIEQADAMVKQATASLSQAKLELGYTRIVAPIDGVISNRNLQVGMMVQPGQSVVSIVSDR
TPWILANFKETQKSRMHKGQSVDVTIDAYPGKTFSARIDSVSPATGATFALLPPDNATGN
FTKVVQRVPVKIVFNDSVQVDNGLSAVVTVDTRQ
>fig|675814.3.peg.3440 Permease of the drug/metabolite transporter (DMT) superfamily
MKKNDLILAVFVMAIWGFNFSMIKMGITNVHPLIATAARFALAVIPAIFFIARPNVAWRY
LVSYGLVFGVGIWGMASWSITAGLSSGMSSVLLSSNVLIGMAVGLFVFKEKSSPRKLMGA
LLAMVALLVLVSATNGNITASGLMLIMIAAISWTLMGVIVKASKTKQAFAFNVWGMLFAP
VPLVLFATALHGEQILWQAYENWDMNTTIAVVFQAYPTTLFGYWVWNRTLIKYPLSTAAP
LTLLVPVFALVSGYFMYDEVLSMPQVIASALFLIGIGLIVKPASEKHRAASAKLAGQSR
>fig|675814.3.peg.3470 Permease of the drug/metabolite transporter (DMT) superfamily
MAVFQILLFRQLVFVVLLTPAICSNIQVLLKPKRLKLHTFRILGAFTALYLGFVTVSNIP
LADATALGFTQVLFVACISRLFLAESISASRLFTIMVGFIGVMLVVQPSFEQGSLLYVGL
GLVGALGAAVAVVCVRKVAQVEPKITLLAYQAIFVGLMALIPSLRNWQWPSASEFGLLIC
VGVLSSFAQWIGISAYKYGEANVIANVEYAKILYSLLFGYWLFAEIPNWMAIVGAMIIIA
SAILPMLYKNKTIS
>fig|675814.3.peg.3574 Permease of the drug/metabolite transporter (DMT) superfamily
MTTAANSLKKGNVRFPVTESLLLLVAIFWGTSYGLTKSALAYTSVLVFISIRFSITFLCL
LPVVIRDFRRGLNKDWKIAIPTGFILSAIFFCEVFGVSQTSASNAAFLISMSVILTAFAE
LLINKKKVSNTLWGLTACSVAGVLLLTSEESVEFSLNSGDYFILTAALLRALMVTMTKRF
TEGKVITTSTLTSLQSLVVALVAIVCAVTYLPTSEFVVPASWEFWLTVIYLVLFCTLFAF
YVQNYAVRRTSPTRVSLLMGSEPLFGALFAMAWCRSRSLQCRLLVGC
>fig|675817.3.peg.3034 Multidrug resistance protein D
MKKLPPIWLLVCLMMLPQIAETIYSPILPSISQAFYVSVVDAGQTLSIYFIAFAVGVVFW
GRMADILGRRSSMLLGLLCYALACIVAALTNSFSILLAARAMSAFGLAVGSVISQTILRD
GYSGKDLAQTFNIMGLAISISPIIGLLAGTGLNILGGYRIVFIMLAVLALFIFIICYSRL
NETQNELNVTDSFFSVAKKMVMDTKIWLSACLVAGFNLLIFVYYQQGAFFFESLGYSSQQ
FGYSGIVLALGTFGGGILNRRLLSMGYTSYFVIAIAGVISFFGGLCAYQLSNSLWLLAAV
LVIVCSFGLAIPNILSVALNNYKTSIGSAGAIFGLFYYLMLGLGLNITAYVNHLSLSLLF
TSAFIMIIAGLFFWLRNKQY
>fig|679192.3.peg.231 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKKKIVGELAHYLLPSMLAVMGTSLYILADTFFIAKAEGSNGIAALNLVLPLYSITYGVG
GMIGIGSATRYSLQKARGSKDIDFYFSNAIMWNLCLSLLFALIFGFFTEPILRFLGADAV
LLQVGIPYMRTAMILSPFTMVNSCFVAFIRNDHNPKLAMVATLFSGLFNIVMDWWLMFPM
RLGMLGAALATAIAPMVSMSICSLHFWRKENHLYWIWRRPSISKLFRSMSLGLVVFIGEM
ASGMTTMVFNFVLLGLGGNITVAAYGIVANCALVIIAIYNGIAQGLQPLASHYFGSGKKE
ESQKVYQYSLLFGLSLTAVLVGITFMFTEELVAVFNEEGSLALAQLAQRGTRLYFIGFFL
AVINVVQAGYYSAIGLAKESFVISMLRGTALICLFALILPKLIGVDGVWLSFLSAELGTV
LISYCLVRKSYQKKLLDTEQREKSLW
>fig|679192.3.peg.305 Methicillin resistance protein
MIYKLMDDPQQFNAFVQNHPYSHFQKTSMWGEFIQKTEHNPYRMLGFFEHNQLVATAMLL
VKKTLLGHFLYVPKGPCVDYQDKKLTNQVLSSLKDYAKKDKAMFITIDPNVLRMERTIDG
HEIEGGENNEFVTEYIDQIGFKHHGYTYAYDGSFSNRFTLITKLDQPIESIFKGFSTLRK
RSIKKNEKFHLYTLEANRNEIQEFVRLENDLGKTKEVIRHSLSFYEAIYDAFKGHVHFYK
TILPMEKYLSVLLEKTKSDNPNEASSALKHYQEAIELQKTKGNEPVLAVGMIFDDGHVSY
GKYYYRDHSIESLSPLDSLLFHAIQQAKQNGHKAFDFLGFGGLTTPHDWDIGYSLYQYKH
QWNSTFIEEIGQFEFVLNPTQKKVFELSRKIKRKLQSFFIKFK
>fig|679192.3.peg.703 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLVTNIYNMADTYFVGTINTSATAATGIVVAIMSILQALGFMFGHGAGSNISRLLGSENK
EGAREYGATSFWLSILVGILSMIFGLLFLDPMLRLMGSTETILPYARIYGWYILIAAPAF
TASCVCNNILRYEGMAFFAMIGLTFGGVLNIFGDYLLVHIFHMGIGGAGLSTTISQYISL
LILMLPFIQGKTQAKLGLQYFKGRRQNIKNILTCGIPSLARQGLNSISTMVLNGSVAMYG
DAAVAAISVATRVVNLMFCIAIGIGQGLQPVAAFNYGAKYYSRVKEGLKFSLMIASSLML
ALAFITFFHAETLVHLFRNDPEVIAIGKVALRFLCVSFVFMPLASFGAMMFQAIGESGIA
TILSALRSGGVLIPVIVLFSSLWGLKGLEMAQAVSEILSGLFSIPFIFRSVHRFPKDHYG
ES
>fig|679192.3.peg.841 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRSHNMLKGPIWKEILIFFFPILLGYLFQQLYNTVDAMVVGNFVGTIALGAVGGSTSIII
NLIIGFVVGLSAGATVIIAQFIGANENQKVHLTVSTTMIMNIVLGMILMVIGLIFSKDML
KLLSVPDEMMKDALVYLRLYLLGLVPTMIYNAGAGILRAVGDSKRPLYFLIAASITNIVL
DILLVVYGHMGVAGAAMATIASQVVTCVLTLYVFQDKDEIYYLDLKHMNFDYALFKRIIG
IGLPTAIQGSVYSFANLFIQASVNSYGTISVASFTAFGKIDMFFWNFSGAMGASCLTFVG
QNFGAKQFERVKKGIRIALVMFLIGSIGITILSISFGEHFYRLFTQDPEVLKVGMQILWL
VGPFWNVISFLEIYSASLRAMNVILAPMLMSLFGVGVIRIFWVLFYPGKSILDTLLVYPL
SWCLTSFFFIVFYNSGLWKKKRKSSQKKER
>fig|679192.3.peg.1092 Methicillin resistance factor
MRFIEGVKAERFDTFAVNDPLNHYSKTSPFIQLAKLNGYQSGDLLGVEDEQGHLMATAVM
VHKKYRLINLQYSYCQYGFNGDFENRKLMHFLIHHLKNFAQKKGSCFLRMDPNITRLEHE
KDGKIKEGGFNHEWFTEFLKEQGFRHLGYNYGYSGNWMSRFTYVKNLDLDWNGCLKSIKR
QANYSTKNEERFVKVRQGSKEDLWILVRAEKELAKKLGFIPKSEEYFAKFWDIYEPYAHF
YVVKTNYHQAKLSLQTQLEQAKNHLLEIKDAHKLEVETKHIEALEKEIQEIEQGGYDQDE
EAYLGAKFILRQGTKVWNVNMYTNKTLMNFRSAFALHMRAMKDVYDQGAKSYDFEGVVGT
NDPKDPLYGQQNFKKSFGGDFLEFIGEFDCVFNEKKYGFWKKYDHLWRGLRRRYARWFIR
LK
>fig|679192.3.peg.1311 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIKSMTKGNALRLILEFSLPLLLGNLFQQTYNMADAAIVGQILGPNALAAVGATSSVQFL
VLGFCIGSMVGFAIPVAQEFGGNRLSHMRQYEYQGAFWMIILAVSVTSITIFMIHPLLHA
LQVPQEIYQDTYRYILMIFIGIPFTLLYNFLSSILRAVGDSKTPFYFLTLSAILNIFLDV
FCIVVLKMGVFGAAFATVLSQAISGFLCLILIRRKFTILQMGKKERMFQWSKSRKVLGMG
IPMGLQYSITAIGSMVLQAANNGLGTLYVSGFTAGLKIKLFMLSPFDAFGAAVSTYVSQN
YGAKEEGRIREGIYKGIGIALIYSLISGAIMILFGYQLSMLFVNRDSWAVLNASALYLRR
MGYGWWLLSFLNIGRMAVQGLGFANRAIFCGVIEMICRVFVSLVFVKDFGYEAITWADQT
AWLGADLFLMPMLLMTLRQVHGALENERKAIALEK
>fig|679197.3.peg.172 Permease of the drug/metabolite transporter (DMT) superfamily
MTAAARRLAPGQQWSLALIAVTAVWGWSFTAIHDVLARIAPSTFVAYRFALAALVLALFA
RMRGLTGKEALAGLGAGVFLGLGFALQTLGLTTTTPSNSGFITGMTVVFIPAAAFLVHRA
RPSPAHLLAIALAVVGLALLTLRGLRVSSGDLWTLGCAVAFSCHVLALGVVNRWGNILRI
TVVQLAVVAALSLLWAGAAGDPVVLAGDPRVWCALAVTATAGTAVAYLVQAKAQTVLPAS
RVALIFTAEPVFAAGFGYWLAGDRFTAQSVLGGVLVLAAMLLAEFGGRSPEPDHYAGPVG
>fig|679197.3.peg.954 Permease of the drug/metabolite transporter (DMT) superfamily
MTTRTDDEAATAPSETTRPGSRRQRFALPPILVAALGPIQWGVNPLVVTELTVPGRFILT
ALCSTLPVGLVMTAATRSLPSGAWWWRYLILSWCNFAISTPLFYYGMQHMPGGIATLLIA
TQPLFAMLLSLPILGVRPTRAQLCAVAAGIAGVGLVVFKGHARIDLLASALLLFSAMTAA
LGLVLTKRWSPPVSAIRHNGWQLLLAGLTLLPMTFFLEGFPAHITWRNVLGFAIIGFVSK
LLGFAAMFRSVPTIGATSAAILTLLTPTTAFVLGFLFKDETLGAQQWLGVALVVGAVVLA
GTGASSRRARR
>fig|679197.3.peg.2059 Permease of the drug/metabolite transporter (DMT) superfamily
MAAQHEVPERYAETIETMEAAANGFAVEAGRGPSDKPRHLALAEAIQGPVLIVSWSSAFV
AGVIGTKAGTPLLLCFLRFACAALLLTALAFALRSKWPKGKTLAHTVFAGVFMHAVQFCG
FYYGMAHGLGGGVSALIQGLSSMIVVVLAALTLGERLAKAQWLGFVIGIVGVVVAIEDRL
AFSPVAVASAFLGLAGISVGTYWQKRFVSGVDVVSGTAVQLAASAPLGLAATLLFEHPQV
TDSTRFAGAVAWIVLVNSLGVFLLLNHMLRTLPASSVSTLFLAVPATTSLLSWVFAGQTM
SAQAVAGLVIGGIGAALAAWGATRRTKA
>fig|679197.3.peg.3345 Multidrug resistance transporter, MFS superfamily
MAGGPMSVSAAPSAERAVPLRLSASLGIGSMLQPLNSSMIGVALVGIAVQFGNASSVAWV
LSAFYISSAVSSTVAGALAEMFGPKRVYLVGLAIIALSAVVGGLAPNLGVLLLARVLLAV
GTGTQYPSAMTIVRRHADQHNARASSAIVVLSVCSLSVVALGPTVGGFLVGLWGWQSIFW
VNVPVAALAAILVSRVVEKDERGERLGVLARVRRLDLPGMAAFASAVTSAMLFLLSLTTS
PDWWWFGAAVAFAAAFVVLERSAAYPFIELRALVGNRTLATTMLRSLCTYIAFYLVFLEI
PQWLQTARALSPEHGGLVQLPMAVVGVLATMAAGRVYARSGAVATLLTGTLSLLVGGSAL
VFAVRHDSSWPLLVSVLMLLGLPNGFNNIANQNLIESSAKPHELGVALGFYRTVQAFGAL
AAAAVIFFAQHGAVSPDTALHRVGATVAVLGLVLTSEAALRRKALSLS
>fig|680198.5.peg.492 Vancomycin B-type resistance protein VanW
MRLRIASLPSPVLTGGALTVGLGGLYLAGLLVTSGDIEAGTTVRGVDIGGLSRTEAIRKL
DAHLAAAGPSELAVRVGDRSGTVDTRQAGLGFDSERTVDRATRTASDPLSVIGGFFHSGG
DIEPVVRLDEDKAHAALGNLAKALDQKVRDGAVTFADGRVAQVAAHSGYALDVDAAADTL
RTSFLHGARGRAVVLPARETRPGVTADEVRRAVRDFAQPAMSAPVTLTAAGTRFTVDQAV
LGEHLRMVPDGSGRLVPKLDVKGLRSAPAVAGPLAAVTTTAQNARLELDGDKVAVAEDAR
PGVQISDSALSEAVLPLLTRTGSARTADVAVRRIQPEVTRENAARLGLTQKMSSFTVNFE
PAPYRTKNIGRAAQLINGSVVMPDETWSFNRTVGRRTEANGFVEGIMILDDQFTKAAGGG
VSAVATTVYNAMFFAGVKPVEHGAHSFYIERYPEGREATVAWGSLDLRFTNDSGKALYIQ
AEATDTSVTISFIGTRHYDEIRSVKGPRTHVQPPAKKVRTDDKCVPQTPLEGFDVTVERV
FYDAGKEVRREPFRTHYTPRDEITCETPEPSDTPSPGPTTGQTAPPATHG
>fig|680198.5.peg.1464 Glyoxalase/bleomycin resistance protein/dioxygenase
MAITGLGHTGFWVDDLEKMRDFYSRVMGLTVTDEDPEQGIVFFSARPEDEHHEFVLQQGR
TAPAGAKLTHQVSWRVDSLESIIDFHHRFRAEGIEVQQEVTHGNAIGIYFFDPEGNRNEV
YLRLERDVRQPFRKSLDLDLPPEEIMAEAERLLTEGGPAYQPVQ
>fig|680198.5.peg.1746 Glyoxalase/bleomycin resistance protein/dioxygenase
MAVNRLNHAVLFVRDIECSVAFYSQVFGFAVEHEMPGRAAFLRARGSDNDHDLGLFTLGP
DAPGPQRDRVGLHHLAWEVGTLGELADTADLLDARRALTGSTDYLVAKSLHGVDPDGHEF
EVLWRVPRADWPAPEENRRPLPLDLRSAIDRWGPDLRTGAAARSVT
>fig|680198.5.peg.8565 Multi-drug efflux transporter
MDGDLGRWRRCLLGGAVFAVCMAGTTLPTPLYGLYQEKFGFSELTVTVVYAVYAFGVIGV
LLLAGNASDSVGRRPVLWWGLGFAAASAVCFLCATALGWLYAGRLLSGLSAGLFTGAATA
YVMELAPPGGASRATFVATAANMGGLGCGPLLAGVLAQYAARPLHLPFAVHLALVACSAL
VLLKLSETVRERRPLGTVRPQRPSLPPRVRAVFGPAAAASFAGFALFGVFTSVSPAFLAQ
SLDVHDHAVSGLVVALAFFASTAGQLAVGRVGVRRSLPLGCAGLLAGLALLAGALRWDLL
ALVVPSAVVGGVGQGLAFRGALSAVAAASEADRRAAVISALFVVAYTGISVPVIGVGLLA
EPLGLEGAGLVFIACMALLVSAAGAYLLRRPVPAAEADGAR
>fig|685035.3.peg.746 Acriflavin resistance protein
MARNGVAANLLLLAMLVAGYFSYTSIVQEVFPESSLDTISVSVTYPGATPEEIEESIVQK
VEEAVEAIEGVKQITATAAEGRGTVNVELELGADIARALDEVKSEVDQIQTFPDEAEEPD
IRELTTRLVVLRIALFGDVNERTLKETAYRLEDAAAALPEISYVDTSAVRNYEIYADVPQ
SRLRALGLSLPQVAQIVGQSSLDTPAGSIETGREEVRVRTIGQNYDQQDFENIIVLTTQD
GATLRLGDIADVDDSFEDSDLITRFNDQPLAFVDVYRTSDERVLDIAEAAKNLVANEFDM
PPGISYAIWEDSSELLEDRLDLLLRNAAFGLVLVLAALTLFLDLRLAMWTAVGIGATFVG
AIFILDWAGSSINMFSLFGFILALGLVVDDAVVVGENVYAERERGRTGMGAAIAGAQRVK
VPVFFAVATTITAFLPLLAVGGVIGKILADIPLVVIAVLTLSLIEALYVLPHHLSTLPDP
SHKPGNPVTRFFARVQAWVDERFKAFVEGPLDRTLRFVVAAPYLVVAGGIALLILFVAML
PAGIIKFSFFPEIEGDIVTASLEMPAGTTVERTAEITSRIEAAADRALARLESSPSGETQ
AQTGAASGGPNPSFLEATYTTIGLAQTGQGPGGPQRTVRPNLANVQLSLVPAAQRDISAV
RIEEAWREELGEVPEAKSLSISSSLLGIGEPVNVQLSHPDDAVLDLAGDRLMNQLAGVAG
VFDIESDQDAGQQEIELRLKPSARTLGVTLQDVAGQVRAAFFGAEAVRVQRGREDVRVYI
RLPEEERDSIADIENYRVRVPGGEVALSSLAQVSFGEAPSVIRREDGHRITTITADVDSD
TITGQEVADLLDNEIMPELQADYPSLQYDFGGEQEEQQESFGDLGQAFLLALVAIYALLA
VPFRSYIQPLIIMAAIPFGMIGALIGHLLLGIPLGILSMFGIIALSGVIINGALVLIDFL
NENLANGMEPGEAVIDAAKSRFRPIMLTAITTFLGVAPITFETSLQAQFLIPMSASLGFG
VLFGTALLILLIPALATIQMRAVARVQRWRGRNRDAVDPGGEPMVP
>fig|685035.3.peg.1633 Glyoxalase/bleomycin resistance protein/dioxygenase
MLNHAAWVTHDVEATADFYMNVMGMDLASTVVGNSVPSTGDEFPYFHIFFRMKDGSTIAF
FEAPGLPERPAVSHPAYEIFDHIALQAESREEVDEWFDWLTSKGLEVVGPTDHDGLIYSV
YFKDPNGIRLEITYPTDPDWNNHSEKGIAHLKAWKDGKQRAIEMGSDIVQSMTNVINDIK
RAR
>fig|685727.3.peg.242 Permease of the drug/metabolite transporter (DMT) superfamily
MLFGAAVLFGAAVLFGAAVLFGAAVFFGPAPIRAPPPVRPLSDRSRRECW
>fig|685727.3.peg.3212 Probable multidrug resistance transporter, MFS superfamily
MPAPWLRLAVALFAVSWGANQFAPMQLVYSRHLGLTSGSFTAMLGAYVLGLVPALLYFGR
VADRAGRRVVIRSMIPVSVVSSLVLLLGPLSPELLYVGRVLAGVASGMAFGAGTAWMKEL
SARAPVGAGARRAAVSLSAGFGCGALFAGVVAQWLPAPQVSPYVVHIALMIAALALVWPV
PETRTVRTAPAATRVTALSKAPFLRGVVPWTPWVFGTATIAFATLPPRVEQSLGAVSIAF
TGTIAALTMITGAVIQPWARRFLEHREEWGAPAGAVLGVLGLGAAGVVVHTDGAVAVVAV
FGAALLLGSCYGVLLISGLVAVERLAPEDELAQSVAVYYCLIYLGFALPFLVSVLAPRIG
YGTCFAAIAVLMIASVLVARTAPAPRARPARRDDVSPVGR
>fig|685727.3.peg.3595 ABC drug resistance transporter, permease component
MSESPERTMTSSRAARASASSIDFPPPTEAWPESSPKALWVHSTVQCRRLLKRWSRDPST
MIQALLYPALTLVMFRIVIGNTVTAATGQPAVYGQVPMIILIGAMFGSIVSAVGLRAERK
NGLLSRFWTLPIHRAAGLVGRMMAEAVRVTITTIVILVVGVFLGFRLTQGFLPSVFLVIL
PVIFGMGFAMMVTALATVSGDAPLVELVSIGCTLLMFFNSGFVPVMAYPTWLQPVVAAQP
MSCAIDAMRGLAMGGPILEPVLQTLAWSFGMMAVFVYPAIKGYRRAAATG
>fig|685727.3.peg.4262 Probable multidrug resistance transporter, MFS superfamily
MSTTSLRSGTASQDTPPRTRRWAARHFHGIGYVLAILLVGANMPTALYGVYRADFGFSPV
TQTLIFAVYAAALVPALFLFGPLSDRVGRRPVLVTALGAGLVGAVVLAAADATAWLVVGR
ILQGVSVGACSAAGAAALLDHVPGRDTVRAARAASASTAAGAALGPLLAGAVAEYLPHST
VLPYVLFAAALVPGAVALAALPKTTEPSHRGAAPGSRRRLVEVPRLPRDIRSVFVLATLP
AAIAWATVGLFQSVVPSWIAELLGMSNLLVGAAAAALVMGCSVLSQLGMRGIDPLVAQRV
GLGVMFGGTVGLFVVDRFPSLPLLFAVTVAVGLGHGWAFAGGMQRVGAAVAARAPETSGA
VLAAFFTVTYIGLGVPAIVAGLLVTYQGTSTAVAEFSVAAAVLCLIALVLNMIRRSESAG
AARE
>fig|688269.3.peg.280 Bacitracin resistance protein BacA
MPVSSSGHIVLLGNLFKVETDVSLTVLLHLGTLLAILIFAAKHILRVLKKPRLIFLVILS
TLPAALIGIAFDEIIEKTFQKLEYLPVFFCITALLLALASAKNGSKTMEEMKALDSLIIG
IFQAAAIFPGVSRSGATIAAAILLGFDKKDSLGYSFLLAIPAITGAGLLKAETFKIADLY
LLLLSFVSGLVALFVLRKIVLANKLKVFSVYCLVVALMSYLLR
>fig|688269.3.peg.1648 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSRDLTQGSLTRNLFYMAFPTMGGFALQALYDIVDMFWIGQVSAKAIAGVAVFSSVFWLI
EVLNEIIGVSSVSLISQNYGAKNYERTNRIVEQTLVFKAFVALIASGLLIVFLPPLMRFF
SKDQEVVNYGLQYGYWRSFFMPIFFMTYSTYTAMRQTGESRLPTIIMGTSAILNVFLDPI
FIFDDVPFLGISGFGMGVAGAAVATVLCTVVAFVWGFLVLLKGIGPVKISIKGLFKLDRE
IDVKLITIGLPSGFEMLLRSASNAVLVKILGFYGANTLAAAGVVSRLVGLSFIPLMGFSM
GASAIVGQNLGANKVERAEKTVWLAAVYGSLFVLGFIVLANISPKTIIGLFLHESEAITE
GIAAVRIGSWSMLFASFAISMMSAFFGSGNTLPAMFASVVGRWFAQLPYLVLVALVLKLP
SNYIWYSFIIAEIAELLYAYFVFSKGKWKQYRVS
>fig|688270.3.peg.1653 Permease of the drug/metabolite transporter (DMT) superfamily
MFALFGFYRVIIQRFAASKKIKMNNHLKGVLYVGVGAASYGILATFVKFANNNGSGTAGL
AFAQYFVGVVVLTLLSFLFSKKNTAPTDKKEIRKDKLKLVAFGSFLGLTSSFYYLSIQYI
PVSVGIILLMQTIWMGVVLEFFMNRKLVTQKKIIGAGAVIIGTLLAAKIFEVDAALNFKG
LIFGLLAALCYTGTLYATSSIALELPLFTRSKYLILGGLIVTMIFWNVQIIADFDWWVFL
KWGTFLGFFGTILPPILFNKGIPVIGTGLGSIISALEIPISVMSAYLILHEEISSLQWLG
ILIILISVVYINLKPKAKK
>fig|69014.3.peg.508 Tetracycline resistance protein
MDLIKKFKLLMALMSTGFLGNLLVIYFLSKGFSYAQIGLETSVMVLGGFLFEVPTGVVGD
KISRKLSVLLGFTIHAFGSVVLLFLHNFPMLLLYALISALGASFVSGSFEAWLFDDLKHI
GREREYRKVMREAKSITIPLSATTLVVGAFLAQFYGFTLPIVLGLIVELLAVVLILSIPE
YEFKKTERNYLGHTLSSLRELFQPRLFWLVLLSIIVGMQTNQFRKFFEPYLGGVLAKSLG
TTLMGTLGLLGVVEVTVRTVPRLIGVRLRDSWSRKAYSLAPVLLPLLTVLSVVYTNPLWI
VALGIALTIITAAFGFNLNVEFQHRIPSEKRATILSLDRMLAGLVMAVFYAVYGFAVDKL
GLSGARLMFAIALLVLGAGFKAGEVLGFLGEHLKLHHLEESGD
>fig|69014.3.peg.881 Probable antibiotic-transport integral membrane leucine and valine rich protein ABC transporter
MMKNLLKTSVIVGFRSFVYPIYMLIGLAYGLMLLAFPEQYLPTMVPIFLLFEPGLVGFMF
VGTEIFAEKKDGAISALAVTPIEWRSYILAKTIIMSVLSVIGAILIMAVGTRSLDGLPYV
IAGVFLCSAVYTLLGIAISAKYRDLDDYFIPIMAVLVVSLLPFAHYHGYLTHPLWKVLYL
VPSYPALYFFKAPFVEVSSDTLALSGVALLLWSAVAYYAAKIQFYKYAVEGLR
>fig|69014.3.peg.882 Probable antibiotic-transport ATP-binding protein ABC transporter
MPVIEVKNIRKYYGDVRGVENLSFEVEEGEIYGFLGPNGAGKTTTVKILVKIIRDYEGTA
KVLGKDLREWGKDYYNRIGVSFEFPAVYSRLTALENLEFFASFYKKHLDPMEVLKMVGLD
KEADQLVAGFSKGMRKKLDIARALLPDPDILFLDEPLEGLDPASARKFKDLFLEMRESGK
TIFLTTHNMYVADELCDRVAFIVDGSVRLVDNPGELKVKMGKRLVKVEYVENGSVKTAEF
PLEGIGQNEEFLNILRNHEIRRINTEEPTLEEIFLKVTGRRLV
>fig|69014.3.peg.973 Daunorubicin resistance ATP-binding protein drrA
MAAEEAIIAKNLVKRYGDFEAVRGISFTVKRGEAFALLGPNGAGKTTTVRMLTTLTRITS
GEAYVNGYDVKKEGLMVRRSIGLVPDISNLYEELTVEENLKFTANLYDAPKENVARLIKE
FNLPAKRKFGKLSSGFKRRVTIAAALVHEPEILFLDEPTNGLDVHSAKALRALIRELNKR
GMTIFLTTHNMVEAETIPQRVAIMNKGKIIAEGTRTELPKLIGKGTRIRLQVEPLSNKLL
DALSAYGPTFDEGDIVITVPDADAFMAELCKLREELGFKVLKVSTEAPSIEEVFIELTTE
VPKGGACGCGGCPL
>fig|69014.3.peg.1012 Multidrug resistance protein
MLVAVTRAPNVGWTAKETLILFGVGVIGAVLLVLWERRVENPLLPLKIISSRNPAIANLG
IMLAAFGLSMMSQANTYLLQMPEPYGFGKTILQSGLLMTPMALVMLIVAPLAGKFMPKIG
AKPIAIAGALIGSGALAVMSLYATKMSLWQFVTMMTVVGIGINLMNISLINVLVFSVPPR
MMGVATGSNSLFRNFGSTWGPAIAGTVMSTYYVLFHPPGAPAFVQIKIPTEKAYEVLFGG
ASVVYLLLALLAFAIVEVMKGGKIREVEEGGEKEIMVS
>fig|694427.4.peg.66 Permease of the drug/metabolite transporter (DMT) superfamily
MFNSIKLYSAIVLSMVFWSFSFIWTRVAIHSFQPMTLITLRLILASLLLFVVLKSTGRFQ
KLRRKDVKWFLSLAFFEPFIYYVGETYGLTMVESTLAAVIVSTIPLFAPVVAFVVLRERI
SWSNIVGIVVSLIGVFFVIYEPTGGLKANPQGVALLFLAVFAAICYATVLRKVPDYYNNM
SVIFYQSLLGLLFFIPTFLVTDYPTIHTLRVSGESLIALFMLSVFASVIAFVLFAGAVRK
VGVTRTNVFVNLIPVFTAILSWVILDEILTLSKWIGIVIVVVGLFVSQWGKIKFNKEVEE
IL
>fig|694427.4.peg.150 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTSQAEITNNLATEKIGKLIWTYSLPAIVGTVVMSLYNIVDRIFIGQGVGPLAISGLALT
FPFMILLMASGMLVGAGSAARISITLGENNKEKAEKILGNALTLTFIISGTVIILSYIFM
HDLLHLFGGTENTTRYAEDFMRVIIPGGIFSALSYGFNNIMRASGYPHKAMYTMIICAVL
NAILAPIFIFVFHWGIQGAAHATNISYFVGTIWVLTHFLKPDSNIRFYRKNFKLEKKIIL
SIISIGLSPFSMQLATCFVVILVNTTLIHYGGDLAIGAFGIINSINTLIVMIIIGLNQGT
QPIVGFNYGAKNFERMFKTLKYAIVIGTCITTLGFLIGTFAPTLIARLFTTDAKLQAIAA
KALQISVIMFPIIGSQIVITNFFQSIGKAKVSIFLSLTRQFLFLIPCLLIFPRFLGVTGA
WTAMPVSDGLASIVAYVTIFLFVRRFKATTPRRA
>fig|694427.4.peg.1929 Permease of the drug/metabolite transporter (DMT) superfamily
MENKKLGGHIALFSANVIFGINNPISRALMPEILSPFTLTFFRLFGGMLLFWSVSLFTRK
ERVAPKDILLLFCASFFGLTLNQLPFFVGLSMTSPIDASIVVTMLPILTMILAAIIIKEP
ITLMKAVGVVVGASGALLLVFSSQTKHTGNGNFWGDLIVFSATFSFAIYLTVFKNLISRY
SPVTIMKWMFLFATIVCTPFCYKPLMQTDFTLLSANTYWRIGYMVVFATFLGYLLVPIGQ
KVLRPTTLSMYNYVQPIVASMLAVAIGMDTFGYEKALSGVLVFAGVYIVTQSKSRAQMEA
ERLAKRK
>fig|696127.4.peg.574 Permease of the drug/metabolite transporter (DMT) superfamily
MNEFWRVISKLKSIVIFFSVLIMFFITILGSGFLFLKYYGPVSSKFIGRLIGTILERRIE
GTKIEIDYVELGVEDNVVDFSVFDLKVTYSQNIVRVPYLKVDIYMSKVLRGSFIEALSHI
SVSSDIELSRAPRPNNITVKKTPKHAAKSVKAYLMSHIGFISYLPELLRDINFKIRDVDK
KPVLTLSLNSLNFTLIEDRILNFRGDFNAGNDFINFDFNIDTTNPNMIELGGKLNFIPVS
LLWASSTYYTKIQSNLKLDLILGGKIGKSGLEYLNFDVVNYHGFIQKNDYLKHDIVPKKF
LLSGGVSSQYDIEATSVLEADDLTLKALIANKNGKLVGNIIAGKMKLRSVLDYWPSFILE
ETRTWLVSNLDKGYVTGVDAKINIDLNASRPIPKESINVRVNLANNVVRCMPLPYIVPVV
HINEGVVEVSAEDVVLKLNDATILNSRTNNMIGIINYKNERVDLVLNGRVAGLAQDVIDI
GFAYAQSNNRELKNFKGEAETEIKIVVPLTQEFVLDERSVVVHSKMKNVSNKDLSGLVSL
SQFDISGQFIGTKLSVRGEGTVNNVIRAGFDLEKSLFNEPGIKTNVTVHASIDELKRNGI
FKSEIADGELKGNISIFLLDDQYNVSGSLDLQQLALTHSLGIEKKIGEKGELSFSIHGTA
ANALIDMPTYSLTLPTFSSAGSGILNEEGLVQLVSEKSRINATDFSFKYSKSYQGDIKLQ
LYGDKLDLSQINIIGLVKDSGFGKGGSNSFILKTDFKSIILHQGQTLIAPKINLSCKAGK
CREFSLIGSFFDNTKINIFYSHPVISVVTDSAYKALSAFGLYDRMEGGTLQFKGEFDEKD
LMKGRLFVLDFYIKKAPLLAKLISPLTSFRGLIDSLNNKGIYFDKMSAGIAYDKKKVFVD
GLVITGPSLHIKCSGVLNEESGKVSGEGIMVPSNIINTATKHIPLIGKMLSGGEDSGIIA
TNFSVIGDIDHMSIIINPFSMLMPGFLGGFFDKEKNFRKKEQFPE
>fig|696127.4.peg.915 MFS-type bicyclomycin resistance protein
MYLVITVLMIGMLAGAELDIFVPSFPEIQAQFHLSPFMTQLILSLNFIAYCICSLFAGAV
SDKYDRRKVIIISLLIFIFGSILCSLAQNYGTLLLGRVLQGFGIAGPSVLGYVIIADEYS
TTKQVYLIGLMHGLIAFAMSAAPVFGSQITCYFGWRGNFVSLLIFALICLILSALFIPTK
AMKPQVTLSLKAYLPLLRSKKLMLFTATLCLFMVPYWVFIGISPILYRKDLGVSLEEFGF
YQGTLAAIFAIGSALGSLLMKRIGLKKAFFIGISMCSAHVIALCCLMVLDIKNPLIITSC
MAIASAGVAIPINTLYPHALEILENTKGRASAFISGVRLIISSVGLWLVSSTYNSTFVPI
GLWIVITMSLAIILSLVLVKQEAIFSNS
>fig|696127.4.peg.1012 Permease of the drug/metabolite transporter (DMT) superfamily
MGSLGLVDGVVVFVYITGYLATTFYKARSINNEYSINDHSIWRDVVAVSAMLAVSISTVT
IGAMENIYLYGLFFAIPRIVAPLSWLLILKVYAERTGEFKGCLSISDIMQRLYGVPGRWV
TDIATVLFGKGMVACQLAALGYIFSYFFDLSYGLSITVGFFLLTLYSIIDKAKQVEFIKV
SHLCIFLVALPMACYTAYHDEYKTLTSSAHASLFKLDLNLSNIWVFLSLVLYSMVPAAES
IHVQRFLMAYNRIRLIKSLKIVMAVAIPFTVLTCIIAFLIKAQSPDLEPKFAFMHFISSY
TSAGIEGLVLVGLIAIIMSSASSWLSYAGLVCTENIIKKIFPDLTVRQELSVLYTSTFAI
TILSTLLALSKSNIFSLLWMADNFWQPVILVPLAAGFLGFRANSLSFVISTILAIFFILA
GRSITGEFSIISLTLGILGSGVSLFAVHYLQKYGEKRYGHEQLEIFNIVSRRKIEKIYGV
IAQFMKSQIEKSGTKSHSFCLFIAVNYFMPLIVVNVTGNVLHDSIIYLRVISILLCLILL
FAEYWTRKSKNRYYALYWYFCLFFCIPFTASYTIFVTYTSGFWLLNAILSIILLFIITDW
ISFGILMLSGPFVGYLLYTSLSHQVYPHYSHSGDILLLFYLYGFLLIIMFLFIRDKEKIQ
EKRLEHMELFGGAIAHEVNTPIATIQMIAMTLSDLAATSSKEVVKKEQPDGSINYVLTIP
EAEYEMIFESLPYDLVKTSKEAKRVVDVLLMLLRHRGTEYGSVYSMVEVIQEVLDDYMLE
AEKKNRIILKQVNDFKFFGTKQYMKQVLKNLINNSFKYAGEDAKITILVEGNSLCVRDNG
IGIEPEYMKNLFKPFHEKGTKGTGIGLAFCGILIHNMGGTIECNSEYGKYTEFLITLPVA
K
>fig|696281.4.peg.1474 Permease of the drug/metabolite transporter (DMT) superfamily
MSQKNQPWAGIFLVVIATIALSTEAIAAKIAYQGGATVLTTLTVRYVLAVLFFAMMLHSA
GTSIKLSLKHTLQAIGLGIGCQAVTALSLFNAYRYIPAAMAILLLYVYPTITAILAYFIL
KEPLHWQKWLALVLTSTGCVIILGHPQENLHPLGVALALLAALINALFLVLSGKVLKEIP
VPVFNTYLTGSCALLFLGLGSLLGQLNFNLPLRAWLALLFLSIVCTVVAMSALLKGVTLI
GPSRSAIISTLEPAFTAVLGFFLLSESLSLWQMIGGAVILSGVLLQKKEPEVQNNG
>fig|696281.4.peg.1537 EmrB/QacA subfamily drug resistance transporter
MNTGELQNKVNWPVTSVIIMGTFLQALTGNIVNVALPKLMAVFGTNANDIQWVLTAYMMT
QGIIIALAGYLGDKYGYKQTFVFALIAFTLGSFLCGSAFNFNMMIISRVLQGIGAGIIMP
LGMAICFRVTPISKIGMVLGVWGIAGMATMAIGPSLGGYLIEVASWRTLFYINVPIGLLA
IFMGITLLPEMEKKATTTFDTIGITTICIGLFCLIFALSKGNQMGWGDPVIVAMLFVGIV
NLLVMVVHELRCPEPVLDMRLFKDKLFTLSTITSSFIQVAMVVVVYLFPLFMQSVLGQTA
MQTGLVLLPSAVVTAIFMPISGKLFDKYGARYLVLSGLVIMAVSSYAMKDFNGSTSFSTM
MFWLSIRGIGIGLALSPAINVGMVSLPKESTGTASSLGNVIRSVTSTFGIAVMTNLMQSR
STFHYANLAQNVVLDKADGLQMLSALQGIGLNAGLGAQGGQILSMSVLYKYVSQQSMVMA
ISDCFIIGAVLCGLAFILALFLHDQKKVNVAAGGSDIAEVK
>fig|696281.4.peg.2160 Small multidrug resistance protein
MLTDGNKTISQNKAWTFVLLGGALEIVWASGFKYEQIPWLAVIGSLLFSFDLIIRATKVL
PVGTVYAVFAGIGTIGTTVVEAVITPETFQWIKIPVILVLLFCIIGLKLTAEGTIKGGGV
Q
>fig|696281.4.peg.4077 Glyoxalase/bleomycin resistance protein/dioxygenase
MELEHIGLRVKDVQRSFRFYKQIFGCELIESYQDERVEIIFAQCGKNVLELIRDKGGMSG
RAAGVIDHLAFRVERLEDWMDKLAELQVPFISEQPRDFKGGRIFFFKGPDGEILELVEEP
PQK
>fig|696748.4.peg.1781 5-nitroimidazole antibiotic resistance protein
MGFQEEQGVYILPLNFAFKQFDDRLELYFHGHQKGKKIDLIKQQKIVGFQMDRKHELVTA
EIACHYSFRYQSIIGKGEISLIEERSEKVTILQYLMEHYTGKSDWQFEENELNRIAVMKL
IVTEWACKEH
>fig|702113.7.peg.412 Antibiotic transport system ATP-binding protein
MTSTAAPAISIRDLKKRYAPAGGDEGKLALKGVSFDVPEGGIFGLLGPNGAGKSTLINIM
AGLVRKTSGSIDIWGFDIDRDQRNAKRSIGIVPQEIVFDPFFTPYEVLEIQAGLYGIAKH
LRRSEELLRAVHLADKRDAYSRTLSGGMKRRLLIAKALVHQPPVLVLDEPTAGVDVELRR
QLWELVTEMNREGVTIVLTTHYLEEAEELCDRIAIINHGELIANKPTRELVGMAREKILV
LTLDRDLTEMPSHPGFVKCETSGERMLEITYDKDRANAGEILSAVQAQGFSIVDVTTREA
DLEDVFVSLTSQAA
>fig|702113.7.peg.431 Multiple antibiotic resistance (MarC)-like protein
MLELFLSAFVSLFVVIDPPGCAPIYAGLSADATRRQAIAMAARACVIAAIILVIFALFGE
KLLGALHIELNAFRIAGGIMLFMIATEMVFEKRTQRREERAEKIMATPEVEDVSVFPMAM
PMLAGPGSIATIMLLTARAQGIEQTFAVLGAMLLVLLLSFAALAAAGPLMRVLGDKVEAV
ITRLLGVLLAALAAQYVIDGVTAVLRFPAAA
>fig|702113.7.peg.1286 Glyoxalase/bleomycin resistance protein/dioxygenase
MARLGFHHGAMSVADIEAAARWYVEVLDFRVERRFAIPGGTKAMFLERDGLRIELFQVAD
PQPMSPARLDPRKDLQTLGNKHVAFTVDDYEGFRANLVARGVEIVLEVGERFGRGLFIRD
RADNVLEFLESD
>fig|702113.7.peg.1299 Glyoxalase/bleomycin resistance protein/dioxygenase
MTNSLIFFDFATDNPDKAGKFYAEVFGWEDDARMGGLYHRMVPGGFFKNKDGSDSQIGNL
HFGVFDARNARPNPNPDGAEPRTLSTEGRKARIWVLVSDDDTPERILDTAEKLGAKILWR
NHYWKEFNGFNHCFADPWGNEILLWVKAGENPQIPEGYTCE
>fig|702113.7.peg.1354 MFS transporter, DHA1 family,bicyclomycin/chloramphenicol resistance protein
MRHSRQREVTTAKAGPTTREPGLGLGIALGFLSALGPFAIDLYLPAMPDMTASIGAAEAN
VQRTLSAFFLGLAIAQIPIGSLSDRFGRKAPLLGGLCLFVAASIACMLATDLNQLVAFRF
LQGMGACAGTSSARAIIRDLHRGHKAARLMAFTFLIIGISPMVAPLLGTGLLQLFSWRGL
FGVLAGAGALAAILVLSFLPETLPPTNRTKDWSNLPRHHARLLQSPRFVGWALVAGLATT
IPFAFITAAPFIYSGLYALTPATFSLLLAANAAASVLATQFAPNLLQRVGAPRLAGSAAF
VALAATTSLALLGTSGVSLALFQTYSMFLFMIAGLLLTPAATSALDSVRSGIGAAAGLLG
TIQLAVTALASAAVTLWPPTSLRPLTSVLGTAFAAMVVIVVVLGRLPSPAEDTRAN
>fig|702113.7.peg.1374 Glyoxalase/bleomycin resistance protein/dioxygenase
MNSPFMAFETRIRARVVALDHFNVIVSDLDRSEAFYRDVLSLESCAPPAPLTREMARWIY
NSDERPILHLNAQDVPRAMDRDMRPGPTGALHHIALRCEGFDEIRDRLEDRGLRYESNVI
RSIGLRQIFVHDPDGVLLELNFFDE
>fig|702113.7.peg.1552 Glyoxalase/bleomycin resistance protein/dioxygenase
MSRKLPGVIGVHHIGVSVPDLDKAREFYLDILGAVEEVEPLSWADNPFIDRIVGLEGSAA
RQFFCRLGNVQIEVFEYSAPRQAPLAPGRGVNEYGYTHFAIQVEDLEAVHERIVAAGLPV
HAPPDMSSITVDADGTKHGYSGTYCRDFFGNVFEILEIHETPEILPI
>fig|702113.7.peg.1876 Antibiotic transport system permease
MADQTNSTEMLTPAGIPQPRQFPTKGEPVIHQVNWVGLKTLYMKEVRRFFKVQTQTIWAP
AITTLLFLVIFTVALGRGGREILGVNFATFVAPGLIVMGMMQNAFANASFSFLSGKIQGT
IIDFLMPPLSEGELMLAMVAAAVTRAVLVGLALCAAMLLWPGVDLSVAHPWAVVWFGLMG
SVFLALLGFISSIWAEKFDHNAAVTNFVIAPLSLLSGTFYVIDNLAPAFQAVSRVNPFFY
VISGFRFGFLGQSDIGDTNMAVLHSAIGIGIVNAVLAFVVYRVLRSGWKLKG
>fig|702113.7.peg.2009 Outer membrane component of tripartite multidrug resistance system
MLAVTLSLSACAAPDLGPRPQMRAPANLDSGRSLQTSATDAAWPREQWWKAYGDPRLDAL
VDEALANSPSVAMAEARIRQARGAAQVSGAQTQPQLGGRGSAGLTKQSYNNGVPSGFVPK
GWNSTGTLALTGDFDLDLWGRARKELAAATSEEMAAQADARQAELMLSSNVVSSYFDLGR
LVARGKALAEAVKARQSMVDLTGQRVEQGLDNESPLRQAQAAAAQARVALSANQEEELLR
RHALAALLGAGPDRGLAITAPAIDSLPETPVPADAGIALAGRRPDIVAARLRAEAAASRI
DAAKAAYMPDISISGLIGLTSLGLSNLIDSGSTYGNVGGALSLPIFQGGRLKGQFTQARG
GYDAAVANYNDTVVGALRDVADSLASRNAAAEQEKDALQAREQSAAAYDIALKRYRGGLS
NYLEALTTETAALQARTSAIDAHFRTLALEVALKRALGGGFDDNSSEKAPDNE
>fig|702113.7.peg.2370 Inner membrane component of tripartite multidrug resistance system
MSSEQPIQYPSPARRLLITIPSMIASTMVFVDVTIANVALPHMQASLSASQEQVLWVLTS
YLVAGAIATPLSGWLAGRVGRKNVMLFSVGGFTLASMLCGLSTDLGTIVFARFLQGSCGA
ALVPLSQAILLDINPPKDHAKAMAIFTIGSLAGPIIGPTLGGYLTDTLSWRWVFFINVPF
GILAFIGMLVFLGRRHNRDCPPFDKFGFLTISIALAALQLLLDRGEHLDWFDSDEIRIYG
LILIIALYLAAIHLATSPNPFLRPELFKDRNFTVSVLVNTILGMVTFASMPMIVVMTQSL
LGYSAMQTGLVSLPRTLGALIAMIAVTRLVAMFEARFLLLAGMIIMCIGMLMYSNIDLFV
DERTLVVTGFVLGLGSGLMFVPLSVVAFSTLQARLRNEGTAMYALTRNIGNAVGISLLQF
QYSHFAAQSQDSLVQGVRPDNPIMQYTRPDFDFNSVAALSGMKAQIMRQAAMVGDISVYH
LIFLASIATMPLILLMRGRKADKVDPATLPHGE
>fig|702113.7.peg.2371 Membrane fusion component of tripartite multidrug resistance system
MNAQSTIPAASEIDPVITPRKRSRRTILMIAGPAIILLIALVVYLWSGRYESTDNASLQT
GMVAISPSISGKVTSIEVKENQHVKKGDVLFRIESNSLKAAVAEAEAALATARTDVRSRQ
ADYREALSQVSAAQARYDFATSESARQKSLVAEGISSRAQFDEATTVMRTARDAIAAAKA
KADSLRAELSGQVEGSIDSQPDVRKAAAQLARARINLNDAVVRAPQDGVVTRVNQLQVGN
YVLPGRPVFMMTGLRYWVQANFKEDQLRYMRVGQPVTITIDAFPSLELHGRVESFSPGTG
SSFSVLPADNATGNWIKVVQRLPVQIAIDDVPEGLPLGAGLSADVEVDTGHERHLFSADS
PPAAPGGKQ
>fig|702113.7.peg.3011 Glyoxalase/bleomycin resistance protein/dioxygenase
MTNPTGSFIWYELMTTDPDAAARFYGSVVGWTVAAGTPDQTGGMDYRMFERSDGGNAGGM
LKLTDEMVAGGARPTWLPYLHTPDVDREVAEIEAEGGKVMMPASDLPVGRIAMVTDPQGV
PIYLMAPIPPADKPDAASDVFSVSENQHVRWNELASPDQAASMDFYARHFGYAFNEKMAM
GEMGDYCFIDHHGVTLGAIMPQMNPQQPTLWLFYFGVPSLLAAKQRIEDAGGQIIMGPHE
VPGGEWIVVGLDPHGAPFGLVGPKGE
>fig|702113.7.peg.3149 MFS transporter, DHA2 family, multidrug resistance protein
MLQLRNEMSSASAGKPVGSDLSFADDAMPANAEASAGHEDDGLAMPRRIWAIVAISFGTA
LFVLDGTIANVALPTIARDLHVEGGAIVNVVTLYQLVMVMALLPFSNLGERLGLRRVYQI
GQVIFMAASALTLAVNSLPALLMVRVGQALGAGMAMSVSTAMIRQIYPKTKLGSGLGINS
VIVASSNAVAPVLGGLIVARADWRLIFVAAVPCALVSLLIGRFLPDPVRGKVPFNWRSGL
WSAATFAMLVGGIELAVHGGWLFAGIALALVGLASALLLARSEKARINPVFPVDLLSRPA
IGISILAAMAGFIGSAGLVVALPFRLEQGMGFSPSEVGLLILPLPLTMLFVSPAAGWLSD
RVSPSILGLTGMVIAAIGLILLAFMPVQAGAAAIAWRLVVCALGFGLFFSPNARMVVSNA
PRERTAAAGGLLATGRLFGQTLGAASIGLFLSFGAGLGPIPMLFAAGLALLAGLGSLTRW
RVAENPRG
>fig|702113.7.peg.3421 Glyoxalase/bleomycin resistance protein/dioxygenase
MALSLHHINISTPNLQRMQEFYEKAFGFEPVFVHNLEDYQEEAERVIGVKDAVCTTVTMK
GGNVYIELFQWSNPVGKRLEPLRPYDYGYTHLCFNVDDIDAEFERLSGLGLPFVHGSPTK
TVFDGKTYGSVYGRDPDGNLIEIMQSPSDSDMSLNRCEALALG
>fig|702113.7.peg.3439 Glyoxalase/bleomycin resistance protein/dioxygenase
MIRGIHHIGIHTGNLDRLRAFYEAAFGFEAVGEEVRLEDFEVATLVVGVPDAKARILMMR
TANCLIELFEWQTPKGDKLEPAKAYDRGYTHFMVDVTDIDAEYERLSALGMTFVHPMPLH
FGANASVYGHDPDGNLIEIGMIPESESLHLKMPA
>fig|702113.7.peg.3501 Glyoxalase/bleomycin resistance protein/dioxygenase
MKVSGIDHVNILTDDLEKTASFYETVLGLTRSENPAIASGVAGFWMRDATGAPIVHLIDR
GTVSGRYDAYRPGEPTNALHHVALRCEGFAATCARLDELGCAYRVNDLSHINLMQINLSD
PNAVNLELNFADL
>fig|702113.7.peg.4003 MFS transporter, DHA1 family,bicyclomycin/chloramphenicol resistance protein
MERNNRKLVLLAGIAAMGSMAIHMLVPALPMIAADFAVGPGEAQHILGFYLFFLGAGQLV
AGQFVDRIGRRPVLLAGLMAYTAGAFTAFLAPSLSALLAARVLQAAGGAAGVVTARVIVS
DDASPGEGAARQATLMMVVLISPALSPVVGGLIASSAGWRGVFVLLALAGLFALAAAWIA
IAESRPGDGEAMPARSLVQSLWAGYHRLLTDRAFLGAAGALAAMSSALYIFLANAPFLLE
SRYGLSPDEVGIAFLFVAVGGIAGSRLVALLERRTDALVAGVALGVTGSVAALAGDLSGL
TGPAALIAPLILLGVSAGVAGPAGIGRAIAVNPSLAGTAASLAGAGQMLISSLAITVISW
FSPVGSSKLCIALVIATAIAAGCAALARPRETA
>fig|702113.7.peg.4207 Glyoxalase/bleomycin resistance protein/dioxygenase
MGIKALGYVVVETAKPEEWNTFLTQFAGAMRAPDAADGAALYRVDDRVFRFRIEAGTREW
FVAAGYELTDRAALDALAVRIGDAARPVEWADANEAAGRGAEAMFRTSDPAGNGLEFYCG
DARSDKPFVSPIGVPEFLTGDLGMGHAVFSAPDFEETIAFHRDVVGFHETDMPRFHLMGP
DAPSMGFAFLHADNGRHHSIAFGEGPVPPSGAVHIMLELPDLIEVGKAHDRMKRFGYPES
ATLGRHVNDETTGFYVQTPSGFDLEIGCDSLIIDPASWEVTKHEGISVWGHEWAWQKALK
EQQEQEKGA
>fig|702113.7.peg.4249 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily protein
MTKRVPRAIDQVAWIVDDLDAAIVRRLHADGTGPWTVFRNVEMAGTYLGRETKVTMDVGL
AYAGDLQLELIAPTNSAPSPYRGKDGKARIGLHHVAYVVEQLEEAVAEARAAGLDPVFEA
ANAAVRVAYLQHPAEPGALTELIEGEGMRALMKQGIAEAANWGGTDPIREISAS
>fig|702113.7.peg.4446 Glyoxalase/bleomycin resistance protein/dioxygenase
MIRGVHHLAISTPDLERFIDHYRRWFGFERVGEGGWERGNARIDTMVGLENSAARYAMIR
LGNLHIEVFEYASNDPREVYPRMCDHGITHLCLYCDDVFAEYERLKGMGMTFNCPPGGSG
MTRATYGRDCDGNVVELLQIVDPDCTFAFEKQCATC
>fig|70601.1.peg.599 Permease of the drug/metabolite transporter (DMT) superfamily
MLLGVLLALTSAFCWGTSSVLIKVGLRGKSPVSANLIRLYFSSILYFLIFYFGGNYKEIA
GLPLEYHILAFISAQFGFVIGDYFYFSALKLLGVSRTVPITSTYPLWTIIWAYLFLGRSV
TLRIITGAVLIVIAIIMVGRVESQEHLSYKGILFALITPILWSIAIVIMDWLSNFISSLT
LAGLRIIYAAVGVTFISGKFIGEIRNSNLVEVLIISTAGLLGLVVGQYSFVKSVSLLGSQ
IATPITAINPIISTGLAIIFLGESPNWKIIVSLILVVLGIWLISS
>fig|706191.3.peg.503 Outer membrane component of tripartite multidrug resistance system
MKSRLPAVLVLLLSGCTVGPDYQRPLMAMPVHYKEARGWQQATPQDDRHKGEWWSVYQDA
TLNSLLSQVSLSNQNVAEYAAQYRQAQALVAQSRAALFPTLDYDASTTRSGSHTDSTRTT
SSSHQAALNASWELDLWGKLRRTREEDQASAQASAAELANITLSAQTELAEDYFQLRIMD
EKIGLYQQSITAYQRYLSVIQNQYQAGTESRATVAQAQQQLESASASAQDYQWQRAQMEH
AIALLVGKAPADFSLPAATLTATLPAIPGGLPAELLQRRPDIAMAERKMAAANAAIGVAT
AGYYPDLTLSASGGVSASALHNLFALPNRVWSLGPELSGSLLDFGATSASVDQARAAYDA
SVANYRQTVLTAMQDVEDRLVELNTLQGEIAAQQRATAAAQTSAQVTRNQYEAGMIDYLD
VATTENSSLSAQQSLLTLKSTQWVSSVALIAALGGGWHTAP
>fig|706191.3.peg.1607 Permease of the drug/metabolite transporter superfamily
MAVRHFFMVLMVVSIWAFNNVAVKWGLVELPPLFLTWMRFAVVAIVLVPFCRINRQQFPW
LLLLAFTFGFMHFSLLFVGMRFTDAGTGAIVVQLGTPIAMLLAMVVLKEKLRLIQLIGIM
ISLSGVVVLSGSPTIPAWWVLCILLCSATGWAISNLIVKKSPPIKPLTLTGWIAFLALPI
VGAASLMLESHQLYALQHAGWRGWFAILYSAIASSVVAYTLWYALLKKYNVNLIMPYSLL
TPVLAVLMGIVVLGDSLNSFKIIGASLVILGTTIAVINLRNLRMHARFPRLRRR
>fig|706191.3.peg.2844 Inner membrane component of tripartite multidrug resistance system
MTTRPGNAPTLHPFTLRLALGLLGVWIAALTSGLNDRVSDIALADIRAALGIGYDQGSWI
VSVYQAAEVAAMMIAPWFAVTFSLRRFSLIMSAGFLLSGVLLPLMTNPALFIALRVVQGL
FGGALPPMLMTVALRFLPPPVKLYGLGAYALTATFGPNMAASLAAFWTDEVSWMFVFWQV
VPGMLIALVLMAWGLPQDPLRTERFQQIDLFGMLTGCSGMALVVLVLTQGERLDWLDSQL
IAAMLLAALPLLIVFLINEWFHPLPLFKLQMLRRRNLMHGLLVLAGVLIVSLSGSALPST
YFAQVEGFRIAQFAPLALTIGLPQLIIAPFIAALLNIRWIDCRWVLSLGLGLLIASCMLG
MQITTGWARDNFWLIQALQAAGQPMVILPVLMSATSVVAPPEGPFASAMFNTVRGFSSIA
ASTLVSWFVSHREQFHSSILINQAASRPWLMTAPDSGQASGRYPLLPDGSASSVENLRAF
ATQVKHQALVLGLSDTWLLLIGFALLLLLITALLPKRVWPPQTLIHSATSTSG
>fig|706191.3.peg.2954 Permease of the drug/metabolite transporter (DMT) superfamily
MSYRILWSIALLAVTAVWGWSFVAKHDTLGFMAASTLNAWMFTLAALALLPFSIRSFRHL
KPRDWVSAVLAGIVLFAAFSLQTSGTAYTTPSNAGFITGLCTVFTPLCIYLIGRGRPSAK
QAAGTAIAVFGLGLLSLDGFRVHYGDLLILGCAVCFAVHIVIVSTFTTPDISLASTSIQL
GIVGVLSLLWSVARDQFSLPHSLPTALTILSLALFATALAYAIQNRAQAVLAPEKVALIL
ICEPVFSGIFGYFLAGDRLPPERLAGAALILVGIVVTELRVVRLLPAAWRRS
>fig|706433.3.peg.1362 Permease of the drug/metabolite transporter (DMT) superfamily
MRNFFSKSNLLLILASIIWGCAFVAQNVGMNYIGPWTFSTIRFLIAGFSLLAIIPILDKK
RTHVIRPKTKEEKMKLLLGSVLCGLALSIGSIVQQIAMLTVPVAKAGFLTTLYVLFVPMI
TLLFGKKIPLKVWIGIAMALFGLYLLSMAGNLAIGIGEILLILAAFLFAIHIIIIGHFST
RVDPVRLSCGQLLIGGFATVIPMIVIEKPTMGSILAAYIPLLYTGIFSSCVAYTLQIFAQ
KEANPTIAGMLLSLESVFAALAGYLILHQVLNTRELIGCVVIFIAIVIAQLPDRRDMVNV
TKET
>fig|706433.3.peg.1488 Permease of the drug/metabolite transporter (DMT) superfamily
MKIKGIIYILLAALIYGFTPLLCAFTYPLGNNGFSMTFFRSFFVIPILYLIIVLKKIDLH
LDRNELKALLPACIMGACLSTLFLYTSYKYISIGSATTLHFSYPVFVLMISFIFFKEPIK
FANIFVIAVAVIGISCFMKISDGIDIKGVLYAIASGIAYAFFMVALDKNNLSYMNRYKLS
FYIAVISVFVLLSFNIVLKQLVLIQTLHSYFYMFIVAILTSIFGIIFFKEGIKLIGATNA
SIFSLFEPLSSIIVSYIFLGIKISILQMFGCFLIILSVLLLIKFNNNSC
>fig|706434.3.peg.73 Probable acriflavin resistance lipoprotein A precursor
MNVKHAFGLLGAFLLSVSLLTGCGNTISAKTEKVTKSPHPVALTLDANITALHSAEIMPK
VSGKLVSAPPVVGQDIKAGEVIAQVDPTPYQQSLSSAEAELMSASASSAPVYEAPAVDTG
ERAKLDVWYQMGAISRVEYNQMQSRANGGGTYRATPAVDTEKLAQLQQTIQTAREMLSNA
TIYSPIDGRVTAVAENSSVAVAGNVLATVQQLTPLVATFAVPQDYIDAVQAARTAGTLKV
QVLTPGGETEAGELTFLSTEVDGATNAYLAKITFNNNKNLFVPGEFYHIRLSTPQEINQI
TVPKEAVKTKDSGDFVYVVNSDGVVDARAVLTGDEEGGRVIVLSGLKEGDTIVSDPPDSL
EIGMKVSS
>fig|706434.3.peg.1328 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIRPESNQITHFLGVFFPLLLTQFALVGSSLFSSIFSGNAGTTDLAGVAVAANIWYPLFA
GACGIAFGISPIIAQLRGARKTEDIPVFITQGIYTSFFLTIIIVCGSRFLLTPFLSLLNL
EPAVQAIAEHYWLALSFGIFPMLVQATLRYAVDAHGMTRLSMGVLLSNLFISIGLFKLFI
FGGCGFPALGGAGTAYAMTTASWITCTVFIIILHFKAPFKAYRLWSDFRKFSWVHCREQL
RLGLPMFVAIFCETSLFSIVGLLMSEFGTLYIAANQAAISYSTFVYTVPWSISLTATIVV
GYEVGAKNKIKALQYDTICFFVSLSLLVLTALFTFTFLNDIAALFTHDKATLVTIRAFLI
FALIFSACDAMGTPVQGMLRGYKDVRIITYVAFVTYWIIAVPMGYVLAHYTSFGPYGYWL
SLVISLGLNALILNGRLWFYTSRRSL
>fig|706434.3.peg.1351 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVRNMTEGSPMKLIIAFTIPLLIGNLFQQFYNIADIIIVGRFIGVHALAAVGATAPLFMG
LLALTIGLASGFTVITAQRFGAGDEAGVRHSAATAAMLSAVITLILMIASGLLMPKILQL
MNISAELYDDAYHYVIIVSYGLAATMMYNLLSCICRALGDSRTPLYFLILSTLLNVGLAI
LFIVAFDWGVPGSAIALVVSQGIAAFLCLFYMRIKFPFLRLSREDWRFDSAFAKEHLKVG
MPMALQFSIITLGIIVVQAVCNTFEAETIAAFISATRIEQVAMQPMISFGIAMAVYTAQN
YGARKFDRIRKGVRQCSLLSFGLCVCAVALMYFFGIEIISGFTTDPDQFLLDQAALYLLF
TVPFYFFLGQLFVYRNALQGMGIAIVPLLSSILELVIRSGSALLLADKWGYPGLCAASPV
CWVAACLFTTGCYFYFSRRLFAEK
>fig|706434.3.peg.1456 Permease of the drug/metabolite transporter (DMT) superfamily
MRFWLGGLAIVPAYCLLKTRIRSIPKSEKPPYSLLTATLTLGFLLFTGAALQQIGIIYTT
AGKAGFITSLYIVFVPVVSLLFYNPLRLSHLFGCVVALIGVYFLSFHGGFDDANIGDILT
LASVLFWTLHIVSVSRFVRYYDGVKLAIGQFFFCGLFNFLAMYPAGESLTVSIFLNALLP
VLYCAIFSTGIAFTFQILGQKGVPPTEASLICSLEMVFGLIAGCLFLGETLTSSEILGAV
LMSVGIVSAQLSSRVIYSRKA
>fig|709032.3.peg.95 Acriflavin resistance protein
MHHHKPKIIENTVLKILQDKRRQVGVIIATLLILGISLLMFPTMLVKAKLLPKPTADYFT
IYVDLPSGKSIEETKQVTECITNTLTSEKEIENMSTFLGESLPVDFSAIIKWRVLKSNEN
TANILVNLTKKEERDENSLVIVSRLRPIVQKACSAEGANIKFIEDPAGPPVLASLVAEIT
SPNYYQNNLNTLADEIYAIFKNTKTLVDIDIERDQTYKKYDVILNEEKIFRAGLSMDHVK
NVLYAAFEGMDIAYVNDPYANNQIPIHLVLSNETKKLSDNRSETLLFKLNELKLLNSQGM
MVPMSELVDIKDTTNTKKIVSKNLTPLISIIAEADMESQIYPLLDARKAIIEKLGNKYSI
EKTKFLDLKLTNKKTGEEFFLHWDGEQKLTFETFRDLGFALLVSIIMIFLLMVIYYHSFS
LATGIILASFISIAGVIYMHFIIDIFSPTTFFITGTSLIGFIGLIGINSRNSLLIIDFAK
QLIEEKHFSVDKAIAVSIQTRAKPILLTVLAIVFASSLLVLDPVFSGLGAALIGGTLIAY
MVSLFVVPILIFRPLKKMYPDYADCYEKNHDDSLQST
>fig|709032.3.peg.106 Acriflavin resistance A precursor
MKRITNPILSVSAAILVGVIPLSLQGAQKTPAEQSQQVPKVDVYKVGSAQPIPVTFAYPA
RLNALANATVTSRITGVLIQKLYTEGSFVKKGDLLYRIEPDSYAALVNERSADLEVKKAA
FTNAQRDWERVENLFKNNAISKKEYDASLSAYEMAKADVSSAKARLQSAKIDLNYTAVKA
PISGIVEMKQIDVGNVVTAGTPLVSITQVDPIYAEFSIPDVDVRKAGGSLQNLAKGGKLQ
VSFNYNGTLYSGIVDYVAPQINTNTGSIKVRARLKNPNNALIPGAFGRINIVGVHAEGAI
TVPQKAVLQNKMGTIVMVVDKGVVGIRPIKLGKKSGDGFIIEQGLKAGDTVIVNNFFRIQ
PGAPVAIDKVVNSEGK
>fig|709032.3.peg.890 Outer membrane component of tripartite multidrug resistance system
MQPKILITACLSLLLLSGCVPKMDKAVPLSDMTINADLEKMSRDFDDERLVRDWWKMYGD
EQLNGIIEEALAKAPSIQSLEAKFAQANTIIQSVESRNLPHLSANASVIRERFSENHIFP
PPLGGGTYTQYQPELMLEYDFDFWNERSSHISAAKNTALAQRATIEASKIALSSALCETY
IAWHYEEQKLSILNALDRTTREELKIVEKQYALGLIDAIALNDKKSAQMQIAQRMEELKR
SIEGKKEAICVLGGFLPSYAETLRTPTIKHGFNLPLPKEVMLNLVAHRSDVAIAKYTALS
KSYTIEQTKAQFYPNISLSGLIGFTSFNWSKLMDHSSYSPSAGIAVSLPLLDWGMRKANL
QNSVSDYNASVYEYNQAVIKAANEVVVLLKQTKLIQSQLQLHDREMNAKKGNETIECKKL
FLGLSDKLPYLSAKKTVYEGEMDTLSLNETKSLIQINLIKALGGGYVLKEDKNASR
>fig|709032.3.peg.891 Fusaric acid resistance protein conserved region
MQVDSAFISTFKSFPWQRTLYEWLTIDAPVVIYMAKVIMAALLALWISMKLNLPDPRTAI
FTVFIVMQPQSGLVFSKSYYRVLGTIAGVGMSLVIMGMFSQDPVWFISFVALWIGLTTAA
GFKYRNFQSYGFVLAGYTMCIVALPVIETPLEIFDIAVSRFSEVVVGIMSATVISDVVFP
RRLLDSLISSEQERFQNVLSTLSDPESVFAAFDEKNPAVTRFSSGVVGLNAVRINSSFES
KSDQKERQHYGHLNHEYMNLSTTFRSLKSIVASIKESEKTELLEALEHLYEPISAALKNR
PNTVVTPEDLSRVLTELFEAKAGVKKQYELEKIMFEGEDKFTSGAYLISRLLNELYNHCA
TYLSLLKHRLSGNATRELSRTVRFSTHTDNVLVGLAALRGSGVLLLTMMFWIWTAWPFAT
LSITMAVVIGLLLGTMPSPLDGVKDFFKGAVVALVFAGVYDFFIIPAYTSDLLTLGLLLS
PTLAFIGWMTTRPKLPVFTFGFVFMFMSQCALDTYYKIEPTKFLESSLAALIGIVFGGLA
YIVVNFWSCSLTQRRVAKILRRQIVRLCVGALNVERSALESTGRDLVQQFSTQGRLNMRS
SRLVYEWLLTTLEIGRAILAIRRSIQRLYAHNRHPRISDALESIKSYFEGPTDVRREFLL
RELKETIAILRSSDRPNEKVQFKRFESLITELALIRTVLLHSTTFPLAKEDSCR
>fig|709032.3.peg.999 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLKHRVLHLAIPAALKHFLDIVQILIDMLMVGVLGVAALAAVGLSMQFMMVIQAFMSVYA
IGSSALISRYIGSGRRHRASSVVFVGLWVALGGALIVGIAGWSFSSDFFRWMGSSAEVTK
LGSGYFGILSLGMGLIFLDTLAYNALSAAGDTRTSLFIKIASAFLNAGLNYLFIFGHGGF
EPMGVEGAAYATVSAYGFTVLIYSWLLIKKGGILDIYPIFVRSDFKKMIAIGTPAAVERV
IGVASFLLFVMMIASQGTVALAGYQIGLRIEALAFMPGFGFSVAAMVLAGQFIGSKQYDY
AYESGILSAKIATLFMGSVGIILVSIPEVLIRFFTQDSVTIDQAALYLRLVGIAQIPLAL
TFVLSGALRGAGATNLSMRISIGSLWLFRIIPAYVVMKLGGGILGIYIAMTVETFIKGWL
FWQVYRQKEWITRTI
>fig|709991.3.peg.328 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MADLFPNYTEEKQSIRKFFRSYVYPAMFNMVVMALYNIVDRIFIGQGAGALAICGLALTL
PCVSLLSTVGTLTGVGAAARISTSISLGNRSLACRILGNATVLNILLSTILIVYSLYHLD
FILDIFGGSGQTIPYARKYMSILIPASLLTNLNFTYCHAIRASGFSRKSMTIVFAGVIAN
IILDPIFIFGFGLGIEGAAIATALSMCISSVLVIRHFRSPSNILKLQSKCFSPRFPILVS
IVGIGMAAFIMNITTGMVNIIMNRYLENNGGDYAIGAFGIISSYSIQVSMLLMGICQGMQ
SVIGYFYAAGHRQMTLHILRKAIRTGSLIACCGFIIGEAFAPWLVKAFTSDPTLLQLSEE
GLRYTFLAMPLLGFQLIVTSYFQSIRQAPKAITMNISRQFLFLIPALGLFSHWWGLTGIW
LAIPFADLMATLIALFFLWRTDRKAD
>fig|709991.3.peg.891 Permease of the drug/metabolite transporter (DMT) superfamily
MMYRLKGLIYGVISSATFGLIPLFALPAIRNGIGVDSVMFYRFGISALVLGLWLVIRRYD
LRISGRELFTLAGLGIFYAMTALLLTTSYLYIPSGIATTIHFLYPVVVTTVMILFFKDKV
SVPVIGATLMAILGVYLLSNNGTAGTVSLKGLLLVLTTVVTYALYIVGVNKSCVHRMDGL
KLTFYVLLAGAMVFGLNLSVKGVPLDPIPDWETGVYLLLLALIPTLVSDFTLILSVQHVG
STTTAVLGCMEPLTAVCMGVWFLHESLGFWQLAGIVIILSAVSVVILANSKDGFRPRRLI
PLKLRKAVRWIKPINFSH
>fig|709991.3.peg.1490 Permease of the drug/metabolite transporter (DMT) superfamily
MPKSKAYIGHLMILATTFIYSFNTNFMKVIIPEWIGPNGLVLLRCSASTLVFWLIGLYFP
TSSDRPHPQKKEIGMMILGGILGLGGNLLFYINGLSLTGPIDAFVIRTTQPIIVIALAVI
FLHTVFTKYKAFGILLGIAGALYASIMPHTGSLVKDSFGGDVLVFCSSVSYSFFLILIKP
YTQKFDSVTVMKWMSLSSMIISLPFGLSDLVRSPLFSAQAPLHIWLEICYILFVATVIGY
FLSVYALNYITPFVESAYKYVLPVTGAAVSILMGLQKFSWHDPIALALIVTGFILINKKT
NEIQTNHVSIHHSPTGPEDRENHPG
>fig|709991.3.peg.2303 Probable multidrug resistance protein norM
MSYFTPYKEHYKALIRLGIPIVIGQIGIVVVGLADNMMVGQYATLDLAAASFVNSAFNIP
ILFGLGFSYGLTPLVGQFFGRHDKYHVGQLLRNSLLVNLFIGLLLTLAMTVVWFNIDRLG
QPEELLPLIRPYFLLQLASLVFVMLFNSFKQFADGITDTKTPMYIMISANLVNIAGNYIL
IYGKFGLPALGVVGAGISTLTARILMFAAFAVLFYRSLRYRRYLVGYKRGKYNFTDILSL
NKMGWMVGLQMGLETALFSITGIMIGWLGSIALAAHQVMVAISTLGFMIYYGVGAAVSVR
VSNYFGRQELLHVRRTTMAGFHLILCLAVCACTVFLFSRELIGYLFTTSEEVIRVVSTLV
YILLAYQFGDALQITYANSLRGIGDVISMAVISFIGYFLIAMPVCYICGFVLEWGITGIW
IGYPIGLTLTGVMLCGRYYWKLKTKTQSKEFY
>fig|709991.3.peg.2887 Permease of the drug/metabolite transporter (DMT) superfamily
MTKDKWLGHGAILATNLIFGLNTPIAKTIVPEWISPYALTFVRMVFATLVFWGIGLLAPK
EEVGKRDLWTIFGGALFGLVGAQVSFANALLYTSPVNITIIAAMTPLAVMLIAALILKEP
VTFKKAAGVLIGASGALLIIFQSSAINTDSSGNWIGNLLCIVNVITYAIYLVITRPISQR
YSAITLMKWMFLFSALISFPPGISDLPEAKVFGTESNPFVILKLSYIVIMATGIAYFLVP
MALKRIRPTTASMYNNLQPIIASIIAILIGQDVFSWDKPIAALLVFTGVYLVTQSKAKEE
VKGIK
>fig|709991.3.peg.3425 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKTTDLTQGSIFKSLWIMAVPLISASFIQMAYSMTDMLWLGHLGSDAVAAAGAAGFFTWL
CNALSFMTKIGAEITVSQSVGSKDYRRAAHYASQAITLSTTIGFIYACIIILAAPLLMGL
FRFETSISTQAIDYMRLVAPGLFFQFNNNTFSGLYNGQGDSRTPFRTSAVGLIVNIILDP
LLIYGIGPFPAWGTAGAAVATALAQLVVYGIFARRIFSDRFPLGRMHLLNRLKQDYARRI
ILLGLPVSIQNALFSMFSLTLATLAARWGAVGVAAQSIGAQIEAISWMTAAGFSTALAAF
TGQNYGAGNYERIRKGYRLTLGIAGSIGLGAGILFFVLNHEIFGLFVNEPEAIEAGGNYL
KILALSQLFMVTESVTAGAFNGTGHTTPPALTGIIFTGARIPMAYFLTSFPQLGLTGIWW
SITISSILKGSVLPLWFLHFQRKLK
>fig|710696.3.peg.22 Antibiotic efflux protein
MEREEAVEVPAGRGLGRLLASTSVSIAGQGMVLAAVPLLAARLTDDPFQVSLTVAATYAA
WLVVGLPAGALVDRWPRRRTMVVADLVRALIIGGLGLAVVAGVAQIWLLILSVFLLGVAS
CFFDPAAQAAIPAVVGRDSKVLATANARIWSLDLMGRSLIGPPAGAALFVVAAGLPFVAN
AATFILSAMFLAGLGSLQPATARDGRPRLLASVKEGIHYLARHRELRTLTIGMASFNFVY
NTANATFVLFAMDQLGVSEQGFGLLLASAAVGGLVAGYVVPKFKSKVSATNLYGVGLAVQ
GLGWLAVLAAPNPWVAAIAVAAVGGTSMAVTVLGAVARQRLTPDLMLGRVSATTRVAGIG
SGALGALTGGLVASQLYIDAALWAAFITACLISVTLWMSKSAEH
>fig|710696.3.peg.2175 Permease of the drug/metabolite transporter (DMT) superfamily
MTPSAASATRSSRVDLRGALLVMGAACCYALSVVFAKGAYAMDVAVATLTLWRFAIGAVI
FWALVAVRRPARVSRRTVLTCIGLGAIGYAVQALTYFGAVAVMDAGLAALLVYTYPAIIA
LIGFLTRREPPTRRRIVALACSGAGMLLLLGLGGFTSVSGVGISLALTAGVTYAVYTIVA
SSLPVEADVSLLMAVVATSALGSVALFTMVTGQPFGLEADPVVLGWVLTYVLVGTVLAML
LHQRGITRVGASTGGIISSVEPLVAAAAVALVYGETMTPVQVVGGMVILVGVVVVQLPQR
RPRRIPEQLRPAARAGRAVPWKANSISGSAREPCGSSQFLSRS
>fig|710696.3.peg.3261 Drug/metabolite transporter (DMT) superfamily protein
MPDLRTRNADRTWLIALAASLWGLSAIWRDPLAKQYPSVAIVFWEHVVLALLVSPWLVGA
LRAVAVARRRTQVSVLVIGAGSSALATTLFTSAFRLGDPITPQVLQKLQPLIALLLAAVL
LGERLRASFAFFAVPAIAGAWLLSFPEPFAVSVTSLYAAGLALGAAALWAAGTVLGRAAS
AELTFRQLTTLRFGVGLVALAVISLVTGTSVRIDAGSAGNIVVLALVPGLVALLLYYRGL
RTTPASRATLAELAFPITAAVVGVTVLGRTLDGSQWVGFAIVLAAVVALALHERRSERPS
VAVPDRADEAIGVGG
>fig|710696.3.peg.3555 Glyoxalase/bleomycin resistance protein/dioxygenase
MADVRAAVAWYADVFGFVEHVRIGEGHRSQLGLPDGQPAELVVAEVRPGRRTPQSGRSHQ
VMLKVADVAGVAETATARGAVLVDPPHDWEYGERQATIDDSFGHQWVLNQTIVDVAPEQW
GGQTVTPRPRPQ
>fig|71421.1.peg.1187 Permeases of the drug/metabolite transporter (DMT) superfamily
MSEQSSKYIAALLAVLSISMVLGIDLFIFSLQSEKQTMPHLGVGVLVAQLISLLVFYRGE
ICPGQRGRLIKVNMTFAIYWAVWLLISLLQNNHTLTNVMSVCGLSVVYFIWKQPKTEKIR
NSFLLMAALIAGLGCLSYLMIFTELPASDFAEYNPFAPILSGVILANLVLVIARNRLQGF
IALLPLAMIILLALNALAMFLFLLLNGMESAVNSESVFAYIIYFVCHFVIAAILILHSFQ
KWTLSTNSLFILLFIAVCLPLWMVFV
>fig|716544.4.peg.541 Drug resistance transporter, Bcr/CflA family
MKKIAISLCLIIGLVSLPQISETIYTPALPDVAKGLKASVHAVEASLSVYFLGFAFGVFL
WGGCSDLIGRRKTLLIGLTIYIISCVACLISHRIDLLLVWRFFQAVGASVGSVITQTILR
DVYEGKERSRLFATISAALSLSPAIGPVIGGLLSEDWGWRSNFAFLIALGSVLLAWAYLK
LPETRPSHVELPGKREYQNLCRRMFSSTALWGHVLLIGATNGILFCFYQEAPFIFINQIG
LSPKAYGLLGLVVASATVFSARLTYRLAGKYSQECLISSGAFTATIGAIALILLQQAGYF
QIEGLTSVVFALFVTFVGVGMIIPNSLSIALKDYQAMVGTAGSIFGALYYLIISLATWGM
SILHDGSALPLPLYLTLLCLLLLIGSFFIQQTLTVEEVIDQPEQSA
>fig|716544.4.peg.694 Permease of the drug/metabolite transporter (DMT) superfamily
MKNLPVSQILVVGQLVGGLISIYFEKSRFSLHSMKNRIRKGWAILAIFWISQYGYIYAFQ
NAPPAQINLIFYTWPAILIIIKAWNITRKLNKWDIAGIWLGFMGIAILLSPDLKQDAFSL
RYLSGYLGSILGALGWVAYLLYTDQEKKDKKGFTSIGEDILILGIFNFFHLMITEHWIQP
NTNEWMMLGYYSVSMFGIPYYLWRITLKKDPKMAGALSNATPVLSIIWLILAKITPFTIE
LAVSIVMVNLGIYCIDRSAKSTSSITG
>fig|716544.4.peg.863 Permease of the drug/metabolite transporter (DMT) superfamily
MKFRDFFGLVLLAAFWGPTFLLIKIGVEAVSPLALTTVRCGSAALFLLGYCLLTQRSLSA
VFPSGKHLLFMAIFGNVVPFLCCAIGETMVQSSTAGIIEGSVPLIVALFTALFTPHRRLS
KNEILGIAIGFLGILTIFAPDIMQTSGHTEERFLGKMFLVVMAVSFAASFVYSKEKLDNV
PHIAAVTVQLILSGLILFLMTFFIEGRAAFHGFTFKVSAVALSLGIFGTAIPWCIYFHLI
KKGSAAQVSLAVYLLPVVAVFLGWVFLDETLRWNLWLGVALILFSLILASGMLAKRRKTD
HDNPLLRN
>fig|717231.3.peg.2308 EmrB/QacA subfamily drug resistance transporter
MTGTFMAILDTTIVDVVIPKMIAPLKTDLYGVQWVITSYMAAAATGLLLIESLDKVLGLR
VMFIMGITLFTLSSVACGFAENLTQMIIARSAQGVGEAFVVATAQTILFSIYPPNRKGIA
MGIYGMGVSFAPALGPTLGGWLTEHLTWRYIFFVNLPVGAMVVLVGLLILPKIIKQKQKL
RFNFISYAFLGTFTISLLILLSKGQQKGWLQSDFIIKALIIAVGALFLYAIAELLSKHKL
IDFKIFKVPQYRYACVIYFFTLGLSIYQLFYMIPLFYENLKGYSTLNTGLHMLGFAVFIG
MTSPIAGILSDKFGEKYVLVVNAALYITTSIFLMPNLNYFTPSLRTILLTIPLGFSLGTF
FAPITTMAMRHLREYTSLGVSLMHYLRFMGGAFGTAIATNTLQSKTAIHYEGIISIQNFD
YARMYLNSVSEKFSAYMPERMAELRSETLLAKLQQLMGLNEAFQDVFLHAGFFGIFGLSF
LILIFLHDKKIEKNDKTV
>fig|717606.6.peg.390 Multidrug resistance protein-related protein
MLTSPFVIQLLIIMFFVEFVKGALIVSILPVYMGTVLGLSAYAIGWALALQYIGDNAFRS
PLGWIIDRVGYRTVMLFGVLLTFASVIIVTVTDDLPWIICACVLIGMGTSPLWPCVITGA
TAVAGNEAGGTIMGVVYMAWLTGVGAGPIVINFFIAKSNESSSSYDTAFKLLIALMVIVL
FVALFLPGRTKSRELEGKEEQANPEEHEHLPLGERIRAYLAKVSSSMHASKVLYPAMFLQ
NFALGLLVPILTLYARTVLHLTPQQYSYYLLAGGAFTVLGLIPIGKAVDKYGTSRFLHIG
FPAAAISLPLLGYTRDLVLVLPIVALVGLSYAFIIPAWNALIAEAIPKEERGAVWGFFLT
IEGLGMVLGSIMSGKMWDSFGPHSPFLVSGVVLITLFVLHLFITRKPKVMVR
>fig|717606.6.peg.850 Glyoxalase/bleomycin resistance protein/dioxygenase
MQSIKLFMRLTSYINVNWKLTSLAYLCTILALTLNLAQPFIFSYLIDEVLIAGHQEKLVF
LLTLFGSFALGSVVLSIIRTGLFRYLGIRHMLDLRDVLLAHIRRIPLTEIEKHGVGKYSA
LLGWDTASMGNFLNHIVVEMVTQWFTMLFAISMIFYMDARLGWITVASIPVLLAIPRIFV
KPMKKYADGVRSHNEEVGTYLYESIEGSKEIRAYGLEGWERKKNQSMYKDLVAVSTKETL
FRMFSGQTGTLAFSFILIAVYSMGSKQVLAGTLSVGMLVAAVQYLNNALQPIQVMNNFFG
EMQQSEVAMKRIEQFLESPVEQAAQQKNKAVSIPFPGESAEVSCKQVHVSYEGTQILRDI
DITVRKGQVAAFVGPSGSGKSTLFKTLAGFMEAEAGDIRIRNLPMNQMSRSDLTAHMAIL
SQDSYLFSGTLYENIAIGRLDATEDEIKEAARLASLQSLLDTLPNGLQTVVDHQGFQLSG
GQRQRFAIARALLKRPDILILDEPTSALDRETEEQVMVQIKQAMKGKTLLISTHRLDIIR
NADIIYVMDQGTVLDCGTHEELVGRCRKYAALVAGQEQEELLEKIG
>fig|717606.6.peg.1643 Permease of the drug/metabolite transporter (DMT) superfamily
MSKTISYLLLFSNVLLLVAGQILFKWGLQKAGGLQWARIALSPSIWSGLTLYGLATLLWF
AVLTRLPLSVAYPMQSTAYVLGLLAAWFIFDESLSATKLVGCAVILVGVYLIAK
>fig|717606.6.peg.1698 Daunorubicin resistance transmembrane protein
MRKARKYWELMKSQIKVDTAYNVWYWAGTASSIFRLLIIYAFWHAVYENKTTIDGMPLST
MITYVIIAMTINNYVAGVGTQLASNVRDGSVAIELMRPYNLLDKLVALDLGNKVTGTLRE
ALPMLLVAYLFIGINGPASWSSFLLFLFSAILGILIGTQLDLVIGIAAFWLLYVWGLRVL
RNAIFLFFSGALLPISMFPEWLQTVSRFLPFQSMVYVPTSIYTGQLAGSDALYAVLGQVL
WLAAIYIAIRLAWSVAIRRVTIFGG
>fig|717606.6.peg.1905 Permease of the drug/metabolite transporter (DMT) superfamily
MPCCPAFCAVGGGKQLKAPGYGLAVLFVLLGASSYGFLSPIVKLTYDQGYTFEQITVHQV
GIGAILLWIMVLLRRDVWSNPFRGPWIKLASIGIFGMGATTILYNLALARLDASLAIVLL
FQFTWITILIDSIWNRKWPNRWHWIAIAIVLAGTVLAVGVTSDGIDRLASIGTVYGLLSA
ITYSLFLWLTGRVDTAGDPVIKSAFITTASLVLVVVLYGWHAGAGERELQMAGIGLVLGT
LGQVFPTVLFSIGIPRIGSSLASMLGSIELPVAACAAWLIAGERISMWQTFGIVLILCGI
VVAERRSGNRTEEQSSRLGE
>fig|717606.6.peg.2007 Drug resistance transporter, EmrB/QacA subfamily
MSSAIAGIGGLSGRGGSRFMMATLFLGSFLSIYHVVSLNAVLPGFITIFDTDLSTAQWLM
TGFTLATGMVAPVCAYLEERFGTRRLFLSCIVMLTLCSIICSFAWNIYSLIVFRTLQGIF
CGILQPLTLSILYGTLPREQHSTALGWWTASTILGPALAPTISGWLQQSDWRLIFWATVP
IGLVVWRMGFACLPAAKARSTERPDLLSLSYVMTGTLAVLTLFSKMNRWGLLSLSSLLCA
AVSLLFITLFIRRSLKSEHPLLQLRLFANRMFTSSLAASLILIVGLYSGIYFIPLFLQQV
QGMTPLHVGLLLLPPALSMTLATMISTRYYKKLGPSTLLITGTILLMVATWQFSRLQPAS
GHGFVMLWMAVRYVGIGLSMTPAMNAGMSAVSQQFSSHASALINWIRQAGGALAIGLFTA
FFYSRISAYGGQAGVSPSAAAVDASSQLNILMPYMKGLNDVFLLALLFTSLSVPLALLLR
KRKRTAL
>fig|717606.6.peg.2309 Multidrug resistance protein B
MSAEVHANEPASVRSLLAPLIAIVVGLFMVILDTTAVNVAIPVLADDLHSSLSLIQWTIT
GYSLAQAVVIPMAGWFSDRFGAKQTFIVSIILFTVGSILCAFAGTAEQLIAFRVVQGLGG
GMVMPIAFAMTYRISPPESVGKIMGMMGVPVLLAPALGPVVSGYLVDYVNWQWIFLINIP
VGIAGVIMSIVSLPNLPKKASVSLDFAGIALAPFAFGGLSYGLSEAGEGWTSAKTVTGLV
VGAIAMALFVVVELGRRREPLLELRVFRSMQFTRGIVVQWVMQFTMFGLIFAIPYFMQRL
MGMSAFEAGLWTLPQALASATMMPFSGRLFDRIGARPLVIGGLTLITVGAYLFALIDPSD
SPWLFLAPRALIGFGTGMSFIALNTHLIQTAPKELVGKVTSLTSAFQQVVGSFSIAGLTT
LLVSRTNHYAKQGEAPIPDAMSHAFHNAYILIAIIAAVGLLLAFTLRRPAKEQAAHPTVV
MDAGH
>fig|717606.6.peg.3206 Probable cation efflux pump (multidrug resistance protein)
MSERQSFYKNIYKIAIPVTLQSLLMSLLYLTDQLMIGQLGDVAIASVGMATRIFGIISVV
LAGLSVGVSVYAAQFWGTKDNKSITQVLGIGLFTGILLSLTFAIAVFFNPSFFLGLFTTD
TSVTDGGAIFLQIVAISYVPTMLTMMYSAILRSTEHAKWPMYVSLVSVVLNIILNYMLVF
GHWGAAEMGLKGSAVATVISKIVECLLIIGVVYFYRLPGATGMRNLFTIPKPLIKKFFST
SYPIILTELVWVLGETVYAIIYSRMGTTEMTAMMMTSPLQGLSIGLLTGLSSAAGVMIGN
KLGAGEFDTALAHARRFVKLGITISLILGVIVAAISPLYVKAYNVSDEASRLGIYIILVF
AGFLWVKVSNMIMAGGILNSGGDSKYVFAMESAATWLIGVPSGLLLSFVWKQPVFLVYLV
LSCEEVVRFMLGWVRLTSKKWMKNLVSDVSA
>fig|717606.6.peg.4709 Permease of the drug/metabolite transporter (DMT) superfamily
MNAKQFFTHPAGIAAGSIGATLLWGSAYPTLKRSYEELGIDGTDWFEQFLFAGYRFTLAG
LLIFLFMLVIREPLRYRQGSLKCIVSLGLVQTVLQYVFFYTGLAHSSGVFGSVIAGMISF
FSMVLAYFYDPSERFTRNKIIGLVLGITGLLLLALPQAVQHGWNQAFGIGEWLLLIAALC
AGFGNVLSKKAVSVYPVAYVNGYQMLAGGLALILIGGTVDGFMPFHWTAAAIILLLYSAI
ISSAGFIVWNYVMKYNSVGSTASYLFLTPVFGVMLSALFLNESIGIAVIASLTAVCAGII
IINRRTEQKQAAAKTANVR
>fig|717773.3.peg.741 Permease of the drug/metabolite transporter (DMT) superfamily
MFPISLAYLVVILIWTTTPLAIQWSGESDWFFGVAARLILSALIILPMIIVFKQQRFDLS
WSAFKVYAAAAIGLLGGMTPVYWAAQTMPSGWIALIWGMNPIVTGLLIYFILRTERLTPA
KWLGIGVSLIGLMVLFVPNLESVSTQDLLLQGLIVALIGVFFHSLSTVLVKKTAHNLPPL
HVVTGALWITSIVFLIIHPTVLLDWPPLSTRTSWALGYLILVGSVIGFALYYYVLKHLDA
LRLGMIPMITPVFAVALGVAVNNEQLSLPVIFGAILILAGLLLFELERFYRLIKRRQQTN
SID
>fig|717773.3.peg.1121 Glyoxalase/bleomycin resistance protein/dioxygenase
MVKGINHVSFIVSDVEAAREFYQSVLGLTLVKRPNLDFPGYWLDLGGGQTLHLLAVDDPY
HDVPRPLHLGRDRHLALSVANLESTMTRLAEHKIAYKVSQSGRSALFFYDPDLNVIELTE
V
>fig|717960.3.peg.1047 Permease of the drug/metabolite transporter (DMT) superfamily
MSKQTANLICLLVAAIWGGGFLATAGALEAFDPFSVLMIRFIGAAIVSWIVIKVKKLKVT
KEALIKGSISGVLMYLAFAFQTFGLDLTNTGQNAFLTSVNVVLVPYISWFLFKRKPMGIQ
VFASFICLAGIACLSLSSDGFHFSFGDLLSLICAFFFASQIISLEFATKNCDSTVINTIQ
MCAAAIVSIPFALILEDFPTSIDTNVILSCLYMICIATWLAFQLQTLAQKYTDASSASLL
LCTESLFANIFGYFLLHEEKTLTMVFGGLLIFISVILVESSDRIKPVLAKLKRT
>fig|717960.3.peg.1086 Permease of the drug/metabolite transporter (DMT) superfamily
MKQKFFKKPLNVVLIAIFCTALWGSAAPFIKTGYALFDIASNDTASILVFAGLRFTLAGV
LVIVAGSKIQNKILLPVKKSIKAIFVLSIFQTMGQYFFYYVGLAHTSGVNGAIITGTGAF
ISLLVAALVFKYERMDLNKVTGCMLGFMGIVLMNMDDFASLKVSFLGDGLVLCSQLCSSF
SASFIKKYTQSFNAVMLSGYQFFVGGILLTLIGILMGGSLLLTNISGMMVLIYLAFVSAC
AYTLWGILLSYHPVSKIGIFNCLIPVVGVLLSSLILHEEAFSMNIVFALIFISFGIYFVS
KEKDPLTMDAS
>fig|717960.3.peg.1758 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MERKYLNSQFWKYILPSMFTMLLSGFYSIVDGLFVGNSVGNDALAAINLVYPIQVILNAS
AIGIGIGGAVALSYFSGRDETKSADRSLGSTITLLIVVGIVLSIVLFFATPTLLEILGAS
GTIYEYAYDYIFVILCGGLLPVLGNGLSPLIRNYGKTIVATICMNSGLVTNIVLDYIFVF
LMEMGLSGAALATIIAQGVVALSCLVFLYASKLKEISLHCYVPSVSLIKRIITVGISPFG
QTMIPCIMIILTNWTCIMYGGNDALTIYSVISYVLSSAQLLLQGIGDGVQPLLSYYHGKG
NKDVIHYLYRKAFFVSLGVSVILFMGVYLFNEPLTGLFGVSHSLYDGTKLALIITALSFP
FIGISRLTSAVFYASGRSKNSTFLVYIEPCLLLPVFLIVFSSLFQLTGVWCAYPATQVVL
SVIALVLQSPNLVADHEKKIVEVSI
>fig|717961.3.peg.857 5-nitroimidazole antibiotic resistance protein
MRRKDREITDKNEIRDIIGRSKVIRIAFTGEEYPYVLPFNFGYEEKDGRMYFYIHTATEG
KKNRLLDENNKVAFELDNCRDYVEGSITSLYESVAGCGVMTEITDMSEKLSALGLILKQY
GEKTYKPDSSCASRTRVYRLEVKEVSGKANRGK
>fig|717961.3.peg.957 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MANVVAEFFAFLLSLMFLIVKRKKYGYWQKNVALPAEPESEMTNKNAD
>fig|718255.3.peg.493 Vancomycin B-type resistance protein VanW
MIKRKNWTKKMLAVAACAGLLMTNPAFTEAATAAERSAYQAVFDADYYRSAYPDVAAAFG
NNKAALFNHFVNYGLREGRSCSADFNPQAYRAKYADLQQAFGDDMAAYCRHYVTCGKAEG
RDGGGTGSVSATTQTSAATVGQGNILSSCTTQYDATVPRANNVELAAARINGVVVQPGKS
FSFSSTILPRTAANGYVVAPIYISGTVGTGTGGGVCQVSSTLYAAMRYANLPATERYPHS
LPVTYLPDGYDAAIAGTSKDLKFTNTFSQPLLIQASASGGTLTVTLTLQ
>fig|718255.3.peg.1105 Vancomycin B-type resistance protein VanW
MKKTGKILAALGLAVAFGAILNPTQAKAEDTDRIAQGVYIGNIDVGGMTEQEALNAVTDY
VNNAGEAVFTLTAGEHSTQVKASDLALEFTDMNVVSEAMDVGKSGNLIKKYKDKKDLENG
SVVIDMVLNVDHDTVSELLAEKADELDQKAVDNGLVRENGTFKIIKGSQGVEVNVEKSIA
AIENYVSNDWDGQGGNIELTAEIVEPKGSEEELSKVKDLLGGFNTNYSSSTQNRCDNIAT
AAGKINGTVLYPGEEFSVYETIGPLDAANGYELAGAYENGQTVQSYGGGVCQVSTTLYNA
VILAELEVTERSNHSMIVTYVKPSMDAAIAGDYKDLKFVNNQDVPIYIEGYTSGKNVYFN
IYGEETRPANRKVTYESEVVSEQDPGTQFVATGDPVGTMSVSQGKHVGYVAQLWKVVTVN
GVEESREVFNKSTYKASPKIVNVGTASEDPNASATIGAALATGDEGTIYAAVAQFTAAAA
ATPEQPAENQSAEEQAIVGDGQVDVSGDNGGNGQ
>fig|718255.3.peg.1347 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKRNGANLTEGKPVKLILQFAIPVFLGNLFQLFYGLIDTKIVGSTLGEGALAAVGSVSIL
YNLLTGFFNGLTLGFSVVTARYFGAGDTEKLKKSVAGTILLGFVTAAILVTGVFVFLRPL
LSIMHVPAEQKEMAYTYISILVLGMFVTLAYNMCANVLRAIGDSMTPLIFLILAAVLNVI
LDYVCILVFSMGVGGAAAATVISQVVSVVLCVIHIKRHFPILQVERRHFKLEKSEVRTML
SGGLSMGMMSSLVNLGTLILQTGINTLGTSVIVAHTAARKVFEIWGLPVTVLGATMATYS
GQNYGAGKYDRITSGLKAALMLGCGWAVMVMIMAYTISTCLVGFIASTQNAEILYWGTTY
LRVDMLFEMVCVWIVILRNTMQGVGDYKTPIFSSFLELACKIVFTAVFVRYFGYWGVIWT
EPVTWIIMVIPLIVMLKKNPVFHQKKTA
>fig|718255.3.peg.2326 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTKDMTTGSSLKIILLFSIPVLLGNLFQQFYNMVDTIIVGRYLGEDALAAVGSTGCIMFL
VLGFATGIAQGFGVMISHAFGAKDFRLLKHYVALSLILTVIVSAILTIPTVAASRLFLVW
MHTPDNILSMADAYIKVIFAGIILTMLYNVSAGILRGIGDSKTPLYFLIISSILNVVLDL
LFIVVLKAGTAGAAYATIIAQGISAILCFIHMFRQFEILRTTKADYYLDRPGVINMLSIG
IPMALNYSITAIGTMILQSAVNVFGSSVVASFTAASKVNNIATQTMPTLGTAMATYCGQN
LGAGKYDRIFDGMRKGFFICIAAAAIGAAICIFGGEFIVSWFVSNPSDEIFSYAMMYLKT
VSWFFLPLAMIFLYRNALQGLGEGLVPMLSGVIELVCRFVAIALLQKPLGYQGICLADPA
AWVGAGIPLMITYIIWKSKKIRQHSSSPA
>fig|741091.3.peg.1952 Inner membrane component of tripartite multidrug resistance system
MSVTLTPAATLSPADYPTSRKFLIFSIMAFGMFLALIDIQIVAASLNDVQAGLSAGPDEI
SWVQTSYLIAELVMIPFSAFLTQALSTRWLFSASAALFTLSSIGCGLSWNIESMIFFRAL
QGFTGGAMVPTVFATGFAMFQGKQQALIPAILGMVSVLAPTLGPTVGGIVTQLLDWRWIF
FINILPGALVATGAVLFIHVDKADYPMLKRIDWIHLLSMAIALGCLEYVLEEGPRKNWFS
DPQIQISAWFSLVAFVLFLERSFYSKNPIVRLTPFRDPTFTFACLFNLVVGFGLYASTYL
TPVFLGRIRDFNSLQIGTTVFVVGVGQFFSTIIAARLISRVDRRILITVGLSGFALSLWL
TTAVTPYWGAEQFFWPQVVRGLFIMLCIVPSVNMALTAFQGPELRYASGLFNLMRNLGGA
IGIATVNTWLQDWTRVHAARFGESLGQYGDHAQEVMGSLAQKIGHLTPDTAQALLMAKGV
FGAKVAAQSLTLAFNDIFQVMAWMFIAALVMVPFCRK
>fig|741091.3.peg.1953 Membrane fusion component of tripartite multidrug resistance system
MSEATADEGSASPAVKATKRSKRIFVVSGIALMVALSGAAWLLAAPASESTDDAYLTADT
TSVAPKVKGFVSTVLVRHNQRVHAGDKLVLIDSEEFTARLASAQGELEDARAQVTQQEAA
LLSQQAQEQLALTQIEAARTAIRSSRAEQQHAEAEQQRYQSLAVSGATSRNDADRYKTVA
VTAEQTSAHAAAMLDVAQNQAAVTHARRAEIQAALALAKAAVVKAQAAQALAQQDLNHTT
IVAAIDGIAGNRQVQVGDYVTPGQRLMTLVPEQGIYVTANFKETQTGRMQPGQRADVHVD
ALPGVTFRGEVDSLAPGSGSTFALLPFEPGTGNFTKIVQRVPVRIRLDAGQPDLAALRPG
LSVDARVSLTDAVR
>fig|741091.3.peg.4668 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNTSPEMTLLRRNSLSKDIADLLKLAWPMIVVAIAVSFSQNIQTAILGHGKETSSIYLLS
MLQPFSFLFLAILECLAITNQVFSARSLNMWSRQKVLAATSLLATLGIVIVALLSGGTAL
CAPLLQTLLPVAGNAFYSSALPLYFLSMLPFIQLEMCNSALRGQGKSALSMLLVIAYIVL
NALICYTGYQVYGLGFNSIIISNALASALLIPVALWLVWRTGRHVEDDRPGAFIPRLSGL
LLQVGMPIFASLVVLFFSSLLIFPLIGTLGEQYVAGFLIVTKIRMFIVIPAVACGSALAI
LINQRLAISSGEELKRLLHRGLAFICIIYLLLTSGVYFTEVSLIKILSGDRIIQDVSSQI
LLILLPTFFMTSFVASLQALLEQLEQARRVLVLTVIIELLTVITLLVGWDKFSQLQSIMN
LIIVFNVVYFIAFGREYWRLANKIGSENVL
>fig|742159.3.peg.1403 Permease of the drug/metabolite transporter (DMT) superfamily
MRGGDWLRLLVLSAVWGASFIFMRVVAPVLGPVVTADLRVAIGAGVLLLYFALIRFKPRW
RAHWRQYAIVGAFNVGLPFLMFSYAAQHIPASYSAIINATTPLFGTVFSVLWLGDSMTRT
KGVGLLLGLLGVATITGVGPPMAASASFVSAILACLAAAASYAGAGIYIKRCASHVNPLE
SAGCAQLFAAVALLPFWFVAPPQGQVDLNIALNVLGLGVLSSGLGFLLYFRLVRDIGPAR
AMMVAFLTPLFGIVWGVAFLGEALTPAVLLGAAMIIVSTLLILGSATRARPLAGKAGLP
>fig|742159.3.peg.3700 Permease of the drug/metabolite transporter (DMT) superfamily
MRLIPVALALFWGLNWPAVKIILSIFPPFTLRVLGLGSGAVLLLLLARAKRLALLPPRAA
WPGIVVGGVLAVAVFNLAVAWAQLSTSTSRAAVLTFTMPMMSALLAWLVLGERLDRRRAL
ALTLGAAGVAILAWPVLRAVFAQHDLAATKGLVFPLVAAFGWAAGTVYLKRWPVAGHRIV
VTAWQLAVGAACALAGVLIAGESFPTQGWNGRIVVALSFHIILGTAVAYWLWFVLSERVS
ATVAALTTLMVPVVGVLGAMALVGDRPAAADWWGFAFVLAGAALIVLNLGRARG
>fig|742159.3.peg.4101 Glyoxalase/bleomycin resistance protein/dioxygenase
MEDKSYRARLVPELMVRDLARSRQFWIDLCGFEIVYQREEEGFVFLDREGAQFMLEEIRG
DDGWITAPLEAPLGRGVNFEIKAKSVDALYERLLDAAWPMYRTMQQRWYRSGGIEIGVRQ
FLVQDPDGYLLRFSAWTGDRPA
>fig|742821.3.peg.271 Multiple antibiotic resistance (MarC)-related protein
MFSLIILMVCLFAGHIILGFFGISVGVLRCAGGIVLFAAGWNALNAPAQDGTSSPKMELP
RSRLKAMAFYPFTLPLTTGPGAIAVTVAIGTTLPYNFSNLAGTILAILAVVAVIWLCFRY
GDRVSRAVGAAGADALARIFAFILICLGVAVFWQGFTELWLNLGK
>fig|742821.3.peg.779 Bicyclomycin resistance protein
MAAAATEIHVFLVMRFFEGLGAAGAIVLSRSIAADRYTGRELGSFMGVMGAIQGIAPVTA
PMLGALIADAAGWRGIFWILFGMGVVLAFITLFVFVETLPRSRINSAQRSSNGTQRESIR
ESSAKLIADPVFCGIVFQQLLASGILFGHISSSPFIFRGHFDLSPELYGLTFGLLALGIT
AGAVISSRIDPLKALGVGAVGMLVCAVLVAVCFITNLSLWAVLPFYFLLMAFLGLTLPAA
MTAALTLHRQRAGFAAAVIGSVRFVGGGLVAPLTAIGEVTRTASIIFVVCGVLLVLISFW
LNRRMKLIRGDELKL
>fig|742821.3.peg.898 Acriflavin resistance protein
MNPRHTLTGQLAGGFIESKLTLVLMIAALIFGIWAVLSTPREENPQISMPAAAVQAVLPG
AEPDEMEAKVIRPLEAIINQIPGVDHYWSTAVDSAAVVVVQFKVGENKEESLVKLADRIV
GGRAELPADMLGPWVKSADVDDVPILAVSLVSEKYGDEGLRRIAWDVLDRLMGLEDISTV
DVIGGRDRELIVEIDPARLESFGLSFASVTAAVRAAGSAGPLGTTVTKGTEARVRLANAI
KSAADLKRLVVGFSPAGNPVHLEDVAKIRDGATQQAAASSRFGWGRASSQYESAAGGIVE
HPSVSLAIAKRKNANAVVVADEAIARIERMKGTVIPADVDVVVTRDDGAKANDAVNTLIE
HLAIAVIAVVTVTLVFLGWRAAVIVAVTVPLILAITLGVVGLSGFTINRLTLYALIIALG
LLVDDSIVVIENIVRHYGLSKLSGRQDRSNRAIEAAGEIGSATLLATITVMVVFASLIPA
LTGMPKQYFYPVGFTVPVALAASFLIAYTVAPWAARRWIPQPPIDSSSAGGRTLPGGRFG
KLYSIPARLLIGHPRREIVFVCATAFLCIAVFIMPFGQCLIPGGLNSPTPAWGVEMGFLP
KDNKNTFNVTIELPVGTPVEALDRAVRDTAAEVAKIPEVVNWQSWAGLSGVADFNSMMRM
TPAKGSEIGAVRVNLTDKNSGRRSSIEIARELRTALRSVSDAYPGSTIQVVEDPPGPPLR
GTIYAEIYANDPEELRWLADRTQKEFRKTYDVVEVTNTQKADQTEWRLSIDREKAVAAGV
LPAAAAFELKNLASGSIIGWAHADGERSPQPIRLEIPYAEEFDPTLLSGITIAGAAGVRV
PLSSIIKVEKTTAARRIEKKDGVRMAAVGGEMGSTTPTYAVLDLNNRLRGMALPEGGKLA
TGNLTWSDERPDLTQSPAVLLWQGEMRMMLDSYRDLAVSLCLSLGSIFLIFVAYYRSFAL
ALIALSAVPLCFIGLIPGHWLFGTQFSASSLVGVTALAGVVVRSSLLIIDFVLDYLKAGL
PLKDALIDAGAVRLRPILLTTLAIILGSVILIPDPVFGGLAITFIFGTTASTLFTIFLIP
ILLNVYFTRHPYRTSEEGAGMTAEAN
>fig|742821.3.peg.904 Modulator of drug activity B
MNFLIINAGCRINGQGGTLSAAMAELAERTLKHHGHCVVVTDLNEPYVVADEVKKILEAD
VLIFQTPGWWMTTPWQLIKYEDDVFVSPELCGGDGRTRSDPEKKYGSGGFLTNKRYVLST
TWNAPLEAFTDPHQFFEGKGLDGLFMPFHKTMQFLGLKAYPSFMVNDVFKHPTIEADFKR
WEAYLTEHFGQNA
>fig|742821.3.peg.905 Permease of the drug/metabolite transporter (DMT) superfamily
MSSSSSDTLFQLRQSAILLLTAMIWGATFVAQSLGMDSVGPFTFTTTRMLLGAFFLLPIV
LLRRKRLAAEKPAEAARRSAPQYRRTLLMGGILCGLCLFGGESLQQFGFVHDTEVGKSGF
ITALYIVFVPIISLFLGRRGSPLLWAAVALSLVGLWFLCIPPEGFTIAAGDLFVLACAVV
FSLHILVIGRYVLLVDAVELSMMQFFCGSILAFFAMLALESPTWIGWQTALPAMLWAGIM
SNGIAYTLQIVGQRGMNDTTSSLILSLESVFSVISGWLILNEVLSVREGLGCVLMAAAVV
LAQLPGNKK
>fig|742821.3.peg.1298 5-nitroimidazole antibiotic resistance protein
MRKISNALSKNRLESIRGEVKETLVMTISAQPQRPMRRRDRELPREEALRAARAAGHAVL
SFIHPDTGVPQGVPISPVVTPEGIVYWHSTNEASLKGEGLKKDPRASLTFIAYAEDLPEE
YTVDYASTVMTGRAHIVTDPQERRQAMLEICRRYAGADRDATSTEYFDHAGSQIDVWRFD
PEMVSGKSRSWTEKVSHILAKQGF
>fig|742821.3.peg.1506 Multiple antibiotic resistance (MarC)-related proteins
MEYSFWGGLMLMVLMADPLGNIPITISCMKNVPNKRRTFVLFRECMIAMGMLLLAMFFGR
PFLAAIGLSDAALSIGGSVIVMLMAIRMVFPTQEGVFGQTPGGEPYIVPIAIPAIAGPST
LATIMMLAASEPNRLFEWGAVVVITCVVSFFVLASADWLERHMGEKLTLAFERLTGLLLA
MMATQMFLGGVEAFLAKLPH
>fig|742821.3.peg.2169 Drug resistance transporter Bcr/CflA subfamily
MSLVKTPADDSKTAAAEDHEVAAATKSGRPTTKDAALLAFVSSIGPFAANAYVPAFDEIG
QHYGVGLVTVQQTLSIYLAAFACTSLLIGAASDAFGRKAVLALSMTVFAVSSLGLLFADS
MEAFFIWRFVMGMAAAAGPVVTQAIVRDRWSGGDAAKIIALIAVIFGLAPALAPVVGGEL
TVHLGWRSIFIFLAVLSAAMAFCSACVLKESLPSERRVSFRPWATLLRYGEVLKVPAFTS
GVVAHGFIFLGLIVYSAGAADFVLNVMGLGVDEFGWLMIPMVVAGMTGSWACAHLLAMFG
QNRLLFGGVGILAASGLFGVVFDHGPFAVFPWVLLAPVVYNLAAAAVRPALNVMNLDYFP
KSRGLAASVQQFFQTGAFAVSSALLIPIVLGEAWKYAAVMLGSGLIALVLLLVVRRTRPA
ALAAAEAEEQAEVELRVKPTKLS
>fig|742821.3.peg.2214 Permease of the drug/metabolite transporter (DMT) superfamily
MIPKALVGQSALLPFLALIAATGFWGSSFITVARTLESTDPFTLVFLRFGVGALLVALWL
RGRIFRIPLETWKMGAVCAVVIYASYLFNHIGLMTILSSTSGFLTALYVPITPFLFWAIA
GRRPELCAFAGAAVAFGGLVLLADPFNLEFSSSWGEWTTIFSAFLSALEIILMGRFAPHC
KAPEIAFAQIALVALFALAGTAVAHFCAPAVGWTLTPTALDLNLVFGVVWLAVILTCAQL
LLAWAQKYVPPAQAAVIFALESIFAAVIGWFAGERLGFLGLTGGLCIVLGILITEYPRIM
GKTR
>fig|742821.3.peg.2299 Permease of the drug/metabolite transporter (DMT) superfamily
MRSWSYHLLALFVVLCWGMTLVSSKVLLNFGMQPWALVELRSVLAYGILIFLAPMQLYSG
TMRGEITVALLGLTSIPLFFGLQTLALEHGVVSTTASLIAMGPLLSGLLAMAALRTWKLH
WMTFLGICTAATGTFLLYFDNAVLQDLPRLGFYLGLAAAAAYAVYSLVLRALADLPALFV
MRKSTGYGILGALPFYLNEQPTDAAILFEVPVAGANLVFLALAATVIGYTLWHKAEQEIG
ASGTRWYTYLSPAVGIIGGLWFLNEEMSYIGVMGVGMILCGVVCAQTGLVRVAAEMAKRW
>fig|742821.3.peg.2369 Permease of the drug/metabolite transporter (DMT) superfamily
MSAEDFAPKRYPFYFPRRPIDSISGASFFFVRVMPDSSRRPIDGYALITCLVLCIIWGLQ
QVAIKAAGSDVSPMLQVSVRSGVAALLLLITAKFVLHEKWNPKLRWRDGFLLALGFAGEF
FFVAEGLRFTSAAHMSVLLYTAPLFAAVGLAIKLPEERLTVIQWGGVLLAFLGIGAAFLL
PALMSHSPAAEGSELWWWGDILGLCSGISWGFTIIVMRVTTVSEAAPTQMLFWQLAGGFV
LLFPCALLTGQNHFEGTAIGWTSLLFQIFIVSFASYLVWCRLIKIYLAARLGILVFMTPI
FGVILSVLLLGESVGLPFVAGSLMVFCGIMVVQRPHFFQRRRSS
>fig|743718.4.peg.179 Antibiotic resistance transcriptional regulator, MerR family
MNRSIQDVARLAGVSSRTLRHYDQIGLLPPSGTGAGRLRYYDDAAIRRLQRILLLRDLGM
PLIDIATVLDEQTDEATALRRHLDQLRAEQDRLARQIASVERTVTALEEGDTIMAEDMLD
GFDHTQYKDEVVERWGADAYATSDAWWRGLGEEGRRAFMERSKTLAEDWAAAAASGIEPT
SDEAQGLAARHAEWLGSIPGTPGSEQGRPPKEYVVGLAEMYVADPRFSANYGGAEGAEFV
RDALVAYAERSL
>fig|743718.4.peg.196 Glyoxalase/bleomycin resistance protein/dioxygenase
MLGVTFDVPDASAAAAFWSRVLGDPVGYDAGGRAMLDGERPLLFQTVEGYSAPRWPDPAF
PQQLHLDLWTGTRSLDDAEALVLEAGASKLPGGGESFRVFADPAGHPFCLLG
>fig|743718.4.peg.1678 Drug exporter of the RND superfamily-like protein
MPREVHGPVVPPEHHGVHRERQRVRADQSIRLFTMNAGAAVTASSRYWSSGRTGVSRGAR
AGRVAVAFAARARSNRCSRSAPSSISAPAIASSTVSETPRRFPRSSRVKYSTLTPASRAT
SSRRSPGTRRRSPYVSTPASCGVTRARRVMRNSRTSARSSMRPRYVRTCGRRQVPAEPPG
TTSGRGLDKHERLLVQSQRGKNTTCRSCSVGGSWKGRPVIGRLVTRVPVVVLVVAGVVTV
VLGALAAGAVDALSLNRYEAPGSQSIAARAELAERFGTGSPNVALLVTATDGTVDDADVD
AAGAALTEELSRHPGVGDVWSYWSAGAPATLASEDRRHGMVLAWVPGDADHVRSDVLPDL
EQDVVAPADGGPVDVRLGGGDEVFRVVAEQARTDFLRAELVIVPLVGVLLWVVYRRLAPA
LLTLAVAVFSVIGTLGILRVVASFTEISTFAANIALVMGIGLGVDYCLFVTYRYREELAA
GMAVGAAVRRAVSQAGRTVAFSGATVAASLAVLFVFPFPFLSSFAYAGIAVVLTAVAGAV
VVLPAGLRLLGHRAARRHAAPPVDGGFWFRVATGVMRRPVASGGAALLLLVLLGAPALGV
TFGAPDDRVLPASQPVRAMYDTVREEFTTEDADVVHVVAPALEPSDPAVAEHAARLSAVE
GVERVDSAAGAFVDGARVAEAGPGGPDRYAADDGGTGTWFAVLPTGQRLAADPTGLVEDV
RALPSPAGDVLVGGYPAELADYRDGVVERLPLVGALIVLVTFLVLFLMTGSVVAPLKASA
LNLLSLTVMFGVLVWGFQDGGLAGVLGFTATGTIEPSIPLLMFCIAYGLSMDYEVFLLAR
IKADYDRTGDVVGSVPRGIARSAPLVTAAALILATSFAVYATSDVTFLQQLGIGMALAVL
VDATVIRGVLLPATMRLAGPLNWWAPGPLRRLHARIGLREGDDRPARATVAGTSHRDEVI
THA
>fig|743718.4.peg.2069 Glyoxalase/bleomycin resistance protein/dioxygenase
MDQRLSLVTLVVGDLTATRRFYVDGLGWEPLLEAPGEVLMFRVGEHLVLSLWDEGHAREE
IGPVGRDGTPPVTLAHNLASPSAIDQVLDDARRAGAPMVSDAVDRAWGGYSGYFADPDGF
RWEVAWAPGPLSEIVLPGEPGEH
>fig|743718.4.peg.2635 Glyoxalase/bleomycin resistance protein/dioxygenase
MARLNPYLSFRTEARDALEYYRSALGGEVQIDTYGSIPGMVDDPEEQHLVMHGQLETPHG
LCLMAADTPSVMEYVAPNRGVTVALTGGAEDHEYVATAYERLASDATVSVPFEKAPWGDY
FGQLTDKYGVSWMFDVGDPGAE
>fig|743720.3.peg.888 Permease of the drug/metabolite transporter (DMT) superfamily
MNKPSRQLAIAGVLMAVLCWAGNALVARAFAGEIPPFALAFWRWSLALVLILPFVALPLW
SHRAALRHAGWRLVVIAAFGIAGYNTFLYSAAQTTAAINITLVNTCIPLMTFIFAGLLLG
DWPARRAWWGMALAVSGLLVLICRGDWQTLAGMAFNRGDLIMLLAVLDWALYTVLLRRWS
KYLAPIPPLALLGIFMLLGVPMILPLYLYELSTGAQLLATPANLSAIAYTAVFASLVAYL
GWNNGVKVLGASTAAMGNYLMPVFTAILGWILLGEALQLFHWFGGAMIFAGLLLATLPKR
SQRAAA
>fig|743720.3.peg.1981 Drug resistance transporter EmrB/QacA subfamily
MQDLSLLQRRYGPRYPSYLLIVLMLGSMAMILASTSVNVALPAIMADFRIGRPLAQWLST
GFLASMTSGLLLSAWAQARFGARATAQGGLALFIVTSLLALVCDAAWQLITLRIIQGLCA
GIVQPLAMVLIFRVFAGGGRGAALGAYGLGVMIAPTLGPTVGGYLVDGFGWYAVFWLPLP
MCVLAMLAGLFLMPSERERRTPLLDLWAFLLLNVGLFATLGALAEAQRFPWGEPRVWGPG
LVGLLAVAGFLWRSRSSRQPLLPLALWRHAGFRKASWVALALGMGLYGTTYIIPLHVQAV
EGYSAGQAGLLLLPTGIVMGVASFMGGRLSDRLSTALLLVFGLLALVVSSAGLGWLEPGA
SFLVLCFWACIGRIGLGILLPALTTGALDALDREQVPHGAGAITFVRQLGGAFGVNLLTF
FLEWRHRQEGGDFAGEVAAFQQSFWLMGALFAVTILAAWNLRPSQR
>fig|743720.3.peg.2005 Glyoxalase/bleomycin resistance protein/dioxygenase
MFSYLSLGCSDLQRAARFYDAALAPLGLQRCTPGGDGWDDWIGWGTYLDDGREELALWLC
KPFNGEPPSIGNGSMIALRAHSWQAVRDFHQAALAHGGRCDGPPGLRLHYGADFFSAYVR
DPDGHKLAAVCRGFTADPALSHTPD
>fig|743720.3.peg.2041 Glyoxalase/bleomycin resistance protein/dioxygenase
MSTLQTTTPARLLYLHMGSKEPQRQIDFYKRMMDLQGERQADGSAVLLGPNRAVHISPAD
QSGLLAAAYRLASAQHLGELRQRLEQKCCPVADIDSPLLDAGAFSIRDPQGRETIFGTSS
TLQHADLPGMPGRLQHVVFQTTELEAVVDFYVNTVGFTISDNVVDAQSGQLMVCFLRSDD
EHHSLAFFRGSRNEWDHHCYETNEWNDIRDWGDRFAKEHINIFFGPGRHGPGNNLFFMVV
DADRNRLEFSAELQTTTSDTPPGQWPQCEHTLNSWGRAWIRT
>fig|743720.3.peg.2047 Fusaric acid resistance protein conserved region
MSGVLLQRTRQALAEARAPLLFSLHSTAAALLALALANAAGIHHPWWAAMTVWLVAQPTR
GLFIERSIARLTGSLVGALVGGVLLYFFFGWPNLLLCLLALWLALCAAVGNFFRHFRNYA
WVLAGYTAAIVALFGLADPVFDPELASGRVICTLLGILCCSCISWLFTAKAEPSVLLEER
LDALVNDCLRWCMSGPVQTENATDLNRILGAIKTLDGVLDFAAAGSRKGRQRVRHAHEVI
DALLVSVALVHSLHETHSTFLCDARFADERSEQENLEAFIGALQLHPSKYPQLLLALERL
QQLFANPSSRANWRERVLNHDWRAASTSAARPLSALIIAALAWRLSGWSEGAIMTMTAVL
FASLFSSHNDARMALKDVFIGSLLGASAGMVARLWLLPQVHSDWQLLACIAPFLLTGAAL
MARARTAKLAIDLNMTFLLTAQPGVQLPSDLPLVAQQTLAIVLGVLAAAASLLLWYPALA
AGRRLALARRIARQTRRATAPSQFAAAHGRARALLRSLVVSDGYASVLVSAALRCIAATA
PFVTDDSSPVPDSAQAAYNAEQAARTLARLTSKD
>fig|743720.3.peg.2394 Glyoxalase/bleomycin resistance protein/dioxygenase
MRPILTHLALHVPDLEACIAFYEDFCSMRVIHRRPGKGSQIVWMAEPGRESEFIFVIMPG
GEPRQLAPGDYSHFGFAVQSRDEVDAVVAKAEAAGCLLWAQRDEPYPVGYYCGVRDPAGH
QVEFSYGQPLGPGAKPINEI
>fig|743722.3.peg.81 Glyoxalase/bleomycin resistance protein/dioxygenase
MKVKRIVANIETDNIELAATFYGDVLGLQNVMNHGWIATYASSEESGTQVSFASQGGDGL
PVPYLSIEVDDLDQALTEITKHGFEIIYGPSHEPWGVRRFFVKDPFDNIINILSHE
>fig|743722.3.peg.273 Tetracycline resistance element mobilization regulatory protein rteC
MILEIANNLYRQLSDELVMIEQEEITDKLEIAKKLLTARSYLVELKNRTVKYTFSSEQEE
IAFFKTKKPTFISQVLYYSARQRIELTKPEGTADQLKKYYRYRLKGIEKFYRDNRELHSY
HRSGADHLDRLLFMRSSTEPPSWLCPVRIDYDERFSTPADYLIGKILSNERMTTYLRKLI
DGKDNVTDTEAGNDMVWTGESINLLETAYGWYCTGQINKGQAGIGEIVRKLETLFNVKIG
RPYRRFAEIKQRKRLSRTKYIDEMGKAIIQKLDDEDAYRPDIQNRRF
>fig|743722.3.peg.576 Permease of the drug/metabolite transporter (DMT) superfamily
MTKAKNTSTAAIIIAYLLIYIVWGSTYFFIHIALQGFTPFLLGAIRFTIAGTLLLIWCNK
MKEPIWNKQLLKTAAVTGILLLFIDMGLVMKAQQYLPSSLIAIVAASTAIWILLLDKKMW
KVNFRNWNTVVGVIVGFVGVILLFSEQLAASFTETGLSNKAIGMCLLILGTLSWASGSVY
SKYSVLPSGVTFANAAWQMLIAGILFWGAAFAHGDVQQFHMQATPISSWLAIGYLIIFGS
ILAFTSYIWLLKVRPATEVSTHAYVNPLVAVFLGSTFANEQVTLIQIIGLAIILCGVAMI
NFVKAKKGKQMKPLCPDQ
>fig|743722.3.peg.1881 Outer membrane component of tripartite multidrug resistance system
MRAEPLSLEKAWQLADLNSKKIQISEMDVQVSAARLQIAKDGRLPEVSIHGQYAYVFNMP
IYEDGLFHTPKQFPVDRKYYKAGAEAYLNLYNGGKTGREIMYAKKEQEIVEVEHHRTAAD
IHFSVAVHYYDVYRNQAYRTLLLHDIKEREKQLEEIKQLYANGTVLKSDVLRAELRLSKQ
RMLLVEINNSIKIAGQRLNVLIGKPDDTPVQLDVDTGGHAAFQLQSLQTYLDEAHAHAFN
GLLSGKAKELRALNLQQVKSNTSPKVGFFAEYGYGYPQIQFYPYSLALYGSGMAGIKLSI
PISGLYTNKHKVQEASLALKQQEIAYENAHDEIRQAVEEAYLRCTEAMKKIEVAKENIKQ
AAESYRIMRNTYFNQLSLLTDFLDAETQLLQSRFELSTAQANAQVQFYKLQRTIGNL
>fig|743722.3.peg.2865 Drug resistance transporter, Bcr/CflA family
MKLYNSKFEKISTISTFILIPLSGLVTDVYIPSFPEMQSVFQTSAAGIQLTLSCFLISYG
ITMFVAGSVVDSFGRYRIILGALLLFALSNFSIAYVHNLYFLYAIRVLQGILTALIVVAK
RAFLVDIYTGEKLKHYMGLLSVVWSLGPITAPFLGGYLQSYWGWTSNFIFLGVYALFSFT
LEYIFCGEAMRQAQAFRMPTIIASYRKVLGTKEFSLGLFVLAASYSMVLIFGMTAPFIIE
EQFHLSSVVTGYCALISGLGLFVGGMLAKQLTSRPLLMKLRIANFSECMIALLMFFVGTL
FTNLYVLMLFVFSMHVCAGFMYNVYFTFCLTRFPQNAGISSGITSGGSYLITSVLSYSTI
SLVKVSSQSTLAICYFAMAVVTFSLLQVLKKIRMSGAD
>fig|743722.3.peg.3922 Permease of the drug/metabolite transporter (DMT) superfamily
MYIKQLQYILAGLVFAVLWSSASIATKWGLQVSQPFVLAITRFCLAGGIMIFISHIMLKH
RLPHGNEWKQLFAYGILNIGVYLGLYVLAMQHVSAGLGSLFPATSPVFVSVISALVYKQR
ITAKILFSLSLCLIGIVVAAYPLLMKSYASPIGLFLLLLSMLSYSLGSIYFAKKNWQKLN
ILTINGWQTILGGLLLVPFMLFYYDRSLNTYNITFWSAVSWLAFVVSIGAVQIWLYLIRQ
DAVKASFWLFLCPISGFFIAWLLANEPIDAYTGLGVMLVIAGLALVLKRK
>fig|743722.3.peg.5159 Drug resistance transporter, Bcr/CflA family
MGPAIFFHGWTLRRIHLLRGILILIMFAAIAQFASFALIQGHVVAFYGVQAEDVSFAWLI
AYVGIATALPLQFKVAGSFSVRTYLLLSFLLSMTLNLGFTYTQNLWLFSVLRFFTGVTTC
LVVGRTLVLLFTTLPETKRVLIGTSFFFSLILIGGPLVSWGASWVVDRMDWTAFYYVLMG
LQLLAMAFVIAVFKGNTPQAKIPPADWLGAMLFAIAGGALAFAMIYGPRYYWLADPPIEI
AAVLVFIFTLLFIWRQRIISFPLIDLVVFKYRRFIFGLLLLIFFYGVKDSLNLIYGYAVS
VKGWSAQDIVEATTFNVVGIVLATIISVIAILQHKRNLIPLILVGFLVLFAYHLYFSTLI
SHDLSVANLSIPIFTHGFACGLLFVPISILCITALPPQNALTGIVICTYARFIASLNSIA
GFFTLQLVCNRKHTDVFIANLNFLNQQFVERRSFFDNFLLATGFSNADAGKISNTLLAKS
LATQAQLATIRSIFLLFTAMIGLMILFLFIYLLWSWKQRLVAQRVS
>fig|743722.3.peg.5424 Glyoxalase/bleomycin resistance protein/dioxygenase
MEKAEAFYKNTLGLQVTRAEMGVLELHLIDGHTIIIYPKKNYQPATFTVLNFVVEDIVST
VNQLSANGVHFLSYTGEIRTDERGIANADGTGPGPKIAWFADPAGNILSILEERV
>fig|744980.3.peg.607 Glyoxalase/bleomycin resistance protein/dioxygenase
MTIKRLEHVNVVTTKLNEMVAWYEAILGLTSGPRPNFPFCGAWLYTDEVPVIHLVENTQL
DRVGSEAALKLEHFAFSAKGSEEFERRLNEYGAPFQKIEIQETGLVQFHIADPDGNHLHV
DFVIDE
>fig|744980.3.peg.1693 Multiple antibiotic resistance protein MarC
MDTAFFLKMFAALFAIMNPIANLPVFLSLTSDRDAAGQRKVVVTLIIALVCGAALVGIGG
NAILNLFGISVDAFRLAGGFLILLIALNLIQGEQSKAHHGTEAEQAHHAEQDHPAIYPLT
VPILLGPGTISTMIIFRGQASTVEQDIAYVAAISCAIGLLAVTFFAAPFLGRVLGQTATS
VMSRLMGMILAAIAMSMMVESLKVLLPGLA
>fig|744980.3.peg.3967 Glyoxalase/bleomycin resistance protein/dioxygenase
MENIHKTKERAVCIFRTLLVSEGKLMPKIETITLRCLNPEAMRRFYIDILGMDQREDGAV
SYGPAQAGIIFEKAEYPYRHSAGDVYWKIALAVPNIELAYEQLTTQGLAVGVPHQFRDIG
YLAHFQDPEGFTIELIEHWFQGNRPSINHDPSRLGGGASLNLLTLRTHEINPIRDACLTW
GMRPLSVQSVESHGFTLHFFAFTEDTPPSADLTAVKNREWLYQRPYTVLEIQEVHGSAPM
TGIPVKTAGYSATRVTGVDVMIDCEALRITGQRA
>fig|744980.3.peg.4376 Bicyclomycin resistance protein
MKPEVYEVPKPVLTGKPSIVILIAISTVSPVAMNIYLPSLAGMKQAFDATAGQVQMTMSL
YFVAVAVAQLFLGPLSDRYGRRPIVLGGMASFVVGTVICLLAGSIETLIGGRIIQAIGGS
AGLILARAIVRDLYGRDQAASMIGYVTMGMTAGPMVGPAIGGLLDESFGWSGSFVLLLVL
GVIVLIASYLGLYETNKNRGDGEASFSFFKNYGVLLRERLFWAYGLTAMFTATVYFSYLG
GAPFVAADVLKISPSEMGIYFMIIAGGYLIGNFISGRFSERFGLMPMIVFGSLFPVVAVL
AMIAVLLSGEVTPIRFFAPMFLVGLGNGICLPSIIAGSVSVRPDMAGAASGLTASMQIGM
GAFASAGVAWALSESMWPATVWPLAAMMTGAVALTLAGVVAIFVLEKTERR
>fig|744980.3.peg.4559 Permease of the drug/metabolite transporter (DMT) superfamily
MSSTSIGLGGRLYGNAILLLILTTLFWAGNAVAGRLAIGEVSPMVIVTLRWWIVAVVMGL
FLWPRIRAEWPMMKPYFGRMILMAGFGFIAFNSLFYIAAYTTTAVNIGIIQGSVPIFVLI
GAMLFFQTRTTLAQVIGIFITLVGVALVASKGNLEILLSLSVNPGDGIMLLACLLYSGYT
LALRQRPQVSGLVFFAVLSMIAAVTSLPALWFEIATNTAQWPTFNGWMVVLYISLFPSCL
AQIFFMRGVELIGPARAGVFVNLVPIFAPILAVLVLGEPFRWHHGVALALVLGGIYLSER
KGSKS
>fig|746697.3.peg.782 Outer membrane component of tripartite multidrug resistance system
MTVQELAESVQANNIQLKLAKSSVDVSDATIGEVKVNRLPDIGTDVSAFYLSDVSIYDTG
FNKLQKVDIPNFGNQFNVNVSQLIFAGGKINKSIELAEMSKTLSENQLGDTEQGIKLSAT
ELYLNLYNLQNQKTILKNNRDLATERTKNTEYFYEQDMITKNEMLRAQVLERQLEQSILQ
VENAILITNKNLTLLAGLDENILIIPTIDNINHQIRKQDETFYREIAFQKNPQLTASDTQ
IAIAEKNLELTRTDRSPILAGFAGYNASRPQTSGTPADLYSNTYQVGLSLSYNIETLFKN
PKKEAVDKVLIDQATLAKEAVRQRIEGDVNAAFKNYNLAIAQLEVSSVNQSAADENYRIT
ELKYKNQLVTYIEIIDAANTKLQAELQMLDDQTDIILNYVRLLRVTGQL
>fig|746697.3.peg.783 Membrane fusion component of tripartite multidrug resistance system
MATSESKSETAPESTPESAPKATPKAKKKNKLYLTLLNAFVFIITLLVIWFVVKNYLHIN
DDTYVSDAQVKAYISPVNSRVPGYIDEIYFTEHQSVKKGDTLLTLDKTDFLNAIAQAEAG
LSQAIAGKASVKTSIARVGSSEGTVAANMLGVKAQLNNSQADLARYKNLLANDAVTLQQY
QQIETQVKTLQSQYNALSKQKNTAQLSTNETESQLAVSDAQIKAAEAGLERAKLNLNYTV
ITAPEDGIMGRRTITAGQYIQPGQQIAALVQNNKKWIEAICWKRNYH
>fig|746697.3.peg.785 Major facilitator superfamily (MFS) drug efflux pump, EmrB/QacA subfamily
MLVLILVFLIPILVVNGVYTGNISYMVGSLGTHNEWIVFANYAGVVGMGVSLPLIFRYKL
RFYTKFLMVRTLLFLAIASFMIGTTDNVIVIVSSTFFIGFLKMFALIELIMPTMFMISPD
GNRPKFYSIFYPSAIVFPQLAGYLMVRFGFSTYWQNANFIMAIIMLSLAGLALIFMHNQR
YDKKVSLKGIDWTGLFLFTNVFLALAYFISFAKQQNYFRSDNIMLAVGIMVLGSVLYAIN
QRLKENPFIHFGFLKNYSVIHGIMMLLMLGFFLAGGSLQSKITMGILGFDSVMDNSFNLW
MIPGLLIAIVFSMKWLVNNKSLKIYILTGFTAFILYYVLMYFLVSRGLSYEQLIIPNIIR
GFGMAVLFIGVWLYALGDLKPDAMLGAAAVMIIVRTMIGPGLWSLGFNYIDSIWSLEALT
NMAGKMDASAYSQQTAMGLYKTINLDSLMISTKRLYGLLVMLGGAVLVYVSFLNLDGLSK
RSVILLRKRLKGQTTKGYVREVALQEEEELQEEIKAASAVAV
>fig|746697.3.peg.1993 Drug resistance transporter, EmrB/QacA family
MQEKPVKEMRRNWVLFALMITMMLAAMDNTIVATAIPQIVGDLGGFSLFSWLFSIYLLIQ
TITIPVYGKLADIYGRKPILIIGIIIFLIGSAACAGAWNMHSLIFFRGLQAVGAGAIMAT
VNTVAGDIYTIKERAKIQGWLSSVWGISAIMGPAVGGALADYASWRWIFLINIPIGLGAI
ALIVLFLHENKSHKGHKIDWAGAVAMLVTGTVIMFGLLQGGQSWPWFSLNTLGIIALSVV
LIMITIRIERKSAEPILPRWVWKKRVILGANLATIGMGIMTMGPNMFLPVFAQSVTGVGA
IAAGFILASMSITWPLSSALSGNLYLRIGFRNTAICGIIIVIIGAASFLFLPFPGPVWYL
VAVQMTLGAGFGLITTPLLVGIQSTVEWGQRGVVTGTSMFSRYFGQSIGAAVFAAVFNSS
LTDSMENAPARLQSELPSVNKVVEVLQSHKSVSDVSLYLRESFFAATHNVYLGMVIAGLV
TLVILLLTPAKFPSIEEVR
>fig|749219.3.peg.107 Acriflavin resistance protein
MSDTKLSWFVDDTITKQLSNIAGVGSVSRIGGVERQILIQPKMDMMTSLSMPINQLARQI
YAKWQDASGGEAKIGNQIQTIRILGSGQRV
>fig|749222.3.peg.812 Permease of the drug/metabolite transporter (DMT) superfamily
MLSRRLTGHLFTFITVAIWSVAFVGNKVLLAYLTPIEIMLYRFTLAWGLLLILYPKDLLP
RSLRDEAYFFLLGFLGIFVYFLLENFALRYTQASNVGLYMGAIPILTALLAHFLIRGERF
RPALLLGFLIAVTGMGLILFTERHFTLRLRGDLLALAGAATFALYSVALKRAPEGYHFLQ
IARKSFFYGIGLMLLYLLLTGEATHIQALREPTVWGNLIFLGFFSSGLAFVLWQQGIERI
DPVAAGNYIYLVPLLTALTGVFVLSEEITAAMLLGGALILGGLYVAQRGSKAAE
>fig|749927.5.peg.112 Glyoxalase/bleomycin resistance protein/dioxygenase
MPEPFDALRRPSERVAPDPDFAAELRDDLRRAILNGADMTTTAVPATAASLRSLTPYLAV
SDARAALDFYVEVFGAVRRGDPILMDDGRVGHAELAIGDAVLMLAEEYPEIGHVAPREGG
ASVRVEVPDVDGSVARALELGATLIRAVSDSPYGRGGSFRDPFGQRWLVSQAATAAAGPR
PARHGEAMYFTFQVPEASPAKAFYGAVLGWQFTPGSTTDSWGFSGPGLEGGLWAGDRQVG
WKLMYAVDDLESAMARVREQGGRAGEVEHHPYGNTADCTDNQGIEFWLWEKPGQ
>fig|749927.5.peg.144 Drug resistance transporter EmrB/QacA subfamily
MTTAVRPDAALWRLGGVLIMGAVLSILDATIVTVGIGSIAHDLDSPLTTVQWVASAYLLA
ASAAIPLSGWLTDRFGGRAVWLAAVAIFTAGTLLCGFAWSAPALIAFRVLHGLGGGLMQP
VGQAVFAQAAGPALGRMIGVITLPATVAPVLGPMLGGALVAGLGWRWMFFGIVPLGVATF
LCARRLLPAPAPGGVPAALDVRGLALLSPGLGAFVYGLAEGVVVAWVAGAALLLAYGVHA
SRVASPVLELALFRNKGFAVASASTFLLGASLYSSMLLLPLYYEQVEQASALRAGLLLAP
QALGSAAVMLASGRLLARFGPRRTMLAGIALSLLGTIAFTQLGSAPGGALLTLSLLIRGA
GLGAATAPGMTTLYGSLERSHIPRAASAFNVVNRIGGSLGTALLAAILHSELTAAPAPAA
FGTTFTWALALSALTLIPALFFPQRSTR
>fig|749927.5.peg.684 Tetracycline resistance protein
MGTSTVTGRTRSMGALFAGVALLNTATVGLGTAATLIVAAGSGAVWSGLPSVANVLGTAA
GALGAGRLLPVHGSRRVLAGGYGLAAAGALVAFAGALATSVVPLLLGILLVGLGNGGAQL
SRYLAADLYPQDRRGRALSTVVWGGTVGALAGPALMVPAAGAAAGFGWPSLSGPAAVAVL
ATAGAALAAAFLPRHVPPPRQPGLRPGPGAPPPEPPKSPPREPAVAARGPVRPAGFVRPL
VAMVLAQLTMSAVMTMTPVQLQAHGHDLGVVGWVLSAHLFGMFALAPLSGRIADRWGPHV
AVNAGLGVLALAAATALAAPTAHTSGLPIALFLLGYGWNLVFVGGSAQLSRDLAPETRSR
VQGTVDAVVWSASALAGLGSGALFAGGGYGLVAVVGGVLAVLPLAFSAARDGR
>fig|749927.5.peg.2402 Permease of the drug/metabolite transporter (DMT) superfamily
MSLPTRARSSAALVLAGVLWGTGGLAGSLLGGLSGLHPLAVADYRLLVGGGVATLFVLLT
GGTFPRTPGAVRRTLAVGGLFALFQASYFAAVALSSVSVATMTTIGAAPVFVTLASVRKL
RRWTVVSVAGTLAGLVLLQWSPGEAISFGGLGCALLAATGFAALTLLTAKPVEGLEPLST
TAFGCLTGGLLLVPVASWSGMAIPLHADVLALVCYLGAVPTALAYAAYLRGLADAHPVLG
SLSAVLEPLTAAVLSAALLGERLGVTAWCGAAVLVAALVVGYWRPEPR
>fig|749927.5.peg.2833 Glyoxalase/bleomycin resistance protein/dioxygenase
MSDIHRAVEFYEGKLGLRALQSGPSAHVAGGSRTYGSGGGPALNVYQSVTAGKSPATLAT
WYVDDLDEIVDELTSTGVEFTRYDQLEHDAKGITARAGGGRIAWFQDPDGNTFAIEADV
>fig|749927.5.peg.7704 Glyoxalase/bleomycin resistance protein/dioxygenase
MAIRLGSTVINCTDLETMTRFWCAALGLEPASEADDFRLLRGPHVNLSLQRSPVSARDQM
HLDLYTDDQEHEVDRLIGLGARFVRHVDDDPADDWVILADPEENLFCVCAKPADEVRDPG
AGSAA
>fig|749927.5.peg.8242 Glyoxalase/bleomycin resistance protein/dioxygenase
MVGVEDQARAKEFWSAVVGFAVTTDVPYDDQGRRWVEVTAPDGTILVLSENPEDRPRSTG
DQLPTSNFFLYADDVEKTYEELSAKGVEFPAKPEKQPWGWWSMFTDSEGNRFALQQRG
>fig|749927.5.peg.8244 Glyoxalase/bleomycin resistance protein/dioxygenase
MSRPLGLVPHLFVRDVDVALSFYTKAFGAVELFRTVLPDGTVLFVELAVGDARLLVSQEI
AALDALAPSTIGGIPMLLTLETADPDDLARRAVFAGATVEAPVAEMFFGERYGRVVDPDG
HRWALTTKREQYTPEDIDARKPHNAAFGGPGGGAPGSGRSPGPH
>fig|749927.5.peg.8460 Ribosome protection-type tetracycline resistance related proteins
MPEPSLNIGILAHVDAGKTSLTERLLFDTGAVGALGRVDDGSTQTDTLDIERRRGITIST
GVVSFRAGDRTVNVIDTPGHADFVAEVERALGVLDGVVLVVSGPAGVQASTRILWRILRR
LRVPTLVFVNKLDQAGADPAAVLESLRKKLSRALVPMVTVDAAGSAAITIRDRPRSADDL
FRRQVAAGEAYPVFLGSAVTGAGVPELVAGIVDFLPTAVPGAELRATVFKVERGRGGDRI
AYARVHGGTLRVRDRVELFRRTGDGTVERSRRRITAMTLAGAKVTRADAGDLIRLSGLGD
VRVDDRLGSPDGVADAGLFPPPGLVSVVKAQPGEETRLHRALRELCDQDPLLGLRADRGT
LSVRTYGEVQIEVLLERLREDFGLVAGFAPPAPIHVEKPVGVGEAVQFLDRLGPTDPVAT
VGLRVAPGRTGSGVRYELAVERGSLPRAFHTAIEQTVYRTAACGPHGWEVTDCVVTLTHS
GFQPPLSTAGGFREVTARLLSLAFARARTRVYEPVDRFDLEVPEHAAGAAVIALAKLEAV
VEPPVVEAGVARLSGSVPAAATAAFRRRLPALGQGEAVFTAEPGGYRPLRP
>fig|749927.5.peg.9541 COG4767: Glycopeptide antibiotics resistance protein
MTNAQLTALQYGFIAFLALWAVVLVPQLITQLARHGGLRLRGLATTAAVLLYGCMTLAVV
LLPLPGPGSRRLGQTVQLHPFQWIADIHTELLKHGGQWFMTQTFQQACLNVLLFVPLGVF
ARILWRRGLTGTALIGFTASLLIEFMQLTANFGTAPFVYRIFDVDDLMNNTFGAVAGWVF
GALLLTLRRSPVDVQPARSERVHFAETR
>fig|749927.5.peg.9549 Vancomycin B-type resistance protein VanW
MTVAGIEVGGLSHAEAEAKLRRELEPRLIRPVVVHGGDVQAELVPSQSGLGLDWPNTLGL
AGHQPLSPITRIMSFFSSREVGVATHTDQNRIGQAVQELAEGKLNHPATEGTVGFTPIPG
SDGGVTAHPVLPRQGQQLTDLAGAVHTVTDHWLDPGGVKLAMAITPVRATAAGVQAACQQ
IVVPAVAKPVVVHGEGKDVPLKPATIASSFQFAVVEGGAVEVRIDQGKLQGALKDPLAST
ETDGKDAQIVFTGDQPTVEPSEEARKINWEKTFLPLIDVLKKTEGRDLPVVYSTAAPGVT
TDAASALGIKEVIGEFTTGGLTGPAATNNRTLAARVSGAIVKPGETFSLGVRSGPRTADA
GYVPAPVDEDGTGPSVVGGGVSQLASTLYNAAYLAGLADAGHLEHDHYLDRYPAGRDAKA
VNADGSPVELKLTNDTTTGIAVQATVSGDSVTVRIWGTRHFRVEGQTGAQTPGDPPPIQF
GSGAAGSCQPSIGSSGFSVTDTRVLYDLASGTELRRTSHTATYGPRPTVLC
>fig|754252.3.peg.1532 Permease of the drug/metabolite transporter (DMT) superfamily
MSSAPEHPAARRLSSLPAASALLLIAMLWGSSYFMNKALVGMMPPGDITAVRFTMSAIVL
ALVAPRALRMSRRTLLQGIAMGTAYGIAQLFLMFGIVHTSASVSGFLTGMYAVFTAVMVA
LILRRNPPPRVWISVGLATAALGVLTLAPGATGGLGLGELLSIAAAVGFAAHIVLTDMFI
DQRRVMSLAIVQTATVAVWSLAVAAPGGITMPHGTVQWGALIYLGVLCGALTLFLQAWGQ
ARMEASRAAVIMSSEPLWAAVFAVLAGQEALSVRTVVGGTLMMGAIWLAVRIPPLRRRTD
PPPTAAS
>fig|754252.3.peg.1983 MCBG protein-like (microcin resistance protein)
MLITEADLQDCHFEAVNLEGATLKSSALEDCDFHECNLANAQLVGTVFTRCRFVDCKLVG
ADWSRAGLSLLPPVTITFERCILDYASLSRVNFSRARFIDCSMRDTDFTDANLSKATLGN
CELTGARFHGRTCARPTCVARADTSSIPATTRPAA
>fig|755732.3.peg.95 Glyoxalase/bleomycin resistance protein/dioxygenase
MGKAIGIGGIFFKFKDEKAMRNWYKEALSLNPNDYGVLFAFNGNSNPRGYLQLGTFPENS
DYFGDGNQQAMINFRVEGIESLLVHLQTMGTVICDNIETYEYGKFVHILDPEGNRIELWE
PVDTSFDEGTRQEMR
>fig|755732.3.peg.303 Multiple antibiotic resistance (MarC)-like protein
MSGIQSFIDMLFIGVITLFPVVNPIGSAFIVNPYLSNLEIQEKRKAVKKIALYAFILCTI
ALFAGHWILEIFGITIPVVQLAGGIMICKIGWEFLSSDKKEEKTLIDESGESPNSNYTLI
QDKLFYPITFPITTGAGSISVLFTLSAHSANAHINMYLINTGAILSAIVVICLLIYFFYL
NTKKIIRVIGKEGEQILNRIMAFLIFCVGLQIGITGIKSLIIA
>fig|755732.3.peg.1539 Glyoxalase/bleomycin resistance protein/dioxygenase
MNLNQLTVPSLDIPKSIAFYQTLGLKLIVKSDHYARFECPDGTSTFSVHLTEKLPTGTGI
SVYFECAELDEKVDDLIQKGVAFDELPNDKSWLWREAYLKDPDGNQLILFFAGENRLNPP
WKIN
>fig|755732.3.peg.1787 Drug resistance transporter, EmrB/QacA subfamily
MVITAISCAILELLDTTIVNVSLREISGNVGATTTEIAWVVTAYAISNVIIIPLTSMLSD
FFGRKNYFTGSVVIFTVASLMCGLSTDLWTLVFWRFVQGLGGGGLLSTAQSIIIGAFPPE
KISTANAIFGMGLILGPTFGPTLGGYITDNFSWHWIFFVNIPIGITATILSYRYVTDRVG
AVKPRRIDWWGILFLVVSIGSIQYVLEEGTAEDWFESHEITAMTIIAVASLTAFIIRELK
IDYPAVNIRLYKNYNMIMGSIMNFLLGLMLFGTVFIFPLFVQISLGWTATQTGMFMIPGA
LCTAVAMPLVGRLLGGGVNPKTVILFGVGMTFTFVMMLAFSSPDSSEGNFYLPFVLRGFG
MAFMMSPILSLAVQGLNPKDMPQAIGLANMIRQLGGSVGIALINVYLTNTNALVRGNMIG
YINQYSDAASERIQMFTQNFLSKGYDSVQAAEMANRTMDGLMTKQQMLVSYNHGFFMVAC
LILICVPVVFLIRYKKGTKAVVADGH
>fig|755732.3.peg.2598 Glyoxalase/bleomycin resistance protein/dioxygenase
MTKEIWLNLPVKDVEASRNFFTAIGFTAKLEQSAPEERACIQAGKSIIMLFPDAILKQFN
GGLEKNDTSKTAQILISFDAETREEIDELAQKVKKAGGNVFSEPSEIQGWMYGFTFADLD
GHRWNGLHMDLSKTD
>fig|755732.3.peg.2765 Glyoxalase/bleomycin resistance protein/dioxygenase
MTKIICGIQQMGIGVPDVQSIWKWYREHFGVDVRIFEEAAEAPLMTRYTGGVIHSRTATL
ALSMESGGGFEIWQFTSRPTEKSTSPILLGDFGLYACRIKSKDVKVTYDFLVKKGAKVLS
EPQELPNGSLHFLVEDPNGNLFDIVEGSGWFMDTKFEGKTGGVAGSMIGVSSIEKALPLY
QKILGYDQIVYDTTETFEAFNNVPNGNQKVRRVLLQHSEARKGPFAKLLGPTQIELIQAV
ERTDSKSIFKDRFWGDWGFIHLCFDVQGMDDLQKECEELGFPFTVDSGKTFDMGEAGGRF
SYIEDPDGTWIEFVETHKVPVMKKLGWYIHLKNKKPGAFLPNWMLKAMRFNRVKN
>fig|755732.3.peg.3794 Acriflavin resistance protein
MIVVIFAVLGFLGIISYSKLNYELMPKFSIPVVTVTTAYPGASPSEVENSVTKKIEDALS
GVENLDDIQSTSMEGISSIVLMLKNDADPDKALQEAQRKINAMLSTLPEEILSPSLGKFS
FDEAPIMNVGVTANMPPTELYSLIKDEISPSLAKMEGMAQVTMVGGEEREIKVQVNREAC
SNYGISILQITNAIRSANLELPTGKIKSDDSQALVRLRGKYKDLSELNNLVILSDPKTGS
PVRLNEVATVSDASKEIKTFNRINGTNSLGLLIQKQTDANAVSLSKKVRAEFKELEIQYK
KQGMKFEVASDSSDFTIAAADAVVVDLGLAIFIVALVMLLFLHSVRNAFIIMISIPASLI
SVFIAMYLLGFTMNLMTLLAISLVVGILVDDSIVVLENIYRHLEMGKERKKAALEGRNEI
GFTAMGITLVDVVVFLPLTMVGGLISNLLSQFSLVIVISTLMSLFVSFTLTPLLASRFAK
ETKLNNKTLGGRIVMAFEGVLKRITTSYGRTLTVALRRKRYIVIAAFLGIIGIPVLLGPY
IGGEFVSAGDRGEFVISLELPQDATIQQTNTTVQRVEDYLFHDKRVINVFTSVGTASGNM
GSSSNANNKAQLTVKIVDKEKRDKSAAIIAQLMKQDIEHMLPDVKVNSAAVGIMGGADDA
PIQIGISGNNMDSNYVAANKVMAKLKSIKGTAEVKVSVETGNPEVTVNIDRDKMAELGLT
MSTVGSTLQMSFNGDDNSKYTEGGKDFDILVNYDDFDRKSTQDVKEVYFINDRGEEIKLS
QFATIGKASGPSKLERKNRVPSITVTSQALGTSSQQVTTEFAQMMEKDPLPSNTAYTFEG
DAKNMAEAFGNLLLAILASILFVYLIMVALYDSYVYPFVVLFSIPLAIIGALLALALAME
PISIFSMLGMIMLIGLVAKNAILIVDFTNQKKADGHNTVEALIIAGQARLRPILMTTLAM
VFGMMPIAFAHGAGAEWKSGLAWVLIGGLTSSMLLTLIIVPCVYLIFDIFKREISNKKAK
ALLKEVDVVALGHEYDHK
>fig|756067.3.peg.681 Glyoxalase/bleomycin resistance protein/dioxygenase
MIGYVTLGTNDIETAAKFYDALLAEIGARRFMEFDQFIAWGVSIEQPGLAITKPFDGNTA
TVGNGVMIALQVDSPEKVNLVYNKAIELGAKDEGPAGPRGVLPGFYAGYFRDLDGNKLNV
FCMMAPNI
>fig|756067.3.peg.6258 Glyoxalase/bleomycin resistance protein/dioxygenase
MIDIGLTHIALPVSDVDRTIEFYSKYAGMQVVHRRIDAETGVTVVWLSDRTRPFVIVLIQ
TDSVHPVLSPFAHLGVGCKSREYMDSLCDKARQEGVLLEEPKDSGYPIGYWAFLRDPDGH
TRELSYGQEIGFTVEDAS
>fig|756272.5.peg.881 Multidrug resistance protein 12 (P-glycoprotein 14)
MTAFSTESQQTWQRLFPTQAWWKTSAWKLVILAVLAGLLLAIMFLISLMVVDLFDNNGRL
VLTSEELPVAGDLFGESLGVTTPTVTTNLSETIVLEDRGILATLWHFRDRLWTRPLIQLY
QQMPALQQNSSALVVLLLAGAVVGLLRGLTLSGCRLISARVGIRSADQFRRSLHRQAMRL
GPGDLLDEKVNEAYKLFVNDTAVIRDGVSAYVYRLGLHPITLTVLTLLAVITSPRLFMQM
LFPLLGCWLLVERERTRNTQAKRLAEAEAEHRTNVLAESLLKTRLIRGYSMEPFESEQFT
RHLEQSSKATITFRKRDVFSRWLCWLLVLGCVLVIVLLMGIKVLLPLDHSQHLQLSEITL
LSLCFGFAYRPLAKLRQFRSLYKETALATERIERYLKHIPEVGQAVGAKFLDPLAKAITF
ENVTYAANGKKLLDQLELKIPAGGMTVIASANPLEARAMLYMLPRFLEPQNGRVLIDGED
IAWVTFESLRAETLYVGGPDPFFTGSVLDNITCGDDKYVLSDAIAAAKRVHAHNFIQRLP
NGYETRLGEHGEQLDASEAYRLGLARAILRNPTLLILEEPENIESEEAKSMIDDAHDQVA
QGRSVIIIPSRMHTIRKSDRIVLLYQGKVATMNSHSNLLSGNELYRHWEYTKFNVFRHMS
GS
>fig|756272.5.peg.2491 Acriflavin resistance protein
MSLPRFSVNNSVLVNMLMLVLLFAGTAMAFTLVREMFPETRADQVRISVMYPAVQPDELE
KAVTIKIEEAIRDLEEIEKVDSTVQEGMSTTVATLYNEVDDIDNVREKIDTEISAINNEL
PDDIESITIRNVEPLLPVLSVSLYGEGSEASLKQAARDLRDELLELPGVSDITVGGIRDD
EISVEVRPEKLFEYDLTFSEIAQAIRATNLDVSAGSLKGPRSNVNVRTLGEEIEGDELGD
IEIKTTPDGTKIFLRDVATIRDEFVDVDLESYFDGKPSVTLVVQKTETQDAIQIANLVKA
FVNGKQQVEFDAYGLTAASEQSWYSRPFAIALAYFSKGVNSLAGRPDPQAIYDASYANPF
RHNFEIAMHGDLSRFIRGRLDLMTRNGMSGLVLVCASLLLFLNWRVAFWAGMGLPISFMG
TFLVMWLLGVSINLLSMFGLIIVLGIIVDDAIVIGENIFRHVEEGEEAEEAAVNGAEEVM
WPVTVAVMTTIAGFAPLLFIKGRIGDFMRELPIVVLAALSVSLVEALVILPAHLKHLKKP
KQKAEPTTAWGRRWKVVSNFQHHIMEDVLNVIYEKFLRACMRWRYVTIAAAFSMVLVSLS
MVAGGIVPFVFIQKMDSETITADVELPIGTVLDTTRDKLVDISRFVADIPEVTSVQTSVG
SQINLGGTGATGGNAQSHLGQVIVELMEADQREREGMRSSEELLAEFRKRTETMSGINSI
KWEAMNGGPAGKDIEIRITGNDFDELLQVSNEMKAELASYDGVVDLDDDYDIGKREVQLR
LLPSARPTGITVSDLGNFVRFALYGVEARRITRNREDVKIMVRLPEEYRAEVYNLEALRI
PRPNAPINSAGEVNEETFRWVPISEVAELTEARSYTSIHRAQQRRSISIFGDVQSETNNA
NDVMRQFQTTFVPELLAKHPGIHVDFEGTTEEQQKSFSSLALALPAAFLLIYMLLAGLFR
SYFQPLVVMSAIPFGLLGAVIGHYITDNPITILSCIGFLALSGILVNDSLVLVDFINTRL
RRGVDPFEANVLGAKLRLRAILLTTLTTAAGLTPLMFETSFQAKFLIPMAVTLTYGLIFA
TGLTLIIVPCLNMIFLDMLHAFERFAESLGLSRREESTTQPAEATG
>fig|756272.5.peg.3142 Probable multidrug resistance efflux pump
MNIIRIGQEAIRLAAPVIILGAGVIGFAGLASMRQPPESRETEATRPLVEVAPVTIAAAE
LDIVTDGRVVPFREVRLSAEVSGRITRKTDACRAGRYVTAGTPLLEIDERTYQLAVERLR
EEVEQAQNSLDELEVELQNNDALIALLQEDLQLKKRELDRMNKLFSRGVLNESEVDEYRA
KELSARNALTLQQNNRRKADSSRDRLRNSLDLARTRLAEAELELQKSKIVAPIDGVVVTE
SVEEGNYVSAGTELVTIDDTSAAEVRTTLRMDELNWVWQQGRSSGNTESPSIEQDYQLTS
TPATISYRLAGQDYSWKGELWRYEGIGLNEKTRTVPVRILVSEPRDVRAERGEGLSVLAG
PKALVRGMYVEVTLHTRPNVGFLSLPDEAVQPGNVVWVINGDTLRRVNLRNVRFQGDRVL
VPEGGNELAVGDEVVVTPLQLAAEGMAVDVQREMNAVNDQNTSEGQQG
>fig|757424.7.peg.2417 Outer membrane component of tripartite multidrug resistance system
MMNLPVSLMRKWLAWMLLATQAGCLVGPDFVAPTPPRVSQYTRDPVLLDRMSEPDMSQQL
LMGENPPARWWQLFGSPELDAAVTQALTRNPTLQAAVSNLLLAEDNLRAGGAVFYPRLDA
NMMAERTRSASLVQGSSAPDKVFSVATLSGAVSYAIDLFGEKRRTLEQLEAMVDVQQQLH
HAAYLTLTANVVNAYIARAGYLSQISLVRQIIALEELQLEAIQARVDTGVAPLADLLSQA
SLLAGNQALLAQLTQRLYQIEHLLAQLQGEFPAQASLPELVLADLHLPSDIPVSLPSALV
RRRPDILAAEARMHAASAAIGMSSAAQYPSLELTATYGVAARNLSQLTGPATSLWSFGPS
LSTPLFNGGRLRAQRDAAVNAFEASQSEYQQTVLTAFEQVADALRALQADGHIVSAQSAA
ARYAYDTLLLQRASYSAGLSSYADMLLYEVQYRSAAIASLQATVQRYQDTVALLVASGGG
WLDTAAQRR
>fig|757424.7.peg.2754 Outer membrane component of tripartite multidrug resistance system
MNRINSSAFRLRAIAAVAALAGVLGLSGCASFAGIGSDRQVAQAGDFATQRSLSDPNPGA
PNGQWPGSDWVRQFGDAQLVALVEQALTSSPSLQQARARIAAASALAESRGAPLLPSVNA
EASVTRNQFSSTTIYPPPYGGNWYNEKKAGLNVGYELDLWNKNQAALAQAISSEKAAQAS
EQEARLALTASIVTVYSQLAAQYALHDILQSTVDQRTSLEKITAERLRTGLDSQIERDQS
RTSSADARAQLAQSEGQIVLLRQQLGALAGKGPDYGLQLAPPALQGLATPGLPAELPLNL
MGRRPDIVAARWQVEAASRGVDVAKARFYPDINLSAMIGFDTLLDSNPFTAASKSIAFGP
AITLPIFEGGALRAGLKGEYASYELAVATYNKTLNDAYADVARQIAAIHATERQLPIRSE
ALQAAERAYALARERYRLGLVSQLTLLSAQTGVLAQRQAMVALQAQRRDQQVALYKALGG
GFDAQRDGLAYGAQP
>fig|757424.7.peg.3992 Glyoxalase/bleomycin resistance protein/dioxygenase
MSATATPAASAASVIKPRIRRTHLALFVKDPHGSAPWYEDVLGMTVTARAERWVFLSFGK
KHHDIALIRVEEPSQAVRGEVNMQHYGLEVEGDMEEFRRLYGMLLAKGIEIFKITDHKVG
YGIYFHDPDGHRFEFFFETAHDDEEGKRLLGQYNAPSDSFHLDPL
>fig|757424.7.peg.4181 Permease of the drug/metabolite transporter (DMT) superfamily
MWRKRTGGDEGWRGHVCHPQSASRLVNRREYPCEEDGRAGELLLQRSSNAKISRQKVQSP
LLRALSSIYRGTTGCPENPCLYASKYSTLRFALSTHMQKHFSTPRLAALDSFFVTTSHRD
ALGCYAWNQAVSAGFLPLLADVEVSLRNALHRALSQYFHAVDSSDWMMPRPNPAHGINPA
APVQLPPVHKLTPKAREDVVSAMGKIKARKPAGYLVSPDDVVAALPFGFWEVLIAGLAHR
SQPPGLQAAILAAAFPYAADTATTPYGSQDFRMRLVKLLKRIRDIRNRIGHHEALWSTPE
FNVFGVLGHIPRRPRHTVNSLRKFAEKLSWFGGWIDPGISAYMQNNDHWWSLQVLLQRQA
LATYRVLGGAVGTYRRLLEATRTPANGTMPTLRTRHKRHKRRIVDRYYF
>fig|757424.7.peg.4619 Permease of the drug/metabolite transporter (DMT) superfamily
MSSSNLCKLLLLAAIWGTSFMLMRIAAPVFGPMLTTFGRASLATLALLAFARVRGVPMQW
RSNWLPYLVIGIFNTALPFALFAWSALHIPSAYMATMNSLAPVFTAMFGFLLMGERLSLV
RCAAFVLGLVGVAVLVGIGPAPADAMVIAGVLAAMGAAVSYGFAATFTRLRAGGISPIAL
ATGSQFAAALCLLPLAAPSMPHALQAGTLPALLAVLVLGVVCTGIAYALFFQLIAAEGAT
KAITVTFLVPMTASLWAWLLLDEPVTLGTVTGIAIVLVATATALRAKPAVAARTKATA
>fig|760011.3.peg.755 Methicillin resistance protein
MPFAPEGCMTGVDMEVLSQAILSLLPHGVFVLRYDLPWGTPGLQEDFRISRLRSCKESVQ
PVATVRISLHKGMSAVYQGFRQRCRRNLKKAVDNGITIRHWEKNATVLSQWYELYLGTAR
RDGFSPRPLPYIKDVLEVEESDGQADLYVAYDANGDLAGGIIVLFGRQEAVYLHGSSRRD
VFSMGASWLLQVHAMEKACEVGCKVYDLHGISASHDGRGHLGRLDLFKTSFGGEIIDRPA
SLDFIRGRLRRRAYVMLENLRYSVRRGTV
>fig|760011.3.peg.906 Glyoxalase/bleomycin resistance protein/dioxygenase
MVSFIDHIHITVRDIGISESFYNKFLPLVGFDLRDKEYAQVPEHAYELIEYNSASFSFGI
VSPRAEYLDDCVSRRRPGAVHHVAFGTREKVDVDSIFSAVQSIPNVRIINKPCFYPEYCD
DYYAFFFTDCDGIELEVVNYSRTSRIGSSLA
>fig|760142.3.peg.1120 Permease of the drug/metabolite transporter (DMT) superfamily
MLKISKEYIADLMLLSVTVFWGSTFIVVKKSIEIIPTFAFLSIRFWIATLLLVIIFHKRL
VNINKRLLKDGVVLGVVLFLAYAFQTVALEYSKATIVGFLTGLNVIITPFLSALLIKKIP
RIYSQIGAVFAFIGMTMMSLNENLSLSYGDILGVICAVFVAIQIVLTDKYSRRNDTYLLT
VVEISILAILSSIISITTETHIIPQHFSWYLVFSFLITAVFATVYAFIVQNTAQKYTTPT
KTAIIFIMEPVFAAVFGYFLGGEVLSFRAYVGAFVMFIGLFISEIGPLVFKK
>fig|760192.3.peg.149 Glyoxalase/bleomycin resistance protein/dioxygenase
MNQLIIYLTFNGNCREAMSFYQACLGGELEFQTIGESPMAEQLPEKIKDFILHATLRNEH
LLLMGTDMVGEQGLVKGNAMSILIECQNEAEIQVYYQLLSRGGRTTHPIESTFWGALFGG
LTDKYGNNWLLHCAKNQRLTQVEAAN
>fig|760192.3.peg.1146 Glyoxalase/bleomycin resistance protein/dioxygenase
MDNSVNTLNWFEISVSDMSRAKSFYQTVFSIEMDQQEMMGMQMAMFPYNPMSGKVAGALV
QSEMHKPSTDGAVIYLNGNPDLSVALGKVESAGGQVVMPKTHIDEDTGYMAFFIDTEGNK
VGLHSNK
>fig|760192.3.peg.1307 Multiple antibiotic resistance (MarC)-like protein
MIELFFAVLGALFSVVNPLGAVPVFLAMTPDYTVPERNSTARSTGVYFTLILLGFFFAGT
QILEFFGIHISAMRIAGGVMILSSGYGLISGKFAENRAINKEVEEEALKRQDISFAPLAM
PLLSGPGSISYLITQYNENPSWEAHLVVAAVIVLLGFLVYLILRSARYLYTILGEAGLKA
LSRVMGFIVMSLGVQYMIAGVIQLVGEMK
>fig|760192.3.peg.2381 Glyoxalase/bleomycin resistance protein/dioxygenase
MAKAIGINHVALVVSNLEAACEFYEKELGLEVIPAFLFDYPTAFFKINETQQLHLTEWDD
VFSFRGHVCMQVDDINAIFWRMKELGVVDTSPWGKVRQLPDGPIQMFVRDPSGNLLELSC
KPGSEIDPAIFEDELFQAGIYVSGRNDFRGYKSKDATLYHN
>fig|760192.3.peg.2537 Glyoxalase/bleomycin resistance protein/dioxygenase
MIIEHVAIWTAQLEALKDYYIQYFGAQANDKYTNVQKQFQSYFLSFASGARLELMSRPDI
PANANDPISAQYLGLIHLAFGVDTMAEVEAKAAELRAAGFPILSGPRKTGDGYYEFETLD
PDNNRLEVSAVAE
>fig|760192.3.peg.2699 Glyoxalase/bleomycin resistance protein/dioxygenase
MKPIWIEIPTTDIQRAKTFYESVFDEKLQLLDMGEFKMAIFTSGGFALCQLKDVYRPSTE
GPLIYLNGNPDLNTILEKVAPAGGEILIEKRQISEEQGYMAVFTDTEGNRLGLRSKN
>fig|760192.3.peg.3041 Acriflavin resistance protein
MTHSLSPVRILIFFTALALPALFILPYLQVNLLPAEPNTELQIRIQVPNTPPFGVERSTV
SQLENALSAIRGLKNIRSESRYAEGSIYLEFGRKEDMAARRFEVATVLRSIYPKLPTGAS
YPTLSGGNDVAQEDKGPSLLYTVEGPGDVAAVRQRCETFFRQVLHQVEQVSNLEFQGGQE
ERMVIEFDPQLLKIHQVDPHELEQVLHRANGSYFPGSSEDAWGRKLFVRSIPADISLSTI
ENTLIKTEGGYPLRIKSVARVYQDRETPSSYYRINGKNAVSVFVFLSPDCNKVYEAVRIQ
QLITRAAAQQQDLHVRLAEDKTTFVRVELQKSWLRASASLLILLLLLLLTYRNWRLVLIL
LFCLMINLAITVLTSWAFQVEWHTYTLAGLSVAFGLMIDNAIVMLDAYRRRLNRRIFTAL
LAATLTTAAALLLVFFLPIEEQRNLVDFSIIIVISLISSLFTVLFLVPACYDLWIGAPAL
KSSNALKVAQKRRIFFRLAVYKSAIEFFSRWRLLFYVAGVLLFGLPVFLLPLETQSRQWH
LQWLNSPNFQREVRPHLEFWLGGTLRLFVDTFNAESYYRQAEATALYVRAELPHGHTLAQ
MNTLMHHFERFLSQQNGLEVFGTSVNSGQYGDIEIHFTSDAEKTSLPLSLQARLQELAQG
FSGVQWSIYGKGEGFSNNLFMDNQASSRLILRGYDYQELGRQAEKLGQLLAQNMRVQSIE
LDQNLNYFDRPLPEMYLSLDASKVAARHTNTGDLLNALNQMASPISFSLSSEKTSSEGLI
KAQNTAQFDVYHLLHDPLSPSPKSNLHIQELGKMELRQSSSSIQRENRQYLRLVTFDYVG
SYDLARQLNEQVIRKMNREMPLGYSVEGEQGSVSAATKRQFYLLLILLALNFFICAILFE
RLRQPFFILLTVPISFIGVFLSFAWGEFTFDQGGFAAFVMLGGIVVNAAIFIINDLNNAK
GQVHNFQNTLIKVLYRRSGTILLTIVSTICGFVPFLYEGPETPFWFALAIGTIGGLMASI
LAVFLVLPVLLWKKKKLL
>fig|760192.3.peg.3043 Acriflavin resistance protein
MIHYLLQRPIAVLLSFIVLCIFGLIALNLLPISLLPDVDVPQIVVKVSYPNTAAEALEAR
IIRPLRETLTGIPGLKDIESRSSNHRGIIYLAFEYNTKMDLAYIEVNERIDRLSAQFPRD
MPRPQTTRINTSDIPIVRLQVTPKIQEDFVQISDLVDKLIKRRLEQLEGISIVDINGLQQ
TNIAIEPHREVLQALHVSENDLAQTIQAANLDFGGLSVRDGNYQYFVKVSNGFESIADIG
RLPVPTTSGLSVPLAKLATIRSIAEPPSGYHLFNGQPALGITIQKQAASRMNELVPRIQN
LVKQFEKDYPQANFALTQDQTYLLNAGINNLYQDLMYGGILAVLVLFLFLGNYASSGLMS
LNIPISLIITFALFYVLGISLNIISLSGLALGIGMLIDNSIIVLDSITRKRREGMAMLAS
CERGISEVVTPVLSQVLTTVAVYAPLILLPGLAGLLVYDQAIALTISLGVSLVVAFILSP
LLYKLFLGNKPQSIKEDTRFYLWILAGYHRMIQFIFQRKILFFSITCLFGLLAFWLFPKI
PIANLPKVEKRETLVKIDWQTPLSVEENVQRVQKLDRVLASSAVSREAEVGIPQFLLASA
DQSIQQAQVYYACKNQSEKESLDQKAKAWLQKTYPGASFQFEDASNAFTQLFNASNPYFE
IRLRPANGHYNAAILEGLKASMPSFPLPNPQLGLGIAKEPSIKLLVDAEKMALYGVDWNN
LQEKFRLLFGHYPITELRKFSGAQQMHFTSEKGKIDDLLQQGITTSHGNTLPIAAFVKYE
LDEMPKYITADKSGKYVALSLDENSPQIAQAKTKILHWANQHGFTAGFSGNYFEGLQNSH
ALFKIFLISLLLLYFILALQFENLIQPLLVMLTIPLGVTGALLLLYLQQGALDIMAAIGF
VVVLGIIVDDPILKVEVINRLLKLYESSGMSRRQALEKAIHDAGDISLKPLLMTSLTTSL
ALVPVLFTPGIGSDLQKPMVFVIIGGLTIGTFFTTWFIPLAYWFITKKK
>fig|760192.3.peg.3236 Permease of the drug/metabolite transporter (DMT) superfamily
MSATTTSSVPENIFSQRRRIIASVLVLIAALCFSAKAVLVKLAYRYEIDSISLLTLRMVF
SLPFFLAIAIWAKNRAVKENRHIILSRREWFYIFILGLSGYYLASMLDFIGLAYITAGLE
RLILFLYPTMVLGMNVLFFKKTVTRVQWIALALTYGGVALALLDRTQLGVGSNVPLGAIL
IFFSGFTYAIYLVGSGQYIAKVGSLRYTCLAMIAASIGVIAQHGIIYQWDLWHYPLQVYT
LSIIMAIFSTVLPTFMMSEAIRIIGSGNVAIIGSIGPVVTIILGYFLLGESFGIWQLLGT
ILVIIGVLRISLK
>fig|760192.3.peg.3914 Glyoxalase/bleomycin resistance protein/dioxygenase
MNQRIAHIALVVDDYDRAIAFYTQKLNFRLLEDTPLSDTKRWVMVAPQGQGECCLLLAKA
ANEEQASRIGNQTGGRVFLFLYTDDFWRDFRNYQDQGIRFVREPVEETYGTVAVFEDVYG
NLWDLIEPR
>fig|760192.3.peg.4214 Glyoxalase/bleomycin resistance protein/dioxygenase
MHLKLLVIRTSSPDQLAQFYTYLGLEFEYHQHGSGPFHYACTIDGMVLEIYPLAKGQPAT
DPYLRLGFAVDDFETLIYKLEQLNVKFISTPAQTDFGWMCVVQDPDGRKIEMYKK
>fig|760192.3.peg.4441 Glyoxalase/bleomycin resistance protein/dioxygenase
MKAVQFRIARPTNQLEAVIEFYTKGLGLTIIGQFSAHDGYDGVMLGMPDHTHHLEFTQHM
SKHPLPEPTKENLLVFYFDDHHQYLEANLHLQRLNHYPVKPENPYWIGKSETYEDPDKWR
VVLFNGRFI
>fig|760192.3.peg.4477 Permease of the drug/metabolite transporter (DMT) superfamily
MRERYLIIAAFATVYLVWGSTYLVNYLAILEIPPFLMSGTRFLLAGSLLFGVAALRKIPW
PQTIHWKSAAWAGLMFMALGTGLVVWAEQWVDSGMAALLVSFEPLVVVMLLWFMRGQSPK
LHSLLGVALGVLGMFLLVGQPQISADRQTLIGVGVIALSLFAWGYASIYIGQANLPKSKM
QSAGMQMMCGGICLLIMSLIFGDYKQFAWERLTPQGIFSFFYLVVLGSLLAFSAFNYLLT
KVSPEKVATTNYVNPVVAMFLGWSLNNEEVTTRSLIAAAIMLTGVFFINGKFGQKKLI
>fig|760192.3.peg.5518 Glyoxalase/bleomycin resistance protein/dioxygenase
MDTKQLIKGIHHVTATVNDAQEDYHFYTRTLGMRLVKKTVNFDNIRVYHFYYADRMGTPG
TIFTTFPYKGQPKVKTGEEGTGMIIATALSVPSSALAFWDQRLREKGTKVTHGERFGQPY
LWFRDPADLQIELIGDSTDTRAAWLNSEEPAITEATAIRGIHHVTLSIAPEHWDKMIEFL
STDMNMSIAAQENNRIRFDVNGGGAGNYLEIRKDAHAQPGKNGIGTVHHVAWKVTDDEAL
MAMHARVTELGFAPTEMKDRKYFHSIYFKPYAGMWFEIATMQPGFAIDEPEAELGNKLLL
PEWEEVKRAEIEAALPQLS
>fig|760192.3.peg.5780 Glyoxalase/bleomycin resistance protein/dioxygenase
MASVSTYLNFPGNTEVAFNFYKSVFGTEFSSDGIVRFSSVPPQEGTPPMAEEDLNLVMHV
ALPIMGGHSIMGTDATESMGFKVQFGNNSYICLSPDTKVETKRLFDALSVGGKVEMELQE
MFWGSLFGSFTDQFGVQWMFDCVEQA
>fig|76114.4.peg.695 Drug resistance transporter Bcr/CflA subfamily
MNGSSPRFARAPRPAPAETRVAAVLLPGRTRPAHLLWLITGFWMLQPLSTDLYLASLPEL
ASYFHASPALVQQTLSMFALGVAVSQLVSGPLSDRFGRRPILLAGVLVYAAASLACTLAT
RIDALLIGRFMQAAGSCTVAVIARAVVRDTYPIGEGAHVIARSTSILAVALLLAPVVGAQ
LQASFGWRANFALLTLGGAALGLASVLRFAETIARRNPAAMRPATLLGNYGALLRSPAFW
AYALPGSLSFGMVFVYISGASFALIDVLHVPTRYFGYCFALGVLGYLFGTQACRRLLRHY
GLSRTLRVGSTLGLAAGTTFAAGLALDLQHWATVVVAHFLVTLAHGINSPCAQSGAVAPF
PEKAGAAAALLGSLTMLCAFSVATLLGATYDGTLQPLATLSALLAIALFVAERALAAHRL
RDKALS
>fig|761193.3.peg.280 Glyoxalase/bleomycin resistance protein/dioxygenase
MNAIQWFEIPALDLERAFTFYSEILHGNVRKGTFGDGELILFNVPFNTGEAVGGSIVARP
DLIPTTEGPILYLNTFGKLSEAVNKVENAGGKVLVPRLDLGKFGFSAIIIDSEGNRIGLL
SNEP
>fig|761193.3.peg.554 Multidrug resistance transporter, Bcr/CflA family
MTKKQERTIILLLGALQGIGPFSTDMYLAAFPSIAADLKVSIAQVAYSMSSYFVGICLGQ
LLNGPLIDRFGRKVPLLLMLGVYTLASVGCTMVTSVEGLIMLRFFQAIGGSMGMVANRAI
VRDVFPADRLAHVFSTMTLVMGVAPIIAPTVGGFVVVSFGWRAIFWVLAGFAFFVTLLVY
FLLSESKGKDRSISLKPQAVMADFYSILRNPSFLAYTIVGAMNTAGIFTFISNAPFVYME
LLGVSEQTFGWIFGLNAVFFVVGSQLNRWLLKYYSSQTVALYGLLVQAVMGVALVACVIL
NQLSIPILVALVGFYSLCLGMIGANAIALAIRPFTKNTGSATALMGSFQMGAGAVASAVC
SYFYDGTAKPMVIVMTGVAFIGLLAIWAGSYRKPVTA
>fig|761193.3.peg.3398 Acriflavin resistance protein
MKGIYPLLLGFAVLSLVGLLLVPRLSVQLAPSGGGQNITVSYAWAGASPLMLEAQVTALL
EGTFSTVQGVKKVSSVSGYGYGYVSLELDKNADADALRLEVASLVRQVYKRLPTEMSYPQ
VALNTPNQQERQKPLLTLQLDGPAAAAALLRYAEEQLKPALAQVRGVYQVEVSGGNRQEW
VIAYDIDALKNLQLSENQIITTIQQHFRQEALGSLTQPNGQRLLVSLNTPFSAWKGARGE
VKTPPLQMERGAGGEVLAAIPIANLSGRIVRLGEIATITRQEQPATTFYRVNGQNALNMT
LSAAAGANQLKVAQEVRKRITTLQQQLPAGYQLRTEYDATQYIEENLQRIGIQSGFAVLI
LFLFVLLTTRSWRYMALIGVSMAVCLLLSVILFYVFKVEIHLYSLAALTTSLGIIIDNVI
VMIEHYRRYRNLRVFSALLGATLTTCAGLAVIWFLPDEARVDLLDFAVVMVITLGVSLAV
AVGFVPALMGITLRSKAQKATPNKRVDMFYKTDYKSASDSVRITNPDEQKLIVPASSFRK
GCWGSTPFGEAFYRAILHLLVRFRKTVILAGVLLFGTPIFLLPNQLEKENPLAAYYNPLF
GNEWFNDELRPVLNKWLGGTLRLFVNYVYEGAYFGKPERTALYVVAELPNNSTIAQMNLV
FERLEKEMSSYPEIDRFMTQIYNGQQGSMVVYFKKSHEDGSFPYQLKNRTIALSTEMSGI
SWNIYGVGQGFSQSLEENQTPSFNVRMLGYNYQQLEDQATRLKTLLEAHPRIQEVNINRG
MGMFSNKNLYEYALQTQTGALALRNTTLSGIYEGLHQRSKRSNADIYTFMTGQYESIQVL
PTQSQHFDVYQLNNQPLQSDLVTYKLNSLAKITKEKVIPEIFKEDQQYVRMVSFEYFGSG
HFGDKFLTKTLDEFRPTLPVGYTAKKSEYNWFSEETRTQYELIGLVMVLIYIVCAVIFES
LVQPLALIGMIPLSYVGVFLAFYWFDYNFDQGGYASFVLLAGNVVCAGIFIIAEWNILRK
TDPKSPPFALYLRAFQHKIRPILLTVLSTVVGLVPFLLYENEPFWFALGVGTIGGLLMSL
LILVFFLPVFLMNKREFITNDYLYT
>fig|761193.3.peg.3412 Acriflavin resistance protein
MTRFLLHRPVAVLITALALSVLGVVVFRLLPVSLLPDIPVPEITVQVSYPNAAARELQQA
VVLPLKNQLLQVNHLEDIEATTQDGFSVLKLRFDFGTDVRLAYLETNEKIDGILSQFPRD
MERPKVIKAGAGDIAVFQLNVSPKRNQTLRGEVELSDFCQNVLKRRIEQLPEVALVDATG
LALPEVVVSADRNKMQSLGISENQIAELLRQNNVNLGNVVVKDGQYQYNIRFSSVLRTPQ
DIESITFWVGGSGRSVGTQNSEGERAVRTQPLAGIQNSAANERPTLATGRLMRLGELVKV
SIQEQQQRGLYTFNGQRAVGLAIIKQSDAQLLQMRTQLDQLLTQFRNDYPELAFTLSQDQ
TELLDVSINNLVSNILTGALLTFVMIFFFLPNPRVPVLIGIVIPVSLSITFLGFYLLGLS
INIVSLAGLVLGIGEIIDSAIILIENIEEKREKGLSLDEACVEGTEEVIRPLFTSVLTNS
AVFLPLVFLSGLAGALFFDQAVSVSLALAVSLLTSYTLIPVLYRLAFLKSKKEGPQMAKE
TWLMRRIEKVYNRTFDVAFRFRKGAWVLVVALLGSAVWAVQGLEKRGMPAISRSELEVKI
DWNEPLSVSQNEQRIAQLLKTLSPAPLYVSAYVGQQQFVLNQQLQQSFSQATLSLKVADH
PSYQRLSSQFSTKIRQAYPNAVVEVRPARNVFEQLFGTQQPPLQIRLFSTQNQDVPTPQQ
ATETLRRLEEKGFKTNPIGYQKRLAVSLREEQLLLYGVTAEQTYQSLKTLFNENQIGQLQ
SEQKFVPIVLATQHPTGVQSVLQTAFVPNRQNQLIPLRELVEMHSIDDYRLFHTGKDGAY
LPVDLEVENKQTAAFLPEIEKILKQDATLNYRLVGDYFRNIGYLEELAWVLLIAVALLFC
ILTAQFESLLQPLIVMLTALLGIAGALLTLVLFGESLNALSVIGLVVLIGLIDNDSILKI
DTMNRERERLGIIEAIRLSGKRRLKSQLMTYLTTILGLLPVLFSGGLGAELQRPLAFTVI
GGMTVGVIASWTLIPLLYYWIARPKRQ
>fig|761193.3.peg.3939 Glyoxalase/bleomycin resistance protein/dioxygenase
MIIQELTLLTDNLIETEQFYTERLGLSLTTKETNGITFQAGETLLRFKKSRIHRHPRYHF
AFNIPYNAVLDAFASMSSTLNILPVSATTNIADFANWNAKAFYFYDNNGNIVEYIGRFDL
GRHDPPTFTPSAIQSVSEMGLPVKNVKEECEKLMARGGLSYFVKQPPCETFSVLGDDSGL
LIMVPIGRNWYPTADLASEAHPVKMRISHAGRTIDINL
>fig|761193.3.peg.4017 Glyoxalase/bleomycin resistance protein/dioxygenase
MTDIERAIKFYNAVFHFNFDKENIDDNEMALFPFADENSGISGALAKGEIYKPTKDGVVI
YFKTENIDETLKLATSNGGQVLYPKTDNGIGFVAEFEDTEGNRIALYQTK
>fig|761193.3.peg.4824 Glyoxalase/bleomycin resistance protein/dioxygenase
MERSINFYKTIVGLTSLVRPAFDFPGAWFRLGTTQELHLIGIRTEVVVSGSRSNHFALEV
DDLDAWEAHFKANAATYRPPKFRPDGVRQLFLQDPDGYWIEFFSVKGNQPA
>fig|761193.3.peg.4995 Glyoxalase/bleomycin resistance protein/dioxygenase
MNQTITQKDKAPGGLRATFLGVDHPAVAADDVQALSDWYCDVLGYERWFLHQKAKTVWML
KAPDDTLLEIMPKDDTLRHNRTTWTPGWSHLALRVSDIEAAIAFLEQFGVIWGGDLTNAI
GGGRVRNFFDPEGNMLQLLQRTASLPPLGE
>fig|761193.3.peg.5625 Glyoxalase/bleomycin resistance protein/dioxygenase
MKSTFKNVWPYQKDPLNLSVAKIEGAIPFYETVMGFQVVSRSEAPVKSAVLERDGIQIGL
AENGGDPTQDGCFFEVDNADNAFAELRANGLAQEEPNFTFQSYGPTYKVFFVVAPDGLCY
CLGERQ
>fig|761193.3.peg.6219 Acriflavin resistance protein
MTLTELAIKRPSLLIVLFLVLALGGIMSYNRLGYEILPRFTPQLLTITTVYPGAAPNEIE
SQVTKKIEDQLSNQNGIVSINSSSFEGLSLVSLELSNDASLKAVKQDVIAKINSLQSLLP
NDAQTPTVSELSFNDLPVLRISATADLTATQFFSELKNRIIPQLSQLDGVGSVELLGGEE
REIRVNINQDKISAYGISILQVNQAINNANLDFPTGKIEAGKTQTVIRLTGKFNKIEQLK
DLIVATSRMGGTIKLQDIAEVIDSKKDIRNINRLNGKEAVGVQVRKRTDANSVAVSKAVR
DKIAELENKYSNINLKFVVAIDTSSFSLEAAEAVQHDLLIAILLVALVMLIFLHSIRNSF
IVMVAVPCSLVTAFIIMYLAGYTFNLMTLLAMSLVIGILVDDSIVVLENIYRHLEMGKDA
RTAAIDGRNEIGFTALSITLVDVVVFVPFLLLTNTTGKLLAPFAAVVVVSTLMSLFVSFT
VTPWLASRFAKAEDVKTKKGVWGRFVRSLEIGIEHLSHFYAAALSRCLQHKTITILFIVA
MIMGAGQLVRFGFIGDEFVKQGDQREFIIKLEYDKSITFQQNNLTTKQVEDFLREKPYVK
SVFANVGGSSDLINLGNSNNQSEINVKIYPNEIVEKATDQAATECQMALQRQFPQIKITS
AKPSFLGGNEDDPIEIIFSGENPDSVLAVVKSVEKTVRKIPGAIDTKVSIKEGFPEVNVS
LDRDKMAKLGLDINLVGATMQSALAGNDKAKFRDGFDEYDIKVQLDKFDRRNEADVAALS
FINNKGQTIRLDQFASLSYGISASKLERKNRRSSVTFKSQVLGTPSGNVADAIQAEMDKM
NLPKNIEYSWAGEIKRSKDSTDTLLAVLGIAIILIYLIMVALYDSFIYPFVVLFSIPVAL
IGALLALALAKSSFSLFTGLGIIMMLGLVAKNGILIVDFTNQLKEKGLNTIDALMESGKT
RLRPILMTTLALVFGMIPIAIAKGAGAEWKNGLGWVLIGGLTSSMLLTLIIVPVVYLTVD
NIKAWFGKLGANKKKIERMSVAK
>fig|762948.4.peg.824 Quinolone resistance protein NorA
MALAMIAAGFDFYVPVSAFFLESRGLSLTDIFMLESVLVASILVAEIPAGIIGDRFDRRR
LVCAGFVFNAIAEILFAAGTNFSIYALSFVMSGLSIAMLTGVQDAYIYDSLGDDADAKAV
GAWGHLSALMLTAGVTGSVVGSALGSVDISLPALLSAAMAVVAAVCVAFLPQQNPKTHDK
HPETSWVSLKIGVKLLFTSPLLLYVAVGSSASFALFNAVYTLNQPLFAAQDVPIATWGVI
AGAGQLLAAGYNYAAGRIEKRVGRKTALLLAMGYGAAGFCLMAVPHVLAVVSGFLLVVVG
IHARGPITSAVTNKLIPAHRRATVLNVASSVGSLVGIVVNPLVGLGAETSTRLTVLAIGG
VLLALTLTWIPIANRYLEADEDADMSEAHVS
>fig|762948.4.peg.827 Glycopeptide antibiotics resistance protein
MLQTPGTGGATSRAFAQLFFNIGLFIPIGLFTAGCLRWGLRASALAGFGLSLFIELSQLS
GNWGLVPCAYRTFDVDDIINNTVGALIGALLVLVWRRIRRRMRYRHLPDHIG
>fig|762948.4.peg.1086 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIHKPTHALPENTGAADKPNAAAKLGTVAPSEANPPVTGAVPAVIGTVPSTTGAIPAVPA
PDAGPGMPNMDDPKNIYLLKDAPVFKALLSLGIPMAAGLAITSIYNVINSYFVGHYGTVE
ELAATGYGVPVFGIIMAIAGVFGLGSSTLASRLLGEGNKARIRNVTSFALYSALACGVVV
AIAGFLFADPITGLMGASGSSFEPTKTFVHLLFLGAPFSVGLFTLEQLVRSEGYAKQSMY
GIIWGVVINSIFDVLLIAVLGWGIAGAGWAMLAANAASMVYYLQFLIRKSPNFSWKPSDF
VIAGDIIKPVFAVGAAELIQSANLTVSALVLNNIAAGYGDDSVAAFGLAMRLNMVPEMLC
MGICMGGIPLFAYAYGARNRDRVRSALKTAAMVSVATSIIFTTPVLIFRRQLLELVGDSS
LVATGEKVLVALMLAAVFNAVSIVFVSWFQAAGKGLPATLMTLGIALLFFPAVIFGNMWF
GFDGLTWAFPFTQISACVLGVILFFATGGTKVKDAPASGTPEHGVTEIKVESE
>fig|762948.4.peg.1287 Multidrug resistance transporter, Bcr/CflA family
MSSSQTTSQQGHEHPDHVKVSFGIPAPVIVTLAALTAIAPLGIDMYLASLPTVARELNTT
DAAASMTLSAFMIGMALGQLIIGPLSDKTGRRTPLLIGSAVCFAATALCAFSPTIEVFIA
ARFLMGFSGSVGAVLARSIVADTTKGLTTAKLMGIMMMINGFAPVLAPLFGGWVLSWGTW
RSVFNVLTVITGALMLAVIFILRETLPAEKRYQGTALSVYSEIPKVFRIRRYMGFSLTMC
FAFGALFSYISGSTFVLQKILGLDAGQYTLAFGVNSLGIVAMSSLATALVGKVAQRTIVN
VGVSALLVVSVLLTGSFLIGISLWPTLVLLFCLTCSVGLIFGNASALALNEARHMAGSAS
AVMGTIQALLGGVAAPLVSLGGEGAYLPMAFSILGFAVLTGITLFSTPRKDSDYAADGGA
GGH
>fig|762948.4.peg.1443 Vancomycin B-type resistance protein VanW
MKFARKATTAVGLALTLGLSGLAPVGPVAYAAEDASVHDGSSSDKAAASCYEAKQVNKDA
KSGKYWLYTPSMSAPQQFYCDQETDGGGWVLIGRGRDGWTENYHGRGAASKLYTSPEGDD
AMTPVQLPSTTVDELLNGQKPQDLEDGVRFRRALNTDGTEWQNITAHRDQTERWTWALRS
NNIWSNIDVSADNPQYMQRDRTHFDKTEGHIQQNGTYSVLNFDEQREQGWKLGFSYSRDV
RANGNRNESASNSYLYRPSGSNATPFAFTQVYLRPKLTQQNMGAQAIGDNGTAASNRRAL
PKSGSMPWKWRTSDKSGTGNVNEMNTYVQAITQVGDTVFTGGDFAYLESAAGAHVDQSYL
AGFNVNTGELVQTFKPKFNGQIKSLEALPNNKLAVGGEFTEVNGEKVPGFAVLDPATGQL
DRELNLQVENNVSGSALSVKTLQAQGDYLYLGGTFTHLKSSGTPNKVYSRNAARVKISTN
QVDRTWTPRFNGTVNGMSASADNSEVFAAGYFTEMNDQRAFRVARILDSAKKVGTWEVTP
SYLPDAQTREKRVWGFHFDVQDAGSSVWLGGTEHMISQYTKNEPMTRLSSSITRNGGDFQ
DLHLNGNNIYGACHCGDFLYQGSGTHDYAWRGSTVTDSIRLVAAFDKDSGKTLPEFAPTL
KGKSGHGIWESFVDSNGVLWVGGDLNRSLGENGVQQESVGFVRYAPRDVTPPPAPSNLTV
TQSGDNDQLNWSASGEAGARYHVLRNDRVIATVNGTSYRVKHTDNARYFVRAADANGNYS
ASTSVAVSGKKAEQPKQENPKQENPQPQPENPKQEDPKQEDPKQEQPKQEQPKQENPKQE
QPKQDDPKQDNPKQEDPKQEQPKQDDPKQDDNKNIVKPQPENPIQDDPKQEQPKQDNPPK
QEDPKQDEQPQPENPATDDQVQPADPNDDLKPNEPKQQENPKQEQPKQEDPKQDNPKQEQ
PKQEDPKQEQKPQGDQVLVDSGSSWVYRVGSDRAESEWKTRSWLGGAWSRGKAPLGAGSV
NVETEVNTFFGTPMSIYARKDVTLTKEQAQQYLKLTTYADDGTVVYVNGKEVARKNMPQG
RISANTPATQRPESQNAQLFSVDVPAEYLREGRNAIAVEVHANSHWSNNISFDMQVISTA
QHQNPLPEVQNQEDNGQQHRPQVWYWYYPEYYGNYGNGDYYGRRNQRVAYNYDHRGFGYM
GGFGYAHGFFGRAFYDYGFGW
>fig|765420.3.peg.1215 Daunorubicin resistance ABC transporter ATP-binding subunit
MTEMAIEARGLVKRYAEVTAVDGIDLQVPAGMIYAMLGPNGAGKTTTISMLTTLVRPTAG
AGRVAGYDLLREAPQVRTRIGVTFQDIVLDNDLTGRQVLDIHGQLYRQPADLRRKRIADL
VDLVQLGDAIDRLVKTYSGGMKRRLELARGLMTDPAILFLDEPTQGLDPQNRTGIWGYLR
ELNRQRGLTVLLTTHYMEEAEALASQVGIVDHGKLVSQGQPTELVAAMGADVIRVRGHGD
SAAFLNQVAGLPFVERVETDRASGHLSLYVDQGSRRLVEIIAANTNGYQIEDVTIARPTL
ADVFLHHTGHALRDE
>fig|765420.3.peg.2000 Permease of the drug/metabolite transporter (DMT) superfamily
MSQQLKGYITALIGIIVWSTTGIFMSHLITVYHIPAFVLALWRNLLVCIVLFPILLFMNR
TLLRIKRNDLSLYHWYGFVLALLNTLWALSVQANGAAVATVLVYSSAGFTAIFAIWVFKE
RLGIIKGIAILLSLTGCVMVSNAYDGAVWSLNPLGVITGILSGVVFAIYTLMGKETARRG
INTWNALFYSFTLGSIWITLFNLWPGMPGSTGSYMRLWPELPLNGWLILFMLSFVPTLLG
FGLYNTSMNYLSASIANLLATLEPAMTAVQAYIFLDERMSVVQIIGSCIIILAVFVVQVE
KEPKLEHKQQPA
>fig|765420.3.peg.2346 Multidrug resistance efflux pump-like protein
MSTSATPTPSVPNGATSVPVVGGTLRAEAKVVPLRSASLSMPVGGVVAEVLVSEGATVQA
DQPLIRIERSRLEAALAQAQAEVQVAQASYDRLLAGATPEQIAAAEAQLAQARAGLRQVS
GGVTPSDIAAAQAQLAQAQAALAQLQQGPEDADLRQAQAQLAQAQANAQNQRDSFVAAKL
RAESQLEQAANALRTAQDTYSRIYWENQEIGADDLTQAQKDAETAALRAVEDAEQALAQA
QIALQNAQDAERSGTEVAEAQVRDAQARLDKLLTPAAADKLAAARAQVSQAEANLNRLRG
EQRAGSLAAARAQIDQAEANLAGLRAGTSEGDLNVAAAQIQRAEAALNLAQVALAETELR
APFAGTIASITPAPGEYVSMGTPLITLADLSAWQIETTDLTEQDIARVHEGDQVLITLDA
LPDLELQGVVSHIRLVGENKQGDITYTVTITPETQDSRLRWNMTASVRFVE
>fig|765420.3.peg.2482 Permease of the drug/metabolite transporter (DMT) superfamily
MISSKPTTKAAPNQGMAFIIAAALIWGTIGASVRLLYTQAPADPLGVGFLRLLIAAPALI
LLGWAMVGPHFWRVQRRDLWVVALMGSTFAGYQVSYFAAIAHIGVAAAVMINICSAPIFT
AILARIFLGEALSRMTLLALVGAVLGTAMLVGGVPQQGTLNVLLTGAALALTAGFSYSIV
VLTGRVLAPRYHPIQPITLAFTLGAVLLAPVVALSGNLYLDYTAWGWGILIYLGVVPTAI
AYVLYLHGMRTTSATITAILTLLEPLGSTLLAILFLGERLAPFGMVGMMLLLGSMGLLYK
KA
>fig|765912.4.peg.2106 Acriflavin resistance protein
MRFLVGWDEEQAIVQLYQKLYANLDRIPAGASRLLLKPRRIDDVPILALTFHGGGLDGYS
LQRIAAEVDEVVKRIRDVSETTLIGGERRQVRVEPDASLLTAYGQDPSHVLKILRAANRQ
ERAGSFPLDEQETLVETGGFLRDAAEVPPGPPVLQTLVAEVYGPDYAEQIAIAREIERLF
EEIPGVVDVDSHIEADQPLLRFCFDQEKAARNGISAAQVSQVVEIAEKGASAGLLHVDAE
REDVLIPVRLPIGQRAQSGEQRPIPVCVGERCVPLGEVTRIEADVGEKSICHKNQLPVVY
VTGDVAGAEESPVYAILKLN
>fig|767100.3.peg.1 5-nitroimidazole antibiotic resistance protein NimB family protein
MSYAYCNDVIYIHCTNQGGHKLKNIEENSKISFTVVDKVERLPNQFSTKYMSVIVFGRIS
IVDDEEKIRVFSQSCLNILLIL
>fig|767100.3.peg.46 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKKINLLDNRIYRNLVMMSIPIMTTSFIQMSYTLMDTFWVGKLGTEAIAGVGIVSFIMWF
ANSLVLVSKTGIEIGVAYSVGSRDDKQFRKYIDTSVAINLFMSITFGLLVYFFRLDIIKF
FNIKSELVISLANSYLKIVILGLPFTFLNPLFSGVFNGSANSKVPFIANSIGLIINIVLD
PILIYGYFGLPEFGVSGAAIATTLSQIIVTFIFIIFSILDGKILKGINLVKNFNNATFKE
VLRLGVPNAFKSCIFAFISTILLRIIANWGENAVAAENVAVQIEAINWMTVEGFSIALCA
LIAQNFGAKNYDNIASGYKKGLKIILWIGVFCSFFLFFSSDYIIRLFIRDDVDTIRMGVS
YLKVLAFSEIFLALEIGISGMFNGLKNTKTPTIISTFSNALRIPLAYLVLLLKLDITYIW
AVISFCTFLKGILNYIFFKKFIRENFDFKL
>fig|767100.3.peg.314 Vancomycin B-type resistance protein VanW
MDGKVGLKVESEKILDNFNTVPVKFDLEIPTIVTEYKKIDKTLLSSIKGVIGEATTKFDN
QPNRNNNIKIAANKINEFVVNPGETFSFSKELGEVSKNTGYKPAGTFINSKIVDSIGGGI
CQVSSTLYQALVKSDLKIVERNQHSMRVPYCTIGLDAMYYEGSSDLKFQNTFDFPIVITS
YVSNGEITFRILGDTDKKNYDIKLFTTDVSRIPMPIEEVPDPSLPEGKKVVVEKGFPGYR
GSSYKQKGNEKAELLNSDYYKPKKQIVKVGTKKEVKETIEKEKND
>fig|767100.3.peg.532 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MMGATGDLAKYSIIYLKYSYLGIPFIFLYYIYSSILSAQGKNTIPTMISTICVILNMILN
PIFIFDIIPFTSISGFGLGVKGAAVATVLTQGIMCIVGFIHLRINKDIIKLNLNSLVYIK
WEKHILKRIYRITLPSVIGQVGTAIGFMIMNSFIQSYGTETVAAYGMVNRISGLLNIPPG
GVGSAITSIIGQNIGNNNIKRVKETFKKASIIIIIMSIIIAIISFIFRYEILSFFISAPK
DSVLMVQANSYMFYTLITLVMLNMFFVYQGLFQGSGNSKYSMAIDMIRLWIIRLPLILFF
KNFTSYGATGIWLAMAISNVLVSMIAHAIYLKGGWQQGSFYR
>fig|767100.3.peg.861 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDTKSIYYETNIVKAILHFAIPGILSILIAELYNMVDTFFVGRYVGADSIGALSVVFPLQ
RLVIAISVCLGIGVSNLISRRLGEKRNKDITKYTTAVNGLTLLIIFAVTIISILFVEDIC
MFLGARNDILIYSIKYLRIVMFGSIFLAFTTVFGYMNIAYGNMKVMLIASSIGALINIFV
DYILIKNLNMAVEGAAIATISSQFISFLFSLIFVKKLQRENNFSLIPRLDFKISFNILAI
GFSSFIIEFSDAILISVLNHLLLPVGGNDAIILVGVITKVSMFMFVAMIGVSSSIQPLIS
FNYGAKNFVKIKKILKTGFIFVFSLSTLIWIFMNYNVKFIIGLFLKDERLLQMAADSFKY
VILVFPILSFYYICIYFFQSVGKEKYNFFLSIYRETLLYIPIVIIMVGRFGVLGAWISYP
IVDFISAVTGLILLLKTVKKISTF
>fig|768066.3.peg.793 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MARFITDLFEVSRRDTGPLIRLALPICGAQLAQAGMSVVDVMMTGRLSATDLAAVSVGSS
LWMPLMLFMTGTLMGLTPVVAHLLGAQRRADIRIQVHQALWIGLALGILSAVLLWTAVMP
IFAAMDVPDEVAQRSAGYLAAVGFGMPGVAIFQSLRAFSDGMNHTRPALWISLIGLAVNI
PSNYVLIYGGEGLTALLGDGLPAPLQALPALGAMGCGIATALSMWVMGLSMAAYTRRSRA
YGDVELWREPSPPRWRLIGELLHIGVPIGVAIFVEVTLFTLIALFVASLGEVTVAAHQVA
LNYTGLLFMLPLSLGMALTVRVGNTLGQARPDLARLVAWNGILIALVVALLNSLILWLTA
VPVIELYTHDTAVQQLTLSLIGLAMIYQVSDSLQVSLAGALRGYKDTRVIMLITMLAYWL
VGLGGGHWLGVYGLFDAVAPMGVHGYWTGLIAGLTVAAILLGERLRRRSKAVARGDEAIP
DTD
>fig|768066.3.peg.2376 Glyoxalase/bleomycin resistance protein/dioxygenase
MNLLINIDVPELGPAVDFYRDALGFTLNRFLDDDVAELTGASSRLYLLKNEAGTSSSTPG
SAPRHYTRHWTPIHFDVVVDDLEAAARRAEHAGALREGECREWLGSRCMTFSDPFGHGFC
LIEFTNDTYA
>fig|768066.3.peg.2431 Multidrug resistance protein B
MRADSLPGISGRTWKIAAVTGAGAFMAMLDATVANLAIEAIRRDFGVSLALVQWVATGYL
VALAVSLPVAGWLGRRHGYGRLWSAAMVLFVFGSVGCALAPGPWNLIGARVLQGLAAGLM
VPAGQAVIGSMADSRQLGRLMGTLGLVVALGPAVGPGLGGLLLEIASWRWLFWINVPVGI
AALLIARPLVPGGDTDPHSPLDGRGLLLIVAGLPALLYGAMRLGERDVEVVSLSSVTLGI
VLAVVFVWHAGRQRHPLIDVRLLHGRRFAAATLTAGLAGANMYGGLLVLPLYLQTAAHQS
AASTGMQLLAMGLGSALMLPVAGALTDRLDACRVAMVGAALLALATLPLALGVALTRGEL
AMLLVVRGAGLALAQMPAMTAAYTSVTRAQMGDATTIVNVVQRTGGALGAIAMVVLLAQA
ERAGESGPGSGGHGEAFLLLVLLAVAAIGSAAAIRPRRMAS
>fig|768066.3.peg.2797 Permease of the drug/metabolite transporter (DMT) superfamily
MTADRRAILYGIGAVGLWSTVATAFKVALGHMSPLTLMWIASLVSWAVIGMLVLRRGQLR
EALSHGWGTAAWAGLMNPVAYYLVLFAAYDRLPGQEAMALNYTWALTMAFLAVPILGQRL
TRMDVLAGLIAYSGVWVIATRGRVLDVDFADPLGVGLALVSTLIWALYWLLNTRDRRSPL
VAQWQNFSVGVPVLTLILLLGPEVEWVGATGLAAGIYVGLFEMGIAFVLWQLAMRTVSRT
ARISNLIFLSPPISLVLLFFIVGEPVLPSTLLGLVLILGGLGLQQRQKTPAEPAEAKS
>fig|768066.3.peg.2816 Bacteriocin resistance protein, putative
MNFKRMSFKRLRLFTAMVTGICISVASADMALAASMSLGNVLSDTMVRKDVQSIRERRYE
DLVEQHTDFSCGAAALATVLKYAYGRAEITENDVLAGMLEVSDPEVVRQRGFSLLDLKRY
VETNGYRGRGYEVDPDTLDEISIPVIVLLDLEGYKHFVVMKKARGDRVYVGDPALGNRVM
SRDDFMTAWNNIIFAVVGEGYDRYTVLLDPRQPLTAHRLQDVFSPAPRDQLIDFGFRHAE
LF
>fig|768066.3.peg.3105 Acriflavin resistance protein
MNLSQLAHRRRPVLYLATLVAMLYGIFSYFAMPAREDPEITIREALVTTAYPGLPAEQVE
QNISKPLEESIRTIGEVERIRSTSMRGRSILHVEIKDRYFNLDQIWDELRKKVEATTPQL
PEGTQDPVINDDFGDVAVVTAALTADDFPQADQQEIAEHIRAALYGVEGTKKVELLGVQE
QRIFIDVGEARLAELGLSPSELAGQIQSRNIYPPGGIMDSGEQRLALEVTGEFESLDALG
DTEIRLPEGGTLRLRDIGELYRGYEDPADRTAYFNGKPAIVFAISMLDGESVLDYGHAIE
SRLDELRDTLPAGYSLDIMTFQPEQVANAVYGVTSSVMQTLVIVLAVVVLFLGLRTGLIV
GSIIPAVMLVTLAIMGLTEMTLQRASLATLVIALGLLVDNAIVIAEDFKTRLEGGATRDQ
ALAETGGELAMPLFSSTLTTILVFLPLMLAEHVAGEYTRSISIVIAITLLSSWFLSLTVT
PALCHRFLKAPTAPREDAASPPLSDRLFRWMSGRYAWLLRRMLHHRTIFLIIMGLALVGG
VGLMQLVPQKFFPDSDRNQVLVTIDFPSDIAANATDRRVSELSKALLEAPSLHDDLTSVA
AYSGFGGPRFVLSLTPIDPAPNKGFMVLNVADRDRVDAVIHATRHYLATHHPDISPQVTR
MFLGPSDSTLLQVQVKGPDREVLFDAAKRVKGILAGIDGSQDIRQSWEARIPSLTIDVDQ
ARARSAGITSEDIARSLSAAIDGYHLSHYREGDDIIPVMMRYAERERTSIERLESLTVYP
GEAADEGVPLSQVAEVRLDNGYYRIDRENLVRTITVESRNRHLTAEDMVPRVEPALRQLE
DDLPPGHWIEFDGVVKESAEGQAALQANLPLCLGLIFILLVAQFNSFKRPLLIVATIPLV
IVGVALGLLATRADFGFMVMLGLYSLAGIIINNAIVLIDRIDIERRALPPDLPARDAVVR
ASARRLRPILMSAITTILGFLPLIVGRDPLFYGMAAAMAFGLGVGTIMSLGVVPVLYTLF
FGIDTADHHGGA
>fig|768066.3.peg.3689 Inner membrane component of tripartite multidrug resistance system
MLLACIGADINQEATTLALADIRGAFGYSVDQGSWFTTLYSIGAAMGMLVAPWLAMTFSV
RRFAAVAAVLLGLLGLACATTESRSLLLMLRWCQGLTTGFLIPLLMMVALRFLTPALKLF
GLAAYGLTATFAPNIAMPVVAWAHHGLGIGFVFWAVLPLCLTAAGLILHGLPQDPLRLER
WQQFDWLGWGLGWALCASIVTLFTQGERLDWLHSPLIRGLALATLVVLPLFLWRCAFGPN
PLIRPQLLGRINFGFGVCMLVGVITLSASSASLPAEFLAEVQGYRPLQSLPVTLAVALPP
LLVLPFAAFVLNFERIDSRWIMASGLLLMAAASWSNSHVTLAWMREQFYIAQVVFAIGQS
MVVVGLLMTATAVVDPMEGPFASATINTSRALAGPLASGLIGHYLAVAIDRHAHGLMERL
GTMRFSLMQSAPLSGHGREALSWPTGGPGGGALLQLHERIDAQATVLAYADAWRLLALLA
LLLVPLCLLPKRTHAPRFNRPRPI
>fig|768066.3.peg.3690 Membrane fusion component of tripartite multidrug resistance system
MILVGVFLIAPALLHYDEVWTNNAKLDADYTVISPRVAGDIVAVHVEDHEAVSRGDALID
IDPRDYRATVDASEARVTSAQAKLAEIEAELARQPSQIRHAQAVVDEDIANVDYARLDAD
RYRRLRHNGNASQQNAQQAAANASALDARREADQASLESVRHQTQVLEARRAGAEAALAQ
ARAELEQARLSLSHTRITAPRDGIVAQQAGRVGAWAEAGGALMAIVPTEEIYVTANYREV
DITEVRVGQPVTISVDAYPGLTLEGHVDSLAPATGTTFSPISHDDASGNFTKIVQRLPVR
IAIEAGQSGIDRLKVGLSVETTIHTDA
>fig|768704.3.peg.654 Permease of the drug/metabolite transporter (DMT) superfamily
MLNKSYWADLSLLLITLVWGSTFVIVKWAIVDLPPFPFLAVRFAIAFVSLLPFLWFQKKY
LNWDTLLRGAAIGTFLFSGYAWQTVGLQYTTSSNAGFITGLSVVFVPTLVAVTTRKLPSR
SLVLGVLFALIGLALLSLSNSFQLNNGDLMILVCAISFALHIYFVGRYAPSTNATVLASI
QILTVSVLSGISSFIFPQPSINFSSTAWVGLLVTAIPATSIAFFVQSKMQQFTSSTHTAL
IFSMEPVFAAISAYFLAGEFLTPRGFLGAGLVLAGMLVVEFSGSKNEQLSK
>fig|768704.3.peg.2504 Vancomycin B-type resistance protein VanW
MEEDANPAELSQLQNFLKRYKPFLIILGILMTAIGLITLTLVIYTWDRGQIVRGVELEIP
LEELTIEEARDKLEQQRNEYYQRSVHFIADDKNFVINMKDLGFTYDYQEPLQEAYLIGRE
GTILDKAVSKYKASFGIIKEPNYQWDDLILAEALTTHSSFLNMPAQDAHFLINPDNSLDI
IPENQGKEVDLDSLAQIVKTQALKGDNSIVVPFKEVKPAITKKNLELVNKSDVISEYTTT
FDQTLIERSLNIKLAAKAIDGKVLKPGEIFSFNNTVGPRTEEAGYQTSMIIEGNTFVPGL
GGGVCQVSSTLYNAVCLAAPALSVVERSPHSLPVKYVPLGQDATVAYPNLDFKFQNLSEG
YLLIRSIVNSNTLTFRIYGKPKELS
>fig|768704.3.peg.2921 Fosmidomycin resistance protein
MSNLYLIFLSIGHLVVDLGQGILPILTPVLAKSFDLSYFQVGIIALAFTFSSAIIQPIFG
VLSDRYSMPWLMPVSLFLSGFGLALTGMVHSYGLLLLAVLLSGIGVAGYHPEGSKLAHFL
SEDSKAGSSMAIFSVGGNLGFGLGPMLAVFVLSFAGLKSIQGVMIPGALAALLFLFLLPR
YKAILAEKSHKQKKNTKQGVKSKVRIGSLILLLLYVTIRSWIQSGLVYFIPFYFPSFRGI
SDPEYIVSIFLIAGAVGTILGGPFADRFGGKNGLLVSMIVSLIAIYPFLHLNSTLIPVLA
FIVGAALISTFSTTVVFGQRLLPNNIGLASGMLLGFGVGMGSIGVTLLGGIADHFGLPLT
INIISLLPILGIILAVTLPDIRAREAVVEPNPAA
>fig|768704.3.peg.3241 Drug resistance transporter, EmrB/QacA family
MEKTTQRKMVTTAMLVSILLVAIDTTIVTTAMPHIVEQLGGLNLLSWVFAIYLLTSSVTT
PIYGKLADLFGRKSIFIFGIVLFVIGSMVSGMAQTMYQLIIFRGFQGLGAGAVMPLTFTI
IADLYPGEARAKMQGVFSSVWGVAGLLGPLVGGLFVDHISWRWIFYINVPIGMVAIFLVL
SFLHETPLEKSKKIIDYWGAALFTLSMSSLLFALISGGQVYAWYSVEIILLFTAAITFLT
AFLYVETKAQEPMLPLSLFKIPVIAVSNAVGFVASGVLIGVNVYLPIWIQTLLGHSATSS
GLTLMPMSFAWPLASTLAGQFMYRIGSKATAVFGAVLIMAGSAWLLLVHTGSPYWYFVGV
MVVIGFGMGFSFTPLTVLVQSAVGWNLRGAATASNTFSRSLGQTVGIAVFGTVFNNTMNQ
SGMAQGLHVVFILVFAISMVTLLISILLPSHRSIMAQQNAD
>fig|768704.3.peg.3806 Acriflavin resistance protein
MIEYLIKKRKITLLFFIMLVVYGFITFFQLAHQEQPDIVVDTAMVLTVYPGASPEKVEQT
VTKKIEEKINEIQGLKSITSQSNPQYSKIVVQLQEGVDPKEKWNELRNKVKDVESSLPSD
CKQPEINDDLSKTFIETFTVTADSYQEVYALRDTLKVWKDQLRTLPNVADVSIMGLPDQE
IRIDVDTHKINQLEIPWTQVAGAIKKENERTPLGDLEQGDRLYQLKIKDTHDPEALYNTV
ISMNNQGVPVYLRDVATITVACEKEESLVSFNGQPAISISVQGEIGSDVPGMQKNVDEMM
KELEKQLPSGAQLNHVYSQNERIEDLFSDLTLEVLLAVAAVLLVCSLGLNFVTSCIIAMA
IPISLSMGLMLTPNLNITMNLVSVAALIIVLGILVDDAVVVNDNIERRLIELGEPPLQAV
VKGTNEVFISILTATAATIFAFGPIAFLQGNVGQFIRPLPIIISLSMISSMAMSLTIVPI
FRHWRAEKLSVFPARHSKSNGFLGKQLDRLALWYSEKLMPRILRKPLKVGLMAVLISTLA
YGLFPLLPVQLFPNSVRGEMLIDVRMPKGESLDGTNQKVQEIASWVQKQEGITLVNTYAG
DSAPSMFRGDLSIGKGNNLGQIVVKINTEQKRTEELVPEWNAKFSEMYPGIRVLAKEIKF
GPPIGAPIDIRIYGEDLYVLQTLENEVKESLLKYPGAVNINGSIGQDKTGIELTINKAQM
DQNLVKYDDLTKTLRLATEGIEVSEFDNGKDLINIVMYSDKSSPDPRLVFDRLYVPNASG
KLIPLKEVAQMEPSFSINTVPRRNLSRLAEVTSDLDGVTATEAMEKIRPLMAGIKLPAGY
TLEFGGETSEQTDIFTDMGRLMIVAIFLILIVIAMQFYSLSLPILVMSTVYLAFAGSMIG
LLITRTPFGFGSVMGLICLVGIVVRNGIVLIEFIENERHAGVALEQAVINAGRARLKPVL
LTAGTAIAGLLSLATGKELMFRALAITIIAGLFYSTVMTLVVVPSFYTVLTKWKEKRRLS
RQTNNFNV
>fig|768704.3.peg.3966 Antibiotic resistance protein (antibiotic efflux protein)
MIKANPSQNEQIWSKTFFLILLVSFLMFLSMYMLLPTLPLYAQSLGGNETIAGTIVGIFT
LSAVLVRPWFGNLLDYRGRKLILIIGIAIFLVSVLAYNLAYTIIFLLTIRAVHGIGWGAS
TTATGTMASDVIPAARRAEGMGYYGIAATIAMSLGPALGLYLVKNNSYSLLFAGSAILAG
LGFIGSFFINYETSPKRQAKKKDPRVKGVILEKTAIPSALVLFFITLTYGGIVSFLPAYA
GFRGVDNIGIFFTVYALVLLLGRPIIGKLSDKYGPRRFLVPGILMLVAALVLLSMASSLS
MFLLVAVVYGLGFGTVQPILNALVITLSPPERRGAANATFAVAMDLGIGLGAVILGFIAQ
ELGYVYMYGSSVIFALLALVMYFSFLRKKLPDEPRILS
>fig|768704.3.peg.4000 Permease of the drug/metabolite transporter (DMT) superfamily
MILPKKEHLRHYLTNKYWVVIIALFCAVLWGSAFPVLKVSYLELKIAPDDRSAIIVFAGI
RFFLAGILIFLITMLGLGQTPKVRKTILPQLFLLGLLQISLQYFFFYNGLAHTTGMKAAI
LSSLSTFFVVVLAHFVYKDDRLDIRKVAGLAAGFLGIILINSGQNFTFVFSWQGEGFMIL
SGGVSALGTILAKRISQEVHPFVLTGWQMILGSSLLIVVGLPGLQPQAIVFSNKAILLLG
YSAFLSAAAFSLWYAILKYNKAGEISVYKFMTPVSGTILSALLIPGEHLAVNMFLALALV
ALGIIIVNYQRKVPEENLLR
>fig|768710.3.peg.2243 Permease of the drug/metabolite transporter (DMT) superfamily
MLIKTKIARLPKHWLGVIQVTGAAILWGTSATLAKHLFNSAVSAFDVAQMRLTLSFVLLF
LVLSVCKPELLRVRRSDLGYLAIFGIVGLGLLQFTYLFALSLTNVATALFLQYTAPIIIL
IVGLLLRTEVLTGIKLAALGASIVGGYLIVAGTASGFGLNPLGVVYGLAAACTFAFYSMY
GKRGLKTYNSWTLLAWGMGFGSFVWCFYQSPWTLALRYGGLEWLQFLYIAVFATVLPFGL
YIRGLQNLSAFRAGMIGMLEPVVGAISAFFFLGELLSLTQIFGSSLILLAVALLQMNALK
QSRDEGYDRPENALREDGI
>fig|768710.3.peg.2577 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MPAEKARNKNMTEGAIGKQLILFALPLLAGSLIQQLYNTVDLIFVGQLLGKEAAAAVGAS
SLLITCMVGFFTGMSVGSGIVAAKCFGVGNYRELGRIIHTGVAIGVFGGALLMAVGYIFA
PVFLRWLNTPEDIFIQATGYIRIYFLSLIPLVGYNIGAGILRALGDSKSPMIYQLVGGLT
NVAANALFICLLGWGVKGSALASLIAQGLAAALVFFHLSRLDEAYRLRPRQIRIDRTAGG
QILAVGIPAGIQAMVITLSNLIVQYNINSLGVDSIAAFTAYFKVELFIYLPIMAYGQAAT
IFTGQNFGAGKLERVKRGTRVSLWAGIITTVVLSGLVLIFARQAFALFSNDAGVIELGRK
LAFTTFPFYFIYLVMEVLAASIRGTGKALPPMLIILTNICILRIALLSIMTVIAPGIRGI
AIVYPITWASTALCMFVYYRRMPKEV
>fig|768710.3.peg.4098 Permease of the drug/metabolite transporter (DMT) superfamily
MPTGKKQIYLILLLVVMLWGLNVIMIKYLAQLMPPILVAGLRMLLAGGFLLIFVFKTYGF
YNPDRKQWRLLFLIGLISVFIHQLFLGYGVLTTSATNAALILALNPLTTALLASLFVNEK
FTRNLGLGILLGFTGVVLVVFSNSSDGSVEFSLIGDILMVLAMLTYVIGALLIKKLMETS
IPTVVVTAYSTLIGGILLNIGVMGSLGLSVYGQIHFSATAGLVLLLSAWGATALGTLGWN
HGIKHLGANRTAMFLNGMPFASMVGGVVFLDEKIGLIHIIALMLTTLGIVIGSIKPKEVK
SMYAGISPD
>fig|795359.3.peg.290 Membrane fusion component of tripartite multidrug resistance system
MIKDKKRIGFFILVALALFFLSWLIYFLWHRYHYAVTDAVFVQADNLIYVSFPKVNGKLI
KLYKNEGDLVKKGEILAEIESTDYALKVAQLEKALKEVENQQSALGFNIAKLEKEIPLKV
DQLTKQKDRLKEEERAKFYDIEKLKARLNQVRRDKVRYEKLYKDGLISAHELEEIQTQEK
ELENQISSVSAQLLAIKKQQEEIDKNIALTLNEKNTVLAYKSFLLSLEAKKKNLEKQKEE
AEVYHTYTKLYSPVDGVIAKKFHSEGDVLNPGEPVYAIVDPNSFYVLVLLEETKLKGVKK
GCPAKIKLDAYPDKDFEGIVDEVLPASAATFALVPRDISAGEFTKLAQRIYVKIKITKGD
RSLLRVGLGGEVEIKRSL
>fig|795359.3.peg.1007 Drug resistance transporter, EmrB/QacA subfamily
MKPIEFYYQVTPLERIAITITLMIGHFLAILNTTVVNTIMPKLLGPLSTDLYGVQWVGIS
YMISAAITLLFVETFSRYVGYALCYTIGLILFITFSAFSGLANSLPQMIIFRSFQGVGEA
FIMATAQTILLNVYPPEKRGTAMGIYSLGVSFAPALGPTVGGFLTEYISWRWAFYINVPI
GILDLVAAISFLPYTLGKRKEFSFNFISYGLISLATIFLLIAVSKGQQYGWFQSTFIVSF
LILSLTFYSLYFASEIMSKKPLIDFKIYTIPEFGLAMAFQFFILGFVMYQVFYLIPIYYQ
NLKGLTTFQAGLHMLSYASFTGIFAIISGKLSDKFSPIIILSINFLILSVTTIFLLPKLN
YYTPALKAAILTIPLGIAMGCFFAPLTTLAFRNLGEKTGLGVVLFHYQRFVGGSIGIAIA
TNTLEKRTNYHFLRITELQEFRYINMLVEKWWYNAQKYFSEAYAFKKAKALLYKTEYIQA
LSFAFQDAFKQTFFWTQIGGIFLIILILYKFKILTFKSSIYNKKLIKNFR
>fig|795359.3.peg.1085 Multiple antibiotic resistance (MarC)-related protein
METGFLIKSFLTLFTIIDPIGGVPFFLSISAGYSEEERKKIALRASLTACLTLLFFLWIG
KYLLSFFQISVSSFRIAGGILLFLISMEMLFGKTTQVKTTEKETLKVKEKEDVSIVPLGI
PYLAGPGAITTTIILGETSTLHTKLGLSLIIFLVLLITYLIFSYSSKISKLLGELGTKAI
VRILGLILASIAIEYITTGLKEIF
>fig|83332.1.peg.2335 Drug resistance transporter, EmrB/QacA subfamily
MNRTQLLTLIATGLGLFMIFLDALIVNVALPDIQRSFAVGEDGLQWVVASYSLGMAVFIM
SAATLADLDGRRRWYLIGVSLFTLGSIACGLAPSIAVLTTARGAQGLGAAAVSVTSLALV
SAAFPEAKEKARAIGIWTAIASIGTTTGPTLGGLLVDQWGWRSIFYVNLPMGALVLFLTL
CYVEESCNERARRFDLSGQLLFIVAVGALVYAVIEGPQIGWTSVQTIVMLWTAAVGCALF
VWLERRSSNPMMDLTLFRDTSYALAIATICTVFFAVYGMLLLTTQFLQNVRGYTPSVTGL
MILPFSAAVAIVSPLVGHLVGRIGARVPILAGLCMLMLGLLMLIFSEHRSSALVLVGLGL
CGSGVALCLTPITTVAMTAVPAERAGMASGIMSAQRAIGSTIGFAVLGSVLAAWLSATLE
PHLERAVPDPVQRHVLAEIIIDSANPRAHVGGIVPRRHIEHRDPVAIAEEDFIEGIRVAL
LVATATLAVVFLAGWRWFPRDVHTAGSDLSERLPTAMTVECAVSHMPGATWCRLWPA
>fig|83332.1.peg.2461 Multidrug resistance integral membrane efflux protein EmrB
MTPRQRLTVLATGLGIFMVFVDVNIVNVALPSIQKVFHTGEQGLQWAVAGYSLGMAAVLM
SCALLGDRYGRRRSFVFGVTLFVVSSIVCVLPVSLAVFTVARVIQGLGAAFISVLSLALL
SHSFPNPRMKARAISNWMAIGMVGAASAPALGGLMVDGLGWRSVFLVNVPLGAIVWLLTL
VGVDESQDPEPTQLDWVGQLTLIPAVALIAYTIIEAPRFDRQSAGFVAALLLAAGVLLWL
FVRHEHRAAFPLVDLKLFAEPLYRSVLIVYFVVMSCFFGTLMVITQHFQNVRDLSPLHAG
LMMLPVPAGFGVASLLAGRAVNKWGPQLPVLTCLAAMFIGLAIFAISMDHAHPVALVGLT
IFGAGAGGCATPLLHLGMTKVDDGRAGMAAGMLNLQRSLGGIFGVAFLGTIVAAWLGAAL
PNTMADEIPDPIARAIVVDVIVDSANPHAHAAFIGPGHRITAAQEDEIVLAADAVFVSGI
KLALGGAAVLLTGAFVLGWTRFPRTPAS
>fig|85643.4.peg.542 Permease of the drug/metabolite transporter (DMT) superfamily
MHKTELDRLAIGLMVVLCSIWGLQQVAIKLASAGISPVWQAGLRSIGATAIVVVWALLRG
VKLFERDRSLAPGLLAGALFAGEFAMIFLGLQHTSASRGVIFLYTAPFFVALGAVWLLPQ
EHMRRRQWMGMALAFVGVLALFGENLFAATEGAWVGDLMLLGAALLWAATTLTVKASALA
RASAEKTLLYQLGVSALVLPPLSLAMGEPGVFAPTPMVWANLFFQAAIVAGVSYLAWFWL
VREYPATRLSSFSFLTPVMGVLAGGLILGEPLTPAVYAALFLVGSGIWVANRS
>fig|85643.4.peg.3880 Permease of the drug/metabolite transporter (DMT) superfamily
MTTPHPSHSDAVRGLLAALAVVVFWSGFNLVSRFGATTSFSPFDLAAMRYGVSGMIALPF
FLRFVPMRDWPRHAVLACVGGLAYGLCVYWGFAFAPSAHAGVFVNGGIPFWTIVIMAVTS
GFRIARPTVVALLLSTAGLLLIGFESLLAPAQGSAWIGDLLFLAAALAWAIFGLLMRRWQ
VKPQFGILGIASFSALVFMPIYLLWLPSGIGAASWGEIALQCVYQGVIASMLAAGFYSYA
VQKVGAGEASMMLALVPAFTAIGAYLILDEALGTTTIVGIVVVSAGALLGALPPAALARV
RGSGSAHSAR
>fig|856793.5.peg.84 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRSETDTTDNTASSATANPLHGRGRHGDLTSGPVQAHLVRLSVPMIWGILAIVASQLVNT
FYISMISPAHLAAISFTFPVTMTVLSLIIGLGIGMSSVVSRAIGEGNHDTVVRLSSHGLI
LAVIAGVIMALVGHAIMEPLFRAMGATDDMMPMVLDYMGLWFAGIVFITVPMVGNSAIRA
TGDTLTPALIMMGTTAFLVILDPLLIFGLFGLPRMEMHGAALATIISYGVSMLVALWILK
YKKRIIFQDGLHLDQFGDSARRLLFIALPAGITSTIQPMTSGVLTAILAQSGTHAVAAFG
VATRVEAFAFIVIMALATGMSPILGQNWGARRFDRVHETLRLAIRFCVLWSVAVAAILMI
GAYPLAGLFSTDAETVRMTALYFLIVPFSYAAGNLVPGWSSAFNAIGLPQRSAAMIGVKM
IIVQIPLAFIGNHFFGVIGVFASIAIANIGTGLYYHWRNKQHMTTAELAHSPA
>fig|856793.5.peg.589 Glyoxalase/Bleomycin resistance /Dioxygenase superfamily protein
MKRLHIHLGVKNIDDSVRFYSALFGADPVKHKPDYAKWMLDDPHVNFAISTRAGKTGVDH
MGIQVDTADELNAIRTQMSDANISTHSDGETTCCYAKSEKSWVEDPNGIAWEAYHTMEDA
QIFSAADTSSESGACCVPTTKSGSCCG
>fig|857087.3.peg.594 Glyoxalase/bleomycin resistance protein/dioxygenase
MSKFDLTIHHASLIVSDTQQSLTFYRDILGMQPTERPPLPFPGAWLQIGEQQIHLLELDN
PDPTTGRPPHGGRDRHVALHCSSVDALRDELEKAGMAYTMSISGRKALFCRDRDGNALEF
IERPS
>fig|857087.3.peg.2544 EmrB/QacA subfamily drug resistance transporter
MLFNLCLGLSHVLVIFNAGAYIAMLPRVAAGLGIPPSFATWTQTDYMVGLALAFPVGGWL
SRRLGEYRPFVAAFFVFALASVICATMTSFYAYLAGRIVLGFAGGLTLPLGQSLLIKEYP
EQKKSIGIGVWSVFTLTPFTFAQPIGGWIADTLGWRWLFWLNIPTALTIGGVVGALLYRR
GITRIRHRFDGVGFVLIALALFGTQTVLNQGNDWDWTNSLYIGGLIIVVVATLIYWVIWE
CSHRRPFLDIRLFTHRNFTIGVIILFLGFLMFQGLLSMLIVQLQLALGYSSLLAGLVFLP
MAILAKPVAGVFHEVVKYIDARWWVSLNCLGFAAIYFWLSHFDGHDAFAQLFWPKVLEGA
CLGSFFVPVTALILHGLAPEQTWRAVELASLLRIAAGAMGISLQGIVIYRRAPVHITRFA
ESHTLFDGRLEQTLDTLVSAGFNESTAIARLAKLAGRDAVIHAMNDAFWLASCLFVGLSI
LVWFANPTKLSAKRTLKQLQRRETQEMLVEAP
>fig|857290.3.peg.215 Daunorubicin resistance ATP-binding protein drrA
MHKDIQDIHSKDGRAPVRDFGQFPGQAVLELDNVSRSFNKGAVQAVRDVSFKLHPGEVLG
LIGVNGAGKTTTVKMCSTLLDPTSGQIHVAGIDTRTSPREARSHIGLMLGGSGGFYPRST
LKDNLLFFADLAGVSSRERQAEVRRTLELVSLGDMENRKAYELSRGQRQRLHIARALLGS
PELLMLDEPTTGLDPDIALKIRGLIRSVADSGVGILLTSHSMEEAEELADRFVVIDRGAV
RVSGSLDDVARYADISRTTTFTFTPSGSFGLDDISRLVDNDGFIMHRAVGSQWRVTVMWH
SAAAGRVAQRCGAIASCTSADDLLTRPANLEDAFLAIAEMGQSPAVSAASSGERG
>fig|861360.3.peg.389 Glyoxalase/bleomycin resistance protein/dioxygenase
MAQIGMITLDTVDEQSAAAWWRAVLGGKYAGQYPGFTMIRVPGFSAMLGFQKVPEVTAGK
NRVHLDLSATSDRAREVEIFVKAGATRLEEHCDDPDFGWSVLRDPYGIVFCISDPHDQ
>fig|861360.3.peg.1714 Vancomycin B-type resistance protein VanW
MQTPSPDSSSTTPTHSPQDKKKPKSKAKPWIITGSCVAAIAAAYFGGAAYVSSQVPANAS
IAGVNIGSMNKDQARSELEREVLPLAEKDIDVTVNGEKYTLDPAKAGLALNVDETINDLT
SYEINPVELYERLTGDVHVDPAVDVDQEMLSTQLEALAKKANAELAEGAIEFKDGTAKLT
KPIDGVVLKADEAASLITDEWEIAGPALTLPAEVTKPKISAESLQAFYDKDIKALLKDDV
TLSSDKKKATISVESIVAAASYTPKDGAPAITLDDKKLYKAATKNSDLSSTAENAKIVLK
DGKPSIVKSSKGVSLETEGLGAKVLAATADKKRTATVEMTETEAEFTTADAKKLGIKEPI
VTFSTPYPASDKVRTKNLYAGSARVNGDIIKPGERFSLLEALGPITVANGYFSSGVVESG
FSTEAVGGGLSQISTQMYNVGFLAGYDDITHKPHSRWFERYPAGREATLWEGQIDMIWEN
NTPYGVMIQAWVSGDKVNTRLWSTKYWDVSQKSSGKYNLTNPETKYNPAEKCVSESGGKK
GFSIDITRYRETFDGSKKLPAETKSWTYSPWHKIVCGEKPKD
>fig|861360.3.peg.2944 Probable multidrug resistance transporter, MFS superfamily
MASYLLGMIPALAFGGPLADKFGRKPFSLLALMCSILGSAGLIFGSMHDSGLYAGRVFTG
FGMGLAMVAITSWVKLISPGPAGATRAALCTSLGFALGPVISGAIVGATASPELAYSVHG
VAAFAWLLLLFTAKEDSSVDLAGNHSRAEPTTPENLQRFYRIVLPAAPWVFGMAATGFAI
VPALSNGAGESSLFYTTLAVAVTMGMGTLIQPFVKRFNDLGKIQLLMAGLATSLAGLLLM
IVVSLSGSEFLGTIAFVIAGAANGILLVAGLSQVLDLAGSADVGKLTGRFYMCCFIGFTF
PTFFALWRSIAHPAIFIGILAVLCLLSMMQVYRSRKYLPNVVLEEVRNSP
>fig|862517.3.peg.61 Permease of the drug/metabolite transporter (DMT) superfamily
MKNKNLKGYLYTLLGATFWGLSGTCAYYLMNDRSIPPLDLSTYRMLIAGSIMLIYILIKN
GKEALRVFTNLKDTFVLISFSIFGMAAMQVTYLITISYTNAPTATVLQYTGIVMIVVLVC
VLETRLPYRAEGFSIIFAILGTFFLATRGNIHTLVISNEGLLYGGLSAVAMMIYTLVPPK
LLKKYGTINITALATFISGVMMILVSRPPIPEKIDSLIILAFMGLTFFGTIISYTLYFEG
LSIIGPVKTSLIACVEPISALLFSMVLLGEHFVFMDFVGIMCILFAVAILSIKDLWVKE
>fig|862517.3.peg.974 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKRYLKFIIPSVLSMWVFALYSMVDGFFVSNYVGEVEFSAVNISMPIITLFFATGILFSI
GTQAKVGMNLGKGDFNLANKIFSTSIVSLIFIGMLFSGVIYILLDRIIYILGASDATSEF
VREYLKAIVPFGMFFMLSYQLEVLVKVDGAPHISALSVIIAAVSNIVLDYLFIVELHMGI
FGAALATGIAQAISSFSFILYFSRKTGRLRFVKNFDFSILKSTLPLGVGDAISEVAIGFT
VFLFNVNLFKVYGEDAVIAYTVISYVSVLVTVTMTGVAQGLAPIFSFDYGKRDYKKIRKF
VERGVITIILISIIFIFVAHKFAEPIVNIFLGADSGVLHETSIALARYSWAYPFIGLNGL
MVTFFASLGRGRLATTLSVLRTPILVSLVMFVFRTFMPDYFLWYVLAFSEGLVFPLGVYF
VNRFIIKPIKYQL
>fig|862517.3.peg.1142 Multidrug resistance protein 1
MLNKNLLREIGREKNSLLILILLKVFELFTNIALIFSIGNFLNEIVKGNYLVKGFIFQIF
AIILIKIIIIKYNFYISHKISNRIKKSLRQRLFKKVYGFKMEYGEKISISEVINLSVEGI
EQLNIFYGELLPQLVFSLIGPIMLFIIMSFVNLKIAIVGLVFLPFIPIAIFMVQKLAKRV
VKSYWKSYANLGEVFIDFLYGLTTLKIFNADEKYNDKLNEMAEDFRVKTMKLLMVQLNNI
TVMDLVSYTGSATVIYMTLKYFSMGQISIFTGFVFILLSQEFFNPLRRLGALFHVAMNGI
SAATTLFEVLEIEEPVDGSQVIDEDRVTIELKNLDFSYDKEQVLENINLTCKENEITCLV
GKSGCGKSTIAKLICGMLGSNGKNIFYNGKNDIKSDSIIENICMIDNNPFIFSNSLRYNL
LFANPTASDEELMDKLKIVGLYEYFENQDGLDTIIESQGNNLSGGQKQRISIARALLRKP
KVLILDEAISNIDIESEEIILDILSRLKKDMTIVLITHRLRNTENADYIYFLKDRKVIEE
GSFVEMKEKENFGNLYNSQMDLEMWGVK
>fig|862517.3.peg.1255 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSNNINLTTRADIRNRIWQLSYPAMVSMLLQTVYDLVDMAWVGQISKQAIAAVTIFSTIF
WLFLFFNELIGASSVSMISQNYGKGDKEMTRLVSEQTMSFKVFMGFISGVLLYFTINPLL
NFYLKNPSTVKLAMDYGYIRIFFLPAMYASYSVNTIFRCQGDPKTPMKIMIFSTILNIIL
DPILMFETIPFTNIPGFNMGVKGAGVATVISVMFSLIYGLSILLSGKNEIYVSLKGLFKL
NWNIDLDLLKIGLPNALKQFAGGLFMAIMVKFVSHYGDSVITAVGIIAKLQTFIYMPVNG
LMMGGSIVVGHFLGRREIENAEISASIASRINFLIMAFFSILFAIFPQYLFSIFNKDPEI
IQMGKELVPIVTLTIPLTGYAFGQSIVFMGSGYTKPYLVGSLVSQWLLQLPFVAICVYVL
KLSYRSIAFSFPLADIVYFVIILIFFKSGKWKTMDVTKKINSNM
>fig|862517.3.peg.1891 Permease of the drug/metabolite transporter (DMT) superfamily
MNSLKKAKNLGPIYMIASSFFFALMAVFIRYTKDLPTFEQVVFRNFVISILMFLLIVKEK
RTHEMKVKDGKKEIFYRSLFGFIGMVCNFYAVKYLNIADSSAIGKLSPFFVMIFAALLLG
EKLEKHSIVAIILSILGMLLVVKPKFDGSMVPSLVAVAGAVSAGLAMAMLSAVGKKVRGE
VIILYFGIFSTLACFPFLVGNFVIPNGTEILNLLMIGVSAGFGQFFLTLAYKSGKASEIA
IYNFSQIIFSIFIGYFLFSEKTDLISLTGMAIIILSAYYNYKRSIVYD
>fig|862965.3.peg.384 Permease of the drug/metabolite transporter (DMT) superfamily
MVILWGASWPWGRVVAQAMPTFVASSLRFFFAIIPLIIWLYAANRFKYAKQLNANQWMGL
FVTAFFGVFAYSTFFIWGLKYLPAGQAAVIVATNPVFTTLLAIFLFKEKWNRWVILGMVI
AMSGTLLALTKGNFLQMMDSFGFGQILLIGALICWVVYTLLARKVLAGIDSLTATTLSSI
FGFLLLFISALCVESSGDWLTVLNLSQGEWISLLGLAFGATVLAYAWYFDGVKHLGAGNA
SAYIILVPILGILFSAVWLNEQVDSSLIIGGILAVSGLGIMHWGRRLIK
>fig|862965.3.peg.582 Permease of the drug/metabolite transporter (DMT) superfamily
MIIESVCLVVFGSLVALWQGESAVDFSLGFICAFVPFCAFAYIVFFRKQDFSTKLTAFYR
GETLKFMLTIVLVGVSFKWLSISHFILFFVGFFTALALNNVIPFLLNRS
>fig|864564.3.peg.866 Permease of the drug/metabolite transporter (DMT) superfamily
MNRKNELRTFEGSVALVVAAACWGFAFVFSVQGSQTMSFWFFNATRFTLASVSLLPFAVW
SFIKNHKIVIPDENRRMRVNSGAFRVPVISLSDLQRKGSFLYRVLIYCVCGVLLFVASTI
QQLGLEVSKQAAHAGFISSLYIIAVPILARIFLHKRTSLFTMIGILVAIIGFYFLSIPAG
AGFSRMDPVDLIFLASATLFGAHIVVLDANVHHVDSMMLSFVQSLVVAILSWIGAAFDGS
INMTAATHGWISIAYTGIVSVGVAYTLQIFGQRFVQPAQASILMSLESLFSAVGGILILH
EFMSGRAIFGSSLIFVGTLLSQIPVENLRLRRNRLESTGNTADFAPVDEDDPAPLPLPDG
AQVPGAESEDKTVETAPSQSATL
>fig|865937.3.peg.967 Tetracycline resistance element mobilization regulatory protein rteC
MILLNIKKMDFQITKEEIEAEILRIEQTFLNKLSAYNKIISYCREILESYRKEIRLNDFQ
DIASEILFFKKQKALPLTYLIYYENRLSIELEIPSAGEAFRQKFIFKMIERTNSFFFAHK
NFLQYMALDQEYLDEFYFTRRFTSKNHMINYKNYERDPLFSTSHDLLLSELNSHKFLLQY
LNKLSVQVKLSSSLVFEEPIKIKWTTSKVALTELVYALQLSGAINNGNTTLKDLFSIFEI
LTGLDMGDYHHTFLKLRGRSEPLKFIEKMKNSMLEHMAGLDA
>fig|866536.3.peg.1119 Tetracycline resistance element mobilization regulatory protein rteC
MLREHAKDLISNLEQEISMLTLEDSNRLQQLEKAFHLAEKAVISMRSYLDTYKFQSEEEE
ISFFKLINPLLLKEAFYYAELFAVESNKPLGSNKKIRSYYSKAIRRIVKMLGKHKHLYNY
VNLNESKFDHFYFLRNSENNLKQPTGELLYMDTKYVTLQSYNLGKIYAWIQVVEQLQEDI
LLLDGQQGISTSVKQGLTWTAPKVQLIELIYALKASGVFNNGNADIKQIANALGCLFDKK
LTDYYRTFQEIRGRKKSRTVFLDIMQERLVKWMEEGEGLN
>fig|866775.3.peg.155 Tetracycline resistance protein TetT
MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRAST
VSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLN
IPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQ
IIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFA
ITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIK
SLESIMNGEIVKVDQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPC
DLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILKLFGNIQMEVIESLLKSRYKIDARF
GELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSF
QNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGT
EILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSEL
LSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN
>fig|866775.3.peg.342 Glycopeptide antibiotics resistance protein
MIFLGPLYHLLAYLLADRVNHFPLIRLLVFSLDKTILYTLIFLTISALIAHVKKRRQAQW
QVDWSKYGHILALFVYLVLLHLTVLRYDWQWWRLSLVPGVTLRDFHWLPLVDTIKLAYGD
SSFSYWYNFFGNVLWFIPFGWLLAYFFCGQRSFFRVLFMGMGFSFMIECGQLFLGTGLGH
IDDVIFNSMGVVIGHFAYDFKHFFLMKHESR
>fig|866775.3.peg.728 Drug/metabolite transporter (DMT) superfamily protein
MMPLQLTMYRMLTAGISICLFLAYKRKLPIEKLKNDKRSLLQIAIFGICGIVFNQFSYLM
TIHYSNSGMATILQFIGPIFLLVYYCLVGRRWPIRREIVALLFTIIGVFLLVTHGQLGHF
VLSTEAFFWGLMSAFGLALLNVLPLRVIEHYGSLPVTGIGMLFGGIFLIFFNFEHLVPPE
LSLHFLAWFTLTIIVGTIVPYIFYLSSVTFIGPLAASLIGSVEPLTATILSVILLGESFA
LIDYLGMAFILLTVFLTAHE
>fig|867900.3.peg.1912 MFS permease (drug)
MQFCNMKKITNLGIFTLLLVSSLTIMVGTVIAPSLTGIVENLNFSFSPGWLITLPSLGVV
VFAPIVGKLLHKTGSYTMLCLGLVPYALLGVAGAYITNDYILMLDRFLLGAATVAVQVSV
TSFIADFFTGEKRMKLIAWQGMSIELGGVIFLSIGGILGQWHWQYPFFIYLLAIVCWLLV
IKTLFKTIKSDEVVAKQEKKESKLAIKTIFYASLLSMVLFFVSFVTLPIYLPKSIGFTES
YTGYFMAFISVIAIITASQMPRAVKKIGDGKVVALGFLFFMLGYVTLAFFNSIPLLILSA
VFIGTGFGFTIPLLNHMMIEVSAPKNLGKNLGLYSMGVFGGQFLSTFIEYISTNYAVVYT
VTALLALVIGIVLYYAFKKIEEHNQ
>fig|867902.3.peg.504 Multidrug resistance transporter, Bcr/CflA family
MNLKTRLIFLIGAIAAIGPFTVDMYLPGFPAIARDLNTTEKMVSYTLTSYFIGISIGQLF
YGPILDKFGRKKPLLLGLTLYLISSVVCALSPHVYVLILARFVQALGASVGMVAGTAIIR
DQYGASEVAKMLSSVLLVMGVAPVIAPSLGSFFISHLSWRYIFYFLTLVSGVLILSLKIF
LSETHGYQPHMDFRIRPILYNYYTALRQSKFVKYTLGGSIAMAIMFAYVSSIPFILMNIY
KVSAGTFGIIFACNAAGFISGSQFNRLLLRKFQLHNLTRIISLVQLVISVVFLILAYNFE
LPLPVFLAFVFVVLFLLGFINPNATALALESFEKNIGVASALNGAVRMAAAALTSAMMGV
CYNGTQFPLIWFMVILSLFGFVFIAWARRSSLA
>fig|867902.3.peg.2032 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLSQAGQIVVNVADNVMVGGLGGRFDYVENIQLGTTALAGVALGNSVLFIIMSTAFGFSF
GMSPLVAQTDAKNNIQRGAKVFSHGLLLNLIITALLLIVLFSIEPLLFKMKQPVEVVQAA
IPYIRIAGISIIPLMIFQSLRQLSEGLSLTLNVAIATIVANVLNIFFNYLFIYGNWGMPR
LEIAGAALGTLISRVIMIFVLLFLMLKNPKTQMYLKAVSFKIFNKFIFRKLAFLGTPTAM
QMFFEMGTFSAAAFICGMAGTDQLAAHQIALNLASITFMLCIGISTAATVRVGNQFGLKH
FQNLRKAGFSAIVMTMIIMSISGISFIIFRHVLPEFYTENPAVIGIASQLLIIAALFQLA
DGTQVTALGSLRGMQDVFVPAMITLVAYFVIALPLGYFLTIPKGMGALGMWIGLGSGLIF
SAIALVSRFYLKTKQLLLQN
>fig|868864.3.peg.1531 Acriflavin resistance protein, AcrA/AcrE family
MKTKILFIAIIVGLVLIGVTAIKKKKEEISKIPPPKIYPISVKWTTIKSGELQEEFNYIG
TFQPYKHATISTKIYGTVLKVYKSEGDFFKKGELLAKIDDSEIKSNISALEEEKRAKENL
IPGLRAELRAAEIALKNAKEEFNREKFLYEKGAVPKVAVEKVENQLAIAESKVESIKAKW
KELKSAISSIEKKIEALKSQLKYTEIRALDDGVVSEVLAYEGSLATPGKPIIKVYYPKYG
FKILINIPPEDAKEIPIDSPVFKGEKKIGKLVKYYPSANENFLYIAEIKVNKSEKIKPFE
NVSVKVLGKPYKGQIVPIYAILHLKNGDYVLSVEQNNKVKPVKIKVLKTVKDKAIISSNL
QEGTKVIVGRESKLLEVMRRGSVVLSEAFDG
>fig|869209.3.peg.216 Acriflavin resistance protein
MVSEKTLEHPVLTLMVFTLLGLMGIFSLGNTSVSLMPDVDMPYLMVSATYENAGPESVEK
SVTTLIEDALVSLSNLKEITSTSSEGRSSVFLEFNYGTNLDIATNDVRDKLDRITRRLPD
DVTPTIFKMDSDSQPIMRIAVRGNRSVDELKKIAEDQVVDILEQAQGVGQAESMGGRTQI
VRVELEQNRLQAYNLTLSEVSSSLSKQNLEIGGGTITEGTMDYSVRTTGEYTSIEQINNT
VITTKNGYDVKLSDIGRAFMGYKDASNVVYINGLPGVYVSITKQSGENSVAVANAVYEKI
SELEKTLPADISLEIIRDDTESIRDTLNTLFDSAWQGLLLAVVILFVFLCAIKTTIIIAV
SVPLSIIITVLCMNFAGITLNMMTLTGLILGVGMVVDASVVMIDNIYSYRMRGAKPNVAA
VLGSSEMILSVVSGNLTTICVFIPFLFFMKDLGFMGQMFKGIIFTIVIALVSSLFVAIFL
VPVLAGHFLPITNRNEKPVKSRFFKVLYGIFTKSQDIVSLGYEKLLKKALDNRGVTVVVC
VTALAFSFMLIPTLRIQLMTGGHDDSVSVKLGLPVGTSLEETSDVVLRFEEIVKNEIKGY
KNIITSIGSSWRSSGSYNGTIQISLPNSDKQIDNDETIKQKLRKHFTEFAGVDFSFGQSR
RQQMTGDDIDVVLRSSSLDSALDVAKKIQEVMAAIPDIGESSVDTDEGLPQVQVEIDRQR
AYSFGVNVATVANEIQASIEGVSTTTYREDGDDYTVYVMLRPEDRQKVVDLEQIYVNGTN
GRVCVANFARAVKGYGPVTISRENRRRIVHVTADIVSDENANVVEEKIKEGIKNSFIVPD
NVSVSYEGSWKDVKEQTAIFAKIMVMAVLLVFGVMAATYESFKAPFINLMTIPFLAIGVV
LIYKITGQSFSLLSAVGLVMLVGIVVNNGIILVDYTNLLVERGMPLKDACYKAGCSRLRP
VLMTTLTTILGMIPMCFASSGSAGMVQPISVAVVGGLTSSTFITLFFIPVLYTFVMKKKK
NQQSVVQLALPEEK
>fig|869209.3.peg.1407 Methicillin resistance protein
MQNHEQRFLQTEFWADFKGSHGWKTFFFIFDGDNVSKVKSLKECKENEKCLSVLVRSFSL
KIKKFSIAYIPMSPEFSSNEENLSQKFSNELESISKKIFKFLPEDTICIRFDPALDFESL
EEKNNFVSNVKKLFKQHNTKKENFRIEKTATDIQPPDTVLLSLLESEEKILSEMKSKWRY
NIRLASKKGVEVKSYSAKDADFPCAFEEFFKLFMQTSERDGVQFHQKNYYLGLLNSSAET
QNAPVVRLYIAKHEADVLAGIITLFCKKEAVYLYGASGNIKRNFMPAYLLQWNAICDAKK
IGCPVYDFYGCPPEENKNHPMHGLFLFKTGFGGKLIHRPGSFDVVLKKNWYAFYKTAEKL
RAWFYKYLKKKIAGR
>fig|869209.3.peg.2276 Small multi-drug export protein
MLKNFLWVFFISMVPLIELRGAIPVSQALKLPVISSYVVSIIGNMIPVPFIFLFARKFLE
WGQDKRLVGGICRFFLLRGTSAGEKMQAKAGRGLYFALFLFVGIPLPGTGAWTGTLAASL
LDLDGKKTSLAVMGGVLLAGVIMLVLTLLGVGAANAVAG
>fig|869209.3.peg.2679 5-nitroimidazole antibiotic resistance protein
MRRKEREITDFEEIIKILDESNFLTLAMINGTEPYSVPVNFGYKLDGDRKRIQIFIHGAT
EGTKLNCIKNCPRVSFSAVSYSEIGENKEPCAWTDFYRSVCGKGNASILEDADEKKEGLI
CILKKYGYKGPSVFPAIMIKKVSMIRIEVDDLTGKFHEK
>fig|869210.3.peg.102 Small multi-drug export protein
MEMLWVILTAMAPVLELRGAIPLGVALGLEPWPTFALAVLGNLTIVPPLLWGLPWLVRRL
EDWPPFARAWGWLEARVRLKGEARVQRYGALGLLLFVGIPLPGTGAWTGAVLAVVLGVAP
RYAFPAIALGVVLAGVLVTLATTGVLVGLRYWVGG
>fig|869210.3.peg.317 Glyoxalase/bleomycin resistance protein/dioxygenase
MYATRLSHAHLKVRNLERSVTFYTRFLDLQLTERWAHTALLVSSSSPYPYELALEEAATP
TTGVRLGFALEGREAFQEAYRFLKLEGAPFRAEDRGFAWVLVLEDPDGNRVELVWDRRAA
GGAAFWRGQARPLPEAEVLGGA
>fig|869210.3.peg.599 Glyoxalase/bleomycin resistance protein/dioxygenase
MLLHTVRLPTPDLEASVGFYQALGFALSELEASRARVVPRSGARLELVQAPLPLGAVAVL
QGARGWIRDPDGNLLLYAPAPAAPRAVGQATVHAVLYPVGNVRASTHWYARALGWPERFA
DARLPWSELAPTPKAPRLALTPPLANEARAALLLRVPAVFRELERLQEHGLEPGWVREVA
WGRLAGYTDPGGNPLVLMERNGSG
>fig|869210.3.peg.708 Glyoxalase/bleomycin resistance protein/dioxygenase
MPFRMPETAQLSQATLRVRDLEAHLAFWRDLLGLELTQVRGDRYTLAPSGGAFTLELVHA
PQAPPRPHPSVGLYHLAVLLPGPEALGALLRRLLEARYPLEGVADHGVSEALYLRDPEGN
GLELYRDRPKSAWPYRDGALAMFTRPLDVEGLLAQAPHARPLPPETRLGHVHLHVADLEA
AEAFYTQALGLTVTQRTYPGARFLAAGDYHHHLGLNTWARGRRAPPEATGLVRYAWRVTP
QALEELKHHLEARRVPYREDGAALELVDPAGVRVAVTGGTARSA
>fig|869210.3.peg.910 Glyoxalase/bleomycin resistance protein/dioxygenase
MEVIETCVYAEDLEAARAFYEGVLGLECFAFKPPRHAFFRAGRGVFLVFNPKETEEEAAL
PPHGARGSVHVAFRVDEAELPGWDEKLRRLGYTTYWAEWPRGRSLYVYDPAGNLVELAPA
RIWGLG
>fig|869212.3.peg.929 Permease of the drug/metabolite transporter (DMT) superfamily
MLVLCTVIWGGTFPAVKVALSFTTPWIIVAFRFAVAGIIFAVLYRRAAFRVAPVIWLRGA
ILGFFFFIGFTLQSMGLEYTTTSRSAFITELLVLFTPILYFILYRRLPSRYTLAGAVLVL
AGLYYLTSPEGFMDWNYGDWLTLACAAAFSAYIIGVGAWSNAETRRPLATLQSLTVAFLA
LPMAFGKGVYVPPALDLWLALLYLTLPGTVFVIMLQMRFQPLTTPSRAGVIFALEPVFAT
AYAFLLALEPFSNRGVFGAVIVTAGVVWSEAGHLFFLSAPHSSQSQKELPPD
>fig|869212.3.peg.1229 Permease of the drug/metabolite transporter (DMT) superfamily
MFWGLSFVAIRIGLESFAPFTLCAIRFFLAGFPLILLYKFPPLDWRRLVAYSIFIGVLQY
GLMFWAIYLRLPAGMSSVLIQTQVYITIFLAWVIFRERVSLLQIAGFVISALGLLVIGYD
YFGGAEAVGFILILLSALFWSAGNILLKTFRIQDFAGFIAWTSFLSSLPLFVLALSVEGP
GQMLQQIQSASLRSWLALAFMALFATQLAFSLFSKMMLKLPAGKVMPFGTLVPVFGLGSN
ALFLGERLPTRVLWGALLVLAGLVVAVVISSLLRGLEQRSKREQA
>fig|869212.3.peg.1239 Permease of the drug/metabolite transporter (DMT) superfamily
MTAEVLPRDKRFIAGLLFTVIGAAGFSAKAILAKLTYRYGVTGFATLTLRMVFAMPVYAL
IFVWYFRQQTPEQQRGFRRDWYLIGIVGLFGYYLASWFDFVGLEYISASFERLLLFIYPT
LVLIISLVWLKNRAGRREIAALLITYVGIGISYHSEAALAGNRVQIGATYVIFAAITYAV
YLVATEKLARHYSPLVFTSFAILISAVAIILHGVIAGEKLLGFPAEVYYLTLGMAIFCTV
LPSLFVAQGIALIGSNRAAIISTLGPVMTIYLAYSFLGEVISTTQTVGTVLVIAGVALLT
LKRRKVVSDV
>fig|869212.3.peg.2287 Acriflavin resistance protein
MKEKSLITERARFFWFLGLALALYGFFSWFTVAKEEDPRIKPRFGTVNVIYPGESPSELN
SFVVREIEKELTAVRGIENVDIRIRPEFAFVRIELKGSVATDAAITREWDEVENALRRAE
LKFPKGVIPPALNRKTLDQEAILIALTGPAADRHRALIVLENRVLRIKNVASAVRIGDDG
RQITLALDKSRLASSGLTAQQILSQLSAANQRLGGGSFDAGGEKINVKPHNGFESISEIE
NFSLIAKNGGTITLKTLARVSETERRPLADEMRFNSKPASALGIVARSGIDLVAFGDQVA
AAVKEFQPGPGVEIVILNSQPEFVRGRLSELAFALLESMAILGAMMLVTMGFRVGLLVTL
MLPVVGLITLALNGIAGGVLQQISIAAFVMSLGLLIDNIIVVAESVQEKLDSGLGKAEAA
VSTVKTFTVPLLSSTLTTVASFLPMLLARGTTAEFTFAIPAIAITALSVSWLAAVYLTPA
FAAAWLRPGTSRQWPFLSKVADLIAETVLQRTRRIGYGLVVLLVVAILSAVTVGQKFFPS
ADRNQLVVEIVYPEGTALSRTRSAVEQVERFLSQSPHVSGFAAFVGRSTPRFYYNLNQEP
NSPQLAQVLVLTRGQKYHAALRKELASLPIDKSPRLIVRSLEQGPPIPAPVEIRLMGDEA
LPYAEKMVTALQSLQGIGTLRHDSEGTIREFALRGRDGQLAENGLTRADLALATLATTRG
IEAGFYRTSDETLPIVVGYPEGENASSKSLAAAVVGQTTDRAILVGASAVASEHRHPGII
NRRNRENVVRILAETDNKLNSAQTLSVAKSYLTANPLPEGVRFEIGGEFGESLKANGAIL
AALPLAMIILIAILIWEFNSIRLTAIIMTAVPTAALGIMPGLAIGRQPMGFMGMLALFAL
IGIVVNNGILLIDRFRSAEEEGLDRNSAVRTGILERLRPILLTSGSTILGMVPLTFTNST
LWPPFAWAMISGLAVSTLFTLFIVPWLYAKMAWRKPAARLLSAAALLLLFVPGISADDTK
VQPISITEVIEGAARSPAAKAAWHRAAAAKAGKNTEILGVWGPRVTAGAEYIVRDREFFL
QTPFGQFPYGRQNYGQVGVELYQTLWSSEGALAKIPSSTLRSEAADLMARWETMSAQHTA
IGRFYDCAEISARSDVLKDRLKNINQLRIELKRLIRGGKARDIDDAKAAMRLAEAQNSLQ
SLADAAAACEADLGRLTNSEGARRPESRASALQPKTEQIALDKRADLQALALLVEAARKE
RDGILLESMPEIYARGNYTHFGARQFTPEDWFQASVGARIRILDGGTQITRRQVKDAAYE
EKNQQYIDALKAARVQLDDIETRYRTADGQFLAIQSELKAAEERLSGERARVNQGRVAAT
DLLEALDIYWRRREALALTELQAERLNWTRAYLKGELLK
>fig|869212.3.peg.3145 Tetracycline resistance protein
MQGVTDTEKPVSRREKLMVLFMGVAVVLVIMNTMMFNLALPKVALEFQLNAAETSWIVTA
YSIMFAIASITYSRLADFIPIRRLFLIGLSSLGVAAIAGFFIHDFYILIGVRVLQASGAG
SIPGLALVFISRHIPLARRGRAMARVMAAVGLGLGLGPVVGGAIVEYAGWHYLFLLTASA
LLLVPVFAVLVPQEEVRHGTFDVIGAVFAATGITALLMALTQKSIPALLGGSISVLLFVW
RIRSAREPFVLPTLFTNRNYLKLAAVGVAAYIVSFALLFIMPQMLVKLHGLSAIHAGLAI
FPGSIMAMLVSPVTGKTIDRRGNTGILRLLPWLMAAGTLLLALFAKDGYLYLSLAYILVS
VAFTFITSAVSNEMSRLLVPAQIGSGLGLFQLMQFFSGAFGVALSATALVWQRDLPQAES
YSNIYFGMTFIVLLSVVSASDYLKSKNRSED
>fig|869212.3.peg.3497 Permease of the drug/metabolite transporter (DMT) superfamily
MHDISFFLKIAAIAILLFSSSTLFIAGRFSARALASGLFTLSIAGYLGCQIFHGSSVSEW
FLWFVHLGCFVAPLTFYLLTESLFEDKFRFRWHHLALFVFIEAVNFYLIIYLRVYAADGH
LQYGDFLTLLRALPQTVSLVFILVALGKTLLKRKADLIESRRNFRIKFIAITSAYMLLVL
ISELAYQGQHAPPMLDLLHSAGILATVWYFASKMFTVRSGTLGEVNTIVTKSTAIPERET
VNQELLSKLEKAMDTGKIYTQESLSIRELAKFLETQEYILRRLINAGLGYRNFNDYLNEL
RITAAARILADKEQASTPIIRIAMDLGFGSLAPFNKAFRERKGMTPTEFRKKSA
>fig|870187.4.peg.3760 Permease of the drug/metabolite transporter (DMT) superfamily
MTTTFLDRFSPYLLLVLTVLFWSGNFNLARAVHADIPPLALSFWRWATAGLILLPFAGQP
MRQALPLLRAHWRLVGALALLGVAGFNSLVYEGLQTTTATNGVLIQTITPVLTVLLASAL
LREHSSLRQWLGVGLSLLGVLVIISHADVGILQRMDFTSGDLWMLAAALDWAFYTVLLRK
LPEGLKGLPILGFTVLLGALAILPLYVHESLTFHIMPVTLVSMGSVLYVAVFPSLLSYLF
WNHATQQLGAGRTGQFSYLLPVFGILLAVAFLGERLHLFHVAGMALVAVGLLLTNWQRK
>fig|870187.4.peg.4488 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MIQRDLTHGSERQHLLAMSIPTIWGILAIMAMHLADTWYVGQLGTDALAAMGFTFPVVMI
IGSLAFGVGTGTSAVIAQAIGSERTDWVRSYSTQSLIIALAIALVFAVVGLLTLEPVFRL
LGAPERLLPLIRDYMGVWYLGGFLVVVPMVGNAGIRAAGNTRLPSYVMMGVALTNLVLDP
VFIFGLFGFPRMELQGAALATLCAYVVACTIMLYVLGVKLKFLSLQALRQGVVQSWRDIL
RIAVPSAGTNLIAPVATAITTWLIAQYGADAIAGYSIAARIESLGLIAFGALATSLAPFA
GQNWGARKLDRLNRALDLSFRFAWLWGLLFAVLLWVAAEPLIGLFTRDPEAIAAAKHYLY
IVPVTFGLLGTIMMTSSVSNGTGNPHPALLMTLLRLLLVYLPLAWLLSQWLGLEGIFLAN
AVANVLVGVGAFLWIKRKCRRGTNARQAEQRRKAMWEERYATDEYLFGTEPNDFLREHAA
ELPVGDTLSIGEGEGRNAVFLAGLGHRVTALDASAAALEKARKLAREKQVDIETVHNNLD
NYRFEARRWDTVVSIFCHMPVQMRRRLHQQVVKALRPGGIFILEAYTPAQLKYGTGGPPV
EALMMNLASLREELKGLEFIHALETTREIHEGKWHHGMSAVVQVIARRVG
>fig|870187.4.peg.4562 Drug resistance transporter, EmrB/QacA subfamily
MFYINLPVGILNLLMVWTLLQVESGHRVKADWLGVLFMAVGIGSLQLMLDQGNQKNWFDS
GLIQVVAAISVLALLYFVARSWSRPDSIVKLQLLKDRNLATACFMIVVGVISPPGE
>fig|871585.3.peg.1978 Permease of the drug/metabolite transporter (DMT) superfamily
MLFKIALIMAAFAANSVLCRLALVGRHIDPMTFSLIRVGSGAVVLLGLFLYSKSSQTKVQ
WSLKNAFFLAVYILAFSYAYLQIDAGIGALLLFGVVQLTMVLYGYWQGEQIGIYRGIGLC
IALAGIIVLLLPGAHAPDWGYALIMVISGLAWAGYSIAGRNMTQPIGSTLANFTLAVPMV
LLANVLVTQDRYIDVQGWVLAILSGGVTSSGAYVLWYAILKHIDRVTASTVQLSVPCLAI
IGGSLFVNETVTGRVILSSFIVLFGILLVIYVRPQKAKNA
>fig|871585.3.peg.2308 Quaternary ammonium compound-resistance protein
MLGLISKINPGAWWLLFAIATDVLSTFYSAKGNGLVNKTAQGIALVLYIISFACAAIALK
YMQAGILYVLWSGIGVLATAFLAKIFLGQNIDVAGWVGIGFITVGLMIIAQYSNIDV
>fig|871968.4.peg.211 Permease of the drug/metabolite transporter (DMT) superfamily
MFQGLIGSLGTSLFYAYALLYLPVSVATLLLYLYPVLVLGAGVVFLHKKVGLMEKTALAC
TFVGTTLASGSFSGFEGIPLLGVLLGIIAAITYAFFNVVGEVALQEVSPLTAMAYSQWFS
SLGLIFYLKGNILQLPWSNLDIWGIGLALATIASIVPFYLIMFGIQKVGSDRASILSTFE
LPVTFVMAALILKEIPRLAQWAGGGFVLVGIILLNWRSSHEREQTG
>fig|871968.4.peg.771 Multidrug resistance protein B
MEIQRQTKRGFILVSIMLAMFMAAIEGTIIATAMPNIVAELGGFSLFSWVFSVFLLAQAV
TIPLYGKFADIYGRKPVFTIGIIIFIIGSFLCGFAKTMQTLILFRLVQGLGAGAIQSIAM
TIVGDIYSLKERAKVQGYISSVWGFASIFGPALGAFFVQYIHWAWVFWVNIPIGIFAALG
IVVFLKEDIQMQPHEIDYLGSIYIFISISVLMIVLIQAGTVWKWLSPQVLSMFVAFGVGI
TLFIFQEKIASEPIIKLELWRDPAILISNIATLTTGIVLIGISSFLPTYVQGVMNQSALI
AGFSLGVMSIGWLISAALAGKFVLKYGFRKIALWGGIWIVSGSIFFVNIMPNRGWVWGAI
GSFLIGIGMGFTRTVFIVAIQDSVGWEDRGVATASNMFMNILGNTIGAALLGGILNMRLL
SYFKSISAGQYSLDLNVVNTLLDETKRSQLPQELIQQITTGLSLSLKNVFWGVLFFSVVS
LFLIFLLPQHKVES
>fig|871968.4.peg.922 Drug resistance transporter, Bcr/CflA family
MSLIFAIGLVISFIGIFIDFLKRKWITVESAINFDFIDWIKIMINNEKTLNKLSLPLLLI
SLPLTVMTVLLPMYTSALGLTPLQVTGLFSVFSLGLVIMRLLIGYIADKAGRKPVFVLGL
IFYTLSYFIYSNAKMISLIYIGRGLQAIASAFISISSYSMIADLNMKNNAHNFGKVDSYS
EKGGLLGIILCFFVLNTPKLVDGWSVLFMICAIASIIAVIYSIIILNETKPILNKDFLNI
SLPTKKNNIIIFNLIISIFTSIVSAIFVLYLQSRFNSNLLQIGVAFLLPTVIIAFASPKL
GRISDNIGSKKILVTSLSTLIFILLILPYTDNVYLYGVVWTVYCIAVTLIGITLNGVYVE
DIAEEIRGTAIGKLTMGANIGTVIGPIIGGLAFQEISIQAPFFISSIGFAILLMLYMKYN
KIRSQRRIKYRSY
>fig|871968.4.peg.2061 Permease of the drug/metabolite transporter (DMT) superfamily
MLKSYFAILLSSLLYGGNVIAGRLIAGSIPPISLSAIRALLGLSILLPLAWPALKSAPKP
TTKELFQLILISLLGVSLPYVSLIYGLADTTATNASVIFATLPAMTNLMFFIIFKSKPSK
FQVLGILTSFLGLVIVFTQGDIFHLLSFRIGGGEIFLFLNVLCISLFNVVGQSFMKKFSS
LVTSVYSLVFAILTLTPLALWQLNSFVWYLSWSQWLLVIYMGCFAAGFAYFLNLYGIEKI
GGGQTSILNNLQHVFSISLGVLVLKESLYVYHGLGFVLVISGVVLSLMRTSTSSPKLARS
KSSNPAI
>fig|871968.4.peg.2440 Permease of the drug/metabolite transporter (DMT) superfamily
MKITKRMANMVLLLISALWGSGFVVTRMALDANVSAGFINFARGLIFALLVLLLFHQKIF
RMTFNDFKIGLIAGLLNFGGYIAQTVGVKYTTPSNNAFISATYVVIVPFMAYLAFKKSLK
IKSFIAIAFCLWGMAILTGIMRRGFVLNIGDVYSLICAFFYAGSITYISYGARETDATIV
AFMLAIVQAIGGLGYFFIADGGQLVNVNWQAAILPLLYMGVMCSFVAQTLQVIAQKHTSA
TTAGLIMMLEGLFGSLFSVAFRFEPFTSSMAVGGTIIMLALILMEVNIEQLRNKTSPISE
KRIE
>fig|873533.3.peg.1509 Probable multidrug resistance protein norM
MPIIVGQLGTIILGFADTLMIGRHSMPELAAAAFVNNMFVLVLLFSMGFSYGLTPIVGSL
YGQGEKGKIGIMLKNSLAANLFLSVVLMGIMALLYLNIAHLGQPEELLPLMKPYFIVNLV
SIPFVACFNTFKQLADGTTDTKTAMWILLGGNLLNIIGNYLLIYGKCGLPEMGLLGAGLS
TMLSRMLMAVAFAVIVFCSKRYRIYRQGFAAGQINRGDMRHLCGLGVPLGLQMGMEAAAF
SLSSVIVGWIGTAALAAHQVMLTVSQFFYMVYYGMAAAVAIRVSYFAGQRDYEALNRSTV
AGFHLILLIAFAVSVPVMLLRGAIGSWFTDSSEVCLMVSQVIIPLVVYQFGDGLQCTYAN
ALRGISHVKPLMYVAFVAYFIISLPLGYLFGITFRWGLLGIWSAFPFGLTTAGVLYYYYY
RRYLRRIVRGSGAA
>fig|873533.3.peg.1648 Permease of the drug/metabolite transporter (DMT) superfamily
MESNKIRGFTEAIISAAAFGLIPLFSIPVLADGMRLPSLVVYRFTFGALILLLILMYNRQ
SLRLRFGESLRIMFLSLLYAISAVSLISGYAYLPSGVATTLVFSYPVWTAILMIVFFHER
LTLRTALAIFLAVAGVCLLSGIENGISISSVTGVALELLSGLTYAVYMVTFPAMKVRHLS
TLKVTFYVFFFTILLLMLYASFTEGGIQPIVSGKQFVNLALLGLLPTAVSNITLIMALKR
IESTIVAILGAFEPITAMSVGCIVFDEPLTIMSCIGFALIIVAVVLLILKN
>fig|87626.5.peg.435 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTTNTLELAVLSDNKSSPLITSSIFKQFGFLALPAILGMLINGMYSFVDALFISQGIGAN
AMAAVSSVFPIQMFLISISTMLGSGMASLIARYLGAKRQRDADIVFSTSFLLSIICAFIF
CLFTFLALDHIYELLAVPLTLRDQASSYITPIIIFWVIGFISNQITEGFRASGNPKAMMQ
VLSTASILNIILDALFIFVFEWDVAGAAWATIIAVSLGLMMAIALQKKGESAVSFSFKNL
TSPIKIHFKILSLGLPVLLSHGGFSITIAVTVYSISTVFIDVSEPLIAAHGILVRCFMFL
FLPIIGMMVALQTLSGYNFGAKQYQRVKQAYLVAIAMSATWGVVVTGILCFYSDTLLAMF
TSNANIIKLGANIAPICFSGFITASFCMMSSGLFQGLGKALPATLLDAARTYVLLLPLMY
FLPSLIGPEGLWFAFPIADITGGLFAFIYSLIYLNRLIKHST
>fig|87626.5.peg.551 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MRLAIPVFIAQVIQVLMGVVDTIMAGQVSPTDLAALSIATGLWIPVMLTLQGILLALTGI
VAQHHGANDQNSIRQQFHQALYLAFGLTIVGFVVINWVSIPISYINMEPAVAAMSLDYIN
FVKFGLPAYLLFCTFRNVAEGKTLTKPALFISVLGLAVNIPANYIFIHGKFGMPTLGGAG
CGVATAIVYWAMAAGMITYSYFSKKIDGRFLLKNPMKPDFPAIYSMFKMGLPISLATFFE
VTLFACIPLFIASMGAVVVSGHQVAASVSTVLFMMPLSLAMAITIRVGNLAGQKNYSQMK
QAIFTSFMLAIGISAIVASITFIGREFISGIYSDDPEVIILASSILVLACFYQLPDALQV
AANGVLRGLKYTKPISYITFLSYWVIGFSLGYVLARTDLIVEPLGPHGFWLGIIVGLTIA
AVLLITTVVKRLKNETYN
>fig|880070.3.peg.432 Glyoxalase/bleomycin resistance protein/dioxygenase
MVLLGFCLAACEGQDQSNTVNRPIDLNGTQKNIPMNSFISIFEIPATEISRAVDFYQAIL
DIHIVKMEFPEMQMGIFPYEEQMVTGVIMKAEGYTPSASGVTIYLNGGDDLQVILDKVEK
NGGEIIVPKSLHADESGFFAIFLDSEGNKMGLHSPN
>fig|880070.3.peg.641 Acriflavin resistance protein
MPQIIIKVNYPNTSPESIERNVLKPIREGMVTLNGLQDIESKAGSEVGNVRLTFDFQTKM
ELAYIEVNEKIDRLTNSLPDDMPRPQVVRINSNDIPIVRLQIIPKEGVDYAEVSLLTENV
IKKRLEQLDGVALVNINGRQERVIAVTPNKPVMSGLGFMESDLVQAIQDGNRELPGISVE
DGQFRYYLRLASKLETAEDVGNLPVRGPEGNTVLLSKIAKVNHTLSKPTGYHLFKGKESL
VVTVHKQTAAKMNETMPLIYEAVELFKEDYPQVDFELTQDQSSLLNAGINNLQTSLFFGG
LFAFAILFVFMGNYRMPIIIGISLPASLVISFMVFYFFNISINVISLSGLALGLGMLIDN
AIIVLDNINRKREEGFSLFEACVVGVNEVQSALISSVLTTLAVFVPLVFLSGVAGALFYD
QAVSVAAILSVSLLVAFILLPLLYFLLFKNKDKQSVKEDSRLFRGMLKGYKLLFKRFFTR
PGLSLMVLFLLIPLLLASIQFLKVEGLPPVEKFDVLISLDWNEPINASQNKNRIQHLLEQ
LEGKFTVAESDIGLRQFILYEGENAIQQADLYLMFANQTDKENVSRQLQQFFIKQFPQAS
IEIKDAPNAFDQLFSSNRPNFEVRFKNTETKRSVGPNQMNALMENFPVKDWSKGPGLQEG
ASVIFKTDLEKLALYGLEVNQLITSIERLFGDYLITDIRQFGEIIPIRLRNDQLDFQSLL
KRNFIHGEEGVAYALDEFITANYDTHYKFVTADRSGIFQSVNLNITEPTSYEDEIRSWAV
NENLTVNFAGQYFEDQETIKQLIGILMVSILLLYFILAAQFESFLQPLIVIFTLPLGVGG
AFLVLWLTGTSLNVMSAIGLVVMLGIMVNDAILKIDTINRLRVNYRANGIVGKEALTKAL
YRAGEIRLKPIVMTSITTILALVPVVFSAGLGADLQRPLVFSVIGGLTIGTFTALYFVPL
AYYFLSGESGSVKFGDER
>fig|880070.3.peg.1285 Multidrug resistance efflux pump/antiporter
MKFFIPTKKLQKAFLVAILLLLILNILSIFLAINHDQNNSLGSFLILLFDFNQEANIPSL
FSTLQFLVASLLLLIIALFKKSNGKKHWGWLGISLLFFLLMLDEAASIHEFLFTFLQEKY
HNSTLFYYISLLVFGLVLVGMALIYIPFFNHLNKRLLTGMLLSMGIFLLGAIVFESIGKN
VFDTYGLSFGYRLIYTIEETLEMLGLAIFINVLNWYIGIKMQKISIVLTV
>fig|880070.3.peg.1574 Permease of the drug/metabolite transporter (DMT) superfamily
MRGRYSLLVLLFGLVNFKTYTHKALDPEKSNRMKRISKGNLLILTAVFFFMALGITTEVS
ALEAVMVFQLAEAETTFWLWKFLGRLHPLAVHFPVSFLLLAALLELFTLKEFNHKLRPGI
NALVWTGAIGALVAVVLGLLLANIEEYGGELLDIHQWTGIITAVLGVLLLFLLGKIKNGT
PKQAIKTFRIVLFITALGVSIAGHFGASLTHGEEYLTETLPWNESSYTPEDLNIDLVAFE
EEGALSEQKQIELVGKVRAVLAHNCYKCHSDAKIKGELRLDSKAFTFAGGESGPVIIPGN
ADKSELVRRIKLPKDHKEAMPSKGKVLSDDEIALITFWVNKGAPWPDAAEEVSVFRVAEL
APRRPNLPAQRKGLTQAIDIWVDEYFEKQKIAWKEPVDDKVYLRRIYLDIVGLQPSPEEY
SAFINDSRPDKRAIWVSELLDRDDDYATHWLTFWNDALRNDYTGTGYITKGRYAITDWLY
NSLRDNKPYDQFVKQLLNPDEKSKGFIEGIRWRGDVNASQVTEMQAAQNVGQVILGLNLK
CASCHDSFISDWKLKEAYAFANIFSDSSLVVSRCDIPTGEKAGTKILWEELGEIDSTASR
SKKLEQLAEYLVQPANGRLYRTIVNRIWKQMMGRGLVEPADEMDNVPWSQDLLDWLATDF
EEDGYDLKQLIYKIAISKAYQQPAVGVESPLFLAEDDFVFEGAVIRRMTAEQFTDGVSQK
IHPLFTEEEMKYDPNQLAVSEQSDIGFVRAALVANNGLLKALGRTNREVVMTSRDSQASL
LQALELTNGEKLNNTLKEGAVKWKEKYEAGEIIVEEVYQQLLGRAPQEKEFNIAMAALGD
QPEPEAIQDLFWAVLLLPEFQLIY
>fig|880070.3.peg.2053 Glyoxalase/bleomycin resistance protein/dioxygenase
MERAKKFYSQVLDQTLEEMKVPEGAGDLRMVCFPYVDGGINASGALVKSSEMKPGTGGTL
IYFSCKDCAVEQSRIAAAGGQVVQPKFQIGEHGYCAIGMDTEGNTFGLYSM
>fig|880070.3.peg.2297 Glyoxalase/bleomycin resistance protein/dioxygenase
MEHKIKSIRPFIGAKDYKLSRQFYSDLGFAEIVLSSKMSYFKSGAFGFYLQDAYVKDWVD
NTMVFMEVEDLAMHLEKIKAFNLPQKYSGVRLSEIVTNDWGSEYFLHDPSGILWHIGAFL
G
>fig|880070.3.peg.2377 Glyoxalase/bleomycin resistance protein/dioxygenase
MRRIVPNIYSNNMAESKHFYGEFLDMELAMDLGWVTTFVSKDNPTAQISILENKNSSPLD
NSAIFLSIEVADVNHYYKKAQELAINISYKIRDEDWGVRRFFVTDPNGVTLNLLSHI
>fig|880070.3.peg.2656 Glyoxalase/bleomycin resistance protein/dioxygenase
MSEFAHLKVNHVAIYAKDLEKTNQFYEEIIGLPKIEDPFKDHLHTWFGIGYGLSIHVIAR
EVPWKEQNIDRTNHLCFCVKDMDAFIKKLQEKNIPFGNSEGLNGKVNLRPDGIHQIFFQD
PNGYWIEINDDFI
>fig|880070.3.peg.4530 Multiple antibiotic resistance (MarC)-like protein
MLAMVNPIGLIPIWYEMTGDASPKVRRKIALMVTGTSFLTLLLFLILGEYILVFFNIDIE
VFKIAGGFLLMFTALSMINGSATKLEELKEEADTNFGLAKLRFEKVMVPLVIPMLAGPGS
ITTVLLYSFRATGPTTYVGLSGILLLSYFLLFLVFSFSYKVENKVDDILFVGFTRLFGLI
VAAIAVQFMVEGLGEVFPNWMEGGSAVELEDK
>fig|880070.3.peg.4685 Glyoxalase/bleomycin resistance protein/dioxygenase
MTQELWLNLPVKDLQNTKVFFSELGFEKLRVAPEMIGFKIGGVSVLMVTETQFEKYALNK
VTDTSQGNELLLSIGAPSKAFVDRMASKVEEAGGKVISVPTVIQGWMYGFTFKDLDGHRW
NYLYMDFDKMKQ
>fig|880070.3.peg.5167 Glyoxalase/bleomycin resistance protein/dioxygenase
MPLISKEDQRHVFFRCGDSVLLCFLPEVTKHDSNLPPHYAYGKQHIAFEVEHKDYSEIKK
KLNDKGISITHQQDWKKNISSFYFEDPFGNVLEIVPTGMWE
>fig|880070.3.peg.5344 Glyoxalase/bleomycin resistance protein/dioxygenase
MKIEHIAFNVKHPLEVSDWYEEHLGMKVVKKMTTSPYMIFLSDDSGKAMIELYNNPAAEI
LDYANQDPLMVHLAFVSENPEEEKERLQKAGAVLVSDDTLDDGTRLLMMRDPWGLAIQFC
KRANPMLK
>fig|880071.3.peg.1623 Acriflavin resistance protein
MKKLVEYFVKYPIWANAIIFTMVIFGAVSYGWVMKRSFFPETDPTTITVGVVMAGASPEE
MEEGVTIKIEESLKGIEGIKEITSTSSENNASIIVQLERGIDADEALAEVKNAVDRINSF
PTSAEKPLVFKVKPRSRTMFLGLRGREGKNLDLFLLKKYAEEIEDDMLASGIVSQLNISG
YPDIEISIEVPEATLLRYNLRFDQIAAAVRLNNQDISAGAIKSKEEEILIRSRSKEKIAE
KIGSIVLRANDDGSNLLLRDIATIKEQFADVPSSLHINGERAVSLEITKLQEEDLEEISI
YANKYVEEFNKRHSDVEMVISFDFFDLLSQRLQMLIENGAMGLLLVLICLGLFLSLRLSF
WVAMGIPISFAGMFVIAALMGITINMVSLFGMILVVGILVDDGIVIGENIFTHFEMGKSP
MRATVDGTFEVMPSVFTSVLTTIVAFLPIAIGIEGFDFLQEMGLIVVLCLAVSLVEAFFI
LPSHLTHKDMGDTESDGKWRGILNKGIEFFRHKIYGTALKHVLRFRYIYVFVPVVFVMMI
LGMINGQLIKVVFFPNIPFDSFNANIAFKAGTPEEKVISYLEDFEVAAWAVNDDLKKEYN
DEKDFINFTFRNLGSTSDGSESGSHAGNLSISLLDMDDREITSNEISERVRKKIGNIPEA
ETFTVAGQNRFGKPVSVRLLSKNNEALEQATEDLKKELENFSELKEITDNQRAGRRELQL
ELKPKAYFLGLTHSDITNQIRQGFFGEEIQRLQKGTDEVRVWVRYPEANRETLGQLETMR
IKTTDGKEIPLSEVASYTIDRGIVDIKHFNGSREIAIEAELADPNGSPVAIIAKLQDSIF
IDMKSKYPSLSFEFGGQQQRSSESQESLQFALPIMIFIIILLITLTFRSLSQSLLVMMLI
PLGLFCAVFGHYFADKPVSLLSLWGILALSGVIINDAVVLVSKFNSNLQEGMSMHDAIYN
AGVSRFRAILLTTITTVAGLAPLIMETSFQAQFLIPMAVSVAYGVGFGTFLILLIFPVII
LVVNDIRRMTGYAKRWVAHTWKGNKGEVSYPTQEEVEPANREMARLKIMEEMEGL
>fig|880071.3.peg.2937 Acriflavin resistance protein
MKTNQNPFLHFLFSRPVGVLMAMLGILVLSLVAFSKLPVSLLPSLDVPELVIQLDYRGHS
PEEIEQTILRPIRENVLTLNGLKRTESEARSQIGQVRLYFEFGTDMTLAYIDANEKLDRL
LGSLPKELPRPRIIKINTADIPILHLQIVPKKQENQNNLLATSELVEKVIKKQLEAVEGI
SLVDANGLKEKQISISTNLRKLQSLGLSETDLITTIKSANQTLSSISVKEGQYRYFVKIA
TILEDKKDLENLPIRLNINSDATKNKQKGTVVLLKDIAKIELEEPTPQGFHLFNQKEAFV
LTLHKQSQAQIQELTPKIDQTLEDLKQNFPELEFITTQNQTTLLNLAIDNLKNSLLIGGI
CVFLVLFIFMGNWRVPLIIGISLPVSLIYGFGLFYVFDVSINVISLSGMALGLGMLIDNS
IIVLENIEQFRNRNFEMKEAAILGVQEVIAPLVSSVLTTLSVFVPLIFLNGLSGALFYDQ
AISAGAVLFTSLVVAFLMLPHLYLILNRKKSSMTTLDLLRGEKNKETKIYKFLLSLYQKI
FLFLENHKKIFLSFSLFLIILPVFLFYQLDIEGAPKINKTDCSLLINWNEPIDATENKIR
CKRLLETFSNQITFSESDIGQKKYFLQNDNSTQIQANLYLFFDNQNQKETTQNQIAEWIF
KTYPATIFDFLPAPDAFSQLFISEEPSIELRIRTTTQNQILEYAIFDSIYNQINFETNNT
AQKGKGTSRETLVLLEINTEKAALYGFSQQDILQKLTYELGEFAVTDLTSFGQIVPIRFK
KGNKTVEEIINESSLKVNNVESNTDFAENSSQTINQIPLRLFIDFKKSNSYNTLTADELG
IYQSVFWEDINNIQPTKQQQIKNDILTYLPNIQTNFKGTYFSNQENLTQFIFILSISIGL
LYFILVAQFESFWQPLLVLFTLPLGISGSLLLLIFSQTSLNTMAIIGIIVMLGIMVNDAI
LKIDTINKLKKEMSLYDAVHEAGKLRLKPILMTSITTILAVIPILFSEGLGADLQKPLVW
AVVGGLSVGTITALFFIPMAYFEIAKYQKNE
>fig|880071.3.peg.2942 Antirepressor regulating drug resistance protein
MKLKILVLFILIISFLGSYKPYKIVLEEEKQNELIKNSIQADYKIENIYKINRKSVLELN
LQEGKKYKFQYFSKRYFDMILLDSQTEIRAKNKISYGDSSYFTKTIIFECKNTGIYNLKL
EGKHFPNSSLLAVASQNIENQIDDKEEYTFAKKYHVAHKWYRSYSENPQYTCVFYKGVTY
KYTFEKGIAALLFYNSRRELIMEYTPSTNEKEFEFKNKSTGIYYLTIINPINHKDSVAVI
NAYHNRPDSTDLK
>fig|880071.3.peg.3361 Permease of the drug/metabolite transporter (DMT) superfamily
MKNSTQNPLVVSWLLLLSLALIWGSSFILMKRGLLVFSPLEIASLRISAAFVALLPFAVF
HARKIPLSKWKYLLVSGLLGNAIPALLFPLAQTQLLSSVTGVLNGLTPLFTVLVGALFFS
QKLKYKQLVGLGIAFIGAALLSIAKKGGGFGDINIYVLLVVLASFCYGISLNVIKSNLAE
IDSFPIASCAFLTVGIPSILFLFFGTPFLSHFQEAQEITIQTSVIPHSVLVWKSFFYIVI
LGVVGTAIALVIFNKVIQLNDAVFASTVTYFIPIVAIFWGVIDDEPLQSGHFIGMALIVF
GVFVANRWK
>fig|880071.3.peg.3483 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDYLINKFRSAFLFFKSKKETLAPQSGSNTVAYSLKDDTVQKLLFAFVGPAVLGLLVNAL
YNFVDRIFVGQFVGAEGLSAVTLVFPVTLFQFGFILLLGSGSGILIAKYSGEERMDKAED
ALGNVIAALLIIIILFTTAGLFFYKPLLVAFGAQGTLLNLSAEYLVIIIMGFPLSFFLAF
EFTCRAEGNPSFPAKLILLSSIINVSLDYVFMKILNMGITGAALATLIAQSTNAILLIRY
YVSGRSLVKIVWKKIKLKKQTILPILSVGFAPFLMDVATSFQNVFANVLLLETGGTDGVA
AMGIIFGFNIFFMMTALGTGDGMQPIISYNFGAKLYERVTKTFEYALKMVLLVALIGLIM
LELFPTSIISVFIDENENITKITKIAIQIFAISIPFYMVQIVMTRYFQALQRNKIATFLA
ILRPALFVPIAYVLNNMYGLIGIWVAFVVSDSIAANITLLFVKKYSTNELKPIKSINSDK
Q
>fig|880071.3.peg.3632 Permease of the drug/metabolite transporter (DMT) superfamily
MKIPKIDKTILVHLALFAVALIYGANYTIAKEVMPLYISPSATILMRVLGAAILFWILVG
KKRLILSNKREKIILLLSAIFGVVVNQLLFFEGLARTTPINAALIMTTTPLLVLMVSAIT
GGEKFTFFKIIGISLGLLGAAMLIGSKTVSDSSLPFSFVFDFNLGDLLILLNAVSYAIYL
VIAKPLLKKYSALSISKWMFTLALPFVLPFGFSDLGTTNFEQIPTEIYVGLGYIVLFTTF
LTYLLNAWALKSVSSSVVGIYIYLQPVLATFIAVALDKDSLTPTKLIWAACIFLGVFLVS
RK
>fig|880072.3.peg.3030 Polymyxin resistance protein PmrJ, predicted deacetylase
MRLALKIDVDTLVGFKEGVPALLALLAQKGIKTSFFVAMGPDHSGRAIRRLFTHKGFLQK
MLRTGAPRLYGFKTMCYGTILPGPPIAASAPELLHKITAAGHELGLHGYDHVRWQDSLSR
LSTPAVLKEIIQAQKVFVEIMGYPAVSFAAPGWQCTAAALDVLVQEKFYYCSNTRGYGPY
LPCTPDRTWPLLEIPTTLPTMDELLGLNGRTGADFNREILASLKSGQTQVLTIHAEVEGR
LYAAEFSSLLDQIQDKGVKFIRLLDYAQELWRYPELLEKAEVAPGRLPGRAGTVSCQHSK
RGTV
>fig|880073.4.peg.891 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKNDFQPIIYRNIHGTIFRLSLPGMISSVLETLFQLIDAYWVGRLGADALAAIGGCAFIL
WAIFSLTALSVNGIAALVAQNIGAQKAEEGRVAAGQGLILNTLTVVFAGGLVYLFQNDLY
RLMGFDARVLSLARQYMSIILSGMIFIFWFTAFEAVFRGLGDTKTPMIVLAFGLTLNAIA
DPFFIFGWWIFPEMGIGGAAFATVVSELAAVVGLWWLLKRKHYLPTFNRRLIIDRALMKK
LMAIGAPVAFGGFFFSIIYVVLTRIIAQFGMEAIAAIGIGHRIEGIAWFACVGFSVAAST
LVGQNVGAGRIKQAAKAAWLVNGYGVAILLIVSAIYYFFPDVLMGVFTQDPLVQKIGTDY
LRIIALFEIFLALEVIMEGAFSGAGYTLPVMLVSVPITAARIPLAYLLAVNMGLGANGIW
WAIAITTGLKGFLNAVLFATGIWKRKLQREVNHEIEQNR
>fig|880073.4.peg.1720 Permease of the drug/metabolite transporter (DMT) superfamily
MTRLKADLGLLSVTVFWGTTFIVSKLLLSEMSLAVYMFYRMAVAALAMTLIALKFKKAWN
KQVLRHGLILGVLLYASYFFQMWGITQTSASNAGFITGLSVVLVPVLGFLFYKEETPLQV
WGSVILAVTGLLLLSGANPFKWSVGDLKVLICAIIFAFHIIYTGRFSRVNNVYLLTAVQL
VAIAAFSFLAFLPEVQTLSTISLKNVILLIYLALFGTVFTFLMQTSMQRFTTVARTAIIF
SMEPVFAALFAFLIAGEKLTAEGWLGGLFIVLAMVNAEFPYQSLRRQKQKS
>fig|880073.4.peg.1801 Permease of the drug/metabolite transporter (DMT) superfamily
MRSTKLIAILVVVLLSIIWSSTWLAIKIGLESLPPFLSAGWRFLIAFVPLFIYSIKMDHP
IPRDLKTHLFFLWFSVINFTGGYALVYWGEQYINSGLASVLFAVMPFYVALFSIKLLPSE
DITLKKMLGILTGFLGVVIIFHDQLNITHPYGIYGMIAVLISPAFSALGTIVGKKARAKF
HPVTLNTFPILYAALTLFLLHLATESGQTATYDLNAILSLLYLALLGTALAFVLYFWLLK
TTSAVLMSLITFVTPPLALFWGWLIRDEQISWQLIAGMVIIFAGIGLVSKASEK
>fig|880073.4.peg.1838 Acriflavin resistance protein
MLPPLNFPQITVHVSYSNSSPEEVEQNITRYLEEAFSTVNGVTDVISRSLSGESIITLKF
AWGTDMKYAALNVRQQADRVYSYFPKQAGRPVVNLKQPQNRPIVTLALSGNSLWELKRFA
EYVLKKRMEQIPGIAEAAIIGAPVREIKVYIDPDFLRIYGFSYNDIEQALKNNNILISGG
SIKKGHFRLALRINSEVQSVEDIAQIPVLNRKRGTFVPLKKLARVIDGSKEPESLARING
KPCIAIDIYKESQSNTLKINSQIEKVVKEIRDAFPDIKIHTIYSQASFIRTTINNVSYAI
LSGAVLAIAVLFFFLSNWRAPLIIAISIPVSVIIAFLCMKYFGIGLNIISLAGLALGGGM
LVDNSIVVLENIHRYRENGFTTFEAAVNGASEVALPITASTLTTIAVFIPILFLKDVSAA
VFTQEAETVTFALLASLLVSLTLLPVIFILLEKKRKTVSENVLVSKGLERFYESGINFTL
KRENLFLSVVFFLLILSLFLLKNLDRRLLPETDQHAVEMRCNYLPGVSLNYIDKHIQRTE
KILKEQQGIKYYYAELGKKQGVFLEPDERKLNRSYLYIQLDKNQNSNRFIHHFKEKNRSG
EKIQIEYRKIEPALSGVLGKKEAPLSVFISSPSLKILDSLGHALVQKIEEIQPGAIYNSN
FFERYPTISLDLDLERMALYDLTASDVAQLLKVALNGVVATQLRDFDRKIDVLVKAEESF
RENLDKLLNLRINNYPIRNFVKIKRTNELSYIERKNQNRVFRLDLNVENISNFVKKLNTQ
IEEIDRPSDSNIYLGGEWQESGKSIKQLYFAFIMAIVLVYLILAAQFESFLAPFVIMFTV
PLALIGIIPALLITGMTINIMSVIGLVVIVGIVVNDGILKIDFIQRHQRKGMNLNDAIHA
AGKMRIRPIVMTTVTTLFGLLPLALGIGPGADFQQPMAIAIIGGEGVATILTLFVLPLLY
KKLVSK
>fig|880073.4.peg.2008 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKPAAKSSRALGEEKIGPLLFRLSVPATVGMLAMALYNVVDTIFIGRGLGALAIAGVSIV
MPIQMLIFSLSQTLGLGAASIISRRLGAKDLGGAKNAFGNVLLLNIVISSLIVFLGYLFA
EELLYLFGSQGAMVSYAHDYFVYILFGTPFLMFDMILNNVNRAEGNIKFAMMTMVMAAVL
NIIFDPIFIFTLKLGVKGAALASVLSQFLTLLVLLYYFYSGRSNLTFEWKYFSPNFKVMK
EILAIGASSFARHGAASVLAAILNHSLFIFGGEMAVAIYGIINRILRMTFMPLFGLVQAF
LPITGYNYGAGNYERVLQTLKFAVKYATLTVIGIFIFLMIFAQPIFFLFNDDPVLVKEGA
RALRMIILLTPLIGFQMIGAGYFQALGKALAAFILAIARQILFLLPLIFILPRFYKLDGI
WLAFPAADILAVGVTLLLVVPEWKRLKAKVDLINLHSQN
>fig|880073.4.peg.2443 Acriflavin resistance protein
MTLPRFSLQNKYTIYALSIAAIIFGVLAYISLPIQLFPDTAPPLVNVLTPYPGAAAKDVA
DLVSDPIETECAALEGVHKVTSTSQDGLSLVSIEFNYDRDVDIAAVDVQNAISRIRSKLP
RQIGEPQVLKFSTSDRPVLTMGLTGENLVEIRRLAEDILAPELQRVAGVALVDVFGGHQP
EISVLVDRDKLEAYRLRLPMIVNAITTHNVSLPAGQIRSEGRQYSFRVDERSRTPEDIRN
IVLTTPMGKRIRVGDIATVSEGSAEDLSRFHVNGKSAIAMQIFKQDDANTVDVVEKAQQK
FAELQKRYPQIKMIEAEESASFTRQVVSNMFGSVWQALLLAAIIIFLFLSSFQRGLVVTV
SMPMSFLLTFAGMKFFGIEVNLVTLTAIILSVGMVVDASVVILENITRRYHEDKLSPKEA
ALAGAEEIQFAVIAGNATTLVVLVPLLFLYGFIGKTFGPLASTLIIAFVGSLLVSLTLVP
ILTELVTREGGKLEKLAIKITAPWNRAMEKLRGFYIGLLTRSLKARWLVFVTAIALFIVG
LGLLRYLGMELLPKMDGGTSFVTVETPSGSSLDETEAVVRQVEQIIMQEPEVERISTQIG
FEPGMHSFGGGGVQGPTNAFISITLTPRTERDETIWQIQDRIRQKLAKIPNIQNYVVRES
GSTAKVTTAASIVVSVRGEDELVLNKLGDQILEIVRGVPGVVNPYRSWRMDQRSILLSVD
EERARELGLPPAAISQELTQSLDGINAGILRGPLGEDTPIRVRYSKAFRETEQDAYAVRA
LSPGDGNIFPVGAVASGREVKVQGLVTRENLEPTLQILALHQDRPLNFVTADVEKAVAQI
VAPQGYSIRLEGENKDMAESRDELMGALGIAVIAIYLLLVAQFRSWVHPITVMMAIPLSL
IGVSIALLIAGKSVSMPVMVGLILLVGIVVNNSIILIDFIRQRREAGAERQKAIIDSVAT
RFRPIMMTSFSTIVGMIPLAMEWALGAERFSPLAIAVIGGMTAATFLTMLVIPILYDTFD
ELGNKIRNVSLK
>fig|880073.4.peg.2539 Daunorubicin resistance ATP-binding protein
MELIAEKIVKRFGNFLVLRNISFQVKSGSSIAITGANGSGKTTLVKILCNLMAPTRGKVI
YRNNGNVIERGEIYRYIGLVGPYLQLYQELTAQENIDFFARMRNLKNYSEKIRKMMELFK
LAGREDDPVKTYSSGMQQRLKYICALMHDPEILFVDEPRSNLDQEGIQAVYRILEEHKKE
KILVISTNDQDDLLLADQIIKVGN
>fig|880073.4.peg.2786 Permease of the drug/metabolite transporter (DMT) superfamily
MLNYLILLFGVFVTSWSSIFIRWIGDVHPLVISFYRLFFSVLVLSPFLLKRMKSGRHLPS
NVFSKNTLFLILSGFFLAMHFFTWIQSLQWTTVGNSIFLESTHPIFAVILSYFVLKEKSS
PLIIGGIALALLGIFVIVNSDMGAHPFATLGDFLAIISAFCLAAYLLIARFYRQKIDLLP
YLVLVYAAAALFTLLLILFLKINFLNLALKSWFFLGLLALGPNLIGHSLLNWASRKMPVY
LVNLAMQGEAVLATFYAALLLNEIPGEQFYFGAGLILLAVSFIFLNRR
>fig|880073.4.peg.3764 Permeases of the drug/metabolite transporter (DMT) superfamily
MAFSISLVLNTVAYHLLLKAIAHYPVSIVMPYVGLTPLFLTMTSYLILGEALTKGKIVGI
IFIVLGGFILQLPENLKEKGWRHLINWREKGIWMMVLVAFIWSITASVEKIAVNASSPEF
YGAFIHLALGGVFVFWGKWQNRNSIKKPEALKITSGGKKYILLIGIVSAALAWCQLVAIK
LTFVSYVIAFKRAGVLVSTLLAFFILKERHYLKALSGTILILTGAAFITL
>fig|880591.3.peg.1325 Glyoxalase/bleomycin resistance protein/dioxygenase
MKIVAISGFSVISRDGPTSAALYIDTLGLPMQQQGDYAFIDGFSGAHHFGVWPLKDVAQA
CFGMDDWPDDLSIPSASVEFELETAAAVAVAVAEMQAQGQVFIHTARDEPWGQTIARFIS
PEGVLTGLSFAPWLHDAT
>fig|880591.3.peg.2299 Permease of the drug/metabolite transporter (DMT) superfamily
MFGVAAAGFSRGRIDPPTLVGMSAILMWSATVGLYRNISEIFGPIGGSALIFTVSGIVAL
IHAGPKAFRGHSPRYLLIGGAMFVTYEIALALAVGFAQTRAQSVEVGLINYLWPSFTIAL
AIWAGHARAGIMVIPGILICLLGVFWAATGSANFSLAAMVHNIGSNPLPYILAFIAAITW
PLYTILTKGMAQGRSAVPLFLLATAALLWVYYGVSDQPTLVYNSKGAMMVLTFGVLTTLA
YSAWTYGVNHGNLTLMATASYFSPLLSVMLSSVLLSMVPGLNFWLGASLVTAGSLICLAA
TKR
>fig|880591.3.peg.2576 Permease of the drug/metabolite transporter (DMT) superfamily
MPLSPKAAAAAATILWGFTYILTTTMLPHNPWFIAAVRALGGGLPLLLFARALPPAGWWG
KMIVLGTLNNGLFFGLLFVAAIRLPGGVAATFQALGPLFMVLLALPLLGVRPAGGKLIAV
AAGVVGVAMVVLQGGAALDLIGVLAALGAALSVALGGTLYSKWKPPVSVVTMAAWQMIIA
GIELAIIAAILGDIPPAITATNVLGLAILALAITALPFVLWFTGIKGVGPAAVAPMLLLT
PITAFVLDALVRGIVPSAVQTLGIAIVIGSLLYGQYVDRNTAKG
>fig|880591.3.peg.2589 Permease of the drug/metabolite transporter (DMT) superfamily
MLTRLWNSPQILLTLASLFWAGNFVVGRAILTEAPPVAMAFWRWALAIIPVVLVARGRVD
VKHELALVRRHWLIIVVLGVLGISCFNTFVYLGLRETASINALLMQSAMPLLILLACFVL
YRERPLPQQIIGVVLSLGGVIFIAARGHLETLTSLGFNTGDLWVLAAVVAYTFYSALLRK
KPAMHPLSFLVALFIVGALALLPPYLTEHASGQVMRLTPQMVAALAYLVIFPSFLSYLCF
NRGVELLGAGRAGLFIHLLPVFGSALAVIFLGERFESFHLIGAVLIGVGLLVAARRGRSA
RRKMS
>fig|880591.3.peg.2884 Daunorubicin resistance ABC transporter, ATP-binding protein
MSTTTPADAVNAIEVRGISKRFGRIEALKGVDLTVPKNSIFALLGPNGAGKSTLIDILCT
IRQQDKGTASVAGFDTRKNPLSVRRNIGVVFQNPTVDSRLSVRENLEFHGMVYQMPYRAR
KKRLLEVLELVDLSDWIDATVGSLSGGMKRRLEIARALMHEPRILFMDEPTVGLDAQSRA
AIWDHLGRLRAGSDLTVVVTTHYIDEVDSCDRVCIIDHGMILADDAPQALKDAHGTTTLR
LRPTSPDTASALRSRFPTAQPGAGDTLVLPLTGTEDLAGLMAEIGPLSSGLELHQPSLES
VFLGLTGRDLREAGPAKPARKGARNG
>fig|882.5.peg.62 Outer membrane component of tripartite multidrug resistance system
MIRRMTAMLLGAALLSGCAIGPDYQRPGMDLPSAWRAESADAGMVAGEKWWTLFGDATLD
ALEEEALAANGDLATAMANVDASRAQLTVATSYLLPSITGQGSSVRQRGSERGQNPPVEG
REVTDLHKASALASFELDLWGKYRRAHEAARAGLLGTEAAYATVRLAVVSQVAQSYFGLR
AADRQLDIARQTLTSREESLKIREARFNSGLTSELDYRQAQAETASARASVRQLEQAVAA
AETALSSLLGRSPRDIVERSPERGLDIETFAVPPQIPAGLPAGLLARRPDVARAEADLHY
ATASIGVAKADLLPAISLTGLMGYESIDLTRLVSSSSGTWSYGASATMPLLDFGRTLANI
DMADAKQRAALAAYEQAVRDAFRETQDALVANRKTRQVVDAQATQVAALERSLTLARLRY
ENGYSSYLEVLDAERSLFQAQLNLVEARRNQLDAVVQVCKSLGGGWKAPGEEGADATGAA
EAASGDADDAAPQGVAPTPPRTEG
>fig|882.5.peg.1901 Permease of the drug/metabolite transporter (DMT) superfamily
MNVRLRAYIHLTLAMCIAGSAVVAGKLMVSSMPVFLAAEAGLLASLAVQVPFTFMMKRER
IPADLSVHLYLVLQALFGVVLYRVFIFQGLQHTTATVGGVISSTTPLCIVLLSAIFLREH
ITRRTIAGAVCVVTGLATISLTPLMDATPAATGSFTGNVLILAAVVSESAFSVMSRAKRD
HLSPLARTAMVSVYAALCLLPFAIHDALHYDMATLDAETLSCIAYYGVFVSFLSYLLWFK
GVAVIAAGTAASFTGLIPLSSMGIAWLVLNETITSAHIAGLACVGAGIVIACIRPATSPT
TSSVAV
>fig|882.5.peg.2194 Permease of the drug/metabolite transporter (DMT) superfamily
MTMAFGTGELAALGTACIWAVSCQIHSQLSREMGATNLTLLRLPLAVALLGAACVFSGVS
FDHPASVWWYFSLSGLTGVALCDWLFYGSTVLLGPRVACVCQSLAASMTAFLGVMFLGES
LGWAGVLGIAVATVGVIIVVTDGGGRSDGLATTPGQRRKGIALALGSALALALAMFFSKK
GFSTGADPLFCAFLRNVAAAVVFWPVVALMGGSRAAMQSLRSGRGVLPRMALGAVLGPGI
GMWLSLVAVANTDTGVAATLIGLEPIAIMPVVWFMTGRRPTVRAVVGAAVAFAGTALLLM
RHHL
>fig|882.5.peg.2608 Permease of the drug/metabolite transporter (DMT) superfamily
MKVAVQTLGTWQMMWARMVFALLLLVPLARRLAPARIERRDLPLLAGMALMQPCLYFLCE
STALQLTTSSQAGVMAASMPLMMAVGGFLLGEKVSPRLWFGVGVSCIGVAWLTSSGGEGG
GSAPDPFTGNLLELAAMACATGSSLCIGALISRGKGRWNALTLTGIQTLAGAVFFLPGAP
GVIGGVADWSTEVLLAVVYLGGASSLGAFGLYNWALGHMPASRAGNFINLVPVAAIFFGW
LLLGETLTTTQYLATGLVMGGVLMGTRAR
>fig|882102.3.peg.1539 Drug/metabolite exporter family transporter
MRPIKSPIFLAVLTLLLAMTTIQSGASLAKQLFPIVGPGGTIALRVGLSALILLMIFRPW
QLRLSLSQWRSMIIYGASLGGMQLMFYFAIERIPLGIGVALEFSGPLLIAFLSSKRKKDL
IWVALAILGIVFLLPDLTGVDALDPIGVALALAAGGCWAAYIWFGQRAGSVGSGGSTVAI
GMTIAALFAFPIGVVLSEASIFTWSILPMALSVAILSSAVPYCLEMSALKRLSTQHFSVL
MSLEPAIAALAGLIILQEQLSLTQWIAITMIITASMGSTLSAKK
>fig|882102.3.peg.2954 Acriflavin resistance periplasmic protein
MKRRIWIACIALITSGYWAVGYADDRYIVTYEQIPQQIAFEGVVQPVNKGTVAAQTSGRV
VGVYVDVNDFVKKGDVLLEISAIQQSASLDASQAQLTSAEARNREAQAQLKRYRLLFPKG
AISQDQMDGAEAQARSAAAAVKAAKAAVVQAKESLGYTNITAPYDGVVTERHVELGETVA
PGTALLSGFSFNELRVETAIPQRYQPAVTNVAQFQVIMPTGDKITPIDYSLFSYADPQSH
TFKIRLELPRADQTNKLGQVMPGMWVKTEFNYGQREVMLIPVAAVIRRAELSAVYRIVDD
KRLLNPVRLGQTYGEYVEVLSGLEQGDTVASRVFTQVGE
>fig|883.3.peg.2258 Efflux pump antibiotic resistance protein
MVLATVCIAQFMVPFMLTAVGVALPSLGRDLGASAVQLGLVEQLYALALAMSMLACGRLG
DIVGQRRVLLPGLAVFTGITLLVGLAPSVELVMALRFGQGIGAAMMLSGSLALVAVAYPP
ELRGRVIGIVSAFTYAGLSIGPVLGGYTTDHFGWRSVFLMVVPPGLGATAMCLWRMRPQP
GADKGAHMDWPGSLVYAASVCMVMTGAARATSVPLGPVLMAAGLAGLVLFLKVEGRSKSP
LLDVNLLLRNRFFSLSCLAAFGNYAAVFGVTFLFSLFLQYAKGLPPREAGLILLIQPVMQ
VLTAPLSGRLSDRADPGRVATAGMLFSAAGLLLAMATLSPGMPVWLLAAELVCIGIGFGI
FVTANSVAIMSSVDKAHFGVASGMVGAMRTLGMACSMTTVSLIFALHLGEAAITPAVLPE
FLSATRTGLAVAAAFSCLGVLVSVGRGRKRD
>fig|883.3.peg.3374 Permeases of the drug/metabolite transporter (DMT) superfamily
MLAALDATLLRRLAGDLPPARMVAYPVFWSLPPFLALLAARGVSDLPAPFWLATLAAVPV
NMAGHLLTAWAVRLAPVSRTVPYLCFSPVFVVVHEYLLLGVAPRPAGVAGVLLVVAGSWV
LNAGGAETHDPGHDEDGGSGIMTRLLRPFRTLMAEPGARIMLGVALLWGLGSVLNRKMVL
YATPAVAGGVFFAIYGPAMLAALMLFGGVRPRMLVDRPLRGAAMGAVLFLAAYAHFTAMS
LTTAANMIAVKRLDGVFAVLIDRLSEWLAGRAEGPRSVRRAGLPAAGAGWRPVRDGRLPG
AALMAAGAALVVLAS
>fig|883098.3.peg.2344 Multidrug resistance protein B
MLAFVMFINQSGAMILPFMAIYMEEELVFSDVKKGIVLGLFGLGSIIGSLYGGKLTDQLG
SYKVQLMSLLCVVPLYISLAFLKNFELLCLGVLLTSCTKELFRPANSVSVAKYAKPENLT
KAFSLNRMALNLGFSVGPAIGGFLAIYSFQWLFFANAFMSLTAGVLFWWYFRNKSTNALA
KHKTEKIKTTDTRFKDYDFLLYSFFVALFAFCFFQLLNTLPLFYKNVALLKENQIGLLMA
FNGLMVFSLEMFIIHIAEKKFTIATNLIIGMIFCGLAYATLLFSSELSFLYLSLFFLSLS
EILIMPFSSTVAVHRSNTENRGKYMGINGISYSSALIFSPIIGTWIIEKYNFSTLWGVNI
VISLITVFGFWHILKKWNMR
>fig|883111.3.peg.523 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MQDLKEFIHYTLSNTLSMIGISIYIMADVYFIAKGVGPEGIAALNLALPVYNLVNACGLM
LAVGSAIYFIQAKAQNNQPARNQAYSTGLIACLIIGGLFLLIGLSASSQLTQWLGADTHV
YESTHVYLRYVLLFAPFFILNQFFSLFVKNDGYPQLAMYAMLTGSLFNTIFDYVFIFIFD
MGMKGAVLATAFSPILGILVNSWHLIKGKPNFSFQVQAFQFQRLKAALSAGLPSFISELS
VGLVMLVFNFLILDLAGNTGVAAYGILVNLLFVIIAIYNGIAMGTQPLLGRFYALRDFKG
LQRILHYSLITVILVSLIFYSVALLIPHELIALFNYHEDLAMAQVAYQAFGPYFSQCLFL
GINTVLIMYFISSNRARLAQVLAILKGFALVLPLALVLSHIAGLSGLWVSMTLSEGIVMA
LGLYYWRSSPRL
>fig|883111.3.peg.739 Permease of the drug/metabolite transporter (DMT) superfamily
MKNKHMLGKLGLLLTALIWGSGFTFSSIALKYFTTFQVIALRFTIAFVILLVINVGKLKR
ISKDEFIKGVTVGVILFLAYFFQTKGLEFTTTSKNSFLTAVNVVIVPFIGWLVLREKLSK
NALLGALISLIGIGFTSFSGGIGQIAFNFGDALSLIGAVFFGAHIFYMDHYGEGMPNWSL
MLLQMGAAAALSWIAAFFLGEANIHFTQESILPILYVGIVATLVGYGLQTISQNYTTSNE
TAVILSTEAFFGMLTAILILGEPVMLTMIVGGILIFCGILVVDLKPLKES
>fig|883111.3.peg.935 Multidrug resistance ABC transporter ATP-binding and permease protein
MKAIRWDLSLIAGIVLTILAALMSVTIPLFLKTMIDGGGHFSLKNIFILLLLFVLQAALA
GLGGFLAALNGEKTVESLRSRLNAHLIYLPQSFFDQQESGEFVSRIMTDSQEIREFVTQS
LPNFILGIFTIIFSVIALIRLDWKLSLAMVITFPVMLSLLIPISKLSFANAEKFQTSNSR
LTSKLITIYKNMAFIKLLTAEDQVSNDFDQANQENFSLAVQKKKIEAFTQPVGLAFLFAA
ITIVFAYGGYRVSSGAITVGTLMSFLVFTLQLLNPMGGLSDQISSYFRMKGASAKLFSFF
EMAKEDVGGDQAFQAGDILIKDVSFAYQDKEIITGLDLVIPRGCRLAIVGPSGSGKSTLT
RLLMRLYQPQKGQISINGQEINRIDLYQWRNAISYIAQGSFFISGSLRDNLLFGLKSRPT
DQKIHQVLQQVGLSEDLARMEQGLDTPVGEDGNLLSGGQKQRLSIARALLREHSIIIFDE
ATSNLDADKESVIIQLIKDLPESITVIIVAHRLSTVVDADEIIFFDQGRITGLGSHRVLY
ANHEDYRRYVNEQMIQ
>fig|883111.3.peg.1311 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSKQAVSRKEWMTQGPIMPMLLTLSAPLMFNNLVRTFYTVADGLYLAQLSAEDFAASSFS
WPLNNLFISIGMGIGVAATALIAHFIGSNQLKKIQVYLDSTLFLTLVLGAMLTVLGIASS
EWLLKAMGGQGSFLQKSDLYLKISFLGLFFDFGFFAYQSILNAQGMTKTLTIISAISMGV
NLLLDPFFIYDQVPVFHWSGLGWGIAGAAWATLISKWVLLALAAWIVAKQSAIKPSRKWF
RWDLGSQGHILRMALPSALGYGGSSLGFTVMNALITSYGTNTLAAFSMINRVSDIVMQPQ
MGVGMALTPIIGQNMGAKQFDRAHLIFKRAIQFILGMSILASACILLGQEPILRLFIKAD
APRDLWNQAREYLYYSAFIIFFMGLFNALNGFFQGCGQTKYSMFMTMGRLWLIRVPIVFL
LGRLTDLGSTGIWISMLISNMGIVVWGFYIYRRNNWELMSQMA
>fig|883111.3.peg.1373 Permease of the drug/metabolite transporter (DMT) superfamily
MKHKLSLLALLVVTLIWGGGYAMSALSLDYFTPVQTMAVRFSLAFLGSLLIYRRDLATMR
WQQLKPGMWIGLMVFLGFIFQTVGLQYTTASKNAFLTTTNIVFVPLLNLLIFKKHLSRQK
WLGVLLVLLGIGLLSIDFKDLSQLFTYNIGDGLTLVCALFFAGQIILIDHFLHELSSASL
MVGQLGTAAFLSWLVCLWQGDLSFSSHPTGWAALLYLSFASTLIAFALQTWAQKYSSPTQ
VAVILSTEALVGMIASSLILGEPITSTIFIGGILIIVGVLRVELSGN
>fig|883111.3.peg.1558 Zwittermicin A resistance protein ZmaR
MIYQESSDINEACKNLFNPPWNHILDSVLSGFQGRVLVDRLTSPQSALAIVGKGAPFAFL
GGQVNEDLWMHLPKGDLIMVPQSSAWSNYLMTIKQHEVRPFIRYAMEAPQKFNGQRINQM
KQSLADSYSISVINQQLFNQCLEETWSKDLVSNFDNYSDFCQQALGFVILNQGKIISGAS
TFFPLANGIEIEVDTHPRYQGQGLASIGVSYLINACLDREWYPSWDAHTAISRDFSKKFG
YSVAFDYQAFEWK
>fig|883111.3.peg.1620 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNMTEGPIIKKTVLFSLPLIIGNLFQLFYNMVDTFIVGRTLGLEALAGVGVSGSLTFFI
LGFAQGFTSGTAIPLAQAFGAGDYRKVKRSVAINIMLACAVTGVLTLASTYFLGDILRLI
RTPEEIIGYAYDYIFIIFAGMIVTILFNMLSNILRAIGDSRTPVVALIVTTVVNIILDYV
LIIYFKMGVKGAAYATVIAQVAAIMICLYVIYKGIYVLQVEKKDFKLVGDELALHCKLGF
PMGFQMSIIAIGSVSVSMALNTLGPNAVAGYSAAIKIDLLVEQIMASLGLAAATFVAQNF
GAKKYDRLLTGVKKLVTLNILISWVAGLIVFFVGGQLTAIFGDQAVSNTLYEYGNTFFHI
MGPSFWLLAILFVLRYSLQGMNDSLFPTLAGIGELVMRVLAAFFLTPRMGFAGAVLANPM
AWIGSVAFLIPAFLMHQKKLKAIMNATQDQLSMVE
>fig|883114.3.peg.457 Multidrug resistance ABC transporter ATP-binding and permease protein
MLTGYGILAFSDATIYPISIILIMGFTISWPMTLISIILLPLLIIITKILGQKLHVGYLK
LQKSYEIMNESVMENISSVRVIKGFSTQEVSSKRFEKAADDLYEDQFKQDKLHSLFIPSG
RLIPSLTFIIALIFGQHLMSTGNLTLGQLTSFFLYLNMLVWPMFAFGDLVNVIQESSASL
VRLQEIYDYKEDLVDIENPEEYQAKDSITFQNFSFKYPGDEKYSLKDINLKINKGETLGI
VGKIGSGKTTLLKQLLRFYDIAEGEILFDGKPAEMYSIKSIRDKTGYVPQQHLLFSKSVY
DNIAFGKENATEEEVMDAIEFADFTKDLDTLPNSLETMIGEKGISISGGQKQRVSISRAI
IKDPEILILDDSLSAVDSITEKRIIENIVTNRQGKTTIIVAHRLSGLKHAENIIVLDRGE
IVESGTHEELIKNRGWYYSQYESQKSGGSDE
>fig|883114.3.peg.763 Permease of the drug/metabolite transporter (DMT) superfamily
MSNILKKKPIAYLISIFCMFLWGSAFPTIKLTYGELNIGKGDYFSMIFVAGLRFFLAGVI
VFILMLIFDNKSKIEFKIKFWKLLVLSLIVTTFGYLFFYIGTGNTSGMKSALITSLSTFL
VVIFSHYFLQDERFNRYKFIAIILGILGVIITNIDKEFNLIFTLTGEGFMLINSILNAMG
TIYVKKYLNKVSPFVVSSSQFLFGSIFLIIIGYFGMPTNLVFTPKSVILIIYASLISSIA
FTLWYFILKQYKASEIAFLRLFIPFFGTFLSAIVLGENLSFSILIGLVFVILGIIIINRN
KTLIEKK
>fig|883161.3.peg.911 Multidrug resistance protein 1
MNAKMAEITRLGRRDRITQTALLVAQTLAICVFCLSLGLLIADALSPASVSKTAILVALG
SLLIATLTGYLAASIAATSKADLEATLRQMVIGHSLALGPARMSQAQTGAVVSMATDTVD
RVANFRQSFLGTTFSAMLSPLVTLVVVAVAIDVPAALVLTAFLPLILATIYLFQKLFRNV
SGESRKARTKLAAAFLEALQGLTTLVSLKAADRVGDRLAERGEKNRQATMKLLARNQLVI
LVTDAAFSLFAICASVLVAWWRLDEATISPGEAIALVLLSTQLCAPLAKMGSLFYVGMAG
RAGQRQINKFVSIAVPDQNEAQAAQNFDPVRFESVDFSYAEKPVLKDLDLSVKQGQKVVL
LGRSGSGKSTILSLTGGDLLPDQGSVSVAGIELTSKTQDQVREKSAVVNQKTWLFLGTLA
QNLRVGNKNATEDEMWQALAQVGLDTWARSLPDGLDSQVGERGMAMSGGQAQRLSIARAI
LSGRKLLLLDEPTSQVDLNSEQIIMSAIDRLAEDHTIVLATHRPSSTKSADLIFNLEER
>fig|887898.3.peg.477 Probable multiple antibiotic resistance protein marC
MVEDSFTAFLVGSFVSLITIINPPATLPIFTSVTGNLDADATRRTATSASIYCFCILVGS
LFAGSLIMKAFGISYGAMRVAGGMIIALLGHGMLYGKAEVSEVAKAQYSNPAFFPLALPG
ITGPGSIAVVIGLETKIRELGTFQHRISAYLAVLGAMLGVCLVEFLLLRSARTVTTRLGN
TGIEVITRLSGFLLICVGVQFVASGAQTLYATLVQAAAATAGH
>fig|887898.3.peg.1757 Drug resistance transporter Bcr/CflA subfamily
MLKNTGITIALAMLSMVGALGIDAYLPSFPAIIQDFQATPLAVQQTLSIYVGAMAITTLF
AGTLSDSFGRRPTVIVSLLLFTAGSALAIFAKDIQVLLLARGLQGVAAGFGAVLSRTIVQ
DRFQGAEAQRVMALIMMVFSIAPSFAPVIGGWLQATFGWHSVFIMLTGYGLVLWLIWQLG
IPETLPKAQRMPLQLGRIVGNYGKVLFHRVFILRVLSIALVFIGVAIYISSAAPYIINIL
GLSETSFAWMFIPMTLGMLGGSSTSRRLARKVAPSRLTFVGFVLMLGATFTSVVYTSVAT
PQVPWAVIPLGIYTLGMTLAVPGMTVQVLSIFPQMRGLAASLQSFVQMGIFALVSAFVAP
LLFHSAQWLAIAHFTGVVIAALLWALGPRHEAGAGAAPAGHAPGTPGPQGAPAASGTAAA
PAIAQPAPEKSAPSSDTSKARS
>fig|887898.3.peg.2487 Permease of the drug/metabolite transporter (DMT) superfamily
MPVSRWKPEHLGLFYGLLGSMLFACKGILIKLAYRHGVSTETFLGLRMMWAAPFFAWVAW
RSDGAALRRRWHRQAPAGATGLSDDATPRADSVWRSGDVWRVAGLGFSGYYLASYLDFLG
LQYVSAGLERVLLYLGPTFVLLLSVFWLKRPVSRTQWTALGVSYLGVILVYLHDLDGSLQ
VNVPLGSALVLGSCLSYSFYLVGAGEMVRRLGPMRLTAWASLVACVLCVTQALLVGGGDL
FRQPIEVQGIALMTAIFCTVFPLFLTTASVNHLGAGKAAQVGMIGPVWTIFLGAVVLGEP
TGGLQIVGTAVVILGVLILSRAATRR
>fig|891968.3.peg.19 Permease of the drug/metabolite transporter (DMT) superfamily
MNAREPKFAEAEIGLKESVDWPSLIALMVTLLVWSSAFAAIKAGLSFYSPLHLAVLRFIT
SSIILLPFLLFKFGLPDLSDLPFIFFLAATGMLLYHIPLCIGEQTVSAGSSSLLISTAPV
FTAIIAVIGLKEKMTFLGWTGIAVSFAGAALIAVGESGIRISFGALWILCAAFMESFYFV
FQKMFLPKYGAFRLTSYVIIAGTILMMPFGKGLFDAVAAAPLSATLTVVYLAIFPTCIGY
AGWAYASSRNPASLVASSLFLNPVLAIFIAWVWLEEIPSLLSVIGGSVAILGVWILQRTR
>fig|891968.3.peg.50 Permease of the drug/metabolite transporter (DMT) superfamily
MGVGVLFISLMVGKHHNLSRSFKELVYMALLGLMGVTFHNWIQAEGLKTAQAATSAWIVS
TTPIIIALLGWAFLKEEVTKKKLIGILSAALGVLMVLGKGSSLLPQGITKGDLLISLSAV
NWAAFTVISRKFLGDKDQTVSLFYVMLFGWAFSNAFALPSGIYFAMSWQAWISLAFLGIF
CSGIAYIFWYDALHALPASQVGVFMYLNPLTATATAIAFLGETLSPRDIVGASLVALGLW
LVNKKKP
>fig|891968.3.peg.75 Permease of the drug/metabolite transporter (DMT) superfamily
MKREAEERPLFLPIVVLLIGVVAVSTGATIIRLADAPALVISAYRVGLASLILIPAALLF
ARKEIMSLSFADIKIAIASGAFLSLHFAAWISSLDYTTVASSVVLVNTNPIWVALLTPFL
SSDRLTKMSILGVVFSVIGSAIISAGDFALGGKALLGDLLAIAGSWAAAFYLLFGRRLRQ
RMSLLSYITICYATAAIILFAIVMGLGYPLHGYPARTWLCLWGLAIFPQIIGHSSYNWSL
KYFSASFVAIALLGEPVVSPILAYFILKEAIMPVTVLGGLLVLVGIALAALGESR
>fig|891968.3.peg.219 Membrane fusion component of tripartite multidrug resistance system
MKMSKKAKKYVGMAILLAAAIVCGVYFLPKVFYNFTHVSTDDAYVEGTIVPIAPQVSGKV
INVYAERNQLVKKGQILFEIDPTDYVQEVEDTKNAYEASVVQLEDIKVAIQGKEAEIEKA
HQDLLASQAKYEYAQKQRDRYYNLLKENVISQDEYDNVEAAFKVNQANVAAQIANIKKLE
LDLKDLQTQLIKQQHLIEQAEAKYELARINLDRTKIYAPIDGYVAKRNVEVGQHVQAGTP
LLNIVDLTHVWITANFEETSISKIRVGAKVAVKVDAYPGKIFYGYVHSFQSGSGAVFSLL
PPENAVGNFIKVVQRIPVKIDLTSPYDPNAPLYPGLSVVPYVSVK
>fig|891968.3.peg.220 Drug resistance transporter, EmrB/QacA subfamily
MLGTLASALLGSIVNVAIPYIQGAMGASIEQITWVSTGYLLSNTIIMPIIALLSARFGRK
NFYMFGMAVFLLGSALCGISWNLYSIVAFRILQGLGGGILIPVAQAILREVFLKEEQGMA
MSIYGLGVVLGPAVGPTLGGWLIEHHNWRWIFYVNLPIGILDLILISLFIRDPDFLVREK
SKIDYLGLFFMVIGLGAFQVFLAEGENKNWFASPYITRLAIISALSTIFFVIRELTTQNP
AVNLRILKNINFTMGTLLGGTLGMGLYGGLFVLPLFLQNLLGYTPLDAGLAMLPRAIAMA
MVMPIGGRLFNRLGPKPIVGFGLILVVISFFQFSKLNMNAGYWDIFMPQFLQGTGFGFIF
VCISTSTLLTIEKKNLTFATGIYNVFRLISGSIGVAIAATFVDRGTNNYYSLLAKNVSLF
NRNALEYIAKVEQVLGLPHSIQPDMVTKEVLNKLVLEQAQMLSYNHVYTLIMFVFLASIP
LVFFLKGLKDVEIDESGT
>fig|891968.3.peg.231 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTNIDNKTERLGREPVGKLLLYFSLPAIAGLFANALYNIVDRIFIGQNVGEIGLAAVTVA
FPLFEVSIALCVLICVGAASIASRSLGAGKKKRAELVLGNALALSLIFVLFVCLGMLFLL
NPALKFFGASEAVLGSARDYMLIVLLGMPFFMISFVLNSLIRVEGSPRWAMGTLIIGTIA
NIFLDWLFICAFGWGVKGAAWGTSIAEFLSCLWVALYYAKYSVLKISYKNLKIRMPLVAN
ILAIGITPCITSISFAVLLVILNQTALKLGGDLAVSSVGIFLTLDTLFFLPALGISEAAQ
PIIGYNYGAGFYHRVRRAIMLALISCLCAFSLSWVATQFFGWQIVRIFCNDHKALIDMTV
RALRIGYFFLPAAAIFVVTSYTLQSLGRAREALIIQLVRQLGICYPAMLIMPHIFGLDGI
WMAFPATDLGGSILAFFAMYRELGKLKEENVVALKVASDRSSGCR
>fig|891968.3.peg.1015 Permease of the drug/metabolite transporter (DMT) superfamily
MFEPKSKKAVLLADAALFVAAMFWGSGFGVTNWLLKFMSPLWLLSVRFMLSAGILALIFR
SRLPLLSRRDVFLGFLLGSLLASTFIAHIFGLLFTTPGKQSFIAGSNVVMVPFIYALIYR
KMPSLIATAGAFLTTAGLLIMAFTPGMSFNFGDYLSLLLAFGCALHVLFVGNLSRKMDPI
ALTVVQITAASLILTVLALFLEPLPPFGKVPSKAWLGILYVAVFVTVIPFLIQTVAQRYS
PEIHAAVLLSLESPSGYMFAYLIGEELINFQVILGGMVVFAGVVLTELEAFLTKKFHHSS
HEDAMTLCDINGSRDR
>fig|891968.3.peg.1058 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKMRVDMGRDPVSKVLWSLAIPSVITMFAHTVFHIVDTMFIAWLGTVPLAGMSLMLPVIF
VEYALMSGCTIGATTLISRNLGMGRLHRGRYLANATLSLVFLLSLLPCALLVPSVKTLFF
SYMGASPEALVHIDKYLFWQVWSFPVAAWTLVLDAVYRSQGNATVPMYALLIGNLANILL
DPLLMFTFGMAIGGASLATLIGRSLTLIYSVAKLRQYSQIKPKFNITRNTIPTWRSVITI
GLPLSLSQISFSVGAALLNRMLAKYGEAAISGWTLGNRIEDIAFLFVFGFNTALVPFVAY
NLGRGAYDRVKEGFIFTAKWSFILMSAVGIVLYLFPYVFLAVFKPEALTLAYSTASIRAS
TTAYPVIALTIVIGGLFQGAGHTHYNLFTQVIRNILIRYPLAVLLNSIFGINGIWWCQPV
SSGFAFLVSLYFLKKLKPELFGTG
>fig|891968.3.peg.1249 Drug resistance transporter, EmrB/QacA family
MNYMIFATVSVALMLSSISATSIAVAFPIITSYFMVPLTIAGWIISVYQLGFTVTMPIIG
KVSDVFSRKSTFIICLVLFIVSSAMCAVAKNIEMLIFFRLVQAFGGGGFMPSAVGIISEV
FPESRQKMIGLFSSIFPIGQIIGPNVGGWLVDSFGWRSVFLINIPIGLFALILSVFLLPA
GERKKGSIDFLGTGLLGMSLAMLMLGLTFLGYGSAAKWAWPSFAASVVLAFLLLRHENKV
SDPILDLDILKRKPFVAANFYNLIYGGAVVGVLSLIPTYATAIYGMTPSECGLLLTPRSV
GMIIASILSSIYIMEWGYRWPLIIGNSATVIGLFLLGAEPASVLFLYVIMFLIGVGVGIL
SPTANNACIELLPDRAATITGIRGMFRQMGGALSVTIATLVVETVGDPSRGFAIVFFGLA
IAFIAAMPLIFMMPSRPGAGVERSEHALRRQEATAKERVQ
>fig|891968.3.peg.1401 5-nitroimidazole antibiotic resistance protein
MRRKDREITDQKWIEEVLEEGKVCFLSLCRNNEPYIVPMHYAWKDGFLYLHSALEGKKVD
IVRENPRVSFCVVPEWKIIEGPRPCDWTTHYRSVIGSGIVSFVEDETEKRKALTIFADRF
VQGDFELPKPMLDRVLVWKIKVDDITGKQNPNPR
>fig|891968.3.peg.1698 Acriflavin resistance protein
MKLWEIAVQRPIATLMVFVAVILLGAVSFIGIKVDLLPEFEPPVILAITTWEGAAASDIE
QEITEEVEDRMATIQGLDEITSTSSDGASAVVLRFKWGEDLDARMGDARDQVNIIRRRLP
EDADDPILIKVTSSAMPVMLVVFKAGPTFPGLYHFVDNDISKAIQQVPGVGDVSVFGGEQ
REIKILLDVEKLKAYNLSPQQIYSVMQQEHFNLPAGSFKEGMIEYQMRVPGRFQIPSDMG
YTIVGTFNGKPVYLKDVARVEDGYKDASTFGWADGARSVVMMVTKNTDANTVQVSNEIKA
RLAELKGSLFPPDVDYIIGYDQSKFILNSLQQLASTLIYGIVLVFLVTYAFLRRIPGTLA
ICGAIPFSLIVTFIAMRLLGYTVNLMTLSALTVASGMVVDNAIVATDQIIYHIEAGEKRS
IASILGAGEVGSALAASTLTTLAVLIPLIFITGLVGIFFSSLSVVMSLAIAASLVVSLTF
IPMVGSRTFRTREDKLFIHRYSKRFLAWLEHRYALSINWALHNRKKIIALAMLCMVFTVF
GFTRLGYELVPKSDTGSVRVNFRLPEGTRVEETERVAKDIMSFALKNIPELQSVYIYGGS
SGSGMGALRGESSNTGTASIELIPKGERKRSGFQVAAQLRQYLTAKPGFESVSSSISSPI
MTGGSSKPIVIELYGDDINELLKVGDMIKKKVETVPGAVDVELTQKASRPEVWVHVDRQR
SGLAGVRTSDIAQALRTYYYGVQLDEDYWQGADNYEIWLRLEPEQRHSWDTLNKLLVPSV
DGQMVRLNNLASIDEELGPPEVHRKNRQRYVTIELDAEGRSVGQVAADVQRLLDATELPA
GMRTAISGDVEDMKETYMQMTLLILLGVVLVYMIMAGQYEAFLDPFVIMFSVPFALTGVV
AGLLLTGVYLSLLALLGIVMLVGTVVNNAIVLVDYVNLLRARGYTMHDALVEGGERRLRP
ILMTTLTTIFGMLPMAISRGEGAEIWRPLAISVIGGLTFSTLVTLVLIPVVYSLVEEKIR
RRPRFVEAKGGFSR
>fig|903814.3.peg.328 Transcriptional activator BmrR for multidrug resistance transporter
MYRISEFSKITNLTVKALRYYDEQGILVPSHRDSQNGYRYYSEEDFKRAQLVALLRSFEF
SISELRDVMENFDEDTDLAYFLEEKKAMIEHKIEKEKKLLKKISLYIEPTGQEESPMQYK
IEVKRLEPVIVASIRYQGLYSEVGKYIARIYKAVKGNAGGIPFNLYYNEAYQEKADIEIC
VPVKRYIEAAGIECRTLPAVERAVSTIHQGSYSQFNHAYKALLDYSRAQDLKLLIPSREK
YIKGPGAIFRGNENKYMTEIVIPFE
>fig|903814.3.peg.527 Permease of the drug/metabolite transporter (DMT) superfamily
MLSFYVREMYNKSRGRKANDKNRGAIILENNESIKKTIFFKKKSNTILTAILCTFLWGSA
FPVLKIGYQWFQIPSGDIWSKMVFAGLRFFLAGFVVLALNRLFNRGDRVRWHPEYGRWIV
ALALLGTTVQYFFFYIGVGNTTGVKGSIAATAGTFLVVLLAPLFFKRDRLNRNKVLGMVL
GFTGILLTAVNGGTEGLNFDFTLTGEGFLLIAGLGDAGGVLVAKYLSDKINPFHFSFYQM
VLGALVLLALGVGFGMAGGGLHLIFTLKGVLLLIYAAIISGVAFSLWNVLLRYNEASAIT
AFKFLIPVFGSLLSILLLPGESFTGFILLGLLAASLGIYLVNRKVGR
>fig|903814.3.peg.594 Permease of the drug/metabolite transporter (DMT) superfamily
MKNIQTKNKTLLADLALITVALIWGVGFIASKAALVTITPLWVMTFRFLGSGVLLLILFL
KRVRRLDKRTVLMGMVVGSFMFTGMVFQTIGLDHTTASNQAFLIPSYVVLVPFVSWMMTR
VKPRALDVAAALLTFAGVAVISLKPDFSMNLGDALTLIFAVVYSFQIVFLGLFVKETDVM
SFTVVQMLTAGGLSLFAALVFAPPLDGVSATSAFGILYLVVFNTALAFLIQNIAQQYTTS
THASLLISLESVFGLIVSVIFLHDPFGPRMALGCGLVFAAVLLSKLELKKEKAPLSLK
>fig|903814.3.peg.1242 Quinolone resistance protein
MRLQPPAFPDPLKPYNDLLTVIYECIDAEEDIESFEFSDTSLEAFHQSKLEFHHCQFKNC
QFLSSGLTHTFFADVIFTGCDLSNLNLSDSTFHRVIFKNCKLLGTDFNACILEECHFTEC
LGNFMNFSTSKTKHVFFENCPLQNVSFQDCKLKTTQFQQCDLSEADFLHTPLKGIDFTSN
TLSRITVSGSQELRGVVVNLFQAAELSKLLGVVIKE
>fig|903814.3.peg.1951 Permease of the drug/metabolite transporter (DMT) superfamily
MEKKKTIKGCLCAIFCEILFGLSYLFTKHATTSVDSLTLLSWRFATAFLVINLCVALGVV
KISLRGKRLLPLFWIAVFQPVIYFVGETVGISLTTASESGAVLSVIPAATLIAGGLILKE
KPTKLQAAGVCITMAGVMVCVLSKGMEASFNPLGYLMLLMSVISYSLYSVFSEKAVSFSS
AEKTYVMIAFGAVVFTAAALVQNLRTGTLPEFLSAPFTNPALLTAVLYQGIGCSILAFFL
YNLAIATIGTNRSASFVGISTVVSILAGVFFLKEQFSTFQAAGAFFVIGGVYLANLTRKS
KSARPNRRDAKNAE
>fig|903814.3.peg.1955 Permease of the drug/metabolite transporter (DMT) superfamily
MKSKITDIIVLAIATLIWGTSLVAQSIGTNYYGPFTFNAARFLIGAIVLIPFTLLINYHK
NKKETRNLFYKASNKKLVQGGIICGVIIFFTATLQQIGIAYTTAGKAGFITALYIVIVPL
LRIRSGKKFPLRIWLCIFFAIIGMSLLCLNEKFVFEFGDTFILCCALFTGIHILLIDYYS
SYVDCVKLSCLQFLVCGVVSTVIALIVERPNLQVMSEGGASILYTGIFSCGVAYTLQAIG
QKSVPPIAASLILSLESVFSALTGWFILGETLSFKETVGCLLMLGAIIISQIPMSKRKKI
KKS
>fig|903814.3.peg.2354 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MKAQAVDKKFFKFVLPSMFTMFLSGLYTIVDGFFVGHAVGDVGLAGIGLVWPITAVLIAL
GMGIGVGGSVLMSTARGAGCDENANAARANTLMLLVAASALLTLFLVFMNPVLVYALGAR
GEVYDAAMAYIRIISIGGSMQILASGLIPMIRNSHKTIQAMVIMSTGLVCNIILDACLTM
VVPMGLAGAALATIIAQSLTVAGSLICLFRDREHPVRRRHFRLQKRMMVKMLRIGVSPFG
LSLMPSVITVYNNLQCLAYGGDLAVSAYAVINYFIGSVLLLLEGVGEGMQPLISYASGAG
DYAAMRRLKNRGLMTVLVFSALFLIACVPAVDLLPGFFGTSAGTAAVIRSALPILGLAFP
MMGLGKLFTSYFYACGETLYSTLLVYLDPVLFTPLCIFILPRLFGLKGVWMALPGAQALI
MAVLVVLWGLHKSTLRSKEAEYAG
>fig|903814.3.peg.2500 Permease of the drug/metabolite transporter (DMT) superfamily
MTTDTIKKRYGLFTAIAMIIGIVIGSGIFFKSDNILIATGGNVILGVIIFCFAAVSIIFG
SLTVAELASRTDEPGGVLTYARVFINPMAGSAYGWFQTFVYLPTITVVLSWVSGIYFCIF
FNINASLELQCLVGFGLLTGLYLMNMLSARLAGLFQNAATVIKLIPLLIIAAAGLLHGNT
ETAGAAMPAPATGMLHVSWIMAIPSVAFSFDGWIISTSVAHEIKNSRRNLPIALVISPLF
ILLMYILYFVGVTNLLGAPAIMQLGDAHLDQAAAMVFGPFGAKLIGFFVLISVLGGLNGL
VMGISQMPYSLALQKMIPGADKLKVLTPKSDFPLNSTIASYLIVTCWFVVHYFTQRFGLL
TNSDVSEIAIVVSYLLYLPLYYQVFKLGRKQQIGAFRGILCPVLAAVGSLVIFSGGLQSP
LFILYIAICLVFLAAGMVYYQKITKAQV
>fig|903814.3.peg.2557 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MDKNQLVKQPVPKMFFHYLLPAVSGTMVTSIYILADTIIIGKGIGTEAMAALNIVLPVFN
LVFGTGLLFGVGGSVLMSISRGRGEEKKGQQYFTTAFILNLLAGIVYISLFFAFGENIML
FLGGTAVTMPYIMEYAPYIAGGALIFSFSSFLQAFVRNDGAPRRAMAAVIAGGVFNIIFD
ILLVFPFQMGMSGAALASVMGSVLTDCILISHFFSRQNGLRFCFGGLRLSFFKAVFANGF
TSFLIEISAGIVIFAFNHQLLRYVGEIGVSAYGVITNTAFVVTALSNGVSQAAQPILSTN
YGAGKFDRIYEVRALGVRTALAVCALPALLGLLMPDLFTYIFLNPSPEVLALSATAIRIY
FIGFFVTGTNMFIINYFQAVVRPRISLGLCLFRGCVFNLFLVTVLPLLWGVTGIWMAVPL
TEFISLGIGVLLIKRISIEQ
>fig|903814.3.peg.2814 Permease of the drug/metabolite transporter (DMT) superfamily
MKSLKGNLFIILSACIFGFTPIMGKITYLNGSNSIMLTFLRTFFCVPVLWIILKQQKVSF
KLSKTQLKQLLIISFIGSAVTTLMLYQSYNYIPVGTATTLHFVYPVFVALGAILIFKEHL
TKPKILALVIATAGISFFMGGKIEGGLLGILLALVSGLTYAFYILYLDKSSLLALHPLKL
SFYINLFVAGFVFIYGLFTGTLTLDITPMGWLLSFLVAMLCGFLGITLFQVGVKLSGGTT
AAILSMFEPITSVVCGIAFLGEPITVKSVLGCALILTGVTILTVFKGKEPAETPDLNLEL
AASEEMEN
>fig|903814.3.peg.3084 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNRLGDRHLEQRVQNLTKGNIYKTLAVFALPYLMANFIQALYGAVDMMVVGWFNDAAVVA
AVSIGTQMMQIVISFVAGLTMGGTIIIAQYYGGGREKDTVETISTMLTLFAIAALLMTLA
LFLLAAPFLGLLKTPAESFASAMDYVRICACGIFFIFGYNALAAMLRGLGDSKSPLYFIA
AACVFNIVFDLLLVGGLKMGAAGAALATAGSQGVSMILAIVYLNRKSFIFKFKKDNFRIY
RDKAERLLKVGIPVSLQETLLQISFLFITAIINTMGVVAAAAVGIAGKFDAFAMLPASAF
SGAIAAIAAQNIGAGQPDRAKKSLFASIVMSLLCSIPFFIWAQVFPASVLQIFRAEPAVI
SAGTAYLRTFSIDFMLVAFGFCFLGFFNGCGRTAFSMVNGVAASLLVRLPLAWILSVTLS
GSLMAIGLAAPAATLVSVVAEIIYLRLGRWKTPVV
>fig|903814.3.peg.3541 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MVKKKHREAEMVAEHGFLVAVILSLAAAVLGAVFSNIFVKMFTDNPEIIKGCTDYLLIVT
IFSFGSIITQAGFSTLQGSGDMIQPMIGQLIGAITNIILDPIMIFGLLGFPALGVTGAAI
ATVTGQIIAMVYILIVVLKRKKNLLKLHFRSFKYRGAIMKDIAVVGLPSAIMQGIGSFMV
TGYNLILAGYGMTAVAVFGVYFKVQSFIFMPIFGLGQGAMPIFGYNYGAQNAKRFKETLK
VSILTSLVIMFVGVLLFQLFPAQIFMLFNASEEMTEIGINCFRAISLAFPLAGISIMLST
SFQAMGKSYLSMISSFLRQMIFLLPFSYLFSLIGGLDTVWYGFIVSEIACLVFEVIVYRH
YKKKVLDRW
>fig|903814.3.peg.3902 Permease of the drug/metabolite transporter (DMT) superfamily
MIYGSFIILQCMFWGLGNPVAKIGMETISPFYCLALRFLVAFIICYGLFRKKIKTQVNKN
NFKDAVVISIFNAAAFIFSTLALIYSSATIAGFLMALAVIFTPFMAYIVLGRKLKKRTLI
FVGLVVLGLYFLCGSQGGFRFGIGELLALLSSISYAATITYSSKHVTNIGPEVLSTIQSG
VAAVICFVFAFFLEDGQVLSQVGITGWFAVVYLALGCTVIAYLLQNVALKHLSAVFVSLP
LCSEPIFTAIFSFFLLGERLTLSGIFGAALIMASIVLASLFNGE
>fig|907.4.peg.1337 Multidrug resistance transporter, Bcr/CflA family
MTQNKRSRWLLLMTVLLGMLAAIAPLSTDMYLPALPSMMTAFGVTPSVIQLTLTASMAGM
ALGQIAVGPISDDKGRRLPLMVGMAIFTLSTVGCIWSPSIQIFLIFRLIQGCAGGAGIVL
SRAIARDICKGSALTRLFAMLMLVNGIAPILAPVIGGQILRFAPWEGVFLFIAIVGLLLT
VSAGLMRETLPQRRRVSGGMAASLNGFTALFRQPYFMGHCIMQCFAFAAFFAYISGSSFV
FQNVYSVSAQAFSLIFGINGVGLMINGAVTGRLTGRIADWKLLRFSLFLAAVGSVALLAA
FSTGMPLPVIMVLLFLTVSTLSMMSTSSFSMAMQDQGRSAGSASALIGFFSMISGAVMAP
VVGIAGDHTAIPMGIVMVIGEIGALLTFYALIYPRHKDSL
>fig|907.4.peg.1587 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MERKQNKGRRGMDMLHGSIADKLFFFAMPIGLMGLFEQLFNSADVFILGRFVGKSAMAAV
GNNMPVIGILVTLLMGISLGANVTIAQYLGARRDDKVERTVQTAILMSFGLGVLLAIIGE
LIVYPAFWVLEVPPDVYDMAEQYLRIFLLGLPFLSLYNFEAAIFRSCGDGKTPLYSLIAA
NLVNIVFDLLSVLVFDFGLAGVVWATVLAFAVNSLILLALLCRTTDRIRLERHHMRFSQE
ELHHIIHIGLPAGIQGMVFALSNVLIQSALNSLGTEAMAASAAAFIIEGNIYCFVNGFSQ
ATTTFVGQNYGARNLRRCFRITKVAFGVEAAFLLAVTVPVLFFSPELIRLFNGDPNVVAL
GTKRLFYVAGTLYLNGIIDIISGSLRGYGYSLPPAVVVLAGICGVRITWLYTVFAAHRDF
LVLMAAYPASWLVTAIVLTFVYQSCRKHIVRGLLSER
>fig|907.4.peg.1786 Vancomycin B-type resistance protein VanW
MTDEERARKERMKEYRRRYREKHGLPPEKERPSWKKRAAVIVALCVIGFGGFFAAQSKAE
QMVTLNGQSIADMTPDDITNYLDLHEKDVEDKKLRLATDGVDVTLDLDELGAKLDRAYID
DELHLVGRRGLPWQRVADVVTTLRHGKDVPLAIAVDDDKLDKVLSDVHDKYDKDPQNAYA
YVKDDQKTVAIEDAKDRIVINTGKLKDAVTDELHTGKTDTLDVPVDSREGADIKADDLKD
IDTVLSYYTTHFDDTNPDRNVNIRLAQQRLNHAVVMAQKDFSFNKYVGTRTADKGYKPAP
SYFENKLEQSTGGGVCQVSTTLFNAALRAGLFIASREPHFAPAAYVPVGMDATVADDGLD
FSFTNPFQHPVCVYTVAGKNTVTTYILGNHADTCSVSFETTHLQNLPHKVIKKHDDSVTE
DKRKQEGYDGHDVTIRRTVAYSDGDRHVDTIESHYDPNDEIILTPGDDSEEVVSTADLEP
QDPLLNAPHDMMDFNVPAADTADTADTADTADEE
>fig|907.4.peg.1927 Permease of the drug/metabolite transporter (DMT) superfamily
MSKGVIYAILSALAFSIQNVIVKELSYTTSTGEIAFFRGFLSALLILGLMRIQHVHLSKQ
DIPTLTLRGVLGGIGMICIFYALRGMPLADVSIISQLSAFFVMLFAALFLKEVLPPGSKL
PLLIIFIGGCLVVRPWNFSSFNVYSLFALGQAVFAAGAYTTVSKLTGSGRHHPYEVVLYF
LVCAALAGIVLMALTGGFVMPAHGDWIYYGGLALFSVIAQIWMTNAYATANPVVVSFVSY
IGVFFNALWGFVIFGEILTGLTVAGGVLIIGGSMYLTKLKHDKIAEMAKMQERK
>fig|908337.3.peg.7 Drug-export protein
MSETKQWRVIPAVIMTAVMSFGGILVETSMNVTFPLLMSQFNLLASQVQWVTTAYLLAVS
IVVPSFAYLVRNFSIRNLFITANLLFLSGLVIDSFAQSFIILLLGRILQGFATGLALPLM
FHIILTKVHQDKRGLMMGVGSMTTSFAPAIGPTYGGILTEMLDWHAIFWLLLPLLVLSLA
GGLWAIPQEPVGRGEVFNGPAFIGLAAFLVTSLLAIEQNLWYQWMLAFLAAFAFYQSNRN
NPLINLNLFSKGHYLVFLWGALTYQALLLGMSFIIPNYLQLGRGLSTTQAGNFMFLGPIV
LSLVLPLAGRLYDSLGPKKPILAGLTLSLFALLIFVIYYHQLPIWSLLVVHVMMMLGIAL
SLSNIMTHSYGQIEDNLEADANTLMNLGQQYMGAISTALVSKLLSLGISQNPEFGAVLGA
GWGIILMFLLVLSAYILIIIVFRSNTI
>fig|911045.3.peg.32 Permease of the drug/metabolite transporter (DMT) superfamily
MRVDWKRAISSTGNRFFSSTRNASIRFRAITLGILTLIGFGGVGLVYLWGQQQTEAAFQQ
SKDYTELAELSQAIAITAGVLQSTQKDYENVPSDSLKSRFDELVGEAQKELQELNALPVA
MDYFLEISDARDTIDAISGAFEMLHGYQSTLGYDADRGLQKELSASLSQAEAAVKQKHRR
SKDPNTLKLMHTFSDLARAQLDYAITGSQNSQGAFEVAFSRYERTIPRAQIDPAVAEKVK
TNMAAYKKAFEAYTKAYDKRATSSELLANLFDLLPPRLNDLKNSAVQGASDAQARLTATT
QQTNLYLGLAVGGIALTLFILGSLLIFGILRNLNALRNAMALLAKNDLSAVIPLNKGGKE
ISAMAQTLQVFRDNIEERRKLREQQDHENSEKQARAEQVDTLIMGFEQTVAEALNSLHSA
ADGLGEASNDVGSAADNVSKEAESAGRAVENAAENVSSASAATEELAMSINEIAGQAEQS
TRVADRAVEGSKATAETMSLLSDAANRIGDAVGLIRDIANQTNLLALNATIEAARAGEHG
KGFAVVASEVKMLANQTSQATEEIAQQVGSIQEASTEAVGAIGDVSDVIHEMSQIASAVA
ASVEQQNAAIQAITENVANATQSSQQGANAMQMVENASDNARSTGGTVSDLADALSRQAD
HINNTVGAFLEKVRAA
>fig|911045.3.peg.60 Tetracycline resistance protein, class A (TetA(A))
MKRERREAMGWSRFALLLLVLVDVMGQGMIFPIVNTLVMVPGSTFVPRGDSLAIREIDFS
LLTAAFYISWFFGGAYISKLSDYIGRKKAILVCLFGALFGYGLAVVALLWSNLALLVLAR
AITGFSAGNQPIAQAALVDLSTTSAERNRNMGYVTAAIALGLIIGPLFAGTLSDPSIMGS
YASLELPFYAALVLILINIALIIIFFEETNQTRRKIDFGLSEVFLVLWRAHSRPTILKLC
AVFLFVEVGLSAFYIYLNNYMVLRFGFDTLQNSILMIIFGSVLALVSSLLVGPISQRFSK
VATIVVSVTVMGVGLLVFTVNDVAWLSYFLTVPIVAAFALTLPLMFSLFSAAVDESEQGW
IMGITISSSTGGQFILAIAGASLMTANIHGVFIAGITCFAIALGLIFLLWRQPDIRALDY
G
>fig|911045.3.peg.804 Lincomycin resistance protein lmrB
MLLAAMSFILGLTLLDETVVSLALPTISEEFGMTLTQAHWVVNSYLLMFAALVALGGKLA
DLVNINYLILSGMIIFGLASLACGFAPNGSFLVGARVVQGIGAAIMFPLPIVAISRIFPP
ERRGFALGIFGSIATIFLSSGPLVSGYFTSYFSWRWIFWINPPFVLIVCLVIALAPLKGR
VAHGPDRDMSNYSFDWLGFITLLVGLFFFVLAIMQAPEWGWSSRDILLSFIIGVTALTIF
VWNELRRKAPLIQVRFFRKPSFAVAAFVVFQAQYSKIVMFIFGALYFQDKLGFAPFFAGL
ALMSAVVMNAATAGLSGVCVDKFGVRTPAMCGLFVLSSATLWLTAFIAQDDYWLLLPALL
AWGAAMPLLFLPSMKSSVDSVELTKKGQASGVMITSQMLGGTIGMSISSSIFLYTQSYEF
VFGTAAAVTLLCYLLCYFHFGKGIEAADAGSRD
>fig|911045.3.peg.1482 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MLVSQKQVLTGAPLRQFLLYAIPSTFGLLALAIAEIVDAYFLGNYVGPHALEAVNFSLPI
ITAIYGLMLMIAVGASVITGKYVGEGKEEAACQVFIKTLLTTILLGFALTILILVFIKDI
VELVAFDPEASDYIADYLKVFAWAFPLIGCAIVLTTFGRIDGRPALVLLAIVLGTALNVP
LDHVLVAELEMGVTGAAIATGSSQVVVVLVLLPHLLRGAGIMRLLRPDGKWRVMLRAAYT
GLAEFINEISTGVIVFVSNWILILELGTDSIVAFGMLNYLVFLSIMIFYGFGEALGPLIS
INLGAHRYDRIKTFLFYALSANLLVGGGLAIFILLFPVFISTVFLNMASMMVVDLTEEFS
NYLWPIFIFNGINITLSCYFVAIQSASRAAIVALSRSLVFPVIFMIVFHMLFDGGMVILA
LPLAEIVSLTICLYLFWQRTPGKLQA
>fig|911045.3.peg.1486 Multiple antibiotic resistance (MarC)-related protein
MLHAFFSITTACKANNRKHLMTETALITYVAALFSMMNPIGNTGVFAGMTADRDAATARR
IAWTCAGAIALTLLTVTWTGGILLKFFGITVHELRAAGGVIVLLIALSMLRSDNSHRQTP
EEAASAAEQNHIAVVPLAIPIVAGPGAIATAIVAAERHSGIWAKIDLSIAAVGLALFTGF
LFSVSKPIANKLGESGMGVVTRLMGMVLAAIAMGMLADGVKGMIPALAS
>fig|911045.3.peg.1853 Lincomycin resistance protein lmrB
MMFSRFSRHFLLIMSVAMSLAAFLSVVVTLAEFNSGLNPFLLAKARSLSKTVKQNLEYAS
EIGIPFSEIRGVNKYLTDLTAEHNEISSISMVAANSSEHLGESKAVHPELMNNESSTFLL
AQQTLDSLSKLGTFIFGSNNVKQTVSTDVVVNGAIVVRVQTTLDEDYVNSQLTSIFLDTF
VLLLAACLIAVEVVIVCVNSTITMPLRLVEAAIVKCAGGHLGTYHGSDRKDWAGRFISAM
NRQNAKIRKTLEQLQQAKNITHEELRTFAKKYKLYRVEEGNKASISDARIPLFVFCLADE
LQKSFLPFFSMEYYGENAWFEKDIMMGLPISAFMLVVAITSPFSGQLIERFSNKTLYLAG
LVPAIGGYIFCILAQNANDIVIARSITAIGYGIITISCQSYIAAVAEEGSRAKAMATYVG
VTMTATMCGTAIGAILADWVGYKPVFVIAISLMILAGILGWRMLQNELPSPKSDASSTVS
KASKPLTTLIGNTQFVAILMFCAIPTKIVLTGFLYFFVPIYLASLDASQSEIGRIMMAYS
LIIIPISPLASRLSDQLGKNLSVITYATIASGVALMALYQNTNIIAVFIVVALVGLAHAF
IKAPIMVAVMEAVEKDQYISRTGALSYLRMFERVGSAAGPLIVAALLVQQEFTTVAALLG
AAIIGSGLIMLLVSRSTKQEIQAHA
>fig|911045.3.peg.2164 Glyoxalase/bleomycin resistance protein/dioxygenase
MTILSLQHFNLPIAPGGDKLAREFYVDLLGFEEVERPESIRHRPGGWFSVGSINLHLSVQ
DPFVANKVGHPAFVVDDIIKLAQRLRDADYEVSDDAIFIGYIRKTTHDPFGNRIELMQPE
DMVQHKL
>fig|911045.3.peg.2513 Permease of the drug/metabolite transporter (DMT) superfamily
MLVQLRTALTPAIWGTTYAVTTLLLPSEDPVWMVVYRLLPAGLLLLAFAPGVLKGQWVKR
AMIIGLTNLSMIFFVFIAAFRLPSGMAGTLMATLPLQIIFYIWILDGKTPVARQMFASLI
GLFGVGMLLLGAVELDWIGIGAALAACLSTFTGVYLSGKWGRPDVSMVTYTGWHVTLGGL
YAVPIALMLEGAAPVPDLNMALAFFWIGILGMGWASVNWLNGIVQLNPTTIGFLSLVNPV
SAVLCGQLLVGEEFGWRQWTGIVIVLGSIVYALKTPSAAKVATQTKDAAATS
>fig|911045.3.peg.2870 Glyoxalase/bleomycin resistance protein/dioxygenase
MEHQDKSINYIEFPLLKTEETKSFYGSVFGWLFEDWGPNYISFSGAGVEGGFNGESGTPV
QAPGVLVVLYAKDLAGTLATVREAGGKILQEIYSFPGGQRFHFADPNGNELAVWTEASS
>fig|911045.3.peg.3180 Multiple antibiotic resistance (MarC)-related protein
MLIEFLINAFAMLFVTIDPIGLAPIFLAVTAGASSVERRQIAIKAVIISGVTLLAFFFAG
RQLLEVLGISQAAFKVAGGLLLFIIATEMVFEHRQKRKAESAEKVVEQEDLSQTAVFPLA
IPLIAGPATISAIILLAGQAPGFTGQMSLIAVLLSVLALSFFVFLLAARIDKLLGSTVQL
IITRLFGVILAALSVQFVADGIFSLIEMHS
>fig|911045.3.peg.3249 Permease of the drug/metabolite transporter (DMT) superfamily
MPHSSTKLLPEIFLLIVLSFLWGASFTLIEIAITTIPPATMVFFRLLIGAAILIGLTLLS
GIKFPSSAKRWGELLVQGILQNALPFTLISWGQLHITSGLAGLLNTTPSLFVFLISYFVF
RNSTADIRKFLGILIGFAGVIVIIGPTAFAGEQNSTLGQLAITGASLCYALAAFNAKRFF
NQPPLLTAACSMALAACLMAPIAFILDEPQNLSPTVEALTSVLALGVLSTAIAMVIYFRL
IRTLGPLGVTTGSYMRAGFSVALGALILGESLTPHLMLGLLLIFTGVAFTTGLLKLPQFQ
KKST
>fig|911045.3.peg.3270 Chloramphenicol resistance protein
MSRRTFALIIIFMLTPLGPLAIDIFLPSVPEMLSVFEATNQQMRLTIPLYIFALGFAQLV
GGPISDRFGRRASAMIGLSLYALGSLGAAFAPSLDWLYGARLVQGFGASFTMVTTFAWVR
DNFEGDEAGKWLSYMSGLTGSVPMIAPMIGGILGVIWGWQAAFFLMAAAGLLLLFLTPLA
LPPTKKRHRMLGAPDQITCNLGDMARNRAFILYSLANAATFGAVMTYVSIAPEVAMEQGG
MSEMQFATILGAIGLLQMLFSFLAPRMVEMIGAPTTVLVGLSLSVISGLGLLFVPQSVTM
TFFAFAALGSAGFSLMIGISTGLTLQPFPNCAGLAASIGGFLRMFGGASIATLTNLTDLQ
GPATLATALLFSLLPLTFLLFDRRMESKIEGETF
>fig|911045.3.peg.3290 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSTAQSENIVSQSVDGVYEGPLLPVIIQMSVPIVIGFLIQVFYNIADTVWISMIDPSNPA
IIAGVGLVFPLGMILFAIGNGLQVAMGSVLSRAIGAREDAATQELFAVGLLQALLIGALV
LALALIFGEQLLALLGASGELETYALEFFIYSLPGVVPIVLIGTLMGMLQGQGRMTAMMQ
AVLIGSVVNIVLDPVLIFVFDMGVKGAALATVIAQFIVMAKLLLTLAMEPGELRLKLIPV
KGGFSLSKRLSTIGSAQMWIQIIIAGSVLIYNRFVIDVDPMAMAAFTLVGRLDFLIMIPM
FGISTALLTIAGQNWGRKNYDRAFAVLRIATILAFVCVLVLALLHILIAPLIYPLFSQVP
EVVNYAVLQVRIMELSLPFIAISLCVAEFHQAIGKPAPALMLTVIRHFVLSVPVVYVLIY
MQQMGIMGVYFGAMSGTFFAAAVAYYMRFRLVSAYSNETSIPAMGDAS
>fig|911045.3.peg.3314 Permease of the drug/metabolite transporter (DMT) superfamily
MPVFMSSNIIIAKPAIAHTEPWTLAFFRWGLASLILLPFTYRELKRSLPIIRKNLKLLSF
MAFLAMWICGAIVYLALKETSATNGTLIYSAAPALILALEWLFRGRAVAMRELVGISLAI
VGVFVIVTKGSLGNLLSLQLNSGDLLFALCTLSWAIYSVLIKKSQLQSISTAPLFTILAI
LGTLILAPFAVTEMAITSSVPNTGEVWMSIAGVALVASVASFLTYQFSIRLVGPSIAGMF
MYLMTPYGVGMAVLFLGEKLQTFHYLGFAPIMAGLLLATLPAGIFRKKASA
>fig|911045.3.peg.3423 Glyoxalase/bleomycin resistance protein/dioxygenase
MTTADTIELLPTLPSLNIQETKAFYAGQLGFTNVVYERDDFLILRRDNLEIHFWLTSEKH
LCENSSVYFRGGPIAALHEEFRKLGLPEDGKSEPRLTPLAKRPWDMEEFYIHDPHGNLLK
FGRIPL
>fig|911045.3.peg.3784 Transporter, drug/metabolite exporter family protein
MSTSRSSTRASAAVVGASWMVFAGAAFAVTNSAMQYLTMVQGLSSTSATFWQYLISLVAM
VPVIWRIGVDGLHTEQLALHIFRVFLAALGVQFWVAGLANGVPIWQGIALLMTSPFFVTI
GAAVFLREKASGQRWVATAVGFVGGMIILSPWDEAFQLVAFLPIIAALLWGSSILCMKKL
EESESPQSVTLYLLLLLTPVNLVLALLAPGGLSIPDGMNMWWLIILAGLLGAIAQGSLAM
AYEKVDAAYLQPFDHLKLPLNVLCGFIVFSWVPPGNLWLGAALIIGASLYIVHVERERN
>fig|911045.3.peg.4286 Multidrug resistance protein B-like protein
MDGRWLASLIMILGVGSASMNSFLSSAIMPDIIRDLGGQQRAFWVLSLFQIGSILAGTVT
GSLKANIGARPLFIAAALSFLAGSFVAGAANSLEHLLLGRMLQGLGEGMIVSLCYTLISD
LYPKTAVSSVFALLSGVWAVSAGIGPLTAGMLTDSWSWRAVFYANLPLALLLLILAITVI
PATTREKTETSASTGKKNIIPRLSLLAVAVLLIAYVGELRDLRHISLALVVGVALLFMAV
SWDKKSSAPFIPRSAFRFNGIIGLGMWVTLLLSISSAARVVYGTAMGQVLWGLTVTQASY
AMAITAFSWTAAAWIVARVQTPHVQTYLIRVGTLSIIAGSLLTMWALSAMSLWIFLVSSI
FAGAGFGMSSQFLKKAIIYAEQDDERDRASGFIGPLQSAGMAIGAALAGLLAGLTGFSIP
GAEDLITLENAASSGPLVFLIMAFISSLAAIAAFKMPKMT
>fig|911045.3.peg.4426 Acriflavin resistance protein
MQQNTHKGWIAWFAHNPVAANLLMVCIIVAGVYTAMNIRTEGFPGFEANQVTISVEYKSG
AAQETERGVTEKIERALTGTEGIKKVTSTSTASNSTIIIEKSSGTDLDKLLSDVKTKVDA
VSLPSAAEKPVVVRAEEIEDAIQVEIFGDADPDVLDTVARRIKDRLLEDQLIPSVTISGE
RTQEISIEVQEDALQRYQLSFSELVRQVGNFSLISQQGSLKNENGRILIKADKQGYFLQD
FESIPVITLTDGTVVRLQDVARITDAYTDDRSIYLYQGQPARKLSVQLIGKASLIPAAVR
AREIINEVQAEGSLPTNIQFDFWEDESENISDRLSLMLKNGLMGMGLVLVTLALFLNLRT
AFWVAMGLPIAFAGALALMGDGFWGMTLNELTTFGFIIALGIVVDDAIVVAESAHSVTEK
EGDGIDNVIKGVKLVATPAIFGVLTTIAAFYPITLVTGRLAEIFSVFAWVVVFCLVFSII
ESKFILPAHLAHLKHNAKPNNPLSRGWKVIQNGVSAGLERFKQSVYRPMVKLSLRMRYLS
ALGFVVLFVAVVYMVPSGIVRVVFFPEIPRQIVTATYKGEPDLGYGRLFAEANRIEAAAH
KLKAQLDAESDTDVSPITGIEMQASDDGTVTVLAIATPPLERNITSNEIAERWRKLVGPV
EGAQTIKFAADDFDFADFRVELLLDDVDQLIAASQYVEDMLATQAGVLSVTNDFRAVRGR
LNIELTDYGRSVGLTTSAISEQVFQAIGGAEIQEFQRNQQEVKVRVRYPEAQRSSAAALQ
TLYVRTPAGDPILLSSVANLHSDLTVDEIYRSSRKRVATLDAQINKDEISADTLVTYFNE
ELLPQLQAKFPGVAVDFGGEVEQQREAIGGLITAFGITIIAIYVLLAVPLKSYMQPIVVM
IAIPFGITGAIMGHWVVGIPVSILSINGILALSGIVVNDSLLLVSAFNDNRAKGMPIRQA
LVAAGTQRMRAVILTSTTTFAGLAPMIFETAEQAQFLIPAAVSLGFGILFATLITLFLIP
TFMMILEDFSRLKAVVLGIASLKMEDTGAPEVTAAGE
>fig|911045.3.peg.4509 Permease of the drug/metabolite transporter (DMT) superfamily
MSNNIKGVLWGLLSAALFTLVSALAKIAVIEYHVLQILFVRQCIVFASALPVLLKTFPHG
FKTQHPLPHALRLGGAFVALSTGIWAVALLPLTTATTLAFAKVFFVALLASLFLGEATTK
TRVLGIALGFLGVLIVVRPGFDGLASLYALVPLAGALGAAVAVVCVRKLSQTESTATLLG
YQAVFVGLMAGLPMFWLWKTPDLFGFVLLISMALIATLGQWIGIKALRLGEASLVSSTEY
FSLIYAALLGLVLFSELPDAFTLIGAATIIFSALYMMQKEHRRKASLKPT
>fig|911045.3.peg.4552 Glyoxalase/bleomycin resistance protein/dioxygenase
MAKLDTLRLRVRDAAALKRFYCDVLGMSDQGEGRIGYTPEQVALRFEEVGGAYRPQPTDL
YWKIAISVPNIELACAQLRAQGVPVTEPQQFRDVGYLTKFVDPEGFTIELIDHHFQGERP
EEEHDQTLLGGGPHISLVTLRCADISAVEPDLLNGGMAPLSVQPVEPYGFTLYFYALTSE
QPLNADLTAVENRCWTYQRPYTVLEIQHVPAMQEETQPDADASGYEGLTVSGASLALNRL
RISSQ
>fig|911045.3.peg.4593 Permease of the drug/metabolite transporter (DMT) superfamily
MNAQKLDWLAWSILLLLGTLWGGAFFFAKIAVVELDPITLVFLRVAIAATAMWCFLLVTR
QSIPLTAKWIGSFLLLGFMNNVVPFSLIFWGQQYIASGLASVLNAFTPIFTMIVMQILSN
EEKLTVTKLIAAIIGIIGVAIMVGSDALSGASNQVLPQLAVLGAALSYAFGAFIIMRLKK
LPPAALATGQLTASTILLIPALIYMAPTQQLMSASALTWSSVLVLALACTAFAYILYFQL
FKLAGATNAASVTLLIPVSAIILGAIFLNERLEPNHWLGMAAIFIALLLIDGRLTSRWTN
KQQATA
>fig|911045.3.peg.4832 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MSEVSSSQPDNIFLSGSIPILFAKTALPISIVMMVNGLHTVVDAYFLGTYVGTQALTGVT
LMFPLFMILVSLFTLVSNGFASIYARAFGASNFRIATKIIDSAICLALIFCSLLILSFLA
AGFQLALFLTNGSHELAEIGYEYMAILILGSPLGFILSINIDRLRCEGLLPLMTVITLSS
AFLNIFFDWLYVVQFGWGVAGSAYGTLTAQLISLAAMVTYYTSKRGEFSFLNWRPVSFQW
KSLIALGVPQSLGYTGVSLAAAVTLFAIQLWPESGYETTAGAYGILTRMLTFTFLPLLGI
SMALQSISGNNFGAQKHDRTSQTLKIALIISLVYCVVVQAIYFLFSTQLGAIFVDDAATI
SEVARITPIVTLIFFLSGPLMMIGTFFQAIGDAARAGILLLAKTYLFAIPLTLVLPYAVG
EAGIWYSSALAEILLLGLTFIVVVSHKKAAAPAAAVASS
>fig|911045.3.peg.4939 Permease of the drug/metabolite transporter (DMT) superfamily
MIKIGVASLEPALLVFGRMLVGSLIIFSALKIRGLSLSKDLADWVSYAVTGLLGSALPFL
LISYGEQSVDSALTSILMGTSPMVTLLLAAWLVPEEALTLRTILGVLGGLTGVAILVGPS
ALSGLGMQVTGQFAIIAATASYATSTVYIRKYVKRPPLEMAAGSMIVGTVTIGIYAVATG
TDFSAIELTGSSLGAVVYLGVISTACANLIYFYLVPQIGANRMSQVNFAVPVGGAILSVV
LLGEAMTPQRFIALLVIIGSVYLGTTKGRGRVAEQTGETV
>fig|911045.3.peg.5085 Drug antiporter protein
MSDATLKARWGQISLLFSANFLSLLGNGLSAIAIPWFVYDLTGNAVITATVAIAGQLPNI
IVGLFSGPLIDRYSARTVSIFCDAVNAVAVLLIPLLYAVEMLDVALLGFLVFLSQVIDVP
GQTSKAVMIPALIDKEGLPRERVNGLNSLLETGADLLTPSLAGILIAAFGATTVLLLDSL
SFLMALMIVSMGIKASHVSAPPQSEPQPTKEAWKWMFTTPSILKLGIYDLIINTVAVSLL
SLVLPVLANTNDKQAIWLGIWLTCFACGTTLTTIAYTVLGHRISSLRLLQLTPIGQAIGL
GLLLWVFADMANTNLTSTTGIIAALGMFLYGLNLGVGSVVDATVLQKLVPEAKRGTVFST
FSSLRYTGVPLGLLLSGILLEQNNPITLFSTFIGLLLVNAVIWLWGRLEV
>fig|911045.3.peg.5370 Tetracenomycin C resistance and export protein
MARKHLVLLNMIGALALVMIDQTVLGVILPSLQRTYAFGPVHLQWAVNAYLIALASMLMC
GGWLGDKFGYFTSLRMGVALFTAASLACAYAPTGEFFITARVFQGAGAALMQPAATALVF
SAYPADERGKALAHYVGAGLFFLACGPLVGGLLVEFFSWRVVFLLNVPIGLAVLIMAFAI
GKSKTNKDTGSFDFQGAILFVMALLVFTVAVQLFGDYRLSLGEGVVSAGFVVLACSLLFV
RRHRVAHPFIQFSLFENKVYLGCCLLLFCIPFALLAQVVFGAVFLQNVLSLTPLEAGLSM
LPVVLTIIICAQFGGRLVGNIKFRNLAVCGSLAMGIGFATQALVIHFNNLWLLFPGMILM
GAGLGFLISTVSTEALSHVSLLARARATALLQTCRQVGGVFGIACVGALINWREKTMISA
AAELMEPNDEDRELLQLLLYKFMGDQPAAAALLHERWPQSLYILKAISSRALADAYIFSA
VVLFGAAVMSLWAFKGHTPRQRPQAPEGPPPMNSAND
>fig|926556.3.peg.2072 Tetracycline resistance element mobilization regulatory protein rteC
MKNICFELYQELQSQIQNIQGQQYAELQQAEACFVAVGTALNRLKEKLWDYEFTPPEEIY
FFKKAKPRIVAEQLYYGELYYIHSTLPVEKREVLDHYRNQLSFIRSYFQRHHFLYTYYRL
DRSDLDEYLFKRNAPKAPFLAETIAIQKDSRFSTHGSYRFARFKAFTRLKEYLLGKIHHL
QNPAPAPEKKRLKWTAPKVALIELTYALKAAGVFNNGQATIRDIATVVEQIFQQDMSQYY
RTFQEIRIRKSGRTYFLNRLTQALERWMDNTDLDGKGDKWD
>fig|926556.3.peg.3068 Multidrug resistance efflux pump
MNIVAPSSHDVRVMNYNVEVVPRVTGLVVDVPVEPNEHVKKGDTLFRIDPLPFELEVKNI
EAKLPGLEAKLVSAEAFDRELESQLTTSNNHIRVINTQIDLAVKRLEQTKELAQSGAGSQ
FDYEQAETNLKNLEAQLAVAESEKSQVIQRLSAQSDEGEFAQVSEARAALEQAKSDLAMA
KWRLDQTVYRAPADGRVVNLQLRTGAMAVQFPIKPVMSFVEDEQWVVALFAQNELRRVEK
GNEAEIALRTHPNRIIKCTVDHIVWANAQGQLTASGRIPDTKEMGHHEGRFAVRLTIDED
NDVFLAPGAVGQGAIYTEHGKLIHLIRKVIIRVGTKIDWLILKLH
>fig|926556.3.peg.4611 Tetracycline resistance element mobilization regulatory protein rteC
MDIQKLAQTLKERLDRELPEASALGEDRLFHLQAAHKNAEKVLGELDVALAKYEFGDEAA
EIHFFKHIKPDFHSESIYYAELFNLESARPISQKGDQVKYLLKEQQKLQAFLNFNRDLHQ
YYMLDRTHFDRHYFLRAGRADFLVSRAFHTPIDRSSCTVACLGISTILAAIRINKYINSA
IQSLQGPPATAQKQVTLKWTGKKNQLVELVYALKVAGVLNHGQAEIREVAKVMGQLLGGD
MGDVYKRFQEIRIRKKGRTLFLEVLKEKLEDYILESEGL
>fig|926569.3.peg.649 Vancomycin B-type resistance protein VanW
MSTISYPVRRPTPQPRAITLEQVLLAGMLGVVLFVVVLVIFFLGFQIVYAGRIFPGVSVA
GIDVSGMTPREAAQEIQRRITYPQTGKLVLKDGERFWIVTPAELGLALDASASARAAFQI
GRSGDPFTRLWEQSLTLASGKDVPPVLLLDQRVTFAYLNNLATQIDVPAKDATLQVEGTE
VKVTPGQIGRKLDLNASLILVSVQMQTLKDAILNLYVQEEKPAILDASTAAEQARRILST
PLTLTLPATDNSGDGPWTIPPEQLAQMLVIRRAEADGNTRYQVGLNETYLLTYLSDLAPK
LRRSPVNARFIFKDDTRQLEVIQNAVIGRELDVSASANFIQEKLAQGEHEIALQINYTNP
PVTDEMTGEQLGITELVQATTTYFRGSSAARVQNIKAAASKFHGLLVAPGETFSMAQALG
DITLDNGYAEALIIIGGQTIKGVGGGVCQVSTTLFRNAFFAGFPIVERHAHAYRVGYYEQ
TASGHSDRLAGLDATVFVPLVDFKFVNDTPYWLLMETYINGYSLTWKFYSTKDGRTVEWD
TTGPTNVVDPPETVYRENPDLKQGEIKQVEWAAKGADVTVTRRVYKNGALYFSDQFVTHY
EPWGEVFEYGPGTELPPKE
>fig|926569.3.peg.1405 Tetracycline resistance protein
MTKNKPLSSIFLVVFIDLLGFSLILPLLPYLAKSFSASEFQIGLLVASYALAQFIGAPFL
GRLSDRFGRRPILLISIAGNAIGFFLLGIAQNLEMLFLSRILAGFTAANISVAQAYISDV
TDAQSRARGLGLIGAAFGLGFILGPAIGGALSQFGYAYPAFAATGLSALNFLLVFSWLKE
SLTPERRQALNHQQRPPITLKAMLETLRRPYVGPLLHTRFFFGLAFSLFQTIFSLYALER
FNLQARDTGYILAYVGVISVLTQGVFIGKLTRKFNEIQLMFVAILTMAFSLLAWGFAPSV
PVLLITLLPIAMSGGILNTVINSALSKSVAPIETGGILGLSASLESLTRVIAPSLGTLLL
QITSQSYGVFIGTAVPGLAAFVLLIWLGSYFWRMIYRVPPVVHSPSGMD
>fig|926569.3.peg.1825 Tetracycline resistance protein
MIKKTSARLVYLILSGGNTLADTIMFTVNMVYFVEIIGLSPLQLVLVGTVLEGAILLFEI
PTGVLADTIGRKVSIVTGWFIMAGGFLLVGIVPELWAVFIGQVLWGLGYTFTSGATEAWL
ADEIGEDLVGKINIESGQINRILGLIGSAISVAIASVALNLPIVIGGLMYLFLAVFLLFT
MPETQFTPRYKSSKSLETPFQSFIQTFQEGVKAVGKSPILLALLLVELFIGAASEGYDRL
SSAHLLKNFQIPPIGALQPVVWFGILNITGSLASFSTTAMFRKKLEVISQSYQLAARYLV
LLHSLGIAMVVMLALTGNFYAAIAAILVKGVMGALIFPLYNAWLVQNILPTTRATVISIV
GQANAFGQVVGGPGIGAVGNRSLRLAILLTALLSIPALPLYTSAQKKQTVFSPESTR
>fig|926569.3.peg.2165 Permease of the drug/metabolite transporter (DMT) superfamily
MTSLHKPFTEFRLPPYLVLVIGVFCVSTASILIRLVQNEASALTIAAYRMVLSVLILFPL
AWQKREEWLSLPHSSLKFIGLGGIFLALHFAFWISSLRFTSVTSSVVLVTTTPLWVALVS
PLVLKEHPSARTWAGLTIGITGGVIVSLAQGCTWQAWALSCPDFASFFQGKAFLGNIMAL
IGAWMASGYMVVGRKVRAGLSLISYVFMVYAVSAFVLLIFAILAQEKILGFSPLTYVYLL
GLAIIPQLLGHSSYNYALGYLPAAFVALTILLEPIGASLLAMAILREFPNTLEILGGLII
LLGVGLTSLPAKK
>fig|926569.3.peg.2969 Permease of the drug/metabolite transporter (DMT) superfamily
MTLKNWLIFLALGTIWGSSFLWIKVGVGEIGPFMLVTLRVVVAFTALALVIARKRTILPD
LRRTWWIFAVLGLFNLAVPFVLISTAEQSLSSGLAAILNATVPLFTLVIAPFFISEERMT
LPRLGGLLVGFAGVVVLMSDELRAGANWGDLKGQALMLLATFSYGAASVFARLKTRGMPV
EVQAGGQALFASLAMLAILPFAENPLVFPRLPITWLAVLWLGVLGTCLATLMYYYLLHEV
GPTRATLVTYLFPLVGVVLGAVFLRERLQVWHLLGGAMILSGIVLVNRYKPPAAVAVTPE
TAQAD
>fig|929562.3.peg.222 Permease of the drug/metabolite transporter (DMT) superfamily
MNKNTFTNPENKSLIAWLLLSILAMMWGSSFIIIKKSLDAFTPIQIGTIRILAAGIVFLP
WIISSRKQYPKEKTKYFLASGLLGYFLPAFLFAFAGSRINSSLSGTLNSATPIFVLIVGA
IFFQQFIRSWQVAGLILGFIGSVVLVLSSSKDGLSISQLNPYALLVILASLMYGFNVNIV
GKHLSEINAVLLSGWTLFSMAILSAIILFSSDFVSRINADTLNPLLMLLLLGAINSGLAA
IIFNYILQISSPVFASSVTYLIPVVATMMGFIDGESISFLHYFGMTIILVGVYLINKK
>fig|929562.3.peg.432 Permease of the drug/metabolite transporter (DMT) superfamily
MFSFKFKIICAFTAIYLVWGSTYLFVKISLHSFPPFMLSTLRFFIGGGALLIYTLAIKDT
LPKSKELIRQAILGCVTFIGGIMSVVWAQQHLSSSLASTIITTPFWFVVLDSKQWRYYFS
NFHILIGLLLGLVGVSLLMILKTNTHISGPISMQLISILVIIAGSFLWVLGSLYLRNNPS
STSVYANTTVQLFAAGICCLFISLFNGEMNHFNLSQTRLDGWLSVTYLAIFSNTLTFLAF
VWLIKIKPPAIVSTYSYVNPMVATLLGWSLGNEHITLVQILALSLILSGVLFVNLGRNKV
>fig|929562.3.peg.1892 Permease of the drug/metabolite transporter (DMT) superfamily
MSQKTKILIALGIVYIVWGSTYLGVKFALDSLPPLLISCTRFLLGGSLLFLFTLLRGQGL
PTLQQARNAALIGVLLSGVGNCAVAYALLLMPSGLVALLVATLPAWMILLDFLFFSNEKP
SFIGTIGLVLGLVGMAVLLNPTQQIGQREVALFPAFIVFLGSIAWAFGSLKSPYLVLPKS
LQSTAIQMVVGGCFSLTMSIIFEKDQIHSLLNMSNSTFWAMVYLILIGSYVGYTAYVWLI
NNAPPQLTATYAYVNPVVAIFLGWIFINERLTSRSMLASAIILAGVAMMTLGRKRKPHEV
DV
>fig|929562.3.peg.1929 Multidrug resistance transporter, Bcr/CflA family
MDKNNNRFLLIIILGLLSAIGAFSIDTYLSGFPIMASDLHVSVDDVSYSLSSFFVGISIG
QMLYGPLLDRFGRKKPLIVGLVIYVLASMGCAVSTSLEMLVVFRFLQALGGCVGMVTPRA
IVRDTFPIQESAKIFSTLILILGVSPIIAPSVGSLMITTMGWHSVFWLQAIIGVVLFLAV
LFLLAESKKADDSISLKPEHVTKVFWGIARNPQFITFSVAGSLVSGAIYAYLSGSPFVFM
EIFKVSEQQYGIIFGVLAGGLILSSQINNLALRRFSSQQIINVALSIQTILGLLLLTLSA
FNLLNLYGTLILIFLFLCCQGFSFPNSSALALMPFSKEAGSASALMGSLQMAIGSLSAAM
VGFISNGTSLPMLGVMAGCASLGLIVFKIGNNNIVAKNK
>fig|929562.3.peg.2211 Membrane fusion component of tripartite multidrug resistance system
MENAPKKSFKNYIPRIILLLIVIGAAIYAYQKYQYNQHFETTDNAQIETYTVPVVPRVGG
YVNTVNMKDFEEVKKGQLLVDIDDREQQLALVEMEAMYQQMLTDVENARASIKNTNLTIG
AAEANLKSTVLRQDKARKDAERDAKLLADNAITKRQADDSKANLDIISAQLDGQKQDISA
SKSRLDILVANLHKAEAALAVQKAKIEQQKLKLTYSKVYATENGKIGRKSVEPGQFIQPG
QTLATIVQDSLYWVVANFKETQISRMAVGQEVKITLDAFPEMELKGKIADFSDATGAKYA
LLPPDNASGNFVKVTQKIPVKIAIEGVEKLRDKLRAGMSVEAEVKIK
>fig|929562.3.peg.2213 Outer membrane component of tripartite multidrug resistance system
MKINKAFIIICLFLGGEVFAQSTEQVLPKLINQAIEYSPRVKEQQQLLTTGDYRIKVQET
GLKPQVSGELSYSRVDPIAQATLPVNGEPRTIQFQPHNNYNASVGASYVIYDWGRFKAGV
QKTLLEIQQQGGGIETLKHTLAYQVTQLYYSIVYLQKAIVVQQEQVKLVQENGKIIADRI
KSGDALDYDAIQTQVRYKNAEMRVIDLQGQLEKQFIFLSSLIGSDARKLIPANAELQFPY
AKSDLQTAYNEAIQNNVDLKYLLSKESILEQEVKISGMSSLPTLAASASVGVRNGYLPDI
SILRPNSLLGVKLSIPIYTGKRGAYNTQIAKINLDAAKQGTESQKVQISRDLENAYNDIK
VANQKKELAASNVFQAEYGLKLAKNRLANGVSTPLEIQAAETGLEEAKFNLLQYDYQALM
AKLEIGRLSGVKFW
>fig|929562.3.peg.2459 Bleomycin resistance protein
MISIAIPKLPFIEKQQTIDFYVNQLGFSLISDYGEYFIIKKDNAELHFFHHPQLKPAASH
FMIYLRIDKGIDEFYQNLLSKKVSMITPLETKPWGQKEFALTDTNSTLLTFGESN
>fig|929562.3.peg.2673 Glyoxalase/bleomycin resistance protein/dioxygenase
MSNKLSIKAFNHVALQISEIERSRRFYGEILDLKEIPTPNFDYPVIWFDLGNGRELHLIG
RQPERTFTPVRSNHFALEVSDVYLAEKVLIEYGVKYFPIKARPDGILQLFLNDPDGNFIE
LCQI
>fig|929563.3.peg.163 Glyoxalase/Bleomycin resistance protein/Dioxygenase family protein
MIVLESLDHISLGSSDLKKSIEFYVDVLDFEVAEETDRFAILQLDHFSLRLNHIDGYVCQ
QDNPSAFSLSFIVDVDDFTNAISELEEKKIQIVVGPVVIEGGESMIIRDPGGNWIELFYK
E
>fig|929563.3.peg.580 Acriflavine resistance protein homolog
MAALIEFFLKRSIFGNLLTFLIITWGGYTAATLNREAFPRVDFDIVVVTTVYPGASPAEI
EKLITNPLEEELKGVDGIEEMRSSSIDNRSGITIKIDPDTEDTQKVVDDIRSAVDRVNDL
PDDAETPLVLEIGSDLTPVLDICLELDVDEFGRPLMSYRQLRDEAEKLEDSLLLLDEVAR
IERKGWRDAEYHVLLDPDRLASNYLGLEQVLLALLERNVNFPGGEVIQRGRSSSVRTVGE
LLTAEDIASVYIRSNDAGQGIKIASVGSVRADFAPEEYIERTNGKPTINLTVIKRSNADI
IETVARVQETVDQYSKDKPASIHVAYVNDISYYVKRRLGVLLSNAASGLVLVVASLFFFM
GWRTSLMVALGIPISIATSFIIMSFLGVTLNLISMFGMIIVIGILVDDAIVISENFYRML
EQGYRTYEAALKGTAEVILPVFASVFTTMVSFAPLMSMTGIFGKFVYTIPLVVIITLAAS
LFESIFILPSHLYDVNKFSQHASEIREEGTRFYRFRTNYYEPLLSFSLRHKLSVLGGMFA
LLVGSFIAFGAFGSFKLFPGAVEQFQIKMVADPSTPLEQMDRYTVAVTRALERLPKEEIE
HVTSRAGIIQQNSTDPFTRRGYNYAQVMVFLTPENKRERTEGEIIDQLRDEISWLLNEEK
RKQMEAALPEDPERKRYSAYKPQGSEDLAGLLRNLDIEVLRGGPPVGKPVAIEITGKEYD
RLEEIGERFKAVLATYVGVKDIDDDHEPGKEEVRLFINEAVAARAGVSVQSVALAVNTAL
SGARPTSIKQGTEEIDIRVRFHDAHYKKTEALNRIKVLNRTADSS
>fig|929563.3.peg.793 Acriflavine resistance protein homolog
MTKALSFFMEHRLVTTVFLSMLLALGFVSLSSMNREAFPKVTLDKVVIQTPYPGGTPEEI
ERLVSIPLEKQLRSVSNIDEVRSYNLENVSVIMVFLKEGMPDTRPAVEDIKDAVERTALP
PGALAPTVEEITTDKQQVVDVAFSLKRDGAHVPTTEEYRMLRDTAKAFEDKLYELPEIAE
VERFGYRNRQFLVEADPAALNAKRVGLNQILNVLGMRNVDMPSGVMRLNGTEYLLRTRGQ
FSEALEMRSVPIVGNATGFMTVLSDVAQVFDTYEDPTIYEKYDGSHVIVLRVWKTETADI
INAAEAAKATVEKMKERYPEVEVTVFLDQSTDVVRQLNDLIMNFVTGLTLVVAALFFILG
FRLSMIISFAIPSIFLIAFTIIHAAGITINTISIFALVMVLGMMVDNSIVVAENSFRLMQ
EGQARGDAIRNTLSEVFAPLLVTMLAIGAAFAPLLFMGGIIGKFVFGIPAVILIVLVVSL
VFSLVFLPSWLNTFLPERVKATYGGDDEEAGGFGLIVRAYRKTMAIALRYRYAVIGGFTV
FFFGLLFLAGRFLPFVLFPAGGEDQIDIKTYMPQGTTLQRNLEVMDKAEGLITEVVGDQL
VFLRDRVGIHEPPFDDPKPGEETHRSTVIVKLTPVQERDDEASAAIYVKKIRDRLKKAQQ
AGELPAEFRYDVEAALHGPPVGKPVSLQIRGPEFAQLKEIAALYMKELEGMPGVYDVSLD
LEEGKEEIRFYVKDDVAAKAGLSVNDVAESIRTAFNGEVASSISKGEDRINIVVRFPDEA
RHKIESLKKVKVQNNQGRLVPLERVAYFTRERSYSMINRQDLMRVVRVEASVDTDLTTSL
DVNRLLQKKIDISKDYQDYSVNFGGEQEDAQDSFTDLVISFAFAMGVIFAIFLVYFNSAT
TTGVVMGAIPFGIAGVLLGLMLHGKPLSFMSMLAIVALSGSIVANTLVLVTFTEELRKKG
QDLHEAIINAGAIRLRPVLLTTVTTVIGLLPSAYGIPTVDHFVQPLSLSFAWGLMFATLI
TLVLCPLLYMMKEDFLARLRKA
>fig|929563.3.peg.1212 Daunorubicin resistance transmembrane protein
MVYLKFISMSFQRSLAYRVEYFTAILNAFLYIFIFVSVWQALIPEEGLADGITRESMTAY
AVLSTLIKASFGRNDSLLSQKVKSGEIATDLMKPFYFPLMYLSDTIGSTLFQLFSRVIPL
LLFCIFLFDIKLPVDGELFLRFLPVYILAFLLFFLLSFFISSLSFYFVEIFPFYIFYYAL
ITLASGAVIPLDFFPEGISGMLEWTPFPYLFYYPTMLLLQKPGLPEYSDLLLRYGVLTFG
LLLPCTLLYRTGLRKLTIAGG
>fig|929563.3.peg.2355 Tetracycline resistance protein
MLLFILILDLMGFTLIFPLVPDLLAFYVHSTPHAIDSYLPSLIQTLLQFAPGIGTGEERE
IILLGGILASVYALLQFFLSPFWGRLSDRIGRRPVLLLTSSGLAFAYLLWGFSTTFTLFL
ISRVVAGVMAGNLGVATAAMADLSTEEGRTKSMGLVGAAFGVGFIVGPALGGALSKLDLS
GLPFAYHPFSAAAFVSVALSLLSAVLNYFFLQETLPEHLRSKGPLRIEYPFRVLSELKEP
TFRRMLALNFAFMFLFTSFEFTVTFFYKIDFGLIPSQIGLVFFYLGLLLALGQGVLVRRL
SGIISEQRMIVAGVILIAFALPLLALSAPSVPLSLLALAPVAIGSSLLQPAMAGLASRSI
SADRQGLAMGSFRSMGSLARGVGPIFGSYVYGSVGITVTYIVIGALLLVSFAVGAGTLRQ
AQSEASRT
>fig|929563.3.peg.2467 Acriflavin resistance
MRSLLTFFLQRPMVVTISMLALLLIGFQSLVTSRKEGFPEISLNRIVVRTLYPGASARDV
ESEVTDLIEEELQEVEGIKEILSYSEENISRIEVRGKEELKPEQFRRLYSDVENAIGRID
DLPDGIRGRPAIDDVTTADIPILEIAYSGSPDALTVYLEGLERRLRRIPGVSGIDIAGLP
DEEIHVLIDAALARKHHVDLRMISKALAQRNITGSGGILYNPDEEQKITISQGLASFEEI
LNTPILGNTDGFDVRLRDVARVERGREDVRLIVRNNGQNGAILSVRKSGQADLLDTVERV
HRLLESEELPDGVSQSVLVDQSTLTRDRISLLAGNAAMGFVLVLLVLMYFLDRTTALWTA
FGIPVTLLGMIVFLKFNDISINLISLAGFIILIGMLVDDAVVIAEQYRSNRENGMEPREA
ATQSVTRMFLPVLASSATTMIAFAPLFMIGGFPGAFIWTIPLMIIVGLTISLLESFFFLP
VHLAHARQRAPRQNRLMPLLERLYRQSLEFFIRHRYRAMGVFLLMLVTSLVTLRLSVRKD
PFPQDAADTFSISITLPAGATIMQAQAEMESLEAILRERIGPDLKGTSIRIGTQIEDSTV
DRGAQSNLIVALVYLISYEERDRTAETIMNDLHDPLKDLARKNGMQYALNLKRLGPPMGR
AIEIRLLSDDDVSRTTKAREIMTYLESIPGVTHVELDEREGLRETELVLNQGLLSAAGLH
NQDILTSLRIALDGTIVSRIRESDMDIRLKLNRRINESGDFIKKIPVINRLGIVVPLERF
VTAGEGRSPASITHVNAMRSTTVLGNVDNRIISPTDIMDIVNQKFSRADGVLLEFSGQPV
ETSLIFAGLSSASVVALIGIYLIIALIFNSYTKPFIILLSLPFMAIGIAFVLISHDVPGS
MMVGVAVVGLMGVVVNASIVMVDTILTDTQAATPGEIPGKQIVIEGAVSRLRPIVLTTAT
TVLGVLPTGYGIGGYDPFLSHMSLVLAYGLGFATIIILIIIPLLFMIGTDIRGMLDRRKR
NAFSFLTALFDRKAF
>fig|929563.3.peg.2924 Glyoxalase/bleomycin resistance protein/dioxygenase
MNPTNNEQGSRIMPTLRYRDVGKAIDWLEKAFGFERHAAHADESGSIVHAELKKGADMIM
LGAARDDAFGKLQTMPDQTGGQVTQSAYIIVPDVPALHDHVQRLGARIVMPLSKEPYGTM
FSCLDLEGHLWNFGDYDPRV
>fig|929563.3.peg.2940 Permease of the drug/metabolite transporter (DMT) superfamily
MYLQIIVLALIWGVNWVFMKAGMAYFPPILFSALRFLSAGAVLLIISRWRGVTAPTGDEW
RPILFTGLVQIAFTNAVLQNALLVIDAGLASVLFYTMPLWLSILAHFLLPDDRLSPLKIS
ALLLGVVGLTILLKLNPDTLLQLWQRPGTLSELLVLVASVAWALCNIVMKRVSGRINALR
FTTYQMITGGLLLLAYSALTEPFQLPPALAYQGWATVAFSGIVASALAFLMWFRLLRAIP
ASTAGISLLLVPVVGVFSGVLLLGETVDLAMITGMALILISIGLVNVSGRRGRGAV
>fig|929563.3.peg.3458 Glyoxalase/bleomycin resistance protein/dioxygenase
MNVGYVTHNLQPCRDFYVQKLGFSVQFENEWYVLLKAPDSGIEISFLQPGLEFQAPVFQT
AYNGKGTYLTIEVPDVEALYGDFKERGITIYRDLKNEEWGDHHFIVLDPNGTGLDFVTYR
PTE
>fig|929563.3.peg.3671 Glyoxalase/bleomycin resistance protein/dioxygenase
MITVIGLLALFIVWGVVSARREYYARTDDQHIFQNVTIAAVHPAALASFYIEALGCEIIP
ADGGFELPGESSAIVLRLPGYRQGPTLRIIPCSTSPLCGPLEVNDRGYAHLCFETNDVPG
LVQKAVEAGGTISSTFDRIEKSLSVYTKDPEGNTIEVHIPLPAPFNPYTFYRALKSVWQI
KRRRSDPQRSKVRFIHVNIISEDWKETAEFYRKTIHARPTGMKRDYKGLFIEQMVGIKGV
TVKGRHIALPGYRNGGPTFELFTYNKPANQGPPGLADRGIIATGFLVHDLMQTVTAIETA
GGQIIRRPENGMAVVTDRDRNIIQLVQR
>fig|929563.3.peg.3858 Permease of the drug/metabolite transporter (DMT) superfamily
MSRWRDTLLLLLTVLFWGTTFHAARYAMQSFTPVALAAARFLIGALFLLIVTGRLTDLTL
LRNRDFLGRIVLLGAVGVGIYNLLFYEGIARVNPARAALIAAANPGITALLLRVWKKEAL
PVASLAGIVLAFAGVAFVVFEPGSGWSIGVGELCIMGAATAWSIYSIAGRDVMRTYEQRA
VTLYSVVAGSLMLPLFVGSVDDTHFAIGPFIAVLYMAIFATGLAYVWWARAVQSLGPAPA
AVFMNLVPVTALVIEVLLGGSIETRQLFGGALVIAGVWLTNRR
>fig|929713.3.peg.1596 Outer membrane component of tripartite multidrug resistance system
MNTRITTIAVFLSVIMVFNNPLSAQDIKKLSLKEAVELGLQNSKHLKIDQAKIQEATAAV
DEAKNHQLPDVKVTGSYMRLTNANVDLKAAKSGGGSSSGSSGGSSVPTISQAMYGIANVS
LPLYAGGKIRYGIQSAKYLLEAVRLNEGNDKNAIAYNLTEAYANLFKSAQLIGVIQENLV
ASQHRDSNFLQLENNGLMARNDRLKAQLQTSDIELQLLEAQNNNAIANVNMDLLLGLPEN
TVIEVDSSFVNGITEAQPVTYYEAQAIQNRKDMQALDYQEKAAQTGIKAARADYFPSLAL
TGGYIAADIPKVLTITNAINGGIGVQYSLSSLWKTGATIRKAKAQAQELTASRDLLTDNI
RLEINRDYQNALLAKKKIDVNAQSLIQAEENYRITKNKYDNSLVTITDLLDANASLLSSR
IKLLNAKADAALASQKLLEASGTLIK
>fig|929713.3.peg.1956 Permease of the drug/metabolite transporter (DMT) superfamily
MNQQKAPSALMVILAFAAVYIIWGSTYFFIERGVKYIPPMLLGGLRFVTAGVMMLVWVAA
KGERVWNRKAILHSVISGILMLFVGNGAVIWAEQYLHSSFVAIFLASAPIWFLVFDKPNW
TENFTNRFTLLGVFIGLLGVIALFYEKLTSDGSTNTLVPILAIFIGNIGWVVGSLYSKYK
VKGVSPSVNSAWQIFSAGIVFFIIGFADGSIEKTNWGAIPGEAWGALIYLIIMGSIVGYS
AYVFLLSARSAAQVSSYAYVNPLVAVLLGVFINGDHLTRLQLTGLAIILGSVLCINLAKK
EREKKQAQRQEPEADRMPVCKELVDN
>fig|929713.3.peg.2067 Glyoxalase/bleomycin resistance protein/dioxygenase
MKIANGHQPLMPYLILVKANDFIGFTQRVFGAREVFKSYRDANSREIMHAEVQINGCNIL
FADVTEGYDAAPANLFIYVEDAAETLRKAVDNGCVVIDELAQRDYGLSAGVRDPFGNVWW
LTSMK
>fig|929713.3.peg.2142 Nisin-resistance protein
MKKPLLFFAILYFSFSLNQEISAQVNDYAFLIDTAITVMKSKSYMKDKVNWEALRTALVN
RAKAATNINEFGGVAKDLLGTANDFHGAFFYRDSVFKYKQKIERPFPGAVTEEWKKGVYL
KSLLLERQTGYLRIPYITVGSKEEMSKKAQQLNDSLCSLLEKGVKGLIIDLRLNGGGAMY
PMMLGLEQVLGNGKLGSFTAAPKEQWIIKQHSFLMDARVLCTIQPKCTISATEMPVVVLI
GGGTGSSGEFLAMSFKGRKHTLFLGSPTVGYVTSIEGLPIGKAYLYLSTGYGMDRNGIIY
TDAITPDIIDDSIDQFNNIANDPKVKKAMQWILKQ
>fig|931626.3.peg.162 Antibiotic ABC transporter, permease protein
MIPVVVASLFLFYYAVSAWEPMAKLSGFLEVISIGFPLMIGLICGIAVDQEWQAGGAQVM
LRETKSRAIAYSSKFLLLFLMGAFSVMVTVGIFAIGFKTVPLLFYVKTVGILMVANSFLY
ILHLLVSFLYGKGASIGLGIGESLISALALTGLGDGRWYYLPCAWSVRLNDYLVYIWDQP
ASATIGKIEIVRGLVIALVVAGIGFWVSLRWFKKWDGRKSFE
>fig|931626.3.peg.492 Glyoxalase/bleomycin resistance protein/dioxygenase
MKCKFTHTNIIAKDWKKLSQFYQEVFGCVPVPPERDLHGDWINRLTGLKGAHIRGEHLRL
PGYEENLPTLEIFSYENGIDSGIPQINRTGFGHIAFEVNDVDAVLKALLAAGGGQIGERI
VADYPDNVVATFVYATDPEGNIVELQNWGTR
>fig|931626.3.peg.2154 5-nitroimidazole antibiotic resistance protein
MRRANREVKNKSELIKIIESCKTCRMGMIDDGKPYVVPLNFGYKIVDSVITIYLHSAKEG
RKVEVLTRNNTVCIEMDQMSELITGKNGCDYSCYFESFIGEGQAVILENVEAKIDALNAI
MKHQTGKDDFSYDLRVLDKTLIIAIELNHYTGKRH
>fig|931626.3.peg.2468 Drug resistance ABC transporter,ATP-binding protein
MENCIEVKNLTKYYGNRVAVNNLNLTVKKGEVFGLLDPNGAGKSTTIDCILGLKSFENGS
VRVLGVDPTNDRKRLFEQVGVQLQASSYQGNIRVGEICTEISALYRSPADYHDLLAQFKL
NQYLKHPVAKLSGGEKQKLSVLLALIPQPEVLFLDELTTGLDTEARREVWQVLTNLKKQG
LTLFLTSHYMDEVEVLCDRVCIINQGHELITDTVPELIRTSPYQRLEEAYLWVMKEEITL
>fig|931626.3.peg.2944 Permease of the drug/metabolite transporter (DMT) superfamily
MSIGIFAAIAAALAAGLIPVLTKALMLDGLSATTILFYRYVVVFVVLGITFIVKKENIKL
SIRQVFGLCIFSVFGYGGATFLLAQAFNFMPMGLATMLYFSYPFFVVLIMRVVFKEKPNR
TKIIALGIAILGIIFLINFDFQLVNFGSILAMGSGLAYGIYLVSLQKSVLQKLKDPVIIF
YLGGISAVIFGLQGCLVSGNPEFLRLPVKGVFFTVALGLITIFVLKMVTYAIKKIGSTQT
SLIIAFEAVVTLVLGIVLYGEPWNGNTVFGALLMLVSVILVSRTSDIDIILE
>fig|931626.3.peg.3385 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MNNQHFVNKAFRVFAINSILASAGVVLGTFVDAIILGNAFGETGLSVLAVSMPIYMVYNL
FGYAFGVGGSLKVSESIGAEDKQGARTYFTQAIFFALVIGLLSTLLGMLFLPQIIAATGG
SGLDTAIDYLRPVILAAPIFILAPVISLLIRSDADPFLSTVGISLSVVVNLVLDLVFIFG
LNMGVFGGALAMVIGQFVAVAVYSVHFFKKNSHLKFCRAPLSLKDGYHLFHGGFGSGSAF
IYQGISLVVINNLLSVTVGVSGLAVYNILFNVSLFAYAIFDGISLALAPLVATFAGEKDT
AGVYNTMHLSLKTAVLLSIGSGLILIVFAAPIASMFGVAENAMVVVQTIRIFAFGVVQTC
INCVMAHFYQTIKRPTLAGVIYFMRGFLLLIAFSAWLIPIWGVMGTALAIVGSETVTMLL
MFMAAVVLKKQGGYRNVLLFREPVIAKDNIYETTLSSDIKELENCVVEIEAFCERQDIDT
KNAYFINLTIEELAANIINFGFNDGKPHFIHIKIALFDGDIYIRLRDDSTTYNPFEESEK
PDEALDYLGVSIVRKKAKSFAYNRTLVFNNLLIIL
>fig|931626.3.peg.3389 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTDTMMVGTLGEVPLSGASLANQFIMIFQICCMGIGMGASVLTSRFWGMQNPDALKKTIT
IMFRICLSFALCFSLATYFFPEAIIGIYSTDPEVIREGTLYFKWAIPCYLLLGLSLTSTI
VLRSVGQVRLPLISSICAFFINIFFNYLFIFGNFGAPRMAIEGSALSTLIARTVEFSIIC
GYLFLIDKKIRYRLQHLFMHCRDILAEYFRVAIPVLISDALLALGNNTVVMVIGRLGVSF
VSANAITLVLQQLSTVFIQGIANASAIITGHTLGRGDEEAAQQQGFTFLYMGIAVGIIGA
VLIWLISKPMISFYNLTLETQLITYQLTFAIGFIVIFQSANSILTKGVLRGGGDTRFLML
ADIIFLWVVSIPLGALAGLVWHLPAFWIYTLLKIDQVLKCVWCVYRLKSRKWIKKIVACP
VNQNQ
>fig|931626.3.peg.3637 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MENNQGSQVQPSKEADIPPEKILHPKNPQNFLGTDGITKLILQYSIPSIIGLLVNALYNI
VDQIFIGIGIGYLGIAAANVAQPLTTLSIAFALLFGVGGATNYSLFLGKGNTKRANQLAG
NGIIFLILSGTVLGFGTLIFLKPTLYLLGATDLVMPYAIPYTALIAIGLPFLTFTHGACT
YIRADGSPTYSMVVQLIGSVFNLIFDPVFLFACHMGILGIALATALSQILTAAISVHYLI
KKRRLMSFGKKDMLPTTNCLKPISAIGFGVFINQIAGAAVLIVLNDVLRHYGAASTYGSE
IPIAAAGVASKVFILYQAFTIGIVQGFQPVLAYNYGARLYDRVKQIYQVSLSLSSLFSIV
TFLLCMIFPGQISSLFGTKNVAFYAFTTRFLRIYMLLTFANGIQPIVYNILNSIGKVKSG
MIATLSRQILFAIPLLILLPALFGLEGALWAVPIADFLAAILSIILFAREMKEINKLILK
SSENTASG
>fig|937774.3.peg.1079 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTWPILIGQLAGISYAVLDTMMIGNYSAVGLQAMSLGSAIFVTISISLMGVIHAIIPIIA
QLIGARKNAEVGIFWGQGTWLAFILSLLVGLLMLFPDMWLSISGEVSQVVRDEITIYLRI
CYLALPAMMMYRAVYAICTSSQNPRHIMYISIVGTLSKALLNWILIFGKLGLPALGSAGA
GLSTLIVSWITYTVGLFIIFKNPVYDKFLLHLGRPKFKPIKQILNLGIPMGGSYFVEISI
FSFMALFVAREGIYVSGAHQILTSFVSVMYMIPQSISICTSALAAQAIGARKYILSHNTV
KMGTYLVLAGYAILALTVILFKVPLVDLYTNNTDVAHITLIMISIIPFFHLADALQCYVP
YILRAHKIATVPFVTQSIILLGIGLAGGYYFGFGAGRGNIKFLTEFIVPNAPIGIASMWT
MNTISLYICTVILGTWYYFVIKELIPKSRKNNMPFYYKKDLFKRKKP
>fig|937774.3.peg.1310 Outer membrane component of tripartite multidrug resistance system
MIKHSKQFILLATCLISACSPIKVDIPESKVDLDNLEFEQTKKAKAIVSLDKWWEDWNDP
ILTTLIEEGLRENFDIAIAKAKLLESRANANLANADMGPTFGLTANGGFHSTSVSNPIEP
ALSKVGFNVSDDFQTTGLTGFAGAVASWEPDFFGSKLSDAKAAEYGASAQEEGVHGASLL
TSSEIALNYLYYRYYQKKIFYAQRTLSYMQEMRRYLKGRYDVGHVGIELVTDLDSKILAH
KARTKTLPAQRDKHLRAIAVLLGKKPQGFTISNSNRDLFEHIPQAPSGQYPISVIERRPD
LRAALLNINARASQVASAKADLYPRVKINFLGHNGVVEINSDYLANPSAFGGLFNVGISI
PIFTNGRIQRNIEVKDAKLKQAVIEYDQKVLKSLSEVDSVYQAQFAINEQNNLLSSSLVV
QNKKTRQLNQMYKLGNKTLDDVLKSKIEASEFKDKILESSLAEAENLIRLYKALGGGW
>fig|945713.3.peg.1410 Antibiotic acetyltransferase( EC:2.3.1.28 )
MSKNELKVDLSTYKNYLSRKNQIARFIWSVVWGIFARPIPRSLFNSWKLLLLRIFGAKVH
KKSVVYSSAKIFMPWNLEMEEYACLGPEVDCYNVGLVKIGKHTTVSQKSYLCTATHDIEK
SNNPLVIKSIIIEDQAWIAADVFVGPGVTIGQGAVVGARAAVFKDVEPWTIVGGNPAKFI
KNREIKN
>fig|945713.3.peg.2271 Permease of the drug/metabolite transporter (DMT) superfamily
MKKYIGESALLLNTIIWGGTFALIKNALADISPLLFLGIRFFLAAIILLPFIYTVIIKTD
KKTFLAGSILGLFYFLGFATQTIGLNYTTATKSGFITGTFVVIIPILQTIIEKKKPKWYN
IVSILFVMIGLVFLSSSGDNLIQFITELGSDFNLGDFLTLLCAVLFAFQVVYVDVFTKKY
DYIPMVFIQLLITGLGGFIGSIILSSIGLEIVKFTLNTNVIIALIYTSVFASIIATILQL
KYQKIVTPTKAGIIYSFEPIMAAVLASFIIGEKISKFGMFGGLFIVVGLLLSEILENRNE
QTVKSNNNS
>fig|945713.3.peg.2715 Glyoxalase/bleomycin resistance protein/dioxygenase
MNPKPEIGSITWCDLTVPDATVIKNFYEKVIGWKADPVSMGDYDDFSMIAPESSKIAAGI
CNAKGINAKLPPQWLIYITVENVDTSAQTCLELGGRVLIEPKTISNYGRFCVIQDPAGAV
CALFKPE
>fig|945713.3.peg.3037 Permease of the drug/metabolite transporter (DMT) superfamily
MLEEVSPETIISLRLILAIILLTMVAVITKSDFSLNLKNHLRILLLAAVAVFHLWIQITG
LKYTTAANTGWIIGTAPIFIAILGFIFLKEKLNPLKISGIIIAFIGLLLLVGKGNPLNID
LVKNVGDMLVLFSSFTWGVYSIINKKISLNYSPLMTILYLFIMMALIIIPFNINQKAIDS
VIHLSSIGWISILFLGLLCSGVSYVIWAYSLREMESARVGAYLYFEPFVTVITAGLFLKE
EITLLMVLSGLLIILGVYLVNKE
>fig|945713.3.peg.3128 Permease of the drug/metabolite transporter (DMT) superfamily
MIKNESKTQVFPASLVSIAATLWAIDGIVLRPYLYNLSVPLVVFIETTIVAIILTPFFYK
QFSSLRKLKLKDWIAFIGVAFFGGALGTMAITKALFFVNYVNLSIVIFIQKLQPVFAIIL
AAIILKEKLTKEFLFWATLAIIGAYIITFEFNLPLLETGDKTAVAALFALIAAFSFGIST
VLSKRALRNIGFQLGTYLRFAITALIMLIVVSITNDFKSFSEISINQFYVFLIIAFSTGG
PAIFIYYYGLKKISASVATICELAFPLSAVILEYFVHGKILSPVQWIGAVLLLISIIKVS
GIEISSFFNNKEE
>fig|95666.5.peg.153 Multidrug resistance ABC transporter
MNQQSQTIKPVSKLHLIYYYFKDFKKSFIGLSIAIVLWLAATIAATFLLQETVDKYAVAN
GVVDTVVKMCGGLIGIYFLSFIFLLIMNEFAIRISFKIESHLSMMVINRIRYLPMKYFDV
NKSGEIFTKTLSDPTSVQDGIVNFYIELNKTFFGALGFGIALLVTSPYIALIGIAIYTLV
MLFNILIFKKSRQLMRKKRQDFGEMNGYIEEMIHGQNVVANFDEQAYFVKKLDNMIKNLY
KNWVKAQYSSQIIFPWSIFSMRLMNAVLIVSYLLISIKGIHLPGIVSNIDPVTNMISFGG
LVSISLFGNFFCDNFSQLSNAIPIFIIARTSLAKIDEIVKTPNEIDWDEKLVIDDSQGIE
VRFENVNFNYSKNKPTLKNINFVAKKNQKIAIIGPTGAGKTTITNLINKFYDINSGHIYF
NDVDITNKSRASVREHISIVLQDPFLFSESIYENIKKGKMNATKEEIVEAAKKAQAHELI
LSFEKDYGTVISEKQSLSQGQKQLITIARAIVSDAKIIILDEATSSVDTQTEHKLQLAIN
NLLKGRTSFVVAHRLSTIINSDLILVVKDGEIIAQGNHDYLIKNSSFYQDLYYTNFAE
>fig|96561.3.peg.1627 Tetracycline resistance protein
MSLHIIIDGYNLIRQSPVLSRIEQENLQAGREALVASLVSYKRIKAHTITVVFDGTDAPS
YYSHRDRVGGIDVRFSGPGQTADSVIRKMAAEKREKALVVSSDRGITDFAQSAGAAIIAS
REFEDRMAQAMMMDAAGMAEEDGAFSPWSGTTKKKGPGHRLSKKQRKSRTKAEKL
>fig|96561.3.peg.1890 Glyoxalase/bleomycin resistance protein/dioxygenase
MNLHHIGIACRSSSAGDRFYRDLLGLEKKRERTVPGEMIKKIFDIDQDALIIEYGNETML
LEVFVIPELEEDHPVSHLCLEVNNRVAFMEKCAAMGFGARQIPKTDGTAIVFVKDDDGNQ
YEIKEQP
>fig|96561.3.peg.2416 Bacteriocin resistance protein, putative
MHIFIAFLITVSLIAGFKPEKEPSEKETRLVIGYDGGIVTQTMPVEIRTTVTPASELEYQ
AVIKQQFDYSCGSAALSTLLRYHLGEDFSETQVIHGLFRYGDKERVREKRAFSLLDMKKF
VGVLGYNGVGYKADIQDLETLDMPCIIPIELYDYRHFTVFKGIHQGHVFLADPFRGNSSY
PVADFKKMWHQNVIFVVYPKNQQQLTLLSLSERDLRFVDEDKRFDLLFKDWPVMEGRPPE
PFPGEIQYYKR
>fig|96561.3.peg.2457 Polymyxin resistance protein ArnC, glycosyl transferase (EC 2.4.-.-)
MPEKTPLVSVIVPVWNDGPCVGRAADRIHTVLKRTCASYEVIFVDDGSSDNSFEEICRAC
AAHAHTMGIRLARHAGQHAALRAGLAKASGEVLVNFDVDMQGVPEDIPRLVEKVGEGFDL
VCGWRTERREAWHRRVFSFFLNRWVNRHTGRFLHDNGCFKAINRKVADRIGQNDSSRFLT
ALVPALADRVTEVPVSWRKREQGRSRYALRETASMVLDFFLVYPVLPFVWFFWGGLTVLM
AGGAVLGIGLCRLTDSGYWQPSWLTWTGGALLALGGMLFAVWTWAHRGIHRRKKISNVSL
LLIERIVGKTDGNNG
>fig|96561.3.peg.2525 Permease of the drug/metabolite transporter (DMT) superfamily
MRAELWALLTAACWATGSLLEKRGVISGGLAPVMGTTVRTLVSLAFLTIISFPYWGQVRA
AGPKPIALIALGGGILAGGLGIMFLYTGLKHGHLSTVMTIAFCMAPVLGTVLGYLFLNER
LSLVQTVGIVLCVAGAAMVTFFKQG
>fig|97084.1.peg.9 Acriflavin resistance plasma membrane protein
MKILSFLQSHKLFVHYATIVTVVLGISSFFLLQRETRPNVNFNRVNITAAYPGASPVDIE
GLVIDPIEDKLAEVDGIEEYRSVSYMGAGSISVIVDENYPDPNEVINEVRRKVSEVDGLP
VEVDDPIVTELKAESMPVLNLALYGDAKPFDLKFQAEKLKDFLQQQDGVTNVSYTGITNL
QLKVLLKRVKLTKFDLTIDEIFTKLSNWSKQKPGGIFENSELVASMTIGEDLNSLEKVGD
FIVQSNDSGKKIRLKDVADIIYDLEENQTGNLFEDQVAVLFTVTKSPSADAIRTVDSVKK
ELTSYKKSLPSGLNLKLYKDESINIRTKLKIVTGNAIVGLLLVLVILIIFLDWRSALITS
LGIPVSILGGVLILFLLGFTLNSLVVVGVIIVLGMLVDDAIVVCENIYSKIEQGLPPARA
AIEGTREVAAPVMSSVATTVFAFLPIAFMGDVIGQFLRVIPITVIALLFVSVLEAFFVIP
VHSEELMKPQENKSKKGIMQKVESLYEKYVLWSIRKRAFVVGSLVLFFIISLFQGQKIFD
QFSLVPSEGLEGLSVRLELDKNTPLSATSDRVKNLSRRLINISDGTFDNIYSDLGQVTTG
GSGGSRQNGTHLAMINISFTSDPSFIHKEKEVLKRISKEVENFSSEFNVKTTITLDLPGP
PVGKPVQVQIATRDFDFGISIIKKIKEKLQSISGTYSIETDFAGDSIQYRFRIDNEFTIS
QGVDPSKISRTIFAASTGLVSSEILKNSEKIDILVGLEKGSNLKNKNLVKSEEIESILNL
TVRNSNNQAVPIRNFVKIYEELGPSSIQRLNGIRTLTLFGEVDERVTSGKKVNQELAPYL
EELREKYPNLKIIIGGGEKDRASALIDTLKLYAIAILLIYIAISLTFDSVIYPFLVLTAL
PMGVSGVVWALVLHGKSLSLMGIIGLVGLSGVVVNVSIIYLKFIQDNIRSGEVLDKAIVL
ASVNRIRPIIMTTISTLLGLFPTIYGVGGVDAFVQPIALVLGWGLFVATLLTITTLPALL
SFFTILNKK
>fig|97084.1.peg.17 Multiple antibiotic resistance protein MarC
MYQAFEDTLKFSITLISILNPIGIIPIFLNLTKANSESQIIKIAHSCSLAVVITILVSLV
AGQYVLEFFGISIASFTIGGGILLSSMAFSMIQATSSNAKINDDEIEQMQDLRELGIVPL
AIPLLSGPGAISTSIIHAKAFATPLHWVGAILAVILIGILVRNVLAYSKRIGERLGTIGQ
NVMTRIMGIILLAISIEMIVGGVKEIIPILKGA
>fig|97084.1.peg.152 Acriflavin resistance plasma membrane protein
MGVLMKKIVSYFVDNSFIVNTLSLSMIVVGLISFFSMQRDLIPQWKDKRITISATLPGAT
PYQVEQYLTSPIEDAIKSLSGVDKMVSTSSPSSMSINMRLKDSMEEDDIDDLYERVNSII
LNLERDLPNETENLSVINNKVSSFWFTTLSVLNFDEHNSRHQKWLSDIQKQLGKINGVVE
VRNWTSKPQIYIQFDQEKLARYQIHINELTQNIVRRFAFLPLGTITKNGNEVSVEIDNDV
DGIKDIEETIVNANASGKVLRVKDIASVEYKIAEKETVSFTNGAPAAVLVLFKDIDSDII
TMKEDLEKMLVNINESAPKGLSILLTGDGPSFIEKQLKVLNSNGIMGGILVVFILFIFFG
IKSSLMTSFGLPLSYLATFTVLRLLDINIDLISVVGMLLIVGILVDDAIIVSELYMQKLE
KGMTPRDAAIESSMETMMPIFGTVLTTIIAFAPILFSKSGVGDVLVAIPWVVIAALTMSL
LECFFILPNHLAHFVKTPVKEKKFSIFNKLTRLYEASLSIALKWRYIVLTLLVGSLIGTF
VITKEKVPFKFNLRIGSERVKVDFILKKSDALEETRSKLLPIFDLIKTIDKDKYAYVTTQ
IGRNWYNGVEQIGYRYGGINIRFSQTDDLALESKEEIIKLLEQKLPALKTDDFEVLSVKS
AKEGYDDKKENTFKLSTFIEGKLRDQFVIDEVKKVFSTIEGIKEVYIDPGLVATTWMFIP
NKEVLYSYGIDPIDLSSKVQGFIRKSHIKEYRHDGEVVNIYGYINDGKKLSFNELGNLSI
NIGNGQIIKLKNIGEWKKVTSLKEIHHEDGKRALNFDLTYDEKVLKKEKIADHVKEKFPE
IKSSVPGLSFALEDADLQEAKNSKAMSSMLITCIFLILFVLALILKSFVQPLIIATAIPF
GLIGIVWAFYFHSLPIDVMGMVGVMGMAGVVVNDSLIMVTTINSKKSKLWFLTREDILSG
AVSRFRAIILTSITTLGGVFPMAYGIGGDSGFTRPLALSMGWGLLFATCLTLFALPSLLE
IQRDSWRLLAKLPFLRSYFENSMEEVDSVSIVANEESIPLVANQESENNSNQLH
>fig|97084.1.peg.192 Multidrug resistance ABC transporter ATP-binding and permease protein
MNNSQSSSLNIWKSYLLNNKSVYFVGTLMVLLTNICQVLTTRIIGWIIDFFSGVSYPHFF
SKASKIETFYFFFICMFACRVLITLGRMGWRVTLARQTHMASAMLRKRIWENARFFNKKD
LVTDFSKGNLMNASNSDVNSSRFIFGFTLVGLVDVIFLGILTLVTMGMINLKMTLISVLS
LSILPYFVKKLSSKEVQRYKDSQKALGDFNDLSTQVISTIRLQRLTQTGNYWEGKLIESA
TKFKNSRLLALFTSLNYIPMMGGASIISYGVLFVVGVGLVIDQQMTIGDFVSMQGLIFLL
QDPLMEMGFIISDWKRGTTSLDRLNKIYKNKKEEFLFKKGDRISDSQYVLSAKNLSFRYY
DSDKKTPLIENFNLNLLPGERLGITGDIGTGKSTLLKILSGLERNYEGRLFFQGKDYNNY
EHGQLREFMSFVQQKPFLFADTIKKNIEMDRELSDDDVWYYLELAGLDKDVLDFPDKLNT
PLGEWGINLSGGQRQRLTLARALSRRPKLLFLDDCLSAVDTVTEDLILNNLDRELSDTTL
IWVAHRSSTLKYCNKVLNLSDKAEVIHE
>fig|97084.1.peg.309 Multi antimicrobial extrusion protein (Na(+)/drug antiporter), MATE family of MDR efflux pumps
MTSLLKLCKLLRRCYNRYMKAQLTQGDITKQLVSLAGPMIFGVFSIIIFNLVDTYYIGKL
GHRELAAVAFTFPIPLIVGAVAFGIGIAATSFVSMALGSGRSHEVARYATDSISMVVILG
IILAIIGELTIEPLFLFMGAPKDLIPLIAEYMRVWYLSIPLIVIPMTGNSVIRAMGNTKF
PAMVMAVAGLGNFIFDPLLIFGIGPFPAMGLKGAAVATAISRFFTLIAALYVLRKKYDVL
TNPFIPFKQLLDNWRKITQVAFPAFLNNLVNPIAMFILTKLVASHGEIVVAGFGVGTRIE
SLFAIVLIGVAASLSPFVGQNYGAKKYSRIRKAIYLANKYSALWIFICGIFLMFLADGLV
RVFNDNPKVIEVASTYLKIMIFSIIGLALMQNSVASHNSIGKSKTSLTINLLRIFVIHLP
LAIVLGNLFSYEGIYWAGFIANFLGGIIGSFFLYKLFQKFPAEDPI
>fig|97084.1.peg.482 Acriflavin resistance plasma membrane protein
MKALLKYLFDNPLITKFTFIIILVGALIGMKNLKRTSYPQVDLHKVIITTFYPDASPNDV
EVNITNNLEYELKKVEGVKYYTSRSMEGQSTITMVLDQEYGDFQSVKDNIYRALGKVRNL
PSRVTQRPKVMEMKVDNFPIYDVALISNEMSEEEVIEVTKKLRRKILQIPEIYKAEVSGK
REKEFQIILDPKKLTLYDISFEDVINAVKGNQIRATGGTIESFVNEKKIITLSEMDTPKK
LRNIIVRSNYSGKKVRVSDLGEVSFSFSKKNIMTSYNGDEGIGLWLYKVPSSDIIRTIDK
VRKVIADFKEENKSRDLKIVNTHDLSSETRSRLEMVYSNIIMGLILILAILIFFFNIKLA
LWVCVGIPFSLAFLMIAMPLLGLTLNSISLCGVIVVLGMIVDDAIIVSEAIYSREGNSEE
SLIKAVLGVARPISITILTTIISFIPIYFIPGMMGQFTAEIPSVVIIVLLGSFFESLIFL
PIHLRNIKSGTVEELRATHLGKRTMNFLESQYSKFLKKLISKKEIALVSLISILALFLSI
GIYKFKFQMFPEFQAQRIYLYGDVERGKTLEYTAQVAKKVESVLQNVVAGDIKSFRTRVG
RNYEGQYHCEQCFYTKLELTHFNSRERSALDIESKILEEIKGISELKSFGSRIDSGAPPR
GNDLELVILSDNESKRVDVIRSLESKLKELGEVSNDFILGDSSLVLRPLYEKMSRMGTNV
QEVAKSLRIAFSGEFIGFISKGDERNYIKVTSNLSDKGFGAPLEDLSVLNNQGRKIPLKK
LVSLQEEKMPVVLTHYNGENSNTLSINKISRKDAKEVISKIVKDVKSEFSDVDIILKGRM
FKDREGRANLFLGALITCLIIYFSLVILYKSYLLPLLICSSVPVGLIGILFSFKIHGAPL
SALGLVGIIGFIGVVINDALLMVEVMKEPRSIESIDGLARGATKRFAPIFLTTITTVFGL
LPSIYGFLGGTDAFISPMVLSMGSGLLFGTISDLILIPLVFGFIYRDKHV
>fig|97084.1.peg.556 Probable multidrug resistance protein norM
MSFMKKELKKIIQLSLPLIFAQIGVVLLGVSDMVMLGHYSDTALKASGLANVWIIGTLMF
GIGCSLGVDPIISKLVGQGESERTKVSLITGKALAVAIAVLTGLLWANTGAILGLFDQNA
EYAELAHSYALIQIPSLIPFFMYMVFRQYLIARESTMPVALVLLLTNFINIFLNWIFIFG
VGPFEEMGLFGAGLSSCLMRAAQYILLCLIILKSKKYRYHWVPYKAKYIDSEMLKKIVLI
GLPIGAHLMLEAFGLQVTAFMAGKIGDDDLGAHSILLNLQYLFFILPMAFSLCAATRVGN
EIGARSSNIFNVFKATSLLCLILFLCSSLGMFYFGESLVRAYGTSEAIILKARESLFYSS
LFLFFYGLQLVGSGFLRGAGLTVITSLSNILSLYVIAIPLAYFLGVSREWGLQGLWAALA
IGMVVATCANAILNLRYLFRVKSELSLSH
>fig|97084.1.peg.955 Permease, MDR related, probably tetracycline resistance protein
MMDNSLKKNISKIFALNSAWMFLIILPIIVPFYRSKGLSMQEVFELQSFFSLIVLIFELP
SGYVADLIGRKNTLISASLFQGVGFSLLPFFDHYWGLIFVQLLLGIGVSLFSGTDISIIY
DSLHAMKNRIFNGSEAKLIGKKIFYTQTSEAIAALVGGALVVSSLDTPVKVQAFICWIPF
LISLTVTEPPREKLSSSAHGDNWREISKKLFKSGPLIKFILFNNIIYSAATLLAVWTFQD
YWHSLGVDYKYFGYLWCLTNFSVGLVARYAHDLEKKIGSVNILLLIGSLPIIGFFGMGKS
AGLVGIIFCFSFQLCRGLNQVILKDALNARVESQMRATANSIIGLGMRVVFIIFGPILGW
LIDNKGYEISLNIFGAIFIVSFFIILLPLIKLRGEFRK
>fig|97084.1.peg.1178 Probable multidrug resistance protein norM
MIFMKKTYLSTIKEIFLFSIPLIAGQVGQMLFGIGDIIVAGRYSNDVVAALGVANGLLAP
LLMFGLGITFAVGPLTSQFRGKNEKDKSIFANAHYLMLTVSVGLLVAIGALIVALPLFNF
NPTITPLIKDYILIAGPSIIPAILFQISKEYLQAWDKNIFSNSLILFFNVINVGMNYIFI
FGEFGFPEMGIKGAALATLISRTLMFGALFIYTKAKFEIDWNFNQVLFKRIYKFGIPIGL
GTLSEVLMFSAVTVLIGKMSIIASASHNIVINLASCTFMIPLAISSAASVKVGKEYGAGS
QQGILIYSLSSIIMVAIIMIGTCAMYLSFPDILVRFATDDPELISYSAGLLLYVGLFQIP
DGIQVTLWGILRGLEETKHPMILSLIFNWCIGIPIGYWLATSKGMEAAGLWAGLAIGLTI
MSVGLSCVFFFKFRVVKSTLVPMA
>fig|97084.1.peg.1263 Acriflavin resistance plasma membrane protein
MKSIITYFTKNHLVSNILFVGVFLMAIFAWNQIGKEEMPEFESNWMRVSASYPGAAAEDV
ELFVTKPIEDELKEVTGIEEIYTTSSTGSSSFRIVIDEDSANYSEVVQNIKDATLRASLP
REVDTPTFRQFKSTEKAIIDVGFYLEGERALDYAARKKLQSMVLNFENQIKSLGVVSGID
KKGYDDPELHILIDPDKLNENDLSIDRLVSIIRNNHIRVPLGTLEDKDQSKVTAIHELED
KESLDSLFVVGNYGGKGVRLGEIAHVEPQFKKSTTIRKLQGHEGIVINVKKKFSTDILTA
QENVVKFVEEFKKTHSESGLRVVLMDDESYDVKNRLSIVASNGIIGFILIFLVLFVFLDF
KSGLWVGMGIPFTLAFAIISMTLVGYTINNMTLAAVIIVMGIVVDDAIVVAENISRKRYL
GESPIDAAVNGTHQIITPVFGSILTTCVAFVPLLFFEGFFGKFVEYIPFVIISMLVASLL
ESTTILPSHLLERKSFFSRFKFLSFNSSWFFKYEEKFSVLLEKCLRWRAAVLLVAVLLSG
ISGYLFKTKMKFVMFPREEGKEVHIKVIGPKGANRFEMSKLIEPLEEMILRDKKDGVVAV
QSTIGESRRGSGVLENQASVNVELVNKDDRELGLNDFIERWEKESQEIKGLTKINFLKSR
WGRSSGSALEIQVQENNDKNRDEVTKLIEKYMLEDESLKDVEIEKPLNRREYNFKINQER
LVRFNLSPENITTSLRSFVEGAILYTISKGDEDVEVRLTVDDKNKFDLSNLRELKIENNS
GGFITLDKVVSIEEYMKPANIQRKDYKRTTIVYGNIKDGVAITPVEVAEKYEAKVFPKII
KDYPSSVITFIGEVKDTRESGGDFVISLIMVIGVIYIILVIMFNSLGAPLLIMAIVPFGL
SGVVYALLAHGMYVYGFFAAVGALGMIGVVVNDAIIMISKLEEDISTMEENSLAKIASVS
STRLRPIVVTTLTTVAGVLPTAYGIAGYDSMLAEMMLSMGWGLLLATIVTLFLIPCLYSY
FFSVRLFILKKTHIHLEDE
>fig|97084.1.peg.1447 Melittin resistance protein PqaB
MLNRLQKYSKELLLICTFLIFYGHSINLWGFFHDGYLYAALGKNFPWDSWLIPSQSASQF
HEFSHHPPLFFILEGVFFKLFGSSFAAARIFGSLWVLASALITFHFIKKNYNSILASVSS
ILLLTLPSLMKKSRFPNMDQALLFSYLTCLLIYFEAYRNRSSKTMALSGLFWGLSLLIKG
LSGVLILPLVFIHQLMVRKSLRFLLEREIWVAFIVGGLVFSLWPISLFSIGRFDIFLSYL
DFQLFSTAISGRGETELNFFLYFFHLLKSAPHICFLTLLSVYLFVKGRIKEFREFYFFNL
VCVVSYLLILSCMKFKYSHYLIPIYPFLSILAGFSVYSLVEKNLKRVTISYVAILIISFV
VLFPLGVTNKVKRDKEVYEISKLFKSLERVPRNWVIVDNSYSYWAISGLSSYLYGANPYN
LNSDEARKKALSLSDTLFVTRGSLMSSELKKSYKPLMSVESDLKFWVPKKSLKRKIE
>fig|97084.1.peg.1697 Acriflavin resistance plasma membrane protein
MKTLSKFFIDNSKLSIVLMLGLLIYGIMGLAKMNAESYPNVSFATAIVTTRYDGATAQDI
ETKITKPIEDEIRTVRGLKDVNSTSQSGLSTIVIRVDMDRAGIDVETVISDIQKAVDRTN
KLPADLIDRPKFSEIKSEEMPVFQIAVLGSNENRSRDIIADHLKEELEDNKLIKGVTLEG
FAKRTFQIEVNNDLLNKHHIGMQELISKIQARNVNIPGGNLKQDKTQQLLRLEGKIKNTK
ELENILIRSNFSGQSIYLKDVAKVVDGEEEIKVRTRYNGEEATLLTIAKKAGADTITLVD
DVEKKLHEYEKLYTDKADFKVFLNESIKVKDKLDVLANNAVSGLILVIVFLFIFLPGKIG
LMASLSLPLAIMGTLGIMPAFGMNLNTITVLALVIALGMLVDNSVVISENFTRLRQEGKN
SKEAALESIKSLWLPITATAFTTIAAFLPMLVTKGIMGQFIKWIPIIVTISLLLSLVESF
FFLPMRLVSAGNSVKKDKDGNSKKDWFHKFENKFEKIMTVIVRRRYIAVAGFSALIVFAL
FMMTAGNKFILFPADQTEIYIARFELPNGTKLEETNSKLRDLSNDIKEVLGKDVKHLIGK
SGESKVQLTDPKATEGNNVGIVFIYVTDEAKLNLFYTTVLEKLRAQVPKDGYKSLTFEAQ
VNGPPVGSDIEATFRSNDMEQLDSLIGKIKARLEKVPGVLDLKVNDIIGDDEVFINIDYE
KADQLGLNIFNAGDTVRSAISGRIISEVTLNNKDVDLRVSFKESDRTDITKLKDVNIMDS
RGNLVPLGTFAKFETKDGTPQIKRFDFKRSKTLAGSINEKKITAMEANQILLKTYEELRK
DFPSVSLVFGGVAESTKESMESLAQASVLAAIGIFAILVFLFKSYLRPLIIMMTIPLGLL
GFSIAFATPVLSGYMDRTRPISFLALIGIIGLAGIIVNSGIVLISFIDEMRAEGKLSLEE
ILIKASGMRLRAVLVTSLTTVSGLFPTAYGVGGSDPTLVPMTLAMAWGLTSGTILTLSFI
PPAYAILEDFLNLVNRITKRKKHIEEDMDGSEELA
>fig|97084.1.peg.1952 Bicyclomycin resistance protein
MSRTIEKSLLLILGALAAFGPMTIDLYLPAFVEIGKDLLVPTEDIQYSLTSFLAGLSIGQ
LIYGPISDRFGRKKPLLIGITIFIITSIFISMVKSLEALVILRFIQALGSCVGMVITRAI
IRDLYEPRDAAKVFSLIILVMGVAPIIAPLLGTQILLFSTWRMLFIFLAVFGAVTLLGSI
VKIPESLKVVVPIKKGFVNYYELLRDRQFLMASFVCGTITAGMFSYIAGSAFIFLNIFKV
SATAYPIIFGSNALGFIICSQINARLLNHYSIDSILEKAIFFAIVAAACTLISIGLHLDL
IYFLIPLFCSIASIGFIIPNITAKALEFQHERAAVASAMMGSIQFSISSLGSVLVTIFAN
GTAWPMVLTLFTFNALTFSFYFFGLRSYEKKLCM
>fig|97084.1.peg.1957 Acriflavin resistance plasma membrane protein
MIEIFVKRPATTIIFIAIFMVMGLVSIGNLIIEPTPKIEFPIITIQTTYGGASPEEIETQ
VLKRVEDAVSEISQIKKISSEARDSYGVVIIEFLIEADVNIKSIEVKDKVEAIMNDFPSG
ADRPIIAKFDPLIKPIATLALMSDKHNLTELFEYADKKLKTRLSAINGVATVDVFGGRER
QINVELDNNLMIQNYLSIEDVINSVSSKNLNVPGGSINRKDSKVSVRFVGEFESVEEIKN
LSIVSREGRTIKLSSVGTVSDSYKDVDSIARFNGKDTVGIAVKKLSDGDAVKIVGTLKSD
LEVIKKELPEGMKLEIAVDTTRVTVDNTVGTINSILLGVVLTIIILLVFLGDWRGAIIAA
VVIPTSIISTFFIMDMSDFSINMMTLLAFGTCLGTLIANALIIIESIYKHLQMGKDPQLA
SIDGTKEVLLAIFASSGTNLVVFTPLAFMGGIVGQFMVQFGMTVVYATIFSIMASVTLTP
MLCSILLKDPSRLKGPFPFIAKITDRVIAWITTQYKWFFDKMMDWPITATILSLAVFFTI
VVPAGQLGSEFVPKSDRDEYTVTVVMPDGTPVEKTGEVVAKIDVLLKEYPEVTSTLSDIG
YDGEEKARVTVSLTPAESREKSYDVLMAELLIDLAKIPEAEVTLSGGDSGSGGQGDITID
VTGRNFEEMAKASEKMKEIMANSGYFGSIESSYRIPKMEVQFNPDASKIIRQGLSNVQIG
QVIRGLVNGNDDSVYKEEGEEYDINITLGDDFKKNVEDFDSFLIHGKDGLIPIASLGKVE
FTEATSPLKRRDKKSIIQLNGYLAKSNTGTVMGELTKKFSELDLPESVEYAYTGNAENQA
ESSQELGKAFMLAVILTYMLLVAVLDSFVFPISIGSAILTSFLGSFALMFYTDQTVNIGS
MMAMVMVVGLAVNNAILMIEYAQQKIAEGIEVREAIWLGAKEKLKPILMTSIAIIAGTLP
QLFALDKIKSAMGAVIIGGMIGSIIFTYFLVPIVHYLVYKVKNLIAKFRNKEVIS
>fig|97084.1.peg.2282 Multidrug resistance ABC transporter ATP-binding and permease protein
MNTSKIKWSSIFFFKGSYRYVVLIFICLVLSAGLGAMVPKLVAKLAESYENENIFYQSIE
HLLYLFMGVYANRSLYQLGVNKYVKYLVQNVRSWCFEKWILSYEIQEGDTGHEEKYPQGE
ILSRIVNDTESIRELVTSGTFGIFIDLFFVVSCMLSFISINTVTGVTLVVAEVLAASLLI
YGSKYMRKIFLSVRHSRGNVYKTVANLVGGVGETYFTNHERYASKKAEVVFDDYLGKILK
SNVWDSGYYSIAESLYPLLLALVVLIFPYSHITQAAVILVIVDLIQRSIGPVKDIAGKIA
NVQRAASGVDRISEFMNDLDQTISSPKSYTKKEESLESVSVEVEEFSYPVRREGEPAFSL
NNISFEAKRGELVGIVGISGCGKSTLLKILSGNLIPQRAEIKVSGTDGEQVSFPGSSFKD
VTRYRELVGIVSQDSHIFSESIAFNICLCEDIPESFYSFWKWVEEQIPYITEIWGVGPDT
ILDQKSISIGQKQLLAAIRSCYLKKPIVLFDEVSSGLDSRLELALRKVILLIQEQSLTFI
VAHRLETVIESNKILVLDKGRLVSSGTHHSLLDNCEIYKEFLNELSH
>fig|97084.1.peg.3048 Melittin resistance protein PqaB
MTSFSSIKKLSIFSIFLVFILYTWDIGNLDAIRQGTEGFYLQIAKEMFNAGSILTPLYNG
ENHWSKPPLQFWMANIFYFIGGGPSILLSRLSIVLFSLATLILTSQIVSKLLSKSFLLIF
VFLSATFGMFKYSRIFMMEMPLTMLTTLGALYFYLYLNDKKYSLHLASLFIGLSILVKGP
VSIVMAAGGIGLFLVLEWYMFGFNSKDLKKALICFFYSLAIASIWFIICTLKYGHEFIDY
FFLRENLGKFASKSYPIRHVFQGLIIFALPWSLYLPISISQIKDHWIKVKNDKFLLFSNC
CFFVFFTLWLIPSQRSHHYAMPSIIFFLISNFILLNNYQLSQKREKMMKLANIVISILMA
LTGILLSSLLVFNEVNQSASLTIKVLTTVALLFVGAFLFIKSKKQVSKYFIALFIIGNLW
NIFIPSFILPYMPDRVIKTIGSAQVSASVRKPYFIEEALERKINWIGSQSIRQYILENNH
YYIMHEATYRSNKLEDLTNVVTTWKVWRRGVKAKAGVNALLNKNIEELKDTVYLLENKPL
R
>fig|97084.1.peg.3318 Tetracycline resistance protein
MLLVSVFGLALSYVLWFFSGSFTTLIIARFIGGIMGGNISTATAVVADVTSKGNRSKGMA
TIGIAFALGFIIGPAMGGIMSLIDLTKSFPELAAYGVNPFSMAAGIAFILSAFNLFFLYR
NFKESLPEEKRGNAHSSERTFNPLQLFKPLPYEGVNLTNFGHFLFLMAFSGMEFTLTFLA
VERMNYSSMDNAYMFIFIGFIIAMVQGGFVRRKAGQIGEKKVALMGLICLIPGLISIGLS
TSSFLLYVGLFFLAVGSSMAIPCLTSLVSLYTPAAEQGHSIGIFRSLGALSRVIGPIIAS
IIYWKFGSSSPYFLGSAFLIIPIILISMLKKPNEAI
>fig|97393.1.peg.158 Permease of the drug/metabolite transporter (DMT) superfamily
MGKQGDILLFAIMVISWSINYPVIKIALNYTGPFTLLFYRILFSFIFIYIIFRPKLHLRI
TKDEIVPLFILSLLNVLIWMELWFLAETTISSSLTSIIIYTYPIISTLMAIIFLKEQYNK
YVFLGIGIGFAGLLVIFSNSLLSGFKPGIIIALLGAIVWSVGTIYFMKYHVKKDRETTNF
FQFGFALLPSLLIAGIATPSISIFEPSLLLILLVLIISIPGTAVAYFAFLHLNRKYGVST
ISSFLFLVPALSVVFGVIILDEIPSSYEIIGLALVGIGIYFSARGTKIKASAKPVS
>fig|97393.1.peg.171 Multidrug resistance protein NorA related protein
MNYGTRAGLVHTARALYALNWMDMAPALEYIKTDMNLTVVELGTLVTAFYVGIAVFQVLG
GYLSSYIGDKTTSLIGLLFVSIFAITSGLSVNFTELIVSRFFAGLSAALFFSPALSLLAS
IVPENKYAFHIGIYNGAFNVGGGVGIIGWAILDQYMGYRIPFIIAGVLTLALFFVLVFLF
RNIENIKTNKSDIFASFKKVFSNRIIILVAFIGIAAMVAETILGQFFVYYLESIKYSIDL
AGSISSLYLLIGFLGGVLGGYHFSRTKYKIGTFLAINIVLSLLLILIGFVHYYIFIIIIA
IAMGMITVYGMSITYTLVRYLARRDLVSLTLSFVNTLQLLVAVAVPIIFTIIVSQYNYEL
AWVSMGILGLIFVPLIFLAKGNLIKVVPS
>fig|97393.1.peg.384 Fosmidomycin resistance protein
MKDQGKSLIFTSLGHFANDGNFLLFPTLIAYYKVIPHVSIAFLGVMAIIYNLLSGLLGPS
IGKLADRIDRDGALIFLGILLEAISAIFFGLAFVFTAYVNYIILVAAVILGIGQAFYHPI
GASILAFTYGKKDSSTAMGINGSFGSLGRALIPSVLVYAIVFFGKFYGLVAVAAYTTIAA
VIILGGLSFFKRSKYIKIDTKKHAKNTEESKASESEYKKYGKFLYILTAIVFIRSFFLMG
TVTFTPDYFDNIFHSKVIMGDLLTISFLGAVVGQPYFGRVVKDHGGKFTIAVTTIASTVF
FGLMLLTDNVYLVTVIYLLYATFAFTSFPVLLGYVAQTIPQKFSTRSNALVWSFGNIVGG
AIGIAIVTILLYVHVALYTSLVVMLIFSVISIIMLPLLPSKKKQEELASGI
>fig|97393.1.peg.553 Multidrug resistance protein B
MTTISKLMSGGGTFSKIRKQTPTVKILALVSLLSSATRYPVWIVLTLLLSSVYHTPFLII
GVIFFLSSAISFPFNILAGRIMDRIGRRTLSLIIPILISITYFLLFYTAYRELQLIYIII
ETVASTTLLSVQNVLINAITTDMSIDQERLSAFSLIRVAANAGVGIGLVIAGVMSLISPY
VFFIVPVIASIFEFYIFYRFVPESLNRVLEKLNTIKKKFTVHRDRLLVAVSIFMAISMLF
ADQFEMPTLPLYLETYRHITEFYITLIYGVNALVVILLQFRLNSIGERFGYIKSFSVGML
LYAFSFLGFAATGNLVLLAGNTAMLTVGECLCNPFLSVTISRISPANKRGEYFGFSSSLI
GTIFPLGPLVGTIFLTYLFNPQILMWALFFAINASLAIISLVARKSIKSRERQLGNLSHS
>fig|97393.1.peg.638 Multidrug resistance protein B
MRSLGMGASWPFMAIFLSLYIHLAVYIVGIIFTLLSLMSMVFSILGGYLADLKGRKFTLM
LGSISGIFIYLSIALTFLFHIYTLTIILFIFSSFSGSLVYPSASALIADVTNPESREGGY
SIYRILSNVGWAVGPLMGSFIYSTGIIYIFYALVVASILQTIIILFVKKQNVLKTGKGTR
NPFLVYDKYLFIFSIATFFIILLSSQFSVSLPLYSEIAIKINVADLGYIYAINGLVVVIG
QYPLIQLFARFGDLITFIAGALFYALGYFIIAFSTNLYGLMFDMVIITMGENLTTPTINT
VISKMSPPGKTGRYMGFNSMVNSIGRAFGPSMGTYIMYTFHYNGLATWSLIAIFGVFSAI
VIVIFAISYNKSGNTYIARGTKT
>fig|97393.1.peg.662 Multidrug resistance protein B
MDHRYGILTVTTLSTLMAAIDSTIVYLALPAMGQTFHSGISYLTLVVAAYIISTTVMLVP
AIEITKRIGNRNFYIIGFSIFTVSSLIIAVSLNIAMVIIFRFVEGIGAGIMTSSDIPIIL
GAFRKGERGKAIGLNSIAWSIGTLIGPVLGGFLVAINWRYIFLINVPIGIGTIFAGYKII
KKDKVNKLPIKYKSTISMALFLIPLIMGIALINEYYLLIALIILPVFIYVQIKQPVIDRK
LLGNIRFSLITLASFLESFVFFSVLFALSLYFQSDLGLSSIDTGLIIFTYPVASIVSSPI
GGILYDRYRHPETIMAIGTILECVPVLIIGIYLKYIPELLLIAGFGGSFFWSPSTTMITD
ALGEKFRVQANNAMFILRNIGIITAISILPLFILHFSRINVSIGEIFVSKARIDISAGIG
AYLVFTAIISLSSLIFIFVYHRRARSSNTMDTAGVVDLQHRTIK
>fig|97393.1.peg.775 Multidrug resistance protein
MAERNVPLITGASTVRGFGYSSIWIYSSLYMHDILHISLLYVGIIFTAGGFIAALVNIYG
GAISDRVGYKGTMIFSFSISVVIYAVLSFVPGVSLSALLYPVAFIMFMIANAIMSPASNA
LISRSSDIQLKGFSILRVGNNIGWGFGPAIGGFIESFGGYHLLFVFGLIMGIISLGISLF
LKNVKYDGKIGKVPLTTSNTWLIQLSLIALLLFVVQSQETVTLTNYATIFRSIKIYQLGI
VYLTNGIFVIVLQGFIYKIIRKIGNFSSFAIGSFVYSFGFFSYAFDTGIIGMVISTIVLT
IGEDFAFPVGYSMVSAVSKPENIGKNMGIYNAFLSVGRAIGPTLGGVAFTLFTVPYEIWL
FTTFTGFVACIIFIIKFRNVESLKHV
>fig|97393.1.peg.1398 Multidrug resistance protein B
MDRRVFYLGLTRLIRASGRVSSFIFLPLIFVFIYHISFIETGIVLGVAILLMSAIQYYSG
ILTDRIGRRVFLILIPVPAGLLYISMYFTVLYRLPVMLLIGLFYSTIAINALQYPAIQAS
IADVTSLKQRLSGYTEIRVMANAGAAIGPILGAILSVYGFQYIFLMAGIATFIEIIILYF
NVKETYFPSKIEYLTKNDIKLAYKDRFFILFIIIGIIMAFVLRQRGASLTLYAFDFEGLP
ILYLAYIYSLNGILVVLLQYPIFKLMNRETRPVLFRSVGMLFYFLGFIVLMFSKNIDYFL
LSMGIMTVGEDFVAPTTQTIITSIAPNNMKGTYIGIYNLFISFGSFSGSIVGLYMLSYYE
SATATFWLLIAMSSLVVSVLYLAINNAFLKRMNLSIKKKISSYKKTSGQ
>fig|97393.1.peg.1719 Multidrug resistance protein B
MYCNFKLMQEKWIALSNTTIGQLMATINTSIIIVALPSIFVGIHLNPMQASSFPYLLWLI
MSYMIVLSVLLVSIGKLSDIFGRVKIFNLGFLIFTIGSILLYIAPGTGYTVALELIIFRI
VQAVGGAFIMANTFAIITDNFSPKERGFAISINSVAAVSGVSIGVVLGGILSTIYWRDIF
LISIPIGVFGTLWSFLKLKDVRERAARHIDIPGNILFAVGLIILLLGVTYGITPYRNNPM
GWTNPLVISALAIGAIMLVLFPFVENRVKGPMFDMRLFKSRNFSISIFTAFVSAMTMMGL
MYMLTLIFQGIWLPIRGYRYAVTPLWAGIYMLPLPIFMGILGVLSSKLAERFDARWLTTI
GLFISGFALLALVTLTYNFSYVFLAIVISIFGIGYGIFNVPNLTVAMSSVPADERGATSG
ILNTMRNTGYAASIGAFFSILLLGLSLTYPGSITHGLTAENAGSLVQYFNNIPPTEILFS
TFLGLNTVKDVISTIPTSVVSGLPSGVMDTISGNIWFPETIATAFMTSMHDVFYVGFGAS
IIAGIASLFRTPSGDNGEAKVGGNNASRNNRSK
>fig|979556.3.peg.1719 Drug resistance transporter EmrB/QacA subfamily
MTLSPARLRILVASLLTVSFLGALDHTVVSTSLATIAGDLGALEHMSWIMVGYTLAATVM
LPVLGKLGDVVGPRRVFLVSLVLFLVASLACGFAPDLGWLIAARVLQGLGSAGLQLMSQT
IIARVTSPRQRPRYMAIIGAAFPVAIVVGPVVGGLITDFWGWSWVFWINLPVGLVALALA
LVAIPRLPGGAHPRFDIPGSIAFTGTLVALVLAVTWIGDDALRPAAILCATAVVIGIPAL
VVIERRAAEPILPPRILRHRTILVCLGLSLVVGAGLFAIVAYVPTYIQMAFRTTATVSGL
VPIATVLGMLVSSLLTGWLVSRSGRYRAYPVIGTALGAAGLTAMAALPVGTPLWVPMAVM
AVVGIGTGSFTNLIFAVVQSAAARSDLGAVTATTNLVRQIGSAVGTAIVGGVVGFGVASS
LPAGLDANTLTPAVARATSESVREEIAVVYHDVFAPVFLGLAAVYACGVVIALLLPAGRL
SDEAPTPVSSDARPQHA
>fig|979556.3.peg.2658 Permease of the drug/metabolite transporter (DMT) superfamily
MTTFALAPRLALSRRTVVGTAALAGVIALWSAFALSTRALEATGLTTADAAILRFAVPVV
LLAPWIPRTLRSLRGAGAGALALVLLAGIPHFLLFAWGAQLTSAGLTGLLVPGTVPLFVT
LLLFLRHRTRVSPRRLLALTAIVVGVAASAILRGGSADLGGIAILLAAGLVWALYTLGLA
SARLDLVSVIVVISVTSTLAAVALALTGAMPSHLLDGTVPWSQIGTYALVQGVGTGLLST
ACYVVAVQNLGGSLASSAGALSPVLTAVVAVPLLGEPITAGLAVALALIVSGVALFHLAP
RR
>fig|979556.3.peg.3658 Glyoxalase/bleomycin resistance protein/dioxygenase
MRQRITLVTLGVGELERAIAFYSALGWRPHPTSVEGEVAFFDVGGMVLALWDRRKLAEDS
GVEDAGGWGGVTLAHNVGDAHEVDALLEQAVAAGATLARGGASTPWGGYSGVFIDPDGHP
WEVAVNPGWPLDAEGRPQL
>fig|983544.3.peg.193 Glyoxalase/bleomycin resistance protein/dioxygenase
MNCFTFNHIALSVKDVDVSVLFYKNVFNLEEIKNTASTSKTRWLKFNDDRQLHLIPRPDS
EIKTNKAVHFALATLNFNAFVEHLESLGIDYSDWRNTPKKDYIRNDGIKQIYFQDPDDYW
IEVNNDY
>fig|983544.3.peg.2741 Glyoxalase/bleomycin resistance protein/dioxygenase
MKTNKNYPKSFSHIGLTVPDINEAVKFYSEVMGWYIIMEPSTIKKESETAIGQMCIDVFG
DDWTTFEIAHLATSDGIGVELFSFPQGKKEAPEFNPFNTGLFHFCIQDPNIEDLIEKIVS
YGGKQRMPIREYYPEDKPFKMCYVEDPFGIVFEIYTHSYELTYSSGAYQK
>fig|983544.3.peg.2771 Multiple antibiotic resistance (MarC)-like protein
MELYLIAFGALFSIMNPLGTVPVFVGLTLEHTKKERAVTAFWTAVDVLIILLLSFFAGKY
ILSFFGISLNALKIAGGLIIASSGFALLTGKFREHKGMKRQKVQEDIHSREAISLTPLAI
PMLAGPGTISLLITYNQEFQLTQDICIIVGALFTAALTIYLVLKSAHFIVKFLGASGINA
LSRIIGFIVIAIGVEYIIASVVSVLGL
>fig|983545.3.peg.392 Glyoxalase/bleomycin resistance protein/dioxygenase
MNIIGIGYLGFESTEMEEWRTYGPEVMGFQITGSPENDPDSIYFKLDDRRHRIAIHPGEI
DRIAYIGWEARNRVDFVAACERFKEYNVEITFGDAELCEKRGVKELIRFRDPAGYQHELF
YAQKWTPRSFVAGRPHGGFICDDRGVGHIVLITPEFGPELELFLLEIMEFNWYGWGAGKG
KTGFFRSKLNTQTSHDIAFGFAPGRMGVQHVGLFVNAVRDVGETFDIVKQQELPLMMTLG
QHTQDPHMSFYHFNPSGFAFETIAELEPWHGDPFELNPEKMSTWGHEIVGPILGPSVKTP
EELLQE
>fig|983545.3.peg.464 Glyoxalase/bleomycin resistance protein/dioxygenase
MQQSVCNVSLLVDDYDKGIEFYTKTLGFTLLDDIENSPDSRWVRVAPNNKAGQSGAALVL
MKAAVNQQQWIGNQTGGSVSFFLQTDDFHRDYQSILQRGVTFLEEPRDEPYAIVAIFQDC
FGNKWDLLQPK
>fig|983545.3.peg.821 Glyoxalase/bleomycin resistance protein/dioxygenase
MRHYLSGFLALLLLSGCSWFVTPPSRVDNPVIEGVNYVGMAVSDLERSEKLYRDATEVQL
IEAGKLNDNALINEVAQRSGVTARTKLLRGVNAQVLLMQFDDPSEKAKASNFVDANGPGL
AHLAFQVIDTTQTYQKILAGGARHIGDKEMVTNPKTHVSYAYVRDPDNIMIEIEHVDIEK
LNLPMPPKNARRLRHVSLATTDMERLIDFYSILLETENPRRSGQYFHNSGEPVDKISGLK
DSEMEMAWFQVRNLELEIIQYHNPAPKVLDAPRPIDATGFNMIMFDVTNLETAKQMLLDA
GGSVVTKTHLLNGGKTFFGRDPDGNLLGFQTLAAKSPFSAKNFKNNGME
>fig|983545.3.peg.1674 Glyoxalase/bleomycin resistance protein/dioxygenase
MKITSSLFAFMLCFLVSSHALAEPVSEDKRISVDIRRTTFIVNDIDTSLKLYRDALGLNV
IYDQMINSPMENGETRKRRLVLMQANDTFIGALGLLQYIHPLKPQRQEHFDEPVPGDPIM
VMNVSDLDTRWPAVEKSPEVEVIEAPHHVEYPRAGGGKIAVMVSMIRDPDGYWIEVNQLL
DAPAKASD
>fig|983545.3.peg.1677 Glyoxalase/bleomycin resistance protein/dioxygenase
MRIFIAFFFVFSWVSHAQDFTLKGFTEAVFIVSDINKSSQFYQDYAGWEVRSKAQVSPEL
RQLWQLPQQAKLQQVLLANKGENRGYVRLIQIDNVPQQVIRANTQSWDVGGIFDVNVRVA
DMASKRKQLQDVGWRGTSDPVSFTFGPYEVSEWITSGFDGVSFALIQRHKPVLEGWPNLK
HFSRVFNSTQVVNDIDSSLAFYRDVLGFKVYLQHKGASKEAGPNVLGLPFNLTTKIPRSV
YILHPQKRNEGSIELLQFHGAQGKNVSELASPPNLGIVTLRFPVDNLAALRAHLIENKVE
IVSQTSLTLAPYGQVDILAIRTPDRTWIEFYQVVDTIIK
>fig|983545.3.peg.1993 Glyoxalase/bleomycin resistance protein/dioxygenase
MLNAAFLTMCELATPLVNFRIKSKARISRIHKKRHLVLLIWLVLCAVLESNRRKIRDLTS
SIGERYCYAYRSVCSNINYPISEVPMKRFLLCVGLCLMFSVNAQEPKQEQSVQGVDHVGL
AVRNLKASERFFTQYVGFHVLNRDEKYPSVFLSNNSVVITLWRVTDPNRAVAFDRKHNVG
LHHLALRVSSETTLNALHDTFLHDKQVKIEFAPELAGNGPNKHMMVYEPSGNRIEFIYRA
AAR
>fig|983545.3.peg.2450 Glyoxalase/bleomycin resistance protein/dioxygenase
MSNPVGWFEIYVEDMDRATAFYQTVLAVELTLLTDPTEEQVHMMAFPSDMEKYGASGALV
KMAGMAPGGNSTLVYFSCEDCAVEAERVSQAGGAVEQAKMSIGEYGFISLIKDTEGNMVG
LHSQA
>fig|983545.3.peg.2582 Glyoxalase/bleomycin resistance protein/dioxygenase
MISHLTLGTNNLQKAQQFFEIILKPLGAKPVAKTSEVVFFAFSNSDTKLALTKPFDGGLA
TAGNGTMLALKASSQNIVKSVYKLAIDLKAESEGEPGPRNNGAYFAAYFRDLDGNKIAVF
HRSDDANT
>fig|983545.3.peg.3129 Small multidrug resistance protein
MLCIDNAARSSTIWETNMSWLFLILGVVAEAMSHVALKETNGFTKVIPSALVLMGHLAAF
VFLGQAMKGMPIGIVHALWAGLAIVTVTLLSTVIYRQHLDLTTWFGMAFVAIGVAMINLS
QGHSH
>fig|983917.3.peg.1005 Permease of the drug/metabolite transporter (DMT) superfamily
MAAACGAGFLWGTGALVVNLLIARFGLSPENVSFWRFVVGAALLLAVFGRPGLWRAMRPH
LGLLAAAGACMALYVSFWFLGIARIGAAVPTLIALCLPPVLVTLLAAARGRERLDAPLVL
ALAAALGGTAMVVARHEGAGEVSTATLAAGVGFSVASALLYAGFTLVTGRLSTTLGPGQA
TTGLTVVAAAVMGLSALYTPLAWPNELPPEAWLLYLGLVTAAIALLCFNWGAQRLSPTAL
TVATLVEPLTAVLLAALLLGQDLSATQWLGAVLMIASIGALGRRDARRAAGGA
>fig|983917.3.peg.1825 Fusaric acid resistance protein
MRSILAACLALVAAYLLDLHAPYAAASSVLLVINPVQGAVVGKGVWRVLGTLAGMLAAFV
LMSAFGQMPWLFLLGFGLWLGICVVGMTLLRHFRAYGATLAGYTVGLAAYGAMQHPELSF
DQVMGRGASVLIGVVSLAVVSAVFSTRSVRTRLALQLDRLAAATASVLATDHQAIHGSGV
PDGRPLDARRRQLIVDVYGVDDLLALGKAESADLAHHAGTVRQTMVSLFSALVGGAPPMR
ENSASLQALRSLQPDWECAWHEAAEALAREPGATGRARAADVLNGLRVRLARRLETSSLE
QASEQAALMIAGDRLLEQLDDYLEALDGIERFHRPRPTAARVSVPFHRDTSAAVQNGLRA
LLTVTMGGAFWLATGWTHGNLMLAGLAAACALLSTAPNPALGAVEFIKGTVAAVVMAGLC
RFGVLPQVSGLPLLLVVLSLFWLPGVYATTMPRHALAGVAYLVAFTTLAAADNTMHYDFA
LFLDSAVAWILATCFTLLGFRIVLPRNLARDARRLRQRIRDEALGTLRGELPDAKAWQWR
QQHRTAQLGALLRTQPEAMDRAVARALASIHLGREVLRLRRWQRRAPEDAQLHRVLVVAL
RHMRQRAADPARAARHARRAARSLSRLSRLSAAAAAETRRLGVVLLDIAALLEGHAEEAP
REAGGRAHAQ
>fig|983917.3.peg.2600 Glyoxalase/bleomycin resistance protein/dioxygenase
MPLAHVALWTRDLDASAAFWQRLFDATIAPPYRSERRPGFVSVFATLPGDALRLELMAAP
WLADAPAGDAVGWDHVAISLGDAAAVDALATLCASEGCLVSAPRRTGDGFYEAVIETPDG
TRVEVTA
>fig|983917.3.peg.3868 Permease of the drug/metabolite transporter (DMT) superfamily
MTTTAAPLAAAPGATAPTTPLLWPAVFILMWSTGYVAGKLGLPYAGPFTLLFLRFGVAAA
VLLVVALATRAPWPRTARQWLHVVVVGLLIQALQFSGLYAGLALGVSAGVSAVIVGLMPV
CTALGAVVFLGERIGLRQVIGLTLGLAGVALVVAHKLGGGGGVAGHLAVGLALLGITAGT
LYQKKFCAGMDLRSGGAIQLGASTLVVGVLGAWQEGLAVQWTPALVGASLWLSLVNSIGA
VSVMFVLLRRGEASRVASLFYLIPAVTAVMGYAVLGETLTVWQGVGVGVSAAGVYLATRR
E
>fig|983954.3.peg.3920 Permease of the drug/metabolite transporter (DMT) superfamily
MRTRVEFLLLALIWGASFALYRVAIPELGLPLTVGLRLALASMALLALFGWPLRDVAAGQ
RRRVSGWLLLTGAGSTALPFVLFAETVMRSSAGFAAVLNATSPLFSALLGVWVWREALSR
SKQLGLLLGFTGVALLAGLREVGGLKVGLDAVALGLIASASYGLCVQWVRRQLHDVHPSA
VATGISLVGALLLLPWALVSLPDQLPSWRPLLAVVVLGLLSTALANALYFRLIGRMGATQ
ALSVTFLIPPFAMLWGHLLFDERPTLAMLASTVIILVGTALSLGWRRTSVR
>fig|985867.6.peg.40 Permease of the drug/metabolite transporter (DMT) superfamily
MGAGLASLVLQSQAFFTVLFCVLVFKSRIRFNQVMGMLIAAAGMMLIGWKMQAQSSVLGF
SLIIAAAVSWGIVNILYRKVGQVDMFALTVWSSVVPPIPMLCLSLYCDGYEAVATCLTSM
SALGWICLAYTACISSWVATTLWAVLIRSYDPQRVAPFSMLVPVFGMGFASLFLDERLTL
LTGVAAILIFTGLIITQWRSKKIPRKVIIADAKTLPLPDLEHQKAA
>fig|985867.6.peg.198 Permease of the drug/metabolite transporter (DMT) superfamily
MTNIFTFLTTSLIWGTTWLAIKFQLGKVHPLWSVCYRFALAGIILLLYCYLRGLNLNYSL
RDHKWIALQALFLFSLNYFFYYCGTDYFVSGIVAVIFASVSILNIFNARIFLKTPLSKSA
ILGAVIGMAGLMRIFHNEIYRLMDQELQTIITGLGICLLGTALASLGQIIATANMRRSLP
YLQINAIGMSYGALYTGIGALVLGEWPTFDFTPKYIGSLLYLSIVGTVIAFGLYMKLVHN
IGPGKASYANILIPVIALTVSSYFEDFSWSVEMIYGVIMVVLGNVVVMVSKTLQSRRPKL
DIASPEEPRKAA
>fig|985867.6.peg.1206 Bicyclomycin resistance protein
MSMPPLSHKQLLVLPLILVLAIIVFEMSSDLYIPCLPEMSSFYGVQDHTIVMTISLYMIG
FSFMGLIGGALSDGLGRKSIFMLGLVIFTVGSIGTYFADSIEVLSLFRLIQGMGAGTSYV
ISTAMVKDIFPDHLCSRIFSLMGTAIALSPTIAPIIGGQISAVWGWRFNFTIILWAAVVT
LCACQIGLFETLKPDKRQPISFKATVNAYLALFSNLRVCGYALISGMTYGSLWAWIALAP
FFFIKSLGITAQEYGYYAMIGPISYMGGAFINQALVVKHGVDRLLRSGLAIITAGSLYLN
FSSFNNLSDQWGLISGLILFCIGLAPVFSNSATRCLDVPDHQRGAASAVLGLVEMVSAAA
YAYVASWLNDGTIRPATIMMGVSAAACILLYIWIQHSIKYTHNPS
>fig|985867.6.peg.1208 Multidrug resistance transporter, Bcr/CflA family
MSKISSPALWLLVFIVGLPQLSETVYSPALPQIAQALRVEENWVEFTLTIYLISFAVGTL
LWGYISDQYGRKPCLILGLAIYCLGCYGCYAASSIEWLMIARFIQALGGSTGSVLGQTIC
REAFSGAERGRVFATIGSALSLSPAIGPVVGGFISQSFGWSTIFLFLLGVGFLVLLACAK
KLPETNLHLGKKNVSIISVWKELLCDKMVMGFCCLVGLGNGITFSYYAEGSFFMIDMLGL
SPSQYGLTFILLACAGGIGGLLGRHLFKTLSAVQILQYGLLLILLGCIVLASSVFGLSVS
PSNMVMITLACMTVMMLGMSLATISSLSVALAKYQAVIGTASALFGFMYYAIISGVTFVM
GILHDDTLAPMPLLFLTLAVLMLIIYFIAIRQSESVKA
>fig|985867.6.peg.1657 Glyoxalase/bleomycin resistance protein/dioxygenase
MNTRPYKPDGIPALFPYLVVKDANKAIEFYKKAFGFTLSSDPAKDDNGKIQHVEMKFGQD
VWVMFAPEGCWDSPRRSPATLGVMCPLSLYIYCKDVDALYEQALANGATSTMKPKDGFWG
DRFCTLIDPDGYEWMFATNIADHKS
>fig|985867.6.peg.1868 Permeases of the drug/metabolite transporter (DMT) superfamily
MDVTERPASYSNHQSLLKSSYLKGILWFILSLIISNFNDLTMKFLGQNLPSIEIIFLRFL
FGTLSLIPFMIYFGKSSWKSERPLIHLARGSILFAALSLWCYGLKFVPIATVTVISFTIP
LFTLVLAYLFLHENVGWQRLAATILGFIGIIIVLGPTASDFPLMAFVLIGASLMFSVLDI
INKKFIVREGMLSMLFYSALITMILSAVPTYFMWQSPTPQQLGILALLGVGANLILFCIL
KAFAIIEASALSPFRYFELVVSVIFGFLVFGEIPSMITLLGTAVIIPSTFFIARYEYRQG
SKNK
>fig|985867.6.peg.1974 Drug resistance transporter
MTKDFKYLILIVAIFISAVIETDIYLPSFPDMMVFFNQSQPDIQKLLTWNFLGLCLSGPL
YGPLSDCYGRRKLLLLALIVFLLGSLITLWADSFTLMLLARVLQGLGSGGCFTLGTAIIF
DIFQKEKAIEALNKINMLVPFIMAAAPLLGGYLNAKYGFRANFAVIAVCVSISFSICLFF
LEETLPQNLRNKFEMRGILLNFLRVITNLEFVQLTTIISLVFAGFLLFLSSSALLFVADF
GVSKFHYPYYQFSLLLAYLGSSLSCTLFVKRKGIAFVKRLGLLSIFLGCSTLAGVTFWAP
KNPMSLTLAMLPYSCGFIWVQTPYVTELMALMPDIKGIVASLLTSLRLLITAGIIGLTAE
FYNATISPITIAITFISGLICLLSFSYEQSKAAKE
>fig|985867.6.peg.2111 Inner membrane component of tripartite multidrug resistance system
MTRAQANPWLIAAIASLATFMEVLDTTITNVSLKHISGALGAGEDESTWVLTSYLVSNGI
ILPLSGWLSDIVGRKRFFIGCILGFTATSFLCGAATSLPALIFFRVLQGLFGGGLQPTQQ
AIILDTFPIEKRGTVFAITGITIVIAPILGPTLGGLITDNFSWRWIFYINVPVGIMAAFL
VWQLIQESPSLRDTAAKVDIMGLGLVSLGLAALQIVLDKGQQEDWFASPFIITWALVCFA
ALGVAIIWLVGQKEPIIDLSLFENWAFASSCILIFLVGFVLYGTNVILPLMLQSYYGYDA
TLAGLVLSPGGLILLVLMPLCGKLIGKFQARFLIMIGFALSAAGMVHSMSFNPQTDFHTF
QWIRVAQVCGLPFLFISVSTLAFSTIPKEKSNKASALYALSRNIGGSVGIAVVTTYAVRQ
QQVHQNFLSEHLIPGHAPFENLLQKAVTVTRDMDQGMVKIYQMLQKQAALKAYIDTFELL
GYIMVALIVFTLVVLPANRPANQETPIGH
>fig|99598.3.peg.165 Glyoxalase/bleomycin resistance protein/dioxygenase
MNQPPILGNISPIIPAGEDIEKAILFYEQKLGFKTIHTEGKPVSMAIVKRDSAQIFLQNN
DDKHLAEGTKFLIQVTHIENLYAELLAKGEEIIHPNGHLATKPWGLKEITVIDSAGVCIT
FYEVAIS
>fig|99598.3.peg.1559 Fusaric acid resistance protein conserved region
MLLGKMALKTAIASAISFAIAQALRSEYPFYAVIAAIIVMASTHGSTLKLGMQRLIGTAI
GAISGAIFVITLGSNVWSLGVCVSITIFLTSYWQFNEAAKLAGYVSAIVILAHNQSPWLY
AWGRFLETLLGIGVALLVNNLFFPASAGSELRRCLSQTLVNLEQFYGLVVEGALTGTYDR
PTVDVLKTSIISSLIKGQELWKEVRQGRTNEPPETRVNEAWEFLIRRIWEHILTMEHTIL
AREQDTFWQILSPQITNLAQETQSTMLGLATAVKSQESYVSLPDIEIALTNATERLNRLP
EIKGENDPIDELLRFFTFFYTMEEVGRKLQRMAATLNQV
>fig|99598.3.peg.2599 Glyoxalase/bleomycin resistance protein/dioxygenase superfamily
MTLQAVHHIQVTYPPEAEDATHLFYSQVLGLTEIPRPEVIQNDPGVWYNLGSIELHLSQE
KNTNNHATRRHICFQVDHLQAYEEYLKAHGVEIIPDQLPIPGFKRFFLRDPAGNRIEITE
ITNNFPVKFTADDLSLNRPSAVVS
>fig|99598.3.peg.4487 Multidrug resistance transporter, Bcr/CflA family
MRFPAKMRIRPKSLGFTIFLGMLAALPPLSIDMGLPAFPTISASLNASSGSVGLTLSLFM
AGFAIAQLIFGPLSDRYGRKPILLIGCGLFALAGAACAVAPSINTLIAWRLVQGAGAGAG
MVLTLATVRDLFDGAAARAQLSYVNLVMSVAPMIAPTIGGWVLVLANWRAIYGVLALAGF
LLLLTVAFGLSESLAHPDLTALQPHRLFKNYTRILSNPICLGYALVNALNFGCMFAYVAG
SPLVMLQVFGVSTTTYGWLFASTAFGIMVGSFLNGRLSLRGVLPSRLLIVGLVTATISAV
ALVIVSVSGIAQVSTLMPLLILNTFCRGIISPNAMHGAIQPVPESAGVAAAVVGFLQMLG
GAVASGLVAFLYDGKTAIAMSSLMAIFAIASLAAYTVLARPAEHRLQLSK
